| date |
work |
doi |
| 2023-09-01 |
Kaempferol inhibits SARS-CoV-2 invasion by impairing heptad repeats-mediated viral fusion (edit) |
10.1016/J.PHYMED.2023.154942 |
| 2023-06-01 |
Head and neck reconstruction in the SARS-CoV-2 pandemic era: outcomes and lessons learned (edit) |
10.21037/FOMM-21-4 |
| 2023-06-01 |
Uptake and effectiveness of a mobile application for real-time reporting and quality assurance of decentralized SARS-CoV-2 testing in Uganda (edit) |
10.3389/FPUBH.2023.1053544 |
| 2023-05-31 |
Single-cell analysis of adult human heart across healthy and cardiovascular disease patients reveals the cellular landscape underlying SARS-CoV-2 invasion of myocardial tissue through ACE2 (edit) |
10.1186/S12967-023-04224-1 |
| 2023-05-18 |
Impact of peptide:HLA complex stability for the identification of SARS-CoV-2-specific CD8+T cells (edit) |
10.3389/FIMMU.2023.1151659 |
| 2023-05-08 |
Excess risk of SARS-CoV-2 infection among in-person nonhealthcare workers in six states, September 2020-June 2021 (edit) |
10.1002/AJIM.23487 |
| 2023-04-19 |
Seroprevalence and SARS-CoV-2 invasion in general populations: A scoping review over the first year of the pandemic (edit) |
10.1371/JOURNAL.PONE.0269104 |
| 2023-04-03 |
Oral Supplementation with AHCC, a Standardized Extract of Cultured Mycelia, Enhances Host Resistance against SARS-CoV-2 Infection (edit) |
10.3390/PATHOGENS12040554 |
| 2023-04-01 |
Novel bispecific human antibody platform specifically targeting a fully open spike conformation potently neutralizes multiple SARS-CoV-2 variants (edit) |
10.1016/J.ANTIVIRAL.2023.105576 |
| 2023-04-01 |
Lessons learned during COVID-19 pandemic, a worldwide survey: impact of SARS-CoV-2 vaccination on neurosurgeons and neurosurgical practice (edit) |
10.23736/S0390-5616.22.05885-4 |
| 2023-03-31 |
Molecular In-Depth on the Epidemiological Expansion of SARS-CoV-2 XBB.1.5 (edit) |
10.3390/MICROORGANISMS11040912 |
| 2023-03-27 |
Risk of death following COVID-19 vaccination or positive SARS-CoV-2 test in young people in England (edit) |
10.1038/S41467-023-36494-0 |
| 2023-03-23 |
New workflow predicts drug targets against SARS-CoV-2 via metabolic changes in infected cells (edit) |
10.1371/JOURNAL.PCBI.1010903 |
| 2023-03-20 |
An in-solution snapshot of SARS-COV-2 main protease maturation process and inhibition (edit) |
10.1038/S41467-023-37035-5 |
| 2023-03-17 |
A Novel Y-Shaped, S-O-N-O-S-Bridged Cross-Link between Three Residues C22, C44, and K61 Is Frequently Observed in the SARS-CoV-2 Main Protease (edit) |
10.1021/ACSCHEMBIO.2C00695 |
| 2023-03-17 |
SARS-CoV-2 Vaccines, Vaccine Development Technologies, and Significant Efforts in Vaccine Development during the Pandemic: The Lessons Learned Might Help to Fight against the Next Pandemic (edit) |
10.3390/VACCINES11030682 |
| 2023-03-17 |
Assessing suicidality during the SARS-CoV-2 pandemic: Lessons learned from adaptation and implementation of a telephone-based suicide risk assessment and response protocol in Malawi (edit) |
10.1371/JOURNAL.PONE.0281711 |
| 2023-03-17 |
Lessons learned from the SARS-CoV-2 pandemic; from nucleic acid nanomedicines, to clinical trials, herd immunity, and the vaccination divide (edit) |
10.1080/17425247.2023.2189697 |
| 2023-03-16 |
Links between Vitamin K, Ferroptosis and SARS-CoV-2 Infection (edit) |
10.3390/ANTIOX12030733 |
| 2023-03-14 |
SARS-CoV-2 receptor-binding domain deep mutational AlphaFold2 structures (edit) |
10.1038/S41597-023-02035-Z |
| 2023-03-12 |
Functional humoral and cellular response of monovalent COVID-19-vaccines against Omicron BA.2 variant of SARS-CoV-2 in patients with chronic lymphocytic leukemia (edit) |
10.1080/10428194.2023.2183730 |
| 2023-03-11 |
Lack of SARS-CoV-2 RNA evidence in the lungs from wild European polecats (Mustela putorius) from Spain (edit) |
10.1007/S10344-023-01662-6 |
| 2023-03-09 |
Occupational risk factors for SARS-CoV-2 seropositivity in healthcare workers: results of a longitudinal cohort (edit) |
10.1097/JOM.0000000000002831 |
| 2023-03-08 |
The interactions of SARS-CoV-2 with cocirculating pathogens: Epidemiological implications and current knowledge gaps (edit) |
10.1371/JOURNAL.PPAT.1011167 |
| 2023-03-04 |
Transmission of SARS-CoV-2 in the workplace: key findings from a rapid review of the literature (edit) |
10.1080/02786826.2023.2166394 |
| 2023-03-03 |
Could the lake ecosystems influence the pathogenicity of the SARS-COV-2 in the air? (edit) |
10.18388/ABP.2020_6514 |
| 2023-03-02 |
Managing the Next Wave of Influenza and/or SARS-CoV-2 in the ICU—Practical Recommendations from an Expert Group for CAPA/IAPA Patients (edit) |
10.3390/JOF9030312 |
| 2023-03-01 |
Sensitivity of wastewater surveillance: What is the minimum COVID-19 cases required in population for SARS-CoV-2 RNA to be detected in wastewater? (edit) |
10.1016/J.JES.2022.08.020 |
| 2023-03-01 |
Extreme value modelling of SARS-CoV-2 community transmission using discrete generalized Pareto distributions (edit) |
10.1098/RSOS.220977 |
| 2023-03-01 |
Extreme differences in SARS-CoV-2 viral loads among respiratory specimen types during presumed pre-infectious and infectious periods (edit) |
10.1093/PNASNEXUS/PGAD033 |
| 2023-03-01 |
Evolution of increased positive charge on the SARS-CoV-2 spike protein may be adaptation to human transmission (edit) |
10.1016/J.ISCI.2023.106230 |
| 2023-03-01 |
Development of a rapid and ultra-sensitive RNA:DNA hybrid immunocapture based biosensor for visual detection of SARS-CoV-2 RNA (edit) |
10.1093/PNASNEXUS/PGAD031 |
| 2023-02-28 |
Hydroxychloroquine to prevent SARS-CoV-2 infection among healthcare workers: early termination of a phase 3, randomised, open-label, controlled clinical trial (edit) |
10.1186/S13104-023-06281-7 |
| 2023-02-27 |
Temporal distribution and clinical characteristics of the Alpha, Delta and Omicron SARS-CoV-2 variants of concern in Laikipia, Kenya: institutional and community-based genomic surveillance (edit) |
10.12688/WELLCOMEOPENRES.18306.2 |
| 2023-02-24 |
SARS-CoV-2 Omicron variant of concern in the Seychelles: Introduction and spread (edit) |
10.12688/WELLCOMEOPENRES.18908.1 |
| 2023-02-23 |
SARS-CoV-2 Main Protease Targets Host Selenoproteins and Glutathione Biosynthesis for Knockdown via Proteolysis, Potentially Disrupting the Thioredoxin and Glutaredoxin Redox Cycles (edit) |
10.3390/ANTIOX12030559 |
| 2023-02-22 |
Effectiveness of BNT162b2 and ChAdOx1 against SARS-CoV-2 household transmission: a prospective cohort study in England (edit) |
10.12688/WELLCOMEOPENRES.17995.1 |
| 2023-02-21 |
SARS-CoV-2 antibody prevalence among industrial livestock operation workers and nearby community residents, North Carolina, 2021 to 2022 (edit) |
10.1128/MSPHERE.00522-22 |
| 2023-02-16 |
Optimized workplace risk mitigation measures for SARS-CoV-2 in 2022 (edit) |
10.1038/S41598-023-29087-W |
| 2023-02-15 |
Performance of a SARS-CoV-2 RT-PCR Assay with Non-Traditional Specimen Types (edit) |
10.55504/2473-2869.1260 |
| 2023-02-13 |
Performance of the GeneSoC Rapid PCR System in Detection of SARS-CoV-2 from Saliva Specimens (edit) |
10.1128/SPECTRUM.03259-22 |
| 2023-02-09 |
Accurate Detection of SARS-CoV-2 by Next-Generation Sequencing in Low Viral Load Specimens (edit) |
10.3390/IJMS24043478 |
| 2023-02-08 |
Clinical Validation of GenBody COVID-19 Ag, Nasal and Nasopharyngeal Rapid Antigen Tests for Detection of SARS-CoV-2 in European Adult Population (edit) |
10.3390/BIOMEDICINES11020493 |
| 2023-02-02 |
Proteomic Analysis of Mucosal and Systemic Responses to SARS-CoV-2 Antigen (edit) |
10.3390/VACCINES11020334 |
| 2023-02-01 |
Global asymptotic stability, extinction and ergodic stationary distribution in a stochastic model for dual variants of SARS-CoV-2 (edit) |
10.1016/J.MATCOM.2022.08.012 |
| 2023-02-01 |
Inactivation of two SARS-CoV-2 virus surrogates by electron beam irradiation on large yellow croaker slices and their packaging surfaces (edit) |
10.1016/J.FOODCONT.2022.109340 |
| 2023-02-01 |
Co-testing a single sputum specimen for TB and SARS-CoV-2 (edit) |
10.5588/IJTLD.22.0404 |
| 2023-02-01 |
Indicators of Cardiometabolic Function in Pregnancy and Long-Term Risk of COVID-19: Population-Based Cohort Study (edit) |
10.7759/CUREUS.35325 |
| 2023-02-01 |
Lessons Learned from COVID-19 Pandemic: Outcomes after Sars-Cov-2 Infection in Hematopoietic Cell Transplant and Cell Therapy Recipients (edit) |
10.1016/S2666-6367(23)00500-6 |
| 2023-01-31 |
Reconocimiento de la presencia de sars-cov-2 en pulmones a través de imágenes de radiodiagnóstico haciendo uso de Machine Learning con Python (edit) |
10.56712/LATAM.V4I1.296 |
| 2023-01-30 |
Performance Evaluation of Different RT-PCR Kits for the Direct Detection of SARS-CoV-2 in Preheated Specimens (edit) |
10.1055/S-0043-1760752 |
| 2023-01-26 |
Exposed seronegative: Cellular immune responses to SARS-CoV-2 in the absence of seroconversion (edit) |
10.3389/FIMMU.2023.1092910 |
| 2023-01-25 |
Remdesivir Influence on SARS-CoV-2 RNA Viral Load Kinetics in Nasopharyngeal Swab Specimens of COVID-19 Hospitalized Patients: A Real-Life Experience (edit) |
10.3390/MICROORGANISMS11020312 |
| 2023-01-24 |
PCSK9 Inhibition During the Inflammatory Stage of SARS-CoV-2 Infection (edit) |
10.1016/J.JACC.2022.10.030 |
| 2023-01-13 |
Booster Vaccination Against SARS-CoV-2 Induces Potent Immune Responses in People With Human Immunodeficiency Virus (edit) |
10.1093/CID/CIAC796 |
| 2023-01-07 |
Anti-SARS-CoV-2 IgG ELISA: Replacing the Absorbance Plate Reader by a Regular Scanner with Open-Source Software (edit) |
10.3390/PR11010194 |
| 2023-01-06 |
Patient Care Satisfaction and Emergency Room Utilization among Young Adult Colorectal Cancer Survivors during the SARS-CoV-2 Pandemic: Lessons Learned (edit) |
10.3390/JCM12020469 |
| 2023-01-03 |
Assessment of a SARS-CoV-2 wastewater monitoring program in El Paso, Texas, from November 2020 to June 2022 (edit) |
10.1080/09603123.2022.2159017 |
| 2023-01-02 |
Infectiousness of SARS-CoV-2 breakthrough infections and reinfections during the Omicron wave (edit) |
10.1038/S41591-022-02138-X |
| 2023-01-01 |
SARS-CoV-2 getting into the brain; neurological phenotype of COVID-19, and management by nano-biotechnology (edit) |
10.4103/1673-5374.346486 |
| 2023-01-01 |
Audiological and vestibular symptoms following SARS-CoV-2 infection and COVID-19 vaccination in children aged 5–11 years (edit) |
10.1016/J.AMJOTO.2022.103669 |
| 2023-01-01 |
Postmortem detectability and viability of SARS-COV-2 virus in various biological specimens (edit) |
10.2298/SARH220118014P |
| 2023-01-01 |
PS-C16-11: PREVALENCE AND HOSPITAL OUTCOME OF BACTERIAL CO-INFECTION IN RESPIRATORY TRACT SPECIMEN AMONG COVID 19 PATIENTS WITH SARS-COV-2 PNEUMONIA (edit) |
10.1097/01.HJH.0000915116.70234.A3 |
| 2023-01-01 |
Detailed characterization of SARS-CoV-2-specific T and B cells after infection or heterologous vaccination (edit) |
10.3389/FIMMU.2023.1123724 |
| 2023-01-01 |
One Health investigation of SARS-CoV-2 in people and animals on multiple mink farms in Utah (edit) |
10.3390/V15010096 |
| 2022-12-29 |
LARGE-SCALE SCREENING FOR SARS-COV-2 INFECTION IN ENT PATIENTS DURING THE COVID-19 PANDEMIC (edit) |
10.17430/JHS.2022.12.4.3 |
| 2022-12-23 |
Rapid Detection of SARS-CoV-2 RNA in Human Nasopharyngeal Specimens Using Surface-Enhanced Raman Spectroscopy and Deep Learning Algorithms (edit) |
10.1021/ACSSENSORS.2C02194 |
| 2022-12-22 |
The presence of SARS-CoV-2 in multiple clinical specimens of a fatal case of COVID-19: a case report (edit) |
10.1186/S13256-022-03706-Y |
| 2022-12-21 |
Limited Impact of SARS-CoV-2 on the Human Naso-Oropharyngeal Microbiota in Hospitalized Patients (edit) |
10.1128/SPECTRUM.02196-22 |
| 2022-12-14 |
SARS-CoV-2 infection and persistence in the human body and brain at autopsy (edit) |
10.1038/S41586-022-05542-Y |
| 2022-12-12 |
SARS-CoV-2 Omicron (B.1.1.529) Infection of Wild White-Tailed Deer in New York City (edit) |
10.3390/V14122770 |
| 2022-12-12 |
Determinants of the Level of Anti-SARS-CoV-2 IgG ANTibodiEs after Vaccination (DANTE-SIRIO 7) Study in a Large Cohort of Healthcare Workers (edit) |
10.3390/VACCINES10122125 |
| 2022-12-12 |
Ocular tropism of SARS-CoV-2 in animal models with retinal inflammation via neuronal invasion following intranasal inoculation (edit) |
10.1038/S41467-022-35225-1 |
| 2022-12-03 |
Genetic and Structural Data on the SARS-CoV-2 Omicron BQ.1 Variant Reveal Its Low Potential for Epidemiological Expansion (edit) |
10.3390/IJMS232315264 |
| 2022-12-02 |
RETRACTED: Gradual emergence followed by exponential spread of the SARS-CoV-2 Omicron variant in Africa (edit) |
10.1126/SCIENCE.ADD8737 |
| 2022-12-01 |
ABO blood group is involved in the quality of the specific immune response anti-SARS-CoV-2 (edit) |
10.1080/21505594.2021.2019959 |
| 2022-12-01 |
Omicron variant showed lower neutralizing sensitivity than other SARS-CoV-2 variants to immune sera elicited by vaccines after boost (edit) |
10.1080/22221751.2021.2022440 |
| 2022-12-01 |
Folic acid: a potential inhibitor against SARS-CoV-2 nucleocapsid protein (edit) |
10.1080/13880209.2022.2063341 |
| 2022-12-01 |
Analysis of SARS-CoV-2 variants B.1.617: host tropism, proteolytic activation, cell-cell fusion, and neutralization sensitivity (edit) |
10.1080/22221751.2022.2054369 |
| 2022-12-01 |
Reduced sensitivity of the SARS-CoV-2 Lambda variant to monoclonal antibodies and neutralizing antibodies induced by infection and vaccination (edit) |
10.1080/22221751.2021.2008775 |
| 2022-12-01 |
A monoclonal antibody that neutralizes SARS-CoV-2 variants, SARS-CoV, and other sarbecoviruses (edit) |
10.1080/22221751.2021.2011623 |
| 2022-12-01 |
Identification of circulating microRNA profiles associated with pulmonary function and radiologic features in survivors of SARS-CoV-2-induced ARDS (edit) |
10.1080/22221751.2022.2081615 |
| 2022-12-01 |
Drastic decline in sera neutralization against SARS-CoV-2 Omicron variant in Wuhan COVID-19 convalescents (edit) |
10.1080/22221751.2022.2031311 |
| 2022-12-01 |
A year living with SARS-CoV-2: an epidemiological overview of viral lineage circulation by whole-genome sequencing in Barcelona city (Catalonia, Spain) (edit) |
10.1080/22221751.2021.2011617 |
| 2022-12-01 |
Highly valued despite burdens: Qualitative implementation research on rapid tests for hospital-based SARS-CoV-2 screening (edit) |
10.1016/J.SSMQR.2022.100140 |
| 2022-12-01 |
A standardized instrument quantifying risk factors associated with bi-directional transmission of SARS-CoV-2 and other zoonotic pathogens: The COVID-19 human-animal interactions survey (CHAIS) (edit) |
10.1016/J.ONEHLT.2022.100422 |
| 2022-12-01 |
Beyond COVID-19: Do biothermodynamic properties allow predicting the future evolution of SARS-CoV-2 variants? (edit) |
10.1016/J.MRAN.2022.100232 |
| 2022-12-01 |
Heterologous Prime-boost of SARS-CoV-2 inactivated vaccine and mRNA BNT162b2 among Healthy Thai Adolescents (edit) |
10.1016/J.JVACX.2022.100211 |
| 2022-12-01 |
Computational investigation of potent inhibitors against SARS-CoV-2 2′-O-methyltransferase (nsp16): Structure-based pharmacophore modeling, molecular docking, molecular dynamics simulations and binding free energy calculations (edit) |
10.1016/J.JMGM.2022.108306 |
| 2022-12-01 |
Impact of SARS-CoV-2 variants on mobility and air pollution in the United Kingdom (edit) |
10.1016/J.SCITOTENV.2022.158279 |
| 2022-12-01 |
Is the virus-laden standing water change the transmission intensity of SARS-CoV-2 after precipitation? A framework for empirical studies (edit) |
10.1016/J.ENVRES.2022.114127 |
| 2022-12-01 |
Evaluation of SARS-CoV-2 concentrations in wastewater and river water samples (edit) |
10.1016/J.CSCEE.2022.100214 |
| 2022-12-01 |
Impedimetric and amperometric genosensors for the highly sensitive quantification of SARS-CoV-2 nucleic acid using an avidin-functionalized multi-walled carbon nanotubes biocapture platform (edit) |
10.1016/J.BIOSX.2022.100222 |
| 2022-12-01 |
Zonal modeling of air distribution impact on the long-range airborne transmission risk of SARS-CoV-2 (edit) |
10.1016/J.APM.2022.08.027 |
| 2022-12-01 |
Application of a high-throughput quantitative PCR system for simultaneous monitoring of SARS-CoV-2 variants and other pathogenic viruses in wastewater (edit) |
10.1016/J.SCITOTENV.2022.158659 |
| 2022-12-01 |
Protocol to quantify and phenotype SARS-CoV-2-specific T cell response using a rapid flow-cytometry-based whole blood assay (edit) |
10.1016/J.XPRO.2022.101771 |
| 2022-12-01 |
Fractal–fractional age-structure study of omicron SARS-CoV-2 variant transmission dynamics (edit) |
10.1016/J.PADIFF.2022.100455 |
| 2022-12-01 |
Comparison of Dose–Response Relationships for Two Isolates of SARS-CoV-2 in a Nonhuman Primate Model of Inhalational COVID-19 (edit) |
10.1089/JAMP.2022.0043 |
| 2022-12-01 |
1880. Detection of Infectious SARS-CoV-2 in Specimens with High CT Values Is More Common for Omicron than for Delta Variants (edit) |
10.1093/OFID/OFAC492.1507 |
| 2022-12-01 |
Next-Day Discharge after Kidney Transplant During the SARS-CoV-2 Pandemic (edit) |
10.6002/ECT.2021.0309 |
| 2022-12-01 |
The role of antigen availability during B cell induction and its effect on sustained memory and antibody production after infection and vaccination—lessons learned from the SARS-CoV-2 pandemic (edit) |
10.1093/CEI/UXAC113 |
| 2022-11-30 |
Detection of Respiratory Viruses in SARS-CoV-2-Negative Specimens from January to March 2020 in Fukuoka, Japan (edit) |
10.7883/YOKEN.JJID.2022.079 |
| 2022-11-30 |
Inflammatory responses in SARS-CoV-2 associated Multisystem Inflammatory Syndrome and Kawasaki Disease in children: An observational study (edit) |
10.1371/JOURNAL.PONE.0266336 |
| 2022-11-26 |
Optimal control strategies of SARS-CoV-2 Omicron supported by invasive and dynamic models (edit) |
10.1186/S40249-022-01039-Y |
| 2022-11-26 |
Pathological Evidence for Residual SARS-CoV-2 in the Micrometastatic Niche of a Patient with Ovarian Cancer (edit) |
10.3390/CIMB44120400 |
| 2022-11-23 |
Variation in the ACE2 receptor has limited utility for SARS-CoV-2 host prediction (edit) |
10.7554/ELIFE.80329 |
| 2022-11-18 |
Long-term Follow-up Results of Tinnitus and Dizziness Disorders in Patients after SARS-CoV-2 Infection Based on a Questionnaire (edit) |
10.4274/BALKANMEDJ.GALENOS.2022.2022-7-8 |
| 2022-11-18 |
Perception of Local COVID-19 Transmission and Use of Preventive Behaviors Among Adults with Recent SARS-CoV-2 Infection - Illinois and Michigan, June 1-July 31, 2022 (edit) |
10.15585/MMWR.MM7146A2 |
| 2022-11-18 |
Diagnosis of SARS-CoV-2 during the Pandemic by Multiplex RT-rPCR hCoV Test: Future Perspectives (edit) |
10.3390/PATHOGENS11111378 |
| 2022-11-15 |
Lessons Learned from COVID-19 Pandemic: Outcomes after Sars-Cov-2 Infection in Hematopoietic Cell Transplant and Cell Therapy Recipients (edit) |
10.1182/BLOOD-2022-158716 |
| 2022-11-12 |
Post-Viral Olfactory Loss: What We Learned from the SARS-CoV-2 Pandemic (edit) |
10.3390/LIFE12111868 |
| 2022-11-11 |
Imprinted antibody responses against SARS-CoV-2 Omicron sublineages (edit) |
10.1126/SCIENCE.ADC9127 |
| 2022-11-10 |
Functional Expression of the Recombinant Spike Receptor Binding Domain of SARS-CoV-2 Omicron in the Periplasm of Escherichia coli (edit) |
10.3390/BIOENGINEERING9110670 |
| 2022-11-03 |
Covid-19 vaccination programme effectiveness against SARS-CoV-2 related infections, hospital admissions and deaths in the Apulia region of Italy: a one-year retrospective cohort study (edit) |
10.1038/S41598-022-23235-4 |
| 2022-11-03 |
Retrospective analysis of SARS-CoV-2 omicron invasion over delta in French regions in 2021–22: a status-based multi-variant model (edit) |
10.1186/S12879-022-07821-5 |
| 2022-11-02 |
Characterizing altruistic motivation in potential volunteers for SARS-CoV-2 challenge trials (edit) |
10.1371/JOURNAL.PONE.0275823 |
| 2022-11-01 |
Cardiovascular symptom phenotypes of post-acute sequelae of SARS-CoV-2 (edit) |
10.1016/J.IJCARD.2022.07.018 |
| 2022-11-01 |
Bioinformatics pipeline unveils genetic variability to synthetic vaccine design for Indian SARS-CoV-2 genomes (edit) |
10.1016/J.INTIMP.2022.109224 |
| 2022-11-01 |
“Ventilator-free days” composite outcome in patients with SARS-CoV-2 infection treated with tocilizumab: A retrospective competing risk analysis (edit) |
10.1016/J.HRTLNG.2022.06.024 |
| 2022-11-01 |
Carlina oxide inhibits the interaction of SARS-CoV-2 S glycoprotein with angiotensin-converting enzyme 2 (edit) |
10.1016/J.INDCROP.2022.115338 |
| 2022-11-01 |
Early identification of high-risk individuals for monoclonal antibody therapy and prophylaxis is feasible by SARS-CoV-2 anti-spike antibody specific lateral flow assay (edit) |
10.1016/J.DIAGMICROBIO.2022.115788 |
| 2022-11-01 |
Hotspot residues and resistance mutations in the nirmatrelvir-binding site of SARS-CoV-2 main protease: Design, identification, and correlation with globally circulating viral genomes (edit) |
10.1016/J.BBRC.2022.09.010 |
| 2022-11-01 |
Macro-level drivers of SARS-CoV-2 transmission: A data-driven analysis of factors contributing to epidemic growth during the first wave of outbreaks in the United States (edit) |
10.1016/J.SSTE.2022.100539 |
| 2022-11-01 |
Exploring the anti-SARS-CoV-2 main protease potential of FDA approved marine drugs using integrated machine learning templates as predictive tools (edit) |
10.1016/J.IJBIOMAC.2022.09.086 |
| 2022-11-01 |
Positivization time of a COVID-19 rapid antigen self-test predicts SARS-CoV-2 viral load: a proof of concept (edit) |
10.1515/CCLM-2022-0873 |
| 2022-11-01 |
Antibody correlates of protection from SARS-CoV-2 reinfection prior to vaccination: A nested case-control within the SIREN study (edit) |
10.1016/J.JINF.2022.09.004 |
| 2022-11-01 |
Virus replication and competition in a cell culture: Application to the SARS-CoV-2 variants (edit) |
10.1016/J.AML.2022.108217 |
| 2022-11-01 |
The Assessment of the Diagnostic Accuracy of Antigen-Detecting Rapid Diagnostic Test using Nasopharyngeal Swab Specimen in Detecting SARS-CoV-2 among Patients in a Private Hospital in Bulacan, Philippines (edit) |
10.1093/AJCP/AQAC126.302 |
| 2022-11-01 |
Identification of hACE2-interacting sites in SARS-CoV-2 spike receptor binding domain for antiviral drugs screening (edit) |
10.1016/J.VIRUSRES.2022.198915 |
| 2022-11-01 |
The Absence of Permanent Sensorineural Hearing Loss in a Cohort of Children with SARS-CoV-2 Infection and the Importance of Performing the Audiological “Work-Up” (edit) |
10.3390/CHILDREN9111681 |
| 2022-10-31 |
Characterizing Longitudinal Antibody Responses in Recovered Individuals Following COVID-19 Infection and Single-Dose Vaccination: A Prospective Cohort Study (edit) |
10.3390/V14112416 |
| 2022-10-29 |
Rapid Identification of SARS-CoV-2 Omicron BA.5 Spike Mutation F486V in Clinical Specimens Using a High-Resolution Melting-Based Assay (edit) |
10.3390/V14112401 |
| 2022-10-27 |
Infection with SARS-CoV-2 Variants Is Associated with Different Long COVID Phenotypes (edit) |
10.3390/V14112367 |
| 2022-10-27 |
Air travel and SARS-CoV-2: many remaining knowledge gaps (edit) |
10.1093/JTM/TAAC123 |
| 2022-10-27 |
Managing Complexity: The Experience of an Italian Internal Medicine Unit During the SARS-CoV-2 Pandemic, Looking to the Future (edit) |
10.1007/S42399-022-01320-Z |
| 2022-10-26 |
A pseudovirus-based platform to measure neutralizing antibodies in Mexico using SARS-CoV-2 as proof-of-concept (edit) |
10.1038/S41598-022-22921-7 |
| 2022-10-26 |
Correlation of SARS-CoV-2 Viral Neutralizing Antibody Titers with Anti-Spike Antibodies and ACE-2 Inhibition among Vaccinated Individuals (edit) |
10.1128/SPECTRUM.01315-22 |
| 2022-10-26 |
Erratum for Nikiforuk et al., "Performance of Immunoglobulin G Serology on Finger Prick Capillary Dried Blood Spot Samples to Detect a SARS-CoV-2 Antibody Response" (edit) |
10.1128/SPECTRUM.03376-22 |
| 2022-10-26 |
SARS-CoV-2: Searching for the Missing Variants (edit) |
10.3390/V14112364 |
| 2022-10-25 |
A Timeframe for SARS-CoV-2 Genomes: A Proof of Concept for Postmortem Interval Estimations (edit) |
10.3390/IJMS232112899 |
| 2022-10-24 |
SARS-CoV-2 Is Not Special, but the Pandemic Is: The Ecology, Evolution, Policy, and Future of the Deadliest Pandemic in Living Memory (edit) |
10.1146/ANNUREV-ANTHRO-041420-100047 |
| 2022-10-22 |
Targeting an evolutionarily conserved “E-L-L” motif in spike protein to identify a small molecule fusion inhibitor against SARS-CoV-2 (edit) |
10.1093/PNASNEXUS/PGAC198 |
| 2022-10-21 |
Erratum for the Research Article “Structural basis of ribosomal frameshifting during translation of the SARS-CoV-2 RNA genome,” by P. R. Bhatt et al (edit) |
10.1126/SCIENCE.ADF3953 |
| 2022-10-20 |
Lack of evidence of viability and infectivity of SARS-CoV-2 in the fecal specimens of COVID-19 patients (edit) |
10.3389/FPUBH.2022.1030249 |
| 2022-10-15 |
Lipidomics Revealed Plasma Phospholipid Profile Differences between Deceased and Recovered COVID-19 Patients (edit) |
10.3390/BIOM12101488 |
| 2022-10-15 |
Discriminating cross-reactivity in polyclonal IgG1 responses against SARS-CoV-2 variants of concern (edit) |
10.1038/S41467-022-33899-1 |
| 2022-10-12 |
Clinical phenotypes and outcomes associated with SARS-CoV-2 variant Omicron in critically ill French patients with COVID-19 (edit) |
10.1038/S41467-022-33801-Z |
| 2022-10-12 |
SARS-CoV-2 placentitis, stillbirth, and maternal COVID-19 vaccination: clinical-pathologic correlations (edit) |
10.1016/J.AJOG.2022.10.001 |
| 2022-10-11 |
Association of Primary and Booster Vaccination and Prior Infection With SARS-CoV-2 Infection and Severe COVID-19 Outcomes (edit) |
10.1001/JAMA.2022.17876 |
| 2022-10-10 |
Dysphagia in the Presence of Varicella-Zoster Virus and SARS-CoV-2: A Case Report on the Role of Speech-Language Pathology (edit) |
10.1044/2022_PERSP-22-00070 |
| 2022-10-10 |
Occupational characteristics associated with SARS-CoV-2 infection in the UK Biobank during August-November 2020: a cohort study (edit) |
10.1186/S12889-022-14311-5 |
| 2022-10-10 |
Lifestyle changes during the SARS-CoV-2 pandemic confinement in Europe: a systematic review (edit) |
10.53519/ANALESRANF.2022.88.03.03 |
| 2022-10-07 |
The spike gene is a major determinant for the SARS-CoV-2 Omicron-BA.1 phenotype (edit) |
10.1038/S41467-022-33632-Y |
| 2022-10-06 |
Risk assessment for long- and short-range airborne transmission of SARS-CoV-2, indoors and outdoors (edit) |
10.1093/PNASNEXUS/PGAC223 |
| 2022-10-05 |
Diversified Effects of COVID-19 as a Consequence of the Differential Metabolism of Phospholipids and Lipid Peroxidation Evaluated in the Plasma of Survivors and Deceased Patients upon Admission to the Hospital (edit) |
10.3390/IJMS231911810 |
| 2022-10-04 |
Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution (edit) |
10.1101/2022.09.15.507787 |
| 2022-10-04 |
Evidence for the heterologous benefits of prior BCG vaccination on COVISHIELD™ vaccine-induced immune responses in SARS-CoV-2 seronegative young Indian adults (edit) |
10.3389/FIMMU.2022.985938 |
| 2022-10-01 |
Eco-friendly stability-indicating HPTLC micro-determination of the first FDA approved SARS-CoV-2 antiviral prodrug Remdesivir: Study of degradation kinetics and structural elucidation of the degradants using HPTLC-MS (edit) |
10.1016/J.SCP.2022.100744 |
| 2022-10-01 |
Wastewater-based epidemiology in countries with poor wastewater treatment — Epidemiological indicator function of SARS-CoV-2 RNA in surface waters (edit) |
10.1016/J.SCITOTENV.2022.156964 |
| 2022-10-01 |
Docking and molecular dynamics studies of human ezrin protein with a modelled SARS-CoV-2 endodomain and their interaction with potential invasion inhibitors (edit) |
10.1016/J.JKSUS.2022.102277 |
| 2022-10-01 |
Comment to the article by Pedro Brotons: Validation and implementation of a direct RT-qPCR method for rapid screening of SARS-CoV-2 infection by using non-invasive saliva samples, IJID 110 (2021) 363–370 (edit) |
10.1016/J.IJID.2022.08.005 |
| 2022-10-01 |
Nanosponges: An overlooked promising strategy to combat SARS-CoV-2 (edit) |
10.1016/J.DRUDIS.2022.07.015 |
| 2022-10-01 |
Single-particle detection of native SARS-CoV-2 virions by microfluidic resistive pulse sensing (edit) |
10.1016/J.COLSURFB.2022.112716 |
| 2022-10-01 |
Native, engineered and de novo designed ligands targeting the SARS-CoV-2 spike protein (edit) |
10.1016/J.BIOTECHADV.2022.107986 |
| 2022-10-01 |
Thromboembolic events in deceased patients with proven SARS-CoV-2 infection: Frequency, characteristics and risk factors (edit) |
10.1016/J.THROMRES.2022.08.021 |
| 2022-10-01 |
Preexisting anti-PF4 antibodies are not further triggered upon vaccination with SARS-CoV-2 vector vaccines in a cohort of 400 health care workers (edit) |
10.1016/J.THROMRES.2022.08.005 |
| 2022-10-01 |
SARS-CoV-2 vaccination in haemodialysis patients: Insides from a prospective study comparing mRNA and viral vector vaccines (edit) |
10.1016/J.LANEPE.2022.100491 |
| 2022-10-01 |
SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis (edit) |
10.1016/J.JAUT.2022.102906 |
| 2022-10-01 |
Immediate need for next-generation and mutation-proof vaccine to protect against current emerging Omicron sublineages and future SARS-CoV-2 variants: An urgent call for researchers and vaccine companies – Correspondence (edit) |
10.1016/J.IJSU.2022.106903 |
| 2022-10-01 |
Good and bad get together: Inactivation of SARS-CoV-2 in particulate matter pollution from different fuels (edit) |
10.1016/J.SCITOTENV.2022.157241 |
| 2022-10-01 |
Genetic sequencing detected the SARS-CoV-2 delta variant in wastewater a month prior to the first COVID-19 case in Ahmedabad (India) (edit) |
10.1016/J.ENVPOL.2022.119757 |
| 2022-10-01 |
Wastewater-based epidemiological surveillance to monitor the prevalence of SARS-CoV-2 in developing countries with onsite sanitation facilities (edit) |
10.1016/J.ENVPOL.2022.119679 |
| 2022-10-01 |
Association between long-term exposure to particulate air pollution with SARS-CoV-2 infections and COVID-19 deaths in California, U.S.A (edit) |
10.1016/J.ENVADV.2022.100270 |
| 2022-10-01 |
Molecular dynamics simulations highlight the altered binding landscape at the spike-ACE2 interface between the Delta and Omicron variants compared to the SARS-CoV-2 original strain (edit) |
10.1016/J.COMPBIOMED.2022.106035 |
| 2022-10-01 |
Predicting COVID-19 disease severity from SARS-CoV-2 spike protein sequence by mixed effects machine learning (edit) |
10.1016/J.COMPBIOMED.2022.105969 |
| 2022-10-01 |
Persistence of SARS-CoV-2 on surfaces and relevance to the food industry (edit) |
10.1016/J.COFS.2022.100875 |
| 2022-10-01 |
A geometric deep learning model for display and prediction of potential drug-virus interactions against SARS-CoV-2 (edit) |
10.1016/J.CHEMOLAB.2022.104640 |
| 2022-10-01 |
A fast, ultrasensitive SERS immunoassay to detect SARS-CoV-2 in saliva (edit) |
10.1016/J.ACA.2022.340290 |
| 2022-10-01 |
Tailored lipopeptide surfactants as potentially effective drugs to treat SARS-CoV-2 infection (edit) |
10.1016/J.MEHY.2022.110948 |
| 2022-10-01 |
Cerebral microvascular complications associated with SARS-CoV-2 infection: How did it occur and how should it be treated? (edit) |
10.1016/J.BIOPHA.2022.113534 |
| 2022-10-01 |
Ethics and governance challenges related to genomic data sharing in southern Africa: the case of SARS-CoV-2 (edit) |
10.1016/S2214-109X(22)00417-X |
| 2022-10-01 |
Reported exposures among in-person workers with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in 6 states, September 2020-June 2021 (edit) |
10.1093/CID/CIAC486 |
| 2022-10-01 |
GPS tracking of free-roaming cats (Felis catus) on SARS-CoV-2-infected mink farms in Utah (edit) |
10.3390/V14102131 |
| 2022-10-01 |
Detecting time-evolving phenotypic components of adverse reactions against BNT162b2 SARS-CoV-2 vaccine via non-negative tensor factorization (edit) |
10.1016/J.ISCI.2022.105237 |
| 2022-10-01 |
The effect of Omicron breakthrough infection and extended BNT162b2 booster dosing on neutralization breadth against SARS-CoV-2 variants of concern (edit) |
10.1371/JOURNAL.PPAT.1010882 |
| 2022-10-01 |
Functional immune responses against SARS-CoV-2 variants of concern after fourth COVID-19 vaccine dose or infection in patients with blood cancer (edit) |
10.1016/J.XCRM.2022.100781 |
| 2022-09-30 |
Evaluation of Free Light Chains (FLCs) Synthesis in Response to Exposure to SARS-CoV-2 (edit) |
10.3390/IJMS231911589 |
| 2022-09-26 |
High-yield production in Escherichia coli and convenient purification of a candidate vaccine against SARS-CoV-2 (edit) |
10.1007/S10529-022-03298-Z |
| 2022-09-24 |
Sustained Delivery of a Monoclonal Antibody against SARS-CoV-2 by Microencapsulated Cells: A Proof-of-Concept Study (edit) |
10.3390/PHARMACEUTICS14102042 |
| 2022-09-22 |
An ACE2-dependent Sarbecovirus in Russian bats is resistant to SARS-CoV-2 vaccines (edit) |
10.1371/JOURNAL.PPAT.1010828 |
| 2022-09-21 |
Considerations regarding Interpretation of Positive SARS-CoV-2 Molecular Results with Late Cycle Threshold Values (edit) |
10.1128/JCM.00501-22 |
| 2022-09-20 |
Baculovirus-Free SARS-CoV-2 Virus-like Particle Production in Insect Cells for Rapid Neutralization Assessment (edit) |
10.3390/V14102087 |
| 2022-09-20 |
Understanding and combating COVID-19 using the biology and chemistry of SARS-CoV-2 (edit) |
10.1007/S00449-022-02788-8 |
| 2022-09-20 |
Alterations of the Antioxidant and Inflammatory Response of the Peripheral Blood Granulocytes to SARS-CoV-2 Infection in the Deceased COVID-19 Patients (edit) |
10.20944/PREPRINTS202209.0298.V1 |
| 2022-09-19 |
'Like building a plane and flying it all in one go': an interview study of infection prevention and control in Australian general practice during the first 2 years of the SARS-CoV-2 pandemic (edit) |
10.1136/BMJOPEN-2022-061513 |
| 2022-09-19 |
Barriers to SARS-CoV-2 Testing among U.S. Employers in the COVID-19 Pandemic: A Qualitative Analysis Conducted January through April 2021 (edit) |
10.3390/IJERPH191811805 |
| 2022-09-17 |
Predicting onset risk of COVID-19 symptom to support healthy travel route planning in the new normal of long-term coexistence with SARS-CoV-2 (edit) |
10.1177/23998083221127703 |
| 2022-09-16 |
Outbreak of SARS-CoV-2 B.1.617.2 (Delta Variant) in a Youth Camp Associated With Community Spread, Nebraska, June–July 2021 (edit) |
10.1177/00333549221123582 |
| 2022-09-15 |
The Waxing, Waning, and Predictors of Humoral Responses to Vector-Based SARS-CoV-2 Vaccine in Hemodialysis Patients (edit) |
10.3390/VACCINES10091537 |
| 2022-09-15 |
Phylodynamic analysis of SARS-CoV-2 spread in Rio de Janeiro, Brazil, highlights how metropolitan areas act as dispersal hubs for new variants (edit) |
10.1099/MGEN.0.000859 |
| 2022-09-15 |
When the Dust Has Settled: Calculation of Binding Affinities from First Principles for SARS-CoV-2 Variants with Quantitative Accuracy (edit) |
10.1021/ACS.JCTC.2C00604 |
| 2022-09-14 |
Synthesis of Novel N4-Hydrocytidine Analogs as Potential Anti-SARS-CoV-2 Agents (edit) |
10.3390/PH15091144 |
| 2022-09-14 |
Identification of three conserved linear B cell epitopes on the SARS-CoV-2 spike protein (edit) |
10.1080/22221751.2022.2109515 |
| 2022-09-14 |
Anti-Spike Mucosal IgA Protection against SARS-CoV-2 Omicron Infection (edit) |
10.1056/NEJMC2209651 |
| 2022-09-14 |
Utilization of Receptor-Binding Domain of SARS-CoV-2 Spike Protein Expressed in Escherichia coli for the Development of Neutralizing Antibody Assay (edit) |
10.1007/S12033-022-00563-4 |
| 2022-09-13 |
Liver Fibrosis Indices Predict the Severity of SARS-CoV-2 Infection (edit) |
10.3390/JCM11185369 |
| 2022-09-13 |
SP-A binding to the SARS-CoV-2 spike protein using hybrid quantum and classical in silico modeling and molecular pruning by Quantum Approximate Optimization Algorithm (QAOA) Based MaxCut with ZDOCK (edit) |
10.3389/FIMMU.2022.945317 |
| 2022-09-13 |
Quantum chemical studies on the binding domain of SARS-CoV-2 S-protein: human ACE2 interface complex (edit) |
10.1080/07391102.2022.2120537 |
| 2022-09-13 |
Single-cell sequencing of brain tissues reveal the central nervous system’s susceptibility to SARS-CoV-2 and the drug (edit) |
10.3389/FPHAR.2022.971017 |
| 2022-09-12 |
Chemoenzymatic Synthesis of SARS-CoV-2 Homogeneous O-Linked Glycopeptides for Exploring Their Inhibition Functions (edit) |
10.1021/ACSINFECDIS.2C00383 |
| 2022-09-12 |
Development of a Deep Learning Generative Neural Network for Computer-Aided Design of Potential SARS-Cov-2 Inhibitors (edit) |
10.17537/2022.17.188 |
| 2022-09-09 |
A Quantitative ELISA to Detect Anti-SARS-CoV-2 Spike IgG Antibodies in Infected Patients and Vaccinated Individuals (edit) |
10.3390/MICROORGANISMS10091812 |
| 2022-09-09 |
Tracing the trajectories of SARS-CoV-2 variants of concern between December 2020 and September 2021 in the Canary Islands (Spain) (edit) |
10.3389/FCIMB.2022.919346 |
| 2022-09-09 |
Detection of Higher Cycle Threshold Values in Culturable SARS-CoV-2 Omicron BA.1 Sublineage Compared with Pre-Omicron Variant Specimens — San Francisco Bay Area, California, July 2021—March 2022 (edit) |
10.15585/MMWR.MM7136A3 |
| 2022-09-09 |
Sensing of SARS-CoV-2 by pDCs and their subsequent production of IFN-I contribute to macrophage-induced cytokine storm during COVID-19 (edit) |
10.1126/SCIIMMUNOL.ADD4906 |
| 2022-09-09 |
IMM-BCP-01, a patient-derived anti–SARS-CoV-2 antibody cocktail, is active across variants of concern including Omicron BA.1 and BA.2 (edit) |
10.1126/SCIIMMUNOL.ABL9943 |
| 2022-09-09 |
SARS-CoV-2 reinfections during the first three major COVID-19 waves in Bulgaria (edit) |
10.1371/JOURNAL.PONE.0274509 |
| 2022-09-09 |
Epidemiological and Serological Analysis of a SARS-CoV-2 Outbreak in a Nursing Home: Impact of SARS-CoV-2 Vaccination and Enhanced Neutralizing Immunity Following Breakthrough Infection (edit) |
10.3390/MICROORGANISMS10091809 |
| 2022-09-08 |
Are higher antibody levels against seasonal human coronaviruses associated with a more robust humoral immune response after SARS-CoV-2 vaccination? (edit) |
10.3389/FIMMU.2022.954093 |
| 2022-09-08 |
mRNA vaccination drives differential mucosal neutralizing antibody profiles in naïve and SARS-CoV-2 previously-infected individuals (edit) |
10.3389/FIMMU.2022.953949 |
| 2022-09-07 |
Murine Hepatitis Virus, a Biosafety Level 2 Model for SARS-CoV-2, Can Remain Viable on Meat and Meat Packaging Materials for at Least 48 Hours (edit) |
10.1128/SPECTRUM.01862-22 |
| 2022-09-07 |
Time Series Analysis of SARS-CoV-2 Genomes and Correlations among Highly Prevalent Mutations (edit) |
10.1128/SPECTRUM.01219-22 |
| 2022-09-07 |
Durability of Booster mRNA Vaccine against SARS-CoV-2 BA.2.12.1, BA.4, and BA.5 Subvariants (edit) |
10.1056/NEJMC2210546 |
| 2022-09-07 |
Vaccination willingness in association with personality traits in patients with multiple sclerosis in the course of SARS-CoV-2 pandemic (edit) |
10.1038/S41598-022-18912-3 |
| 2022-09-06 |
Risk of Myocarditis After Sequential Doses of COVID-19 Vaccine and SARS-CoV-2 Infection by Age and Sex (edit) |
10.1161/CIRCULATIONAHA.122.059970 |
| 2022-09-06 |
Genomic surveillance of SARS-CoV-2 Omicron variants on a university campus (edit) |
10.1038/S41467-022-32786-Z |
| 2022-09-06 |
Electrostatic Features for the Receptor Binding Domain of SARS-COV-2 Wildtype and Its Variants. Compass to the Severity of the Future Variants with the Charge-Rule (edit) |
10.1021/ACS.JPCB.2C04225 |
| 2022-09-05 |
Benchmark datasets for SARS-CoV-2 surveillance bioinformatics (edit) |
10.7717/PEERJ.13821 |
| 2022-09-05 |
Levantamento bibliográfico do mecanismo de desenvolvimento de Diabetes Mellitus tipo II após infeção pelo SARS-COV-2 (edit) |
10.33448/RSD-V11I12.33999 |
| 2022-09-05 |
Prediction of the effects of the top 10 synonymous mutations from 26645 SARS-CoV-2 genomes (edit) |
10.12688/F1000RESEARCH.72896.2 |
| 2022-09-05 |
The Impact of SARS-CoV-2 Variants on the Clinical Phenotype and Severity of Multisystem Inflammatory Syndrome in Children in South Africa (edit) |
10.1097/INF.0000000000003691 |
| 2022-09-02 |
SARS-CoV-2 vaccination in androgen sensitive phenotypes – A study on associated factors for SARS-CoV-2 vaccination and its adverse effects among androgenetic alopecia and benign prostate hyperplasia patients (edit) |
10.3389/FIMMU.2022.919958 |
| 2022-09-02 |
Łysienie telogenowe jako przejaw zakażenia SARS-CoV-2 (edit) |
10.5603/FD.A2022.0025 |
| 2022-09-02 |
Predicting the Kinetic Coordination of Immune Response Dynamics in SARS-CoV-2 Infection: Implications for Disease Pathogenesis (edit) |
10.3390/MATH10173154 |
| 2022-09-02 |
Impact of SARS-CoV-2 Delta and Omicron variants on viral burden and cycle threshold in BNT162b2-vaccinated 12–18 years group (edit) |
10.1007/S42770-022-00820-3 |
| 2022-09-02 |
Impact of hypertension on long-term humoral and cellular response to SARS-CoV-2 infection (edit) |
10.3389/FIMMU.2022.915001 |
| 2022-09-01 |
SARS-CoV-2 reinfections during the Delta and Omicron waves (edit) |
10.1172/JCI.INSIGHT.162007 |
| 2022-09-01 |
A Study on the Fractal-Fractional Epidemic Probability-Based Model of SARS-CoV-2 Virus along with the Taylor Operational Matrix Method for Its Caputo Version (edit) |
10.1155/2022/2388557 |
| 2022-09-01 |
Breakthrough SARS-CoV-2 infections, morbidity, and seroreactivity following initial COVID-19 vaccination series and additional dose in patients with SLE in New York City (edit) |
10.1016/S2665-9913(22)00190-4 |
| 2022-09-01 |
Immunogenicity and reactogenicity of an inactivated SARS-CoV-2 vaccine (BBV152) in children aged 2–18 years: interim data from an open-label, non-randomised, age de-escalation phase 2/3 study (edit) |
10.1016/S1473-3099(22)00307-3 |
| 2022-09-01 |
Pathophysiology of light phenotype SARS-CoV-2 interstitial pneumonia: from histopathological features to clinical presentations (edit) |
10.1016/J.PULMOE.2021.03.003 |
| 2022-09-01 |
New insights on circular RNAs and their potential applications as biomarkers, therapeutic agents, and preventive vaccines in viral infections: with a glance at SARS-CoV-2 (edit) |
10.1016/J.OMTN.2022.08.012 |
| 2022-09-01 |
SARS-CoV-2-specific CD4+ T cell longevity correlates with Th17-like phenotype (edit) |
10.1016/J.ISCI.2022.104959 |
| 2022-09-01 |
SARS-CoV-2 and the central nervous system: Emerging insights into hemorrhage-associated neurological consequences and therapeutic considerations (edit) |
10.1016/J.ARR.2022.101687 |
| 2022-09-01 |
Psychopathological Symptoms Among Chronically Ill Patients During SARS-CoV-2 Pandemic in Poland (edit) |
10.2147/PRBM.S362918 |
| 2022-09-01 |
Mitigation of the biosafety risks of SARS-CoV-2 at BSL-3 laboratories (edit) |
10.15312/EURASIANJVETSCI.2021.344 |
| 2022-09-01 |
Pre-Illness Training And Acute Symptom Clusters Predict Prolonged Return-To-Play In Athletes After Recent SARS-CoV-2 Infection (edit) |
10.1249/01.MSS.0000882600.84039.EA |
| 2022-09-01 |
Subtyping of major SARS-CoV-2 variants reveals different transmission dynamics based on 10 million genomes (edit) |
10.1093/PNASNEXUS/PGAC181 |
| 2022-09-01 |
Tobacco product use and the risks of SARS-CoV-2 infection and COVID-19: current understanding and recommendations for future research (edit) |
10.1016/S2213-2600(22)00182-5 |
| 2022-09-01 |
Afección pericárdica y miocárdica tras infección por SARS-CoV-2: estudio descriptivo transversal en trabajadores sanitarios (edit) |
10.1016/J.RECESP.2021.10.021 |
| 2022-09-01 |
Pericardial and myocardial involvement after SARS-CoV-2 infection: a cross-sectional descriptive study in healthcare workers (edit) |
10.1016/J.REC.2021.11.001 |
| 2022-09-01 |
Can systemic immune inflammation index at admission predict in-hospital mortality in chronic kidney disease patients with SARS-CoV-2 infection? (edit) |
10.1016/J.NEFRO.2021.09.001 |
| 2022-09-01 |
TNF-related apoptosis-inducing ligand, interferon gamma-induced protein 10, and C-reactive protein in predicting the progression of SARS-CoV-2 infection: a prospective cohort study (edit) |
10.1016/J.IJID.2022.05.051 |
| 2022-09-01 |
Considering the precautionary principle and its application to MRSA and SARS-CoV-2 as emerging novel pathogens of their time (edit) |
10.1016/J.IDH.2022.08.003 |
| 2022-09-01 |
Predicting the dispersal of SARS-CoV-2 RNA from the wastewater treatment plant to the coast (edit) |
10.1016/J.HELIYON.2022.E10547 |
| 2022-09-01 |
Protection against SARS-CoV-2 transmission by a parenteral prime—Intranasal boost vaccine strategy (edit) |
10.1016/J.EBIOM.2022.104248 |
| 2022-09-01 |
Role of the coronary and non-coronary cardiovascular findings on non-cardiac gated thoracic CT in predicting mortality in SARS-CoV-2 infection (edit) |
10.1016/J.CLINIMAG.2022.06.002 |
| 2022-09-01 |
FDA authorized molecular point-of-care SARS-CoV-2 tests: A critical review on principles, systems and clinical performances (edit) |
10.1016/J.BIOSX.2022.100158 |
| 2022-09-01 |
Monocytosis in the acute phase of SARS-CoV-2 infection predicts the presence of anosognosia for cognitive deficits in the chronic phase (edit) |
10.1016/J.BBIH.2022.100511 |
| 2022-09-01 |
Depressive symptoms predict antibody titers after a second dose of the SARS-CoV-2 BNT162b2 vaccine among hospital workers in Japan (edit) |
10.1016/J.BBI.2022.09.004 |
| 2022-09-01 |
Association of masking policies with mask adherence and distancing during the SARS-COV-2 pandemic (edit) |
10.1016/J.AJIC.2022.04.010 |
| 2022-09-01 |
Before blaming SARS-CoV-2 for intra-cerebral aneurysm formation and rupture, alternative mechanisms need to be ruled out (edit) |
10.1016/J.HEST.2022.09.001 |
| 2022-09-01 |
SARS-CoV-2 infection showing signs of cerebral sinus vein thrombosis in the infantile period (edit) |
10.1016/J.DSCB.2022.100051 |
| 2022-09-01 |
Curating a knowledge base for individuals with coinfection of HIV and SARS-CoV-2: a study protocol of EHR-based data mining and clinical implementation (edit) |
10.1136/BMJOPEN-2022-067204 |
| 2022-09-01 |
Third dose corrects waning immunity to SARS-CoV-2 mRNA vaccines in immunocompromised patients with immune-mediated inflammatory diseases (edit) |
10.1136/RMDOPEN-2022-002622 |
| 2022-09-01 |
Effect of SARS-CoV-2 infection in neonates or in pregnancy on developmental outcomes at 21–24 months (SINEPOST): study protocol for a prospective cohort study (edit) |
10.1136/BMJPO-2022-001571 |
| 2022-09-01 |
Lockdowns exert selection pressure on overdispersion of SARS-CoV-2 variants (edit) |
10.1016/J.EPIDEM.2022.100613 |
| 2022-09-01 |
TARGETING THE MAIN PROTEASE AND THE SPIKE PROTEIN OF SARS-COV-2 WITH NATURALLY OCCURRING COMPOUNDS FROM SOME CAMEROONIAN MEDICINAL PLANTS: AN IN-SILICO STUDY FOR DRUG DESIGNING (edit) |
10.4067/S0717-97072022000305602 |
| 2022-09-01 |
Wastewater sequencing reveals early cryptic SARS-CoV-2 variant transmission (edit) |
10.1038/S41586-022-05049-6 |
| 2022-09-01 |
Estimating R0 from early exponential growth: parallels between 1918 influenza and 2020 SARS-CoV-2 pandemics (edit) |
10.1093/PNASNEXUS/PGAC194 |
| 2022-09-01 |
Pandemic-scale phylogenomics reveals the SARS-CoV-2 recombination landscape (edit) |
10.1038/S41586-022-05189-9 |
| 2022-09-01 |
Phylogenetic and phylodynamic approaches to understanding and combating the early SARS-CoV-2 pandemic (edit) |
10.1038/S41576-022-00483-8 |
| 2022-09-01 |
Debulking different Corona (SARS-CoV-2 delta, omicron, OC43) and Influenza (H1N1, H3N2) virus strains by plant viral trap proteins in chewing gums to decrease infection and transmission (edit) |
10.1016/J.BIOMATERIALS.2022.121671 |
| 2022-09-01 |
UV 254 nm is more efficient than UV 222 nm in inactivating SARS-CoV-2 present in human saliva (edit) |
10.1016/J.PDPDT.2022.103015 |
| 2022-09-01 |
Can SARS-CoV-2 positive pregnant women affect the hearing of their newborns: A systematic review (edit) |
10.1016/J.AMJOTO.2022.103523 |
| 2022-09-01 |
COVID-19 clusters in a teaching hospital during the second wave of the SARS-CoV-2 pandemic in France: A descriptive study and lessons learned for waves to come (edit) |
10.1016/J.AJIC.2022.06.018 |
| 2022-09-01 |
Probing the mutational landscape of the SARS-CoV-2 spike protein via quantum mechanical modeling of crystallographic structures (edit) |
10.1093/PNASNEXUS/PGAC180 |
| 2022-09-01 |
Frequent occurrence of mutations in nsp3 and nsp4 of SARS-CoV-2, presumably caused by the inhaled asthma drug ciclesonide (edit) |
10.1093/PNASNEXUS/PGAC197 |
| 2022-08-31 |
The Effect of SARS-CoV-2 Vaccination on B-Cell Phenotype in Systemic Sclerosis Patients (edit) |
10.3390/JPM12091420 |
| 2022-08-31 |
Humoral and Cellular Immune Responses to Vector, Mix-and-Match, or mRNA Vaccines against SARS-CoV-2 and the Relationship between the Two Immune Responses (edit) |
10.1128/SPECTRUM.02495-21 |
| 2022-08-31 |
Retraction: Potential of antiviral peptide-based SARS-CoV-2 inactivators to combat COVID-19 (edit) |
10.1371/JOURNAL.PONE.0273489 |
| 2022-08-31 |
Symptomatic and Asymptomatic Transmission of SARS-CoV-2 in K-12 Schools, British Columbia, Canada April to June 2021 (edit) |
10.1128/SPECTRUM.00622-22 |
| 2022-08-30 |
A Retinol Derivative Inhibits SARS-CoV-2 Infection by Interrupting Spike-Mediated Cellular Entry (edit) |
10.1128/MBIO.01485-22 |
| 2022-08-30 |
Author Correction: Mathematical modelling of SARS-CoV-2 variant outbreaks reveals their probability of extinction (edit) |
10.1038/S41598-022-19152-1 |
| 2022-08-29 |
Vandetanib Blocks the Cytokine Storm in SARS-CoV-2-Infected Mice (edit) |
10.1021/ACSOMEGA.2C02794 |
| 2022-08-29 |
SARS-CoV-2 Surface Swabs in Locations With Public Access—Potential for Improved Source Control (edit) |
10.1093/OFID/OFAC431 |
| 2022-08-29 |
In Silico Evaluation of Sesquiterpenes and Benzoxazinoids Phytotoxins against Mpro, RNA Replicase and Spike Protein of SARS-CoV-2 by Molecular Dynamics. Inspired by Nature (edit) |
10.3390/TOXINS14090599 |
| 2022-08-29 |
Seropositivity of SARS-CoV-2 in an unvaccinated cohort in British Columbia, Canada: a cross-sectional survey with dried blood spot samples (edit) |
10.1136/BMJOPEN-2022-062567 |
| 2022-08-28 |
Ergonomic Factors That Impact Job Satisfaction and Occupational Health during the SARS-CoV-2 Pandemic Based on a Structural Equation Model: A Cross-Sectional Exploratory Analysis of University Workers (edit) |
10.3390/IJERPH191710714 |
| 2022-08-26 |
Seasonal variation in SARS-CoV-2 transmission in temperate climates: A Bayesian modelling study in 143 European regions (edit) |
10.1371/JOURNAL.PCBI.1010435 |
| 2022-08-26 |
A bibliometric analysis of the 100 most cited articles describing SARS-CoV-2 variants (edit) |
10.3389/FPUBH.2022.966847 |
| 2022-08-26 |
SARS-CoV-2 PCR positivity in elementary school classes in Bavaria in the school year 2021/22—initial results from the evaluation of the Bavarian pool test project in elementary and special schools (edit) |
10.3238/ARZTEBL.M2022.0310 |
| 2022-08-26 |
The molecular epidemiology of multiple zoonotic origins of SARS-CoV-2 (edit) |
10.1126/SCIENCE.ABP8337 |
| 2022-08-26 |
Wildlife trade is likely the source of SARS-CoV-2 (edit) |
10.1126/SCIENCE.ADD8384 |
| 2022-08-25 |
Computational Pipeline for Reference-Free Comparative Analysis of RNA 3D Structures Applied to SARS-CoV-2 UTR Models (edit) |
10.3390/IJMS23179630 |
| 2022-08-24 |
Assessment of a Computational Approach to Predict Drug Resistance Mutations for HIV, HBV and SARS-CoV-2 (edit) |
10.3390/MOLECULES27175413 |
| 2022-08-24 |
Major severe acute respiratory coronavirus-2 (SARS-CoV-2) vaccine-associated adverse effects; benefits outweigh the risks (edit) |
10.1080/14760584.2022.2116008 |
| 2022-08-24 |
Surface charge changes in spike RBD mutations of SARS-CoV-2 and its variant strains alter the virus evasiveness via HSPGs: A review and mechanistic hypothesis (edit) |
10.3389/FPUBH.2022.952916 |
| 2022-08-23 |
Plant-derived compounds effectively inhibit the main protease of SARS-CoV-2: An in silico approach (edit) |
10.1371/JOURNAL.PONE.0273341 |
| 2022-08-23 |
The roles of cellular protease interactions in viral infections and programmed cell death: a lesson learned from the SARS-CoV-2 outbreak and COVID-19 pandemic (edit) |
10.1007/S43440-022-00394-9 |
| 2022-08-22 |
Structure-Based Virtual Screening, Docking, ADMET, Molecular Dynamics, and MM-PBSA Calculations for the Discovery of Potential Natural SARS-CoV-2 Helicase Inhibitors from the Traditional Chinese Medicine (edit) |
10.1155/2022/7270094 |
| 2022-08-21 |
The Impact of Severe COVID-19 on Plasma Antioxidants (edit) |
10.3390/MOLECULES27165323 |
| 2022-08-19 |
Containing novel SARS-CoV-2 variants at source is possible with high-intensity sequencing (edit) |
10.1093/PNASNEXUS/PGAC159 |
| 2022-08-18 |
Awake Prone-Positioning in Patients on Non-Invasive Ventilation for Management of SARS-CoV-2 Pneumonia: A Systematic Review (edit) |
10.3390/ARM90040046 |
| 2022-08-18 |
In silico identification of novel SARS-CoV-2 main protease and non-structural protein 13 (nsp13) inhibitors through consensus docking and free binding energy calculations. (edit) |
10.2174/1386207325666220818141112 |
| 2022-08-17 |
Folic acid restricts SARS-CoV-2 invasion by methylating ACE2 (edit) |
10.3389/FMICB.2022.980903 |
| 2022-08-17 |
Multisystem Inflammatory Syndrome in Adults (MIS-A) After COVID-19 Infection and Recent Vaccination with Recombinant Adenoviral Vector Encoding the Spike Protein Antigen of SARS-CoV-2 (ChAdOx1 nCoV-19, Vaxzevria) (edit) |
10.1177/08850666221121589 |
| 2022-08-16 |
Personalized survival probabilities for SARS-CoV-2 positive patients by explainable machine learning (edit) |
10.1038/S41598-022-17953-Y |
| 2022-08-12 |
SARS-CoV-2 Viroporins: A Multi-Omics Insight from Nucleotides to Amino Acids (edit) |
10.3390/APPLMICROBIOL2030045 |
| 2022-08-12 |
Leveraging artificial intelligence and data science techniques in harmonizing, sharing, accessing and analyzing SARS-COV-2/COVID-19 data in Rwanda (LAISDAR Project): study design and rationale (edit) |
10.1186/S12911-022-01965-9 |
| 2022-08-12 |
ACE2-binding exposes the SARS-CoV-2 fusion peptide to broadly neutralizing coronavirus antibodies (edit) |
10.1126/SCIENCE.ABQ2679 |
| 2022-08-12 |
Vaccines against SARS-CoV-2 variants and future pandemics (edit) |
10.1080/14760584.2022.2110075 |
| 2022-08-11 |
Descriptive analysis of clinical and laboratory findings in relation to changes in SARS-CoV-2 viral dynamics and cyclic threshold: a retrospective, single center observational study in patients treated with Hydroxychloroquine/Azithromycin combinatio (edit) |
10.12688/F1000RESEARCH.28290.1 |
| 2022-08-11 |
Small molecules targeting endolysosomal acidification and signaling in sepsis and severe SARS-CoV-2 infection/COVID-19 (edit) |
10.37349/EI.2022.00063 |
| 2022-08-10 |
An exploration on the topologies of SARS-CoV-2/human protein-protein interaction network (edit) |
10.1080/07391102.2022.2108496 |
| 2022-08-10 |
Impact on Education and Ecological Footprint as a Consequence of SARS-CoV-2 in the Perception of the Quality of Teaching Engineering Students in the Brazilian Amazon (edit) |
10.3390/SU14169891 |
| 2022-08-09 |
Immune defects associated with lower SARS-CoV-2 BNT162b2 mRNA vaccine response in elderly people (edit) |
10.1172/JCI.INSIGHT.161045 |
| 2022-08-09 |
The mechanism of RNA capping by SARS-CoV-2 (edit) |
10.1038/S41586-022-05185-Z |
| 2022-08-08 |
Roles and functions of SARS-CoV-2 proteins in host immune evasion (edit) |
10.3389/FIMMU.2022.940756 |
| 2022-08-08 |
Markers of fungal translocation are elevated during post-acute sequelae of SARS-CoV-2 and induce NF-κB signaling (edit) |
10.1172/JCI.INSIGHT.160989 |
| 2022-08-08 |
SARS-CoV-2 Transmission by Arthropod Vectors: A Scoping Review (edit) |
10.1155/2022/4329423 |
| 2022-08-07 |
Forecasting the spread of SARS-CoV-2 in the campania region using genetic programming (edit) |
10.1007/S00500-022-07385-1 |
| 2022-08-06 |
Whole blood DNA methylation analysis reveals respiratory environmental traits involved in COVID-19 severity following SARS-CoV-2 infection (edit) |
10.1038/S41467-022-32357-2 |
| 2022-08-05 |
Conformational flexibility in neutralization of SARS-CoV-2 by naturally elicited anti-SARS-CoV-2 antibodies (edit) |
10.1038/S42003-022-03739-5 |
| 2022-08-04 |
SARS-CoV-2 Transmission Potential and Policy Changes in South Carolina, February 2020 – January 2021 (edit) |
10.1017/DMP.2022.212 |
| 2022-08-04 |
Nasopharyngeal microbiota profiling of pregnant women with SARS-CoV-2 infection (edit) |
10.1038/S41598-022-17542-Z |
| 2022-08-03 |
The Microalgal Diatoxanthin Inflects the Cytokine Storm in SARS-CoV-2 Stimulated ACE2 Overexpressing Lung Cells (edit) |
10.3390/ANTIOX11081515 |
| 2022-08-02 |
Mixed-methods process evaluation of a residence-based SARS-CoV-2 testing participation pilot on a UK university campus during the COVID-19 pandemic (edit) |
10.1186/S12889-022-13792-8 |
| 2022-08-01 |
Availability of oral antivirals against SARS-CoV-2 infection and the requirement for an ethical prescribing approach (edit) |
10.1016/S1473-3099(22)00119-0 |
| 2022-08-01 |
Immunomodulatory LncRNA on antisense strand of ICAM-1 augments SARS-CoV-2 infection-associated airway mucoinflammatory phenotype (edit) |
10.1016/J.ISCI.2022.104685 |
| 2022-08-01 |
Screening of SARS-CoV-2 antivirals through a cell-based RNA-dependent RNA polymerase (RdRp) reporter assay (edit) |
10.1016/J.CELLIN.2022.100046 |
| 2022-08-01 |
Amphiphilic anti-SARS-CoV-2 drug remdesivir incorporates into the lipid bilayer and nerve terminal membranes influencing excitatory and inhibitory neurotransmission (edit) |
10.1016/J.BBAMEM.2022.183945 |
| 2022-08-01 |
Gut microbiota-derived metabolites confer protection against SARS-CoV-2 infection (edit) |
10.1080/19490976.2022.2105609 |
| 2022-08-01 |
Early SARS-CoV-2 Reinfections within 60 Days and Implications for Retesting Policies (edit) |
10.3201/EID2808.220617 |
| 2022-08-01 |
Safety and immunogenicity of a live-attenuated influenza virus vector-based intranasal SARS-CoV-2 vaccine in adults: randomised, double-blind, placebo-controlled, phase 1 and 2 trials (edit) |
10.1016/S2213-2600(22)00131-X |
| 2022-08-01 |
Recombinant chimpanzee adenovirus vector vaccine expressing the spike protein provides effective and lasting protection against SARS-CoV-2 infection in mice (edit) |
10.1016/J.VIRS.2022.05.006 |
| 2022-08-01 |
Potential linear B-cells epitope change to a helix structure in the spike of Omicron 21L or BA.2 predicts increased SARS-CoV-2 antibodies evasion (edit) |
10.1016/J.VIROL.2022.06.010 |
| 2022-08-01 |
Simple approximation of sample size for precise estimates of SARS-CoV-2 infection from point-seroprevalence studies (edit) |
10.1016/J.PUHE.2022.08.008 |
| 2022-08-01 |
Association of neutralizing breadth against SARS-CoV-2 with inoculation orders of heterologous prime-boost vaccines (edit) |
10.1016/J.MEDJ.2022.05.003 |
| 2022-08-01 |
A Case of Leukocytoclastic Vasculitis Following SARS-COV-2 Vaccination (edit) |
10.1016/J.JEMERMED.2021.10.005 |
| 2022-08-01 |
Maintaining safe office spaces to minimise risks of SARS-CoV-2 transmission (edit) |
10.1016/J.IDH.2022.03.003 |
| 2022-08-01 |
Safety and immunogenicity following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373): a secondary analysis of a randomised, placebo-controlled, phase 2 trial (edit) |
10.1016/S1473-3099(22)00420-0 |
| 2022-08-01 |
Elucidation of correlation between SARS-CoV-2 RdRp and N gene cycle threshold (Ct) by RT-PCR with age and gender (edit) |
10.1016/J.CCA.2022.06.008 |
| 2022-08-01 |
Deep mutational learning predicts ACE2 binding and antibody escape to combinatorial mutations in the SARS-CoV-2 receptor-binding domain (edit) |
10.1016/J.CELL.2022.08.024 |
| 2022-08-01 |
Persistently positive PCR SARS-CoV-2 at low cycle threshold in an immunosuppressed patient (edit) |
10.1016/J.BJID.2022.102696 |
| 2022-08-01 |
Maternal fructose intake reinforces the effects of a Western-type diet in promoting SARS-CoV-2 cell entry factors in male offspring (edit) |
10.1016/J.ATHEROSCLEROSIS.2022.06.840 |
| 2022-08-01 |
A study on the role of aedes mosquitoes in arboviruses and SARS-CoV-2 infection: A new challenge (edit) |
10.1016/J.JKSUS.2022.102179 |
| 2022-08-01 |
Why do people consent to receiving SARS-CoV-2 vaccinations? A representative survey in Germany (edit) |
10.1136/BMJOPEN-2021-060555 |
| 2022-08-01 |
Speed and need: twin development challenges in rapid response for a SARS-CoV-2 antibody cocktail (edit) |
10.1016/J.COPBIO.2022.102715 |
| 2022-08-01 |
Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5 (edit) |
10.1038/S41586-022-05053-W |
| 2022-08-01 |
Pandemic Preparedness: The Potential Advantage of Medicines That Prevent Acute Side Effects of Vaccination, SARS-CoV-2 as an Example (edit) |
10.3390/FUTUREPHARMACOL2030019 |
| 2022-08-01 |
Sensitivity of the Elecsys Nucleocapsid Assay for the Detection of Preceding SARS-CoV-2 Infections (edit) |
10.1093/OFID/OFAC349 |
| 2022-08-01 |
Useful molecular tools for facing next pandemic events: Effective sample preparation and improved RT-PCR for highly sensitive detection of SARS-CoV-2 in wastewater environment (edit) |
10.1016/J.IJHEH.2022.114017 |
| 2022-07-31 |
Long-Term Health Consequences of SARS-CoV-2: Assumptions Based on SARS-CoV-1 and MERS-CoV Infections (edit) |
10.3390/DIAGNOSTICS12081852 |
| 2022-07-30 |
Regional disparities in SARS-CoV-2 infections by labour market indicators: a spatial panel analysis using nationwide German data on notified infections (edit) |
10.1186/S12879-022-07643-5 |
| 2022-07-29 |
Exosomal Vaccine Loading T Cell Epitope Peptides of SARS-CoV-2 Induces Robust CD8+ T Cell Response in HLA-A Transgenic Mice (edit) |
10.2147/IJN.S367494 |
| 2022-07-29 |
Immune Heterogeneity and Epistasis Explain Punctuated Evolution of SARS-CoV-2 (edit) |
10.1101/2022.07.27.22278129 |
| 2022-07-28 |
COVID-19 (SARS-CoV-2) in Patients Treated in The Unified Health System (SUS) with Flu and Respiratory Symptoms from Three Brazilian Municipalities in the Border Region (edit) |
10.1017/DMP.2022.195 |
| 2022-07-28 |
Comparing the Psychological Problems Among the Health Care Workers Across Two Waves of SARS-CoV-2 (COVID-19) Pandemic: An Observational Study from India (edit) |
10.1017/DMP.2022.192 |
| 2022-07-27 |
Influencing factors for the persistence of SARS-CoV-2 (COVID-19) exposed in environmental matrices and disinfection methods: systematic review (edit) |
10.18203/2394-6040.IJCMPH20222040 |
| 2022-07-27 |
Covariance predicts conserved protein residue interactions important for the emergence and continued evolution of SARS-CoV-2 as a human pathogen (edit) |
10.1371/JOURNAL.PONE.0270276 |
| 2022-07-27 |
Elevated Myl9 reflects the Myl9-containing microthrombi in SARS-CoV-2–induced lung exudative vasculitis and predicts COVID-19 severity (edit) |
10.1073/PNAS.2203437119 |
| 2022-07-27 |
Cross-reactivity of eight SARS-CoV-2 variants rationally predicts immunogenicity clustering in sarbecoviruses (edit) |
10.1038/S41392-022-01123-7 |
| 2022-07-27 |
Low SARS-CoV-2 Antibodies in Blood Donors After the First 6 Months of COVID-19 Epidemic in the Tobruk Region, Eastern Libya (edit) |
10.1017/DMP.2022.180 |
| 2022-07-27 |
Implementation of Multi-level Interventions to Mitigate Risk of SARS-CoV-2 Delta Variant at a PUBLIC UNIVERSITY in Southern United States (edit) |
10.1017/DMP.2022.179 |
| 2022-07-27 |
Using Species a Rotavirus Reverse Genetics to Engineer Chimeric Viruses Expressing SARS-CoV-2 Spike Epitopes (edit) |
10.1128/JVI.00488-22 |
| 2022-07-26 |
Vertical Transmission of SARS-CoV-2 Infection and Miscarriage in the Second Trimester: Report of an Immunohistochemically Proven Case (edit) |
10.3390/CLINPRACT12040061 |
| 2022-07-25 |
BNT162b2 booster after heterologous prime-boost vaccination induces potent neutralizing antibodies and T cell reactivity against SARS-CoV-2 Omicron BA.1 in young adults (edit) |
10.3389/FIMMU.2022.882918 |
| 2022-07-23 |
SARS-ANI: a global open access dataset of reported SARS-CoV-2 events in animals (edit) |
10.1038/S41597-022-01543-8 |
| 2022-07-22 |
Evaluation of SARS-CoV-2-Neutralizing Nanobody Using Virus Receptor Binding Domain-Administered Model Mice (edit) |
10.34133/2022/9864089 |
| 2022-07-22 |
Histopathological and Immunological Findings in the Common Marmoset Following Exposure to Aerosolized SARS-CoV-2 (edit) |
10.3390/V14071580 |
| 2022-07-22 |
Forecasting the Post-Pandemic Effects of the SARS-CoV-2 Virus Using the Bullwhip Phenomenon Alongside Use of Nanosensors for Disease Containment and Cure (edit) |
10.3390/MA15145078 |
| 2022-07-22 |
Characterization of Clinical Features of Hospitalized Patients Due to the SARS-CoV-2 Infection in the Absence of Comorbidities Regarding the Sex: An Epidemiological Study of the First Year of the Pandemic in Brazil (edit) |
10.3390/IJERPH19158895 |
| 2022-07-22 |
An update on the impact of SARS-CoV-2 pandemic public awareness on cancer patients' COVID-19 vaccine compliance: Outcomes and recommendations (edit) |
10.3389/FPUBH.2022.923815 |
| 2022-07-22 |
Resilience and Protection of Health Care and Research Laboratory Workers During the SARS-CoV-2 Pandemic: Analysis and Case Study From an Austrian High Security Laboratory (edit) |
10.3389/FPSYG.2022.901244 |
| 2022-07-22 |
Effectiveness and Waning of Protection With Different SARS-CoV-2 Primary and Booster Vaccines During the Delta Pandemic Wave in 2021 in Hungary (HUN-VE 3 Study) (edit) |
10.3389/FIMMU.2022.919408 |
| 2022-07-22 |
Evolution of ACE2-Independent SARS-CoV-2 Infection and Mouse Adaption After Passage in Cells Expressing Human and Mouse ACE2 (edit) |
10.1093/VE/VEAC063 |
| 2022-07-22 |
Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated — VISION Network, 10 States, December 2021–June 2022 (edit) |
10.15585/MMWR.MM7129E1 |
| 2022-07-22 |
Immune response to anti-SARS-CoV-2 prime-vaccination in patients with cancer: a systematic review and meta-analysis (edit) |
10.1007/S00432-022-04185-W |
| 2022-07-22 |
Pathogenicity, transmissibility, and fitness of SARS-CoV-2 Omicron in Syrian hamsters (edit) |
10.1126/SCIENCE.ABN8939 |
| 2022-07-22 |
Shifting mutational constraints in the SARS-CoV-2 receptor-binding domain during viral evolution (edit) |
10.1126/SCIENCE.ABO7896 |
| 2022-07-22 |
Crisis management checklist: lessons learned from the SARS-CoV-2 pandemic (edit) |
10.1007/S44186-022-00033-0 |
| 2022-07-21 |
Structure-selected RBM immunogens prime polyclonal memory responses that neutralize SARS-CoV-2 variants of concern (edit) |
10.1371/JOURNAL.PPAT.1010686 |
| 2022-07-21 |
The importance of effect sizes when comparing cycle threshold values of SARS-CoV-2 variants (edit) |
10.1371/JOURNAL.PONE.0271808 |
| 2022-07-21 |
The trispecific DARPin ensovibep inhibits diverse SARS-CoV-2 variants (edit) |
10.1038/S41587-022-01382-3 |
| 2022-07-20 |
Development of Lateral Flow Immunochromatographic Test for Rapid Detection of SARS-CoV-2 Virus Antigens in Clinical Specimens (edit) |
10.3390/NANO12142477 |
| 2022-07-20 |
Progress in Electrochemical Biosensing of SARS-CoV-2 Virus for COVID-19 Management (edit) |
10.3390/CHEMOSENSORS10070287 |
| 2022-07-20 |
COVID-19 infection in patients with chronic myeloid leukemia in the Orenburg region during the SARS-CoV-2 pandemic (edit) |
10.17650/1818-8346-2022-17-3-119-126 |
| 2022-07-20 |
Co-existence of a pandemic (SARS-CoV-2) and an epidemic (Dengue virus) at some focal points in Southeast Asia: Pathogenic importance, preparedness, and strategy of tackling (edit) |
10.1016/J.LANSEA.2022.100046 |
| 2022-07-20 |
LB981 Pandemic associated chilblain-like lesions result from an inducible type 1 interferon response to SARS-CoV-2 (edit) |
10.1016/J.JID.2022.05.1004 |
| 2022-07-20 |
The Biological Properties of the SARS-CoV-2 Cameroon Variant Spike: An Intermediate between the Alpha and Delta Variants (edit) |
10.3390/PATHOGENS11070814 |
| 2022-07-19 |
SARS-CoV-2 pandemics and RSV off-season outbreaks (edit) |
10.23822/EURANNACI.1764-1489.263 |
| 2022-07-19 |
Omicron mutations enhance infectivity and reduce antibody neutralization of SARS-CoV-2 virus-like particles (edit) |
10.1073/PNAS.2200592119 |
| 2022-07-18 |
A qualitative process analysis of daily contact testing as an alternative to self-isolation following close contact with a confirmed carrier of SARS-CoV-2 (edit) |
10.1186/S12889-022-13800-X |
| 2022-07-18 |
Think like a Virus: Toward Improving Nanovaccine Development against SARS-CoV-2 (edit) |
10.3390/V14071553 |
| 2022-07-18 |
Immunogenicity and protective potential of chimeric virus-like particles containing SARS-CoV-2 spike and H5N1 matrix 1 proteins (edit) |
10.3389/FCIMB.2022.967493 |
| 2022-07-18 |
Drug repurposing based on a quantum-inspired method versus classical fingerprinting uncovers potential antivirals against SARS-CoV-2 (edit) |
10.1371/JOURNAL.PCBI.1010330 |
| 2022-07-18 |
Evaluation of apigenin-based biflavonoid derivatives as potential therapeutic agents against viral protease (3CLpro) of SARS-CoV-2 via molecular docking, molecular dynamics and quantum mechanics studies (edit) |
10.1080/07391102.2022.2098821 |
| 2022-07-18 |
In vitro evolution predicts emerging SARS-CoV-2 mutations with high affinity for ACE2 and cross-species binding (edit) |
10.1371/JOURNAL.PPAT.1010733 |
| 2022-07-16 |
Hepatitis C virus NS3/4A inhibitors and other drug-like compounds as covalent binders of SARS-CoV-2 main protease (edit) |
10.1038/S41598-022-15930-Z |
| 2022-07-15 |
The T Cell Epitope Landscape of SARS-CoV-2 Variants of Concern (edit) |
10.3390/VACCINES10071123 |
| 2022-07-15 |
Interaction of Bioactive Compounds of Moringa oleifera Leaves with SARS-CoV-2 Proteins to Combat COVID-19 Pathogenesis: a Phytochemical and In Silico Analysis (edit) |
10.1007/S12010-022-04040-1 |
| 2022-07-15 |
Heterologous saRNA Prime, DNA Dual-Antigen Boost SARS-CoV-2 Vaccination Elicits Robust Cellular Immunogenicity and Cross-Variant Neutralizing Antibodies (edit) |
10.3389/FIMMU.2022.910136 |
| 2022-07-14 |
Immunopathology and pulmonary complications associated with SARS-CoV-2 virus infection. Can plants help us? (edit) |
10.53301/LW/147770 |
| 2022-07-14 |
Evolutionary and Structural Insights about Potential SARS-CoV-2 Evasion of Nirmatrelvir (edit) |
10.1021/ACS.JMEDCHEM.2C00404 |
| 2022-07-14 |
Single vs replicate Real-Time PCR SARS-CoV-2 testing: Lessons learned for effective pandemic management (edit) |
10.1371/JOURNAL.PONE.0269883 |
| 2022-07-13 |
T-cell responses to SARS-CoV-2 in unexposed South African women (edit) |
10.12688/GATESOPENRES.13373.2 |
| 2022-07-13 |
Respiratory syncytial virus after the SARS-CoV-2 pandemic — what next? (edit) |
10.1038/S41577-022-00764-7 |
| 2022-07-12 |
The Host Response to Influenza A Virus Interferes with SARS-CoV-2 Replication during Coinfection (edit) |
10.1128/JVI.00765-22 |
| 2022-07-12 |
Tropism of SARS-CoV-2 for human cortical astrocytes (edit) |
10.1073/PNAS.2122236119 |
| 2022-07-11 |
Neuroinvasion of severe acute respiratory syndrome corona virus-2 (SARS-CoV-2): future risk of epilepsy (edit) |
10.1080/00207454.2022.2100784 |
| 2022-07-11 |
Air dispersal of respiratory viruses other than severe acute respiratory coronavirus virus 2 (SARS-CoV-2) and the implication on hospital infection control (edit) |
10.1017/ICE.2022.186 |
| 2022-07-11 |
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunoglobulins using chemiluminescence immunoassay and its correlation with neutralizing antibodies (edit) |
10.1016/J.VIRUSRES.2022.198852 |
| 2022-07-11 |
Analysis of the docking property of host variants of hACE2 for SARS-CoV-2 in a large cohort (edit) |
10.1371/JOURNAL.PCBI.1009834 |
| 2022-07-11 |
Harnessing Natural Products by a Pharmacophore-Oriented Semisynthesis Approach for the Discovery of Potential Anti-SARS-CoV-2 Agents (edit) |
10.1002/ANIE.202201684 |
| 2022-07-09 |
NUCLEOSIDE ANALOG FAVIPIRAVIR IS A POOR INHIBITOR AGAINST THE SARS-COV-2 VIRUS IN CELL CULTURE, BUT FAVIPIRAVIR IS HIGHLY ACTIVE AGAINST VENEZUELAN EQUINE ENCEPHALITIS VIRUS (edit) |
10.11134/BTP.2.2022.7 |
| 2022-07-09 |
Intranasal administration of cold-adapted live-attenuated SARS-CoV-2 candidate vaccine confers protection against SARS-CoV-2 (edit) |
10.1016/J.VIRUSRES.2022.198857 |
| 2022-07-08 |
Consequences of Transplacental Transmission of the SARS-CoV-2 Virus: A Single-Center Experience (edit) |
10.3390/CHILDREN9071020 |
| 2022-07-08 |
A third vaccination with a single T cell epitope confers protection in a murine model of SARS-CoV-2 infection (edit) |
10.1038/S41467-022-31721-6 |
| 2022-07-08 |
The pandemic toll and post-acute sequelae of SARS-CoV-2 in healthcare workers at a Swiss University Hospital (edit) |
10.1016/J.PMEDR.2022.101899 |
| 2022-07-07 |
Lack of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) transmission from a healthcare worker to a cohort of immunosuppressed patients during the SARS-CoV-2 omicron variant surge, California, 2022 (edit) |
10.1017/ICE.2022.175 |
| 2022-07-07 |
How Reproducible Are QM/MM Simulations? Lessons from Computational Studies of the Covalent Inhibition of the SARS-CoV-2 Main Protease by Carmofur (edit) |
10.1021/ACS.JCTC.2C00286 |
| 2022-07-07 |
Multisystem Inflammatory Syndrome in Children and Long COVID: The SARS-CoV-2 Viral Superantigen Hypothesis (edit) |
10.3389/FIMMU.2022.941009 |
| 2022-07-07 |
Gasdermin-D activation by SARS-CoV-2 triggers NET and mediate COVID-19 immunopathology (edit) |
10.1186/S13054-022-04062-5 |
| 2022-07-06 |
RG203KR Mutations in SARS-CoV-2 Nucleocapsid: Assessing the Impact Using a Virus-Like Particle Model System (edit) |
10.1128/SPECTRUM.00781-22 |
| 2022-07-06 |
Clinical and epidemiological characteristics of SARS-CoV-2 Infection in Los Angeles County youth during the first year of the pandemic (edit) |
10.1016/J.IJID.2022.06.040 |
| 2022-07-06 |
Vaccination Is Associated With Shorter Time to Target Cycle Threshold Value in Patients With SARS-CoV-2 Omicron Variant (edit) |
10.3389/FCIMB.2022.943407 |
| 2022-07-06 |
SARS-CoV-2 seroprevalence among public school staff in Metro Vancouver after the first Omicron wave in British Columbia, Canada (edit) |
10.1101/2022.07.04.22277230 |
| 2022-07-05 |
Saponin and Immune Stimulant Based Gargles and Nasal Rinses: A Potential Virucidal for Preventive Management of SARS-CoV-2 Infection? (edit) |
10.14218/ERHM.2021.00007 |
| 2022-07-05 |
Hygiene in der Dermatologie: SARS-CoV-2 und weitere Virus-Varianten (edit) |
10.1055/A-1703-1692 |
| 2022-07-04 |
Investigating the influence of shift work rosters on stress measured as cortisol in hair during the SARS-CoV-2 pandemic (edit) |
10.1016/J.PSYNEUEN.2022.105858 |
| 2022-07-04 |
Lack of Difference in Tocilizumab Efficacy in the Treatment of Severe COVID-19 Caused by Different SARS-CoV-2 Variants (edit) |
10.3390/JPM12071103 |
| 2022-07-04 |
Virofree, an Herbal Medicine-Based Formula, Interrupts the Viral Infection of Delta and Omicron Variants of SARS-CoV-2 (edit) |
10.3389/FPHAR.2022.905197 |
| 2022-07-02 |
Quantification of SARS-CoV-2 RNA in wastewater treatment plants mirrors the pandemic trend in Hong Kong (edit) |
10.1016/J.SCITOTENV.2022.157121 |
| 2022-07-02 |
Importance score of SARS-CoV-2 genome predicts the death risk of COVID-19 (edit) |
10.1038/S41420-022-01100-7 |
| 2022-07-01 |
CRISPR-based assays for rapid detection of SARS-CoV-2 (edit) |
10.1016/J.YMETH.2020.10.003 |
| 2022-07-01 |
Suspected Cat-to-Human Transmission of SARS-CoV-2, Thailand, July–September 2021 (edit) |
10.3201/EID2807.212605 |
| 2022-07-01 |
Regional clustering and waves patterns due to COVID-19 by the index virus and the lambda/gamma, and delta/omicron SARS-CoV-2 variants in Peru (edit) |
10.12688/GATESOPENRES.13644.1 |
| 2022-07-01 |
Monkeypox genomic surveillance will challenge lessons learned from SARS-CoV-2 (edit) |
10.1016/S0140-6736(22)01106-0 |
| 2022-07-01 |
An alternative to airborne droplet transmission route of SARS-CoV-2, the feco-oral route, as a factor shaping COVID-19 pandemic (edit) |
10.1016/J.MEHY.2022.110903 |
| 2022-07-01 |
SARS-CoV-2 vaccine safety in adolescents with inflammatory rheumatic and musculoskeletal diseases and adults with juvenile idiopathic arthritis: data from the EULAR COVAX physician-reported registry (edit) |
10.1136/RMDOPEN-2022-002322 |
| 2022-07-01 |
Incidence and clinical phenotype of multisystem inflammatory syndrome in children after infection with the SARS-CoV-2 delta variant by vaccination status: a Danish nationwide prospective cohort study (edit) |
10.1016/S2352-4642(22)00100-6 |
| 2022-07-01 |
Modeling mutational effects on biochemical phenotypes using convolutional neural networks: application to SARS-CoV-2 (edit) |
10.1016/J.ISCI.2022.104500 |
| 2022-07-01 |
Viral load is associated with mitochondrial dysfunction and altered monocyte phenotype in acute severe SARS-CoV-2 infection (edit) |
10.1016/J.INTIMP.2022.108697 |
| 2022-07-01 |
Hematological Findings and Alteration of Oxidative Stress Markers in Hospitalized Patients with SARS-COV-2 (edit) |
10.2478/PRILOZI-2022-0029 |
| 2022-07-01 |
Durability of Humoral and Cellular Immunity after an Extended Primary Series with Heterologous Inactivated SARS-CoV-2 Prime-Boost and ChAdOx1 nCoV-19 in Dialysis Patients (ICON3) (edit) |
10.3390/VACCINES10071064 |
| 2022-07-01 |
Durability of SARS-CoV-2 specific immune response following different primary prime-boost vaccine platforms and subsequent humoral response to booster dose among liver transplant recipients (edit) |
10.1016/S0168-8278(22)01927-4 |
| 2022-07-01 |
Immunogenicity and safety of heterologous versus homologous prime-boost regimens with adenoviral vectored and mRNA SARS-CoV-2 vaccine in liver transplant recipients: a prospective study (edit) |
10.1016/S0168-8278(22)01860-8 |
| 2022-07-01 |
Safety and protective capability of an inactivated SARS-CoV-2 vaccine on pregnancy, lactation and the growth of offspring in hACE2 mice (edit) |
10.1016/J.VACCINE.2022.06.020 |
| 2022-07-01 |
A surge of pediatric hepatitis: Why SARS-CoV-2 should be considered guilty until proven innocent (edit) |
10.1016/J.AMSU.2022.103956 |
| 2022-07-01 |
Parálisis de cuerda vocal tras vacunación contra el SARS-CoV-2 (edit) |
10.1016/J.MEDCLI.2021.12.013 |
| 2022-07-01 |
Vocal fold palsy after vaccination against SARS-CoV-2 (edit) |
10.1016/J.MEDCLE.2021.12.008 |
| 2022-07-01 |
What SARS-CoV-2 does to our brains (edit) |
10.1016/J.IMMUNI.2022.06.013 |
| 2022-07-01 |
Development of a cost-effective ovine antibody-based therapy against SARS-CoV-2 infection and contribution of antibodies specific to the spike subunit proteins (edit) |
10.1016/J.ANTIVIRAL.2022.105332 |
| 2022-07-01 |
The Seroprevalence of SARS-CoV-2 IgG Antibodies in Children Hospitalized for Reasons Other Than COVID-19 (edit) |
10.3390/JCM11133819 |
| 2022-07-01 |
Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination (edit) |
10.1038/S41586-022-04865-0 |
| 2022-07-01 |
Increased memory B cell potency and breadth after a SARS-CoV-2 mRNA boost (edit) |
10.1038/S41586-022-04778-Y |
| 2022-07-01 |
Author Correction: Bat coronaviruses related to SARS-CoV-2 and infectious for human cells (edit) |
10.1038/S41586-022-05048-7 |
| 2022-07-01 |
T-cell proliferation assay for the detection of SARS-CoV-2-specific T-cells (edit) |
10.1016/J.CCA.2022.05.025 |
| 2022-07-01 |
A Prospective Observational Cohort Comparison of SARS-CoV-2 Seroprevalence Between Paramedics and Matched Blood Donors in Canada During the COVID-19 Pandemic (edit) |
10.1016/J.ANNEMERGMED.2022.03.009 |
| 2022-07-01 |
Serological testing for SARS-CoV-2 antibodies in clinical practice: A comparative diagnostic accuracy study (edit) |
10.1111/ALL.15206 |
| 2022-07-01 |
SARS-CoV-2 and influenza coinfection throughout the COVID-19 pandemic: an assessment of coinfection rates, cohort characteristics, and clinical outcomes (edit) |
10.1093/PNASNEXUS/PGAC071 |
| 2022-07-01 |
Quantifying the immunological distinctiveness of emerging SARS-CoV-2 variants in the context of prior regional herd exposure (edit) |
10.1093/PNASNEXUS/PGAC105 |
| 2022-07-01 |
Modeling pandemic to endemic patterns of SARS-CoV-2 transmission using parameters estimated from animal model data (edit) |
10.1093/PNASNEXUS/PGAC096 |
| 2022-07-01 |
Quarantine and serial testing for variants of SARS-CoV-2 with benefits of vaccination and boosting on consequent control of COVID-19 (edit) |
10.1093/PNASNEXUS/PGAC100 |
| 2022-06-30 |
A Topology-Matching Spike Protein-Capping Tetrahedral DNA Nanocrown for SARS-CoV-2 Neutralization (edit) |
10.31635/CCSCHEM.022.202201945 |
| 2022-06-30 |
Is There a Correlation Between the Cycle Threshold of SARS-CoV-2 RT-PCR and the Clinical Course of COVID-19? (edit) |
10.4274/ATFM.GALENOS.2022.97658 |
| 2022-06-30 |
An Altered Metabolism in Leukocytes Showing in vitro igG Memory From SARS-CoV-2-Infected Patients (edit) |
10.3389/FMOLB.2022.894207 |
| 2022-06-29 |
Duration of Shedding of Culturable Virus in SARS-CoV-2 Omicron (BA.1) Infection (edit) |
10.1056/NEJMC2202092 |
| 2022-06-29 |
Analysis of SARS-CoV-2 in Nasopharyngeal Samples from Patients with COVID-19 Illustrates Population Variation and Diverse Phenotypes, Placing the Growth Properties of Variants of Concern in Context with Other Lineages (edit) |
10.1128/MSPHERE.00913-21 |
| 2022-06-29 |
Contrasting Epidemiology and Population Genetics of COVID-19 Infections Defined by Multilocus Genotypes in SARS-CoV-2 Genomes Sampled Globally (edit) |
10.3390/V14071434 |
| 2022-06-29 |
Global m6A RNA Methylation in SARS-CoV-2 Positive Nasopharyngeal Samples in a Mexican Population: A First Approximation Study (edit) |
10.3390/EPIGENOMES6030016 |
| 2022-06-29 |
Insertion-and-Deletion Mutations between the Genomes of SARS-CoV, SARS-CoV-2, and Bat Coronavirus RaTG13 (edit) |
10.1128/SPECTRUM.00716-22 |
| 2022-06-29 |
Transmission of SARS-CoV-2 on Cold-Chain Food: Precautions Can Effectively Reduce the Risk (edit) |
10.1007/S12560-022-09521-4 |
| 2022-06-29 |
Entorhinal Cortex and Persistent Olfactory Loss in COVID-19 Patients: A Neuroanatomical Hypothesis. Comment on Fiorentino et al. Correlations between Persistent Olfactory and Semantic Memory Disorders after SARS-CoV-2 Infection. Brain Sci. 2022, 12, (edit) |
10.3390/BRAINSCI12070850 |
| 2022-06-28 |
A computational essential dynamics approach to investigate structural influences of ligand binding on Papain like protease from SARS-CoV-2 (edit) |
10.1016/J.COMPBIOLCHEM.2022.107721 |
| 2022-06-28 |
Putative Host-Derived Insertions in the Genomes of Circulating SARS-CoV-2 Variants (edit) |
10.1128/MSYSTEMS.00179-22 |
| 2022-06-27 |
Importance of external quality assessment for SARS-CoV-2 antigen detection during the COVID-19 pandemic (edit) |
10.1016/J.JCV.2022.105222 |
| 2022-06-27 |
Estimating decay curves of neutralizing antibodies to SARS-CoV-2 infection (edit) |
10.1093/IMAMMB/DQAC008 |
| 2022-06-27 |
Drug repurposing against main protease and RNA-dependent RNA polymerase of SARS-CoV-2 using molecular docking, MM-GBSA calculations and molecular dynamics (edit) |
10.1007/S11224-022-01999-9 |
| 2022-06-27 |
Effectiveness of Coronavirus Disease 2019 (COVID-19) mRNA Vaccines Against Infection During an Outbreak of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Beta (B.1.351) Variant in a Skilled Nursing Facility: Virginia, March–April 2021 (edit) |
10.1093/CID/CIAC526 |
| 2022-06-26 |
Evaluation of the DiaSorin LIAISON SARS-CoV-2 antigen assay on nasopharyngeal swabs in two different SARS-CoV-2 pandemic waves in Switzerland: The impact of the Omicron variant on its performance (edit) |
10.1016/J.JCVP.2022.100095 |
| 2022-06-25 |
Screening of honey bee pollen constituents against COVID-19: an emerging hot spot in targeting SARS-CoV-2-ACE-2 interaction (edit) |
10.1080/14786419.2022.2092865 |
| 2022-06-23 |
Differences in pediatric SARS-CoV-2 symptomology and Co-infection rates among COVID-19 Pandemic waves (edit) |
10.1016/J.JCV.2022.105220 |
| 2022-06-22 |
Time of Day of BNT162b2 COVID-19 Immunization Affects Total SARS-CoV-2 Antibody Levels but Not Neutralizing Activity (edit) |
10.1177/07487304221100951 |
| 2022-06-21 |
In-silico screening to delineate novel antagonists to SARS-CoV-2 nucleocapsid protein (edit) |
|
| 2022-06-21 |
The Cellular Characterization of SARS-CoV-2 Spike Protein in Virus-Infected Cells Using the Receptor Binding Domain Binding Specific Human Monoclonal Antibodies (edit) |
10.1128/JVI.00455-22 |
| 2022-06-20 |
SARS-CoV-2 Transmission Associated with an Indoor Music Event That Required Proof of Full Vaccination Against COVID-19 Prior to Entry—Seattle, July 2021 (edit) |
10.1093/CID/CIAC494 |
| 2022-06-20 |
SARS-CoV-2 infection and seizures: the perfect storm (edit) |
10.31083/J.JIN2104115 |
| 2022-06-19 |
Cerebral vasospasm after subarachnoid hemorrhage from intracranial aneurysm rupture in SARS-CoV-2 positive patients. A retrospective review from two Bulgarian hospitals (edit) |
10.1080/13102818.2022.2092421 |
| 2022-06-18 |
Ligand-based and structure-based studies to develop predictive models for SARS-CoV-2 main protease inhibitors through the 3d-qsar.com portal (edit) |
|
| 2022-06-17 |
QSAR, homology modeling, and docking simulation on SARS-CoV-2 and pseudomonas aeruginosa inhibitors, ADMET, and molecular dynamic simulations to find a possible oral lead candidate (edit) |
|
| 2022-06-17 |
Comparison of commercial SARS-CoV-2 surrogate neutralization assays with a full virus endpoint dilution neutralization test in two different cohorts (edit) |
10.1016/J.JVIROMET.2022.114569 |
| 2022-06-17 |
SARS-CoV-2: phenotype, genotype, and characterization of different variants (edit) |
10.1186/S11658-022-00352-6 |
| 2022-06-17 |
Early Emergence and Dispersal of Delta SARS-CoV-2 Lineage AY.99.2 in Brazil (edit) |
10.3389/FMED.2022.930380 |
| 2022-06-17 |
Analysis of 6.4 million SARS-CoV-2 genomes identifies mutations associated with fitness (edit) |
10.1126/SCIENCE.ABM1208 |
| 2022-06-17 |
A global lipid map reveals host dependency factors conserved across SARS-CoV-2 variants (edit) |
10.1038/S41467-022-31097-7 |
| 2022-06-17 |
Electrostatic features for the Receptor binding domain of SARS-COV-2 wildtype and its variants. Compass to the severity of the future variants with the charge-rule (edit) |
10.1101/2022.06.16.496458 |
| 2022-06-17 |
Abnormal antibodies to self-carbohydrates in SARS-CoV-2-infected patients (edit) |
10.1093/PNASNEXUS/PGAC062 |
| 2022-06-17 |
An intranasally administrated SARS-CoV-2 beta variant subunit booster vaccine prevents beta variant replication in rhesus macaques (edit) |
10.1093/PNASNEXUS/PGAC091 |
| 2022-06-15 |
De Novo design of potential inhibitors against SARS-CoV-2 Mpro (edit) |
|
| 2022-06-15 |
Fcγ-Receptor-Based Enzyme-Linked Immunosorbent Assays for Sensitive, Specific, and Persistent Detection of Anti-SARS-CoV-2 Nucleocapsid Protein IgG Antibodies in Human Sera (edit) |
10.1128/JCM.00075-22 |
| 2022-06-14 |
Immune boosting by B.1.1.529 (Omicron) depends on previous SARS-CoV-2 exposure (edit) |
10.1126/SCIENCE.ABQ1841 |
| 2022-06-14 |
SARS-CoV-2 Risk Quantification Model and Validation Based on Large-Scale Dutch Test Events (edit) |
10.3390/IJERPH19127238 |
| 2022-06-14 |
Spatial Sampling Design to Improve the Efficiency of the Estimation of the Critical Parameters of the SARS-CoV-2 Epidemic (edit) |
10.2478/JOS-2022-0019 |
| 2022-06-13 |
Molecular and computational analysis of spike protein of newly emerged omicron variant in comparison to the delta variant of SARS-CoV-2 in Iraq (edit) |
10.1007/S11033-022-07545-4 |
| 2022-06-13 |
RelCoVax®, a two antigen subunit protein vaccine candidate against SARS-CoV-2 induces strong immune responses in mice (edit) |
|
| 2022-06-13 |
SARS-CoV-2 IgG Antibody Levels After Inactivated Vaccine (CoronaVac) among Elderly (edit) |
10.36519/IDCM.2022.115 |
| 2022-06-12 |
Targeting SARS-CoV-2 non-structural protein 13 via helicase-inhibitor-repurposing and non-structural protein 16 through pharmacophore-based screening (edit) |
10.1007/S11030-022-10468-8 |
| 2022-06-11 |
Antibody-nanobody combination increases their neutralizing activity against SARS-CoV-2 and nanobody H11-H4 is effective against Alpha, Kappa and Delta variants (edit) |
10.1038/S41598-022-14263-1 |
| 2022-06-11 |
Epitope identification of SARS-CoV-2 structural proteins using in silico approaches to obtain a conserved rational immunogenic peptide (edit) |
|
| 2022-06-11 |
Can machines learn the mutation signatures of SARS-CoV-2 and enable viral-genotype guided predictive prognosis? (edit) |
10.1016/J.JMB.2022.167684 |
| 2022-06-10 |
High and Sustained Ex Vivo Frequency but Altered Phenotype of SARS-CoV-2-Specific CD4+ T-Cells in an Anti-CD20-Treated Patient with Prolonged COVID-19 (edit) |
10.3390/V14061265 |
| 2022-06-10 |
Neutralising reactivity against SARS-CoV-2 Delta and Omicron variants by vaccination and infection history (edit) |
10.1186/S13073-022-01066-2 |
| 2022-06-09 |
Seroprevalence of SARS-CoV-2 on health professionals via Bayesian estimation: a Brazilian case study before and after vaccines (edit) |
|
| 2022-06-09 |
Implementation of Immuno-chemoinformatics Approaches to Construct Multi-epitope for Vaccine Development against Omicron and Delta SARS-CoV-2 Variants Implementación de enfoques inmunoquimioinformáticos para construir múltiples epítopos para la vacun (edit) |
|
| 2022-06-09 |
Binding of the SARS-CoV-2 envelope E protein to human BRD4 is essential for infection (edit) |
10.1016/J.STR.2022.05.020 |
| 2022-06-09 |
A diminished immune response underlies age-related SARS-CoV-2 pathologies (edit) |
|
| 2022-06-09 |
An influenza virus vector candidate vaccine stably expressing SARS-CoV-2 receptor-binding domain produces high and long-lasting neutralizing antibodies in mice (edit) |
10.1016/J.VETMIC.2022.109491 |
| 2022-06-09 |
Mitigation of SARS-CoV-2 transmission at a large public university (edit) |
10.1038/S41467-022-30833-3 |
| 2022-06-09 |
Induction of high affinity monoclonal antibodies against SARS-CoV-2 variant infection using a DNA prime-protein boost strategy (edit) |
10.1186/S12929-022-00823-0 |
| 2022-06-08 |
A So-Far Overlooked Secondary Conformation State in the Binding Mode of SARS-CoV-2 Spike Protein to Human ACE2 and Its Conversion Rate Are Crucial for Estimating Infectivity Efficacy of the Underlying Virus Variant (edit) |
10.1128/JVI.00685-22 |
| 2022-06-08 |
Do SNPs in Glutathione S-Transferase-Omega Allow Predictions of the Susceptibility of Vertebrates to SARS-CoV-2? (edit) |
10.20455/ROS.2022.C805 |
| 2022-06-08 |
SARS-CoV-2 Detection Limits in Swab and Gargle Samples by Comparing Antigen and RT-qPCR Testing (edit) |
10.3390/COVID2060056 |
| 2022-06-08 |
SARS-CoV-2 Mutant Spectra at Different Depth Levels Reveal an Overwhelming Abundance of Low Frequency Mutations (edit) |
10.3390/PATHOGENS11060662 |
| 2022-06-08 |
Durability analysis of the highly effective BNT162b2 vaccine against COVID-19 (edit) |
10.1093/PNASNEXUS/PGAC082 |
| 2022-06-07 |
Clinical Profiles at the Time of Diagnosis of SARS-CoV-2 Infection in Costa Rica During the Pre-vaccination Period Using a Machine Learning Approach (edit) |
|
| 2022-06-07 |
Computational repurposing approach for targeting the critical spike mutations in B.1.617.2 (delta), AY.1 (delta plus) and C.37 (lambda) SARS-CoV-2 variants using exhaustive structure-based virtual screening, molecular dynamic simulations and MM-PBSA (edit) |
|
| 2022-06-07 |
A modified porous silicon microparticle potentiates protective systemic and mucosal immunity for SARS-CoV-2 subunit vaccine (edit) |
10.1016/J.TRSL.2022.06.004 |
| 2022-06-07 |
Metagenomic pipeline for identifying co-infections among distinct SARS-CoV-2 variants of concern: study cases from Alpha to Omicron (edit) |
10.1038/S41598-022-13113-4 |
| 2022-06-07 |
Insight towards the effect of the multi basic cleavage site of SARS-CoV-2 spike protein on cellular proteases (edit) |
10.1016/J.VIRUSRES.2022.198845 |
| 2022-06-07 |
Paradoxes of pandemic infection control: Proximity, pace and care within and beyond SARS-CoV-2 (edit) |
10.1016/J.SSMQR.2022.100110 |
| 2022-06-06 |
COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant and implications for vaccination (edit) |
10.1098/RSIF.2021.0900 |
| 2022-06-06 |
Insight towards the effect of the multi basic cleavage site of SARS-CoV-2 spike protein on cellular proteases (edit) |
|
| 2022-06-06 |
Omicron-specific mRNA vaccination alone and as a heterologous booster against SARS-CoV-2 (edit) |
10.1038/S41467-022-30878-4 |
| 2022-06-06 |
Wastewater surveillance of SARS-CoV-2 in dormitories as a part of comprehensive university campus COVID-19 monitoring (edit) |
10.1016/J.ENVRES.2022.113580 |
| 2022-06-06 |
Classification of SARS-CoV-2 viral genome sequences using Neurochaos Learning (edit) |
10.1007/S11517-022-02591-3 |
| 2022-06-06 |
Efferocytosis of SARS-CoV-2-infected dying cells impairs macrophage anti-inflammatory functions and clearance of apoptotic cells (edit) |
10.7554/ELIFE.74443 |
| 2022-06-06 |
Deleterious effects of nervous system in the offspring following maternal SARS-CoV-2 infection during the COVID-19 pandemic (edit) |
10.1038/S41398-022-01985-Z |
| 2022-06-05 |
Long-range enhancement of N501Y-endowed mouse infectivity of SARS-CoV-2 by the non-RBD mutations of Ins215KLRS and H655Y (edit) |
10.1186/S13062-022-00325-X |
| 2022-06-05 |
Development of Nested PCR for SARS-CoV-2 Detection and Its Application for Diagnosis of Active Infection in Cats (edit) |
10.3390/VETSCI9060272 |
| 2022-06-04 |
In silico SARS-CoV-2 vaccine development for Omicron strain using reverse vaccinology (edit) |
10.1007/S13258-022-01255-8 |
| 2022-06-04 |
Appearance and re-appearance of zoonotic disease during the pandemic period: long-term monitoring and analysis of zoonosis is crucial to confirm the animal origin of SARS-CoV-2 and monkeypox virus (edit) |
10.1080/01652176.2022.2086718 |
| 2022-06-03 |
Potential of antiviral peptide-based SARS-CoV-2 inactivators to combat COVID-19 (edit) |
10.1371/JOURNAL.PONE.0268919 |
| 2022-06-03 |
Manufacturer Signal-to-Cutoff Threshold Underestimates Cumulative Incidence of SARS-CoV-2 Infection: Evidence from the Los Angeles Firefighters Study (edit) |
10.1093/JALM/JFAC034 |
| 2022-06-03 |
The impact of pre-existing thyroid diseases on susceptibility to respiratory infections or self-reported sickness during the SARS-CoV-2 pandemic (edit) |
10.20945/2359-3997000000436 |
| 2022-06-02 |
Profiling of lung SARS-CoV-2 and influenza virus infection dissects virus-specific host responses and gene signatures (edit) |
10.1183/13993003.01881-2021 |
| 2022-06-02 |
Identification of conserved regions from 230,163 SARS-CoV-2 genomes and their use in diagnostic PCR primer design (edit) |
10.1007/S13258-022-01264-7 |
| 2022-06-02 |
A Universal Fluorescent Immunochromatography Assay Based on Quantum Dot Nanoparticles for the Rapid Detection of Specific Antibodies against SARS-CoV-2 Nucleocapsid Protein (edit) |
10.3390/IJMS23116225 |
| 2022-06-02 |
A Tale of Three Recent Pandemics: Influenza, HIV and SARS-CoV-2 (edit) |
10.3389/FMICB.2022.889643 |
| 2022-06-02 |
Emergency SARS-CoV-2 variants of concern: rapidly direct RT-qPCR detection without RNA extraction, clinical comparison, cost-effective, and high-throughput (edit) |
10.18632/AGING.204095 |
| 2022-06-01 |
SARS-CoV-2 triggering autoimmune diseases (edit) |
10.1016/J.CYTO.2022.155873 |
| 2022-06-01 |
Precision health diagnostic and surveillance network uses S gene target failure (SGTF) combined with sequencing technologies to track emerging SARS-CoV-2 variants (edit) |
10.1002/IID3.634 |
| 2022-06-01 |
The SARS-CoV2 envelope differs from host cells, exposes procoagulant lipids, and is disrupted in vivo by oral rinses (edit) |
10.1016/J.JLR.2022.100208 |
| 2022-06-01 |
Perceptions of the ethical permissibility of strict travel restrictions to mitigate transmission of SARS-CoV-2 (edit) |
10.1016/J.TRIP.2022.100577 |
| 2022-06-01 |
The level of depressive, anxiety and obsessive-compulsive psychopathological dimensions in symptomatic versus asymptomatic SARS-CoV-2 infected pregnant women (edit) |
10.1192/J.EURPSY.2022.1372 |
| 2022-06-01 |
Spherical neutralizing aptamer suppresses SARS-CoV-2 Omicron escape (edit) |
10.1016/J.NANTOD.2022.101499 |
| 2022-06-01 |
Ongoing positive selection drives the evolution of SARS-CoV-2 genomes (edit) |
10.1016/J.GPB.2022.05.009 |
| 2022-06-01 |
Decontamination of SARS-CoV-2 from cold-chain food packaging provides no marginal benefit in risk reduction to food workers (edit) |
10.1016/J.FOODCONT.2022.108845 |
| 2022-06-01 |
SARS-CoV-2 cycle threshold (Ct) values predict future COVID-19 cases (edit) |
10.1016/J.JCV.2022.105153 |
| 2022-06-01 |
IMPACT OF HYPERTENSION AS AN ADDITIONAL RISK FACTOR IN CARDIORESPIRATORY STATUS OF POST SARS-COV-2 INFECTED SUBJECTS (edit) |
10.1097/01.HJH.0000837180.39534.C1 |
| 2022-06-01 |
WITHDRAWN: Elevated histamine etiology model for most major vaccine associated adverse events including SARS-CoV-2 spike vaccines (edit) |
10.1016/J.MEHY.2022.110893 |
| 2022-06-01 |
Engineered extracellular vesicles antagonize SARS-CoV-2 infection by inhibiting mTOR signaling (edit) |
10.1016/J.BBIOSY.2022.100042 |
| 2022-06-01 |
Comparable neutralisation evasion of SARS-CoV-2 omicron subvariants BA.1, BA.2, and BA.3 (edit) |
10.1016/S1473-3099(22)00224-9 |
| 2022-06-01 |
Rapid Increase of Community SARS-CoV-2 Seroprevalence during Second Wave of COVID-19, Yaoundé, Cameroon (edit) |
10.3201/EID2806.212580 |
| 2022-06-01 |
The Ministry of Religious Congregations to People Affected by the SARS-CoV-2 Coronavirus in Poland: Geographies of Care During the COVID-19 Pandemic (edit) |
10.1007/S10943-022-01570-0 |
| 2022-06-01 |
Relationship between SARS-CoV-2 and hearing loss: A mini-review (edit) |
10.1177/20101058221139957 |
| 2022-05-31 |
High-resolution analysis of long-term serum antibodies in humans following convalescence of SARS-CoV-2 infection (edit) |
10.1038/S41598-022-12032-8 |
| 2022-05-31 |
Target and drug predictions for SARS-CoV-2 infection in hepatocellular carcinoma patients (edit) |
10.1371/JOURNAL.PONE.0269249 |
| 2022-05-31 |
Amentoflavone derivatives significantly act towards the main protease (3CLPRO/MPRO) of SARS-CoV-2: in silico admet profiling, molecular docking, molecular dynamics simulation, network pharmacology (edit) |
10.1007/S11030-022-10459-9 |
| 2022-05-31 |
Atomic-Resolution Structure of SARS-CoV-2 Nucleocapsid Protein N-Terminal Domain (edit) |
10.1021/JACS.2C03320 |
| 2022-05-31 |
Seeking antiviral drugs to inhibit SARS-CoV-2 RNA dependent RNA polymerase: A molecular docking analysis (edit) |
10.1371/JOURNAL.PONE.0268909 |
| 2022-05-31 |
In Silico Identification of Potential Inhibitors of the SARS-CoV-2 Nucleocapsid Through Molecular Docking-Based Drug Repurposing (edit) |
|
| 2022-05-31 |
Assessing the Reliability of SARS-CoV-2 Neutralization Studies That Use Post-Vaccination Sera (edit) |
10.3390/VACCINES10060850 |
| 2022-05-31 |
Genome Sequencing of Omicron Variants of SARS-CoV-2 Circulating in Bangladesh during the Third Wave of the COVID-19 Pandemic (edit) |
10.1128/MRA.00381-22 |
| 2022-05-31 |
Mask wearing in community settings reduces SARS-CoV-2 transmission (edit) |
10.1073/PNAS.2119266119 |
| 2022-05-31 |
Mutational analysis of SARS-CoV-2 variants of concern reveals key tradeoffs between receptor affinity and antibody escape (edit) |
10.1371/JOURNAL.PCBI.1010160 |
| 2022-05-30 |
Prevalence and Dynamics of SARS-CoV-2 Antibodies in the Population of St. Petersburg, Russia (edit) |
10.1007/S44197-022-00041-9 |
| 2022-05-30 |
Phytochemistry, biological activities and in silico molecular docking studies of Oxalis pes-caprae L. compounds against SARS-CoV-2 (edit) |
|
| 2022-05-30 |
Early detection and improved genomic surveillance of SARS-CoV-2 variants from deep sequencing data (edit) |
10.1016/J.ISCI.2022.104487 |
| 2022-05-30 |
Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of Omicron in Australia (edit) |
10.1038/S41564-022-01135-7 |
| 2022-05-30 |
Cell response analysis in SARS-CoV-2 infected bronchial organoids (edit) |
10.1038/S42003-022-03499-2 |
| 2022-05-30 |
Vaccines Associated Cardiac Adverse Events, Including SARS-Cov-2 Myocarditis, Elevated Histamine Etiology Hypothesis (edit) |
10.54289/JVVD2200108 |
| 2022-05-29 |
Real-time allelic assays of SARS-CoV-2 variants to enhance sewage surveillance (edit) |
|
| 2022-05-29 |
A subunit vaccine candidate based on the Spike protein of SARS-CoV-2 prevents infectious virus shedding in cats (edit) |
10.1016/J.RVSC.2022.05.003 |
| 2022-05-29 |
Could the SARS-CoV-2 Outbreak Cause An Increase In Rickettsia Infection? North Cyprus Observation (edit) |
10.19127/MBSJOHS.1082154 |
| 2022-05-28 |
Identification and application of a pair of noncompeting monoclonal antibodies broadly binding to the nucleocapsid proteins of SARS-CoV-2 variants including Omicron (edit) |
10.1186/S12985-022-01827-W |
| 2022-05-28 |
GMI, a protein from Ganoderma microsporum, induces ACE2 degradation to alleviate infection of SARS-CoV-2 Spike-pseudotyped virus (edit) |
10.1016/J.PHYMED.2022.154215 |
| 2022-05-27 |
Computational investigation of benzalacetophenone derivatives against SARS-CoV-2 as potential multi-target bioactive compounds (edit) |
|
| 2022-05-27 |
Transmission of SARS-CoV-2 from humans to animals and potential host adaptation (edit) |
10.1038/S41467-022-30698-6 |
| 2022-05-27 |
The mechanisms of catalysis and ligand binding for the SARS-CoV-2 NSP3 macrodomain from neutron and x-ray diffraction at room temperature (edit) |
10.1126/SCIADV.ABO5083 |
| 2022-05-27 |
Broadly recognized, cross-reactive SARS-CoV-2 CD4 T cell epitopes are highly conserved across human coronaviruses and presented by common HLA alleles (edit) |
10.1016/J.CELREP.2022.110952 |
| 2022-05-27 |
The COVID-19 pandemic: SARS-CoV-2, childhood hepatitis and monkeypox raise five new questions for the global health research community (edit) |
10.7189/JOGH.12.01002 |
| 2022-05-27 |
Assessing the impact of lateral flow testing strategies on within-school SARS-CoV-2 transmission and absences: A modelling study (edit) |
10.1371/JOURNAL.PCBI.1010158 |
| 2022-05-27 |
Time Trend in SARS-CoV-2 Seropositivity, Surveillance Detection- and Infection Fatality Ratio until Spring 2021 in the Tirschenreuth County—Results from a Population-Based Longitudinal Study in Germany (edit) |
10.3390/V14061168 |
| 2022-05-26 |
Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: Update of a living systematic review and meta-analysis (edit) |
10.1371/JOURNAL.PMED.1003987 |
| 2022-05-26 |
Parsing the role of NSP1 in SARS-CoV-2 infection (edit) |
|
| 2022-05-26 |
Genomic surveillance of SARS-CoV-2 in a university community: insights into tracking variants, transmission, and spread of Gamma (P.1) variant (edit) |
|
| 2022-05-26 |
Incidence of SARS-CoV-2 over four epidemic waves in a low-resource community in Rio de Janeiro, Brazil: A prospective cohort study (edit) |
10.1016/J.LANA.2022.100283 |
| 2022-05-26 |
Evolving strategy for an evolving virus: Development of real-time PCR assays for detecting all SARS-CoV-2 variants of concern (edit) |
10.1016/J.JVIROMET.2022.114553 |
| 2022-05-26 |
Excess Mortality on Italian Small Islands during the SARS-CoV-2 Pandemic: An Ecological Study (edit) |
10.3390/IDR14030043 |
| 2022-05-25 |
Single-cell RNA sequencing reveals immunological rewiring at the maternal-fetal interface following asymptomatic/mild SARS-CoV-2 infection (edit) |
|
| 2022-05-25 |
SARS-CoV-2 transmission from infected owner to household dogs and cats is associated to food sharing (edit) |
10.1016/J.IJID.2022.05.049 |
| 2022-05-25 |
Quantitative and ultrasensitive in situ immunoassay technology for SARS-CoV-2 detection in saliva (edit) |
10.1126/SCIADV.ABN3481 |
| 2022-05-25 |
A conserved subunit vaccine designed against SARS-CoV-2 variants showed evidence in neutralizing the virus (edit) |
10.1007/S00253-022-11988-X |
| 2022-05-25 |
Importance of the Precautionary Principle With Regard to the Risk of Exposure to Aerosols Containing Viral Loads of SARS-CoV-2 Present in Feces: In Perspective (edit) |
10.3389/FPUBH.2022.892290 |
| 2022-05-24 |
Deep phylogenetic-based clustering analysis uncovers new and shared mutations in SARS-CoV-2 variants as a result of directional and convergent evolution (edit) |
10.1371/JOURNAL.PONE.0268389 |
| 2022-05-24 |
The SARS-CoV-2 main protease doesn't induce cell death in human cells in vitro (edit) |
10.1371/JOURNAL.PONE.0266015 |
| 2022-05-24 |
Protective effect of a first SARS-CoV-2 infection from reinfection: a matched retrospective cohort study using PCR testing data in England (edit) |
10.1017/S0950268822000966 |
| 2022-05-24 |
SPIKES: Identification of physicochemical properties of spike proteins across diverse host species of SARS-CoV-2 (edit) |
|
| 2022-05-24 |
Anti-SARS-CoV-2 activity of various PET-bottled Japanese green teas and tea compounds in vitro (edit) |
10.1007/S00705-022-05483-X |
| 2022-05-24 |
SARS-CoV-2 and the Vaccination Hype (edit) |
10.56098/IJVTPR.V2I1.34 |
| 2022-05-24 |
Twin peaks: The Omicron SARS-CoV-2 BA.1 and BA.2 epidemics in England (edit) |
10.1126/SCIENCE.ABQ4411 |
| 2022-05-24 |
Epidemiological, virological and clinical features of SARS-CoV-2 among individuals during the first wave in Cameroon: Baseline analysis for the EDCTP PERFECT-Study RIA2020EF-3000 (edit) |
10.4081/JPHIA.2022.2142 |
| 2022-05-23 |
Seroprevalence of SARS-CoV-2 antibody among urban Iranian population: findings from the second large population-based cross-sectional study (edit) |
10.1186/S12889-022-13464-7 |
| 2022-05-23 |
The effect of the probiotic consortia on SARS-CoV-2 infection in ferrets and on human immune cell response in vitro (edit) |
10.1016/J.ISCI.2022.104445 |
| 2022-05-23 |
Seroprevalence of SARS-CoV-2 infection and associated factors among Bangladeshi slum and non-slum dwellers in pre-COVID-19 vaccination era: October 2020 to February 2021 (edit) |
10.1371/JOURNAL.PONE.0268093 |
| 2022-05-23 |
Characterization of the Interaction Between SARS-CoV-2 Membrane Protein (M) and Proliferating Cell Nuclear Antigen (PCNA) as a Potential Therapeutic Target (edit) |
10.3389/FCIMB.2022.849017 |
| 2022-05-23 |
AB1163 ATTITUDES AND HESITANCY IN PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES TOWARDS SARS-CoV-2 VACCINATION: A SINGLE-CENTER STUDY FROM BULGARIA (edit) |
10.1136/ANNRHEUMDIS-2022-EULAR.4447 |
| 2022-05-22 |
In-Silico Selection of Aptamer Targeting SARS-CoV-2 Spike Protein (edit) |
10.3390/IJMS23105810 |
| 2022-05-22 |
E2UbcH5B-derived peptide ligands target HECT E3-E2 binding site and block the Ub-dependent SARS-CoV-2 egression: A computational study (edit) |
|
| 2022-05-21 |
Tixagevimab and Cilgavimab (Evusheld) boosts antibody levels to SARS-CoV-2 in patients with multiple sclerosis on b-cell depleters (edit) |
10.1016/J.MSARD.2022.103905 |
| 2022-05-20 |
Twelve-Month Longitudinal Serology in SARS-CoV-2 Naïve and Experienced Vaccine Recipients and Unvaccinated COVID-19-Infected Individuals (edit) |
10.3390/VACCINES10050813 |
| 2022-05-20 |
Refolding of lid subdomain of SARS-CoV-2 nsp14 upon nsp10 interaction releases exonuclease activity (edit) |
10.1016/J.STR.2022.04.014 |
| 2022-05-20 |
A new RT-LAMP-on-a-Chip Instrument for SARS-CoV-2 diagnostics (edit) |
10.1016/J.MICROC.2022.107600 |
| 2022-05-20 |
Whole-genome sequencing of SARS-CoV-2 reveals diverse mutations in circulating Alpha and Delta variants during the first, second, and third waves of COVID-19 in South Kivu, east of the Democratic Republic of the Congo (edit) |
10.1016/J.IJID.2022.05.041 |
| 2022-05-20 |
Nanoparticle-delivered TLR4 and RIG-I agonists enhance immune response to SARS-CoV-2 subunit vaccine (edit) |
10.1016/J.JCONREL.2022.05.023 |
| 2022-05-20 |
Lebanese SARS-CoV-2 genomics: 24 months of the pandemic (edit) |
10.1016/J.VIRUSRES.2022.198824 |
| 2022-05-20 |
Molecular evolution and structural analyses of the spike glycoprotein from Brazilian SARS-CoV-2 genomes: the impact of selected mutations (edit) |
10.1080/07391102.2022.2076154 |
| 2022-05-19 |
Low expression of TMPRSS2-a SARS-CoV-2 internalization protease-associates with basal subtype of head and neck squamous cell carcinoma (edit) |
10.1016/J.TRANON.2022.101458 |
| 2022-05-19 |
Caspase-4/11 exacerbates disease severity in SARS-CoV-2 infection by promoting inflammation and immunothrombosis (edit) |
10.1073/PNAS.2202012119 |
| 2022-05-19 |
Identification of vaccine targets & design of vaccine against SARS-CoV-2 coronavirus using computational and deep learning-based approaches (edit) |
10.7717/PEERJ.13380 |
| 2022-05-19 |
SARS-CoV-2 delta variant infection in domestic dogs and cats, Thailand (edit) |
10.1038/S41598-022-12468-Y |
| 2022-05-19 |
Inactivating SARS-CoV-2 Surrogates on Surfaces Using Engineered Water Nanostructures Incorporated with Nature Derived Antimicrobials (edit) |
10.3390/NANO12101735 |
| 2022-05-19 |
Selection for infectivity profiles in slow and fast epidemics, and the rise of SARS-CoV-2 variants (edit) |
10.7554/ELIFE.75791 |
| 2022-05-19 |
Clinical Validation of a Rapid Variant-Proof RT-RPA Assay for the Detection of SARS-CoV-2 (edit) |
10.3390/DIAGNOSTICS12051263 |
| 2022-05-18 |
Distinguishing Admissions Specifically for COVID-19 From Incidental SARS-CoV-2 Admissions: National Retrospective Electronic Health Record Study (edit) |
10.2196/37931 |
| 2022-05-18 |
A Potent Neutralizing Nanobody Targeting the Spike Receptor-Binding Domain of SARS-CoV-2 and the Structural Basis of Its Intimate Binding (edit) |
10.3389/FIMMU.2022.820336 |
| 2022-05-18 |
Detecting Potentially Adaptive Mutations from the Parallel and Fixed Patterns in SARS-CoV-2 Evolution (edit) |
10.3390/V14051087 |
| 2022-05-18 |
Discovery of Natural Lead Compound from Dendrobium sp. against SARS-CoV-2 Infection (edit) |
10.3390/PH15050620 |
| 2022-05-18 |
Validation of a COVID-19 Job Exposure Matrix (COVID-19-JEM) for Occupational Risk of a SARS-CoV-2 Infection at Work: Using Data of Dutch Workers (edit) |
10.1093/ANNWEH/WXAC032 |
| 2022-05-18 |
Structural and functional analysis of an inter-Spike bivalent neutralizing antibody against SARS-CoV-2 variants (edit) |
10.1016/J.ISCI.2022.104431 |
| 2022-05-18 |
Paving the way to point of care (POC) devices for SARS-CoV-2 detection (edit) |
10.1016/J.TALANTA.2022.123542 |
| 2022-05-18 |
Natural Polyphenols, 1,2,3,4,6-O-Pentagalloyglucose and Proanthocyanidins, as Broad-Spectrum Anticoronaviral Inhibitors Targeting Mpro and RdRp of SARS-CoV-2 (edit) |
10.3390/BIOMEDICINES10051170 |
| 2022-05-18 |
Co-infection with SARS-CoV-2 Omicron and Delta variants revealed by genomic surveillance (edit) |
10.1038/S41467-022-30518-X |
| 2022-05-18 |
Evolutionary Traits and Genomic Surveillance of SARS-CoV-2 in South America (edit) |
10.1155/2022/8551576 |
| 2022-05-17 |
At Least Three Doses of Leading Vaccines Essential for Neutralisation of SARS-CoV-2 Omicron Variant (edit) |
10.3389/FIMMU.2022.883612 |
| 2022-05-17 |
The SARS-CoV-2 Variant Omicron Is Able to Escape Vaccine-Induced Humoral Immune Responses, but Is Counteracted by Booster Vaccination (edit) |
10.3390/VACCINES10050794 |
| 2022-05-17 |
Spectral and theoretical study of SARS-CoV-2 ORF10 protein interaction with endogenous and exogenous macroheterocyclic compounds (edit) |
10.1016/J.SAA.2022.121403 |
| 2022-05-17 |
Antibody engineering improves neutralization activity against K417 spike mutant SARS-CoV-2 variants (edit) |
10.1186/S13578-022-00794-7 |
| 2022-05-17 |
NGS data vectorization, clustering, and finding key codons in SARS-CoV-2 variations (edit) |
10.1186/S12859-022-04718-7 |
| 2022-05-17 |
Impact of natural selection on global patterns of genetic variation and association with clinical phenotypes at genes involved in SARS-CoV-2 infection (edit) |
10.1073/PNAS.2123000119 |
| 2022-05-17 |
Molecular Analysis of SARS-CoV-2 Lineages in Armenia (edit) |
10.3390/V14051074 |
| 2022-05-17 |
SARS-CoV-2 Omicron variant escapes neutralizing antibodies and T cell responses more efficiently than other variants in mild COVID-19 convalescents (edit) |
10.1016/J.XCRM.2022.100651 |
| 2022-05-17 |
Inactivation of SARS-CoV-2 by a chitosan/α-Ag2WO4 composite generated by femtosecond laser irradiation (edit) |
10.1038/S41598-022-11902-5 |
| 2022-05-17 |
The impacts of gradually terminating nonpharmaceutical interventions for SARS-CoV-2: A mathematical modelling analysis (edit) |
10.1016/J.FMRE.2022.05.007 |
| 2022-05-17 |
Lessons We Have Learned Regarding Seroprevalence in High and Low SARS-CoV-2 Contexts in Greece before the Omicron Pandemic Wave (edit) |
10.3390/IJERPH19106110 |
| 2022-05-16 |
Development of a new antigen-based microarray platform for screening and detection of human IgG antibodies against SARS-CoV-2 (edit) |
10.1038/S41598-022-10823-7 |
| 2022-05-16 |
IgG targeting distinct seasonal coronavirus- conserved SARS-CoV-2 spike subdomains correlates with differential COVID-19 disease outcomes (edit) |
10.1016/J.CELREP.2022.110904 |
| 2022-05-16 |
Multifaceted membrane binding head of the SARS-CoV-2 spike protein (edit) |
10.1016/J.CRSTBI.2022.05.001 |
| 2022-05-16 |
SARS-CoV-2 in silico binding affinity to human leukocyte antigen (HLA) Class II molecules predicts vaccine effectiveness across variants of concern (VOC) (edit) |
10.1038/S41598-022-11956-5 |
| 2022-05-16 |
Molecular docking analysis reveals the functional inhibitory effect of Genistein and Quercetin on TMPRSS2: SARS-COV-2 cell entry facilitator spike protein (edit) |
10.1186/S12859-022-04724-9 |
| 2022-05-16 |
Chimeric Virus-like Particle-Based COVID-19 Vaccine Confers Strong Protection against SARS-CoV-2 Viremia in K18-hACE2 Mice (edit) |
10.3390/VACCINES10050786 |
| 2022-05-16 |
Importance of Influenza Anti-Hemagglutinin Antibodies During the SARS-CoV-2 Pandemic in the 2019/2020 Epidemic Season in Poland (edit) |
10.12659/MSM.936495 |
| 2022-05-16 |
RT-qPCR-based tests for SARS-CoV-2 detection in pooled saliva samples for massive population screening to monitor epidemics (edit) |
10.1038/S41598-022-12179-4 |
| 2022-05-16 |
Appropriate relaxation of non-pharmaceutical interventions minimizes the risk of a resurgence in SARS-CoV-2 infections in spite of the Delta variant (edit) |
10.1371/JOURNAL.PCBI.1010054 |
| 2022-05-16 |
Six Feet under Microbiota: Microbiologic Contamination and Toxicity Profile in Three Urban Cemeteries from Lisbon, Portugal (edit) |
10.3390/TOXINS14050348 |
| 2022-05-16 |
Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2 (edit) |
10.1038/S41586-022-04856-1 |
| 2022-05-14 |
Interaction of the new inhibitor paxlovid (PF-07321332) and ivermectin with the monomer of the main protease SARS-CoV-2: A volumetric study based on molecular dynamics, elastic networks, classical thermodynamics and SPT (edit) |
10.1016/J.COMPBIOLCHEM.2022.107692 |
| 2022-05-14 |
Nasal vaccine or monoclonal therapy: Which is winning weapon against SARS-CoV-2 variants in 2022? (edit) |
10.7189/JOGH.12.03023 |
| 2022-05-13 |
Severe acute hepatitis in children: investigate SARS-CoV-2 superantigens (edit) |
10.1016/S2468-1253(22)00166-2 |
| 2022-05-13 |
Prevalence and prospective evaluation of cognitive dysfunctions after SARS due to SARS-CoV-2 virus. The COgnitiVID study (edit) |
10.1016/J.NEUROL.2022.03.014 |
| 2022-05-13 |
MAIT cell compartment characteristics are associated with the immune response magnitude to the BNT162b2 mRNA anti-SARS-CoV-2 vaccine (edit) |
10.1186/S10020-022-00484-7 |
| 2022-05-13 |
How Does Temperature Affect the Dynamics of SARS-CoV-2 M Proteins? Insights from Molecular Dynamics Simulations (edit) |
10.1007/S00232-022-00244-Y |
| 2022-05-13 |
Correction to “Differential Interactions between Human ACE2 and Spike RBD of SARS-CoV-2 Variants of Concern” (edit) |
10.1021/ACS.JCTC.2C00364 |
| 2022-05-13 |
Testing Affordable Strategies for the Computational Study of Reactivity in Cysteine Proteases: The Case of SARS-CoV-2 3CL Protease Inhibition (edit) |
10.1021/ACS.JCTC.2C00294 |
| 2022-05-12 |
The role of NSP6 in the biogenesis of the SARS-CoV-2 replication organelle (edit) |
10.1038/S41586-022-04835-6 |
| 2022-05-12 |
Safety of Vaccines against SARS-CoV-2 among Polish Patients with Multiple Sclerosis Treated with Disease-Modifying Therapies (edit) |
10.3390/VACCINES10050763 |
| 2022-05-12 |
Potential for a Plant-Made SARS-CoV-2 Neutralizing Monoclonal Antibody as a Synergetic Cocktail Component (edit) |
10.3390/VACCINES10050772 |
| 2022-05-12 |
B-Cell-Epitope-Based Fluorescent Quantum Dot Biosensors for SARS-CoV-2 Enable Highly Sensitive COVID-19 Antibody Detection (edit) |
10.3390/V14051031 |
| 2022-05-12 |
Structural dynamics of SARS-CoV-2 nucleocapsid protein induced by RNA binding (edit) |
10.1371/JOURNAL.PCBI.1010121 |
| 2022-05-12 |
SARS-CoV-2 RNA and N Antigen Quantification via Wastewater at the Campus Level, Building Cluster Level, and Individual-Building Level (edit) |
|
| 2022-05-12 |
Transmembrane Protease Serine 2 Proteolytic Cleavage of the SARS-CoV-2 Spike Protein: A Mechanistic Quantum Mechanics/Molecular Mechanics Study to Inspire the Design of New Drugs To Fight the COVID-19 Pandemic (edit) |
10.1021/ACS.JCIM.1C01561 |
| 2022-05-12 |
Invalidation of dieckol and 1,2,3,4,6-pentagalloylglucose (PGG) as SARS-CoV-2 main protease inhibitors and the discovery of PGG as a papain-like protease inhibitor (edit) |
10.1007/S00044-022-02903-0 |
| 2022-05-12 |
Structural insights of a highly potent pan-neutralizing SARS-CoV-2 human monoclonal antibody (edit) |
10.1073/PNAS.2120976119 |
| 2022-05-12 |
Mutations in spike protein T cell epitopes of SARS-COV-2 variants: Plausible influence on vaccine efficacy (edit) |
10.1016/J.BBADIS.2022.166432 |
| 2022-05-12 |
Human-to-dog transmission of SARS-CoV-2, Colombia (edit) |
10.1038/S41598-022-11847-9 |
| 2022-05-12 |
A diabetic milieu increases ACE2 expression and cellular susceptibility to SARS-CoV-2 infections in human kidney organoids and patient cells (edit) |
10.1016/J.CMET.2022.04.009 |
| 2022-05-12 |
Tuaimenal A, a Meroterpene from the Irish Deep-Sea Soft Coral Duva florida, Displays Inhibition of the SARS-CoV-2 3CLpro Enzyme (edit) |
10.1021/ACS.JNATPROD.2C00054 |
| 2022-05-11 |
SARS-CoV-2 Variants of Concern Hijack IFITM2 for Efficient Replication in Human Lung Cells (edit) |
10.1128/JVI.00594-22 |
| 2022-05-11 |
The Biological Interaction of SARS-CoV-2 Infection and Osteoporosis: A Preliminary Study (edit) |
10.3389/FCELL.2022.917907 |
| 2022-05-11 |
Understanding the Driving Forces That Trigger Mutations in SARS-CoV-2: Mutational Energetics and the Role of Arginine Blockers in COVID-19 Therapy (edit) |
10.3390/V14051029 |
| 2022-05-11 |
Hybrid drug-screening strategy identifies potential SARS-CoV-2 cell-entry inhibitors targeting human transmembrane serine protease (edit) |
10.1007/S11224-022-01960-W |
| 2022-05-11 |
Consensus Receptor-Binding Domain-Targeted Aptamer Selection and Designing of a Photonic Crystal-Decorated Aptasensor for SARS-CoV-2 (edit) |
10.1021/ACS.ANALCHEM.2C00937 |
| 2022-05-11 |
Mechanisms underlying inactivation of SARS-CoV-2 by nano-sized electrostatic atomized water particles (edit) |
10.1007/S11051-022-05485-5 |
| 2022-05-11 |
Phase Separation Drives SARS-CoV-2 Replication: A Hypothesis (edit) |
10.3389/FMOLB.2022.893067 |
| 2022-05-11 |
Assessing of Humoral Immunity to SARS-COV-2 in Residents of Orenburg During the Epidemic Period (edit) |
10.31631/20733046-2022-21-2-17-22 |
| 2022-05-11 |
Neuroinvasion and Neurotropism by SARS-CoV-2 Variants in the K18-hACE2 Mouse (edit) |
10.3390/V14051020 |
| 2022-05-11 |
Shared genetic background between SARS-CoV-2 infection and large artery stroke (edit) |
10.1177/17474930221095696 |
| 2022-05-10 |
Repurposing of FDA Approved Drugs Against SARS-CoV-2 Papain-Like Protease: Computational, Biochemical, and in vitro Studies (edit) |
10.3389/FMICB.2022.877813 |
| 2022-05-10 |
Cumulative SARS-CoV-2 mutations and corresponding changes in immunity in an immunocompromised patient indicate viral evolution within the host (edit) |
10.1038/S41467-022-30163-4 |
| 2022-05-10 |
Mutations in the nonstructural proteins of SARS-CoV-2 may contribute to adverse clinical outcome in patients with COVID-19 (edit) |
10.1016/J.IJID.2022.05.010 |
| 2022-05-10 |
Phylogenetic and amino acid signature analysis of the SARS-CoV-2s lineages circulating in Tunisia (edit) |
10.1016/J.MEEGID.2022.105300 |
| 2022-05-10 |
Sample Buffer Containing Guanidine-Hydrochloride Combines Biological Safety and RNA Preservation for SARS-CoV-2 Molecular Diagnostics (edit) |
10.3390/DIAGNOSTICS12051186 |
| 2022-05-09 |
A glucose-like metabolite deficient in diabetes inhibits cellular entry of SARS-CoV-2 (edit) |
10.1038/S42255-022-00567-Z |
| 2022-05-09 |
At-home sample collection is an effective strategy for diagnosis and management of symptomatic and asymptomatic SARS-CoV-2 carriers (edit) |
10.1186/S12879-022-07377-4 |
| 2022-05-09 |
The interplay between lncRNAs, RNA-binding proteins and viral genome during SARS-CoV-2 infection reveals strong connections with regulatory events involved in RNA metabolism and immune response (edit) |
10.7150/THNO.73268 |
| 2022-05-09 |
SARS-CoV-2 infection induces inflammatory bone loss in golden Syrian hamsters (edit) |
10.1038/S41467-022-30195-W |
| 2022-05-09 |
Insights into the Antimicrobial, Antioxidant, Anti-SARS-CoV-2 and Cytotoxic Activities of Pistacia lentiscus Bark and Phytochemical Profile; In Silico and In Vitro Study (edit) |
10.3390/ANTIOX11050930 |
| 2022-05-09 |
Rapid Hypermutation B Cell Trajectory Recruits Previously Primed B Cells Upon Third SARS-Cov-2 mRNA Vaccination (edit) |
10.3389/FIMMU.2022.876306 |
| 2022-05-09 |
Robust models of disease heterogeneity and control, with application to the SARS-CoV-2 epidemic (edit) |
10.1371/JOURNAL.PGPH.0000412 |
| 2022-05-08 |
ADAM10 and ADAM17 promote SARS‐CoV‐2 cell entry and spike protein‐mediated lung cell fusion (edit) |
10.15252/EMBR.202154305 |
| 2022-05-08 |
Longitudinal analyses reveal distinct immune response landscapes in lung and intestinal tissues from SARS-CoV-2-infected rhesus macaques (edit) |
10.1016/J.CELREP.2022.110864 |
| 2022-05-08 |
SARS-CoV-2 Envelope (E) Protein Binds and Activates TLR2 Pathway: A Novel Molecular Target for COVID-19 Interventions (edit) |
10.3390/V14050999 |
| 2022-05-07 |
SARS-CoV-2 vaccine effectiveness against infection, symptomatic and severe COVID-19: a systematic review and meta-analysis (edit) |
10.1186/S12879-022-07418-Y |
| 2022-05-07 |
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of ThymoQuinone Formula (TQF) for Treating Outpatient SARS-CoV-2 (edit) |
10.3390/PATHOGENS11050551 |
| 2022-05-06 |
Design of a Recombinant Multivalent Epitope Vaccine Based on SARS-CoV-2 and Its Variants in Immunoinformatics Approaches (edit) |
10.3389/FIMMU.2022.884433 |
| 2022-05-06 |
RHAMNETIN IS A BETTER INHIBITOR OF SARS-COV-2 2'-O-METHYLTRANSFERASE THAN DOLUTEGRAVIR: A COMPUTATIONAL PREDICTION (edit) |
10.21010/AJID.V16I2.9 |
| 2022-05-06 |
Analysis of a SARS-CoV-2 convalescent cohort identified a common strategy for escape of vaccine-induced anti-RBD antibodies by Beta and Omicron variants (edit) |
10.1016/J.EBIOM.2022.104025 |
| 2022-05-06 |
Identification of FDA-approved bifonazole as a SARS-CoV-2 blocking agent following a bioreporter drug screen (edit) |
10.1016/J.YMTHE.2022.04.025 |
| 2022-05-06 |
Rapid Generation of In-House Serological Assays Is Comparable to Commercial Kits Critical for Early Response to Pandemics: A Case With SARS-CoV-2 (edit) |
10.3389/FMED.2022.864972 |
| 2022-05-06 |
Determining the Efficacy of Various Governmental Interventions in Stemming the Spread of SARS-CoV-2 in Seven Locations (edit) |
10.3389/FPUBH.2022.828090 |
| 2022-05-06 |
Rapid response modeling of SARS-CoV-2 transmission (edit) |
10.1126/SCIENCE.ABP9498 |
| 2022-05-06 |
O efeito do vírus SARS-CoV-2 na audição de pacientes adultos / The effect of the SARS-CoV-2 virus on hearing in adult patients (edit) |
10.34119/BJHRV5N3-066 |
| 2022-05-05 |
Effects of spike protein and toxin-like peptides found in COVID-19 patients on human 3D neuronal/glial model undergoing differentiation: Possible implications for SARS-CoV-2 impact on brain development (edit) |
10.1016/J.REPROTOX.2022.04.011 |
| 2022-05-05 |
Four cases of audio-vestibular disorders related to immunisation with SARS-CoV-2 mRNA vaccines (edit) |
10.1080/14992027.2022.2056721 |
| 2022-05-04 |
Oral dysbiosis and its linkage with SARS-CoV-2 infection (edit) |
10.1016/J.MICRES.2022.127055 |
| 2022-05-04 |
Comparison of the Prevalence of Antibodies to SARS-CoV-2 in 9954 Recruits in the Korean Army Training Center with the General Korean Population of Equivalent Age Between September and November, 2020 (edit) |
10.12659/MSM.934926 |
| 2022-05-04 |
Antigenic Cross-Reactivity Between SARS-CoV-2 S1-RBD and Its Receptor ACE2 (edit) |
10.3389/FIMMU.2022.868724 |
| 2022-05-04 |
Identification of DAXX as a restriction factor of SARS-CoV-2 through a CRISPR/Cas9 screen (edit) |
10.1038/S41467-022-30134-9 |
| 2022-05-04 |
Synthesis, antimicrobial, molecular docking and molecular dynamics studies of lauroyl thymidine analogs against SARS-CoV-2: POM study and identification of the pharmacophore sites (edit) |
10.1016/J.BIOORG.2022.105850 |
| 2022-05-04 |
A Case Study to Dissect Immunity to SARS-CoV-2 in a Neonate Nonhuman Primate Model (edit) |
10.3389/FIMMU.2022.855230 |
| 2022-05-03 |
Pandemic, Epidemic, Endemic: B Cell Repertoire Analysis Reveals Unique Anti-Viral Responses to SARS-CoV-2, Ebola and Respiratory Syncytial Virus (edit) |
10.3389/FIMMU.2022.807104 |
| 2022-05-03 |
TNF-α+ CD4+ T cells dominate the SARS-CoV-2 specific T cell response in COVID-19 outpatients and are associated with durable antibodies (edit) |
10.1016/J.XCRM.2022.100640 |
| 2022-05-03 |
COVID-19 patient serum less potently inhibits ACE2-RBD binding for various SARS-CoV-2 RBD mutants (edit) |
10.1038/S41598-022-10987-2 |
| 2022-05-02 |
SARS-CoV-2/COVID-19 and its relationship with NOD2 and ubiquitination (edit) |
10.1016/J.CLIM.2022.109027 |
| 2022-05-02 |
Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike (edit) |
10.1016/J.CELL.2022.04.035 |
| 2022-05-02 |
Prediction of binding miRNAs involved with immune genes to the SARS-CoV-2 by using sequence features extraction and One-class SVM (edit) |
10.1016/J.IMU.2022.100958 |
| 2022-05-02 |
Predictive Ability of the MEWS, REMS, and RAPS in Geriatric Patients With SARS-CoV-2 Infection in the Emergency Department (edit) |
10.1017/DMP.2022.107 |
| 2022-05-02 |
Reply to “Intensification of an Essential Tremor by SARS-CoV-2” (edit) |
10.1007/S12311-022-01410-7 |
| 2022-05-02 |
Intensification of an Essential Tremor by SARS-CoV-2 (edit) |
10.1007/S12311-022-01409-0 |
| 2022-05-02 |
SARS-CoV-2 omicron variant and the future of the pandemic (edit) |
10.12968/DENU.2022.49.5.432 |
| 2022-05-01 |
Pasteurization, storage conditions and viral concentration methods influence RT-qPCR detection of SARS-CoV-2 RNA in wastewater (edit) |
10.1016/J.SCITOTENV.2022.153228 |
| 2022-05-01 |
Recognition and Cleavage of Human tRNA Methyltransferase TRMT1 by the SARS‐CoV‐2 Main Protease (edit) |
10.1096/FASEBJ.2022.36.S1.R4632 |
| 2022-05-01 |
Variation in ORF3a Protein of SARS‐CoV‐2 Decreases The Severity of Host Cell Damage (edit) |
10.1096/FASEBJ.2022.36.S1.R4149 |
| 2022-05-01 |
The Effect of Glycosylation Modulators on the Trafficking and Interaction of Spike Protein S1 Subunit and Angiotensin‐Converting Enzyme 2 (edit) |
10.1096/FASEBJ.2022.36.S1.R3340 |
| 2022-05-01 |
Synthesis of the transmembrane domain of the accessory protein ORF7a of SARS‐CoV‐2 using solid phase peptide synthesis and analyzing the oligomerization state (edit) |
10.1096/FASEBJ.2022.36.S1.R3870 |
| 2022-05-01 |
Going viral in the islet: mediators of SARS-CoV-2 entry beyond ACE2 (edit) |
10.1530/JME-21-0282 |
| 2022-05-01 |
Reducing occupational exposure to SARS-CoV-2: a survey of changes in caseload and controls among medical examiner and coroners' offices in Pennsylvania during 2020 (edit) |
10.1080/15459624.2022.2050740 |
| 2022-05-01 |
Analysis of SARS-CoV-2 known and novel subgenomic mRNAs in cell culture, animal model, and clinical samples using LeTRS, a bioinformatic tool to identify unique sequence identifiers (edit) |
10.1093/GIGASCIENCE/GIAC045 |
| 2022-05-01 |
Human phospho-signaling networks of SARS-CoV-2 infection are rewired by population genetic variants (edit) |
10.15252/MSB.202110823 |
| 2022-05-01 |
Unheeded SARS-CoV-2 proteins? A deep look into negative-sense RNA (edit) |
10.1093/BIB/BBAC045 |
| 2022-05-01 |
Risk of Healthcare-Associated Transmission of Sever Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Hospitalized Cancer Patients (edit) |
10.1093/CID/CIAB670 |
| 2022-05-01 |
Development of a multi-epitope spike glycoprotein vaccine to combat SARS-CoV-2 using the bioinformatics approach (edit) |
10.56499/JPPRES21.1210_10.3.445 |
| 2022-05-01 |
In Silico Analysis of Peptide-Based Derivatives Containing Bifunctional Warheads Engaging Prime and Non-Prime Subsites to Covalent Binding SARS-CoV-2 Main Protease (Mpro) (edit) |
10.3390/COMPUTATION10050069 |
| 2022-05-01 |
Use of DFT Distance Metrics for Classification of SARS-CoV-2 Genomes (edit) |
10.1089/CMB.2021.0229 |
| 2022-05-01 |
Tu1269: IMMUNOGENICITY AND SAFETY OF HETEROLOGOUS VERSUS HOMOLOGOUS PRIME-BOOST REGIMENS WITH ADENOVIRAL VECTORED AND MRNA SARS-COV-2 VACCINE IN LIVER TRANSPLANT RECIPIENTS (edit) |
10.1016/S0016-5085(22)63690-4 |
| 2022-05-01 |
Ex vivo and in vivo suppression of SARS-CoV-2 with combinatorial AAV/RNAi expression vectors (edit) |
10.1016/J.YMTHE.2022.01.024 |
| 2022-05-01 |
Fibrin clot characteristics and anticoagulant response in a SARS-CoV-2-infected endothelial model (edit) |
10.1002/JHA2.407 |
| 2022-05-01 |
Positive effects of the decrease of hydraulic dredging due to the SARS-CoV-2 pandemic on benthic fauna and clam harvesting in the northern Adriatic (Mediterranean Sea) (edit) |
10.35800/JASM.V10I1.37485 |
| 2022-05-01 |
Calcitonin gene-related peptide: A biomarker for stroke in SARS-CoV-2 infection? (edit) |
10.1016/J.MEHY.2022.110807 |
| 2022-05-01 |
Vocal cord dysfunction/inducible laryngeal obstruction(s) mimicking anaphylaxis during SARS-CoV-2 (COVID-19) vaccination (edit) |
10.1016/J.JAIP.2022.02.025 |
| 2022-05-01 |
Source terms for benchmarking models of SARS-CoV-2 transmission via aerosols and droplets (edit) |
10.1098/RSOS.212022 |
| 2022-05-01 |
Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant (edit) |
10.1016/J.CELREP.2022.110829 |
| 2022-05-01 |
Prospective Pilot Study Evaluating SARS-CoV-2 Transmission-Limiting Measures in an On-Site School (edit) |
10.1016/J.ACAP.2021.11.019 |
| 2022-05-01 |
Durability analysis of the highly effective mRNA-1273 vaccine against COVID-19 (edit) |
10.1093/PNASNEXUS/PGAC058 |
| 2022-05-01 |
Quantitation of SARS-CoV-2 neutralizing antibodies with a virus-free, authentic test (edit) |
10.1093/PNASNEXUS/PGAC045 |
| 2022-05-01 |
Plasticity in structure and assembly of SARS-CoV-2 nucleocapsid protein (edit) |
10.1093/PNASNEXUS/PGAC049 |
| 2022-05-01 |
Omicron variant of SARS-CoV-2 exhibits an increased resilience to the antiviral type I interferon response (edit) |
10.1093/PNASNEXUS/PGAC067 |
| 2022-04-30 |
A new approach for determining SARS-CoV-2 epitopes using machine learning-based in silico methods (edit) |
10.1016/J.COMPBIOLCHEM.2022.107688 |
| 2022-04-29 |
SARS-CoV-2 and other airborne respiratory viruses in outdoor aerosols in three Swiss cities before and during the first wave of the COVID-19 pandemic (edit) |
10.1016/J.ENVINT.2022.107266 |
| 2022-04-29 |
Age and sex associations of SARS-CoV-2 antibody responses post BNT162b2 vaccination in healthcare workers: A mixed effects model across two vaccination periods (edit) |
10.1371/JOURNAL.PONE.0266958 |
| 2022-04-29 |
Treatment of SARS-CoV-2-induced pneumonia with NAD+ and NMN in two mouse models (edit) |
10.1038/S41421-022-00409-Y |
| 2022-04-29 |
Investigation of changes in protein stability and substrate affinity of 3CL-protease of SARS-CoV-2 caused by mutations (edit) |
10.1590/1678-4685-GMB-2021-0404 |
| 2022-04-29 |
In silico evidence of antiviral activity against SARS-CoV-2 main protease of oligosaccharides from Porphyridium sp (edit) |
10.1016/J.SCITOTENV.2022.155580 |
| 2022-04-29 |
Could SARS-CoV-2 Have Bacteriophage Behavior or Induce the Activity of Other Bacteriophages? (edit) |
10.3390/VACCINES10050708 |
| 2022-04-29 |
Transcriptomic analysis reveals optimal cytokine combinations for SARS-CoV-2-specific T cell therapy products (edit) |
10.1016/J.OMTM.2022.04.013 |
| 2022-04-29 |
Computational study and design of effective siRNAs to silence structural proteins associated genes of Indian SARS-CoV-2 strains (edit) |
10.1016/J.COMPBIOLCHEM.2022.107687 |
| 2022-04-29 |
Wpływ pandemii Sars-CoV-2 na postrzeganie idei „Slow Food” przez studentów (edit) |
10.15199/65.2022.4.6 |
| 2022-04-28 |
Do the Successive Waves of SARS-CoV-2, Vaccination Status and Place of Infection Influence the Clinical Picture and COVID-19 Severity among Patients with Persistent Clinical Symptoms? The Retrospective Study of Patients from the STOP-COVID Registry o (edit) |
10.3390/JPM12050706 |
| 2022-04-28 |
A combination of potently neutralizing monoclonal antibodies isolated from an Indian convalescent donor protects against the SARS-CoV-2 Delta variant (edit) |
10.1371/JOURNAL.PPAT.1010465 |
| 2022-04-28 |
Comparative Analysis of RNA-Extraction Approaches and Associated Influences on RT-qPCR of the SARS-CoV-2 RNA in a University Residence Hall and Quarantine Location (edit) |
|
| 2022-04-28 |
Neutralizing Effect of Synthetic Peptides toward SARS-CoV-2 (edit) |
10.1021/ACSOMEGA.2C02203 |
| 2022-04-28 |
In silico bioprospecting of taraxerol as a main protease inhibitor of SARS-CoV-2 to develop therapy against COVID-19 (edit) |
10.1007/S11224-022-01943-X |
| 2022-04-28 |
Mutations in the SARS-CoV-2 RNA dependent RNA polymerase confer resistance to remdesivir by distinct mechanisms (edit) |
10.1126/SCITRANSLMED.ABO0718 |
| 2022-04-28 |
Impact of SARS-CoV-2 Mutations on PCR Assay Sequence Alignment (edit) |
10.3389/FPUBH.2022.889973 |
| 2022-04-28 |
Circulating microRNA profiling is altered in the acute respiratory distress syndrome related to SARS-CoV-2 infection (edit) |
10.1038/S41598-022-10738-3 |
| 2022-04-28 |
The determination of haemagglutinin influenza antibodies in the Polish population in the epidemic season 2020/2021 during the SARS-CoV-2 pandemic (edit) |
10.18388/ABP.2020_6015 |
| 2022-04-28 |
All hands on deck: A multidisciplinary approach to SARS-CoV-2-associated MIS-C (edit) |
10.1093/PCH/PXAB110 |
| 2022-04-28 |
EU-Funded Telemedicine Projects – Assessment of, and Lessons Learned From, in the Light of the SARS-CoV-2 Pandemic (edit) |
10.3389/FMED.2022.849998 |
| 2022-04-28 |
Third dose vaccination with mRNA-1273 or BNT162b2 vaccines improves protection against SARS-CoV-2 infection (edit) |
10.1093/PNASNEXUS/PGAC042 |
| 2022-04-27 |
Distinct miRNAs associated with various clinical presentations of SARS-CoV-2 infection (edit) |
10.1016/J.ISCI.2022.104309 |
| 2022-04-27 |
Broadly neutralizing antibodies against Omicron-included SARS-CoV-2 variants induced by vaccination (edit) |
10.1038/S41392-022-00987-Z |
| 2022-04-27 |
Antibody response to double SARS-CoV-2 mRNA vaccination in Japanese kidney transplant recipients (edit) |
10.1038/S41598-022-10510-7 |
| 2022-04-27 |
Design of D-Amino Acids SARS-CoV-2 Main Protease Inhibitors Using the Cationic Peptide from Rattlesnake Venom as a Scaffold (edit) |
10.3390/PH15050540 |
| 2022-04-27 |
Design, Synthesis and Evaluation of Fused Bicyclo[2.2.2]octene as a Potential Core Scaffold for the Non-Covalent Inhibitors of SARS-CoV-2 3CLpro Main Protease (edit) |
10.3390/PH15050539 |
| 2022-04-27 |
Curcumin inhibits spike protein of new SARS-CoV-2 variant of concern (VOC) Omicron, an in silico study (edit) |
10.1016/J.COMPBIOMED.2022.105552 |
| 2022-04-27 |
First Identification of Reinfection by a Genetically Different Variant of SARS-CoV-2 in a Homeless Person from the Metropolitan Area of Santiago, Chile (edit) |
10.1155/2022/3859071 |
| 2022-04-27 |
ECG Utilization Patterns of Patients With Arrhythmias During COVID-19 Epidemic and Post-SARS-CoV-2 Eras in Shanghai, China (edit) |
10.3389/FCVM.2022.829679 |
| 2022-04-27 |
Seroprevalence of anti-SARS-CoV-2 antibodies in Thai adults during the first three epidemic waves (edit) |
10.1371/JOURNAL.PONE.0263316 |
| 2022-04-27 |
Adenovirus 5 Vectors Expressing SARS-CoV-2 Proteins (edit) |
10.1128/MSPHERE.00998-21 |
| 2022-04-27 |
Performance of Immunoglobulin G Serology on Finger Prick Capillary Dried Blood Spot Samples to Detect a SARS-CoV-2 Antibody Response (edit) |
10.1128/SPECTRUM.01405-21 |
| 2022-04-26 |
Tracking SARS-CoV-2 Omicron diverse spike gene mutations identifies multiple inter-variant recombination events (edit) |
10.1038/S41392-022-00992-2 |
| 2022-04-26 |
Seroprevalence of Infection-Induced SARS-CoV-2 Antibodies — United States, September 2021–February 2022 (edit) |
10.15585/MMWR.MM7117E3 |
| 2022-04-26 |
Variant-specific vaccination induces systems immune responses and potent in vivo protection against SARS-CoV-2 (edit) |
10.1016/J.XCRM.2022.100634 |
| 2022-04-26 |
Resilience of Spike-Specific Immunity Induced by COVID-19 Vaccines against SARS-CoV-2 Variants (edit) |
10.3390/BIOMEDICINES10050996 |
| 2022-04-26 |
SARS-CoV-2 pan-variant inhibitory peptides deter S1-ACE2 interaction and neutralize delta and omicron pseudoviruses (edit) |
10.1016/J.CSBJ.2022.04.030 |
| 2022-04-26 |
In silico prediction and experimental evaluation of potential siRNAs against SARS-CoV-2 inhibition in Vero E6 cells (edit) |
10.1016/J.JKSUS.2022.102049 |
| 2022-04-26 |
Chronic Exposure to the Food Additive tBHQ Modulates Expression of Genes Related to SARS-CoV-2 and Influenza Viruses (edit) |
10.3390/LIFE12050642 |
| 2022-04-26 |
SARS-CoV-2 Omicron Variant in Croatia-Rapid Detection of the First Case and Cross-Border Spread (edit) |
10.3390/PATHOGENS11050511 |
| 2022-04-26 |
Detection of SARS-CoV-2 in the air in Indian hospitals and houses of COVID-19 patients (edit) |
10.1016/J.JAEROSCI.2022.106002 |
| 2022-04-25 |
Genome-wide CRISPR screens identify GATA6 as a proviral host factor for SARS-CoV-2 via modulation of ACE2 (edit) |
10.1038/S41467-022-29896-Z |
| 2022-04-25 |
Histamine Potentiates SARS-CoV-2 Spike Protein Entry Into Endothelial Cells (edit) |
10.3389/FPHAR.2022.872736 |
| 2022-04-25 |
Culture and identification of a "Deltamicron" SARS-CoV-2 in a three cases cluster in southern France (edit) |
10.1002/JMV.27789 |
| 2022-04-25 |
Nanobodies Protecting From Lethal SARS-CoV-2 Infection Target Receptor Binding Epitopes Preserved in Virus Variants Other Than Omicron (edit) |
10.3389/FIMMU.2022.863831 |
| 2022-04-25 |
Berbamine hydrochloride potently inhibits SARS-CoV-2 infection by blocking S protein-mediated membrane fusion (edit) |
10.1371/JOURNAL.PNTD.0010363 |
| 2022-04-25 |
Genetic differentiation and diversity of SARS-CoV-2 omicron variant in Its early outbreak (edit) |
10.1016/J.BSHEAL.2022.04.004 |
| 2022-04-25 |
Shell Disorder Models Detect That Omicron Has Harder Shells with Attenuation but Is Not a Descendant of the Wuhan-Hu-1 SARS-CoV-2 (edit) |
10.3390/BIOM12050631 |
| 2022-04-25 |
Enrichment analysis on regulatory subspaces: A novel direction for the superior description of cellular responses to SARS-CoV-2 (edit) |
10.1016/J.COMPBIOMED.2022.105443 |
| 2022-04-25 |
A single intranasal dose of human parainfluenza virus type 3-vectored vaccine induces effective antibody and memory T cell response in the lungs and protects hamsters against SARS-CoV-2 (edit) |
10.1038/S41541-022-00471-3 |
| 2022-04-25 |
Identification of SARS-CoV-2 variants using viral sequencing for the Centers for Disease Control and Prevention genomic surveillance program (edit) |
10.1186/S12879-022-07374-7 |
| 2022-04-25 |
Field Evaluation of the New Rapid NG-Test® SARS-CoV-2 Ag for Diagnosis of COVID-19 in the Emergency Department of an Academic Referral Hospital (edit) |
10.3389/FPUBH.2022.840984 |
| 2022-04-24 |
Omicron-included mutation-induced changes in epitopes of SARS-CoV-2 spike protein and effectiveness assessments of current antibodies (edit) |
10.1186/S43556-022-00074-3 |
| 2022-04-24 |
Probing the competitive inhibitor efficacy of frog-skin alpha helical AMPs identified against ACE2 binding to SARS-CoV-2 S1 spike protein as therapeutic scaffold to prevent COVID-19 (edit) |
10.1007/S00894-022-05117-8 |
| 2022-04-24 |
Risk mitigation and disease control challenges of SARS-CoV-2 multidirectional transmission at ski resorts (edit) |
10.21037/JPHE-21-112 |
| 2022-04-24 |
Phylodynamic Dispersal of SARS-CoV-2 Lineages Circulating across Polish–German Border Provinces (edit) |
10.3390/V14050884 |
| 2022-04-23 |
SARS-CoV-2 Infection of Human Ovarian Cells: A Potential Negative Impact on Female Fertility (edit) |
10.3390/CELLS11091431 |
| 2022-04-23 |
SARS-CoV-2 infection of human-induced pluripotent stem cells-derived lung lineage cells evokes inflammatory and chemosensory responses by targeting mitochondrial pathways (edit) |
10.1002/JCP.30755 |
| 2022-04-23 |
SARS-COV-2 as potential microRNA sponge in COVID-19 patients (edit) |
10.1186/S12920-022-01243-7 |
| 2022-04-22 |
The challenge of SARS-CoV-2 environmental monitoring in schools using floors and portable HEPA filtration units: Fresh or relic RNA? (edit) |
10.1371/JOURNAL.PONE.0267212 |
| 2022-04-22 |
Binding and neutralizing antibody responses to SARS-CoV-2 in very young children exceed those in adults (edit) |
10.1172/JCI.INSIGHT.157963 |
| 2022-04-22 |
Comparison of SARS-CoV-2 sequencing using the ONT GridION and the Illumina MiSeq (edit) |
10.1186/S12864-022-08541-5 |
| 2022-04-22 |
Monoclonal antibody targeting the conserved region of the SARS-CoV-2 spike protein to overcome viral variants (edit) |
10.1172/JCI.INSIGHT.157597 |
| 2022-04-22 |
Anti-SARS-CoV-2 potential of Cissampelos pareira L. identified by connectivity map-based analysis and in vitro studies (edit) |
10.1186/S12906-022-03584-3 |
| 2022-04-22 |
RT- PCR testing of upper respiratory tract samples for diagnosis of SARS-CoV-2: Between justification and overestimation, a multi-center international study (edit) |
10.1016/J.TMAID.2022.102334 |
| 2022-04-22 |
Protocols for SARS-CoV-2 infection in primary ocular cells and eye organoids (edit) |
10.1016/J.XPRO.2022.101383 |
| 2022-04-21 |
An in-silico study of the mutation-associated effects on the spike protein of SARS-CoV-2, Omicron variant (edit) |
10.1371/JOURNAL.PONE.0266844 |
| 2022-04-21 |
Nasally delivered interferon-λ protects mice against infection by SARS-CoV-2 variants including Omicron (edit) |
10.1016/J.CELREP.2022.110799 |
| 2022-04-21 |
Human Wharton's Jelly Mesenchymal Stem Cells Secretome Inhibits Human SARS-CoV-2 and Avian Infectious Bronchitis Coronaviruses (edit) |
10.3390/CELLS11091408 |
| 2022-04-21 |
Presumptive positive with the Cepheid Xpert Xpress SARS-CoV-2 assay due to N mutations in the Delta variant (edit) |
10.1016/J.DIAGMICROBIO.2022.115699 |
| 2022-04-21 |
SARS-CoV-2 mutations acquired during serial passage in human cell lines are consistent with several of those found in recent natural SARS-CoV-2 variants (edit) |
10.1016/J.CSBJ.2022.04.022 |
| 2022-04-21 |
SARS-CoV-2 epidemic in Brazil: how the displacement of variants has driven distinct epidemic waves (edit) |
10.1016/J.VIRUSRES.2022.198785 |
| 2022-04-20 |
Delta Variant of SARS-CoV-2 Replacement in Brazil: A National Epidemiologic Surveillance Program (edit) |
10.3390/V14050847 |
| 2022-04-20 |
Visibility, wind speed, and dew point temperature are important factors in SARS-CoV-2 transmissibility (edit) |
10.1002/PUL2.12081 |
| 2022-04-20 |
SARS-CoV-2 Employ BSG/CD147 and ACE2 Receptors to Directly Infect Human Induced Pluripotent Stem Cell-Derived Kidney Podocytes (edit) |
10.3389/FCELL.2022.855340 |
| 2022-04-20 |
Development and validation of cost-effective one-step multiplex RT-PCR assay for detecting the SARS-CoV-2 infection using SYBR Green melting curve analysis (edit) |
10.1038/S41598-022-10413-7 |
| 2022-04-20 |
Differences in Immunogenicity of Three Different Homo- and Heterologous Vaccination Regimens against SARS-CoV-2 (edit) |
10.3390/VACCINES10050649 |
| 2022-04-20 |
Immunoinformatics approach of epitope prediction for SARS-CoV-2 (edit) |
10.1186/S43141-022-00344-1 |
| 2022-04-20 |
Isolation, characterization, and structure-based engineering of a neutralizing nanobody against SARS-CoV-2 (edit) |
10.1016/J.IJBIOMAC.2022.04.096 |
| 2022-04-20 |
Preclinical study of a DNA vaccine targeting SARS-CoV-2 (edit) |
10.1016/J.RETRAM.2022.103348 |
| 2022-04-20 |
First Analytical Solution of Intracellular life Cycle of SARS-CoV-2 (edit) |
10.14302/ISSN.2643-2811.JMBR-22-4130 |
| 2022-04-20 |
Current Drug Targets for Gut Microbiota Biocorrection during the SARS-CoV-2 Pandemic: A Systematic Review (edit) |
10.2174/1389450123666220418094853 |
| 2022-04-20 |
The Endolysosomal System: The Acid Test for SARS-CoV-2 (edit) |
10.3390/IJMS23094576 |
| 2022-04-19 |
Differential effects of macrophage subtypes on SARS-CoV-2 infection in a human pluripotent stem cell-derived model (edit) |
10.1038/S41467-022-29731-5 |
| 2022-04-19 |
Potent Inhibition of SARS-CoV-2 nsp14 N7-Methyltransferase by Sulfonamide-Based Bisubstrate Analogues (edit) |
10.1021/ACS.JMEDCHEM.2C00120 |
| 2022-04-19 |
Inter-domain communication in SARS-CoV-2 spike proteins controls protease-triggered cell entry (edit) |
10.1016/J.CELREP.2022.110786 |
| 2022-04-19 |
The Fungal Gut Microbiome Exhibits Reduced Diversity and Increased Relative Abundance of Ascomycota in Severe COVID-19 Illness and Distinct Interconnected Communities in SARS-CoV-2 Positive Patients (edit) |
10.3389/FCIMB.2022.848650 |
| 2022-04-19 |
First computational design using lambda-superstrings and in vivo validation of SARS-CoV-2 vaccine (edit) |
10.1038/S41598-022-09615-W |
| 2022-04-19 |
Properties of the Omicron Variant of SARS-CoV-2 Affect Public Health Measure Effectiveness in the COVID-19 Epidemic (edit) |
10.3390/IJERPH19094930 |
| 2022-04-19 |
Shifts of SARS-CoV-2 exposure settings in the transmission clusters of 2 epidemic waves in Hong Kong (edit) |
10.1080/09603123.2022.2064438 |
| 2022-04-19 |
Efficacy of a “stay-at-home” policy on SARS-CoV-2 transmission in Toronto, Canada: a mathematical modelling study (edit) |
10.9778/CMAJO.20200242 |
| 2022-04-18 |
The SARS-CoV-2 helicase as a target for antiviral therapy: Identification of potential small molecule inhibitors by in silico modelling (edit) |
10.1016/J.JMGM.2022.108193 |
| 2022-04-18 |
An endogenously activated antiviral state restricts SARS-CoV-2 infection in differentiated primary airway epithelial cells (edit) |
10.1371/JOURNAL.PONE.0266412 |
| 2022-04-18 |
Occurrence of a novel cleavage site for cathepsin G adjacent to the polybasic sequence within the proteolytically sensitive activation loop of the SARS-CoV-2 Omicron variant: The amino acid substitution N679K and P681H of the spike protein (edit) |
10.1371/JOURNAL.PONE.0264723 |
| 2022-04-17 |
Clinically observed deletions in SARS-CoV-2 Nsp1 affect its stability and ability to inhibit translation (edit) |
10.1002/1873-3468.14354 |
| 2022-04-17 |
Identification of Transcription Factors Regulating SARS-CoV-2 Tropism Factor Expression by Inferring Cell-Type-Specific Transcriptional Regulatory Networks in Human Lungs (edit) |
10.3390/V14040837 |
| 2022-04-16 |
Electrochemical genosensor for the specific detection of SARS-CoV-2 (edit) |
10.1016/J.TALANTA.2022.123482 |
| 2022-04-16 |
Control of common viral epidemics but not of SARS-CoV-2 through the application of hygiene and distancing measures (edit) |
10.1016/J.JCV.2022.105163 |
| 2022-04-15 |
One-year surveillance of SARS-CoV-2 transmission of the ELISA cohort: A model for population-based monitoring of infection risk (edit) |
10.1126/SCIADV.ABM5016 |
| 2022-04-15 |
ChAdOx1 nCoV-19 vaccine elicits monoclonal antibodies with cross-neutralizing activity against SARS-CoV-2 viral variants (edit) |
10.1016/J.CELREP.2022.110757 |
| 2022-04-15 |
Mitoxantrone modulates a heparan sulfate-spike complex to inhibit SARS-CoV-2 infection (edit) |
10.1038/S41598-022-10293-X |
| 2022-04-15 |
COVID-profiler: a webserver for the analysis of SARS-CoV-2 sequencing data (edit) |
10.1186/S12859-022-04632-Y |
| 2022-04-15 |
MALDI-TOF-MS-Based Identification of Monoclonal Murine Anti-SARS-CoV-2 Antibodies within One Hour (edit) |
10.3390/ANTIB11020027 |
| 2022-04-15 |
Detection of SARS-CoV-2 with RAPID: A prospective cohort study (edit) |
10.1016/J.ISCI.2022.104055 |
| 2022-04-14 |
Abnormal global alternative RNA splicing in COVID-19 patients (edit) |
10.1371/JOURNAL.PGEN.1010137 |
| 2022-04-14 |
Wastewater surveillance of SARS-CoV-2 mutational profiles at a university and its surrounding community reveals a 20G outbreak on campus (edit) |
10.1371/JOURNAL.PONE.0266407 |
| 2022-04-14 |
Estimating the Neutralizing Effect and Titer Correlation of Semi-Quantitative Anti-SARS-CoV-2 Antibody Immunoassays (edit) |
10.3389/FCIMB.2022.822599 |
| 2022-04-14 |
Molecular insights into the differential dynamics of SARS-CoV-2 variants of concern (edit) |
10.1016/J.JMGM.2022.108194 |
| 2022-04-14 |
Inducible CRISPR activation screen for interferon-stimulated genes identifies OAS1 as a SARS-CoV-2 restriction factor (edit) |
10.1371/JOURNAL.PPAT.1010464 |
| 2022-04-14 |
Computational prediction of the molecular mechanism of statin group of drugs against SARS-CoV-2 pathogenesis (edit) |
10.1038/S41598-022-09845-Y |
| 2022-04-14 |
Effectiveness of Messenger RNA Coronavirus Disease 2019 Vaccines Against Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infections During the Delta Variant Epidemic in Japan: Vaccine Effectiveness Real-time Surveillance for (edit) |
10.1093/CID/CIAC292 |
| 2022-04-14 |
Research on COVID-19, SARS-CoV-2 in dermatology journals: A brief bibliometric analysis based on PubMed (edit) |
10.4103/IJD.IJD_397_21 |
| 2022-04-14 |
Identification of Compounds With Antiviral Activity Against SARS-CoV-2 in the MMV Pathogen Box Using a Phenotypic High-Throughput Screening Assay (edit) |
10.3389/FVIRO.2022.854363 |
| 2022-04-14 |
Surviving the Storm: Cytokine Biosignature in SARS-CoV-2 Severity Prediction (edit) |
10.3390/VACCINES10040614 |
| 2022-04-14 |
A magnetic bead immunoassay to detect high affinity human IgG reactive to SARS-CoV-2 Spike S1 RBD produced in Escherichia coli (edit) |
10.1007/S42770-022-00753-X |
| 2022-04-13 |
Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infection (edit) |
10.1016/J.MEDJ.2022.04.001 |
| 2022-04-13 |
Transcriptomic analysis of asymptomatic and symptomatic severe Turkish patients in SARS-CoV-2 infection (edit) |
10.14744/NCI.2022.28000 |
| 2022-04-13 |
Impact of SARS-CoV-2 Gamma lineage introduction and COVID-19 vaccination on the epidemiological landscape of a Brazilian city (edit) |
10.1038/S43856-022-00108-5 |
| 2022-04-13 |
Highly Thermotolerant SARS-CoV-2 Vaccine Elicits Neutralising Antibodies against Delta and Omicron in Mice (edit) |
10.3390/V14040800 |
| 2022-04-13 |
PipeCoV: a pipeline for SARS-CoV-2 genome assembly, annotation and variant identification (edit) |
10.7717/PEERJ.13300 |
| 2022-04-13 |
Molecularly Imprinted Polymer Nanoparticles Enable Rapid, Reliable, and Robust Point-of-Care Thermal Detection of SARS-CoV-2 (edit) |
10.1021/ACSSENSORS.2C00100 |
| 2022-04-13 |
Comparative Evaluation of Six SARS-CoV-2 Real-Time RT-PCR Diagnostic Approaches Shows Substantial Genomic Variant–Dependent Intra- and Inter-Test Variability, Poor Interchangeability of Cycle Threshold and Complementary Turn-Around Times (edit) |
10.3390/PATHOGENS11040462 |
| 2022-04-13 |
Free PoC Testing for SARS-CoV-2 in Germany: Factors Expanding Access to Various Communities in a Medium-Sized City (edit) |
10.3390/IJERPH19084721 |
| 2022-04-12 |
SARS-CoV-2 spike protein–induced cell fusion activates the cGAS-STING pathway and the interferon response (edit) |
10.1126/SCISIGNAL.ABG8744 |
| 2022-04-12 |
SARS-CoV-2 monitoring by automated target-driven molecular machine-based engineering (edit) |
10.1007/S10311-022-01434-9 |
| 2022-04-12 |
[Geospatial models for SARS-CoV-2 outbreak control in Cartagena and Barranquilla, Colombia, 2020Modelos geoespaciais para controle de surtos de SARS-CoV-2 em Cartagena e Barranquilla, Colômbia, 2020] (edit) |
10.26633/RPSP.2022.26 |
| 2022-04-12 |
Semi-Mechanistic Pharmacokinetic-Pharmacodynamic Model of Camostat Mesylate-Predicted Efficacy against SARS-CoV-2 in COVID-19 (edit) |
10.1128/SPECTRUM.02167-21 |
| 2022-04-12 |
Evaluation of SARS-CoV-2 diagnostics and risk factors associated with SARS-CoV-2 infection in Zambia (edit) |
10.1016/J.IJID.2022.04.017 |
| 2022-04-12 |
Insights Into Drug Repurposing, as Well as Specificity and Compound Properties of Piperidine-Based SARS-CoV-2 PLpro Inhibitors (edit) |
10.3389/FCHEM.2022.861209 |
| 2022-04-12 |
Identification of Neutrophil-Related Factor LCN2 for Predicting Severity of Patients With Influenza A Virus and SARS-CoV-2 Infection (edit) |
10.3389/FMICB.2022.854172 |
| 2022-04-12 |
Severe Adams-Oliver Syndrome after Maternal COVID-19 Infection Could Be Another Effect of the SARS-CoV-2 Inflammatory Storm? Case Report (edit) |
10.1080/15513815.2022.2064018 |
| 2022-04-11 |
Inflammatory responses in the placenta upon SARS-CoV-2 infection late in pregnancy (edit) |
10.1016/J.ISCI.2022.104223 |
| 2022-04-11 |
Detailed analysis of antibody responses to SARS-CoV-2 vaccination and infection in macaques (edit) |
10.1371/JOURNAL.PPAT.1010155 |
| 2022-04-11 |
Drug-Repurposing Screening Identified Tropifexor as a SARS-CoV-2 Papain-like Protease Inhibitor (edit) |
10.1021/ACSINFECDIS.1C00629 |
| 2022-04-11 |
Cocktail of REGN Antibodies Binds More Strongly to SARS-CoV-2 Than Its Components, but the Omicron Variant Reduces Its Neutralizing Ability (edit) |
10.1021/ACS.JPCB.2C00708 |
| 2022-04-11 |
Computational drug repurposing against SARS-CoV-2 reveals plasma membrane cholesterol depletion as key factor of antiviral drug activity (edit) |
10.1371/JOURNAL.PCBI.1010021 |
| 2022-04-11 |
Potent Anti-SARS-CoV-2 Efficacy of COVID-19 Hyperimmune Globulin from Vaccine-Immunized Plasma (edit) |
10.1002/ADVS.202104333 |
| 2022-04-11 |
Intranasal administration of a VLP-based vaccine induces neutralizing antibodies against SARS-CoV-2 and variants of concern (edit) |
10.1111/ALL.15311 |
| 2022-04-11 |
Structural and functional impact by SARS-CoV-2 Omicron spike mutations (edit) |
10.1016/J.CELREP.2022.110729 |
| 2022-04-11 |
Dentist’s Experiences and Perceptions One Year into the SARS-CoV-2 Pandemic (edit) |
10.33140/JODH.05.04.03 |
| 2022-04-10 |
Increased close proximity airborne transmission of the SARS-CoV-2 Delta variant (edit) |
10.1016/J.SCITOTENV.2021.151499 |
| 2022-04-09 |
Replication of the coronavirus genome: a paradox among positive-strand RNA viruses (edit) |
10.1016/J.JBC.2022.101923 |
| 2022-04-09 |
Mechanistic Origin of Different Binding Affinities of SARS-CoV and SARS-CoV-2 Spike RBDs to Human ACE2 (edit) |
10.3390/CELLS11081274 |
| 2022-04-09 |
Characteristic analysis of Omicron-included SARS-CoV-2 variants of concern (edit) |
10.1002/MCO2.129 |
| 2022-04-09 |
Dynamic Ca2+ sensitivity stimulates the evolved SARS-CoV-2 spike strain-mediated membrane fusion for enhanced entry (edit) |
10.1016/J.CELREP.2022.110694 |
| 2022-04-09 |
MutCov: A pipeline for evaluating the effect of mutations in spike protein on infectivity and antigenicity of SARS-CoV-2 (edit) |
10.1016/J.COMPBIOMED.2022.105509 |
| 2022-04-08 |
Ad26.COV2.S prevents upregulation of SARS-CoV-2 induced pathways of inflammation and thrombosis in hamsters and rhesus macaques (edit) |
10.1371/JOURNAL.PPAT.1009990 |
| 2022-04-08 |
Emergence and phenotypic characterization of the global SARS-CoV-2 C.1.2 lineage (edit) |
10.1038/S41467-022-29579-9 |
| 2022-04-08 |
Efficient recall of Omicron-reactive B cell memory after a third dose of SARS-CoV-2 mRNA vaccine (edit) |
10.1016/J.CELL.2022.04.009 |
| 2022-04-08 |
Genome Profiling of SARS-CoV-2 in Indonesia, ASEAN and the Neighbouring East Asian Countries: Features, Challenges and Achievements (edit) |
10.3390/V14040778 |
| 2022-04-08 |
Unveiling the nature's fruit basket to computationally identify Citrus sinensis csi-mir169-3p as a probable plant miRNA against Reference and Omicron SARS-CoV-2 genome (edit) |
10.1016/J.COMPBIOMED.2022.105502 |
| 2022-04-08 |
SMYD2 Inhibition Downregulates TMPRSS2 and Decreases SARS-CoV-2 Infection in Human Intestinal and Airway Epithelial Cells (edit) |
10.3390/CELLS11081262 |
| 2022-04-07 |
SARS-CoV-2 nsp5 Exhibits Stronger Catalytic Activity and Interferon Antagonism than Its SARS-CoV Ortholog (edit) |
10.1128/JVI.00037-22 |
| 2022-04-07 |
The Alpha Variant (B.1.1.7) of SARS-CoV-2 Failed to Become Dominant in Mexico (edit) |
10.1128/SPECTRUM.02240-21 |
| 2022-04-07 |
Development of optimized drug-like small molecule inhibitors of the SARS-CoV-2 3CL protease for treatment of COVID-19 (edit) |
10.1038/S41467-022-29413-2 |
| 2022-04-07 |
Identification of host transcriptome-guided repurposable drugs for SARS-CoV-1 infections and their validation with SARS-CoV-2 infections by using the integrated bioinformatics approaches (edit) |
10.1371/JOURNAL.PONE.0266124 |
| 2022-04-07 |
Interference of Chaga mushroom terpenoids with the attachment of SARS-CoV-2; in silico perspective (edit) |
10.1016/J.COMPBIOMED.2022.105478 |
| 2022-04-07 |
Impairment of SARS-CoV-2 spike glycoprotein maturation and fusion activity by nitazoxanide: an effect independent of spike variants emergence (edit) |
10.1007/S00018-022-04246-W |
| 2022-04-07 |
Systematic evaluating and modeling of SARS-CoV-2 UVC disinfection (edit) |
10.1038/S41598-022-09930-2 |
| 2022-04-07 |
Analysis of mRNA vaccination-elicited RBD-specific memory B cells reveals strong but incomplete immune escape of the SARS-CoV-2 Omicron variant (edit) |
10.1016/J.IMMUNI.2022.04.002 |
| 2022-04-07 |
Analysis of memory B cells identifies conserved neutralizing epitopes on the N-terminal domain of variant SARS-Cov-2 spike proteins (edit) |
10.1016/J.IMMUNI.2022.04.003 |
| 2022-04-07 |
Inactivation of SARS-CoV-2 and influenza A virus by dry fogging hypochlorous acid solution and hydrogen peroxide solution (edit) |
10.1371/JOURNAL.PONE.0261802 |
| 2022-04-06 |
FcγR-mediated SARS-CoV-2 infection of monocytes activates inflammation (edit) |
10.1038/S41586-022-04702-4 |
| 2022-04-06 |
Long-Read RNA Sequencing Identifies Polyadenylation Elongation and Differential Transcript Usage of Host Transcripts During SARS-CoV-2 In Vitro Infection (edit) |
10.3389/FIMMU.2022.832223 |
| 2022-04-06 |
Imatinib inhibits SARS-CoV-2 infection by an off-target-mechanism (edit) |
10.1038/S41598-022-09664-1 |
| 2022-04-06 |
Prolonged and extended impacts of SARS-CoV-2 on the olfactory neurocircuit (edit) |
10.1038/S41598-022-09731-7 |
| 2022-04-06 |
What Do We Know About the Impacts of Novel Coronavirus (SARS-Cov-2) on Freshwater Ecosystems? (edit) |
10.38125/OAJBS.000357 |
| 2022-04-06 |
Hospital Disaster and Emergency Plan in Biological Disasters (HDEP): Coronavirus (SARS-CoV-2) COVID-19 Pandemic System Model Example (edit) |
10.29333/JCONSEPH/11975 |
| 2022-04-06 |
Mathematical modeling and analysis of the SARS-Cov-2 disease with reinfection (edit) |
10.1016/J.COMPBIOLCHEM.2022.107678 |
| 2022-04-06 |
Evaluation of a machine learning approach utilizing wearable data for prediction of SARS-CoV-2 infection in healthcare workers (edit) |
10.1093/JAMIAOPEN/OOAC041 |
| 2022-04-05 |
pH- and Calcium-Dependent Aromatic Network in the SARS-CoV-2 Envelope Protein (edit) |
10.1021/JACS.2C00973 |
| 2022-04-05 |
Structural basis for replicase polyprotein cleavage and substrate specificity of main protease from SARS-CoV-2 (edit) |
10.1073/PNAS.2117142119 |
| 2022-04-05 |
Online Hydrophilic Interaction Chromatography (HILIC) Enhanced Top-Down Mass Spectrometry Characterization of the SARS-CoV-2 Spike Receptor-Binding Domain (edit) |
10.1021/ACS.ANALCHEM.2C00139 |
| 2022-04-05 |
Asymptomatic SARS-CoV-2 Infection Is Associated With Higher Levels of Serum IL-17C, Matrix Metalloproteinase 10 and Fibroblast Growth Factors Than Mild Symptomatic COVID-19 (edit) |
10.3389/FIMMU.2022.821730 |
| 2022-04-05 |
Two Different Therapeutic Approaches for SARS-CoV-2 in hiPSCs-Derived Lung Organoids (edit) |
10.3390/CELLS11071235 |
| 2022-04-05 |
Characterisation and natural progression of SARS-CoV-2 infection in ferrets (edit) |
10.1038/S41598-022-08431-6 |
| 2022-04-05 |
Anti-SARS-CoV-2 IgG and Neutralizing Antibody Levels in Patients with Past COVID-19 Infection: A Longitudinal Study (edit) |
10.4274/BALKANMEDJ.GALENOS.2022.2021-8-131 |
| 2022-04-05 |
Safety of an Inactivated SARS-CoV-2 Vaccine Among Healthcare Workers in Turkey: An Online Survey (edit) |
10.4274/BALKANMEDJ.GALENOS.2022.2021-11-25 |
| 2022-04-05 |
SARS-CoV-2 seroprevalence among Vancouver public school staff in British Columbia, Canada: a cross-sectional study (edit) |
10.1136/BMJOPEN-2021-057846 |
| 2022-04-04 |
Comparison of different sequencing techniques for identification of SARS-CoV-2 variants of concern with multiplex real-time PCR (edit) |
10.1371/JOURNAL.PONE.0265220 |
| 2022-04-04 |
Humanized mice reveal a macrophage-enriched gene signature defining human lung tissue protection during SARS-CoV-2 infection (edit) |
10.1016/J.CELREP.2022.110714 |
| 2022-04-04 |
Hit Expansion of a Noncovalent SARS-CoV-2 Main Protease Inhibitor (edit) |
10.1021/ACSPTSCI.2C00026 |
| 2022-04-04 |
Genetic Surveillance of Five SARS-CoV-2 Clinical Samples in Henan Province Using Nanopore Sequencing (edit) |
10.3389/FIMMU.2022.814806 |
| 2022-04-04 |
Previous SARS-CoV-2 Infection Status Among the Current RT-PCR-Positive Individuals Affected During the Second Wave of COVID-19 Infections in Chennai, India (edit) |
10.3389/FPUBH.2022.836454 |
| 2022-04-04 |
Tracking of SARS-CoV-2 Alpha variant (B.1.1.7) in Palestine (edit) |
10.1016/J.MEEGID.2022.105279 |
| 2022-04-04 |
Prime-boost vaccination regimens with INO-4800 and INO-4802 augment and broaden immune responses against SARS-CoV-2 in nonhuman primates (edit) |
10.1016/J.VACCINE.2022.03.060 |
| 2022-04-04 |
Meteorological factors and non-pharmaceutical interventions explain local differences in the spread of SARS-CoV-2 in Austria (edit) |
10.1371/JOURNAL.PCBI.1009973 |
| 2022-04-04 |
The Effects of Migration and Limited Medical Resources of the Transmission of SARS-CoV-2 Model with Two Patches (edit) |
10.1007/S11538-022-01010-W |
| 2022-04-04 |
Wastewater sequencing uncovers early, cryptic SARS-CoV-2 variant transmission (edit) |
10.1101/2021.12.21.21268143 |
| 2022-04-02 |
Child transmission of SARS-CoV-2: a systematic review and meta-analysis (edit) |
10.1186/S12887-022-03175-8 |
| 2022-04-02 |
mRNA- and Adenovirus-Based Vaccines against SARS-CoV-2 in HIV-Positive People (edit) |
10.3390/V14040748 |
| 2022-04-01 |
Salivary diagnostics of the novel corona virus SARS-CoV-2 (COVID-19) (edit) |
10.1111/ODI.13729 |
| 2022-04-01 |
SARS-CoV-2 is associated with changes in brain structure in UK Biobank (edit) |
10.1038/S41586-022-04569-5 |
| 2022-04-01 |
Early reduction of SARS-CoV-2-replication in bronchial epithelium by kinin B receptor antagonism (edit) |
10.1007/S00109-022-02182-7 |
| 2022-04-01 |
SARS-CoV-2 vaccination can elicit a CD8 T-cell dominant hepatitis (edit) |
10.1016/J.JHEP.2022.03.040 |
| 2022-04-01 |
Portable air cleaners and residential exposure to SARS-CoV-2 aerosols: a real-world study (edit) |
10.1111/INA.13029 |
| 2022-04-01 |
Assessment of SARS-CoV-2 airborne infection transmission risk in public buses (edit) |
10.1016/J.GSF.2022.101398 |
| 2022-04-01 |
Link between SARS-CoV-2 emissions and airborne concentrations: Closing the gap in understanding (edit) |
10.1016/J.JHAZMAT.2022.128279 |
| 2022-04-01 |
Nanopore ReCappable sequencing maps SARS-CoV-2 5' capping sites and provides new insights into the structure of sgRNAs (edit) |
10.1093/NAR/GKAC144 |
| 2022-04-01 |
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Naturally Acquired Immunity versus Vaccine-induced Immunity, Reinfections versus Breakthrough Infections: A Retrospective Cohort Study (edit) |
10.1093/CID/CIAC262 |
| 2022-04-01 |
Structural conservation among variants of the SARS-CoV-2 spike postfusion bundle (edit) |
10.1073/PNAS.2119467119 |
| 2022-04-01 |
Increased resistance of SARS-CoV-2 Omicron variant to neutralization by vaccine-elicited and therapeutic antibodies (edit) |
10.1016/J.EBIOM.2022.103944 |
| 2022-04-01 |
Deciphering the quality of SARS-CoV-2 specific T-cell response associated with disease severity, immune memory and heterologous response (edit) |
10.1002/CTM2.802 |
| 2022-04-01 |
Determinants of Immune Response to Anti-SARS-CoV-2 mRNA Vaccines in Kidney Transplant Recipients: A Prospective Cohort Study (edit) |
10.1097/TP.0000000000004044 |
| 2022-04-01 |
SARS-CoV-2 detection in multi-sample pools in a real pandemic scenario: A screening strategy of choice for active surveillance (edit) |
10.1371/JOURNAL.PONE.0266408 |
| 2022-04-01 |
Pulmonary endothelial NEDD9 and the prothrombotic pathophenotype of acute respiratory distress syndrome due to SARS-CoV-2 infection (edit) |
10.1002/PUL2.12071 |
| 2022-04-01 |
Toxicity and Local Tolerance of a Novel Spike Protein RBD Vaccine Against SARS-CoV-2, Produced Using the C1 Thermothelomyces Heterothallica Protein Expression Platform (edit) |
10.1177/01926233221090518 |
| 2022-04-01 |
Hybrid Proteins with Short Conformational Epitopes of the Receptor-Binding Domain of SARS-CoV-2 Spike Protein Promote Production of Virus-Neutralizing Antibodies When Used for Immunization (edit) |
10.1134/S0006297922040022 |
| 2022-04-01 |
Amplification-free detection of SARS-CoV-2 using gold nanotriangles functionalized with oligonucleotides (edit) |
10.1007/S00604-022-05272-Y |
| 2022-04-01 |
Impact of air temperature and containment measures on mitigating the intrahousehold transmission of SARS-CoV-2: a data-based modelling analysis (edit) |
10.1136/BMJOPEN-2021-049383 |
| 2022-04-01 |
All about that trait: Examining extraversion and state anxiety during the SARS-CoV-2 pandemic using a machine learning approach (edit) |
10.1016/J.PAID.2021.111461 |
| 2022-04-01 |
Triamcinolone as a potential inhibitor of SARS-CoV-2 main protease and cytokine storm: An in-silico study (edit) |
10.2174/1570180819666220401142351 |
| 2022-04-01 |
Applying lessons learned from nanomedicines to understand rare hypersensitivity reactions to mRNA-based SARS-CoV-2 vaccines (edit) |
10.1038/S41565-022-01071-X |
| 2022-04-01 |
Combatting future variants of SARS-CoV-2 using an in-silico peptide vaccine approach by targeting the spike protein (edit) |
10.1016/J.MEHY.2022.110810 |
| 2022-04-01 |
l-Methionine may modulate the assembly of SARS-CoV-2 by interfering with the mechanism of RNA polymerase (edit) |
10.1016/J.MEHY.2022.110798 |
| 2022-04-01 |
Are SARS-CoV-2 Antibodies Detectable in Human Milk After Vaccination Against COVID-19? (edit) |
10.1093/JPIDS/PIAC024 |
| 2022-04-01 |
The variants of SARS-CoV-2 and the challenges of vaccines (edit) |
10.1002/JMV.27513 |
| 2022-04-01 |
Association between SARS-CoV-2 infection and disease severity among prostate cancer patients on androgen deprivation therapy: a systematic review and meta-analysis (edit) |
10.1007/S00345-021-03810-6 |
| 2022-04-01 |
The Possible Role of Prion-Like Viral Protein Domains on the Emergence of Novel Viruses as SARS-CoV-2 (edit) |
10.1007/S00239-022-10054-4 |
| 2022-04-01 |
Hygienic assessment of digestate from a high solids anaerobic co-digestion of sewage sludge with biowaste by testing Salmonella Typhimurium, Escherichia coli and SARS-CoV-2 (edit) |
10.1016/J.ENVRES.2021.112585 |
| 2022-04-01 |
Publisher Correction: Evolution of enhanced innate immune evasion by SARS-CoV-2 (edit) |
10.1038/S41586-022-04653-W |
| 2022-04-01 |
Antibody evasion properties of SARS-CoV-2 Omicron sublineages (edit) |
10.1038/S41586-022-04594-4 |
| 2022-04-01 |
Author Correction: T cell responses to SARS-CoV-2 spike cross-recognize Omicron (edit) |
10.1038/S41586-022-04708-Y |
| 2022-04-01 |
ZERO projects in intensive care units: Challenges during SARS-CoV-2 pandemic and future recommendations (edit) |
10.1016/J.ENFIE.2022.03.001 |
| 2022-04-01 |
CLOTH FACE COVERINGS FOR USE AS FACEMASKS DURING THE CORONAVIRUS (SARS-CoV-2) PANDEMIC: WHAT SCIENCE AND EXPERIENCE HAVE TAUGHT US (edit) |
10.1017/DMP.2020.354 |
| 2022-03-31 |
A cohort study measuring SARS-CoV-2 seroconversion and serial viral testing in university students (edit) |
10.1186/S12879-022-07314-5 |
| 2022-03-31 |
Variable susceptibility of intestinal organoid-derived monolayers to SARS-CoV-2 infection (edit) |
10.1371/JOURNAL.PBIO.3001592 |
| 2022-03-31 |
Profiling of the most reliable mutations from sequenced SARS-CoV-2 genomes scattered in Uzbekistan (edit) |
10.1371/JOURNAL.PONE.0266417 |
| 2022-03-31 |
Identification, propagation and molecular characterization of SARS-CoV-2 delta variant isolated from Egyptian COVID-19 patients (edit) |
10.1016/J.MEEGID.2022.105278 |
| 2022-03-31 |
Near real-time surveillance of the SARS-CoV-2 epidemic with incomplete data (edit) |
10.1371/JOURNAL.PCBI.1009964 |
| 2022-03-31 |
The Finding of the Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2) in a Wild Eurasian River Otter (Lutra lutra) Highlights the Need for Viral Surveillance in Wild Mustelids (edit) |
10.3389/FVETS.2022.826991 |
| 2022-03-31 |
Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection (edit) |
10.1056/NEJMOA2118691 |
| 2022-03-31 |
Defining the risk of SARS-CoV-2 variants on immune protection (edit) |
10.1038/S41586-022-04690-5 |
| 2022-03-30 |
Microfluidic Antibody Affinity Profiling Reveals the Role of Memory Reactivation and Cross-Reactivity in the Defense Against SARS-CoV-2 (edit) |
10.1021/ACSINFECDIS.1C00486 |
| 2022-03-30 |
Phytochemicals-based targeting RdRp and main protease of SARS-CoV-2 using docking and steered molecular dynamic simulation: A promising therapeutic approach for Tackling COVID-19 (edit) |
10.1016/J.COMPBIOMED.2022.105468 |
| 2022-03-30 |
Computer-Based Immunoinformatic Analysis to Predict Candidate T-Cell Epitopes for SARS-CoV-2 Vaccine Design (edit) |
10.3389/FIMMU.2022.847617 |
| 2022-03-30 |
RNA editing increases the nucleotide diversity of SARS-CoV-2 in human host cells (edit) |
10.1371/JOURNAL.PGEN.1010130 |
| 2022-03-30 |
Inferring age-specific differences in susceptibility to and infectiousness upon SARS-CoV-2 infection based on Belgian social contact data (edit) |
10.1371/JOURNAL.PCBI.1009965 |
| 2022-03-29 |
Detection of SARS-CoV-2 Proteins in Wastewater Samples by Mass Spectrometry (edit) |
10.1021/ACS.EST.1C04705 |
| 2022-03-29 |
In silico analysis of SARS-CoV-2 proteins as targets for clinically available drugs (edit) |
10.1038/S41598-022-08320-Y |
| 2022-03-29 |
Conservation and Enhanced Binding of SARS-CoV-2 Omicron Spike Protein to Coreceptor Neuropilin-1 Predicted by Docking Analysis (edit) |
10.3390/IDR14020029 |
| 2022-03-29 |
Mutation rate of SARS-CoV-2 and emergence of mutators during experimental evolution (edit) |
10.1093/EMPH/EOAC010 |
| 2022-03-29 |
Intranasal administration of a single dose of a candidate live attenuated vaccine derived from an NSP16-deficient SARS-CoV-2 strain confers sterilizing immunity in animals (edit) |
10.1038/S41423-022-00855-4 |
| 2022-03-29 |
SARS-CoV-2 Point Mutation and Deletion Spectra and Their Association with Different Disease Outcomes (edit) |
10.1128/SPECTRUM.00221-22 |
| 2022-03-29 |
In vitro Suppression of SARS-CoV-2 Infection by Existing Kampo Formulas and Crude Constituent Drugs Used for Treatment of Common Cold Respiratory Symptoms (edit) |
10.3389/FPHAR.2022.804103 |
| 2022-03-28 |
Viral Mimicry of Interleukin-17A by SARS-CoV-2 ORF8 (edit) |
10.1128/MBIO.00402-22 |
| 2022-03-28 |
SARS-CoV-2 pseudovirus enters the host cells through spike protein-CD147 in Arf6-dependent manner (edit) |
10.1080/22221751.2022.2059403 |
| 2022-03-28 |
Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity (edit) |
10.1128/JVI.00128-22 |
| 2022-03-28 |
Molecular consequences of SARS-CoV-2 liver tropism (edit) |
10.1038/S42255-022-00552-6 |
| 2022-03-28 |
Structural Basis for Human Receptor Recognition by SARS-CoV-2 Omicron Variant BA.1. (edit) |
10.1128/JVI.00249-22 |
| 2022-03-28 |
Monospecific and bispecific monoclonal SARS-CoV-2 neutralizing antibodies that maintain potency against B.1.617 (edit) |
10.1038/S41467-022-29288-3 |
| 2022-03-28 |
SARS-CoV-2 3CLpro whole human proteome cleavage prediction and enrichment/depletion analysis (edit) |
10.1016/J.COMPBIOLCHEM.2022.107671 |
| 2022-03-28 |
Risk of SARS-CoV-2 reinfections in children: a prospective national surveillance study between January, 2020, and July, 2021, in England (edit) |
10.1016/S2352-4642(22)00059-1 |
| 2022-03-28 |
A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeutic (edit) |
10.1038/S41586-022-04661-W |
| 2022-03-28 |
NGS analysis of nasopharyngeal microbiota in SARS-CoV-2 positive patients during the first year of the pandemic in the Campania Region of Italy (edit) |
10.1016/J.MICPATH.2022.105506 |
| 2022-03-28 |
Virucidal efficacy of laundry sanitizers against SARS-CoV-2 and other coronaviruses and influenza viruses (edit) |
10.1038/S41598-022-08259-0 |
| 2022-03-28 |
Identification of Potential Semisynthetic Andrographolide Derivatives to Combat COVID-19 by Targeting the SARS-COV-2 Spike Protein and Human ACE2 Receptor– An In-silico Approach (edit) |
10.33263/BRIAC132.155 |
| 2022-03-28 |
Waning immunity to inactive SARS-CoV-2 vaccine in healthcare workers: booster required (edit) |
10.1007/S11845-022-02984-1 |
| 2022-03-28 |
Phylogenetic analysis of 17271 Indian SARS-CoV-2 genomes to identify temporal and spatial hotspot mutations (edit) |
10.1371/JOURNAL.PONE.0265579 |
| 2022-03-28 |
Global landscape of SARS-CoV-2 genomic surveillance and data sharing (edit) |
10.1038/S41588-022-01033-Y |
| 2022-03-27 |
RNA–protein interactomes as invaluable resources to study RNA viruses: Insights from SARS CoV‐2 studies (edit) |
10.1002/WRNA.1727 |
| 2022-03-27 |
Emergence of Two Distinct SARS-CoV-2 Gamma Variants and the Rapid Spread of P.1-like-II SARS-CoV-2 during the Second Wave of COVID-19 in Santa Catarina, Southern Brazil (edit) |
10.3390/V14040695 |
| 2022-03-27 |
What Is Currently Known about the Role of CXCL10 in SARS-CoV-2 Infection? (edit) |
10.3390/IJMS23073673 |
| 2022-03-26 |
BNT162b2 and ChAdOx1 nCoV-19 vaccinations, incidence of SARS-CoV-2 infections and COVID-19 hospitalisations in Scotland in the Delta era (edit) |
10.7189/JOGH.12.05008 |
| 2022-03-26 |
Early Administration of Anti-SARS-CoV-2 Monoclonal Antibodies Prevents Severe COVID-19 in Kidney Transplant Patients (edit) |
10.1016/J.EKIR.2022.03.020 |
| 2022-03-26 |
Multidimensional in silico strategy for identification of natural polyphenols-based SARS-CoV-2 main protease (Mpro) inhibitors to unveil a hope against COVID-19 (edit) |
10.1016/J.COMPBIOMED.2022.105452 |
| 2022-03-26 |
Phylogenetic-based inference reveals distinct transmission dynamics of SARS-CoV-2 lineages Gamma and P.2 in Brazil (edit) |
10.1016/J.ISCI.2022.104156 |
| 2022-03-25 |
Autoimmune Encephalitis in COVID-19 Infection: Our Experience and Systematic Review of the Literature (edit) |
10.3390/BIOMEDICINES10040774 |
| 2022-03-25 |
Neutralizing antibodies to SARS-CoV-2 Omicron variant after third mRNA vaccination in health care workers and elderly subjects (edit) |
10.1002/EJI.202149785 |
| 2022-03-25 |
The Molecular Basis of the Effect of Temperature on the Structure and Function of SARS-CoV-2 Spike Protein (edit) |
10.3389/FMOLB.2022.794960 |
| 2022-03-25 |
Timing of exposure is critical in a highly sensitive model of SARS-CoV-2 transmission (edit) |
10.1371/JOURNAL.PPAT.1010181 |
| 2022-03-25 |
Structural diversity of the SARS-CoV-2 Omicron spike (edit) |
10.1016/J.MOLCEL.2022.03.028 |
| 2022-03-25 |
Anti-Fungal Drug Anidulafungin Inhibits SARS-CoV-2 Spike-Induced Syncytia Formation by Targeting ACE2-Spike Protein Interaction (edit) |
10.3389/FGENE.2022.866474 |
| 2022-03-25 |
Multivariate mining of an alpaca immune repertoire identifies potent cross-neutralizing SARS-CoV-2 nanobodies (edit) |
10.1126/SCIADV.ABM0220 |
| 2022-03-25 |
Associations among eHealth literacy, social support, individual resilience, and emotional status in primary care providers during the outbreak of the SARS-CoV-2 Delta variant (edit) |
10.1177/20552076221089789 |
| 2022-03-25 |
Assessing the best time interval between doses in a two-dose vaccination regimen to reduce the number of deaths in an ongoing epidemic of SARS-CoV-2 (edit) |
10.1371/JOURNAL.PCBI.1009978 |
| 2022-03-25 |
Targeting Specific Checkpoints in the Management of SARS-CoV-2 Induced Cytokine Storm (edit) |
10.3390/LIFE12040478 |
| 2022-03-25 |
Survival and Fate of Novel Coronavirus (SARS-CoV-2) in Water and Wastewater: Possible Health Concerns (edit) |
10.5296/JEE.V13I1.19674 |
| 2022-03-24 |
Plant-based expression and characterization of SARS-CoV-2 virus-like particles presenting a native spike protein (edit) |
10.1111/PBI.13813 |
| 2022-03-24 |
An extended conformation of SARS-CoV-2 main protease reveals allosteric targets (edit) |
10.1073/PNAS.2120913119 |
| 2022-03-24 |
The inherent flexibility of receptor binding domains in SARS-CoV-2 spike protein (edit) |
10.7554/ELIFE.75720 |
| 2022-03-24 |
Conformational dynamics and allosteric modulation of the SARS-CoV-2 spike (edit) |
10.7554/ELIFE.75433 |
| 2022-03-24 |
Epitope-based peptide vaccine design and elucidation of novel compounds against 3C like protein of SARS-CoV-2 (edit) |
10.1371/JOURNAL.PONE.0264700 |
| 2022-03-24 |
Mice infected with Mycobacterium tuberculosis are resistant to acute disease caused by secondary infection with SARS-CoV-2 (edit) |
10.1371/JOURNAL.PPAT.1010093 |
| 2022-03-24 |
Preclinical Studies on Convalescent Human Immune Plasma-Derived Exosome: Omics and Antiviral Properties to SARS-CoV-2 (edit) |
10.3389/FIMMU.2022.824378 |
| 2022-03-24 |
SARS-CoV-2 infects and replicates in photoreceptor and retinal ganglion cells of human retinal organoids (edit) |
10.1016/J.STEMCR.2022.02.015 |
| 2022-03-24 |
EDGE COVID-19: a web platform to generate submission-ready genomes from SARS-CoV-2 sequencing efforts (edit) |
10.1093/BIOINFORMATICS/BTAC176 |
| 2022-03-24 |
Cannabidiol and SARS-CoV-2 Infection (edit) |
10.3389/FIMMU.2022.870787 |
| 2022-03-23 |
Omicron: What Makes the Latest SARS-CoV-2 Variant of Concern So Concerning? (edit) |
10.1128/JVI.02077-21 |
| 2022-03-23 |
Tuftsin: A Natural Molecule Against SARS-CoV-2 Infection (edit) |
10.3389/FMOLB.2022.859162 |
| 2022-03-23 |
A scalable serology solution for profiling humoral immune responses to SARS-CoV-2 infection and vaccination (edit) |
10.1002/CTI2.1380 |
| 2022-03-23 |
High Seroprevalence of SARS-CoV-2 in White-Tailed Deer (Odocoileus virginianus) at One of Three Captive Cervid Facilities in Texas (edit) |
10.1128/SPECTRUM.00576-22 |
| 2022-03-23 |
Genomic Epidemiology of SARS-CoV-2 in Tocantins State and the Diffusion of P.1.7 and AY.99.2 Lineages in Brazil (edit) |
10.3390/V14040659 |
| 2022-03-23 |
Molnupiravir Does Not Induce Mutagenesis in Host Lung Cells during SARS-CoV-2 Treatment (edit) |
10.1177/11779322221085077 |
| 2022-03-23 |
Glycosylation is key for enhancing drug recognition into spike glycoprotein of SARS-CoV-2 (edit) |
10.1016/J.COMPBIOLCHEM.2022.107668 |
| 2022-03-22 |
SARS-CoV-2 NSP13 helicase suppresses interferon signaling by perturbing JAK1 phosphorylation of STAT1 (edit) |
10.1186/S13578-022-00770-1 |
| 2022-03-22 |
SARS-CoV-2, SARS-CoV and MERS-CoV encode circular RNAs of spliceosome-independent origin (edit) |
10.1002/JMV.27734 |
| 2022-03-22 |
In Silico Insights towards the Identification of SARS-CoV-2 NSP13 Helicase Druggable Pockets (edit) |
10.3390/BIOM12040482 |
| 2022-03-22 |
Generalized Methodology for the Quick Prediction of Variant SARS-CoV-2 Spike Protein Binding Affinities with Human Angiotensin-Converting Enzyme II (edit) |
10.1021/ACS.JPCB.1C10718 |
| 2022-03-22 |
E-Volve: understanding the impact of mutations in SARS-CoV-2 variants spike protein on antibodies and ACE2 affinity through patterns of chemical interactions at protein interfaces (edit) |
10.7717/PEERJ.13099 |
| 2022-03-22 |
The dynamics of circulating SARS-CoV-2 lineages in Bogor and surrounding areas reflect variant shifting during the first and second waves of COVID-19 in Indonesia (edit) |
10.7717/PEERJ.13132 |
| 2022-03-21 |
Profiling of SARS-CoV-2 Subgenomic RNAs in Clinical Specimens (edit) |
10.1128/SPECTRUM.00182-22 |
| 2022-03-21 |
Interaction Analysis of the Spike Protein of Delta and Omicron Variants of SARS-CoV-2 with hACE2 and Eight Monoclonal Antibodies Using the Fragment Molecular Orbital Method (edit) |
10.1021/ACS.JCIM.2C00100 |
| 2022-03-21 |
SARS-CoV-2 Mutations and COVID-19 Clinical Outcome: Mutation Global Frequency Dynamics and Structural Modulation Hold the Key (edit) |
10.3389/FCIMB.2022.868414 |
| 2022-03-21 |
The early SARS-CoV-2 epidemic in Senegal was driven by the local emergence of B.1.416 and the introduction of B.1.1.420 from Europe (edit) |
10.1093/VE/VEAC025 |
| 2022-03-21 |
Comparison of Saliva and Midturbinate Swabs for Detection of SARS-CoV-2 (edit) |
10.1128/SPECTRUM.00128-22 |
| 2022-03-21 |
SARS-CoV-2 Lineage Tracking, and Evolving Trends Seen during Three Consecutive Peaks of Infection in Delhi, India: a Clinico-Genomic Study (edit) |
10.1128/SPECTRUM.02729-21 |
| 2022-03-21 |
From Deer-to-Deer: SARS-CoV-2 is efficiently transmitted and presents broad tissue tropism and replication sites in white-tailed deer (edit) |
10.1371/JOURNAL.PPAT.1010197 |
| 2022-03-21 |
Intra-protein interactions of SARS-CoV-2 and SARS: a bioinformatic analysis for plausible explanation regarding stability, divergency, and severity (edit) |
|
| 2022-03-21 |
Genetic alteration of human MYH6 is mimicked by SARS-CoV-2 polyprotein: mapping viral variants of cardiac interest (edit) |
10.1038/S41420-022-00914-9 |
| 2022-03-21 |
HSP90 Inhibitors Modulate SARS-CoV-2 Spike Protein Subunit 1-Induced Human Pulmonary Microvascular Endothelial Activation and Barrier Dysfunction (edit) |
10.3389/FPHYS.2022.812199 |
| 2022-03-21 |
No man is an island: management of the emergency response to the SARS-CoV-2 (COVID-19) outbreak in a large public decentralised service delivery organisation (edit) |
10.1186/S12913-022-07716-W |
| 2022-03-21 |
The Traditional Chinese Medicine Formula Jing Guan Fang for Preventing SARS-CoV-2 Infection: From Clinical Observation to Basic Research (edit) |
10.3389/FPHAR.2022.744439 |
| 2022-03-21 |
Coronavirus Genomes and Unique Mutations in Structural and Non-Structural Proteins in Pakistani SARS-CoV-2 Delta Variants during the Fourth Wave of the Pandemic (edit) |
10.3390/GENES13030552 |
| 2022-03-21 |
Trajectory of IgG to SARS-CoV-2 After Vaccination With BNT162b2 or mRNA-1273 in an Employee Cohort and Comparison With Natural Infection (edit) |
10.3389/FIMMU.2022.850987 |
| 2022-03-19 |
SARS-CoV-2 IgG Seroprevalence among Blood Donors as a Monitor of the COVID-19 Epidemic, Brazil (edit) |
10.3201/EID2804.211961 |
| 2022-03-18 |
Metataxonomic Analysis of Milk Samples From SARS-CoV-2-Positive and SARS-CoV-2-Negative Women (edit) |
10.3389/FNUT.2022.853576 |
| 2022-03-18 |
Neutralizing immunity in vaccine breakthrough infections from the SARS-CoV-2 Omicron and Delta variants (edit) |
10.1016/J.CELL.2022.03.019 |
| 2022-03-18 |
Both simulation and sequencing data reveal coinfections with multiple SARS-CoV-2 variants in the COVID-19 pandemic (edit) |
10.1016/J.CSBJ.2022.03.011 |
| 2022-03-17 |
The SARS-CoV-2 Entry Inhibition Mechanisms of Serine Protease Inhibitors, OM-85, Heparin and Soluble HS Might Be Linked to HS Attachment Sites (edit) |
10.3390/MOLECULES27061947 |
| 2022-03-17 |
Determinants of SARS-CoV-2 transmission to guide vaccination strategy in an urban area (edit) |
10.1093/VE/VEAC002 |
| 2022-03-17 |
Short-Term Instantaneous Prophylaxis and Efficient Treatment Against SARS-CoV-2 in hACE2 Mice Conferred by an Intranasal Nanobody (Nb22) (edit) |
10.3389/FIMMU.2022.865401 |
| 2022-03-17 |
Intranasal delivery of SARS-CoV-2 spike protein is sufficient to cause olfactory damage, inflammation and olfactory dysfunction in zebrafish (edit) |
10.1016/J.BBI.2022.03.006 |
| 2022-03-17 |
Evolutionary history and introduction of SARS-CoV-2 Alpha VOC/B.1.1.7 in Pakistan through international travelers (edit) |
10.1093/VE/VEAC020 |
| 2022-03-17 |
Mutations and Phylogenetic Analyses of SARS-CoV-2 Among Imported COVID-19 From Abroad in Nanjing, China (edit) |
10.3389/FMICB.2022.851323 |
| 2022-03-17 |
De novo emergence of a remdesivir resistance mutation during treatment of persistent SARS-CoV-2 infection in an immunocompromised patient: a case report (edit) |
10.1038/S41467-022-29104-Y |
| 2022-03-17 |
Immunoassay platform with surface-enhanced resonance Raman scattering for detecting trace levels of SARS-CoV-2 spike protein (edit) |
10.1016/J.TALANTA.2022.123381 |
| 2022-03-16 |
Free ISG15 and protein ISGylation emerging in SARS-CoV-2 infection (edit) |
10.2174/1389450123666220316094720 |
| 2022-03-16 |
Coagulation factors directly cleave SARS-CoV-2 spike and enhance viral entry (edit) |
10.7554/ELIFE.77444 |
| 2022-03-16 |
SARS-CoV-2: Receptor and Co-receptor Tropism Probability (edit) |
10.1007/S00284-022-02807-7 |
| 2022-03-16 |
SARS-CoV-2 Nsp14 mediates the effects of viral infection on the host cell transcriptome (edit) |
10.7554/ELIFE.71945 |
| 2022-03-16 |
When Poly(A) Binding Proteins Meet Viral Infections, Including SARS-CoV-2 (edit) |
10.1128/JVI.00136-22 |
| 2022-03-16 |
Monitoring SARS-CoV-2 in wastewater during New York City's second wave of COVID-19: sewershed-level trends and relationships to publicly available clinical testing data (edit) |
10.1039/D1EW00747E |
| 2022-03-16 |
Effect of insilico predicted and designed potential siRNAs on inhibition of SARS-CoV-2 in HEK-293 cells (edit) |
10.1016/J.JKSUS.2022.101965 |
| 2022-03-16 |
SARS-CoV-2 spike E156G/Δ157-158 mutations contribute to increased infectivity and immune escape (edit) |
10.26508/LSA.202201415 |
| 2022-03-16 |
The accessible promoter-mediated supplementary effect of host factors provides new insight into the tropism of SARS-CoV-2 (edit) |
10.1016/J.OMTN.2022.03.010 |
| 2022-03-16 |
Sensitive, smartphone-based SARS-CoV-2 detection from clinical saline gargle samples (edit) |
10.1093/PNASNEXUS/PGAC028 |
| 2022-03-16 |
Collaboration between Clinical and Academic Laboratories for Sequencing SARS-CoV-2 Genomes (edit) |
10.1128/JCM.01288-21 |
| 2022-03-15 |
Characterization of Altered Oropharyngeal Microbiota in Hospitalized Patients With Mild SARS-CoV-2 Infection (edit) |
10.3389/FCIMB.2022.824578 |
| 2022-03-15 |
Isolation of Thioinosine and Butenolides from a Terrestrial Actinomycetes sp. GSCW-51 and Their in Silico Studies for Potential against SARS-CoV-2 (edit) |
10.1002/CBDV.202100843 |
| 2022-03-15 |
Virus blocking textile for SARS-CoV-2 using human body triboelectric energy harvesting (edit) |
10.1016/J.XCRP.2022.100813 |
| 2022-03-14 |
When cyclin‐dependent kinases meet viral infections, including SARS‐CoV‐2 (edit) |
10.1002/JMV.27719 |
| 2022-03-14 |
SARS-CoV-2 mRNA vaccine induced higher antibody affinity and IgG titers against variants of concern in post-partum vs non-post-partum women (edit) |
10.1016/J.EBIOM.2022.103940 |
| 2022-03-14 |
Intranasal administration of BReC-CoV-2 COVID-19 vaccine protects K18-hACE2 mice against lethal SARS-CoV-2 challenge (edit) |
10.1038/S41541-022-00451-7 |
| 2022-03-14 |
Design of SARS-CoV-2 Variant-Specific PCR Assays Considering Regional and Temporal Characteristics (edit) |
10.1128/AEM.02289-21 |
| 2022-03-14 |
Host Cell Glycocalyx Remodeling Reveals SARS-CoV-2 Spike Protein Glycomic Binding Sites (edit) |
10.3389/FMOLB.2022.799703 |
| 2022-03-14 |
Association of high SARS-CoV-2 RNAemia with diabetes and mortality in critically ill COVID-19 patients (edit) |
10.1016/J.ISCI.2022.104075 |
| 2022-03-14 |
Data on Transfer of Human Coronavirus SARS-CoV-2 from Foods and Packaging Materials to Gloves Indicate That Fomite Transmission Is of Minor Importance (edit) |
10.1128/AEM.02338-21 |
| 2022-03-14 |
Antigenic evolution will lead to new SARS-CoV-2 variants with unpredictable severity (edit) |
10.1038/S41579-022-00722-Z |
| 2022-03-13 |
Oridonin Inhibits SARS-CoV-2 by Targeting Its 3C-Like Protease (edit) |
10.1002/SMSC.202100124 |
| 2022-03-13 |
Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY.4.2. (edit) |
10.1016/J.EBIOM.2022.103934 |
| 2022-03-12 |
Risk of SARS-CoV-2 transmission upon return to work in RNA-positive healthcare workers (edit) |
10.1016/J.JHIN.2022.02.024 |
| 2022-03-12 |
Characterization of persons with reported SARS-CoV-2 infection in the Oklahoma City tri-county area: Evidence from the first 12 months of transmission (edit) |
10.1016/J.AJIC.2022.03.007 |
| 2022-03-11 |
Evaluation of Serologic Cross-Reactivity Between Dengue Virus and SARS-CoV-2 in Patients with Acute Febrile Illness - United States and Puerto Rico, April 2020-March 2021 (edit) |
10.15585/MMWR.MM7110A3 |
| 2022-03-11 |
SARS-CoV-2 Incidence in K-12 School Districts with Mask-Required Versus Mask-Optional Policies - Arkansas, August-October 2021 (edit) |
10.15585/MMWR.MM7110E1 |
| 2022-03-11 |
Efficient Identification of Anti-SARS-CoV-2 Compounds Using Chemical Structure- and Biological Activity-Based Modeling (edit) |
10.1021/ACS.JMEDCHEM.1C01372 |
| 2022-03-11 |
Computational identification of host genomic biomarkers highlighting their functions, pathways and regulators that influence SARS-CoV-2 infections and drug repurposing (edit) |
10.1038/S41598-022-08073-8 |
| 2022-03-11 |
ACE2-independent infection of T lymphocytes by SARS-CoV-2 (edit) |
10.1038/S41392-022-00919-X |
| 2022-03-11 |
Persistence of Endogenous SARS-CoV-2 and Pepper Mild Mottle Virus RNA in Wastewater-Settled Solids (edit) |
|
| 2022-03-11 |
RBD trimer mRNA vaccine elicits broad and protective immune responses against SARS-CoV-2 variants (edit) |
10.1016/J.ISCI.2022.104043 |
| 2022-03-11 |
Comparative transmissibility of SARS-CoV-2 variants Delta and Alpha in New England, USA (edit) |
10.1016/J.XCRM.2022.100583 |
| 2022-03-11 |
Exploring Zebrafish Larvae as a COVID-19 Model: Probable Abortive SARS-CoV-2 Replication in the Swim Bladder (edit) |
10.3389/FCIMB.2022.790851 |
| 2022-03-11 |
Erythro-VLPs: Anchoring SARS-CoV-2 spike proteins in erythrocyte liposomes (edit) |
10.1371/JOURNAL.PONE.0263671 |
| 2022-03-11 |
Waning Humoral Response after COVID-19 mRNA Vaccination in Maintenance Dialysis Patients and Recovery after a Complementary Third Dose (edit) |
10.3390/VACCINES10030433 |
| 2022-03-11 |
Vaccination with BNT162b2 reduces transmission of SARS-CoV-2 to household contacts in Israel (edit) |
10.1126/SCIENCE.ABL4292 |
| 2022-03-11 |
Indirect protection of children from SARS-CoV-2 infection through parental vaccination (edit) |
10.1126/SCIENCE.ABM3087 |
| 2022-03-11 |
The changing epidemiology of SARS-CoV-2 (edit) |
10.1126/SCIENCE.ABM4915 |
| 2022-03-10 |
Decline in Respiratory Functions in Hospitalized SARS-CoV-2 Infected Cancer Patients Following Cytotoxic Chemotherapy-An Additional Risk for Post-chemotherapy Complications (edit) |
10.3389/FMED.2022.835098 |
| 2022-03-10 |
Divergent trajectories of antiviral memory after SARS-CoV-2 infection (edit) |
10.1038/S41467-022-28898-1 |
| 2022-03-10 |
SARS-CoV-2 infection in public hospital medical doctors in an Eastern Cape metro (edit) |
10.4102/SAJID.V37I1.335 |
| 2022-03-10 |
Structural basis of nanobodies neutralizing SARS-CoV-2 variants (edit) |
10.1016/J.STR.2022.02.011 |
| 2022-03-10 |
Broad neutralization of SARS-CoV-2 variants by an inhalable bispecific single-domain antibody (edit) |
10.1016/J.CELL.2022.03.009 |
| 2022-03-10 |
Mild SARS-CoV-2 infection in rhesus macaques is associated with viral control prior to antigen-specific T cell responses in tissues (edit) |
10.1126/SCIIMMUNOL.ABO0535 |
| 2022-03-10 |
Analyzing the interaction of human ACE2 and RBD of spike protein of SARS-CoV-2 in perspective of Omicron variant (edit) |
10.17179/EXCLI2022-4721 |
| 2022-03-10 |
Anti-SARS-CoV-2 equine F (Ab')2 immunoglobulin as a possible therapy for COVID-19 (edit) |
10.1038/S41598-022-07793-1 |
| 2022-03-10 |
Histones released by NETosis enhance the infectivity of SARS-CoV-2 by bridging the spike protein subunit 2 and sialic acid on host cells (edit) |
10.1038/S41423-022-00845-6 |
| 2022-03-10 |
SARS-CoV-2 B.1.214.1, B.1.214.2 and B.1.620 are predominant lineages between December 2020 and July 2021 in the Republic of Congo (edit) |
|
| 2022-03-10 |
Stopping pandemics before they start: Lessons learned from SARS-CoV-2 (edit) |
10.1126/SCIENCE.ABN1900 |
| 2022-03-10 |
Unsupervised explainable AI for molecular evolutionary study of forty thousand SARS-CoV-2 genomes (edit) |
10.1186/S12866-022-02484-3 |
| 2022-03-10 |
Overview SARS-CoV-2 Pandemic as January-February 2022: Likely Cometary Origin, Global Spread, Prospects for Future Vaccine Efficacy (edit) |
10.31038/IDT.2022311 |
| 2022-03-09 |
In silico discovery of 3 novel quercetin derivatives against papain-like protease, spike protein, and 3C-like protease of SARS-CoV-2 (edit) |
10.1186/S43141-022-00314-7 |
| 2022-03-09 |
Coronavirus Resistance Database (CoV-RDB): SARS-CoV-2 susceptibility to monoclonal antibodies, convalescent plasma, and plasma from vaccinated persons (edit) |
10.1371/JOURNAL.PONE.0261045 |
| 2022-03-09 |
RespiCoV: Simultaneous identification of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and 46 respiratory tract viruses and bacteria by amplicon-based Oxford-Nanopore MinION sequencing (edit) |
10.1371/JOURNAL.PONE.0264855 |
| 2022-03-09 |
CovDif, a Tool to Visualize the Conservation between SARS-CoV-2 Genomes and Variants (edit) |
10.3390/V14030561 |
| 2022-03-09 |
Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study (edit) |
10.1136/BMJ-2021-069761 |
| 2022-03-08 |
An intra-cytoplasmic route for SARS-CoV-2 transmission unveiled by Helium-ion microscopy (edit) |
10.1038/S41598-022-07867-0 |
| 2022-03-08 |
Ensemble cryo-EM reveals conformational states of the nsp13 helicase in the SARS-CoV-2 helicase replication–transcription complex (edit) |
10.1038/S41594-022-00734-6 |
| 2022-03-08 |
RIG-I-induced innate antiviral immunity protects mice from lethal SARS-CoV-2 infection (edit) |
10.1016/J.OMTN.2022.02.008 |
| 2022-03-07 |
Cytoplasmic domain and enzymatic activity of ACE2 are not required for PI4KB dependent endocytosis entry of SARS-CoV-2 into host cells (edit) |
10.1016/J.VIRS.2022.03.003 |
| 2022-03-07 |
HLA-dependent variation in SARS-CoV-2 CD8 + T cell cross-reactivity with human coronaviruses (edit) |
10.1111/IMM.13451 |
| 2022-03-07 |
Conserved Pattern and Potential Role of Recurrent Deletions in SARS-CoV-2 Evolution (edit) |
10.1128/SPECTRUM.02191-21 |
| 2022-03-07 |
Rationally designed immunogens enable immune focusing following SARS-CoV-2 spike imprinting (edit) |
10.1016/J.CELREP.2022.110561 |
| 2022-03-07 |
Biparatopic sybodies neutralize SARS-CoV-2 variants of concern and mitigate drug resistance (edit) |
10.15252/EMBR.202154199 |
| 2022-03-07 |
Generation of human tonsil epithelial organoids as an ex vivo model for SARS-CoV-2 infection (edit) |
10.1016/J.BIOMATERIALS.2022.121460 |
| 2022-03-07 |
Using genomic epidemiology of SARS-CoV-2 to support contact tracing and public health surveillance in rural Humboldt County, California (edit) |
10.1186/S12889-022-12790-0 |
| 2022-03-07 |
Cross-species tropism and antigenic landscapes of circulating SARS-CoV-2 variants (edit) |
10.1016/J.CELREP.2022.110558 |
| 2022-03-06 |
An engineered nano-liposome-human ACE2 decoy neutralizes SARS-CoV-2 Spike protein-induced inflammation in both murine and human macrophages (edit) |
10.7150/THNO.66831 |
| 2022-03-05 |
Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression (edit) |
10.1016/S0140-6736(22)00152-0 |
| 2022-03-04 |
Transport Safety Concerning a Patient Infected With SARS-CoV-2 and Emergency Service Officers in an Ambulance Accident—A Case Study (edit) |
10.1017/DMP.2022.50 |
| 2022-03-04 |
Immune responses against different variants of SARS-CoV-2 including Omicron following 6 months of administration of heterologous prime-boost COVID-19 vaccine (edit) |
10.1093/JTM/TAAC033 |
| 2022-03-04 |
Broad anti–SARS-CoV-2 antibody immunity induced by heterologous ChAdOx1/mRNA-1273 vaccination (edit) |
10.1126/SCIENCE.ABN2688 |
| 2022-03-04 |
Determining the optimal SARS-CoV-2 mRNA vaccine dosing interval for maximum immunogenicity (edit) |
10.1101/2022.03.01.482592 |
| 2022-03-03 |
SARS-CoV-2 ORF3a induces RETREG1/FAM134B-dependent reticulophagy and triggers sequential ER stress and inflammatory responses during SARS-CoV-2 infection (edit) |
10.1080/15548627.2022.2039992 |
| 2022-03-03 |
Cryo-EM structure of a SARS-CoV-2 omicron spike protein ectodomain (edit) |
10.1038/S41467-022-28882-9 |
| 2022-03-03 |
CEBIT screening for inhibitors of the interaction between SARS-CoV-2 spike and ACE2 (edit) |
|
| 2022-03-03 |
Statewide Evaluation of SARS-CoV-2 Diagnoses and Sexual Orientation and Gender Identity (edit) |
10.1177/00333549221077073 |
| 2022-03-03 |
Truncating fined-tuned vision-based models to lightweight deployable diagnostic tools for SARS-CoV-2 infected chest X-rays and CT-scans (edit) |
10.1007/S11042-022-12484-0 |
| 2022-03-03 |
Mini-XT, a miniaturized tagmentation-based protocol for efficient sequencing of SARS-CoV-2 (edit) |
10.1186/S12967-022-03307-9 |
| 2022-03-03 |
Viral load of SARS-CoV-2 in droplets and bioaerosols directly captured during breathing, speaking and coughing (edit) |
10.1038/S41598-022-07301-5 |
| 2022-03-03 |
Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant (edit) |
10.1186/S12916-022-02312-5 |
| 2022-03-02 |
Missense variants in human ACE2 strongly affect binding to SARS-CoV-2 Spike providing a mechanism for ACE2 mediated genetic risk in Covid-19: A case study in affinity predictions of interface variants (edit) |
10.1371/JOURNAL.PCBI.1009922 |
| 2022-03-02 |
Secondary structural ensembles of the SARS-CoV-2 RNA genome in infected cells (edit) |
10.1038/S41467-022-28603-2 |
| 2022-03-02 |
Travel ban effects on SARS-CoV-2 transmission lineages in the UAE as inferred by genomic epidemiology (edit) |
10.1371/JOURNAL.PONE.0264682 |
| 2022-03-01 |
SARS-CoV-2 viroporin encoded by ORF3a triggers the NLRP3 inflammatory pathway (edit) |
10.1016/J.VIROL.2022.01.003 |
| 2022-03-01 |
The key features of SARS-CoV-2 leader and NSP1 required for viral escape of NSP1-mediated repression (edit) |
10.1261/RNA.079086.121 |
| 2022-03-01 |
Modulation of the monomer-dimer equilibrium and catalytic activity of SARS-CoV-2 main protease by a transition-state analog inhibitor (edit) |
10.1038/S42003-022-03084-7 |
| 2022-03-01 |
Elucidating important structural features for the binding affinity of spike - SARS-CoV-2 neutralizing antibody complexes (edit) |
10.1002/PROT.26277 |
| 2022-03-01 |
Periodically aperiodic pattern of SARS-CoV-2 mutations underpins the uncertainty of its origin and evolution (edit) |
10.1016/J.ENVRES.2021.112092 |
| 2022-03-01 |
Factors Responsible for Emergence of Novel Viruses: An emphasis on SARS-CoV-2 (edit) |
10.1016/J.COESH.2022.100358 |
| 2022-03-01 |
Feasibility of a high-volume filter sampler for detecting SARS-CoV-2 RNA in COVID-19 patient rooms (edit) |
10.1093/ANNWEH/WXAB100 |
| 2022-03-01 |
Laboratory study of physical barrier efficiency for worker protection against SARS-CoV-2 while standing or sitting (edit) |
10.1080/02786826.2021.2020210 |
| 2022-03-01 |
Histopathology and localization of SARS-CoV-2 and its host cell entry receptor ACE2 in tissues from naturally infected US-farmed mink (Neovison vison) (edit) |
10.1177/03009858221079665 |
| 2022-03-01 |
TLR2 and TLR7 mediate distinct immunopathological and antiviral plasmacytoid dendritic cell responses to SARS-CoV-2 infection (edit) |
10.15252/EMBJ.2021109622 |
| 2022-03-01 |
Evaluation of Commercially Available High-Throughput SARS-CoV-2 Serologic Assays for Serosurveillance and Related Applications (edit) |
10.3201/EID2803.211885 |
| 2022-03-01 |
Comparison of anti-peptide and anti-protein antibody-based purification techniques for detection of SARS-CoV-2 by targeted LC-MS/MS (edit) |
|
| 2022-03-01 |
Virus-specific editing identification approach reveals the landscape of A-to-I editing and its impacts on SARS-CoV-2 characteristics and evolution (edit) |
10.1093/NAR/GKAC120 |
| 2022-03-01 |
The FDA-Approved Drug Cobicistat Synergizes with Remdesivir To Inhibit SARS-CoV-2 Replication In Vitro and Decreases Viral Titers and Disease Progression in Syrian Hamsters (edit) |
10.1128/MBIO.03705-21 |
| 2022-03-01 |
Computational studies on the interaction of SARS-CoV-2 Omicron SGp RBD with human receptor ACE2, limonin and glycyrrhizic acid (edit) |
10.1016/J.COMPBIOMED.2022.105367 |
| 2022-03-01 |
SARS-CoV-2 Omicron Spike recognition by plasma from individuals receiving BNT162b2 mRNA vaccination with a 16-week interval between doses (edit) |
10.1016/J.CELREP.2022.110429 |
| 2022-03-01 |
Potentialities of graphene and its allied derivatives to combat against SARS-CoV-2 infection (edit) |
10.1016/J.MTADV.2022.100208 |
| 2022-03-01 |
HBD-2 binds SARS-CoV-2 RBD and blocks viral entry: Strategy to combat COVID-19 (edit) |
10.1016/J.ISCI.2022.103856 |
| 2022-03-01 |
Cytokine storm and histopathological findings in 60 cases of COVID-19-related death: from viral load research to immunohistochemical quantification of major players IL-1β, IL-6, IL-15 and TNF-α (edit) |
10.1007/S12024-021-00414-9 |
| 2022-03-01 |
Dynamic SARS-CoV-2-specific B-cell and T-cell responses following immunization with an inactivated COVID-19 vaccine (edit) |
10.1016/J.CMI.2021.10.006 |
| 2022-03-01 |
Vaccine efficacy and SARS-CoV-2 control in California and U.S. during the session 2020–2026: A modeling study (edit) |
10.1016/J.IDM.2021.11.002 |
| 2022-03-01 |
Experiences of the SARS-CoV-2 pandemic amongst Australian healthcare workers: from stressors to protective factors (edit) |
10.1016/J.JHIN.2021.12.002 |
| 2022-03-01 |
Mitochondrial hijacking: A potential mechanism for SARS-CoV-2 to impair female fertility (edit) |
10.1016/J.MEHY.2022.110778 |
| 2022-03-01 |
Copper acetate aerosols: A possible tool complementary to vaccination in fight against SARS-CoV-2 and variants replication (edit) |
10.1016/J.MEHY.2022.110775 |
| 2022-03-01 |
Existing human mobility data sources poorly predicted the spatial spread of SARS-CoV-2 in Madagascar (edit) |
10.1016/J.EPIDEM.2021.100534 |
| 2022-03-01 |
The effects of SARS-CoV-2 on hearing thresholds in COVID-19 patients with non-hospitalized mild disease (edit) |
10.1016/J.AMJOTO.2021.103320 |
| 2022-03-01 |
Impact of residual risk messaging to reduce false reassurance following test-negative results from asymptomatic coronavirus (SARS-CoV-2) testing: an online experimental study of a hypothetical test (edit) |
10.1136/BMJOPEN-2021-056533 |
| 2022-03-01 |
Does SARS-CoV-2 affect cochlear functions in children? (edit) |
10.15537/SMJ.2022.43.3.20210782 |
| 2022-03-01 |
SARS-CoV-2 vaccine-associated-tinnitus: A review (edit) |
10.1016/J.AMSU.2022.103293 |
| 2022-03-01 |
Vaccines elicit highly conserved cellular immunity to SARS-CoV-2 Omicron (edit) |
10.1038/S41586-022-04465-Y |
| 2022-03-01 |
T cell responses to SARS-CoV-2 spike cross-recognize Omicron (edit) |
10.1038/S41586-022-04460-3 |
| 2022-03-01 |
Impact of SARS-CoV-2 Infection Among Non-Invasive Ventilated ALS Patients (edit) |
10.3233/JND-210733 |
| 2022-03-01 |
Spike mutations in SARS-CoV-2 AY sublineages of the Delta variant of concern: implications for the future of the pandemic (edit) |
10.2217/FMB-2021-0286 |
| 2022-03-01 |
Coupling freedom from disease principles and early warning from wastewater surveillance to improve health security (edit) |
10.1093/PNASNEXUS/PGAC001 |
| 2022-03-01 |
Continuous genomic diversification of long polynucleotide fragments drives the emergence of new SARS-CoV-2 variants of concern (edit) |
10.1093/PNASNEXUS/PGAC018 |
| 2022-02-28 |
SARS-CoV-2 nucleocapsid protein targets a conserved surface groove of the NTF2-like domain of G3BP1 (edit) |
10.1016/J.JMB.2022.167516 |
| 2022-02-28 |
ACE2-Fc fusion protein overcomes viral escape by potently neutralizing SARS-CoV-2 variants of concern (edit) |
10.1016/J.ANTIVIRAL.2022.105271 |
| 2022-02-28 |
The SARS-CoV-2 Mu variant should not be left aside: It warrants attention for its immuno-escaping ability (edit) |
10.1002/JMV.27663 |
| 2022-02-28 |
Optimizing peptide inhibitors of SARS-Cov-2 nsp10/nsp16 methyltransferase predicted through molecular simulation and machine learning (edit) |
10.1016/J.IMU.2022.100886 |
| 2022-02-26 |
Comparison of analytical sensitivity and efficiency for SARS-CoV-2 primer sets by TaqMan-based and SYBR Green-based RT-qPCR (edit) |
10.1007/S00253-022-11822-4 |
| 2022-02-26 |
Machine learning prediction of 3CL SARS-CoV-2 docking scores (edit) |
10.1016/J.COMPBIOLCHEM.2022.107656 |
| 2022-02-25 |
A Deadly Embrace: Hemagglutination Mediated by SARS-CoV-2 Spike Protein at Its 22 N-Glycosylation Sites, Red Blood Cell Surface Sialoglycoproteins, and Antibody (edit) |
10.3390/IJMS23052558 |
| 2022-02-25 |
The first baseline of ALDFG generated by the artisanal fishery during the SARS-CoV-2 pandemic on the north coast of Pernambuco, Brazil (edit) |
10.1016/J.MARPOLBUL.2022.113470 |
| 2022-02-25 |
Non-Invasive Monitoring for Rejection in Kidney Transplant Recipients After SARS-CoV-2 mRNA Vaccination (edit) |
10.3389/FIMMU.2022.838985 |
| 2022-02-25 |
Simian Immunodeficiency Virus Infection Mediated Changes in Jejunum and Peripheral SARS-CoV-2 Receptor ACE2 and Associated Proteins or Genes in Rhesus Macaques (edit) |
10.3389/FIMMU.2022.835686 |
| 2022-02-25 |
Identification of SARS-CoV-2 inhibitors targeting Mpro and PLpro using in-cell-protease assay (edit) |
10.1038/S42003-022-03090-9 |
| 2022-02-25 |
Evaluating the in vitro efficacy of bovine lactoferrin products against SARS-CoV-2 variants of concern (edit) |
10.3168/JDS.2021-21247 |
| 2022-02-25 |
Index-Based Policy to Guide Mask-Wearing for SARS-CoV-2 and Other Pandemics (edit) |
10.2139/SSRN.4039299 |
| 2022-02-25 |
Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement (edit) |
10.1126/SCIENCE.ABN8652 |
| 2022-02-24 |
Targeting SARS-CoV-2 Proteases and Polymerase for COVID-19 Treatment: State of the Art and Future Opportunities (edit) |
10.1021/ACS.JMEDCHEM.0C01140 |
| 2022-02-24 |
Viroporins: structure, function, and their role in the life cycle of SARS-CoV-2 (edit) |
10.1016/J.BIOCEL.2022.106185 |
| 2022-02-24 |
Modeling comparative cost-effectiveness of SARS-CoV-2 vaccine dose fractionation in India (edit) |
10.1038/S41591-022-01736-Z |
| 2022-02-24 |
Diminishing Immune Responses against Variants of Concern in Dialysis Patients 4 Months after SARS-CoV-2 mRNA Vaccination (edit) |
10.3201/EID2804.211907 |
| 2022-02-24 |
Insights into Binding of Single-Stranded Viral RNA Template to the Replication-Transcription Complex of SARS-CoV-2 for the Priming Reaction from Molecular Dynamics Simulations (edit) |
10.1021/ACS.BIOCHEM.1C00755 |
| 2022-02-24 |
Improving the efficiency and effectiveness of an industrial SARS-CoV-2 diagnostic facility (edit) |
10.1038/S41598-022-06873-6 |
| 2022-02-23 |
Neuropilin‐1‐Mediated SARS‐CoV‐2 Infection in Bone Marrow‐Derived Macrophages Inhibits Osteoclast Differentiation (edit) |
10.1002/ADBI.202200007 |
| 2022-02-23 |
Is heparan sulfate a target for inhibition of RNA virus infection? (edit) |
10.1152/AJPCELL.00028.2022 |
| 2022-02-23 |
Evaluation of Swab-Seq as a scalable, sensitive assay for community surveillance of SARS-CoV-2 infection (edit) |
10.1038/S41598-022-06901-5 |
| 2022-02-23 |
The stalk domain of SARS-CoV-2 NSP13 is essential for its helicase activity (edit) |
10.1016/J.BBRC.2022.02.068 |
| 2022-02-23 |
Interactions of Severe Acute Respiratory Syndrome Coronavirus 2 Protein E With Cell Junctions and Polarity PSD-95/Dlg/ZO-1-Containing Proteins (edit) |
10.3389/FMICB.2022.829094 |
| 2022-02-23 |
IMPACT of PCSK9 inhibition on clinical outcome in patients during the inflammatory stage of the SARS-COV-2 infection: Rationale and protocol of the IMPACT-SIRIO 5 study (edit) |
10.5603/CJ.A2021.0148 |
| 2022-02-23 |
Decline in Antibody Concentration 6 Months After Two Doses of SARS-CoV-2 BNT162b2 Vaccine in Solid Organ Transplant Recipients and Healthy Controls (edit) |
10.3389/FIMMU.2022.832501 |
| 2022-02-23 |
Detection of SARS-CoV-2 RNA throughout wastewater treatment plants and a modeling approach to understand COVID-19 infection dynamics in Winnipeg, Canada (edit) |
10.1016/J.SCITOTENV.2022.153906 |
| 2022-02-23 |
Protective immune trajectories in early viral containment of non-pneumonic SARS-CoV-2 infection (edit) |
10.1038/S41467-022-28508-0 |
| 2022-02-23 |
Serially passaged, conditionally reprogrammed nasal epithelial cells as a model to study epithelial functions and SARS-CoV-2 infection (edit) |
10.1152/AJPCELL.00363.2021 |
| 2022-02-23 |
Spread of Gamma (P.1) Sub-Lineages Carrying Spike Mutations Close to the Furin Cleavage Site and Deletions in the N-Terminal Domain Drives Ongoing Transmission of SARS-CoV-2 in Amazonas, Brazil (edit) |
10.1128/SPECTRUM.02366-21 |
| 2022-02-23 |
Limited Recognition of Highly Conserved Regions of SARS-CoV-2 (edit) |
10.1128/SPECTRUM.02780-21 |
| 2022-02-23 |
An adjuvanted subunit SARS-CoV-2 spike protein vaccine provides protection against Covid-19 infection and transmission (edit) |
10.1038/S41541-022-00450-8 |
| 2022-02-23 |
Emergency SARS-CoV-2 Variants of Concern: Novel Multiplex Real-Time RT-PCR Assay for Rapid Detection and Surveillance (edit) |
10.1128/SPECTRUM.02513-21 |
| 2022-02-23 |
Combined Prospective Seroconversion and PCR Data of Selected Cohorts Indicate a High Rate of Subclinical SARS-CoV-2 Infections—an Open Observational Study in Lower Saxony, Germany (edit) |
10.1128/SPECTRUM.01512-21 |
| 2022-02-23 |
Stillbirth after COVID-19 in Unvaccinated Mothers Can Result from SARS-CoV-2 Placentitis, Placental Insufficiency, and Hypoxic Ischemic Fetal Demise, Not Direct Fetal Infection: Potential Role of Maternal Vaccination in Pregnancy (edit) |
10.3390/V14030458 |
| 2022-02-23 |
Evaluation of the Performance of a Multiplexed Serological Assay in the Detection of SARS-CoV-2 Infections in a Predominantly Vaccinated Population (edit) |
10.1128/SPECTRUM.01454-21 |
| 2022-02-22 |
Polymorphisms and mutations of ACE2 and TMPRSS2 genes are associated with COVID-19: a systematic review (edit) |
10.1186/S40001-022-00647-6 |
| 2022-02-22 |
The SARS‐CoV‐2 Spike Glycoprotein Directly Binds Exogeneous Sialic Acids: A NMR View (edit) |
10.1002/ANIE.202201432 |
| 2022-02-22 |
Identification of a SARS-CoV-2 host metalloproteinase-dependent entry pathway differentially used by SARS-CoV-2 and variants of concern Alpha, Delta, and Omicron (edit) |
10.1101/2022.02.19.481107 |
| 2022-02-22 |
Multi-omics evaluation of SARS-CoV-2 infected mouse lungs reveals dynamics of host responses (edit) |
10.1016/J.ISCI.2022.103967 |
| 2022-02-22 |
Combination of antiviral drugs inhibits SARS-CoV-2 polymerase and exonuclease and demonstrates COVID-19 therapeutic potential in viral cell culture (edit) |
10.1038/S42003-022-03101-9 |
| 2022-02-22 |
BNT162b2 vaccination enhances interferon-JAK-STAT-regulated antiviral programs in COVID-19 patients infected with the SARS-CoV-2 Beta variant (edit) |
10.1038/S43856-022-00083-X |
| 2022-02-22 |
A cell-based system combined with flow cytometry to evaluate antibody responses against SARS-CoV-2 transmembrane proteins in patients with COVID-19 (edit) |
10.1016/J.XPRO.2022.101229 |
| 2022-02-22 |
Shedding Light on SARS-CoV-2, COVID-19, COVID-19 Vaccination, and Auditory Symptoms: Causality or Spurious Conjunction? (edit) |
10.3389/FPUBH.2022.837513 |
| 2022-02-21 |
Decoupling SARS-CoV-2 ORF6 localization and interferon antagonism (edit) |
10.1242/JCS.259666 |
| 2022-02-21 |
SARS-CoV-2 Nsp13 encodes for an HLA-E-stabilizing peptide that abrogates inhibition of NKG2A-expressing NK cells (edit) |
10.1016/J.CELREP.2022.110503 |
| 2022-02-21 |
Limited extent and consequences of pancreatic SARS-CoV-2 infection (edit) |
10.1016/J.CELREP.2022.110508 |
| 2022-02-21 |
Classical and Next-Generation Vaccine Platforms to SARS-CoV-2: Biotechnological Strategies and Genomic Variants (edit) |
10.3390/IJERPH19042392 |
| 2022-02-21 |
Low clinical protective response to SARS-CoV-2 mRNA COVID-19 vaccine in patients with multiple myeloma (edit) |
10.1007/S12185-022-03300-4 |
| 2022-02-21 |
Active site prediction of phosphorylated SARS-CoV-2 N-Protein using molecular simulation (edit) |
10.1016/J.IMU.2022.100889 |
| 2022-02-19 |
Can spike fragments of SARS-CoV-2 induce genomic instability and DNA damage in the guppy, Poecilia reticulate? An unexpected effect of the COVID-19 pandemic (edit) |
10.1016/J.SCITOTENV.2022.153988 |
| 2022-02-19 |
How tetraspanin-mediated cell entry of SARS-CoV-2 can dysregulate the shedding of the ACE2 receptor by ADAM17 (edit) |
10.1016/J.BBRC.2022.01.038 |
| 2022-02-18 |
SARS-CoV-2 Infects Red Blood Cell Progenitors and Dysregulates Hemoglobin and Iron Metabolism (edit) |
10.1007/S12015-021-10322-8 |
| 2022-02-18 |
Refolding of lid subdomain of SARS-CoV-2 nsp14 upon nsp10 interaction releases exonuclease activity (edit) |
10.1101/2022.02.17.480845 |
| 2022-02-18 |
Immune transcriptome analysis of COVID-19 patients infected with SARS-CoV-2 variants carrying the E484K escape mutation identifies a distinct gene module (edit) |
10.1038/S41598-022-06752-0 |
| 2022-02-18 |
Whole-genome analysis of SARS-CoV-2 in a 2020 infection cluster in a nursing home of Southern Italy (edit) |
10.1016/J.MEEGID.2022.105253 |
| 2022-02-18 |
Emergence in southern France of a new SARS-CoV-2 variant harbouring both N501Y and E484K substitutions in the spike protein (edit) |
10.1007/S00705-022-05385-Y |
| 2022-02-18 |
SARS-CoV-2 Beta variant infection elicits potent lineage-specific and cross-reactive antibodies (edit) |
10.1126/SCIENCE.ABM5835 |
| 2022-02-18 |
SARS-CoV-2 Omicron variant: Antibody evasion and cryo-EM structure of spike protein-ACE2 complex (edit) |
10.1126/SCIENCE.ABN7760 |
| 2022-02-17 |
Impacts of the SARS-CoV-2 pandemic on the global demand for exotic pets: An expert elicitation approach (edit) |
10.1016/J.GECCO.2022.E02067 |
| 2022-02-17 |
Identification of a Potential mRNA-based Vaccine Candidate against the SARS-CoV-2 Spike Glycoprotein: A Reverse Vaccinology Approach (edit) |
10.1002/SLCT.202103903 |
| 2022-02-17 |
Synthesis of Dihydrobenzofuro[3,2-b]chromenes as Potential 3CLpro Inhibitors of SARS-CoV-2: A Molecular Docking and Molecular Dynamics Study (edit) |
10.1002/CMDC.202100782 |
| 2022-02-17 |
The effect of prostacyclin infusion on markers of endothelial activation and damage in mechanically ventilated patients with SARS-CoV-2 infection (edit) |
10.1016/J.JCRC.2022.154010 |
| 2022-02-17 |
Impact of new variants on SARS-CoV-2 infectivity and neutralization: A molecular assessment of the alterations in the spike-host protein interactions (edit) |
10.1016/J.ISCI.2022.103939 |
| 2022-02-17 |
SARS-CoV-2 variant B.1.1.7 caused HLA-A2+ CD8+ T cell epitope mutations for impaired cellular immune response (edit) |
10.1016/J.ISCI.2022.103934 |
| 2022-02-17 |
Diltiazem inhibits SARS-CoV-2 cell attachment and internalization and decreases the viral infection in mouse lung (edit) |
10.1371/JOURNAL.PPAT.1010343 |
| 2022-02-17 |
Detecting SARS-CoV-2 lineages and mutational load in municipal wastewater and a use-case in the metropolitan area of Thessaloniki, Greece (edit) |
10.1038/S41598-022-06625-6 |
| 2022-02-17 |
Antiviral activities of 4H-chromen-4-one scaffold-containing flavonoids against SARS-CoV-2 using computational and in vitro approaches (edit) |
10.1016/J.MOLLIQ.2022.118775 |
| 2022-02-17 |
Sensitivity and efficiency of RNA sample pooling for real-time quantitative polymerase chain reaction testing for SARS-CoV-2 (edit) |
10.21037/JPHE-21-97 |
| 2022-02-17 |
A Multi-Center, Randomised, Double-Blind, Placebo-Controlled Phase III Clinical Trial Evaluating the Impact of BCG Re-Vaccination on the Incidence and Severity of SARS-CoV-2 Infections among Symptomatic Healthcare Professionals during the COVID-19 Pa (edit) |
10.3390/VACCINES10020314 |
| 2022-02-16 |
Lipid and Nucleocapsid N-Protein Accumulation in COVID-19 Patient Lung and Infected Cells (edit) |
10.1128/SPECTRUM.01271-21 |
| 2022-02-16 |
Reproduction Numbers of SARS-CoV-2 Variants: A Systematic Review and Meta-analysis (edit) |
10.1093/CID/CIAC137 |
| 2022-02-16 |
Real-Time RT-PCR Allelic Discrimination Assay for Detection of N501Y Mutation in the Spike Protein of SARS-CoV-2 Associated with B.1.1.7 Variant of Concern (edit) |
10.1128/SPECTRUM.00681-21 |
| 2022-02-16 |
Antibody attributes that predict the neutralization and effector function of polyclonal responses to SARS-CoV-2 (edit) |
10.1186/S12865-022-00480-W |
| 2022-02-16 |
Comparative Magnitude and Persistence of Humoral SARS-CoV-2 Vaccination Responses in the Adult Population in Germany (edit) |
10.3389/FIMMU.2022.828053 |
| 2022-02-16 |
Inactivation of SARS-CoV-2 and COVID-19 Patient Samples for Contemporary Immunology and Metabolomics Studies (edit) |
10.4049/IMMUNOHORIZONS.2200005 |
| 2022-02-16 |
A Novel Glucocorticoid and Androgen Receptor Modulator Reduces Viral Entry and Innate Immune Inflammatory Responses in the Syrian Hamster Model of SARS-CoV-2 Infection (edit) |
10.3389/FIMMU.2022.811430 |
| 2022-02-16 |
Infection clusters can elevate risk of diagnostic target failure for detection of SARS-CoV-2 (edit) |
10.1371/JOURNAL.PONE.0264008 |
| 2022-02-16 |
Glycolytic inhibitor 2-deoxy-d-glucose attenuates SARS-CoV-2 multiplication in host cells and weakens the infective potential of progeny virions (edit) |
10.1016/J.LFS.2022.120411 |
| 2022-02-16 |
Bayes Lines Tool (BLT): a SQL-script for analyzing diagnostic test results with an application to SARS-CoV-2-testing (edit) |
10.12688/F1000RESEARCH.51061.3 |
| 2022-02-16 |
Bat coronaviruses related to SARS-CoV-2 and infectious for human cells (edit) |
10.1038/S41586-022-04532-4 |
| 2022-02-15 |
Inhibition of Protein Glycosylation Blocks SARS-CoV-2 Infection (edit) |
10.1128/MBIO.03718-21 |
| 2022-02-15 |
Operationalizing a routine wastewater monitoring laboratory for SARS-CoV-2 (edit) |
10.1371/JOURNAL.PWAT.0000007 |
| 2022-02-15 |
Unrecognized introductions of SARS-CoV-2 into the US state of Georgia shaped the early epidemic (edit) |
10.1093/VE/VEAC011 |
| 2022-02-15 |
SARS-CoV-2 RNA is enriched by orders of magnitude in primary settled solids relative to liquid wastewater at publicly owned treatment works (edit) |
10.1039/D1EW00826A |
| 2022-02-15 |
Non-covalent SARS-CoV-2 Mpro inhibitors developed from in silico screen hits (edit) |
10.1038/S41598-022-06306-4 |
| 2022-02-15 |
Rapid SARS-CoV-2 Intra-Host and Within-Household Emergence of Novel Haplotypes (edit) |
10.3390/V14020399 |
| 2022-02-15 |
Assessment of performance and implementation characteristics of rapid point of care SARS-CoV-2 antigen testing (edit) |
10.12688/AASOPENRES.13323.1 |
| 2022-02-14 |
Structure and dynamics of SARS-CoV-2 proofreading exoribonuclease ExoN (edit) |
10.1073/PNAS.2106379119 |
| 2022-02-14 |
Strikingly Different Roles of SARS-CoV-2 Fusion Peptides Uncovered by Neutron Scattering (edit) |
10.1021/JACS.1C09856 |
| 2022-02-14 |
Structural polymorphism of coiled‐coils from the stalk domain of SARS‐CoV‐2 spike protein (edit) |
10.1096/FJ.202101670R |
| 2022-02-14 |
SARS-CoV-2 Immunization Orchestrates the Amplification of IFNγ-Producing T Cell and NK Cell Persistence (edit) |
10.3389/FIMMU.2022.798813 |
| 2022-02-14 |
Real world data on cardiometabolic diseases in U.S. adults during the SARS-CoV-2 pandemic: a decentralized registry study (edit) |
10.1186/S12933-022-01462-3 |
| 2022-02-14 |
Mass Screening of SARS-CoV-2 Variants using Sanger Sequencing Strategy in Hiroshima, Japan (edit) |
10.1038/S41598-022-04952-2 |
| 2022-02-14 |
Synthetic virions reveal fatty acid-coupled adaptive immunogenicity of SARS-CoV-2 spike glycoprotein (edit) |
10.1038/S41467-022-28446-X |
| 2022-02-14 |
Post SARS-CoV-2 Urban India: Computing Air Quality Health Indicators (AQHI) for Gurugram City to Assess Imminent Threats to Public Health (edit) |
10.53550/EEC.2022.V28I01S.027 |
| 2022-02-13 |
Disposition of PF-07321332 (Nirmatrelvir), an Orally Bioavailable Inhibitor of SARS-CoV-2 3CL Protease, across Animals and Humans (edit) |
10.1124/DMD.121.000801 |
| 2022-02-13 |
Expression, purification and characterization of SARS-CoV-2 spike RBD in ExpiCHO cells (edit) |
10.1016/J.PEP.2022.106071 |
| 2022-02-13 |
Use of ozonation technology to combat viruses and bacteria in aquatic environments: problems and application perspectives for SARS-CoV-2 (edit) |
10.1080/09593330.2022.2034981 |
| 2022-02-12 |
Structure and dynamics of the SARS‐CoV ‐2 envelope protein monomer (edit) |
10.1002/PROT.26317 |
| 2022-02-12 |
Drug repurposing for identification of potential spike inhibitors for SARS-CoV-2 using molecular docking and molecular dynamics simulations (edit) |
10.1016/J.YMETH.2022.02.004 |
| 2022-02-12 |
Human inhalable antibody fragments neutralizing SARS-CoV-2 variants for COVID-19 therapy (edit) |
10.1016/J.YMTHE.2022.02.013 |
| 2022-02-11 |
SARS-CoV-2 accessory protein ORF8 is secreted extracellularly as a glycoprotein homodimer (edit) |
10.1016/J.JBC.2022.101724 |
| 2022-02-11 |
Evaluation of Interactions between SARS-CoV-2 RBD and Full-Length ACE2 with Coarse-Grained Molecular Dynamics Simulations (edit) |
10.1021/ACS.JCIM.1C01306 |
| 2022-02-11 |
Efficient SARS-CoV-2 Quantitative Reverse Transcriptase PCR Saliva Diagnostic Strategy utilizing Open-Source Pipetting Robots (edit) |
10.3791/63395 |
| 2022-02-11 |
Neutralization of SARS-CoV-2 Omicron by BNT162b2 mRNA vaccine–elicited human sera (edit) |
10.1126/SCIENCE.ABN7591 |
| 2022-02-10 |
Plasma Neutralization of the SARS-CoV-2 Omicron Variant (edit) |
10.1056/NEJMC2119641 |
| 2022-02-10 |
Effect of an exercise bout before the booster dose of an inactivated SARS-CoV-2 vaccine on immunogenicity in immunocompromised patients (edit) |
10.1152/JAPPLPHYSIOL.00015.2022 |
| 2022-02-10 |
Seroprevalence of SARS-CoV-2 antibodies in social housing areas in Denmark (edit) |
10.1186/S12879-022-07102-1 |
| 2022-02-10 |
Factors affecting the transmission of SARS-CoV-2 in school settings (edit) |
10.1111/IRV.12968 |
| 2022-02-10 |
Ultralarge Virtual Screening Identifies SARS-CoV-2 Main Protease Inhibitors with Broad-Spectrum Activity against Coronaviruses (edit) |
10.1021/JACS.1C08402 |
| 2022-02-10 |
The B.1.427/1.429 (epsilon) SARS-CoV-2 variants are more virulent than ancestral B.1 (614G) in Syrian hamsters (edit) |
10.1371/JOURNAL.PPAT.1009914 |
| 2022-02-10 |
A protease-activatable luminescent biosensor and reporter cell line for authentic SARS-CoV-2 infection (edit) |
10.1371/JOURNAL.PPAT.1010265 |
| 2022-02-10 |
Predicted impact of the viral mutational landscape on the cytotoxic response against SARS-CoV-2 (edit) |
10.1371/JOURNAL.PCBI.1009726 |
| 2022-02-10 |
Elicitation of potent SARS-CoV-2 neutralizing antibody responses through immunization with a versatile adenovirus-inspired multimerization platform (edit) |
10.1016/J.YMTHE.2022.02.011 |
| 2022-02-10 |
Impact on HIV-1 RNA Levels and Antibody Responses Following SARS-CoV-2 Vaccination in HIV-Infected Individuals (edit) |
10.3389/FIMMU.2021.820126 |
| 2022-02-10 |
Obatoclax inhibits SARS-CoV-2 entry by altered endosomal acidification and impaired cathepsin and furin activity in vitro (edit) |
10.1080/22221751.2022.2026739 |
| 2022-02-09 |
Integrin mediates cell entry of the SARS-CoV-2 virus independent of cellular receptor ACE2 (edit) |
10.1016/J.JBC.2022.101710 |
| 2022-02-09 |
Transcriptional landscape of circulating platelets from patients with COVID-19 reveals key subnetworks and regulators underlying SARS-CoV-2 infection: implications for immunothrombosis (edit) |
10.1186/S13578-022-00750-5 |
| 2022-02-09 |
The atlas of ACE2 expression in fetal and adult human hearts reveals the potential mechanism of heart-injured patients infected with SARS-CoV-2 (edit) |
10.1152/AJPCELL.00169.2021 |
| 2022-02-09 |
Mutations in human SARS-CoV-2 spike proteins, potential drug binding and epitope sites for COVID-19 therapeutics development (edit) |
10.1016/J.CRSTBI.2022.01.002 |
| 2022-02-09 |
Monitoring of SARS-CoV-2 seroprevalence among primary healthcare patients in the Barcelona Metropolitan Area: the SeroCAP sentinel network protocol (edit) |
10.1136/BMJOPEN-2021-053237 |
| 2022-02-09 |
Selection of surrogate viruses for process control in detection of SARS-CoV-2 in wastewater (edit) |
10.1016/J.SCITOTENV.2022.153737 |
| 2022-02-08 |
Descriptive comparison of admission characteristics between pandemic waves and multivariable analysis of the association of the Alpha variant (B.1.1.7 lineage) of SARS-CoV-2 with disease severity in inner London (edit) |
10.1136/BMJOPEN-2021-055474 |
| 2022-02-08 |
B Cell Depletion and SARS-CoV-2 Vaccine Responses in Neuroimmunologic Patients (edit) |
10.1002/ANA.26309 |
| 2022-02-08 |
Structural and biochemical rationale for enhanced spike protein fitness in delta and kappa SARS-CoV-2 variants (edit) |
10.1038/S41467-022-28324-6 |
| 2022-02-08 |
Genomic epidemiology of SARS-CoV-2 in a UK university identifies dynamics of transmission (edit) |
10.1038/S41467-021-27942-W |
| 2022-02-08 |
An extended motif in the SARS-CoV-2 spike modulates binding and release of host coatomer in retrograde trafficking (edit) |
10.1038/S42003-022-03063-Y |
| 2022-02-08 |
Effects of theaflavin-gallate in-silico binding with different proteins of SARS-CoV-2 and host inflammation and vasoregulations referring an experimental rat-lung injury (edit) |
10.1016/J.PHYPLU.2022.100237 |
| 2022-02-08 |
SARS-CoV-2 Variants Associated with Vaccine Breakthrough in the Delaware Valley through Summer 2021 (edit) |
10.1128/MBIO.03788-21 |
| 2022-02-08 |
Development and validation of a high throughput SARS-CoV-2 whole genome sequencing workflow in a clinical laboratory (edit) |
10.1038/S41598-022-06091-0 |
| 2022-02-08 |
Genomic epidemiology of SARS-CoV-2 under an elimination strategy in Hong Kong (edit) |
10.1038/S41467-022-28420-7 |
| 2022-02-08 |
Human SARS-CoV-2 has evolved to increase U content and reduce genome size (edit) |
10.1016/J.IJBIOMAC.2022.02.034 |
| 2022-02-08 |
Subcellular Detection of SARS-CoV-2 RNA in Human Tissue Reveals Distinct Localization in Alveolar Type 2 Pneumocytes and Alveolar Macrophages (edit) |
10.1128/MBIO.03751-21 |
| 2022-02-08 |
SARS-CoV-2 Spike Glycoprotein Binds Heparan Sulfate Chains and N-Glycans in Psoriatic Keratinocytes: A Hypothesis. (edit) |
10.33425/2690-537X.1019 |
| 2022-02-08 |
Age-related differences in SARS-CoV-2 binding factors: An explanation for reduced susceptibility to severe COVID-19 among children? (edit) |
10.1016/J.PRRV.2022.01.008 |
| 2022-02-08 |
Metabolic Snapshot of Plasma Samples Reveals New Pathways Implicated in SARS-CoV-2 Pathogenesis (edit) |
10.1021/ACS.JPROTEOME.1C00786 |
| 2022-02-07 |
Cryo-EM structure of the SARS-CoV-2 Omicron spike (edit) |
10.1016/J.CELREP.2022.110428 |
| 2022-02-07 |
The spike protein of SARS-CoV-2 induces endothelial inflammation through integrin α5β1 and NF-κB signaling (edit) |
10.1016/J.JBC.2022.101695 |
| 2022-02-07 |
Assessment of activity of chalcone compounds as inhibitors of 3-chymotrypsin like protease (3CLPro) of SARS-CoV-2: in silico study (edit) |
10.1007/S11224-022-01887-2 |
| 2022-02-07 |
Third dose of SARS-CoV-2 vaccination in hemato-oncological patients and health care workers: immune responses and adverse events - a retrospective cohort study (edit) |
10.1016/J.EJCA.2022.01.019 |
| 2022-02-07 |
Analysis of SARS-CoV-2 Variants From 24,181 Patients Exemplifies the Role of Globalization and Zoonosis in Pandemics (edit) |
10.3389/FMICB.2021.786233 |
| 2022-02-07 |
Omicron Variant (B.1.1.529) of SARS-CoV-2, A Worldwide Public Health Emergency! (edit) |
10.24018/CLINICMED.2022.3.1.159 |
| 2022-02-07 |
Anti-SARS-CoV-2 antibodies among indigenous populations of the Brazilian Amazon: a cross-sectional study (edit) |
10.1136/BMJOPEN-2021-054271 |
| 2022-02-07 |
Pyrimidine inhibitors synergize with nucleoside analogues to block SARS-CoV-2 (edit) |
10.1038/S41586-022-04482-X |
| 2022-02-06 |
Identification of potential target endoribonuclease NSP15 inhibitors of SARS-COV-2 from natural products through high-throughput virtual screening and molecular dynamics simulation (edit) |
10.1111/JFBC.14085 |
| 2022-02-05 |
Spatiotemporal clustering patterns and sociodemographic determinants of COVID-19 (SARS-CoV-2) infections in Helsinki, Finland (edit) |
|
| 2022-02-05 |
Epidemiology and genetic diversity of SARS-CoV-2 lineages circulating in Africa (edit) |
10.1016/J.ISCI.2022.103880 |
| 2022-02-05 |
Seroprevalence of anti-SARS-CoV-2 antibodies in Colombia, 2020: A population-based study (edit) |
10.1016/J.LANA.2022.100195 |
| 2022-02-05 |
Tracing the SARS-CoV-2 infection on the ocular surface: Overview and preliminary corneoscleral transcriptome sequencing (edit) |
10.1016/J.EXER.2022.108975 |
| 2022-02-05 |
Escherichia coli recombinant expression of SARS-CoV-2 protein fragments (edit) |
10.1186/S12934-022-01753-0 |
| 2022-02-04 |
Immune Response Is Key to Genetic Mechanisms of SARS-CoV-2 Infection With Psychiatric Disorders Based on Differential Gene Expression Pattern Analysis (edit) |
10.3389/FIMMU.2022.798538 |
| 2022-02-04 |
Global conserved RBD fraction of SARS-CoV-2 S-protein with T500S mutation in silico significantly blocks ACE2 and rejects viral spike (edit) |
10.1186/S41231-022-00109-5 |
| 2022-02-04 |
SARS-CoV-2 variant surge and vaccine breakthrough infection: A computational analysis (edit) |
10.1016/J.IMU.2022.100873 |
| 2022-02-04 |
Limited genomic reconstruction of SARS-CoV-2 transmission history within local epidemiological clusters (edit) |
10.1093/VE/VEAC008 |
| 2022-02-04 |
Biomimetic Alveolus-on-a-Chip for SARS-CoV-2 Infection Recapitulation (edit) |
10.34133/2022/9819154 |
| 2022-02-04 |
Secondary Structure of Subgenomic RNA M of SARS-CoV-2 (edit) |
10.3390/V14020322 |
| 2022-02-03 |
Omicron (B.1.1.529) variant of SARS-CoV-2 – Concerns, challenges and recent updates (edit) |
10.1002/JMV.27633 |
| 2022-02-03 |
Tracking cryptic SARS-CoV-2 lineages detected in NYC wastewater (edit) |
10.1038/S41467-022-28246-3 |
| 2022-02-03 |
A combination of two human neutralizing antibodies prevents SARS-CoV-2 infection in cynomolgus macaques (edit) |
10.1016/J.MEDJ.2022.01.004 |
| 2022-02-03 |
Myeloid cell interferon responses correlate with clearance of SARS-CoV-2 (edit) |
10.1038/S41467-022-28315-7 |
| 2022-02-03 |
Designed SARS-CoV-2 receptor binding domain variants form stable monomers (edit) |
10.1002/BIOT.202100422 |
| 2022-02-03 |
Robust and Functional Immune Memory Up to 9 Months After SARS-CoV-2 Infection: A Southeast Asian Longitudinal Cohort (edit) |
10.3389/FIMMU.2022.817905 |
| 2022-02-03 |
Profiling Selective Packaging of Host RNA and Viral RNA Modification in SARS-CoV-2 Viral Preparations (edit) |
10.3389/FCELL.2022.768356 |
| 2022-02-03 |
The Slowing Rate of CpG Depletion in SARS-CoV-2 Genomes Is Consistent with Adaptations to the Human Host (edit) |
10.1093/MOLBEV/MSAC029 |
| 2022-02-02 |
Host cellular RNA helicases regulate SARS-CoV-2 infection (edit) |
10.1128/JVI.00002-22 |
| 2022-02-02 |
Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individuals (edit) |
10.1016/J.CELL.2022.01.027 |
| 2022-02-02 |
Mass spectrometry and proteome analysis to identify SARS-CoV-2 protein from COVID-19 patient swab samples (edit) |
|
| 2022-02-02 |
A dual mechanism of action of AT-527 against SARS-CoV-2 polymerase (edit) |
10.1038/S41467-022-28113-1 |
| 2022-02-02 |
Analysis of SARS-CoV-2 synonymous codon usage evolution throughout the COVID-19 pandemic (edit) |
10.1016/J.VIROL.2022.01.011 |
| 2022-02-02 |
Glucosinolates and their hydrolysis products as potential nutraceuticals to combat cytokine storm in SARS-COV-2 (edit) |
10.1007/S40199-022-00435-X |
| 2022-02-01 |
Rapid detection of novel coronavirus SARS-CoV-2 by RT-LAMP coupled solid-state nanopores (edit) |
10.1016/J.BIOS.2021.113759 |
| 2022-02-01 |
SARS-CoV-2 might transmit through the skin while the skin barrier function could be the mediator (edit) |
10.1016/J.MEHY.2021.110752 |
| 2022-02-01 |
SARS-CoV-2 RNA elements share human sequence identity and upregulate hyaluronan via NamiRNA-enhancer network (edit) |
10.1016/J.EBIOM.2022.103861 |
| 2022-02-01 |
Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant (edit) |
10.1038/S41586-022-04462-1 |
| 2022-02-01 |
The E3 Ubiquitin Ligase RNF5 Facilitates SARS-CoV-2 Membrane Protein-Mediated Virion Release (edit) |
10.1128/MBIO.03168-21 |
| 2022-02-01 |
Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts tropism and fusogenicity (edit) |
10.1038/S41586-022-04474-X |
| 2022-02-01 |
Postvaccination Multisystem Inflammatory Syndrome in Adult with No Evidence of Prior SARS-CoV-2 Infection (edit) |
10.3201/EID2802.211938 |
| 2022-02-01 |
A Case Report of Pediatric Germinoma With SARS-CoV-2: Lessons Learned From an Academic Tertiary Referral Hospital in Asian COVID Epicentrum (edit) |
10.1016/J.IJSCR.2022.106774 |
| 2022-02-01 |
Genome-wide analyses reveal the detrimental impacts of SARS-CoV-2 viral gene Orf9c on human pluripotent stem cell-derived cardiomyocytes (edit) |
10.1016/J.STEMCR.2022.01.014 |
| 2022-02-01 |
Testing for SARS-CoV-2 in symptomatic vaccinated and unvaccinated health care workers during the Delta variant surge (edit) |
10.1097/JOM.0000000000002431 |
| 2022-02-01 |
Age-related Differences in the Nasal Mucosal Immune Response to SARS-CoV-2 (edit) |
10.1165/RCMB.2021-0292OC |
| 2022-02-01 |
Structural Comparison and Drug Screening of Spike Proteins of Ten SARS-CoV-2 Variants (edit) |
10.34133/2022/9781758 |
| 2022-02-01 |
SARS-CoV-2 genomes from Saudi Arabia implicate nucleocapsid mutations in host response and increased viral load (edit) |
10.1038/S41467-022-28287-8 |
| 2022-02-01 |
Apigenin analogues as SARS-CoV-2 main protease inhibitors: In-silico screening approach (edit) |
10.1080/21655979.2022.2027181 |
| 2022-02-01 |
Molecular Docking Studies to Identify Promising Natural Inhibitors Targeting SARS-CoV-2 Nsp10-Nsp16 Protein Complex (edit) |
10.4274/TJPS.GALENOS.2021.56957 |
| 2022-02-01 |
Spatio-temporal dynamics of intra-host variability in SARS-CoV-2 genomes (edit) |
10.1093/NAR/GKAB1297 |
| 2022-02-01 |
A COVID-19 T-Cell Response Detection Method Based on a Newly Identified Human CD8+ T Cell Epitope from SARS-CoV-2 - Hubei Province, China, 2021 (edit) |
10.46234/CCDCW2021.258 |
| 2022-02-01 |
Comparison of SARS-CoV-2 Test Positivity in NCAA Division I Student Athletes vs Nonathletes at 12 Institutions (edit) |
10.1001/JAMANETWORKOPEN.2021.47805 |
| 2022-02-01 |
SARS-CoV-2 Variant Tracking and Mitigation During In-Person Learning at a Midwestern University in the 2020-2021 School Year (edit) |
10.1001/JAMANETWORKOPEN.2021.46805 |
| 2022-02-01 |
SARS-CoV-2 Inhibitors from Nigella Sativa (edit) |
10.1007/S12010-021-03790-8 |
| 2022-02-01 |
A SARS-CoV-2 Delta variant containing mutation in the probe binding region used for RT-qPCR test in Japan exhibited atypical PCR amplification and might induce false negative result (edit) |
10.1016/J.JIAC.2022.01.019 |
| 2022-02-01 |
Identification of SARS-CoV-2 Papain-like Protease (PLpro) Inhibitors Using Combined Computational Approach (edit) |
10.1002/OPEN.202100248 |
| 2022-02-01 |
The mechanisms of action of ivermectin against SARS-CoV-2—an extensive review (edit) |
10.1038/S41429-021-00491-6 |
| 2022-02-01 |
The nsp15 Nuclease as a Good Target to Combat SARS-CoV-2: Mechanism of Action and Its Inactivation with FDA-Approved Drugs (edit) |
10.3390/MICROORGANISMS10020342 |
| 2022-02-01 |
Corrigendum to “Error rates in SARS-CoV-2 testing examined with Bayes' theorem” [Heliyon 7, (4), (April 2021), Article e06905] (edit) |
10.1016/J.HELIYON.2022.E08836 |
| 2022-02-01 |
Microplastics and Macroplastic Debris as Potential Physical Vectors of SARS-CoV-2: A Hypothetical Overview with Implications for Public Health (edit) |
10.3390/MICROPLASTICS1010010 |
| 2022-02-01 |
Bovine-derived antibodies and camelid-derived nanobodies as biotherapeutic weapons against SARS-CoV-2 and its variants: A review article (edit) |
10.1016/J.IJSU.2022.106233 |
| 2022-02-01 |
A one-step platform for screening high-efficient and minimal off-target CRISPR/Cas13 crRNAs to eradicate SARS-CoV-2 virus for treatment of COVID-19 patients (edit) |
10.1016/J.MEHY.2021.110754 |
| 2022-02-01 |
Restructuring the ONYX-015 adenovirus by using spike protein genes from SARS-CoV-2 and MERS-CoV: Possible implications in breast cancer treatment (edit) |
10.1016/J.MEHY.2021.110750 |
| 2022-02-01 |
Impaired hearing following SARS-CoV-2 vaccinations (edit) |
10.1016/J.IJID.2021.12.317 |
| 2022-02-01 |
Dysphagia Characteristics of Patients Post SARS-CoV-2 During Inpatient Rehabilitation (edit) |
10.1016/J.APMR.2021.10.007 |
| 2022-02-01 |
Serological profile of first SARS-CoV-2 reinfection cases detected within the SIREN study (edit) |
10.1016/J.JINF.2021.09.019 |
| 2022-02-01 |
Expression of recombinant SARS-CoV-2 papain-like protease (SARS-CoV-2 PLpro) in Escherichia coli RIPL (edit) |
10.1088/1755-1315/976/1/012033 |
| 2022-02-01 |
SARS-CoV-2 infection in free-ranging white-tailed deer (edit) |
10.1038/S41586-021-04353-X |
| 2022-02-01 |
Enhanced fitness of SARS-CoV-2 variant of concern Alpha but not Beta (edit) |
10.1038/S41586-021-04342-0 |
| 2022-02-01 |
SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo (edit) |
10.1038/S41586-022-04479-6 |
| 2022-02-01 |
Early Evidence of Circulating SARS-CoV-2 in Unvaccinated and Vaccinated Measles Patients, September 2019–February 2020 (edit) |
10.2147/IDR.S344437 |
| 2022-02-01 |
Evaluation of observed and unobserved self-collection of saline gargle samples for the detection of SARS-CoV-2 in outpatients (edit) |
10.1016/J.DIAGMICROBIO.2021.115566 |
| 2022-02-01 |
Odds of Testing Positive for SARS-CoV-2 Following Receipt of 3 vs 2 Doses of the BNT162b2 mRNA Vaccine (edit) |
10.1001/JAMAINTERNMED.2021.7382 |
| 2022-01-31 |
Virus interactions with the actin cytoskeleton—what we know and do not know about SARS-CoV-2 (edit) |
10.1007/S00705-022-05366-1 |
| 2022-01-31 |
Antibody Response to SARS-CoV-2 Vaccination in Patients following Allogeneic Hematopoietic Cell Transplantation (edit) |
10.1016/J.JTCT.2022.01.019 |
| 2022-01-31 |
The interplay between SARS-CoV-2 infected airway epithelium and immune cells modulates regulatory/inflammatory signals (edit) |
10.1016/J.ISCI.2022.103854 |
| 2022-01-31 |
Andrographolide Derivatives Target the KEAP1/NRF2 Axis and Possess Potent Anti-SARS-CoV-2 Activity (edit) |
10.1002/CMDC.202100732 |
| 2022-01-31 |
An in silico analysis identifies drugs potentially modulating the cytokine storm triggered by SARS-CoV-2 infection (edit) |
10.1038/S41598-022-05597-X |
| 2022-01-31 |
SARS-CoV-2 S Protein Subunit 1 Elicits Ca2+ Influx - Dependent Ca2+ Signals in Pancreatic Stellate Cells and Macrophages In Situ (edit) |
10.1093/FUNCTION/ZQAC002 |
| 2022-01-31 |
SARS-CoV-2 in Egypt: epidemiology, clinical characterization and bioinformatics analysis (edit) |
10.1016/J.HELIYON.2022.E08864 |
| 2022-01-31 |
In silico, in vitro screening of plant extracts for anti-SARS-CoV-2 activity and evaluation of their acute and sub-acute toxicity (edit) |
10.1016/J.PHYPLU.2022.100233 |
| 2022-01-31 |
Investigating vaccine-induced immunity and its effect in mitigating SARS-CoV-2 epidemics in China (edit) |
10.1186/S12916-022-02243-1 |
| 2022-01-31 |
Sulfated Polysaccharide from Marine Red Microalga Porphyridium against SARS-CoV-2 - A Mini-Review (edit) |
10.31080/ASMI.2022.05.1012 |
| 2022-01-31 |
Differences between Omicron SARS-CoV-2 RBD and other variants in their ability to interact with cell receptors and monoclonal antibodies (edit) |
10.1101/2022.01.29.478316 |
| 2022-01-30 |
Inhibitory efficacy of 2, 4-diacetylphloroglucinol against SARS-COV-2 proteins: in silico study (edit) |
10.1007/S11756-021-00979-4 |
| 2022-01-29 |
The function of SARS-CoV-2 spike protein is impaired by disulfide-bond disruption with mutation at cysteine-488 and by thiol-reactive N-acetyl-cysteine and glutathione (edit) |
10.1016/J.BBRC.2022.01.106 |
| 2022-01-29 |
Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study (edit) |
10.1016/S0140-6736(22)00017-4 |
| 2022-01-29 |
SARS-CoV-2 RNAemia Predicts Clinical Deterioration and Extrapulmonary Complications from COVID-19 (edit) |
10.1093/CID/CIAB394 |
| 2022-01-29 |
Montelukast is a dual-purpose inhibitor of SARS-CoV-2 infection and virus-induced IL-6 expression identified by structure-based drug repurposing (edit) |
10.1016/J.CSBJ.2022.01.024 |
| 2022-01-29 |
The mutational dynamics of the SARS-CoV-2 virus in serial passages in vitro (edit) |
10.1016/J.VIRS.2022.01.029 |
| 2022-01-29 |
Early introduction, dispersal and evolution of Delta SARS-CoV-2 in Southern Brazil, late predominance of AY.99.2 and AY.101 related lineages (edit) |
10.1016/J.VIRUSRES.2022.198702 |
| 2022-01-29 |
Persistence of SARS-CoV-2 RNA in wastewater after the end of the COVID-19 epidemics (edit) |
10.1016/J.JHAZMAT.2022.128358 |
| 2022-01-28 |
Trends in disease severity and health care utilization during the early Omicron variant period compared with previous SARS-CoV-2 high transmission periods - United States, December 2020-January 2022 (edit) |
10.15585/MMWR.MM7104E4 |
| 2022-01-28 |
Seroprevalence, spatial distribution, and social determinants of SARS-CoV-2 in three urban centers of Chile (edit) |
10.1186/S12879-022-07045-7 |
| 2022-01-28 |
SARS-CoV-2 Infection Triggers Auto-Immune Response in ARDS (edit) |
10.3389/FIMMU.2022.732197 |
| 2022-01-28 |
Aggregation of high-frequency RBD mutations of SARS-CoV-2 with three VOCs did not cause significant antigenic drift (edit) |
10.1002/JMV.27596 |
| 2022-01-28 |
Antiviral activities of natural compounds and ionic liquids to inhibit the Mpro of SARS-CoV-2: a computational approach (edit) |
10.1039/D1RA08604A |
| 2022-01-28 |
Attenuation of SARS-CoV-2 infection by losartan in human kidney organoids (edit) |
10.1016/J.ISCI.2022.103818 |
| 2022-01-28 |
Memory B cell repertoire from triple vaccinees against diverse SARS-CoV-2 variants (edit) |
10.1038/S41586-022-04466-X |
| 2022-01-27 |
Effect of SARS-CoV-2 spike mutations on its activation by TMPRSS2 and TMPRSS13 (edit) |
10.1101/2022.01.26.477969 |
| 2022-01-27 |
Genome-scale CRISPR screens identify host factors that promote human coronavirus infection (edit) |
10.1186/S13073-022-01013-1 |
| 2022-01-27 |
Integrated Analysis Reveals the Characteristics and Effects of SARS-CoV-2 Maternal-Fetal Transmission (edit) |
10.3389/FMICB.2022.813187 |
| 2022-01-27 |
Multiplex Antibody Analysis of IgM, IgA and IgG to SARS-CoV-2 in Saliva and Serum From Infected Children and Their Close Contacts (edit) |
10.3389/FIMMU.2022.751705 |
| 2022-01-27 |
Identification of potential edible mushroom as SARS-CoV-2 main protease inhibitor using rational drug designing approach (edit) |
10.1038/S41598-022-05349-X |
| 2022-01-27 |
Clinically Suspected and Biopsy-Proven Myocarditis Temporally Associated with SARS-CoV-2 Infection (edit) |
10.1146/ANNUREV-MED-042220-023859 |
| 2022-01-27 |
Effectiveness of Disinfectants Suitable for Inactivating SARS-CoV-2 at Cold-Chain Temperature (edit) |
10.1007/S12560-022-09509-0 |
| 2022-01-26 |
Trypsin enhances SARS-CoV-2 infection by facilitating viral entry (edit) |
10.1007/S00705-021-05343-0 |
| 2022-01-26 |
Despite the odds: formation of the SARS-CoV-2 methylation complex (edit) |
10.1101/2022.01.25.477673 |
| 2022-01-26 |
Discovering potent inhibitors against the Mpro of the SARS-CoV-2. A medicinal chemistry approach (edit) |
10.1016/J.COMPBIOMED.2022.105235 |
| 2022-01-26 |
End-to-end system for rapid and sensitive early-detection of SARS-CoV-2 for resource-poor and field-test environments using a $51 lab-in-a-backpack (edit) |
10.1371/JOURNAL.PONE.0259886 |
| 2022-01-26 |
Stable Cell Clones Harboring Self-Replicating SARS-CoV-2 RNAs for Drug Screen (edit) |
10.1128/JVI.02216-21 |
| 2022-01-26 |
Evaluating Antibody Mediated Protection against Alpha, Beta, and Delta SARS-CoV-2 Variants of Concern in K18-hACE2 Transgenic Mice (edit) |
10.1128/JVI.02184-21 |
| 2022-01-26 |
Inhalable SARS-CoV-2 Mimetic Particles Induce Pleiotropic Antigen Presentation (edit) |
10.1021/ACS.BIOMAC.1C01447 |
| 2022-01-26 |
Epidemiology and control of SARS-CoV-2 epidemics in partially vaccinated populations: a modeling study applied to France (edit) |
10.1186/S12916-022-02235-1 |
| 2022-01-26 |
A Structurally Conserved RNA Element within SARS-CoV-2 ORF1a RNA and S mRNA Regulates Translation in Response to Viral S Protein-Induced Signaling in Human Lung Cells (edit) |
10.1128/JVI.01678-21 |
| 2022-01-25 |
Extracellular vimentin is an attachment factor that facilitates SARS-CoV-2 entry into human endothelial cells (edit) |
10.1073/PNAS.2113874119 |
| 2022-01-25 |
Dual RNA-Seq analysis of SARS-CoV-2 correlates specific human transcriptional response pathways directly to viral expression (edit) |
10.1038/S41598-022-05342-4 |
| 2022-01-25 |
N7-Methylation of the Coronavirus RNA Cap Is Required for Maximal Virulence by Preventing Innate Immune Recognition (edit) |
10.1128/MBIO.03662-21 |
| 2022-01-25 |
Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination (edit) |
10.1016/J.CELL.2022.01.018 |
| 2022-01-25 |
Persistent B cell memory after SARS-CoV-2 vaccination is functional during breakthrough infections (edit) |
10.1016/J.CHOM.2022.01.003 |
| 2022-01-25 |
A Fc-enhanced NTD-binding non-neutralizing antibody delays virus spread and synergizes with a nAb to protect mice from lethal SARS-CoV-2 infection (edit) |
10.1016/J.CELREP.2022.110368 |
| 2022-01-25 |
Nanobubble Ozone Stored in Hyaluronic Acid Decorated Liposomes: Antibacterial, Anti-SARS-CoV-2 Effect and Biocompatibility Tests (edit) |
10.2147/IJN.S328090 |
| 2022-01-25 |
Characteristics of SARS-CoV-2 transmission in a medium-sized city with traditional communities during the early COVID-19 epidemic in China (edit) |
10.1016/J.VIRS.2022.01.030 |
| 2022-01-24 |
SARS-CoV-2 NSP5 and N protein counteract the RIG-I signaling pathway by suppressing the formation of stress granules (edit) |
10.1038/S41392-022-00878-3 |
| 2022-01-24 |
Insights on the mutational landscape of the SARS-CoV-2 Omicron variant receptor-binding domain (edit) |
10.1016/J.XCRM.2022.100527 |
| 2022-01-24 |
Omicron: A Heavily Mutated SARS-CoV-2 Variant Exhibits Stronger Binding to ACE2 and Potently Escapes Approved COVID-19 Therapeutic Antibodies (edit) |
10.3389/FIMMU.2021.830527 |
| 2022-01-24 |
Langerhans cells and cDC1s play redundant roles in mRNA-LNP induced protective anti-influenza and anti-SARS-CoV-2 immune responses (edit) |
10.1371/JOURNAL.PPAT.1010255 |
| 2022-01-24 |
SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron (edit) |
10.1016/J.CELL.2022.01.015 |
| 2022-01-24 |
Protocol for structure determination of SARS-CoV-2 main protease at near-physiological-temperature by serial femtosecond crystallography (edit) |
10.1016/J.XPRO.2022.101158 |
| 2022-01-24 |
Clinical course impacts early kinetics,magnitude, and amplitude of SARS-CoV-2 neutralizing antibodies beyond 1 year after infection (edit) |
|
| 2022-01-23 |
Development and Evaluation of Peptidomimetic Compounds Against SARS-CoV-2 Spike Protein: an In Silico and In Vitro Study (edit) |
10.1002/MINF.202100231 |
| 2022-01-22 |
Insights into the specificity for the interaction of the promiscuous SARS-CoV-2 nucleocapsid protein N-terminal domain with deoxyribonucleic acids (edit) |
10.1016/J.IJBIOMAC.2022.01.121 |
| 2022-01-22 |
HACE2-Exosome-Based Nano-Bait for Concurrent SARS-CoV-2 Trapping and Antioxidant Therapy (edit) |
10.1021/ACSAMI.1C19541 |
| 2022-01-22 |
Dynamics of SARS-CoV-2 Alpha (B.1.1.7) variant spread: The wastewater surveillance approach (edit) |
10.1016/J.ENVRES.2022.112720 |
| 2022-01-22 |
Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concern (edit) |
10.1016/J.EBIOM.2022.103818 |
| 2022-01-22 |
An investigation for the interaction of gamma oryzanol with the Mpro of SARS-CoV-2 to combat COVID-19: DFT, molecular docking, ADME and molecular dynamics simulations (edit) |
10.1080/07391102.2022.2029770 |
| 2022-01-21 |
ACE2 can act as the secondary receptor in the FcγR-dependent ADE of SARS-CoV-2 infection (edit) |
10.1016/J.ISCI.2021.103720 |
| 2022-01-21 |
The intrinsically disordered SARS-CoV-2 nucleoprotein in dynamic complex with its viral partner nsp3a (edit) |
10.1126/SCIADV.ABM4034 |
| 2022-01-21 |
Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron (edit) |
10.1038/S41586-022-04442-5 |
| 2022-01-21 |
SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters (edit) |
10.1038/S41586-022-04441-6 |
| 2022-01-21 |
Functional evaluation of the P681H mutation on the proteolytic activation of the SARS-CoV-2 variant B.1.1.7 (Alpha) spike (edit) |
10.1016/J.ISCI.2021.103589 |
| 2022-01-21 |
Tracking the circulating SARS-CoV-2 variant of concern in South Africa using wastewater-based epidemiology (edit) |
10.1038/S41598-022-05110-4 |
| 2022-01-21 |
Measurement of SARS-CoV-2 Antibody Titers Improves the Prediction Accuracy of COVID-19 Maximum Severity by Machine Learning in Non-Vaccinated Patients (edit) |
10.3389/FIMMU.2022.811952 |
| 2022-01-21 |
Mutations in SARS-CoV-2 variants of concern link to increased spike cleavage and virus transmission (edit) |
10.1016/J.CHOM.2022.01.006 |
| 2022-01-21 |
Regional and temporal coordinated mutation patterns in SARS-CoV-2 spike protein revealed by a clustering and network analysis (edit) |
10.1038/S41598-022-04950-4 |
| 2022-01-21 |
Evidence of a SARS-CoV-2 double Spike mutation D614G/S939F potentially affecting immune response of infected subjects (edit) |
10.1016/J.CSBJ.2022.01.021 |
| 2022-01-21 |
Operational Constraints of Detecting SARS-CoV-2 on Passive Samplers using Electronegative Filters: A Kinetic and Equilibrium Analysis (edit) |
|
| 2022-01-21 |
SARS-CoV-2 vaccine protection and deaths among US veterans during 2021 (edit) |
10.1126/SCIENCE.ABM0620 |
| 2022-01-21 |
Studies reveal dangers of SARS-CoV-2 infection in pregnancy (edit) |
10.1126/SCIENCE.ADA0233 |
| 2022-01-21 |
Identification of Marine Fungi-Based Antiviral Agents as Potential Inhibitors of SARS-CoV-2 by Molecular Docking, ADMET and Molecular Dynamic Study (edit) |
10.1142/S2737416522500065 |
| 2022-01-21 |
Patients’ perspective about speech, swallowing and hearing status post-SARS-CoV-2 (COVID-19) recovery: E-survey (edit) |
10.1007/S00405-021-07217-2 |
| 2022-01-20 |
Absolute quantitation of individual SARS-CoV-2 RNA molecules provides a new paradigm for infection dynamics and variant differences (edit) |
10.7554/ELIFE.74153 |
| 2022-01-20 |
Molecular dynamics simulations and MM-GBSA reveal novel guanosine derivatives against SARS-CoV-2 RNA dependent RNA polymerase (edit) |
10.1039/D1RA07447D |
| 2022-01-20 |
RNA reference materials with defined viral RNA loads of SARS-CoV-2-A useful tool towards a better PCR assay harmonization (edit) |
10.1371/JOURNAL.PONE.0262656 |
| 2022-01-20 |
SARS-CoV-2 mRNA vaccine induces robust specific and cross-reactive IgG and unequal neutralizing antibodies in naive and previously infected people (edit) |
10.1016/J.CELREP.2022.110336 |
| 2022-01-20 |
The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2 (edit) |
10.1016/J.STEMCR.2021.12.011 |
| 2022-01-20 |
SARS-CoV-2 spike protein inhibits growth of prostate cancer: a potential role of the COVID-19 vaccine killing two birds with one stone (edit) |
10.1007/S12032-021-01628-1 |
| 2022-01-19 |
An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies (edit) |
10.1038/S41591-021-01678-Y |
| 2022-01-19 |
Maintenance of broad neutralizing antibodies and memory B cells 1 year post-infection is predicted by SARS-CoV-2-specific CD4+ T cell responses (edit) |
10.1016/J.CELREP.2022.110345 |
| 2022-01-19 |
Engineered ACE2 decoy mitigates lung injury and death induced by SARS-CoV-2 variants (edit) |
10.1038/S41589-021-00965-6 |
| 2022-01-19 |
Kinetics of the Antibody Response to Boostering With Three Different Vaccines Against SARS-CoV-2 (edit) |
10.3389/FIMMU.2022.811020 |
| 2022-01-19 |
Extended ensemble simulations of a SARS-CoV-2 nsp1-5'-UTR complex (edit) |
10.1371/JOURNAL.PCBI.1009804 |
| 2022-01-19 |
Genomic characterization unravelling the causative role of SARS-CoV-2 Delta variant of lineage B.1.617.2 in 2nd wave of COVID-19 pandemic in Chhattisgarh, India (edit) |
10.1016/J.MICPATH.2022.105404 |
| 2022-01-19 |
The antigenicity of SARS-CoV-2 Delta variants aggregated 10 high-frequency mutations in RBD has not changed sufficiently to replace the current vaccine strain (edit) |
10.1038/S41392-022-00874-7 |
| 2022-01-19 |
Tissue-level alveolar epithelium model for recapitulating SARS-CoV-2 infection and cellular plasticity (edit) |
10.1038/S42003-022-03026-3 |
| 2022-01-19 |
Genomic surveillance of SARS-CoV-2 in the state of Delaware reveals tremendous genomic diversity (edit) |
10.1371/JOURNAL.PONE.0262573 |
| 2022-01-19 |
Mutations that adapt SARS-CoV-2 to mink or ferret do not increase fitness in the human airway (edit) |
10.1016/J.CELREP.2022.110344 |
| 2022-01-19 |
Mucosal Vaccines, Sterilizing Immunity, and the Future of SARS-CoV-2 Virulence (edit) |
10.3390/V14020187 |
| 2022-01-18 |
Development and utilization of a surrogate SARS-CoV-2 viral neutralization assay to assess mRNA vaccine responses (edit) |
10.1371/JOURNAL.PONE.0262657 |
| 2022-01-18 |
Maternal-fetal immune responses in pregnant women infected with SARS-CoV-2 (edit) |
10.1038/S41467-021-27745-Z |
| 2022-01-18 |
Human Nasal Epithelial Cells Sustain Persistent SARS-CoV-2 Infection In Vitro, despite Eliciting a Prolonged Antiviral Response (edit) |
10.1128/MBIO.03436-21 |
| 2022-01-18 |
Distinct mutations and lineages of SARS-CoV-2 virus in the early phase of COVID-19 pandemic and subsequent 1-year global expansion (edit) |
10.1002/JMV.27580 |
| 2022-01-18 |
Two short low complexity regions (LCRs) are hallmark sequences of the Delta SARS-CoV-2 variant spike protein (edit) |
10.1038/S41598-022-04976-8 |
| 2022-01-18 |
JIB-04 Has Broad-Spectrum Antiviral Activity and Inhibits SARS-CoV-2 Replication and Coronavirus Pathogenesis (edit) |
10.1128/MBIO.03377-21 |
| 2022-01-18 |
Sequence analysis for SNP detection and phylogenetic reconstruction of SARS-cov-2 isolated from Nigerian COVID-19 cases (edit) |
10.1016/J.NMNI.2022.100955 |
| 2022-01-18 |
SARS-CoV-2 antibody seroprevalence in healthcare personnel during the pandemics peak: The experience of single hospital (edit) |
10.5455/MEDSCIENCE.2021.09.294 |
| 2022-01-18 |
Early-stage spatial disease surveillance of novel SARS-CoV-2 variants of concern in Germany with crowdsourced data (edit) |
10.1038/S41598-021-04573-1 |
| 2022-01-18 |
Sickle Cell Trait and SARS-CoV-2-Induced Rhabdomyolysis: A Case Report (edit) |
10.12659/AJCR.934220 |
| 2022-01-18 |
Immunogenicity of Extended mRNA SARS-CoV-2 Vaccine Dosing Intervals (edit) |
10.1001/JAMA.2021.21921 |
| 2022-01-17 |
Competing endogenous RNA network mediated by circ_3205 in SARS-CoV-2 infected cells (edit) |
10.1007/S00018-021-04119-8 |
| 2022-01-17 |
Characterization of the SARS-CoV-2 ExoN (nsp14ExoN–nsp10) complex: implications for its role in viral genome stability and inhibitor identification (edit) |
10.1093/NAR/GKAB1303 |
| 2022-01-17 |
Factors associated with SARS-CoV-2 test positivity in long-term care homes: A population-based cohort analysis using machine learning (edit) |
10.1016/J.LANA.2021.100146 |
| 2022-01-17 |
Exosomes Recovered From the Plasma of COVID-19 Patients Expose SARS-CoV-2 Spike-Derived Fragments and Contribute to the Adaptive Immune Response (edit) |
10.3389/FIMMU.2021.785941 |
| 2022-01-17 |
Detection of the Omicron (B.1.1.529) variant of SARS-CoV-2 in aircraft wastewater (edit) |
10.1016/J.SCITOTENV.2022.153171 |
| 2022-01-17 |
Detection of homologous recombination events in SARS-CoV-2 (edit) |
10.1007/S10529-021-03218-7 |
| 2022-01-17 |
Dimerization of SARS-CoV-2 nucleocapsid protein affects sensitivity of ELISA based diagnostics of COVID-19 (edit) |
10.1016/J.IJBIOMAC.2022.01.094 |
| 2022-01-17 |
Screening and identification of B cell epitope of the nucleocapsid protein in SARS-CoV-2 using the monoclonal antibodies (edit) |
10.1007/S00253-022-11769-6 |
| 2022-01-17 |
Methyl β-D-galactopyranoside esters as potential inhibitors for SARS-CoV-2 protease enzyme: synthesis, antimicrobial, PASS, molecular docking, molecular dynamics simulations and quantum computations (edit) |
10.1007/S10719-021-10039-3 |
| 2022-01-17 |
Asthma Associated Cytokines Regulate the Expression of SARS-CoV-2 Receptor ACE2 in the Lung Tissue of Asthmatic Patients (edit) |
10.3389/FIMMU.2021.796094 |
| 2022-01-17 |
Purifying Selection Determines the Short-Term Time Dependency of Evolutionary Rates in SARS-CoV-2 and pH1N1 Influenza (edit) |
10.1093/MOLBEV/MSAC009 |
| 2022-01-16 |
Y380Q novel mutation in receptor-binding domain of SARS-CoV-2 spike protein together with C379W interfere in the neutralizing antibodies interaction (edit) |
10.1016/J.DIAGMICROBIO.2022.115636 |
| 2022-01-15 |
Automatic system for high-throughput and high-sensitivity diagnosis of SARS-CoV-2 (edit) |
10.1007/S00449-021-02674-9 |
| 2022-01-15 |
Identification of broad anti-coronavirus chemical agents for repurposing against SARS-CoV-2 and variants of concern (edit) |
10.1016/J.CRVIRO.2022.100019 |
| 2022-01-15 |
SARS-CoV-2 rapid antigen tests provide benefits for epidemic control – observations from Austrian schools (edit) |
10.1016/J.JCLINEPI.2022.01.002 |
| 2022-01-14 |
Detection and discrimination of SARS-CoV-2 spike protein-derived peptides using THz metamaterials (edit) |
10.1016/J.BIOS.2022.113981 |
| 2022-01-14 |
Antigenicity of the Mu (B.1.621) and A.2.5 SARS-CoV-2 Spikes (edit) |
10.3390/V14010144 |
| 2022-01-14 |
Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection (edit) |
10.1186/S12916-021-02228-6 |
| 2022-01-14 |
In Silico Studies on Psilocybin Drug Derivatives Against SARS-CoV-2 and Cytokine Storm of Human Interleukin-6 Receptor (edit) |
10.3389/FIMMU.2021.794780 |
| 2022-01-14 |
Spike-Dependent Opsonization Indicates Both Dose-Dependent Inhibition of Phagocytosis and That Non-Neutralizing Antibodies Can Confer Protection to SARS-CoV-2 (edit) |
10.3389/FIMMU.2021.808932 |
| 2022-01-14 |
Implementation of SARS-CoV-2 Monoclonal Antibody Infusion Sites at Three Medical Centers in the United States: Strengths and Challenges Assessment to Inform COVID-19 Pandemic and Future Public Health Emergency Use (edit) |
10.1017/DMP.2022.15 |
| 2022-01-14 |
4′-Fluorouridine is an oral antiviral that blocks respiratory syncytial virus and SARS-CoV-2 replication (edit) |
10.1126/SCIENCE.ABJ5508 |
| 2022-01-14 |
Heterologous infection and vaccination shapes immunity against SARS-CoV-2 variants (edit) |
10.1126/SCIENCE.ABM0811 |
| 2022-01-13 |
Large-Scale Structure-Based Screening of Potential T Cell Cross-Reactivities Involving Peptide-Targets From BCG Vaccine and SARS-CoV-2 (edit) |
10.3389/FIMMU.2021.812176 |
| 2022-01-13 |
The SARS-CoV-2 Omicron (B.1.1.529) variant exhibits altered pathogenicity, transmissibility, and fitness in the golden Syrian hamster model (edit) |
10.1101/2022.01.12.476031 |
| 2022-01-13 |
Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection (edit) |
10.1038/S41590-021-01113-X |
| 2022-01-13 |
Development of targeted nanoparticles loaded with antiviral drugs for SARS-CoV-2 inhibition (edit) |
10.1016/J.EJMECH.2022.114121 |
| 2022-01-13 |
A short plus long-amplicon based sequencing approach improves genomic coverage and variant detection in the SARS-CoV-2 genome (edit) |
10.1371/JOURNAL.PONE.0261014 |
| 2022-01-12 |
SARS-CoV-2 membrane protein causes the mitochondrial apoptosis and pulmonary edema via targeting BOK (edit) |
10.1038/S41418-022-00928-X |
| 2022-01-12 |
SNX27 suppresses SARS-CoV-2 infection by inhibiting viral lysosome/late endosome entry (edit) |
10.1073/PNAS.2117576119 |
| 2022-01-12 |
Human airway lineages derived from pluripotent stem cells reveal the epithelial responses to SARS-CoV-2 infection (edit) |
10.1152/AJPLUNG.00397.2021 |
| 2022-01-12 |
Syndecan-4 Is a Key Facilitator of the SARS-CoV-2 Delta Variant's Superior Transmission (edit) |
10.3390/IJMS23020796 |
| 2022-01-12 |
Epistatic models predict mutable sites in SARS-CoV-2 proteins and epitopes (edit) |
10.1073/PNAS.2113118119 |
| 2022-01-12 |
Strong humoral immune responses against SARS-CoV-2 Spike after BNT162b2 mRNA vaccination with a 16-week interval between doses (edit) |
10.1016/J.CHOM.2021.12.004 |
| 2022-01-12 |
Rapid SARS-CoV-2 Adaptation to Available Cellular Proteases (edit) |
10.1128/JVI.02186-21 |
| 2022-01-12 |
Amantadine-assembled nanostimulator enhances dimeric RBD antigen-elicited cross-neutralization against SARS-CoV-2 strains (edit) |
10.1016/J.NANTOD.2022.101393 |
| 2022-01-12 |
SARS-CoV-2 infection induces a pro-inflammatory cytokine response through cGAS-STING and NF-κB (edit) |
10.1038/S42003-021-02983-5 |
| 2022-01-11 |
Alpha-Soluble NSF Attachment Protein Prevents the Cleavage of the SARS-CoV-2 Spike Protein by Functioning as an Interferon-Upregulated Furin Inhibitor (edit) |
10.1128/MBIO.02443-21 |
| 2022-01-11 |
Clinical outcomes among patients infected with Omicron (B.1.1.529) SARS-CoV-2 variant in southern California (edit) |
10.1101/2022.01.11.22269045 |
| 2022-01-11 |
Spatially refined time-varying reproduction numbers of SARS-CoV-2 in Arkansas and Kentucky and their relationship to population size and public health policy, March - November 2020 (edit) |
10.1016/J.ANNEPIDEM.2021.12.012 |
| 2022-01-11 |
Structural insights in cell-type specific evolution of intra-host diversity by SARS-CoV-2 (edit) |
10.1038/S41467-021-27881-6 |
| 2022-01-11 |
Acriflavine, a clinically approved drug, inhibits SARS-CoV-2 and other betacoronaviruses (edit) |
10.1016/J.CHEMBIOL.2021.11.006 |
| 2022-01-11 |
Nucleic acid delivery of immune-focused SARS-CoV-2 nanoparticles drives rapid and potent immunogenicity capable of single-dose protection (edit) |
10.1016/J.CELREP.2022.110318 |
| 2022-01-11 |
Variant analysis of SARS-CoV-2 strains with phylogenetic analysis and the Coronavirus Antiviral and Resistance Database (edit) |
10.2217/CER-2021-0208 |
| 2022-01-11 |
SARS-CoV-2 Saliva Mass Screening in Primary Schools: A 10-Week Sentinel Surveillance Study in Munich, Germany (edit) |
10.3390/DIAGNOSTICS12010162 |
| 2022-01-11 |
Increased immune escape of the new SARS-CoV-2 variant of concern Omicron (edit) |
10.1038/S41423-021-00836-Z |
| 2022-01-11 |
Exploring the Local Determinants of SARS-CoV-2 Transmission and Control via an Exposure-Based Model (edit) |
10.1021/ACS.EST.1C05633 |
| 2022-01-10 |
The MEK1/2-inhibitor ATR-002 efficiently blocks SARS-CoV-2 propagation and alleviates pro-inflammatory cytokine/chemokine responses (edit) |
10.1007/S00018-021-04085-1 |
| 2022-01-10 |
Anti-SARS-CoV-2 IgG against the S Protein: A Comparison of BNT162b2, mRNA-1273, ChAdOx1 nCoV-2019 and Ad26.COV2.S Vaccines (edit) |
10.3390/VACCINES10010099 |
| 2022-01-10 |
The Potential Mechanism of Cancer Patients Appearing More Vulnerable to SARS-CoV-2 and Poor Outcomes: A Pan-Cancer Bioinformatics Analysis (edit) |
10.3389/FIMMU.2021.804387 |
| 2022-01-10 |
Phenotypic analysis of the pediatric immune response to SARS-CoV-2 by flow cytometry (edit) |
10.1002/CYTO.A.24528 |
| 2022-01-10 |
Robust and durable serological response following pediatric SARS-CoV-2 infection (edit) |
10.1038/S41467-021-27595-9 |
| 2022-01-10 |
Structural assessment of HLA-A2-restricted SARS-CoV-2 spike epitopes recognized by public and private T-cell receptors (edit) |
10.1038/S41467-021-27669-8 |
| 2022-01-10 |
Naturally occurring anthraquinones as potential inhibitors of SARS-CoV-2 main protease: an integrated computational study (edit) |
10.1007/S11756-021-01004-4 |
| 2022-01-10 |
Emergence of a recurrent insertion in the N-terminal domain of the SARS-CoV-2 spike glycoprotein (edit) |
10.1016/J.VIRUSRES.2022.198674 |
| 2022-01-10 |
Age-dependent pathogenic characteristics of SARS-CoV-2 infection in ferrets (edit) |
10.1038/S41467-021-27717-3 |
| 2022-01-10 |
Identification and characterisation of SARS-CoV-2 and Human alphaherpesvirus 1 from a productive coinfection in a fatal COVID-19 case (edit) |
10.1590/0074-02760210176 |
| 2022-01-10 |
Evidence of SARS-CoV-2 symptomatic reinfection in four healthcare professionals from the same hospital despite the presence of antibodies (edit) |
10.1016/J.IJID.2022.01.006 |
| 2022-01-10 |
'All In One' SARS-CoV-2 variant recognition platform: Machine learning-enabled point of care diagnostics (edit) |
10.1016/J.BIOSX.2022.100105 |
| 2022-01-10 |
The discovery of herbal drugs and natural compounds as inhibitors of SARS-CoV-2 infection in vitro (edit) |
10.1007/S11418-021-01596-W |
| 2022-01-10 |
Ozone for SARS-CoV-2 inactivation on surfaces and in liquid cell culture media (edit) |
10.1016/J.JHAZMAT.2022.128251 |
| 2022-01-10 |
Evaluating the Impact of SARS-CoV-2 Variants on the COVID-19 Epidemic and Social Restoration in the United States: A Mathematical Modelling Study (edit) |
10.3389/FPUBH.2021.801763 |
| 2022-01-10 |
Attenuated response to SARS-CoV-2 vaccine in patients with asymptomatic precursor stages of multiple myeloma and Waldenstrom macroglobulinemia (edit) |
10.1016/J.CCELL.2021.12.003 |
| 2022-01-09 |
Long COVID symptoms and duration in SARS-CoV-2 positive children — a nationwide cohort study (edit) |
10.1007/S00431-021-04345-Z |
| 2022-01-09 |
Tokophobia and Anxiety in Pregnant Women during the SARS-CoV-2 Pandemic in Poland-A Prospective Cross-Sectional Study (edit) |
10.3390/IJERPH19020714 |
| 2022-01-09 |
Seasonal Betacoronavirus Antibodies' Expansion Post-BNT161b2 Vaccination Associates with Reduced SARS-CoV-2 VoC Neutralization (edit) |
10.1007/S10875-021-01190-5 |
| 2022-01-09 |
Impaired neutralisation of SARS-CoV-2 delta variant in vaccinated patients with B cell chronic lymphocytic leukaemia (edit) |
10.1186/S13045-021-01219-7 |
| 2022-01-08 |
SARS-CoV-2 non-structural protein 6 triggers NLRP3-dependent pyroptosis by targeting ATP6AP1 (edit) |
10.1038/S41418-021-00916-7 |
| 2022-01-08 |
Potential of phytocompounds from Brassica oleracea targeting S2-domain of SARS-CoV-2 spike glycoproteins: Structural and molecular insights (edit) |
10.1016/J.MOLSTRUC.2022.132369 |
| 2022-01-08 |
Ferrets are valuable models for SARS-CoV-2 research (edit) |
10.1177/03009858211071012 |
| 2022-01-08 |
UV and violet light can Neutralize SARS-CoV-2 Infectivity (edit) |
10.1016/J.JPAP.2021.100107 |
| 2022-01-07 |
Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa (edit) |
10.1038/D41586-021-03832-5 |
| 2022-01-07 |
Sensitive visualization of SARS-CoV-2 RNA with CoronaFISH (edit) |
10.26508/LSA.202101124 |
| 2022-01-07 |
SARS-CoV-2 NSP13 Inhibits Type I IFN Production by Degradation of TBK1 via p62-Dependent Selective Autophagy (edit) |
10.4049/JIMMUNOL.2100684 |
| 2022-01-07 |
Toward wide-spectrum antivirals against coronaviruses: Molecular characterization of SARS-CoV-2 NSP13 helicase inhibitors (edit) |
10.1126/SCIADV.ABJ4526 |
| 2022-01-07 |
Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa (edit) |
10.1038/S41586-022-04411-Y |
| 2022-01-07 |
Antigenic properties of the SARS-CoV-2 nucleoprotein are altered by the RNA admixture (edit) |
10.7717/PEERJ.12751 |
| 2022-01-07 |
Mutational landscape and in silico structure models of SARS-CoV-2 spike receptor binding domain reveal key molecular determinants for virus-host interaction (edit) |
10.1186/S12860-021-00403-4 |
| 2022-01-07 |
Immunity to SARS-CoV-2 up to 15 months after infection (edit) |
10.1016/J.ISCI.2022.103743 |
| 2022-01-07 |
Point-of-Care Platform for Rapid Multiplexed Detection of SARS-CoV-2 Variants and Respiratory Pathogens (edit) |
10.1002/ADMT.202101013 |
| 2022-01-07 |
Vulnerability of SARS-CoV-2 and PR8 H1N1 virus to cold atmospheric plasma activated media (edit) |
10.1038/S41598-021-04360-Y |
| 2022-01-07 |
A lethal mouse model for evaluating vaccine-associated enhanced respiratory disease during SARS-CoV-2 infection (edit) |
10.1126/SCIADV.ABH3827 |
| 2022-01-07 |
A vaccine built from potential immunogenic pieces derived from the SARS-CoV-2 spike glycoprotein: A computational approximation (edit) |
10.1016/J.JIM.2022.113216 |
| 2022-01-07 |
Predicting SARS-CoV-2 infection duration at hospital admission:a deep learning solution (edit) |
10.1007/S11517-021-02479-8 |
| 2022-01-07 |
Financial Burden and Shortage of Respiratory Rehabilitation for SARS-CoV-2 Survivors: The Next Step of the Pandemic? (edit) |
10.3390/JRFM15010020 |
| 2022-01-06 |
Inferring the stabilization effects of SARS-CoV-2 variants on the binding with ACE2 receptor (edit) |
10.1038/S42003-021-02946-W |
| 2022-01-06 |
Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2 (edit) |
10.1016/J.CELL.2022.01.001 |
| 2022-01-06 |
Modeling SARS-CoV-2 spike/ACE2 protein-protein interactions for predicting the binding affinity of new spike variants for ACE2, and novel ACE2 structurally related human protein targets, for COVID-19 handling in the 3PM context (edit) |
10.1007/S13167-021-00267-W |
| 2022-01-06 |
Palindromic target site identification in SARS-CoV-2, MERS-CoV and SARS-CoV-1 by adopting CRISPR-Cas technique (edit) |
10.1016/J.GENE.2021.146136 |
| 2022-01-06 |
Omicron Variant (B.1.1.529): Infectivity, Vaccine Breakthrough, and Antibody Resistance (edit) |
10.1021/ACS.JCIM.1C01451 |
| 2022-01-06 |
Worsening of Essential Tremor After SARS-CoV-2 Infection (edit) |
10.1007/S12311-022-01366-8 |
| 2022-01-05 |
UV-4B potently inhibits replication of multiple SARS-CoV-2 strains in clinically relevant human cell lines (edit) |
10.31083/J.FBL2701003 |
| 2022-01-05 |
Developing an Amplification Refractory Mutation System-Quantitative Reverse Transcription-PCR Assay for Rapid and Sensitive Screening of SARS-CoV-2 Variants of Concern (edit) |
10.1128/SPECTRUM.01438-21 |
| 2022-01-05 |
Cyclosporine A Inhibits Viral Infection and Release as Well as Cytokine Production in Lung Cells by Three SARS-CoV-2 Variants (edit) |
10.1128/SPECTRUM.01504-21 |
| 2022-01-05 |
Towards an optimal monoclonal antibody with higher binding affinity to the receptor-binding domain of SARS-CoV-2 spike proteins from different variants (edit) |
10.1101/2022.01.04.474958 |
| 2022-01-04 |
SARS-CoV-2 spreads through cell-to-cell transmission (edit) |
10.1073/PNAS.2111400119 |
| 2022-01-04 |
SARS-CoV-2 spike engagement of ACE2 primes S2' site cleavage and fusion initiation (edit) |
10.1073/PNAS.2111199119 |
| 2022-01-04 |
A Telemedicine-Guided Self-Collection Approach for PCR-Based SARS-CoV-2 Testing: Comparative Study (edit) |
10.2196/32564 |
| 2022-01-04 |
SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses (edit) |
10.1016/J.CELL.2021.12.046 |
| 2022-01-04 |
Bioengineering of Novel Non-Replicating mRNA (NRM) and Self-Amplifying mRNA (SAM) Vaccine Candidates Against SARS-CoV-2 Using Immunoinformatics Approach (edit) |
10.1007/S12033-021-00432-6 |
| 2022-01-04 |
IgG3 and IgM Identified as Key to SARS-CoV-2 Neutralization in Convalescent Plasma Pools (edit) |
10.1371/JOURNAL.PONE.0262162 |
| 2022-01-04 |
Analysis of Neutralization Titers against SARS-CoV-2 in Health-Care Workers Vaccinated with Prime-Boost mRNA–mRNA or Vector–mRNA COVID-19 Vaccines (edit) |
10.3390/VACCINES10010075 |
| 2022-01-03 |
The hyper-transmissible SARS-CoV-2 Omicron variant exhibits significant antigenic change, vaccine escape and a switch in cell entry mechanism (edit) |
10.1101/2022.01.03.21268111 |
| 2022-01-03 |
Persistence of Anti-SARS-CoV-2 Antibodies in Long Term Care Residents Over Seven Months After Two COVID-19 Outbreaks (edit) |
10.3389/FIMMU.2021.775420 |
| 2022-01-03 |
Artesunate induces substantial topological alterations in the SARS-CoV-2 Nsp1 protein structure (edit) |
10.1016/J.JKSUS.2021.101810 |
| 2022-01-03 |
Impact of the COVID-19 pandemic on the oncologic activities (diagnosis, treatment, clinical trials enrollment) of a general hospital in a district with high prevalence of SARS-COV-2 in Italy (edit) |
10.1007/S00520-021-06667-Y |
| 2022-01-03 |
Sequencing SARS-CoV-2 genomes from saliva (edit) |
10.1093/VE/VEAB098 |
| 2022-01-03 |
Viral Prefusion Targeting Using Entry Inhibitor Peptides: The Case of SARS-CoV-2 and Influenza A virus (edit) |
10.1007/S10989-021-10357-Y |
| 2022-01-03 |
Immunogenicity of a Heterologous Prime-Boost COVID-19 Vaccination with mRNA and Inactivated Virus Vaccines Compared with Homologous Vaccination Strategy against SARS-CoV-2 Variants (edit) |
10.3390/VACCINES10010072 |
| 2022-01-03 |
A stem-loop RNA RIG-I agonist protects against acute and chronic SARS-CoV-2 infection in mice (edit) |
10.1084/JEM.20211818 |
| 2022-01-02 |
Omicron mutations enhance infectivity and reduce antibody neutralization of SARS-CoV-2 virus-like particles (edit) |
10.1101/2021.12.20.21268048 |
| 2022-01-02 |
A high throughput screening assay for inhibitors of SARS-CoV-2 pseudotyped particle entry (edit) |
10.1016/J.SLASD.2021.12.005 |
| 2022-01-02 |
The Remarkable Evolutionary Plasticity of Coronaviruses by Mutation and Recombination: Insights for the COVID-19 Pandemic and the Future Evolutionary Paths of SARS-CoV-2 (edit) |
10.3390/V14010078 |
| 2022-01-01 |
Impact of the Alpha VOC on disease severity in SARS-CoV-2-positive adults in Sweden (edit) |
10.1016/J.JINF.2021.08.043 |
| 2022-01-01 |
Proteolytic activation of SARS-CoV-2 spike protein (edit) |
10.1111/1348-0421.12945 |
| 2022-01-01 |
Structure of the 5′ untranslated region in SARS-CoV-2 genome and its specific recognition by innate immune system via the human oligoadenylate synthase 1 (edit) |
10.1039/D1CC07006A |
| 2022-01-01 |
Emergence of new SARS-CoV-2 Variant of Concern Omicron (B.1.1.529) - highlights Africa's research capabilities, but exposes major knowledge gaps, inequities of vaccine distribution, inadequacies in global COVID-19 response and control efforts (edit) |
10.1016/J.IJID.2021.11.040 |
| 2022-01-01 |
Pathophysiological and molecular considerations of viral and bacterial infections during maternal-fetal and –neonatal interactions of SARS-CoV-2, Zika, and Mycoplasma infectious diseases (edit) |
10.1016/J.BBADIS.2021.166285 |
| 2022-01-01 |
SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study (edit) |
10.1111/ANAE.15563 |
| 2022-01-01 |
Reduced Requests for Medical Rehabilitation Because of the SARS-CoV-2 Pandemic: A Difference-in-Differences Analysis (edit) |
10.1016/J.APMR.2021.07.791 |
| 2022-01-01 |
D155Y substitution of SARS-CoV-2 ORF3a weakens binding with Caveolin-1 (edit) |
10.1016/J.CSBJ.2022.01.017 |
| 2022-01-01 |
Identification of fragments binding to SARS-CoV-2 nsp10 reveals ligand-binding sites in conserved interfaces between nsp10 and nsp14/nsp16 (edit) |
10.1039/D1CB00135C |
| 2022-01-01 |
Heterologous Immunity Between SARS-CoV-2 and Pathogenic Bacteria (edit) |
10.3389/FIMMU.2022.821595 |
| 2022-01-01 |
Emerging Insights on Caspases in COVID-19 Pathogenesis, Sequelae, and Directed Therapies (edit) |
10.3389/FIMMU.2022.842740 |
| 2022-01-01 |
Caspases and therapeutic potential of caspase inhibitors in moderate-severe SARS-CoV-2 infection and long COVID (edit) |
10.1111/ALL.14907 |
| 2022-01-01 |
Nebulized delivery of a broadly neutralizing SARS-CoV-2 RBD-specific nanobody prevents clinical, virological, and pathological disease in a Syrian hamster model of COVID-19 (edit) |
10.1080/19420862.2022.2047144 |
| 2022-01-01 |
Understanding the Role of SARS-CoV-2 ORF3a in Viral Pathogenesis and COVID-19 (edit) |
10.3389/FMICB.2022.854567 |
| 2022-01-01 |
An easy pipeline for one-step purification of SARS-CoV-2 nucleocapsid protein from insect cell suspension culture (edit) |
10.1016/J.JVIROMET.2021.114341 |
| 2022-01-01 |
Glycomimetic ligands block the interaction of SARS-CoV-2 spike protein with C-type lectin co-receptors (edit) |
10.1039/D2CC00121G |
| 2022-01-01 |
Multisystem Inflammatory Syndrome and Autoimmune Diseases Following COVID-19: Molecular Mechanisms and Therapeutic Opportunities (edit) |
10.3389/FMOLB.2022.804109 |
| 2022-01-01 |
How informative were early SARS-CoV-2 treatment and prevention trials? a longitudinal cohort analysis of trials registered on ClinicalTrials.gov (edit) |
10.1371/JOURNAL.PONE.0262114 |
| 2022-01-01 |
Assessment of SARS-CoV-2 seroprevalence by community survey and residual specimens, Denver, Colorado, July-August 2020 (edit) |
10.1177/00333549211055137 |
| 2022-01-01 |
Multistate outbreak of SARS-CoV-2 infections, including vaccine breakthrough infections, associated with large public gatherings, United States (edit) |
10.3201/EID2801.212220 |
| 2022-01-01 |
Vitamin D supplementation to treat SARS-CoV-2 positive patients. Evidence from meta-analysis (edit) |
10.5603/CJ.A2021.0122 |
| 2022-01-01 |
Puerarin: A Potential Therapeutic for Colon Adenocarcinoma (COAD) Patients Suffering From SARS-CoV-2 Infection (edit) |
|
| 2022-01-01 |
A high-risk gut microbiota configuration associates with fatal hyperinflammatory immune and metabolic responses to SARS-CoV-2 (edit) |
10.1080/19490976.2022.2073131 |
| 2022-01-01 |
Puerarin: A Potential Therapeutic for SARS-CoV-2 and Hantavirus Co-Infection (edit) |
|
| 2022-01-01 |
Design of a multi-epitope vaccine against SARS-CoV-2: immunoinformatic and computational methods (edit) |
10.1039/D1RA06532G |
| 2022-01-01 |
Proteomic and Metabolomic Signatures Associated With the Immune Response in Healthy Individuals Immunized With an Inactivated SARS-CoV-2 Vaccine (edit) |
|
| 2022-01-01 |
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Sequence Characteristics of Coronavirus Disease 2019 (COVID-19) Persistence and Reinfection (edit) |
10.1093/CID/CIAB380 |
| 2022-01-01 |
Reduced Antibodies and Innate Cytokine Changes in SARS-CoV-2 BNT162b2 mRNA Vaccinated Transplant Patients With Hematological Malignancies (edit) |
|
| 2022-01-01 |
Repurposing Halicin as a potent covalent inhibitor for the SARS-CoV-2 main protease (edit) |
|
| 2022-01-01 |
The Impact of Cocirculating Pathogens on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/Coronavirus Disease 2019 Surveillance: How Concurrent Epidemics May Introduce Bias and Decrease the Observed SARS-CoV-2 Percentage Positivity (edit) |
10.1093/INFDIS/JIAB459 |
| 2022-01-01 |
Structures and therapeutic potential of anti-RBD human monoclonal antibodies against SARS-CoV-2 (edit) |
10.7150/THNO.65563 |
| 2022-01-01 |
SARS-CoV-2 productively infects human brain microvascular endothelial cells (edit) |
|
| 2022-01-01 |
Cardiac SARS-CoV-2 infection is associated with pro-inflammatory transcriptomic alterations within the heart (edit) |
10.1093/CVR/CVAB322 |
| 2022-01-01 |
Prediction of SARS-CoV-2-positivity from million-scale complete blood counts using machine learning (edit) |
|
| 2022-01-01 |
High throughput SARS-CoV-2 variant analysis using molecular barcodes coupled with next generation sequencing (edit) |
|
| 2022-01-01 |
Defining the substrate envelope of SARS-CoV-2 main protease to predict and avoid drug resistance (edit) |
|
| 2022-01-01 |
Bioinformatics Approach Predicts Candidate Targets for SARS-CoV-2 Infections to COPD Patients (edit) |
|
| 2022-01-01 |
Binding and structural basis of equine ACE2 to RBDs from SARS-CoV, SARS-CoV-2 and related coronaviruses (edit) |
|
| 2022-01-01 |
A Rapid, Whole Genome Sequencing Assay for Detection and Characterization of Novel Coronavirus (SARS-CoV-2) Clinical Specimens Using Nanopore Sequencing (edit) |
|
| 2022-01-01 |
Investigation of target sequencing of SARS-CoV-2 and immunogenic GWAS profiling in host cells of COVID-19 in Vietnam (edit) |
|
| 2022-01-01 |
A bipotential organoid model of respiratory epithelium recapitulates high infectivity of SARS-CoV-2 Omicron variant (edit) |
|
| 2022-01-01 |
Characteristics of 24 SARS-CoV-2-Sequenced Reinfection Cases in a Tertiary Hospital in Spain (edit) |
|
| 2022-01-01 |
Increased Frequency of Indels in Hypervariable Regions of SARS-CoV-2 Proteins—A Possible Signature of Adaptive Selection (edit) |
|
| 2022-01-01 |
Structural Characterization of a Neutralizing Nanobody With Broad Activity Against SARS-CoV-2 Variants (edit) |
|
| 2022-01-01 |
Single-cell profiling of the antigen-specific response to BNT162b2 SARS-CoV-2 RNA vaccine (edit) |
|
| 2022-01-01 |
Saliva molecular testing bypassing RNA extraction is suitable for monitoring and diagnosing SARS-CoV-2 infection in children (edit) |
|
| 2022-01-01 |
Heterogeneous SARS-CoV-2-Neutralizing Activities After Infection and Vaccination (edit) |
|
| 2022-01-01 |
Prediction of the effects of the top 10 nonsynonymous variants from 30229 SARS-CoV-2 strains on their proteins [version 2; peer review: 2 approved] (edit) |
|
| 2022-01-01 |
Identification of Potential Vaccine Candidates Against SARS-CoV-2 to Fight COVID-19: Reverse Vaccinology Approach (edit) |
10.2196/32401 |
| 2022-01-01 |
Sequencing SARS-CoV-2 from antigen tests (edit) |
|
| 2022-01-01 |
SARS-CoV-2 infection enhances mitochondrial PTP complex activity to perturb cardiac energetics (edit) |
10.1016/J.ISCI.2021.103722 |
| 2022-01-01 |
SARS-CoV-2 and Environment: Transmission and Green Combat (edit) |
10.31632/IJALSR.2022.V05I02.001 |
| 2022-01-01 |
Ångstrom-scale silver particles potently combat SARS-CoV-2 infection by suppressing the ACE2 expression and inflammatory responses (edit) |
10.1039/D2TB00336H |
| 2022-01-01 |
Inactive SARS-CoV-2 vaccine generates high antibody responses in healthcare workers with and without prior infection (edit) |
10.1016/J.VACCINE.2021.11.051 |
| 2022-01-01 |
Thromboembolic Events in Deceased Patients with Proven SARS-CoV-2 Infection: Frequency, Characteristics and Risk Factors (edit) |
10.2139/SSRN.4075484 |
| 2022-01-01 |
Pre-Clinical Testing of Two Serologically Distinct Chimpanzee-Origin Adenovirus Vectors Expressing Spike of SARS-CoV-2 (edit) |
10.2139/SSRN.4059223 |
| 2022-01-01 |
Detecting Time-Evolving Phenotypic Components of Adverse Reactions Against BNT162b2 mRNA SARS-CoV-2 Vaccine Via Non-Negative Tensor Factorization (edit) |
10.2139/SSRN.4041409 |
| 2022-01-01 |
Air exchanges, climate change, and severe acute respiratory coronavirus virus 2 (SARS-CoV-2): Results from a survey of the Society of Healthcare Epidemiology of America Research Network (SRN) (edit) |
10.1017/ASH.2021.256 |
| 2022-01-01 |
Whole-body metabolic modelling predicts isoleucine dependency of SARS-CoV-2 replication (edit) |
10.1016/J.CSBJ.2022.07.019 |
| 2022-01-01 |
Seroprevalence of SARS-CoV-2 antibodies among Jordanian citizens: A cross-sectional study of the demographic and clinical factors that ameliorate serum IgG concentration (edit) |
10.7324/JAPS.2022.121116 |
| 2022-01-01 |
Study protocol for monitoring SARS-CoV-2 infection and its determinants in Catalonia (Spain): an observational and participatory research approach in a Sentinel Network of Schools (edit) |
10.1136/BMJOPEN-2021-055649 |
| 2022-01-01 |
First evidence of SARS-CoV-2 genome detection in zebra mussel (Dreissena polymorpha) (edit) |
10.1016/J.JENVMAN.2021.113866 |
| 2022-01-01 |
Nicotinic receptors as SARS-CoV-2 spike co-receptors? (edit) |
10.1016/J.MEHY.2021.110741 |
| 2022-01-01 |
Are there medium to short-term multifaceted effects of the airborne pollutant PM2.5 determining the emergence of SARS-CoV-2 variants? (edit) |
10.1016/J.MEHY.2021.110718 |
| 2022-01-01 |
Grammatical evolution-based design of SARS-CoV-2 main protease inhibitors (edit) |
10.1039/D1CP04159B |
| 2022-01-01 |
Short- and Long-Term Self-Reported Audiovestibular Symptoms of SARS-CoV-2 Infection in Hospitalized and Nonhospitalized Patients (edit) |
10.1159/000521963 |
| 2022-01-01 |
Using Open-Source Bioinformatics and Visualization Tools to Explore the Structure and Function of SARS-CoV-2 Spike Protein (edit) |
10.24918/CS.2022.5 |
| 2022-01-01 |
Assessment of cochlear functions in hospitalized patients with SARS-CoV-2 infection (edit) |
10.5455/MEDSCIENCE.2022.07.154 |
| 2022-01-01 |
Persisting, unilateral tinnitus 22 days after first dose of an mRNA-based SARS-CoV-2 vaccine (edit) |
10.4103/JFMPC.JFMPC_1927_21 |
| 2022-01-01 |
SARS-CoV-2 Disease in Cameroon:& Theoretical and Computational Analysis of a Delayed SIQR Model with Optimal Control (edit) |
10.2139/SSRN.4229706 |
| 2022-01-01 |
Computational Structural and Functional Analyses of ORF10 in Novel Coronavirus SARS-CoV-2 Variants to Understand Evolutionary Dynamics (edit) |
10.1177/11769343221108218 |
| 2022-01-01 |
Targeting proteases involved in the viral replication of SARS-CoV-2 by sesquiterpene lactones from chicory (Cichorium intybus L.) (edit) |
10.1039/D2FO00933A |
| 2022-01-01 |
Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2 (edit) |
10.1038/S41586-021-04186-8 |
| 2022-01-01 |
COVID-19 in children: I. Epidemiology, prevention and indirect impacts (edit) |
10.1111/JPC.15791 |
| 2022-01-01 |
COVID-19 in children. II: Pathogenesis, disease spectrum and management (edit) |
10.1111/JPC.15811 |
| 2022-01-01 |
SARS-Cov-2 and hearing loss: Two sibling cases (edit) |
10.5455/MEDSCIENCE.2021.09.295 |
| 2022-01-01 |
Influence of atmospheric environment on SARS-CoV-2 transmission: A review (edit) |
|
| 2022-01-01 |
Research progress and intervention strategies against SARS-CoV-2 viral entry (edit) |
|
| 2022-01-01 |
Application of Nanotechnology for Virus Inactivation in Water: Implications for Transmission-Blocking of the Novel Coronavirus SARS-CoV-2 (edit) |
|
| 2022-01-01 |
Research Progress on Nano Photonics Technology-based SARS-CoV-2 Detection (edit) |
|
| 2022-01-01 |
Inorganic-based Surface Materials with Anti-SARS-CoV-2 Properties and Their Mechanisms of Action (edit) |
|
| 2022-01-01 |
SARS-CoV-2 antibody screening in healthcare workers: lessons learned from the first months of COVID-19 outbreak in Europe. Significance of serology testing for effective pandemic management and reduction of the occupational risk (edit) |
10.2478/PJPH-2022-0001 |
| 2022-01-01 |
Impact of a Non-Invasive Respiratory Support Strategy and Switches in Therapy During Acute Respiratory Failure Due to SARS-CoV-2 (edit) |
10.2139/SSRN.4313559 |
| 2022-01-01 |
Are We Hearing Right? The Negative Impact of New SARS-CoV-2 Preventive Measures and Prolonged Use of Treatment Modalities during Orthodontic Treatment (edit) |
10.1590/PBOCI.2022.023 |
| 2022-01-01 |
A case of sudden mixed hearing loss in SARS-CoV-2 (edit) |
10.1177/2050313X221080642 |
| 2022-01-01 |
CHANGES IN CARDIO-PHYSIOLOGICAL PARAMETERS ANALYZED WITH BRUCE PROTOCOL FOLLOWING SARS-COV-2 INFECTION IN SOCCER PLAYERS (edit) |
10.53582/AMJ2222025M |
| 2021-12-31 |
Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron (edit) |
10.1038/S41586-022-04399-5 |
| 2021-12-31 |
Evaluation of test to stay strategy on secondary and tertiary transmission of SARS-CoV-2 in K-12 schools - Lake County, Illinois, August 9-October 29, 2021 (edit) |
10.15585/MMWR.MM705152E2 |
| 2021-12-31 |
SARS-CoV-2 causes a significant stress response mediated by small RNAs in the blood of COVID-19 patients (edit) |
10.1016/J.OMTN.2021.12.034 |
| 2021-12-31 |
Cellular miR-150-5p may have a crucial role to play in the biology of SARS-CoV-2 infection by regulating nsp10 gene (edit) |
10.1080/15476286.2021.2010959 |
| 2021-12-31 |
Microsecond molecular dynamics simulations revealed the inhibitory potency of amiloride analogs against SARS-CoV-2 E viroporin (edit) |
10.5808/GI.21040 |
| 2021-12-31 |
Modelling policy combinations of vaccination and transmission suppression of SARS-CoV-2 in Rio de Janeiro, Brazil (edit) |
10.1016/J.IDM.2021.12.007 |
| 2021-12-31 |
High-performance computing for SARS-CoV-2 RNAs clustering: a data science‒based genomics approach (edit) |
10.5808/GI.21056 |
| 2021-12-31 |
AB035. Comparative sensitivity of different self-sampling methods for SARS-CoV-2 RT-PCR testing (edit) |
10.21037/JPHE-21-AB035 |
| 2021-12-31 |
Active environmental surveillance of SARS-CoV-2 in Midwestern United States meatpacking plants (edit) |
10.1371/JOURNAL.PONE.0261704 |
| 2021-12-31 |
In silico bioprospecting of antiviral compounds from marine fungi and mushroom for rapid development of nutraceuticals against SARS-CoV-2 (edit) |
10.1080/07391102.2021.2023048 |
| 2021-12-30 |
Diagnostic Value of Nucleocapsid Protein in Blood for SARS-CoV-2 Infection (edit) |
10.1093/CLINCHEM/HVAB148 |
| 2021-12-30 |
Interactome profiling reveals interaction of SARS-CoV-2 NSP13 with host factor STAT1 to suppress interferon signaling (edit) |
10.1093/JMCB/MJAB068 |
| 2021-12-30 |
Morbidity, Clinical Course and Vaccination against SARS-CoV-2 Virus in Patients with Duchenne Muscular Dystrophy: A Patient Reported Survey (edit) |
10.3390/IJERPH19010406 |
| 2021-12-30 |
A deep learning method for repurposing antiviral drugs against new viruses via multi-view nonnegative matrix factorization and its application to SARS-CoV-2 (edit) |
10.1093/BIB/BBAB526 |
| 2021-12-30 |
Mathematical modelling of SARS-CoV-2 variant outbreaks reveals their probability of extinction (edit) |
10.1038/S41598-021-04108-8 |
| 2021-12-29 |
Functional properties of the spike glycoprotein of the emerging SARS-CoV-2 variant B.1.1.529 (edit) |
10.1101/2021.12.27.474288 |
| 2021-12-29 |
Kinetics and persistence of anti-SARS-CoV-2 neutralisation and antibodies after BNT162b2 vaccination in a Swiss cohort (edit) |
10.1002/IID3.583 |
| 2021-12-29 |
Cross-reactive and mono-reactive SARS-CoV-2 CD4+ T cells in prepandemic and COVID-19 convalescent individuals (edit) |
10.1371/JOURNAL.PPAT.1010203 |
| 2021-12-29 |
Hypothetical Immunological and Immunogenetic Model of Heterogenous Effects of BCG Vaccination in SARS-CoV-2 Infections: BCG-induced Trained and Heterologous Immunity (edit) |
10.20883/MEDICAL.E551 |
| 2021-12-28 |
A genome-wide CRISPR screen identifies interactors of the autophagy pathway as conserved coronavirus targets (edit) |
10.1371/JOURNAL.PBIO.3001490 |
| 2021-12-28 |
Intranasal inhibitor blocks omicron and other variants of SARS-CoV-2 (edit) |
10.21203/RS.3.RS-1196079/V1 |
| 2021-12-28 |
Repurposing of Drugs for SARS-CoV-2 Using Inverse Docking Fingerprints (edit) |
10.3389/FCHEM.2021.757826 |
| 2021-12-28 |
DETECTION OF SARS-COV-2 FROM SURFACE OF PATIENTS’ LEFTOVER FOOD PACKAGES AT A COVID-19 QUARANTINE CENTRE (edit) |
10.37268/MJPHM/VOL.21/NO.3/ART.1205 |
| 2021-12-27 |
The interactions of ZDHHC5/GOLGA7 with SARS-CoV-2 spike (S) protein and their effects on S protein's subcellular localization, palmitoylation and pseudovirus entry (edit) |
10.1186/S12985-021-01722-W |
| 2021-12-27 |
Disease severity related to VOC dominance in unvaccinated SARS-CoV-2 positive adults without risk factors in Sweden (edit) |
10.1101/2021.12.23.21268040 |
| 2021-12-27 |
SARS-CoV-2 Omicron VOC Transmission in Danish Households (edit) |
10.1101/2021.12.27.21268278 |
| 2021-12-27 |
An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies (edit) |
10.21203/RS.3.RS-1175516/V1 |
| 2021-12-27 |
Spatial and temporal effects on severe acute respiratory coronavirus virus 2 (SARS-CoV-2) contamination of the healthcare environment (edit) |
10.1017/ICE.2021.530 |
| 2021-12-27 |
Development of SARS-CoV-2 packaged RNA reference material for nucleic acid testing (edit) |
10.1007/S00216-021-03846-Y |
| 2021-12-25 |
SARS-CoV-2 infects the human kidney and drives fibrosis in kidney organoids (edit) |
10.1016/J.STEM.2021.12.010 |
| 2021-12-24 |
An oral SARS-CoV-2 M pro inhibitor clinical candidate for the treatment of COVID-19 (edit) |
10.1126/SCIENCE.ABL4784 |
| 2021-12-24 |
Modulation of the NLRP3 inflammasome by Sars-CoV-2 Envelope protein (edit) |
10.1038/S41598-021-04133-7 |
| 2021-12-24 |
SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with delta variant in TMPRSS2-expressed cells (edit) |
10.1080/22221751.2021.2023329 |
| 2021-12-24 |
Molecular basis of immune evasion by the Delta and Kappa SARS-CoV-2 variants (edit) |
10.1126/SCIENCE.ABL8506 |
| 2021-12-24 |
Rapid assessment of SARS-CoV-2–evolved variants using virus-like particles (edit) |
10.1126/SCIENCE.ABL6184 |
| 2021-12-24 |
Molecular interactions of the M and E integral membrane proteins of SARS-CoV-2 (edit) |
10.1039/D1FD00031D |
| 2021-12-24 |
Stress and Coping Strategies of Nurses Working with Patients Infected with and Not Infected with SARS-CoV-2 Virus (edit) |
10.3390/IJERPH19010195 |
| 2021-12-24 |
Learning From Biological and Computational Machines: Importance of SARS-CoV-2 Genomic Surveillance, Mutations and Risk Stratification (edit) |
10.3389/FCIMB.2021.783961 |
| 2021-12-24 |
Evidence for a mouse origin of the SARS-CoV-2 Omicron variant (edit) |
10.1016/J.JGG.2021.12.003 |
| 2021-12-24 |
Development of an In Vivo Probe to Track SARS-CoV-2 Infection in Rhesus Macaques (edit) |
10.3389/FIMMU.2021.810047 |
| 2021-12-24 |
SARS-CoV-2 Post Vaccinated Adverse Effects and Efficacy in the Egyptian Population (edit) |
10.3390/VACCINES10010018 |
| 2021-12-23 |
Transmission of Omicron (B.1.1.529) - SARS-CoV-2 Variant of Concern in a designated quarantine hotel for travelers: a challenge of elimination strategy of COVID-19 (edit) |
10.1016/J.LANWPC.2021.100360 |
| 2021-12-23 |
Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2 (edit) |
10.1038/S41586-021-04388-0 |
| 2021-12-23 |
Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies (edit) |
10.1038/S41586-021-04385-3 |
| 2021-12-23 |
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift (edit) |
10.1038/S41586-021-04386-2 |
| 2021-12-23 |
Interferon-induced transmembrane protein 3 (IFITM3) limits lethality of SARS-CoV-2 in mice (edit) |
10.1101/2021.12.22.473914 |
| 2021-12-23 |
Comparison of Antigen Tests and qPCR in Rapid Diagnostics of Infections Caused by SARS-CoV-2 Virus (edit) |
10.3390/V14010017 |
| 2021-12-23 |
Critical Role of the Subways in the Initial Spread of SARS-CoV-2 in New York City (edit) |
10.3389/FPUBH.2021.754767 |
| 2021-12-23 |
Comprehensive serologic profile and specificity of maternal and neonatal cord blood SARS-CoV-2 antibodies (edit) |
10.1016/J.XAGR.2021.100046 |
| 2021-12-23 |
SARS-CoV-2 mRNA vaccination elicits a robust and persistent T follicular helper cell response in humans (edit) |
10.1016/J.CELL.2021.12.026 |
| 2021-12-23 |
Efficacy of antiviral drugs against the omicron variant of SARS-CoV-2 (edit) |
10.1101/2021.12.21.473268 |
| 2021-12-23 |
A new insight into sex-specific non-coding RNAs and networks in response to SARS-CoV-2 (edit) |
10.1016/J.MEEGID.2021.105195 |
| 2021-12-23 |
Spatially distributed infection increases viral load in a computational model of SARS-CoV-2 lung infection (edit) |
10.1371/JOURNAL.PCBI.1009735 |
| 2021-12-23 |
Considerable escape of SARS-CoV-2 Omicron to antibody neutralization (edit) |
10.1038/S41586-021-04389-Z |
| 2021-12-23 |
Evolution of enhanced innate immune evasion by SARS-CoV-2 (edit) |
10.1038/S41586-021-04352-Y |
| 2021-12-22 |
The SARS-CoV-2 Spike protein disrupts human cardiac pericytes function through CD147 receptor-mediated signalling: a potential non-infective mechanism of COVID-19 microvascular disease (edit) |
10.1042/CS20210735 |
| 2021-12-22 |
SARS-CoV-2 reactive and neutralizing antibodies discovered by single-cell sequencing of plasma cells and mammalian display (edit) |
10.1016/J.CELREP.2021.110242 |
| 2021-12-22 |
Microglia Do Not Restrict SARS-CoV-2 Replication following Infection of the Central Nervous System of K18-Human ACE2 Transgenic Mice (edit) |
10.1128/JVI.01969-21 |
| 2021-12-22 |
Local and systemic responses to SARS-CoV-2 infection in children and adults (edit) |
10.1038/S41586-021-04345-X |
| 2021-12-21 |
Cross-Neutralization of Emerging SARS-CoV-2 Variants of Concern by Antibodies Targeting Distinct Epitopes on Spike (edit) |
10.1128/MBIO.02975-21 |
| 2021-12-21 |
Virtual screening and in vitro validation of natural compound inhibitors against SARS-CoV-2 spike protein (edit) |
10.1016/J.BIOORG.2021.105574 |
| 2021-12-21 |
Toxicity of spike fragments SARS-CoV-2 S protein for zebrafish: A tool to study its hazardous for human health? (edit) |
10.1016/J.SCITOTENV.2021.152345 |
| 2021-12-21 |
Differential expression in humans of the viral entry receptor ACE2 compared with the short deltaACE2 isoform lacking SARS-CoV-2 binding sites (edit) |
10.1038/S41598-021-03731-9 |
| 2021-12-21 |
The Impact of the SARS-CoV-2 (COVID-19) Coronavirus Pandemic on Ecological Security and the Development of International Environmental Policy (edit) |
10.5604/01.3001.0015.6476 |
| 2021-12-21 |
Interferon-Lambda Intranasal Protection and Differential Sex Pathology in a Murine Model of SARS-CoV-2 Infection (edit) |
10.1128/MBIO.02756-21 |
| 2021-12-20 |
Inhibition of SARS-CoV-2 infection in human iPSC-derived cardiomyocytes by targeting the Sigma-1 receptor disrupts cytoarchitecture and beating (edit) |
10.7717/PEERJ.12595 |
| 2021-12-20 |
Activation of the SARS-CoV-2 NSP14 3'-5' exoribonuclease by NSP10 and response to antiviral inhibitors (edit) |
10.1016/J.JBC.2021.101518 |
| 2021-12-20 |
SARS-CoV-2 infection and persistence throughout the human body and brain (edit) |
10.21203/RS.3.RS-1139035/V1 |
| 2021-12-20 |
Targeting CK2 mediated signaling to impair/tackle SARS-CoV-2 infection: a computational biology approach (edit) |
10.1186/S10020-021-00424-X |
| 2021-12-20 |
Structural and functional insights into the major mutations of SARS-CoV-2 Spike RBD and its interaction with human ACE2 receptor (edit) |
10.1016/J.JKSUS.2021.101773 |
| 2021-12-20 |
METHYLENE BLUE INHIBITS THE INTERACTION BETWEEN HEPARAN SULFATE AND SARS-COV-2 SPIKE PROTEIN; A REVIEW OF EVIDENCE FOR A HYPOTHESIS. (edit) |
10.31674/MJMR.2021.V05I04.002 |
| 2021-12-18 |
The experience of the ethics committee in research in human beings in times of pandemic COVID-19 (SARS-CoV-2) (edit) |
10.54448/MDNT21634 |
| 2021-12-18 |
Investigation of small molecule inhibitors of the SARS-CoV-2 papain-like protease by all-atom microsecond modelling, PELE Monte Carlo simulations, and in vitro activity inhibition (edit) |
10.1016/J.CPLETT.2021.139294 |
| 2021-12-18 |
Mutation profile of SARS-CoV-2 genome in a sample from the first year of the pandemic in Colombia (edit) |
10.1016/J.MEEGID.2021.105192 |
| 2021-12-18 |
SARS-CoV-2 and COVID-19: revisiting the most important research questions (edit) |
10.1186/S13578-021-00730-1 |
| 2021-12-17 |
The binding of heparin to spike glycoprotein inhibits SARS-CoV-2 infection by three mechanisms (edit) |
10.1016/J.JBC.2021.101507 |
| 2021-12-17 |
SARS-CoV-2-triggered mast cell rapid degranulation induces alveolar epithelial inflammation and lung injury (edit) |
10.1038/S41392-021-00849-0 |
| 2021-12-17 |
Geographical Landscape and Transmission Dynamics of SARS-CoV-2 Variants Across India: A Longitudinal Perspective (edit) |
10.3389/FGENE.2021.753648 |
| 2021-12-17 |
QTQTN motif upstream of the furin-cleavage site plays key role in SARS-CoV-2 infection and pathogenesis (edit) |
10.1101/2021.12.15.472450 |
| 2021-12-17 |
An integrative bioinformatics analysis for identifying hub genes associated with infection of lung samples in patients infected with SARS-CoV-2 (edit) |
10.1186/S40001-021-00609-4 |
| 2021-12-17 |
Epicatechin is a promising novel inhibitor of SARS-CoV-2 entry by disrupting interactions between angiotensin-converting enzyme type 2 and the viral receptor binding domain: A computational/simulation study (edit) |
10.1016/J.COMPBIOMED.2021.105155 |
| 2021-12-17 |
Genome sequencing of SARS-CoV-2 reveals the prevalence of variant B 1.1.7 in Egypt (edit) |
10.1016/J.MEEGID.2021.105191 |
| 2021-12-16 |
A virus‐derived microRNA targets immune response genes during SARS‐CoV‐2 infection (edit) |
10.15252/EMBR.202154341 |
| 2021-12-16 |
Outbreak caused by the SARS-CoV-2 Omicron variant in Norway, November to December 2021 (edit) |
10.2807/1560-7917.ES.2021.26.50.2101147 |
| 2021-12-16 |
COVID-19 and antiphospholipid antibodies: A position statement and management guidance from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) (edit) |
10.1177/09612033211062523 |
| 2021-12-16 |
Epidemiological characterisation of the first 785 SARS-CoV-2 Omicron variant cases in Denmark, December 2021 (edit) |
10.2807/1560-7917.ES.2021.26.50.2101146 |
| 2021-12-16 |
Neutralization of the SARS-CoV-2 Mu Variant by Convalescent and Vaccine Serum (edit) |
10.1056/NEJMC2114706 |
| 2021-12-16 |
Modeling the number of people infected with SARS-COV-2 from wastewater viral load in Northwest Spain (edit) |
10.1016/J.SCITOTENV.2021.152334 |
| 2021-12-16 |
Mechanisms of SARS-CoV-2 neutralization by shark variable new antigen receptors elucidated through X-ray crystallography (edit) |
10.1038/S41467-021-27611-Y |
| 2021-12-16 |
SARS-CoV-2 loads in urine, sera and stool specimens in association with clinical features of COVID-19 patients (edit) |
10.1016/J.JCVP.2021.100059 |
| 2021-12-16 |
Modeling the onset of symptoms of COVID-19: Effects of SARS-CoV-2 variant (edit) |
10.1371/JOURNAL.PCBI.1009629 |
| 2021-12-15 |
Highly conserved s2m element of SARS-CoV-2 dimerizes via a kissing complex and interacts with host miRNA-1307-3p (edit) |
10.1093/NAR/GKAB1226 |
| 2021-12-15 |
Metalloproteinase-dependent and TMPRSS2-independnt cell surface entry pathway of SARS-CoV-2 requires the furin-cleavage site and the S2 domain of spike protein (edit) |
10.1101/2021.12.14.472513 |
| 2021-12-15 |
Spatial epidemiology and genetic diversity of SARS-CoV-2 and related coronaviruses in domestic and wild animals (edit) |
10.1371/JOURNAL.PONE.0260635 |
| 2021-12-15 |
Heptad stereotypy, S/Q layering, and remote origin of the SARS-CoV-2 fusion core (edit) |
10.1093/VE/VEAB097 |
| 2021-12-15 |
Understanding Gene Expression and Transcriptome Profiling of COVID-19: An Initiative Towards the Mapping of Protective Immunity Genes Against SARS-CoV-2 Infection (edit) |
10.3389/FIMMU.2021.724936 |
| 2021-12-15 |
Structural basis and mode of action for two broadly neutralizing antibodies against SARS-CoV-2 emerging variants of concern (edit) |
10.1016/J.CELREP.2021.110210 |
| 2021-12-15 |
Transmission of SARS-CoV-2 from humans to a 16-year-old domestic cat with comorbidities in Pennsylvania, USA (edit) |
10.1002/VMS3.695 |
| 2021-12-15 |
Identification of a novel SARS-CoV-2 P.1 sub-lineage in Brazil provides new insights about the mechanisms of emergence of variants of concern (edit) |
10.1093/VE/VEAB091 |
| 2021-12-15 |
Genomic characterization of SARS-CoV-2 and its association with clinical outcomes: a 1-year longitudinal study of the pandemic in Colombia (edit) |
10.1016/J.IJID.2021.12.326 |
| 2021-12-15 |
Reconstructing SARS-CoV-2 infection dynamics through the phylogenetic inference of unsampled sources of infection (edit) |
10.1371/JOURNAL.PONE.0261422 |
| 2021-12-15 |
Comment on “Comparison of two pandemics: H1N1 and SARS-CoV-2” (edit) |
10.1590/1806-9282.20210756 |
| 2021-12-15 |
Cryptocurrency as Epidemiologically Safe Means of Transactions: Diminishing Risk of SARS-CoV-2 Spread (edit) |
10.3390/MATH9243263 |
| 2021-12-14 |
The atomic portrait of SARS‐CoV‐2 as captured by cryo‐electron microscopy (edit) |
10.1111/JCMM.17103 |
| 2021-12-14 |
Inflammasomes and SARS-CoV-2 Infection (edit) |
10.3390/V13122513 |
| 2021-12-14 |
Development of an efficient Sanger sequencing-based assay for detecting SARS-CoV-2 spike mutations (edit) |
10.1371/JOURNAL.PONE.0260850 |
| 2021-12-13 |
Increased transmissibility of SARS-CoV-2 lineage B.1.1.7 by age and viral load (edit) |
10.1038/S41467-021-27202-X |
| 2021-12-13 |
Host Manipulation Mechanisms of SARS-CoV-2 (edit) |
10.1007/S10441-021-09425-Z |
| 2021-12-13 |
Predicting infectivity: comparing four PCR-based assays to detect culturable SARS-CoV-2 in clinical samples (edit) |
10.15252/EMMM.202115290 |
| 2021-12-13 |
A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants (edit) |
10.3389/FIMMU.2021.766821 |
| 2021-12-13 |
Exploring the therapeutic nature of limonoids and triterpenoids against SARS-CoV-2 by targeting nsp13, nsp14, and nsp15 through molecular docking and dynamics simulations (edit) |
10.1016/J.JTCME.2021.12.002 |
| 2021-12-13 |
Seroprevalence of SARS-CoV-2 (COVID-19) among Health Care Workers in Three Health Facilities of Yaounde, Center Region of Cameroon (edit) |
10.24018/EJMED.2021.3.6.1109 |
| 2021-12-11 |
Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic (edit) |
10.1016/S0140-6736(21)02758-6 |
| 2021-12-11 |
Combination of cycle threshold time, absolute lymphocyte count and neutrophil:lymphocyte ratio is predictive of hypoxia in patients with SARS-CoV-2 infection (edit) |
10.1093/TRSTMH/TRAB182 |
| 2021-12-11 |
Risk-focused differences in molecular processes implicated in SARS-CoV-2 infection: corollaries in DNA methylation and gene expression (edit) |
10.1186/S13072-021-00428-1 |
| 2021-12-10 |
Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variant (edit) |
10.1126/SCIENCE.ABL9463 |
| 2021-12-10 |
Design, synthesis and in silico screening of benzoxazole-thiazolidinone hybrids as potential inhibitors of SARS-CoV-2 proteases (edit) |
10.1039/D1RA07504G |
| 2021-12-10 |
Antibody affinity maturation and cross-variant activity following SARS-CoV-2 mRNA vaccination: Impact of prior exposure and sex (edit) |
10.1016/J.EBIOM.2021.103748 |
| 2021-12-10 |
Generation and utility of a single-chain fragment variable monoclonal antibody platform against a baculovirus expressed recombinant receptor binding domain of SARS-CoV-2 spike protein (edit) |
10.1016/J.MOLIMM.2021.12.006 |
| 2021-12-09 |
Foxp3+ CD4+ regulatory T cells control dendritic cells in inducing antigen-specific immunity to emerging SARS-CoV-2 antigens (edit) |
10.1371/JOURNAL.PPAT.1010085 |
| 2021-12-09 |
SARS-CoV-2 ORF3a Induces Incomplete Autophagy via the Unfolded Protein Response (edit) |
10.3390/V13122467 |
| 2021-12-09 |
Numbers of close contacts of individuals infected with SARS-CoV-2 and their association with government intervention strategies (edit) |
10.1186/S12889-021-12318-Y |
| 2021-12-09 |
Computational Saturation Mutagenesis of SARS-CoV-1 Spike Glycoprotein: Stability, Binding Affinity, and Comparison With SARS-CoV-2 (edit) |
10.3389/FMOLB.2021.784303 |
| 2021-12-09 |
SARS-CoV-2 Antibodies Are Persisting in Saliva for More Than 15 Months After Infection and Become Strongly Boosted After Vaccination (edit) |
10.3389/FIMMU.2021.798859 |
| 2021-12-09 |
Evidence of SARS-CoV-2-Specific T-Cell-Mediated Myocarditis in a MIS-A Case (edit) |
10.3389/FIMMU.2021.779026 |
| 2021-12-08 |
Detection of N6-methyladenosine in SARS-CoV-2 RNA by methylated RNA immunoprecipitation sequencing (MeRIP-Seq) (edit) |
10.1016/J.XPRO.2021.101067 |
| 2021-12-08 |
B.1.1.529 escapes the majority of SARS-CoV-2 neutralizing antibodies of diverse epitopes (edit) |
10.21203/RS.3.RS-1148985/V1 |
| 2021-12-08 |
Hotspots for mutations in the SARS-CoV-2 spike glycoprotein: a correspondence analysis (edit) |
10.1038/S41598-021-01655-Y |
| 2021-12-08 |
TREM-2 is a sensor and activator of T cell response in SARS-CoV-2 infection (edit) |
10.1126/SCIADV.ABI6802 |
| 2021-12-08 |
Next-Generation Serology by Mass Spectrometry: Readout of the SARS-CoV-2 Antibody Repertoire (edit) |
10.1021/ACS.JPROTEOME.1C00882 |
| 2021-12-08 |
SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity (edit) |
10.1016/J.CELREP.2021.110143 |
| 2021-12-08 |
Possibilities for the Entrance of SARS-Cov-2 as an Archaeal Vi-rus into the Ecosystem (edit) |
10.18502/IJPH.V50I12.7948 |
| 2021-12-07 |
A single-cell transcriptomic landscape of the lungs of patients with COVID-19 (edit) |
10.1038/S41556-021-00796-6 |
| 2021-12-07 |
N-glycosylation profiles of the SARS-CoV-2 spike D614G mutant and its ancestral protein characterized by advanced mass spectrometry (edit) |
10.1038/S41598-021-02904-W |
| 2021-12-07 |
Cell fusion as a link between the SARS-CoV-2 spike protein, COVID-19 complications, and vaccine side effects (edit) |
10.18632/ONCOTARGET.28088 |
| 2021-12-07 |
Mutational cascade of SARS-CoV-2 leading to evolution and emergence of omicron variant (edit) |
10.1101/2021.12.06.471389 |
| 2021-12-07 |
Omicron: A heavily mutated SARS-CoV-2 variant exhibits stronger binding to ACE2 and potently escape approved COVID-19 therapeutic antibodies (edit) |
10.1101/2021.12.04.471200 |
| 2021-12-07 |
Genomic analysis of SARS-CoV-2 variants of concern identified from the ChAdOx1 nCoV-19 immunized patients from Southwest part of Bangladesh (edit) |
10.1016/J.JIPH.2021.12.002 |
| 2021-12-07 |
Delayed induction of type I and III interferons mediates nasal epithelial cell permissiveness to SARS-CoV-2 (edit) |
10.1038/S41467-021-27318-0 |
| 2021-12-07 |
VDA-RWLRLS: An anti-SARS-CoV-2 drug prioritizing framework combining an unbalanced bi-random walk and Laplacian regularized least squares (edit) |
10.1016/J.COMPBIOMED.2021.105119 |
| 2021-12-07 |
Signature of long-lived memory CD8+ T cells in acute SARS-CoV-2 infection (edit) |
10.1038/S41586-021-04280-X |
| 2021-12-07 |
IL1β Promotes TMPRSS2 Expression and SARS-CoV-2 Cell Entry Through the p38 MAPK-GATA2 Axis (edit) |
10.3389/FIMMU.2021.781352 |
| 2021-12-07 |
Production of SARS-CoV-2 N Protein-Specific Monoclonal Antibody and Its Application in an ELISA-Based Detection System and Targeting the Interaction Between the Spike C-Terminal Domain and N Protein (edit) |
10.3389/FMICB.2021.726231 |
| 2021-12-07 |
Structure-guided design of multi-epitopes vaccine against variants of concern (VOCs) of SARS-CoV-2 and validation through In silico cloning and immune simulations (edit) |
10.1016/J.COMPBIOMED.2021.105122 |
| 2021-12-07 |
Pre-existing humoral immunity to human common cold coronaviruses negatively impacts the protective SARS-CoV-2 antibody response (edit) |
10.1016/J.CHOM.2021.12.005 |
| 2021-12-06 |
SARS-CoV-2 spike protein induces inflammation via TLR2-dependent activation of the NF-kB pathway (edit) |
10.7554/ELIFE.68563 |
| 2021-12-06 |
Forced association of SARS-CoV-2 proteins with the yeast proteome perturb vesicle trafficking (edit) |
10.15698/MIC2021.12.766 |
| 2021-12-06 |
Pre-Steady-State Kinetics of the SARS-CoV-2 Main Protease as a Powerful Tool for Antiviral Drug Discovery (edit) |
10.3389/FPHAR.2021.773198 |
| 2021-12-06 |
Bithiazole Inhibitors of Phosphatidylinositol 4-Kinase (PI4KIIIβ) as Broad-Spectrum Antivirals Blocking the Replication of SARS-CoV-2, Zika Virus, and Human Rhinoviruses (edit) |
10.1002/CMDC.202100483 |
| 2021-12-06 |
A Cross-Disciplinary View of Testing and Bioinformatic Analysis of SARS-CoV-2 and Other Human Respiratory Viruses in Pandemic Settings (edit) |
10.1109/ACCESS.2021.3133417 |
| 2021-12-06 |
Mutational landscape of SARS-CoV-2 genome in Turkey and impact of mutations on spike protein structure (edit) |
10.1371/JOURNAL.PONE.0260438 |
| 2021-12-06 |
Modelling the spreading of the SARS-CoV-2 in presence of the lockdown and quarantine measures by a kinetic-type reactions approach (edit) |
10.1093/IMAMMB/DQAB017 |
| 2021-12-05 |
Extracellular Vimentin as a Target Against SARS‐CoV‐2 Host Cell Invasion (edit) |
10.1002/SMLL.202105640 |
| 2021-12-04 |
SARS-CoV-2 Nucleocapsid protein attenuates stress granules and interacts with mRNAs to impair host stress response (edit) |
10.1016/J.ISCI.2021.103562 |
| 2021-12-04 |
A structural view of the SARS-CoV-2 virus and its assembly (edit) |
10.1016/J.COVIRO.2021.11.011 |
| 2021-12-04 |
Time of Day of Vaccination Affects SARS-CoV-2 Antibody Responses in an Observational Study of Health Care Workers (edit) |
10.1177/07487304211059315 |
| 2021-12-03 |
Exosomes/microvesicles target SARS-CoV-2 via innate and RNA-induced immunity with PIWI-piRNA system (edit) |
10.26508/LSA.202101240 |
| 2021-12-03 |
Investigating the mutational landscape of the SARS-CoV-2 Omicron variant via ab initio quantum mechanical modeling (edit) |
10.1101/2021.12.01.470748 |
| 2021-12-03 |
Anti-prothrombin autoantibodies enriched after infection with SARS-CoV-2 and influenced by strength of antibody response against SARS-CoV-2 proteins (edit) |
10.1371/JOURNAL.PPAT.1010118 |
| 2021-12-03 |
Roles of antiviral sensing and type I interferon signaling in the restriction of SARS-CoV-2 replication (edit) |
10.1016/J.ISCI.2021.103553 |
| 2021-12-03 |
Differential Interactions between Human ACE2 and Spike RBD of SARS-CoV-2 Variants of Concern (edit) |
10.1021/ACS.JCTC.1C00965 |
| 2021-12-03 |
SARS-CoV-2 Nsp5 Protein Causes Acute Lung Inflammation, A Dynamical Mathematical Model (edit) |
10.3389/FSYSB.2021.764155 |
| 2021-12-02 |
The Nuts and Bolts of SARS-CoV-2 Spike Receptor-Binding Domain Heterologous Expression (edit) |
10.3390/BIOM11121812 |
| 2021-12-02 |
The Correlation between Nurses' COVID-19 Infections and Their Emotional State and Work Conditions during the SARS-CoV-2 Pandemic (edit) |
10.3390/IJERPH182312715 |
| 2021-12-02 |
Glycan Masking of Epitopes in the NTD and RBD of the Spike Protein Elicits Broadly Neutralizing Antibodies Against SARS-CoV-2 Variants (edit) |
10.3389/FIMMU.2021.795741 |
| 2021-12-02 |
Identification of TCR repertoires in functionally competent cytotoxic T cells cross-reactive to SARS-CoV-2 (edit) |
10.1038/S42003-021-02885-6 |
| 2021-12-02 |
Patient health records and whole viral genomes from an early SARS-CoV-2 outbreak in a Quebec hospital reveal features associated with favorable outcomes (edit) |
10.1371/JOURNAL.PONE.0260714 |
| 2021-12-02 |
Emergence of unique SARS-CoV-2 ORF10 variants and their impact on protein structure and function (edit) |
10.1016/J.IJBIOMAC.2021.11.151 |
| 2021-12-02 |
Contrasting SARS-CoV-2 epidemics in Singapore: cohort studies in migrant workers and the general population (edit) |
10.1016/J.IJID.2021.11.043 |
| 2021-12-02 |
Mechanical dependency of the SARS-CoV-2 virus and the renin-angiotensin-aldosterone (RAAS) axis: a possible new threat (edit) |
10.1007/S11356-021-16356-2 |
| 2021-12-01 |
Hypoxia reduces cell attachment of SARS-CoV-2 spike protein by modulating the expression of ACE2, neuropilin-1, syndecan-1 and cellular heparan sulfate (edit) |
10.1080/22221751.2021.1932607 |
| 2021-12-01 |
The antiviral activity of lactoferrin against common human coronaviruses and SARS-CoV-2 is mediated by targeting the heparan sulfate co-receptor (edit) |
10.1080/22221751.2021.1888660 |
| 2021-12-01 |
Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic (edit) |
10.1080/22221751.2021.1898291 |
| 2021-12-01 |
Lentil lectin derived from exhibit broad antiviral activities against SARS-CoV-2 variants (edit) |
10.1080/22221751.2021.1957720 |
| 2021-12-01 |
Pannexin-1 channel opening is critical for COVID-19 pathogenesis (edit) |
10.1016/J.ISCI.2021.103478 |
| 2021-12-01 |
Convergent use of phosphatidic acid for hepatitis C virus and SARS-CoV-2 replication organelle formation (edit) |
10.1038/S41467-021-27511-1 |
| 2021-12-01 |
SARS-CoV-2 uses metabotropic glutamate receptor subtype 2 as an internalization factor to infect cells (edit) |
10.1038/S41421-021-00357-Z |
| 2021-12-01 |
Ribavirin Aerosol in the Treatment of SARS-CoV-2: A Case Series (edit) |
10.1007/S40121-021-00493-9 |
| 2021-12-01 |
The spike protein of SARS-CoV-2 virus induces heme oxygenase-1: Pathophysiologic implications (edit) |
10.1016/J.BBADIS.2021.166322 |
| 2021-12-01 |
The short isoform of the host antiviral protein ZAP acts as an inhibitor of SARS-CoV-2 programmed ribosomal frameshifting (edit) |
10.1038/S41467-021-27431-0 |
| 2021-12-01 |
SARS-CoV-2 pseudovirus infectivity and expression of viral entry-related factors ACE2, TMPRSS2, Kim-1, and NRP-1 in human cells from the respiratory, urinary, digestive, reproductive, and immune systems (edit) |
10.1002/JMV.27244 |
| 2021-12-01 |
SARS-CoV-2 and the subsequent development of preeclampsia and preterm birth: evidence of a dose-response relationship supporting causality (edit) |
10.1016/J.AJOG.2021.08.020 |
| 2021-12-01 |
SARS-CoV-2, Zika viruses and mycoplasma: Structure, pathogenesis and some treatment options in these emerging viral and bacterial infectious diseases (edit) |
10.1016/J.BBADIS.2021.166264 |
| 2021-12-01 |
Hybrid immunity improves B cells and antibodies against SARS-CoV-2 variants (edit) |
10.1038/S41586-021-04117-7 |
| 2021-12-01 |
Genomic reconstruction of the SARS-CoV-2 epidemic in England (edit) |
10.1038/S41586-021-04069-Y |
| 2021-12-01 |
Role of ACE2 genetic polymorphisms in susceptibility to SARS-CoV-2 among highly exposed but non infected healthcare workers (edit) |
10.1080/22221751.2021.1902755 |
| 2021-12-01 |
SARS-CoV-2 interaction with Siglec-1 mediates trans-infection by dendritic cells (edit) |
10.1038/S41423-021-00794-6 |
| 2021-12-01 |
SARS-CoV-2 in animals: potential for unknown reservoir hosts and public health implications (edit) |
10.1080/01652176.2021.1921311 |
| 2021-12-01 |
Mining of linear B cell epitopes of SARS-CoV-2 ORF8 protein from COVID-19 patients (edit) |
10.1080/22221751.2021.1931465 |
| 2021-12-01 |
Amantadine has potential for the treatment of COVID-19 because it inhibits known and novel ion channels encoded by SARS-CoV-2 (edit) |
10.1038/S42003-021-02866-9 |
| 2021-12-01 |
A Daily-Updated Database and Tools for Comprehensive SARS-CoV-2 Mutation-Annotated Trees (edit) |
10.1093/MOLBEV/MSAB264 |
| 2021-12-01 |
Host genetics of pediatric SARS-CoV-2 COVID-19 and multisystem inflammatory syndrome in children (edit) |
10.1097/MOP.0000000000001061 |
| 2021-12-01 |
D614G mutation and SARS-CoV-2: impact on S-protein structure, function, infectivity, and immunity (edit) |
10.1007/S00253-021-11676-2 |
| 2021-12-01 |
Mathematical modelling of SARS-CoV-2 infection of human and animal host cells reveals differences in the infection rates and delays in viral particle production by infected cells (edit) |
10.1016/J.JTBI.2021.110895 |
| 2021-12-01 |
Sampling for SARS-CoV-2 aerosols in hospital patient rooms (edit) |
10.3390/V13122347 |
| 2021-12-01 |
A novel multiplex electrochemiluminescent immunoassay for detection and quantification of anti-SARS-CoV-2 IgG and anti-seasonal endemic human coronavirus IgG (edit) |
10.1016/J.JCV.2021.105050 |
| 2021-12-01 |
A novel SARS-CoV-2 related coronavirus with complex recombination isolated from bats in Yunnan province, China (edit) |
10.1080/22221751.2021.1964925 |
| 2021-12-01 |
Quasispecies of SARS-CoV-2 revealed by single nucleotide polymorphisms (SNPs) analysis (edit) |
10.1080/21505594.2021.1911477 |
| 2021-12-01 |
Millisecond dynamic of SARS-CoV-2 spike and its interaction with ACE2 receptor and small extracellular vesicles (edit) |
10.1002/JEV2.12170 |
| 2021-12-01 |
Discovery of 9,10-dihydrophenanthrene derivatives as SARS-CoV-2 3CLpro inhibitors for treating COVID-19 (edit) |
10.1016/J.EJMECH.2021.114030 |
| 2021-12-01 |
Computational screening and biochemical analysis of Pistacia integerrima and Pandanus odorifer plants to find effective inhibitors against Receptor-Binding domain (RBD) of the spike protein of SARS-Cov-2 (edit) |
10.1016/J.ARABJC.2021.103600 |
| 2021-12-01 |
The preclinical inhibitor GS441524 in combination with GC376 efficaciously inhibited the proliferation of SARS-CoV-2 in the mouse respiratory tract (edit) |
10.1080/22221751.2021.1899770 |
| 2021-12-01 |
Highly accurate whole-genome imputation of SARS-CoV-2 from partial or low-quality sequences (edit) |
|
| 2021-12-01 |
Metabolites with SARS-CoV-2 Inhibitory Activity Identified from Human Microbiome Commensals (edit) |
10.1128/MSPHERE.00711-21 |
| 2021-12-01 |
Lyophilized, thermostable Spike or RBD immunogenic liposomes induce protective immunity against SARS-CoV-2 in mice (edit) |
10.1126/SCIADV.ABJ1476 |
| 2021-12-01 |
The ApoA-I mimetic peptide 4F attenuates in vitro replication of SARS-CoV-2, associated apoptosis, oxidative stress and inflammation in epithelial cells (edit) |
10.1080/21505594.2021.1964329 |
| 2021-12-01 |
Host-dependent editing of SARS-CoV-2 in COVID-19 patients (edit) |
10.1080/22221751.2021.1969868 |
| 2021-12-01 |
Impact of cobas PCR Media freezing on SARS-CoV-2 viral RNA integrity and whole genome sequencing analyses (edit) |
10.1016/J.DIAGMICROBIO.2021.115521 |
| 2021-12-01 |
Molecular dynamic simulation analysis of SARS-CoV-2 spike mutations and evaluation of ACE2 from pets and wild animals for infection risk (edit) |
10.1016/J.COMPBIOLCHEM.2021.107613 |
| 2021-12-01 |
Deploying a rapid point-of-care polymerase chain reaction test for SARS-CoV-2 in a clinical research unit to ensure healthy volunteer safety (edit) |
10.4155/BIO-2021-0079 |
| 2021-12-01 |
Normalization of SARS-CoV-2 viral load via RT-qPCR provides higher-resolution data for comparison across time and between patients (edit) |
10.1016/J.VIRUSRES.2021.198604 |
| 2021-12-01 |
Codon usage, phylogeny and binding energy estimation predict the evolution of SARS-CoV-2 (edit) |
10.1016/J.ONEHLT.2021.100352 |
| 2021-12-01 |
Molecular docking of SARS-COV-2 Spike epitope sequences identifies heterodimeric peptide-protein complex formation with human Zo-1, TLR8 and brain specific glial proteins (edit) |
10.1016/J.MEHY.2021.110706 |
| 2021-12-01 |
Models for SARS-CoV-2 associated thrombocytopenia associated with hemophagocytic histiocytes (edit) |
10.1016/J.MEHY.2021.110700 |
| 2021-12-01 |
Bacille Calmette-Guérin (BCG) vaccine and potential cross-protection against SARS-CoV-2 infection — Assumptions, knowns, unknowns and need for developing an accurate scientific evidence base (edit) |
10.1016/J.IJID.2021.03.060 |
| 2021-12-01 |
UnCovid: A versatile, low-cost, and open-source protocol for SARS-CoV-2 RNA detection (edit) |
10.1016/J.XPRO.2021.100878 |
| 2021-12-01 |
SARS-CoV-2 mutational cascades and the risk of hyper-exponential growth (edit) |
10.1016/J.MICPATH.2021.105237 |
| 2021-12-01 |
Production of full-length SARS-CoV-2 nucleocapsid protein from Escherichia coli optimized by native hydrophobic interaction chromatography hyphenated to multi-angle light scattering detection (edit) |
10.1016/J.TALANTA.2021.122691 |
| 2021-12-01 |
Future medico-legal implications on Obstetrics and Gynaecology practice in the SARS-CoV-2 pandemic (edit) |
10.36129/JOG.33.04.07 |
| 2021-12-01 |
Modeling SARS-CoV-2 proteins in the CASP-commons experiment (edit) |
10.1002/PROT.26231 |
| 2021-11-30 |
Multiplex Gene Tagging with CRISPR-Cas9 for Live-Cell Microscopy and Application to Study the Role of SARS-CoV-2 Proteins in Autophagy, Mitochondrial Dynamics, and Cell Growth (edit) |
10.1089/CRISPR.2021.0041 |
| 2021-11-30 |
Molecular insights into receptor binding energetics and neutralization of SARS-CoV-2 variants (edit) |
10.1038/S41467-021-27325-1 |
| 2021-11-30 |
Template switching and duplications in SARS-CoV-2 genomes give rise to insertion variants that merit monitoring (edit) |
10.1038/S42003-021-02858-9 |
| 2021-11-30 |
Is cardiac involvement prevalent in highly trained athletes after SARS-CoV-2 infection? A cardiac magnetic resonance study using sex-matched and age-matched controls (edit) |
10.1136/BJSPORTS-2021-104576 |
| 2021-11-30 |
Severity of SARS-CoV-2 infection is linked to double-negative (CD27- IgD-) B cell subset numbers (edit) |
10.1007/S00011-021-01525-3 |
| 2021-11-30 |
Dynamics of spreading of SARS-CoV-2 in a Belgian hemodialysis facility: The importance of the analysis of viral strains (edit) |
10.1002/JMV.27471 |
| 2021-11-30 |
EpiCurator: an immunoinformatic workflow to predict and prioritize SARS-CoV-2 epitopes (edit) |
10.7717/PEERJ.12548 |
| 2021-11-30 |
A hydrated 2,3-diaminophenazinium chloride as a promising building block against SARS-CoV-2 (edit) |
10.1038/S41598-021-02280-5 |
| 2021-11-30 |
A Higher Antibody Response Is Generated With a 6- to 7-Week (vs Standard) Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Dosing Interval (edit) |
10.1093/CID/CIAB938 |
| 2021-11-30 |
Did social distancing measures deployed for SARS-CoV-2/COVID-19 control have an impact on invasive meningococcal disease? (edit) |
10.1080/20477724.2021.1995657 |
| 2021-11-29 |
The SARS-CoV-2 RNA polymerase is a viral RNA capping enzyme (edit) |
10.1093/NAR/GKAB1160 |
| 2021-11-29 |
SARS-CoV-2 ORF10 suppresses the antiviral innate immune response by degrading MAVS through mitophagy (edit) |
10.1038/S41423-021-00807-4 |
| 2021-11-29 |
Crystal structure of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) frameshifting pseudoknot (edit) |
10.1261/RNA.078825.121 |
| 2021-11-29 |
Immune response against SARS-CoV-2 variants: the role of neutralization assays (edit) |
10.1038/S41541-021-00404-6 |
| 2021-11-29 |
A 3D structural SARS-CoV-2-human interactome to explore genetic and drug perturbations (edit) |
10.1038/S41592-021-01318-W |
| 2021-11-29 |
Effectiveness of BNT162b2 mRNA COVID-19 vaccine against SARS-CoV-2 variant Beta (B.1.351) among persons identified through contact tracing in Israel: A prospective cohort study (edit) |
10.1016/J.ECLINM.2021.101190 |
| 2021-11-29 |
Mechanistic Insights into SARS-CoV-2 Main Protease Inhibition Reveals Hotspot Residues (edit) |
10.1021/ACS.JCIM.1C00928 |
| 2021-11-29 |
Intra-Familial Transmission Patterns of COVID-19 Infection among the Rural Residents of Ahmedabad, Gujarat, during an Epidemic of SARS-CoV-2 in India (edit) |
10.7883/YOKEN.JJID.2021.267 |
| 2021-11-27 |
SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis (edit) |
10.1016/J.CELL.2021.11.033 |
| 2021-11-27 |
The Differences in the Level of Anti-SARS-CoV-2 Antibodies after mRNA Vaccine between Convalescent and Non-Previously Infected People Disappear after the Second Dose-Study in Healthcare Workers Group in Poland (edit) |
10.3390/VACCINES9121402 |
| 2021-11-27 |
A colorimetric sandwich-type bioassay for SARS-CoV-2 using a hACE2-based affinity peptide pair (edit) |
10.1016/J.JHAZMAT.2021.127923 |
| 2021-11-27 |
The antibody response to SARS-CoV-2 Beta underscores the antigenic distance to other variants (edit) |
10.1016/J.CHOM.2021.11.013 |
| 2021-11-27 |
Pharmacologic profiling reveals lapatinib as a novel antiviral against SARS-CoV-2 in vitro (edit) |
10.1016/J.VIROL.2021.11.008 |
| 2021-11-26 |
Oxidative stress transforms 3CLpro into an insoluble and more active form to promote SARS-CoV-2 replication (edit) |
10.1016/J.REDOX.2021.102199 |
| 2021-11-26 |
Receptome profiling identifies KREMEN1 and ASGR1 as alternative functional receptors of SARS-CoV-2 (edit) |
10.1038/S41422-021-00595-6 |
| 2021-11-26 |
Development of a Rapid and Sensitive CasRx-Based Diagnostic Assay for SARS-CoV-2 (edit) |
10.1021/ACSSENSORS.1C01088 |
| 2021-11-26 |
The vaccination threshold for SARS-CoV-2 depends on the indoor setting and room ventilation (edit) |
10.1186/S12879-021-06884-0 |
| 2021-11-26 |
Binder design for targeting SARS-CoV-2 spike protein: An in silico perspective (edit) |
10.1016/J.GENREP.2021.101452 |
| 2021-11-26 |
Epidemiological associations with genomic variation in SARS-CoV-2 (edit) |
10.1038/S41598-021-02548-W |
| 2021-11-26 |
Amilorides inhibit SARS-CoV-2 replication in vitro by targeting RNA structures (edit) |
10.1126/SCIADV.ABL6096 |
| 2021-11-26 |
Target identification for repurposed drugs active against SARS-CoV-2 via high-throughput inverse docking (edit) |
10.1007/S10822-021-00432-3 |
| 2021-11-26 |
Major Complex Trait for Early De Novo Programming ‘CoV-MAC-TED’ Detected in Human Nasal Epithelial Cells Infected by Two SARS-CoV-2 Variants Is Promising to Help in Designing Therapeutic Strategies (edit) |
10.3390/VACCINES9121399 |
| 2021-11-25 |
Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation (edit) |
10.1038/S41586-021-04266-9 |
| 2021-11-25 |
Single-Cell Immunogenomic Approach Identified SARS-CoV-2 Protective Immune Signatures in Asymptomatic Direct Contacts of COVID-19 Cases (edit) |
10.3389/FIMMU.2021.733539 |
| 2021-11-25 |
Epidemic size, trend and spatiotemporal mapping of SARS-CoV-2 using geographical information system in Alborz Province, Iran (edit) |
10.1186/S12879-021-06870-6 |
| 2021-11-25 |
Mitochondrial DNA and TLR9 activation contribute to SARS-CoV-2-induced endothelial cell damage (edit) |
10.1016/J.VPH.2021.106946 |
| 2021-11-25 |
Novel dynamic residue network analysis approaches to study allosteric modulation: SARS-CoV-2 Mpro and its evolutionary mutations as a case study (edit) |
10.1016/J.CSBJ.2021.11.016 |
| 2021-11-25 |
Targeting conserved N-glycosylation blocks SARS-CoV-2 variant infection in vitro (edit) |
10.1016/J.EBIOM.2021.103712 |
| 2021-11-24 |
Glycosylation and disulfide bonding of wild-type SARS-CoV-2 spike glycoprotein (edit) |
10.1128/JVI.01626-21 |
| 2021-11-24 |
Whole-Genome Sequences of SARS-CoV-2 Isolates from the Dominican Republic (edit) |
10.1128/MRA.00952-21 |
| 2021-11-24 |
A comparison of precipitation and filtration-based SARS-CoV-2 recovery methods and the influence of temperature, turbidity, and surfactant load in urban wastewater (edit) |
10.1016/J.SCITOTENV.2021.151916 |
| 2021-11-24 |
Anti-SARS-CoV-2 antibodies elicited by COVID-19 mRNA vaccine exhibit a unique glycosylation pattern (edit) |
10.1016/J.CELREP.2021.110114 |
| 2021-11-24 |
A two-adjuvant multiantigen candidate vaccine induces superior protective immune responses against SARS-CoV-2 challenge (edit) |
10.1016/J.CELREP.2021.110112 |
| 2021-11-24 |
Data-driven multi-scale mathematical modeling of SARS-CoV-2 infection reveals heterogeneity among COVID-19 patients (edit) |
10.1371/JOURNAL.PCBI.1009587 |
| 2021-11-24 |
The N501Y spike substitution enhances SARS-CoV-2 infection and transmission (edit) |
10.1038/S41586-021-04245-0 |
| 2021-11-23 |
SARS‐CoV‐2 N Protein Induces Acute Kidney Injury via Smad3‐Dependent G1 Cell Cycle Arrest Mechanism (edit) |
10.1002/ADVS.202103248 |
| 2021-11-23 |
Spatiotemporal interactions of a novel mesocarnivore community in an urban environment before and during SARS-CoV-2 lockdown (edit) |
10.1111/1365-2656.13635 |
| 2021-11-23 |
Methodological problems of SARS-CoV-2 rapid point-of-care tests when used in mass testing (edit) |
10.3934/PUBLICHEALTH.2022007 |
| 2021-11-23 |
An integrated method for optimized identification of effective natural inhibitors against SARS-CoV-2 3CLpro (edit) |
10.1038/S41598-021-02266-3 |
| 2021-11-23 |
Performance of a computer aided diagnosis system for SARS-CoV-2 pneumonia based on ultrasound images (edit) |
10.1016/J.EJRAD.2021.110066 |
| 2021-11-23 |
Comprehensive occupational health services for healthcare workers in Zimbabwe during the SARS-CoV-2 pandemic (edit) |
10.1371/JOURNAL.PONE.0260261 |
| 2021-11-23 |
COVID-19 and Gynecologic Oncology: What Have We Learned? (edit) |
10.1007/S11864-021-00905-5 |
| 2021-11-23 |
A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity (edit) |
10.1038/S41586-021-04232-5 |
| 2021-11-23 |
Low-Cost Optodiagnostic for Minute-Time Scale Detection of SARS-CoV-2 (edit) |
10.1021/ACSNANO.1C03236 |
| 2021-11-22 |
TMPRSS2 promotes SARS-CoV-2 evasion from NCOA7-mediated restriction (edit) |
10.1371/JOURNAL.PPAT.1009820 |
| 2021-11-22 |
Towards a COVID-19 symptom triad: The importance of symptom constellations in the SARS-CoV-2 pandemic (edit) |
10.1371/JOURNAL.PONE.0258649 |
| 2021-11-22 |
SARS-CoV-2 Infection Fatality Rates in India: Systematic Review, Meta-analysis and Model-based Estimation (edit) |
10.1177/23210222211054324 |
| 2021-11-20 |
Combined deep learning and molecular docking simulations approach identifies potentially effective FDA approved drugs for repurposing against SARS-CoV-2 (edit) |
10.1016/J.COMPBIOMED.2021.105049 |
| 2021-11-20 |
SARS-CoV-2: Can sunlight exposure reduce the risk of developing severe consequences of COVID-19? (edit) |
10.1016/J.COMPBIOLCHEM.2021.107602 |
| 2021-11-20 |
Symptomatic and asymptomatic transmission of SARS-CoV-2 in K-12 schools, British Columbia, April to June 2021 (edit) |
10.1101/2021.11.15.21266284 |
| 2021-11-19 |
SARS-CoV-2 triggers DNA damage response in Vero E6 cells (edit) |
10.1016/J.BBRC.2021.09.024 |
| 2021-11-19 |
SARS-CoV-2 seroprevalence in the city of Hyderabad, India in early 2021 (edit) |
|
| 2021-11-19 |
Large scale discovery of coronavirus-host factor protein interaction motifs reveals SARS-CoV-2 specific mechanisms and vulnerabilities (edit) |
10.1038/S41467-021-26498-Z |
| 2021-11-19 |
SARS-CoV-2 infection generates tissue-localized immunological memory in humans (edit) |
10.1126/SCIIMMUNOL.ABL9105 |
| 2021-11-19 |
In silico validation of anti-viral drugs obtained from marine sources as a potential target against SARS-CoV-2 Mpro (edit) |
|
| 2021-11-19 |
Population impact of SARS-CoV-2 variants with enhanced transmissibility and/or partial immune escape (edit) |
10.1016/J.CELL.2021.11.026 |
| 2021-11-19 |
Association between ambient air pollutants and meteorological factors with SARS-CoV-2 transmission and mortality in India: an exploratory study (edit) |
10.1186/S12940-021-00804-0 |
| 2021-11-19 |
Analysis of Serological Biomarkers of SARS-CoV-2 Infection in Convalescent Samples From Severe, Moderate and Mild COVID-19 Cases (edit) |
10.3389/FIMMU.2021.748291 |
| 2021-11-18 |
Clinical Antiviral Drug Arbidol Inhibits Infection by SARS-CoV-2 and Variants through Direct Binding to the Spike Protein (edit) |
10.1021/ACSCHEMBIO.1C00756 |
| 2021-11-18 |
Backbone and Ile, Leu, Val methyl group resonance assignment of CoV-Y domain of SARS-CoV-2 non-structural protein 3 (edit) |
10.1007/S12104-021-10059-Y |
| 2021-11-18 |
Dissecting the early COVID-19 cases in Wuhan (edit) |
10.1126/SCIENCE.ABM4454 |
| 2021-11-18 |
The role of cell surface sialic acids for SARS-CoV-2 infection (edit) |
10.1093/GLYCOB/CWAB032 |
| 2021-11-18 |
COVID-19 and vertical transmission: assessing the expression of ACE2/TMPRSS2 in the human fetus and placenta to assess the risk of SARS-CoV-2 infection (edit) |
10.1111/1471-0528.16974 |
| 2021-11-18 |
Longitudinal analysis of SARS-CoV-2 spike and RNA-dependent RNA polymerase protein sequences reveals the emergence and geographic distribution of diverse mutations (edit) |
10.1016/J.MEEGID.2021.105153 |
| 2021-11-18 |
Detection of Antibodies Against the SARS-CoV-2 Spike Protein and Analysis of the Peripheral Blood Mononuclear Cell Transcriptomic Profile, 15 Years After Recovery From SARS (edit) |
10.3389/FCIMB.2021.768993 |
| 2021-11-18 |
Fluvastatin mitigates SARS-CoV-2 infection in human lung cells (edit) |
10.1016/J.ISCI.2021.103469 |
| 2021-11-18 |
Multifactorial seroprofiling dissects the contribution of pre-existing human coronaviruses responses to SARS-CoV-2 immunity (edit) |
10.1038/S41467-021-27040-X |
| 2021-11-18 |
Effective Prophylaxis of COVID-19 in Rhesus Macaques Using a Combination of Two Parenterally-Administered SARS-CoV-2 Neutralizing Antibodies (edit) |
10.3389/FCIMB.2021.753444 |
| 2021-11-18 |
Nanopore metagenomic sequencing for detection and characterization of SARS-CoV-2 in clinical samples (edit) |
10.1371/JOURNAL.PONE.0259712 |
| 2021-11-18 |
Metaviromic identification of discriminative genomic features in SARS-CoV-2 using machine learning (edit) |
10.1016/J.PATTER.2021.100407 |
| 2021-11-18 |
Genome-wide identification and prediction of SARS-CoV-2 mutations show an abundance of variants: Integrated study of bioinformatics and deep neural learning (edit) |
10.1016/J.IMU.2021.100798 |
| 2021-11-18 |
Peptides derived from the SARS-CoV-2 receptor binding motif bind to ACE2 but do not block ACE2-mediated host cell entry or pro-inflammatory cytokine induction (edit) |
10.1371/JOURNAL.PONE.0260283 |
| 2021-11-18 |
Critical timing and extent of public health interventions to control outbreaks dominated by SARS-CoV-2 variants in Australia: a mathematical modelling study (edit) |
10.1016/J.IJID.2021.11.024 |
| 2021-11-17 |
Uncovering a conserved vulnerability site in SARS‐CoV‐2 by a human antibody (edit) |
10.15252/EMMM.202114544 |
| 2021-11-17 |
Tunneling nanotubes provide a novel route for SARS-CoV-2 spreading between permissive cells and to non-permissive neuronal cells (edit) |
10.1101/2021.11.15.468633 |
| 2021-11-17 |
The Delta variant of SARS-CoV-2 maintains high sensitivity to interferons in human lung cells (edit) |
10.1101/2021.11.16.468777 |
| 2021-11-17 |
A Pro-Inflammatory Gut Microbiome Characterizes SARS-CoV-2 Infected Patients and a Reduction in the Connectivity of an Anti-Inflammatory Bacterial Network Associates With Severe COVID-19 (edit) |
10.3389/FCIMB.2021.747816 |
| 2021-11-17 |
Identification of Key Pathways and Genes in SARS-CoV-2 Infecting Human Intestines by Bioinformatics Analysis (edit) |
10.1007/S10528-021-10144-W |
| 2021-11-17 |
A Highly Sensitive and Specific SARS-CoV-2 Spike- and Nucleoprotein-Based Fluorescent Multiplex Immunoassay (FMIA) to Measure IgG, IgA, and IgM Class Antibodies (edit) |
10.1128/SPECTRUM.01131-21 |
| 2021-11-17 |
SARS-CoV-2 introduction and lineage dynamics across three epidemic peaks in Southern Brazil: massive spread of P.1. (edit) |
10.1016/J.MEEGID.2021.105144 |
| 2021-11-17 |
Response to the Letter to the Editor “SARS-CoV-2–Associated New Dysphagia in Parkinson’s Disease Requires Exclusion of Differentials” (edit) |
10.1097/PHM.0000000000001928 |
| 2021-11-17 |
SARS-CoV-2–Associated New Dysphagia in Parkinson’s Disease Requires Exclusion of Differentials (edit) |
10.1097/PHM.0000000000001927 |
| 2021-11-16 |
A Bacterial Cell-Based Assay To Study SARS-CoV-2 Protein-Protein Interactions (edit) |
10.1128/MBIO.02936-21 |
| 2021-11-16 |
SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues (edit) |
10.1016/J.CELREP.2021.110020 |
| 2021-11-16 |
SARS-CoV-2 infection and replication in human gastric organoids (edit) |
10.1038/S41467-021-26762-2 |
| 2021-11-16 |
Evolutionary and Phenotypic Characterization of Two Spike Mutations in European Lineage 20E of SARS-CoV-2 (edit) |
10.1128/MBIO.02315-21 |
| 2021-11-16 |
A Comparative Study between Spanish and British SARS-CoV-2 Variants (edit) |
10.3390/CIMB43030140 |
| 2021-11-16 |
Sustained Delivery of SARS-CoV-2 RBD Subunit Vaccine Using a High Affinity Injectable Hydrogel Scaffold (edit) |
10.1002/ADHM.202101714 |
| 2021-11-16 |
Immunological Characterization of HIV and SARS-CoV-2 Coinfected Young Individuals (edit) |
10.3390/CELLS10113187 |
| 2021-11-15 |
Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis (edit) |
10.1016/S2666-5247(21)00267-6 |
| 2021-11-15 |
The glycosylation in SARS-CoV-2 and its receptor ACE2 (edit) |
10.1038/S41392-021-00809-8 |
| 2021-11-15 |
SARS-CoV-2 inhibits induction of the MHC class I pathway by targeting the STAT1-IRF1-NLRC5 axis (edit) |
10.1038/S41467-021-26910-8 |
| 2021-11-15 |
Nanometer-resolution in situ structure of the SARS-CoV-2 postfusion spike protein (edit) |
10.1073/PNAS.2112703118 |
| 2021-11-15 |
Blood Cytokine Analysis Suggests That SARS-CoV-2 Infection Results in a Sustained Tumour Promoting Environment in Cancer Patients (edit) |
10.3390/CANCERS13225718 |
| 2021-11-15 |
SARS-CoV-2 spike protein removes lipids from model membranes and interferes with the capacity of high density lipoprotein to exchange lipids (edit) |
10.1016/J.JCIS.2021.06.056 |
| 2021-11-15 |
The existence, spread, and strategies for environmental monitoring and control of SARS-CoV-2 in environmental media (edit) |
10.1016/J.SCITOTENV.2021.148949 |
| 2021-11-15 |
Targeted Detection of SARS-CoV-2 Nucleocapsid Sequence Variants by Mass Spectrometric Analysis of Tryptic Peptides (edit) |
10.1021/ACS.JPROTEOME.1C00613 |
| 2021-11-15 |
Manufacturing a chimpanzee adenovirus-vectored SARS-CoV-2 vaccine to meet global needs (edit) |
10.1002/BIT.27945 |
| 2021-11-14 |
Hepatitis B virus/hepatitis D virus epidemiology: Changes over time and possible future influence of the SARS-CoV-2 pandemic (edit) |
10.3748/WJG.V27.I42.7271 |
| 2021-11-13 |
SARS-CoV-2 deregulates the vascular and immune functions of brain pericytes via Spike protein (edit) |
10.1016/J.NBD.2021.105561 |
| 2021-11-13 |
Identification of Cellular Factors Required for SARS-CoV-2 Replication (edit) |
10.3390/CELLS10113159 |
| 2021-11-13 |
A rigorous framework for detecting SARS-CoV-2 spike protein mutational ensemble from genomic and structural features (edit) |
10.1016/J.CRSTBI.2021.11.002 |
| 2021-11-13 |
Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic (edit) |
10.1093/BJS/ZNAB336 |
| 2021-11-13 |
Nucleocapsid mutations R203K/G204R increase the infectivity, fitness, and virulence of SARS-CoV-2 (edit) |
10.1016/J.CHOM.2021.11.005 |
| 2021-11-13 |
In depth analysis of Cyprus-specific mutations of SARS-CoV-2 strains using computational approaches (edit) |
10.1186/S12863-021-01007-9 |
| 2021-11-12 |
Disulfide bonds play a critical role in the structure and function of the receptor-binding domain of the SARS-CoV-2 Spike antigen (edit) |
10.1016/J.JMB.2021.167357 |
| 2021-11-12 |
The Emergence of the Spike Furin Cleavage Site in SARS-CoV-2 (edit) |
10.1093/MOLBEV/MSAB327 |
| 2021-11-12 |
Antiviral Potential of the Antimicrobial Drug Atovaquone against SARS-CoV-2 and Emerging Variants of Concern (edit) |
10.1021/ACSINFECDIS.1C00278 |
| 2021-11-12 |
Assessing the efficacy of interventions to control indoor SARS-Cov-2 transmission: An agent-based modeling approach (edit) |
10.1016/J.EPIDEM.2021.100524 |
| 2021-11-12 |
Computational redesign of Fab CC12.3 with substantially better predicted binding affinity to SARS-CoV-2 than human ACE2 receptor (edit) |
10.1038/S41598-021-00684-X |
| 2021-11-12 |
SARS-CoV-2 B.1.1.7 (alpha) and B.1.351 (beta) variants induce pathogenic patterns in K18-hACE2 transgenic mice distinct from early strains (edit) |
10.1038/S41467-021-26803-W |
| 2021-11-12 |
Rapid and Effective Vitamin D Supplementation May Present Better Clinical Outcomes in COVID-19 (SARS-CoV-2) Patients by Altering Serum INOS1, IL1B, IFNg, Cathelicidin-LL37, and ICAM1 (edit) |
10.3390/NU13114047 |
| 2021-11-11 |
Research progress of human coronaviruses and associated eye diseases (edit) |
10.3760/CMA.J.CN112142-20210426-00190 |
| 2021-11-11 |
Epigenetic glycosylation of SARS-CoV-2 impact viral infection through DC&L-SIGN receptors (edit) |
10.1016/J.ISCI.2021.103426 |
| 2021-11-11 |
Spike protein cleavage-activation mediated by the SARS-CoV-2 P681R mutation: a case-study from its first appearance in variant of interest (VOI) A.23.1 identified in Uganda (edit) |
10.1101/2021.06.30.450632 |
| 2021-11-11 |
Dresdner Kinder und Corona - kein schöne(s)r Land zu dieser Zeit: Eine Beobachtung aus Prohlis (edit) |
|
| 2021-11-11 |
Meine Kindheit mit Corona: Bericht einer Zehnjährigen (edit) |
|
| 2021-11-11 |
Targeted proteomics as a tool to detect SARS-CoV-2 proteins in clinical specimens (edit) |
10.1371/JOURNAL.PONE.0259165 |
| 2021-11-11 |
Dietary polyphenols mitigate SARS-CoV-2 main protease (Mpro)-Molecular dynamics, molecular mechanics, and density functional theory investigations (edit) |
10.1016/J.MOLSTRUC.2021.131879 |
| 2021-11-11 |
Evolutionary and Antigenic Profiling of the Tendentious D614G Mutation of SARS-CoV-2 in Gujarat, India (edit) |
10.3389/FGENE.2021.764927 |
| 2021-11-10 |
The P681H mutation in the Spike glycoprotein confers Type I interferon resistance in the SARS-CoV-2 alpha (B.1.1.7) variant (edit) |
10.1101/2021.11.09.467693 |
| 2021-11-10 |
Close proximity risk assessment for SARS-CoV-2 infection (edit) |
10.1016/J.SCITOTENV.2021.148749 |
| 2021-11-10 |
Oral Hsp90 inhibitor SNX-5422 attenuates SARS-CoV-2 replication and dampens inflammation in airway cells (edit) |
10.1016/J.ISCI.2021.103412 |
| 2021-11-10 |
High-Resolution Linear Epitope Mapping of the Receptor Binding Domain of SARS-CoV-2 Spike Protein in COVID-19 mRNA Vaccine Recipients (edit) |
10.1128/SPECTRUM.00965-21 |
| 2021-11-10 |
Identification of a therapeutic interfering particle-A single-dose SARS-CoV-2 antiviral intervention with a high barrier to resistance (edit) |
10.1016/J.CELL.2021.11.004 |
| 2021-11-09 |
CCR2 Signaling Restricts SARS-CoV-2 Infection (edit) |
10.1128/MBIO.02749-21 |
| 2021-11-09 |
Sialic acid-containing glycolipids mediate binding and viral entry of SARS-CoV-2 (edit) |
10.1038/S41589-021-00924-1 |
| 2021-11-09 |
A novel SARS-CoV-2 related coronavirus in bats from Cambodia (edit) |
10.1038/S41467-021-26809-4 |
| 2021-11-09 |
Candidate genes of SARS-CoV-2 gender susceptibility (edit) |
10.1038/S41598-021-01131-7 |
| 2021-11-09 |
Molecular docking and pharmacokinetic studies of phytocompounds from Nigerian Medicinal Plants as promising inhibitory agents against SARS-CoV-2 methyltransferase (nsp16) (edit) |
10.1186/S43141-021-00273-5 |
| 2021-11-09 |
Molecular dynamic study of SARS-CoV-2 with various S protein mutations and their effect on thermodynamic properties (edit) |
10.1016/J.COMPBIOMED.2021.105025 |
| 2021-11-09 |
Discovery of Camellia sinensis catechins as SARS-CoV-2 3CL protease inhibitors through molecular docking, intra and extra cellular assays (edit) |
10.1016/J.PHYMED.2021.153853 |
| 2021-11-09 |
Transparent Polymeric Formulations Effective against SARS-CoV-2 Infection (edit) |
10.1021/ACSAMI.1C10404 |
| 2021-11-08 |
Drug repurposing for coronavirus (SARS-CoV-2) based on gene co-expression network analysis (edit) |
10.1038/S41598-021-01410-3 |
| 2021-11-08 |
Mutation Y453F in the spike protein of SARS-CoV-2 enhances interaction with the mink ACE2 receptor for host adaption (edit) |
10.1371/JOURNAL.PPAT.1010053 |
| 2021-11-08 |
Lipidomics and metabolomics signatures of SARS-CoV-2 mediators/receptors in peripheral leukocytes, jejunum and colon (edit) |
10.1016/J.CSBJ.2021.11.007 |
| 2021-11-08 |
Correction: Collaboration in the time of COVID: a scientometric analysis of multidisciplinary SARS-CoV-2 research (edit) |
10.1057/S41599-021-00957-W |
| 2021-11-08 |
Lasting Changes to Circulating Leukocytes in People with Mild SARS-CoV-2 Infections (edit) |
10.3390/V13112239 |
| 2021-11-07 |
Pathogenic and transcriptomic differences of emerging SARS-CoV-2 variants in the Syrian golden hamster model (edit) |
10.1016/J.EBIOM.2021.103675 |
| 2021-11-06 |
Surveillance and control of SARS-CoV-2 in mustelids: An evolutionary perspective (edit) |
10.1111/EVA.13310 |
| 2021-11-06 |
Aging whole blood transcriptome reveals candidate genes for SARS-CoV-2-related vascular and immune alterations (edit) |
10.1007/S00109-021-02161-4 |
| 2021-11-06 |
Genomic diversity and molecular dynamics interaction on mutational variances among RB domains of SARS-CoV-2 interplay drug inactivation (edit) |
10.1016/J.MEEGID.2021.105128 |
| 2021-11-06 |
Strategy to Develop and Evaluate a Multiplex RT-ddPCR in Response to SARS-CoV-2 Genomic Evolution (edit) |
10.3390/CIMB43030134 |
| 2021-11-05 |
In-solution buffer-free digestion allows full-sequence coverage and complete characterization of post-translational modifications of the receptor-binding domain of SARS-CoV-2 in a single ESI–MS spectrum (edit) |
10.1007/S00216-021-03721-W |
| 2021-11-05 |
Predicting COVID-19 cases in diverse population groups using SARS-CoV-2 wastewater monitoring across Oklahoma City (edit) |
10.1016/J.SCITOTENV.2021.151431 |
| 2021-11-05 |
Molecular strategies for antibody binding and escape of SARS-CoV-2 and its mutations (edit) |
10.1038/S41598-021-01081-0 |
| 2021-11-05 |
Phylogenetic and Ancestral Sequence Reconstruction of SARS-CoV-2 Reveals Latent Capacity to Bind Human ACE2 Receptor (edit) |
10.1007/S00239-021-10034-0 |
| 2021-11-05 |
Diosmectite inhibits the interaction between SARS-CoV-2 and human enterocytes by trapping viral particles, thereby preventing NF-kappaB activation and CXCL10 secretion (edit) |
10.1038/S41598-021-01217-2 |
| 2021-11-05 |
Oral prodrug of remdesivir parent GS-441524 is efficacious against SARS-CoV-2 in ferrets (edit) |
10.1038/S41467-021-26760-4 |
| 2021-11-05 |
Mutation profile of SARS-CoV-2 spike protein and identification of potential multiple epitopes within spike protein for vaccine development against SARS-CoV-2 (edit) |
10.1007/S13337-021-00747-7 |
| 2021-11-05 |
Time Since Last Anti-CD20 Treatment Is a Major Determinant of Sars-Cov-2 Vaccine Response in a Large Cohort of Patients with B-Cell Lymphoma (edit) |
10.1182/BLOOD-2021-153901 |
| 2021-11-04 |
CTD of SARS‐CoV‐2 N protein is a cryptic domain for binding ATP and nucleic acid that interplay in modulating phase separation (edit) |
10.1002/PRO.4221 |
| 2021-11-04 |
SARS-CoV-2 can infect and propagate in human placenta explants (edit) |
10.1016/J.XCRM.2021.100456 |
| 2021-11-04 |
Within-host evolution of SARS-CoV-2 in an immunosuppressed COVID-19 patient as a source of immune escape variants (edit) |
10.1038/S41467-021-26602-3 |
| 2021-11-04 |
Mouse-adapted SARS-CoV-2 protects animals from lethal SARS-CoV challenge (edit) |
10.1371/JOURNAL.PBIO.3001284 |
| 2021-11-04 |
Development of a rapid point-of-care test that measures neutralizing antibodies to SARS-CoV-2 (edit) |
10.1016/J.JCV.2021.105024 |
| 2021-11-04 |
In Silico End-to-End Protein-Ligand Interaction Characterization Pipeline: The Case of SARS-CoV-2 (edit) |
10.1021/ACSSYNBIO.1C00368 |
| 2021-11-03 |
Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study (edit) |
10.1016/S1470-2045(21)00573-8 |
| 2021-11-03 |
Furin cleavage of the SARS-CoV-2 spike is modulated by O-glycosylation (edit) |
10.1073/PNAS.2109905118 |
| 2021-11-03 |
SARS-CoV-2 Spike Protein S1-Mediated Endothelial Injury and Pro-Inflammatory State Is Amplified by Dihydrotestosterone and Prevented by Mineralocorticoid Antagonism (edit) |
10.3390/V13112209 |
| 2021-11-03 |
A non-ACE2 competing human single-domain antibody confers broad neutralization against SARS-CoV-2 and circulating variants (edit) |
10.1038/S41392-021-00810-1 |
| 2021-11-03 |
Potent Anti-SARS-CoV-2 Activity by the Natural Product Gallinamide A and Analogues via Inhibition of Cathepsin L (edit) |
10.1021/ACS.JMEDCHEM.1C01494 |
| 2021-11-03 |
Computational insights into differential interaction of mammalian angiotensin-converting enzyme 2 with the SARS-CoV-2 spike receptor binding domain (edit) |
10.1016/J.COMPBIOMED.2021.105017 |
| 2021-11-03 |
Visualizing in deceased COVID-19 patients how SARS-CoV-2 attacks the respiratory and olfactory mucosae but spares the olfactory bulb (edit) |
10.1016/J.CELL.2021.10.027 |
| 2021-11-03 |
Risk of chlorine dioxide as emerging contaminant during SARS-CoV-2 pandemic: enzyme, cardiac, and behavior effects on amphibian tadpoles (edit) |
|
| 2021-11-03 |
Comprehensive investigation of SARS-CoV-2 fate in wastewater and finding the virus transfer and destruction route through conventional activated sludge and sequencing batch reactor (edit) |
10.1016/J.SCITOTENV.2021.151391 |
| 2021-11-03 |
Insights on the SARS-CoV-2 genome variability: the lesson learned in Brazil and its impacts on the future of pandemics (edit) |
10.1099/MGEN.0.000656 |
| 2021-11-02 |
Bilateral giant cell arteritis with skin necrosis following SARS‐CoV‐2 vaccination (edit) |
10.1111/BJD.20824 |
| 2021-11-02 |
Neutralizing antibody 5-7 defines a distinct site of vulnerability in SARS-CoV-2 spike N-terminal domain (edit) |
10.1016/J.CELREP.2021.109928 |
| 2021-11-02 |
RNA-extraction-free diagnostic method to detect SARS-CoV-2: an assessment from two states, India (edit) |
|
| 2021-11-02 |
A spatial multi-scale fluorescence microscopy toolbox discloses entry checkpoints of SARS-CoV-2 variants in Vero E6 cells (edit) |
10.1016/J.CSBJ.2021.10.038 |
| 2021-11-02 |
Metabologenomics approach to the discovery of novel compounds from Streptomyces sp. GMR22 as anti-SARS-CoV-2 drugs (edit) |
10.1016/J.HELIYON.2021.E08308 |
| 2021-11-01 |
NK cell receptor and ligand composition influences the clearance of SARS-CoV-2 (edit) |
10.1172/JCI146408 |
| 2021-11-01 |
Zn‐Induced Interactions Between SARS‐CoV‐2 orf7a and BST2/Tetherin (edit) |
10.1002/OPEN.202100217 |
| 2021-11-01 |
Heparin interacts with the main protease of SARS-CoV-2 and inhibits its activity (edit) |
10.1016/J.SAA.2021.120595 |
| 2021-11-01 |
Characterization of the emerging B.1.621 variant of interest of SARS-CoV-2 (edit) |
10.1016/J.MEEGID.2021.105038 |
| 2021-11-01 |
Contribution of autophagy machinery factors to HCV and SARS-CoV-2 replication organelle formation (edit) |
10.1016/J.CELREP.2021.110049 |
| 2021-11-01 |
Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations (edit) |
10.1007/S12031-020-01767-6 |
| 2021-11-01 |
Emerging SARS-CoV-2 variants expand species tropism to murines (edit) |
10.1016/J.EBIOM.2021.103643 |
| 2021-11-01 |
SARS-CoV-2 research using human pluripotent stem cells and organoids (edit) |
10.1002/SCTM.21-0183 |
| 2021-11-01 |
In response to the letter to the editor regarding SARS-CoV-2 Presence in the Saliva, Tears, and Cerumen of COVID-19 Patients (edit) |
10.1002/LARY.29723 |
| 2021-11-01 |
In Reference to "SARS-CoV-2 presence in the saliva, tears and cerumen of COVID-19 patients" (edit) |
10.1002/LARY.29727 |
| 2021-11-01 |
Virus detective: searching for Zika, dengue and SARS-CoV-2 (edit) |
10.1038/D41586-021-03001-8 |
| 2021-11-01 |
Water-sanitation-health nexus in the Indus-Ganga-Brahmaputra River Basin: need for wastewater surveillance of SARS-CoV-2 for preparedness during the future waves of pandemic (edit) |
10.1016/J.ECOHYD.2021.11.001 |
| 2021-11-01 |
Membranotropic and biological activities of the membrane fusion peptides from SARS-CoV spike glycoprotein: The importance of the complete internal fusion peptide domain (edit) |
10.1016/J.BBAMEM.2021.183697 |
| 2021-11-01 |
Michaelis-like complex of SARS-CoV-2 main protease visualized by room-temperature X-ray crystallography (edit) |
10.1107/S2052252521010113 |
| 2021-11-01 |
SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion (edit) |
10.1038/S41586-021-03944-Y |
| 2021-11-01 |
In Vivo protection from SARS-CoV-2 infection by ATN-161 in k18-hACE2 transgenic mice (edit) |
10.1016/J.LFS.2021.119881 |
| 2021-11-01 |
Contribution of single mutations to selected SARS-CoV-2 emerging variants spike antigenicity (edit) |
10.1016/J.VIROL.2021.09.001 |
| 2021-11-01 |
The impact of viral mutations on recognition by SARS-CoV-2 specific T cells (edit) |
10.1016/J.ISCI.2021.103353 |
| 2021-11-01 |
Structural biology of SARS-CoV-2 and implications for therapeutic development (edit) |
10.1038/S41579-021-00630-8 |
| 2021-11-01 |
High-throughput screening identifies established drugs as SARS-CoV-2 PLpro inhibitors (edit) |
10.1007/S13238-021-00836-9 |
| 2021-11-01 |
Short-term outcomes in children recovered from multisystem inflammatory syndrome associated with SARS-CoV-2 infection (edit) |
10.1007/S00296-021-04932-1 |
| 2021-11-01 |
The high diversity of SARS-CoV-2-related coronaviruses in pangolins alerts potential ecological risks (edit) |
10.24272/J.ISSN.2095-8137.2021.334 |
| 2021-11-01 |
SARS-CoV-2-host proteome interactions for antiviral drug discovery (edit) |
10.15252/MSB.202110396 |
| 2021-11-01 |
Genome-scale metabolic modeling reveals SARS-CoV-2-induced metabolic changes and antiviral targets (edit) |
10.15252/MSB.202110260 |
| 2021-11-01 |
High anti-SARS-CoV-2 antibody seroconversion rates before the second wave in Manaus, Brazil, and the protective effect of social behaviour measures: results from the prospective DETECTCoV-19 cohort (edit) |
10.1016/S2214-109X(21)00355-7 |
| 2021-11-01 |
Whole genome sequencing for revealing the point mutations of SARS-CoV-2 genome in Bangladeshi isolates and their structural effects on viral proteins (edit) |
10.1039/D1RA05327B |
| 2021-11-01 |
In silico analysis of SARS-CoV-2 papain-like protease potential inhibitors (edit) |
10.1039/D1RA07845C |
| 2021-11-01 |
Novel nucleocapsid protein-targeting phenanthridine inhibitors of SARS-CoV-2 (edit) |
10.1016/J.EJMECH.2021.113966 |
| 2021-11-01 |
The evaluation of potential global impact of the N501Y mutation in SARS-COV-2 positive patients (edit) |
10.1002/JMV.27413 |
| 2021-11-01 |
Monoclonal antibody-mediated neutralization of SARS-CoV-2 in an IRF9-deficient child (edit) |
10.1073/PNAS.2114390118 |
| 2021-11-01 |
Validation and invalidation of SARS-CoV-2 main protease inhibitors using the Flip-GFP and Protease-Glo luciferase assays (edit) |
10.1016/J.APSB.2021.10.026 |
| 2021-11-01 |
Determination of neutralising anti-SARS-CoV-2 antibody half-life in COVID-19 convalescent donors (edit) |
10.1016/J.CLIM.2021.108871 |
| 2021-11-01 |
Generation of potent cellular and humoral immunity against SARS-CoV-2 antigens via conjugation to a polymeric glyco-adjuvant (edit) |
10.1016/J.BIOMATERIALS.2021.121159 |
| 2021-11-01 |
A hybrid PDE–ABM model for viral dynamics with application to SARS-CoV-2 and influenza (edit) |
10.1098/RSOS.210787 |
| 2021-11-01 |
Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection (edit) |
10.1038/S41591-021-01540-1 |
| 2021-11-01 |
Spectra of Photobiological Inactivation of SARS-CoV-2 by Solar UVB Radiation (280–320 nm) (edit) |
10.1134/S1024856021060191 |
| 2021-11-01 |
Rise and exacerbation of oral lichen planus in the background of SARS-CoV-2 infection (edit) |
10.1016/J.MEHY.2021.110681 |
| 2021-11-01 |
SARS-CoV-2 Antibodies in Breast Milk After Vaccination (edit) |
|
| 2021-11-01 |
Dysphagia and mechanical ventilation in SARS-COV-2 pneumonia: It's real (edit) |
10.1016/J.CLNU.2021.11.018 |
| 2021-11-01 |
Interplay between the Genetics of Personality Traits, severe Psychiatric Disorders, and COVID-19 Host Genetics in the Susceptibility to SARS-CoV-2 Infection - ADDENDUM (edit) |
10.1192/BJO.2021.1037 |
| 2021-11-01 |
Prior infection with SARS-CoV-2 boosts and broadens Ad26.COV2.S immunogenicity in a variant-dependent manner (edit) |
10.1016/J.CHOM.2021.10.003 |
| 2021-11-01 |
347. SARS-CoV-2 and Acute Otitis Media in Children: A Case Series (edit) |
10.1093/OFID/OFAB466.548 |
| 2021-11-01 |
Design and development of an oral remdesivir derivative VV116 against SARS-CoV-2 (edit) |
10.1038/S41422-021-00570-1 |
| 2021-11-01 |
Severe autoimmune hemolytic anemia following receipt of SARS-CoV-2 mRNA vaccine (edit) |
10.1111/TRF.16672 |
| 2021-11-01 |
Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study (edit) |
10.1016/S1473-3099(21)00289-9 |
| 2021-11-01 |
Detection of SARS-CoV-2 in the sewerage system in Tunisia: a promising tool to confront COVID-19 pandemic (edit) |
10.2217/FVL-2021-0050 |
| 2021-10-31 |
Structural basis for the interaction of SARS‐CoV‐2 virulence factor nsp1 with DNA Polymerase a ‐ Primase (edit) |
10.1002/PRO.4220 |
| 2021-10-31 |
Mapping SARS-CoV-2 Antibody Epitopes in COVID-19 Patients with a Multi-Coronavirus Protein Microarray (edit) |
10.1128/SPECTRUM.01416-21 |
| 2021-10-30 |
Clinical and Epidemiological Characteristics of 1283 Pediatric Patients with Coronavirus Disease 2019 during the First and Second Waves of the Pandemic-Results of the Pediatric Part of a Multicenter Polish Register SARSTer (edit) |
10.3390/JCM10215098 |
| 2021-10-30 |
Robust Virus-Specific Adaptive Immunity in COVID-19 Patients with SARS-CoV-2 Δ382 Variant Infection (edit) |
10.1007/S10875-021-01142-Z |
| 2021-10-30 |
Analysis on genome variation of SARS-CoV-2 circulating in the world (edit) |
|
| 2021-10-29 |
Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study (edit) |
10.1016/S1473-3099(21)00648-4 |
| 2021-10-29 |
SARS-CoV-2 spike protein causes blood coagulation and thrombosis by competitive binding to heparan sulfate (edit) |
10.1016/J.IJBIOMAC.2021.10.112 |
| 2021-10-29 |
Severity of Disease Among Adults Hospitalized with Laboratory-Confirmed COVID-19 Before and During the Period of SARS-CoV-2 B.1.617.2 (Delta) Predominance — COVID-NET, 14 States, January–August 2021 (edit) |
10.15585/MMWR.MM7043E1 |
| 2021-10-29 |
Low-dose in vivo protection and neutralization across SARS-CoV-2 variants by monoclonal antibody combinations (edit) |
10.1038/S41590-021-01068-Z |
| 2021-10-29 |
In silico identification of potential inhibitors against main protease of SARS-CoV-2 6LU7 from Andrographis panniculata via molecular docking, binding energy calculations and molecular dynamics simulation studies (edit) |
10.1016/J.SJBS.2021.10.060 |
| 2021-10-29 |
Immunizations with diverse sarbecovirus receptor-binding domains elicit SARS-CoV-2 neutralizing antibodies against a conserved site of vulnerability (edit) |
10.1016/J.IMMUNI.2021.10.019 |
| 2021-10-29 |
SARS-CoV-2 beta variant substitutions alter spike glycoprotein receptor binding domain structure and stability (edit) |
10.1016/J.JBC.2021.101371 |
| 2021-10-29 |
BNT162b2 vaccine effectiveness was marginally affected by the SARS-CoV-2 beta variant in fully vaccinated individuals (edit) |
10.1016/J.JCLINEPI.2021.10.011 |
| 2021-10-29 |
Evaluation of virucidal activity of residual quaternary ammonium-treated surfaces on SARS-CoV-2 (edit) |
10.1016/J.AJIC.2021.10.021 |
| 2021-10-28 |
The intersection of COVID-19 and autoimmunity (edit) |
10.1172/JCI154886 |
| 2021-10-28 |
Survey of SARS-CoV-2 genetic diversity in two major Brazilian cities using a fast and affordable Sanger sequencing strategy (edit) |
10.1016/J.YGENO.2021.10.015 |
| 2021-10-28 |
A natural product compound inhibits coronaviral replication in vitro by binding to the conserved Nsp9 SARS-CoV-2 protein (edit) |
10.1016/J.JBC.2021.101362 |
| 2021-10-28 |
Quantification of airborne SARS-CoV-2 genomic particles in different hospital settings (edit) |
10.1038/S41598-021-00761-1 |
| 2021-10-28 |
RT-qPCR assays for SARS-CoV-2 variants of concern in wastewater reveals compromised vaccination-induced immunity (edit) |
10.1016/J.WATRES.2021.117808 |
| 2021-10-28 |
Non-pharmaceutical interventions, vaccination, and the SARS-CoV-2 delta variant in England: a mathematical modelling study (edit) |
10.1016/S0140-6736(21)02276-5 |
| 2021-10-28 |
Dysregulated Inflammation During Obesity: Driving Disease Severity in Influenza Virus and SARS-CoV-2 Infections (edit) |
10.3389/FIMMU.2021.770066 |
| 2021-10-27 |
Structural, Electronic, and Electrostatic Determinants for Inhibitor Binding to Subsites S1 and S2 in SARS-CoV-2 Main Protease (edit) |
10.1021/ACS.JMEDCHEM.1C01475 |
| 2021-10-27 |
Strong Association of Angiotensin Converting Enzyme-2 Gene Insertion/Deletion Polymorphism with Susceptibility to SARS-CoV-2, Hypertension, Coronary Artery Disease and COVID-19 Disease Mortality (edit) |
10.3390/JPM11111098 |
| 2021-10-27 |
The systemic inflammatory landscape of COVID-19 in pregnancy: Extensive serum proteomic profiling of mother-infant dyads with in utero SARS-CoV-2 (edit) |
10.1016/J.XCRM.2021.100453 |
| 2021-10-27 |
Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: The CAPTURE study (edit) |
10.1038/S43018-021-00274-W |
| 2021-10-27 |
Nanodiagnostics to Face SARS-CoV-2 and Future Pandemics: From an Idea to the Market and Beyond (edit) |
10.1021/ACSNANO.1C06839 |
| 2021-10-27 |
Weekly SARS-CoV-2 screening of asymptomatic kindergarten to grade 12 students and staff helps inform strategies for safer in-person learning (edit) |
10.1016/J.XCRM.2021.100452 |
| 2021-10-27 |
qNMR characterization of potential peptide calibrators for isotope dilution LC–MS quantification of a SARS-CoV-2 IgG monoclonal antibody (edit) |
10.1088/1361-6501/AC2FE9 |
| 2021-10-26 |
Mechanistic insights into COVID-19 by global analysis of the SARS-CoV-2 3CL substrate degradome (edit) |
10.1016/J.CELREP.2021.109892 |
| 2021-10-26 |
SARS-CoV-2 exploits host DGAT and ADRP for efficient replication (edit) |
10.1038/S41421-021-00338-2 |
| 2021-10-26 |
Structural mechanism of SARS-CoV-2 neutralization by two murine antibodies targeting the RBD (edit) |
10.1016/J.CELREP.2021.109881 |
| 2021-10-26 |
Betacoronavirus Assembly: Clues and Perspectives for Elucidating SARS-CoV-2 Particle Formation and Egress (edit) |
10.1128/MBIO.02371-21 |
| 2021-10-26 |
OM-85 Broncho-Vaxom, a Bacterial Lysate, Reduces SARS-CoV-2 Binding Proteins on Human Bronchial Epithelial Cells (edit) |
10.3390/BIOMEDICINES9111544 |
| 2021-10-26 |
Polymorphic landscape of SARS-CoV-2 genomes isolated from Indian population in 2020 demonstrates rapid evolution in ORF3a, ORF8, nucleocapsid phosphoprotein and spike glycoprotein (edit) |
10.1016/J.COMPBIOLCHEM.2021.107594 |
| 2021-10-26 |
Detailed phylogenetic analysis tracks transmission of distinct SARS-COV-2 variants from China and Europe to West Africa (edit) |
10.1038/S41598-021-00267-W |
| 2021-10-26 |
Analysis of 329,942 SARS-CoV-2 records retrieved from GISAID database (edit) |
10.1016/J.COMPBIOMED.2021.104981 |
| 2021-10-26 |
Garcinia kola and garcinoic acid suppress SARS-CoV-2 spike glycoprotein S1-induced hyper-inflammation in human PBMCs through inhibition of NF-κB activation (edit) |
10.1002/PTR.7315 |
| 2021-10-26 |
Isolation and Characterization of Mouse Monoclonal Antibodies That Neutralize SARS-CoV-2 and Its Variants of Concern Alpha, Beta, Gamma and Delta by Binding Conformational Epitopes of Glycosylated RBD With High Potency (edit) |
10.3389/FIMMU.2021.750386 |
| 2021-10-26 |
Diurnal Variation in SARS-CoV-2 PCR Test Results: Test Accuracy May Vary by Time of Day (edit) |
10.1177/07487304211051841 |
| 2021-10-25 |
Beta RBD boost broadens antibody-mediated protection against SARS-CoV-2 variants in animal models (edit) |
10.1016/J.XCRM.2021.100450 |
| 2021-10-25 |
Structure-Based Primer Design Minimizes the Risk of PCR Failure Caused by SARS-CoV-2 Mutations (edit) |
10.3389/FCIMB.2021.741147 |
| 2021-10-25 |
De novo design of novel protease inhibitor candidates in the treatment of SARS-CoV-2 using deep learning, docking, and molecular dynamic simulations (edit) |
10.1016/J.COMPBIOMED.2021.104967 |
| 2021-10-24 |
Partial resistance of SARS-CoV-2 Delta variants to vaccine-elicited antibodies and convalescent sera (edit) |
10.1016/J.ISCI.2021.103341 |
| 2021-10-23 |
SARS-CoV-2 Spike Protein Disrupts Blood-Brain Barrier Integrity via RhoA Activation (edit) |
10.1007/S11481-021-10029-0 |
| 2021-10-23 |
DCcov: Repositioning of drugs and drug combinations for SARS-CoV-2 infected lung through constraint-based modeling (edit) |
10.1016/J.ISCI.2021.103331 |
| 2021-10-23 |
SARS-CoV-2-specific B- and T-cell immunity in a population-based study of young Swedish adults (edit) |
10.1016/J.JACI.2021.10.014 |
| 2021-10-22 |
COVID-19 coagulopathies: Human blood proteins mimic SARS-CoV-2 virus, vaccine proteins and bacterial co-infections inducing autoimmunity: Combinations of bacteria and SARS-CoV-2 synergize to induce autoantibodies targeting cardiolipin, cardiolipin-bi (edit) |
10.1002/BIES.202100158 |
| 2021-10-22 |
Crystal structure of SARS-CoV-2 main protease in complex with protease inhibitor PF-07321332 (edit) |
10.1007/S13238-021-00883-2 |
| 2021-10-22 |
Dynamics of SARS-CoV-2 variants of concern (VOC) in Bangladesh during the first half of 2021 (edit) |
10.1016/J.VIROL.2021.10.005 |
| 2021-10-22 |
Potential inhibitors of SARS-CoV-2 (COVID 19) spike protein of the delta and delta plus variant: In silico studies of medicinal plants of North-East India (edit) |
10.1016/J.CRPHAR.2021.100065 |
| 2021-10-22 |
Evolutionary Perspective and Theories on the Possible Origin of SARS-CoV-2 (edit) |
10.7759/CUREUS.18981 |
| 2021-10-22 |
Genomic epidemiology and the role of international and regional travel in the SARS-CoV-2 epidemic in Zimbabwe: a retrospective study of routinely collected surveillance data (edit) |
10.1016/S2214-109X(21)00434-4 |
| 2021-10-22 |
Allotypic variation in antigen processing controls antigenic peptide generation from SARS-CoV-2 S1 spike glycoprotein (edit) |
10.1016/J.JBC.2021.101329 |
| 2021-10-22 |
De Novo and Relapsing Glomerulonephritis following SARS-CoV-2 mRNA Vaccination in Microscopic Polyangiitis (edit) |
10.1155/2021/8400842 |
| 2021-10-21 |
The SARS-CoV-2 main protease Mpro causes microvascular brain pathology by cleaving NEMO in brain endothelial cells (edit) |
10.1038/S41593-021-00926-1 |
| 2021-10-21 |
Micronucleus production, activation of DNA damage response and cGAS-STING signaling in syncytia induced by SARS-CoV-2 infection (edit) |
10.1186/S13062-021-00305-7 |
| 2021-10-21 |
Role of toll-like receptors in modulation of cytokine storm signaling in SARS-CoV-2-induced COVID-19 (edit) |
10.1002/JMV.27405 |
| 2021-10-21 |
Pathology and Immunity After SARS-CoV-2 Infection in Male Ferrets Is Affected by Age and Inoculation Route (edit) |
10.3389/FIMMU.2021.750229 |
| 2021-10-21 |
Design and synthesis of heterocyclic azole based bioactive compounds: Molecular structures, quantum simulation, and mechanistic studies through docking as multi-target inhibitors of SARS-CoV-2 and cytotoxicity (edit) |
10.1016/J.MOLSTRUC.2021.131782 |
| 2021-10-21 |
Are antigen tests useful as screening for the identification of SARS-CoV-2 in emergency rooms? (edit) |
10.1093/EURPUB/CKAB164.813 |
| 2021-10-21 |
Changes in the associations of race and rurality with SARS-CoV-2 infection, mortality, and case fatality in the United States from February 2020 to March 2021: A population-based cohort study (edit) |
10.1371/JOURNAL.PMED.1003807 |
| 2021-10-21 |
SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3 (edit) |
10.1056/NEJMC2113468 |
| 2021-10-21 |
The Impact of SARS-CoV-2 Pandemic on Time to Primary, Secondary Resection and Adjuvant Intravesical Therapy in Patients with High-Risk Non-Muscle Invasive Bladder Cancer: A Retrospective Multi-Institutional Cohort Analysis (edit) |
10.3390/CANCERS13215276 |
| 2021-10-21 |
A Comprehensive Review about the Molecular Structure of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Insights into Natural Products against COVID-19 (edit) |
10.3390/PHARMACEUTICS13111759 |
| 2021-10-20 |
Associations between Genetic Variants in the Vitamin D Metabolism Pathway and Severity of COVID-19 among UAE Residents (edit) |
10.3390/NU13113680 |
| 2021-10-20 |
Direct RNA Sequencing Reveals SARS-CoV-2 m6A Sites and Possible Differential DRACH Motif Methylation among Variants (edit) |
10.3390/V13112108 |
| 2021-10-20 |
Mechanisms of Immunothrombosis by SARS-CoV-2 (edit) |
10.3390/BIOM11111550 |
| 2021-10-20 |
Molecular insights into receptor binding of recent emerging SARS-CoV-2 variants (edit) |
10.1038/S41467-021-26401-W |
| 2021-10-20 |
An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity (edit) |
10.1016/J.CHEMBIOL.2021.10.008 |
| 2021-10-20 |
Deciphering the link between Diabetes mellitus and SARS-CoV-2 infection through differential targeting of microRNAs in the human pancreas (edit) |
10.1007/S40618-021-01693-3 |
| 2021-10-20 |
Key Substitutions in the Spike Protein of SARS-CoV-2 Variants Can Predict Resistance to Monoclonal Antibodies, but Other Substitutions Can Modify the Effects (edit) |
10.1128/JVI.01110-21 |
| 2021-10-20 |
Targeting SARS-CoV-2 with Chaga mushroom: An in silico study toward developing a natural antiviral compound (edit) |
10.1002/FSN3.2576 |
| 2021-10-20 |
SARS-CoV-2 Antibody Binding and Neutralization in Dried Blood Spot Eluates and Paired Plasma (edit) |
10.1128/SPECTRUM.01298-21 |
| 2021-10-20 |
An alphavirus replicon-based vaccine expressing a stabilized Spike antigen induces protective immunity and prevents transmission of SARS-CoV-2 between cats (edit) |
10.1038/S41541-021-00390-9 |
| 2021-10-20 |
Development of a highly specific and sensitive VHH-based sandwich immunoassay for the detection of the SARS-CoV-2 nucleoprotein (edit) |
10.1016/J.JBC.2021.101290 |
| 2021-10-20 |
COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models (edit) |
10.1038/S41467-021-26354-0 |
| 2021-10-20 |
An ultra-low-cost electroporator with microneedle electrodes (ePatch) for SARS-CoV-2 vaccination (edit) |
10.1073/PNAS.2110817118 |
| 2021-10-19 |
COVID19 Disease Map, a computational knowledge repository of virus–host interaction mechanisms (edit) |
10.15252/MSB.202110387 |
| 2021-10-19 |
Acquisition of the L452R Mutation in the ACE2-Binding Interface of Spike Protein Triggers Recent Massive Expansion of SARS-CoV-2 Variants (edit) |
10.1128/JCM.00921-21 |
| 2021-10-19 |
Compartmentalization-aided interaction screening reveals extensive high-order complexes within the SARS-CoV-2 proteome (edit) |
10.1016/J.CELREP.2021.109778 |
| 2021-10-19 |
Computational Analysis of Missense Variants in the Human Transmembrane Protease Serine 2 (TMPRSS2) and SARS-CoV-2 (edit) |
10.1155/2021/9982729 |
| 2021-10-19 |
Release of infectious virus and cytokines in nasopharyngeal swabs from individuals infected with non-alpha or alpha SARS-CoV-2 variants: an observational retrospective study (edit) |
10.1016/J.EBIOM.2021.103637 |
| 2021-10-19 |
Evaluation of SARS-CoV-2 main protease and inhibitor interactions using dihedral angle distributions and radial distribution function (edit) |
10.1016/J.HELIYON.2021.E08220 |
| 2021-10-19 |
Factors affecting aerosol SARS-CoV-2 transmission via HVAC systems; a modeling study (edit) |
10.1371/JOURNAL.PCBI.1009474 |
| 2021-10-19 |
Collaboration in the time of COVID: a scientometric analysis of multidisciplinary SARS-CoV-2 research (edit) |
10.1057/S41599-021-00922-7 |
| 2021-10-18 |
SARS-CoV-2 promotes RIPK1 activation to facilitate viral propagation (edit) |
10.1038/S41422-021-00578-7 |
| 2021-10-18 |
Altered ISGylation drives aberrant macrophage-dependent immune responses during SARS-CoV-2 infection (edit) |
10.1038/S41590-021-01035-8 |
| 2021-10-15 |
Mutation-induced changes in the receptor-binding interface of the SARS-CoV-2 Delta variant B.1.617.2 and implications for immune evasion (edit) |
10.1016/J.BBRC.2021.08.036 |
| 2021-10-15 |
Sweet Drugs for Bad Bugs: A Glycomimetic Strategy against the DC-SIGN-Mediated Dissemination of SARS-CoV-2 (edit) |
10.1021/JACS.1C06778 |
| 2021-10-15 |
An airway organoid-based screen identifies a role for the HIF1α-glycolysis axis in SARS-CoV-2 infection (edit) |
10.1016/J.CELREP.2021.109920 |
| 2021-10-15 |
Sequence complementarity between human noncoding RNAs and SARS-CoV-2 genes: What are the implications for human health? (edit) |
10.1016/J.BBADIS.2021.166291 |
| 2021-10-15 |
Attenuated activation of pulmonary immune cells in mRNA-1273–vaccinated hamsters after SARS-CoV-2 infection (edit) |
10.1172/JCI148036 |
| 2021-10-14 |
Integrin activation is an essential component of SARS-CoV-2 infection (edit) |
10.1038/S41598-021-99893-7 |
| 2021-10-14 |
Surveillance of SARS-CoV-2 lineage B.1.1.7 in Slovakia using a novel, multiplexed RT-qPCR assay (edit) |
10.1038/S41598-021-99661-7 |
| 2021-10-14 |
Rapid incidence estimation from SARS-CoV-2 genomes reveals decreased case detection in Europe during summer 2020 (edit) |
10.1038/S41467-021-26267-Y |
| 2021-10-14 |
Immunodominant linear B cell epitopes in the spike and membrane proteins of SARS-CoV-2 identified by immunoinformatics prediction and immunoassay (edit) |
10.1038/S41598-021-99642-W |
| 2021-10-14 |
Comprehensive mapping of binding hot spots of SARS-CoV-2 RBD-specific neutralizing antibodies for tracking immune escape variants (edit) |
10.1186/S13073-021-00985-W |
| 2021-10-13 |
The effect of glycosylation of SARS-CoV-2 spike protein on the virus interaction with the host cell ACE2 receptor (edit) |
10.1016/J.ISCI.2021.103272 |
| 2021-10-13 |
Host genetic factors determining COVID-19 susceptibility and severity (edit) |
10.1016/J.EBIOM.2021.103629 |
| 2021-10-13 |
SARS–CoV–2 Spike Impairs DNA Damage Repair and Inhibits V(D)J Recombination In Vitro (edit) |
10.3390/V13102056 |
| 2021-10-13 |
Genomic Variations in the Structural Proteins of SARS-CoV-2 and Their Deleterious Impact on Pathogenesis: A Comparative Genomics Approach (edit) |
10.3389/FCIMB.2021.765039 |
| 2021-10-13 |
Thermodynamics and kinetics in antibody resistance of the 501Y.V2 SARS-CoV-2 variant (edit) |
10.1039/D1RA04134G |
| 2021-10-13 |
Strategy and Performance Evaluation of Low-Frequency Variant Calling for SARS-CoV-2 Using Targeted Deep Illumina Sequencing (edit) |
10.3389/FMICB.2021.747458 |
| 2021-10-13 |
Children and Adults in a Household Cohort Study Have Robust Longitudinal Immune Responses Following SARS-CoV-2 Infection or Exposure (edit) |
10.3389/FIMMU.2021.741639 |
| 2021-10-13 |
Ten emerging SARS-CoV-2 spike variants exhibit variable infectivity, animal tropism, and antibody neutralization (edit) |
10.1038/S42003-021-02728-4 |
| 2021-10-13 |
Systemic and mucosal immune profiling in asymptomatic and symptomatic SARS-CoV-2-infected individuals reveal unlinked immune signatures (edit) |
10.1126/SCIADV.ABI6533 |
| 2021-10-13 |
Serology study after BTN162b2 vaccination in participants previously infected with SARS-CoV-2 in two different waves versus naïve (edit) |
10.1038/S43856-021-00039-7 |
| 2021-10-13 |
Genomic surveillance of SARS-CoV-2 tracks early interstate transmission of P.1 lineage and diversification within P.2 clade in Brazil (edit) |
10.1371/JOURNAL.PNTD.0009835 |
| 2021-10-13 |
Oral Microbiome Alterations and SARS-CoV-2 Saliva Viral Load in Patients with COVID-19 (edit) |
10.1128/SPECTRUM.00055-21 |
| 2021-10-13 |
The global epidemic of SARS‐CoV‐2 variants and their mutational immune escape (edit) |
10.1002/JMV.27376 |
| 2021-10-12 |
A potently neutralizing SARS-CoV-2 antibody inhibits variants of concern by utilizing unique binding residues in a highly conserved epitope (edit) |
10.1016/J.IMMUNI.2021.08.016 |
| 2021-10-12 |
B.1.617.2 enters and fuses lung cells with increased efficiency and evades antibodies induced by infection and vaccination (edit) |
10.1016/J.CELREP.2021.109825 |
| 2021-10-12 |
Computational Study on the Function of Palmitoylation on the Envelope Protein in SARS-CoV-2 (edit) |
10.1021/ACS.JCTC.1C00359 |
| 2021-10-12 |
Construction and Investigation of Competing Endogenous RNA Networks and Candidate Genes Involved in SARS-CoV-2 Infection (edit) |
10.2147/IJGM.S335162 |
| 2021-10-12 |
Dietary stigmastane-type saponins as promising dual-target directed inhibitors of SARS-CoV-2 proteases: a structure-based screening (edit) |
10.1039/D1RA05976A |
| 2021-10-12 |
Natural biflavones are potent inhibitors against SARS-CoV-2 papain-like protease (edit) |
10.1016/J.PHYTOCHEM.2021.112984 |
| 2021-10-12 |
Medical Significance of Uterine Corpus Endometrial Carcinoma Patients Infected With SARS-CoV-2 and Pharmacological Characteristics of Plumbagin (edit) |
10.3389/FENDO.2021.714909 |
| 2021-10-12 |
Cannabidiol inhibits SARS-Cov-2 spike (S) protein-induced cytotoxicity and inflammation through a PPARγ-dependent TLR4/NLRP3/Caspase-1 signaling suppression in Caco-2 cell line (edit) |
10.1002/PTR.7302 |
| 2021-10-12 |
Crippling SARS-CoV-2 vaccine supply crunch, vaccination target and scope in Bangladesh (edit) |
10.1016/J.HPOPEN.2021.100054 |
| 2021-10-11 |
SARS-CoV-2 nucleocapsid protein forms condensates with viral genomic RNA (edit) |
10.1371/JOURNAL.PBIO.3001425 |
| 2021-10-11 |
ORF3a of SARS-CoV-2 promotes lysosomal exocytosis-mediated viral egress (edit) |
10.1016/J.DEVCEL.2021.10.006 |
| 2021-10-11 |
The reproductive number of the Delta variant of SARS-CoV-2 is far higher compared to the ancestral SARS-CoV-2 virus (edit) |
10.1093/JTM/TAAB124 |
| 2021-10-11 |
Identification of Berbamine, Oxyacanthine and Rutin from Berberis asiatica as anti-SARS-CoV-2 compounds: An in silico study (edit) |
10.1016/J.JMGM.2021.108028 |
| 2021-10-11 |
Direct and Indirect Proof of SARS-CoV-2 Infections in Indigenous Wiwa Communities in North-Eastern Colombia—A Cross-Sectional Assessment Providing Preliminary Surveillance Data (edit) |
10.3390/VACCINES9101120 |
| 2021-10-11 |
A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and MERS-CoV viral entry and protect human epithelial lung cells (edit) |
10.1073/PNAS.2108728118 |
| 2021-10-09 |
Evolution of the SARS-CoV-2 proteome in three dimensions (3D) during the first 6 months of the COVID-19 pandemic (edit) |
10.1002/PROT.26250 |
| 2021-10-09 |
A student led computational screening of peptide inhibitors against main protease of SARS-CoV-2 (edit) |
10.1002/BMB.21580 |
| 2021-10-08 |
SARS-CoV-2 spike protein harnesses SNX27-mediated endocytic recycling pathway (edit) |
10.1002/MCO2.92 |
| 2021-10-08 |
SARS-CoV-2 inhibition using a mucoadhesive, amphiphilic chitosan that may serve as an anti-viral nasal spray (edit) |
10.1038/S41598-021-99404-8 |
| 2021-10-08 |
Serum IgG anti-SARS-CoV-2 Binding Antibody Level Is Strongly Associated With IgA and Functional Antibody Levels in Adults Infected With SARS-CoV-2 (edit) |
10.3389/FIMMU.2021.693462 |
| 2021-10-08 |
Persistence of neutralizing antibodies a year after SARS-CoV-2 infection in humans (edit) |
10.1002/EJI.202149535 |
| 2021-10-08 |
Non-Invasive Antibody Assessment in Saliva to Determine SARS-CoV-2 Exposure in Young Children (edit) |
10.3389/FIMMU.2021.753435 |
| 2021-10-08 |
Inhibition Potencies of Phytochemicals Derived from Sesame Against SARS-CoV-2 Main Protease: A Molecular Docking and Simulation Study (edit) |
10.3389/FCHEM.2021.744376 |
| 2021-10-08 |
Prevalence of SARS-CoV-2 Infection in Children by Antibody Detection in Saliva: Protocol for a Prospective Longitudinal Study (Coro-Buddy) (edit) |
10.2196/27739 |
| 2021-10-08 |
Remdesivir overcomes the S861 roadblock in SARS-CoV-2 polymerase elongation complex (edit) |
10.1016/J.CELREP.2021.109882 |
| 2021-10-08 |
Study of perinatal transmission of SARS-CoV-2 in a Mexican public hospital (edit) |
10.1016/J.IJID.2021.10.006 |
| 2021-10-08 |
Compelling Evidence Suggesting the Codon Usage of SARS-CoV-2 Adapts to Human After the Split From RaTG13 (edit) |
10.1177/11769343211052013 |
| 2021-10-07 |
Inhibition of SARS-CoV-2 polymerase by nucleotide analogs from a single-molecule perspective (edit) |
10.7554/ELIFE.70968 |
| 2021-10-07 |
Genome Sequences of Community SARS-CoV-2 B.1.526 and P.1 Variants Circulating in the Dominican Republic (edit) |
10.1128/MRA.00744-21 |
| 2021-10-07 |
l-Arginine Improves Solubility and ANTI SARS-CoV-2 Mpro Activity of Rutin but Not the Antiviral Activity in Cells (edit) |
10.3390/MOLECULES26196062 |
| 2021-10-07 |
Nutritional behaviors of women and men in Poland during confinement related to the SARS-CoV-2 epidemic (edit) |
10.1038/S41598-021-99561-W |
| 2021-10-07 |
A cell-free high throughput assay for assessment of SARS-CoV-2 neutralizing antibodies (edit) |
10.1016/J.NBT.2021.10.002 |
| 2021-10-07 |
Polymersomes as Stable Nanocarriers for a Highly Immunogenic and Durable SARS-CoV-2 Spike Protein Subunit Vaccine (edit) |
10.1021/ACSNANO.1C01243 |
| 2021-10-07 |
Biological Significance of the Genomic Variation and Structural Dynamics of SARS-CoV-2 B.1.617 (edit) |
10.3389/FMICB.2021.750725 |
| 2021-10-07 |
SARS-CoV-2 binding and neutralizing antibody levels after Ad26.COV2.S vaccination predict durable protection in rhesus macaques (edit) |
10.1038/S41467-021-26117-X |
| 2021-10-07 |
ChAdOx1 nCoV-19 (AZD1222) protects Syrian hamsters against SARS-CoV-2 B.1.351 and B.1.1.7. (edit) |
10.1038/S41467-021-26178-Y |
| 2021-10-07 |
Domain-specific biochemical and serological characterization of SARS-CoV-2 nucleocapsid protein (edit) |
10.1016/J.XPRO.2021.100906 |
| 2021-10-07 |
A fluorescence-based, gain-of-signal, live cell system to evaluate SARS-CoV-2 main protease inhibition (edit) |
10.1016/J.ANTIVIRAL.2021.105183 |
| 2021-10-07 |
Scalable, effective, and rapid decontamination of SARS-CoV-2 contaminated N95 respirators using germicidal ultraviolet C (UVC) irradiation device (edit) |
10.1038/S41598-021-99431-5 |
| 2021-10-07 |
Airborne microplastics and SARS-CoV-2 in total suspended particles in the area surrounding the largest medical centre in Latin America (edit) |
10.1016/J.ENVPOL.2021.118299 |
| 2021-10-07 |
Evolution of SARS-CoV-2 Key Mutations in Vienna Detected by Large Scale Screening Program (edit) |
10.3390/V13102014 |
| 2021-10-07 |
Interplay between the genetics of personality traits, severe psychiatric disorders and COVID-19 host genetics in the susceptibility to SARS-CoV-2 infection (edit) |
10.1192/BJO.2021.1030 |
| 2021-10-06 |
Highly efficient SARS-CoV-2 infection of human cardiomyocytes: spike protein-mediated cell fusion and its inhibition (edit) |
10.1128/JVI.01368-21 |
| 2021-10-06 |
Transcriptomic analysis revealed increased expression of genes involved in keratinization in the tears of COVID-19 patients (edit) |
10.1038/S41598-021-99344-3 |
| 2021-10-06 |
Averting an Outbreak of SARS-CoV-2 in a University Residence Hall through Wastewater Surveillance (edit) |
10.1128/SPECTRUM.00792-21 |
| 2021-10-06 |
SARS-CoV-2 antibody seroprevalence and associated risk factors in an urban district in Cameroon (edit) |
10.1038/S41467-021-25946-0 |
| 2021-10-06 |
Superspreading events of SARS-CoV-2 in Paris: A retrospective analysis of data from the first wave of COVID-19 in 2020 (edit) |
10.1016/J.JIPH.2021.10.001 |
| 2021-10-06 |
Sex differences in electrolyte imbalances caused by SARS-CoV-2: A cross-sectional study (edit) |
10.1111/IJCP.14882 |
| 2021-10-06 |
Rapid and High-Throughput Reverse Transcriptase Quantitative PCR (RT-qPCR) Assay for Identification and Differentiation between SARS-CoV-2 Variants B.1.1.7 and B.1.351 (edit) |
10.1128/SPECTRUM.00506-21 |
| 2021-10-06 |
Spectrum Bias and Individual Strengths of SARS-CoV-2 Serological Tests—A Population-Based Evaluation (edit) |
10.3390/DIAGNOSTICS11101843 |
| 2021-10-05 |
Mechanisms of SARS-CoV-2 entry into cells (edit) |
10.1038/S41580-021-00418-X |
| 2021-10-05 |
Paired heavy- and light-chain signatures contribute to potent SARS-CoV-2 neutralization in public antibody responses (edit) |
10.1016/J.CELREP.2021.109771 |
| 2021-10-05 |
Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognition (edit) |
10.1016/J.CELREP.2021.109784 |
| 2021-10-05 |
A Bioinformatics Approach for the Prediction of Immunogenic Properties and Structure of the SARS-COV-2 B.1.617.1 Variant Spike Protein (edit) |
10.1155/2021/7251119 |
| 2021-10-05 |
Metabolic Perturbation Associated With COVID-19 Disease Severity and SARS-CoV-2 Replication (edit) |
10.1016/J.MCPRO.2021.100159 |
| 2021-10-05 |
In vivo characterization of emerging SARS-CoV-2 variant infectivity and human antibody escape potential (edit) |
10.1016/J.CELREP.2021.109838 |
| 2021-10-05 |
Blood Transcriptomes of Anti-SARS-CoV-2 Antibody-Positive Healthy Individuals Who Experienced Asymptomatic Versus Clinical Infection (edit) |
10.3389/FIMMU.2021.746203 |
| 2021-10-05 |
A Combination of Receptor-Binding Domain and N-Terminal Domain Neutralizing Antibodies Limits the Generation of SARS-CoV-2 Spike Neutralization-Escape Mutants (edit) |
10.1128/MBIO.02473-21 |
| 2021-10-05 |
Tailoring Our Approach in Response to the SARS-CoV-2 Pandemic and Transcending Science Outreach Modalities for Native American Students in a Cancer Research Education Program (edit) |
10.15695/JSTEM/V4I4.08 |
| 2021-10-05 |
UK Research Ethics Committee’s review of the global first SARS-CoV-2 human infection challenge studies (edit) |
10.1136/MEDETHICS-2021-107709 |
| 2021-10-04 |
The acid sphingomyelinase/ceramide system in COVID-19 (edit) |
10.1038/S41380-021-01309-5 |
| 2021-10-04 |
The early interferon catches the SARS-CoV-2 (edit) |
10.1084/JEM.20211667 |
| 2021-10-04 |
Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs (edit) |
10.1084/JEM.20211211 |
| 2021-10-04 |
Defining the Innate Immune Responses for SARS-CoV-2-Human Macrophage Interactions (edit) |
10.3389/FIMMU.2021.741502 |
| 2021-10-02 |
SARS‐CoV‐2 Alpha, Beta and Delta variants display enhanced Spike‐mediated Syncytia Formation (edit) |
10.15252/EMBJ.2021108944 |
| 2021-10-02 |
Mitochondrial Dynamics in SARS-COV2 Spike Protein Treated Human Microglia: Implications for Neuro-COVID (edit) |
10.1007/S11481-021-10015-6 |
| 2021-10-02 |
The immune landscape of SARS-CoV-2-associated Multisystem Inflammatory Syndrome in Children (MIS-C) from acute disease to recovery (edit) |
10.1016/J.ISCI.2021.103215 |
| 2021-10-02 |
Delineating phenotypes of Kawasaki disease and SARS-CoV-2-related inflammatory multisystem syndrome: a French study and literature review (edit) |
10.1093/RHEUMATOLOGY/KEAB026 |
| 2021-10-01 |
Dermatological aspects of SARS-CoV-2 infection: mechanisms and manifestations (edit) |
10.1007/S00403-020-02156-0 |
| 2021-10-01 |
Will prenatal exposure to SARS-CoV-2 define a birth cohort with accelerated aging in the century ahead? (edit) |
10.1017/S204017442000104X |
| 2021-10-01 |
[SARS-CoV-2 infection and ischemic stroke] (edit) |
10.1016/J.SEMERG.2020.09.007 |
| 2021-10-01 |
The mechanism and consequences of SARS-CoV-2 spike-mediated fusion and syncytia formation (edit) |
10.1016/J.JMB.2021.167280 |
| 2021-10-01 |
S-acylation controls SARS-CoV-2 membrane lipid organization and enhances infectivity (edit) |
10.1016/J.DEVCEL.2021.09.016 |
| 2021-10-01 |
6-Thioguanine blocks SARS-CoV-2 replication by inhibition of PLpro (edit) |
10.1016/J.ISCI.2021.103213 |
| 2021-10-01 |
Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study (edit) |
10.1016/S2666-5247(21)00129-4 |
| 2021-10-01 |
SARS-CoV-2 N501Y variants of concern and their potential transmission by mouse (edit) |
10.1038/S41418-021-00846-4 |
| 2021-10-01 |
APOL1 risk variants in individuals of African genetic ancestry drive endothelial cell defects that exacerbate sepsis (edit) |
10.1016/J.IMMUNI.2021.10.004 |
| 2021-10-01 |
The proximal proteome of 17 SARS-CoV-2 proteins links to disrupted antiviral signaling and host translation (edit) |
10.1371/JOURNAL.PPAT.1009412 |
| 2021-10-01 |
O-glycosylation pattern of the SARS-CoV-2 spike protein reveals an "O-Follow-N" rule (edit) |
10.1038/S41422-021-00545-2 |
| 2021-10-01 |
Identification of lectin receptors for conserved SARS-CoV-2 glycosylation sites (edit) |
10.15252/EMBJ.2021108375 |
| 2021-10-01 |
A Convenient and Biosafe Replicon with Accessory Genes of SARS-CoV-2 and Its Potential Application in Antiviral Drug Discovery (edit) |
10.1007/S12250-021-00385-9 |
| 2021-10-01 |
Breakthrough Infections of SARS-CoV-2 Gamma Variant in Fully Vaccinated Gold Miners, French Guiana, 2021 (edit) |
10.3201/EID2710.211427 |
| 2021-10-01 |
Structures of SARS-CoV-2 B.1.351 neutralizing antibodies provide insights into cocktail design against concerning variants (edit) |
10.1038/S41422-021-00555-0 |
| 2021-10-01 |
Structures of synthetic nanobody-SARS-CoV-2 receptor-binding domain complexes reveal distinct sites of interaction (edit) |
10.1016/J.JBC.2021.101202 |
| 2021-10-01 |
Transmission event of SARS-CoV-2 delta variant reveals multiple vaccine breakthrough infections (edit) |
10.1186/S12916-021-02103-4 |
| 2021-10-01 |
Identification of Niemann-Pick C1 protein as a potential novel SARS-CoV-2 intracellular target (edit) |
10.1016/J.ANTIVIRAL.2021.105167 |
| 2021-10-01 |
H, C and N Backbone chemical shift assignments of the n-terminal and central intrinsically disordered domains of SARS-CoV-2 nucleoprotein (edit) |
10.1007/S12104-021-10014-X |
| 2021-10-01 |
SARS-CoV-2 infects an upper airway model derived from induced pluripotent stem cells (edit) |
10.1002/STEM.3422 |
| 2021-10-01 |
H, C and N assignment of stem-loop SL1 from the 5'-UTR of SARS-CoV-2 (edit) |
10.1007/S12104-021-10047-2 |
| 2021-10-01 |
Pregnancy and viral infections: Mechanisms of fetal damage, diagnosis and prevention of neonatal adverse outcomes from cytomegalovirus to SARS-CoV-2 and Zika virus (edit) |
10.1016/J.BBADIS.2021.166198 |
| 2021-10-01 |
Lesson by SARS-CoV-2 disease (COVID-19): whole-body CT angiography detection of "relevant" and "other/incidental" systemic vascular findings (edit) |
10.1007/S00330-021-07904-Y |
| 2021-10-01 |
An evidence that SARS-Cov-2/COVID-19 spike protein (SP) damages hematopoietic stem/progenitor cells in the mechanism of pyroptosis in Nlrp3 inflammasome-dependent manner (edit) |
10.1038/S41375-021-01332-Z |
| 2021-10-01 |
Short-term and Long-term Rates of Postacute Sequelae of SARS-CoV-2 Infection: A Systematic Review (edit) |
10.1001/JAMANETWORKOPEN.2021.28568 |
| 2021-10-01 |
Proteases and variants: context matters for SARS-CoV-2 entry assays (edit) |
10.1016/J.COVIRO.2021.07.004 |
| 2021-10-01 |
High-dose intravenous immunoglobulins as a therapeutic option in critical illness polyneuropathy accompanying SARS-CoV-2 infection: A case-based review of the literature (Review) (edit) |
10.3892/ETM.2021.10616 |
| 2021-10-01 |
SARS-CoV-2 Delta variant infects ACE2 primary human bronchial epithelial cells more efficiently than other variants (edit) |
10.1002/JMV.27372 |
| 2021-10-01 |
Complementation of contact tracing by mass testing for successful containment of beta COVID-19 variant (SARS-CoV-2 VOC B.1.351) epidemic in Hong Kong (edit) |
10.1016/J.LANWPC.2021.100281 |
| 2021-10-01 |
Estimating the effect of timetabling decisions on the spread of SARS-CoV-2 in medium-to-large engineering schools in Canada: an agent-based modelling study (edit) |
10.9778/CMAJO.20200280 |
| 2021-10-01 |
The Upper Respiratory Tract of Felids Is Highly Susceptible to SARS-CoV-2 Infection (edit) |
10.3390/IJMS221910636 |
| 2021-10-01 |
β-Blockers bearing hydroxyethylamine and hydroxyethylene as potential SARS-CoV-2 Mpro inhibitors: rational based design, in silico, in vitro, and SAR studies for lead optimization (edit) |
10.1039/D1RA04820A |
| 2021-10-01 |
The Emergence of the New P.4 Lineage of SARS-CoV-2 With Spike L452R Mutation in Brazil (edit) |
10.3389/FPUBH.2021.745310 |
| 2021-10-01 |
Comparison of SARS-CoV-2 Antibody Response Following Vaccination With BNT162b2 and mRNA-1273 (edit) |
10.1001/JAMA.2021.15125 |
| 2021-10-01 |
Emergence and spread of SARS-CoV-2 lineage B.1.620 with variant of concern-like mutations and deletions (edit) |
10.1038/S41467-021-26055-8 |
| 2021-10-01 |
OntoRepliCov: an Ontology-Based Approach for Modeling the SARS-CoV-2 Replication Process (edit) |
10.1016/J.PROCS.2021.08.050 |
| 2021-10-01 |
Application of a novel mathematical model to identify intermediate hosts of SARS-CoV-2 (edit) |
10.1016/J.JTBI.2021.110761 |
| 2021-10-01 |
Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe (edit) |
10.1183/23120541.00411-2021 |
| 2021-10-01 |
Increased platelet activation in SARS-CoV-2 infected non-hospitalised children and adults, and their household contacts (edit) |
10.1111/BJH.17629 |
| 2021-10-01 |
Weather, air pollution, and SARS-CoV-2 transmission: a global analysis (edit) |
10.1016/S2542-5196(21)00202-3 |
| 2021-10-01 |
High intelligence may exacerbate paediatric inflammatory response to SARS-CoV-2 infection (edit) |
10.1016/J.MEHY.2021.110677 |
| 2021-10-01 |
Blood transcriptional biomarkers of acute viral infection for detection of pre-symptomatic SARS-CoV-2 infection: a nested, case-control diagnostic accuracy study (edit) |
10.1016/S2666-5247(21)00146-4 |
| 2021-10-01 |
Kawasaki Disease Shock Syndrome vs Classical Kawasaki Disease: A Meta-analysis and Comparison With SARS-CoV-2 Multisystem Inflammatory Syndrome (edit) |
10.1016/J.CJCA.2021.05.014 |
| 2021-10-01 |
SARS-CoV-2 and dengue virus coinfection in an adult with beta-thalassemia (trait): A case report from Bangladesh with literature review (edit) |
10.1016/J.HELIYON.2021.E08229 |
| 2021-10-01 |
Structural modelling of SARS-CoV-2 alpha variant (B.1.1.7) suggests enhanced furin binding and infectivity (edit) |
10.1016/J.VIRUSRES.2021.198522 |
| 2021-10-01 |
Modeling viral dynamics in SARS-CoV-2 infection based on differential equations and numerical analysis (edit) |
10.1016/J.HELIYON.2021.E08207 |
| 2021-10-01 |
Current status and strategic possibilities on potential use of combinational drug therapy against COVID-19 caused by SARS-CoV-2 (edit) |
10.1080/07391102.2020.1802345 |
| 2021-09-30 |
Targeting the coronavirus nucleocapsid protein through GSK-3 inhibition (edit) |
10.1073/PNAS.2113401118 |
| 2021-09-30 |
Cell death mechanisms involved in cell injury caused by SARS‐CoV‐2 (edit) |
10.1002/RMV.2292 |
| 2021-09-30 |
The N-terminal domain of SARS-CoV-2 nsp1 plays key roles in suppression of cellular gene expression and preservation of viral gene expression (edit) |
10.1016/J.CELREP.2021.109841 |
| 2021-09-30 |
Role of miR-2392 in driving SARS-CoV-2 infection (edit) |
10.1016/J.CELREP.2021.109839 |
| 2021-09-30 |
The emergence and ongoing convergent evolution of the SARS-CoV-2 N501Y lineages (edit) |
10.1016/J.CELL.2021.09.003 |
| 2021-09-30 |
No increase in anti-A isohemagglutinin titer after SARS-CoV-2 infection: A retrospective cohort analysis of group O apheresis platelet donors (edit) |
10.1002/JCA.21942 |
| 2021-09-30 |
Theoretical and experimental study of interaction of macroheterocyclic compounds with ORF3a of SARS-CoV-2 (edit) |
10.1038/S41598-021-99072-8 |
| 2021-09-30 |
Expansion of a SARS-CoV-2 Delta variant with an 872 nt deletion encompassing ORF7a, ORF7b and ORF8, Poland, July to August 2021 (edit) |
10.2807/1560-7917.ES.2021.26.39.2100902 |
| 2021-09-30 |
Identification of potent inhibitors against transmembrane serine protease 2 for developing therapeutics against SARS-CoV-2 (edit) |
10.1080/07391102.2021.1980109 |
| 2021-09-30 |
Analysis of SARS-CoV-2 haplotypes and genomic sequences during 2020 in Victoria, Australia, in the context of putative deficits in innate immune deaminase anti-viral responses (edit) |
10.1111/SJI.13100 |
| 2021-09-30 |
Aerosol SARS-CoV-2 in hospitals and long-term care homes during the COVID-19 pandemic (edit) |
10.1371/JOURNAL.PONE.0258151 |
| 2021-09-29 |
The roles of lipids in SARS-CoV-2 viral replication and the host immune response (edit) |
10.1016/J.JLR.2021.100129 |
| 2021-09-29 |
Computational prediction of the effect of amino acid changes on the binding affinity between SARS-CoV-2 spike RBD and human ACE2 (edit) |
10.1073/PNAS.2106480118 |
| 2021-09-29 |
Critical Capability Needs for Reduction of Transmission of SARS-CoV-2 Indoors (edit) |
10.3389/FBIOE.2021.641599 |
| 2021-09-29 |
Active site-specific quantum tunneling of hACE2 receptor to assess its complexing poses with selective bioactive compounds in co-suppressing SARS-CoV-2 influx and subsequent cardiac injury (edit) |
10.5455/JAVAR.2021.H544 |
| 2021-09-29 |
Computational screening of phytochemicals from three medicinal plants as inhibitors of transmembrane protease serine 2 implicated in SARS-CoV-2 infection (edit) |
10.1016/J.PHYPLU.2021.100135 |
| 2021-09-29 |
Genomic sequencing of SARS-CoV-2 in Rwanda reveals the importance of incoming travelers on lineage diversity (edit) |
10.1038/S41467-021-25985-7 |
| 2021-09-29 |
SARS-CoV-2 integral membrane proteins shape the serological responses of patients with COVID-19 (edit) |
10.1016/J.ISCI.2021.103185 |
| 2021-09-29 |
Correlation between α1-Antitrypsin Deficiency and SARS-CoV-2 Infection: Epidemiological Data and Pathogenetic Hypotheses (edit) |
10.3390/JCM10194493 |
| 2021-09-29 |
mRNA vaccination in people over 80 years of age induces strong humoral immune responses against SARS-CoV-2 with cross neutralization of P.1 Brazilian variant (edit) |
10.7554/ELIFE.69375 |
| 2021-09-29 |
Metabolic snapshot of plasma samples reveals new pathways implicated in SARS-CoV-2 pathogenesis (edit) |
10.1101/2021.09.29.462326 |
| 2021-09-28 |
Representing COVID-19 information in collaborative knowledge graphs: the case of Wikidata (edit) |
10.3233/SW-210444 |
| 2021-09-28 |
In vivo structure and dynamics of the SARS-CoV-2 RNA genome (edit) |
10.1038/S41467-021-25999-1 |
| 2021-09-28 |
ORF3a Protein of Severe Acute Respiratory Syndrome Coronavirus 2 Inhibits Interferon-Activated Janus Kinase/Signal Transducer and Activator of Transcription Signaling via Elevating Suppressor of Cytokine Signaling 1 (edit) |
10.3389/FMICB.2021.752597 |
| 2021-09-28 |
Autoimmune Disorders & COVID-19 (edit) |
10.3390/MEDICINES8100055 |
| 2021-09-28 |
Determinants of SARS-CoV-2 entry and replication in airway mucosal tissue and susceptibility in smokers (edit) |
10.1016/J.XCRM.2021.100421 |
| 2021-09-28 |
Drug repurposing for COVID-19 based on an integrative meta-analysis of SARS-CoV-2 induced gene signature in human airway epithelium (edit) |
10.1371/JOURNAL.PONE.0257784 |
| 2021-09-28 |
Impact of sickle cell trait on morbidity and mortality from SARS-CoV-2 infection (edit) |
10.1182/BLOODADVANCES.2021004977 |
| 2021-09-27 |
Identifying Distinct Structural Features of the SARS-CoV-2 Spike Protein Fusion Domain Essential for Membrane Interaction (edit) |
10.1021/ACS.BIOCHEM.1C00543 |
| 2021-09-27 |
Characterization of SARS2 Nsp15 nuclease activity reveals it's mad about U (edit) |
10.1093/NAR/GKAB719 |
| 2021-09-27 |
Cross-neutralizing antibodies bind a SARS-CoV-2 cryptic site and resist circulating variants (edit) |
10.1038/S41467-021-25997-3 |
| 2021-09-27 |
Characterization and structural basis of a lethal mouse-adapted SARS-CoV-2 (edit) |
10.1038/S41467-021-25903-X |
| 2021-09-27 |
Characterization of Phytochemicals in Ulva intestinalis L. and Their Action Against SARS-CoV-2 Spike Glycoprotein Receptor-Binding Domain (edit) |
10.3389/FCHEM.2021.735768 |
| 2021-09-27 |
Viral S protein histochemistry reveals few potential SARS-CoV-2 entry sites in human ocular tissues (edit) |
10.1038/S41598-021-98709-Y |
| 2021-09-27 |
Targeting novel coronavirus SARS-CoV-2 spike protein with phytoconstituents of Momordica charantia (edit) |
10.1186/S13048-021-00872-3 |
| 2021-09-27 |
AGO CLIP-based imputation of potent siRNA sequences targeting SARS-CoV-2 with antifibrotic miRNA-like activity (edit) |
10.1038/S41598-021-98708-Z |
| 2021-09-27 |
High throughput nanopore sequencing of SARS-CoV-2 viral genomes from patient samples (edit) |
|
| 2021-09-27 |
Large-scale analysis of SARS-CoV-2 spike-glycoprotein mutants demonstrates the need for continuous screening of virus isolates (edit) |
10.1371/JOURNAL.PONE.0249254 |
| 2021-09-27 |
Pharmacological inhibition of fatty acid synthesis blocks SARS-CoV-2 replication (edit) |
10.1038/S42255-021-00479-4 |
| 2021-09-27 |
New Tetramic Acid Derivatives From the Deep-Sea-Derived Fungus Penicillium sp. SCSIO06868 With SARS-CoV-2 Mpro Inhibitory Activity Evaluation (edit) |
10.3389/FMICB.2021.730807 |
| 2021-09-27 |
A meta-analysis for the risk and prevalence of preeclampsia among pregnant women with COVID-19 (edit) |
10.4274/TJOD.GALENOS.2021.66750 |
| 2021-09-27 |
Meta-analysis of the frequency of intrauterine growth restriction and preterm premature rupture of the membranes in pregnant women with COVID-19 (edit) |
10.4274/TJOD.GALENOS.2021.74829 |
| 2021-09-27 |
Machine Learning Models Identify Inhibitors of SARS-CoV-2 (edit) |
10.1021/ACS.JCIM.1C00683 |
| 2021-09-27 |
SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study (edit) |
10.1093/BJS/ZNAB101 |
| 2021-09-25 |
Role of microRNAs in COVID-19 with implications for therapeutics (edit) |
10.1016/J.BIOPHA.2021.112247 |
| 2021-09-25 |
Potential Molecular Mechanisms of Rare Anti-Tumor Immune Response by SARS-CoV-2 in Isolated Cases of Lymphomas (edit) |
10.3390/V13101927 |
| 2021-09-25 |
Caspase-4/11 exacerbates disease severity in SARS-CoV-2 infection by promoting inflammation and thrombosis (edit) |
10.1101/2021.09.24.461743 |
| 2021-09-25 |
CD147 antibody specifically and effectively inhibits infection and cytokine storm of SARS-CoV-2 and its variants delta, alpha, beta, and gamma (edit) |
10.1038/S41392-021-00760-8 |
| 2021-09-25 |
Landscape of human antibody recognition of the SARS-CoV-2 receptor binding domain (edit) |
10.1016/J.CELREP.2021.109822 |
| 2021-09-25 |
Reinfection cases by closely related SARS-CoV-2 lineages in Southern Brazil (edit) |
10.1007/S42770-021-00621-0 |
| 2021-09-25 |
The nasal symbiont Staphylococcus species restricts the transcription of SARS-CoV-2 entry factors in human nasal epithelium (edit) |
10.1016/J.ISCI.2021.103172 |
| 2021-09-25 |
Analytical performance comparison of four SARS-CoV-2 RT-qPCR primer-probe sets for wastewater samples (edit) |
10.1016/J.SCITOTENV.2021.150572 |
| 2021-09-24 |
A Linkage-specific Sialic Acid Labeling Strategy Reveals Different Site-specific Glycosylation Patterns in SARS-CoV-2 Spike Protein Produced in CHO and HEK Cell Substrates (edit) |
10.3389/FCHEM.2021.735558 |
| 2021-09-24 |
Distinct shifts in site-specific glycosylation pattern of SARS-CoV-2 spike proteins associated with arising mutations in the D614G and Alpha variants (edit) |
10.1093/GLYCOB/CWAB102 |
| 2021-09-24 |
Azithromycin: characteristics and clinical indications for bacterial and virus infections, including SARS-CoV-2 infections (edit) |
10.33448/RSD-V10I12.19864 |
| 2021-09-24 |
Identification of Unique Peptides for SARS-CoV-2 Diagnostics and Vaccine Development by an In Silico Proteomics Approach (edit) |
10.3389/FIMMU.2021.725240 |
| 2021-09-24 |
Distinct immune signatures discriminate between asymptomatic and presymptomatic SARS-CoV-2pos subjects (edit) |
10.1038/S41422-021-00562-1 |
| 2021-09-24 |
α-Hemolysin-Aided Oligomerization of the Spike Protein RBD Resulted in Improved Immunogenicity and Neutralization Against SARS-CoV-2 Variants (edit) |
10.3389/FIMMU.2021.757691 |
| 2021-09-24 |
D614G mutation in the SARS-CoV-2 spike protein enhances viral fitness by desensitizing it to temperature-dependent denaturation (edit) |
10.1016/J.JBC.2021.101238 |
| 2021-09-24 |
Implications derived from S-protein variants of SARS-CoV-2 from six continents (edit) |
10.1016/J.IJBIOMAC.2021.09.080 |
| 2021-09-24 |
Immunogenicity and protective efficacy of an intranasal live-attenuated vaccine against SARS-CoV-2 (edit) |
10.1016/J.ISCI.2021.102941 |
| 2021-09-23 |
Palmitoylation of SARS‐CoV‐2 S protein is critical for S‐mediated syncytia formation and virus entry (edit) |
10.1002/JMV.27339 |
| 2021-09-23 |
SARS-CoV-2 spike protein receptor-binding domain N-glycans facilitate viral internalization in respiratory epithelial cells (edit) |
10.1016/J.BBRC.2021.09.053 |
| 2021-09-23 |
SARS-CoV-2 mucosal antibody development and persistence and their relation to viral load and COVID-19 symptoms (edit) |
10.1038/S41467-021-25949-X |
| 2021-09-23 |
A robust high-throughput fluorescent polarization assay for the evaluation and screening of SARS-CoV-2 fusion inhibitors (edit) |
10.1016/J.BIOORG.2021.105362 |
| 2021-09-22 |
SARS-CoV-2 infection causes immunodeficiency in recovered patients by downregulating CD19 expression in B cells via enhancing B-cell metabolism (edit) |
10.1038/S41392-021-00749-3 |
| 2021-09-22 |
Direct activation of endothelial cells by SARS-CoV-2 nucleocapsid protein is blocked by Simvastatin (edit) |
10.1128/JVI.01396-21 |
| 2021-09-22 |
"SARS-CoV-2 is transmitted by particulate air pollution": Misinterpretations of statistical data, skewed citation practices, and misuse of specific terminology spreading the misconception (edit) |
10.1016/J.ENVRES.2021.112116 |
| 2021-09-22 |
Good Cholesterol Gone Bad? HDL and COVID-19 (edit) |
10.3390/IJMS221910182 |
| 2021-09-22 |
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase (edit) |
10.1056/NEJMOA2113017 |
| 2021-09-22 |
Therapeutic Significance of microRNA-Mediated Regulation of PARP-1 in SARS-CoV-2 Infection (edit) |
10.3390/NCRNA7040060 |
| 2021-09-22 |
Mechanisms of Antiviral Immune Evasion of SARS-CoV-2 (edit) |
10.1016/J.JMB.2021.167265 |
| 2021-09-22 |
Changes in severity, mortality, and virus genome among a Spanish cohort of patients hospitalized with SARS-CoV-2 (edit) |
10.1038/S41598-021-98308-X |
| 2021-09-22 |
Cloning of a Passage-Free SARS-CoV-2 Genome and Mutagenesis Using Red Recombination (edit) |
10.3390/IJMS221910188 |
| 2021-09-22 |
RNA Viromics of Southern California Wastewater and Detection of SARS-CoV-2 Single-Nucleotide Variants (edit) |
10.1128/AEM.01448-21 |
| 2021-09-22 |
In silico targeting SARS-CoV-2 spike protein and main protease by biochemical compounds (edit) |
10.1007/S11756-021-00881-Z |
| 2021-09-22 |
Newly designed analogues from SARS-CoV inhibitors mimicking the druggable properties against SARS-CoV-2 and its novel variants (edit) |
10.1039/D1RA04107J |
| 2021-09-22 |
Investigating the structure-activity relationship of marine natural polyketides as promising SARS-CoV-2 main protease inhibitors (edit) |
10.1039/D1RA05817G |
| 2021-09-22 |
Neutralization of SARS-CoV-2 requires antibodies against conformational receptor-binding domain epitopes (edit) |
10.1111/ALL.15066 |
| 2021-09-22 |
Destruction mechanisms of ozone over SARS-CoV-2 (edit) |
10.1038/S41598-021-97860-W |
| 2021-09-22 |
Whole-Genome Sequencing of SARS-CoV-2: Assessment of the Ion Torrent AmpliSeq Panel and Comparison with the Illumina MiSeq ARTIC Protocol (edit) |
10.1128/JCM.00649-21 |
| 2021-09-22 |
Identification of SARS-CoV-2 S RBD escape mutants using yeast screening and deep mutational scanning (edit) |
10.1016/J.XPRO.2021.100869 |
| 2021-09-22 |
Direct detection of human adenovirus or SARS-CoV-2 with ability to inform infectivity using DNA aptamer-nanopore sensors (edit) |
10.1126/SCIADV.ABH2848 |
| 2021-09-21 |
Characterising proteolysis during SARS-CoV-2 infection identifies viral cleavage sites and cellular targets with therapeutic potential (edit) |
10.1038/S41467-021-25796-W |
| 2021-09-21 |
SARS-CoV-2 Nsp5 Demonstrates Two Distinct Mechanisms Targeting RIG-I and MAVS To Evade the Innate Immune Response (edit) |
10.1128/MBIO.02335-21 |
| 2021-09-21 |
Intent to Vaccinate SARS-CoV-2 Infected Children in US Households: A Survey (edit) |
10.3390/VACCINES9091049 |
| 2021-09-21 |
mRNA vaccination of naive and COVID-19-recovered individuals elicits potent memory B cells that recognize SARS-CoV-2 variants (edit) |
10.1016/J.IMMUNI.2021.09.011 |
| 2021-09-21 |
Genetic and structural basis for SARS-CoV-2 variant neutralization by a two-antibody cocktail (edit) |
10.1038/S41564-021-00972-2 |
| 2021-09-21 |
Epitope Profiling Reveals the Critical Antigenic Determinants in SARS-CoV-2 RBD-Based Antigen (edit) |
10.3389/FIMMU.2021.707977 |
| 2021-09-21 |
A highly potent antibody effective against SARS-CoV-2 variants of concern (edit) |
10.1016/J.CELREP.2021.109814 |
| 2021-09-21 |
Cohort profile: a national, community-based prospective cohort study of SARS-CoV-2 pandemic outcomes in the USA—the CHASING COVID Cohort study (edit) |
10.1136/BMJOPEN-2021-048778 |
| 2021-09-21 |
Impact of Two Different Recruitment Procedures (Random vs. Volunteer Selection) on the Results of Seroepidemiological Study (SARS-CoV-2) (edit) |
10.3390/IJERPH18189928 |
| 2021-09-20 |
SARS-CoV-2 S glycoprotein binding to multiple host receptors enables cell entry and infection (edit) |
10.1007/S10719-021-10021-Z |
| 2021-09-20 |
On the weak binding and spectroscopic signature of SARS‐CoV‐2 nsp14 interaction with RNA (edit) |
10.1002/CBIC.202100486 |
| 2021-09-20 |
Low dose inocula of SARS-CoV-2 Alpha variant transmits more efficiently than earlier variants in hamsters (edit) |
10.1038/S42003-021-02640-X |
| 2021-09-20 |
Levels of SARS-CoV-2 population exposure are considerably higher than suggested by seroprevalence surveys (edit) |
10.1371/JOURNAL.PCBI.1009436 |
| 2021-09-20 |
The Natural Stilbenoid (-)-Hopeaphenol Inhibits Cellular Entry of SARS-CoV-2 USA-WA1/2020, B.1.1.7, and B.1.351 Variants (edit) |
10.1128/AAC.00772-21 |
| 2021-09-20 |
SAS: A Platform of Spike Antigenicity for SARS-CoV-2 (edit) |
10.3389/FCELL.2021.713188 |
| 2021-09-20 |
Mathematical models of the spread and consequences of the SARS-CoV-2 pandemics (edit) |
10.1186/S13362-021-00111-W |
| 2021-09-19 |
SARS-CoV-2 pandemic and its threats to humans and animals (edit) |
10.21521/MW.6593 |
| 2021-09-17 |
Prolyl isomerase Pin1 plays an essential role in SARS-CoV-2 proliferation, indicating its possibility as a novel therapeutic target (edit) |
10.1038/S41598-021-97972-3 |
| 2021-09-17 |
A CRISPR/Cas9 genetically engineered organoid biobank reveals essential host factors for coronaviruses (edit) |
10.1038/S41467-021-25729-7 |
| 2021-09-17 |
The biological and clinical significance of emerging SARS-CoV-2 variants (edit) |
10.1038/S41576-021-00408-X |
| 2021-09-17 |
SARS-CoV-2 B.1.617 Mutations L452R and E484Q Are Not Synergistic for Antibody Evasion (edit) |
10.1093/INFDIS/JIAB368 |
| 2021-09-17 |
Prevention of SARS-CoV-2 (COVID-19) transmission in residential aged care using ultraviolet light (PETRA): a two-arm crossover randomised controlled trial protocol (edit) |
10.1186/S12879-021-06659-7 |
| 2021-09-17 |
Spatial and temporal variability and data bias in wastewater surveillance of SARS-CoV-2 in a sewer system (edit) |
10.1016/J.SCITOTENV.2021.150390 |
| 2021-09-17 |
Lung disease network reveals impact of comorbidity on SARS-CoV-2 infection and opportunities of drug repurposing (edit) |
10.1186/S12920-021-01079-7 |
| 2021-09-17 |
Enisamium Inhibits SARS-CoV-2 RNA Synthesis (edit) |
10.3390/BIOMEDICINES9091254 |
| 2021-09-17 |
Arjunetin as a promising drug candidate against SARS-CoV-2: molecular dynamics simulation studies (edit) |
10.1080/07391102.2021.1970627 |
| 2021-09-17 |
Inhibition of the RNA-dependent RNA Polymerase of the SARS-CoV-2 by Short Peptide Inhibitors (edit) |
10.1016/J.EJPS.2021.106012 |
| 2021-09-17 |
Structural and kinetic analyses of holothurian sulfated glycans suggest potential treatment for SARS-CoV-2 infection (edit) |
10.1016/J.JBC.2021.101207 |
| 2021-09-17 |
In vitro selection of Remdesivir resistance suggests evolutionary predictability of SARS-CoV-2 (edit) |
10.1371/JOURNAL.PPAT.1009929 |
| 2021-09-17 |
Complete genome sequencing and molecular characterization of SARS-COV-2 from COVID-19 cases in Alborz province in Iran (edit) |
10.1016/J.HELIYON.2021.E08027 |
| 2021-09-17 |
Exploiting genomic surveillance to map the spatio-temporal dispersal of SARS-CoV-2 spike mutations in Belgium across 2020 (edit) |
10.1038/S41598-021-97667-9 |
| 2021-09-17 |
SARS-CoV-2 Epidemiology on a Public University Campus in Washington State (edit) |
10.1093/OFID/OFAB464 |
| 2021-09-16 |
Assessment of the binding interactions of SARS-CoV-2 spike glycoprotein variants (edit) |
10.1016/J.JPHA.2021.09.006 |
| 2021-09-16 |
Association of HLA genotypes, AB0 blood type and chemokine receptor 5 mutant CD195 with the clinical course of COVID-19 (edit) |
10.1186/S40001-021-00560-4 |
| 2021-09-16 |
Memory B cell repertoire for recognition of evolving SARS-CoV-2 spike (edit) |
10.1016/J.CELL.2021.07.025 |
| 2021-09-16 |
Ozone Treatment Is Insufficient to Inactivate SARS-CoV-2 Surrogate under Field Conditions (edit) |
10.3390/ANTIOX10091480 |
| 2021-09-16 |
S19W, T27W, and N330Y mutations in ACE2 enhance SARS-CoV-2 S-RBD binding toward both wild-type and antibody-resistant viruses and its molecular basis (edit) |
10.1038/S41392-021-00756-4 |
| 2021-09-16 |
Potential natural products that target the SARS-CoV-2 spike protein identified by structure-based virtual screening, isothermal titration calorimetry and lentivirus particles pseudotyped (Vpp) infection assay (edit) |
10.1016/J.JTCME.2021.09.002 |
| 2021-09-16 |
Recent advances in SARS-CoV-2 Spike protein and RBD mutations comparison between new variants Alpha (B.1.1.7, United Kingdom), Beta (B.1.351, South Africa), Gamma (P.1, Brazil) and Delta (B.1.617.2, India) (edit) |
10.1016/J.JVE.2021.100054 |
| 2021-09-16 |
In silico approach to design a multi-epitopic vaccine candidate targeting the non-mutational immunogenic regions in envelope protein and surface glycoprotein of SARS-CoV-2 (edit) |
10.1080/07391102.2021.1977702 |
| 2021-09-16 |
Dynamic Interactions of Fully Glycosylated SARS-CoV-2 Spike Protein with Various Antibodies (edit) |
10.1021/ACS.JCTC.1C00552 |
| 2021-09-16 |
In Vitro Rapid Antigen Test Performance with the SARS-CoV-2 Variants of Concern B.1.1.7 (Alpha), B.1.351 (Beta), P.1 (Gamma), and B.1.617.2 (Delta) (edit) |
10.3390/MICROORGANISMS9091967 |
| 2021-09-16 |
Technical Data of Heterologous Expression and Purification of SARS-CoV-2 Proteases Using Escherichia coli System (edit) |
10.3390/DATA6090099 |
| 2021-09-15 |
SARS-CoV-2 nucleocapsid suppresses host pyroptosis by blocking Gasdermin D cleavage (edit) |
10.15252/EMBJ.2021108249 |
| 2021-09-15 |
The NF-κB Transcriptional Footprint Is Essential for SARS-CoV-2 Replication (edit) |
10.1128/JVI.01257-21 |
| 2021-09-15 |
Case-control study evaluating risk factors for SARS-CoV-2 outbreak amongst healthcare personnel at a tertiary care center (edit) |
10.1016/J.AJIC.2021.09.004 |
| 2021-09-15 |
First reported nosocomial SARS-CoV-2 outbreak in a hospital-based laundry facility (edit) |
10.1017/S0950268821002016 |
| 2021-09-15 |
Nanopore Dwell Time Analysis Permits Sequencing and Conformational Assignment of Pseudouridine in SARS-CoV-2 (edit) |
10.1021/ACSCENTSCI.1C00788 |
| 2021-09-14 |
MOV10 Helicase Interacts with Coronavirus Nucleocapsid Protein and Has Antiviral Activity (edit) |
10.1128/MBIO.01316-21 |
| 2021-09-14 |
Live imaging of SARS-CoV-2 infection in mice reveals that neutralizing antibodies require Fc function for optimal efficacy (edit) |
10.1016/J.IMMUNI.2021.08.015 |
| 2021-09-14 |
Characteristics and outcomes of pregnant women with SARS-CoV-2 infection and other severe acute respiratory infections (SARI) in Brazil from January to November 2020 (edit) |
10.1016/J.BJID.2021.101620 |
| 2021-09-14 |
Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy (edit) |
10.1038/S41591-021-01507-2 |
| 2021-09-14 |
High-Frequency, High-Throughput Quantification of SARS-CoV-2 RNA in Wastewater Settled Solids at Eight Publicly Owned Treatment Works in Northern California Shows Strong Association with COVID-19 Incidence (edit) |
10.1128/MSYSTEMS.00829-21 |
| 2021-09-14 |
Honey bee (Apis mellifera L.) colonies as bioindicators of environmental SARS-CoV-2 occurrence (edit) |
10.1016/J.SCITOTENV.2021.150327 |
| 2021-09-14 |
Rapid Detection of SARS-CoV-2 Antigens and Antibodies Using OFET Biosensors Based on a Soft and Stretchable Semiconducting Polymer (edit) |
10.1021/ACSBIOMATERIALS.1C00727 |
| 2021-09-13 |
SARS-COV-2 Mpro conformational changes induced by covalently bound ligands (edit) |
10.1080/07391102.2021.1970626 |
| 2021-09-13 |
Characterization of the NiRAN domain from RNA-dependent RNA polymerase provides insights into a potential therapeutic target against SARS-CoV-2 (edit) |
10.1371/JOURNAL.PCBI.1009384 |
| 2021-09-13 |
On the timing of interventions to preserve hospital capacity: lessons to be learned from the Belgian SARS-CoV-2 pandemic in 2020 (edit) |
10.1186/S13690-021-00685-2 |
| 2021-09-12 |
Infection and transmission of SARS‐CoV‐2 depends on heparan sulfate proteoglycans (edit) |
10.15252/EMBJ.2020106765 |
| 2021-09-12 |
Discovery of a Natural Product with Potent Efficacy Against SARS-CoV-2 by Drug Screening (edit) |
10.1007/S12539-021-00477-W |
| 2021-09-12 |
Potential antiviral properties of antiplatelet agents against SARS-CoV-2 infection: an in silico perspective (edit) |
10.1007/S11239-021-02558-5 |
| 2021-09-12 |
A nanoenzyme linked immunochromatographic sensor for rapid and quantitative detection of SARS-CoV-2 nucleocapsid protein in human blood (edit) |
10.1016/J.SNB.2021.130718 |
| 2021-09-11 |
5-Hydroxymethyltubercidin exhibits potent antiviral activity against flaviviruses and coronaviruses, including SARS-CoV-2 (edit) |
10.1016/J.ISCI.2021.103120 |
| 2021-09-11 |
The Challenge of Using an Antigen Test as a Screening Tool for SARS-CoV-2 Infection in an Emergency Department: Experience of a Tertiary Care Hospital in Southern Italy (edit) |
10.1155/2021/3893733 |
| 2021-09-10 |
Probenecid inhibits SARS-CoV-2 replication in vivo and in vitro (edit) |
10.1038/S41598-021-97658-W |
| 2021-09-10 |
Estimating the impact of reopening schools on the reproduction number of SARS-CoV-2 in England, using weekly contact survey data (edit) |
10.1186/S12916-021-02107-0 |
| 2021-09-10 |
Genomics-guided targeting of stress granule proteins G3BP1/2 to inhibit SARS-CoV-2 propagation (edit) |
10.1016/J.IJBIOMAC.2021.09.018 |
| 2021-09-10 |
Monitoring SARS-CoV-2 in sewage: Toward sentinels with analytical accuracy (edit) |
10.1016/J.SCITOTENV.2021.150244 |
| 2021-09-10 |
Immunological and pathological outcomes of SARS-CoV-2 challenge following formalin-inactivated vaccine in ferrets and rhesus macaques (edit) |
10.1126/SCIADV.ABG7996 |
| 2021-09-10 |
Pan-3C Protease Inhibitor Rupintrivir Binds SARS-CoV-2 Main Protease in a Unique Binding Mode (edit) |
10.1021/ACS.BIOCHEM.1C00414 |
| 2021-09-09 |
Interleukin-1RA Mitigates SARS-CoV-2–Induced Inflammatory Lung Vascular Leakage and Mortality in Humanized K18-hACE-2 Mice (edit) |
10.1161/ATVBAHA.121.316925 |
| 2021-09-09 |
Characterization of a Novel ACE2-Based Therapeutic with Enhanced Rather than Reduced Activity against SARS-CoV-2 Variants (edit) |
10.1128/JVI.00685-21 |
| 2021-09-09 |
Sequences in the cytoplasmic tail of SARS-CoV-2 Spike facilitate expression at the cell surface and syncytia formation (edit) |
10.1038/S41467-021-25589-1 |
| 2021-09-09 |
Seasonal coronavirus-specific B-cells with limited SARS-CoV-2 cross-reactivity dominate the IgG response in severe COVID-19 patients (edit) |
10.1172/JCI150613 |
| 2021-09-09 |
Identifying FDA-approved drugs with multimodal properties against COVID-19 using a data-driven approach and a lung organoid model of SARS-CoV-2 entry (edit) |
10.1186/S10020-021-00356-6 |
| 2021-09-09 |
Machine Learning augmented docking studies of aminothioureas at the SARS-CoV-2-ACE2 interface (edit) |
10.1371/JOURNAL.PONE.0256834 |
| 2021-09-09 |
Infection with SARS-CoV-2 primes immunological memory in human nasal-associated lymphoid tissue (edit) |
10.1016/J.CLIM.2021.108850 |
| 2021-09-08 |
A molecular sensor determines the ubiquitin substrate specificity of SARS-CoV-2 papain-like protease (edit) |
10.1016/J.CELREP.2021.109754 |
| 2021-09-08 |
Structure of SARS-CoV-2 spike protein (edit) |
10.1016/J.COVIRO.2021.08.010 |
| 2021-09-08 |
Interactome Analysis of the Nucleocapsid Protein of SARS-CoV-2 Virus (edit) |
10.3390/PATHOGENS10091155 |
| 2021-09-08 |
SARS-CoV-2 expresses a microRNA-like small RNA able to selectively repress host genes (edit) |
10.1101/2021.09.08.459464 |
| 2021-09-08 |
Identification of SARS-CoV-2 RNA-dependent RNA polymerase inhibitors from the major phytochemicals of Nigella sativa: An in silico approach (edit) |
10.1016/J.SJBS.2021.09.002 |
| 2021-09-08 |
Complete Analysis of the Epidemiological Scenario around a SARS-CoV-2 Reinfection: Previous Infection Events and Subsequent Transmission (edit) |
10.1128/MSPHERE.00596-21 |
| 2021-09-08 |
A universal bacteriophage T4 nanoparticle platform to design multiplex SARS-CoV-2 vaccine candidates by CRISPR engineering (edit) |
10.1126/SCIADV.ABH1547 |
| 2021-09-08 |
The dual role of phytochemicals on SARS-CoV-2 inhibition by targeting host and viral proteins (edit) |
10.1016/J.JTCME.2021.09.001 |
| 2021-09-08 |
In vitro efficacy of Artemisia extracts against SARS-CoV-2 (edit) |
10.1186/S12985-021-01651-8 |
| 2021-09-08 |
Advancements in detection of SARS-CoV-2 infection for confronting COVID-19 pandemics (edit) |
10.1038/S41374-021-00663-W |
| 2021-09-08 |
SARS-CoV-2, Trait Anxiety, and the Microbiome (edit) |
10.3389/FPSYT.2021.720082 |
| 2021-09-07 |
Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19 (edit) |
10.1073/PNAS.2105815118 |
| 2021-09-07 |
SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma (edit) |
10.1073/PNAS.2103154118 |
| 2021-09-07 |
Evaluation of Capillary Blood Gases in Medical Personnel Caring for Patients Isolated Due to SARS-CoV-2 in Intensive Care Units before and after Using Enhanced Filtration Masks: A Prospective Cohort Study (edit) |
10.3390/IJERPH18189425 |
| 2021-09-07 |
Structural and energetic profiling of SARS-CoV-2 receptor binding domain antibody recognition and the impact of circulating variants (edit) |
10.1371/JOURNAL.PCBI.1009380 |
| 2021-09-07 |
Dynamics of SARS-CoV-2 mutations reveals regional-specificity and similar trends of N501 and high-frequency mutation N501Y in different levels of control measures (edit) |
10.1038/S41598-021-97267-7 |
| 2021-09-07 |
Outbreaks of SARS-CoV-2 in naturally infected mink farms: Impact, transmission dynamics, genetic patterns, and environmental contamination (edit) |
10.1371/JOURNAL.PPAT.1009883 |
| 2021-09-07 |
Role of Poly(ADP-ribose) Polymerase (PARP1) in Viral Infection and its Implication in SARS-CoV-2 Pathogenesis (edit) |
10.2174/1389450122666210120142746 |
| 2021-09-06 |
Deamidation drives molecular aging of the SARS-CoV-2 spike protein receptor-binding motif (edit) |
10.1016/J.JBC.2021.101175 |
| 2021-09-06 |
SARS-CoV-2 crosses the blood-brain barrier accompanied with basement membrane disruption without tight junctions alteration (edit) |
10.1038/S41392-021-00719-9 |
| 2021-09-06 |
Emotional Control among Nurses against Work Conditions and the Support Received during the SARS-CoV-2 Pandemic (edit) |
10.3390/IJERPH18179415 |
| 2021-09-06 |
Modelling the active SARS-CoV-2 helicase complex as a basis for structure-based inhibitor design (edit) |
10.1039/D1SC02775A |
| 2021-09-06 |
In silico prediction of natural compounds as potential multi-target inhibitors of structural proteins of SARS-CoV-2 (edit) |
10.1080/07391102.2021.1968497 |
| 2021-09-06 |
Featuring ACE2 binding SARS-CoV and SARS-CoV-2 through a conserved evolutionary pattern of amino acid residues (edit) |
10.1080/07391102.2021.1965028 |
| 2021-09-05 |
Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant (edit) |
10.1101/2021.08.12.456173 |
| 2021-09-05 |
How Informative Were Early SARS-CoV-2 Treatment and Prevention Trials? A longitudinal cohort analysis of trials registered on clinicaltrials.gov (edit) |
10.1101/2021.08.25.21262155 |
| 2021-09-05 |
Genome-scale metabolic modelling of SARS-CoV-2 in cancer cells reveals an increased shift to glycolytic energy production (edit) |
10.1002/1873-3468.14180 |
| 2021-09-04 |
Analysis of Intermediate Hosts and Susceptible Animals of SARS-CoV-2 by Computational Methods (edit) |
10.15212/ZOONOSES-2021-0010 |
| 2021-09-04 |
The dominant strain of SARS-CoV-2 is a mosaicism (edit) |
10.1016/J.VIRUSRES.2021.198553 |
| 2021-09-04 |
The epidemiology of hospital inpatient exposure to SARS-CoV-2: A cohort study (edit) |
10.1016/J.INFPIP.2021.100173 |
| 2021-09-04 |
Evolution of viral variants in remdesivir-treated and untreated SARS-CoV-2-infected pediatrics patients (edit) |
10.1002/JMV.27285 |
| 2021-09-04 |
Exploration of In-silico screening of therapeutic agents against SARS-CoV-2 (edit) |
10.1016/J.CHEMPHYS.2021.111354 |
| 2021-09-03 |
Ethacridine inhibits SARS-CoV-2 by inactivating viral particles (edit) |
10.1371/JOURNAL.PPAT.1009898 |
| 2021-09-03 |
Inhibition of SARS-CoV-2 infection by human defensin HNP1 and retrocyclin RC-101 (edit) |
10.1016/J.JMB.2021.167225 |
| 2021-09-03 |
SARS-CoV-2 3C-like protease antagonizes interferon-beta production by facilitating the degradation of IRF3 (edit) |
10.1016/J.CYTO.2021.155697 |
| 2021-09-03 |
Understanding the Barriers to Pooled SARS-CoV-2 Testing in the United States (edit) |
10.1128/SPECTRUM.00312-21 |
| 2021-09-03 |
SARS-CoV-2 Initiates Programmed Cell Death in Platelets (edit) |
10.1161/CIRCRESAHA.121.319117 |
| 2021-09-03 |
Refining the N-Termini of the SARS-CoV-2 Spike Protein and Its Discrete Receptor-Binding Domain (edit) |
10.1021/ACS.JPROTEOME.1C00349 |
| 2021-09-03 |
Comprehensive landscape of the renin-angiotensin system in Pan-cancer: a potential downstream mediated mechanism of SARS-CoV-2 (edit) |
10.7150/IJBS.53312 |
| 2021-09-03 |
Computational insights into the membrane fusion mechanism of SARS-CoV-2 at the cellular level (edit) |
10.1016/J.CSBJ.2021.08.053 |
| 2021-09-03 |
A Proposed Functional Analysis of Transmission Prevention Behaviors for a Respiratory Virus (SARS-CoV-2) (edit) |
10.1007/S42822-021-00055-1 |
| 2021-09-02 |
Comparative phylogenetic analysis of SARS-CoV-2 spike protein-possibility effect on virus spillover (edit) |
10.1093/BIB/BBAB144 |
| 2021-09-02 |
High seroprevalence of SARS-CoV-2 but low infection fatality ratio eight months after introduction in Nairobi, Kenya (edit) |
10.1016/J.IJID.2021.08.062 |
| 2021-09-02 |
Effectiveness of an Inactivated SARS-CoV-2 Vaccine (edit) |
10.1056/NEJME2111165 |
| 2021-09-02 |
SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19 (edit) |
10.1002/14651858.CD013825.PUB2 |
| 2021-09-02 |
Self-collection and pooling of samples as resources-saving strategies for RT-PCR-based SARS-CoV-2 surveillance, the example of travelers in French Polynesia (edit) |
10.1371/JOURNAL.PONE.0256877 |
| 2021-09-02 |
Activation Pathways and Free Energy Landscapes of the SARS-CoV-2 Spike Protein (edit) |
10.1021/ACSOMEGA.1C03384 |
| 2021-09-02 |
Predicted pH-dependent stability of SARS-CoV-2 spike protein trimer from interfacial acidic groups (edit) |
10.1016/J.CSBJ.2021.08.049 |
| 2021-09-02 |
Potential Achilles heels of SARS-CoV-2 are best displayed by the base order-dependent component of RNA folding energy (edit) |
10.1016/J.COMPBIOLCHEM.2021.107570 |
| 2021-09-02 |
Modeling transmission dynamics and effectiveness of worker screening programs for SARS-CoV-2 in pork processing plants (edit) |
10.1371/JOURNAL.PONE.0249143 |
| 2021-09-01 |
Cellular host factors for SARS-CoV-2 infection (edit) |
10.1038/S41564-021-00958-0 |
| 2021-09-01 |
A dual-role of SARS-CoV-2 nucleocapsid protein in regulating innate immune response (edit) |
10.1038/S41392-021-00742-W |
| 2021-09-01 |
Lipid-based therapies against SARS-CoV-2 infection (edit) |
10.1002/RMV.2214 |
| 2021-09-01 |
Antimicrobial Face Shield: Next Generation of Facial Protective Equipment against SARS-CoV-2 and Multidrug-Resistant Bacteria (edit) |
10.3390/IJMS22179518 |
| 2021-09-01 |
Anosmia, ageusia, and other COVID-19-like symptoms in association with a positive SARS-CoV-2 test, across six national digital surveillance platforms: an observational study (edit) |
10.1016/S2589-7500(21)00115-1 |
| 2021-09-01 |
Prevalence of SARS-CoV-2 IgG antibodies and their association with clinical symptoms of COVID-19 in Estonia (KoroSero-EST-1 study) (edit) |
10.1016/J.VACCINE.2021.07.093 |
| 2021-09-01 |
SARS-CoV-2 on Ocular Surfaces in a Cohort of Patients With COVID-19 From the Lombardy Region, Italy (edit) |
10.1001/JAMAOPHTHALMOL.2020.5464 |
| 2021-09-01 |
Zoonotic and Reverse Zoonotic Transmissibility of SARS-CoV-2 (edit) |
10.1016/J.VIRUSRES.2021.198473 |
| 2021-09-01 |
Association of CXCR6 with COVID-19 severity: delineating the host genetic factors in transcriptomic regulation (edit) |
10.1007/S00439-021-02305-Z |
| 2021-09-01 |
Comparison of approaches to quantify SARS-CoV-2 in wastewater using RT-qPCR: Results and implications from a collaborative inter-laboratory study in Canada (edit) |
10.1016/J.JES.2021.01.029 |
| 2021-09-01 |
Granulomatous vasculitis after the AstraZeneca anti–SARS-CoV-2 vaccine (edit) |
10.1016/J.KINT.2021.06.033 |
| 2021-09-01 |
A human three-dimensional neural-perivascular 'assembloid' promotes astrocytic development and enables modeling of SARS-CoV-2 neuropathology (edit) |
10.1038/S41591-021-01443-1 |
| 2021-09-01 |
Upregulation of pulmonary tissue factor, loss of thrombomodulin and immunothrombosis in SARS-CoV-2 infection (edit) |
10.1016/J.ECLINM.2021.101069 |
| 2021-09-01 |
Identification and evaluation of potential SARS-CoV-2 antiviral agents targeting mRNA cap guanine N7-Methyltransferase (edit) |
10.1016/J.ANTIVIRAL.2021.105142 |
| 2021-09-01 |
Pro-inflammatory microenvironment and systemic accumulation of CXCR3+ cell exacerbate lung pathology of old rhesus macaques infected with SARS-CoV-2 (edit) |
10.1038/S41392-021-00734-W |
| 2021-09-01 |
Development of a high-sensitivity ELISA detecting IgG, IgA and IgM antibodies to the SARS-CoV-2 spike glycoprotein in serum and saliva (edit) |
10.1111/IMM.13349 |
| 2021-09-01 |
The SARS-CoV-2 Nsp3 macrodomain reverses PARP9/DTX3L-dependent ADP-ribosylation induced by interferon signaling (edit) |
10.1016/J.JBC.2021.101041 |
| 2021-09-01 |
The impact of spike N501Y mutation on neutralizing activity and RBD binding of SARS-CoV-2 convalescent serum (edit) |
10.1016/J.EBIOM.2021.103544 |
| 2021-09-01 |
Human Kidney Spheroids and Monolayers Provide Insights into SARS-CoV-2 Renal Interactions (edit) |
10.1681/ASN.2020111546 |
| 2021-09-01 |
Changing composition of SARS-CoV-2 lineages and rise of Delta variant in England (edit) |
10.1016/J.ECLINM.2021.101064 |
| 2021-09-01 |
Targeting neuropilins as a viable SARS-CoV-2 treatment (edit) |
10.1111/FEBS.16096 |
| 2021-09-01 |
Spike protein of SARS-CoV-2 activates macrophages and contributes to induction of acute lung inflammation in male mice (edit) |
10.1096/FJ.202002742RR |
| 2021-09-01 |
Manipulation of autophagy by SARS-CoV-2 proteins (edit) |
10.1080/15548627.2021.1953847 |
| 2021-09-01 |
Loop-Mediated Isothermal Amplification Detection of SARS-CoV-2 and Myriad Other Applications (edit) |
10.7171/JBT.21-3203-017 |
| 2021-09-01 |
SARS-CoV-2 Wastewater Surveillance for Public Health Action (edit) |
10.3201/EID2709.210753 |
| 2021-09-01 |
The rapid adaptation of SARS-CoV-2-rise of the variants: transmission and resistance (edit) |
10.1007/S12275-021-1348-5 |
| 2021-09-01 |
Distinct systemic and mucosal immune responses during acute SARS-CoV-2 infection (edit) |
10.1038/S41590-021-01028-7 |
| 2021-09-01 |
Bioinformatics analysis of SARS-CoV-2 infection-associated immune injury and therapeutic prediction for COVID-19 (edit) |
|
| 2021-09-01 |
Investigating the possible origin and transmission routes of SARS-CoV-2 genomes and variants of concern in Bangladesh (edit) |
10.1016/J.MEEGID.2021.105057 |
| 2021-09-01 |
SARS-CoV-2 N-antigenemia in critically ill adult COVID-19 patients: Frequency and association with inflammatory and tissue-damage biomarkers (edit) |
10.1002/JMV.27300 |
| 2021-09-01 |
Molecular Docking and ADMET Prediction of Natural Compounds towards SARS Spike Glycoprotein-Human Angiotensin-Converting Enzyme 2 and SARS-CoV-2 Main Protease (edit) |
10.22092/ARI.2020.351202.1517 |
| 2021-09-01 |
SARS-CoV-2 Spike Protein Mutations and Escape from Antibodies: A Computational Model of Epitope Loss in Variants of Concern (edit) |
10.1021/ACS.JCIM.1C00857 |
| 2021-09-01 |
SARS-CoV-2 Serology Status Detected by Commercialized Platforms Distinguishes Previous Infection and Vaccination Adaptive Immune Responses (edit) |
10.1093/JALM/JFAB080 |
| 2021-09-01 |
Network-Based Identification and Experimental Validation of Drug Candidates Toward SARS-CoV-2 via Targeting Virus-Host Interactome (edit) |
10.3389/FGENE.2021.728960 |
| 2021-09-01 |
Direct detection of SARS-CoV-2 RNA using high-contrast pH-sensitive dyes (edit) |
10.7171/JBT.21-3203-007 |
| 2021-09-01 |
Alterations in the Plasma Proteome Induced by SARS-CoV-2 and MERS-CoV Reveal Biomarkers for Disease Outcomes for COVID-19 Patients (edit) |
10.2147/JIR.S322430 |
| 2021-09-01 |
Antihypertensive drug treatment and susceptibility to SARS-CoV-2 infection in human PSC-derived cardiomyocytes and primary endothelial cells (edit) |
10.1016/J.STEMCR.2021.08.018 |
| 2021-09-01 |
Single-cell RNA sequencing of SARS-CoV-2 cell entry factors in the preconceptional human endometrium (edit) |
10.1093/HUMREP/DEAB183 |
| 2021-09-01 |
Viral Sequencing to Investigate Sources of SARS-CoV-2 Infection in US Healthcare Personnel (edit) |
10.1093/CID/CIAB281 |
| 2021-09-01 |
Is Environmental Pollen Concentration a Risk Factor for SARS-CoV-2 Infection? (edit) |
10.18176/JIACI.0743 |
| 2021-09-01 |
Approximative He Hamiltonian in descriptive multidimensional scaling statistics of RNA contained information with application to SARS-CoV-2 Spike mRNA and 7SLRNA, RN7SL2 and RN7SL3 (edit) |
10.1016/J.GENREP.2021.101203 |
| 2021-09-01 |
An observational study of a cohort of citizens receiving the AZD1222 vaccine against SARS-CoV-2 (edit) |
10.2144/FSOA-2021-0064 |
| 2021-09-01 |
Citizen volunteers detect SARS-CoV-2 RNA from outdoor urban fomites (edit) |
10.1016/J.SCITOTENV.2021.147719 |
| 2021-09-01 |
Vaccinations in Patients Receiving Systemic Drugs for Skin Disorders: What Can We Learn for SARS-Cov-2 Vaccination Strategies? (edit) |
10.1007/S40268-021-00349-0 |
| 2021-09-01 |
The Relationship Between GI symptoms, State and Trait Anxiety, and Lifestyle Factors in Males and Females During the SARS-CoV-2 Pandemic (edit) |
10.1016/J.JAND.2021.06.101 |
| 2021-09-01 |
The emergence of novel SARS-CoV-2 variant P.1 in Amazonas (Brazil) was temporally associated with a change in the age and sex profile of COVID-19 mortality: A population based ecological study (edit) |
10.1016/J.LANA.2021.100021 |
| 2021-09-01 |
Wastewater monitoring as a supplementary surveillance tool for capturing SARS-COV-2 community spread. A case study in two Greek municipalities (edit) |
10.1016/J.ENVRES.2021.111749 |
| 2021-09-01 |
SARS-CoV-2 serology: Validation of high-throughput chemiluminescent immunoassay (CLIA) platforms and a field study in British Columbia (edit) |
10.1016/J.JCV.2021.104914 |
| 2021-09-01 |
A scoping review of the experience of implementing population testing for SARS-CoV-2 (edit) |
10.1016/J.PUHE.2021.06.012 |
| 2021-09-01 |
Preparing for the next pandemic: Lessons from rapid scale-up of SARS-CoV-2 testing in a South African high-throughput automated HIV molecular laboratory (edit) |
10.1016/J.IJID.2021.06.019 |
| 2021-08-31 |
Genome-wide association study of COVID-19 severity among the Chinese population (edit) |
10.1038/S41421-021-00318-6 |
| 2021-08-31 |
Mechanical activation of spike fosters SARS-CoV-2 viral infection (edit) |
10.1038/S41422-021-00558-X |
| 2021-08-31 |
Trans-ethnic genome-wide association study of severe COVID-19 (edit) |
10.1038/S42003-021-02549-5 |
| 2021-08-31 |
Impact of temperature on the affinity of SARS-CoV-2 Spike glycoprotein for host ACE2 (edit) |
10.1016/J.JBC.2021.101151 |
| 2021-08-31 |
Non-Coding RNAs in COVID-19: Emerging Insights and Current Questions (edit) |
10.3390/NCRNA7030054 |
| 2021-08-31 |
Dynamics of SARS-CoV-2 Spike Proteins in Cell Entry: Control Elements in the Amino-Terminal Domains (edit) |
10.1128/MBIO.01590-21 |
| 2021-08-31 |
SARS-CoV-2 Lambda Variant: Spatiotemporal Distribution and Potential Public Health Impact (edit) |
10.15212/ZOONOSES-2021-0009 |
| 2021-08-31 |
Methyltransferase-like 3 Modulates Severe Acute Respiratory Syndrome Coronavirus-2 RNA N6-Methyladenosine Modification and Replication (edit) |
10.1128/MBIO.01067-21 |
| 2021-08-31 |
The nucleotide addition cycle of the SARS-CoV-2 polymerase (edit) |
10.1016/J.CELREP.2021.109650 |
| 2021-08-31 |
Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies (edit) |
10.1038/S41586-021-03925-1 |
| 2021-08-31 |
D614G Substitution of SARS-CoV-2 Spike Protein Increases Syncytium Formation and Virus Titer via Enhanced Furin-Mediated Spike Cleavage (edit) |
10.1128/MBIO.00587-21 |
| 2021-08-31 |
Evolution, Mode of Transmission, and Mutational Landscape of Newly Emerging SARS-CoV-2 Variants (edit) |
10.1128/MBIO.01140-21 |
| 2021-08-31 |
The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19 (edit) |
10.1128/MBIO.00970-21 |
| 2021-08-31 |
Associations of SARS-CoV-2 serum IgG with occupation and demographics of military personnel (edit) |
10.1371/JOURNAL.PONE.0251114 |
| 2021-08-31 |
Higher entropy observed in SARS-CoV-2 genomes from the first COVID-19 wave in Pakistan (edit) |
10.1371/JOURNAL.PONE.0256451 |
| 2021-08-31 |
Origin of imported SARS-CoV-2 strains in The Gambia identified from whole genome sequences (edit) |
10.1371/JOURNAL.PONE.0241942 |
| 2021-08-31 |
The Clinical Impact and Cost Effectiveness of Intervention Policies Against the SARS-CoV-2 Pandemic: A Mathematical Modelling Analysis (edit) |
10.2139/SSRN.3911364 |
| 2021-08-31 |
Sterically confined rearrangements of SARS-CoV-2 Spike protein control cell invasion (edit) |
10.7554/ELIFE.70362 |
| 2021-08-31 |
Correction for Benton et al., The effect of the D614G substitution on the structure of the spike glycoprotein of SARS-CoV-2 (edit) |
10.1073/PNAS.2112850118 |
| 2021-08-30 |
Substrate Specificity of SARS-CoV-2 Nsp10-Nsp16 Methyltransferase (edit) |
10.3390/V13091722 |
| 2021-08-30 |
Epidemiology, virology, clinical features, diagnosis, and treatment of SARS-CoV-2 infection (edit) |
10.52142/OMUJECM.38.4.44 |
| 2021-08-30 |
In silico drug repositioning against human NRP1 to block SARS-CoV-2 host entry (edit) |
10.3906/BIY-2012-52 |
| 2021-08-30 |
Genomic chronicle of SARS-CoV-2: a mutational analysis with over 1 million genome sequences (edit) |
10.3906/BIY-2106-8 |
| 2021-08-30 |
Epigallocatechin gallate from green tea effectively blocks infection of SARS-CoV-2 and new variants by inhibiting spike binding to ACE2 receptor (edit) |
10.1186/S13578-021-00680-8 |
| 2021-08-30 |
SARS-CoV-2: Origin, Intermediate Host and Allergenicity Features and Hypotheses (edit) |
10.3390/HEALTHCARE9091132 |
| 2021-08-28 |
Assessing the extent of community spread caused by mink-derived SARS-CoV-2 variants (edit) |
10.1016/J.XINN.2021.100128 |
| 2021-08-28 |
Discovering potential inhibitors against SARS-CoV-2 by targeting Nsp13 Helicase (edit) |
10.1080/07391102.2021.1970024 |
| 2021-08-28 |
Diagnostic performance of a colorimetric RT -LAMP for the identification of SARS-CoV-2: A multicenter prospective clinical evaluation in sub-Saharan Africa (edit) |
10.1016/J.ECLINM.2021.101101 |
| 2021-08-28 |
Ultrasensitive Detection of Dopamine, IL-6 and SARS-CoV-2 Proteins on Crumpled Graphene FET Biosensor (edit) |
10.1002/ADMT.202100712 |
| 2021-08-28 |
SARS-CoV-2 infection of the central nervous system in a 14-month-old child: A case report of a complete autopsy (edit) |
10.1016/J.LANA.2021.100046 |
| 2021-08-28 |
In silico study of some selective phytochemicals against a hypothetical SARS-CoV-2 spike RBD using molecular docking tools (edit) |
10.1016/J.COMPBIOMED.2021.104818 |
| 2021-08-28 |
Development of a Web GIS for small-scale detection and analysis of COVID-19 (SARS-CoV-2) cases based on volunteered geographic information for the city of Cologne, Germany, in July/August 2020 (edit) |
10.1186/S12942-021-00290-0 |
| 2021-08-28 |
Receptor-binding domain of SARS-CoV-2 spike protein efficiently inhibits SARS-CoV-2 infection and attachment to mouse lung (edit) |
10.7150/IJBS.61320 |
| 2021-08-28 |
In-silico immunoinformatic analysis of SARS-CoV-2 virus for the development of putative vaccine construct (edit) |
10.1016/J.IMBIO.2021.152134 |
| 2021-08-28 |
Repurposable drugs for SARS-CoV-2 and influenza sepsis with scRNA-seq data targeting post-transcription modifications (edit) |
10.1093/PCMEDI/PBAB022 |
| 2021-08-28 |
SARS-CoV-2 in residential rooms of two self-isolating persons with COVID-19 (edit) |
10.1016/J.JAEROSCI.2021.105870 |
| 2021-08-27 |
Host ADP-ribosylation and the SARS-CoV-2 macrodomain (edit) |
10.1042/BST20201212 |
| 2021-08-27 |
SARS-CoV-2 spike promotes inflammation and apoptosis through autophagy by ROS-suppressed PI3K/AKT/mTOR signaling (edit) |
10.1016/J.BBADIS.2021.166260 |
| 2021-08-27 |
Anti-clustering in the national SARS-CoV-2 daily infection counts (edit) |
10.7717/PEERJ.11856 |
| 2021-08-27 |
Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study (edit) |
10.1016/S1473-3099(21)00475-8 |
| 2021-08-27 |
Designing Short Peptides to Block the Interaction of SARS-CoV-2 and Human ACE2 for COVID-19 Therapeutics (edit) |
10.3389/FPHAR.2021.731828 |
| 2021-08-27 |
Profiling CD8+ T cell epitopes of COVID-19 convalescents reveals reduced cellular immune responses to SARS-CoV-2 variants (edit) |
10.1016/J.CELREP.2021.109708 |
| 2021-08-27 |
A Dedicated SARS-CoV-2 Testing Center for Public Service Agency Personnel: Implementation, Results, and Impact on Human Resources (edit) |
10.1080/10903127.2021.1973627 |
| 2021-08-26 |
Recognition of Divergent Viral Substrates by the SARS-CoV-2 Main Protease (edit) |
10.1021/ACSINFECDIS.1C00237 |
| 2021-08-26 |
5α-Reductase Inhibitors are Associated with Reduced Risk of SARS-COV-2 Infection: A Matched-Pair, Registry-Based Analysis (edit) |
10.1097/JU.0000000000002180 |
| 2021-08-26 |
Phosphorylation of SARS-CoV-2 Orf9b Regulates Its Targeting to Two Binding Sites in TOM70 and Recruitment of Hsp90 (edit) |
10.3390/IJMS22179233 |
| 2021-08-26 |
Seroprevalence and risk factors of SARS-CoV-2 infection in an urban informal settlement in Nairobi, Kenya, December 2020 (edit) |
10.12688/F1000RESEARCH.72914.1 |
| 2021-08-26 |
Investigation of Interaction between the Spike Protein of SARS-CoV-2 and ACE2-Expressing Cells Using an In Vitro Cell Capturing System (edit) |
10.1186/S12575-021-00153-9 |
| 2021-08-26 |
Ivermectin as a SARS-CoV-2 Pre-Exposure Prophylaxis Method in Healthcare Workers: A Propensity Score-Matched Retrospective Cohort Study (edit) |
10.7759/CUREUS.17455 |
| 2021-08-26 |
Neutralization of SARS-CoV-2 variants by convalescent and BNT162b2 vaccinated serum (edit) |
10.1038/S41467-021-25479-6 |
| 2021-08-26 |
A Remote Control System for Emergency Ventilators During SARS-CoV-2 (edit) |
10.1109/LES.2021.3107837 |
| 2021-08-25 |
A high-resolution temporal atlas of the SARS-CoV-2 translatome and transcriptome (edit) |
10.1038/S41467-021-25361-5 |
| 2021-08-25 |
Comprehensive mapping of SARS-CoV-2 interactions in vivo reveals functional virus-host interactions (edit) |
10.1038/S41467-021-25357-1 |
| 2021-08-25 |
SARS-CoV-2 Membrane Glycoprotein M Triggers Apoptosis With the Assistance of Nucleocapsid Protein N in Cells (edit) |
10.3389/FCIMB.2021.706252 |
| 2021-08-25 |
Distinct weather conditions and human mobility impacts on the SARS-CoV-2 outbreak in Colombia: Application of an artificial neural network approach (edit) |
10.1016/J.IJHEH.2021.113833 |
| 2021-08-25 |
Oligonucleotide capture sequencing of the SARS-CoV-2 genome and subgenomic fragments from COVID-19 individuals (edit) |
10.1371/JOURNAL.PONE.0244468 |
| 2021-08-25 |
Sex Disparities and Neutralizing-Antibody Durability to SARS-CoV-2 Infection in Convalescent Individuals (edit) |
10.1128/MSPHERE.00275-21 |
| 2021-08-25 |
In silico molecular docking of SARS-CoV-2 surface proteins with microbial non-ribosomal peptides: identification of potential drugs (edit) |
10.1007/S42485-021-00072-Z |
| 2021-08-25 |
The low contagiousness and new A958D mutation of SARS-CoV-2 in children: An observational cohort study (edit) |
10.1016/J.IJID.2021.08.036 |
| 2021-08-25 |
Extraction-Free Rapid Cycle Quantitative RT-PCR and Extreme RT-PCR for SARS-CoV-2 Virus Detection (edit) |
10.1016/J.JMOLDX.2021.08.004 |
| 2021-08-25 |
Spatial scales, patterns, and positivity trends of SARS-CoV-2 pandemics in mass rapid antigen testing in Slovakia (edit) |
10.1371/JOURNAL.PONE.0256669 |
| 2021-08-25 |
Preliminary Findings on the Association of the Lipid Peroxidation Product 4-Hydroxynonenal with the Lethal Outcome of Aggressive COVID-19 (edit) |
10.3390/ANTIOX10091341 |
| 2021-08-25 |
Molecular Pathology Demonstration of SARS-CoV-2 in Cytotrophoblast from Placental Tissue with Chronic Histiocytic Intervillositis, Trophoblast Necrosis and COVID-19 (edit) |
10.3390/JDB9030033 |
| 2021-08-24 |
Autoimmune Complications of COVID‐19 (edit) |
10.1002/JMV.27292 |
| 2021-08-24 |
Critically ill COVID-19 patients exhibit hyperactive cytokine responses associated with effector exhausted senescent T cells in acute infection (edit) |
10.1093/INFDIS/JIAB425 |
| 2021-08-24 |
Pyroptosis of syncytia formed by fusion of SARS-CoV-2 spike and ACE2-expressing cells (edit) |
10.1038/S41421-021-00310-0 |
| 2021-08-24 |
Targeted in situ cross-linking mass spectrometry and integrative modeling reveal the architectures of three proteins from SARS-CoV-2 (edit) |
10.1073/PNAS.2103554118 |
| 2021-08-24 |
Binding of boswellic acids to functional proteins of the SARS-CoV-2 virus: Bioinformatic studies (edit) |
10.1002/ARDP.202100160 |
| 2021-08-24 |
A SARS-CoV-2 antibody broadly neutralizes SARS-related coronaviruses and variants by coordinated recognition of a virus-vulnerable site (edit) |
10.1016/J.IMMUNI.2021.08.025 |
| 2021-08-24 |
A next generation sequencing (NGS) analysis to reveal genomic and proteomic mutation landscapes of SARS-CoV-2 in South Asia (edit) |
10.1016/J.CRMICR.2021.100065 |
| 2021-08-23 |
Integrative approach identifies SLC6A20 and CXCR6 as putative causal genes for the COVID-19 GWAS signal in the 3p21.31 locus (edit) |
10.1186/S13059-021-02454-4 |
| 2021-08-23 |
Cryo-EM and antisense targeting of the 28-kDa frameshift stimulation element from the SARS-CoV-2 RNA genome (edit) |
10.1038/S41594-021-00653-Y |
| 2021-08-23 |
Multiple Roles of SARS-CoV-2 N Protein Facilitated by Proteoform-Specific Interactions with RNA, Host Proteins, and Convalescent Antibodies (edit) |
10.1021/JACSAU.1C00139 |
| 2021-08-23 |
Model-based assessment of SARS-CoV-2 Delta variant transmission dynamics within partially vaccinated K-12 school populations (edit) |
10.1101/2021.08.20.21262389 |
| 2021-08-23 |
Revelation of Potent Epitopes Present in Unannotated ORF Antigens of SARS-CoV-2 for Epitope-Based Polyvalent Vaccine Design Using Immunoinformatics Approach (edit) |
10.3389/FIMMU.2021.692937 |
| 2021-08-23 |
Potential bioactive compounds as SARS-CoV-2 inhibitors from extracts of the marine red alga Halymenia durvillei (Rhodophyta) - A computational study (edit) |
10.1016/J.ARABJC.2021.103393 |
| 2021-08-23 |
Acute SARS-CoV-2 infections harbor limited within-host diversity and transmit via tight transmission bottlenecks (edit) |
10.1371/JOURNAL.PPAT.1009849 |
| 2021-08-22 |
Cell-Free Hemoglobin Does Not Attenuate the Effects of SARS-CoV-2 Spike Protein S1 Subunit in Pulmonary Endothelial Cells (edit) |
10.3390/IJMS22169041 |
| 2021-08-21 |
SARS-CoV-2 Proteins Bind to Hemoglobin and Its Metabolites (edit) |
10.3390/IJMS22169035 |
| 2021-08-21 |
Characterization of SARS-CoV-2 worldwide transmission based on evolutionary dynamics and specific viral mutations in the spike protein (edit) |
10.1186/S40249-021-00895-4 |
| 2021-08-21 |
Nasopharyngeal microbiome reveals the prevalence of opportunistic pathogens in SARS-CoV-2 infected individuals and their association with host types (edit) |
10.1016/J.MICINF.2021.104880 |
| 2021-08-21 |
Human small intestinal infection by SARS-CoV-2 is characterized by a mucosal infiltration with activated CD8+ T cells (edit) |
10.1038/S41385-021-00437-Z |
| 2021-08-21 |
HLA repertoire of 115 UAE nationals infected with SARS-CoV-2 (edit) |
10.1016/J.HUMIMM.2021.08.012 |
| 2021-08-21 |
Molecular characterization of SARS-CoV-2 from Bangladesh: implications in genetic diversity, possible origin of the virus, and functional significance of the mutations (edit) |
10.1016/J.HELIYON.2021.E07866 |
| 2021-08-20 |
mRNA-1273 protects against SARS-CoV-2 beta infection in nonhuman primates (edit) |
10.1038/S41590-021-01021-0 |
| 2021-08-20 |
Genome-wide CRISPR activation screen identifies candidate receptors for SARS-CoV-2 entry (edit) |
10.1007/S11427-021-1990-5 |
| 2021-08-20 |
N501Y mutation of spike protein in SARS-CoV-2 strengthens its binding to receptor ACE2 (edit) |
10.7554/ELIFE.69091 |
| 2021-08-20 |
Low SARS-CoV-2 seroprevalence but high perception of risk among healthcare workers at children's hospital before second pandemic wave in Germany (edit) |
10.1007/S12519-021-00447-8 |
| 2021-08-20 |
Severe SARS-CoV-2 Breakthrough Reinfection With Delta Variant After Recovery From Breakthrough Infection by Alpha Variant in a Fully Vaccinated Health Worker (edit) |
10.3389/FMED.2021.737007 |
| 2021-08-20 |
Enumerating asymptomatic COVID-19 cases and estimating SARS-CoV-2 fecal shedding rates via wastewater-based epidemiology (edit) |
10.1016/J.SCITOTENV.2021.149794 |
| 2021-08-20 |
Generation of a Novel SARS-CoV-2 Sub-genomic RNA Due to the R203K/G204R Variant in Nucleocapsid: Homologous Recombination has Potential to Change SARS-CoV-2 at Both Protein and RNA Level (edit) |
10.20411/PAI.V6I2.460 |
| 2021-08-20 |
CovidPhy: A tool for phylogeographic analysis of SARS-CoV-2 variation (edit) |
10.1016/J.ENVRES.2021.111909 |
| 2021-08-20 |
Epitope diversity of SARS-CoV-2 hyperimmune intravenous human immunoglobulins and neutralization of variants of concern (edit) |
10.1016/J.ISCI.2021.103006 |
| 2021-08-20 |
Management of SARS-CoV-2 in the Military and Lessons for Future Pandemics (edit) |
10.1093/MILMED/USAB337 |
| 2021-08-20 |
The Prevention of Common Respiratory Virus Epidemics in 2020-21 during the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pandemic: An Unexpected Benefit of the Implementation of Public Health Measures (edit) |
10.1016/J.LANA.2021.100043 |
| 2021-08-19 |
A glycan gate controls opening of the SARS-CoV-2 spike protein (edit) |
10.1038/S41557-021-00758-3 |
| 2021-08-19 |
Association of Apolipoprotein e polymorphism with SARS-CoV-2 infection (edit) |
10.1016/J.MEEGID.2021.105043 |
| 2021-08-19 |
Comparative study of the interaction of ivermectin with proteins of interest associated with SARS-CoV-2: A computational and biophysical approach (edit) |
10.1016/J.BPC.2021.106677 |
| 2021-08-19 |
SARS-CoV-2 infection initiates interleukin-17-enriched transcriptional response in different cells from multiple organs (edit) |
10.1038/S41598-021-96110-3 |
| 2021-08-19 |
Wastewater-based SARS-CoV-2 environmental monitoring for Piedmont, Italy (edit) |
10.1016/J.ENVRES.2021.111901 |
| 2021-08-19 |
Neutralisation titres against SARS-CoV-2 are sustained 6 months after onset of symptoms in individuals with mild COVID-19 (edit) |
10.1016/J.EBIOM.2021.103519 |
| 2021-08-19 |
Wastewater SARS-CoV-2 monitoring as a community-level COVID-19 trend tracker and variants in Ohio, United States (edit) |
10.1016/J.SCITOTENV.2021.149757 |
| 2021-08-19 |
A Community-Adapted Approach to SARS-CoV-2 Testing for Medically Underserved Populations, Rhode Island, USA (edit) |
10.3201/EID2709.204874 |
| 2021-08-18 |
Wide Application of Minimally Processed Saliva on Multiple RT-qPCR Kits for SARS-CoV-2 Detection in Indonesia (edit) |
10.3389/FCIMB.2021.691538 |
| 2021-08-18 |
Pre-activated antiviral innate immunity in the upper airways controls early SARS-CoV-2 infection in children (edit) |
10.1038/S41587-021-01037-9 |
| 2021-08-18 |
Group Testing for SARS-CoV-2 Allows for Up to 10-Fold Efficiency Increase Across Realistic Scenarios and Testing Strategies (edit) |
10.3389/FPUBH.2021.583377 |
| 2021-08-18 |
HIF-1α promotes SARS-CoV-2 infection and aggravates inflammatory responses to COVID-19 (edit) |
10.1038/S41392-021-00726-W |
| 2021-08-18 |
SARS-CoV-2 Viral Load Is Correlated With the Disease Severity and Mortality in Patients With Cancer (edit) |
10.3389/FONC.2021.715794 |
| 2021-08-18 |
Genomics-guided identification of potential modulators of SARS-CoV-2 entry proteases, TMPRSS2 and Cathepsins B/L (edit) |
10.1371/JOURNAL.PONE.0256141 |
| 2021-08-18 |
A systematic review of the sensitivity and specificity of lateral flow devices in the detection of SARS-CoV-2 (edit) |
10.1186/S12879-021-06528-3 |
| 2021-08-18 |
Fluoxetine hydrochloride loaded lipid polymer hybrid nanoparticles showed possible efficiency against SARS-CoV-2 infection (edit) |
10.1016/J.IJPHARM.2021.121023 |
| 2021-08-18 |
Co-expression of the SARS-CoV-2 entry molecules ACE2 and TMPRSS2 in human ovaries: Identification of cell types and trends with age (edit) |
10.1016/J.YGENO.2021.08.012 |
| 2021-08-18 |
Synergistic Block of SARS-CoV-2 Infection by Combined Drug Inhibition of the Host Entry Factors PIKfyve Kinase and TMPRSS2 Protease (edit) |
10.1128/JVI.00975-21 |
| 2021-08-18 |
Natural and Recombinant SARS-CoV-2 Isolates Rapidly Evolve In Vitro to Higher Infectivity through More Efficient Binding to Heparan Sulfate and Reduced S1/S2 Cleavage (edit) |
10.1128/JVI.01357-21 |
| 2021-08-18 |
Intranasal ChAdOx1 nCoV-19/AZD1222 vaccination reduces viral shedding after SARS-CoV-2 D614G challenge in preclinical models (edit) |
10.1126/SCITRANSLMED.ABH0755 |
| 2021-08-17 |
Regulation of the Dimerization and Activity of SARS-CoV-2 Main Protease through Reversible Glutathionylation of Cysteine 300 (edit) |
10.1128/MBIO.02094-21 |
| 2021-08-17 |
A proteome-wide genetic investigation identifies several SARS-CoV-2-exploited host targets of clinical relevance (edit) |
10.7554/ELIFE.69719 |
| 2021-08-17 |
Molecular determinants for regulation of G3BP1/2 phase separation by the SARS-CoV-2 nucleocapsid protein (edit) |
10.1038/S41421-021-00306-W |
| 2021-08-17 |
Rapid Global Spread of the SARS-CoV-2 Delta (B.1.617.2) Variant: Spatiotemporal Variation and Public Health Impact (edit) |
10.15212/ZOONOSES-2021-0005 |
| 2021-08-17 |
No evidence of SARS-CoV-2 reverse transcription and integration as the origin of chimeric transcripts in patient tissues (edit) |
10.1073/PNAS.2109066118 |
| 2021-08-17 |
Respiratory epithelial cell responses to SARS-CoV-2 in COVID-19 (edit) |
10.1136/THORAXJNL-2021-217561 |
| 2021-08-17 |
A broadly neutralizing humanized ACE2-targeting antibody against SARS-CoV-2 variants (edit) |
10.1038/S41467-021-25331-X |
| 2021-08-17 |
Deep survey for designing a vaccine against SARS-CoV-2 and its new mutations (edit) |
10.1007/S11756-021-00866-Y |
| 2021-08-17 |
A vaccine-induced public antibody protects against SARS-CoV-2 and emerging variants (edit) |
10.1016/J.IMMUNI.2021.08.013 |
| 2021-08-17 |
SARS-CoV-2 disease severity and transmission efficiency is increased for airborne compared to fomite exposure in Syrian hamsters (edit) |
10.1038/S41467-021-25156-8 |
| 2021-08-17 |
Generation and transmission of interlineage recombinants in the SARS-CoV-2 pandemic (edit) |
10.1016/J.CELL.2021.08.014 |
| 2021-08-17 |
“Armed for the future Coronavirus pandemic”: a promising use of the multimeric SARS-CoV-2 receptor binding domain nanoparticle as a new Pan-Coronavirus vaccine (edit) |
10.1038/S41392-021-00721-1 |
| 2021-08-16 |
Structure and Function of N-Terminal Zinc Finger Domain of SARS-CoV-2 NSP2 (edit) |
10.1007/S12250-021-00431-6 |
| 2021-08-16 |
Association of Age and Pediatric Household Transmission of SARS-CoV-2 Infection (edit) |
10.1001/JAMAPEDIATRICS.2021.2770 |
| 2021-08-16 |
Antimicrobial Face Shield: Next Generation of Facial Protective Equipment against SARS-CoV-2 and Multidrug-Resistant Bacteria (edit) |
10.20944/PREPRINTS202108.0329.V1 |
| 2021-08-16 |
Molecular docking and dynamic simulation of conserved B cell epitope of SARS-CoV-2 glycoprotein Indonesian isolates: an immunoinformatic approach (edit) |
10.12688/F1000RESEARCH.54258.1 |
| 2021-08-16 |
Occurrence of COVID-19 Symptoms During SARS-CoV-2 Infection Defines Waning of Humoral Immunity (edit) |
10.3389/FIMMU.2021.722027 |
| 2021-08-16 |
SARS-CoV-2 in Solid Organ Transplant Recipients: A Structured Review of 2020 (edit) |
10.1016/J.TRANSPROCEED.2021.08.019 |
| 2021-08-16 |
Trends in Pediatric Viral Symptoms, Influenza Testing, and SARS-CoV-2 Testing From a Statewide Electronic Health Record Consortium, January 2017 to July 2021 (edit) |
10.1016/J.ACAP.2021.08.008 |
| 2021-08-16 |
Near-physiological-temperature serial crystallography reveals conformations of SARS-CoV-2 main protease active site for improved drug repurposing (edit) |
10.1016/J.STR.2021.07.007 |
| 2021-08-16 |
An enveloped virus-like particle vaccine expressing a stabilized prefusion form of the SARS-CoV-2 spike protein elicits highly potent immunity (edit) |
10.1016/J.VACCINE.2021.07.034 |
| 2021-08-16 |
Ultrarapid detection of SARS-CoV-2 RNA using a reverse transcription–free exponential amplification reaction, RTF-EXPAR (edit) |
10.1073/PNAS.2100347118 |
| 2021-08-15 |
EVOLUTION OF THE INFECTION OF THE SARS-COV-2 IN ITALY, GENERAL EPIDEMIOLOGICAL RESULTS AND NEW STRADEGIC HYPOTHESES RELATED TO TERRESTRIAL CLIMATE (edit) |
10.26821/IJSRC.9.8.2021.9822 |
| 2021-08-14 |
An overview of the COVID-19 related content of Wikimedia projects (edit) |
10.5281/ZENODO.5201623 |
| 2021-08-14 |
Does face mask use elicit risk-compensation? Quasi-experimental evidence from Denmark during the SARS-CoV-2 pandemic (edit) |
10.1093/EURPUB/CKAB136 |
| 2021-08-14 |
Recovery of Deleted Deep Sequencing Data Sheds More Light on the Early Wuhan SARS-CoV-2 Epidemic (edit) |
10.1093/MOLBEV/MSAB246 |
| 2021-08-14 |
Comparison of positive SARS-CoV-2 incidence rate with environmental and socioeconomic factors in northern Illinois (edit) |
10.1016/J.HELIYON.2021.E07806 |
| 2021-08-14 |
A monocyte/dendritic cell molecular signature of SARS-CoV-2-related multisystem inflammatory syndrome in children with severe myocarditis (edit) |
10.1016/J.MEDJ.2021.08.002 |
| 2021-08-14 |
Proteomic Signature of Host Response to SARS-CoV-2 Infection in the Nasopharynx (edit) |
10.1016/J.MCPRO.2021.100134 |
| 2021-08-13 |
The challenge of structural heterogeneity in the native mass spectrometry studies of the SARS-CoV-2 spike protein interactions with its host cell-surface receptor (edit) |
10.1007/S00216-021-03601-3 |
| 2021-08-13 |
The effect of SARS-CoV-2 on the nervous system: a review of neurological impacts caused by human coronaviruses (edit) |
10.1515/REVNEURO-2021-0041 |
| 2021-08-13 |
The Structure-Based Design of SARS-CoV-2 nsp14 Methyltransferase Ligands Yields Nanomolar Inhibitors (edit) |
10.1021/ACSINFECDIS.1C00131 |
| 2021-08-13 |
Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants (edit) |
10.1126/SCIENCE.ABH1139 |
| 2021-08-13 |
Protracted yet Coordinated Differentiation of Long-Lived SARS-CoV-2-Specific CD8+ T Cells during Convalescence (edit) |
10.4049/JIMMUNOL.2100465 |
| 2021-08-13 |
A distinct ssDNA/RNA binding interface in the Nsp9 protein from SARS-CoV-2 (edit) |
10.1002/PROT.26205 |
| 2021-08-13 |
Rapid induction of antigen-specific CD4+ T cells is associated with coordinated humoral and cellular immunity to SARS-CoV-2 mRNA vaccination (edit) |
10.1016/J.IMMUNI.2021.08.001 |
| 2021-08-13 |
Remdesivir and Cyclosporine Synergistically Inhibit the Human Coronaviruses OC43 and SARS-CoV-2 (edit) |
10.3389/FPHAR.2021.706901 |
| 2021-08-12 |
Pneumocytes are distinguished by highly elevated expression of the ER stress biomarker GRP78, a co-receptor for SARS-CoV-2, in COVID-19 autopsies (edit) |
10.1007/S12192-021-01230-4 |
| 2021-08-12 |
Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variants (edit) |
10.1126/SCIENCE.ABJ4176 |
| 2021-08-12 |
SARS-CoV-2 infection risk during delivery of childhood vaccination campaigns: a modelling study (edit) |
10.1186/S12916-021-02072-8 |
| 2021-08-12 |
Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants (edit) |
10.1056/NEJMC2107799 |
| 2021-08-12 |
Effect of SARS-CoV-2 B.1.1.7 mutations on spike protein structure and function (edit) |
10.1038/S41594-021-00652-Z |
| 2021-08-12 |
Molecular basis of immune evasion by the delta and kappa SARS-CoV-2 variants (edit) |
10.1101/2021.08.11.455956 |
| 2021-08-12 |
Role of ATP in the RNA Translocation Mechanism of SARS-CoV-2 NSP13 Helicase (edit) |
10.1021/ACS.JPCB.1C04528 |
| 2021-08-12 |
Systems level insights into the impact of airborne exposure on SARS-CoV-2 pathogenesis and COVID-19 outcome - A multi-omics big data study (edit) |
10.1016/J.GENREP.2021.101312 |
| 2021-08-12 |
The janus-kinase inhibitor ruxolitinib in SARS-CoV-2 induced acute respiratory distress syndrome (ARDS) (edit) |
10.1038/S41375-021-01374-3 |
| 2021-08-12 |
Identification of Natural Inhibitors Against SARS-CoV-2 Drugable Targets Using Molecular Docking, Molecular Dynamics Simulation, and MM-PBSA Approach (edit) |
10.3389/FCIMB.2021.730288 |
| 2021-08-12 |
Dynamics of SARS-CoV-2 in wastewater in three districts of the Buenos Aires metropolitan region, Argentina, throughout nine months of surveillance: A pilot study (edit) |
10.1016/J.SCITOTENV.2021.149578 |
| 2021-08-12 |
Cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine in patients on haemodialysis (edit) |
10.1016/J.EBIOM.2021.103524 |
| 2021-08-12 |
Comparison of anti-SARS-CoV-2 activity and intracellular metabolism of remdesivir and its parent nucleoside (edit) |
10.1016/J.CRPHAR.2021.100045 |
| 2021-08-12 |
Perturbation of ACE2 Structural Ensembles by SARS-CoV-2 Spike Protein Binding (edit) |
10.1021/ACS.JCTC.1C00325 |
| 2021-08-11 |
Structure, mechanism and crystallographic fragment screening of the SARS-CoV-2 NSP13 helicase (edit) |
10.1038/S41467-021-25166-6 |
| 2021-08-11 |
Decreased inhibition of exosomal miRNAs on SARS-CoV-2 replication underlies poor outcomes in elderly people and diabetic patients (edit) |
10.1038/S41392-021-00716-Y |
| 2021-08-11 |
Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis (edit) |
10.1038/S41594-021-00651-0 |
| 2021-08-11 |
Distinct Lipid Metabolic Dysregulation in Asymptomatic COVID-19 (edit) |
10.1016/J.ISCI.2021.102974 |
| 2021-08-11 |
Potential use of ivermectin for the treatment and prophylaxis of SARS-CoV-2 infection (edit) |
10.1016/J.RETRAM.2021.103309 |
| 2021-08-11 |
Detection of SARS-CoV-2 Derived Small RNAs and Changes in Circulating Small RNAs Associated with COVID-19 (edit) |
10.3390/V13081593 |
| 2021-08-11 |
Structural O-Glycoform Heterogeneity of the SARS-CoV-2 Spike Protein Receptor-Binding Domain Revealed by Top-Down Mass Spectrometry (edit) |
10.1021/JACS.1C02713 |
| 2021-08-11 |
Multiplexed detection of SARS-CoV-2 genomic and subgenomic RNA using hybridization (edit) |
10.1101/2021.08.11.455959 |
| 2021-08-11 |
Mild and Severe SARS-CoV-2 Infection Induces Respiratory and Intestinal Microbiome Changes in the K18-hACE2 Transgenic Mouse Model (edit) |
10.1128/SPECTRUM.00536-21 |
| 2021-08-11 |
A Methyltransferase-Defective Vesicular Stomatitis Virus-Based SARS-CoV-2 Vaccine Candidate Provides Complete Protection against SARS-CoV-2 Infection in Hamsters (edit) |
10.1128/JVI.00592-21 |
| 2021-08-11 |
A computational study of cooperative binding to multiple SARS-CoV-2 proteins (edit) |
10.1038/S41598-021-95826-6 |
| 2021-08-11 |
Plant-produced SARS-CoV-2 receptor binding domain (RBD) variants showed differential binding efficiency with anti-spike specific monoclonal antibodies (edit) |
10.1371/JOURNAL.PONE.0253574 |
| 2021-08-11 |
TMPRSS2 and RNA-Dependent RNA Polymerase Are Effective Targets of Therapeutic Intervention for Treatment of COVID-19 Caused by SARS-CoV-2 Variants (B.1.1.7 and B.1.351) (edit) |
10.1128/SPECTRUM.00472-21 |
| 2021-08-11 |
SARS-CoV-2 Genome Sequencing Methods Differ in Their Abilities To Detect Variants from Low-Viral-Load Samples (edit) |
10.1128/JCM.01046-21 |
| 2021-08-11 |
Public Health Leadership in a VUCA World Environment: Lessons Learned during the Regional Emergency Rollout of SARS-CoV-2 Vaccinations in Heidelberg, Germany, during the COVID-19 Pandemic (edit) |
10.3390/VACCINES9080887 |
| 2021-08-10 |
Asymptomatic SARS-CoV-2 infection: A systematic review and meta-analysis (edit) |
10.1073/PNAS.2109229118 |
| 2021-08-10 |
Secretory Vesicles Are the Principal Means of SARS-CoV-2 Egress (edit) |
10.3390/CELLS10082047 |
| 2021-08-10 |
Contribution of SARS-CoV-2 Accessory Proteins to Viral Pathogenicity in K18 Human ACE2 Transgenic Mice (edit) |
10.1128/JVI.00402-21 |
| 2021-08-10 |
Temporal maturation of neutralizing antibodies in COVID-19 convalescent individuals improves potency and breadth to circulating SARS-CoV-2 variants (edit) |
10.1016/J.IMMUNI.2021.06.015 |
| 2021-08-10 |
Determination of vulnerable regions of SARS-CoV-2 in Malaysia using meteorology and air quality data (edit) |
10.1007/S10668-021-01719-Z |
| 2021-08-10 |
Comparative transcriptome analyses reveal genes associated with SARS-CoV-2 infection of human lung epithelial cells (edit) |
10.1038/S41598-021-95733-W |
| 2021-08-10 |
Computational screening of 645 antiviral peptides against the receptor-binding domain of the spike protein in SARS-CoV-2 (edit) |
10.1016/J.COMPBIOMED.2021.104759 |
| 2021-08-10 |
Structural basis of biased T cell receptor recognition of an immunodominant HLA-A2 epitope of the SARS-CoV-2 spike protein (edit) |
10.1016/J.JBC.2021.101065 |
| 2021-08-10 |
Tracking the introduction and spread of SARS-CoV-2 in coastal Kenya (edit) |
10.1038/S41467-021-25137-X |
| 2021-08-10 |
Cold atmospheric plasma: A non-negligible strategy for viral RNA inactivation to prevent SARS-CoV-2 environmental transmission (edit) |
10.1063/5.0060530 |
| 2021-08-10 |
Reduced Relative Sensitivity of the Elecsys SARS-CoV-2 Antigen Assay in Saliva Compared to Nasopharyngeal Swabs (edit) |
10.3390/MICROORGANISMS9081700 |
| 2021-08-09 |
Detection and characterization of the SARS-CoV-2 lineage B.1.526 in New York (edit) |
10.1038/S41467-021-25168-4 |
| 2021-08-09 |
Direct Comparison of N-Glycans and Their Isomers Derived from Spike Glycoprotein 1 of MERS-CoV, SARS-CoV-1, and SARS-CoV-2 (edit) |
10.1021/ACS.JPROTEOME.1C00323 |
| 2021-08-09 |
Online bioinformatics teaching practice: Comparison of popular docking programs using SARS-CoV-2 spike RBD-ACE2 complex as a benchmark (edit) |
10.1002/BMB.21566 |
| 2021-08-09 |
Neutralization of SARS-CoV-2 by highly potent, hyperthermostable, and mutation-tolerant nanobodies (edit) |
10.15252/EMBJ.2021107985 |
| 2021-08-09 |
A Computational Approach to Evaluate the Combined Effect of SARS-CoV-2 RBD Mutations and ACE2 Receptor Genetic Variants on Infectivity: The COVID-19 Host-Pathogen Nexus (edit) |
10.3389/FCIMB.2021.707194 |
| 2021-08-09 |
Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 Infection and Escherichia coli Sepsis (edit) |
10.1097/RHU.0000000000001783 |
| 2021-08-07 |
HD5 and LL-37 Inhibit SARS-CoV and SARS-CoV-2 Binding to Human ACE2 by Molecular Simulation (edit) |
10.1007/S12539-021-00462-3 |
| 2021-08-06 |
Outbreak of SARS-CoV-2 infections, including COVID-19 vaccine breakthrough infections, associated with large public gatherings - Barnstable County, Massachusetts, July 2021 (edit) |
10.15585/MMWR.MM7031E2 |
| 2021-08-06 |
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants (edit) |
10.1126/SCIENCE.ABI9745 |
| 2021-08-06 |
Structural dynamics of single SARS-CoV-2 pseudoknot molecules reveal topologically distinct conformers (edit) |
10.1038/S41467-021-25085-6 |
| 2021-08-06 |
Recombination and lineage-specific mutations linked to the emergence of SARS-CoV-2 (edit) |
10.1186/S13073-021-00943-6 |
| 2021-08-06 |
Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity (edit) |
10.1126/SCIENCE.ABI6226 |
| 2021-08-06 |
Informed consent and informed intervention: SARS-CoV-2 vaccinations not just call for disclosure of newly emerging safety data but also for hypothesis generation and testing (edit) |
10.1186/S40001-021-00558-Y |
| 2021-08-06 |
The Hyperlipidaemic Drug Fenofibrate Significantly Reduces Infection by SARS-CoV-2 in Cell Culture Models (edit) |
10.3389/FPHAR.2021.660490 |
| 2021-08-05 |
SARS-CoV-2 Unrevealed: Ultrastructural and Nanomechanical Analysis (edit) |
10.1021/ACS.LANGMUIR.1C01488 |
| 2021-08-05 |
NMPylation and de-NMPylation of SARS-CoV-2 nsp9 by the NiRAN domain (edit) |
10.1093/NAR/GKAB677 |
| 2021-08-05 |
Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum (edit) |
10.1016/J.CELL.2021.06.020 |
| 2021-08-05 |
Structure-guided design of a perampanel-derived pharmacophore targeting the SARS-CoV-2 main protease (edit) |
10.1016/J.STR.2021.06.002 |
| 2021-08-05 |
Mutation hotspots and spatiotemporal distribution of SARS-CoV-2 lineages in Brazil, February 2020-2021 (edit) |
10.1016/J.VIRUSRES.2021.198532 |
| 2021-08-05 |
Previous vitamin D status and total cholesterol are associated with SARS-CoV-2 infection (edit) |
10.1016/J.CCA.2021.08.003 |
| 2021-08-05 |
Possible therapeutic targets and promising drugs based on unsymmetrical hetaryl-substituted porphyrins to combat SARS-CoV-2 (edit) |
10.1016/J.JPHA.2021.08.003 |
| 2021-08-05 |
Real-time SARS-CoV-2 diagnostic and variants tracking over multiple candidates using nanopore DNA sequencing (edit) |
10.1038/S41598-021-95563-W |
| 2021-08-05 |
Modelling conformational state dynamics and its role on infection for SARS-CoV-2 Spike protein variants (edit) |
10.1371/JOURNAL.PCBI.1009286 |
| 2021-08-04 |
Overlapping of Independent SARS-CoV-2 Nosocomial Transmissions in a Complex Outbreak (edit) |
10.1128/MSPHERE.00389-21 |
| 2021-08-04 |
Par ici la sortie ! Le SARS-CoV-2 utilise les lysosomes pour sortir de la cellule infectée (edit) |
10.1051/MEDSCI/2021100 |
| 2021-08-04 |
Auditory Disturbances and SARS-CoV-2 Infection: Brain Inflammation or Cochlear Affection? Systematic Review and Discussion of Potential Pathogenesis (edit) |
10.3389/FNEUR.2021.707207 |
| 2021-08-03 |
SARS‑CoV-2 RBD219-N1C1: A yeast-expressed SARS-CoV-2 recombinant receptor-binding domain candidate vaccine stimulates virus neutralizing antibodies and T-cell immunity in mice (edit) |
10.1080/21645515.2021.1901545 |
| 2021-08-03 |
Estimating SARS-CoV-2 infections from deaths, confirmed cases, tests, and random surveys (edit) |
10.1073/PNAS.2103272118 |
| 2021-08-03 |
Inhibitors of VPS34 and fatty-acid metabolism suppress SARS-CoV-2 replication (edit) |
10.1016/J.CELREP.2021.109479 |
| 2021-08-03 |
Antigen Presentation of mRNA-Based and Virus-Vectored SARS-CoV-2 Vaccines (edit) |
10.3390/VACCINES9080848 |
| 2021-08-03 |
Transient and stabilized complexes of Nsp7, Nsp8, and Nsp12 in SARS-CoV-2 replication (edit) |
10.1016/J.BPJ.2021.06.006 |
| 2021-08-03 |
Mass Spectrometry Analysis of SARS-CoV-2 Nucleocapsid Protein Reveals Camouflaging Glycans and Unique Post-Translational Modifications (edit) |
|
| 2021-08-03 |
N439K Variant in Spike Protein Alter the Infection Efficiency and Antigenicity of SARS-CoV-2 Based on Molecular Dynamics Simulation (edit) |
10.3389/FCELL.2021.697035 |
| 2021-08-03 |
Catching SARS-CoV-2 by Sequence Hybridization: a Comparative Analysis (edit) |
10.1128/MSYSTEMS.00392-21 |
| 2021-08-03 |
SARS-COV-2 invasion in lakes: A rare transferability of the dreaded virus by nature or manmade (edit) |
10.4314/JAS.V36I1.3 |
| 2021-08-03 |
Analysis of the SARS-CoV-2-host protein interaction network reveals new biology and drug candidates: focus on the spike surface glycoprotein and RNA polymerase (edit) |
10.1080/17460441.2021.1909566 |
| 2021-08-02 |
Dynamic innate immune response determines susceptibility to SARS-CoV-2 infection and early replication kinetics (edit) |
|
| 2021-08-02 |
SARS-CoV-2 N protein promotes NLRP3 inflammasome activation to induce hyperinflammation (edit) |
10.1038/S41467-021-25015-6 |
| 2021-08-02 |
Why All the Fury over Furin? (edit) |
10.1021/ACS.JMEDCHEM.1C00518 |
| 2021-08-02 |
β-d-N4-hydroxycytidine Inhibits SARS-CoV-2 Through Lethal Mutagenesis But Is Also Mutagenic To Mammalian Cells (edit) |
10.1093/INFDIS/JIAB247 |
| 2021-08-02 |
SARS-CoV-2 sensing by RIG-I and MDA5 links epithelial infection to macrophage inflammation (edit) |
10.15252/EMBJ.2021107826 |
| 2021-08-02 |
The Emergence and Spread of Novel SARS-CoV-2 Variants (edit) |
10.3389/FPUBH.2021.696664 |
| 2021-08-02 |
Quantification of Specific Antibodies Against SARS-CoV-2 in Breast Milk of Lactating Women Vaccinated With an mRNA Vaccine (edit) |
10.1001/JAMANETWORKOPEN.2021.20575 |
| 2021-08-02 |
Identification of cell lines CL-14, CL-40 and CAL-51 as suitable models for SARS-CoV-2 infection studies (edit) |
10.1371/JOURNAL.PONE.0255622 |
| 2021-08-02 |
An optimized, amplicon-based approach for sequencing of SARS-CoV-2 from patient samples using COVIDSeq assay on Illumina MiSeq sequencing platforms (edit) |
10.1016/J.XPRO.2021.100755 |
| 2021-08-01 |
Air pollution particulate matter as a potential carrier of SARS-CoV-2 to the nervous system and/or neurological symptom enhancer: arguments in favor (edit) |
10.1007/S11356-020-11183-3 |
| 2021-08-01 |
Why Are Physicists Involved in the Studies on the Origin of SARS-CoV-2? (edit) |
10.31661/JBPE.V0I0.2106-1361 |
| 2021-08-01 |
Targeting SARS-CoV-2 Nsp3 macrodomain structure with insights from human poly(ADP-ribose) glycohydrolase (PARG) structures with inhibitors (edit) |
10.1016/J.PBIOMOLBIO.2021.02.002 |
| 2021-08-01 |
Serum neutralising activity against SARS-CoV-2 variants elicited by CoronaVac (edit) |
10.1016/S1473-3099(21)00287-5 |
| 2021-08-01 |
The Origins of SARS-CoV-2: A Critical Review (edit) |
10.1016/J.CELL.2021.08.017 |
| 2021-08-01 |
S-acylation of SARS-CoV-2 Spike Protein: Mechanistic Dissection, In Vitro Reconstitution and Role in Viral Infectivity (edit) |
10.1016/J.JBC.2021.101112 |
| 2021-08-01 |
SARS-CoV-2 suppresses IFNβ production mediated by NSP1, 5, 6, 15, ORF6 and ORF7b but does not suppress the effects of added interferon (edit) |
10.1371/JOURNAL.PPAT.1009800 |
| 2021-08-01 |
Implementation of a pooled surveillance testing program for asymptomatic SARS-CoV-2 infections in K-12 schools and universities (edit) |
10.1016/J.ECLINM.2021.101028 |
| 2021-08-01 |
Predictable fold switching by the SARS-CoV-2 protein ORF9b (edit) |
10.1002/PRO.4097 |
| 2021-08-01 |
Proposed framework for considering SARS-CoV-2 antigen testing of unexposed asymptomatic workers in selected workplaces (edit) |
10.1097/JOM.0000000000002269 |
| 2021-08-01 |
Mental health, substance use, and suicidal ideation during a prolonged COVID-19-related lockdown in a region with low SARS-CoV-2 prevalence (edit) |
10.1016/J.JPSYCHIRES.2021.05.080 |
| 2021-08-01 |
Comparison of SARS-CoV-2 Variants of Concern 202012/01 (U.K. Variant) and D614G Variant Transmission by Different Routes in Syrian Hamsters (edit) |
10.1089/VBZ.2021.0032 |
| 2021-08-01 |
ACE I/D polymorphism in Czech first-wave SARS-CoV-2-positive survivors (edit) |
10.1016/J.CCA.2021.04.024 |
| 2021-08-01 |
Novel SARS-CoV-2 variants: the pandemics within the pandemic (edit) |
10.1016/J.CMI.2021.05.022 |
| 2021-08-01 |
One year into the pandemic: Short-term evolution of SARS-CoV-2 and emergence of new lineages (edit) |
10.1016/J.MEEGID.2021.104869 |
| 2021-08-01 |
Rapid SARS-CoV-2 variant monitoring using PCR confirmed by whole genome sequencing in a high-volume diagnostic laboratory (edit) |
10.1016/J.JCV.2021.104906 |
| 2021-08-01 |
Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals (edit) |
10.1038/S41591-021-01413-7 |
| 2021-08-01 |
In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies (edit) |
10.1016/J.CELL.2021.06.021 |
| 2021-08-01 |
p-cymene impairs SARS-CoV-2 and Influenza A (H1N1) viral replication: In silico predicted interaction with SARS-CoV-2 nucleocapsid protein and H1N1 nucleoprotein (edit) |
10.1002/PRP2.798 |
| 2021-08-01 |
Impact of vaccination on new SARS-CoV-2 infections in the United Kingdom (edit) |
10.1038/S41591-021-01410-W |
| 2021-08-01 |
Famotidine inhibits toll-like receptor 3-mediated inflammatory signaling in SARS-CoV-2 infection (edit) |
10.1016/J.JBC.2021.100925 |
| 2021-08-01 |
Mortality after surgery with SARS-CoV-2 infection in England: a population-wide epidemiological study (edit) |
10.1016/J.BJA.2021.05.018 |
| 2021-08-01 |
Persisting Salivary IgG Against SARS-CoV-2 at 9 Months After Mild COVID-19: A Complementary Approach to Population Surveys (edit) |
10.1093/INFDIS/JIAB256 |
| 2021-08-01 |
MUC1-C influences cell survival in lung adenocarcinoma Calu-3 cells after SARS-CoV-2 infection (edit) |
|
| 2021-08-01 |
Phylogenetic pattern of SARS-CoV-2 from COVID-19 patients from Bosnia and Herzegovina: lessons learned to optimize future molecular and epidemiological approaches (edit) |
10.17305/BJBMS.2020.5381 |
| 2021-08-01 |
On the Sensitivity and Specificity of Postmortem Upper Respiratory Tract Testing for SARS-CoV-2 (edit) |
10.1093/INFDIS/JIAB270 |
| 2021-08-01 |
Immunogenicity of BNT162b2 mRNA COVID-19 vaccine and SARS-CoV-2 infection in lung transplant recipients (edit) |
10.1016/J.HEALUN.2021.05.004 |
| 2021-08-01 |
In Silico Identification of Potential Inhibitors of SARS-CoV-2 Papain-like Protease From Natural Sources: A Natural Weapon to Fight COVID-19 (edit) |
10.2174/2666796701999201203211330 |
| 2021-08-01 |
The conundrum of current anti-SARS-CoV-2 vaccines (edit) |
10.1016/J.CYTOGFR.2021.03.001 |
| 2021-08-01 |
Highly expressed ACE-2 receptors during pregnancy: A protective factor for SARS-COV-2 infection? (edit) |
10.1016/J.MEHY.2021.110641 |
| 2021-08-01 |
B cell receptor (BCR) guided mechanotransduction: Critical hypothesis to instruct SARS-CoV-2 specific B cells to trigger proximal signalling and antibody reshaping (edit) |
10.1016/J.MEHY.2021.110640 |
| 2021-08-01 |
Carpal, cubital or tarsal tunnel syndrome after SARS-CoV-2 infection: A causal link? (edit) |
10.1016/J.MEHY.2021.110638 |
| 2021-08-01 |
Early multidrug treatment of SARS-CoV-2 infection (COVID-19) and reduced mortality among nursing home (or outpatient/ambulatory) residents (edit) |
10.1016/J.MEHY.2021.110622 |
| 2021-08-01 |
Optimized protocol for a quantitative SARS-CoV-2 duplex RT-qPCR assay with internal human sample sufficiency control (edit) |
10.1016/J.JVIROMET.2021.114174 |
| 2021-08-01 |
Rapid diagnostics for SARS-CoV-2 virus: point-of-care testing and lessons learned during the pandemic (edit) |
10.4155/BIO-2021-0100 |
| 2021-08-01 |
Development and validation of a new triplex real-time quantitative reverse Transcriptase-PCR assay for the clinical detection of SARS-CoV-2 (edit) |
10.1016/J.MCP.2021.101744 |
| 2021-08-01 |
Future developments in biosensors for field-ready SARS-CoV-2 virus diagnostics (edit) |
10.1002/BAB.2033 |
| 2021-07-31 |
An Oral SARS-CoV-2 Mpro Inhibitor Clinical Candidate for the Treatment of COVID-19 (edit) |
10.1101/2021.07.28.21261232 |
| 2021-07-31 |
Differences in the Concentration of Anti-SARS-CoV-2 IgG Antibodies Post-COVID-19 Recovery or Post-Vaccination (edit) |
10.3390/CELLS10081952 |
| 2021-07-31 |
Heparin: A simplistic repurposing to prevent SARS-CoV-2 transmission in light of its in-vitro nanomolar efficacy (edit) |
10.1016/J.IJBIOMAC.2021.04.148 |
| 2021-07-31 |
Performance of Immunoglobulin G Serology on Finger Prick Capillary Dried Blood Spot Samples to Measure SARS-CoV-2 Humoral Immunogenicity (edit) |
10.1101/2021.07.29.21261156 |
| 2021-07-30 |
The household secondary attack rate of SARS-CoV-2: A rapid review (edit) |
10.1093/CID/CIAA1558 |
| 2021-07-30 |
SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: Implications for microclot formation in COVID-19 (edit) |
10.1042/BSR20210611 |
| 2021-07-30 |
Quantum simulations of SARS-CoV-2 main protease M enable high-quality scoring of diverse ligands (edit) |
10.1007/S10822-021-00412-7 |
| 2021-07-30 |
Correlative multi-scale cryo-imaging unveils SARS-CoV-2 assembly and egress (edit) |
10.1038/S41467-021-24887-Y |
| 2021-07-30 |
"Bucket brigade" using lysine residues in RNA-dependent RNA polymerase of SARS-CoV-2 (edit) |
10.1016/J.BPJ.2021.07.026 |
| 2021-07-30 |
A synthetic nanobody targeting RBD protects hamsters from SARS-CoV-2 infection (edit) |
10.1038/S41467-021-24905-Z |
| 2021-07-30 |
Origin, phylogeny, variability and epitope conservation of SARS-CoV-2 worldwide (edit) |
10.1016/J.VIRUSRES.2021.198526 |
| 2021-07-30 |
Host metabolic reprogramming in response to SARS-CoV-2 infection: A systems biology approach (edit) |
10.1016/J.MICPATH.2021.105114 |
| 2021-07-30 |
JAK inhibitors dampen activation of interferon-activated transcriptomes and the SARS-CoV-2 receptor ACE2 in human renal proximal tubules (edit) |
10.1016/J.ISCI.2021.102928 |
| 2021-07-30 |
Occupational and environmental exposure to SARS-CoV-2 in and around infected mink farms (edit) |
10.1136/OEMED-2021-107443 |
| 2021-07-30 |
Synthesis of Hetaryl-Substituted Asymmetric Porphyrins and Their Affinity to SARS-CoV-2 Helicase (edit) |
10.1134/S1070363221060098 |
| 2021-07-30 |
An in-depth in silico and immunoinformatics approach for designing a potential multi-epitope construct for the effective development of vaccine to combat against SARS-CoV-2 encompassing variants of concern and interest (edit) |
10.1016/J.COMPBIOMED.2021.104703 |
| 2021-07-29 |
The genetic structure of SARS‐CoV‐2 is consistent with both natural or laboratory origin: Response to Tyshkovskiy and Panchin (10.1002/bies.202000325) (edit) |
10.1002/BIES.202100137 |
| 2021-07-29 |
Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates (edit) |
10.1126/SCIENCE.ABJ0299 |
| 2021-07-29 |
Localization of SARS-CoV-2 Capping Enzymes Revealed by an Antibody against the nsp10 Subunit (edit) |
10.3390/V13081487 |
| 2021-07-29 |
SARS-CoV-2 infection induces the activation of tissue factor-mediated coagulation via activation of acid sphingomyelinase (edit) |
10.1182/BLOOD.2021010685 |
| 2021-07-29 |
Structural and functional basis for pan-CoV fusion inhibitors against SARS-CoV-2 and its variants with preclinical evaluation (edit) |
10.1038/S41392-021-00712-2 |
| 2021-07-29 |
Detection of IFNγ-Secreting CD4 and CD8 Memory T Cells in COVID-19 Convalescents after Stimulation of Peripheral Blood Mononuclear Cells with Live SARS-CoV-2 (edit) |
10.3390/V13081490 |
| 2021-07-29 |
Combination of a Sindbis-SARS-CoV-2 Spike Vaccine and αOX40 Antibody Elicits Protective Immunity Against SARS-CoV-2 Induced Disease and Potentiates Long-Term SARS-CoV-2-Specific Humoral and T-Cell Immunity (edit) |
10.3389/FIMMU.2021.719077 |
| 2021-07-29 |
Comprehensive virtual screening of 4.8 k flavonoids reveals novel insights into allosteric inhibition of SARS-CoV-2 MPRO (edit) |
10.1038/S41598-021-94951-6 |
| 2021-07-29 |
Identification of a special cell type as a determinant of the kidney tropism of SARS-CoV-2 (edit) |
10.1111/FEBS.16114 |
| 2021-07-29 |
Human embryonic stem cell-derived cardiomyocyte platform screens inhibitors of SARS-CoV-2 infection (edit) |
10.1038/S42003-021-02453-Y |
| 2021-07-29 |
Modeling neutral viral mutations in the spread of SARS-CoV-2 epidemics (edit) |
10.1371/JOURNAL.PONE.0255438 |
| 2021-07-29 |
Vaccine breakthrough infection and onward transmission of SARS-CoV-2 Beta (B.1.351) variant, Bavaria, Germany, February to March 2021 (edit) |
10.2807/1560-7917.ES.2021.26.30.2100673 |
| 2021-07-28 |
Aberrant glycosylation of anti-SARS-CoV-2 IgG is a pro-thrombotic stimulus for platelets (edit) |
10.1182/BLOOD.2021011871 |
| 2021-07-28 |
CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2 (edit) |
10.1021/ACSCENTSCI.0C01537 |
| 2021-07-28 |
Sewage Systems Surveillance for SARS-CoV-2: Identification of Knowledge Gaps, Emerging Threats, and Future Research Needs (edit) |
10.3390/PATHOGENS10080946 |
| 2021-07-28 |
Rapid and stable mobilization of CD8+ T cells by SARS-CoV-2 mRNA vaccine (edit) |
10.1038/S41586-021-03841-4 |
| 2021-07-28 |
IFITM proteins promote SARS-CoV-2 infection and are targets for virus inhibition in vitro (edit) |
10.1038/S41467-021-24817-Y |
| 2021-07-28 |
Kinetic Multi-omic Analysis of Responses to SARS-CoV-2 Infection in a Model of Severe COVID-19 (edit) |
10.1128/JVI.01010-21 |
| 2021-07-28 |
Structure-based study of immune receptors as eligible binding targets of coronavirus SARS-CoV-2 spike protein (edit) |
10.1016/J.JMGM.2021.107997 |
| 2021-07-28 |
poreCov-An Easy to Use, Fast, and Robust Workflow for SARS-CoV-2 Genome Reconstruction via Nanopore Sequencing (edit) |
10.3389/FGENE.2021.711437 |
| 2021-07-27 |
COVID-19 generates hyaluronan fragments that directly induce endothelial barrier dysfunction (edit) |
10.1172/JCI.INSIGHT.147472 |
| 2021-07-27 |
SARS-CoV-2 infection triggers widespread host mRNA decay leading to an mRNA export block (edit) |
10.1261/RNA.078923.121 |
| 2021-07-27 |
Structural basis of mismatch recognition by a SARS-CoV-2 proofreading enzyme (edit) |
10.1126/SCIENCE.ABI9310 |
| 2021-07-27 |
An intranasal vaccine durably protects against SARS-CoV-2 variants in mice (edit) |
10.1016/J.CELREP.2021.109452 |
| 2021-07-27 |
Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates (edit) |
10.1126/SCITRANSLMED.ABI4547 |
| 2021-07-27 |
B.1.526 SARS-CoV-2 Variants Identified in New York City are Neutralized by Vaccine-Elicited and Therapeutic Monoclonal Antibodies (edit) |
10.1128/MBIO.01386-21 |
| 2021-07-27 |
Anti-Phospholipid Antibodies and COVID-19 Thrombosis: A Co-Star, Not a Supporting Actor (edit) |
10.3390/BIOMEDICINES9080899 |
| 2021-07-27 |
N501Y mutation imparts cross-species transmission of SARS-CoV-2 to mice by enhancing receptor binding (edit) |
10.1038/S41392-021-00704-2 |
| 2021-07-27 |
Non-RBM Mutations Impaired SARS-CoV-2 Spike Protein Regulated to the ACE2 Receptor Based on Molecular Dynamic Simulation (edit) |
10.3389/FMOLB.2021.614443 |
| 2021-07-27 |
Screening of potent neutralizing antibodies against SARS-CoV-2 using convalescent patients-derived phage-display libraries (edit) |
10.1038/S41421-021-00295-W |
| 2021-07-27 |
Emerging mutations in envelope protein of SARS-CoV-2 and their effect on thermodynamic properties (edit) |
10.1016/J.IMU.2021.100675 |
| 2021-07-27 |
Single-cell transcriptome of bronchoalveolar lavage fluid reveals sequential change of macrophages during SARS-CoV-2 infection in ferrets (edit) |
10.1038/S41467-021-24807-0 |
| 2021-07-27 |
Determination of the characteristic inactivation fluence for SARS-CoV-2 under UV-C radiation considering light absorption in culture media (edit) |
10.1038/S41598-021-94648-W |
| 2021-07-27 |
SARS-CoV-2 airborne transmission: A validated sampling and analytical method (edit) |
10.1016/J.ENVRES.2021.111783 |
| 2021-07-27 |
Minute-scale detection of SARS-CoV-2 using a low-cost biosensor composed of pencil graphite electrodes (edit) |
10.1073/PNAS.2106724118 |
| 2021-07-26 |
Single-cell RNA sequencing reveals ex vivo signatures of SARS-CoV-2-reactive T cells through 'reverse phenotyping' (edit) |
10.1038/S41467-021-24730-4 |
| 2021-07-26 |
N-glycosylation profiles of the SARS-CoV-2 spike D614G mutant and its ancestral protein characterized by advanced mass spectrometry (edit) |
10.1101/2021.07.26.453787 |
| 2021-07-26 |
S494 O-glycosylation site on the SARS-CoV-2 RBD affects the virus affinity to ACE2 and its infectivity; a molecular dynamics study (edit) |
10.1038/S41598-021-94602-W |
| 2021-07-26 |
Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variants (edit) |
10.1038/S41467-021-24909-9 |
| 2021-07-26 |
A realistic transfer method reveals low risk of SARS-CoV-2 transmission via contaminated euro coins and banknotes (edit) |
10.1016/J.ISCI.2021.102908 |
| 2021-07-25 |
Target-Based In Silico Screening for Phytoactive Compounds Targeting SARS-CoV-2 (edit) |
10.1007/S12539-021-00461-4 |
| 2021-07-24 |
Perspective of the Relationship between the Susceptibility to Initial SARS-CoV-2 Infectivity and Optimal Nasal Conditioning of Inhaled Air (edit) |
10.3390/IJMS22157919 |
| 2021-07-23 |
Management of pregnancy-related hypertensive disorders in patients infected with SARS CoV-2: pharmacological and clinical issues (edit) |
10.1093/EHJCVP/PVAA105 |
| 2021-07-23 |
SARS-CoV-2 N Protein Targets TRIM25-Mediated RIG-I Activation to Suppress Innate Immunity (edit) |
10.3390/V13081439 |
| 2021-07-23 |
Experimental Evidence for Enhanced Receptor Binding by Rapidly Spreading SARS-CoV-2 Variants (edit) |
10.1016/J.JMB.2021.167058 |
| 2021-07-23 |
SARS-CoV-2 Neutralizing Antibody Responses towards Full-Length Spike Protein and the Receptor-Binding Domain (edit) |
10.4049/JIMMUNOL.2100272 |
| 2021-07-23 |
RBM15-mediated N6-methyladenosine modification affects COVID-19 severity by regulating the expression of multitarget genes (edit) |
10.1038/S41419-021-04012-Z |
| 2021-07-23 |
ACE2 interaction with cytoplasmic PDZ protein enhances SARS-CoV-2 invasion (edit) |
10.1016/J.ISCI.2021.102770 |
| 2021-07-23 |
The Inherent Dynamics and Interaction Sites of the SARS-CoV-2 Nucleocapsid N-Terminal Region (edit) |
10.1016/J.JMB.2021.167108 |
| 2021-07-23 |
Lung Ultrasound Examination in Patients with SARS-CoV-2 Infection: Multicenter Study (edit) |
10.3390/JCM10153255 |
| 2021-07-23 |
Identifying molecular insight of synergistic complexities for SARS-CoV-2 infection with pre-existing type 2 diabetes (edit) |
10.1016/J.COMPBIOMED.2021.104668 |
| 2021-07-23 |
Target capture sequencing of SARS-CoV-2 genomes using the ONETest Coronaviruses Plus (edit) |
10.1016/J.DIAGMICROBIO.2021.115508 |
| 2021-07-23 |
Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19 (edit) |
10.1016/J.CELL.2021.07.023 |
| 2021-07-23 |
Systemic IL-15, IFN-γ, and IP-10/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients (edit) |
10.1016/J.CELREP.2021.109504 |
| 2021-07-22 |
Genome-wide analysis of protein-protein interactions and involvement of viral proteins in SARS-CoV-2 replication (edit) |
10.1186/S13578-021-00644-Y |
| 2021-07-22 |
Increasing SARS-CoV-2 antibody prevalence in England at the start of the second wave: REACT-2 Round 4 cross-sectional study in 160,000 adults (edit) |
10.1101/2021.07.21.21260926 |
| 2021-07-22 |
Influenza-like illness among personnel responding to U.S. quarantine of cruise ship passengers exposed to SARS-CoV-2 (edit) |
10.1097/JOM.0000000000002335 |
| 2021-07-22 |
L-SIGN is a receptor on liver sinusoidal endothelial cells for SARS-CoV-2 virus (edit) |
10.1172/JCI.INSIGHT.148999 |
| 2021-07-22 |
SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2 (edit) |
10.1016/J.CELL.2021.06.005 |
| 2021-07-22 |
Binding of SARS-CoV-2 Fusion Peptide to Host Endosome and Plasma Membrane (edit) |
10.1021/ACS.JPCB.1C04176 |
| 2021-07-22 |
Highly feasible immunoprotective multicistronic SARS-CoV-2 vaccine candidate blending novel eukaryotic expression and Salmonella bactofection (edit) |
10.1016/J.JARE.2021.07.007 |
| 2021-07-22 |
SARS-CoV-2 attenuates corticosteroid sensitivity by suppressing DUSP1 expression and activating p38 MAPK pathway (edit) |
10.1016/J.EJPHAR.2021.174374 |
| 2021-07-22 |
Discovery of SARS-CoV-2-E channel inhibitors as antiviral candidates (edit) |
10.1038/S41401-021-00732-2 |
| 2021-07-22 |
Altered oral and gut microbiota and its association with SARS-CoV-2 viral load in COVID-19 patients during hospitalization (edit) |
10.1038/S41522-021-00232-5 |
| 2021-07-22 |
A single dose of replication-competent VSV-vectored vaccine expressing SARS-CoV-2 S1 protects against virus replication in a hamster model of severe COVID-19 (edit) |
10.1038/S41541-021-00352-1 |
| 2021-07-21 |
The virological impacts of SARS-CoV-2 D614G mutation (edit) |
10.1093/JMCB/MJAB045 |
| 2021-07-21 |
Lipid bilayer degradation induced by SARS-CoV-2 spike protein as revealed by neutron reflectometry (edit) |
10.1038/S41598-021-93996-X |
| 2021-07-21 |
Decrypting the role of predicted SARS-CoV-2 miRNAs in COVID-19 pathogenesis: A bioinformatics approach (edit) |
10.1016/J.COMPBIOMED.2021.104669 |
| 2021-07-21 |
In-Silico analysis reveals lower transcription efficiency of C241T variant of SARS-CoV-2 with host replication factors MADP1 and hnRNP-1 (edit) |
10.1016/J.IMU.2021.100670 |
| 2021-07-21 |
Dendritic cell deficiencies persist seven months after SARS-CoV-2 infection (edit) |
10.1038/S41423-021-00728-2 |
| 2021-07-21 |
Structure-based virtual screening suggests inhibitors of 3-Chymotrypsin-Like Protease of SARS-CoV-2 from Vernonia amygdalina and Occinum gratissimum (edit) |
10.1016/J.COMPBIOMED.2021.104671 |
| 2021-07-21 |
A benchmarking study of SARS-CoV-2 whole-genome sequencing protocols using COVID-19 patient samples (edit) |
10.1016/J.ISCI.2021.102892 |
| 2021-07-21 |
Classification of SARS-CoV-2 and non-SARS-CoV-2 using machine learning algorithms (edit) |
10.1016/J.COMPBIOMED.2021.104650 |
| 2021-07-21 |
Polymersomes Decorated with the SARS-CoV-2 Spike Protein Receptor-Binding Domain Elicit Robust Humoral and Cellular Immunity (edit) |
10.1021/ACSCENTSCI.1C00596 |
| 2021-07-20 |
Comprehensive O-Glycosylation Analysis of the SARS-CoV-2 Spike Protein with Biomimetic Trp-Arg Materials (edit) |
10.1021/ACS.ANALCHEM.0C04634 |
| 2021-07-20 |
SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination (edit) |
10.1016/J.CELREP.2021.109415 |
| 2021-07-20 |
Shedding light on toxicity of SARS-CoV-2 peptides in aquatic biota: A study involving neotropical mosquito larvae (Diptera: Culicidae) (edit) |
10.1016/J.ENVPOL.2021.117818 |
| 2021-07-20 |
SARS-CoV-2 Spike Mutations, L452R, T478K, E484Q and P681R, in the Second Wave of COVID-19 in Maharashtra, India (edit) |
10.3390/MICROORGANISMS9071542 |
| 2021-07-20 |
SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunity (edit) |
10.1136/ANNRHEUMDIS-2021-220781 |
| 2021-07-20 |
Flavonoids from Siparuna cristata as Potential Inhibitors of SARS-CoV-2 Replication (edit) |
10.1007/S43450-021-00162-5 |
| 2021-07-20 |
Ultrasensitive, high-throughput, and rapid simultaneous detection of SARS-CoV-2 antigens and IgG/IgM antibodies within 10 min through an immunoassay biochip (edit) |
10.1007/S00604-021-04896-W |
| 2021-07-20 |
Combining SARS-CoV-2 Proofreading Exonuclease and RNA-Dependent RNA Polymerase Inhibitors as a Strategy to Combat COVID-19: A High-Throughput in silico Screening (edit) |
10.3389/FMICB.2021.647693 |
| 2021-07-20 |
To Knot or Not to Knot: Multiple Conformations of the SARS-CoV-2 Frameshifting RNA Element (edit) |
10.1021/JACS.1C03003 |
| 2021-07-19 |
Using a household-structured branching process to analyse contact tracing in the SARS-CoV-2 pandemic (edit) |
10.1098/RSTB.2020.0267 |
| 2021-07-19 |
SARS-CoV-2: from its discovery to genome structure, transcription, and replication (edit) |
10.1186/S13578-021-00643-Z |
| 2021-07-19 |
Systematic evaluation of SARS-CoV-2 antigens enables a highly specific and sensitive multiplex serological COVID-19 assay (edit) |
10.1002/CTI2.1312 |
| 2021-07-19 |
Influence of HLA Class II Polymorphism on Predicted Cellular Immunity Against SARS-CoV-2 at the Population and Individual Level (edit) |
10.3389/FIMMU.2021.669357 |
| 2021-07-19 |
Whole-genome sequencing of SARS-CoV-2 in Uganda: implementation of the low-cost ARTIC protocol in resource-limited settings (edit) |
10.12688/F1000RESEARCH.53567.1 |
| 2021-07-19 |
Traces of SARS-CoV-2 RNA in Peripheral Blood Cells of Patients with COVID-19 (edit) |
10.1089/OMI.2021.0068 |
| 2021-07-19 |
Identifying potential human and medicinal plant microRNAs against SARS-CoV-2 3'UTR region: A computational genomics assessment (edit) |
10.1016/J.COMPBIOMED.2021.104662 |
| 2021-07-19 |
Role of Laboratory Medicine in SARS-CoV-2 Diagnostics. Lessons Learned from a Pandemic (edit) |
10.3390/HEALTHCARE9070915 |
| 2021-07-18 |
Vaccine uptake and SARS-CoV-2 antibody prevalence among 207,337 adults during May 2021 in England: REACT-2 study (edit) |
10.1101/2021.07.14.21260497 |
| 2021-07-18 |
The ROMANOV study found impaired humoral and cellular immune responses to SARS-CoV-2 mRNA vaccine in virus-unexposed patients receiving maintenance hemodialysis (edit) |
10.1016/J.KINT.2021.07.005 |
| 2021-07-18 |
Targeting SARS-CoV-2 main protease by teicoplanin: A mechanistic insight by docking, MM/GBSA and molecular dynamics simulation (edit) |
10.1016/J.MOLSTRUC.2021.131124 |
| 2021-07-18 |
Outcomes of SARS-CoV-2 Infection in Patients With Chronic Liver Disease and Cirrhosis: A National COVID Cohort Collaborative Study (edit) |
10.1053/J.GASTRO.2021.07.010 |
| 2021-07-18 |
Secreted Expression of mRNA-Encoded Truncated ACE2 Variants for SARS-CoV-2 via Lipid-Like Nanoassemblies (edit) |
10.1002/ADMA.202101707 |
| 2021-07-17 |
SARS-CoV-2 Cellular Entry Is Independent of the ACE2 Cytoplasmic Domain Signaling (edit) |
10.3390/CELLS10071814 |
| 2021-07-17 |
HAVoC, a bioinformatic pipeline for reference-based consensus assembly and lineage assignment for SARS-CoV-2 sequences (edit) |
10.1186/S12859-021-04294-2 |
| 2021-07-16 |
Biochemical characterization of protease activity of Nsp3 from SARS-CoV-2 and its inhibition by nanobodies (edit) |
10.1371/JOURNAL.PONE.0253364 |
| 2021-07-16 |
Nodosome Inhibition as a Novel Broad-Spectrum Antiviral Strategy against Arboviruses, Enteroviruses, and SARS-CoV-2 (edit) |
10.1128/AAC.00491-21 |
| 2021-07-16 |
Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp15 endoribonuclease (edit) |
10.1042/BCJ20210199 |
| 2021-07-16 |
SARS-CoV-2 infection induces the dedifferentiation of multiciliated cells and impairs mucociliary clearance (edit) |
10.1038/S41467-021-24521-X |
| 2021-07-16 |
Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp13 helicase (edit) |
10.1042/BCJ20210201 |
| 2021-07-16 |
Updated SARS-CoV-2 single nucleotide variants and mortality association (edit) |
10.1002/JMV.27191 |
| 2021-07-16 |
Mutants of human ACE2 differentially promote SARS-CoV and SARS-CoV-2 spike mediated infection (edit) |
10.1371/JOURNAL.PPAT.1009715 |
| 2021-07-16 |
Investigation of nonsynonymous mutations in the spike protein of SARS-CoV-2 and its interaction with the ACE2 receptor by molecular docking and MM/GBSA approach (edit) |
10.1016/J.COMPBIOMED.2021.104654 |
| 2021-07-16 |
Performance of five rapid serological tests in mild-diseased subjects using finger prick blood for exposure assessment to SARS-CoV-2 (edit) |
10.1016/J.JCV.2021.104897 |
| 2021-07-16 |
High-Density Blood Transcriptomics Reveals Precision Immune Signatures of SARS-CoV-2 Infection in Hospitalized Individuals (edit) |
10.3389/FIMMU.2021.694243 |
| 2021-07-16 |
Genomic characterization of SARS-CoV-2 isolates from patients in Turkey reveals the presence of novel mutations in spike and nsp12 proteins (edit) |
10.1002/JMV.27188 |
| 2021-07-16 |
Conformational Variability Correlation Prediction of Transmissibility and Neutralization Escape Ability for Multiple Mutation SARS-CoV-2 Strains using SSSCPreds (edit) |
10.1021/ACSOMEGA.1C03055 |
| 2021-07-16 |
Seq12, Seq12m, and Seq13m, peptide analogues of the spike glycoprotein shows antiviral properties against SARS-CoV-2: An in silico study through molecular docking, molecular dynamics simulation, and MM-PB/GBSA calculations (edit) |
10.1016/J.MOLSTRUC.2021.131113 |
| 2021-07-16 |
In vitro efficacy of artemisinin-based treatments against SARS-CoV-2 (edit) |
10.1038/S41598-021-93361-Y |
| 2021-07-16 |
Patterns of SARS-CoV-2 exposure and mortality suggest endemic infections, in addition to space and population factors, shape dynamics across countries (edit) |
10.1101/2021.07.12.21260394 |
| 2021-07-15 |
Sex and age bias viral burden and interferon responses during SARS-CoV-2 infection in ferrets (edit) |
10.1038/S41598-021-93855-9 |
| 2021-07-15 |
A hybrid computational framework for intelligent inter-continent SARS-CoV-2 sub-strains characterization and prediction (edit) |
10.1038/S41598-021-93757-W |
| 2021-07-15 |
Mutational analysis in international isolates and drug repurposing against SARS-CoV-2 spike protein: molecular docking and simulation approach (edit) |
10.1007/S13337-021-00720-4 |
| 2021-07-15 |
Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2 (edit) |
10.1038/S41422-021-00531-8 |
| 2021-07-15 |
Prospects for controlling future pandemics of SARS in highlights of SARS-CoV-2 (edit) |
10.1007/S13337-021-00715-1 |
| 2021-07-14 |
SARS-CoV-2 disrupts proximal elements in the JAK-STAT pathway (edit) |
10.1128/JVI.00862-21 |
| 2021-07-14 |
The Strand-biased Transcription of SARS-CoV-2 and Unbalanced Inhibition by Remdesivir (edit) |
10.1016/J.ISCI.2021.102857 |
| 2021-07-14 |
Innate immune and inflammatory responses to SARS-CoV-2: Implications for COVID-19 (edit) |
10.1016/J.CHOM.2021.05.004 |
| 2021-07-14 |
Real-world evidence for improved outcomes with histamine antagonists and aspirin in 22,560 COVID-19 patients (edit) |
10.1038/S41392-021-00689-Y |
| 2021-07-14 |
SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity (edit) |
10.1016/J.CHOM.2021.06.006 |
| 2021-07-14 |
SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape (edit) |
10.1038/S41586-021-03807-6 |
| 2021-07-14 |
Chronic lung diseases are associated with gene expression programs favoring SARS-CoV-2 entry and severity (edit) |
10.1038/S41467-021-24467-0 |
| 2021-07-14 |
SARS-CoV-2 detection in wastewater using multiplex quantitative PCR (edit) |
10.1016/J.SCITOTENV.2021.148890 |
| 2021-07-14 |
Analysis of SARS-CoV-2 reverse transcription-quantitative polymerase chain reaction cycle threshold values vis-à-vis anti-SARS-CoV-2 antibodies from a high incidence region (edit) |
10.1016/J.IJID.2021.07.014 |
| 2021-07-14 |
Antiviral peptides against the main protease of SARS-CoV-2: A molecular docking and dynamics study (edit) |
10.1016/J.ARABJC.2021.103315 |
| 2021-07-14 |
Emergence of the E484K mutation in SARS-COV-2-infected immunocompromised patients treated with bamlanivimab in Germany (edit) |
10.1016/J.LANEPE.2021.100164 |
| 2021-07-14 |
Rapid Base-Specific Calling of SARS-CoV-2 Variants of Concern Using Combined RT-PCR Melting Curve Screening and SIRPH Technology (edit) |
10.1093/OFID/OFAB364 |
| 2021-07-14 |
Implementation of an open-source robotic platform for SARS-CoV-2 testing by real-time RT-PCR (edit) |
10.1371/JOURNAL.PONE.0252509 |
| 2021-07-13 |
A head-to-head comparison of the inhibitory activities of 15 peptidomimetic SARS-CoV-2 3CLpro inhibitors (edit) |
10.1016/J.BMCL.2021.128263 |
| 2021-07-13 |
Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell (edit) |
10.1016/J.CELREP.2021.109364 |
| 2021-07-13 |
What Impact Have SARS-CoV-2/Covid-19 Pandemic induced lockdown on the number of OPD patients of Diabetes, Hypertension, Stroke (CVA), Acute Heart Disease, Mental Illness, Epilepsy, Ophthalmic, Dental and oncology in India during the lockdown months ( (edit) |
10.21203/RS.3.RS-708392/V1 |
| 2021-07-13 |
What Impact has lockdown on SARS-CoV-2/COVID-19 incidence, prevalence and mortality during second wave of pandemic in 2021: - observational analysis of Bihar (edit) |
10.32388/KWXMBG |
| 2021-07-13 |
A high-throughput cell- and virus-free assay shows reduced neutralization of SARS-CoV-2 variants by COVID-19 convalescent plasma (edit) |
10.1126/SCITRANSLMED.ABI8452 |
| 2021-07-13 |
RNA-Protein Interaction Analysis of SARS-CoV-2 5' and 3' Untranslated Regions Reveals a Role of Lysosome-Associated Membrane Protein-2a during Viral Infection (edit) |
10.1128/MSYSTEMS.00643-21 |
| 2021-07-13 |
Computational and network pharmacology studies of Phyllanthus emblica to tackle SARS-CoV-2 (edit) |
10.1016/J.PHYPLU.2021.100095 |
| 2021-07-13 |
Placental response to maternal SARS-CoV-2 infection (edit) |
10.1038/S41598-021-93931-0 |
| 2021-07-13 |
SARS-CoV-2 test positivity rate in Reno, Nevada: association with PM2.5 during the 2020 wildfire smoke events in the western United States (edit) |
10.1038/S41370-021-00366-W |
| 2021-07-12 |
Current Perspectives in the Discovery of Newer Medications Against the Outbreak of COVID-19 (edit) |
10.3389/FMOLB.2021.648232 |
| 2021-07-12 |
What Impact Have SARS-CoV-2/Covid-19 Pandemic induced lockdown on the number of OPD patients of Diabetes, Hypertension, Stroke (CVA), Acute Heart Disease, Mental Illness, Epilepsy, Ophthalmic, Dental and oncology in India during the lockdown months ( (edit) |
10.31219/OSF.IO/ENAFH |
| 2021-07-12 |
What Impact Have SARS-CoV-2/Covid-19 Pandemic induced lockdown on the number of OPD patients of Diabetes, Hypertension, Stroke (CVA), Acute Heart Disease, Mental Illness, Epilepsy, Ophthalmic, Dental and oncology in India during the lockdown months ( (edit) |
10.32388/8I2HH5 |
| 2021-07-12 |
Viral MicroRNAs Encoded by Nucleocapsid Gene of SARS-CoV-2 Are Detected during Infection, and Targeting Metabolic Pathways in Host Cells (edit) |
10.3390/CELLS10071762 |
| 2021-07-12 |
Transmission event of SARS-CoV-2 Delta variant reveals multiple vaccine breakthrough infections (edit) |
10.1101/2021.06.28.21258780 |
| 2021-07-12 |
Host-Virus Chimeric Events in SARS-CoV-2-Infected Cells Are Infrequent and Artifactual (edit) |
10.1128/JVI.00294-21 |
| 2021-07-12 |
Role of Extracellular Vimentin in Cancer-Cell Functionality and Its Influence on Cell Monolayer Permeability Changes Induced by SARS-CoV-2 Receptor Binding Domain (edit) |
10.3390/IJMS22147469 |
| 2021-07-12 |
Emerging SARS-CoV-2 variants of concern and potential intervention approaches (edit) |
10.1186/S13054-021-03662-X |
| 2021-07-12 |
ILRUN Downregulates ACE2 Expression and Blocks Infection of Human Cells by SARS-CoV-2 (edit) |
10.1128/JVI.00327-21 |
| 2021-07-12 |
Deep learning identifies antigenic determinants of severe SARS-CoV-2 infection within T-cell repertoires (edit) |
10.1038/S41598-021-93608-8 |
| 2021-07-12 |
Attenuation of clinical and immunological outcomes during SARS-CoV-2 infection by ivermectin (edit) |
10.15252/EMMM.202114122 |
| 2021-07-12 |
Strategies to target SARS-CoV-2 entry and infection using dual mechanisms of inhibition by acidification inhibitors (edit) |
10.1371/JOURNAL.PPAT.1009706 |
| 2021-07-12 |
SARS-CoV-2 Crisis Management With a Wastewater Early-Warning System in the Bavarian District of Berchtesgadener Land, Germany (edit) |
10.3238/ARZTEBL.M2021.0261 |
| 2021-07-10 |
RAAS, ACE2 and COVID-19; a mechanistic review (edit) |
10.1016/J.SJBS.2021.07.003 |
| 2021-07-10 |
Structural Evaluation of the Spike Glycoprotein Variants on SARS-CoV-2 Transmission and Immune Evasion (edit) |
10.3390/IJMS22147425 |
| 2021-07-10 |
Investigations into the origin of SARS-CoV-2: an update (edit) |
|
| 2021-07-10 |
Exploiting the molecular basis of age and gender differences in outcomes of SARS-CoV-2 infections (edit) |
10.1016/J.CSBJ.2021.07.002 |
| 2021-07-09 |
Pathogenic lipid‐binding antiphospholipid antibodies are associated with severity of COVID‐19 (edit) |
10.1111/JTH.15455 |
| 2021-07-09 |
Efficacy of Portable Air Cleaners and Masking for Reducing Indoor Exposure to Simulated Exhaled SARS-CoV-2 Aerosols - United States, 2021 (edit) |
10.15585/MMWR.MM7027E1 |
| 2021-07-09 |
Estimating infectiousness throughout SARS-CoV-2 infection course (edit) |
10.1126/SCIENCE.ABI5273 |
| 2021-07-09 |
COVseq is a cost-effective workflow for mass-scale SARS-CoV-2 genomic surveillance (edit) |
10.21203/RS.3.PEX-1338/V3 |
| 2021-07-09 |
Peptidomimetic α-Acyloxymethylketone Warheads with Six-Membered Lactam P1 Glutamine Mimic: SARS-CoV-2 3CL Protease Inhibition, Coronavirus Antiviral Activity, and in Vitro Biological Stability (edit) |
10.1021/ACS.JMEDCHEM.1C00616 |
| 2021-07-09 |
Evaluation of Screening Tests in Bavarian Healthcare Facilities during the Second Wave of the SARS-CoV-2 Pandemic (edit) |
10.3390/IJERPH18147371 |
| 2021-07-09 |
SARS-CoV-2 (COVID-19), viral load and clinical outcomes; lessons learned one year into the pandemic: A systematic review (edit) |
10.5492/WJCCM.V10.I4.132 |
| 2021-07-08 |
Targeting liquid–liquid phase separation of SARS-CoV-2 nucleocapsid protein promotes innate antiviral immunity by elevating MAVS activity (edit) |
10.1038/S41556-021-00710-0 |
| 2021-07-08 |
Autoimmunity to Annexin A2 predicts mortality among hospitalised COVID-19 patients (edit) |
10.1183/13993003.00918-2021 |
| 2021-07-08 |
REACT-1 round 13 interim report: acceleration of SARS-CoV-2 Delta epidemic in the community in England during late June and early July 2021 (edit) |
10.1101/2021.07.08.21260185 |
| 2021-07-08 |
Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization (edit) |
10.1038/S41586-021-03777-9 |
| 2021-07-08 |
SARS-CoV-2 Variants and Vaccines (edit) |
10.1056/NEJMSR2105280 |
| 2021-07-08 |
Immunoinformatics approach for multi-epitope vaccine design against structural proteins and ORF1a polyprotein of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) (edit) |
10.1186/S40794-021-00147-1 |
| 2021-07-08 |
First detection and molecular analysis of SARS-CoV-2 from a naturally infected cat from Argentina (edit) |
10.1016/J.VETMIC.2021.109179 |
| 2021-07-08 |
Evaluation of in vitro activity of copper gluconate against SARS-CoV-2 using confocal microscopy-based high content screening (edit) |
10.1016/J.JTEMB.2021.126818 |
| 2021-07-08 |
Estimating the wave 1 and wave 2 infection fatality rates from SARS-CoV-2 in India (edit) |
10.1186/S13104-021-05652-2 |
| 2021-07-07 |
Interactomes of SARS-CoV-2 and human coronaviruses reveal host factors potentially affecting pathogenesis (edit) |
10.15252/EMBJ.2021107776 |
| 2021-07-07 |
SARS-CoV-2 Nsp3 unique domain SUD interacts with guanine quadruplexes and G4-ligands inhibit this interaction (edit) |
10.1093/NAR/GKAB571 |
| 2021-07-07 |
Glycosylation of SARS-CoV-2: structural and functional insights (edit) |
10.1007/S00216-021-03499-X |
| 2021-07-07 |
Drugs repurposed for COVID-19 by virtual screening of 6,218 drugs and cell-based assay (edit) |
10.1073/PNAS.2024302118 |
| 2021-07-07 |
SARS-CoV-2-specific immune response in COVID-19 convalescent individuals (edit) |
10.1038/S41392-021-00686-1 |
| 2021-07-07 |
Determination of intermediate state structures in the opening pathway of SARS-CoV-2 spike using cryo-electron microscopy (edit) |
10.1039/D1SC00244A |
| 2021-07-07 |
Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies (edit) |
10.1038/S41467-021-24435-8 |
| 2021-07-07 |
Generation of glucocorticoid-resistant SARS-CoV-2 T cells for adoptive cell therapy (edit) |
10.1016/J.CELREP.2021.109432 |
| 2021-07-07 |
Remdesivir Strongly Binds to RNA-Dependent RNA Polymerase, Membrane Protein, and Main Protease of SARS-CoV-2: Indication From Molecular Modeling and Simulations (edit) |
10.3389/FPHAR.2021.710778 |
| 2021-07-07 |
A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutations (edit) |
10.1016/J.CELREP.2021.109433 |
| 2021-07-07 |
A selective sweep in the Spike gene has driven SARS-CoV-2 human adaptation (edit) |
10.1016/J.CELL.2021.07.007 |
| 2021-07-07 |
ROS/RNS Balancing, Aerobic Fermentation Regulation and Cell Cycle Control - a Complex Early Trait ('CoV-MAC-TED') for Combating SARS-CoV-2-Induced Cell Reprogramming (edit) |
10.3389/FIMMU.2021.673692 |
| 2021-07-07 |
Low-cost biosensor for rapid detection of SARS-CoV-2 at the point of care (edit) |
10.1016/J.MATT.2021.05.003 |
| 2021-07-06 |
Mechanisms of immunothrombosis in COVID-19 (edit) |
10.1097/MOH.0000000000000666 |
| 2021-07-06 |
What makes (hydroxy)chloroquine ineffective against COVID-19: insights from cell biology (edit) |
10.1093/JMCB/MJAB016 |
| 2021-07-06 |
Meta-analysis of randomized trials of ivermectin to treat SARS-CoV-2 infection (edit) |
10.1093/OFID/OFAB358 |
| 2021-07-06 |
Kidney injury molecule-1 is a potential receptor for SARS-CoV-2 (edit) |
10.1093/JMCB/MJAB003 |
| 2021-07-06 |
Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: the COVIDSurg mortality score (edit) |
10.1093/BJS/ZNAB183 |
| 2021-07-06 |
Entry, egress and vertical transmission of SARS-CoV-2 (edit) |
10.1093/JMCB/MJAB013 |
| 2021-07-06 |
Mendelian randomization analysis provides causality of smoking on the expression of ACE2, a putative SARS-CoV-2 receptor (edit) |
10.7554/ELIFE.64188 |
| 2021-07-06 |
First molecular-based detection of SARS-CoV-2 virus in the field-collected houseflies (edit) |
10.1038/S41598-021-93439-7 |
| 2021-07-06 |
SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants (edit) |
10.1371/JOURNAL.PMED.1003656 |
| 2021-07-06 |
SARS-CoV-2 infection in the mouse olfactory system (edit) |
10.1038/S41421-021-00290-1 |
| 2021-07-06 |
Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis (edit) |
10.1038/S41418-021-00817-9 |
| 2021-07-06 |
Electrostatic Interactions Explain the Higher Binding Affinity of the CR3022 Antibody for SARS-CoV-2 than the 4A8 Antibody (edit) |
10.1021/ACS.JPCB.1C03639 |
| 2021-07-06 |
Prevalence of SARS-CoV-2 genes in water reclamation facilities: From influent to anaerobic digester (edit) |
10.1016/J.SCITOTENV.2021.148905 |
| 2021-07-06 |
Human immunoglobulin from transchromosomic bovines hyperimmunized with SARS-CoV-2 spike antigen efficiently neutralizes viral variants (edit) |
10.1080/21645515.2021.1940652 |
| 2021-07-06 |
Lockdowns exert selection pressure on overdispersion of SARS-CoV-2 variants (edit) |
10.1101/2021.06.30.21259771 |
| 2021-07-05 |
Recombinant SARS-CoV-2 envelope protein traffics to the trans-Golgi network following amphipol-mediated delivery into human cells (edit) |
10.1016/J.JBC.2021.100940 |
| 2021-07-05 |
Host factors facilitating SARS-CoV-2 virus infection and replication in the lungs (edit) |
10.1007/S00018-021-03889-5 |
| 2021-07-05 |
SARS-CoV-2 respiratory screening of asymptomatic stem cell donors on day of collection; to test or not to test. UK Aligned Stem Cell Donor Registry (edit) |
10.1038/S41409-021-01379-7 |
| 2021-07-05 |
Increased susceptibility of human endothelial cells to infections by SARS-CoV-2 variants (edit) |
10.1007/S00395-021-00882-8 |
| 2021-07-05 |
SARS-COV-2 seroprevalence among employees of a University Hospital in Belgium during the 2020 COVID-19 outbreak (COVEMUZ-study) (edit) |
10.1017/S0950268821001540 |
| 2021-07-05 |
SARS-CoV-2-specific humoral and cellular immunity persists through 9 months irrespective of COVID-19 severity at hospitalisation (edit) |
10.1002/CTI2.1306 |
| 2021-07-05 |
Early detection of SARS-CoV-2 P.1 variant in Southern Brazil and reinfection of the same patient by P.2. (edit) |
10.1590/S1678-9946202163058 |
| 2021-07-05 |
In silico analysis of the aggregation propensity of the SARS-CoV-2 proteome: Insight into possible cellular pathologies (edit) |
10.1016/J.BBAPAP.2021.140693 |
| 2021-07-05 |
Lectin Pathway Mediates Complement Activation by SARS-CoV-2 Proteins (edit) |
10.3389/FIMMU.2021.714511 |
| 2021-07-05 |
Personal protective equipment waste potentially infected with SARS-CoV-2 – a new global challenge for biological safety (edit) |
10.17816/PHF71586 |
| 2021-07-05 |
COVID-19 vaccines dampen genomic diversity of SARS-CoV-2: Unvaccinated patients exhibit more antigenic mutational variance (edit) |
10.1101/2021.07.01.21259833 |
| 2021-07-04 |
SARS-CoV-2 RBD-Tetanus Toxoid Conjugate Vaccine Induces a Strong Neutralizing Immunity in Preclinical Studies (edit) |
10.1021/ACSCHEMBIO.1C00272 |
| 2021-07-03 |
Between immunomodulation and immunotolerance: The role of IFNγ in SARS-CoV-2 disease (edit) |
10.1016/J.CYTO.2021.155637 |
| 2021-07-03 |
SARS-CoV-2 Infection Remodels the Phenotype and Promotes Angiogenesis of Primary Human Lung Endothelial Cells (edit) |
10.3390/MICROORGANISMS9071438 |
| 2021-07-03 |
The SARS-CoV-2 receptor-binding domain expressed in Pichia pastoris as a candidate vaccine antigen (edit) |
10.1101/2021.06.29.21259605 |
| 2021-07-03 |
SARS-CoV-2 Lambda Variant Remains Susceptible to Neutralization by mRNA Vaccine-elicited Antibodies and Convalescent Serum (edit) |
10.1101/2021.07.02.450959 |
| 2021-07-03 |
A mass spectrometry-based targeted assay for detection of SARS-CoV-2 antigen from clinical specimens (edit) |
10.1016/J.EBIOM.2021.103465 |
| 2021-07-02 |
Implications of Spike-glycoprotein processing at S1/S2 by Furin, at S2’ by Furin and/or TMPRSS2 and shedding of ACE2: cell-to-cell fusion, cell entry and infectivity of SARS-CoV-2 (edit) |
10.1101/2021.07.02.450896 |
| 2021-07-02 |
Recent advances in developing small-molecule inhibitors against SARS-CoV-2 (edit) |
10.1016/J.APSB.2021.06.016 |
| 2021-07-02 |
Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp14/nsp10 exoribonuclease (edit) |
10.1042/BCJ20210198 |
| 2021-07-02 |
Site-Specific Steric Control of SARS-CoV-2 Spike Glycosylation (edit) |
10.1021/ACS.BIOCHEM.1C00279 |
| 2021-07-02 |
An all-out assault on SARS-CoV-2 replication (edit) |
10.1042/BCJ20210256 |
| 2021-07-02 |
Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp14 RNA cap methyltransferase (edit) |
10.1042/BCJ20210219 |
| 2021-07-02 |
ACE2-lentiviral transduction enables mouse SARS-CoV-2 infection and mapping of receptor interactions (edit) |
10.1371/JOURNAL.PPAT.1009723 |
| 2021-07-01 |
Potential zoonotic sources of SARS-CoV-2 infections (edit) |
10.1111/TBED.13872 |
| 2021-07-01 |
How to study SARS-CoV-2 in soils? (edit) |
10.1016/J.ENVRES.2020.110464 |
| 2021-07-01 |
Pharmacogenomics of genetic polymorphism within the genes responsible for SARS-CoV-2 susceptibility and the drug-metabolising genes used in treatment (edit) |
10.1002/RMV.2194 |
| 2021-07-01 |
Mutations in SARS-CoV-2 nsp7 and nsp8 proteins and their predicted impact on replication/transcription complex structure (edit) |
10.1002/JMV.26791 |
| 2021-07-01 |
SARS-Cov-2 spike protein fragment 674–685 protects mitochondria from releasing cytochrome c in response to apoptogenic influence (edit) |
10.1016/J.BBRC.2021.05.018 |
| 2021-07-01 |
SARS-CoV-2's claimed natural origin is undermined by issues with genome sequences of its relative strains: Coronavirus sequences RaTG13, MP789 and RmYN02 raise multiple questions to be critically addressed by the scientific community (edit) |
10.1002/BIES.202100015 |
| 2021-07-01 |
Variations in Orf3a protein of SARS-CoV-2 alter its structure and function (edit) |
10.1016/J.BBREP.2021.100933 |
| 2021-07-01 |
SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern (edit) |
10.1126/SCIENCE.ABI7994 |
| 2021-07-01 |
Science, not speculation, is essential to determine how SARS-CoV-2 reached humans (edit) |
10.1016/S0140-6736(21)01419-7 |
| 2021-07-01 |
SARS-CoV-2 neutralising antibody testing in Europe: towards harmonisation of neutralising antibody titres for better use of convalescent plasma and comparability of trial data (edit) |
10.2807/1560-7917.ES.2021.26.27.2100568 |
| 2021-07-01 |
Predicted dominance of variant Delta of SARS-CoV-2 before Tokyo Olympic Games, Japan, July 2021 (edit) |
10.2807/1560-7917.ES.2021.26.27.2100570 |
| 2021-07-01 |
Sputnik V Vaccine Elicits Seroconversion and Neutralizing Capacity to SARS CoV-2 after a Single Dose (edit) |
10.1016/J.XCRM.2021.100359 |
| 2021-07-01 |
Compartmentalization-aided interaction screening reveals extensive high-order complexes within the SARS-CoV-2 proteome (edit) |
10.1016/J.CELREP.2021.109482 |
| 2021-07-01 |
Biochemical features and mutations of key proteins in SARS-CoV-2 and their impacts on RNA therapeutics (edit) |
10.1016/J.BCP.2021.114424 |
| 2021-07-01 |
Can coronavirus disease 2019 (COVID-19) trigger exacerbation of multiple sclerosis? A retrospective study (edit) |
10.1016/J.MSARD.2021.102947 |
| 2021-07-01 |
Targeting Runt-Related Transcription Factor 1 Prevents Pulmonary Fibrosis and Reduces Expression of Severe Acute Respiratory Syndrome Coronavirus 2 Host Mediators (edit) |
10.1016/J.AJPATH.2021.04.006 |
| 2021-07-01 |
SARS-CoV-2 transmission during rugby league matches: do players become infected after participating with SARS-CoV-2 positive players? (edit) |
10.1136/BJSPORTS-2020-103714 |
| 2021-07-01 |
What Impact has lockdown on SARS-CoV-2/COVID-19 incidence, prevalence and mortality during second wave of pandemic in 2021: - observational & statistical analysis of Bihar-version 2 (edit) |
10.31219/OSF.IO/63WJ5 |
| 2021-07-01 |
Genetic epidemiology of SARS-CoV-2 transmission in renal dialysis units - A high risk community-hospital interface (edit) |
10.1016/J.JINF.2021.04.020 |
| 2021-07-01 |
Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study (edit) |
10.1016/S1473-3099(21)00224-3 |
| 2021-07-01 |
The development and kinetics of functional antibody-dependent cell-mediated cytotoxicity (ADCC) to SARS-CoV-2 spike protein (edit) |
10.1016/J.VIROL.2021.03.009 |
| 2021-07-01 |
COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets (edit) |
10.1038/S41586-021-03570-8 |
| 2021-07-01 |
Altered microRNA expression in COVID-19 patients enables identification of SARS-CoV-2 infection (edit) |
10.1371/JOURNAL.PPAT.1009759 |
| 2021-07-01 |
A weak COPI binding motif in the cytoplasmic tail of SARS-CoV-2 spike glycoprotein is necessary for its cleavage, glycosylation, and localization (edit) |
10.1002/1873-3468.14109 |
| 2021-07-01 |
Nasal ciliated cells are primary targets for SARS-CoV-2 replication in the early stage of COVID-19 (edit) |
10.1172/JCI148517 |
| 2021-07-01 |
Intranasal gene therapy to prevent infection by SARS-CoV-2 variants (edit) |
10.1371/JOURNAL.PPAT.1009544 |
| 2021-07-01 |
Fetal and placental infection with SARS-CoV-2 in early pregnancy (edit) |
10.1002/JMV.26965 |
| 2021-07-01 |
Structural basis for accommodation of emerging B.1.351 and B.1.1.7 variants by two potent SARS-CoV-2 neutralizing antibodies (edit) |
10.1016/J.STR.2021.05.014 |
| 2021-07-01 |
Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants (edit) |
10.1038/S41586-021-03676-Z |
| 2021-07-01 |
SARS-CoV-2 variants, spike mutations and immune escape (edit) |
10.1038/S41579-021-00573-0 |
| 2021-07-01 |
Probing the SAM Binding Site of SARS-CoV-2 Nsp14 In Vitro Using SAM Competitive Inhibitors Guides Developing Selective Bisubstrate Inhibitors (edit) |
10.1177/24725552211026261 |
| 2021-07-01 |
Coronavirus genomic nsp14-ExoN, structure, role, mechanism, and potential application as a drug target (edit) |
10.1002/JMV.27009 |
| 2021-07-01 |
Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions (edit) |
10.1016/J.IMMUNI.2021.06.002 |
| 2021-07-01 |
Validation of a combined ELISA to detect IgG, IgA and IgM antibody responses to SARS-CoV-2 in mild or moderate non-hospitalised patients (edit) |
10.1016/J.JIM.2021.113046 |
| 2021-07-01 |
Salivary glands are a target for SARS-CoV-2: a source for saliva contamination (edit) |
10.1002/PATH.5679 |
| 2021-07-01 |
The RNA sensor MDA5 detects SARS-CoV-2 infection (edit) |
10.1038/S41598-021-92940-3 |
| 2021-07-01 |
Role of host factors in SARS-CoV-2 entry (edit) |
10.1016/J.JBC.2021.100847 |
| 2021-07-01 |
The role of the SARS-CoV-2 envelope protein as a pH-dependent cation channel (edit) |
10.1113/JP281785 |
| 2021-07-01 |
SARS-CoV-2 viremia is associated with distinct proteomic pathways and predicts COVID-19 outcomes (edit) |
10.1172/JCI148635 |
| 2021-07-01 |
The SARS-CoV-2 envelope (E) protein has evolved towards membrane topology robustness (edit) |
10.1016/J.BBAMEM.2021.183608 |
| 2021-07-01 |
Serum sample neutralisation of BBIBP-CorV and ZF2001 vaccines to SARS-CoV-2 501Y.V2 (edit) |
10.1016/S2666-5247(21)00082-3 |
| 2021-07-01 |
Neurological manifestations temporally associated with SARS-CoV-2 infection in pediatric patients in Mexico (edit) |
10.1007/S00381-021-05104-Z |
| 2021-07-01 |
Concurrent mutations in RNA-dependent RNA polymerase and spike protein emerged as the epidemiologically most successful SARS-CoV-2 variant (edit) |
10.1038/S41598-021-91662-W |
| 2021-07-01 |
Assessment of weather and atmospheric pollution as a co-factor in the spread of SARS-CoV-2 (edit) |
10.23750/ABM.V92I3.11354 |
| 2021-07-01 |
SARS-CoV-2 transmission in kindergarten to grade 12 schools in the Vancouver Coastal Health region: a descriptive epidemiologic study (edit) |
10.9778/CMAJO.20210106 |
| 2021-07-01 |
AmpliCoV: Rapid Whole-Genome Sequencing Using Multiplex PCR Amplification and Real-Time Oxford Nanopore MinION Sequencing Enables Rapid Variant Identification of SARS-CoV-2 (edit) |
10.3389/FMICB.2021.651151 |
| 2021-07-01 |
An Evolutionary Portrait of the Progenitor SARS-CoV-2 and Its Dominant Offshoots in COVID-19 Pandemic (edit) |
10.1093/MOLBEV/MSAB118 |
| 2021-07-01 |
SARS-CoV-2 (COVID-19) pneumonia: Incidental finding on 18F-FDG PET/CT study for vasculitis diagnosis (edit) |
10.1016/J.REMNIE.2020.08.004 |
| 2021-07-01 |
Inflammatory cytokine storms severity may be fueled by interactions of micronuclei and RNA viruses such as COVID-19 virus SARS-CoV-2. A hypothesis (edit) |
10.1016/J.MRREV.2021.108395 |
| 2021-07-01 |
Evolution and spread of SARS-CoV-2 likely to be affected by climate (edit) |
10.1016/J.ECOCHG.2021.100005 |
| 2021-07-01 |
Hypotheses behind the very rare cases of thrombosis with thrombocytopenia syndrome after SARS-CoV-2 vaccination (edit) |
10.1016/J.THROMRES.2021.05.010 |
| 2021-07-01 |
The soluble catalytic ectodomain of ACE2 a biomarker of cardiac remodelling: new insights for heart failure and COVID19 (edit) |
10.1007/S10741-020-10066-6 |
| 2021-07-01 |
Clinical efficacy and security of glycyrrhizic acid preparation in the treatment of anti-SARS-CoV-2 drug-induced liver injury: a protocol of systematic review and meta-analysis (edit) |
10.1136/BMJOPEN-2021-051484 |
| 2021-07-01 |
Evaluation of cochlear functions in infants exposed to SARS-CoV-2 intrauterine (edit) |
10.1016/J.AMJOTO.2021.102982 |
| 2021-07-01 |
Expansion of SARS-CoV-2 sequencing capacity globally is vital for future control of the COVID-19 pandemic (edit) |
10.4038/SLJM.V30I1.273 |
| 2021-07-01 |
Decontamination of respirators amid shortages due to SARS-CoV-2 (edit) |
10.1007/S43630-021-00064-4 |
| 2021-07-01 |
SARS-CoV-2 and hearing: An audiometric analysis of COVID-19 hospitalized patients (edit) |
10.1016/J.JOTO.2021.01.005 |
| 2021-07-01 |
Hearing screening outcomes in neonates of SARS-CoV-2 positive pregnant women (edit) |
10.1016/J.IJPORL.2021.110754 |
| 2021-07-01 |
The origins and potential future of SARS-CoV-2 variants of concern in the evolving COVID-19 pandemic (edit) |
10.1016/J.CUB.2021.06.049 |
| 2021-06-30 |
Untangling COVID-19 and autoimmunity: Identification of plausible targets suggests multi organ involvement (edit) |
10.1016/J.MOLIMM.2021.06.021 |
| 2021-06-30 |
Binding of the SARS-CoV-2 spike protein to glycans (edit) |
10.1016/J.SCIB.2021.01.010 |
| 2021-06-30 |
Antibodies elicited by mRNA-1273 vaccination bind more broadly to the receptor binding domain than do those from SARS-CoV-2 infection (edit) |
10.1126/SCITRANSLMED.ABI9915 |
| 2021-06-30 |
Replication Kinetics, Cell Tropism, and Associated Immune Responses in SARS-CoV-2- and H5N1 Virus-Infected Human Induced Pluripotent Stem Cell-Derived Neural Models (edit) |
10.1128/MSPHERE.00270-21 |
| 2021-06-30 |
Exploitation of the Secretory Pathway by SARS-CoV-2 Envelope (edit) |
10.1101/2021.06.30.450614 |
| 2021-06-30 |
Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update (edit) |
10.3389/FIMMU.2021.658519 |
| 2021-06-30 |
Seleno-Functionalization of Quercetin Improves the Non-Covalent Inhibition of M and Its Antiviral Activity in Cells against SARS-CoV-2 (edit) |
10.3390/IJMS22137048 |
| 2021-06-30 |
SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescent patients for 10 months with successful development of stem cell-like memory T cells (edit) |
10.1038/S41467-021-24377-1 |
| 2021-06-30 |
Enhanced Expression of Autoantigens During SARS-CoV-2 Viral Infection (edit) |
10.3389/FIMMU.2021.686462 |
| 2021-06-30 |
Molecular Epidemiology of SARS-CoV-2 in Greece Reveals Low Rates of Onward Virus Transmission after Lifting of Travel Restrictions Based on Risk Assessment during Summer 2020 (edit) |
10.1128/MSPHERE.00180-21 |
| 2021-06-30 |
Symptom-based early-stage differentiation between SARS-CoV-2 versus other respiratory tract infections-Upper Silesia pilot study (edit) |
10.1038/S41598-021-93046-6 |
| 2021-06-29 |
IL-13 is a driver of COVID-19 severity (edit) |
10.1172/JCI.INSIGHT.150107 |
| 2021-06-29 |
Identification of a High-Frequency Intrahost SARS-CoV-2 Spike Variant with Enhanced Cytopathic and Fusogenic Effects (edit) |
10.1128/MBIO.00788-21 |
| 2021-06-29 |
Activation of NF-κB and induction of proinflammatory cytokine expressions mediated by ORF7a protein of SARS-CoV-2 (edit) |
10.1038/S41598-021-92941-2 |
| 2021-06-29 |
Inhibition of the 3CL Protease and SARS-CoV-2 Replication by Dalcetrapib (edit) |
10.1021/ACSOMEGA.1C01797 |
| 2021-06-29 |
Allosteric Activation of SARS-CoV-2 RNA-Dependent RNA Polymerase by Remdesivir Triphosphate and Other Phosphorylated Nucleotides (edit) |
10.1128/MBIO.01423-21 |
| 2021-06-29 |
Absolute quantitation of individual SARS-CoV-2 RNA molecules: a new paradigm for infection dynamics and variant differences (edit) |
10.1101/2021.06.29.450133 |
| 2021-06-29 |
Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7 (edit) |
10.1016/J.CELREP.2021.109292 |
| 2021-06-29 |
Meta-Analysis and Structural Dynamics of the Emergence of Genetic Variants of SARS-CoV-2 (edit) |
10.3389/FMICB.2021.676314 |
| 2021-06-29 |
Relevant SARS-CoV-2 Genome Variation through Six Months of Worldwide Monitoring (edit) |
10.1155/2021/5553173 |
| 2021-06-29 |
Distinctive features of SARS-CoV-2-specific T cells predict recovery from severe COVID-19 (edit) |
10.1016/J.CELREP.2021.109414 |
| 2021-06-29 |
Production of SARS-CoV-2 Specific IFN-γ/IL-10 Co-producing CD4 T Cells from Convalescent Donors to Treat COVID-19: A Hypothesis (edit) |
10.14218/ERHM.2021.00008 |
| 2021-06-29 |
Antiviral Activity of Vitis vinifera Leaf Extract against SARS-CoV-2 and HSV-1 (edit) |
10.3390/V13071263 |
| 2021-06-28 |
SARS-CoV-2 signaling pathway map: A functional landscape of molecular mechanisms in COVID-19 (edit) |
|
| 2021-06-28 |
The endogenous cellular protease inhibitor SPINT2 controls SARS-CoV-2 viral infection and is associated to disease severity (edit) |
10.1371/JOURNAL.PPAT.1009687 |
| 2021-06-28 |
Dynamics of the SARS-CoV-2 nucleoprotein N-terminal domain triggers RNA duplex destabilization (edit) |
10.1016/J.BPJ.2021.06.003 |
| 2021-06-28 |
What Impact has lockdown on SARS-CoV-2/COVID-19 incidence, prevalence and mortality during second wave of pandemic in 2021: - observational analysis of Bihar (edit) |
10.21203/RS.3.RS-635528/V2 |
| 2021-06-28 |
One Health: EAACI Position Paper on coronaviruses at the human-animal interface, with a specific focus on comparative and zoonotic aspects of SARS-Cov-2 (edit) |
10.1111/ALL.14991 |
| 2021-06-28 |
A STING in the tail for SARS-CoV-2 (edit) |
10.1038/S41590-021-00971-9 |
| 2021-06-28 |
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial (edit) |
10.1016/S1473-3099(21)00319-4 |
| 2021-06-28 |
COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants (edit) |
10.1038/S41467-021-24285-4 |
| 2021-06-28 |
Insilico study on the effect of SARS-CoV-2 RBD hotspot mutants' interaction with ACE2 to understand the binding affinity and stability (edit) |
10.1016/J.VIROL.2021.06.009 |
| 2021-06-27 |
Variants in SARS-CoV-2 associated with mild or severe outcome (edit) |
10.1093/EMPH/EOAB019 |
| 2021-06-27 |
Effect of Tenofovir Disoproxil Fumarate and Emtricitabine on nasopharyngeal SARS-CoV-2 viral load burden amongst outpatients with COVID-19: A pilot, randomized, open-label phase 2 trial (edit) |
10.1016/J.ECLINM.2021.100993 |
| 2021-06-26 |
SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness (edit) |
10.1016/S0140-6736(21)01358-1 |
| 2021-06-26 |
Antibody landscape against SARS-CoV-2 reveals significant differences between non-structural/accessory and structural proteins (edit) |
10.1016/J.CELREP.2021.109391 |
| 2021-06-26 |
Upregulation of oxidative stress gene markers during SARS-COV-2 viral infection (edit) |
10.1016/J.FREERADBIOMED.2021.06.018 |
| 2021-06-25 |
SARS-CoV-2–Related Acute Respiratory Distress Syndrome Uncovers a Patient with Severe Combined Immunodeficiency Disease (edit) |
10.1007/S10875-021-01063-X |
| 2021-06-25 |
Characterization of SARS-CoV-2 nucleocapsid protein reveals multiple functional consequences of the C-terminal domain (edit) |
10.1016/J.ISCI.2021.102681 |
| 2021-06-25 |
Energetic and structural features of SARS-CoV-2 N-protein co-assemblies with nucleic acids (edit) |
10.1016/J.ISCI.2021.102523 |
| 2021-06-25 |
Averting an outbreak of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in a university residence hall through wastewater surveillance (edit) |
10.1101/2021.06.23.21259176 |
| 2021-06-25 |
Quantification of SARS-CoV-2 variant mutations (HV69-70 and E484K/N501Y) in settled solids using digital RT-PCR v1 (edit) |
10.17504/PROTOCOLS.IO.BV5BN82N |
| 2021-06-25 |
An automatic pipeline for the design of irreversible derivatives identifies a potent SARS-CoV-2 Mpro inhibitor (edit) |
10.1016/J.CHEMBIOL.2021.05.018 |
| 2021-06-25 |
Using mixed-effects modeling to estimate decay kinetics of response to SARS-CoV-2 infection (edit) |
10.1093/ABT/TBAB013 |
| 2021-06-25 |
Limited intestinal inflammation despite diarrhea, fecal viral RNA and SARS-CoV-2-specific IgA in patients with acute COVID-19 (edit) |
10.1038/S41598-021-92740-9 |
| 2021-06-25 |
Persistence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Virus and Viral RNA in Relation to Surface Type and Contamination Concentration (edit) |
10.1128/AEM.00526-21 |
| 2021-06-24 |
Autoantibodies stabilize neutrophil extracellular traps in COVID-19 (edit) |
10.1172/JCI.INSIGHT.150111 |
| 2021-06-24 |
The architecture of the SARS-CoV-2 RNA genome inside virion (edit) |
10.1038/S41467-021-22785-X |
| 2021-06-24 |
Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant (edit) |
10.1016/J.CELL.2021.04.025 |
| 2021-06-24 |
Targeting the Conserved Stem Loop 2 Motif in the SARS-CoV-2 Genome (edit) |
10.1128/JVI.00663-21 |
| 2021-06-24 |
Phosphatidylserine Receptors Enhance SARS-CoV-2 Infection: AXL as a Therapeutic Target for COVID-19 (edit) |
10.1101/2021.06.15.448419 |
| 2021-06-24 |
An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies (edit) |
10.1016/J.CELL.2021.05.032 |
| 2021-06-24 |
Human Nasal and Lung Tissues Infected with SARS-CoV-2 Provide Insights into Differential Tissue-Specific and Virus-Specific Innate Immune Responses in the Upper and Lower Respiratory Tract (edit) |
10.1128/JVI.00130-21 |
| 2021-06-24 |
Targeting the m6A RNA modification pathway blocks SARS-CoV-2 and HCoV-OC43 replication (edit) |
10.1101/GAD.348320.121 |
| 2021-06-24 |
Evolution, correlation, structural impact and dynamics of emerging SARS-CoV-2 variants (edit) |
10.1016/J.CSBJ.2021.06.037 |
| 2021-06-24 |
In silico study of medicinal plants with cyclodextrin inclusion complex as the potential inhibitors against SARS-CoV-2 main protease (Mpro) and spike (S) receptor (edit) |
10.1016/J.IMU.2021.100645 |
| 2021-06-24 |
A novel G-quadruplex aptamer-based spike trimeric antigen test for the detection of SARS-CoV-2 (edit) |
10.1016/J.OMTN.2021.06.014 |
| 2021-06-24 |
Novel adenosine derivatives against SARS-CoV-2 RNA-dependent RNA polymerase: an in silico perspective (edit) |
10.1007/S43440-021-00300-9 |
| 2021-06-24 |
Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection (edit) |
10.1101/2021.06.21.21258528 |
| 2021-06-24 |
The Role of Neuropilin-1 (NRP-1) in SARS-CoV-2 Infection: Review (edit) |
10.3390/JCM10132772 |
| 2021-06-23 |
TMPRSS2 expression dictates the entry route used by SARS‐CoV‐2 to infect host cells (edit) |
10.15252/EMBJ.2021107821 |
| 2021-06-23 |
Nsp2 has the potential to be a drug target revealed by global identification of SARS-CoV-2 Nsp2-interacting proteins (edit) |
10.1093/ABBS/GMAB088 |
| 2021-06-23 |
SARS-CoV-2 spike protein induces paracrine senescence and leukocyte adhesion in endothelial cells (edit) |
10.1128/JVI.00794-21 |
| 2021-06-23 |
Interfering Reactive Cysteine Proteome in Covid-19 Disease (edit) |
10.2174/0929867328666210623142811 |
| 2021-06-23 |
Deletion of ER-retention motif on SARS-CoV-2 spike protein reduces cell hybrid during cell–cell fusion (edit) |
10.1186/S13578-021-00626-0 |
| 2021-06-23 |
Heparan Sulfate Proteoglycans as Attachment Factor for SARS-CoV-2 (edit) |
10.1021/ACSCENTSCI.1C00010 |
| 2021-06-23 |
COVseq is a cost-effective workflow for mass-scale SARS-CoV-2 genomic surveillance (edit) |
10.1038/S41467-021-24078-9 |
| 2021-06-23 |
In silico analysis of RNA-dependent RNA polymerase of the SARS-CoV-2 and therapeutic potential of existing antiviral drugs (edit) |
10.1016/J.COMPBIOMED.2021.104591 |
| 2021-06-23 |
Soluble Neuropilin-1 Response to Hypoglycemia in Type 2 Diabetes: Increased Risk or Protection in SARS-CoV-2 Infection? (edit) |
10.3389/FENDO.2021.665134 |
| 2021-06-23 |
Deleterious Effects of SARS-CoV-2 Infection on Human Pancreatic Cells (edit) |
10.3389/FCIMB.2021.678482 |
| 2021-06-23 |
Natural variants in SARS-CoV-2 Spike protein pinpoint structural and functional hotspots with implications for prophylaxis and therapeutic strategies (edit) |
10.1038/S41598-021-92641-X |
| 2021-06-22 |
The SARS-CoV-2 Spike Protein Subunit 1 induces COVID-19-like acute lung injury in Κ18-hACE2 transgenic mice and barrier dysfunction in human endothelial cells (edit) |
10.1152/AJPLUNG.00223.2021 |
| 2021-06-22 |
Cryo-EM structure of SARS-CoV-2 ORF3a in lipid nanodiscs (edit) |
10.1038/S41594-021-00619-0 |
| 2021-06-22 |
Genome‐wide association analysis of COVID‐19 mortality risk in SARS‐CoV‐2 genomes identifies mutation in the SARS‐CoV‐2 spike protein that colocalizes with P.1 of the Brazilian strain (edit) |
10.1002/GEPI.22421 |
| 2021-06-22 |
Impact of Expressing Cells on Glycosylation and Glycan of the SARS-CoV-2 Spike Glycoprotein (edit) |
10.1021/ACSOMEGA.1C01785 |
| 2021-06-22 |
Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2 (edit) |
10.1126/SCIENCE.ABI4708 |
| 2021-06-22 |
Factors affecting the transmission of SARS-CoV-2 in school settings (edit) |
10.1101/2021.06.18.21259156 |
| 2021-06-22 |
The total number and mass of SARS-CoV-2 virions (edit) |
10.1073/PNAS.2024815118 |
| 2021-06-22 |
Interplay between SARS-CoV-2-derived miRNAs, immune system, vitamin D pathway and respiratory system (edit) |
10.1111/JCMM.16694 |
| 2021-06-21 |
Simultaneous enrichment and separation of neutral and sialyl glycopeptides of SARS-CoV-2 spike protein enabled by dual-functionalized Ti-IMAC material (edit) |
10.1007/S00216-021-03433-1 |
| 2021-06-21 |
Unique autoantibody prevalence in long-term recovered SARS-CoV-2-infected individuals (edit) |
10.1016/J.JAUT.2021.102682 |
| 2021-06-21 |
Seroprevalence of SARS-CoV-2 antibodies in Saint Petersburg, Russia: a population-based study (edit) |
10.1038/S41598-021-92206-Y |
| 2021-06-21 |
What impacts have geographical locations on the cases and deaths from COVID-19/SARS-CoV-2 pandemic in 36 states and union territories of India:-observational analysis in India (edit) |
10.21203/RS.3.RS-640243/V1 |
| 2021-06-21 |
SARS-CoV-2-mediated dysregulation of metabolism and autophagy uncovers host-targeting antivirals (edit) |
10.1038/S41467-021-24007-W |
| 2021-06-21 |
Structure-function relations of the SARS-CoV-2 spike protein and impact of mutations in the variants of concern (edit) |
10.5802/CRBIOL.53 |
| 2021-06-21 |
Quantifying SARS-CoV-2 Infection Risk Within the Google/Apple Exposure Notification Framework to Inform Quarantine Recommendations (edit) |
10.1111/RISA.13768 |
| 2021-06-21 |
Engineered ACE2 receptor therapy overcomes mutational escape of SARS-CoV-2 (edit) |
10.1038/S41467-021-24013-Y |
| 2021-06-21 |
Transmission of SARS-CoV-2 in Inpatient and Outpatient Settings in a Veterans Affairs Health Care System (edit) |
|
| 2021-06-21 |
A Novel SARS-CoV-2 Viral Sequence Bioinformatic Pipeline Has Found Genetic Evidence That the Viral 3' Untranslated Region (UTR) Is Evolving and Generating Increased Viral Diversity (edit) |
10.3389/FMICB.2021.665041 |
| 2021-06-21 |
On the airborne transmission of SARS-CoV-2 and relationship with indoor conditions at a hospital (edit) |
10.1016/J.ATMOSENV.2021.118563 |
| 2021-06-21 |
Ingestion of Cyanogens from Cassava Generates Disinfectant Hypothiocyanite That May Decrease the Transmissibility of SARS-CoV-2 (edit) |
10.20935/AL1211 |
| 2021-06-20 |
Effect of clinical isolate or cleavage site mutations in the SARS-CoV-2 spike protein on protein stability, cleavage, and cell-cell fusion (edit) |
10.1016/J.JBC.2021.100902 |
| 2021-06-20 |
SARS-CoV-2 antibody persistence in COVID-19 convalescent plasma donors: Dependency on assay format and applicability to serosurveillance (edit) |
10.1111/TRF.16555 |
| 2021-06-19 |
Selinexor, a novel selective inhibitor of nuclear export, reduces SARS-CoV-2 infection and protects the respiratory system in vivo (edit) |
10.1016/J.ANTIVIRAL.2021.105115 |
| 2021-06-19 |
What impacts have geographical locations on the cases and deaths from COVID-19/SARS-CoV-2 pandemic in 36 states and union territories of India:-observational analysis in India (edit) |
10.31219/OSF.IO/GR6VU |
| 2021-06-19 |
Construction of an autophagy interaction network based on competitive endogenous RNA reveals the key pathways and central genes of SARS-CoV-2 infection in vivo (edit) |
10.1016/J.MICPATH.2021.105051 |
| 2021-06-19 |
Methods to Identify Immunogenic Peptides in SARS-CoV-2 Spike and Protective Monoclonal Antibodies in COVID-19 Patients (edit) |
10.1002/SMTD.202100058 |
| 2021-06-18 |
What Impact has lockdown on SARS-CoV-2/COVID-19 incidence, prevalence and mortality during second wave of pandemic in 2021: - observational analysis of Bihar (edit) |
10.21203/RS.3.RS-635528/V1 |
| 2021-06-18 |
Heparan Sulfate Proteoglycans in Viral Infection and Treatment: A Special Focus on SARS-CoV-2 (edit) |
10.3390/IJMS22126574 |
| 2021-06-18 |
In vitro antiviral activity of the anti-HCV drugs daclatasvir and sofosbuvir against SARS-CoV-2, the aetiological agent of COVID-19 (edit) |
10.1093/JAC/DKAB072 |
| 2021-06-18 |
A Computational-Based Drug Repurposing Method Targeting SARS-CoV-2 and its Neurological Manifestations Genes and Signaling Pathways (edit) |
10.1177/11779322211026728 |
| 2021-06-18 |
Discovery of SARS-CoV-2 Papain-like Protease Inhibitors through a Combination of High-Throughput Screening and a FlipGFP-Based Reporter Assay (edit) |
10.1021/ACSCENTSCI.1C00519 |
| 2021-06-18 |
The landscape of antibody binding in SARS-CoV-2 infection (edit) |
10.1371/JOURNAL.PBIO.3001265 |
| 2021-06-18 |
The First Molecular Characterization of Serbian SARS-CoV-2 Isolates From a Unique Early Second Wave in Europe (edit) |
10.3389/FMICB.2021.691154 |
| 2021-06-18 |
Immunohistochemistry for protein detection in PFA-fixed paraffin-embedded SARS-CoV-2-infected COPD airway epithelium (edit) |
10.1016/J.XPRO.2021.100663 |
| 2021-06-18 |
Bayes Lines Tool (BLT): a SQL-script for analyzing diagnostic test results with an application to SARS-CoV-2-testing (edit) |
10.12688/F1000RESEARCH.51061.2 |
| 2021-06-18 |
Molecular insight into the genomic variation of SARS-CoV-2 strains from current outbreak (edit) |
10.1016/J.COMPBIOLCHEM.2021.107533 |
| 2021-06-18 |
COVID-19: Sleep, Circadian Rhythms and Immunity – Repurposing Drugs and Chronotherapeutics for SARS-CoV-2 (edit) |
10.3389/FNINS.2021.674204 |
| 2021-06-18 |
SARS-CoV-2 seroprevalence among Vancouver public school staff in British Columbia, Canada (edit) |
10.1101/2021.06.16.21258861 |
| 2021-06-17 |
A cautionary perspective regarding the isolation and serial propagation of SARS-CoV-2 in Vero cells (edit) |
10.1038/S41541-021-00346-Z |
| 2021-06-17 |
Functional landscape of SARS-CoV-2 cellular restriction (edit) |
10.1016/J.MOLCEL.2021.04.008 |
| 2021-06-17 |
Neutralization of SARS-CoV-2 Variants B.1.429 and B.1.351 (edit) |
10.1056/NEJMC2103740 |
| 2021-06-17 |
Development of potent and selective inhibitors targeting the papain-like protease of SARS-CoV-2 (edit) |
10.1016/J.CHEMBIOL.2021.04.020 |
| 2021-06-17 |
What Impact has lockdown on SARS-CoV-2/COVID-19 incidence, prevalence and mortality during second wave of pandemic in 2021: - observational analysis of Bihar (edit) |
10.31219/OSF.IO/SH97Q |
| 2021-06-17 |
Overcoming Culture Restriction for SARS-CoV-2 in Human Cells Facilitates the Screening of Compounds Inhibiting Viral Replication (edit) |
10.1128/AAC.00097-21 |
| 2021-06-17 |
Immunological Response to SARS-CoV-2 Is Sustained by Vitamin D: A Case Presentation of One-Year Follow-Up (edit) |
10.3390/REPORTS4020018 |
| 2021-06-17 |
Cold and dry winter conditions are associated with greater SARS-CoV-2 transmission at regional level in western countries during the first epidemic wave (edit) |
10.1038/S41598-021-91798-9 |
| 2021-06-17 |
Energetic and structural basis for the differences in infectivity between the wild-type and mutant spike proteins of SARS-CoV-2 in the Mexican population (edit) |
10.1016/J.JMGM.2021.107970 |
| 2021-06-17 |
The Antigenicity of Epidemic SARS-CoV-2 Variants in the United Kingdom (edit) |
10.3389/FIMMU.2021.687869 |
| 2021-06-17 |
Peptides of H. sapiens and P. falciparum that are predicted to bind strongly to HLA-A*24:02 and homologous to a SARS-CoV-2 peptide (edit) |
10.1016/J.ACTATROPICA.2021.106013 |
| 2021-06-17 |
Defining the methodological approach for wastewater-based epidemiological studies-Surveillance of SARS-CoV-2 (edit) |
10.1016/J.ETI.2021.101696 |
| 2021-06-17 |
Computational search of hybrid human/SARS-CoV-2 dsRNA reveals unique viral sequences that diverge from those of other coronavirus strains (edit) |
10.1016/J.HELIYON.2021.E07284 |
| 2021-06-17 |
ELV-N32 and RvD6 isomer decrease pro-inflammatory cytokines, senescence programming, ACE2 and SARS-CoV-2-spike protein RBD binding in injured cornea (edit) |
10.1038/S41598-021-92293-X |
| 2021-06-17 |
Dynamic Profiling of Binding and Allosteric Propensities of the SARS-CoV-2 Spike Protein with Different Classes of Antibodies: Mutational and Perturbation-Based Scanning Reveals the Allosteric Duality of Functionally Adaptable Hotspots (edit) |
10.1021/ACS.JCTC.1C00372 |
| 2021-06-16 |
SARS-CoV-2 NSP12 protein is not an IFN-β antagonist (edit) |
10.1128/JVI.00747-21 |
| 2021-06-16 |
Current State of Knowledge about Role of Pets in Zoonotic Transmission of SARS-CoV-2 (edit) |
10.3390/V13061149 |
| 2021-06-16 |
Structural Basis and Function of the N Terminus of SARS-CoV-2 Nonstructural Protein 1 (edit) |
10.1128/SPECTRUM.00169-21 |
| 2021-06-16 |
Multivalency transforms SARS-CoV-2 antibodies into ultrapotent neutralizers (edit) |
10.1038/S41467-021-23825-2 |
| 2021-06-16 |
Low Acyl Gellan as an Excipient to Improve the Sprayability and Mucoadhesion of Iota Carrageenan in a Nasal Spray to Prevent Infection With SARS-CoV-2 (edit) |
10.3389/FMEDT.2021.687681 |
| 2021-06-16 |
Serology in COVID-19: Comparison of Two Methods (edit) |
10.3390/IJERPH18126497 |
| 2021-06-15 |
Screening a Library of FDA-Approved and Bioactive Compounds for Antiviral Activity against SARS-CoV-2 (edit) |
10.1021/ACSINFECDIS.1C00017 |
| 2021-06-15 |
The mechanisms of action of Ivermectin against SARS-CoV-2: An evidence-based clinical review article (edit) |
10.1038/S41429-021-00430-5 |
| 2021-06-15 |
Multi-omic profiling reveals widespread dysregulation of innate immunity and hematopoiesis in COVID-19 (edit) |
10.1084/JEM.20210582 |
| 2021-06-15 |
Mn2+ coordinates Cap-0-RNA to align substrates for efficient 2'--methyl transfer by SARS-CoV-2 nsp16 (edit) |
|
| 2021-06-15 |
Discovery of pan-ErbB inhibitors protecting from SARS-CoV-2 replication, inflammation, and lung injury by a drug repurposing screen (edit) |
10.1101/2021.05.15.444128 |
| 2021-06-15 |
COVID-19 pandemic: SARS-CoV-2 specific vaccines and challenges, protection via BCG trained immunity, and clinical trials (edit) |
10.1080/14760584.2021.1938550 |
| 2021-06-15 |
Identification of pyrogallol as a warhead in design of covalent inhibitors for the SARS-CoV-2 3CL protease (edit) |
10.1038/S41467-021-23751-3 |
| 2021-06-15 |
Rapid Increase of SARS-CoV-2 Variant B.1.1.7 Detected in Sewage Samples from England between October 2020 and January 2021 (edit) |
10.1128/MSYSTEMS.00353-21 |
| 2021-06-15 |
Design and in silico validation of polymerase chain reaction primers to detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (edit) |
10.1038/S41598-021-91817-9 |
| 2021-06-15 |
Molecular benchmarks of a SARS-CoV-2 epidemic (edit) |
10.1038/S41467-021-23883-6 |
| 2021-06-15 |
Neurotropism of SARS-CoV-2 in idiopathic hearing disorders (edit) |
10.26444/JPCCR/136055 |
| 2021-06-15 |
Impaired humoral immunity to SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients and dialysis patients (edit) |
10.1126/SCIIMMUNOL.ABJ1031 |
| 2021-06-14 |
Molecular biology of the SARs‐CoV‐2 spike protein: A review of current knowledge (edit) |
10.1002/JMV.27132 |
| 2021-06-14 |
Revealing the Structural Plasticity of SARS-CoV-2 nsp7 and nsp8 Using Structural Proteomics (edit) |
10.1021/JASMS.1C00086 |
| 2021-06-14 |
Restriction of SARS-CoV-2 replication by targeting programmed −1 ribosomal frameshifting (edit) |
10.1073/PNAS.2023051118 |
| 2021-06-14 |
Landscape and selection of vaccine epitopes in SARS-CoV-2 (edit) |
10.1186/S13073-021-00910-1 |
| 2021-06-14 |
Genes with 5' terminal oligopyrimidine tracts preferentially escape global suppression of translation by the SARS-CoV-2 Nsp1 protein (edit) |
10.1261/RNA.078661.120 |
| 2021-06-14 |
Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection (edit) |
10.1038/S41586-021-03696-9 |
| 2021-06-14 |
SARS-CoV-2 infection and transmission in the North American deer mouse (edit) |
10.1038/S41467-021-23848-9 |
| 2021-06-12 |
Emerging Infection, Vaccination, and Guillain–Barré Syndrome: A Review (edit) |
10.1007/S40120-021-00261-4 |
| 2021-06-12 |
Identification of Monocytes Associated with Severe COVID-19 in the PBMCs of Severely Infected patients Through Single-Cell Transcriptome Sequencing (edit) |
10.1016/J.ENG.2021.05.009 |
| 2021-06-12 |
Review: SARS-CoV-2 infection in farmed minks – an overview of current knowledge on occurrence, disease and epidemiology (edit) |
10.1016/J.ANIMAL.2021.100272 |
| 2021-06-12 |
Multilevel systems biology analysis of lung transcriptomics data identifies key miRNAs and potential miRNA target genes for SARS-CoV-2 infection (edit) |
10.1016/J.COMPBIOMED.2021.104570 |
| 2021-06-12 |
Rational optimization of a human neutralizing antibody of SARS-CoV-2 (edit) |
10.1016/J.COMPBIOMED.2021.104550 |
| 2021-06-12 |
Technical framework for wastewater-based epidemiology of SARS-CoV-2 (edit) |
10.1016/J.SCITOTENV.2021.148271 |
| 2021-06-11 |
Recent Insights into Emerging Coronavirus: SARS-CoV-2 (edit) |
10.1021/ACSINFECDIS.0C00646 |
| 2021-06-11 |
Therapeutic Potential of Nitazoxanide: An Appropriate Choice for Repurposing versus SARS-CoV-2? (edit) |
10.1021/ACSINFECDIS.0C00478 |
| 2021-06-11 |
Structural basis of coronavirus E protein interactions with human PALS1 PDZ domain (edit) |
10.1038/S42003-021-02250-7 |
| 2021-06-11 |
Autoantibodies against ACE2 and angiotensin type-1 receptors increase severity of COVID-19 (edit) |
10.1016/J.JAUT.2021.102683 |
| 2021-06-11 |
Challenges for Targeting SARS-CoV-2 Proteases as a Therapeutic Strategy for COVID-19 (edit) |
10.1021/ACSINFECDIS.0C00815 |
| 2021-06-11 |
Palmitoylation of SARS-CoV-2 S protein is essential for viral infectivity (edit) |
10.1038/S41392-021-00651-Y |
| 2021-06-11 |
Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy (edit) |
10.1038/S41392-021-00653-W |
| 2021-06-11 |
Small-Molecule Inhibitors of the Coronavirus Spike: ACE2 Protein-Protein Interaction as Blockers of Viral Attachment and Entry for SARS-CoV-2 (edit) |
10.1021/ACSINFECDIS.1C00070 |
| 2021-06-11 |
Capivasertib restricts SARS-CoV-2 cellular entry: a potential clinical application for COVID-19 (edit) |
10.7150/IJBS.57810 |
| 2021-06-11 |
Distinct clinical and immunological profiles of patients with evidence of SARS-CoV-2 infection in sub-Saharan Africa (edit) |
10.1038/S41467-021-23267-W |
| 2021-06-11 |
Symptoms reported by SARS-CoV-2 seropositive and seronegative healthcare and administrative employees in Denmark from May to August 2020 (edit) |
10.1016/J.IJID.2021.06.017 |
| 2021-06-10 |
Conformational Dynamics in the Interaction of SARS-CoV-2 Papain-like Protease with Human Interferon-Stimulated Gene 15 Protein (edit) |
10.1021/ACS.JPCLETT.1C00831 |
| 2021-06-10 |
Mechanism of Inhibition of the Reproduction of SARS-CoV-2 and Ebola Viruses by Remdesivir (edit) |
10.1021/ACS.BIOCHEM.1C00292 |
| 2021-06-10 |
SARS-CoV-2 envelope protein causes acute respiratory distress syndrome (ARDS)-like pathological damages and constitutes an antiviral target (edit) |
10.1038/S41422-021-00519-4 |
| 2021-06-10 |
Conformational dynamics of 13 amino acids long NSP11 of SARS-CoV-2 under membrane mimetics and different solvent conditions (edit) |
10.1016/J.MICPATH.2021.105041 |
| 2021-06-10 |
BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants (edit) |
10.1038/S41586-021-03693-Y |
| 2021-06-10 |
SARS-CoV-2 Genetic Variability and Non-Specific Immunity Associated with the Use of Different BCG Strains-A Molecular and Clinical Approach (edit) |
10.3390/VACCINES9060639 |
| 2021-06-10 |
The SARS-CoV-2 Nucleocapsid Protein and Its Role in Viral Structure, Biological Functions, and a Potential Target for Drug or Vaccine Mitigation (edit) |
10.3390/V13061115 |
| 2021-06-10 |
SARS-CoV-2 Nonstructural Protein 1 Inhibits the Interferon Response by Causing Depletion of Key Host Signaling Factors (edit) |
10.1128/JVI.00266-21 |
| 2021-06-10 |
Genome-wide analysis in 756,646 individuals provides first genetic evidence that expression influences COVID-19 risk and yields genetic risk scores predictive of severe disease (edit) |
10.1101/2020.12.14.20248176 |
| 2021-06-10 |
Phycobilins as Potent Food Bioactive Broad-Spectrum Inhibitors Against Proteases of SARS-CoV-2 and Other Coronaviruses: A Preliminary Study (edit) |
10.3389/FMICB.2021.645713 |
| 2021-06-10 |
Discovery and optimization of 2-((1H-indol-3-yl)thio)-N-benzyl-acetamides as novel SARS-CoV-2 RdRp inhibitors (edit) |
10.1016/J.EJMECH.2021.113622 |
| 2021-06-10 |
Entry-inhibitory role of catechins against SARS-CoV-2 and its UK variant (edit) |
10.1016/J.COMPBIOMED.2021.104560 |
| 2021-06-10 |
Elovanoids downregulate SARS-CoV-2 cell-entry, canonical mediators and enhance protective signaling in human alveolar cells (edit) |
10.1038/S41598-021-91794-Z |
| 2021-06-10 |
Transmission and Protection against Reinfection in the Ferret Model with the SARS-CoV-2 USA-WA1/2020 Reference Isolate (edit) |
10.1128/JVI.02232-20 |
| 2021-06-10 |
Simulated sunlight decreases the viability of SARS-CoV-2 in mucus (edit) |
10.1371/JOURNAL.PONE.0253068 |
| 2021-06-10 |
Comparative analysis of viral infection outcomes in human seminal fluid from prior viral epidemics and Sars-CoV-2 may offer trends for viral sexual transmissibility and long-term reproductive health implications (edit) |
10.1186/S12978-021-01172-1 |
| 2021-06-10 |
Estimates and Determinants of SARS-Cov-2 Seroprevalence and Infection Fatality Ratio Using Latent Class Analysis: The Population-Based Tirschenreuth Study in the Hardest-Hit German County in Spring 2020 (edit) |
10.3390/V13061118 |
| 2021-06-10 |
Discovery of Antivirals Using Phage Display (edit) |
10.3390/V13061120 |
| 2021-06-09 |
(4-Hydroxyphenyl) retinamide suppresses SARS-CoV-2 spike protein-mediated cell-cell fusion by a dihydroceramide Δ4-desaturase 1-independent mechanism (edit) |
|
| 2021-06-09 |
SARS-CoV-2 Envelope (E) protein interacts with PDZ-domain-2 of host tight junction protein ZO1 (edit) |
10.1371/JOURNAL.PONE.0251955 |
| 2021-06-09 |
Viral and host transcriptomes in SARS-CoV-2 infected human lung cells (edit) |
|
| 2021-06-09 |
Endothelial glycocalyx shields the interaction of SARS-CoV-2 spike protein with ACE2 receptors (edit) |
10.1038/S41598-021-91231-1 |
| 2021-06-09 |
What’s in the Pipeline? Evidence on the Transmission of SARS-CoV-2 via Building Wastewater Plumbing Systems (edit) |
10.3389/FBUIL.2021.641745 |
| 2021-06-09 |
Conformational Ensembles of Noncoding Elements in the SARS-CoV-2 Genome from Molecular Dynamics Simulations (edit) |
10.1021/JACS.1C01094 |
| 2021-06-09 |
Fast-spreading SARS-CoV-2 variants: challenges to and new design strategies of COVID-19 vaccines (edit) |
10.1038/S41392-021-00644-X |
| 2021-06-09 |
SARS-CoV-2 Variants of Interest and Concern naming scheme conducive for global discourse (edit) |
10.1038/S41564-021-00932-W |
| 2021-06-09 |
Extraction of Viral Nucleic Acids with Carbon Nanotubes Increases SARS-CoV-2 Quantitative Reverse Transcription Polymerase Chain Reaction Detection Sensitivity (edit) |
10.1021/ACSNANO.1C02494 |
| 2021-06-09 |
Landscape-Based Mutational Sensitivity Cartography and Network Community Analysis of the SARS-CoV-2 Spike Protein Structures: Quantifying Functional Effects of the Circulating D614G Variant (edit) |
10.1021/ACSOMEGA.1C02336 |
| 2021-06-09 |
Glycyrrhizic Acid for COVID-19: Findings of Targeting Pivotal Inflammatory Pathways Triggered by SARS-CoV-2 (edit) |
10.3389/FPHAR.2021.631206 |
| 2021-06-09 |
Antibody Responses to SARS-CoV-2 Following an Outbreak Among Marine Recruits With Asymptomatic or Mild Infection (edit) |
10.3389/FIMMU.2021.681586 |
| 2021-06-09 |
Rational Design of Hybrid SARS-CoV-2 Main Protease Inhibitors Guided by the Superimposed Cocrystal Structures with the Peptidomimetic Inhibitors GC-376, Telaprevir, and Boceprevir (edit) |
10.1021/ACSPTSCI.1C00099 |
| 2021-06-09 |
Network medicine links SARS-CoV-2/COVID-19 infection to brain microvascular injury and neuroinflammation in dementia-like cognitive impairment (edit) |
10.1186/S13195-021-00850-3 |
| 2021-06-09 |
Screening of FDA-approved compound library identifies potential small-molecule inhibitors of SARS-CoV-2 non-structural proteins NSP1, NSP4, NSP6 and NSP13: molecular modeling and molecular dynamics studies (edit) |
10.1007/S42485-021-00067-W |
| 2021-06-09 |
Protein purification and crystallization of HLA-A∗02:01 in complex with SARS-CoV-2 peptides (edit) |
10.1016/J.XPRO.2021.100635 |
| 2021-06-08 |
Senolytics reduce coronavirus-related mortality in old mice (edit) |
10.1126/SCIENCE.ABE4832 |
| 2021-06-08 |
Structural basis for SARS-CoV-2 envelope protein recognition of human cell junction protein PALS1 (edit) |
10.1038/S41467-021-23533-X |
| 2021-06-08 |
SARS-CoV-2 exacerbates proinflammatory responses in myeloid cells through C-type lectin receptors and Tweety family member 2 (edit) |
10.1016/J.IMMUNI.2021.05.006 |
| 2021-06-08 |
Recognition and inhibition of SARS-CoV-2 by humoral innate immunity pattern recognition molecules (edit) |
10.1101/2021.06.07.21258350 |
| 2021-06-08 |
SARS-CoV-2 Neutralizing Human Antibodies Protect Against Lower Respiratory Tract Disease in a Hamster Model (edit) |
10.1093/INFDIS/JIAB289 |
| 2021-06-08 |
Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant (edit) |
10.1016/J.IMMUNI.2021.03.023 |
| 2021-06-08 |
SARS-CoV-2 detection status associates with bacterial community composition in patients and the hospital environment (edit) |
10.1186/S40168-021-01083-0 |
| 2021-06-08 |
Molecular evidence of SARS-CoV-2 in New York before the first pandemic wave (edit) |
10.1038/S41467-021-23688-7 |
| 2021-06-08 |
Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics (edit) |
10.1016/J.CELREP.2021.109305 |
| 2021-06-08 |
Interaction of selected terpenoids with two SARS-CoV-2 key therapeutic targets: An in silico study through molecular docking and dynamics simulations (edit) |
10.1016/J.COMPBIOMED.2021.104538 |
| 2021-06-08 |
Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species (edit) |
10.1016/J.IMMUNI.2021.06.003 |
| 2021-06-08 |
A versatile reverse genetics platform for SARS-CoV-2 and other positive-strand RNA viruses (edit) |
10.1038/S41467-021-23779-5 |
| 2021-06-08 |
A computational approach for rational discovery of inhibitors for non-structural protein 1 of SARS-CoV-2 (edit) |
10.1016/J.COMPBIOMED.2021.104555 |
| 2021-06-08 |
Can Antiviral Activity of Licorice Help Fight COVID-19 Infection? (edit) |
10.3390/BIOM11060855 |
| 2021-06-07 |
Hepatitis C Virus Protease Inhibitors Show Differential Efficacy and Interactions with Remdesivir for Treatment of SARS-CoV-2 (edit) |
|
| 2021-06-07 |
Cell entry by SARS-CoV-2 (edit) |
10.1016/J.TIBS.2021.06.001 |
| 2021-06-07 |
B.1.1.7 and B.1.351 variants are highly virulent in K18-ACE2 transgenic mice and show different pathogenic patterns from early SARS-CoV-2 strains (edit) |
10.1101/2021.06.05.447221 |
| 2021-06-07 |
Evolution of enhanced innate immune evasion by the SARS-CoV-2 B.1.1.7 UK variant (edit) |
10.1101/2021.06.06.446826 |
| 2021-06-07 |
ACE2-Independent Interaction of SARS-CoV-2 Spike Protein with Human Epithelial Cells Is Inhibited by Unfractionated Heparin (edit) |
10.3390/CELLS10061419 |
| 2021-06-07 |
A potential antiviral activity of Esculentoside A against binding interactions of SARS-COV-2 spike protein and angiotensin converting enzyme 2 (ACE2) (edit) |
10.1016/J.IJBIOMAC.2021.06.017 |
| 2021-06-07 |
SARS-CoV-2 RNAemia and proteomic trajectories inform prognostication in COVID-19 patients admitted to intensive care (edit) |
10.1038/S41467-021-23494-1 |
| 2021-06-07 |
A comparison of five epidemiological models for transmission of SARS-CoV-2 in India (edit) |
10.1186/S12879-021-06077-9 |
| 2021-06-05 |
The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies (edit) |
10.1016/J.CELL.2021.06.002 |
| 2021-06-05 |
Potential inhibitors of SARS-CoV-2 (COVID 19) proteases PLpro and Mpro/ 3CLpro: molecular docking and simulation studies of three pertinent medicinal plant natural components (edit) |
10.1016/J.CRPHAR.2021.100038 |
| 2021-06-05 |
Understanding the SARS-CoV-2 virus to mitigate current and future pandemic(s) (edit) |
10.1007/S13337-021-00696-1 |
| 2021-06-04 |
Evidence-based approach to early outpatient treatment of SARS-CoV-2 (COVID-19) infection (edit) |
10.1080/08998280.2021.1925049 |
| 2021-06-04 |
Atomic force microscopy analysis of native infectious and inactivated SARS-CoV-2 virions (edit) |
10.1038/S41598-021-91371-4 |
| 2021-06-04 |
Rapid endotheliitis and vascular damage characterize SARS-CoV-2 infection in a human lung-on-chip model (edit) |
10.15252/EMBR.202152744 |
| 2021-06-04 |
The Many Faces of Innate Immunity in SARS-CoV-2 Infection (edit) |
10.3390/VACCINES9060596 |
| 2021-06-04 |
High SARS-CoV-2 Viral Load in Urine Sediment Correlates with Acute Kidney Injury and Poor COVID-19 Outcome (edit) |
10.1681/ASN.2021010059 |
| 2021-06-04 |
Two novel oxetane containing lignans and a new megastigmane from Paronychia arabica and in silico analysis of them as prospective SARS-CoV-2 inhibitors (edit) |
10.1039/D1RA02486H |
| 2021-06-04 |
Epitope Classification and RBD Binding Properties of Neutralizing Antibodies Against SARS-CoV-2 Variants of Concern (edit) |
10.3389/FIMMU.2021.691715 |
| 2021-06-04 |
A single dose of the SARS-CoV-2 vaccine BNT162b2 elicits Fc-mediated antibody effector functions and T cell responses (edit) |
10.1016/J.CHOM.2021.06.001 |
| 2021-06-04 |
Engineering of Chinese Hamster Ovary Cells With NDPK-A to Enhance DNA Nuclear Delivery Combined With EBNA1 Plasmid Maintenance Gives Improved Exogenous Transient Reporter, mAb and SARS-CoV-2 Spike Protein Expression (edit) |
10.3389/FBIOE.2021.679448 |
| 2021-06-03 |
Development of SARS-CoV-2 vaccines: challenges, risks, and the way forward (edit) |
10.1080/21645515.2020.1845524 |
| 2021-06-03 |
SARS-CoV-2 proteins and anti-COVID-19 drugs induce lytic reactivation of an oncogenic virus (edit) |
10.1038/S42003-021-02220-Z |
| 2021-06-03 |
Fe-S cofactors in the SARS-CoV-2 RNA-dependent RNA polymerase are potential antiviral targets (edit) |
10.1126/SCIENCE.ABI5224 |
| 2021-06-03 |
Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination (edit) |
10.1016/S0140-6736(21)01290-3 |
| 2021-06-03 |
The Pro-Inflammatory Chemokines CXCL9, CXCL10 and CXCL11 Are Upregulated Following SARS-CoV-2 Infection in an AKT-Dependent Manner (edit) |
10.3390/V13061062 |
| 2021-06-03 |
Immunological dysfunction persists for 8 months following initial mild-moderate SARS-CoV-2 infection (edit) |
10.1101/2021.06.01.21257759 |
| 2021-06-03 |
Nasal delivery of an IgM offers broad protection from SARS-CoV-2 variants (edit) |
10.1038/S41586-021-03673-2 |
| 2021-06-02 |
COVID-19 disrupts spermatogenesis through the oxidative stress pathway following induction of apoptosis (edit) |
10.1007/S10495-021-01680-2 |
| 2021-06-02 |
Surface Proteins of SARS-CoV-2 Drive Airway Epithelial Cells to Induce IFN-Dependent Inflammation (edit) |
10.4049/JIMMUNOL.2001407 |
| 2021-06-02 |
A metal ion orients SARS-CoV-2 mRNA to ensure accurate 2′-O methylation of its first nucleotide (edit) |
10.1038/S41467-021-23594-Y |
| 2021-06-02 |
Epigallocatechin Gallate Inhibits the Uridylate-Specific Endoribonuclease Nsp15 and Efficiently Neutralizes the SARS-CoV-2 Strain (edit) |
10.1021/ACS.JAFC.1C02050 |
| 2021-06-02 |
High titers and low fucosylation of early human anti-SARS-CoV-2 IgG promote inflammation by alveolar macrophages (edit) |
10.1126/SCITRANSLMED.ABF8654 |
| 2021-06-02 |
Variant-genetic and transcript-expression analysis showed a role for the chemokine-receptor CCR5 in COVID-19 severity (edit) |
10.1016/J.INTIMP.2021.107825 |
| 2021-06-02 |
Nanoluciferase complementation-based bioreporter reveals the importance of N-linked glycosylation of SARS-CoV-2 S for viral entry (edit) |
10.1016/J.YMTHE.2021.02.007 |
| 2021-06-02 |
Practices and activities among healthcare personnel with severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection working in different healthcare settings-ten Emerging Infections Program sites, April-November 2020 (edit) |
10.1017/ICE.2021.262 |
| 2021-06-02 |
Active Learning and the Potential of Neural Networks Accelerate Molecular Screening for the Design of a New Molecule Effective against SARS-CoV-2 (edit) |
10.1155/2021/6696012 |
| 2021-06-02 |
Point-of-care CRISPR-Cas-assisted SARS-CoV-2 detection in an automated and portable droplet magnetofluidic device (edit) |
10.1016/J.BIOS.2021.113390 |
| 2021-06-02 |
Designing an effective therapeutic siRNA to silence RdRp gene of SARS-CoV-2 (edit) |
10.1016/J.MEEGID.2021.104951 |
| 2021-06-01 |
The association of smoking status with SARS-CoV-2 infection, hospitalisation and mortality from COVID-19: A living rapid evidence review with Bayesian meta-analyses (version 7) (edit) |
10.1111/ADD.15276 |
| 2021-06-01 |
Understanding Viral Shedding of SARS-CoV-2: Review of Current Literature (edit) |
10.1017/ICE.2020.1273 |
| 2021-06-01 |
Comparison of Infection Risks and Clinical Outcomes in Patients with and without SARS-CoV-2 Lung Infection under Renin-Angiotensin-Aldosterone-System Blockade - Systematic Review and Meta-Analysis (edit) |
10.1111/BCP.14660 |
| 2021-06-01 |
JAK-STAT pathway inhibition and their implications in COVID-19 therapy (edit) |
10.1080/00325481.2020.1855921 |
| 2021-06-01 |
Spheroids and organoids as humanized 3D scaffold-free engineered tissues for SARS-CoV-2 viral infection and drug screening (edit) |
10.1111/AOR.13880 |
| 2021-06-01 |
The role of renin-angiotensin system activated phagocytes in the SARS-CoV-2 coronavirus infection (edit) |
10.1016/J.JVS.2020.12.056 |
| 2021-06-01 |
The fate of SARS-COV-2 in WWTPS points out the sludge line as a suitable spot for detection of COVID-19 (edit) |
10.1016/J.SCITOTENV.2021.145268 |
| 2021-06-01 |
Conflicting and ambiguous names of overlapping ORFs in the SARS-CoV-2 genome: A homology-based resolution (edit) |
10.1016/J.VIROL.2021.02.013 |
| 2021-06-01 |
Rare mutations in the accessory proteins ORF6, ORF7b, and ORF10 of the SARS-CoV-2 genomes (edit) |
10.1016/J.MGENE.2021.100873 |
| 2021-06-01 |
Mutational analysis of SARS-CoV-2 during six months of COVID-19 pandemic (edit) |
10.1016/J.GENREP.2021.101024 |
| 2021-06-01 |
Neuropilin-1 Assists SARS-CoV-2 Infection by Stimulating the Separation of Spike Protein Domains S1 and S2 (edit) |
10.1016/J.BPJ.2021.05.026 |
| 2021-06-01 |
Inhibitory effect on SARS‐CoV‐2 infection of neferine by blocking Ca 2+ ‐dependent membrane fusion (edit) |
10.1002/JMV.27117 |
| 2021-06-01 |
Proteomics-based Insights into the SARS-CoV-2 Mediated COVID-19 Pandemic: A Review of the First Year of Research (edit) |
10.1016/J.MCPRO.2021.100103 |
| 2021-06-01 |
Construction of a Human Cell Landscape of COVID-19 Infection at Single-cell Level (edit) |
10.14336/AD.2021.0301 |
| 2021-06-01 |
The folate antagonist methotrexate diminishes replication of the coronavirus SARS-CoV-2 and enhances the antiviral efficacy of remdesivir in cell culture models (edit) |
10.1016/J.VIRUSRES.2021.198469 |
| 2021-06-01 |
Human Type II Taste Cells Express ACE2 and are Infected by SARS-CoV-2 (edit) |
10.1016/J.AJPATH.2021.05.010 |
| 2021-06-01 |
Epitope mimicry analysis of SARS-COV-2 surface proteins and human lung proteins (edit) |
10.1016/J.JMGM.2021.107836 |
| 2021-06-01 |
SARS-CoV-2 therapeutics: how far do we stand from a remedy? (edit) |
10.1007/S43440-020-00204-0 |
| 2021-06-01 |
Identification of novel bat coronaviruses sheds light on the evolutionary origins of SARS-CoV-2 and related viruses (edit) |
10.1016/J.CELL.2021.06.008 |
| 2021-06-01 |
A High-Throughput RNA Displacement Assay for Screening SARS-CoV-2 nsp10-nsp16 Complex toward Developing Therapeutics for COVID-19 (edit) |
10.1177/2472555220985040 |
| 2021-06-01 |
A Crystallographic Snapshot of SARS-CoV-2 Main Protease Maturation Process (edit) |
10.1016/J.JMB.2021.167118 |
| 2021-06-01 |
SARS-CoV-2 genomic surveillance identifies naturally occurring truncation of ORF7a that limits immune suppression (edit) |
10.1016/J.CELREP.2021.109197 |
| 2021-06-01 |
Extracellular vesicles carry SARS-CoV-2 spike protein and serve as decoys for neutralizing antibodies (edit) |
10.1002/JEV2.12112 |
| 2021-06-01 |
The envelope protein of SARS-CoV-2 increases intra-Golgi pH and forms a cation channel that is regulated by pH (edit) |
10.1113/JP281037 |
| 2021-06-01 |
Genome-wide analysis of 10664 SARS-CoV-2 genomes to identify virus strains in 73 countries based on single nucleotide polymorphism (edit) |
10.1016/J.VIRUSRES.2021.198401 |
| 2021-06-01 |
The WHO mission report struggles to trace the origins of the SARS-CoV-2 epidemic (edit) |
10.1684/VIR.2021.0902 |
| 2021-06-01 |
Anti-SARS-CoV-2 vaccination strategy for pregnant women in Japan (edit) |
10.1111/JOG.14748 |
| 2021-06-01 |
Rapid Detection of SARS-CoV-2 Variants of Concern, Including B.1.1.28/P.1, British Columbia, Canada (edit) |
10.3201/EID2706.210532 |
| 2021-06-01 |
Increased transmissibility and global spread of SARS-CoV-2 variants of concern as at June 2021 (edit) |
10.2807/1560-7917.ES.2021.26.24.2100509 |
| 2021-06-01 |
Structure and function of SARS-CoV-2 polymerase (edit) |
10.1016/J.COVIRO.2021.03.010 |
| 2021-06-01 |
Piece of the puzzle: Remdesivir disassembles the multimeric SARS-CoV-2 RNA-dependent RNA polymerase complex (edit) |
10.1007/S12013-021-00977-Y |
| 2021-06-01 |
Fine-Scale Temporal Dynamics of SARS-CoV-2 RNA Abundance in Wastewater during A COVID-19 Lockdown (edit) |
10.1016/J.WATRES.2021.117093 |
| 2021-06-01 |
MuSK Antibody-Associated Myasthenia Gravis With SARS-CoV-2 Infection: A Case Report (edit) |
10.7326/L20-1298 |
| 2021-06-01 |
A map of the SARS-CoV-2 RNA structurome (edit) |
10.1093/NARGAB/LQAB043 |
| 2021-06-01 |
Drugs that inhibit TMEM16 proteins block SARS-CoV-2 spike-induced syncytia (edit) |
10.1038/S41586-021-03491-6 |
| 2021-06-01 |
Saliva as a gold-standard sample for SARS-CoV-2 detection (edit) |
10.1016/S2213-2600(21)00178-8 |
| 2021-06-01 |
The new SARS-CoV-2 strain shows a stronger binding affinity to ACE2 due to N501Y mutant (edit) |
10.1016/J.MEDIDD.2021.100086 |
| 2021-06-01 |
Synthetic Homogeneous Glycoforms of the SARS-CoV-2 Spike Receptor-Binding Domain Reveals Different Binding Profiles of Monoclonal Antibodies (edit) |
10.1002/ANIE.202100543 |
| 2021-06-01 |
A cross-sectional and prospective cohort study of the role of schools in the SARS-CoV-2 second wave in Italy (edit) |
10.1016/J.LANEPE.2021.100092 |
| 2021-06-01 |
Drug synergy of combinatory treatment with remdesivir and the repurposed drugs fluoxetine and itraconazole effectively impairs SARS-CoV-2 infection in vitro (edit) |
10.1111/BPH.15418 |
| 2021-06-01 |
The zoonotic and natural foci characteristics of SARS-CoV-2 (edit) |
10.1016/J.JOBB.2021.06.002 |
| 2021-06-01 |
Multisystem Inflammatory Syndrome in Adults after Mild SARS-CoV-2 Infection, Japan (edit) |
10.3201/EID2706.210728 |
| 2021-06-01 |
Repurposing of Tetracyclines for COVID-19 Neurological and Neuropsychiatric Manifestations: A Valid Option to Control SARS-CoV-2-Associated Neuroinflammation? (edit) |
10.1007/S11481-021-09986-3 |
| 2021-06-01 |
Syncytia formation during SARS-CoV-2 lung infection: a disastrous unity to eliminate lymphocytes (edit) |
10.1038/S41418-021-00795-Y |
| 2021-06-01 |
First detection of SARS-CoV-2 spike protein N501 mutation in Italy in August, 2020 (edit) |
10.1016/S1473-3099(21)00007-4 |
| 2021-06-01 |
SARS-CoV-2 Infection Hospitalization Rate and Infection Fatality Rate Among the Non-Congregate Population in Connecticut (edit) |
10.1016/J.AMJMED.2021.01.020 |
| 2021-06-01 |
The basis of a more contagious 501Y.V1 variant of SARS-CoV-2 (edit) |
10.1038/S41422-021-00496-8 |
| 2021-06-01 |
Structural insights into the cross-neutralization of SARS-CoV and SARS-CoV-2 by the human monoclonal antibody 47D11 (edit) |
10.1126/SCIADV.ABF5632 |
| 2021-06-01 |
Characterization of the SARS-CoV-2 E Protein: Sequence, Structure, Viroporin, and Inhibitors (edit) |
10.1002/PRO.4075 |
| 2021-06-01 |
Multifaced Roles of HDL in Sepsis and SARS-CoV-2 Infection: Renal Implications (edit) |
10.3390/IJMS22115980 |
| 2021-06-01 |
Autophagy, Unfolded Protein Response, and Neuropilin-1 Cross-Talk in SARS-CoV-2 Infection: What Can Be Learned from Other Coronaviruses (edit) |
10.3390/IJMS22115992 |
| 2021-06-01 |
Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study (edit) |
10.1111/ANAE.15458 |
| 2021-06-01 |
SARS-CoV-2 Spreads through Cell-to-Cell Transmission (edit) |
10.1101/2021.06.01.446579 |
| 2021-06-01 |
Asymptomatic SARS-CoV-2 infection: Incidental findings on FDG PET/CT (edit) |
10.1016/J.JMIR.2021.03.002 |
| 2021-06-01 |
Why does SARS-CoV-2 hit in different ways? Host genetic factors can influence the acquisition or the course of COVID-19 (edit) |
10.1016/J.EJMG.2021.104227 |
| 2021-06-01 |
SARS-CoV-2 Infection in the Central and Peripheral Nervous System-Associated Morbidities and Their Potential Mechanism (edit) |
10.1007/S12035-020-02245-1 |
| 2021-06-01 |
Transport mechanisms of SARS-CoV-E viroporin in calcium solutions: Lipid-dependent Anomalous Mole Fraction Effect and regulation of pore conductance (edit) |
10.1016/J.BBAMEM.2021.183590 |
| 2021-06-01 |
Identification of proteasome and caspase inhibitors targeting SARS-CoV-2 M (edit) |
10.1038/S41392-021-00639-8 |
| 2021-06-01 |
SARS-CoV-2 mutation 614G creates an elastase cleavage site enhancing its spread in high AAT-deficient regions (edit) |
10.1016/J.MEEGID.2021.104760 |
| 2021-06-01 |
Multiple sites on SARS-CoV-2 spike protein are susceptible to proteolysis by cathepsins B, K, L, S, and V (edit) |
10.1002/PRO.4073 |
| 2021-06-01 |
Glycyrrhizin prevents SARS-CoV-2 S1 and Orf3a induced high mobility group box 1 (HMGB1) release and inhibits viral replication (edit) |
10.1016/J.CYTO.2021.155496 |
| 2021-06-01 |
Proteomic analysis identifies the RNA helicase DDX3X as a host target against SARS-CoV-2 infection (edit) |
10.1016/J.ANTIVIRAL.2021.105064 |
| 2021-06-01 |
An autoantigen profile of human A549 lung cells reveals viral and host etiologic molecular attributes of autoimmunity in COVID-19 (edit) |
10.1016/J.JAUT.2021.102644 |
| 2021-06-01 |
Conserved and Novel Mouse CD8 T Cell Epitopes within SARS-CoV-2 Spike Receptor Binding Domain Protein Identified following Subunit Vaccination (edit) |
10.4049/JIMMUNOL.2100195 |
| 2021-06-01 |
Upregulation of CCR4 in activated CD8 T cells indicates enhanced lung homing in patients with severe acute SARS-CoV-2 infection (edit) |
10.1002/EJI.202049135 |
| 2021-06-01 |
Assessment of Effectiveness of 1 Dose of BNT162b2 Vaccine for SARS-CoV-2 Infection 13 to 24 Days After Immunization (edit) |
10.1001/JAMANETWORKOPEN.2021.15985 |
| 2021-06-01 |
Convalescent-Phase Sera and Vaccine-Elicited Antibodies Largely Maintain Neutralizing Titer against Global SARS-CoV-2 Variant Spikes (edit) |
10.1128/MBIO.00696-21 |
| 2021-06-01 |
Identifying Primate ACE2 Variants That Confer Resistance to SARS-CoV-2 (edit) |
10.1093/MOLBEV/MSAB060 |
| 2021-06-01 |
Nasopharyngeal Microbiota in SARS-CoV-2 Positive and Negative Patients (edit) |
10.1186/S12575-021-00148-6 |
| 2021-06-01 |
Could SARS-CoV-2 blocking of ACE2 in endothelial cells result in upregulation of CX3CL1, promoting thrombosis in COVID-19 patients? (edit) |
10.1016/J.MEHY.2021.110570 |
| 2021-06-01 |
Structure-based drug design of an inhibitor of the SARS-CoV-2 (COVID-19) main protease using free software: A tutorial for students and scientists (edit) |
10.1016/J.EJMECH.2021.113390 |
| 2021-06-01 |
Systematic rapid living review of the impact of the COVID-19 pandemic on cancer survivors: update to August 27, 2020 (edit) |
10.1007/S00520-020-05908-W |
| 2021-06-01 |
Modelling of hypothetical SARS-CoV-2 point of care tests for routine testing in residential care homes: rapid cost-effectiveness analysis (edit) |
10.3310/HTA25390 |
| 2021-06-01 |
COVID-19: Rapid antigen detection for SARS-CoV-2 by lateral flow assay: A national systematic evaluation of sensitivity and specificity for mass-testing (edit) |
10.1016/J.ECLINM.2021.100924 |
| 2021-06-01 |
Expectations of Young People Towards Their Future Work and Career After the SARS-CoV-2 Pandemic Outbreak in Poland (edit) |
10.35808/ERSJ/2188 |
| 2021-06-01 |
The SARS-CoV-2 pandemic: the race to trace: contact tracing scale-up in San Francisco—early lessons learned (edit) |
10.1057/S41271-021-00285-Y |
| 2021-06-01 |
Why do SARS-CoV-2 NSPs rush to the ER? (edit) |
10.1007/S00415-020-10197-8 |
| 2021-06-01 |
Lopinavir-Ritonavir in SARS-CoV-2 Infection and Drug-Drug Interactions with Cardioactive Medications (edit) |
10.1007/S10557-020-07070-1 |
| 2021-05-31 |
Structure-based design and characterization of novel fusion-inhibitory lipopeptides against SARS-CoV-2 and emerging variants (edit) |
|
| 2021-05-31 |
Ephrin-A1 and the sheddase ADAM12 are upregulated in COVID-19 (edit) |
10.1016/J.HELIYON.2021.E07200 |
| 2021-05-31 |
Revealing the host antiviral protein ZAP-S as an inhibitor of SARS-CoV-2 programmed ribosomal frameshifting (edit) |
10.1101/2021.05.31.445667 |
| 2021-05-31 |
Formulation of a Composite Nasal Spray Enabling Enhanced Surface Coverage and Prophylaxis of SARS-COV-2 (edit) |
10.1002/ADMA.202008304 |
| 2021-05-31 |
Transcriptomic Signature Differences Between SARS-CoV-2 and Influenza Virus Infected Patients (edit) |
10.3389/FIMMU.2021.666163 |
| 2021-05-31 |
The Significance of COVID-19 Immunological Status in Severe Neurological Complications and Multiple Sclerosis-A Literature Review (edit) |
10.3390/IJMS22115894 |
| 2021-05-31 |
Impact of the SARS-CoV-2 Pandemic in Candidaemia, Invasive Aspergillosis and Antifungal Consumption in a Tertiary Hospital (edit) |
10.3390/JOF7060440 |
| 2021-05-30 |
Improved SARS-CoV-2 Mpro inhibitors based on feline antiviral drug GC376: Structural enhancements, increased solubility, and micellar studies (edit) |
10.1016/J.EJMECH.2021.113584 |
| 2021-05-29 |
Identification of E484K and other novel SARS-COV-2 variants from the Kingdom of Bahrain (edit) |
10.1016/J.MICPATH.2021.104955 |
| 2021-05-28 |
ALG-097111, a potent and selective SARS-CoV-2 3-chymotrypsin-like cysteine protease inhibitor exhibits in vivo efficacy in a Syrian Hamster model (edit) |
10.1016/J.BBRC.2021.03.096 |
| 2021-05-28 |
S-Variant SARS-CoV-2 Lineage B1.1.7 Is Associated With Significantly Higher Viral Load in Samples Tested by TaqPath Polymerase Chain Reaction (edit) |
10.1093/INFDIS/JIAB082 |
| 2021-05-28 |
Broad Auto-Reactive IgM Responses are Common in Critically Ill Patients Including Those with COVID-19 (edit) |
10.1016/J.XCRM.2021.100321 |
| 2021-05-28 |
Resurgence of SARS-CoV-2: Detection by community viral surveillance (edit) |
10.1126/SCIENCE.ABF0874 |
| 2021-05-28 |
A diamidobenzimidazole STING agonist protects against SARS-CoV-2 infection (edit) |
10.1126/SCIIMMUNOL.ABI9002 |
| 2021-05-28 |
Pharmacological activation of STING blocks SARS-CoV-2 infection (edit) |
10.1126/SCIIMMUNOL.ABI9007 |
| 2021-05-28 |
Correlating qRT-PCR, dPCR and Viral Titration for the Identification and Quantification of SARS-CoV-2: A New Approach for Infection Management (edit) |
10.3390/V13061022 |
| 2021-05-28 |
Metformin Suppresses Monocyte Immunometabolic Activation by SARS-CoV-2 and Spike Protein Subunit 1 (edit) |
10.1101/2021.05.27.445991 |
| 2021-05-28 |
The SARS-CoV-2 variants associated with infections in India, B.1.617, show enhanced spike cleavage by furin (edit) |
10.1101/2021.05.28.446163 |
| 2021-05-28 |
Probing effects of the SARS-CoV-2 E protein on membrane curvature and intracellular calcium (edit) |
10.1101/2021.05.28.446179 |
| 2021-05-28 |
Genome-wide screening of SARS-CoV-2 infection-related genes based on the blood leukocytes sequencing data set of patients with COVID-19 (edit) |
10.1002/JMV.27093 |
| 2021-05-28 |
Respiratory Co-Infections: Modulators of SARS-CoV-2 Patients' Clinical Sub-Phenotype (edit) |
10.3389/FMICB.2021.653399 |
| 2021-05-28 |
A Computational Framework for Pattern Detection on Unaligned Sequences: An Application on SARS-CoV-2 Data (edit) |
10.3389/FGENE.2021.618170 |
| 2021-05-28 |
Modeling the Consequences of Social Distancing Over Epidemics Spreading in Complex Social Networks: From Link Removal Analysis to SARS-CoV-2 Prevention (edit) |
10.3389/FPHY.2021.681343 |
| 2021-05-28 |
Outbreak investigation of SARS-CoV-2 transmission in an emergency childcare centre (edit) |
10.17269/S41997-021-00544-1 |
| 2021-05-28 |
A review of the Cochrane COVID-19 Study Register reveals inconsistency in the choice and measurement of SARS-CoV-2 infection outcomes in prevention trials (edit) |
10.12688/F1000RESEARCH.52491.1 |
| 2021-05-27 |
Identification of SARS-CoV-2 Receptor Binding Inhibitors by In Vitro Screening of Drug Libraries (edit) |
10.3390/MOLECULES26113213 |
| 2021-05-27 |
Translational shutdown and evasion of the innate immune response by SARS-CoV-2 NSP14 protein (edit) |
10.1073/PNAS.2101161118 |
| 2021-05-27 |
NPC1-regulated dynamic of clathrin-coated pits is essential for viral entry (edit) |
10.1007/S11427-021-1929-Y |
| 2021-05-27 |
TMEM41B is a host factor required for the replication of diverse coronaviruses including SARS-CoV-2 (edit) |
10.1371/JOURNAL.PPAT.1009599 |
| 2021-05-27 |
Molecular Biology Clues Portray SARS-CoV-2 as a Gain-of-Function Laboratory Manipulation of Bat CoV RaTG13 (edit) |
10.1021/ACSMEDCHEMLETT.1C00274 |
| 2021-05-27 |
Antibody evasion by the P.1 strain of SARS-CoV-2 (edit) |
10.1016/J.CELL.2021.03.055 |
| 2021-05-27 |
SARS-CoV-2 variants of concern are emerging in India (edit) |
10.1038/S41591-021-01397-4 |
| 2021-05-27 |
Reduced sensitivity of infectious SARS-CoV-2 variant B.1.617.2 to monoclonal antibodies and sera from convalescent and vaccinated individuals (edit) |
10.1101/2021.05.26.445838 |
| 2021-05-27 |
Asymptomatic COVID-19: disease tolerance with efficient anti-viral immunity against SARS-CoV-2 (edit) |
10.15252/EMMM.202114045 |
| 2021-05-27 |
Dynamic changes in gene-to-gene regulatory networks in response to SARS-CoV-2 infection (edit) |
10.1038/S41598-021-90556-1 |
| 2021-05-27 |
Evolution and spread of SARS-CoV-2 likely to be affected by climate (edit) |
|
| 2021-05-27 |
SARS-CoV-2-associated Guillain-Barré syndrome is a para-infectious disease (edit) |
10.1093/QJMED/HCAB157 |
| 2021-05-27 |
Breakthrough infection after COVID-19 vaccination: A threat for Nepal due to SARS-CoV-2 variants circulating in 2nd wave ravaging India (edit) |
10.3126/JPAHS.V8I2.37287 |
| 2021-05-27 |
SARS-CoV-2: One Year in the Pandemic. What Have We Learned, the New Vaccine Era and the Threat of SARS-CoV-2 Variants (edit) |
10.3390/BIOMEDICINES9060611 |
| 2021-05-26 |
Similarities and differences in the conformational stability and reversibility of ORF8, an accessory protein of SARS-CoV-2, and its L84S variant (edit) |
10.1016/J.BBRC.2021.05.074 |
| 2021-05-26 |
Could Histamine H1 Receptor Antagonists Be Used for Treating COVID-19? (edit) |
10.3390/IJMS22115672 |
| 2021-05-26 |
“Vaccine-Induced Covid-19 Mimicry” Syndrome:Splice reactions within the SARS-CoV-2 Spike open reading frame result in Spike protein variants that may cause thromboembolic events in patients immunized with vector-based vaccines (edit) |
10.21203/RS.3.RS-558954/V1 |
| 2021-05-26 |
How to understand and manage Mucormycosis infections during Covid-19/ SARS-CoV-2/ novel coronavirus pandemic era in India & developing countries? (edit) |
10.31219/OSF.IO/J3R7B |
| 2021-05-26 |
Post-vaccination SARS-CoV-2 infection: risk factors and illness profile in a prospective, observational community-based case-control study (edit) |
10.1101/2021.05.24.21257738 |
| 2021-05-26 |
COVseq is a cost-effective workflow for mass-scale SARS-CoV-2 genomic surveillance (edit) |
10.21203/RS.3.PEX-1338/V2 |
| 2021-05-26 |
The effects of non-pharmaceutical interventions on SARS-CoV-2 transmission in different socioeconomic populations in Kuwait: a modeling study (edit) |
10.1186/S12889-021-10984-6 |
| 2021-05-26 |
Engineering a multi epitope vaccine against SARS-CoV-2 by exploiting its non structural and structural proteins (edit) |
10.1080/07391102.2021.1924265 |
| 2021-05-26 |
SARS-CoV-2 Epidemics in Retirement and Nursing Homes in Italy: A New Preparedness Assessment Model after the First Epidemic Wave (edit) |
10.3390/IJERPH18115712 |
| 2021-05-26 |
SARS-CoV-2 a public health emergency: challenges in vaccination in Indian setup (edit) |
10.18203/2394-6040.IJCMPH20212029 |
| 2021-05-25 |
Reverse-transcribed SARS-CoV-2 RNA can integrate into the genome of cultured human cells and can be expressed in patient-derived tissues (edit) |
10.1073/PNAS.2105968118 |
| 2021-05-25 |
Azelastine inhibits viropexis of SARS-CoV-2 spike pseudovirus by binding to SARS-CoV-2 entry receptor ACE2 (edit) |
|
| 2021-05-25 |
SARS-CoV-2 nucleocapsid protein impairs stress granule formation to promote viral replication (edit) |
10.1038/S41421-021-00275-0 |
| 2021-05-25 |
2'-O methylation of RNA cap in SARS-CoV-2 captured by serial crystallography (edit) |
10.1073/PNAS.2100170118 |
| 2021-05-25 |
Urinary Levels of SARS-CoV-2 Nucleocapsid Protein Associate With Risk of AKI and COVID-19 Severity: A Single-Center Observational Study (edit) |
10.3389/FMED.2021.644715 |
| 2021-05-25 |
Correction: Bueckert et al. Infectivity of SARS-CoV-2 and Other Coronaviruses on Dry Surfaces: Potential for Indirect Transmission. Materials 2020, 13, 5211 (edit) |
10.3390/MA14112816 |
| 2021-05-25 |
Human cardiosphere-derived stromal cells exposed to SARS-CoV-2 evolve into hyper-inflammatory/pro-fibrotic phenotype and produce infective viral particles depending on the levels of ACE2 receptor expression (edit) |
10.1093/CVR/CVAB082 |
| 2021-05-25 |
SARS-CoV-2: Possible recombination and emergence of potentially more virulent strains (edit) |
10.1371/JOURNAL.PONE.0251368 |
| 2021-05-25 |
Immune response to SARS-CoV-2 variants of concern in vaccinated individuals (edit) |
10.1038/S41467-021-23473-6 |
| 2021-05-25 |
E484K as an innovative phylogenetic event for viral evolution: Genomic analysis of the E484K spike mutation in SARS-CoV-2 lineages from Brazil (edit) |
10.1016/J.MEEGID.2021.104941 |
| 2021-05-25 |
Multiplexed detection of SARS-CoV-2 and other respiratory infections in high throughput by SARSeq (edit) |
10.1038/S41467-021-22664-5 |
| 2021-05-25 |
Existence of SARS-CoV-2 RNA on ambient particulate matter samples: A nationwide study in Turkey (edit) |
10.1016/J.SCITOTENV.2021.147976 |
| 2021-05-24 |
Comparative transcriptome analysis reveals key epigenetic targets in SARS-CoV-2 infection (edit) |
10.1038/S41540-021-00181-X |
| 2021-05-24 |
SARS-CoV-2 simulations go exascale to predict dramatic spike opening and cryptic pockets across the proteome (edit) |
10.1038/S41557-021-00707-0 |
| 2021-05-24 |
Coupling of N7-methyltransferase and 3'-5' exoribonuclease with SARS-CoV-2 polymerase reveals mechanisms for capping and proofreading (edit) |
10.1016/J.CELL.2021.05.033 |
| 2021-05-24 |
Inhibition mechanism of SARS-CoV-2 main protease by ebselen and its derivatives (edit) |
10.1038/S41467-021-23313-7 |
| 2021-05-24 |
Extremes of age are associated with differences in the expression of selected pattern recognition receptor genes and ACE2, the receptor for SARS-CoV-2: implications for the epidemiology of COVID-19 disease (edit) |
10.1186/S12920-021-00970-7 |
| 2021-05-24 |
Comparative Immunomodulatory Evaluation of the Receptor Binding Domain of the SARS-CoV-2 Spike Protein; a Potential Vaccine Candidate Which Imparts Potent Humoral and Th1 Type Immune Response in a Mouse Model (edit) |
10.3389/FIMMU.2021.641447 |
| 2021-05-24 |
Contrasting SARS-CoV-2 RNA copies and clinical symptoms in a large cohort of Colombian patients during the first wave of the COVID-19 pandemic (edit) |
10.1186/S12941-021-00445-8 |
| 2021-05-24 |
Integrative web-based analysis of omics data for study of drugs against SARS-CoV-2 (edit) |
10.1038/S41598-021-89578-6 |
| 2021-05-24 |
Targeting novel LSD1-dependent ACE2 demethylation domains inhibits SARS-CoV-2 replication (edit) |
10.1038/S41421-021-00279-W |
| 2021-05-23 |
Presence of SARS-CoV-2 and Its Entry Factors in Oral Tissues and Cells: A Systematic Review (edit) |
10.3390/MEDICINA57060523 |
| 2021-05-22 |
Glycosylation is a key in SARS-CoV-2 infection (edit) |
10.1007/S00109-021-02092-0 |
| 2021-05-22 |
Comparative protein structure network analysis on 3CLpro from SARS-CoV-1 and SARS-CoV-2 (edit) |
10.1002/PROT.26143 |
| 2021-05-22 |
SARS-CoV-2 outbreak in Iran: The dynamics of the epidemic and evidence on two independent introductions (edit) |
10.1111/TBED.14104 |
| 2021-05-22 |
SARS-CoV-2 mutations, vaccines, and immunity: implication of variants of concern (edit) |
10.1038/S41392-021-00623-2 |
| 2021-05-21 |
Viewing SARS-CoV-2 Nucleocapsid Protein in Terms of Molecular Flexibility (edit) |
10.3390/BIOLOGY10060454 |
| 2021-05-21 |
The ORF8 protein of SARS-CoV-2 mediates immune evasion through down-regulating MHC-Ι (edit) |
10.1073/PNAS.2024202118 |
| 2021-05-21 |
The SARS-CoV-2 SSHHPS Recognized by the Papain-like Protease (edit) |
10.1021/ACSINFECDIS.0C00866 |
| 2021-05-21 |
The burden of active infection and anti-SARS-CoV-2 IgG antibodies in the general population: Results from a statewide sentinel-based population survey in Karnataka, India (edit) |
10.1016/J.IJID.2021.05.043 |
| 2021-05-21 |
Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil (edit) |
10.1126/SCIENCE.ABH2644 |
| 2021-05-21 |
Bidirectional genome-wide CRISPR screens reveal host factors regulating SARS-CoV-2, MERS-CoV and seasonal coronaviruses (edit) |
10.1101/2021.05.19.444823 |
| 2021-05-21 |
Addressing personal protective equipment (PPE) decontamination: methylene blue and light inactivates SARS-CoV-2 on N95 respirators and medical masks with maintenance of integrity and fit (edit) |
10.1017/ICE.2021.230 |
| 2021-05-21 |
Crystal structure of SARS-CoV-2 nsp10 bound to nsp14-ExoN domain reveals an exoribonuclease with both structural and functional integrity (edit) |
10.1093/NAR/GKAB320 |
| 2021-05-21 |
Cell-type-resolved quantitative proteomics map of interferon response against SARS-CoV-2 (edit) |
10.1016/J.ISCI.2021.102420 |
| 2021-05-21 |
Modelling the SARS-CoV-2 outbreak: Assessing the usefulness of protective measures to reduce the pandemic at population level (edit) |
10.1016/J.SCITOTENV.2021.147816 |
| 2021-05-21 |
SARS-CoV-2 and other human coronavirus show genome patterns previously associated to reduced viral recognition and altered immune response (edit) |
10.1038/S41598-021-90278-4 |
| 2021-05-21 |
Evaluation of potency of the selected bioactive molecules from Indian medicinal plants with MPro of SARS-CoV-2 through in silico analysis (edit) |
10.1016/J.JAIM.2021.05.003 |
| 2021-05-21 |
Humoral immune response to circulating SARS-CoV-2 variants elicited by inactivated and RBD-subunit vaccines (edit) |
10.1038/S41422-021-00514-9 |
| 2021-05-21 |
SARS-CoV-2 variant from India to Marseille: The still active role of ports in the introduction of epidemics (edit) |
10.1016/J.TMAID.2021.102085 |
| 2021-05-21 |
Dolosigranulum pigrum Modulates Immunity against SARS-CoV-2 in Respiratory Epithelial Cells (edit) |
10.3390/PATHOGENS10060634 |
| 2021-05-20 |
Metabolomics and computational analysis of the role of monoamine oxidase activity in delirium and SARS-COV-2 infection (edit) |
10.1038/S41598-021-90243-1 |
| 2021-05-20 |
The SARS-CoV-2 subgenome landscape and its novel regulatory features (edit) |
10.1016/J.MOLCEL.2021.02.036 |
| 2021-05-20 |
Circulating SARS-CoV-2 Vaccine Antigen Detected in the Plasma of mRNA-1273 Vaccine Recipients (edit) |
10.1093/CID/CIAB465 |
| 2021-05-20 |
Does prior treatment with anti-PD 1 immune check point inhibitors (ICIs) mitigate infection with herpes and SARS-CoV-2 viruses: Clinical evidence supporting basic hypotheses (edit) |
10.1200/JCO.2021.39.15_SUPPL.E24045 |
| 2021-05-20 |
SARS-CoV-2 in the environment-Non-droplet spreading routes (edit) |
10.1016/J.SCITOTENV.2021.145260 |
| 2021-05-20 |
Exploration of hosts and transmission traits for SARS-CoV-2 based on the k-mer natural vector (edit) |
10.1016/J.MEEGID.2021.104933 |
| 2021-05-20 |
Marine algal antagonists targeting 3CL protease and spike glycoprotein of SARS-CoV-2: a computational approach for anti-COVID-19 drug discovery (edit) |
10.1080/07391102.2021.1921032 |
| 2021-05-20 |
Genomic epidemiology of SARS-CoV-2 in Esteio, Rio Grande do Sul, Brazil (edit) |
10.1186/S12864-021-07708-W |
| 2021-05-19 |
Contribution of Syndecans to the Cellular Entry of SARS-CoV-2 (edit) |
10.3390/IJMS22105336 |
| 2021-05-19 |
SARS-CoV-2 infection induces beta cell transdifferentiation (edit) |
10.1016/J.CMET.2021.05.015 |
| 2021-05-19 |
Peroxisomes exhibit compromised structure and matrix protein content in SARS-CoV-2-infected cells (edit) |
10.1091/MBC.E21-02-0074 |
| 2021-05-19 |
Diverse Functional Autoantibodies in Patients with COVID-19 (edit) |
10.1038/S41586-021-03631-Y |
| 2021-05-19 |
Research Article What Impact has SARS-CoV-2/Covid-19 Pandemic on Healthcare Workers (HCWs) Mortality & Infections across 36 states & union territories of India? How to prevent mortality & morbidity of HCWs? (edit) |
10.31219/OSF.IO/TK4F3 |
| 2021-05-19 |
What Impact has SARS-CoV-2/Covid-19 Pandemic on Healthcare Workers (HCWs) Mortality & Infections across 36 states & union territories of India? How to prevent mortality & morbidity of HCWs? (edit) |
10.21203/RS.3.RS-538781/V1 |
| 2021-05-19 |
COVID-19 Disease Severity and Death in Relation to Vitamin D Status among SARS-CoV-2-Positive UAE Residents (edit) |
10.3390/NU13051714 |
| 2021-05-19 |
Detection of SARS-CoV-2 genome and whole transcriptome sequencing in frontal cortex of COVID-19 patients (edit) |
10.1016/J.BBI.2021.05.012 |
| 2021-05-19 |
Multivalent nanoparticle-based vaccines protect hamsters against SARS-CoV-2 after a single immunization (edit) |
10.1038/S42003-021-02128-8 |
| 2021-05-18 |
Hepatitis C virus drugs that inhibit SARS-CoV-2 papain-like protease synergize with remdesivir to suppress viral replication in cell culture (edit) |
10.1016/J.CELREP.2021.109133 |
| 2021-05-18 |
SARS-CoV-2 infects human pancreatic β cells and elicits β cell impairment (edit) |
10.1016/J.CMET.2021.05.013 |
| 2021-05-18 |
ZMPSTE24 Regulates SARS-CoV-2 Spike Protein-enhanced Expression of Endothelial Plasminogen Activator Inhibitor-1 (edit) |
10.1165/RCMB.2020-0544OC |
| 2021-05-18 |
Interactions of SARS-CoV-2 envelope protein with amilorides correlate with antiviral activity (edit) |
10.1371/JOURNAL.PPAT.1009519 |
| 2021-05-18 |
Disruption of disulfides within RBD of SARS‐CoV‐2 spike protein prevents fusion and represents a target for viral entry inhibition by registered drugs (edit) |
10.1096/FJ.202100560R |
| 2021-05-18 |
Systematic functional analysis of SARS-CoV-2 proteins uncovers viral innate immune antagonists and remaining vulnerabilities (edit) |
10.1016/J.CELREP.2021.109126 |
| 2021-05-18 |
Avoiding culture shock with the SARS-CoV-2 spike protein (edit) |
10.7554/ELIFE.69496 |
| 2021-05-18 |
Type-I interferon signatures in SARS-CoV-2 infected Huh7 cells (edit) |
10.1038/S41420-021-00487-Z |
| 2021-05-18 |
Fast SARS-CoV-2 virus detection using disposable cartridge strips and a semiconductor-based biosensor platform (edit) |
10.1116/6.0001060 |
| 2021-05-17 |
Moxidectin and ivermectin inhibit SARS-CoV-2 replication in Vero E6 cells but not in human primary airway epithelium cells (edit) |
10.1101/2021.05.17.444467 |
| 2021-05-17 |
Two conserved oligomer interfaces of NSP7 and NSP8 underpin the dynamic assembly of SARS-CoV-2 RdRP (edit) |
10.1093/NAR/GKAB370 |
| 2021-05-17 |
A glycan gate controls opening of the SARS-CoV-2 spike protein (edit) |
10.1101/2021.02.15.431212 |
| 2021-05-17 |
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection (edit) |
10.1038/S41591-021-01377-8 |
| 2021-05-17 |
Verification of SARS-CoV-2-Encoded small RNAs and contribution to Infection-Associated lung inflammation (edit) |
10.1101/2021.05.16.444324 |
| 2021-05-17 |
First Description of SARS-CoV-2 Infection in Two Feral American Mink (Neovison vison) Caught in the Wild (edit) |
10.3390/ANI11051422 |
| 2021-05-17 |
Rapid isolation and immune profiling of SARS-CoV-2 specific memory B cell in convalescent COVID-19 patients via LIBRA-seq (edit) |
10.1038/S41392-021-00610-7 |
| 2021-05-17 |
SARS-CoV-2 infects human adult donor eyes and hESC-derived ocular epithelium (edit) |
10.1016/J.STEM.2021.04.028 |
| 2021-05-17 |
A large-scale computational screen identifies strong potential inhibitors for disrupting SARS-CoV-2 S-protein and human ACE2 interaction (edit) |
10.1080/07391102.2021.1921034 |
| 2021-05-17 |
Calendulaglycoside A showing potential activity against SARS-CoV-2 main protease: Molecular docking, molecular dynamics, and SAR studies (edit) |
10.1016/J.JTCME.2021.05.001 |
| 2021-05-17 |
Genome-wide bioinformatic analyses predict key host and viral factors in SARS-CoV-2 pathogenesis (edit) |
10.1038/S42003-021-02095-0 |
| 2021-05-16 |
Durability of mRNA-1273-induced antibodies against SARS-CoV-2 variants (edit) |
10.1101/2021.05.13.444010 |
| 2021-05-16 |
Investigation of the Presence of SARS-CoV-2 in Aerosol After Dental Treatment (edit) |
10.1016/J.IDENTJ.2021.05.002 |
| 2021-05-15 |
Differential host circRNA expression profiles in human lung epithelial cells infected with SARS-CoV-2 (edit) |
10.1016/J.MEEGID.2021.104923 |
| 2021-05-15 |
The human pandemic coronaviruses on the show: The spike glycoprotein as the main actor in the coronaviruses play (edit) |
10.1016/J.IJBIOMAC.2021.02.203 |
| 2021-05-15 |
Heparan sulfates from bat and human lung and their binding to the spike protein of SARS-CoV-2 virus (edit) |
10.1016/J.CARBPOL.2021.117797 |
| 2021-05-15 |
Application of niclosamide and analogs as small molecule inhibitors of Zika virus and SARS-CoV-2 infection (edit) |
10.1016/J.BMCL.2021.127906 |
| 2021-05-14 |
ACE2 polymorphism and susceptibility for SARS-CoV-2 infection and severity of COVID-19 (edit) |
10.1097/FPC.0000000000000436 |
| 2021-05-14 |
Crystal structure of SARS-CoV-2 Orf9b in complex with human TOM70 suggests unusual virus-host interactions (edit) |
10.1038/S41467-021-23118-8 |
| 2021-05-14 |
SARS-CoV-2 Fusion Peptide has a Greater Membrane Perturbating Effect than SARS-CoV with Highly Specific Dependence on Ca (edit) |
10.1016/J.JMB.2021.166946 |
| 2021-05-14 |
Siglec-1 on dendritic cells mediates SARS-CoV-2 trans-infection of target cells while on macrophages triggers proinflammatory responses (edit) |
10.1101/2021.05.11.443572 |
| 2021-05-14 |
Maternal respiratory SARS-CoV-2 infection in pregnancy is associated with a robust inflammatory response at the maternal-fetal interface (edit) |
10.1016/J.MEDJ.2021.04.016 |
| 2021-05-14 |
Glucosidase inhibitors suppress SARS-CoV-2 in tissue culture and may potentiate (edit) |
10.1101/2021.05.14.444190 |
| 2021-05-14 |
A rapid, point-of-care red blood cell agglutination assay detecting antibodies against SARS-CoV-2 (edit) |
10.1016/J.BBRC.2021.03.016 |
| 2021-05-14 |
Repurposing of the herbal formulations: molecular docking and molecular dynamics simulation studies to validate the efficacy of phytocompounds against SARS-CoV-2 proteins (edit) |
10.1080/07391102.2021.1922095 |
| 2021-05-14 |
Modeling the binding of protoporphyrin IX, verteporfin, and chlorin e6 to SARS-CoV-2 proteins (edit) |
10.1007/S10593-021-02920-8 |
| 2021-05-13 |
Structural basis of ribosomal frameshifting during translation of the SARS-CoV-2 RNA genome (edit) |
10.1126/SCIENCE.ABF3546 |
| 2021-05-13 |
Variable post-translational modifications of SARS-CoV-2 nucleocapsid protein (edit) |
10.1093/GLYCOB/CWAB044 |
| 2021-05-13 |
Emergence and rapid transmission of SARS-CoV-2 B.1.1.7 in the United States (edit) |
10.1016/J.CELL.2021.03.052 |
| 2021-05-13 |
New SARS-CoV-2 Variants - Clinical, Public Health, and Vaccine Implications (edit) |
10.1056/NEJMC2100362 |
| 2021-05-13 |
Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection (edit) |
10.1126/SCIIMMUNOL.ABH2259 |
| 2021-05-13 |
Citizen volunteers detect SARS-CoV-2 RNA from outdoor urban fomites (edit) |
|
| 2021-05-13 |
In silico analysis suggests the RNAi-enhancing antibiotic enoxacin as a potential inhibitor of SARS-CoV-2 infection (edit) |
10.1038/S41598-021-89605-6 |
| 2021-05-13 |
Mapping the SARS-CoV-2 spike glycoprotein-derived peptidome presented by HLA class II on dendritic cells (edit) |
10.1016/J.CELREP.2021.109179 |
| 2021-05-13 |
Computational design and modeling of nanobodies toward SARS-CoV-2 receptor binding domain (edit) |
10.1111/CBDD.13847 |
| 2021-05-13 |
SARS-CoV-2 antibody immunoassays in serial samples reveal earlier seroconversion in acutely ill COVID-19 patients developing ARDS (edit) |
10.1371/JOURNAL.PONE.0251587 |
| 2021-05-13 |
Repurposing potential of posaconazole and grazoprevir as inhibitors of SARS-CoV-2 helicase (edit) |
10.1038/S41598-021-89724-0 |
| 2021-05-13 |
IPD 2.0: To derive insights from an evolving SARS-CoV-2 genome (edit) |
10.1186/S12859-021-04172-X |
| 2021-05-13 |
Plant-Produced Receptor-Binding Domain of SARS-CoV-2 Elicits Potent Neutralizing Responses in Mice and Non-human Primates (edit) |
10.3389/FPLS.2021.682953 |
| 2021-05-13 |
Studies of Melody Efficacy Vaccine Against SARS-CoV-2 are Closing COVID-19 Pandemic Doors? Single Dose is Recommended as Therapeutic Drug and Two Doses Application as Preventive Vaccine (edit) |
10.47485/2693-2504.1042 |
| 2021-05-12 |
Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization (edit) |
10.1016/J.CHOM.2021.04.007 |
| 2021-05-12 |
SARS-CoV-2 uses a multipronged strategy to impede host protein synthesis (edit) |
10.1038/S41586-021-03610-3 |
| 2021-05-12 |
The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates (edit) |
10.1126/SCITRANSLMED.ABF1906 |
| 2021-05-12 |
Discovery of human ACE2 variants with altered recognition by the SARS-CoV-2 spike protein (edit) |
10.1371/JOURNAL.PONE.0251585 |
| 2021-05-12 |
Sources of SARS-CoV-2 and Other Microorganisms in Dental Aerosols (edit) |
10.1177/00220345211015948 |
| 2021-05-12 |
A simple, sensitive, and low-cost FACS assay for detecting antibodies against the native SARS-CoV-2 spike protein (edit) |
10.1002/IID3.446 |
| 2021-05-11 |
Molnupiravir promotes SARS-CoV-2 mutagenesis via the RNA template (edit) |
10.1016/J.JBC.2021.100770 |
| 2021-05-11 |
Structural basis for backtracking by the SARS-CoV-2 replication-transcription complex (edit) |
10.1073/PNAS.2102516118 |
| 2021-05-11 |
Mass spectrometry analytical responses to the SARS-CoV2 coronavirus in review (edit) |
10.1016/J.TRAC.2021.116328 |
| 2021-05-11 |
RIG-I triggers a signaling-abortive anti-SARS-CoV-2 defense in human lung cells (edit) |
10.1038/S41590-021-00942-0 |
| 2021-05-11 |
A SARS-CoV-2 antibody curbs viral nucleocapsid protein-induced complement hyperactivation (edit) |
10.1038/S41467-021-23036-9 |
| 2021-05-11 |
Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival (edit) |
10.1038/S41467-021-22958-8 |
| 2021-05-11 |
Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike (edit) |
10.1073/PNAS.2100425118 |
| 2021-05-11 |
Neutralizing Antibodies Against SARS-CoV-2 Variants After Infection and Vaccination (edit) |
10.1001/JAMA.2021.4388 |
| 2021-05-11 |
METTL3 regulates viral m6A RNA modification and host cell innate immune responses during SARS-CoV-2 infection (edit) |
10.1016/J.CELREP.2021.109091 |
| 2021-05-11 |
SARS-CoV-2 gene content and COVID-19 mutation impact by comparing 44 Sarbecovirus genomes (edit) |
10.1038/S41467-021-22905-7 |
| 2021-05-11 |
Erythroid precursors and progenitors suppress adaptive immunity and get invaded by SARS-CoV-2 (edit) |
10.1016/J.STEMCR.2021.04.001 |
| 2021-05-11 |
SARS-CoV-2 targets glial cells in human cortical organoids (edit) |
10.1016/J.STEMCR.2021.01.016 |
| 2021-05-11 |
A SARS-CoV-2 neutralizing antibody with extensive Spike binding coverage and modified for optimal therapeutic outcomes (edit) |
10.1038/S41467-021-22926-2 |
| 2021-05-11 |
Immune dysregulation and autoreactivity correlate with disease severity in SARS-CoV-2-associated multisystem inflammatory syndrome in children (edit) |
10.1016/J.IMMUNI.2021.04.003 |
| 2021-05-11 |
Virtual screening of potential phyto-candidates as therapeutic leads against SARS-CoV-2 infection (edit) |
|
| 2021-05-11 |
Plant-derived exosomal microRNAs inhibit lung inflammation induced by exosomes SARS-CoV-2 Nsp12 (edit) |
10.1016/J.YMTHE.2021.05.005 |
| 2021-05-10 |
A review of the impact of weather and climate variables to COVID-19: In the absence of public health measures high temperatures cannot probably mitigate outbreaks (edit) |
10.1016/J.SCITOTENV.2020.144578 |
| 2021-05-10 |
Cellular and Humoral Immune Responses in Mice Immunized with Vaccinia Virus Expressing the SARS-CoV-2 Spike Protein (edit) |
10.4049/JIMMUNOL.2100054 |
| 2021-05-10 |
Just 2% of SARS-CoV-2−positive individuals carry 90% of the virus circulating in communities (edit) |
10.1073/PNAS.2104547118 |
| 2021-05-10 |
Deletion of the SARS-CoV-2 Spike Cytoplasmic Tail Increases Infectivity in Pseudovirus Neutralization Assays (edit) |
10.1128/JVI.00044-21 |
| 2021-05-10 |
What are the factors responsible for increase in SARS-CoV-2/Covid-19 Pandemic related cases and death in India in 2021? How does environmental, host & agent factors of epidemiological triad do influence & can be utilised to manage ongoing pandemic ca (edit) |
10.22541/AU.162066514.40049074/V1 |
| 2021-05-10 |
A comprehensive library of fluorescent constructs of SARS‐CoV‐2 proteins and their initial characterisation in different cell types (edit) |
10.1111/BOC.202000158 |
| 2021-05-10 |
Infection and vaccine-induced neutralizing antibody responses to the SARS-CoV-2 B.1.617.1 variant (edit) |
10.1101/2021.05.09.443299 |
| 2021-05-10 |
Downregulation of ACE2 expression by SARS-CoV-2 worsens the prognosis of KIRC and KIRP patients via metabolism and immunoregulation (edit) |
10.7150/IJBS.57802 |
| 2021-05-10 |
Silencing of SARS-CoV-2 with modified siRNA-peptide dendrimer formulation (edit) |
10.1111/ALL.14850 |
| 2021-05-10 |
A higher flexibility at the SARS-CoV-2 main protease active site compared to SARS-CoV and its potentialities for new inhibitor virtual screening targeting multi-conformers (edit) |
10.1080/07391102.2021.1924271 |
| 2021-05-10 |
The interaction of the bioflavonoids with five SARS-CoV-2 proteins targets: An in silico study (edit) |
10.1016/J.COMPBIOMED.2021.104464 |
| 2021-05-10 |
Predictors for inpatient mortality during the first wave of the SARS-CoV-2 pandemic: A retrospective analysis (edit) |
10.1371/JOURNAL.PONE.0251262 |
| 2021-05-10 |
Bayes Lines Tool (BLT): a SQL-script for analyzing diagnostic test results with an application to SARS-CoV-2-testing (edit) |
10.12688/F1000RESEARCH.51061.1 |
| 2021-05-09 |
SARS-CoV-2 B.1.617.2 Delta variant replication, sensitivity to neutralising antibodies and vaccine breakthrough (edit) |
10.1101/2021.05.08.443253 |
| 2021-05-09 |
Distinct immunological signatures discriminate severe COVID-19 from non-SARS-CoV-2-driven critical pneumonia (edit) |
10.1016/J.IMMUNI.2021.05.002 |
| 2021-05-08 |
Illness duration and symptom profile in a large cohort of symptomatic UK school-aged children tested for SARS-CoV-2 (edit) |
10.1101/2021.05.05.21256649 |
| 2021-05-08 |
Mutations in the B.1.1.7 SARS-CoV-2 Spike Protein Reduce Receptor-Binding Affinity and Induce a Flexible Link to the Fusion Peptide (edit) |
10.3390/BIOMEDICINES9050525 |
| 2021-05-08 |
SARS-CoV-2 promote autophagy to suppress type I interferon response (edit) |
10.1038/S41392-021-00574-8 |
| 2021-05-08 |
Inhibition of SARS-CoV-2 reproduction using Boswellia carterii: A theoretical study (edit) |
10.1016/J.MOLLIQ.2021.116440 |
| 2021-05-08 |
A novel study on SARS-COV-2 virus associated bradycardia as a predictor of mortality-retrospective multicenter analysis (edit) |
10.1002/CLC.23622 |
| 2021-05-08 |
Image processing unravels the evolutionary pattern of SARS-CoV-2 against SARS and MERS through position-based pattern recognition (edit) |
10.1016/J.COMPBIOMED.2021.104471 |
| 2021-05-08 |
Prevention and control measures significantly curbed the SARS-CoV-2 and influenza epidemics in China (edit) |
10.1016/J.JVE.2021.100040 |
| 2021-05-07 |
Cnicin as an Anti-SARS-CoV-2: An Integrated In Silico and In Vitro Approach for the Rapid Identification of Potential COVID-19 Therapeutics (edit) |
10.3390/ANTIBIOTICS10050542 |
| 2021-05-07 |
TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines (edit) |
10.1038/S41590-021-00937-X |
| 2021-05-07 |
X-ray screening identifies active site and allosteric inhibitors of SARS-CoV-2 main protease (edit) |
10.1126/SCIENCE.ABF7945 |
| 2021-05-07 |
Subtle differences in the pathogenicity of SARS-CoV-2 variants of concern B.1.1.7 and B.1.351 in rhesus macaques (edit) |
10.1101/2021.05.07.443115 |
| 2021-05-07 |
Mutation Rates and Selection on Synonymous Mutations in SARS-CoV-2 (edit) |
10.1093/GBE/EVAB087 |
| 2021-05-07 |
Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19 (edit) |
10.1093/BRAIN/AWAB009 |
| 2021-05-07 |
The impact of population-wide rapid antigen testing on SARS-CoV-2 prevalence in Slovakia (edit) |
10.1126/SCIENCE.ABF9648 |
| 2021-05-07 |
Ubiquitin-Modified Proteome of SARS-CoV-2-Infected Host Cells Reveals Insights into Virus-Host Interaction and Pathogenesis (edit) |
10.1021/ACS.JPROTEOME.0C00758 |
| 2021-05-07 |
Structural basis for SARS-CoV-2 neutralizing antibodies with novel binding epitopes (edit) |
10.1371/JOURNAL.PBIO.3001209 |
| 2021-05-06 |
Preliminary Analysis of Safety and Immunogenicity of a SARS-CoV-2 Variant Vaccine Booster (edit) |
10.1101/2021.05.05.21256716 |
| 2021-05-06 |
Role of epithelial-endothelial cell interaction in the pathogenesis of SARS-CoV-2 infection (edit) |
10.1093/CID/CIAB406 |
| 2021-05-06 |
Rapid development of neutralizing and diagnostic SARS-COV-2 mouse monoclonal antibodies (edit) |
10.1038/S41598-021-88809-0 |
| 2021-05-06 |
SARS-CoV-2 infections in kindergartens and associated households at the start of the second wave in Berlin, Germany - a cross sectional study (edit) |
10.1093/EURPUB/CKAB079 |
| 2021-05-06 |
Structure-based design of a highly stable, covalently-linked SARS-CoV-2 spike trimer with improved structural properties and immunogenicity (edit) |
10.1101/2021.05.06.441046 |
| 2021-05-06 |
Epitope profiling reveals binding signatures of SARS-CoV-2 immune response in natural infection and cross-reactivity with endemic human CoVs (edit) |
10.1016/J.CELREP.2021.109164 |
| 2021-05-06 |
SARS-CoV-2 vaccination responses in untreated, conventionally treated and anticytokine-treated patients with immune-mediated inflammatory diseases (edit) |
10.1136/ANNRHEUMDIS-2021-220461 |
| 2021-05-06 |
Comparative immune profiling of acute respiratory distress syndrome patients with or without SARS-CoV-2 infection (edit) |
10.1016/J.XCRM.2021.100291 |
| 2021-05-06 |
Detection of SARS-CoV-2 RNA in bivalve mollusks and marine sediments (edit) |
10.1016/J.SCITOTENV.2021.147534 |
| 2021-05-06 |
Designing potential siRNA molecule for the nucleocapsid(N) gene silencing of different SARS-CoV-2 strains of Bangladesh: Computational approach (edit) |
10.1016/J.COMPBIOLCHEM.2021.107486 |
| 2021-05-05 |
SARS-CoV-2 infection among healthcare workers in South Africa: a longitudinal cohort study (edit) |
10.1093/CID/CIAB398 |
| 2021-05-05 |
SARS-CoV-2 cell-to-cell infection is resistant to neutralizing antibodies (edit) |
10.1101/2021.05.04.442701 |
| 2021-05-05 |
SARS-CoV-2 variant B.1.617 is resistant to Bamlanivimab and evades antibodies induced by infection and vaccination (edit) |
10.1101/2021.05.04.442663 |
| 2021-05-05 |
Profiling of T Cell Repertoire in SARS-CoV-2-Infected COVID-19 Patients Between Mild Disease and Pneumonia (edit) |
10.1007/S10875-021-01045-Z |
| 2021-05-05 |
Quantum biochemistry, molecular docking, and dynamics simulation revealed synthetic peptides induced conformational changes affecting the topology of the catalytic site of SARS-CoV-2 main protease (edit) |
10.1080/07391102.2021.1920464 |
| 2021-05-05 |
Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset (edit) |
10.1016/J.XCRM.2021.100290 |
| 2021-05-05 |
A cyclic peptide inhibitor of the SARS-CoV-2 main protease (edit) |
10.1016/J.EJMECH.2021.113530 |
| 2021-05-04 |
Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes (edit) |
10.1126/SCIENCE.ABG5268 |
| 2021-05-04 |
The SARS-CoV-2 protein ORF3a inhibits fusion of autophagosomes with lysosomes (edit) |
10.1038/S41421-021-00268-Z |
| 2021-05-04 |
Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection (edit) |
10.1128/MBIO.00384-21 |
| 2021-05-04 |
Structural and Functional Characterization of SARS-CoV-2 RBD Domains Produced in Mammalian Cells (edit) |
10.1021/ACS.ANALCHEM.1C00893 |
| 2021-05-04 |
A novel highly potent inhibitor of TMPRSS2-like proteases blocks SARS-CoV-2 variants of concern and is broadly protective against infection and mortality in mice (edit) |
10.1101/2021.05.03.442520 |
| 2021-05-04 |
Molecular Docking and Dynamics Simulation Revealed the Potential Inhibitory Activity of ACEIs Against SARS-CoV-2 Targeting the hACE2 Receptor (edit) |
10.3389/FCHEM.2021.661230 |
| 2021-05-04 |
High-resolution profiling of pathways of escape for SARS-CoV-2 spike-binding antibodies (edit) |
10.1016/J.CELL.2021.04.045 |
| 2021-05-04 |
Decontamination of Food Packages from SARS-CoV-2 RNA with a Cold Plasma-Assisted System (edit) |
10.3390/APP11094177 |
| 2021-05-03 |
Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection (edit) |
10.1084/JEM.20202617 |
| 2021-05-03 |
The Coronavirus Network Explorer: mining a large-scale knowledge graph for effects of SARS-CoV-2 on host cell function (edit) |
10.1186/S12859-021-04148-X |
| 2021-05-03 |
SARS-CoV-2—Morphology, Transmission and Diagnosis during Pandemic, Review with Element of Meta-Analysis (edit) |
10.3390/JCM10091962 |
| 2021-05-03 |
The differences in SARS-CoV and SARS-CoV-2 specific co-expression network mediated biological process in human gut enterocytes (edit) |
10.1016/J.MEEGID.2021.104892 |
| 2021-05-03 |
Evidence of the presence of SARS-CoV-2 virus in atmospheric air and surfaces of a dedicated COVID hospital (edit) |
10.1002/JMV.27029 |
| 2021-05-03 |
The Indirect Impact of the SARS-CoV-2 Pandemic on Invasive Group a Streptococcus, Streptococcus Pneumoniae and Staphylococcus Aureus Infections in Houston Area Children (edit) |
10.1097/INF.0000000000003195 |
| 2021-05-02 |
Virtual screening FDA approved drugs against multiple targets of SARS-CoV-2 (edit) |
10.1111/CTS.13007 |
| 2021-05-01 |
[Coercive measures and the SARS-CoV-2 pandemic] (edit) |
10.1007/S00115-020-01002-Y |
| 2021-05-01 |
Dental Education in the Time of SARS-CoV-2 (edit) |
10.1111/EJE.12608 |
| 2021-05-01 |
Extrapulmonary Manifestations of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Infection (edit) |
10.1002/JMV.26595 |
| 2021-05-01 |
COVID-19: time to flatten the infodemic curve (edit) |
10.1007/S10238-020-00680-X |
| 2021-05-01 |
Pathophysiological Clues to How the Emergent SARS-CoV-2 Can Potentially Increase the Susceptibility to Neurodegeneration (edit) |
10.1007/S12035-020-02236-2 |
| 2021-05-01 |
Arginine Methylation of SARS-Cov-2 Nucleocapsid Protein Regulates RNA Binding, its Ability to Suppress Stress Granule Formation and Viral Replication (edit) |
10.1016/J.JBC.2021.100821 |
| 2021-05-01 |
COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection (edit) |
10.1007/S10096-020-04138-6 |
| 2021-05-01 |
Host PDZ‐containing proteins targeted by SARS‐CoV‐2 (edit) |
10.1111/FEBS.15881 |
| 2021-05-01 |
Global analysis of protein-RNA interactions in SARS-CoV-2-infected cells reveals key regulators of infection (edit) |
10.1016/J.MOLCEL.2021.05.023 |
| 2021-05-01 |
Human SARS CoV-2 spike protein mutations (edit) |
10.1002/PROT.26042 |
| 2021-05-01 |
Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial (edit) |
10.1016/S2213-2600(20)30566-X |
| 2021-05-01 |
DC/L-SIGN recognition of spike glycoprotein promotes SARS-CoV-2 trans-infection and can be inhibited by a glycomimetic antagonist (edit) |
10.1371/JOURNAL.PPAT.1009576 |
| 2021-05-01 |
Antiphospholipid antibodies in COVID-19: a meta-analysis and systematic review (edit) |
10.1136/RMDOPEN-2021-001580 |
| 2021-05-01 |
Mass spectrometry-based proteomic platforms for better understanding of SARS-CoV-2 induced pathogenesis and potential diagnostic approaches (edit) |
10.1002/PMIC.202000279 |
| 2021-05-01 |
Coronavirus-induced autoimmunity (edit) |
10.1016/J.CLIM.2021.108694 |
| 2021-05-01 |
Unproven Therapy Algorithms for Early SARS-CoV-2 Infection Are Dangerous (edit) |
10.1016/J.AMJMED.2021.01.009 |
| 2021-05-01 |
SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity (edit) |
10.1016/S1473-3099(21)00262-0 |
| 2021-05-01 |
CovMT: an interactive SARS-CoV-2 mutation tracker, with a focus on critical variants (edit) |
10.1016/S1473-3099(21)00078-5 |
| 2021-05-01 |
There is no evidence of SARS-CoV-2 laboratory origin: Response to Segreto and Deigin (DOI: 10.1002/bies.202000240) (edit) |
10.1002/BIES.202000325 |
| 2021-05-01 |
Interferon antagonism by SARS-CoV-2: a functional study using reverse genetics (edit) |
10.1016/S2666-5247(21)00027-6 |
| 2021-05-01 |
Host-cell recognition through GRP78 is enhanced in the new UK variant of SARS-CoV-2, in silico (edit) |
10.1016/J.JINF.2021.01.015 |
| 2021-05-01 |
From genomes to molecular dynamics - A bottom up approach in extrication of SARS CoV-2 main protease inhibitors (edit) |
10.1016/J.COMTOX.2021.100156 |
| 2021-05-01 |
SARS-CoV-2 can recruit a heme metabolite to evade antibody immunity (edit) |
10.1126/SCIADV.ABG7607 |
| 2021-05-01 |
Diagnosis value of SARS-CoV-2 antigen/antibody combined testing using rapid diagnostic tests at hospital admission (edit) |
10.1002/JMV.26855 |
| 2021-05-01 |
Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study (edit) |
10.1016/S2468-2667(21)00055-4 |
| 2021-05-01 |
Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite (edit) |
10.1016/J.CHOM.2021.03.005 |
| 2021-05-01 |
Micro-RNAs in the regulation of immune response against SARS CoV-2 and other viral infections (edit) |
10.1016/J.JARE.2020.11.013 |
| 2021-05-01 |
The SARS-CoV-2 pandemic: real-time training and service for Preventive Medicine residents (edit) |
10.1097/PHH.0000000000001304 |
| 2021-05-01 |
SARS-CoV-2-related Multisystem Inflammatory Syndrome in Children: A case series (edit) |
10.18295/SQUMJ.2021.21.02.021 |
| 2021-05-01 |
O‐glycosylation of the novel SARS‐CoV‐2 coronavirus spike protein influences furin cleavage (edit) |
10.1096/FASEBJ.2021.35.S1.00261 |
| 2021-05-01 |
Enhanced binding of the N501Y-mutated SARS-CoV-2 spike protein to the human ACE2 receptor: insights from molecular dynamics simulations (edit) |
10.1002/1873-3468.14076 |
| 2021-05-01 |
Genomic Evidence of SARS-CoV-2 Reinfection Involving E484K Spike Mutation, Brazil (edit) |
10.3201/EID2705.210191 |
| 2021-05-01 |
Type I and III interferon responses in SARS-CoV-2 infection (edit) |
10.1038/S12276-021-00592-0 |
| 2021-05-01 |
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial (edit) |
10.1016/S1473-3099(20)30942-7 |
| 2021-05-01 |
Immunoglobin G/total antibody testing for SARS-CoV-2: A prospective cohort study of ambulatory patients and health care workers in two Belgian oncology units comparing three commercial tests (edit) |
10.1016/J.EJCA.2021.02.024 |
| 2021-05-01 |
Susceptibility to SARS-CoV-2 of Cell Lines and Substrates Commonly Used to Diagnose and Isolate Influenza and Other Viruses (edit) |
10.3201/EID2705.210023 |
| 2021-05-01 |
Structural basis for bivalent binding and inhibition of SARS-CoV-2 infection by human potent neutralizing antibodies (edit) |
10.1038/S41422-021-00487-9 |
| 2021-05-01 |
Pyroptotic macrophages stimulate the SARS-CoV-2-associated cytokine storm (edit) |
10.1038/S41423-021-00665-0 |
| 2021-05-01 |
SARS-CoV-2 infection of the oral cavity and saliva (edit) |
10.1038/S41591-021-01296-8 |
| 2021-05-01 |
Transmission of SARS-CoV-2 on cold-chain food overpacks: A new challenge (edit) |
10.7189/JOGH.11.03071 |
| 2021-05-01 |
The age-dependent decline of the extracellular thiol-disulfide balance and its role in SARS-CoV-2 infection (edit) |
10.1016/J.REDOX.2021.101902 |
| 2021-05-01 |
Angiotensin System Polymorphisms’ in SARS-CoV-2 Positive Patients: Assessment Between Symptomatic and Asymptomatic Patients: A Pilot Study (edit) |
10.2147/PGPM.S303666 |
| 2021-05-01 |
SARS-CoV-2 biology and variants: anticipation of viral evolution and what needs to be done (edit) |
10.1111/1462-2920.15487 |
| 2021-05-01 |
Introduction of ORF3a-Q57H SARS-CoV-2 Variant Causing Fourth Epidemic Wave of COVID-19, Hong Kong, China (edit) |
10.3201/EID2705.210015 |
| 2021-05-01 |
Risk for International Importations of Variant SARS-CoV-2 Originating in the United Kingdom (edit) |
10.3201/EID2705.210050 |
| 2021-05-01 |
SARS-CoV-2-associated multisystem inflammatory syndrome in children: clinical manifestations and the role of infliximab treatment (edit) |
10.1007/S00431-021-03935-1 |
| 2021-05-01 |
Disinfectants Used in Stomatology and SARS-CoV-2 Infection (edit) |
10.1055/S-0041-1724154 |
| 2021-05-01 |
Performance assessment of SARS-CoV-2 IgM & IgG ELISAs in comparison with plaque reduction neutralization test (edit) |
10.4103/IJMR.IJMR_3806_20 |
| 2021-05-01 |
Differential Signaling and Virus Production in Calu-3 Cells and Vero Cells upon SARS-CoV-2 Infection (edit) |
10.4062/BIOMOLTHER.2020.226 |
| 2021-05-01 |
Monitoring SARS-CoV-2 Circulation and Diversity through Community Wastewater Sequencing, the Netherlands and Belgium (edit) |
10.3201/EID2705.204410 |
| 2021-05-01 |
Immunological Features and Hypotheses: Do SARS-CoV and MERS-CoV-Reported Individuals have Immunity against SARS-CoV-2 Infection (edit) |
10.9734/JPRI/2021/V33I26B31480 |
| 2021-05-01 |
Testicles, adipose organ and heart: A new axis in the management of SARS-CoV-2? (edit) |
10.1016/J.MEHY.2021.110587 |
| 2021-05-01 |
Anticholinergic drugs versus preprocedural mouth rinses for reduction of SARS-CoV-2 load in dental aerosols (edit) |
10.1016/J.MEHY.2021.110577 |
| 2021-05-01 |
Aminoglycosides and their potential as SARS-CoV-2 antivirals (edit) |
10.1016/J.MEHY.2021.110559 |
| 2021-05-01 |
Targeting RAGE to prevent SARS-CoV-2-mediated multiple organ failure: Hypotheses and perspectives (edit) |
10.1016/J.LFS.2021.119251 |
| 2021-05-01 |
Sudden sensorineural hearing loss and SARS-CoV-2: Don’t forget the standard work-up! (edit) |
10.1016/J.ANORL.2021.02.010 |
| 2021-05-01 |
Multifactorial Traits of SARS-CoV-2 Cell Entry Related to Diverse Host Proteases and Proteins (edit) |
10.4062/BIOMOLTHER.2021.048 |
| 2021-05-01 |
Effective drugs used to combat SARS-CoV-2 infection and the current status of vaccines (edit) |
10.1016/J.BIOPHA.2021.111330 |
| 2021-05-01 |
Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data (edit) |
10.1016/S0140-6736(21)00947-8 |
| 2021-05-01 |
Pediatric urology amidst SARS-CoV-2 pandemic: Building the future with current knowledge (edit) |
10.1016/J.JPEDSURG.2021.01.017 |
| 2021-05-01 |
Animal coronaviruses and SARS-CoV-2 (edit) |
10.1111/TBED.13791 |
| 2021-05-01 |
Management of patients with neuromuscular disorders at the time of the SARS-CoV-2 pandemic (edit) |
10.1007/S00415-020-10149-2 |
| 2021-04-30 |
SARS-CoV-2 Spike Protein Impairs Endothelial Function via Downregulation of ACE 2 (edit) |
10.1161/CIRCRESAHA.121.318902 |
| 2021-04-30 |
Structural impact on SARS-CoV-2 spike protein by D614G substitution (edit) |
10.1126/SCIENCE.ABF2303 |
| 2021-04-30 |
Inhibitors of Protein Glycosylation Are Active against the Coronavirus Severe Acute Respiratory Syndrome Coronavirus SARS-CoV-2 (edit) |
10.3390/V13050808 |
| 2021-04-30 |
Clinical course and outcome of SARS-CoV-2 infection in multiple sclerosis patients treated with disease-modifying therapies — the Polish experience (edit) |
10.5603/PJNNS.A2021.0031 |
| 2021-04-30 |
Integrated Biophysical Modeling of the SARS-CoV-2 Spike Protein Binding and Allosteric Interactions with Antibodies (edit) |
10.1021/ACS.JPCB.1C00395 |
| 2021-04-30 |
Standard blood laboratory values as a clinical support tool to distinguish between SARS-CoV-2 positive and negative patients (edit) |
10.1038/S41598-021-88844-X |
| 2021-04-30 |
Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England: an observational cohort study using the OpenSAFELY platform (edit) |
10.1016/S0140-6736(21)00634-6 |
| 2021-04-30 |
Viral transmission and evolution dynamics of SARS-CoV-2 in shipboard quarantine (edit) |
10.2471/BLT.20.255752 |
| 2021-04-30 |
Pathogenic perspective of missense mutations of ORF3a protein of SARS-CoV-2 (edit) |
10.1016/J.VIRUSRES.2021.198441 |
| 2021-04-30 |
Reduced A-to-I editing of endogenous Alu RNAs in lung after SARS-CoV-2 infection (edit) |
10.1016/J.CRIMMU.2021.04.001 |
| 2021-04-29 |
Widespread SARS-CoV-2 Transmission Among Attendees at a Large Motorcycle Rally and their Contacts, 30 US Jurisdictions, August–September, 2020 (edit) |
10.1093/CID/CIAB321 |
| 2021-04-29 |
SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies (edit) |
10.1016/J.CELL.2021.03.036 |
| 2021-04-29 |
Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity (edit) |
10.1016/J.CELL.2021.03.013 |
| 2021-04-29 |
Discovery and functional interrogation of SARS-CoV-2 RNA-host protein interactions (edit) |
10.1016/J.CELL.2021.03.012 |
| 2021-04-29 |
Reconstitution and functional characterization of SARS-CoV-2 proofreading complex (edit) |
10.1016/J.PEP.2021.105894 |
| 2021-04-29 |
SARS-CoV-2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG-I/MDA-5-MAVS, TLR3-TRIF, and cGAS-STING signaling pathways (edit) |
10.1002/JMV.27050 |
| 2021-04-29 |
SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape (edit) |
10.1016/J.CELL.2021.02.042 |
| 2021-04-29 |
Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity (edit) |
10.1016/J.CELL.2021.04.006 |
| 2021-04-29 |
How SARS-CoV-2 first adapted in humans (edit) |
10.1126/SCIENCE.ABI4711 |
| 2021-04-29 |
Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein (edit) |
10.1016/J.CELL.2021.03.029 |
| 2021-04-29 |
SARS-CoV-2 interacts with platelets and megakaryocytes via ACE2-independent mechanism (edit) |
10.1186/S13045-021-01082-6 |
| 2021-04-29 |
The dimer-monomer equilibrium of SARS-CoV-2 main protease is affected by small molecule inhibitors (edit) |
10.1038/S41598-021-88630-9 |
| 2021-04-29 |
Molecular interactions of the M and E integral membrane proteins of SARS-CoV-2 (edit) |
10.1101/2021.04.29.442018 |
| 2021-04-29 |
Towards computer-aided severity assessment via deep neural networks for geographic and opacity extent scoring of SARS-CoV-2 chest X-rays (edit) |
10.1038/S41598-021-88538-4 |
| 2021-04-29 |
Hospitalization and interventional procedures in cardiology departments covering a region with 2.5 million inhabitants during the SARS-CoV-2 pandemic (edit) |
10.33963/KP.15984 |
| 2021-04-28 |
SARS-CoV-2 elimination, not mitigation, creates best outcomes for health, the economy, and civil liberties (edit) |
10.1016/S0140-6736(21)00978-8 |
| 2021-04-28 |
Coiled-coil heterodimers with increased stability for cellular regulation and sensing SARS-CoV-2 spike protein-mediated cell fusion (edit) |
10.1038/S41598-021-88315-3 |
| 2021-04-28 |
Assessing Antigen Structural Integrity through Glycosylation Analysis of the SARS-CoV-2 Viral Spike (edit) |
10.1021/ACSCENTSCI.1C00058 |
| 2021-04-28 |
Native-like SARS-CoV-2 Spike Glycoprotein Expressed by ChAdOx1 nCoV-19/AZD1222 Vaccine (edit) |
10.1021/ACSCENTSCI.1C00080 |
| 2021-04-28 |
Seroprevalence of anti-SARS-CoV-2 antibodies in a cohort of New York City metro blood donors using multiple SARS-CoV-2 serological assays: Implications for controlling the epidemic and "Reopening" (edit) |
10.1371/JOURNAL.PONE.0250319 |
| 2021-04-28 |
Risk of rapid evolutionary escape from biomedical interventions targeting SARS-CoV-2 spike protein (edit) |
10.1371/JOURNAL.PONE.0250780 |
| 2021-04-28 |
Protection against SARS-CoV-2 infection by a mucosal vaccine in rhesus macaques (edit) |
10.1172/JCI.INSIGHT.148494 |
| 2021-04-28 |
Cameroonian medicinal plants as potential candidates of SARS-CoV-2 inhibitors (edit) |
10.1080/07391102.2021.1914170 |
| 2021-04-28 |
Nutritional status, diet and viral respiratory infections: perspectives for SARS-CoV-2 (edit) |
10.1017/S0007114520003311 |
| 2021-04-27 |
A Nanoscaffolded Spike-RBD Vaccine Provides Protection against SARS-CoV-2 with Minimal Anti-Scaffold Response (edit) |
10.3390/VACCINES9050431 |
| 2021-04-27 |
The SARS-CoV-2 RNA interactome (edit) |
10.1016/J.MOLCEL.2021.04.022 |
| 2021-04-27 |
The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets (edit) |
10.1038/S41564-021-00908-W |
| 2021-04-27 |
A monoclonal antibody against staphylococcal enterotoxin B superantigen inhibits SARS-CoV-2 entry in vitro (edit) |
10.1016/J.STR.2021.04.005 |
| 2021-04-27 |
ORF10-Cullin-2-ZYG11B complex is not required for SARS-CoV-2 infection (edit) |
10.1073/PNAS.2023157118 |
| 2021-04-27 |
Assessment of basic reproduction number (R0), spatial and temporal epidemiological determinants, and genetic characterization of SARS-CoV-2 in Bangladesh (edit) |
10.1016/J.MEEGID.2021.104884 |
| 2021-04-27 |
NeutrobodyPlex-monitoring SARS-CoV-2 neutralizing immune responses using nanobodies (edit) |
10.15252/EMBR.202052325 |
| 2021-04-27 |
Identification and host response interaction study of SARS-CoV-2 encoded miRNA-like sequences: an in silico approach (edit) |
10.1016/J.COMPBIOMED.2021.104451 |
| 2021-04-27 |
Overview of SARS-CoV-2 infection in adults living with HIV (edit) |
10.1016/S2352-3018(21)00070-9 |
| 2021-04-27 |
Humoral immunity to SARS-CoV-2 among the population of Murmansk region amid COVID-19 epidemic (edit) |
10.22328/2077-9828-2021-13-1-17-27 |
| 2021-04-26 |
Duration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectivity: When Is It Safe to Discontinue Isolation? (edit) |
10.1093/CID/CIAA1249 |
| 2021-04-26 |
Fundamental evolution of all Orthocoronavirinae including three deadly lineages descendent from Chiroptera‐hosted coronaviruses: SARS‐CoV, MERS‐CoV and SARS‐CoV‐2 (edit) |
10.1111/CLA.12454 |
| 2021-04-26 |
Comparative Perturbation-Based Modeling of the SARS-CoV-2 Spike Protein Binding with Host Receptor and Neutralizing Antibodies: Structurally Adaptable Allosteric Communication Hotspots Define Spike Sites Targeted by Global Circulating Mutations (edit) |
10.1021/ACS.BIOCHEM.1C00139 |
| 2021-04-26 |
Experimental and natural evidence of SARS-CoV-2-infection-induced activation of type I interferon responses (edit) |
10.1016/J.ISCI.2021.102477 |
| 2021-04-26 |
Can tweets be used to detect problems early with scientific papers? A case study of three retracted COVID-19/SARS-CoV-2 papers (edit) |
10.1007/S11192-021-03962-7 |
| 2021-04-26 |
Therapeutic antibodies, targeting the SARS-CoV-2 spike N-terminal domain, protect lethally infected K18-hACE2 mice (edit) |
10.1016/J.ISCI.2021.102479 |
| 2021-04-26 |
Analysis and forecasting of global real time RT-PCR primers and probes for SARS-CoV-2 (edit) |
10.1038/S41598-021-88532-W |
| 2021-04-26 |
Distinguishing non severe cases of dengue from COVID-19 in the context of co-epidemics: A cohort study in a SARS-CoV-2 testing center on Reunion island (edit) |
10.1371/JOURNAL.PNTD.0008879 |
| 2021-04-25 |
SARS-CoV-2 Viral Entry Proteins in Hyperandrogenemic Female Mice: Implications for Women with PCOS and COVID-19 (edit) |
10.3390/IJMS22094472 |
| 2021-04-24 |
RNA-induced liquid phase separation of SARS-CoV-2 nucleocapsid protein facilitates NF-κB hyper-activation and inflammation (edit) |
10.1038/S41392-021-00575-7 |
| 2021-04-24 |
The olfactory route is a potential way for SARS-CoV-2 to invade the central nervous system of rhesus monkeys (edit) |
10.1038/S41392-021-00591-7 |
| 2021-04-24 |
Convergent evolution of SARS-CoV-2 spike mutations, L452R, E484Q and P681R, in the second wave of COVID-19 in Maharashtra, India (edit) |
10.1101/2021.04.22.440932 |
| 2021-04-24 |
Diverse immunoglobulin gene usage and convergent epitope targeting in neutralizing antibody responses to SARS-CoV-2 (edit) |
10.1016/J.CELREP.2021.109109 |
| 2021-04-24 |
Identification of Vitamin K3 and its analogues as covalent inhibitors of SARS-CoV-2 3CLpro (edit) |
10.1016/J.IJBIOMAC.2021.04.129 |
| 2021-04-24 |
B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoV (edit) |
10.1016/J.CELL.2021.04.032 |
| 2021-04-24 |
In vitro cell culture model of human nasal-associated lymphoid tissue (NALT) to evaluate the humoral immune response to SARS-CoV-2 spike proteins (edit) |
10.1016/J.SJBS.2021.04.051 |
| 2021-04-24 |
Isolation of SARS-CoV-2 from the air in a car driven by a COVID patient with mild illness (edit) |
10.1016/J.IJID.2021.04.063 |
| 2021-04-24 |
Designing a SARS-CoV-2 T-Cell-Inducing Vaccine for High-Risk Patient Groups (edit) |
10.3390/VACCINES9050428 |
| 2021-04-23 |
ORF8 contributes to cytokine storm during SARS-CoV-2 infection by activating IL-17 pathway (edit) |
10.1016/J.ISCI.2021.102293 |
| 2021-04-23 |
SARS-CoV-2 variants combining spike mutations and the absence of ORF8 may be more transmissible and require close monitoring (edit) |
10.1016/J.BBRC.2021.02.080 |
| 2021-04-23 |
Laboratory modeling of SARS-CoV-2 exposure reduction through physically distanced seating in aircraft cabins using bacteriophage aerosol - November 2020 (edit) |
10.15585/MMWR.MM7016E1 |
| 2021-04-23 |
SARS-CoV-2 requires cholesterol for viral entry and pathological syncytia formation (edit) |
10.7554/ELIFE.65962 |
| 2021-04-23 |
Genome-wide, bidirectional CRISPR screens identify mucins as critical host factors modulating SARS-CoV-2 infection (edit) |
10.1101/2021.04.22.440848 |
| 2021-04-23 |
Cell-Type Apoptosis in Lung during SARS-CoV-2 Infection (edit) |
10.3390/PATHOGENS10050509 |
| 2021-04-23 |
Structure and function analysis of a potent human neutralizing antibody CA521 against SARS-CoV-2 (edit) |
10.1038/S42003-021-02029-W |
| 2021-04-23 |
Expedited Approach toward the Rational Design of Noncovalent SARS-CoV-2 Main Protease Inhibitors (edit) |
10.1021/ACS.JMEDCHEM.1C00509 |
| 2021-04-23 |
Online biophysical predictions for SARS-CoV-2 proteins (edit) |
10.1186/S12860-021-00362-W |
| 2021-04-23 |
Transcriptional and epi-transcriptional dynamics of SARS-CoV-2 during cellular infection (edit) |
10.1016/J.CELREP.2021.109108 |
| 2021-04-23 |
Rational Engineering of the DNA Walker Amplification Strategy by Using a Au@Ti3C2@PEI-Ru(dcbpy)32+ Nanocomposite Biosensor for Detection of the SARS-CoV-2 RdRp Gene (edit) |
10.1021/ACSAMI.1C04453 |
| 2021-04-23 |
Re-positive of SARS-CoV-2 test is common in COVID-19 patients after hospital discharge. Data from high standard post-discharge quarantined patients in Macao SAR, China (edit) |
10.7717/PEERJ.11170 |
| 2021-04-22 |
Misleading clinical evidence and systematic reviews on ivermectin for COVID-19 (edit) |
10.1136/BMJEBM-2021-111678 |
| 2021-04-22 |
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19 (edit) |
10.1056/NEJMOA2100433 |
| 2021-04-22 |
N-Terminal Finger Stabilizes the S1 Pocket for the Reversible Feline Drug GC376 in the SARS-CoV-2 Mpro Dimer (edit) |
10.1016/J.JMB.2021.167003 |
| 2021-04-22 |
High-throughput screening of the ReFRAME, Pandemic Box, and COVID Box drug repurposing libraries against SARS-CoV-2 nsp15 endoribonuclease to identify small-molecule inhibitors of viral activity (edit) |
10.1371/JOURNAL.PONE.0250019 |
| 2021-04-22 |
Nanoparticle composite TPNT1 is effective against SARS-CoV-2 and influenza viruses (edit) |
10.1038/S41598-021-87254-3 |
| 2021-04-22 |
Uncertainties around COVID-19 from the perspectives of oral health care workers during the first wave of SARS-CoV-2 infections in British Columbia, Canada (edit) |
10.1371/JOURNAL.PONE.0249186 |
| 2021-04-22 |
New framework for recombination and adaptive evolution analysis with application to the novel coronavirus SARS-CoV-2 (edit) |
10.1093/BIB/BBAB107 |
| 2021-04-22 |
Wastewater Surveillance for SARS-CoV-2 on College Campuses: Initial Efforts, Lessons Learned, and Research Needs (edit) |
10.3390/IJERPH18094455 |
| 2021-04-22 |
A majority of uninfected adults show preexisting antibody reactivity against SARS-CoV-2 (edit) |
10.1172/JCI.INSIGHT.146316 |
| 2021-04-21 |
COVID-19 Outbreak Associated with a SARS-CoV-2 R.1 Lineage Variant in a Skilled Nursing Facility After Vaccination Program — Kentucky, March 2021 (edit) |
10.15585/MMWR.MM7017E2 |
| 2021-04-21 |
Postvaccination SARS-CoV-2 Infections Among Skilled Nursing Facility Residents and Staff Members — Chicago, Illinois, December 2020–March 2021 (edit) |
10.15585/MMWR.MM7017E1 |
| 2021-04-21 |
Vaccine Breakthrough Infections with SARS-CoV-2 Variants (edit) |
10.1056/NEJMOA2105000 |
| 2021-04-21 |
The Impact of COVID-19 Management Policies Tailored to Airborne SARS-CoV-2 Transmission: Policy Analysis (edit) |
10.2196/20699 |
| 2021-04-21 |
SARS-CoV-2 infection of human iPSC-derived cardiac cells reflects cytopathic features in hearts of patients with COVID-19 (edit) |
10.1126/SCITRANSLMED.ABF7872 |
| 2021-04-21 |
Fast Prediction of Binding Affinities of the SARS-CoV-2 Spike Protein Mutant N501Y (UK Variant) with ACE2 and Miniprotein Drug Candidates (edit) |
10.1021/ACS.JPCB.1C00869 |
| 2021-04-21 |
SARS-CoV-2 shifting transmission dynamics and hidden reservoirs potentially limit efficacy of public health interventions in Italy (edit) |
10.1038/S42003-021-02025-0 |
| 2021-04-21 |
Evidence of a dysregulated vitamin D endocrine system in SARS-CoV-2 infected patient's lung cells (edit) |
10.1038/S41598-021-87703-Z |
| 2021-04-21 |
Immunoinformatics and molecular modeling approach to design universal multi-epitope vaccine for SARS-CoV-2 (edit) |
10.1016/J.IMU.2021.100578 |
| 2021-04-20 |
Sharing COVID data? Check these recommendations and guidelines (edit) |
10.1038/D41586-021-01028-5 |
| 2021-04-20 |
The SARS‐unique domain (SUD) of SARS‐CoV and SARS‐CoV‐2 interacts with human Paip1 to enhance viral RNA translation (edit) |
10.15252/EMBJ.2019102277 |
| 2021-04-20 |
Origins of SARS-CoV-2: Focusing on Science (edit) |
10.1097/ID9.0000000000000008 |
| 2021-04-20 |
Sentinel cells enable genetic detection of SARS-CoV-2 Spike protein (edit) |
10.1101/2021.04.20.440678 |
| 2021-04-20 |
Sensitive detection of SARS-CoV-2 seroconversion by flow cytometry reveals the presence of nucleoprotein-reactive antibodies in unexposed individuals (edit) |
10.1038/S42003-021-02011-6 |
| 2021-04-20 |
Hypoxic and pharmacological activation of HIF inhibits SARS-CoV-2 infection of lung epithelial cells (edit) |
10.1016/J.CELREP.2021.109020 |
| 2021-04-20 |
Differences in the concentration of anti-SARS-CoV-2 IgG antibodies as a result of post-covid or/and post-vaccination immunization (edit) |
10.21203/RS.3.RS-388040/V2 |
| 2021-04-20 |
SARS-CoV-2 spike protein dictates syncytium-mediated lymphocyte elimination (edit) |
10.1038/S41418-021-00782-3 |
| 2021-04-20 |
Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016 (edit) |
10.1016/J.XCRM.2021.100255 |
| 2021-04-20 |
SARS-CoV-2 induces double-stranded RNA-mediated innate immune responses in respiratory epithelial-derived cells and cardiomyocytes (edit) |
10.1073/PNAS.2022643118 |
| 2021-04-20 |
Assessment of S1-, S2-, and NCP-Specific IgM, IgA, and IgG Antibody Kinetics in Acute SARS-CoV-2 Infection by a Microarray and Twelve Other Immunoassays (edit) |
10.1128/JCM.02890-20 |
| 2021-04-20 |
Identification of SARS-CoV-2 origin: Using Ngrams, principal component analysis and Random Forest algorithm (edit) |
10.1016/J.IMU.2021.100577 |
| 2021-04-20 |
Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies (edit) |
10.1016/J.XCRM.2021.100275 |
| 2021-04-20 |
Promising phytochemicals of traditional Himalayan medicinal plants against putative replication and transmission targets of SARS-CoV-2 by computational investigation (edit) |
10.1016/J.COMPBIOMED.2021.104383 |
| 2021-04-20 |
SARS-CoV-2 Switches 'on' MAPK and NFκB Signaling via the Reduction of Nuclear DUSP1 and DUSP5 Expression (edit) |
10.3389/FPHAR.2021.631879 |
| 2021-04-20 |
Immunoinformatics Identification of B- and T-Cell Epitopes in the RNA-Dependent RNA Polymerase of SARS-CoV-2 (edit) |
10.1155/2021/6627141 |
| 2021-04-20 |
C5aR inhibition of nonimmune cells suppresses inflammation and maintains epithelial integrity in SARS-CoV-2-infected primary human airway epithelia (edit) |
10.1016/J.JACI.2021.03.038 |
| 2021-04-20 |
Exploring SARS-COV-2 structural proteins to design a multi-epitope vaccine using immunoinformatics approach: An in silico study (edit) |
10.1016/J.COMPBIOMED.2021.104390 |
| 2021-04-20 |
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infecting Pregnant Women and the Fetus, Intrauterine Transmission, and Placental Pathology During the Coronavirus Disease 2019 (COVID-19) Pandemic: It's Complicated (edit) |
10.5858/ARPA.2021-0164-ED |
| 2021-04-19 |
Safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine formulations in healthy adults: interim results of a randomised, placebo-controlled, phase 1-2, dose-ranging study (edit) |
10.1016/S1473-3099(21)00147-X |
| 2021-04-19 |
Global dynamics of SARS-CoV-2 clades and their relation to COVID-19 epidemiology (edit) |
10.1038/S41598-021-87713-X |
| 2021-04-19 |
Large scale discovery of coronavirus-host factor protein interaction motifs reveals SARS-CoV-2 specific mechanisms and vulnerabilities (edit) |
10.1101/2021.04.19.440086 |
| 2021-04-19 |
Low dose inocula of SARS-CoV-2 B.1.1.7 variant initiate more robust infections in the upper respiratory tract of hamsters than earlier D614G variants (edit) |
10.1101/2021.04.19.440414 |
| 2021-04-19 |
The Challenging Diagnosis of Pediatric Multisystem Inflammatory Syndrome Associated with Sars-Cov-2 Infection-Two Case Reports and Literature Review (edit) |
10.3390/JPM11040318 |
| 2021-04-19 |
Molecular Aspects Concerning the Use of the SARS-CoV-2 Receptor Binding Domain as a Target for Preventive Vaccines (edit) |
10.1021/ACSCENTSCI.1C00216 |
| 2021-04-19 |
Sterilizing Immunity against SARS-CoV-2 Infection in Mice by a Single-Shot and Lipid Amphiphile Imidazoquinoline TLR7/8 Agonist-Adjuvanted Recombinant Spike Protein Vaccine* (edit) |
10.1002/ANIE.202015362 |
| 2021-04-19 |
Rapid decay of host basal mRNAs during SARS-CoV-2 infection perturbs host antiviral mRNA biogenesis and export (edit) |
10.1101/2021.04.19.440452 |
| 2021-04-19 |
Identification of potential antiviral compounds against SARS-CoV-2 structural and non structural protein targets: A pharmacoinformatics study of the CAS COVID-19 dataset (edit) |
10.1016/J.COMPBIOMED.2021.104364 |
| 2021-04-19 |
Profiling SARS-CoV-2 mutation fingerprints that range from the viral pangenome to individual infection quasispecies (edit) |
10.1186/S13073-021-00882-2 |
| 2021-04-19 |
Modelling studies reveal the importance of the C-terminal inter motif loop of NSP1 as a promising target site for drug discovery and screening of potential phytochemicals to combat SARS-CoV-2 (edit) |
10.1016/J.JMGM.2021.107920 |
| 2021-04-19 |
New Drug/Vaccine RNA-Peptide Named Melody Against SARS-CoV-2: Adapting Antiviral Pathways in Cell Culture WM-266 as Temporal Memory of “In Vitro Cell” (edit) |
10.47485/2693-2504.1040 |
| 2021-04-17 |
SARS-CoV-2 transmission in a Georgia school district — United States, December 2020–January 2021 (edit) |
10.1093/CID/CIAB332 |
| 2021-04-17 |
How do we can control SARS-CoV-2/ Covid -19 pandemic through various clinical and public health approaches? What are the agent (Covid-19 virus), host & environmental factors responsible for continuation & recurrence of SARS-CoV-2/ Covid -19 pandemic? (edit) |
10.31219/OSF.IO/VDHG3 |
| 2021-04-17 |
COVID-19: What Does Confirmation of the Airborne Transmission of SARS-CoV-2 Virus Mean? (edit) |
|
| 2021-04-17 |
Discovery of chebulagic acid and punicalagin as novel allosteric inhibitors of SARS-CoV-2 3CLpro (edit) |
10.1016/J.ANTIVIRAL.2021.105075 |
| 2021-04-16 |
The Mechanism of SARS-CoV-2 Nucleocapsid Protein Recognition by the Human 14-3-3 Proteins (edit) |
10.1016/J.JMB.2021.166875 |
| 2021-04-16 |
Orally delivered MK-4482 inhibits SARS-CoV-2 replication in the Syrian hamster model (edit) |
10.1038/S41467-021-22580-8 |
| 2021-04-16 |
SARS-CoV-2 within-host diversity and transmission (edit) |
10.1126/SCIENCE.ABG0821 |
| 2021-04-16 |
Screening of potent phytochemical inhibitors against SARS-CoV-2 protease and its two Asian mutants (edit) |
10.1016/J.COMPBIOMED.2021.104362 |
| 2021-04-16 |
Structural equation modeling to shed light on the controversial role of climate on the spread of SARS-CoV-2 (edit) |
10.1038/S41598-021-87113-1 |
| 2021-04-16 |
Prediction of Epitope based Peptides for Vaccine Development from Complete Proteome of Novel Corona Virus (SARS-COV-2) Using Immunoinformatics (edit) |
10.1007/S10989-021-10205-Z |
| 2021-04-16 |
Development and performance characteristics evaluation of a new Bioelectric Recognition Assay (BERA) method for rapid Sars-CoV-2 detection in clinical samples (edit) |
10.1016/J.JVIROMET.2021.114166 |
| 2021-04-15 |
The novel SARS-CoV-2 pandemic: Possible environmental transmission, detection, persistence and fate during wastewater and water treatment (edit) |
10.1016/J.SCITOTENV.2020.142746 |
| 2021-04-15 |
Coronavirus (SARS-CoV-2) in the environment: Occurrence, persistence, analysis in aquatic systems and possible management (edit) |
10.1016/J.SCITOTENV.2020.142698 |
| 2021-04-15 |
A unique view of SARS-COV-2 through the lens of ORF8 protein (edit) |
10.1016/J.COMPBIOMED.2021.104380 |
| 2021-04-15 |
Simeprevir Potently Suppresses SARS-CoV-2 Replication and Synergizes with Remdesivir (edit) |
10.1021/ACSCENTSCI.0C01186 |
| 2021-04-15 |
Pervasive transmission of E484K and emergence of VUI-NP13L with evidence of SARS-CoV-2 co-infection events by two different lineages in Rio Grande do Sul, Brazil (edit) |
10.1016/J.VIRUSRES.2021.198345 |
| 2021-04-15 |
Soluble ACE2-mediated cell entry of SARS-CoV-2 via interaction with proteins related to the renin-angiotensin system (edit) |
10.1016/J.CELL.2021.02.053 |
| 2021-04-15 |
SARS-CoV-2 one year on: evidence for ongoing viral adaptation (edit) |
10.1099/JGV.0.001584 |
| 2021-04-15 |
Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera (edit) |
10.1016/J.CELL.2021.02.033 |
| 2021-04-15 |
REACT-1 round 10 report: Level prevalence of SARS-CoV-2 swab-positivity in England during third national lockdown in March 2021 (edit) |
10.1101/2021.04.08.21255100 |
| 2021-04-15 |
The antigenic anatomy of SARS-CoV-2 receptor binding domain (edit) |
10.1016/J.CELL.2021.02.032 |
| 2021-04-15 |
A trans-complementation system for SARS-CoV-2 recapitulates authentic viral replication without virulence (edit) |
10.1016/J.CELL.2021.02.044 |
| 2021-04-15 |
Deciphering the introduction and transmission of SARS-CoV-2 in the Colombian Amazon Basin (edit) |
10.1371/JOURNAL.PNTD.0009327 |
| 2021-04-15 |
CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity (edit) |
10.1016/J.IMMUNI.2021.04.009 |
| 2021-04-15 |
A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection (edit) |
10.1016/J.CHOM.2021.04.005 |
| 2021-04-15 |
A COVID moonshot: assessment of ligand binding to the SARS-CoV-2 main protease by saturation transfer difference NMR spectroscopy (edit) |
10.1007/S10858-021-00365-X |
| 2021-04-15 |
Assessing Public Interest Based on Wikipedia’s Most Visited Medical Articles During the SARS-CoV-2 Outbreak: Search Trends Analysis (edit) |
10.2196/26331 |
| 2021-04-15 |
Molecular Pathology Analysis of SARS-CoV-2 in Syncytiotrophoblast and Hofbauer Cells in Placenta from a Pregnant Woman and Fetus with COVID-19 (edit) |
10.3390/PATHOGENS10040479 |
| 2021-04-14 |
SARS-CoV-2 genome-wide T cell epitope mapping reveals immunodominance and substantial CD8 T cell activation in COVID-19 patients (edit) |
10.1126/SCIIMMUNOL.ABF7550 |
| 2021-04-14 |
What Impact Have SARS-CoV-2/Covid-19 Pandemic on domestic violence against women in India across different states and union territories from the beginning of lockdown due to covid-19 pandemic in March 2020 till 20th September 2020? How Covid-19 pande (edit) |
10.31219/OSF.IO/5T3Z2 |
| 2021-04-14 |
What Impact Have SARS-CoV-2/Covid-19 Pandemic on domestic violence against women in India across different states and union territories from the beginning of lockdown due to covid-19 pandemic in March 2020 till 20th September 2020? How Covid-19 pande (edit) |
10.21203/RS.3.RS-414848/V2 |
| 2021-04-14 |
Evidence for SARS-CoV-2 Spike Protein in the Urine of COVID-19 Patients (edit) |
10.34067/KID.0002172021 |
| 2021-04-14 |
L-Carnitine Tartrate Downregulates the ACE2 Receptor and Limits SARS-CoV-2 Infection (edit) |
10.3390/NU13041297 |
| 2021-04-14 |
In Silico Evaluation of Cyclophilin Inhibitors as Potential Treatment for SARS-CoV-2 (edit) |
10.1093/OFID/OFAB189 |
| 2021-04-14 |
Human Cathelicidin Inhibits SARS-CoV-2 Infection: Killing Two Birds with One Stone (edit) |
10.1021/ACSINFECDIS.1C00096 |
| 2021-04-14 |
Resourcing, annotating, and analysing synthetic peptides of SARS-CoV-2 for immunopeptidomics and other immunological studies (edit) |
10.1002/PMIC.202100036 |
| 2021-04-14 |
Temporal landscape of human gut RNA and DNA virome in SARS-CoV-2 infection and severity (edit) |
10.1186/S40168-021-01008-X |
| 2021-04-13 |
Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19: A Randomized Clinical Trial (edit) |
10.1001/JAMA.2021.3071 |
| 2021-04-13 |
SARS-CoV-2 ORF6 Disrupts Bidirectional Nucleocytoplasmic Transport through Interactions with Rae1 and Nup98 (edit) |
10.1128/MBIO.00065-21 |
| 2021-04-13 |
Clinical course and predictive risk factors for fatal outcome of SARS-CoV-2 infection in patients with chronic kidney disease (edit) |
10.1007/S15010-021-01597-7 |
| 2021-04-13 |
The effect of in-person primary and secondary school instruction on county-level SARS-CoV-2 spread in Indiana (edit) |
10.1093/CID/CIAB306 |
| 2021-04-13 |
Structure, Dynamics, Receptor Binding, and Antibody Binding of the Fully Glycosylated Full-Length SARS-CoV-2 Spike Protein in a Viral Membrane (edit) |
10.1021/ACS.JCTC.0C01144 |
| 2021-04-13 |
CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope cross-react with selective seasonal coronaviruses (edit) |
10.1016/J.IMMUNI.2021.04.006 |
| 2021-04-13 |
Highly Accurate Chip-Based Resequencing of SARS-CoV-2 Clinical Samples (edit) |
10.1021/ACS.LANGMUIR.0C02927 |
| 2021-04-13 |
Does my patient have SARS-CoV-2 infection? A reminder of clinical probability formulas (edit) |
10.1136/BMJEBM-2020-111633 |
| 2021-04-12 |
Virus Caused Imbalance of Type I IFN Responses and Inflammation in COVID-19 (edit) |
10.3389/FIMMU.2021.633769 |
| 2021-04-12 |
SARS-CoV-2 and SARS-CoV Spike-Mediated Cell-Cell Fusion Differ in Their Requirements for Receptor Expression and Proteolytic Activation (edit) |
10.1128/JVI.00002-21 |
| 2021-04-12 |
Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV (edit) |
10.1038/S41586-021-03493-4 |
| 2021-04-12 |
Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2 (edit) |
10.1038/S42003-021-02030-3 |
| 2021-04-12 |
The Polybasic Cleavage Site in SARS-CoV-2 Spike Modulates Viral Sensitivity to Type I Interferon and IFITM2 (edit) |
10.1128/JVI.02422-20 |
| 2021-04-12 |
What Impact Have SARS-CoV-2/Covid-19 Pandemic on domestic violence against women in India across different states and union territories from the beginning of lockdown due to covid-19 pandemic in March 2020 till 20th September 2020? (edit) |
10.31219/OSF.IO/7VGPX |
| 2021-04-12 |
What Impact Have SARS-CoV-2/Covid-19 Pandemic on domestic violence against women in India across different states and union territories from the beginning of lockdown due to covid-19 pandemic in March 2020 till 20th September 2020? (edit) |
10.21203/RS.3.RS-414848/V1 |
| 2021-04-12 |
Elucidating the Neuropathologic Mechanisms of SARS-CoV-2 Infection (edit) |
10.3389/FNEUR.2021.660087 |
| 2021-04-12 |
A study of differential circRNA and lncRNA expressions in COVID-19-infected peripheral blood (edit) |
10.1038/S41598-021-86134-0 |
| 2021-04-12 |
The binding mechanism of ivermectin and levosalbutamol with spike protein of SARS-CoV-2 (edit) |
10.1007/S11224-021-01776-0 |
| 2021-04-12 |
Potential Mechanism Prediction of Herbal Medicine for Pulmonary Fibrosis Associated with SARS-CoV-2 Infection Based on Network Analysis and Molecular Docking (edit) |
10.3389/FPHAR.2021.602218 |
| 2021-04-12 |
Inhibition of SARS-CoV-2 3CL Mpro by Natural and Synthetic Inhibitors: Potential Implication for Vaccine Production Against COVID-19 (edit) |
10.3389/FMOLB.2021.640819 |
| 2021-04-12 |
Genetic Evidence and Host Immune Response in Persons Reinfected with SARS-CoV-2, Brazil (edit) |
10.3201/EID2705.204912 |
| 2021-04-10 |
Airborne spread of infectious SARS-CoV-2: Moving forward using lessons from SARS-CoV and MERS-CoV (edit) |
10.1016/J.SCITOTENV.2020.142802 |
| 2021-04-10 |
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial (edit) |
10.1016/S0140-6736(21)00628-0 |
| 2021-04-10 |
In silico structure-based discovery of a SARS-CoV-2 main protease inhibitor (edit) |
10.7150/IJBS.59191 |
| 2021-04-10 |
Comparison of Throat Washings, Nasopharyngeal Swabs and Oropharyngeal Swabs for Detection of SARS-CoV-2 (edit) |
10.3390/V13040653 |
| 2021-04-09 |
Seroprevalence of SARS-CoV-2 following the largest initial epidemic wave in the United States: Findings from New York City, May 13-July 21, 2020 (edit) |
10.1093/INFDIS/JIAB200 |
| 2021-04-09 |
Autoantibodies against type I interferons are associated with multi-organ failure in COVID-19 patients (edit) |
10.1007/S00134-021-06392-4 |
| 2021-04-09 |
Pityriasis rosea Gibert triggered by SARS-CoV-2 infection: A case report (edit) |
10.1097/MD.0000000000025352 |
| 2021-04-09 |
Synergistic Inhibition of SARS-CoV-2 Replication Using Disulfiram/Ebselen and Remdesivir (edit) |
10.1021/ACSPTSCI.1C00022 |
| 2021-04-09 |
Human airway cells prevent SARS-CoV-2 multibasic cleavage site cell culture adaptation (edit) |
10.7554/ELIFE.66815 |
| 2021-04-09 |
Assembly and Entry of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2): Evaluation Using Virus-Like Particles (edit) |
10.3390/CELLS10040853 |
| 2021-04-09 |
Genome-wide CRISPR activation screen identifies novel receptors for SARS-CoV-2 entry (edit) |
10.1101/2021.04.08.438924 |
| 2021-04-09 |
IL-33 expression in response to SARS-CoV-2 correlates with seropositivity in COVID-19 convalescent individuals (edit) |
10.1038/S41467-021-22449-W |
| 2021-04-09 |
Mutations derived from horseshoe bat ACE2 orthologs enhance ACE2-Fc neutralization of SARS-CoV-2 (edit) |
10.1371/JOURNAL.PPAT.1009501 |
| 2021-04-09 |
GCG inhibits SARS-CoV-2 replication by disrupting the liquid phase condensation of its nucleocapsid protein (edit) |
10.1038/S41467-021-22297-8 |
| 2021-04-09 |
The Spike Glycoprotein of SARS-CoV-2 Binds to β1 Integrins Expressed on the Surface of Lung Epithelial Cells (edit) |
10.3390/V13040645 |
| 2021-04-09 |
In Silico Analysis of High-Risk Missense Variants in Human ACE2 Gene and Susceptibility to SARS-CoV-2 Infection (edit) |
10.1155/2021/6685840 |
| 2021-04-09 |
SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN) (edit) |
10.1016/S0140-6736(21)00675-9 |
| 2021-04-09 |
The safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in Chinese adults aged 18-59 years: A phase I randomized, double-blinded, controlled trial (edit) |
10.1016/J.VACCINE.2021.04.006 |
| 2021-04-09 |
In Silico Identification of Multi-target Anti-SARS-CoV-2 Peptides from Quinoa Seed Proteins (edit) |
10.1007/S10989-021-10214-Y |
| 2021-04-09 |
Construction of Non-infectious SARS-CoV-2 Replicons and Their Application in Drug Evaluation (edit) |
10.1007/S12250-021-00369-9 |
| 2021-04-09 |
Swabbing the Urban Environment - A Pipeline for Sampling and Detection of SARS-CoV-2 From Environmental Reservoirs (edit) |
10.3791/62379 |
| 2021-04-08 |
Determining the communicable period of SARS-CoV-2: A rapid review of the literature, March to September 2020 (edit) |
10.2807/1560-7917.ES.2021.26.14.2001506 |
| 2021-04-08 |
Structural Insights into Plasticity and Discovery of Remdesivir Metabolite GS-441524 Binding in SARS-CoV-2 Macrodomain (edit) |
10.1021/ACSMEDCHEMLETT.0C00684 |
| 2021-04-08 |
Inhibition of SARS-CoV-2 polymerase by nucleotide analogs: a single molecule perspective (edit) |
10.1101/2020.08.06.240325 |
| 2021-04-08 |
Bioinformatic prediction of immunodominant regions in spike protein for early diagnosis of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (edit) |
10.7717/PEERJ.11232 |
| 2021-04-08 |
High-throughput, single-copy sequencing reveals SARS-CoV-2 spike variants coincident with mounting humoral immunity during acute COVID-19 (edit) |
10.1371/JOURNAL.PPAT.1009431 |
| 2021-04-08 |
Survival of SARS-CoV-2 on Clothing Materials (edit) |
10.1155/2021/6623409 |
| 2021-04-07 |
The SARS-CoV-2 Nsp3 macrodomain reverses PARP9/DTX3L-dependent ADP-ribosylation induced by interferon signalling (edit) |
10.1101/2021.04.06.438552 |
| 2021-04-07 |
Are antiphospholipid antibodies just a common epiphenomenon or are they causative of immune-mediated coagulopathy in COVID-19? (edit) |
10.1007/S10067-021-05724-5 |
| 2021-04-07 |
SARS-CoV-2 drives JAK1/2-dependent local complement hyperactivation (edit) |
10.1126/SCIIMMUNOL.ABG0833 |
| 2021-04-07 |
Temporal dynamics of SARS-CoV-2 mutation accumulation within and across infected hosts (edit) |
10.1371/JOURNAL.PPAT.1009499 |
| 2021-04-07 |
Temperature effect on the SARS-CoV-2: A molecular dynamics study of the spike homotrimeric glycoprotein (edit) |
10.1016/J.CSBJ.2021.03.037 |
| 2021-04-06 |
Susceptibility of Circulating SARS-CoV-2 Variants to Neutralization (edit) |
10.1056/NEJMC2103022 |
| 2021-04-06 |
SARS-CoV-2 Viral Variants—Tackling a Moving Target (edit) |
10.1001/JAMA.2021.2088 |
| 2021-04-06 |
Optical Tracking of the Interfacial Dynamics of Single SARS-CoV-2 Pseudoviruses (edit) |
10.1021/ACS.EST.0C06962 |
| 2021-04-06 |
Antiviral drug screen identifies DNA-damage response inhibitor as potent blocker of SARS-CoV-2 replication (edit) |
10.1016/J.CELREP.2021.108940 |
| 2021-04-06 |
Role of Structural and Non-Structural Proteins and Therapeutic Targets of SARS-CoV-2 for COVID-19 (edit) |
10.3390/CELLS10040821 |
| 2021-04-06 |
Sars-Cov-2 Wastewater Surveillance for Public Health Action: Connecting Perspectives From Wastewater Researchers and Public Health Officials During a Global Pandemic (edit) |
10.20944/PREPRINTS202104.0167.V1 |
| 2021-04-06 |
Modular basis for potent SARS-CoV-2 neutralization by a prevalent VH1-2-derived antibody class (edit) |
10.1016/J.CELREP.2021.108950 |
| 2021-04-06 |
ACE2 models of frequently contacted animals provide clues of their SARS-CoV-2 S protein affinity and viral susceptibility (edit) |
10.1002/JMV.26953 |
| 2021-04-06 |
Circadian clock modulating small molecules repurposing as inhibitors of SARS-CoV-2 Mpro for pharmacological interventions in COVID-19 pandemic (edit) |
10.1080/07420528.2021.1903027 |
| 2021-04-06 |
Functional comparison of SARS-CoV-2 with closely related pangolin and bat coronaviruses (edit) |
10.1038/S41421-021-00256-3 |
| 2021-04-06 |
In silico investigation of the viroporin E as a vaccine target against SARS-CoV-2 (edit) |
10.1152/AJPLUNG.00443.2020 |
| 2021-04-06 |
On the many advantages of using the VariantExperiment class to store, exchange and analyze SARS-CoV-2 genomic data and associated metadata (edit) |
10.1101/2021.04.05.438328 |
| 2021-04-06 |
The Up state of the SARS-COV-2 Spike homotrimer favors an increased virulence for new variants (edit) |
10.1101/2021.04.05.438465 |
| 2021-04-05 |
Outcome of ivermectin treated mild to moderate COVID-19 cases: a single-centre, open-label, randomised controlled study (edit) |
10.3329/IMCJMS.V14I2.52826 |
| 2021-04-05 |
Repositioning of histamine H receptor antagonist: Doxepin inhibits viropexis of SARS-CoV-2 Spike pseudovirus by blocking ACE2 (edit) |
10.1016/J.EJPHAR.2021.173897 |
| 2021-04-05 |
Persistent cellular immunity to SARS-CoV-2 infection (edit) |
10.1084/JEM.20202515 |
| 2021-04-05 |
SARS-CoV-2 induces human plasmacytoid predendritic cell diversification via UNC93B and IRAK4 (edit) |
10.1084/JEM.20201387 |
| 2021-04-05 |
Differences in the concentration of anti-SARS-CoV-2 IgG antibodies as a result of post-covid or/and post-vaccination immunization (edit) |
10.21203/RS.3.RS-388040/V1 |
| 2021-04-05 |
Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccination (edit) |
10.1101/2021.04.01.21252379 |
| 2021-04-05 |
Multi-schema computational prediction of the comprehensive SARS-CoV-2 vs. human interactome (edit) |
10.7717/PEERJ.11117 |
| 2021-04-05 |
Secondary analysis of transcriptomes of SARS-CoV-2 infection models to characterize COVID-19 (edit) |
10.1016/J.PATTER.2021.100247 |
| 2021-04-05 |
AutoVEM: An automated tool to real-time monitor epidemic trends and key mutations in SARS-CoV-2 evolution (edit) |
10.1016/J.CSBJ.2021.04.002 |
| 2021-04-05 |
In silico approach to understand the epigenetic mechanism of SARS-CoV-2 and its impact on the environment (edit) |
10.1007/S13337-021-00655-W |
| 2021-04-04 |
Structure and dynamics of SARS-CoV-2 proofreading exoribonuclease ExoN (edit) |
10.1101/2021.04.02.438274 |
| 2021-04-03 |
A Public Health Antibody Screening Indicates a Marked Increase of SARS-CoV-2 Exposure Rate in Children during the Second Wave (edit) |
10.1016/J.MEDJ.2021.03.019 |
| 2021-04-03 |
Early introductions and transmission of SARS-CoV-2 variant B.1.1.7 in the United States (edit) |
10.1016/J.CELL.2021.03.061 |
| 2021-04-03 |
Virtual high throughput screening: Potential inhibitors for SARS-CoV-2 PLPRO and 3CLPRO proteases (edit) |
10.1016/J.EJPHAR.2021.174082 |
| 2021-04-03 |
Evidence that Maackia amurensis seed lectin (MASL) exerts pleiotropic actions on oral squamous cells with potential to inhibit SARS-CoV-2 infection and COVID-19 disease progression (edit) |
10.1016/J.YEXCR.2021.112594 |
| 2021-04-02 |
Rapid Spread of SARS-CoV-2 in a State Prison After Introduction by Newly Transferred Incarcerated Persons — Wisconsin, August 14–October 22, 2020 (edit) |
10.15585/MMWR.MM7013A4 |
| 2021-04-02 |
Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations (edit) |
|
| 2021-04-02 |
In silico characterization of mutations circulating in SARS-CoV-2 structural proteins (edit) |
10.1080/07391102.2021.1908170 |
| 2021-04-02 |
Virtual Screening of Peptides with High Affinity for SARS-CoV-2 Main Protease (edit) |
|
| 2021-04-02 |
Immunogenicity and antigenicity based T-cell and B-cell epitopes identification from conserved regions of 10664 SARS-CoV-2 genomes (edit) |
10.1016/J.MEEGID.2021.104823 |
| 2021-04-02 |
Novel mutations in NSP-1 and PLPro of SARS-CoV-2 NIB-1 genome mount for effective therapeutics (edit) |
10.1186/S43141-021-00152-Z |
| 2021-04-02 |
Rapid screening for SARS-CoV-2 variants of concern in clinical and environmental samples using nested RT-PCR assays targeting key mutations of the spike protein (edit) |
|
| 2021-04-02 |
Can the SARS-CoV-2 virus damage human hearing and balance? (edit) |
10.13075/MP.5893.01083 |
| 2021-04-01 |
Epidemiology of SARS-CoV-2 (edit) |
10.1007/S15010-020-01531-3 |
| 2021-04-01 |
Use of Powered Air-Purifying Respirator(PAPR) as part of protective equipment against SARS-CoV-2-a narrative review and critical appraisal of evidence (edit) |
10.1016/J.AJIC.2020.11.009 |
| 2021-04-01 |
Gastrointestinal and Renal Complications in SARS-CoV-2-Infected Patients: Role of Immune System (edit) |
10.1111/SJI.12999 |
| 2021-04-01 |
SARS-CoV-2: Targeted managements and vaccine development (edit) |
10.1016/J.CYTOGFR.2020.11.001 |
| 2021-04-01 |
G6PD deficiency, redox homeostasis, and viral infections: implications for SARS-CoV-2 (COVID-19) (edit) |
10.1080/10715762.2020.1866757 |
| 2021-04-01 |
Crystallographic molecular replacement using an in silico-generated search model of SARS-CoV-2 ORF8 (edit) |
10.1002/PRO.4050 |
| 2021-04-01 |
The ORF8 protein of SARS-CoV-2 induced endoplasmic reticulum stress and mediated immune evasion by antagonizing production of interferon beta (edit) |
10.1016/J.VIRUSRES.2021.198350 |
| 2021-04-01 |
Type I and III IFN-mediated antiviral actions counteracted by SARS-CoV-2 proteins and host inherited factors (edit) |
10.1016/J.CYTOGFR.2021.01.003 |
| 2021-04-01 |
SARS-CoV-2, SARS-CoV-1, and HIV-1 derived ssRNA sequences activate the NLRP3 inflammasome in human macrophages through a non-classical pathway (edit) |
10.1016/J.ISCI.2021.102295 |
| 2021-04-01 |
SARS-CoV-2 induced intestinal responses with a biomimetic human gut-on-chip (edit) |
10.1016/J.SCIB.2020.11.015 |
| 2021-04-01 |
Estimating the strength of selection for new SARS-CoV-2 variants (edit) |
10.1101/2021.03.29.21254233 |
| 2021-04-01 |
Ten scientific reasons in support of airborne transmission of SARS-CoV-2 (edit) |
10.1016/S0140-6736(21)00869-2 |
| 2021-04-01 |
Dual Nature of Type I Interferons in SARS-CoV-2-Induced Inflammation (edit) |
10.1016/J.IT.2021.02.003 |
| 2021-04-01 |
Considerations for the Discovery and Development of 3-Chymotrypsin-Like Cysteine Protease Inhibitors Targeting SARS-CoV-2 Infection (edit) |
10.1016/J.COVIRO.2021.04.006 |
| 2021-04-01 |
Structural insight into SARS-CoV-2 neutralizing antibodies and modulation of syncytia (edit) |
10.1016/J.CELL.2021.04.033 |
| 2021-04-01 |
Drug repurposing screens reveal cell-type-specific entry pathways and FDA-approved drugs active against SARS-Cov-2 (edit) |
10.1016/J.CELREP.2021.108959 |
| 2021-04-01 |
Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection (edit) |
10.1016/J.CELL.2021.02.026 |
| 2021-04-01 |
Testing of the inhibitory effects of loratadine and desloratadine on SARS-CoV-2 spike pseudotyped virus viropexis (edit) |
10.1016/J.CBI.2021.109420 |
| 2021-04-01 |
Short Communication:Evidence of Novel SARS-CoV-2 Variants Circulation in Romania (edit) |
10.1089/AID.2021.0009 |
| 2021-04-01 |
The Role of the SARS-CoV-2 S-Protein Glycosylation in the Interaction of SARS-CoV-2/ACE2 and Immunological Responses (edit) |
10.1089/VIM.2020.0174 |
| 2021-04-01 |
In vivo structural characterization of the SARS-CoV-2 RNA genome identifies host proteins vulnerable to repurposed drugs (edit) |
10.1016/J.CELL.2021.02.008 |
| 2021-04-01 |
Computational epitope map of SARS-CoV-2 spike protein (edit) |
10.1371/JOURNAL.PCBI.1008790 |
| 2021-04-01 |
Nucleocapsid and Spike Proteins of SARS-CoV-2 Drive Neutrophil Extracellular Trap Formation (edit) |
10.4110/IN.2021.21.E16 |
| 2021-04-01 |
Diagnostic performance of different sampling approaches for SARS-CoV-2 RT-PCR testing: a systematic review and meta-analysis (edit) |
10.1016/S1473-3099(21)00146-8 |
| 2021-04-01 |
Exploring the binding efficacy of ivermectin against the key proteins of SARS-CoV-2 pathogenesis: an in silico approach (edit) |
10.2217/FVL-2020-0342 |
| 2021-04-01 |
Analysis of glycosylation and disulfide bonding of wild-type SARS-CoV-2 spike glycoprotein (edit) |
10.1101/2021.04.01.438120 |
| 2021-04-01 |
Potential APOBEC-mediated RNA editing of the genomes of SARS-CoV-2 and other coronaviruses and its impact on their longer term evolution (edit) |
10.1016/J.VIROL.2020.12.018 |
| 2021-04-01 |
Potential intestinal infection and faecal-oral transmission of SARS-CoV-2 (edit) |
10.1038/S41575-021-00416-6 |
| 2021-04-01 |
The SARS-CoV-2 and other human coronavirus spike proteins are fine-tuned towards temperature and proteases of the human airways (edit) |
10.1371/JOURNAL.PPAT.1009500 |
| 2021-04-01 |
ISG15-dependent activation of the sensor MDA5 is antagonized by the SARS-CoV-2 papain-like protease to evade host innate immunity (edit) |
10.1038/S41564-021-00884-1 |
| 2021-04-01 |
SARS-CoV-2 immune evasion by variant B.1.427/B.1.429 (edit) |
10.1101/2021.03.31.437925 |
| 2021-04-01 |
Quantitative Microbial Risk Assessment for Airborne Transmission of SARS-CoV-2 via Breathing, Speaking, Singing, Coughing, and Sneezing (edit) |
10.1289/EHP7886 |
| 2021-04-01 |
N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2 (edit) |
10.1016/J.CELL.2021.03.028 |
| 2021-04-01 |
Imported SARS-CoV-2 Variant P.1 in Traveler Returning from Brazil to Italy (edit) |
10.3201/EID2704.210183 |
| 2021-04-01 |
Remdesivir is a delayed translocation inhibitor of SARS-CoV-2 replication (edit) |
10.1016/J.MOLCEL.2021.01.035 |
| 2021-04-01 |
Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking (edit) |
10.1126/SCIADV.ABF8711 |
| 2021-04-01 |
SARS-CoV-2 RNA-dependent RNA polymerase as a therapeutic target for COVID-19 (edit) |
10.1080/13543776.2021.1880568 |
| 2021-04-01 |
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies (edit) |
10.1038/S41591-021-01294-W |
| 2021-04-01 |
Ultrastructural modifications induced by SARS-CoV-2 in Vero cells: a kinetic analysis of viral factory formation, viral particle morphogenesis and virion release (edit) |
10.1007/S00018-020-03745-Y |
| 2021-04-01 |
Coronavirus entry: how we arrived at SARS-CoV-2 (edit) |
10.1016/J.COVIRO.2021.02.006 |
| 2021-04-01 |
Stability of SARS-CoV-2 RNA in Nonsupplemented Saliva (edit) |
10.3201/EID2704.204199 |
| 2021-04-01 |
Increased SARS-CoV-2 Testing Capacity with Pooled Saliva Samples (edit) |
10.3201/EID2704.204200 |
| 2021-04-01 |
Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021 (edit) |
10.2807/1560-7917.ES.2021.26.16.2100348 |
| 2021-04-01 |
The highly flexible disordered regions of the SARS-CoV-2 nucleocapsid N protein within the 1-248 residue construct: sequence-specific resonance assignments through NMR (edit) |
10.1007/S12104-021-10009-8 |
| 2021-04-01 |
SARS-CoV-2 infection in schools in a northern French city: a retrospective serological cohort study in an area of high transmission, France, January to April 2020 (edit) |
10.2807/1560-7917.ES.2021.26.15.2001695 |
| 2021-04-01 |
What are the agent (Covid-19 virus) factors responsible for continuation & recurrence of SARS-CoV-2/ Covid -19? How does environmental and host factors of epidemiological triad do influence ongoing pandemic? (edit) |
10.31219/OSF.IO/T8NYX |
| 2021-04-01 |
Detection of SARS-CoV-2 in respiratory samples from cats in the UK associated with human-to-cat transmission (edit) |
10.1002/VETR.247 |
| 2021-04-01 |
Codon usage analysis of zoonotic coronaviruses reveals lower adaptation to humans by SARS-CoV-2 (edit) |
10.1016/J.MEEGID.2021.104736 |
| 2021-04-01 |
The role of iron in the pathogenesis of COVID-19 and possible treatment with lactoferrin and other iron chelators (edit) |
10.1016/J.BIOPHA.2021.111228 |
| 2021-04-01 |
On the origin and evolution of SARS-CoV-2 (edit) |
10.1038/S12276-021-00604-Z |
| 2021-04-01 |
The mA methylome of SARS-CoV-2 in host cells (edit) |
10.1038/S41422-020-00465-7 |
| 2021-04-01 |
The SARS-CoV-2 Spike variant D614G favors an open conformational state (edit) |
10.1126/SCIADV.ABF3671 |
| 2021-04-01 |
Cryo-electron microscopy structures of the N501Y SARS-CoV-2 spike protein in complex with ACE2 and 2 potent neutralizing antibodies (edit) |
10.1371/JOURNAL.PBIO.3001237 |
| 2021-04-01 |
Coagulation factors directly cleave SARS-CoV-2 spike and enhance viral entry (edit) |
10.1101/2021.03.31.437960 |
| 2021-04-01 |
H, C and N backbone chemical shift assignments of SARS-CoV-2 nsp3a (edit) |
10.1007/S12104-020-10001-8 |
| 2021-04-01 |
Inter-proteomic posttranslational modifications of the SARS-CoV-2 and the host proteins ‒ A new frontier (edit) |
10.1177/1535370220986785 |
| 2021-04-01 |
Screening of SARS-CoV-2 among homeless people, asylum-seekers and other people living in precarious conditions in Marseille, France, March-April 2020 (edit) |
10.1016/J.IJID.2021.02.026 |
| 2021-04-01 |
Effects of pancreatic SARS-CoV-2 infection identified (edit) |
10.1038/S41574-021-00481-6 |
| 2021-04-01 |
SARS-CoV-2 Infects Human Engineered Heart Tissues and Models COVID-19 Myocarditis (edit) |
10.1016/J.JACBTS.2021.01.002 |
| 2021-04-01 |
SARS-CoV-2 infection: The role of PD-1/PD-L1 and CTLA-4 axis (edit) |
10.1016/J.LFS.2021.119124 |
| 2021-04-01 |
Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors (edit) |
10.1038/S41467-021-22362-2 |
| 2021-04-01 |
Can the SARS-CoV-2 infection trigger systemic lupus erythematosus? A case-based review (edit) |
10.1007/S00296-021-04794-7 |
| 2021-04-01 |
SARS-CoV-2 infection leading to ischemic and hemorrhagic brain lesions and acute respiratory distress syndrome (edit) |
10.1016/J.RADCR.2021.01.025 |
| 2021-04-01 |
SARS-Cov-2 and COVID-19, Basic and Clinical Aspects of the Human Pandemic: A Review (edit) |
10.18502/IJPH.V50I4.5991 |
| 2021-04-01 |
Characteristics of SARS-CoV-2 transmission among meat processing workers in Nebraska, USA, and effectiveness of risk mitigation measures (edit) |
10.3201/EID2704.204800 |
| 2021-04-01 |
Dismantling myths on the airborne transmission of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) (edit) |
10.1016/J.JHIN.2020.12.022 |
| 2021-04-01 |
Nicotine upregulates ACE2 expression and increases competence for SARS-CoV-2 in human pneumocytes (edit) |
|
| 2021-04-01 |
Molecular dynamics and in silico mutagenesis on the reversible inhibitor-bound SARS-CoV-2 main protease complexes reveal the role of lateral pocket in enhancing the ligand affinity (edit) |
10.1038/S41598-021-86471-0 |
| 2021-04-01 |
Genomic Epidemiology of SARS-CoV-2 Infection During the Initial Pandemic Wave and Association With Disease Severity (edit) |
10.1001/JAMANETWORKOPEN.2021.7746 |
| 2021-04-01 |
Human Pluripotent Stem Cell-Derived Intestinal Organoids Model SARS-CoV-2 Infection Revealing a Common Epithelial Inflammatory Response (edit) |
10.1016/J.STEMCR.2021.02.019 |
| 2021-04-01 |
Sequencing of SARS-CoV-2 genome using different nanopore chemistries (edit) |
10.1007/S00253-021-11250-W |
| 2021-04-01 |
Intraventricular Conundrum in a SARS-CoV-2–Positive Patient With Elevated Biomarkers of Myocardial Injury (edit) |
10.1016/J.JACCAS.2021.01.030 |
| 2021-04-01 |
SARS-CoV-2 mediated neuroinflammation and the impact of COVID-19 in neurological disorders (edit) |
10.1016/J.CYTOGFR.2021.02.002 |
| 2021-04-01 |
Validation testing to determine the sensitivity of lateral flow testing for asymptomatic SARS-CoV-2 detection in low prevalence settings: Testing frequency and public health messaging is key (edit) |
10.1371/JOURNAL.PBIO.3001216 |
| 2021-04-01 |
Coronavirus from cities to forests: mapping vulnerable interfaces and hotspots for SARS-CoV-2 spillover from humans to biodiversity (edit) |
10.1016/S2542-5196(21)00099-1 |
| 2021-04-01 |
Pulmonary lipid modulation: A possible therapeutic target for SARS-CoV-2 infection (edit) |
10.1016/J.MEHY.2021.110529 |
| 2021-04-01 |
SARS-CoV-2 transmission via aquatic food animal species or their products: A review (edit) |
10.1016/J.AQUACULTURE.2021.736460 |
| 2021-04-01 |
Anticoagulant treatment in COVID-19: a narrative review (edit) |
10.1007/S11239-020-02242-0 |
| 2021-04-01 |
Biological characteristics and biomarkers of novel SARS-CoV-2 facilitated rapid development and implementation of diagnostic tools and surveillance measures (edit) |
10.1016/J.BIOS.2021.112969 |
| 2021-04-01 |
Maternal endothelial dysfunction in HIV-associated preeclampsia comorbid with COVID-19: a review (edit) |
10.1038/S41440-020-00604-Y |
| 2021-04-01 |
Polyphenols as promising biologically active substances for preventing SARS-CoV-2: A review with research evidence and underlying mechanisms (edit) |
10.1016/J.FBIO.2021.100891 |
| 2021-04-01 |
Homeschooling during the SARS-CoV-2 pandemic: the role of students’ trait self-regulation and task attributes of daily learning tasks for students’ daily self-regulation (edit) |
10.1007/S11618-021-01011-W |
| 2021-04-01 |
Dissolvable Microneedle Patches to Enable Increased Access to Vaccines against SARS-CoV-2 and Future Pandemic Outbreaks (edit) |
10.3390/VACCINES9040320 |
| 2021-04-01 |
Hearing disorders secondary to infection with SARS-CoV-2 (edit) |
10.1121/10.0005350 |
| 2021-04-01 |
Genotype and phenotype of COVID-19: Their roles in pathogenesis (edit) |
10.1016/J.JMII.2020.03.022 |
| 2021-04-01 |
Infection control in dental health care during and after the SARS-CoV-2 outbreak (edit) |
10.1111/ODI.13408 |
| 2021-04-01 |
SARS-CoV-2 host diversity: An update of natural infections and experimental evidence (edit) |
10.1016/J.JMII.2020.06.006 |
| 2021-04-01 |
Genetic comparison among various coronavirus strains for the identification of potential vaccine targets of SARS-CoV2 (edit) |
10.1016/J.MEEGID.2020.104490 |
| 2021-04-01 |
Safety and Impact of Nasal Lavages During Viral Infections Such as SARS-CoV-2 (edit) |
10.1177/0145561320950491 |
| 2021-04-01 |
What we have to know about corticosteroids use during Sars-Cov-2 infection (edit) |
10.1007/S40618-020-01384-5 |
| 2021-04-01 |
Glycogen synthase kinase-3: A putative target to combat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic (edit) |
10.1016/J.CYTOGFR.2020.08.002 |
| 2021-04-01 |
Diagnosis of SARS-CoV-2 by RT-PCR Using Different Sample Sources: Review of the Literature (edit) |
10.1177/0145561320953231 |
| 2021-04-01 |
SARS-CoV-2 myopathy (edit) |
10.1002/JMV.26550 |
| 2021-03-31 |
Structural basis for SARS-CoV-2 envelope protein in recognition of human cell junction protein PALS1 (edit) |
10.2210/PDB7M4R/PDB |
| 2021-03-31 |
Two-Step Reverse Transcription Droplet Digital PCR Protocols for SARS-CoV-2 Detection and Quantification (edit) |
10.3791/62295 |
| 2021-03-31 |
SARS-CoV-2 Serological testing in frontline health workers in Zimbabwe (edit) |
10.1371/JOURNAL.PNTD.0009254 |
| 2021-03-31 |
Simultaneous detection and mutation surveillance of SARS-CoV-2 and multiple respiratory viruses by rapid field-deployable sequencing (edit) |
10.1016/J.MEDJ.2021.03.015 |
| 2021-03-31 |
Adoptive transfer of ex vivo expanded SARS-CoV-2-specific cytotoxic lymphocytes: A viable strategy for COVID-19 immunosuppressed patients? (edit) |
10.1111/TID.13602 |
| 2021-03-31 |
A Multifunctional Peptide From Bacillus Fermented Soybean for Effective Inhibition of SARS-CoV-2 S1 Receptor Binding Domain and Modulation of Toll Like Receptor 4: A Molecular Docking Study (edit) |
10.3389/FMOLB.2021.636647 |
| 2021-03-30 |
WHO-convened Global Study of Origins of SARS-CoV-2: China Part (edit) |
|
| 2021-03-30 |
SARS-CoV-2 in severe COVID-19 induces a TGF-β-dominated chronic immune response that does not target itself (edit) |
10.1038/S41467-021-22210-3 |
| 2021-03-30 |
What Impact Have SARS-CoV-2/Covid-19 Pandemic on the Reproductive and Child Health Programme of Bihar in India over the 3 months after nationwide Lock down announcement in March 2020? How SARS-CoV-2 Pandemic era does influence RCH Programme? Immunisa (edit) |
10.21203/RS.3.RS-348841/V4 |
| 2021-03-30 |
An Integrative in silico Drug Repurposing Approach for Identification of Potential Inhibitors of SARS-CoV-2 Main Protease (edit) |
10.1002/MINF.202000187 |
| 2021-03-30 |
Integrated characterization of SARS-CoV-2 genome, microbiome, antibiotic resistance and host response from single throat swabs (edit) |
10.1038/S41421-021-00248-3 |
| 2021-03-30 |
TOP1 inhibition therapy protects against SARS-CoV-2-induced lethal inflammation (edit) |
10.1016/J.CELL.2021.03.051 |
| 2021-03-29 |
Multivalent binding of the partially disordered SARS-CoV-2 nucleocapsid phosphoprotein dimer to RNA (edit) |
10.1016/J.BPJ.2021.03.023 |
| 2021-03-29 |
Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine (edit) |
10.1038/S41591-021-01316-7 |
| 2021-03-29 |
SARS-CoV-2 infection risk among unvaccinated is negatively associated with community-level vaccination rates (edit) |
10.1101/2021.03.26.21254394 |
| 2021-03-29 |
The association between the use of ivermectin and mortality in patients with COVID-19: a meta-analysis (edit) |
10.1007/S43440-021-00245-Z |
| 2021-03-29 |
The SARS-CoV-2 nucleocapsid protein is dynamic, disordered, and phase separates with RNA (edit) |
10.1038/S41467-021-21953-3 |
| 2021-03-29 |
SARS-CoV-2 Nsp16 activation mechanism and a cryptic pocket with pan-coronavirus antiviral potential (edit) |
10.1016/J.BPJ.2021.03.024 |
| 2021-03-29 |
Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma (edit) |
10.1038/S41586-021-03471-W |
| 2021-03-29 |
What Impact Have SARS-CoV-2/Covid-19 Pandemic on the Reproductive and Child Health Programme of India over the 3 months after nationwide Lock down announcement in March 2020? How SARS-CoV-2 Pandemic era does influence RCH Programme? Immunisation? (edit) |
10.22541/AU.161705127.75041334/V1 |
| 2021-03-29 |
Association between Postmortem Kidney Biopsy Findings and Acute Kidney Injury from Patients with SARS-CoV-2 (COVID-19) (edit) |
10.2215/CJN.16281020 |
| 2021-03-29 |
A haemagglutination test for rapid detection of antibodies to SARS-CoV-2 (edit) |
10.1038/S41467-021-22045-Y |
| 2021-03-29 |
Disparate temperature-dependent virus-host dynamics for SARS-CoV-2 and SARS-CoV in the human respiratory epithelium (edit) |
10.1371/JOURNAL.PBIO.3001158 |
| 2021-03-29 |
Antiviral Essential Oil Components Against SARS-CoV-2 in Pre-procedural Mouth Rinses for Dental Settings During COVID-19: A Computational Study (edit) |
10.3389/FCHEM.2021.642026 |
| 2021-03-29 |
Novel inhibitors of the main protease enzyme of SARS-CoV-2 identified via molecular dynamics simulation-guided in vitro assay (edit) |
10.1016/J.BIOORG.2021.104862 |
| 2021-03-29 |
Network-based virus-host interaction prediction with application to SARS-CoV-2 (edit) |
10.1016/J.PATTER.2021.100242 |
| 2021-03-29 |
Exploring the effectiveness of the TSR-based protein 3-D structural comparison method for protein clustering, and structural motif identification and discovery of protein kinases, hydrolases, and SARS-CoV-2’s protein via the application of amino aci (edit) |
10.1016/J.COMPBIOLCHEM.2021.107479 |
| 2021-03-28 |
What Impact Have SARS-CoV-2/Covid-19 Pandemic on the Reproductive and Child Health Programme (Immunisation, Maternal Health, Family Planning) of Andhra Pradesh in India over the 3 months after nationwide Lock down announcement in March 2020? Immunisa (edit) |
10.31219/OSF.IO/DPHGA |
| 2021-03-28 |
What Impact Have SARS-CoV-2/Covid-19 Pandemic on the Reproductive and Child Health Programme of Bihar in India over the 3 months after nationwide Lock down announcement in March 2020? How SARS-CoV-2Pandemic era does influence RCH Programme? Immunisat (edit) |
10.31219/OSF.IO/N45FR |
| 2021-03-28 |
What Impact Have SARS-CoV-2/Covid-19 Pandemic on the Reproductive and Child Health Programme of India over the 3 months after nationwide Lock down announcement in March 2020? How SARS-CoV-2 Pandemic era does influence RCH Programme? (edit) |
10.31219/OSF.IO/VJZHR |
| 2021-03-28 |
What Impact Have SARS-CoV-2/Covid-19 Pandemic on the Reproductive and Child Health Programme of Uttar Pradesh in India over the 3 months after nationwide Lock down announcement in March 2020? Immunisation? Maternal Health? Family Planning? (edit) |
10.31219/OSF.IO/GS8Q2 |
| 2021-03-27 |
The nucleotide addition cycle of the SARS-CoV-2 polymerase (edit) |
10.1101/2021.03.27.437309 |
| 2021-03-27 |
Cathepsin L plays a key role in SARS-CoV-2 infection in humans and humanized mice and is a promising target for new drug development (edit) |
10.1038/S41392-021-00558-8 |
| 2021-03-26 |
Single dose of a mRNA SARS-CoV-2 vaccine is associated with lower nasopharyngeal viral load among nursing home residents with asymptomatic COVID-19 (edit) |
10.1093/CID/CIAB263 |
| 2021-03-26 |
Q106488914 (edit) |
|
| 2021-03-26 |
Understanding the phase separation characteristics of nucleocapsid protein provides a new therapeutic opportunity against SARS-CoV-2 (edit) |
10.1007/S13238-021-00832-Z |
| 2021-03-26 |
SARS-CoV-2 M inhibitors with antiviral activity in a transgenic mouse model (edit) |
10.1126/SCIENCE.ABF1611 |
| 2021-03-26 |
Low SARS-CoV-2 transmission in elementary schools - Salt Lake County, Utah, December 3, 2020-January 31, 2021 (edit) |
10.15585/MMWR.MM7012E3 |
| 2021-03-26 |
Effect of Inactivation Methods on SARS-CoV-2 Virion Protein and Structure (edit) |
10.3390/V13040562 |
| 2021-03-26 |
Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies (edit) |
10.1038/S41591-021-01318-5 |
| 2021-03-26 |
Pilot Investigation of SARS-CoV-2 Secondary Transmission in Kindergarten Through Grade 12 Schools Implementing Mitigation Strategies - St. Louis County and City of Springfield, Missouri, December 2020 (edit) |
10.15585/MMWR.MM7012E4 |
| 2021-03-26 |
What Impact Have SARS-CoV-2/Covid-19 Pandemic on the Reproductive and Child Health Programme of Bihar in India over the 3 months after nationwide Lock down announcement in March 2020 -A brief analysis (edit) |
10.21203/RS.3.RS-348841/V3 |
| 2021-03-26 |
What Impact Have SARS-CoV-2/Covid-19 Pandemic on the Reproductive and Child Health Programme of Bihar in India over the 3 months after nationwide Lock down announcement in March 2020 -A brief analysis (edit) |
10.21203/RS.3.RS-348841/V2 |
| 2021-03-26 |
Genetic epidemiology of SARS-CoV-2 transmission in renal dialysis units - a high risk community-hospital interface (edit) |
10.1101/2021.03.24.21253587 |
| 2021-03-26 |
D155Y Substitution of SARS-CoV-2 ORF3a Weakens Binding with Caveolin-1: An in silico Study (edit) |
10.1101/2021.03.26.437194 |
| 2021-03-26 |
SARS-CoV-2: Cross-scale Insights from Ecology and Evolution (edit) |
10.1016/J.TIM.2021.03.013 |
| 2021-03-26 |
Genomic variation and epidemiology of SARS-CoV-2 importation and early circulation in Israel (edit) |
10.1371/JOURNAL.PONE.0243265 |
| 2021-03-26 |
In-silico screening for identification of potential inhibitors against SARS-CoV-2 transmembrane serine protease 2 (TMPRSS2) (edit) |
10.1016/J.EJPS.2021.105820 |
| 2021-03-26 |
Association between self-reported signs and symptoms and SARS-CoV-2 antibody detection in UK key workers (edit) |
10.1016/J.JINF.2021.03.019 |
| 2021-03-25 |
The emerging plasticity of SARS-CoV-2 (edit) |
10.1126/SCIENCE.ABG4493 |
| 2021-03-25 |
Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England (edit) |
10.1038/S41586-021-03470-X |
| 2021-03-25 |
Characterization of SARS-CoV-2 proteins reveals Orf6 pathogenicity, subcellular localization, host interactions and attenuation by Selinexor (edit) |
10.1186/S13578-021-00568-7 |
| 2021-03-25 |
Functional analysis of SARS-CoV-2 proteins in Drosophila identifies Orf6-induced pathogenic effects with Selinexor as an effective treatment (edit) |
10.1186/S13578-021-00567-8 |
| 2021-03-25 |
Sulforaphane exhibits in vitro and in vivo antiviral activity against pandemic SARS-CoV-2 and seasonal HCoV-OC43 coronaviruses (edit) |
10.1101/2021.03.25.437060 |
| 2021-03-25 |
Site-Specific O-Glycosylation Analysis of SARS-CoV-2 Spike Protein Produced in Insect and Human Cells (edit) |
10.3390/V13040551 |
| 2021-03-25 |
Freely accessible ready to use global infrastructure for SARS-CoV-2 monitoring (edit) |
10.1101/2021.03.25.437046 |
| 2021-03-25 |
SARS-CoV-2 infection rewires host cell metabolism and is potentially susceptible to mTORC1 inhibition (edit) |
10.1038/S41467-021-22166-4 |
| 2021-03-25 |
What Impact Have SARS-CoV-2/Covid-19 Pandemic on the Reproductive and Child Health Programme of India over the 3 months after nationwide Lock down announcement in March 2020 -A brief analysis (edit) |
10.21203/RS.3.RS-360551/V1 |
| 2021-03-25 |
What Impact Have SARS-CoV-2/Covid-19 Pandemic on the Reproductive and Child Health Programme of Uttar Pradesh in India over the 3 months after nationwide Lockdown announcement in March 2020 -A brief analysis (edit) |
10.21203/RS.3.RS-350287/V1 |
| 2021-03-25 |
Symptoms and syndromes associated with SARS-CoV-2 infection and severity in pregnant women from two community cohorts (edit) |
10.1038/S41598-021-86452-3 |
| 2021-03-25 |
mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection (edit) |
10.1126/SCIENCE.ABG9175 |
| 2021-03-25 |
Conformational Changes of the Receptor Binding Domain of SARS-CoV-2 Spike Protein and Prediction of a B-Cell Antigenic Epitope Using Structural Data (edit) |
10.3389/FRAI.2021.630955 |
| 2021-03-25 |
AI Aided Design of Epitope-Based Vaccine for the Induction of Cellular Immune Responses Against SARS-CoV-2 (edit) |
10.3389/FGENE.2021.602196 |
| 2021-03-25 |
In silico investigation of critical binding pattern in SARS-CoV-2 spike protein with angiotensin-converting enzyme 2 (edit) |
10.1038/S41598-021-86380-2 |
| 2021-03-25 |
The effect of SARS-CoV-2 D614G mutation on BNT162b2 vaccine-elicited neutralization (edit) |
10.1038/S41541-021-00313-8 |
| 2021-03-25 |
Vaccinomic approach for novel multi epitopes vaccine against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) (edit) |
10.1186/S12865-021-00412-0 |
| 2021-03-25 |
In silico studies of selected multi-drug targeting against 3CLpro and nsp12 RNA-dependent RNA-polymerase proteins of SARS-CoV-2 and SARS-CoV (edit) |
10.1007/S13721-021-00299-2 |
| 2021-03-24 |
Arginine Methylation Regulates SARS-CoV-2 Nucleocapsid Protein Function and Viral Replication (edit) |
10.1101/2021.03.24.436822 |
| 2021-03-24 |
Dimeric form of SARS-CoV-2 polymerase (edit) |
10.1101/2021.03.23.436644 |
| 2021-03-24 |
B.1.526 SARS-CoV-2 variants identified in New York City are neutralized by vaccine-elicited and therapeutic monoclonal antibodies (edit) |
10.1101/2021.03.24.436620 |
| 2021-03-24 |
SARS-CoV-2 variants reveal features critical for replication in primary human cells (edit) |
10.1371/JOURNAL.PBIO.3001006 |
| 2021-03-24 |
Topography, Spike Dynamics, and Nanomechanics of Individual Native SARS-CoV-2 Virions (edit) |
10.1021/ACS.NANOLETT.0C04465 |
| 2021-03-24 |
Inhibition of HECT E3 ligases as potential therapy for COVID-19 (edit) |
10.1038/S41419-021-03513-1 |
| 2021-03-24 |
A phytochemical-based medication search for the SARS-CoV-2 infection by molecular docking models towards spike glycoproteins and main proteases (edit) |
10.1039/D0RA10458B |
| 2021-03-24 |
Molecular characterization of interactions between the D614G variant of SARS-CoV-2 S-protein and neutralizing antibodies: A computational approach (edit) |
10.1016/J.MEEGID.2021.104815 |
| 2021-03-23 |
SARS-CoV-2 variants lacking ORF8 occurred in farmed mink and pangolin (edit) |
10.1016/J.GENE.2021.145596 |
| 2021-03-23 |
Famotidine Repurposing for Novel Corona Virus Disease of 2019: A Systematic Review (edit) |
|
| 2021-03-23 |
Antibody response to a single dose of SARS-CoV-2 mRNA vaccine in patients with rheumatic and musculoskeletal diseases (edit) |
10.1136/ANNRHEUMDIS-2021-220289 |
| 2021-03-23 |
Characterization and functional interrogation of SARS-CoV-2 RNA interactome (edit) |
10.1101/2021.03.23.436611 |
| 2021-03-23 |
What Impact Have SARS-CoV-2/Covid-19 Pandemic on the Reproductive and Child Health Programme of Bihar in India over the 3 months after nationwide Lock down announcement in March 2020 -A brief analysis (edit) |
10.21203/RS.3.RS-348841/V1 |
| 2021-03-23 |
Antidepressant and antipsychotic drugs reduce viral infection by SARS-CoV-2 and fluoxetine show antiviral activity against the novel variants in vitro (edit) |
10.1101/2021.03.22.436379 |
| 2021-03-23 |
Functional and genetic analysis of viral receptor ACE2 orthologs reveals a broad potential host range of SARS-CoV-2 (edit) |
10.1073/PNAS.2025373118 |
| 2021-03-23 |
The effect of spike mutations on SARS-CoV-2 neutralization (edit) |
10.1016/J.CELREP.2021.108890 |
| 2021-03-23 |
Blockers of the SARS-CoV-2 3a Channel Identified by Targeted Drug Repurposing (edit) |
10.3390/V13030532 |
| 2021-03-23 |
SARS-CoV-2 cell tropism and multiorgan infection (edit) |
10.1038/S41421-021-00249-2 |
| 2021-03-23 |
Higher airborne pollen concentrations correlated with increased SARS-CoV-2 infection rates, as evidenced from 31 countries across the globe (edit) |
10.1073/PNAS.2019034118 |
| 2021-03-23 |
Dynamics of SARS-CoV-2 neutralising antibody responses and duration of immunity: a longitudinal study (edit) |
10.1016/S2666-5247(21)00025-2 |
| 2021-03-23 |
Specific epitopes form extensive hydrogen-bonding networks to ensure efficient antibody binding of SARS-CoV-2: Implications for advanced antibody design (edit) |
10.1016/J.CSBJ.2021.03.021 |
| 2021-03-23 |
SARS-CoV-2 Proteome-Wide Analysis Revealed Significant Epitope Signatures in COVID-19 Patients (edit) |
10.3389/FIMMU.2021.629185 |
| 2021-03-23 |
Double insult: flu bug enhances SARS-CoV-2 infectivity (edit) |
10.1038/S41422-021-00498-6 |
| 2021-03-22 |
Computational strategies to combat COVID-19: useful tools to accelerate SARS-CoV-2 and coronavirus research (edit) |
10.1093/BIB/BBAA232 |
| 2021-03-22 |
Why Does SARS-CoV-2 Infection Induce Autoantibody Production? (edit) |
10.3390/PATHOGENS10030380 |
| 2021-03-22 |
Longitudinal assessment of diagnostic test performance over the course of acute SARS-CoV-2 infection (edit) |
10.1101/2021.03.19.21253964 |
| 2021-03-22 |
Serial co-expression analysis of host factors from SARS-CoV viruses highly converges with former high-throughput screenings and proposes key regulators (edit) |
10.1093/BIB/BBAA419 |
| 2021-03-22 |
A Resource for the Network Representation of Cell Perturbations Caused by SARS-CoV-2 Infection (edit) |
10.3390/GENES12030450 |
| 2021-03-22 |
Identification of biomarkers and pathways for the SARS-CoV-2 infections that make complexities in pulmonary arterial hypertension patients (edit) |
10.1093/BIB/BBAB026 |
| 2021-03-22 |
Characterisation of B.1.1.7 and Pangolin coronavirus spike provides insights on the evolutionary trajectory of SARS-CoV-2 (edit) |
10.1101/2021.03.22.436468 |
| 2021-03-22 |
Genomic diversity of SARS-CoV-2 during early introduction into the Baltimore-Washington metropolitan area (edit) |
10.1172/JCI.INSIGHT.144350 |
| 2021-03-22 |
A Rapid and Efficient Screening System for Neutralizing Antibodies and Its Application for SARS-CoV-2 (edit) |
10.3389/FIMMU.2021.653189 |
| 2021-03-22 |
SARS-CoV-2 infection induces sustained humoral immune responses in convalescent patients following symptomatic COVID-19 (edit) |
10.1038/S41467-021-22034-1 |
| 2021-03-22 |
Comprehensive evaluation of eight commercial SARS-CoV-2 IgG assays (edit) |
10.1016/J.DIAGMICROBIO.2021.115382 |
| 2021-03-22 |
Stand on the Same Side Against Covid – 19: Ics-Containing Products in Treatment Covid-19 Patients with Asthma and COPD (edit) |
10.36253/SUBSTANTIA-1234 |
| 2021-03-20 |
SARS-CoV-2 in hospital wastewater during outbreak of COVID-19: A review on detection, survival and disinfection technologies (edit) |
10.1016/J.SCITOTENV.2020.143192 |
| 2021-03-20 |
SARS-CoV-2 Detection in Fecal Sample from a Patient with Typical Findings of COVID-19 Pneumonia on CT but Negative to Multiple SARS-CoV-2 RT-PCR Tests on Oropharyngeal and Nasopharyngeal Swab Samples (edit) |
10.3390/MEDICINA57030290 |
| 2021-03-20 |
Indels in SARS-CoV-2 occur at template-switching hotspots (edit) |
10.1186/S13040-021-00251-0 |
| 2021-03-19 |
Favipiravir antiviral efficacy against SARS-CoV-2 in a hamster model (edit) |
10.1038/S41467-021-21992-W |
| 2021-03-19 |
Outcomes and Risk Factors Associated With SARS-CoV-2 Infection in a North American Registry of Patients With Multiple Sclerosis (edit) |
10.1001/JAMANEUROL.2021.0688 |
| 2021-03-19 |
Exposure to SARS-CoV-2 generates T-cell memory in the absence of a detectable viral infection (edit) |
10.1038/S41467-021-22036-Z |
| 2021-03-19 |
Transcriptomic profiling of SARS-CoV-2 infected human cell lines identifies HSP90 as target for COVID-19 therapy (edit) |
10.1016/J.ISCI.2021.102151 |
| 2021-03-19 |
Mass spectrometric based detection of protein nucleotidylation in the RNA polymerase of SARS-CoV-2 (edit) |
10.1038/S42004-021-00476-4 |
| 2021-03-19 |
Expression and purification of tag-free SARS-CoV-2 RNA-dependent RNA polymerase in (edit) |
10.1016/J.XPRO.2021.100357 |
| 2021-03-19 |
RNA sequence and ligand binding alter conformational profile of SARS-CoV-2 stem loop II motif (edit) |
10.1016/J.BBRC.2021.01.013 |
| 2021-03-19 |
Alpha-1 antitrypsin inhibits TMPRSS2 protease activity and SARS-CoV-2 infection (edit) |
10.1038/S41467-021-21972-0 |
| 2021-03-19 |
Minimal SARS-CoV-2 Transmission After Implementation of a Comprehensive Mitigation Strategy at a School - New Jersey, August 20-November 27, 2020 (edit) |
10.15585/MMWR.MM7011A2 |
| 2021-03-19 |
Correlation of SARS-CoV-2 Nucleocapsid Antigen and RNA Concentrations in Nasopharyngeal Samples from Children and Adults Using an Ultrasensitive and Quantitative Antigen Assay (edit) |
10.1128/JCM.03077-20 |
| 2021-03-19 |
Exaptation of Retroviral Syncytin for Development of Syncytialized Placenta, Its Limited Homology to the SARS-CoV-2 Spike Protein and Arguments against Disturbing Narrative in the Context of COVID-19 Vaccination (edit) |
10.3390/BIOLOGY10030238 |
| 2021-03-19 |
TMBIM6, a potential virus target protein identified by integrated multiomics data analysis in SARS-CoV-2-infected host cells (edit) |
10.18632/AGING.202718 |
| 2021-03-19 |
OverCOVID: an integrative web portal for SARS-CoV-2 bioinformatics resources (edit) |
10.1515/JIB-2020-0046 |
| 2021-03-19 |
SARS-CoV-2 outbreak in a tri-national urban area is dominated by a B.1 lineage variant linked to a mass gathering event (edit) |
10.1371/JOURNAL.PPAT.1009374 |
| 2021-03-19 |
Comprehensive Virtual Screening of the Antiviral Potentialities of Marine Polycyclic Guanidine Alkaloids against SARS-CoV-2 (COVID-19) (edit) |
10.3390/BIOM11030460 |
| 2021-03-19 |
Self-Collected Saline Gargle Samples as an Alternative to Health Care Worker-Collected Nasopharyngeal Swabs for COVID-19 Diagnosis in Outpatients (edit) |
10.1128/JCM.02427-20 |
| 2021-03-19 |
High Efficacy of Saliva in Detecting SARS-CoV-2 by RT-PCR in Adults and Children (edit) |
10.3390/MICROORGANISMS9030642 |
| 2021-03-18 |
Timing the SARS-CoV-2 index case in Hubei province (edit) |
10.1126/SCIENCE.ABF8003 |
| 2021-03-18 |
Sialic acid-Dependent Binding and Viral Entry of SARS-CoV-2 (edit) |
10.21203/RS.3.RS-318912/V1 |
| 2021-03-18 |
Identification of guanylyltransferase activity in the SARS-CoV-2 RNA polymerase (edit) |
10.1101/2021.03.17.435913 |
| 2021-03-18 |
AT-527, a Double Prodrug of a Guanosine Nucleotide Analog, Is a Potent Inhibitor of SARS-CoV-2 In Vitro and a Promising Oral Antiviral for Treatment of COVID-19 (edit) |
10.1128/AAC.02479-20 |
| 2021-03-18 |
The B1.351 and P.1 variants extend SARS-CoV-2 host range to mice (edit) |
10.1101/2021.03.18.436013 |
| 2021-03-18 |
Extracellular vimentin as a target against SARS-CoV-2 host cell invasion (edit) |
10.1101/2021.01.08.425793 |
| 2021-03-18 |
Analysis of Three Mutations in Italian Strains of SARS-CoV-2: Implications for Pathogenesis (edit) |
10.1159/000515342 |
| 2021-03-18 |
Prioritizing antiviral drugs against SARS-CoV-2 by integrating viral complete genome sequences and drug chemical structures (edit) |
10.1038/S41598-021-83737-5 |
| 2021-03-18 |
A comprehensive SARS-CoV-2 genomic analysis identifies potential targets for drug repurposing (edit) |
10.1371/JOURNAL.PONE.0248553 |
| 2021-03-17 |
Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study (edit) |
10.1016/S0140-6736(21)00575-4 |
| 2021-03-17 |
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): a Systemic Infection (edit) |
10.1128/CMR.00133-20 |
| 2021-03-17 |
SARS-CoV-2 Infections in Animals: Reservoirs for Reverse Zoonosis and Models for Study (edit) |
10.3390/V13030494 |
| 2021-03-17 |
SARS-CoV-2 Entry Related Viral and Host Genetic Variations: Implications on COVID-19 Severity, Immune Escape, and Infectivity (edit) |
10.3390/IJMS22063060 |
| 2021-03-17 |
Circular RNA-MicroRNA-MRNA interaction predictions in SARS-CoV-2 infection (edit) |
10.1515/JIB-2020-0047 |
| 2021-03-17 |
SARS-CoV-2 spike protein induces inflammation via TLR2-dependent activation of the NF-κB pathway (edit) |
10.1101/2021.03.16.435700 |
| 2021-03-17 |
Therapeutic Role of Tocilizumab in SARS-CoV-2-Induced Cytokine Storm: Rationale and Current Evidence (edit) |
10.3390/IJMS22063059 |
| 2021-03-17 |
Nasopharyngeal Microbial Communities of Patients Infected With SARS-CoV-2 That Developed COVID-19 (edit) |
10.3389/FMICB.2021.637430 |
| 2021-03-17 |
Immuno-informatics design of a multimeric epitope peptide based vaccine targeting SARS-CoV-2 spike glycoprotein (edit) |
10.1371/JOURNAL.PONE.0248061 |
| 2021-03-17 |
Virtual screening of plant-derived compounds against SARS-CoV-2 viral proteins using computational tools (edit) |
10.1016/J.SCITOTENV.2021.146400 |
| 2021-03-17 |
The Effects of Social Distancing Policies on Non-SARS-CoV-2 Respiratory Pathogens (edit) |
10.1093/OFID/OFAB133 |
| 2021-03-17 |
Transmission dynamics and timing of key events for SARS-CoV-2 infection in healthcare workers (edit) |
10.1080/23744235.2021.1900599 |
| 2021-03-16 |
Tackling SARS-CoV-2 Infections using Remdesivir and Favipiravir as Therapeutic Options (edit) |
10.1002/CBIC.202000595 |
| 2021-03-16 |
Metabolic programs define dysfunctional immune responses in severe COVID-19 patients (edit) |
10.1016/J.CELREP.2021.108863 |
| 2021-03-16 |
Ca-dependent mechanism of membrane insertion and destabilization by the SARS-CoV-2 fusion peptide (edit) |
10.1016/J.BPJ.2021.02.023 |
| 2021-03-16 |
Clofazimine broadly inhibits coronaviruses including SARS-CoV-2 (edit) |
10.1038/S41586-021-03431-4 |
| 2021-03-16 |
SARS-CoV-2 Variants of Concern in the United States—Challenges and Opportunities (edit) |
10.1001/JAMA.2021.2294 |
| 2021-03-16 |
Neutrophil Elastase and Proteinase 3 Cleavage Sites Are Adjacent to the Polybasic Sequence within the Proteolytic Sensitive Activation Loop of the SARS-CoV-2 Spike Protein (edit) |
10.1021/ACSOMEGA.1C00363 |
| 2021-03-16 |
Development of a High-Throughput Screening Assay to Identify Inhibitors of the SARS-CoV-2 Guanine-N7-Methyltransferase Using RapidFire Mass Spectrometry (edit) |
10.1177/24725552211000652 |
| 2021-03-16 |
Network Analysis and Transcriptome Profiling Identify Autophagic and Mitochondrial Dysfunctions in SARS-CoV-2 Infection (edit) |
10.3389/FGENE.2021.599261 |
| 2021-03-16 |
Exploration and validation of related hub gene expression during SARS-CoV-2 infection of human bronchial organoids (edit) |
10.1186/S40246-021-00316-5 |
| 2021-03-16 |
Immune Interaction Map of Human SARS-CoV-2 Target Genes: Implications for Therapeutic Avenues (edit) |
10.3389/FIMMU.2021.597399 |
| 2021-03-16 |
BET inhibition blocks inflammation-induced cardiac dysfunction and SARS-CoV-2 infection (edit) |
10.1016/J.CELL.2021.03.026 |
| 2021-03-16 |
Clinical Predictors of SARS-CoV-2 Testing Pressure on Clinical Laboratories: A Multinational Study Analyzing Google Trends and Over 100 Million Diagnostic Tests (edit) |
10.1093/LABMED/LMAB013 |
| 2021-03-16 |
Neuropsychiatric Complications of COVID-19 (edit) |
10.1007/S11920-021-01237-9 |
| 2021-03-15 |
The potential application of electrochemical biosensors in the COVID-19 pandemic: A perspective on the rapid diagnostics of SARS-CoV-2 (edit) |
10.1016/J.BIOS.2020.112905 |
| 2021-03-15 |
The local and systemic response to SARS-CoV-2 infection in children and adults (edit) |
10.1101/2021.03.09.21253012 |
| 2021-03-15 |
Unique and complementary suppression of cGAS-STING and RNA sensing- triggered innate immune responses by SARS-CoV-2 proteins (edit) |
10.1038/S41392-021-00515-5 |
| 2021-03-15 |
SARS-CoV-2 Nsp8 N-terminal domain dimerizes and harbors autonomously folded elements (edit) |
10.1101/2021.03.12.435186 |
| 2021-03-15 |
Structure, Mechanism and Crystallographic fragment screening of the SARS-CoV-2 NSP13 helicase (edit) |
10.1101/2021.03.15.435326 |
| 2021-03-15 |
A map of binary SARS-CoV-2 protein interactions implicates host immune regulation and ubiquitination (edit) |
10.1101/2021.03.15.433877 |
| 2021-03-15 |
SARS-CoV-2 hijacks folate and one-carbon metabolism for viral replication (edit) |
10.1038/S41467-021-21903-Z |
| 2021-03-15 |
Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7 (edit) |
10.1038/S41586-021-03426-1 |
| 2021-03-15 |
The serotonin reuptake inhibitor Fluoxetine inhibits SARS-CoV-2 in human lung tissue (edit) |
10.1038/S41598-021-85049-0 |
| 2021-03-15 |
Disinfection of Contaminated Heritage Surfaces from SARS-CoV-2 Virus (edit) |
10.5334/JCMS.209 |
| 2021-03-15 |
Global and local mutations in Bangladeshi SARS-CoV-2 genomes (edit) |
10.1016/J.VIRUSRES.2021.198390 |
| 2021-03-15 |
Repurposing of thalidomide and its derivatives for the treatment of SARS-coV-2 infections: Hints on molecular action (edit) |
10.1111/BCP.14792 |
| 2021-03-15 |
Subgenomic RNA identification in SARS-CoV-2 genomic sequencing data (edit) |
10.1101/GR.268110.120 |
| 2021-03-15 |
Transmission of SARS-CoV-2 in northern Ghana: insights from whole-genome sequencing (edit) |
10.1007/S00705-021-04986-3 |
| 2021-03-14 |
Structural basis for backtracking by the SARS-CoV-2 replication-transcription complex (edit) |
10.1101/2021.03.13.435256 |
| 2021-03-13 |
A SARS-CoV-2 -human metalloproteome interaction map (edit) |
10.1016/J.JINORGBIO.2021.111423 |
| 2021-03-12 |
Shotgun transcriptome, spatial omics, and isothermal profiling of SARS-CoV-2 infection reveals unique host responses, viral diversification, and drug interactions (edit) |
10.1038/S41467-021-21361-7 |
| 2021-03-12 |
Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera (edit) |
10.1126/SCIENCE.ABG6105 |
| 2021-03-12 |
Contribution of SARS-CoV-2 accessory proteins to viral pathogenicity in K18 hACE2 transgenic mice (edit) |
10.1101/2021.03.09.434696 |
| 2021-03-12 |
Effect of natural mutations of SARS-CoV-2 on spike structure, conformation and antigenicity (edit) |
10.1101/2021.03.11.435037 |
| 2021-03-12 |
Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape (edit) |
10.1126/SCIENCE.ABF6950 |
| 2021-03-12 |
SalivaDirect: A simplified and flexible platform to enhance SARS-CoV-2 testing capacity (edit) |
10.1016/J.MEDJ.2020.12.010 |
| 2021-03-12 |
Abstract S03-03: Cancer patients display diminished viral RNA clearance and altered T cell responses during SARS-CoV-2 infection (edit) |
10.1158/1557-3265.COVID-19-21-S03-03 |
| 2021-03-12 |
Factors affecting SARS-CoV-2 (COVID-19) Pandemic, including Zoonotic, Human Transmission and Chain of Infection. Reducing Public health Risk by Serum Antibody Testing, Avoiding Screening in Unhygienic Places and False PCR Reporting. A Scientific Revi (edit) |
10.53986/IBJM.2021.0023 |
| 2021-03-12 |
Evidences for lipid involvement in SARS-CoV-2 cytopathogenesis (edit) |
10.1038/S41419-021-03527-9 |
| 2021-03-12 |
Immunity to SARS-CoV-2 variants of concern (edit) |
10.1126/SCIENCE.ABG7404 |
| 2021-03-12 |
Compounds of plants with activity against SARS-CoV-2 targets (edit) |
10.1080/17512433.2021.1903317 |
| 2021-03-12 |
Linear epitope landscape of the SARS-CoV-2 Spike protein constructed from 1,051 COVID-19 patients (edit) |
10.1016/J.CELREP.2021.108915 |
| 2021-03-12 |
SARS-CoV and SARS-CoV-2 are transmitted through the air between ferrets over more than one meter distance (edit) |
10.1038/S41467-021-21918-6 |
| 2021-03-12 |
Experimental Analysis of Structures for Trapping SARS-CoV-2-Related Floating Waste in Rivers (edit) |
10.3390/W13060771 |
| 2021-03-11 |
Safety and efficacy of Favipiravir in moderate to severe SARS-CoV-2 pneumonia (edit) |
10.1016/J.INTIMP.2021.107522 |
| 2021-03-11 |
Immunoinformatic analysis of structural and epitope variations in the spike and Orf8 proteins of SARS-CoV-2/B.1.1.7 (edit) |
|
| 2021-03-11 |
Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies (edit) |
10.1038/S41586-021-03412-7 |
| 2021-03-11 |
Emerging SARS-CoV-2 Variants and Impact in Global Vaccination Programs against SARS-CoV-2/COVID-19 (edit) |
10.3390/VACCINES9030243 |
| 2021-03-11 |
New targets for drug design: importance of nsp14/nsp10 complex formation for the 3'-5' exoribonucleolytic activity on SARS-CoV-2 (edit) |
10.1111/FEBS.15815 |
| 2021-03-11 |
ChAdOx1 nCoV-19 (AZD1222) protects Syrian hamsters against SARS-CoV-2 B.1.351 and B.1.1.7 (edit) |
10.1101/2021.03.11.435000 |
| 2021-03-11 |
Identification of Inhibitors of SARS-CoV-2 3CL-Pro Enzymatic Activity Using a Small Molecule in Vitro Repurposing Screen (edit) |
10.1021/ACSPTSCI.0C00216 |
| 2021-03-11 |
Bat and pangolin coronavirus spike glycoprotein structures provide insights into SARS-CoV-2 evolution (edit) |
10.1038/S41467-021-21767-3 |
| 2021-03-11 |
SARS-CoV-2 non-structural protein 13 (nsp13) hijacks host deubiquitinase USP13 and counteracts host antiviral immune response (edit) |
10.1038/S41392-021-00509-3 |
| 2021-03-11 |
Withanone from Withania somnifera Attenuates SARS-CoV-2 RBD and Host ACE2 Interactions to Rescue Spike Protein Induced Pathologies in Humanized Zebrafish Model (edit) |
10.2147/DDDT.S292805 |
| 2021-03-11 |
Coding-Complete Genome Sequence and Phylogenetic Relatedness of a SARS-CoV-2 Strain Detected in March 2020 in Cameroon (edit) |
10.1128/MRA.00093-21 |
| 2021-03-10 |
Wastewater surveillance for SARS-CoV-2: Lessons learnt from recent studies to define future applications (edit) |
10.1016/J.SCITOTENV.2020.143493 |
| 2021-03-10 |
Vertical Transmission of SARS-CoV-2 in Second Trimester Associated with Severe Neonatal Pathology (edit) |
10.3390/V13030447 |
| 2021-03-10 |
Q106488918 (edit) |
|
| 2021-03-10 |
Q106489168 (edit) |
|
| 2021-03-10 |
Genomic monitoring of SARS-CoV-2 uncovers an Nsp1 deletion variant that modulates type I interferon response (edit) |
10.1016/J.CHOM.2021.01.015 |
| 2021-03-10 |
Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies (edit) |
10.1016/J.CHOM.2021.02.003 |
| 2021-03-10 |
The great escape? SARS-CoV-2 variants evading neutralizing responses (edit) |
10.1016/J.CHOM.2021.02.010 |
| 2021-03-10 |
The dual function monoclonal antibodies VIR-7831 and VIR-7832 demonstrate potent in vitro and in vivo activity against SARS-CoV-2 (edit) |
10.1101/2021.03.09.434607 |
| 2021-03-10 |
Computational approach to decipher cellular interactors and drug targets during co-infection of SARS-CoV-2, Dengue, and Chikungunya virus (edit) |
10.1007/S13337-021-00665-8 |
| 2021-03-10 |
In vitro characterization of engineered red blood cells as viral traps against HIV-1 and SARS-CoV-2 (edit) |
10.1016/J.OMTM.2021.03.003 |
| 2021-03-10 |
Living Donor Hepatectomy After Proven SARS-CoV-2 Infection: First Report of 9 Cases From 3 Centers (edit) |
10.1097/TP.0000000000003750 |
| 2021-03-09 |
Systemic Tissue and Cellular Disruption from SARS-CoV-2 Infection revealed in COVID-19 Autopsies and Spatial Omics Tissue Maps (edit) |
10.1101/2021.03.08.434433 |
| 2021-03-09 |
Leveraging the antiviral type I interferon system as a first line of defense against SARS-CoV-2 pathogenicity (edit) |
10.1016/J.IMMUNI.2021.01.017 |
| 2021-03-09 |
Bepridil is potent against SARS-CoV-2 in vitro (edit) |
10.1073/PNAS.2012201118 |
| 2021-03-09 |
Transmission, infectivity, and antibody neutralization of an emerging SARS-CoV-2 variant in California carrying a L452R spike protein mutation (edit) |
10.1101/2021.03.07.21252647 |
| 2021-03-09 |
Detection of a SARS-CoV-2 variant of concern in South Africa (edit) |
10.1038/S41586-021-03402-9 |
| 2021-03-09 |
Effectiveness of Mask Wearing to Control Community Spread of SARS-CoV-2 (edit) |
10.1001/JAMA.2021.1505 |
| 2021-03-09 |
Structure-Function Analyses of New SARS-CoV-2 Variants B.1.1.7, B.1.351 and B.1.1.28.1: Clinical, Diagnostic, Therapeutic and Public Health Implications (edit) |
10.3390/V13030439 |
| 2021-03-09 |
Revealing Tissue-Specific SARS-CoV-2 Infection and Host Responses using Human Stem Cell-Derived Lung and Cerebral Organoids (edit) |
10.1016/J.STEMCR.2021.02.005 |
| 2021-03-09 |
Cross-linking peptide and repurposed drugs inhibit both entry pathways of SARS-CoV-2 (edit) |
10.1038/S41467-021-21825-W |
| 2021-03-09 |
Common Genetic Variation in Humans Impacts In Vitro Susceptibility to SARS-CoV-2 Infection (edit) |
10.1016/J.STEMCR.2021.02.010 |
| 2021-03-09 |
Revisiting activity of some glucocorticoids as a potential inhibitor of SARS-CoV-2 main protease: theoretical study (edit) |
10.1039/D0RA10674G |
| 2021-03-08 |
Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7 (edit) |
10.1038/S41586-021-03398-2 |
| 2021-03-08 |
The in-vitro effect of famotidine on sars-cov-2 proteases and virus replication (edit) |
10.1038/S41598-021-84782-W |
| 2021-03-08 |
De novo3D models of SARS-CoV-2 RNA elements from consensus experimental secondary structures (edit) |
10.1093/NAR/GKAB119 |
| 2021-03-08 |
Genome-wide CRISPR screening identifies TMEM106B as a proviral host factor for SARS-CoV-2 (edit) |
10.1038/S41588-021-00805-2 |
| 2021-03-08 |
SARS-CoV-2 suppresses anticoagulant and fibrinolytic gene expression in the lung (edit) |
10.7554/ELIFE.64330 |
| 2021-03-08 |
A network-informed analysis of SARS-CoV-2 and hemophagocytic lymphohistiocytosis genes’ interactions points to Neutrophil extracellular traps as mediators of thrombosis in COVID-19 (edit) |
10.1371/JOURNAL.PCBI.1008810 |
| 2021-03-08 |
SARS-CoV-2 infects blood monocytes to activate NLRP3 and AIM2 inflammasomes, pyroptosis and cytokine release (edit) |
10.1101/2021.03.06.21252796 |
| 2021-03-08 |
Sialic acid-Dependent Binding and Viral Entry of SARS-CoV-2 (edit) |
10.1101/2021.03.08.434228 |
| 2021-03-08 |
Can shellfish be used to monitor SARS-CoV-2 in the coastal environment? (edit) |
10.1016/J.SCITOTENV.2021.146270 |
| 2021-03-08 |
Long-term monitoring of SARS-CoV-2 RNA in wastewater of the Frankfurt metropolitan area in Southern Germany (edit) |
10.1038/S41598-021-84914-2 |
| 2021-03-08 |
MRC5 cells engineered to express ACE2 serve as a model system for the discovery of antivirals targeting SARS-CoV-2 (edit) |
10.1038/S41598-021-84882-7 |
| 2021-03-08 |
Characterization of the bioaerosol in a natural thermal cave and assessment of the risk of transmission of SARS-CoV-2 virus (edit) |
10.1007/S10653-021-00870-W |
| 2021-03-07 |
Antibodies to neutralising epitopes synergistically block the interaction of the receptor‐binding domain of SARS‐CoV‐2 to ACE 2 (edit) |
10.1002/CTI2.1260 |
| 2021-03-07 |
Screening potential FDA-approved inhibitors of the SARS-CoV-2 major protease 3CLpro through high-throughput virtual screening and molecular dynamics simulation (edit) |
10.18632/AGING.202703 |
| 2021-03-06 |
Interactions of SARS-CoV-2 with the Blood–Brain Barrier (edit) |
10.3390/IJMS22052681 |
| 2021-03-06 |
REACT-1 round 9 final report: Continued but slowing decline of prevalence of SARS-CoV-2 during national lockdown in England in February 2021 (edit) |
10.1101/2021.03.03.21252856 |
| 2021-03-06 |
A hijack mechanism of Indian SARS-CoV-2 isolates for relapsing contemporary antiviral therapeutics (edit) |
10.1016/J.COMPBIOMED.2021.104315 |
| 2021-03-06 |
COVID-19: A Hypothesis to Prevent SARS-CoV-2 From Entering Respiratory Cells (edit) |
10.18502/PBR.V6I(S2).5657 |
| 2021-03-06 |
Molecular Evolutionary Characteristics of the 2019 Novel Coronavirus (SARS-CoV-2) Contracted by Tunisian Citizens: Comparison and Relationship to Other Human and Animal Coronaviruses Based on Spike Glycoprotein-Coding Gene Sequences Analysis (edit) |
10.14302/ISSN.2692-1537.IJCV-21-3756 |
| 2021-03-05 |
A chronicle of SARS-CoV-2: Seasonality, environmental fate, transport, inactivation, and antiviral drug resistance (edit) |
10.1016/J.JHAZMAT.2020.124043 |
| 2021-03-05 |
The extent of molecular variation in novel SARS-CoV-2 after the six-month global spread (edit) |
10.1016/J.MEEGID.2021.104800 |
| 2021-03-05 |
Inhibition of amyloid formation of the Nucleoprotein of SARS-CoV-2 (edit) |
10.1101/2021.03.05.434000 |
| 2021-03-05 |
IFN signaling and neutrophil degranulation transcriptional signatures are induced during SARS-CoV-2 infection (edit) |
10.1038/S42003-021-01829-4 |
| 2021-03-05 |
RNA-dependent RNA polymerase (RdRp) inhibitors: The current landscape and repurposing for the COVID-19 pandemic (edit) |
10.1016/J.EJMECH.2021.113201 |
| 2021-03-05 |
Association between SARS-CoV-2 Transmissibility, Viral Load, and Age in Households (edit) |
10.1101/2021.02.28.21252608 |
| 2021-03-05 |
Community Transmission of SARS-CoV-2 at Three Fitness Facilities — Hawaii, June–July 2020 (edit) |
10.15585/MMWR.MM7009E1 |
| 2021-03-05 |
The Nucleocapsid protein triggers the main humoral immune response in COVID-19 patients (edit) |
10.1016/J.BBRC.2021.01.073 |
| 2021-03-05 |
CNBP Binds and Unfolds In Vitro G-Quadruplexes Formed in the SARS-CoV-2 Positive and Negative Genome Strands (edit) |
10.3390/IJMS22052614 |
| 2021-03-05 |
Zoonotic spillover of SARS-CoV-2: mink-adapted virus in humans (edit) |
10.1101/2021.03.05.433713 |
| 2021-03-05 |
Molecular optimization, docking, and dynamic simulation profiling of selective aromatic phytochemical ligands in blocking the SARS-CoV-2 S protein attachment to ACE2 receptor: an in silico approach of targeted drug designing (edit) |
10.5455/JAVAR.2021.H481 |
| 2021-03-05 |
Structural analogues of existing anti-viral drugs inhibit SARS-CoV-2 RNA dependent RNA polymerase: A computational hierarchical investigation (edit) |
10.1016/J.HELIYON.2021.E06435 |
| 2021-03-05 |
Point-of-care bulk testing for SARS-CoV-2 by combining hybridization capture with improved colorimetric LAMP (edit) |
10.1038/S41467-021-21627-0 |
| 2021-03-04 |
Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity (edit) |
10.1016/J.CELL.2021.01.037 |
| 2021-03-04 |
Saliva for Detection of SARS-CoV-2. Reply (edit) |
|
| 2021-03-04 |
Polyunsaturated ω-3 fatty acids inhibit ACE2-controlled SARS-CoV-2 binding and cellular entry (edit) |
10.1038/S41598-021-84850-1 |
| 2021-03-04 |
Clinical Features of Emergency Department Patients from Early COVID-19 Pandemic that Predict SARS-CoV-2 Infection: Machine-learning Approach (edit) |
10.5811/WESTJEM.2020.12.49370 |
| 2021-03-03 |
Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England (edit) |
10.1126/SCIENCE.ABG3055 |
| 2021-03-03 |
Q106488966 (edit) |
|
| 2021-03-03 |
Heterogeneity of Glycan Processing on Trimeric SARS-CoV-2 Spike Protein Revealed by Charge Detection Mass Spectrometry (edit) |
10.1021/JACS.1C00353 |
| 2021-03-03 |
Altered Subgenomic RNA Expression in SARS-CoV-2 B.1.1.7 Infections (edit) |
10.1101/2021.03.02.433156 |
| 2021-03-03 |
The SARS-CoV-2 receptor-binding domain preferentially recognizes blood group A (edit) |
10.1182/BLOODADVANCES.2020003259 |
| 2021-03-03 |
Monitoring of SARS-CoV-2 infection in mustelids (edit) |
10.2903/J.EFSA.2021.6459 |
| 2021-03-03 |
A high-affinity RBD-targeting nanobody improves fusion partner's potency against SARS-CoV-2 (edit) |
10.1371/JOURNAL.PPAT.1009328 |
| 2021-03-03 |
Viability of SARS-CoV-2 in river water and wastewater at different temperatures and solids content (edit) |
10.1016/J.WATRES.2021.117002 |
| 2021-03-03 |
Epithelial response to IFN-γ promotes SARS-CoV-2 infection (edit) |
10.15252/EMMM.202013191 |
| 2021-03-03 |
SARS-CoV-2 Genome from the Khyber Pakhtunkhwa Province of Pakistan (edit) |
10.1021/ACSOMEGA.0C05163 |
| 2021-03-03 |
Different selection dynamics of S and RdRp between SARS-CoV-2 genomes with and without the dominant mutations (edit) |
10.1016/J.MEEGID.2021.104796 |
| 2021-03-02 |
Emergence of a Severe Acute Respiratory Syndrome Coronavirus 2 virus variant with novel genomic architecture in Hong Kong (edit) |
10.1093/CID/CIAB198 |
| 2021-03-02 |
SARS-CoV-2 Nucleocapsid Protein Targets RIG-I-Like Receptor Pathways to Inhibit the Induction of Interferon Response (edit) |
10.3390/CELLS10030530 |
| 2021-03-02 |
SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma (edit) |
10.1038/S41591-021-01285-X |
| 2021-03-02 |
Rapid review of the effects of cloth and medical masks for preventing transmission of SARS-CoV-2 in community and household settings (edit) |
10.7196/SAMJ.2021.V111I3.15119 |
| 2021-03-02 |
miRCOVID-19: Potential Targets of Human miRNAs in SARS-CoV-2 for RNA-Based Drug Discovery (edit) |
10.3390/NCRNA7010018 |
| 2021-03-02 |
Introduction of Two Prolines and Removal of the Polybasic Cleavage Site Lead to Higher Efficacy of a Recombinant Spike-Based SARS-CoV-2 Vaccine in the Mouse Model (edit) |
10.1128/MBIO.02648-20 |
| 2021-03-02 |
Diffusion and Relaxation Edited Proton NMR Spectroscopy of Plasma Reveals a High-Fidelity Supramolecular Biomarker Signature of SARS-CoV-2 Infection (edit) |
10.1021/ACS.ANALCHEM.0C04952 |
| 2021-03-02 |
SARS-CoV-2 Vaccines and the Growing Threat of Viral Variants (edit) |
10.1001/JAMA.2021.1114 |
| 2021-03-02 |
Enhanced Cholesterol-Dependent Hemifusion by Internal Fusion Peptide 1 of SARS Coronavirus-2 Compared to Its N-Terminal Counterpart (edit) |
10.1021/ACS.BIOCHEM.1C00046 |
| 2021-03-02 |
Major role of IgM in the neutralizing activity of convalescent plasma against SARS-CoV-2 (edit) |
10.1016/J.CELREP.2021.108790 |
| 2021-03-02 |
Risk factors and on-site simulation of environmental transmission of SARS-CoV-2 in the largest wholesale market of Beijing, China (edit) |
10.1016/J.SCITOTENV.2021.146040 |
| 2021-03-02 |
New Acaciin-Loaded Self-Assembled Nanofibers as MPro Inhibitors Against BCV as a Surrogate Model for SARS-CoV-2 (edit) |
10.2147/IJN.S298900 |
| 2021-03-02 |
High-Throughput Wastewater SARS-CoV-2 Detection Enables Forecasting of Community Infection Dynamics in San Diego County (edit) |
10.1128/MSYSTEMS.00045-21 |
| 2021-03-01 |
Evidence of central nervous system infection and neuroinvasive routes, as well as neurological involvement in the lethality of SARS-CoV-2 infection (edit) |
10.1002/JMV.26570 |
| 2021-03-01 |
SARS-CoV-2 triggered Takotsubo in 38 patients (edit) |
10.1002/JMV.26581 |
| 2021-03-01 |
Characteristics of SARS-CoV-2 and COVID-19 (edit) |
10.1038/S41579-020-00459-7 |
| 2021-03-01 |
Effect of different human tissue processing techniques on SARS-CoV-2 inactivation-review (edit) |
10.1007/S10561-020-09869-6 |
| 2021-03-01 |
Videotherapy and Therapeutic Alliance in the Age of COVID-19 (edit) |
10.1002/CPP.2521 |
| 2021-03-01 |
Fecal-oral transmission of SARS-CoV-2: review of laboratory-confirmed virus in gastrointestinal system (edit) |
10.1007/S00384-020-03785-7 |
| 2021-03-01 |
Micronutrients and bioactive compounds in the immunological pathways related to SARS-CoV-2 (adults and elderly) (edit) |
10.1007/S00394-020-02410-1 |
| 2021-03-01 |
Coronavirus biology and replication: implications for SARS-CoV-2 (edit) |
10.1038/S41579-020-00468-6 |
| 2021-03-01 |
Biophysical analysis of SARS-CoV-2 transmission and theranostic development via N protein computational characterization (edit) |
10.1002/BTPR.3096 |
| 2021-03-01 |
Evolutionary study of COVID-19, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as an emerging coronavirus: Phylogenetic analysis and literature review (edit) |
10.1002/VMS3.394 |
| 2021-03-01 |
Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo (edit) |
10.1084/JEM.20201993 |
| 2021-03-01 |
Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients (edit) |
10.1084/JEM.20201707 |
| 2021-03-01 |
The central role of the nasal microenvironment in the transmission, modulation, and clinical progression of SARS-CoV-2 infection (edit) |
10.1038/S41385-020-00359-2 |
| 2021-03-01 |
Urological tumors treatment in Brazil during the SARS-Cov-2 outbrake (edit) |
10.1590/S1677-5538.IBJU.2020.0479.1 |
| 2021-03-01 |
Potential SARS-CoV-2 main protease inhibitors (edit) |
10.1016/J.DRUDIS.2020.12.005 |
| 2021-03-01 |
The unique features of SARS-CoV-2 transmission: Comparison with SARS-CoV, MERS-CoV and 2009 H1N1 pandemic influenza virus (edit) |
10.1002/RMV.2171 |
| 2021-03-01 |
[Ethical issues in primary care during the coronavirus (SARS-CoV-2) pandemic] (edit) |
10.1016/J.SEMERG.2020.11.002 |
| 2021-03-01 |
Relationship Between Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the Etiology of Acute Kidney Injury (AKI) (edit) |
10.1016/J.AMJMS.2020.10.025 |
| 2021-03-01 |
Biological Significance of Anti-SARS-CoV-2 Antibodies: Lessons Learned From Progressive Multifocal Leukoencephalopathy (edit) |
10.1212/NXI.0000000000000935 |
| 2021-03-01 |
Technical considerations to development of serological tests for SARS-CoV-2 (edit) |
10.1016/J.TALANTA.2020.121883 |
| 2021-03-01 |
Structural insights of key enzymes into therapeutic intervention against SARS-CoV-2 (edit) |
10.1016/J.JSB.2020.107690 |
| 2021-03-01 |
Relative Sensitivity of Saliva and Upper Airway Swabs for Initial Detection of SARS-CoV-2 in Ambulatory Patients: Rapid Review (edit) |
10.1016/J.JMOLDX.2020.12.008 |
| 2021-03-01 |
Recent trends in analytical and digital techniques for the detection of the SARS-Cov-2 (edit) |
10.1016/J.BPC.2020.106538 |
| 2021-03-01 |
Could cilostazol be beneficial in COVID-19 treatment? Thinking about phosphodiesterase-3 as a therapeutic target (edit) |
10.1016/J.INTIMP.2020.107336 |
| 2021-03-01 |
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial (edit) |
10.1016/S1473-3099(21)00070-0 |
| 2021-03-01 |
SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral Spike vaccines (edit) |
10.1016/J.CHOM.2021.03.002 |
| 2021-03-01 |
Surveillance-based informative testing for detection and containment of SARS-CoV-2 outbreaks on a public university campus: an observational and modelling study (edit) |
10.1016/S2352-4642(21)00060-2 |
| 2021-03-01 |
SARS-CoV-2 evolution in an immunocompromised host reveals shared neutralization escape mechanisms (edit) |
10.1016/J.CELL.2021.03.027 |
| 2021-03-01 |
The potential health and economic value of SARS-CoV-2 vaccination alongside physical distancing in the UK: a transmission model-based future scenario analysis and economic evaluation (edit) |
10.1016/S1473-3099(21)00079-7 |
| 2021-03-01 |
Infection and vaccine-induced antibody binding and neutralization of the B.1.351 SARS-CoV-2 variant (edit) |
10.1016/J.CHOM.2021.03.009 |
| 2021-03-01 |
Perfect as the enemy of good: tracing transmissions with low-sensitivity tests to mitigate SARS-CoV-2 outbreaks (edit) |
10.1016/S2666-5247(21)00004-5 |
| 2021-03-01 |
Ubiquitination of SARS-CoV-2 ORF7a promotes antagonism of interferon response (edit) |
10.1038/S41423-020-00603-6 |
| 2021-03-01 |
Structural insight reveals SARS-CoV-2 ORF7a as an immunomodulating factor for human CD14+ monocytes (edit) |
10.1016/J.ISCI.2021.102187 |
| 2021-03-01 |
SARS-CoV-2, the pandemic coronavirus: Molecular and structural insights (edit) |
10.1002/JOBM.202000537 |
| 2021-03-01 |
Q106489324 (edit) |
|
| 2021-03-01 |
Dual inhibition of SARS-CoV-2 and human rhinovirus with protease inhibitors in clinical development (edit) |
10.1016/J.ANTIVIRAL.2021.105020 |
| 2021-03-01 |
3D culture models to study SARS-CoV-2 infectivity and antiviral candidates: From spheroids to bioprinting (edit) |
10.1016/J.BJ.2020.11.009 |
| 2021-03-01 |
Comprehensive and systemic optimization for improving the yield of SARS-CoV-2 spike pseudotyped virus (edit) |
10.1016/J.OMTM.2020.12.007 |
| 2021-03-01 |
The SARS-CoV-2 RNA-protein interactome in infected human cells (edit) |
10.1038/S41564-020-00846-Z |
| 2021-03-01 |
Hallmarks of Alpha- and Betacoronavirus non-structural protein 7+8 complexes (edit) |
10.1126/SCIADV.ABF1004 |
| 2021-03-01 |
Dysregulation of Cell Signaling by SARS-CoV-2 (edit) |
10.1016/J.TIM.2020.12.007 |
| 2021-03-01 |
Human Safety, Tolerability, and Pharmacokinetics of Molnupiravir, a Novel Broad-Spectrum Oral Antiviral Agent with Activity Against SARS-CoV-2 (edit) |
10.1128/AAC.02428-20 |
| 2021-03-01 |
SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801 (edit) |
10.1038/S41586-021-03312-W |
| 2021-03-01 |
Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity (edit) |
10.1016/J.EBIOM.2021.103255 |
| 2021-03-01 |
Single-cell longitudinal analysis of SARS-CoV-2 infection in human airway epithelium identifies target cells, alterations in gene expression, and cell state changes (edit) |
10.1371/JOURNAL.PBIO.3001143 |
| 2021-03-01 |
Single-cell meta-analysis of SARS-CoV-2 entry genes across tissues and demographics (edit) |
10.1038/S41591-020-01227-Z |
| 2021-03-01 |
Natural selection in the evolution of SARS-CoV-2 in bats created a generalist virus and highly capable human pathogen (edit) |
10.1371/JOURNAL.PBIO.3001115 |
| 2021-03-01 |
Structural O-Glycoform Heterogeneity of the SARS-CoV-2 Spike Protein Receptor-Binding Domain Revealed by Native Top-Down Mass Spectrometry (edit) |
10.1101/2021.02.28.433291 |
| 2021-03-01 |
Neuroinvasion of SARS-CoV-2 in human and mouse brain (edit) |
10.1084/JEM.20202135 |
| 2021-03-01 |
Hydroxychloroquine serum concentrations in non-critical care patients infected with SARS-CoV-2 (edit) |
10.1016/J.JGAR.2020.12.018 |
| 2021-03-01 |
Genetic and epigenetic factors associated with increased severity of Covid‐19 (edit) |
10.1002/CBIN.11572 |
| 2021-03-01 |
The polybasic insert, the RBD of the SARS-CoV-2 spike protein, and the feline coronavirus - evolved or yet to evolve (edit) |
10.1016/J.BBREP.2021.100907 |
| 2021-03-01 |
The localized rise of a B.1.526 SARS-CoV-2 variant containing an E484K mutation in New York State (edit) |
10.1101/2021.02.26.21251868 |
| 2021-03-01 |
A novel cell culture system modeling the SARS-CoV-2 life cycle (edit) |
10.1371/JOURNAL.PPAT.1009439 |
| 2021-03-01 |
Structural basis for inhibition of the SARS-CoV-2 RNA polymerase by suramin (edit) |
10.1038/S41594-021-00570-0 |
| 2021-03-01 |
SARS-CoV-2-induced SIADH: a novel cause of hyponatremia (edit) |
10.1007/S00391-021-01863-1 |
| 2021-03-01 |
Genome composition and genetic characterization of SARS-CoV-2 (edit) |
10.1016/J.SJBS.2020.12.053 |
| 2021-03-01 |
Immunogenicity of clinically relevant SARS-CoV-2 vaccines in nonhuman primates and humans (edit) |
10.1126/SCIADV.ABE8065 |
| 2021-03-01 |
Low secondary transmission rates of SARS-CoV-2 infection among contacts of construction laborers at open air environment (edit) |
10.18683/GERMS.2021.1250 |
| 2021-03-01 |
Pharmacotherapeutics of SARS-CoV-2 Infections (edit) |
10.1007/S11481-020-09968-X |
| 2021-03-01 |
Multisystem Inflammatory Syndrome in Children Related to SARS-CoV-2 (edit) |
10.1007/S40272-020-00435-X |
| 2021-03-01 |
Onset of rheumatoid arthritis after COVID-19: coincidence or connected? (edit) |
10.1136/ANNRHEUMDIS-2021-219859 |
| 2021-03-01 |
Autoimmune limbic encephalitis related to SARS-CoV-2 infection: Case-report and review of the literature (edit) |
10.1016/J.BBIH.2021.100210 |
| 2021-03-01 |
Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization (edit) |
10.1016/J.CHOM.2021.01.014 |
| 2021-03-01 |
SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes (edit) |
10.1038/S41420-021-00428-W |
| 2021-03-01 |
Human Erythroid Progenitors Are Directly Infected by SARS-CoV-2: Implications for Emerging Erythropoiesis in Severe COVID-19 Patients (edit) |
10.1016/J.STEMCR.2021.02.001 |
| 2021-03-01 |
Mask-wearing and control of SARS-CoV-2 transmission in the USA: a cross-sectional study (edit) |
10.1016/S2589-7500(20)30293-4 |
| 2021-03-01 |
Author Correction: Genomic epidemiology reveals multiple introductions of SARS-CoV-2 from mainland Europe into Scotland (edit) |
10.1038/S41564-021-00869-0 |
| 2021-03-01 |
The roles of signaling pathways in SARS-CoV-2 infection; lessons learned from SARS-CoV and MERS-CoV (edit) |
10.1007/S00705-021-04958-7 |
| 2021-03-01 |
Las zoonosis emergentes y la infección provocada por el SARS-CoV-2 (edit) |
10.31434/RMS.V6I3.656 |
| 2021-03-01 |
Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males (edit) |
10.1016/J.EBIOM.2021.103246 |
| 2021-03-01 |
Genomic characterization of a novel SARS-CoV-2 lineage from Rio de Janeiro, Brazil (edit) |
10.1128/JVI.00119-21 |
| 2021-03-01 |
SARS-CoV-2 Variant of Concern 202012/01 Has about Twofold Replicative Advantage and Acquires Concerning Mutations (edit) |
10.3390/V13030392 |
| 2021-03-01 |
ACE2 receptor usage reveals variation in susceptibility to SARS-CoV and SARS-CoV-2 infection among bat species (edit) |
10.1038/S41559-021-01407-1 |
| 2021-03-01 |
Free SARS-CoV-2 Spike Protein S1 Particles May Play a Role in the Pathogenesis of COVID-19 Infection (edit) |
10.1134/S0006297921030032 |
| 2021-03-01 |
A genetic element in the SARS-CoV-2 genome is shared with multiple insect species (edit) |
10.1099/JGV.0.001551 |
| 2021-03-01 |
Pre-screening and preventive quarantine likely explains the low SARS-CoV-2 prevalence among Norwegian conscripts (edit) |
10.1080/02813432.2021.1880101 |
| 2021-03-01 |
Absence of SARS-CoV-2 RNA in COVID-19-associated intestinal endothelialitis (edit) |
10.1007/S00134-020-06326-6 |
| 2021-03-01 |
SARS-CoV-2 Infects Human Pluripotent Stem Cell-Derived Cardiomyocytes, Impairing Electrical and Mechanical Function (edit) |
10.1016/J.STEMCR.2021.02.008 |
| 2021-03-01 |
Nicotinic cholinergic system and COVID-19: In silico identification of interactions between α7 nicotinic acetylcholine receptor and the cryptic epitopes of SARS-Co-V and SARS-CoV-2 Spike glycoproteins (edit) |
10.1016/J.FCT.2021.112009 |
| 2021-03-01 |
Current opinion in neurological manifestations of SARS-CoV-2 infection (edit) |
10.1016/J.COTOX.2021.03.004 |
| 2021-03-01 |
Tracking SARS-CoV-2 lineage B.1.1.7 dissemination: insights from nationwide spike gene target failure (SGTF) and spike gene late detection (SGTL) data, Portugal, week 49 2020 to week 3 2021 (edit) |
10.2807/1560-7917.ES.2021.26.10.2100130 |
| 2021-03-01 |
How we prepared our operating theatre for patients with SARS-CoV-2 virus (edit) |
10.5114/WIITM.2020.95090 |
| 2021-03-01 |
Identification of Potential SARS-CoV-2 Main Protease and Spike Protein Inhibitors from the Genus Aloe: An In Silico Study for Drug Development (edit) |
|
| 2021-03-01 |
Mutations in spike protein and allele variations in ACE2 impact targeted therapy strategies against SARS-CoV-2 (edit) |
10.24272/J.ISSN.2095-8137.2020.301 |
| 2021-03-01 |
Seroprevalence of SARS-CoV-2 Antibodies in the US Adult Asymptomatic Population as of September 30, 2020 (edit) |
10.1001/JAMANETWORKOPEN.2021.1552 |
| 2021-03-01 |
Genetic Characteristics and Phylogeny of 969-bp S Gene Sequence of SARS-CoV-2 from Hawai'i Reveals the Worldwide Emerging P681H Mutation (edit) |
|
| 2021-03-01 |
A potential peptide inhibitor of SARS-CoV-2 S and human ACE2 complex (edit) |
10.1080/07391102.2021.1889665 |
| 2021-03-01 |
Spike protein fusion loop controls SARS-CoV-2 fusogenicity and infectivity (edit) |
10.1016/J.JSB.2021.107713 |
| 2021-03-01 |
The study of antiviral drugs targeting SARS-CoV-2 nucleocapsid and spike proteins through large-scale compound repurposing (edit) |
10.1016/J.HELIYON.2021.E06387 |
| 2021-03-01 |
The networks of m6A-SARS-CoV-2 related genes and immune infiltration patterns in idiopathic pulmonary fibrosis (edit) |
10.18632/AGING.202725 |
| 2021-03-01 |
Whole genome analysis of more than 10 000 SARS-CoV-2 virus unveils global genetic diversity and target region of NSP6 (edit) |
10.1093/BIB/BBAB025 |
| 2021-03-01 |
An integrated approach to determine the abundance, mutation rate and phylogeny of the SARS-CoV-2 genome (edit) |
10.1093/BIB/BBAA437 |
| 2021-03-01 |
Topological Analysis for Sequence Variability: Case Study on more than 2K SARS-CoV-2 sequences of COVID-19 infected 54 countries in comparison with SARS-CoV-1 and MERS-CoV (edit) |
10.1016/J.MEEGID.2021.104708 |
| 2021-03-01 |
SARS-CoV-2 associated polyradiculitis and myocarditis may favour Takotsubo syndrome (edit) |
10.1016/J.MEHY.2021.110509 |
| 2021-03-01 |
Modelling of hypothetical SARS-CoV-2 point-of-care tests on admission to hospital from A&E: rapid cost-effectiveness analysis (edit) |
10.3310/HTA25210 |
| 2021-03-01 |
Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals (edit) |
10.1016/S0140-6736(21)00501-8 |
| 2021-03-01 |
Stability of SARS-CoV-2 and other coronaviruses in the environment and on common touch surfaces and the influence of climatic conditions: a review (edit) |
10.1111/TBED.13707 |
| 2021-03-01 |
Hypothetical targets and plausible drugs of Coronavirus infection caused by SARS-CoV-2 (edit) |
10.1111/TBED.13734 |
| 2021-03-01 |
SARS-CoV-2, COVID-19, skin and immunology - what do we know so far? (edit) |
10.1111/ALL.14498 |
| 2021-03-01 |
Management of SARS-CoV-2 Pneumonia (edit) |
10.1002/JMV.26470 |
| 2021-03-01 |
Immune response following infection with SARS-CoV-2 and other coronaviruses: A rapid review (edit) |
10.1002/RMV.2162 |
| 2021-03-01 |
A five-step risk management process for geriatric dental practice during SARS-CoV-2 pandemic (edit) |
10.1111/GER.12499 |
| 2021-02-28 |
TMPRSS11D and TMPRSS13 Activate the SARS-CoV-2 Spike Protein (edit) |
10.3390/V13030384 |
| 2021-02-28 |
A call for governments to pause Twitter censorship: using Twitter data as social-spatial sensors of COVID-19/SARS-CoV-2 research diffusion (edit) |
10.1007/S11192-020-03843-5 |
| 2021-02-27 |
Inhibitors of endosomal acidification suppress SARS-CoV-2 replication and relieve viral pneumonia in hACE2 transgenic mice (edit) |
10.1186/S12985-021-01515-1 |
| 2021-02-27 |
Inactivation and Elimination of SARS-CoV-2 in Biosamples Using Simple Fixatives and Ultrafiltration (edit) |
10.3390/MPS4010018 |
| 2021-02-27 |
COVID-19 outbreak in Malaysia: Decoding D614G mutation of SARS-CoV-2 virus isolated from an asymptomatic case in Pahang (edit) |
10.1016/J.MATPR.2021.02.387 |
| 2021-02-26 |
SARS-CoV-2 nsp12 attenuates type I interferon production by inhibiting IRF3 nuclear translocation (edit) |
10.1038/S41423-020-00619-Y |
| 2021-02-26 |
SARS-CoV-2 causes severe epithelial inflammation and barrier dysfunction (edit) |
10.1128/JVI.00110-21 |
| 2021-02-26 |
Detection of B.1.351 SARS-CoV-2 Variant Strain — Zambia, December 2020 (edit) |
10.15585/MMWR.MM7008E2 |
| 2021-02-26 |
A SARS-CoV-2 cytopathicity dataset generated by high-content screening of a large drug repurposing collection (edit) |
10.1038/S41597-021-00848-4 |
| 2021-02-26 |
SARS-CoV-2 spike D614G change enhances replication and transmission (edit) |
10.1038/S41586-021-03361-1 |
| 2021-02-26 |
Exploratory analysis of immunization records highlights decreased SARS-CoV-2 rates in individuals with recent non-COVID-19 vaccinations (edit) |
10.1038/S41598-021-83641-Y |
| 2021-02-26 |
SARS-CoV-2 spike protein: a key target for eliciting persistent neutralizing antibodies (edit) |
10.1038/S41392-021-00523-5 |
| 2021-02-26 |
Clusters of SARS-CoV-2 Infection Among Elementary School Educators and Students in One School District - Georgia, December 2020-January 2021 (edit) |
10.15585/MMWR.MM7008E4 |
| 2021-02-26 |
SARS-CoV-2 Nonstructural Proteins 1 and 13 Suppress Caspase-1 and the NLRP3 Inflammasome Activation (edit) |
10.3390/MICROORGANISMS9030494 |
| 2021-02-26 |
Assessing the potential of unmanned aerial vehicle spraying of aqueous ozone as an outdoor disinfectant for SARS-CoV-2 (edit) |
10.1016/J.ENVRES.2021.110944 |
| 2021-02-26 |
Immunoinformatics and Molecular Docking Studies Predicted Potential Multiepitope-Based Peptide Vaccine and Novel Compounds against Novel SARS-CoV-2 through Virtual Screening (edit) |
10.1155/2021/1596834 |
| 2021-02-26 |
Hospitalization and mortality associated with SARS-CoV-2 viral clades in COVID-19 (edit) |
10.1038/S41598-021-82850-9 |
| 2021-02-25 |
A single-cell and spatial atlas of autopsy tissues reveals pathology and cellular targets of SARS-CoV-2 (edit) |
10.1101/2021.02.25.430130 |
| 2021-02-25 |
SARS-CoV-2 dependence on host pathways (edit) |
10.1126/SCIENCE.ABG6837 |
| 2021-02-25 |
A Novel SARS-CoV-2 Variant of Concern, B.1.526, Identified in New York (edit) |
10.1101/2021.02.23.21252259 |
| 2021-02-25 |
A Neanderthal OAS1 isoform protects individuals of European ancestry against COVID-19 susceptibility and severity (edit) |
10.1038/S41591-021-01281-1 |
| 2021-02-25 |
In-Frame 12-Nucleotide Deletion within Open Reading Frame 3a in a SARS-CoV-2 Strain Isolated from a Patient Hospitalized with COVID-19 (edit) |
10.1128/MRA.00137-21 |
| 2021-02-25 |
Therapeutic activity of an inhaled potent SARS-CoV-2 neutralizing human monoclonal antibody in hamsters (edit) |
10.1016/J.XCRM.2021.100218 |
| 2021-02-25 |
Nonstructural protein 7 and 8 complexes of SARS-CoV-2 (edit) |
10.1002/PRO.4046 |
| 2021-02-25 |
Structural insights into SARS-CoV-2 spike protein and its natural mutants found in Mexican population (edit) |
10.1038/S41598-021-84053-8 |
| 2021-02-25 |
In silico evaluation of the compounds of the ayurvedic drug, AYUSH-64, for the action against the SARS-CoV-2 main protease (edit) |
10.1016/J.JAIM.2021.02.004 |
| 2021-02-25 |
Robust SARS-CoV-2 infection in nasal turbinates after treatment with systemic neutralizing antibodies (edit) |
10.1016/J.CHOM.2021.02.019 |
| 2021-02-24 |
The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem (edit) |
|
| 2021-02-24 |
A Biochemical Perspective of the Nonstructural Proteins (NSPs) and the Spike Protein of SARS CoV-2 (edit) |
10.1007/S10930-021-09967-8 |
| 2021-02-24 |
SARS-CoV-2 genomic surveillance identifies naturally occurring truncations of ORF7a that limit immune suppression (edit) |
10.1101/2021.02.22.21252253 |
| 2021-02-24 |
SARS-CoV-2 ORF6 disturbs nucleocytoplasmic trafficking to advance the viral replication (edit) |
10.1101/2021.02.24.432656 |
| 2021-02-24 |
Evaluation of the Effectiveness and Safety of Adding Ivermectin to Treatment in Severe COVID-19 Patients (edit) |
10.21203/RS.3.RS-224203/V1 |
| 2021-02-24 |
Implications of central carbon metabolism in SARS-CoV-2 replication and disease severity (edit) |
10.1101/2021.02.24.432759 |
| 2021-02-24 |
Two Different Antibody-Dependent Enhancement (ADE) Risks for SARS-CoV-2 Antibodies (edit) |
10.3389/FIMMU.2021.640093 |
| 2021-02-24 |
Involvement of Oxidative Stress and the Innate Immune System in SARS-CoV-2 Infection (edit) |
10.3390/DISEASES9010017 |
| 2021-02-24 |
Low compositions of human toll-like receptor 7/8-stimulating RNA motifs in the MERS-CoV, SARS-CoV and SARS-CoV-2 genomes imply a substantial ability to evade human innate immunity (edit) |
10.7717/PEERJ.11008 |
| 2021-02-24 |
Association of SARS-CoV-2 viral load at admission with in-hospital acute kidney injury: A retrospective cohort study (edit) |
10.1371/JOURNAL.PONE.0247366 |
| 2021-02-23 |
Viral load and contact heterogeneity predict SARS-CoV-2 transmission and super-spreading events (edit) |
10.7554/ELIFE.63537 |
| 2021-02-23 |
The proximal proteome of 17 SARS-CoV-2 proteins links to disrupted antiviral signaling and host translation (edit) |
10.1101/2021.02.23.432450 |
| 2021-02-23 |
Efficacy and safety of Ivermectin and Hydroxychloroquine in patients with severe COVID-19. A randomized controlled trial (edit) |
10.1101/2021.02.18.21252037 |
| 2021-02-23 |
Isolation and characterization of the new SARS-CoV-2 variant in travellers from the United Kingdom to India: VUI-202012/01 of the B.1.1.7 lineage (edit) |
10.1093/JTM/TAAB009 |
| 2021-02-23 |
Quantifying the transmission advantage associated with N501Y substitution of SARS-CoV-2 in the UK: an early data-driven analysis (edit) |
10.1093/JTM/TAAB011 |
| 2021-02-23 |
COVID-19 CG enables SARS-CoV-2 mutation and lineage tracking by locations and dates of interest (edit) |
10.7554/ELIFE.63409 |
| 2021-02-23 |
Use of masks in public places in Poland during SARS-Cov-2 epidemic: a covert observational study (edit) |
10.1186/S12889-021-10418-3 |
| 2021-02-23 |
REACT-1 round 9 interim report: downward trend of SARS-CoV-2 in England in February 2021 but still at high prevalence (edit) |
10.1101/2021.02.18.21251973 |
| 2021-02-23 |
Structural and functional characterization of SARS-CoV-2 RBD domains produced in mammalian cells (edit) |
10.1101/2021.02.23.432424 |
| 2021-02-23 |
Clinical correlates of anti-SARS-CoV-2 antibody profiles in Spanish COVID-19 patients from a high incidence region (edit) |
10.1038/S41598-021-83969-5 |
| 2021-02-23 |
Ensemble-based screening of natural products and FDA-approved drugs identified potent inhibitors of SARS-CoV-2 that work with two distinct mechanisms (edit) |
10.1016/J.JMGM.2021.107871 |
| 2021-02-23 |
Anxiety and depression due to 2019 SARS-CoV-2 among frontier healthcare workers in Kenya (edit) |
10.1016/J.HELIYON.2021.E06351 |
| 2021-02-22 |
Reduced binding and neutralization of infection- and vaccine-induced antibodies to the B.1.351 (South African) SARS-CoV-2 variant (edit) |
10.1101/2021.02.20.432046 |
| 2021-02-22 |
Identification and functional analysis of the SARS-COV-2 nucleocapsid protein (edit) |
10.1186/S12866-021-02107-3 |
| 2021-02-22 |
ORF3a of the COVID-19 virus SARS-CoV-2 blocks HOPS complex-mediated assembly of the SNARE complex required for autolysosome formation (edit) |
10.1016/J.DEVCEL.2020.12.010 |
| 2021-02-22 |
Structural Basis for Accommodation of Emerging B.1.351 and B.1.1.7 Variants by Two Potent SARS-CoV-2 Neutralizing Antibodies (edit) |
10.1101/2021.02.21.432168 |
| 2021-02-22 |
Intra-host variation and evolutionary dynamics of SARS-CoV-2 populations in COVID-19 patients (edit) |
10.1186/S13073-021-00847-5 |
| 2021-02-22 |
Genome-scale deconvolution of RNA structure ensembles (edit) |
10.1038/S41592-021-01075-W |
| 2021-02-22 |
Genome and epigenome editing identify CCR9 and SLC6A20 as target genes at the 3p21.31 locus associated with severe COVID-19 (edit) |
10.1038/S41392-021-00519-1 |
| 2021-02-22 |
SARS-CoV-2 viral shedding characteristics and potential evidence for the priority for faecal specimen testing in diagnosis (edit) |
10.1371/JOURNAL.PONE.0247367 |
| 2021-02-22 |
Cordifolioside: potent inhibitor against Mpro of SARS-CoV-2 and immunomodulatory through human TGF-β and TNF-α (edit) |
10.1007/S13205-021-02685-Z |
| 2021-02-22 |
In silico detection of SARS-CoV-2 specific B-cell epitopes and validation in ELISA for serological diagnosis of COVID-19 (edit) |
10.1038/S41598-021-83730-Y |
| 2021-02-22 |
Potential Role of Galectin-glycan Lattices in SARS-CoV-2 Infection and Pathogenesis: A Hypothesis (edit) |
10.14218/ERHM.2020.00079 |
| 2021-02-22 |
Air circulation in a gastrointestinal light source box and endoscope in the era of SARS-CoV-2 and airborne transmission of microorganisms (edit) |
10.1055/A-1336-3280 |
| 2021-02-22 |
Lessons Learned From SARS-CoV-2 Pandemic in Donation and Tissue Banking Activities: Key Takeaways (edit) |
10.1097/TP.0000000000003716 |
| 2021-02-20 |
Next-generation diagnostics: virus capture facilitates a sensitive viral diagnosis for epizootic and zoonotic pathogens including SARS-CoV-2 (edit) |
10.1186/S40168-020-00973-Z |
| 2021-02-20 |
Whole-genome Sequencing of SARS-CoV-2: Using Phylogeny and Structural Modeling to Contextualize Local Viral Evolution (edit) |
10.1093/MILMED/USAB031 |
| 2021-02-20 |
Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19 (edit) |
10.1101/2021.02.20.431155 |
| 2021-02-20 |
Docking-based virtual screening studies aiming at the covalent inhibition of SARS-CoV-2 MPro by targeting the cysteine 145 (edit) |
10.1016/J.COMPBIOLCHEM.2021.107463 |
| 2021-02-19 |
SARS-CoV-2 Positivity on or After 9 Days Among Quarantined Student Contacts of Confirmed Cases (edit) |
10.1001/JAMA.2021.2392 |
| 2021-02-19 |
Importation of SARS‐CoV‐2 Variant B.1.1.7 in Pakistan (edit) |
10.1002/JMV.26869 |
| 2021-02-19 |
Decreased neutralization of SARS-CoV-2 global variants by therapeutic anti-spike protein monoclonal antibodies (edit) |
10.1101/2021.02.18.431897 |
| 2021-02-19 |
Probing the SAM Binding Site of SARS-CoV-2 nsp14 in vitro Using SAM Competitive Inhibitors Guides Developing Selective bi-substrate Inhibitors (edit) |
10.1101/2021.02.19.424337 |
| 2021-02-19 |
COVID-19: a review on SARS-CoV-2 origin, epidemiology, virology, clinical manifestations and complications with special emphasis on adverse outcome in Bhopal Gas Tragedy survivor (edit) |
10.1515/HMBCI-2020-0070 |
| 2021-02-19 |
Viral dynamics of SARS-CoV-2 variants in vaccinated and unvaccinated individuals (edit) |
10.1101/2021.02.16.21251535 |
| 2021-02-19 |
In silico identification of available drugs targeting cell surface BiP to disrupt SARS-CoV-2 binding and replication: Drug repurposing approach (edit) |
10.1016/J.EJPS.2021.105771 |
| 2021-02-19 |
Evaluation of drug repositioning by molecular docking of pharmaceutical resources available in the Brazilian healthcare system against SARS-CoV-2 (edit) |
10.1016/J.IMU.2021.100539 |
| 2021-02-19 |
Immune transcriptomes of highly exposed SARS-CoV-2 asymptomatic seropositive versus seronegative individuals from the Ischgl community (edit) |
10.1038/S41598-021-83110-6 |
| 2021-02-19 |
SARS-CoV-2 Infection-Induced Promoter Hypomethylation as an Epigenetic Modulator of Heat Shock Protein A1L (HSPA1L) Gene (edit) |
10.3389/FGENE.2021.622271 |
| 2021-02-19 |
Emulsion-based isothermal nucleic acid amplification for rapid SARS-CoV-2 detection via angle-dependent light scatter analysis (edit) |
10.1016/J.BIOS.2021.113099 |
| 2021-02-19 |
Open Science Resources for the Mass Spectrometry-Based Analysis of SARS-CoV-2 (edit) |
10.1021/ACS.JPROTEOME.0C00929 |
| 2021-02-18 |
Maintaining Safety with SARS-CoV-2 Vaccines (edit) |
10.1056/NEJMRA2035343 |
| 2021-02-18 |
Circulating SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity (edit) |
10.1101/2021.02.14.21251704 |
| 2021-02-18 |
SARS-CoV-2 nucleocapsid protein dually regulates innate immune responses (edit) |
10.1101/2021.02.17.431755 |
| 2021-02-18 |
Adaptive immunity to SARS-CoV-2 and COVID-19 (edit) |
10.1016/J.CELL.2021.01.007 |
| 2021-02-18 |
Direct activation of endothelial cells by SARS-CoV-2 nucleocapsid protein is blocked by Simvastatin (edit) |
10.1101/2021.02.14.431174 |
| 2021-02-18 |
Duration of Culturable SARS-CoV-2 in Hospitalized Patients with Covid-19 (edit) |
10.1056/NEJMC2027040 |
| 2021-02-18 |
SARS-CoV-2 genomic diversity and the implications for qRT-PCR diagnostics and transmission (edit) |
10.1101/GR.268961.120 |
| 2021-02-18 |
SARS-CoV-2 early infection signature identified potential key infection mechanisms and drug targets (edit) |
10.1186/S12864-021-07433-4 |
| 2021-02-18 |
Correlation of SARS-CoV-2 Serology and Clinical Phenotype Amongst Hospitalised Children in a Tertiary Children’s Hospital in India (edit) |
10.1093/TROPEJ/FMAB015 |
| 2021-02-18 |
High-throughput Wastewater SARS-CoV-2 Detection Pipeline v1 (edit) |
10.17504/PROTOCOLS.IO.BSHVNB66 |
| 2021-02-17 |
Evidence and magnitude of the effects of meteorological changes on SARS-CoV-2 transmission (edit) |
10.1371/JOURNAL.PONE.0246167 |
| 2021-02-17 |
Intranasal fusion inhibitory lipopeptide prevents direct-contact SARS-CoV-2 transmission in ferrets (edit) |
10.1126/SCIENCE.ABF4896 |
| 2021-02-17 |
SARS-CoV-2 spillover transmission due to recombination event (edit) |
10.1016/J.GENREP.2021.101045 |
| 2021-02-17 |
A comparative genomics-based study of positive strand RNA viruses emphasizing on SARS-CoV-2 utilizing dinucleotide signature, codon usage and codon context analyses (edit) |
10.1016/J.GENREP.2021.101055 |
| 2021-02-17 |
Dysregulated transcriptional responses to SARS-CoV-2 in the periphery (edit) |
10.1038/S41467-021-21289-Y |
| 2021-02-17 |
High throughput detection and genetic epidemiology of SARS-CoV-2 using COVIDSeq next-generation sequencing (edit) |
10.1371/JOURNAL.PONE.0247115 |
| 2021-02-17 |
Histologic and Immunohistochemical Evaluation of 65 Placentas From Women With Polymerase Chain Reaction–Proven Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (edit) |
10.5858/ARPA.2020-0793-SA |
| 2021-02-16 |
Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases (edit) |
10.1016/J.XCRM.2021.100204 |
| 2021-02-16 |
Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19 (edit) |
10.1001/JAMA.2021.0202 |
| 2021-02-16 |
Structure of the SARS-CoV-2 RNA-dependent RNA polymerase in the presence of favipiravir-RTP (edit) |
10.1073/PNAS.2021946118 |
| 2021-02-16 |
Endothelial cells elicit a pro-inflammatory response to SARS-CoV-2 without productive viral infection (edit) |
10.1101/2021.02.14.431177 |
| 2021-02-16 |
Risk factors for community transmission of SARS-CoV-2. A cross-sectional study in 116,678 people (edit) |
10.21203/RS.3.RS-179906/V1 |
| 2021-02-16 |
Quantifying Absolute Neutralization Titers against SARS-CoV-2 by a Standardized Virus Neutralization Assay Allows for Cross-Cohort Comparisons of COVID-19 Sera (edit) |
10.1128/MBIO.02492-20 |
| 2021-02-16 |
Respiratory viral co-infections among SARS-CoV-2 cases confirmed by virome capture sequencing (edit) |
10.1038/S41598-021-83642-X |
| 2021-02-15 |
Diagnostics for SARS-CoV-2 infections (edit) |
10.1038/S41563-020-00906-Z |
| 2021-02-15 |
SARS-CoV-2 B.1.1.7 sensitivity to mRNA vaccine-elicited, convalescent and monoclonal antibodies (edit) |
10.1101/2021.01.19.21249840 |
| 2021-02-15 |
Causal network models of SARS-CoV-2 expression and aging to identify candidates for drug repurposing (edit) |
10.1038/S41467-021-21056-Z |
| 2021-02-15 |
Mass spectrometry reveals potential of β-lactams as SARS-CoV-2 M inhibitors (edit) |
10.1039/D0CC06870E |
| 2021-02-15 |
Analysis of SARS-CoV-2 mutations in the United States suggests presence of four substrains and novel variants (edit) |
10.1038/S42003-021-01754-6 |
| 2021-02-15 |
Discrete SARS-CoV-2 antibody titers track with functional humoral stability (edit) |
10.1038/S41467-021-21336-8 |
| 2021-02-15 |
Corilagin inhibits SARS-CoV-2 replication by targeting viral RNA-dependent RNA polymerase (edit) |
10.1016/J.APSB.2021.02.011 |
| 2021-02-15 |
In silico identification and validation of natural antiviral compounds as potential inhibitors of SARS-CoV-2 methyltransferase (edit) |
10.1080/07391102.2021.1886174 |
| 2021-02-14 |
SARS-CoV-2, Covid-19, and the debunking of conspiracy theories (edit) |
10.1002/RMV.2222 |
| 2021-02-14 |
Mesenchymal Stem Cells: The Secret Children’s Weapons against the SARS-CoV-2 Lethal Infection (edit) |
10.3390/APP11041696 |
| 2021-02-13 |
On the effect of age on the transmission of SARS-CoV-2 in households, schools and the community (edit) |
10.1093/INFDIS/JIAA691 |
| 2021-02-13 |
Variant analysis of SARS-CoV-2 genomes in the Middle East (edit) |
10.1016/J.MICPATH.2021.104741 |
| 2021-02-13 |
Structural genetics of circulating variants affecting the SARS-CoV-2 spike/human ACE2 complex (edit) |
10.1080/07391102.2021.1886175 |
| 2021-02-13 |
Aggregation hot spots in the SARS-CoV-2 proteome may constitute potential therapeutic targets for the suppression of the viral replication and multiplication (edit) |
10.1007/S42485-021-00057-Y |
| 2021-02-13 |
Multicenter interim guidance on use of antivirals for children with COVID-19/SARS-CoV-2 (edit) |
10.1093/JPIDS/PIAA115 |
| 2021-02-12 |
Proteolytic Activation of SARS-CoV-2 Spike at the S1/S2 Boundary: Potential Role of Proteases beyond Furin (edit) |
10.1021/ACSINFECDIS.0C00701 |
| 2021-02-12 |
Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape (edit) |
10.1126/SCIENCE.ABE6230 |
| 2021-02-12 |
Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7 (edit) |
10.1101/2021.01.25.428137 |
| 2021-02-12 |
Immunoinformatics prediction of overlapping CD8 T-cell, IFN-γ and IL-4 inducer CD4 T-cell and linear B-cell epitopes based vaccines against COVID-19 (SARS-CoV-2) (edit) |
10.1016/J.VACCINE.2021.01.003 |
| 2021-02-12 |
The effect of the D614G substitution on the structure of the spike glycoprotein of SARS-CoV-2 (edit) |
10.1073/PNAS.2022586118 |
| 2021-02-12 |
Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies (edit) |
10.1101/2021.02.12.430472 |
| 2021-02-12 |
SARS-CoV-2, Hypoxia, and Calcium Signaling: The Consequences and Therapeutic Options (edit) |
10.1021/ACSPTSCI.0C00219 |
| 2021-02-12 |
COVID-19–associated Nephropathy Includes Tubular Necrosis and Capillary Congestion, with Evidence of SARS-CoV-2 in the Nephron (edit) |
10.34067/KID.0006992020 |
| 2021-02-12 |
Immunoreactive peptide maps of SARS-CoV-2 (edit) |
10.1038/S42003-021-01743-9 |
| 2021-02-12 |
[Evaluation of a SARS-CoV-2 test strategy in a southwestern university hospital at the beginning of the COVID-19 pandemic] (edit) |
10.1007/S00103-021-03287-Z |
| 2021-02-12 |
SARS-CoV-2 genomic surveillance in Rondônia, Brazilian Western Amazon (edit) |
10.1038/S41598-021-83203-2 |
| 2021-02-11 |
The Spike D614G mutation increases SARS-CoV-2 infection of multiple human cell types (edit) |
10.7554/ELIFE.65365 |
| 2021-02-11 |
A genome-wide CRISPR screen identifies host factors that regulate SARS-CoV-2 entry (edit) |
10.1038/S41467-021-21213-4 |
| 2021-02-11 |
Identification of ebselen and its analogues as potent covalent inhibitors of papain-like protease from SARS-CoV-2 (edit) |
10.1038/S41598-021-83229-6 |
| 2021-02-11 |
Differential roles of RIG-I-like receptors in SARS-CoV-2 infection (edit) |
10.1101/2021.02.10.430677 |
| 2021-02-11 |
SARS-CoV-2 infection induces protective immunity and limits transmission in Syrian hamsters (edit) |
10.26508/LSA.202000886 |
| 2021-02-11 |
The Impact of SARS-CoV-2 Infection on the Development of Neurodegeneration in Multiple Sclerosis (edit) |
10.3390/IJMS22041804 |
| 2021-02-11 |
Post-exposure protection of SARS-CoV-2 lethal infected K18-hACE2 transgenic mice by neutralizing human monoclonal antibody (edit) |
10.1038/S41467-021-21239-8 |
| 2021-02-11 |
Berberine and Obatoclax Inhibit SARS-Cov-2 Replication in Primary Human Nasal Epithelial Cells In Vitro (edit) |
10.3390/V13020282 |
| 2021-02-11 |
Factors associated with SARS-CoV-2 infection and outbreaks in long-term care facilities in England: a national cross-sectional survey (edit) |
10.1016/S2666-7568(20)30065-9 |
| 2021-02-11 |
Multi-clonal SARS-CoV-2 neutralization by antibodies isolated from severe COVID-19 convalescent donors (edit) |
10.1371/JOURNAL.PPAT.1009165 |
| 2021-02-10 |
Maximizing fit for cloth and medical procedure masks to improve performance and reduce SARS-COV-2 transmission and exposure, 2021 (edit) |
10.15585/MMWR.MM7007E1 |
| 2021-02-10 |
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants (edit) |
10.1038/S41586-021-03324-6 |
| 2021-02-10 |
Can ACE2 Receptor Polymorphism Predict Species Susceptibility to SARS-CoV-2? (edit) |
10.3389/FPUBH.2020.608765 |
| 2021-02-10 |
Morphometry of SARS-CoV and SARS-CoV-2 particles in ultrathin plastic sections of infected Vero cell cultures (edit) |
10.1038/S41598-021-82852-7 |
| 2021-02-10 |
Severe Reinfection With South African Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variant 501Y.V2 (edit) |
10.1093/CID/CIAB129 |
| 2021-02-10 |
Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6-8 months after the infection (edit) |
10.1016/J.MEDJ.2021.02.001 |
| 2021-02-10 |
Identification of potential antivirals against SARS-CoV-2 using virtual screening method (edit) |
10.1016/J.IMU.2021.100531 |
| 2021-02-10 |
Serological Test to Determine Exposure to SARS-CoV-2: ELISA Based on the Receptor-Binding Domain of the Spike Protein (S-RBDN318-V510) Expressed in Escherichia coli (edit) |
10.3390/DIAGNOSTICS11020271 |
| 2021-02-09 |
Energetic and structural features of SARS-CoV-2 N-protein co-assemblies with nucleic acids (edit) |
10.1101/2021.02.08.430344 |
| 2021-02-09 |
Tipiracil binds to uridine site and inhibits Nsp15 endoribonuclease NendoU from SARS-CoV-2 (edit) |
10.1038/S42003-021-01735-9 |
| 2021-02-09 |
Dynamic competition between SARS-CoV-2 NSP1 and mRNA on the human ribosome inhibits translation initiation (edit) |
10.1073/PNAS.2017715118 |
| 2021-02-09 |
Disruption of nuclear architecture as a cause of COVID-19 induced anosmia (edit) |
10.1101/2021.02.09.430314 |
| 2021-02-09 |
Evidence for SARS-CoV-2 related coronaviruses circulating in bats and pangolins in Southeast Asia (edit) |
10.1038/S41467-021-21240-1 |
| 2021-02-09 |
Coronavirus replication-transcription complex: Vital and selective NMPylation of a conserved site in nsp9 by the NiRAN-RdRp subunit (edit) |
10.1073/PNAS.2022310118 |
| 2021-02-09 |
Lasting antibody and T cell responses to SARS-CoV-2 in COVID-19 patients three months after infection (edit) |
10.1038/S41467-021-21155-X |
| 2021-02-09 |
Specific and Rapid SARS-CoV-2 Identification Based on LC-MS/MS Analysis (edit) |
10.1021/ACSOMEGA.0C04691 |
| 2021-02-09 |
Galectin-3 as a potential prognostic biomarker of severe COVID-19 in SARS-CoV-2 infected patients (edit) |
10.1101/2021.02.07.21251281 |
| 2021-02-09 |
Fluoxetine Can Inhibit SARS-CoV-2 In Vitro (edit) |
10.3390/MICROORGANISMS9020339 |
| 2021-02-09 |
Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients (edit) |
10.1016/J.CELREP.2021.108728 |
| 2021-02-09 |
CoronaHiT: high-throughput sequencing of SARS-CoV-2 genomes (edit) |
10.1186/S13073-021-00839-5 |
| 2021-02-09 |
COVID-19 (SARS-CoV-2) outbreak monitoring using wastewater-based epidemiology in Qatar (edit) |
10.1016/J.SCITOTENV.2021.145608 |
| 2021-02-09 |
“COVID-19/SARS-CoV-2 virus spike protein-related delayed inflammatory reaction to hyaluronic acid dermal fillers: a challenging clinical conundrum in diagnosis and treatment” (edit) |
10.1007/S00403-021-02190-6 |
| 2021-02-08 |
Decreased SARS-CoV-2 viral load following vaccination (edit) |
10.1101/2021.02.06.21251283 |
| 2021-02-08 |
Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera (edit) |
10.1038/S41591-021-01270-4 |
| 2021-02-08 |
SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity (edit) |
10.1038/S41467-021-21118-2 |
| 2021-02-08 |
SARS-CoV-2 S protein:ACE2 interaction reveals novel allosteric targets (edit) |
10.7554/ELIFE.63646 |
| 2021-02-08 |
Distinct mechanisms for TMPRSS2 expression explain organ-specific inhibition of SARS-CoV-2 infection by enzalutamide (edit) |
10.1038/S41467-021-21171-X |
| 2021-02-08 |
In Silico Investigation of the New UK (B.1.1.7) and South African (501Y.V2) SARS-CoV-2 Variants with a Focus at the ACE2-Spike RBD Interface (edit) |
10.3390/IJMS22041695 |
| 2021-02-08 |
Proteo-Genomic Analysis of SARS-CoV-2: A Clinical Landscape of Single-Nucleotide Polymorphisms, COVID-19 Proteome, and Host Responses (edit) |
10.1021/ACS.JPROTEOME.0C00808 |
| 2021-02-08 |
Comparison of real-time and droplet digital PCR to detect and quantify SARS-CoV-2 RNA in plasma (edit) |
10.1111/ECI.13501 |
| 2021-02-08 |
Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers (edit) |
10.1038/S41467-021-21111-9 |
| 2021-02-07 |
Targeting CTP Synthetase 1 to Restore Interferon Induction and Impede Nucleotide Synthesis in SARS-CoV-2 Infection (edit) |
10.1101/2021.02.05.429959 |
| 2021-02-07 |
Neutralization of viruses with European, South African, and United States SARS-CoV-2 variant spike proteins by convalescent sera and BNT162b2 mRNA vaccine-elicited antibodies (edit) |
10.1101/2021.02.05.430003 |
| 2021-02-05 |
Essential functional molecules associated with SARS-CoV-2 infection: Potential therapeutic targets for COVID-19 (edit) |
10.1016/J.GENE.2020.145313 |
| 2021-02-05 |
SARS-CoV-2 evolution during treatment of chronic infection (edit) |
10.1038/S41586-021-03291-Y |
| 2021-02-05 |
Infection and mRNA-1273 vaccine antibodies neutralize SARS-CoV-2 UK variant (edit) |
10.1101/2021.02.02.21250799 |
| 2021-02-05 |
SARS-CoV-2 ORF7b: is a bat virus protein homologue a major cause of COVID-19 symptoms? (edit) |
10.1101/2021.02.05.428650 |
| 2021-02-05 |
Protein glycosylation is essential for SARS-CoV-2 infection (edit) |
10.1101/2021.02.05.429940 |
| 2021-02-05 |
The impact of non-pharmaceutical interventions on SARS-CoV-2 transmission across 130 countries and territories (edit) |
10.1186/S12916-020-01872-8 |
| 2021-02-05 |
Low Volume in Vitro Diagnostic Proton NMR Spectroscopy of Human Blood Plasma for Lipoprotein and Metabolite Analysis: Application to SARS-CoV-2 Biomarkers (edit) |
10.1021/ACS.JPROTEOME.0C00815 |
| 2021-02-05 |
NMR Spectroscopic Windows on the Systemic Effects of SARS-CoV-2 Infection on Plasma Lipoproteins and Metabolites in Relation to Circulating Cytokines (edit) |
10.1021/ACS.JPROTEOME.0C00876 |
| 2021-02-05 |
Susceptibility of neuroblastoma and glioblastoma cell lines to SARS-CoV-2 infection (edit) |
10.1016/J.BRAINRES.2021.147344 |
| 2021-02-05 |
COVseq is a cost-effective workflow for mass-scale SARS-CoV-2 genomic surveillance (edit) |
10.21203/RS.3.PEX-1338/V1 |
| 2021-02-05 |
PACIFIC: a lightweight deep-learning classifier of SARS-CoV-2 and co-infecting RNA viruses (edit) |
10.1038/S41598-021-82043-4 |
| 2021-02-04 |
Multi-organ proteomic landscape of COVID-19 autopsies (edit) |
10.1016/J.CELL.2021.01.004 |
| 2021-02-04 |
Chemokine Regulation During Epidemic Coronavirus Infection (edit) |
10.3389/FPHAR.2020.600369 |
| 2021-02-04 |
Targeted in situ cross-linking mass spectrometry and integrative modeling reveal the architectures of Nsp1, Nsp2, and Nucleocapsid proteins from SARS-CoV-2 (edit) |
10.1101/2021.02.04.429751 |
| 2021-02-04 |
Tracing the origins of SARS-COV-2 in coronavirus phylogenies: a review (edit) |
10.1007/S10311-020-01151-1 |
| 2021-02-04 |
Sensitive visualization of SARS-CoV-2 RNA with CoronaFISH (edit) |
10.1101/2021.02.04.429604 |
| 2021-02-04 |
Dynamics of binding ability prediction between spike protein and human ACE2 reveals the adaptive strategy of SARS-CoV-2 in humans (edit) |
10.1038/S41598-021-82938-2 |
| 2021-02-04 |
Structural basis for the inhibition of the SARS-CoV-2 main protease by the anti-HCV drug narlaprevir (edit) |
10.1038/S41392-021-00468-9 |
| 2021-02-04 |
On the usefulness of the bioclimatic correlative models of SARS-CoV-2 (edit) |
10.1016/J.ENVRES.2021.110818 |
| 2021-02-04 |
Evolution of SARS-CoV-2 Envelope, Membrane, Nucleocapsid, and Spike Structural Proteins from the Beginning of the Pandemic to September 2020: A Global and Regional Approach by Epidemiological Week (edit) |
10.3390/V13020243 |
| 2021-02-04 |
An Androsterone-H2 @C60 hybrid: Synthesis, Properties and Molecular Docking Simulations with SARS-Cov-2 (edit) |
10.1002/CPLU.202000770 |
| 2021-02-04 |
Epigallocatechin-3-gallate, an active ingredient of Traditional Chinese Medicines, inhibits the 3CLpro activity of SARS-CoV-2 (edit) |
10.1016/J.IJBIOMAC.2021.02.012 |
| 2021-02-04 |
Mutational analysis and assessment of its impact on proteins of SARS-CoV-2 genomes from India (edit) |
10.1016/J.GENE.2021.145470 |
| 2021-02-04 |
Estimated seroprevalence of SARS-CoV-2 antibodies among adults in Orange County, California (edit) |
10.1038/S41598-021-82662-X |
| 2021-02-03 |
Treatment of influenza and SARS-CoV-2 infections via mRNA-encoded Cas13a in rodents (edit) |
10.1038/S41587-021-00822-W |
| 2021-02-03 |
Increased hazard of death in community-tested cases of SARS-CoV-2 Variant of Concern 202012/01 (edit) |
10.1101/2021.02.01.21250959 |
| 2021-02-03 |
Bacterial expression and purification of functional recombinant SARS-CoV-2 spike receptor binding domain (edit) |
10.1101/2021.02.03.429601 |
| 2021-02-03 |
Urban Rail Transportation and SARS-Cov-2 Infections: An Ecological Study in the Lisbon Metropolitan Area (edit) |
10.3389/FPUBH.2021.611565 |
| 2021-02-03 |
ViralLink: An integrated workflow to investigate the effect of SARS-CoV-2 on intracellular signalling and regulatory pathways (edit) |
10.1371/JOURNAL.PCBI.1008685 |
| 2021-02-03 |
Systematic Network and Meta-analysis on the Antiviral Mechanisms of Probiotics: A Preventive and Treatment Strategy to Mitigate SARS-CoV-2 Infection (edit) |
10.1007/S12602-021-09748-W |
| 2021-02-03 |
Evaluating the effects of cardiometabolic exposures on circulating proteins which may contribute to severe SARS-CoV-2 (edit) |
10.1016/J.EBIOM.2021.103228 |
| 2021-02-03 |
Toolkit for Quickly Generating and Characterizing Molecular Probes Specific for SARS-CoV-2 Nucleocapsid as a Primer for Future Coronavirus Pandemic Preparedness (edit) |
10.1021/ACSSYNBIO.0C00566 |
| 2021-02-03 |
Open-source RNA extraction and RT-qPCR methods for SARS-CoV-2 detection (edit) |
10.1371/JOURNAL.PONE.0246647 |
| 2021-02-02 |
Mechanisms of Coronavirus Nsp1-Mediated Control of Host and Viral Gene Expression (edit) |
10.3390/CELLS10020300 |
| 2021-02-02 |
Structure of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitors (edit) |
10.1038/S41467-021-21060-3 |
| 2021-02-02 |
Identification of existing pharmaceuticals and herbal medicines as inhibitors of SARS-CoV-2 infection (edit) |
10.1073/PNAS.2021579118 |
| 2021-02-02 |
Ivermectin in mild and moderate COVID-19 (RIVET-COV): a randomized, placebo-controlled trial (edit) |
10.21203/RS.3.RS-191648/V1 |
| 2021-02-02 |
Sixteen novel lineages of SARS-CoV-2 in South Africa (edit) |
10.1038/S41591-021-01255-3 |
| 2021-02-02 |
De novo design and bioactivity prediction of SARS-CoV-2 main protease inhibitors using recurrent neural network-based transfer learning (edit) |
10.1186/S13065-021-00737-2 |
| 2021-02-02 |
Outcome of SARS-CoV-2 infection is linked to MAIT cell activation and cytotoxicity (edit) |
10.1038/S41590-021-00870-Z |
| 2021-02-02 |
Enhancement versus neutralization by SARS-CoV-2 antibodies from a convalescent donor associates with distinct epitopes on the RBD (edit) |
10.1016/J.CELREP.2021.108699 |
| 2021-02-02 |
Maturation and persistence of the anti-SARS-CoV-2 memory B cell response (edit) |
10.1016/J.CELL.2021.01.050 |
| 2021-02-02 |
Clinical and whole genome characterization of SARS-CoV-2 in India (edit) |
10.1371/JOURNAL.PONE.0246173 |
| 2021-02-02 |
High-resolution mining of the SARS-CoV-2 main protease conformational space: supercomputer-driven unsupervised adaptive sampling (edit) |
10.1039/D1SC00145K |
| 2021-02-01 |
Hunting coronavirus by transmission electron microscopy - a guide to SARS-CoV-2-associated ultrastructural pathology in COVID-19 tissues (edit) |
10.1111/HIS.14264 |
| 2021-02-01 |
SARS-CoV-2 coronavirus in water and wastewater: A critical review about presence and concern (edit) |
10.1016/J.ENVRES.2020.110265 |
| 2021-02-01 |
SARS-CoV-2 infection, COVID-19 pathogenesis, and exposure to air pollution: What is the connection? (edit) |
10.1111/NYAS.14512 |
| 2021-02-01 |
Inflammation Triggered by SARS-CoV-2 and ACE2 Augment Drives Multiple Organ Failure of Severe COVID-19: Molecular Mechanisms and Implications (edit) |
10.1007/S10753-020-01337-3 |
| 2021-02-01 |
SARS-CoV-2 infection and its association with thrombosis and ischemic stroke: a review (edit) |
10.1016/J.AJEM.2020.09.072 |
| 2021-02-01 |
SARS-CoV-2 mediated lung inflammatory responses in host: targeting the cytokine storm for therapeutic interventions (edit) |
10.1007/S11010-020-03935-Z |
| 2021-02-01 |
Antiviral Activity of Reagents in Mouth Rinses against SARS-CoV-2 (edit) |
10.1177/0022034520967933 |
| 2021-02-01 |
Host sphingolipids: Perspective immune adjuvant for controlling SARS-CoV-2 infection for managing COVID-19 disease (edit) |
10.1016/J.PROSTAGLANDINS.2020.106504 |
| 2021-02-01 |
Potential mechanisms of SARS-CoV-2 action on male gonadal function and fertility: Current status and future prospects (edit) |
10.1111/AND.13883 |
| 2021-02-01 |
Role of Systemic and Nasal Glucocorticoid Treatment in the Regulation of the Inflammatory Response in Patients with SARS-Cov-2 Infection (edit) |
10.1016/J.ARCMED.2020.10.014 |
| 2021-02-01 |
CB2 receptor-selective agonists as candidates for targeting infection, inflammation, and immunity in SARS-CoV-2 infections (edit) |
10.1002/DDR.21752 |
| 2021-02-01 |
Panic and pandemic: Narrative review of the literature on the links and risks of panic disorder as a consequence of the SARS-CoV-2 pandemic (edit) |
10.1016/J.ENCEP.2020.08.001 |
| 2021-02-01 |
Contamination of inert surfaces by SARS-CoV-2: persistence, stability and infectivity. A review (edit) |
10.1016/J.ENVRES.2020.110559 |
| 2021-02-01 |
Ravaging SARS-CoV-2: rudimentary diagnosis and puzzling immunological responses (edit) |
10.1080/03007995.2020.1862532 |
| 2021-02-01 |
Targeting host cell proteases as a potential treatment strategy to limit the spread of SARS-CoV-2 in the respiratory tract (edit) |
10.1002/PRP2.698 |
| 2021-02-01 |
Potential of pulsed light technology for control of SARS-CoV-2 in hospital environments (edit) |
10.1016/J.JPHOTOBIOL.2020.112106 |
| 2021-02-01 |
[Recommendations from the German Ophthalmological Society and the Professional Association of Ophthalmologists in Germany on perimetry during the SARS-CoV-2 pandemic : Status: 30 November 2020] (edit) |
10.1007/S00347-020-01299-9 |
| 2021-02-01 |
The role of serum specific- SARS-CoV-2 antibody in COVID-19 patients (edit) |
10.1016/J.INTIMP.2020.107325 |
| 2021-02-01 |
Neurological infection with SARS-CoV-2 - the story so far (edit) |
10.1038/S41582-020-00453-W |
| 2021-02-01 |
New variant of SARS-CoV-2 in UK causes surge of COVID-19 (edit) |
10.1016/S2213-2600(21)00005-9 |
| 2021-02-01 |
PCR assay to enhance global surveillance for SARS-CoV-2 variants of concern (edit) |
10.1101/2021.01.28.21250486 |
| 2021-02-01 |
SARS-CoV-2 variants and ending the COVID-19 pandemic (edit) |
10.1016/S0140-6736(21)00370-6 |
| 2021-02-01 |
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine induced sera (edit) |
10.1016/J.CELL.2021.02.037 |
| 2021-02-01 |
Nsp1 protein of SARS-CoV-2 disrupts the mRNA export machinery to inhibit host gene expression (edit) |
10.1126/SCIADV.ABE7386 |
| 2021-02-01 |
Force-Dependent Stimulation of RNA Unwinding by SARS-CoV-2 NSP13 Helicase (edit) |
10.1016/J.BPJ.2020.11.772 |
| 2021-02-01 |
Mn2+ coordinates Cap-0-RNA to align substrates for efficient 2′-O-methyl transfer by SARS-CoV-2 nsp16 (edit) |
10.1101/2021.01.31.429023 |
| 2021-02-01 |
SARS-CoV-2 ORF9b inhibits RIG-I-MAVS antiviral signaling by interrupting K63-linked ubiquitination of NEMO (edit) |
10.1016/J.CELREP.2021.108761 |
| 2021-02-01 |
Comprehensive in vivo secondary structure of the SARS-CoV-2 genome reveals novel regulatory motifs and mechanisms (edit) |
10.1016/J.MOLCEL.2020.12.041 |
| 2021-02-01 |
The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial (edit) |
10.1016/J.ECLINM.2020.100720 |
| 2021-02-01 |
SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas (edit) |
10.1038/S42255-021-00347-1 |
| 2021-02-01 |
Syncytia formation by SARS-CoV-2-infected cells (edit) |
10.15252/EMBJ.2020107405 |
| 2021-02-01 |
SARS-CoV-2 tropism, entry, replication, and propagation: Considerations for drug discovery and development (edit) |
10.1371/JOURNAL.PPAT.1009225 |
| 2021-02-01 |
Effect of High-Dose Zinc and Ascorbic Acid Supplementation vs Usual Care on Symptom Length and Reduction Among Ambulatory Patients With SARS-CoV-2 Infection: The COVID A to Z Randomized Clinical Trial (edit) |
10.1001/JAMANETWORKOPEN.2021.0369 |
| 2021-02-01 |
SARS-CoV-2 spike protein S1 subunit induces pro-inflammatory responses via toll-like receptor 4 signaling in murine and human macrophages (edit) |
10.1016/J.HELIYON.2021.E06187 |
| 2021-02-01 |
Structural Basis of SARS-CoV-2 Polymerase Inhibition by Favipiravir (edit) |
10.1016/J.XINN.2021.100080 |
| 2021-02-01 |
Bats, pangolins, minks and other animals - villains or victims of SARS-CoV-2? (edit) |
10.1007/S11259-021-09787-2 |
| 2021-02-01 |
Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia (edit) |
10.1038/S41586-020-03148-W |
| 2021-02-01 |
Multimerization- and glycosylation-dependent receptor binding of SARS-CoV-2 spike proteins (edit) |
10.1371/JOURNAL.PPAT.1009282 |
| 2021-02-01 |
Cold sensitivity of the SARS-CoV-2 spike ectodomain (edit) |
10.1038/S41594-020-00547-5 |
| 2021-02-01 |
An engineered decoy receptor for SARS-CoV-2 broadly binds protein S sequence variants (edit) |
10.1126/SCIADV.ABF1738 |
| 2021-02-01 |
Remdesivir Metabolite GS-441524 Effectively Inhibits SARS-CoV-2 Infection in Mouse Models (edit) |
10.1021/ACS.JMEDCHEM.0C01929 |
| 2021-02-01 |
Transmission of SARS-CoV-2 in domestic cats imposes a narrow bottleneck (edit) |
10.1371/JOURNAL.PPAT.1009373 |
| 2021-02-01 |
The potential of rapalogs to enhance resilience against SARS-CoV-2 infection and reduce the severity of COVID-19 (edit) |
10.1016/S2666-7568(20)30068-4 |
| 2021-02-01 |
The temporal association of introducing and lifting non-pharmaceutical interventions with the time-varying reproduction number (R) of SARS-CoV-2: a modelling study across 131 countries (edit) |
10.1016/S1473-3099(20)30785-4 |
| 2021-02-01 |
A plasmid DNA-launched SARS-CoV-2 reverse genetics system and coronavirus toolkit for COVID-19 research (edit) |
10.1371/JOURNAL.PBIO.3001091 |
| 2021-02-01 |
Publisher Correction: Genomic epidemiology reveals multiple introductions of SARS-CoV-2 from mainland Europe into Scotland (edit) |
10.1038/S41564-021-00865-4 |
| 2021-02-01 |
SARS-CoV-2-Specific T Cell Responses in Patients with COVID-19 and Unexposed Individuals (edit) |
10.4110/IN.2021.21.E2 |
| 2021-02-01 |
Chromosome 3 cluster rs11385942 variant links complement activation with severe COVID-19 (edit) |
10.1016/J.JAUT.2021.102595 |
| 2021-02-01 |
Increased placental expression of angiotensin-converting enzyme 2, the receptor of SARS-CoV-2, associated with hypoxia in twin anemia-polycythemia sequence (TAPS) (edit) |
10.1016/J.PLACENTA.2021.01.008 |
| 2021-02-01 |
Phlegmonous Ileocolitis as a Presentation of Post SARS-CoV-2 (COVID-19) Multisystem Inflammatory Syndrome in Children (edit) |
10.1097/PG9.0000000000000040 |
| 2021-02-01 |
Flavonol morin targets host ACE2, IMP-α, PARP-1 and viral proteins of SARS-CoV-2, SARS-CoV and MERS-CoV critical for infection and survival: a computational analysis (edit) |
10.1080/07391102.2021.1871863 |
| 2021-02-01 |
Immunoinformatics based prediction of recombinant multi-epitope vaccine for the control and prevention of SARS-CoV-2 (edit) |
|
| 2021-02-01 |
SARS-CoV-2 infection remodels the host protein thermal stability landscape (edit) |
10.15252/MSB.202010188 |
| 2021-02-01 |
SARS-CoV-2 innate effector associations and viral load in early nasopharyngeal infection (edit) |
10.14814/PHY2.14761 |
| 2021-02-01 |
Disposable face masks and reusable face coverings as non-pharmaceutical interventions (NPIs) to prevent transmission of SARS-CoV-2 variants that cause coronavirus disease (COVID-19): Role of new sustainable NPI design innovations and predictive math (edit) |
10.1016/J.SCITOTENV.2021.145530 |
| 2021-02-01 |
BNT162b vaccines protect rhesus macaques from SARS-CoV-2 (edit) |
10.1038/S41586-021-03275-Y |
| 2021-02-01 |
Human Oocytes Express Both ACE2 and BSG Genes and Corresponding Proteins: Is SARS-CoV-2 Infection Possible? (edit) |
10.1007/S12015-020-10101-X |
| 2021-02-01 |
Documento español de consenso sobre diagnóstico, estabilización y tratamiento del síndrome inflamatorio multisistémico pediátrico vinculado a SARS-CoV-2 (SIM-PedS) (edit) |
10.1016/J.ANPEDI.2020.09.005 |
| 2021-02-01 |
763 Hemostasis changes among COVID-19 gravidas during SARS-CoV-2 pandemic on rotational thromboelastography (edit) |
10.1016/J.AJOG.2020.12.786 |
| 2021-02-01 |
An effective approach for recombinant production of select SARS-CoV-2 proteins in Escherichia coli (edit) |
10.1016/J.JACI.2020.12.264 |
| 2021-02-01 |
HIV/SARS-CoV-2 coinfection: a global perspective (edit) |
10.1002/JMV.26321 |
| 2021-02-01 |
Placental SARS-CoV-2 in a Pregnant Woman with Mild COVID-19 Disease (edit) |
10.1002/JMV.26386 |
| 2021-02-01 |
Containing SARS-CoV-2 in hospitals facing finite PPE, limited testing, and physical space variability: Navigating resource constrained enhanced traffic control bundling (edit) |
10.1016/J.JMII.2020.07.009 |
| 2021-02-01 |
Cardiac manifestations in SARS-CoV-2-associated multisystem inflammatory syndrome in children: a comprehensive review and proposed clinical approach (edit) |
10.1007/S00431-020-03766-6 |
| 2021-02-01 |
Bee products as a source of promising therapeutic and chemoprophylaxis strategies against COVID-19 (SARS-CoV-2) (edit) |
10.1002/PTR.6872 |
| 2021-02-01 |
Neurological Complications Associated with the Blood-Brain Barrier Damage Induced by the Inflammatory Response During SARS-CoV-2 Infection (edit) |
10.1007/S12035-020-02134-7 |
| 2021-01-31 |
REACT-1 round 8 final report: high average prevalence with regional heterogeneity of trends in SARS-CoV-2 infection in the community in England during January 2021 (edit) |
10.1101/2021.01.28.21250606 |
| 2021-01-31 |
Evidence for SARS-CoV-2 Spike Protein in the Urine of COVID-19 patients (edit) |
10.1101/2021.01.27.21250637 |
| 2021-01-29 |
Recognition of the SARS-CoV-2 receptor binding domain by neutralizing antibodies (edit) |
10.1016/J.BBRC.2020.10.012 |
| 2021-01-29 |
Humoral immune responses and neutralizing antibodies against SARS-CoV-2; implications in pathogenesis and protective immunity (edit) |
10.1016/J.BBRC.2020.10.108 |
| 2021-01-29 |
T cell immunity to SARS-CoV-2 following natural infection and vaccination (edit) |
10.1016/J.BBRC.2020.10.060 |
| 2021-01-29 |
The D614G mutations in the SARS-CoV-2 spike protein: Implications for viral infectivity, disease severity and vaccine design (edit) |
10.1016/J.BBRC.2020.10.109 |
| 2021-01-29 |
Functional importance of the D614G mutation in the SARS-CoV-2 spike protein (edit) |
10.1016/J.BBRC.2020.11.026 |
| 2021-01-29 |
Host-directed editing of the SARS-CoV-2 genome (edit) |
10.1016/J.BBRC.2020.10.092 |
| 2021-01-29 |
The main protease and RNA-dependent RNA polymerase are two prime targets for SARS-CoV-2 (edit) |
10.1016/J.BBRC.2020.10.091 |
| 2021-01-29 |
The biogenesis of SARS-CoV-2 spike glycoprotein: multiple targets for host-directed antiviral therapy (edit) |
10.1016/J.BBRC.2020.10.080 |
| 2021-01-29 |
The broad spectrum host-directed agent ivermectin as an antiviral for SARS-CoV-2 ? (edit) |
10.1016/J.BBRC.2020.10.042 |
| 2021-01-29 |
A nidovirus perspective on SARS-CoV-2 (edit) |
10.1016/J.BBRC.2020.11.015 |
| 2021-01-29 |
New-Onset IgG Autoantibodies in Hospitalized Patients with COVID-19 (edit) |
10.1101/2021.01.27.21250559 |
| 2021-01-29 |
SARS-CoV-2 triggers an MDA-5-dependent interferon response which is unable to control replication in lung epithelial cells (edit) |
10.1128/JVI.02415-20 |
| 2021-01-29 |
ACE2 Nascence, trafficking, and SARS-CoV-2 pathogenesis: the saga continues (edit) |
10.1186/S40246-021-00304-9 |
| 2021-01-29 |
Apoptosis induced by SARS-CoV-2: can we target it? (edit) |
10.1007/S10495-021-01656-2 |
| 2021-01-29 |
Engaging the spikes: heparan sulfate facilitates SARS-CoV-2 spike protein binding to ACE2 and potentiates viral infection (edit) |
10.1038/S41392-021-00470-1 |
| 2021-01-29 |
Infection Mechanism of SARS-COV-2 and Its Implication on the Nervous System (edit) |
10.3389/FIMMU.2020.621735 |
| 2021-01-29 |
Severe SARS-CoV-2 Infection: A Multisystem Inflammatory Syndrome in Moroccan Children (edit) |
10.7759/CUREUS.12991 |
| 2021-01-29 |
SARS-CoV-2 specific antibody and neutralization assays reveal the wide range of the humoral immune response to virus (edit) |
10.1038/S42003-021-01649-6 |
| 2021-01-29 |
Strong Binding of Leupeptin with TMPRSS2 Protease May Be an Alternative to Camostat and Nafamostat for SARS-CoV-2 Repurposed Drug: Evaluation from Molecular Docking and Molecular Dynamics Simulations (edit) |
10.1007/S12010-020-03475-8 |
| 2021-01-29 |
High SARS-CoV-2 load in the nasopharynx of patients with a mild form of COVID-19 is associated with clinical deterioration regardless of the hydroxychloroquine administration (edit) |
10.1371/JOURNAL.PONE.0246396 |
| 2021-01-29 |
Applying high throughput and comprehensive immunoinformatics approaches to design a trivalent subunit vaccine for induction of immune response against emerging human coronaviruses SARS-CoV, MERS-CoV and SARS-CoV-2 (edit) |
10.1080/07391102.2021.1876774 |
| 2021-01-29 |
Engineering SARS-CoV-2 using a reverse genetic system (edit) |
10.1038/S41596-021-00491-8 |
| 2021-01-28 |
Bioaerosol sampling for SARS-CoV-2 in a referral center with critically ill COVID-19 patients March-May 2020 (edit) |
10.1093/CID/CIAA1880 |
| 2021-01-28 |
The SARS-Coronavirus Infection Cycle: A Survey of Viral Membrane Proteins, Their Functional Interactions and Pathogenesis (edit) |
10.3390/IJMS22031308 |
| 2021-01-28 |
A small molecule compound with an indole moiety inhibits the main protease of SARS-CoV-2 and blocks virus replication (edit) |
10.1038/S41467-021-20900-6 |
| 2021-01-28 |
SARS-CoV-2 spike protein positivity in pityriasis rosea-like and urticaria-like rashes of COVID-19 (edit) |
10.1111/BJD.19833 |
| 2021-01-28 |
Effect of SARS-CoV-2 spike mutations on animal ACE2 usage and in vitro neutralization sensitivity (edit) |
10.1101/2021.01.27.428353 |
| 2021-01-28 |
D614G Substitution of SARS-CoV-2 Spike Protein Increases Syncytium Formation and Viral Transmission via Enhanced Furin-mediated Spike Cleavage (edit) |
10.1101/2021.01.27.428541 |
| 2021-01-28 |
Distinct Features and Functions of Systemic and Mucosal Humoral Immunity Among SARS-CoV-2 Convalescent Individuals (edit) |
10.3389/FIMMU.2020.618685 |
| 2021-01-28 |
Genomic epidemiology of the early stages of the SARS-CoV-2 outbreak in Russia (edit) |
10.1038/S41467-020-20880-Z |
| 2021-01-28 |
ACE2 and FURIN variants are potential predictors of SARS-CoV-2 outcome: A time to implement precision medicine against COVID-19 (edit) |
10.1016/J.HELIYON.2021.E06133 |
| 2021-01-27 |
Single-cell RNA sequencing reveals SARS-CoV-2 infection dynamics in lungs of African green monkeys (edit) |
10.1126/SCITRANSLMED.ABE8146 |
| 2021-01-27 |
Outcomes of Ivermectin in the treatment of COVID-19: a systematic review and meta-analysis (edit) |
10.1101/2021.01.26.21250420 |
| 2021-01-27 |
Cryo-EM structures of the SARS-CoV-2 endoribonuclease Nsp15 reveal insight into nuclease specificity and dynamics (edit) |
10.1038/S41467-020-20608-Z |
| 2021-01-27 |
Natural killer cells associated with SARS-CoV-2 viral RNA shedding, antibody response and mortality in COVID-19 patients (edit) |
10.1186/S40164-021-00199-1 |
| 2021-01-27 |
Identification of natural compounds as potent inhibitors of SARS-CoV-2 main protease using combined docking and molecular dynamics simulations (edit) |
10.1016/J.SJBS.2021.01.040 |
| 2021-01-26 |
Data and Policy to Guide Opening Schools Safely to Limit the Spread of SARS-CoV-2 Infection (edit) |
10.1001/JAMA.2021.0374 |
| 2021-01-26 |
Escape of SARS-CoV-2 501Y.V2 variants from neutralization by convalescent plasma (edit) |
10.1101/2021.01.26.21250224 |
| 2021-01-26 |
Complete aortic thrombosis in SARS-CoV-2 infection (edit) |
10.1093/EURHEARTJ/EHAB011 |
| 2021-01-26 |
Quantitative Assessment of SARS-CoV-2 Virus in Nasopharyngeal Swabs Stored in Transport Medium by a Straightforward LC-MS/MS Assay Targeting Nucleocapsid, Membrane, and Spike Proteins (edit) |
10.1021/ACS.JPROTEOME.0C00887 |
| 2021-01-26 |
The immunodominant and neutralization linear epitopes for SARS-CoV-2 (edit) |
10.1016/J.CELREP.2020.108666 |
| 2021-01-26 |
One Year of SARS-CoV-2: How Much Has the Virus Changed? (edit) |
10.3390/BIOLOGY10020091 |
| 2021-01-26 |
Role of endothelial cell receptors in the context of SARS-CoV-2 infection (COVID-19) (edit) |
10.1080/08998280.2021.1874231 |
| 2021-01-26 |
Generalized linear models provide a measure of virulence for specific mutations in SARS-CoV-2 strains (edit) |
10.1371/JOURNAL.PONE.0238665 |
| 2021-01-26 |
Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection (edit) |
10.1016/J.CELL.2021.01.035 |
| 2021-01-26 |
Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2 (edit) |
10.1016/J.CELREP.2021.108737 |
| 2021-01-26 |
A new SYBR Green real-time PCR to detect SARS-CoV-2 (edit) |
10.1038/S41598-021-81245-0 |
| 2021-01-26 |
Different SARS-CoV-2 haplotypes associate with geographic origin and case fatality rates of COVID-19 patients (edit) |
10.1016/J.MEEGID.2021.104730 |
| 2021-01-26 |
Genome-wide in silico identification and characterization of Simple Sequence Repeats in diverse completed SARS-CoV-2 genomes (edit) |
10.1016/J.GENREP.2021.101020 |
| 2021-01-26 |
Current Updates on Naturally Occurring Compounds Recognizing SARS-CoV-2 Druggable Targets (edit) |
10.3390/MOLECULES26030632 |
| 2021-01-25 |
Detection of SARS-CoV-2 infection by rapid antigen test in comparison with RT-PCR in a public setting (edit) |
10.1101/2021.01.22.21250042 |
| 2021-01-25 |
mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-CoV-2 variants (edit) |
10.1101/2021.01.25.427948 |
| 2021-01-25 |
Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis (edit) |
10.1038/S41586-021-03237-4 |
| 2021-01-25 |
Elucidating the Interactions Between Heparin/Heparan Sulfate and SARS-CoV-2-Related Proteins—An Important Strategy for Developing Novel Therapeutics for the COVID-19 Pandemic (edit) |
10.3389/FMOLB.2020.628551 |
| 2021-01-25 |
Similarities and Dissimilarities of COVID-19 and Other Coronavirus Diseases (edit) |
10.1146/ANNUREV-MICRO-110520-023212 |
| 2021-01-25 |
2019 Novel Human Coronavirus Sars-Cov-2 And Covid-19: A Brief Review (edit) |
10.22376/IJPBS/LPR.2021.11.1.L273-283 |
| 2021-01-25 |
Crystal Structure of SARS-CoV-2 Main Protease in Complex with the Non-Covalent Inhibitor ML188 (edit) |
10.3390/V13020174 |
| 2021-01-25 |
Ultrasonography of the larynx: Novel use during the SARS‑CoV‑2 pandemic (Review) (edit) |
10.3892/ETM.2021.9704 |
| 2021-01-25 |
Correlation between SARS-COV-2 antibody screening by immunoassay and neutralizing antibody testing (edit) |
10.1111/TRF.16268 |
| 2021-01-24 |
Screening of potent drug inhibitors against SARS-CoV-2 RNA polymerase: an in silico approach (edit) |
10.1007/S13205-020-02610-W |
| 2021-01-23 |
SARS-CoV-2 and other human coronaviruses: Mapping of protease recognition sites, antigenic variation of spike protein and their grouping through molecular phylogenetics (edit) |
10.1016/J.MEEGID.2021.104729 |
| 2021-01-23 |
Reverse vaccinology approach towards the in-silico multiepitope vaccine development against SARS-CoV-2 (edit) |
10.12688/F1000RESEARCH.36371.1 |
| 2021-01-22 |
Structural insights into SARS-CoV-2 proteins (edit) |
10.1016/J.JMB.2020.11.024 |
| 2021-01-22 |
Natural Products with Potential to Treat RNA Virus Pathogens Including SARS-CoV-2 (edit) |
10.1021/ACS.JNATPROD.0C00968 |
| 2021-01-22 |
A protocol for adding knowledge to Wikidata: aligning resources on human coronaviruses (edit) |
10.1186/S12915-020-00940-Y |
| 2021-01-22 |
Emergence of SARS-CoV-2 B.1.1.7 Lineage - United States, December 29, 2020-January 12, 2021 (edit) |
10.15585/MMWR.MM7003E2 |
| 2021-01-22 |
Transcriptomic similarities and differences in host response between SARS-CoV-2 and other viral infections (edit) |
10.1016/J.ISCI.2020.101947 |
| 2021-01-22 |
SARS-CoV-2 induces robust germinal center CD4 T follicular helper cell responses in rhesus macaques (edit) |
10.1038/S41467-020-20642-X |
| 2021-01-22 |
ABO Blood Types and COVID-19: Spurious, Anecdotal, or Truly Important Relationships? A Reasoned Review of Available Data (edit) |
10.3390/V13020160 |
| 2021-01-22 |
REACT-1 round 8 interim report: SARS-CoV-2 prevalence during the initial stages of the third national lockdown in England (edit) |
10.1101/2021.01.20.21250158 |
| 2021-01-22 |
High-throughput rational design of the remdesivir binding site in the RdRp of SARS-CoV-2: implications for potential resistance (edit) |
10.1016/J.ISCI.2020.101992 |
| 2021-01-22 |
Molecular docking analysis of rutin reveals possible inhibition of SARS-CoV-2 vital proteins (edit) |
10.1016/J.JTCME.2021.01.006 |
| 2021-01-22 |
Isolating SARS-CoV-2 Strains From Countries in the Same Meridian: Genome Evolutionary Analysis (edit) |
10.2196/25995 |
| 2021-01-22 |
Prediction of death status on the course of treatment in SARS-COV-2 patients with deep learning and machine learning methods (edit) |
10.1016/J.CMPB.2021.105951 |
| 2021-01-22 |
In silico evaluation of lapachol derivatives binding to the Nsp9 of SARS-CoV-2 (edit) |
10.1080/07391102.2021.1875050 |
| 2021-01-21 |
SARS-CoV-2 nucleocapsid protein undergoes liquid-liquid phase separation into stress granules through its N-terminal intrinsically disordered region (edit) |
10.1038/S41421-020-00240-3 |
| 2021-01-21 |
The SARS-CoV-2 nucleocapsid phosphoprotein forms mutually exclusive condensates with RNA and the membrane-associated M protein (edit) |
10.1038/S41467-020-20768-Y |
| 2021-01-21 |
Newcastle Disease Virus-Like Particles Displaying Prefusion-Stabilized SARS-CoV-2 Spikes Elicit Potent Neutralizing Responses (edit) |
10.3390/VACCINES9020073 |
| 2021-01-21 |
SARS-CoV-2 and Zoonotic Preparedness: Unknown Knowns? (edit) |
10.1097/IM9.0000000000000051 |
| 2021-01-21 |
Horizontal gene transfer and recombination analysis of SARS-CoV-2 genes helps discover its close relatives and shed light on its origin (edit) |
10.1186/S12862-020-01732-2 |
| 2021-01-21 |
Elucidation of interactions regulating conformational stability and dynamics of SARS-CoV-2 S-protein (edit) |
10.1016/J.BPJ.2021.01.012 |
| 2021-01-21 |
Network analysis of Down syndrome and SARS-CoV-2 identifies risk and protective factors for COVID-19 (edit) |
10.1038/S41598-021-81451-W |
| 2021-01-21 |
SARSCOVIDB-A New Platform for the Analysis of the Molecular Impact of SARS-CoV-2 Viral Infection (edit) |
10.1021/ACSOMEGA.0C05701 |
| 2021-01-21 |
Insight into molecular characteristics of SARS-CoV-2 spike protein following D614G point mutation, a molecular dynamics study (edit) |
10.1080/07391102.2021.1872418 |
| 2021-01-21 |
P251 The induction of early, dynamic airway mucosal and systemic immune responses following recent SARS-CoV-2 household exposure (edit) |
10.1136/THORAX-2020-BTSABSTRACTS.395 |
| 2021-01-20 |
The complex structure of GRL0617 and SARS-CoV-2 PLpro reveals a hot spot for antiviral drug discovery (edit) |
10.1038/S41467-020-20718-8 |
| 2021-01-20 |
Emergence of a novel SARS-CoV-2 strain in Southern California, USA (edit) |
10.1101/2021.01.18.21249786 |
| 2021-01-20 |
Molecular determinants and mechanism for antibody cocktail preventing SARS-CoV-2 escape (edit) |
10.1038/S41467-020-20789-7 |
| 2021-01-20 |
Can SARS-CoV-2 Virus Use Multiple Receptors to Enter Host Cells? (edit) |
10.3390/IJMS22030992 |
| 2021-01-20 |
Epidemic waves of COVID-19 in Scotland: a genomic perspective on the impact of the introduction and relaxation of lockdown on SARS-CoV-2 (edit) |
10.1101/2021.01.08.20248677 |
| 2021-01-20 |
Identification of 3-chymotrypsin like protease (3CLPro) inhibitors as potential anti-SARS-CoV-2 agents (edit) |
10.1038/S42003-020-01577-X |
| 2021-01-20 |
The N501Y mutation in SARS-CoV-2 spike leads to morbidity in obese and aged mice and is neutralized by convalescent and post-vaccination human sera (edit) |
10.1101/2021.01.19.21249592 |
| 2021-01-20 |
Biological and Clinical Consequences of Integrin Binding via a Rogue RGD Motif in the SARS CoV-2 Spike Protein (edit) |
10.3390/V13020146 |
| 2021-01-19 |
Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera (edit) |
10.1101/2021.01.18.426984 |
| 2021-01-19 |
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants (edit) |
10.1101/2021.01.15.426911 |
| 2021-01-19 |
Genome‐wide DNA methylation profiling of peripheral blood reveals an epigenetic signature associated with severe COVID‐19 (edit) |
10.1002/JLB.5HI0720-466R |
| 2021-01-19 |
Engineering a Reliable and Convenient SARS-CoV-2 Replicon System for Analysis of Viral RNA Synthesis and Screening of Antiviral Inhibitors (edit) |
10.1128/MBIO.02754-20 |
| 2021-01-19 |
Meta-analysis of randomized trials of ivermectin to treat SARS-CoV-2 infection (edit) |
10.21203/RS.3.RS-148845/V1 |
| 2021-01-19 |
Modeling the structure of the frameshift-stimulatory pseudoknot in SARS-CoV-2 reveals multiple possible conformers (edit) |
10.1371/JOURNAL.PCBI.1008603 |
| 2021-01-19 |
An all-solid-state heterojunction oxide transistor for the rapid detection of biomolecules and SARS-CoV-2 spike S1 protein (edit) |
10.1101/2021.01.19.427256 |
| 2021-01-19 |
Correlative Multi-scale Cryo-imaging Unveils SARS-CoV-2 Assembly and Egress (edit) |
10.21203/RS.3.RS-134794/V1 |
| 2021-01-19 |
Structural Analysis of Neutralizing Epitopes of the SARS-CoV-2 Spike to Guide Therapy and Vaccine Design Strategies (edit) |
10.3390/V13010134 |
| 2021-01-19 |
Atypical Divergence of SARS-CoV-2 Orf8 from Orf7a within the Coronavirus Lineage Suggests Potential Stealthy Viral Strategies in Immune Evasion (edit) |
10.1128/MBIO.03014-20 |
| 2021-01-19 |
Native-like SARS-CoV-2 spike glycoprotein expressed by ChAdOx1 nCoV-19/AZD1222 vaccine (edit) |
10.1101/2021.01.15.426463 |
| 2021-01-19 |
COVseq is a cost-effective workflow for mass-scale SARS-CoV-2 genomic surveillance (edit) |
10.21203/RS.3.RS-147464/V1 |
| 2021-01-19 |
Epitope-resolved profiling of the SARS-CoV-2 antibody response identifies cross-reactivity with endemic human coronaviruses (edit) |
10.1016/J.XCRM.2020.100189 |
| 2021-01-19 |
The Rhinolophus affinis bat ACE2 and multiple animal orthologs are functional receptors for bat coronavirus RaTG13 and SARS-CoV-2 (edit) |
10.1016/J.SCIB.2021.01.011 |
| 2021-01-19 |
Cell-Based High-Throughput Screening Protocol for Discovering Antiviral Inhibitors Against SARS-COV-2 Main Protease (3CLpro) (edit) |
10.1007/S12033-021-00299-7 |
| 2021-01-19 |
Clade GR and clade GH isolates of SARS-CoV-2 in Asia show highest amount of SNPs (edit) |
10.1016/J.MEEGID.2021.104724 |
| 2021-01-18 |
Fluorescent Glycan Fingerprinting of SARS2 Spike Proteins (edit) |
10.1101/2021.01.16.426965 |
| 2021-01-18 |
Not only ACE2-the quest for additional host cell mediators of SARS-CoV-2 infection: Neuropilin-1 (NRP1) as a novel SARS-CoV-2 host cell entry mediator implicated in COVID-19 (edit) |
10.1038/S41392-020-00460-9 |
| 2021-01-18 |
Evolution of antibody immunity to SARS-CoV-2 (edit) |
10.1038/S41586-021-03207-W |
| 2021-01-18 |
Household transmission of SARS-CoV-2 and risk factors for susceptibility and infectivity in Wuhan: a retrospective observational study (edit) |
10.1016/S1473-3099(20)30981-6 |
| 2021-01-18 |
An in silico analysis of Ibuprofen enantiomers in high concentrations of sodium chloride with SARS-CoV-2 main protease (edit) |
10.1080/07391102.2021.1872420 |
| 2021-01-18 |
Predicting mammalian species at risk of being infected by SARS-CoV-2 from an ACE2 perspective (edit) |
10.1038/S41598-020-80573-X |
| 2021-01-18 |
MERS-CoV: epidemiology, molecular dynamics, therapeutics, and future challenges (edit) |
10.1186/S12941-020-00414-7 |
| 2021-01-18 |
The impact of the COVID-19 pandemic on maternal and perinatal health: a scoping review (edit) |
10.1186/S12978-021-01070-6 |
| 2021-01-17 |
Lipid nanoparticle formulation of niclosamide (nano NCM) effectively inhibits SARS-CoV-2 replication in vitro (edit) |
10.33218/001C.18813 |
| 2021-01-16 |
MicroRNAs for Virus Pathogenicity and Host Responses, Identified in SARS-CoV-2 Genomes, May Play Roles in Viral-Host Co-Evolution in Putative Zoonotic Host Species (edit) |
10.3390/V13010117 |
| 2021-01-16 |
A meta-analysis of comorbidities in COVID-19: Which diseases increase the susceptibility of SARS-CoV-2 infection? (edit) |
10.1016/J.COMPBIOMED.2021.104219 |
| 2021-01-16 |
The “false-positive” conundrum: IgA reference level overestimates the seroprevalence of antibodies to SARS-CoV-2 (edit) |
10.7189/JOGH.11.05001 |
| 2021-01-15 |
Flavonols as potential antiviral drugs targeting SARS-CoV-2 proteases (3CLpro and PLpro), spike protein, RNA-dependent RNA polymerase (RdRp) and angiotensin-converting enzyme II receptor (ACE2) (edit) |
10.1016/J.EJPHAR.2020.173759 |
| 2021-01-15 |
SARS-CoV-2 Structural Analysis of Receptor Binding Domain New Variants from United Kingdom and South Africa (edit) |
10.3897/RIO.7.E62936 |
| 2021-01-15 |
The challenges of containing SARS-CoV-2 via test-trace-and-isolate (edit) |
10.1038/S41467-020-20699-8 |
| 2021-01-15 |
Increased infections, but not viral burden, with a new SARS-CoV-2 variant (edit) |
10.1101/2021.01.13.21249721 |
| 2021-01-15 |
Early analysis of a potential link between viral load and the N501Y mutation in the SARS-COV-2 spike protein (edit) |
10.1101/2021.01.12.20249080 |
| 2021-01-15 |
Nucleocapsid and Spike Proteins of the Coronavirus SARS-CoV-2 Induce IL6 in Monocytes and Macrophages-Potential Implications for Cytokine Storm Syndrome (edit) |
10.3390/VACCINES9010054 |
| 2021-01-15 |
SARS-CoV-2 infection susceptibility influenced by ACE2 genetic polymorphisms: insights from Tehran Cardio-Metabolic Genetic Study (edit) |
10.1038/S41598-020-80325-X |
| 2021-01-15 |
TSP-based PCR for rapid identification of L and S type strains of SARS-CoV-2 (edit) |
10.1016/J.IJMMB.2021.01.003 |
| 2021-01-15 |
Dynamic Network Modeling of Allosteric Interactions and Communication Pathways in the SARS-CoV-2 Spike Trimer Mutants: Differential Modulation of Conformational Landscapes and Signal Transmission via Cascades of Regulatory Switches (edit) |
10.1021/ACS.JPCB.0C10637 |
| 2021-01-14 |
SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice (edit) |
10.1038/S41467-020-20653-8 |
| 2021-01-14 |
Domains and Functions of Spike Protein in Sars-Cov-2 in the Context of Vaccine Design (edit) |
10.3390/V13010109 |
| 2021-01-14 |
Simulating SARS-CoV-2 epidemics by region-specific variables and modeling contact tracing app containment (edit) |
10.1038/S41746-020-00374-4 |
| 2021-01-13 |
Disease severity-specific neutrophil signatures in blood transcriptomes stratify COVID-19 patients (edit) |
10.1186/S13073-020-00823-5 |
| 2021-01-13 |
Enfuvirtide, an HIV-1 fusion inhibitor peptide, can act as a potent SARS-CoV-2 fusion inhibitor: an in silico drug repurposing study (edit) |
10.1080/07391102.2021.1871958 |
| 2021-01-13 |
Zooanthroponotic potential of SARS-CoV-2 and implications of reintroduction into human populations (edit) |
10.1016/J.CHOM.2021.01.004 |
| 2021-01-13 |
Classification and specific primer design for accurate detection of SARS-CoV-2 using deep learning (edit) |
10.1038/S41598-020-80363-5 |
| 2021-01-13 |
A Comparison of Five Epidemiological Models for Transmission of SARS-CoV-2 in India (edit) |
10.21203/RS.3.RS-141247/V1 |
| 2021-01-12 |
Mechanism of SARS-CoV-2 polymerase stalling by remdesivir (edit) |
10.1038/S41467-020-20542-0 |
| 2021-01-12 |
Structural Insight Into the SARS-CoV-2 Nucleocapsid Protein C-Terminal Domain Reveals a Novel Recognition Mechanism for Viral Transcriptional Regulatory Sequences (edit) |
10.3389/FCHEM.2020.624765 |
| 2021-01-12 |
Snake venom phospholipases A2 possess a strong virucidal activity against SARS-CoV-2 in vitro and block the cell fusion mediated by spike glycoprotein interaction with the ACE2 receptor (edit) |
10.1101/2021.01.12.426042 |
| 2021-01-12 |
Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications (edit) |
10.1186/S12929-020-00703-5 |
| 2021-01-12 |
Characterization of the SARS-CoV-2 S Protein: Biophysical, Biochemical, Structural, and Antigenic Analysis (edit) |
10.1021/ACSOMEGA.0C03512 |
| 2021-01-12 |
Cytoplasmic short linear motifs in ACE2 and integrin β link SARS-CoV-2 host cell receptors to mediators of endocytosis and autophagy (edit) |
10.1126/SCISIGNAL.ABF1117 |
| 2021-01-12 |
Short linear motif candidates in the cell entry system used by SARS-CoV-2 and their potential therapeutic implications (edit) |
10.1126/SCISIGNAL.ABD0334 |
| 2021-01-12 |
Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity (edit) |
10.1038/S41467-020-20251-8 |
| 2021-01-12 |
Factual insights of the allosteric inhibition mechanism of SARS-CoV-2 main protease by quercetin: an in silico analysis (edit) |
10.1007/S13205-020-02630-6 |
| 2021-01-11 |
A comparative analysis of remdesivir and other repurposed antivirals against SARS-CoV-2 (edit) |
10.15252/EMMM.202013105 |
| 2021-01-11 |
Architectured Therapeutic and Diagnostic Nanoplatforms for Combating SARS-CoV-2: Role of Inorganic, Organic, and Radioactive Materials (edit) |
10.1021/ACSBIOMATERIALS.0C01243 |
| 2021-01-11 |
Functional Analysis of SARS-CoV-2 Proteins in Drosophila Identifies Orf6-induced Pathogenicity Attenuated by Selinexor (edit) |
10.21203/RS.3.RS-141269/V1 |
| 2021-01-11 |
Reviews on Biological Activity, Clinical Trial and Synthesis Progress of Small Molecules for the Treatment of COVID-19 (edit) |
10.1007/S41061-020-00318-2 |
| 2021-01-11 |
No evidence for basigin/CD147 as a direct SARS-CoV-2 spike binding receptor (edit) |
10.1038/S41598-020-80464-1 |
| 2021-01-11 |
Generation and Characterization of recombinant SARS-CoV-2 expressing reporter genes (edit) |
10.1128/JVI.02209-20 |
| 2021-01-11 |
Stabilizing the closed SARS-CoV-2 spike trimer (edit) |
10.1038/S41467-020-20321-X |
| 2021-01-11 |
SARS-CoV-2 Spike Protein Elicits Cell Signaling in Human Host Cells: Implications for Possible Consequences of COVID-19 Vaccines (edit) |
10.3390/VACCINES9010036 |
| 2021-01-11 |
Hypoxia reduces cell attachment of SARS-CoV-2 spike protein by modulating the expression of ACE2, neuropilin-1, syndecan-1 and cellular heparan sulfate (edit) |
10.1101/2021.01.09.426021 |
| 2021-01-11 |
A trimeric human angiotensin-converting enzyme 2 as an anti-SARS-CoV-2 agent (edit) |
10.1038/S41594-020-00549-3 |
| 2021-01-11 |
Development and structural basis of a two-MAb cocktail for treating SARS-CoV-2 infections (edit) |
10.1038/S41467-020-20465-W |
| 2021-01-11 |
Predictive medicinal metabolites from Momordica dioica against comorbidity related proteins of SARS-CoV-2 infections (edit) |
10.1080/07391102.2020.1868340 |
| 2021-01-11 |
Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry (edit) |
10.1038/S41467-020-20501-9 |
| 2021-01-11 |
In silico docking analysis revealed the potential of phytochemicals present in Phyllanthus amarus and Andrographis paniculata, used in Ayurveda medicine in inhibiting SARS-CoV-2 (edit) |
10.1007/S13205-020-02578-7 |
| 2021-01-11 |
Designing a next generation multi-epitope based peptide vaccine candidate against SARS-CoV-2 using computational approaches (edit) |
10.1007/S13205-020-02574-X |
| 2021-01-11 |
In silico validation of potent phytochemical orientin as inhibitor of SARS-CoV-2 spike and host cell receptor GRP78 binding (edit) |
10.1016/J.HELIYON.2021.E05923 |
| 2021-01-11 |
SARS-CoV-2 and Glutamine: SARS-CoV-2 Triggered Pathogenesis via Metabolic Reprograming of Glutamine in Host Cells (edit) |
10.3389/FMOLB.2020.627842 |
| 2021-01-11 |
Dissecting strategies to tune the therapeutic potential of SARS-CoV-2–specific monoclonal antibody CR3022 (edit) |
10.1172/JCI.INSIGHT.143129 |
| 2021-01-10 |
ACE2-derived peptides interact with the RBD domain of SARS-CoV-2 spike glycoprotein, disrupting the interaction with the human ACE2 receptor (edit) |
10.1080/07391102.2020.1871415 |
| 2021-01-10 |
Lung adenocarcinoma patients have higher risk of SARS-CoV-2 infection (edit) |
10.18632/AGING.202375 |
| 2021-01-10 |
The SARS-CoV-2 and mental health: From biological mechanisms to social consequences (edit) |
10.1016/J.PNPBP.2020.110046 |
| 2021-01-09 |
Ivermectin as a potential treatment for mild to moderate COVID-19 – A double blind randomized placebo-controlled trial (edit) |
10.1101/2021.01.05.21249310 |
| 2021-01-09 |
Myasthenia gravis associated with anti-MuSK antibodies developed after SARS-CoV-2 infection (edit) |
10.1111/ENE.14721 |
| 2021-01-09 |
Planning for monitoring the introduction and effectiveness of new vaccines using real-word data and geospatial visualization: An example using rotavirus vaccines with potential application to SARS-CoV-2 (edit) |
10.1016/J.JVACX.2021.100084 |
| 2021-01-08 |
New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates (edit) |
10.1016/J.VACCINE.2020.11.054 |
| 2021-01-08 |
Beschluss der STIKO zur 1. Aktualisierung der COVID-19-Impfempfehlung und die dazugehörige wissenschaftliche Begründung (edit) |
10.25646/7820 |
| 2021-01-08 |
Balance on slack line; diagnostic intensity and patient safety during the SARS-CoV-2 pandemic (edit) |
10.1080/0284186X.2020.1867766 |
| 2021-01-08 |
Identification of potential SARS-CoV-2 Mpro inhibitors integrating molecular docking and water thermodynamics (edit) |
10.1080/07391102.2020.1867642 |
| 2021-01-08 |
Unsupervised cluster analysis of SARS-CoV-2 genomes reflects its geographic progression and identifies distinct genetic subgroups of SARS-CoV-2 virus (edit) |
10.1002/GEPI.22373 |
| 2021-01-08 |
Can natural products stop the SARS-CoV-2 virus? A docking and molecular dynamics study of a natural product database (edit) |
10.4155/FMC-2020-0248 |
| 2021-01-08 |
Searching for potential drugs against SARS-CoV-2 through virtual screening on several molecular targets (edit) |
10.1080/07391102.2020.1869096 |
| 2021-01-08 |
Assessment of inactivation procedures for SARS-CoV-2 (edit) |
10.1099/JGV.0.001539 |
| 2021-01-08 |
SARS-CoV-2 3D database: understanding the coronavirus proteome and evaluating possible drug targets (edit) |
10.1093/BIB/BBAA404 |
| 2021-01-08 |
Rapid recovery of taste and smell in a patient with SARS-CoV-2 following convalescent plasma therapy (edit) |
10.1093/QJMED/HCAA341 |
| 2021-01-08 |
Bioinformatics resources for SARS-CoV-2 discovery and surveillance (edit) |
10.1093/BIB/BBAA386 |
| 2021-01-08 |
Acute pulmonary embolism in hospitalized patients with SARS-CoV-2-related pneumonia: multicentric experience from Italian endemic area (edit) |
10.1007/S11547-020-01328-2 |
| 2021-01-08 |
Prevalence and Clinical Significance of Persistent Viral Shedding in Hospitalized Adult Patients with SARS-CoV-2 Infection: A Prospective Observational Study (edit) |
10.1007/S40121-020-00381-8 |
| 2021-01-08 |
Headache during SARS-CoV-2 infection as an early symptom associated with a more benign course of disease: a case-control study (edit) |
10.1111/ENE.14718 |
| 2021-01-08 |
Early Returns on Small Molecule Therapeutics for SARS-CoV-2 (edit) |
10.1021/ACSINFECDIS.0C00874 |
| 2021-01-08 |
Time from Start of Quarantine to SARS-CoV-2 Positive Test Among Quarantined College and University Athletes - 17 States, June-October 2020 (edit) |
10.15585/MMWR.MM7001A2 |
| 2021-01-08 |
Computational drug repurposing strategy predicted peptide-based drugs that can potentially inhibit the interaction of SARS-CoV-2 spike protein with its target (humanACE2) (edit) |
10.1371/JOURNAL.PONE.0245258 |
| 2021-01-08 |
Granulomatous interstitial nephritis in a patient with SARS-CoV-2 infection (edit) |
10.1186/S12882-020-02213-W |
| 2021-01-08 |
SARS-CoV-2 pneumonia succesfully treated with cpap and cycles of tripod position: a case report (edit) |
10.1186/S12871-020-01221-5 |
| 2021-01-08 |
Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial (edit) |
10.1186/S13063-020-04982-Z |
| 2021-01-08 |
Incidence and Secondary Transmission of SARS-CoV-2 Infections in Schools (edit) |
10.1542/PEDS.2020-048090 |
| 2021-01-08 |
Establishment and lineage dynamics of the SARS-CoV-2 epidemic in the UK (edit) |
10.1126/SCIENCE.ABF2946 |
| 2021-01-08 |
Performance characteristics of the VIDAS® SARS-COV-2 IgM and IgG serological assays (edit) |
10.1128/JCM.02292-20 |
| 2021-01-08 |
Performance of saliva specimens for the molecular detection of SARS-CoV-2 in the community setting: does sample collection method matter? (edit) |
10.1128/JCM.03033-20 |
| 2021-01-08 |
Law No. 14117 of January 8, 2021 (edit) |
|
| 2021-01-08 |
Transcriptomic Analysis of Respiratory Tissue and Cell Line Models to Examine Glycosylation Machinery during SARS-CoV-2 Infection (edit) |
10.3390/V13010082 |
| 2021-01-08 |
AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells (edit) |
10.1038/S41422-020-00460-Y |
| 2021-01-08 |
Host and viral determinants for efficient SARS-CoV-2 infection of the human lung (edit) |
10.1038/S41467-020-20457-W |
| 2021-01-08 |
Protective Face Mask Filter Capable of Inactivating SARS-CoV-2, and Methicillin-Resistant Staphylococcus aureus and Staphylococcus epidermidis (edit) |
10.3390/POLYM13020207 |
| 2021-01-08 |
Target SARS-CoV-2: computation of binding energies with drugs of dexamethasone/umifenovir by molecular dynamics using OPLS-AA force field (edit) |
|
| 2021-01-08 |
SARS-CoV-2 Viral RNA Shedding for More Than 87 Days in an Individual With an Impaired CD8+ T Cell Response (edit) |
10.3389/FIMMU.2020.618402 |
| 2021-01-08 |
Host mitochondrial transcriptome response to SARS-CoV-2 in multiple cell models and clinical samples (edit) |
10.1038/S41598-020-79552-Z |
| 2021-01-07 |
Exploration of natural compounds with anti-SARS-CoV-2 activity via inhibition of SARS-CoV-2 Mpro (edit) |
10.1093/BIB/BBAA382 |
| 2021-01-07 |
Critical role of neutralizing antibody for SARS-CoV-2 reinfection and transmission (edit) |
10.1080/22221751.2021.1872352 |
| 2021-01-07 |
SARS-CoV-2 pandemic-induced PPE and single-use plastic waste generation scenario (edit) |
10.1177/0734242X20980828 |
| 2021-01-07 |
Association of mental disorders with SARS-CoV-2 infection and severe health outcomes: nationwide cohort study (edit) |
10.1192/BJP.2020.251 |
| 2021-01-07 |
Junctional tachycardia due to Multisystem Inflammatory Syndrome in Children with SARS-CoV-2 infection in a 12-year-old female (edit) |
10.1017/S1047951120005016 |
| 2021-01-07 |
Impact of population density and weather on COVID-19 pandemic and SARS-CoV-2 mutation frequency in Bangladesh (edit) |
10.1017/S0950268821000029 |
| 2021-01-07 |
Pitfalls of barcodes in the study of worldwide SARS-CoV-2 variation and phylodynamics (edit) |
10.24272/J.ISSN.2095-8137.2020.364 |
| 2021-01-07 |
Novel Dual Multiplex Real-time RT-PCR Assays for the Rapid Detection of SARS-CoV-2, Influenza A/B, and Respiratory Syncytial Virus using the BD Max Open System (edit) |
10.1080/22221751.2021.1873073 |
| 2021-01-07 |
SARS-CoV-2 Testing to Assure Safety in Air Travel (edit) |
10.1093/JTM/TAAA241 |
| 2021-01-07 |
Diagnosis of SARS-CoV-2 in children: accuracy of nasopharyngeal swab compared to nasopharyngeal aspirate (edit) |
10.1007/S10096-020-04131-Z |
| 2021-01-07 |
The value of decreasing the duration of the infectious period of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (edit) |
10.1371/JOURNAL.PCBI.1008470 |
| 2021-01-07 |
Seroprevalence and asymptomatic carrier status of SARS-CoV-2 in Wuhan City and other places of China (edit) |
10.1371/JOURNAL.PNTD.0008975 |
| 2021-01-07 |
Monte Carlo Simulation of SARS-CoV-2 Radiation-Induced Inactivation for Vaccine Development (edit) |
10.1667/RADE-20-00241.1 |
| 2021-01-07 |
COVID-19 convalescent plasma and the SARS-CoV-2 neutralizing titer (edit) |
10.1093/INFDIS/JIAB008 |
| 2021-01-07 |
Association of endopeptidases, involved in SARS-CoV-2 infection, with microbial aggravation in sputum of severe asthma (edit) |
10.1111/ALL.14731 |
| 2021-01-07 |
Computational Insight Into the Mechanism of SARS-CoV-2 Membrane Fusion (edit) |
10.1021/ACS.JCIM.0C01231 |
| 2021-01-07 |
H2V: a database of human genes and proteins that respond to SARS-CoV-2, SARS-CoV, and MERS-CoV infection (edit) |
10.1186/S12859-020-03935-2 |
| 2021-01-07 |
Incorporating and addressing testing bias within estimates of epidemic dynamics for SARS-CoV-2 (edit) |
10.1186/S12874-020-01196-4 |
| 2021-01-07 |
Characteristics of SARS-CoV-2 positive cases beyond health-care professionals or social and health-care facilities (edit) |
10.1186/S12889-020-10093-W |
| 2021-01-07 |
Computational analysis to repurpose drugs for COVID-19 based on transcriptional response of host cells to SARS-CoV-2 (edit) |
10.1186/S12911-020-01373-X |
| 2021-01-07 |
Transcriptome of nasopharyngeal samples from COVID-19 patients and a comparative analysis with other SARS-CoV-2 infection models reveal disparate host responses against SARS-CoV-2 (edit) |
10.1186/S12967-020-02695-0 |
| 2021-01-07 |
COVID-19 vaccine candidates based on modified vaccinia virus Ankara expressing the SARS-CoV-2 spike induce robust T- and B-cell immune responses and full efficacy in mice (edit) |
10.1128/JVI.02260-20 |
| 2021-01-07 |
Neuroimaging Offers Low Yield in Children Positive for SARS-CoV-2 (edit) |
10.3174/AJNR.A7022 |
| 2021-01-07 |
Genome Sequences of Two GH Clade SARS-CoV-2 Strains Isolated from Patients with COVID-19 in South Korea (edit) |
10.1128/MRA.01384-20 |
| 2021-01-07 |
Mutation Profile of SARS-CoV-2 Genome Sequences Originating from Eight Israeli Patient Isolates (edit) |
10.1128/MRA.01387-20 |
| 2021-01-07 |
Genomic Sequences and Analysis of Five SARS-CoV-2 Variants Obtained from Patients in Lambayeque, Peru (edit) |
10.1128/MRA.01267-20 |
| 2021-01-07 |
SARS-CoV-2: characterisation and mitigation of risks associated with aerosol generating procedures in dental practices (edit) |
10.1038/S41415-020-2504-8 |
| 2021-01-07 |
The aftermath of SARS-CoV-2 in NICU: saving or checking accounts? Projected cost-effectiveness analysis (edit) |
10.1007/S00431-020-03884-1 |
| 2021-01-07 |
How to use imperfect tests for COVID-19 (SARS-CoV-2) to make clinical decisions (edit) |
10.5694/MJA2.50907 |
| 2021-01-07 |
Development and implementation of a RT-qPCR extraction-free protocol for the detection of SARS-CoV-2 and impact on the turn-around-time (edit) |
10.1002/JMV.26782 |
| 2021-01-07 |
Neutralization of N501Y mutant SARS-CoV-2 by BNT162b2 vaccine-elicited sera (edit) |
10.1101/2021.01.07.425740 |
| 2021-01-07 |
New targets for drug design: Importance of nsp14/nsp10 complex formation for the 3’-5’ exoribonucleolytic activity on SARS-CoV-2 (edit) |
10.1101/2021.01.07.425745 |
| 2021-01-07 |
Mapping the SARS-CoV-2-Host Protein-Protein Interactome by Affinity Purification Mass Spectrometry and Proximity-Dependent Biotin Labeling: A Rational and Straightforward Route to Discover Host-Directed Anti-SARS-CoV-2 Therapeutics (edit) |
10.3390/IJMS22020532 |
| 2021-01-07 |
Circulating Platelet-Derived Extracellular Vesicles Are a Hallmark of Sars-Cov-2 Infection (edit) |
10.3390/CELLS10010085 |
| 2021-01-07 |
A computational approach for the screening of potential antiviral compounds against SARS-CoV-2 protease: Ionic liquid vs herbal and natural compounds (edit) |
10.1016/J.MOLLIQ.2021.115298 |
| 2021-01-07 |
Expression of SARS-COV-2 cell receptor gene ACE2 is associated with immunosuppression and metabolic reprogramming in lung adenocarcinoma based on bioinformatics analyses of gene expression profiles (edit) |
10.1016/J.CBI.2021.109370 |
| 2021-01-06 |
The duration, dynamics and determinants of SARS-CoV-2 antibody responses in individual healthcare workers (edit) |
10.1093/CID/CIAB004 |
| 2021-01-06 |
Computational analysis of dynamic allostery and control in the SARS-CoV-2 main protease (edit) |
10.1098/RSIF.2020.0591 |
| 2021-01-06 |
In silico design of multi-epitope-based peptide vaccine against SARS-CoV-2 using its spike protein (edit) |
10.1080/07391102.2020.1869092 |
| 2021-01-06 |
In silico analyses on the comparative sensing of SARS-CoV-2 mRNA by the intracellular TLRs of human (edit) |
10.1002/JMV.26776 |
| 2021-01-06 |
Antihypertensive and its relation to mortality by SARS-CoV-2 infection (edit) |
10.1002/JMV.26775 |
| 2021-01-06 |
Hybrid physiologically-based pharmacokinetic model for remdesivir: Application to SARS-CoV-2 (edit) |
10.1111/CTS.12975 |
| 2021-01-06 |
Parallels in the pathogenesis of SARS-CoV-2 and M. tuberculosis: a synergistic or antagonistic alliance? (edit) |
10.2217/FMB-2020-0179 |
| 2021-01-06 |
Existing antiviral options against SARS-CoV-2 replication in COVID-19 patients (edit) |
10.2217/FMB-2020-0120 |
| 2021-01-06 |
Clinical evaluation of a fully automated, laboratory-developed multiplex RT-PCR assay integrating dual-target SARS-CoV-2 and influenza A/B detection on a high-throughput platform (edit) |
10.1099/JMM.0.001295 |
| 2021-01-06 |
Genetic Variants of SARS-CoV-2-What Do They Mean? (edit) |
10.1001/JAMA.2020.27124 |
| 2021-01-06 |
False Positive Results With SARS-CoV-2 RT-PCR Tests and How to Evaluate a RT-PCR-Positive Test for the Possibility of a False Positive Result (edit) |
10.1097/JOM.0000000000002138 |
| 2021-01-06 |
Development of a reverse transcription recombinase polymerase amplification assay for rapid and direct visual detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (edit) |
10.1371/JOURNAL.PONE.0245164 |
| 2021-01-06 |
Evaluation of PCL rapid point of care antigen test for detection of SARS-CoV-2 in nasopharyngeal swabs (edit) |
10.1002/JMV.26765 |
| 2021-01-06 |
Rationale for Effective Prophylaxis Against COVID-19 Through Simultaneous Blockade of Both Endosomal and Non-Endosomal SARS-CoV-2 Entry into Host Cell (edit) |
10.1111/CTS.12949 |
| 2021-01-06 |
N- and O-Glycosylation of the SARS-CoV-2 Spike Protein (edit) |
10.1021/ACS.ANALCHEM.0C03173 |
| 2021-01-06 |
Identification and characterization of a silent mutation in RNA binding domain of N protein coding gene from SARS-CoV-2 (edit) |
10.1186/S13104-020-05439-X |
| 2021-01-06 |
Endoscopes used in positive and critically ill patients are SARS-CoV-2 negative at virological assessment (edit) |
10.1136/GUTJNL-2020-323577 |
| 2021-01-06 |
Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection (edit) |
10.1126/SCIENCE.ABF4063 |
| 2021-01-06 |
Recommendations for SARS-CoV-2/COVID-19 testing: a scoping review of current guidance (edit) |
10.1136/BMJOPEN-2020-043004 |
| 2021-01-06 |
A CRISPR-Cas12a-Derived Biosensor Enabling Portable Personal Glucose Meter Readout for Quantitative Detection of SARS-CoV-2 (edit) |
10.1002/BIT.27673 |
| 2021-01-06 |
Comparison of Five Serological Assays for the Detection of SARS-CoV-2 Antibodies (edit) |
10.3390/DIAGNOSTICS11010078 |
| 2021-01-06 |
Population-Specific ACE2 Single-Nucleotide Polymorphisms Have Limited Impact on SARS-CoV-2 Infectivity In Vitro (edit) |
10.3390/V13010067 |
| 2021-01-06 |
Modes of Transmission of Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) and Factors Influencing on the Airborne Transmission: A Review (edit) |
10.3390/IJERPH18020395 |
| 2021-01-06 |
SARS-CoV-2 Testing for Asymptomatic Patients with Cancer Prior and during Treatment: A Single Centre Experience (edit) |
10.3390/CURRONCOL28010032 |
| 2021-01-06 |
Immunogenicity of Multiple Doses of pDNA Vaccines against SARS-CoV-2 (edit) |
10.3390/PH14010039 |
| 2021-01-06 |
A longitudinal study of SARS-CoV-2-infected patients reveals a high correlation between neutralizing antibodies and COVID-19 severity (edit) |
10.1038/S41423-020-00588-2 |
| 2021-01-06 |
Dynamics of antibodies to SARS-CoV-2 in convalescent plasma donors (edit) |
10.1101/2021.01.06.20249035 |
| 2021-01-06 |
SARS-CoV-2: vaccines in the pandemic era (edit) |
10.1186/S40779-020-00296-Y |
| 2021-01-06 |
SARS-CoV-2 RBD in vitro evolution follows contagious mutation spread, yet generates an able infection inhibitor (edit) |
10.1101/2021.01.06.425392 |
| 2021-01-06 |
Genomic epidemiology of the SARS-CoV-2 epidemic in Zimbabwe: Role of international travel and regional migration in spread (edit) |
10.1101/2021.01.04.20232520 |
| 2021-01-06 |
In-silico analysis of the inhibition of the SARS-CoV-2 main protease by some active compounds from selected African plants (edit) |
10.1016/J.JTUMED.2020.12.005 |
| 2021-01-06 |
In silico investigation of saponins and tannins as potential inhibitors of SARS-CoV-2 main protease (Mpro) (edit) |
10.1007/S40203-020-00071-W |
| 2021-01-06 |
Surveillance of SARS-CoV-2 spread using wastewater-based epidemiology: Comprehensive study (edit) |
10.1016/J.SCITOTENV.2020.144704 |
| 2021-01-05 |
Computational and theoretical exploration for clinical suitability of Remdesivir drug to SARS-CoV-2 (edit) |
10.1016/J.EJPHAR.2020.173642 |
| 2021-01-05 |
Gordian Knot: Gastrointestinal lesions caused by three highly pathogenic coronaviruses from SARS-CoV and MERS-CoV to SARS-CoV-2 (edit) |
10.1016/J.EJPHAR.2020.173659 |
| 2021-01-05 |
Update Alert 7: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults (edit) |
10.7326/L20-1446 |
| 2021-01-05 |
Virtual screening of curcumin and its analogs against the spike surface glycoprotein of SARS-CoV-2 and SARS-CoV (edit) |
10.1080/07391102.2020.1868338 |
| 2021-01-05 |
A Discussion on Implementing Pooling Detection Tests of Novel Coronavirus (SARS-CoV-2) for Large Population (edit) |
10.1017/S0950268820003155 |
| 2021-01-05 |
Evaluation of a multi-sectoral intervention to mitigate the risk of SARS-CoV-2 transmission in long-term care facilities (edit) |
10.1017/ICE.2020.1407 |
| 2021-01-05 |
Characterization of SARS-CoV-2 ORF6 deletion variants detected in a nosocomial cluster during routine genomic surveillance, Lyon, France (edit) |
10.1080/22221751.2021.1872351 |
| 2021-01-05 |
Colorimetric loop-mediated isothermal amplification (LAMP) for cost-effective and quantitative detection of SARS-CoV-2: the change in color in LAMP-based assays quantitatively correlates with viral copy number (edit) |
10.1039/D0AY01658F |
| 2021-01-05 |
Asymptomatic Patient Testing After 10:1 Pooling Using the Xpert Xpress SARS-CoV-2 Assay (edit) |
10.1093/AJCP/AQAA273 |
| 2021-01-05 |
Fast inactivation of SARS-CoV-2 by UV-C and ozone exposure on different materials (edit) |
10.1080/22221751.2021.1872354 |
| 2021-01-05 |
Evaluation of high-throughput SARS-CoV-2 serological assays in a longitudinal cohort of patients with mild COVID-19: clinical sensitivity, specificity and association with virus neutralization test (edit) |
10.1093/CLINCHEM/HVAA336 |
| 2021-01-05 |
In vitro Characterisation of SARS-CoV-2 and Susceptibility of Domestic Ferrets (Mustela putorius furo) (edit) |
10.1111/TBED.13978 |
| 2021-01-05 |
Genomic Evidence of In-Flight Transmission of SARS-CoV-2 Despite Predeparture Testing (edit) |
10.3201/EID2703.204714 |
| 2021-01-05 |
SARS-CoV-2 seroprevalence survey estimates are affected by anti-nucleocapsid antibody decline (edit) |
10.1093/INFDIS/JIAA796 |
| 2021-01-05 |
COVID-19 and the revival of passive immunization: Antibody therapy for inhibiting SARS-CoV-2 and preventing host cell infection: IUPHAR review: 31 (edit) |
10.1111/BPH.15359 |
| 2021-01-05 |
Acute dacryoadenitis in a patient with SARS-CoV-2 infection (edit) |
10.1080/01676830.2020.1867193 |
| 2021-01-05 |
SARS-CoV-2 myocarditis: what physicians need to know (edit) |
10.1136/BMJEBM-2020-111527 |
| 2021-01-05 |
Assessing seropositivity for IgG antibodies against SARS-CoV-2 in Ahmedabad city of India: a cross-sectional study (edit) |
10.1136/BMJOPEN-2020-044101 |
| 2021-01-05 |
Endemic SARS-CoV-2 will maintain post-pandemic immunity (edit) |
10.1101/2020.11.04.355842 |
| 2021-01-05 |
Acute Generalized Exanthematous Pustulosis (AGEP) in 12 Patients Treated for SARS-CoV-2 Positive Pneumonia (edit) |
10.1097/DAD.0000000000001819 |
| 2021-01-05 |
SARS-CoV-2 infection is associated with a pro-thrombotic platelet phenotype (edit) |
10.1038/S41419-020-03333-9 |
| 2021-01-05 |
Decontamination of common healthcare facility surfaces contaminated with SARS-CoV-2 using peracetic acid dry fogging (edit) |
10.1016/J.JHIN.2020.12.016 |
| 2021-01-05 |
Production of ORF8 protein from SARS-CoV-2 using an inducible virus-mediated expression system in suspension-cultured tobacco BY-2 cells (edit) |
10.1007/S00299-020-02654-5 |
| 2021-01-05 |
European context of the diversity and phylogenetic position of SARS-CoV-2 sequences from Polish COVID-19 patients (edit) |
10.1007/S13353-020-00603-2 |
| 2021-01-04 |
There are no in-principle ethical objections to controlled voluntary SARS-CoV-2 infection (edit) |
10.1111/BIOE.12835 |
| 2021-01-04 |
SARS-CoV-2 entry into human airway organoids is serine protease-mediated and facilitated by the multibasic cleavage site (edit) |
10.7554/ELIFE.64508 |
| 2021-01-04 |
Metaproteomics Analysis of SARS-CoV-2-Infected Patient Samples Reveals Presence of Potential Coinfecting Microorganisms (edit) |
10.1021/ACS.JPROTEOME.0C00822 |
| 2021-01-04 |
Performance characteristics of a rapid SARS-CoV-2 antigen detection assay at a public plaza testing site in San Francisco (edit) |
10.1093/INFDIS/JIAA802 |
| 2021-01-04 |
Nasopharyngeal swab-induced pain for SARS-CoV-2 screening: a randomised controlled trial of conventional and self-swabbing (edit) |
10.1002/EJP.1722 |
| 2021-01-04 |
Illuminating the immunopathology of SARS-CoV-2 (edit) |
10.1002/CYTO.B.21988 |
| 2021-01-04 |
Universal Admission Screening for SARS-CoV-2 Infections among Hospitalized Patients, Switzerland, 2020 (edit) |
10.3201/EID2702.202318 |
| 2021-01-04 |
SARS-CoV-2 encephalitis is a cytokine release syndrome: evidences from cerebrospinal fluid analyses (edit) |
10.1093/CID/CIAA1933 |
| 2021-01-04 |
Tropism of SARS-CoV-2, SARS-CoV and influenza virus in canine tissue explants (edit) |
10.1093/INFDIS/JIAB002 |
| 2021-01-04 |
SARS-CoV-2: An insight into detection tools (edit) |
10.2174/1871526520666210104151849 |
| 2021-01-04 |
Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilo (edit) |
10.1186/S13063-020-04976-X |
| 2021-01-04 |
Stereotypic neutralizing VH antibodies against SARS-CoV-2 spike protein receptor binding domain in COVID-19 patients and healthy individuals (edit) |
10.1126/SCITRANSLMED.ABD6990 |
| 2021-01-04 |
Author Correction: Exploring the structural distribution of genetic variation in SARS-CoV-2 with the COVID-3D online resource (edit) |
10.1038/S41588-020-00775-X |
| 2021-01-04 |
Prevalence, incidence and clinical features of SARS-CoV-2 infection in adult coeliac patients (edit) |
10.1097/MEG.0000000000001969 |
| 2021-01-04 |
Estimation of US SARS-CoV-2 Infections, Symptomatic Infections, Hospitalizations, and Deaths Using Seroprevalence Surveys (edit) |
10.1001/JAMANETWORKOPEN.2020.33706 |
| 2021-01-04 |
YouTube Videos of the SARS-CoV-2 Nasopharyngeal Swab Technique: Content Analysis (edit) |
10.2196/24220 |
| 2021-01-04 |
A Direct Method for RT-PCR Detection of SARS-CoV-2 in Clinical Samples (edit) |
10.3390/HEALTHCARE9010037 |
| 2021-01-04 |
Poor Sleep during the First Peak of the SARS-CoV-2 Pandemic: A Cross-Sectional Study (edit) |
10.3390/IJERPH18010306 |
| 2021-01-04 |
Test Groups, Not Individuals: A Review of the Pooling Approaches for SARS-CoV-2 Diagnosis (edit) |
10.3390/DIAGNOSTICS11010068 |
| 2021-01-04 |
SARS-CoV-2/COVID-19 Vaccines: The Promises and the Challenges Ahead (edit) |
10.3390/VACCINES9010021 |
| 2021-01-04 |
Seroprevalence to SARS-CoV-2 Among Healthcare Workers in an Exclusive Pediatric Hospital (edit) |
|
| 2021-01-04 |
SARS-CoV-2 Transmission From People Without COVID-19 Symptoms (edit) |
10.1001/JAMANETWORKOPEN.2020.35057 |
| 2021-01-04 |
Can SARS-CoV-2 infect the central nervous system via the olfactory bulb or the blood-brain barrier? (edit) |
10.1016/J.BBI.2020.12.031 |
| 2021-01-04 |
Secondary hemophagocytic lymphohistiocytosis and severe liver injury induced by hepatic SARS-CoV-2 infection unmasking Wilson's disease: balancing immunosuppression (edit) |
10.1016/J.IJID.2020.12.047 |
| 2021-01-04 |
SARS-CoV-2 infection associated with hepatitis in an infant with X-linked severe combined immunodeficiency (edit) |
10.1016/J.CLIM.2020.108662 |
| 2021-01-04 |
Polycations and polyanions in SARS-CoV-2 infection (edit) |
10.1016/J.MEHY.2020.110470 |
| 2021-01-04 |
Comprehensive mapping of mutations to the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human serum antibodies (edit) |
10.1101/2020.12.31.425021 |
| 2021-01-04 |
Transmission of SARS-CoV-2 Lineage B.1.1.7 in England: Insights from linking epidemiological and genetic data (edit) |
10.1101/2020.12.30.20249034 |
| 2021-01-04 |
Analysis of SARS-CoV-2 antibodies in COVID-19 convalescent blood using a coronavirus antigen microarray (edit) |
10.1038/S41467-020-20095-2 |
| 2021-01-04 |
Dose-dependent response to infection with SARS-CoV-2 in the ferret model and evidence of protective immunity (edit) |
10.1038/S41467-020-20439-Y |
| 2021-01-04 |
Strategies to minimize SARS-CoV-2 transmission in classroom settings: Combined impacts of ventilation and mask effective filtration efficiency (edit) |
10.1101/2020.12.31.20249101 |
| 2021-01-04 |
SARS-CoV-2 induces a durable and antigen specific humoral immunity after asymptomatic to mild COVID-19 infection (edit) |
10.1101/2021.01.03.21249162 |
| 2021-01-04 |
Molecular modeling of natural and synthesized inhibitors against SARS-CoV-2 spike glycoprotein (edit) |
|
| 2021-01-04 |
HIV and SARS-CoV-2: Intersecting Epidemics with Many Unknowns (edit) |
10.1093/AJE/KWAA158 |
| 2021-01-03 |
Co-Infection with Common Respiratory Pathogens and SARS-CoV-2 in Patients with COVID-19 Pneumonia and Laboratory Biochemistry Findings: A Retrospective Cross-Sectional Study of 78 Patients from a Single Center in China (edit) |
10.12659/MSM.929783 |
| 2021-01-03 |
Longitudinal testing for respiratory and gastrointestinal shedding of SARS-CoV-2 in day care centres in Hesse, Germany (edit) |
10.1093/CID/CIAA1912 |
| 2021-01-03 |
Prospective Longitudinal Serosurvey of Health Care Workers in the First Wave of the SARS-CoV-2 Pandemic in a Quaternary Care Hospital in Munich, Germany (edit) |
10.1093/CID/CIAA1935 |
| 2021-01-03 |
Association between upper respiratory tract viral load, comorbidities, disease severity and outcome of patients with SARS-CoV-2 infection (edit) |
10.1093/INFDIS/JIAA804 |
| 2021-01-03 |
Recent advancements in glycoproteomic studies: Glycopeptide enrichment and derivatization, characterization of glycosylation in SARS CoV2, and interacting glycoproteins (edit) |
10.1002/MAS.21679 |
| 2021-01-03 |
Neurological and Neuropsychological Changes Associated with SARS-CoV-2 Infection: New Observations, New Mechanisms (edit) |
10.1177/1073858420984106 |
| 2021-01-03 |
SARS-CoV-2-Cholesterol Interaction: A Lot of Food for Thought (edit) |
10.3390/PATHOGENS10010032 |
| 2021-01-03 |
SARS-CoV-2 Entry Genes Expression in Relation with Interferon Response in Cystic Fibrosis Patients (edit) |
10.3390/MICROORGANISMS9010093 |
| 2021-01-03 |
The anti-HCV, Sofosbuvir, versus the anti-EBOV Remdesivir against SARS-CoV-2 RNA dependent RNA polymerase in silico (edit) |
10.1007/S11030-020-10178-Z |
| 2021-01-02 |
Anti-Inflammatory Drugs and the Renin-Angiotensin-Aldosterone System: Current Knowledge and Potential Effects on Early SARS-CoV-2 Infection (edit) |
10.1016/J.VIRUSRES.2020.198190 |
| 2021-01-02 |
SARS-COV-2 RECEPTOR ACE2 GENE is associated with hypertension and SEVERity of COVID 19: interaction with sex, obesity and SMOKING (edit) |
10.1093/AJH/HPAA223 |
| 2021-01-02 |
SARS-CoV-2 immunity and reinfection (edit) |
10.1093/CID/CIAA1936 |
| 2021-01-02 |
SARS-CoV-2-induced remission of Hodgkin lymphoma (edit) |
10.1111/BJH.17116 |
| 2021-01-02 |
Performance and feasibility of universal PCR admission screening for SARS-CoV-2 in a German tertiary care hospital (edit) |
10.1002/JMV.26770 |
| 2021-01-02 |
SARS-CoV-2 nucleocapsid protein intranasal inoculation induces local and systemic T cell responses in mice (edit) |
10.1002/JMV.26769 |
| 2021-01-02 |
Social restriction versus herd immunity policies in the early phase of the SARS-CoV-2 pandemic: A mathematical modelling study (edit) |
10.12932/AP-140720-0914 |
| 2021-01-02 |
Using bioinformatic protein sequence similarity to investigate if SARS CoV-2 infection could cause an ocular autoimmune inflammatory reactions? (edit) |
10.1016/J.EXER.2020.108433 |
| 2021-01-02 |
Are the emerging SARS-COV-2 mutations friend or foe? (edit) |
10.1016/J.IMLET.2020.12.014 |
| 2021-01-02 |
The scRNA-seq Expression Profiling of the Receptor ACE2 and the Cellular Protease TMPRSS2 Reveals Human Organs Susceptible to SARS-CoV-2 Infection (edit) |
10.3390/IJERPH18010284 |
| 2021-01-02 |
Role of Melatonin on Virus-Induced Neuropathogenesis-A Concomitant Therapeutic Strategy to Understand SARS-CoV-2 Infection (edit) |
10.3390/ANTIOX10010047 |
| 2021-01-02 |
Comprehensive analysis of the host-virus interactome of SARS-CoV-2 (edit) |
10.1101/2020.12.31.424961 |
| 2021-01-02 |
Aerosol phobia and SARS-CoV-2 spread amongst dentists: Hype vs reality! (edit) |
10.18231/J.IJOHD.2020.054 |
| 2021-01-02 |
SARS-CoV-2-Induced ARDS Associates with MDSC Expansion, Lymphocyte Dysfunction, and Arginine Shortage (edit) |
10.1007/S10875-020-00920-5 |
| 2021-01-01 |
SARS-COV-2 (COVID-19): Cellular and biochemical properties and pharmacological insights into new therapeutic developments (edit) |
10.1002/CBF.3591 |
| 2021-01-01 |
Genetics and genomics of SARS-CoV-2: A review of the literature with the special focus on genetic diversity and SARS-CoV-2 genome detection (edit) |
10.1016/J.YGENO.2020.09.059 |
| 2021-01-01 |
SARS-CoV-2 viability under different meteorological conditions, surfaces, fluids and transmission between animals (edit) |
10.1016/J.ENVRES.2020.110293 |
| 2021-01-01 |
SARS-CoV-2 in wastewater: Challenges for developing countries (edit) |
10.1016/J.IJHEH.2020.113634 |
| 2021-01-01 |
Paediatric Inflammatory Multisystem Syndrome Temporally-Associated with SARS-CoV-2 Infection: An Overview (edit) |
10.1007/S00134-020-06273-2 |
| 2021-01-01 |
Coronavirus Disease 2019 (SARS-CoV-2) and polycystic ovarian disease: is there a higher risk for these women? (edit) |
10.1016/J.JSBMB.2020.105770 |
| 2021-01-01 |
SARS-CoV-2 pandemic: a review of molecular diagnostic tools including sample collection and commercial response with associated advantages and limitations (edit) |
10.1007/S00216-020-02958-1 |
| 2021-01-01 |
Recurrence of SARS-CoV-2 viral RNA in recovered COVID-19 patients: a narrative review (edit) |
10.1007/S10096-020-04088-Z |
| 2021-01-01 |
SARS-CoV-2 in water services: Presence and impacts (edit) |
10.1016/J.ENVPOL.2020.115806 |
| 2021-01-01 |
First results of investigations of SARS-CoV-2 RNA in human corneal tissue (edit) |
10.1007/S00347-020-01254-8 |
| 2021-01-01 |
What is the significance of the conjunctiva as a potential transmission route for SARS-CoV-2 infections? (edit) |
10.1007/S00347-020-01255-7 |
| 2021-01-01 |
Time-varying Reproductive Rates for SARS-CoV-2 and its Implications as a Means of Disease Surveillance on Lockdown Restrictions (edit) |
10.1097/SLA.0000000000004590 |
| 2021-01-01 |
A moment for reflection. Ethical aspects in the pandemic SARS-CoV-2/COVID-19 in our clinical practice (edit) |
10.1016/J.REDAR.2020.09.004 |
| 2021-01-01 |
Clinically suspected myocarditis in the course of SARS-CoV-2 infection: fact or fiction? (edit) |
10.1016/J.CARDFAIL.2020.11.002 |
| 2021-01-01 |
Adaptation of advanced clinical virology assays from HIV-1 to SARS-CoV-2 (edit) |
10.1097/COH.0000000000000656 |
| 2021-01-01 |
Molecular epidemiology in the HIV and SARS-CoV-2 pandemics (edit) |
10.1097/COH.0000000000000660 |
| 2021-01-01 |
SARS-CoV 2; Possible alternative virus receptors and pathophysiological determinants (edit) |
10.1016/J.MEHY.2020.110368 |
| 2021-01-01 |
The key role of Warburg effect in SARS-CoV-2 replication and associated inflammatory response (edit) |
10.1016/J.BIOCHI.2020.11.010 |
| 2021-01-01 |
SARS-CoV-2 infection in patients with a normal or abnormal liver (edit) |
10.1111/JVH.13440 |
| 2021-01-01 |
Repurposing existing drugs for the treatment of COVID-19/SARS-CoV-2 infection: A review describing drug mechanisms of action (edit) |
10.1016/J.BCP.2020.114296 |
| 2021-01-01 |
Decontamination of N95 respirators against SARS-CoV-2: a scoping review (edit) |
10.1016/J.JDENT.2020.103534 |
| 2021-01-01 |
SARS-CoV-2 microbiome dysbiosis linked disorders and possible probiotics role (edit) |
10.1016/J.BIOPHA.2020.110947 |
| 2021-01-01 |
A Prototype QSP Model of the Immune Response to SARS-CoV-2 for Community Development (edit) |
10.1002/PSP4.12574 |
| 2021-01-01 |
The emerging role of microRNAs in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (edit) |
10.1016/J.INTIMP.2020.107204 |
| 2021-01-01 |
SARS-CoV-2: a new dimension to our understanding of coronaviruses (edit) |
10.1007/S10123-020-00152-Y |
| 2021-01-01 |
SARS-CoV-2 (COVID-19) Superspreader Events (edit) |
10.1016/J.JINF.2020.11.021 |
| 2021-01-01 |
Maternal and perinatal outcomes in pregnant women infected by SARS-CoV-2: A meta-analysis (edit) |
10.1016/J.EJOGRB.2020.11.038 |
| 2021-01-01 |
SARS-COV-2 (Covid-19) and Male Fertility: where are we? (edit) |
10.1016/J.REPROTOX.2020.11.012 |
| 2021-01-01 |
Exploring the magic bullets to identify Achilles' heel in SARS-CoV-2: Delving deeper into the sea of possible therapeutic options in Covid-19 disease: An update (edit) |
10.1016/J.FCT.2020.111887 |
| 2021-01-01 |
Potential molecular targets of nonstructural proteins for the development of antiviral drugs against SARS-CoV-2 infection (edit) |
10.1016/J.BIOPHA.2020.111035 |
| 2021-01-01 |
The human coronaviruses (HCoVs) and the molecular mechanisms of SARS-CoV-2 infection (edit) |
10.1007/S00109-020-02012-8 |
| 2021-01-01 |
T Cells: Warriors of SARS-CoV-2 Infection (edit) |
10.1016/J.IT.2020.11.002 |
| 2021-01-01 |
Can SARS-CoV-2 infect the eye? An overview of the receptor status in ocular tissue (edit) |
10.1007/S00347-020-01281-5 |
| 2021-01-01 |
A comparative analysis for anti-viral drugs: Their efficiency against SARS-CoV-2 (edit) |
10.1016/J.INTIMP.2020.107232 |
| 2021-01-01 |
Therapeutic drugs for SARS-CoV-2 treatment: Current state and perspective (edit) |
10.1016/J.INTIMP.2020.107228 |
| 2021-01-01 |
How does SARS-CoV-2 targets the elderly patients? A review on potential mechanisms increasing disease severity (edit) |
10.1016/J.EJIM.2020.11.024 |
| 2021-01-01 |
Recent trends on omics and bioinformatics approaches to study SARS-CoV-2: A bibliometric analysis and mini-review (edit) |
10.1016/J.COMPBIOMED.2020.104162 |
| 2021-01-01 |
Overexpression of SARS-CoV-2 protein ORF6 dislocates RAE1 and NUP98 from the nuclear pore complex (edit) |
10.1016/J.BBRC.2020.11.115 |
| 2021-01-01 |
Flexible Bedside Bronchoscopy Using Closed Sheath System Devised From Ultrasound Probe Cover for Use in SARS-CoV-2 Patients (edit) |
10.1097/LBR.0000000000000703 |
| 2021-01-01 |
Cross-species recognition of SARS-CoV-2 to bat ACE2 (edit) |
10.1101/2020.09.08.284737 |
| 2021-01-01 |
SARS-CoV-2 neuroinvasion (edit) |
10.1038/S41590-020-00854-5 |
| 2021-01-01 |
Correlation between takotsubo cardiomyopathy and SARS-CoV-2 infection (edit) |
10.1016/J.MEHY.2020.110454 |
| 2021-01-01 |
Overview of Targets and Potential Drugs of SARS-CoV-2 According to the Viral Replication (edit) |
10.1021/ACS.JPROTEOME.0C00526 |
| 2021-01-01 |
The Role of Testing in Reducing SARS-CoV-2 Transmission on College Campuses (edit) |
10.1016/J.JADOHEALTH.2020.10.006 |
| 2021-01-01 |
Kidney Transplantation in Patients With SARS-CoV-2 Infection: A Case Series Report (edit) |
10.1097/TP.0000000000003521 |
| 2021-01-01 |
The Unpredictable Outcome of SARS-CoV-2 in Kidney Transplant Recipients With HIV-infection (edit) |
10.1097/TP.0000000000003529 |
| 2021-01-01 |
Spatial and temporal roles of SARS-CoV PLpro -A snapshot (edit) |
10.1096/FJ.202002271 |
| 2021-01-01 |
Might proton pump or sodium-hydrogen exchanger inhibitors be of value to ameliorate SARs-CoV-2 pathophysiology? (edit) |
10.14814/PHY2.14649 |
| 2021-01-01 |
Potential effects of SARS-CoV-2 on the gastrointestinal tract and liver (edit) |
10.1016/J.BIOPHA.2020.111064 |
| 2021-01-01 |
Implications of Shortened Quarantine Among Household Contacts of Index Patients with Confirmed SARS-CoV-2 Infection - Tennessee and Wisconsin, April-September 2020 (edit) |
10.15585/MMWR.MM695152A1 |
| 2021-01-01 |
Performance of an Antigen-Based Test for Asymptomatic and Symptomatic SARS-CoV-2 Testing at Two University Campuses - Wisconsin, September-October 2020 (edit) |
10.15585/MMWR.MM695152A3 |
| 2021-01-01 |
A mouse model for SARS-CoV-2-induced acute respiratory distress syndrome (edit) |
10.1038/S41392-020-00451-W |
| 2021-01-01 |
DCs-based therapies: potential strategies in severe SARS-CoV-2 infection (edit) |
10.7150/IJMS.47706 |
| 2021-01-01 |
The role of chest CT in management of asymptomatic SARS-CoV-2 infections: A longitudinal multi-center study in Chongqing, China (edit) |
10.7150/IJMS.50705 |
| 2021-01-01 |
Current advances in the development of SARS-CoV-2 vaccines (edit) |
10.7150/IJBS.52569 |
| 2021-01-01 |
SARS-CoV-2 variants evolved during the early stage of the pandemic and effects of mutations on adaptation in Wuhan populations (edit) |
10.7150/IJBS.47827 |
| 2021-01-01 |
Rapid design and development of CRISPR-Cas13a targeting SARS-CoV-2 spike protein (edit) |
10.7150/THNO.51479 |
| 2021-01-01 |
Laboratory Management and Quality Control Practice of SARS-CoV-2 Nucleic Acid Detection (edit) |
10.1093/LABMED/LMAA077 |
| 2021-01-01 |
Nucleic Acid-Based Diagnostic Tests for the Detection SARS-CoV-2: An Update (edit) |
10.3390/DIAGNOSTICS11010053 |
| 2021-01-01 |
Upper gastrointestinal stenting during the SARS-CoV-2 outbreak: impact of mitigation measures and risk of contamination for patients and staff (edit) |
10.1055/A-1319-1201 |
| 2021-01-01 |
Audio Interview: Planning for the SARS-CoV-2 Vaccine Rollout (edit) |
10.1056/NEJME2100295 |
| 2021-01-01 |
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial revisited (edit) |
10.1016/J.IJANTIMICAG.2020.106243 |
| 2021-01-01 |
Response to uncertain effect of hydroxychloroquine and azithromycin on SARS-CoV-2 viral load (edit) |
10.1016/J.IJANTIMICAG.2020.106244 |
| 2021-01-01 |
Effect of hydroxychloroquine and azithromycin on SARS-CoV-2 clearance in COVID-19 patients, a meta-analysis (edit) |
10.1016/J.IJANTIMICAG.2020.106240 |
| 2021-01-01 |
Uncertain effects of hydroxychloroquine and azithromycin on SARS-Cov-2 viral load (edit) |
10.1016/J.IJANTIMICAG.2020.106169 |
| 2021-01-01 |
Interpretation of SARS-CoV-2 PCR results for the diagnosis of COVID-19 (edit) |
10.1016/J.IJANTIMICAG.2020.106238 |
| 2021-01-01 |
Boundaries of solidarity: a meta-ethnography of mask use during past epidemics to inform SARS-CoV-2 suppression (edit) |
10.1136/BMJGH-2020-004068 |
| 2021-01-01 |
The 2020 race towards SARS-CoV-2 specific vaccines (edit) |
10.7150/THNO.53691 |
| 2021-01-01 |
Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom, October to November 2020 (edit) |
10.2807/1560-7917.ES.2020.26.1.2002106 |
| 2021-01-01 |
Impact of mass testing during an epidemic rebound of SARS-CoV-2: a modelling study using the example of France (edit) |
10.2807/1560-7917.ES.2020.26.1.2001978 |
| 2021-01-01 |
Minimal transmission of SARS-CoV-2 from paediatric COVID-19 cases in primary schools, Norway, August to November 2020 (edit) |
10.2807/1560-7917.ES.2020.26.1.2002011 |
| 2021-01-01 |
SARS-CoV-2 spillover events (edit) |
10.1126/SCIENCE.ABF6097 |
| 2021-01-01 |
Actionable Cytopathogenic Host Responses of Human Alveolar Type 2 Cells to SARS-CoV-2 (edit) |
10.1016/J.MOLCEL.2020.12.028 |
| 2021-01-01 |
What are SARS-CoV-2 genomes from the WHO Africa region member states telling us? (edit) |
10.1136/BMJGH-2020-004408 |
| 2021-01-01 |
An action plan for pan-European defence against new SARS-CoV-2 variants (edit) |
10.1016/S0140-6736(21)00150-1 |
| 2021-01-01 |
The Health Protection (Coronavirus) (International Travel) (Scotland) Amendment Regulations 2021 (edit) |
|
| 2021-01-01 |
Shifts in global bat diversity suggest a possible role of climate change in the emergence of SARS-CoV-1 and SARS-CoV-2 (edit) |
10.1016/J.SCITOTENV.2021.145413 |
| 2021-01-01 |
Considerations for pooled testing of employees for SARS-CoV-2 (edit) |
10.1097/JOM.0000000000002049 |
| 2021-01-01 |
Signs, Symptoms, and Comorbidities Associated With Poor Outcomes Among Residents of a Skilled Nursing Facility With SARS-CoV-2 Infection—King County, Washington (edit) |
10.1016/J.JAMDA.2021.01.070 |
| 2021-01-01 |
Levels of SARS-CoV-2 Lineage P.1 Neutralization by Antibodies Elicited after Natural Infection and Vaccination (edit) |
10.2139/SSRN.3793486 |
| 2021-01-01 |
The Functional Classification of ORF8 in SARS-CoV-2 Replication, Immune Evasion, and Viral Pathogenesis Inferred through Phylogenetic Profiling (edit) |
10.1177/11769343211003079 |
| 2021-01-01 |
SARS-CoV-2 nucleocapsid protein phase separates with G3BPs to disassemble stress granules and facilitate viral production (edit) |
10.1016/J.SCIB.2021.01.013 |
| 2021-01-01 |
Latent rheumatic, thyroid and phospholipid autoimmunity in hospitalized patients with COVID-19 (edit) |
10.1016/J.JTAUTO.2021.100091 |
| 2021-01-01 |
Retrospective Detection of SARS-CoV-2 in Symptomatic Patients prior to Widespread Diagnostic Testing in Southern California (edit) |
10.1093/CID/CIAB360 |
| 2021-01-01 |
Human Surfactant Protein D Binds Spike Protein and Acts as an Entry Inhibitor of SARS-CoV-2 Pseudotyped Viral Particles (edit) |
10.3389/FIMMU.2021.641360 |
| 2021-01-01 |
Establishment of a well-characterized SARS-CoV-2 lentiviral pseudovirus neutralization assay using 293T cells with stable expression of ACE2 and TMPRSS2 (edit) |
10.1371/JOURNAL.PONE.0248348 |
| 2021-01-01 |
First Report on the Latvian SARS-CoV-2 Isolate Genetic Diversity (edit) |
10.3389/FMED.2021.626000 |
| 2021-01-01 |
Hydroxychloroquine-mediated inhibition of SARS-CoV-2 entry is attenuated by TMPRSS2 (edit) |
10.1371/JOURNAL.PPAT.1009212 |
| 2021-01-01 |
Furin cleavage of SARS-CoV-2 Spike promotes but is not essential for infection and cell-cell fusion (edit) |
10.1371/JOURNAL.PPAT.1009246 |
| 2021-01-01 |
The Case for S2: The Potential Benefits of the S2 Subunit of the SARS-CoV-2 Spike Protein as an Immunogen in Fighting the COVID-19 Pandemic (edit) |
10.3389/FIMMU.2021.637651 |
| 2021-01-01 |
Epithelial-mesenchymal transition induced by SARS-CoV-2 required transcriptional upregulation of Snail (edit) |
|
| 2021-01-01 |
An Optimized High-Throughput Immuno-Plaque Assay for SARS-CoV-2 (edit) |
10.3389/FMICB.2021.625136 |
| 2021-01-01 |
MDA5 Governs the Innate Immune Response to SARS-CoV-2 in Lung Epithelial Cells (edit) |
10.1016/J.CELREP.2020.108628 |
| 2021-01-01 |
Molecular mechanism of inhibiting the SARS-CoV-2 cell entry facilitator TMPRSS2 with camostat and nafamostat (edit) |
10.1039/D0SC05064D |
| 2021-01-01 |
Transcriptional Start Site Coverage Analysis in Plasma Cell-Free DNA Reveals Disease Severity and Tissue Specificity of COVID-19 Patients (edit) |
10.3389/FGENE.2021.663098 |
| 2021-01-01 |
Relational interaction between T-lymphocytes and SARS-CoV-2: A review (edit) |
10.4149/AV_2021_202 |
| 2021-01-01 |
On the origins of SARS-CoV-2 (edit) |
10.1038/S41591-020-01205-5 |
| 2021-01-01 |
SARS-CoV-2 NSP1 C-terminal (residues 131–180) is an intrinsically disordered region in isolation (edit) |
10.1016/J.CRVIRO.2021.100007 |
| 2021-01-01 |
Understanding the Molecular Biology of SARS-CoV-2 and the COVID-19 Pandemic: A Review (edit) |
10.2147/IDR.S306441 |
| 2021-01-01 |
Do Antibody Positive Healthcare Workers Have Lower SARS-CoV-2 Infection Rates than Antibody Negative Healthcare Workers? Large Multi-Centre Prospective Cohort Study (The SIREN Study), England: June to November 2020 (edit) |
10.2139/SSRN.3768524 |
| 2021-01-01 |
SARS-CoV-2 viral proteins NSP1 and NSP13 inhibit interferon activation through distinct mechanisms (edit) |
10.1371/JOURNAL.PONE.0253089 |
| 2021-01-01 |
On the Origin of SARS-CoV-2: Did Cell Culture Experiments Lead to Increased Virulence of the Progenitor Virus for Humans? (edit) |
10.21873/INVIVO.12384 |
| 2021-01-01 |
SARS-COV-2 as an artificial creation: scientific arguments and counterarguments (edit) |
10.25122/JML-2020-0175 |
| 2021-01-01 |
How glycobiology can help us treat and beat the COVID-19 pandemic (edit) |
10.1016/J.JBC.2021.100375 |
| 2021-01-01 |
Glycans of SARS-CoV-2 Spike Protein in Virus Infection and Antibody Production (edit) |
10.3389/FMOLB.2021.629873 |
| 2021-01-01 |
Heparan Sulfate Facilitates Spike Protein-Mediated SARS-CoV-2 Host Cell Invasion and Contributes to Increased Infection of SARS-CoV-2 G614 Mutant and in Lung Cancer (edit) |
10.3389/FMOLB.2021.649575 |
| 2021-01-01 |
SARS-CoV-2 ORF8 Forms Intracellular Aggregates and Inhibits IFNγ-Induced Antiviral Gene Expression in Human Lung Epithelial Cells (edit) |
10.3389/FIMMU.2021.679482 |
| 2021-01-01 |
SARS-CoV-2 Spike Protein Induces Degradation of Junctional Proteins That Maintain Endothelial Barrier Integrity (edit) |
10.3389/FCVM.2021.687783 |
| 2021-01-01 |
Identification of key signaling pathways induced by SARS-CoV2 that underlie thrombosis and vascular injury in COVID-19 patients (edit) |
10.1002/JLB.4COVR0920-552RR |
| 2021-01-01 |
Structure of SARS-CoV-2 ORF8, a rapidly evolving immune evasion protein (edit) |
10.1073/PNAS.2021785118 |
| 2021-01-01 |
Responses to acute infection with SARS-CoV-2 in the lungs of rhesus macaques, baboons and marmosets (edit) |
10.1038/S41564-020-00841-4 |
| 2021-01-01 |
SARS-CoV-2 variants with mutations at the S1/S2 cleavage site are generated in vitro during propagation in TMPRSS2-deficient cells (edit) |
10.1371/JOURNAL.PPAT.1009233 |
| 2021-01-01 |
Genomics-guided identification of potential modulators of SARS-CoV-2 entry proteases, TMPRSS2 and Cathepsins B/L (edit) |
10.21203/RS.3.RS-138273/V1 |
| 2021-01-01 |
SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis (edit) |
10.1016/S2666-5247(20)30172-5 |
| 2021-01-01 |
Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms (edit) |
10.3389/FMICB.2021.698169 |
| 2021-01-01 |
RIG-I-Like Receptor-Mediated Recognition of Viral Genomic RNA of Severe Acute Respiratory Syndrome Coronavirus-2 and Viral Escape From the Host Innate Immune Responses (edit) |
10.3389/FIMMU.2021.700926 |
| 2021-01-01 |
Asymmetric dynamics of dimeric SARS-CoV-2 and SARS-CoV main proteases in an apo form: Molecular dynamics study on fluctuations of active site, catalytic dyad, and hydration water (edit) |
10.1016/J.BBADVA.2021.100016 |
| 2021-01-01 |
Associastion of In-hospital Use of Statins, Aspirin, and Renin-Angiotensin-Aldosterone Inhibitors with Mortality and ICU Admission Due to COVID-19 (edit) |
|
| 2021-01-01 |
The chemical biology of coronavirus host–cell interactions (edit) |
10.1039/D0CB00197J |
| 2021-01-01 |
SARS-CoV-2 infection and the COVID-19 pandemic: a call to action for therapy and interventions to resolve the crisis of hospitalization, death, and handle the aftermath (edit) |
10.31083/J.RCM.2021.01.301 |
| 2021-01-01 |
SARS-CoV-2 Accessory Proteins in Viral Pathogenesis: Knowns and Unknowns (edit) |
10.3389/FIMMU.2021.708264 |
| 2021-01-01 |
The SARS-CoV-2 Y453F mink variant displays a pronounced increase in ACE-2 affinity but does not challenge antibody neutralization (edit) |
10.1016/J.JBC.2021.100536 |
| 2021-01-01 |
Possible host-adaptation of SARS-CoV-2 due to improved ACE2 receptor binding in mink (edit) |
10.1093/VE/VEAA094 |
| 2021-01-01 |
Commentary: Lethal Pneumonia Cases in Mojiang Miners (2012) and the Mineshaft Could Provide Important Clues to the Origin of SARS-CoV-2 (edit) |
10.3389/FPUBH.2021.702199 |
| 2021-01-01 |
The Many Faces of JAKs and STATs Within the COVID-19 Storm (edit) |
10.3389/FIMMU.2021.690477 |
| 2021-01-01 |
SARS-CoV-2 Lineages and Sub-Lineages Circulating Worldwide: A Dynamic Overview (edit) |
10.1159/000515340 |
| 2021-01-01 |
Multi-omic profiling of plasma reveals molecular alterations in children with COVID-19 (edit) |
10.7150/THNO.61832 |
| 2021-01-01 |
Drug Repurposing and Polypharmacology to Fight SARS-CoV-2 Through Inhibition of the Main Protease (edit) |
10.3389/FPHAR.2021.636989 |
| 2021-01-01 |
ORF3a-Mediated Incomplete Autophagy Facilitates Severe Acute Respiratory Syndrome Coronavirus-2 Replication (edit) |
10.3389/FCELL.2021.716208 |
| 2021-01-01 |
Single-Cell Transcriptomic Profiling of MAIT Cells in Patients With COVID-19 (edit) |
10.3389/FIMMU.2021.700152 |
| 2021-01-01 |
Global Geographic and Temporal Analysis of SARS-CoV-2 Haplotypes Normalized by COVID-19 Cases During the Pandemic (edit) |
10.3389/FMICB.2021.612432 |
| 2021-01-01 |
Poliovirus Vaccination Induces a Humoral Immune Response That Cross Reacts With SARS-CoV-2 (edit) |
10.3389/FMED.2021.710010 |
| 2021-01-01 |
BCG Vaccine Derived Peptides Induce SARS-CoV-2 T Cell Cross-Reactivity (edit) |
10.3389/FIMMU.2021.692729 |
| 2021-01-01 |
A computational study on hydroxychloroquine binding to target proteins related to SARS-COV-2 infection (edit) |
10.1016/J.IMU.2021.100714 |
| 2021-01-01 |
SARS-CoV-2 Proteome Harbors Peptides Which Are Able to Trigger Autoimmunity Responses: Implications for Infection, Vaccination, and Population Coverage (edit) |
10.3389/FIMMU.2021.705772 |
| 2021-01-01 |
First flare of ACPA-positive rheumatoid arthritis after SARS-CoV-2 infection (edit) |
10.1016/S2665-9913(20)30396-9 |
| 2021-01-01 |
SARS-CoV-2 Membrane Protein Inhibits Type I Interferon Production Through Ubiquitin-Mediated Degradation of TBK1 (edit) |
10.3389/FIMMU.2021.662989 |
| 2021-01-01 |
Development of ACE2 autoantibodies after SARS-CoV-2 infection (edit) |
10.1371/JOURNAL.PONE.0257016 |
| 2021-01-01 |
Transcriptomic Signatures of Airway Epithelium Infected With SARS-CoV-2: A Balance Between Anti-infection and Virus Load (edit) |
10.3389/FCELL.2021.735307 |
| 2021-01-01 |
Single cell resolution of SARS-CoV-2 tropism, antiviral responses, and susceptibility to therapies in primary human airway epithelium (edit) |
10.1371/JOURNAL.PPAT.1009292 |
| 2021-01-01 |
SARS-CoV-2 leads to a small vessel endotheliitis in the heart (edit) |
10.1016/J.EBIOM.2020.103182 |
| 2021-01-01 |
The Importance of Glycosylation in COVID-19 Infection (edit) |
|
| 2021-01-01 |
SARS-CoV-2 and endothelial cell interaction in COVID-19: molecular perspectives (edit) |
10.1530/VB-20-0017 |
| 2021-01-01 |
SARS-CoV-2 Accessory Protein ORF7b Mediates Tumor Necrosis Factor-α-Induced Apoptosis in Cells (edit) |
10.3389/FMICB.2021.654709 |
| 2021-01-01 |
Zinc2+ ion inhibits SARS-CoV-2 main protease and viral replication in vitro (edit) |
10.1039/D1CC03563K |
| 2021-01-01 |
Tracking the international spread of SARS-CoV-2 lineages B.1.1.7 and B.1.351/501Y-V2 (edit) |
10.12688/WELLCOMEOPENRES.16661.1 |
| 2021-01-01 |
Immunological Aspects of SARS-CoV-2 Infection and the Putative Beneficial Role of Vitamin-D (edit) |
10.3390/IJMS22105251 |
| 2021-01-01 |
The Effects of Aβ1-42 Binding to the SARS-CoV-2 Spike Protein S1 Subunit and Angiotensin-Converting Enzyme 2 (edit) |
10.3390/IJMS22158226 |
| 2021-01-01 |
Boosted Pro-Inflammatory Activity in Human PBMCs by Lipopolysaccharide and SARS-CoV-2 Spike Protein Is Regulated by α-1 Antitrypsin (edit) |
10.3390/IJMS22157941 |
| 2021-01-01 |
Inflammatory Response in COVID-19 Patients Resulting from the Interaction of the Inflammasome and SARS-CoV-2 (edit) |
10.3390/IJMS22157914 |
| 2021-01-01 |
SARS-CoV-2 Infected Pediatric Cerebral Cortical Neurons: Transcriptomic Analysis and Potential Role of Toll-like Receptors in Pathogenesis (edit) |
10.3390/IJMS22158059 |
| 2021-01-01 |
SARS-CoV-2 main protease suppresses type I interferon production by preventing nuclear translocation of phosphorylated IRF3 (edit) |
10.7150/IJBS.59943 |
| 2021-01-01 |
501Y.V2 and 501Y.V3 variants of SARS-CoV-2 lose binding to bamlanivimab in vitro (edit) |
10.1080/19420862.2021.1919285 |
| 2021-01-01 |
Molecular recognition of SARS-CoV-2 spike glycoprotein: quantum chemical hot spot and epitope analyses (edit) |
10.1039/D0SC06528E |
| 2021-01-01 |
Molecular characterization and the mutation pattern of SARS-CoV-2 during first and second wave outbreaks in Hiroshima, Japan (edit) |
10.1371/JOURNAL.PONE.0246383 |
| 2021-01-01 |
Structural Analysis of SARS-CoV-2 ORF8 Protein: Pathogenic and Therapeutic Implications (edit) |
10.3389/FGENE.2021.693227 |
| 2021-01-01 |
Pattern of circulating SARS-CoV-2-specific antibody-secreting and memory B-cell generation in patients with acute COVID-19 (edit) |
10.1002/CTI2.1245 |
| 2021-01-01 |
SARS-CoV-2 transmission in students of public schools of Catalonia (Spain) after a month of reopening (edit) |
10.1371/JOURNAL.PONE.0251593 |
| 2021-01-01 |
Surveillance of Acute SARS-CoV-2 Infections in School Children and Point-Prevalence During a Time of High Community Transmission in Switzerland (edit) |
10.3389/FPED.2021.645577 |
| 2021-01-01 |
What Impact Have SARS-CoV-2/COVID-19 Pandemic Induced Lockdown on the Number of OPD Patients of Diabetes, Hypertension, Stroke (CVA), Acute Heart Disease, Mental Illness, Epilepsy, Ophthalmic, Dental and Oncology in India During the Lockdown Months ( (edit) |
10.2139/SSRN.3884940 |
| 2021-01-01 |
What Impact Has Lockdown on SARS-CoV-2/COVID-19 Incidence, Prevalence and Mortality During Second Wave of Pandemic in 2021: Observational Analysis of Bihar (edit) |
10.2139/SSRN.3871321 |
| 2021-01-01 |
What Are the Factors Responsible for Increase in SARS-CoV-2/COVID-19 Pandemic Related Cases and Death in India in 2021? How Does Environmental, Host & Agent Factors of Epidemiological Triad Do Influence & Can Be Utilised to Manage Ongoing Pandemic Ca (edit) |
10.2139/SSRN.3833788 |
| 2021-01-01 |
What Impact Have SARS-CoV-2/COVID-19 Pandemic on Domestic Violence against Women in India across Different States and Union Territories from the Beginning of Lockdown Due to COVID-19 Pandemic in March 2020 Till 20Th September 2020? How COVID-19 Pande (edit) |
10.2139/SSRN.3826837 |
| 2021-01-01 |
Effect of ORF7 of SARS-CoV-2 on the Chemotaxis of Monocytes and Neutrophils In Vitro (edit) |
10.1155/2021/6803510 |
| 2021-01-01 |
Long-Term Elevated Inflammatory Protein Levels in Asymptomatic SARS-CoV-2 Infected Individuals (edit) |
10.3389/FIMMU.2021.709759 |
| 2021-01-01 |
SARS-CoV-2 Causes a Different Cytokine Response Compared to Other Cytokine Storm-Causing Respiratory Viruses in Severely Ill Patients (edit) |
10.3389/FIMMU.2021.629193 |
| 2021-01-01 |
Attenuating the Effects of Novel COVID-19 (SARS-CoV-2) Infection-Induced Cytokine Storm and the Implications (edit) |
10.2147/JIR.S301784 |
| 2021-01-01 |
High Seroprevalence of SARS-CoV-2 Eight Months After Introduction in Nairobi, Kenya (edit) |
10.2139/SSRN.3844795 |
| 2021-01-01 |
The emerging SARS-CoV, MERS-CoV, and SARS-CoV-2: An insight into the viruses zoonotic aspects (edit) |
10.14202/VETWORLD.2021.190-199 |
| 2021-01-01 |
Coronavirus Nsp1: Immune Response Suppression and Protein Expression Inhibition (edit) |
10.3389/FMICB.2021.752214 |
| 2021-01-01 |
Genetic risk for severe COVID-19 correlates with lower inflammatory marker levels in a SARS-CoV-2-negative cohort (edit) |
10.1002/CTI2.1292 |
| 2021-01-01 |
Impact of physical distancing policy on reducing transmission of SARS-CoV-2 globally: Perspective from government's response and residents' compliance (edit) |
10.1371/JOURNAL.PONE.0255873 |
| 2021-01-01 |
Circulating Exosomes Are Strongly Involved in SARS-CoV-2 Infection (edit) |
10.3389/FMOLB.2021.632290 |
| 2021-01-01 |
Metabolic Alterations in SARS-CoV-2 Infection and Its Implication in Kidney Dysfunction (edit) |
10.3389/FPHYS.2021.624698 |
| 2021-01-01 |
Partial N Gene Sequencing for SARS-CoV-2 Verification and Pathway Tracing (edit) |
10.2147/IMCRJ.S291166 |
| 2021-01-01 |
SARS-CoV-2 Infection Inducing Immune Thrombocytopenic Purpura: Case Series (edit) |
10.31486/TOJ.20.0100 |
| 2021-01-01 |
Current status of structure-based drug repurposing against COVID-19 by targeting SARS-CoV-2 proteins (edit) |
10.2142/BIOPHYSICO.BPPB-V18.025 |
| 2021-01-01 |
The high infectivity of SARS-CoV-2 B.1.1.7 is associated with increased interaction force between Spike-ACE2 caused by the viral N501Y mutation (edit) |
10.1101/2020.12.29.424708 |
| 2021-01-01 |
Large-Scale Recombinant Production of the SARS-CoV-2 Proteome for High-Throughput and Structural Biology Applications (edit) |
10.3389/FMOLB.2021.653148 |
| 2021-01-01 |
Angiotensin II receptor I auto-antibodies following SARS-CoV-2 infection (edit) |
10.1371/JOURNAL.PONE.0259902 |
| 2021-01-01 |
O-Glycosylation Landscapes of SARS-CoV-2 Spike Proteins (edit) |
10.3389/FCHEM.2021.689521 |
| 2021-01-01 |
The Fc-mediated effector functions of a potent SARS-CoV-2 neutralizing antibody, SC31, isolated from an early convalescent COVID-19 patient, are essential for the optimal therapeutic efficacy of the antibody (edit) |
10.1371/JOURNAL.PONE.0253487 |
| 2021-01-01 |
ACE2 glycans preferentially interact with SARS-CoV-2 over SARS-CoV (edit) |
10.1039/D1CC02305E |
| 2021-01-01 |
Genome-Wide Profiling Reveals Alternative Polyadenylation of Innate Immune-Related mRNA in Patients With COVID-19 (edit) |
10.3389/FIMMU.2021.756288 |
| 2021-01-01 |
SARS-CoV-2 Causes Acute Kidney Injury by Directly Infecting Renal Tubules (edit) |
10.3389/FCELL.2021.664868 |
| 2021-01-01 |
Inflammatory stress in SARS-COV-2 associated Acute Kidney Injury (edit) |
10.7150/IJBS.58791 |
| 2021-01-01 |
SARS-CoV-2 Antibodies Mediate Complement and Cellular Driven Inflammation (edit) |
10.3389/FIMMU.2021.767981 |
| 2021-01-01 |
BAT1 Amino Acid Transporter Complexed With SARS-CoV-2 Receptor ACE2 Forms a Heterodimer Functional Unit: Conformation Using Radiation Inactivation Analysis (edit) |
10.1093/FUNCTION/ZQAB027 |
| 2021-01-01 |
Role of Serine Proteases and Host Cell Receptors Involved in Proteolytic Activation, Entry of SARS-CoV-2 and Its Current Therapeutic Options (edit) |
10.2147/IDR.S308176 |
| 2021-01-01 |
Generation of a Sleeping Beauty Transposon-Based Cellular System for Rapid and Sensitive Screening for Compounds and Cellular Factors Limiting SARS-CoV-2 Replication (edit) |
10.3389/FMICB.2021.701198 |
| 2021-01-01 |
Prediction of Non-canonical Routes for SARS-CoV-2 Infection in Human Placenta Cells (edit) |
10.3389/FMOLB.2021.614728 |
| 2021-01-01 |
Recent progress in the development of potential drugs against SARS-CoV-2 (edit) |
10.1016/J.CRPHAR.2021.100057 |
| 2021-01-01 |
Site-Specific Glycosylation Patterns of the SARS-CoV-2 Spike Protein Derived From Recombinant Protein and Viral WA1 and D614G Strains (edit) |
10.3389/FCHEM.2021.767448 |
| 2021-01-01 |
Why Females Do Better: The X Chromosomal TLR7 Gene-Dose Effect in COVID-19 (edit) |
10.3389/FIMMU.2021.756262 |
| 2021-01-01 |
Metformin Suppresses Monocyte Immunometabolic Activation by SARS-CoV-2 Spike Protein Subunit 1 (edit) |
10.3389/FIMMU.2021.733921 |
| 2021-01-01 |
SARS-CoV-2-induced Overexpression of miR-4485 Suppresses Osteogenic Differentiation and Impairs Fracture Healing (edit) |
10.7150/IJBS.56657 |
| 2021-01-01 |
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Membrane (M) and Spike (S) Proteins Antagonize Host Type I Interferon Response (edit) |
10.3389/FCIMB.2021.766922 |
| 2021-01-01 |
SARS-CoV-2 N Protein Induces Acute Lung Injury in Mice NF-ĸB Activation (edit) |
10.3389/FIMMU.2021.791753 |
| 2021-01-01 |
Cholesterol-Rich Lipid Rafts as Platforms for SARS-CoV-2 Entry (edit) |
10.3389/FIMMU.2021.796855 |
| 2021-01-01 |
Structure and Function of Major SARS-CoV-2 and SARS-CoV Proteins (edit) |
10.1177/11779322211025876 |
| 2021-01-01 |
Dependence of SARS-CoV-2 infection on cholesterol-rich lipid raft and endosomal acidification (edit) |
10.1016/J.CSBJ.2021.04.001 |
| 2021-01-01 |
No Evidence for Human Monocyte-Derived Macrophage Infection and Antibody-Mediated Enhancement of SARS-CoV-2 Infection (edit) |
10.3389/FCIMB.2021.644574 |
| 2021-01-01 |
SARS-CoV-2-Encoded MiRNAs Inhibit Host Type I Interferon Pathway and Mediate Allelic Differential Expression of Susceptible Gene (edit) |
10.3389/FIMMU.2021.767726 |
| 2021-01-01 |
COVID-19 and Toll-Like Receptor 4 (TLR4): SARS-CoV-2 May Bind and Activate TLR4 to Increase ACE2 Expression, Facilitating Entry and Causing Hyperinflammation (edit) |
10.1155/2021/8874339 |
| 2021-01-01 |
COVID-19 Transcriptomic Atlas: A Comprehensive Analysis of COVID-19 Related Transcriptomics Datasets (edit) |
10.3389/FGENE.2021.755222 |
| 2021-01-01 |
SARS-CoV-2 Infects Endothelial Cells and (edit) |
10.3389/FCIMB.2021.701278 |
| 2021-01-01 |
Comprehensive Comparison of RNA-Seq Data of SARS-CoV-2, SARS-CoV and MERS-CoV Infections: Alternative Entry Routes and Innate Immune Responses (edit) |
10.3389/FIMMU.2021.656433 |
| 2021-01-01 |
Exploiting Connections for Viral Replication (edit) |
10.3389/FCELL.2021.640456 |
| 2021-01-01 |
Cytokine Storm and Mucus Hypersecretion in COVID-19: Review of Mechanisms (edit) |
10.2147/JIR.S271292 |
| 2021-01-01 |
The first year of Sars-Cov-2: Which mutations spread rapidly around the word? Minireview (edit) |
10.15761/GIMCI.1000204 |
| 2021-01-01 |
Multiple detection and spread of novel strains of the SARS-CoV-2 B.1.177 (B.1.177.75) lineage that test negative by a commercially available nucleocapsid gene real-time RT-PCR (edit) |
10.1080/22221751.2021.1933609 |
| 2021-01-01 |
Comparative Host Interactomes of the SARS-CoV-2 Nonstructural Protein 3 and Human Coronavirus Homologs (edit) |
10.1016/J.MCPRO.2021.100120 |
| 2021-01-01 |
SARS-CoV-2 Spike Antagonizes Innate Antiviral Immunity by Targeting Interferon Regulatory Factor 3 (edit) |
10.3389/FCIMB.2021.789462 |
| 2021-01-01 |
SARS-CoV-2 Spike Protein Suppresses ACE2 and Type I Interferon Expression in Primary Cells From Macaque Lung Bronchoalveolar Lavage (edit) |
10.3389/FIMMU.2021.658428 |
| 2021-01-01 |
Analysis of Emerging Variants in Structured Regions of the SARS-CoV-2 Genome (edit) |
10.1177/11769343211014167 |
| 2021-01-01 |
Discovery of Pre-Existing Drugs that Suppress the Replication of SARS-CoV-2 in Vitro (edit) |
10.2139/SSRN.3770925 |
| 2021-01-01 |
Gaps in Knowledge About SARS-CoV-2 & COVID-19 Among University Students Are Associated With Negative Attitudes Toward People With COVID-19: A Cross-Sectional Study in Cyprus (edit) |
10.3389/FPUBH.2021.758030 |
| 2021-01-01 |
Real-life validation of the Panbio™ COVID-19 antigen rapid test (Abbott) in community-dwelling subjects with symptoms of potential SARS-CoV-2 infection (edit) |
10.1016/J.ECLINM.2020.100677 |
| 2021-01-01 |
The Landscape of Aminoacyl-tRNA Synthetases Involved in Severe Acute Respiratory Syndrome Coronavirus 2 Infection (edit) |
10.3389/FPHYS.2021.818297 |
| 2021-01-01 |
SARS-CoV-2 uses major endothelial integrin αvβ3 to cause vascular dysregulation in-vitro during COVID-19 (edit) |
10.1371/JOURNAL.PONE.0253347 |
| 2021-01-01 |
Predictors of infection, symptoms development, and mortality in people with SARS-CoV-2 living in retirement nursing homes (edit) |
10.1371/JOURNAL.PONE.0248009 |
| 2021-01-01 |
Chronic SARS-CoV-2, a Cause of Post-acute COVID-19 Sequelae (Long-COVID)? (edit) |
10.3389/FMICB.2021.724654 |
| 2021-01-01 |
In-Silico Evidence for a Two Receptor Based Strategy of SARS-CoV-2 (edit) |
10.3389/FMOLB.2021.690655 |
| 2021-01-01 |
Imaging of SARS-CoV-2 infected Vero E6 cells by helium ion microscopy (edit) |
10.3762/BJNANO.12.13 |
| 2021-01-01 |
Morphology and morphogenesis of SARS-CoV-2 in Vero-E6 cells (edit) |
10.1590/0074-02760200443 |
| 2021-01-01 |
Endothelial cells are not productively infected by SARS-CoV-2 (edit) |
10.1002/CTI2.1350 |
| 2021-01-01 |
Functional Analysis of Human and Feline Coronavirus Cross-Reactive Antibodies Directed Against the SARS-CoV-2 Fusion Peptide (edit) |
10.3389/FIMMU.2021.790415 |
| 2021-01-01 |
Increased risk of hospitalisation and intensive care admission associated with reported cases of SARS-CoV-2 variants B.1.1.7 and B.1.351 in Norway, December 2020 -May 2021 (edit) |
10.1371/JOURNAL.PONE.0258513 |
| 2021-01-01 |
Immune evasion of SARS-CoV-2 from interferon antiviral system (edit) |
10.1016/J.CSBJ.2021.07.023 |
| 2021-01-01 |
The Global Epidemic of the SARS-CoV-2 Delta Variant, Key Spike Mutations and Immune Escape (edit) |
10.3389/FIMMU.2021.751778 |
| 2021-01-01 |
Alpha 1 Antitrypsin is an Inhibitor of the SARS-CoV-2-Priming Protease TMPRSS2 (edit) |
10.20411/PAI.V6I1.408 |
| 2021-01-01 |
The screening and evaluation of potential clinically significant HIV drug combinations against the SARS-CoV-2 virus (edit) |
10.1016/J.IMU.2021.100529 |
| 2021-01-01 |
A recently explored aspect of the iceberg named COVID-19: multisystem inflammatory syndrome in children (MIS-C) (edit) |
10.5152/TURKARCHPEDIATR.2020.20245 |
| 2021-01-01 |
SARS-CoV-2 genetic diversity in Venezuela: Predominance of D614G variants and analysis of one outbreak (edit) |
10.1371/JOURNAL.PONE.0247196 |
| 2021-01-01 |
Preliminary Evidence for IL-10-Induced ACE2 mRNA Expression in Lung-Derived and Endothelial Cells: Implications for SARS-Cov-2 ARDS Pathogenesis (edit) |
10.3389/FIMMU.2021.718136 |
| 2021-01-01 |
Parsing Immune Correlates of Protection Against SARS-CoV-2 from Biomedical Literature (edit) |
|
| 2021-01-01 |
Feasibility analysis on the construction of a web solution for hydrometeorological forecasting considering water body management and indicators for the SARS-COV-2 pandemic (edit) |
|
| 2021-01-01 |
Epidemiological dynamics of SARS-CoV-2 VOC Gamma in Rio de Janeiro, Brazil (edit) |
|
| 2021-01-01 |
Rigid monoclonal antibodies improve detection of SARS-CoV-2 nucleocapsid protein (edit) |
10.1080/19420862.2021.1905978 |
| 2021-01-01 |
Transcriptome Analysis of Peripheral Blood Mononuclear Cells in SARS-CoV-2 Naïve and Recovered Individuals Vaccinated With Inactivated Vaccine (edit) |
10.3389/FCIMB.2021.821828 |
| 2021-01-01 |
Molecular Mechanisms of Cardiac Injury Associated With Myocardial SARS-CoV-2 Infection (edit) |
10.3389/FCVM.2021.643958 |
| 2021-01-01 |
Growth, Antigenicity, and Immunogenicity of SARS-CoV-2 Spike Variants Revealed by a Live rVSV-SARS-CoV-2 Virus (edit) |
10.3389/FMED.2021.793437 |
| 2021-01-01 |
Impact of SARS-CoV-2 in Online Education, Predicting and Contrasting Mental Stress of Young Students: A Machine Learning Approach (edit) |
|
| 2021-01-01 |
SARS-CoV-2 infection in nonhuman primates alters the composition and functional activity of the gut microbiota (edit) |
10.1080/19490976.2021.1893113 |
| 2021-01-01 |
Bayes Lines Tool (BLT): a SQL-script for analyzing diagnostic test results with an application to SARS-CoV-2-testing [version 3; peer review: 2 approved] (edit) |
|
| 2021-01-01 |
A Computer-Aided Approach for the Discovery of D-Peptides as Inhibitors of SARS-CoV-2 Main Protease (edit) |
10.3389/FMOLB.2021.816166 |
| 2021-01-01 |
Molecular Docking and Dynamics Studies to Explore Effective Inhibitory Peptides Against the Spike Receptor Binding Domain of SARS-CoV-2 (edit) |
10.3389/FMOLB.2021.791642 |
| 2021-01-01 |
Carbon nanotubes for rapid capturing of SARS-COV-2 virus: revealing a mechanistic aspect of binding based on computational studies (edit) |
10.1039/D0RA08888A |
| 2021-01-01 |
In silico screening of antiviral compounds from Moringa oleifera for inhibition of SARS-CoV-2 main protease (edit) |
|
| 2021-01-01 |
In silico analysis of Phyllanthus amarus phytochemicals as potent drugs against SARS-CoV-2 main protease (edit) |
|
| 2021-01-01 |
Structural Consequences of Variation in SARS-CoV-2 B.1.1.7. (edit) |
10.33696/IMMUNOLOGY.3.085 |
| 2021-01-01 |
Evaluating angiotensin-converting enzyme 2-mediated SARS-CoV-2 entry across species (edit) |
10.1016/J.JBC.2021.100435 |
| 2021-01-01 |
Genomic surveillance of Nevada patients revealed prevalence of unique SARS-CoV-2 variants bearing mutations in the RdRp gene (edit) |
10.1016/J.JGG.2021.01.004 |
| 2021-01-01 |
Comparative genetic analyses of Korean bat coronaviruses with SARS-CoV and the newly emerged SARS-CoV-2 (edit) |
10.4142/JVS.2021.22.E12 |
| 2021-01-01 |
A Novel Prognostic Signature for Survival Prediction and Immune Implication Based on SARS-CoV-2-Related Genes in Kidney Renal Clear Cell Carcinoma (edit) |
10.3389/FBIOE.2021.744659 |
| 2021-01-01 |
SARS-CoV-2 Outbreak on a Spanish Mink Farm: Epidemiological, Molecular, and Pathological Studies (edit) |
10.3389/FVETS.2021.805004 |
| 2021-01-01 |
Transmission dynamics of SARS-CoV-2 within-host diversity in two major hospital outbreaks in South Africa (edit) |
10.1093/VE/VEAB041 |
| 2021-01-01 |
Honeysuckle (Lonicera japonica) and Huangqi (Astragalus membranaceus) Suppress SARS-CoV-2 Entry and COVID-19 Related Cytokine Storm in Vitro (edit) |
10.3389/FPHAR.2021.765553 |
| 2021-01-01 |
Rapid inactivation of SARS-CoV-2 by titanium dioxide surface coating [version 2; peer review: 2 approved] (edit) |
|
| 2021-01-01 |
Focus on renal blood flow in mechanically ventilated patients with SARS-CoV-2: a prospective pilot study (edit) |
10.1007/S10877-020-00633-5 |
| 2021-01-01 |
SARS-CoV-2 and self-medication in Cameroon: a mathematical model (edit) |
10.1080/17513758.2021.1883130 |
| 2021-01-01 |
Targeting the PI3K/AKT pathway: a potential new weapon in the global fight against SARS-CoV-2? (edit) |
10.7150/IJBS.63969 |
| 2021-01-01 |
Glycolytic Inhibitor 2-Deoxy-D-Glucose Attenuates SARS-CoV-2 Multiplication in Host Cells and Weakens the Infective Potential of Progeny Virions (edit) |
10.2139/SSRN.3981554 |
| 2021-01-01 |
Clinical and morphological characteristics of SARS-CoV-2-related myocarditis proven by the presence of viral RNA and proteins in myocardial tissue (edit) |
10.17116/PATOL2021830415 |
| 2021-01-01 |
SARS-CoV-2: the “Uncensored” Truth about Its Origin and Adipose-Derived Mesenchymal Stem Cells as New Potential Immune-Modulatory Weapon (edit) |
10.14336/AD.2021.0121 |
| 2021-01-01 |
Click triazole as a linker for drug repurposing against SARs-CoV-2: A greener approach in race to find COVID-19 therapeutic (edit) |
10.1016/J.CRGSC.2021.100064 |
| 2021-01-01 |
Overview of COVID-19 inflammatory pathogenesis from the therapeutic perspective (edit) |
10.1007/S12272-020-01301-7 |
| 2021-01-01 |
The effect of environmental pollution on immune evasion checkpoints of SARS-CoV-2 (edit) |
10.1016/J.ETAP.2020.103520 |
| 2021-01-01 |
Facing the challenge of viral mutations in the age of pandemic: Developing highly potent, broad-spectrum, and safe COVID-19 vaccines and therapeutics (edit) |
10.1002/CTM2.284 |
| 2021-01-01 |
Detection technologies and recent developments in the diagnosis of COVID-19 infection (edit) |
10.1007/S00253-020-11061-5 |
| 2021-01-01 |
Similarities and differences between HIV and SARS-CoV-2 (edit) |
10.7150/IJMS.50133 |
| 2021-01-01 |
SARS-CoV-2 Pandemic Impact Assessment for Hearing Impaired Patients (edit) |
10.4236/AID.2021.113023 |
| 2021-01-01 |
Inhibition of SARS-CoV-2 pseudovirus invasion by ACE2 protecting and Spike neutralizing peptides: An alternative approach to COVID19 prevention and therapy (edit) |
10.7150/IJBS.61476 |
| 2021-01-01 |
Open-source real-time quantitative RT-PCR-based on a RNA standard for the assessment of SARS-CoV-2 viral load (edit) |
10.1590/0074-02760210237 |
| 2021-01-01 |
Impaired Neutralisation of SARS-CoV-2 Delta Variant in Vaccinated Patients With B Cell Chronic Lymphocytic Leukaemia (edit) |
10.2139/SSRN.3941045 |
| 2021-01-01 |
Recommendations for primary healthcare doctors for the management of acute respiratory infections in children during the SARS-CoV-2 pandemic – COVID COMPASS (edit) |
10.5114/FMPCR.2021.102647 |
| 2021-01-01 |
Effectiveness of Tocilizumab with and without Dexamethasone in Patients with Severe COVID-19: A Retrospective Study (edit) |
10.2147/JIR.S322645 |
| 2021-01-01 |
An Update on SARS-CoV-2 Diversity in the Unites States National Capital Region: Evolution of Novel and Variants of Concern (edit) |
10.2139/SSRN.3854571 |
| 2021-01-01 |
SARS-CoV-2 Antibody Seroprevalence and Associated Risk Factors in an Urban District in Cameroon (edit) |
10.2139/SSRN.3812428 |
| 2021-01-01 |
SARS-CoV-2 Omicron Variant Exponential Transmission & Mitigation Dynamics: Translational Immuno-Epidemiologic Perspective (edit) |
10.2139/SSRN.3993979 |
| 2021-01-01 |
A multicenter survey on the aspects of everyday life in adult patients with primary antibody deficiencies treated with immunoglobulin G replacement during the COVID-19 pandemic (edit) |
10.1177/20587384211044344 |
| 2021-01-01 |
Medicinal Plants and Isolated Molecules Demonstrating Immunomodulation Activity as Potential Alternative Therapies for Viral Diseases Including COVID-19 (edit) |
10.3389/FIMMU.2021.637553 |
| 2021-01-01 |
Applications of SARS-CoV-2 sewage surveillance to fight against COVID-19 (edit) |
|
| 2021-01-01 |
Dominant transmission route of SARS-CoV-2 and its implication to indoor environment (edit) |
|
| 2021-01-01 |
The challenge and management of nosocomial infection control during the “post-outbreak” period of SARS-CoV-2 (edit) |
|
| 2021-01-01 |
The Mechanism of Glycosylation in SARS-CoV-2 Infection and Application in Drug Development (edit) |
|
| 2021-01-01 |
Air disinfection for SARS-CoV-2 and other pathogens:A review (edit) |
10.16511/J.CNKI.QHDXXB.2021.25.004 |
| 2021-01-01 |
The BNT162b2 mRNA Vaccine Against SARS-CoV-2 Reprograms Both Adaptive and Innate Immune Responses (edit) |
10.2139/SSRN.3839624 |
| 2021-01-01 |
Examining the Public's Most Frequently Asked Questions Regarding COVID-19 Vaccines Using Search Engine Analytics in the United States: Observational Study (edit) |
10.2196/28740 |
| 2021-01-01 |
A case of peritoneal dialysis in which SARS-CoV-2 was diagnosed by sudden hearing loss (edit) |
10.1080/0886022X.2021.1882493 |
| 2021-01-01 |
Resources and computational strategies to advance small molecule SARS-CoV-2 discovery: Lessons from the pandemic and preparing for future health crises (edit) |
10.1016/J.CSBJ.2021.04.059 |
| 2021-01-01 |
Medication management and adherence during the COVID-19 pandemic: Perspectives and experiences from low-and middle-income countries (edit) |
10.1016/J.SAPHARM.2020.04.007 |
| 2021-01-01 |
Drugs supply and pharmaceutical care management practices at a designated hospital during the COVID-19 epidemic (edit) |
10.1016/J.SAPHARM.2020.04.001 |
| 2021-01-01 |
SARS-CoV-2 in the semen: where does it come from? (edit) |
10.1111/ANDR.12839 |
| 2021-01-01 |
The impact of the SARS-CoV-2 infection, with special reference to the haematological setting (edit) |
10.1002/JMV.26197 |
| 2021-01-01 |
Discharged COVID-19 Patients Testing Positive Again for SARS-CoV-2 RNA: A Minireview of Published Studies from China (edit) |
10.1002/JMV.26250 |
| 2021-01-01 |
SARS-CoV-2 and Male Infertility: Possible Multifaceted Pathology (edit) |
10.1007/S43032-020-00261-Z |
| 2021-01-01 |
SARS-CoV-2 replicating in non-primate mammalian cells probably have critical advantages for COVID-19 vaccines due to anti-Gal antibodies: A minireview and proposals (edit) |
10.1002/JMV.26312 |
| 2021-01-01 |
Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection (edit) |
10.1016/J.AMJMED.2020.07.003 |
| 2021-01-01 |
Bats in Ecosystems and their Wide Spectrum of Viral Infectious Threats: SARS-CoV-2 and other emerging viruses (edit) |
10.1016/J.IJID.2020.08.050 |
| 2021-01-01 |
Viral, host and environmental factors that favor anthropozoonotic spillover of coronaviruses: An opinionated review, focusing on SARS-CoV, MERS-CoV and SARS-CoV-2 (edit) |
10.1016/J.SCITOTENV.2020.141483 |
| 2021-01-01 |
Ocular manifestations of SARS-CoV-2: Literature review (edit) |
10.1016/J.OFTAL.2020.07.020 |
| 2021-01-01 |
Ocular tropism of coronavirus (CoVs): a comparison of the interaction between the animal-to-human transmitted coronaviruses (SARS-CoV-1, SARS-CoV-2, MERS-CoV, CoV-229E, NL63, OC43, HKU1) and the eye (edit) |
10.1007/S10792-020-01575-2 |
| 2021-01-01 |
Obesity and SARS-CoV-2: Considerations on bariatric surgery and recommendations for the start of surgical activity (edit) |
10.1016/J.CIRESP.2020.06.005 |
| 2021-01-01 |
T cell responses and therapies against SARS-CoV-2 infection (edit) |
10.1111/IMM.13262 |
| 2021-01-01 |
Transmission of SARS-CoV-2: A Review of Viral, Host, and Environmental Factors (edit) |
10.7326/M20-5008 |
| 2021-01-01 |
COVID-19 Racial/Ethnic Inequities in Acute Care and Critical Illness Survivorship (edit) |
10.1513/ANNALSATS.202005-549VP |
| 2020-12-31 |
A novel virtual screening procedure identifies Pralatrexate as inhibitor of SARS-CoV-2 RdRp and it reduces viral replication in vitro (edit) |
10.1371/JOURNAL.PCBI.1008489 |
| 2020-12-31 |
Is the association between IgG anti-cardiolipin autoantibodies and COVID-19 severity related to the lung injury or to the SARS-CoV-2 infection? (edit) |
10.1002/ART.41633 |
| 2020-12-31 |
Fisetin 8-C-glucoside as entry inhibitor in SARS CoV-2 infection: molecular modelling study (edit) |
10.1080/07391102.2020.1868335 |
| 2020-12-31 |
MicroRNAs and SARS-CoV-2 life cycle, pathogenesis, and mutations: biomarkers or therapeutic agents? (edit) |
10.1080/15384101.2020.1867792 |
| 2020-12-31 |
Changes of peripheral lymphocyte subset in patients with SARS-CoV-2 infection during the whole course of disease (edit) |
10.1080/17476348.2021.1866991 |
| 2020-12-31 |
SARS-CoV-2 infection induces mixed M1/M2 phenotype in circulating monocytes and alterations in both dendritic cell and monocyte subsets (edit) |
10.1371/JOURNAL.PONE.0241097 |
| 2020-12-31 |
Antibody response to SARS-CoV-2 infection in humans: A systematic review (edit) |
10.1371/JOURNAL.PONE.0244126 |
| 2020-12-31 |
SARS-CoV-2 PCR cycle threshold at hospital admission associated with patient mortality (edit) |
10.1371/JOURNAL.PONE.0244777 |
| 2020-12-31 |
A direct RT-qPCR approach to test large numbers of individuals for SARS-CoV-2 (edit) |
10.1371/JOURNAL.PONE.0244824 |
| 2020-12-31 |
Optimizing direct RT-LAMP to detect transmissible SARS-CoV-2 from primary nasopharyngeal swab samples (edit) |
10.1371/JOURNAL.PONE.0244882 |
| 2020-12-31 |
SARS-CoV-2 / COVID-19 in patients on the Swiss national transplant waiting list (edit) |
10.4414/SMW.2020.20451 |
| 2020-12-31 |
Mass population screening for SARS-CoV-2 and false positives-why Liverpool shows we have a problem (edit) |
10.1136/BMJ.M4954 |
| 2020-12-31 |
Identifying the natural polyphenol catechin as a multi-targeted agent against SARS-CoV-2 for the plausible therapy of COVID-19: an integrated computational approach (edit) |
10.1093/BIB/BBAA378 |
| 2020-12-31 |
Diabetes mellitus and SARS-CoV-2 infection: pathophysiologic mechanisms and implications in management (edit) |
10.2174/1573399817666210101110253 |
| 2020-12-31 |
Healthcare Worker Seroconversion for SARS-CoV-2 at Two Large Health Systems in San Diego (edit) |
10.1016/J.AJIC.2020.12.017 |
| 2020-12-31 |
Does coronaviruses induce neurodegenerative diseases? A systematic review on the neurotropism and neuroinvasion of SARS-CoV-2 (edit) |
10.5582/DDT.2020.03106 |
| 2020-12-31 |
Lead SARS-CoV-2 Candidate Vaccines: Expectations from Phase III Trials and Recommendations Post-Vaccine Approval (edit) |
10.3390/V13010054 |
| 2020-12-31 |
Unpacking Pandora From Its Box: Deciphering the Molecular Basis of the SARS-CoV-2 Coronavirus (edit) |
10.3390/IJMS22010386 |
| 2020-12-31 |
A Novel Perspective Approach to Explore Pros and Cons of Face Mask in Prevention the Spread of SARS-CoV-2 and other pathogens (edit) |
10.1016/J.JSPS.2020.12.014 |
| 2020-12-31 |
Computational Design of SARS-CoV-2 Spike Glycoproteins to Increase Immunogenicity by T Cell Epitope Engineering (edit) |
10.1016/J.CSBJ.2020.12.039 |
| 2020-12-31 |
Interactive SARS-CoV-2 mutation timemaps (edit) |
|
| 2020-12-31 |
SARS-CoV-2 infection in infants aged 28 days and younger. A multicentre case series (edit) |
10.1016/J.ANPEDE.2020.12.005 |
| 2020-12-31 |
Computationally predicted SARS-COV-2 encoded microRNAs target NFKB, JAK/STAT and TGFB signaling pathways (edit) |
10.1016/J.GENREP.2020.101012 |
| 2020-12-31 |
Early-pandemic wastewater surveillance of SARS-CoV-2 in Southern Nevada: Methodology, occurrence, and incidence/prevalence considerations (edit) |
10.1016/J.WROA.2020.100086 |
| 2020-12-31 |
SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans (edit) |
10.21203/RS.3.RS-132821/V1 |
| 2020-12-31 |
Calcio-Herbal Medicine Divya-Swasari-Vati Ameliorates SARS-CoV-2 Spike Protein-Induced Pathological Features and Inflammation in Humanized Zebrafish Model by Moderating IL-6 and TNF-α Cytokines (edit) |
10.2147/JIR.S286199 |
| 2020-12-31 |
Botulinum toxin as an ultrasensitive reporter for bacterial and SARS-CoV-2 nucleic acid diagnostics (edit) |
10.1016/J.BIOS.2020.112953 |
| 2020-12-31 |
Implementation of early management of iron deficiency in pregnancy during the SARS-CoV-2 pandemic (edit) |
10.1016/J.EJOGRB.2020.12.055 |
| 2020-12-31 |
COVID-19 Evolution in the Post-Vaccination Phase: Endemic or Extinct? (edit) |
10.1021/ACSPTSCI.0C00220 |
| 2020-12-31 |
Free Energy Landscapes for RBD Opening in SARS-CoV-2 Spike Glycoprotein Simulations Suggest Key Interactions and a Potentially Druggable Allosteric Pocket (edit) |
10.26434/CHEMRXIV.13502646.V1 |
| 2020-12-31 |
SARS-CoV-2 spike protein-, main protease- and papain-like-protease-targeting peptides from seed proteins following gastrointestinal digestion: An in silico study (edit) |
10.1016/J.PHYPLU.2020.100016 |
| 2020-12-31 |
Clinical Traits of SARS-CoV-2 Infection (edit) |
10.22416/1382-4376-2020-30-6-28-39 |
| 2020-12-30 |
Evolutionary and codon usage preference insights into spike glycoprotein of SARS-CoV-2 (edit) |
10.1093/BIB/BBAA383 |
| 2020-12-30 |
Microscopy-based assay for semi-quantitative detection of SARS-CoV-2 specific antibodies in human sera: A semi-quantitative, high throughput, microscopy-based assay expands existing approaches to measure SARS-CoV-2 specific antibody levels in human (edit) |
10.1002/BIES.202000257 |
| 2020-12-30 |
The development of neutralizing antibodies against SARS-CoV-2 and their common features (edit) |
10.1093/JMCB/MJAA070 |
| 2020-12-30 |
SARS-CoV-2 infection and the antiviral innate immune response (edit) |
10.1093/JMCB/MJAA071 |
| 2020-12-30 |
Informed sequential pooling approach to detect SARS-CoV-2 infection (edit) |
10.1371/JOURNAL.PONE.0244475 |
| 2020-12-30 |
Safety, tolerability, and outcomes of losartan use in patients hospitalized with SARS-CoV-2 infection: A feasibility study (edit) |
10.1371/JOURNAL.PONE.0244708 |
| 2020-12-30 |
Vaccinating Detained Migrants against SARS-CoV-2 - Preventing Another Tragedy (edit) |
10.1056/NEJMPV2035416 |
| 2020-12-30 |
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine (edit) |
10.1056/NEJMOA2035389 |
| 2020-12-30 |
Developing multiplex ddPCR assays for SARS-CoV-2 detection based on probe mix and amplitude based multiplexing (edit) |
10.1080/14737159.2021.1865807 |
| 2020-12-30 |
Design of a companion bioinformatic tool to detect the emergence and geographical distribution of SARS-CoV-2 Spike protein genetic variants (edit) |
10.1186/S12967-020-02675-4 |
| 2020-12-30 |
ACE2: the molecular doorway to SARS-CoV-2 (edit) |
10.1186/S13578-020-00519-8 |
| 2020-12-30 |
Impact of corticosteroids and immunosuppressive therapies on symptomatic SARS-CoV-2 infection in a large cohort of patients with chronic inflammatory arthritis (edit) |
10.1186/S13075-020-02395-6 |
| 2020-12-30 |
Patients with Cancer Seroconvert Typically After SARS-CoV-2 Infection (edit) |
10.1158/2159-8290.CD-RW2020-188 |
| 2020-12-30 |
Unraveling the mechanism of arbidol binding and inhibition of SARS-CoV-2: Insights from atomistic simulations (edit) |
10.1016/J.EJPHAR.2020.173836 |
| 2020-12-30 |
Dysbiosis in SARS-CoV-2 infected patients (edit) |
10.1053/J.GASTRO.2020.12.056 |
| 2020-12-30 |
Correlation between liver function tests abnormalities and interleukin-6 serum levels in patients with SARS-CoV-2 infection (edit) |
10.1053/J.GASTRO.2020.05.103 |
| 2020-12-30 |
Does sampling saliva increase detection of SARS-CoV-2 by RT-PCR? Comparing saliva with oro-nasopharyngeal swabs (edit) |
10.1016/J.JVIROMET.2020.114049 |
| 2020-12-30 |
Inhibition of the replication of SARS-CoV-2 in human cells by the FDA-approved drug chlorpromazine (edit) |
10.1016/J.IJANTIMICAG.2020.106274 |
| 2020-12-30 |
Stability of SARS-CoV-2 RNA in Viral Lysis Buffer Stored at Different Temperatures (edit) |
10.1055/S-0040-1722551 |
| 2020-12-30 |
Interferon-α2b Treatment for COVID-19 Is Associated with Improvements in Lung Abnormalities (edit) |
10.3390/V13010044 |
| 2020-12-30 |
PSGL-1 Inhibits the Incorporation of SARS-CoV and SARS-CoV-2 Spike Glycoproteins into Pseudovirions and Impairs Pseudovirus Attachment and Infectivity (edit) |
10.3390/V13010046 |
| 2020-12-30 |
SARS-CoV-2 Nucleocapsid Protein Interacts with RIG-I and Represses RIG-Mediated IFN-β Production (edit) |
10.3390/V13010047 |
| 2020-12-30 |
Computational Analysis of SARS-CoV-2 and SARS-Like Coronavirus Diversity in Human, Bat and Pangolin Populations (edit) |
10.3390/V13010049 |
| 2020-12-30 |
SARS-CoV-2 related Acute on chronic liver failure (S-ACLF) (edit) |
10.1016/J.JCEH.2020.12.007 |
| 2020-12-30 |
UMAP-assisted $K$-means clustering of large-scale SARS-CoV-2 mutation datasets (edit) |
|
| 2020-12-30 |
Synonymous mutations and the molecular evolution of SARS-CoV-2 origins (edit) |
10.1093/VE/VEAA098 |
| 2020-12-30 |
Screening a library of FDA-approved and bioactive compounds for antiviral activity against SARS-CoV-2 (edit) |
10.1101/2020.12.30.424862 |
| 2020-12-30 |
Network analysis and molecular mapping for SARS-CoV-2 to reveal drug targets and repurposing of clinically developed drugs (edit) |
10.1016/J.VIROL.2020.12.006 |
| 2020-12-30 |
Inactivating SARS-CoV-2 by electrochemical oxidation (edit) |
10.1016/J.SCIB.2020.12.025 |
| 2020-12-29 |
Update Alert 4: Masks for Prevention of Respiratory Virus Infections, Including SARS-CoV-2, in Health Care and Community Settings (edit) |
10.7326/L20-1429 |
| 2020-12-29 |
SARS-Cov-2 infection in transplant-related biology: Where do we stand? (edit) |
10.12659/AOT.924768 |
| 2020-12-29 |
Susceptibility of turkeys, chickens and chicken embryos to SARS-CoV-2 (edit) |
10.1111/TBED.13970 |
| 2020-12-29 |
In silico analysis of phytochemicals as potential inhibitors of proteases involved in SARS-CoV-2 infection (edit) |
10.1080/07391102.2020.1866669 |
| 2020-12-29 |
Rebuttal to Overinterpretation of the antiviral results for human coronavirus 229E (HCoV-229E) relative to severe acute respiratory syndrome coronavirus -2 (SARS-CoV-2) by Rowpar Pharmaceuticals (edit) |
10.1002/JMV.26762 |
| 2020-12-29 |
SARS-CoV-2 proteases PLpro and 3CLpro cleave IRF3 and critical modulators of inflammatory pathways (NLRP12 and TAB1): implications for disease presentation across species (edit) |
10.1080/22221751.2020.1870414 |
| 2020-12-29 |
Using in silico viral kinetic models to guide therapeutic strategies during a pandemic: An example in SARS-CoV-2 (edit) |
10.1111/BCP.14718 |
| 2020-12-29 |
Uncovering Flexible Active Site Conformations of SARS-CoV-2 3CL Proteases through Protease Pharmacophore Clusters and COVID-19 Drug Repurposing (edit) |
10.1021/ACSNANO.0C07383 |
| 2020-12-29 |
Time to Enhance Immunity via Functional Foods and Supplements: Hope for SARS-CoV-2 Outbreak (edit) |
|
| 2020-12-29 |
Estimating the susceptibility to SARS-CoV-2 infection with rituximab use for pemphigus vulgaris (edit) |
10.1080/09546634.2020.1870648 |
| 2020-12-29 |
Differential Effects of SARS-CoV-2 Pandemic on Patients Presenting to a Neurological Emergency Room Depending on Their Triage Score in an Area with low COVID-19 Incidence (edit) |
10.1111/ENE.14709 |
| 2020-12-29 |
Perceptions and Experiences of the University of Nottingham Pilot SARS-CoV-2 Asymptomatic Testing Service: A Mixed-Methods Study (edit) |
10.3390/IJERPH18010188 |
| 2020-12-29 |
SARS-CoV-2/COVID-19 in multiple sclerosis patients receiving disease-modifying therapy (edit) |
10.1016/J.CLINEURO.2020.106451 |
| 2020-12-29 |
Exogenous pulmonary surfactant: a review focused on adjunctive therapy for SARS CoV-2 including SP-A and SP-D as added clinical marker (edit) |
10.1016/J.COCIS.2020.101413 |
| 2020-12-29 |
Computational modelling supports that Dengue virus envelope antibodies can bind to SARS-CoV-2 receptor binding sites: Is pre-exposure to dengue virus protective against COVID-19 severity? (edit) |
10.1016/J.CSBJ.2020.12.037 |
| 2020-12-29 |
Exploiting cheminformatic and machine learning to navigate the available chemical space of potential small molecule inhibitors of SARS-CoV-2 (edit) |
10.1016/J.CSBJ.2020.12.028 |
| 2020-12-29 |
LinearSampling: Linear-Time Stochastic Sampling of RNA Secondary Structure with Applications to SARS-CoV-2 (edit) |
10.1101/2020.12.29.424617 |
| 2020-12-29 |
Neutralising antibodies in Spike mediated SARS-CoV-2 adaptation (edit) |
10.1101/2020.12.05.20241927 |
| 2020-12-29 |
Neutralizing antibody-dependent and -independent immune responses against SARS-CoV-2 in cynomolgus macaques (edit) |
10.1016/J.VIROL.2020.12.013 |
| 2020-12-29 |
Reciprocating-flowing on-a-chip enables ultra-fast immunobinding for multiplexed rapid ELISA detection of SARS-CoV-2 antibody (edit) |
10.1016/J.BIOS.2020.112920 |
| 2020-12-29 |
In-depth blood proteome profiling analysis revealed distinct functional characteristics of plasma proteins between severe and non-severe COVID-19 patients (edit) |
10.1038/S41598-020-80120-8 |
| 2020-12-29 |
Structural dynamics of the SARS-CoV-2 frameshift-stimulatory pseudoknot reveal topologically distinct conformers (edit) |
10.1101/2020.12.28.424630 |
| 2020-12-29 |
The immune system view of the coronavirus SARS-CoV-2 (edit) |
10.1186/S13062-020-00283-2 |
| 2020-12-29 |
Environmental Dependence of the Structure of the C-terminal Domain of the SARS-CoV-2 Envelope Protein (edit) |
10.1101/2020.12.29.424646 |
| 2020-12-29 |
Assessment of SARS-CoV-2 infection by Reverse transcription-PCR and serology in the Paris area: a cross-sectional study (edit) |
10.1136/BMJPO-2020-000887 |
| 2020-12-28 |
Small molecule stabilization of non-native protein-protein interactions of SARS-CoV-2 N protein as a mechanism of action against COVID-19 (edit) |
10.1080/07391102.2020.1860828 |
| 2020-12-28 |
Authors' reply re: Maternal transmission of SARS-COV-2 to the neonate, and possible routes for such transmission: a systematic review and critical analysis (edit) |
10.1111/1471-0528.16436 |
| 2020-12-28 |
Development of a Low-Cost Cotton-Tipped Electrochemical Immunosensor for the Detection of SARS-CoV-2 (edit) |
10.1021/ACS.ANALCHEM.0C04719 |
| 2020-12-28 |
Seroprevalence of SARS-CoV-2 IgG specific antibodies among healthcare workers in the Northern Metropolitan Area of Barcelona, Spain, after the first pandemic wave (edit) |
10.1371/JOURNAL.PONE.0244348 |
| 2020-12-28 |
SARS-CoV-2: a protocol for disinfection of toothbrushes (edit) |
10.1093/INFDIS/JIAA794 |
| 2020-12-28 |
Persistence of SARS-CoV-2 antibodies in kidney transplant recipients (edit) |
10.1111/AJT.16469 |
| 2020-12-28 |
A Review on Screening Models for Potential Therapeutic Candidates and Targets Against SARS-CoV-2 (edit) |
10.2174/1389450121666201228122845 |
| 2020-12-28 |
Effect of SARS-CoV-2 Infection in Pregnancy on Maternal and Neonatal Outcomes in Africa: An AFREhealth Call for Evidence through Multicountry Research Collaboration (edit) |
10.4269/AJTMH.20-1553 |
| 2020-12-28 |
Seroprevalence of SARS-CoV-2 infections among children visiting a hospital (edit) |
10.1002/PED4.12231 |
| 2020-12-28 |
Cell-mediated immunity to SARS-CoV-2 (edit) |
10.1002/PED4.12228 |
| 2020-12-28 |
Comparison of Four SARS-CoV-2 Neutralization Assays (edit) |
10.3390/VACCINES9010013 |
| 2020-12-28 |
Performance of a Point-of-Care Test for the Rapid Detection of SARS-CoV-2 Antigen (edit) |
10.3390/MICROORGANISMS9010058 |
| 2020-12-28 |
Nicotine Changes Airway Epithelial Phenotype and May Increase the SARS-COV-2 Infection Severity (edit) |
10.3390/MOLECULES26010101 |
| 2020-12-28 |
Emergence of a new SARS-CoV-2 variant in the UK (edit) |
10.1016/J.JINF.2020.12.024 |
| 2020-12-28 |
Comparison of seven commercial SARS-CoV-2 nucleic acid detection reagents with pseudovirus as quality control material (edit) |
10.1016/J.JMOLDX.2020.12.002 |
| 2020-12-28 |
False Positive Results Of IgM/IgG antibodies against antigen of the SARS-CoV-2 in sera stored before the 2020 Endemia in Italy (edit) |
10.1016/J.IJID.2020.12.067 |
| 2020-12-28 |
Identification and computational analysis of mutations in SARS-CoV-2 (edit) |
10.1016/J.COMPBIOMED.2020.104166 |
| 2020-12-28 |
Periprocedural complications in patients with SARS-CoV-2 infection compared to those without infection: A nationwide propensity-matched analysis (edit) |
10.1016/J.AMJSURG.2020.12.024 |
| 2020-12-28 |
Extracellular vesicles containing ACE2 efficiently prevent infection by SARS-CoV-2 Spike protein-containing virus (edit) |
10.1002/JEV2.12050 |
| 2020-12-28 |
Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and the Risk of SARS-CoV-2 Infection or Hospitalization With COVID-19 Disease: A Systematic Review and Meta-Analysis (edit) |
10.1097/MJT.0000000000001319 |
| 2020-12-28 |
SARS-CoV-2 disease severity and transmission efficiency is increased for airborne but not fomite exposure in Syrian hamsters (edit) |
10.1101/2020.12.28.424565 |
| 2020-12-28 |
Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions and monocytes for optimal therapeutic protection (edit) |
10.1101/2020.12.28.424554 |
| 2020-12-28 |
Emerging SARS-CoV-2 diversity revealed by rapid whole genome sequence typing (edit) |
10.1101/2020.12.28.424582 |
| 2020-12-28 |
SARS-CoV-2 escape in vitro from a highly neutralizing COVID-19 convalescent plasma (edit) |
10.1101/2020.12.28.424451 |
| 2020-12-28 |
MHC-II constrains the natural neutralizing antibody response to the SARS-CoV-2 spike RBM in humans (edit) |
10.1101/2020.12.26.424449 |
| 2020-12-28 |
An in-silico evaluation of different bioactive molecules of tea for their inhibition potency against non structural protein-15 of SARS-CoV-2 (edit) |
10.1016/J.FOODCHEM.2020.128933 |
| 2020-12-28 |
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) membrane (M) protein inhibits type I and III interferon production by targeting RIG-I/MDA-5 signaling (edit) |
10.1038/S41392-020-00438-7 |
| 2020-12-28 |
The Global Landscape of SARS-CoV-2 Genomes, Variants, and Haplotypes in 2019nCoVR (edit) |
10.1016/J.GPB.2020.09.001 |
| 2020-12-27 |
Vertical Transmission of SARS-CoV-2 from COVID-19 Infected Pregnant Women: A Review on Intrauterine Transmission (edit) |
10.1080/15513815.2020.1865491 |
| 2020-12-27 |
Design and in silico study of the novel coumarin derivatives against SARS-CoV-2 main enzymes (edit) |
10.1080/07391102.2020.1863263 |
| 2020-12-27 |
Prediction of potential inhibitors against SARS-CoV-2 endoribonuclease: RNA immunity sensing (edit) |
10.1080/07391102.2020.1863265 |
| 2020-12-27 |
Dual inhibition of SARS-CoV-2 spike and main protease through a repurposed drug, rutin (edit) |
10.1080/07391102.2020.1864476 |
| 2020-12-27 |
A Computational Approach to Explore the Interaction of Semisynthetic Nitrogenous Heterocyclic Compounds with the SARS-CoV-2 Main Protease (edit) |
10.3390/BIOM11010018 |
| 2020-12-27 |
Computational investigations of three main drugs and its comparison with synthesized compounds as potent inhibitors of SARS-CoV-2 main protease (Mᵖʳᵒ): DFT, QSAR, Molecular docking, and in silico toxicity analysis (edit) |
10.1016/J.JKSUS.2020.101315 |
| 2020-12-26 |
Field performance and public health response using the BinaxNOW TM Rapid SARS-CoV-2 antigen detection assay during community-based testing (edit) |
10.1093/CID/CIAA1890 |
| 2020-12-26 |
No cases of asymptomatic SARS-CoV-2 infection among healthcare staff in a city under lockdown restrictions: lessons to inform 'Operation Moonshot' (edit) |
10.1093/PUBMED/FDAA237 |
| 2020-12-26 |
SARS-CoV-2 serosurveillance in a patient population reveals differences in virus exposure and antibody-mediated immunity according to host demography and healthcare setting (edit) |
10.1093/INFDIS/JIAA788 |
| 2020-12-26 |
Quantitative Detection of SARS-CoV-2 RNA in nasopharyngeal samples from infected patients with mild disease (edit) |
10.1002/JMV.26761 |
| 2020-12-26 |
Classical and alternative receptors for SARS-CoV-2 therapeutic strategy (edit) |
10.1002/RMV.2207 |
| 2020-12-26 |
Prior SARS-CoV-2 infection is associated with protection against symptomatic reinfection (edit) |
10.1016/J.JINF.2020.12.023 |
| 2020-12-26 |
Transmission of SARS-CoV-2 in surgical smoke during laparoscopy: a prospective, proof-of-concept study (edit) |
10.1016/J.JMIG.2020.12.026 |
| 2020-12-26 |
Environmental Contamination of SARS-CoV-2 in a Non-Healthcare Setting (edit) |
10.3390/IJERPH18010117 |
| 2020-12-26 |
Endothelium Infection and Dysregulation by SARS-CoV-2: Evidence and Caveats in COVID-19 (edit) |
10.3390/V13010029 |
| 2020-12-26 |
A New Transmission Route for the Propagation of the SARS-CoV-2 Coronavirus (edit) |
10.3390/BIOLOGY10010010 |
| 2020-12-26 |
In silico study of the potential interactions of 4'-acetamidechalcones with protein targets in SARS-CoV-2 (edit) |
10.1016/J.BBRC.2020.12.074 |
| 2020-12-26 |
SARS-CoV-2 paediatric inflammatory syndrome (edit) |
10.1016/J.PAED.2020.12.003 |
| 2020-12-26 |
Atlas of ACE2 gene expression reveals novel insights into transmission of SARS-CoV-2 (edit) |
10.1016/J.HELIYON.2020.E05850 |
| 2020-12-26 |
TCR meta-clonotypes for biomarker discovery with tcrdist3: quantification of public, HLA-restricted TCR biomarkers of SARS-CoV-2 infection (edit) |
10.1101/2020.12.24.424260 |
| 2020-12-26 |
Evaluation of a new simultaneous anti-SARS-CoV-2 IgA, IgM and IgG screening automated assay based on native inactivated virus (edit) |
10.1016/J.INTIMP.2020.107330 |
| 2020-12-26 |
D614G Mutation Alters SARS-CoV-2 Spike Conformation and Enhances Protease Cleavage at the S1/S2 Junction (edit) |
10.1016/J.CELREP.2020.108630 |
| 2020-12-26 |
Extensive High-Order Complexes within SARS-CoV-2 Proteome Revealed by Compartmentalization-Aided Interaction Screening (edit) |
10.1101/2020.12.26.424422 |
| 2020-12-26 |
Genomic diversity of SARS-CoV-2 can be accelerated by a mutation in the nsp14 gene (edit) |
10.1101/2020.12.23.424231 |
| 2020-12-25 |
SARS-CoV-2 Serologic Assays in Control and Unknown Populations Demonstrate the Necessity of Virus Neutralization Testing (edit) |
10.1093/INFDIS/JIAA797 |
| 2020-12-25 |
Overinterpretation of the antiviral results for human coronavirus strain 229E (HCoV-229E) relative to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) (edit) |
10.1002/JMV.26722 |
| 2020-12-25 |
The impact of the SARS-CoV-2 pandemic and COVID-19 on Lung Transplantation in the UK: lessons learned from the first wave (edit) |
10.1111/CTR.14210 |
| 2020-12-25 |
Commentary on Simons et al. (2020): Public health implications of the suggested association between nicotine, smoking and infection with SARS-CoV-2 (edit) |
10.1111/ADD.15356 |
| 2020-12-25 |
Peripheral Blood Immune Profiling of Convalescent Plasma Donors Reveals Alterations in Specific Immune Subpopulations Even at 2 Months Post SARS-CoV-2 Infection (edit) |
10.3390/V13010026 |
| 2020-12-25 |
Platforms Exploited for SARS-CoV-2 Vaccine Development (edit) |
10.3390/VACCINES9010011 |
| 2020-12-25 |
Impaired anti-SARS-CoV-2 antibody response in non-severe COVID-19 patients with diabetes mellitus: A preliminary report (edit) |
10.1016/J.DSX.2020.12.035 |
| 2020-12-25 |
Rapid Determination of Remdesivir (SARS-CoV-2 Drug) in Human Plasma for Therapeutic Drug Monitoring in COVID-19-Patients (edit) |
10.1016/J.PROCBIO.2020.12.014 |
| 2020-12-25 |
Comparison of digital PCR and quantitative PCR with various SARS-CoV-2 primer-probe sets (edit) |
10.4014/JMB.2009.09006 |
| 2020-12-24 |
On the Challenges for the Diagnosis of SARS-CoV-2 Based on a Review of Current Methodologies (edit) |
10.1021/ACSSENSORS.0C01382 |
| 2020-12-24 |
Two prolonged viremic SARS-CoV-2 infections with conserved viral genome for two months (edit) |
10.1016/J.MEEGID.2020.104684 |
| 2020-12-24 |
Rationally Designed ACE2-Derived Peptides Inhibit SARS-CoV-2 (edit) |
10.1021/ACS.BIOCONJCHEM.0C00664 |
| 2020-12-24 |
Pediatric and adult patients diagnosed with celiac disease are not at higher risk of contracting SARS-CoV-2 (COVID-19) (edit) |
10.1016/J.CGH.2020.12.027 |
| 2020-12-24 |
Re: Moore et al., Detection of SARS-CoV-2 within the healthcare environment: a multicentre study conducted during the first wave of the COVID-19 outbreak in England, Journal of Hospital Infection, 2020 (edit) |
10.1016/J.JHIN.2020.12.014 |
| 2020-12-24 |
Naringerin as candidate drug against SARS-CoV-2: The role for TPC2 genomic variants in COVID-19 (edit) |
10.1016/J.PHRS.2020.105402 |
| 2020-12-24 |
Structure and regulation of coronavirus genomes: state-of-the-art and novel insights from SARS-CoV-2 studies (edit) |
10.1042/BST20200670 |
| 2020-12-24 |
SARS-CoV-2 serologic immune response in exogenously immunosuppressed patients (edit) |
10.1093/JALM/JFAA232 |
| 2020-12-24 |
Fostamatinib Inhibits Neutrophils Extracellular Traps Induced by COVID-19 Patient Plasma: A Potential Therapeutic (edit) |
10.1093/INFDIS/JIAA789 |
| 2020-12-24 |
Role of IgM and IgA Antibodies in the Neutralization of SARS-CoV-2 (edit) |
10.1093/INFDIS/JIAA784 |
| 2020-12-24 |
De novo acquired hemophilia as an immune dysregulation phenomenon following SARS-CoV-2 infection (edit) |
10.1111/TRF.16254 |
| 2020-12-24 |
Simple Modifications of Therapeutic Plasma Exchange Treatments during the SARS-CoV-2 Pandemic (edit) |
10.1111/TRF.16248 |
| 2020-12-24 |
Co-infection of malaria and early clearance of SARS-CoV-2 in healthcare workers (edit) |
10.1002/JMV.26760 |
| 2020-12-24 |
Repurposing of renin inhibitors as SARS-COV-2 main protease inhibitors: A computational study (edit) |
10.1016/J.VIROL.2020.12.008 |
| 2020-12-24 |
Do Animals Play a Role in the Transmission of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)? A Commentary (edit) |
10.3390/ANI11010016 |
| 2020-12-24 |
Inactivation of Human Coronavirus by Titania Nanoparticle Coatings and UVC Radiation: Throwing Light on SARS-CoV-2 (edit) |
10.3390/V13010019 |
| 2020-12-24 |
Blocking Effect of Demethylzeylasteral on the Interaction between Human ACE2 Protein and SARS-CoV-2 RBD Protein Discovered Using SPR Technology (edit) |
10.3390/MOLECULES26010057 |
| 2020-12-24 |
Impact of Genetic Variability in ACE2 Expression on the Evolutionary Dynamics of SARS-CoV-2 Spike D614G Mutation (edit) |
10.3390/GENES12010016 |
| 2020-12-24 |
Evaluation of a commercially-available surrogate virus neutralization test for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) (edit) |
10.1016/J.DIAGMICROBIO.2020.115294 |
| 2020-12-24 |
Two SARS-CoV-2 IgG immunoassays comparison and time-course profile of antibodies response (edit) |
10.1016/J.DIAGMICROBIO.2020.115297 |
| 2020-12-24 |
Comparison of SARS-CoV-2 IgM and IgG seroconversion profiles among hospitalized patients in two US cities (edit) |
10.1016/J.DIAGMICROBIO.2020.115300 |
| 2020-12-24 |
Poor outcome of SARS-CoV-2 infection in patients with severe asthma on biologic therapy (edit) |
10.1016/J.RMED.2020.106287 |
| 2020-12-24 |
Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial (edit) |
10.1016/J.ECLINM.2020.100689 |
| 2020-12-24 |
SARS-CoV-2 serological cross-reactivity with autoantibodies (edit) |
10.1016/S2665-9913(20)30358-1 |
| 2020-12-24 |
SARS-CoV-2 serological cross-reactivity with autoantibodies - Authors' reply (edit) |
10.1016/S2665-9913(20)30359-3 |
| 2020-12-24 |
Potent in vitro anti-SARS-CoV-2 activity by gallinamide A and analogues via inhibition of cathepsin L (edit) |
10.1101/2020.12.23.424111 |
| 2020-12-24 |
Cell-type apoptosis in lung during SARS-CoV-2 infection (edit) |
10.1101/2020.12.23.424254 |
| 2020-12-24 |
Patterns of SARS-CoV-2 testing preferences in a national cohort in the United States (edit) |
10.1101/2020.12.22.20248747 |
| 2020-12-24 |
A method for prioritizing risk groups for early SARS-CoV-2 Vaccination, By the Numbers (edit) |
10.1101/2020.12.18.20248504 |
| 2020-12-24 |
SARS-CoV-2 Testing in Florida, Illinois, and Maryland: Access and Barriers (edit) |
10.1101/2020.12.23.20248789 |
| 2020-12-24 |
Analysis of the prison population's mental health in Sars-Cov-2 pandemic: Qualitative analysis (edit) |
10.1016/J.PSYCHRES.2020.113669 |
| 2020-12-24 |
Biosensing Detection of the SARS-CoV-2 D614G Mutation (edit) |
10.1016/J.TIG.2020.12.004 |
| 2020-12-24 |
Performance evaluation of antibody-based point-of-care devices intended for the identification of immune responses to SARS-CoV-2 (edit) |
10.1016/J.DIAGMICROBIO.2020.115298 |
| 2020-12-24 |
Risk factors for community transmission of SARS-CoV-2. A cross-sectional study in 116,678 people (edit) |
10.1101/2020.12.23.20248514 |
| 2020-12-23 |
Suppression of SARS-CoV-2 after a second wave in Victoria, Australia (edit) |
10.1093/CID/CIAA1882 |
| 2020-12-23 |
Research Status of SARS-CoV-2 on Cardiovascular System Injury in Children (edit) |
10.21470/1678-9741-2020-0192 |
| 2020-12-23 |
Prevalence and Clinical Impact of Sars-CoV-2 Silent Carriers Among Actively Treated CANCER Patients During The COVID-19 Pandemic (edit) |
10.1002/ONCO.13654 |
| 2020-12-23 |
Susceptibility of rabbits to SARS-CoV-2 (edit) |
10.1080/22221751.2020.1868951 |
| 2020-12-23 |
Thoughts of death, depression, and guilt in a healthcare worker who infected her husband with SARS-CoV-2: A case report (edit) |
10.2174/1871527319666201223155533 |
| 2020-12-23 |
Lack of Association of Initial Viral Load in SARS-CoV-2 Patients with In-Hospital Mortality (edit) |
10.4269/AJTMH.20-1427 |
| 2020-12-23 |
Evaluation of variant frequency in SARS-CoV-2 infection-related genes utilizing lung cancer genomic database (edit) |
10.1016/J.LUNGCAN.2020.12.016 |
| 2020-12-23 |
Analytical and clinical evaluation of four commercial SARS-CoV-2 serological immunoassaysin hospitalized patients and ambulatory individuals (edit) |
10.1016/J.JVIROMET.2020.114060 |
| 2020-12-23 |
SARS-Cov-2 ORF3a: Mutability and function (edit) |
10.1016/J.IJBIOMAC.2020.12.142 |
| 2020-12-23 |
The Importance and Challenges of Identifying SARS-CoV-2 Reinfections (edit) |
10.1128/JCM.02769-20 |
| 2020-12-23 |
Risk of SARS-CoV-2 Transmission in Health Care Personnel Working in a Pediatric COVID-19 Unit (edit) |
10.1542/HPEDS.2020-003855 |
| 2020-12-23 |
Prevalence of Health Care and Hospital Worker SARS-CoV-2 IgG Antibody in a Pediatric Hospital (edit) |
10.1542/HPEDS.2020-003517 |
| 2020-12-23 |
Comparison of the immunogenicity & protective efficacy of various SARS-CoV-2 vaccine candidates in non-human primates (edit) |
|
| 2020-12-23 |
Heparin Inhibits Cellular Invasion by SARS-CoV-2: Structural Dependence of the Interaction of the Spike S1 Receptor-Binding Domain with Heparin (edit) |
10.1055/S-0040-1721319 |
| 2020-12-23 |
Stillbirths and the COVID-19 pandemic: Looking beyond SARS-CoV-2 infection (edit) |
10.1002/IJGO.13564 |
| 2020-12-23 |
Effects of cigarette smoking on SARS-CoV-2 receptor ACE2 expression in the respiratory epithelium† (edit) |
10.1002/PATH.5607 |
| 2020-12-23 |
Erythema annulare centrifugum with anosmia and ageusia in a SARS-CoV-2 exposed patient successfully treated with doxycycline (edit) |
10.1111/IJD.15356 |
| 2020-12-23 |
Evaluation of SARS-CoV-2 antibody titers and potency for convalescent plasma donation: a brief commentary (edit) |
10.1111/VOX.13060 |
| 2020-12-23 |
Dynamic tracking of variant frequencies depicts the evolution of mutation sites amongst SARS-CoV-2 genomes from India (edit) |
10.1002/JMV.26756 |
| 2020-12-23 |
Association Between Low Zinc Levels and Severity of Acute Respiratory Distress Syndrome by New Coronavirus (SARS-CoV-2) (edit) |
10.1002/NCP.10612 |
| 2020-12-23 |
Prolonged SARS-CoV-2 viral shedding in patients with chronic kidney disease (edit) |
10.1111/NEP.13844 |
| 2020-12-23 |
Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers (edit) |
10.1056/NEJMOA2034545 |
| 2020-12-23 |
Childhood B-Cell Acute Lymphoblastic Leukemia Following SARS CoV-2 Infection: A Potential Second "Hit" in Leukemogenesis (edit) |
10.1097/MPH.0000000000002037 |
| 2020-12-23 |
SARS-CoV-2 related pneumonia in an adult with cystic fibrosis: natural favourable clinical course or effective therapy? (edit) |
10.4081/MONALDI.2020.1579 |
| 2020-12-23 |
Anomaly Identification during Polymerase Chain Reaction for Detecting SARS-CoV-2 Using Artificial Intelligence Trained from Simulated Data (edit) |
10.3390/MOLECULES26010020 |
| 2020-12-23 |
Fluoroquinolone Antibiotics Exhibit Low Antiviral Activity against SARS-CoV-2 and MERS-CoV (edit) |
10.3390/V13010008 |
| 2020-12-23 |
Drug Repurposing Approach against Novel Coronavirus Disease (COVID-19) through Virtual Screening Targeting SARS-CoV-2 Main Protease (edit) |
10.3390/BIOLOGY10010002 |
| 2020-12-23 |
Road Map to Understanding SARS-CoV-2 Clinico-Immunopathology and COVID-19 Disease Severity (edit) |
10.3390/PATHOGENS10010005 |
| 2020-12-23 |
Multiple Recombination Events and Strong Purifying Selection at the Origin of SARS-CoV-2 Spike Glycoprotein Increased Correlated Dynamic Movements (edit) |
10.3390/IJMS22010080 |
| 2020-12-23 |
Structure and Hierarchy of SARS-CoV-2 Infection Dynamics Models Revealed by Reaction Network Analysis (edit) |
10.3390/V13010014 |
| 2020-12-23 |
The Use of Medical and Non-Medical Services by the Elderly during the SARS-CoV-2 Pandemic Differs between General and Specialist Practice: A One-Center Study in Poland (edit) |
10.3390/HEALTHCARE9010008 |
| 2020-12-23 |
Severe SARS-CoV-2 patients develop a higher specific T-cell response (edit) |
10.1002/CTI2.1217 |
| 2020-12-23 |
High Rate of SARS-CoV-2 Transmission Due to Choir Practice in France at the Beginning of the COVID-19 Pandemic (edit) |
10.1016/J.JVOICE.2020.11.029 |
| 2020-12-23 |
Evaluation of clinical utility of novel coronavirus antigen detection reagent, Espline® SARS-CoV-2 (edit) |
10.1016/J.JIAC.2020.11.015 |
| 2020-12-23 |
The use of convalescent plasma for pediatric patients with SARS-CoV-2: A systematic literature review (edit) |
10.1016/J.TRANSCI.2020.103043 |
| 2020-12-23 |
Immunochromatographic test for the detection of SARS-CoV-2 in saliva (edit) |
10.1016/J.JIAC.2020.11.016 |
| 2020-12-23 |
SARS-CoV-2 Receptors are Expressed on Human Platelets and the Effect of Aspirin on Clinical Outcomes in COVID-19 Patients (edit) |
10.21203/RS.3.RS-119031/V1 |
| 2020-12-23 |
SARS-CoV-2 Envelope (E) Protein Interacts with PDZ-Domain-2 of Host Tight Junction Protein ZO1 (edit) |
10.1101/2020.12.22.422708 |
| 2020-12-23 |
Assessing the risk of COVID-19 from multiple pathways of exposure to SARS-CoV-2: Modeling in health-care settings and effectiveness of nonpharmaceutical interventions (edit) |
10.1016/J.ENVINT.2020.106338 |
| 2020-12-23 |
A novel screening strategy of anti-SARS-CoV-2 drugs via blocking interaction between Spike RBD and ACE2 (edit) |
10.1016/J.ENVINT.2020.106361 |
| 2020-12-23 |
Host Cell Proteases Drive Early or Late SARS-CoV-2 Penetration (edit) |
10.1101/2020.12.22.423906 |
| 2020-12-23 |
COVID-19: Coronavirus Vaccine Development Updates (edit) |
10.3389/FIMMU.2020.602256 |
| 2020-12-23 |
Direct RNA nanopore sequencing of SARS-CoV-2 extracted from critical material from swabs (edit) |
10.1101/2020.12.21.20191346 |
| 2020-12-23 |
Visualization of SARS-CoV-2 using Immuno RNA-Fluorescence In Situ Hybridization (edit) |
10.3791/62067 |
| 2020-12-23 |
Compromised SARS-CoV-2-specific placental antibody transfer (edit) |
10.1016/J.CELL.2020.12.027 |
| 2020-12-23 |
Computational Prediction of Potential Inhibitors of the Main Protease of SARS-CoV-2 (edit) |
10.3389/FCHEM.2020.590263 |
| 2020-12-23 |
A Comprehensive Analysis of cis-Acting RNA Elements in the SARS-CoV-2 Genome by a Bioinformatics Approach (edit) |
10.3389/FGENE.2020.572702 |
| 2020-12-22 |
The impact of structural bioinformatics tools and resources on SARS-CoV-2 research and therapeutic strategies (edit) |
10.1093/BIB/BBAA362 |
| 2020-12-22 |
Polypropylene oxygenators: Risk of SARS-CoV-2 contamination in the operation theatre? (edit) |
10.1177/0391398820981586 |
| 2020-12-22 |
SARS-CoV-2 effects on the renin-angiotensin-aldosterone system, therapeutic implications (edit) |
10.1111/APHA.13608 |
| 2020-12-22 |
Structure-Based Screening to Discover New Inhibitors for Papain-like Proteinase of SARS-CoV-2: An In Silico Study (edit) |
10.1021/ACS.JPROTEOME.0C00836 |
| 2020-12-22 |
Sensitivity and specificity of 14 SARS-CoV-2 serological assays and their diagnostic potential in RT-PCR negative COVID-19 infections (edit) |
10.1080/17843286.2020.1861885 |
| 2020-12-22 |
Sex differences in immune responses to SARS-CoV-2 in patients with COVID-19 (edit) |
10.1042/BSR20202074 |
| 2020-12-22 |
Fully automated detection and differentiation of pandemic and endemic coronaviruses (NL63, 229E, HKU1, OC43 and SARS-CoV-2) on the Hologic Panther Fusion (edit) |
10.1002/JMV.26749 |
| 2020-12-22 |
Antibody Responses 8 Months after Asymptomatic or Mild SARS-CoV-2 Infection (edit) |
10.3201/EID2703.204543 |
| 2020-12-22 |
Summary of the Detection Kits for SARS-CoV-2 Approved by the National Medical Products Administration of China and Their Application for Diagnosis of COVID-19 (edit) |
10.1007/S12250-020-00331-1 |
| 2020-12-22 |
Preparing for SARS-CoV-2 Vaccines in US Immigrant Communities: Strategies for Allocation, Distribution, and Communication (edit) |
10.2105/AJPH.2020.306047 |
| 2020-12-22 |
A spatial-temporal description of the SARS-CoV-2 infections in Indonesia during the first six months of outbreak (edit) |
10.1371/JOURNAL.PONE.0243703 |
| 2020-12-22 |
Designing of a next generation multiepitope based vaccine (MEV) against SARS-COV-2: Immunoinformatics and in silico approaches (edit) |
10.1371/JOURNAL.PONE.0244176 |
| 2020-12-22 |
Robust and sustained antibody response to SARS-CoV-2 in a child pre and post autologous hematopoietic stem cell transplant (edit) |
10.1002/PBC.28848 |
| 2020-12-22 |
SARS-CoV-2 Infection in a Spanish Cohort of CKD-5D Patients: Prevalence, Clinical Presentation, Outcomes, and De-Isolation Results (edit) |
10.1159/000510557 |
| 2020-12-22 |
Structure and dynamics of membrane protein in SARS-CoV-2 (edit) |
10.1080/07391102.2020.1861983 |
| 2020-12-22 |
Robuste T-Zell-Antwort schützt vor SARS-CoV-2-Re-Infektion (edit) |
10.1007/S15033-020-1936-9 |
| 2020-12-22 |
Modeling the Stability of SARS-CoV-2 on Personal Protective Equipment (PPE) (edit) |
10.4269/AJTMH.20-1508 |
| 2020-12-22 |
Muscle Biopsy Findings in a Case of SARS-CoV-2-Associated Muscle Injury (edit) |
10.1093/JNEN/NLAA155 |
| 2020-12-22 |
Tmprss2 specific miRNAs as promising regulators for SARS-CoV-2 entry checkpoint (edit) |
10.1016/J.VIRUSRES.2020.198275 |
| 2020-12-22 |
Closing the portal to SARS-CoV-2 cellular entry: May open newer avenues… (edit) |
10.1016/J.MEHY.2020.110464 |
| 2020-12-22 |
Spontaneous portomesenteric thrombosis in a non-cirrhotic patient with SARS-CoV-2 infection (edit) |
10.1136/BCR-2020-238906 |
| 2020-12-22 |
SARS-CoV-2 RNAaemia predicts clinical deterioration and extrapulmonary complications from COVID-19 (edit) |
10.1101/2020.12.19.20248561 |
| 2020-12-22 |
SARS-CoV-2 and Asbestos Exposure: Can Our Experience With Mesothelioma Patients Help Us Understand the Psychological Consequences of COVID-19 and Develop Interventions? (edit) |
10.3389/FPSYG.2020.584320 |
| 2020-12-22 |
Acute Ischemic Stroke in SARS-CoV, MERS-CoV, SARS-CoV-2: Neurorehabilitation Implications of Inflammation Induced Immunological Responses Affecting Vascular Systems (edit) |
10.3389/FNEUR.2020.565665 |
| 2020-12-22 |
Improving Detection Efficiency of SARS-CoV-2 Nucleic Acid Testing (edit) |
10.3389/FCIMB.2020.558472 |
| 2020-12-22 |
Public Database-Driven Insights Into Aging Stress-Associated Defective Gut Barrier With Low SARS-CoV-2 Receptors (edit) |
10.3389/FMED.2020.606991 |
| 2020-12-22 |
SARS CoV-2 Organotropism Associated Pathogenic Relationship of Gut-Brain Axis and Illness (edit) |
10.3389/FMOLB.2020.606779 |
| 2020-12-22 |
An integrative look at SARS‑CoV‑2 (Review) (edit) |
10.3892/IJMM.2020.4828 |
| 2020-12-22 |
Emergence and rapid spread of a new severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa (edit) |
10.1101/2020.12.21.20248640 |
| 2020-12-22 |
Early empirical assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom, October to November 2020 (edit) |
10.1101/2020.12.20.20248581 |
| 2020-12-22 |
Not Only Survival but Stronger: The Impact of Alarming Invader of SARS-CoV-2 on Global Education (edit) |
10.15354/SIEF.20.OR061 |
| 2020-12-21 |
SARS-CoV-2 hot-spot mutations are significantly enriched within inverted repeats and CpG island loci (edit) |
10.1093/BIB/BBAA385 |
| 2020-12-21 |
The SARS-CoV-2 Cytopathic Effect Is Blocked by Lysosome Alkalizing Small Molecules (edit) |
10.1021/ACSINFECDIS.0C00349 |
| 2020-12-21 |
Persistence of SARS-CoV-2 in the first trimester placenta leading to transplacental transmission and fetal demise from an asymptomatic mother (edit) |
10.1093/HUMREP/DEAA367 |
| 2020-12-21 |
CorGAT: a tool for the functional annotation of SARS-CoV-2 genomes (edit) |
10.1093/BIOINFORMATICS/BTAA1047 |
| 2020-12-21 |
The SARS-CoV-2 Spike protein has a broad tropism for mammalian ACE2 proteins (edit) |
10.1371/JOURNAL.PBIO.3001016 |
| 2020-12-21 |
Positive association of angiotensin II receptor blockers, not angiotensin-converting enzyme inhibitors, with an increased vulnerability to SARS-CoV-2 infection in patients hospitalized for suspected COVID-19 pneumonia (edit) |
10.1371/JOURNAL.PONE.0244349 |
| 2020-12-21 |
Assessment and comparison of recombinant proteins from different sources for the detection of SARS-CoV-2 infection by using protein microarray (edit) |
10.1093/ABBS/GMAA152 |
| 2020-12-21 |
A comparative insight into genomic landscape of SARS-CoV-2 and identification of mutations associated with origin of infection and diversity (edit) |
10.1002/JMV.26744 |
| 2020-12-21 |
Decontamination of SARS-CoV-2 Contaminated N95 Filtering Facepiece Respirators (FFRs) with Moist Heat Generated by a Multicooker (edit) |
10.1111/LAM.13443 |
| 2020-12-21 |
Usage of peptidases by SARS-CoV-2 and several human coronaviruses as receptors: A mysterious story (edit) |
10.1002/BAB.2087 |
| 2020-12-21 |
SARS-CoV-2 nach Lungentransplantation: Eine Fallserie mit heterogenen Merkmalen im CT (edit) |
10.1055/A-1309-2140 |
| 2020-12-21 |
Action of dipeptidyl peptidase-4 inhibitors on SARS-CoV-2 main protease (edit) |
10.1002/CMDC.202000921 |
| 2020-12-21 |
Search for SARS-CoV-2 RNA in platelets from COVID-19 patients (edit) |
10.1080/09537104.2020.1859104 |
| 2020-12-21 |
SARS-CoV-2 infection in farmed minks, associated zoonotic concerns, and importance of the One Health approach during the ongoing COVID-19 pandemic (edit) |
10.1080/01652176.2020.1867776 |
| 2020-12-21 |
Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020 (edit) |
10.3201/EID2702.201960 |
| 2020-12-21 |
A ligand selection strategy identifies chemical probes targeting the proteases of SARS-CoV-2 (edit) |
10.1002/ANIE.202016113 |
| 2020-12-21 |
SARS-CoV-2 not found in pressure injury exudates from COVID-19 patients (edit) |
10.1111/JOCD.13887 |
| 2020-12-21 |
Potential drawbacks of SARS-COV-2 seroprevalence surveys (edit) |
10.1016/J.JHIN.2020.12.011 |
| 2020-12-21 |
Persistent replication of SARS-CoV-2 in a severely immunocompromised treated with several courses of remdesivir (edit) |
10.1016/J.IJID.2020.12.050 |
| 2020-12-21 |
The RNA Architecture of the SARS-CoV-2 3'-Untranslated Region (edit) |
10.3390/V12121473 |
| 2020-12-21 |
SARS-CoV-2 and Other Respiratory Viruses: What Does Oxidative Stress Have to Do with It? (edit) |
10.1155/2020/8844280 |
| 2020-12-21 |
[Perinatal outcomes and serological results in neonates of pregnant women seropositive to SARS-CoV-2: A cross-sectional descriptive study] (edit) |
10.5867/MEDWAVE.2020.11.8084 |
| 2020-12-21 |
Frequency of nasopharyngeal swab collection and positivity for SARS-CoV-2 infection in the population of the Italian province of Udine with and without chronic conditions (edit) |
10.1016/J.HEALTHPOL.2020.12.009 |
| 2020-12-21 |
Full-length genome characterization and phylogenetic analysis of SARS-CoV-2 virus strains from Yogyakarta and Central Java, Indonesia (edit) |
10.7717/PEERJ.10575 |
| 2020-12-21 |
Laboratory organisation and management of SARS-CoV-2 infection in Niger, West Africa (edit) |
10.4102/AJLM.V9I1.1308 |
| 2020-12-21 |
SARS-CoV-2 safety guidelines for frontline nurses (edit) |
10.1097/01.NURSE.0000731824.79728.40 |
| 2020-12-21 |
Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes in COVID-19 convalescent plasma (edit) |
10.1101/2020.12.20.423708 |
| 2020-12-21 |
Tetravalent SARS-CoV-2 Neutralizing Antibodies Show Enhanced Potency and Resistance to Escape Mutations (edit) |
10.1101/2020.10.31.362848 |
| 2020-12-21 |
An engineered decoy receptor for SARS-CoV-2 broadly binds protein S sequence variants (edit) |
10.1101/2020.10.18.344622 |
| 2020-12-21 |
A recombinant protein SARS-CoV-2 candidate vaccine elicits high-titer neutralizing antibodies in macaques (edit) |
10.1101/2020.12.20.422693 |
| 2020-12-21 |
Genomic epidemiology reveals multiple introductions of SARS-CoV-2 from mainland Europe into Scotland (edit) |
10.1038/S41564-020-00838-Z |
| 2020-12-21 |
Fatty Acid Synthase inhibition prevents palmitoylation of SARS-CoV2 Spike Protein and improves survival of mice infected with murine hepatitis virus (edit) |
10.1101/2020.12.20.423603 |
| 2020-12-20 |
Prediction of Potential Respiratory Tract Infection from SARS-CoV-2 Through Hand-to-face Contact Transmission (edit) |
|
| 2020-12-20 |
COVID-19 global pandemic planning: Dry heat incubation and ambient temperature fail to consistently inactivate SARS-CoV-2 on N95 respirators (edit) |
10.1177/1535370220977819 |
| 2020-12-20 |
Real-world data suggest antibody positivity to SARS-CoV-2 is associated with a decreased risk of future infection (edit) |
10.1101/2020.12.18.20248336 |
| 2020-12-20 |
Preliminary optimisation of a simplified sample preparation method to permit direct detection of SARS-CoV-2 within saliva samples using reverse-transcription loop-mediated isothermal amplification (RT-LAMP) (edit) |
10.1016/J.JVIROMET.2020.114048 |
| 2020-12-20 |
Lipid-based vaccine nanoparticles for induction of humoral immune responses against HIV-1 and SARS-CoV-2 (edit) |
10.1016/J.JCONREL.2020.12.031 |
| 2020-12-20 |
SARS-CoV-2 protein ORF3a is pathogenic in Drosophila and causes phenotypes associated with COVID-19 post-viral syndrome (edit) |
10.1101/2020.12.20.423533 |
| 2020-12-20 |
Effects of obesity on serum levels of SARS-CoV-2-specific antibodies in COVID-19 patients (edit) |
10.1101/2020.12.18.20248483 |
| 2020-12-20 |
Implications of Spike-glycoprotein processing at S1/S2 by Furin, at S2’ by Furin and/or TMPRSS2 and shedding of ACE2: cell-to-cell fusion, cell entry and infectivity of SARS-CoV-2 (edit) |
10.1101/2020.12.18.423106 |
| 2020-12-19 |
Acute Meningoencephalitis in a Child Secondary to SARS-CoV-2 Virus (edit) |
|
| 2020-12-19 |
Comparison of three automatic chemiluminescent immunoassays for monitoring dynamic profile of SARS-CoV-2 IgG and IgM (edit) |
10.1002/JCLA.23681 |
| 2020-12-19 |
Transverse orange nail lesions following SARS-CoV-2 infection (edit) |
10.1111/DTH.14688 |
| 2020-12-19 |
Machine Learning Prediction of SARS-CoV-2 Polymerase Chain Reaction Results with Routine Blood Tests (edit) |
10.1093/LABMED/LMAA111 |
| 2020-12-19 |
SARS-CoV-2 candidate vaccines - composition, mechanisms of action and stages of clinical development (edit) |
10.1111/ALL.14714 |
| 2020-12-19 |
Non-COVID Co-Morbidity: Potential Indirect Consequences of the SARS-CoV-2 Pandemic in a Neonatal Intensive Care Unit (edit) |
10.1016/J.JHIN.2020.12.010 |
| 2020-12-19 |
Re-evaluating positive serum samples for SARS-CoV-2 specific IgA and IgG antibodies using an in-house serological assay (edit) |
10.1016/J.CMI.2020.12.014 |
| 2020-12-19 |
Identification of FDA approved drugs and nucleoside analogues as potential SARS-CoV-2 A1pp domain inhibitor: An in silico study (edit) |
10.1016/J.COMPBIOMED.2020.104185 |
| 2020-12-19 |
SARS-Cov-2 Interactome with Human Ghost Proteome: A Neglected World Encompassing a Wealth of Biological Data (edit) |
10.3390/MICROORGANISMS8122036 |
| 2020-12-19 |
SARS-CoV-2 Seroprevalence Survey in People Involved in Different Essential Activities during the General Lock-Down Phase in the Province of Prato (Tuscany, Italy) (edit) |
10.3390/VACCINES8040778 |
| 2020-12-19 |
Performance of Commercially Available Rapid Serological Assays for the Detection of SARS-CoV-2 Antibodies (edit) |
10.3390/PATHOGENS9121067 |
| 2020-12-19 |
Unraveling the Origin of Interactions of Hydroxychloroquine with the Receptor-Binding Domain of SARS-CoV-2 in Aqueous Medium (edit) |
10.1016/J.CPLETT.2020.138280 |
| 2020-12-19 |
Mechanistic modelling of SARS-CoV-2 and other infectious diseases and the effects of therapeutics (edit) |
10.1002/CPT.2160 |
| 2020-12-19 |
Interoperable HL7 FHIR platform to report PCR SARS-CoV-2 tests from laboratories to the Chilean government (edit) |
10.2196/25149 |
| 2020-12-18 |
A pocket guide on how to structure SARS-CoV-2 drugs and therapies (edit) |
10.1042/BST20200396 |
| 2020-12-18 |
SARS-CoV-2 infection and pulmonary tuberculosis: an analysis of the situation in Peru (edit) |
10.1590/0102-311X00094520 |
| 2020-12-18 |
Factors That Might Affect SARS-CoV-2 Transmission Among Foreign-Born and U.S.-Born Poultry Facility Workers - Maryland, May 2020 (edit) |
10.15585/MMWR.MM6950A5 |
| 2020-12-18 |
Factors Associated with Positive SARS-CoV-2 Test Results in Outpatient Health Facilities and Emergency Departments Among Children and Adolescents Aged <18 Years - Mississippi, September-November 2020 (edit) |
10.15585/MMWR.MM6950E3 |
| 2020-12-18 |
Health Center Testing for SARS-CoV-2 During the COVID-19 Pandemic - United States, June 5-October 2, 2020 (edit) |
10.15585/MMWR.MM6950A3 |
| 2020-12-18 |
Gene expression profiling of SARS-CoV-2 infections reveal distinct primary lung cell and systemic immune infection responses that identify pathways relevant in COVID-19 disease (edit) |
10.1093/BIB/BBAA376 |
| 2020-12-18 |
Characteristics of Nosocomial Infections in Children Screened for SARS-CoV-2 Infection in China (edit) |
10.12659/MSM.928835 |
| 2020-12-18 |
MIS-C in February 2020 and Implications of Genomic Sequencing for SARS-CoV-2 (edit) |
10.1093/JPIDS/PIAA167 |
| 2020-12-18 |
microRNA-146a and -155, upregulated by periodontitis and type 2 diabetes in oral fluids, are predicted to regulate SARS-CoV-2 oral receptors genes (edit) |
10.1002/JPER.20-0623 |
| 2020-12-18 |
Body mass index (BMI) and outcomes of SARS-CoV-2 among US veterans (edit) |
10.1002/OBY.23111 |
| 2020-12-18 |
Renin-angiotensin system blockers, risk of SARS-CoV-2 infection and outcomes fromCoViD-19: systematic review and meta-analysis (edit) |
10.1093/EHJCVP/PVAA138 |
| 2020-12-18 |
A Nanomechanical Study on Deciphering the Stickiness of SARS-CoV-2 on Inanimate Surfaces (edit) |
10.1021/ACSAMI.0C16800 |
| 2020-12-18 |
A simplified SARS-CoV-2 detection protocol for research laboratories (edit) |
10.1371/JOURNAL.PONE.0244271 |
| 2020-12-18 |
Reinfection with SARS-CoV-2: Implications for Vaccines (edit) |
10.1093/CID/CIAA1866 |
| 2020-12-18 |
A tale of two studies: Study design and our understanding of SARS-CoV-2 seroprevalence (edit) |
10.1093/CID/CIAA1868 |
| 2020-12-18 |
Could Simultaneous Nasal and Oral Irrigation Be a Nontherapeutic Tool against SARS-CoV-2? (edit) |
10.1021/ACSCHEMNEURO.0C00740 |
| 2020-12-18 |
Diagnostic testing for SARS-CoV-2 infection in HHT patients: nasopharyngeal versus oropharyngeal swab (edit) |
10.1186/S13023-020-01628-W |
| 2020-12-18 |
Scientific evidence supports aerosol transmission of SARS-COV-2 (edit) |
10.1186/S13756-020-00868-6 |
| 2020-12-18 |
Clinical characteristics and outcome of SARS-CoV-2 infection in admitted patients with chronic lymphocytic leukemia from a single European country (edit) |
10.1186/S40164-020-00195-X |
| 2020-12-18 |
Efficient SARS-CoV-2 detection in unextracted oro-nasopharyngeal specimens by rRT-PCR with the Seegene Allplex™ 2019-nCoV assay (edit) |
10.1186/S12985-020-01468-X |
| 2020-12-18 |
Calling for pan-European commitment for rapid and sustained reduction in SARS-CoV-2 infections (edit) |
10.1016/S0140-6736(20)32625-8 |
| 2020-12-18 |
Clinical application of a rapid antigen test for the detection of SARS-CoV-2 infection in symptomatic and asymptomatic patients evaluated in the emergency department: a preliminary report (edit) |
10.1016/J.JINF.2020.12.012 |
| 2020-12-18 |
Results of Testing Children for SARS-CoV-2 through a Community-based Testing Site (edit) |
10.1016/J.JPEDS.2020.12.030 |
| 2020-12-18 |
Different mutations in SARS-CoV-2 associate with severe and mild outcome (edit) |
10.1016/J.IJANTIMICAG.2020.106272 |
| 2020-12-18 |
Evidence of SARS-CoV-2 Transcriptional Activity in Cardiomyocytes of COVID-19 Patients without Clinical Signs of Cardiac Involvement (edit) |
10.3390/BIOMEDICINES8120626 |
| 2020-12-18 |
SARS-CoV-2 Spike Alterations Enhance Pseudoparticle Titers and Replication-Competent VSV-SARS-CoV-2 Virus (edit) |
10.3390/V12121465 |
| 2020-12-18 |
[Use of masks by children to prevent infection with SARS-CoV-2] (edit) |
10.1007/S00112-020-01090-9 |
| 2020-12-18 |
Efficient detection of SARS-CoV-2 RNA in the solid fraction of wastewater (edit) |
10.1016/J.SCITOTENV.2020.144587 |
| 2020-12-18 |
Preliminary genomic characterisation of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations. (edit) |
|
| 2020-12-18 |
Mutational spectra of SARS-CoV-2 isolated from animals (edit) |
10.7717/PEERJ.10609 |
| 2020-12-18 |
Humoral Responses and Serological Assays in SARS-CoV-2 Infections (edit) |
10.3389/FIMMU.2020.610688 |
| 2020-12-18 |
A Potent SARS-CoV-2 Neutralizing Human Monoclonal Antibody That Reduces Viral Burden and Disease Severity in Syrian Hamsters (edit) |
10.3389/FIMMU.2020.614256 |
| 2020-12-18 |
Is the "Common Cold" Our Greatest Ally in the Battle Against SARS-CoV-2? (edit) |
10.3389/FCIMB.2020.605334 |
| 2020-12-18 |
Evaluating SARS-CoV-2 Seroconversion Following Relieve of Confinement Measures (edit) |
10.3389/FMED.2020.603996 |
| 2020-12-18 |
Surveying the Side-Chain Network Approach to Protein Structure and Dynamics: The SARS-CoV-2 Spike Protein as an Illustrative Case (edit) |
10.3389/FMOLB.2020.596945 |
| 2020-12-18 |
Human Mesenchymal Stem Cells: The Present Alternative for High-Incidence Diseases, Even SARS-Cov-2 (edit) |
10.1155/2020/8892189 |
| 2020-12-18 |
Remdesivir Is Effective in Combating COVID-19 because It Is a Better Substrate than ATP for the Viral RNA-Dependent RNA Polymerase (edit) |
10.1016/J.ISCI.2020.101849 |
| 2020-12-18 |
The Interpretation of SARS-CoV-2 Diagnostic Tests (edit) |
10.1016/J.MEDJ.2020.08.001 |
| 2020-12-17 |
Structural Characterization of SARS-CoV-2: Where We Are, and Where We Need to Be (edit) |
10.3389/FMOLB.2020.605236 |
| 2020-12-17 |
Comparative molecular dynamics study of the receptor-binding domains in SARS-CoV-2 and SARS-CoV and the effects of mutations on the binding affinity (edit) |
10.1080/07391102.2020.1860829 |
| 2020-12-17 |
A novel STING agonist for cancer immunotherapy and a SARS-CoV-2 vaccine adjuvant (edit) |
10.1039/D0CC06959K |
| 2020-12-17 |
Dysregulation of the mevalonate pathway during SARS-CoV-2 infection: an in-silico study (edit) |
10.1002/JMV.26743 |
| 2020-12-17 |
Incidence of SARS-CoV-2 Infection Among Patients Undergoing Active Antitumor Treatment in Italy (edit) |
10.1001/JAMAONCOL.2020.6778 |
| 2020-12-17 |
Assessment of multiplex digital droplet RT-PCR as a diagnostic tool for SARS-CoV-2 detection in nasopharyngeal swabs and saliva samples (edit) |
10.1093/CLINCHEM/HVAA323 |
| 2020-12-17 |
A challenging complication following SARS-CoV-2 infection: a case of pulmonary mucormycosis (edit) |
10.1007/S15010-020-01561-X |
| 2020-12-17 |
Current Status of Diagnostic Testing for SARS-CoV-2 Infection and Future Developments: A Review (edit) |
10.12659/MSM.928552 |
| 2020-12-17 |
Pre-test probability for SARS-Cov-2-related infection score: The PARIS score (edit) |
10.1371/JOURNAL.PONE.0243342 |
| 2020-12-17 |
Genomic epidemiology reveals multiple introductions and spread of SARS-CoV-2 in the Indian state of Karnataka (edit) |
10.1371/JOURNAL.PONE.0243412 |
| 2020-12-17 |
Pediatric Ischemic Stroke: An Infrequent Complication of SARS-CoV-2 (edit) |
10.1002/ANA.25991 |
| 2020-12-17 |
Role of serum albumin and proteinuria in patients with SARS-CoV-2 pneumonia (edit) |
10.1111/IJCP.13946 |
| 2020-12-17 |
Comparison of Diabetic Ketoacidosis in Adults During the SARS-CoV-2 Outbreak and Over the Same Time Period for the Preceding 3 Years (edit) |
10.2337/DC20-2062 |
| 2020-12-17 |
CoV2-ID, a MIQE-compliant sub-20-min 5-plex RT-PCR assay targeting SARS-CoV-2 for the diagnosis of COVID-19 (edit) |
10.1038/S41598-020-79233-X |
| 2020-12-17 |
Biochemical and biophysical characterization of the main protease, 3-chymotrypsin-like protease (3CLpro) from the novel coronavirus SARS-CoV 2 (edit) |
10.1038/S41598-020-79357-0 |
| 2020-12-17 |
Publisher Correction: Fast detection of SARS-CoV-2 RNA via the integration of plasmonic thermocycling and fluorescence detection in a portable device (edit) |
10.1038/S41551-020-00676-8 |
| 2020-12-17 |
SARS-CoV-2 infection increases tacrolimus concentrations in solid-organ transplant recipients (edit) |
10.1111/CTR.14193 |
| 2020-12-17 |
The Challenge of Managing Bilateral Acute Angle Closure Glaucoma in the Presence of Active SARS-CoV-2 Infection (edit) |
10.1097/IJG.0000000000001763 |
| 2020-12-17 |
Persistence of IgG response to SARS-CoV-2 (edit) |
10.1016/S1473-3099(20)30943-9 |
| 2020-12-17 |
Evaluation of extraction and amplification assays for the detection of SARS-CoV-2 at Auckland Hospital laboratory during the COVID-19 outbreak in New Zealand (edit) |
10.1016/J.JVIROMET.2020.114042 |
| 2020-12-17 |
A Newcastle Disease Virus (NDV) Expressing a Membrane-Anchored Spike as a Cost-Effective Inactivated SARS-CoV-2 Vaccine (edit) |
10.3390/VACCINES8040771 |
| 2020-12-17 |
Occurrence of Antibodies against SARS-CoV-2 in the Domestic Cat Population of Germany (edit) |
10.3390/VACCINES8040772 |
| 2020-12-17 |
Monitoring Viral Entry in Real-Time Using a Luciferase Recombinant Vesicular Stomatitis Virus Producing SARS-CoV-2, EBOV, LASV, CHIKV, and VSV Glycoproteins (edit) |
10.3390/V12121457 |
| 2020-12-17 |
Paper-based electrochemical biosensor for diagnosing COVID-19: Detection of SARS-CoV-2 antibodies and antigen (edit) |
10.1016/J.BIOS.2020.112912 |
| 2020-12-17 |
Commercial immunoglobulin products contain cross-reactive but not neutralizing antibodies against SARS-CoV-2 (edit) |
10.1016/J.JACI.2020.12.003 |
| 2020-12-17 |
Assessment and Comparison of Two Serological Approaches for the Surveillance of Health Workers Exposed to SARS-CoV-2 (edit) |
10.2147/IDR.S282652 |
| 2020-12-17 |
Role of the Bronchoalveolar Lavage in Noncritically Ill Patients during the SARS-CoV-2 Epidemic (edit) |
10.1155/2020/9012187 |
| 2020-12-17 |
Perceived Effectiveness, Safety, and Attitudes Toward the Use of Nucleic Tests of SARS-CoV-2 Among Clinicians and General Public in China (edit) |
10.3389/FPUBH.2020.599862 |
| 2020-12-17 |
Identification of Potential Inhibitors of 3CL Protease of SARS-CoV-2 From ZINC Database by Molecular Docking-Based Virtual Screening (edit) |
10.3389/FMOLB.2020.603037 |
| 2020-12-17 |
Structure-Based Virtual Screening and Biochemical Validation to Discover a Potential Inhibitor of the SARS-CoV-2 Main Protease (edit) |
10.1021/ACSOMEGA.0C04808 |
| 2020-12-17 |
Viral Clearance and Serological Response to SARS-CoV-2 in Kidney Transplant Recipients (edit) |
10.1016/J.TRANSPROCEED.2020.11.008 |
| 2020-12-17 |
Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses (edit) |
10.1038/S41591-020-01179-4 |
| 2020-12-16 |
Deleterious Outcomes in Long-Hauler COVID-19: The Effects of SARS-CoV-2 on the CNS in Chronic COVID Syndrome (edit) |
10.1021/ACSCHEMNEURO.0C00725 |
| 2020-12-16 |
Impfung gegen Influenza, Hygiene gegen SARS-CoV-2 (edit) |
10.1007/S11298-020-8156-9 |
| 2020-12-16 |
Evaluation of a home-based 7-day infection control strategy for healthcare workers following high-risk exposure to SARS-CoV-2: a cohort study (edit) |
10.1017/ICE.2020.1389 |
| 2020-12-16 |
A 61-Year-Old Man with SARS-CoV-2 Infection and Venous Thrombosis Presenting with Painful Swelling and Gangrene of the Lower Limb Consistent with Phlegmasia Cerulea Dolens (edit) |
10.12659/AJCR.928342 |
| 2020-12-16 |
[Response of the Catalonia neonatal screening laboratory to the pandemic of SARS-CoV-2.] (edit) |
|
| 2020-12-16 |
SARS-CoV-2 has not been detected directly by electron microscopy in the endothelium of chilblain lesions: reply from the authors (edit) |
10.1111/BJD.19595 |
| 2020-12-16 |
Genomic analysis of SARS-CoV-2 reveals local viral evolution in Ghana (edit) |
10.1177/1535370220975351 |
| 2020-12-16 |
A promiscuous interaction of SARS-CoV-2 with bacterial products (edit) |
10.1093/JMCB/MJAA068 |
| 2020-12-16 |
China NMPA perspective on clinical evaluation of SARS-CoV-2 antibody test reagents in the process of emergency approval (edit) |
10.4155/BIO-2020-0188 |
| 2020-12-16 |
SARS-CoV-2 Detected on Environmental Fomites for both Asymptomatic and Symptomatic COVID-19 Patients (edit) |
10.1164/RCCM.202006-2136LE |
| 2020-12-16 |
Lipid droplets fuel SARS-CoV-2 replication and production of inflammatory mediators (edit) |
10.1371/JOURNAL.PPAT.1009127 |
| 2020-12-16 |
The accuracy of healthcare worker versus self collected (2-in-1) Oropharyngeal and Bilateral Mid-Turbinate (OPMT) swabs and saliva samples for SARS-CoV-2 (edit) |
10.1371/JOURNAL.PONE.0244417 |
| 2020-12-16 |
Subjects with blood group O are not at lower risk to acquire SARS-CoV-2 infection (edit) |
10.1111/VOX.13062 |
| 2020-12-16 |
Emergence of a Highly Fit SARS-CoV-2 Variant (edit) |
10.1056/NEJMCIBR2032888 |
| 2020-12-16 |
Early evidence of effectiveness of digital contact tracing for SARS-CoV-2 in Switzerland (edit) |
10.4414/SMW.2020.20457 |
| 2020-12-16 |
SARS-CoV-2 Infections among Recent Organ Recipients, March-May 2020, United States (edit) |
10.3201/EID2702.204046 |
| 2020-12-16 |
Postmortem Stability of SARS-CoV-2 in Nasopharyngeal Mucosa (edit) |
10.3201/EID2701.203112 |
| 2020-12-16 |
Dynamic profiles of SARS-Cov-2 infection from five Chinese family clusters in the early stage of the COVID-19 pandemic (edit) |
10.1038/S41598-020-79035-1 |
| 2020-12-16 |
Bioactivity Potential of Marine Natural Products from Scleractinia-Associated Microbes and In Silico Anti-SARS-COV-2 Evaluation (edit) |
10.3390/MD18120645 |
| 2020-12-16 |
Prevalence of SARS-CoV-2 Antibodies in Multiple Sclerosis: The Hidden Part of the Iceberg (edit) |
10.3390/JCM9124066 |
| 2020-12-16 |
Inosine Pranobex Significantly Decreased the Case-Fatality Rate among PCR Positive Elderly with SARS-CoV-2 at Three Nursing Homes in the Czech Republic (edit) |
10.3390/PATHOGENS9121055 |
| 2020-12-16 |
Subtle influence of ACE2 glycan processing on SARS-CoV-2 recognition (edit) |
10.1016/J.JMB.2020.166762 |
| 2020-12-16 |
Force-dependent stimulation of RNA unwinding by SARS-CoV-2 nsp13 helicase (edit) |
10.1016/J.BPJ.2020.11.2276 |
| 2020-12-16 |
Reducing transmission of SARS-CoV-2 with intranasal prophylaxis (edit) |
10.1016/J.EBIOM.2020.103170 |
| 2020-12-16 |
Temperature Dependence of the SARS-CoV-2 affinity to human ACE2 determines COVID-19 progression and clinical outcome (edit) |
10.1016/J.CSBJ.2020.12.005 |
| 2020-12-16 |
Anosmia and other SARS-CoV-2 positive test-associated symptoms, across three national, digital surveillance platforms as the COVID-19 pandemic and response unfolded: an observation study (edit) |
10.1101/2020.12.15.20248096 |
| 2020-12-16 |
A Comprehensive Clinical Description of Pediatric SARS-CoV-2 Infection in Western Pennsylvania (edit) |
10.1101/2020.12.14.20248192 |
| 2020-12-16 |
Rapid detection of SARS-CoV-2 with Cas13 (edit) |
10.1101/2020.12.14.20247874 |
| 2020-12-16 |
Intranasal vaccination with a lentiviral vector protects against SARS-CoV-2 in preclinical animal models (edit) |
10.1016/J.CHOM.2020.12.010 |
| 2020-12-16 |
Functional interrogation of a SARS-CoV-2 host protein interactome identifies unique and shared coronavirus host factors (edit) |
10.1016/J.CHOM.2020.12.009 |
| 2020-12-16 |
Simultaneous Circulation of DENV, CHIKV, ZIKV and SARS-CoV-2 in Brazil: an Inconvenient Truth (edit) |
10.1016/J.ONEHLT.2020.100205 |
| 2020-12-16 |
Genome-wide analysis of Indian SARS-CoV-2 genomes to identify T-cell and B-cell epitopes from conserved regions based on immunogenicity and antigenicity (edit) |
10.1016/J.INTIMP.2020.107276 |
| 2020-12-16 |
Dexamethasone inhibits SARS-CoV-2 spike pseudotyped virus viropexis by binding to ACE2 (edit) |
10.1016/J.VIROL.2020.12.001 |
| 2020-12-16 |
Different Innate and Adaptive Immune Responses to SARS-CoV-2 Infection of Asymptomatic, Mild, and Severe Cases (edit) |
10.3389/FIMMU.2020.610300 |
| 2020-12-16 |
Prediction of an increase in oxygen requirement of SARS-CoV-2 pneumonia using three different scoring systems (edit) |
10.1016/J.JIAC.2020.12.009 |
| 2020-12-16 |
SARS-CoV-2: A Trigger for Kawasaki Disease or a New Syndrome? (edit) |
10.1177/2333794X20982436 |
| 2020-12-16 |
A single dose of recombinant VSV-∆G-spike vaccine provides protection against SARS-CoV-2 challenge (edit) |
10.1038/S41467-020-20228-7 |
| 2020-12-16 |
Genetic architecture of host proteins involved in SARS-CoV-2 infection (edit) |
10.1038/S41467-020-19996-Z |
| 2020-12-16 |
The S1 protein of SARS-CoV-2 crosses the blood–brain barrier in mice (edit) |
10.1038/S41593-020-00771-8 |
| 2020-12-16 |
REACT-1 round 7 updated report: regional heterogeneity in changes in prevalence of SARS-CoV-2 infection during the second national COVID-19 lockdown in England (edit) |
10.1101/2020.12.15.20248244 |
| 2020-12-15 |
Novel insights into the treatment of SARS-CoV-2 infection: An overview of current clinical trials (edit) |
10.1016/J.IJBIOMAC.2020.09.204 |
| 2020-12-15 |
Narrative review of non-pharmaceutical behavioural measures for the prevention of COVID-19 (SARS-CoV-2) based on the Health-EDRM framework (edit) |
10.1093/BMB/LDAA030 |
| 2020-12-15 |
Phylogenetic analysis of SARS-CoV-2 data is difficult (edit) |
10.1093/MOLBEV/MSAA314 |
| 2020-12-15 |
Multitarget in silico studies of Ocimum menthiifolium, family Lamiaceae against SARS-CoV-2 supported by molecular dynamics simulation (edit) |
10.1080/07391102.2020.1852964 |
| 2020-12-15 |
A household case evidences shorter shedding of SARS-CoV-2 in naturally infected cats compared to their human owners (edit) |
10.1080/22221751.2020.1863132 |
| 2020-12-15 |
SARS-CoV-2 detection in sewage samples: Standardization of method & preliminary observations (edit) |
10.4103/IJMR.IJMR_3541_20 |
| 2020-12-15 |
The first laboratory-confirmed imported infections of SARS-CoV-2 in Sudan (edit) |
10.1093/TRSTMH/TRAA151 |
| 2020-12-15 |
SARS-CoV-2 Presence in Cerumen (edit) |
10.1177/0145561320981451 |
| 2020-12-15 |
Comparison of Tracheal vs Nasopharyngeal Secretions for SARS-CoV-2 RT-PCR Testing in Patients With Tracheostomy (edit) |
10.1177/0194599820980706 |
| 2020-12-15 |
COVID-19 Vaccines May Not Prevent Nasal SARS-CoV-2 Infection and Asymptomatic Transmission (edit) |
10.1177/0194599820982633 |
| 2020-12-15 |
Neutralizing SARS-CoV-2 (edit) |
10.7554/ELIFE.64496 |
| 2020-12-15 |
Response to "ACE-2 downregulation and incidence of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection" (edit) |
10.1093/AJH/HPAA212 |
| 2020-12-15 |
Cutaneous Hyperaesthesia in SARS-CoV-2 Infection: Rare but not Unique Clinical Manifestation (edit) |
10.2340/00015555-3729 |
| 2020-12-15 |
Annular lichen planus associated with coronavirus SARS-CoV-2 disease (COVID-19) (edit) |
10.1111/IJD.15338 |
| 2020-12-15 |
Pregnant women with SARS-CoV-2 infection are at higher risk of death and severe pneumonia: propensity score-matched analysis of a nationwide prospective cohort study (COV19Mx) (edit) |
10.1002/UOG.23575 |
| 2020-12-15 |
Evidence and implications of pre-existing humoral cross-reactive immunity to SARS-CoV-2 (edit) |
10.1002/IID3.367 |
| 2020-12-15 |
Clinical, laboratory, and temporal predictors of neutralizing antibodies to SARS-CoV-2 among COVID-19 convalescent plasma donor candidates (edit) |
10.1172/JCI144930 |
| 2020-12-15 |
A sensitive and affordable multiplex RT-qPCR assay for SARS-CoV-2 detection (edit) |
10.1371/JOURNAL.PBIO.3001030 |
| 2020-12-15 |
Rapid detection of SARS-CoV-2 with CRISPR-Cas12a (edit) |
10.1371/JOURNAL.PBIO.3000978 |
| 2020-12-15 |
Seroprevalence of SARS-CoV-2 IgG antibodies in the current COVID-19 pandemic amongst co-workers at a UK renal transplant centre (edit) |
10.1111/TRI.13791 |
| 2020-12-15 |
Coagulation abnormalities in SARS-CoV-2 infection: overexpression tissue factor (edit) |
10.1186/S12959-020-00250-X |
| 2020-12-15 |
Acute disseminated encephalomyelitis after SARS-CoV-2 infection (edit) |
10.1212/NXI.0000000000000949 |
| 2020-12-15 |
Factors Associated With Severe SARS-CoV-2 Infection (edit) |
10.1542/PEDS.2020-023432 |
| 2020-12-15 |
SARS-CoV-2 detection goes mobile (edit) |
10.1038/S41576-020-00321-9 |
| 2020-12-15 |
T and B cell Epitope analysis of SARS-CoV-2 S protein based on immunoinformatics and experimental research (edit) |
10.1111/JCMM.16200 |
| 2020-12-15 |
[The pitfalls of preventive testing for SARS-CoV-2] (edit) |
|
| 2020-12-15 |
COVID-19 and autoimmune diseases (edit) |
10.1097/BOR.0000000000000776 |
| 2020-12-15 |
Identification of Host Cellular Protein Substrates of SARS-COV-2 Main Protease (edit) |
10.3390/IJMS21249523 |
| 2020-12-15 |
Application of Lean 6s Methodology in an Engineering Education Environment during the SARS-CoV-2 Pandemic (edit) |
10.3390/IJERPH17249407 |
| 2020-12-15 |
Antimicrobial and Amyloidogenic Activity of Peptides. Can Antimicrobial Peptides Be Used against SARS-CoV-2? (edit) |
10.3390/IJMS21249552 |
| 2020-12-15 |
SARS-CoV-2 and Viral Sepsis: Immune Dysfunction and Implications in Kidney Failure (edit) |
10.3390/JCM9124057 |
| 2020-12-15 |
Neuroimaging manifestations in children with SARS-CoV-2 infection: a multinational, multicentre collaborative study (edit) |
10.1016/S2352-4642(20)30362-X |
| 2020-12-15 |
SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study (edit) |
10.1016/S1473-3099(20)30858-6 |
| 2020-12-15 |
Increased expression of key SARS-CoV-2 entry points in multiple tissues in individuals with NAFLD (edit) |
10.1016/J.JHEP.2020.12.007 |
| 2020-12-15 |
Comparative evaluation of six immunoassays for the detection of antibodies against SARS-CoV-2 (edit) |
10.1016/J.JVIROMET.2020.114047 |
| 2020-12-15 |
Impact of severe acute respiratory syndrome coronavirus-2 (SARS CoV-2) pandemic on carbapenemase-producing Klebsiella pneumoniae (KPC-Kp) prevention and control program: convergent or divergent action? (edit) |
10.1016/J.JHIN.2020.11.030 |
| 2020-12-15 |
Saliva sampling for chasing SARS-CoV-2: A Game-changing strategy (edit) |
10.1016/J.PHRS.2020.105380 |
| 2020-12-15 |
Neutralizing antibodies targeting SARS-CoV-2 spike protein (edit) |
10.1016/J.SCR.2020.102125 |
| 2020-12-15 |
[SARS-CoV-2/COVID-19-epidemiology and prevention] (edit) |
10.1007/S11560-020-00472-0 |
| 2020-12-15 |
The impact of SARS-CoV-2 on the cystic fibrosis foundation therapeutics development network (edit) |
10.1016/J.JCF.2020.12.007 |
| 2020-12-15 |
Gaucher disease and SARS-CoV-2 infection: Experience from 181 patients in New York (edit) |
10.1016/J.YMGME.2020.12.288 |
| 2020-12-15 |
Prevalence of the SARS-CoV-2 Infection Among Post-Quarantine Healthcare Workers (edit) |
10.2147/JMDH.S279469 |
| 2020-12-15 |
Glycomics-informed glycoproteomic analysis of site-specific glycosylation for SARS-CoV-2 spike protein (edit) |
10.1016/J.XPRO.2020.100214 |
| 2020-12-15 |
Mesenchymal stromal cells to fight SARS-CoV-2: Taking advantage of a pleiotropic therapy (edit) |
10.1016/J.CYTOGFR.2020.12.002 |
| 2020-12-15 |
Cross-Neutralization of a SARS-CoV-2 Antibody to a Functionally Conserved Site Is Mediated by Avidity (edit) |
10.1016/J.IMMUNI.2020.10.023 |
| 2020-12-15 |
A Daily Measure of the SARS-CoV-2 Effective Reproduction Number for all Countries (edit) |
10.5201/IPOL.2020.304 |
| 2020-12-15 |
Addressing Postpandemic Clinician Mental Health : A Narrative Review and Conceptual Framework (edit) |
10.7326/M20-4199 |
| 2020-12-14 |
Epidemiology and precision of SARS-CoV-2 detection following lockdown and relaxation measures (edit) |
10.1002/JMV.26731 |
| 2020-12-14 |
Symptomatic SARS-CoV-2 reinfection of a health care worker in a Belgian nosocomial outbreak despite primary neutralizing antibody response (edit) |
10.1093/CID/CIAA1850 |
| 2020-12-14 |
Assessment of the risk of SARS-CoV-2 reinfection in an intense re-exposure setting (edit) |
10.1093/CID/CIAA1846 |
| 2020-12-14 |
Evaluating SARS-CoV-2 Vaccines After Emergency Use Authorization or Licensing of Initial Candidate Vaccines (edit) |
10.1001/JAMA.2020.25127 |
| 2020-12-14 |
SARS-CoV‑2, a virus with many faces: a series of cases with prolonged persistence of COVID-19 symptoms (edit) |
10.1007/S10354-020-00793-8 |
| 2020-12-14 |
Efficacy of commercial mouth-rinses on SARS-CoV-2 viral load in saliva: randomized control trial in Singapore (edit) |
10.1007/S15010-020-01563-9 |
| 2020-12-14 |
A 23-Year-Old Man with SARS-CoV-2 Infection Who Presented with Auditory Hallucinations and Imaging Findings of Cytotoxic Lesions of the Corpus Callosum (CLOCC) (edit) |
10.12659/AJCR.928798 |
| 2020-12-14 |
CRISPR-Based Approaches for Efficient and Accurate Detection of SARS-CoV-2 (edit) |
10.1093/LABMED/LMAA101 |
| 2020-12-14 |
SARS-CoV-2 infection in patients with primary Sjögren syndrome: characterization and outcomes of 51 patients (edit) |
10.1093/RHEUMATOLOGY/KEAA748 |
| 2020-12-14 |
The prevalence of SARS-CoV-2 infection and the severity of the course of COVID-19 in patients with psoriasis treated with biologic therapy (edit) |
10.1080/09546634.2020.1861177 |
| 2020-12-14 |
Immunologic testing for SARS-CoV-2 infection from the antigen perspective (edit) |
10.1128/JCM.02160-20 |
| 2020-12-14 |
Gene expression network analysis provides potential targets against SARS-CoV-2 (edit) |
10.1038/S41598-020-78818-W |
| 2020-12-14 |
Minimal system for assembly of SARS-CoV-2 virus like particles (edit) |
10.1038/S41598-020-78656-W |
| 2020-12-14 |
Development of immunohistochemistry and in situ hybridisation for the detection of SARS-CoV and SARS-CoV-2 in formalin-fixed paraffin-embedded specimens (edit) |
10.1038/S41598-020-78949-0 |
| 2020-12-14 |
Pathological and molecular examinations of postmortem testis biopsies reveal SARS-CoV-2 infection in the testis and spermatogenesis damage in COVID-19 patients (edit) |
10.1038/S41423-020-00604-5 |
| 2020-12-14 |
Bioengineered in Vitro Tissue Models to Study SARS-CoV-2 Pathogenesis and Therapeutic Validation (edit) |
10.1021/ACSBIOMATERIALS.0C01226 |
| 2020-12-14 |
Prolonged PCR Positivity Stigma and Return-To-Work after SARS-CoV-2 Infection (edit) |
10.1097/JOM.0000000000002111 |
| 2020-12-14 |
HCoV-NL63 and SARS-CoV-2 Share Recognized Epitopes by the Humoral Response in Sera of People Collected Pre- and during CoV-2 Pandemic (edit) |
10.3390/MICROORGANISMS8121993 |
| 2020-12-14 |
Genomic Epidemiology of the First Wave of SARS-CoV-2 in Italy (edit) |
10.3390/V12121438 |
| 2020-12-14 |
Population-based seroprevalence of SARS-CoV-2 and the herd immunity threshold in Maranhão (edit) |
10.11606/S1518-8787.2020054003278 |
| 2020-12-14 |
Genomic Sequencing Effort for SARS-CoV-2 by Country during the Pandemic (edit) |
10.1016/J.IJID.2020.12.034 |
| 2020-12-14 |
Synergistic and Antagonistic Drug Combinations against SARS-CoV-2 (edit) |
10.1016/J.YMTHE.2020.12.016 |
| 2020-12-14 |
PD-1-Expressing SARS-CoV-2-Specific CD8+ T Cells Are Not Exhausted, but Functional in Patients with COVID-19 (edit) |
10.1016/J.IMMUNI.2020.12.002 |
| 2020-12-14 |
Bioinformatic evaluation of the potential animal models for studying SARS-Cov-2 (edit) |
10.1016/J.HELIYON.2020.E05725 |
| 2020-12-14 |
Identifying epitopes for cluster of differentiation and design of new peptides inhibitors against human SARS-CoV-2 spike RBD by an in-silico approach (edit) |
10.1016/J.HELIYON.2020.E05739 |
| 2020-12-14 |
A New Crystal Form of the SARS-CoV-2 Receptor Binding Domain: CR3022 Complex-An Ideal Target for In-Crystal Fragment Screening of the ACE2 Binding Site Surface (edit) |
10.3389/FPHAR.2020.615211 |
| 2020-12-14 |
The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19 - A systematic review of the literature (edit) |
10.1016/J.JAUT.2020.102592 |
| 2020-12-14 |
Early Experience With Methylprednisolone on SARS-CoV-2 Infection in the African American Population, a Retrospective Analysis (edit) |
10.1177/1179548420980699 |
| 2020-12-14 |
Hepatitis C Virus Drugs Simeprevir and Grazoprevir Synergize with Remdesivir to Suppress SARS-CoV-2 Replication in Cell Culture (edit) |
10.1101/2020.12.13.422511 |
| 2020-12-14 |
SARS-CoV-2 Requires Cholesterol for Viral Entry and Pathological Syncytia Formation (edit) |
10.1101/2020.12.14.422737 |
| 2020-12-14 |
Recurrent emergence and transmission of a SARS-CoV-2 spike deletion H69/V70 (edit) |
10.1101/2020.12.14.422555 |
| 2020-12-14 |
Interpretation of SARS-CoV-2 behaviour on different substrates and denaturation of virions using ethanol: an atomic force microscopy study (edit) |
10.1039/D0RA09083B |
| 2020-12-13 |
The immunology of SARS-CoV-2 infection, the potential antibody based treatments and vaccination strategies (edit) |
10.1080/14787210.2020.1863144 |
| 2020-12-13 |
SARS-CoV-2 seroprevalence and risk factors among oligo/asymptomatic healthcare workers(HCW): estimating the impact of community transmission (edit) |
10.1093/CID/CIAA1845 |
| 2020-12-13 |
Convalescent plasma treatment of persistent severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in patients with lymphoma with impaired humoral immunity and lack of neutralising antibodies (edit) |
10.1111/BJH.17266 |
| 2020-12-13 |
Prolonged SARS-CoV-2 positivity: a challenge for Australian clinicians (edit) |
10.5694/MJA2.50900 |
| 2020-12-13 |
Mental health consequences of infections by coronaviruses including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (edit) |
10.1002/BRB3.1901 |
| 2020-12-13 |
Attributing increased prevalence of facial palsy to SARS-CoV-2 requires evidence (edit) |
10.1002/BRB3.1996 |
| 2020-12-13 |
SARS-COV-2 Serological Profile in Healthcare Professionals of a Southern Italy Hospital (edit) |
10.3390/IJERPH17249324 |
| 2020-12-13 |
Possible Transmission Flow of SARS-CoV-2 Based on ACE2 Features (edit) |
10.3390/MOLECULES25245906 |
| 2020-12-13 |
Simultaneous detection and differentiation of SARS-CoV-2, influenza A virus and influenza B virus by one-step quadruplex real-time RT-PCR in patients with clinical manifestations (edit) |
10.1016/J.IJID.2020.12.027 |
| 2020-12-13 |
SARS-CoV-2 RNA reverse-transcribed and integrated into the human genome (edit) |
10.1101/2020.12.12.422516 |
| 2020-12-13 |
Investigation on penetration of saffron components through lipid bilayer bound to spike protein of SARS-CoV-2 using steered molecular dynamics simulation (edit) |
10.1016/J.HELIYON.2020.E05681 |
| 2020-12-13 |
Unraveling the Zoonotic Origin and Transmission of SARS-CoV-2 (edit) |
10.1016/J.TREE.2020.12.002 |
| 2020-12-12 |
Analytical evaluation and critical appraisal of early commercial SARS-CoV-2 immunoassays for routine use in a diagnostic laboratory (edit) |
10.1080/09674845.2020.1864108 |
| 2020-12-12 |
DNA Cross-Reactivity of the CDC-Specified SARS-CoV-2 Specimen Control Leads to Potential for False Negatives and Underreporting of Viral Infection (edit) |
10.1093/CLINCHEM/HVAA284 |
| 2020-12-12 |
Host metabolism dysregulation and cell tropism identification in human airway and alveolar organoids upon SARS-CoV-2 infection (edit) |
10.1007/S13238-020-00811-W |
| 2020-12-12 |
Type-I Interferon assessment in 45 minutes using the FilmArray® PCR platform in SARS-CoV-2 and other viral infections (edit) |
10.1002/EJI.202048978 |
| 2020-12-12 |
Trophoblast Damage with Acute and Chronic Intervillositis: Disruption of Placental Barrier by SARS-CoV-2 (edit) |
10.1016/J.HUMPATH.2020.12.004 |
| 2020-12-12 |
SARS-CoV-2 infections among healthcare workers at Helsinki University Hospital, Finland, spring 2020: serosurvey, symptoms and risk factors (edit) |
10.1016/J.TMAID.2020.101949 |
| 2020-12-12 |
A computational approach to design potential siRNA molecules as a prospective tool for silencing nucleocapsid phosphoprotein and surface glycoprotein gene of SARS-CoV-2 (edit) |
10.1016/J.YGENO.2020.12.021 |
| 2020-12-12 |
Challenges and Opportunities from Targeting Inflammatory Responses to SARS-CoV-2 Infection: A Narrative Review (edit) |
10.3390/JCM9124021 |
| 2020-12-12 |
IgA2 Antibodies against SARS-CoV-2 Correlate with NET Formation and Fatal Outcome in Severely Diseased COVID-19 Patients (edit) |
10.3390/CELLS9122676 |
| 2020-12-12 |
Diverse Functional Autoantibodies in Patients with COVID-19 (edit) |
10.1101/2020.12.10.20247205 |
| 2020-12-12 |
Intradermal delivery of receptor-binding domain of SARS-CoV-2 spike protein with dissolvable microneedles to induce humoral and cellular responses in mice (edit) |
10.1002/BTM2.10202 |
| 2020-12-11 |
How SARS-CoV-2 (COVID-19) spreads within infected hosts - what we know so far (edit) |
10.1042/ETLS20200165 |
| 2020-12-11 |
Nose-pharyngeal swabs as a screening test for SARS-CoV-2 infection in patients with scheduled elective surgery: the experience of the Hygiene Service of the Local Health Authority Roma 1 (edit) |
10.7416/AI.2020.2400 |
| 2020-12-11 |
Implementing Mitigation Strategies in Early Care and Education Settings for Prevention of SARS-CoV-2 Transmission - Eight States, September-October 2020 (edit) |
10.15585/MMWR.MM6949E3 |
| 2020-12-11 |
Summary of Guidance for Public Health Strategies to Address High Levels of Community Transmission of SARS-CoV-2 and Related Deaths, December 2020 (edit) |
10.15585/MMWR.MM6949E2 |
| 2020-12-11 |
Structure-aided ACEI-capped remdesivir-loaded novel PLGA nanoparticles: toward a computational simulation design for anti-SARS-CoV-2 therapy (edit) |
10.1039/D0CP04389C |
| 2020-12-11 |
SARS-CoV-2 Associated Coagulopathy And Thromboembolism Prophylaxis In Children: A Single Centre Observational Study (edit) |
10.1111/JTH.15216 |
| 2020-12-11 |
Clinical stage molecule PT150 is a modulator of glucocorticoid and androgen receptors with antiviral activity against SARS-CoV-2 (edit) |
10.1080/15384101.2020.1859752 |
| 2020-12-11 |
Anisotine and amarogentin as promising inhibitory candidates against SARS-CoV-2 proteins: a computational investigation (edit) |
10.1080/07391102.2020.1860133 |
| 2020-12-11 |
SARS-CoV-2 pneumonia in a newborn treated with remdesivir and COVID-19 convalescent plasma (edit) |
10.1093/JPIDS/PIAA165 |
| 2020-12-11 |
SARS-CoV-2 Infection as a trigger of autoimmune response (edit) |
10.1111/CTS.12953 |
| 2020-12-11 |
Candidate Binding Sites for Allosteric Inhibition of the SARS-CoV-2 Main Protease from the Analysis of Large-Scale Molecular Dynamics Simulations (edit) |
10.1021/ACS.JPCLETT.0C03182 |
| 2020-12-11 |
Vascular Alterations Among Young Adults with SARS-CoV-2 (edit) |
10.1152/AJPHEART.00897.2020 |
| 2020-12-11 |
SARS-CoV-2 genomic characterization and clinical manifestation of the COVID-19 outbreak in Uruguay (edit) |
10.1080/22221751.2020.1863747 |
| 2020-12-11 |
High-Throughput Screening and Quantum Mechanics for Identifying Potent Inhibitors against Mac1 Domain of SARS-CoV-2 Nsp3 (edit) |
10.1109/TCBB.2020.3037136 |
| 2020-12-11 |
Disentangling the dynamical underpinnings of differences in SARS-CoV-2 pathology using within-host ecological models (edit) |
10.1371/JOURNAL.PPAT.1009105 |
| 2020-12-11 |
Genetic mechanisms of critical illness in Covid-19 (edit) |
10.1038/S41586-020-03065-Y |
| 2020-12-11 |
Lateral flow tests cannot rule out SARS-CoV-2 infection (edit) |
10.1136/BMJ.M4787 |
| 2020-12-11 |
Spike glycoprotein and host cell determinants of SARS-CoV-2 entry and cytopathic effects (edit) |
10.1128/JVI.02304-20 |
| 2020-12-11 |
Available Antiretrovirals in the Treatment and Pre-Exposure Prophylaxis of SARS-CoV-2: Quo Vadis? (edit) |
10.1159/000512134 |
| 2020-12-11 |
Drug repurposing for COVID-19 using machine learning and mechanistic models of signal transduction circuits related to SARS-CoV-2 infection (edit) |
10.1038/S41392-020-00417-Y |
| 2020-12-11 |
Cationic nanocarriers as potent adjuvants for recombinant S-RBD vaccine of SARS-CoV-2 (edit) |
10.1038/S41392-020-00434-X |
| 2020-12-11 |
Structural and functional comparison of SARS-CoV-2-spike receptor binding domain produced in Pichia pastoris and mammalian cells (edit) |
10.1038/S41598-020-78711-6 |
| 2020-12-11 |
Can the hyperthermia-mediated Heat Shock Factor (HSF) /Heat Shock Protein (HSP) 70 pathway dampen the cytokine storm during SARS-CoV-2 infection? (edit) |
10.1111/BPH.15343 |
| 2020-12-11 |
Computational Drug Repurposing Study of the RNA Binding Domain of SARS-CoV-2 Nucleocapsid Protein with Antiviral Agents (edit) |
10.1002/BTPR.3110 |
| 2020-12-11 |
SARS-CoV-2 Impact on Screening Colonoscopy: Implications for Postpandemic Recovery (edit) |
10.14309/AJG.0000000000001097 |
| 2020-12-11 |
Novel automated sample-to-result SARS-CoV-2 laboratory-developed RT-PCR assay for high-throughput testing using LabTurbo AIO 48 system (edit) |
10.1016/J.CCA.2020.12.003 |
| 2020-12-11 |
Sample pooling strategies for SARS-CoV-2 detection (edit) |
10.1016/J.JVIROMET.2020.114044 |
| 2020-12-11 |
Effect of hydroxychloroquine pre-exposure on infection with SARS-CoV-2 in rheumatic disease patients: A population-based cohort study (edit) |
10.1016/J.CMI.2020.12.003 |
| 2020-12-11 |
Transcriptional Profiling of Immune and Inflammatory Responses in the Context of SARS-CoV-2 Fungal Superinfection in a Human Airway Epithelial Model (edit) |
10.3390/MICROORGANISMS8121974 |
| 2020-12-11 |
Picomolar SARS-CoV-2 Neutralization Using Multi-Arm PEG Nanobody Constructs (edit) |
10.3390/BIOM10121661 |
| 2020-12-11 |
SARS-CoV-2 Infections and COVID-19 Fatality: Estimation of Infection Fatality Ratio and Current Prevalence (edit) |
10.3390/IJERPH17249290 |
| 2020-12-11 |
Wandlungsmotor SARS-CoV-2: Wegweiser zum Gesundheitsstandort der Zukunft (edit) |
10.1007/S00608-020-00852-8 |
| 2020-12-11 |
Oligonucleotide Capture Sequencing of the SARS-CoV-2 Genome and Subgenomic Fragments from COVID-19 Individuals (edit) |
10.1101/2020.12.11.421057 |
| 2020-12-11 |
Characterizing superspreading of SARS-CoV-2 : from mechanism to measurement (edit) |
10.1101/2020.12.08.20246082 |
| 2020-12-11 |
Factors associated with clinical severity in Emergency Department patients presenting with symptomatic SARS-CoV-2 infection (edit) |
10.1101/2020.12.08.20246017 |
| 2020-12-11 |
IGI-LuNER: single-well multiplexed RT-qPCR test for SARS-CoV-2 (edit) |
10.1101/2020.12.10.20247338 |
| 2020-12-11 |
SARS-CoV-2 Viral Load in Saliva Rises Gradually and to Moderate Levels in Some Humans (edit) |
10.1101/2020.12.09.20239467 |
| 2020-12-11 |
Impact of Nasopharyngeal Specimen Quality on SARS-CoV-2 Test Sensitivity (edit) |
10.1101/2020.12.09.20246520 |
| 2020-12-11 |
Prevalence of SARS-CoV-2 infection in patients presenting for intravitreal injection (edit) |
10.1007/S00717-020-00473-3 |
| 2020-12-11 |
Men and women affected by Sars-CoV-2 pneumonia: same CT features but different outcome (edit) |
10.1016/J.CRAD.2020.11.119 |
| 2020-12-11 |
Cytokine storm induced by SARS-CoV-2 infection: The spectrum of its neurological manifestations (edit) |
10.1016/J.CYTO.2020.155404 |
| 2020-12-11 |
Delirium in a pregnant woman with SARS-CoV-2 infection in India (edit) |
10.1016/J.AJP.2020.102513 |
| 2020-12-11 |
SARS-CoV-2 Spike-Heat Shock Protein A5 (GRP78) Recognition may be Related to the Immersed Human Coronaviruses (edit) |
10.3389/FPHAR.2020.577467 |
| 2020-12-11 |
SARS-CoV-2 Is Not Detected in the Cerebrospinal Fluid of Encephalopathic COVID-19 Patients (edit) |
10.3389/FNEUR.2020.587384 |
| 2020-12-11 |
Evaluating ELISA, Immunofluorescence, and Lateral Flow Assay for SARS-CoV-2 Serologic Assays (edit) |
10.3389/FMICB.2020.597529 |
| 2020-12-11 |
SARS-CoV-2: Immune Response Elicited by Infection and Development of Vaccines and Treatments (edit) |
10.3389/FIMMU.2020.569760 |
| 2020-12-11 |
Increased Red Cell Distribution Width Is Associated With Disease Severity in Hospitalized Adults With SARS-CoV-2 Infection: An Observational Multicentric Study (edit) |
10.3389/FMED.2020.616292 |
| 2020-12-11 |
A Potential Peptide From Soy Cheese Produced Using Lactobacillus delbrueckii WS4 for Effective Inhibition of SARS-CoV-2 Main Protease and S1 Glycoprotein (edit) |
10.3389/FMOLB.2020.601753 |
| 2020-12-11 |
An Overview of SARS-CoV-2 and Animal Infection (edit) |
10.3389/FVETS.2020.596391 |
| 2020-12-11 |
Analysis of non-structural proteins, NSPs of SARS-CoV-2 as targets for computational drug designing (edit) |
10.1016/J.BBREP.2020.100847 |
| 2020-12-11 |
Identification of eight SARS-CoV-2 ORF7a deletion variants in 2,726 clinical specimens (edit) |
10.1101/2020.12.10.418855 |
| 2020-12-11 |
The burden of active infection and anti-SARS-CoV-2 IgG antibodies in the general population: Results from a statewide survey in Karnataka, India (edit) |
10.1101/2020.12.04.20243949 |
| 2020-12-11 |
Recombinant ACE2 Expression Is Required for SARS-CoV-2 To Infect Primary Human Endothelial Cells and Induce Inflammatory and Procoagulative Responses (edit) |
10.1128/MBIO.03185-20 |
| 2020-12-11 |
Q111521954 (edit) |
10.24215/26838559E013 |
| 2020-12-11 |
SARS-CoV-2 genome diversity at the binding sites of oligonucleotides used for COVID-19 diagnosis (edit) |
10.1101/2020.12.10.20236943 |
| 2020-12-10 |
In vitro antimicrobial, physicochemical, pharmacokinetics and molecular docking studies of benzoyl uridine esters against SARS-CoV-2 main protease (edit) |
10.1080/07391102.2020.1850358 |
| 2020-12-10 |
Estimating the Predictive Value of Negative SARS-CoV-2 Results: A Prospective Study (edit) |
10.1017/ICE.2020.1362 |
| 2020-12-10 |
An overview of research on air and environmental contamination with SARS-CoV-2 in healthcare settings (edit) |
10.1017/ICE.2020.1366 |
| 2020-12-10 |
Phylogenetic analysis of SARS-CoV-2 in Boston highlights the impact of superspreading events (edit) |
10.1126/SCIENCE.ABE3261 |
| 2020-12-10 |
Immunohistochemical expression of angiotensin-converting enzyme 2 (ACE2) in minor salivary glands during SARS-CoV-2 infection (edit) |
10.1002/JMV.26723 |
| 2020-12-10 |
Response to Tembhre et al.: 'Enhanced expression of ACE2 in psoriatic skin and its upregulation in keratinocytes by interferon-gamma: Implication of inflammatory milieu in skin tropism of SARS-CoV-2' (edit) |
10.1111/BJD.19714 |
| 2020-12-10 |
Biflavonoids from Rhus succedanea as probable natural inhibitors against SARS-CoV-2: a molecular docking and molecular dynamics approach (edit) |
10.1080/07391102.2020.1858165 |
| 2020-12-10 |
How concerned should we be about neurotropism of SARS-Cov-2? A brief clinical consideration of the possible psychiatric implications (edit) |
10.1017/S1092852920002175 |
| 2020-12-10 |
Comparison of Estimated SARS-CoV-2 Seroprevalence through Commercial Laboratory Residual Sera Testing and a Community Survey (edit) |
10.1093/CID/CIAA1804 |
| 2020-12-10 |
SARS-CoV-2 Vaccination - An Ounce (Actually, Much Less) of Prevention (edit) |
10.1056/NEJME2034717 |
| 2020-12-10 |
The transcriptomic profiling of SARS-CoV-2 compared to SARS, MERS, EBOV, and H1N1 (edit) |
10.1371/JOURNAL.PONE.0243270 |
| 2020-12-10 |
Universal screening for SARS-CoV-2 infection among pregnant women at Elmhurst Hospital Center, Queens, New York (edit) |
10.1371/JOURNAL.PONE.0238409 |
| 2020-12-10 |
CD8 T cell epitope generation toward the continually mutating SARS-CoV-2 spike protein in genetically diverse human population: Implications for disease control and prevention (edit) |
10.1371/JOURNAL.PONE.0239566 |
| 2020-12-10 |
Epidemiological profile of SARS-CoV-2 among selected regions in Ghana: A cross-sectional retrospective study (edit) |
10.1371/JOURNAL.PONE.0243711 |
| 2020-12-10 |
The SARS-CoV-2 ORF10 is not essential in vitro or in vivo in humans (edit) |
10.1371/JOURNAL.PPAT.1008959 |
| 2020-12-10 |
SARS-CoV-2 virtual biochemistry labs on bioinformatics and drug design (edit) |
10.1002/BMB.21480 |
| 2020-12-10 |
Training and Incorporating Students in SARS-CoV-2 Case Investigations and Contact Tracing (edit) |
10.1177/0033354920974664 |
| 2020-12-10 |
Middle East and North Africa SARS-CoV-2 Surveillance: A Longitudinal Trend Analysis (edit) |
10.2196/25830 |
| 2020-12-10 |
Silybin B and Cianidanol Inhibit M pro and Spike Protein of SARS-CoV-2: Evidence from in Silico Molecular Docking Studies (edit) |
10.2174/1381612826666201210122726 |
| 2020-12-10 |
A super-spreader of SARS-CoV-2 in incubation period among health-care workers (edit) |
10.1186/S12931-020-01592-W |
| 2020-12-10 |
Comparative analysis of clinical features of SARS-CoV-2 and adenovirus infection among children (edit) |
10.1186/S12985-020-01461-4 |
| 2020-12-10 |
Head-to-head comparison of SARS-CoV-2 antigen-detecting rapid test with self-collected anterior nasal swab versus professional-collected nasopharyngeal swab (edit) |
10.1183/13993003.03961-2020 |
| 2020-12-10 |
In vitro virucidal activity of povidone iodine gargle and mouthwash against SARS-CoV-2: implications for dental practice (edit) |
10.1038/S41415-020-2402-0 |
| 2020-12-10 |
Limited Secondary Transmission of the Novel Coronavirus (SARS-CoV-2) by Asymptomatic and Mild COVID-19 Patients in Bhutan (edit) |
10.4269/AJTMH.20-0672 |
| 2020-12-10 |
Community prevalence of SARS-CoV-2 in England from April to November, 2020: results from the ONS Coronavirus Infection Survey (edit) |
10.1016/S2468-2667(20)30282-6 |
| 2020-12-10 |
The ACE2-binding interface of SARS-CoV-2 Spike inherently deflects immune recognition (edit) |
10.1016/J.JMB.2020.166748 |
| 2020-12-10 |
Comparison of six commercially available SARS-CoV-2 antibody assays - choice of assay depends on intended use (edit) |
10.1016/J.IJID.2020.12.017 |
| 2020-12-10 |
Screened antipsychotic drugs inhibit SARS-CoV-2 binding with ACE2 in vitro (edit) |
10.1016/J.LFS.2020.118889 |
| 2020-12-10 |
SARS-COV-2 IgG antibody response in pregnant women at delivery (edit) |
10.1016/J.JOGOH.2020.102041 |
| 2020-12-10 |
Dual targeting of 3CLpro and PLpro of SARS-CoV-2: A novel structure-based design approach to treat COVID-19 (edit) |
10.1016/J.CRSTBI.2020.12.001 |
| 2020-12-10 |
Pre-Emption of Affliction Severity Using HRV Measurements from a Smart Wearable; Case-Study on SARS-Cov-2 Symptoms (edit) |
10.3390/S20247068 |
| 2020-12-10 |
Molecular Docking Study on Several Benzoic Acid Derivatives against SARS-CoV-2 (edit) |
10.3390/MOLECULES25245828 |
| 2020-12-10 |
Post-Mortem Diagnosis and Autopsy Findings in SARS-CoV-2 Infection: Forensic Case Series (edit) |
10.3390/DIAGNOSTICS10121070 |
| 2020-12-10 |
A Computer-Aided Drug Design Approach to Predict Marine Drug-Like Leads for SARS-CoV-2 Main Protease Inhibition (edit) |
10.3390/MD18120633 |
| 2020-12-10 |
Sustained Positivity and Reinfection With SARS-CoV-2 in Children: Does Quarantine/Isolation Period Need Reconsideration in a Pediatric Population? (edit) |
10.7759/CUREUS.12012 |
| 2020-12-10 |
SARS-CoV-2 Nsp16 activation mechanism and a cryptic pocket with pan-coronavirus antiviral potential (edit) |
10.1101/2020.12.10.420109 |
| 2020-12-10 |
A comparison of SARS-CoV-2 wastewater concentration methods for environmental surveillance (edit) |
10.1016/J.SCITOTENV.2020.144215 |
| 2020-12-10 |
The differential roles of zinc in immune responses and their potential implications in antiviral immunity against SARS-CoV-2 (edit) |
10.1016/J.CLNU.2020.12.005 |
| 2020-12-10 |
SARS-CoV-2 existence in sewage and wastewater: A global public health concern? (edit) |
10.1016/J.JENVMAN.2020.111825 |
| 2020-12-10 |
Pathophysiology of SARS-CoV-2 in Lung of Diabetic Patients (edit) |
10.3389/FPHYS.2020.587013 |
| 2020-12-10 |
Dynamic SARS-CoV-2-Specific Immunity in Critically Ill Patients With Hypertension (edit) |
10.3389/FIMMU.2020.596684 |
| 2020-12-10 |
Bee Venom-A Potential Complementary Medicine Candidate for SARS-CoV-2 Infections (edit) |
10.3389/FPUBH.2020.594458 |
| 2020-12-10 |
Host DDX Helicases as Possible SARS-CoV-2 Proviral Factors: A Structural Overview of Their Hijacking Through Multiple Viral Proteins (edit) |
10.3389/FCHEM.2020.602162 |
| 2020-12-10 |
Genomic recombination events may reveal the evolution of coronavirus and the origin of SARS-CoV-2 (edit) |
10.1038/S41598-020-78703-6 |
| 2020-12-10 |
SARS-CoV-2 inhibition in human airway epithelial cells using a mucoadhesive, amphiphilic chitosan that may serve as an anti-viral nasal spray (edit) |
10.1101/2020.12.10.413609 |
| 2020-12-09 |
Sensing the interactions between carbohydrate-binding agents and N-linked glycans of SARS-CoV-2 spike glycoprotein using molecular docking and simulation studies (edit) |
10.1080/07391102.2020.1851303 |
| 2020-12-09 |
Depicting the inhibitory potential of polyphenols from Isatis indigotica root against the main protease of SARS CoV-2 using computational approaches (edit) |
10.1080/07391102.2020.1858164 |
| 2020-12-09 |
SARS-CoV-2 Seroprevalence in Healthcare Personnel in Northern California Early in the COVID-19 Pandemic (edit) |
10.1017/ICE.2020.1358 |
| 2020-12-09 |
Simultaneous dual-gene diagnosis of SARS-CoV-2 based on CRISPR/Cas9-mediated lateral flow assay (edit) |
10.1002/ANIE.202014506 |
| 2020-12-09 |
Experimental challenge of a North American bat species, big brown bat (Eptesicus fuscus), with SARS-CoV-2 (edit) |
10.1111/TBED.13949 |
| 2020-12-09 |
Assessing uncertainty in the rooting of the SARS-CoV-2 phylogeny (edit) |
10.1093/MOLBEV/MSAA316 |
| 2020-12-09 |
SARS-CoV-2 Spike protein binds to bacterial lipopolysaccharide and boosts proinflammatory activity (edit) |
10.1093/JMCB/MJAA067 |
| 2020-12-09 |
Saliva for diagnosis of SARS-CoV-2: first report from India (edit) |
10.1002/JMV.26719 |
| 2020-12-09 |
SARS-CoV-2 positive tests efficiently predict pressure on healthcare system (edit) |
10.1002/JMV.26718 |
| 2020-12-09 |
Expression of ACE2, TMPRSS2, and Furin in mouse ear tissue, and the implications for SARS-CoV-2 infection (edit) |
10.1002/LARY.29324 |
| 2020-12-09 |
Biomarkers of acute respiratory distress syndrome in adults hospitalised for severe SARS-CoV-2 infection in Tenerife Island, Spain (edit) |
10.1001/JAMAINTERNMED.2019.4346 |
| 2020-12-09 |
Ischemic stroke in COVID-19-positive patients: an overview of SARS-CoV-2 and thrombotic mechanisms for the neurointerventionalist (edit) |
10.1136/NEURINTSURG-2020-016794 |
| 2020-12-09 |
SARS-CoV-2 safer infection sites: moral entitlement, pragmatic harm reduction strategy or ethical outrage? (edit) |
10.1136/MEDETHICS-2020-106567 |
| 2020-12-09 |
Variable sensitivity in molecular detection of SARS-CoV-2 in European Expert Laboratories: External Quality Assessment, June - July 2020 (edit) |
10.1128/JCM.02676-20 |
| 2020-12-09 |
Multi-center Evaluation of the Cepheid Xpert® Xpress SARS-CoV-2/Flu/RSV Test (edit) |
10.1128/JCM.02955-20 |
| 2020-12-09 |
A Highly Specific Assay for the Detection of SARS-CoV-2-Reactive CD4+ and CD8+ T Cells in COVID-19 Patients (edit) |
10.4049/JIMMUNOL.2000811 |
| 2020-12-09 |
A Tip of the Iceberg on the Mechanism of SARS-CoV-2-Induced Liver Injury (edit) |
10.14309/AJG.0000000000001103 |
| 2020-12-09 |
Anti-malarial Drugs are Not Created Equal for SARS-CoV-2 Treatment: A Computational Analysis Evidence (edit) |
10.2174/1381612826666201210092736 |
| 2020-12-09 |
Ritonavir may inhibit exoribonuclease activity of nsp14 from the SARS-CoV-2 virus and potentiate the activity of chain terminating drugs (edit) |
10.1016/J.IJBIOMAC.2020.12.038 |
| 2020-12-09 |
A systematic review of possible airborne transmission of the COVID-19 virus (SARS-CoV-2) in the indoor air environment (edit) |
10.1016/J.ENVRES.2020.110612 |
| 2020-12-09 |
Clinical evaluation of commercial automated SARS-CoV-2 immunoassays (edit) |
10.1016/J.IJID.2020.12.003 |
| 2020-12-09 |
Persistence of SARS-CoV-2-specific antibodies in COVID-19 patients (edit) |
10.1016/J.INTIMP.2020.107271 |
| 2020-12-09 |
6-month SARS-CoV-2 antibody persistency in a Tyrolian COVID-19 cohort (edit) |
10.1007/S00508-020-01795-7 |
| 2020-12-09 |
Testing, Testing: What SARS-CoV-2 testing services do adults in the United States actually want? A discrete choice experiment (edit) |
10.2196/25546 |
| 2020-12-09 |
Multiple Introductions Followed by Ongoing Community Spread of SARS-CoV-2 at One of the Largest Metropolitan Areas of Northeast Brazil (edit) |
10.3390/V12121414 |
| 2020-12-09 |
Characterization of a Pan-Immunoglobulin Assay Quantifying Antibodies Directed against the Receptor Binding Domain of the SARS-CoV-2 S1-Subunit of the Spike Protein: A Population-Based Study (edit) |
10.3390/JCM9123989 |
| 2020-12-09 |
Genetic Screens Identify Host Factors for SARS-CoV-2 and Common Cold Coronaviruses (edit) |
10.1016/J.CELL.2020.12.004 |
| 2020-12-09 |
Protoporphyrin IX and verteporfin potently inhibit SARS-CoV-2 infection in vitro and in a mouse model expressing human ACE2 (edit) |
10.1016/J.SCIB.2020.12.005 |
| 2020-12-09 |
Identification of a Novel Susceptibility Marker for SARS-CoV-2 Infection in Human Subjects and Risk Mitigation with a Clinically Approved JAK Inhibitor in Human/Mouse Cells (edit) |
10.1101/2020.12.09.416586 |
| 2020-12-09 |
The D614G Mutation Enhances the Lysosomal Trafficking of SARS-CoV-2 Spike (edit) |
10.1101/2020.12.08.417022 |
| 2020-12-09 |
Persistent Cellular Immunity to SARS-CoV-2 Infection (edit) |
10.1101/2020.12.08.416636 |
| 2020-12-09 |
Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases (edit) |
10.1101/2020.12.08.416750 |
| 2020-12-09 |
Proposed recommendations for antithrombotic prophylaxis for children and adolescents with severe infection and/or multisystem inflammatory syndrome caused by SARS-CoV-2 (edit) |
10.6061/CLINICS/2020/E2252 |
| 2020-12-09 |
Natural versus Recombinant Viral Antigens in SARS-CoV-2 Serology: Challenges in Optimizing Laboratory Diagnosis of COVID-19 (edit) |
10.6061/CLINICS/2020/E2290 |
| 2020-12-09 |
Heparan sulfate consumption as a potential mechanism of intra-cardiac thrombosis in SARS-CoV-2 infection (edit) |
10.1016/J.HRTLNG.2020.12.008 |
| 2020-12-09 |
Tracing surface and airborne SARS-CoV-2 RNA inside public buses and subway trains (edit) |
10.1016/J.ENVINT.2020.106326 |
| 2020-12-09 |
A Streamlined Approach to Rapidly Detect SARS-CoV-2 Infection Avoiding RNA Extraction: Workflow Validation (edit) |
10.1155/2020/8869424 |
| 2020-12-09 |
Persistence of SARS-CoV-2 RNA in post-mortem swab 35 days after death: A case report (edit) |
10.1016/J.FORSCIINT.2020.110653 |
| 2020-12-09 |
Will SARS-CoV-2 Infection Elicit Long-Lasting Protective or Sterilising Immunity? Implications for Vaccine Strategies (2020) (edit) |
10.3389/FIMMU.2020.571481 |
| 2020-12-09 |
A Network-Based Analysis Reveals the Mechanism Underlying Vitamin D in Suppressing Cytokine Storm and Virus in SARS-CoV-2 Infection (edit) |
10.3389/FIMMU.2020.590459 |
| 2020-12-09 |
Coronavirus Disease (COVID-19) Caused by (SARS-CoV-2) Infections: A Real Challenge for Human Gut Microbiota (edit) |
10.3389/FCIMB.2020.575559 |
| 2020-12-09 |
Spike Proteins of SARS-CoV and SARS-CoV-2 Utilize Different Mechanisms to Bind With Human ACE2 (edit) |
10.3389/FMOLB.2020.591873 |
| 2020-12-09 |
No Detection of SARS-CoV-2 RNA on Urethral Swab in Patients with Positive Nasopharyngeal Swab (edit) |
10.1155/2020/8826943 |
| 2020-12-09 |
Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks (edit) |
10.1016/J.CELL.2020.12.006 |
| 2020-12-09 |
Druggability for COVID-19: in silico discovery of potential drug compounds against nucleocapsid (N) protein of SARS-CoV-2 (edit) |
10.5808/GI.2020.18.4.E43 |
| 2020-12-09 |
Efficacy and safety of hydroxychloroquine in healthcare professionals with mild SARS-CoV-2 infection: Prospective, non-randomized trial (edit) |
10.1016/J.EIMC.2020.10.023 |
| 2020-12-09 |
Real-Time Conformational Dynamics of SARS-CoV-2 Spikes on Virus Particles (edit) |
10.1016/J.CHOM.2020.11.001 |
| 2020-12-09 |
Analytical validity of nanopore sequencing for rapid SARS-CoV-2 genome analysis (edit) |
10.1038/S41467-020-20075-6 |
| 2020-12-09 |
Temporal and spatial heterogeneity of host response to SARS-CoV-2 pulmonary infection (edit) |
10.1038/S41467-020-20139-7 |
| 2020-12-08 |
Summary for Patients: Postexposure Hydroxychloroquine Prophylaxis to Prevent SARS-CoV-2 Infection (edit) |
10.7326/P20-0015 |
| 2020-12-08 |
Design of an epitope-based peptide vaccine against the SARS-CoV-2: a vaccine-informatics approach (edit) |
10.1093/BIB/BBAA340 |
| 2020-12-08 |
Virtual screening of phytoconstituents from miracle herb nigella sativa targeting nucleocapsid protein and papain-like protease of SARS-CoV-2 for COVID-19 treatment (edit) |
10.1080/07391102.2020.1852117 |
| 2020-12-08 |
Evaluation of hand hygiene and onset of hand eczema after the outbreak of SARS-CoV-2 in Munich (edit) |
10.1684/EJD.2020.3923 |
| 2020-12-08 |
A SARS-CoV-2 Reference Standard Quantified by Multiple Digital PCR Platforms for Quality Assessment of Molecular Tests (edit) |
10.1021/ACS.ANALCHEM.0C03996 |
| 2020-12-08 |
Corrigendum to Efficacy of Povidone-Iodine Nasal and Oral Antiseptic Preparations Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (edit) |
10.1177/0145561320977784 |
| 2020-12-08 |
Asymptomatic SARS-CoV-2 infection: Is it all about being refractile to innate immune sensing of viral spare-parts? - Clues from exotic animal reservoirs (edit) |
10.1093/FEMSPD/FTAA076 |
| 2020-12-08 |
Correction to: CT and clinical assessment in asymptomatic and pre-symptomatic patients with early SARS-CoV-2 in outbreak settings (edit) |
10.1007/S00330-020-07552-8 |
| 2020-12-08 |
Targeting TMPRSS2 and Cathepsin B/L together may be synergistic against SARS-CoV-2 infection (edit) |
10.1371/JOURNAL.PCBI.1008461 |
| 2020-12-08 |
Evidence of SARS-CoV-2 RNA in an Oropharyngeal Swab Specimen, Milan, Italy, Early December 2019 (edit) |
10.3201/EID2702.204632 |
| 2020-12-08 |
SARS-CoV-2 infection and adverse outcomes in users of ACE inhibitors and angiotensin-receptor blockers: a nationwide case-control and cohort analysis (edit) |
10.1136/THORAXJNL-2020-215768 |
| 2020-12-08 |
Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic (edit) |
10.1126/SCIENCE.ABE9728 |
| 2020-12-08 |
A Fast and Accessible Method for the Isolation of RNA, DNA, and Protein to Facilitate the Detection of SARS-CoV-2 (edit) |
10.1128/JCM.02403-20 |
| 2020-12-08 |
SARS-CoV-2 infection of the CNS in a patient with meningeosis carcinomatosa (edit) |
10.1212/WNL.0000000000011357 |
| 2020-12-08 |
A cross-talk between epithelium and endothelium mediates human alveolar-capillary injury during SARS-CoV-2 infection (edit) |
10.1038/S41419-020-03252-9 |
| 2020-12-08 |
SARS-CoV-2 receptor ACE2 is co-expressed with genes related to transmembrane serine proteases, viral entry, immunity and cellular stress (edit) |
10.1038/S41598-020-78402-2 |
| 2020-12-08 |
Older adults lack SARS CoV-2 cross-reactive T lymphocytes directed to human coronaviruses OC43 and NL63 (edit) |
10.1038/S41598-020-78506-9 |
| 2020-12-08 |
Impact of 2020 SARS-CoV-2 outbreak on telemedicine management of cardiovascular disease in Italy (edit) |
10.1007/S11739-020-02564-0 |
| 2020-12-08 |
Pediatric COVID-19 and Appendicitis: A Gut Reaction to SARS-CoV-2? (edit) |
10.1097/INF.0000000000002998 |
| 2020-12-08 |
SARS-CoV-2 IgM False-Positivity in a Psoriatic Arthritis Patient Seropositive for Rheumatoid Factor and ACPA: An Interference of Immune Response? (edit) |
10.1097/RHU.0000000000001659 |
| 2020-12-08 |
Inhibition of SARS-CoV-2 Entry into Host Cells Using Small Molecules (edit) |
10.3390/PH13120447 |
| 2020-12-08 |
Mechanisms of Dysregulated Humoral and Cellular Immunity by SARS-CoV-2 (edit) |
10.3390/PATHOGENS9121027 |
| 2020-12-08 |
Comprehensive Structural and Molecular Comparison of Spike Proteins of SARS-CoV-2, SARS-CoV and MERS-CoV, and Their Interactions with ACE2 (edit) |
10.3390/CELLS9122638 |
| 2020-12-08 |
SARS-CoV-2 infection and transmission in educational settings: a prospective, cross-sectional analysis of infection clusters and outbreaks in England (edit) |
10.1016/S1473-3099(20)30882-3 |
| 2020-12-08 |
The role of schools and school-aged children in SARS-CoV-2 transmission (edit) |
10.1016/S1473-3099(20)30927-0 |
| 2020-12-08 |
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK (edit) |
10.1016/S0140-6736(20)32661-1 |
| 2020-12-08 |
The gastrointestinal tract is an alternative route for SARS-CoV-2 infection in a nonhuman primate model (edit) |
10.1053/J.GASTRO.2020.12.001 |
| 2020-12-08 |
On the concentration of SARS-CoV-2 in outdoor air and the interaction with pre-existing atmospheric particles (edit) |
10.1016/J.ENVRES.2020.110603 |
| 2020-12-08 |
Total Infectomes of 162 SARS-CoV-2 Cases Using Meta-Transcriptomic Sequencing (edit) |
10.1016/J.JINF.2020.12.004 |
| 2020-12-08 |
Detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives (edit) |
10.1016/J.CMI.2020.11.025 |
| 2020-12-08 |
Sars-CoV-2 et lésions rénales aiguës (edit) |
10.1016/S1773-035X(20)30336-1 |
| 2020-12-08 |
Mutational insights into the envelope protein of SARS-CoV-2 (edit) |
10.1016/J.GENREP.2020.100997 |
| 2020-12-08 |
Human activity pattern implications for modeling SARS-CoV-2 transmission (edit) |
10.1016/J.CMPB.2020.105896 |
| 2020-12-08 |
Circular RNA profiling reveals abundant and diverse circRNAs of SARS-CoV-2, SARS-CoV and MERS-CoV origin (edit) |
10.1101/2020.12.07.415422 |
| 2020-12-08 |
Natural SARS-CoV-2 infections, including virus isolation, among serially tested cats and dogs in households with confirmed human COVID-19 cases in Texas, USA (edit) |
10.1101/2020.12.08.416339 |
| 2020-12-08 |
Binding of SARS-CoV-2 spike protein to ACE2 is disabled by thiol-based drugs; evidence from in vitro SARS-CoV-2 infection studies (edit) |
10.1101/2020.12.08.415505 |
| 2020-12-08 |
Evaluation of SARS-CoV-2 neutralization assays for antibody monitoring in natural infection and vaccine trials (edit) |
10.1101/2020.12.07.20245431 |
| 2020-12-08 |
The SARS-COV-2 outbreak around the Amazon rainforest: The relevance of the airborne transmission (edit) |
10.1016/J.SCITOTENV.2020.144312 |
| 2020-12-08 |
Comparing analytical methods to detect SARS-CoV-2 in wastewater (edit) |
10.1016/J.SCITOTENV.2020.143870 |
| 2020-12-08 |
SARS-CoV-2 and Anti-Cardiolipin Antibodies (edit) |
10.1177/1179547620980381 |
| 2020-12-08 |
Identification of Small Molecule Inhibitors of the Deubiquitinating Activity of the SARS-CoV-2 Papain-Like Protease: in silico Molecular Docking Studies and in vitro Enzymatic Activity Assay (edit) |
10.3389/FCHEM.2020.623971 |
| 2020-12-08 |
Estimating the time-varying reproduction number of SARS-CoV-2 using national and subnational case counts (edit) |
10.12688/WELLCOMEOPENRES.16006.2 |
| 2020-12-08 |
Auditory Performance in Recovered SARS-COV-2 Patients (edit) |
10.1097/MAO.0000000000003037 |
| 2020-12-07 |
Next generation sequencing of SARS-CoV-2 genomes: challenges, applications and opportunities (edit) |
10.1093/BIB/BBAA297 |
| 2020-12-07 |
Drug repurposing for identification of potential inhibitors against SARS-CoV-2 spike receptor-binding domain: An in silico approach (edit) |
|
| 2020-12-07 |
SARS-CoV-2 RNA in Wastewater Settled Solids Is Associated with COVID-19 Cases in a Large Urban Sewershed (edit) |
10.1021/ACS.EST.0C06191 |
| 2020-12-07 |
IODINE MOUTHWASHES AS DETERRENTS AGAINST SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-CoV-2) (edit) |
10.1017/ICE.2020.1356 |
| 2020-12-07 |
Detection of RNA viruses from influenza and HIV to Ebola and SARS-CoV-2: a review (edit) |
10.1039/D0AY01886D |
| 2020-12-07 |
A Quick Route to Multiple Highly Potent SARS-CoV-2 Main Protease Inhibitors (edit) |
10.1002/CMDC.202000924 |
| 2020-12-07 |
Metabolic reprogramming and epigenetic changes of vital organs in SARS-CoV-2 induced systemic toxicity (edit) |
10.1172/JCI.INSIGHT.145027 |
| 2020-12-07 |
Changes in Preterm Birth Phenotypes and Stillbirth at 2 Philadelphia Hospitals During the SARS-CoV-2 Pandemic, March-June 2020 (edit) |
10.1001/JAMA.2020.20991 |
| 2020-12-07 |
In silico mutagenesis of human ACE2 with S protein and translational efficiency explain SARS-CoV-2 infectivity in different species (edit) |
10.1371/JOURNAL.PCBI.1008450 |
| 2020-12-07 |
Alignment of virus-host protein-protein interaction networks by integer linear programming: SARS-CoV-2 (edit) |
10.1371/JOURNAL.PONE.0236304 |
| 2020-12-07 |
Infection of human Nasal Epithelial Cells with SARS-CoV-2 and a 382-nt deletion isolate lacking ORF8 reveals similar viral kinetics and host transcriptional profiles (edit) |
10.1371/JOURNAL.PPAT.1009130 |
| 2020-12-07 |
Molecular detection of SARS-CoV-2 using a reagent-free approach (edit) |
10.1371/JOURNAL.PONE.0243266 |
| 2020-12-07 |
SARS-CoV-2 spike protein promotes IL-6 trans-signaling by activation of angiotensin II receptor signaling in epithelial cells (edit) |
10.1371/JOURNAL.PPAT.1009128 |
| 2020-12-07 |
Molecular epidemiology of SARS-CoV-2 clusters caused by asymptomatic cases in Anhui Province, China (edit) |
10.1186/S12879-020-05612-4 |
| 2020-12-07 |
Lung ultrasound in the emergency department - a valuable tool in the management of patients presenting with respiratory symptoms during the SARS-CoV-2 pandemic (edit) |
10.1186/S12873-020-00389-W |
| 2020-12-07 |
Epidemiological and viral features of a cohort of SARS-CoV-2 symptomatic and asymptomatic individuals in an area of the Colombian Caribbean (edit) |
10.1186/S12941-020-00397-5 |
| 2020-12-07 |
Criteria for referral of pediatric SARS-CoV-2 infection: a real-life experience in the pandemic era (edit) |
10.1186/S13052-020-00946-W |
| 2020-12-07 |
Enhanced SARS-CoV-2 neutralization by dimeric IgA (edit) |
10.1126/SCITRANSLMED.ABF1555 |
| 2020-12-07 |
IgA dominates the early neutralizing antibody response to SARS-CoV-2 (edit) |
10.1126/SCITRANSLMED.ABD2223 |
| 2020-12-07 |
Alimentary System is Directly Attacked by SARS-COV-2 and Further Prevents Immune Dysregulation Caused by COVID-19 (edit) |
10.1111/IJCP.13893 |
| 2020-12-07 |
Repurposing potential of FDA approved and investigational drugs for COVID-19 targeting SARS-CoV-2 spike and main protease and validation by machine learning algorithm (edit) |
10.1111/CBDD.13812 |
| 2020-12-07 |
Expression and clinical significance of SARS-CoV-2 human targets in neoplastic and non-neoplastic lung tissues (edit) |
10.2174/1568009620666201207145019 |
| 2020-12-07 |
Evaluation of the Binding Affinity of Anti-Viral Drugs against Main Protease of SARS-CoV-2 through a Molecular Docking Study (edit) |
10.2174/1871526520666201207124408 |
| 2020-12-07 |
[SARS CoV-2 related disease features in a population of chronic hemodialysis patients] (edit) |
|
| 2020-12-07 |
Towards an accurate and systematic characterisation of persistently asymptomatic infection with SARS-CoV-2 (edit) |
10.1016/S1473-3099(20)30837-9 |
| 2020-12-07 |
SARS-CoV-2 Manuscripts Submitted to The Journal of Pediatrics: The Nimbleness and Resource Costs of Expedited Review and Concerns of Duplicate Publication (edit) |
10.1016/J.JPEDS.2020.12.003 |
| 2020-12-07 |
Rapid, high-yield production of full-length SARS-CoV-2 spike ectodomain by transient gene expression in CHO cells (edit) |
10.1016/J.JBIOTEC.2020.12.005 |
| 2020-12-07 |
Fatal SARS-CoV-2 infection in a male patient with Good's syndrome (edit) |
10.1016/J.CLIM.2020.108644 |
| 2020-12-07 |
Host range projection of SARS-CoV-2: South Asia perspective (edit) |
10.1016/J.MEEGID.2020.104670 |
| 2020-12-07 |
Spike Protein of SARS-CoV-2 Activates Macrophages and Contributes to Induction of Acute Lung Inflammations in Mice (edit) |
10.1101/2020.12.07.414706 |
| 2020-12-07 |
Rapid detection of SARS-CoV-2-specific memory T-cell immunity in recovered COVID-19 cases (edit) |
10.1002/CTI2.1219 |
| 2020-12-07 |
Structural characterization of Nonstructural protein 1 from SARS-CoV-2 (edit) |
10.1016/J.ISCI.2020.101903 |
| 2020-12-07 |
IgG Antibodies against SARS-CoV-2 Correlate with Days from Symptom Onset, Viral Load and IL-10 (edit) |
10.1101/2020.12.05.20244541 |
| 2020-12-07 |
Sensitive detection and quantification of SARS-CoV-2 in saliva (edit) |
10.1101/2020.12.04.20241059 |
| 2020-12-07 |
Breath biomarkers of pediatric SARS-CoV-2 infection: a pilot study (edit) |
10.1101/2020.12.04.20230755 |
| 2020-12-07 |
What about incorporating selenium in the therapeutic regimen of SARS-CoV-2? (edit) |
10.17179/EXCLI2020-2968 |
| 2020-12-07 |
PB28, the Sigma-1 and Sigma-2 Receptors Modulator With Potent Anti-SARS-CoV-2 Activity: A Review About Its Pharmacological Properties and Structure Affinity Relationships (edit) |
10.3389/FPHAR.2020.589810 |
| 2020-12-07 |
Can Natural Killer Cells Be a Principal Player in Anti-SARS-CoV-2 Immunity? (edit) |
10.3389/FIMMU.2020.586765 |
| 2020-12-07 |
Quantitative SARS-CoV-2 Antibody Screening of Healthcare Workers in the Southern Part of Kyoto City During the COVID-19 Pre-pandemic Period (edit) |
10.3389/FPUBH.2020.595348 |
| 2020-12-07 |
Preparing for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Self-Testing Implementation: Lessons Learned From HIV Self-Testing (edit) |
10.3389/FMED.2020.599521 |
| 2020-12-07 |
Correlation Between the COVID-19 Respiratory Triage Score and SARS-COV-2 PCR Test (edit) |
10.3389/FMED.2020.605689 |
| 2020-12-07 |
Spike protein D614G and RdRp P323L: the SARS-CoV-2 mutations associated with severity of COVID-19 (edit) |
10.5808/GI.2020.18.4.E44 |
| 2020-12-07 |
The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with mild COVID-19: a pilot, double-blind, placebo-controlled, randomized clinical trial (edit) |
10.21203/RS.3.RS-116547/V1 |
| 2020-12-07 |
SARS-CoV-2 infection and COVID-19 severity in individuals with prior seasonal coronavirus infection (edit) |
10.1101/2020.12.04.20243741 |
| 2020-12-06 |
An Organoid-derived Bronchioalveolar Model for SARS-CoV-2 Infection of Human Alveolar-type II-like Cells (edit) |
10.15252/EMBJ.2020105912 |
| 2020-12-06 |
Multiple SARS-CoV-2 Introductions Shaped the Early Outbreak in Central Eastern Europe: Comparing Hungarian Data to a Worldwide Sequence Data-Matrix (edit) |
10.3390/V12121401 |
| 2020-12-06 |
The Contribution of Endothelial Dysfunction in Systemic Injury Subsequent to SARS-Cov-2 Infection (edit) |
10.3390/IJMS21239309 |
| 2020-12-06 |
An Updated Review on SARS-CoV-2 Main Proteinase (MPro): Protein Structure and Small-Molecule Inhibitors (edit) |
10.2174/1568026620666201207095117 |
| 2020-12-06 |
Amilorides inhibit SARS-CoV-2 replication in vitro by targeting RNA structures (edit) |
10.1101/2020.12.05.409821 |
| 2020-12-06 |
Elevated SARS-CoV-2 Antibodies Distinguish Severe Disease in Early COVID-19 Infection (edit) |
10.1101/2020.12.04.410589 |
| 2020-12-06 |
L1000 connectivity map interrogation identifies candidate drugs for repurposing as SARS-CoV-2 antiviral therapies (edit) |
10.1016/J.CSBJ.2020.11.054 |
| 2020-12-06 |
Willingness of Patients With Knee Osteoarthritis to Use Telemedicine Amid Sars-CoV-2 Outbreak (edit) |
10.1177/2151459320979974 |
| 2020-12-05 |
Co-infection, SARS-CoV-2 and influenza: an evolving puzzle (edit) |
10.1093/CID/CIAA1810 |
| 2020-12-05 |
Amotosalen and ultraviolet A light treatment efficiently inactivates severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human plasma (edit) |
10.1111/VOX.13043 |
| 2020-12-05 |
American College of Rheumatology Clinical Guidance for Pediatric Patients with Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2 and Hyperinflammation in COVID-19. Version 2 (edit) |
10.1002/ART.41616 |
| 2020-12-05 |
SARS-CoV-2-induced immune activation and death of monocyte-derived human macrophages and dendritic cells (edit) |
10.1093/INFDIS/JIAA753 |
| 2020-12-05 |
Editorial: Proteins of SARS CoV-2, the Cause of COVID-19, and the Proteins that Interact with Them (edit) |
10.1007/S10930-020-09947-4 |
| 2020-12-05 |
Six months into the pandemic. A review of skin manifestations in SARS-CoV-2 infection (edit) |
10.1111/DTH.14641 |
| 2020-12-05 |
Incidence and outcome of SARS-CoV-2 infection on solid organ transplantation recipients: A nationwide population-based study (edit) |
10.1111/AJT.16428 |
| 2020-12-05 |
Transmission of SARS-CoV-2 Infection by Children: A Study of Contacts of Index Paediatric Cases in India (edit) |
10.1093/TROPEJ/FMAA081 |
| 2020-12-05 |
Exploring the real-world effect of the SARS-CoV-2 pandemic on the molecular diagnostics for cancer patients and high-risk individuals (edit) |
10.1080/14737159.2021.1860760 |
| 2020-12-05 |
Assessment of antiviral potencies of cannabinoids against SARS-CoV-2 using computational and in vitro approaches (edit) |
10.1016/J.IJBIOMAC.2020.12.020 |
| 2020-12-05 |
Genomic and evolutionary comparison between SARS-CoV-2 and other human coronaviruses (edit) |
10.1016/J.JVIROMET.2020.114032 |
| 2020-12-05 |
Aerosol Release by Healthy People during Speaking: Possible Contribution to the Transmission of SARS-CoV-2 (edit) |
10.3390/IJERPH17239088 |
| 2020-12-05 |
IMU-838, a Developmental DHODH Inhibitor in Phase II for Autoimmune Disease, Shows Anti-SARS-CoV-2 and Broad-Spectrum Antiviral Efficacy In Vitro (edit) |
10.3390/V12121394 |
| 2020-12-05 |
RECURRENT SARS-CoV-2 INFECTION RESULTING IN ACUTE RESPIRATORY DISTRESS SYNDROME AND DEVELOPMENT OF PULMONARY HYPERTENSION: A CASE REPORT (edit) |
10.1016/J.RMCR.2020.101314 |
| 2020-12-05 |
Chasing COVID-19 through SARS-CoV-2 spike glycoprotein (edit) |
10.1007/S13337-020-00642-7 |
| 2020-12-05 |
A double-edged sword: Prolonged detection of SARS-COV-2 in patients receiving cancer directed therapy (edit) |
10.1053/J.SEMINONCOL.2020.11.001 |
| 2020-12-05 |
Evaluation of a SARS-CoV-2 rapid antigen test: Potential to help reduce community spread? (edit) |
10.1016/J.JCV.2020.104713 |
| 2020-12-05 |
Lung ultrasonography unmasking the asymptomatic SARS-CoV-2 carrier (edit) |
10.1016/J.MEDCLI.2020.11.008 |
| 2020-12-05 |
Patient characterization and adverse health care-related events in SARS-CoV-2 infected patients who died in a tertiary hospital (edit) |
10.1016/J.MEDCLI.2020.11.002 |
| 2020-12-05 |
SARS-CoV-2 RNA monitoring in wastewater as a potential early warning system for COVID-19 transmission in the community: A temporal case study (edit) |
10.1016/J.SCITOTENV.2020.144216 |
| 2020-12-05 |
[Role of the emergency department pediatrician during SARS-CoV-2 pandemic] (edit) |
10.1016/J.ANPEDI.2020.11.026 |
| 2020-12-05 |
Effectiveness of glucocorticoids in patients hospitalized for severe SARS-CoV-2 pneumonia (edit) |
10.1016/J.MEDCLI.2020.11.004 |
| 2020-12-05 |
[Palmar pulpitis as an isolated expression of SARS-CoV-2 infection] (edit) |
10.1016/J.APRIM.2020.08.008 |
| 2020-12-04 |
SARS-CoV-2 indoor contamination: considerations on anti-COVID-19 management of ventilation systems, and finishing materials in healthcare facilities (edit) |
|
| 2020-12-04 |
Prediction of potential small interfering RNA molecules for silencing of the spike gene of SARS-CoV-2 (edit) |
|
| 2020-12-04 |
Is there an association between SARS-CoV-2 and Streptococcus pneumoniae? (edit) |
10.1093/CID/CIAA1812 |
| 2020-12-04 |
SARS-CoV-2 pandemic impact on traumatic brain injury epidemiology: an overview of the Veneto region (edit) |
10.23736/S0375-9393.20.15148-4 |
| 2020-12-04 |
Computational Insights into the Conformational Accessibility and Binding Strength of SARS-CoV-2 Spike Protein to Human Angiotensin-Converting Enzyme 2 (edit) |
10.1021/ACS.JPCLETT.0C02958 |
| 2020-12-04 |
SARS-CoV-2, ACE2 expression, and systemic organ invasion (edit) |
10.1152/PHYSIOLGENOMICS.00087.2020 |
| 2020-12-04 |
A natural mutation between SARS-CoV-2 and SARS-CoV determines neutralization by a cross-reactive antibody (edit) |
10.1371/JOURNAL.PPAT.1009089 |
| 2020-12-04 |
Correlates of protection against SARS-CoV-2 in rhesus macaques (edit) |
10.1038/S41586-020-03041-6 |
| 2020-12-04 |
A rapid, cost-effective tailed amplicon method for sequencing SARS-CoV-2 (edit) |
10.1186/S12864-020-07283-6 |
| 2020-12-04 |
Correction to: Effect of PEEP decremental on respiratory mechanics, gas exchange, pulmonary regional ventilation, and hemodynamics in patients with SARS-Cov-2-associated Acute Respiratory Distress Syndrome (edit) |
10.1186/S13054-020-03392-6 |
| 2020-12-04 |
Conformational dynamics of SARS-CoV-2 trimeric spike glycoprotein in complex with receptor ACE2 revealed by cryo-EM (edit) |
10.1126/SCIADV.ABE5575 |
| 2020-12-04 |
Household transmission and incidence of positive SARS-CoV-2 RT-PCR in symptomatic healthcare workers, clinical course and outcome: a French hospital experience (edit) |
10.1136/OEMED-2020-106866 |
| 2020-12-04 |
Cutting Edge: Severe SARS-CoV-2 Infection in Humans Is Defined by a Shift in the Serum Lipidome, Resulting in Dysregulation of Eicosanoid Immune Mediators (edit) |
10.4049/JIMMUNOL.2001025 |
| 2020-12-04 |
CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells (edit) |
10.1038/S41392-020-00426-X |
| 2020-12-04 |
Characteristics of SARS-CoV-2-specific cytotoxic T cells revealed by single-cell immune profiling of longitudinal COVID-19 blood samples (edit) |
10.1038/S41392-020-00425-Y |
| 2020-12-04 |
Evidence of exposure to SARS-CoV-2 in cats and dogs from households in Italy (edit) |
10.1038/S41467-020-20097-0 |
| 2020-12-04 |
Determining the infectious potential of individuals with positive RT-PCR SARS-CoV-2 tests (edit) |
10.1093/CID/CIAA1819 |
| 2020-12-04 |
Diagnostic testing for SARS-CoV-2/COVID19 (edit) |
10.1097/MOP.0000000000000972 |
| 2020-12-04 |
Epidemiologic trends and characteristics of SARS-CoV-2 infections among children in the United States (edit) |
10.1097/MOP.0000000000000971 |
| 2020-12-04 |
EVALUATION OF SYBR GREEN REAL TIME PCR FOR DETECTING SARS-CoV-2 FROM CLINICAL SAMPLES (edit) |
10.1016/J.JVIROMET.2020.114035 |
| 2020-12-04 |
SARS-CoV-2 and aerosols-Arguing over the evidence (edit) |
10.1016/J.JVIROMET.2020.114033 |
| 2020-12-04 |
Which adults presenting for SARS-CoV-2 testing are most likely to have a positive swab? A population-based cohort of 15,132 adults from Alberta, Canada (edit) |
10.1016/J.CHEST.2020.11.043 |
| 2020-12-04 |
High rate of infections during ICU admission of patients with severe SARS-CoV-2 pneumonia: a matter of time? (edit) |
10.1016/J.JINF.2020.12.001 |
| 2020-12-04 |
Prevalence of SARS-CoV-2 IgG antibodies in a large prospective cohort study of elite football players in Germany (May-June 2020): implications for a testing protocol in asymptomatic individuals and estimation of the rate of undetected cases (edit) |
10.1016/J.CMI.2020.11.033 |
| 2020-12-04 |
COVID-19 Convalescent Plasma Treatment of Moderate and Severe Cases of SARS-CoV-2 Infection: A Multicenter Interventional Study (edit) |
10.1016/J.IJID.2020.11.198 |
| 2020-12-04 |
Rapid implementation of SARS-CoV-2 emergency use authorization RT-PCR testing and experience at an academic medical institution (edit) |
10.1016/J.JMOLDX.2020.10.019 |
| 2020-12-04 |
Performance Characteristics of SARS-CoV-2 PCR Tests in A Single Health System: Analysis of over 10,000 Results from Three Different Assays (edit) |
10.1016/J.JMOLDX.2020.11.008 |
| 2020-12-04 |
Identification of SARS-CoV-2 Proteins Binding Human mRNAs As a Novel Signature Predicting Overall Survival in Hepatocellular Carcinoma (edit) |
10.1089/DNA.2020.6278 |
| 2020-12-04 |
Pediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2 Treated with Tocilizumab (edit) |
10.3390/PEDIATRIC12030029 |
| 2020-12-04 |
Early Phase Management of the SARS-CoV-2 Pandemic in the Geographic Area of the Veneto Region, in One of the World's Oldest Populations (edit) |
10.3390/IJERPH17239045 |
| 2020-12-04 |
Predicting SARS-CoV-2 Weather-Induced Seasonal Virulence from Atmospheric Air Enthalpy (edit) |
10.3390/IJERPH17239059 |
| 2020-12-04 |
Prevention of SARS-CoV-2 Infection Among Police Officers in Poland-Implications for Public Health Policies (edit) |
10.3390/IJERPH17239072 |
| 2020-12-04 |
Evolution of the SARS-CoV-2 proteome in three dimensions (3D) during the first six months of the COVID-19 pandemic (edit) |
10.1101/2020.12.01.406637 |
| 2020-12-04 |
Ca 2+ -dependent mechanism of membrane insertion and destabilization by the SARS-CoV-2 fusion peptide (edit) |
10.1101/2020.12.03.410472 |
| 2020-12-04 |
SARS-CoV-2 Spike Protein Impairs Endothelial Function via Downregulation of ACE2 (edit) |
10.1101/2020.12.04.409144 |
| 2020-12-04 |
Amplification-free detection of SARS-CoV-2 with CRISPR-Cas13a and mobile phone microscopy (edit) |
10.1016/J.CELL.2020.12.001 |
| 2020-12-04 |
Pregnant people deserve the protection offered by SARS-CoV-2 vaccines (edit) |
10.1016/J.VACCINE.2020.12.007 |
| 2020-12-04 |
[Changes in adherence to the Mediterranean diet observed in a Spanish population during confinement for the SARS-CoV-2 pandemic] (edit) |
10.20960/NH.03275 |
| 2020-12-04 |
Prolonged viral shedding of SARS-CoV-2 in an immunocompromised patient (edit) |
10.1016/J.JIAC.2020.12.001 |
| 2020-12-04 |
Evaluation of rapid antigen detection kit from the WHO Emergency Use List for detecting SARS-CoV-2 (edit) |
10.1016/J.JCV.2020.104712 |
| 2020-12-04 |
Human Leukocyte Antigen Complex and Other Immunogenetic and Clinical Factors Influence Susceptibility or Protection to SARS-CoV-2 Infection and Severity of the Disease Course. The Sardinian Experience (edit) |
10.3389/FIMMU.2020.605688 |
| 2020-12-04 |
Pediatric Inflammatory Multisystem Syndrome and Rheumatic Diseases During SARS-CoV-2 Pandemic (edit) |
10.3389/FPED.2020.605807 |
| 2020-12-04 |
Iterative Monitoring of Temperatures in Confinement for Early Screening of SARS-CoV-2 Infections (edit) |
10.3389/FMED.2020.564377 |
| 2020-12-04 |
Recent Progress in the Drug Development Targeting SARS-CoV-2 Main Protease as Treatment for COVID-19 (edit) |
10.3389/FMOLB.2020.616341 |
| 2020-12-04 |
SARS-CoV-2-related ARDS in a maintenance hemodialysis patient: case report on tailored approach by daily hemodialysis, noninvasive ventilation, tocilizumab, anxiolytics, and point-of-care ultrasound (edit) |
10.1002/CCR3.3623 |
| 2020-12-04 |
Priority of SARS-CoV-2 test, trace, and isolation in Japan (edit) |
10.1002/JGF2.409 |
| 2020-12-03 |
Commentary for "Endocrine significance of SARS-CoV-2's reliance on ACE2" (edit) |
10.1210/ENDOCR/BQAA222 |
| 2020-12-03 |
EXPRESS: Development of a High Throughput SARS-CoV-2 Antibody Testing Pathway Using Dried Blood Spot Specimens (edit) |
10.1177/0004563220981106 |
| 2020-12-03 |
Detection of SARS-CoV-2 in saliva: implications for specimen transport and storage (edit) |
10.1099/JMM.0.001285 |
| 2020-12-03 |
Absence of SARS-CoV-2 neutralizing activity in pre-pandemic sera from individuals with recent seasonal coronavirus infection (edit) |
10.1093/CID/CIAA1803 |
| 2020-12-03 |
Dose-response effects of hydroxychloroquine on prophylaxis against SARS-CoV-2 / COVID-19 infection (edit) |
10.1093/CID/CIAA1807 |
| 2020-12-03 |
1H, 13C, and 15N backbone chemical shift assignments of the C-terminal dimerization domain of SARS-CoV-2 nucleocapsid protein (edit) |
10.1007/S12104-020-09995-Y |
| 2020-12-03 |
Interpretative immune targets and contemporary position for vaccine development against SARS-CoV-2: A systematic review (edit) |
10.1002/JMV.26709 |
| 2020-12-03 |
Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination (edit) |
10.1056/NEJMC2032195 |
| 2020-12-03 |
Non-Receptor-Mediated Lipid Membrane Permeabilization by the SARS-CoV-2 Spike Protein S1 Subunit (edit) |
10.1021/ACSAMI.0C17044 |
| 2020-12-03 |
Colorimetric Detection of SARS-CoV-2 and Drug-Resistant pH1N1 Using CRISPR/dCas9 (edit) |
10.1021/ACSSENSORS.0C01929 |
| 2020-12-03 |
Over time relationship between platelet reactivity, myocardial injury and mortality in patients with SARS-CoV-2-associated respiratory failure (edit) |
10.1080/09537104.2020.1852543 |
| 2020-12-03 |
Vaccine safety - is the SARS-CoV-2 vaccine any different? (edit) |
10.1080/21645515.2020.1829414 |
| 2020-12-03 |
SARS-CoV-2-Triggered Immune Reaction: For COVID-19, Nothing is as Old as Yesterday's Knowledge (edit) |
10.1164/RCCM.202011-4194ED |
| 2020-12-03 |
Insights on cross-species transmission of SARS-CoV-2 from structural modeling (edit) |
10.1371/JOURNAL.PCBI.1008449 |
| 2020-12-03 |
Antibodies against SARS-CoV-2 among health care workers in a country with low burden of COVID-19 (edit) |
10.1371/JOURNAL.PONE.0243025 |
| 2020-12-03 |
U-shaped-aggressiveness of SARS-CoV-2: Period between initial symptoms and clinical progression to COVID-19 suspicion. A population-based cohort study (edit) |
10.1371/JOURNAL.PONE.0243268 |
| 2020-12-03 |
Opposing activities of IFITM proteins in SARS-CoV-2 infection (edit) |
10.15252/EMBJ.2020106501 |
| 2020-12-03 |
ADAMTS13 activity to von Willebrand factor antigen ratio predicts acute kidney injury in patients with COVID-19: Evidence of SARS-CoV-2 induced secondary thrombotic microangiopathy (edit) |
10.1111/IJLH.13415 |
| 2020-12-03 |
Molecular characterization of SARS-CoV-2 (edit) |
10.2174/1566524020999201203213037 |
| 2020-12-03 |
Risk factors for a positive SARS-CoV-2 PCR in patients with common cold symptoms in a primary care setting - a retrospective analysis based on a joint documentation standard (edit) |
10.1186/S12875-020-01322-7 |
| 2020-12-03 |
Impact of SARS-CoV-2 pandemic on bariatric care in Poland: results of national survey (edit) |
10.1186/S12893-020-00990-7 |
| 2020-12-03 |
Establishing a mass spectrometry-based system for rapid detection of SARS-CoV-2 in large clinical sample cohorts (edit) |
10.1038/S41467-020-19925-0 |
| 2020-12-03 |
Fast detection of SARS-CoV-2 RNA via the integration of plasmonic thermocycling and fluorescence detection in a portable device (edit) |
10.1038/S41551-020-00654-0 |
| 2020-12-03 |
Rapid lateral flow immunoassay for the fluorescence detection of SARS-CoV-2 RNA (edit) |
10.1038/S41551-020-00655-Z |
| 2020-12-03 |
Evolutionary and structural analysis of SARS-CoV-2 specific evasion of host immunity (edit) |
10.1038/S41435-020-00120-6 |
| 2020-12-03 |
Therapeutically administered ribonucleoside analogue MK-4482/EIDD-2801 blocks SARS-CoV-2 transmission in ferrets (edit) |
10.1038/S41564-020-00835-2 |
| 2020-12-03 |
[SARS-CoV-2 antibodies in ICU and clinic staff : From Germany's region with the highest infection rate] (edit) |
10.1007/S00063-020-00761-5 |
| 2020-12-03 |
Modeling Multi-organ Infection by SARS-CoV-2 Using Stem Cell Technology (edit) |
10.1016/J.STEM.2020.11.012 |
| 2020-12-03 |
SALVAGE LOBECTOMY TO TREAT NECROTIZING SARS-CoV-2 PNEUMONIA COMPLICATED BY A BRONCHOPLEURAL FISTULA (edit) |
10.1016/J.ATHORACSUR.2020.10.038 |
| 2020-12-03 |
Prophylactic intranasal administration of a TLR2/6 agonist reduces upper respiratory tract viral shedding in a SARS-CoV-2 challenge ferret model (edit) |
10.1016/J.EBIOM.2020.103153 |
| 2020-12-03 |
Infection and Risk Perception of SARS-CoV-2 among Airport Workers: A Mixed Methods Study (edit) |
10.3390/IJERPH17239002 |
| 2020-12-03 |
Persistent Detection and Infectious Potential of SARS-CoV-2 Virus in Clinical Specimens from COVID-19 Patients (edit) |
10.3390/V12121384 |
| 2020-12-03 |
Effects of Ozone Treatment on Personal Protective Equipment Contaminated with SARS-CoV-2 (edit) |
10.3390/ANTIOX9121222 |
| 2020-12-03 |
Geranii Herba as a Potential Inhibitor of SARS-CoV-2 Main 3CLpro, Spike RBD, and Regulation of Unfolded Protein Response: An In Silico Approach (edit) |
10.3390/ANTIBIOTICS9120863 |
| 2020-12-03 |
Asymptomatic reactivation of SARS-CoV-2 in a child with neuroblastoma characterised by whole genome sequencing (edit) |
10.1016/J.IDCR.2020.E01018 |
| 2020-12-03 |
Research During the SARS-CoV-2 Pandemic (edit) |
10.1016/J.MEDCLE.2020.09.001 |
| 2020-12-03 |
Risk Factors of SARS-CoV-2 Antibodies in Arapahoe County First Responders - the COVID-19 Arapahoe SErosurveillance Study (CASES) Project (edit) |
10.1097/JOM.0000000000002099 |
| 2020-12-03 |
A single intranasal or intramuscular immunization with chimpanzee adenovirus vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters (edit) |
10.1101/2020.12.02.408823 |
| 2020-12-03 |
Impact of social distancing regulations and epidemic risk perception on social contact and SARS-CoV-2 transmission potential in rural South Africa: analysis of repeated cross-sectional surveys (edit) |
10.1101/2020.12.01.20241877 |
| 2020-12-03 |
Sewage, Salt, Silica and SARS-CoV-2 (4S): An economical kit-free method for direct capture of SARS-CoV-2 RNA from wastewater (edit) |
10.1101/2020.12.01.20242131 |
| 2020-12-03 |
Clinical characteristics of SARS-CoV-2 infection in children with cystic fibrosis: An international observational study (edit) |
10.1016/J.JCF.2020.11.021 |
| 2020-12-03 |
Identification of antiviral antihistamines for COVID-19 repurposing (edit) |
10.1016/J.BBRC.2020.11.095 |
| 2020-12-03 |
Deaths after confirmed SARS-CoV-2 in Norway (edit) |
10.4045/TIDSSKR.20.0693 |
| 2020-12-03 |
Clinical characteristics and infectivity of asymptomatic carriers of SARS-CoV-2 (Review) (edit) |
10.3892/ETM.2020.9547 |
| 2020-12-03 |
Body Localization of ACE-2: On the Trail of the Keyhole of SARS-CoV-2 (edit) |
10.3389/FMED.2020.594495 |
| 2020-12-03 |
Possible Prophylactic Approach for SARS-CoV-2 Infection by Combination of Melatonin, Vitamin C and Zinc in Animals (edit) |
10.3389/FVETS.2020.585789 |
| 2020-12-03 |
Incidence of SARS-CoV-2 infection in close contacs. Telephone follow-up in Primary Care (edit) |
10.1016/J.MEDCLI.2020.11.003 |
| 2020-12-03 |
E-scouts in support of online teaching during the SARS-CoV-2 pandemic (edit) |
10.3205/ZMA001367 |
| 2020-12-03 |
Crisis as a chance. A digital training of social competencies with simulated persons at the Medical Faculty of RWTH Aachen, due to the lack of attendance teaching in the SARS-Cov-2 pandemic (edit) |
10.3205/ZMA001375 |
| 2020-12-03 |
SARS-CoV-2 infection triggering a giant cell arteritis (edit) |
10.1016/J.MEDCLI.2020.11.005 |
| 2020-12-03 |
Is SARS-CoV-2 Infection a Risk for Potentiation of Epileptic Seizures in Children With Pre-existing Epilepsy? (edit) |
10.1016/J.PEDIATRNEUROL.2020.11.021 |
| 2020-12-03 |
Results of Open-Label non-Randomized Comparative Clinical Trial: “BromhexIne and Spironolactone for CoronаvirUs Infection requiring hospiTalization (BISCUIT) (edit) |
10.18087/CARDIO.2020.11.N1440 |
| 2020-12-03 |
In Vitro Analysis of the Anti-viral Potential of nasal spray constituents against SARS-CoV-2 (edit) |
10.1101/2020.12.02.408575 |
| 2020-12-02 |
THE IMPACT OF SARS-CoV-2 INFECTION ON THE SURGICAL MANAGEMENT OF COLORECTAL CANCER: LESSONS LEARNED FROM A MULTICENTER STUDY IN SPAIN (edit) |
10.17235/REED.2020.7460/2020 |
| 2020-12-02 |
Pre-Procedural Antibody Testing for SARS-CoV-2 in routine endoscopic practice (edit) |
10.17235/REED.2020.7434/2020 |
| 2020-12-02 |
Comparative Multiplexed Interactomics of SARS-CoV-2 and Homologous Coronavirus Nonstructural Proteins Identifies Unique and Shared Host-Cell Dependencies (edit) |
10.1021/ACSINFECDIS.0C00500 |
| 2020-12-02 |
Healthcare-associated SARS-CoV-2 transmission in a neonatal unit: the importance of universal masking, hand hygiene and symptom screening in containment (edit) |
10.1093/JPIDS/PIAA160 |
| 2020-12-02 |
SARS-CoV-2 antibody responses in children with MIS-C and mild and severe COVID-19 (edit) |
10.1093/JPIDS/PIAA161 |
| 2020-12-02 |
Remdesivir Strongly Binds to Both RNA-Dependent RNA Polymerase and Main Protease of SARS-CoV-2: Evidence from Molecular Simulations (edit) |
10.1021/ACS.JPCB.0C07312 |
| 2020-12-02 |
Frontrunners in the race to develop a SARS-CoV-2 vaccine (edit) |
10.1139/CJM-2020-0465 |
| 2020-12-02 |
Structural basis of RNA recognition by the SARS-CoV-2 nucleocapsid phosphoprotein (edit) |
10.1371/JOURNAL.PPAT.1009100 |
| 2020-12-02 |
Remote fingerstick blood collection for SARS-CoV-2 antibody testing (edit) |
10.5858/ARPA.2020-0713-SA |
| 2020-12-02 |
The Structural Basis of Accelerated Host Cell Entry by SARS-CoV-2† (edit) |
10.1111/FEBS.15651 |
| 2020-12-02 |
Decrease and Recovery of Olfactory and Gustatory Function in a Case of SARS-CoV-2 Infection (edit) |
10.1159/000512875 |
| 2020-12-02 |
Highly Effective Inactivation of SARS-CoV-2 by Conjugated Polymers and Oligomers (edit) |
10.1021/ACSAMI.0C17445 |
| 2020-12-02 |
Identification of SARS-CoV-2 RNA in the conjunctival swab of an Italian pediatric patient affected with COVID-19: A case report (edit) |
10.1177/1120672120977822 |
| 2020-12-02 |
Serpiginous choroiditis presenting after SARS-CoV-2 infection: A new immunological trigger? (edit) |
10.1177/1120672120977817 |
| 2020-12-02 |
High prevalence of SARS-CoV-2 infection among symptomatic healthcare workers in a large university tertiary hospital in São Paulo, Brazil (edit) |
10.1186/S12879-020-05662-8 |
| 2020-12-02 |
Does respiratory co-infection facilitate dispersal of SARS-CoV-2? investigation of a super-spreading event in an open-space office (edit) |
10.1186/S13756-020-00861-Z |
| 2020-12-02 |
Priming of SARS-CoV-2 S protein by several membrane-bound serine proteinases could explain enhanced viral infectivity and systemic COVID-19 infection (edit) |
10.1074/JBC.REV120.015980 |
| 2020-12-02 |
Randomised controlled trial for high-dose intravenous zinc as adjunctive therapy in SARS-CoV-2 (COVID-19) positive critically ill patients: trial protocol (edit) |
10.1136/BMJOPEN-2020-040580 |
| 2020-12-02 |
The viral protein NSP1 acts as a ribosome gatekeeper for shutting down host translation and fostering SARS-CoV-2 translation (edit) |
10.1261/RNA.078121.120 |
| 2020-12-02 |
The global and local distribution of RNA structure throughout the SARS-CoV-2 genome (edit) |
10.1128/JVI.02190-20 |
| 2020-12-02 |
Identification of HLA-A*02:01-restricted candidate epitopes derived from the non-structural polyprotein 1a of SARS-CoV-2 that may be natural targets of CD8+ T cell recognition in vivo (edit) |
10.1128/JVI.01837-20 |
| 2020-12-02 |
Climate change and the origin of SARS-CoV-2 (edit) |
10.1093/JTM/TAAA224 |
| 2020-12-02 |
Applying the electronic nose for pre-operative SARS-CoV-2 screening (edit) |
10.1007/S00464-020-08169-0 |
| 2020-12-02 |
[Health protection of employees against SARS-CoV-2 coronavirus infection causing the COVID-19 disease - the current state of knowledge and recommendations] (edit) |
10.13075/MP.5893.01042 |
| 2020-12-02 |
Development and Validation of a Multiplex, Bead-Based Assay to Detect Antibodies Directed Against SARS-CoV-2 Proteins (edit) |
10.1097/TP.0000000000003524 |
| 2020-12-02 |
Safety Considerations for In Situ Simulation in Closed SARS-CoV-2 Units (edit) |
10.1097/SIH.0000000000000542 |
| 2020-12-02 |
2-Pyridone natural products as inhibitors of SARS-CoV-2 main protease (edit) |
10.1016/J.CBI.2020.109348 |
| 2020-12-02 |
No evidence of SARS-CoV-2 circulation in HIV-infected patients between December 2019 and February 2020 in Rome, Italy (edit) |
10.1016/J.CMI.2020.11.026 |
| 2020-12-02 |
Comparative evaluation of four rapid SARS-CoV-2 antigen detection tests using universal transport medium (edit) |
10.1016/J.TMAID.2020.101942 |
| 2020-12-02 |
Impact of low serum calcium at hospital admission on SARS-CoV-2 infection outcome (edit) |
10.1016/J.IJID.2020.11.207 |
| 2020-12-02 |
Comments on 'Development of a PCR-RFLP method for detection of D614G mutation in SARS-CoV-2' (edit) |
10.1016/J.MEEGID.2020.104661 |
| 2020-12-02 |
The potential of Paritaprevir and Emetine as inhibitors of SARS-CoV-2 RdRp (edit) |
10.1016/J.SJBS.2020.11.078 |
| 2020-12-02 |
Over 90% of clinical swabs used for SARS-CoV-2 diagnostics contain sufficient nucleic acid concentrations (edit) |
10.1002/JMV.26706 |
| 2020-12-02 |
Significance of IgA antibody testing for early detection of SARS-CoV-2 (edit) |
10.1002/JMV.26703 |
| 2020-12-02 |
Antigenic variation of SARS-CoV-2 in response to immune pressure (edit) |
10.1111/MEC.15730 |
| 2020-12-02 |
Rapidly developing large pneumatocele and spontaneous pneumothorax in SARS-CoV-2 infection (edit) |
10.1016/J.RMCR.2020.101303 |
| 2020-12-02 |
Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine and Pyronaridine: In vitro Activity Against SARS-CoV-2 and Potential Mechanisms (edit) |
10.1101/2020.12.01.407361 |
| 2020-12-02 |
Predicting patients with false negative SARS-CoV-2 testing at hospital admission: A retrospective multi-center study (edit) |
10.1101/2020.11.30.20241414 |
| 2020-12-02 |
Physicochemical susceptibility of SARS-CoV-2 to disinfection and physical approach of prophylaxis (edit) |
10.1002/HSR2.213 |
| 2020-12-02 |
Persistent SARS-CoV-2 RNA Positive in Feces but Negative in Breastmilk: A Case Report of COVID-19 in a Breastfeeding Patient (edit) |
10.3389/FMED.2020.562700 |
| 2020-12-02 |
[The Beginning of the End: Sars-Cov-2 Vaccines] (edit) |
10.31053/1853.0605.V77.N4.31138 |
| 2020-12-02 |
Subacute De Quervain thyroiditis after SARS-CoV-2 infection (edit) |
10.1016/J.ENDINU.2020.10.003 |
| 2020-12-02 |
[Strategy for planning and execution of a large-scale SARS-CoV-2 seroprevalence study on teaching hospital workers during a pandemic situation] (edit) |
10.1016/J.JHQR.2020.11.003 |
| 2020-12-02 |
Identification and characterization of circRNAs encoded by MERS-CoV, SARS-CoV-1 and SARS-CoV-2 (edit) |
10.1093/BIB/BBAA334 |
| 2020-12-02 |
Validation of a combined ELISA to detect IgG, IgA and IgM antibody responses to SARS-CoV-2 in mild or moderate non-hospitalised patients (edit) |
10.1101/2020.11.30.20229732 |
| 2020-12-01 |
Occurrence of SARS-CoV-2 in the intraocular milieu (edit) |
10.1016/J.EXER.2020.108273 |
| 2020-12-01 |
An ace model for SARS-CoV-2 infection (edit) |
10.1084/JEM.20201748 |
| 2020-12-01 |
Hematological manifestations of SARS-CoV-2 in children (edit) |
10.1002/PBC.28745 |
| 2020-12-01 |
Intestinal permeability changes with bacterial translocation as key events modulating systemic host immune response to SARS-CoV-2: A working hypothesis (edit) |
10.1016/J.DLD.2020.09.009 |
| 2020-12-01 |
Canadian Society of Clinical Chemists (CSCC) Interim Consensus Guidance for Testing and Reporting of SARS-CoV-2 Serology (edit) |
10.1016/J.CLINBIOCHEM.2020.09.005 |
| 2020-12-01 |
[Infection with SARS-CoV-2 in pregnancy. Update of Information and proposed care. CNGOF.] (edit) |
10.1016/J.GOFS.2020.10.001 |
| 2020-12-01 |
An aberrant STAT pathway is central to COVID-19 (edit) |
10.1038/S41418-020-00633-7 |
| 2020-12-01 |
Potential Inhibitors for SARS-CoV-2 and Functional Food Components as Nutritional Supplement for COVID-19: A Review (edit) |
10.1007/S11130-020-00861-9 |
| 2020-12-01 |
Molecular mechanisms of the novel coronavirus SARS-CoV-2 and potential anti-COVID19 pharmacological targets since the outbreak of the pandemic (edit) |
10.1016/J.FCT.2020.111805 |
| 2020-12-01 |
Population-based seroprevalence surveys of anti-SARS-CoV-2 antibody: An up-to-date review (edit) |
10.1016/J.IJID.2020.10.011 |
| 2020-12-01 |
Generation of Recombinant SARS-CoV-2 Using a Bacterial Artificial Chromosome (edit) |
10.1002/CPMC.126 |
| 2020-12-01 |
The duration of infectiousness of individuals infected with SARS-CoV-2 (edit) |
10.1016/J.JINF.2020.10.009 |
| 2020-12-01 |
A Cytokine Circus with a Viral Ringleader: SARS-CoV-2-Associated Cytokine Storm Syndromes (edit) |
10.1016/J.MOLMED.2020.09.012 |
| 2020-12-01 |
Higher mortality of COVID-19 in males: Sex differences in immune response and cardiovascular comorbidities (edit) |
10.1093/CVR/CVAA284 |
| 2020-12-01 |
A Crowned Killer's Résumé: Genome, Structure, Receptors, and Origin of SARS-CoV-2 (edit) |
10.1007/S12250-020-00298-Z |
| 2020-12-01 |
[SARS-COV-2 myocarditis. An update] (edit) |
10.1016/J.ANCARD.2020.10.001 |
| 2020-12-01 |
Recommendations for use of antigenic tests in the diagnosis of acute SARS-CoV-2 infection in the second pandemic wave: attitude in different clinical settings (edit) |
10.37201/REQ/120.2020 |
| 2020-12-01 |
Reliability of induced sputum test is greater than that of throat swab test for detecting SARS-CoV-2 in patients with COVID-19: A multi-center cross-sectional study (edit) |
10.1080/21505594.2020.1831342 |
| 2020-12-01 |
Neurotropism of SARS-CoV-2 and its neuropathological alterations: Similarities with other coronaviruses (edit) |
10.1016/J.NEUBIOREV.2020.10.012 |
| 2020-12-01 |
Similarities between the effect of SARS-CoV-2 and HCV on the cellular level, and the possible role of ion channels in COVID19 progression: a review of potential targets for diagnosis and treatment (edit) |
10.1080/19336950.2020.1837439 |
| 2020-12-01 |
An Overview of the Crystallized Structures of the SARS-CoV-2 (edit) |
10.1007/S10930-020-09933-W |
| 2020-12-01 |
Are children with SARS-CoV-2 infection at high risk for thrombosis? Viscoelastic testing and coagulation profiles in a case series of pediatric patients (edit) |
10.1002/PBC.28737 |
| 2020-12-01 |
SARS-CoV-2 and displaced persons in Afghanistan: A blind spot in epidemic preparedness (edit) |
10.7189/JOGH.10.020308 |
| 2020-12-01 |
SARS-CoV-2 in Malawi: Are we sacrificing the Youth in sub-Saharan Africa? (edit) |
10.7189/JOGH.10.020336 |
| 2020-12-01 |
SARS-CoV-2 updates in a West African population and precautionary measures for sustaining quality antenatal care delivery (edit) |
10.7189/JOGH.10.020365 |
| 2020-12-01 |
The myth that Nigerians are immune to SARS-CoV-2 and that COVID-19 is a hoax are putting lives at risk (edit) |
10.7189/JOGH.10.020375 |
| 2020-12-01 |
SARS-CoV-2-related pneumonia cases in pneumonia picture in Russia in March-May 2020: Secondary bacterial pneumonia and viral co-infections (edit) |
|
| 2020-12-01 |
A SARS-CoV-2 variant with the 12-bp deletion at E gene (edit) |
10.1080/22221751.2020.1837017 |
| 2020-12-01 |
Global scenario, public health concerns and mitigation strategies to counter current ongoing SARS-CoV-2 / COVID-19 pandemic (edit) |
10.1080/21645515.2020.1810496 |
| 2020-12-01 |
Medical Nutrition Therapy in Hospitalized Patients With SARS-CoV-2 (COVID-19) Infection in a Non-critical Care Setting: Knowledge in Progress (edit) |
10.1007/S13668-020-00337-X |
| 2020-12-01 |
Virus isolation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for diagnostic and research purposes (edit) |
10.1016/J.PATHOL.2020.09.012 |
| 2020-12-01 |
Current status on treatment options for feline infectious peritonitis and SARS-CoV-2 positive cats (edit) |
10.1080/01652176.2020.1845917 |
| 2020-12-01 |
Measuring immunity to SARS-CoV-2 infection: comparing assays and animal models (edit) |
10.1038/S41577-020-00471-1 |
| 2020-12-01 |
Questions and Answers on Practical Thrombotic Issues in SARS-CoV-2 Infection: A Guidance Document from the Italian Working Group on Atherosclerosis, Thrombosis and Vascular Biology (edit) |
10.1007/S40256-020-00446-6 |
| 2020-12-01 |
Role of Oxidative Stress on SARS-CoV (SARS) and SARS-CoV-2 (COVID-19) Infection: A Review (edit) |
10.1007/S10930-020-09935-8 |
| 2020-12-01 |
Favipiravir use for SARS CoV-2 infection (edit) |
10.1007/S43440-020-00175-2 |
| 2020-12-01 |
Viral RNA level, serum antibody responses, and transmission risk in recovered COVID-19 patients with recurrent positive SARS-CoV-2 RNA test results: a population-based observational cohort study (edit) |
10.1080/22221751.2020.1837018 |
| 2020-12-01 |
Fast-track ruling in/out SARS-CoV-2 infection with rapid 0/1.5 h molecular test in patients with acute coronary syndromes (edit) |
10.2459/JCM.0000000000001117 |
| 2020-12-01 |
Bis(monoacylglycero)phosphate, an important actor in the host endocytic machinery hijacked by SARS-CoV-2 and related viruses (edit) |
10.1016/J.BIOCHI.2020.10.018 |
| 2020-12-01 |
ACE2: The Major Cell Entry Receptor for SARS-CoV-2 (edit) |
10.1007/S00408-020-00408-4 |
| 2020-12-01 |
Peptide and peptide-based inhibitors of SARS-CoV-2 entry (edit) |
10.1016/J.ADDR.2020.11.007 |
| 2020-12-01 |
Innovations in Geroscience to enhance mobility in older adults (edit) |
10.1016/J.EXGER.2020.111123 |
| 2020-12-01 |
Letter: SARS-CoV-2 induced gastrointestinal inflammation-authors' reply (edit) |
|
| 2020-12-01 |
Letter: SARS-CoV-2-induced gastrointestinal inflammation (edit) |
|
| 2020-12-01 |
Development of a Rapid Focus Reduction Neutralization Test Assay for Measuring SARS-CoV-2 Neutralizing Antibodies (edit) |
10.1002/CPIM.116 |
| 2020-12-01 |
Detection and Characterization of Bat Sarbecovirus Phylogenetically Related to SARS-CoV-2, Japan (edit) |
10.3201/EID2612.203386 |
| 2020-12-01 |
Lack of Susceptibility to SARS-CoV-2 and MERS-CoV in Poultry (edit) |
10.3201/EID2612.202989 |
| 2020-12-01 |
Large SARS-CoV-2 Outbreak Caused by Asymptomatic Traveler, China (edit) |
10.3201/EID2612.203437 |
| 2020-12-01 |
Seroprevalence of SARS-CoV-2 antibodies among physicians from a children's hospital (edit) |
10.5546/AAP.2020.ENG.381 |
| 2020-12-01 |
Microvasculature dysfunction as the common thread between atherosclerosis, Kawasaki disease, and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-associated multi-system inflammatory syndrome in children (edit) |
10.1093/EJCTS/EZAA367 |
| 2020-12-01 |
The severe acute respiratory syndrome due to coronavirus 2 (SARS-CoV-2) infection and the climacteric woman (edit) |
10.1080/13697137.2020.1837547 |
| 2020-12-01 |
Update Alert 6: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults (edit) |
10.7326/L20-1355 |
| 2020-12-01 |
Cerebral Venous Sinus Thromboses in Patients with SARS-CoV-2 Infection: Three Cases and a Review of the Literature (edit) |
10.1016/J.JSTROKECEREBROVASDIS.2020.105412 |
| 2020-12-01 |
Pervasive generation of non-canonical subgenomic RNAs by SARS-CoV-2 (edit) |
10.1186/S13073-020-00802-W |
| 2020-12-01 |
Risk factors for delayed negative conversion of SARS-CoV-2 in patients with COVID-19 pneumonia: a retrospective cohort study (edit) |
10.1017/S0950268820002940 |
| 2020-12-01 |
After SARS-CoV-2, will H5N6 and other influenza viruses follow the pandemic path? (edit) |
|
| 2020-12-01 |
Viral dynamics in the Upper Respiratory Tract (URT) of SARS-CoV-2 (edit) |
|
| 2020-12-01 |
Monocyte absolute count as a preliminary tool to distinguish between SARS-CoV-2 and influenza A/B infections in patients requiring hospitalization (edit) |
|
| 2020-12-01 |
Discharge ward during the SARS-CoV-2 pandemic: an effective way to increase patient turnover when human resources are scarce (edit) |
|
| 2020-12-01 |
A Patient with Asymptomatic SARS-CoV-2 Infection Who Presented 86 Days Later with COVID-19 Pneumonia Possibly Due to Reinfection with SARS-CoV-2 (edit) |
10.12659/AJCR.927154 |
| 2020-12-01 |
Detection of breastmilk antibodies targeting SARS-CoV-2 nucleocapsid, spike and receptor-binding-domain antigens (edit) |
10.1080/22221751.2020.1858699 |
| 2020-12-01 |
A practical and economic approach for assessing potential SARS-CoV-2 transmission risk in COVID-19 patients (edit) |
10.1093/CID/CIAA1789 |
| 2020-12-01 |
Lack of skin manifestations in COVID-19 hospitalized patients during the second epidemic wave in Spain: a possible association with a novel SARS-CoV-2 variant. A cross-sectional study (edit) |
10.1111/JDV.17051 |
| 2020-12-01 |
Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer (edit) |
10.1056/NEJMC2031670 |
| 2020-12-01 |
High seroprevalence but short-lived immune response to SARS-CoV-2 infection in Paris (edit) |
10.1002/EJI.202049058 |
| 2020-12-01 |
Impact of SARS-CoV-2 on multiple gestation pregnancy (edit) |
10.1002/IJGO.13508 |
| 2020-12-01 |
Reconversion of neurosurgical practice in times of the SARS-CoV-2 pandemic: a narrative review of the literature and guideline implementation in a Mexican neurosurgical referral center (edit) |
10.3171/2020.9.FOCUS20553 |
| 2020-12-01 |
A single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate (edit) |
10.1038/S41586-020-3035-9 |
| 2020-12-01 |
Development of machine learning models to predict RT-PCR results for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in patients with influenza-like symptoms using only basic clinical data (edit) |
10.1186/S13049-020-00808-8 |
| 2020-12-01 |
Prevalence of SARS-CoV-2, Verona, Italy, April-May 2020 (edit) |
10.3201/EID2701.202740 |
| 2020-12-01 |
Limited Specificity of Serologic Tests for SARS-CoV-2 Antibody Detection, Benin (edit) |
10.3201/EID2701.203281 |
| 2020-12-01 |
Intrafamilial Exposure to SARS-CoV-2 Associated with Cellular Immune Response without Seroconversion, France (edit) |
10.3201/EID2701.203611 |
| 2020-12-01 |
Characteristics and outcomes of pregnant Black and minority ethnic women admitted to hospital with confirmed SARS-CoV-2 infection in the UK (edit) |
10.1136/EBNURS-2020-103380 |
| 2020-12-01 |
Hospitalisation of children with SARS-CoV-2 on the general paediatric ward: coping with a persistent pandemic (edit) |
10.1136/ARCHDISCHILD-2020-321058 |
| 2020-12-01 |
Why is COVID-19 less severe in children? A review of the proposed mechanisms underlying the age-related difference in severity of SARS-CoV-2 infections (edit) |
10.1136/ARCHDISCHILD-2020-320338 |
| 2020-12-01 |
Pooled Saliva Specimens for SARS-CoV-2 Testing (edit) |
10.1128/JCM.02486-20 |
| 2020-12-01 |
Targeting the coronavirus SARS-CoV-2: computational insights into the mechanism of action of the protease inhibitors lopinavir, ritonavir and nelfinavir (edit) |
10.1038/S41598-020-77700-Z |
| 2020-12-01 |
B cell persistence and evolution to SARS-CoV-2 (edit) |
10.1038/S41577-020-00481-Z |
| 2020-12-01 |
Mapping host restriction of SARS-CoV-2 (edit) |
10.1038/S41577-020-00482-Y |
| 2020-12-01 |
Cross-viral protection against SARS-CoV-2? (edit) |
10.1038/S41577-020-00483-X |
| 2020-12-01 |
SARS-CoV-2-induced lung pathology: AHR as a candidate therapeutic target (edit) |
10.1038/S41422-020-00447-9 |
| 2020-12-01 |
Dalbavancin binds ACE2 to block its interaction with SARS-CoV-2 spike protein and is effective in inhibiting SARS-CoV-2 infection in animal models (edit) |
10.1038/S41422-020-00450-0 |
| 2020-12-01 |
Structure-based development of human antibody cocktails against SARS-CoV-2 (edit) |
10.1038/S41422-020-00446-W |
| 2020-12-01 |
Cellular basis for SARS-CoV-2 infection (edit) |
10.1038/S41580-020-00319-5 |
| 2020-12-01 |
Corrigendum to SARS-CoV-2 Serology: Much Hype, Little Data (edit) |
10.1093/CLINCHEM/HVAA235 |
| 2020-12-01 |
Characteristics and Outcomes Based on Perceived Illness Severity in SARS-CoV-2 (edit) |
10.14423/SMJ.0000000000001182 |
| 2020-12-01 |
Impact of SARS-CoV-2 Pandemic on Patients with Primary Immunodeficiency (edit) |
10.1007/S10875-020-00928-X |
| 2020-12-01 |
Questionnaire-based vs universal PCR testing for SARS-CoV-2 in women admitted for delivery (edit) |
10.1111/BIRT.12520 |
| 2020-12-01 |
PNEUMONIA IN HOSPITALIZED CHILDREN DURING SARS-CoV-2 PANDEMIC. IS IT ALL COVID-19? COMPARISON BETWEEN COVID AND NON-COVID PNEUMONIA (edit) |
10.1097/INF.0000000000003008 |
| 2020-12-01 |
Variables Associated With Perceived Risk of Contracting SARS-CoV-2 Infection During the COVID-19 Pandemic Among Patients With Systemic Rheumatic Diseases (edit) |
10.1097/RHU.0000000000001686 |
| 2020-12-01 |
The epidemiology of community-acquired respiratory viruses during the SARS-CoV-2 pandemic (edit) |
10.1111/AJT.16382 |
| 2020-12-01 |
SARS-CoV-2 IgG seroprevalence in healthcare workers and other staff at North Bristol NHS Trust: A sociodemographic analysis (edit) |
10.1016/J.JINF.2020.11.036 |
| 2020-12-01 |
SARS-CoV-2 has been circulating in northeastern Brazil since February 2020: Evidence for antibody detection in asymptomatic patients (edit) |
10.1016/J.JINF.2020.11.037 |
| 2020-12-01 |
Establishment of Murine Hybridoma Cells Producing Antibodies against Spike Protein of SARS-CoV-2 (edit) |
10.3390/IJMS21239167 |
| 2020-12-01 |
Association between SARS-CoV-2 infection and Kawasaki-like multisystem inflammatory syndrome: a retrospective matched case-control study, Paris, France, April to May 2020 (edit) |
10.2807/1560-7917.ES.2020.25.48.2001813 |
| 2020-12-01 |
A Study of Potential SARS-CoV-2 Antiviral Drugs and Preliminary Research of Their Molecular Mechanism, Based on Anti-SARS-CoV Drug Screening and Molecular Dynamics Simulation (edit) |
10.1089/CMB.2020.0112 |
| 2020-12-01 |
Multiscale Feedback Loops in SARS-CoV-2 Viral Evolution (edit) |
10.1089/CMB.2020.0343 |
| 2020-12-01 |
Successful double-lung transplantation from a donor previously infected with SARS-CoV-2 (edit) |
10.1016/S2213-2600(20)30524-5 |
| 2020-12-01 |
Risks of lung transplantation in the SARS-CoV-2 era (edit) |
10.1016/S2213-2600(20)30561-0 |
| 2020-12-01 |
Comparison of potency assays to assess SARS-CoV-2 neutralizing antibody capacity in COVID-19 convalescent plasma (edit) |
10.1016/J.JVIROMET.2020.114031 |
| 2020-12-01 |
Comparison of three TaqMan real-time reverse transcription-pcr assays in detecting SARS-CoV-2 (edit) |
10.1016/J.JVIROMET.2020.114030 |
| 2020-12-01 |
A comprehensive guide to the pharmacologic regulation of angiotensin converting enzyme 2 (ACE2), the SARS-CoV-2 entry receptor (edit) |
10.1016/J.PHARMTHERA.2020.107750 |
| 2020-12-01 |
Screening for SARS-CoV-2: Health Policy Implications in Low- and Middle-Income Countries (edit) |
10.1016/J.MAYOCP.2020.10.007 |
| 2020-12-01 |
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) universal screening in gravids during labor and delivery (edit) |
10.1016/J.EJOGRB.2020.11.069 |
| 2020-12-01 |
Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome (edit) |
10.1126/SCIIMMUNOL.ABE0240 |
| 2020-12-01 |
Extrapulmonary SARS-CoV-2 manifestations (edit) |
10.1038/S41591-020-01162-Z |
| 2020-12-01 |
Coding Errors in Study of Factors Associated With SARS-CoV-2 Antibodies in Health Care Personnel (edit) |
10.1001/JAMA.2020.20994 |
| 2020-12-01 |
Evidence of thrombotic microangiopathy in children with SARS-CoV-2 across the spectrum of clinical presentations (edit) |
10.1182/BLOODADVANCES.2020003471 |
| 2020-12-01 |
A Systematic Review on the Investigation of SARS-CoV-2 in Semen (edit) |
10.2147/RRU.S277679 |
| 2020-12-01 |
Differences in Clinical Features and Laboratory Results between Adults and Children with SARS-CoV-2 Infection (edit) |
10.1155/2020/6342598 |
| 2020-12-01 |
[Strategies and current status of the race to develop a SARS-CoV-2 vaccine] (edit) |
10.17843/RPMESP.2020.373.6522 |
| 2020-12-01 |
[Considerations on the evaluation under field conditions of a rapid test for detection of IgM and IgG antibodies against SARS-CoV-2] (edit) |
10.17843/RPMESP.2020.373.5753 |
| 2020-12-01 |
[Reply: considerations on the evaluation under field conditions of a rapid test for detection of IgM and IgG antibodies against SARS-CoV-2] (edit) |
10.17843/RPMESP.2020.373.5918 |
| 2020-12-01 |
[Laboratory tests for identification of SARS-CoV-2 during pandemic times in Peru: some clarification regarding «diagnostic performance»] (edit) |
10.17843/RPMESP.2020.373.5802 |
| 2020-12-01 |
[Reply: laboratory tests for identification of SARS-CoV-2 during pandemic times in Peru: some clarification regarding «diagnostic performance»] (edit) |
10.17843/RPMESP.2020.373.5929 |
| 2020-12-01 |
Audio Interview: SARS-CoV-2 Vaccination and Vulnerable Populations (edit) |
10.1056/NEJME2034906 |
| 2020-12-01 |
Potential Therapeutic Role of Purinergic Receptors in Cardiovascular Disease Mediated by SARS-CoV-2 (edit) |
10.1155/2020/8632048 |
| 2020-12-01 |
Differential effects of antiseptic mouth rinses on SARS-CoV-2 infectivity in vitro (edit) |
10.1101/2020.12.01.405662 |
| 2020-12-01 |
Role of Long-range Allosteric Communication in Determining the Stability and Disassembly of SARS-COV-2 in Complex with ACE2 (edit) |
10.1101/2020.11.30.405340 |
| 2020-12-01 |
Topoisomerase 1 inhibition therapy protects against SARS-CoV-2-induced inflammation and death in animal models (edit) |
10.1101/2020.12.01.404483 |
| 2020-12-01 |
Genomic epidemiology reveals transmission patterns and dynamics of SARS-CoV-2 in Aotearoa New Zealand (edit) |
10.1038/S41467-020-20235-8 |
| 2020-12-01 |
A Data-Driven Rationale for High-Throughput SARS-CoV-2 Mass Screening Programs (edit) |
10.1001/JAMANETWORKOPEN.2020.31577 |
| 2020-12-01 |
Assessment of an Online Tool to Simulate the Effect of Pooled Testing for SARS-CoV-2 Detection in Asymptomatic and Symptomatic Populations (edit) |
10.1001/JAMANETWORKOPEN.2020.31517 |
| 2020-12-01 |
Immunochromatographic test for differentiation detection of IgM and IgG to SARS-CoV-2 (edit) |
10.18821/0869-2084-2020-65-11-688-692 |
| 2020-12-01 |
FRETing over SARS-CoV-2: Conformational Dynamics of the Spike Glycoprotein (edit) |
10.1016/J.CHOM.2020.11.008 |
| 2020-12-01 |
D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization (edit) |
10.1016/J.CHOM.2020.11.012 |
| 2020-12-01 |
Subtle olfactory dysfunction after SARS-CoV-2 virus infection in children (edit) |
10.1016/J.IJPORL.2020.110539 |
| 2020-12-01 |
Association of SARS-CoV-2 renal tropism with acute kidney injury (edit) |
10.1016/S0140-6736(20)32588-5 |
| 2020-12-01 |
Association of SARS-CoV-2 renal tropism with acute kidney injury - Authors' reply (edit) |
10.1016/S0140-6736(20)32586-1 |
| 2020-12-01 |
Need for a high-specificity test for confirming weakly positive result in an immunochromatographic SARS-CoV-2-specific antigen test: A case report (edit) |
10.1016/J.JMII.2020.11.004 |
| 2020-12-01 |
A mysterious surge of aspergillosis among non-SARS-CoV-2 patients during COVID-19 pandemic (edit) |
10.1016/J.JMII.2020.11.002 |
| 2020-12-01 |
Maternal, fetal and neonatal outcomes of large series of SARS-CoV-2 positive pregnancies in peripartum period: A single-center prospective comparative study (edit) |
10.1016/J.EJOGRB.2020.11.068 |
| 2020-12-01 |
Analyzing the dominant SARS-CoV-2 transmission routes toward an ab initio disease spread model (edit) |
10.1063/5.0034032 |
| 2020-12-01 |
Investigation of 100 SARS-CoV-2 infected families in Wuhan: Transmission patterns and follow-up (edit) |
|
| 2020-12-01 |
Estimation of unreported SARS-CoV-2 cases in Italy using a Susceptible-Exposed-Infectious-Recovered-Dead model (edit) |
|
| 2020-12-01 |
Physicians' deaths related to SARS-Cov-2 infections in Italy (edit) |
10.1093/OCCMED/KQAA127 |
| 2020-12-01 |
Clinical Characteristics and Disease Severity Among Infants With SARS-CoV-2 Infection in Montreal, Quebec, Canada (edit) |
10.1001/JAMANETWORKOPEN.2020.30470 |
| 2020-12-01 |
Household Transmission of SARS-CoV-2: A Systematic Review and Meta-analysis (edit) |
10.1001/JAMANETWORKOPEN.2020.31756 |
| 2020-12-01 |
Rapid antigen and molecular tests had varied sensitivity and ≥97% specificity for detecting SARS-CoV-2 infection (edit) |
10.7326/ACPJ202012150-069 |
| 2020-12-01 |
A Crisp(r) New Perspective on SARS-CoV-2 Biology (edit) |
10.1016/J.CELL.2020.12.003 |
| 2020-12-01 |
[Paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2] (edit) |
|
| 2020-12-01 |
The nervous system-A new territory being explored of SARS-CoV-2 (edit) |
10.1016/J.JOCN.2020.10.056 |
| 2020-12-01 |
Deep Vein Thrombosis After Trivial Blunt Trauma at High Altitude in a SARS-CoV-2 Positive Child: Complication of the Hypercoagulable State (edit) |
|
| 2020-12-01 |
Tobacco Products and the Risks of SARS-CoV-2 Infection and COVID-19 (edit) |
10.1093/NTR/NTAA187 |
| 2020-12-01 |
An ACE2 Microbody Containing a Single Immunoglobulin Fc Domain Is a Potent Inhibitor of SARS-CoV-2 (edit) |
10.1016/J.CELREP.2020.108528 |
| 2020-12-01 |
Occupation- and age-associated risk of SARS-CoV-2 test positivity, the Netherlands, June to October 2020 (edit) |
10.2807/1560-7917.ES.2020.25.50.2001884 |
| 2020-12-01 |
Evaluation of lockdown effect on SARS-CoV-2 dynamics through viral genome quantification in waste water, Greater Paris, France, 5 March to 23 April 2020 (edit) |
10.2807/1560-7917.ES.2020.25.50.2000776 |
| 2020-12-01 |
Estimating the false-negative test probability of SARS-CoV-2 by RT-PCR (edit) |
10.2807/1560-7917.ES.2020.25.50.2000568 |
| 2020-12-01 |
Duodenal perforation in a SARS-CoV-2-positive patient with negative PCR results for SARS-CoV-2 in the peritoneal fluid (edit) |
10.26355/EURREV_202012_24048 |
| 2020-12-01 |
Age-stratified analysis of SARS-CoV-2 infection and case fatality rate in China, Italy, and South Korea (edit) |
10.26355/EURREV_202012_24054 |
| 2020-12-01 |
Challenges of SARS-CoV-2 prevention in flights, suggested solutions with potential on-site diagnosis resembling cancer biomarkers and urgency of travel medicine (edit) |
10.26355/EURREV_202012_24056 |
| 2020-12-01 |
CD147 as an alternative binding site for the spike protein on the surface of SARS-CoV-2 (edit) |
10.26355/EURREV_202012_23985 |
| 2020-12-01 |
Antagonism of Type I Interferon by Severe Acute Respiratory Syndrome Coronavirus 2 (edit) |
10.1089/JIR.2020.0214 |
| 2020-12-01 |
Sewage surveillance for the presence of SARS-CoV-2 genome as a useful wastewater based epidemiology (WBE) tracking tool in India (edit) |
10.2166/WST.2020.540 |
| 2020-12-01 |
Healthy neonate born to a SARS-CoV-2 infected woman: A case report and review of literature (edit) |
10.12998/WJCC.V8.I23.6016 |
| 2020-12-01 |
Suspected SARS-CoV-2 infection with fever and coronary heart disease: A case report (edit) |
10.12998/WJCC.V8.I23.6056 |
| 2020-12-01 |
Fourty-nine years old woman co-infected with SARS-CoV-2 and Mycoplasma: A case report (edit) |
10.12998/WJCC.V8.I23.6080 |
| 2020-12-01 |
Von einem Grenzwert, der keiner ist - Kommentar zur "7-Tage-Inzidenz" auf SARS-Cov-2 (edit) |
10.1016/J.ZEFQ.2020.11.006 |
| 2020-12-01 |
Assessment of Maternal and Neonatal SARS-CoV-2 Viral Load, Transplacental Antibody Transfer, and Placental Pathology in Pregnancies During the COVID-19 Pandemic (edit) |
10.1001/JAMANETWORKOPEN.2020.30455 |
| 2020-12-01 |
Favorable outcome of SARS-CoV-2 infection in a patient with pituitary insufficiency (edit) |
10.31053/1853.0605.V77.N4.29997 |
| 2020-12-01 |
Assessment of Air Contamination by SARS-CoV-2 in Hospital Settings (edit) |
10.1001/JAMANETWORKOPEN.2020.33232 |
| 2020-12-01 |
Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection (edit) |
10.1126/SCIIMMUNOL.ABF3698 |
| 2020-12-01 |
ACE2 role in SARS-CoV-2 infectivity and Covid-19 severity (edit) |
|
| 2020-12-01 |
Effects of mask-wearing on the inhalability and deposition of airborne SARS-CoV-2 aerosols in human upper airway (edit) |
10.1063/5.0034580 |
| 2020-12-01 |
Intention to receive a vaccine against SARS-CoV-2 in Italy and its association with trust, worry and beliefs about the origin of the virus (edit) |
10.1093/HER/CYAA043 |
| 2020-12-01 |
Detection of SARS-CoV-2 RNA in nasopharyngeal swabs from COVID-19 patients and asymptomatic cases of infection by real-time and digital PCR (edit) |
10.18821/0869-2084-2020-65-12-785-792 |
| 2020-12-01 |
[Progress in source tracking of SARS-CoV-2] (edit) |
10.12122/J.ISSN.1673-4254.2020.12.22 |
| 2020-12-01 |
FBA reveals guanylate kinase as a potential target for antiviral therapies against SARS-CoV-2 (edit) |
10.1093/BIOINFORMATICS/BTAA813 |
| 2020-12-01 |
Visualization of SARS-CoV-2 in the Lung. Reply (edit) |
10.1056/NEJMC2030450 |
| 2020-12-01 |
Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19) (edit) |
10.31083/J.RCM.2020.04.264 |
| 2020-12-01 |
Clinical outcomes after early ambulatory multidrug therapy for high-risk SARS-CoV-2 (COVID-19) infection (edit) |
10.31083/J.RCM.2020.04.260 |
| 2020-12-01 |
Virus load and virus shedding of SARS-CoV-2 and their impact on patient outcomes (edit) |
10.12998/WJCC.V8.I24.6252 |
| 2020-12-01 |
SARS-CoV-2 and Influenza Coinfection in a Deployed Military Setting-Two Case Reports (edit) |
|
| 2020-12-01 |
Special focus 'SARS-CoV-2 / COVID-19: advances in developing vaccines and immunotherapeutics' (edit) |
10.1080/21645515.2020.1847952 |
| 2020-12-01 |
SARS-CoV-2 reinfection and implications for vaccine development (edit) |
10.1080/21645515.2020.1830683 |
| 2020-12-01 |
A SARS-CoV-2 antiviral therapy score card (edit) |
10.35772/GHM.2020.01082 |
| 2020-12-01 |
The reliability of SARS-CoV-2 IgG antibody testing - a pilot study in asymptomatic health care workers in a Croatian university hospital (edit) |
|
| 2020-12-01 |
Tannic acid suppresses SARS-CoV-2 as a dual inhibitor of the viral main protease and the cellular TMPRSS2 protease (edit) |
|
| 2020-12-01 |
Mechanisms of SARS-CoV-2 Transmission and Pathogenesis (edit) |
10.1016/J.IT.2020.10.004 |
| 2020-12-01 |
Transcriptional profiling of leukocytes in critically ill COVID19 patients: implications for interferon response and coagulation (edit) |
10.1186/S40635-020-00361-9 |
| 2020-12-01 |
Self-Reported Symptoms of COVID-19, Including Symptoms Most Predictive of SARS-CoV-2 Infection, Are Heritable (edit) |
10.1017/THG.2020.85 |
| 2020-12-01 |
The N-glycosylation sites and Glycan-binding ability of S-protein in SARS-CoV-2 Coronavirus (edit) |
10.1101/2020.12.01.406025 |
| 2020-12-01 |
Multisystemic Inflammatory Syndrome in Children Associated With SARS-CoV-2 Infection: A Case Series Report in a Pediatric Center in Mexico (edit) |
10.14740/JMC3584 |
| 2020-12-01 |
Identification of Potential Flavonoid Inhibitors of the SARS-CoV-2 Main Protease 6YNQ: A Molecular Docking Study (edit) |
|
| 2020-12-01 |
The Virological, Immunological, and Imaging Approaches for COVID-19 Diagnosis and Research (edit) |
10.1177/2472630320950248 |
| 2020-12-01 |
Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses (edit) |
10.1016/J.DRUP.2020.100721 |
| 2020-12-01 |
PET Imaging as a Tool for Assessing COVID-19 Brain Changes (edit) |
10.1016/J.TINS.2020.10.010 |
| 2020-12-01 |
E-learning Practice at Medical Universities in Poland in the Perspective of the SARS-CoV-2 Pandemic (edit) |
10.2478/SLGR-2020-0039 |
| 2020-12-01 |
The first wave: lessons learned from the initial surge of general medicine inpatients during the SARS-CoV-2 pandemic (edit) |
10.21037/JHMHP-20-117 |
| 2020-12-01 |
Emerging novel coronavirus (2019-nCoV)-current scenario, evolutionary perspective based on genome analysis and recent developments (edit) |
10.1080/01652176.2020.1727993 |
| 2020-12-01 |
COVID-19: What implications for sexual and reproductive health and rights globally? (edit) |
10.1080/26410397.2020.1746065 |
| 2020-12-01 |
Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia (edit) |
10.1080/22221751.2020.1746199 |
| 2020-12-01 |
Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2 (edit) |
10.1080/22221751.2020.1743767 |
| 2020-12-01 |
Clinical observation and management of COVID-19 patients (edit) |
10.1080/22221751.2020.1741327 |
| 2020-12-01 |
The different clinical characteristics of corona virus disease cases between children and their families in China - the character of children with COVID-19 (edit) |
10.1080/22221751.2020.1744483 |
| 2020-12-01 |
Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension (edit) |
10.1080/22221751.2020.1746200 |
| 2020-12-01 |
Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients (edit) |
10.1080/22221751.2020.1747363 |
| 2020-12-01 |
Lack of cross-neutralization by SARS patient sera towards SARS-CoV-2 (edit) |
10.1080/22221751.2020.1761267 |
| 2020-12-01 |
COVID-19 under spotlight: A close look at the origin, transmission, diagnosis, and treatment of the 2019-nCoV disease (edit) |
10.1002/JCP.29735 |
| 2020-12-01 |
The endosomal lipid bis(monoacylglycero) phosphate as a potential key player in the mechanism of action of chloroquine against SARS-COV-2 and other enveloped viruses hijacking the endocytic pathway (edit) |
10.1016/J.BIOCHI.2020.05.013 |
| 2020-12-01 |
Targeting SARS-CoV-2 Receptors as a Means for Reducing Infectivity and Improving Antiviral and Immune Response: An Algorithm-based Method For Overcoming Resistance To Antiviral Agents (edit) |
10.1080/22221751.2020.1776161 |
| 2020-12-01 |
Dynamic surveillance of SARS-CoV-2 shedding and neutralizing antibody in children with COVID-19 (edit) |
10.1080/22221751.2020.1772677 |
| 2020-12-01 |
Genetic cluster analysis of SARS-CoV-2 and the identification of those responsible for the major outbreaks in various countries (edit) |
10.1080/22221751.2020.1773745 |
| 2020-12-01 |
Ultrasound in the management of the critically ill patient with SARS-CoV-2 infection (COVID-19): narrative review (edit) |
10.1016/J.MEDIN.2020.04.016 |
| 2020-12-01 |
Mechanisms and evidence of vertical transmission of infections in pregnancy including SARS-CoV-2 (edit) |
10.1002/PD.5765 |
| 2020-12-01 |
What lies in the year ahead for medical education? A medical student's perspective during the COVID-19 pandemic (edit) |
10.1080/10872981.2020.1781749 |
| 2020-12-01 |
Laboratory management for SARS-CoV-2 detection: a user-friendly combination of the heat treatment approach and rt-Real-time PCR testing (edit) |
10.1080/22221751.2020.1775500 |
| 2020-12-01 |
Vaccine development and therapeutic design for 2019-nCoV/SARS-CoV-2: Challenges and chances (edit) |
10.1002/JCP.29771 |
| 2020-12-01 |
Autophagy and SARS-CoV-2 infection: Apossible smart targeting of the autophagy pathway (edit) |
10.1080/21505594.2020.1780088 |
| 2020-12-01 |
Enteric involvement of SARS-CoV-2: Implications for the COVID-19 management, transmission, and infection control (edit) |
10.1080/21505594.2020.1794410 |
| 2020-12-01 |
FDA approved drugs with pharmacotherapeutic potential for SARS-CoV-2 (COVID-19) therapy (edit) |
10.1016/J.DRUP.2020.100719 |
| 2020-12-01 |
Development of a fully automated high throughput PCR for the detection of SARS-CoV-2: The need for speed (edit) |
10.1080/21505594.2020.1798041 |
| 2020-12-01 |
Flavonoids with inhibitory activity against SARS-CoV-2 3CLpro (edit) |
10.1080/14756366.2020.1801672 |
| 2020-12-01 |
Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling (edit) |
10.1084/JEM.20201241 |
| 2020-12-01 |
Update on recommendations for the diagnosis and treatment of SARS-CoV-2 infection in children (edit) |
10.1007/S10096-020-03973-X |
| 2020-12-01 |
Role of antibody-dependent enhancement (ADE) in the virulence of SARS-CoV-2 and its mitigation strategies for the development of vaccines and immunotherapies to counter COVID-19 (edit) |
10.1080/21645515.2020.1796425 |
| 2020-12-01 |
Recent advances in therapeutic modalities and vaccines to counter COVID-19/SARS-CoV-2 (edit) |
10.1080/21645515.2020.1794685 |
| 2020-12-01 |
Drive-through testing for SARS-CoV-2 in symptomatic health and social care workers and household members: an observational cohort study (edit) |
10.1136/THORAXJNL-2020-215128 |
| 2020-12-01 |
Studying the neuropsychological sequelae of SARS-CoV-2: lessons learned from 35 years of neuroHIV research (edit) |
10.1007/S13365-020-00897-2 |
| 2020-12-01 |
SARS-CoV-2 in children: spectrum of disease, transmission and immunopathological underpinnings (edit) |
10.1016/J.PATHOL.2020.08.001 |
| 2020-12-01 |
Prospects for SARS-CoV-2 diagnostics, therapeutics and vaccines in Africa (edit) |
10.1038/S41579-020-00441-3 |
| 2020-12-01 |
SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology (edit) |
10.1084/JEM.20201129 |
| 2020-12-01 |
Impact of SARS-CoV-2 virus pandemic on the future of cadaveric dissection anatomical teaching (edit) |
10.1080/10872981.2020.1823089 |
| 2020-12-01 |
Prospects for mucosal vaccine: shutting the door on SARS-CoV-2 (edit) |
10.1080/21645515.2020.1805992 |
| 2020-12-01 |
[Immunity against SARS-CoV-2: walking to the vaccination] (edit) |
10.37201/REQ/086.2020 |
| 2020-12-01 |
Potential sources, modes of transmission and effectiveness of prevention measures against SARS-CoV-2 (edit) |
10.1016/J.JHIN.2020.09.022 |
| 2020-12-01 |
A serological survey of SARS-CoV-2 in cat in Wuhan (edit) |
10.1080/22221751.2020.1817796 |
| 2020-12-01 |
Understanding the Immunologic Characteristics of Neurologic Manifestations of SARS-CoV-2 and Potential Immunological Mechanisms (edit) |
10.1007/S12035-020-02094-Y |
| 2020-12-01 |
SARS-CoV-2 infection: diagnostic testing results occasionally require special attention (edit) |
10.1080/22221751.2020.1814165 |
| 2020-12-01 |
The emergence of COVID-19 as a global pandemic: Understanding the epidemiology, immune response and potential therapeutic targets of SARS-CoV-2 (edit) |
10.1016/J.BIOCHI.2020.09.018 |
| 2020-12-01 |
Current approaches for target-specific drug discovery using natural compounds against SARS-CoV-2 infection (edit) |
10.1016/J.VIRUSRES.2020.198169 |
| 2020-11-30 |
Going to war with COVID-19: Strategies for SARS-CoV-2 management in the Padua Nephrology and Dialysis Unit's hemodialysis facility (edit) |
10.5414/CN110330 |
| 2020-11-30 |
Comparison of IgG antibodies, SARS-CoV-2 load, and prognostic indicators in patients with severe and mild COVID-19 in Japan (edit) |
10.1272/JNMS.JNMS.2021_88-417 |
| 2020-11-30 |
Comparison of clinical and laboratory features and treatment options of 237 Comparison of clinical and laboratory features and treatment options of 237 symptomatic and asymptomatic children infected with SARS-CoV-2 in the early phase of the COVID-19 (edit) |
10.7883/YOKEN.JJID.2020.781 |
| 2020-11-30 |
Evaluation of traditional ayurvedic Kadha for prevention and management of the novel Coronavirus (SARS-CoV-2) using in silico approach (edit) |
10.1080/07391102.2020.1852119 |
| 2020-11-30 |
Synthetic flavonoids as potential antiviral agents against SARS-CoV-2 main protease (edit) |
10.1080/07391102.2020.1850359 |
| 2020-11-30 |
Ileum Perforation in Crohn's Disease Patient During SARS-Cov-2 Infection (edit) |
10.1093/IBD/IZAA319 |
| 2020-11-30 |
Negative Conversion Rate of SARS-CoV-2 Infection (edit) |
10.1001/JAMAINTERNMED.2020.7201 |
| 2020-11-30 |
Negative Conversion Rate of SARS-CoV-2 Infection-Reply (edit) |
10.1001/JAMAINTERNMED.2020.7204 |
| 2020-11-30 |
Serologic testing of U.S. blood donations to identify SARS-CoV-2-reactive antibodies: December 2019-January 2020 (edit) |
10.1093/CID/CIAA1785 |
| 2020-11-30 |
SARS-CoV-2 Among Military and Civilian Patients, Metro Manila, Philippines (edit) |
10.1093/MILMED/USAA525 |
| 2020-11-30 |
Lessons from BCG for SARS-CoV-2 vaccine candidates (edit) |
10.1093/INFDIS/JIAA637 |
| 2020-11-30 |
Viral Dynamics of SARS-CoV-2 in Critically Ill Allogeneic Hematopoietic Stem Cell Transplant Recipients and Immunocompetent Patients with COVID-19 (edit) |
10.1164/RCCM.202009-3386LE |
| 2020-11-30 |
A Gapless, Unambiguous RNA Metagenome-Assembled Genome Sequence of a Unique SARS-CoV-2 Variant Encoding Spike S813I and ORF1a A859V Substitutions (edit) |
10.1089/OMI.2020.0194 |
| 2020-11-30 |
Study on SARS-CoV-2 transmission and the effects of control measures in China (edit) |
10.1371/JOURNAL.PONE.0242649 |
| 2020-11-30 |
SARS-CoV-2 lineage B.6 was the major contributor to early pandemic transmission in Malaysia (edit) |
10.1371/JOURNAL.PNTD.0008744 |
| 2020-11-30 |
Seroprevalence analysis of SARS-CoV-2 in pregnant women along the first pandemic outbreak and perinatal outcome (edit) |
10.1371/JOURNAL.PONE.0243029 |
| 2020-11-30 |
Key genetic elements, single and in clusters, underlying geographically dependent SARS-CoV-2 genetic adaptation and their impact on binding affinity for drugs and immune control (edit) |
10.1093/JAC/DKAA444 |
| 2020-11-30 |
Co-infection of human immunodeficiency virus, herpes simplex virus-2 and SARS-CoV-2 with false-negative real-time polymerase chain reaction (edit) |
10.11622/SMEDJ.2020158 |
| 2020-11-30 |
Detection of viral RNA fragments in human iPSC cardiomyocytes following treatment with extracellular vesicles from SARS-CoV-2 coding sequence overexpressing lung epithelial cells (edit) |
10.1186/S13287-020-02033-7 |
| 2020-11-30 |
Absence of SARS-CoV-2 Transmission from Children in Isolation to Guardians, South Korea (edit) |
10.3201/EID2701.203450 |
| 2020-11-30 |
A Versatile Reporter System to Monitor Virus Infected Cells and Its Application to Dengue Virus and SARS-CoV-2 (edit) |
10.1128/JVI.01715-20 |
| 2020-11-30 |
Incidence of SARS-CoV-2/COVID-19 in military personnel of Bolivia (edit) |
10.1136/BMJMILITARY-2020-001705 |
| 2020-11-30 |
Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice (edit) |
10.1038/S41467-020-19891-7 |
| 2020-11-30 |
Development of a multi-antigenic SARS-CoV-2 vaccine candidate using a synthetic poxvirus platform (edit) |
10.1038/S41467-020-19819-1 |
| 2020-11-30 |
ELISA detection of SARS-CoV-2 antibodies in saliva (edit) |
10.1038/S41598-020-77555-4 |
| 2020-11-30 |
Immunoinformatic design of a COVID-19 subunit vaccine using entire structural immunogenic epitopes of SARS-CoV-2 (edit) |
10.1038/S41598-020-77547-4 |
| 2020-11-30 |
Conserved interactions required for inhibition of the main protease of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (edit) |
10.1038/S41598-020-77794-5 |
| 2020-11-30 |
Detection of SARS-CoV-2 in placental but not fetal tissues in the second trimester (edit) |
10.1038/S41372-020-00877-8 |
| 2020-11-30 |
Investigation of COVID-19 comorbidities reveals genes and pathways coincident with the SARS-CoV-2 viral disease (edit) |
10.1038/S41598-020-77632-8 |
| 2020-11-30 |
Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19 (edit) |
10.1038/S41593-020-00758-5 |
| 2020-11-30 |
Toward superhuman SARS-CoV-2 immunity? (edit) |
10.1038/S41591-020-01180-X |
| 2020-11-30 |
Effective control of SARS-CoV-2 transmission in Wanzhou, China (edit) |
10.1038/S41591-020-01178-5 |
| 2020-11-30 |
Age-related macular degeneration and mortality in SARS-CoV-2-infected patients (edit) |
10.1111/AOS.14685 |
| 2020-11-30 |
Evidence of Long-Distance Droplet Transmission of SARS-CoV-2 by Direct Air Flow in a Restaurant in Korea (edit) |
10.3346/JKMS.2020.35.E415 |
| 2020-11-30 |
Differences among Severe Cases of Sars-CoV-2, Influenza, and Other Respiratory Viral Infections in Pediatric Patients: Symptoms, Outcomes and Preexisting Comorbidities (edit) |
10.6061/CLINICS/2020/E2273 |
| 2020-11-30 |
SARS-CoV-2 Inhibition by Sulfonated Compounds (edit) |
10.3390/MICROORGANISMS8121894 |
| 2020-11-30 |
Modeling the Molecular Impact of SARS-CoV-2 Infection on the Renin-Angiotensin System (edit) |
10.3390/V12121367 |
| 2020-11-30 |
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: Triggering a Lethal Fight to Keep Control of the Ten-Eleven Translocase (TET)-Associated DNA Demethylation? (edit) |
10.3390/PATHOGENS9121006 |
| 2020-11-30 |
Characterization of SARS-CoV-2 N protein reveals multiple functional consequences of the C-terminal domain (edit) |
10.1101/2020.11.30.404905 |
| 2020-11-30 |
A Neutralizing Antibody-Conjugated Photothermal Nanoparticle Captures and Inactivates SARS-CoV-2 (edit) |
10.1101/2020.11.30.404624 |
| 2020-11-30 |
Investigation of beta-lactoglobulin derived bioactive peptides against SARS-CoV-2 (COVID-19): in silico analysis (edit) |
10.1016/J.EJPHAR.2020.173781 |
| 2020-11-30 |
A highly effective reverse-transcription loop-mediated isothermal amplification (RT-LAMP) assay for the rapid detection of SARS-CoV-2 infection (edit) |
10.1016/J.JINF.2020.10.039 |
| 2020-11-30 |
SARS-CoV-2 and superimposed infection by trichomonads (edit) |
10.1016/J.JINF.2020.11.038 |
| 2020-11-30 |
Test on stool samples improves the diagnosis of hospitalized patients: detection of SARS-CoV-2 genomic and subgenomic RNA (edit) |
10.1016/J.JINF.2020.11.034 |
| 2020-11-30 |
Clinical status and lung function 10 weeks after severe SARS-CoV-2 infection (edit) |
10.1016/J.RMED.2020.106276 |
| 2020-11-30 |
Development of a SARS-CoV-2-specific biosensor for antigen detection using scFv-Fc fusion proteins (edit) |
10.1016/J.BIOS.2020.112868 |
| 2020-11-30 |
Proteo-genomic analysis of SARS-CoV-2: A clinical landscape of SNPs, COVID-19 proteome and host responses (edit) |
10.1101/2020.11.27.20237032 |
| 2020-11-30 |
Modulation of Autophagy by SARS-CoV-2: A Potential Threat for Cardiovascular System (edit) |
10.3389/FPHYS.2020.611275 |
| 2020-11-30 |
Lessons Learned Comparing Immune System Alterations of Bacterial Sepsis and SARS-CoV-2 Sepsis (edit) |
10.3389/FIMMU.2020.598404 |
| 2020-11-30 |
Mucosal Immunity in COVID-19: A Neglected but Critical Aspect of SARS-CoV-2 Infection (edit) |
10.3389/FIMMU.2020.611337 |
| 2020-11-30 |
Docking Characterization and in vitro Inhibitory Activity of Flavan-3-ols and Dimeric Proanthocyanidins Against the Main Protease Activity of SARS-Cov-2 (edit) |
10.3389/FPLS.2020.601316 |
| 2020-11-30 |
Foundation and Clinical Evaluation of a New Method for Detecting SARS-CoV-2 Antigen by Fluorescent Microsphere Immunochromatography (edit) |
10.3389/FCIMB.2020.553837 |
| 2020-11-30 |
Case Report: Recurrence of Positive SARS-CoV-2 Results in Patients Recovered From COVID-19 (edit) |
10.3389/FMED.2020.585485 |
| 2020-11-30 |
Repurposing FDA-approved phytomedicines, natural products, antivirals and cell protectives against SARS-CoV-2 (COVID-19) RNA-dependent RNA polymerase (edit) |
10.7717/PEERJ.10480 |
| 2020-11-30 |
Seroprevalence of SARS-CoV-2 antibodies among hospital workers in a German tertiary care center: A sequential follow-up study (edit) |
10.1016/J.IJHEH.2020.113671 |
| 2020-11-30 |
Impact of the first wave of the SARS-CoV-2 pandemic on preferential/emergent pacemaker implantation rate. Spanish study (edit) |
10.1016/J.REC.2020.10.015 |
| 2020-11-30 |
SARS-CoV-2 infection leads to cardiac pericyte loss, fibrosis, cardiomyocyte hypertrophy, and diastolic dysfunction (edit) |
10.21203/RS.3.RS-105963/V1 |
| 2020-11-29 |
Assessment of risks associated with SARS-CoV-2 experimental human infection studies (edit) |
10.1093/CID/CIAA1784 |
| 2020-11-29 |
Outdoor Transmission of SARS-CoV-2 and Other Respiratory Viruses, a Systematic Review (edit) |
10.1093/INFDIS/JIAA742 |
| 2020-11-29 |
Impaired type I interferon response in SARS-CoV-2 infection: looking through the cutaneous window (edit) |
10.1111/BJD.19596 |
| 2020-11-29 |
Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection (edit) |
10.1080/22221751.2020.1858177 |
| 2020-11-29 |
Duration of Viral Clearance in Children With SARS-CoV-2 Infection in Rajasthan, India (edit) |
|
| 2020-11-29 |
Repositioning of Ligands That Target the Spike Glycoprotein as Potential Drugs for SARS-CoV-2 in an In Silico Study (edit) |
10.3390/MOLECULES25235615 |
| 2020-11-29 |
Scrutinizing the SARS-CoV-2 protein information for designing an effective vaccine encompassing both the T-cell and B-cell epitopes (edit) |
10.1016/J.MEEGID.2020.104648 |
| 2020-11-29 |
Acute kidney injury in severe SARS-CoV-2 infection: An experience report in Eastern France (edit) |
10.1016/J.ACCPM.2020.100788 |
| 2020-11-29 |
SARS-CoV-2 and limb ischemia: A systematic review (edit) |
10.1016/J.JCOT.2020.11.018 |
| 2020-11-29 |
"When My Information Changes, I Alter My Conclusions." What Can We Learn From the Failures to Adaptively Respond to the SARS-CoV-2 Pandemic and the Under Preparedness of Health Systems to Manage COVID-19? (edit) |
10.34172/IJHPM.2020.240 |
| 2020-11-29 |
Potential implications of SARS-CoV-2 oral infection in the host microbiota (edit) |
10.1080/20002297.2020.1853451 |
| 2020-11-28 |
High impact of SARS-CoV-2/COVID-19 in the Honduran Health Personnel (edit) |
10.1002/JMV.26702 |
| 2020-11-28 |
SARS-CoV-2-specific neutralizing antibody responses in Norwegian healthcare workers after the first wave of COVID-19 pandemic: a prospective cohort study (edit) |
10.1093/INFDIS/JIAA737 |
| 2020-11-28 |
Nationwide seroprevalence of SARS-CoV-2 and identification of risk factors in the general population of the Netherlands during the first epidemic wave (edit) |
10.1136/JECH-2020-215678 |
| 2020-11-28 |
Response to "Is the outcome of SARS-CoV-2 infection in solid organ transplant recipients really similar to that of the general population?" (edit) |
10.1111/AJT.16413 |
| 2020-11-28 |
Alcohol-free hand sanitizer and other quaternary ammonium disinfectants quickly and effectively inactivate SARS-CoV-2 (edit) |
10.1016/J.JHIN.2020.11.023 |
| 2020-11-28 |
Detection of SARS-CoV-2 within the healthcare environment: a multicentre study conducted during the first wave of the COVID-19 outbreak in England (edit) |
10.1016/J.JHIN.2020.11.024 |
| 2020-11-28 |
Comparison of 12 Molecular Detection Assays for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (edit) |
10.1016/J.JMOLDX.2020.11.007 |
| 2020-11-28 |
Anti-SARS-CoV-2 Antibody Responses in Convalescent Plasma Donors Are Increased in Hospitalized Patients; Subanalyses of a Phase 2 Clinical Study (edit) |
10.3390/MICROORGANISMS8121885 |
| 2020-11-28 |
Structural stability of SARS-CoV-2 virus like particles degrades with temperature (edit) |
10.1016/J.BBRC.2020.11.080 |
| 2020-11-28 |
Effect of SARS-CoV-2 coinfection was not apparent on the dynamics of chronic hepatitis B infection (edit) |
10.1016/J.VIROL.2020.11.012 |
| 2020-11-28 |
Molecular docking of potential SARS-CoV-2 papain-like protease inhibitors (edit) |
10.1016/J.BBRC.2020.11.083 |
| 2020-11-28 |
Why does SARS-CoV-2 survive longer on plastic than on paper? (edit) |
10.1016/J.MEHY.2020.110429 |
| 2020-11-28 |
Is Bordetella pertussis co-infecting SARS-CoV-2 patients? (edit) |
10.1016/J.BJANE.2020.09.008 |
| 2020-11-28 |
Evaluation of viral concentration methods for SARS-CoV-2 recovery from wastewaters (edit) |
10.1016/J.SCITOTENV.2020.144105 |
| 2020-11-28 |
SARS-CoV-2 infections in melanoma patients treated with PD-1 inhibitors: A survey of the German ADOREG melanoma registry (edit) |
10.1016/J.EJCA.2020.11.015 |
| 2020-11-28 |
[Control of SARS-CoV-2 in prisons] (edit) |
10.1016/J.SEMERG.2020.10.009 |
| 2020-11-28 |
Prolonged 59-day course of COVID-19: The case of a SARS-CoV-2 shedding persistency in a healthcare provider (edit) |
10.1002/CCR3.3547 |
| 2020-11-28 |
[Frequency of chest X-ray suggestive of SARS-CoV-2 involvement from March to May 2020 in the population of an urban health area] (edit) |
10.1016/J.SEMERG.2020.10.005 |
| 2020-11-27 |
Decline in SARS-CoV-2 Antibodies After Mild Infection Among Frontline Health Care Personnel in a Multistate Hospital Network - 12 States, April-August 2020 (edit) |
10.15585/MMWR.MM6947A2 |
| 2020-11-27 |
EXPRESS: SARS-CoV-2 immunochromatographic IgM/IgG rapid test in pregnancy: a false friend? (edit) |
10.1177/0004563220980495 |
| 2020-11-27 |
Assessing COVID-19 susceptibility through analysis of the genetic and epigenetic diversity of ACE2 mediated SARS-CoV-2 entry (edit) |
10.2217/PGS-2020-0092 |
| 2020-11-27 |
Inactivation of SARS-CoV-2 by gamma irradiation (edit) |
|
| 2020-11-27 |
Novel SARS-CoV-2 encoded small RNAs in the passage to humans (edit) |
10.1093/BIOINFORMATICS/BTAA1002 |
| 2020-11-27 |
How Could In Vitro Antiviral Activity Be Applied to Optimize the Dosing Regimens of Candidates for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)? (edit) |
10.1093/CID/CIAA1325 |
| 2020-11-27 |
Atypical HCoV-NL63 Infection in an Infant During the SARS-CoV-2 Pandemic (edit) |
10.1007/S12098-020-03580-W |
| 2020-11-27 |
SARS-CoV-2 Transmission in an Urban Community: The Role of Children and Household Contacts (edit) |
10.1093/JPIDS/PIAA158 |
| 2020-11-27 |
Influence of Sars-Cov 2 lockdown on the incidence of facial trauma in a tertiary care hospital in Rome, Italy (edit) |
10.23736/S0026-4970.20.04446-5 |
| 2020-11-27 |
Multiple epitope-based vaccine prediction against SARS-CoV-2 spike glycoprotein (edit) |
10.1080/07391102.2020.1846626 |
| 2020-11-27 |
Infection fatality risk for SARS-CoV-2 in community dwelling population of Spain: nationwide seroepidemiological study (edit) |
10.1136/BMJ.M4509 |
| 2020-11-27 |
Implementing testing approaches for SARS-CoV-2 to address health disparities: lessons learned from sexually transmitted infections (edit) |
10.1136/SEXTRANS-2020-054678 |
| 2020-11-27 |
Mask shortage during epidemics and pandemics: a scoping review of interventions to overcome limited supply (edit) |
10.1136/BMJOPEN-2020-040547 |
| 2020-11-27 |
SARS-CoV-2 genomic and subgenomic RNAs in diagnostic samples are not an indicator of active replication (edit) |
10.1038/S41467-020-19883-7 |
| 2020-11-27 |
Nucleocapsid protein of SARS-CoV-2 phase separates into RNA-rich polymerase-containing condensates (edit) |
10.1038/S41467-020-19843-1 |
| 2020-11-27 |
RBD-Fc-based COVID-19 vaccine candidate induces highly potent SARS-CoV-2 neutralizing antibody response (edit) |
10.1038/S41392-020-00402-5 |
| 2020-11-27 |
Cellular events of acute, resolving or progressive COVID-19 in SARS-CoV-2 infected non-human primates (edit) |
10.1038/S41467-020-19967-4 |
| 2020-11-27 |
Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19 (edit) |
10.1038/S41467-020-19943-Y |
| 2020-11-27 |
SARS-CoV-2 and the risk of Parkinson's disease: facts and fantasy (edit) |
10.1016/S1474-4422(20)30442-7 |
| 2020-11-27 |
Thermal Inactivation Scaling Applied for SARS-CoV-2 (edit) |
10.1016/J.BPJ.2020.11.2259 |
| 2020-11-27 |
A Multiscale Coarse-grained Model of the SARS-CoV-2 Virion (edit) |
10.1016/J.BPJ.2020.10.048 |
| 2020-11-27 |
Comparative analyses of SARS-CoV-2 binding (IgG, IgM, IgA) and neutralizing antibodies from human serum samples (edit) |
10.1016/J.JIM.2020.112937 |
| 2020-11-27 |
Association of liver steatosis and fibrosis with clinical outcomes in patients with SARS-CoV-2 infection (COVID-19) (edit) |
10.1016/J.AOHEP.2020.100295 |
| 2020-11-27 |
Prevalence of SARS-CoV-2 IgG antibodies in an area of North-eastern Italy with a high incidence of COVID-19 cases: a population-based study (edit) |
10.1016/J.CMI.2020.11.013 |
| 2020-11-27 |
Mechanistic insight on the remdesivir binding to RNA-Dependent RNA polymerase (RdRp) of SARS-cov-2 (edit) |
10.1016/J.COMPBIOMED.2020.104156 |
| 2020-11-27 |
Persisting Neutralizing Activity to SARS-CoV-2 over Months in Sera of COVID-19 Patients (edit) |
10.3390/V12121357 |
| 2020-11-27 |
Repurposing of Plasminogen: An Orphan Medicinal Product Suitable for SARS-CoV-2 Inhalable Therapeutics (edit) |
10.3390/PH13120425 |
| 2020-11-27 |
Impacts of different operational temperatures and organic loads in anaerobic co-digestion of food waste and sewage sludge on the fate of SARS-CoV-2 (edit) |
10.1016/J.PSEP.2020.11.035 |
| 2020-11-27 |
Subacute onset dystonia in a woman affected by Parkinson's disease following SARS-COV-2 infection (edit) |
10.1016/J.PRDOA.2020.100082 |
| 2020-11-27 |
Potential mouth rinses and nasal sprays that reduce SARS-CoV-2 viral load: What we know so far? (edit) |
10.6061/CLINICS/2020/E2328 |
| 2020-11-27 |
Inactivation of SARS-CoV-2 on surfaces and in solution with Virusend (TX-10), a novel disinfectant (edit) |
10.1101/2020.11.25.394288 |
| 2020-11-27 |
Emergence and spread of a SARS-CoV-2 variant through Europe in the summer of 2020 (edit) |
10.1101/2020.10.25.20219063 |
| 2020-11-27 |
SARS-CoV-2 infection among asymptomatic healthcare workers of the emergency department in a tertiary care facility (edit) |
10.1016/J.JCV.2020.104710 |
| 2020-11-27 |
[Guide for management of patients with possible respiratory sequelae after a SARS-CoV-2 pneumonia. Support proposals developed by the French-speaking Respiratory Medicine Society. Version of 10 November 2020] (edit) |
10.1016/J.RMR.2020.11.009 |
| 2020-11-27 |
Can preprocedural mouthrinses reduce SARS-CoV-2 load in dental aerosols? (edit) |
10.1016/J.MEHY.2020.110436 |
| 2020-11-27 |
Genomic RNA Elements Drive Phase Separation of the SARS-CoV-2 Nucleocapsid (edit) |
10.1016/J.MOLCEL.2020.11.041 |
| 2020-11-27 |
Unheeded SARS-CoV-2 protein? Look deep into negative-sense RNA (edit) |
10.1101/2020.11.27.400788 |
| 2020-11-27 |
Predicted Cellular Immunity Population Coverage Gaps for SARS-CoV-2 Subunit Vaccines and Their Augmentation by Compact Peptide Sets (edit) |
10.1016/J.CELS.2020.11.010 |
| 2020-11-27 |
Monoclonal Antibodies B38 and H4 Produced in Nicotiana benthamiana Neutralize SARS-CoV-2 in vitro (edit) |
10.3389/FPLS.2020.589995 |
| 2020-11-27 |
Whole Genome Identification of Potential G-Quadruplexes and Analysis of the G-Quadruplex Binding Domain for SARS-CoV-2 (edit) |
10.3389/FGENE.2020.587829 |
| 2020-11-27 |
Delirium in Patients with SARS-CoV-2 Infection: A Multicenter Study (edit) |
10.1111/JGS.16969 |
| 2020-11-27 |
Nature's therapy for COVID-19: Targeting the vital non-structural proteins (NSP) from SARS-CoV-2 with phytochemicals from Indian medicinal plants (edit) |
10.1016/J.PHYPLU.2020.100002 |
| 2020-11-26 |
Isothermal Amplification and Ambient Visualization in a Single Tube for the Detection of SARS-CoV-2 Using Loop-Mediated Amplification and CRISPR Technology (edit) |
10.1021/ACS.ANALCHEM.0C04047 |
| 2020-11-26 |
Convalescent Memory T Cell Immunity in Individuals with Mild or Asymptomatic SARS-CoV-2 Infection May Result from an Evolutionarily Adapted Immune Response to Coronavirus and the 'Common Cold' (edit) |
10.12659/MSM.929789 |
| 2020-11-26 |
Seroprevalence of Antibodies Against SARS-CoV-2 Among Health Care Workers in Mumbai, India (edit) |
10.1177/1010539520977307 |
| 2020-11-26 |
Analysis of the efficacy of HIV protease inhibitors against SARS-CoV-2's main protease (edit) |
10.1186/S12985-020-01457-0 |
| 2020-11-26 |
Severe manifestations of SARS-CoV-2 in children and adolescents: from COVID-19 pneumonia to multisystem inflammatory syndrome: a multicentre study in pediatric intensive care units in Spain (edit) |
10.1186/S13054-020-03332-4 |
| 2020-11-26 |
SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity (edit) |
10.1038/S41467-020-19808-4 |
| 2020-11-26 |
Recurrent SARS-CoV-2 RNA positivity after COVID-19: a systematic review and meta-analysis (edit) |
10.1038/S41598-020-77739-Y |
| 2020-11-26 |
HDL-scavenger receptor B type 1 facilitates SARS-CoV-2 entry (edit) |
10.1038/S42255-020-00324-0 |
| 2020-11-26 |
New strategy for COVID-19 vaccination: targeting the receptor-binding domain of the SARS-CoV-2 spike protein (edit) |
10.1038/S41423-020-00584-6 |
| 2020-11-26 |
Deciphering the ins and outs of SARS-CoV-2-specific T cells (edit) |
10.1038/S41590-020-00838-5 |
| 2020-11-26 |
Investigation of SARS-CoV-2 in semen samples and the effects of COVID-19 on male sexual health by using semen analysis and serum male hormone profile: A cross-sectional, pilot study (edit) |
10.1111/AND.13912 |
| 2020-11-26 |
Safety of hydroxychloroquine for treatment or prevention of SARS-CoV-2 infection: A rapid systematic review and meta-analysis of randomized clinical trials (edit) |
10.1002/IID3.374 |
| 2020-11-26 |
The DHODH Inhibitor PTC299 Arrests SARS-CoV-2 Replication and Suppresses Induction of Inflammatory Cytokines (edit) |
10.1016/J.VIRUSRES.2020.198246 |
| 2020-11-26 |
Antiviral Photodynamic Therapy: Inactivation and Inhibition of SARS-CoV-2 In Vitro Using Methylene Blue and Radahlorin (edit) |
10.1016/J.PDPDT.2020.102112 |
| 2020-11-26 |
Coevolutionary forces shaping the fitness of SARS-CoV-2 spike glycoprotein against human receptor ACE2 (edit) |
10.1016/J.MEEGID.2020.104646 |
| 2020-11-26 |
Characterization of Structural and Energetic Differences between Conformations of the SARS-CoV-2 Spike Protein (edit) |
10.3390/MA13235362 |
| 2020-11-26 |
Comparing and Contrasting MERS, SARS-CoV, and SARS-CoV-2: Prevention, Transmission, Management, and Vaccine Development (edit) |
10.3390/PATHOGENS9120985 |
| 2020-11-26 |
Identification of an Antiviral Compound from the Pandemic Response Box that Efficiently Inhibits SARS-CoV-2 Infection In Vitro (edit) |
10.3390/MICROORGANISMS8121872 |
| 2020-11-26 |
Quantification of SARS-CoV-2 antigen levels in the blood of patients with COVID-19 (edit) |
10.1007/S11427-020-1830-8 |
| 2020-11-26 |
Genomic characterization of SARS-CoV-2 in Egypt (edit) |
10.1016/J.JARE.2020.11.012 |
| 2020-11-26 |
Acute appendicitis in four children with SARS-CoV-2 infection (edit) |
10.1016/J.EPSC.2020.101734 |
| 2020-11-26 |
Low-Avidity CD4+ T Cell Responses to SARS-CoV-2 in Unexposed Individuals and Humans with Severe COVID-19 (edit) |
10.1016/J.IMMUNI.2020.11.016 |
| 2020-11-26 |
Using Genetics To Dissect SARS-CoV-2 Infection (edit) |
10.1016/J.TIG.2020.11.007 |
| 2020-11-26 |
Infectious Mononucleosis Presenting with Loss of Taste and Smell During the SARS-CoV-2 Pandemic? (edit) |
10.12890/2020_002048 |
| 2020-11-26 |
Association Between Vitamin D and Novel SARS-CoV-2 Respiratory Dysfunction - A Scoping Review of Current Evidence and Its Implication for COVID-19 Pandemic (edit) |
10.3389/FPHYS.2020.564387 |
| 2020-11-26 |
Electroencephalographic Abnormalites in SARS-CoV-2 Patients (edit) |
10.3389/FNEUR.2020.582794 |
| 2020-11-26 |
Evaluation of Humoral Immunity to SARS-CoV-2: Diagnostic Value of a New Multiplex Addressable Laser Bead Immunoassay (edit) |
10.3389/FMICB.2020.603931 |
| 2020-11-26 |
SARS-CoV-2, multiple sclerosis, and focal deficit in a postpartum woman: A case report (edit) |
10.3892/ETM.2020.9524 |
| 2020-11-26 |
Periodontal tissues are targets for Sars-Cov-2: a post-mortem study (edit) |
10.1080/20002297.2020.1848135 |
| 2020-11-25 |
Evidence for treatment with estradiol for women with SARS-CoV-2 infection (edit) |
10.1186/S12916-020-01851-Z |
| 2020-11-25 |
Computational guided identification of a citrus flavonoid as potential inhibitor of SARS-CoV-2 main protease (edit) |
10.1007/S11030-020-10150-X |
| 2020-11-25 |
Practical challenges to the clinical implementation of saliva for SARS-CoV-2 detection (edit) |
10.1007/S10096-020-04090-5 |
| 2020-11-25 |
Comparison of various serological assays for novel SARS-COV-2 (edit) |
10.1007/S10096-020-04091-4 |
| 2020-11-25 |
Suitability of Two Rapid Lateral Flow Immunochromatographic Assays for Predicting SARS-CoV-2 Neutralizing Activity of Sera (edit) |
10.1002/JMV.26697 |
| 2020-11-25 |
The Impact of Charlson Comorbidity Index on mortality from SARS-CoV-2 virus infection and A novel COVID 19 mortality index: CoLACD (edit) |
10.1111/IJCP.13858 |
| 2020-11-25 |
Treatment of SARS-cov-2 pneumonia with favipiravir: Early results from the Ege University cohort, Turkey (edit) |
10.3906/SAG-2008-33 |
| 2020-11-25 |
Progenitor identification and SARS-CoV-2 infection in human distal lung organoids (edit) |
10.1038/S41586-020-3014-1 |
| 2020-11-25 |
SARS-CoV-2 and COVID-19 "covidiosyncrasies" and their impact on endoscopists and endoscopy (edit) |
10.1055/A-1214-6252 |
| 2020-11-25 |
Early cases of SARS-CoV-2 infection in Uganda: epidemiology and lessons learned from risk-based testing approaches - March-April 2020 (edit) |
10.1186/S12992-020-00643-7 |
| 2020-11-25 |
Comparison of Quidel Sofia SARS FIA Test to Hologic Aptima SARS-CoV-2 TMA Test for Diagnosis of COVID-19 in Symptomatic Outpatients (edit) |
10.1128/JCM.02727-20 |
| 2020-11-25 |
Inference of Active Viral Replication in Cases with Sustained Positive RT-PCRs for SARS-CoV-2 (edit) |
10.1128/JCM.02277-20 |
| 2020-11-25 |
Saliva is a Promising Alternative Specimen for the Detection of SARS-CoV-2 in Children and Adults (edit) |
10.1128/JCM.02686-20 |
| 2020-11-25 |
Evaluating Ten Commercially-Available SARS-CoV-2 Rapid Serological Tests Using the STARD (Standards for Reporting of Diagnostic Accuracy Studies) Method (edit) |
10.1128/JCM.02342-20 |
| 2020-11-25 |
Clinical performance of the point-of-care cobas Liat for detection of SARS-CoV-2 in 20 minutes: A multicenter study (edit) |
10.1128/JCM.02811-20 |
| 2020-11-25 |
No evidence for increased transmissibility from recurrent mutations in SARS-CoV-2 (edit) |
10.1038/S41467-020-19818-2 |
| 2020-11-25 |
In silico studies evidenced the role of structurally diverse plant secondary metabolites in reducing SARS-CoV-2 pathogenesis (edit) |
10.1038/S41598-020-77602-0 |
| 2020-11-25 |
Can Host Cell Proteins Like ACE2, ADAM17, TMPRSS2, Androgen Receptor be the Efficient Targets in SARS-CoV-2 Infection? (edit) |
10.2174/1389450121999201125201112 |
| 2020-11-25 |
Ionophore antibiotic X-206 is a potent inhibitor of SARS-CoV-2 infection in vitro (edit) |
10.1016/J.ANTIVIRAL.2020.104988 |
| 2020-11-25 |
Evaluation of saliva as an alternative diagnostic specimen source for SARS-CoV-2 detection by RT-dPCR (edit) |
10.1016/J.JINF.2020.11.023 |
| 2020-11-25 |
SARS-CoV-2 RNAemia is associated with severe chronic underlying diseases but not with nasopharyngeal viral load (edit) |
10.1016/J.JINF.2020.11.024 |
| 2020-11-25 |
Improved production of SARS-CoV-2 spike receptor-binding domain (RBD) for serology assays (edit) |
10.1016/J.PEP.2020.105802 |
| 2020-11-25 |
SARS-CoV-2 infection: can ferroptosis be a potential treatment target for multiple organ involvement? (edit) |
10.1038/S41420-020-00369-W |
| 2020-11-25 |
SARS-CoV-2 receptors and entry genes are expressed in the human olfactory neuroepithelium and brain (edit) |
10.1016/J.ISCI.2020.101839 |
| 2020-11-25 |
SARS-CoV-2 Pandemic Impact on Pediatric Emergency Rooms: A Multicenter Study (edit) |
10.3390/IJERPH17238753 |
| 2020-11-25 |
In Silico Discovery of Antimicrobial Peptides as an Alternative to Control SARS-CoV-2 (edit) |
10.3390/MOLECULES25235535 |
| 2020-11-25 |
Impact of SARS-CoV-2 Infection on Patients with Cancer: Retrospective and Transversal Studies in Spanish Population (edit) |
10.3390/CANCERS12123513 |
| 2020-11-25 |
In silico analysis of mismatches in RT-qPCR assays of 177 SARS-CoV-2 sequences from Brazil (edit) |
10.1590/0037-8682-0657-2020 |
| 2020-11-25 |
Ischemic stroke related to HIV and SARS-COV-2 co-infection: a case report (edit) |
10.1590/0037-8682-0692-2020 |
| 2020-11-25 |
"Test and Standard Precautions"-Is it Enough to Protect Us from False Negative SARS-CoV-2 Test Results? (edit) |
10.1213/ANE.0000000000005351 |
| 2020-11-25 |
Nanoparticle Vaccines Based on the Receptor Binding Domain (RBD) and Heptad Repeat (HR) of SARS-CoV-2 Elicit Robust Protective Immune Responses (edit) |
10.1016/J.IMMUNI.2020.11.015 |
| 2020-11-25 |
An Immunoinformatics Study to Predict Epitopes in the Envelope Protein of SARS-CoV-2 (edit) |
10.1155/2020/7079356 |
| 2020-11-25 |
SARS-CoV-2 utilizes a multipronged strategy to suppress host protein synthesis (edit) |
10.1101/2020.11.25.398578 |
| 2020-11-25 |
Global analysis of protein-RNA interactions in SARS-CoV-2 infected cells reveals key regulators of infection (edit) |
10.1101/2020.11.25.398008 |
| 2020-11-25 |
Effect of environmental pollutants PM-2.5, carbon monoxide, and ozone on the incidence and mortality of SARS-COV-2 infection in ten wildfire affected counties in California (edit) |
10.1016/J.SCITOTENV.2020.143948 |
| 2020-11-25 |
An Evaluation of Traditional Persian Medicine for the Management of SARS-CoV-2 (edit) |
10.3389/FPHAR.2020.571434 |
| 2020-11-25 |
Comparative Transcriptome Analysis Reveals the Intensive Early Stage Responses of Host Cells to SARS-CoV-2 Infection (edit) |
10.3389/FMICB.2020.593857 |
| 2020-11-25 |
Identification of Potent and Safe Antiviral Therapeutic Candidates Against SARS-CoV-2 (edit) |
10.3389/FIMMU.2020.586572 |
| 2020-11-25 |
SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development (edit) |
10.3389/FCIMB.2020.587269 |
| 2020-11-25 |
Cholesterol 25-hydroxylase suppresses SARS-CoV-2 replication by blocking membrane fusion (edit) |
10.1073/PNAS.2012197117 |
| 2020-11-25 |
Sec-Eliminating the SARS-CoV-2 by AlGaN Based High Power Deep Ultraviolet Light Source (edit) |
10.1002/ADFM.202008452 |
| 2020-11-25 |
Indication of high-flow oxygen therapy in patients with SARS-CoV-2 pneumonia (edit) |
10.1016/J.MEDIN.2020.11.001 |
| 2020-11-25 |
Recovery From Acute Kidney Injury With Diabetic Ketoacidosis Following SARS-CoV-2 Infection: A Case Report and Literature Review (edit) |
10.7759/CUREUS.11702 |
| 2020-11-25 |
Conserved Genomic Terminals of SARS-CoV-2 as Coevolving Functional Elements and Potential Therapeutic Targets (edit) |
10.1128/MSPHERE.00754-20 |
| 2020-11-25 |
Trimeric SARS-CoV-2 Spike Proteins Produced from CHO Cells in Bioreactors Are High-Quality Antigens (edit) |
10.3390/PR8121539 |
| 2020-11-25 |
Chinese therapeutic strategy for fighting COVID-19 and potential small-molecule inhibitors against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (edit) |
10.1021/ACS.JMEDCHEM.0C00626 |
| 2020-11-24 |
Association Between ABO and Rh Blood Groups and SARS-CoV-2 Infection or Severe COVID-19 Illness : A Population-Based Cohort Study (edit) |
10.7326/M20-4511 |
| 2020-11-24 |
Establishment and utilization of an evaluation system for virucidal activity of disinfectants against a coronavirus with apparent applicability to SARS-CoV-2 (edit) |
10.1292/JVMS.20-0462 |
| 2020-11-24 |
Co-infections with SARS-CoV-2 and other respiratory viruses in Southeastern France: a matter of sampling time (edit) |
10.1002/JMV.26692 |
| 2020-11-24 |
No SARS-CoV-2 carriage observed in children attending daycare centers during the first weeks of the epidemic in Belgium (edit) |
10.1002/JMV.26689 |
| 2020-11-24 |
How could we conclude cat-to-human transmission of SARS-CoV-2? (edit) |
10.1111/ZPH.12788 |
| 2020-11-24 |
[Use of the SARS-CoV-2 antigen detection test in nasopharyngeal swab for COVID-19 infection control] (edit) |
10.37201/REQ/127.2020 |
| 2020-11-24 |
Detection of SARS-CoV-2 in a case of DRESS by sulfasalazine: could there be a relationship with clinical importance? (edit) |
10.1111/IJD.15316 |
| 2020-11-24 |
Development, Performance Evaluation and Clinical Application of A Rapid SARS-CoV-2 IgM and IgG Test Kit Based on Automated Fluorescence Immunoassay (edit) |
10.1002/JMV.26696 |
| 2020-11-24 |
Synthesis of Palladium(II) Complexes via Michael Addition: Antiproliferative Effects through ROS-Mediated Mitochondrial Apoptosis and Docking with SARS-CoV-2 (edit) |
10.1021/ACS.INORGCHEM.0C02373 |
| 2020-11-24 |
Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020 (edit) |
10.1001/JAMAINTERNMED.2020.7976 |
| 2020-11-24 |
Distance from the outbreak of infection, ozone pollution and public health consequences of SARS-CoV-2 epidemic (edit) |
10.1093/EURPUB/CKAA221 |
| 2020-11-24 |
Correction to: Dynamic Changes of Antibodies to SARS-CoV-2 in COVID-19 Patients at Early Stage of Outbreak (edit) |
10.1007/S12250-020-00318-Y |
| 2020-11-24 |
Biochemical and antigenic characterization of the structural proteins and their post-translational modifications in purified SARS-CoV-2 virions of an inactivated vaccine candidate (edit) |
10.1080/22221751.2020.1855945 |
| 2020-11-24 |
Biodistribution and serologic response in SARS-CoV-2 induced ARDS: A cohort study (edit) |
10.1371/JOURNAL.PONE.0242917 |
| 2020-11-24 |
The tyrosine kinase inhibitor nilotinib inhibits SARS-CoV-2 In Vitro (edit) |
10.1111/BCPT.13537 |
| 2020-11-24 |
Clinical and pathological findings of SARS-CoV-2 infection and concurrent IgA nephropathy: a case report (edit) |
10.1186/S12882-020-02163-3 |
| 2020-11-24 |
Symptoms associated with a positive result for a swab for SARS-CoV-2 infection among children in Alberta (edit) |
10.1503/CMAJ.202065 |
| 2020-11-24 |
Preventing the introduction of SARS-CoV-2 into school settings (edit) |
10.1503/CMAJ.202568 |
| 2020-11-24 |
Detection of SARS-CoV-2 antibodies in oral fluid obtained using a rapid collection device (edit) |
10.1128/JCM.02510-20 |
| 2020-11-24 |
Structure of nonstructural protein 1 from SARS-CoV-2 (edit) |
10.1128/JVI.02019-20 |
| 2020-11-24 |
Inhibiting the reproduction of SARS-CoV-2 through perturbations in human lung cell metabolic network (edit) |
10.26508/LSA.202000869 |
| 2020-11-24 |
Transmission heterogeneities, kinetics, and controllability of SARS-CoV-2 (edit) |
10.1126/SCIENCE.ABE2424 |
| 2020-11-24 |
The effect of whey protein on viral infection and replication of SARS-CoV-2 and pangolin coronavirus in vitro (edit) |
10.1038/S41392-020-00408-Z |
| 2020-11-24 |
Battle at the entrance gate: CIITA as a weapon to prevent the internalization of SARS-CoV-2 and Ebola viruses (edit) |
10.1038/S41392-020-00405-2 |
| 2020-11-24 |
Evaluation of diagnostic accuracy of 10 serological assays for detection of SARS-CoV-2 antibodies (edit) |
10.1007/S10096-020-04092-3 |
| 2020-11-24 |
Association between different screening strategies for SARS-CoV-2 and deaths and severe disease in Italy (edit) |
10.1111/IJCP.13867 |
| 2020-11-24 |
Storm at the Time of Corona: A Glimpse at the Current Understanding and Therapeutic Opportunities of the SARS-CoV-2 Cytokine Storm (edit) |
10.2174/1381612826666201125102649 |
| 2020-11-24 |
Nerve compression injuries after prolonged prone position ventilation in SARS-CoV-2 patient: a case series (edit) |
10.1016/J.APMR.2020.10.131 |
| 2020-11-24 |
A model to identify individuals with a high probability of a SARS-CoV-2 infection (edit) |
10.1016/J.JINF.2020.11.028 |
| 2020-11-24 |
SARS-CoV-2 and ECMO: early results and experience (edit) |
10.1007/S12055-020-01084-Y |
| 2020-11-24 |
Evaluation of SARS-CoV-2 Serological Testing in Patients with Multiple Myeloma and Other Hematologic Malignancies on Monoclonal Antibody Therapies (edit) |
10.3390/DIAGNOSTICS10120992 |
| 2020-11-24 |
Maternal Coronavirus Infections and Neonates Born to Mothers with SARS-CoV-2: A Systematic Review (edit) |
10.3390/HEALTHCARE8040511 |
| 2020-11-24 |
Comparative transcriptome analysis of SARS-CoV, MERS-CoV, and SARS-CoV-2 to identify potential pathways for drug repurposing (edit) |
10.1016/J.COMPBIOMED.2020.104123 |
| 2020-11-24 |
Synthesis, molecular docking, and in silico ADME/Tox profiling studies of new 1-aryl-5-(3-azidopropyl)indol-4-ones: Potential inhibitors of SARS CoV-2 main protease (edit) |
10.1016/J.BIOORG.2020.104497 |
| 2020-11-24 |
A betacoronavirus multiplex microsphere immunoassay detects early SARS-CoV-2 seroconversion and antibody cross reactions (edit) |
10.21203/RS.3.RS-105768/V1 |
| 2020-11-24 |
Fragment Binding to the Nsp3 Macrodomain of SARS-CoV-2 Identified Through Crystallographic Screening and Computational Docking (edit) |
10.1101/2020.11.24.393405 |
| 2020-11-24 |
Ipomoeassin-F inhibits the in vitro biogenesis of the SARS-CoV-2 spike protein and its host cell membrane receptor (edit) |
10.1101/2020.11.24.390039 |
| 2020-11-24 |
A monoclonal antibody against staphylococcal enterotoxin B superantigen inhibits SARS-CoV-2 entry in vitro (edit) |
10.1101/2020.11.24.395079 |
| 2020-11-24 |
Timing the SARS-CoV-2 Index Case in Hubei Province (edit) |
10.1101/2020.11.20.392126 |
| 2020-11-24 |
Passive inhaled mRNA vaccination for SARS-Cov-2 (edit) |
10.1016/J.MEHY.2020.110417 |
| 2020-11-24 |
SARS-CoV-2 replicates in respiratory ex vivo organ cultures of domestic ruminant species (edit) |
10.1016/J.VETMIC.2020.108933 |
| 2020-11-24 |
Risk Factors for SARS-CoV-2 in a Statewide Correctional System (edit) |
10.1056/NEJMC2029354 |
| 2020-11-24 |
SARS-CoV-2, Early Entry Events (edit) |
10.1155/2020/9238696 |
| 2020-11-24 |
Is the oral cavity a reservoir for prolonged SARS-CoV-2 shedding? (edit) |
10.1016/J.MEHY.2020.110419 |
| 2020-11-24 |
Mild SARS-CoV-2 Infection After Gene Therapy in a Child With Wiskott-Aldrich Syndrome: A Case Report (edit) |
10.3389/FIMMU.2020.603428 |
| 2020-11-24 |
Field-Effect Sensors for Virus Detection: From Ebola to SARS-CoV-2 and Plant Viral Enhancers (edit) |
10.3389/FPLS.2020.598103 |
| 2020-11-24 |
Computational Investigation of Structural Dynamics of SARS-CoV-2 Methyltransferase-Stimulatory Factor Heterodimer nsp16/nsp10 Bound to the Cofactor SAM (edit) |
10.3389/FMOLB.2020.590165 |
| 2020-11-24 |
Ivermectin as an adjunct treatment for hospitalized adult COVID-19 patients: A randomized multi-center clinical trial (edit) |
10.21203/RS.3.RS-109670/V1 |
| 2020-11-24 |
The phylogenetic relationship within SARS-CoV-2s: An expanding basal clade (edit) |
10.1016/J.YMPEV.2020.107017 |
| 2020-11-23 |
[Strategies in the prevention and control of the Covid-19 pandemic caused by SARS-CoV-2. Environmental factors.] (edit) |
|
| 2020-11-23 |
Increased sensitivity using real-time dPCR for detection of SARS-CoV-2 (edit) |
10.2144/BTN-2020-0133 |
| 2020-11-23 |
SARS-CoV-2 analysis on environmental surfaces collected in an intensive care unit: keeping Ernest Shackleton's spirit (edit) |
10.1186/S40635-020-00349-5 |
| 2020-11-23 |
1H,13C and 15N chemical shift assignments of the SUD domains of SARS-CoV-2 non-structural protein 3c: "the N-terminal domain-SUD-N" (edit) |
10.1007/S12104-020-09987-Y |
| 2020-11-23 |
Recurrence of SARS-CoV-2 nucleic acid positive test in patients with COVID-19: a report of two cases (edit) |
10.1186/S12890-020-01348-8 |
| 2020-11-23 |
Evaluation on the use of Nanopore sequencing for direct characterization of coronaviruses from respiratory specimens, and a study on emerging missense mutations in partial RdRP gene of SARS-CoV-2 (edit) |
10.1186/S12985-020-01454-3 |
| 2020-11-23 |
Outcomes of the Ophthalmic Examinations in Patients Infected by SARS-CoV-2 (edit) |
10.1080/09273948.2020.1844904 |
| 2020-11-23 |
Targeting SARS-CoV-2 main protease: structure based virtual screening, in silico ADMET studies and molecular dynamics simulation for identification of potential inhibitors (edit) |
10.1080/07391102.2020.1848636 |
| 2020-11-23 |
SARS-CoV-2 Infection: Symptoms of the Nervous System and Implications for Therapy in Neurological Disorders (edit) |
10.1007/S40120-020-00225-0 |
| 2020-11-23 |
Kinetics of torquetenovirus DNA load in a recent kidney transplant recipient with mild SARS-CoV-2 infection and a failed antibody response (edit) |
10.1111/TID.13524 |
| 2020-11-23 |
Theoretical Design of Functionalized Gold Nanoparticles as Antiviral Agents against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (edit) |
10.1021/ACS.JPCLETT.0C02677 |
| 2020-11-23 |
An update on COVID-19: SARS-CoV-2 life cycle, immunopathology, and BCG vaccination (edit) |
10.1080/10826068.2020.1848869 |
| 2020-11-23 |
Response by Mac Grory and Yaghi to Letter Regarding Article, "SARS-CoV-2 and Stroke in a New York Healthcare System" (edit) |
10.1161/STROKEAHA.120.032519 |
| 2020-11-23 |
Letter by Bayona et al Regarding Article, "SARS-CoV-2 and Stroke in a New York Healthcare System" (edit) |
10.1161/STROKEAHA.120.031838 |
| 2020-11-23 |
Testing IgG antibodies against the RBD of SARS-CoV-2 is sufficient and necessary for COVID-19 diagnosis (edit) |
10.1371/JOURNAL.PONE.0241164 |
| 2020-11-23 |
A Systematic Review of Surface Contamination, Stability, and Disinfection Data on SARS-CoV-2 (Through July 10, 2020) (edit) |
10.1021/ACS.EST.0C05651 |
| 2020-11-23 |
Molecular dynamics simulation perception study of the binding affinity performance for main protease of SARS-CoV-2 (edit) |
10.1080/07391102.2020.1850362 |
| 2020-11-23 |
SARS-CoV-2-associated encephalitis: arguments for a post-infectious mechanism (edit) |
10.1186/S13054-020-03389-1 |
| 2020-11-23 |
The SARS-CoV-2 Envelope and Membrane proteins modulate maturation and retention of the Spike protein, allowing assembly of virus-like particles (edit) |
10.1074/JBC.RA120.016175 |
| 2020-11-23 |
Genomic epidemiology of superspreading events in Austria reveals mutational dynamics and transmission properties of SARS-CoV-2 (edit) |
10.1126/SCITRANSLMED.ABE2555 |
| 2020-11-23 |
Targeted intracellular degradation of SARS-CoV-2 via computationally optimized peptide fusions (edit) |
10.1038/S42003-020-01470-7 |
| 2020-11-23 |
Virtual screening of anti-HIV1 compounds against SARS-CoV-2: machine learning modeling, chemoinformatics and molecular dynamics simulation based analysis (edit) |
10.1038/S41598-020-77524-X |
| 2020-11-23 |
The seroprevalence of SARS-CoV-2 in patients on haemodialysis (edit) |
10.1038/S41581-020-00379-Y |
| 2020-11-23 |
Indirect benefits are a crucial consideration when evaluating SARS-CoV-2 vaccine candidates (edit) |
10.1038/S41591-020-01172-X |
| 2020-11-23 |
Ventilator-associated pneumonia in patients with SARS-CoV-2-associated acute respiratory distress syndrome requiring ECMO: a retrospective cohort study (edit) |
10.1186/S13613-020-00775-4 |
| 2020-11-23 |
Seroprevalence of Novel Coronavirus SARS-CoV-2 at a Community Hospital Emergency Department and Outpatient Laboratory in Northern Orange County, California (edit) |
10.1007/S40615-020-00918-0 |
| 2020-11-23 |
[Recommendations of the German Respiratory Society (DGP) on Hygiene Measures During Treatment of Patients with Lung Diseases in the Outpatient Physiotherapy Practice in Times of the SARS-CoV-2 Pandemic] (edit) |
10.1055/A-1305-7450 |
| 2020-11-23 |
Care Coordination in a SARS-CoV-2-infected Child With Newly Diagnosed Medulloblastoma and Fanconi Anemia (edit) |
10.1097/MPH.0000000000002021 |
| 2020-11-23 |
Long-Term SARS-CoV-2 Infection Associated with Viral Dissemination in Different Body Fluids Including Bile in Two Patients with Acute Cholecystitis (edit) |
10.3390/LIFE10110302 |
| 2020-11-23 |
Drawing Comparisons between SARS-CoV-2 and the Animal Coronaviruses (edit) |
10.3390/MICROORGANISMS8111840 |
| 2020-11-23 |
Effectiveness of Sample Pooling Strategies for SARS-CoV-2 Mass Screening by RT-PCR: A Scoping Review (edit) |
10.1055/S-0040-1721159 |
| 2020-11-23 |
Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19 (edit) |
10.1016/J.CELL.2020.11.029 |
| 2020-11-23 |
A molecular docking study of EGCG and theaflavin digallate with the druggable targets of SARS-CoV-2 (edit) |
10.1016/J.COMPBIOMED.2020.104137 |
| 2020-11-23 |
Alveolar epithelial cell type II as main target of SARS-CoV-2 virus and COVID-19 development via NF-Kb pathway deregulation: A physio-pathological theory (edit) |
10.1016/J.MEHY.2020.110412 |
| 2020-11-23 |
Analysis of Indian SARS-CoV-2 Genomes Reveals Prevalence of D614G Mutation in Spike Protein Predicting an Increase in Interaction With TMPRSS2 and Virus Infectivity (edit) |
10.3389/FMICB.2020.594928 |
| 2020-11-23 |
Pilot Study: Long-Term Shedding of SARS-CoV-2 in Urine: A Threat for Dispersal in Wastewater (edit) |
10.3389/FPUBH.2020.569209 |
| 2020-11-23 |
Impact of SARS-CoV-2 on Provided Healthcare. Evidence From the Emergency Phase in Italy (edit) |
10.3389/FPUBH.2020.583583 |
| 2020-11-23 |
Aerosol Transmission of SARS-CoV-2: Physical Principles and Implications (edit) |
10.3389/FPUBH.2020.590041 |
| 2020-11-23 |
Participatory Budget and the SARS-COV-2 Pandemic in Poland (edit) |
10.24193/TRAS.SI2020.2 |
| 2020-11-22 |
Does level of education influence mortality of SARS-CoV-2 in a developing country? (edit) |
10.1093/IJE/DYAA193 |
| 2020-11-22 |
SARS-CoV-2 viral shedding among diabetic patients: from upper to lower respiratory tract (edit) |
10.1007/S12020-020-02551-7 |
| 2020-11-22 |
Resveratrol inhibits the replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in cultured Vero cells (edit) |
10.1002/PTR.6916 |
| 2020-11-22 |
Testing-on-a-probe biosensors reveal association of early SARS-CoV-2 total antibodies and surrogate neutralizing antibodies with mortality in COVID-19 patients (edit) |
10.1101/2020.11.19.20235044 |
| 2020-11-22 |
Microbial context predicts SARS-CoV-2 prevalence in patients and the hospital built environment (edit) |
10.1101/2020.11.19.20234229 |
| 2020-11-22 |
A review on hospital wastewater treatment: A special emphasis on occurrence and removal of pharmaceutically active compounds, resistant microorganisms, and SARS-CoV-2 (edit) |
10.1016/J.JECE.2020.104812 |
| 2020-11-22 |
Are oral manifestations related to SARS-CoV-2 mediated hemolysis and anemia? (edit) |
10.1016/J.MEHY.2020.110413 |
| 2020-11-22 |
A simple direct RT-LAMP SARS-CoV-2 saliva diagnostic (edit) |
10.1101/2020.11.19.20234948 |
| 2020-11-21 |
Cirrhosis and SARS-CoV-2 infection in US Veterans: risk of infection, hospitalization, ventilation and mortality (edit) |
10.1002/HEP.31649 |
| 2020-11-21 |
The Impact of SARS-CoV-2 on Stroke Epidemiology and Care: A Meta-analysis (edit) |
10.1002/ANA.25967 |
| 2020-11-21 |
Individuals With Less Severe Manifestations of SARS-CoV-2 Infection May Not Develop Long-Lasting Humoral Immunity (edit) |
10.1093/AJCP/AQAA233 |
| 2020-11-21 |
Vitamin D and SARS-CoV-2 infection-evolution of evidence supporting clinical practice and policy development : A position statement from the Covit-D Consortium (edit) |
10.1007/S11845-020-02427-9 |
| 2020-11-21 |
SARS-CoV-2-induced telogen effluvium: a multicentric study (edit) |
10.1111/JDV.17045 |
| 2020-11-21 |
SARS-CoV-2 spike protein-mediated cell signaling in lung vascular cells (edit) |
10.1016/J.VPH.2020.106823 |
| 2020-11-21 |
Non-neutralizing antibodies and limitations of serological testing for SARS-CoV-2 in patients receiving replacement immunoglobulin products (edit) |
10.1016/J.ANAI.2020.11.009 |
| 2020-11-21 |
Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as a live virus vaccine candidate (edit) |
10.1016/J.EBIOM.2020.103132 |
| 2020-11-21 |
Pre-Hospital Management of Critically Ill Patients with SARS-CoV-2 Infection: A Retrospective Multicenter Study (edit) |
10.3390/JCM9113744 |
| 2020-11-21 |
An Original ELISA-Based Multiplex Method for the Simultaneous Detection of 5 SARS-CoV-2 IgG Antibodies Directed against Different Antigens (edit) |
10.3390/JCM9113752 |
| 2020-11-21 |
Expression profiles revealed potential kidney injury caused by SARS-CoV-2: a systematic analysis of ACE2 and clinical lessons learned from this discovery (edit) |
10.18632/AGING.202224 |
| 2020-11-21 |
Role of mitochondria, oxidative stress and the response to antioxidants in myalgic encephalomyelitis/chronic fatigue syndrome: a possible approach to SARS-CoV-2 'long-haulers'? (edit) |
10.1016/J.CDTM.2020.11.002 |
| 2020-11-21 |
High affinity of host human microRNAs to SARS-CoV-2 genome: An in silico analysis (edit) |
10.1016/J.NCRNA.2020.11.005 |
| 2020-11-21 |
Screening marine algae metabolites as high-affinity inhibitors of SARS-CoV-2 main protease (3CLpro): an in silico analysis to identify novel drug candidates to combat COVID-19 pandemic (edit) |
10.1186/S13765-020-00564-4 |
| 2020-11-21 |
Techniques assisting peptide vaccine and peptidomimetic design. Sidechain exposure in the SARS-CoV-2 spike glycoprotein (edit) |
10.1016/J.COMPBIOMED.2020.104124 |
| 2020-11-21 |
SARS-CoV-2 mRNA Vaccines Foster Potent Antigen-Specific Germinal Center Responses Associated with Neutralizing Antibody Generation (edit) |
10.1016/J.IMMUNI.2020.11.009 |
| 2020-11-20 |
Implementation of a Pooled Surveillance Testing Program for Asymptomatic SARS-CoV-2 Infections on a College Campus - Duke University, Durham, North Carolina, August 2-October 11, 2020 (edit) |
10.15585/MMWR.MM6946E1 |
| 2020-11-20 |
Unrecognized SARS-CoV-2 Seroprevalence among healthcare personnel in a low prevalence area (edit) |
10.1017/ICE.2020.1341 |
| 2020-11-20 |
Pooling is an insufficient strategy to avoid health care staff to patient transmission of SARS-CoV-2 (edit) |
10.1017/ICE.2020.1340 |
| 2020-11-20 |
High seroprevalence of SARS_COV-2 in Bergamo: evidence for herd immunity or reason to be cautious? (edit) |
10.1007/S00038-020-01524-X |
| 2020-11-20 |
Myasthenic crisis following SARS-CoV-2 infection and delayed virus clearance in a patient treated with rituximab: clinical course and 6-month follow-up (edit) |
10.1007/S00415-020-10310-X |
| 2020-11-20 |
Chest X-ray findings in a large cohort of 1117 patients with SARS-CoV-2 infection: a multicenter study during COVID-19 outbreak in Italy (edit) |
10.1007/S11739-020-02561-3 |
| 2020-11-20 |
SARS-CoV-2 persistence and non-protective immunity in infected haematological patients (edit) |
10.1111/BJH.17212 |
| 2020-11-20 |
SARS-CoV-2 screening for asymptomatic health care workers in UK stem cell transplant units (edit) |
10.1111/BJH.17196 |
| 2020-11-20 |
SARS-CoV-2 B cell receptor signatures in risk populations (edit) |
10.1172/JCI144685 |
| 2020-11-20 |
Effectiveness of infection-containment measures on SARS-CoV-2 seroprevalence and circulation from May to July 2020, in Milan, Italy (edit) |
10.1371/JOURNAL.PONE.0242765 |
| 2020-11-20 |
Performance of the COVID-19 SEROSpeed IgM/IgG Rapid Test, an immunochromatographic assay for the diagnosis of SARS-CoV-2 infection: a multicenter European study (edit) |
10.1128/JCM.02240-20 |
| 2020-11-20 |
Response to: 'Correspondence on 'Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort' by Pouletty et al ' by Ventura et al (edit) |
10.1136/ANNRHEUMDIS-2020-218984 |
| 2020-11-20 |
Prescription profile in patients with SARS-CoV-2 infection hospitalised in Aragon, Spain (edit) |
10.1136/EJHPHARM-2020-002476 |
| 2020-11-20 |
HTCC as a Polymeric Inhibitor of SARS-CoV-2 and MERS-CoV (edit) |
10.1128/JVI.01622-20 |
| 2020-11-20 |
Streamlined inactivation, amplification, and Cas13-based detection of SARS-CoV-2 (edit) |
10.1038/S41467-020-19097-X |
| 2020-11-20 |
Post-lockdown SARS-CoV-2 nucleic acid screening in nearly ten million residents of Wuhan, China (edit) |
10.1038/S41467-020-19802-W |
| 2020-11-20 |
1H, 13C, and 15N backbone and side chain chemical shift assignments of the SARS-CoV-2 non-structural protein 7 (edit) |
10.1007/S12104-020-09985-0 |
| 2020-11-20 |
The benefit of statins in SARS-CoV-2 patients: further metabolic and prospective clinical studies are needed (edit) |
10.1007/S12020-020-02550-8 |
| 2020-11-20 |
Clinical Characteristics of Pediatric SARS-CoV-2 Infection and Coronavirus Disease 2019 (COVID-19) in Kuwait (edit) |
10.1002/JMV.26684 |
| 2020-11-20 |
A comparison of SARS-CoV-2 antibody assays evaluated in Auckland, New Zealand (edit) |
|
| 2020-11-20 |
SARS-CoV-2 and the human-animal interface: outbreaks on mink farms (edit) |
10.1016/S1473-3099(20)30912-9 |
| 2020-11-20 |
Evaluating SARS-CoV-2 spike and nucleocapsid proteins as targets for antibody detection in severe and mild COVID-19 cases using a Luminex bead-based assay (edit) |
10.1016/J.JVIROMET.2020.114025 |
| 2020-11-20 |
Comparison of the SARS-CoV-2 Rapid Antigen Test to the Real Star Sars-CoV-2 RT PCR Kit (edit) |
10.1016/J.JVIROMET.2020.114024 |
| 2020-11-20 |
Genomic surveillance of SARS-CoV-2 in Thailand reveals mixed imported populations, a local lineage expansion and a virus with truncated ORF7a (edit) |
10.1016/J.VIRUSRES.2020.198233 |
| 2020-11-20 |
Corona's new coat: SARS-CoV-2 in Danish minks and implications for travel medicine (edit) |
10.1016/J.TMAID.2020.101922 |
| 2020-11-20 |
Low dose and oral exposure to SARS-CoV-2 may help us understand and prevent severe COVID-19 (edit) |
10.1016/J.IJID.2020.11.171 |
| 2020-11-20 |
Clinical Performance Evaluation of a SARS-CoV-2 Rapid Antibody Test for Determining Past Exposure to SARS-CoV-2 (edit) |
10.1016/J.IJID.2020.11.164 |
| 2020-11-20 |
Genomic, epigenomic, and immune subtype analysis of CTSL/B and SARS-CoV-2 receptor ACE2 in pan-cancer (edit) |
10.18632/AGING.104147 |
| 2020-11-20 |
Immune-Modulating Drug MP1032 with SARS-CoV-2 Antiviral Activity In Vitro: A potential Multi-Target Approach for Prevention and Early Intervention Treatment of COVID-19 (edit) |
10.3390/IJMS21228803 |
| 2020-11-20 |
Congenital, Intrapartum and Postnatal Maternal-Fetal-Neonatal SARS-CoV-2 Infections: A Narrative Review (edit) |
10.3390/NU12113570 |
| 2020-11-20 |
Analytical methodologies for the detection of SARS-CoV-2 in wastewater: Protocols and future perspectives (edit) |
10.1016/J.TRAC.2020.116125 |
| 2020-11-20 |
Community evidence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission through air (edit) |
10.1016/J.ATMOSENV.2020.118083 |
| 2020-11-20 |
Plasma-activated water: An alternative disinfectant for S protein inactivation to prevent SARS-CoV-2 infection (edit) |
10.1016/J.CEJ.2020.127742 |
| 2020-11-20 |
Immunopathology, host-virus genome interactions, and effective vaccine development in SARS-CoV-2 (edit) |
10.1016/J.CSBJ.2020.11.011 |
| 2020-11-20 |
AI-Driven Multiscale Simulations Illuminate Mechanisms of SARS-CoV-2 Spike Dynamics (edit) |
10.1101/2020.11.19.390187 |
| 2020-11-20 |
Impact of SARS-CoV-2 lockdown and de-escalation on air-quality parameters (edit) |
10.1016/J.CHEMOSPHERE.2020.129027 |
| 2020-11-20 |
Phosphoregulation of Phase Separation by the SARS-CoV-2 N Protein Suggests a Biophysical Basis for its Dual Functions (edit) |
10.1016/J.MOLCEL.2020.11.025 |
| 2020-11-20 |
SARS-COV-2 infection in the perioperative of pulmonary lobectomy. About a case (edit) |
10.1016/J.IJSCR.2020.11.020 |
| 2020-11-20 |
Therapeutic Potential of Mesenchymal Stem Cells and Their Secretome in the Treatment of SARS-CoV-2-Induced Acute Respiratory Distress Syndrome (edit) |
10.1155/2020/1939768 |
| 2020-11-20 |
Dual ELISA using SARS-CoV-2 nucleocapsid protein produced in E. coli and CHO cells reveals epitope masking by N-glycosylation (edit) |
10.1016/J.BBRC.2020.11.060 |
| 2020-11-20 |
MINERVA: A Facile Strategy for SARS-CoV-2 Whole-Genome Deep Sequencing of Clinical Samples (edit) |
10.1016/J.MOLCEL.2020.11.030 |
| 2020-11-20 |
Seroprevalence of SARS-CoV-2 (COVID-19) among healthcare workers in Saudi Arabia: comparing case and control hospitals (edit) |
10.1016/J.DIAGMICROBIO.2020.115273 |
| 2020-11-20 |
Facial Surgery in the Era of SARS-CoV-2 and Beyond: Challenges, Considerations, and Initiatives (edit) |
10.1097/GOX.0000000000003301 |
| 2020-11-20 |
Improved COVID-19 Testing by Extraction-Free SARS-CoV-2 RT-PCR (edit) |
|
| 2020-11-20 |
REACT-1 round 6 updated report: high prevalence of SARS-CoV-2 swab positivity with reduced rate of growth in England at the start of November 2020 (edit) |
10.1101/2020.11.18.20233932 |
| 2020-11-20 |
Expert Opinion on Restoration of Pediatric Pulmonology Services During the SARS-CoV-2 Pandemic (edit) |
10.1007/S13312-020-2035-Z |
| 2020-11-20 |
Recent Hearing Loss and Earache due to Bilateral Otitis Media associated with SARS-CoV-2 infection (edit) |
10.17352/2455-1759.000135 |
| 2020-11-20 |
SARS-CoV-2 in the environment: Modes of transmission, early detection and potential role of pollutions (edit) |
10.1016/J.SCITOTENV.2020.140946 |
| 2020-11-20 |
Isothermal SARS-CoV-2 diagnostics: Tools for enabling distributed pandemic testing as a means of supporting safe reopenings (edit) |
10.1021/ACSSYNBIO.0C00359 |
| 2020-11-19 |
Unraveling the Role of ACE2, the Binding Receptor for SARS-CoV-2, in Inflammatory Bowel Disease (edit) |
10.1093/IBD/IZAA249 |
| 2020-11-19 |
Structure-based identification of potential SARS-CoV-2 main protease inhibitors (edit) |
10.1080/07391102.2020.1848634 |
| 2020-11-19 |
Distinct expression of SARS-CoV-2 receptor ACE2 correlates with endotypes of chronic rhinosinusitis with nasal polyps (edit) |
10.1111/ALL.14665 |
| 2020-11-19 |
The potential effects of clinical antidiabetic agents on SARS-CoV-2 (edit) |
10.1111/1753-0407.13135 |
| 2020-11-19 |
Potential inhibitors of SARS-CoV-2: Recent advances (edit) |
10.1080/1061186X.2020.1853736 |
| 2020-11-19 |
A SARS-CoV-2 Surveillance System in Sub-Saharan Africa: Modeling Study for Persistence and Transmission to Inform Policy (edit) |
10.2196/24248 |
| 2020-11-19 |
[Electrical surgical instruments in times of the SARS-CoV-2 pandemic] (edit) |
10.1007/S00104-020-01314-4 |
| 2020-11-19 |
Direct inhibitory effect on viral entry of influenza A and SARS-CoV-2 viruses by azithromycin (edit) |
10.1111/CPR.12953 |
| 2020-11-19 |
COVID-19 symptoms and SARS-CoV-2 infection among people living with HIV in the US: the MACS/WIHS combined cohort study (edit) |
10.1080/25787489.2020.1844521 |
| 2020-11-19 |
BCG vaccination history associates with decreased SARS-CoV-2 seroprevalence across a diverse cohort of healthcare workers (edit) |
10.1172/JCI145157 |
| 2020-11-19 |
Comparison of deep learning with regression analysis in creating predictive models for SARS-CoV-2 outcomes (edit) |
10.1186/S12911-020-01316-6 |
| 2020-11-19 |
SARS-CoV-2 viral budding and entry can be modeled using BSL-2 level virus-like particles (edit) |
10.1074/JBC.RA120.016148 |
| 2020-11-19 |
A serological assay to detect SARS-CoV-2 antibodies in at-home collected finger-prick dried blood spots (edit) |
10.1038/S41598-020-76913-6 |
| 2020-11-19 |
Insights from Patterns of SARS-CoV-2 Immunoglobulin G Serology Test Results from a National Clinical Laboratory, United States, March-July 2020 (edit) |
10.1089/POP.2020.0256 |
| 2020-11-19 |
Saliva as a possible tool for the SARS-CoV-2 detection: a review (edit) |
10.1016/J.TMAID.2020.101920 |
| 2020-11-19 |
Kinetics and seroprevalence of SARS-CoV-2 antibodies in children (edit) |
10.1016/S1473-3099(20)30884-7 |
| 2020-11-19 |
Ct values and infectivity of SARS-CoV-2 on surfaces (edit) |
10.1016/S1473-3099(20)30883-5 |
| 2020-11-19 |
Absence of SARS-CoV-2 antibodies in health care workers of a tertiary referral hospital for COVID-19 in southern Vietnam (edit) |
10.1016/J.JINF.2020.11.018 |
| 2020-11-19 |
Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19 (edit) |
10.1016/J.JACI.2020.10.040 |
| 2020-11-19 |
The role of the lectin pathway of the complement system in SARS-CoV-2 lung injury (edit) |
10.1016/J.TRSL.2020.11.008 |
| 2020-11-19 |
Molecular targets and system biology approaches for drug repurposing against SARS-CoV-2 (edit) |
10.1186/S42269-020-00444-3 |
| 2020-11-19 |
Protein-ligand binding interactions of imidazolium salts with SARS CoV-2 (edit) |
10.1016/J.HELIYON.2020.E05544 |
| 2020-11-19 |
Virology, epidemiology, immunology and vaccine development of SARS-CoV-2, update after nine months of pandemic (edit) |
10.1016/J.BIOLOGICALS.2020.11.003 |
| 2020-11-19 |
[Prevalence of SARS-CoV-2 in children from a cohort of 2192 patients] (edit) |
10.1007/S00112-020-01067-8 |
| 2020-11-19 |
Universal admission screening strategy for COVID-19 highlighted the clinical importance of reporting SARS-CoV-2 viral loads (edit) |
10.1016/J.NMNI.2020.100820 |
| 2020-11-19 |
Multi-center nationwide comparison of seven serology assays reveals a SARS-CoV-2 non-responding seronegative subpopulation (edit) |
10.1016/J.ECLINM.2020.100651 |
| 2020-11-19 |
Cold-chain transportation in the frozen food industry may have caused a recurrence of COVID-19 cases in destination: Successful isolation of SARS-CoV-2 virus from the imported frozen cod package surface (edit) |
10.1016/J.BSHEAL.2020.11.003 |
| 2020-11-19 |
Diamond Light Source: contributions to SARS-CoV-2 biology and therapeutics (edit) |
10.1016/J.BBRC.2020.11.041 |
| 2020-11-19 |
Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition (edit) |
10.1016/J.CHOM.2020.11.007 |
| 2020-11-19 |
Actionable Cytopathogenic Host Responses of Human Alveolar Type 2 Cells to SARS-CoV-2 (edit) |
10.1016/J.MOLCEL.2020.11.028 |
| 2020-11-19 |
The Roborovski Dwarf Hamster Is A Highly Susceptible Model for a Rapid and Fatal Course of SARS-CoV-2 Infection (edit) |
10.1016/J.CELREP.2020.108488 |
| 2020-11-19 |
Multiepitope Subunit Vaccine Design against COVID-19 Based on the Spike Protein of SARS-CoV-2: An In Silico Analysis (edit) |
10.1155/2020/8893483 |
| 2020-11-19 |
Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity (edit) |
10.1016/J.CELL.2020.11.020 |
| 2020-11-19 |
Syndrome of inappropriate antidiuretic hormone secretion associated with a SARS-CoV-2 pneumonia (edit) |
10.1016/J.MEDCLI.2020.10.003 |
| 2020-11-19 |
Synergism of TNF-α and IFN-γ Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes (edit) |
10.1016/J.CELL.2020.11.025 |
| 2020-11-19 |
Increased mortality from head and neck cancer due to SARS-CoV-2 pandemic (edit) |
10.1016/J.BJORL.2020.11.001 |
| 2020-11-19 |
Screening of Natural Products Targeting SARS-CoV-2-ACE2 Receptor Interface - A MixMD Based HTVS Pipeline (edit) |
10.3389/FCHEM.2020.589769 |
| 2020-11-19 |
Impact of SARS-CoV-2 on Male Reproductive Health: A Review of the Literature on Male Reproductive Involvement in COVID-19 (edit) |
10.3389/FMED.2020.594364 |
| 2020-11-19 |
'The long tail of Covid-19' - The detection of a prolonged inflammatory response after a SARS-CoV-2 infection in asymptomatic and mildly affected patients (edit) |
10.12688/F1000RESEARCH.27287.1 |
| 2020-11-19 |
SSSCPreds: Deep Neural Network-Based Software for the Prediction of Conformational Variability and Application to SARS-CoV-2 (edit) |
10.1021/ACSOMEGA.0C04472 |
| 2020-11-18 |
Epidemiological and clinical characteristics of SARS-CoV-2 infection among healthcare workers in Hubei Province of China (edit) |
10.1017/ICE.2020.1321 |
| 2020-11-18 |
Sensitivity of mid-turbinate versus nasopharyngeal swabs for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (edit) |
10.1017/ICE.2020.1326 |
| 2020-11-18 |
Potential SARS-CoV-2 protease Mpro inhibitors: Repurposing FDA-approved drugs (edit) |
10.1088/1478-3975/ABCB66 |
| 2020-11-18 |
The SARS-CoV-2 receptor, Angiotensin converting enzyme 2 (ACE2) is required for human endometrial stromal cell decidualization (edit) |
10.1093/BIOLRE/IOAA211 |
| 2020-11-18 |
Exploring the Mechanism of Covalent Inhibition: Simulating the Binding Free Energy of α-Ketoamide Inhibitors of the Main Protease of SARS-CoV-2 (edit) |
10.1021/ACS.BIOCHEM.0C00782 |
| 2020-11-18 |
Loss of orf3b in the circulating SARS-CoV-2 strains (edit) |
10.1080/22221751.2020.1852892 |
| 2020-11-18 |
coronapp: A Web Application to Annotate and Monitor SARS-CoV-2 Mutations (edit) |
10.1002/JMV.26678 |
| 2020-11-18 |
Increased susceptibility to SARS-CoV-2 infection in patients with reduced left ventricular ejection fraction (edit) |
10.1002/EHF2.13083 |
| 2020-11-18 |
Detection, Mapping, and Proteotyping of SARS-CoV-2 Coronavirus with High Resolution Mass Spectrometry (edit) |
10.1021/ACSINFECDIS.0C00664 |
| 2020-11-18 |
Effectiveness of Adding a Mask Recommendation to Other Public Health Measures to Prevent SARS-CoV-2 Infection in Danish Mask Wearers : A Randomized Controlled Trial (edit) |
10.7326/M20-6817 |
| 2020-11-18 |
The Role of Masks in Mitigating the SARS-CoV-2 Pandemic: Another Piece of the Puzzle (edit) |
10.7326/M20-7448 |
| 2020-11-18 |
A Lateral Flow Immunoassay test performance in SARS-CoV-2 seroprevalence surveys: a validation study among healthcare workers (edit) |
10.1080/22221751.2020.1852893 |
| 2020-11-18 |
Low incidence of airborne SARS-CoV-2 in acute care hospital rooms with optimized ventilation (edit) |
10.1080/22221751.2020.1850184 |
| 2020-11-18 |
Will a new clade of SARS-CoV-2 imported into the community spark a fourth wave of the COVID-19 outbreak in Hong Kong? (edit) |
10.1080/22221751.2020.1851146 |
| 2020-11-18 |
A Proposed Framework and Timeline of the Spectrum of Disease Due to SARS-CoV-2 Infection: Illness Beyond Acute Infection and Public Health Implications (edit) |
10.1001/JAMA.2020.22717 |
| 2020-11-18 |
ACE-2 downregulation and incidence of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection (edit) |
10.1093/AJH/HPAA191 |
| 2020-11-18 |
SARS-CoV-2 Antibody Testing: Important but Imperfect (edit) |
10.1093/CID/CIAA1755 |
| 2020-11-18 |
What the neuroradiologist should additionally consider in SARS-CoV-2 infection (edit) |
10.1007/S10140-020-01872-4 |
| 2020-11-18 |
Stability of SARS-CoV-2 phylogenies (edit) |
10.1371/JOURNAL.PGEN.1009175 |
| 2020-11-18 |
EGYVIR: An immunomodulatory herbal extract with potent antiviral activity against SARS-CoV-2 (edit) |
10.1371/JOURNAL.PONE.0241739 |
| 2020-11-18 |
Sensitivity evaluation of 2019 novel coronavirus (SARS-CoV-2) RT-PCR detection kits and strategy to reduce false negative (edit) |
10.1371/JOURNAL.PONE.0241469 |
| 2020-11-18 |
Reactive arthritis and cutaneous vasculitis after SARS-CoV-2 infection (edit) |
10.1093/RHEUMATOLOGY/KEAA689 |
| 2020-11-18 |
A case of psoriatic arthritis triggered by SARS-CoV-2 infection (edit) |
10.1093/RHEUMATOLOGY/KEAA691 |
| 2020-11-18 |
Global SNP analysis of 11,183 SARS-CoV-2 strains reveals high genetic diversity (edit) |
10.1111/TBED.13931 |
| 2020-11-18 |
SARS-CoV-2 Transmission between Mink (Neovison vison) and Humans, Denmark (edit) |
10.3201/EID2702.203794 |
| 2020-11-18 |
Sensitive and Simultaneous Detection of SARS-CoV-2-Specific IgM/IgG Using Lateral Flow Immunoassay Based on Dual-Mode Quantum Dot Nanobeads (edit) |
10.1021/ACS.ANALCHEM.0C03484 |
| 2020-11-18 |
A Longitudinal, 3-Month Serologic Assessment of SARS-CoV-2 Infections in a Belgian Hemodialysis Facility (edit) |
10.2215/CJN.12490720 |
| 2020-11-18 |
SARS-CoV-2 Antibody Responses Are Correlated to Disease Severity in COVID-19 Convalescent Individuals (edit) |
10.4049/JIMMUNOL.2000898 |
| 2020-11-18 |
Systematic Examination of Antigen-Specific Recall T Cell Responses to SARS-CoV-2 versus Influenza Virus Reveals a Distinct Inflammatory Profile (edit) |
10.4049/JIMMUNOL.2001067 |
| 2020-11-18 |
Evaluation of Serological SARS-CoV-2 Lateral Flow Assays for Rapid Point of Care Testing (edit) |
10.1128/JCM.02020-20 |
| 2020-11-18 |
Crystallographic structure of wild-type SARS-CoV-2 main protease acyl-enzyme intermediate with physiological C-terminal autoprocessing site (edit) |
10.1038/S41467-020-19662-4 |
| 2020-11-18 |
Architecture of a SARS-CoV-2 mini replication and transcription complex (edit) |
10.1038/S41467-020-19770-1 |
| 2020-11-18 |
SARS-CoV-2 structure and replication characterized by in situ cryo-electron tomography (edit) |
10.1038/S41467-020-19619-7 |
| 2020-11-18 |
Serological follow-up of SARS-CoV-2 asymptomatic subjects (edit) |
10.1038/S41598-020-77125-8 |
| 2020-11-18 |
Development of CpG-adjuvanted stable prefusion SARS-CoV-2 spike antigen as a subunit vaccine against COVID-19 (edit) |
10.1038/S41598-020-77077-Z |
| 2020-11-18 |
Repurposing FDA-approved drugs for SARS-CoV-2 through an ELISA-based screening for the inhibition of RBD/ACE2 interaction (edit) |
10.1007/S13238-020-00803-W |
| 2020-11-18 |
Why are ACE2 binding coronavirus strains SARS-CoV/SARS-CoV-2 wild and NL63 mild? (edit) |
10.1002/PROT.26024 |
| 2020-11-18 |
SARS-CoV-2 Clinical Outcomes in Patients with Cancer in a Large Integrated Health Care System in Northern California (edit) |
10.1002/ONCO.13602 |
| 2020-11-18 |
COVID-19 Infection Detection and Prevention by SARS-CoV-2 Active Antigens: A Synthetic Vaccine Approach (edit) |
10.3390/VACCINES8040692 |
| 2020-11-18 |
A Novel Purification Procedure for Active Recombinant Human DPP4 and the Inability of DPP4 to Bind SARS-CoV-2 (edit) |
10.3390/MOLECULES25225392 |
| 2020-11-18 |
Preventing Airborne Transmission of SARS-CoV-2 in Hospitals and Nursing Homes (edit) |
10.3390/IJERPH17228553 |
| 2020-11-18 |
Infectivity of SARS-CoV-2 and Other Coronaviruses on Dry Surfaces: Potential for Indirect Transmission (edit) |
10.3390/MA13225211 |
| 2020-11-18 |
A case of acute disseminate encephalomyelitis after SARS-CoV-2 related acute respiratory distress syndrome (edit) |
10.1016/J.NEURAD.2020.11.001 |
| 2020-11-18 |
Increasing SARS-CoV-2 RT-qPCR testing capacity by sample pooling (edit) |
10.1016/J.IJID.2020.11.155 |
| 2020-11-18 |
Therapeutic potential of miRNAs targeting SARS-CoV-2 host cell receptor ACE2 (edit) |
10.1016/J.MGENE.2020.100831 |
| 2020-11-18 |
Patients with SARS-CoV-2 and HBV co-infection are at risk of greater liver injury (edit) |
10.1016/J.GENDIS.2020.11.005 |
| 2020-11-18 |
Development of a SERS-based lateral flow immunoassay for rapid and ultra-sensitive detection of anti-SARS-CoV-2 IgM/IgG in clinical samples (edit) |
10.1016/J.SNB.2020.129196 |
| 2020-11-18 |
Mental health, coping, and social support among people living with HIV in the Americas: A comparative study between Argentina and the USA during the SARS-CoV-2 pandemic (edit) |
10.21203/RS.3.RS-109131/V1 |
| 2020-11-18 |
An engineered receptor-binding domain improves the immunogenicity of multivalent SARS-CoV-2 vaccines (edit) |
10.1101/2020.11.18.388934 |
| 2020-11-18 |
Replicating bacterium-vectored vaccine expressing SARS-CoV-2 Membrane and Nucleocapsid proteins protects against severe COVID-19 disease in hamsters (edit) |
10.1101/2020.11.17.387555 |
| 2020-11-18 |
Improved production of SARS-CoV-2 spike receptor-binding domain (RBD) for serology assays (edit) |
10.1101/2020.11.18.388868 |
| 2020-11-18 |
Detection of the SARS-CoV-2 spike protein in saliva with Shrinky-Dink© electrodes (edit) |
10.1101/2020.11.14.20231811 |
| 2020-11-18 |
Patterns and persistence of SARS-CoV-2 IgG antibodies in a US metropolitan site (edit) |
10.1101/2020.11.17.20233452 |
| 2020-11-18 |
Zinc and SARS‑CoV‑2: A molecular modeling study of Zn interactions with RNA‑dependent RNA‑polymerase and 3C‑like proteinase enzymes (edit) |
10.3892/IJMM.2020.4790 |
| 2020-11-18 |
Simple Questionnaires to Improve Pooling Strategies for SARS-CoV-2 Laboratory Testing (edit) |
10.5334/AOGH.3126 |
| 2020-11-18 |
Sequential ER stress and inflammatory responses are induced by SARS-CoV-2 ORF3 through ERphagy (edit) |
10.1101/2020.11.17.387902 |
| 2020-11-18 |
Room Temperature Structure of SARS-CoV-2 Nsp10/16 Methyltransferase in a Complex with Cap-0 and SAM Determined by Pink-Beam Serial Crystallography (edit) |
10.2210/PDB7KOA/PDB |
| 2020-11-18 |
High throughput wastewater SARS-CoV-2 detection enables forecasting of community infection dynamics in San Diego county (edit) |
10.1101/2020.11.16.20232900 |
| 2020-11-17 |
Early plasma IL-37 responses accompanied with low inflammatory cytokines correlate with benign clinical outcomes during SARS-CoV-2 infection (edit) |
10.1093/INFDIS/JIAA713 |
| 2020-11-17 |
Characteristics of Clinically Asymptomatic Patients with SARS-CoV-2 Infections, Case Series (edit) |
10.1017/S1049023X20001466 |
| 2020-11-17 |
Repeat SARS-CoV-2 testing models for residential college populations (edit) |
10.1007/S10729-020-09526-0 |
| 2020-11-17 |
Inhibitory potential of repurposed drugs against the SARS-CoV-2 main protease: a computational-aided approach (edit) |
10.1080/07391102.2020.1847197 |
| 2020-11-17 |
In silico screening and molecular dynamics of phytochemicals from Indian cuisine against SARS-CoV-2 MPro (edit) |
10.1080/07391102.2020.1845980 |
| 2020-11-17 |
Determination of potential inhibitors based on isatin derivatives against SARS-CoV-2 main protease (mpro): a molecular docking, molecular dynamics and structure-activity relationship studies (edit) |
10.1080/07391102.2020.1845800 |
| 2020-11-17 |
Computational investigation of binding of chloroquinone and hydroxychloroquinone against PLPro of SARS-CoV-2 (edit) |
10.1080/07391102.2020.1844804 |
| 2020-11-17 |
SARS-CoV-2 nucleocapsid protein phase-separates with RNA and with human hnRNPs (edit) |
10.15252/EMBJ.2020106478 |
| 2020-11-17 |
Clinical performances of three fully automated anti-SARS-CoV-2 immunoassays targeting the nucleocapsid or spike proteins (edit) |
10.1002/JMV.26669 |
| 2020-11-17 |
The genetic structure of SARS-CoV-2 does not rule out a laboratory origin: SARS-COV-2 chimeric structure and furin cleavage site might be the result of genetic manipulation (edit) |
10.1002/BIES.202000240 |
| 2020-11-17 |
Computational Design of 25-mer Peptide Binders of SARS-CoV-2 (edit) |
10.1021/ACS.JPCB.0C07890 |
| 2020-11-17 |
[The pandemic caused by SARS-CoV-2: more than a serious health crisis, a change of time and lessons to be learned urgently] (edit) |
10.1051/MEDSCI/2020245 |
| 2020-11-17 |
Secondary attack rate and family clustering of SARS-CoV-2 infection in children of healthcare workers with confirmed COVID-19 (edit) |
10.1093/CID/CIAA1737 |
| 2020-11-17 |
ceRNA analysis of SARS-CoV-2 (edit) |
10.1007/S00705-020-04856-4 |
| 2020-11-17 |
Molecular docking studies, molecular dynamics and ADME/tox reveal therapeutic potentials of STOCK1N-69160 against papain-like protease of SARS-CoV-2 (edit) |
10.1007/S11030-020-10151-W |
| 2020-11-17 |
A prospective study on the incidence of postponed time-sensitive urological procedures during the SARS-CoV-2 pandemic due to patient preference (edit) |
10.1007/S11845-020-02438-6 |
| 2020-11-17 |
Psychological characteristics of parents in a Paediatric Outpatient during the SARS-CoV-2 Epidemic (edit) |
10.1080/13548506.2020.1849747 |
| 2020-11-17 |
Implications of SARS-CoV-2-Associated Myocarditis in the Medical Evaluation of Athletes (edit) |
10.1177/1941738120974747 |
| 2020-11-17 |
Association of SARS-CoV-2 genomic load trends with clinical status in COVID-19: A retrospective analysis from an academic hospital center in New York City (edit) |
10.1371/JOURNAL.PONE.0242399 |
| 2020-11-17 |
Genetic diversity of SARS-CoV-2 and clinical, epidemiological characteristics of COVID-19 patients in Hanoi, Vietnam (edit) |
10.1371/JOURNAL.PONE.0242537 |
| 2020-11-17 |
Correction to: Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial (edit) |
10.1186/S13063-020-04877-Z |
| 2020-11-17 |
Global analysis of more than 50,000 SARS-CoV-2 genomes reveals epistasis between eight viral genes (edit) |
10.1073/PNAS.2012331117 |
| 2020-11-17 |
Bimodular effects of D614G mutation on the spike glycoprotein of SARS-CoV-2 enhance protein processing, membrane fusion, and viral infectivity (edit) |
10.1038/S41392-020-00392-4 |
| 2020-11-17 |
GSK-LSD1, an LSD1 inhibitor, quashes SARS-CoV-2-triggered cytokine release syndrome in-vitro (edit) |
10.1038/S41392-020-00391-5 |
| 2020-11-17 |
A systemic and molecular study of subcellular localization of SARS-CoV-2 proteins (edit) |
10.1038/S41392-020-00372-8 |
| 2020-11-17 |
STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters (edit) |
10.1038/S41467-020-19684-Y |
| 2020-11-17 |
Upper airway gene expression reveals suppressed immune responses to SARS-CoV-2 compared with other respiratory viruses (edit) |
10.1038/S41467-020-19587-Y |
| 2020-11-17 |
High-content screening of Thai medicinal plants reveals Boesenbergia rotunda extract and its component Panduratin A as anti-SARS-CoV-2 agents (edit) |
10.1038/S41598-020-77003-3 |
| 2020-11-17 |
Detection of SARS-CoV-2 from Saliva as Compared to Nasopharyngeal Swabs in Outpatients (edit) |
10.3390/V12111314 |
| 2020-11-17 |
COVID-19 and domestic animals: Exploring the species barrier crossing, zoonotic and reverse zoonotic transmission of SARS-CoV-2 (edit) |
10.2174/1381612826666201118112203 |
| 2020-11-17 |
Meta-Analysis on Serial Intervals and Reproductive Rates for SARS-CoV-2 (edit) |
10.1097/SLA.0000000000004400 |
| 2020-11-17 |
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial (edit) |
10.1016/S1473-3099(20)30843-4 |
| 2020-11-17 |
Lower respiratory tract myeloid cells harbor SARS-CoV-2 and display an inflammatory phenotype (edit) |
10.1016/J.CHEST.2020.10.083 |
| 2020-11-17 |
A bacterial artificial chromosome (BAC)-vectored noninfectious replicon of SARS-CoV-2 (edit) |
10.1016/J.ANTIVIRAL.2020.104974 |
| 2020-11-17 |
Comparison of Saliva and Nasopharyngeal Swab SARS-CoV-2 RT-qPCR Testing in a Community Setting (edit) |
10.1016/J.JINF.2020.11.015 |
| 2020-11-17 |
Performance of SARS-CoV-2 Real-time RT-PCR Tests on Oral Rinses and Saliva Samples (edit) |
10.1016/J.JMOLDX.2020.10.018 |
| 2020-11-17 |
Clinical and epidemiological features discriminating confirmed COVID-19 patients from SARS-CoV-2 negative patients at screening centres in Madagascar (edit) |
10.1016/J.IJID.2020.11.151 |
| 2020-11-17 |
Perioperative SARS-CoV-2 infection among women undergoing major gynecologic cancer surgery in the COVID-19 era: A nationwide, cohort study from Turkey (edit) |
10.1016/J.YGYNO.2020.11.014 |
| 2020-11-17 |
[Simulation-based pediatric emergency team training in times of the SARS-CoV-2 pandemic] (edit) |
10.1007/S00112-020-01055-Y |
| 2020-11-17 |
The link between ego-resiliency, social support, SARS-CoV-2 anxiety and trauma effects. Polish adaptation of the Coronavirus Anxiety Scale (edit) |
10.1016/J.PAID.2020.110540 |
| 2020-11-17 |
Molecular Interaction Analysis of Sulawesi Propolis Compounds with SARS-CoV-2 Main Protease as Preliminary Study for COVID-19 Drug Discovery (edit) |
10.1016/J.JKSUS.2020.101234 |
| 2020-11-17 |
SARS-CoV-2 RT-PCR test, false result problem, public risk assessment and reliability of epidemiology statistics (edit) |
10.1016/J.JTUMED.2020.10.012 |
| 2020-11-17 |
COVID-19 pandemic crisis-a complete outline of SARS-CoV-2 (edit) |
10.1186/S43094-020-00133-Y |
| 2020-11-17 |
Ultrasensitive and Selective Detection of SARS-CoV-2 using Thermotropic Liquid Crystals and Image-based Machine Learning (edit) |
10.1016/J.XCRP.2020.100276 |
| 2020-11-17 |
Androgen Signaling Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men (edit) |
10.1016/J.STEM.2020.11.009 |
| 2020-11-17 |
An alternative way to perform diagnostic nasopharyngeal swab for SARS-CoV-2 infection (edit) |
10.1016/J.AMJOTO.2020.102828 |
| 2020-11-17 |
SARS-CoV-2 Infected Cardiomyocytes Recruit Monocytes by Secreting CCL2 (edit) |
10.21203/RS.3.RS-94634/V1 |
| 2020-11-17 |
Transmission of SARS-CoV-2 in domestic cats imposes a narrow bottleneck (edit) |
10.1101/2020.11.16.384917 |
| 2020-11-17 |
The Development of a Novel Nanobody Therapeutic for SARS-CoV-2 (edit) |
10.1101/2020.11.17.386532 |
| 2020-11-17 |
Mosaic RBD nanoparticles elicit neutralizing antibodies against SARS-CoV-2 and zoonotic coronaviruses (edit) |
10.1101/2020.11.17.387092 |
| 2020-11-17 |
The total number and mass of SARS-CoV-2 virions in an infected person (edit) |
10.1101/2020.11.16.20232009 |
| 2020-11-17 |
Development of a nano-luciferase based assay to measure the binding of SARS-CoV-2 spike receptor binding domain to ACE-2 (edit) |
10.1016/J.BBRC.2020.11.055 |
| 2020-11-17 |
MEK inhibitors reduce cellular expression of ACE2, pERK, pRb while stimulating NK-mediated cytotoxicity and attenuating inflammatory cytokines relevant to SARS-CoV-2 infection (edit) |
10.18632/ONCOTARGET.27799 |
| 2020-11-17 |
Integrative Imaging Reveals SARS-CoV-2-Induced Reshaping of Subcellular Morphologies (edit) |
10.1016/J.CHOM.2020.11.003 |
| 2020-11-17 |
Upper extremity emergencies during SARS-COV-2 pandemic: Turnout trends (edit) |
10.1016/J.INJURY.2020.11.045 |
| 2020-11-17 |
Comparison of SARS-CoV-2 serological tests with different antigen targets (edit) |
10.1016/J.JCV.2020.104690 |
| 2020-11-17 |
Direct Exposure to SARS-CoV-2 and Cigarette Smoke Increases Infection Severity and Alters the Stem Cell-Derived Airway Repair Response (edit) |
10.1016/J.STEM.2020.11.010 |
| 2020-11-17 |
The immunology of SARS-CoV-2 infections and vaccines (edit) |
10.1016/J.SMIM.2020.101422 |
| 2020-11-17 |
Cryo-EM Structures of SARS-CoV-2 Spike without and with ACE2 Reveal a pH-Dependent Switch to Mediate Endosomal Positioning of Receptor-Binding Domains (edit) |
10.1016/J.CHOM.2020.11.004 |
| 2020-11-17 |
Identification of Potential Key Agents for Targeting RNA-Dependent RNA Polymerase of SARS-CoV-2 by Integrated Analysis and Virtual Drug Screening (edit) |
10.3389/FGENE.2020.581668 |
| 2020-11-17 |
SARS-CoV-2: what it is, how it acts, and how it manifests in imaging studies (edit) |
10.1016/J.RX.2020.10.006 |
| 2020-11-17 |
In silico evaluation of flavonoids as effective antiviral agents on the spike glycoprotein of SARS-CoV-2 (edit) |
10.1016/J.SJBS.2020.11.049 |
| 2020-11-16 |
COVID-19 in Australia: Our national response to the first cases of SARS-CoV-2 infection during the early biocontainment phase (edit) |
10.1111/IMJ.15105 |
| 2020-11-16 |
Impact of the COVID-19 Pandemic on Invasive Pneumococcal Disease and Risk of Pneumococcal Coinfection with SARS-CoV-2: prospective national cohort study, England (edit) |
10.1093/CID/CIAA1728 |
| 2020-11-16 |
Continuing care for patients affected by urologic chronic pelvic pain in the era of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic (edit) |
10.1002/NAU.24574 |
| 2020-11-16 |
Immunodominant regions prediction of nucleocapsid protein for SARS-CoV-2 early diagnosis: a bioinformatics and immunoinformatics study (edit) |
10.1080/20477724.2020.1838190 |
| 2020-11-16 |
Predictive accuracy of a hierarchical logistic model of cumulative SARS-CoV-2 case growth until May 2020 (edit) |
10.1186/S12874-020-01160-2 |
| 2020-11-16 |
Modeling the impact of school reopening on SARS-CoV-2 transmission using contact structure data from Shanghai (edit) |
10.1186/S12889-020-09799-8 |
| 2020-11-16 |
Prevalence of SARS-CoV-2 infection in previously undiagnosed health care workers in New Jersey, at the onset of the U.S. COVID-19 pandemic (edit) |
10.1186/S12879-020-05587-2 |
| 2020-11-16 |
Health-care organization for the management and surveillance of SARS-CoV-2 infection in children during pandemic in Campania region, Italy (edit) |
10.1186/S13052-020-00928-Y |
| 2020-11-16 |
Detection of SARS-CoV-2 antibodies is insufficient for the diagnosis of active or cured COVID-19 (edit) |
10.1038/S41598-020-76914-5 |
| 2020-11-16 |
Demographic and occupational determinants of anti-SARS-CoV-2 IgG seropositivity in hospital staff (edit) |
10.1093/PUBMED/FDAA199 |
| 2020-11-16 |
Computational study of pomegranate peel extract polyphenols as potential inhibitors of SARS-CoV-2 virus internalization (edit) |
10.1007/S11010-020-03981-7 |
| 2020-11-16 |
Natural Compounds as Inhibitors of SARS-CoV-2 Main Protease (3CLpro): A Molecular Docking and Simulation Approach to Combat COVID-19 (edit) |
10.2174/1381612826999201116195851 |
| 2020-11-16 |
Perceptions of immunity and vaccination certificates among the general population: a nested study within a serosurvey of anti-SARS-CoV-2 antibodies (SEROCoV-POP) (edit) |
10.4414/SMW.2020.20398 |
| 2020-11-16 |
CLINICAL AND LABORATORY CHARACTERISTICS OF SARS-COV-2 INFECTION IN CHILDREN AND ADOLESCENTS (edit) |
10.1590/1984-0462/2021/39/2020231 |
| 2020-11-16 |
Computational Analysis of Targeting SARS-CoV-2, Viral Entry Proteins ACE2 and TMPRSS2, and Interferon Genes by Host MicroRNAs (edit) |
10.3390/GENES11111354 |
| 2020-11-16 |
No Evidence of SARS-CoV-2 Circulation in Rome (Italy) during the Pre-Pandemic Period: Results of a Retrospective Surveillance (edit) |
10.3390/IJERPH17228461 |
| 2020-11-16 |
Antibody Responses to SARS-CoV-2 Antigens in Humans and Animals (edit) |
10.3390/VACCINES8040684 |
| 2020-11-16 |
Cancer and Immune Checkpoint Inhibitor Treatment in the Era of SARS-CoV-2 Infection (edit) |
10.3390/CANCERS12113383 |
| 2020-11-16 |
Large-Scale Plasma Analysis Revealed New Mechanisms and Molecules Associated with the Host Response to SARS-CoV-2 (edit) |
10.3390/IJMS21228623 |
| 2020-11-16 |
Seroprevalence of SARS-CoV-2 antibodies and associated factors in health care workers: a systematic review and meta-analysis (edit) |
10.1016/J.JHIN.2020.11.008 |
| 2020-11-16 |
SARS-CoV-2 in Migrant Worker Dormitories: Geospatial Epidemiology Supporting Outbreak Management (edit) |
10.1016/J.IJID.2020.11.148 |
| 2020-11-16 |
SARS-CoV-2 sensitivity limbo - how low can we go? (edit) |
10.1016/J.IJID.2020.11.138 |
| 2020-11-16 |
A commentary revisiting the viral hypothesis of schizophrenia: Onset of a schizophreniform disorder subsequent to SARS CoV-2 infection (edit) |
10.1016/J.PSYCHRES.2020.113573 |
| 2020-11-16 |
Temporal Course of SARS-CoV-2 Antibody Positivity in Patients with COVID-19 following the First Clinical Presentation (edit) |
10.1155/2020/9878453 |
| 2020-11-16 |
Safety Pathway Design for Patients Not Affected by COVID-19 During the SARS-CoV-2 Pandemic in an Italian University Hospital (edit) |
10.2147/RMHP.S265942 |
| 2020-11-16 |
High resolution profiling of pathways of escape for SARS-CoV-2 spike-binding antibodies (edit) |
10.1101/2020.11.16.385278 |
| 2020-11-16 |
Role of air temperature and humidity in the transmission of SARS-CoV-2 in the United States (edit) |
10.1101/2020.11.13.20231472 |
| 2020-11-16 |
Dysregulated immunity in SARS-CoV-2 infected pregnant women (edit) |
10.1101/2020.11.13.20231373 |
| 2020-11-16 |
High Resolution analysis of Transmission Dynamics of Sars-Cov-2 in Two Major Hospital Outbreaks in South Africa Leveraging Intrahost Diversity (edit) |
10.1101/2020.11.15.20231993 |
| 2020-11-16 |
Serological responses to SARS-CoV-2 following non-hospitalised infection: clinical and ethnodemographic features associated with the magnitude of the antibody response (edit) |
10.1101/2020.11.12.20230763 |
| 2020-11-16 |
Development and validation of a highly sensitive and specific electrochemical assay to quantify anti-SARS-CoV-2 IgG antibodies to facilitate pandemic surveillance and monitoring of vaccine response (edit) |
10.1101/2020.11.12.20230656 |
| 2020-11-16 |
Estimating the cumulative incidence of SARS-CoV-2 infection and the infection fatality ratio in light of waning antibodies (edit) |
10.1101/2020.11.13.20231266 |
| 2020-11-16 |
Disappearance of summer influenza in the Okinawa prefecture during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic (edit) |
10.1016/J.RESINV.2020.10.010 |
| 2020-11-16 |
Reversibility of venous dilatation and parenchymal changes density in Sars-Cov-2 pneumonia: toward the definition of a peculiar pattern (edit) |
10.1016/J.PULMOE.2020.10.010 |
| 2020-11-16 |
Adaptation of an Academic Inpatient Consultation-Liaison Psychiatry Service During the SARS-CoV-2 Pandemic: Effects on Clinical Practice and Trainee Supervision (edit) |
10.1016/J.PSYM.2020.11.002 |
| 2020-11-16 |
How Does SARS-CoV-2 Affect the Central Nervous System? A Working Hypothesis (edit) |
10.3389/FPSYT.2020.582345 |
| 2020-11-16 |
Impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in the Nervous System: Implications of COVID-19 in Neurodegeneration (edit) |
10.3389/FNEUR.2020.583459 |
| 2020-11-16 |
Repurposing Known Drugs as Covalent and Non-covalent Inhibitors of the SARS-CoV-2 Papain-Like Protease (edit) |
10.3389/FCHEM.2020.594009 |
| 2020-11-16 |
Single-Cell Sequencing of Glioblastoma Reveals Central Nervous System Susceptibility to SARS-CoV-2 (edit) |
10.3389/FONC.2020.566599 |
| 2020-11-16 |
Fast Clearance of the SARS-CoV-2 Virus in a Patient Undergoing Vaccine Immunotherapy for Metastatic Chordoma: A Case Report (edit) |
10.3389/FONC.2020.603248 |
| 2020-11-16 |
Analysis of SARS-CoV-2 spike glycosylation reveals shedding of a vaccine candidate (edit) |
10.1101/2020.11.16.384594 |
| 2020-11-16 |
Natural Products Database Screening for the Discovery of Naturally Occurring SARS-Cov-2 Spike Glycoprotein Blockers (edit) |
10.1002/SLCT.202003349 |
| 2020-11-16 |
Recurrent mutations in SARS-CoV-2 genomes isolated from mink point to rapid host-adaptation (edit) |
10.1101/2020.11.16.384743 |
| 2020-11-16 |
Effects of inactivation method on SARS-CoV-2 virion protein and structure (edit) |
10.1101/2020.11.14.383026 |
| 2020-11-15 |
Expert Opinion on Restoration of Pediatric Pulmonology Services During SARS-COV-2 Pandemic (edit) |
|
| 2020-11-15 |
Revealing the Inhibition Mechanism of RNA-Dependent RNA Polymerase (RdRp) of SARS-CoV-2 by Remdesivir and Nucleotide Analogues: A Molecular Dynamics Simulation Study (edit) |
10.1021/ACS.JPCB.0C06747 |
| 2020-11-15 |
Multi-species ELISA for the detection of antibodies against SARS-CoV-2 in animals (edit) |
10.1111/TBED.13926 |
| 2020-11-15 |
Seroprevalence of SARS-CoV-2 infection among pet animals in Croatia and potential public health impact (edit) |
10.1111/TBED.13924 |
| 2020-11-15 |
Outcomes from elective colorectal cancer surgery during the SARS-CoV-2 pandemic (edit) |
10.1111/CODI.15431 |
| 2020-11-15 |
Expression Analyses of MicroRNAs in Hamster Lung Tissues Infected by SARS-CoV-2 (edit) |
10.14348/MOLCELLS.2020.0177 |
| 2020-11-15 |
Variations in state-level SARS-COV-2 testing recommendations in the United States, March-July 2020 (edit) |
10.1101/2020.09.04.20188326 |
| 2020-11-15 |
Placental Pathology of COVID-19 with and without Fetal and Neonatal Infection: Trophoblast Necrosis and Chronic Histiocytic Intervillositis as Risk Factors for Transplacental Transmission of SARS-CoV-2 (edit) |
10.3390/V12111308 |
| 2020-11-15 |
SARS-CoV-2 has displaced other seasonal respiratory viruses: results from a prospective cohort study (edit) |
10.1016/J.JINF.2020.11.010 |
| 2020-11-15 |
Evidence of SARS-CoV-2 re-infection with a different genotype (edit) |
10.1016/J.JINF.2020.11.011 |
| 2020-11-15 |
SARS-CoV-2 droplet deposition path and its effects on the human upper airway in the oral inhalation (edit) |
10.1016/J.CMPB.2020.105843 |
| 2020-11-15 |
An in-silico study on selected organosulfur compounds as potential drugs for SARS-CoV-2 infection via binding multiple drug targets (edit) |
10.1016/J.CPLETT.2020.138193 |
| 2020-11-15 |
Forecasting of the SARS-CoV-2 epidemic in India using SIR model, flatten curve and herd immunity (edit) |
10.1007/S12652-020-02641-4 |
| 2020-11-15 |
SARS-CoV-2 from faeces to wastewater treatment: What do we know? A review (edit) |
10.1016/J.SCITOTENV.2020.140444 |
| 2020-11-14 |
SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates (edit) |
10.1016/S0140-6736(20)32137-1 |
| 2020-11-14 |
A Retrospective Study of Coinfection of SARS-CoV-2 and Streptococcus pneumoniae in 11 Hospitalized Patients with Severe COVID-19 Pneumonia at a Single Center (edit) |
10.12659/MSM.928754 |
| 2020-11-14 |
Coinfection with SARS-CoV-2 and Influenza A Virus in a 32-Year-Old Man (edit) |
10.12659/AJCR.926092 |
| 2020-11-14 |
SARS-CoV-2 triggering severe ARDS and secondary HLH in a 3-year-old child with Down syndrome (edit) |
10.1093/JPIDS/PIAA148 |
| 2020-11-14 |
Human mesenchymal stromal cells do not express ACE2 and TMPRSS2 and are not permissive to SARS-CoV-2 infection (edit) |
10.1002/SCTM.20-0385 |
| 2020-11-14 |
COVID-19 and systemic sclerosis: analysis of lifestyle changes during the SARS-CoV-2 pandemic in an Italian single-center cohort (edit) |
10.1007/S10067-020-05504-7 |
| 2020-11-14 |
Poor sensitivity of "AccuPower SARS-CoV-2 real time RT-PCR kit (Bioneer, South Korea)" (edit) |
10.1186/S12985-020-01445-4 |
| 2020-11-14 |
Telogen effluvium related to post severe Sars-Cov-2 Infection: clinical aspects and our management experience (edit) |
10.1111/DTH.14547 |
| 2020-11-14 |
Avis de l’HAS: recherche directe combinée virus influenza A et B et SARS-CoV-2 (edit) |
10.1016/J.JPP.2020.10.003 |
| 2020-11-14 |
Cryo-EM Structure of an Extended SARS-CoV-2 Replication and Transcription Complex Reveals an Intermediate State in Cap Synthesis (edit) |
10.1016/J.CELL.2020.11.016 |
| 2020-11-14 |
Signs suggestive of congenital SARS-CoV-2 infection with intrauterine fetal death: A case report (edit) |
10.1016/J.EJOGRB.2020.11.042 |
| 2020-11-14 |
Randomness for Nucleotide Sequences of SARS-CoV-2 and Its Related Subfamilies (edit) |
10.1155/2020/8819942 |
| 2020-11-14 |
Guillain-Barré syndrome as a parainfectious manifestation of SARS-CoV-2 infection: A case series (edit) |
10.1016/J.JOCN.2020.11.013 |
| 2020-11-13 |
Targeting Crucial Host Factors of SARS-CoV-2 (edit) |
10.1021/ACSINFECDIS.0C00456 |
| 2020-11-13 |
Declines in SARS-CoV-2 Transmission, Hospitalizations, and Mortality After Implementation of Mitigation Measures- Delaware, March-June 2020 (edit) |
10.15585/MMWR.MM6945E1 |
| 2020-11-13 |
Identification of natural inhibitors against prime targets of SARS-CoV-2 using molecular docking, molecular dynamics simulation and MM-PBSA approaches (edit) |
10.1080/07391102.2020.1846624 |
| 2020-11-13 |
Clinical significance of the serum IgM and IgG to SARS-CoV-2 in coronavirus disease-2019 (edit) |
10.1002/JCLA.23649 |
| 2020-11-13 |
Associations between hematological parameters and disease severity in patients with SARS-CoV-2 infection (edit) |
10.1002/JCLA.23604 |
| 2020-11-13 |
Risk of SARS-CoV-2 Exposure in a Hospital-Based Allergy Practice (edit) |
10.1111/CEA.13786 |
| 2020-11-13 |
Higher prevalence of pulmonary macrothrombi in SARS-CoV-2 than in influenza A: autopsy results from 'Spanish flu' 1918/1919 in Switzerland to Coronavirus disease 2019 (edit) |
10.1002/CJP2.189 |
| 2020-11-13 |
Forecasting the burden of COVID-19 hospitalized patients during the SARS-CoV-2 second wave in Lombardy, Italy (edit) |
10.23736/S0031-0808.20.04212-3 |
| 2020-11-13 |
Intrauterine Transmission of SARS-CoV-2 (edit) |
10.3201/EID2702.203824 |
| 2020-11-13 |
Hospital-Acquired SARS-CoV-2 Infection: Lessons for Public Health (edit) |
10.1001/JAMA.2020.21399 |
| 2020-11-13 |
SARS-CoV-2: Remarks on the COVID-19 Pandemic (edit) |
10.1007/S00005-020-00600-7 |
| 2020-11-13 |
Comparison of Binding Site of Remdesivir and Its Metabolites with NSP12-NSP7-NSP8, and NSP3 of SARS CoV-2 Virus and Alternative Potential Drugs for COVID-19 Treatment (edit) |
10.1007/S10930-020-09942-9 |
| 2020-11-13 |
Evaluating the clinical utility and sensitivity of SARS-CoV-2 antigen testing in relation to RT-PCR Ct values (edit) |
10.1007/S15010-020-01542-0 |
| 2020-11-13 |
SARS-CoV-2-mediated immune system activation and potential application in immunotherapy (edit) |
10.1002/MED.21756 |
| 2020-11-13 |
Epidemiology, risk factors and clinical course of SARS-CoV-2 infected patients in a Swiss university hospital: An observational retrospective study (edit) |
10.1371/JOURNAL.PONE.0240781 |
| 2020-11-13 |
Umbilical cord clamping and skin-to-skin contact in deliveries from women positive for SARS-CoV-2: a prospective observational study (edit) |
10.1111/1471-0528.16597 |
| 2020-11-13 |
Rapid SARS-CoV-2 antigen detection assay in comparison with real-time RT-PCR assay for laboratory diagnosis of COVID-19 in Thailand (edit) |
10.1186/S12985-020-01452-5 |
| 2020-11-13 |
JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality (edit) |
10.1126/SCIADV.ABE4724 |
| 2020-11-13 |
Baicalein inhibits SARS-CoV-2/VSV replication with interfering mitochondrial oxidative phosphorylation in a mPTP dependent manner (edit) |
10.1038/S41392-020-00353-X |
| 2020-11-13 |
Characterization of neutralizing antibody with prophylactic and therapeutic efficacy against SARS-CoV-2 in rhesus monkeys (edit) |
10.1038/S41467-020-19568-1 |
| 2020-11-13 |
Identification of Patient Characteristics Associated With SARS-CoV-2 Infection and Outcome in Kidney Transplant Patients Using Serological Screening (edit) |
10.1097/TP.0000000000003526 |
| 2020-11-13 |
Seroprevalence of SARS-CoV-2 in slums versus non-slums in Mumbai, India (edit) |
10.1016/S2214-109X(20)30467-8 |
| 2020-11-13 |
Clinical characteristics of 51815 patients presenting with positive and negative SARS-CoV-2 swab results in primary health care settings (edit) |
10.1016/J.JINF.2020.11.014 |
| 2020-11-13 |
SARS-CoV-2 Clinical Syndromes and Predictors of Disease Severity in Hospitalized Children and Youth (edit) |
10.1016/J.JPEDS.2020.11.016 |
| 2020-11-13 |
SARS-CoV-2 in semen: Potential for sexual transmission in COVID-19 (edit) |
10.1016/J.IJSU.2020.11.011 |
| 2020-11-13 |
Letter to the Editor in response to the articles 'Lianhuaqingwen exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2)' and 'Liu Shen capsule shows antiviral and anti-inflammatory abilities against novel coronavir (edit) |
10.1016/J.PHRS.2020.105289 |
| 2020-11-13 |
Molecular basis for a germline-biased neutralizing antibody response to SARS-CoV-2 (edit) |
10.1101/2020.11.13.381533 |
| 2020-11-13 |
Epidemiological and immunological features of obesity and SARS-CoV-2 (edit) |
10.1101/2020.11.11.20229724 |
| 2020-11-13 |
Diesel Particulate Matter 2.5 Induces Epithelial-to-Mesenchymal Transition and Upregulation of SARS-CoV-2 Receptor during Human Pluripotent Stem Cell-Derived Alveolar Organoid Development (edit) |
10.3390/IJERPH17228410 |
| 2020-11-13 |
Infections of the lung: a predictive, preventive and personalized perspective through the lens of evolution, the emergence of SARS-CoV-2 and its pathogenesis (edit) |
10.1007/S13167-020-00230-1 |
| 2020-11-13 |
Innate and adaptive immunity of murine neural stem cell-derived piRNA exosomes/microvesicles against pseudotyped SARS-CoV-2 and HIV-based lentivirus (edit) |
10.1016/J.ISCI.2020.101806 |
| 2020-11-13 |
Prevalence of anti-SARS-CoV-2 antibodies in outpatients of a large public university hospital in Sao Paulo, Brazil (edit) |
10.1590/S1678-9946202062091 |
| 2020-11-13 |
Expression of SARS-CoV-2 Entry Factors in the Pancreas of Normal Organ Donors and Individuals with COVID-19 (edit) |
10.1016/J.CMET.2020.11.005 |
| 2020-11-13 |
SARS-CoV-2 Cell Entry Factors ACE2 and TMPRSS2 Are Expressed in the Microvasculature and Ducts of Human Pancreas but Are Not Enriched in β Cells (edit) |
10.1016/J.CMET.2020.11.006 |
| 2020-11-13 |
The Human Leukocyte Antigen Class II Immunopeptidome of the SARS-CoV-2 Spike Glycoprotein (edit) |
10.1016/J.CELREP.2020.108454 |
| 2020-11-13 |
Nanozyme chemiluminescence paper test for rapid and sensitive detection of SARS-CoV-2 antigen (edit) |
10.1016/J.BIOS.2020.112817 |
| 2020-11-13 |
Konsequente Schutzmaßnahmen gegen Ansteckung: Wissenschaftliche Evidenz für die AHA-Regeln zur SARS-CoV-2 Infektionsprävention (edit) |
10.1007/S00735-020-1261-X |
| 2020-11-13 |
SARS-CoV-2 Receptor Angiotensin I-Converting Enzyme Type 2 (ACE2) Is Expressed in Human Pancreatic β-Cells and in the Human Pancreas Microvasculature (edit) |
10.3389/FENDO.2020.596898 |
| 2020-11-13 |
Lymphocyte-depleting chemotherapy for aggressive hematologic malignancies in two patients with positive SARS-CoV-2 PCR (edit) |
10.1016/J.LEUKRES.2020.106473 |
| 2020-11-13 |
[Prevalence of SARS-CoV-2 coronavirus infection in patients and professional staff at a medium or long-stay hospital in Spain] (edit) |
10.1016/J.REGG.2020.10.005 |
| 2020-11-13 |
Influenza vaccination in the time of SARS-CoV-2 (edit) |
10.1016/J.MEDCLI.2020.10.012 |
| 2020-11-13 |
SARS-CoV-2 Epitopes Are Recognized by a Public and Diverse Repertoire of Human T Cell Receptors (edit) |
10.1016/J.IMMUNI.2020.11.004 |
| 2020-11-13 |
Sexual transmission of SARS-CoV-2 virus and its role in the spread of COVID-19: A living systematic review protocol (edit) |
10.5867/MEDWAVE.2020.10.8062 |
| 2020-11-13 |
Retracted: Efficacy and Safety of Ivermectin for Treatment and prophylaxis of COVID-19 Pandemic (edit) |
10.21203/RS.3.RS-100956/V1 |
| 2020-11-12 |
A case of postpartum thyroiditis following SARS-CoV-2 infection (edit) |
10.1507/ENDOCRJ.EJ20-0553 |
| 2020-11-12 |
Long-term survival of SARS-CoV-2 on salmon as a source for international transmission (edit) |
10.1093/INFDIS/JIAA712 |
| 2020-11-12 |
Association of HLA-B22 serotype with SARS-CoV-2 susceptibility in Hong Kong Chinese patients (edit) |
10.1111/TAN.14135 |
| 2020-11-12 |
Effective optimization of SARS-CoV-2 laboratory testing variables in an era of supply chain constraints (edit) |
10.2217/FMB-2020-0094 |
| 2020-11-12 |
In-silico drug repurposing for targeting SARS-CoV-2 main protease (Mpro) (edit) |
10.1080/07391102.2020.1844058 |
| 2020-11-12 |
Reprofiling of approved drugs against SARS-CoV-2 main protease: an in-silico study (edit) |
10.1080/07391102.2020.1845976 |
| 2020-11-12 |
Human soluble ACE2 improves the effect of remdesivir in SARS-CoV-2 infection (edit) |
10.15252/EMMM.202013426 |
| 2020-11-12 |
Challenges in Testing for SARS-CoV-2 Among Patients Who Recovered From COVID-19 (edit) |
10.1001/JAMAINTERNMED.2020.7575 |
| 2020-11-12 |
Assessment of SARS-CoV-2 RNA Test Results Among Patients Who Recovered From COVID-19 With Prior Negative Results (edit) |
10.1001/JAMAINTERNMED.2020.7570 |
| 2020-11-12 |
Will vaccine hesitancy compromise our efforts to face the next SARS-CoV-2 epidemic wave? (edit) |
10.1080/21645515.2020.1829413 |
| 2020-11-12 |
Age-determined expression of priming protease TMPRSS2 and localization of SARS-CoV-2 in lung epithelium (edit) |
10.1172/JCI140766 |
| 2020-11-12 |
Superspreading events in the transmission dynamics of SARS-CoV-2: Opportunities for interventions and control (edit) |
10.1371/JOURNAL.PBIO.3000897 |
| 2020-11-12 |
SARS-CoV-2 antibody prevalence in health care workers: Preliminary report of a single center study (edit) |
10.1371/JOURNAL.PONE.0240006 |
| 2020-11-12 |
Analysis of the SARS-CoV-2 epidemic in Italy: The role of local and interventional factors in the control of the epidemic (edit) |
10.1371/JOURNAL.PONE.0242305 |
| 2020-11-12 |
Virulence and pathogenesis of SARS-CoV-2 infection in rhesus macaques: A nonhuman primate model of COVID-19 progression (edit) |
10.1371/JOURNAL.PPAT.1008949 |
| 2020-11-12 |
Susceptibility to Sars-COV-2 Infection Among Children And Adults: A Seroprevalence Study of Family Households in the Barcelona Metropolitan Region, Spain (edit) |
10.1093/CID/CIAA1721 |
| 2020-11-12 |
High-Throughput Screening of an FDA-Approved Drug Library Identifies Inhibitors against Arenaviruses and SARS-CoV-2 (edit) |
10.1021/ACSINFECDIS.0C00486 |
| 2020-11-12 |
Extraction-free methods for the detection of SARS-CoV-2 by RT-PCR: a comparison with the Cepheid Xpert Xpress SARS-CoV-2 assay across two medical centers (edit) |
10.1128/JCM.02643-20 |
| 2020-11-12 |
'Test, test, test' even after death: persistence of SARS-CoV-2 RNA in postmortem nasopharyngeal swabs (edit) |
10.1136/JCLINPATH-2020-207091 |
| 2020-11-12 |
Efficacy of pragmatic same-day ring prophylaxis for adult individuals exposed to SARS-CoV-2 in Switzerland (COPEP): protocol of an open-label cluster randomised trial (edit) |
10.1136/BMJOPEN-2020-040110 |
| 2020-11-12 |
SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo (edit) |
10.1126/SCIENCE.ABE8499 |
| 2020-11-12 |
Low SARS-CoV-2 seroprevalence in blood donors in the early COVID-19 epidemic in the Netherlands (edit) |
10.1038/S41467-020-19481-7 |
| 2020-11-12 |
Molecular targeting of vulnerable RNA sequences in SARS CoV-2: identifying clinical feasibility (edit) |
10.1038/S41434-020-00210-0 |
| 2020-11-12 |
Characterization of pre-existing and induced SARS-CoV-2-specific CD8+ T cells (edit) |
10.1038/S41591-020-01143-2 |
| 2020-11-12 |
Highlight of SARS-CoV-2 Vaccine Development against COVID-19 Pandemic (edit) |
10.1097/JCMA.0000000000000461 |
| 2020-11-12 |
Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial (edit) |
10.1016/S2213-2600(20)30511-7 |
| 2020-11-12 |
The flexibility of ACE2 in the context of SARS-CoV-2 infection (edit) |
10.1016/J.BPJ.2020.10.036 |
| 2020-11-12 |
SARS-CoV-2 detection by nasal strips: a superior tool for surveillance of pediatric population (edit) |
10.1016/J.JINF.2020.11.009 |
| 2020-11-12 |
Field evaluation of a rapid antigen test (Panbio™ COVID-19 Ag Rapid Test Device) for COVID-19 diagnosis in primary healthcare centers (edit) |
10.1016/J.CMI.2020.11.004 |
| 2020-11-12 |
Lack of SARS-CoV-2 among Grand Magal de Touba pilgrims consulting for respiratory symptoms in October 2020 (edit) |
10.1016/J.TMAID.2020.101916 |
| 2020-11-12 |
Early transmission of SARS-CoV-2 in South Africa: An epidemiological and phylogenetic report (edit) |
10.1016/J.IJID.2020.11.128 |
| 2020-11-12 |
SARS-CoV-2 Proteins Induce IFNG in Th1 Lymphocytes Generated from CD4+ Cells from Healthy, Unexposed Polish Donors (edit) |
10.3390/VACCINES8040673 |
| 2020-11-12 |
Synthesis of novel coumarin analogues: Investigation of molecular docking interaction of SARS-CoV-2 proteins with natural and synthetic coumarin analogues and their pharmacokinetics studies (edit) |
10.1016/J.SJBS.2020.11.038 |
| 2020-11-12 |
Mutations in the SARS-CoV-2 Spike RBD are responsible for stronger ACE2 binding and poor anti-SARS-CoV mAbs cross-neutralization (edit) |
10.1016/J.CSBJ.2020.11.002 |
| 2020-11-12 |
Enhanced expression of immune checkpoint receptors during SARS-CoV-2 viral infection (edit) |
10.1016/J.OMTM.2020.11.002 |
| 2020-11-12 |
Goblet Cell Hyperplasia Increases SARS-CoV-2 Infection in COPD (edit) |
10.1101/2020.11.11.379099 |
| 2020-11-12 |
Quantitative measurement of IgG to SARS-CoV-2 proteins using ImmunoCAP (edit) |
10.1101/2020.11.09.20228411 |
| 2020-11-12 |
Targeted Disassembling of SARS-CoV-2 as It Gets Ready for Cell Penetration (edit) |
10.1021/ACSMEDCHEMLETT.0C00548 |
| 2020-11-12 |
Peripheral Neuropathy as a Complication of SARS-Cov-2 (edit) |
10.7759/CUREUS.11452 |
| 2020-11-12 |
Evaluation of acridinedione analogs as potential SARS-CoV-2 main protease inhibitors and their comparison with repurposed anti-viral drugs (edit) |
10.1016/J.COMPBIOMED.2020.104117 |
| 2020-11-12 |
Survey-reported medication changes among older adults during the SARS-CoV-2 (COVID-19) pandemic (edit) |
10.1016/J.SAPHARM.2020.11.005 |
| 2020-11-12 |
SARS-CoV-2 concentrations and virus-laden aerosol size distributions in outdoor air in north and south of Italy (edit) |
10.1016/J.ENVINT.2020.106255 |
| 2020-11-12 |
Bifurcations and mutation hot-spots in SARS-CoV-2 spike protein (edit) |
10.1101/2020.11.11.378828 |
| 2020-11-12 |
ORF3a mediated-incomplete autophagy facilitates SARS-CoV-2 replication (edit) |
10.1101/2020.11.12.380709 |
| 2020-11-12 |
Multicenter registry of United States emergency department patients tested for SARS-CoV-2 (edit) |
10.1002/EMP2.12313 |
| 2020-11-12 |
Defensive Properties of Mucin Glycoproteins during Respiratory Infections-Relevance for SARS-CoV-2 (edit) |
10.1128/MBIO.02374-20 |
| 2020-11-12 |
Inhibitors of SARS-CoV-2 Entry: Current and Future Opportunities (edit) |
10.1021/ACS.JMEDCHEM.0C00502 |
| 2020-11-11 |
SARS-CoV-2 bei Rheuma: Haben es Männer schwerer? (edit) |
10.1007/S11298-020-8070-1 |
| 2020-11-11 |
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host (edit) |
10.1056/NEJMC2031364 |
| 2020-11-11 |
Comparison of clinical characteristics of patients with pandemic SARS-CoV-2-related and community-acquired pneumonias in Hungary - a pilot historical case-control study (edit) |
10.1007/S11357-020-00294-X |
| 2020-11-11 |
Interactive Molecular Dynamics in Virtual Reality Is an Effective Tool for Flexible Substrate and Inhibitor Docking to the SARS-CoV-2 Main Protease (edit) |
10.1021/ACS.JCIM.0C01030 |
| 2020-11-11 |
Dysregulation of endocytic machinery and ACE2 in small airways of smokers and COPD patients can augment their susceptibility to SARS-CoV-2 (COVID-19) infections (edit) |
10.1152/AJPLUNG.00437.2020 |
| 2020-11-11 |
Context contribution to the intermolecular recognition of human ACE2-derived peptides by SARS-CoV-2 spike protein: implications for improving the peptide affinity but not altering the peptide specificity by optimizing indirect readout (edit) |
10.1039/D0MO00103A |
| 2020-11-11 |
Computational Hot-Spot Analysis of the SARS-CoV-2 Receptor Binding Domain / ACE2 Complex (edit) |
10.1002/CBIC.202000562 |
| 2020-11-11 |
SARS-CoV-2: Influence of phosphate and magnesium, moderated by vitamin D, on energy (ATP)-metabolism and on severity of COVID-19 (edit) |
10.1152/AJPENDO.00474.2020 |
| 2020-11-11 |
Authors' Reply to: Errors in Tracing Coronavirus SARS-CoV-2 Transmission Using a Maximum Likelihood Tree. Comment on "A Snapshot of SARS-CoV-2 Genome Availability up to April 2020 and its Implications: Data Analysis" (edit) |
10.2196/24661 |
| 2020-11-11 |
Errors in Tracing Coronavirus SARS-CoV-2 Transmission Using a Maximum Likelihood Tree. Comment on "A Snapshot of SARS-CoV-2 Genome Availability up to April 2020 and its Implications: Data Analysis" (edit) |
10.2196/23542 |
| 2020-11-11 |
SARS-CoV-2 seroprevalence and antibody kinetics among health care workers in a Spanish hospital after three months of follow-up (edit) |
10.1093/INFDIS/JIAA696 |
| 2020-11-11 |
Multisystem inflammatory syndrome in children associated with SARS-CoV-2 in an 8-week old infant (edit) |
10.1093/JPIDS/PIAA137 |
| 2020-11-11 |
Molecular basis for drug repurposing to study the interface of the S protein in SARS-CoV-2 and human ACE2 through docking, characterization, and molecular dynamics for natural drug candidates (edit) |
10.1007/S00894-020-04599-8 |
| 2020-11-11 |
Characterizing and Managing Pediatric SARS-CoV-2 Infection. Learning about the Virus in a Global Classroom (edit) |
10.1111/APA.15662 |
| 2020-11-11 |
Identifying the Zoonotic Origin of SARS-CoV-2 by Modeling the Binding Affinity between the Spike Receptor-Binding Domain and Host ACE2 (edit) |
10.1021/ACS.JPROTEOME.0C00717 |
| 2020-11-11 |
Seroprevalence of SARS-CoV-2 specific IgG antibodies in District Srinagar, northern India - A cross-sectional study (edit) |
10.1371/JOURNAL.PONE.0239303 |
| 2020-11-11 |
SARS-CoV-2 in the U.S. Military - Lessons for Civil Society (edit) |
10.1056/NEJME2032179 |
| 2020-11-11 |
SARS-CoV-2 Transmission among Marine Recruits during Quarantine (edit) |
10.1056/NEJMOA2029717 |
| 2020-11-11 |
Camostat Mesylate against SARS-CoV-2 and COVID-19 - Rationale, Dosing and Safety (edit) |
10.1111/BCPT.13533 |
| 2020-11-11 |
Unexpected detection of SARS-CoV-2 antibodies in the prepandemic period in Italy (edit) |
10.1177/0300891620974755 |
| 2020-11-11 |
Pharmacophore modelling of vanillin derivatives, favipiravir, chloroquine, hydroxychloroquine, monolaurin and tetrodotoxin as MPro inhibitors of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) (edit) |
10.1186/S13104-020-05379-6 |
| 2020-11-11 |
Accuracy of UK Rapid Test Consortium (UK-RTC) "AbC-19 Rapid Test" for detection of previous SARS-CoV-2 infection in key workers: test accuracy study (edit) |
|
| 2020-11-11 |
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Kenyan blood donors (edit) |
10.1126/SCIENCE.ABE1916 |
| 2020-11-11 |
Too slow, less dough for SARS-CoV-2 tests? A Micro-Comic Strip (edit) |
10.1128/JCM.02786-20 |
| 2020-11-11 |
Immune responses to SARS-CoV-2 in three children of parents with symptomatic COVID-19 (edit) |
10.1038/S41467-020-19545-8 |
| 2020-11-11 |
Long-distance airborne dispersal of SARS-CoV-2 in COVID-19 wards (edit) |
10.1038/S41598-020-76442-2 |
| 2020-11-11 |
SARS-CoV-2 receptor is co-expressed with elements of the kinin-kallikrein, renin-angiotensin and coagulation systems in alveolar cells (edit) |
10.1038/S41598-020-76488-2 |
| 2020-11-11 |
Engineered trimeric ACE2 binds viral spike protein and locks it in "Three-up" conformation to potently inhibit SARS-CoV-2 infection (edit) |
10.1038/S41422-020-00438-W |
| 2020-11-11 |
Structure and drug binding of the SARS-CoV-2 envelope protein transmembrane domain in lipid bilayers (edit) |
10.1038/S41594-020-00536-8 |
| 2020-11-11 |
Type I IFNs: A Blessing in Disguise or Partner in Crime in MERS-CoV-, SARS-CoV-, and SARS-CoV-2-Induced Pathology and Potential Use of Type I IFNs in Synergism with IFN-γ as a Novel Antiviral Approach Against COVID-19 (edit) |
10.1089/VIM.2020.0085 |
| 2020-11-11 |
The Role of the SARS-CoV-2 Pandemic on Suicide Rates: Preliminary Study in a Sample of the Greek Population (edit) |
10.1097/PAF.0000000000000598 |
| 2020-11-11 |
Multisystem inflammatory syndrome with refractory cardiogenic shock due to acute myocarditis and mononeuritis multiplex after SARS-CoV-2 infection in an adult (edit) |
10.4414/SMW.2020.20387 |
| 2020-11-11 |
SARS-CoV-2 Seropositivity in Asymptomatic Frontline Health Workers in Ibadan, Nigeria (edit) |
10.4269/AJTMH.20-1235 |
| 2020-11-11 |
Immune responses and residual SARS-CoV-2 in two critically ill COVID-19 patients before and after lung transplantation (edit) |
10.1016/J.JINF.2020.11.006 |
| 2020-11-11 |
Detection of SARS-CoV-2 on laboratory paper request forms; a potential source of infection for laboratory personnel (edit) |
10.1016/J.JHIN.2020.11.003 |
| 2020-11-11 |
Isolation gown contamination during health care of confirmed SARS-CoV-2 infected patients (edit) |
10.1016/J.JHIN.2020.11.004 |
| 2020-11-11 |
Food Products as Potential Carriers of SARS-CoV-2 (edit) |
10.1016/J.FOODCONT.2020.107754 |
| 2020-11-11 |
The potential antiviral effect of major royal jelly protein2 and its isoform X1 against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Insight on their sialidase activity and molecular docking (edit) |
10.1016/J.JFF.2020.104282 |
| 2020-11-11 |
Chinese herbal compounds against SARS-CoV-2: puerarin and quercetin impair the binding of viral S-protein to ACE2 receptor (edit) |
10.1016/J.CSBJ.2020.11.010 |
| 2020-11-11 |
In silico and In vitro Studies Reveal Complement System Drives Coagulation Cascade in SARS-CoV-2 Pathogenesis (edit) |
10.1016/J.CSBJ.2020.11.005 |
| 2020-11-11 |
The behaviour of infection, survival and testing effort variables of SARS-CoV-2: A theoretical modelling based on optimization technique (edit) |
10.1016/J.RINP.2020.103568 |
| 2020-11-11 |
Structure-guided discovery approach identifies potential lead compounds targeting Mpro of SARS-CoV-2 (edit) |
10.1007/S13337-020-00627-6 |
| 2020-11-11 |
Engineering a Novel Subunit Vaccine against SARS-CoV-2 by Exploring Immunoformatics Approach (edit) |
10.1016/J.IMU.2020.100478 |
| 2020-11-11 |
Collateral damages in the SARS-CoV-2 pandemia- two cases (edit) |
10.1186/S42466-020-00080-2 |
| 2020-11-11 |
Acute Coronary Syndromes in the Era of SARS-CoV-2 Infection: A Registry of the French Group of Acute Cardiac Care (edit) |
10.1016/J.CJCO.2020.11.003 |
| 2020-11-11 |
Ozone exposure upregulates the expression of host susceptibility protein TMPRSS2 to SARS-CoV-2 (edit) |
10.1101/2020.11.10.377408 |
| 2020-11-11 |
Inadequate Minority Representation within SARS-CoV-2 Vaccine Trials (edit) |
10.4269/AJTMH.20-1294 |
| 2020-11-11 |
Enabling liver transplantation during the COVID-19 era: More than screening donors and recipients for SARS-CoV-2 (edit) |
10.6061/CLINICS/2020/E2377 |
| 2020-11-11 |
Diagnostic accuracy of two commercially available rapid assays for detection of IgG and IgM antibodies to SARS-CoV-2 compared to ELISA in a low-prevalence population (edit) |
10.3205/DGKH000363 |
| 2020-11-11 |
Validation of a modified CDC assay and performance comparison with the NeuMoDx™ and DiaSorin® automated assays for rapid detection of SARS-CoV-2 in respiratory specimens (edit) |
10.1016/J.JCV.2020.104688 |
| 2020-11-11 |
Can Algal Derived Bioactive Metabolites Serve as Potential Therapeutics for the Treatment of SARS-CoV-2 Like Viral Infection? (edit) |
10.3389/FMICB.2020.596374 |
| 2020-11-11 |
Testing for antibodies to SARS-CoV-2 (edit) |
10.1136/BMJ.M4288 |
| 2020-11-11 |
[SARS-CoV-2 infection in infants aged 28 days and younger. A multicentre case series] (edit) |
10.1016/J.ANPEDI.2020.10.019 |
| 2020-11-11 |
A case of area postrema variant of neuromyelitis optica spectrum disorder following SARS-CoV-2 infection (edit) |
10.1016/J.JNEUROIM.2020.577439 |
| 2020-11-11 |
Nsp1 of SARS-CoV-2 Stimulates Host Translation Termination (edit) |
10.1101/2020.11.11.377739 |
| 2020-11-11 |
Characterization and structural basis of a lethal mouse-adapted SARS-CoV-2 (edit) |
10.1101/2020.11.10.377333 |
| 2020-11-10 |
Genome-wide mapping of SARS-CoV-2 RNA structures identifies therapeutically-relevant elements (edit) |
10.1093/NAR/GKAA1053 |
| 2020-11-10 |
Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy (edit) |
10.1093/NAR/GKAA1013 |
| 2020-11-10 |
NANDA-I, NOC, and NIC linkages to SARS-CoV-2 (COVID-19): Part 2. Individual response (edit) |
10.1111/2047-3095.12307 |
| 2020-11-10 |
Airborne spread of SARS-CoV-2 while using high-flow nasal cannula oxygen therapy: myth or reality? (edit) |
10.1007/S00134-020-06314-W |
| 2020-11-10 |
Hemolytic crisis in a patient treated with eculizumab for paroxysmal nocturnal hemoglobinuria possibly triggered by SARS-CoV-2 (COVID-19): a case report (edit) |
10.1007/S00277-020-04318-6 |
| 2020-11-10 |
Rapidly Deployable Mouse Models of SARS-CoV-2 Infection Add Flexibility to the COVID-19 Toolbox (edit) |
10.1165/RCMB.2020-0456ED |
| 2020-11-10 |
Static all-atom energetic mappings of the SARS-Cov-2 spike protein and dynamic stability analysis of "Up" versus "Down" protomer states (edit) |
10.1371/JOURNAL.PONE.0241168 |
| 2020-11-10 |
Large scale genomic analysis of 3067 SARS-CoV-2 genomes reveals a clonal geo-distribution and a rich genetic variations of hotspots mutations (edit) |
10.1371/JOURNAL.PONE.0240345 |
| 2020-11-10 |
Clinical experience with SARS CoV-2 related illness in children - hospital experience in Cape Town, South Africa (edit) |
10.1093/CID/CIAA1666 |
| 2020-11-10 |
Renal transplantation during the SARS-CoV-2 pandemic in the UK: experience from a large volume centre (edit) |
10.1111/CTR.14150 |
| 2020-11-10 |
Racial and Workplace Disparities in Seroprevalence of SARS-CoV-2, Baton Rouge, Louisiana, USA (edit) |
10.3201/EID2701.203808 |
| 2020-11-10 |
Tinocordiside from Tinospora cordifolia (Giloy) May Curb SARS-CoV-2 Contagion by Disrupting the Electrostatic Interactions between Host ACE2 and Viral S-Protein Receptor Binding Domain (edit) |
10.2174/1386207323666201110152615 |
| 2020-11-10 |
Seroprevalence of SARS-CoV-2 antibodies in children: a prospective multicentre cohort study (edit) |
10.1136/ARCHDISCHILD-2020-320558 |
| 2020-11-10 |
Do proton pump inhibitors influence SARS-CoV-2 related outcomes? A meta-analysis (edit) |
10.1136/GUTJNL-2020-323366 |
| 2020-11-10 |
Transmission of SARS-CoV-2 on mink farms between humans and mink and back to humans (edit) |
10.1126/SCIENCE.ABE5901 |
| 2020-11-10 |
Differences in terms of presentation and outcomes between patients with lung cancer as opposed to other solid organ cancer after infection with SARS-CoV-2: protocol for a systematic review (edit) |
10.1136/BMJOPEN-2020-041790 |
| 2020-11-10 |
Effective Inhibition of SARS-CoV-2 Entry by Heparin and Enoxaparin Derivatives (edit) |
10.1128/JVI.01987-20 |
| 2020-11-10 |
Low-dose ruxolitinib plus steroid in severe SARS-CoV-2 pneumonia (edit) |
10.1038/S41375-020-01087-Z |
| 2020-11-10 |
Experience of SARS-CoV-2 infection in two kidney transplant recipients living with HIV-1 infection (edit) |
10.1111/TID.13500 |
| 2020-11-10 |
Computational Evidences of Phytochemical Mediated Disruption of PLpro Driven Replication of SARS-CoV-2: A Therapeutic Approach Against COVID-19 (edit) |
10.2174/1389201021999201110204116 |
| 2020-11-10 |
Fatal SARS-CoV-2 Inflammatory Syndrome and Myocarditis in an Adolescent: A Case Report (edit) |
10.1097/INF.0000000000002978 |
| 2020-11-10 |
Dried Blood Spot as an Alternative to Plasma/Serum for SARS-CoV-2 IgG Detection, an Opportunity to Be Sized to Facilitate COVID-19 Surveillance Among Schoolchildren (edit) |
10.1097/INF.0000000000002955 |
| 2020-11-10 |
Pediatric Inflammatory Multisystem Syndrome Associated With SARS-CoV-2: A Case Series Quantitative Systematic Review (edit) |
10.1097/PEC.0000000000002306 |
| 2020-11-10 |
SARS-CoV-2 Vaccines: Inactivation by Gamma Irradiation for T and B Cell Immunity (edit) |
10.3390/PATHOGENS9110928 |
| 2020-11-10 |
SARS-CoV-2 Infection and Cardioncology: From Cardiometabolic Risk Factors to Outcomes in Cancer Patients (edit) |
10.3390/CANCERS12113316 |
| 2020-11-10 |
Drug inhibition of SARS-CoV-2 replication in human pluripotent stem cell-derived intestinal organoids (edit) |
10.1016/J.JCMGH.2020.11.003 |
| 2020-11-10 |
A clade of SARS-CoV-2 viruses associated with lower viral loads in patient upper airways (edit) |
10.1016/J.EBIOM.2020.103112 |
| 2020-11-10 |
Designing of Nucleocapsid Protein Based Novel Multi-epitope Vaccine Against SARS-COV-2 Using Immunoinformatics Approach (edit) |
10.1007/S10989-020-10140-5 |
| 2020-11-10 |
Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection (edit) |
10.1101/2020.11.06.20227215 |
| 2020-11-10 |
Repurposing screens of FDA-approved drugs identify 29 inhibitors of SARS-CoV-2 (edit) |
10.4014/JMB.2009.09009 |
| 2020-11-10 |
Surveillance of wastewater revealed peaks of SARS-CoV-2 preceding those of hospitalized patients with COVID-19 (edit) |
10.1016/J.WATRES.2020.116620 |
| 2020-11-10 |
Detection of SARS-CoV-2 in wastewater in Japan during a COVID-19 outbreak (edit) |
10.1016/J.SCITOTENV.2020.143578 |
| 2020-11-10 |
The challenges of containing SARS-CoV-2 via test-trace-and-isolate (edit) |
10.1038/S41467-020-20699-8 |
| 2020-11-10 |
Baricitinib treatment resolves lower-airway macrophage inflammation and neutrophil recruitment in SARS-CoV-2-infected rhesus macaques (edit) |
10.1016/J.CELL.2020.11.007 |
| 2020-11-10 |
SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling (edit) |
10.1073/PNAS.2016650117 |
| 2020-11-10 |
Evaluation of the BioFire® COVID-19 test and Respiratory Panel 2.1 for rapid identification of SARS-CoV-2 in nasopharyngeal swab samples (edit) |
10.1016/J.DIAGMICROBIO.2020.115260 |
| 2020-11-10 |
A Pediatric Infectious Disease Perspective of SARS-CoV-2 and COVID-19 in Children (edit) |
10.1093/JPIDS/PIAA099 |
| 2020-11-09 |
Excretion of SARS-CoV-2 through faecal specimens (edit) |
10.1080/22221751.2020.1844551 |
| 2020-11-09 |
Flow-Mediated Susceptibility and Molecular Response of Cerebral Endothelia to SARS-CoV-2 Infection (edit) |
10.1161/STROKEAHA.120.032764 |
| 2020-11-09 |
Mechanic Forces Promote Brain Endothelial Activation by SARS-CoV-2 Spike Protein (edit) |
10.1161/STROKEAHA.120.033119 |
| 2020-11-09 |
Inhibition of SARS-CoV-2 in Vero cell cultures by peptide-conjugated morpholino oligomers (edit) |
10.1093/JAC/DKAA460 |
| 2020-11-09 |
Multi-epitope vaccine against SARS-CoV-2 applying immunoinformatics and molecular dynamics simulation approaches (edit) |
10.1080/07391102.2020.1844060 |
| 2020-11-09 |
ACE2: Evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities (edit) |
10.7554/ELIFE.61390 |
| 2020-11-09 |
Colorimetric reverse transcription loop-mediated isothermal amplification (RT-LAMP) as a visual diagnostic platform for the detection of the emerging coronavirus SARS-CoV-2 (edit) |
10.1039/D0AN01775B |
| 2020-11-09 |
Randomized, double-blinded and placebo-controlled phase II trial of an inactivated SARS-CoV-2 vaccine in healthy adults (edit) |
10.1093/CID/CIAA1703 |
| 2020-11-09 |
[Case report-a cornea donor with a positive SARS-CoV-2 finding] (edit) |
10.1007/S00347-020-01264-6 |
| 2020-11-09 |
Correction to: Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2 (edit) |
10.1007/S13238-020-00801-Y |
| 2020-11-09 |
Rapid adaptation and continuous performance evaluation of SARS-CoV-2 envelope gene (E-gene) real-time RT-PCR assays to support the hospital surge in test demand (edit) |
10.1002/JMV.26660 |
| 2020-11-09 |
Sars-Cov-2 in Argentina: Lockdown, Mobility, and Contagion (edit) |
10.1002/JMV.26659 |
| 2020-11-09 |
Can immunological manipulation defeat SARS-CoV-2? Why G-CSF induced neutrophil expansion is worth a clinical trial: G-CSF treatment against COVID-19 (edit) |
10.1002/BIES.202000232 |
| 2020-11-09 |
COVID-19 unfolding filariasis: The first case of SARS-CoV-2 and Wuchereria bancrofti coinfection (edit) |
10.1371/JOURNAL.PNTD.0008853 |
| 2020-11-09 |
Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection (edit) |
10.1371/JOURNAL.PONE.0240784 |
| 2020-11-09 |
Modeling the stability of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on skin, currency, and clothing (edit) |
10.1371/JOURNAL.PNTD.0008831 |
| 2020-11-09 |
Prevalence of SARS-CoV-2 among high-risk populations in Lomé (Togo) in 2020 (edit) |
10.1371/JOURNAL.PONE.0242124 |
| 2020-11-09 |
Recommendations for sample pooling on the Cepheid GeneXpert® system using the Cepheid Xpert® Xpress SARS-CoV-2 assay (edit) |
10.1371/JOURNAL.PONE.0241959 |
| 2020-11-09 |
SARS-CoV-2 and interferon blockade (edit) |
10.1186/S10020-020-00231-W |
| 2020-11-09 |
Author Correction: In vitro virucidal activity of Echinaforce®, an Echinacea purpurea preparation, against coronaviruses, including common cold coronavirus 229E and SARS-CoV-2 (edit) |
10.1186/S12985-020-01439-2 |
| 2020-11-09 |
Pooled testing for SARS-CoV-2 could provide the solution to UK's testing strategy (edit) |
10.1136/BMJ.M4312 |
| 2020-11-09 |
Secondary sclerosing cholangitis in critically ill patients: a rare disease precipitated by severe SARS-CoV-2 infection (edit) |
10.1136/BCR-2020-237984 |
| 2020-11-09 |
Covid-19 vaccines: Should we allow human challenge studies to infect healthy volunteers with SARS-CoV-2? (edit) |
10.1136/BMJ.M4258 |
| 2020-11-09 |
The outcomes of the postulated interaction between SARS-CoV-2 and the renin-angiotensin system on the clinician's attitudes toward hypertension treatment (edit) |
10.1038/S41371-020-00436-W |
| 2020-11-09 |
Preserving Bodily Integrity of Deceased Patients From the Novel SARS-CoV-2 Pandemic in West Africa (edit) |
10.1007/S11673-020-10061-4 |
| 2020-11-09 |
Granuloma annulare triggered by SARS-CoV-2 infection. The first reported case (edit) |
10.1111/1346-8138.15594 |
| 2020-11-09 |
Natural compounds as inhibitors of SARS-CoV-2 endocytosis: A promising approach against COVID-19 (edit) |
10.23750/ABM.V91I13-S.10520 |
| 2020-11-09 |
Pilot study for the evaluation of safety profile of a potential inhibitor of SARS-CoV-2 endocytosis (edit) |
10.23750/ABM.V91I13-S.10583 |
| 2020-11-09 |
A pilot study on the preventative potential of alpha-cyclodextrin and hydroxytyrosol against SARS-CoV-2 transmission (edit) |
10.23750/ABM.V91I13-S.10817 |
| 2020-11-09 |
Establishing diagnostic algorithms for SARS-CoV-2 nucleic acid testing in clinical practice (edit) |
10.1097/JCMA.0000000000000456 |
| 2020-11-09 |
Increased prevalence of myocardial injury in patients with SARS-CoV-2 viremia (edit) |
10.1016/J.AMJMED.2020.09.046 |
| 2020-11-09 |
In silico analysis of selected alkaloids against main protease (Mpro) of SARS-CoV-2 (edit) |
10.1016/J.CBI.2020.109309 |
| 2020-11-09 |
Characteristics and outcomes of neonatal SARS-CoV-2 infection in the UK: a prospective national cohort study using active surveillance (edit) |
10.1016/S2352-4642(20)30342-4 |
| 2020-11-09 |
Comparing SARS-CoV-2 and influenza A(H1N1)pdm09-infected patients requiring ECMO - a single-centre, retrospective observational cohort experience (edit) |
10.1016/J.JINF.2020.11.003 |
| 2020-11-09 |
Molecular docking simulation reveals ACE2 polymorphisms that may increase the affinity of ACE2 with the SARS-CoV-2 Spike protein (edit) |
10.1016/J.BIOCHI.2020.11.004 |
| 2020-11-09 |
Analysis of the potential impact of genomic variants in global SARS-CoV-2 genomes on molecular diagnostic assays (edit) |
10.1016/J.IJID.2020.10.086 |
| 2020-11-09 |
CD4 and CD8 Lymphocyte Counts as Surrogate Early Markers for Progression in SARS-CoV-2 Pneumonia: A Prospective Study (edit) |
10.3390/V12111277 |
| 2020-11-09 |
Epidemiological Impact of SARS-CoV-2 Vaccination: Mathematical Modeling Analyses (edit) |
10.3390/VACCINES8040668 |
| 2020-11-09 |
Peptide modelling and screening against human ACE2 and spike glycoprotein RBD of SARS-CoV-2 (edit) |
10.1007/S40203-020-00055-W |
| 2020-11-09 |
Multisystem inflammatory syndrome in children (MIS-C) during SARS-CoV-2 pandemic in Brazil: a multicenter, prospective cohort study (edit) |
10.1016/J.JPED.2020.10.008 |
| 2020-11-09 |
Does Working in a COVID-19 Receiving Health Facility Influence Seroprevalence to SARS-CoV-2? (edit) |
10.7759/CUREUS.11389 |
| 2020-11-09 |
Connecting the dots on vertical transmission of SARS-CoV-2 using protein-protein interaction network analysis - Potential roles of placental ACE2 and ENDOU (edit) |
10.1016/J.PLACENTA.2020.11.001 |
| 2020-11-09 |
Gain-of-function assay for SARS-CoV-2 M pro inhibition in living cells (edit) |
10.1101/2020.11.09.375139 |
| 2020-11-09 |
SARS-CoV-2 and COVID-19: a scientometric analysis of research output and international cooperation (edit) |
10.2196/24514 |
| 2020-11-09 |
The Secretive Liaison of Particulate Matter and SARS-CoV-2. A Hypothesis and Theory Investigation (edit) |
10.3389/FGENE.2020.579964 |
| 2020-11-09 |
SARS-CoV-2 and mitochondrial health: implications of lifestyle and ageing (edit) |
10.1186/S12979-020-00204-X |
| 2020-11-09 |
Towards Targeting the Disordered SARS-CoV-2 Nsp2 C-terminal Region: Partial Structure and Dampened Mobility Revealed by NMR Spectroscopy (edit) |
10.1101/2020.11.09.374173 |
| 2020-11-09 |
Sensitization of Non-permissive Laboratory Mice to SARS-CoV-2 with a Replication-Deficient Adenovirus Expressing Human ACE2 (edit) |
10.1016/J.XPRO.2020.100169 |
| 2020-11-09 |
Resistance of endothelial cells to SARS-CoV-2 infection in vitro (edit) |
10.1101/2020.11.08.372581 |
| 2020-11-09 |
Severe infection due to the SARS-CoV-2 coronavirus: Experience of a tertiary hospital with COVID-19 patients during the 2020 pandemic☆ Infección grave por coronavirus SARS-CoV-2: experiencia en un hospital de tercer nivel con pacientes afectados por (edit) |
|
| 2020-11-09 |
Assessing potential inhibitors of SARS-CoV-2 main protease from available drugs using free energy perturbation simulations† † Electronic supplementary information (ESI) available. See DOI: 10.1039/d0ra07352k (edit) |
|
| 2020-11-09 |
Geographic access to United States SARS-CoV-2 testing sites highlights healthcare disparities and may bias transmission estimates (edit) |
10.1093/JTM/TAAA076 |
| 2020-11-08 |
The Effect of SARS-CoV-2 Mitigation Strategies on Seasonal Respiratory Viruses: A Tale of Two Large Metropolitan Centers in the United States (edit) |
10.1093/CID/CIAA1704 |
| 2020-11-08 |
Prevalence of IgG against SARS-CoV-2 and evaluation of a rapid MEDsan IgG test in children seeking medical care (edit) |
10.1093/CID/CIAA1702 |
| 2020-11-08 |
A Cell-Based ELISA to Improve the Serological Analysis of Anti-SARS-CoV-2 IgG (edit) |
10.3390/V12111274 |
| 2020-11-08 |
The performance of the National Early Warning Score and National Early Warning Score 2 in hospitalised patients infected by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (edit) |
10.1016/J.RESUSCITATION.2020.10.039 |
| 2020-11-08 |
Casting the net wide: Universal testing of emergency admissions for SARS-CoV-2 to prevent onward transmission (edit) |
10.1016/J.JHIN.2020.11.002 |
| 2020-11-08 |
High prevalence of pre-existing serological cross-reactivity against SARS-CoV-2 in sub-Sahara Africa (edit) |
10.1016/J.IJID.2020.10.104 |
| 2020-11-08 |
Prevalence of SARS-CoV-2 in human post-mortem ocular tissues (edit) |
10.1016/J.JTOS.2020.11.002 |
| 2020-11-08 |
Clinical value of procalcitonin in critically ill patients infected by SARS-CoV-2 (edit) |
10.1016/J.AJEM.2020.11.011 |
| 2020-11-08 |
Clinical performance and sample freeze-thaw stability of the cobas®6800 SARS-CoV-2 assay for the detection of SARS-CoV-2 in oro-/nasopharyngeal swabs and lower respiratory specimens (edit) |
10.1016/J.JCV.2020.104686 |
| 2020-11-08 |
RNA 2'-O-methylation modification and its implication in COVID-19 immunity (edit) |
10.1038/S41420-020-00358-Z |
| 2020-11-07 |
Hydroxychloroquine for Prevention of SARS-CoV-2 Infection: challenges to trial conduct during the global pandemic (edit) |
10.1093/CID/CIAA1707 |
| 2020-11-07 |
Possible auto-antigens that may explain the post-infection autoimmune manifestations in COVID-19 patients displaying neurological conditions (edit) |
10.1093/INFDIS/JIAA703 |
| 2020-11-07 |
1H, 13C, and 15N backbone chemical shift assignments of coronavirus-2 non-structural protein Nsp10 (edit) |
10.1007/S12104-020-09984-1 |
| 2020-11-07 |
Assessing the effects of exposure to a SARS-CoV-2 re-positive patient in healthcare personnel (edit) |
10.1186/S13104-020-05365-Y |
| 2020-11-07 |
Interpretation of laboratory tests for prevention of the SARS-CoV-2 transmission (edit) |
10.1007/S00540-020-02872-X |
| 2020-11-07 |
Acute Respiratory Distress in Aged, SARS-CoV-2 Infected African Green Monkeys but not Rhesus Macaques (edit) |
10.1016/J.AJPATH.2020.10.016 |
| 2020-11-07 |
Cardiovascular Active Peptides of Marine Origin with ACE Inhibitory Activities: Potential Role as Anti-Hypertensive Drugs and in Prevention of SARS-CoV-2 Infection (edit) |
10.3390/IJMS21218364 |
| 2020-11-07 |
Comparative analysis of SARS-CoV-2 and its receptor ACE2 with evolutionarily related coronaviruses (edit) |
10.18632/AGING.104024 |
| 2020-11-07 |
A look at the global impact of SARS CoV-2 on orthopedic services (edit) |
10.1016/J.JCOT.2020.10.052 |
| 2020-11-07 |
Snoring and obstructive sleep apnoea as risk factors in SARS-Cov-2: can nasal CPAP during sleep reduce pneumonia risk? (edit) |
10.1007/S41105-020-00295-5 |
| 2020-11-07 |
SARS-CoV-2 and nervous system: From pathogenesis to clinical manifestation (edit) |
10.1016/J.JNEUROIM.2020.577436 |
| 2020-11-07 |
Origin and genomic characteristics of SARS-CoV-2 and its interaction with angiotensin converting enzyme type 2 receptors, focusing on the gastrointestinal tract (edit) |
10.3748/WJG.V26.I41.6335 |
| 2020-11-07 |
International comparisons of coronavirus deaths and infections should be avoided if not adjusted per capita (edit) |
10.1016/J.PUHE.2020.10.030 |
| 2020-11-06 |
A Novel Strategy for the Development of Vaccines for SARS-CoV-2 (COVID-19) and Other Viruses Using AI and Viral Shell Disorder (edit) |
10.1021/ACS.JPROTEOME.0C00672 |
| 2020-11-06 |
Molecular Basis of SARS-CoV-2 Infection and Rational Design of Potential Antiviral Agents: Modeling and Simulation Approaches (edit) |
10.1021/ACS.JPROTEOME.0C00779 |
| 2020-11-06 |
An overview of the gut side of the SARS-CoV-2 infection (edit) |
10.5217/IR.2020.00087 |
| 2020-11-06 |
Transmission of SARS-COV-2 Infections in Households - Tennessee and Wisconsin, April-September 2020 (edit) |
10.15585/MMWR.MM6944E1 |
| 2020-11-06 |
Birth and Infant Outcomes Following Laboratory-Confirmed SARS-CoV-2 Infection in Pregnancy - SET-NET, 16 Jurisdictions, March 29-October 14, 2020 (edit) |
10.15585/MMWR.MM6944E2 |
| 2020-11-06 |
Update: Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status - United States, January 22-October 3, 2020 (edit) |
10.15585/MMWR.MM6944E3 |
| 2020-11-06 |
A SARS-CoV-2 Outbreak Illustrating the Challenges in Limiting the Spread of the Virus - Hopi Tribe, May-June 2020 (edit) |
10.15585/MMWR.MM6944A5 |
| 2020-11-06 |
[Ethical considerations during health crisis: about SARS-CoV-2 coronavirus pandemic.] (edit) |
|
| 2020-11-06 |
Variable Performance in 6 Commercial SARS-CoV-2 Antibody Assays May Affect Convalescent Plasma and Seroprevalence Screening (edit) |
10.1093/AJCP/AQAA228 |
| 2020-11-06 |
Enhanced expression of ACE2 in psoriatic skin and its upregulation in keratinocytes by interferon-gamma: Implication of inflammatory milieu in skin tropism of SARS-CoV-2 (edit) |
10.1111/BJD.19670 |
| 2020-11-06 |
Saporin, a Polynucleotide-Adenosine Nucleosidase, May Be an Efficacious Therapeutic Agent for SARS-CoV-2 Infection (edit) |
10.1177/2472555220970911 |
| 2020-11-06 |
Computationally validated SARS-CoV-2 CTL and HTL Multi-Patch vaccines, designed by reverse epitomics approach, show potential to cover large ethnically distributed human population worldwide (edit) |
10.1080/07391102.2020.1838329 |
| 2020-11-06 |
SARS-CoV-2 mutations and where to find them: an in silico perspective of structural changes and antigenicity of the spike protein (edit) |
10.1080/07391102.2020.1844052 |
| 2020-11-06 |
First It Was Masks; Now Some Refuse Testing for SARS-CoV-2 (edit) |
10.1001/JAMA.2020.22003 |
| 2020-11-06 |
Long-Term Existence of SARS-CoV-2 in COVID-19 Patients: Host Immunity, Viral Virulence, and Transmissibility (edit) |
10.1007/S12250-020-00308-0 |
| 2020-11-06 |
An overview of antiviral strategies for coronavirus 2 (SARS-CoV-2) infection with special reference to antimalarial drugs chloroquine and hydroxychloroquine (edit) |
10.1111/IJCP.13825 |
| 2020-11-06 |
Risks of SARS-CoV-2 on male reproductive health and the practice of semen analysis and cryopreservation (edit) |
10.2217/FMB-2020-0114 |
| 2020-11-06 |
Outpatient Management of Oligosymptomatic Patients with respiratory infection in the era of SARS-CoV-2: Experience from rural German general practitioners (edit) |
10.1186/S12879-020-05538-X |
| 2020-11-06 |
Weak anti-SARS-CoV-2 antibody response is associated with mortality in a Swedish cohort of COVID-19 patients in critical care (edit) |
10.1186/S13054-020-03362-Y |
| 2020-11-06 |
Airborne disinfection by dry fogging efficiently inactivates SARS-CoV-2, mycobacteria and bacterial spores and shows the limits of commercial spore carriers for process control (edit) |
10.1128/AEM.02019-20 |
| 2020-11-06 |
Structure and inhibition of the SARS-CoV-2 main protease reveals strategy for developing dual inhibitors against Mpro and cathepsin L (edit) |
10.1126/SCIADV.ABE0751 |
| 2020-11-06 |
The SARS-CoV-2 conserved macrodomain is a mono-ADP-ribosylhydrolase (edit) |
10.1128/JVI.01969-20 |
| 2020-11-06 |
Mandatory preprocedure testing for SARS-CoV-2 for all-comers may not be required for resuming endoscopic services amidst the ongoing COVID-19 pandemic (edit) |
10.1136/GUTJNL-2020-323154 |
| 2020-11-06 |
Preexisting and de novo humoral immunity to SARS-CoV-2 in humans (edit) |
10.1126/SCIENCE.ABE1107 |
| 2020-11-06 |
Shelter from the cytokine storm: pitfalls and prospects in the development of SARS-CoV-2 vaccines for an elderly population (edit) |
10.1007/S00281-020-00821-0 |
| 2020-11-06 |
Humanized COVID-19 decoy antibody effectively blocks viral entry and prevents SARS-CoV-2 infection (edit) |
10.15252/EMMM.202012828 |
| 2020-11-06 |
Retrospective Post-mortem SARS-CoV-2 RT-PCR of Autopsies with COVID-19-Suggestive Pathology Supports the Absence of Lethal Community Spread in Basel, Switzerland, before February 2020 (edit) |
10.1159/000512563 |
| 2020-11-06 |
SARS-CoV-2 may not cause unilateral hypoglossal nerve palsy after a fortnight of intubation (edit) |
10.1097/PHM.0000000000001639 |
| 2020-11-06 |
Analytical performance of lateral flow immunoassay for SARS-CoV-2 exposure screening on venous and capillary blood samples (edit) |
10.1016/J.JIM.2020.112909 |
| 2020-11-06 |
Deletion in the C-terminal region of the envelope glycoprotein in some of the Indian SARS-CoV-2 genome (edit) |
10.1016/J.VIRUSRES.2020.198222 |
| 2020-11-06 |
Development of a PCR-RFLP method for detection of D614G mutation in SARS-CoV-2 (edit) |
10.1016/J.MEEGID.2020.104625 |
| 2020-11-06 |
Drugs Repurposing Using QSAR, Docking and Molecular Dynamics for Possible Inhibitors of the SARS-CoV-2 Mpro Protease (edit) |
10.3390/MOLECULES25215172 |
| 2020-11-06 |
Intestinal Barrier Function in Health and Disease-Any role of SARS-CoV-2? (edit) |
10.3390/MICROORGANISMS8111744 |
| 2020-11-06 |
Determining the relationship between SARS-CoV-2 infection, dopamine, and COVID-19 complications (edit) |
10.1016/J.JTUMED.2020.10.006 |
| 2020-11-06 |
Hyperinflammation bei SARS-CoV-2-Infektion (edit) |
10.1007/S12688-020-00385-9 |
| 2020-11-06 |
SARS-CoV-2-Verlauf bei Rheuma: Warnsignal nur für Glukokortikoide (edit) |
10.1007/S12688-020-00386-8 |
| 2020-11-06 |
High prevalence of SARS-CoV-2 antibodies in care homes affected by COVID-19: Prospective cohort study, England (edit) |
10.1016/J.ECLINM.2020.100597 |
| 2020-11-06 |
Differing impacts of global and regional responses on SARS-CoV-2 transmission cluster dynamics (edit) |
10.1101/2020.11.06.370999 |
| 2020-11-06 |
SARS-CoV-2. Long Distance Airborne Transmission and its Public Health Implications (edit) |
10.6061/CLINICS/2020/E2343 |
| 2020-11-06 |
Pattern of SARS-CoV-2 infection among dependant elderly residents living in long-term care facilities in Marseille, France, March-June 2020 (edit) |
10.1016/J.IJANTIMICAG.2020.106219 |
| 2020-11-06 |
Evolution patterns of SARS-CoV-2: Snapshot on its genome variants (edit) |
10.1016/J.BBRC.2020.10.102 |
| 2020-11-06 |
Tuning Proton Transfer Thermodynamics in SARS-Cov-2 Main Protease: Implications for Catalysis and Inhibitor Design (edit) |
10.26434/CHEMRXIV.13200227 |
| 2020-11-06 |
SARS-CoV-2 Aiming for the Heart: A Multicenter Italian Perspective About Cardiovascular Issues in COVID-19 (edit) |
10.3389/FPHYS.2020.571367 |
| 2020-11-06 |
Recent Advances in Pathophysiology, Drug Development and Future Perspectives of SARS-CoV-2 (edit) |
10.3389/FCELL.2020.580202 |
| 2020-11-06 |
Bovine Interferon Lambda Is a Potent Antiviral Against SARS-CoV-2 Infection in vitro (edit) |
10.3389/FVETS.2020.603622 |
| 2020-11-06 |
New evidences that discard the possible vertical transmission of SARS-CoV-2 during pregnancy (edit) |
10.1016/J.MEDCLI.2020.09.021 |
| 2020-11-06 |
Nutritional therapy for patients with coronavirus disease 2019 (COVID-19): Practical protocol from a single center highly affected by an outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (edit) |
10.1016/J.NUT.2020.111048 |
| 2020-11-06 |
Long-Term Modeling of SARS-CoV-2 Infection of Cultured Polarized Human Airway Epithelium (edit) |
10.1128/MBIO.02852-20 |
| 2020-11-06 |
Wastewater Analysis of SARS-CoV-2 as a Predictive Metric of Positivity Rate for a Major Metropolis (edit) |
10.1101/2020.11.04.20226191 |
| 2020-11-06 |
SARS-CoV-2 encoded proteome and human genetics: from interaction-based to ribosomal biology impact on disease and risk processes (edit) |
10.1021/ACS.JPROTEOME.0C00421 |
| 2020-11-05 |
Shock and Myocardial Injury in Children With Multisystem Inflammatory Syndrome Associated With SARS-CoV-2 Infection: What We Know. Case Series and Review of the Literature (edit) |
10.1177/0885066620969350 |
| 2020-11-05 |
SARS-CoV-2 Mpro inhibitors: identification of anti-SARS-CoV-2 Mpro compounds from FDA approved drugs (edit) |
10.1080/07391102.2020.1842807 |
| 2020-11-05 |
Traditional medicinal plants against replication, maturation and transmission targets of SARS-CoV-2: computational investigation (edit) |
10.1080/07391102.2020.1842246 |
| 2020-11-05 |
SARS-CoV-2 and inflammatory responses: from mechanisms to the potential therapeutic use of intravenous immunoglobulin (edit) |
10.1002/JMV.26651 |
| 2020-11-05 |
Mitochondrial metabolic manipulation by SARS-CoV-2 in peripheral blood mononuclear cells of COVID-19 patients (edit) |
10.1152/AJPCELL.00426.2020 |
| 2020-11-05 |
Lysine 164 is critical for SARS-CoV-2 Nsp1 inhibition of host gene expression (edit) |
10.1099/JGV.0.001513 |
| 2020-11-05 |
ACE2 and SARS-CoV-2 - tissue or plasma, good or bad? (edit) |
10.1093/AJH/HPAA175 |
| 2020-11-05 |
Air and surface measurements of SARS-CoV-2 inside a bus during normal operation (edit) |
10.1371/JOURNAL.PONE.0235943 |
| 2020-11-05 |
Variant analysis of 1,040 SARS-CoV-2 genomes (edit) |
10.1371/JOURNAL.PONE.0241535 |
| 2020-11-05 |
Scientific quality of COVID-19 and SARS CoV-2 publications in the highest impact medical journals during the early phase of the pandemic: A case control study (edit) |
10.1371/JOURNAL.PONE.0241826 |
| 2020-11-05 |
Analytical and Clinical Analysis of Two Automated Anti-SARS-CoV-2 Immunoassays in Pre-pandemic and Pandemic Patient Populations (edit) |
10.1093/JALM/JFAA204 |
| 2020-11-05 |
Effects of SARS-CoV-2 Infection on Male Sex-related Hormones in Recovering Patients (edit) |
10.1111/ANDR.12942 |
| 2020-11-05 |
The wide spectrum of Kawasaki-like disease associated with SARS-CoV-2 infection (edit) |
10.1080/1744666X.2021.1847643 |
| 2020-11-05 |
Coronavirus Pandemic - SARS-CoV-2 in Orthopedics and Trauma Surgery (edit) |
10.1055/A-1208-0182 |
| 2020-11-05 |
Rapid improvement of a critically ill obstetric patient with SARS-CoV-2 infection after administration of convalescent plasma (edit) |
10.1002/IJGO.13467 |
| 2020-11-05 |
Highlights in the fight against COVID-19: does autophagy play a role in SARS-CoV-2 infection? (edit) |
10.1080/15548627.2020.1844940 |
| 2020-11-05 |
SARS-CoV-2 Related Encephalitis: MRI Pattern of the Olfactory Tract Involvement (edit) |
10.1212/WNL.0000000000011150 |
| 2020-11-05 |
An ultrapotent synthetic nanobody neutralizes SARS-CoV-2 by stabilizing inactive Spike (edit) |
10.1126/SCIENCE.ABE3255 |
| 2020-11-05 |
De novo design of potent and resilient hACE2 decoys to neutralize SARS-CoV-2 (edit) |
10.1126/SCIENCE.ABE0075 |
| 2020-11-05 |
Versatile and multivalent nanobodies efficiently neutralize SARS-CoV-2 (edit) |
10.1126/SCIENCE.ABE4747 |
| 2020-11-05 |
Design of a highly thermotolerant, immunogenic SARS-CoV-2 spike fragment (edit) |
10.1074/JBC.RA120.016284 |
| 2020-11-05 |
Effective screening of SARS-CoV-2 neutralizing antibodies in patient serum using lentivirus particles pseudotyped with SARS-CoV-2 spike glycoprotein (edit) |
10.1038/S41598-020-76135-W |
| 2020-11-05 |
Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum (edit) |
10.1038/S41590-020-00826-9 |
| 2020-11-05 |
The provision of neuro-oncology and glioma neurosurgery during the SARS-CoV-2 pandemic: a single national tertiary centre experience (edit) |
10.1007/S11845-020-02429-7 |
| 2020-11-05 |
Computational drug re-purposing targeting the spike glycoprotein of SARS-CoV-2 as an effective strategy to neutralize COVID-19 (edit) |
10.1016/J.EJPHAR.2020.173720 |
| 2020-11-05 |
Trends of mutation accumulation across global SARS-CoV-2 genomes: Implications for the evolution of the novel coronavirus (edit) |
10.1016/J.YGENO.2020.11.003 |
| 2020-11-05 |
SARS-CoV-2 infection: the environmental endurance of the virus can be influenced by the increase of temperature (edit) |
10.1016/J.CMI.2020.10.034 |
| 2020-11-05 |
Reactivation of Elective Surgery During SARS-CoV-2 Pandemic: Pediatric Medically Necessary Time-Sensitive Score Implementation at a High-Complexity Pediatric Hospital (edit) |
10.1016/J.JAMCOLLSURG.2020.10.015 |
| 2020-11-05 |
The first 6 months of HIV-SARS-CoV-2 coinfection: outcomes for 6947 individuals (edit) |
10.1097/COH.0000000000000654 |
| 2020-11-05 |
Development and validation of a simple and rapid UHPLC-MS/MS method for the quantification of hydroxychloroquine in plasma and blood samples in the emergency context of SARS-CoV-2 pandemic (edit) |
10.1097/FTD.0000000000000836 |
| 2020-11-05 |
SARS-CoV-2 Infection in Cancer Patients: Effects on Disease Outcomes and Patient Prognosis (edit) |
10.3390/CANCERS12113266 |
| 2020-11-05 |
Development of Diagnostic Tests for Detection of SARS-CoV-2 (edit) |
10.3390/DIAGNOSTICS10110905 |
| 2020-11-05 |
Seroprevalence of SARS-CoV-2 IgG Antibodies in Corsica (France), April and June 2020 (edit) |
10.3390/JCM9113569 |
| 2020-11-05 |
Clinical features of critically ill patients infected with SARS-CoV-2 outside Wuhan with and without diabetes (edit) |
10.1007/S13410-020-00888-3 |
| 2020-11-05 |
Coagulopathies in novel coronavirus (SARS-CoV-2) pandemic: emerging evidence for hematologists (edit) |
10.1016/J.SJBS.2020.11.006 |
| 2020-11-05 |
SARS-CoV-2 associated COVID-19 in Geriatric Population: A Brief Narrative Review (edit) |
10.1016/J.SJBS.2020.11.001 |
| 2020-11-05 |
Synergy of melanin and vitamin-D may play a fundamental role in preventing SARS-CoV-2 infections and halt COVID-19 by inactivating furin protease (edit) |
10.1186/S41231-020-00073-Y |
| 2020-11-05 |
Modeling aerosol transmission of SARS-CoV-2 in multi-room facility (edit) |
10.1016/J.JLP.2020.104336 |
| 2020-11-05 |
Field grand challenge with emerging superbugs and the novel coronavirus (SARS-CoV-2) on plastics and in water (edit) |
10.1016/J.JECE.2020.104721 |
| 2020-11-05 |
New putative animal reservoirs of SARS-CoV-2 in Italian fauna: a bioinformatic approach (edit) |
10.1016/J.HELIYON.2020.E05430 |
| 2020-11-05 |
The translational landscape of SARS-CoV-2 and infected cells (edit) |
10.1101/2020.11.03.367516 |
| 2020-11-05 |
SARS-CoV-2 RBD219-N1C1: A Yeast-Expressed SARS-CoV-2 Recombinant Receptor-Binding Domain Candidate Vaccine Stimulates Virus Neutralizing Antibodies and T-cell Immunity in Mice (edit) |
10.1101/2020.11.04.367359 |
| 2020-11-05 |
Intranasal fusion inhibitory lipopeptide prevents direct contact SARS-CoV-2 transmission in ferrets (edit) |
10.1101/2020.11.04.361154 |
| 2020-11-05 |
Evolution of Antibody Immunity to SARS-CoV-2 (edit) |
10.1101/2020.11.03.367391 |
| 2020-11-05 |
SARS-CoV-2 Assembly and Egress Pathway Revealed by Correlative Multi-modal Multi-scale Cryo-imaging (edit) |
10.1101/2020.11.05.370239 |
| 2020-11-05 |
SARS-CoV-2 Infects Human Engineered Heart Tissues and Models COVID-19 Myocarditis (edit) |
10.1101/2020.11.04.364315 |
| 2020-11-05 |
A city cluster risk-based approach for Sars-CoV-2 and isolation barriers based on anonymized mobile phone users' location data (edit) |
10.1016/J.SCS.2020.102574 |
| 2020-11-05 |
SARS-CoV-2 cell receptor gene ACE2 -mediated immunomodulation in breast cancer subtypes (edit) |
10.1016/J.BBREP.2020.100844 |
| 2020-11-05 |
Robustness analysis in an inter-cities mobility network: modeling municipal, state and federal initiatives as failures and attacks toward SARS-CoV-2 containment (edit) |
10.7717/PEERJ.10287 |
| 2020-11-05 |
Haemodynamic impact of positive end-expiratory pressure in SARS-CoV-2 acute respiratory distress syndrome: oxygenation versus oxygen delivery (edit) |
10.1016/J.BJA.2020.10.026 |
| 2020-11-05 |
Acute Seizures Occurring in Association With SARS-CoV-2 (edit) |
10.3389/FNEUR.2020.576329 |
| 2020-11-05 |
SARS-CoV-2 attachment to host cells is possibly mediated via RGD-integrin interaction in a calcium-dependent manner and suggests pulmonary EDTA chelation therapy as a novel treatment for COVID 19 (edit) |
10.1016/J.IMBIO.2020.152021 |
| 2020-11-05 |
Potential CD8+ T Cell Cross-Reactivity Against SARS-CoV-2 Conferred by Other Coronavirus Strains (edit) |
10.3389/FIMMU.2020.579480 |
| 2020-11-05 |
Supporting SARS-CoV-2 Papain-Like Protease Drug Discovery: In silico Methods and Benchmarking (edit) |
10.3389/FCHEM.2020.592289 |
| 2020-11-05 |
The Short- and Long-Range RNA-RNA Interactome of SARS-CoV-2 (edit) |
10.1016/J.MOLCEL.2020.11.004 |
| 2020-11-05 |
Viral pandemics and oral health: Lessons learned from HIV to SARS-CoV-2 (edit) |
10.1016/J.OOOO.2020.10.022 |
| 2020-11-05 |
Screening and Testing Pregnant Patients for SARS-CoV-2: First-Wave Experience of a Designated COVID-19 Hospitalization Centre in Montreal (edit) |
10.1016/J.JOGC.2020.11.001 |
| 2020-11-05 |
Conservation analysis of SARS-CoV-2 spike suggests complicated viral adaptation history from bat to human (edit) |
10.1093/EMPH/EOAA041 |
| 2020-11-05 |
The N-terminal domain of spike glycoprotein mediates SARS-CoV-2 infection by associating with L-SIGN and DC-SIGN (edit) |
10.1101/2020.11.05.369264 |
| 2020-11-05 |
Impact of Sickle Cell Trait on Morbidity and Mortality from Sars-Cov-2 Infection (edit) |
10.1182/BLOOD-2020-142835 |
| 2020-11-05 |
Molecular effects and retinopathy induced by hydroxychloroquine during SARS-CoV-2 therapy: Role of CYP450 isoforms and epigenetic modulations (edit) |
10.1016/J.EJPHAR.2020.173454 |
| 2020-11-04 |
Identification of natural inhibitors against Mpro of SARS-CoV-2 by molecular docking, molecular dynamics simulation, and MM/PBSA methods (edit) |
10.1080/07391102.2020.1842806 |
| 2020-11-04 |
Beyond R0: heterogeneity in secondary infections and probabilistic epidemic forecasting (edit) |
10.1098/RSIF.2020.0393 |
| 2020-11-04 |
At what times during infection is SARS-CoV-2 detectable and no longer detectable using RT-PCR-based tests? A systematic review of individual participant data (edit) |
10.1186/S12916-020-01810-8 |
| 2020-11-04 |
Clinical characteristics and persistence of SARS-CoV-2 IgG antibodies in 4607 French healthcare workers: comparison with European countries (edit) |
10.1017/ICE.2020.1309 |
| 2020-11-04 |
SARS-CoV-2 in first trimester pregnancy: a cohort study (edit) |
10.1093/HUMREP/DEAA311 |
| 2020-11-04 |
Pathway enrichment analysis of virus-host interactome and prioritization of novel compounds targeting the spike glycoprotein receptor binding domain-human angiotensin-converting enzyme 2 interface to combat SARS-CoV-2 (edit) |
10.1080/07391102.2020.1841681 |
| 2020-11-04 |
Modelling the spread of SARS-CoV-2 pandemic - Impact of lockdowns & interventions (edit) |
|
| 2020-11-04 |
Performance evaluation of Truenat™ Beta CoV & Truenat™ SARS-CoV-2 point-of-care assays for coronavirus disease 2019 (edit) |
|
| 2020-11-04 |
CT and clinical assessment in asymptomatic and pre-symptomatic patients with early SARS-CoV-2 in outbreak settings (edit) |
10.1007/S00330-020-07401-8 |
| 2020-11-04 |
Comparison of Clinical and Epidemiological Characteristics of Asymptomatic and Symptomatic SARS-CoV-2 Infection in Children (edit) |
10.1007/S12250-020-00312-4 |
| 2020-11-04 |
Evaluation of uro-oncological surgical treatment during the Sars-CoV-2 pandemic in a Brazilian tertiary oncology institution, the new world epicenter (edit) |
10.1590/S1677-5538.IBJU.2020.0479 |
| 2020-11-04 |
Seeding Brain Protein Aggregation by SARS-CoV-2 as a Possible Long-Term Complication of COVID-19 Infection (edit) |
10.1021/ACSCHEMNEURO.0C00676 |
| 2020-11-04 |
Boosting test-efficiency by pooled testing for SARS-CoV-2-Formula for optimal pool size (edit) |
10.1371/JOURNAL.PONE.0240652 |
| 2020-11-04 |
Public perceptions of the effectiveness of recommended non-pharmaceutical intervention behaviors to mitigate the spread of SARS-CoV-2 (edit) |
10.1371/JOURNAL.PONE.0241662 |
| 2020-11-04 |
Lack of antibodies to SARS-CoV-2 in a large cohort of previously infected persons (edit) |
10.1093/CID/CIAA1685 |
| 2020-11-04 |
Early Spread of SARS-CoV-2 in the Icelandic Population (edit) |
10.1056/NEJMC2027653 |
| 2020-11-04 |
Early Spread of SARS-CoV-2 in the Icelandic Population. Reply (edit) |
10.1056/NEJMC2027653 |
| 2020-11-04 |
SARS-CoV-2 in the bile of a patient with COVID-19-associated gallbladder disease (edit) |
10.1055/A-1290-7446 |
| 2020-11-04 |
SARS-CoV-2 Cysteine-like Protease Antibodies Can Be Detected in Serum and Saliva of COVID-19-Seropositive Individuals (edit) |
10.4049/JIMMUNOL.2000842 |
| 2020-11-04 |
Effects of temperature, humidity, air quality and anthropic activities on the transmission of SARS-CoV-2: a systematic review protocol (edit) |
10.1136/BMJOPEN-2020-039623 |
| 2020-11-04 |
Electric field-driven microfluidics for rapid CRISPR-based diagnostics and its application to detection of SARS-CoV-2 (edit) |
10.1073/PNAS.2010254117 |
| 2020-11-04 |
Selection, biophysical and structural analysis of synthetic nanobodies that effectively neutralize SARS-CoV-2 (edit) |
10.1038/S41467-020-19204-Y |
| 2020-11-04 |
Optimized and scalable synthesis of magnetic nanoparticles for RNA extraction in response to developing countries' needs in the detection and control of SARS-CoV-2 (edit) |
10.1038/S41598-020-75798-9 |
| 2020-11-04 |
Epitope similarity cannot explain the pre-formed T cell immunity towards structural SARS-CoV-2 proteins (edit) |
10.1038/S41598-020-75972-Z |
| 2020-11-04 |
Novel device to prevent droplets in bronchoscopy during the SARS-CoV-2 pandemic (edit) |
10.1111/1759-7714.13729 |
| 2020-11-04 |
No Detection of SARS-CoV-2 from Urine, Expressed Prostatic Secretions and Semen in 74 Recovered COVID-19 Male Patients: A Perspective and Urogenital Evaluation (edit) |
10.1111/ANDR.12939 |
| 2020-11-04 |
A Risk Model of Admitting Patients with Silent SARS-CoV-2 Infection to Surgery and Development of Severe Postoperative Outcomes and Death: Projections Over 24 Months for 5 Geographical Regions (edit) |
10.1097/SLA.0000000000004583 |
| 2020-11-04 |
Threading the Pieces Together: Integrative Perspective on SARS-CoV-2 (edit) |
10.3390/PATHOGENS9110912 |
| 2020-11-04 |
Rapid High-Yield Production of Functional SARS-CoV-2 Receptor Binding Domain by Viral and Non-Viral Transient Expression for Pre-Clinical Evaluation (edit) |
10.3390/VACCINES8040654 |
| 2020-11-04 |
Coevolution, Dynamics and Allostery Conspire in Shaping Cooperative Binding and Signal Transmission of the SARS-CoV-2 Spike Protein with Human Angiotensin-Converting Enzyme 2 (edit) |
10.3390/IJMS21218268 |
| 2020-11-04 |
Challenges in creating herd immunity to SARS-CoV-2 infection by mass vaccination (edit) |
10.1016/S0140-6736(20)32318-7 |
| 2020-11-04 |
Differences of SARS-CoV-2 serological test performance between hospitalized and outpatient COVID-19 cases (edit) |
10.1016/J.CCA.2020.10.035 |
| 2020-11-04 |
Digital PCR is a sensitive new technique for SARS-CoV-2 detection in clinical applications (edit) |
10.1016/J.CCA.2020.10.032 |
| 2020-11-04 |
If skin is a potential host of SARS-CoV-2, IL-17 antibody could reduce the risk of COVID-19 (edit) |
10.1016/J.JAAD.2020.10.084 |
| 2020-11-04 |
Seropositivity and risk factors for SARS-CoV-2 infection in staff working in care homes during the COVID-19 pandemic (edit) |
10.1016/J.JINF.2020.10.035 |
| 2020-11-04 |
SARS-CoV-2: Comparative analysis of different RNA extraction methods (edit) |
10.1016/J.JVIROMET.2020.114008 |
| 2020-11-04 |
Discovery of cyclic sulfonamide derivatives as potent inhibitors of SARS-CoV-2 (edit) |
10.1016/J.BMCL.2020.127667 |
| 2020-11-04 |
Saliva collected in universal transport media is an effective, simple and high-volume amenable method to detect SARS-CoV-2 (edit) |
10.1016/J.CMI.2020.10.035 |
| 2020-11-04 |
Giardiasis reactivation during severe SARS-CoV-2 infection (edit) |
10.1016/J.PARINT.2020.102241 |
| 2020-11-04 |
Viral Kinetics of SARS-CoV-2 over the preclinical, clinical, and postclinical period (edit) |
10.1016/J.IJID.2020.10.099 |
| 2020-11-04 |
Letter to the Editor in response to the article 'Candidate drugs against SARS-CoV-2 and COVID-19' (edit) |
10.1016/J.PHRS.2020.105285 |
| 2020-11-04 |
Analytical and clinical performances of five immunoassays for the detection of SARS-CoV-2 antibodies in comparison with neutralization activity (edit) |
10.1016/J.EBIOM.2020.103101 |
| 2020-11-04 |
SARS-CoV-2 antibody-based SURVEILLANCE: New light in the SHADOW (edit) |
10.1016/J.EBIOM.2020.103087 |
| 2020-11-04 |
High prevalence of SARS-CoV-2 antibodies in pets from COVID-19+ households (edit) |
10.1016/J.ONEHLT.2020.100192 |
| 2020-11-04 |
Comparative sensitivity of different respiratory specimen types for molecular diagnosis and monitoring of SARS-CoV-2 shedding in COVID-19 patients (edit) |
10.1016/J.XINN.2020.100061 |
| 2020-11-04 |
Is Guillain Barre syndrome truly caused by SARS-CoV-2? (edit) |
10.1016/J.AJEM.2020.11.002 |
| 2020-11-04 |
Sex differences in viral entry protein expression, host responses to SARS-CoV-2, and in vitro responses to sex steroid hormone treatment in COVID-19 (edit) |
10.21203/RS.3.RS-100914/V1 |
| 2020-11-04 |
Zinc-embedded fabrics inactivate SARS-CoV-2 and influenza A virus (edit) |
10.1101/2020.11.02.365833 |
| 2020-11-04 |
SARS-CoV-2 Innate Effector Associations and Viral Load in Early Nasopharyngeal Infection (edit) |
10.1101/2020.10.30.20223545 |
| 2020-11-04 |
Rapid SARS-CoV-2 Detection by Carbon Nanotube-Based Near-Infrared Nanosensors (edit) |
10.1101/2020.11.02.20223404 |
| 2020-11-04 |
Profiling SARS-CoV-2 mutation fingerprints that range from the viral pangenome to individual infection quasispecies (edit) |
10.1101/2020.11.02.20224816 |
| 2020-11-04 |
Performance characteristics of a rapid SARS-CoV-2 antigen detection assay at a public plaza testing site in San Francisco (edit) |
10.1101/2020.11.02.20223891 |
| 2020-11-04 |
SARS-CoV-2 Testing Disparities in Massachusetts (edit) |
10.1101/2020.11.02.20224469 |
| 2020-11-04 |
Multiple Expression Assessments of ACE2 and TMPRSS2 SARS-CoV-2 Entry Molecules in the Urinary Tract and Their Associations with Clinical Manifestations of COVID-19 (edit) |
10.2147/IDR.S270543 |
| 2020-11-04 |
The global impact of SARS-CoV-2 in 181 people with cystic fibrosis (edit) |
10.1016/J.JCF.2020.10.003 |
| 2020-11-04 |
Duration of anti-SARS-CoV-2 antibodies much shorter in India (edit) |
10.1016/J.VACCINE.2020.10.094 |
| 2020-11-04 |
Genetic analysis of SARS-CoV-2 isolates collected from Bangladesh: Insights into the origin, mutational spectrum and possible pathomechanism (edit) |
10.1016/J.COMPBIOLCHEM.2020.107413 |
| 2020-11-04 |
Case Study: Prolonged Infectious SARS-CoV-2 Shedding from an Asymptomatic Immunocompromised Individual with Cancer (edit) |
10.1016/J.CELL.2020.10.049 |
| 2020-11-04 |
Combinations of PCR and Isothermal Amplification Techniques Are Suitable for Fast and Sensitive Detection of SARS-CoV-2 Viral RNA (edit) |
10.3389/FBIOE.2020.604793 |
| 2020-11-04 |
Psychological Health Issues Subsequent to SARS-Cov 2 Restrictive Measures: The Role of Parental Bonding and Attachment Style (edit) |
10.3389/FPSYT.2020.589444 |
| 2020-11-04 |
Heparan sulfate assists SARS-CoV-2 in cell entry and can be targeted by approved drugs in vitro (edit) |
10.1038/S41421-020-00222-5 |
| 2020-11-04 |
Early COVID-19 Therapy with Azithromycin Plus Nitazoxanide, Ivermectin or Hydroxychloroquine in Outpatient Settings Significantly Reduced Symptoms Compared to Known Outcomes in Untreated Patients (edit) |
10.1101/2020.10.31.20223883 |
| 2020-11-04 |
Bioinformatics analyses of significant genes, related pathways, and candidate diagnostic biomarkers and molecular targets in SARS-CoV-2/COVID-19 (edit) |
10.1016/J.GENREP.2020.100956 |
| 2020-11-03 |
Emerging of composition variations of SARS-CoV-2 spike protein and human ACE2 contribute to the level of infection: in silico approaches (edit) |
10.1080/07391102.2020.1841032 |
| 2020-11-03 |
A 67-Year-Old Woman with Sudden Hearing Loss Associated with SARS-CoV-2 Infection (edit) |
10.12659/AJCR.927519 |
| 2020-11-03 |
The experience of the health care workers of a severely hit SARS-CoV-2 referral Hospital in Italy: incidence, clinical course and modifiable risk factors for COVID-19 infection (edit) |
10.1093/PUBMED/FDAA195 |
| 2020-11-03 |
DFT and docking studies of designed conjugates of noscapines & repurposing drugs: promising inhibitors of main protease of SARS-CoV-2 and falcipan-2 (edit) |
10.1080/07391102.2020.1841030 |
| 2020-11-03 |
Computer aided identification of potential SARS CoV-2 main protease inhibitors from diterpenoids and biflavonoids of Torreya nucifera leaves (edit) |
10.1080/07391102.2020.1841680 |
| 2020-11-03 |
Targeting SARS-CoV-2 nucleocapsid oligomerization: Insights from molecular docking and molecular dynamics simulations (edit) |
10.1080/07391102.2020.1839563 |
| 2020-11-03 |
Targeting the initiation and termination codons of SARS-CoV-2 spike protein as possible therapy against COVID-19: the role of novel harpagide 5-O-β-D-glucopyranoside from Clerodendrum volubile P Beauv. (Labiatae) (edit) |
10.1080/07391102.2020.1840439 |
| 2020-11-03 |
Structure-based lead optimization of herbal medicine rutin for inhibiting SARS-CoV-2's main protease (edit) |
10.1039/D0CP03867A |
| 2020-11-03 |
Beyond the 405 and the 5: Geographic variations and factors associated with SARS-CoV-2 positivity rates in Los Angeles County (edit) |
10.1093/CID/CIAA1692 |
| 2020-11-03 |
SARS-CoV-2 Infections Among Children in the Biospecimens from Respiratory Virus-Exposed Kids (BRAVE Kids) Study (edit) |
10.1093/CID/CIAA1693 |
| 2020-11-03 |
Sociodemographic variables as predictors of adverse outcome in SARS-CoV-2 infection: an Irish hospital experience (edit) |
10.1007/S11845-020-02407-Z |
| 2020-11-03 |
A comprehensive review on promising anti-viral therapeutic candidates identified against main protease from SARS-CoV-2 through various computational methods (edit) |
10.1186/S43141-020-00085-Z |
| 2020-11-03 |
How can science be well-ordered in times of crisis? Learning from the SARS-CoV-2 pandemic (edit) |
10.1007/S40656-020-00348-5 |
| 2020-11-03 |
Letter to the Editor: Diabetes, obesity and hypertension may promote oral SARS-CoV-2 infection- salivary soluble ACE2 perspective (edit) |
10.1111/ODI.13711 |
| 2020-11-03 |
Chilblains-like lesions and SARS-CoV-2 in children: an overview in therapeutic approach (edit) |
10.1111/DTH.14502 |
| 2020-11-03 |
Low-dose chest CT for diagnosing and assessing the extent of lung involvement of SARS-CoV-2 pneumonia using a semi quantitative score (edit) |
10.1371/JOURNAL.PONE.0241407 |
| 2020-11-03 |
Repeated cross-sectional sero-monitoring of SARS-CoV-2 in New York City (edit) |
10.1038/S41586-020-2912-6 |
| 2020-11-03 |
Environmental factors involved in SARS-CoV-2 transmission: effect and role of indoor environmental quality in the strategy for COVID-19 infection control (edit) |
10.1186/S12199-020-00904-2 |
| 2020-11-03 |
Preliminary Assessment of Acute Kidney Injury in Critically Ill Children Associated with SARS-CoV-2 Infection: A Multicenter Cross-Sectional Analysis (edit) |
10.2215/CJN.11470720 |
| 2020-11-03 |
Changes in SARS-CoV-2 Spike versus Nucleoprotein Antibody Responses Impact the Estimates of Infections in Population-Based Seroprevalence Studies (edit) |
10.1128/JVI.01828-20 |
| 2020-11-03 |
Extended storage of SARS-CoV-2 nasopharyngeal swabs does not negatively impact results of molecular-based testing across three clinical platforms (edit) |
10.1136/JCLINPATH-2020-206738 |
| 2020-11-03 |
Outsmarting SARS-CoV-2 by empowering a decoy ACE2 (edit) |
10.1038/S41392-020-00370-W |
| 2020-11-03 |
Revealing fine-scale spatiotemporal differences in SARS-CoV-2 introduction and spread (edit) |
10.1038/S41467-020-19346-Z |
| 2020-11-03 |
Pooling RT-qPCR testing for SARS-CoV-2 in 1000 individuals of healthy and infection-suspected patients (edit) |
10.1038/S41598-020-76043-Z |
| 2020-11-03 |
Favorable outcomes among neonates not separated from their symptomatic SARS-CoV-2-infected mothers (edit) |
10.1038/S41390-020-01226-3 |
| 2020-11-03 |
New-onset refractory status epilepticus (NORSE) in post SARS-CoV-2 autoimmune encephalitis: a case report (edit) |
10.1007/S10072-020-04846-Z |
| 2020-11-03 |
A comment on "Serological survey of SARS-CoV-2 for experimental, domestic, companion and wild animals excludes intermediate hosts of 35 different species of animals" (edit) |
10.1111/TBED.13910 |
| 2020-11-03 |
Impact of SARS-CoV-2 (COVID-19) on pregnancy: a systematic review and meta-analysis protocol (edit) |
10.1136/BMJOPEN-2020-039933 |
| 2020-11-03 |
Anti-SARS-Cov-2 IgA Response in Tears of COVID-19 Patients (edit) |
10.3390/BIOLOGY9110374 |
| 2020-11-03 |
A Computational Approach for Identifying Potential Phytochemicals Against Non-structural Protein 1 (Nsp1) of SARS-CoV-2 (edit) |
10.2174/1386207323999201103211106 |
| 2020-11-03 |
Significantly decreased mortality in a large cohort of COVID-19 patients transfused early with convalescent plasma containing high titer anti-SARS-CoV-2 spike protein IgG (edit) |
10.1016/J.AJPATH.2020.10.008 |
| 2020-11-03 |
Halting a SARS-CoV-2 Outbreak in a U.S. Veterans Affairs Nursing Home (edit) |
10.1016/J.AJIC.2020.10.022 |
| 2020-11-03 |
DETECTION OF SARS-CoV-2 IN AIR OF TWO HOSPITAL IN HERMOSILLO, SONORA, MÉXICO, UTILIZING A LOW-COST ENVIRONMENTAL MONITORING SYSTEM (edit) |
10.1016/J.IJID.2020.10.089 |
| 2020-11-03 |
SARS-CoV-2 spread across the Colombian-Venezuelan border (edit) |
10.1016/J.MEEGID.2020.104616 |
| 2020-11-03 |
Seroprevalence of SARS-Cov-2 in the setting of a non-dedicated COVID-19 hospital in a low CoV-2 incidence area: Implications for surgery (edit) |
10.1016/J.AMSU.2020.11.006 |
| 2020-11-03 |
NON-SARS-CoV-2 INFECTIONS AMONG PATIENTS EVALUATED FOR MIS-C ASSOCIATED WITH COVID-19 (edit) |
10.1097/INF.0000000000002977 |
| 2020-11-03 |
The SARS-CoV-2 Pandemic in Latin America: the Need for Multidisciplinary Approaches (edit) |
10.1007/S40475-020-00219-W |
| 2020-11-03 |
Using Anti-SARS-CoV-2 IgG and IgM Antibodies to Detect Outpatient Cases with Olfactory and Taste Disorders Suspected as Mild Form of COVID-19: a Retrospective Survey (edit) |
10.1007/S42399-020-00623-3 |
| 2020-11-03 |
Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production (edit) |
10.1016/J.CELL.2020.10.051 |
| 2020-11-03 |
The ACE2-binding interface of SARS-CoV-2 Spike inherently deflects immune recognition (edit) |
10.1101/2020.11.03.365270 |
| 2020-11-03 |
Structure of nonstructural protein 1 from SARS-CoV-2 (edit) |
10.1101/2020.11.03.366757 |
| 2020-11-03 |
Quantification of occupational and community risk factors for SARS-CoV-2 seropositivity among healthcare workers in a large U.S. healthcare system (edit) |
10.1101/2020.10.30.20222877 |
| 2020-11-03 |
Rapid, simplified whole blood-based multiparameter assay to quantify and phenotype SARS-CoV-2 specific T cells (edit) |
10.1101/2020.10.30.20223099 |
| 2020-11-03 |
Association between anti-interferon-alpha autoantibodies and COVID-19 in systemic lupus erythematosus (edit) |
10.1101/2020.10.29.20222000 |
| 2020-11-03 |
Numbers and phenotype of non-classical CD14dimCD16+ monocytes are predictors of adverse clinical outcome in patients with coronary artery disease and severe SARS-CoV-2 infection (edit) |
10.1093/CVR/CVAA328 |
| 2020-11-03 |
Culinary spice bioactives as potential therapeutics against SARS-CoV-2: Computational investigation (edit) |
10.1016/J.COMPBIOMED.2020.104102 |
| 2020-11-03 |
Chicken Egg Yolk Antibodies (IgYs) block the binding of multiple SARS-CoV-2 spike protein variants to human ACE2 (edit) |
10.1016/J.INTIMP.2020.107172 |
| 2020-11-03 |
Compromised Humoral Functional Evolution Tracks with SARS-CoV-2 Mortality (edit) |
10.1016/J.CELL.2020.10.052 |
| 2020-11-03 |
Integrative vectors for regulated expression of SARS-CoV-2 proteins implicated in RNA metabolism (edit) |
10.12688/WELLCOMEOPENRES.16322.1 |
| 2020-11-03 |
A Phylodynamic Workflow to Rapidly Gain Insights into the Dispersal History and Dynamics of SARS-CoV-2 Lineages (edit) |
10.1093/MOLBEV/MSAA284 |
| 2020-11-03 |
Docking Prediction of Amantadine in the Receptor Binding Domain of Spike Protein of SARS-CoV-2 (edit) |
10.1021/ACSPTSCI.0C00172 |
| 2020-11-03 |
SARS-CoV-2 Viral Load on Admission Is Associated With 30-Day Mortality (edit) |
10.1093/OFID/OFAA535 |
| 2020-11-03 |
High prevalence of SARS-CoV-2 swab positivity and increasing R number in England during October 2020: REACT-1 round 6 interim report (edit) |
10.1101/2020.10.30.20223123 |
| 2020-11-02 |
An in-silico analysis of ivermectin interaction with potential SARS-CoV-2 targets and host nuclear importin α (edit) |
10.1080/07391102.2020.1841028 |
| 2020-11-02 |
Massive dissemination of a SARS-CoV-2 Spike Y839 variant in Portugal (edit) |
10.1080/22221751.2020.1844552 |
| 2020-11-02 |
EFFECT oF STATIN THERAPY oN SARS-CoV-2 INFECTION-RELATED (edit) |
10.1093/EHJCVP/PVAA128 |
| 2020-11-02 |
Evaluation of the Truvian Easy Check COVID-19 IgM/IgG Lateral Flow Device for Rapid Anti-SARS-CoV-2 Antibody Detection (edit) |
10.1093/AJCP/AQAA221 |
| 2020-11-02 |
Characterization of Antibody Responses to SARS-CoV-2 in Convalescent COVID-19 Patients (edit) |
10.1002/JMV.26646 |
| 2020-11-02 |
Assessing the potential association between SARS-CoV-2 RNA load in the respiratory tract and COVID-19 mortality (edit) |
10.1002/JMV.26644 |
| 2020-11-02 |
Structure of the SARS-CoV-2 Nsp1/5'-Untranslated Region Complex and Implications for Potential Therapeutic Targets, a Vaccine, and Virulence (edit) |
10.1021/ACS.JPCLETT.0C02818 |
| 2020-11-02 |
Clinical progression and changes of chest CT findings among asymptomatic and pre-symptomatic patients with SARS-CoV-2 infection in Wuhan, China (edit) |
10.1080/17476348.2021.1840358 |
| 2020-11-02 |
Rapid SARS-CoV-2 testing in primary material based on a novel multiplex RT-LAMP assay (edit) |
10.1371/JOURNAL.PONE.0238612 |
| 2020-11-02 |
Performance of nucleocapsid and spike-based SARS-CoV-2 serologic assays (edit) |
10.1371/JOURNAL.PONE.0237828 |
| 2020-11-02 |
Detection of SARS-CoV-2 from raw patient samples by coupled high temperature reverse transcription and amplification (edit) |
10.1371/JOURNAL.PONE.0241740 |
| 2020-11-02 |
Age-specific mortality and immunity patterns of SARS-CoV-2 (edit) |
10.1038/S41586-020-2918-0 |
| 2020-11-02 |
Is there a link between vitamin D status, SARS-CoV-2 infection risk and COVID-19 severity? (edit) |
10.1002/CBF.3597 |
| 2020-11-02 |
SARS-CoV-2 Detection in Gingival Crevicular Fluid (edit) |
10.1177/0022034520970536 |
| 2020-11-02 |
Necessity for detection of SARS-CoV-2 RNA in multiple types of specimens for the discharge of the patients with COVID-19 (edit) |
10.1186/S12967-020-02580-W |
| 2020-11-02 |
Detection of novel coronavirus (SARS-CoV-2) RNA in peripheral blood specimens (edit) |
10.1186/S12967-020-02589-1 |
| 2020-11-02 |
Salivary and Nasal Detection of the SARS-CoV-2 Virus After Antiviral Mouthrinses (BBCovid): A structured summary of a study protocol for a randomised controlled trial (edit) |
10.1186/S13063-020-04846-6 |
| 2020-11-02 |
Comparative performance of five commercially available serologic assays to detect antibodies to SARS-CoV-2 and identify individuals with high neutralizing titers (edit) |
10.1128/JCM.02257-20 |
| 2020-11-02 |
Evaluation of a SARS-CoV-2 surrogate virus neutralization test for detection of antibody in human, canine, cat and hamster sera (edit) |
10.1128/JCM.02504-20 |
| 2020-11-02 |
A multiplex microsphere IgG assay for SARS-CoV-2 using ACE2-mediated inhibition as a surrogate for neutralization (edit) |
10.1128/JCM.02489-20 |
| 2020-11-02 |
Approach to assessment of new swabs and viral transport media for SARS-CoV-2 testing (edit) |
10.1128/JCM.01562-20 |
| 2020-11-02 |
Full genome viral sequences inform patterns of SARS-CoV-2 spread into and within Israel (edit) |
10.1038/S41467-020-19248-0 |
| 2020-11-02 |
How to establish an academic SARS-CoV-2 testing laboratory (edit) |
10.1038/S41564-020-00818-3 |
| 2020-11-02 |
Low serum neutralizing anti-SARS-CoV-2 S antibody levels in mildly affected COVID-19 convalescent patients revealed by two different detection methods (edit) |
10.1038/S41423-020-00573-9 |
| 2020-11-02 |
The SARS-CoV-2 spike protein: balancing stability and infectivity (edit) |
10.1038/S41422-020-00430-4 |
| 2020-11-02 |
Abrupt Deterioration of COVID-19 Patients and Spreading of SARS COV-2 Virions in the Lungs (edit) |
10.1007/S10439-020-02676-W |
| 2020-11-02 |
Oral vesiculobullous lesions as an early sign of COVID-19: immunohistochemical detection of SARS-CoV-2 spike protein (edit) |
10.1111/BJD.19569 |
| 2020-11-02 |
First Phylogenetic Analysis of Malian SARS-CoV-2 Sequences Provides Molecular Insights into the Genomic Diversity of the Sahel Region (edit) |
10.3390/V12111251 |
| 2020-11-02 |
Application of Humanized Zebrafish Model in the Suppression of SARS-CoV-2 Spike Protein Induced Pathology by Tri-Herbal Medicine Coronil via Cytokine Modulation (edit) |
10.3390/MOLECULES25215091 |
| 2020-11-02 |
Negative polymerase chain reaction for SARS-CoV-2 in aqueous sample of patient with confirmed SARS-CoV-2 and recurrence of herpetic stromal keratitis (edit) |
10.1097/J.JCRS.0000000000000462 |
| 2020-11-02 |
SARS-CoV-2 seroprevalence and transmission risk factors among high-risk close contacts: a retrospective cohort study (edit) |
10.1016/S1473-3099(20)30833-1 |
| 2020-11-02 |
A High-throughput Anti-SARS-CoV-2 IgG Testing Platform for COVID-19 (edit) |
10.1016/J.JVIROMET.2020.114009 |
| 2020-11-02 |
Intracranial Hemorrhage in Hospitalized SARS-CoV-2 Patients: A Case Series (edit) |
10.1016/J.JSTROKECEREBROVASDIS.2020.105428 |
| 2020-11-02 |
Estimating the cumulative rate of SARS-CoV-2 infection (edit) |
10.1016/J.ECONLET.2020.109652 |
| 2020-11-02 |
An Overview on SARS-CoV-2 (COVID-19) and Other Human Coronaviruses and Their Detection Capability via Amplification Assay, Chemical Sensing, Biosensing, Immunosensing, and Clinical Assays (edit) |
10.1007/S40820-020-00533-Y |
| 2020-11-02 |
Aptamer BC 007 - Efficient binder of spreading-crucial SARS-CoV-2 proteins (edit) |
10.1016/J.HELIYON.2020.E05421 |
| 2020-11-02 |
Role of IgM and IgA Antibodies in the Neutralization of SARS-CoV-2 (edit) |
10.1101/2020.08.18.20177303 |
| 2020-11-02 |
Prolonged shedding of SARS-CoV-2 in an elderly liver transplant patient infected by COVID-19: a case report (edit) |
10.21037/APM-20-996 |
| 2020-11-02 |
SARS-CoV-2 RNA detection and persistence in wastewater samples: An experimental network for COVID-19 environmental surveillance in Padua, Veneto Region (NE Italy) (edit) |
10.1016/J.SCITOTENV.2020.143329 |
| 2020-11-02 |
Non-SARS-CoV-2 genome sequences identified in clinical samples from COVID-19 infected patients: Evidence for co-infections (edit) |
10.7717/PEERJ.10246 |
| 2020-11-02 |
Corrigendum: Impact of Hydroxychloroquine on Antibody Responses to the SARS-CoV-2 Coronavirus (edit) |
10.3389/FIMMU.2020.615628 |
| 2020-11-02 |
Significant Correlations of SARS-CoV-2 Infection With Prevalence of Overweight/Obesity and Mean Body Mass Index in the SARS-CoV-2 Endemic Countries (edit) |
10.14740/CR1160 |
| 2020-11-02 |
SARS-CoV-2 and Risk to Food Safety (edit) |
10.3389/FNUT.2020.580551 |
| 2020-11-02 |
Acute Cerebrovascular Disorders and Vasculopathies Associated with Significant Mortality in SARS-CoV-2 Patients Admitted to The Intensive Care Unit in The New York Epicenter (edit) |
10.1016/J.JSTROKECEREBROVASDIS.2020.105429 |
| 2020-11-02 |
Ruling In and Ruling Out COVID-19: Computing SARS-CoV-2 Infection Risk From Symptoms, Imaging and Test Data (edit) |
10.2196/24478 |
| 2020-11-02 |
The SARS-CoV-2 RNA interactome (edit) |
10.1101/2020.11.02.364497 |
| 2020-11-02 |
Psychological Impact of the Pandemic on Ambulatory Cardiometabolic Patients Without Evidence of SARS-CoV-2 Infection. The CorCOVID Latam Psy Study (edit) |
10.1016/J.CPCARDIOL.2020.100737 |
| 2020-11-01 |
Role of heterocyclic compounds in SARS and SARS CoV-2 pandemic (edit) |
10.1016/J.BIOORG.2020.104315 |
| 2020-11-01 |
Cross-reactive memory T cells and herd immunity to SARS-CoV-2 (edit) |
10.1038/S41577-020-00460-4 |
| 2020-11-01 |
Effects of SARS-CoV-2 and its functional receptor ACE2 on the cardiovascular system (edit) |
10.1007/S00059-020-04989-X |
| 2020-11-01 |
Emergence and molecular mechanisms of SARS-CoV-2 and HIV to target host cells and potential therapeutics (edit) |
10.1016/J.MEEGID.2020.104583 |
| 2020-11-01 |
SARS-CoV-2 pharmacologic therapies and their safety/effectiveness according to level of evidence (edit) |
10.1016/J.AJEM.2020.08.091 |
| 2020-11-01 |
Structural Basis of SARS-CoV-2 and SARS-CoV Antibody Interactions (edit) |
10.1016/J.IT.2020.09.004 |
| 2020-11-01 |
SARS-CoV-2 vaccine development, access, and equity (edit) |
10.1084/JEM.20201288 |
| 2020-11-01 |
Developing health policies in patients presenting with SARS-CoV-2: consider tuberculosis (edit) |
10.1016/S2214-109X(20)30413-7 |
| 2020-11-01 |
Presence and Duration of Symptoms in Febrile Infants With and Without SARS-CoV-2 Infection (edit) |
10.1097/INF.0000000000002858 |
| 2020-11-01 |
Infection Prevention Precautions for Routine Anesthesia Care During the SARS-CoV-2 Pandemic (edit) |
10.1213/ANE.0000000000005169 |
| 2020-11-01 |
Webinar zur S1-Leitlinie : „Interdisziplinär abgestimmte Empfehlungen zum Personal- und Patientenschutz bei Durchführung planbarer Eingriffe zur Zeit der SARS-CoV-2-Pandemie“ (edit) |
10.1007/S00104-020-01296-3 |
| 2020-11-01 |
SARS-CoV-2 and the nose: Risks and implications for primary care (edit) |
10.31128/AJGP-05-20-5452 |
| 2020-11-01 |
In Pursuit of a SARS-CoV-2 Vaccine (edit) |
10.1053/J.JFAS.2020.09.011 |
| 2020-11-01 |
SARS-CoV-2 and COVID-19 for the ophthalmologist (edit) |
10.1111/CEO.13877 |
| 2020-11-01 |
What is the long-term clinical significance of anti-SARS-CoV-2-specific IgG? (edit) |
10.1111/IRV.12825 |
| 2020-11-01 |
Evaluation of droplet digital PCR for quantification of SARS-CoV-2 Virus in discharged COVID-19 patients (edit) |
10.18632/AGING.104020 |
| 2020-11-01 |
A case of asymptomatic SARS-CoV-2 infection followed by secondary community acquired pneumonia (edit) |
10.21037/QIMS-20-847 |
| 2020-11-01 |
Longitudinal monitoring of SARS-CoV-2 RNA on high-touch surfaces in a community setting (edit) |
10.1101/2020.10.27.20220905 |
| 2020-11-01 |
The effect of eviction moratoriums on the transmission of SARS-CoV-2 (edit) |
10.1101/2020.10.27.20220897 |
| 2020-11-01 |
Phenotypic characterization of acute headache attributed to SARS-CoV-2: An ICHD-3 validation study on 106 hospitalized patients (edit) |
10.1177/0333102420965146 |
| 2020-11-01 |
Pentraxin 3: potential prognostic role in SARS-CoV-2 patients admitted to the emergency department (edit) |
10.1016/J.JINF.2020.10.027 |
| 2020-11-01 |
HSV-1 and Zika Virus but Not SARS-CoV-2 Replicate in the Human Cornea and Are Restricted by Corneal Type III Interferon (edit) |
10.1016/J.CELREP.2020.108339 |
| 2020-11-01 |
SARS-CoV-2 convalescent plasma therapy in pediatric patient after hematopoietic stem cell transplantation (edit) |
10.1016/J.TRANSCI.2020.102983 |
| 2020-11-01 |
Interim Guidance on the Preparticipation Physical Examination for Athletes During the SARS-CoV-2 Pandemic (edit) |
10.1249/JSR.0000000000000776 |
| 2020-11-01 |
ReumaCoV Brasil Registry: a Brazilian cohort of Patients with Immuno-mediated Chronic Inflammatory Diseases Infected by SARS-CoV-2 (edit) |
10.2196/24357 |
| 2020-11-01 |
SARS CoV-2 Detection From Upper and Lower Respiratory Tract Specimens: Diagnostic and Infection Control Implications (edit) |
10.1016/J.CHEST.2020.07.061 |
| 2020-11-01 |
SARS-CoV-2 seroprevalence in Spain (edit) |
10.1016/S0140-6736(20)32273-X |
| 2020-11-01 |
SARS-CoV-2 seroprevalence in Spain - Authors' reply (edit) |
10.1016/S0140-6736(20)32266-2 |
| 2020-11-01 |
ChAdOx1 nCoV-19 vaccine for SARS-CoV-2 (edit) |
10.1016/S0140-6736(20)32271-6 |
| 2020-11-01 |
ChAdOx1 nCoV-19 vaccine for SARS-CoV-2 - Authors' reply (edit) |
10.1016/S0140-6736(20)32267-4 |
| 2020-11-01 |
How the zoonotic origins of SARS-CoV-2 ensure its survival as a human disease (edit) |
10.12968/BJCN.2020.25.11.562 |
| 2020-11-01 |
Covid-19: que sait-on de la réponse immune humorale au virus SARS-CoV-2 ? (edit) |
|
| 2020-11-01 |
Les stratégies subversives utilisées par SARS-CoV-2 pour supprimer les défenses de l’hôte (edit) |
|
| 2020-11-01 |
A high proportion of SARS-CoV-2-infected university students are asymptomatic (edit) |
|
| 2020-11-01 |
Enhancing host cell infection by SARS-CoV-2 (edit) |
10.1126/SCIENCE.ABF0732 |
| 2020-11-01 |
SARS-CoV-2 Infected Patient: from a Hematologist's Perspective (edit) |
10.4084/MJHID.2020.078 |
| 2020-11-01 |
Antibody tests have higher sensitivity at ≥15 days after symptom onset and 99% specificity for detecting SARS-CoV-2 (edit) |
10.7326/ACPJ202011170-057 |
| 2020-11-01 |
Lessons of the month: Co-infection with SARS-CoV-2 and influenza B virus in a patient with community-acquired pneumonia (edit) |
10.7861/CLINMED.2020-0598 |
| 2020-11-01 |
[Progress in possible effects of BCG vaccine on the prevention of SARS-CoV-2 infection: An update] (edit) |
|
| 2020-11-01 |
New models of care and multidimensional solutions for oncological patients in the post-acute SARS-COV-2 period: a "Second Phase" also for cancer patients (edit) |
10.26355/EURREV_202011_23639 |
| 2020-11-01 |
[Multisystem inflammatory syndrome in children after SARS-CoV-2 infection] (edit) |
|
| 2020-11-01 |
SARS-CoV-2 endgame: attitudes and predictions of Australian and New Zealand infectious diseases and microbiology specialists (edit) |
10.1111/IMJ.14985 |
| 2020-11-01 |
Prolonged Duration of Viral Shedding of SARS-CoV-2: A Case Report (edit) |
10.5811/CPCEM.2020.7.49005 |
| 2020-11-01 |
Je höher der Blutzucker, desto gefährlicher die SARS-CoV-2-Infektion : COVID-19 bei Diabetikern (edit) |
10.1007/S15006-020-4593-3 |
| 2020-11-01 |
So wird ein präventiver SARS-CoV-2-Test gehandhabt (edit) |
10.1007/S15006-020-4571-9 |
| 2020-11-01 |
Repurposing Fostamatinib to Combat SARS-CoV-2-Induced Acute Lung Injury (edit) |
10.1016/J.XCRM.2020.100145 |
| 2020-11-01 |
Conflicting evidence on vertical transmission and maternal SARS-CoV-2 infection (edit) |
10.1503/CMAJ.76892 |
| 2020-11-01 |
SARS-CoV-2 infection and neonates: a review of evidence and unresolved questions (edit) |
10.1111/PAI.13349 |
| 2020-11-01 |
Gastrointestinal involvement in children with SARS-COV-2 infection: An overview for the pediatrician (edit) |
10.1111/PAI.13373 |
| 2020-11-01 |
Serology- and PCR-based cumulative incidence of SARS-CoV-2 infection in adults in a successfully contained early hotspot (CoMoLo study), Germany, May to June 2020 (edit) |
10.2807/1560-7917.ES.2020.25.47.2001752 |
| 2020-11-01 |
Cold atmospheric plasma for SARS-CoV-2 inactivation (edit) |
10.1063/5.0031332 |
| 2020-11-01 |
Possible association between myocardial infarction with nonobstructed coronary arteries and SARS-CoV-2 infection (edit) |
10.1503/CMAJ.202106 |
| 2020-11-01 |
Characterisation and outcomes of ARDS secondary to pneumonia in patients with and without SARS-CoV-2: a single-centre experience (edit) |
10.1136/BMJRESP-2020-000731 |
| 2020-11-01 |
Mortality in patients undergoing surgery with perioperative SARS-CoV-2 infection: an Italian COVID-19 Hub point of view (edit) |
10.26355/EURREV_202011_23786 |
| 2020-11-01 |
SARS-CoV-2 systemic infection in a kidney transplant recipient: sequence analysis in clinical specimens (edit) |
10.26355/EURREV_202011_23850 |
| 2020-11-01 |
Surgical emergencies during SARS-CoV-2 pandemic lockdown: what happened? (edit) |
10.26355/EURREV_202011_23851 |
| 2020-11-01 |
Application of machine intelligence technology in the detection of vaccines and medicines for SARS-CoV-2 (edit) |
10.26355/EURREV_202011_23860 |
| 2020-11-01 |
Factors associated with revisits by patients with SARS-CoV-2 infection discharged from a hospital emergency department (edit) |
|
| 2020-11-01 |
Experience of an emergency surgery department during the pandemic caused by SARS-CoV-2 infection (edit) |
|
| 2020-11-01 |
Ozone fails to disinfect emergency vehicles contaminated with viruses similar to SARS-CoV-2 (edit) |
|
| 2020-11-01 |
Social mixing and risk exposures for SARS-CoV-2 infections in elderly persons (edit) |
10.4414/SMW.2020.20416 |
| 2020-11-01 |
The perspective of fluid flow behavior of respiratory droplets and aerosols through the facemasks in context of SARS-CoV-2 (edit) |
10.1063/5.0029767 |
| 2020-11-01 |
Hospital emergency management plan during 2019 novel coronavirus (SARS-CoV-2) pandemic in non-epidemic areas (edit) |
|
| 2020-11-01 |
Patienten mit psychischen Erkrankungen und einer SARS-CoV-2-Infektion : Vorgehen an der Klinik für Psychiatrie und Psychotherapie der LMU München (edit) |
10.1007/S15006-020-4465-X |
| 2020-11-01 |
Communication: Correlation of Point of Care SARS-CoV-2 Serological Assay with Quantitative ELISA (edit) |
|
| 2020-11-01 |
An insight into SARS-CoV-2 Membrane protein interaction with Spike, Envelope, and Nucleocapsid proteins (edit) |
10.1101/2020.10.30.363002 |
| 2020-11-01 |
Microfluidic immunoassay for detection of serological antibodies: A potential tool for rapid evaluation of immunity against SARS-CoV-2 (edit) |
10.1063/5.0031521 |
| 2020-11-01 |
Multisystem Inflammatory Syndrome of Children Related to SARS-CoV-2: A Novel Experience in Children with a Novel Virus (edit) |
10.5005/JP-JOURNALS-10071-23652 |
| 2020-11-01 |
SARS-CoV-2 Infection Presenting with Hyperglycemia and Ketosis: A Case Series of Three Diabetic Patients (edit) |
10.5005/JP-JOURNALS-10071-23595 |
| 2020-11-01 |
Quality of Ribonucleic Acid Extraction for Real-Time Reverse Transcription-PCR (rRT-PCR) of SARS-CoV-2: Importance of Internal Control Monitoring (edit) |
10.3343/ALM.2020.40.6.490 |
| 2020-11-01 |
The added value of pirfenidone to fight inflammation and fibrotic state induced by SARS-CoV-2 : Anti-inflammatory and anti-fibrotic therapy could solve the lung complications of the infection? (edit) |
10.1007/S00228-020-02947-4 |
| 2020-11-01 |
Transmission of SARS-CoV-2: an update of current literature (edit) |
10.1007/S10096-020-03961-1 |
| 2020-11-01 |
SARS-CoV2 and pregnancy: an Invisible enemy? (edit) |
10.1111/AJI.13308 |
| 2020-11-01 |
SARS-CoV-2 and the cardiovascular system (edit) |
10.1016/J.CCA.2020.07.019 |
| 2020-11-01 |
Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses (edit) |
10.1084/JEM.20201181 |
| 2020-11-01 |
AGA Institute Rapid Review and Recommendations on the Role of Pre-Procedure SARS-CoV2 Testing and Endoscopy (edit) |
10.1053/J.GASTRO.2020.07.043 |
| 2020-11-01 |
Potential link between compromised air quality and transmission of the novel corona virus (SARS-CoV-2) in affected areas (edit) |
10.1016/J.ENVRES.2020.110001 |
| 2020-11-01 |
Drugs against SARS-CoV-2: What do we know about their mode of action? (edit) |
10.1002/RMV.2143 |
| 2020-11-01 |
G-quadruplex based biosensor: A potential tool for SARS-CoV-2 detection (edit) |
10.1016/J.BIOS.2020.112494 |
| 2020-11-01 |
From SARS to SARS-CoV-2, insights on structure, pathogenicity and immunity aspects of pandemic human coronaviruses (edit) |
10.1016/J.MEEGID.2020.104502 |
| 2020-11-01 |
Therapeutic Strategies in the Development of Anti-viral Drugs and Vaccines Against SARS-CoV-2 Infection (edit) |
10.1007/S12035-020-02074-2 |
| 2020-11-01 |
Animal and translational models of SARS-CoV-2 infection and COVID-19 (edit) |
10.1038/S41385-020-00340-Z |
| 2020-11-01 |
Concise practice recommendations for the provision of andrological services and assisted reproductive technology for male infertility patients during the SARS-CoV-2 in Brazil (edit) |
10.1590/S1677-5538.IBJU.2020.06.03 |
| 2020-11-01 |
Testicular pain as an unusual presentation of COVID-19: a brief review of SARS-CoV-2 and the testis (edit) |
10.1016/J.RBMO.2020.07.017 |
| 2020-11-01 |
Neurocovid-19: A clinical neuroscience-based approach to reduce SARS-CoV-2 related mental health sequelae (edit) |
10.1016/J.JPSYCHIRES.2020.08.008 |
| 2020-11-01 |
Do we have serological evidences that chilblain-like lesions are related to SARS-CoV-2? A review of the literature (edit) |
10.1111/DTH.14229 |
| 2020-11-01 |
The interaction of SARS-CoV-2 and other coronavirus with Angiotensin Converting Enzyme 2 (ACE2) as their main receptor: therapeutic implications (edit) |
10.1161/HYPERTENSIONAHA.120.15256 |
| 2020-11-01 |
Intrinsic disorder perspective of an interplay between the renin-angiotensin-aldosterone system and SARS-CoV-2 (edit) |
10.1016/J.MEEGID.2020.104510 |
| 2020-11-01 |
The Collision of Meta-Inflammation and SARS-CoV-2 Pandemic Infection (edit) |
10.1210/ENDOCR/BQAA154 |
| 2020-11-01 |
Cutaneous Manifestations in the Context of SARS-CoV-2 Infection (COVID-19) (edit) |
10.1016/J.AD.2020.08.002 |
| 2020-11-01 |
SARS-CoV-2 infections in children and young people (edit) |
10.1016/J.CLIM.2020.108588 |
| 2020-11-01 |
A structured review of placental morphology and histopathological lesions associated with SARS-CoV-2 infection (edit) |
10.1016/J.PLACENTA.2020.08.018 |
| 2020-11-01 |
Can a metabolism-targeted therapeutic intervention successfully subjugate SARS-COV-2? A scientific rational (edit) |
10.1016/J.BIOPHA.2020.110694 |
| 2020-11-01 |
Human animal interface of SARS-CoV-2 (COVID-19) transmission: a critical appraisal of scientific evidence (edit) |
10.1007/S11259-020-09781-0 |
| 2020-11-01 |
New insight on possible vaccine development against SARS-CoV-2 (edit) |
10.1016/J.LFS.2020.118421 |
| 2020-11-01 |
Important Pharmacogenetic Information for Drugs Prescribed During the SARS-CoV-2 Infection (COVID-19) (edit) |
10.1111/CTS.12866 |
| 2020-11-01 |
SARS-CoV-2 and coagulation disorders in different organs (edit) |
10.1016/J.LFS.2020.118431 |
| 2020-11-01 |
Seroprevalence of SARS-CoV-2-specific antibodies in cancer outpatients in Madrid (Spain): A single center, prospective, cohort study and a review of available data (edit) |
10.1016/J.CTRV.2020.102102 |
| 2020-11-01 |
Druggable targets of SARS-CoV-2 and treatment opportunities for COVID-19 (edit) |
10.1016/J.BIOORG.2020.104269 |
| 2020-11-01 |
Use of Weather Variables in SARS-CoV-2 Transmission Studies (edit) |
10.1016/J.IJID.2020.09.032 |
| 2020-11-01 |
Therapeutic Options in the Treatment of SARS-CoV-2 in the Pregnant Patient (edit) |
10.1016/J.AJOGMF.2020.100224 |
| 2020-11-01 |
SARS-CoV-2 and the possible connection to ERs, ACE2, and RAGE: Focus on susceptibility factors (edit) |
10.1096/FJ.202001394RR |
| 2020-11-01 |
Hypertension and SARS-Cov-2 infection: is inflammation the missing link? (edit) |
10.1093/CVR/CVAA273 |
| 2020-11-01 |
Endocrine aspects of ACE2 regulation: RAAS, steroid hormones and SARS-CoV-2 (edit) |
10.1530/JOE-20-0260 |
| 2020-11-01 |
Overview of the current promising approaches for the development of an effective severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine (edit) |
10.1016/J.INTIMP.2020.106928 |
| 2020-11-01 |
Innate immunity during SARS-CoV-2: evasion strategies and activation trigger hypoxia and vascular damage (edit) |
10.1111/CEI.13523 |
| 2020-10-31 |
Effectiveness of the measures aimed at containing Sars-cov-2 virus spreading in work settings: a survey in companies based in the Veneto region of Italy (edit) |
10.23749/MDL.V111I5.10037 |
| 2020-10-31 |
Analysis of humoral immune responses in SARS-CoV-2 infected patients (edit) |
10.1093/INFDIS/JIAA680 |
| 2020-10-31 |
Production of Trimeric SARS-CoV-2 Spike Protein by CHO Cells for Serological COVID-19 Testing (edit) |
10.1002/BIT.27615 |
| 2020-10-31 |
Evaluation of transport media for laboratory detection of SARS-CoV-2 in upper respiratory tract swab specimens (edit) |
10.1002/JMV.26643 |
| 2020-10-31 |
A 44-Year-Old Hispanic Man with Loss of Taste and Bilateral Facial Weakness Diagnosed with Guillain-Barré Syndrome and Bell's Palsy Associated with SARS-CoV-2 Infection Treated with Intravenous Immunoglobulin (edit) |
10.12659/AJCR.927956 |
| 2020-10-31 |
Animal Models for SARS-CoV-2 research: A Comprehensive Literature Review (edit) |
10.1111/TBED.13907 |
| 2020-10-31 |
Undetectable SARS-CoV-2 in a nasopharyngeal swab but persistent viral RNA from deep lung swabs: findings from an autopsy (edit) |
10.1136/BCR-2020-237446 |
| 2020-10-31 |
A disparity in the number of studies related to COVID-19 and SARS-CoV-2 between low- and middle-income countries and high-income countries (edit) |
10.1093/INTHEALTH/IHAA088 |
| 2020-10-31 |
Indoor transmission of SARS-CoV-2 (edit) |
10.1111/INA.12766 |
| 2020-10-31 |
Diagnostic Salivary Tests for SARS-CoV-2 (edit) |
10.1177/0022034520969670 |
| 2020-10-31 |
SARS-CoV-2 IgG/IgM Rapid Test as a Diagnostic Tool in Hospitalized Patients and Healthcare Workers, at a large Teaching Hospital in northern Italy, during the 2020 COVID-19 Pandemic (edit) |
|
| 2020-10-31 |
There is a Role in Detection of SARS-CoV-2 in Conjunctiva and Tears: a comprehensive review (edit) |
|
| 2020-10-31 |
Coronavirus (SARS-CoV-2) Pandemic: Future Challenges for Dental Practitioners (edit) |
10.3390/MICROORGANISMS8111704 |
| 2020-10-31 |
In Vitro Antiviral Activity of Doxycycline against SARS-CoV-2 (edit) |
10.3390/MOLECULES25215064 |
| 2020-10-31 |
What does SARS-CoV-2 mean for global pneumonia prevention, diagnosis and treatment? (edit) |
10.1016/J.CHEST.2020.10.066 |
| 2020-10-31 |
Rates of recurrent positive SARS-CoV-2 swab results among patients attending primary care in Qatar (edit) |
10.1016/J.JINF.2020.10.029 |
| 2020-10-31 |
Intrahost non-synonymous diversity at a neutralising antibody epitope of SARS-CoV-2 spike protein N-terminal domain (edit) |
10.1016/J.CMI.2020.10.030 |
| 2020-10-31 |
Linked HIV/SARS-CoV-2 testing could reduce incidence of HIV and costs (edit) |
10.1007/S40274-020-7247-X |
| 2020-10-31 |
Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2 (edit) |
10.1016/J.CELL.2020.10.043 |
| 2020-10-31 |
Covid-Quantigene®, sur la piste du Sars-CoV-2 (edit) |
10.1016/S1773-035X(20)30280-X |
| 2020-10-31 |
Vaccin Sars-CoV-2 futur : fixer dès maintenant une stratégie opérationnelle (edit) |
10.1016/S1773-035X(20)30283-5 |
| 2020-10-31 |
Sars-CoV-2 perturbe l’exercice médical dans 9 pays sur 10 (edit) |
10.1016/S1773-035X(20)30293-8 |
| 2020-10-31 |
Brève : Infection à Sars-CoV-2 maladie professionnelle (edit) |
10.1016/S1773-035X(20)30299-9 |
| 2020-10-31 |
[Biological diagnosis of Sars-CoV-2 infection: strategies and interpretation of results] (edit) |
10.1016/S1773-035X(20)30313-0 |
| 2020-10-31 |
[Sars-CoV-2 genomic and phylodynamic analyses] (edit) |
10.1016/S1773-035X(20)30314-2 |
| 2020-10-31 |
Detection of SARS-CoV-2 in Nasal Swabs: comparison with Nasopharyngeal Swabs (edit) |
10.3855/JIDC.12942 |
| 2020-10-31 |
Cost Effectiveness of Sample Pooling to Test for SARS-CoV-2 (edit) |
10.3855/JIDC.13935 |
| 2020-10-31 |
Androgen-deprivation therapy and SARS-Cov-2 infection: the potential double-face role of testosterone (edit) |
10.1177/2042018820969019 |
| 2020-10-31 |
SARS-CoV-2 detection by fluorescence loop-mediated isothermal amplification with and without RNA extraction (edit) |
10.1016/J.JIAC.2020.10.029 |
| 2020-10-31 |
Serological diagnosis of SARS-CoV-2. Diagnostic rentability of a chemiluminescence test (edit) |
10.1016/J.EIMC.2020.10.006 |
| 2020-10-30 |
SARS-CoV-2 Exposure and Infection Among Health Care Personnel - Minnesota, March 6-July 11, 2020 (edit) |
10.15585/MMWR.MM6943A5 |
| 2020-10-30 |
Potential of Ficus microcarpa metabolites against SARS-CoV-2 main protease supported by docking studies (edit) |
10.1080/14786419.2020.1839452 |
| 2020-10-30 |
SARS-CoV-2 will continue to circulate in the human population: no worries with state-of-the-art research and dependably useful results (edit) |
10.1007/S00011-020-01417-Y |
| 2020-10-30 |
The effects of aging on host resistance and disease tolerance to SARS-CoV-2 infection (edit) |
10.1111/FEBS.15613 |
| 2020-10-30 |
Transcriptomic analysis reveals novel mechanisms of SARS-CoV-2 infection in human lung cells (edit) |
10.1002/IID3.366 |
| 2020-10-30 |
A path towards SARS-CoV-2 attenuation: metabolic pressure on CTP synthesis rules the virus evolution (edit) |
10.1093/GBE/EVAA229 |
| 2020-10-30 |
Maternal SARS-CoV-2 infection associated to systemic inflammatory response and pericardial effusion in the newborn: a Case-Report (edit) |
10.1093/JPIDS/PIAA133 |
| 2020-10-30 |
Transfusion Reactions Associated with COVID-19 Convalescent Plasma Therapy for SARS-CoV-2 (edit) |
10.1111/TRF.16177 |
| 2020-10-30 |
Validation of a SARS-CoV-2 RNA RT-PCR assay for high-throughput testing in blood of COVID-19 convalescent plasma donors and patients (edit) |
10.1111/TRF.16178 |
| 2020-10-30 |
Comparing Nasopharyngeal and Bronchoalveolar Lavage SARS-CoV-2 Assays in Respiratory Failure (edit) |
10.1164/RCCM.202008-3137LE |
| 2020-10-30 |
Modeling the load of SARS-CoV-2 virus in human expelled particles during coughing and speaking (edit) |
10.1371/JOURNAL.PONE.0241539 |
| 2020-10-30 |
Silent disease and loss of taste and smell are common manifestations of SARS-COV-2 infection in a quarantine facility: Saudi Arabia (edit) |
10.1371/JOURNAL.PONE.0241258 |
| 2020-10-30 |
On the whereabouts of SARS-CoV-2 in the human body: A systematic review (edit) |
10.1371/JOURNAL.PPAT.1009037 |
| 2020-10-30 |
Neurological manifestations of patients infected with the SARS-CoV-2: a systematic review of the literature (edit) |
10.1007/S00415-020-10285-9 |
| 2020-10-30 |
Computed tomography semi-automated lung volume quantification in SARS-CoV-2-related pneumonia (edit) |
10.1007/S00330-020-07271-0 |
| 2020-10-30 |
Profile of SARS-CoV-2 (edit) |
10.1007/S00508-020-01763-1 |
| 2020-10-30 |
Unfractionated heparin inhibits live wild-type SARS-CoV-2 cell infectivity at therapeutically relevant concentrations (edit) |
10.1111/BPH.15304 |
| 2020-10-30 |
Atorvastatin and Aspirin as Adjuvant Therapy in Patients with SARS-CoV-2 Infection: A structured summary of a study protocol for a randomised controlled trial (edit) |
10.1186/S13063-020-04840-Y |
| 2020-10-30 |
Correction to: The role of passive immunization in the age of SARS-CoV-2: an update (edit) |
10.1186/S40001-020-00449-8 |
| 2020-10-30 |
Association between SARS-CoV-2 infection, exposure risk and mental health among a cohort of essential retail workers in the USA (edit) |
10.1136/OEMED-2020-106774 |
| 2020-10-30 |
A FOUNDER EFFECT LED EARLY SARS-COV-2 TRANSMISSION IN SPAIN (edit) |
10.1128/JVI.01583-20 |
| 2020-10-30 |
Development of a SARS-CoV-2 Total Antibody Assay and the Dynamics of Antibody Response over Time in Hospitalized and Nonhospitalized Patients with COVID-19 (edit) |
10.4049/JIMMUNOL.2000767 |
| 2020-10-30 |
Highly sensitive and specific multiplex antibody assays to quantify immunoglobulins M, A and G against SARS-CoV-2 antigens (edit) |
10.1128/JCM.01731-20 |
| 2020-10-30 |
SARS-CoV-2 spike behavior in situ: a Cryo-EM images for a better understanding of the COVID-19 pandemic (edit) |
10.1038/S41392-020-00365-7 |
| 2020-10-30 |
SARS-CoV-2 spike protein: flexibility as a new target for fighting infection (edit) |
10.1038/S41392-020-00369-3 |
| 2020-10-30 |
SARS-CoV-2 viral load is associated with increased disease severity and mortality (edit) |
10.1038/S41467-020-19057-5 |
| 2020-10-30 |
Assessment of the direct quantitation of SARS-CoV-2 by droplet digital PCR (edit) |
10.1038/S41598-020-75958-X |
| 2020-10-30 |
SARS-CoV-2 in patients with chronic liver disease (edit) |
10.1038/S41575-020-00384-3 |
| 2020-10-30 |
Immunoassays for anti-SARS-CoV-2 antibodies: recent insights (edit) |
10.1016/S1473-3099(20)30846-X |
| 2020-10-30 |
Specificity and cross-reactivity of a test for anti-SARS-CoV-2 antibodies (edit) |
10.1016/S1473-3099(20)30787-8 |
| 2020-10-30 |
Specificity and cross-reactivity of a test for anti-SARS-CoV-2 antibodies - Authors' reply (edit) |
10.1016/S1473-3099(20)30849-5 |
| 2020-10-30 |
SARS-CoV-2 variants lacking a functional ORF8 may reduce accuracy of serological testing (edit) |
10.1016/J.JIM.2020.112906 |
| 2020-10-30 |
Functional and druggability analysis of the SARS-CoV-2 proteome (edit) |
10.1016/J.EJPHAR.2020.173705 |
| 2020-10-30 |
The risk of COVID-19 for pregnant women: Evidences of molecular alterations associated with preeclampsia in SARS-CoV-2 infection (edit) |
10.1016/J.BBADIS.2020.165999 |
| 2020-10-30 |
Increased risks of SARS-CoV-2 Nosocomial Acquisition in high-risk COVID-19 units justify personal Protective Equipment: a cross sectional study (edit) |
10.1016/J.JHIN.2020.10.022 |
| 2020-10-30 |
Stability of SARS-CoV-2 on environmental surfaces and in human excreta (edit) |
10.1016/J.JHIN.2020.10.021 |
| 2020-10-30 |
Impact of sandstorm and carnival celebrations on SARS-CoV-2 spreading in Tenerife and Gran Canaria (Canary Islands, Spain) (edit) |
10.1016/J.GACETA.2020.09.006 |
| 2020-10-30 |
A cysteine protease inhibitor blocks SARS-CoV-2 infection of human and monkey cells (edit) |
10.1101/2020.10.23.347534 |
| 2020-10-30 |
A cell-free antibody engineering platform rapidly generates SARS-CoV-2 neutralizing antibodies (edit) |
10.1101/2020.10.29.361287 |
| 2020-10-30 |
Durable SARS-CoV-2 B cell immunity after mild or severe disease (edit) |
10.1101/2020.10.28.20220996 |
| 2020-10-30 |
HLA and AB0 Polymorphisms May Influence SARS-CoV-2 Infection and COVID-19 Severity (edit) |
10.1097/TP.0000000000003507 |
| 2020-10-30 |
miR-98 Regulates TMPRSS2 Expression in Human Endothelial Cells: Key Implications for COVID-19 (edit) |
10.3390/BIOMEDICINES8110462 |
| 2020-10-30 |
Aprotinin Inhibits SARS-CoV-2 Replication (edit) |
10.3390/CELLS9112377 |
| 2020-10-30 |
Cardiovascular Disease and SARS-CoV-2: the Role of Host Immune Response Versus Direct Viral Injury (edit) |
10.3390/IJMS21218141 |
| 2020-10-30 |
[The virology of SARS-CoV-2] (edit) |
10.1007/S11377-020-00482-3 |
| 2020-10-30 |
Editorial note about SARS-CoV-2 in the pandemic era (edit) |
|
| 2020-10-30 |
SARS-CoV-2 and rhinovirus/enterovirus co-infection in a critically ill young adult patient in Colombia (edit) |
10.7705/BIOMEDICA.5516 |
| 2020-10-30 |
Neonatal late-onset infection with SARS CoV-2 (edit) |
10.7705/BIOMEDICA.5609 |
| 2020-10-30 |
Prognostic factors in hospitalized patients diagnosed with SARS-CoV-2 infection, Bogotá, Colombia (edit) |
10.7705/BIOMEDICA.5764 |
| 2020-10-30 |
Isolation and characterization of an early SARS-CoV-2 isolate from the 2020 epidemic in Medellín, Colombia (edit) |
10.7705/BIOMEDICA.5834 |
| 2020-10-30 |
SARS-CoV-2 and RT-PCR in asymptomatic patients: Results of a cohort of workers at El Dorado International Airport in Bogotá, 2020 (edit) |
10.7705/BIOMEDICA.5802 |
| 2020-10-30 |
SARS-CoV-2 sequencing: The technological initiative to strengthen early warning systems for public health emergencies in Latin America and the Caribbean (edit) |
10.7705/BIOMEDICA.5841 |
| 2020-10-30 |
Persistence of viral RNA, pneumocyte syncytia and thrombosis are hallmarks of advanced COVID-19 pathology (edit) |
10.1016/J.EBIOM.2020.103104 |
| 2020-10-30 |
First performance report of QIAreach™ Anti-SARS-CoV-2 Total Test, an innovative nanoparticle fluorescence digital detection platform (edit) |
10.1016/J.JCV.2020.104681 |
| 2020-10-30 |
Fulminant myocarditis and cardiogenic shock during SARS-CoV-2 infection (edit) |
10.1016/J.MEDCLE.2020.07.012 |
| 2020-10-30 |
CoVaccine HT™ Adjuvant Potentiates Robust Immune Responses to Recombinant SARS-CoV-2 Spike S1 Immunization (edit) |
10.3389/FIMMU.2020.599587 |
| 2020-10-30 |
Assessment of Seroconversion to SARS-CoV-2 in a Cohort of Pediatric Kidney Transplant Recipients (edit) |
10.3389/FPED.2020.601327 |
| 2020-10-30 |
The Necessity of Stool Examination in Asymptomatic Carriers as a Strategic Measure to Control Further Spread of SARS-CoV-2 (edit) |
10.3389/FPUBH.2020.553589 |
| 2020-10-30 |
Identification of a New Potential SARS-COV-2 RNA-Dependent RNA Polymerase Inhibitor via Combining Fragment-Based Drug Design, Docking, Molecular Dynamics, and MM-PBSA Calculations (edit) |
10.3389/FCHEM.2020.584894 |
| 2020-10-30 |
Implementing COVID-19 (SARS-CoV-2) Rapid Diagnostic Tests in Sub-Saharan Africa: A Review (edit) |
10.3389/FMED.2020.557797 |
| 2020-10-30 |
nSARS-Cov-2, pulmonary edema and thrombosis: possible molecular insights using miRNA-gene circuits in regulatory networks (edit) |
10.1186/S41544-020-00057-Y |
| 2020-10-30 |
Recent discovery and development on SARS-CoV-2: A review of current literature (edit) |
10.4103/JFMPC.JFMPC_851_20 |
| 2020-10-30 |
Pervasive RNA Secondary Structure in the Genomes of SARS-CoV-2 and Other Coronaviruses (edit) |
10.1128/MBIO.01661-20 |
| 2020-10-30 |
Molecular Architecture of Early Dissemination and Massive Second Wave of the SARS-CoV-2 Virus in a Major Metropolitan Area (edit) |
10.1128/MBIO.02707-20 |
| 2020-10-30 |
Pre-existing conditions are associated with COVID patients’ hospitalization, despite confirmed clearance of SARS-CoV-2 virus (edit) |
10.1101/2020.10.28.20221655 |
| 2020-10-29 |
Uncaria tomentosa (cat's claw): a promising herbal medicine against SARS-CoV-2/ACE-2 junction and SARS-CoV-2 spike protein based on molecular modeling (edit) |
10.1080/07391102.2020.1837676 |
| 2020-10-29 |
SARS-CoV-2 INFECTION IN AN INFANT WITH SEVERE DILATED CARDIOMYOPATHY (edit) |
10.1017/S1047951120004060 |
| 2020-10-29 |
SARS-CoV-2 infection among hospital workers of one of the most severely affected institutions in Madrid, Spain: a surveillance cross-sectional study (edit) |
10.1017/ICE.2020.1303 |
| 2020-10-29 |
Unravelling the modes of transmission of SARS-CoV-2 during a nursing home outbreak: looking beyond the church super-spread event (edit) |
10.1093/CID/CIAA1664 |
| 2020-10-29 |
Swab-free transport as an optimized pre-analytical workflow for SARS-COV-2 amplification (edit) |
10.1093/JALM/JFAA197 |
| 2020-10-29 |
Is there a role for the ACE2 receptor in SARS-CoV-2 interactions with platelets? (edit) |
10.1111/JTH.15156 |
| 2020-10-29 |
Management of SARS-CoV-2 infection: recommendations of the Polish Association of Epidemiologists and Infectiologists. Annex no. 2 as of October 13, 2020 (edit) |
10.20452/PAMW.15658 |
| 2020-10-29 |
Use of corticosteroids in SARS-CoV-2 infection: foe, or can they become a friend? Authors' reply (edit) |
10.20452/PAMW.15662 |
| 2020-10-29 |
Use of corticosteroids in SARS-CoV-2 infection: foe, or can they become a friend? (edit) |
10.20452/PAMW.15661 |
| 2020-10-29 |
Can Neurotropic Free-Living Amoeba Serve as a Model to Study SARS-CoV-2 Pathogenesis? (edit) |
10.1021/ACSCHEMNEURO.0C00653 |
| 2020-10-29 |
Profiling SARS-CoV-2 Main Protease (MPRO) Binding to Repurposed Drugs Using Molecular Dynamics Simulations in Classical and Neural Network-Trained Force Fields (edit) |
10.1021/ACSCOMBSCI.0C00140 |
| 2020-10-29 |
Association of SARS-CoV-2 Genomic Load with COVID-19 Patient Outcomes (edit) |
10.1513/ANNALSATS.202008-931RL |
| 2020-10-29 |
Sustained cellular immune dysregulation in individuals recovering from SARS-CoV-2 infection (edit) |
10.1172/JCI140491 |
| 2020-10-29 |
Impact of sars-cov-2 interventions on dengue transmission (edit) |
10.1371/JOURNAL.PNTD.0008719 |
| 2020-10-29 |
SARS-CoV-2 in the Amazon region: A harbinger of doom for Amerindians (edit) |
10.1371/JOURNAL.PNTD.0008686 |
| 2020-10-29 |
On the temporal spreading of the SARS-CoV-2 (edit) |
10.1371/JOURNAL.PONE.0240777 |
| 2020-10-29 |
SARS-CoV-2 transmission routes from genetic data: A Danishcase study (edit) |
10.1371/JOURNAL.PONE.0241405 |
| 2020-10-29 |
SARS-CoV-2 RNA shedding in recovered COVID-19 cases and the presence of antibodies against SARS-CoV-2 in recovered COVID-19 cases and close contacts, Thailand, April-June 2020 (edit) |
10.1371/JOURNAL.PONE.0236905 |
| 2020-10-29 |
The first 2 months of the SARS-CoV-2 epidemic in Yemen: Analysis of the surveillance data (edit) |
10.1371/JOURNAL.PONE.0241260 |
| 2020-10-29 |
Fully automated dried blood spot sample handling and extraction for serological testing of human anti-SARS-COV-2 antibodies (edit) |
10.1002/DTA.2946 |
| 2020-10-29 |
SARS-CoV-2 vaccine candidates in rapid development (edit) |
10.1080/21645515.2020.1804777 |
| 2020-10-29 |
Serum interleukin-6 is an indicator for severity in 901 patients with SARS-CoV-2 infection: a cohort study (edit) |
10.1186/S12967-020-02571-X |
| 2020-10-29 |
Prediction and evolution of B cell epitopes of surface protein in SARS-CoV-2 (edit) |
10.1186/S12985-020-01437-4 |
| 2020-10-29 |
Contamination of SARS-CoV-2 in patient surroundings and on personal protective equipment in a non-ICU isolation ward for COVID-19 patients with prolonged PCR positive status (edit) |
10.1186/S13756-020-00839-X |
| 2020-10-29 |
Development of a simple in vitro assay to identify and evaluate nucleotide analogs against SARS-CoV-2 RNA-dependent RNA polymerase (edit) |
10.1128/AAC.01508-20 |
| 2020-10-29 |
High affinity binding of SARS-CoV-2 spike protein enhances ACE2 carboxypeptidase activity (edit) |
10.1074/JBC.RA120.015303 |
| 2020-10-29 |
Leucocytoclastic vasculitis in a patient with COVID-19 with positive SARS-CoV-2 PCR in skin biopsy (edit) |
10.1136/BCR-2020-238039 |
| 2020-10-29 |
Detection of SARS-CoV-2 Antibodies in Kidney Transplant Recipients (edit) |
10.1681/ASN.2020081152 |
| 2020-10-29 |
Fetal Inflammatory Response Syndrome Associated with Maternal SARS-CoV-2 Infection (edit) |
10.1542/PEDS.2020-010132 |
| 2020-10-29 |
Opinion: For now, it's unethical to use human challenge studies for SARS-CoV-2 vaccine development (edit) |
10.2139/SSRN.3674548 |
| 2020-10-29 |
Kinetics of SARS-CoV-2 positivity of infected and recovered patients from a single center (edit) |
10.1038/S41598-020-75629-X |
| 2020-10-29 |
Quantification of antibody avidities and accurate detection of SARS-CoV-2 antibodies in serum and saliva on plasmonic substrates (edit) |
10.1038/S41551-020-00642-4 |
| 2020-10-29 |
Vaginal delivery in SARS-CoV-2-infected pregnant women in Israel: a multicenter prospective analysis (edit) |
10.1007/S00404-020-05854-2 |
| 2020-10-29 |
Delayed hospital admission and high-dose corticosteroids potentially prolong SARS-CoV-2 RNA detection duration of patients with COVID-19 (edit) |
10.1007/S10096-020-04085-2 |
| 2020-10-29 |
Aerosol transmission for SARS-CoV-2 in the dental practice. A review by SIdP Covid 19 task-force (edit) |
10.1111/ODI.13649 |
| 2020-10-29 |
Seroprevalence of SARS-CoV-2-Specific IgG Antibodies Among Adults Living in Connecticut: Post-Infection Prevalence (PIP) Study (edit) |
10.1016/J.AMJMED.2020.09.024 |
| 2020-10-29 |
Field Evaluation of the Performance of a SARS-CoV-2 Antigen Rapid Diagnostic Test in Uganda using Nasopharyngeal Samples (edit) |
10.1016/J.IJID.2020.10.073 |
| 2020-10-29 |
Adjusting RT-qPCR conditions to avoid unspecific amplification in SARS-CoV-2 diagnostic (edit) |
10.1016/J.IJID.2020.10.079 |
| 2020-10-29 |
Residual SARS-CoV-2 RNA in nasal swabs of convalescent COVID-19: is prolonged quarantine always justified? (edit) |
10.1016/J.IJID.2020.10.072 |
| 2020-10-29 |
In silico identification of strong binders of the SARS-CoV-2 receptor-binding domain (edit) |
10.1016/J.EJPHAR.2020.173701 |
| 2020-10-29 |
Unravelling high-affinity binding compounds towards transmembrane protease serine 2 enzyme in treating SARS-CoV-2 infection using molecular modelling and docking studies (edit) |
10.1016/J.EJPHAR.2020.173688 |
| 2020-10-29 |
Comprehensive characterization of N- and O- glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2 (edit) |
10.1093/GLYCOB/CWAA101 |
| 2020-10-29 |
Phylogeography of 27,000 SARS-CoV-2 Genomes: Europe as the Major Source of the COVID-19 Pandemic (edit) |
10.3390/MICROORGANISMS8111678 |
| 2020-10-29 |
Man-Specific, GalNAc/T/Tn-Specific and Neu5Ac-Specific Seaweed Lectins as Glycan Probes for the SARS-CoV-2 (COVID-19) Coronavirus (edit) |
10.3390/MD18110543 |
| 2020-10-29 |
Emerging Mechanisms of Pulmonary Vasoconstriction in SARS-CoV-2-Induced Acute Respiratory Distress Syndrome (ARDS) and Potential Therapeutic Targets (edit) |
10.3390/IJMS21218081 |
| 2020-10-29 |
Single-Cell Transcriptome Analysis Highlights a Role for Neutrophils and Inflammatory Macrophages in the Pathogenesis of Severe COVID-19 (edit) |
10.3390/CELLS9112374 |
| 2020-10-29 |
A needle in the haystack? Assessing the significance of envelope (E) gene-negative, nucleocapsid (N2) gene-positive SARS-CoV-2 detection by the Cepheid Xpert Xpress SARS-COV-2 assay (edit) |
10.1016/J.JCV.2020.104683 |
| 2020-10-29 |
First confirmed detection of SARS-COV-2 in untreated municipal and aircraft wastewater in Dubai, UAE: The use of wastewater based epidemiology as an early warning tool to monitor the prevalence of COVID-19 (edit) |
10.1016/J.SCITOTENV.2020.143350 |
| 2020-10-29 |
[Classroom teaching at universities and colleges under the conditions of the SARS-CoV-2 pandemic] (edit) |
10.1007/S40664-020-00411-9 |
| 2020-10-29 |
[Epidemiology of SARS-CoV-2/COVID-19] (edit) |
10.1007/S11377-020-00479-Y |
| 2020-10-29 |
Contribution of VitaPCR SARS-CoV-2 to the emergency diagnosis of COVID-19 (edit) |
10.1016/J.JCV.2020.104682 |
| 2020-10-29 |
Pandemic danger to the deep: The risk of marine mammals contracting SARS-CoV-2 from wastewater (edit) |
10.1016/J.SCITOTENV.2020.143346 |
| 2020-10-29 |
Risk assessment of SARS-CoV-2 in Antarctic wildlife (edit) |
10.1016/J.SCITOTENV.2020.143352 |
| 2020-10-29 |
Crystal structure of SARS-CoV-2 main protease in complex with the natural product inhibitor shikonin illuminates a unique binding mode (edit) |
10.1016/J.SCIB.2020.10.018 |
| 2020-10-29 |
Pharmacological inhibition of acid sphingomyelinase prevents uptake of SARS-CoV-2 by epithelial cells (edit) |
10.1016/J.XCRM.2020.100142 |
| 2020-10-29 |
Public health antibody screening indicates a six-fold higher SARS-CoV-2 exposure rate than reported cases in children (edit) |
10.1016/J.MEDJ.2020.10.003 |
| 2020-10-29 |
Prevalence of antibodies against SARS-CoV-2 according to socioeconomic and ethnic status in a nationwide Brazilian survey (edit) |
10.26633/RPSP.2020.135 |
| 2020-10-29 |
Analytical sensitivity and clinical sensitivity of the three rapid antigen detection kits for detection of SARS-CoV-2 virus (edit) |
10.1016/J.JCV.2020.104684 |
| 2020-10-29 |
Analysis of a persistent viral shedding patient infected with SARS-CoV-2 by RT-qPCR, FilmArray Respiratory Panel v2.1, and antigen detection (edit) |
10.1016/J.JIAC.2020.10.026 |
| 2020-10-29 |
Nonstructural Protein 1 of SARS-CoV-2 Is a Potent Pathogenicity Factor Redirecting Host Protein Synthesis Machinery toward Viral RNA (edit) |
10.1016/J.MOLCEL.2020.10.034 |
| 2020-10-29 |
miR-1207-5p Can Contribute to Dysregulation of Inflammatory Response in COVID-19 via Targeting SARS-CoV-2 RNA (edit) |
10.3389/FCIMB.2020.586592 |
| 2020-10-29 |
Safe Perinatal Management of Neonates Born to SARS-CoV-2 Positive Mothers at the Epicenter of the Italian Epidemic (edit) |
10.3389/FPED.2020.565522 |
| 2020-10-29 |
Position Statement of the Surgery-AEC-COVID Working Group of the Spanish Association of Surgeons on the Planning of Surgical Activity During the Second Wave of the SARS-CoV-2 Pandemic: Surgery Must Continue (edit) |
10.1016/J.CIRESP.2020.10.013 |
| 2020-10-29 |
[Sars-CoV-2, a new virus of the coronavirus family] (edit) |
10.1016/J.REVINF.2020.10.006 |
| 2020-10-29 |
[Nurses in multi-disciplinary team to face Sars-CoV-2 in intensive care] (edit) |
10.1016/J.REVINF.2020.10.007 |
| 2020-10-29 |
The complex distribution of SARS-CoV-2 in a population invalidates the use of the per capita rates of death and infection in international comparisons (edit) |
10.1016/J.PUHE.2020.10.019 |
| 2020-10-29 |
Modeling the Opening SARS-CoV-2 Spike: an Investigation of its Dynamic Electro-Geometric Properties (edit) |
10.1101/2020.10.29.361261 |
| 2020-10-29 |
Patient-derived SARS-CoV-2 mutations impact viral replication dynamics and infectivity in vitro and with clinical implications in vivo (edit) |
10.1038/S41421-020-00226-1 |
| 2020-10-28 |
Aligning SARS-CoV-2 indicators via an epidemic model: application to hospital admissions and RNA detection in sewage sludge (edit) |
10.1007/S10729-020-09525-1 |
| 2020-10-28 |
Successful containment to date of SARS-CoV-2 transmission in the Northern Territory (edit) |
10.5694/MJA2.50840 |
| 2020-10-28 |
SARS-CoV-2 RBD Neutralizing Antibody Induction is Enhanced by Particulate Vaccination (edit) |
10.1002/ADMA.202005637 |
| 2020-10-28 |
N-Terminomics for the Identification of in vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease (edit) |
10.1002/PMIC.202000246 |
| 2020-10-28 |
Evidence-Based Management of the Critically Ill Adult With SARS-CoV-2 Infection (edit) |
10.1177/0885066620969132 |
| 2020-10-28 |
Binding mechanism and structural insights into the identified protein target of COVID-19 and importin-α with in-vitro effective drug ivermectin (edit) |
10.1080/07391102.2020.1839564 |
| 2020-10-28 |
Deciphering underlying mechanism of Sars-CoV-2 infection in humans and revealing the therapeutic potential of bioactive constituents from Nigella sativa to combat COVID19: in-silico study (edit) |
10.1080/07391102.2020.1839560 |
| 2020-10-28 |
SARS-CoV-2 evades immune detection in alveolar macrophages (edit) |
10.15252/EMBR.202051252 |
| 2020-10-28 |
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants (edit) |
10.7554/ELIFE.61312 |
| 2020-10-28 |
Guillain-Barré syndrome associated with SARS-CoV-2 infection: a systematic review and individual participant data meta-analysis (edit) |
10.1111/JNS.12419 |
| 2020-10-28 |
Bioinformatic characterization of angiotensin-converting enzyme 2, the entry receptor for SARS-CoV-2 (edit) |
10.1371/JOURNAL.PONE.0240647 |
| 2020-10-28 |
Investigating the association between ethnicity and health outcomes in SARS-CoV-2 in a London secondary care population (edit) |
10.1371/JOURNAL.PONE.0240960 |
| 2020-10-28 |
Estimation of the percentages of undiagnosed patients of the novel coronavirus (SARS-CoV-2) infection in Hokkaido, Japan by using birth-death process with recursive full tracing (edit) |
10.1371/JOURNAL.PONE.0241170 |
| 2020-10-28 |
Common childhood vaccines do not elicit a cross-reactive antibody response against SARS-CoV-2 (edit) |
10.1371/JOURNAL.PONE.0241471 |
| 2020-10-28 |
Rapid deployment of SARS-CoV-2 testing: The CLIAHUB (edit) |
10.1371/JOURNAL.PPAT.1008966 |
| 2020-10-28 |
Isolation or De-isolation: Measuring the Infectivity of SARS-CoV-2? (edit) |
10.1093/CID/CIAA1671 |
| 2020-10-28 |
[Interdisciplinary COVID board for patients with SARS-CoV-2-triggered hyperferritinemic Inflammation] (edit) |
10.1007/S00063-020-00750-8 |
| 2020-10-28 |
Pediatric stroke associated with a sedentary lifestyle during the SARS-CoV-2 (COVID-19) pandemic: a case report on a 17-year-old (edit) |
10.1007/S10072-020-04857-W |
| 2020-10-28 |
SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19 (edit) |
10.1056/NEJMOA2029849 |
| 2020-10-28 |
SARS-CoV-2 infection in a patient with propionic acidemia (edit) |
10.1186/S13023-020-01563-W |
| 2020-10-28 |
SARS-CoV-2 Positivity Rates among Children of Racial and Ethnic Minority Groups in Mississippi (edit) |
10.1542/PEDS.2020-024349 |
| 2020-10-28 |
Will vaccination refusal prolong the war on SARS-CoV-2? (edit) |
10.1136/POSTGRADMEDJ-2020-138903 |
| 2020-10-28 |
Commentary on 'Will vaccination refusal prolong the war on SARS-CoV-2?' (edit) |
10.1136/POSTGRADMEDJ-2020-139043 |
| 2020-10-28 |
Robust neutralizing antibodies to SARS-CoV-2 infection persist for months (edit) |
10.1126/SCIENCE.ABD7728 |
| 2020-10-28 |
Identification of SARS-CoV-2 entry inhibitors among already approved drugs (edit) |
10.1038/S41401-020-00556-6 |
| 2020-10-28 |
Identification of SARS-CoV-2 Inhibitors using Lung and Colonic Organoids (edit) |
10.1038/S41586-020-2901-9 |
| 2020-10-28 |
Editorial Comment to Nosocomial SARS-CoV-2 infection in urology departments: Results of a prospective multicentric study (edit) |
10.1111/IJU.14416 |
| 2020-10-28 |
The role of nicotinic receptors in SARS-CoV-2 receptor ACE2 expression in intestinal epithelia (edit) |
10.1186/S42234-020-00057-1 |
| 2020-10-28 |
Impact of Timely Public Health Measures on Kidney Transplantation in Austria during the SARS-CoV-2 Outbreak-A Nationwide Analysis (edit) |
10.3390/JCM9113465 |
| 2020-10-28 |
Quantifying the impact of public health protection measures on the spread of SARS-CoV-2 (edit) |
10.1016/J.JINF.2020.10.026 |
| 2020-10-28 |
Could SARS-CoV-2-induced lung injury be attenuated by vitamin D? (edit) |
10.1016/J.IJID.2020.10.059 |
| 2020-10-28 |
SARS-CoV-2, the autoimmune virus (edit) |
10.1016/J.AUTREV.2020.102695 |
| 2020-10-28 |
A connectivity map-based drug repurposing study and integrative analysis of transcriptomic profiling of SARS-CoV-2 infection (edit) |
10.1016/J.MEEGID.2020.104610 |
| 2020-10-28 |
A natural food preservative peptide nisin can interact with the SARS-CoV-2 spike protein receptor human ACE2 (edit) |
10.1016/J.VIROL.2020.10.002 |
| 2020-10-28 |
The SARS-CoV-2 targets by the pscRNA profiling of ACE2, TMPRSS2 and Furin proteases (edit) |
10.1016/J.ISCI.2020.101744 |
| 2020-10-28 |
SARS-CoV-2 desensitizes host cells to interferon through inhibition of the JAK-STAT pathway (edit) |
10.1101/2020.10.27.358259 |
| 2020-10-28 |
Ethacridine inhibits SARS-CoV-2 by inactivating viral particles in cellular models (edit) |
10.1101/2020.10.28.359042 |
| 2020-10-28 |
Problems of Interpreting Diagnostic Tests for SARS-CoV-2: Analytical Chemistry Concerns (edit) |
10.1590/0001-3765202020201208 |
| 2020-10-28 |
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Associated Urogenital Disease: A Current Update (edit) |
10.5534/WJMH.200168 |
| 2020-10-28 |
Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19 (edit) |
10.1016/J.CELL.2020.10.037 |
| 2020-10-28 |
Detection of SARS-CoV-2 RNA in hospital wastewater from a low COVID-19 disease prevalence area (edit) |
10.1016/J.SCITOTENV.2020.143226 |
| 2020-10-28 |
Immunoinformatic Analysis of SARS-CoV-2 Nucleocapsid Protein and Identification of COVID-19 Vaccine Targets (edit) |
10.3389/FIMMU.2020.587615 |
| 2020-10-28 |
Systems Thinking About SARS-CoV-2 (edit) |
10.3389/FPUBH.2020.585229 |
| 2020-10-28 |
Community COVID-19 activity level and nursing home staff testing for active SARS-CoV-2 infection in Indiana (edit) |
10.1016/J.JAMDA.2020.10.038 |
| 2020-10-28 |
[Horizontal SARS-COV-2 infection in three newborns: We can also avoid unnecessary irradiation] (edit) |
10.1016/J.ANPEDI.2020.10.010 |
| 2020-10-28 |
Response to «Emphysematous cholecystitis in suspected SARS-CoV-2 infection» (edit) |
10.1016/J.CIRESP.2020.10.012 |
| 2020-10-28 |
The effect of lockdown regulations on SARS-CoV-2 infectivity in Gauteng Province, South Africa (edit) |
10.7196/SAMJ.2020.V110I11.15222 |
| 2020-10-28 |
COVID-19 Disease Map, a computational knowledge repository of SARS-CoV-2 virus-host interaction mechanisms (edit) |
10.1101/2020.10.26.356014 |
| 2020-10-28 |
Reproducibly sampling SARS-CoV-2 genomes across time, geography, and viral diversity (edit) |
10.12688/F1000RESEARCH.24751.2 |
| 2020-10-27 |
Repeat COVID-19 Molecular Testing: Correlation of SARS-CoV-2 Culture with Molecular Assays and Cycle Thresholds (edit) |
10.1093/CID/CIAA1616 |
| 2020-10-27 |
Structural basis for potent neutralization of SARS-CoV-2 and role of antibody affinity maturation (edit) |
10.1038/S41467-020-19231-9 |
| 2020-10-27 |
Early expansion of myeloid-derived suppressor cells inhibits SARS-CoV-2 specific T-cell response and may predict fatal COVID-19 outcome (edit) |
10.1038/S41419-020-03125-1 |
| 2020-10-27 |
SARS-Cov-2 trajectory predictions and scenario simulations from a global perspective: a modelling study (edit) |
10.1038/S41598-020-75332-X |
| 2020-10-27 |
Protection against SARS-CoV-2 by BCG vaccination is not supported by epidemiological analyses (edit) |
10.1038/S41598-020-75491-X |
| 2020-10-27 |
SARS-CoV-2 membrane glycoprotein M antagonizes the MAVS-mediated innate antiviral response (edit) |
10.1038/S41423-020-00571-X |
| 2020-10-27 |
No benefit of hydroxychloroquine on SARS-CoV-2 viral load reduction in non-critical hospitalized patients with COVID-19 (edit) |
10.1007/S42770-020-00395-X |
| 2020-10-27 |
Balint-Holmes syndrome due to stroke following SARS-CoV-2 infection: a single-case report (edit) |
10.1007/S10072-020-04860-1 |
| 2020-10-27 |
Prevalence of SARS-CoV-2 Infections in a Pediatric Orthopedic Hospital (edit) |
10.1111/PAN.14047 |
| 2020-10-27 |
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibodies at Delivery in Women, Partners, and Newborns (edit) |
10.1097/AOG.0000000000004199 |
| 2020-10-27 |
The Association between Influenza Vaccination and the Risk of SARS-CoV-2 Infection, Severe Illness, and Death: A Systematic Review of the Literature (edit) |
10.3390/IJERPH17217870 |
| 2020-10-27 |
The Role of COVID-19 in the Death of SARS-CoV-2-Positive Patients: A Study Based on Death Certificates (edit) |
10.3390/JCM9113459 |
| 2020-10-27 |
What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2 (edit) |
10.1016/S1473-3099(20)30773-8 |
| 2020-10-27 |
Can SARS-CoV-2 trigger reactive arthritis? (edit) |
10.1016/J.JBSPIN.2020.105086 |
| 2020-10-27 |
Performance evaluation of five ELISA kits for detecting anti-SARS-COV-2 IgG antibodies (edit) |
10.1016/J.IJID.2020.10.042 |
| 2020-10-27 |
Anti-SARS-CoV-2 antibody detection in healthcare workers of two tertiary hospitals in Athens, Greece (edit) |
10.1016/J.CLIM.2020.108619 |
| 2020-10-27 |
Can dexamethasone prevent the seizures induced by SARS-CoV-2 infection? (edit) |
10.1016/J.MSARD.2020.102606 |
| 2020-10-27 |
ISG15-dependent Activation of the RNA Sensor MDA5 and its Antagonism by the SARS-CoV-2 papain-like protease (edit) |
10.1101/2020.10.26.356048 |
| 2020-10-27 |
SARS-CoV-2 spike D614G variant confers enhanced replication and transmissibility (edit) |
10.1101/2020.10.27.357558 |
| 2020-10-27 |
Integrated Single-Cell Atlases Reveal an Oral SARS-CoV-2 Infection and Transmission Axis (edit) |
10.1101/2020.10.26.20219089 |
| 2020-10-27 |
Saliva is a promising alternative specimen for the detection of SARS-CoV-2 in children and adults (edit) |
10.1101/2020.10.25.20219055 |
| 2020-10-27 |
Seroprevalence of anti-SARS-CoV-2 IgG Antibodies in the Staff of a Public School System in the Midwestern United States (edit) |
10.1101/2020.10.23.20218651 |
| 2020-10-27 |
Baseline phenotype and 30-day outcomes of people tested for COVID-19: an international network cohort including >3.32 million people tested with real-time PCR and >219,000 tested positive for SARS-CoV-2 in South Korea, Spain and the United States (edit) |
10.1101/2020.10.25.20218875 |
| 2020-10-27 |
The spatio-temporal landscape of lung pathology in SARS-CoV-2 infection (edit) |
10.1101/2020.10.26.20219584 |
| 2020-10-27 |
HIV and SARS-CoV-2: points to consider to face this new pandemic (edit) |
10.5867/MEDWAVE.2020.09.8049 |
| 2020-10-27 |
Update Alert 5: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults (edit) |
10.7326/L20-1293 |
| 2020-10-27 |
Update Alert 3: Masks for Prevention of Respiratory Virus Infections, Including SARS-CoV-2, in Health Care and Community Settings (edit) |
10.7326/L20-1292 |
| 2020-10-27 |
Risk Factors for testing positive for SARS-CoV-2 in a national US healthcare system (edit) |
10.1093/CID/CIAA1624 |
| 2020-10-27 |
Unexpected high frequency of unspecific reactivities by testing pre-epidemic blood specimens from Europe and Africa with SARS-CoV-2 IgG-IgM antibody rapid tests points IgM as Achilles heel (edit) |
10.1002/JMV.26628 |
| 2020-10-27 |
Comparing two sample pooling strategies for SARS-CoV-2 RNA detection for efficient screening of COVID-19 (edit) |
10.1002/JMV.26632 |
| 2020-10-27 |
Secondary metabolites from spice and herbs as potential multitarget inhibitors of SARS-CoV-2 proteins (edit) |
10.1080/07391102.2020.1837679 |
| 2020-10-27 |
Inflammatory syndromes associated with SARS-CoV-2 infection: dysregulation of the immune response across the age spectrum (edit) |
10.1172/JCI145301 |
| 2020-10-27 |
Evaluation of SARS-CoV-2 IgG antibody response in PCR positive patients: Comparison of nine tests in relation to clinical data (edit) |
10.1371/JOURNAL.PONE.0237548 |
| 2020-10-27 |
COVID-19 vaccine race: analysis of age-dependent immune responses against SARS-CoV-2 indicates that more than just one strategy may be needed (edit) |
10.2174/0929867327666201027153123 |
| 2020-10-27 |
The Binding of Remdesivir to SARS-CoV-2 RNA-Dependent RNA polymerase May Pave The Way Towards the Design of Potential Drugs for COVID-19 Treatment (edit) |
10.2174/1389201021666201027154833 |
| 2020-10-27 |
Povidone-iodine solution as SARS-CoV-2 prophylaxis for procedures of the upper aerodigestive tract a theoretical framework (edit) |
10.1186/S40463-020-00474-X |
| 2020-10-27 |
Vitamin D Status in Hospitalized Patients with SARS-CoV-2 Infection (edit) |
10.1210/CLINEM/DGAA733 |
| 2020-10-27 |
Clinical application of the COVID-19 Reporting and Data System (CO-RADS) in patients with suspected SARS-CoV-2 infection: observational study in an emergency department (edit) |
10.1016/J.CRAD.2020.10.007 |
| 2020-10-27 |
Detection of SARS-CoV-2 in Milk From COVID-19 Positive Mothers and Follow-Up of Their Infants (edit) |
10.3389/FPED.2020.597699 |
| 2020-10-27 |
Trends in MERS-CoV, SARS-CoV, and SARS-CoV-2 (COVID-19) Diagnosis Strategies: A Patent Review (edit) |
10.3389/FPUBH.2020.563095 |
| 2020-10-27 |
Natural Infection by SARS-CoV-2 in Companion Animals: A Review of Case Reports and Current Evidence of Their Role in the Epidemiology of COVID-19 (edit) |
10.3389/FVETS.2020.591216 |
| 2020-10-27 |
SARS-CoV-2 viroporin triggers the NLRP3 inflammatory pathway (edit) |
10.1101/2020.10.27.357731 |
| 2020-10-27 |
Highly accurate and sensitive diagnostic detection of SARS-CoV-2 by digital PCR (edit) |
10.1016/J.TALANTA.2020.121726 |
| 2020-10-27 |
Controlled randomized clinical trial on using Ivermectin with Doxycycline for treating COVID-19 patients in Baghdad, Iraq (edit) |
10.1101/2020.10.26.20219345 |
| 2020-10-27 |
Remdesivir targets a structurally analogous region of the Ebola virus and SARS-CoV-2 polymerases (edit) |
10.1073/PNAS.2012294117 |
| 2020-10-27 |
Favipiravir at high doses has potent antiviral activity in SARS-CoV-2-infected hamsters, whereas hydroxychloroquine lacks activity (edit) |
10.1073/PNAS.2014441117 |
| 2020-10-27 |
Cathepsin L plays a key role in SARS-CoV-2 infection in humans and humanized mice and is a promising target for new drug development (edit) |
10.1101/2020.10.25.20218990 |
| 2020-10-26 |
Effectiveness of steroid treatment for SARS-CoV-2 pneumonia with COP-like reaction: a case report (edit) |
10.1017/DMP.2020.415 |
| 2020-10-26 |
SARS-CoV-2 IgG Results Among Healthcare Workers in a Rural Upstate New York Hospital System (edit) |
10.1017/ICE.2020.1296 |
| 2020-10-26 |
ORF3a mutation associated higher mortality rate in SARS-CoV-2 infection (edit) |
10.1017/S0950268820002599 |
| 2020-10-26 |
SARS-CoV-2 infection fatality rate among elderly retired Danish blood donors - A cross-sectional study (edit) |
10.1093/CID/CIAA1627 |
| 2020-10-26 |
Supervised molecular dynamics for exploring the druggability of the SARS-CoV-2 spike protein (edit) |
10.1007/S10822-020-00356-4 |
| 2020-10-26 |
Computational Identification of Human Biological Processes and Protein Sequence Motifs Putatively Targeted by SARS-CoV-2 Proteins Using Protein-Protein Interaction Networks (edit) |
10.1021/ACS.JPROTEOME.0C00422 |
| 2020-10-26 |
Lack of association between ABO blood groups and susceptibility to SARS-CoV-2 infection (edit) |
10.1111/VOX.13015 |
| 2020-10-26 |
Blood supply management in times of SARS-CoV-2 pandemic - challenges, strategies adopted, and the lessons learned from the experience of a hospital-based blood centre (edit) |
10.1111/VOX.13019 |
| 2020-10-26 |
Evidence of Structural Protein Damage and Membrane Lipid Remodeling in Red Blood Cells from COVID-19 Patients (edit) |
10.1021/ACS.JPROTEOME.0C00606 |
| 2020-10-26 |
Inhibition of SARS-CoV-2 viral entry upon blocking N- and O-glycan elaboration (edit) |
10.7554/ELIFE.61552 |
| 2020-10-26 |
Preventing the Spread of SARS-CoV-2 With Masks and Other "Low-tech" Interventions (edit) |
10.1001/JAMA.2020.21946 |
| 2020-10-26 |
SARS-CoV-2 specific T-cells Are Rapidly Expanded for Therapeutic Use and Target Conserved Regions of Membrane Protein (edit) |
10.1182/BLOOD.2020008488 |
| 2020-10-26 |
Reply to Cimolai: Even With Variable Viral Culture Methods, Culturing SARS-CoV-2 After 10 Days Appears to be Rare and Has Unclear Implications for Transmission (edit) |
10.1093/CID/CIAA1634 |
| 2020-10-26 |
COSMO-RS-Based Descriptors for the Machine Learning-Enabled Screening of Nucleotide Analogue Drugs against SARS-CoV-2 (edit) |
10.1021/ACS.JPCLETT.0C02836 |
| 2020-10-26 |
Letter by Sajeev et al Regarding Article, "SARS-CoV-2 and Stroke in a New York Healthcare System" (edit) |
10.1161/STROKEAHA.120.031113 |
| 2020-10-26 |
Response by Ishida et al Regarding Article, "SARS-CoV-2 and Stroke in a New York Healthcare System" (edit) |
10.1161/STROKEAHA.120.031606 |
| 2020-10-26 |
Single-cell expression profiles of ACE2 and TMPRSS2 reveals potential vertical transmission and fetus infection of SARS-CoV-2 (edit) |
10.18632/AGING.104015 |
| 2020-10-26 |
A concern regarding estimated sensitivities and specificities of nasopharyngeal and saliva specimens for SARS-CoV-2 infection (edit) |
10.1093/CID/CIAA1655 |
| 2020-10-26 |
Facial palsy as a neurological complication of SARS-CoV-2 (edit) |
10.1590/0004-282X20200127 |
| 2020-10-26 |
SARS-CoV-2 and arbovirus infection: a rapid systematic review (edit) |
10.1590/1516-3180.2020.0422.08092020 |
| 2020-10-26 |
Antibody Binding to SARS-CoV-2 S Glycoprotein Correlates with but Does Not Predict Neutralization (edit) |
10.3390/V12111214 |
| 2020-10-26 |
SARS-CoV-2 positive virus culture 7 weeks after onset of COVID-19 in an immunocompromised patient suffering from X chromosome-linked agammaglobulinemia (edit) |
10.1016/J.JINF.2020.10.025 |
| 2020-10-26 |
opvCRISPR: One-pot visual RT-LAMP-CRISPR platform for SARS-cov-2 detection (edit) |
10.1016/J.BIOS.2020.112766 |
| 2020-10-26 |
Robust and specific secretory IgA against SARS-CoV-2 detected in human milk (edit) |
10.1016/J.ISCI.2020.101735 |
| 2020-10-26 |
Diversity of ACE2 and its interaction with SARS-CoV-2 receptor binding domain (edit) |
10.1101/2020.10.25.354548 |
| 2020-10-26 |
Identifying SARS-CoV-2 infections in South Africa: Balancing public health imperatives with saving lives (edit) |
10.1016/J.BBRC.2020.10.059 |
| 2020-10-26 |
Sensitive detection and quantification of SARS-CoV-2 by multiplex droplet digital RT-PCR (edit) |
10.1007/S10096-020-04076-3 |
| 2020-10-26 |
Origin of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and COVID-19 (edit) |
10.1007/S12024-020-00323-3 |
| 2020-10-26 |
Response to the letter by Meng-jun Zhan et al. regarding the paper "A technical report from the Italian SARS-CoV-2 outbreak. Postmortem sampling and autopsy investigation in cases of suspected or probable COVID-19" (edit) |
10.1007/S12024-020-00324-2 |
| 2020-10-26 |
Regarding "A technical report from the Italian SARS-CoV-2 outbreak. Postmortem sampling and autopsy investigation in cases of suspected or probable COVID-19" (edit) |
10.1007/S12024-020-00322-4 |
| 2020-10-26 |
A comparative phylogenomic analysis of SARS-CoV-2 strains reported from non-human mammalian species and environmental samples (edit) |
10.1007/S11033-020-05879-5 |
| 2020-10-26 |
Airborne transmission of SARS-CoV-2 via aerosols (edit) |
10.1002/RMV.2184 |
| 2020-10-26 |
Computer simulations of the interaction between SARS-CoV-2 spike glycoprotein and different surfaces (edit) |
10.1116/6.0000502 |
| 2020-10-26 |
Mechanistic Insights to the Binding of Antibody CR3022 Against RBD from SARS-CoV and HCoV-19/SARS-CoV-2: A Computational Study (edit) |
10.2174/1386207323666201026160500 |
| 2020-10-26 |
Comparison of the Clinical Performance of the Abbott Alinity IgG, Abbott Architect IgM, and Roche Elecsys Total SARS-CoV-2 Antibody Assays (edit) |
10.1128/JCM.02104-20 |
| 2020-10-26 |
The impact of social ties and SARS memory on the public awareness of 2019 novel coronavirus (SARS-CoV-2) outbreak (edit) |
10.1038/S41598-020-75318-9 |
| 2020-10-26 |
Vertical transmission of SARS-CoV-2 from infected pregnant mother to the neonate detected by cord blood real-time polymerase chain reaction (RT-PCR) (edit) |
10.1038/S41390-020-01193-9 |
| 2020-10-26 |
The global population of SARS-CoV-2 is composed of six major subtypes (edit) |
10.1038/S41598-020-74050-8 |
| 2020-10-26 |
Spike mutation D614G alters SARS-CoV-2 fitness (edit) |
10.1038/S41586-020-2895-3 |
| 2020-10-26 |
Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans (edit) |
10.1038/S41564-020-00813-8 |
| 2020-10-26 |
Evaluation of SARS-CoV-2 in the female reproductive tract of COVID-19 patients: A prospective study (edit) |
10.23812/20-352-L |
| 2020-10-26 |
Raltegravir, Indinavir, Tipranavir, Dolutegravir, and Etravirine against main protease and RNA-dependent RNA polymerase of SARS-CoV-2: A molecular docking and drug repurposing approach (edit) |
10.1016/J.JIPH.2020.10.015 |
| 2020-10-26 |
Spatial modeling could not differentiate early SARS-CoV-2 cases from the distribution of humans on the basis of climate in the United States (edit) |
10.7717/PEERJ.10140 |
| 2020-10-26 |
[Impact of the SARS-CoV-2 pandemic on the use of the emergency department and admissions in a tertiary hospital] (edit) |
10.1016/J.ANPEDI.2020.10.014 |
| 2020-10-26 |
Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? (edit) |
10.1183/23120541.00542-2020 |
| 2020-10-26 |
Characterization and structural prediction of the putative ORF10 protein in SARS-CoV-2 (edit) |
10.1101/2020.10.26.355784 |
| 2020-10-26 |
Structural basis of ribosomal frameshifting during translation of the SARS-CoV-2 RNA genome (edit) |
10.1101/2020.10.26.355099 |
| 2020-10-25 |
A Case of a Newborn Baby Girl Infected with SARS-CoV-2 Due to Transplacental Viral Transmission (edit) |
10.12659/AJCR.925766 |
| 2020-10-25 |
Management of gestational diabetes in women with a concurrent Sars-Cov-2 infection, experience of a single center in Northern Italy (edit) |
10.1002/IJGO.13434 |
| 2020-10-25 |
Prurigo pigmentosa and new-onset type 1 diabetes in a black female patient testing positive for SARS-CoV-2 IgG (edit) |
10.1111/BJD.19568 |
| 2020-10-25 |
High-throughput virtual screening of drug databanks for potential inhibitors of SARS-CoV-2 spike glycoprotein (edit) |
10.1080/07391102.2020.1835721 |
| 2020-10-25 |
Lack of detrimental effect of corticosteroids on antibody responses to SARS-CoV-2 and viral clearance in patients hospitalized with COVID-19 (edit) |
10.1016/J.JINF.2020.10.018 |
| 2020-10-25 |
A case of SARS-CoV-2 re-infection (edit) |
10.1016/J.JINF.2020.10.019 |
| 2020-10-25 |
HIV/SARS-CoV-2 co-infection: T cell profile, cytokine dynamics and role of exhausted lymphocytes (edit) |
10.1016/J.IJID.2020.10.049 |
| 2020-10-25 |
Co-infection of SARS-CoV-2 with other respiratory viruses and performance of lower respiratory tract samples for the diagnosis of COVID-19 (edit) |
10.1016/J.IJID.2020.10.040 |
| 2020-10-25 |
Analytical sensitivity and clinical performance of a triplex RT-qPCR assay using CDC N1, N2 and RP targets for SARS-CoV-2 diagnosis (edit) |
10.1016/J.IJID.2020.10.047 |
| 2020-10-25 |
The role of case importation in explaining differences in early SARS-CoV-2 transmission dynamics in Canada - a mathematical modeling study of surveillance data (edit) |
10.1016/J.IJID.2020.10.046 |
| 2020-10-25 |
Repurposed Drugs, Molecular Vaccines, Immune-Modulators, and Nanotherapeutics to Treat and Prevent COVID-19 Associated with SARS-CoV-2, a Deadly Nanovector (edit) |
10.1002/ADTP.202000172 |
| 2020-10-25 |
Identification of 14 Known Drugs as Inhibitors of the Main Protease of SARS-CoV-2 (edit) |
10.1021/ACSMEDCHEMLETT.0C00521 |
| 2020-10-24 |
Positive Postmortem Test for SARS-CoV-2 Following Embalming in Confirmed COVID-19 Autopsy (edit) |
10.1093/AJCP/AQAA220 |
| 2020-10-24 |
Cell-based culture of SARS-CoV-2 informs infectivity and safe de-isolation assessments during COVID-19 (edit) |
10.1093/CID/CIAA1579 |
| 2020-10-24 |
Correlation of SARS-CoV-2 neutralizing antibodies to an automated chemiluminescent serological immunoassay (edit) |
10.1093/JALM/JFAA195 |
| 2020-10-24 |
Rapid and extraction-free detection of SARS-CoV-2 from saliva by colorimetric reverse-transcription loop-mediated isothermal amplification (edit) |
10.1093/CLINCHEM/HVAA267 |
| 2020-10-24 |
Corona Immunitas: study protocol of a nationwide program of SARS-CoV-2 seroprevalence and seroepidemiologic studies in Switzerland (edit) |
10.1007/S00038-020-01494-0 |
| 2020-10-24 |
Persistence of humoral and cellular immune response after SARS-CoV-2 infection: opportunities and challenges (edit) |
10.1007/S11684-020-0823-4 |
| 2020-10-24 |
CD147 inhibitors as a treatment for melanoma: promising agents against SARS-CoV-2 infection (edit) |
10.1111/DTH.14449 |
| 2020-10-24 |
SARS-CoV-2 infection and the gut-liver axis (edit) |
10.1111/1751-2980.12951 |
| 2020-10-24 |
Risk analysis and hot spots detection of SARS-CoV-2 in Nigeria using demographic and environmental variables: an early assessment of transmission dynamics (edit) |
10.1080/09603123.2020.1834080 |
| 2020-10-24 |
SARS-CoV-2/Renin-Angiotensin System: Deciphering the Clues for a Couple with Potentially Harmful Effects on Skeletal Muscle (edit) |
10.3390/IJMS21217904 |
| 2020-10-24 |
Olfactory bulb magnetic resonance imaging in SARS-CoV-2-induced anosmia in pediatric cases (edit) |
10.1016/J.IJPORL.2020.110469 |
| 2020-10-24 |
Ct values from SARS-CoV-2 diagnostic PCR assays should not be used as direct estimates of viral load (edit) |
10.1016/J.JINF.2020.10.017 |
| 2020-10-24 |
Screening Malaria-box compounds to identify potential inhibitors against SARS-CoV-2 Mpro, using molecular docking and dynamics simulation studies (edit) |
10.1016/J.EJPHAR.2020.173664 |
| 2020-10-24 |
Experience of an Orthopaedic Surgery Department Early During the COVID-19 Outbreak in Japan Including Real-Time Polymerase Chain Reaction Assay Results for SARS-CoV-2 (edit) |
10.7759/CUREUS.11140 |
| 2020-10-24 |
Antidiabetes Agents against Sars-Cov-2 Infection (edit) |
10.1007/S42399-020-00608-2 |
| 2020-10-24 |
Identification of Required Host Factors for SARS-CoV-2 Infection in Human Cells (edit) |
10.1016/J.CELL.2020.10.030 |
| 2020-10-24 |
Frequency of Long QT in Patients with SARS-CoV-2 Infection Treated with Hydroxychloroquine: A Meta-analysis (edit) |
10.1016/J.IJANTIMICAG.2020.106212 |
| 2020-10-24 |
Biomimetic Human Disease Model of SARS-CoV-2 Induced Lung Injury and Immune Responses on Organ Chip System (edit) |
10.1002/ADVS.202002928 |
| 2020-10-24 |
SARS-CoV-2 seroprevalence worldwide: a systematic review and meta-analysis (edit) |
10.1016/J.CMI.2020.10.020 |
| 2020-10-24 |
Characterization of neonates born to mothers with SARS-CoV-2 infection: Review and meta-analysis (edit) |
10.1016/J.PEDNEO.2020.10.001 |
| 2020-10-23 |
A multi-stage virtual screening of FDA-approved drugs reveals potential inhibitors of SARS-CoV-2 main protease (edit) |
10.1080/07391102.2020.1837680 |
| 2020-10-23 |
Potential therapeutic use of corticosteroids as SARS CoV-2 main protease inhibitors: a computational study (edit) |
10.1080/07391102.2020.1835728 |
| 2020-10-23 |
Caffeine and caffeine-containing pharmaceuticals as promising inhibitors for 3-chymotrypsin-like protease of SARS-CoV-2 (edit) |
10.1080/07391102.2020.1835732 |
| 2020-10-23 |
SARS-CoV-2 presence in the saliva, tears and cerumen of COVID-19 patients (edit) |
10.1002/LARY.29218 |
| 2020-10-23 |
Discovery of novel pyrazole derivatives as a potent anti-inflammatory agent in RAW264.7 cells via inhibition of NF-ĸB for possible benefit against SARS-CoV-2 (edit) |
10.1002/JBT.22656 |
| 2020-10-23 |
Antiviral Peptides as Promising Therapeutics against SARS-CoV-2 (edit) |
10.1021/ACS.JPCB.0C05621 |
| 2020-10-23 |
Evolutionary dynamics of SARS-CoV-2 nucleocapsid (N) protein and its consequences (edit) |
10.1002/JMV.26626 |
| 2020-10-23 |
Bilateral pulmonary emboli in a teenager with positive SARS-CoV-2 antibody (edit) |
10.1002/PPUL.25132 |
| 2020-10-23 |
Sociodemographic features and mortality of individuals on haemodialysis treatment who test positive for SARS-CoV-2: A UK Renal Registry data analysis (edit) |
10.1371/JOURNAL.PONE.0241263 |
| 2020-10-23 |
Potency and timing of antiviral therapy as determinants of duration of SARS-CoV-2 shedding and intensity of inflammatory response (edit) |
10.1126/SCIADV.ABC7112 |
| 2020-10-23 |
Virology, transmission, and pathogenesis of SARS-CoV-2 (edit) |
10.1136/BMJ.M3862 |
| 2020-10-23 |
Use of exhaled breath condensate (EBC) in the diagnosis of SARS-COV-2 (COVID-19) (edit) |
10.1136/THORAXJNL-2020-215705 |
| 2020-10-23 |
A platform incorporating trimeric antigens into self-assembling nanoparticles reveals SARS-CoV-2-spike nanoparticles to elicit substantially higher neutralizing responses than spike alone (edit) |
10.1038/S41598-020-74949-2 |
| 2020-10-23 |
Non-infectious status indicated by detectable IgG antibody to SARS-CoV-2 (edit) |
10.1038/S41415-020-2228-9 |
| 2020-10-23 |
Electrocardiographic findings at presentation and clinical outcome in patients with SARS-CoV-2 infection (edit) |
10.1093/EUROPACE/EUAA245 |
| 2020-10-23 |
A Sensitive Reverse Transcription Loop-Mediated Isothermal Amplification Assay for Direct Visual Detection of SARS-CoV-2 (edit) |
10.4269/AJTMH.20-1079 |
| 2020-10-23 |
SARS-CoV-2 in Semen (edit) |
10.1159/000511616 |
| 2020-10-23 |
Novel Coronavirus SARS-CoV-2 (COVID-19) and Pregnancy: A hypothetical view (edit) |
10.2174/1871530320666201023124843 |
| 2020-10-23 |
Temporal and spatial concomitance of exanthema and dysesthesia in a patient with SARS-Cov-2 infection (edit) |
10.1016/J.BBIH.2020.100165 |
| 2020-10-23 |
SARS-CoV-2 isolation from the first reported patients in Brazil and establishment of a coordinated task network (edit) |
10.1590/0074-02760200342 |
| 2020-10-23 |
Nucleic Acid and Immunological Diagnostics for SARS-CoV-2: Processes, Platforms and Pitfalls (edit) |
10.3390/DIAGNOSTICS10110866 |
| 2020-10-23 |
More than Pneumonia: Distinctive Features of SARS-Cov-2 Infection. From Autopsy Findings to Clinical Implications: A Systematic Review (edit) |
10.3390/MICROORGANISMS8111642 |
| 2020-10-23 |
Low Seroprevalence of SARS-CoV-2 Antibodies during Systematic Antibody Screening and Serum Responses in Patients after COVID-19 in a German Transplant Center (edit) |
10.3390/JCM9113401 |
| 2020-10-23 |
Evaluation of Commercially Available Viral Transport Medium (VTM) for SARS-CoV-2 Inactivation and Use in Point-of-Care (POC) Testing (edit) |
10.3390/V12111208 |
| 2020-10-23 |
Ebselen, a new candidate therapeutic against SARS-CoV-2 (edit) |
10.1016/J.IJSU.2020.10.018 |
| 2020-10-23 |
Statins and SARS-CoV-2 disease: Current concepts and possible benefits (edit) |
10.1016/J.DSX.2020.10.021 |
| 2020-10-23 |
Dried SARS-CoV-2 virus maintains infectivity to Vero E6 cells for up to 48 h (edit) |
10.1016/J.VETMIC.2020.108907 |
| 2020-10-23 |
Long-acting nanoparticulate DNase-1 for effective suppression of SARS-CoV-2-mediated neutrophil activities and cytokine storm (edit) |
10.1016/J.BIOMATERIALS.2020.120389 |
| 2020-10-23 |
In the Age of CoVID: Genomic Changes Over the Lifespan Help Explain Severe SARS-CoV-2 Disease (edit) |
10.1016/J.JACBTS.2020.10.004 |
| 2020-10-23 |
Quantitative analysis of SARS-CoV-2 RNA from wastewater solids in communities with low COVID-19 incidence and prevalence (edit) |
10.1016/J.WATRES.2020.116560 |
| 2020-10-23 |
Interaction of small molecules with the SARS-CoV-2 main protease in silico and in vitro validation of potential lead compounds using an enzyme-linked immunosorbent assay (edit) |
10.1016/J.COMPBIOLCHEM.2020.107408 |
| 2020-10-23 |
NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge (edit) |
10.1016/J.VACCINE.2020.10.064 |
| 2020-10-23 |
Nano-targeting lessons from the SARS-CoV-2 (edit) |
10.1016/J.NANTOD.2020.101012 |
| 2020-10-23 |
New Pathways of Mutational Change in SARS-CoV-2 Proteomes Involve Regions of Intrinsic Disorder Important for Virus Replication and Release (edit) |
10.1177/1176934320965149 |
| 2020-10-23 |
Evidence that Maackia amurensis seed lectin (MASL) exerts pleiotropic actions on oral squamous cells to inhibit SARS-CoV-2 infection and COVID-19 disease progression (edit) |
10.21203/RS.3.RS-93851/V1 |
| 2020-10-23 |
Sterilizing Immunity against SARS-CoV-2 Infection in Mice by a Single-Shot and Modified Imidazoquinoline TLR7/8 Agonist-Adjuvanted Recombinant Spike Protein Vaccine (edit) |
10.1101/2020.10.23.344085 |
| 2020-10-23 |
Broadly-targeted autoreactivity is common in severe SARS-CoV-2 Infection (edit) |
10.1101/2020.10.21.20216192 |
| 2020-10-23 |
Malleability of the SARS-CoV-2 3CL Mpro Active-Site Cavity Facilitates Binding of Clinical Antivirals (edit) |
10.1016/J.STR.2020.10.007 |
| 2020-10-23 |
Positive Selection of ORF1ab, ORF3a, and ORF8 Genes Drives the Early Evolutionary Trends of SARS-CoV-2 During the 2020 COVID-19 Pandemic (edit) |
10.3389/FMICB.2020.550674 |
| 2020-10-23 |
G-Quadruplexes Are Present in Human Coronaviruses Including SARS-CoV-2 (edit) |
10.3389/FMICB.2020.567317 |
| 2020-10-23 |
Predicting the Animal Susceptibility and Therapeutic Drugs to SARS-CoV-2 Based on Spike Glycoprotein Combined With ACE2 (edit) |
10.3389/FGENE.2020.575012 |
| 2020-10-23 |
Neonatal Infection Due to SARS-CoV-2: An Epidemiological Study in Spain (edit) |
10.3389/FPED.2020.580584 |
| 2020-10-23 |
Hijacking SARS-CoV-2/ACE2 Receptor Interaction by Natural and Semi-synthetic Steroidal Agents Acting on Functional Pockets on the Receptor Binding Domain (edit) |
10.3389/FCHEM.2020.572885 |
| 2020-10-23 |
The Landscape of Coronavirus Disease 2019 (COVID-19) and Integrated Analysis SARS-CoV-2 Receptors and Potential Inhibitors in Lung Adenocarcinoma Patients (edit) |
10.3389/FCELL.2020.577032 |
| 2020-10-23 |
Brazilian Consortium for the Study on Renal Diseases Associated With COVID-19: A Multicentric Effort to Understand SARS-CoV-2-Related Nephropathy (edit) |
10.3389/FMED.2020.584235 |
| 2020-10-23 |
Genetic and hormonal influence on SARS-CoV-2-infection susceptibility: Re: The potential influence of human Y-chromosome haplogroup on COVID-19 prevalence and mortality (edit) |
10.1016/J.ANNONC.2020.07.022 |
| 2020-10-23 |
SARS-CoV-2 Nucleocapsid protein attenuates stress granule formation and alters gene expression via direct interaction with host mRNAs (edit) |
10.1101/2020.10.23.342113 |
| 2020-10-23 |
Transferrin receptor is another receptor for SARS-CoV-2 entry (edit) |
10.1101/2020.10.23.350348 |
| 2020-10-22 |
Specific re-distribution of SARS-CoV-2 variants in the respiratory system and intestinal tract (edit) |
10.1093/CID/CIAA1617 |
| 2020-10-22 |
ACE2 (Angiotensin-Converting Enzyme 2) and TMPRSS2 (Transmembrane Serine Protease 2) Expression and Localization of SARS-CoV-2 Infection in the Human Heart (edit) |
10.1161/ATVBAHA.120.315229 |
| 2020-10-22 |
Dynamics of SARS-CoV-2 transmission among Indian nationals evacuated from Iran (edit) |
10.1017/DMP.2020.393 |
| 2020-10-22 |
A perspective on re-detectable positive SARS-CoV-2 nucleic acid results in recovered COVID-19 patients (edit) |
10.1017/DMP.2020.392 |
| 2020-10-22 |
In Utero SARS-CoV-2 Infection (edit) |
10.1093/JPIDS/PIAA127 |
| 2020-10-22 |
Prolonged SARS-CoV-2 replication in an immunocompromised patient (edit) |
10.1093/INFDIS/JIAA666 |
| 2020-10-22 |
Safety considerations for the use of Point-Of-Care diagnostics during SARS-CoV-2 pandemic (edit) |
10.1002/JCLA.23631 |
| 2020-10-22 |
Prevention of SARS-CoV-2 cell entry: insight from in silico interaction of drug-like alkaloids with spike glycoprotein, human ACE2, and TMPRSS2 (edit) |
10.1080/07391102.2020.1835726 |
| 2020-10-22 |
Susceptibility of Raccoon Dogs for Experimental SARS-CoV-2 Infection (edit) |
10.3201/EID2612.203733 |
| 2020-10-22 |
Serologic Responses in Healthy Adult with SARS-CoV-2 Reinfection, Hong Kong, August 2020 (edit) |
10.3201/EID2612.203833 |
| 2020-10-22 |
CD147 as a novel receptor in the pathogenesis of SARS-CoV-2: Is there any correlation with risk of COVID-19 in dermatological diseases? (edit) |
10.1111/DTH.14443 |
| 2020-10-22 |
SARS CoV-2 Surveillance and Exposure in the Perioperative Setting with Universal testing and Personal Protective Equipment (PPE) Policies (edit) |
10.1093/CID/CIAA1607 |
| 2020-10-22 |
Diaphragmatic myoclonus due to SARS-CoV-2 infection (edit) |
10.1007/S10072-020-04766-Y |
| 2020-10-22 |
Possible vertical transmission and antibodies against SARS-CoV-2 among infants born to mothers with COVID-19: A living systematic review (edit) |
10.1002/JMV.26622 |
| 2020-10-22 |
Sex differences in antiviral immunity in SARS-CoV-2 infection: mitochondria and mitomiR come into view (edit) |
10.1111/APHA.13571 |
| 2020-10-22 |
Virtual Double-System Single-Box: A Nonequilibrium Alchemical Technique for Absolute Binding Free Energy Calculations: Application to Ligands of the SARS-CoV-2 Main Protease (edit) |
10.1021/ACS.JCTC.0C00634 |
| 2020-10-22 |
Hydroxychloroquine prophylaxis and treatment is ineffective in macaque and hamster SARS-CoV-2 disease models (edit) |
10.1172/JCI.INSIGHT.143174 |
| 2020-10-22 |
Antibody kinetics and serologic profiles of SARS-CoV-2 infection using two serologic assays (edit) |
10.1371/JOURNAL.PONE.0240395 |
| 2020-10-22 |
Time-lapse sentinel surveillance of SARS-CoV-2 spread in India (edit) |
10.1371/JOURNAL.PONE.0241172 |
| 2020-10-22 |
Alternative clinical specimens for the detection of SARS-CoV-2: A rapid review (edit) |
10.1002/RMV.2185 |
| 2020-10-22 |
Animals and SARS-CoV-2: Species susceptibility and viral transmission in experimental and natural conditions, and the potential implications for community transmission (edit) |
10.1111/TBED.13885 |
| 2020-10-22 |
SARS-CoV-2 infection as a risk factor for herpesviridae reactivation: consider the potential influence of corticosteroid therapy (edit) |
10.1186/S13054-020-03349-9 |
| 2020-10-22 |
Human genetic factors associated with susceptibility to SARS-CoV-2 infection and COVID-19 disease severity (edit) |
10.1186/S40246-020-00290-4 |
| 2020-10-22 |
[Letter to the Editor Regarding Torres-Costa et al "SARS-CoV-2 in Ophtalmology: Current Evidence and Recommendations for Clinical Practice"] (edit) |
10.20344/AMP.14855 |
| 2020-10-22 |
Comparison of upper respiratory viral load distributions in asymptomatic and symptomatic children diagnosed with SARS-CoV-2 infection in pediatric hospital testing programs (edit) |
10.1128/JCM.02593-20 |
| 2020-10-22 |
Protocol for a prospective, observational, hospital-based multicentre study of nosocomial SARS-CoV-2 transmission: NOSO-COR Project (edit) |
10.1136/BMJOPEN-2020-039088 |
| 2020-10-22 |
Sequencing identifies multiple early introductions of SARS-CoV-2 to the New York City Region (edit) |
10.1101/GR.266676.120 |
| 2020-10-22 |
Engineered ACE2 receptor traps potently neutralize SARS-CoV-2 (edit) |
10.1073/PNAS.2016093117 |
| 2020-10-22 |
Understanding protection from SARS-CoV-2 by studying reinfection (edit) |
10.1038/S41591-020-1121-Z |
| 2020-10-22 |
SARS-CoV-2 Mpro inhibitors and activity-based probes for patient-sample imaging (edit) |
10.1038/S41589-020-00689-Z |
| 2020-10-22 |
Computational selection of flavonoid compounds as inhibitors against SARS-CoV-2 main protease, RNA-dependent RNA polymerase and spike proteins: A molecular docking study (edit) |
10.1016/J.SJBS.2020.10.028 |
| 2020-10-22 |
Potential SARS-CoV-2 interactions with proteins involved in trophoblast functions - An in-silico study (edit) |
10.1016/J.PLACENTA.2020.10.027 |
| 2020-10-22 |
Anti-SARS-CoV-2 IgG antibody response among Indian COVID-19 patients using β-propiolactone-inactivated, whole virus-based indirect ELISA (edit) |
10.1016/J.JVIROMET.2020.113996 |
| 2020-10-22 |
Low-threshold SARS-CoV-2 testing facility for hospital staff: Prevention of COVID-19 outbreaks? (edit) |
10.1016/J.IJHEH.2020.113653 |
| 2020-10-22 |
Association between personal protective equipment and SARS-CoV-2 infection risk in emergency department healthcare workers (edit) |
10.1097/MEJ.0000000000000766 |
| 2020-10-22 |
Global Reports of Intussusception in Infants With SARS-CoV-2 Infection (edit) |
10.1097/INF.0000000000002946 |
| 2020-10-22 |
The Importance of Research on the Origin of SARS-CoV-2 (edit) |
10.3390/V12111203 |
| 2020-10-22 |
The SARS-CoV-2 Spike Glycoprotein as a Drug and Vaccine Target: Structural Insights into Its Complexes with ACE2 and Antibodies (edit) |
10.3390/CELLS9112343 |
| 2020-10-22 |
Pediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2: a New Challenge amid the Pandemic (edit) |
10.1007/S42399-020-00602-8 |
| 2020-10-22 |
Analysis of SARS-CoV-2 ORF3a structure reveals chloride binding sites (edit) |
10.1101/2020.10.22.349522 |
| 2020-10-22 |
Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: Results from a statewide epidemiological study (edit) |
10.1101/2020.10.11.20210922 |
| 2020-10-22 |
TEMPORARY REMOVAL: Hospital factors associated with SARS-CoV-2 infection among healthcare personnel in Greece (edit) |
10.1016/J.JHIN.2020.10.010 |
| 2020-10-22 |
Human coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 in children (edit) |
10.1016/J.PEDN.2020.10.020 |
| 2020-10-22 |
Craig Wilen and Asma Hatoum-Aslan: Tales from within and without the SARS-CoV-2 Research Sphere (edit) |
10.1016/J.TIM.2020.10.006 |
| 2020-10-22 |
SARS-CoV-2 risk misclassification explains poor COVID-19 management (edit) |
10.1016/S0140-6736(20)32169-3 |
| 2020-10-22 |
Physical distancing in schools for SARS-CoV-2 and the resurgence of rhinovirus (edit) |
10.1016/S2213-2600(20)30502-6 |
| 2020-10-22 |
Risk of SARS-CoV-2 Transmission Among Coworkers in a Surgical Environment (edit) |
10.1016/J.MAYOCP.2020.10.016 |
| 2020-10-21 |
Lockdown measures and relative changes in the age-specific incidence of SARS-CoV-2 in Spain (edit) |
10.1017/S0950268820002551 |
| 2020-10-21 |
Saliva is the Key Element for SARS-CoV-2 Mass Screening (edit) |
10.1093/CID/CIAA1440 |
| 2020-10-21 |
Seroprevalence of anti-SARS-CoV-2 antibodies in COVID-19 patients and healthy volunteers up to six months post disease onset (edit) |
10.1002/EJI.202048970 |
| 2020-10-21 |
Is the outcome of SARS-CoV-2 infection in solid organ transplant recipients really similar to that of the general population? (edit) |
10.1111/AJT.16370 |
| 2020-10-21 |
Targeting the 3CLpro and RdRp of SARS-CoV-2 with phytochemicals from medicinal plants of the Andean Region: molecular docking and molecular dynamics simulations (edit) |
10.1080/07391102.2020.1835716 |
| 2020-10-21 |
Commercial Serology Assays Predict Neutralization Activity Against SARS-CoV-2 (edit) |
10.1093/CLINCHEM/HVAA262 |
| 2020-10-21 |
Transmission and prevention of SARS-CoV-2 (edit) |
10.1042/BST20200693 |
| 2020-10-21 |
SARS-CoV-2 specific virulence factors in COVID-19 (edit) |
10.1002/JMV.26615 |
| 2020-10-21 |
Can urine be a potential biohazard in times of SARS-CoV-2 pandemic? (edit) |
10.1002/JMV.26616 |
| 2020-10-21 |
Intricacies in characterizing positivity in pooled sample testing for SARS-CoV-2 (edit) |
10.1002/JMV.26618 |
| 2020-10-21 |
An estimation of airborne SARS-CoV-2 infection transmission risk in New York City nail salons (edit) |
10.1177/0748233720964650 |
| 2020-10-21 |
Systematic screening for SARS-CoV-2 in pregnant women admitted for delivery in a Portuguese maternity (edit) |
10.1515/JPM-2020-0387 |
| 2020-10-21 |
Serum-IgG responses to SARS-CoV-2 after mild and severe COVID-19 infection and analysis of IgG non-responders (edit) |
10.1371/JOURNAL.PONE.0241104 |
| 2020-10-21 |
The detection of SARS-CoV-2 virus in the vaginal fluid of females with severe COVID-19 infection: scientific facts (edit) |
10.1093/CID/CIAA1608 |
| 2020-10-21 |
Dose Prediction for Repurposing Nitazoxanide in SARS-CoV-2 Treatment or Chemoprophylaxis (edit) |
10.1111/BCP.14619 |
| 2020-10-21 |
The Missing Piece - SARS-CoV-2 Testing and School Reopening (edit) |
10.1056/NEJMP2028209 |
| 2020-10-21 |
Epigenetic regulation of ACE2, the receptor of the SARS-CoV-2 virus (edit) |
10.1139/GEN-2020-0124 |
| 2020-10-21 |
A pooled testing strategy for identifying SARS-CoV-2 at low prevalence (edit) |
10.1038/S41586-020-2885-5 |
| 2020-10-21 |
Risk factors for the critical illness in SARS-CoV-2 infection: a multicenter retrospective cohort study (edit) |
10.1186/S12931-020-01492-Z |
| 2020-10-21 |
Rapid point-of-care detection of SARS-CoV-2 using reverse transcription loop-mediated isothermal amplification (RT-LAMP) (edit) |
10.1186/S12985-020-01435-6 |
| 2020-10-21 |
Combined Self-collected Anterior Nasal and Oropharyngeal Specimens versus Provider-collected Nasopharyngeal Swabs for the Detection of SARS-CoV-2 (edit) |
10.1128/JCM.02291-20 |
| 2020-10-21 |
Upcoming SARS-CoV-2 vaccine: expectations and reality (edit) |
10.1136/POSTGRADMEDJ-2020-138821 |
| 2020-10-21 |
Pasteurization Inactivates SARS-CoV-2 Spiked Breast Milk (edit) |
10.1542/PEDS.2020-031690 |
| 2020-10-21 |
Bench Research, Human Milk, and SARS-CoV-2 (edit) |
10.1542/PEDS.2020-033852 |
| 2020-10-21 |
Antibody-mediated disruption of the SARS-CoV-2 spike glycoprotein (edit) |
10.1038/S41467-020-19146-5 |
| 2020-10-21 |
Immunological considerations for SARS-CoV-2 human challenge studies (edit) |
10.1038/S41577-020-00472-0 |
| 2020-10-21 |
Human Hematopoietic Stem, Progenitor, and Immune Cells Respond Ex Vivo to SARS-CoV-2 Spike Protein (edit) |
10.1007/S12015-020-10056-Z |
| 2020-10-21 |
SARS-CoV-2 virus outbreak and the emergency public health measures in Bosnia and Herzegovina: January - July, 2020 (edit) |
10.17305/BJBMS.2020.5081 |
| 2020-10-21 |
Seroprevalence of Specific Antibodies against SARS-CoV-2 from Hotspot Communities in the Dominican Republic (edit) |
10.4269/AJTMH.20-0907 |
| 2020-10-21 |
High Levels of Stress Due to the SARS-CoV-2 Pandemic among Parents of Children with and without Chronic Conditions across the USA (edit) |
10.3390/CHILDREN7100193 |
| 2020-10-21 |
Low impact of SARS-CoV-2 infection among paediatric acute respiratory disease hospitalizations (edit) |
10.1016/J.JINF.2020.10.013 |
| 2020-10-21 |
Seroconversion in patients with cancer and oncology healthcare workers infected by SARS-CoV-2 (edit) |
10.1016/J.ANNONC.2020.10.473 |
| 2020-10-21 |
Association of liver steatosis and fibrosis with clinical outcomes in patients with SARS-CoV-2 infection (COVID-19) (edit) |
10.1016/J.AOHEP.2020.09.015 |
| 2020-10-21 |
SARS-CoV 2 (Covid-19) Heterogeneous Mortality Rates across Countries May Be Partly Explained by Life Expectancy, Calorie Intake, and Prevalence of Diabetes (edit) |
10.1007/S10745-020-00191-Z |
| 2020-10-21 |
In silico analysis of ACE2 orthologues to predict animal host range with high susceptibility to SARS-CoV-2 (edit) |
10.1007/S13205-020-02471-3 |
| 2020-10-21 |
Is the shielding effect of cholecalciferol in SARS CoV-2 infection dependable? An evidence based unraveling (edit) |
10.1016/J.CEGH.2020.10.005 |
| 2020-10-21 |
Human Lung Stem Cell-Based Alveolospheres Provide Insights into SARS-CoV-2-Mediated Interferon Responses and Pneumocyte Dysfunction (edit) |
10.1016/J.STEM.2020.10.005 |
| 2020-10-21 |
Three-Dimensional Human Alveolar Stem Cell Culture Models Reveal Infection Response to SARS-CoV-2 (edit) |
10.1016/J.STEM.2020.10.004 |
| 2020-10-21 |
Targeting the GRP78-Dependant SARS-CoV-2 Cell Entry by Peptides and Small Molecules (edit) |
10.1177/1177932220965505 |
| 2020-10-21 |
Paraneoplastic syndrome and SARS-CoV-2 - incremental effect of two thrombogenic conditions? (edit) |
10.1016/J.CJCO.2020.10.010 |
| 2020-10-21 |
Restriction of SARS-CoV-2 Replication by Targeting Programmed -1 Ribosomal Frameshifting In Vitro (edit) |
10.1101/2020.10.21.349225 |
| 2020-10-21 |
IMPACT-Restart: the influence of COVID-19 on postoperative mortality and risk factors associated with SARS-CoV-2 infection after orthopaedic and trauma surgery (edit) |
10.1302/0301-620X.102B12.BJJ-2020-1395.R2 |
| 2020-10-21 |
Benign SARS-CoV-2 infection in MOG-antibodies associated disorder during tocilizumab treatment (edit) |
10.1016/J.MSARD.2020.102592 |
| 2020-10-21 |
SARS-CoV-2 Proteome Microarray for Mapping COVID-19 Antibody Interactions at Amino Acid Resolution (edit) |
10.1021/ACSCENTSCI.0C00742 |
| 2020-10-21 |
Structural Characterization of N‐Linked Glycans in the Receptor Binding Domain of the SARS‐CoV‐2 Spike Protein and their Interactions with Human Lectins (edit) |
10.1002/ANGE.202011015 |
| 2020-10-21 |
Effectiveness of Face Masks in Preventing Airborne Transmission of SARS-CoV-2 (edit) |
10.1128/MSPHERE.00637-20 |
| 2020-10-20 |
Asymptomatische Patienten haben relativ schwache Immunantwort auf SARS-CoV-2 (edit) |
10.1007/S15033-020-1920-4 |
| 2020-10-20 |
Rapid response flow cytometric assay for the detection of antibody responses to SARS-CoV-2 (edit) |
10.1007/S10096-020-04072-7 |
| 2020-10-20 |
Neurological Manifestations in Pediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2 (PIMS-TS) (edit) |
10.1007/S12098-020-03530-6 |
| 2020-10-20 |
Impaired lung regeneration after SARS-CoV-2 infection (edit) |
10.1111/CPR.12927 |
| 2020-10-20 |
Potential therapeutic effect of turmeric contents against SARS-CoV-2 compared with experimental COVID-19 therapies: in silico study (edit) |
10.1080/07391102.2020.1835719 |
| 2020-10-20 |
Long-term intermittent detection of SARS CoV 2 in the upper respiratory tract: what is the meaning of it? (edit) |
10.1080/23744235.2020.1837944 |
| 2020-10-20 |
MCCS: a novel recognition pattern-based method for fast track discovery of anti-SARS-CoV-2 drugs (edit) |
10.1093/BIB/BBAA260 |
| 2020-10-20 |
Using Chou's 5-steps rule to study pharmacophore-based virtual screening of SARS-CoV-2 Mpro inhibitors (edit) |
10.1007/S11030-020-10148-5 |
| 2020-10-20 |
Interpretive discrepancies caused by target values inter-batch variations in chemiluminescence immunoassay for SARS-CoV-2 IgM/IgG by MAGLUMI™ (edit) |
10.1002/JMV.26612 |
| 2020-10-20 |
Saliva-based testing for diagnosis of SARS-CoV-2 infection: A meta-analysis (edit) |
10.1002/JMV.26613 |
| 2020-10-20 |
Rapid, Ultrasensitive, and Quantitative Detection of SARS-CoV-2 Using Antisense Oligonucleotides Directed Electrochemical Biosensor Chip (edit) |
10.1021/ACSNANO.0C06392 |
| 2020-10-20 |
Complete blood counts and cell population data from Sysmex XN analyser in the detection of SARS-CoV-2 infection (edit) |
10.1515/CCLM-2020-1416 |
| 2020-10-20 |
Proteins associated with neutrophil degranulation are upregulated in nasopharyngeal swabs from SARS-CoV-2 patients (edit) |
10.1371/JOURNAL.PONE.0240012 |
| 2020-10-20 |
The implementation of a rapid sample preparation method for the detection of SARS-CoV-2 in a diagnostic laboratory in South Africa (edit) |
10.1371/JOURNAL.PONE.0241029 |
| 2020-10-20 |
Multiplex rt-Real Time PCR assays for diagnostic testing of SARS-CoV-2 and seasonal influenza viruses. A challenge of the phase 3 pandemic setting (edit) |
10.1093/INFDIS/JIAA658 |
| 2020-10-20 |
Cell-mediated and humoral adaptive immune responses to SARS-CoV-2 are lower in asymptomatic than symptomatic COVID-19 patients (edit) |
10.1002/EJI.202048915 |
| 2020-10-20 |
Impact of a Nationwide Lockdown on SARS-CoV-2 Transmissibility, Italy (edit) |
10.3201/EID2701.202114 |
| 2020-10-20 |
Cost-effectiveness analysis of SARS-CoV-2 infection-prevention strategies including pre-endoscopic virus testing and use of high-risk personal protective equipment (edit) |
10.1055/A-1294-0427 |
| 2020-10-20 |
Comparative analysis of the main haematological indexes and RNA detection for the diagnosis of SARS-CoV-2 infection (edit) |
10.1186/S12879-020-05489-3 |
| 2020-10-20 |
Detecting SARS-CoV-2 at point of care: preliminary data comparing loop-mediated isothermal amplification (LAMP) to polymerase chain reaction (PCR) (edit) |
10.1186/S12879-020-05484-8 |
| 2020-10-20 |
Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity (edit) |
10.1126/SCIENCE.ABD2985 |
| 2020-10-20 |
Neuropilin-1 is a host factor for SARS-CoV-2 infection (edit) |
10.1126/SCIENCE.ABD3072 |
| 2020-10-20 |
Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate (edit) |
10.1126/SCIENCE.ABE1502 |
| 2020-10-20 |
Author Correction: Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication (edit) |
10.1038/S41467-020-19339-Y |
| 2020-10-20 |
Expression of SARS-CoV-2 entry factors in lung epithelial stem cells and its potential implications for COVID-19 (edit) |
10.1038/S41598-020-74598-5 |
| 2020-10-20 |
Multiple early introductions of SARS-CoV-2 into a global travel hub in the Middle East (edit) |
10.1038/S41598-020-74666-W |
| 2020-10-20 |
Point mutation bias in SARS-CoV-2 variants results in increased ability to stimulate inflammatory responses (edit) |
10.1038/S41598-020-74843-X |
| 2020-10-20 |
Development of humanized tri-specific nanobodies with potent neutralization for SARS-CoV-2 (edit) |
10.1038/S41598-020-74761-Y |
| 2020-10-20 |
Author Correction: SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation (edit) |
10.1038/S41594-020-00533-X |
| 2020-10-20 |
HCQ use not protective against SARS-CoV-2 (edit) |
10.1038/S41584-020-00529-3 |
| 2020-10-20 |
Bi-paratopic and multivalent VH domains block ACE2 binding and neutralize SARS-CoV-2 (edit) |
10.1038/S41589-020-00679-1 |
| 2020-10-20 |
Author Correction: Rapid SARS-CoV-2 whole-genome sequencing and analysis for informed public health decision-making in the Netherlands (edit) |
10.1038/S41591-020-1128-5 |
| 2020-10-20 |
Detailed Molecular Interactions of Favipiravir with SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza Virus Polymerases In Silico (edit) |
10.3390/MICROORGANISMS8101610 |
| 2020-10-20 |
Frequency and Duration of SARS-CoV-2 Shedding in Oral Fluid Samples Assessed by a Modified Commercial Rapid Molecular Assay (edit) |
10.3390/V12101184 |
| 2020-10-20 |
The N gene of SARS-CoV-2 was the main positive component in repositive samples from a cohort of COVID-19 patients in Wuhan, China (edit) |
10.1016/J.CCA.2020.10.019 |
| 2020-10-20 |
Structure-Altering Mutations of the SARS-CoV-2 Frame Shifting RNA Element (edit) |
10.1016/J.BPJ.2020.10.012 |
| 2020-10-20 |
Serum pooling for rapid expansion of anti-SARS-CoV-2 antibody testing capacity (edit) |
10.1016/J.TRACLI.2020.10.008 |
| 2020-10-20 |
Post-donation information and haemovigilance reporting for COVID-19 in Greece: information supporting the absence of SARS-CoV-2 possible transmission through blood components (edit) |
10.1016/J.TRACLI.2020.10.007 |
| 2020-10-20 |
NARINGENIN IS A POWERFUL INHIBITOR OF SARS-CoV-2 INFECTION IN VITRO (edit) |
10.1016/J.PHRS.2020.105255 |
| 2020-10-20 |
Has the door closed on hydroxychloroquine for SARS-COV-2? (edit) |
10.1016/J.CMI.2020.10.011 |
| 2020-10-20 |
Anti-infective therapy against SARS-CoV-2: some light at the end of the tunnel? (edit) |
10.1016/J.ACCPM.2020.10.004 |
| 2020-10-20 |
Sequence Analysis and Structure Prediction of SARS-CoV-2 Accessory Proteins 9b and ORF14: Evolutionary Analysis Indicates Close Relatedness to Bat Coronavirus (edit) |
10.1155/2020/7234961 |
| 2020-10-20 |
"One health" inspired SARS-CoV-2 surveillance: The Galapagos Islands experience (edit) |
10.1016/J.ONEHLT.2020.100185 |
| 2020-10-20 |
High-Density Amplicon Sequencing Identifies Community Spread and Ongoing Evolution of SARS-CoV-2 in the Southern United States (edit) |
10.1016/J.CELREP.2020.108352 |
| 2020-10-20 |
Cytokine Response in SARS-CoV-2 Infection in the Elderly (edit) |
10.2147/JIR.S276091 |
| 2020-10-20 |
In silico identification of Tretinoin as a SARS-CoV-2 envelope (E) protein ion channel inhibitor (edit) |
10.1016/J.COMPBIOMED.2020.104063 |
| 2020-10-20 |
Unbiased Screens Show CD8+ T Cells of COVID-19 Patients Recognize Shared Epitopes in SARS-CoV-2 that Largely Reside outside the Spike Protein (edit) |
10.1016/J.IMMUNI.2020.10.006 |
| 2020-10-20 |
Effect of a strict hygiene bundle for the prevention of nosocomial transmission of SARS-CoV-2 in the hospital: a practical approach from the field (edit) |
10.1016/J.JIPH.2020.10.005 |
| 2020-10-20 |
Genome-wide CRISPR Screens Reveal Host Factors Critical for SARS-CoV-2 Infection (edit) |
10.1016/J.CELL.2020.10.028 |
| 2020-10-20 |
Identification of evolutionarily stable sites across the SARS-CoV-2 proteome (edit) |
10.21203/RS.3.RS-95030/V1 |
| 2020-10-20 |
SARS-CoV-2 Cell Entry Factors ACE2 and TMPRSS2 are Expressed in the Pancreas but are Not Enriched in Islet Endocrine Cells (edit) |
10.1101/2020.08.31.275719 |
| 2020-10-20 |
Single-cell RNA-sequencing reveals dysregulation of molecular programs associated with SARS-CoV-2 severity and outcomes in patients with chronic lung disease (edit) |
10.1101/2020.10.20.347187 |
| 2020-10-20 |
A Sensitive, Rapid, and Portable CasRx-based Diagnostic Assay for SARS-CoV-2 (edit) |
10.1101/2020.10.14.20212795 |
| 2020-10-20 |
Emerging Molecular Prospective of SARS-CoV-2: Feasible Nanotechnology Based Detection and Inhibition (edit) |
10.3389/FMICB.2020.02098 |
| 2020-10-20 |
Lethal Pneumonia Cases in Mojiang Miners (2012) and the Mineshaft Could Provide Important Clues to the Origin of SARS-CoV-2 (edit) |
10.3389/FPUBH.2020.581569 |
| 2020-10-20 |
Accurate Diagnosis of COVID-19 by a Novel Immunogenic Secreted SARS-CoV-2 orf8 Protein (edit) |
10.1128/MBIO.02431-20 |
| 2020-10-20 |
Different mutations in SARS-CoV-2 associate with severe and mild outcome (edit) |
10.1101/2020.10.16.20213710 |
| 2020-10-19 |
Postoperative Onset and Detection of SARS-CoV-2 in Surgically Resected Specimens From Gastrointestinal Cancer Patients With Pre/Asymptomatic COVID-19 (edit) |
10.1097/SLA.0000000000004362 |
| 2020-10-19 |
B cell targeting therapies in MS patients during the SARS-CoV-2 pandemic - when immunosuppression meets infection? (edit) |
10.5603/PJNNS.A2020.0083 |
| 2020-10-19 |
Passive Immunity in Newborn from SARS-CoV-2 Infected Mother (edit) |
10.1002/JMV.26609 |
| 2020-10-19 |
SARS-CoV-2-related lung pathology: macroscopic and histologic features and their clinical implications (edit) |
10.23736/S0031-0808.20.04157-9 |
| 2020-10-19 |
Antiviral activity of traditional medicinal plants from Ayurveda against SARS-CoV-2 infection (edit) |
10.1080/07391102.2020.1832577 |
| 2020-10-19 |
Detection of SARS-CoV-2 in saliva and characterization of oral symptoms in COVID-19 patients (edit) |
10.1111/CPR.12923 |
| 2020-10-19 |
Herd Immunity and Implications for SARS-CoV-2 Control (edit) |
10.1001/JAMA.2020.20892 |
| 2020-10-19 |
Favourable perioperative outcomes for children with SARS-CoV-2 (edit) |
|
| 2020-10-19 |
Self-Collected Oral Fluid and Nasal Swab Specimens Demonstrate Comparable Sensitivity to Clinician-Collected Nasopharyngeal Swab Specimens for the Detection of SARS-CoV-2 (edit) |
10.1093/CID/CIAA1589 |
| 2020-10-19 |
SARS-CoV-2 Detection on Bronchoalveolar Lavage: An Italian Multicenter experience (edit) |
10.1159/000511964 |
| 2020-10-19 |
Continuous thrombocytopenia after SARS-CoV-2 nucleic acid negative in a non-severe COVID-19 patient for several months (edit) |
10.1186/S12879-020-05495-5 |
| 2020-10-19 |
Excess mortality in the first COVID pandemic peak: cross-sectional analyses of the impact of age, sex, ethnicity, household size, and long-term conditions in people of known SARS-Cov-2 status in England (edit) |
10.3399/BJGP20X713393 |
| 2020-10-19 |
Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins (edit) |
10.1074/MCP.RA120.002295 |
| 2020-10-19 |
Multiple myeloma and SARS-CoV-2 infection: clinical characteristics and prognostic factors of inpatient mortality (edit) |
10.1038/S41408-020-00372-5 |
| 2020-10-19 |
Reduced numbers of T cells and B cells correlates with persistent SARS-CoV-2 presence in non-severe COVID-19 patients (edit) |
10.1038/S41598-020-73955-8 |
| 2020-10-19 |
Rapid production of SARS-CoV-2 receptor binding domain (RBD) and spike specific monoclonal antibody CR3022 in Nicotiana benthamiana (edit) |
10.1038/S41598-020-74904-1 |
| 2020-10-19 |
Interferons and viruses induce a novel truncated ACE2 isoform and not the full-length SARS-CoV-2 receptor (edit) |
10.1038/S41588-020-00731-9 |
| 2020-10-19 |
Impact of stopping therapy during the SARS-CoV-2 pandemic in persons with lymphoma (edit) |
10.1007/S00432-020-03426-0 |
| 2020-10-19 |
Are Patients With Inflammatory Bowel Disease at an Increased Risk of Developing SARS-CoV-2 than Patients Without Inflammatory Bowel Disease? Results From a Nationwide Veterans' Affairs Cohort Study (edit) |
10.14309/AJG.0000000000001012 |
| 2020-10-19 |
SARS-COV-2 Infection in Patients With Alcohol-Associated Hepatitis: Metabolic Similarities and Treatment Challenges (edit) |
10.14309/AJG.0000000000001002 |
| 2020-10-19 |
Estimating the infection-fatality risk of SARS-CoV-2 in New York City during the spring 2020 pandemic wave: a model-based analysis (edit) |
10.1016/S1473-3099(20)30769-6 |
| 2020-10-19 |
Antiviral activity and safety of remdesivir against SARS-CoV-2 infection in human pluripotent stem cell-derived cardiomyocytes (edit) |
10.1016/J.ANTIVIRAL.2020.104955 |
| 2020-10-19 |
Variant analysis of the first Lebanese SARS-CoV-2 isolates (edit) |
10.1016/J.YGENO.2020.10.021 |
| 2020-10-19 |
Change of Antigenic Determinants of SARS-CoV-2 Virus S-Protein as a Possible Cause of Antibody-Dependent Enhancement of Virus Infection and Cytokine Storm (edit) |
10.1134/S0006350920040119 |
| 2020-10-19 |
Identification of alkaloids from Justicia adhatoda as potent SARS CoV-2 main protease inhibitors: An in silico perspective (edit) |
10.1016/J.MOLSTRUC.2020.129489 |
| 2020-10-19 |
Falling Dynamics of SARS-CoV-2 as a Function of Respiratory Droplet Size and Human Height (edit) |
10.1007/S40846-020-00575-Y |
| 2020-10-19 |
Unexpected Ground-Glass Opacities on Abdominopelvic CT of a Patient With a Negative SARS-CoV-2 Antigen Test Result and No Respiratory Symptoms Upon Admission (edit) |
10.7759/CUREUS.11044 |
| 2020-10-19 |
Detection and quantification of SARS-CoV-2 RNA in wastewater and treated effluents: Surveillance of COVID-19 epidemic in the United Arab Emirates (edit) |
10.1016/J.SCITOTENV.2020.142929 |
| 2020-10-19 |
Single cell resolution of SARS-CoV-2 tropism, antiviral responses, and susceptibility to therapies in primary human airway epithelium (edit) |
10.1101/2020.10.19.343954 |
| 2020-10-19 |
The Structure of the Membrane Protein of SARS-CoV-2 Resembles the Sugar Transporter SemiSWEET (edit) |
10.20411/PAI.V5I1.377 |
| 2020-10-19 |
Titanium (IV) complexes of some tetra-dentate symmetrical bis-Schiff bases of 1,6-hexanediamine: Synthesis, characterization, and in silico prediction of potential inhibitor against coronavirus (SARS-CoV-2) (edit) |
10.1002/AOC.6067 |
| 2020-10-19 |
Anti-spike, Anti-nucleocapsid and Neutralizing Antibodies in SARS-CoV-2 Inpatients and Asymptomatic Individuals (edit) |
10.3389/FMICB.2020.584251 |
| 2020-10-19 |
Identifying SARS-CoV-2 Entry Inhibitors through Drug Repurposing Screens of SARS-S and MERS-S Pseudotyped Particles (edit) |
10.1021/ACSPTSCI.0C00112 |
| 2020-10-19 |
SARS-CoV-2 genome-wide mapping of CD8 T cell recognition reveals strong immunodominance and substantial CD8 T cell activation in COVID-19 patients (edit) |
10.1101/2020.10.19.344911 |
| 2020-10-18 |
Transmission of SARS-CoV-2 via Contaminated Surfaces: What is to be Done? (edit) |
10.1093/CID/CIAA1586 |
| 2020-10-18 |
SARS-CoV-2 in pleural fluid in a kidney transplant patient (edit) |
10.1080/00325481.2020.1838817 |
| 2020-10-18 |
Added value of anti-SARS-CoV-2 antibody testing in a Flemish nursing home during an acute COVID-19 outbreak in April 2020 (edit) |
10.1080/17843286.2020.1834285 |
| 2020-10-18 |
Divergent SARS-CoV-2-specific T and B cell responses in severe but not mild COVID-19 patients (edit) |
10.1002/EJI.202048908 |
| 2020-10-18 |
Psychological Functioning of Patients Undergoing Oral Surgery Procedures during the Regime Related with SARS-CoV-2 Pandemic (edit) |
10.3390/JCM9103344 |
| 2020-10-18 |
Serological Survey following SARS-COV-2 Outbreaks at Long Term Care Facilities in Metro Vancouver, British Columbia: Implications for Outbreak Management and Infection Control Policies (edit) |
10.1016/J.AJIC.2020.10.009 |
| 2020-10-18 |
Pooling Samples to Increase SARS-CoV-2 Testing (edit) |
10.1007/S41745-020-00204-2 |
| 2020-10-18 |
Clinical Cutaneous Features of Patients Infected With SARS-CoV-2 Hospitalized for Pneumonia: A Cross-sectional Study (edit) |
10.1093/OFID/OFAA394 |
| 2020-10-18 |
Author response: Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants (edit) |
10.7554/ELIFE.61312.SA2 |
| 2020-10-17 |
Diagnosing the novel SARS-CoV-2 by quantitative RT-PCR: variations and opportunities (edit) |
10.1007/S00109-020-01992-X |
| 2020-10-17 |
Bone marrow haemophagocytosis designate severe SARS-CoV-2 infections (edit) |
10.1111/HIS.14281 |
| 2020-10-17 |
Effects of Storage Temperature and Media/Buffer for SARS-CoV-2 Nucleic Acid Detection (edit) |
10.1093/AJCP/AQAA207 |
| 2020-10-17 |
Engineered nanomaterials as fighters against SARS-CoV-2: The way to control and treat pandemics (edit) |
10.1007/S11356-020-11032-3 |
| 2020-10-17 |
Structural analysis of SARS-CoV-2 genome and predictions of the human interactome (edit) |
10.1093/NAR/GKAA864 |
| 2020-10-17 |
Comparison of Transgenic and Adenovirus hACE2 Mouse Models for SARS-CoV-2 Infection (edit) |
10.1080/22221751.2020.1838955 |
| 2020-10-17 |
Designed variants of ACE2-Fc that decouple anti-SARS-CoV-2 activities from unwanted cardiovascular effects (edit) |
10.1016/J.IJBIOMAC.2020.10.120 |
| 2020-10-17 |
Mass screening of healthcare personnel for SARS-CoV-2 in the northern emirates (edit) |
10.1016/J.JHIN.2020.10.008 |
| 2020-10-17 |
Functionalized TiO2 Nanotube-Based Electrochemical Biosensor for Rapid Detection of SARS-CoV-2 (edit) |
10.3390/S20205871 |
| 2020-10-17 |
In silico Investigation on the Inhibiting Role of Nicotine/Caffeine by Blocking the S Protein of SARS-CoV-2 Versus ACE2 Receptor (edit) |
10.3390/MICROORGANISMS8101600 |
| 2020-10-17 |
Synthesis, anti-bacterial evaluation, DFT study and molecular docking as a potential 3-chymotrypsin-like protease (3CLpro) of SARS-CoV-2 inhibitors of a novel Schiff bases (edit) |
10.1016/J.MOLSTRUC.2020.129454 |
| 2020-10-17 |
[Impact of the first wave of the SARS-CoV-2 pandemic on preferential/emergent pacemaker implantation rate. Spanish study] (edit) |
10.1016/J.RECESP.2020.10.006 |
| 2020-10-17 |
Biochemical parameters and pathogenesis of SARS-CoV-2 infection in vital organs: COVID-19 outbreak in Iran (edit) |
10.1016/J.NMNI.2020.100792 |
| 2020-10-17 |
Dynamics of respiratory droplets carrying SARS-CoV-2 virus in closed atmosphere (edit) |
10.1016/J.RINP.2020.103482 |
| 2020-10-17 |
[Pharmacokinetic changes related to acute infection. Examples from the SARS-CoV-2 pandemic] (edit) |
10.1016/J.THERAP.2020.10.001 |
| 2020-10-17 |
Applicability of polyethylene glycol precipitation followed by acid guanidinium thiocyanate-phenol-chloroform extraction for the detection of SARS-CoV-2 RNA from municipal wastewater (edit) |
10.1016/J.SCITOTENV.2020.143067 |
| 2020-10-17 |
Generation of Chicken IgY against SARS-COV-2 Spike Protein and Epitope Mapping (edit) |
10.1155/2020/9465398 |
| 2020-10-17 |
Comparison of 4 molecular assays for detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (edit) |
10.1016/J.DIAGMICROBIO.2020.115196 |
| 2020-10-17 |
The role of epidemiologists in SARS-CoV-2 and COVID-19 research (edit) |
10.1016/J.PUHE.2020.10.006 |
| 2020-10-16 |
Pooling of samples to optimize SARS-CoV-2 diagnosis by RT-qPCR: comparative analysis of two protocols (edit) |
10.1007/S10096-020-04071-8 |
| 2020-10-16 |
Superspreading Event of SARS-CoV-2 Infection at a Bar, Ho Chi Minh City, Vietnam (edit) |
10.3201/EID2701.203480 |
| 2020-10-16 |
Asymptomatic COVID-19 in a rehabilitation facility: evolution of the presence of nasopharyngeal SARS-CoV-2 and serological antibody responses (edit) |
10.1093/INFDIS/JIAA610 |
| 2020-10-16 |
A point-of-care selenium nanoparticle-based test for the combined detection of anti-SARS-CoV-2 IgM and IgG in human serum and blood (edit) |
10.1039/D0LC00828A |
| 2020-10-16 |
An overlooked role for fecal transmission of SARS-CoV-2? (edit) |
10.1093/CID/CIAA1575 |
| 2020-10-16 |
Association of ABO/Rh With SARS-CoV-2 Positivity: the Role of Race/Ethnicity in a Female Cohort (edit) |
10.1002/AJH.26019 |
| 2020-10-16 |
Weak correlation between antibody titers and neutralizing activity in sera from SARS-CoV-2 infected subjects (edit) |
10.1002/JMV.26605 |
| 2020-10-16 |
Comprehensive Analysis of the Glycan Complement of SARS-CoV-2 Spike Proteins Using Signature Ions-Triggered Electron-Transfer/Higher-Energy Collisional Dissociation (EThcD) Mass Spectrometry (edit) |
10.1021/ACS.ANALCHEM.0C03301 |
| 2020-10-16 |
SARS-CoV-2 specific antibody rearrangements in pre-pandemic immune repertoires of risk cohorts and COVID-19 patients (edit) |
10.1172/JCI142966 |
| 2020-10-16 |
Independent side-by-side validation and comparison of four serological platforms for SARS-CoV-2 antibody testing (edit) |
10.1093/INFDIS/JIAA656 |
| 2020-10-16 |
Evaluation of Three SARS CoV-2 IgG Antibody Assays and Correlation with Neutralizing Antibodies (edit) |
10.1093/JALM/JFAA188 |
| 2020-10-16 |
A patient infected with SARS-CoV-2 over 100 days (edit) |
10.1093/QJMED/HCAA296 |
| 2020-10-16 |
A parallel-group, multicenter randomized, double-blinded, placebo-controlled, phase 2/3, clinical trial to test the efficacy of pyridostigmine bromide at low doses to reduce mortality or invasive mechanical ventilation in adults with severe SARS-CoV (edit) |
10.1186/S12879-020-05485-7 |
| 2020-10-16 |
SARS-CoV-2 detection in the lower respiratory tract of invasively ventilated ARDS patients (edit) |
10.1186/S13054-020-03323-5 |
| 2020-10-16 |
Activity profiling and crystal structures of inhibitor-bound SARS-CoV-2 papain-like protease: A framework for anti-COVID-19 drug design (edit) |
10.1126/SCIADV.ABD4596 |
| 2020-10-16 |
COVID-19 serology at population scale: SARS-CoV-2-specific antibody responses in saliva (edit) |
10.1128/JCM.02204-20 |
| 2020-10-16 |
Identification of a polymorphism in the N gene of SARS-CoV-2 that adversely impacts detection by RT-PCR (edit) |
10.1128/JCM.02369-20 |
| 2020-10-16 |
Triaging of respiratory protective equipment on the assumed risk of SARS-CoV-2 aerosol exposure in patient-facing healthcare workers delivering secondary care: a rapid review (edit) |
10.1136/BMJOPEN-2020-040321 |
| 2020-10-16 |
SARS-CoV-2 Is Restricted by Zinc Finger Antiviral Protein despite Preadaptation to the Low-CpG Environment in Humans (edit) |
10.1128/MBIO.01930-20 |
| 2020-10-16 |
Quantifying the adhesive strength between the SARS-CoV-2 S-proteins and human receptor and its effect in therapeutics (edit) |
10.1038/S41598-020-74189-4 |
| 2020-10-16 |
Author Correction: A stochastic agent-based model of the SARS-CoV-2 epidemic in France (edit) |
10.1038/S41591-020-1129-4 |
| 2020-10-16 |
Development and clinical application of a rapid SARS-CoV-2 antibody test strip: A multi-center assessment across China (edit) |
10.1002/JCLA.23619 |
| 2020-10-16 |
Semen Does Not Cause Additional Risk for SARS-CoV-2 Transmission during Sexual Contact (edit) |
10.1159/000511618 |
| 2020-10-16 |
The Impact of the Global SARS-CoV-2 (COVID-19) Pandemic on Neuroanesthesiology Fellowship Programs Worldwide and the Potential Future Role for ICPNT Accreditation (edit) |
10.1097/ANA.0000000000000738 |
| 2020-10-16 |
The SARS-CoV-2 attachment receptor ACE2 is decreased in Crohn's disease and regulated by microbial and inflammatory signaling (edit) |
10.1053/J.GASTRO.2020.10.021 |
| 2020-10-16 |
Methylene blue inhibits the replication of SARS-Cov-2 in vitro (edit) |
10.1016/J.IJANTIMICAG.2020.106202 |
| 2020-10-16 |
Ototoxicity prevention during the SARS-CoV-2 (Covid-19) emergency (edit) |
10.1016/J.JGAR.2020.09.030 |
| 2020-10-16 |
Higher binding affinity of Furin to SARS-CoV-2 spike (S) protein D614G could be associated with higher SARS-CoV-2 infectivity (edit) |
10.1016/J.IJID.2020.10.033 |
| 2020-10-16 |
A Prospective Sero-epidemiological Evaluation of SARS-CoV-2 among Health Care Workers in a German Secondary Care Hospital (edit) |
10.1016/J.IJID.2020.10.026 |
| 2020-10-16 |
SARS-CoV-2 Seroprevalence Among Health Care Workers in a New York City Hospital: A Cross-Sectional Analysis During the COVID-19 Pandemic (edit) |
10.1016/J.IJID.2020.10.036 |
| 2020-10-16 |
Viral Related Tools against SARS-CoV-2 (edit) |
10.3390/V12101172 |
| 2020-10-16 |
Expression Pattern of the SARS-CoV-2 Entry Genes ACE2 and TMPRSS2 in the Respiratory Tract (edit) |
10.3390/V12101174 |
| 2020-10-16 |
Leaving no stone unturned: Allosteric targeting of SARS-CoV-2 Spike protein at putative druggable sites disrupts human angiotensin-converting enzyme interactions at the receptor binding domain (edit) |
10.1016/J.IMU.2020.100451 |
| 2020-10-16 |
The effect of temperature and humidity on the stability of SARS-CoV-2 and other enveloped viruses (edit) |
10.1101/2020.10.16.341883 |
| 2020-10-16 |
Abnormal antibodies to self-carbohydrates in SARS-CoV-2 infected patients (edit) |
10.1101/2020.10.15.341479 |
| 2020-10-16 |
A betacoronavirus multiplex microsphere immunoassay detects early SARS-CoV-2 seroconversion and controls for pre-existing seasonal human coronavirus antibody cross-reactivity (edit) |
10.1101/2020.10.14.20207050 |
| 2020-10-16 |
Rabies virus-based COVID-19 vaccine CORAVAX™ induces high levels of neutralizing antibodies against SARS-CoV-2 (edit) |
10.1038/S41541-020-00248-6 |
| 2020-10-16 |
Positive selection within the genomes of SARS-CoV-2 and other Coronaviruses independent of impact on protein function (edit) |
10.7717/PEERJ.10234 |
| 2020-10-16 |
Exploring the intrinsic dynamics of SARS-CoV-2, SARS-CoV and MERS-CoV spike glycoprotein through normal mode analysis using anisotropic network model (edit) |
10.1016/J.JMGM.2020.107778 |
| 2020-10-16 |
A dynamical model of SARS-CoV-2 based on people flow networks (edit) |
10.1016/J.SSCI.2020.105034 |
| 2020-10-16 |
Molecular docking analysis of selected phytochemicals against SARS-CoV-2 Mpro receptor (edit) |
10.1007/S42535-020-00162-1 |
| 2020-10-16 |
New-onset pustular psoriasis in the setting of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection causing Coronavirus Disease 2019 (COVID-19) (edit) |
10.1016/J.JDCR.2020.10.013 |
| 2020-10-16 |
The Integrin Binding Peptide, ATN-161, as a Novel Therapy for SARS-CoV-2 Infection (edit) |
10.1016/J.JACBTS.2020.10.003 |
| 2020-10-16 |
Kawasaki-like disease and acute myocarditis in the SARS-CoV-2 pandemic - reports of three adolescents (edit) |
10.17305/BJBMS.2020.5037 |
| 2020-10-16 |
Evaluation of a SARS-CoV-2 lateral flow assay using the plaque reduction neutralization test (edit) |
10.1016/J.DIAGMICROBIO.2020.115248 |
| 2020-10-16 |
Can immunity during pregnancy influence SARS-CoV-2 infection? - A systematic review (edit) |
10.1016/J.JRI.2020.103215 |
| 2020-10-16 |
Panbio antigen rapid test is reliable to diagnose SARS-CoV-2 infection in the first 7 days after the onset of symptoms (edit) |
10.1016/J.JCV.2020.104659 |
| 2020-10-16 |
Tempering Macrophage Plasticity for Controlling SARS-CoV-2 Infection for Managing COVID-19 Disease (edit) |
10.3389/FPHAR.2020.570698 |
| 2020-10-16 |
Potential Cross-Reactive Immunity to SARS-CoV-2 From Common Human Pathogens and Vaccines (edit) |
10.3389/FIMMU.2020.586984 |
| 2020-10-16 |
Identifying Pathways and Networks Associated With the SARS-CoV-2 Cell Receptor ACE2 Based on Gene Expression Profiles in Normal and SARS-CoV-2-Infected Human Tissues (edit) |
10.3389/FMOLB.2020.568954 |
| 2020-10-16 |
Investigation of the Effect of Temperature on the Structure of SARS-CoV-2 Spike Protein by Molecular Dynamics Simulations (edit) |
10.3389/FMOLB.2020.583523 |
| 2020-10-16 |
SARS-CoV-2: Future potential impact on timing of menarche and onset of the regular menstrual cycle in adolescents (edit) |
10.1016/J.PEDN.2020.10.011 |
| 2020-10-16 |
A Testimony of the Surgent SARS-CoV-2 in the Immunological Panorama of the Human Host (edit) |
10.3389/FCIMB.2020.575404 |
| 2020-10-16 |
No Traces of SARS-CoV-2 In Wounds of COVID-19 Positive Patients: A Pilot Study (edit) |
10.1055/S-0040-1718852 |
| 2020-10-16 |
Decline of Humoral Responses against SARS-CoV-2 Spike in Convalescent Individuals (edit) |
10.1128/MBIO.02590-20 |
| 2020-10-16 |
SARS-CoV-2 S protein ACE2 interaction reveals novel allosteric targets (edit) |
10.1101/2020.10.13.337212 |
| 2020-10-15 |
SARS-CoV-2 and acute pancreatitis: a new etiological agent? (edit) |
10.17235/REED.2020.7481/2020 |
| 2020-10-15 |
Assessment of SARS-CoV-2 in the Cerumen of COVID-19-Positive Patients (edit) |
10.1177/0145561320966067 |
| 2020-10-15 |
Increasing SARS-CoV-2 nucleic acid testing capacity during the COVID-19 epidemic in Beijing: experience from a general hospital (edit) |
10.1080/22221751.2020.1837016 |
| 2020-10-15 |
What are protective antibody responses to pandemic SARS-CoV-2? (edit) |
10.1172/JCI143466 |
| 2020-10-15 |
Capillary whole-blood IgG-IgM COVID-19 self-test as a serological screening tool for SARS-CoV-2 infection adapted to the general public (edit) |
10.1371/JOURNAL.PONE.0240779 |
| 2020-10-15 |
Potential bioactive glycosylated flavonoids as SARS-CoV-2 main protease inhibitors: A molecular docking and simulation studies (edit) |
10.1371/JOURNAL.PONE.0240653 |
| 2020-10-15 |
Important Concerns Over SARS-CoV-2 Infection in Children With Cancer (edit) |
10.1001/JAMAONCOL.2020.4756 |
| 2020-10-15 |
Important Concerns Over SARS-CoV-2 Infection in Children With Cancer-Reply (edit) |
10.1001/JAMAONCOL.2020.4767 |
| 2020-10-15 |
Background immunity: how important is it for SARS-CoV-2? (edit) |
10.1002/JMV.26602 |
| 2020-10-15 |
Characterization of community-wide transmission of SARS-CoV-2 in congregate living settings and local public health-coordinated response during the initial phase of the COVID-19 pandemic (edit) |
10.1111/IRV.12819 |
| 2020-10-15 |
Cellular Immunity in COVID-19 Convalescents with PCR-Confirmed Infection but with Undetectable SARS-CoV-2-Specific IgG (edit) |
10.3201/2701.203772 |
| 2020-10-15 |
The undiscovered potential of essential oils for treating SARS-CoV-2 (COVID- 19) (edit) |
10.2174/1381612826666201015154611 |
| 2020-10-15 |
Progression/remission of COVID-19: data-driven recommendations for repeating SARS-CoV-2 nucleic acid amplification tests (edit) |
10.1136/JCLINPATH-2020-206866 |
| 2020-10-15 |
Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms (edit) |
10.1126/SCIENCE.ABE9403 |
| 2020-10-15 |
Unusual zwitterionic catalytic site of SARS-CoV-2 main protease revealed by neutron crystallography (edit) |
10.1074/JBC.AC120.016154 |
| 2020-10-15 |
Synthesis and systematic review of reported neonatal SARS-CoV-2 infections (edit) |
10.1038/S41467-020-18982-9 |
| 2020-10-15 |
A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19 (edit) |
10.1038/S41467-020-19055-7 |
| 2020-10-15 |
Statin use is associated with lower disease severity in COVID-19 infection (edit) |
10.1038/S41598-020-74492-0 |
| 2020-10-15 |
Rapid genomic characterization of SARS-CoV-2 viruses from clinical specimens using nanopore sequencing (edit) |
10.1038/S41598-020-74656-Y |
| 2020-10-15 |
Author Correction: Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2 (edit) |
10.1038/S41594-020-00527-9 |
| 2020-10-15 |
Seroprevalence and immunity of SARS-CoV-2 infection in children and adolescents in schools in Switzerland: design for a longitudinal, school-based prospective cohort study (edit) |
10.1007/S00038-020-01495-Z |
| 2020-10-15 |
Ciprofloxacin and moxifloxacin could interact with SARS-CoV-2 protease: preliminary in silico analysis (edit) |
10.1007/S43440-020-00169-0 |
| 2020-10-15 |
Comment on "SARS-CoV-2 is Present in Peritoneal Fluid in COVID-19 Patients" (edit) |
10.1097/SLA.0000000000004541 |
| 2020-10-15 |
Comment on: SARS-CoV-2 is Present in Peritoneal Fluid in COVID-19 Patients (edit) |
10.1097/SLA.0000000000004540 |
| 2020-10-15 |
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial (edit) |
10.1016/S1473-3099(20)30831-8 |
| 2020-10-15 |
A promising inactivated whole-virion SARS-CoV-2 vaccine (edit) |
10.1016/S1473-3099(20)30832-X |
| 2020-10-15 |
Assessing the consequences of environmental exposures on the expression of the human receptor and proteases involved in SARS-CoV-2 cell-entry (edit) |
10.1016/J.ENVRES.2020.110317 |
| 2020-10-15 |
The double-edged sword of SARS-CoV-2 vs. market economy: a perspective of Brazilian dental providers (edit) |
10.1016/J.JORMAS.2020.10.001 |
| 2020-10-15 |
Ultra-sensitive viral glycoprotein detection NanoSystem toward accurate tracing SARS-CoV-2 in biological/non-biological media (edit) |
10.1016/J.BIOS.2020.112731 |
| 2020-10-15 |
Influenza Vaccination and Risk of SARS-CoV-2 Infection in a Cohort of Health Workers (edit) |
10.3390/VACCINES8040611 |
| 2020-10-15 |
SARS-CoV-2 Viral Load, IFNλ Polymorphisms and the Course of COVID-19: An Observational Study (edit) |
10.3390/JCM9103315 |
| 2020-10-15 |
Breath-, air- and surface-borne SARS-CoV-2 in hospitals (edit) |
10.1016/J.JAEROSCI.2020.105693 |
| 2020-10-15 |
Clinical spectrum and risk factors for complicated disease course in children admitted with SARS-CoV-2 infection (edit) |
10.1016/J.ANPEDE.2020.07.005 |
| 2020-10-15 |
Computer-aided drug design against spike glycoprotein of SARS-CoV-2 to aid COVID-19 treatment (edit) |
10.1016/J.HELIYON.2020.E05278 |
| 2020-10-15 |
Disease course in patients with systemic autoimmune diseases: insights on the safety of immunosuppression during the SARS-CoV-2 outbreak in Italy (edit) |
10.1016/J.EJIM.2020.10.010 |
| 2020-10-15 |
A novel rapid detection for SARS-CoV-2 spike 1 antigens using human angiotensin converting enzyme 2 (ACE2) (edit) |
10.1016/J.BIOS.2020.112715 |
| 2020-10-15 |
One-step rapid quantification of SARS-CoV-2 virus particles via low-cost nanoplasmonic sensors in generic microplate reader and point-of-care device (edit) |
10.1016/J.BIOS.2020.112685 |
| 2020-10-15 |
Co-detection of SARS-CoV-2 and other respiratory pathogens: Lessons from the field to face the second wave (edit) |
10.1016/J.JCV.2020.104658 |
| 2020-10-15 |
Sample pooling on the Cepheid Xpert® Xpress SARS-CoV-2 assay (edit) |
10.1016/J.DIAGMICROBIO.2020.115238 |
| 2020-10-15 |
A Hydrophobic-Interaction-Based Mechanism Triggers Docking between the SARS-CoV-2 Spike and Angiotensin-Converting Enzyme 2 (edit) |
10.1002/GCH2.202000067 |
| 2020-10-15 |
Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome (edit) |
10.3389/FIMMU.2020.584241 |
| 2020-10-15 |
From Standard to Escalated Anticoagulant Prophylaxis in Fractured Older Adults With SARS-CoV-2 Undergoing Accelerated Orthopedic Surgery (edit) |
10.3389/FMED.2020.566770 |
| 2020-10-15 |
Analytical and Clinical Validation for RT-qPCR Detection of SARS-CoV-2 Without RNA Extraction (edit) |
10.3389/FMED.2020.567572 |
| 2020-10-15 |
The Clinical Features and Prognostic Assessment of SARS-CoV-2 Infection-Induced Sepsis Among COVID-19 Patients in Shenzhen, China (edit) |
10.3389/FMED.2020.570853 |
| 2020-10-15 |
Locked-in Syndrome in a Young Patient Due to SARS-CoV-2: A Case Report (edit) |
10.3389/FMED.2020.574690 |
| 2020-10-15 |
Determine the Potential Epitope Based Peptide Vaccine Against Novel SARS-CoV-2 Targeting Structural Proteins Using Immunoinformatics Approaches (edit) |
10.3389/FMOLB.2020.00227 |
| 2020-10-15 |
Unsupervised explainable AI for molecular evolutionary study of forty thousand SARS-CoV-2 genomes (edit) |
10.21203/RS.3.RS-91227/V1 |
| 2020-10-15 |
Quantifying the risk of indoor drainage system in multi-unit apartment building as a transmission route of SARS-CoV-2 (edit) |
10.1016/J.SCITOTENV.2020.143056 |
| 2020-10-15 |
Defusing SARS-CoV-2: Emergency Brakes in a Vaccine Failure Scenario (edit) |
10.1021/ACSPTSCI.0C00152 |
| 2020-10-15 |
The Impact of the German Strategy for Containment of Coronavirus SARS-CoV-2 on Training Characteristics, Physical Activity and Sleep of Highly Trained Kayakers and Canoeists: A Retrospective Observational Study (edit) |
10.3389/FSPOR.2020.579830 |
| 2020-10-15 |
A high throughput RNA displacement assay for screening SARS-CoV-2 nsp10-nsp16 complex towards developing therapeutics for COVID-19 (edit) |
10.1101/2020.10.14.340034 |
| 2020-10-15 |
Imperfect innate immune antagonism renders SARS-CoV-2 vulnerable towards IFN-γ and -λ (edit) |
10.1101/2020.10.15.340612 |
| 2020-10-15 |
The Strand-biased Transcription of SARS-CoV-2 and Unbalanced Inhibition by Remdesivir (edit) |
10.1101/2020.10.15.325050 |
| 2020-10-15 |
The Lord of the NanoRings: cyclodextrins and the battle against SARS-CoV-2 (edit) |
10.1016/J.IJPHARM.2020.119689 |
| 2020-10-15 |
SARS-CoV-2 in wastewater: State of the knowledge and research needs (edit) |
10.1016/J.SCITOTENV.2020.139076 |
| 2020-10-15 |
SARS-CoV-2 - a new challenge for laboratory medicine (edit) |
10.11613/BM.2020.030503 |
| 2020-10-15 |
Prospect of SARS-CoV-2 spike protein: Potential role in vaccine and therapeutic development (edit) |
10.1016/J.VIRUSRES.2020.198141 |
| 2020-10-14 |
Platelets Promote Thromboinflammation in SARS-CoV-2 Pneumonia (edit) |
10.1161/ATVBAHA.120.315175 |
| 2020-10-14 |
Griffithsin with A Broad-Spectrum Antiviral Activity by Binding Glycans in Viral Glycoprotein Exhibits Strong Synergistic Effect in Combination with A Pan-Coronavirus Fusion Inhibitor Targeting SARS-CoV-2 Spike S2 Subunit (edit) |
10.1007/S12250-020-00305-3 |
| 2020-10-14 |
Discovery of COVID-19 Inhibitors Targeting the SARS-CoV-2 Nsp13 Helicase (edit) |
10.1021/ACS.JPCLETT.0C02421 |
| 2020-10-14 |
Continuous Positive Airway Pressure (CPAP) face-mask ventilation is an easy and cheap option to manage a massive influx of patients presenting acute respiratory failure during the SARS-CoV-2 outbreak: A retrospective cohort study (edit) |
10.1371/JOURNAL.PONE.0240645 |
| 2020-10-14 |
SARS-CoV-2 RT-PCR profile in 298 Indian COVID-19 patients: a retrospective observational study (edit) |
10.1093/FEMSPD/FTAA064 |
| 2020-10-14 |
Using student-centered approaches to teach the biochemistry of SARS-CoV-2 (edit) |
10.1002/BMB.21462 |
| 2020-10-14 |
Will SARS-CoV-2 become endemic? (edit) |
10.1126/SCIENCE.ABE5960 |
| 2020-10-14 |
Prolonged SARS-CoV-2 Viral RNA Shedding and IgG Antibody Response to SARS-CoV-2 in Patients on Hemodialysis (edit) |
10.2215/CJN.11120720 |
| 2020-10-14 |
The inhaled steroid ciclesonide blocks SARS-CoV-2 RNA replication by targeting the viral replication-transcription complex in cultured cells (edit) |
10.1128/JVI.01648-20 |
| 2020-10-14 |
Potential neuroinvasive and neurotrophic properties of SARS-CoV-2 in pediatric patients: comparison of SARS-CoV-2 with non-segmented RNA viruses (edit) |
10.1007/S13365-020-00913-5 |
| 2020-10-14 |
SARS-CoV-2 virus infection: Targets and antiviral pharmacological strategies (edit) |
10.1111/JEBM.12414 |
| 2020-10-14 |
The Architecture of Inactivated SARS-CoV-2 with Postfusion Spikes Revealed by Cryo-EM and Cryo-ET (edit) |
10.1016/J.STR.2020.10.001 |
| 2020-10-14 |
A Possible Path towards Rapid Development of Live-Attenuated SARS-CoV-2 Vaccines: Plunging into the Natural Pool (edit) |
10.3390/BIOM10101438 |
| 2020-10-14 |
Presentation, Treatment Response and Short-Term Outcomes in Paediatric Multisystem Inflammatory Syndrome Temporally Associated with SARS-CoV-2 (PIMS-TS) (edit) |
10.3390/JCM9103293 |
| 2020-10-14 |
Is There a Link between Bisphenol A (BPA), a Key Endocrine Disruptor, and the Risk for SARS-CoV-2 Infection and Severe COVID-19? (edit) |
10.3390/JCM9103296 |
| 2020-10-14 |
Amplicon-Based Detection and Sequencing of SARS-CoV-2 in Nasopharyngeal Swabs from Patients With COVID-19 and Identification of Deletions in the Viral Genome That Encode Proteins Involved in Interferon Antagonism (edit) |
10.3390/V12101164 |
| 2020-10-14 |
Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon (edit) |
10.1016/J.JACI.2020.09.034 |
| 2020-10-14 |
The Role of Air Conditioning in the Diffusion of Sars-CoV-2 in Indoor Environments: a First Computational Fluid Dynamic Model, based on Investigations performed at the Vatican State Children's Hospital (edit) |
10.1016/J.ENVRES.2020.110343 |
| 2020-10-14 |
ACE2 expression on the keratinocytes and SARS-CoV-2 percutaneous transmission, are they related? (edit) |
10.1016/J.JID.2020.09.019 |
| 2020-10-14 |
Hock-a-loogie saliva as a diagnostic specimen for SARS-CoV-2 by a PCR-based assay: a diagnostic validity study (edit) |
10.1016/J.CCA.2020.10.004 |
| 2020-10-14 |
Rapid in vitro assays for screening neutralizing antibodies and antivirals against SARS-CoV-2 (edit) |
10.1016/J.JVIROMET.2020.113995 |
| 2020-10-14 |
Specificity and positive predictive value of SARS-CoV-2 nucleic acid amplification testing in a low prevalence setting (edit) |
10.1016/J.CMI.2020.10.003 |
| 2020-10-14 |
Acute Retrograde Type A Intramural Hematoma during SARS-CoV-2 time (edit) |
10.1016/J.JVS.2020.09.019 |
| 2020-10-14 |
The Clinical and Economic Value of a Successful Shutdown During the SARS-CoV-2 Pandemic in Germany (edit) |
10.1016/J.QREF.2020.10.007 |
| 2020-10-14 |
Development of a novel platform of virus-like particle (VLP) based vaccine against coronavirus 2019 (SARS-CoV-2) by exposing of epitopes: an immunoinformatics approach (edit) |
10.1016/J.NMNI.2020.100786 |
| 2020-10-14 |
Structural and molecular basis of the interaction mechanism of selected drugs towards multiple targets of SARS-CoV-2 by molecular docking and dynamic simulation studies- deciphering the scope of repurposed drugs (edit) |
10.1016/J.COMPBIOMED.2020.104054 |
| 2020-10-14 |
Cerebral venous sinus thrombosis associated with SARS-CoV-2; a multinational case series (edit) |
10.1016/J.JNS.2020.117183 |
| 2020-10-14 |
Schnellnachweis von SARS-CoV-2 mit recombinase polymerase amplification (edit) |
10.1007/S12268-020-1458-3 |
| 2020-10-14 |
Structural stability of SARS-CoV-2 degrades with temperature (edit) |
10.1101/2020.10.12.336818 |
| 2020-10-14 |
Effects of SARS-CoV-2 mutations on protein structures and intraviral protein-protein interactions (edit) |
10.1002/JMV.26597 |
| 2020-10-14 |
Vaccine design based on 16 epitopes of SARS-CoV-2 spike protein (edit) |
10.1002/JMV.26596 |
| 2020-10-14 |
Identification of tuna protein-derived peptides as potent SARS-CoV-2 inhibitors via molecular docking and molecular dynamic simulation (edit) |
10.1016/J.FOODCHEM.2020.128366 |
| 2020-10-14 |
Benchmarking virus concentration methods for quantification of SARS-CoV-2 in raw wastewater (edit) |
10.1016/J.SCITOTENV.2020.142939 |
| 2020-10-14 |
Orthogonal SARS-CoV-2 Serological Assays Enable Surveillance of Low-Prevalence Communities and Reveal Durable Humoral Immunity (edit) |
10.1016/J.IMMUNI.2020.10.004 |
| 2020-10-14 |
Computational studies reveal mechanism by which quinone derivatives can inhibit SARS-CoV-2. Study of embelin and two therapeutic compounds of interest, methyl prednisolone and dexamethasone (edit) |
10.1016/J.JIPH.2020.09.015 |
| 2020-10-14 |
Sero-epidemiological study of SARS-CoV-2 infection among healthcare personnel in a healthcare department (edit) |
10.1016/J.EIMC.2020.09.015 |
| 2020-10-14 |
Commentary: A Human Pluripotent Stem Cell-Based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and Organoids (edit) |
10.3389/FENDO.2020.585922 |
| 2020-10-14 |
A Review of the Progress and Challenges of Developing a Vaccine for COVID-19 (edit) |
10.3389/FIMMU.2020.585354 |
| 2020-10-14 |
Recommendations for use of the diverse tests for detection of SARS-COV-2 infection (edit) |
10.1016/J.ENFCLI.2020.10.001 |
| 2020-10-14 |
Identification of Novel SARS-CoV-2 Drug Targets by Host MicroRNAs and Transcription Factors Co-regulatory Interaction Network Analysis (edit) |
10.3389/FGENE.2020.571274 |
| 2020-10-14 |
The Mystery of MIS-C Post-SARS-CoV-2 Infection (edit) |
10.1016/J.TIM.2020.10.004 |
| 2020-10-14 |
Unfortunate Outcomes in Patients With SARS-CoV-2 Superimposed on Pneumococcal Pneumonia (edit) |
10.7759/CUREUS.10939 |
| 2020-10-14 |
Epileptic discharges in acutely ill patients investigated for SARS-CoV-2/COVID-19 and the absence of evidence (edit) |
10.1002/EPI4.12435 |
| 2020-10-14 |
Response: Epileptic discharges in acutely ill patients investigated for SARS-CoV-2/COVID-19 and the absence of evidence (edit) |
10.1002/EPI4.12437 |
| 2020-10-14 |
The biomaterial polyphosphate blocks stoichiometric binding of the SARS-CoV-2 S-protein to the cellular ACE2 receptor (edit) |
10.1039/D0BM01244K |
| 2020-10-14 |
The viral protein NSP1 acts as a ribosome gatekeeper for shutting down host translation and fostering SARS-CoV-2 translation (edit) |
10.1101/2020.10.14.339515 |
| 2020-10-14 |
Evolutionary medical insights into the SARS-CoV-2 pandemic (edit) |
10.1093/EMPH/EOAA036 |
| 2020-10-14 |
[The agreed experts' position of the Eurasian Association of Therapists on tactics of management of patients with comorbid pathology infected with SARS-Cov-2] (edit) |
10.26442/00403660.2020.09.000703 |
| 2020-10-14 |
Methyltransferase-like 3 modulates severe acute respiratory syndrome coronavirus-2 RNA N6-methyladenosine modification and replication (edit) |
10.1101/2020.10.14.338558 |
| 2020-10-14 |
High and increasing prevalence of SARS-CoV-2 swab positivity in England during end September beginning October 2020: REACT-1 round 5 updated report (edit) |
10.1101/2020.10.12.20211227 |
| 2020-10-13 |
Mass gathering events and undetected transmission of SARS-CoV-2 in vulnerable populations leading to an outbreak with high case fatality ratio in the district of Tirschenreuth, Germany (edit) |
10.1017/S0950268820002460 |
| 2020-10-13 |
A Case of Fulminant Liver Failure in a 24-Year-Old Man with Coinfection with Hepatitis B Virus and SARS-CoV-2 (edit) |
10.12659/AJCR.925932 |
| 2020-10-13 |
Vaccine development in the SARS-CoV-2 pandemic: a balancing act on accuracy and speed (edit) |
10.1007/S00038-020-01511-2 |
| 2020-10-13 |
Cysteine focused covalent inhibitors against the main protease of SARS-CoV-2 (edit) |
10.1080/07391102.2020.1831610 |
| 2020-10-13 |
Comment on: SARS-Cov-2 in peritoneal fluid: an important finding in the Covid-19 pandemic (edit) |
|
| 2020-10-13 |
Author response to: Comment on: SARS-Cov-2 in peritoneal fluid: an important finding in the Covid-19 pandemic (edit) |
|
| 2020-10-13 |
Longitudinal Profile of Laboratory Parameters and Their Application in the Prediction for Fatal Outcome Among Patients Infected With SARS-CoV-2: A Retrospective Cohort Study (edit) |
10.1093/CID/CIAA574 |
| 2020-10-13 |
[What should urologists know about SARS-CoV-2? Risk analysis for urological operations and recommendations for action in clinical routine] (edit) |
10.1007/S00120-020-01264-Z |
| 2020-10-13 |
SARS-CoV-2 viral dynamics in immunocompromised patients (edit) |
10.1111/AJT.16353 |
| 2020-10-13 |
Immunocompromised Seroprevalence and Course of Illness of SARS-CoV-2 in One Pediatric Quaternary Care Center (edit) |
10.1093/JPIDS/PIAA123 |
| 2020-10-13 |
Analysis of SARS-CoV-2 mutations in Mexico, Belize and isolated regions of Guatemala and its implication in the diagnosis (edit) |
10.1002/JMV.26591 |
| 2020-10-13 |
Pentoxifylline, a drug with antiviral, anti-inflammatory and bronchodilatory effects may be a possible drug candidate for SARS-CoV-2 (edit) |
10.1159/000512234 |
| 2020-10-13 |
Home Treatment of Older People with Symptomatic SARS-CoV-2 Infection (COVID-19): A structured Summary of a Study Protocol for a Multi-Arm Multi-Stage (MAMS) Randomized Trial to Evaluate the Efficacy and Tolerability of Several Experimental Treatment (edit) |
10.1186/S13063-020-04619-1 |
| 2020-10-13 |
Sociodemographic Predictors of SARS-CoV-2 Infection in Obstetric Patients, Georgia, USA (edit) |
10.3201/EID2611.203091 |
| 2020-10-13 |
Waning Antibody Responses in Asymptomatic and Symptomatic SARS-CoV-2 Infection (edit) |
10.3201/EID2701.203515 |
| 2020-10-13 |
Performance evaluation of the SAMBA II SARS-CoV-2 Test for point-of-care detection of SARS-CoV-2 (edit) |
10.1128/JCM.01262-20 |
| 2020-10-13 |
Identify potent SARS-CoV-2 main protease inhibitors via accelerated free energy perturbation-based virtual screening of existing drugs (edit) |
10.1101/2020.05.21.108605 |
| 2020-10-13 |
Does SARS-CoV-2 Infect the Kidney? (edit) |
10.1681/ASN.2020081229 |
| 2020-10-13 |
A systematic review of SARS-CoV-2 vaccine candidates (edit) |
10.1038/S41392-020-00352-Y |
| 2020-10-13 |
SARS-CoV-2 testing and infection control strategies in European paediatric emergency departments during the first wave of the pandemic (edit) |
10.1007/S00431-020-03843-W |
| 2020-10-13 |
Critical illness neuro-myopathy (CINM) and focal amyotrophy in intensive care unit (ICU) patients with SARS-CoV-2: a case series (edit) |
10.1007/S10072-020-04820-9 |
| 2020-10-13 |
Syncytia formation by SARS-CoV-2 infected cells (edit) |
10.15252/EMBJ.2020106267 |
| 2020-10-13 |
Nosocomial SARS-CoV-2 infection in urology departments: Results of a prospective multicentric study (edit) |
10.1111/IJU.14402 |
| 2020-10-13 |
SARS-CoV-2 versus influenza associated acute respiratory distress syndrome requiring veno-venous extracorporeal membrane oxygenation support (edit) |
10.1097/MAT.0000000000001325 |
| 2020-10-13 |
Murine Typhus Outbreak Presenting as Multisystem Inflammatory Syndrome in Children During SARS-CoV-2 Pandemic (edit) |
10.1097/INF.0000000000002947 |
| 2020-10-13 |
Congenital SARS-CoV-2 Infection in a Neonate With Severe Acute Respiratory Syndrome (edit) |
10.1097/INF.0000000000002941 |
| 2020-10-13 |
Use of Ivermectin is Associated with Lower Mortality in Hospitalized Patients with COVID-19 (ICON study) (edit) |
10.1016/J.CHEST.2020.10.009 |
| 2020-10-13 |
SARS-CoV-2 testing in low- and middle-income countries: availability and affordability in the private health sector (edit) |
10.1016/J.MICINF.2020.10.005 |
| 2020-10-13 |
Kinetics of Nucleo- and Spike Protein-Specific Immunoglobulin G and of Virus-Neutralizing Antibodies after SARS-CoV-2 Infection (edit) |
10.3390/MICROORGANISMS8101572 |
| 2020-10-13 |
Estimating the Percentage of a Population Infected with SARS-CoV-2 Using the Number of Reported Deaths: A Policy Planning Tool (edit) |
10.3390/PATHOGENS9100838 |
| 2020-10-13 |
High-Throughput Screening for Inhibitors of the SARS-CoV-2 Protease Using a FRET-Biosensor (edit) |
10.3390/MOLECULES25204666 |
| 2020-10-13 |
Evolution to Online Education around the globe during a SARS-CoV-2 Coronavirus (COVID-19) Pandemic: Do develop and underdeveloped cope alike? (edit) |
10.1016/J.CHILDYOUTH.2020.105582 |
| 2020-10-13 |
Structure-Based Design of Novel Peptidomimetics Targeting the SARS-CoV-2 Spike Protein (edit) |
10.1007/S12195-020-00658-5 |
| 2020-10-13 |
Angiotensin-converting enzyme 2 (ACE2): SARS-CoV-2 receptor and RAS modulator (edit) |
10.1016/J.APSB.2020.10.006 |
| 2020-10-13 |
Reversible splenial lesion syndrome associated with SARS-CoV-2 infection in two children (edit) |
10.1016/J.BRAINDEV.2020.10.002 |
| 2020-10-13 |
Sunitinib reduces the infection of SARS-CoV, MERS-CoV and SARS-CoV-2 partially by inhibiting AP2M1 phosphorylation (edit) |
10.1038/S41421-020-00217-2 |
| 2020-10-13 |
Reconstructing SARS-CoV-2 response signaling and regulatory networks (edit) |
10.1101/2020.06.01.127589 |
| 2020-10-13 |
Ongoing Adaptive Evolution and Globalization of Sars-Cov-2 (edit) |
10.1101/2020.10.12.336644 |
| 2020-10-13 |
Structural impact on SARS-CoV-2 spike protein by D614G substitution (edit) |
10.1101/2020.10.13.337980 |
| 2020-10-13 |
Characteristics and clinical features of SARS-CoV-2 infections among ambulatory and hospitalized children and adolescents in an integrated health care system in Tennessee (edit) |
10.1101/2020.10.08.20208751 |
| 2020-10-13 |
No SARS-CoV-2 detected in air samples (pollen and particulate matter) in Leipzig during the first spread (edit) |
10.1016/J.SCITOTENV.2020.142881 |
| 2020-10-13 |
Phytochemicals from Selective Plants Have Promising Potential against SARS-CoV-2: Investigation and Corroboration through Molecular Docking, MD Simulations, and Quantum Computations (edit) |
10.1155/2020/6237160 |
| 2020-10-13 |
SARS-CoV-2 Infects the Brain Choroid Plexus and Disrupts the Blood-CSF Barrier in Human Brain Organoids (edit) |
10.1016/J.STEM.2020.10.001 |
| 2020-10-13 |
Anterior Acute Uveitis Report in a SARS-CoV-2 Patient Managed with Adjunctive Topical Antiseptic Prophylaxis Preventing 2019-nCoV Spread Through the Ocular Surface Route (edit) |
10.2147/IMCRJ.S260252 |
| 2020-10-13 |
Is oro/nasopharyngeal swab for SARS-CoV-2 detection a safe procedure? Complications observed among a case series of 4876 consecutive swabs (edit) |
10.1016/J.AMJOTO.2020.102758 |
| 2020-10-13 |
Subacute thyroiditis might be a complication triggered by SARS-CoV-2 (edit) |
10.1016/J.ENDINU.2020.09.002 |
| 2020-10-13 |
Prevalence of asymptomatic SARS-CoV-2 infection in children undergoing hospital screening (edit) |
10.1016/J.EIMC.2020.10.004 |
| 2020-10-13 |
Painless thyroiditis in SARS-CoV-2 infection (edit) |
10.1016/J.ENDINU.2020.09.001 |
| 2020-10-13 |
[Incidence of SARS-CoV-2 infection and its impact on the first week of reopening schools in Catalonia] (edit) |
10.1016/J.GACETA.2020.09.007 |
| 2020-10-13 |
On build-up of epidemiologic models-Development of a SEI3RSD model for the spread of SARS-CoV-2 (edit) |
10.1002/ZAMM.202000230 |
| 2020-10-13 |
Prevalence of obesity and hypovitaminosis D in elderly with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (edit) |
10.1016/J.CLNESP.2020.10.008 |
| 2020-10-13 |
SARS-CoV-2 screening in chronic hemodialysis patients in a third-level hospital and its peripheral centers:'one hour less in the Canary Islands' (edit) |
10.1016/J.NEFRO.2020.08.004 |
| 2020-10-13 |
From People to : Natural SARS-CoV-2 Infection in Tigers and Lions at the Bronx Zoo (edit) |
10.1128/MBIO.02220-20 |
| 2020-10-13 |
SARS-CoV-2 infects brain astrocytes of COVID-19 patients and impairs neuronal viability (edit) |
10.1101/2020.10.09.20207464 |
| 2020-10-13 |
Gargle-Direct: Extraction-Free Detection of SARS-CoV-2 using Real-time PCR (RT-qPCR) of Saline Gargle Rinse Samples (edit) |
10.1101/2020.10.09.20203430 |
| 2020-10-12 |
Histopathology of Third Trimester Placenta from SARS-CoV-2-Positive Women (edit) |
10.1080/15513815.2020.1828517 |
| 2020-10-12 |
Implementation of Infection Control Measures to Prevent Healthcare-associated Transmission of SARS-CoV-2 (edit) |
10.1017/ICE.2020.1262 |
| 2020-10-12 |
Clinical implications of SARS-CoV-2 cycle threshold values in solid organ transplant recipients (edit) |
10.1111/AJT.16357 |
| 2020-10-12 |
Validation and clinical evaluation of a SARS-CoV-2 Surrogate Virus Neutralisation Test (sVNT) (edit) |
10.1080/22221751.2020.1835448 |
| 2020-10-12 |
Clinical Profile of SARS-CoV-2 Infected Neonates From a Tertiary Government Hospital in Mumbai, India (edit) |
|
| 2020-10-12 |
SARS-CoV-2 Infection and Dual-Biologic Therapy for Crohn's Disease (edit) |
10.1093/IBD/IZAA275 |
| 2020-10-12 |
Comment about the article "SARS-CoV-2 can induce brain and spine demyelinating lesions," Acta Neurochir (Wien) 2020 Jul;162(7):1491-1494 (edit) |
10.1007/S00701-020-04604-2 |
| 2020-10-12 |
To transplant or not to transplant during the SARS COV 2 pandemic? That is the question (edit) |
10.1002/ONCO.13563 |
| 2020-10-12 |
Deus ex machina? Predicting SARS-CoV-2 Infection from Lab Tests Using Machine Learning (edit) |
10.1093/CLINCHEM/HVAA212 |
| 2020-10-12 |
SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies (edit) |
10.1038/S41586-020-2852-1 |
| 2020-10-12 |
GESS: a database of global evaluation of SARS-CoV-2/hCoV-19 sequences (edit) |
10.1093/NAR/GKAA808 |
| 2020-10-12 |
Role of the neutrophil chemoattractant CXCL5 in the SARS-CoV-2 infection-induced lung inflammatory innate immune response determined using an in vivo hACE2 transfection mouse model (edit) |
10.24272/J.ISSN.2095-8137.2020.118 |
| 2020-10-12 |
Pooling for SARS-CoV-2 control in care institutions (edit) |
10.1186/S12879-020-05446-0 |
| 2020-10-12 |
Sensitive recovery of complete SARS-CoV-2 genomes from clinical samples using Swift Biosciences' SARS-CoV-2 multiplex amplicon sequencing panel (edit) |
10.1128/JCM.02226-20 |
| 2020-10-12 |
Analysis of SARS-CoV-2 vertical transmission during pregnancy (edit) |
10.1038/S41467-020-18933-4 |
| 2020-10-12 |
Type 2 and interferon inflammation regulate SARS-CoV-2 entry factor expression in the airway epithelium (edit) |
10.1038/S41467-020-18781-2 |
| 2020-10-12 |
Drug binding dynamics of the dimeric SARS-CoV-2 main protease, determined by molecular dynamics simulation (edit) |
10.1038/S41598-020-74099-5 |
| 2020-10-12 |
Clinical status determines the efficacy of salivary and nasopharyngeal samples for detection of SARS-CoV-2 (edit) |
10.1007/S00784-020-03630-9 |
| 2020-10-12 |
T cell and antibody responses to SARS-CoV-2: experience from a French transplantation and hemodialysis center during the COVID-19 pandemic (edit) |
10.1111/AJT.16348 |
| 2020-10-12 |
Therapeutic MK-4482/EIDD-2801 Blocks SARS-CoV-2 Transmission in Ferrets (edit) |
10.21203/RS.3.RS-89433/V1 |
| 2020-10-12 |
SARS-CoV-2 spike protein-mediated cell signaling in lung vascular cells (edit) |
10.1101/2020.10.12.335083 |
| 2020-10-12 |
D614G mutation alters SARS-CoV-2 spike conformational dynamics and protease cleavage susceptibility at the S1/S2 junction (edit) |
10.1101/2020.10.11.335299 |
| 2020-10-12 |
Variability of Salivary and Nasal Specimens for SARS-CoV-2 Detection (edit) |
10.1101/2020.10.07.20208520 |
| 2020-10-12 |
SARS-CoV-2-specific peripheral T follicular helper cells correlate with neutralizing antibodies and increase during convalescence (edit) |
10.1101/2020.10.07.20208488 |
| 2020-10-12 |
Analytical Sensitivity and Specificity of Two RT-qPCR Protocols for SARS-CoV-2 Detection Performed in an Automated Workflow (edit) |
10.3390/GENES11101183 |
| 2020-10-12 |
Docking and QSAR of Aminothioureas at the SARS-CoV-2 S-Protein-Human ACE2 Receptor Interface (edit) |
10.3390/MOLECULES25204645 |
| 2020-10-12 |
Genomic evidence for reinfection with SARS-CoV-2: a case study (edit) |
10.1016/S1473-3099(20)30764-7 |
| 2020-10-12 |
Evaluation of the clinical performance of single-, dual-, and triple-target SARS-CoV-2 RT-qPCR methods (edit) |
10.1016/J.CCA.2020.10.008 |
| 2020-10-12 |
Docked SARS CoV-2 Proteins within the Cutaneous and Subcutaneous Microvasculature and their Role in the Pathogenesis of Severe COVID-19 (edit) |
10.1016/J.HUMPATH.2020.10.002 |
| 2020-10-12 |
Overall decrease of SARS-CoV-2 viral load and reduction of clinical burden: the experience of a Northern Italy hospital (edit) |
10.1016/J.CMI.2020.10.006 |
| 2020-10-12 |
Immunopathogenesis of SARS-CoV-2-induced pneumonia: lessons from influenza virus infection (edit) |
10.1186/S41232-020-00148-1 |
| 2020-10-12 |
Systematic Analyses on the Potential Immune and anti-inflammatory Mechanisms of Shufeng Jiedu Capsule against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-caused Pneumonia (edit) |
10.1016/J.JFF.2020.104243 |
| 2020-10-12 |
Understand variability of COVID-19 through population and tissue variations in expression of SARS-CoV-2 host genes (edit) |
10.1016/J.IMU.2020.100443 |
| 2020-10-12 |
Time to Treat: Applying Lessons Learned from Other Viral Syndromes to SARS-CoV-2 (edit) |
10.1016/J.MAYOCPIQO.2020.09.010 |
| 2020-10-12 |
Reversible Myocardial Injury Associated with SARS-CoV-2 in an Infant (edit) |
10.1016/J.JACCAS.2020.09.031 |
| 2020-10-12 |
Mutations of SARS-CoV-2 nsp14 exhibit strong association with increased genome-wide mutation load (edit) |
10.7717/PEERJ.10181 |
| 2020-10-12 |
Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular Probes (edit) |
10.1016/J.CELREP.2020.108322 |
| 2020-10-12 |
Transmission of SARS-CoV-2 in the Karaoke Room: An Outbreak of COVID-19 in Guangzhou, China, 2020 (edit) |
10.2991/JEGH.K.201007.001 |
| 2020-10-12 |
Natalizumab safety in paediatric-onset multiple sclerosis at the time of SARS-Cov-2 pandemic (edit) |
10.1177/2055217320966346 |
| 2020-10-12 |
A physicochemical model for rationalizing SARS-CoV-2 concentration in sewage. Case study: The city of Thessaloniki in Greece (edit) |
10.1016/J.SCITOTENV.2020.142855 |
| 2020-10-12 |
Unsupervised explainable AI for simultaneous molecular evolutionary study of forty thousand SARS-CoV-2 genomes (edit) |
10.1101/2020.10.11.335406 |
| 2020-10-12 |
Sequences in the cytoplasmic tail of SARS-CoV-2 spike facilitate syncytia formation (edit) |
10.1101/2020.10.12.335562 |
| 2020-10-12 |
Understanding the phase separation characteristics of nucleocapsid protein provides a new therapeutic opportunity against SARS-CoV-2 (edit) |
10.1101/2020.10.09.332734 |
| 2020-10-11 |
An online tool for predicting the prognosis of cancer patients with SARS-CoV-2 infection: a multi-center study (edit) |
10.1007/S00432-020-03420-6 |
| 2020-10-11 |
Atypical presentations in the hospitalised older adult testing positive for SARS-CoV-2: a retrospective observational study in Glasgow, Scotland (edit) |
10.1177/0036933020962891 |
| 2020-10-11 |
Prevalence of Current and Past SARS-CoV-2 Infections among Police Employees in Poland, June-July 2020 (edit) |
10.3390/JCM9103245 |
| 2020-10-11 |
The landscape of antibody binding to SARS-CoV-2 (edit) |
10.1101/2020.10.10.334292 |
| 2020-10-11 |
Single-dose intranasal administration of AdCOVID elicits systemic and mucosal immunity against SARS-CoV-2 in mice (edit) |
10.1101/2020.10.10.331348 |
| 2020-10-11 |
SARS-CoV-2 genomic characterization and clinical manifestation of the COVID-19 outbreak in Uruguay (edit) |
10.1101/2020.10.08.20208546 |
| 2020-10-11 |
Absence of SARS-CoV-2 neutralizing activity in pre-pandemic sera from individuals with recent seasonal coronavirus infection (edit) |
10.1101/2020.10.08.20209650 |
| 2020-10-11 |
The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood-brain barrier (edit) |
10.1016/J.NBD.2020.105131 |
| 2020-10-11 |
Incubation period of SARS-CoV-2: A systematic review and meta-analysis (edit) |
10.1016/J.CURTHERES.2020.100607 |
| 2020-10-11 |
Pancytopenia during SARS-CoV-2 infection (edit) |
10.1016/J.MEDCLE.2020.06.021 |
| 2020-10-10 |
The Impact of Social Distancing for SARS-CoV-2 on Respiratory Syncytial Virus and Influenza Burden (edit) |
10.1093/CID/CIAA1543 |
| 2020-10-10 |
SARS-CoV-2 has the advantage of competing the iMet-tRNAs with human hosts to allow efficient translation (edit) |
10.1007/S00438-020-01731-4 |
| 2020-10-10 |
Observational study of people infected with SARS-Cov-2, treated with amantadine (edit) |
10.1007/S43440-020-00168-1 |
| 2020-10-10 |
Sperm cryopreservation during the SARS-CoV-2 pandemic (edit) |
10.1007/S40618-020-01438-8 |
| 2020-10-10 |
Antibody dynamics to SARS-CoV-2 in asymptomatic COVID-19 infections (edit) |
10.1111/ALL.14622 |
| 2020-10-10 |
High-Throughput Screening for Drugs That Inhibit Papain-Like Protease in SARS-CoV-2 (edit) |
10.1177/2472555220963667 |
| 2020-10-10 |
A whole blood test to measure SARS-CoV-2 specific response in COVID-19 patients (edit) |
10.1016/J.CMI.2020.09.051 |
| 2020-10-10 |
Inactivation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by gaseous ozone treatment (edit) |
10.1016/J.JHIN.2020.10.004 |
| 2020-10-10 |
Non-synonymous Mutations of SARS-CoV-2 Leads Epitope Loss and Segregates its Variants (edit) |
10.1016/J.MICINF.2020.10.004 |
| 2020-10-10 |
Cardiovascular magnetic resonance imaging in children with pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 and heart dysfunction (edit) |
10.1016/J.CMI.2020.10.005 |
| 2020-10-10 |
Protease Inhibitory Effect of Natural Polyphenolic Compounds on SARS-CoV-2: An In Silico Study (edit) |
10.3390/MOLECULES25204604 |
| 2020-10-10 |
Genomic Diversity and Hotspot Mutations in 30,983 SARS-CoV-2 Genomes: Moving Toward a Universal Vaccine for the "Confined Virus"? (edit) |
10.3390/PATHOGENS9100829 |
| 2020-10-10 |
The Neutrophil-to-Monocyte Ratio and Lymphocyte-to-Neutrophil Ratio at Admission Predict In-Hospital Mortality in Mexican Patients with Severe SARS-CoV-2 Infection (Covid-19) (edit) |
10.3390/MICROORGANISMS8101560 |
| 2020-10-10 |
Invasive Pulmonary Aspergillosis in Patients with SARS-CoV-2 Infection: A Systematic Review of the Literature (edit) |
10.3390/DIAGNOSTICS10100807 |
| 2020-10-10 |
Reply to comment: Asymptomatic screening for SARS COV-2 prior to commencement of biologic therapies in patients with inflammatory bowel disease - a potentially harmful practice (edit) |
10.1016/J.DLD.2020.09.020 |
| 2020-10-10 |
Perinatal mortality and morbidity of SARS-COV-2 infection during pregnancy in European countries: Findings from an international study (edit) |
10.1016/J.EJOGRB.2020.10.009 |
| 2020-10-10 |
Initial SARS-CoV-2 PCR crossing point does not predict hospitalization and duration of PCR positivity (edit) |
10.1016/J.JMII.2020.08.020 |
| 2020-10-10 |
The role of death domain proteins in host response upon SARS-CoV-2 infection: modulation of programmed cell death and translational applications (edit) |
10.1038/S41420-020-00331-W |
| 2020-10-10 |
Identification of novel mutations in the methyltransferase complex (Nsp10-Nsp16) of SARS-CoV-2 (edit) |
10.1016/J.BBREP.2020.100833 |
| 2020-10-10 |
SARS-CoV-2 in 2020 (edit) |
10.1016/J.COESH.2020.10.001 |
| 2020-10-10 |
A prediction model to prioritize individuals for SARS-CoV-2 test built from national symptom surveys (edit) |
10.1016/J.MEDJ.2020.10.002 |
| 2020-10-10 |
Sex-biased Immune Responses Following SARS-CoV-2 Infection (edit) |
10.1016/J.TIM.2020.10.002 |
| 2020-10-10 |
Multi-omics-based identification of SARS-CoV-2 infection biology and candidate drugs against COVID-19 (edit) |
10.1016/J.COMPBIOMED.2020.104051 |
| 2020-10-10 |
Analysis of SARS-CoV-2 in the air of an ICU dedicated to covid-19 patients (edit) |
10.1016/J.MEDIN.2020.09.004 |
| 2020-10-10 |
A Rare Presentation of Multi-System Inflammatory Disease in Children Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (edit) |
10.7759/CUREUS.10892 |
| 2020-10-10 |
A case of COVID-19 pneumonia successfully treated with favipiravir (Avigan) in which serum SARS-CoV-2 RNA detected by LAMP method was clinically useful (edit) |
10.1016/J.JIAC.2020.10.011 |
| 2020-10-09 |
Case Series of Multisystem Inflammatory Syndrome in Adults Associated with SARS-CoV-2 Infection - United Kingdom and United States, March-August 2020 (edit) |
10.15585/MMWR.MM6940E1 |
| 2020-10-09 |
Differences in Performance Characteristics Among Four High-Throughput Assays for the Detection of Antibodies Against SARS-CoV-2 Using a Common Set of Patient Samples (edit) |
10.1093/AJCP/AQAA200 |
| 2020-10-09 |
Temperature Screening for SARS-CoV-2 in Nursing Homes: Evidence from Two National Cohorts (edit) |
10.1111/JGS.16876 |
| 2020-10-09 |
Predicting susceptibility for SARS-CoV-2 infection in domestic and wildlife animals using ACE2 protein sequence homology (edit) |
10.1002/ZOO.21576 |
| 2020-10-09 |
Experimental Infection of Cattle with SARS-CoV-2 (edit) |
10.3201/EID2612.203799 |
| 2020-10-09 |
Povidone-iodine and carrageenan are candidates for SARS-CoV-2 infection control (edit) |
10.12809/HKMJ208889 |
| 2020-10-09 |
Antimicrobial Nanomaterials and Coatings: Current Mechanisms and Future Perspectives to Control the Spread of Viruses Including SARS-CoV-2 (edit) |
10.1021/ACSNANO.0C05937 |
| 2020-10-09 |
Whole genome sequencing and phylogenetic classification of Tunisian SARS-CoV-2 strains from patients of the Military Hospital in Tunis (edit) |
10.1007/S11262-020-01795-9 |
| 2020-10-09 |
Retest positive for SARS-CoV-2 RNA of recovered pregnant women with COVID-19 (edit) |
10.1002/UOG.23144 |
| 2020-10-09 |
SARS-CoV-2 Cluster in Nursery, Poland (edit) |
10.3201/EID2701.203849 |
| 2020-10-09 |
Neutralizing antibody against SARS-CoV-2 spike in COVID-19 patients, health care workers and convalescent plasma donors (edit) |
10.1172/JCI.INSIGHT.143213 |
| 2020-10-09 |
Antibody responses to SARS-CoV-2 in patients with differing severities of coronavirus disease 2019 (edit) |
10.1371/JOURNAL.PONE.0240502 |
| 2020-10-09 |
Interferon-gamma release assay for accurate detection of SARS-CoV-2 T cell response (edit) |
10.1093/CID/CIAA1537 |
| 2020-10-09 |
Re-infection with SARS-CoV-2: What Goes Around May Come Back Around (edit) |
10.1093/CID/CIAA1541 |
| 2020-10-09 |
DockCoV2: a drug database against SARS-CoV-2 (edit) |
10.1093/NAR/GKAA861 |
| 2020-10-09 |
Analysis of SARS-CoV-2 Transmission in Different Settings, Brunei (edit) |
10.3201/EID2611.202263 |
| 2020-10-09 |
Molecular modeling study of tectoquinone and acteoside from Tectona grandis linn: a new SARS-CoV-2 main protease inhibitor against COVID-19 (edit) |
10.1080/07391102.2020.1832580 |
| 2020-10-09 |
Students' and lecturers' perspective on the implementation of online learning in dental education due to SARS-CoV-2 (COVID-19): a cross-sectional study (edit) |
10.1186/S12909-020-02266-3 |
| 2020-10-09 |
Cross-reactive neutralization of SARS-CoV-2 by serum antibodies from recovered SARS patients and immunized animals (edit) |
10.1126/SCIADV.ABC9999 |
| 2020-10-09 |
REGN-COV2 antibodies prevent and treat SARS-CoV-2 infection in rhesus macaques and hamsters (edit) |
10.1126/SCIENCE.ABE2402 |
| 2020-10-09 |
Heterogeneity in testing, diagnosis and outcome in SARS-CoV-2 infection across outbreak settings in the Greater Toronto Area, Canada: an observational study (edit) |
10.9778/CMAJO.20200213 |
| 2020-10-09 |
Rhabdomyolysis as the Initial Presentation of SARS-CoV-2 in an Adolescent (edit) |
10.1542/PEDS.2020-019273 |
| 2020-10-09 |
Mortality and pulmonary complications in patients undergoing upper extremity surgery at the peak of the SARS-CoV-2 pandemic in the UK: a national cohort study (edit) |
10.1136/BMJQS-2020-012156 |
| 2020-10-09 |
Inhibition of translation and immune responses by the virulence factor Nsp1 of SARS-CoV-2 (edit) |
10.1038/S41392-020-00350-0 |
| 2020-10-09 |
SARS-CoV-2 triggers inflammatory responses and cell death through caspase-8 activation (edit) |
10.1038/S41392-020-00334-0 |
| 2020-10-09 |
Accommodating individual travel history and unsampled diversity in Bayesian phylogeographic inference of SARS-CoV-2 (edit) |
10.1038/S41467-020-18877-9 |
| 2020-10-09 |
A compromised specific humoral immune response against the SARS-CoV-2 receptor-binding domain is related to viral persistence and periodic shedding in the gastrointestinal tract (edit) |
10.1038/S41423-020-00550-2 |
| 2020-10-09 |
Seroreactivity with COVID 19 antibody testing in CCP donors presenting without a SARS-CoV-2 diagnostic test (edit) |
10.1111/TRF.16146 |
| 2020-10-09 |
Targeted delivery of CRISPR/Cas13 as a promising therapeutic approach to treat SARS-CoV-2 (edit) |
10.2174/1389201021666201009154517 |
| 2020-10-09 |
Impact of SARS-CoV-2 Infection on patients suffering from Liver Injury (edit) |
10.1159/000512153 |
| 2020-10-09 |
Response to the letter: Impact of SARS-CoV-2 infection on patients suffering from liver injury (edit) |
10.1159/000512151 |
| 2020-10-09 |
Reinfection of SARS-CoV-2 in an immunocompromised patient: a case report (edit) |
10.1093/CID/CIAA1538 |
| 2020-10-09 |
Comparison of Clinical and Epidemiologic Characteristics of Young Febrile Infants with and without SARS-CoV-2 Infection (edit) |
10.1016/J.JPEDS.2020.10.002 |
| 2020-10-09 |
A combined approach of MALDI-TOF Mass Spectrometry and multivariate analysis as a potential tool for the detection of SARS-CoV-2 virus in nasopharyngeal swabs (edit) |
10.1016/J.JVIROMET.2020.113991 |
| 2020-10-09 |
Proof of SARS-CoV-2 Genomes in Endomyocardial Biopsy with Latency After Acute Infection (edit) |
10.1016/J.IJID.2020.10.012 |
| 2020-10-09 |
A CRISPR-Cas12a-based specific enhancer for more sensitive detection of SARS-CoV-2 infection (edit) |
10.1016/J.EBIOM.2020.103036 |
| 2020-10-09 |
Advancement in biosensors for inflammatory biomarkers of SARS-CoV-2 during 2019-2020 (edit) |
10.1016/J.BIOS.2020.112703 |
| 2020-10-09 |
Tracking SARS-CoV-2 in Sewage: Evidence of Changes in Virus Variant Predominance during COVID-19 Pandemic (edit) |
10.3390/V12101144 |
| 2020-10-09 |
The IGNITE trial: Participant recruitment lessons prior to SARS-CoV-2 (edit) |
10.1016/J.CONCTC.2020.100666 |
| 2020-10-09 |
idCOV: a pipeline for quick clade identification of SARS-CoV-2 isolates (edit) |
10.1101/2020.10.08.330456 |
| 2020-10-09 |
Non-permissive SARS-CoV-2 infection of neural cells in the developing human brain and neurospheres (edit) |
10.1101/2020.09.11.293951 |
| 2020-10-09 |
Antibody reactivity to SARS-CoV-2 in adults from the Vancouver metropolitan area, Canada (edit) |
10.1101/2020.10.05.20206664 |
| 2020-10-09 |
The Road Less Traveled: SARS-CoV-2 and Cell-Mediated Immunity (edit) |
10.1016/J.YMTHE.2020.10.003 |
| 2020-10-09 |
Severe SARS-CoV-2 Infection in a Pediatric Patient Requiring Extracorporeal Membrane Oxygenation (edit) |
10.1155/2020/8885022 |
| 2020-10-09 |
Vascular Disease and Thrombosis in SARS-CoV-2-Infected Rhesus Macaques (edit) |
10.1016/J.CELL.2020.10.005 |
| 2020-10-09 |
Pros and Cons of Adenovirus-Based SARS-CoV-2 Vaccines (edit) |
10.1016/J.YMTHE.2020.10.002 |
| 2020-10-09 |
Modelling a pandemic with asymptomatic patients, impact of lockdown and herd immunity, with applications to SARS-CoV-2 (edit) |
10.1016/J.ARCONTROL.2020.10.003 |
| 2020-10-09 |
Clinical Ordering Practices of the SARS-CoV-2 Antibody Test at a Large Academic Medical Center (edit) |
10.1093/OFID/OFAA406 |
| 2020-10-09 |
Cross-reactions between rheumatoid factor and IgM SARS-CoV-2 (edit) |
10.1016/J.MEDCLE.2020.07.006 |
| 2020-10-09 |
Cardiorenal tissues express SARS-CoV-2 entry genes and basigin (BSG/CD147) increases with age in endothelial cells (edit) |
10.1016/J.JACBTS.2020.09.010 |
| 2020-10-09 |
Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches (edit) |
10.1016/J.VACCINE.2020.10.016 |
| 2020-10-09 |
Virtual Interviews May Fall Short for Pediatric Surgery Fellowships: Lessons Learned From COVID-19/SARS-CoV-2 (edit) |
10.1016/J.JSS.2020.09.029 |
| 2020-10-09 |
Implementation of musculoskeletal specialists in the emergency department at a level A1 VA Hospital during the SARS-CoV-2 pandemic (edit) |
10.1016/J.AJEM.2020.10.010 |
| 2020-10-09 |
[Biochemical and statistical lessons from the evolution of the SARS-CoV-2 virus: paths for novel antiviral warfare] (edit) |
10.5802/CRBIOL.16 |
| 2020-10-09 |
Vulnerabilities of the SARS-CoV-2 Virus to Proteotoxicity-Opportunity for Repurposed Chemotherapy of COVID-19 Infection (edit) |
10.3389/FPHAR.2020.585408 |
| 2020-10-09 |
An Italian Neurorehabilitation Hospital Facing the SARS-CoV-2 Pandemic: Data From 1207 Patients and Workers (edit) |
10.3389/FNEUR.2020.584317 |
| 2020-10-09 |
A Novel In-Cell ELISA Assay Allows Rapid and Automated Quantification of SARS-CoV-2 to Analyze Neutralizing Antibodies and Antiviral Compounds (edit) |
10.3389/FIMMU.2020.573526 |
| 2020-10-09 |
A Pediatric Strategy for the Next Phase of the SARS-CoV-2 Pandemic (edit) |
10.3389/FPED.2020.582798 |
| 2020-10-09 |
Sars-Cov-2 in children - insights and conclusions from the mandatory reporting data in Frankfurt am Main, Germany, March-July 2020 (edit) |
10.3205/DGKH000359 |
| 2020-10-09 |
Development of a High-Throughput Homogeneous AlphaLISA Drug Screening Assay for the Detection of SARS-CoV-2 Nucleocapsid (edit) |
10.1021/ACSPTSCI.0C00122 |
| 2020-10-09 |
Ebselen, Disulfiram, Carmofur, PX-12, Tideglusib, and Shikonin Are Nonspecific Promiscuous SARS-CoV-2 Main Protease Inhibitors (edit) |
10.1021/ACSPTSCI.0C00130 |
| 2020-10-08 |
SARS-CoV-2 infection, disease and transmission in domestic cats (edit) |
10.1080/22221751.2020.1833687 |
| 2020-10-08 |
Prevalence of SARS-CoV-2 Antibodies among Swiss Hospital Workers - Results of a Prospective Cohort Study (edit) |
10.1017/ICE.2020.1244 |
| 2020-10-08 |
Antibody response to multiple antigens of SARS-CoV-2 in patients with diabetes: an observational cohort study (edit) |
10.1007/S00125-020-05284-4 |
| 2020-10-08 |
Correction to: Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2 (edit) |
10.1007/S13238-020-00792-W |
| 2020-10-08 |
Molecular dynamics analysis predicts ritonavir and naloxegol strongly block the SARS-CoV-2 spike protein-hACE2 binding (edit) |
10.1080/07391102.2020.1830854 |
| 2020-10-08 |
Comparison of SARS-CoV-2 RT-PCR on a high-throughput molecular diagnostic platform and the cobas SARS-CoV-2 test for the diagnostic of COVID-19 on various clinical samples (edit) |
10.1093/FEMSPD/FTAA061 |
| 2020-10-08 |
Covert Pathways to the Cranial Cavity: Could These Be Potential Routes of SARS-CoV-2 to the Brain? (edit) |
10.1021/ACSCHEMNEURO.0C00604 |
| 2020-10-08 |
What is holding back the development of antiviral metallodrugs? A literature overview and implications for SARS-CoV-2 therapeutics and future viral outbreaks (edit) |
10.1039/D0DT02478C |
| 2020-10-08 |
Screening Procedure for SARS-CoV-2 infection combining Triage, nasopharyngeal swab and serological test in allogeneic stem cell transplantation Recipients Undergoing Outpatient Post Transplant Follow-Up (edit) |
10.1002/JMV.26586 |
| 2020-10-08 |
What do we know about SARS-CoV-2 transmission? A systematic review and meta-analysis of the secondary attack rate and associated risk factors (edit) |
10.1371/JOURNAL.PONE.0240205 |
| 2020-10-08 |
SARS-CoV-2: how safe is it to fly and what can be done to enhance protection? (edit) |
10.1093/TRSTMH/TRAA106 |
| 2020-10-08 |
Nosocomial SARS-CoV-2 transmission in postoperative infection and mortality: analysis of 14 798 procedures (edit) |
|
| 2020-10-08 |
Angiotensin-converting enzyme 2: A protective factor in regulating disease virulence of SARS-COV-2 (edit) |
10.1002/IUB.2391 |
| 2020-10-08 |
Characteristics of Hospitalized Children With SARS-CoV-2 in the New York City Metropolitan Area (edit) |
10.1542/HPEDS.2020-001917 |
| 2020-10-08 |
Symptoms and Transmission of SARS-CoV-2 among Children-Utah and Wisconsin, March-May 2020 (edit) |
10.1542/PEDS.2020-027268 |
| 2020-10-08 |
SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden (edit) |
10.1038/S41467-020-18848-0 |
| 2020-10-08 |
Hot spot profiles of SARS-CoV-2 and human ACE2 receptor protein protein interaction obtained by density functional tight binding fragment molecular orbital method (edit) |
10.1038/S41598-020-73820-8 |
| 2020-10-08 |
The specific metabolome profiling of patients infected by SARS-COV-2 supports the key role of tryptophan-nicotinamide pathway and cytosine metabolism (edit) |
10.1038/S41598-020-73966-5 |
| 2020-10-08 |
Nasopharyngeal SARS-CoV-2 viral RNA shedding in patients with diabetes mellitus (edit) |
10.1007/S12020-020-02516-W |
| 2020-10-08 |
SARS-CoV-2 Vertical Transmission: Rare But a Potential Possibility (edit) |
10.1007/S12098-020-03498-3 |
| 2020-10-08 |
Urticaria and coronavirus infection: a lesson from SARS-CoV-2 pandemic (edit) |
10.23822/EURANNACI.1764-1489.173 |
| 2020-10-08 |
Near-patient SARS-CoV-2 molecular platforms: new-old tools for new-old problems (edit) |
10.1016/S2213-2600(20)30451-3 |
| 2020-10-08 |
Reduced SARS-CoV-2 entry factors and enhanced innate immune gene expression in the nasal epithelium of pregnant rats (edit) |
10.1016/J.AJOG.2020.10.010 |
| 2020-10-08 |
SARS-CoV-2 massive testing: a window of opportunity to catch up with HCV elimination (edit) |
10.1016/J.JHEP.2020.10.001 |
| 2020-10-08 |
SARS-CoV-2 IgG Seroprevalence among Medical Staff in a General Hospital that Treated COVID-19 Patients in Japan: Retrospective Evaluation of Nosocomial Infection Control (edit) |
10.1016/J.JHIN.2020.10.001 |
| 2020-10-08 |
Immunoinformatics approach to understand molecular interaction between multi-epitopic regions of SARS-CoV-2 spike-protein with TLR4/MD-2 complex (edit) |
10.1016/J.MEEGID.2020.104587 |
| 2020-10-08 |
Detected SARS-CoV-2 in Ascitic Fluid Followed by Cryptococcemia: a Case Report (edit) |
10.1007/S42399-020-00574-9 |
| 2020-10-08 |
Anti-Xa monitoring improves low-molecular-weight heparin effectiveness in patients with SARS-CoV-2 infection (edit) |
10.1016/J.THROMRES.2020.09.039 |
| 2020-10-08 |
Spontaneous Rectal Perforation in a Patient with SARS-CoV-2 Infection (edit) |
10.3390/JPM10040157 |
| 2020-10-08 |
Evolutionary Analysis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reveals Genomic Divergence with Implications for Universal Vaccine Efficacy (edit) |
10.3390/VACCINES8040591 |
| 2020-10-08 |
Comparative docking studies to understand the binding affinity of nicotine with soluble ACE2 (sACE2)-SARS-CoV-2 complex over sACE2 (edit) |
10.1016/J.TOXREP.2020.10.002 |
| 2020-10-08 |
Skin manifestations associated with the new coronavirus SARS-CoV-2 disease (edit) |
10.1016/J.MEDCLE.2020.04.026 |
| 2020-10-08 |
Use of oral antiseptics for SARS-CoV-2 infection (edit) |
10.1016/J.MEDCLE.2020.07.008 |
| 2020-10-08 |
Spike protein-based epitopes predicted against SARS-CoV-2 through literature mining (edit) |
10.1016/J.MEDNTD.2020.100048 |
| 2020-10-08 |
SARS-CoV-2 Morbidity and Mortality in Racial/Ethnic Minority Populations: A Window into the Stress Related Inflammatory Basis of Health Disparities (edit) |
10.1016/J.BBIH.2020.100158 |
| 2020-10-08 |
Orally delivered MK-4482 inhibits SARS-CoV-2 replication in the Syrian hamster model (edit) |
10.21203/RS.3.RS-86289/V1 |
| 2020-10-08 |
Genome-scale identification of SARS-CoV-2 and pan-coronavirus host factor networks (edit) |
10.1101/2020.10.07.326462 |
| 2020-10-08 |
Preferential recognition and antagonism of SARS-CoV-2 spike glycoprotein binding to 3- O -sulfated heparan sulfate (edit) |
10.1101/2020.10.08.331751 |
| 2020-10-08 |
CD8+ T cell responses in convalescent COVID-19 individuals target epitopes from the entire SARS-CoV-2 proteome and show kinetics of early differentiation (edit) |
10.1101/2020.10.08.330688 |
| 2020-10-08 |
Clinical, laboratory, and temporal predictors of neutralizing antibodies to SARS-CoV-2 after COVID-19 (edit) |
10.1101/2020.10.06.20207472 |
| 2020-10-08 |
In silico drug discovery of major metabolites from spices as SARS-CoV-2 main protease inhibitors (edit) |
10.1016/J.COMPBIOMED.2020.104046 |
| 2020-10-08 |
NCAM protein and SARS-COV-2 surface proteins: In-silico hypothetical evidence for the immunopathogenesis of Guillain-Barré syndrome (edit) |
10.1016/J.MEHY.2020.110342 |
| 2020-10-08 |
[SARS-CoV-2 and the Importance of Dialogue Between Clinicians and the Laboratory] (edit) |
10.20344/AMP.14954 |
| 2020-10-08 |
SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to Suppress Host Defenses (edit) |
10.1016/J.CELL.2020.10.004 |
| 2020-10-08 |
Experimental and in silico evidence suggests vaccines are unlikely to be affected by D614G mutation in SARS-CoV-2 spike protein (edit) |
10.1038/S41541-020-00246-8 |
| 2020-10-08 |
Co-infection of malaria and dengue in pregnant women with SARS-CoV-2 (edit) |
10.1002/IJGO.13415 |
| 2020-10-08 |
SARS-CoV-2 Infection in Pregnant Women and Their Newborns (edit) |
10.5334/AOGH.3072 |
| 2020-10-08 |
Three Quarters of People with SARS-CoV-2 Infection are Asymptomatic: Analysis of English Household Survey Data (edit) |
10.2147/CLEP.S276825 |
| 2020-10-08 |
Focus on SARS-CoV-2 and COVID-19 (edit) |
10.1016/J.PATHOL.2020.09.010 |
| 2020-10-08 |
ssRNA Virus and Host Lipid Rearrangements: Is There a Role for Lipid Droplets in SARS-CoV-2 Infection? (edit) |
10.3389/FMOLB.2020.578964 |
| 2020-10-08 |
Adaptive Evolution of Peptide Inhibitors for Mutating SARS-CoV-2 (edit) |
10.1002/ADTS.202000156 |
| 2020-10-08 |
Real-world effectiveness of hydroxychloroquine, azithromycin, and ivermectin among hospitalized COVID-19 patients: results of a target trial emulation using observational data from a nationwide healthcare system in Peru (edit) |
10.1101/2020.10.06.20208066 |
| 2020-10-07 |
The effect of temperature on persistence of SARS-CoV-2 on common surfaces (edit) |
10.1186/S12985-020-01418-7 |
| 2020-10-07 |
Human-Animal Interaction and the Emergence of SARS-CoV-2 (edit) |
10.2196/22117 |
| 2020-10-07 |
Antecedent Administration of Angiotensin Converting Enzyme Inhibitors or Angiotensin II Receptor Antagonists and Survival After Hospitalization for SARS-CoV-2 (COVID-19) (edit) |
10.1161/JAHA.120.017364 |
| 2020-10-07 |
Making a case for using γδ T cells against SARS-CoV-2 (edit) |
10.1080/1040841X.2020.1822279 |
| 2020-10-07 |
In silico exploration of small-molecule α-helix mimetics as inhibitors of SARS-COV-2 attachment to ACE2 (edit) |
10.1080/07391102.2020.1830175 |
| 2020-10-07 |
Prolonged incubation of SARS-CoV-2 in a Patient on Rituximab Therapy (edit) |
10.1017/ICE.2020.1239 |
| 2020-10-07 |
Assessing SARS-CoV-2 Preparedness in US Community Hospitals: A Forgotten Entity (edit) |
10.1017/ICE.2020.1238 |
| 2020-10-07 |
SARS-CoV-2 Transmission: A Sociological Review (edit) |
10.1017/S095026882000240X |
| 2020-10-07 |
Network-based identification genetic effect of SARS-CoV-2 infections to Idiopathic pulmonary fibrosis (IPF) patients (edit) |
10.1093/BIB/BBAA235 |
| 2020-10-07 |
Ambulatory Rehabilitation of Patients Hospitalized with SARS CoV-2 Infections: Early Pandemic Experience in New York City and Boston (edit) |
10.1002/PMRJ.12506 |
| 2020-10-07 |
A Study on Knowledge, Behavior, and Attitude Toward Novel Coronavirus 2019 (SARS-CoV-2) Among the Jordanian Population (edit) |
10.1177/1010539520965360 |
| 2020-10-07 |
Discovery of potent inhibitors for SARS-CoV-2's main protease by ligand-based/structure-based virtual screening, MD simulations, and binding energy calculations (edit) |
10.1039/D0CP04326E |
| 2020-10-07 |
SARS-CoV-2 Infection Among Serially Tested Emergency Medical Services Workers (edit) |
10.1080/10903127.2020.1831668 |
| 2020-10-07 |
Suppression of SARS-CoV-2 infection in ex-vivo human lung tissues by targeting class III phosphoinositide 3-kinase (edit) |
10.1002/JMV.26583 |
| 2020-10-07 |
Correction to: Renin-Angiotensin-Aldosterone System Inhibitors and Outcome in Patients With SARS-CoV-2 Pneumonia: A Case Series Study (edit) |
10.1161/HYP.0000000000000185 |
| 2020-10-07 |
IFCC interim guidelines on molecular testing of SARS-CoV-2 infection (edit) |
10.1515/CCLM-2020-1412 |
| 2020-10-07 |
IFCC interim guidelines on serological testing of antibodies against SARS-CoV-2 (edit) |
10.1515/CCLM-2020-1413 |
| 2020-10-07 |
Detection of SARS-CoV-2 RNA by multiplex RT-qPCR (edit) |
10.1371/JOURNAL.PBIO.3000867 |
| 2020-10-07 |
Burden, risk assessment, surveillance and management of SARS-CoV-2 infection in health workers: a scoping review (edit) |
10.1186/S40249-020-00756-6 |
| 2020-10-07 |
COVID-19 with repeated positive test results for SARS-CoV-2 by PCR and then negative test results twice during intensive care: a case report (edit) |
10.1186/S13256-020-02534-2 |
| 2020-10-07 |
Hybrid dialysis: a promising strategy to reduce hospital access during the SARS-CoV-2 pandemic (edit) |
10.1136/BCR-2020-236411 |
| 2020-10-07 |
Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease (edit) |
10.1038/S41467-020-18709-W |
| 2020-10-07 |
Metallodrug ranitidine bismuth citrate suppresses SARS-CoV-2 replication and relieves virus-associated pneumonia in Syrian hamsters (edit) |
10.1038/S41564-020-00802-X |
| 2020-10-07 |
Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19 (edit) |
10.1038/S41590-020-00814-Z |
| 2020-10-07 |
Epidemiological investigation of the first 5685 cases of SARS-CoV-2 infection in Qatar, 28 February-18 April 2020 (edit) |
10.1136/BMJOPEN-2020-040428 |
| 2020-10-07 |
SARS-CoV-2 and Oral Manifestation: An Observational, Human Study (edit) |
10.3390/JCM9103218 |
| 2020-10-07 |
Interim Guidance on the Preparticipation Physical Examination for Athletes During the SARS-CoV-2 Pandemic (edit) |
10.1097/JSM.0000000000000892 |
| 2020-10-07 |
SARS-CoV-2 receptor networks in diabetic and COVID-19 associated kidney disease (edit) |
10.1016/J.KINT.2020.09.015 |
| 2020-10-07 |
Targeted Rapid Testing for SARS-CoV-2 in the Emergency Department is Associated with Large Reductions in Uninfected Patient Exposure Time (edit) |
10.1016/J.JHIN.2020.09.035 |
| 2020-10-07 |
Asthma and COPD are not risk factors for ICU stay and death in case of SARS-CoV-2 infection (edit) |
10.1016/J.JAIP.2020.09.044 |
| 2020-10-07 |
Promising terpenes as SARS-CoV-2 spike receptor-binding domain (RBD) attachment inhibitors to the human ACE2 receptor: Integrated computational approach (edit) |
10.1016/J.MOLLIQ.2020.114493 |
| 2020-10-07 |
Identification of potential inhibitors of SARS-CoV-2 papain-like protease from tropane alkaloids from Schizanthus porrigens: A molecular docking study (edit) |
10.1016/J.CPLETT.2020.138068 |
| 2020-10-07 |
Clofazimine is a broad-spectrum coronavirus inhibitor that antagonizes SARS-CoV-2 replication in primary human cell culture and hamsters (edit) |
10.21203/RS.3.RS-86169/V1 |
| 2020-10-07 |
Pregnancy and Neonatal Outcomes in SARS-CoV-2 Infection: A Systematic Review (edit) |
10.1155/2020/4592450 |
| 2020-10-07 |
Rapid detection of SARS-CoV-2 antibodies using electrochemical impedance-based detector (edit) |
10.1016/J.BIOS.2020.112709 |
| 2020-10-07 |
Clinical characteristics and outcome of hospitalized patients with SARS-CoV-2 infection at Toulouse University hospital (France). Results from the Covid-clinic-Toul cohort (edit) |
10.1016/J.REVMED.2020.08.006 |
| 2020-10-07 |
Correlates of death among SARS-CoV-2 positive veterans: The contribution of lifetime tobacco use (edit) |
10.1016/J.ADDBEH.2020.106692 |
| 2020-10-07 |
The SARS-CoV-2 Spike Glycoprotein Biosynthesis, Structure, Function, and Antigenicity: Implications for the Design of Spike-Based Vaccine Immunogens (edit) |
10.3389/FIMMU.2020.576622 |
| 2020-10-07 |
SARS-CoV-2 diagnostics: Some reflections on current assays (edit) |
10.1016/J.DIAGMICROBIO.2020.115237 |
| 2020-10-07 |
Ethical Considerations for Treating Cancer Patients During the SARS-CoV-2 Virus Crisis: To Treat or Not to Treat? A Literature Review and Perspective From a Cancer Center in Low-Middle Income Country (edit) |
10.3389/FMED.2020.561168 |
| 2020-10-07 |
NSP 11 of SARS-CoV-2 is an Intrinsically Disordered Protein (edit) |
10.1101/2020.10.07.330068 |
| 2020-10-07 |
Mass spectrometric based detection of protein nucleotidylation in the RNA polymerase of SARS-CoV-2 (edit) |
10.1101/2020.10.07.330324 |
| 2020-10-07 |
Production of ORF8 protein from SARS-CoV-2 using an inducible virus-mediated expression system in suspension-cultured tobacco BY-2 cells (edit) |
10.1101/2020.10.07.325910 |
| 2020-10-07 |
Persistence of SARS-CoV-2 in Water and Wastewater (edit) |
10.1021/ACS.ESTLETT.0C00730 |
| 2020-10-06 |
Nano antiviral photodynamic therapy: A probable biophysicochemical management modality in SARS-CoV-2 (edit) |
10.1080/17425247.2021.1829591 |
| 2020-10-06 |
Upper respiratory tract levels of SARS-CoV-2 RNA and duration of viral RNA shedding do not differ between patients with mild and severe/critical COVID-19 (edit) |
10.1093/INFDIS/JIAA632 |
| 2020-10-06 |
Baricitinib improves respiratory function in patients treated with corticosteroids for SARS-CoV-2 pneumonia: an observational cohort study (edit) |
10.1093/RHEUMATOLOGY/KEAA587 |
| 2020-10-06 |
Benefits of bariatric surgery prior to SARS CoV 2 infection in modulating the response to COVID-19 (edit) |
10.1002/OBY.23059 |
| 2020-10-06 |
A New Syndrome and Kawasaki Disease Associated With SARS-CoV-2 in Otolaryngology Practice (edit) |
10.1177/0194599820964728 |
| 2020-10-06 |
Acute Onset of Bilateral Follicular Conjunctivitis in two Patients with Confirmed SARS-CoV-2 Infections (edit) |
10.1080/09273948.2020.1821901 |
| 2020-10-06 |
Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study (edit) |
10.1200/JCO.20.01933 |
| 2020-10-06 |
Risk for SARS-CoV-2 Infection in Healthcare Workers, Turin, Italy (edit) |
10.3201/EID2701.203027 |
| 2020-10-06 |
Biochemical screening for SARS-CoV-2 main protease inhibitors (edit) |
10.1371/JOURNAL.PONE.0240079 |
| 2020-10-06 |
Correlation of ELISA method with three other automated serological tests for the detection of anti-SARS-CoV-2 antibodies (edit) |
10.1371/JOURNAL.PONE.0240076 |
| 2020-10-06 |
SARS-CoV-2 infections in cancer outpatients-Most infected patients are asymptomatic carriers without impact on chemotherapy (edit) |
10.1002/CAM4.3435 |
| 2020-10-06 |
SARS-COV-2 infection during pregnancy, a risk factor for eclampsia or neurological manifestations of COVID-19? Case report (edit) |
10.1186/S12884-020-03275-2 |
| 2020-10-06 |
Effect of PEEP decremental on respiratory mechanics, gasses exchanges, pulmonary regional ventilation, and hemodynamics in patients with SARS-Cov-2-associated acute respiratory distress syndrome (edit) |
10.1186/S13054-020-03311-9 |
| 2020-10-06 |
Association between autoimmune diseases and COVID-19 as assessed in both a test-negative case-control and population case-control design (edit) |
10.1186/S13317-020-00141-1 |
| 2020-10-06 |
A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study pr (edit) |
10.1186/S13063-020-04735-Y |
| 2020-10-06 |
Clinical evaluation of BD Veritor SARS-CoV-2 point-of-care test performance compared to PCR-based testing and versus the Sofia 2 SARS Antigen point-of-care test (edit) |
10.1128/JCM.02338-20 |
| 2020-10-06 |
Response to 'Correspondence on 'Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID19): a multicentre cohort'' by Mastrolia et al (edit) |
10.1136/ANNRHEUMDIS-2020-218814 |
| 2020-10-06 |
Expression of ACE2, the SARS-CoV-2 Receptor, in Lung Tissue of Patients With Type 2 Diabetes (edit) |
10.2337/DB20-0669 |
| 2020-10-06 |
SARS-CoV-2: the many pros of targeting PLpro (edit) |
10.1038/S41392-020-00335-Z |
| 2020-10-06 |
Main protease of SARS-CoV-2 serves as a bifunctional molecule in restricting type I interferon antiviral signaling (edit) |
10.1038/S41392-020-00332-2 |
| 2020-10-06 |
Salvianolic acid C potently inhibits SARS-CoV-2 infection by blocking the formation of six-helix bundle core of spike protein (edit) |
10.1038/S41392-020-00325-1 |
| 2020-10-06 |
SARS-CoV-2-specific T-cells in unexposed humans: presence of cross-reactive memory cells does not equal protective immunity (edit) |
10.1038/S41392-020-00338-W |
| 2020-10-06 |
A simple RNA preparation method for SARS-CoV-2 detection by RT-qPCR (edit) |
10.1038/S41598-020-73616-W |
| 2020-10-06 |
SARS-CoV-2 S1 and N-based serological assays reveal rapid seroconversion and induction of specific antibody response in COVID-19 patients (edit) |
10.1038/S41598-020-73491-5 |
| 2020-10-06 |
Sofosbuvir terminated RNA is more resistant to SARS-CoV-2 proofreader than RNA terminated by Remdesivir (edit) |
10.1038/S41598-020-73641-9 |
| 2020-10-06 |
Identification of novel mutations in SARS-COV-2 isolates from Turkey (edit) |
10.1007/S00705-020-04830-0 |
| 2020-10-06 |
Are Lessons Learned in Setting Cut Points for Detection of Anti-Drug Antibodies Also Useful in Serology Assays for Robust Detection of SARS-CoV-2 Reactive Antibodies? (edit) |
10.1208/S12248-020-00510-8 |
| 2020-10-06 |
An approach to lifting self-isolation for health care workers with prolonged shedding of SARS-CoV-2 RNA (edit) |
10.1007/S15010-020-01530-4 |
| 2020-10-06 |
Mechanisms by Which SARS-CoV-2 May Impact Male Fertility (edit) |
10.1007/S43032-020-00304-5 |
| 2020-10-06 |
Detection of SARS-COV-2 receptor ACE-2 mRNA in thyroid cells: a clue for COVID-19-related subacute thyroiditis (edit) |
10.1007/S40618-020-01436-W |
| 2020-10-06 |
Prevalence of asymptomatic SARS-CoV-2-positive individuals in the general population of northern Italy and evaluation of a diagnostic serological ELISA test: a cross-sectional study protocol (edit) |
10.1136/BMJOPEN-2020-040036 |
| 2020-10-06 |
Children and Adolescents With SARS-CoV-2 Infection: Epidemiology, Clinical Course and Viral Loads (edit) |
10.1097/INF.0000000000002899 |
| 2020-10-06 |
The Direct and Indirect Impact of SARS-CoV-2 Infections on Neonates: A Series of 26 Cases in Bangladesh (edit) |
10.1097/INF.0000000000002921 |
| 2020-10-06 |
Beekeepers who tolerate bee stings are not protected against SARS-CoV-2 infections (edit) |
10.1016/J.TOXICON.2020.10.004 |
| 2020-10-06 |
The role of close contacts of COVID-19 patients in the SARS-CoV-2 transmission: an emphasis on the percentage of non-evaluated positivity in Mexico (edit) |
10.1016/J.AJIC.2020.10.002 |
| 2020-10-06 |
Seroprevalence of SARS-CoV-2 immunoglobulin antibodies in Wuhan, China: part of the city-wide massive testing campaign (edit) |
10.1016/J.CMI.2020.09.044 |
| 2020-10-06 |
First COVID-19 Case in Zambia - Comparative phylogenomic analyses of SARS-CoV-2 detected in African countries (edit) |
10.1016/J.IJID.2020.09.1480 |
| 2020-10-06 |
Crystal Structure of Non-Structural Protein 10 from Severe Acute Respiratory Syndrome Coronavirus-2 (edit) |
10.3390/IJMS21197375 |
| 2020-10-06 |
Clean Grinding Technique: A Facile Synthesis and In Silico Antiviral Activity of Hydrazones, Pyrazoles, and Pyrazines Bearing Thiazole Moiety against SARS-CoV-2 Main Protease (Mpro) (edit) |
10.3390/MOLECULES25194565 |
| 2020-10-06 |
Older adults should not be omitted from inclusion in clinical trials of SARS-CoV-2 vaccines (edit) |
10.1016/J.MATURITAS.2020.10.002 |
| 2020-10-06 |
Complémentaire à l’avis du 9 septembre 2020 sur les stratégies de prévention de la diffusion du virus SARS-CoV-2 en Établissement d’Accueil du Jeune Enfant (EAJE) et en milieu scolaire (edit) |
10.1016/J.JPP.2020.09.005 |
| 2020-10-06 |
Characterization of SARS-CoV-2 Dynamics in the Host (edit) |
10.1016/J.ARCONTROL.2020.09.008 |
| 2020-10-06 |
Seroprevalence of SARS-CoV-2 IgM and IgG antibodies in an asymptomatic population in Sergipe, Brazil (edit) |
10.26633/RPSP.2020.108 |
| 2020-10-06 |
Transmission routes for SARS-COV-2 infection: Review of Evidence (edit) |
10.1016/J.NMNI.2020.100778 |
| 2020-10-06 |
Applying fixed point methods and fractional operators in the modelling of novel coronavirus 2019-nCoV/SARS-CoV-2 (edit) |
10.1016/J.RINP.2020.103433 |
| 2020-10-06 |
All surfaces are not equal in contact transmission of SARS-CoV-2 (edit) |
10.1016/J.MATT.2020.10.006 |
| 2020-10-06 |
Homologies between SARS-CoV-2 and allergen proteins may direct T cell-mediated heterologous immune responses (edit) |
10.21203/RS.3.RS-86873/V1 |
| 2020-10-06 |
Systematic discovery and functional interrogation of SARS-CoV-2 viral RNA-host protein interactions during infection (edit) |
10.1101/2020.10.06.327445 |
| 2020-10-06 |
Multi-Clonal Live SARS-CoV-2 In Vitro Neutralization by Antibodies Isolated from Severe COVID-19 Convalescent Donors (edit) |
10.1101/2020.10.06.323634 |
| 2020-10-06 |
GNS561 exhibits potent in vitro antiviral activity against SARS-CoV-2 through autophagy inhibition (edit) |
10.1101/2020.10.06.327635 |
| 2020-10-06 |
A multiplex microsphere IgG assay for SARS-CoV-2 using ACE2-mediated inhibition as a surrogate for neutralization (edit) |
10.1101/2020.10.05.20203976 |
| 2020-10-06 |
Prevalence of SARS-CoV-2 in human post-mortem ocular tissues (edit) |
10.1101/2020.10.05.20201574 |
| 2020-10-06 |
Highly Effective Inactivation of SARS-CoV-2 by Conjugated Polymers and Oligomers (edit) |
10.1101/2020.09.29.20204164 |
| 2020-10-06 |
Scalable, effective, and rapid decontamination of SARS-CoV-2 contaminated N95 respirators using germicidal ultra-violet C (UVC) irradiation device (edit) |
10.1101/2020.10.05.20206953 |
| 2020-10-06 |
Update on Neurological Manifestations of SARS-CoV-2 (edit) |
10.5811/WESTJEM.2020.8.48839 |
| 2020-10-06 |
Risk estimation of SARS-CoV-2 transmission from bluetooth low energy measurements (edit) |
10.1038/S41746-020-00340-0 |
| 2020-10-06 |
From Influenza Virus to Novel Corona Virus (SARS-CoV-2)-The Contribution of Obesity (edit) |
10.3389/FENDO.2020.556962 |
| 2020-10-06 |
SARS-CoV-2: Pathogenesis, and Advancements in Diagnostics and Treatment (edit) |
10.3389/FIMMU.2020.570927 |
| 2020-10-06 |
Within-Host Diversity of SARS-CoV-2 in COVID-19 Patients With Variable Disease Severities (edit) |
10.3389/FCIMB.2020.575613 |
| 2020-10-06 |
Online Liver Imaging Course; Pivoting to Transform Radiology Education During the SARS-CoV-2 Pandemic (edit) |
10.1016/J.ACRA.2020.10.001 |
| 2020-10-06 |
Decreased Mortality in Patients With Severe Bronchospasm Associated With SARS-CoV-2: An Alternative to Invasive Mechanical Ventilation (edit) |
10.7759/CUREUS.10822 |
| 2020-10-06 |
SARS-CoV-2-related rapid reorganization of an epilepsy outpatient clinic from personal appointments to telemedicine services: A German single-center experience (edit) |
10.1016/J.YEBEH.2020.107483 |
| 2020-10-06 |
Risk of human-to-wildlife transmission of SARS-CoV-2 (edit) |
10.1111/MAM.12225 |
| 2020-10-06 |
Autoproteolytic Products of the SARS-CoV-2 Nucleocapsid Protein are Primed for Antibody Evasion and Virus Proliferation (edit) |
10.1101/2020.10.06.328112 |
| 2020-10-06 |
End-to-End Protocol for the Detection of SARS-CoV-2 from Built Environments (edit) |
10.1128/MSYSTEMS.00771-20 |
| 2020-10-05 |
A Comparison of Five SARS-CoV-2 Molecular Assays With Clinical Correlations (edit) |
10.1093/AJCP/AQAA181 |
| 2020-10-05 |
Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy (edit) |
10.23812/20-1-E |
| 2020-10-05 |
Is androgen deprivation therapy protective against SARS-CoV-2 infection and related complications in prostate cancer patients? (edit) |
10.23736/S0393-2249.20.04021-7 |
| 2020-10-05 |
Incidence of appendicitis during SARS-CoV-2 pandemic quarantine: report of a single area experience (edit) |
10.23736/S0026-4946.20.05901-0 |
| 2020-10-05 |
Durability of neutralizing antibodies and T-cell response post SARS-CoV-2 infection (edit) |
10.1007/S11684-020-0822-5 |
| 2020-10-05 |
Sampling manholes to home in on SARS-CoV-2 infections (edit) |
10.1371/JOURNAL.PONE.0240007 |
| 2020-10-05 |
Management of a Unique Sinonasal Undifferentiated Carcinoma Subtype in the Era of SARS-CoV-2 (edit) |
10.1159/000511713 |
| 2020-10-05 |
Potential repurposing of drugs with anti-SARS-CoV-2 activity in preclinical trials: a systematic review (edit) |
10.2174/0929867327666201005113204 |
| 2020-10-05 |
Is extensive cardiopulmonary screening useful in athletes with previous asymptomatic or mild SARS-CoV-2 infection? (edit) |
10.1136/BJSPORTS-2020-102789 |
| 2020-10-05 |
Application, Verification and Implementation of SARS-CoV-2 Serologic Assays with Emergency Use Authorization (edit) |
10.1128/JCM.02148-20 |
| 2020-10-05 |
Evaluation of Three Commercial SARS-CoV-2 Serologic Assays and their Performance in Two-Test Algorithms (edit) |
10.1128/JCM.01892-20 |
| 2020-10-05 |
Gynecologic cancer surveillance in the era of SARS-CoV-2 (COVID-19) (edit) |
10.1136/IJGC-2020-001942 |
| 2020-10-05 |
Airborne transmission of SARS-CoV-2 (edit) |
10.1126/SCIENCE.ABF0521 |
| 2020-10-05 |
SARS-CoV-2 spike protein predicted to form complexes with host receptor protein orthologues from a broad range of mammals (edit) |
10.1038/S41598-020-71936-5 |
| 2020-10-05 |
The SARS-CoV-2 pandemic scenario in Africa: What should be done to address the needs of pregnant women? (edit) |
10.1002/IJGO.13403 |
| 2020-10-05 |
Detection of SARS-CoV-2 in vaginal swabs of women with acute SARS-CoV-2 infection: a prospective study (edit) |
10.1111/1471-0528.16556 |
| 2020-10-05 |
Interventions of emergency medical teams in Poland during the SARS-CoV-2 pandemic (edit) |
10.33963/KP.15632 |
| 2020-10-05 |
[SARS-CoV-2: recommendations on nursing care for dialyzed and transplanted patient] (edit) |
|
| 2020-10-05 |
Positive Anti-SSA/Ro Antibody in a Woman with SARS-CoV-2 Infection Using Immunophenotyping: A Case Report (edit) |
10.3390/MEDICINA56100521 |
| 2020-10-05 |
Catch me if you can: SARS-CoV-2 detection in brains of deceased patients with COVID-19 (edit) |
10.1016/S1474-4422(20)30371-9 |
| 2020-10-05 |
Prevalence, management, and outcomes of SARS-CoV-2 infections in older people and those with dementia in mental health wards in London, UK: a retrospective observational study (edit) |
10.1016/S2215-0366(20)30434-X |
| 2020-10-05 |
Why misinterpretation of electron micrographs in SARS-CoV-2-infected tissue goes viral (edit) |
10.1016/S0140-6736(20)32079-1 |
| 2020-10-05 |
Serial semiquantitative detection of SARS-CoV-2 in saliva samples (edit) |
10.1016/J.JINF.2020.10.002 |
| 2020-10-05 |
Study presence of COVID-19 (SARS-CoV-2) in the sweat of patients infected with Covid-19 (edit) |
10.1016/J.MICPATH.2020.104556 |
| 2020-10-05 |
Accuracy of a nucleocapsid protein antigen rapid test in the diagnosis of SARS-CoV-2 infection (edit) |
10.1016/J.CMI.2020.09.057 |
| 2020-10-05 |
SARS-CoV-2 as a causative agent of idiopathic interstitial pneumonia and interstitial pneumonia associated with collagen vascular disorders (edit) |
10.1016/J.RESINV.2020.09.002 |
| 2020-10-05 |
Assessing the SARS-CoV-2 threat to wildlife: Potential risk to a broad range of mammals (edit) |
10.1016/J.PECON.2020.09.008 |
| 2020-10-05 |
SARS-CoV-2 infection dysregulates the metabolomic and lipidomic profiles of serum (edit) |
10.1016/J.ISCI.2020.101645 |
| 2020-10-05 |
Thromboprophylaxis with enoxaparin is associated with a lower death rate in patients hospitalized with SARS-CoV-2 infection. A cohort study (edit) |
10.1016/J.ECLINM.2020.100562 |
| 2020-10-05 |
Structures and dynamics of the novel S1/S2 protease cleavage site loop of the SARS-CoV-2 spike glycoprotein (edit) |
10.1016/J.YJSBX.2020.100038 |
| 2020-10-05 |
SARS-CoV-2 RapidPlex: A Graphene-based Multiplexed Telemedicine Platform for Rapid and Low-Cost COVID-19 Diagnosis and Monitoring (edit) |
10.1016/J.MATT.2020.09.027 |
| 2020-10-05 |
Pooled Saliva Specimens for SARS-CoV-2 Testing (edit) |
10.1101/2020.10.02.20204859 |
| 2020-10-05 |
SARS-CoV-2 severity in african americans - A role for Duffy Null? (edit) |
10.3324/HAEMATOL.2020.269415 |
| 2020-10-05 |
Low prevalence of SARS-CoV-2 in plasma of COVID-19 patients presenting to the emergency department (edit) |
10.1016/J.JCV.2020.104655 |
| 2020-10-05 |
Prevention is not adapting to the model of coronavirus spread (edit) |
|
| 2020-10-05 |
Supporting Clinical Decision-Making during the SARS-CoV-2 Pandemic through a Global Research Commitment: The TERAVOLT Experience (edit) |
10.1016/J.CCELL.2020.10.002 |
| 2020-10-05 |
Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4+ T Cells in COVID-19 (edit) |
10.1016/J.CELL.2020.10.001 |
| 2020-10-05 |
Obese patients with NASH have increased hepatic expression of SARS-CoV-2 critical entry points (edit) |
10.1016/J.JHEP.2020.09.027 |
| 2020-10-05 |
The impact of viral transport media on PCR assay results for the detection of nucleic acid from SARS-CoV-2 (edit) |
10.1016/J.PATHOL.2020.09.013 |
| 2020-10-05 |
A multi-target lateral flow immunoassay enabling the specific and sensitive detection of total antibodies to SARS COV-2 (edit) |
10.1016/J.TALANTA.2020.121737 |
| 2020-10-04 |
Dangerous shortage of blood banks as an indirect effect of SARS-CoV-2: An obstetrics perspective (edit) |
10.1002/IJGO.13409 |
| 2020-10-04 |
Characterization of asthma and risk factors for delayed SARS-CoV-2 clearance in adult COVID-19 inpatients in Daegu (edit) |
10.1111/ALL.14609 |
| 2020-10-04 |
SARS-CoV-2 outbreak investigation in a German meat processing plant (edit) |
10.15252/EMMM.202013296 |
| 2020-10-04 |
Predicting susceptibility to SARS-CoV-2 infection based on structural differences in ACE2 across species (edit) |
10.1096/FJ.202001808R |
| 2020-10-04 |
Absence of SARS-CoV-2 viraemia in a blood donor with COVID-19 post-donation (edit) |
10.1111/TME.12724 |
| 2020-10-04 |
SARS-CoV-2: Impact on, Risk Assessment and Countermeasures in German Eye Banks (edit) |
10.1080/02713683.2020.1828487 |
| 2020-10-04 |
Structural analysis, virtual screening and molecular simulation to identify potential inhibitors targeting 2'-O-ribose methyltransferase of SARS-CoV-2 coronavirus (edit) |
10.1080/07391102.2020.1828172 |
| 2020-10-04 |
First Case of Mild Encephalopathy with Reversible Splenial Lesion in SARS-CoV-2 Infection (edit) |
10.1016/J.MEDMAL.2020.09.018 |
| 2020-10-04 |
Gold Nanorod Assisted Enhanced Plasmonic Detection Scheme of COVID-19 SARS-CoV-2 Spike Protein (edit) |
10.1002/ADTS.202000185 |
| 2020-10-04 |
Efficient culture of SARS-CoV-2 in human hepatoma cells enhances viability of the virus in human lung cancer cell lines permitting the screening of antiviral compounds (edit) |
10.1101/2020.10.04.325316 |
| 2020-10-04 |
Early Evidence of Effectiveness of Digital Contact Tracing for SARS-CoV-2 in Switzerland (edit) |
10.1101/2020.09.07.20189274 |
| 2020-10-03 |
A 63-Year-Old Woman with a History of Non-Hodgkin Lymphoma with Persistent SARS-CoV-2 Infection Who Was Seronegative and Treated with Convalescent Plasma (edit) |
10.12659/AJCR.927812 |
| 2020-10-03 |
Repeat-positive SARS-CoV-2 in a child with cancer (edit) |
10.1002/PBC.28744 |
| 2020-10-03 |
Survival of SARS-CoV-2 and influenza virus on the human skin: Importance of hand hygiene in COVID-19 (edit) |
10.1093/CID/CIAA1517 |
| 2020-10-03 |
A dual antigen ELISA allows the assessment of SARS-CoV-2 antibody seroprevalence in a low transmission setting (edit) |
10.1093/INFDIS/JIAA623 |
| 2020-10-03 |
Immunological and virological profile of children with chilblain-like lesions and SARS-CoV-2 (edit) |
10.1111/JDV.16972 |
| 2020-10-03 |
A meta-analysis of SARS-CoV-2 patients identifies the combinatorial significance of D-dimer, C-reactive protein, lymphocyte, and neutrophil values as a predictor of disease severity (edit) |
10.1111/IJLH.13354 |
| 2020-10-03 |
A cell-based large-scale screening of natural compounds for inhibitors of SARS-CoV-2 (edit) |
10.1038/S41392-020-00343-Z |
| 2020-10-03 |
SARS-CoV-2 seroprevalence survey among 17,971 healthcare and administrative personnel at hospitals, pre-hospital services, and specialist practitioners in the Central Denmark Region (edit) |
10.1093/CID/CIAA1471 |
| 2020-10-03 |
Minor allele of Interferon-Induced Transmembrane Protein-3 (IFITM3) polymorphism (rs12252) is covered against SARS-CoV-2 infection and mortality: a worldwide epidemiological investigation (edit) |
10.1093/INFDIS/JIAA630 |
| 2020-10-03 |
Lung ultrasound as diagnostic tool for SARS-CoV-2 infection (edit) |
10.1007/S11739-020-02512-Y |
| 2020-10-03 |
ACE2-containing extracellular vesicles and exomeres bind the SARS-CoV-2 spike protein (edit) |
10.1053/J.GASTRO.2020.09.042 |
| 2020-10-03 |
Is a COPD patient protected against SARS-CoV-2 virus? (edit) |
10.1016/J.MEDMAL.2020.09.015 |
| 2020-10-03 |
Implementing a Negative Pressure Isolation Space within a Skilled Nursing Facility to Control SARS-CoV-2 Transmission (edit) |
10.1016/J.AJIC.2020.09.014 |
| 2020-10-03 |
SARS-CoV-2 ACE-Receptor detection in the placenta throughout pregnancy (edit) |
10.1016/J.CMI.2020.09.049 |
| 2020-10-03 |
Cold-Adapted Live Attenuated SARS-Cov-2 Vaccine Completely Protects Human ACE2 Transgenic Mice from SARS-Cov-2 Infection (edit) |
10.3390/VACCINES8040584 |
| 2020-10-03 |
High-resolution structure and biophysical characterization of the nucleocapsid phosphoprotein dimerization domain from the Covid-19 severe acute respiratory syndrome coronavirus 2 (edit) |
10.1016/J.BBRC.2020.09.131 |
| 2020-10-03 |
Screening of potential drug from Azadiractha Indica (Neem) extracts for SARS-CoV-2: An insight from molecular docking and MD-simulation studies (edit) |
10.1016/J.MOLSTRUC.2020.129390 |
| 2020-10-03 |
Letter to the editor: Training mental health professionals to provide support in brief telepsychotherapy and telepsychiatry for health workers in the SARS-CoV-2 pandemic (edit) |
10.1016/J.JPSYCHIRES.2020.09.036 |
| 2020-10-03 |
Magnetic beads combined with carbon black-based screen-printed electrodes for COVID-19: A reliable and miniaturized electrochemical immunosensor for SARS-CoV-2 detection in saliva (edit) |
10.1016/J.BIOS.2020.112686 |
| 2020-10-02 |
Susceptibility of swine cells and domestic pigs to SARS-CoV-2 (edit) |
10.1080/22221751.2020.1831405 |
| 2020-10-02 |
Immunocompromised myasthenia gravis patient not infected with SARS-CoV-2 after close exposure - what is the risk of COVID-19? (edit) |
10.5603/PJNNS.A2020.0072 |
| 2020-10-02 |
Systemic effects of missense mutations on SARS-CoV-2 spike glycoprotein stability and receptor-binding affinity (edit) |
10.1093/BIB/BBAA233 |
| 2020-10-02 |
HLA and immunological features of SARS-CoV-2-induced Guillain-Barré syndrome (edit) |
10.1007/S10072-020-04787-7 |
| 2020-10-02 |
Rates and characteristics of SARS-CoV-2 infection in persons with hepatitis C virus infection (edit) |
10.1111/LIV.14681 |
| 2020-10-02 |
Molecular Simulations and Network Modeling Reveal an Allosteric Signaling in the SARS-CoV-2 Spike Proteins (edit) |
10.1021/ACS.JPROTEOME.0C00654 |
| 2020-10-02 |
Similarity between mutation spectra in hypermutated genomes of rubella virus and in SARS-CoV-2 genomes accumulated during the COVID-19 pandemic (edit) |
10.1371/JOURNAL.PONE.0237689 |
| 2020-10-02 |
Direct RT-qPCR detection of SARS-CoV-2 RNA from patient nasopharyngeal swabs without an RNA extraction step (edit) |
10.1371/JOURNAL.PBIO.3000896 |
| 2020-10-02 |
In-silico drug repurposing study predicts the combination of pirfenidone and melatonin as a promising candidate therapy to reduce SARS-CoV-2 infection progression and respiratory distress caused by cytokine storm (edit) |
10.1371/JOURNAL.PONE.0240149 |
| 2020-10-02 |
Correction: Detection of SARS-CoV-2 RNA by direct RT-qPCR on nasopharyngeal specimens without extraction of viral RNA (edit) |
10.1371/JOURNAL.PONE.0240343 |
| 2020-10-02 |
Reasoned action approach and compliance with recommended behaviours to prevent the transmission of the SARS-CoV-2 virus in the UK (edit) |
10.1111/BJHP.12474 |
| 2020-10-02 |
Piglets inoculated by different routes are not susceptible to SARS-CoV-2, but those inoculated parenterally were immunized against the virus (edit) |
10.1111/TBED.13861 |
| 2020-10-02 |
SARS-CoV2-mediated suppression of NRF2-signaling reveals potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate (edit) |
10.1038/S41467-020-18764-3 |
| 2020-10-02 |
SARS-CoV-2 antibody seroconversion in care home (edit) |
10.1038/S41577-020-00463-1 |
| 2020-10-02 |
A systematic review of emerging human coronavirus (SARS-CoV-2) outbreak: focus on disinfection methods, environmental survival, and control and prevention strategies (edit) |
10.1007/S11356-020-11060-Z |
| 2020-10-02 |
Investigation of SARS-CoV-2 in Semen of Patients in the Acute Stage of COVID-19 Infection (edit) |
10.1159/000511617 |
| 2020-10-02 |
SARS-CoV-2 and the Possible Role of Raf/MEK/ERK Pathway in Viral Survival: Is This a Potential Therapeutic Strategy for COVID-19? (edit) |
10.1159/000511280 |
| 2020-10-02 |
Human respiratory viruses, including SARS-CoV-2, circulating in the winter season 2019-2020 in Parma, Northern Italy (edit) |
10.1016/J.IJID.2020.09.1473 |
| 2020-10-02 |
[SARS-CoV-2] (edit) |
10.1007/S00772-020-00705-5 |
| 2020-10-02 |
Benchmarking evolutionary tinkering underlying human-viral molecular mimicry shows multiple host pulmonary-arterial peptides mimicked by SARS-CoV-2 (edit) |
10.1038/S41420-020-00321-Y |
| 2020-10-02 |
SARS-CoV-2 infected cells present HLA-I peptides from canonical and out-of-frame ORFs (edit) |
10.1101/2020.10.02.324145 |
| 2020-10-02 |
A Multiscale Coarse-grained Model of the SARS-CoV-2 Virion (edit) |
10.1101/2020.10.02.323915 |
| 2020-10-02 |
SARS-CoV-2 proteins and anti-COVID-19 drugs induce lytic reactivation of an oncogenic virus (edit) |
10.1101/2020.10.02.324228 |
| 2020-10-02 |
Glycyrrhizic acid exerts inhibitory activity against the spike protein of SARS-CoV-2 (edit) |
10.1016/J.PHYMED.2020.153364 |
| 2020-10-02 |
Development of e-service virtual museum tours in Poland during the SARS-CoV-2 pandemic (edit) |
10.1016/J.PROCS.2020.09.303 |
| 2020-10-02 |
Reactivation of SARS-CoV-2 after Asymptomatic Infection while on High-Dose Corticosteroids. Case Report (edit) |
10.1007/S42399-020-00548-X |
| 2020-10-02 |
Sarilumab use in severe SARS-CoV-2 pneumonia (edit) |
10.1016/J.ECLINM.2020.100553 |
| 2020-10-02 |
Antibody response to SARS-CoV-2 in people living with HIV (edit) |
10.1016/J.JMII.2020.09.005 |
| 2020-10-02 |
The Role of the Ocular Tissue in SARS-CoV-2 Transmission (edit) |
10.2147/OPTH.S269868 |
| 2020-10-02 |
Detection of SARS-CoV-2 RNA on public surfaces in a densely populated urban area of Brazil: A potential tool for monitoring the circulation of infected patients (edit) |
10.1016/J.SCITOTENV.2020.142645 |
| 2020-10-02 |
Progress and Pitfalls in the Quest for Effective SARS-CoV-2 (COVID-19) Vaccines (edit) |
10.3389/FIMMU.2020.579250 |
| 2020-10-02 |
New Chemical Modalities Enabling Specific RNA Targeting and Degradation: Application to SARS-CoV-2 RNA (edit) |
10.1021/ACSCENTSCI.0C01187 |
| 2020-10-02 |
Implications of the SARS-CoV-2 pandemic for the development and update of clinical practice guidelines: A viewpoint (edit) |
10.2196/20064 |
| 2020-10-02 |
High prevalence of SARS-CoV-2 swab positivity in England during September 2020: interim report of round 5 of REACT-1 study (edit) |
10.1101/2020.09.30.20204727 |
| 2020-10-01 |
Colorimetric Test for Fast Detection of SARS-CoV-2 in Nasal and Throat Swabs (edit) |
10.1021/ACSSENSORS.0C01742 |
| 2020-10-01 |
The inhibitory effect of some natural bioactive compounds against SARS-CoV-2 main protease: insights from molecular docking analysis and molecular dynamic simulation (edit) |
10.1080/10934529.2020.1826192 |
| 2020-10-01 |
Contamination inside CT gantry in the SARS-CoV-2 era (edit) |
10.1186/S41747-020-00182-1 |
| 2020-10-01 |
Dynamically evolving novel overlapping gene as a factor in the SARS-CoV-2 pandemic (edit) |
10.7554/ELIFE.59633 |
| 2020-10-01 |
Waning of SARS-CoV-2 RBD antibodies in longitudinal convalescent plasma samples within four months after symptom onset (edit) |
10.1182/BLOOD.2020008367 |
| 2020-10-01 |
First results of the "Lean European Open Survey on SARS-CoV-2-Infected Patients (LEOSS)" (edit) |
10.1007/S15010-020-01499-0 |
| 2020-10-01 |
Variability of symptoms in neuralgic amyotrophy following infection with SARS-CoV-2 (edit) |
10.1002/MUS.27084 |
| 2020-10-01 |
Seroprevalence of SARS-CoV-2 antibodies in people with an acute loss in their sense of smell and/or taste in a community-based population in London, UK: An observational cohort study (edit) |
10.1371/JOURNAL.PMED.1003358 |
| 2020-10-01 |
In-silico design of a potential inhibitor of SARS-CoV-2 S protein (edit) |
10.1371/JOURNAL.PONE.0240004 |
| 2020-10-01 |
Ophthalmological emergencies and the SARS-CoV-2 outbreak (edit) |
10.1371/JOURNAL.PONE.0239796 |
| 2020-10-01 |
SARS-CoV-2 spike protein is present in both endothelial and eccrine cells of a chilblain-like skin lesion (edit) |
10.1111/JDV.16970 |
| 2020-10-01 |
A computational toolset for rapid identification of SARS-CoV-2, other viruses and microorganisms from sequencing data (edit) |
10.1093/BIB/BBAA231 |
| 2020-10-01 |
Effectiveness of tests to detect the presence of SARS-CoV-2 virus, and antibodies to SARS-CoV-2, to inform COVID-19 diagnosis: a rapid systematic review (edit) |
10.1136/BMJEBM-2020-111511 |
| 2020-10-01 |
SARS-CoV-2 infection in London, England: changes to community point prevalence around lockdown time, March-May 2020 (edit) |
10.1136/JECH-2020-214730 |
| 2020-10-01 |
Antiviral activity of digoxin and ouabain against SARS-CoV-2 infection and its implication for COVID-19 (edit) |
10.1038/S41598-020-72879-7 |
| 2020-10-01 |
Designing a multi-epitope peptide based vaccine against SARS-CoV-2 (edit) |
10.1038/S41598-020-73371-Y |
| 2020-10-01 |
Creating a safe workplace by universal testing of SARS-CoV-2 infection in asymptomatic patients and healthcare workers in the electrophysiology units: a multi-center experience (edit) |
10.1007/S10840-020-00886-9 |
| 2020-10-01 |
SARS-CoV-2 samples may escape detection because of a single point mutation in the N gene (edit) |
10.2807/1560-7917.ES.2020.25.39.2001650 |
| 2020-10-01 |
SARS-CoV-2 Spike protein co-opts VEGF-A/Neuropilin-1 receptor signaling to induce analgesia (edit) |
10.1097/J.PAIN.0000000000002097 |
| 2020-10-01 |
Cardiac troponin I in SARS-CoV-2-patients: The additional prognostic value of serial monitoring (edit) |
10.1016/J.CCA.2020.09.036 |
| 2020-10-01 |
COVID-19 associated pancytopenia can be self-limiting and does not necessarily warrant bone marrow biopsy for the purposes of Sars-CoV-2 diagnostics (edit) |
10.1016/J.ANNONC.2020.09.020 |
| 2020-10-01 |
Novel cyclohexanone compound as a potential ligand against SARS-CoV-2 main-protease (edit) |
10.1016/J.MICPATH.2020.104546 |
| 2020-10-01 |
SARS-CoV-2 Vaccine Development: Current Status (edit) |
10.1016/J.MAYOCP.2020.07.021 |
| 2020-10-01 |
Effective Anti-SARS-CoV-2 RNA Dependent RNA Polymerase Drugs Based on Docking Methods: The Case of Milbemycin, Ivermectin, and Baloxavir Marboxil (edit) |
|
| 2020-10-01 |
How lethal is SARS-CoV-2 pneumonia when compared with respiratory syncytial virus and influenza in young children? (edit) |
10.31128/AJGP-04-20-5357 |
| 2020-10-01 |
Pediatric Surgery during the SARS-CoV-2 pandemic (edit) |
|
| 2020-10-01 |
Remote Monitoring Empowerment of Patients with IBDs during the SARS-CoV-2 Pandemic (edit) |
10.3390/HEALTHCARE8040377 |
| 2020-10-01 |
Persistence of Anti-SARS-CoV-2 Antibodies in Non-Hospitalized COVID-19 Convalescent Health Care Workers (edit) |
10.3390/JCM9103188 |
| 2020-10-01 |
Structural insight into the recognition of S-adenosyl-L-homocysteine and sinefungin in SARS-CoV-2 Nsp16/Nsp10 RNA cap 2'-O-Methyltransferase (edit) |
10.1016/J.CSBJ.2020.09.032 |
| 2020-10-01 |
Tocilizumab-Associated Bowel Perforation in SARS-CoV-2 Infection (edit) |
10.1097/MJT.0000000000001273 |
| 2020-10-01 |
A Novel Bat Coronavirus Closely Related to SARS-CoV-2 Contains Natural Insertions at the S1/S2 Cleavage Site of the Spike Protein (edit) |
10.1016/J.CUB.2020.09.030 |
| 2020-10-01 |
miRNAs in SARS-CoV 2: A Spoke in the Wheel of Pathogenesis (edit) |
10.2174/1381612826999201001200529 |
| 2020-10-01 |
Risk of SARS-CoV-2 infection and clinical outcomes in multiple sclerosis patients in La Rioja (Spain): [[es]]Riesgo de infección por SARS-CoV-2 y resultados clínicos en pacientes con Esclerosis Múltiple en la Rioja (España) (edit) |
10.1016/J.MEDCLE.2020.06.017 |
| 2020-10-01 |
Expression profiles of the SARS-CoV-2 host invasion genes in nasopharyngeal and oropharyngeal swabs of COVID-19 patients (edit) |
10.1016/J.HELIYON.2020.E05143 |
| 2020-10-01 |
Implementation of environmental surveillance for SARS-CoV-2 virus to support public health decisions: opportunities and challenges (edit) |
10.1016/J.COESH.2020.09.006 |
| 2020-10-01 |
SARS-CoV-2 gene content and COVID-19 mutation impact by comparing 44 Sarbecovirus genomes (edit) |
10.21203/RS.3.RS-80345/V1 |
| 2020-10-01 |
LY-CoV555, a rapidly isolated potent neutralizing antibody, provides protection in a non-human primate model of SARS-CoV-2 infection (edit) |
10.1101/2020.09.30.318972 |
| 2020-10-01 |
SARS-CoV-2 viral budding and entry can be modeled using virus-like particles (edit) |
10.1101/2020.09.30.320903 |
| 2020-10-01 |
Analysis of Genomic Characteristics and Transmission Routes of Patients With Confirmed SARS-CoV-2 in Southern California During the Early Stage of the US COVID-19 Pandemic (edit) |
10.1001/JAMANETWORKOPEN.2020.24191 |
| 2020-10-01 |
Commentaries on Viewpoint: The interaction between SARS-CoV-2 and ACE2 may have consequences for skeletal muscle viral susceptibility and myopathies (edit) |
10.1152/JAPPLPHYSIOL.00775.2020 |
| 2020-10-01 |
Last Word on Viewpoint: The interaction between SARS-CoV-2 and ACE2 may have consequences for skeletal muscle viral susceptibility and myopathies (edit) |
10.1152/JAPPLPHYSIOL.00785.2020 |
| 2020-10-01 |
Successful transfer of anti-SARS-CoV-2 immunity using convalescent plasma in an MM patient with hypogammaglobulinemia and COVID-19 (edit) |
10.1182/BLOODADVANCES.2020002595 |
| 2020-10-01 |
Mining the Antibody Repertoire for Solutions to SARS-CoV-2 (edit) |
10.1016/J.CHOM.2020.09.010 |
| 2020-10-01 |
Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients (edit) |
10.1126/SCIIMMUNOL.ABE0367 |
| 2020-10-01 |
Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients (edit) |
10.1126/SCIIMMUNOL.ABE5511 |
| 2020-10-01 |
Inhibiting Ebola virus and SARS-CoV-2 entry (edit) |
10.1126/SCIENCE.ABE2977 |
| 2020-10-01 |
SARS-CoV-2 Infection in Children: Special Considerations (edit) |
10.3928/19382359-20200919-01 |
| 2020-10-01 |
Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: an international registry study (edit) |
10.1016/J.JHEP.2020.09.024 |
| 2020-10-01 |
Effectiveness of negative pressure isolation stretcher and rooms for SARS-CoV-2 nosocomial infection control and maintenance of South Korean emergency department capacity (edit) |
10.1016/J.AJEM.2020.09.081 |
| 2020-10-01 |
Age-related D-dimer elevation and occasional lethality in SARS-CoV-2 infected patients (edit) |
10.1556/650.2020.31998 |
| 2020-10-01 |
Lifestyle and severe SARS-CoV-2 infections: Does the individual metabolic burden determines the outcome? (edit) |
10.1177/1470320320963929 |
| 2020-10-01 |
[Detection and evaluation of SARS-CoV-2 nucleic acid contamination in corona virus disease 19 ward surroundings and the surface of medical staff's protective equipment] (edit) |
|
| 2020-10-01 |
Viral replication of SARS-CoV-2 could be self-limitative - The role of the renin-angiotensin system on COVID-19 pathophysiology (edit) |
10.1016/J.MEHY.2020.110330 |
| 2020-10-01 |
[The Peripheral Neuropathy and Myopathy Associated with Severe Acute Respiratory Syndrome-Correlated New Coronavirus (SARS-Cov-2)] (edit) |
10.11477/MF.1416201646 |
| 2020-10-01 |
Reduced prevalence of SARS-CoV-2 infection in ABO blood group O (edit) |
10.1182/BLOODADVANCES.2020002657 |
| 2020-10-01 |
Twenty years of progress in angiotensin converting enzyme 2 and its link to SARS-CoV-2 disease (edit) |
10.1042/CS20200901 |
| 2020-10-01 |
Characteristics and Outcomes of Patients Infected with SARS-CoV-2 in Israel: Correlation between Laboratory Findings on Admission to Emergency Department and Subsequent Respiratory Failure (edit) |
|
| 2020-10-01 |
Comparison of a rapid immunochromatographic test with a chemiluminescence immunoassay for detection of anti-SARS-CoV-2 IgM and IgG (edit) |
10.11613/BM.2020.030901 |
| 2020-10-01 |
Accuracy of point-of-care diagnostic tests for SARS-CoV-2 antibodies (IgM/IgG) is heterogeneous (edit) |
10.7326/ACPJ202010200-047 |
| 2020-10-01 |
All eyes on a hurdle race for a SARS-CoV-2 vaccine (edit) |
10.1038/D41586-020-02926-W |
| 2020-10-01 |
Clinical application of combined detection of SARS-CoV-2-specific antibody and nucleic acid (edit) |
10.12998/WJCC.V8.I19.4360 |
| 2020-10-01 |
Controversies over hydroxychloroquine in the prevention of SARS-CoV-2 infection put rheumatologists on the frontline (edit) |
10.1136/RMDOPEN-2020-001323 |
| 2020-10-01 |
Production and application of polyclonal antibodies against SARS-CoV-2 viral spike protein. Development to rapid, highly sensitive diagnosis kit for early Corona viral detection among the population (edit) |
10.26355/EURREV_202010_23244 |
| 2020-10-01 |
A critical appraisal of evidence in the use of preprocedural mouthwash to avoid SARS-CoV-2 transmission during oral interventions (edit) |
10.26355/EURREV_202010_23245 |
| 2020-10-01 |
Prediction of in-hospital mortality of patients with SARS-CoV-2 infection by comorbidity indexes: an Italian internal medicine single center study (edit) |
10.26355/EURREV_202010_23250 |
| 2020-10-01 |
Wildfire and COVID-19 pandemic: effect of environmental pollution PM-2.5 and carbon monoxide on the dynamics of daily cases and deaths due to SARS-COV-2 infection in San-Francisco USA (edit) |
10.26355/EURREV_202010_23253 |
| 2020-10-01 |
The engines of SARS-CoV-2 spread (edit) |
10.1126/SCIENCE.ABD8755 |
| 2020-10-01 |
Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020 (edit) |
10.2807/1560-7917.ES.2020.25.42.2000685 |
| 2020-10-01 |
SARS-CoV-2 antibody prevalence, titres and neutralising activity in an antenatal cohort, United Kingdom, 14 April to 15 June 2020 (edit) |
10.2807/1560-7917.ES.2020.25.41.2001721 |
| 2020-10-01 |
Seropositive Prevalence of Antibodies Against SARS-CoV-2 in Wuhan, China (edit) |
10.1001/JAMANETWORKOPEN.2020.25717 |
| 2020-10-01 |
Severe Acute Respiratory Distress Syndrome Secondary to Coronavirus 2 (SARS-CoV-2) (edit) |
|
| 2020-10-01 |
Que savons-nous de la transmission de SARS-CoV-2 ? (edit) |
|
| 2020-10-01 |
Euglycemic Diabetic Ketoacidosis Associated with Empagliflozin Use in the Course of the SARS-Cov-2 Pandemic (edit) |
|
| 2020-10-01 |
Polycythemia in SARS-CoV-2 Positive Patients: An Early Screening Marker (edit) |
|
| 2020-10-01 |
Air Evacuation of Passengers with Potential SARS-CoV-2 Infection Under the Guidelines for Appropriate Infection Control and Prevention (edit) |
10.24171/J.PHRP.2020.11.5.10 |
| 2020-10-01 |
Comment on Considering the Effects of Microbiome and Diet on SARS-CoV-2 Infection: Nanotechnology Roles (edit) |
10.1021/ACSNANO.0C04871 |
| 2020-10-01 |
Response to Comment on Considering the Effects of Microbiome and Diet on SARS-CoV-2 Infection (edit) |
10.1021/ACSNANO.0C05759 |
| 2020-10-01 |
Comparison of clinical, laboratory, and radiological characteristics between SARS-CoV-2 infection and community-acquired pneumonia caused by influenza virus: A cross-sectional retrospective study (edit) |
10.1097/MD.0000000000023064 |
| 2020-10-01 |
Usefulness of the antigen for diagnosing SARS-CoV-2 infection in patients with and without symptoms (edit) |
10.1016/J.EIMC.2020.09.009 |
| 2020-10-01 |
Slovakia to test all adults for SARS-CoV-2 (edit) |
10.1016/S0140-6736(20)32261-3 |
| 2020-10-01 |
Transplant programmes in areas with high SARS-CoV-2 transmission (edit) |
10.1016/S0140-6736(20)32209-1 |
| 2020-10-01 |
Instantaneous "catch-and-kill" inactivation of SARS-CoV-2 by nitride ceramics (edit) |
10.1002/CTM2.212 |
| 2020-10-01 |
SARS-CoV-2 (COVID-19) and the Endocrine System (edit) |
10.1210/JENDSO/BVAA144 |
| 2020-10-01 |
[Structure of SARS-CoV-2 and treatment of COVID-19] (edit) |
|
| 2020-10-01 |
[Evaluation of SARS-CoV-2 PCR Positive Cases in the Pediatric Emergency Department] (edit) |
10.5578/MB.70086 |
| 2020-10-01 |
Health Care Worker SARS-CoV-2 Infection Is Flying Under the Radar (edit) |
10.1001/JAMA.2020.19554 |
| 2020-10-01 |
The role of football as a super-spreading event in the SARS-CoV-2 pandemic (edit) |
10.23736/S0022-4707.20.11267-2 |
| 2020-10-01 |
Aerosol persistence in relation to possible transmission of SARS-CoV-2 (edit) |
10.1063/5.0027844 |
| 2020-10-01 |
Central involvement of SARS-CoV-2 may aggravate ARDS and hypertension (edit) |
10.1177/1470320320972015 |
| 2020-10-01 |
Comprehensive review on the prevailing COVID-19 therapeutics and the potential of repurposing SARS-CoV-1 candidate drugs to target SARS-CoV-2 as a fast-track treatment and prevention option (edit) |
10.21037/ATM-20-4071 |
| 2020-10-01 |
Clinical characteristics and outcomes of discharged COVID-19 patients with reoccurrence of SARS-CoV-2 RNA (edit) |
10.2217/FVL-2020-0142 |
| 2020-10-01 |
Environmental contamination related to SARS-CoV-2 in ICU patients (edit) |
10.1183/23120541.00595-2020 |
| 2020-10-01 |
Lung ultrasound findings in patients with novel SARS-CoV-2 (edit) |
10.1183/23120541.00238-2020 |
| 2020-10-01 |
Outbreak of SARS-CoV-2 infection at a large refugee shelter in Toronto, April 2020: a clinical and epidemiologic descriptive analysis (edit) |
10.9778/CMAJO.20200165 |
| 2020-10-01 |
SARS-CoV-2 Transmission Channels: A Review of the Literature (edit) |
|
| 2020-10-01 |
Lost in deletion: The enigmatic ORF8 protein of SARS-CoV-2 (edit) |
10.1016/J.BBRC.2020.10.045 |
| 2020-10-01 |
[Crisis management in the face of SARS-CoV-2: management and leadership in health care] (edit) |
10.1016/S0038-0814(20)30237-1 |
| 2020-10-01 |
[SARS-CoV-2: the experience of the Legouest armed forces teaching hospital] (edit) |
10.1016/S0038-0814(20)30238-3 |
| 2020-10-01 |
[Hygiene as a weapon in the fight against SARS-Cov-2. All experts in taking care!] (edit) |
10.1016/S0038-0814(20)30241-3 |
| 2020-10-01 |
[Eating better to improve resistance to sars-Cov-2] (edit) |
10.1016/S0038-0814(20)30249-8 |
| 2020-10-01 |
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Codon Usage and Replicative Fitness (edit) |
10.1055/S-0040-1721080 |
| 2020-10-01 |
Assessment of SARS-CoV-2 infection through rapid serology testing in the homeless population in the City of Rome, Italy. Preliminary results (edit) |
10.4081/JPHR.2020.1986 |
| 2020-10-01 |
398. Risk Factors Associated with Requiring Invasive Mechanical Ventilation in Patients with SARS-CoV-2 Infection: Experience in a Tertiary Care Hospital in Mexico City (edit) |
10.1093/OFID/OFAA439.593 |
| 2020-10-01 |
423. SARS-CoV-2 NGS Assay Powered by Biotia COVID-DX Software (edit) |
10.1093/OFID/OFAA439.617 |
| 2020-10-01 |
395. Rapid, Non-invasive Detection of Infection Using Plasma-based Next-Generation Sequencing for Microbial Cell-free DNA in Individuals Testing Negative for SARS-CoV-2 in a Pandemic Setting (edit) |
10.1093/OFID/OFAA439.590 |
| 2020-10-01 |
A case of COVID-19 patient with the diarrhea as initial symptom and literature review (edit) |
10.1016/J.CLINRE.2020.03.013 |
| 2020-10-01 |
Clinical consensus recommendations regarding non-invasive respiratory support in the adult patient with acute respiratory failure secondary to SARS-CoV-2 infection (edit) |
10.1016/J.MEDIN.2020.03.005 |
| 2020-10-01 |
Neurological manifestations of patients with COVID-19: potential routes of SARS-CoV-2 neuroinvasion from the periphery to the brain (edit) |
10.1007/S11684-020-0786-5 |
| 2020-10-01 |
SARS-CoV-2/COVID-19: Evolving Reality, Global Response, Knowledge Gaps and Opportunities (edit) |
10.1097/SHK.0000000000001565 |
| 2020-10-01 |
Prioritisation of Anti-SARS-Cov-2 Drug Repurposing Opportunities Based on Plasma and Target Site Concentrations Derived from their Established Human Pharmacokinetics (edit) |
10.1002/CPT.1909 |
| 2020-10-01 |
SARS-CoV-2 and human milk: What is the evidence? (edit) |
10.1111/MCN.13032 |
| 2020-10-01 |
SARS-CoV-2 and COVID-19: A genetic, epidemiological, and evolutionary perspective (edit) |
10.1016/J.MEEGID.2020.104384 |
| 2020-10-01 |
SARS-CoV-2 and COVID-19: between pathophysiology complexity and therapeutic uncertainty (edit) |
10.1152/PHYSREV.00020.2020 |
| 2020-10-01 |
SARS-CoV-2: A comprehensive review from pathogenicity of the virus to clinical consequences (edit) |
10.1002/JMV.26123 |
| 2020-10-01 |
A compendium answering 150 questions on COVID-19 and SARS-CoV-2 (edit) |
10.1111/ALL.14449 |
| 2020-10-01 |
Cytokine Storm Induced by SARS-CoV-2 (edit) |
10.1016/J.CCA.2020.06.017 |
| 2020-10-01 |
The impact of the COVID-19 pandemic on suicide rates (edit) |
10.1093/QJMED/HCAA202 |
| 2020-10-01 |
Resilience strategies to manage psychological distress amongst healthcare workers during the COVID-19 pandemic: a narrative review (edit) |
10.1111/ANAE.15180 |
| 2020-10-01 |
Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach (edit) |
10.1016/J.BBADIS.2020.165878 |
| 2020-10-01 |
Persistence of SARS-CoV-2 in the environment and COVID-19 transmission risk from environmental matrices and surfaces (edit) |
10.1016/J.ENVPOL.2020.115010 |
| 2020-10-01 |
The clinical course of SARS-CoV-2 positive neonates (edit) |
10.1038/S41372-020-0715-0 |
| 2020-10-01 |
Autoimmune and rheumatic musculoskeletal diseases as a consequence of SARS-CoV-2 infection and its treatment (edit) |
10.1007/S00296-020-04639-9 |
| 2020-10-01 |
Intermittent fasting, a possible priming tool for host defense against SARS-CoV-2 infection: Crosstalk among calorie restriction, autophagy and immune response (edit) |
10.1016/J.IMLET.2020.07.001 |
| 2020-10-01 |
Viruses and asthma: the role of common respiratory viruses in asthma and its potential meaning for SARS-CoV-2 (edit) |
10.1111/IMM.13240 |
| 2020-10-01 |
COVID-19 treatment: Much research and testing, but far, few magic bullets against SARS-CoV-2 coronavirus (edit) |
10.1016/J.EJMECH.2020.112647 |
| 2020-10-01 |
Approaching Coronavirus Disease 2019: mechanisms of action of repurposed drugs with potential activity against SARS-CoV-2 (edit) |
10.1016/J.BCP.2020.114169 |
| 2020-10-01 |
Drugs targeting various stages of the SARS-CoV-2 life cycle: Exploring promising drugs for the treatment of Covid-19 (edit) |
10.1016/J.CELLSIG.2020.109721 |
| 2020-10-01 |
Mechanistic insights of host cell fusion of SARS-CoV-1 and SARS-CoV-2 from atomic resolution structure and membrane dynamics (edit) |
10.1016/J.BPC.2020.106438 |
| 2020-10-01 |
Drug discovery strategies for SARS-CoV-2 (edit) |
10.1124/JPET.120.000123 |
| 2020-10-01 |
Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients (edit) |
10.1007/S10072-020-04575-3 |
| 2020-10-01 |
Diagnostics for SARS-CoV-2 detection: A comprehensive review of the FDA-EUA COVID-19 testing landscape (edit) |
10.1016/J.BIOS.2020.112454 |
| 2020-10-01 |
Differences and similarities between SARS-CoV and SARS-CoV-2: spike receptor-binding domain recognition and host cell infection with support of cellular serine proteases (edit) |
10.1007/S15010-020-01486-5 |
| 2020-10-01 |
The pathophysiology of SARS-CoV-2: A suggested model and therapeutic approach (edit) |
10.1016/J.LFS.2020.118166 |
| 2020-10-01 |
Targeting SARS-CoV2 Spike Protein Receptor Binding Domain by Therapeutic Antibodies (edit) |
10.1016/J.BIOPHA.2020.110559 |
| 2020-10-01 |
Options for screening for gestational diabetes mellitus during the SARS-CoV-2 pandemic (edit) |
10.1111/AJO.13224 |
| 2020-10-01 |
Potential effects of SARS-CoV-2 infection during pregnancy on fetuses and newborns are worthy of attention (edit) |
10.1111/JOG.14406 |
| 2020-10-01 |
Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality (edit) |
10.1083/JCB.202006159 |
| 2020-10-01 |
An updated min-review on environmental route of the SARS-CoV-2 transmission (edit) |
10.1016/J.ECOENV.2020.111015 |
| 2020-10-01 |
Supportive Management and Interventions for Respiratory Failure Due to SARS-CoV-2 (edit) |
10.1097/CNQ.0000000000000322 |
| 2020-10-01 |
Follow-up Study of Long-time Positive RT-PCR in Stool Specimens From Asymptomatic Children Infected With SARS-CoV-2 (edit) |
10.1097/INF.0000000000002837 |
| 2020-10-01 |
THYROID DISORDERS AND SARS-CoV-2 INFECTION: from pathophysiological mechanism to patient management (edit) |
10.1016/J.ANDO.2020.09.001 |
| 2020-10-01 |
[SARS-CoV-2, a new causal agent of Guillain-Barre syndrome] (edit) |
10.33588/RN.7107.2020264 |
| 2020-10-01 |
High Prevalence of Obesity in Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Requiring Invasive Mechanical Ventilation (edit) |
10.1002/OBY.23006 |
| 2020-10-01 |
Do free radical NETwork and oxidative stress disparities in African Americans enhance their vulnerability to SARS-CoV-2 infection and COVID-19 severity? (edit) |
10.1016/J.REDOX.2020.101721 |
| 2020-10-01 |
Quantitative Proteomic Analysis of the Expression of SARS-CoV-2 Receptors in the Gut of Patients with Chronic Enterocolitis (edit) |
10.3349/YMJ.2020.61.10.891 |
| 2020-09-30 |
[Origin of SARS-CoV-2 theories, keys and unknowns of an emerged disease.] (edit) |
|
| 2020-09-30 |
Pregnancies recovered from SARS-CoV-2 infection in the second and third trimesters: obstetric evolution (edit) |
10.1002/UOG.23134 |
| 2020-09-30 |
Microbiology Society online workshop on SARS-CoV-2 and COVID-19, Wednesday 29 July 2020 (edit) |
10.1099/JGV.0.001504 |
| 2020-09-30 |
Performance evaluation of Panther Fusion SARS-CoV-2 assay for detection of SARS-CoV-2 from deep throat saliva, nasopharyngeal and lower-respiratory-tract specimens (edit) |
10.1002/JMV.26574 |
| 2020-09-30 |
Muscle involvement in SARS-CoV-2 infection (edit) |
10.1111/ENE.14564 |
| 2020-09-30 |
Paediatric Inflammatory Multisystem Syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in a patient receiving Infliximab therapy for Inflammatory Bowel Disease (edit) |
10.1093/ECCO-JCC/JJAA201 |
| 2020-09-30 |
Accuracy of serological testing for SARS-CoV-2 antibodies: first results of a large mixed-method evaluation study (edit) |
10.1111/ALL.14608 |
| 2020-09-30 |
The Enemy Within: Sudden Onset Reversible Cardiogenic Shock with Biopsy Proven Cardiac Myocyte Infection by SARS-CoV-2 (edit) |
10.1161/CIRCULATIONAHA.120.050097 |
| 2020-09-30 |
Undetectable viral RNA in oocytes from SARS-CoV-2 positive women (edit) |
10.1093/HUMREP/DEAA284 |
| 2020-09-30 |
An initiative to evaluate the safety of maternal bonding in patients with SARS-CoV-2 infection (edit) |
10.1080/14767058.2020.1828335 |
| 2020-09-30 |
Severe Apparent Life-threatening Event (ALTE) in an Infant with SARS-CoV 2 Infection (edit) |
10.7883/YOKEN.JJID.2020.572 |
| 2020-09-30 |
Ultrastructural analysis of SARS-CoV-2 interactions with the host cell via high resolution scanning electron microscopy (edit) |
10.1038/S41598-020-73162-5 |
| 2020-09-30 |
Response to "the role of the exposome in promoting resilience or susceptibility after SARS-CoV-2 infection" (edit) |
10.1038/S41370-020-00274-5 |
| 2020-09-30 |
Effective treatment of SARS-CoV-2-infected rhesus macaques by attenuating inflammation (edit) |
10.1038/S41422-020-00414-4 |
| 2020-09-30 |
Imatinib is not a potent anti-SARS-CoV-2 drug (edit) |
10.1038/S41375-020-01045-9 |
| 2020-09-30 |
SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition (edit) |
10.1038/S41590-020-00808-X |
| 2020-09-30 |
Dynamics of neutralizing antibody titers in the months after SARS-CoV-2 infection (edit) |
10.1093/INFDIS/JIAA618 |
| 2020-09-30 |
Increased dengue transmissions in Singapore attributable to SARS-CoV-2 social distancing measures (edit) |
10.1093/INFDIS/JIAA619 |
| 2020-09-30 |
SARS-CoV-2 Has Not Been Detected Directly by Electron Microscopy in the Endothelium of Chilblain Lesions (edit) |
10.1111/BJD.19572 |
| 2020-09-30 |
SARS-CoV-2 Has Not Been Detected Directly by Electron Microscopy in the Endothelium of Chilblain Lesions: reply from authors (edit) |
10.1111/BJD.19579 |
| 2020-09-30 |
Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: A Randomized Clinical Trial (edit) |
10.1001/JAMAINTERNMED.2020.6319 |
| 2020-09-30 |
Peptide Nucleic Acid (PNA)-Enhanced Specificity of a Dual-Target Real-Time Quantitative Polymerase Chain Reaction (RT-qPCR) Assay for the Detection and Differentiation of SARS-CoV-2 from Related Viruses (edit) |
10.3390/DIAGNOSTICS10100775 |
| 2020-09-30 |
The spread rate of SARS-CoV-2 is strongly associated with population density (edit) |
10.1093/JTM/TAAA186 |
| 2020-09-30 |
Screening for SARS-CoV-2 antibodies among healthcare workers in a university hospital in southern France (edit) |
10.1016/J.JINF.2020.09.035 |
| 2020-09-30 |
Therapeutic Strategies for SARS-CoV-2 acting on ACE-2 (edit) |
10.1016/J.EJPS.2020.105579 |
| 2020-09-30 |
Sudden sensorineural hearing loss and COVID-19: (commentary about "Could sudden sensorineural hearing loss be the sole manifestation of COVID-19? An investigation into SARS-COV-2 in the etiology of sudden sensorineural hearing loss" from Osman Kılıc (edit) |
10.1016/J.IJID.2020.09.1467 |
| 2020-09-30 |
SARS-CoV-2 induces a more robust innate immune response and replicates less efficiently than SARS-CoV in the human intestines: an ex vivo study with implications on pathogenesis of COVID-19 (edit) |
10.1016/J.JCMGH.2020.09.017 |
| 2020-09-30 |
Investigation of hospital indoor air quality for the presence of SARS-Cov-2 (edit) |
10.1007/S40201-020-00543-3 |
| 2020-09-30 |
Cross-sectional evaluation of humoral responses against SARS-CoV-2 Spike (edit) |
10.1016/J.XCRM.2020.100126 |
| 2020-09-30 |
The role of culture on 2020 SARS-CoV-2 Country deaths: a pandemic management based on cultural dimensions (edit) |
10.1007/S10708-020-10306-0 |
| 2020-09-30 |
Functional Landscape of SARS-CoV-2 Cellular Restriction (edit) |
10.1101/2020.09.29.319566 |
| 2020-09-30 |
Inhibition of SARS-CoV-2 in Vero cell cultures by peptide-conjugated morpholino-oligomers (edit) |
10.1101/2020.09.29.319731 |
| 2020-09-30 |
Viral genomes reveal patterns of the SARS-CoV-2 outbreak in Washington State (edit) |
10.1101/2020.09.30.20204230 |
| 2020-09-30 |
Geospatial Analysis of Individual and Community-Level Socioeconomic Factors Impacting SARS-CoV-2 Prevalence and Outcomes (edit) |
10.1101/2020.09.30.20201830 |
| 2020-09-30 |
ERRATUM: SARS-CoV-2 infections with emphasis on pediatric patients: a narrative review (edit) |
10.1590/S1678-9946202062065ERR |
| 2020-09-30 |
Flavonoid glycosides and their putative human metabolites as potential inhibitors of the SARS-CoV-2 main protease (Mpro) and RNA-dependent RNA polymerase (RdRp) (edit) |
10.1590/0074-02760200207 |
| 2020-09-30 |
Investigating Potential Inhibitory Effect of Uncaria tomentosa (Cat's Claw) against the Main Protease 3CLpro of SARS-CoV-2 by Molecular Modeling (edit) |
10.1155/2020/4932572 |
| 2020-09-30 |
Physical distancing reduced the incidence of influenza and supports a favorable impact on SARS-CoV-2 spread in Mexico (edit) |
10.3855/JIDC.13250 |
| 2020-09-30 |
Detection of SARS-CoV-2 in the tears and conjunctival secretions of Coronavirus disease 2019 patients (edit) |
10.3855/JIDC.13224 |
| 2020-09-30 |
SARS-CoV-2 cell entry receptor ACE2 mediated endothelial dysfunction leads to vascular thrombosis in COVID-19 patients (edit) |
10.1016/J.MEHY.2020.110320 |
| 2020-09-30 |
The distribution of SARS-CoV-2 contamination on the environmental surfaces during incubation period of COVID-19 patients (edit) |
10.1016/J.ECOENV.2020.111438 |
| 2020-09-30 |
Diagnostic and methodological evaluation of studies on the urinary shedding of SARS-CoV-2, compared to stool and serum: A systematic review and meta-analysis (edit) |
|
| 2020-09-30 |
Strengthening respiratory protection from SARS-CoV-2 in certain general practice contexts (edit) |
10.31128/AJGP-COVID-38 |
| 2020-09-30 |
Surveillance of SARS-CoV-2 RNA in wastewater: Methods optimisation and quality control are crucial for generating reliable public health information (edit) |
10.1016/J.COESH.2020.09.003 |
| 2020-09-30 |
Comparative evaluation of nasopharyngeal swab and saliva specimens for the molecular detection of SARS-CoV-2 RNA in Japanese patients with COVID-19 (edit) |
10.1016/J.JIAC.2020.09.027 |
| 2020-09-30 |
Comprehensive analysis of two potential novel SARS-CoV-2 entries, TMPRSS2 and IFITM3, in healthy individuals and cancer patients (edit) |
10.7150/IJBS.51234 |
| 2020-09-30 |
Comparative analysis of three laboratory based serological assays for SARS-CoV-2 in an Australian cohort (edit) |
10.1016/J.PATHOL.2020.09.008 |
| 2020-09-30 |
Laboratory biosafety measures involving SARS-CoV-2 and the classification as a Risk Group 3 biological agent (edit) |
10.1016/J.PATHOL.2020.09.006 |
| 2020-09-30 |
Accuracy amidst ambiguity: false positive SARS-CoV-2 nucleic acid tests when COVID-19 prevalence is low (edit) |
10.1016/J.PATHOL.2020.09.009 |
| 2020-09-30 |
Head-to-head evaluation on diagnostic accuracies of six SARS-CoV-2 serological assays (edit) |
10.1016/J.PATHOL.2020.09.007 |
| 2020-09-30 |
Acute myelitis and SARS-CoV-2 infection. A new etiology of myelitis? (edit) |
10.1016/J.JOCN.2020.07.074 |
| 2020-09-30 |
The Potential Intermediate Hosts for SARS-CoV-2 (edit) |
10.3389/FMICB.2020.580137 |
| 2020-09-30 |
Is Herd Immunity Against SARS-CoV-2 a Silver Lining? (edit) |
10.3389/FIMMU.2020.586781 |
| 2020-09-30 |
Mutations Observed in the SARS-CoV-2 Spike Glycoprotein and Their Effects in the Interaction of Virus with ACE-2 Receptor (edit) |
10.5222/MMJ.2020.98048 |
| 2020-09-30 |
Can Beta-2-Adrenergic Pathway Be a New Target to Combat SARS-CoV-2 Hyperinflammatory Syndrome?-Lessons Learned From Cancer (edit) |
10.3389/FIMMU.2020.588724 |
| 2020-09-30 |
The Role of Type I Interferons in the Pathogenesis and Treatment of COVID-19 (edit) |
10.3389/FIMMU.2020.595739 |
| 2020-09-30 |
Targeting the SARS-CoV-2 RNA Genome with Small Molecule Binders and Ribonuclease Targeting Chimera (RIBOTAC) Degraders (edit) |
10.1021/ACSCENTSCI.0C00984 |
| 2020-09-30 |
Evidence-based treatment during the SARS-CoV-2 pandemic: Identifying the knowns and unknowns of nebulization (edit) |
10.1016/J.JAPH.2020.09.014 |
| 2020-09-30 |
Analysis of sputum/tracheal aspirate and nasopharyngeal samples for SARS-CoV-2 detection by laboratory-developed test and Panther Fusion system (edit) |
10.1016/J.DIAGMICROBIO.2020.115228 |
| 2020-09-30 |
ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives (edit) |
10.3389/FMOLB.2020.588618 |
| 2020-09-30 |
Socio-economic impact of first 21 days nationwide lockdown- 1 on the spread of SARS-COV-2 in India in relation to health (edit) |
10.4103/JFMPC.JFMPC_662_20 |
| 2020-09-30 |
Immune response in SARS-CoV-2 (edit) |
10.4103/JFMPC.JFMPC_1539_20 |
| 2020-09-30 |
SARS-CoV-2 viral load peaks prior to symptom onset: a systematic review and individual-pooled analysis of coronavirus viral load from 66 studies (edit) |
10.1101/2020.09.28.20202028 |
| 2020-09-30 |
The furin cleavage site of SARS-CoV-2 spike protein is a key determinant for transmission due to enhanced replication in airway cells (edit) |
10.1101/2020.09.30.318311 |
| 2020-09-29 |
Late incidence of SARS-CoV-2 infection in a highly-endemic remote rural village. A prospective population-based cohort study (edit) |
10.1080/20477724.2020.1826152 |
| 2020-09-29 |
Massive application of the SARS-CoV-2 diagnostic test. Simulation of its effect on the evolution of the epidemic in Spain (edit) |
10.1017/S0950268820002289 |
| 2020-09-29 |
Alcohol-based hand sanitizers as first line of defense against SARS CoV-2: a review of biology, chemistry and formulations (edit) |
10.1017/S0950268820002319 |
| 2020-09-29 |
Development of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) thermal inactivation method with preservation of diagnostic sensitivity (edit) |
10.1007/S12275-020-0335-6 |
| 2020-09-29 |
Establishment of replication-competent vesicular stomatitis virus-based recombinant viruses suitable for SARS-CoV-2 entry and neutralization assays (edit) |
10.1080/22221751.2020.1830715 |
| 2020-09-29 |
Diagnosis of SARS-CoV-2 infection in the setting of cytokine release syndrome (edit) |
10.1080/14737159.2020.1830760 |
| 2020-09-29 |
SARS-CoV-2 infection associated with the recurrence of nephrotic syndrome in a Japanese boy (edit) |
10.1007/S00467-020-04782-2 |
| 2020-09-29 |
The cytokine storm - An appropriate, over-reactive response to SARS-COV-2 or the wrong immune pathway? (edit) |
10.1111/SJI.12979 |
| 2020-09-29 |
SARS-CoV-2: Disinfection Strategies to Prevent Transmission of Neuropathogens via Air Conditioning Systems (edit) |
10.1021/ACSCHEMNEURO.0C00595 |
| 2020-09-29 |
Neutralizing antibody response elicited by SARS-CoV-2 receptor-binding domain (edit) |
10.1080/21645515.2020.1814098 |
| 2020-09-29 |
SARS-CoV-2, immunosenescence and inflammaging: partners in the COVID-19 crime (edit) |
10.18632/AGING.103989 |
| 2020-09-29 |
COVID-19 survival associates with the immunoglobulin response to the SARS-CoV-2 spike Receptor Binding Domain (edit) |
10.1172/JCI142804 |
| 2020-09-29 |
A 63-Year-Old Woman with SARS-CoV-2 Infection, Who Developed Severe COVID-19 Pneumonia and Was Supported with Convalescent Plasma Therapy (edit) |
10.12659/AJCR.927662 |
| 2020-09-29 |
Routine screening for SARS CoV-2 in unselected pregnant women at delivery (edit) |
10.1371/JOURNAL.PONE.0239887 |
| 2020-09-29 |
Overexpression of the SARS-CoV-2 receptor ACE2 is induced by cigarette smoke in bronchial and alveolar epithelia (edit) |
10.1002/PATH.5555 |
| 2020-09-29 |
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults (edit) |
10.1056/NEJMOA2028436 |
| 2020-09-29 |
Lung Expression of Human ACE2 Sensitizes the Mouse to SARS-CoV-2 Infection (edit) |
10.1165/RCMB.2020-0354OC |
| 2020-09-29 |
SARS-CoV-2 and Pregnancy: A Review of the Facts (edit) |
10.1055/S-0040-1715137 |
| 2020-09-29 |
Expression of SARS-CoV-2 entry receptors in the respiratory tract of healthy individuals, smokers and asthmatics (edit) |
10.1186/S12931-020-01521-X |
| 2020-09-29 |
Presence of SARS-CoV-2 in urine is rare and not associated with acute kidney injury in critically ill COVID-19 patients (edit) |
10.1186/S13054-020-03302-W |
| 2020-09-29 |
High-resolution structures of the SARS-CoV-2 2'-O-methyltransferase reveal strategies for structure-based inhibitor design (edit) |
10.1126/SCISIGNAL.ABE1202 |
| 2020-09-29 |
SARS-CoV-2 Seroprevalence among a Southern U.S. Population Indicates Limited Asymptomatic Spread under Physical Distancing Measures (edit) |
10.1128/MBIO.02426-20 |
| 2020-09-29 |
Experimental infection of domestic dogs and cats with SARS-CoV-2: Pathogenesis, transmission, and response to reexposure in cats (edit) |
10.1073/PNAS.2013102117 |
| 2020-09-29 |
Susceptibility of tree shrew to SARS-CoV-2 infection (edit) |
10.1038/S41598-020-72563-W |
| 2020-09-29 |
A Novel Use of Romiplostim for SARS-CoV-2-induced Thrombocytopenia (edit) |
10.1097/MPH.0000000000001961 |
| 2020-09-29 |
Performance of Targeted Library Preparation Solutions for SARS-CoV-2 Whole Genome Analysis (edit) |
10.3390/DIAGNOSTICS10100769 |
| 2020-09-29 |
Interaction of Human ACE2 to Membrane-Bound SARS-CoV-1 and SARS-CoV-2 S Glycoproteins (edit) |
10.3390/V12101104 |
| 2020-09-29 |
Effective Immune Functions of Micronutrients against SARS-CoV-2 (edit) |
10.3390/NU12102992 |
| 2020-09-29 |
Low risk of SARS-CoV-2 transmission by fomites in real-life conditions (edit) |
10.1016/S1473-3099(20)30678-2 |
| 2020-09-29 |
Severe SARS-CoV-2 Disease In The Context Of A NFκB2 Loss-Of-Function Pathogenic Variant (edit) |
10.1016/J.JACI.2020.09.020 |
| 2020-09-29 |
SARS-CoV-2 variant tracing within the first COVID-19 clusters in Northern Germany (edit) |
10.1016/J.CMI.2020.09.034 |
| 2020-09-29 |
Transmission of SARS CoV-2 virus through the ocular mucosa worth taking precautions (edit) |
10.1016/J.VACUN.2020.09.003 |
| 2020-09-29 |
Early detection of SARS-CoV-2 from staging PET-CT (edit) |
10.1007/S13566-020-00436-W |
| 2020-09-29 |
Characterization of local SARS-CoV-2 isolates and pathogenicity in IFNAR-/- mice (edit) |
10.1016/J.HELIYON.2020.E05116 |
| 2020-09-29 |
Transmittance and Survival of SARS-CoV-2 in Global Trade: The Role of Supply Chain and Packaging (edit) |
10.1007/S41783-020-00101-0 |
| 2020-09-29 |
The SARS-CoV-2 Outbreak: an Epidemiological and Clinical Perspective (edit) |
10.1007/S42399-020-00546-Z |
| 2020-09-29 |
Mitochondria - in the crossfire of SARS-CoV-2 and immunity (edit) |
10.1016/J.ISCI.2020.101631 |
| 2020-09-29 |
Broad host range of SARS-CoV-2 and the molecular basis for SARS-CoV-2 binding to cat ACE2 (edit) |
10.1038/S41421-020-00210-9 |
| 2020-09-29 |
Possible transmission of viruses from contaminated human feces and sewage: Implications for SARS-CoV-2 (edit) |
10.1016/J.SCITOTENV.2020.142575 |
| 2020-09-29 |
SARS-CoV-2 D614G Variant Exhibits Enhanced Replication ex vivo and Earlier Transmission in vivo (edit) |
10.1101/2020.09.28.317685 |
| 2020-09-29 |
Molecular Architecture of Early Dissemination and Massive Second Wave of the SARS-CoV-2 Virus in a Major Metropolitan Area (edit) |
10.1101/2020.09.22.20199125 |
| 2020-09-29 |
An Alternative Binding Mode of IGHV3-53 Antibodies to the SARS-CoV-2 Receptor Binding Domain (edit) |
10.1016/J.CELREP.2020.108274 |
| 2020-09-29 |
Urgent need of rapid tests for SARS CoV-2 antigen detection: Evaluation of the SD-Biosensor antigen test for SARS-CoV-2 (edit) |
10.1016/J.JCV.2020.104654 |
| 2020-09-29 |
A Conversation Between Two Viruses: SARS-CoV and SARS-CoV-2 - Based on a True Story (edit) |
|
| 2020-09-29 |
Computational perspectives revealed prospective vaccine candidates from five structural proteins of novel SARS corona virus 2019 (SARS-CoV-2) (edit) |
10.7717/PEERJ.9855 |
| 2020-09-29 |
Continuous flexibility analysis of SARS-CoV-2 spike prefusion structures (edit) |
10.1107/S2052252520012725 |
| 2020-09-29 |
Urological surgery during SARS-CoV-2 pandemic. Descriptive analysis of the experience in a Urology Department across the pandemic phases (edit) |
10.1016/J.ACURO.2020.09.007 |
| 2020-09-29 |
[Impact of the SARS-CoV-2 pandemic on the start of prescriptions] (edit) |
10.1016/J.JHQR.2020.09.001 |
| 2020-09-29 |
Case Series of COVID-19 Asymptomatic Newborns With Possible Intrapartum Transmission of SARS-CoV-2 (edit) |
10.3389/FPED.2020.568979 |
| 2020-09-29 |
Pooling of Upper Respiratory Specimens Using a SARS-CoV-2 Real-time RT-PCR Assay Authorized for Emergency Use in Low-Prevalence Populations for High-Throughput Testing (edit) |
10.1093/OFID/OFAA466 |
| 2020-09-28 |
Discovery of Drug-Like Ligands for the Mac1 Domain of SARS-CoV-2 Nsp3 (edit) |
10.1177/2472555220960428 |
| 2020-09-28 |
Pharmacophore based virtual screening, molecular docking, molecular dynamics and MM-GBSA approach for identification of prospective SARS-CoV-2 inhibitor from natural product databases (edit) |
10.1080/07391102.2020.1824814 |
| 2020-09-28 |
The possibility of SARS-CoV-2 transmission in a hemodialysis unit - report from a large in-hospital centre (edit) |
10.1017/S0950268820002277 |
| 2020-09-28 |
Pre-exposure prophylaxis during the SARS-CoV-2 pandemic: can PrEP prevent COVID-19-related symptoms? (edit) |
10.1017/S0950268820002253 |
| 2020-09-28 |
Diagnosis of SARS-CoV-2: A Review on the Current Scenario and Future Outlook (edit) |
10.4149/AV_2020_402 |
| 2020-09-28 |
SARS-CoV-2 and COVID-19: How much do we know? (edit) |
10.4149/AV_2020_301 |
| 2020-09-28 |
SARS-CoV-2: Zoonotic origin of pandemic coronavirus (edit) |
10.4149/AV_2020_302 |
| 2020-09-28 |
Genomic characterization and phylogenetic evolution of the SARS-CoV-2 (edit) |
10.4149/AV_2020_403 |
| 2020-09-28 |
Potential therapeutic effects of Resveratrol against SARS-CoV-2 (edit) |
10.4149/AV_2020_309 |
| 2020-09-28 |
Structural and functional modelling of SARS-CoV-2 entry in animal models (edit) |
10.1038/S41598-020-72528-Z |
| 2020-09-28 |
The role of the healthcare surface environment in SARS-CoV-2 transmission and potential control measures (edit) |
10.1093/CID/CIAA1467 |
| 2020-09-28 |
Clinical Characteristics and Mortality of Healthcare Workers with SARS-CoV-2 infection in Mexico City (edit) |
10.1093/CID/CIAA1465 |
| 2020-09-28 |
Epidemiological Correlates of PCR Cycle Threshold Values in the Detection of SARS-CoV-2 (edit) |
10.1093/CID/CIAA1469 |
| 2020-09-28 |
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Screening With Specimen Pools: Time to Swim, or Too Deep for Comfort? (edit) |
10.1093/CID/CIAA1145 |
| 2020-09-28 |
Children were less frequently infected with SARS-CoV-2 than adults during 2020 COVID-19 pandemic in Warsaw, Poland (edit) |
10.1007/S10096-020-04038-9 |
| 2020-09-28 |
Effect of Corticosteroid Therapy on the Duration of SARS-CoV-2 Clearance in Patients with Mild COVID-19: A Retrospective Cohort Study (edit) |
10.1007/S40121-020-00337-Y |
| 2020-09-28 |
Identifying the Risk of SARS-CoV-2 Infection and Environmental Monitoring in Airborne Infectious Isolation Rooms (AIIRs) (edit) |
10.1007/S12250-020-00301-7 |
| 2020-09-28 |
Partial compliance with symptom-based testing pathways reveals asymptomatic carriage of SARS-CoV-2 in Ireland (edit) |
10.1007/S11845-020-02375-4 |
| 2020-09-28 |
Retarded decline of the share of SARS-CoV-2-positive children in North Rhine-Westphalia, Germany (edit) |
10.1002/JMV.26564 |
| 2020-09-28 |
Risk factors for mortality among patients with SARS-CoV-2 infection: A longitudinal observational study (edit) |
10.1002/JMV.26560 |
| 2020-09-28 |
A bioinformatic prediction of antigen presentation from SARS-CoV-2 spike protein revealed a theorical correlation of HLA-DRB1*01 with COVID-19 fatality in Mexican population: an ecological approach (edit) |
10.1002/JMV.26561 |
| 2020-09-28 |
Testing of commercial masks and respirators and cotton mask insert materials using SARS-CoV-2 virion-sized particulates: comparison of ideal aerosol filtration efficiency versus fitted filtration efficiency (edit) |
10.1021/ACS.NANOLETT.0C03182 |
| 2020-09-28 |
A Bayesian Framework for Estimating the Risk Ratio of Hospitalization for People with Comorbidity Infected by SARS-CoV-2 Virus (edit) |
10.1093/JAMIA/OCAA246 |
| 2020-09-28 |
Correlation between 3790 qPCR positives samples and positive cell cultures including 1941 SARS-CoV-2 isolates (edit) |
10.1093/CID/CIAA1491 |
| 2020-09-28 |
Asymptomatic carriage rates and case-fatality of SARS-CoV-2 infection in residents and staff in Irish nursing homes (edit) |
10.1093/AGEING/AFAA220 |
| 2020-09-28 |
Remdesivir failure with SARS-CoV-2 RNA-dependent RNA-polymerase mutation in a B-cell immunodeficient patient with protracted Covid-19 (edit) |
10.1093/CID/CIAA1474 |
| 2020-09-28 |
Clinical presentation and outcomes of SARS-CoV-2 related encephalitis: the ENCOVID multicentre study (edit) |
10.1093/INFDIS/JIAA609 |
| 2020-09-28 |
Binding of SARS-CoV-2 to cell receptors: a tale of molecular evolution (edit) |
10.1002/CBIC.202000618 |
| 2020-09-28 |
Takotsubo cardiomyopathy in early term pregnancy: a rare cardiac complication of SARS-CoV-2 infection (edit) |
10.1136/BCR-2020-239104 |
| 2020-09-28 |
Effects of SARS-CoV-2 emergency measures on high-risk lesions detection: a multicentre cross-sectional study (edit) |
10.1136/GUTJNL-2020-323116 |
| 2020-09-28 |
Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation (edit) |
10.1073/PNAS.2010722117 |
| 2020-09-28 |
Keeping track of the SARS-CoV-2 vaccine pipeline (edit) |
10.1038/S41577-020-00455-1 |
| 2020-09-28 |
Don't worry! The next generation would be more resistant to SARS-CoV-2 (edit) |
10.1007/S00011-020-01405-2 |
| 2020-09-28 |
SARS-CoV-2 infection in children requiring hospitalization: the experience of Navarra, Spain (edit) |
10.1007/S12519-020-00393-X |
| 2020-09-28 |
Immune characteristics distinguish patients with severe disease associated with SARS-CoV-2 (edit) |
10.1007/S12026-020-09156-2 |
| 2020-09-28 |
COVID-19 pandemic: environmental and social factors influencing the spread of SARS-CoV-2 in São Paulo, Brazil (edit) |
10.1007/S11356-020-10930-W |
| 2020-09-28 |
COVID-19 CG: Tracking SARS-CoV-2 mutations by locations and dates of interest (edit) |
10.1101/2020.09.23.310565 |
| 2020-09-28 |
Is Higher Viral Load in SARS-CoV-2 Associated with Death? (edit) |
10.4269/AJTMH.20-0954 |
| 2020-09-28 |
Role of Vitamin K-Dependent Factors Protein S and GAS6 and TAM Receptors in SARS-CoV-2 Infection and COVID-19-Associated Immunothrombosis (edit) |
10.3390/CELLS9102186 |
| 2020-09-28 |
Development and Optimization of In-house ELISA for Detection of Human IgG Antibody to SARS-CoV-2 Full Length Spike Protein (edit) |
10.3390/PATHOGENS9100803 |
| 2020-09-28 |
SARS-CoV-2 infection serology validation of different methods: Usefulness of IgA in the early phase of infection (edit) |
10.1016/J.CCA.2020.09.033 |
| 2020-09-28 |
SARS-CoV-2-associated critical ill myopathy or pure toxic myopathy? (edit) |
10.1016/J.IJID.2020.09.1463 |
| 2020-09-28 |
Reply to "SARS-CoV-2-associated critical ill myopathy or pure toxic myopathy?" (edit) |
10.1016/J.IJID.2020.09.1461 |
| 2020-09-28 |
Serological cross-reactivity using a SARS-CoV-2 ELISA test in acute Zika virus infection, Colombia (edit) |
10.1016/J.IJID.2020.09.1451 |
| 2020-09-28 |
Acute pericarditis and SARS-CoV-2: case report (edit) |
10.1016/J.IJID.2020.09.1440 |
| 2020-09-28 |
Molecular and serological characterization of SARS-CoV-2 infection among COVID-19 patients (edit) |
10.1016/J.VIROL.2020.09.008 |
| 2020-09-28 |
Conventional PCR Assisted Single-Component Assembly of Spherical Nucleic Acids for Simple Colorimetric Detection of SARS-CoV-2 (edit) |
10.1016/J.SNB.2020.128971 |
| 2020-09-28 |
Screening of FDA Approved Drugs Against SARS-CoV-2 Main Protease: Coronavirus Disease (edit) |
10.1007/S10989-020-10115-6 |
| 2020-09-28 |
Identification of twenty-five mutations in surface glycoprotein (Spike) of SARS-CoV-2 among Indian isolates and their impact on protein dynamics (edit) |
10.1016/J.GENREP.2020.100891 |
| 2020-09-28 |
The SARS-CoV-2 pandemic course in Saudi Arabia: A dynamic epidemiological model (edit) |
10.1016/J.IDM.2020.09.006 |
| 2020-09-28 |
SARS-CoV-2, an Underestimated Pathogen of the Nervous System (edit) |
10.1007/S42399-020-00522-7 |
| 2020-09-28 |
A potent SARS-CoV-2 neutralizing human monoclonal antibody that reduces viral burden and disease severity in Syrian hamsters (edit) |
10.1101/2020.09.25.313601 |
| 2020-09-28 |
Ultrafast Sample Placement on Existing Trees (UShER) Empowers Real-Time Phylogenetics for the SARS-CoV-2 Pandemic (edit) |
10.1101/2020.09.26.314971 |
| 2020-09-28 |
Genome-Wide Asymptomatic B-Cell, CD4 + and CD8 + T-Cell Epitopes, that are Highly Conserved Between Human and Animal Coronaviruses, Identified from SARS-CoV-2 as Immune Targets for Pre-Emptive Pan-Coronavirus Vaccines (edit) |
10.1101/2020.09.27.316018 |
| 2020-09-28 |
Exploring dynamics and network analysis of spike glycoprotein of SARS-COV-2 (edit) |
10.1101/2020.09.28.317206 |
| 2020-09-28 |
Wrong person, place and time: viral load and contact network structure predict SARS-CoV-2 transmission and super-spreading events (edit) |
10.1101/2020.08.07.20169920 |
| 2020-09-28 |
Mitigating the transmission of infection and death due to SARS-CoV-2 through non-pharmaceutical interventions and repurposing drugs (edit) |
10.1016/J.ISATRA.2020.09.015 |
| 2020-09-28 |
Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses (edit) |
10.1038/S41541-020-00243-X |
| 2020-09-28 |
Influenza, SARS-CoV-2 and Invasive Pulmonary Aspergillosis (edit) |
10.1016/J.ARBRES.2020.09.012 |
| 2020-09-28 |
Identification of TMEM106B as proviral host factor for SARS-CoV-2 (edit) |
10.1101/2020.09.28.316281 |
| 2020-09-27 |
Delayed Diagnosis and Treatment of a Critically Ill Patient with Infective Endocarditis Due to a False-Positive Molecular Diagnostic Test for SARS-CoV-2 (edit) |
10.12659/AJCR.925931 |
| 2020-09-27 |
Characteristics and short-term obstetric outcomes in a case series of 67 women tested positive for SARS-CoV-2 in Stockholm, Sweden (edit) |
10.1111/AOGS.14006 |
| 2020-09-27 |
The probability of the 6-week lockdown in Victoria (commencing 9 July 2020) achieving elimination of community transmission of SARS-CoV-2 (edit) |
10.5694/MJA2.50786 |
| 2020-09-27 |
Covid-19.bioreproducibility.org: A web resource for SARS-CoV-2-related structural models (edit) |
10.1002/PRO.3959 |
| 2020-09-27 |
Monocyte volumetric parameters and lymph index are increased in SARS-CoV-2 infection (edit) |
10.1111/IJLH.13323 |
| 2020-09-27 |
Does SARS-CoV-2 have influence on male reproductive system? (edit) |
10.1093/HUMREP/DEAA239 |
| 2020-09-27 |
Virtual screening for functional foods against the main protease of SARS-CoV-2 (edit) |
10.1111/JFBC.13481 |
| 2020-09-27 |
Host Immune Response Driving SARS-CoV-2 Evolution (edit) |
10.3390/V12101095 |
| 2020-09-27 |
Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection (edit) |
10.1101/2020.09.25.314070 |
| 2020-09-27 |
Clinical characteristics, symptoms and outcomes of 1054 adults presenting to hospital with suspected COVID-19: a comparison of patients with and without SARS-CoV-2 infection (edit) |
10.1016/J.JINF.2020.09.033 |
| 2020-09-27 |
Decrease in Strokes during SARS-CoV-2 Pandemic: Where Did All Our Stroke Patients Go? (edit) |
10.2196/21608 |
| 2020-09-27 |
Eculizumab, SARS-CoV-2 and atypical hemolytic uremic syndrome (edit) |
10.1093/CKJ/SFAA166 |
| 2020-09-27 |
Kinetics of SARS-CoV-2 infection in the human upper and lower respiratory tracts and their relationship with infectiousness (edit) |
10.1101/2020.09.25.20201772 |
| 2020-09-26 |
Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes Platform to Study SARS-CoV-2 Related Myocardial Injury (edit) |
10.1253/CIRCJ.CJ-20-0881 |
| 2020-09-26 |
The iminosugars celgosivir, castanospermine and UV-4 inhibit SARS-CoV-2 replication (edit) |
10.1093/GLYCOB/CWAA091 |
| 2020-09-26 |
Hospital Visitation Policies During the SARS-CoV-2 Pandemic (edit) |
10.1016/J.AJIC.2020.09.007 |
| 2020-09-26 |
SARS-CoV-2 receptor ACE2 is expressed in human conjunctival tissue, especially in diseased conjunctival tissue (edit) |
10.1016/J.JTOS.2020.09.010 |
| 2020-09-26 |
Relationship of the Cycle Threshold Values of SARS-CoV-2 Polymerase Chain Reaction and Total Severity Score of Computerized Tomography in Patients with COVID 19 (edit) |
10.1016/J.IJID.2020.09.1449 |
| 2020-09-26 |
Challenging diagnostics in familial transmission from asymptomatic COVID-19 carrier. Should we group SARS-CoV-2 samples from households? (edit) |
10.1016/J.IJID.2020.09.1442 |
| 2020-09-26 |
Findings of Severe Hepatic SARS-CoV-2 Infection (edit) |
10.1016/J.JCMGH.2020.09.015 |
| 2020-09-26 |
Network Controllability-Based Prioritization of Candidates for SARS-CoV-2 Drug Repositioning (edit) |
10.3390/V12101087 |
| 2020-09-26 |
Potential Anti-SARS-CoV-2 Therapeutics That Target the Post-Entry Stages of the Viral Life Cycle: A Comprehensive Review (edit) |
10.3390/V12101092 |
| 2020-09-26 |
Antibody seroconversion in asymptomatic and symptomatic patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (edit) |
10.1002/CTI2.1182 |
| 2020-09-26 |
Systematic Review of Ocular Involvement of SARS-CoV-2 in Coronavirus Disease 2019 (edit) |
10.1007/S40135-020-00257-7 |
| 2020-09-26 |
Anti-SARS-Cov-2 IgA in Current Scenario of IgM and IgG Rapid Test: a New Alternative for the Diagnostic of COVID-19 (edit) |
10.1007/S42399-020-00551-2 |
| 2020-09-26 |
An Assumed Vertical Transmission of SARS-CoV-2 During Pregnancy: A Case Report and Review of Literature (edit) |
10.7759/CUREUS.10659 |
| 2020-09-26 |
Expanded use of teleservices in otology and neurotology in response to the COVID-19 (SARS-Cov-2) pandemic (edit) |
10.1002/LIO2.466 |
| 2020-09-26 |
SARS-CoV-2 Infection and COVID-19 in 5 Patients in Ecuador After Prior Treatment with Hydroxychloroquine for Systemic Lupus Erythematosus (edit) |
10.12659/AJCR.927304 |
| 2020-09-26 |
Re-detectable positive SARS-CoV-2 RNA tests in patients who recovered from COVID-19 with intestinal infection (edit) |
10.1007/S13238-020-00778-8 |
| 2020-09-26 |
Transmission of SARS-CoV-2 by inhalation of respiratory aerosol in the Skagit Valley Chorale superspreading event (edit) |
10.1111/INA.12751 |
| 2020-09-25 |
Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study (edit) |
10.1016/S0140-6736(20)32009-2 |
| 2020-09-25 |
SARS-CoV-2 antibody seroprevalence in patients receiving dialysis in the USA (edit) |
10.1016/S0140-6736(20)32006-7 |
| 2020-09-25 |
Design of novel viral attachment inhibitors of the spike glycoprotein (S) of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) through virtual screening and dynamics (edit) |
10.1016/J.IJANTIMICAG.2020.106177 |
| 2020-09-25 |
Identification of Novel Hypothalamic MicroRNAs as Promising Therapeutics for SARS-CoV-2 by Regulating ACE2 and TMPRSS2 Expression: An In Silico Analysis (edit) |
10.3390/BRAINSCI10100666 |
| 2020-09-25 |
Impact of Comorbidities on SARS-CoV-2 Viral Entry-Related Genes (edit) |
10.3390/JPM10040146 |
| 2020-09-25 |
Mental Health and the SARS-COV-2 Epidemic-Polish Research Study (edit) |
10.3390/IJERPH17197015 |
| 2020-09-25 |
Role of SARS-CoV-2 in Altering the RNA-Binding Protein and miRNA-Directed Post-Transcriptional Regulatory Networks in Humans (edit) |
10.3390/IJMS21197090 |
| 2020-09-25 |
Unraveling the Possible Routes of SARS-COV-2 Invasion into the Central Nervous System (edit) |
10.1007/S11940-020-00647-Z |
| 2020-09-25 |
Distinct B cell subsets give rise to antigen-specific antibody responses against SARS-CoV-2 (edit) |
10.21203/RS.3.RS-80476/V1 |
| 2020-09-25 |
Cyclooxgenase-2 is induced by SARS-CoV-2 infection but does not affect viral entry or replication (edit) |
10.1101/2020.09.24.312769 |
| 2020-09-25 |
SARS-CoV-2 induces double-stranded RNA-mediated innate immune responses in respiratory epithelial derived cells and cardiomyocytes (edit) |
10.1101/2020.09.24.312553 |
| 2020-09-25 |
Nitazoxanide and JIB-04 have broad-spectrum antiviral activity and inhibit SARS-CoV-2 replication in cell culture and coronavirus pathogenesis in a pig model (edit) |
10.1101/2020.09.24.312165 |
| 2020-09-25 |
Outcomes associated with SARS-CoV-2 viral clades in COVID-19 (edit) |
10.1101/2020.09.24.20201228 |
| 2020-09-25 |
Reinfection with SARS-CoV-2 and Failure of Humoral Immunity: a case report (edit) |
10.1101/2020.09.22.20192443 |
| 2020-09-25 |
Genomic and phylogenetic characterisation of an imported case of SARS-CoV-2 in Amazonas State, Brazil (edit) |
10.1590/0074-02760200310 |
| 2020-09-25 |
IS VERTICAL TRANSMISSION OF SARS-CoV-2 INFECTION POSSIBLE IN PRETERM TRIPLET PREGNANCY? A CASE SERIES (edit) |
10.1097/INF.0000000000002926 |
| 2020-09-25 |
Comparison of Primer-Probe Sets among Different Master Mixes for Laboratory Screening of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (edit) |
10.1155/2020/7610678 |
| 2020-09-25 |
Examining Equitable Online Federal Food Assistance during the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Case Study in 2 Regions (edit) |
10.1093/CDN/NZAA154 |
| 2020-09-25 |
Prescription profile of medication in patients with SARS-CoV-2 infection hospitalized in Aragón, Spain (edit) |
10.1016/J.MEDCLI.2020.08.002 |
| 2020-09-25 |
Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2): A Perspective Through the Lens of the Veterinary Diagnostic Laboratory (edit) |
10.3389/FVETS.2020.576267 |
| 2020-09-25 |
Anti-SARS-CoV Natural Products With the Potential to Inhibit SARS-CoV-2 (COVID-19) (edit) |
10.3389/FPHAR.2020.561334 |
| 2020-09-25 |
SAMHD1 as the Potential Link Between SARS-CoV-2 Infection and Neurological Complications (edit) |
10.3389/FNEUR.2020.562913 |
| 2020-09-25 |
Unfractionated Heparin in SARS-CoV-2 Pneumonia: Ischemic Stroke Case Report (edit) |
10.3389/FNEUR.2020.573356 |
| 2020-09-25 |
Rapid Genomic Characterization of SARS-CoV-2 by Direct Amplicon-Based Sequencing Through Comparison of MinION and Illumina iSeq100TM System (edit) |
10.3389/FMICB.2020.571328 |
| 2020-09-25 |
Genetic Spectrum and Distinct Evolution Patterns of SARS-CoV-2 (edit) |
10.3389/FMICB.2020.593548 |
| 2020-09-25 |
Inflammation, Thrombosis, and Destruction: The Three-Headed Cerberus of Trauma- and SARS-CoV-2-Induced ARDS (edit) |
10.3389/FIMMU.2020.584514 |
| 2020-09-25 |
SARS-CoV-2 Infections in the World: An Estimation of the Infected Population and a Measure of How Higher Detection Rates Save Lives (edit) |
10.3389/FPUBH.2020.00489 |
| 2020-09-25 |
An Asymptomatic SARS-CoV-2-Infected Infant With Persistent Fecal Viral RNA Shedding in a Family Cluster: A Rare Case Report (edit) |
10.3389/FMED.2020.562875 |
| 2020-09-25 |
Case Report: A Recovered SARS CoV-2 Patient Protected From Reinfection (edit) |
10.3389/FMED.2020.564264 |
| 2020-09-25 |
CD64, CD11a and CD18 leukocytes expression in children with SARS-CoV-2 multisystem inflammatory syndrome versus children with Kawasaki disease: Similar but not the same (edit) |
10.1016/J.MEDCLI.2020.09.002 |
| 2020-09-25 |
Research during the SARS-CoV-2 pandemic (edit) |
10.1016/J.MEDCLI.2020.09.001 |
| 2020-09-25 |
Genetic mechanisms of critical illness in Covid-19 (edit) |
10.1101/2020.09.24.20200048 |
| 2020-09-25 |
SARS-CoV-2 antibody performances: we need better criteria (edit) |
10.1515/CCLM-2020-1358 |
| 2020-09-25 |
Vertical Transmission of SARS-CoV-2 from an Asymptomatic Pregnant Woman in India (edit) |
10.1093/TROPEJ/FMAA048 |
| 2020-09-25 |
Delaying surgery for patients with a previous SARS-CoV-2 infection (edit) |
10.1002/BJS.12050 |
| 2020-09-25 |
Response to 'No evidence of SARS-CoV-2 infection by polymerase chain reaction or serology in children with pseudo-chilblain'. Reply from the authors (edit) |
10.1111/BJD.19563 |
| 2020-09-25 |
Upper respiratory samples pooling for screening SARS-CoV-2 infection: ready for the prime time? (edit) |
10.1515/CCLM-2020-1342 |
| 2020-09-25 |
Detection of the SARS-CoV-2 humanized antibody with paper-based ELISA (edit) |
10.1039/D0AN01609H |
| 2020-09-25 |
No SARS-CoV-2 antibody response in 25 patients with pseudo-chilblains (edit) |
10.1111/DTH.14332 |
| 2020-09-25 |
Targeting the endolysosomal host-SARS-CoV-2 interface by clinically licensed functional inhibitors of acid sphingomyelinase (FIASMA) including the antidepressant fluoxetine (edit) |
10.1080/22221751.2020.1829082 |
| 2020-09-25 |
Concerns and public health challenges for arboviral and other respiratory infections amidst SARS-CoV-2 pandemic (edit) |
10.1080/20477724.2020.1826154 |
| 2020-09-25 |
Susceptibility to SARS-CoV-2 Infection Among Children and Adolescents Compared With Adults: A Systematic Review and Meta-analysis (edit) |
10.1001/JAMAPEDIATRICS.2020.4573 |
| 2020-09-25 |
In-flight Transmission of SARS-CoV-2: a review of the attack rates and available data on the efficacy of face masks (edit) |
10.1093/JTM/TAAA178 |
| 2020-09-25 |
COVID-19 in people living with HIV: clinical implications of dynamics of immune response to SARS-CoV-2 (edit) |
10.1002/JMV.26556 |
| 2020-09-25 |
Inactivation of SARS-CoV-2 and HCoV-229E in vitro by ColdZyme® a medical device mouth spray against common cold (edit) |
10.1002/JMV.26554 |
| 2020-09-25 |
11Evolution of SARS-CoV-2 genome from December 2019 to late March 2020: emerged haplotypes and informative Tag nucleotide variations (edit) |
10.1002/JMV.26553 |
| 2020-09-25 |
Comparison of two automated immunoassays for the detection of SARS-CoV-2 nucleocapsid antibodies (edit) |
10.1093/JALM/JFAA175 |
| 2020-09-25 |
Mass screening of asymptomatic persons for SARS-CoV-2 using saliva (edit) |
10.1093/CID/CIAA1388 |
| 2020-09-25 |
Comparison of the diagnostic efficacy between two PCR test kits for SARS-CoV-2 nucleic acid detection (edit) |
10.1002/JCLA.23554 |
| 2020-09-25 |
Oral favipiravir for patients with delayed SARS-CoV-2 viral RNA clearance: a case series (edit) |
10.1186/S13054-020-03288-5 |
| 2020-09-25 |
Correspondence on 'Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort' by Pouletty et al (edit) |
10.1136/ANNRHEUMDIS-2020-218959 |
| 2020-09-25 |
Anti-SARS-CoV-2 antibodies in the CSF, blood-brain barrier dysfunction, and neurological outcome: Studies in 8 stuporous and comatose patients (edit) |
10.1212/NXI.0000000000000893 |
| 2020-09-25 |
SARS-CoV-2 challenge studies: ethics and risk minimisation (edit) |
10.1136/MEDETHICS-2020-106504 |
| 2020-09-25 |
S Protein-Reactive IgG and Memory B Cell Production after Human SARS-CoV-2 Infection Includes Broad Reactivity to the S2 Subunit (edit) |
10.1128/MBIO.01991-20 |
| 2020-09-25 |
Rescue of SARS-CoV-2 from a Single Bacterial Artificial Chromosome (edit) |
10.1128/MBIO.02168-20 |
| 2020-09-25 |
Quantification of SARS-CoV-2 neutralizing antibody by a pseudotyped virus-based assay (edit) |
10.1038/S41596-020-0394-5 |
| 2020-09-25 |
Characterization of 100 sequential SARS-CoV-2 convalescent plasma donations (edit) |
10.1111/TRF.16119 |
| 2020-09-25 |
SARS-CoV-2 associated Guillain-Barre syndrome in 62 patients (edit) |
10.1111/ENE.14544 |
| 2020-09-25 |
Response to: SARS-CoV-2 associated Guillain-Barré syndrome in 62 patients (edit) |
10.1111/ENE.14543 |
| 2020-09-24 |
Intestinal inflammation modulates the expression of ACE2 and TMPRSS2 and potentially overlaps with the pathogenesis of SARS-CoV-2 related disease (edit) |
10.1053/J.GASTRO.2020.09.029 |
| 2020-09-24 |
Practical School Algorithms for Symptomatic or SARS-CoV-2-Exposed Students Are Essential for Returning Children to In-Person Learning (edit) |
10.1016/J.JPEDS.2020.09.060 |
| 2020-09-24 |
Evaluation of the potency of FDA-approved drugs on wild type and mutant SARS-CoV-2 helicase (Nsp13) (edit) |
10.1016/J.IJBIOMAC.2020.09.138 |
| 2020-09-24 |
A Rapid SARS-CoV-2 RT-PCR Assay for Low Resource Settings (edit) |
10.3390/DIAGNOSTICS10100739 |
| 2020-09-24 |
Possible Cross-Reactivity between SARS-CoV-2 Proteins, CRM197 and Proteins in Pneumococcal Vaccines May Protect Against Symptomatic SARS-CoV-2 Disease and Death (edit) |
10.3390/VACCINES8040559 |
| 2020-09-24 |
SARS-CoV-2: From Structure to Pathology, Host Immune Response and Therapeutic Management (edit) |
10.3390/MICROORGANISMS8101468 |
| 2020-09-24 |
Venous Thrombo-Embolism in Hospitalized SARS-CoV-2 Patients Treated with Three Different Anticoagulation Protocols: Prospective Observational Study (edit) |
10.3390/BIOLOGY9100310 |
| 2020-09-24 |
Development of a Clinical MALDI-ToF Mass Spectrometry Assay for SARS-CoV-2: Rational Design and Multi-Disciplinary Team Work (edit) |
10.3390/DIAGNOSTICS10100746 |
| 2020-09-24 |
Proposed Individual Risk Score for Educational Institutions Utilizing Risk of Morbidity/Mortality by SARS-CoV-2, Occupational Exposure, and Type of Transportation (edit) |
10.1097/JOM.0000000000002032 |
| 2020-09-24 |
Low prevalence of SARS-CoV-2 among patients presenting at a Parisian psychiatry University Hospital Group (edit) |
10.1016/J.EJPSY.2020.09.003 |
| 2020-09-24 |
ReScan, a Multiplex Diagnostic Pipeline, Pans Human Sera for SARS-CoV-2 Antigens (edit) |
10.1016/J.XCRM.2020.100123 |
| 2020-09-24 |
Structure and Drug Binding of the SARS-CoV-2 Envelope Protein in Phospholipid Bilayers (edit) |
10.21203/RS.3.RS-77124/V1 |
| 2020-09-24 |
Acute SARS-CoV-2 Infection is Highly Cytopathic, Elicits a Robust Innate Immune Response and is Efficiently Prevented by EIDD-2801 (edit) |
10.21203/RS.3.RS-80404/V1 |
| 2020-09-24 |
An evolutionary portrait of the progenitor SARS-CoV-2 and its dominant offshoots in COVID-19 pandemic (edit) |
10.1101/2020.09.24.311845 |
| 2020-09-24 |
Functional genomic screens identify human host factors for SARS-CoV-2 and common cold coronaviruses (edit) |
10.1101/2020.09.24.312298 |
| 2020-09-24 |
Computational analysis of SARS-CoV-2, SARS-CoV, and MERS-CoV genome using MEGA (edit) |
10.5808/GI.2020.18.3.E30 |
| 2020-09-24 |
Molecular docking between human TMPRSS2 and SARS-CoV-2 spike protein: conformation and intermolecular interactions (edit) |
10.3934/MICROBIOL.2020021 |
| 2020-09-24 |
Airborne Particulate Matter and SARS-CoV-2 Partnership: Virus Hitchhiking, Stabilization and Immune Cell Targeting - A Hypothesis (edit) |
10.3389/FIMMU.2020.579352 |
| 2020-09-24 |
Perioperative SARS-CoV-2 infections increase mortality, pulmonary complications, and thromboembolic events: A Dutch, multicenter, matched-cohort clinical study (edit) |
10.1016/J.SURG.2020.09.022 |
| 2020-09-24 |
Proteomic analysis reveals upregulation of ACE2, the putative SARS-CoV-2 receptor in pressure- but not volume-overloaded human hearts (edit) |
10.1161/HYPERTENSIONAHA.120.16261 |
| 2020-09-24 |
Repurposing of the approved small molecule drugs in order to inhibit SARS-CoV-2 S protein and human ACE2 interaction through virtual screening approaches (edit) |
10.1080/07391102.2020.1824816 |
| 2020-09-24 |
The natural way forward: Molecular dynamics simulation analysis of phytochemicals from Indian medicinal plants as potential inhibitors of SARS-CoV-2 targets (edit) |
10.1002/PTR.6868 |
| 2020-09-24 |
Prevalence of SARS-CoV-2 infection in the obstetric population before the hospital admission (edit) |
10.23736/S0026-4784.20.04654-7 |
| 2020-09-24 |
An Urgent Need for Studies of the Late Effects of SARS-CoV-2 on the Cardiovascular System (edit) |
10.1161/CIRCULATIONAHA.120.051362 |
| 2020-09-24 |
Robust and persistent SARS-CoV-2 infection in the human intestinal brush border expressing cells (edit) |
10.1080/22221751.2020.1827985 |
| 2020-09-24 |
Rapid Determination of SARS-CoV-2 Antibodies Using a Bedside, Point-of-Care, Serological Test (edit) |
10.1080/22221751.2020.1826892 |
| 2020-09-24 |
Sensitive Detection of SARS-CoV-2-Specific Antibodies in Dried Blood Spot Samples (edit) |
10.3201/EID2612.203309 |
| 2020-09-24 |
Handling immune-suppressive therapies during SARS-CoV-2 pandemic: insights from pediatric datasets (edit) |
10.1007/S40620-020-00821-1 |
| 2020-09-24 |
Genomic and Proteomic Mutation Landscapes of SARS-CoV-2 (edit) |
10.1002/JMV.26548 |
| 2020-09-24 |
A 29-Year-Old Male Construction Worker from India Who Presented with Left- Sided Abdominal Pain Due to Isolated Superior Mesenteric Vein Thrombosis Associated with SARS-CoV-2 Infection (edit) |
10.12659/AJCR.926785 |
| 2020-09-24 |
Significant relaxation of SARS-CoV-2-targeted non-pharmaceutical interventions may result in profound mortality: A New York state modelling study (edit) |
10.1371/JOURNAL.PONE.0239647 |
| 2020-09-24 |
COVID-19 hygiene measures: hand eczema and insights into ACE2 and integrins as key molecules for SARS-CoV-2 cutaneous transmission (edit) |
10.1111/IJD.15208 |
| 2020-09-24 |
Seroprevalence of SARS-CoV-2 antibodies among pregnant women in Estonia: a call for epidemiological studies (edit) |
10.1111/AOGS.13995 |
| 2020-09-24 |
Liquid-based cytological and immunohistochemical study of nasopharyngeal swab from persons under investigation for SARS-CoV-2 infection (edit) |
10.1111/HIS.14257 |
| 2020-09-24 |
Targeting host cell proteases to prevent SARS-CoV-2 invasion (edit) |
10.2174/1389450121666200924113243 |
| 2020-09-24 |
Sensitivity of point-of-care IgM and IgG test in critically ill patients with SARS-Cov-2 (edit) |
10.1186/S13054-020-03290-X |
| 2020-09-24 |
Octenidine disinfection during the SARS-CoV-2 pandemia (edit) |
10.1684/EJD.2020.3856 |
| 2020-09-24 |
Coding-Complete Genome Sequences of Three SARS-CoV-2 Strains from Bangladesh (edit) |
10.1128/MRA.00764-20 |
| 2020-09-24 |
Whole-Genome Sequence of SARS-CoV-2 Isolate Siena-1/2020 (edit) |
10.1128/MRA.00944-20 |
| 2020-09-24 |
Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms (edit) |
10.1126/SCIENCE.ABE3354 |
| 2020-09-24 |
"Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study." Rong-Hui Du, Li-Rong Liang, Cheng-Qing Yang, Wen Wang, Tan-Ze Cao, Ming Li, Guang-Yun Guo, Juan Du, Chun-Lan Zheng, Qi Zhu, Ming Hu, Xu- (edit) |
10.1183/13993003.50524-2020 |
| 2020-09-24 |
Multisystem Inflammatory Syndrome in Children and SARS-CoV-2 Serology (edit) |
10.1542/PEDS.2020-032888 |
| 2020-09-24 |
Sequence analysis of SARS-CoV-2 genome reveals features important for vaccine design (edit) |
10.1038/S41598-020-72533-2 |
| 2020-09-23 |
SARS-CoV-2-Related Kidney Injury: Current Concern and Challenges (edit) |
10.1007/S42399-020-00529-0 |
| 2020-09-23 |
Disparities in SARS-CoV-2 Positivity Rates: Associations with Race and Ethnicity (edit) |
10.1089/POP.2020.0163 |
| 2020-09-23 |
Outcome of SARS-CoV-2 and immune thrombocytopenia in a pediatric patient (edit) |
10.1016/J.HTCT.2020.09.145 |
| 2020-09-23 |
SARS-CoV-2 Infection Boosts MX1 Antiviral Effector in COVID-19 Patients (edit) |
10.1016/J.ISCI.2020.101585 |
| 2020-09-23 |
Immune transcriptomes of highly exposed SARS-CoV-2 asymptomatic seropositive versus seronegative individuals from the Ischgl community (edit) |
10.21203/RS.3.RS-69657/V1 |
| 2020-09-23 |
Cross-reactive serum and memory B cell responses to spike protein in SARS-CoV-2 and endemic coronavirus infection (edit) |
10.1101/2020.09.22.308965 |
| 2020-09-23 |
In silico identification and validation of inhibitors of the interaction between neuropilin receptor 1 and SARS-CoV-2 Spike protein (edit) |
10.1101/2020.09.22.308783 |
| 2020-09-23 |
Furin Inhibitors Block SARS-CoV-2 Spike Protein Cleavage to Suppress Virus Production and Cytopathic Effects (edit) |
10.1016/J.CELREP.2020.108254 |
| 2020-09-23 |
Pushing beyond specifications: Evaluation of linearity and clinical performance of the cobas 6800/8800 SARS-CoV-2 RT-PCR assay for reliable quantification in blood and other materials outside recommendations (edit) |
10.1016/J.JCV.2020.104650 |
| 2020-09-23 |
Resistance Training Safety during and after the SARS-Cov-2 Outbreak: Practical Recommendations (edit) |
10.1155/2020/3292916 |
| 2020-09-23 |
A Mouse-Adapted SARS-CoV-2 Induces Acute Lung Injury and Mortality in Standard Laboratory Mice (edit) |
10.1016/J.CELL.2020.09.050 |
| 2020-09-23 |
Multisystem inflammatory syndrome in SARS-CoV-2 infection mimicking acute appendicitis in children (edit) |
10.1016/J.PEDNEO.2020.09.007 |
| 2020-09-23 |
Possible fates of the spread of SARS-CoV-2 in the Mexican context (edit) |
10.1098/RSOS.200886 |
| 2020-09-23 |
A Therapeutic Non-self-reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster Model (edit) |
10.1016/J.CELL.2020.09.049 |
| 2020-09-23 |
SARS-CoV-2 in Myelodysplastic Syndromes: A Snapshot From Early Italian Experience (edit) |
10.1097/HS9.0000000000000483 |
| 2020-09-23 |
Beyond Shielding: The Roles of Glycans in the SARS-CoV-2 Spike Protein (edit) |
10.1021/ACSCENTSCI.0C01056 |
| 2020-09-23 |
Computational Study of the Ion and Water Permeation and Transport Mechanisms of the SARS-CoV-2 Pentameric E Protein Channel (edit) |
10.3389/FMOLB.2020.565797 |
| 2020-09-23 |
Targeting SARS-CoV-2 RNA-dependent RNA polymerase: An in silico drug repurposing for COVID-19 (edit) |
10.12688/F1000RESEARCH.26359.1 |
| 2020-09-23 |
A National Survey Assessing SARS-CoV-2 Vaccination Intentions: Implications for Future Public Health Communication Efforts (edit) |
10.1177/1075547020960463 |
| 2020-09-23 |
The SARS-COV-2 Spike Protein Binds Sialic Acids and Enables Rapid Detection in a Lateral Flow Point of Care Diagnostic Device (edit) |
10.1021/ACSCENTSCI.0C00855 |
| 2020-09-23 |
Universal screening identifies asymptomatic carriers of SARS-CoV-2 among pregnant women in India (edit) |
10.1016/J.EJOGRB.2020.09.030 |
| 2020-09-23 |
SARS-CoV-2 and the skin, a hidden treasure (edit) |
10.4081/DR.2020.8881 |
| 2020-09-23 |
Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with Uridine-3',5'-Diphosphate (edit) |
10.2210/PDB7K1O/PDB |
| 2020-09-23 |
Establishment of a reverse genetics system for SARS-CoV-2 using circular polymerase extension reaction (edit) |
10.1101/2020.09.23.309849 |
| 2020-09-23 |
Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Infection Among VA Healthcare System Employees Suggests Higher Risk of Infection When Exposed to SARS-CoV-2 Outside of the Work Environment (edit) |
10.1017/ICE.2020.1220 |
| 2020-09-23 |
May we learn a useful lesson from prevention rules against SARS-CoV-2? (edit) |
10.1017/ICE.2020.1228 |
| 2020-09-23 |
COVID Abdomen: SARS-CoV-2 Infection Presenting as 'Acute Abdomen' in a Child (edit) |
10.1007/S12098-020-03508-4 |
| 2020-09-23 |
Repurposing drugs for treatment of SARS-CoV-2 infection: computational design insights into mechanisms of action (edit) |
10.1080/07391102.2020.1825232 |
| 2020-09-23 |
SARS-CoV-2 transmission dynamics should inform policy (edit) |
10.2139/SSRN.3692807 |
| 2020-09-23 |
Asymptomatic reinfection in two healthcare workers from India with genetically distinct SARS-CoV-2 (edit) |
10.1093/CID/CIAA1451 |
| 2020-09-23 |
Regional extracorporeal membrane oxygenation retrieval service during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic: an interdisciplinary team approach to maintain service provision despite increased demand (edit) |
10.1093/EJCTS/EZAA327 |
| 2020-09-23 |
Blood group ABO polymorphism inhibits SARS-CoV-2 infection and affects COVID-19 progression (edit) |
10.1111/VOX.13004 |
| 2020-09-23 |
Secondary structure of the SARS-CoV-2 5'-UTR (edit) |
10.1080/15476286.2020.1814556 |
| 2020-09-23 |
Association of SARS-CoV-2 Test Status and Pregnancy Outcomes (edit) |
10.1001/JAMA.2020.19124 |
| 2020-09-23 |
High Frequency of SARS-CoV-2 RNAemia and Association With Severe Disease (edit) |
10.1093/CID/CIAA1054 |
| 2020-09-23 |
Insights into the biased activity of dextromethorphan and haloperidol towards SARS-CoV-2 NSP6: in silico binding mechanistic analysis (edit) |
10.1007/S00109-020-01980-1 |
| 2020-09-23 |
Fahr's syndrome presenting with seizures in SARS-CoV-2 (COVID-19) pneumonia-a case report (edit) |
10.1007/S10072-020-04733-7 |
| 2020-09-23 |
N-terminally truncated nucleocapsid protein of SARS-CoV-2 as a better serological marker than whole nucleocapsid protein in evaluating the immunogenicity of inactive SARS-CoV-2 (edit) |
10.1002/JMV.26541 |
| 2020-09-23 |
SARS-CoV-2 infection in India bucks the trend: Trained innate immunity? (edit) |
10.1002/AJHB.23504 |
| 2020-09-23 |
Reducing aerosol transmission of SARS-CoV-2 in hospital elevators (edit) |
10.1111/INA.12744 |
| 2020-09-23 |
Development of a parallel reaction monitoring (PRM) mass spec-trometry-assay for the detection of SARS-CoV-2 spike glycoprotein and nucleoprotein (edit) |
10.1021/ACS.ANALCHEM.0C02288 |
| 2020-09-23 |
Healthy donor T-cell responses to common cold coronaviruses and SARS-CoV-2 (edit) |
10.1172/JCI143120 |
| 2020-09-23 |
Highlighted prospects of an IgM/IgG antibodies test in identifying individuals with asymptomatic SARS CoV-2 infection (edit) |
10.5858/ARPA.2020-0310-SA |
| 2020-09-23 |
SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes (edit) |
10.1093/CVR/CVAA267 |
| 2020-09-23 |
Clinical value anti-SARS-COV-2 serum IgA titration in patients with COVID-19 (edit) |
10.1002/JMV.26539 |
| 2020-09-23 |
One-Step Quantitative RT-PCR Assay with Armored RNA Controls for Detection of SARS-CoV-2 (edit) |
10.1002/JMV.26540 |
| 2020-09-23 |
Phylogenetic analysis of SARS-CoV-2 IN THE FIRST MONTHS SINCE ITS EMERGENCE (edit) |
10.1002/JMV.26545 |
| 2020-09-23 |
Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19 (edit) |
10.1056/NEJMC2027051 |
| 2020-09-23 |
Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19. Reply (edit) |
10.1056/NEJMC2027051 |
| 2020-09-23 |
SARS-CoV-2 vaccines in development (edit) |
10.1038/S41586-020-2798-3 |
| 2020-09-23 |
Empfehlungen von DOG, BVA und BDOC für planbare Augenoperationen während der SARS-CoV-2-Pandemie (edit) |
10.1055/A-1233-6854 |
| 2020-09-23 |
Development of a Lateral Flow Strip Membrane Assay for Rapid and Sensitive Detection of the SARS-CoV-2 (edit) |
10.1021/ACS.ANALCHEM.0C03202 |
| 2020-09-23 |
Vertical transmission of SARS-CoV-2 infection in early pregnancy: what is the evidence? (edit) |
10.1080/14767058.2020.1825671 |
| 2020-09-23 |
Zoonotic and Reverse Zoonotic Events of SARS-CoV-2 and their Impact on Global Health (edit) |
10.1080/22221751.2020.1827984 |
| 2020-09-23 |
A persistently replicating SARS-CoV-2 variant derived from an asymptomatic individual (edit) |
10.1186/S12967-020-02535-1 |
| 2020-09-23 |
TMPRSS2, a SARS-CoV-2 internalization protease is downregulated in head and neck cancer patients (edit) |
10.1186/S13046-020-01708-6 |
| 2020-09-23 |
Massive and rapid COVID-19 testing is feasible by extraction-free SARS-CoV-2 RT-PCR (edit) |
10.1038/S41467-020-18611-5 |
| 2020-09-23 |
Reply to "A SARS-CoV-2 RT-PCR and Chest CT, two complementary approaches for COVID-19 diagnosis" (edit) |
10.1007/S11604-020-01046-9 |
| 2020-09-23 |
Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-CoV-2) and its Effect on Gametogenesis and Early Pregnancy (edit) |
10.1111/AJI.13351 |
| 2020-09-23 |
SARS-CoV-2 Infection Among Hospitalized Pregnant Women: Reasons for Admission and Pregnancy Characteristics - Eight U.S. Health Care Centers, March 1-May 30, 2020 (edit) |
10.15585/MMWR.MM6938E2 |
| 2020-09-23 |
Community Masks During the SARS-CoV-2 Pandemic: Filtration Efficacy and Air Resistance (edit) |
10.1089/JAMP.2020.1635 |
| 2020-09-23 |
Patient's perspective on the implementation of measures to contain the SARS-CoV-2 pandemic in a Portuguese Gastroenterology Department (edit) |
10.1097/MEG.0000000000001942 |
| 2020-09-23 |
Serological Tests for SARS-CoV-2 Coronavirus by Commercially Available Point-of-Care and Laboratory Diagnostics in Pre-COVID-19 Samples in Japan (edit) |
10.3390/DISEASES8040036 |
| 2020-09-23 |
Minimum Sizes of Respiratory Particles Carrying SARS-CoV-2 and the Possibility of Aerosol Generation (edit) |
10.3390/IJERPH17196960 |
| 2020-09-23 |
SARS-CoV-2 antibody prevalence in Brazil: results from two successive nationwide serological household surveys (edit) |
10.1016/S2214-109X(20)30387-9 |
| 2020-09-23 |
The complexities of SARS-CoV-2 serology (edit) |
10.1016/S1473-3099(20)30699-X |
| 2020-09-23 |
Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison (edit) |
10.1016/S1473-3099(20)30634-4 |
| 2020-09-23 |
SARS-CoV-2 pathophysiology and its clinical implications: An integrative overview of the pharmacotherapeutic management of COVID-19 (edit) |
10.1016/J.FCT.2020.111769 |
| 2020-09-23 |
Concentration of infectious SARS-CoV-2 by polyethylene glycol precipitation (edit) |
10.1016/J.JVIROMET.2020.113977 |
| 2020-09-23 |
Determination of SARS-CoV-2 antibodies with assays from Diasorin, Roche and IDvet (edit) |
10.1016/J.JVIROMET.2020.113978 |
| 2020-09-23 |
The structure-activity relationship of the interactions of SARS-CoV-2 spike glycoproteins with glucuronomannan and sulfated galactofucan from Saccharina japonica (edit) |
10.1016/J.IJBIOMAC.2020.09.184 |
| 2020-09-23 |
"Sample pooling of RNA extracts to speed up SARS-CoV-2 diagnosis using CDC FDA EUA RT-qPCR kit" (edit) |
10.1016/J.VIRUSRES.2020.198173 |
| 2020-09-23 |
Signal hotspot mutations in SARS-CoV-2 genomes evolve as the virus spreads and actively replicates in different parts of the world (edit) |
10.1016/J.VIRUSRES.2020.198170 |
| 2020-09-23 |
Performance of a novel diagnostic assay for rapid SARS-CoV-2 antigen detection in nasopharynx samples (edit) |
10.1016/J.CMI.2020.09.030 |
| 2020-09-23 |
High-speed large-scale automated isolation of SARS-CoV-2 from clinical samples using miniaturized co-culture coupled to high-content screening (edit) |
10.1016/J.CMI.2020.09.018 |
| 2020-09-22 |
Individuals with "A" Rh-positive but not Rh-negative blood group are more vulnerable to SARS-COV-2 infection: Demographics and trend study on COVID-19 cases in Sudan (edit) |
10.1016/J.NMNI.2020.100763 |
| 2020-09-22 |
Positive or Negative? Implementation Processes and Pitfalls of Preoperative SARS-CoV-2 Testing at a Single Academic Institution (edit) |
10.1016/J.PCORM.2020.100132 |
| 2020-09-22 |
Oral SARS-CoV-2 inoculation establishes subclinical respiratory infection with virus shedding in golden Syrian hamsters (edit) |
10.1016/J.XCRM.2020.100121 |
| 2020-09-22 |
Solving Community SARS-CoV-2 Testing with Telehealth (edit) |
10.2196/20419 |
| 2020-09-22 |
Enhanced elicitation of potent neutralizing antibodies by the SARS-CoV-2 spike receptor binding domain Fc fusion protein in mice (edit) |
10.1016/J.VACCINE.2020.09.058 |
| 2020-09-22 |
Letter to the editor "SARS-CoV-2: What prevents this highly contagious virus from reaching the fetus?" (edit) |
10.1016/J.PLACENTA.2020.09.063 |
| 2020-09-22 |
1,2,4 triazolo[1,5-a] pyrimidin-7-ones as novel SARS-CoV-2 Main protease inhibitors: In silico screening and molecular dynamics simulation of potential COVID-19 drug candidates (edit) |
10.1016/J.BPC.2020.106478 |
| 2020-09-22 |
Alkaloids from Cryptolepis sanguinolenta as Potential Inhibitors of SARS-CoV-2 Viral Proteins: An In Silico Study (edit) |
10.1155/2020/5324560 |
| 2020-09-22 |
Sample pooling is a viable strategy for SARS-CoV-2 detection in low-prevalence settings (edit) |
10.1016/J.PATHOL.2020.09.005 |
| 2020-09-22 |
Clinical evaluation of SARS-CoV-2 point-of-care antibody tests (edit) |
10.1016/J.PATHOL.2020.09.002 |
| 2020-09-22 |
Discrete SIR modelling using empirical infection data shows that SARS-CoV-2 infection provides short-term immunity (edit) |
10.2196/21168 |
| 2020-09-22 |
Proteomics Insights Into the Molecular Basis of SARS-CoV-2 Infection: What We Can Learn From the Human Olfactory Axis (edit) |
10.3389/FMICB.2020.02101 |
| 2020-09-22 |
Translation-Associated Mutational U-Pressure in the First ORF of SARS-CoV-2 and Other Coronaviruses (edit) |
10.3389/FMICB.2020.559165 |
| 2020-09-22 |
Geographical Distribution of Genetic Variants and Lineages of SARS-CoV-2 in Chile (edit) |
10.3389/FPUBH.2020.562615 |
| 2020-09-22 |
Update Alert 4: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults (edit) |
10.7326/L20-1177 |
| 2020-09-22 |
[Description of Influenza B in seasonal epidemic in Cantabria during the beginning of the pandemia due to SARS-CoV-2] (edit) |
10.37201/REQ/077.2020 |
| 2020-09-22 |
Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment (edit) |
10.1002/JCP.30055 |
| 2020-09-22 |
Chemical Translational Biology-Guided Molecular Diagnostics: The Front Line To Mediate the Current SARS-CoV-2 Pandemic (edit) |
10.1002/CBIC.202000518 |
| 2020-09-22 |
Theoretical insights into the anti-SARS-CoV-2 activity of chloroquine and its analogs and insilico screening of main protease inhibitors (edit) |
10.1021/ACS.JPROTEOME.0C00683 |
| 2020-09-22 |
Operation of the First Regional Milk Bank in Poland During a SARS-CoV-2 (COVID-19) Pandemic (edit) |
10.1177/0890334420957971 |
| 2020-09-22 |
Universal Screening for SARS-CoV-2 of all Human Milk Bank Samples (edit) |
10.1177/0890334420962074 |
| 2020-09-22 |
The potential role of procyanidin as a therapeutic agent against SARS-CoV-2: a text mining, molecular docking and molecular dynamics simulation approach (edit) |
10.1080/07391102.2020.1823887 |
| 2020-09-22 |
[Adaptive immunity against SARS-CoV-2] (edit) |
10.1051/MEDSCI/2020168 |
| 2020-09-22 |
With regard to the article "Acute abdomen in patients with SARS-CoV-2 infection or co-infection" (edit) |
10.1007/S00423-020-01992-Y |
| 2020-09-22 |
Assessment, Diagnosis, and Treatment of Dysphagia in Patients Infected With SARS-CoV-2: A Review of the Literature and International Guidelines (edit) |
10.1044/2020_AJSLP-20-00163 |
| 2020-09-22 |
Assessment and mitigation of aerosol airborne SARS-CoV-2 transmission in laboratory and office environments (edit) |
10.1080/15459624.2020.1805117 |
| 2020-09-22 |
Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis (edit) |
10.1371/JOURNAL.PMED.1003346 |
| 2020-09-22 |
Viral pandemic preparedness: A pluripotent stem cell-based machine-learning platform for simulating SARS-CoV-2 infection to enable drug discovery and repurposing (edit) |
10.1002/SCTM.20-0181 |
| 2020-09-22 |
Perspectives on development of vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (edit) |
10.1080/21645515.2020.1787064 |
| 2020-09-22 |
Measures to Protect the Health and Safety of Massachusetts Employees Who Must Work at the Workplace During the SARS-CoV-2 Pandemic (edit) |
10.1177/1048291120960229 |
| 2020-09-22 |
Progress in Studies on Structural and Remedial Aspects of Newly Born Coronavirus, SARS-CoV-2 (edit) |
10.2174/1568026620666200922112300 |
| 2020-09-22 |
Exposure of hospital healthcare workers to the novel coronavirus (SARS-CoV-2) (edit) |
10.7861/CLINMED.2020-0566 |
| 2020-09-22 |
A treatment that eliminates SARS-CoV-2 replication in human airway epithelial cells and is safe for inhalation as an aerosol in healthy human subjects (edit) |
10.4187/RESPCARE.08425 |
| 2020-09-22 |
In Silico Structure-Based Repositioning of Approved Drugs for Spike Glycoprotein S2 Domain Fusion Peptide of SARS-CoV-2: Rationale from Molecular Dynamics and Binding Free Energy Calculations (edit) |
10.1128/MSYSTEMS.00382-20 |
| 2020-09-22 |
Upper respiratory viral load in asymptomatic individuals and mildly symptomatic patients with SARS-CoV-2 infection (edit) |
10.1136/THORAXJNL-2020-215042 |
| 2020-09-22 |
Receptor-binding domain-specific human neutralizing monoclonal antibodies against SARS-CoV and SARS-CoV-2 (edit) |
10.1038/S41392-020-00318-0 |
| 2020-09-22 |
Aframomum melegueta secondary metabolites exhibit polypharmacology against SARS-CoV-2 drug targets: in vitro validation of furin inhibition (edit) |
10.1002/PTR.6843 |
| 2020-09-22 |
Distinguishing Multisystem Inflammatory Syndrome in Children From Kawasaki Disease and Benign Inflammatory Illnesses in the SARS-CoV-2 Pandemic (edit) |
10.1097/PEC.0000000000002248 |
| 2020-09-22 |
Imaging Diagnostics and Pathology in SARS-CoV-2-Related Diseases (edit) |
10.3390/IJMS21186960 |
| 2020-09-22 |
SARS-CoV-2 Serosurvey in Addis Ababa, Ethiopia (edit) |
10.4269/AJTMH.20-0816 |
| 2020-09-22 |
Does Mask Use Affect the Quantitative SARS-CoV-2 Load In the Nasopharynx? (edit) |
10.1016/J.JPEDS.2020.09.050 |
| 2020-09-22 |
Temporal and age distributions of SARS-CoV-2 and other coronaviruses, Southeastern France (edit) |
10.1016/J.IJID.2020.09.1417 |
| 2020-09-22 |
Low-impact social distancing interventions to mitigate local epidemics of SARS-CoV-2 (edit) |
10.1016/J.MICINF.2020.09.006 |
| 2020-09-21 |
Comment on "A global-scale ecological niche model to predict SARS-CoV-2 coronavirus infection rate", author Coro (edit) |
10.1016/J.ECOLMODEL.2020.109288 |
| 2020-09-21 |
SARS-CoV-2 infection presenting as colitis with chest and abdomen CT findings (edit) |
10.1016/J.RADCR.2020.09.035 |
| 2020-09-21 |
The efficacy and safety of traditional Chinese medicines, modified Radix Fici Simplicissimae, combined with Western medicines amongst patients infected with the 2019 novel coronavirus (SARS-CoV-2) in tropical tourist area, China (edit) |
10.1016/J.IMR.2020.100665 |
| 2020-09-21 |
Selective pressure on SARS-CoV-2 protein coding genes and glycosylation site prediction (edit) |
10.1016/J.HELIYON.2020.E05001 |
| 2020-09-21 |
Long-term hydroxychloroquine use in patients with rheumatic conditions and development of SARS-CoV-2 infection: a retrospective cohort study (edit) |
10.1016/S2665-9913(20)30305-2 |
| 2020-09-21 |
Rapid detection of inter-clade recombination in SARS-CoV-2 with Bolotie (edit) |
10.1101/2020.09.21.300913 |
| 2020-09-21 |
Neutralization Assay with SARS-CoV-1 and SARS-CoV-2 Spike Pseudotyped Murine Leukemia Virions (edit) |
10.1101/2020.07.17.207563 |
| 2020-09-21 |
Common genetic variation in humans impacts in vitro susceptibility to SARS-CoV-2 infection (edit) |
10.1101/2020.09.20.300574 |
| 2020-09-21 |
A natural mutation between SARS-CoV-2 and SARS-CoV determines neutralization by a cross-reactive antibody (edit) |
10.1101/2020.09.21.305441 |
| 2020-09-21 |
Investigation of COVID-19 comorbidities reveals genes and pathways coincident with the SARS-CoV-2 viral disease (edit) |
10.1101/2020.09.21.306720 |
| 2020-09-21 |
Adaptation of an obstetric anesthesia service for the SARS-CoV-2 pandemic: description of checklists, workflows, and development tools (edit) |
10.1213/ANE.0000000000005256 |
| 2020-09-21 |
Mitigation of the replication of SARS-CoV-2 by nitric oxide in vitro (edit) |
10.1016/J.REDOX.2020.101734 |
| 2020-09-21 |
Array-based analysis of SARS-CoV-2, other coronaviruses, and influenza antibodies in convalescent COVID-19 patients (edit) |
10.1016/J.BIOS.2020.112643 |
| 2020-09-21 |
In silico molecular docking: Evaluation of coumarin based derivatives against SARS-CoV-2 (edit) |
10.1016/J.JIPH.2020.09.002 |
| 2020-09-21 |
Human Pluripotent Stem Cell-Derived Neural Cells and Brain Organoids Reveal SARS-CoV-2 Neurotropism Predominates in Choroid Plexus Epithelium (edit) |
10.1016/J.STEM.2020.09.016 |
| 2020-09-21 |
Computational Evaluation of the Inhibition Efficacies of HIV Antivirals on SARS-CoV-2 (COVID-19) Protease and Identification of 3D Pharmacophore and Hit Compounds (edit) |
10.1155/2020/8818008 |
| 2020-09-21 |
Clinical evaluation of four commercial immunoassays for the detection of antibodies against established SARS-CoV-2 infection (edit) |
10.1016/J.PATHOL.2020.09.003 |
| 2020-09-21 |
Room-temperature X-ray crystallography reveals the oxidation and reactivity of cysteine residues in SARS-CoV-2 3CL Mpro: insights into enzyme mechanism and drug design (edit) |
10.1107/S2052252520012634 |
| 2020-09-21 |
The Potential Role of Super Spread Events in SARS-COV-2 Pandemic; a Narrative Review (edit) |
|
| 2020-09-21 |
Efficacy of Povidone-Iodine Nasal and Oral Antiseptic Preparations Against Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2) (edit) |
10.1177/0145561320957237 |
| 2020-09-21 |
Hospital-acquired SARS-CoV-2 pneumonia in a person living with HIV (edit) |
10.1177/0956462420957528 |
| 2020-09-21 |
Protecting healthcare workers from SARS-CoV-2 and other infections (edit) |
10.1017/S0950268820002198 |
| 2020-09-21 |
Evaluation of endoscopy requests in the resumption of activity during the SARS-CoV-2 pandemic: denial of nonindicated requests and prioritization of accepted requests (edit) |
10.17235/REED.2020.7375/2020 |
| 2020-09-21 |
Correction to: Discrimination of False Negative Results in RT-PCR Detection of SARS-CoV-2 RNAs in Clinical Specimens by Using an Internal Reference (edit) |
10.1007/S12250-020-00293-4 |
| 2020-09-21 |
Decontamination of SARS-CoV-2 and Other RNA Viruses from N95 Level Meltblown Polypropylene Fabric Using Heat under Different Humidities (edit) |
10.1021/ACSNANO.0C06565 |
| 2020-09-21 |
Clinical characteristics of SARS-CoV-2 infection in a rural area in Germany (edit) |
10.22605/RRH6325 |
| 2020-09-21 |
The SARS-CoV-2 crisis and its impact on neglected tropical diseases: Threat or opportunity? (edit) |
10.1371/JOURNAL.PNTD.0008680 |
| 2020-09-21 |
SARS-CoV-2 Seroprevalence among Healthcare, First Response, and Public Safety Personnel, Detroit Metropolitan Area, Michigan, USA, May-June 2020 (edit) |
10.3201/EID2612.203764 |
| 2020-09-21 |
Immuno-Informatics Quest against COVID-19/SARS-COV-2: Determining Putative T-Cell Epitopes for Vaccine Prediction (edit) |
10.2174/1871526520666200921154149 |
| 2020-09-21 |
Transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to animals: an updated review (edit) |
10.1186/S12967-020-02534-2 |
| 2020-09-21 |
COVID19-world: a shiny application to perform comprehensive country-specific data visualization for SARS-CoV-2 epidemic (edit) |
10.1186/S12874-020-01121-9 |
| 2020-09-21 |
Endobronchial ultrasound is feasible and safe to diagnose pulmonary embolism in non-transportable SARS-CoV-2 ARDS patients requiring extracorporeal lung support (edit) |
10.1186/S13054-020-03292-9 |
| 2020-09-21 |
Correspondence to 'Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort' (edit) |
10.1136/ANNRHEUMDIS-2020-218797 |
| 2020-09-21 |
Free fatty acid binding pocket in the locked structure of SARS-CoV-2 spike protein (edit) |
10.1126/SCIENCE.ABD3255 |
| 2020-09-21 |
Immune life history, vaccination, and the dynamics of SARS-CoV-2 over the next 5 years (edit) |
10.1126/SCIENCE.ABD7343 |
| 2020-09-21 |
Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patients (edit) |
10.1126/SCITRANSLMED.ABD5487 |
| 2020-09-21 |
Low genetic diversity may be an Achilles heel of SARS-CoV-2 (edit) |
10.1073/PNAS.2017726117 |
| 2020-09-21 |
Immune Response Resetting as a Novel Strategy to Overcome SARS-CoV-2-Induced Cytokine Storm (edit) |
10.4049/JIMMUNOL.2000892 |
| 2020-09-21 |
SARS-CoV-2 host receptors ACE2 and CD147 (BSG) are present on human oocytes and blastocysts (edit) |
10.1007/S10815-020-01952-X |
| 2020-09-21 |
Clinical characteristics and predictors of the duration of SARS-CoV-2 viral shedding in 140 healthcare workers (edit) |
10.1111/JOIM.13160 |
| 2020-09-21 |
Real Asymptomatic SARS-CoV-2 Infection Might Be Rare: Importance of Careful Interviews and Follow-up (edit) |
10.3346/JKMS.2020.35.E333 |
| 2020-09-21 |
Multiple pregnancy in SARS-CoV-2 outbreak: the prenatal care challenge (edit) |
10.31744/EINSTEIN_JOURNAL/2020CE5990 |
| 2020-09-21 |
Current evidence of SARS-CoV-2 vertical transmission: an integrative review (edit) |
10.1590/1806-9282.66.S2.130 |
| 2020-09-21 |
Seroprevalence of Antibodies against SARS-CoV-2 among the Personnel and Students of the National and Kapodistrian University of Athens, Greece: A Preliminary Report (edit) |
10.3390/LIFE10090214 |
| 2020-09-21 |
Atypical Endovascular Cells in SARS-CoV-2 Pneumonia (edit) |
10.1097/PAF.0000000000000626 |
| 2020-09-21 |
SARS-CoV-2 Antibodies in Pregnant Women Admitted to Labor and Delivery (edit) |
10.1016/J.AJOG.2020.09.022 |
| 2020-09-21 |
The spread of SARS-CoV-2 in Spain: hygiene habits, sociodemographic profile, mobility patterns and comorbidities (edit) |
10.1016/J.ENVRES.2020.110223 |
| 2020-09-21 |
You say potato, I say tomato: reassessing SARS-CoV-2 viral loads in children (edit) |
10.1016/J.JPEDS.2020.09.048 |
| 2020-09-21 |
SARS-CoV-2 Pandemic Impacts on NASA Ground Operations to Protect ISS Astronauts (edit) |
10.1016/J.JAIP.2020.08.064 |
| 2020-09-21 |
Syncope at SARS-CoV-2 onset (edit) |
10.1016/J.AUTNEU.2020.102734 |
| 2020-09-21 |
Positive, again! What to make of "re-positive" SARS-CoV-2 molecular test results (edit) |
10.1016/J.EBIOM.2020.103011 |
| 2020-09-20 |
The epidemiology and pathogenesis of SARS-CoV-2 infection in pregnancy: More questions than answers (edit) |
10.1016/J.ECLINM.2020.100534 |
| 2020-09-20 |
Serology assessment of antibody response to SARS-CoV-2 in patients with COVID-19 by rapid IgM/IgG antibody test (edit) |
10.1080/20008686.2020.1821513 |
| 2020-09-20 |
Is naso-pharyngeal swab always safe for SARS-CoV-2 testing? An unusual, accidental foreign body swallowing (edit) |
10.1007/S12328-020-01236-Y |
| 2020-09-20 |
Comprehensive annotations of the mutational spectra of SARS-CoV-2 spike protein: a fast and accurate pipeline (edit) |
10.1111/TBED.13834 |
| 2020-09-20 |
Automated SARS-COV-2 RNA extraction from patient nasopharyngeal samples using a modified DNA extraction kit for high throughput testing (edit) |
10.5144/0256-4947.2020.373 |
| 2020-09-20 |
AR12 (OSU-03012) suppresses GRP78 expression and inhibits SARS-CoV-2 replication (edit) |
10.1016/J.BCP.2020.114227 |
| 2020-09-20 |
Contamination-free visual detection of SARS-CoV-2 with CRISPR/Cas12a: A promising method in the point-of-care detection (edit) |
10.1016/J.BIOS.2020.112642 |
| 2020-09-19 |
Do not blame bats and pangolins! Global consequences for wildlife conservation after the SARS-CoV-2 pandemic (edit) |
10.1007/S10531-020-02053-Y |
| 2020-09-19 |
Thermodynamic equilibrium dose-response models for MERS-CoV infection reveal a potential protective role of human lung mucus but not for SARS-CoV-2 (edit) |
10.1016/J.MRAN.2020.100140 |
| 2020-09-19 |
A SARS-CoV-2 host infection model network based on genomic Human Transcription Factors (TFs) depletion (edit) |
10.1016/J.HELIYON.2020.E05010 |
| 2020-09-19 |
Laboratory biosafety emergency management for SARS-CoV-2 (edit) |
10.1016/J.JOBB.2020.08.001 |
| 2020-09-19 |
Clinical Characteristics of Asymptomatic Patients with SARS-CoV-2 in Zhejiang: An Imperceptible Source of Infection (edit) |
10.1155/2020/2045341 |
| 2020-09-19 |
Mental Health Impact of SARS-COV-2 Pandemic on Long-Term Care Facility Personnel in Poland (edit) |
10.1016/J.JAMDA.2020.09.020 |
| 2020-09-19 |
Impact of the SARS-CoV-2 Pandemic on Emergency Department Presentations in an Integrated Health System (edit) |
10.1016/J.MAYOCP.2020.09.019 |
| 2020-09-19 |
Transthoracic echocardiographic findings in patients admitted with SARS-CoV-2 infection (edit) |
10.1111/ECHO.14835 |
| 2020-09-19 |
SARS-CoV-2 molecular testing for the diagnosis of COVID-19: One test does not fit all (edit) |
10.1002/JMV.26532 |
| 2020-09-19 |
A Case of Early Re-infection with SARS-CoV-2 (edit) |
10.1093/CID/CIAA1436 |
| 2020-09-19 |
Comment on: Abdominal fluid samples (negative for SARS-CoV-2) from a critically unwell patient with respiratory COVID-19 (edit) |
10.1002/BJS.11899 |
| 2020-09-19 |
Author response to: Comment on: Abdominal fluid samples (negative for SARS-CoV-2) from a critically unwell patient with respiratory COVID-19 (edit) |
10.1002/BJS.11898 |
| 2020-09-19 |
The protective effect of O blood type against SARS-CoV-2 infection (edit) |
10.1111/VOX.13003 |
| 2020-09-19 |
Whole-genome sequencing to track SARS-CoV-2 transmission in nosocomial outbreaks (edit) |
10.1093/CID/CIAA1433 |
| 2020-09-19 |
Seroprevalence of SARS-CoV-2 significantly varies with age: preliminary results from a mass population screening (edit) |
10.1016/J.JINF.2020.09.021 |
| 2020-09-19 |
Vaccines for COVID-19: perspectives from nucleic acid vaccines to BCG as delivery vector system (edit) |
10.1016/J.MICINF.2020.09.004 |
| 2020-09-19 |
Development of a New Multiplex Real Time RT-PCR Assay for SARS-CoV-2 Detection (edit) |
10.1016/J.JMOLDX.2020.09.004 |
| 2020-09-19 |
Possible Role for Bacteriophages in the Treatment of SARS-CoV-2 Infection (edit) |
10.1155/2020/8844963 |
| 2020-09-19 |
Evasion of Type I Interferon by SARS-CoV-2 (edit) |
10.1016/J.CELREP.2020.108234 |
| 2020-09-18 |
A non-homogeneous Markov early epidemic growth dynamics model. Application to the SARS-CoV-2 pandemic (edit) |
10.1016/J.CHAOS.2020.110297 |
| 2020-09-18 |
Bronchopleural fistula development in the setting of novel therapies for acute respiratory distress syndrome in SARS-CoV-2 pneumonia (edit) |
10.1016/J.RADCR.2020.09.026 |
| 2020-09-18 |
An immersive journey to the molecular structure of SARS-CoV-2: Virtual Reality in COVID-19 (edit) |
10.1016/J.CSBJ.2020.09.018 |
| 2020-09-18 |
Computational biophysical characterization of the SARS-CoV-2 spike protein binding with the ACE2 receptor and implications for infectivity (edit) |
10.1016/J.CSBJ.2020.09.019 |
| 2020-09-18 |
An anaesthetic and intensive care perspective on infection control measures for the prevention of airborne transmission of SARS-CoV-2 (edit) |
10.12968/HMED.2020.0538 |
| 2020-09-18 |
A trimeric human angiotensin-converting enzyme 2 as an anti-SARS-CoV-2 agent in vitro (edit) |
10.1101/2020.09.18.301952 |
| 2020-09-18 |
SARS-CoV-2 Nsp1 suppresses host but not viral translation through a bipartite mechanism (edit) |
10.1101/2020.09.18.302901 |
| 2020-09-18 |
Testing, Testing: What SARS-CoV-2 testing services do adults in the United States actually want? (edit) |
10.1101/2020.09.15.20195180 |
| 2020-09-18 |
SARS-CoV-2 antibody signatures robustly predict diverse antiviral functions relevant for convalescent plasma therapy (edit) |
10.1101/2020.09.16.20196154 |
| 2020-09-18 |
KIM-1/TIM-1 is a Receptor for SARS-CoV-2 in Lung and Kidney (edit) |
10.1101/2020.09.16.20190694 |
| 2020-09-18 |
COVID-19 and human milk: SARS-CoV-2, antibodies, and neutralizing capacity (edit) |
10.1101/2020.09.16.20196071 |
| 2020-09-18 |
Early Release Estimates for SARS-CoV-2 Prevalence and Antibody Response Interim Weighting for Probability-Based Sample Surveys (edit) |
10.1101/2020.09.15.20195099 |
| 2020-09-18 |
Viruses That Can and Cannot Coexist With Humans and the Future of SARS-CoV-2 (edit) |
10.3389/FMICB.2020.583252 |
| 2020-09-18 |
Review of novel human β-coronavirus (2019-nCoV or SARS-CoV-2) from the food industry perspective-Appropriate approaches to food production technology (edit) |
10.1002/FSN3.1892 |
| 2020-09-18 |
Direct Clinical Evidence Recommending the Use of Proteinase K or Dithiothreitol to Pretreat Sputum for Detection of SARS-CoV-2 (edit) |
10.3389/FMED.2020.549860 |
| 2020-09-18 |
SARS-CoV-2 Vaccine Development: An Overview and Perspectives (edit) |
10.1021/ACSPTSCI.0C00109 |
| 2020-09-18 |
Small Non-coding RNAs: Do They Encode Answers for Controlling SARS-CoV-2 in the Future? (edit) |
10.3389/FMICB.2020.571553 |
| 2020-09-18 |
Strategies for Targeting SARS CoV-2: Small Molecule Inhibitors-The Current Status (edit) |
10.3389/FIMMU.2020.552925 |
| 2020-09-18 |
Case Report: Tocilizumab for the Treatment of SARS-CoV-2 Infection in a Patient With Aplastic Anemia (edit) |
10.3389/FONC.2020.562625 |
| 2020-09-18 |
Epidemiological and Genomic Analysis of SARS-CoV-2 in 10 Patients From a Mid-Sized City Outside of Hubei, China in the Early Phase of the COVID-19 Outbreak (edit) |
10.3389/FPUBH.2020.567621 |
| 2020-09-18 |
Finding Prediction of Interaction between SARS-CoV-2 and Human Protein: A Data Driven Approach (edit) |
10.21203/RS.3.RS-73045/V1 |
| 2020-09-18 |
Epidemiology of SARS-CoV-2 infection in Karnataka State, South India: Transmission dynamics of symptomatic vs. asymptomatic infections (edit) |
10.1101/2020.09.17.20196501 |
| 2020-09-18 |
Discovery of SARS-CoV-2 antiviral synergy between remdesivir and approved drugs in human lung cells (edit) |
10.1101/2020.09.18.302398 |
| 2020-09-18 |
Interactions between SARS-CoV-2 and Influenza and the impact of coinfection on disease severity: A test negative design (edit) |
10.1101/2020.09.18.20189647 |
| 2020-09-18 |
Carotane sesquiterpenes from Ferula vesceritensis: in silico analysis as SARS-CoV-2 binding inhibitors (edit) |
10.1039/D0RA06901A |
| 2020-09-18 |
Transmission of SARS-CoV-2 in South Asian countries: molecular evolutionary model based phylogenetic and mutation analysis (edit) |
|
| 2020-09-18 |
SARS-CoV-2-Associated Deaths Among Persons Aged <21 Years - United States, February 12-July 31, 2020 (edit) |
10.15585/MMWR.MM6937E4 |
| 2020-09-18 |
Potential inhibitors for the novel coronavirus (SARS-CoV-2) (edit) |
10.1093/BIB/BBAA209 |
| 2020-09-18 |
The HIV and SARS-CoV-2 Parallel in Dentistry from the Perspectives of the Oral Health Care Team (edit) |
10.1177/2380084420961089 |
| 2020-09-18 |
Detection of SARS-CoV-2 viremia before onset of COVID-19 symptoms in an allo-transplanted patient with acute leukemia (edit) |
10.1038/S41409-020-01059-Y |
| 2020-09-18 |
Cholesterol 25-Hydroxylase inhibits SARS-CoV-2 and coronaviruses by depleting membrane cholesterol (edit) |
10.15252/EMBJ.2020106057 |
| 2020-09-18 |
SARS-CoV-2 infection in an advanced Rheumatoid Arthritis patient (edit) |
10.1111/APM.13080 |
| 2020-09-18 |
SARS-CoV-2 screening of asymptomatic women admitted for delivery must be performed with a combination of microbiological techniques: an observational study (edit) |
10.37201/REQ/088.2020 |
| 2020-09-18 |
Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19 (edit) |
10.23812/20-2EDIT |
| 2020-09-18 |
Irrigation System and COVID-19 Recurrence: A Potential Risk Factor in the Transmission of SARS-CoV-2 (edit) |
10.1021/ACSCHEMNEURO.0C00570 |
| 2020-09-18 |
Combined anti-SARS-CoV-2 IgA, IgG, and IgM Detection as a Better Strategy to Prevent Second Infection Spreading Waves (edit) |
10.1080/08820139.2020.1823407 |
| 2020-09-18 |
Clinical Impact, Costs, and Cost-Effectiveness of Expanded SARS-CoV-2 Testing in Massachusetts (edit) |
10.1093/CID/CIAA1418 |
| 2020-09-18 |
High rates of severe disease and death due to SARS-CoV-2 infection in rheumatic disease patients treated with rituximab: a descriptive study (edit) |
10.1007/S00296-020-04699-X |
| 2020-09-18 |
Molecular mimicry between SARS-CoV-2 spike glycoprotein and mammalian proteomes: implications for the vaccine (edit) |
10.1007/S12026-020-09152-6 |
| 2020-09-18 |
Surfaces disinfection and protective masks for SARS-CoV-2 and other respiratory viruses. A review by SIdP Covid 19 task-force (edit) |
10.1111/ODI.13646 |
| 2020-09-18 |
Structural, biophysical and biochemical elucidation of the SARS-CoV-2 nonstructural protein 3 macro domain (edit) |
10.1021/ACSINFECDIS.0C00441 |
| 2020-09-18 |
Effects of Asthma and Human Rhinovirus A16 on the Expression of the SARS-CoV-2 Entry Factors in Human Airway Epithelium (edit) |
10.1165/RCMB.2020-0394LE |
| 2020-09-18 |
SARS-CoV-2 Targeting the Retina: Host-virus Interaction and Possible Mechanisms of Viral Tropism (edit) |
10.1080/09273948.2020.1799037 |
| 2020-09-18 |
SARS-CoV-2 infection of African green monkeys results in mild respiratory disease discernible by PET/CT imaging and shedding of infectious virus from both respiratory and gastrointestinal tracts (edit) |
10.1371/JOURNAL.PPAT.1008903 |
| 2020-09-18 |
Disentangling primer interactions improves SARS-CoV-2 genome sequencing by multiplex tiling PCR (edit) |
10.1371/JOURNAL.PONE.0239403 |
| 2020-09-18 |
The association between ABO blood group and SARS-CoV-2 infection: A meta-analysis (edit) |
10.1371/JOURNAL.PONE.0239508 |
| 2020-09-18 |
Author's reply to correspondence regarding the article 'Prolonged persistence of SARS-CoV-2 in the upper respiratory tract of asymptomatic infected individuals' (edit) |
10.1093/QJMED/HCAA269 |
| 2020-09-18 |
Letter to the editor regarding the article 'Prolonged persistence of SARS-CoV-2 in the upper respiratory tract of asymptomatic infected individuals' (edit) |
10.1093/QJMED/HCAA268 |
| 2020-09-18 |
SARS-CoV-2 infection of Chinese hamsters (Cricetulus griseus) reproduces COVID-19 pneumonia in a well-established small animal model (edit) |
10.1111/TBED.13837 |
| 2020-09-18 |
Testicular Changes Associated with SARS-CoV-2 (edit) |
10.5858/ARPA.2020-0487-LE |
| 2020-09-18 |
Infant Outcomes Following Maternal Infection with SARS-CoV-2: First Report from the PRIORITY Study (edit) |
10.1093/CID/CIAA1411 |
| 2020-09-18 |
A computational approach to drug repurposing against SARS-CoV-2 RNA dependent RNA polymerase (RdRp) (edit) |
10.1080/07391102.2020.1822209 |
| 2020-09-18 |
Identification of potential inhibitors of SARS-CoV-2 main protease and spike receptor from 10 important spices through structure-based virtual screening and molecular dynamic study (edit) |
10.1080/07391102.2020.1819883 |
| 2020-09-18 |
Antibody-like proteins that capture and neutralize SARS-CoV-2 (edit) |
10.1126/SCIADV.ABD3916 |
| 2020-09-18 |
Evaluation and Comparison of the Hologic Aptima SARS-CoV-2 and the CDC 2019 nCoV real-time RT-PCR Diagnostic Panel using a Four-Sample Pooling Approach (edit) |
10.1128/JCM.02241-20 |
| 2020-09-18 |
αlphavbeta6 targeted molecular PET/CT imaging of lung post SARS-CoV-2 infection (edit) |
10.2967/JNUMED.120.255364 |
| 2020-09-18 |
Detection of SARS-CoV-2 in a cat owned by a COVID-19-affected patient in Spain (edit) |
10.1073/PNAS.2010817117 |
| 2020-09-18 |
Ultrasensitive and visual detection of SARS-CoV-2 using all-in-one dual CRISPR-Cas12a assay (edit) |
10.1038/S41467-020-18575-6 |
| 2020-09-18 |
Sensitive fluorescence detection of SARS-CoV-2 RNA in clinical samples via one-pot isothermal ligation and transcription (edit) |
10.1038/S41551-020-00617-5 |
| 2020-09-18 |
Measurement of SARS-CoV-2 RNA in wastewater tracks community infection dynamics (edit) |
10.1038/S41587-020-0684-Z |
| 2020-09-18 |
SARS-CoV-2 spreads to lymph nodes and strongly expands CD4+ TEMRA cells in a patient with mild COVID-19 (edit) |
10.1093/CID/CIAA1422 |
| 2020-09-18 |
SARS-CoV-2: recommendations for treatment in intensive care medicine (edit) |
10.1007/S00508-020-01734-6 |
| 2020-09-18 |
SARS-CoV-2 viral clearance during bone marrow aplasia after allogeneic hematopoietic stem cell transplantation - a case report (edit) |
10.1111/PETR.13875 |
| 2020-09-18 |
Placental Pathology Findings during and after SARS-CoV-2 Infection: Features of Villitis and Malperfusion (edit) |
10.1159/000511324 |
| 2020-09-18 |
Switching Host Metabolism as an Approach to Dampen SARS-CoV-2 Infection (edit) |
10.1159/000510508 |
| 2020-09-18 |
Environmental Nanoparticles, SARS-CoV-2 Brain Involvement, and Potential Acceleration of Alzheimer's and Parkinson's Diseases in Young Urbanites Exposed to Air Pollution (edit) |
10.3233/JAD-200891 |
| 2020-09-18 |
Assessment of Alternative Personal Protective Equipment by Emergency Department Personnel During the SARS-CoV-2 Pandemic: A Simulation-Based Pilot Study (edit) |
10.1097/SIH.0000000000000508 |
| 2020-09-18 |
SARS-CoV-2 infection in liver transplant recipients: collaboration in the time of COVID-19 (edit) |
10.1016/S2468-1253(20)30293-4 |
| 2020-09-18 |
Assessment of effective imidazole derivatives against SARS-CoV-2 main protease through computational approach (edit) |
10.1016/J.LFS.2020.118469 |
| 2020-09-18 |
Comment Regarding Pediatric SARS-CoV-2: Clinical Presentation, Infectivity, and Immune Responses (edit) |
10.1016/J.JPEDS.2020.09.034 |
| 2020-09-18 |
Kinetics of SARS-CoV-2 specific antibodies (IgM, IgA, IgG) in non-hospitalized patients four months following infection (edit) |
10.1016/J.JINF.2020.09.015 |
| 2020-09-18 |
Serial simultaneously self-swabbed samples from multiple sites show similarly decreasing SARS-CoV-2 loads in COVID-19 cases of differing clinical severity (edit) |
10.1016/J.JINF.2020.09.016 |
| 2020-09-18 |
Pneumocystis jirevocii and SARS-CoV-2 Co-Infection: A Common Feature in Transplant Recipients? (edit) |
10.3390/VACCINES8030544 |
| 2020-09-18 |
A Putative Prophylactic Solution for COVID-19: Development of Novel Multiepitope Vaccine Candidate against SARS-COV-2 by Comprehensive Immunoinformatic and Molecular Modelling Approach (edit) |
10.3390/BIOLOGY9090296 |
| 2020-09-18 |
Identification of SARS-CoV-2 and additional respiratory pathogens cases under the investigation of COVID-19 initial phase in a Brazilian reference laboratory (edit) |
10.1590/0074-02760200232 |
| 2020-09-18 |
Are SARS-CoV-2 reinfection and Covid-19 recurrence possible? a case report from Brazil (edit) |
10.1590/0037-8682-0619-2020 |
| 2020-09-18 |
Serial Testing for SARS-CoV-2 and Virus Whole Genome Sequencing Inform Infection Risk at Two Skilled Nursing Facilities with COVID-19 Outbreaks - Minnesota, April-June 2020 (edit) |
10.15585/MMWR.MM6937A3 |
| 2020-09-18 |
Human Induced Pluripotent Stem Cell-Derived Lung Epithelial System for SARS-CoV-2 Infection Modeling and Its Potential in Drug Repurposing (edit) |
10.1089/SCD.2020.0152 |
| 2020-09-18 |
Delayed SARS-COV-2 leukoencephalopathy without Severe Hypoxia (edit) |
10.1016/J.JNS.2020.117146 |
| 2020-09-18 |
SARS-CoV-2 Infection of Pluripotent Stem Cell-Derived Human Lung Alveolar Type 2 Cells Elicits a Rapid Epithelial-Intrinsic Inflammatory Response (edit) |
10.1016/J.STEM.2020.09.013 |
| 2020-09-17 |
Introduction of two prolines and removal of the polybasic cleavage site leads to optimal efficacy of a recombinant spike based SARS-CoV-2 vaccine in the mouse model (edit) |
10.1101/2020.09.16.300970 |
| 2020-09-17 |
Discovery of human ACE2 variants with altered recognition by the SARS-CoV-2 spike protein (edit) |
10.1101/2020.09.17.301861 |
| 2020-09-17 |
Joint Detection of Serum IgM/IgG Antibody Is an Important Key to Clinical Diagnosis of SARS-CoV-2 Infection (edit) |
10.1155/2020/1020843 |
| 2020-09-17 |
Etiologic Subtypes of Ischemic Stroke in SARS-CoV-2 Patients in a Cohort of New York City Hospitals (edit) |
10.3389/FNEUR.2020.01004 |
| 2020-09-17 |
The Potential Role of SARS-COV-2 in the Pathogenesis of Parkinson's Disease (edit) |
10.3389/FNEUR.2020.01044 |
| 2020-09-17 |
Neuromuscular Complications With SARS-COV-2 Infection: A Review (edit) |
10.3389/FNEUR.2020.01052 |
| 2020-09-17 |
Flexible, Functional, and Familiar: Characteristics of SARS-CoV-2 Spike Protein Evolution (edit) |
10.3389/FMICB.2020.02112 |
| 2020-09-17 |
Blocking of the High-Affinity Interaction-Synapse Between SARS-CoV-2 Spike and Human ACE2 Proteins Likely Requires Multiple High-Affinity Antibodies: An Immune Perspective (edit) |
10.3389/FIMMU.2020.570018 |
| 2020-09-17 |
SARS-CoV-2 Virion Stabilization by Zn Binding (edit) |
10.3389/FMOLB.2020.00222 |
| 2020-09-17 |
Monocytes and macrophages, targets of SARS-CoV-2: the clue for Covid-19 immunoparalysis (edit) |
10.1101/2020.09.17.300996 |
| 2020-09-17 |
The Concept of Organization and the Strategic Position of Chemistry in a Generic Research and Development Project Focused on SARS-CoV-2 (edit) |
10.13128/SUBSTANTIA-941 |
| 2020-09-17 |
Platelets Can Associate with SARS-Cov-2 RNA and Are Hyperactivated in COVID-19 (edit) |
10.1161/CIRCRESAHA.120.317703 |
| 2020-09-17 |
In silico investigation of spice molecules as potent inhibitor of SARS-CoV-2 (edit) |
10.1080/07391102.2020.1819879 |
| 2020-09-17 |
Possible autoimmune encephalitis with claustrum sign in case of acute SARS-CoV-2 infection (edit) |
10.1017/CJN.2020.209 |
| 2020-09-17 |
Sensitivity of nasopharyngeal, oropharyngeal, and nasal wash specimens for SARS-CoV-2 detection in the setting of sampling device shortage (edit) |
10.1007/S10096-020-04039-8 |
| 2020-09-17 |
Tocilizumab in Sars-cov-2 Patients with the Syndrome of Cytokine Storm; a Narrative review (edit) |
10.2174/1574887115666200917110954 |
| 2020-09-17 |
Seroprevalence of anti-SARS-CoV-2 antibodies in residents of Karachi-challenges in acquiring herd immunity for COVID 19 (edit) |
10.1093/PUBMED/FDAA170 |
| 2020-09-17 |
Multicenter evaluation of two chemiluminescence and three lateral flow immunoassays for the diagnosis of COVID-19 and assessment of antibody dynamic responses to SARS-CoV-2 in Taiwan (edit) |
10.1080/22221751.2020.1825016 |
| 2020-09-17 |
Change in Antibodies to SARS-CoV-2 Over 60 Days Among Health Care Personnel in Nashville, Tennessee (edit) |
10.1001/JAMA.2020.18796 |
| 2020-09-17 |
SARS-CoV-2 Nasopharyngeal Swab Testing-False-Negative Results From a Pervasive Anatomical Misconception (edit) |
10.1001/JAMAOTO.2020.2946 |
| 2020-09-17 |
In Vitro Efficacy of a Povidone-Iodine Nasal Antiseptic for Rapid Inactivation of SARS-CoV-2 (edit) |
10.1001/JAMAOTO.2020.3053 |
| 2020-09-17 |
American Politics and the Spread of SARS-CoV-2 (edit) |
10.1093/CID/CIAA1414 |
| 2020-09-17 |
A rare case of acute motor axonal neuropathy and myelitis related to SARS-CoV-2 infection (edit) |
10.1007/S00415-020-10219-5 |
| 2020-09-17 |
Digging metagenomic data of pangolins revealed SARS-CoV-2 related viruses and other significant viruses (edit) |
10.1002/JMV.26524 |
| 2020-09-17 |
Potential Interventions for SARS-CoV-2 Infections: Zinc Showing Promise (edit) |
10.1002/JMV.26523 |
| 2020-09-17 |
Genetic grouping of SARS-CoV-2 coronavirus sequences using informative subtype markers for pandemic spread visualization (edit) |
10.1371/JOURNAL.PCBI.1008269 |
| 2020-09-17 |
Interventions for treatment of COVID-19: A living systematic review with meta-analyses and trial sequential analyses (The LIVING Project) (edit) |
10.1371/JOURNAL.PMED.1003293 |
| 2020-09-17 |
Evaluation of performance of two SARS-CoV-2 Rapid IgM-IgG combined antibody tests on capillary whole blood samples from the fingertip (edit) |
10.1371/JOURNAL.PONE.0237694 |
| 2020-09-17 |
SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levels (edit) |
10.1371/JOURNAL.PONE.0239252 |
| 2020-09-17 |
Clinical, laboratory and radiological characteristics and outcomes of novel coronavirus (SARS-CoV-2) infection in humans: A systematic review and series of meta-analyses (edit) |
10.1371/JOURNAL.PONE.0239235 |
| 2020-09-17 |
Carving out a niche for SARS-CoV-2 plasma RNA testing (edit) |
10.1093/CID/CIAA1412 |
| 2020-09-17 |
Potential pathogenicity determinants identified from structural proteomics of SARS-CoV and SARS-CoV-2 (edit) |
10.1093/MOLBEV/MSAA231 |
| 2020-09-17 |
No SARS-CoV-2 neutralization by intravenous immunoglobulins produced from plasma collected before the 2020 pandemic (edit) |
10.1093/INFDIS/JIAA593 |
| 2020-09-17 |
Therapeutic antibodies and fusion inhibitors targeting the spike protein of SARS-CoV-2 (edit) |
10.1080/14728222.2020.1820482 |
| 2020-09-17 |
Receptor binding and priming of the spike protein of SARS-CoV-2 for membrane fusion (edit) |
10.1038/S41586-020-2772-0 |
| 2020-09-17 |
Social network analysis methods for exploring SARS-CoV-2 contact tracing data (edit) |
10.1186/S12874-020-01119-3 |
| 2020-09-17 |
Rapid incorporation of Favipiravir by the fast and permissive viral RNA polymerase complex results in SARS-CoV-2 lethal mutagenesis (edit) |
10.1038/S41467-020-18463-Z |
| 2020-09-17 |
SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood (edit) |
10.1038/S41467-020-18468-8 |
| 2020-09-17 |
Author Correction: A role for Biofoundries in rapid development and validation of automated SARS-CoV-2 clinical diagnostics (edit) |
10.1038/S41467-020-18720-1 |
| 2020-09-17 |
Author Correction: Detection of SARS-CoV-2 in nasal swabs using MALDI-MS (edit) |
10.1038/S41587-020-0701-2 |
| 2020-09-17 |
Clustering and superspreading potential of SARS-CoV-2 infections in Hong Kong (edit) |
10.1038/S41591-020-1092-0 |
| 2020-09-17 |
Detection of SARS-CoV-2 in conjunctival secretions from patients without ocular symptoms (edit) |
10.1007/S15010-020-01524-2 |
| 2020-09-17 |
Single-cell RNA sequencing analysis of SARS-CoV-2 entry receptors in human organoids (edit) |
10.1002/JCP.30054 |
| 2020-09-17 |
Prediction of potential inhibitors for RNA-dependent RNA polymerase of SARS-CoV-2 using comprehensive drug repurposing and molecular docking approach (edit) |
10.1016/J.IJBIOMAC.2020.09.098 |
| 2020-09-17 |
Does nosocomial SARS-CoV-2 infection result in increased 30-day mortality? A multi-centre observational study to identify risk factors for worse outcomes in COVID-19 disease (edit) |
10.1016/J.JHIN.2020.09.017 |
| 2020-09-17 |
Substitutions in Spike and Nucleocapsid proteins of SARS-CoV-2 circulating in South America (edit) |
10.1016/J.MEEGID.2020.104557 |
| 2020-09-17 |
Linking ACE2 and angiotensin II to pulmonary immunovascular dysregulation in SARS-CoV-2 infection (edit) |
10.1016/J.IJID.2020.09.041 |
| 2020-09-17 |
SARS-CoV-2 infection does not induce HIV viral escape in Central Nervous System: a case series (edit) |
10.1016/J.IJID.2020.09.040 |
| 2020-09-17 |
SARS-CoV-2 Infections and Impact of the COVID-19 Pandemic in Pregnancy and Breastfeeding: Results from an Observational Study in Primary Care in Belgium (edit) |
10.3390/IJERPH17186766 |
| 2020-09-17 |
Novel Binding Mechanisms of Fusion Broad Range Anti-Infective Protein Ricin A Chain Mutant-Pokeweed Antiviral Protein 1 (RTAM-PAP1) against SARS-CoV-2 Key Proteins in Silico (edit) |
10.3390/TOXINS12090602 |
| 2020-09-17 |
Identification of Main Protease of Coronavirus SARS-CoV-2 (Mpro)Inhibitors from Melissa officinalis (edit) |
10.2174/1570163817999200918103705 |
| 2020-09-17 |
Targeting SARS-CoV-2 Main Protease: A Computational Drug Repurposing Study (edit) |
10.1016/J.ARCMED.2020.09.013 |
| 2020-09-17 |
Schulöffnung in Sars-CoV-2-Zeiten (edit) |
10.1007/S00740-020-00359-9 |
| 2020-09-17 |
Sars-CoV-2 isolation from a 10-day-old newborn in Italy: a case report (edit) |
10.1016/J.IDCR.2020.E00960 |
| 2020-09-17 |
Attenuated Subcomponent Vaccine Design Targeting the SARS-CoV-2 Nucleocapsid Phosphoprotein RNA Binding Domain: In Silico Analysis (edit) |
10.1155/2020/2837670 |
| 2020-09-17 |
Assessing a novel, lab-free, point-of-care test for SARS-CoV-2 (CovidNudge): a diagnostic accuracy study (edit) |
10.1016/S2666-5247(20)30121-X |
| 2020-09-16 |
Evaluation of the SARS-CoV-2-IgG response in outpatients by five commercial immunoassays (edit) |
10.3205/ID000066 |
| 2020-09-16 |
Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology (edit) |
10.1016/J.CELL.2020.09.037 |
| 2020-09-16 |
The flexibility of ACE2 in the context of SARS-CoV-2 infection (edit) |
10.1101/2020.09.16.300459 |
| 2020-09-16 |
Bromelain Inhibits SARS-CoV-2 Infection in VeroE6 Cells (edit) |
10.1101/2020.09.16.297366 |
| 2020-09-16 |
Baricitinib treatment resolves lower airway inflammation and neutrophil recruitment in SARS-CoV-2-infected rhesus macaques (edit) |
10.1101/2020.09.16.300277 |
| 2020-09-16 |
Ebselen, disulfiram, carmofur, PX-12, tideglusib, and shikonin are non-specific promiscuous SARS-CoV-2 main protease inhibitors (edit) |
10.1101/2020.09.15.299164 |
| 2020-09-16 |
Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity (edit) |
10.1016/J.CELL.2020.09.038 |
| 2020-09-16 |
Insights on SARS-CoV-2 Molecular Interactions With the Renin-Angiotensin System (edit) |
10.3389/FCELL.2020.559841 |
| 2020-09-16 |
Designing of cytotoxic and helper T cell epitope map provides insights into the highly contagious nature of the pandemic novel coronavirus SARS-CoV-2 (edit) |
10.1098/RSOS.201141 |
| 2020-09-16 |
Dacron swab and PBS are acceptable alternatives to flocked swab and viral transport media for SARS-CoV-2 (edit) |
10.1016/J.DIAGMICROBIO.2020.115209 |
| 2020-09-16 |
Identifying Effective Antiviral Drugs Against SARS-CoV-2 by Drug Repositioning Through Virus-Drug Association Prediction (edit) |
10.3389/FGENE.2020.577387 |
| 2020-09-16 |
REDIAL-2020: A Suite of Machine Learning Models to Estimate Anti-SARS-CoV-2 Activities (edit) |
10.26434/CHEMRXIV.12915779 |
| 2020-09-16 |
A hypothesis for examining dihydroxyacetone, the active component in sunless tanning products, as a topical prophylactic against SARS-COV-2 transmission (edit) |
10.1016/J.MEHY.2020.110280 |
| 2020-09-16 |
Characterisation of protease activity during SARS-CoV-2 infection identifies novel viral cleavage sites and cellular targets for drug repurposing (edit) |
10.1101/2020.09.16.297945 |
| 2020-09-16 |
SARS-CoV-2 protein Nsp1 alters actomyosin cytoskeleton and phenocopies arrhythmogenic cardiomyopathy-related PKP2 mutant (edit) |
10.1101/2020.09.14.296178 |
| 2020-09-16 |
ACE2, the Receptor that Enables the Infection by SARS-CoV-2: Biochemistry, Structure, Allostery and Evaluation of the Potential Development of ACE2 Modulators (edit) |
10.1002/CMDC.202000368 |
| 2020-09-16 |
Central Nervous System Targets and Routes for SARS-CoV-2: Current Views and New Hypotheses (edit) |
10.1021/ACSCHEMNEURO.0C00434 |
| 2020-09-16 |
Schädigt SARS-CoV-2 bevorzugt Blutgefäße? (edit) |
10.1007/S11298-020-7994-9 |
| 2020-09-16 |
Sicherheit der Sars-CoV-2-Vakzine (edit) |
10.1007/S11298-020-8035-4 |
| 2020-09-16 |
Targeting SARS-CoV-2 Nsp12/Nsp8 interaction interface with approved and investigational drugs: an in silico structure-based approach (edit) |
10.1080/07391102.2020.1819882 |
| 2020-09-16 |
Prolonged SARS-CoV-2 detection and reversed RT-PCR results in mild or asymptomatic patients (edit) |
10.1080/23744235.2020.1820076 |
| 2020-09-16 |
Identification of the RNase-binding site of SARS-CoV-2 RNA for anchor primer-PCR detection of viral loading in 306 COVID-19 patients (edit) |
10.1093/BIB/BBAA193 |
| 2020-09-16 |
Screening for SARS-CoV-2 antibodies in convalescent plasma in Brazil: Preliminary lessons from a voluntary convalescent donor program (edit) |
10.1111/TRF.16065 |
| 2020-09-16 |
Molecular basis of the potential interaction of SARS-CoV-2 spike protein to CD147 in COVID-19 associated-lymphopenia (edit) |
10.1080/07391102.2020.1822208 |
| 2020-09-16 |
[18F]-FDG PET/CT in oncologic patients with unsuspected asymptomatic infection with SARS-CoV-2 (edit) |
10.1007/S00259-020-04979-5 |
| 2020-09-16 |
Assessing the Dilution Effect of Specimen Pooling on the Sensitivity of SARS-CoV-2 PCR Tests (edit) |
10.1002/JMV.26519 |
| 2020-09-16 |
SARS-CoV-2 multifaceted interaction with the human host. Part II: Innate immunity response, immunopathology, and epigenetics (edit) |
10.1002/IUB.2379 |
| 2020-09-16 |
Leveraging on the genomics and immunopathology of SARS-CoV-2 for vaccines development: prospects and challenges (edit) |
10.1080/21645515.2020.1812313 |
| 2020-09-16 |
Positive Pleural Fluid RT-PCR for Virus Detection in SARS-CoV-2 Pneumonia (edit) |
10.1093/QJMED/HCAA276 |
| 2020-09-16 |
Coronavirus disease 2019 and transplantation: tackling the challenges of SARS-CoV-2 infection in waiting list candidates (edit) |
10.1111/TRI.13742 |
| 2020-09-16 |
Detection of SARS-CoV-2 with SHERLOCK One-Pot Testing (edit) |
10.1056/NEJMC2026172 |
| 2020-09-16 |
High levels of SARS-CoV-2 specific T-cells with restricted functionality in severe course of COVID-19 (edit) |
10.1172/JCI.INSIGHT.142167 |
| 2020-09-16 |
SARS-CoV-2 and the reproductive system: assessment of risk and considerations for infection control in reproductive departments (edit) |
10.1080/19396368.2020.1817627 |
| 2020-09-16 |
Reverse vaccinology assisted designing of multiepitope-based subunit vaccine against SARS-CoV-2 (edit) |
10.1186/S40249-020-00752-W |
| 2020-09-16 |
SARS-CoV-2 in Quarantined Domestic Cats from COVID-19 Households or Close Contacts, Hong Kong, China (edit) |
10.3201/EID2612.202786 |
| 2020-09-16 |
Competitive SARS-CoV-2 Serology Reveals Most Antibodies Targeting the Spike Receptor-Binding Domain Compete for ACE2 Binding (edit) |
10.1128/MSPHERE.00802-20 |
| 2020-09-16 |
Type I interferon susceptibility distinguishes SARS-CoV-2 from SARS-CoV (edit) |
10.1128/JVI.01410-20 |
| 2020-09-16 |
The enzymatic activity of the nsp14 exoribonuclease is critical for replication of MERS-CoV and SARS-CoV-2 (edit) |
10.1128/JVI.01246-20 |
| 2020-09-16 |
Education Research: Impact of SARS-CoV-2 pandemic on neurology trainees in Italy: A resident-driven survey (edit) |
10.1212/WNL.0000000000010878 |
| 2020-09-16 |
Reductions in commuting mobility correlate with geographic differences in SARS-CoV-2 prevalence in New York City (edit) |
10.1038/S41467-020-18271-5 |
| 2020-09-16 |
Structural models of human ACE2 variants with SARS-CoV-2 Spike protein for structure-based drug design (edit) |
10.1038/S41597-020-00652-6 |
| 2020-09-16 |
Correction: Difference in levels of SARS-CoV-2 S1 and S2 subunits- and nucleocapsid protein-reactive SIgM/IgM, IgG and SIgA/IgA antibodies in human milk (edit) |
10.1038/S41372-020-00816-7 |
| 2020-09-16 |
SARS-CoV-2 infection among patients with haematological disorders: Severity and one-month outcome in 66 Danish patients in a nationwide cohort study (edit) |
10.1111/EJH.13519 |
| 2020-09-16 |
Targeting RNA G-quadruplex in SARS-CoV-2: A Promising Therapeutic Target for COVID-19? (edit) |
10.1002/ANIE.202011419 |
| 2020-09-16 |
A case of probable Parkinson's disease after SARS-CoV-2 infection (edit) |
10.1016/S1474-4422(20)30305-7 |
| 2020-09-16 |
REGULAR MASS SCREENING FOR SARS-CoV-2 INFECTION IN CARE HOMES ALREADY AFFECTED BY COVID-19 OUTBREAKS: implications of false positive test results (edit) |
10.1016/J.JINF.2020.09.008 |
| 2020-09-16 |
Value of swab types and collection time on SARS-COV-2 detection using RT-PCR assay (edit) |
10.1016/J.JVIROMET.2020.113974 |
| 2020-09-16 |
SARS-CoV-2 antibodies in healthcare workers in a large university hospital, Kerala, India (edit) |
10.1016/J.CMI.2020.09.013 |
| 2020-09-16 |
Viable SARS-CoV-2 in the air of a hospital room with COVID-19 patients (edit) |
10.1016/J.IJID.2020.09.025 |
| 2020-09-16 |
Impact of interleukin-6 blockade with tocilizumab on SARS-CoV-2 viral kinetics and antibody responses in patients with COVID-19: A prospective cohort study (edit) |
10.1016/J.EBIOM.2020.102999 |
| 2020-09-16 |
[Recommendations for reopening elective surgery services during the SARS-CoV-2 pandemic] (edit) |
10.26633/RPSP.2020.114 |
| 2020-09-16 |
A comparative evaluation between the Abbott Panbio™ COVID-19 IgG/IgM rapid test device and Abbott Architect™ SARS CoV-2 IgG assay (edit) |
10.1016/J.JCV.2020.104645 |
| 2020-09-16 |
Tea Polyphenols EGCG and Theaflavin Inhibit the Activity of SARS-CoV-2 3CL-Protease In Vitro (edit) |
10.1155/2020/5630838 |
| 2020-09-16 |
Neuroinvasion of SARS-CoV-2 may play a role in the breakdown of respiratory center of the brain (edit) |
10.1002/JMV.26521 |
| 2020-09-16 |
Universal SARS-CoV-2 testing versus symptom based screening and testing in inpatient psychiatric setting (edit) |
10.1016/J.PSYCHRES.2020.113444 |
| 2020-09-15 |
Assessment of Coronavirus in the Conjunctival Tears and Secretions in Patients with SARS-CoV-2 Infection in Sohag Province, Egypt (edit) |
10.2147/OPTH.S270006 |
| 2020-09-15 |
Temporal antibody responses to SARS-CoV-2 in patients of coronavirus disease 2019 (edit) |
10.1038/S41421-020-00209-2 |
| 2020-09-15 |
Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant (edit) |
10.1016/J.CELL.2020.09.032 |
| 2020-09-15 |
Antibody potency, effector function and combinations in protection from SARS-CoV-2 infection in vivo (edit) |
10.1101/2020.09.15.298067 |
| 2020-09-15 |
Generation of glucocorticoid resistant SARS-CoV-2 T-cells for adoptive cell therapy (edit) |
10.1101/2020.09.15.298547 |
| 2020-09-15 |
Quantifying heterogeneity in SARS-CoV-2 transmission during the lockdown in India (edit) |
10.1101/2020.09.10.20190017 |
| 2020-09-15 |
SARS-CoV-2 Viral Load Predicts Mortality in Patients with and without Cancer Who Are Hospitalized with COVID-19 (edit) |
10.1016/J.CCELL.2020.09.007 |
| 2020-09-15 |
Neuropilin‑1 as a new potential SARS‑CoV‑2 infection mediator implicated in the neurologic features and central nervous system involvement of COVID‑19 (edit) |
10.3892/MMR.2020.11510 |
| 2020-09-15 |
SARS-CoV-2 infection in pediatric population (edit) |
10.23750/ABM.V91I11-S.10298 |
| 2020-09-15 |
Room-temperature neutron and X-ray data collection of 3CL Mpro from SARS-CoV-2 (edit) |
10.1107/S2053230X20011814 |
| 2020-09-15 |
Six Gynecological Cancer Patients Infected With SARS-CoV-2 After Surgery or Radio-/Chemo-Therapy Treatment: Case Series (edit) |
10.3389/FONC.2020.01606 |
| 2020-09-15 |
Achilles' Heel of SARS-CoV-2 Structure (edit) |
10.1021/ACSPTSCI.0C00128 |
| 2020-09-15 |
A Novel Case of Severe Respiratory Symptoms and Persistent Pulmonary Hypertension in a Saudi Neonate With SARS-CoV-2 Infection (edit) |
10.7759/CUREUS.10472 |
| 2020-09-15 |
Decay of SARS-CoV-2 RNA along the wastewater treatment outfitted with Upflow Anaerobic Sludge Blanket (UASB) system evaluated through two sample concentration techniques (edit) |
10.1016/J.SCITOTENV.2020.142329 |
| 2020-09-15 |
Extensive Peripheral Arterial Thrombosis in a Patient with SARS-CoV-2 Infection (edit) |
10.12691/AJMCR-8-12-15 |
| 2020-09-15 |
Potential secondary transmission of SARS-CoV-2 via wastewater (edit) |
10.1016/J.SCITOTENV.2020.142358 |
| 2020-09-15 |
Safety and Efficacy of the combined use of ivermectin, dexamethasone, enoxaparin and aspirin against COVID 19 (edit) |
10.1101/2020.09.10.20191619 |
| 2020-09-15 |
Quinazoline-Schiff base conjugates: in silico study and ADMET predictions as multi-target inhibitors of coronavirus (SARS-CoV-2) proteins (edit) |
10.1039/D0RA06424F |
| 2020-09-15 |
Update on therapeutic approaches and emerging therapies for SARS-CoV-2 virus (edit) |
10.1016/J.EJPHAR.2020.173348 |
| 2020-09-15 |
Considerations for Management of Acute Coronary Syndromes During the SARS-CoV-2 (COVID-19) Pandemic (edit) |
10.1016/J.AMJCARD.2020.06.039 |
| 2020-09-15 |
Implications of Sex Differences in Immunity for SARS-CoV-2 Pathogenesis and Design of Therapeutic Interventions (edit) |
10.1016/J.IMMUNI.2020.08.003 |
| 2020-09-15 |
Caveats of Reporting Cycles Threshold from SARS-CoV-2 Qualitative PCR Assays: A Molecular Diagnostic Laboratory Perspective (edit) |
10.1093/CID/CIAA1399 |
| 2020-09-15 |
SARS-CoV-2 Neutralizing Antibody Responses Are More Robust in Patients with Severe Disease (edit) |
10.1080/22221751.2020.1823890 |
| 2020-09-15 |
Pathological Post Mortem Findings in Lungs Infected With Sars-Cov 2 (edit) |
10.1002/PATH.5549 |
| 2020-09-15 |
Regulatory CD4+ and CD8+ T cells are negatively correlated with CD4+ /CD8+ T cell ratios in patients acutely infected with SARS-CoV-2 (edit) |
10.1002/JLB.5COVA0720-421RR |
| 2020-09-15 |
SAR of novel benzamides and isoindolines, designed as SARS-CoV protease inhibitors - effective against SARS-CoV-2 (edit) |
10.1002/CMDC.202000548 |
| 2020-09-15 |
Infectivity of SARS-CoV-2: there Is Something More than D614G? (edit) |
10.1007/S11481-020-09954-3 |
| 2020-09-15 |
Relationship of D-dimer with severity and mortality in SARS-CoV-2 patients : A meta-analysis (edit) |
10.1111/IJLH.13336 |
| 2020-09-15 |
Generation of SARS-CoV-2 S1 spike glycoprotein putative antigenic epitopes in vitro by intracellular aminopeptidases (edit) |
10.1021/ACS.JPROTEOME.0C00457 |
| 2020-09-15 |
Radiotherapy in the fight against pneumonia associated with SARS-CoV-2 (edit) |
10.1080/09553002.2020.1822560 |
| 2020-09-15 |
Performance of an extended triage questionnaire to detect suspected cases of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection in obstetric patients: Experience from two large teaching hospitals in Lombardy, Northern Italy (edit) |
10.1371/JOURNAL.PONE.0239173 |
| 2020-09-15 |
Rapid quantitative screening assay for SARS-CoV-2 neutralizing antibodies using HiBiT-tagged virus-like particles (edit) |
10.1093/JMCB/MJAA047 |
| 2020-09-15 |
Risk Assessment of Autopsy-Acquired SARS-CoV-2 Coronavirus (COVID-19) (edit) |
10.5858/ARPA.2020-0500-LE |
| 2020-09-15 |
Sequence characterization and molecular modeling of clinically relevant variants of the SARS-CoV-2 main protease (edit) |
10.1021/ACS.BIOCHEM.0C00462 |
| 2020-09-15 |
SARS-CoV-2 and Dentistry-Review (edit) |
10.1055/S-0040-1716438 |
| 2020-09-15 |
Paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS): what does the future hold? (edit) |
10.1136/ANNRHEUMDIS-2020-218738 |
| 2020-09-15 |
Concomitant SARS-CoV-2 infection and severe neurologic involvement in a late preterm neonate (edit) |
10.1212/WNL.0000000000010729 |
| 2020-09-15 |
SARS-COV-2 (COVID-19) has neurotropic and neuroinvasive properties (edit) |
10.1111/IJCP.13708 |
| 2020-09-15 |
SARS-CoV-2 Infection: A Role for S1P/S1P Receptor Signaling in the Nervous System? (edit) |
10.3390/IJMS21186773 |
| 2020-09-15 |
SARS-CoV-2 identification and IgA antibodies in saliva: one sample two tests approach for diagnosis (edit) |
10.1016/J.CCA.2020.09.018 |
| 2020-09-15 |
Absence of specific cutaneous manifestations of SARS-Cov-2 in a reference center in Brazil (edit) |
10.1016/J.JAAD.2020.09.030 |
| 2020-09-15 |
SARS-CoV-2 viremia may predict rapid deterioration of COVID-19 patients (edit) |
10.1016/J.BJID.2020.08.010 |
| 2020-09-15 |
Do animals contaminated with SARS-CoV-2 represent a risk for humans? (edit) |
10.1016/J.BANM.2020.09.011 |
| 2020-09-15 |
Les animaux contaminés par le SARS-CoV-2 représentent-ils un risque pour l’Homme ? (edit) |
10.1016/J.BANM.2020.09.010 |
| 2020-09-15 |
[SARS-CoV-2-How can and must medical personnel protect themselves?] (edit) |
10.1007/S00772-020-00698-1 |
| 2020-09-15 |
SARS-CoV-2 N protein antagonizes type I interferon signaling by suppressing phosphorylation and nuclear translocation of STAT1 and STAT2 (edit) |
10.1038/S41421-020-00208-3 |
| 2020-09-15 |
Tracing asymptomatic SARS-CoV-2 carriers among 3674 hospital staff:a cross-sectional survey (edit) |
10.1016/J.ECLINM.2020.100510 |
| 2020-09-15 |
qRT-PCR Platforms for Diagnosing and Reporting SARS-CoV-2 Infection in Human Samples (edit) |
10.1016/J.XPRO.2020.100102 |
| 2020-09-15 |
Commentary: Pneumatocele and Cysts in a Patient with SARS-CoV-2 Infection - Yet Another New Complication Associated with COVID (edit) |
10.1016/J.XJTC.2020.09.012 |
| 2020-09-15 |
SARS-CoV-2 leading to acute pancreatitis: an unusual presentation (edit) |
10.1016/J.BJID.2020.08.011 |
| 2020-09-15 |
Dynamics of viral load and anti-SARS-CoV-2 antibodies in patients with positive RT-PCR results after recovery from COVID-19 (edit) |
10.3904/KJIM.2020.325 |
| 2020-09-15 |
Measures to maintain regular operations and prevent outbreaks of SARS-CoV-2 in childcare facilities or schools under pandemic conditions and co-circulation of other respiratory pathogens (edit) |
10.3205/DGKH000357 |
| 2020-09-14 |
Genes with 5' terminal oligopyrimidine tracts preferentially escape global suppression of translation by the SARS-CoV-2 NSP1 protein (edit) |
10.1101/2020.09.13.295493 |
| 2020-09-14 |
SARS CoV-2 nucleocapsid protein forms condensates with viral genomic RNA (edit) |
10.1101/2020.09.14.295824 |
| 2020-09-14 |
The expression of SARS-CoV-2 receptor ACE2 and CD147, and protease TMPRSS2 in human and mouse brain cells and mouse brain tissues (edit) |
10.1016/J.BBRC.2020.09.042 |
| 2020-09-14 |
Bowel Ischemia in a Patient With SARS CoV-2-Like Illness and Negative Real-Time Reverse Transcription Polymerase Chain Reaction Test Results During the Peak of the Pandemic (edit) |
10.7759/CUREUS.10442 |
| 2020-09-14 |
Lower levels of vitamin D are associated with SARS-CoV-2 infection and mortality in the Indian population: An observational study (edit) |
10.1016/J.INTIMP.2020.107001 |
| 2020-09-14 |
Spreading of SARS-CoV-2 in West Africa and assessment of risk factors (edit) |
10.1017/S0950268820002149 |
| 2020-09-14 |
The Natural History of SARS-Cov-2 Related Multisystem Inflammatory Syndrome in Children (MIS-C): A Systematic Review (edit) |
10.1093/JPIDS/PIAA112 |
| 2020-09-14 |
Origin-independent analysis links SARS-CoV-2 local genomes with COVID-19 incidence and mortality (edit) |
10.1093/BIB/BBAA208 |
| 2020-09-14 |
Identification of Hub genes associated with infection of three lung cell lines by SARS-CoV-2 with integrated bioinformatics analysis (edit) |
10.1111/JCMM.15862 |
| 2020-09-14 |
Re: Urinary Frequency as a Possibly Overlooked Symptom in COVID-19 Patients: Does SARS-CoV-2 Cause Viral Cystitis? (edit) |
10.1097/JU.0000000000001246.02 |
| 2020-09-14 |
Computational insight of dexamethasone against potential targets of SARS-CoV-2 (edit) |
10.1080/07391102.2020.1819880 |
| 2020-09-14 |
Potential protease inhibitors and their combinations to block SARS-CoV-2 (edit) |
10.1080/07391102.2020.1819881 |
| 2020-09-14 |
An evidence-based systematic review on emerging therapeutic and preventive strategies to treat novel coronavirus (SARS-CoV-2) during an outbreak scenario (edit) |
10.1515/JBCPP-2020-0113 |
| 2020-09-14 |
Change in Donor Characteristics and Antibodies to SARS-CoV-2 in Donated Blood in the US, June-August 2020 (edit) |
10.1001/JAMA.2020.18598 |
| 2020-09-14 |
Abdominal imaging findings in patients with SARS-CoV-2 infection: a scoping review (edit) |
10.1007/S00261-020-02739-5 |
| 2020-09-14 |
Impact of lockdown for SARS-CoV-2 (COVID-19) on surgical site infection rates: a monocentric observational cohort study (edit) |
10.1007/S13304-020-00884-6 |
| 2020-09-14 |
Th17 and Treg cells function in SARS-CoV2 patients compared with healthy controls (edit) |
10.1002/JCP.30047 |
| 2020-09-14 |
Methotrexate inhibits SARS-CoV-2 virus replication "in vitro" (edit) |
10.1002/JMV.26512 |
| 2020-09-14 |
Maternal and Perinatal Outcomes of Pregnant Women with SARS-COV-2 infection (edit) |
10.1002/UOG.23107 |
| 2020-09-14 |
Kinetics of SARS-CoV-2 Antibody Avidity Maturation and Association with Disease Severity (edit) |
10.1093/CID/CIAA1389 |
| 2020-09-14 |
Severe hemoptysis in post-tuberculosis bronchiectasis precipitated by SARS-CoV-2 infection (edit) |
10.1186/S12890-020-01285-6 |
| 2020-09-14 |
Characterization of codon usage pattern in SARS-CoV-2 (edit) |
10.1186/S12985-020-01395-X |
| 2020-09-14 |
Fulminant myocarditis as an early presentation of SARS-CoV-2 (edit) |
10.1136/BCR-2020-237553 |
| 2020-09-14 |
Accuracy and stability of saliva as a sample for reverse transcription PCR detection of SARS-CoV-2 (edit) |
10.1136/JCLINPATH-2020-206972 |
| 2020-09-14 |
Analysis of the SARS-CoV-2 spike protein glycan shield reveals implications for immune recognition (edit) |
10.1038/S41598-020-71748-7 |
| 2020-09-14 |
SARS-CoV-2 in the kidney: bystander or culprit? (edit) |
10.1038/S41581-020-00354-7 |
| 2020-09-14 |
A global health perspective on SARS-CoV-2-hazards, disaster and hope (edit) |
10.1007/S10354-020-00769-8 |
| 2020-09-14 |
Representing COVID-19 information in collaborative knowledge graphs: a study of Wikidata (edit) |
10.5281/ZENODO.4033382 |
| 2020-09-14 |
Stability of SARS-CoV-2 on Produce following a Low-Dose Aerosol Exposure (edit) |
10.4269/AJTMH.20-1033 |
| 2020-09-14 |
[Case Series of 103 Children with SARS-CoV-2 Infection in Portugal] (edit) |
10.20344/AMP.14537 |
| 2020-09-14 |
Spatio-Temporal Mutational Profile Appearances of Swedish SARS-CoV-2 during the Early Pandemic (edit) |
10.3390/V12091026 |
| 2020-09-14 |
Serological assays for delayed SARS-CoV-2 case identification (edit) |
10.1016/S2213-2600(20)30409-4 |
| 2020-09-14 |
Serological assays for delayed SARS-CoV-2 case identification - Author's reply (edit) |
10.1016/S2213-2600(20)30406-9 |
| 2020-09-14 |
Corticosteroid therapy is associated with the delay of SARS-CoV-2 clearance in COVID-19 patients (edit) |
10.1016/J.EJPHAR.2020.173556 |
| 2020-09-14 |
Optimization and clinical validation of dual-target RT-LAMP for SARS-CoV-2 (edit) |
10.1016/J.JVIROMET.2020.113972 |
| 2020-09-14 |
Outcomes of patients with confirmed SARS-CoV-2 infection undergoing anesthesia: A pilot study (edit) |
10.1016/J.JCLINANE.2020.110041 |
| 2020-09-14 |
Ultrasensitive supersandwich-type electrochemical sensor for SARS-CoV-2 from the infected COVID-19 patients using a smartphone (edit) |
10.1016/J.SNB.2020.128899 |
| 2020-09-14 |
Thermodynamic insight into viral infections 2: empirical formulas, molecular compositions and thermodynamic properties of SARS, MERS and SARS-CoV-2 (COVID-19) viruses (edit) |
10.1016/J.HELIYON.2020.E04943 |
| 2020-09-14 |
Genetic characterization of structural and open reading Fram-8 proteins of SARS-CoV-2 isolates from different countries (edit) |
10.1016/J.GENREP.2020.100886 |
| 2020-09-14 |
SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2 (edit) |
10.1016/J.CELL.2020.09.033 |
| 2020-09-14 |
Structurally Resolved SARS-CoV-2 Antibody Shows High Efficacy in Severely Infected Hamsters and Provides a Potent Cocktail Pairing Strategy (edit) |
10.1016/J.CELL.2020.09.035 |
| 2020-09-13 |
Rapid serological and SARS-CoV-2 RT-PCR assays: comparison performed simultaneously in symptomatic COVID-19 patients (edit) |
10.2196/19152 |
| 2020-09-13 |
Transmission of SARS-CoV-2 in Public Transportation Vehicles: A Case Study in Hunan Province, China (edit) |
10.1093/OFID/OFAA430 |
| 2020-09-13 |
Relevance of SARS-CoV-2 related factors ACE2 and TMPRSS2 expressions in gastrointestinal tissue with pathogenesis of digestive symptoms, diabetes-associated mortality, and disease recurrence in COVID-19 patients (edit) |
10.1016/J.MEHY.2020.110271 |
| 2020-09-13 |
Are SARS-CoV-2 IgA antibodies in pediatric patients with chilblain-like lesions indicative of COVID-19 asymptomatic or paucisymptomatic infection? (edit) |
10.1111/JDV.16934 |
| 2020-09-13 |
Using WeChat, a Chinese social media, to early detect the SARS-CoV-2 outbreak in 2019: a retrospective study (edit) |
10.2196/19589 |
| 2020-09-13 |
SARS-CoV-2 infection severity is linked to superior humoral immunity against the spike (edit) |
10.1101/2020.09.12.294066 |
| 2020-09-13 |
Real-time conformational dynamics of SARS-CoV-2 spikes on virus particles (edit) |
10.1101/2020.09.10.286948 |
| 2020-09-13 |
Age-dependent regulation of SARS-CoV-2 cell entry genes and cell death programs correlates with COVID-19 disease severity (edit) |
10.1101/2020.09.13.276923 |
| 2020-09-13 |
Identification of risk factors and symptoms of SARS-CoV-2 (COVID-19) using biomedical literature and social media data: Integrative and Consensus study (edit) |
10.2196/20509 |
| 2020-09-13 |
Identification of novel human USP2 inhibitor and its putative role in treatment of COVID-19 by inhibiting SARS-CoV-2 papain-like (PLpro) protease (edit) |
10.1016/J.COMPBIOLCHEM.2020.107376 |
| 2020-09-12 |
Validation of SARS CoV-2 detection by real-time PCR in matched pooled and deconvoluted clinical samples before and after nucleic acid extraction: a study in tertiary care hospital of North India (edit) |
10.1016/J.DIAGMICROBIO.2020.115206 |
| 2020-09-12 |
Pediatric Patients with SARS-CoV-2 Infection: Clinical Characteristics in the United States from a Large Global Health Research Network (edit) |
10.7759/CUREUS.10413 |
| 2020-09-12 |
An online repository of solvation thermodynamic and structural maps of SARS-CoV-2 targets (edit) |
10.1007/S10822-020-00341-X |
| 2020-09-12 |
Prognostic significance of hemoglobin level and autoimmune hemolytic anemia in SARS-CoV-2 infection (edit) |
10.1007/S00277-020-04256-3 |
| 2020-09-12 |
Tocilizumab as a Therapeutic Agent for Critically Ill Patients Infected with SARS-CoV-2 (edit) |
10.1111/CTS.12894 |
| 2020-09-12 |
SARS-CoV-2 multifaceted interaction with human host. Part I: What we have learnt and done so far, and the still unknown realities (edit) |
10.1002/IUB.2380 |
| 2020-09-12 |
Heavy exposure of children aged 9 to 12 years with SARS-CoV-2 did not lead to infection (edit) |
10.1093/JPIDS/PIAA116 |
| 2020-09-12 |
Highly conserved binding region of ACE2 as a receptor for SARS-CoV-2 between humans and mammals (edit) |
10.1080/01652176.2020.1823522 |
| 2020-09-12 |
Partnerships as an Avenue to Translate Emerging Disease Ecology of SARS-CoV-2 to Agricultural Groups (edit) |
10.1080/1059924X.2020.1815626 |
| 2020-09-12 |
Pharmacists' Preparedness to Patients Education at the Time of Pandemic-A Cross-Sectional Study with an Example of SARS-CoV-2 Outbreak in Poland (edit) |
10.3390/IJERPH17186659 |
| 2020-09-12 |
SARS-CoV-2 infection of human iPSC-derived cardiac cells predicts novel cytopathic features in hearts of COVID-19 patients (edit) |
10.1101/2020.08.25.265561 |
| 2020-09-12 |
Making Waves Perspectives of Modelling and Monitoring of SARS-CoV-2 in Aquatic Environment for COVID-19 Pandemic (edit) |
10.1007/S40726-020-00161-5 |
| 2020-09-12 |
SARS-CoV-2 and EBV coinfection (edit) |
10.1016/J.MEDCLE.2020.06.010 |
| 2020-09-12 |
New evidences that discard the possible vertical transmission of SARS-CoV-2 during pregnancy (edit) |
10.1016/J.MEDCLE.2020.05.020 |
| 2020-09-12 |
Lung cysts in a patient with SARS-CoV-2 (edit) |
10.1016/J.MEDCLE.2020.06.009 |
| 2020-09-12 |
Expanded mesenchymal stem cells: a novel therapeutic approach for SARS-CoV-2 pneumonia (COVID-19). Concepts regarding a first case in Spain (edit) |
10.1016/J.MEDCLE.2020.06.011 |
| 2020-09-12 |
Computer-Aided Analysis of Multiple SARS-CoV-2 Therapeutic Targets: Identification of Potent Molecules from African Medicinal Plants (edit) |
10.1155/2020/1878410 |
| 2020-09-11 |
SARS-CoV-2 (COVID-19) in Patients with some Degree of Immunosuppression (edit) |
10.1016/J.REUMA.2020.08.004 |
| 2020-09-11 |
Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses (edit) |
10.3389/FIMMU.2020.552909 |
| 2020-09-11 |
[Myasthenia gravis associated with SARS-CoV-2 infection: a conjunction of several factors] (edit) |
10.1016/J.REGG.2020.08.004 |
| 2020-09-11 |
Seroprevalence of SARS-CoV-2 Among Pediatric Healthcare Workers in Spain (edit) |
10.3389/FPED.2020.00547 |
| 2020-09-11 |
Pediatric Inflammatory Multisystem Syndrome Temporally Related With SARS-CoV-2: Immunological Similarities With Acute Rheumatic Fever and Toxic Shock Syndrome (edit) |
10.3389/FPED.2020.00574 |
| 2020-09-11 |
Pooling samples: a testing option for SARS-CoV-2 during a supply shortage (edit) |
10.1016/J.DIAGMICROBIO.2020.115205 |
| 2020-09-11 |
SARS-CoV-2 NSP1 C-terminal region (residues 130-180) is an intrinsically disordered region (edit) |
10.1101/2020.09.10.290932 |
| 2020-09-11 |
Impacts of lockdown during the SARS-CoV-2 pandemic on patients presenting with cervicofacial infection of odontogenic origin: a comparative study (edit) |
10.1016/J.BJOMS.2020.09.014 |
| 2020-09-11 |
A COVID-19 antibody curbs SARS-CoV-2 nucleocapsid protein-induced complement hyper-activation (edit) |
10.1101/2020.09.10.292318 |
| 2020-09-11 |
Resurgence of SARS-CoV-2 in England: detection by community antigen surveillance (edit) |
10.1101/2020.09.11.20192492 |
| 2020-09-11 |
Clinical and Laboratory Diagnosis of SARS-CoV-2, the Virus Causing COVID-19 (edit) |
10.1021/ACSINFECDIS.0C00274 |
| 2020-09-11 |
Nosocomial infection with SARS-CoV-2 and main outcomes after surgery within an orthopaedic surgery department in a tertiary trauma centre in Spain (edit) |
10.1007/S00264-020-04798-1 |
| 2020-09-11 |
Structures of the SARS-CoV-2 nucleocapsid and their perspectives for drug design (edit) |
10.15252/EMBJ.2020105938 |
| 2020-09-11 |
Synthesis of exfoliated multilayer graphene and its putative interactions with SARS-CoV-2 virus investigated through computational studies (edit) |
10.1080/07391102.2020.1817788 |
| 2020-09-11 |
How ADA methodology informs SARS-CoV-2 assay development (edit) |
10.4155/BIO-2020-0220 |
| 2020-09-11 |
Direct evidence of SARS-CoV-2 in gut endothelium (edit) |
10.1007/S00134-020-06237-6 |
| 2020-09-11 |
Moderate or Severe Impairment in Pulmonary Function is Associated with Mortality in Sarcoidosis Patients Infected with SARS‑CoV‑2 (edit) |
10.1007/S00408-020-00392-9 |
| 2020-09-11 |
Structural characterization of the N-linked glycans in the receptor binding domain of the SARS-CoV-2 spike protein and their interactions with human lectins using NMR spectroscopy (edit) |
10.1002/ANIE.202011015 |
| 2020-09-11 |
A new advanced in silico drug discovery method for novel coronavirus (SARS-CoV-2) with tensor decomposition-based unsupervised feature extraction (edit) |
10.1371/JOURNAL.PONE.0238907 |
| 2020-09-11 |
Intestinal receptor of SARS-CoV-2 in inflamed IBD tissue seems downregulated by HNF4A in ileum and upregulated by interferon regulating factors in colon (edit) |
10.1093/ECCO-JCC/JJAA185 |
| 2020-09-11 |
Utility of lung ultrasound assessment for probable SARS-CoV-2 infection during pregnancy and universal screening of asymptomatic individuals (edit) |
10.1002/UOG.23099 |
| 2020-09-11 |
Analysis of ACE2 genetic variants in 131 Italian SARS-CoV-2-positive patients (edit) |
10.1186/S40246-020-00279-Z |
| 2020-09-11 |
Saliva Alternative to Upper Respiratory Swabs for SARS-CoV-2 Diagnosis (edit) |
10.3201/EID2611.203283 |
| 2020-09-11 |
Efficient high-throughput SARS-CoV-2 testing to detect asymptomatic carriers (edit) |
10.1126/SCIADV.ABC5961 |
| 2020-09-11 |
Molecular characterization of ebselen binding activity to SARS-CoV-2 main protease (edit) |
10.1126/SCIADV.ABD0345 |
| 2020-09-11 |
Sphingosine prevents binding of SARS-CoV-2 spike to its cellular receptor ACE2 (edit) |
10.1074/JBC.RA120.015249 |
| 2020-09-11 |
Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID19 Patients (edit) |
10.1128/JCM.02005-20 |
| 2020-09-11 |
The clinical sensitivity of a single SARS-CoV-2 upper respiratory tract RT-PCR test for diagnosing COVID-19 using convalescent antibody as a comparator (edit) |
10.7861/CLINMED.2020-0555 |
| 2020-09-11 |
SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study (edit) |
10.1136/THORAXJNL-2020-215414 |
| 2020-09-11 |
Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor (edit) |
10.1038/S41467-020-18319-6 |
| 2020-09-11 |
Social Disadvantage, Politics, and SARS-CoV-2 Trends: A County-Level Analysis of United States Data (edit) |
10.1093/CID/CIAA1374 |
| 2020-09-11 |
Reduction of hypoglycemia, lifestyle modifications and psychological distress during lockdown following SARS-CoV-2 outbreak in type 1 diabetic patients using flash continuous glucose monitoring: a retrospective cohort study (edit) |
10.1002/DMRR.3404 |
| 2020-09-11 |
Are Proton Pump Inhibitors Contributing to SARS-COV-2 Infection? (edit) |
10.14309/AJG.0000000000000933 |
| 2020-09-11 |
SARS-CoV-2 Infection During Induction Chemotherapy in a Child With High-risk T-Cell Acute Lymphoblastic Leukemia (T-ALL) (edit) |
10.1097/MPH.0000000000001943 |
| 2020-09-11 |
SARS-CoV-2 transmission via speech-generated respiratory droplets (edit) |
10.1016/S1473-3099(20)30726-X |
| 2020-09-11 |
New SARS-CoV-2 Infection Detected in an Italian Pet Cat by RT-qPCR from Deep Pharyngeal Swab (edit) |
10.3390/PATHOGENS9090746 |
| 2020-09-11 |
Decreased HD-MIR2911 absorption in human subjects with the SIDT1 polymorphism fails to inhibit SARS-CoV-2 replication (edit) |
10.1038/S41421-020-00206-5 |
| 2020-09-11 |
Functional interrogation of a SARS-CoV-2 host protein interactome identifies unique and shared coronavirus host factors (edit) |
10.1101/2020.09.11.291716 |
| 2020-09-11 |
Identifying zoonotic origin of SARS-CoV-2 by modeling the binding affinity between Spike receptor-binding domain and host ACE2 (edit) |
10.1101/2020.09.11.293449 |
| 2020-09-11 |
[Repetition of microbiological tests in suspect of SARS-CoV-2 infection: utility of a score based on clinical probability] (edit) |
10.37201/REQ/080.2020 |
| 2020-09-11 |
Human Mesenchymal Stromal Cells Are Resistant to SARS-CoV-2 Infection under Steady-State, Inflammatory Conditions and in the Presence of SARS-CoV-2-Infected Cells (edit) |
10.1016/J.STEMCR.2020.09.003 |
| 2020-09-11 |
Characteristics of Pleural Effusion in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pneumonia (edit) |
10.1016/J.AMJMS.2020.09.008 |
| 2020-09-11 |
Characteristics of a Diverse Cohort of Stroke Patients with SARS-CoV-2 and Outcome by Sex (edit) |
10.1016/J.JSTROKECEREBROVASDIS.2020.105314 |
| 2020-09-11 |
SARS-CoV-2 infection: physiological and environmental gift factors at high altitude (edit) |
10.1007/S13337-020-00626-7 |
| 2020-09-11 |
Universal Testing for SARS-CoV-2 in Two Philadelphia Hospitals: Carrier Prevalence and Symptom Development Over Two Weeks (edit) |
10.1016/J.AJOGMF.2020.100226 |
| 2020-09-11 |
Intrauterine vertical transmissibility of SARS-CoV-2: The evidence is evolving (edit) |
10.1016/J.AJOGMF.2020.100227 |
| 2020-09-11 |
Potent antiviral effect of silver nanoparticles on SARS-CoV-2 (edit) |
10.1016/J.BBRC.2020.09.018 |
| 2020-09-10 |
Reliability of serological tests for COVID-19: comparison of three immunochromatography test kits for SARS-CoV-2 antibodies (edit) |
10.1016/J.HELIYON.2020.E04929 |
| 2020-09-10 |
No evidence of hemoglobin damage by SARS-CoV-2 infection (edit) |
10.3324/HAEMATOL.2020.264267 |
| 2020-09-10 |
Overview of the Pathogenesis and Treatment of SARS-CoV-2 for Clinicians: A Comprehensive Literature Review (edit) |
10.7759/CUREUS.10357 |
| 2020-09-10 |
Kawasaki-like Syndrome as an Emerging Complication of SARS-CoV-2 Infection in Young Adults (edit) |
10.12890/2020_001886 |
| 2020-09-10 |
Novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) co-infection with HIV: clinical case series analysis in North Central Nigeria (edit) |
|
| 2020-09-10 |
Paradoxical effect of SARS-CoV-2 infection in patients with immune thrombocytopenia (edit) |
10.1111/BJH.17077 |
| 2020-09-10 |
Efficacy of Interferon Gamma in the Prevention of SARS-CoV-2 Infection (COVID-19): Results of a Prospective Controlled Trial (edit) |
10.21103/ARTICLE10(3)_OA1 |
| 2020-09-10 |
A chronicle of SARS-CoV-2: Part-I - Epidemiology, diagnosis, prognosis, transmission and treatment (edit) |
10.1016/J.SCITOTENV.2020.139278 |
| 2020-09-10 |
Appropriate usage of face masks to prevent SARS-CoV-2: sharpening the messaging amid the COVID-19 pandemic (edit) |
10.1017/DMP.2020.336 |
| 2020-09-10 |
Perceived risk of being infected with SARS-CoV-2: A perspective from Indonesia (edit) |
10.1017/DMP.2020.351 |
| 2020-09-10 |
SARS CoV-2 presenting as Lupus Erythematosus-Like Syndrome (edit) |
10.1017/DMP.2020.358 |
| 2020-09-10 |
Psychiatric presentation of patients with acute SARS-CoV-2 infection: a retrospective review of 50 consecutive patients seen by a consultation-liaison psychiatry team (edit) |
10.1192/BJO.2020.85 |
| 2020-09-10 |
Virtual screening of approved clinic drugs with main protease (3CLpro) reveals potential inhibitory effects on SARS-CoV-2 (edit) |
10.1080/07391102.2020.1817786 |
| 2020-09-10 |
Alopecia areata in a patient with SARS-Cov-2 infection (edit) |
10.1111/DTH.14295 |
| 2020-09-10 |
Clinical significance of SARS-CoV-2-specific IgG detection with a rapid antibody kit for COVID-19 patients (edit) |
10.1111/IRV.12802 |
| 2020-09-10 |
Clinical course and risk factors for recurrence of positive SARS-CoV-2 RNA: a retrospective cohort study from Wuhan, China (edit) |
10.18632/AGING.103795 |
| 2020-09-10 |
SARS-CoV-2 Antibody Avidity Responses in COVID-19 Patients and Convalescent Plasma Donors (edit) |
10.1093/INFDIS/JIAA581 |
| 2020-09-10 |
Strongyloides infection manifested during immunosuppressive therapy for SARS-CoV-2 pneumonia (edit) |
10.1007/S15010-020-01522-4 |
| 2020-09-10 |
Comparison of four commercial SARS-CoV-2 IgG immuno-assays in RT-PCR negative patients with suspect CT findings (edit) |
10.1007/S15010-020-01523-3 |
| 2020-09-10 |
Comparative Antiviral Efficacy of Viral Protease Inhibitors against the Novel SARS-CoV-2 In Vitro (edit) |
10.1007/S12250-020-00288-1 |
| 2020-09-10 |
Cause-specific death in hospitalized individuals infected with SARS-CoV-2: more than just acute respiratory failure or thromboembolic events (edit) |
10.1007/S11739-020-02485-Y |
| 2020-09-10 |
SARS-CoV-2 and myasthenia (edit) |
10.1002/JMV.26501 |
| 2020-09-10 |
Convalescent plasma anti-SARS-CoV-2 spike protein ectodomain and receptor binding domain IgG correlate with virus neutralization (edit) |
10.1172/JCI141206 |
| 2020-09-10 |
Neurological Complications of SARS-CoV-2 Infection in Children: A Systematic Review and Meta-Analysis (edit) |
10.1093/TROPEJ/FMAA070 |
| 2020-09-10 |
Paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS): the Evelina Experience (edit) |
10.1136/ARCHDISCHILD-2020-319554 |
| 2020-09-10 |
The emergence of SARS-CoV-2 in Europe and North America (edit) |
10.1126/SCIENCE.ABC8169 |
| 2020-09-10 |
Cryptic transmission of SARS-CoV-2 in Washington state (edit) |
10.1126/SCIENCE.ABC0523 |
| 2020-09-10 |
Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2 (edit) |
10.1128/MBIO.01928-20 |
| 2020-09-10 |
Suboptimal SARS-CoV-2-specific CD8+ T cell response associated with the prominent HLA-A*02:01 phenotype (edit) |
10.1073/PNAS.2015486117 |
| 2020-09-10 |
Heparin-binding peptides as novel therapies to stop SARS-CoV-2 cellular entry and infection (edit) |
10.1124/MOLPHARM.120.000098 |
| 2020-09-10 |
Humanized single domain antibodies neutralize SARS-CoV-2 by targeting the spike receptor binding domain (edit) |
10.1038/S41467-020-18387-8 |
| 2020-09-10 |
A comprehensive, longitudinal analysis of humoral responses specific to four recombinant antigens of SARS-CoV-2 in severe and non-severe COVID-19 patients (edit) |
10.1371/JOURNAL.PPAT.1008796 |
| 2020-09-10 |
COVID-19 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children and adolescents: a systematic review of critically unwell children and the association with underlying comorbidities (edit) |
10.1007/S00431-020-03801-6 |
| 2020-09-10 |
Measures of infection prevention and incidence of SARS-CoV-2 infections in cancer patients undergoing radiotherapy in Germany, Austria and Switzerland (edit) |
10.1007/S00066-020-01681-1 |
| 2020-09-10 |
Mild impact of SARS-CoV-2 infection on the entire population of liver transplant recipients: the experience of an Italian Centre based in a high-risk area (edit) |
10.1007/S13304-020-00881-9 |
| 2020-09-10 |
Reply to SARS-CoV-2 Vertical Transmission and RNA Stability (edit) |
10.1016/J.AJOG.2020.09.004 |
| 2020-09-10 |
Intermittent viral shedding in respiratory samples of patients with SARS-CoV-2: observational analysis with infection control implications (edit) |
10.1016/J.JHIN.2020.09.011 |
| 2020-09-10 |
Thermally bonded disinfectant for self-decontamination of fabric against SARS-CoV-2 (edit) |
10.1016/J.JHIN.2020.09.008 |
| 2020-09-10 |
Comparison of Commercial Assays and Laboratory Developed Tests for Detection of SARS-CoV-2 (edit) |
10.1016/J.JVIROMET.2020.113970 |
| 2020-09-10 |
SARS-CoV-2 transcriptome analysis and molecular cataloguing of immunodominant epitopes for multi-epitope based vaccine design (edit) |
10.1016/J.YGENO.2020.09.019 |
| 2020-09-10 |
Corrigendum to "Viral, host and environmental factors that favor anthropozoonotic spillover of coronaviruses: An opinionated review, focusing on SARS-CoV, MERS-CoV and SARS-CoV-2"[Sci. Total Environ. 750 (2021) 141483] (edit) |
10.1016/J.SCITOTENV.2020.142123 |
| 2020-09-10 |
Response to the letter "Does SARS-CoV-2 truly cause infectious myopathy?" (edit) |
10.1016/J.JFMA.2020.08.046 |
| 2020-09-10 |
Characterisation of SARS-CoV-2 Lentiviral Pseudotypes and Correlation between Pseudotype-Based Neutralisation Assays and Live Virus-Based Micro Neutralisation Assays (edit) |
10.3390/V12091011 |
| 2020-09-10 |
Spike mutation D614G alters SARS-CoV-2 fitness and neutralization susceptibility (edit) |
10.21203/RS.3.RS-70482/V1 |
| 2020-09-10 |
Inhibitor binding influences the protonation states of histidines in SARS-CoV-2 main protease (edit) |
10.1101/2020.09.07.286344 |
| 2020-09-10 |
Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognition (edit) |
10.1101/2020.09.10.292078 |
| 2020-09-10 |
Frailty and SARS-CoV-2 infection. A population-based study in a highly endemic village (edit) |
10.1016/J.JNS.2020.117136 |
| 2020-09-09 |
Role of IFN and Complements System: Innate Immunity in SARS-CoV-2 (edit) |
10.2147/JIR.S267280 |
| 2020-09-09 |
SARS-CoV-2 infection as trigger multisystem inflammatory syndrome? (edit) |
10.1016/J.EIMC.2020.07.012 |
| 2020-09-09 |
Age-Dependent Assessment of Genes Involved in Cellular Senescence, Telomere, and Mitochondrial Pathways in Human Lung Tissue of Smokers, COPD, and IPF: Associations With SARS-CoV-2 COVID-19 ACE2-TMPRSS2-Furin-DPP4 Axis (edit) |
10.3389/FPHAR.2020.584637 |
| 2020-09-09 |
Corrigendum: Construction of SARS-CoV-2 Virus-Like Particles by Mammalian Expression System (edit) |
10.3389/FBIOE.2020.01026 |
| 2020-09-09 |
The Impact of SARS-CoV-2 on the Most Common Comorbidities-A Retrospective Study on 814 COVID-19 Deaths in Romania (edit) |
10.3389/FMED.2020.567199 |
| 2020-09-09 |
SARS-CoV-2 testing for asymptomatic adult cancer patients before initiating systemic treatments: a systematic review (edit) |
10.3332/ECANCER.2020.1100 |
| 2020-09-09 |
Reporting of child maltreatment during the SARS-CoV-2 pandemic in New York City from March to May 2020 (edit) |
10.1016/J.CHIABU.2020.104719 |
| 2020-09-09 |
Environmental virus detection associated with asymptomatic SARS-CoV-2-infected individuals with positive anal swabs (edit) |
10.1016/J.SCITOTENV.2020.142289 |
| 2020-09-09 |
Sources and routes of SARS-CoV-2 transmission in water systems in Africa: Are there any sustainable remedies? (edit) |
10.1016/J.SCITOTENV.2020.142298 |
| 2020-09-09 |
Role of inositol to improve surfactant functions and reduce IL-6 levels: A potential adjuvant strategy for SARS-CoV-2 pneumonia? (edit) |
10.1016/J.MEHY.2020.110262 |
| 2020-09-09 |
Distinguishing between typical Kawasaki disease and multisystem inflammatory syndrome in children (MIS-C) associated with SARS-CoV-2 (edit) |
10.1016/J.MEHY.2020.110263 |
| 2020-09-09 |
Candidate screening of host cell membrane proteins involved in SARS-CoV-2 entry (edit) |
10.1101/2020.09.09.289488 |
| 2020-09-09 |
Interaction network of SARS-CoV-2 with host receptome through spike protein (edit) |
10.1101/2020.09.09.287508 |
| 2020-09-09 |
Modeling the effect of lockdown and other events on the dynamics of SARS-CoV-2 in France (edit) |
10.24072/PCI.MCB.100001 |
| 2020-09-09 |
Approaches and Challenges in SARS-CoV-2 Vaccine Development (edit) |
10.1016/J.CHOM.2020.08.002 |
| 2020-09-09 |
SARS-CoV-2 envelope protein topology in eukaryotic membranes (edit) |
10.1098/RSOB.200209 |
| 2020-09-09 |
ECMO support in SARS-CoV2 multisystem inflammatory syndrome in children in a child (edit) |
10.1177/0267659120954386 |
| 2020-09-09 |
NeuroCOVID: critical review of neuropsychiatric manifestations of SARS-CoV-2 infection (edit) |
10.1007/S11845-020-02367-4 |
| 2020-09-09 |
Ribonucleocapsid assembly/packaging signals in the genomes of the coronaviruses SARS-CoV and SARS-CoV-2: detection, comparison and implications for therapeutic targeting (edit) |
10.1080/07391102.2020.1815581 |
| 2020-09-09 |
Coagulation disorders in SARS-CoV-2 infection (edit) |
10.5507/BP.2020.037 |
| 2020-09-09 |
Targeted therapy strategies against SARS-CoV-2 cell entry mechanisms: A systematic review of in vitro and in vivo studies (edit) |
10.1002/JCP.30032 |
| 2020-09-09 |
Interpersonal Distance in the SARS-CoV-2 Crisis (edit) |
10.1177/0018720820956858 |
| 2020-09-09 |
SARS-CoV-2 outbreaks, age and gender: Getting under the skin (edit) |
10.1002/HPM.3024 |
| 2020-09-09 |
The Emerging SARS-CoV-2 Papain-like Protease: Its Relationship with Recent Coronavirus Epidemics (edit) |
10.1002/JMV.26497 |
| 2020-09-09 |
Identification of immunodominant linear epitopes from SARS-CoV-2 patient plasma (edit) |
10.1371/JOURNAL.PONE.0238089 |
| 2020-09-09 |
Environmental and Aerosolized SARS-CoV-2 Among Hospitalized COVID-19 Patients (edit) |
10.1093/INFDIS/JIAA575 |
| 2020-09-09 |
Emerging algebraic growth trends in SARS-CoV-2 pandemic data (edit) |
10.1088/1478-3975/ABB6DB |
| 2020-09-09 |
The coding capacity of SARS-CoV-2 (edit) |
10.1038/S41586-020-2739-1 |
| 2020-09-09 |
Comparative Clinical Evaluation of the Roche Elecsys and Abbott SARS-CoV-2 Serology assays for COVID-19 (edit) |
10.5858/ARPA.2020-0499-SA |
| 2020-09-09 |
High seroprevalence of anti-SARS-CoV-2 antibodies in Chelsea, Massachusetts (edit) |
10.1093/INFDIS/JIAA579 |
| 2020-09-09 |
Repurposing of FDA-Approved Toremifene to Treat COVID-19 by blocking the spike glycoprotein and NSP14 of SARS-CoV-2 (edit) |
10.1021/ACS.JPROTEOME.0C00397 |
| 2020-09-09 |
Fatal central nervous system co-infection with SARS-CoV-2 and tuberculosis in a healthy child (edit) |
10.1186/S12887-020-02308-1 |
| 2020-09-09 |
In vitro virucidal activity of Echinaforce®, an Echinacea purpurea preparation, against coronaviruses, including common cold coronavirus 229E and SARS-CoV-2 (edit) |
10.1186/S12985-020-01401-2 |
| 2020-09-09 |
Active testing of groups at increased risk of acquiring SARS-CoV-2 in Canada: costs and human resource needs (edit) |
10.1503/CMAJ.201128 |
| 2020-09-09 |
De novo design of picomolar SARS-CoV-2 miniprotein inhibitors (edit) |
10.1126/SCIENCE.ABD9909 |
| 2020-09-09 |
Cross-reactivity of SARS-CoV-2 with HIV chemiluminescent assay leading to false-positive results (edit) |
10.1136/JCLINPATH-2020-206942 |
| 2020-09-09 |
SARS-CoV-2 Polymorphisms and Multisystem Inflammatory Syndrome in Children (MIS-C) (edit) |
10.1542/PEDS.2020-019844 |
| 2020-09-09 |
Substantial underestimation of SARS-CoV-2 infection in the United States (edit) |
10.1038/S41467-020-18272-4 |
| 2020-09-09 |
Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies (edit) |
10.1038/S41564-020-00789-5 |
| 2020-09-09 |
Exploring the structural distribution of genetic variation in SARS-CoV-2 with the COVID-3D online resource (edit) |
10.1038/S41588-020-0693-3 |
| 2020-09-09 |
The UCSC SARS-CoV-2 Genome Browser (edit) |
10.1038/S41588-020-0700-8 |
| 2020-09-09 |
SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation (edit) |
10.1038/S41594-020-0511-8 |
| 2020-09-09 |
Dynamic Panel Estimates of SARS-CoV-2 Infection Rates: Health Surveillance Informs Public Health Policy (edit) |
10.2196/20924 |
| 2020-09-09 |
Improved Detection of Antibodies against SARS-CoV-2 by Microsphere-Based Antibody Assay (edit) |
10.3390/IJMS21186595 |
| 2020-09-09 |
STABILITY OF SARS-Cov-2 RNA IN PLACENTA AND FETAL CELLS (edit) |
10.1016/J.AJOG.2020.09.003 |
| 2020-09-09 |
Accuracy of a RT-qPCR SARS-CoV-2 detection assay without prior RNA extraction (edit) |
10.1016/J.JVIROMET.2020.113969 |
| 2020-09-09 |
SARS-CoV-2 host tropism: an in silico analysis of the main cellular factors (edit) |
10.1016/J.VIRUSRES.2020.198154 |
| 2020-09-09 |
Health status of patients with Autoimmune hepatitis is not affected by the SARS-CoV-2 outbreak in Flanders (Belgium) (edit) |
10.1016/J.JHEP.2020.08.035 |
| 2020-09-09 |
A graph-based approach identifies dynamic H-bond communication networks in spike protein S of SARS-CoV-2 (edit) |
10.1016/J.JSB.2020.107617 |
| 2020-09-09 |
Detection and infectivity potential of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) environmental contamination in isolation units and quarantine facilities (edit) |
10.1016/J.CMI.2020.09.004 |
| 2020-09-09 |
Sample pooling for SARS-COV-2 RT-PCR screening (edit) |
10.1016/J.CMI.2020.09.008 |
| 2020-09-09 |
SARS-CoV-2 and hepatitis (edit) |
10.15403/JGLD-2747 |
| 2020-09-09 |
A Case Series of Coinfection with SARS-CoV-2 and Influenza Virus in Louisiana (edit) |
10.1016/J.RMCR.2020.101214 |
| 2020-09-09 |
Investigation of SARS-CoV-2 outbreaks in six care homes in London, April 2020 (edit) |
10.1016/J.ECLINM.2020.100533 |
| 2020-09-09 |
Aerosol Exposure During Surgical Tracheotomy in SARS-CoV-2 Positive Patients (edit) |
10.1097/SHK.0000000000001655 |
| 2020-09-09 |
Enhanced SARS-CoV-2 Neutralization by Secretory IgA in vitro (edit) |
10.1101/2020.09.09.288555 |
| 2020-09-09 |
Potential impact on coagulopathy of gene variants of coagulation related proteins that interact with SARS-CoV-2 (edit) |
10.1101/2020.09.08.272328 |
| 2020-09-08 |
COVID and CARE®. Mobile application for monitoring SARS-CoV-2 positive patients after hospitalization (edit) |
10.1016/J.EIMC.2020.07.011 |
| 2020-09-08 |
A Preventive Role of Exercise Across the Coronavirus 2 (SARS-CoV-2) Pandemic (edit) |
10.3389/FPHYS.2020.572718 |
| 2020-09-08 |
Can SARS-CoV-2 Accumulate Mutations in the S-Protein to Increase Pathogenicity? (edit) |
10.1021/ACSPTSCI.0C00113 |
| 2020-09-08 |
Brief comparative evaluation of six open one-step RT-qPCR mastermixes for the detection of SARS-CoV-2 RNA using a Taqman probe (edit) |
10.1016/J.JCV.2020.104636 |
| 2020-09-08 |
Evidences of SARS-CoV-2 virus air transmission indoors using several untouched surfaces: A pilot study (edit) |
10.1016/J.SCITOTENV.2020.142317 |
| 2020-09-08 |
Combating SARS-CoV-2: leveraging microbicidal experiences with other emerging/re-emerging viruses (edit) |
10.7717/PEERJ.9914 |
| 2020-09-08 |
Characteristics and outcomes of diabetic patients infected by the SARS-CoV-2 (edit) |
10.11604/PAMJ.2020.37.32.25192 |
| 2020-09-08 |
Identification of a SARS-like bat coronavirus that shares structural features with the spike glycoprotein receptor-binding domain of SARS-CoV-2 (edit) |
10.1099/ACMI.0.000166 |
| 2020-09-08 |
In-silico screening of plant-derived antivirals against main protease, 3CLpro and endoribonuclease, NSP15 proteins of SARS-CoV-2 (edit) |
10.1080/07391102.2020.1808077 |
| 2020-09-08 |
Genetic characterization of SARS-CoV-2 & implications for epidemiology, diagnostics & vaccines in India (edit) |
10.4103/IJMR.IJMR_3667_20 |
| 2020-09-08 |
Cardiovascular disease, therapy and mortality of oligosymptomatic and symptomatic patients infected with SARS-CoV-2: experiences of a designated hospital in Poland (edit) |
10.33963/KP.15596 |
| 2020-09-08 |
Drug similarity and structure-based screening of medicinal compounds to target macrodomain-I from SARS-CoV-2 to rescue the host immune system: a molecular dynamics study (edit) |
10.1080/07391102.2020.1815583 |
| 2020-09-08 |
SARS-CoV-2 spike produced in insect cells elicits high neutralization titers in non-human primates (edit) |
10.1080/22221751.2020.1821583 |
| 2020-09-08 |
Molecular docking, validation, dynamics simulations, and pharmacokinetic prediction of natural compounds against the SARS-CoV-2 main-protease (edit) |
10.1080/07391102.2020.1815584 |
| 2020-09-08 |
Ultra-sensitive Serial Profiling of SARS-CoV-2 Antigens and Antibodies in Plasma to Understand Disease Progression in COVID-19 Patients with Severe Disease (edit) |
10.1093/CLINCHEM/HVAA213 |
| 2020-09-08 |
Results of a national web-based survey on the SARS-CoV-2 infectious state of otorhinolaryngologists in Germany (edit) |
10.1007/S00405-020-06345-5 |
| 2020-09-08 |
Immune response against SARS-CoV-2 in pediatric patients including young infants (edit) |
10.1002/JMV.26493 |
| 2020-09-08 |
Seroconversion against SARS-CoV-2 occurred after the recovery in patients with COVID-19 (edit) |
10.1002/JMV.26495 |
| 2020-09-08 |
Standardization of Reporting Criteria for Lung Pathology in SARS-CoV-2 Infected Hamsters - What Matters? (edit) |
10.1165/RCMB.2020-0280LE |
| 2020-09-08 |
Androgen Deprivation Therapy in Men With Prostate Cancer Does Not Affect Risk of Infection With SARS-CoV-2 (edit) |
10.1097/JU.0000000000001338 |
| 2020-09-08 |
Detection of coronavirus in tear samples of hospitalized patients with confirmed SARS-CoV-2 from oropharyngeal swabs (edit) |
10.1097/ICO.0000000000002562 |
| 2020-09-08 |
Adverse outcomes and mortality in users of non-steroidal anti-inflammatory drugs who tested positive for SARS-CoV-2: A Danish nationwide cohort study (edit) |
10.1371/JOURNAL.PMED.1003308 |
| 2020-09-08 |
Detection and quantification of SARS-CoV-2 by droplet digital PCR in real-time PCR negative nasopharyngeal swabs from suspected COVID-19 patients (edit) |
10.1371/JOURNAL.PONE.0236311 |
| 2020-09-08 |
In vivo antiviral host transcriptional response to SARS-CoV-2 by viral load, sex, and age (edit) |
10.1371/JOURNAL.PBIO.3000849 |
| 2020-09-08 |
Detection of SARS-CoV-2 RNA in Blood of Patients with COVID-19: What Does It Mean? (edit) |
10.1093/CID/CIAA1316 |
| 2020-09-08 |
Cross-neutralization activity against SARS-CoV-2 is present in currently available intravenous immunoglobulins (edit) |
10.2217/IMT-2020-0220 |
| 2020-09-08 |
Testing for SARS-CoV-2 antibodies (edit) |
10.1136/BMJ.M3325 |
| 2020-09-08 |
Disruption of Adaptive Immunity Enhances Disease in SARS-CoV-2 Infected Syrian Hamsters (edit) |
10.1128/JVI.01683-20 |
| 2020-09-08 |
SARS-CoV-2 detection using isothermal amplification and a rapid, inexpensive protocol for sample inactivation and purification (edit) |
10.1073/PNAS.2011221117 |
| 2020-09-08 |
A role for Biofoundries in rapid development and validation of automated SARS-CoV-2 clinical diagnostics (edit) |
10.1038/S41467-020-18130-3 |
| 2020-09-08 |
Liquid-liquid phase separation by SARS-CoV-2 nucleocapsid protein and RNA (edit) |
10.1038/S41422-020-00408-2 |
| 2020-09-08 |
Decreasing High Risk Exposures for Healthcare-workers through Universal Masking and Universal SARS-CoV-2 Testing upon entry to a Tertiary Care Facility (edit) |
10.1093/CID/CIAA1358 |
| 2020-09-08 |
Fusion protein targeted antiviral peptides: fragment based drug design (FBDD) guided rational design of dipeptides against SARS-CoV-2 (edit) |
10.2174/1389203721666200908164641 |
| 2020-09-08 |
A Simulation-Based Failure Mode Analysis of SARS-CoV-2 Infection Control and Prevention in Emergency Departments (edit) |
10.1097/SIH.0000000000000506 |
| 2020-09-08 |
Control Measures for SARS-CoV-2: A Review on Light-Based Inactivation of Single-Stranded RNA Viruses (edit) |
10.3390/PATHOGENS9090737 |
| 2020-09-08 |
Dendritic Cells and SARS-CoV-2 Infection: Still an Unclarified Connection (edit) |
10.3390/CELLS9092046 |
| 2020-09-08 |
Healthcare-Associated SARS-CoV-2 Transmission-Experiences from a German University Hospital (edit) |
10.3390/MICROORGANISMS8091378 |
| 2020-09-08 |
Infection of Brain Organoids and 2D Cortical Neurons with SARS-CoV-2 Pseudovirus (edit) |
10.3390/V12091004 |
| 2020-09-08 |
Rapid SARS-CoV-2 Inactivation by Commonly Available Chemicals on Inanimate Surfaces (edit) |
10.1016/J.JHIN.2020.09.001 |
| 2020-09-08 |
Identification of angiotensin-converting enzyme 2 (ACE2) protein as the potential biomarker in SARS-CoV-2 infection-related lung cancer using computational analysis (edit) |
10.1016/J.YGENO.2020.09.002 |
| 2020-09-08 |
Antimalarial drugs inhibit the replication of SARS-CoV-2: an in vitro evaluation (edit) |
10.1016/J.TMAID.2020.101873 |
| 2020-09-08 |
UV-C (254 nm) lethal doses for SARS-CoV-2 (edit) |
10.1016/J.PDPDT.2020.101995 |
| 2020-09-08 |
A narrative review of venous thrombosis epidemiology, pathophysiology and anticoagulant therapies and trials in SARS-CoV2 infection (edit) |
10.1016/J.JVSV.2020.08.030 |
| 2020-09-08 |
Rotational thromboelastometry in young, previously healthy patients with SARS-Cov2 (edit) |
10.1016/J.JCLINANE.2020.110038 |
| 2020-09-08 |
IMPACT OF CHRONIC USE OF ANTIMALARIALS ON SARS-CoV-2 INFECTION IN PATIENTS WITH IMMUNE-MEDIATED RHEUMATIC DISEASES: PROTOCOL DESIGN FOR A MULTICENTRIC OBSERVATIONAL COHORT IN BRAZIL (edit) |
10.2196/23532 |
| 2020-09-08 |
SARS-CoV-2 Antibody Seroprevalence in Industry Workers in Split-Dalmatia and Šibenik-Knin County, Croatia (edit) |
10.1097/JOM.0000000000002020 |
| 2020-09-08 |
A Systematic Review of Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 Infection (edit) |
10.1097/INF.0000000000002888 |
| 2020-09-08 |
Clinical performance of four immunoassays for antibodies to SARS-CoV-2, including a prospective analysis for the diagnosis of COVID-19 in a real-life routine care setting (edit) |
10.1016/J.JCV.2020.104633 |
| 2020-09-08 |
Antibody binding to SARS-CoV-2 S glycoprotein correlates with, but does not predict neutralization (edit) |
10.1101/2020.09.08.287482 |
| 2020-09-08 |
Neuroinvasion of SARS-CoV-2 in human and mouse brain (edit) |
10.1101/2020.06.25.169946 |
| 2020-09-08 |
SARS-CoV-2-induced immunodysregulation and the need for higher clinical suspicion for co-infection and secondary infection in COVID-19 patients (edit) |
10.1016/J.JMII.2020.08.016 |
| 2020-09-08 |
Racial-ethnic disparities and pregnancy outcomes in SARS-CoV-2 infection in a universally-tested cohort in Houston, Texas (edit) |
10.1016/J.EJOGRB.2020.09.012 |
| 2020-09-08 |
Etiogenic Mechanisms for Dysgeusia in SARS-CoV-2 Infection (edit) |
10.1097/SCS.0000000000007021 |
| 2020-09-07 |
The SARS-CoV-2 multibasic cleavage site facilitates early serine protease-mediated entry into organoid-derived human airway cells (edit) |
10.1101/2020.09.07.286120 |
| 2020-09-07 |
Role of the early secretory pathway in SARS-CoV-2 infection (edit) |
10.1083/JCB.202006005 |
| 2020-09-07 |
In Silico Drug Repurposing for SARS-CoV-2 Main Proteinase and Spike Proteins (edit) |
10.1021/ACS.JPROTEOME.0C00383 |
| 2020-09-07 |
Robust neutralization assay based on SARS-CoV-2 S-protein-bearing vesicular stomatitis virus (VSV) pseudovirus and ACE2-overexpressing BHK21 cells (edit) |
10.1080/22221751.2020.1815589 |
| 2020-09-07 |
Acute chest syndrome in the setting of SARS-COV-2 infections-A case series at an urban medical center in the Bronx (edit) |
10.1002/PBC.28579 |
| 2020-09-07 |
Clinical and laboratory characteristics of SARS-CoV2-infected paediatric patients in Jordan: serial RT-PCR testing until discharge (edit) |
10.1080/20469047.2020.1804733 |
| 2020-09-07 |
Quantifying antibody kinetics and RNA detection during early-phase SARS-CoV-2 infection by time since symptom onset (edit) |
10.7554/ELIFE.60122 |
| 2020-09-07 |
[Ethical dimensions of prevention and planning in assisted-living facilities during the SARS-CoV-2 pandemic (Covid-19): a public health emergency.] (edit) |
|
| 2020-09-07 |
Bacterial and viral co-infections in patients with severe SARS-CoV-2 pneumonia admitted to a French ICU (edit) |
10.1186/S13613-020-00736-X |
| 2020-09-07 |
A Study of Two Cases Co-Infected with SARS-CoV-2 and Human Immunodeficiency Virus (edit) |
10.1007/S12250-020-00280-9 |
| 2020-09-07 |
Stercoraceous transmission of SARS-CoV-2 (Coronavirus) (edit) |
|
| 2020-09-07 |
Detection of environmental SARS-CoV-2 RNA in a high prevalence setting in Spain (edit) |
10.1111/TBED.13817 |
| 2020-09-07 |
Reconsidering assumptions of adolescent and young adult SARS-CoV-2 transmission dynamics (edit) |
10.1093/CID/CIAA1348 |
| 2020-09-07 |
Association between SARS-CoV-2 neutralizing antibodies and commercial serological assays (edit) |
10.1093/CLINCHEM/HVAA211 |
| 2020-09-07 |
Common pediatric respiratory infectious diseases may serve as an early predictor for SARS-CoV-2 new wave of infections (edit) |
10.1093/CID/CIAA1359 |
| 2020-09-07 |
Evaluation of Orthogonal Testing Algorithm for Detection of SARS-CoV-2 IgG Antibodies (edit) |
10.1093/CLINCHEM/HVAA210 |
| 2020-09-07 |
Cautionary note on contamination of reagents used for molecular detection of SARS-CoV-2 (edit) |
10.1093/CLINCHEM/HVAA214 |
| 2020-09-07 |
Will SARS-CoV-2 prevention efforts affect the coming influenza season in the United States and northern hemisphere? (edit) |
10.1093/INFDIS/JIAA571 |
| 2020-09-07 |
Response to: 'Implications of SARS-CoV-2 infection for patients with rheumatic disease' by Lin et al (edit) |
10.1136/ANNRHEUMDIS-2020-218404 |
| 2020-09-07 |
Linear epitopes of SARS-CoV-2 spike protein elicit neutralizing antibodies in COVID-19 patients (edit) |
10.1038/S41423-020-00523-5 |
| 2020-09-07 |
Does a host restriction factor facilitate entry of SARS-CoV-2? (edit) |
10.1038/S41577-020-00448-0 |
| 2020-09-07 |
In vitro comparison of surgical techniques in times of the SARS-CoV-2 pandemic: electrocautery generates more droplets and aerosol than laser surgery or drilling (edit) |
10.1007/S00405-020-06330-Y |
| 2020-09-07 |
Discordant anti-SARS-CoV-2 spike protein and RNA staining in cutaneous perniotic lesions suggests endothelial deposition of cleaved spike protein (edit) |
10.1111/CUP.13866 |
| 2020-09-07 |
The Light and Shadow of Rapid Serological Tests for SARS-CoV-2 Infection: Results from a Study in a Large Emergency Department (edit) |
10.3390/IJERPH17186493 |
| 2020-09-07 |
The New Coronavirus (SARS-CoV-2): A Comprehensive Review on Immunity and the Application of Bioinformatics and Molecular Modeling to the Discovery of Potential Anti-SARS-CoV-2 Agents (edit) |
10.3390/MOLECULES25184086 |
| 2020-09-07 |
Serological Responses to Human Virome Define Clinical Outcomes of Italian Patients Infected with SARS-CoV-2 (edit) |
10.1101/2020.09.04.20187088 |
| 2020-09-07 |
Community-Onset SARS-CoV-2 Infection in Young Infants: A Systematic Review (edit) |
10.1016/J.JPEDS.2020.09.008 |
| 2020-09-07 |
Performance of an automated chemiluminescence SARS-COV-2 IG-G Assay (edit) |
10.1016/J.CCA.2020.09.005 |
| 2020-09-07 |
Evaluation of Abbott Anti-SARS-CoV-2 CMIA IgG and Euroimmun ELISA IgG/IgA Assays In a Clinical Lab (edit) |
10.1016/J.CCA.2020.09.002 |
| 2020-09-07 |
Differentiating characteristics of asthmatic patients in the SARS-CoV2 infection (edit) |
10.1016/J.ANAI.2020.09.004 |
| 2020-09-07 |
Factors associated with asymptomatic infection in health-care workers with SARS-CoV-2 infection in Wuhan, China: a multi-center retrospective cohort study (edit) |
10.1016/J.CMI.2020.08.038 |
| 2020-09-07 |
Viral load of SARS-CoV-2 across patients and compared to other respiratory viruses (edit) |
10.1016/J.MICINF.2020.08.004 |
| 2020-09-07 |
Identification of the antithrombotic protein S as a potential target of the SARS-CoV-2 papain-like protease (edit) |
10.1016/J.THROMRES.2020.09.007 |
| 2020-09-07 |
SARS-CoV-2 recurrent RNA positivity after recovering from coronavirus disease 2019 (COVID-19): a meta-analysis (edit) |
10.23750/ABM.V91I3.10303 |
| 2020-09-07 |
The "perfect" storm: Current evidence on pediatric inflammatory multisystem disease during SARS-CoV-2 pandemic (edit) |
10.23750/ABM.V91I3.10360 |
| 2020-09-07 |
Sars-CoV-2 infection in patients with cystic fibrosis. An overwiew (edit) |
10.23750/ABM.V91I3.10391 |
| 2020-09-07 |
Possible modes of transmission of Novel coronavirus SARS-CoV-2: a review (edit) |
10.23750/ABM.V91I3.10039 |
| 2020-09-07 |
Novel Coronavirus (SARS-CoV-2) resistance in African populations: A cause worth exploring (edit) |
10.23750/ABM.V91I3.9872 |
| 2020-09-07 |
[Lung ultrasound in patients with SARS-CoV-2 infection] (edit) |
10.1007/S10049-020-00767-8 |
| 2020-09-07 |
Preliminary report of In vitro and In vivo Effectiveness of Dornase alfa on SARS-CoV-2 infection (edit) |
10.1016/J.NMNI.2020.100756 |
| 2020-09-07 |
Potential Treatment of Chinese and Western Medicine Targeting Nsp14 of SARS-CoV-2 (edit) |
10.1016/J.JPHA.2020.08.002 |
| 2020-09-07 |
Letter to the Editor: Increased plasma ACE2 concentration does not mean increased risk of SARS-CoV-2 infection and increased fatality rate of COVID-19 (edit) |
10.1016/J.APSB.2020.09.003 |
| 2020-09-07 |
Effects of SARS Cov-2 epidemic on the obstetrical and gynecological emergency service accesses. What happened and what shall we expect now? (edit) |
10.1016/J.EJOGRB.2020.09.006 |
| 2020-09-07 |
Comparison of eight commercial, high-throughput, automated or ELISA assays detecting SARS-CoV-2 IgG or total antibody (edit) |
10.1016/J.JCV.2020.104613 |
| 2020-09-06 |
SARS-CoV-2, A new causative agent of Guillain-Barré syndrome? (edit) |
10.1016/J.MEDIN.2020.08.009 |
| 2020-09-06 |
The Value of C-Reactive Protein-to-Lymphocyte Ratio in Predicting the Severity of SARS-CoV-2 Pneumonia (edit) |
10.1016/J.ARBRES.2020.07.038 |
| 2020-09-06 |
Enzyme-Linked Immunosorbent Assay for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) IgM/IgA and IgG Antibodies Among Healthcare Workers (edit) |
10.7759/CUREUS.10285 |
| 2020-09-06 |
Supra and infratentorial massive strokes in previously healthy young patients with SARS-CoV-2. The role of neurosurgery (edit) |
10.1016/J.NEUCIR.2020.08.001 |
| 2020-09-06 |
Anesthetic planning and management for a caesarian section in a pregnant woman affected by SARS-COV-2 pneumonía (edit) |
10.1016/J.REDAR.2020.08.006 |
| 2020-09-06 |
Oromucosal immunomodulation as clinical spectrum mitigating factor in SARS-CoV-2 infection (edit) |
10.1111/SJI.12972 |
| 2020-09-06 |
Implications of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic for sexual behaviours of men who have sex with men (edit) |
10.1111/HIV.12954 |
| 2020-09-06 |
Platelets and renal failure in the SARS-CoV-2 syndrome (edit) |
10.1080/09537104.2020.1817361 |
| 2020-09-06 |
The inorganic polymer, polyphosphate, blocks binding of SARS-CoV-2 spike protein to ACE2 receptor at physiological concentrations (edit) |
10.1016/J.BCP.2020.114215 |
| 2020-09-06 |
Interim analysis of the Clinical performance of five SARS-Cov-2 Serology Assays (edit) |
10.1016/J.CLINBIOCHEM.2020.09.002 |
| 2020-09-06 |
Detection of SARS-CoV-2 in nasopharynx according to clinical phenotype of affected patients (edit) |
10.1016/J.CMI.2020.08.041 |
| 2020-09-06 |
Using multiple data streams to estimate and forecast SARS-CoV-2 transmission dynamics, with application to the virus spread in Orange County, California (edit) |
|
| 2020-09-06 |
COVID-19 in a Patient with End-Stage Renal Disease on Chronic in-Center Hemodialysis after Evidence of SARS-CoV-2 IgG Antibodies. Reinfection or Inaccuracy of Antibody Testing (edit) |
10.1016/J.IDCR.2020.E00943 |
| 2020-09-06 |
Quantitative assessment of the risk of airborne transmission of SARS-CoV-2 infection: Prospective and retrospective applications (edit) |
10.1016/J.ENVINT.2020.106112 |
| 2020-09-06 |
Activation of the SARS-CoV-2 Receptor Ace2 through JAK/STAT-Dependent Enhancers during Pregnancy (edit) |
10.1016/J.CELREP.2020.108199 |
| 2020-09-06 |
Molecular Architecture of the SARS-CoV-2 Virus (edit) |
10.1016/J.CELL.2020.09.018 |
| 2020-09-05 |
Current pharmacological treatments for SARS-COV-2: A narrative review (edit) |
10.1016/J.EJPHAR.2020.173328 |
| 2020-09-05 |
Symptomatic SARS-CoV-2 reinfection by a phylogenetically distinct strain (edit) |
10.1093/CID/CIAA1330 |
| 2020-09-05 |
Characteristics and predictors of hospitalization and death in the first 11 122 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: a nationwide cohort (edit) |
10.1093/IJE/DYAA140 |
| 2020-09-05 |
Immunosenescence and SARS-CoV-2 Vaccine Development (edit) |
10.1093/INFDIS/JIAA564 |
| 2020-09-05 |
SARS-CoV-2 RNA in plasma is associated with ICU admission and mortality in patients hospitalized with COVID-19 (edit) |
10.1093/CID/CIAA1338 |
| 2020-09-05 |
A Possible Case of Vertical Transmission of SARS-CoV-2 in a Newborn with Positive Placental In Situ Hybridization of SARS-CoV-2 RNA (edit) |
10.1093/JPIDS/PIAA109 |
| 2020-09-05 |
A study of universal SARS-CoV-2 RNA testing of residents and staff in a large group of care homes in South London (edit) |
10.1093/INFDIS/JIAA565 |
| 2020-09-05 |
SARS-CoV-2 respiratory viral loads and association with clinical and biological features (edit) |
10.1002/JMV.26489 |
| 2020-09-05 |
Tongue Ulcers Associated with SARS-COV-2 Infection: A case-series (edit) |
10.1111/ODI.13635 |
| 2020-09-05 |
Mathematical models for devising the optimal SARS-CoV-2 strategy for eradication in China, South Korea, and Italy (edit) |
10.1186/S12967-020-02513-7 |
| 2020-09-05 |
Lessons for the clinical nephrologist: recurrence of nephrotic syndrome induced by SARS-CoV-2 (edit) |
10.1007/S40620-020-00855-5 |
| 2020-09-05 |
Impact of SARS-CoV-2 pandemic on colorectal cancer screening delay: effect on stage shift and increased mortality (edit) |
10.1016/J.CGH.2020.09.008 |
| 2020-09-05 |
The kinetics of viral load and antibodiesto SARS-CoV-2 (edit) |
10.1016/J.CMI.2020.08.043 |
| 2020-09-05 |
Evaluation of Mental Health Factors among People with Systemic Lupus Erythematosus during the SARS-CoV-2 Pandemic (edit) |
10.3390/JCM9092872 |
| 2020-09-05 |
Attenuated Influenza Virions Expressing the SARS-CoV-2 Receptor-Binding Domain Induce Neutralizing Antibodies in Mice (edit) |
10.3390/V12090987 |
| 2020-09-05 |
Switched and unswitched memory B cells detected during SARS-CoV-2 convalescence correlate with limited symptom duration (edit) |
10.1101/2020.09.04.20187724 |
| 2020-09-05 |
SARS-CoV-2-specific IgA and limited inflammatory cytokines are present in the stool of select patients with acute COVID-19 (edit) |
10.1101/2020.09.03.20183947 |
| 2020-09-05 |
Site mapping and small molecule blind docking reveal a possible target site on the SARS-CoV-2 main protease dimer interface (edit) |
10.1016/J.COMPBIOLCHEM.2020.107372 |
| 2020-09-05 |
Etablierung der PCR-basierten SARS-CoV-2-Testung im Hochdurchsatz (edit) |
10.1007/S12268-020-1431-1 |
| 2020-09-04 |
Neurological Aspects of SARS-CoV-2 Infection: Mechanisms and Manifestations (edit) |
10.3389/FNEUR.2020.01039 |
| 2020-09-04 |
Variations in SARS-CoV-2 Spike Protein Cell Epitopes and Glycosylation Profiles During Global Transmission Course of COVID-19 (edit) |
10.3389/FIMMU.2020.565278 |
| 2020-09-04 |
Serum SARS-COV-2 Nucleocapsid Protein: A Sensitivity and Specificity Early Diagnostic Marker for SARS-COV-2 Infection (edit) |
10.3389/FCIMB.2020.00470 |
| 2020-09-04 |
How to Early Identify and Prevent the SARS-CoV-2 Infection in Children for Families? (edit) |
10.3389/FPED.2020.00542 |
| 2020-09-04 |
Selenium and RNA Virus Interactions: Potential Implications for SARS-CoV-2 Infection (COVID-19) (edit) |
10.3389/FNUT.2020.00164 |
| 2020-09-04 |
Defensin 5 for prevention of SARS-CoV-2 invasion and Covid-19 disease (edit) |
10.1016/J.MEHY.2020.110244 |
| 2020-09-04 |
SARS-CoV-2 pandemic: implications in the management of patients with colorectal cancer (edit) |
|
| 2020-09-04 |
Identification of SARS-CoV-2 3CL Protease Inhibitors by a Quantitative High-Throughput Screening (edit) |
10.1021/ACSPTSCI.0C00108 |
| 2020-09-04 |
Effectiveness of non-invasive ventilation in intensive care unit admitted patients due to SARS-CoV-2 pneumonia (edit) |
10.1016/J.MEDIN.2020.08.011 |
| 2020-09-04 |
A SARS-CoV-2 – host proximity interactome (edit) |
10.1101/2020.09.03.282103 |
| 2020-09-04 |
SARS-CoV-2 and miRNA-like inhibition power (edit) |
10.1016/J.MEHY.2020.110245 |
| 2020-09-04 |
Multimerization- and glycosylation-dependent receptor binding of SARS-CoV-2 spike proteins (edit) |
10.1101/2020.09.04.282558 |
| 2020-09-04 |
Preventing and Mitigating SARS-CoV-2 Transmission - Four Overnight Camps, Maine, June-August 2020 (edit) |
10.15585/MMWR.MM6935E1 |
| 2020-09-04 |
Seroprevalence of SARS-CoV-2 Among Frontline Health Care Personnel in a Multistate Hospital Network - 13 Academic Medical Centers, April-June 2020 (edit) |
10.15585/MMWR.MM6935E2 |
| 2020-09-04 |
Evaluation of three commercial assays for SARS-CoV-2 molecular detection in upper respiratory tract samples (edit) |
10.1007/S10096-020-04025-0 |
| 2020-09-04 |
Identification of promising antiviral drug candidates against non-structural protein 15 (NSP15) from SARS-CoV-2: an in silico assisted drug-repurposing study (edit) |
10.1080/07391102.2020.1814870 |
| 2020-09-04 |
Convalescent plasma for pediatric patients with SARS-CoV-2-associated acute respiratory distress syndrome (edit) |
10.1002/PBC.28693 |
| 2020-09-04 |
The Answer Lies in the Energy: How Simple Atomistic Molecular Dynamics Simulations may Hold the Key to Epitope Prediction on the Fully Glycosylated SARS-CoV-2 Spike Protein (edit) |
10.1021/ACS.JPCLETT.0C02341 |
| 2020-09-04 |
[Does SARS-CoV-2 cause lung inflammation even in mild clinical courses? : A multicenter report from outpatient care] (edit) |
10.1007/S00117-020-00746-7 |
| 2020-09-04 |
Strategic Anti-SARS-CoV-2 Serology Testing in a Low Prevalence Setting: The COVID-19 Contact (CoCo) Study in Healthcare Professionals (edit) |
10.1007/S40121-020-00334-1 |
| 2020-09-04 |
Attitudes Toward a Potential SARS-CoV-2 Vaccine: A Survey of U.S. Adults (edit) |
10.7326/M20-3569 |
| 2020-09-04 |
SARS-CoV-2 Vaccine Acceptance: We May Need to Choose Our Battles (edit) |
10.7326/M20-6206 |
| 2020-09-04 |
Can SARS-CoV-2 cause life-threatening bronchiolitis in infants? (edit) |
10.1002/PPUL.25030 |
| 2020-09-04 |
SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19 (edit) |
10.1186/S13045-020-00954-7 |
| 2020-09-04 |
The effect of coronavirus infection (SARS-CoV-2, MERS-CoV, and SARS-CoV) during pregnancy and the possibility of vertical maternal-fetal transmission: a systematic review and meta-analysis (edit) |
10.1186/S40001-020-00439-W |
| 2020-09-04 |
An Early Pandemic Analysis of SARS-CoV-2 Population Structure and Dynamics in Arizona (edit) |
10.1128/MBIO.02107-20 |
| 2020-09-04 |
Antibody Responses to SARS-CoV-2: Let's Stick to Known Knowns (edit) |
10.4049/JIMMUNOL.2000839 |
| 2020-09-04 |
Endemic Non2013SARS-CoV-2 Human Coronaviruses in a Community-Based Australian Birth Cohort (edit) |
10.1542/PEDS.2020-009316 |
| 2020-09-04 |
An alpaca nanobody neutralizes SARS-CoV-2 by blocking receptor interaction (edit) |
10.1038/S41467-020-18174-5 |
| 2020-09-04 |
Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease (edit) |
10.1038/S41467-020-18233-X |
| 2020-09-04 |
Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19 (edit) |
10.1038/S41590-020-0782-6 |
| 2020-09-04 |
Multisystem inflammatory syndrome in an adult with SARS-CoV-2 infection (edit) |
10.1093/EHJCI/JEAA232 |
| 2020-09-04 |
GC usage of SARS-CoV-2 genes might adapt to the environment of human lung expressed genes (edit) |
10.1007/S00438-020-01719-0 |
| 2020-09-04 |
Outpatient management or hospitalization of patients with proven or suspected SARS-CoV-2 infection: the HOME-CoV rule (edit) |
10.1007/S11739-020-02483-0 |
| 2020-09-04 |
The Epistemology of a Positive SARS-CoV-2 Test (edit) |
10.1007/S10441-020-09393-W |
| 2020-09-04 |
SARS-CoV-2 infection, oxidative stress and male reproductive hormones: can testicular-adrenal crosstalk be ruled-out? (edit) |
10.1515/JBCPP-2020-0205 |
| 2020-09-04 |
Evaluation of SARS-CoV-2 3C-like protease inhibitors using self-assembled monolayer desorption ionization mass spectrometry (edit) |
10.1016/J.ANTIVIRAL.2020.104924 |
| 2020-09-04 |
Challenges in Diagnosing Multisystem Inflammatory Syndrome Related to SARS-CoV-2 in a Child With Severe Neurocognitive Impairment and Social Isolation (edit) |
10.1097/RHU.0000000000001619 |
| 2020-09-04 |
MIS-C After ARDS Associated With SARS-COV-2 (edit) |
10.1097/INF.0000000000002879 |
| 2020-09-04 |
SARS-CoV-2 Infection Induces a Dual Response in Liver Function Tests: Association with Mortality during Hospitalization (edit) |
10.3390/BIOMEDICINES8090328 |
| 2020-09-04 |
Testing for SARS-CoV-2 (COVID-19): A General Review (edit) |
|
| 2020-09-04 |
SARS-CoV-2 in Environment Perspective: Occurrence, Persistence, Surveillance, Inactivation and Challenges (edit) |
10.1016/J.CEJ.2020.126893 |
| 2020-09-04 |
A case of corticosteroid-responsive SARS-CoV-2 related massive rhabdomyolysis (edit) |
10.1016/J.IDCR.2020.E00946 |
| 2020-09-04 |
Tracking the onset date of the community spread of SARS-CoV-2 in western countries (edit) |
10.1590/0074-02760200183 |
| 2020-09-04 |
SARS-CoV-2 infections with emphasis on pediatric patients: a narrative review (edit) |
10.1590/S1678-9946202062065 |
| 2020-09-04 |
Improvements to the ARTIC multiplex PCR method for SARS-CoV-2 genome sequencing using nanopore (edit) |
10.1101/2020.09.04.283077 |
| 2020-09-04 |
Monoclonal Antibodies Capable of Binding SARS-CoV-2 Spike Protein Receptor Binding Motif Specifically Prevent GM-CSF Induction (edit) |
10.1101/2020.09.04.280081 |
| 2020-09-04 |
[Erratum to: Histopathological findings following SARS-CoV-2 infection with and without treatment-Report of three autopsies] (edit) |
10.1007/S00194-020-00409-W |
| 2020-09-04 |
An immunoinformatics study on the spike protein of SARS-CoV-2 revealing potential epitopes as vaccine candidates (edit) |
10.1016/J.HELIYON.2020.E04865 |
| 2020-09-04 |
Comparison of SARS-CoV-2 detection from combined nasopharyngeal/oropharyngeal swab samples by a laboratory-developed real-time RT-PCR test and the Roche SARS-CoV-2 assay on a cobas 8800 instrument (edit) |
10.1016/J.JCV.2020.104615 |
| 2020-09-04 |
SARS-CoV-2 ORF3b Is a Potent Interferon Antagonist Whose Activity Is Increased by a Naturally Occurring Elongation Variant (edit) |
10.1016/J.CELREP.2020.108185 |
| 2020-09-04 |
High Potency of a Bivalent Human VH Domain in SARS-CoV-2 Animal Models (edit) |
10.1016/J.CELL.2020.09.007 |
| 2020-09-04 |
Impact of glycan cloud on the B-cell epitope prediction of SARS-CoV-2 Spike protein (edit) |
10.1038/S41541-020-00237-9 |
| 2020-09-04 |
Bell's palsy in a pediatric patient with hyper IgM syndrome and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (edit) |
10.1016/J.BRAINDEV.2020.08.017 |
| 2020-09-04 |
Lung Ultrasound Before and After SARS-CoV-2 (edit) |
10.1016/J.ARBRES.2020.07.040 |
| 2020-09-03 |
Comparative study of four SARS-CoV-2 Nucleic Acid Amplification Test (NAAT) platforms demonstrates that ID NOW performance is impaired substantially by patient and specimen type (edit) |
10.1016/J.DIAGMICROBIO.2020.115200 |
| 2020-09-03 |
Comprehensive Genome Analysis of 6,000 USA SARS-CoV-2 Isolates Reveals Haplotype Signatures and Localized Transmission Patterns by State and by Country (edit) |
10.3389/FMICB.2020.573430 |
| 2020-09-03 |
Identification of Novel Candidate Epitopes on SARS-CoV-2 Proteins for South America: A Review of HLA Frequencies by Country (edit) |
10.3389/FIMMU.2020.02008 |
| 2020-09-03 |
Machine learning techniques for sequence-based prediction of viral-host interactions between SARS-CoV-2 and human proteins (edit) |
10.1016/J.BJ.2020.08.003 |
| 2020-09-03 |
Recommendations for acting in elective and urgent thoracic surgery during SARS-CoV-2 pandemic. Spanish Society of Thoracic Surgery (edit) |
10.1016/J.CIRESP.2020.08.005 |
| 2020-09-03 |
A role of glycation and methylation for SARS-CoV-2 infection in diabetes? (edit) |
10.1016/J.MEHY.2020.110247 |
| 2020-09-03 |
Coronavirus RNA Proofreading: Molecular Basis and Therapeutic Targeting (edit) |
10.1016/J.MOLCEL.2020.07.027 |
| 2020-09-03 |
SARS-CoV-2 transmission, the ambiguous role of children and considerations for the reopening of schools in the fall (edit) |
10.2217/FMB-2020-0195 |
| 2020-09-03 |
SARS-CoV-2 Pandemic: Should Children Wear Masks? (edit) |
10.20344/AMP.14787 |
| 2020-09-03 |
Acute kidney injury in patients with SARS-CoV-2 infection (edit) |
10.1186/S13613-020-00734-Z |
| 2020-09-03 |
Questions concerning the proximal origin of SARS-CoV-2 (edit) |
10.1002/JMV.26478 |
| 2020-09-03 |
Short-term inhibition of SARS-CoV-2 by hydrogen peroxide in persistent nasopharyngeal carriers (edit) |
10.1002/JMV.26485 |
| 2020-09-03 |
Fatal stroke as presentation of SARS-CoV-2 and dengue virus coinfection (edit) |
10.1002/JMV.26476 |
| 2020-09-03 |
A comparative study on the clinical features of COVID-19 with non-SARS-CoV-2 respiratory viral infections (edit) |
10.1002/JMV.26486 |
| 2020-09-03 |
Current perspective on diagnosis, epidemiological assessment, prevention strategies, and potential therapeutic interventions for severe acute respiratory infections caused by 2019 novel coronavirus (SARS-CoV-2) (edit) |
10.1080/21645515.2020.1794684 |
| 2020-09-03 |
Risk factors associated with mortality in hospitalized patients with SARS-CoV-2 infection. A prospective, longitudinal, unicenter study in Reus, Spain (edit) |
10.1371/JOURNAL.PONE.0234452 |
| 2020-09-03 |
Comparative genome analysis of novel coronavirus (SARS-CoV-2) from different geographical locations and the effect of mutations on major target proteins: An in silico insight (edit) |
10.1371/JOURNAL.PONE.0238344 |
| 2020-09-03 |
Possibility for reverse zoonotic transmission of SARS-CoV-2 to free-ranging wildlife: A case study of bats (edit) |
10.1371/JOURNAL.PPAT.1008758 |
| 2020-09-03 |
Oral mucosal lesions in patients with SARS-CoV-2 infection. Report of four cases. Are they a true sign of COVID-19 disease? (edit) |
10.1111/SCD.12520 |
| 2020-09-03 |
Cutaneous Lesions and COVID-19: Cystic Painful Lesion in a Case with Positive SARS-CoV-2 (edit) |
10.1111/DTH.14266 |
| 2020-09-03 |
Does Chronic Treatment with Oral Anticoagulants Ameliorate the Clinical Course of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Coronavirus Disease 2019 (COVID-19)? (edit) |
10.1055/S-0040-1715091 |
| 2020-09-03 |
Effect of serum total testosterone and its relationship with other laboratory parameters on the prognosis of coronavirus disease 2019 (COVID-19) in SARS-CoV-2 infected male patients: a cohort study (edit) |
10.1080/13685538.2020.1807930 |
| 2020-09-03 |
A protein interaction map identifies existing drugs targeting SARS-CoV-2 (edit) |
10.1186/S40360-020-00444-Z |
| 2020-09-03 |
Are we underestimating seroprevalence of SARS-CoV-2? (edit) |
10.1136/BMJ.M3364 |
| 2020-09-03 |
Does Chemotherapy Reactivate SARS-CoV-2 in Cancer Patients Recovered from Prior COVID-19 Infection? (edit) |
10.1183/13993003.02672-2020 |
| 2020-09-03 |
A Direct Comparison of Enhanced Saliva to Nasopharyngeal Swab for the Detection of SARS-CoV-2 in Symptomatic Patients (edit) |
10.1128/JCM.01946-20 |
| 2020-09-03 |
A blueprint for academic labs to produce SARS-CoV-2 RT-qPCR test kits (edit) |
10.1074/JBC.RA120.015434 |
| 2020-09-03 |
Profiling and characterization of SARS-CoV-2 mutants' infectivity and antigenicity (edit) |
10.1038/S41392-020-00302-8 |
| 2020-09-03 |
COVID-19-activated SREBP2 disturbs cholesterol biosynthesis and leads to cytokine storm (edit) |
10.1038/S41392-020-00292-7 |
| 2020-09-03 |
Publisher Correction: SARS-CoV-2 and the brain to be studied long-term (edit) |
10.1038/S41582-020-0407-6 |
| 2020-09-03 |
Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters (edit) |
10.1038/S41591-020-1070-6 |
| 2020-09-03 |
Empiric therapeutic anticoagulation and mortality in critically ill patients with respiratory failure from SARS-CoV-2: A retrospective cohort study (edit) |
10.1002/JCPH.1749 |
| 2020-09-03 |
Site-specific characterisation of SARS-CoV-2 spike glycoprotein receptor binding domain (edit) |
10.1093/GLYCOB/CWAA085 |
| 2020-09-03 |
MicroRNAs targeting the SARS-CoV-2 entry receptor ACE2 in cardiomyocytes (edit) |
10.1016/J.YJMCC.2020.08.017 |
| 2020-09-03 |
Rapid, convenient and efficient kit-independent detection of SARS-CoV-2 RNA (edit) |
10.1016/J.JVIROMET.2020.113965 |
| 2020-09-03 |
Aerosol transmission of SARS-CoV-2: The unresolved paradox (edit) |
10.1016/J.TMAID.2020.101869 |
| 2020-09-03 |
The Effect of Ultraviolet C Radiation Against Different N95 Respirators Inoculated with SARS-CoV-2 (edit) |
10.1016/J.IJID.2020.08.077 |
| 2020-09-03 |
Implications of the Novel Corona Virus SARS-CoV-2 on Vascular Surgery Practices (edit) |
10.1016/J.JVS.2020.08.118 |
| 2020-09-03 |
Improved binding of SARS-CoV-2 Envelope protein to tight junction-associated PALS1 could play a key role in COVID-19 pathogenesis (edit) |
10.1016/J.MICINF.2020.08.006 |
| 2020-09-03 |
Integrative Network Biology Framework Elucidates Molecular Mechanisms of SARS-CoV-2 Pathogenesis (edit) |
10.1016/J.ISCI.2020.101526 |
| 2020-09-03 |
The HMOX1 Pathway as a Promising Target for the Treatment and Prevention of SARS-CoV-2 of 2019 (COVID-19) (edit) |
10.3390/IJMS21176412 |
| 2020-09-03 |
Immunization with the receptor-binding domain of SARS-CoV-2 elicits antibodies cross-neutralizing SARS-CoV-2 and SARS-CoV without antibody-dependent enhancement (edit) |
10.1038/S41421-020-00199-1 |
| 2020-09-03 |
Can disinfection robots reduce the risk of transmission of SARS-CoV-2 in healthcare and educational settings? (edit) |
10.2196/20896 |
| 2020-09-03 |
SARS-CoV-2 and pulmonary embolism: who stole the platelets? (edit) |
10.1186/S12959-020-00229-8 |
| 2020-09-03 |
Development of SARS-CoV-2 Nucleocapsid Specific Monoclonal Antibodies (edit) |
10.1101/2020.09.03.280370 |
| 2020-09-03 |
Digital droplet PCR accurately quantifies SARS-CoV-2 viral load from crude lysate without nucleic acid purification (edit) |
10.1101/2020.09.02.20186023 |
| 2020-09-03 |
Pooling saliva to increase SARS-CoV-2 testing capacity (edit) |
10.1101/2020.09.02.20183830 |
| 2020-09-03 |
Rapid 'mix and read' assay for scalable detection of SARS-CoV-2 antibodies in patient plasma (edit) |
10.1101/2020.09.01.20184101 |
| 2020-09-03 |
Swab-Seq: A high-throughput platform for massively scaled up SARS-CoV-2 testing (edit) |
10.1101/2020.08.04.20167874 |
| 2020-09-03 |
Quantitative microbial risk assessment of SARS-CoV-2 for workers in wastewater treatment plants (edit) |
10.1016/J.SCITOTENV.2020.142163 |
| 2020-09-03 |
Detection of antibodies against SARS-CoV-2 spike protein by gold nanospikes in an opto-microfluidic chip (edit) |
10.1016/J.BIOS.2020.112578 |
| 2020-09-03 |
Silico analysis of interaction between full-length SARS-CoV2 S protein with human Ace2 receptor: Modelling, docking, MD simulation (edit) |
10.1016/J.BPC.2020.106472 |
| 2020-09-03 |
Beyond COVID-19: DO MS/NMO-SD patients treated with anti-CD20 therapies develop SARS-CoV2 antibodies? (edit) |
10.1016/J.MSARD.2020.102482 |
| 2020-09-03 |
Rapid and quantitative detection of SARS-CoV-2 specific IgG for convalescent serum evaluation (edit) |
10.1016/J.BIOS.2020.112572 |
| 2020-09-03 |
Performance evaluation of two SARS-CoV-2 IgG/IgM rapid tests (Covid-Presto and NG-Test) and one IgG automated immunoassay (Abbott) (edit) |
10.1016/J.JCV.2020.104618 |
| 2020-09-03 |
Pooled Testing for Surveillance of SARS-CoV-2 in Asymptomatic Individuals (edit) |
10.1016/J.JCV.2020.104619 |
| 2020-09-03 |
Sequential SARS-CoV-2 IgG assays as confirmatory strategy to confirm equivocal results: Hospital-wide antibody screening in 3,569 staff health care workers in Paris (edit) |
10.1016/J.JCV.2020.104617 |
| 2020-09-03 |
CoV-Seq: SARS-CoV-2 Genome Analysis and Visualization (edit) |
10.2196/22299 |
| 2020-09-03 |
Human B Cell Clonal Expansion and Convergent Antibody Responses to SARS-CoV-2 (edit) |
10.1016/J.CHOM.2020.09.002 |
| 2020-09-03 |
Identification of phytochemicals as potential therapeutic agents that binds to Nsp15 protein target of coronavirus (SARS-CoV-2) that are capable of inhibiting virus replication (edit) |
10.1016/J.PHYMED.2020.153317 |
| 2020-09-03 |
Oral disease-modifying antirheumatic drugs and immunosuppressants with antiviral potential, including SARS-CoV-2 infection: a review (edit) |
10.1177/1759720X20947296 |
| 2020-09-03 |
Collaborative networks enable the rapid establishment of serological assays for SARS-CoV-2 during nationwide lockdown in New Zealand (edit) |
10.7717/PEERJ.9863 |
| 2020-09-03 |
Turning the threat of SARS-CoV-2 crisis into an opportunity for a better lifestyle in adolescents with polycystic ovary syndrome (edit) |
10.1016/J.PEDN.2020.09.001 |
| 2020-09-02 |
Tyrosine Kinase Inhibitors Play an Antiviral Action in Patients Affected by Chronic Myeloid Leukemia: A Possible Model Supporting Their Use in the Fight Against SARS-CoV-2 (edit) |
10.3389/FONC.2020.01428 |
| 2020-09-02 |
Association of acute kidney injury with the severity and mortality of SARS-CoV-2 infection: A meta-analysis (edit) |
10.1016/J.AJEM.2020.08.089 |
| 2020-09-02 |
SARS-CoV-2 Bound Human Serum Albumin and Systemic Septic Shock (edit) |
10.3389/FCVM.2020.00153 |
| 2020-09-02 |
Ketonuria with or without ketoacidosis as the presenting manifestation of SARS-CoV-2 (COVID-19) among uncontrolled type 2 diabetic patients (edit) |
10.1016/J.MEHY.2020.110226 |
| 2020-09-02 |
Red blood cell exchange for SARS-CoV-2: A Gemini of therapeutic opportunities (edit) |
10.1016/J.MEHY.2020.110227 |
| 2020-09-02 |
Premises among SARS-CoV-2, dysbiosis and diarrhea: Walking through the ACE2/mTOR/autophagy route (edit) |
10.1016/J.MEHY.2020.110243 |
| 2020-09-02 |
SARS CoV-2 PLpro in complex with GRL0617 (edit) |
10.2210/PDB7CJM/PDB |
| 2020-09-02 |
SARS-CoV-2: The Increasing Importance of Water Filtration against Highly Pathogenic Microbes (edit) |
10.1021/ACSCHEMNEURO.0C00468 |
| 2020-09-02 |
iPSCs-Derived Platform: A Feasible Tool for Probing the Neurotropism of SARS-CoV-2 (edit) |
10.1021/ACSCHEMNEURO.0C00512 |
| 2020-09-02 |
Potential inhibitors of SARS-cov-2 RNA dependent RNA polymerase protein: molecular docking, molecular dynamics simulations and MM-PBSA analyses (edit) |
10.1080/07391102.2020.1813628 |
| 2020-09-02 |
Repurposing simeprevir, calpain inhibitor IV and a cathepsin F inhibitor against SARS-CoV-2 and insights into their interactions with Mpro (edit) |
10.1080/07391102.2020.1813200 |
| 2020-09-02 |
Risk factors for SARS-CoV-2 detection in blood of critically ill patients (edit) |
10.1093/CID/CIAA1315 |
| 2020-09-02 |
Leveraging mRNA Sequences and Nanoparticles to Deliver SARS-CoV-2 Antigens In Vivo (edit) |
10.1002/ADMA.202004452 |
| 2020-09-02 |
Potential use of noncoding RNAs and innovative therapeutic strategies to target the 5'UTR of SARS-CoV-2 (edit) |
10.2217/EPI-2020-0162 |
| 2020-09-02 |
Proposing a fungal metabolite-flaviolin as a potential inhibitor of 3CLpro of novel coronavirus SARS-CoV-2 identified using docking and molecular dynamics (edit) |
10.1080/07391102.2020.1813202 |
| 2020-09-02 |
Peritoneal dialysis for treatment of acute kidney injury in a case of paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (edit) |
10.1177/0896860820953716 |
| 2020-09-02 |
SARS-CoV-2 targets neurons of 3D human brain organoids (edit) |
10.15252/EMBJ.2020106230 |
| 2020-09-02 |
Host genetic factors and susceptibility to SARS-CoV-2 infection (edit) |
10.1002/AJHB.23497 |
| 2020-09-02 |
A prospective clinical pilot study on the effects of a hydrogen peroxide mouthrinse on the intraoral viral load of SARS-CoV-2 (edit) |
10.1007/S00784-020-03549-1 |
| 2020-09-02 |
Enhanced contact investigations for nine early travel-related cases of SARS-CoV-2 in the United States (edit) |
10.1371/JOURNAL.PONE.0238342 |
| 2020-09-02 |
Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition (edit) |
10.1182/BLOOD.2020008248 |
| 2020-09-02 |
Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine (edit) |
10.1056/NEJMOA2026920 |
| 2020-09-02 |
Rapid real-time tracking of non-pharmaceutical interventions and their association with SARS-CoV-2 positivity: The COVID-19 Pandemic Pulse Study (edit) |
10.1093/CID/CIAA1313 |
| 2020-09-02 |
SARS-CoV-2 surveillance in decedents in a large, urban medical examiner's office (edit) |
10.1093/CID/CIAA1312 |
| 2020-09-02 |
Elevated FiO2 increases SARS-CoV-2 co‑receptor expression in respiratory tract epithelium (edit) |
10.1152/AJPLUNG.00345.2020 |
| 2020-09-02 |
Systemic innate and adaptive immune responses to SARS-CoV-2 as it relates to other coronaviruses (edit) |
10.1080/21645515.2020.1802974 |
| 2020-09-02 |
SARS-CoV-2/COVID-19 and advances in developing potential therapeutics and vaccines to counter this emerging pandemic (edit) |
10.1186/S12941-020-00384-W |
| 2020-09-02 |
Temporal profile and determinants of viral shedding and of viral clearance confirmation on nasopharyngeal swabs from SARS-CoV-2-positive subjects: a population-based prospective cohort study in Reggio Emilia, Italy (edit) |
10.1136/BMJOPEN-2020-040380 |
| 2020-09-02 |
Denovo designing, retrosynthetic analysis, and combinatorial synthesis of a hybrid antiviral (VTAR-01) to inhibit the interaction of SARS-CoV2 spike glycoprotein with human angiotensin-converting enzyme 2 (edit) |
10.1242/BIO.054056 |
| 2020-09-02 |
Expansion of SARS-CoV-2-Specific Antibody-Secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients (edit) |
10.4049/JIMMUNOL.2000717 |
| 2020-09-02 |
Evolution of Early SARS-CoV-2 and Cross-Coronavirus Immunity (edit) |
10.1128/MSPHERE.00622-20 |
| 2020-09-02 |
A Simplified Quantitative Real-Time PCR Assay for Monitoring SARS-CoV-2 Growth in Cell Culture (edit) |
10.1128/MSPHERE.00658-20 |
| 2020-09-02 |
Mapping genome variation of SARS-CoV-2 worldwide highlights the impact of COVID-19 super-spreaders (edit) |
10.1101/GR.266221.120 |
| 2020-09-02 |
Descriptive account of 18 adults with known HIV infection hospitalised with SARS-CoV-2 infection (edit) |
10.1136/SEXTRANS-2020-054660 |
| 2020-09-02 |
Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C) (edit) |
10.1542/PEDS.2020-018242 |
| 2020-09-02 |
Ocular conjunctival inoculation of SARS-CoV-2 can cause mild COVID-19 in rhesus macaques (edit) |
10.1038/S41467-020-18149-6 |
| 2020-09-02 |
Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19 (edit) |
10.1038/S41392-020-00301-9 |
| 2020-09-02 |
Autoantibody-negative insulin-dependent diabetes mellitus after SARS-CoV-2 infection: a case report (edit) |
10.1038/S42255-020-00281-8 |
| 2020-09-02 |
Publisher Correction: SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function (edit) |
10.1038/S41590-020-0794-2 |
| 2020-09-02 |
Discovery of Some Antiviral Natural products to fight against Novel Corona Virus (SARS-CoV-2) using Insilico approach (edit) |
10.2174/1386207323666200902135928 |
| 2020-09-02 |
SARS-CoV-2 infection and COVID-19: The lived experience and perceptions of patients in isolation and care in an Australian healthcare setting (edit) |
10.1016/J.AJIC.2020.08.032 |
| 2020-09-02 |
Evolutionary dynamics of the SARS-CoV-2 ORF8 accessory gene (edit) |
10.1016/J.MEEGID.2020.104525 |
| 2020-09-02 |
Kinetics of viral clearance and antibody production across age groups in SARS-CoV-2 infected children (edit) |
10.1016/J.JPEDS.2020.08.078 |
| 2020-09-02 |
Crystal structure of SARS-CoV-2 papain-like protease (edit) |
10.1016/J.APSB.2020.08.014 |
| 2020-09-02 |
Occurrence, fates and potential treatment approaches for removal of viruses from wastewater: A review with emphasis on SARS-CoV-2 (edit) |
10.1016/J.JECE.2020.104429 |
| 2020-09-02 |
Genomic characterization of SARS-CoV-2 identified in a reemerging COVID-19 outbreak in Beijing's Xinfadi market in 2020 (edit) |
10.1016/J.BSHEAL.2020.08.006 |
| 2020-09-02 |
Acute Meningoencephalitis as Initial Presentation of SARS-CoV-2 Infection in Pediatrics (edit) |
10.1097/INF.0000000000002885 |
| 2020-09-02 |
Spike mutation D614G alters SARS-CoV-2 fitness and neutralization susceptibility (edit) |
10.1101/2020.09.01.278689 |
| 2020-09-02 |
An intestinal cell type in zebrafish is the nexus for the SARS-CoV-2 receptor and the Renin-Angiotensin-Aldosterone System that contributes to COVID-19 comorbidities (edit) |
10.1101/2020.09.01.278366 |
| 2020-09-02 |
Comparative performance of five commercially available serologic assays to detect antibodies to SARS-CoV-2 and identify individuals with high neutralizing titers (edit) |
10.1101/2020.08.31.20184788 |
| 2020-09-02 |
Immune transcriptomes of highly exposed SARS-CoV-2 asymptomatic seropositive versus seronegative individuals from the Ischgl community (edit) |
10.1101/2020.09.01.20185884 |
| 2020-09-02 |
Determinants of SARS-CoV-2 receptor gene expression in upper and lower airways (edit) |
10.1101/2020.08.31.20169946 |
| 2020-09-02 |
Targeting the SARS-CoV-2 main protease using FDA-approved Isavuconazonium, a P2-P3 α-ketoamide derivative and Pentagastrin: An in-silico drug discovery approach (edit) |
10.1016/J.JMGM.2020.107730 |
| 2020-09-02 |
COVID-19 and Microvascular Disease: Pathophysiology of SARS-CoV-2 Infection With Focus on the Renin-Angiotensin System (edit) |
10.1016/J.HLC.2020.08.010 |
| 2020-09-01 |
Management of the emergency response to the SARS-CoV-2 (COVID-19) outbreak in Stockholm, Sweden, and winter preparations (edit) |
10.1071/HC20082 |
| 2020-09-01 |
Levels of anxiety and depression among emergency physicians in Madrid during the SARS-CoV-2 pandemic (edit) |
|
| 2020-09-01 |
Enhancing sensitivity of lateral flow assay with application to SARS-CoV-2 (edit) |
10.1063/5.0021842 |
| 2020-09-01 |
Melanie Saville: the end-to-end process needed for a SARS-CoV-2 vaccine (edit) |
10.2471/BLT.20.030920 |
| 2020-09-01 |
Italian SARS-CoV-2 patients in intensive care: towards an identikit for subjects at risk? (edit) |
10.26355/EURREV_202009_23061 |
| 2020-09-01 |
Vitamin deficiency as risk factor for SARS-CoV-2 infection: correlation with susceptibility and prognosis (edit) |
10.26355/EURREV_202009_23064 |
| 2020-09-01 |
Special features of SARS-CoV-2 in daily practice (edit) |
10.12998/WJCC.V8.I18.3920 |
| 2020-09-01 |
One disease, many faces-typical and atypical presentations of SARS-CoV-2 infection-related COVID-19 disease (edit) |
10.12998/WJCC.V8.I18.3956 |
| 2020-09-01 |
[Vacunas contra el SARS-CoV-2: ¿son una realidad para América Latina?] (edit) |
10.7705/BIOMEDICA.5826 |
| 2020-09-01 |
Sars-CoV-2, de nouvelles données (edit) |
10.1016/S1773-035X(20)30240-9 |
| 2020-09-01 |
Dix minutes seulement pour identifier l’exposition au Sars-CoV-2 (edit) |
10.1016/S1773-035X(20)30256-2 |
| 2020-09-01 |
What Is the Predictive Value of a Single Nasopharyngeal SARS-CoV-2 PCR Swab Test in a Patient With COVID-Like Symptoms and/or Significant COVID-19 Exposure? (edit) |
10.1093/OFID/OFAA399 |
| 2020-09-01 |
SARS-CoV-2 Interstitial Pneumonia Treated With Tocilizumab in a Patient Affected by Classical Hodgkin Lymphoma (edit) |
10.1097/HS9.0000000000000472 |
| 2020-09-01 |
Beyond SARS-CoV-2: Lessons That African Governments Can Apply in Preparation for Possible Future Epidemics (edit) |
10.3961/JPMPH.20.259 |
| 2020-09-01 |
Current targets and drug candidates for prevention and treatment of SARS-CoV-2 (COVID-19) infection (edit) |
10.31083/J.RCM.2020.03.118 |
| 2020-09-01 |
SARS-CoV-2 infection in patients with diabetes mellitus and hypertension: a systematic review (edit) |
10.31083/J.RCM.2020.03.78 |
| 2020-09-01 |
How SARS-Cov-2 can involve the central nervous system. A systematic analysis of literature of the department of human neurosciences of Sapienza University, Italy (edit) |
10.1016/J.JOCN.2020.07.007 |
| 2020-09-01 |
Approach to critical illness myopathy and polyneuropathy in the older SARS-CoV-2 patients (edit) |
10.1016/J.JOCN.2020.07.058 |
| 2020-09-01 |
How to perform and interpret the lung ultrasound by the obstetricians in pregnant women during the SARS-CoV-2 pandemic (edit) |
10.4274/TJOD.GALENOS.2020.93902 |
| 2020-09-01 |
Therapeutically Targeted Destabilization of the Quaternary Structure of the Spike Protein in the Dominant G614 Strain of SARS-CoV-2 (edit) |
10.1021/ACSPTSCI.0C00114 |
| 2020-09-01 |
Mondor's Disease in SARS-CoV-2 Infection: A Case of Superficial Vein Thrombosis in the Era of COVID-19 (edit) |
10.12890/2020_001803 |
| 2020-09-01 |
Mutation profile of over 4500 SARS-CoV-2 isolations reveals prevalent cytosine-to-uridine deamination on viral RNAs (edit) |
10.2217/FMB-2020-0149 |
| 2020-09-01 |
Utilization and Results of Repeat SARS-CoV-2 RT-PCR Testing in a Presumptive Low Prevalence Population (edit) |
|
| 2020-09-01 |
[COVID-19 and work environment: legislative developments about the role of the occupational physician in the emergency management and in the SARS-CoV-2-related work accidents notification] (edit) |
|
| 2020-09-01 |
COVID-19 (SARS-CoV-2) pandemic: fears, facts and preventive measures (edit) |
10.18683/GERMS.2020.1208 |
| 2020-09-01 |
Serum lactate dehydrogenase level may predict acute respiratory distress syndrome of patients with fever infected by SARS-CoV-2 (edit) |
10.21037/ATM-20-2411 |
| 2020-09-01 |
Brainstem Dysfunction in SARS-COV-2 Infection can be a Potential Cause of Respiratory Distress (edit) |
|
| 2020-09-01 |
Could ozone be an effective disinfection measure against the novel coronavirus (SARS-CoV-2)? (edit) |
10.15167/2421-4248/JPMH2020.61.3.1596 |
| 2020-09-01 |
Operative procedures performed during SARS-Cov-2 pandemic: Safe for patients and health care workers under appropriate guidelines (edit) |
10.4103/IJA.IJA_699_20 |
| 2020-09-01 |
Surgeries in asymptomatic carriers during SARS-COV-2 pandemic: Challenges and future (edit) |
10.4103/IJA.IJA_624_20 |
| 2020-09-01 |
Psychomorbidity, Resilience, and Exacerbating and Protective Factors During the SARS-CoV-2 Pandemic (edit) |
10.3238/ARZTEBL.2020.0625 |
| 2020-09-01 |
Perversely expressed long noncoding RNAs can alter host response and viral proliferation in SARS-CoV-2 infection (edit) |
10.2217/FVL-2020-0188 |
| 2020-09-01 |
A comprehensive review about SARS-CoV-2 (edit) |
10.2217/FVL-2020-0124 |
| 2020-09-01 |
[Perinatal transmission of SARS-CoV-2: Need of study by possible congenital infection] (edit) |
10.18597/RCOG.3545 |
| 2020-09-01 |
Clinical and Pathogenic Correlations Between SARS-CoV-2 Infection and Hemolytic Uremic Syndrome in Children (edit) |
|
| 2020-09-01 |
Could the SARS-CoV-2 infection be acquired from Smartphones? (edit) |
10.4314/EJHS.V30I5.26 |
| 2020-09-01 |
[Dental care during SARS-CoV-2 pandemic] (edit) |
10.4067/S0034-98872020000901302 |
| 2020-09-01 |
[SARS-CoV-2 infection sequels: a problem that must be addressed] (edit) |
10.4067/S0034-98872020000901373 |
| 2020-09-01 |
[How the search for new SARS-CoV-2 therapies did hit scientific literature. Is it time now for new approaches?] (edit) |
10.19191/EP20.5-6.S2.097 |
| 2020-09-01 |
[The preparedness of the Italian obstetric surveillance system in the response to the emergency of the SARS-CoV-2 pandemic: methodological aspects of a population-based study] (edit) |
10.19191/EP20.5-6.S2.089 |
| 2020-09-01 |
[Analysis and future scenarios of the SARS-CoV-2 epidemic in Tuscany Region (Central Italy)] (edit) |
10.19191/EP20.5-6.S2.110 |
| 2020-09-01 |
SARS-CoV-2: exposure to high external doses as determinants of higher viral loads and of increased risk for COVID-19. A systematic review of the literature (edit) |
10.19191/EP20.5-6.S2.114 |
| 2020-09-01 |
Evaluating a SARS-CoV-2 screening strategy based on serological tests (edit) |
10.19191/EP20.5-6.S2.118 |
| 2020-09-01 |
[Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?] (edit) |
10.19191/EP20.5-6.S2.119 |
| 2020-09-01 |
[Did social isolation during the SARS-CoV-2 epidemic have an impact on the lifestyles of citizens?] (edit) |
10.19191/EP20.5-6.S2.137 |
| 2020-09-01 |
Proactive machine-learning-based approaches to vaccine hesitancy for a potential SARS-Cov-2 vaccine (edit) |
10.1093/EURPUB/CKAA165.035 |
| 2020-09-01 |
Test Sensitivity for Infection versus Infectiousness of SARS-CoV-2 (edit) |
10.3386/W27780 |
| 2020-09-01 |
Is nicotine exposure linked to cardiopulmonary vulnerability to COVID-19 in the general population? (edit) |
10.1111/FEBS.15303 |
| 2020-09-01 |
Guidelines for Laboratory Diagnosis of Coronavirus Disease 2019 (COVID-19) in Korea (edit) |
|
| 2020-09-01 |
SARS-CoV-2, COVID-19 and inherited arrhythmia syndromes (edit) |
10.1016/J.HRTHM.2020.03.024 |
| 2020-09-01 |
The role of imaging in 2019 novel coronavirus pneumonia (COVID-19) (edit) |
10.1007/S00330-020-06827-4 |
| 2020-09-01 |
Response and Operating Room Preparation for the COVID-19 Outbreak: A Perspective From the National Heart Centre in Singapore (edit) |
10.1053/J.JVCA.2020.03.050 |
| 2020-09-01 |
Challenges of Covid-19 Pandemic for Dermatology (edit) |
10.1111/DTH.13430 |
| 2020-09-01 |
Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2) - an update on the status (edit) |
10.1016/J.MEEGID.2020.104327 |
| 2020-09-01 |
The genetic sequence, origin, and diagnosis of SARS-CoV-2 (edit) |
10.1007/S10096-020-03899-4 |
| 2020-09-01 |
Does SARS-Cov-2 invade the brain? Translational lessons from animal models (edit) |
10.1111/ENE.14277 |
| 2020-09-01 |
Forecasting the timeframe of 2019-nCoV and human cells interaction with reverse engineering (edit) |
10.1016/J.PBIOMOLBIO.2020.04.002 |
| 2020-09-01 |
Systemic Immunobiological, Immunosuppressant and Oncologic Agents for the Treatment of Dermatologic Diseases during the SARS-Cov-2 (COVID19) Pandemic Emergency: a Quick Review for a Quick Consultation (edit) |
10.1111/DTH.13537 |
| 2020-09-01 |
Study of combining virtual screening and antiviral treatments of the Sars-CoV-2 (Covid-19) (edit) |
10.1016/J.MICPATH.2020.104241 |
| 2020-09-01 |
Regional COVID-19 Network for Coordination of SARS-CoV-2 outbreak in Veneto, Italy (edit) |
10.1053/J.JVCA.2020.05.005 |
| 2020-09-01 |
Understanding SARS-CoV-2 endocytosis for COVID-19 drug repurposing (edit) |
10.1111/FEBS.15369 |
| 2020-09-01 |
A Guide to COVID-19: a global pandemic caused by the novel coronavirus SARS-CoV-2 (edit) |
10.1111/FEBS.15375 |
| 2020-09-01 |
May we target double membrane vesicles and oxysterol-binding protein to combat SARS-CoV-2 infection? (edit) |
10.1002/CBIN.11400 |
| 2020-09-01 |
The mechanistic overview of SARS-CoV-2 using angiotensin-converting enzyme 2 to enter the cell for replication: possible treatment options related to the renin-angiotensin system (edit) |
10.1093/EHJCVP/PVAA053 |
| 2020-09-01 |
Testing for SARS-CoV-2: the day the world turned its attention to the clinical laboratory (edit) |
10.1111/CTS.12828 |
| 2020-09-01 |
Potential therapeutic targets for combating SARS-CoV-2: Drug repurposing, clinical trials and recent advancements (edit) |
10.1016/J.LFS.2020.117883 |
| 2020-09-01 |
Vitamin D Receptor stimulation to reduce Acute Respiratory Distress Syndrome (ARDS) in patients with Coronavirus SARS-CoV-2 infections: Revised Ms SBMB 2020_166 (edit) |
10.1016/J.JSBMB.2020.105719 |
| 2020-09-01 |
Vaccination strategies to combat novel corona virus SARS-CoV-2 (edit) |
10.1016/J.LFS.2020.117956 |
| 2020-09-01 |
Prevention of Fogging of Protective Eyewear for Medical Staff During the COVID-19 Pandemic (edit) |
10.1016/J.JEN.2020.05.003 |
| 2020-09-01 |
Recommendations on diagnosis and treatment in hepatobiliary surgery under 2019-nCoV epidemic (edit) |
10.1016/J.CLINRE.2020.04.021 |
| 2020-09-01 |
COVID-19 and the other pandemic: populations made vulnerable by systemic inequity (edit) |
10.1038/S41575-020-0330-8 |
| 2020-09-01 |
Coughs and Sneezes: Their Role in Transmission of Respiratory Viral Infections, Including SARS-CoV-2 (edit) |
10.1164/RCCM.202004-1263PP |
| 2020-09-01 |
COVID-19: review on latest available drugs and therapies against SARS-CoV-2. Coagulation and inflammation cross-talking (edit) |
10.1016/J.VIRUSRES.2020.198070 |
| 2020-09-01 |
An In Vitro Microneutralization Assay for SARS-CoV-2 Serology and Drug Screening (edit) |
10.1002/CPMC.108 |
| 2020-09-01 |
Potential adjuvants for the development of a SARS-CoV-2 vaccine based on experimental results from similar coronaviruses (edit) |
10.1016/J.INTIMP.2020.106717 |
| 2020-09-01 |
The challenging pathway towards the identification of SARS-CoV-2/COVID-19 therapeutics (edit) |
10.1093/JAC/DKAA272 |
| 2020-09-01 |
Antiviral mechanisms of candidate chemical medicines and traditional Chinese medicines for SARS-CoV-2 infection (edit) |
10.1016/J.VIRUSRES.2020.198073 |
| 2020-09-01 |
Diagnostic strategies for SARS-CoV-2 infection and interpretation of microbiological results (edit) |
10.1016/J.CMI.2020.06.019 |
| 2020-09-01 |
Using heat to kill SARS-CoV-2 (edit) |
10.1002/RMV.2115 |
| 2020-09-01 |
Negative SARS-CoV-2 antibody testing following COVID-19 infection in Two MS patients treated with ocrelizumab (edit) |
10.1016/J.MSARD.2020.102341 |
| 2020-09-01 |
Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review (edit) |
10.1016/J.DIAGMICROBIO.2020.115094 |
| 2020-09-01 |
Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics (edit) |
10.1016/S1473-3099(20)30484-9 |
| 2020-09-01 |
A pharmacological perspective of Chloroquine in SARS-CoV-2 infection (edit) |
10.1016/J.IJANTIMICAG.2020.106078 |
| 2020-09-01 |
[SARS-CoV-2, COVID-19 and the eye: An update on publis>hed data] (edit) |
10.1016/J.JFO.2020.05.003 |
| 2020-09-01 |
Research progress on repositioning drugs and specific therapeutic drugs for SARS-CoV-2 (edit) |
10.4155/FMC-2020-0158 |
| 2020-09-01 |
Laboratory Assay Evaluation Demystified: A Review of Key Factors Influencing Interpretation of Test Results Using Different Assays for SARS-CoV-2 Infection Diagnosis (edit) |
10.1093/LABMED/LMAA045 |
| 2020-09-01 |
Baricitinib, a drug with potential effect to prevent SARS-COV-2 from entering target cells and control cytokine storm induced by COVID-19 (edit) |
10.1016/J.INTIMP.2020.106749 |
| 2020-09-01 |
Coagulopathy and thromboembolic events in patients with SARS-CoV-2 infection: pathogenesis and management strategies (edit) |
10.1007/S00277-020-04182-4 |
| 2020-09-01 |
Endocrine significance of SARS-CoV-2's reliance on ACE2 (edit) |
10.1210/ENDOCR/BQAA108 |
| 2020-09-01 |
Obesity, the most common comorbidity in SARS-CoV-2: is leptin the link? (edit) |
10.1038/S41366-020-0640-5 |
| 2020-09-01 |
Types of Assays for SARS-CoV-2 Testing: A Review (edit) |
10.1093/LABMED/LMAA039 |
| 2020-09-01 |
Coagulation Abnormalities and Thrombosis in Patients Infected With SARS-CoV-2 and Other Pandemic Viruses (edit) |
10.1161/ATVBAHA.120.314514 |
| 2020-09-01 |
SARS-CoV-2: Should We Be Concerned about the Nervous System? (edit) |
10.4269/AJTMH.20-0447 |
| 2020-09-01 |
Applying triage principles of mass casualty events to the SARS-CoV-2 pandemic: From the perspective of the acute care surgeons at Long Island Jewish Medical Center in the COVID epicenter of the United States (edit) |
10.1016/J.SURG.2020.06.004 |
| 2020-09-01 |
Novel coronavirus SARS-CoV-2 (Covid-19) dynamics inside the human body (edit) |
10.1002/RMV.2140 |
| 2020-09-01 |
Electroencephalography during SARS-CoV-2 outbreak: practical recommendations from the task force of the Italian Society of Neurophysiology (SINC), the Italian League Against Epilepsy (LICE), and the Italian Association of Neurophysiology Technologis (edit) |
10.1007/S10072-020-04585-1 |
| 2020-09-01 |
Immunological co-ordination between gut and lungs in SARS-CoV-2 infection (edit) |
10.1016/J.VIRUSRES.2020.198103 |
| 2020-09-01 |
Influence of airborne transmission of SARS-CoV-2 on COVID-19 pandemic. A review (edit) |
10.1016/J.ENVRES.2020.109861 |
| 2020-09-01 |
Successful recovery of recurrence of positive SARS-CoV-2 RNA in COVID-19 patient with systemic lupus erythematosus: a case report and review (edit) |
10.1007/S10067-020-05230-0 |
| 2020-09-01 |
Sex-derived attributes contributing to SARS-CoV-2 mortality (edit) |
10.1152/AJPENDO.00295.2020 |
| 2020-09-01 |
SARS-CoV-2 and cancer: Are they really partners in crime? (edit) |
10.1016/J.CTRV.2020.102068 |
| 2020-09-01 |
Tumor markers as an entry for SARS-CoV-2 infection? (edit) |
10.1111/FEBS.15499 |
| 2020-09-01 |
The SARS-CoV-2 main protease as drug target (edit) |
10.1016/J.BMCL.2020.127377 |
| 2020-09-01 |
Sars-CoV-2 in pregnancy: Why is it better than expected? (edit) |
10.1016/J.EJOGRB.2020.07.025 |
| 2020-09-01 |
63 days detection of SARS-CoV-2 RNA from a recovered patient in Southern Italy: A Case Report (edit) |
10.7416/AI.2020.2378 |
| 2020-09-01 |
Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19 (edit) |
10.1038/S41401-020-0485-4 |
| 2020-09-01 |
[Recommendations of the German Society for Rheumatology for management of patients with inflammatory rheumatic diseases in the context of the SARS-CoV-2/COVID-19 pandemic - Update July 2020] (edit) |
10.1007/S00393-020-00851-X |
| 2020-09-01 |
The COVID-19 liquid gold rush: Critical perspectives of human milk and SARS-CoV-2 infection (edit) |
10.1002/AJHB.23481 |
| 2020-09-01 |
Challenges and management of neurological and psychiatric manifestations in SARS-CoV-2 (COVID-19) patients (edit) |
10.1007/S10072-020-04544-W |
| 2020-09-01 |
Strategies and perspectives to develop SARS-CoV-2 detection methods and diagnostics (edit) |
10.1016/J.BIOPHA.2020.110446 |
| 2020-09-01 |
Association between hypertension and pneumonia caused by SARS-CoV-2 in Mexican population (edit) |
10.1097/HJH.0000000000002544 |
| 2020-09-01 |
Beyond serosurveys: Human biology and the measurement of SARS-Cov-2 antibodies (edit) |
10.1002/AJHB.23483 |
| 2020-09-01 |
A theranostic approach based on radiolabeled antiviral drugs, antibodies and CRISPR-associated proteins for early detection and treatment of SARS-CoV-2 disease (edit) |
10.1097/MNM.0000000000001269 |
| 2020-09-01 |
Dizziness in SARS-CoV2: A Red Flag to Clinicians (edit) |
|
| 2020-09-01 |
Erratum to "Pulse immunosuppressive therapy for multiple sclerosis during the SARS-CoV-2 lockdown de-escalation plan: Safety algorithm" [Neurologia. 2020;35(6):357-362] (edit) |
10.1016/J.NRL.2020.07.011 |
| 2020-09-01 |
Mayo Clinic Strategies for COVID-19: Research Response to SARS-CoV-2/COVID-19 (edit) |
10.1016/J.MAYOCP.2020.06.048 |
| 2020-09-01 |
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vertical Transmission in Neonates Born to Mothers With Coronavirus Disease 2019 (COVID-19) Pneumonia (edit) |
10.1097/AOG.0000000000004073 |
| 2020-09-01 |
SARS-CoV-2-Associated Guillain-Barre Syndrome With Good Response to Plasmapheresis (edit) |
10.1097/CND.0000000000000310 |
| 2020-09-01 |
Correction: Role of the early secretory pathway in SARS-CoV-2 infection (edit) |
10.1083/JCB.20200600508132020C |
| 2020-09-01 |
Letter: immunotherapy for IBD patients in a SARS-CoV-2 endemic area-authors' reply (edit) |
10.1111/APT.15955 |
| 2020-09-01 |
Letter: immunotherapy in IBD patients in a SARS-CoV-2 endemic area (edit) |
10.1111/APT.15897 |
| 2020-09-01 |
The origin of SARS-CoV-2 (edit) |
10.1016/S1473-3099(20)30641-1 |
| 2020-09-01 |
Community Outbreak Investigation of SARS-CoV-2 Transmission Among Bus Riders in Eastern China (edit) |
10.1001/JAMAINTERNMED.2020.5225 |
| 2020-09-01 |
SARS-CoV-2 Serological Survey of Cats in China before and after the Pandemic (edit) |
10.1007/S12250-020-00284-5 |
| 2020-09-01 |
Diabetes mellitus is a risk factor for prolonged SARS-CoV-2 viral shedding in lower respiratory tract samples of critically ill patients (edit) |
10.1007/S12020-020-02465-4 |
| 2020-09-01 |
Quantitative and qualitative alterations of circulating myeloid cells and plasmacytoid DC in SARS-CoV-2 infection (edit) |
10.1111/IMM.13254 |
| 2020-09-01 |
SARS-CoV-2: The Growing Case for Potential Transmission in a Building via Wastewater Plumbing Systems (edit) |
10.7326/M20-6134 |
| 2020-09-01 |
Probable Evidence of Fecal Aerosol Transmission of SARS-CoV-2 in a High-Rise Building (edit) |
10.7326/M20-0928 |
| 2020-09-01 |
A simple protein-based surrogate neutralization assay for SARS-CoV-2 (edit) |
10.1172/JCI.INSIGHT.142362 |
| 2020-09-01 |
Humoral Immune Response to SARS-CoV-2 in Iceland (edit) |
10.1056/NEJMOA2026116 |
| 2020-09-01 |
No evidence of SARS-CoV-2 transfusion-transmission despite RNA detection in blood donors showing symptoms after donation (edit) |
10.1182/BLOOD.2020008230 |
| 2020-09-01 |
[Consequences of the SARS-CoV-2 Pandemia on the Early Childhood Examinations] (edit) |
10.1055/A-1247-5119 |
| 2020-09-01 |
Ivermectin Docks to the SARS-CoV-2 Spike Receptor-binding Domain Attached to ACE2 (edit) |
10.21873/INVIVO.12134 |
| 2020-09-01 |
Clinical Study of Hyperglycemia and SARS-CoV-2 Infection in Intensive Care Unit Patients (edit) |
10.21873/INVIVO.12136 |
| 2020-09-01 |
Preliminary Data of a Quantitative Point of Care Test for SARS-CoV-2 Antibodies From Greece (edit) |
10.21873/INVIVO.12138 |
| 2020-09-01 |
Clinical and imaging findings of discharged patients with SARS-CoV-2 positive anal swab samples: a descriptive study (edit) |
10.1186/S12879-020-05363-2 |
| 2020-09-01 |
Serological identification of SARS-CoV-2 infections among children visiting a hospital during the initial Seattle outbreak (edit) |
10.1038/S41467-020-18178-1 |
| 2020-09-01 |
Immune correlates of SARS-CoV-2 protection (edit) |
10.1038/S41577-020-00442-6 |
| 2020-09-01 |
Long-lasting SARS-CoV-2-specific T cell memories (edit) |
10.1038/S41577-020-00441-7 |
| 2020-09-01 |
Difference in levels of SARS-CoV-2 S1 and S2 subunits- and nucleocapsid protein-reactive SIgM/IgM, IgG and SIgA/IgA antibodies in human milk (edit) |
10.1038/S41372-020-00805-W |
| 2020-09-01 |
RNA interference as a promising treatment against SARS-CoV-2 (edit) |
10.1007/S10123-020-00146-W |
| 2020-09-01 |
Cross-Sectional Prevalence of SARS-CoV-2 Among Skilled Nursing Facility Employees and Residents Across Facilities in Seattle (edit) |
10.1007/S11606-020-06165-7 |
| 2020-09-01 |
Upper trunk brachial plexopathy as a consequence of prone positioning due to SARS-CoV-2 acute respiratory distress syndrome (edit) |
10.1002/MUS.27055 |
| 2020-09-01 |
SARS-CoV-2 And Trojan Horse Phenomenon -Caveat In Vaccine Quest? (edit) |
10.1111/SJI.12969 |
| 2020-09-01 |
Online laboratory exercise on computational biology: Phylogenetic analyses and protein modeling based on SARS-CoV-2 data during COVID-19 remote instruction (edit) |
10.1002/BMB.21438 |
| 2020-09-01 |
SARS-CoV-2 infection in people living with HIV: a systematic review (edit) |
10.1002/RMV.2155 |
| 2020-09-01 |
SARS-CoV-2 Infection of Airway Cells (edit) |
10.1056/NEJMICM2023328 |
| 2020-09-01 |
Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1α/Glycolysis-Dependent Axis (edit) |
10.1016/J.CMET.2020.07.015 |
| 2020-09-01 |
SARS-CoV-2 seroprevalence in oncology healthcare professionals and patients with cancer at a tertiary care centre during the COVID-19 pandemic (edit) |
10.1136/ESMOOPEN-2020-000889 |
| 2020-09-01 |
National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRD (edit) |
10.1136/RMDOPEN-2020-001332 |
| 2020-09-01 |
Structure of SARS-CoV-2 main protease in the apo state (edit) |
10.1007/S11427-020-1791-3 |
| 2020-09-01 |
SARS-CoV-2 antibodies, serum inflammatory biomarkers and clinical severity of hospitalized COVID-19 patients (edit) |
10.1016/J.JCV.2020.104611 |
| 2020-09-01 |
Use of Darunavir-Cobicistat as a Treatment Option for Critically Ill Patients with SARS-CoV-2 Infection (edit) |
10.3349/YMJ.2020.61.9.826 |
| 2020-09-01 |
Computational and Transcriptome Analyses Revealed Preferential Induction of Chemotaxis and Lipid Synthesis by SARS-CoV-2 (edit) |
10.3390/BIOLOGY9090260 |
| 2020-09-01 |
Natural Flavonoids as Potential Angiotensin-Converting Enzyme 2 Inhibitors for Anti-SARS-CoV-2 (edit) |
10.3390/MOLECULES25173980 |
| 2020-09-01 |
Potential of Ocular Transmission of SARS-CoV-2: A Review (edit) |
10.3390/VISION4030040 |
| 2020-09-01 |
Artificial Intelligence-Assisted Loop Mediated Isothermal Amplification (AI-LAMP) for Rapid Detection of SARS-CoV-2 (edit) |
10.3390/V12090972 |
| 2020-09-01 |
Cell and animal models of SARS-CoV-2 pathogenesis and immunity (edit) |
10.1242/DMM.046581 |
| 2020-09-01 |
The use of germicidal ultraviolet light, vaporised hydrogen peroxide and dry heat to decontaminate face masks and filtering respirators contaminated with a SARS-CoV-2 surrogate virus (edit) |
10.1016/J.JHIN.2020.08.025 |
| 2020-09-01 |
Inferring the genetic variability in Indian SARS-CoV-2 genomes using consensus of multiple sequence alignment techniques (edit) |
10.1016/J.MEEGID.2020.104522 |
| 2020-09-01 |
Where Did SARS-CoV-2 Come From? (edit) |
10.1093/MOLBEV/MSAA162 |
| 2020-09-01 |
Gastrointestinal involvement of COVID-19 and potential faecal transmission of SARS-CoV-2 (edit) |
10.1631/JZUS.B2000253 |
| 2020-09-01 |
SARS-COV-2 in Argentina (edit) |
10.5935/1518-0557.20200071 |
| 2020-09-01 |
Analysis of a SARS-CoV-2 daily screening programme for healthcare workers at a district hospital in KwaZulu-Natal, a quality improvement initiativ (edit) |
10.4102/PHCFM.V12I1.2525 |
| 2020-09-01 |
The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection (edit) |
10.1016/J.JACI.2020.07.001 |
| 2020-09-01 |
Characteristics and outcomes of admitted patients infected with SARS-CoV-2 in Uganda (edit) |
10.1136/BMJRESP-2020-000646 |
| 2020-09-01 |
Correction: Unpuzzling COVID-19: tissue-related signaling pathways associated with SARS-CoV-2 infection and transmission (edit) |
10.1042/CS-20200904_COR |
| 2020-09-01 |
Bone Metabolism in SARS-CoV-2 Disease: Possible Osteoimmunology and Gender Implications (edit) |
10.1007/S12018-020-09274-3 |
| 2020-09-01 |
SARS-CoV-2 vaccine research and development: conventional vaccines and biomimetic nanotechnology strategies (edit) |
10.1016/J.AJPS.2020.08.001 |
| 2020-09-01 |
Combined point of care nucleic acid and antibody testing for SARS-CoV-2 following emergence of D614G Spike Variant (edit) |
10.1016/J.XCRM.2020.100099 |
| 2020-09-01 |
A Model for SARS-CoV-2 Infection with Treatment (edit) |
10.1155/2020/1352982 |
| 2020-09-01 |
Drug repurposing screen identifies masitinib as a 3CLpro inhibitor that blocks replication of SARS-CoV-2 in vitro (edit) |
10.1101/2020.08.31.274639 |
| 2020-09-01 |
Viral shedding dynamics reveals sputum as a reliable and cost-saving specimen for SARS-CoV-2 diagnosis within the first 10 days since symptom onset: A prospective cohort study (edit) |
10.1101/2020.08.30.20183889 |
| 2020-09-01 |
SARS-CoV-2 Infections Among Children in the Biospecimens from Respiratory Virus-Exposed Kids (BRAVE Kids) Study (edit) |
10.1101/2020.08.18.20166835 |
| 2020-09-01 |
Modeling Dynamic Network Strategies for SARS-CoV-2 Control on a Cruise Ship (edit) |
10.1101/2020.08.26.20182766 |
| 2020-09-01 |
Development of a qualitative real-time RT-PCR assay for the detection of SARS-CoV-2: A guide and case study in setting up an emergency-use, laboratory-developed molecular assay (edit) |
10.1101/2020.08.26.20157297 |
| 2020-09-01 |
Snatching the Crown from SARS-CoV-2 (edit) |
10.1016/J.CHOM.2020.08.007 |
| 2020-09-01 |
Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike (edit) |
10.1016/J.CHOM.2020.07.002 |
| 2020-09-01 |
Transmission of SARS-CoV-2 in children aged 0 to 19 years in childcare facilities and schools after their reopening in May 2020, Baden-Württemberg, Germany (edit) |
10.2807/1560-7917.ES.2020.25.36.2001587 |
| 2020-09-01 |
COVID-19 convalescent plasma clears SARS-CoV-2 refractory to remdesivir in an infant with congenital heart disease (edit) |
10.1182/BLOODADVANCES.2020002507 |
| 2020-09-01 |
Estimating the Binding of Sars-CoV-2 Peptides to HLA Class I in Human Subpopulations Using Artificial Neural Networks (edit) |
10.1016/J.CELS.2020.08.011 |
| 2020-09-01 |
Does SARS-CoV-2 truly cause infectious myopathy? (edit) |
10.1016/J.JFMA.2020.08.041 |
| 2020-09-01 |
Clinical characteristics of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV2) patients in Hospital Tengku Ampuan Afzan (edit) |
|
| 2020-09-01 |
Possibility of SARS-CoV-2 transmission from the breast milk of COVID-19 affected women patients to their infants: worries and strategies to counter it (edit) |
|
| 2020-09-01 |
Natural selection versus creation: a review on the origin of SARS-COV-2 (edit) |
|
| 2020-09-01 |
SARS-CoV-2 and Dengue virus Co-infection. A Case Report (edit) |
|
| 2020-09-01 |
Detection of the first appearance of SARS-CoV-2 virus in Hungary based on retrospective testing of respiratory samples (edit) |
10.1556/650.2020.32000 |
| 2020-09-01 |
Successful management of SARS-CoV-2 acute respiratory distress syndrome and newly diagnosed acute lymphoblastic leukemia (edit) |
10.1182/BLOODADVANCES.2020002745 |
| 2020-09-01 |
Propofol and SARS-CoV-2 infection (edit) |
10.1016/J.BJA.2020.08.032 |
| 2020-09-01 |
Sample collection and stabilization from saliva samples for SARS-CoV-2 detection by qPCR (edit) |
10.2144/BTN-2020-1001AP |
| 2020-09-01 |
C-reactive protein and albumin association with mortality of hospitalised SARS-CoV-2 patients: A tertiary hospital experience (edit) |
10.7861/CLINMED.2020-0424 |
| 2020-09-01 |
Test de détection salivaire du SARS-CoV-2 (edit) |
|
| 2020-09-01 |
The evolving picture of SARS-CoV-2 and COVID-19 in children: critical knowledge gaps (edit) |
10.1136/BMJGH-2020-003454 |
| 2020-09-01 |
Implementation and evaluation of a novel real-time multiplex assay for SARS-CoV-2: in-field learnings from a clinical microbiology laboratory (edit) |
10.1016/J.PATHOL.2020.08.004 |
| 2020-09-01 |
Impact of Circulating SARS-CoV-2 Mutant G614 on the COVID-19 Pandemic (edit) |
|
| 2020-09-01 |
Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients (edit) |
10.1016/J.CELL.2020.08.046 |
| 2020-09-01 |
New molecular diagnostic technologies for clinical detection of SARS-CoV-2 (edit) |
10.16288/J.YCZZ.20-189 |
| 2020-09-01 |
SARS-CoV-2 Transmission and Outcome in Neuro-rehabilitation Patients Hospitalized at Neuroscience Hospital in Italy (edit) |
10.4084/MJHID.2020.063 |
| 2020-09-01 |
Analysis of Host Cell Receptor GRP78 for Potential Natural Reservoirs of SARS-CoV-2 (edit) |
10.2991/JEGH.K.200806.001 |
| 2020-09-01 |
Diving after SARS-CoV-2 (COVID-19) infection: Fitness to dive assessment and medical guidance (edit) |
10.28920/DHM50.3.278-287 |
| 2020-09-01 |
Intensive Care Medicine: Quiet leadership versus protagonist in times of SARS-CoV-2 pandemic crisis (edit) |
10.1016/J.MEDIN.2020.08.001 |
| 2020-09-01 |
SARS-CoV-2 organising pneumonia: 'Has there been a widespread failure to identify and treat this prevalent condition in COVID-19?' (edit) |
10.1136/BMJRESP-2020-000724 |
| 2020-09-01 |
SARS-CoV-2 infection: NLRP3 inflammasome as plausible target to prevent cardiopulmonary complications? (edit) |
10.26355/EURREV_202009_22867 |
| 2020-09-01 |
Pathogenic analysis of suspected COVID-19 patients in a SARS-CoV-2 non-epidemic area of China (edit) |
10.26355/EURREV_202009_22871 |
| 2020-09-01 |
SARS-CoV-2 RNA contamination on surfaces of a COVID-19 ward in a hospital of Northern Italy: what risk of transmission? (edit) |
10.26355/EURREV_202009_22872 |
| 2020-09-01 |
Advances in SARS-CoV-2: a systematic review (edit) |
10.26355/EURREV_202009_22873 |
| 2020-09-01 |
Association of Red Blood Cell Distribution Width With Mortality Risk in Hospitalized Adults With SARS-CoV-2 Infection (edit) |
10.1001/JAMANETWORKOPEN.2020.22058 |
| 2020-09-01 |
Risk Factors for Hospitalization, Mechanical Ventilation, or Death Among 10 131 US Veterans With SARS-CoV-2 Infection (edit) |
10.1001/JAMANETWORKOPEN.2020.22310 |
| 2020-09-01 |
Inhibitory activities of marine sulfated polysaccharides against SARS-CoV-2 (edit) |
10.1039/D0FO02017F |
| 2020-09-01 |
Hohes Risiko für schnelle SARS-CoV-2-Ausbreitung in Seniorenheimen (edit) |
10.1007/S15033-020-1888-0 |
| 2020-09-01 |
Übersicht zu Sensitivität und Spezifität des SARS-CoV-2-Nachweises mittels PCR (edit) |
10.1007/S15033-020-1912-4 |
| 2020-09-01 |
Illuminating, through immunohistochemistry, the link between SARS-CoV-2 and pernio (chilblains) (edit) |
10.1111/BJD.19405 |
| 2020-09-01 |
Renin-angiotensin-aldosterone System Inhibitors and Risks of SARS-CoV-2 Infection: A Systematic Review and Meta-analysis (edit) |
10.1161/HYPERTENSIONAHA.120.15989 |
| 2020-09-01 |
Absence of SARS-CoV-2 in the effluent of peritoneal dialysis patients (edit) |
10.1177/0896860820953061 |
| 2020-09-01 |
Using serpins cysteine protease cross-specificity to possibly trap SARS-CoV-2 Mpro with reactive center loop chimera (edit) |
10.1042/CS20200767 |
| 2020-09-01 |
SARS-CoV-2 and its relationship with the genitourinary tract: implications for male reproductive health in the context of COVID-19 pandemic (edit) |
10.1111/ANDR.12896 |
| 2020-09-01 |
Similarities and Differences of Early Pulmonary CT Features of Pneumonia Caused by SARS-CoV-2, SARS-CoV and MERS-CoV: Comparison Based on a Systemic Review (edit) |
10.24920/003727 |
| 2020-09-01 |
Validity of a Serological Diagnostic Kit for SARS-CoV-2 Available in Iran (edit) |
10.34172/AIM.2020.75 |
| 2020-08-31 |
Considerations for the Selection and Use of Disinfectants Against SARS-CoV-2 in a Health Care Setting (edit) |
10.1093/OFID/OFAA396 |
| 2020-08-31 |
Genomic Cues From Beta-Coronaviruses and Mammalian Hosts Sheds Light on Probable Origins and Infectivity of SARS-CoV-2 Causing COVID-19 (edit) |
10.3389/FGENE.2020.00902 |
| 2020-08-31 |
A rapid and sensitive method to detect SARS-CoV-2 virus using targeted-mass spectrometry (edit) |
10.1007/S42485-020-00044-9 |
| 2020-08-31 |
SARS-CoV-2 Testing and Changes in Primary Care Services in a Multistate Network of Community Health Centers During the COVID-19 Pandemic (edit) |
10.1001/JAMA.2020.15891 |
| 2020-08-31 |
Exploitation of some natural products for prevention and/or nutritional treatment of SARS-CoV2 infection (edit) |
10.2174/1871530320999200831231029 |
| 2020-08-31 |
CLINICAL-EPIDEMIOLOGICAL RELATION BETWEEN SARS-COV-2 AND KAWASAKI DISEASE: AN INTEGRATIVE LITERATURE (edit) |
10.1590/1984-0462/2021/39/2020217 |
| 2020-08-31 |
Schrödinger's Worker: Are They Positive or Negative for SARS-CoV-2? (edit) |
10.3390/IJERPH17176316 |
| 2020-08-31 |
Stigma and Discrimination (SAD) at the Time of the SARS-CoV-2 Pandemic (edit) |
10.3390/IJERPH17176341 |
| 2020-08-31 |
Evaluation of SARS-CoV-2 in tears of moderate to severe COVID-19 patients (edit) |
10.1016/J.OPHTHA.2020.08.029 |
| 2020-08-31 |
Genome based evolutionary lineage of SARS-CoV-2 towards the development of novel chimeric vaccine (edit) |
10.1016/J.MEEGID.2020.104517 |
| 2020-08-31 |
An Unusual Case of Moraxella osleonsis Bacteremia in an Immunocompetent Patient With SARS-CoV-2 Infection (edit) |
10.7759/CUREUS.10154 |
| 2020-08-31 |
Saliva is a reliable, non-invasive specimen for SARS-CoV-2 detection (edit) |
10.1016/J.BJID.2020.08.001 |
| 2020-08-31 |
Use of the variplex™ SARS-CoV-2 RT-LAMP as a rapid molecular assay to complement RT-PCR for COVID-19 diagnosis (edit) |
10.1016/J.JCV.2020.104616 |
| 2020-08-31 |
Cardiogenic Shock Caused by SARS-CoV-2 in a Patient with Serial Negative Nucleic Acid Amplification Tests. Case Report (edit) |
10.1007/S42399-020-00496-6 |
| 2020-08-31 |
Temporal detection and phylogenetic assessment of SARS-CoV-2 in municipal wastewater (edit) |
10.1016/J.XCRM.2020.100098 |
| 2020-08-31 |
Integrate structural analysis, isoform diversity, and interferon-inductive propensity of ACE2 to predict SARS-CoV2 susceptibility in vertebrates (edit) |
10.1016/J.HELIYON.2020.E04818 |
| 2020-08-31 |
[Clinical spectrum and risk factors for complicated disease course in children admitted with SARS-CoV-2 infection] (edit) |
10.1016/J.ANPEDI.2020.07.025 |
| 2020-08-31 |
When should clinicians repeat SARS-CoV-2 RT-PCR?: Repeat PCR testing targeting patients with pulmonary CT findings suggestive of COVID-19 (edit) |
10.7883/YOKEN.JJID.2020.531 |
| 2020-08-31 |
Clinical Validation and Performance Evaluation of the Automated Vitros Total Anti-SARS-CoV-2 Antibodies Assay for Screening of Serostatus in COVID-19 (edit) |
10.1093/AJCP/AQAA157 |
| 2020-08-31 |
Patients with Prolonged Positivity of SARS-CoV-2 RNA Benefit from Convalescent Plasma Therapy: A Retrospective Study (edit) |
10.1007/S12250-020-00281-8 |
| 2020-08-31 |
Frequency of serological non-responders and false-negative RT-PCR results in SARS-CoV-2 testing: a population-based study (edit) |
10.1515/CCLM-2020-0978 |
| 2020-08-31 |
Changes in Interventional Pain Physician Decision-Making, Practice Patterns, and Mental Health During the Early Phase of the SARS-CoV-2 Global Pandemic (edit) |
10.1093/PM/PNAA294 |
| 2020-08-31 |
An accessible and economical evacuation system for surgical fumes and pneumoperitoneum in laparoscopy during the SARS-CoV-2 pandemic (edit) |
|
| 2020-08-31 |
Implications of SARS-CoV-2 on Current and Future Operation and Management of Wastewater Systems (edit) |
10.1002/WER.1446 |
| 2020-08-31 |
Potential interactions of SARS-CoV-2 with human cell receptors in the skin: understanding the enigma for a lower frequency of skin lesions compared to other tissues (edit) |
10.1111/EXD.14186 |
| 2020-08-31 |
Emerging of a SARS-CoV-2 viral strain with a deletion in nsp1 (edit) |
10.1186/S12967-020-02507-5 |
| 2020-08-31 |
Rapid isothermal amplification and portable detection system for SARS-CoV-2 (edit) |
10.1073/PNAS.2014739117 |
| 2020-08-31 |
A SARS-CoV-2 vaccine candidate would likely match all currently circulating variants (edit) |
10.1073/PNAS.2008281117 |
| 2020-08-31 |
Clinical evaluation of COVID-19/SARS-CoV-2 diagnostic testing in asymptomatic urology patients: implications for resumption of elective surgical care (edit) |
10.1007/S00345-020-03423-5 |
| 2020-08-31 |
[Quadruple negative SARS-CoV-2-PCR: still COVID-19 pneumonia!] (edit) |
10.1055/A-1202-3936 |
| 2020-08-31 |
Possible routes of SARS-CoV-2 invasion in brain: In context of neurological symptoms in COVID-19 patients (edit) |
10.1002/JNR.24717 |
| 2020-08-30 |
The Distribution of COVID 19 based on Phylogeny Construction in Silico Sequences SARS-CoV-2 RNA at Genbank NCBI (edit) |
10.48048/WJST.2020.9814 |
| 2020-08-30 |
A Decision Aide for the Risk Stratification of GU Cancer Patients at Risk of SARS-CoV-2 Infection, COVID-19 Related Hospitalization, Intubation, and Mortality (edit) |
10.3390/JCM9092799 |
| 2020-08-30 |
Implications for SARS-CoV-2 Vaccine Design: Fusion of Spike Glycoprotein Transmembrane Domain to Receptor-Binding Domain Induces Trimerization (edit) |
10.3390/MEMBRANES10090215 |
| 2020-08-30 |
Using logical constraints to validate information in collaborative knowledge graphs: a study of COVID-19 on Wikidata (edit) |
10.5281/ZENODO.4008359 |
| 2020-08-30 |
Mass Spectrometry Analysis of Newly Emerging Coronavirus HCoV-19 Spike Protein and Human ACE2 Reveals Camouflaging Glycans and Unique Post-Translational Modifications (edit) |
10.1016/J.ENG.2020.07.014 |
| 2020-08-30 |
Sentinel Coronavirus environmental monitoring can contribute to detecting asymptomatic SARS-CoV-2 virus spreaders and can verify effectiveness of workplace COVID-19 controls (edit) |
10.1016/J.MRAN.2020.100137 |
| 2020-08-30 |
Quantitative microsampling for bioanalytical applications related to the SARS-CoV-2 pandemic: Usefulness, benefits and pitfalls (edit) |
10.1016/J.JPBA.2020.113597 |
| 2020-08-30 |
Study of amniotic fluid in pregnant women infected with SARS-CoV-2 in first and second trimester. Is there evidence of vertical transmission? (edit) |
10.1080/14767058.2020.1811669 |
| 2020-08-30 |
Angiotensin-Converting Enzyme as a new immunologic target for the new SARS-CoV-2 (edit) |
10.1111/IMCB.12396 |
| 2020-08-30 |
'Immunity Passports' for SARS-CoV-2: an online experimental study of the impact of antibody test terminology on perceived risk and behaviour (edit) |
10.1136/BMJOPEN-2020-040448 |
| 2020-08-30 |
Structure-Altering Mutations of the SARS-CoV-2 Frame Shifting RNA Element (edit) |
10.1101/2020.08.28.271965 |
| 2020-08-30 |
Structural classification of neutralizing antibodies against the SARS-CoV-2 spike receptor-binding domain suggests vaccine and therapeutic strategies (edit) |
10.1101/2020.08.30.273920 |
| 2020-08-29 |
Postpartum psychosis in mothers with SARS-CoV-2 infection: A case series from India (edit) |
10.1016/J.AJP.2020.102406 |
| 2020-08-29 |
Global BioID-based SARS-CoV-2 proteins proximal interactome unveils novel ties between viral polypeptides and host factors involved in multiple COVID19-associated mechanisms (edit) |
10.1101/2020.08.28.272955 |
| 2020-08-29 |
The SARS-CoV-2 ORF10 is not essential in vitro or in vivo in humans (edit) |
10.1101/2020.08.29.257360 |
| 2020-08-29 |
Clinical outcome of SARS-CoV-2 infection in immunosuppressed children in Spain (edit) |
10.1007/S00431-020-03793-3 |
| 2020-08-29 |
COVID-19 and nail manifestation: be on the lookout for the red half-moon nail sign (edit) |
10.1111/IJD.15167 |
| 2020-08-29 |
Case report: SARS-CoV-2 induced urticaria or just a concomitance? (edit) |
10.1111/DTH.14250 |
| 2020-08-29 |
Findings from a probability-based survey of U.S. households about prevention measures based on race, ethnicity, and age in response to SARS-CoV-2 (edit) |
10.1093/INFDIS/JIAA554 |
| 2020-08-29 |
A High Through-Put Assay For Circulating Antibodies Directed Against The S Protein Of Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) (edit) |
10.1093/INFDIS/JIAA531 |
| 2020-08-29 |
Viral spreading in asymptomatic cases with SARS-CoV-2 infections: a Pilot study (edit) |
10.1016/J.JINF.2020.08.044 |
| 2020-08-29 |
CCL28 mucosal expression in SARS-CoV-2-infected patients with diarrhea in relation to disease severity (edit) |
10.1016/J.JINF.2020.08.042 |
| 2020-08-29 |
SARS-CoV-2 and the safety margins of cell-based biological medicinal products (edit) |
10.1016/J.BIOLOGICALS.2020.08.010 |
| 2020-08-29 |
Robust T cell response towards spike, membrane, and nucleocapsid SARS-CoV-2 proteins is not associated with recovery in critical COVID-19 patients (edit) |
10.1016/J.XCRM.2020.100092 |
| 2020-08-29 |
Absence of SARS-CoV-2 infection in cats and dogs in close contact with a cluster of COVID-19 patients in a veterinary campus (edit) |
10.1016/J.ONEHLT.2020.100164 |
| 2020-08-29 |
Meckel's diverticulum perforation in a newborn positive to Sars-Cov-2 (edit) |
10.1016/J.EPSC.2020.101641 |
| 2020-08-29 |
Sars-CoV-2 (COVID-19) inactivation capability of copper-coated touch surface fabricated by cold-spray technology (edit) |
10.1016/J.MFGLET.2020.08.007 |
| 2020-08-29 |
Neuroradiological Features of Mild and Severe SARS-CoV-2 Infection (edit) |
10.1016/J.ACRA.2020.08.026 |
| 2020-08-29 |
Scaffold morphing of arbidol (umifenovir) in search of multi-targeting therapy halting the interaction of SARS-CoV-2 with ACE2 and other proteases involved in COVID-19 (edit) |
10.1016/J.VIRUSRES.2020.198146 |
| 2020-08-29 |
Interferon gamma, TGF-β1 and RANTES expression in upper airway samples from SARS-CoV-2 infected patients (edit) |
10.1016/J.CLIM.2020.108576 |
| 2020-08-28 |
Mitochondria Targeted Viral Replication and Survival Strategies-Prospective on SARS-CoV-2 (edit) |
10.3389/FPHAR.2020.578599 |
| 2020-08-28 |
Immune Modulation as a Therapeutic Option During the SARS-CoV-2 Outbreak: The Case for Antimalarial Aminoquinolines (edit) |
10.3389/FIMMU.2020.02159 |
| 2020-08-28 |
Experimental Models for the Study of Central Nervous System Infection by SARS-CoV-2 (edit) |
10.3389/FIMMU.2020.02163 |
| 2020-08-28 |
A Novel Case of Hypoparathyroidism Secondary to SARS-CoV-2 Infection (edit) |
10.7759/CUREUS.10097 |
| 2020-08-28 |
A SARS-CoV-2 BioID-based virus-host membrane protein interactome and virus peptide compendium: new proteomics resources for COVID-19 research (edit) |
10.1101/2020.08.28.269175 |
| 2020-08-28 |
SARS-CoV-2 variants with mutations at the S1/S2 cleavage site are generated in vitro during propagation in TMPRSS2-deficient cells (edit) |
10.1101/2020.08.28.271163 |
| 2020-08-28 |
SARS-CoV-2 spike D614G variant exhibits highly efficient replication and transmission in hamsters (edit) |
10.1101/2020.08.28.271635 |
| 2020-08-28 |
Breadth and function of antibody response to acute SARS-CoV-2 infection in humans (edit) |
10.1101/2020.08.28.267526 |
| 2020-08-28 |
THE VETERINARIAN IN PANDEMY SARS-CoV-2 (COVID-19): BACKGROUND AND ATTRIBUTIONS (edit) |
10.4025/REVCIVET.V7I1.55495 |
| 2020-08-28 |
Limited Secondary Transmission of SARS-CoV-2 in Child Care Programs - Rhode Island, June 1-July 31, 2020 (edit) |
10.15585/MMWR.MM6934E2 |
| 2020-08-28 |
Notes from the Field: Universal Statewide Laboratory Testing for SARS-CoV-2 in Nursing Homes - West Virginia, April 21-May 8, 2020 (edit) |
10.15585/MMWR.MM6934A4 |
| 2020-08-28 |
Multisystem Inflammatory Syndrome Associated with SARS-CoV-2 Infection in 45 Children: A First Report from Iran (edit) |
10.1017/S095026882000196X |
| 2020-08-28 |
SARS-CoV-2 RNA in serum as predictor of severe outcome in COVID-19: a retrospective cohort study (edit) |
10.1093/CID/CIAA1285 |
| 2020-08-28 |
Clinical Features and Outcome of SARS-CoV-2 Infection in Neonates: A Systematic Review (edit) |
10.1093/TROPEJ/FMAA059 |
| 2020-08-28 |
Blood use and transfusion needs at a large health care system in Washington state during the SARS-CoV-2 pandemic (edit) |
10.1111/TRF.16051 |
| 2020-08-28 |
Are SARS-CoV-2 seroprevalence estimates biased? (edit) |
10.1093/INFDIS/JIAA523 |
| 2020-08-28 |
SARS-CoV-2 Point Prevalence among Asymptomatic Hospitalized Children and Subsequent Healthcare Worker Evaluation (edit) |
10.1093/JPIDS/PIAA102 |
| 2020-08-28 |
Symptomatic and Asymptomatic Viral Shedding in Pediatric Patients Infected With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Under the Surface (edit) |
10.1001/JAMAPEDIATRICS.2020.3996 |
| 2020-08-28 |
Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2 (edit) |
10.1056/NEJMC2016359 |
| 2020-08-28 |
Correction to Rapid Detection of COVID-19 Causative Virus (SARS-CoV-2) in Human Nasopharyngeal Swab Specimens Using Field-Effect Transistor-Based Biosensor (edit) |
10.1021/ACSNANO.0C06726 |
| 2020-08-28 |
Azithromycin Downregulates Gene Expression of IL-1β and Pathways Involving TMPRSS2 and TMPRSS11D Required by SARS-CoV-2 (edit) |
10.1165/RCMB.2020-0285LE |
| 2020-08-28 |
Antibody Profiles According to Mild or Severe SARS-CoV-2 Infection, Atlanta, Georgia, USA, 2020 (edit) |
10.3201/EID2612.203334 |
| 2020-08-28 |
SNPs or RNA modifications? Concerns on mutation-based evolutionary studies of SARS-CoV-2 (edit) |
10.1371/JOURNAL.PONE.0238490 |
| 2020-08-28 |
A novel strategy for community screening of SARS-CoV-2 (COVID-19): Sample pooling method (edit) |
10.1371/JOURNAL.PONE.0238417 |
| 2020-08-28 |
Profiling cases with non-respiratory symptoms and asymptomatic SARS-CoV-2 infections in Mexico City (edit) |
10.1093/CID/CIAA1288 |
| 2020-08-28 |
Using Serologic Testing to Assess the Effectiveness of Outbreak Control Efforts, Serial PCR Testing, and Cohorting of Positive SARS-CoV-2 Patients in a Skilled Nursing Facility (edit) |
10.1093/CID/CIAA1286 |
| 2020-08-28 |
COVID-19 patients in earlier stages exhaled millions of SARS-CoV-2 per hour (edit) |
10.1093/CID/CIAA1283 |
| 2020-08-28 |
Comment on 'Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19' by Konig et al. Long-term exposure to hydroxychloroquine or chloroquine and the risk of hospitalisation with C (edit) |
10.1136/ANNRHEUMDIS-2020-218647 |
| 2020-08-28 |
Wnt5a and Wnt11 as acute respiratory distress syndrome biomarkers for SARS-CoV-2 patients (edit) |
10.1183/13993003.01531-2020 |
| 2020-08-28 |
Endothelial to mesenchymal transition (EndMT): a precursor to post-SARS-CoV-2 infection (COVID-19) interstitial pulmonary fibrosis and vascular obliteration? (edit) |
10.1183/13993003.03167-2020 |
| 2020-08-28 |
Utility and safety of bronchoscopy during SARS-CoV-2 outbreak in Italy: a retrospective, multicenter study (edit) |
10.1183/13993003.02767-2020 |
| 2020-08-28 |
Antiganglioside antibodies in Guillain-Barré syndrome associated with SARS-CoV-2 infection (edit) |
10.1136/JNNP-2020-324279 |
| 2020-08-28 |
Neutralizing antibody responses to SARS-CoV-2 in COVID-19 patients (edit) |
10.4103/IJMR.IJMR_2382_20 |
| 2020-08-28 |
Identification of SARS-CoV-2 clusters from symptomatic cases in India (edit) |
10.4103/IJMR.IJMR_2411_20 |
| 2020-08-28 |
Assessing SARS-CoV-2 RNA levels and lymphocyte/T cell counts in COVID-19 patients revealed initial immune status as a major determinant of disease severity (edit) |
10.1007/S00430-020-00693-Z |
| 2020-08-28 |
Transmission of SARS-CoV-2 through breast milk and breastfeeding: a living systematic review (edit) |
10.1111/NYAS.14477 |
| 2020-08-28 |
Effects of renin-angiotensin system blockers on the risk and outcomes of SARS-CoV-2 infection in patients with hypertension (edit) |
10.3904/KJIM.2020.390 |
| 2020-08-28 |
Co-infection of SARS-CoV-2 and Bordetella bronchiseptica in a young man with idiopathic non-cystic bronchiectasis and vitamin D3 deficiency (edit) |
10.1016/J.RMCR.2020.101203 |
| 2020-08-28 |
In silico structure modelling of SARS-CoV-2 Nsp13 helicase and Nsp14 and repurposing of FDA approved antiviral drugs as dual inhibitors (edit) |
10.1016/J.GENREP.2020.100860 |
| 2020-08-28 |
What are the roles of antibodies versus a durable, high quality T-cell response in protective immunity against SARS-CoV2? (edit) |
10.1016/J.JVACX.2020.100076 |
| 2020-08-28 |
EPICOVID19 protocol: repeated serological surveys on SARS-CoV-2 antibodies in Brazil (edit) |
10.1590/1413-81232020259.25532020 |
| 2020-08-28 |
[SARS-CoV-2 in Latin America and the Caribbean: The three intersections for critical thinking in health] (edit) |
10.1590/1413-81232020259.20952020 |
| 2020-08-28 |
Decline of SARS-CoV-2-specific IgG, IgM and IgA in convalescent COVID-19 patients within 100 days after hospital discharge (edit) |
10.1007/S11427-020-1805-0 |
| 2020-08-28 |
[Cardiovascular implications of SARS-CoV-2 infection: A literature review] (edit) |
10.5867/MEDWAVE.2020.07.8008 |
| 2020-08-28 |
Simultaneous occurrence of seasonal influenza virus and SARS CoV-2 strains (edit) |
10.1016/J.VACUN.2020.08.001 |
| 2020-08-28 |
BioAider: An efficient tool for viral genome analysis and its application in tracing SARS-CoV-2 transmission (edit) |
10.1016/J.SCS.2020.102466 |
| 2020-08-28 |
Epidemic Landscape and Forecasting of SARS-CoV-2 in India (edit) |
10.2991/JEGH.K.200823.001 |
| 2020-08-28 |
Testing for responses to the wrong SARS-CoV-2 antigen? (edit) |
10.1016/S0140-6736(20)31830-4 |
| 2020-08-28 |
Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study (edit) |
10.1016/S2468-1253(20)30271-5 |
| 2020-08-28 |
A Simple Approach to Optimum Pool Size for Pooled SARS-CoV-2 Testing (edit) |
10.1016/J.IJID.2020.08.063 |
| 2020-08-28 |
Comprehensive evolution and molecular characteristics of a large number of SARS-CoV-2 genomes reveal its epidemic trends (edit) |
10.1016/J.IJID.2020.08.066 |
| 2020-08-28 |
Identification of 14 Known Drugs as Inhibitors of the Main Protease of SARS-CoV-2 (edit) |
10.1101/2020.08.28.271957 |
| 2020-08-28 |
Long Period Modeling SARS-CoV-2 Infection of in Vitro Cultured Polarized Human Airway Epithelium (edit) |
10.1101/2020.08.27.271130 |
| 2020-08-28 |
Comparative study of a 3CL pro inhibitor and remdesivir against both major SARS-CoV-2 clades in human airway models (edit) |
10.1101/2020.08.28.272880 |
| 2020-08-28 |
A single immunization with spike-functionalized ferritin vaccines elicits neutralizing antibody responses against SARS-CoV-2 in mice (edit) |
10.1101/2020.08.28.272518 |
| 2020-08-28 |
Mask Wearing and Control of SARS-CoV-2 Transmission in the United States (edit) |
10.1101/2020.08.23.20078964 |
| 2020-08-27 |
The Antibody Response to SARS-CoV-2 Infection (edit) |
10.1093/OFID/OFAA387 |
| 2020-08-27 |
Cancer patients in SARS-CoV-2 infection: a single-center experience from Wuhan (edit) |
10.7150/JCA.47065 |
| 2020-08-27 |
COVID-19: Insight into the asymptomatic SARS-COV-2 infection and transmission (edit) |
10.7150/IJBS.48991 |
| 2020-08-27 |
Outcomes Associated with the Use of Renin-Angiotensin-Aldosterone System Blockade in Hospitalized Patients with SARS-CoV-2 Infection (edit) |
10.34067/KID.0003792020 |
| 2020-08-27 |
SARS-CoV-2 Nucleocapsid protein is decorated with multiple N- and O-glycans (edit) |
10.1101/2020.08.26.269043 |
| 2020-08-27 |
Postmortem examination of three SARS-CoV-2-positive autopsies including histopathologic and immunohistochemical analysis (edit) |
10.1007/S00414-020-02406-W |
| 2020-08-27 |
Insights into the structural and dynamical changes of spike glycoprotein mutations associated with SARS-CoV-2 host receptor binding (edit) |
10.1080/07391102.2020.1811774 |
| 2020-08-27 |
Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants - Withania somnifera (Ashwagandha), Tinospora cordifolia (Giloy) and Ocimum sanctum (Tulsi) - a molecular docking study (edit) |
10.1080/07391102.2020.1810778 |
| 2020-08-27 |
Neonates With Complex Cardiac Malformation and Congenital Diaphragmatic Hernia Born to SARS-CoV-2 Positive Women-A Single Center Experience (edit) |
10.1177/2150135120950256 |
| 2020-08-27 |
Systematic review with meta-analysis: SARS-CoV-2 stool testing and the potential for faecal-oral transmission (edit) |
10.1111/APT.16036 |
| 2020-08-27 |
Quantitative In-Vitro Diagnostic NMR Spectroscopy for Lipoprotein and Metabolite Measurements in Plasma and Serum: Recommendations for Analytical Artefact Minimization with Special Reference to COVID-19/SARS-CoV-2 Samples (edit) |
10.1021/ACS.JPROTEOME.0C00537 |
| 2020-08-27 |
Prevalence of Surface Contamination With SARS-CoV-2 in a Radiation Oncology Clinic (edit) |
10.1001/JAMAONCOL.2020.3552 |
| 2020-08-27 |
Acute adrenal infarction as an incidental CT finding and a potential prognosis factor in severe SARS-CoV-2 infection: a retrospective cohort analysis on 219 patients (edit) |
10.1007/S00330-020-07226-5 |
| 2020-08-27 |
Update Alert 2: Masks for Prevention of Respiratory Virus Infections, Including SARS-CoV-2, in Health Care and Community Settings (edit) |
10.7326/L20-1067 |
| 2020-08-27 |
Results of the first pilot external quality assessment (EQA) scheme for anti-SARS-CoV2-antibody testing (edit) |
10.1515/CCLM-2020-1183 |
| 2020-08-27 |
Impact of early pandemic stage mutations on molecular dynamics of SARS-CoV-2 Mpro (edit) |
10.1021/ACS.JCIM.0C00634 |
| 2020-08-27 |
A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures (edit) |
10.1038/S41586-020-2708-8 |
| 2020-08-27 |
The receptor binding domain of SARS-CoV-2 spike protein is the result of an ancestral recombination between the bat-CoV RaTG13 and the pangolin-CoV MP789 (edit) |
10.1186/S13104-020-05242-8 |
| 2020-08-27 |
SARS-CoV-2 assays to detect functional antibody responses that block ACE2 recognition in vaccinated animals and infected patients (edit) |
10.1128/JCM.01533-20 |
| 2020-08-27 |
Four SARS-CoV-2 Genome Sequences from Late April in Stockholm, Sweden, Reveal a Rare Mutation in the Spike Protein (edit) |
10.1128/MRA.00934-20 |
| 2020-08-27 |
Guillain-Barré syndrome in SARS-CoV-2 infection: an instant systematic review of the first six months of pandemic (edit) |
10.1136/JNNP-2020-324491 |
| 2020-08-27 |
Immunosuppression for intracranial vasculitis associated with SARS-CoV-2: therapeutic implications for COVID-19 cerebrovascular pathology (edit) |
10.1136/JNNP-2020-324291 |
| 2020-08-27 |
Promising inhibitors targeting Mpro: an ideal strategy for anti-SARS-CoV-2 drug discovery (edit) |
10.1038/S41392-020-00291-8 |
| 2020-08-27 |
A panel of human neutralizing mAbs targeting SARS-CoV-2 spike at multiple epitopes (edit) |
10.1038/S41467-020-18159-4 |
| 2020-08-27 |
Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication (edit) |
10.1038/S41467-020-18096-2 |
| 2020-08-27 |
Anti-SARS-CoV-2 antibody response in patients with chronic lymphocytic leukemia (edit) |
10.1038/S41375-020-01030-2 |
| 2020-08-27 |
SARS-CoV-2 and the brain to be studied long-term (edit) |
10.1038/S41582-020-0405-8 |
| 2020-08-27 |
Evaluation of SARS-CoV-2 serology assays reveals a range of test performance (edit) |
10.1038/S41587-020-0659-0 |
| 2020-08-27 |
Author Correction: ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infection (edit) |
10.1038/S41590-020-0788-0 |
| 2020-08-27 |
Comparative Population Pharmacokinetics of Darunavir in SARS-CoV-2 Patients vs. HIV Patients: The Role of Interleukin-6 (edit) |
10.1007/S40262-020-00933-8 |
| 2020-08-27 |
Caution With the Use of Lopinavir/Ritonavir in Severely Ill Patients for the Treatment of SARS-CoV-2: A Report of Severe Jaundice (edit) |
10.14309/AJG.0000000000000828 |
| 2020-08-27 |
Tracheal swab from front of neck airway for SARS-CoV-2; a bronchial foreign body (edit) |
10.1136/BCR-2020-237787 |
| 2020-08-27 |
Opioid agonist treatment during SARS-CoV2 & extended lockdown: Adaptations & challenges in the Indian context (edit) |
10.1016/J.AJP.2020.102377 |
| 2020-08-27 |
SARS-CoV-2 sample-to-answer nucleic acid testing in a tertiary care emergency department: evaluation and utility (edit) |
10.1016/J.JCV.2020.104614 |
| 2020-08-27 |
Malnutrition and nutritional therapy in patients with SARS-CoV-2 disease (edit) |
10.1016/J.CLNU.2020.08.021 |
| 2020-08-27 |
Asymptomatic screening for SARS CoV-2 prior to commencement of biologic therapies in patients with inflammatory bowel disease - a potentially harmful practice (edit) |
10.1016/J.DLD.2020.08.035 |
| 2020-08-27 |
Utility of Repeat Nasopharyngeal SARS-CoV-2 RT-PCR Testing and Refinement of Diagnostic Stewardship Strategies at a Tertiary Care Academic Center in a Low-Prevalence Area of the United States (edit) |
10.1093/OFID/OFAA388 |
| 2020-08-27 |
Decay of SARS-CoV-2 and surrogate murine hepatitis virus RNA in untreated wastewater to inform application in wastewater-based epidemiology (edit) |
10.1016/J.ENVRES.2020.110092 |
| 2020-08-27 |
Seroprevalence of SARS-Cov-2 in 646 professionals at the Rothschild Foundation Hospital (ProSeCoV study) (edit) |
10.1016/J.ACCPM.2020.08.003 |
| 2020-08-27 |
Multisystem inflammatory syndrome in children (MIS-C): Report of the clinical and epidemiological characteristics of cases in Santiago de Chile during the SARS-CoV-2 pandemic (edit) |
10.1016/J.IJID.2020.08.062 |
| 2020-08-27 |
Age-Related Differences in Immunological Responses to SARS-CoV-2 (edit) |
10.1016/J.JAIP.2020.08.026 |
| 2020-08-27 |
SARS-CoV-2/COVID-19: Evolution in the Caribbean islands (edit) |
10.1016/J.TMAID.2020.101854 |
| 2020-08-27 |
Study of a SARS-CoV-2 Outbreak in a Belgian Military Education and Training Center in Maradi, Niger (edit) |
10.3390/V12090949 |
| 2020-08-27 |
Using All-Atom Potentials to Refine RNA Structure Predictions of SARS-CoV-2 Stem Loops (edit) |
10.3390/IJMS21176188 |
| 2020-08-27 |
Aryl Hydrocarbon Receptor Role in Co-Ordinating SARS-CoV-2 Entry and Symptomatology: Linking Cytotoxicity Changes in COVID-19 and Cancers; Modulation by Racial Discrimination Stress (edit) |
10.3390/BIOLOGY9090249 |
| 2020-08-27 |
COVID-19 and Genetic Variants of Protein Involved in the SARS-CoV-2 Entry into the Host Cells (edit) |
10.3390/GENES11091010 |
| 2020-08-27 |
Prevalence of Antibodies to SARS-CoV-2 in Italian Adults and Associated Risk Factors (edit) |
10.3390/JCM9092780 |
| 2020-08-27 |
Ultrasound assisted synthesis of 3-alkynyl substituted 2-chloroquinoxaline derivatives: Their in silico assessment as potential ligands for N-protein of SARS-CoV-2 (edit) |
10.1016/J.TETLET.2020.152336 |
| 2020-08-27 |
Novel β-Coronavirus (SARS-CoV-2): Current and Future Aspects of Pharmacological Treatments (edit) |
10.1016/J.JSPS.2020.08.015 |
| 2020-08-27 |
Structure of SARS-CoV-2 ORF8, a rapidly evolving coronavirus protein implicated in immune evasion (edit) |
10.1101/2020.08.27.270637 |
| 2020-08-27 |
Unraveling the Epidemiology, Geographical Distribution, and Genomic Evolution of Potentially Lethal Coronaviruses (SARS, MERS, and SARS CoV-2) (edit) |
10.3389/FCIMB.2020.00499 |
| 2020-08-26 |
SARS-CoV-2 Treatment Approaches: Numerous Options, No Certainty for a Versatile Virus (edit) |
10.3389/FPHAR.2020.01224 |
| 2020-08-26 |
Repurposing Fragile X Drugs to Inhibit SARS-CoV-2 Viral Reproduction (edit) |
10.3389/FCELL.2020.00856 |
| 2020-08-26 |
Measures to Maintain a SARS-CoV-2 Negative Inpatient Hematological Unit in the Midst of the COVID-19 Pandemic (edit) |
10.3389/FMED.2020.00462 |
| 2020-08-26 |
Acute telogen effluvium associated with SARS-CoV-2 infection (edit) |
10.31128/AJGP-COVID-32 |
| 2020-08-26 |
The Yield and Consistency of the Detection of SARS-CoV-2 in Multiple Respiratory Specimens (edit) |
10.1093/OFID/OFAA379 |
| 2020-08-26 |
SARS-CoV-2 dysregulation of PTBP1 and YWHAE/Z gene expression: A primer of neurodegeneration (edit) |
10.1016/J.MEHY.2020.110212 |
| 2020-08-26 |
SARS-CoV-2-mediated encephalitis: Role of AT2R receptors in the blood-brain barrier (edit) |
10.1016/J.MEHY.2020.110213 |
| 2020-08-26 |
Crystal Structure of SARS-CoV-2 NSP7-NSP8 complex (edit) |
10.2210/PDB7JLT/PDB |
| 2020-08-26 |
Room Temperature Structure of SARS-CoV-2 Nsp10/Nsp16 Methyltransferase in a Complex with m7GpppA Cap-0 and SAM Determined by Fixed-Target Serial Crystallography (edit) |
10.2210/PDB7JPE/PDB |
| 2020-08-26 |
[Pediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2: How do we deal with an unpredictable enemy?] (edit) |
|
| 2020-08-26 |
Room Temperature Crystal Structure of Nsp10/Nsp16 from SARS-CoV-2 with Substrates and Products of 2'-O-methylation of the Cap-1 (edit) |
10.2210/PDB7JIB/PDB |
| 2020-08-26 |
Room Temperature Structure of SARS-CoV-2 Nsp10/Nsp16 Methyltransferase in a Complex with 2'-O-methylated m7GpppA Cap-1 and SAH Determined by Fixed-Target Serial Crystallography (edit) |
10.2210/PDB7JHE/PDB |
| 2020-08-26 |
The SARS-CoV-2 Spike mutation D614G increases entry fitness across a range of ACE2 levels, directly outcompetes the wild type, and is preferentially incorporated into trimers (edit) |
10.1101/2020.08.25.267500 |
| 2020-08-26 |
Revealing regional disparities in the transmission potential of SARS-CoV-2 from interventions in Southeast Asia (edit) |
10.1098/RSPB.2020.1173 |
| 2020-08-26 |
A five-compartment model of age-specific transmissibility of SARS-CoV-2 (edit) |
10.1186/S40249-020-00735-X |
| 2020-08-26 |
Healthcare Worker Infection with SARS-CoV-2 and Test-Based Return to Work (edit) |
10.1017/ICE.2020.438 |
| 2020-08-26 |
Asymptomatic SARS-CoV-2 infections in hospitalized patients (edit) |
10.1017/ICE.2020.441 |
| 2020-08-26 |
Antibody evidence of SARS-CoV-2 infection in healthcare workers in the Bronx (edit) |
10.1017/ICE.2020.437 |
| 2020-08-26 |
Functional mapping of B-cell linear epitopes of SARS-CoV-2 in COVID-19 convalescent population (edit) |
10.1080/22221751.2020.1815591 |
| 2020-08-26 |
Lessons Learned: Pediatric Tele-Mental Health in a Rural Medical Center in the Age of SARS-CoV-2 (edit) |
10.1111/JRH.12512 |
| 2020-08-26 |
Mechanism and inhibition of the papain-like protease, PLpro, of SARS-CoV-2 (edit) |
10.15252/EMBJ.2020106275 |
| 2020-08-26 |
Quantum Dot-Conjugated SARS-CoV-2 Spike Pseudo-Virions Enable Tracking of Angiotensin Converting Enzyme 2 Binding and Endocytosis (edit) |
10.1021/ACSNANO.0C05975 |
| 2020-08-26 |
Effectiveness of surgical, KF94, and N95 respirator masks in blocking SARS-CoV-2: a controlled comparison in 7 patients (edit) |
10.1080/23744235.2020.1810858 |
| 2020-08-26 |
Clinical Characteristics and Outcomes of 821 Older Patients with SARS-Cov-2 Infection Admitted to Acute Care Geriatric Wards (edit) |
10.1093/GERONA/GLAA210 |
| 2020-08-26 |
[Impacts of the SARS-CoV-2 pandemic on ophthalmic care in Germany] (edit) |
10.1007/S00347-020-01220-4 |
| 2020-08-26 |
[SARS-CoV-2 & rheumatic disease : Consequences of the SARS-CoV-2 pandemic for patients with inflammatory rheumatic diseases. A comparison of the recommendations for action of rheumatological societies and risk assessment of different antirheumatic t (edit) |
10.1007/S00393-020-00878-0 |
| 2020-08-26 |
Children account for a small proportion of diagnoses of SARS-CoV-2 infection and do not exhibit greater viral loads than adults (edit) |
10.1007/S10096-020-03900-0 |
| 2020-08-26 |
SARS-COV-2 Infection in a Term Neonate Presenting with Respiratory Failure on Day 3 of Life (edit) |
10.1007/S12098-020-03480-Z |
| 2020-08-26 |
Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection (edit) |
10.1002/14651858.CD013705 |
| 2020-08-26 |
Update Alert 3: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults (edit) |
10.7326/L20-1068 |
| 2020-08-26 |
SARS-CoV-2 serosurvey in health care workers of the Veneto Region (edit) |
10.1515/CCLM-2020-1236 |
| 2020-08-26 |
Vitamin C levels in patients with SARS-CoV-2-associated acute respiratory distress syndrome (edit) |
10.1186/S13054-020-03249-Y |
| 2020-08-26 |
Neuronophagia and microglial nodules in a SARS-CoV-2 patient with cerebellar hemorrhage (edit) |
10.1186/S40478-020-01024-2 |
| 2020-08-26 |
SARS-CoV-2 and three related coronaviruses utilize multiple ACE2 orthologs and are potently blocked by an improved ACE2-Ig (edit) |
10.1128/JVI.01283-20 |
| 2020-08-26 |
A Clinical Pathway for Hospitalized Pediatric Patients With Initial SARS-CoV-2 Infection (edit) |
10.1542/HPEDS.2020-0170 |
| 2020-08-26 |
Development and Clinical Application of a Rapid and Sensitive Loop-Mediated Isothermal Amplification Test for SARS-CoV-2 Infection (edit) |
10.1128/MSPHERE.00808-20 |
| 2020-08-26 |
High incidence of false positive results in patients with other acute infections, using the LIAISON® SARS-CoV-2 commercial chemiluminescent micro-particle immunoassay for detection of IgG anti SARS-CoV-2 antibodies (edit) |
10.1128/JCM.01352-20 |
| 2020-08-26 |
Dynamics of the ACE2-SARS-CoV-2/SARS-CoV spike protein interface reveal unique mechanisms (edit) |
10.1038/S41598-020-71188-3 |
| 2020-08-26 |
Clinical validation of a Cas13-based assay for the detection of SARS-CoV-2 RNA (edit) |
10.1038/S41551-020-00603-X |
| 2020-08-26 |
Author Correction: SARS-CoV-2 and bat RaTG13 spike glycoprotein structures inform on virus evolution and furin-cleavage effects (edit) |
10.1038/S41594-020-0509-2 |
| 2020-08-26 |
Thrombosis and antiphospholipid antibodies in patients with SARS-COV-2 infection (COVID-19) (edit) |
10.1111/IJLH.13320 |
| 2020-08-26 |
How does the Hierarchy of Controls Integrate with the Epidemiologic Triangle to Help Address and Understand Transmission of SARS-CoV-2? (edit) |
10.1097/JOM.0000000000002009 |
| 2020-08-26 |
Universal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2) Testing Uptake in the Labor and Delivery Unit: Implications for Health Equity (edit) |
10.1097/AOG.0000000000004127 |
| 2020-08-26 |
Professional Quality of Life and Mental Health Outcomes among Health Care Workers Exposed to Sars-Cov-2 (Covid-19) (edit) |
10.3390/IJERPH17176180 |
| 2020-08-26 |
The Impact and Consequences of SARS-CoV-2 Pandemic on a Single University Dermatology Outpatient Clinic in Germany (edit) |
10.3390/IJERPH17176182 |
| 2020-08-26 |
Prediction and Analysis of SARS-CoV-2-Targeting MicroRNA in Human Lung Epithelium (edit) |
10.3390/GENES11091002 |
| 2020-08-26 |
Compartmentalized Replication of SARS-Cov-2 in Upper vs. Lower Respiratory Tract Assessed by Whole Genome Quasispecies Analysis (edit) |
10.3390/MICROORGANISMS8091302 |
| 2020-08-26 |
Optimization Rules for SARS-CoV-2 Mpro Antivirals: Ensemble Docking and Exploration of the Coronavirus Protease Active Site (edit) |
10.3390/V12090942 |
| 2020-08-26 |
SARS-CoV-2 Spike 1 Protein Controls Natural Killer Cell Activation via the HLA-E/NKG2A Pathway (edit) |
10.3390/CELLS9091975 |
| 2020-08-26 |
Asymptomatic SARS-CoV-2 infection in patients with inflammatory bowel disease under biologic treatment (edit) |
10.1053/J.GASTRO.2020.08.046 |
| 2020-08-26 |
Rethinking environmental contamination and fomite transmission of SARS-CoV-2 in the healthcare (edit) |
10.1016/J.JINF.2020.08.041 |
| 2020-08-26 |
High rates of SARS-CoV-2 seropositivity in nursing home residents (edit) |
10.1016/J.JINF.2020.08.040 |
| 2020-08-26 |
Synergistic effects of anionic surfactants on coronavirus (SARS-CoV-2) virucidal efficiency of sanitizing fluids to fight COVID-19 (edit) |
10.1016/J.FCT.2020.111702 |
| 2020-08-26 |
A Case Report of Newborn Infant with Severe COVID-19 in Mexico: Detection of SARS-CoV-2 in Human Breast Milk and Stool (edit) |
10.1016/J.IJID.2020.08.055 |
| 2020-08-26 |
Quantitative phylogenomic evidence reveals a spatially structured SARS-CoV-2 diversity (edit) |
10.1016/J.VIROL.2020.08.010 |
| 2020-08-26 |
Coinfection of SARS-CoV-2 and Other Respiratory Pathogens (edit) |
10.2147/IDR.S267238 |
| 2020-08-26 |
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (edit) |
10.1016/J.TIG.2020.08.014 |
| 2020-08-26 |
Co-infection of SARS-CoV-2 and dengue virus: a clinical challenge (edit) |
10.1016/J.BJID.2020.07.008 |
| 2020-08-26 |
Immune response in SARS-CoV-2 infection: the role of interferons type I and type III (edit) |
10.1016/J.BJID.2020.07.011 |
| 2020-08-26 |
International Society for Gynecologic Endoscopy (ISGE) guidelines and recommendations on gynecological endoscopy during the evolutionary phases of the SARS-CoV-2 pandemic (edit) |
10.1016/J.EJOGRB.2020.08.039 |
| 2020-08-26 |
Potential clinical drugs as covalent inhibitors of the priming proteases of the spike protein of SARS-CoV-2 (edit) |
10.1016/J.CSBJ.2020.08.016 |
| 2020-08-26 |
A drug screening toolkit based on the -1 ribosomal frameshifting of SARS-CoV-2 (edit) |
10.1016/J.HELIYON.2020.E04793 |
| 2020-08-26 |
SARS-CoV-2 infection in the COPD population is associated with increased healthcare utilization: An analysis of Cleveland clinic's COVID-19 registry (edit) |
10.1016/J.ECLINM.2020.100515 |
| 2020-08-26 |
Furin Cleavage Site Is Key to SARS-CoV-2 Pathogenesis (edit) |
10.1101/2020.08.26.268854 |
| 2020-08-26 |
SARS-CoV-2 genomic and quasispecies analyses in cancer patients reveal relaxed intrahost virus evolution (edit) |
10.1101/2020.08.26.267831 |
| 2020-08-26 |
Genomic surveillance revealed prevalence of unique SARS-CoV-2 variants bearing mutation in the RdRp gene among Nevada patients (edit) |
10.1101/2020.08.21.20178863 |
| 2020-08-25 |
Respiratory Microbial Co-infection With SARS-CoV-2 (edit) |
10.3389/FMICB.2020.02079 |
| 2020-08-25 |
Temporal, Spatial, and Epidemiologic Relationships of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Gene Cycle Thresholds: A Pragmatic Ambi-directional Observation (edit) |
10.1093/CID/CIAA1248 |
| 2020-08-25 |
Prediction Models in Veterinary and Human Epidemiology: Our Experience With Modeling Sars-CoV-2 Spread (edit) |
10.3389/FVETS.2020.00513 |
| 2020-08-25 |
Drug Weaponry to Fight Against SARS-CoV-2 (edit) |
10.3389/FMOLB.2020.00204 |
| 2020-08-25 |
Multi-route transmission potential of SARS-CoV-2 in healthcare facilities (edit) |
10.1016/J.JHAZMAT.2020.123771 |
| 2020-08-25 |
The S1/S2 boundary of SARS-CoV-2 spike protein modulates cell entry pathways and transmission (edit) |
10.1101/2020.08.25.266775 |
| 2020-08-25 |
Curbing the Spread of COVID-19 Pandemic Caused by SARS-CoV-2: Considering Psychological, SocioLegal and Ethical Implications on Preventive Measures in Cameroon (edit) |
10.31829/2692-4242/BIOGEN2020-3(1)-108 |
| 2020-08-25 |
Alkamides and Piperamides as Potential Antivirals Against the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (edit) |
10.1021/ACS.JPCLETT.0C01685 |
| 2020-08-25 |
Hospital discharge diagnoses in patients with SARS-CoV-2 infection in the first months of COVID-19 outbreak in the Italian province of Udine (edit) |
10.1177/1833358320948741 |
| 2020-08-25 |
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), a newly emerged pathogen: an overview (edit) |
10.1093/FEMSPD/FTAA042 |
| 2020-08-25 |
Prevalence of SARS-CoV-2 Infection in Children Without Symptoms of Coronavirus Disease 2019 (edit) |
10.1001/JAMAPEDIATRICS.2020.4095 |
| 2020-08-25 |
Cluster of SARS-CoV-2 infections linked to music clubs in Osaka, Japan: asymptomatically infected persons can transmit the virus as soon as 2 days after infection (edit) |
10.1093/INFDIS/JIAA542 |
| 2020-08-25 |
SARS-CoV-2 Infectivity and Neurological Targets in the Brain (edit) |
10.1007/S10571-020-00947-7 |
| 2020-08-25 |
Prevalence of asymptomatic deep vein thrombosis in patients hospitalized with SARS-CoV-2 pneumonia: a cross-sectional study (edit) |
10.1007/S11739-020-02472-3 |
| 2020-08-25 |
Human angiotensin-converting enzyme 2 transgenic mice infected with SARS-CoV-2 develop severe and fatal respiratory disease (edit) |
10.1172/JCI.INSIGHT.142032 |
| 2020-08-25 |
Operationalizing HIV cure-related trials with analytic treatment interruptions during the SARS-CoV-2 pandemic: A collaborative approach (edit) |
10.1093/CID/CIAA1260 |
| 2020-08-25 |
Concomitant marked decline in prevalence of SARS-CoV-2 and other respiratory viruses among symptomatic patients following public health interventions in Australia: data from St Vincent's Hospital and associated screening clinics, Sydney, NSW (edit) |
10.1093/CID/CIAA1256 |
| 2020-08-25 |
Asymptomatic SARS-CoV-2 infections in pregnant patients in an Italian city during complete lockdown (edit) |
10.1002/JMV.26458 |
| 2020-08-25 |
Saliva sample pooling for the detection of SARS-CoV-2 (edit) |
10.1002/JMV.26460 |
| 2020-08-25 |
Targeting NLRP3 Inflammasome in an Animal Model for SARS-CoV-2 (edit) |
10.1002/JMV.26461 |
| 2020-08-25 |
Allosteric inhibition of the SARS-CoV-2 main protease - insights from mass spectrometry-based assays (edit) |
10.1002/ANIE.202010316 |
| 2020-08-25 |
Clinical Characteristics of Patients with Severe Pneumonia Caused by the SARS-CoV-2 in Wuhan, China (edit) |
10.1159/000507940 |
| 2020-08-25 |
An Uninfected Preterm Newborn Inadvertently Fed SARS-CoV-2-Positive Breast Milk (edit) |
10.1542/PEDS.2020-004960 |
| 2020-08-25 |
Evaluation of High Throughput Serological Tests for SARS-CoV-2 (edit) |
10.1128/JCM.02179-20 |
| 2020-08-25 |
Development of a fluorescence based, high-throughput SARS-CoV-2 3CLpro reporter assay (edit) |
10.1128/JVI.01265-20 |
| 2020-08-25 |
Molecular features of IGHV3-53-encoded antibodies elicited by SARS-CoV-2 (edit) |
10.1038/S41392-020-00287-4 |
| 2020-08-25 |
A broad-spectrum virus- and host-targeting peptide against respiratory viruses including influenza virus and SARS-CoV-2 (edit) |
10.1038/S41467-020-17986-9 |
| 2020-08-25 |
Immunoinformatic identification of B cell and T cell epitopes in the SARS-CoV-2 proteome (edit) |
10.1038/S41598-020-70864-8 |
| 2020-08-25 |
A mouse model for SARS-CoV-2 infection by exogenous delivery of hACE2 using alphavirus replicon particles (edit) |
10.1038/S41422-020-00405-5 |
| 2020-08-25 |
Resuming elective hip and knee arthroplasty after the first phase of the SARS-CoV-2 pandemic: the European Hip Society and European Knee Associates recommendations (edit) |
10.1007/S00167-020-06233-9 |
| 2020-08-25 |
Human post-infection serological response to the spike and nucleocapsid proteins of SARS-CoV-2 (edit) |
10.1111/IRV.12798 |
| 2020-08-25 |
Identification of Exertional Hypoxia and Its Implications in SARS-CoV-2 Pneumonia (edit) |
10.4269/AJTMH.20-1012 |
| 2020-08-25 |
A Case Report of Isopropanol Ingestion During the SARS-CoV-2 Pandemic (edit) |
10.1097/ADM.0000000000000728 |
| 2020-08-25 |
The Antiviral, Anti-Inflammatory Effects of Natural Medicinal Herbs and Mushrooms and SARS-CoV-2 Infection (edit) |
10.3390/NU12092573 |
| 2020-08-25 |
Current Clinical Trials Protocols and the Global Effort for Immunization against SARS-CoV-2 (edit) |
10.3390/VACCINES8030474 |
| 2020-08-25 |
Targeting the sAC-Dependent cAMP Pool to Prevent SARS-Cov-2 Infection (edit) |
10.3390/CELLS9091962 |
| 2020-08-25 |
Evaluation of SARS-CoV-2 prototype serologic test in hospitalized patients (edit) |
10.1016/J.CLINBIOCHEM.2020.08.008 |
| 2020-08-25 |
High clinical performance and quantitative assessment of antibody kinetics using a dual recognition assay for the detection of SARS-CoV-2 IgM and IgG antibodies (edit) |
10.1016/J.CLINBIOCHEM.2020.08.009 |
| 2020-08-25 |
Low incidence of SARS-CoV-2, risk factors of mortality and the course of illness in the French national cohort of dialysis patients (edit) |
10.1016/J.KINT.2020.07.042 |
| 2020-08-25 |
SARS-CoV-2 another kind of liver aggressor, how does it do that? (edit) |
10.1016/J.AOHEP.2020.08.062 |
| 2020-08-25 |
A survey of genetic variants in SARS-CoV-2 interacting domains of ACE2, TMPRSS2 and TLR3/7/8 across populations (edit) |
10.1016/J.MEEGID.2020.104507 |
| 2020-08-25 |
Coinfection by SARS-CoV-2 and dengue virus in a dual viral circulation setting (edit) |
10.1016/J.TMAID.2020.101862 |
| 2020-08-25 |
Another false-positive problem for a SARS-CoV-2 antigen test in Japan (edit) |
10.1016/J.JCV.2020.104612 |
| 2020-08-25 |
SARS-CoV-2 serology and virology trends in donors and recipients of convalescent plasma (edit) |
10.1016/J.TRANSCI.2020.102922 |
| 2020-08-25 |
Design an Efficient Multi-Epitope Peptide Vaccine Candidate Against SARS-CoV-2: An in silico Analysis (edit) |
10.2147/IDR.S264573 |
| 2020-08-25 |
Consistent localization of SARS-CoV-2 spike glycoprotein and ACE2 over TMPRSS2 predominance in placental villi of 15 COVID-19 positive maternal-fetal dyads (edit) |
10.1016/J.PLACENTA.2020.08.015 |
| 2020-08-25 |
[Resuscitation of children during the SARS-CoV-2 pandemic-a balance between self-protection and the factor of time] (edit) |
10.1007/S10049-020-00768-7 |
| 2020-08-25 |
Bacterial pneumonia coinfection and antimicrobial therapy duration in SARS-CoV-2 (COVID-19) infection (edit) |
10.1093/JACAMR/DLAA071 |
| 2020-08-25 |
Versatile, Multivalent Nanobody Cocktails Efficiently Neutralize SARS-CoV-2 (edit) |
10.1101/2020.08.24.264333 |
| 2020-08-25 |
Phylogenetic analysis of SARS-CoV-2 in the Boston area highlights the role of recurrent importation and superspreading events (edit) |
10.1101/2020.08.23.20178236 |
| 2020-08-25 |
A deterministic linear infection model to inform Risk-Cost-Benefit Analysis of activities during the SARS-CoV-2 pandemic (edit) |
10.1101/2020.08.23.20180349 |
| 2020-08-24 |
Prioritizing care for severe asthma during SARS-CoV-2 pandemic (edit) |
10.1016/J.PULMOE.2020.08.001 |
| 2020-08-24 |
COVID-19: Can the symptomatic SARS-CoV-2 infection affect the homeostasis of the gut-brain-microbiota axis? (edit) |
10.1016/J.MEHY.2020.110206 |
| 2020-08-24 |
The SARS-CoV-2 Envelope and Membrane proteins modulate maturation and retention of the Spike protein, allowing optimal formation of VLPs in presence of Nucleoprotein (edit) |
10.1101/2020.08.24.260901 |
| 2020-08-24 |
QSAR Modeling of SARS-CoV Mpro Inhibitors Identifies Sufugolix, Cenicriviroc, Proglumetacin, and other Drugs as Candidates for Repurposing against SARS-CoV-2 (edit) |
10.1002/MINF.202000113 |
| 2020-08-24 |
Dynamics of the N-terminal domain of SARS-CoV-2 nucleocapsid protein drives dsRNA melting in a counterintuitive tweezer-like mechanism (edit) |
10.1101/2020.08.24.264465 |
| 2020-08-24 |
Pathogenicity, immunogenicity, and protective ability of an attenuated SARS-CoV-2 variant with a deletion at the S1/S2 junction of the spike protein (edit) |
10.1101/2020.08.24.264192 |
| 2020-08-24 |
Anti SARS-CoV-2 antibodies monitoring in a group of residents in a long term care facility during COVID-19 pandemic peak (edit) |
10.1515/DX-2020-0094 |
| 2020-08-24 |
Impact of On-site Compared to Send-away Testing for SARS-CoV-2 on Duration of Isolation and Resource Utilization (edit) |
10.1017/ICE.2020.433 |
| 2020-08-24 |
Incidence, Clinical Characteristics, and Evolution of SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: A Single-Center Study in Madrid, Spain (edit) |
10.1093/IBD/IZAA221 |
| 2020-08-24 |
Seroprevalence of Anti-SARS-CoV-2 Antibodies among Outpatients in Southwestern Seoul, Korea (edit) |
10.3346/JKMS.2020.35.E311 |
| 2020-08-24 |
SARS-CoV-2 infection prevalence on repatriation flights from Wuhan City, China (edit) |
10.1093/JTM/TAAA135 |
| 2020-08-24 |
Canakinumab to reduce deterioration of cardiac and respiratory function in SARS-CoV-2 associated myocardial injury with heightened inflammation (canakinumab in Covid-19 cardiac injury: The three C study) (edit) |
10.1002/CLC.23451 |
| 2020-08-24 |
Investigation of the genetic variation in ACE2 on the structural recognition by the novel coronavirus (SARS-CoV-2) (edit) |
10.1186/S12967-020-02486-7 |
| 2020-08-24 |
The contribution of asymptomatic SARS-CoV-2 infections to transmission on the Diamond Princess cruise ship (edit) |
10.7554/ELIFE.58699 |
| 2020-08-24 |
Computational Alanine Scanning and Structural Analysis of the SARS-CoV-2 Spike Protein/Angiotensin-Converting Enzyme 2 Complex (edit) |
10.1021/ACSNANO.0C04674 |
| 2020-08-24 |
SARS-CoV-2 specific T-cell responses and correlations with COVID-19 patient predisposition (edit) |
10.1172/JCI140965 |
| 2020-08-24 |
In silico validation of coumarin derivatives as potential inhibitors against Main Protease, NSP10/NSP16-Methyltransferase, Phosphatase and Endoribonuclease of SARS CoV-2 (edit) |
10.1080/07391102.2020.1808075 |
| 2020-08-24 |
[SARS-CoV-2 and Perinatal Aspects] (edit) |
10.1055/A-1192-7437 |
| 2020-08-24 |
[Period Prevalence of SARS-CoV-2 in an Unselected Sample of Pregnant Women in Jena, Thuringia] (edit) |
10.1055/A-1206-1033 |
| 2020-08-24 |
[Update on Recommendations for SARS-CoV-2/COVID-19 During Pregnancy, Birth and Childbed] (edit) |
10.1055/A-1199-6404 |
| 2020-08-24 |
Vaccination against SARS-CoV-2 and disease enhancement - knowns and unknowns (edit) |
10.1080/14760584.2020.1800463 |
| 2020-08-24 |
Russian SARS-CoV-2 vaccine (edit) |
10.1136/BMJ.M3270 |
| 2020-08-24 |
Inactivation analysis of SARS-CoV-2 by specimen transport media, nucleic acid extraction reagents, detergents and fixatives (edit) |
10.1128/JCM.01713-20 |
| 2020-08-24 |
SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function (edit) |
10.1038/S41590-020-0778-2 |
| 2020-08-24 |
Vaccines targeting SARS-CoV-2 tested in humans (edit) |
10.1038/S41591-020-1048-4 |
| 2020-08-24 |
Anticoagulation use and Hemorrhagic Stroke in SARS-CoV-2 Patients Treated at a New York Healthcare System (edit) |
10.1007/S12028-020-01077-0 |
| 2020-08-24 |
Clinical Characteristics of Hospitalized Patients with SARS-CoV-2 and Hepatitis B Virus Co-infection (edit) |
10.1007/S12250-020-00276-5 |
| 2020-08-24 |
Persistence of SARS-CoV-2 nasopharyngeal swab PCR positivity in COVID-19 convalescent plasma donors (edit) |
10.1111/TRF.16015 |
| 2020-08-24 |
Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 Receptor (edit) |
10.1016/J.CHOM.2020.08.004 |
| 2020-08-24 |
Immune Dysfunction and Multiple Treatment Modalities for the SARS-CoV-2 Pandemic: Races of Uncontrolled Running Sweat? (edit) |
10.3390/BIOLOGY9090243 |
| 2020-08-24 |
A Scalable Topical Vectored Vaccine Candidate against SARS-CoV-2 (edit) |
10.3390/VACCINES8030472 |
| 2020-08-24 |
A New ERAP2/Iso3 Isoform Expression Is Triggered by Different Microbial Stimuli in Human Cells. Could It Play a Role in the Modulation of SARS-CoV-2 Infection? (edit) |
10.3390/CELLS9091951 |
| 2020-08-24 |
Expression of SARS-CoV-2 cell entry genes, ACE2 and TMPRSS2, in the placenta across gestation and at the maternal-fetal interface in pregnancies complicated by preterm birth or preeclampsia (edit) |
10.1016/J.AJOG.2020.08.055 |
| 2020-08-24 |
SARS-CoV-2 IgG and IgA antibody response is gender dependent; and IgG antibodies rapidly decline early on (edit) |
10.1016/J.JINF.2020.08.032 |
| 2020-08-24 |
COVID-19 patients display distinct SARS-CoV-2 specific T-cell responses according to disease severity (edit) |
10.1016/J.JINF.2020.08.036 |
| 2020-08-24 |
Diagnostic significance of SARS-CoV-2 IgM positive/IgG negative antibody profile in symptomatic patients with suspected COVID-19 testing negative by RT-PCR (edit) |
10.1016/J.JINF.2020.08.028 |
| 2020-08-24 |
Characterizing COVID-19 severity, epidemiology and SARS-CoV-2 genotypes in a regional business hub of China (edit) |
10.1016/J.JINF.2020.08.031 |
| 2020-08-24 |
Detection of SARS-CoV-2 in ophthalmic secretions in Pakistan: A preliminary report (edit) |
10.1016/J.JINF.2020.08.035 |
| 2020-08-24 |
Screening and evaluation of approved drugs as inhibitors of main protease of SARS-CoV-2 (edit) |
10.1016/J.IJBIOMAC.2020.08.166 |
| 2020-08-24 |
Clinical, immunological and virological characterization of COVID-19 patients that test re-positive for SARS-CoV-2 by RT-PCR (edit) |
10.1016/J.EBIOM.2020.102960 |
| 2020-08-24 |
SARS-CoV-2 isolation from an appendix (edit) |
10.1093/JSCR/RJAA245 |
| 2020-08-24 |
No transmission of SARS-CoV-2 in a patient undergoing allogeneic hematopoietic cell transplantation from a matched-related donor with unknown COVID-19 (edit) |
10.1016/J.TRANSCI.2020.102921 |
| 2020-08-24 |
Salivary extracellular vesicles inhibit Zika virus but not SARS-CoV-2 infection (edit) |
10.1080/20013078.2020.1808281 |
| 2020-08-24 |
Insights into antiviral mechanisms of remdesivir, lopinavir/ritonavir and chloroquine/hydroxychloroquine affecting the new SARS-CoV-2 (edit) |
10.1016/J.BIOPHA.2020.110668 |
| 2020-08-24 |
Interferon β-1b in treatment of severe COVID-19: A randomized clinical trial (edit) |
10.1016/J.INTIMP.2020.106903 |
| 2020-08-24 |
[Inflammation, malnutrition, and SARS-CoV-2 infection: a disastrous combination] (edit) |
10.1016/J.RCE.2020.07.007 |
| 2020-08-24 |
Hydroxychloroquine in COVID-19: Potential Mechanism of Action Against SARS-CoV-2 (edit) |
10.1007/S40495-020-00231-8 |
| 2020-08-24 |
Comparative evaluation of SARS-CoV-2 IgG assays in India (edit) |
10.1016/J.JCV.2020.104609 |
| 2020-08-24 |
Seroprevalence of SARS-CoV-2 antibodies among healthy blood donors in Karachi, Pakistan (edit) |
10.1016/J.TRANSCI.2020.102923 |
| 2020-08-24 |
SARS-CoV-2 Spike protein co-opts VEGF-A/Neuropilin-1 receptor signaling to induce analgesia (edit) |
10.1101/2020.07.17.209288 |
| 2020-08-23 |
Lipid droplets fuel SARS-CoV-2 replication and production of inflammatory mediators (edit) |
10.1101/2020.08.22.262733 |
| 2020-08-23 |
The Association between Influenza and Pneumococcal Vaccinations and SARS-Cov-2 Infection: Data from the EPICOVID19 Web-Based Survey (edit) |
10.3390/VACCINES8030471 |
| 2020-08-23 |
Drug Repurposing for Candidate SARS-CoV-2 Main Protease Inhibitors by a Novel In Silico Method (edit) |
10.3390/MOLECULES25173830 |
| 2020-08-23 |
COVID-19: Pathophysiology, treatment options, nanotechnology approaches, and research agenda to combating the SARS-CoV2 pandemic (edit) |
10.1016/J.LFS.2020.118336 |
| 2020-08-23 |
Quantifying the effect of remdesivir in rhesus macaques infected with SARS-CoV-2 (edit) |
10.1016/J.VIROL.2020.07.015 |
| 2020-08-23 |
Peripheral blood CD4+ cell counts but not CD3+ and CD8+ cell counts are reduced in SARS-CoV-2 infection (edit) |
10.1016/J.JAD.2020.08.037 |
| 2020-08-23 |
Molecular dynamics simulation of docking structures of SARS-CoV-2 main protease and HIV protease inhibitors (edit) |
10.1016/J.MOLSTRUC.2020.129143 |
| 2020-08-22 |
The impact of the SARS-CoV-2 pandemic on psychiatric emergencies in northern Greece: preliminary study on a sample of the Greek population (edit) |
10.1111/PCN.13136 |
| 2020-08-22 |
Immune Alterations in a Patient with SARS-CoV-2-Related Acute Respiratory Distress Syndrome (edit) |
10.1007/S10875-020-00839-X |
| 2020-08-22 |
SUBLINGUAL MICROCIRCULATION IN PATIENTS WITH SARS-CoV-2 UNDERGOING VENO-VENOUS EXTRACORPOREAL MEMBRANE OXYGENATION (edit) |
10.1016/J.MVR.2020.104064 |
| 2020-08-22 |
Food proteins are a potential resource for mining cathepsin L inhibitory drugs to combat SARS-CoV-2 (edit) |
10.1016/J.EJPHAR.2020.173499 |
| 2020-08-22 |
A genetic barcode of SARS-CoV-2 for monitoring global distribution of different clades during the COVID-19 pandemic (edit) |
10.1016/J.IJID.2020.08.052 |
| 2020-08-22 |
In Silico Identification of Potential Natural Product Inhibitors of Human Proteases Key to SARS-CoV-2 Infection (edit) |
10.3390/MOLECULES25173822 |
| 2020-08-22 |
Rapid Review of SARS-CoV-1 and SARS-CoV-2 Viability, Susceptibility to Treatment, and the Disinfection and Reuse of PPE, Particularly Filtering Facepiece Respirators (edit) |
10.3390/IJERPH17176117 |
| 2020-08-22 |
Possible Retinal Impairment Secondary to Ritonavir Use in SARS-CoV-2 Patients: A Narrative Systematic Review (edit) |
10.1155/2020/5350494 |
| 2020-08-22 |
Persistent COVID-19 Pneumonia and Failure to Develop Anti-SARS-CoV-2 Antibodies During Rituximab Maintenance Therapy for Follicular Lymphoma (edit) |
10.1016/J.CLML.2020.08.017 |
| 2020-08-22 |
Caffeic acid derivatives (CAFDs) as inhibitors of SARS-CoV-2: CAFDs-based functional foods as a potential alternative approach to combat COVID-19 (edit) |
10.1016/J.PHYMED.2020.153310 |
| 2020-08-22 |
SARS-CoV-2 pandemic and epilepsy: The impact on emergency department attendances for seizures (edit) |
10.1016/J.SEIZURE.2020.08.008 |
| 2020-08-21 |
Dynamic competition between SARS-CoV-2 NSP1 and mRNA on the human ribosome inhibits translation initiation (edit) |
10.1101/2020.08.20.259770 |
| 2020-08-21 |
Mass Testing for SARS-CoV-2 in 16 Prisons and Jails - Six Jurisdictions, United States, April-May 2020 (edit) |
10.15585/MMWR.MM6933A3 |
| 2020-08-21 |
Selecting Controls for Minimizing SARS-CoV-2 Aerosol Transmission in Workplaces and Conserving Respiratory Protective Equipment Supplies (edit) |
10.1093/ANNWEH/WXAA083 |
| 2020-08-21 |
Agent-based modelling for SARS-CoV-2 epidemic prediction and intervention assessment: A methodological appraisal (edit) |
10.1111/JEP.13459 |
| 2020-08-21 |
No transmission of SARS-CoV-2 to 23 healthcare professionals involved in advanced life support of COVID-19 patient - association with low viral RNA in respiratory specimens (edit) |
10.1080/23744235.2020.1810309 |
| 2020-08-21 |
Lipid-based nano delivery of Tat-peptide conjugated drug or vaccine-promising therapeutic strategy for SARS-CoV-2 treatment (edit) |
10.1080/17425247.2020.1813712 |
| 2020-08-21 |
Differential occupational risks to healthcare workers from SARS-CoV-2 observed during a prospective observational study (edit) |
10.7554/ELIFE.60675 |
| 2020-08-21 |
SARS-CoV-2 growth, furin-cleavage-site adaptation and neutralization using serum from acutely infected hospitalized COVID-19 patients (edit) |
10.1099/JGV.0.001481 |
| 2020-08-21 |
Routine laboratory blood tests predict SARS-CoV-2 infection using machine learning (edit) |
10.1093/CLINCHEM/HVAA200 |
| 2020-08-21 |
SARS-CoV-2 Community Transmission disproportionately affects Latinx population during Shelter-in-Place in San Francisco (edit) |
10.1093/CID/CIAA1234 |
| 2020-08-21 |
Longitudinal Characteristics of T Cell Responses in Asymptomatic SARS-CoV-2 Infection (edit) |
10.1007/S12250-020-00277-4 |
| 2020-08-21 |
Comparing the binding properties of peptides mimicking the Envelope protein of SARS-CoV and SARS-CoV-2 to the PDZ domain of the tight junction-associated PALS1 protein (edit) |
10.1002/PRO.3936 |
| 2020-08-21 |
Asymptomatic Transmission of SARS-CoV-2 on Evacuation Flight (edit) |
10.3201/EID2611.203353 |
| 2020-08-21 |
Real-time public health communication of local SARS-CoV-2 genomic epidemiology (edit) |
10.1371/JOURNAL.PBIO.3000869 |
| 2020-08-21 |
COVID-19 pandemic: Insights into structure, function, and hACE2 receptor recognition by SARS-CoV-2 (edit) |
10.1371/JOURNAL.PPAT.1008762 |
| 2020-08-21 |
Acalcolous Hemorrhagic Cholecystitis and SARS-CoV-2 Infection (edit) |
10.1002/BJS.11992 |
| 2020-08-21 |
[The impact of SARS-CoV-2 restrictions on medical care in Plastic Surgery] (edit) |
10.1055/A-1220-6920 |
| 2020-08-21 |
SARS-CoV-2 Infection in Children in Southern Italy: A Descriptive Case Series (edit) |
10.3390/IJERPH17176080 |
| 2020-08-21 |
On the Optimal Indoor Air Conditions for SARS-CoV-2 Inactivation. An Enthalpy-Based Approach (edit) |
10.3390/IJERPH17176083 |
| 2020-08-21 |
Red Blood Cell Distribution Width (RDW) Predicts COVID-19 Severity: A Prospective, Observational Study from the Cincinnati SARS-CoV-2 Emergency Department Cohort (edit) |
10.3390/DIAGNOSTICS10090618 |
| 2020-08-21 |
Neutralizing antibodies correlate with protection from SARS-CoV-2 in humans during a fishery vessel outbreak with high attack rate (edit) |
10.1128/JCM.02107-20 |
| 2020-08-21 |
Estimating unobserved SARS-CoV-2 infections in the United States (edit) |
10.1073/PNAS.2005476117 |
| 2020-08-21 |
Broad host range of SARS-CoV-2 predicted by comparative and structural analysis of ACE2 in vertebrates (edit) |
10.1073/PNAS.2010146117 |
| 2020-08-21 |
A cross-reactive human IgA monoclonal antibody blocks SARS-CoV-2 spike-ACE2 interaction (edit) |
10.1038/S41467-020-18058-8 |
| 2020-08-21 |
An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques (edit) |
10.1038/S41467-020-18077-5 |
| 2020-08-21 |
Attacking the defence: SARS-CoV-2 can infect immune cells (edit) |
10.1038/S41577-020-00439-1 |
| 2020-08-21 |
CD8+ T cells remember same bits of SARS-CoV-2 (edit) |
10.1038/S41577-020-00440-8 |
| 2020-08-21 |
Author Correction: Sampling the host response to SARS-CoV-2 in hospitals under siege (edit) |
10.1038/S41591-020-1057-3 |
| 2020-08-21 |
A highly specific and sensitive serological assay detects SARS-CoV-2 antibody levels in COVID-19 patients that correlate with neutralization (edit) |
10.1007/S15010-020-01503-7 |
| 2020-08-21 |
Variability in genes related to SARS-CoV-2 entry into host cells (ACE2, TMPRSS2, TMPRSS11A, ELANE, and CTSL) and its potential use in association studies (edit) |
10.1016/J.LFS.2020.118313 |
| 2020-08-21 |
A simple method for SARS-CoV-2 detection by rRT-PCR without the use of a commercial RNA extraction kit (edit) |
10.1016/J.JVIROMET.2020.113960 |
| 2020-08-21 |
Identification B and T-Cell epitopes and functional exposed amino acids of S protein as a potential vaccine candidate against SARS-CoV-2/COVID-19 (edit) |
10.1016/J.MICPATH.2020.104459 |
| 2020-08-21 |
Diagnostic yield of repeat testing for SARS-CoV-2: Experience from a large health system in Los Angeles (edit) |
10.1016/J.IJID.2020.08.048 |
| 2020-08-21 |
Prolonged QT Interval in SARS-CoV-2 Infection: Prevalence and Prognosis (edit) |
10.3390/JCM9092712 |
| 2020-08-21 |
Single-strand RPA for rapid and sensitive detection of SARS-CoV-2 RNA (edit) |
10.1101/2020.08.17.20177006 |
| 2020-08-21 |
Engineering luminescent biosensors for point-of-care SARS-CoV-2 antibody detection (edit) |
10.1101/2020.08.17.20176925 |
| 2020-08-21 |
Machine learning reveals that prolonged exposure to air pollution is associated with SARS-CoV-2 mortality and infectivity in Italy (edit) |
10.1016/J.ENVPOL.2020.115471 |
| 2020-08-21 |
Assessing oligonucleotide designs from early lab developed PCR diagnostic tests for SARS-CoV-2 using the PCR_strainer pipeline (edit) |
10.1016/J.JCV.2020.104581 |
| 2020-08-21 |
Reduced Prescription of Baloxavir After Suspected Prevalence of a Baloxavir-Resistant Influenza Virus Strain and the Emergence of SARS-CoV-2 in a Tertiary Hospital in Japan (edit) |
10.2147/CPAA.S268666 |
| 2020-08-21 |
Emergence of human pathogenic Coronaviruses: Lectins as antivirals for SARS-CoV-2 (edit) |
10.2174/1381612826666200821120409 |
| 2020-08-21 |
Evaluation of the performance of SARS-CoV-2 serological tools and their positioning in COVID-19 diagnostic strategies (edit) |
10.1016/J.DIAGMICROBIO.2020.115181 |
| 2020-08-21 |
[Virological aspects and diagnosis of SARS-CoV-2 coronavirus] (edit) |
10.1016/J.ACTPHA.2020.08.005 |
| 2020-08-21 |
Dataset of mutational analysis, miRNAs targeting SARS-CoV-2 genes and host gene expression in SARS-CoV and SARS-CoV-2 infections (edit) |
10.1016/J.DIB.2020.106207 |
| 2020-08-21 |
Acute Limb Ischemia as Sole Initial Manifestation of SARS-CoV-2 Infection (edit) |
10.1016/J.JVSCIT.2020.07.017 |
| 2020-08-21 |
Evans syndrome associated with antiphospholipid antibodies in a patient with SARS-COV-2 infection (edit) |
10.1016/J.HTCT.2020.08.003 |
| 2020-08-21 |
Development and effectiveness of Pseudotyped SARS-CoV-2 system as determined by neutralizing efficiency and entry inhibition test in vitro (edit) |
10.1016/J.BSHEAL.2020.08.004 |
| 2020-08-21 |
Pneumatocele and cysts in a patient with SARS-CoV-2 infection (edit) |
10.1016/J.XJTC.2020.08.047 |
| 2020-08-21 |
Virtual screening and molecular dynamics study of approved drugs as inhibitors of spike protein S1 domain and ACE2 interaction in SARS-CoV-2 (edit) |
10.1016/J.JMGM.2020.107716 |
| 2020-08-21 |
Bioactive Virus-Mimicking Nanovesicles From Dendrimersomes: A Novel Approach to Understanding SARS-CoV-2 Host-Interactions to Better Design Therapeutics (edit) |
10.3389/FMOLB.2020.00188 |
| 2020-08-20 |
Easing diagnosis and pushing the detection limits of SARS-CoV-2 (edit) |
10.1093/BIOMETHODS/BPAA017 |
| 2020-08-20 |
Structural basis for the multimerization of nonstructural protein nsp9 from SARS-CoV-2 (edit) |
10.1186/S43556-020-00005-0 |
| 2020-08-20 |
Clinical trials of repurposed antivirals for SARS-CoV-2 (edit) |
10.1128/AAC.01101-20 |
| 2020-08-20 |
The Thrilling Journey of SARS-CoV-2 into the Intestine: From Pathogenesis to Future Clinical Implications (edit) |
10.1093/IBD/IZAA181 |
| 2020-08-20 |
Analytical and Clinical Evaluation of the Automated Elecsys Anti-SARS-CoV-2 Antibody Assay on the Roche cobas e602 Analyzer (edit) |
10.1093/AJCP/AQAA155 |
| 2020-08-20 |
Acral skin eruption observed during SARS-CoV-2 pandemic: possible keratolysis exfoliativa with red palms and soles (edit) |
10.1111/JDV.16881 |
| 2020-08-20 |
Exploring the SARS-CoV-2 structural proteins for Multi-Epitope vaccine development: an in-silico approach (edit) |
10.1080/14760584.2020.1813576 |
| 2020-08-20 |
Molecular docking and simulation studies on SARS-CoV-2 Mpro reveals Mitoxantrone, Leucovorin, Birinapant, and Dynasore as potent drugs against COVID-19 (edit) |
10.1080/07391102.2020.1805019 |
| 2020-08-20 |
Obesity doubles mortality in patients hospitalized for SARS-CoV-2 in Paris hospitals, France: a cohort study on 5795 patients (edit) |
10.1002/OBY.23014 |
| 2020-08-20 |
Sensitive and Specific Detection of SARS-CoV-2 Antibodies Using a High-Throughput, Fully Automated Liquid-Handling Robotic System (edit) |
10.1177/2472630320950663 |
| 2020-08-20 |
Diabetes mellitus and SARS-CoV-2-related mortality: the impact of acute hyperglycemic crises and some further considerations (edit) |
10.1007/S00592-020-01593-7 |
| 2020-08-20 |
Systemic treatment of advanced/metastatic renal cell carcinoma in the context of SARS-CoV-2 pandemic: recommendations from the interdisciplinary working group for renal tumors (IAG-N) (edit) |
10.1007/S00432-020-03341-4 |
| 2020-08-20 |
Geographical reconstruction of the SARS-CoV-2 outbreak in Lombardy (Italy) during the early phase (edit) |
10.1002/JMV.26447 |
| 2020-08-20 |
Surveillance of SARS-CoV-2 infection among frontline health care workers in Wuhan during COVID-19 outbreak (edit) |
10.1002/IID3.340 |
| 2020-08-20 |
Age could be driving variable SARS-CoV-2 epidemic trajectories worldwide (edit) |
10.1371/JOURNAL.PONE.0237959 |
| 2020-08-20 |
Structural basis of SARS-CoV-2 spike protein induced by ACE2 (edit) |
10.1093/BIOINFORMATICS/BTAA744 |
| 2020-08-20 |
The Pandemic Predominantly Hits Poor Neighbourhoods? SARS-CoV-2 Infections and Covid-19 Fatalities in German Districts (edit) |
10.1093/EURPUB/CKAA168 |
| 2020-08-20 |
Accurate Serology for SARS-CoV-2 and common Human Coronaviruses using a Multiplex Approach (edit) |
10.1080/22221751.2020.1813636 |
| 2020-08-20 |
Cytotoxic Lesion of the Corpus Callosum in an Adolescent with Multisystem Inflammatory Syndrome and SARS-CoV-2 Infection (edit) |
10.3174/AJNR.A6755 |
| 2020-08-20 |
GRL-0920, an Indole Chloropyridinyl Ester, Completely Blocks SARS-CoV-2 Infection (edit) |
10.1128/MBIO.01833-20 |
| 2020-08-20 |
Characterizing superspreading events and age-specific infectiousness of SARS-CoV-2 transmission in Georgia, USA (edit) |
10.1073/PNAS.2011802117 |
| 2020-08-20 |
Evolutionary and structural analyses of SARS-CoV-2 D614G spike protein mutation now documented worldwide (edit) |
10.1038/S41598-020-70827-Z |
| 2020-08-20 |
A prediction model of outcome of SARS-CoV-2 pneumonia based on laboratory findings (edit) |
10.1038/S41598-020-71114-7 |
| 2020-08-20 |
Gargle lavage as a viable alternative to swab for detection of SARS-CoV-2 (edit) |
10.4103/IJMR.IJMR_2987_20 |
| 2020-08-20 |
Low Incidence of SARS-CoV-2 in Patients with Solid Tumours on Active Treatment: An Observational Study at a Tertiary Cancer Centre in Lombardy, Italy (edit) |
10.3390/CANCERS12092352 |
| 2020-08-20 |
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Exhibits High Predicted Binding Affinity to ACE2 from Lagomorphs (Rabbits and Pikas) (edit) |
10.3390/ANI10091460 |
| 2020-08-20 |
SARS-CoV-2 ORF8 and SARS-CoV ORF8ab: Genomic Divergence and Functional Convergence (edit) |
10.3390/PATHOGENS9090677 |
| 2020-08-20 |
Existence of SARS-CoV-2 Entry Molecules in the Oral Cavity (edit) |
10.3390/IJMS21176000 |
| 2020-08-20 |
Comparison of RNA In Situ Hybridization and Immunohistochemistry Techniques for the Detection and Localization of SARS-CoV-2 in Human Tissues (edit) |
10.1097/PAS.0000000000001563 |
| 2020-08-20 |
SARS-CoV-2 in cardiac tissue of a child with COVID-19-related multisystem inflammatory syndrome (edit) |
10.1016/S2352-4642(20)30257-1 |
| 2020-08-20 |
Analysis of COVID-19 convalescent plasma for SARS-CoV-2 IgG using two commercial immunoassays (edit) |
10.1016/J.JIM.2020.112837 |
| 2020-08-20 |
Case studies of SARS-CoV-2 treated with favipiravir among patients in critical or severe condition (edit) |
10.1016/J.IJID.2020.08.047 |
| 2020-08-20 |
Effect of a Previous History of Antiretroviral Treatment on Clinical Picture of Patients with Co-infection of SARS-CoV-2 and HIV: A Preliminary Study (edit) |
10.1016/J.IJID.2020.08.045 |
| 2020-08-20 |
Current approach in laboratory testing for SARS-CoV-2 (edit) |
10.1016/J.IJID.2020.08.041 |
| 2020-08-20 |
There is no intraocular affection on a SARS-CoV-2 - Infected ocular surface (edit) |
10.1016/J.AJOC.2020.100884 |
| 2020-08-20 |
miRNA target prediction might explain the reduced transmission of SARS-CoV-2 in Jordan, Middle East (edit) |
10.1016/J.NCRNA.2020.08.002 |
| 2020-08-20 |
Modeling COVID-19 with Human Pluripotent Stem Cell-Derived Cells Reveals Synergistic Effects of Anti-inflammatory Macrophages with ACE2 Inhibition Against SARS-CoV-2 (edit) |
10.21203/RS.3.RS-62758/V1 |
| 2020-08-20 |
Mapping the SARS-CoV-2 spike glycoprotein-derived peptidome presented by HLA class II on dendritic cells (edit) |
10.1101/2020.08.19.255901 |
| 2020-08-20 |
Development of a high-throughput homogeneous AlphaLISA drug screening assay for the detection of SARS-CoV-2 Nucleocapsid (edit) |
10.1101/2020.08.20.258129 |
| 2020-08-20 |
SARS-CoV-2 infection dynamics in lungs of African green monkeys (edit) |
10.1101/2020.08.20.258087 |
| 2020-08-20 |
ACE2 coding variants in different populations and their potential impact on SARS-CoV-2 binding affinity (edit) |
10.1016/J.BBREP.2020.100798 |
| 2020-08-20 |
Integrative analyses of SARS-CoV-2 genomes from different geographical locations reveal unique features potentially consequential to host-virus interaction, pathogenesis and clues for novel therapies (edit) |
10.1016/J.HELIYON.2020.E04658 |
| 2020-08-20 |
Leptin levels in SARS-CoV-2 infection related respiratory failure: A cross-sectional study and a pathophysiological framework on the role of fat tissue (edit) |
10.1016/J.HELIYON.2020.E04696 |
| 2020-08-20 |
Olfactory disorder in patients infected with SARS-CoV-2 (edit) |
10.1016/J.JMII.2020.08.010 |
| 2020-08-20 |
Fatal aspergillosis complicating severe SARS-CoV-2 infection: A case report (edit) |
10.1016/J.MYCMED.2020.101039 |
| 2020-08-20 |
BCG vaccine may generate cross-reactive T cells against SARS-CoV-2: In silico analyses and a hypothesis (edit) |
10.1016/J.VACCINE.2020.08.045 |
| 2020-08-20 |
Neutralization of SARS-CoV-2 Spike Protein via Natural Compounds: A Multi Layered High Throughput Virtual Screening Approach (edit) |
10.2174/1381612826999200820162937 |
| 2020-08-20 |
Single Cell RNA-seq Data Analysis Reveals the Potential Risk of SARS-CoV-2 Infection Among Different Respiratory System Conditions (edit) |
10.3389/FGENE.2020.00942 |
| 2020-08-20 |
An Overview of the Temporal Shedding of SARS-CoV-2 RNA in Clinical Specimens (edit) |
10.3389/FPUBH.2020.00487 |
| 2020-08-20 |
SARS-CoV-2 Codon Usage Bias Downregulates Host Expressed Genes With Similar Codon Usage (edit) |
10.3389/FCELL.2020.00831 |
| 2020-08-20 |
Late Reactivation of SARS-CoV-2: A Case Report (edit) |
10.3389/FMED.2020.00531 |
| 2020-08-19 |
Prevalence of SARS-CoV-2 asymptomatic infections in two large academic health systems in Wisconsin (edit) |
10.1093/CID/CIAA1225 |
| 2020-08-19 |
Interest of the cellular population data analysis as an aid in the early diagnosis of SARS-CoV-2 infection (edit) |
10.1111/IJLH.13312 |
| 2020-08-19 |
Dynamical properties of enzyme-substrate complexes disclose substrate specificity of the SARS-CoV-2 main protease as characterized by the electron density descriptors (edit) |
10.1039/D0CP03560B |
| 2020-08-19 |
Low prevalence of antibodies against SARS-CoV-2 among voluntary blood donors in Guangzhou, China (edit) |
10.1002/JMV.26445 |
| 2020-08-19 |
Behavioural manipulation - key to the successful global spread of the new Coronavirus SARS-Cov-2? (edit) |
10.1002/JMV.26446 |
| 2020-08-19 |
Lack of transmission of SARS-CoV-2 by platelet transfusion from a COVID-19-positive donor in a hematopoietic stem cell transplantation patient (edit) |
10.1002/PBC.28658 |
| 2020-08-19 |
A 28-Year-Old Man from India with SARS-Cov-2 and Pulmonary Tuberculosis Co-Infection with Central Nervous System Involvement (edit) |
10.12659/AJCR.926034 |
| 2020-08-19 |
A SARS-CoV-2 mRNA Vaccine - Preliminary Report (edit) |
10.1056/NEJMC2026616 |
| 2020-08-19 |
A SARS-CoV-2 mRNA Vaccine - Preliminary Report. Reply (edit) |
10.1056/NEJMC2026616 |
| 2020-08-19 |
On-target versus off-target effects of drugs inhibiting the replication of SARS-CoV-2 (edit) |
10.1038/S41419-020-02842-X |
| 2020-08-19 |
Genome-wide analysis of SARS-CoV-2 virus strains circulating worldwide implicates heterogeneity (edit) |
10.1038/S41598-020-70812-6 |
| 2020-08-19 |
Time to bring emergency medicine to the limelight in developing countries to fight pandemics like SARS-CoV-2 effectively (edit) |
10.1136/EMERMED-2020-210089 |
| 2020-08-19 |
Broad anti-coronaviral activity of FDA approved drugs against SARS-CoV-2 in vitro and SARS-CoV in vivo (edit) |
10.1128/JVI.01218-20 |
| 2020-08-19 |
Building the National SARS-CoV-2 Laboratory Diagnostic Capacity in Taiwan (edit) |
10.1089/HS.2020.0056 |
| 2020-08-19 |
Evaluation for SARS-CoV-2 in Breast Milk From 18 Infected Women (edit) |
10.1001/JAMA.2020.15580 |
| 2020-08-19 |
The Sialoside-Binding Pocket of SARS-CoV-2 Spike Glycoprotein Structurally Resembles MERS-CoV (edit) |
10.3390/V12090909 |
| 2020-08-19 |
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Environmental Contamination and Childbirth (edit) |
10.1097/AOG.0000000000004112 |
| 2020-08-19 |
Immunohistochemical study of SARS-CoV-2 viral entry factors in the cornea and ocular surface (edit) |
10.1097/ICO.0000000000002509 |
| 2020-08-19 |
Prolonged Persistence of PCR-detectable Virus During an Outbreak of SARS-CoV-2 in an Inpatient Geriatric Psychiatry Unit in King County, Washington (edit) |
10.1016/J.AJIC.2020.08.025 |
| 2020-08-19 |
Epidemiological and clinical characteristics of SARS-CoV-2 infections at a testing site in Berlin, Germany, March and April 2020 - A cross-sectional study (edit) |
10.1016/J.CMI.2020.08.017 |
| 2020-08-19 |
Identification of potential SARS-CoV-2 inhibitors from South African medicinal plant extracts using molecular modelling approaches (edit) |
10.1016/J.SAJB.2020.07.035 |
| 2020-08-19 |
Fetal Surgery in the era of SARS-CoV-2 pandemic: A single institution review (edit) |
10.1016/J.MAYOCPIQO.2020.08.001 |
| 2020-08-19 |
SARS-CoV-2-specific T cells exhibit phenotypic features of robust helper function, lack of terminal differentiation, and high proliferative potential (edit) |
10.1016/J.XCRM.2020.100081 |
| 2020-08-19 |
SARS-CoV-2 ORF9c Is a Membrane-Associated Protein that Suppresses Antiviral Responses in Cells (edit) |
10.1101/2020.08.18.256776 |
| 2020-08-19 |
SARS-CoV-2 (COVID-19) infection in pregnant women: characterization of symptoms and syndromes predictive of disease and severity through real-time, remote participatory epidemiology (edit) |
10.1101/2020.08.17.20161760 |
| 2020-08-19 |
Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19 (edit) |
10.1016/J.CELL.2020.08.025 |
| 2020-08-19 |
Mutation density changes in SARS-CoV-2 are related to the pandemic stage but to a lesser extent in the dominant strain with mutations in spike and RdRp (edit) |
10.7717/PEERJ.9703 |
| 2020-08-19 |
Contamination of SARS-CoV-2 RT-PCR probes at the oligonucleotide manufacturer (edit) |
10.1016/J.PATHOL.2020.08.002 |
| 2020-08-19 |
Effectiveness of 222-nm ultraviolet light on disinfecting SARS-CoV-2 surface contamination (edit) |
10.1016/J.AJIC.2020.08.022 |
| 2020-08-19 |
SARS-CoV-2 Infection with Associated Rhabdomyolysis and Probable Myocarditis (edit) |
10.12890/2020_001867 |
| 2020-08-19 |
Promising impacts of mesenchymal stem cell therapy in treatment of SARS-CoV-2 (COVID-19) (edit) |
10.1016/J.HRTLNG.2020.08.007 |
| 2020-08-19 |
A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2 (edit) |
10.1016/J.CELL.2020.08.026 |
| 2020-08-19 |
Sunlight ultraviolet radiation dose is negatively correlated with the percent positive of SARS-CoV-2 and four other common human coronaviruses in the U.S. (edit) |
10.1016/J.SCITOTENV.2020.141816 |
| 2020-08-19 |
A Universal Screening Strategy for SARS-CoV-2 Infection in Intensive Care Units: Korean Experience in a Single Hospital (edit) |
|
| 2020-08-19 |
The Strengths of Scanning Electron Microscopy in Deciphering SARS-CoV-2 Infectious Cycle (edit) |
10.3389/FMICB.2020.02014 |
| 2020-08-19 |
The 2020 Pandemic: Current SARS-CoV-2 Vaccine Development (edit) |
10.3389/FIMMU.2020.01880 |
| 2020-08-19 |
Commentary: SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor (edit) |
10.3389/FONC.2020.01448 |
| 2020-08-19 |
SARS-CoV-2 Infection in Cancer Patients: A Picture of an Italian Onco-Covid Unit (edit) |
10.3389/FONC.2020.01722 |
| 2020-08-19 |
Single-Cell RNA-seq Identifies Cell Subsets in Human Placenta That Highly Expresses Factors Driving Pathogenesis of SARS-CoV-2 (edit) |
10.3389/FCELL.2020.00783 |
| 2020-08-19 |
Exploring the Demographics and Clinical Characteristics Related to the Expression of Angiotensin-Converting Enzyme 2, a Receptor of SARS-CoV-2 (edit) |
10.3389/FMED.2020.00530 |
| 2020-08-18 |
Expert Consensus for Treating Cancer Patients During the Pandemic of SARS-CoV-2 (edit) |
10.3389/FONC.2020.01555 |
| 2020-08-18 |
The Spread of SARS-CoV-2 Infection Among the Medical Oncology Staff of ASST Spedali Civili of Brescia: Efficacy of Preventive Measures (edit) |
10.3389/FONC.2020.01574 |
| 2020-08-18 |
Viral Transmission and Clinical Features in Asymptomatic Carriers of SARS-CoV-2 in Wuhan, China (edit) |
10.3389/FMED.2020.00547 |
| 2020-08-18 |
Dipeptidyl Peptidase-4: A Potential Therapeutic Target in Diabetic Kidney Disease with SARS-CoV-2 Infection (edit) |
10.1021/ACSPTSCI.0C00097 |
| 2020-08-18 |
Psychological experience of patients admitted with SARS-CoV-2 infection (edit) |
10.1016/J.AJP.2020.102355 |
| 2020-08-18 |
IFITM proteins promote SARS-CoV-2 infection of human lung cells (edit) |
10.1101/2020.08.18.255935 |
| 2020-08-18 |
Infection and transmission of SARS-CoV-2 depends on heparan sulfate proteoglycans (edit) |
10.1101/2020.08.18.255810 |
| 2020-08-18 |
MATH+ protocol for the treatment of SARS-CoV-2 infection: the scientific rationale (edit) |
10.1080/14787210.2020.1808462 |
| 2020-08-18 |
SARS-CoV: Lessons learned; opportunities missed for SARS-CoV-2 (edit) |
10.1002/RMV.2152 |
| 2020-08-18 |
Scabies outbreak during home confinement due to the SARS-CoV-2 pandemic (edit) |
10.1111/JDV.16879 |
| 2020-08-18 |
Detection of SARS-CoV-2 in pets living with COVID-19 owners diagnosed during the COVID-19 lockdown in Spain: A case of an asymptomatic cat with SARS-CoV-2 in Europe (edit) |
10.1111/TBED.13803 |
| 2020-08-18 |
An in-silico evaluation of dietary components for structural inhibition of SARS-Cov-2 main protease (edit) |
10.1080/07391102.2020.1809522 |
| 2020-08-18 |
Intranasal exposure of African green monkeys to SARS-CoV-2 results in acute phase pneumonia with shedding and lung injury still present in the early convalescence phase (edit) |
10.1186/S12985-020-01396-W |
| 2020-08-18 |
Does Sars-Cov-2 threaten our dreams? Effect of quarantine on sleep quality and body mass index (edit) |
10.1186/S12967-020-02465-Y |
| 2020-08-18 |
25-Hydroxycholesterol is a potent SARS-CoV-2 inhibitor (edit) |
10.1038/S41422-020-00398-1 |
| 2020-08-18 |
Peripheral immunophenotypes in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection (edit) |
10.1038/S41591-020-1054-6 |
| 2020-08-18 |
Author Correction: Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China (edit) |
10.1038/S41591-020-1058-2 |
| 2020-08-18 |
Vitamin B12 may inhibit RNA-dependent-RNA polymerase activity of nsp12 from the SARS-CoV-2 virus (edit) |
10.1002/IUB.2359 |
| 2020-08-18 |
Case Report: COVID-19 Recovery from Triple Infection with Mycobacterium tuberculosis, HIV, and SARS-CoV-2 (edit) |
10.4269/AJTMH.20-0756 |
| 2020-08-18 |
Elevated ACE2 expression in the olfactory neuroepithelium: implications for anosmia and upper respiratory SARS-CoV-2 entry and replication (edit) |
10.1183/13993003.01948-2020 |
| 2020-08-18 |
Detection of SARS-CoV-2 IgG Targeting Nucleocapsid or Spike Protein by Four High Throughput Immunoassays Authorized for Emergency Use (edit) |
10.1128/JCM.01742-20 |
| 2020-08-18 |
In situ structural analysis of SARS-CoV-2 spike reveals flexibility mediated by three hinges (edit) |
10.1126/SCIENCE.ABD5223 |
| 2020-08-18 |
Lead Finding from Selected Flavonoids with Antiviral (SARS-CoV-2) Potentials against COVID-19: An in-silico Evaluation (edit) |
10.2174/1386207323999200818162706 |
| 2020-08-18 |
Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study (edit) |
10.1016/S0140-6736(20)31757-8 |
| 2020-08-18 |
iSCAN: An RT-LAMP-coupled CRISPR-Cas12 module for rapid, sensitive detection of SARS-CoV-2 (edit) |
10.1016/J.VIRUSRES.2020.198129 |
| 2020-08-18 |
Missense mutations in SARS-CoV2 genomes from Indian patients (edit) |
10.1016/J.YGENO.2020.08.021 |
| 2020-08-18 |
Evaluation of SARS-CoV-2 antibodies in 24 patients presenting with chilblains-like lesions during the COVID-19 pandemic (edit) |
10.1016/J.JAAD.2020.08.049 |
| 2020-08-18 |
Skin is a potential host of SARS-CoV-2: a clinical, single-cell transcriptome-profiling and histological study (edit) |
10.1016/J.JAAD.2020.08.057 |
| 2020-08-18 |
Proactive screening approach for SARS-CoV-2 among healthcare workers (edit) |
10.1016/J.CMI.2020.08.009 |
| 2020-08-18 |
The Effects of Lockdown During the SARS-CoV-2 Pandemic on Neuro-Trauma Related Hospital Admissions (edit) |
10.1016/J.WNEU.2020.08.083 |
| 2020-08-18 |
Progress in Developing Inhibitors of SARS-CoV-2 3C-Like Protease (edit) |
10.3390/MICROORGANISMS8081250 |
| 2020-08-18 |
Deciphering SARS-CoV-2 Virologic and Immunologic Features (edit) |
10.3390/IJMS21165932 |
| 2020-08-18 |
Direct-RT-qPCR Detection of SARS-CoV-2 without RNA Extraction as Part of a COVID-19 Testing Strategy: From Sample to Result in One Hour (edit) |
10.3390/DIAGNOSTICS10080605 |
| 2020-08-18 |
SARS-CoV-2 Detection for Diagnosis Purposes in the Setting of a Molecular Biology Research Lab (edit) |
10.3390/MPS3030059 |
| 2020-08-18 |
ACE2 Protein Landscape in the Head and Neck Region: The Conundrum of SARS-CoV-2 Infection (edit) |
10.3390/BIOLOGY9080235 |
| 2020-08-18 |
Containment of a Large SARS-CoV-2 Outbreak Among Healthcare Workers in a Pediatric Intensive Care Unit (edit) |
10.1097/INF.0000000000002866 |
| 2020-08-18 |
Discovery of ACE2 receptors for SARS-CoV-2 (COVID-19) on peripheral small-fiber sensory neurons of uncertain clinical significance (edit) |
10.1097/J.PAIN.0000000000002050 |
| 2020-08-18 |
ACE2 and SCARF expression in human DRG nociceptors: implications for SARS-CoV-2 virus neurological effects (edit) |
10.1097/J.PAIN.0000000000002051 |
| 2020-08-18 |
Pediatric SARS-CoV-2: Clinical Presentation, Infectivity, and Immune Responses (edit) |
10.1016/J.JPEDS.2020.08.037 |
| 2020-08-18 |
Renin-Angiotensin System Overactivation in Polycystic Ovary Syndrome, a Risk for SARS-CoV-2 Infection? (edit) |
10.1016/J.METOP.2020.100052 |
| 2020-08-18 |
Feasibility of using alternative swabs and storage solutions for paired SARS-CoV-2 detection and microbiome analysis in the hospital environment (edit) |
10.21203/RS.3.RS-56028/V1 |
| 2020-08-18 |
Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2 (edit) |
10.1101/2020.08.18.255877 |
| 2020-08-18 |
Identifying SARS-CoV-2 entry inhibitors through drug repurposing screens of SARS-S and MERS-S pseudotyped particles (edit) |
10.1101/2020.07.10.197988 |
| 2020-08-18 |
Bacterial modification of the host glycosaminoglycan heparan sulfate modulates SARS-CoV-2 infectivity (edit) |
10.1101/2020.08.17.238444 |
| 2020-08-18 |
SARS-CoV-2 antibody responses in children with MIS-C and mild and severe COVID-19 (edit) |
10.1101/2020.08.17.20176552 |
| 2020-08-18 |
Oral lesions in patients with SARS-CoV-2 infection: could the oral cavity be a target organ? (edit) |
10.1016/J.OOOO.2020.07.014 |
| 2020-08-18 |
Detection of SARS-CoV-2 in raw and treated wastewater in Germany - Suitability for COVID-19 surveillance and potential transmission risks (edit) |
10.1016/J.SCITOTENV.2020.141750 |
| 2020-08-18 |
Molecular modelling investigation for drugs and nutraceuticals against protease of SARS-CoV-2 (edit) |
10.1016/J.JMGM.2020.107717 |
| 2020-08-17 |
Does SARS-CoV-2 reach peritoneal effluent? (edit) |
10.1177/0896860820947331 |
| 2020-08-17 |
SARS-CoV-2 ORF9b Antagonizes Type I and III Interferons by Targeting Multiple Components of RIG-I/MDA-5-MAVS, TLR3-TRIF, and cGAS-STING Signaling Pathways (edit) |
10.1101/2020.08.16.252973 |
| 2020-08-17 |
Antiviral Activity of Ivermectin Against SARS-CoV-2: An Old-Fashioned Dog with a New Trick—A Literature Review (edit) |
10.3390/SCIPHARM88030036 |
| 2020-08-17 |
SARS-CoV-2 meta-interactome suggests disease-specific, autoimmune pathophysiologies and therapeutic targets (edit) |
10.12688/F1000RESEARCH.25593.1 |
| 2020-08-17 |
SARS-CoV-2 vaccines: 'Warp Speed' needs mind melds not warped minds (edit) |
10.1128/JVI.01083-20 |
| 2020-08-17 |
Scientometric trends for coronaviruses and other emerging viral infections (edit) |
10.1093/GIGASCIENCE/GIAA085 |
| 2020-08-17 |
Establishing A High Sensitivity Detection Method for SARS-CoV-2 IgM/IgG and Developing a Clinical Application of this Method (edit) |
10.1080/22221751.2020.1811161 |
| 2020-08-17 |
In silico molecular investigations of pyridine N-Oxide compounds as potential inhibitors of SARS-CoV-2: 3D QSAR, molecular docking modeling, and ADMET screening (edit) |
10.1080/07391102.2020.1808530 |
| 2020-08-17 |
Severe Rhabdomyolysis in a 35-Year-old Woman with COVID-19 due to SARS-CoV-2 Infection: A Case Report (edit) |
10.12659/AJCR.926733 |
| 2020-08-17 |
A COVID-19 mRNA vaccine encoding SARS-CoV-2 virus-like particles induces a strong antiviral-like immune response in mice (edit) |
10.1038/S41422-020-00392-7 |
| 2020-08-17 |
Highly sensitive quantification of plasma SARS-CoV-2 RNA shelds light on its potential clinical value (edit) |
10.1093/CID/CIAA1196 |
| 2020-08-17 |
Evaluation of the automated cartridge-based ARIES SARS-CoV-2 Assay (RUO) against automated Cepheid Xpert Xpress SARS-CoV-2 PCR as gold standard (edit) |
10.1556/1886.2020.00017 |
| 2020-08-17 |
Mechanistic insights into SARS-CoV-2 epidemic via revealing the features of SARS-CoV-2 coding proteins and host responses upon its infection (edit) |
10.1093/BIOINFORMATICS/BTAA725 |
| 2020-08-17 |
Toxic epidermal necrolysis and co-existent SARS-CoV-2 (COVID-19) treated with Intravenous Immunoglobulin: "Killing 2 birds with one stone" (edit) |
10.1111/JDV.16887 |
| 2020-08-17 |
Structures and distributions of SARS-CoV-2 spike proteins on intact virions (edit) |
10.1038/S41586-020-2665-2 |
| 2020-08-17 |
Integrative Modelling of Quantitative Plasma Lipoprotein, Metabolic and Amino Acid Data Reveals a Multi-organ Pathological Signature of SARS-CoV-2 Infection (edit) |
10.1021/ACS.JPROTEOME.0C00519 |
| 2020-08-17 |
Multi-centre, three arm, randomized controlled trial on the use of methylprednisolone and unfractionated heparin in critically ill ventilated patients with pneumonia from SARS-CoV-2 infection: A structured summary of a study protocol for a randomise (edit) |
10.1186/S13063-020-04645-Z |
| 2020-08-17 |
Spatial resolution of SARS-CoV-2 lung infection (edit) |
10.1038/S41577-020-00432-8 |
| 2020-08-17 |
Shared CD8+ T cell receptors for SARS-CoV-2 (edit) |
10.1038/S41577-020-00433-7 |
| 2020-08-17 |
Author Correction: Pre-existing immunity to SARS-CoV-2: the knowns and unknowns (edit) |
10.1038/S41577-020-00430-W |
| 2020-08-17 |
An integrated drug repurposing strategy for the rapid identification of potential SARS-CoV-2 viral inhibitors (edit) |
10.1038/S41598-020-70863-9 |
| 2020-08-17 |
ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infection (edit) |
10.1038/S41590-020-0773-7 |
| 2020-08-17 |
Evaluation of three immunochromatographic tests for rapid detection of antibodies against SARS-CoV-2 (edit) |
10.1007/S10096-020-04010-7 |
| 2020-08-17 |
Effect of common medications on the expression of SARS-CoV-2 entry receptors in liver tissue (edit) |
10.1007/S00204-020-02869-1 |
| 2020-08-17 |
A comparison of four serological assays for detecting anti-SARS-CoV-2 antibodies in human serum samples from different populations (edit) |
10.1126/SCITRANSLMED.ABC3103 |
| 2020-08-17 |
Genes encoding ACE2, TMPRSS2 and related proteins mediating SARS-CoV-2 viral entry are upregulated with age in human cardiomyocytes (edit) |
10.1016/J.YJMCC.2020.08.009 |
| 2020-08-17 |
Clinical performances of an ELISA for SARS-CoV-2 antibody assay and correlation with neutralization activity (edit) |
10.1016/J.CCA.2020.08.024 |
| 2020-08-17 |
Inactivation of SARS-CoV-2 by commercially available alcohol-based hand sanitizers (edit) |
10.1016/J.AJIC.2020.08.020 |
| 2020-08-17 |
SARS-CoV2 vertical transmission with adverse effects on the newborn revealed through integrated immunohistochemical, electron microscopy and molecular analyses of Placenta (edit) |
10.1016/J.EBIOM.2020.102951 |
| 2020-08-17 |
Risk of stroke in hospitalized SARS-CoV-2 infected patients: A multinational study (edit) |
10.1016/J.EBIOM.2020.102939 |
| 2020-08-17 |
SARS-CoV-2 outbreak on the Caribbean islands of the Dutch Kingdom: a unique challenge (edit) |
10.26633/RPSP.2020.91 |
| 2020-08-17 |
Putative SARS-CoV-2 Mpro Inhibitors from an In-House Library of Natural and Nature-Inspired Products: A Virtual Screening and Molecular Docking Study (edit) |
10.3390/MOLECULES25163745 |
| 2020-08-17 |
Whole Genome Sequencing of SARS-CoV-2: Adapting Illumina Protocols for Quick and Accurate Outbreak Investigation during a Pandemic (edit) |
10.3390/GENES11080949 |
| 2020-08-17 |
SARS-CoV-2 Entry Factors: ACE2 and TMPRSS2 Are Expressed in Peri-Implantation Embryos and the Maternal-Fetal Interface (edit) |
10.1016/J.ENG.2020.07.013 |
| 2020-08-17 |
Protective Effects of CVD and DM Medications in SARS-CoV-2 Infection (edit) |
10.1007/S42399-020-00452-4 |
| 2020-08-17 |
Risk factors for detection of SARS-CoV-2 in healthcare workers during April 2020 in a UK hospital testing programme (edit) |
10.1016/J.ECLINM.2020.100513 |
| 2020-08-17 |
Risk Factors for SARS-CoV2 Infection in Pregnant Women (edit) |
10.1016/J.AJOGMF.2020.100198 |
| 2020-08-17 |
Practical Considerations for Pregnant Women with Diabetes and SARS-CoV-2 Infection (edit) |
10.1016/J.AJOGMF.2020.100210 |
| 2020-08-17 |
Race/ethnicity and spatiotemporal trends in SARS-CoV-2 prevalence on obstetrical units in New York (edit) |
10.1016/J.AJOGMF.2020.100212 |
| 2020-08-17 |
Host immune response driving SARS-CoV-2 evolution (edit) |
|
| 2020-08-17 |
Universal PCR and antibody testing demonstrate little to no transmission of SARS-CoV-2 in a rural community (edit) |
10.1101/2020.08.15.20175786 |
| 2020-08-17 |
SARS-CoV-2 Antibody Responses Correlate with Resolution of RNAemia But Are Short-Lived in Patients with Mild Illness (edit) |
10.1101/2020.08.15.20175794 |
| 2020-08-17 |
Development of vaccines for SARS-CoV-2 (edit) |
10.12688/F1000RESEARCH.25998.1 |
| 2020-08-17 |
Variation and multilevel selection of SARS-CoV-2 (edit) |
10.1111/EVO.14080 |
| 2020-08-17 |
Propolis and its potential against SARS-CoV-2 infection mechanisms and COVID-19 disease: Running title: Propolis against SARS-CoV-2 infection and COVID-19 (edit) |
10.1016/J.BIOPHA.2020.110622 |
| 2020-08-17 |
Structural Impact of Mutation D614G in SARS-CoV-2 Spike Protein: Enhanced Infectivity and Therapeutic Opportunity (edit) |
10.1021/ACSMEDCHEMLETT.0C00410 |
| 2020-08-17 |
Homeless Shelter Characteristics and Prevalence of SARS-CoV-2 (edit) |
10.5811/WESTJEM.2020.7.48725 |
| 2020-08-17 |
Impacts of the SARS-CoV-2 Pandemic on the Mental Health of the Elderly (edit) |
10.3389/FPSYT.2020.00841 |
| 2020-08-16 |
Household Transmission of SARS-CoV-2 in the United States (edit) |
10.1093/CID/CIAA1166 |
| 2020-08-16 |
Story of Coronaviruses: How the ‘’novel Coronavirus (SARS-CoV-2)’’ May Have Emerged? (edit) |
|
| 2020-08-16 |
SARS-CoV-2-Associated Acute Hemorrhagic, Necrotizing Encephalitis (AHNE) Presenting with Cognitive Impairment in a 44-Year-Old Woman without Comorbidities: A Case Report (edit) |
10.12659/AJCR.925641 |
| 2020-08-16 |
Kawasaki disease or Kawasaki-like disease: influence of SARS-CoV-2 infections in Japan (edit) |
10.1111/APA.15535 |
| 2020-08-16 |
Effect of common medications on the expression of SARS-CoV-2 entry receptors in kidney tissue (edit) |
10.1111/CTS.12862 |
| 2020-08-16 |
Impact of the SARS-CoV2 pandemic dissemination on the management of neuroendocrine neoplasia in Italy: a report from the Italian Association for Neuroendocrine Tumors (Itanet) (edit) |
10.1007/S40618-020-01393-4 |
| 2020-08-16 |
Recognizable vascular skin manifestations of SARS CoV-2 infection are uncommon in patients with skin-of-color (edit) |
10.1111/CED.14421 |
| 2020-08-16 |
Potential Leads from Liquorice against SARS-CoV-2 Main Protease using Molecular Docking Simulation Studies (edit) |
10.2174/1386207323999200817103148 |
| 2020-08-16 |
Susceptibility of swine cells and domestic pigs to SARS-CoV-2 (edit) |
10.1101/2020.08.15.252395 |
| 2020-08-16 |
A SARS-CoV-2 neutralizing antibody protects from lung pathology in a COVID-19 hamster model (edit) |
10.1101/2020.08.15.252320 |
| 2020-08-16 |
Prevalence of Asymptomatic SARS-CoV-2 Infection in Children and Adults in Marion County, Indiana (edit) |
10.7759/CUREUS.9794 |
| 2020-08-16 |
Evaluation on testing of deep throat saliva and lower respiratory tract specimens with Xpert Xpress SARS-CoV-2 assay (edit) |
10.1016/J.JCV.2020.104593 |
| 2020-08-16 |
Response to "No evidence of SARS-CoV-2 infection by PCR or serology in children with pseudochilblain" (edit) |
10.1111/BJD.19493 |
| 2020-08-15 |
SARS-CoV-2 was Unexpectedly Deadlier than Push-scooters: Could Hydroxychloroquine be the Unique Solution? (edit) |
|
| 2020-08-15 |
Evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as coronavirus disease 2019 (COVID-19) pandemic: A global health emergency (edit) |
10.1016/J.SCITOTENV.2020.138996 |
| 2020-08-15 |
Part I. SARS-CoV-2 triggered ‘PANIC’ attack in severe COVID-19 (edit) |
10.1016/J.JNS.2020.116936 |
| 2020-08-15 |
Part II. High-dose methotrexate with leucovorin rescue for severe COVID-19: An immune stabilization strategy for SARS-CoV-2 induced ‘PANIC’ attack (edit) |
10.1016/J.JNS.2020.116935 |
| 2020-08-15 |
Methods of inactivation of SARS-CoV-2 for downstream biological assays (edit) |
10.1093/INFDIS/JIAA507 |
| 2020-08-15 |
Anatomical and timely assessment of protein expression of angiotensin-converting enzyme 2, SARS-CoV-2 specific receptor, in fetal and placental tissues: new insight for perinatal counseling (edit) |
10.1002/UOG.22178 |
| 2020-08-15 |
Development and Evaluation of a Novel RT-PCR System for Reliable and Rapid SARS-CoV-2 Screening of Blood Donations (edit) |
10.1111/TRF.16049 |
| 2020-08-15 |
Chilblains and COVID-19: why SARS-CoV-2 endothelial infection is questioned (edit) |
10.1111/BJD.19489 |
| 2020-08-15 |
Chilblains and COVID-19: why SARS-CoV-2 endothelial infection is questioned: reply from authors (edit) |
10.1111/BJD.19491 |
| 2020-08-15 |
SARS CoV-2 viral load might not be the right predictor of COVID-19 mortality (edit) |
10.1016/J.JINF.2020.08.018 |
| 2020-08-15 |
Identification of transcription factors regulating SARS-CoV-2 entry genes in the intestine (edit) |
10.1016/J.JCMGH.2020.08.005 |
| 2020-08-15 |
Possible role of HLA class-I genotype in SARS-CoV-2 infection and progression: A pilot study in a cohort of Covid-19 Spanish patients (edit) |
10.1016/J.CLIM.2020.108572 |
| 2020-08-15 |
Functional SARS-CoV-2-specific immune memory persists after mild COVID-19 (edit) |
10.1101/2020.08.11.20171843 |
| 2020-08-15 |
Quantifying absolute neutralization titers against SARS-CoV-2 by a standardized virus neutralization assay allows for cross-cohort comparisons of COVID-19 sera (edit) |
10.1101/2020.08.13.20157222 |
| 2020-08-15 |
Genomic Diversity of SARS-CoV-2 During Early Introduction into the United States National Capital Region (edit) |
10.1101/2020.08.13.20174136 |
| 2020-08-15 |
Detection, prevalence, and duration of humoral responses to SARS-CoV-2 under conditions of limited population exposure (edit) |
10.1101/2020.08.14.20174490 |
| 2020-08-15 |
The Course of SARS-COV2 Infection Was Not Severe in a Crohn's Patient Who Administered Maintenance Anti-TNF Therapy Overlapping the Early Pre-Symptomatic Period of Infection (edit) |
10.3390/ANTIB9030042 |
| 2020-08-15 |
A Comparison of Whole Genome Sequencing of SARS-CoV-2 Using Amplicon-Based Sequencing, Random Hexamers, and Bait Capture (edit) |
10.3390/V12080895 |
| 2020-08-15 |
Mutations in the phosphorylation sites of SARS-CoV-2 encoded nucleocapsid protein and structure model of sequestration by protein 14-3-3 (edit) |
10.1016/J.BBRC.2020.08.024 |
| 2020-08-15 |
SARS-CoV-2 controlled human infection models: Ethics, challenge agent production and regulatory issues (edit) |
10.1016/J.BIOLOGICALS.2020.08.006 |
| 2020-08-15 |
SARS-CoV-2 has been circulating in northern Italy since December 2019: Evidence from environmental monitoring (edit) |
10.1016/J.SCITOTENV.2020.141711 |
| 2020-08-15 |
SARS-CoV-2 presented in the air of an intensive care unit (ICU) (edit) |
10.1016/J.SCS.2020.102446 |
| 2020-08-15 |
Histopathological evaluation of placentas after diagnosis of maternal SARS-CoV-2 infection (edit) |
10.1016/J.AJOGMF.2020.100211 |
| 2020-08-15 |
Trade-offs in moving citizen-based anuran call surveys online during the SARS-CoV-2 pandemic: Lessons from rural Appalachia, USA (edit) |
10.1002/ECE3.6654 |
| 2020-08-14 |
Furin cleavage of SARS-CoV-2 Spike promotes but is not essential for infection and cell-cell fusion (edit) |
10.1101/2020.08.13.243303 |
| 2020-08-14 |
Methylation of RNA Cap in SARS-CoV-2 captured by serial crystallography (edit) |
10.1101/2020.08.14.251421 |
| 2020-08-14 |
Nanoluciferase complementation-based biosensor reveals the importance of N- linked glycosylation of SARS-CoV-2 Spike for viral entry (edit) |
10.21203/RS.3.RS-58455/V1 |
| 2020-08-14 |
Antibody prevalence for SARS-CoV-2 following the peak of the pandemic in England: REACT2 study in 100,000 adults (edit) |
10.1101/2020.08.12.20173690 |
| 2020-08-14 |
Plastic Surgery During the COVID-19 Pandemic: The Space, Equipment, Expertise Approach (edit) |
10.1093/ASJ/SJAA136 |
| 2020-08-14 |
Notes from the Field: Seroprevalence Estimates of SARS-CoV-2 Infection in Convenience Sample - Oregon, May 11-June 15, 2020 (edit) |
10.15585/MMWR.MM6932A4 |
| 2020-08-14 |
Transmission of SARS-CoV-2 Involving Residents Receiving Dialysis in a Nursing Home - Maryland, April 2020 (edit) |
10.15585/MMWR.MM6932E4 |
| 2020-08-14 |
Maintaining Patient Safety and Data Integrity of NASH Clinical Trials During the SARS-CoV-2 Pandemic (edit) |
10.1002/HEP.31522 |
| 2020-08-14 |
The Biological Rationale for the Repurposing of BCG Vaccine against SARS-CoV-2 (edit) |
10.1021/ACS.JPROTEOME.0C00410 |
| 2020-08-14 |
Anal swab as the potentially optimal specimen for SARS-CoV-2 detection to evaluate the hospital discharge of COVID-19 patients (edit) |
10.2217/FMB-2020-0090 |
| 2020-08-14 |
Protein reliability analysis and virtual screening of natural inhibitors for SARS-CoV-2 main protease (Mpro) through docking, molecular mechanic & dynamic, and ADMET profiling (edit) |
10.1080/07391102.2020.1806930 |
| 2020-08-14 |
SARS-CoV-2 Testing in Patients With Cancer Treated at a Tertiary Care Hospital During the COVID-19 Pandemic (edit) |
10.1200/JCO.20.01442 |
| 2020-08-14 |
Potential therapeutic application of mesenchymal stem cell-derived exosomes in SARS-CoV-2 pneumonia (edit) |
10.1186/S13287-020-01866-6 |
| 2020-08-14 |
Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications on COVID-19 immunity (edit) |
10.1172/JCI.INSIGHT.142386 |
| 2020-08-14 |
Adaptive immune responses to SARS-CoV-2 infection in severe versus mild individuals (edit) |
10.1038/S41392-020-00263-Y |
| 2020-08-14 |
A single dose of an adenovirus-vectored vaccine provides protection against SARS-CoV-2 challenge (edit) |
10.1038/S41467-020-17972-1 |
| 2020-08-14 |
Italian males recovering from mild COVID-19 show no evidence of SARS-CoV-2 in semen despite prolonged nasopharyngeal swab positivity (edit) |
10.1038/S41443-020-00344-0 |
| 2020-08-14 |
High seroprevalence for SARS-CoV-2 among household members of essential workers detected using a dried blood spot assay (edit) |
10.1371/JOURNAL.PONE.0237833 |
| 2020-08-14 |
Association Between Number of In-Person Health Care Visits and SARS-CoV-2 Infection in Obstetrical Patients (edit) |
10.1001/JAMA.2020.15242 |
| 2020-08-14 |
Potential antigenic cross-reactivity between SARS-CoV-2 and Dengue viruses (edit) |
10.1093/CID/CIAA1207 |
| 2020-08-14 |
Recurrence of SARS-CoV-2 infection with a more severe case after mild COVID-19, reversion of RT-qPCR for positive and late antibody response: case report (edit) |
10.1002/JMV.26432 |
| 2020-08-14 |
Anti-SARS-CoV-2 Spike Antibodies are Stable in Convalescent Plasma when Stored at 4° Celsius for at Least 6 Weeks (edit) |
10.1111/TRF.16047 |
| 2020-08-14 |
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19) - anatomic pathology perspective on current knowledge (edit) |
10.1186/S13000-020-01017-8 |
| 2020-08-14 |
Echocardiographic characteristics of patients with SARS-CoV-2 infection (edit) |
10.1007/S00392-020-01727-5 |
| 2020-08-14 |
1H, 13C, and 15N backbone chemical shift assignments of the apo and the ADP-ribose bound forms of the macrodomain of SARS-CoV-2 non-structural protein 3b (edit) |
10.1007/S12104-020-09973-4 |
| 2020-08-14 |
Unravelling host-pathogen interactions: ceRNA network in SARS-CoV-2 infection (COVID-19) (edit) |
10.1016/J.GENE.2020.145057 |
| 2020-08-14 |
Antimalarial artemisinin-based combination therapies (ACT) and COVID-19 in Africa: In vitro inhibition of SARS-CoV-2 replication by mefloquine-artesunate (edit) |
10.1016/J.IJID.2020.08.032 |
| 2020-08-14 |
Immunodominant epitopes based serological assay for detecting SARS-CoV-2 exposure: Promises and challenges (edit) |
10.1016/J.EBIOM.2020.102947 |
| 2020-08-14 |
Hydroxychloroquine: mechanism of action inhibiting SARS-CoV2 entry (edit) |
10.1101/2020.08.13.250217 |
| 2020-08-14 |
The FDA-approved drug Alectinib compromises SARS-CoV-2 nucleocapsid phosphorylation and inhibits viral infection in vitro (edit) |
10.1101/2020.08.14.251207 |
| 2020-08-14 |
Rational Design of SARS-CoV-2 Spike Glycoproteins To Increase Immunogenicity By T Cell Epitope Engineering (edit) |
10.1101/2020.08.14.251496 |
| 2020-08-14 |
Decontamination of SARS-CoV-2 and other RNA viruses from N95 level meltblown polypropylene fabric using heat under different humidities (edit) |
10.1101/2020.08.10.20171728 |
| 2020-08-14 |
Lower respiratory tract myeloid cells harbor SARS-CoV-2 and display an inflammatory phenotype (edit) |
10.1101/2020.08.11.20171967 |
| 2020-08-14 |
Neutralizing antibodies correlate with protection from SARS-CoV-2 in humans during a fishery vessel outbreak with high attack rate (edit) |
10.1101/2020.08.13.20173161 |
| 2020-08-14 |
The operational impact of deploying SARS-CoV-2 vaccines in countries of the WHO African Region (edit) |
10.1101/2020.08.13.20147595 |
| 2020-08-14 |
A high throughput screen for TMPRSS2 expression identifies FDA-approved and clinically advanced compounds that can limit SARS-CoV-2 entry (edit) |
10.21203/RS.3.RS-48659/V1 |
| 2020-08-14 |
SARS-CoV-2 infection induces robust germinal center CD4 T follicular helper cell responses in rhesus macaques (edit) |
10.21203/RS.3.RS-51545/V1 |
| 2020-08-14 |
SARS-CoV-2 renal tropism associates with acute kidney injury (edit) |
10.1016/S0140-6736(20)31759-1 |
| 2020-08-14 |
Survival of SARS-COV-2 under liquid medium, dry filter paper and acidic conditions (edit) |
10.1038/S41421-020-00191-9 |
| 2020-08-14 |
EDTA-Anticoagulated Whole Blood for SARS-CoV-2 Antibody Testing by Electrochemiluminescence Immunoassay (ECLIA) and Enzyme-Linked Immunosorbent Assay (ELISA) (edit) |
10.3390/DIAGNOSTICS10080593 |
| 2020-08-14 |
Proposal of De Novo Antigen Test for COVID-19: Ultrasensitive Detection of Spike Proteins of SARS-CoV-2 (edit) |
10.3390/DIAGNOSTICS10080594 |
| 2020-08-14 |
Molecular Epidemiology Analysis of SARS-CoV-2 Strains Circulating in Romania during the First Months of the Pandemic (edit) |
10.3390/LIFE10080152 |
| 2020-08-14 |
New Anti SARS-Cov-2 Targets for Quinoline Derivatives Chloroquine and Hydroxychloroquine (edit) |
10.3390/IJMS21165856 |
| 2020-08-14 |
The struggle SARS-CoV-2 vs. homo sapiens-Why the earth stood still, and how will it keep moving on? (edit) |
10.1016/J.TECHFORE.2020.120264 |
| 2020-08-14 |
Assessing the Prevalence of Self-Medication among Healthcare Workers before and during the 2019 SARS-CoV-2 (COVID-19) Pandemic in Kenya (edit) |
10.1016/J.JSPS.2020.08.003 |
| 2020-08-14 |
The impact of obesity on severe disease and mortality in people with SARS-CoV-2: A systematic review and meta-analysis (edit) |
10.1002/EDM2.176 |
| 2020-08-14 |
The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections (edit) |
10.3389/FIMMU.2020.02033 |
| 2020-08-14 |
COVID-19 Therapy: Could a Chlorophyll Derivative Promote Cellular Accumulation of Zn2+ Ions to Inhibit SARS-CoV-2 RNA Synthesis? (edit) |
10.3389/FPLS.2020.01270 |
| 2020-08-14 |
Interdisciplinary Model for Scheduling Post-discharge Cardiopulmonary Care of Patients Following Severe and Critical SARS-CoV-2 (Coronavirus) Infection (edit) |
10.3389/FCVM.2020.00157 |
| 2020-08-13 |
Acute Limb Ischemia in Minimally Symptomatic SARS-CoV-2 Infection (edit) |
10.1016/J.JVIR.2020.08.009 |
| 2020-08-13 |
Characterisation of the SARS-CoV-2 ExoN (nsp14ExoN-nsp10) complex: implications for its role in viral genome stability and inhibitor identification (edit) |
10.1101/2020.08.13.248211 |
| 2020-08-13 |
SARS-CoV-2 neutralizing antibody levels are correlated with severity of COVID-19 pneumonia (edit) |
10.1016/J.BIOPHA.2020.110629 |
| 2020-08-13 |
The SARS-CoV-2 Spike harbours a lipid binding pocket which modulates stability of the prefusion trimer (edit) |
10.1101/2020.08.13.249177 |
| 2020-08-13 |
SARS-CoV-2 emergency in the workplace: are companies ready to protect their workers? A cross-sectional survey (edit) |
10.1080/10803548.2020.1810457 |
| 2020-08-13 |
Ligand and structure-based virtual screening applied to the SARS-CoV-2 main protease: an in silico repurposing study (edit) |
10.4155/FMC-2020-0165 |
| 2020-08-13 |
Development of Health Care Workers' Mental Health During the SARS-CoV-2 Pandemic in Switzerland: Two Cross-Sectional Studies (edit) |
10.1017/S0033291720003128 |
| 2020-08-13 |
Holistic Analysis of Coronavirus Literature: A Scientometric Study of the Global Publications Relevant to SARS-CoV-2 (COVID-19), MERS-CoV (MERS) and SARS-CoV (SARS) (edit) |
10.1017/DMP.2020.300 |
| 2020-08-13 |
Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical Trials (edit) |
10.1001/JAMA.2020.15543 |
| 2020-08-13 |
Negative tests for SARS-CoV-2 infection do not rule out its responsibility for chilblains (edit) |
10.1111/BJD.19483 |
| 2020-08-13 |
Results from a survey in healthy blood donors in South Eastern Italy indicate that we are far away from herd immunity to SARS-CoV-2 (edit) |
10.1002/JMV.26425 |
| 2020-08-13 |
Closing the Serological Gap in the Diagnostic Testing for COVID-19: The Value of Anti-SARS-CoV-2 IgA Antibodies (edit) |
10.1002/JMV.26422 |
| 2020-08-13 |
Risk and protective factors of SARS-CoV-2 infection (edit) |
10.1002/JMV.26427 |
| 2020-08-13 |
Low post-pandemic wave SARS-CoV-2 seroprevalence in Kuala Lumpur and Selangor, Malaysia (edit) |
10.1002/JMV.26426 |
| 2020-08-13 |
Shell disorder analysis suggests that pangolins offered a window for a silent spread of an attenuated SARS-CoV-2 precursor among humans (edit) |
10.1021/ACS.JPROTEOME.0C00460 |
| 2020-08-13 |
Streamlined Poststroke Treatment Order Sets During the SARS-CoV-2 Pandemic: Simplifying While Not Compromising Care (edit) |
10.1161/STROKEAHA.120.031008 |
| 2020-08-13 |
Three Cases of Pediatric Multisystem Inflammatory Syndrome Associated with COVID-19 Due to SARS-CoV-2 (edit) |
10.12659/AJCR.925779 |
| 2020-08-13 |
Portable and accurate diagnostics for COVID-19: Combined use of the miniPCR thermocycler and a well-plate reader for SARS-CoV-2 virus detection (edit) |
10.1371/JOURNAL.PONE.0237418 |
| 2020-08-13 |
Ultrastructural Evidence of Direct Viral Damage to the Olfactory Complex in Patients Testing Positive for SARS-CoV-2 (edit) |
10.1001/JAMAOTO.2020.2366 |
| 2020-08-13 |
A model to predict SARS-CoV-2 infection based on the first three-month surveillance data in Brazil (edit) |
10.1111/TMI.13476 |
| 2020-08-13 |
Negative tests for SARS-CoV-2 infection do not rule out its responsibility for chilblains: reply from authors (edit) |
10.1111/BJD.19486 |
| 2020-08-13 |
Sequence-based prediction of SARS-CoV-2 vaccine targets using a mass spectrometry-based bioinformatics predictor identifies immunogenic T cell epitopes (edit) |
10.1186/S13073-020-00767-W |
| 2020-08-13 |
High-dose intravenous vitamin C may help in cytokine storm in severe SARS-CoV-2 infection (edit) |
10.1186/S13054-020-03228-3 |
| 2020-08-13 |
Implications of SARS-CoV-2 infection for patients with rheumatic disease (edit) |
10.1136/ANNRHEUMDIS-2020-218050 |
| 2020-08-13 |
Vitamin D deficiency in African Americans is associated with a high risk of severe disease and mortality by SARS-CoV-2 (edit) |
10.1038/S41371-020-00398-Z |
| 2020-08-13 |
Symptomatology of COVID-19 from the otorhinolaryngology perspective: a survey of 223 SARS-CoV-2 RNA-positive patients (edit) |
10.1007/S00405-020-06284-1 |
| 2020-08-13 |
Receptor utilization of angiotensin converting enzyme 2 (ACE2) indicates a narrower host range of SARS-CoV-2 than that of SARS-CoV (edit) |
10.1111/TBED.13792 |
| 2020-08-13 |
SARS-CoV-2 PCR testing of skin for COVID-19 diagnostics: a case report (edit) |
10.1016/S0140-6736(20)31754-2 |
| 2020-08-13 |
Optimal dosing & time: Issues to get hydroxychloroquine safety & efficacy against COVID-19/SARS-CoV-2 (edit) |
10.4103/IJMR.IJMR_2609_20 |
| 2020-08-13 |
Strong homology between SARS-CoV-2 envelope protein and a Mycobacterium sp. antigen allows rapid diagnosis of Mycobacterial infections and may provide specific anti-SARS-CoV-2 immunity via the BCG vaccine (edit) |
10.1016/J.ANNDIAGPATH.2020.151600 |
| 2020-08-13 |
Attenuated influenza virions expressing the SARS-CoV-2 receptor-binding domain induce neutralizing antibodies in mice (edit) |
10.1101/2020.08.12.248823 |
| 2020-08-13 |
Maraviroc inhibits SARS-CoV-2 multiplication and s-protein mediated cell fusion in cell culture (edit) |
10.1101/2020.08.12.246389 |
| 2020-08-13 |
Transmission heterogeneities, kinetics, and controllability of SARS-CoV-2 (edit) |
10.1101/2020.08.09.20171132 |
| 2020-08-13 |
Intranasal exposure of African green monkeys to SARS-CoV-2 results in acute phase pneumonia with shedding and lung injury still present in the early convalescence phase (edit) |
10.21203/RS.3.RS-50023/V2 |
| 2020-08-13 |
Functional SARS-CoV-2-specific immune memory persists after mild COVID-19 (edit) |
10.21203/RS.3.RS-57112/V1 |
| 2020-08-13 |
Environmental contamination of SARS-CoV-2 on surfaces, air-conditioner and ventilation systems (edit) |
10.1016/J.IJHEH.2020.113599 |
| 2020-08-13 |
Hesperidin and SARS-CoV-2: New Light on the Healthy Function of Citrus Fruits (edit) |
10.3390/ANTIOX9080742 |
| 2020-08-13 |
Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications (edit) |
10.3390/IJMS21165807 |
| 2020-08-13 |
The use of knowledge management tools in viroinformatics. Example study of a highly conserved sequence motif in Nsp3 of SARS-CoV-2 as a therapeutic target (edit) |
10.1016/J.COMPBIOMED.2020.103963 |
| 2020-08-13 |
Covid-19 and ENT practice: Our experience: ENT outpatient department, ward and operating room management during the SARS-CoV-2 pandemic (edit) |
10.1016/J.AMJOTO.2020.102676 |
| 2020-08-13 |
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Glial Cells: insights and perspectives (edit) |
10.1016/J.BBIH.2020.100127 |
| 2020-08-13 |
Radiomics-based model for accurately distinguishing between severe acute respiratory syndrome associated coronavirus 2 (SARS-CoV-2) and influenza A infected pneumonia (edit) |
10.1002/MCO2.14 |
| 2020-08-13 |
Conserved HLA binding peptides from five non-structural proteins of SARS-CoV-2-An in silico glance (edit) |
10.1016/J.HUMIMM.2020.08.001 |
| 2020-08-13 |
Antivirals Against Coronaviruses: Candidate Drugs for SARS-CoV-2 Treatment? (edit) |
10.3389/FMICB.2020.01818 |
| 2020-08-13 |
Evaluation of Four Commercial Kits for SARS-CoV-2 Real-Time Reverse-Transcription Polymerase Chain Reaction Approved by Emergency-Use-Authorization in Korea (edit) |
10.3389/FMED.2020.00521 |
| 2020-08-13 |
Immunomodulatory Drugs in the Management of SARS-CoV-2 (edit) |
10.3389/FIMMU.2020.01844 |
| 2020-08-12 |
Suppression of MDA5-mediated antiviral immune responses by NSP8 of SARS-CoV-2 (edit) |
10.1101/2020.08.12.247767 |
| 2020-08-12 |
High prevalence of SARS-CoV-2 antibodies in care homes affected by COVID-19; a prospective cohort study in England (edit) |
10.1101/2020.08.10.20171413 |
| 2020-08-12 |
From containment to harm reduction from SARS-CoV-2: a fabric mask for enhanced effectiveness, comfort, and compliance (edit) |
10.1080/00405000.2020.1805971 |
| 2020-08-12 |
Impaired cellular immunity to SARS-CoV-2 in severe COVID-19 patients (edit) |
10.1101/2020.08.10.20171371 |
| 2020-08-12 |
Can robots help promote testing capacity for SARS-CoV-2? (edit) |
10.2196/20169 |
| 2020-08-12 |
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Nucleic Acid Contamination of Surfaces on a Coronavirus Disease 2019 Ward and Intensive Care Unit (edit) |
10.1017/ICE.2020.416 |
| 2020-08-12 |
Author Correction: Aerosol and surface contamination of SARS-CoV-2 observed in quarantine and isolation care (edit) |
10.1038/S41598-020-70939-6 |
| 2020-08-12 |
Spectrum of neonatal COVID-19 in Iran: 19 infants with SARS-CoV-2 perinatal infections with varying test results, clinical findings and outcomes (edit) |
10.1080/14767058.2020.1797672 |
| 2020-08-12 |
Annals On Call - Diagnosing SARS-CoV-2 Infection: Symptoms or No Symptoms? (edit) |
10.7326/A19-0036 |
| 2020-08-12 |
Product of natural evolution (SARS, MERS, and SARS-CoV-2); deadly diseases, from SARS to SARS-CoV-2 (edit) |
10.1080/21645515.2020.1797369 |
| 2020-08-12 |
ACE2 (Angiotensin-Converting Enzyme 2) in Cardiopulmonary Diseases: Ramifications for the Control of SARS-CoV-2 (edit) |
10.1161/HYPERTENSIONAHA.120.15595 |
| 2020-08-12 |
Inactivation of SARS-CoV-2 and Diverse RNA and DNA Viruses on 3D Printed Surgical Mask Materials (edit) |
10.1017/ICE.2020.417 |
| 2020-08-12 |
Structural insight into the role of novel SARS-CoV-2 E protein: A potential target for vaccine development and other therapeutic strategies (edit) |
10.1371/JOURNAL.PONE.0237300 |
| 2020-08-12 |
Usability and acceptability of home-based self-testing for SARS-CoV-2 antibodies for population surveillance (edit) |
10.1093/CID/CIAA1178 |
| 2020-08-12 |
A SARS-CoV-2 Prediction Model from Standard Laboratory Tests (edit) |
10.1093/CID/CIAA1175 |
| 2020-08-12 |
Might SARS-CoV-2 Have Arisen via Serial Passage through an Animal Host or Cell Culture?: A potential explanation for much of the novel coronavirus' distinctive genome (edit) |
10.1002/BIES.202000091 |
| 2020-08-12 |
Value of preoperative testing for SARS-CoV-2 for elective surgeries in a cancer center during the peak of pandemic in Brazil (edit) |
10.1002/JSO.26146 |
| 2020-08-12 |
Movement disorders as a new neurological clinical picture in severe SARS-CoV-2 infection (edit) |
10.1111/ENE.14474 |
| 2020-08-12 |
Dynamic changes of throat swabs RNA and serum antibodies for SARS-CoV-2 and their diagnostic performances in patients with COVID-19 (edit) |
10.1080/22221751.2020.1810133 |
| 2020-08-12 |
SARS-CoV-2 Natural Transmission from Human to Cat, Belgium, March 2020 (edit) |
10.3201/EID2612.202223 |
| 2020-08-12 |
Clinical and laboratory evaluation of SARS-CoV-2 lateral flow assays for use in a national COVID-19 seroprevalence survey (edit) |
10.1136/THORAXJNL-2020-215732 |
| 2020-08-12 |
Setting the criteria for SARS-CoV-2 reinfection - six possible cases (edit) |
10.1016/J.JINF.2020.08.011 |
| 2020-08-12 |
Comment on Evidence for and against vertical transmission for SARS-CoV-2 (COVID-19) (edit) |
10.1016/J.AJOG.2020.08.022 |
| 2020-08-12 |
Comparison of Automated SARS-CoV-2 Antigen Test for COVID-19 Infection with Quantitative RT-PCR using 313 Nasopharyngeal Swabs Including from 7 Serially Followed Patients (edit) |
10.1016/J.IJID.2020.08.029 |
| 2020-08-12 |
SARS-CoV-2 in soils (edit) |
10.1016/J.ENVRES.2020.110045 |
| 2020-08-12 |
Of Mice and Men: The Coronavirus MHV and Mouse Models as a Translational Approach to Understand SARS-CoV-2 (edit) |
10.3390/V12080880 |
| 2020-08-12 |
Evaluation of the Ion AmpliSeq SARS-CoV-2 Research Panel by Massive Parallel Sequencing (edit) |
10.3390/GENES11080929 |
| 2020-08-12 |
Low-Cost Polyester-Tipped 3-Dimensionally-Printed Nasopharyngeal Swab for the Diagnosis of Severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) (edit) |
10.1128/JCM.01668-20 |
| 2020-08-12 |
Self-Collected Anterior Nasal and Saliva Specimens versus Healthcare Worker-Collected Nasopharyngeal Swabs for the Molecular Detection of SARS-CoV-2 (edit) |
10.1128/JCM.01824-20 |
| 2020-08-12 |
Autoimmunity complicating SARS-CoV-2 infection in selective IgA-deficiency (edit) |
10.1212/NXI.0000000000000881 |
| 2020-08-12 |
Structure-based drug design of an inhibitor of the SARS-CoV-2 (COVID-19) main protease using free software: a tutorial for students and scientists (edit) |
10.26434/CHEMRXIV.12791954 |
| 2020-08-12 |
Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2 (edit) |
10.1101/2020.08.11.247395 |
| 2020-08-12 |
Efficacy of Targeting SARS-CoV-2 by CAR-NK Cells (edit) |
10.1101/2020.08.11.247320 |
| 2020-08-12 |
Thermal inactivation and nucleic acid amplification-based testing for SARS-CoV-2 (edit) |
10.1016/J.JCV.2020.104588 |
| 2020-08-12 |
How to manage thromboembolic risk in patient with SARS-CoV-2-related disease in the Emergency Department: A case report of cardiogenic shock due to massive pulmonary embolism (edit) |
10.1016/J.RMCR.2020.101185 |
| 2020-08-12 |
Structural Insights into the mechanism of RNA recognition by the N-terminal RNA-binding domain of the SARS-CoV-2 nucleocapsid phosphoprotein (edit) |
10.1016/J.CSBJ.2020.08.006 |
| 2020-08-12 |
Neurological Manifestations of Severe SARS-CoV-2 Infection: Potential Mechanisms and Implications of Individualized Mechanical Ventilation Settings (edit) |
10.3389/FNEUR.2020.00845 |
| 2020-08-12 |
Reactive Arthritis in a 37-Year-Old Female With SARS-CoV2 Infection (edit) |
10.7759/CUREUS.9698 |
| 2020-08-12 |
Histopathology of cutaneous COVID-19 lesion: possible SARS-CoV-2 cytopathogenic effect (edit) |
10.1016/J.PATHOL.2020.07.003 |
| 2020-08-11 |
Obesity-Driven Deficiencies of Specialized Pro-resolving Mediators May Drive Adverse Outcomes During SARS-CoV-2 Infection (edit) |
10.3389/FIMMU.2020.01997 |
| 2020-08-11 |
Does severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) cause orchitis in patients with coronavirus disease 2019 (COVID-19)? (edit) |
10.1080/2090598X.2020.1798862 |
| 2020-08-11 |
Reissuing the sigma receptors for SARS-CoV-2 (edit) |
10.1016/J.JOCN.2020.08.014 |
| 2020-08-11 |
The Public's Perception of the Severity and Global Impact at the Start of the Novel SARS-CoV-2 Pandemic: A Crowdsourcing Based Cross-Sectional Analysis (edit) |
10.2196/19768 |
| 2020-08-11 |
Telmisartan for treatment of Covid-19 patients: an open randomized clinical trial - A preliminary report (edit) |
10.1101/2020.08.04.20167205 |
| 2020-08-11 |
Revealing the Mechanism of SARS-CoV-2 Spike Protein Binding With ACE2 (edit) |
10.1109/MCSE.2020.3015511 |
| 2020-08-11 |
SARS-CoV-2 Neutralizing Antibody Titers in Convalescent Plasma and Recipients in New Mexico: An Open Treatment Study in COVID-19 Patients (edit) |
10.1093/INFDIS/JIAA505 |
| 2020-08-11 |
Mutational spectra of SARS-CoV-2 orf1ab polyprotein and signature mutations in the United States of America (edit) |
10.1002/JMV.26417 |
| 2020-08-11 |
SARS-CoV-2 infection in a 7-year-old girl with pancytopenia during acute lymphocytic leukemia maintenance therapy (edit) |
10.1002/PBC.28391 |
| 2020-08-11 |
Prevalence of SARS-CoV-2 Infection Among Health Care Workers in a Tertiary Community Hospital (edit) |
10.1001/JAMAINTERNMED.2020.4214 |
| 2020-08-11 |
Increased mortality in patients with severe SARS-CoV-2 infection admitted within seven days of disease onset (edit) |
10.1007/S00134-020-06202-3 |
| 2020-08-11 |
Myocardial dysfunction in SARS-CoV-2 infection in infants under 1 year of age (edit) |
10.1007/S12519-020-00384-Y |
| 2020-08-11 |
Response to "Myocardial dysfunction in SARS-CoV-2 infection in infants under 1 year of age" (edit) |
10.1007/S12519-020-00386-W |
| 2020-08-11 |
SARS-CoV-2 infection and early mortality of wait-listed and solid organ transplant recipients in England: a national cohort study (edit) |
10.1111/AJT.16247 |
| 2020-08-11 |
Global cataloguing of variations in untranslated regions of viral genome and prediction of key host RNA binding protein-microRNA interactions modulating genome stability in SARS-CoV-2 (edit) |
10.1371/JOURNAL.PONE.0237559 |
| 2020-08-11 |
Burden of illness in households with SARS-CoV-2 infected children (edit) |
10.1093/JPIDS/PIAA097 |
| 2020-08-11 |
SARS-CoV-2 Serology - Need for Quantitative Testing and Interpretive Reporting (edit) |
10.1093/JALM/JFAA147 |
| 2020-08-11 |
Is subacute thyroiditis an underestimated manifestation of SARS-CoV-2 infection? Insights from a case series (edit) |
10.1210/CLINEM/DGAA537 |
| 2020-08-11 |
Investigation of SARS-CoV-2 in Semen of Patients in the Acute Stage of COVID-19 Infection (edit) |
10.1159/000510531 |
| 2020-08-11 |
Untangling SARS-CoV-2 epidemic control - lessons from Vietnam (edit) |
10.1093/CID/CIAA1195 |
| 2020-08-11 |
[Recommendations for Performance of Lung Function in Times of SARS-CoV-2 Pandemic] (edit) |
10.1055/A-1216-2215 |
| 2020-08-11 |
Antibody response to SARS-CoV-2 - sustained after all? (edit) |
10.1038/S41577-020-00423-9 |
| 2020-08-11 |
SARS-CoV-2 vaccine - think globally, act locally (edit) |
10.1038/S41577-020-00422-W |
| 2020-08-11 |
Getting to the (germinal) centre of SARS-CoV-2 (edit) |
10.1038/S41577-020-00424-8 |
| 2020-08-11 |
SARS-CoV-2 and the next generations: which impact on reproductive tissues? (edit) |
10.1007/S10815-020-01917-0 |
| 2020-08-11 |
Tannins inhibit SARS-CoV-2 through binding with catalytic dyad residues of 3CLpro : An in silico approach with 19 structural different hydrolysable tannins (edit) |
10.1111/JFBC.13432 |
| 2020-08-11 |
SARS-CoV-2 serological testing changes disease management in a PCR-negative patient (edit) |
10.1136/BCR-2020-237239 |
| 2020-08-11 |
Severe pre-eclampsia complicated by acute fatty liver disease of pregnancy, HELLP syndrome and acute kidney injury following SARS-CoV-2 infection (edit) |
10.1136/BCR-2020-237521 |
| 2020-08-11 |
Racial and ethnic disparities in SARS-CoV-2 pandemic: analysis of a COVID-19 observational registry for a diverse US metropolitan population (edit) |
10.1136/BMJOPEN-2020-039849 |
| 2020-08-11 |
Neurological complications of SARS-CoV-2 infection in a 66-year-old man (edit) |
10.20452/PAMW.15548 |
| 2020-08-11 |
Molecular epidemiology of SARS CoV-2: a review of current data on genetic variability of the virus (edit) |
10.20452/PAMW.15550 |
| 2020-08-11 |
Comparative analysis of primer-probe sets for RT-qPCR of COVID-19 causative virus (SARS-CoV-2) (edit) |
10.1021/ACSINFECDIS.0C00464 |
| 2020-08-11 |
Interaction of Drug Candidates with Various SARS-CoV-2 Receptors: An in Silico Study to Combat COVID-19 (edit) |
10.1021/ACS.JPROTEOME.0C00327 |
| 2020-08-11 |
Pentoxifylline and Oxypurinol: Potential Drugs to Prevent the "Cytokine Release (Storm) Syndrome" Caused by SARS-CoV-2? (edit) |
10.2174/1381612826666200811180232 |
| 2020-08-11 |
Optimized pseudotyping conditions for the SARS COV-2 Spike glycoprotein (edit) |
10.1128/JVI.01062-20 |
| 2020-08-11 |
SARS-CoV-2 and the pandemic of COVID-19 (edit) |
10.1136/POSTGRADMEDJ-2020-138386 |
| 2020-08-11 |
SARS-CoV-2 on the ocular surface: is it truly a novel transmission route? (edit) |
10.1136/BJOPHTHALMOL-2020-316263 |
| 2020-08-11 |
Case of adult large vessel vasculitis after SARS-CoV-2 infection (edit) |
10.1136/ANNRHEUMDIS-2020-218440 |
| 2020-08-11 |
SARS-CoV-2/COVID-19 Testing for Research: Willingness to Use Home Specimen Collection Methods (edit) |
10.2196/19471 |
| 2020-08-11 |
Temporal and Location Variations, and Link Categories for the Dissemination of COVID-19-related Information on Twitter during the SARS-CoV-2 Outbreak in Europe: Infoveillance Study (edit) |
10.2196/19629 |
| 2020-08-11 |
Facility-Wide Testing for SARS-CoV-2 in Nursing Homes - Seven U.S. Jurisdictions, March-June 2020 (edit) |
10.15585/MMWR.MM6932E5 |
| 2020-08-11 |
Method comparison of SARS-CoV-2 serology assays involving three commercially available platforms and a novel in-house developed enzyme-linked immunosorbent assay (edit) |
10.1016/J.CLINBIOCHEM.2020.08.004 |
| 2020-08-11 |
Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics (edit) |
10.1016/S1473-3099(20)30648-4 |
| 2020-08-11 |
Identification of SARS-CoV-2 3CL Protease Inhibitors by a Quantitative High-throughput Screening (edit) |
10.1101/2020.07.17.207019 |
| 2020-08-11 |
Opposing activities of IFITM proteins in SARS-CoV-2 infection (edit) |
10.1101/2020.08.11.246678 |
| 2020-08-11 |
Cryo-EM Structures of the SARS-CoV-2 Endoribonuclease Nsp15 (edit) |
10.1101/2020.08.11.244863 |
| 2020-08-11 |
Performance evaluation of serological assays to determine the immunoglobulin status in SARS-CoV-2 infected patients (edit) |
10.1016/J.JCV.2020.104589 |
| 2020-08-11 |
Ambroxol and Ciprofloxacin Show Activity Against SARS-CoV2 in Vero E6 Cells at Clinically-Relevant Concentrations (edit) |
10.1101/2020.08.11.245100 |
| 2020-08-11 |
Considering indirect benefits is critical when evaluating SARS-CoV-2 vaccine candidates (edit) |
10.1101/2020.08.07.20170456 |
| 2020-08-11 |
Salivary anti-SARS-CoV-2 IgA as an accessible biomarker of mucosal immunity against COVID-19 (edit) |
10.1101/2020.08.07.20170258 |
| 2020-08-11 |
Characterizing SARS-CoV-2 mutations in the United States (edit) |
10.21203/RS.3.RS-49671/V1 |
| 2020-08-11 |
SARS-CoV-2 exhibits intra-host genomic plasticity and low-frequency polymorphic quasispecies (edit) |
10.1016/J.JCV.2020.104585 |
| 2020-08-11 |
SARS-CoV-2 seroprevalence in a Belgian cohort of patients with cystic fibrosis (edit) |
10.1016/J.JCF.2020.08.005 |
| 2020-08-11 |
Structural analysis of experimental drugs binding to the SARS-CoV-2 target TMPRSS2 (edit) |
10.1016/J.JMGM.2020.107710 |
| 2020-08-11 |
In Silico Identification of Potential Inhibitors of ADP-Ribose Phosphatase of SARS-CoV-2 nsP3 by Combining E-Pharmacophore- and Receptor-Based Virtual Screening of Database (edit) |
10.1002/SLCT.202001419 |
| 2020-08-11 |
Re-reading the SARS-COV-2 Epidemic in Bergamo (edit) |
10.1007/S42399-020-00431-9 |
| 2020-08-11 |
Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding (edit) |
10.1016/J.CELL.2020.08.012 |
| 2020-08-11 |
Growth Factor Receptor Signaling Inhibition Prevents SARS-CoV-2 Replication (edit) |
10.1016/J.MOLCEL.2020.08.006 |
| 2020-08-11 |
The pharmacist's role in SARS-CoV-2 diagnostic testing (edit) |
10.1016/J.JAPH.2020.08.017 |
| 2020-08-11 |
Two serological approaches for detection of antibodies to SARS-CoV-2 in different scenarios: a screening tool and a point-of-care test (edit) |
10.1016/J.DIAGMICROBIO.2020.115167 |
| 2020-08-11 |
Use of a simplified sample processing step without RNA extraction for direct SARS-CoV-2 RT-PCR detection (edit) |
10.1016/J.JCV.2020.104587 |
| 2020-08-11 |
Effect of Low-Pathogenic Human Coronavirus-Specific Antibodies on SARS-CoV-2 (edit) |
10.1016/J.IT.2020.08.003 |
| 2020-08-10 |
Repeated Testing in SARS-CoV-2 Infection (edit) |
10.1016/J.MAYOCP.2020.08.007 |
| 2020-08-10 |
In Reply-Repeated Testing in SARS-CoV-2 Infection (edit) |
10.1016/J.MAYOCP.2020.08.006 |
| 2020-08-10 |
DC/L-SIGN recognition of spike glycoprotein promotes SARS-CoV-2 trans-infection and can be inhibited by a glycomimetic antagonist (edit) |
10.1101/2020.08.09.242917 |
| 2020-08-10 |
SARS-CoV-2 and the Role of Orofecal Transmission: Systematic Review (edit) |
10.1101/2020.08.04.20168054 |
| 2020-08-10 |
A Novel Hypothesis for Original Antigenic Sin in the Severe Disease of SARS-CoV-2 Infection (edit) |
10.1089/MAB.2020.0029 |
| 2020-08-10 |
Structural insight to hydroxychloroquine-3C-like proteinase complexation from SARS-CoV-2: inhibitor modelling study through molecular docking and MD-simulation study (edit) |
10.1080/07391102.2020.1804458 |
| 2020-08-10 |
Re-Testing for SARS-CoV-2: Patterns of Testing from a Large U.S. Healthcare System (edit) |
10.1017/ICE.2020.413 |
| 2020-08-10 |
Retrouver les origines du SARS-CoV-2 dans les phylogénies de coronavirus (edit) |
10.1051/MEDSCI/2020123 |
| 2020-08-10 |
[Effects of the SARS-CoV-2 pandemic on surgery - a national cross-sectional study] (edit) |
10.1007/S00104-020-01256-X |
| 2020-08-10 |
An analysis of SARS-CoV-2 cell entry genes identifies the intestine and colorectal cancer as susceptible tissues (edit) |
10.1002/BJS.11911 |
| 2020-08-10 |
Early administration of lopinavir/ritonavir plus hydroxychloroquine does not alter the clinical course of SARS-CoV-2 infection: a retrospective cohort study (edit) |
10.1002/JMV.26407 |
| 2020-08-10 |
Viral Load Kinetics of SARS-CoV-2 Infection in Saliva in Korean Patients: a Prospective Multi-center Comparative Study (edit) |
10.3346/JKMS.2020.35.E287 |
| 2020-08-10 |
Myasthenia Gravis Associated With SARS-CoV-2 Infection (edit) |
10.7326/L20-0845 |
| 2020-08-10 |
Diagnostic Performance of Chest CT for SARS-CoV-2 Infection in Individuals with or without COVID-19 Symptoms (edit) |
10.1148/RADIOL.2020202708 |
| 2020-08-10 |
Correction: A Snapshot of SARS-CoV-2 Genome Availability up to April 2020 and its Implications: Data Analysis (edit) |
10.2196/22853 |
| 2020-08-10 |
Validation of the Corona-Score for rapid identification of SARS-CoV-2 infections in patients seeking emergency department care in the United States (edit) |
10.1515/CCLM-2020-1121 |
| 2020-08-10 |
Modeling the role of asymptomatics in infection spread with application to SARS-CoV-2 (edit) |
10.1371/JOURNAL.PONE.0236976 |
| 2020-08-10 |
Side by side comparison of three fully automated SARS-CoV-2 antibody assays with a focus on specificity (edit) |
10.1093/CLINCHEM/HVAA198 |
| 2020-08-10 |
Search for asymptomatic carriers of SARS-CoV-2 in healthcare workers during the pandemic: a Spanish experience (edit) |
10.1093/QJMED/HCAA238 |
| 2020-08-10 |
Vascular inflammation and endothelial injury in SARS-CoV-2 infection: The overlooked regulatory cascades implicated by the ACE2 gene cluster (edit) |
10.1093/QJMED/HCAA241 |
| 2020-08-10 |
Mild vs severe liver injury in SARS-CoV-2 infection (edit) |
10.1159/000510758 |
| 2020-08-10 |
A Public Website for the Automated Assessment and Validation of SARS-CoV-2 Diagnostic PCR Assays (edit) |
10.1093/BIOINFORMATICS/BTAA710 |
| 2020-08-10 |
A cross-sectional study of immune seroconversion to SARS-CoV-2 in frontline maternity health professionals (edit) |
10.1111/ANAE.15229 |
| 2020-08-10 |
A physiological approach to understand the role of respiratory effort in the progression of lung injury in SARS-CoV-2 infection (edit) |
10.1186/S13054-020-03197-7 |
| 2020-08-10 |
High oligoclonality of immunoglobulins in SARS-CoV2 positive patients (edit) |
10.1136/ANNRHEUMDIS-2020-218316 |
| 2020-08-10 |
A paradox of social distancing for SARS-CoV-2: loneliness and heightened immunological risk (edit) |
10.1038/S41380-020-00861-W |
| 2020-08-10 |
[Are there cutaneous manifestations of SARS-CoV-2?] (edit) |
10.1007/S00105-020-04666-4 |
| 2020-08-10 |
Dupilumab in atopic dermatitis, a protocol for SARS-COV 2 infected patients (edit) |
10.1111/DTH.14172 |
| 2020-08-10 |
An Integrated Strategy for the Prevention of SARS-CoV-2 Infection in Healthcare Workers: A Prospective Observational Study (edit) |
10.3390/IJERPH17165785 |
| 2020-08-10 |
Advanced Analysis of Biosensor Data for SARS-CoV-2 RBD and ACE2 Interactions (edit) |
10.1021/ACS.ANALCHEM.0C02475 |
| 2020-08-10 |
Interdiction of Protein Folding for Therapeutic Drug Development in SARS CoV-2 (edit) |
10.1021/ACS.JPCB.0C03716 |
| 2020-08-10 |
Point Prevalence Testing of Residents for SARS-CoV-2 in a Subset of Connecticut Nursing Homes (edit) |
10.1001/JAMA.2020.14984 |
| 2020-08-10 |
Impact of Maternal SARS-CoV-2 Detection on Breastfeeding Due to Infant Separation at Birth (edit) |
10.1016/J.JPEDS.2020.08.004 |
| 2020-08-10 |
ACE deletion allele is associated with susceptibility to SARS-CoV-2 infection and mortality rate: An epidemiological study in the Asian population (edit) |
10.1016/J.CCA.2020.08.008 |
| 2020-08-10 |
Protocol for a national probability survey using home specimen collection methods to assess prevalence and incidence of SARS-CoV-2 infection and antibody response (edit) |
10.1016/J.ANNEPIDEM.2020.07.015 |
| 2020-08-10 |
Evaluating the efficacy of RT-qPCR SARS-CoV-2 direct approaches in comparison to RNA extraction (edit) |
10.1016/J.IJID.2020.08.015 |
| 2020-08-10 |
Repurposing of SARS-CoV nucleocapsid protein specific nuclease resistant RNA aptamer for therapeutics against SARS-CoV-2 (edit) |
10.1016/J.MEEGID.2020.104497 |
| 2020-08-10 |
SARS-CoV-2 Causes a Specific Dysfunction of the Kidney Proximal Tubule (edit) |
10.1016/J.KINT.2020.07.019 |
| 2020-08-10 |
Hanshiyi Formula, an approved medicine for Sars-CoV2 infection in China, reduced the proportion of mild and moderate COVID-19 patients turning to severe status: A cohort study (edit) |
10.1016/J.PHRS.2020.105127 |
| 2020-08-10 |
The cholesterol metabolite 27-hydroxycholesterol inhibits SARS-CoV-2 and is markedly decreased in COVID-19 patients (edit) |
10.1016/J.REDOX.2020.101682 |
| 2020-08-10 |
SARS-CoV-2 neutralization and serology testing of COVID-19 convalescent plasma from donors with non-severe disease (edit) |
10.1101/2020.08.07.242271 |
| 2020-08-10 |
An ultra-high affinity synthetic nanobody blocks SARS-CoV-2 infection by locking Spike into an inactive conformation (edit) |
10.1101/2020.08.08.238469 |
| 2020-08-10 |
The interplay of SARS-CoV-2 evolution and constraints imposed by the structure and functionality of its proteins (edit) |
10.1101/2020.08.10.244756 |
| 2020-08-10 |
Bi-paratopic and multivalent human VH domains neutralize SARS-CoV-2 by targeting distinct epitopes within the ACE2 binding interface of Spike (edit) |
10.1101/2020.08.08.242511 |
| 2020-08-10 |
Discovery of COVID-19 Inhibitors Targeting the SARS-CoV2 Nsp13 Helicase (edit) |
10.1101/2020.08.09.243246 |
| 2020-08-10 |
Host Polymorphisms May Impact SARS-CoV-2 Infectivity (edit) |
10.1016/J.TIG.2020.08.003 |
| 2020-08-10 |
Immunogenicity and Safety of a SARS-CoV-2 Inactivated Vaccine in Healthy Adults Aged 18-59 years: Report of the Randomized, Double-blind, and Placebo-controlled Phase 2 Clinical Trial (edit) |
10.1101/2020.07.31.20161216 |
| 2020-08-10 |
Genome evolution of SARS-CoV-2 and its virological characteristics (edit) |
10.1186/S41232-020-00126-7 |
| 2020-08-10 |
The impact of public health interventions on critical illness in the pediatric emergency department during the SARS-CoV-2 pandemic (edit) |
10.1002/EMP2.12220 |
| 2020-08-10 |
A Pathophysiological Perspective on the SARS-CoV-2 Coagulopathy (edit) |
10.1097/HS9.0000000000000457 |
| 2020-08-10 |
Associated posterior reversible encephalopathy syndrome (PRES) to SARS-CoV-2. Case report (edit) |
10.1016/J.NRL.2020.08.001 |
| 2020-08-10 |
Platypnea-orthodeoxia after fibrotic evolution of SARS-CoV-2 interstitial pneumonia. A case report (edit) |
10.23750/ABM.V91I3.10386 |
| 2020-08-10 |
High mortality of cancer patients in times of SARS-CoV-2: Do not generalize! (edit) |
10.1016/J.EJCA.2020.07.021 |
| 2020-08-09 |
Wikidata Queries around the SARS-CoV-2 virus and pandemic (edit) |
10.5281/ZENODO.3977414 |
| 2020-08-09 |
Pandemic printing: a novel 3D-printed swab for detecting SARS-CoV-2 (edit) |
10.5694/MJA2.50726 |
| 2020-08-09 |
Oral symptoms and lesions in SARS-CoV-2 positive patient (edit) |
10.1111/ODI.13596 |
| 2020-08-09 |
Re: Maternal transmission of SARS-COV-2 to the neonate, and possible routes for such transmission: a systematic review and critical analysis (edit) |
10.1111/1471-0528.16433 |
| 2020-08-09 |
SARS-CoV-2 infection in pediatric patient with hemoglobin SC disease (edit) |
10.1002/PBC.28430 |
| 2020-08-09 |
Projected effects of nonpharmaceutical public health interventions to prevent resurgence of SARS-CoV-2 transmission in Canada (edit) |
10.1503/CMAJ.200990 |
| 2020-08-09 |
Exploring alternative swabs for use in SARS-CoV-2 detection from the oropharynx and anterior nares (edit) |
10.1016/J.JVIROMET.2020.113948 |
| 2020-08-09 |
SARS-CoV-2 Entry Inhibitors: Small Molecules and Peptides Targeting Virus or Host Cells (edit) |
10.3390/IJMS21165707 |
| 2020-08-09 |
Mass Spectrometric detection of SARS-CoV-2 virus in scrapings of the epithelium of the nasopharynx of infected patients via Nucleocapsid N protein (edit) |
10.1021/ACS.JPROTEOME.0C00412 |
| 2020-08-09 |
Post-lockdown detection of SARS-CoV-2 RNA in the wastewater of Montpellier, France (edit) |
10.1016/J.ONEHLT.2020.100157 |
| 2020-08-08 |
SARS-CoV-2-specific antibody detection for sero-epidemiology: a multiplex analysis approach accounting for accurate seroprevalence (edit) |
10.1093/INFDIS/JIAA479 |
| 2020-08-08 |
Serosurveillance for SARS-CoV-2 incidence using global blood donor populations (edit) |
10.1093/CID/CIAA1116 |
| 2020-08-08 |
Alveolar SARS-CoV-2 viral load is tightly correlated with severity in COVID-19 ARDS (edit) |
10.1093/CID/CIAA1172 |
| 2020-08-08 |
SARS-CoV-2-specific antibody detection in healthcare workers in a UK maternity Hospital: Correlation with SARS-CoV-2 RT-PCR results (edit) |
10.1093/CID/CIAA893 |
| 2020-08-08 |
Cerebrospinal fluid features in SARS-CoV-2 RT-PCR positive patients (edit) |
10.1093/CID/CIAA1165 |
| 2020-08-08 |
Posterior oropharyngeal salivafor the detection of SARS-CoV-2 (edit) |
10.1093/CID/CIAA1181 |
| 2020-08-08 |
Intussusception in two children with SARS-CoV-2 infection in children (edit) |
10.1093/JPIDS/PIAA096 |
| 2020-08-08 |
SARS-CoV-2 associated Guillain-Barré syndrome (edit) |
10.1007/S00415-020-10133-W |
| 2020-08-08 |
Clinical and Radiological Diagnosis of Non-SARS-CoV-2 Viruses in the Era of Covid-19 Pandemic (edit) |
10.1002/JMV.26410 |
| 2020-08-08 |
Bacterial co-infections with SARS-CoV-2 (edit) |
10.1002/IUB.2356 |
| 2020-08-08 |
Evaluation of an ELISA for SARS-CoV-2 antibody testing: clinical performances and correlation with plaque reduction neutralization titer (edit) |
10.1515/CCLM-2020-1096 |
| 2020-08-08 |
SARS-CoV-2-specific ELISA development (edit) |
10.1016/J.JIM.2020.112832 |
| 2020-08-08 |
Comparison analysis of different swabs and transport mediums suitable for SARS-CoV-2 testing following shortages (edit) |
10.1016/J.JVIROMET.2020.113947 |
| 2020-08-08 |
SARS-CoV-2-related mortality in a rural Latin American population (edit) |
10.1016/J.IJID.2020.08.003 |
| 2020-08-08 |
All that glisters is not COVID: low prevalence of seroconversion against SARS-CoV-2 in a pediatric cohort of patients with Chilblain-like lesions (edit) |
10.1016/J.JAAD.2020.08.021 |
| 2020-08-08 |
SARS-CoV-2 infection: Advocacy for training and social distancing in healthcare settings (edit) |
10.1016/J.JHIN.2020.08.001 |
| 2020-08-08 |
Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-Cov-2 infection: a multicenter cohort study (PREDI-CO study) (edit) |
10.1016/J.CMI.2020.08.003 |
| 2020-08-08 |
Corrigendum to "Importation of SARS-CoV-2 infection leads to major COVID-19 epidemic in Taiwan" [Int J Infect Dis 97 (2020) 240-244] (edit) |
10.1016/J.IJID.2020.07.060 |
| 2020-08-08 |
Special considerations in the assessment of catastrophic brain injury and determination of brain death in patients with SARS-CoV-2 (edit) |
10.1016/J.JNS.2020.117087 |
| 2020-08-08 |
Molecular docking suggests repurposing of brincidofovir as a potential drug targeting SARS-CoV-2 ACE2 receptor and main protease (edit) |
10.1007/S13721-020-00263-6 |
| 2020-08-08 |
Ramping up of SARS CoV-2 testing for the diagnosis of COVID-19 to better manage the next phase of pandemic and reduce the mortality in India (edit) |
10.1007/S13337-020-00622-X |
| 2020-08-08 |
Experience of a pediatric monographic hospital and strategies adopted for perioperative care during the SARS-CoV-2 epidemic and the reorganization of urgent pediatric care in the Community of Madrid. Spain (edit) |
10.1016/J.REDAR.2020.07.008 |
| 2020-08-08 |
Public perceptions, anxiety and the perceived efficacy of health-protective behaviours to mitigate the spread of the SARS-Cov-2/ COVID-19 pandemic (edit) |
10.1016/J.PUHE.2020.08.002 |
| 2020-08-08 |
Does Cross-neutralization of SARS-CoV-2 Only Relate to High Pathogenic Coronaviruses? (edit) |
10.1016/J.IT.2020.08.002 |
| 2020-08-07 |
Common determinants of severe Covid-19 infection are explicable by SARS-CoV-2 secreted glycoprotein interaction with the CD33-related Siglecs, Siglec-3 and Siglec-5/14 (edit) |
10.1016/J.MEHY.2020.110168 |
| 2020-08-07 |
Immune interaction map of human SARS-CoV-2 target proteins: implications for therapeutic avenues (edit) |
10.21203/RS.3.RS-54541/V1 |
| 2020-08-07 |
Notes from the field:characteristics of meat processing facility workers with confirmed SARS-CoV-2 infection - Nebraska, April-May 2020 (edit) |
10.15585/MMWR.MM6931A3 |
| 2020-08-07 |
SARS-CoV-2 Transmission and Infection Among Attendees of an Overnight Camp - Georgia, June 2020 (edit) |
10.15585/MMWR.MM6931E1 |
| 2020-08-07 |
Identification of polyphenols from Broussonetia papyrifera as SARS CoV-2 main protease inhibitors using in silico docking and molecular dynamics simulation approaches (edit) |
10.1080/07391102.2020.1802347 |
| 2020-08-07 |
Effect of mutation on structure, function and dynamics of receptor binding domain of human SARS-CoV-2 with host cell receptor ACE2: a molecular dynamics simulations study (edit) |
10.1080/07391102.2020.1802348 |
| 2020-08-07 |
In silico investigation of phytoconstituents from Indian medicinal herb 'Tinospora cordifolia (giloy)' against SARS-CoV-2 (COVID-19) by molecular dynamics approach (edit) |
10.1080/07391102.2020.1803968 |
| 2020-08-07 |
In silico virtual screening, characterization, docking and molecular dynamics studies of crucial SARS-CoV-2 proteins (edit) |
10.1080/07391102.2020.1803965 |
| 2020-08-07 |
Immunotherapy for SARS-CoV-2: Potential Opportunities (edit) |
10.1080/14712598.2020.1807933 |
| 2020-08-07 |
Florid aortitis following SARS-CoV-2 infection (edit) |
10.1093/EURHEARTJ/EHAA635 |
| 2020-08-07 |
Infection with SARS-CoV-2 in primary care health care workers assessed by antibody testing (edit) |
10.1093/FAMPRA/CMAA078 |
| 2020-08-07 |
Multi-platform Comparison of SARS-CoV-2 Serology Assays for the Detection of COVID-19 (edit) |
10.1093/JALM/JFAA139 |
| 2020-08-07 |
Neurological features in SARS-CoV-2-infected patients with smell and taste disorder (edit) |
10.1007/S00415-020-10135-8 |
| 2020-08-07 |
Universal screening of high-risk neonates, parents, and staff at a neonatal intensive care unit during the SARS-CoV-2 pandemic (edit) |
10.1007/S00431-020-03765-7 |
| 2020-08-07 |
Screening of SARS-CoV-2 in 299 Hospitalized Children with Hemato-oncological Diseases: A Multicenter Survey in Hubei, China (edit) |
10.1007/S11596-020-2228-7 |
| 2020-08-07 |
COVID-19 and Mycoplasma pneumoniae: SARS-CoV-2 false positive or coinfection? (edit) |
10.1111/IJD.15090 |
| 2020-08-07 |
Pediatric Multisystem Inflammatory Syndrome Temporally Associated With SARS-COV-2: Oral Manifestations and Implications (edit) |
10.1111/IPD.12694 |
| 2020-08-07 |
SARS-CoV-2 in human milk is inactivated by Holder pasteurisation but not cold storage (edit) |
10.1111/JPC.15065 |
| 2020-08-07 |
Report of death in children with SARS-CoV-2 and Human metapneumovirus (hMPV) co-infection: is hMPV the trigger? (edit) |
10.1002/JMV.26401 |
| 2020-08-07 |
Comparative analysis of antiviral efficacy of FDA-approved drugs against SARS-CoV-2 in human lung cells (edit) |
10.1002/JMV.26397 |
| 2020-08-07 |
Transmission dynamics of SARS-CoV-2 within families with children in Greece: a study of 23 clusters (edit) |
10.1002/JMV.26394 |
| 2020-08-07 |
Physiologically-Based Pharmacokinetic Modeling to Predict the Clinical Efficacy of the Coadministration of Lopinavir and Ritonavir against SARS-CoV-2 (edit) |
10.1002/CPT.2014 |
| 2020-08-07 |
Renin-Angiotensin II-Aldosterone Axis in SARS-CoV-2 Associated Xerostomia (edit) |
10.1111/ODI.13594 |
| 2020-08-07 |
Possible Targets and Therapies of SARS-CoV-2 Infection (edit) |
10.2174/1389557520666200807131855 |
| 2020-08-07 |
Recent Discovery for Inhibitors Targeting in SARS-CoV-2 and Developed anti-NCP (edit) |
10.2174/1389557520666200807134619 |
| 2020-08-07 |
No increased rate of SARS-CoV-2 infection for patients with inflammatory rheumatic diseases compared with the general population in the city of Hamburg (Germany) (edit) |
10.1136/ANNRHEUMDIS-2020-218400 |
| 2020-08-07 |
Epigallocatechin gallate and theaflavin gallate interaction in SARS-CoV-2 spike-protein central channel with reference to the hydroxychloroquine interaction: Bioinformatics and molecular docking study (edit) |
10.1002/DDR.21730 |
| 2020-08-07 |
Delayed severe cytokine storm and immune cell infiltration in SARS-CoV-2-infected aged Chinese rhesus macaques (edit) |
10.24272/J.ISSN.2095-8137.2020.202 |
| 2020-08-07 |
SARS-CoV-2 epidemic in African countries-are we losing perspective? (edit) |
10.1016/S1473-3099(20)30563-6 |
| 2020-08-07 |
Why is pre-exposure prophylaxis with hydroxychloroquine a safe and rationale approach against SARS-COV-2 infection? (edit) |
10.1016/J.JGAR.2020.07.022 |
| 2020-08-07 |
SARS-CoV-2 RNA Extraction Using Magnetic Beads for Rapid Large-Scale Testing by RT-qPCR and RT-LAMP (edit) |
10.3390/V12080863 |
| 2020-08-07 |
Development and Evaluation of Novel and Highly Sensitive Single-Tube Nested Real-Time RT-PCR Assays for SARS-CoV-2 Detection (edit) |
10.3390/IJMS21165674 |
| 2020-08-07 |
Expression Profile of SARS-CoV-2 Host Receptors in Human Pancreatic Islets Revealed Upregulation of ACE2 in Diabetic Donors (edit) |
10.3390/BIOLOGY9080215 |
| 2020-08-07 |
Multicenter evaluation of the NeuMoDx™ SARS-CoV-2 Test (edit) |
10.1016/J.JCV.2020.104583 |
| 2020-08-07 |
A Rational Design of a Multi-Epitope Vaccine Against SARS-CoV-2 Which Accounts for the Glycan Shield of the Spike Glycoprotein (edit) |
10.26434/CHEMRXIV.12770225 |
| 2020-08-07 |
SARS-CoV-2 infection, neuropathogenesis and transmission among deer mice: Implications for reverse zoonosis to New World rodents (edit) |
10.1101/2020.08.07.241810 |
| 2020-08-07 |
Infectivity, susceptibility, and risk factors associated with SARS-CoV-2 transmission under intensive contact tracing in Hunan, China (edit) |
10.1101/2020.07.23.20160317 |
| 2020-08-07 |
Specificity and Performance of Nucleocapsid and Spike-based SARS-CoV-2 Serologic Assays (edit) |
10.1101/2020.08.05.20168476 |
| 2020-08-07 |
Surfaces and equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the emergency department at a university hospital (edit) |
10.1016/J.IJHEH.2020.113600 |
| 2020-08-07 |
Estimation of the diagnostic accuracy of real-time reverse transcription quantitative polymerase chain reaction for SARS-CoV-2 using re-analysis of published data (edit) |
|
| 2020-08-07 |
Aerosol transmission of SARS-CoV-2? Evidence, prevention and control (edit) |
10.1016/J.ENVINT.2020.106039 |
| 2020-08-07 |
RCOVID19: Recurrence-based SARS-CoV-2 features using chaos game representation (edit) |
10.1016/J.DIB.2020.106144 |
| 2020-08-07 |
Predicted therapeutic targets for COVID-19 disease by inhibiting SARS-CoV-2 and its related receptors (edit) |
10.1016/J.IMU.2020.100407 |
| 2020-08-07 |
[Infection with SARS-CoV-2] (edit) |
10.1016/J.AMCP.2020.08.002 |
| 2020-08-07 |
Longer Duration of SARS-CoV-2 Infection in a Case of Mild COVID-19 With Weak Production of the Specific IgM and IgG Antibodies (edit) |
10.3389/FIMMU.2020.01936 |
| 2020-08-07 |
Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past (edit) |
10.3389/FIMMU.2020.01949 |
| 2020-08-07 |
No Evidence of SARS-CoV-2 Seminal Shedding Despite SARS-CoV-2 Persistence in the Upper Respiratory Tract (edit) |
10.1093/OFID/OFAA325 |
| 2020-08-07 |
Data of Italian Cancer Centers from two regions with high incidence of SARS CoV-2 infection provide evidence for the successful management of patients with locally advanced and metastatic melanoma treated with immunotherapy in the era of COVID-19 (edit) |
10.1053/J.SEMINONCOL.2020.07.010 |
| 2020-08-06 |
Deep vein thrombosis in SARS-CoV-2 pneumonia-affected patients within standard care units: Exploring a submerged portion of the iceberg (edit) |
10.1016/J.THROMRES.2020.08.008 |
| 2020-08-06 |
Pooled testing conserves SARS-CoV-2 laboratory resources and improves test turn-around time: experience on the Kenyan Coast (edit) |
10.12688/WELLCOMEOPENRES.16113.1 |
| 2020-08-06 |
Structural characterization of the C-terminal domain of SARS-CoV-2 nucleocapsid protein (edit) |
10.1186/S43556-020-00001-4 |
| 2020-08-06 |
Structure of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitors (edit) |
10.1101/2020.08.06.240192 |
| 2020-08-06 |
Peptide Antidotes to SARS-CoV-2 (COVID-19) (edit) |
10.1101/2020.08.06.238915 |
| 2020-08-06 |
Transient dynamics of SARS-CoV-2 as England exited national lockdown (edit) |
10.1101/2020.08.05.20169078 |
| 2020-08-06 |
Plasmin Cascade Mediates Thrombotic Events in SARS-CoV-2 Infection via Complement and Platelet-Activating Systems (edit) |
10.1109/OJEMB.2020.3014798 |
| 2020-08-06 |
Central nervous system complications associated with SARS-CoV-2 infection: integrative concepts of pathophysiology and case reports (edit) |
10.1186/S12974-020-01896-0 |
| 2020-08-06 |
Low seroprevalence of SARS-CoV-2 infection among healthcare workers of the largest children hospital in Milan during the pandemic wave (edit) |
10.1017/ICE.2020.401 |
| 2020-08-06 |
Using Virus Sequencing to Determine Source of SARS-CoV-2 Transmission for Healthcare Worker (edit) |
10.3201/EID2610.202322 |
| 2020-08-06 |
Genetic variability in the expression of the SARS-CoV-2 host cell entry factors across populations (edit) |
10.1038/S41435-020-0107-7 |
| 2020-08-06 |
SARS-CoV-2 infection in China-Before the pandemic (edit) |
10.1371/JOURNAL.PNTD.0008472 |
| 2020-08-06 |
Evaluation of Three Commercial Automated Assays for the Detection of anti-SARS-CoV-2 Antibodies (edit) |
10.1093/CLINCHEM/HVAA193 |
| 2020-08-06 |
Comparison of a Point-of-Care Assay and a High-Complexity Assay for Detection of SARS-CoV-2 RNA (edit) |
10.1093/JALM/JFAA135 |
| 2020-08-06 |
Evaluation of serological tests for SARS-CoV-2: Implications for serology testing in a low-prevalence setting (edit) |
10.1093/INFDIS/JIAA467 |
| 2020-08-06 |
SARS-CoV-2 viral load in the upper respiratory tract of children and adults with early acute COVID-19 (edit) |
10.1093/CID/CIAA1157 |
| 2020-08-06 |
Comparing nasopharyngeal swab and early morning saliva for the identification of SARS-CoV-2 (edit) |
10.1093/CID/CIAA1156 |
| 2020-08-06 |
The arrival and spread of SARS-CoV2 in Colombia (edit) |
10.1002/JMV.26393 |
| 2020-08-06 |
Caveats in interpreting SARS-CoV-2 IgM positive/IgG negative antibody profile in asymptomatic health care workers (edit) |
10.1002/JMV.26400 |
| 2020-08-06 |
SARS-CoV-2 myopathy (edit) |
10.1002/JMV.26399 |
| 2020-08-06 |
Large vessel stroke in six patients following SARS-CoV-2 infection: a retrospective case study series of acute thrombotic complications on stable underlying atherosclerotic disease (edit) |
10.1111/ENE.14466 |
| 2020-08-06 |
Circulating endothelial progenitors are increased in Covid-19 patients and correlate with SARS-CoV-2 RNA in severe cases (edit) |
10.1111/JTH.15044 |
| 2020-08-06 |
Genome Sequences of Six SARS-CoV-2 Strains Isolated in Morocco, Obtained Using Oxford Nanopore MinION Technology (edit) |
10.1128/MRA.00767-20 |
| 2020-08-06 |
A Comprehensive, Flexible Collection of SARS-CoV-2 Coding Regions (edit) |
10.1534/G3.120.401554 |
| 2020-08-06 |
Epidemiology of SARS-CoV-2 antibodies among firefighters/paramedics of a US fire department: a cross-sectional study (edit) |
10.1136/OEMED-2020-106676 |
| 2020-08-06 |
SARS-CoV2 disrupts clinical research - the role of a rare disease-specific trial network (edit) |
10.1183/13993003.02114-2020 |
| 2020-08-06 |
Inhibition of PIKfyve kinase prevents infection by Zaire ebolavirus and SARS-CoV-2 (edit) |
10.1073/PNAS.2007837117 |
| 2020-08-06 |
Morphogenesis and cytopathic effect of SARS-CoV-2 infection in human airway epithelial cells (edit) |
10.1038/S41467-020-17796-Z |
| 2020-08-06 |
[Effects of the SARS-CoV-2 pandemic on the otorhinolaryngology university hospitals in the field of medical care] (edit) |
10.1055/A-1232-4911 |
| 2020-08-06 |
Dupilumab, Severe Asthma Airway Responses, and SARS-CoV2 Serology (edit) |
10.1111/ALL.14534 |
| 2020-08-06 |
Postmortem conjunctival and nasopharyngeal swabs in SARS-CoV-2 infected and uninfected patients (edit) |
10.1111/AOS.14559 |
| 2020-08-06 |
Horses for courses? Assessing the potential value of a surrogate, point-of-care test for SARS-CoV-2 epidemic control (edit) |
10.1111/IRV.12796 |
| 2020-08-06 |
The Plausible role of Indian Traditional Medicine in combating Corona Virus (SARS-CoV 2): a mini-review (edit) |
10.2174/1389201021666200807111359 |
| 2020-08-06 |
Epidemiological and Clinical Profile of Pediatric Inflammatory Multisystem Syndrome - Temporally Associated with SARS-CoV-2 (PIMS-TS) in Indian Children (edit) |
|
| 2020-08-06 |
SARS-CoV-2 viral load predicts COVID-19 mortality (edit) |
10.1016/S2213-2600(20)30354-4 |
| 2020-08-06 |
Seroprevalence and presentation of SARS-CoV-2 in pregnancy (edit) |
10.1016/S0140-6736(20)31714-1 |
| 2020-08-06 |
Modeling the viral dynamics of SARS-CoV-2 infection (edit) |
10.1016/J.MBS.2020.108438 |
| 2020-08-06 |
Pathogenesis of SARS-CoV-2 induced cardiac injury from the perspective of the virus (edit) |
10.1016/J.YJMCC.2020.08.002 |
| 2020-08-06 |
Analysis of codon usage of Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) and its adaptability in dog (edit) |
10.1016/J.VIRUSRES.2020.198113 |
| 2020-08-06 |
Specific risk factors for SARS-CoV-2 transmission among health care workers in a university hospital (edit) |
10.1016/J.AJIC.2020.07.039 |
| 2020-08-06 |
Diagnostic serial interval as a novel indicator for contact tracing effectiveness exemplified with the SARS-CoV-2/COVID-19 outbreak in South Korea (edit) |
10.1016/J.IJID.2020.07.068 |
| 2020-08-06 |
Possible intrauterine infection: Positive nucleic acid testing results and consecutive positive SARS-CoV-2-specific antibody levels within 50 days after birth (edit) |
10.1016/J.IJID.2020.07.063 |
| 2020-08-06 |
Thermal treatment of nasopharyngeal samples prior to cobas® SARS-CoV-2 testing (edit) |
10.1016/J.CMI.2020.07.042 |
| 2020-08-06 |
SARS-CoV-2 and ACE2: The biology and clinical data settling the ARB and ACEI controversy (edit) |
10.1016/J.EBIOM.2020.102907 |
| 2020-08-06 |
Functional prediction and comparative population analysis of variants in genes for proteases and innate immunity related to SARS-CoV-2 infection (edit) |
10.1016/J.MEEGID.2020.104498 |
| 2020-08-06 |
Clinical Course and Molecular Viral Shedding Among Asymptomatic and Symptomatic Patients With SARS-CoV-2 Infection in a Community Treatment Center in the Republic of Korea (edit) |
10.1001/JAMAINTERNMED.2020.3862 |
| 2020-08-06 |
Prevalence of SARS-CoV-2 Antibodies in Health Care Personnel in the New York City Area (edit) |
10.1001/JAMA.2020.14765 |
| 2020-08-06 |
Clinical and Imaging Characteristics in Patients with SARS-CoV-2 Infection and Acute Intracranial Hemorrhage (edit) |
10.3390/JCM9082543 |
| 2020-08-06 |
SARS-CoV-2 Consensus-Sequence and Matching Overlapping Peptides Design for COVID19 Immune Studies and Vaccine Development (edit) |
10.3390/VACCINES8030444 |
| 2020-08-06 |
Molecular binding mechanism and pharmacology comparative analysis of noscapine for repurposing against SARS-CoV-2 protease (edit) |
10.1021/ACS.JPROTEOME.0C00367 |
| 2020-08-06 |
Computational Hot-Spot Analysis of the SARS-CoV-2 Receptor Binding Domain / ACE2 Complex (edit) |
10.1101/2020.08.06.240333 |
| 2020-08-06 |
Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate (edit) |
10.1101/2020.08.06.234674 |
| 2020-08-06 |
IFN signaling and neutrophil degranulation transcriptional signatures are induced during SARS-CoV-2 infection (edit) |
10.1101/2020.08.06.239798 |
| 2020-08-06 |
An Examination of School Reopening Strategies during the SARS-CoV-2 Pandemic (edit) |
10.1101/2020.08.05.20169086 |
| 2020-08-06 |
Features and Functions of Systemic and Mucosal Humoral Immunity Among SARS-CoV-2 Convalescent Individuals (edit) |
10.1101/2020.08.05.20168971 |
| 2020-08-06 |
Reply to "SARS-CoV-2-associated Takotsubo is not necessarily triggered by the infection" (edit) |
10.1016/J.IJCHA.2020.100613 |
| 2020-08-06 |
Predicting novel drugs for SARS-CoV-2 using machine learning from a >10 million chemical space (edit) |
10.1016/J.HELIYON.2020.E04639 |
| 2020-08-06 |
Immune response to SARS-CoV-2 in health care workers following a COVID-19 outbreak: A prospective longitudinal study (edit) |
10.1016/J.JCV.2020.104575 |
| 2020-08-06 |
Repeated COVID-19 relapse during post-discharge surveillance with viral shedding lasting for 67 days in a recovered patient infected with SARS-CoV-2 (edit) |
10.1016/J.JMII.2020.07.017 |
| 2020-08-06 |
Time-series analyses of directional sequence changes in SARS-CoV-2 genomes and an efficient search method for candidates for advantageous mutations for growth in human cells (edit) |
10.1016/J.GENE.2020.100038 |
| 2020-08-06 |
Surface Chemistry Can Unlock Drivers of Surface Stability of SARS-CoV-2 in a Variety of Environmental Conditions (edit) |
10.1016/J.CHEMPR.2020.08.001 |
| 2020-08-06 |
First-in-Human Trial of a SARS CoV 2 Recombinant Spike Protein Nanoparticle Vaccine (edit) |
10.1101/2020.08.05.20168435 |
| 2020-08-06 |
A test-negative design with additional population controls can be used to rapidly study causes of the SARS-CoV-2 epidemic (edit) |
10.1097/EDE.0000000000001251 |
| 2020-08-05 |
Air conditioning system usage and SARS-CoV-2 transmission dynamics in Iran (edit) |
10.1016/J.MEHY.2020.110164 |
| 2020-08-05 |
Diagnostic accuracy of initial chest radiograph compared to SARS-CoV-2 PCR in patients with suspected COVID-19 (edit) |
10.1259/BJRO.20200034 |
| 2020-08-05 |
[SARS-CoV-2 infection in a patient treated by hydroxychloroquine and anti TNF α for Inflammatory Rheumatic Disease] (edit) |
|
| 2020-08-05 |
CNS Penetration Ability: A Critical Factor for Drugs in the Treatment of SARS-CoV-2 Brain Infection (edit) |
10.1021/ACSCHEMNEURO.0C00335 |
| 2020-08-05 |
Expression of SARS-CoV-2 receptor ACE2 and the protease TMPRSS2 suggests susceptibility of the human embryo in the first trimester (edit) |
10.1098/RSOB.200162 |
| 2020-08-05 |
Acute respiratory distress syndrome: a life threatening associated complication of SARS-CoV-2 infection inducing COVID-19 (edit) |
10.1080/07391102.2020.1803139 |
| 2020-08-05 |
In silico identification of widely used and well-tolerated drugs as potential SARS-CoV-2 3C-like protease and viral RNA-dependent RNA polymerase inhibitors for direct use in clinical trials (edit) |
10.1080/07391102.2020.1802346 |
| 2020-08-05 |
Predictive modeling by deep learning, virtual screening and molecular dynamics study of natural compounds against SARS-CoV-2 main protease (edit) |
10.1080/07391102.2020.1802341 |
| 2020-08-05 |
Molecular docking, molecular dynamics simulations and reactivity, studies on approved drugs library targeting ACE2 and SARS-CoV-2 binding with ACE2 (edit) |
10.1080/07391102.2020.1803967 |
| 2020-08-05 |
Naturally occurring SARS-CoV-2 gene deletions close to the spike S1/S2 cleavage site in the viral quasispecies of COVID19 patients (edit) |
10.1080/22221751.2020.1806735 |
| 2020-08-05 |
Mathematical models and deep learning for predicting the number of individuals reported to be infected with SARS-CoV-2 (edit) |
10.1098/RSIF.2020.0494 |
| 2020-08-05 |
Cross-sectional pilot study exploring the feasibility of a rapid SARS-CoV-2 immunization test in health and non-healthcare workers (edit) |
10.1111/ALL.14545 |
| 2020-08-05 |
SARS-CoV-2 may regulate cellular responses through depletion of specific host miRNAs (edit) |
10.1152/AJPLUNG.00252.2020 |
| 2020-08-05 |
Hearing Loss in SARS-CoV-2: What Do We Know? (edit) |
10.1177/0145561320946902 |
| 2020-08-05 |
Response by Yaghi et al to Letter Regarding Article, "SARS-CoV-2 and Stroke in a New York Healthcare System" (edit) |
10.1161/STROKEAHA.120.031676 |
| 2020-08-05 |
Letter by Albiero and Seresini Regarding Article, "SARS-CoV-2 and Stroke in a New York Healthcare System" (edit) |
10.1161/STROKEAHA.120.031093 |
| 2020-08-05 |
Validation of a single-step, single-tube reverse transcription loop-mediated isothermal amplification assay for rapid detection of SARS-CoV-2 RNA (edit) |
10.1099/JMM.0.001238 |
| 2020-08-05 |
[Neurological damage linked to coronaviruses : SARS-CoV-2 and other human coronaviruses] (edit) |
10.1051/MEDSCI/2020122 |
| 2020-08-05 |
[A race against the clock: creation of SARS-Cov-2 in the laboratory, a month after its emergence!] (edit) |
10.1051/MEDSCI/2020124 |
| 2020-08-05 |
SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness (edit) |
10.1038/S41586-020-2622-0 |
| 2020-08-05 |
At-home self-collection of saliva, oropharyngeal swabs and dried blood spots for SARS-CoV-2 diagnosis and serology: Post-collection acceptability of specimen collection process and patient confidence in specimens (edit) |
10.1371/JOURNAL.PONE.0236775 |
| 2020-08-05 |
SARS-CoV-2 detection in setting of viral swabs scarcity: Are MRSA swabs and viral swabs equivalent? (edit) |
10.1371/JOURNAL.PONE.0237127 |
| 2020-08-05 |
Development and simulation of fully glycosylated molecular models of ACE2-Fc fusion proteins and their interaction with the SARS-CoV-2 spike protein binding domain (edit) |
10.1371/JOURNAL.PONE.0237295 |
| 2020-08-05 |
Intra- and intermolecular atomic-scale interactions in the receptor binding domain of SARS-CoV-2 spike protein: implication for ACE2 receptor binding (edit) |
10.1039/D0CP03145C |
| 2020-08-05 |
Unique SARS-CoV-2 clusters causing a large COVID-19 outbreak in Hong Kong (edit) |
10.1093/CID/CIAA1119 |
| 2020-08-05 |
The Psychological Experience of Obstetric Patients and Health Care Workers after Implementation of Universal SARS-CoV-2 Testing (edit) |
10.1055/S-0040-1715505 |
| 2020-08-05 |
Vertical Transmission of SARS-CoV-2 (COVID-19): Are Hypotheses More than Evidences? (edit) |
10.1055/S-0040-1714346 |
| 2020-08-05 |
An increasing public health burden arising from children infected with SARS-CoV2: a systematic review and meta-analysis (edit) |
10.1002/PPUL.25008 |
| 2020-08-05 |
Guillain Barré Syndrome associated with SARS-CoV-2 infection. A Systematic Review (edit) |
10.1111/ENE.14462 |
| 2020-08-05 |
Shielding against SARS-Cov-2 infection is not justified in children with severe asthma (edit) |
10.1111/PAI.13327 |
| 2020-08-05 |
ACE2 isoform diversity predicts the host susceptibility of SARS-CoV-2 (edit) |
10.1111/TBED.13773 |
| 2020-08-05 |
The evidence of indirect transmission of SARS-CoV-2 reported in Guangzhou, China (edit) |
10.1186/S12889-020-09296-Y |
| 2020-08-05 |
Inferred duration of infectious period of SARS-CoV-2: rapid scoping review and analysis of available evidence for asymptomatic and symptomatic COVID-19 cases (edit) |
10.1136/BMJOPEN-2020-039856 |
| 2020-08-05 |
SARS CoV-2 infection among patients using immunomodulatory therapies (edit) |
10.1136/ANNRHEUMDIS-2020-218580 |
| 2020-08-05 |
Response to: 'Correspondence on 'Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort' by Pouletty et al' by Pino et al (edit) |
10.1136/ANNRHEUMDIS-2020-218614 |
| 2020-08-05 |
Correspondence on: 'Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort' by Pouletty et al (edit) |
10.1136/ANNRHEUMDIS-2020-218538 |
| 2020-08-05 |
Atazanavir, alone or in combination with ritonavir, inhibits SARS-CoV-2 replication and pro-inflammatory cytokine production (edit) |
10.1128/AAC.00825-20 |
| 2020-08-05 |
Immunoinformatic approach to assess SARS-CoV-2 protein S epitopes recognised by the most frequent MHC-I alleles in the Brazilian population (edit) |
10.1136/JCLINPATH-2020-206946 |
| 2020-08-05 |
Racial/Ethnic and Socioeconomic Disparities of SARS-CoV-2 Infection Among Children (edit) |
10.1542/PEDS.2020-009951 |
| 2020-08-05 |
A novel receptor-binding domain (RBD)-based mRNA vaccine against SARS-CoV-2 (edit) |
10.1038/S41422-020-0387-5 |
| 2020-08-05 |
Detection of SARS-CoV-2 by RNAscope®in situ hybridization and immunohistochemistry techniques (edit) |
10.1007/S00705-020-04737-W |
| 2020-08-05 |
Winter Is Coming: A Southern Hemisphere Perspective of the Environmental Drivers of SARS-CoV-2 and the Potential Seasonality of COVID-19 (edit) |
10.3390/IJERPH17165634 |
| 2020-08-05 |
Comprehensive Analyses of SARS-CoV-2 Transmission in a Public Health Virology Laboratory (edit) |
10.3390/V12080854 |
| 2020-08-05 |
The Global Emergency of Novel Coronavirus (SARS-CoV-2): An Update of the Current Status and Forecasting (edit) |
10.3390/IJERPH17165648 |
| 2020-08-05 |
SARS-CoV-2 Infection and Lung Cancer: Potential Therapeutic Modalities (edit) |
10.3390/CANCERS12082186 |
| 2020-08-05 |
Clinical and CT imaging features of SARS-CoV-2 patients presented with diarrhea (edit) |
10.1016/J.JINF.2020.08.003 |
| 2020-08-05 |
Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2: A Systematic Review (edit) |
10.1016/J.JPEDS.2020.08.003 |
| 2020-08-05 |
In silico pharmacokinetic and molecular docking studies of natural flavonoids and synthetic indole chalcones against essential proteins of SARS-CoV-2 (edit) |
10.1016/J.EJPHAR.2020.173448 |
| 2020-08-05 |
COVID-19: Time to exonerate the pangolin from the transmission of SARS-CoV-2 to humans (edit) |
10.1016/J.MEEGID.2020.104493 |
| 2020-08-05 |
Comparison of the analytical sensitivity of seven commonly used commercial SARS-CoV-2 automated molecular assays (edit) |
10.1016/J.JCV.2020.104578 |
| 2020-08-05 |
Saliva sampling for diagnosing SARS-CoV-2 infections in symptomatic patients and asymptomatic carriers (edit) |
10.1016/J.JCV.2020.104580 |
| 2020-08-05 |
Structure of Furin Protease Binding to SARS-CoV-2 Spike Glycoprotein and Implications for Potential Targets and Virulence (edit) |
10.1021/ACS.JPCLETT.0C01698 |
| 2020-08-05 |
The DHODH Inhibitor PTC299 Arrests SARS-CoV-2 Replication and Suppresses Induction of Inflammatory Cytokines (edit) |
10.1101/2020.08.05.238394 |
| 2020-08-05 |
Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity (edit) |
10.1101/2020.08.05.237651 |
| 2020-08-05 |
SARS-CoV-2 Infection Among Symptom-Free Healthcare Workers (edit) |
10.1101/2020.07.31.20166066 |
| 2020-08-05 |
Apparent difference in fatalities between Central Europe and East Asia due to SARS-COV-2 and COVID-19: Four hypotheses for possible explanation (edit) |
10.1016/J.MEHY.2020.110160 |
| 2020-08-05 |
SARS-CoV-2 infection and impact on female genital tract: An untested hypothesis (edit) |
10.1016/J.MEHY.2020.110162 |
| 2020-08-05 |
Extraction-free SARS-CoV-2 detection by rapid RT-qPCR universal for all primary respiratory materials (edit) |
10.1016/J.JCV.2020.104579 |
| 2020-08-05 |
Absorbed plant MIR2911 in honeysuckle decoction inhibits SARS-CoV-2 replication and accelerates the negative conversion of infected patients (edit) |
10.1038/S41421-020-00197-3 |
| 2020-08-05 |
Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment (edit) |
10.1016/J.CELL.2020.08.001 |
| 2020-08-05 |
Pandemie durch SARS-CoV-2/Covid-19 (edit) |
10.1007/S00350-020-5614-Z |
| 2020-08-05 |
SARS-CoV-2 Dissemination Through Peripheral Nerves Explains Multiple Organ Injury (edit) |
10.3389/FNCEL.2020.00229 |
| 2020-08-05 |
Particulate matter and SARS-CoV-2: A possible model of COVID-19 transmission (edit) |
10.1016/J.SCITOTENV.2020.141532 |
| 2020-08-05 |
Acute appendicitis during SARS-CoV-2: A brief communication of patients and changes in clinical practice from a single institute in Pakistan (edit) |
10.1016/J.JPEDSURG.2020.07.033 |
| 2020-08-05 |
High seroprevalence of SARS-CoV-2 in elderly care employees in Sweden (edit) |
10.1080/20008686.2020.1789036 |
| 2020-08-04 |
Can Papain-like Protease Inhibitors Halt SARS-CoV-2 Replication? (edit) |
10.1021/ACSPTSCI.0C00093 |
| 2020-08-04 |
A novel methodology and new concept of SARS-CoV-2 elimination in heating and ventilating air conditioning systems using waste heat recovery (edit) |
10.1063/5.0021575 |
| 2020-08-04 |
Estimating the reproductive numberR0of SARS-CoV-2 in the United States and eight European countries and implications for vaccination (edit) |
10.1101/2020.07.31.20166298 |
| 2020-08-04 |
Evaluating the effects of SARS-CoV-2 Spike mutation D614G on transmissibility and pathogenicity (edit) |
10.1101/2020.07.31.20166082 |
| 2020-08-04 |
Evaluation of three fully-automated SARS-CoV-2 antibody assays (edit) |
10.1515/CCLM-2020-0975 |
| 2020-08-04 |
Deciphering the protein motion of S1 subunit in SARS-CoV-2 spike glycoprotein through integrated computational methods (edit) |
10.1080/07391102.2020.1802338 |
| 2020-08-04 |
Seroprevalence of SARS-CoV-2 antibodies in healthcare workers at a London NHS Trust (edit) |
10.1017/ICE.2020.402 |
| 2020-08-04 |
Evaluation of medicinal herbs as a potential therapeutic option against SARS-CoV-2 targeting its main protease (edit) |
10.1002/PTR.6802 |
| 2020-08-04 |
Outcomes and implications of diarrhea in patients with SARS-CoV-2 infection (edit) |
10.1080/00365521.2020.1800078 |
| 2020-08-04 |
Mouse-adapted SARS-CoV-2 replicates efficiently in the upper and lower respiratory tract of BALB/c and C57BL/6J mice (edit) |
10.1007/S13238-020-00767-X |
| 2020-08-04 |
Discrimination of False Negative Results in RT-PCR Detection of SARS-CoV-2 RNAs in Clinical Specimens by Using an Internal Reference (edit) |
10.1007/S12250-020-00273-8 |
| 2020-08-04 |
ACE2 and SARS-CoV-2 Infection: Might GLP-1 Receptor Agonists Play a Role? (edit) |
10.1007/S13300-020-00898-8 |
| 2020-08-04 |
SARS-CoV-2 nucleocapsid and Nsp3 binding: an in silico study (edit) |
10.1007/S00203-020-01998-6 |
| 2020-08-04 |
The role of cholecystostomy drains in the management of acute cholecystitis during the SARS-CoV-2 pandemic. What can we expect? (edit) |
10.1002/BJS.11907 |
| 2020-08-04 |
SARS-CoV-2 Virus Culture and Subgenomic RNA for Respiratory Specimens from Patients with Mild Coronavirus Disease (edit) |
10.3201/EID2611.203219 |
| 2020-08-04 |
Cross-Comparison of a Chemiluminescent Platform and a Commercial Receptor Binding Domain-Based ELISA Assay for Detecting SARS-CoV-2 IgG (edit) |
10.1093/JALM/JFAA133 |
| 2020-08-04 |
Insights on 3D Structures of Potential Drug-Targeting Proteins of SARS-CoV-2: Application of Cavity Search and Molecular Docking (edit) |
10.1002/MINF.202000096 |
| 2020-08-04 |
Humidity is a consistent climatic factor contributing to SARS-CoV-2 transmission (edit) |
10.1111/TBED.13766 |
| 2020-08-04 |
The SARS-CoV-2 Crisis: Has Medicine Finally Entered a Reductionist Era? (edit) |
10.1159/000510453 |
| 2020-08-04 |
Role of key point Mutations in Receptor Binding Domain of SARS-CoV-2 Spike Glycoprotein (edit) |
10.2174/1871526520666200804161650 |
| 2020-08-04 |
Comparison of clinical laboratory tests between bacterial sepsis and SARS-CoV-2-associated viral sepsis (edit) |
10.1186/S40779-020-00267-3 |
| 2020-08-04 |
Persistence of rT-PCR-SARS-CoV-2 infection and delayed serological response, as a possible effect of rituximab according to the hypothesis of Schulze-Koops et al (edit) |
10.1136/ANNRHEUMDIS-2020-218590 |
| 2020-08-04 |
Treatment of patients with inflammatory rheumatic diseases with rituximab should be carefully considered during the SARS-CoV-2/COVID-19 pandemic. Response to: 'Persistence of rT-PCR-SARS-CoV-2 infection and delayed serological response, as a possibl (edit) |
10.1136/ANNRHEUMDIS-2020-218686 |
| 2020-08-04 |
Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans (edit) |
10.1126/SCIENCE.ABD3871 |
| 2020-08-04 |
In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication (edit) |
10.1038/S41598-020-70143-6 |
| 2020-08-04 |
SARS-CoV-2 infects human neural progenitor cells and brain organoids (edit) |
10.1038/S41422-020-0390-X |
| 2020-08-04 |
Human molecular chaperones share with SARS-CoV-2 antigenic epitopes potentially capable of eliciting autoimmunity against endothelial cells: possible role of molecular mimicry in COVID-19 (edit) |
10.1007/S12192-020-01148-3 |
| 2020-08-04 |
Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2 (edit) |
10.1007/S13238-020-00768-W |
| 2020-08-04 |
Laboratory verification of an RT-PCR assay for SARS-CoV-2 (edit) |
10.1002/JCLA.23507 |
| 2020-08-04 |
Household Clustering of SARS-CoV-2 in Community Settings: A Study from Rural Ecuador (edit) |
10.4269/AJTMH.20-0688 |
| 2020-08-04 |
Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) by Mass Spectrometry (edit) |
10.3390/V12080849 |
| 2020-08-04 |
Use of Whole Genome Sequencing Data for a First in Silico Specificity Evaluation of the RT-qPCR Assays Used for SARS-CoV-2 Detection (edit) |
10.3390/IJMS21155585 |
| 2020-08-04 |
SeroTracker: a global SARS-CoV-2 seroprevalence dashboard (edit) |
10.1016/S1473-3099(20)30631-9 |
| 2020-08-04 |
The proper use of corticosteroids for 2019-nCov pneumonia: towards promising results? (edit) |
10.1016/J.JINF.2020.08.001 |
| 2020-08-04 |
Susceptibility of SARS-CoV-2 to UV Irradiation (edit) |
10.1016/J.AJIC.2020.07.031 |
| 2020-08-04 |
Cardiac Involvment in SARS-CoV-2-Associated Inflammatory Syndromes (edit) |
10.1016/J.TCM.2020.07.008 |
| 2020-08-04 |
Body temperature screening to identify SARS-CoV-2 infected young adult travellers is ineffective (edit) |
10.1016/J.TMAID.2020.101832 |
| 2020-08-04 |
Nebulization: A potential source of SARS-CoV-2 transmission (edit) |
10.1016/J.RESMER.2020.100778 |
| 2020-08-04 |
SARS-CoV-2 infection among healthcare workers in India: Limitations of the case-control investigation (edit) |
10.4103/IJMR.IJMR_2360_20 |
| 2020-08-04 |
Mild clinical manifestations of SARS-CoV-2 related pneumonia in two patients with multiple sclerosis under treatment with ocrelizumab (edit) |
10.1016/J.MSARD.2020.102442 |
| 2020-08-04 |
The outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A review of the current global status (edit) |
10.1016/J.JIPH.2020.07.011 |
| 2020-08-04 |
Enhanced Binding of SARS-CoV-2 Spike Protein to Receptor by Distal Polybasic Cleavage Sites (edit) |
10.1021/ACSNANO.0C04798 |
| 2020-08-04 |
Acute SARS-CoV-2 Infection Impairs Dendritic Cell and T Cell Responses (edit) |
10.1016/J.IMMUNI.2020.07.026 |
| 2020-08-04 |
A large-scale database of T-cell receptor beta (TCRβ) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2 (edit) |
10.21203/RS.3.RS-51964/V1 |
| 2020-08-04 |
Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors (edit) |
10.1101/2020.08.03.235291 |
| 2020-08-04 |
Viable SARS-CoV-2 in the air of a hospital room with COVID-19 patients (edit) |
10.1101/2020.08.03.20167395 |
| 2020-08-04 |
Evaluation of Serological SARS-CoV-2 Lateral Flow Assays for Rapid Point of Care Testing (edit) |
10.1101/2020.07.31.20166041 |
| 2020-08-04 |
The impact of relaxing interventions on human contact patterns and SARS-CoV-2 transmission in China (edit) |
10.1101/2020.08.03.20167056 |
| 2020-08-04 |
Magnitude and Dynamics of the T-Cell Response to SARS-CoV-2 Infection at Both Individual and Population Levels (edit) |
10.1101/2020.07.31.20165647 |
| 2020-08-04 |
Simply saliva: stability of SARS-CoV-2 detection negates the need for expensive collection devices (edit) |
10.1101/2020.08.03.20165233 |
| 2020-08-04 |
Comparison of media and standards for SARS-CoV-2 RT-qPCR without prior RNA preparation (edit) |
10.1101/2020.08.01.20166173 |
| 2020-08-04 |
Neutralizing antibody against SARS-CoV-2 spike in COVID-19 patients, health care workers and convalescent plasma donors: a cohort study using a rapid and sensitive high-throughput neutralization assay (edit) |
10.1101/2020.08.02.20166819 |
| 2020-08-04 |
Impact of SARS-COV-2 pandemic on elective and emergency surgery in a university hospital (edit) |
10.1016/J.CIRESP.2020.07.013 |
| 2020-08-04 |
Understanding air and water borne transmission and survival of coronavirus: Insights and way forward for SARS-CoV-2 (edit) |
10.1016/J.SCITOTENV.2020.141486 |
| 2020-08-04 |
Investigating the potential antiviral activity drugs against SARS-CoV-2 by molecular docking simulation (edit) |
10.1016/J.MOLLIQ.2020.113968 |
| 2020-08-04 |
Impact of Hydroxychloroquine on Antibody Responses to the SARS-CoV-2 Coronavirus (edit) |
10.3389/FIMMU.2020.01739 |
| 2020-08-04 |
Genetic Analysis of the Coronavirus SARS-CoV-2 Host Protease TMPRSS2 in Different Populations (edit) |
10.3389/FGENE.2020.00872 |
| 2020-08-04 |
Insights Into Dynamics of Inhibitor and Ubiquitin-Like Protein Binding in SARS-CoV-2 Papain-Like Protease (edit) |
10.3389/FMOLB.2020.00174 |
| 2020-08-04 |
Unexpected diagnosis of COVID-19-associated disorders by SARS-CoV-2-specific serology (edit) |
10.1016/J.JCV.2020.104568 |
| 2020-08-04 |
Cholecystitis enfisematous suspected SARS-CoV-2 infection (edit) |
10.1016/J.CIRESP.2020.07.015 |
| 2020-08-04 |
[PCR test for SARS-CoV-2 persistently positive. Virus detection is not always COVID-19] (edit) |
10.1016/J.ANPEDI.2020.07.015 |
| 2020-08-03 |
Integrated genomic view of SARS-CoV-2 in India (edit) |
10.12688/WELLCOMEOPENRES.16119.1 |
| 2020-08-03 |
SARS-CoV-2 ORF6 disrupts nucleocytoplasmic transport through interactions with Rae1 and Nup98 (edit) |
10.1101/2020.08.03.234559 |
| 2020-08-03 |
Structure of SARS-CoV-2 2′-O-methyltransferase heterodimer with RNA Cap analog and sulfates bound reveals new strategies for structure-based inhibitor design (edit) |
10.1101/2020.08.03.234716 |
| 2020-08-03 |
SARS-CoV-2 genome sequences from late April in Stockholm, Sweden reveal a novel mutation in the spike protein (edit) |
10.1101/2020.08.03.233866 |
| 2020-08-03 |
SARS-CoV-2 infection of the nervous system: A review of the literature on neurological involvement in novel coronavirus disease (COVID-19) (edit) |
10.17305/BJBMS.2020.4860 |
| 2020-08-03 |
Anthocyanin derivatives as potent inhibitors of SARS-CoV-2 main protease: An in-silico perspective of therapeutic targets against COVID-19 pandemic (edit) |
10.1080/07391102.2020.1801510 |
| 2020-08-03 |
Identification of potential drug candidates to combat COVID-19: a structural study using the main protease (mpro) of SARS-CoV-2 (edit) |
10.1080/07391102.2020.1798286 |
| 2020-08-03 |
Identification of promising drug candidates against NSP16 of SARS-CoV-2 through computational drug repurposing study (edit) |
10.1080/07391102.2020.1802349 |
| 2020-08-03 |
Lack of Nosocomial Transmission to Exposed Inpatients and Co-Workers in an Investigation of Five SARS-CoV-2 Infected Healthcare Workers (edit) |
10.1017/ICE.2020.392 |
| 2020-08-03 |
We Must Rigorously Follow Basic Infection Control Procedures to Protect Our Healthcare Workers from SARS-CoV-2 (edit) |
10.1017/ICE.2020.394 |
| 2020-08-03 |
Seroprevalence of SARS-CoV-2 Antibodies Among Healthcare Workers With Differing Levels of COVID-19 Patient Exposure (edit) |
10.1017/ICE.2020.390 |
| 2020-08-03 |
Early Experience with Universal Pre-procedural Testing for SARS-CoV-2 in a Relatively Low-Prevalence Area (edit) |
10.1017/ICE.2020.398 |
| 2020-08-03 |
Deactivation of SARS-CoV-2 with Pulsed Xenon Ultraviolet: implications for environmental COVID-19 control (edit) |
10.1017/ICE.2020.399 |
| 2020-08-03 |
Letter to the Editor: Discussion of the Article "Prognostic Accuracy of the SIRS, qSOFA, and NEWS for Early Detection of Clinical Deterioration in SARS-CoV-2 Infected Patients" (edit) |
10.3346/JKMS.2020.35.E274 |
| 2020-08-03 |
The Author's Response: Prognostic Accuracy of the SIRS, qSOFA, and NEWS for Early Detection of Clinical Deterioration in SARS-CoV-2 Infected Patients (edit) |
10.3346/JKMS.2020.35.E275 |
| 2020-08-03 |
Vaccination Against SARS-2-nCoV (edit) |
10.1093/JPIDS/PIAA093 |
| 2020-08-03 |
Transient lymphopenia and interstitial pneumonia with endotheliitis in SARS-CoV-2-infected macaques (edit) |
10.1093/INFDIS/JIAA486 |
| 2020-08-03 |
A COVID-19 patient with repeatedly undetectable SARS-CoV-2 antibodies (edit) |
10.1093/JALM/JFAA137 |
| 2020-08-03 |
Longitudinal dynamics of the neutralizing antibody response to SARS-CoV-2 infection (edit) |
10.1093/CID/CIAA1143 |
| 2020-08-03 |
Perniosis during the COVID-19 pandemic: Negative Anti-SARS-CoV-2 Immunohistochemistry in Six Patients and Comparison to Perniosis Before the Emergence of SARS-CoV-2 (edit) |
10.1111/CUP.13830 |
| 2020-08-03 |
Re: Predictors of mortality for patients with COVID-19 pneumonia caused by SARSCoV-2: a prospective cohort study (edit) |
10.1183/13993003.02439-2020 |
| 2020-08-03 |
Development and Validation of the Elecsys Anti-SARS-CoV-2 Immunoassay as a Highly Specific Tool for Determining Past Exposure to SARS-CoV-2 (edit) |
10.1128/JCM.01694-20 |
| 2020-08-03 |
Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection (edit) |
10.1038/S41591-020-1021-2 |
| 2020-08-03 |
Considerations in treating patients with advance lung cancer during the epidemic outbreak of novel coronavirus (SARS-CoV-2) (edit) |
10.1007/S12032-020-01401-W |
| 2020-08-03 |
Comment on "Possible prophylactic or preventive role of topical povidone iodine during accidental ocular exposure to 2019-nCoV" (edit) |
10.1007/S00417-020-04863-W |
| 2020-08-03 |
Could SARS-CoV-2 burst the use of Non-Invasive and Minimally Invasive treatments in paediatric dentistry? (edit) |
10.1111/IPD.12679 |
| 2020-08-03 |
What factors increase the risk of complications in SARS-Cov-2 infected patients? A cohort study in a nationwide Israeli health organization (edit) |
10.2196/20872 |
| 2020-08-03 |
SARS-CoV-2 Complicated by Sinusitis and Co-Infection with Human Metapneumovirus (edit) |
|
| 2020-08-03 |
SARS-CoV-2 (COVID-19) serology: implications for clinical practice, laboratory medicine and public health (edit) |
10.1503/CMAJ.201588 |
| 2020-08-03 |
Gut Microbiota and Liver Interaction through Immune System Cross-Talk: A Comprehensive Review at the Time of the SARS-CoV-2 Pandemic (edit) |
10.3390/JCM9082488 |
| 2020-08-03 |
Using serological data to understand unobserved SARS-CoV-2 risk in health-care settings (edit) |
10.1016/S1473-3099(20)30579-X |
| 2020-08-03 |
Transmission of SARS-CoV-2 in Australian educational settings: a prospective cohort study (edit) |
10.1016/S2352-4642(20)30251-0 |
| 2020-08-03 |
In silico molecular docking analysis for repurposing therapeutics against multiple proteins from SARS-CoV-2 (edit) |
10.1016/J.EJPHAR.2020.173430 |
| 2020-08-03 |
Immunoinformatic construction of an adenovirus-based modular vaccine platform and its application in the design of a SARS-CoV-2 vaccine (edit) |
10.1016/J.MEEGID.2020.104489 |
| 2020-08-03 |
SARS-CoV-2 Clearance in COVID-19 Patients with Novaferon Treatment: A Randomized, Open-label, Parallel Group Trial (edit) |
10.1016/J.IJID.2020.07.053 |
| 2020-08-03 |
Asymptomatic infection by SARS-CoV-2 in healthcare workers: a study in a large teaching hospital in Wuhan, China (edit) |
10.1016/J.IJID.2020.07.082 |
| 2020-08-03 |
Coronavirus (SARS-CoV-2) and the risk of obesity for critically illness and ICU admitted: Meta-analysis of the epidemiological evidence (edit) |
10.1016/J.ORCP.2020.07.007 |
| 2020-08-03 |
Observations on article on healthcare workers & SARS-CoV-2 infection (edit) |
10.4103/IJMR.IJMR_2649_20 |
| 2020-08-03 |
Reopening of dental clinics during SARS-CoV-2 pandemic: an evidence-based review of literature for clinical interventions (edit) |
10.1186/S40902-020-00268-1 |
| 2020-08-03 |
De novo design of picomolar SARS-CoV-2 miniprotein inhibitors (edit) |
10.1101/2020.08.03.234914 |
| 2020-08-03 |
Cross-neutralization of a SARS-CoV-2 antibody to a functionally conserved site is mediated by avidity (edit) |
10.1101/2020.08.02.233536 |
| 2020-08-03 |
Similarity between mutation spectra in hypermutated genomes of rubella virus and in SARS-CoV-2 genomes accumulated during the COVID-19 pandemic (edit) |
10.1101/2020.08.03.234005 |
| 2020-08-03 |
Natural Killer cell activation, reduced ACE2, TMPRSS2, cytokines G-CSF, M-CSF and SARS-CoV-2-S pseudovirus infectivity by MEK inhibitor treatment of human cells (edit) |
10.1101/2020.08.02.230839 |
| 2020-08-03 |
De novo design of ACE2 protein decoys to neutralize SARS-CoV-2 (edit) |
10.1101/2020.08.03.231340 |
| 2020-08-03 |
A Multi-Targeting Approach to Fight SARS-CoV-2 Attachment (edit) |
10.3389/FMOLB.2020.00186 |
| 2020-08-03 |
Encefalitis anti-NMDA-R secundaria a infección por SARS-CoV-2 (edit) |
10.1016/J.NRL.2020.07.013 |
| 2020-08-03 |
Brain inflammatory thrombogenic vasculopathy related with SARS-CoV-2 infection (edit) |
10.1016/J.NRL.2020.07.012 |
| 2020-08-03 |
Assessment of SARS-CoV-2 Transmission on an International Flight and Among a Tourist Group (edit) |
10.1001/JAMANETWORKOPEN.2020.18044 |
| 2020-08-03 |
The Effect of Sample Site, Illness Duration, and the Presence of Pneumonia on the Detection of SARS-CoV-2 by Real-time Reverse Transcription PCR (edit) |
10.1093/OFID/OFAA335 |
| 2020-08-02 |
A Systemic and Molecular Study of Subcellular Localization of SARS-CoV-2 Proteins (edit) |
10.1101/2020.08.02.233023 |
| 2020-08-02 |
Novel coronavirus (SARS-CoV-2) infection in a patient with multivisceral transplant (edit) |
10.1111/TID.13430 |
| 2020-08-02 |
Management Plan of a Paediatric Outpatient Department during the SARS-CoV-2 Epidemic (edit) |
10.1002/PPUL.25000 |
| 2020-08-02 |
SARS-CoV-2 can infect the placenta and is not associated with specific placental histopathology: a series of 19 placentas from COVID-19-positive mothers (edit) |
10.1038/S41379-020-0639-4 |
| 2020-08-02 |
Impact of SARS-CoV-2 outbreak on heart and lung transplant: a patient-perspective survey (edit) |
10.1111/TID.13428 |
| 2020-08-02 |
Blood Myeloperoxidase-DNA, a biomarker of early response to SARS-CoV-2 infection? (edit) |
10.1111/ALL.14533 |
| 2020-08-02 |
Evidence-Based Considerations Exploring Relations between SARS-CoV-2 Pandemic and Air Pollution: Involvement of PM2.5-Mediated Up-Regulation of the Viral Receptor ACE-2 (edit) |
10.3390/IJERPH17155573 |
| 2020-08-02 |
SARS-CoV-2 jumping the species barrier: zoonotic lessons from SARS, MERS and recent advances to combat this pandemic virus (edit) |
10.1016/J.TMAID.2020.101830 |
| 2020-08-02 |
Clinical Utility of a Highly Sensitive Lateral Flow Immunoassay as determined by Titer Analysis for the Detection of anti-SARS-CoV-2 Antibodies at the Point-of-Care (edit) |
10.1101/2020.07.30.20163824 |
| 2020-08-02 |
Temporal and Spatial Heterogeneity of Host Response to SARS-CoV-2 Pulmonary Infection (edit) |
10.1101/2020.07.30.20165241 |
| 2020-08-02 |
Comparison of different serological assays for SARS-CoV-2 in real life (edit) |
10.1016/J.JCV.2020.104569 |
| 2020-08-02 |
Evaluation of a novel multiplexed assay for determining IgG levels and functional activity to SARS-CoV-2 (edit) |
10.1016/J.JCV.2020.104572 |
| 2020-08-02 |
Pooling of SARS-CoV-2 samples to increase molecular testing throughput (edit) |
10.1016/J.JCV.2020.104570 |
| 2020-08-02 |
Retrospective clinical evaluation of 4 lateral flow assays for the detection of SARS-CoV-2 IgG (edit) |
10.1016/J.DIAGMICROBIO.2020.115161 |
| 2020-08-01 |
Visual Loss Following Assisted Mechanical Ventilation Due to SARS-CoV-2-a Case Series (edit) |
10.3238/ARZTEBL.2020.0561 |
| 2020-08-01 |
Salivary Testing for SARS-CoV-2 Detection: Will It Help the Implant Dentist? (edit) |
10.1563/AAID-JOI-D-20-EDITORIAL.4604 |
| 2020-08-01 |
Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal (edit) |
10.1016/J.IJANTIMICAG.2020.106020 |
| 2020-08-01 |
First Cases of SARS-CoV-2 in Iran, 2020: Case Series Report (edit) |
10.18502/IJPH.V49I8.3903 |
| 2020-08-01 |
Dynamics of SARS-CoV-2 infection model with two modes of transmission and immune response (edit) |
10.3934/MBE.2020288 |
| 2020-08-01 |
Comparative Analysis of Symptomatic and Asymptomatic SARS-CoV-2 Infection in Children (edit) |
|
| 2020-08-01 |
[Pediatric multisystem inflammatory syndrome associated with SARS-CoV-2] (edit) |
10.32641/RCHPED.V91I4.2616 |
| 2020-08-01 |
[Features of 164 SARS-CoV-2 (+) patients consulting at an emergency room] (edit) |
10.4067/S0034-98872020000801096 |
| 2020-08-01 |
Niska prewalencja swoistych przeciwciał przeciwko SARS-CoV-2 w klasie Igg – badanie przesiewowe personelu Warszawskiego Szpitala dla Dzieci (edit) |
10.15374/FZ2020031 |
| 2020-08-01 |
Antivirals for COVID-19: A critical review (edit) |
10.1016/J.CEGH.2020.07.006 |
| 2020-08-01 |
Effect of combination of interferon alpha-2b and interferon-gamma or interferon alpha-2b alone for elimination of SARS-CoV-2 viral RNA. Preliminary results of a randomized controlled clinical trial (edit) |
10.1101/2020.07.29.20164251 |
| 2020-08-01 |
Novel coronavirus SARS-CoV-2 and COVID-19. Practice recommendations for obstetric anaesthesia: what we have learned thus far (edit) |
10.1016/J.IJOA.2020.04.006 |
| 2020-08-01 |
Coronavirus Disease 2019 (COVID-19): A Perspective from China (edit) |
10.1148/RADIOL.2020200490 |
| 2020-08-01 |
Chest CT manifestations of new coronavirus disease 2019 (COVID-19): a pictorial review (edit) |
10.1007/S00330-020-06801-0 |
| 2020-08-01 |
AGA Institute Rapid Recommendations for Gastrointestinal Procedures During the COVID-19 Pandemic (edit) |
10.1053/J.GASTRO.2020.03.072 |
| 2020-08-01 |
COVID-19 and the use of immunomodulatory and biologic agents for severe cutaneous disease: An Australia/New Zealand consensus statement (edit) |
10.1111/AJD.13313 |
| 2020-08-01 |
Point-of-care lung ultrasound in patients with COVID-19 - a narrative review (edit) |
10.1111/ANAE.15082 |
| 2020-08-01 |
CT features of novel coronavirus pneumonia (COVID-19) in children (edit) |
10.1007/S00330-020-06860-3 |
| 2020-08-01 |
COVID-19 pandemic will have a long-lasting impact on the quality of cirrhosis care (edit) |
10.1016/J.JHEP.2020.04.005 |
| 2020-08-01 |
Portable chest X-ray in coronavirus disease-19 (COVID-19): A pictorial review (edit) |
10.1016/J.CLINIMAG.2020.04.001 |
| 2020-08-01 |
Recommendations for general surgery activities in a pandemic scenario (SARS-CoV-2) (edit) |
10.1002/BJS.11652 |
| 2020-08-01 |
The SARS-CoV-2/COVID-19 pandemic and challenges in stroke care in India (edit) |
10.1111/NYAS.14379 |
| 2020-08-01 |
The possible mechanisms of action of 4-aminoquinolines (chloroquine/hydroxychloroquine) against Sars-Cov-2 infection (COVID-19): A role for iron homeostasis? (edit) |
10.1016/J.PHRS.2020.104904 |
| 2020-08-01 |
The dynamics of humoral immune responses following SARS-CoV-2 infection and the potential for reinfection (edit) |
10.1099/JGV.0.001439 |
| 2020-08-01 |
Active implications for dermatologists in "SARS-CoV-2 era": Personal experience and review of literature (edit) |
10.1111/JDV.16646 |
| 2020-08-01 |
Two important controversial risk factors in SARS-CoV-2 infection: Obesity and smoking (edit) |
10.1016/J.ETAP.2020.103411 |
| 2020-08-01 |
The pharmacological development of direct acting agents for emerging needed therapy against SARS-CoV-2 (edit) |
10.1097/JCMA.0000000000000353 |
| 2020-08-01 |
Spiking Pandemic Potential: Structural and Immunological aspects of SARS-CoV-2 (edit) |
10.1016/J.TIM.2020.05.012 |
| 2020-08-01 |
SARS-CoV-2 infection-induced immune responses: friends or foes? (edit) |
10.1111/SJI.12895 |
| 2020-08-01 |
Molecular and serological assays for SARS-CoV-2: insights from genome and clinical characteristics (edit) |
10.1093/CLINCHEM/HVAA122 |
| 2020-08-01 |
Repositioning PARP inhibitors for SARS-CoV-2 infection (COVID-19); a new multi-pronged therapy for ARDS? (edit) |
10.1111/BPH.15137 |
| 2020-08-01 |
A review of therapeutic agents and Chinese herbal medicines against SARS-COV-2 (COVID-19) (edit) |
10.1016/J.PHRS.2020.104929 |
| 2020-08-01 |
Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms (edit) |
10.1007/S00415-020-09929-7 |
| 2020-08-01 |
Mechanistic inferences from clinical reports of SARS-CoV-2 (edit) |
10.1080/23744235.2020.1769853 |
| 2020-08-01 |
SARS-CoV-2 infection, male fertility and sperm cryopreservation: a position statement of the Italian Society of Andrology and Sexual Medicine (SIAMS) (Società Italiana di Andrologia e Medicina della Sessualità) (edit) |
10.1007/S40618-020-01290-W |
| 2020-08-01 |
Comprehensive analysis of drugs to treat SARS‑CoV‑2 infection: Mechanistic insights into current COVID‑19 therapies (Review) (edit) |
10.3892/IJMM.2020.4608 |
| 2020-08-01 |
A Comprehensive Updated Review on SARS-CoV-2 and COVID-19 (edit) |
10.1002/JCPH.1673 |
| 2020-08-01 |
COVID-19 and SARS-Cov-2 Infection: Pathophysiology and Clinical Effects on the Nervous System (edit) |
10.1016/J.WNEU.2020.05.193 |
| 2020-08-01 |
SARS-CoV-2 entry in host cells-multiple targets for treatment and prevention (edit) |
10.1016/J.BIOCHI.2020.05.012 |
| 2020-08-01 |
Factors preventing materno-fetal transmission of SARS-CoV-2 (edit) |
10.1016/J.PLACENTA.2020.05.012 |
| 2020-08-01 |
An approach towards development of monoclonal IgY antibodies against SARS CoV-2 spike protein (S) using phage display method: A review (edit) |
10.1016/J.INTIMP.2020.106654 |
| 2020-08-01 |
SARS-CoV-2 infection: The role of cytokines in COVID-19 disease (edit) |
10.1016/J.CYTOGFR.2020.06.001 |
| 2020-08-01 |
When to Operate, Hesitate and Reintegrate: Society of Gynecologic Oncology Surgical Considerations during the COVID-19 Pandemic (edit) |
10.1016/J.YGYNO.2020.06.001 |
| 2020-08-01 |
Understanding SARS-CoV-2-related multisystem inflammatory syndrome in children (edit) |
10.1038/S41577-020-0367-5 |
| 2020-08-01 |
Development of child immunity in the context of COVID-19 pandemic (edit) |
10.1016/J.CLIM.2020.108510 |
| 2020-08-01 |
Time course of anosmia and dysgeusia in patients with mild SARS-CoV-2 infection (edit) |
10.1080/23744235.2020.1772992 |
| 2020-08-01 |
In Vitro and Animal Models for SARS-CoV-2 research (edit) |
10.1016/J.TIPS.2020.05.005 |
| 2020-08-01 |
Responding to the Challenges of SARS-CoV-2: Perspectives from the Association for Molecular Pathology (AMP) Infectious Disease Subdivision Leadership (edit) |
10.1016/J.JMOLDX.2020.06.003 |
| 2020-08-01 |
SARS-CoV-2 and Cardiovascular Complications: from Molecular Mechanisms to Pharmaceutical Management (edit) |
10.1016/J.BCP.2020.114114 |
| 2020-08-01 |
Testing of natural products in clinical trials targeting the SARS-CoV-2 (Covid-19) Viral Spike Protein-Angiotensin Converting Enzyme-2 (ACE2) interaction (edit) |
10.1016/J.BCP.2020.114123 |
| 2020-08-01 |
Simulations of Deliveries of SARS-CoV-2 Positive Pregnant Women and Their Newborn Babies: Plan to Implement a Complex and Ever-Changing Protocol (edit) |
10.1055/S-0040-1713602 |
| 2020-08-01 |
Pre-existing immunity to SARS-CoV-2: the knowns and unknowns (edit) |
10.1038/S41577-020-0389-Z |
| 2020-08-01 |
SARS-CoV-2 testing in infertile patients: different recommendations in Europe and America (edit) |
10.1007/S10815-020-01887-3 |
| 2020-08-01 |
[Being cardiologist at the time of SARS-CoV-2: what do not forget during the post-pandemic phase?] (edit) |
10.1714/3405.33886 |
| 2020-08-01 |
Home medical nutrition during SARS-CoV-2 pandemic - A position paper (edit) |
10.1016/J.CLNESP.2020.05.002 |
| 2020-08-01 |
Geographic components of SARS-CoV-2 expansion: a hypothesis (edit) |
10.1152/JAPPLPHYSIOL.00362.2020 |
| 2020-08-01 |
[The virology of SARS-CoV-2] (edit) |
10.1007/S00108-020-00853-6 |
| 2020-08-01 |
Biochemical Dynamics and Clinical Features of Novel Corona Virus (2019-nCoV) (edit) |
|
| 2020-08-01 |
The four horsemen of a viral Apocalypse: The pathogenesis of SARS-CoV-2 infection (COVID-19) (edit) |
10.1016/J.EBIOM.2020.102887 |
| 2020-08-01 |
The first 100 days of SARS-CoV-2 control in Vietnam (edit) |
10.1093/CID/CIAA1130 |
| 2020-08-01 |
Effect of SARS-CoV-2 on the Incidence of Appendicitis: The Role of Quarantine (edit) |
10.1097/PEC.0000000000002182 |
| 2020-08-01 |
In Silico Screening of Potential Spike Glycoprotein Inhibitors of SARS-CoV-2 with Drug Repurposing Strategy (edit) |
10.1007/S11655-020-3427-6 |
| 2020-08-01 |
Interferon-α2b spray inhalation did not shorten virus shedding time of SARS-CoV-2 in hospitalized patients: a preliminary matched case-control study (edit) |
10.1631/JZUS.B2000211 |
| 2020-08-01 |
Gyorstesztek értéke a SARS-CoV-2-fertőzés kimutatásában (edit) |
10.1556/650.2020.33M |
| 2020-08-01 |
Effects of SARS-CoV-2 on the cardiovascular system: More issues to be addressed (edit) |
10.14744/ANATOLJCARDIOL.2020.11813 |
| 2020-08-01 |
The immune system as a target for therapy of SARS-CoV-2: A systematic review of the current immunotherapies for COVID-19 (edit) |
10.1016/J.LFS.2020.118185 |
| 2020-08-01 |
SARS-CoV-2 Infection and COVID-19 During Pregnancy: A Multidisciplinary Review (edit) |
10.1016/J.MAYOCP.2020.05.011 |
| 2020-08-01 |
Peripheral Blood Examination Findings in SARS-CoV-2 Infection (edit) |
10.1093/AJCP/AQAA108 |
| 2020-08-01 |
Repeated leftover serosurvey of SARS-CoV-2 IgG antibodies, Greece, March and April 2020 (edit) |
10.2807/1560-7917.ES.2020.25.31.2001369 |
| 2020-08-01 |
Age-specific SARS-CoV-2 infection fatality ratio and associated risk factors, Italy, February to April 2020 (edit) |
10.2807/1560-7917.ES.2020.25.31.2001383 |
| 2020-08-01 |
Clinical application of Chemiluminescence Microparticle Immunoassay for SARS-CoV-2 infection diagnosis (edit) |
10.1016/J.JCV.2020.104576 |
| 2020-08-01 |
Engineered ACE2 receptor traps potently neutralize SARS-CoV-2 (edit) |
10.1101/2020.07.31.231746 |
| 2020-08-01 |
High SARS-CoV-2 seroprevalence in Health Care Workers but relatively low numbers of deaths in urban Malawi (edit) |
10.1101/2020.07.30.20164970 |
| 2020-08-01 |
Five approaches to the suppression of SARS-CoV-2 without intensive social distancing (edit) |
10.1101/2020.07.30.20165159 |
| 2020-08-01 |
Nosocomial outbreak of SARS-CoV-2 infection in a haematological unit - High mortality rate in infected patients with haematologic malignancies (edit) |
10.1016/J.JCV.2020.104574 |
| 2020-08-01 |
An in-silico approach to study the possible interactions of miRNA between human and SARS-CoV2 (edit) |
10.1016/J.COMPBIOLCHEM.2020.107352 |
| 2020-08-01 |
NK cells: A double edge sword against SARS-CoV-2 (edit) |
10.1016/J.JBIOR.2020.100737 |
| 2020-08-01 |
Genomic variance of Open Reading Frames (ORFs) and Spike protein in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (edit) |
10.1097/JCMA.0000000000000387 |
| 2020-08-01 |
[The prevalence rate of anti-SARS-CoV-2-IgG is 1.2% - Screening in asymptomatic outpatients in Germany (Northrhine-Westfalia)] (edit) |
10.1007/S15006-020-0750-Y |
| 2020-08-01 |
BCG-Vakzine als Lückenfüller? : SARS-CoV-2-Impfung (edit) |
10.1007/S15006-020-0729-8 |
| 2020-08-01 |
SARS-CoV-2 dringt bis ins Herzgewebe vor (edit) |
10.1007/S15006-020-0716-0 |
| 2020-08-01 |
How close is SARS-CoV-2 to canine and feline coronaviruses? (edit) |
10.1111/JSAP.13207 |
| 2020-08-01 |
Ritonavir- and lopinavir-induced eryptosis in a SARS-CoV-2-infected patient (edit) |
10.1182/BLOOD.2020006228 |
| 2020-08-01 |
Leukoerythroblastosis and plasmacytoid lymphocytes in a child with SARS-CoV-2-associated multisystem inflammatory syndrome (edit) |
10.1182/BLOOD.2020007132 |
| 2020-08-01 |
Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020 (edit) |
10.2807/1560-7917.ES.2020.25.32.2001410 |
| 2020-08-01 |
SARS-CoV-2 Transmission and the Risk of Aerosol-Generating Procedures (edit) |
10.1164/RCCM.2024P13 |
| 2020-08-01 |
Potent inhibitors of SARS-CoV-2 3C-like protease derived from N-substituted isatin compounds (edit) |
10.1016/J.EJMECH.2020.112702 |
| 2020-08-01 |
Histopathologic Changes and SARS-CoV-2 Immunostaining in the Lung of a Patient With COVID-19 (edit) |
10.7326/L20-0895 |
| 2020-08-01 |
Unpuzzling COVID-19: tissue-related signaling pathways associated with SARS-CoV-2 infection and transmission (edit) |
10.1042/CS20200904 |
| 2020-08-01 |
Conformational transition of SARS-CoV-2 spike glycoprotein between its closed and open states (edit) |
10.1063/5.0011141 |
| 2020-08-01 |
Emergence, Transmission, and Potential Therapeutic Targets for the COVID-19 Pandemic Associated with the SARS-CoV-2 (edit) |
10.33594/000000254 |
| 2020-08-01 |
[SARS-CoV-2 and sodium transport: a diabolical strategy] (edit) |
|
| 2020-08-01 |
Mutation dans la protéine Spike de SARS-CoV-2 (edit) |
|
| 2020-08-01 |
Clinical significance summary: Preliminary results of a rapid review of zinc for the prevention and treatment of SARS-CoV-2 and other acute viral respiratory infections (edit) |
10.1016/J.AIMED.2020.07.009 |
| 2020-08-01 |
[The mechanism and treatment strategies of SARS-CoV-2 mediated inflammatory response] (edit) |
10.7507/1001-5515.202003030 |
| 2020-08-01 |
Understanding the epidemiology, pathophysiology, diagnosis and management of SARS-CoV-2 (edit) |
10.1177/0300060520949077 |
| 2020-08-01 |
Persistent SARS-COV-2 RNA positivity in a patient for 92 days after disease onset: A case report (edit) |
10.1097/MD.0000000000021865 |
| 2020-08-01 |
Ocular Features and Associated Systemic Findings in SARS-CoV-2 Infection (edit) |
10.1080/09273948.2020.1781198 |
| 2020-08-01 |
Viral exanthema as manifestation of SARS-CoV-2 infection: A case report (edit) |
10.1097/MD.0000000000021810 |
| 2020-08-01 |
Fractional diffusion on the human proteome as an alternative to the multi-organ damage of SARS-CoV-2 (edit) |
10.1063/5.0015626 |
| 2020-08-01 |
Covid-19 (Sars-Cov-2 Infection) Information for Patients with Predialytic Chronic Kidney Disease (edit) |
10.1590/2175-8239-JBN-2020-S104 |
| 2020-08-01 |
Legal Implications of Personal Protective Equipment Use When Treating Patients for COVID-19 (SARS-CoV-2) (edit) |
|
| 2020-08-01 |
Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development (edit) |
10.1055/S-0040-1715790 |
| 2020-08-01 |
Direct or Collateral Liver Damage in SARS-CoV-2-Infected Patients (edit) |
10.1055/S-0040-1715108 |
| 2020-08-01 |
Phillyrin (KD-1) exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2) and human coronavirus 229E (HCoV-229E) by suppressing the nuclear factor kappa B (NF-κB) signaling pathway (edit) |
10.1016/J.PHYMED.2020.153296 |
| 2020-08-01 |
Structural basis of SARS-CoV-2 main protease inhibition by a broad-spectrum anti-coronaviral drug (edit) |
|
| 2020-08-01 |
Acute Transverse Myelitis Secondary to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Case Report (edit) |
10.5811/CPCEM.2020.6.48462 |
| 2020-08-01 |
A Case Report of Acute Motor and Sensory Polyneuropathy as the Presenting Symptom of SARS-CoV-2 (edit) |
10.5811/CPCEM.2020.6.48683 |
| 2020-08-01 |
Coinfection of SARS-CoV-2 and Measles morbillivirus in a front-line health worker in Rio de Janeiro, Brasil (edit) |
10.1590/1806-9282.66.8.1027 |
| 2020-08-01 |
Laboratory findings in SARS-CoV-2 infections: State of the art (edit) |
10.1590/1806-9282.66.8.1152 |
| 2020-08-01 |
Reduction of Contagion Risks by SARS-Cov-2 (COVID-19) in Air-Conditioned Work Environments (edit) |
|
| 2020-08-01 |
Cell morphological analysis of SARS-CoV-2 infection by transmission electron microscopy (edit) |
10.21037/JTD-20-1368 |
| 2020-08-01 |
Expert consensus-based laboratory testing of SARS-CoV-2 (edit) |
10.21037/JTD-20-1928 |
| 2020-08-01 |
Mesenchymal stromal cells as potential immunomodulatory players in severe acute respiratory distress syndrome induced by SARS-CoV-2 infection (edit) |
10.4252/WJSC.V12.I8.731 |
| 2020-08-01 |
Proprotein convertase furin in SARS-CoV-2 and non-small cell lung cancer (edit) |
10.21037/TLCR-20-716 |
| 2020-08-01 |
SARS-CoV-2 antibodies titration: a reappraisal (edit) |
10.21037/ATM-20-5361 |
| 2020-08-01 |
Transmission risk of respiratory viruses in natural and mechanical ventilation environments: implications for SARS-CoV-2 transmission in Africa (edit) |
10.1136/BMJGH-2020-003522 |
| 2020-07-31 |
Comparative molecular docking analysis of the SARS CoV-2 Spike glycoprotein with the human ACE-2 receptors and thrombin (edit) |
10.6026/97320630016532 |
| 2020-07-31 |
Factors affecting antibody response to SARS-CoV-2 in patients with severe COVID-19 (edit) |
10.1002/JMV.26379 |
| 2020-07-31 |
Targetable Biological Mechanisms Implicated in Emergent Psychiatric Conditions Associated With SARS-CoV-2 Infection (edit) |
10.1001/JAMAPSYCHIATRY.2020.2795 |
| 2020-07-31 |
Dihydroorotate Dehydrogenase Inhibitors in SARS-CoV-2 Infection (edit) |
10.1111/ECI.13366 |
| 2020-07-31 |
Update on the COVID-19-associated inflammatory syndrome in children and adolescents; paediatric inflammatory multisystem syndrome-temporally associated with SARS-CoV-2 (edit) |
10.1111/JPC.15049 |
| 2020-07-31 |
Prolonged asymptomatic SARS-CoV-2 infection in a child receiving immunosuppressive therapy (edit) |
10.1002/PPUL.24983 |
| 2020-07-31 |
[Infection Prevention in Anesthesiology during the SARS-CoV 2-pandemic] (edit) |
10.1055/A-1174-7359 |
| 2020-07-31 |
ACEI/ARB therapy in COVID-19: the double-edged sword of ACE2 and SARS-CoV-2 viral docking (edit) |
10.1186/S13054-020-03195-9 |
| 2020-07-31 |
Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients (edit) |
10.1158/2159-8290.CD-20-0773 |
| 2020-07-31 |
Outcomes of Maternal-Newborn Dyads After Maternal SARS-CoV-2 (edit) |
10.1542/PEDS.2020-005637 |
| 2020-07-31 |
Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient (edit) |
10.1038/S41594-020-0480-Y |
| 2020-07-31 |
A thermostable, closed SARS-CoV-2 spike protein trimer (edit) |
10.1038/S41594-020-0478-5 |
| 2020-07-31 |
Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients (edit) |
10.1038/S41401-020-0483-6 |
| 2020-07-31 |
Monitoring of high-flow nasal cannula for SARS-CoV-2 severe pneumonia: less is more, better look at respiratory rate (edit) |
10.1007/S00134-020-06199-9 |
| 2020-07-31 |
A palindromic RNA sequence as a common breakpoint contributor to copy-choice recombination in SARS-COV-2 (edit) |
10.1007/S00705-020-04750-Z |
| 2020-07-31 |
An evaluation of the SARS-CoV-2 epidemic 16 days after the end of social confinement in Hungary (edit) |
10.1007/S11357-020-00237-6 |
| 2020-07-31 |
Masks Do More Than Protect Others During COVID-19: Reducing the Inoculum of SARS-CoV-2 to Protect the Wearer (edit) |
10.1007/S11606-020-06067-8 |
| 2020-07-31 |
Correction to: SARS-CoV-2 testing in infertile patients: different recommendations in Europe and America (edit) |
10.1007/S10815-020-01903-6 |
| 2020-07-31 |
Application of Bayesian phylogenetic inference modelling for evolutionary genetic analysis and dynamic changes in 2019-nCoV (edit) |
10.1093/BIB/BBAA154 |
| 2020-07-31 |
Probing antiviral drugs against SARS-CoV-2 through virus-drug association prediction based on the KATZ method (edit) |
10.1016/J.YGENO.2020.07.044 |
| 2020-07-31 |
Structural stability of SARS-CoV-2 3CLpro and identification of quercetin as an inhibitor by experimental screening (edit) |
10.1016/J.IJBIOMAC.2020.07.235 |
| 2020-07-31 |
Antibody response against SARS-CoV-2 spike protein and nucleoprotein evaluated by 4 automated immunoassays and 3 ELISAs (edit) |
10.1016/J.CMI.2020.07.038 |
| 2020-07-31 |
Angiotensin-converting enzyme 2 (ACE2) receptor and SARS-CoV-2: Potential therapeutic targeting (edit) |
10.1016/J.EJPHAR.2020.173455 |
| 2020-07-31 |
Clinical course and outcomes in patients with asthma hospitalized for SARS-CoV-2 pneumonia:a single-center, retrospective study (edit) |
10.1016/J.ANAI.2020.07.029 |
| 2020-07-31 |
Sensitivity of different RT-qPCR solutions for SARS-CoV-2 detection (edit) |
10.1016/J.IJID.2020.07.058 |
| 2020-07-31 |
Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France (edit) |
10.1016/J.EBIOM.2020.102915 |
| 2020-07-31 |
Evaluation of the Quotient® MosaiQ™ COVID-19 antibody microarray for the detection of IgG and IgM antibodies to SARS-CoV-2 virus in humans (edit) |
10.1016/J.JCV.2020.104571 |
| 2020-07-31 |
Challenges in use of saliva for detection of SARS CoV-2 RNA in symptomatic outpatients (edit) |
10.1016/J.JCV.2020.104567 |
| 2020-07-31 |
SARS-CoV-2 and the Nervous System: From Clinical Features to Molecular Mechanisms (edit) |
10.3390/IJMS21155475 |
| 2020-07-31 |
Wellbeing at Work before and during the SARS-COV-2 Pandemic: A Brazilian Nationwide Study among Dietitians (edit) |
10.3390/IJERPH17155541 |
| 2020-07-31 |
Olfactory and Taste Disorders in Patients with SARS-CoV-2 Infection (edit) |
10.1055/S-0040-1713142 |
| 2020-07-31 |
Therapeutic plasma exchange in adult critically ill patients with life-threatening SARS-CoV-2 disease: A pilot study (edit) |
10.1016/J.JCRC.2020.07.001 |
| 2020-07-31 |
A Newcastle disease virus (NDV) expressing membrane-anchored spike as a cost-effective inactivated SARS-CoV-2 vaccine (edit) |
10.1101/2020.07.30.229120 |
| 2020-07-31 |
Biomechanical Characterization of SARS-CoV-2 Spike RBD and Human ACE2 Protein-Protein Interaction (edit) |
10.1101/2020.07.31.230730 |
| 2020-07-31 |
Force-dependent stimulation of RNA unwinding by SARS-CoV-2 nsp13 helicase (edit) |
10.1101/2020.07.31.231274 |
| 2020-07-31 |
The SARS-CoV-2 Nucleocapsid phosphoprotein forms mutually exclusive condensates with RNA and the membrane-associated M protein (edit) |
10.1101/2020.07.30.228023 |
| 2020-07-31 |
Household transmission of SARS-CoV-2: a systematic review and meta-analysis of secondary attack rate (edit) |
10.1101/2020.07.29.20164590 |
| 2020-07-31 |
Rapid real-time tracking of non-pharmaceutical interventions and their association SARS-CoV-2 positivity: The COVID-19 Pandemic Pulse Study (edit) |
10.1101/2020.07.29.20164665 |
| 2020-07-31 |
Buzz about RT-qPCR: An RT-qPCR formulation for SARS-CoV-2 detection using reagents produced at Georgia Institute of Technology (edit) |
10.1101/2020.07.29.20163949 |
| 2020-07-31 |
Multicenter comparison of the Cobas 6800 system with the RealStar RT-PCR kit for the detection of SARS-CoV-2 (edit) |
10.1016/J.JCV.2020.104573 |
| 2020-07-31 |
Repurposing approved drugs as potential inhibitors of 3CL-protease of SARS-CoV-2: Virtual screening and structure based drug design (edit) |
10.1016/J.COMPBIOLCHEM.2020.107351 |
| 2020-07-31 |
An understanding of discordant SARS-CoV-2 test results: an examination of the data from a central Auckland laboratory (edit) |
|
| 2020-07-31 |
Age-related differences in SARS-CoV-2 testing in the Northern Region of New Zealand (edit) |
|
| 2020-07-31 |
Anti-SARS-CoV-2 Potential of Artemisinins In Vitro (edit) |
10.1021/ACSINFECDIS.0C00522 |
| 2020-07-31 |
One-step nested RT-PCR for COVID-19 detection: A flexible, locally developed test for SARS-CoV2 nucleic acid detection (edit) |
10.3855/JIDC.12726 |
| 2020-07-31 |
Aerosol and surface persistence: Novel SARS-CoV-2 versus other coronaviruses (edit) |
10.3855/JIDC.12887 |
| 2020-07-31 |
Trends in adaptation of fifteen European countries population to SARS-CoV-2 in March-May 2020: Can Taiwanese experience be adopted? (edit) |
10.1016/J.JFMA.2020.07.038 |
| 2020-07-31 |
Effect of SARS-CoV-2 Infection on the Microbial Composition of Upper Airway (edit) |
10.2147/IDR.S259984 |
| 2020-07-31 |
Critical Care Management for Novel 2019 SARS-CoV-2 and HCoV-NL63 Coinfection in a Young Immunocompromised Patient: A Chicago Experience (edit) |
10.1155/2020/8877641 |
| 2020-07-31 |
Fruitful Neutralizing Antibody Pipeline Brings Hope To Defeat SARS-Cov-2 (edit) |
10.1016/J.TIPS.2020.07.004 |
| 2020-07-31 |
Shedding of SARS-CoV-2 in feces and urine and its potential role in person-to-person transmission and the environment-based spread of COVID-19 (edit) |
10.1016/J.SCITOTENV.2020.141364 |
| 2020-07-31 |
Genomics insights of SARS-CoV-2 (COVID-19) into target-based drug discovery (edit) |
10.1007/S00044-020-02610-8 |
| 2020-07-31 |
Rapid production of clinical-grade SARS-CoV-2 specific T cells (edit) |
10.1002/ACG2.101 |
| 2020-07-31 |
Oral Microbiome and SARS-CoV-2: Beware of Lung Co-infection (edit) |
10.3389/FMICB.2020.01840 |
| 2020-07-31 |
SARS-CoV-2 or Pnuemocystis jirovecii? A case report (edit) |
10.1016/J.MEDIN.2020.07.007 |
| 2020-07-31 |
A Reality Check on Antiphospholipid Antibodies in COVID-19-Associated Coagulopathy (edit) |
10.1002/ART.41472 |
| 2020-07-31 |
Unlocking COVID therapeutic targets: A structure-based rationale against SARS-CoV-2, SARS-CoV and MERS-CoV Spike (edit) |
10.1016/J.CSBJ.2020.07.017 |
| 2020-07-31 |
Acetylated K676 TGFBIp as a severity diagnostic blood biomarker for SARS-CoV-2 pneumonia (edit) |
10.1126/SCIADV.ABC1564 |
| 2020-07-31 |
[Thrombotic microangiopathy: A renal manifestation in SARS-CoV-2 infection (COVID-19 disease)] (edit) |
10.1016/J.ANPEDI.2020.06.030 |
| 2020-07-31 |
Standard Operating Procedure for Specimen Collection, Packaging and Transport for Diagnosis of SARS-COV-2 (edit) |
10.31729/JNMA.5260 |
| 2020-07-30 |
Duration of SARS-CoV-2 detection in Israel Defense Forces soldiers with mild COVID-19 (edit) |
10.1002/JMV.26374 |
| 2020-07-30 |
A dynamic regulatory interface on SARS-CoV-2 RNA polymerase (edit) |
10.1101/2020.07.30.229187 |
| 2020-07-30 |
Substrate specificity of SARS-CoV-2 nsp10-nsp16 methyltransferase (edit) |
10.1101/2020.07.30.228478 |
| 2020-07-30 |
Mucin-type O-glycosylation Landscapes of SARS-CoV-2 Spike Proteins (edit) |
10.1101/2020.07.29.227785 |
| 2020-07-30 |
COVID-19 (SARS-CoV-2) Infection in Pregnancy: A Systematic Review (edit) |
10.1159/000509290 |
| 2020-07-30 |
18F-FDG brain PET hypometabolism in post-SARS-CoV-2 infection: substrate for persistent/delayed disorders? (edit) |
10.1007/S00259-020-04973-X |
| 2020-07-30 |
The show must go on. The impacts of SARS-CoV-2 pandemic on cutaneous allergology and patch testing (edit) |
10.23822/EURANNACI.1764-1489.165 |
| 2020-07-30 |
Universal SARS-CoV-2 testing on admission to the labor and delivery unit: Low prevalence among asymptomatic obstetric patients (edit) |
10.1017/ICE.2020.382 |
| 2020-07-30 |
Neuropathogenesis of SARS-CoV-2 infection (edit) |
10.7554/ELIFE.59136 |
| 2020-07-30 |
A study of SARS-CoV-2 epidemiology in Italy: from early days to secondary effects after social distancing (edit) |
10.1080/23744235.2020.1797157 |
| 2020-07-30 |
Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS-CoV-2 (edit) |
10.1172/JCI140970 |
| 2020-07-30 |
Pooled RNA sample reverse transcriptase real time PCR assay for SARS CoV-2 infection: A reliable, faster and economical method (edit) |
10.1371/JOURNAL.PONE.0236859 |
| 2020-07-30 |
Persistent minimal sequences of SARS-CoV-2 (edit) |
10.1093/BIOINFORMATICS/BTAA686 |
| 2020-07-30 |
Cutaneous signs in SARS CoV-2 infection: A plea for more rigorous peer-review in the time of COVID-19 (edit) |
10.1111/BJD.19429 |
| 2020-07-30 |
Differential Tropism of SARS-CoV and SARS-CoV-2 in Bat Cells (edit) |
10.3201/EID2612.202308 |
| 2020-07-30 |
Detection of SARS-CoV-2 in Hemodialysis Effluent of Patient with COVID-19 Pneumonia, Japan (edit) |
10.3201/EID2611.201956 |
| 2020-07-30 |
Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques (edit) |
10.1038/S41586-020-2607-Z |
| 2020-07-30 |
ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques (edit) |
10.1038/S41586-020-2608-Y |
| 2020-07-30 |
Seroprevalence of SARS-CoV-2 and Infection Fatality Ratio, Orleans and Jefferson Parishes, Louisiana, USA, May 2020 (edit) |
10.3201/EID2611.203029 |
| 2020-07-30 |
Effect of moist heat reprocessing of N95 respirators on SARS-CoV-2 inactivation and respirator function (edit) |
10.1503/CMAJ.201203 |
| 2020-07-30 |
SARS-CoV-2 Genome Sequence from Morocco, Obtained Using Ion AmpliSeq Technology (edit) |
10.1128/MRA.00690-20 |
| 2020-07-30 |
Reports of Coding-Complete Genome Sequences of Five 2019 Novel Coronavirus (SARS-CoV-2) Strains Isolated in Bangladesh (edit) |
10.1128/MRA.00692-20 |
| 2020-07-30 |
Genome Sequences of SARS-CoV-2 Strains Detected in Hong Kong (edit) |
10.1128/MRA.00697-20 |
| 2020-07-30 |
Pressing Issues in COVID-19: Probable Cause to Seize SARS-CoV-2 for Its Preferential Involvement of Posterior Circulation Manifesting as Severe Posterior Reversible Encephalopathy Syndrome and Posterior Strokes (edit) |
10.3174/AJNR.A6679 |
| 2020-07-30 |
Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy (edit) |
10.1126/SCIENCE.ABC4730 |
| 2020-07-30 |
Activation and evasion of type I interferon responses by SARS-CoV-2 (edit) |
10.1038/S41467-020-17665-9 |
| 2020-07-30 |
Detection of SARS-CoV-2 in nasal swabs using MALDI-MS (edit) |
10.1038/S41587-020-0644-7 |
| 2020-07-30 |
Immune-mediated neurological syndromes in SARS-CoV-2-infected patients (edit) |
10.1007/S00415-020-10108-X |
| 2020-07-30 |
Botulinum toxin therapy in the SARS-CoV-2 pandemic: patient perceptions from a German cohort (edit) |
10.1007/S00702-020-02235-6 |
| 2020-07-30 |
Recommendations for Cardiovascular Prevention During the Sars-Cov-2 Pandemic: An Executive Document by the Board of the Italian Society of Cardiovascular Prevention (edit) |
10.1007/S40292-020-00401-1 |
| 2020-07-30 |
Innate immune evasion by SARS-CoV-2: Comparison with SARS-CoV (edit) |
10.1002/RMV.2135 |
| 2020-07-30 |
Validation of small-size-pooling approach targeted to hospital surveillance of SARS-CoV-2 infection (edit) |
10.1017/ICE.2020.380 |
| 2020-07-30 |
SARS-CoV-2-related atypical thyroiditis (edit) |
10.1016/S2213-8587(20)30266-7 |
| 2020-07-30 |
Approaches and advances in the development of potential therapeutic targets and antiviral agents for the management of SARS-CoV-2 infection (edit) |
10.1016/J.EJPHAR.2020.173450 |
| 2020-07-30 |
The chemokine receptor antagonist cenicriviroc inhibits the replication of SARS-CoV-2 in vitro (edit) |
10.1016/J.ANTIVIRAL.2020.104902 |
| 2020-07-30 |
Apparent inefficacy of hydroxychloroquine combined with azithromycin on SARS-CoV-2 clearance in an incident cohort of geriatric patients with COVID-19 (edit) |
10.1016/J.TMAID.2020.101826 |
| 2020-07-30 |
Large-scale, molecular and serological SARS-CoV-2 screening of healthcare workers in a 4-site public hospital in Belgium after COVID-19 outbreak (edit) |
10.1016/J.JINF.2020.07.033 |
| 2020-07-30 |
Characterising differential antibody response is integral to future SARS-CoV-2 serostudies (edit) |
10.1016/J.JINF.2020.07.029 |
| 2020-07-30 |
Kinetics and performance of the Abbott Architect SARS-CoV-2 IgG antibody assay (edit) |
10.1016/J.JINF.2020.07.031 |
| 2020-07-30 |
SARS-CoV-2 IgM and IgG rapid serologic test for the diagnosis of COVID-19 in the emergency department (edit) |
10.1016/J.JINF.2020.07.032 |
| 2020-07-30 |
From Mutation Signature to Molecular Mechanism in the RNA World: A Case of SARS-CoV-2 (edit) |
10.1016/J.GPB.2020.07.003 |
| 2020-07-30 |
Risk of SARS-CoV-2 Transmission During Flexible Laryngoscopy: A Systematic Review (edit) |
10.1001/JAMAOTO.2020.1973 |
| 2020-07-30 |
Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19) (edit) |
10.1001/JAMAPEDIATRICS.2020.3651 |
| 2020-07-30 |
Discovery of Potent SARS-CoV-2 Inhibitors from Approved Antiviral Drugs via Docking Screening (edit) |
10.2174/1386207323999200730205447 |
| 2020-07-30 |
Preliminary Study of Sars-Cov-2 Occurrence in Wastewater in the Czech Republic (edit) |
10.3390/IJERPH17155508 |
| 2020-07-30 |
The rate of SARS-CoV-2 positivity in asymptomatic pregnant women admitted to hospital for delivery: Experience of a pandemic center in Turkey (edit) |
10.1016/J.EJOGRB.2020.07.051 |
| 2020-07-30 |
SARS-CoV-2 Spike Protein Interacts with Multiple Innate Immune Receptors (edit) |
10.1101/2020.07.29.227462 |
| 2020-07-30 |
Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2 (edit) |
10.1101/2020.07.30.229377 |
| 2020-07-30 |
Serological detection of 2019-nCoV respond to the epidemic: A useful complement to nucleic acid testing (edit) |
10.1016/J.INTIMP.2020.106861 |
| 2020-07-30 |
SARS-CoV 2 and the pathobiology of the respiratory control mechanisms in the brainstem (edit) |
10.1016/J.JFMA.2020.07.035 |
| 2020-07-30 |
Imaging findings of SARS-CoV-2 infection in pediatrics: A systematic review of coronavirus disease 2019 (COVID-19) in 850 patients (edit) |
10.1016/J.ACRA.2020.07.031 |
| 2020-07-30 |
Transcriptome & viral growth analysis of SARS-CoV-2-infected Vero CCL-81 cells (edit) |
10.4103/IJMR.IJMR_2257_20 |
| 2020-07-30 |
A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice (edit) |
10.1016/J.IMMUNI.2020.07.019 |
| 2020-07-30 |
Distinct Early Serological Signatures Track with SARS-CoV-2 Survival (edit) |
10.1016/J.IMMUNI.2020.07.020 |
| 2020-07-30 |
Replication-Competent Vesicular Stomatitis Virus Vaccine Vector Protects against SARS-CoV-2-Mediated Pathogenesis in Mice (edit) |
10.1016/J.CHOM.2020.07.018 |
| 2020-07-30 |
How We Manage Patients With Chronic Lymphocytic Leukemia During the SARS-CoV-2 Pandemic (edit) |
10.1097/HS9.0000000000000432 |
| 2020-07-30 |
Use of chest CT-scan images to differentiate between SARS-CoV-2 infection and fat embolism: a clinical case (edit) |
10.1016/J.RADCR.2020.07.071 |
| 2020-07-30 |
Ad26-vector based COVID-19 vaccine encoding a prefusion stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses (edit) |
10.1101/2020.07.30.227470 |
| 2020-07-30 |
Construction of SARS-CoV-2 Virus-Like Particles by Mammalian Expression System (edit) |
10.3389/FBIOE.2020.00862 |
| 2020-07-30 |
COVID-19: Rational discovery of the therapeutic potential of Melatonin as a SARS-CoV-2 main Protease Inhibitor (edit) |
10.7150/IJMS.48053 |
| 2020-07-29 |
SARS-CoV-2 Tackles the Tobacco Industry: Comment on "Tobacco Industry Interference Index: Implementation of the World Health Organization's Framework Convention on Tobacco Control Article 5.3 in India" (edit) |
10.1177/1010539520944700 |
| 2020-07-29 |
Rapid Screening Evaluation of SARS-CoV-2 IgG Assays Using Z-Scores to Standardize Results (edit) |
10.3201/EID2610.202632 |
| 2020-07-29 |
Nationwide External Quality Assessment of SARS-CoV-2 Molecular Testing, South Korea (edit) |
10.3201/EID2610.202551 |
| 2020-07-29 |
Letter to the editor: Possible role of topical povidone iodine in case of accidental ocular exposure to SARS-CoV-2 (edit) |
10.1007/S00417-020-04864-9 |
| 2020-07-29 |
Variation in mortality of HIV/SARS-CoV-2 co-infected patients in the Bronx, New York City (edit) |
10.1002/JMV.26370 |
| 2020-07-29 |
Body Mass Index and Risk for Intubation or Death in SARS-CoV-2 Infection: A Retrospective Cohort Study (edit) |
10.7326/M20-3214 |
| 2020-07-29 |
The ongoing COVID-19 epidemic in Minas Gerais, Brazil: insights from epidemiological data and SARS-CoV-2 whole genome sequencing (edit) |
10.1080/22221751.2020.1803146 |
| 2020-07-29 |
Seroprevalence of SARS-CoV-2-Specific Antibodies, Faroe Islands (edit) |
10.3201/EID2611.202736 |
| 2020-07-29 |
Interplay between SARS-CoV-2 and the type I interferon response (edit) |
10.1371/JOURNAL.PPAT.1008737 |
| 2020-07-29 |
Differences in antibody kinetics and functionality between severe and mild SARS-CoV-2 infections (edit) |
10.1093/INFDIS/JIAA463 |
| 2020-07-29 |
Virucidal efficacy of different oral rinses against SARS-CoV-2 (edit) |
10.1093/INFDIS/JIAA471 |
| 2020-07-29 |
Epidemiology of SARS-CoV-2 Emergence Amidst Community-Acquired Respiratory Viruses (edit) |
10.1093/INFDIS/JIAA464 |
| 2020-07-29 |
Plasmodium falciparum infection may protect a population from SARS-CoV-2 infection (edit) |
10.1093/INFDIS/JIAA455 |
| 2020-07-29 |
Oral mucositis in a Sars-CoV-2 infected patient: secondary or truly associated condition? (edit) |
10.1111/ODI.13570 |
| 2020-07-29 |
SARS-CoV-2 receptorACE2 protein expression in serum is significantly associated with age (edit) |
10.1111/ALL.14522 |
| 2020-07-29 |
SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19 (edit) |
10.1038/S41586-020-2598-9 |
| 2020-07-29 |
A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity (edit) |
10.1038/S41586-020-2599-8 |
| 2020-07-29 |
Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity (edit) |
10.1038/S41586-020-2601-5 |
| 2020-07-29 |
Productivity of Young Experts in Hemostasis and Thrombosis before and during the SARS-CoV-2 Pandemic-A Special Issue (edit) |
10.1055/A-1081-6973 |
| 2020-07-29 |
SARS-CoV-2 specific serological pattern in healthcare workers of an Italian COVID-19 forefront hospital (edit) |
10.1186/S12890-020-01237-0 |
| 2020-07-29 |
SARS-CoV-2: characteristics and current advances in research (edit) |
10.1186/S12985-020-01369-Z |
| 2020-07-29 |
Performance characteristics of a high throughput automated transcription mediated amplification test for SARS-CoV-2 detection (edit) |
10.1128/JCM.01669-20 |
| 2020-07-29 |
Identification of an anti-SARS-CoV-2 receptor binding domain directed human monoclonal antibody from a naïve semi-synthetic library (edit) |
10.1074/JBC.AC120.014918 |
| 2020-07-29 |
Crystal structure of SARS-CoV-2 nsp10/nsp16 2'-O-methylase and its implication on antiviral drug design (edit) |
10.1038/S41392-020-00241-4 |
| 2020-07-29 |
Nanotechnology-based disinfectants and sensors for SARS-CoV-2 (edit) |
10.1038/S41565-020-0751-0 |
| 2020-07-29 |
Aerosol and surface contamination of SARS-CoV-2 observed in quarantine and isolation care (edit) |
10.1038/S41598-020-69286-3 |
| 2020-07-29 |
SARS-CoV-2 Orf9b suppresses type I interferon responses by targeting TOM70 (edit) |
10.1038/S41423-020-0514-8 |
| 2020-07-29 |
No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic (edit) |
10.1093/RHEUMATOLOGY/KEAA388 |
| 2020-07-29 |
SARS-CoV-2 and Guillain-Barré syndrome: molecular mimicry with human heat shock proteins as potential pathogenic mechanism (edit) |
10.1007/S12192-020-01145-6 |
| 2020-07-29 |
Molecular Insights into Small Molecule Drug Discovery for SARS-CoV-2 (edit) |
10.1002/ANIE.202008835 |
| 2020-07-29 |
Ocular COVID-19: Eyes as a reservoir to conceal and spread SARS-CoV-2 (edit) |
10.2174/1871526520999200729182242 |
| 2020-07-29 |
An enzyme-based immunodetection assay to quantify SARS-CoV-2 infection (edit) |
10.1016/J.ANTIVIRAL.2020.104882 |
| 2020-07-29 |
Proposal of Reverse Transcription-PCR-Based Mass Population Screening for SARS-CoV-2 (COVID-19) (edit) |
10.1016/J.JMOLDX.2020.07.001 |
| 2020-07-29 |
In silico Study of Azithromycin, Chloroquine and Hydroxychloroquine and their Potential Mechanisms of Action against SARS-CoV-2 Infection (edit) |
10.1016/J.IJANTIMICAG.2020.106119 |
| 2020-07-29 |
Computational guided drug repurposing for targeting 2'-O-ribose methyltransferase of SARS-CoV-2 (edit) |
10.1016/J.LFS.2020.118169 |
| 2020-07-29 |
Orientation of immobilized antigens on common surfaces by a simple computational model: Exposition of SARS-CoV-2 Spike protein RBD epitopes (edit) |
10.1016/J.BPC.2020.106441 |
| 2020-07-29 |
Newcastle Disease Virus as a Vaccine Vector for SARS-CoV-2 (edit) |
10.3390/PATHOGENS9080619 |
| 2020-07-29 |
A reverse-transcription recombinase-aided amplification assay for the rapid detection of N gene of severe acute respiratory syndrome coronavirus 2(SARS-CoV-2) (edit) |
10.1016/J.VIROL.2020.07.006 |
| 2020-07-29 |
DNA nanoscaffold-based SARS-CoV-2 detection for COVID-19 diagnosis (edit) |
10.1016/J.BIOS.2020.112479 |
| 2020-07-29 |
A vaccine for SARS-CoV-2: goals and promises (edit) |
10.1016/J.ECLINM.2020.100494 |
| 2020-07-29 |
Structural and functional analysis of female sex hormones against SARS-Cov2 cell entry (edit) |
10.1101/2020.07.29.227249 |
| 2020-07-29 |
Direct exposure to SARS-CoV-2 and cigarette smoke increases infection severity and alters the stem cell-derived airway repair response (edit) |
10.1101/2020.07.28.226092 |
| 2020-07-29 |
On the molecular mechanism of SARS-CoV-2 retention in the upper respiratory tract (edit) |
10.1101/2020.07.29.227389 |
| 2020-07-29 |
Baseline Cardiometabolic Profiles and SARS-CoV-2 Risk in the UK Biobank (edit) |
10.1101/2020.07.25.20161091 |
| 2020-07-29 |
High-throughput SARS-CoV-2 and host genome sequencing from single nasopharyngeal swabs (edit) |
10.1101/2020.07.27.20163147 |
| 2020-07-29 |
Does SARS-CoV-2 Bind to Human ACE2 Stronger Than SARS-CoV? (edit) |
10.1021/ACS.JPCB.0C04511 |
| 2020-07-29 |
Hospital indoor air quality monitoring for the detection of SARS-CoV-2 (COVID-19) virus (edit) |
10.1016/J.SCITOTENV.2020.141324 |
| 2020-07-29 |
Rettelse: Multiorgan inflammatorisk syndrom assosiert med sars-CoV-2 hos et barn (edit) |
10.4045/TIDSSKR.20.0576 |
| 2020-07-29 |
An optimal predictive control strategy for COVID-19 (SARS-CoV-2) social distancing policies in Brazil (edit) |
10.1016/J.ARCONTROL.2020.07.001 |
| 2020-07-28 |
Excessive G-U transversions in novel allele variants in SARS-CoV-2 genomes (edit) |
10.7717/PEERJ.9648 |
| 2020-07-28 |
Serial co-expression analysis of host factors from SARS-CoV viruses highly converges with former high-throughput screenings and proposes key regulators and co-option of cellular pathways (edit) |
10.1101/2020.07.28.225078 |
| 2020-07-28 |
A prospective cohort study in non-hospitalized household contacts with SARS-CoV-2 infection: symptom profiles and symptom change over time (edit) |
10.1093/CID/CIAA1072 |
| 2020-07-28 |
The impact of SARS-CoV-2 (COVID-19) pandemic on trauma bay management and guideline adherence in a European level-one-trauma centre (edit) |
10.1007/S00264-020-04740-5 |
| 2020-07-28 |
Letter Regarding "Fatal Eosinophilic Myocarditis in a Healthy 17-Year-Old Male with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)" (edit) |
10.1080/15513815.2020.1797253 |
| 2020-07-28 |
Investigating the binding affinity, interaction, and structure-activity-relationship of 76 prescription antiviral drugs targeting RdRp and Mpro of SARS-CoV-2 (edit) |
10.1080/07391102.2020.1796804 |
| 2020-07-28 |
Plant-derived natural polyphenols as potential antiviral drugs against SARS-CoV-2 via RNA-dependent RNA polymerase (RdRp) inhibition: an in-silico analysis (edit) |
10.1080/07391102.2020.1796810 |
| 2020-07-28 |
Identification of some novel oxazine substituted 9-anilinoacridines as SARS-CoV-2 inhibitors for COVID-19 by molecular docking, free energy calculation and molecular dynamics studies (edit) |
10.1080/07391102.2020.1798285 |
| 2020-07-28 |
Relationship Between serum SARS-CoV-2 nucleic acid(RNAemia) and Organ Damage in COVID-19 Patients: A Cohort Study (edit) |
10.1093/CID/CIAA1085 |
| 2020-07-28 |
High prevalence of SARS-CoV-2 and influenza A virus (H1N1) co-infection in dead patients in Northeastern Iran (edit) |
10.1002/JMV.26364 |
| 2020-07-28 |
Clinical validation of an immunochromatographic SARS-Cov-2 IgM/IgG antibody assay with Japanese cohort (edit) |
10.1002/JMV.26363 |
| 2020-07-28 |
A Computational Approach to Identify Potential Novel Inhibitors against the Coronavirus SARS-CoV-2 (edit) |
10.1002/MINF.202000090 |
| 2020-07-28 |
Identification of analytical issues in method verification of SARS CoV-2 serology (edit) |
10.1177/0004563220944973 |
| 2020-07-28 |
No evidence for vertical transmission of SARS-CoV-2 in two neonates with mothers infected in the second trimester (edit) |
10.1080/23744235.2020.1798499 |
| 2020-07-28 |
Estimation of SARS-CoV-2 mortality during the early stages of an epidemic: A modeling study in Hubei, China, and six regions in Europe (edit) |
10.1371/JOURNAL.PMED.1003189 |
| 2020-07-28 |
In silico Drug Repurposing for COVID-19: Targeting SARS-CoV-2 Proteins through Docking and Consensus Ranking (edit) |
10.1002/MINF.202000115 |
| 2020-07-28 |
Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates (edit) |
10.1056/NEJMOA2024671 |
| 2020-07-28 |
Universal screening for SARS-CoV-2 in pregnant women admitted for delivery: how to manage antibody testing? (edit) |
10.1080/14767058.2020.1793317 |
| 2020-07-28 |
Age, sex, and comorbidities predict ICU admission or mortality in cases with SARS-CoV2 infection: a population-based cohort study (edit) |
10.1186/S13054-020-03173-1 |
| 2020-07-28 |
Characterisation of the transcriptome and proteome of SARS-CoV-2 reveals a cell passage induced in-frame deletion of the furin-like cleavage site from the spike glycoprotein (edit) |
10.1186/S13073-020-00763-0 |
| 2020-07-28 |
Evaluation of K18-hACE2 Mice as a Model of SARS-CoV-2 Infection (edit) |
10.4269/AJTMH.20-0762 |
| 2020-07-28 |
Frequency and clinical correlates of antiphospholipid antibodies arising in patients with SARS-CoV-2 infection: findings from a multicentre study on 122 cases (edit) |
|
| 2020-07-28 |
Comparative Genomic Analysis of Rapidly Evolving SARS-CoV-2 Reveals Mosaic Pattern of Phylogeographical Distribution (edit) |
10.1128/MSYSTEMS.00505-20 |
| 2020-07-28 |
Haplotype networks of SARS-CoV-2 infections in the Diamond Princess cruise ship outbreak (edit) |
10.1073/PNAS.2006824117 |
| 2020-07-28 |
Molecular Psychiatry, August 2020: new impact factor, and highlights of recent advances in psychiatry, including an overview of the brain's response to stress during infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (edit) |
10.1038/S41380-020-0845-Y |
| 2020-07-28 |
Evolutionary origins of the SARS-CoV-2 sarbecovirus lineage responsible for the COVID-19 pandemic (edit) |
10.1038/S41564-020-0771-4 |
| 2020-07-28 |
Pharmacokinetics/Pharmacodynamics of Antiviral Agents Used to Treat SARS-CoV-2 and Their Potential Interaction with Drugs and Other Supportive Measures: A Comprehensive Review by the PK/PD of Anti-Infectives Study Group of the European Society of An (edit) |
10.1007/S40262-020-00924-9 |
| 2020-07-28 |
Absent immune response to SARS-CoV-2 in a 3-month recurrence of coronavirus disease 2019 (COVID-19) case (edit) |
10.1007/S15010-020-01485-6 |
| 2020-07-28 |
Co-infection of SARS-CoV-2 with Chlamydia or Mycoplasma pneumoniae: a case series and review of the literature (edit) |
10.1007/S15010-020-01483-8 |
| 2020-07-28 |
A Liaison between Sudden Sensorineural Hearing Loss and SARS-CoV-2 Infection (edit) |
10.1055/S-0040-1714370 |
| 2020-07-28 |
SARS-CoV-2 infection associated acute kidney injury in patients with pre-existing chronic renal disease: A report of two cases (edit) |
10.1002/IID3.333 |
| 2020-07-28 |
Bats and humans during the SARS-CoV-2 outbreak: the case of bat-coronavirus from Mexico (edit) |
10.1111/TBED.13751 |
| 2020-07-28 |
Structure-based drug repositioning over the human TMPRSS2 protease domain: search for chemical probes able to repress SARS-CoV-2 Spike protein cleavages (edit) |
10.1016/J.EJPS.2020.105495 |
| 2020-07-28 |
Computational Studies of SARS-CoV-2 3CLpro: Insights from MD Simulations (edit) |
10.3390/IJMS21155346 |
| 2020-07-28 |
Vaccine Design from the Ensemble of Surface Glycoprotein Epitopes of SARS-CoV-2: An Immunoinformatics Approach (edit) |
10.3390/VACCINES8030423 |
| 2020-07-28 |
Molecular profiling of immune cell-enriched Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) interacting protein USP13 (edit) |
10.1016/J.LFS.2020.118170 |
| 2020-07-28 |
Network perturbation analysis in human bronchial epithelial cells following SARS-CoV2 infection (edit) |
10.1016/J.YEXCR.2020.112204 |
| 2020-07-28 |
INCREASED RISK OF SARS-CoV-2 INFECTION IN STAFF WORKING ACROSS DIFFERENT CARE HOMES ENCHANCED CoVID-19 OUTBREAK INVESTIGATIONS IN LONDON CARE HOMES (edit) |
10.1016/J.JINF.2020.07.027 |
| 2020-07-28 |
Evaluating the newly developed BioFire® COVID-19 test for SARS-Cov-2 molecular detection (edit) |
10.1016/J.CMI.2020.07.026 |
| 2020-07-28 |
The MERS-CoV Receptor DPP4 as a Candidate Binding Target of the SARS-CoV-2 Spike (edit) |
10.1016/J.ISCI.2020.101400 |
| 2020-07-28 |
Human Pluripotent Stem Cell-Derived Neural Cells and Brain Organoids Reveal SARS-CoV-2 Neurotropism (edit) |
10.1101/2020.07.28.225151 |
| 2020-07-28 |
A Speedy Route to Multiple Highly Potent SARS-CoV-2 Main Protease Inhibitors (edit) |
10.1101/2020.07.28.223784 |
| 2020-07-28 |
First proof of the capability of wastewater surveillance for COVID-19 in India through detection of genetic material of SARS-CoV-2 (edit) |
10.1016/J.SCITOTENV.2020.141326 |
| 2020-07-28 |
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Associated with Rhabdomyolysis and Acute Kidney Injury (AKI) (edit) |
10.1016/J.AMJMS.2020.07.032 |
| 2020-07-28 |
Potential treatment methods targeting 2019-nCoV infection (edit) |
10.1016/J.EJMECH.2020.112687 |
| 2020-07-28 |
Two Cases of SARS-CoV-2 Infection in Pediatric Oncohematologic Patients in Spain (edit) |
10.1097/INF.0000000000002841 |
| 2020-07-28 |
Medically Attended Outpatient Coronavirus Infections in Ecuadorean Children During the 20 Months Preceding Countrywide Lockdown Related to the SARS-CoV-2 Pandemic of 2020 (edit) |
10.1097/INF.0000000000002840 |
| 2020-07-28 |
Dermatological Manifestations in Patients With SARS-CoV-2: A Systematic Review (edit) |
10.7759/CUREUS.9446 |
| 2020-07-28 |
Paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS): providing resuscitative care (edit) |
|
| 2020-07-28 |
Cross-reactions between rheumatoid factor and IgM SARS-CoV-2 (edit) |
10.1016/J.MEDCLI.2020.07.008 |
| 2020-07-28 |
Structural Basis for Helicase-Polymerase Coupling in the SARS-CoV-2 Replication-Transcription Complex (edit) |
10.1016/J.CELL.2020.07.033 |
| 2020-07-28 |
Computational Prediction of Mutational Effects on the SARS-CoV-2 Binding by Relative Free Energy Calculations (edit) |
10.1021/ACS.JCIM.0C00679 |
| 2020-07-28 |
Fulminant myocarditis and cardiogenic shock during SARS-CoV-2 infection (edit) |
10.1016/J.MEDCLI.2020.07.010 |
| 2020-07-28 |
Recommendations on the management of adult patients with rheumatic diseases in the context of SARS-CoV-2/COVID-19 infection. Colombian Association of Rheumatology (edit) |
10.1016/J.REUMA.2020.06.011 |
| 2020-07-28 |
COVID-19 and SARS-CoV-2. Modeling the present, looking at the future (edit) |
10.1016/J.PHYSREP.2020.07.005 |
| 2020-07-28 |
Analysis of the evolution of the Sars-Cov-2 in Italy, the role of the asymptomatics and the success of Logistic model (edit) |
10.1016/J.CHAOS.2020.110150 |
| 2020-07-28 |
[Treatment of Sars-Cov2 with hydroxychloroquine is ineffective and potentially harmful] (edit) |
10.1016/J.AMCP.2020.07.007 |
| 2020-07-28 |
The challenges of informative wastewater sampling for SARS-CoV-2 must be met: lessons from polio eradication (edit) |
10.1016/S2666-5247(20)30100-2 |
| 2020-07-28 |
Indication of glucocorticoid pulses for patients with SARS-CoV-2 infection (edit) |
10.1016/J.MEDCLI.2020.06.041 |
| 2020-07-28 |
Can Drinking Microfiltered Raw Immune Milk From Cows Immunized Against SARS-CoV-2 Provide Short-Term Protection Against COVID-19? (edit) |
10.3389/FIMMU.2020.01888 |
| 2020-07-28 |
Spironolactone: An Anti-androgenic and Anti-hypertensive Drug That May Provide Protection Against the Novel Coronavirus (SARS-CoV-2) Induced Acute Respiratory Distress Syndrome (ARDS) in COVID-19 (edit) |
10.3389/FMED.2020.00453 |
| 2020-07-28 |
Palmar rash for the new coronavirus SARS-CoV-2 (edit) |
10.1016/J.MEDCLI.2020.05.039 |
| 2020-07-28 |
Therapeutic attitudes towards multiple sclerosis in Central America and the Caribbean facing the SARS-CoV-2 pandemia (edit) |
10.1016/J.NRL.2020.07.009 |
| 2020-07-28 |
Standard headache and neuralgia treatments and SARS-CoV-2: opinion of the Spanish Society of Neurology's Headache Study Group (edit) |
10.1016/J.NRL.2020.07.007 |
| 2020-07-27 |
Epitope-based chimeric peptide vaccine design against S, M and E proteins of SARS-CoV-2, the etiologic agent of COVID-19 pandemic: an in silico approach (edit) |
10.7717/PEERJ.9572 |
| 2020-07-27 |
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Membrane (M) Protein Inhibits Type I and III Interferon Production by Targeting RIG-I/MDA-5 Signaling (edit) |
10.1101/2020.07.26.222026 |
| 2020-07-27 |
A-to-I RNA editing in SARS-COV-2: real or artifact? (edit) |
10.1101/2020.07.27.223172 |
| 2020-07-27 |
COVID-19 Patients Form Memory CD8+ T Cells that Recognize a Small Set of Shared Immunodominant Epitopes in SARS-CoV-2 (edit) |
10.1101/2020.07.24.20161653 |
| 2020-07-27 |
Ozone: A Potential Oxidant for COVID-19 Virus (SARS-CoV-2) (edit) |
10.1080/01919512.2020.1795614 |
| 2020-07-27 |
Potential role of medicinal plants and their constituents in the mitigation of SARS-CoV-2: identifying related therapeutic targets using network pharmacology and molecular docking analyses (edit) |
10.1039/D0RA05126H |
| 2020-07-27 |
Stranger months: how SARS-CoV-2, fear of contagion, and lockdown measures impacted attendance and clinical activity during February and March 2020 at an urban Emergency Department in Milan (edit) |
10.1017/DMP.2020.265 |
| 2020-07-27 |
SARS-CoV-2 viral and serological testing when college campuses reopen - some practical considerations (edit) |
10.1017/DMP.2020.266 |
| 2020-07-27 |
Facing the SARS-Cov-2 outbreak: What should Obstetricians and Gynecologists need to do? (edit) |
10.1017/DMP.2020.263 |
| 2020-07-27 |
SARS-CoV-2 Whole Genome Amplification and Sequencing for Effective Population-Based Surveillance and Control of Viral Transmission (edit) |
10.1093/CLINCHEM/HVAA187 |
| 2020-07-27 |
National Institutes of Health social and behavioral research in response to the SARS-CoV2 Pandemic (edit) |
10.1093/TBM/IBAA075 |
| 2020-07-27 |
Response to Comment on "Genetic Variants and Source of Introduction of SARS-CoV-2 in South America" (edit) |
10.1002/JMV.26359 |
| 2020-07-27 |
SARS-CoV-2 in rural Latin America. A population-based study in coastal Ecuador (edit) |
10.1093/CID/CIAA1055 |
| 2020-07-27 |
Diagnosing SARS-CoV-2 Related Multisystem Inflammatory Syndrome in Children (MIS-C): Focus on the Gastrointestinal Tract and the Myocardium (edit) |
10.1093/CID/CIAA1080 |
| 2020-07-27 |
Head-to-Head Comparison of Two SARS-CoV-2 Serology Assays (edit) |
10.1093/JALM/JFAA125 |
| 2020-07-27 |
Evaluation of an electrochemiluminescent SARS-CoV-2 antibody assay (edit) |
10.1093/JALM/JFAA134 |
| 2020-07-27 |
SARS-CoV2 OMT: A Relative Contraindication to Thoracic Pump Technique and an Additional Indication for the Elderly (edit) |
10.7556/JAOA.2020.093 |
| 2020-07-27 |
Peptidyl Acyloxymethyl Ketones as Activity-Based Probes for the Main Protease of SARS-CoV-2 (edit) |
10.1002/CBIC.202000371 |
| 2020-07-27 |
In Silico Identification of a Potent Arsenic Based Approved Drug Darinaparsin against SARS-CoV-2: Inhibitor of RNA Dependent RNA polymerase (RdRp) and Essential Proteases (edit) |
10.2174/1871526520666200727153643 |
| 2020-07-27 |
Posterior reversible encephalopathy syndrome associated with SARS-CoV-2 infection (edit) |
10.1136/JNNP-2020-323923 |
| 2020-07-27 |
A colorimetric RT-LAMP assay and LAMP-sequencing for detecting SARS-CoV-2 RNA in clinical samples (edit) |
10.1126/SCITRANSLMED.ABC7075 |
| 2020-07-27 |
Predictive model of increased mortality and bed occupancy if thrombolysis becomes the initial treatment strategy for STEMI during the SARS-CoV-2 pandemic (edit) |
10.7861/CLINMED.2020-0293 |
| 2020-07-27 |
Sacubitril, valsartan and SARS-CoV-2 (edit) |
10.1136/BMJEBM-2020-111497 |
| 2020-07-27 |
Identification of key interactions between SARS-CoV-2 main protease and inhibitor drug candidates (edit) |
10.1038/S41598-020-69337-9 |
| 2020-07-27 |
Sampling the host response to SARS-CoV-2 in hospitals under siege (edit) |
10.1038/S41591-020-1004-3 |
| 2020-07-27 |
Assessing the extent of SARS-CoV-2 circulation through serological studies (edit) |
10.1038/S41591-020-1018-X |
| 2020-07-27 |
Effortful speech with distortion of prosody following SARS-CoV-2 infection (edit) |
10.1007/S10072-020-04603-2 |
| 2020-07-27 |
[Recommendations of the German Ophthalmological Society (DOG), the Professional Association of German Ophthalmologists (BVA) and the German Association of Ophthalmic Surgeons (BDOC) for elective eye surgery during the SARS-CoV-2 pandemic : Situation (edit) |
10.1007/S00347-020-01193-4 |
| 2020-07-27 |
Acute abdomen in patients with SARS-CoV-2 infection or co-infection (edit) |
10.1007/S00423-020-01948-2 |
| 2020-07-27 |
Patients' and healthcare personnel expectations for SARS-CoV-2 screening in dialysis unit during the Covid-19 pandemic (edit) |
10.1007/S40620-020-00811-3 |
| 2020-07-27 |
Dynamic Changes of Antibodies to SARS-CoV-2 in COVID-19 Patients at Early Stage of Outbreak (edit) |
10.1007/S12250-020-00268-5 |
| 2020-07-27 |
Estimating the risk of SARS-CoV-2 transmission to pediatric anesthesiologists: a microsimulation model (edit) |
10.1007/S12630-020-01771-9 |
| 2020-07-27 |
Preliminary results of SARS-CoV-2 detection in sewerage system in Niterói municipality, Rio de Janeiro, Brazil (edit) |
10.1590/0074-02760200196 |
| 2020-07-27 |
Association of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases (edit) |
10.1001/JAMACARDIO.2020.3551 |
| 2020-07-27 |
When is SARS-CoV-2 in your shopping list? (edit) |
10.1016/J.MBS.2020.108434 |
| 2020-07-27 |
Air and surface contamination by SARS-CoV-2 virus in a tertiary hospital in Wuhan, China (edit) |
10.1016/J.IJID.2020.07.027 |
| 2020-07-27 |
Diagnosing myasthenic crisis in SARS-CoV-2 infected patients requires adherence to appropriate criteria (edit) |
10.1016/J.JNS.2020.117062 |
| 2020-07-27 |
Associations of viral ribonucleic acid (RNA) shedding patterns with clinical illness and immune responses in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection (edit) |
10.1002/CTI2.1160 |
| 2020-07-27 |
Epitope-resolved profiling of the SARS-CoV-2 antibody response identifies cross-reactivity with an endemic human CoV (edit) |
10.1101/2020.07.27.222943 |
| 2020-07-27 |
An alternative binding mode of IGHV3-53 antibodies to the SARS-CoV-2 receptor binding domain (edit) |
10.1101/2020.07.26.222232 |
| 2020-07-27 |
Progenitor identification and SARS-CoV-2 infection in long-term human distal lung organoid cultures (edit) |
10.1101/2020.07.27.212076 |
| 2020-07-27 |
Implications for air quality management of changes in air quality during lockdown in Auckland (New Zealand) in response to the 2020 SARS-CoV-2 epidemic (edit) |
10.1016/J.SCITOTENV.2020.141129 |
| 2020-07-27 |
Oligonucleotide capture sequencing of the SARS-CoV-2 genome and subgenomic fragments from COVID-19 individuals (edit) |
10.1101/2020.07.27.223495 |
| 2020-07-27 |
Structure and inhibition of the SARS-CoV-2 main protease reveals strategy for developing dual inhibitors against Mpro and cathepsin L (edit) |
10.1101/2020.07.27.223727 |
| 2020-07-27 |
Massive-scale biological activity-based modeling identifies novel antiviral leads against SARS-CoV-2 (edit) |
10.1101/2020.07.27.223578 |
| 2020-07-27 |
Use of oral antiseptics for SARS-CoV-2 infection (edit) |
10.1016/J.MEDCLI.2020.07.014 |
| 2020-07-27 |
Homo sapiens versus SARS-CoV-2 (edit) |
10.1021/ACSCHEMNEURO.0C00436 |
| 2020-07-27 |
Studying the Effects of ACE2 Mutations on Stability, Dynamics and Dissociation Process of SARS-CoV-2 S1/hACE2 Complexes (edit) |
10.1021/ACS.JPROTEOME.0C00348 |
| 2020-07-27 |
Safe administration of corticosteroids in severe ulcerative colitis and active SARS-CoV2 infection (edit) |
10.1016/J.DLD.2020.07.022 |
| 2020-07-27 |
Sewage analysis as a tool for the COVID-19 pandemic response and management: the urgent need for optimised protocols for SARS-CoV-2 detection and quantification (edit) |
10.1016/J.JECE.2020.104306 |
| 2020-07-27 |
Animal Models to Study Emerging Technologies Against SARS-CoV-2 (edit) |
10.1007/S12195-020-00638-9 |
| 2020-07-27 |
Functional Pangenome Analysis Shows Key Features of E Protein Are Preserved in SARS and SARS-CoV-2 (edit) |
10.3389/FCIMB.2020.00405 |
| 2020-07-26 |
COVID-19 induces a hyperactive phenotype in circulating platelets (edit) |
10.1101/2020.07.24.20156240 |
| 2020-07-26 |
No evidence for basigin/CD147 as a direct SARS-CoV-2 spike binding receptor (edit) |
10.1101/2020.07.25.221036 |
| 2020-07-26 |
Allograft infiltration and meningoencephalitis by SARS-CoV-2 in a pancreas-kidney transplant recipient (edit) |
10.1111/AJT.16223 |
| 2020-07-26 |
Prolonged shedding of SARS-CoV-2 in COVID-19 infected hemodialysis patients (edit) |
10.1111/1744-9987.13566 |
| 2020-07-26 |
Perinatal transmission with SARS-CoV-2 and route of pregnancy termination: a narrative review (edit) |
10.1080/14767058.2020.1788533 |
| 2020-07-26 |
In Silico Insights into the SARS CoV-2 Main Protease Suggest NADH Endogenous Defences in the Control of the Pandemic Coronavirus Infection (edit) |
10.3390/V12080805 |
| 2020-07-26 |
SARS-CoV-2 RNA Persistence in Naso-Pharyngeal Swabs (edit) |
10.3390/MICROORGANISMS8081124 |
| 2020-07-26 |
Acute Onset Olfactory/Taste Disorders are Associated with a High Viral Burden in Mild or Asymptomatic SARS-CoV-2 Infections (edit) |
10.1016/J.IJID.2020.07.034 |
| 2020-07-26 |
Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as vaccine candidate (edit) |
10.1101/2020.07.26.221861 |
| 2020-07-26 |
The SARS-CoV-2 Spike Variant D614G Favors an Open Conformational State (edit) |
10.1101/2020.07.26.219741 |
| 2020-07-26 |
CoVaccine HT™ adjuvant potentiates robust immune responses to recombinant SARS-CoV-2 Spike S1 immunisation (edit) |
10.1101/2020.07.24.220715 |
| 2020-07-26 |
Dysregulated transcriptional responses to SARS-CoV-2 in the periphery support novel diagnostic approaches (edit) |
10.1101/2020.07.20.20155507 |
| 2020-07-26 |
Dataset for homologous proteins in Drosophila melanogaster for SARS-CoV-2/human interactome (edit) |
10.1016/J.DIB.2020.106082 |
| 2020-07-25 |
SARS-CoV-2 and SARS-CoV spike-mediated cell-cell fusion differ in the requirements for receptor expression and proteolytic activation (edit) |
10.1101/2020.07.25.221135 |
| 2020-07-25 |
COVID-19 as a Conscious Organism: A Novel Understanding of the SARS-CoV-2 as a Natural Evolution of the SARS Virus (edit) |
10.37506/IJPHRD.V11I7.10069 |
| 2020-07-25 |
False negative RT-PCR or false positive serological testing in SARS-CoV-2 diagnostics? Navigating between Scylla and Charybdis to prevent misclassification bias in COVID-19 clinical investigations (edit) |
10.1515/DX-2020-0091 |
| 2020-07-25 |
Specimens Received as a Critical Indicator for Blood Bank Preparedness in the SARS-CoV-2 Era (edit) |
10.1093/AJCP/AQAA129 |
| 2020-07-25 |
Impact of SARS-CoV-2 on elective surgical volume in Tuscany: effects on local planning and resource prioritization (edit) |
10.1002/BJS.11832 |
| 2020-07-25 |
Endomyocardial biopsy findings in Kawasaki-like disease associated with SARS-CoV-2 (edit) |
10.1093/EURHEARTJ/EHAA588 |
| 2020-07-25 |
Multi-Inflammatory Syndrome in Children related to SARS-CoV-2 in Spain (edit) |
10.1093/CID/CIAA1042 |
| 2020-07-25 |
Serial Interval Distribution of SARS-CoV-2 Infection in Brazil (edit) |
10.1093/JTM/TAAA115 |
| 2020-07-25 |
Antibody responses to SARS-CoV-2 in healthy individuals returning to Shenzhen (edit) |
10.1002/JMV.26355 |
| 2020-07-25 |
Validation and Performance Comparison of Three SARS-CoV-2 Antibody Assays (edit) |
10.1002/JMV.26341 |
| 2020-07-25 |
Neuralgic amyotrophy following infection with SARS-CoV-2 (edit) |
10.1002/MUS.27035 |
| 2020-07-25 |
Insight into the Pediatric and Adult Dichotomy of COVID-19: Age-Related Differences in the Immune Response to SARS-CoV-2 infection (edit) |
10.1002/PPUL.24981 |
| 2020-07-25 |
A 65-Year-Old Woman with a History of Type 2 Diabetes Mellitus and Hypertension and a 15-Day History of Dry Cough and Fever Who Presented with Acute Renal Failure Due to Infection with SARS-Cov-2 (edit) |
10.12659/AJCR.926737 |
| 2020-07-25 |
Systematic SARS-CoV-2 screening at hospital admission in children:a French prospective multicenter study (edit) |
10.1093/CID/CIAA1044 |
| 2020-07-25 |
Post-pandemic testing of SARS-CoV-2 in Huanan Seafood Market area in Wuhan, China (edit) |
10.1093/CID/CIAA1043 |
| 2020-07-25 |
Comment on "Stroke in patients with SARS‑CoV‑2 infection: case series" from a London hospital experience (edit) |
10.1007/S00415-020-10105-0 |
| 2020-07-25 |
Understanding COVID-19 via comparative analysis of dark proteomes of SARS-CoV-2, human SARS and bat SARS-like coronaviruses (edit) |
10.1007/S00018-020-03603-X |
| 2020-07-25 |
What the physicians should know about mast cells, dendritic cells, urticaria and omalizumab during COVID-19 or asymptomatic infections due to SARS-CoV-2? (edit) |
10.1111/DTH.14068 |
| 2020-07-25 |
Virtual screening, ADMET prediction and dynamics simulation of potential compounds targeting the main protease of SARS-CoV-2 (edit) |
10.1080/07391102.2020.1796812 |
| 2020-07-25 |
Immunological detection of serum antibodies in pediatric medical workers exposed to varying levels of SARS-CoV-2 (edit) |
10.1016/J.JINF.2020.07.023 |
| 2020-07-25 |
Isolation and phylogenetic analysis of SARS-CoV-2 variants collected in Russia during COVID-19 outbreak (edit) |
10.1016/J.IJID.2020.07.024 |
| 2020-07-25 |
A Message from the Human Placenta: Structural and Immunomodulatory Defense against SARS-CoV-2 (edit) |
10.3390/CELLS9081777 |
| 2020-07-25 |
Nasopharyngeal Microbiota Profiling of SARS-CoV-2 Infected Patients (edit) |
10.1186/S12575-020-00131-7 |
| 2020-07-25 |
COVID-19 Serology in Oncology Staff Study: Understanding SARS-CoV-2 in the Oncology Workforce (edit) |
10.1016/J.CLON.2020.07.015 |
| 2020-07-25 |
Rapid generation of circulating and mucosal decoy ACE2 using mRNA nanotherapeutics for the potential treatment of SARS-CoV-2 (edit) |
10.1101/2020.07.24.205583 |
| 2020-07-25 |
High incidence of false-positive results of IgG antibody against SARS-CoV-2 with rapid immunochromatographic antibody test due to human common cold coronavirus infection (edit) |
10.1016/J.RMCR.2020.101180 |
| 2020-07-25 |
SARS-CoV-2-associated Takotsubo is not necessarily triggered by the infection (edit) |
10.1016/J.IJCHA.2020.100606 |
| 2020-07-25 |
Could the antipsychotic chlorpromazine be a potential treatment for SARS-CoV-2? (edit) |
10.1016/J.SCHRES.2020.07.015 |
| 2020-07-25 |
Can SARS-CoV-2 be a Risk Factor for Pulmonary Aspergillosis? (edit) |
10.1016/J.ARBRES.2020.06.028 |
| 2020-07-25 |
SARS-CoV2 induced pulmonary embolism and complications from anticoagulation (edit) |
10.1016/J.RMCR.2020.101176 |
| 2020-07-24 |
A Multi-Pronged Approach Targeting SARS-CoV-2 Proteins Using Ultra-Large Virtual Screening (edit) |
10.26434/CHEMRXIV.12682316 |
| 2020-07-24 |
SARS-CoV-2 ORF8 and SARS-CoV ORF8ab: Genomic Divergence and Functional Convergence (edit) |
10.20944/PREPRINTS202007.0587.V1 |
| 2020-07-24 |
Identification, Mapping and Relative Quantitation of SARS-CoV-2 Spike Glycopeptides by Mass-Retention Time Fingerprinting (edit) |
10.1101/2020.07.24.217562 |
| 2020-07-24 |
Population Point Prevalence of SARS-CoV-2 Infection Based on a Statewide Random Sample - Indiana, April 25-29, 2020 (edit) |
10.15585/MMWR.MM6929E1 |
| 2020-07-24 |
Estimated Community Seroprevalence of SARS-CoV-2 Antibodies - Two Georgia Counties, April 28-May 3, 2020 (edit) |
10.15585/MMWR.MM6929E2 |
| 2020-07-24 |
Computational drug repurposing for the identification of SARS-CoV-2 main protease inhibitors (edit) |
10.1080/07391102.2020.1796805 |
| 2020-07-24 |
Identification of a potential SARS-CoV2 inhibitor via molecular dynamics simulations and amino acid decomposition analysis (edit) |
10.1080/07391102.2020.1797536 |
| 2020-07-24 |
Molecular docking and dynamics study of natural compound for potential inhibition of main protease of SARS-CoV-2 (edit) |
10.1080/07391102.2020.1796808 |
| 2020-07-24 |
Cytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis (edit) |
10.1172/JCI.INSIGHT.140289 |
| 2020-07-24 |
Detection profile of SARS-CoV-2 using RT-PCR in different types of clinical specimens: a systematic review and meta-analysis (edit) |
10.1002/JMV.26349 |
| 2020-07-24 |
SARS-Cov-2 infection causes pulmonary shunt by vasodilatation (edit) |
10.1002/JMV.26342 |
| 2020-07-24 |
SARS-CoV-2 infection in persons living with HIV: a single center prospective cohort (edit) |
10.1002/JMV.26352 |
| 2020-07-24 |
SARS-CoV-2 Causes Kawasaki like Disease in children; Cases reported in Pakistan (edit) |
10.1002/JMV.26340 |
| 2020-07-24 |
Characteristics and roles of SARS-CoV-2 specific antibodies in patients with different severities of COVID-19 (edit) |
10.1111/CEI.13500 |
| 2020-07-24 |
Qualitative assessment of SARS-CoV-2-specific antibody avidity by lateral flow immunochromatographic IgG/IgM antibody assay (edit) |
10.1002/JMV.26344 |
| 2020-07-24 |
aThe dynamic changes of serum IgM and IgG against SARS-CoV-2 in patients with COVID-19 (edit) |
10.1002/JMV.26353 |
| 2020-07-24 |
In silico identification of potential inhibitors of key SARS-CoV-2 3CL hydrolase (Mpro) via molecular docking, MMGBSA predictive binding energy calculations, and molecular dynamics simulation (edit) |
10.1371/JOURNAL.PONE.0235030 |
| 2020-07-24 |
Quantitative lung lesion features and temporal changes on chest CT in patients with common and severe SARS-CoV-2 pneumonia (edit) |
10.1371/JOURNAL.PONE.0236858 |
| 2020-07-24 |
Detection of SARS-CoV-2 RNA by direct RT-qPCR on nasopharyngeal specimens without extraction of viral RNA (edit) |
10.1371/JOURNAL.PONE.0236564 |
| 2020-07-24 |
Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing (edit) |
10.1038/S41586-020-2577-1 |
| 2020-07-24 |
Autoimmune encephalitis concomitant with SARS-CoV-2 infection: insight from 18F-FDG PET imaging and neuronal autoantibodies (edit) |
10.2967/JNUMED.120.249292 |
| 2020-07-24 |
Structural basis of RNA cap modification by SARS-CoV-2 (edit) |
10.1038/S41467-020-17496-8 |
| 2020-07-24 |
Structural analysis of the SARS-CoV-2 methyltransferase complex involved in RNA cap creation bound to sinefungin (edit) |
10.1038/S41467-020-17495-9 |
| 2020-07-24 |
Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversion (edit) |
10.1038/S41467-020-17703-6 |
| 2020-07-24 |
New view on older adults with COVID-19: comments on "SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes" (edit) |
10.1007/S11357-020-00232-X |
| 2020-07-24 |
Preliminary Analysis of B- and T-Cell Responses to SARS-CoV-2 (edit) |
10.1007/S40291-020-00486-3 |
| 2020-07-24 |
Sulfated polysaccharides effectively inhibit SARS-CoV-2 in vitro (edit) |
10.1038/S41421-020-00192-8 |
| 2020-07-24 |
Point-of-care serological assays for delayed SARS-CoV-2 case identification among health-care workers in the UK: a prospective multicentre cohort study (edit) |
10.1016/S2213-2600(20)30315-5 |
| 2020-07-24 |
Genomics approaches to synthesis plant-based biomolecules for therapeutic applications to combat SARS-CoV-2 (edit) |
10.1016/J.YGENO.2020.07.033 |
| 2020-07-24 |
Identification of high-affinity inhibitors of SARS-CoV-2 main protease: Towards the development of effective COVID-19 therapy (edit) |
10.1016/J.VIRUSRES.2020.198102 |
| 2020-07-24 |
Evolution of viral quasispecies during SARS-CoV-2 infection (edit) |
10.1016/J.CMI.2020.07.032 |
| 2020-07-24 |
Flavonoids Activation of the Transcription Factor Nrf2 as a Hypothesis Approach for the Prevention and Modulation of SARS-CoV-2 Infection Severity (edit) |
10.3390/ANTIOX9080659 |
| 2020-07-24 |
Molecular Tracing of SARS-CoV-2 in Italy in the First Three Months of the Epidemic (edit) |
10.3390/V12080798 |
| 2020-07-24 |
SARS-CoV-2 and human reproduction: An open question (edit) |
10.1016/J.ECLINM.2020.100473 |
| 2020-07-24 |
The Anatomy of SARS-CoV-2 BioMedical Literature: Introducing the CovidX Network Algorithm for Drug Repurposing Recommendation (edit) |
10.2196/21169 |
| 2020-07-24 |
Immuno-informatics approach for multi-epitope vaccine designing against SARS-CoV-2 (edit) |
10.1101/2020.07.23.218529 |
| 2020-07-24 |
Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 Receptor (edit) |
10.1101/2020.06.25.172403 |
| 2020-07-24 |
Elucidation of cryptic and allosteric pockets within the SARS-CoV-2 protease (edit) |
10.1101/2020.07.23.218784 |
| 2020-07-24 |
High variation expected in the pace and burden of SARS-CoV-2 outbreaks across sub-Saharan Africa (edit) |
10.1101/2020.07.23.20161208 |
| 2020-07-24 |
Clinical Impact, Costs, and Cost-Effectiveness of Expanded SARS-CoV-2 Testing in Massachusetts (edit) |
10.1101/2020.07.23.20160820 |
| 2020-07-24 |
Time to SARS-CoV-2 Clearance Among Patients with Cancer and COVID-19 (edit) |
10.1101/2020.07.23.20161000 |
| 2020-07-24 |
On the effect of age on the transmission of SARS-CoV-2 in households, schools and the community (edit) |
10.1101/2020.07.19.20157362 |
| 2020-07-24 |
Polyacylated anthocyanins constructively network with catalytic dyad residues of 3CLpro of 2019-nCoV than monomeric anthocyanins: A structural-relationship activity study with 10 anthocyanins using in-silico approaches (edit) |
10.1016/J.JMGM.2020.107690 |
| 2020-07-24 |
A Carbohydrate-Binding Protein from the Edible Lablab Beans Effectively Blocks the Infections of Influenza Viruses and SARS-CoV-2 (edit) |
10.1016/J.CELREP.2020.108016 |
| 2020-07-24 |
Observations on healthcare workers & SARS-CoV-2 infection (edit) |
10.4103/IJMR.IJMR_2564_20 |
| 2020-07-24 |
University Lecturers and Students Could Help in Community Education About SARS-CoV-2 Infection in Uganda (edit) |
10.1177/1178632920944167 |
| 2020-07-24 |
Clinical characteristics, prognostic factors, and maternal and neonatal outcomes of SARS-CoV-2 infection among hospitalized pregnant women: a systematic review (edit) |
10.1002/IJGO.13329 |
| 2020-07-24 |
Potential Role of Peptide-Based Antiviral Therapy Against SARS-CoV-2 Infection (edit) |
10.1021/ACSPTSCI.0C00081 |
| 2020-07-24 |
Global Psychological Implications of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease-2019 (COVID-19). What Can Be Learned From Italy. Reflections, Perspectives, Opportunities (edit) |
10.3389/FPSYG.2020.01836 |
| 2020-07-24 |
Skin manifestations associated with the new coronavirus SARS-CoV-2 disease (edit) |
10.1016/J.MEDCLI.2020.04.057 |
| 2020-07-24 |
Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia (edit) |
10.1126/SCIADV.ABC5801 |
| 2020-07-23 |
From people to Panthera: Natural SARS-CoV-2 infection in tigers and lions at the Bronx Zoo (edit) |
10.1101/2020.07.22.213959 |
| 2020-07-23 |
The Role of Antibody Testing for SARS-CoV-2: Is There One? (edit) |
10.1128/JCM.00797-20 |
| 2020-07-23 |
Understanding, verifying and implementing Emergency Use Authorization molecular diagnostics for the detection of SARS-CoV-2 RNA (edit) |
10.1128/JCM.00796-20 |
| 2020-07-23 |
Comparative pathogenesis of bovine and porcine respiratory coronaviruses in the animal host species and SARS-CoV-2 in humans (edit) |
10.1128/JCM.01355-20 |
| 2020-07-23 |
Perinatal management of SARS-CoV-2 infection in a level III University Hospital (edit) |
10.1080/14767058.2020.1786526 |
| 2020-07-23 |
The Role of Multidisciplinary Infection Prevention Teams in Identifying Community Transmission of SARS-CoV-2 in the United States (edit) |
10.1017/ICE.2020.360 |
| 2020-07-23 |
SARS-CoV-2 screening of asymptomatic healthcare workers (edit) |
10.1017/ICE.2020.361 |
| 2020-07-23 |
Universal Screening for the SARS-CoV-2 virus on Hospital Admission in an area with low COVID-19 Prevalence (edit) |
10.1017/ICE.2020.358 |
| 2020-07-23 |
Size-dependent filtration efficiencies of face masks and respirators for removing SARS-CoV-2-laden aerosols (edit) |
10.1017/ICE.2020.366 |
| 2020-07-23 |
[Impact of SARS-CoV-2 (Covid-19) on the mental health of healthcare professionals: a systematic review.] (edit) |
|
| 2020-07-23 |
Screening testing for SARS-CoV-2 upon admission to rehabilitation hospitals in a high COVID-19 prevalence community (edit) |
10.1002/PMRJ.12454 |
| 2020-07-23 |
Targeting SARS-CoV-2 RBD interface: a supervised computational data-driven approach to identify potential modulators (edit) |
10.1002/CMDC.202000259 |
| 2020-07-23 |
SARS-CoV-2 Virus Isolated From the Mastoid and Middle Ear: Implications for COVID-19 Precautions During Ear Surgery (edit) |
10.1001/JAMAOTO.2020.1922 |
| 2020-07-23 |
News Flash!-SARS-CoV-2 Isolated From the Middle Ear and Mastoid (edit) |
10.1001/JAMAOTO.2020.2067 |
| 2020-07-23 |
Geolocated Twitter social media data to describe the geographic spread of SARS-CoV-2 (edit) |
10.1093/JTM/TAAA120 |
| 2020-07-23 |
Emergence of European and North American mutant variants of SARS-CoV-2 in Southeast Asia (edit) |
10.1111/TBED.13748 |
| 2020-07-23 |
Influence of Immunosuppression on Seroconversion Against SARS-Cov-2 in Two Kidney Transplant Recipients (edit) |
10.1111/TID.13423 |
| 2020-07-23 |
COVID-19-like symptoms observed in Chinese tree shrews infected with SARS-CoV-2 (edit) |
10.24272/J.ISSN.2095-8137.2020.053 |
| 2020-07-23 |
Update Alert 2: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults (edit) |
10.7326/L20-0969 |
| 2020-07-23 |
Distinct clinical and immunological features of SARS-COV-2-induced multisystem inflammatory syndrome in children (edit) |
10.1172/JCI141113 |
| 2020-07-23 |
COVID-19 - Recent advancements in identifying novel vaccine candidates and current status of upcoming SARS-CoV-2 vaccines (edit) |
10.1080/21645515.2020.1788310 |
| 2020-07-23 |
ABO blood groups are not associated with risk of acquiring the SARS-CoV-2 infection in young adults (edit) |
10.3324/HAEMATOL.2020.265066 |
| 2020-07-23 |
Saliva sampling and its direct lysis, an excellent option to increase the number of SARS CoV2 diagnostic tests in settings with supply shortages (edit) |
10.1128/JCM.01659-20 |
| 2020-07-23 |
TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells (edit) |
10.26508/LSA.202000786 |
| 2020-07-23 |
High-flow nasal cannula oxygen therapy to treat patients with hypoxemic acute respiratory failure consequent to SARS-CoV-2 infection (edit) |
10.1136/THORAXJNL-2020-214993 |
| 2020-07-23 |
My Experience with SARS-CoV-2, with a Focus on Testing (edit) |
10.1128/JCM.01228-20 |
| 2020-07-23 |
The First Quarter of SARS-CoV-2 Testing: the University of Washington Medicine Experience (edit) |
10.1128/JCM.01416-20 |
| 2020-07-23 |
Structure-based design of prefusion-stabilized SARS-CoV-2 spikes (edit) |
10.1126/SCIENCE.ABD0826 |
| 2020-07-23 |
Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody (edit) |
10.1126/SCIENCE.ABC5881 |
| 2020-07-23 |
Evolution and epidemic spread of SARS-CoV-2 in Brazil (edit) |
10.1126/SCIENCE.ABD2161 |
| 2020-07-23 |
Human SARS-CoV-2 has evolved to reduce CG dinucleotide in its open reading frames (edit) |
10.1038/S41598-020-69342-Y |
| 2020-07-23 |
A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2-spike protein-protein interaction (edit) |
10.1038/S41587-020-0631-Z |
| 2020-07-23 |
SARS-CoV-2 post-infective myocarditis: the tip of COVID-19 immune complications? (edit) |
10.1186/S13613-020-00717-0 |
| 2020-07-23 |
Serologic Response to SARS-CoV-2 in COVID-19 Patients with Different Severity (edit) |
10.1007/S12250-020-00270-X |
| 2020-07-23 |
High doses of hydroxychloroquine do not affect viral clearance in patients with SARS-CoV-2 infection (edit) |
10.1111/ECI.13358 |
| 2020-07-23 |
American College of Rheumatology Clinical Guidance for Pediatric Patients with Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2 and Hyperinflammation in COVID-19. Version 1 (edit) |
10.1002/ART.41454 |
| 2020-07-23 |
Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19 (edit) |
10.1056/NEJMX200017 |
| 2020-07-23 |
Letter in Response to 'Modelling SARS-COV2 Spread in London: Approaches to Lift the Lockdown' Local Experience, National Questions. How Local is Local Enough? (edit) |
10.1016/J.JINF.2020.07.020 |
| 2020-07-23 |
Decoding the proteome of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for cell-penetrating peptides involved in pathogenesis or applicable as drug delivery vectors (edit) |
10.1016/J.MEEGID.2020.104474 |
| 2020-07-23 |
ENCEPHALOPATHY IN SEVERE SARS-CoV2 INFECTION: INFLAMMATORY OR INFECTIOUS? (edit) |
10.1016/J.IJID.2020.07.020 |
| 2020-07-23 |
Immunogenic SARS-CoV-2 Epitopes: In Silico Study Towards Better Understanding of COVID-19 Disease-Paving the Way for Vaccine Development (edit) |
10.3390/VACCINES8030408 |
| 2020-07-23 |
Computationally Optimized SARS-CoV-2 MHC Class I and II Vaccine Formulations Predicted to Target Human Haplotype Distributions (edit) |
10.1016/J.CELS.2020.06.009 |
| 2020-07-23 |
Low-cost devices to prevent SARS-CoV-2 infection during open and laparoscopic surgery (edit) |
10.1016/J.AMJSURG.2020.07.014 |
| 2020-07-23 |
Single-dose intranasal vaccination elicits systemic and mucosal immunity against SARS-CoV-2 (edit) |
10.1101/2020.07.23.212357 |
| 2020-07-23 |
Evidence of exposure to SARS-CoV-2 in cats and dogs from households in Italy (edit) |
10.1101/2020.07.21.214346 |
| 2020-07-23 |
Impact of SARS-CoV-2 pandemic on pulmonary hypertension out-patient clinics in Germany: a multi-centre study (edit) |
10.1177/2045894020941682 |
| 2020-07-23 |
SARS-CoV-2 RNA Dependent RNA polymerase (RdRp) - A drug repurposing study (edit) |
10.1016/J.HELIYON.2020.E04502 |
| 2020-07-23 |
Age-induced NLRP3 Inflammasome Over-activation Increases Lethality of SARS-CoV-2 Pneumonia in Elderly Patients (edit) |
10.14336/AD.2020.0601 |
| 2020-07-23 |
Use of HEPA filters to reduce the risk of nosocomial spread of SARS-CoV-2 via operating theatre ventilation systems (edit) |
10.1016/J.BJA.2020.07.013 |
| 2020-07-23 |
Quasispecies analysis of the SARS-CoV-2 from representative clinical samples: A preliminary analysis (edit) |
10.4103/IJMR.IJMR_2251_20 |
| 2020-07-23 |
Quinolines-Based SARS-CoV-2 3CLpro and RdRp Inhibitors and Spike-RBD-ACE2 Inhibitor for Drug-Repurposing Against COVID-19: An in silico Analysis (edit) |
10.3389/FMICB.2020.01796 |
| 2020-07-23 |
Epidemiology of SARS-CoV-2 in Egypt (edit) |
10.26719/EMHJ.20.084 |
| 2020-07-23 |
SARS-CoV-2 Receptor ACE2 Is Enriched in a Subpopulation of Mouse Tongue Epithelial Cells in Nongustatory Papillae but Not in Taste Buds or Embryonic Oral Epithelium (edit) |
10.1021/ACSPTSCI.0C00062 |
| 2020-07-23 |
SARS CoV 2 infection in chronic myelogenous leukemia: Severe hematological presentation (edit) |
10.1016/J.TRANSCI.2020.102881 |
| 2020-07-23 |
Clinical Samples for SARS-CoV-2 Detection: Review of the Early Literature (edit) |
10.1016/J.CLINMICNEWS.2020.07.001 |
| 2020-07-23 |
Unclear but present danger: An asymptomatic SARS-CoV-2 carrier (edit) |
10.1016/J.GENDIS.2020.07.010 |
| 2020-07-23 |
Investigation of Anti-SARS-CoV-2 IgG and IgM Antibodies in the Patients with COVID-19 by Three Different ELISA Test Kits (edit) |
10.1007/S42399-020-00409-7 |
| 2020-07-23 |
Confirming Vertical Fetal Infection with COVID-19: Neonatal and Pathology Criteria for Early Onset and Transplacental Transmission of SARS-CoV-2 from Infected Pregnant Mothers (edit) |
10.5858/ARPA.2020-0442-SA |
| 2020-07-22 |
Hydroxychloroquine-mediated inhibition of SARS-CoV-2 entry is attenuated by TMPRSS2 (edit) |
10.1101/2020.07.22.216150 |
| 2020-07-22 |
Reconciling early-outbreak estimates of the basic reproductive number and its uncertainty: framework and applications to the novel coronavirus (SARS-CoV-2) outbreak (edit) |
10.1098/RSIF.2020.0144 |
| 2020-07-22 |
Novel transportation capsule technology could reduce the exposure risk to SARS-CoV-2 infection among health care workers: a feasibility study (edit) |
10.1017/ICE.2020.352 |
| 2020-07-22 |
Multiple Thrombotic Events in a 67-Year-Old Man 2 Weeks After Testing Positive for SARS-CoV-2: A Case Report (edit) |
10.12659/AJCR.925786 |
| 2020-07-22 |
Comparative molecular investigation of the potential inhibitors against SARS-CoV-2 main protease: a molecular docking study (edit) |
10.1080/07391102.2020.1796813 |
| 2020-07-22 |
Antimalarial-agent artemisinin and derivatives portray more potent binding to Lys353 and Lys31-binding hotspots of SARS-CoV-2 spike protein than hydroxychloroquine: potential repurposing of artenimol for COVID-19 (edit) |
10.1080/07391102.2020.1796809 |
| 2020-07-22 |
Repurposing drugs against the main protease of SARS-CoV-2: mechanism-based insights supported by available laboratory and clinical data (edit) |
10.1039/D0MO00057D |
| 2020-07-22 |
Urticaria in an Infant with SARS-CoV-2 Positivity (edit) |
10.1111/DTH.14043 |
| 2020-07-22 |
Proteotyping SARS-CoV-2 virus from nasopharyngeal swabs: a proof-of-concept focused on a 3 min mass spectrometry window (edit) |
10.1021/ACS.JPROTEOME.0C00535 |
| 2020-07-22 |
Transmission route and introduction of Pandemic SARS-CoV-2 between China, Italy and Spain (edit) |
10.1002/JMV.26333 |
| 2020-07-22 |
SARS-CoV-2 diagnostics in the virology laboratory of a University Hospital in Rome during the lockdown period (edit) |
10.1002/JMV.26332 |
| 2020-07-22 |
Stable and safe organ procurement and transplantation during SARS-CoV-2 pandemic in Germany (edit) |
10.1111/TRI.13704 |
| 2020-07-22 |
Recurrent presence of SARS-CoV-2 RNA in a 33-year-old man (edit) |
10.1002/JMV.26334 |
| 2020-07-22 |
Potential Influence of Menstrual Status and Sex Hormones on female SARS-CoV-2 Infection: A Cross-sectional Study from Multicentre in Wuhan, China (edit) |
10.1093/CID/CIAA1022 |
| 2020-07-22 |
Seroconversion of immunoglobulins to SARS-CoV2 in patients with inflammatory bowel disease patients treated by biologics (edit) |
10.1093/ECCO-JCC/JJAA154 |
| 2020-07-22 |
Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2 (edit) |
10.1038/S41586-020-2575-3 |
| 2020-07-22 |
Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates (edit) |
10.1038/S41586-020-2558-4 |
| 2020-07-22 |
Potent neutralizing antibodies directed to multiple epitopes on SARS-CoV-2 spike (edit) |
10.1038/S41586-020-2571-7 |
| 2020-07-22 |
Targeting SARS-CoV-2 spike protein of COVID-19 with naturally occurring phytochemicals: an in silico study for drug development (edit) |
10.1080/07391102.2020.1796811 |
| 2020-07-22 |
Dual inhibitors of SARS-CoV-2 proteases: pharmacophore and molecular dynamics based drug repositioning and phytochemical leads (edit) |
10.1080/07391102.2020.1796802 |
| 2020-07-22 |
Saliva as a diagnostic specimen for detection of SARS-CoV-2 in suspected patients: a scoping review (edit) |
10.1186/S40249-020-00728-W |
| 2020-07-22 |
Rapid roll out of SARS-CoV-2 antibody testing: even at high levels of specificity, an important proportion of test results will be false positives (edit) |
10.1136/BMJ.M2910 |
| 2020-07-22 |
Type I and Type III IFN Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures (edit) |
10.1128/JVI.00985-20 |
| 2020-07-22 |
A multicentre observational study on neonates exposed to SARS-CoV-2 in China: the Neo-SARS-CoV-2 Study protocol (edit) |
10.1136/BMJOPEN-2020-038004 |
| 2020-07-22 |
Controlling the SARS-CoV-2 spike glycoprotein conformation (edit) |
10.1038/S41594-020-0479-4 |
| 2020-07-22 |
SARS-CoV-2 genomic variations associated with mortality rate of COVID-19 (edit) |
10.1038/S10038-020-0808-9 |
| 2020-07-22 |
Occupational risks for SARS-CoV-2 infection: the Polish experience (edit) |
10.13075/IJOMEH.1896.01663 |
| 2020-07-22 |
Possible sequelae in post-SARS-CoV-2 patients: effects on sleep and general health condition (edit) |
10.1007/S11325-020-02152-8 |
| 2020-07-22 |
Initiation of Antiviral Treatment in SARS-CoV2: Modeling Viral Dynamics and Drug Properties (edit) |
10.1002/PSP4.12550 |
| 2020-07-22 |
Incident SARS-CoV-2 Infection and a Shared Latrine (edit) |
10.4269/AJTMH.20-0793 |
| 2020-07-22 |
Copper-Alloy Surfaces and Cleaning Regimens against the Spread of SARS-CoV-2 in Dentistry and Orthopedics. From Fomites to Anti-Infective Nanocoatings (edit) |
10.3390/MA13153244 |
| 2020-07-22 |
SARS-CoV-2 Positive Hospitalized Cancer Patients during the Italian Outbreak: The Cohort Study in Reggio Emilia (edit) |
10.3390/BIOLOGY9080181 |
| 2020-07-22 |
Defining the CD39/CD73 Axis in SARS-CoV-2 Infection: The CD73- Phenotype Identifies Polyfunctional Cytotoxic Lymphocytes (edit) |
10.3390/CELLS9081750 |
| 2020-07-22 |
A Clustering Approach to Classify Italian Regions and Provinces Based on Prevalence and Trend of SARS-CoV-2 Cases (edit) |
10.3390/IJERPH17155286 |
| 2020-07-22 |
Presentation of SARS-CoV-2 Infection As Cholestatic Jaundice in Two Healthy Adolescents (edit) |
10.1016/J.JPEDS.2020.07.054 |
| 2020-07-22 |
An analysis of cancer patients with asymptomatic infection of SARS-CoV-2 in a cancer center in Wuhan, China (edit) |
10.1016/J.ANNONC.2020.07.008 |
| 2020-07-22 |
Mutations Strengthened SARS-CoV-2 Infectivity (edit) |
10.1016/J.JMB.2020.07.009 |
| 2020-07-22 |
USEFULNESS OF SALIVA SAMPLES FOR DETECTING SARS-CoV-2 RNA AMONG LIVER DISEASE PATIENTS (edit) |
10.1016/J.JINF.2020.07.017 |
| 2020-07-22 |
Prevalence and Clinical Characterization of Cancer Patients with Asymptomatic SARS-CoV-2 Infection History (edit) |
10.1016/J.JINF.2020.07.018 |
| 2020-07-22 |
Viable SARS-CoV-2 in various specimens from COVID-19 patients (edit) |
10.1016/J.CMI.2020.07.020 |
| 2020-07-22 |
Linear B-cell epitopes in the spike and nucleocapsid proteins as markers of SARS-CoV-2 exposure and disease severity (edit) |
10.1016/J.EBIOM.2020.102911 |
| 2020-07-22 |
Spatial and temporal dynamics of SARS-CoV-2 in COVID-19 patients: A systematic review and meta-analysis (edit) |
10.1016/J.EBIOM.2020.102916 |
| 2020-07-22 |
Municipal solid waste management during the SARS-COV-2 outbreak and lockdown ease: Lessons from Italy (edit) |
10.1016/J.SCITOTENV.2020.141159 |
| 2020-07-22 |
The war against the SARS-CoV2 infection: Is it better to fight or mitigate it? (edit) |
10.1016/J.MEHY.2020.110129 |
| 2020-07-22 |
Universal screening for SARS-CoV-2 in pregnant women at term admitted to an East London maternity unit (edit) |
10.1016/J.EJOGRB.2020.07.035 |
| 2020-07-22 |
Severe SARS-CoV-2 infection in humans is defined by a shift in the serum lipidome resulting in dysregulation of eicosanoid immune mediators (edit) |
10.21203/RS.3.RS-42999/V1 |
| 2020-07-22 |
The D614G mutation in the SARS-CoV2 Spike protein increases infectivity in an ACE2 receptor dependent manner (edit) |
10.1101/2020.07.21.214932 |
| 2020-07-22 |
Rescue of SARS-CoV-2 from a single bacterial artificial chromosome (edit) |
10.1101/2020.07.22.216358 |
| 2020-07-22 |
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants (edit) |
10.1101/2020.07.21.214759 |
| 2020-07-22 |
Neonatal hyperoxia enhances age-dependent expression of SARS-CoV-2 receptors in mice (edit) |
10.1101/2020.07.22.215962 |
| 2020-07-22 |
Low Incidence and Mortality from SARS-CoV-2 in Southern Europe. Proposal of a hypothesis for Arthropod borne Herd immunity (edit) |
10.1016/J.MEHY.2020.110121 |
| 2020-07-22 |
[Is SARS-CoV-2 also attacking the French language?] (edit) |
10.1016/J.REVMED.2020.07.009 |
| 2020-07-22 |
Geographic and Genomic Distribution of SARS-CoV-2 Mutations (edit) |
10.3389/FMICB.2020.01800 |
| 2020-07-22 |
Evaluation of the exposure risk of SARS-CoV-2 in different hospital environment (edit) |
10.1016/J.SCS.2020.102413 |
| 2020-07-21 |
Copper(II) Inhibition of the SARS-CoV-2 Main Protease (edit) |
10.26434/CHEMRXIV.12673436 |
| 2020-07-21 |
SARS-CoV-2 infection induces a pro-inflammatory cytokine response through cGAS-STING and NF-κB (edit) |
10.1101/2020.07.21.212639 |
| 2020-07-21 |
The PRRA insert at the S1/S2 site modulates cellular tropism of SARS-CoV-2 and ACE2 usage by the closely related Bat raTG13 (edit) |
10.1101/2020.07.20.213280 |
| 2020-07-21 |
Cellular events of acute, resolving or progressive COVID-19 in SARS-CoV-2 infected non-human primates (edit) |
10.1101/2020.07.21.213777 |
| 2020-07-21 |
Ebola prepared these countries for coronavirus — but now even they are floundering (edit) |
10.1038/D41586-020-02173-Z |
| 2020-07-21 |
[Isolation of SARS-CoV-2 on reproductive tissue, a possible path of transmission.] (edit) |
|
| 2020-07-21 |
Outcomes of universal SARS-CoV-2 testing program in pregnant women admitted to hospital and the adjuvant role of lung ultrasound in screening: A prospective cohort study (edit) |
10.1080/14767058.2020.1798398 |
| 2020-07-21 |
Cyanobacterial metabolites as promising drug leads against the Mpro and PLpro of SARS-CoV-2: an in silico analysis (edit) |
10.1080/07391102.2020.1794972 |
| 2020-07-21 |
Dysregulation in Akt/mTOR/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells (edit) |
10.1080/22221751.2020.1799723 |
| 2020-07-21 |
Natural derivatives with dual binding potential against SARS-CoV-2 main protease and human ACE2 possess low oral bioavailability: a brief computational analysis (edit) |
10.1080/07391102.2020.1794970 |
| 2020-07-21 |
Co-infection with SARS-CoV-2 and parainfluenza virus in a hemodialysis patient: A case report (edit) |
10.5414/CN110164 |
| 2020-07-21 |
Global seasonality of human seasonal coronaviruses: a clue for post-pandemic circulating season of SARS-CoV-2 virus? (edit) |
10.1093/INFDIS/JIAA436 |
| 2020-07-21 |
SARS-CoV-2 S1 is superior to the RBD as a COVID-19 subunit vaccine antigen (edit) |
10.1002/JMV.26320 |
| 2020-07-21 |
ACE2, TMPRSS2, and Furin variants and SARS-CoV-2 infection in Madrid, Spain (edit) |
10.1002/JMV.26319 |
| 2020-07-21 |
Hydroxychloroquine, Dermatology and SARS-CoV-2: Updating an Old Association (edit) |
10.1002/JMV.26322 |
| 2020-07-21 |
Nucleotide Analogues as Inhibitors of SARS-CoV-2 Polymerase, a Key Drug Target for COVID-19 (edit) |
10.1021/ACS.JPROTEOME.0C00392 |
| 2020-07-21 |
Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020 (edit) |
10.1001/JAMAINTERNMED.2020.4130 |
| 2020-07-21 |
Third Trimester Placentas of SARS-CoV-2-Positive Women: Histomorphology, including Viral Immunohistochemistry and in Situ Hybridization (edit) |
10.1111/HIS.14215 |
| 2020-07-21 |
Preliminary evaluation of Roche Cobas Elecsys Anti-SARS-CoV-2 chemiluminescence immunoassay (edit) |
10.1515/CCLM-2020-1042 |
| 2020-07-21 |
High-Dose Prednisone for Treatment of Autoimmune Pancreatitis in a Patient with Coronavirus Disease 2019 (COVID-19) due to Infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (edit) |
10.12659/AJCR.926475 |
| 2020-07-21 |
Use of External Ventilator Control Panel for Mechanical Ventilation in Patients with Severe SARS-CoV-2 Infection (edit) |
10.1093/QJMED/HCAA229 |
| 2020-07-21 |
Hydroxychloroquine in the COVID-19 pandemic era: in pursuit of a rational use for prophylaxis of SARS-CoV-2 infection (edit) |
10.1080/14787210.2020.1799785 |
| 2020-07-21 |
Vertical transmission of SARS CoV-2: a systematic review (edit) |
10.1080/14767058.2020.1793322 |
| 2020-07-21 |
SARS-CoV-2 Titers in Wastewater Are Higher than Expected from Clinically Confirmed Cases (edit) |
10.1128/MSYSTEMS.00614-20 |
| 2020-07-21 |
Discovery and Genomic Characterization of a 382-Nucleotide Deletion in ORF7b and ORF8 during the Early Evolution of SARS-CoV-2 (edit) |
10.1128/MBIO.01610-20 |
| 2020-07-21 |
Serial interval of SARS-CoV-2 was shortened over time by nonpharmaceutical interventions (edit) |
10.1126/SCIENCE.ABC9004 |
| 2020-07-21 |
Distinct conformational states of SARS-CoV-2 spike protein (edit) |
10.1126/SCIENCE.ABD4251 |
| 2020-07-21 |
The Combined Use of Tocilizumab and Hemoadsorption in a Patient with SARS-COV-2-19-Associated Pneumonia: A Case Report (edit) |
10.1159/000509738 |
| 2020-07-21 |
Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies (edit) |
10.1007/S00228-020-02963-4 |
| 2020-07-21 |
The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 Infections (edit) |
10.1007/S11481-020-09944-5 |
| 2020-07-21 |
Influence of Race and Ethnicity on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Rates and Clinical Outcomes in Pregnancy (edit) |
10.1097/AOG.0000000000004088 |
| 2020-07-21 |
Prolonged Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) RNA in an Obstetric Patient With Antibody Seroconversion (edit) |
10.1097/AOG.0000000000004086 |
| 2020-07-21 |
Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19 (edit) |
10.1056/NEJMC2025179 |
| 2020-07-21 |
Differential immune activation profile of SARS-CoV-2 and SARS-CoV infection in human lung and intestinal cells: implications for treatment with IFN-β and IFN inducer (edit) |
10.1016/J.JINF.2020.07.016 |
| 2020-07-21 |
Lack of antibody-mediated cross-protection between SARS-CoV-2 and SARS-CoV infections (edit) |
10.1016/J.EBIOM.2020.102890 |
| 2020-07-21 |
Factors Associated with the Perception of Risk and Knowledge of Contracting the SARS-Cov-2 among Adults in Bangladesh: Analysis of Online Surveys (edit) |
10.3390/IJERPH17145252 |
| 2020-07-21 |
A Comprehensive Mapping of the Druggable Cavities within the SARS-CoV-2 Therapeutically Relevant Proteins by Combining Pocket and Docking Searches as Implemented in Pockets 2.0. (edit) |
10.3390/IJMS21145152 |
| 2020-07-21 |
Oral cancer and ACE2 receptor of SARS-CoV-2 (edit) |
10.1016/J.ORALONCOLOGY.2020.104920 |
| 2020-07-21 |
Neurological Disorders Identified during Treatment of a SARS-CoV-2 Infection (edit) |
10.2169/INTERNALMEDICINE.5447-20 |
| 2020-07-21 |
The Novel Insight of SARS-CoV-2 Molecular Biology and Pathogenesis and Therapeutic Options (edit) |
10.1089/DNA.2020.5703 |
| 2020-07-21 |
SARS-CoV-2 infection among healthcare workers of a gastroenterological service in a tertiary care facility (edit) |
10.1016/J.AJG.2020.07.005 |
| 2020-07-21 |
An evidence-based theory of change for reducing SARS-CoV-2 transmission in reopened schools (edit) |
10.1016/J.HEALTHPLACE.2020.102398 |
| 2020-07-21 |
COVID: the new ultrasound alphabet in SARS-CoV-2 era (edit) |
10.1213/ANE.0000000000005142 |
| 2020-07-21 |
Is Nasopharyngeal Swab Comparable With Nasopharyngeal Aspirate to Detect SARS-CoV-2 in Children? (edit) |
10.1097/INF.0000000000002824 |
| 2020-07-21 |
Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular Probes (edit) |
10.2139/SSRN.3639618 |
| 2020-07-21 |
RdRp mutations are associated with SARS-CoV-2 genome evolution (edit) |
10.7717/PEERJ.9587 |
| 2020-07-21 |
Simulations support the interaction of the SARS-CoV-2 spike protein with nicotinic acetylcholine receptors and suggest subtype specificity (edit) |
10.1101/2020.07.16.206680 |
| 2020-07-21 |
Clinical Characteristics and Outcomes for 7,995 Patients with SARS-CoV-2 Infection (edit) |
10.1101/2020.07.19.20157305 |
| 2020-07-21 |
High Community SARS-CoV-2 Antibody Seroprevalence in a Ski Resort Community, Blaine County, Idaho, US. Preliminary Results (edit) |
10.1101/2020.07.19.20157198 |
| 2020-07-21 |
SARS-CoV-2-host dynamics: Increased risk of adverse outcomes of COVID-19 in obesity (edit) |
10.1016/J.DSX.2020.07.030 |
| 2020-07-21 |
COVID-19: The Influence of ACE Genotype and ACE-I and ARBs on the Course of SARS-CoV-2 Infection in Elderly Patients (edit) |
10.2147/CIA.S261516 |
| 2020-07-21 |
SARS-CoV-2 IgG antibody responses in New York City (edit) |
10.1016/J.DIAGMICROBIO.2020.115128 |
| 2020-07-21 |
Atomistic simulation reveals structural mechanisms underlying D614G spike glycoprotein-enhanced fitness in SARS-COV-2 (edit) |
10.1002/JCC.26383 |
| 2020-07-21 |
Out of Sight but Not Out of Mind: Caring for Patients Receiving OPAT During the SARS-CoV-2 Pandemic (edit) |
10.1093/OFID/OFAA309 |
| 2020-07-21 |
Will all SARS-CoV-2 seroprevalence surveys provide the right picture? (edit) |
10.1016/J.PUHE.2020.07.020 |
| 2020-07-21 |
Establishment and validation of a drug-target microarray for SARS-CoV-2 (edit) |
10.1016/J.BBRC.2020.05.217 |
| 2020-07-21 |
An Ayurvedic Perspective along with in Silico Study of the Drugs for the Management of Sars-Cov-2 (edit) |
10.1016/J.JAIM.2020.07.002 |
| 2020-07-21 |
Morbilliform Rash: An Uncommon Herald of SARS-CoV-2 (edit) |
10.7759/CUREUS.9321 |
| 2020-07-21 |
Coronavirus (SARS-CoV-2) and Mortality Rate in India: The Winning Edge (edit) |
10.3389/FPUBH.2020.00397 |
| 2020-07-21 |
Myopathy associated with serious SARS-CoV-2 infection (edit) |
10.1016/J.NRL.2020.07.003 |
| 2020-07-21 |
[Immunopsychiatry and SARS-CoV-2 pandemic: Links and possible consequences] (edit) |
10.1016/J.ENCEP.2020.07.002 |
| 2020-07-20 |
The folate antagonist methotrexate diminishes replication of the coronavirus SARS-CoV-2 and enhances the antiviral efficacy of remdesivir in cell culture models (edit) |
10.1101/2020.07.18.210013 |
| 2020-07-20 |
Evaluation of the Effect and Safety of HeberFERON vs Heberon Alpha in Patients Infected with Corona Virus SARS-CoV-2 (Study ESPERANZA/HOPE): Study Protocol for a Randomized Controlled Trial (edit) |
10.21203/RS.3.RS-28958/V1 |
| 2020-07-20 |
Minimizing cross transmission of SARS-CoV-2 in obstetric ultrasound during COVID-19 pandemic (edit) |
10.1515/JPM-2020-0228 |
| 2020-07-20 |
Universal screening for SARS-CoV-2 before labor admission during Covid-19 pandemic in Madrid (edit) |
10.1515/JPM-2020-0236 |
| 2020-07-20 |
[Scoping review of coronavirus case series (SARS-CoV, MERS-CoV and SARS-CoV-2) and their obstetric and neonatal results] (edit) |
10.37201/REQ/064.2020 |
| 2020-07-20 |
In-silico drug repurposing and molecular dynamics puzzled out potential SARS-CoV-2 main protease inhibitors (edit) |
10.1080/07391102.2020.1791958 |
| 2020-07-20 |
Work at inpatient care units is associated with an increased risk of SARS-CoV-2 infection; a cross-sectional study of 8679 healthcare workers in Sweden (edit) |
10.1080/03009734.2020.1793039 |
| 2020-07-20 |
Antibody responses to SARS-CoV-2 short-lived (edit) |
10.1038/S41577-020-0405-3 |
| 2020-07-20 |
Serosurvey of SARS-CoV-2 among hospital visitors in China (edit) |
10.1038/S41422-020-0371-0 |
| 2020-07-20 |
Identification of SARS-CoV-2 in a Proficiency Testing Program (edit) |
10.1093/AJCP/AQAA128 |
| 2020-07-20 |
Evidence for strong mutation bias towards, and selection against, U content in SARS-CoV-2: implications for vaccine design (edit) |
10.1093/MOLBEV/MSAA188 |
| 2020-07-20 |
Distribution of SARS-CoV-2 PCR Cycle Threshold Values Provide Practical Insight Into Overall and Target-Specific Sensitivity Among Symptomatic Patients (edit) |
10.1093/AJCP/AQAA133 |
| 2020-07-20 |
Structure-based virtual screening to discover potential lead molecules for the SARS-CoV-2 main protease (edit) |
10.1021/ACS.JCIM.0C00546 |
| 2020-07-20 |
Update Alert: Masks for Prevention of Respiratory Virus Infections, Including SARS-CoV-2, in Health Care and Community Settings (edit) |
10.7326/L20-0948 |
| 2020-07-20 |
SARS-Cov-2 in peritoneal fluid: an important finding in the Covid-19 pandemic (edit) |
10.1002/BJS.11816 |
| 2020-07-20 |
[Social Participation, Inclusion and Mental Well-Being Following SARS-CoV-2 Related Restrictions on Going Out - A Follow-up Study from Germany] (edit) |
10.1055/A-1202-2427 |
| 2020-07-20 |
SARS-CoV-2 in pregnancy: characteristics and outcomes of hospitalized and non-hospitalized women due to COVID-19 (edit) |
10.1080/14767058.2020.1793320 |
| 2020-07-20 |
A recurrent mutation at position 26,340 of SARS-CoV-2 is associated with failure of the E-gene qRT-PCR utilized in a commercial dual-target diagnostic assay (edit) |
10.1128/JCM.01598-20 |
| 2020-07-20 |
Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19 (edit) |
10.1136/GUTJNL-2020-322294 |
| 2020-07-20 |
An alphavirus-derived replicon RNA vaccine induces SARS-CoV-2 neutralizing antibody and T cell responses in mice and nonhuman primates (edit) |
10.1126/SCITRANSLMED.ABC9396 |
| 2020-07-20 |
Preparing for the SARS-CoV-2 pandemic: creation and implementation of new recommendations (edit) |
10.1007/S00540-020-02827-2 |
| 2020-07-20 |
SARS-CoV-2 Entry Receptor ACE2 Is Expressed on Very Small CD45- Precursors of Hematopoietic and Endothelial Cells and in Response to Virus Spike Protein Activates the Nlrp3 Inflammasome (edit) |
10.1007/S12015-020-10010-Z |
| 2020-07-20 |
Chromosome X riddle in SARS-CoV-2 (COVID-19) - related lung pathology (edit) |
10.1007/S12253-020-00878-0 |
| 2020-07-20 |
Upper Gastrointestinal Bleeding Caused by SARS-CoV-2 Infection (edit) |
10.14309/AJG.0000000000000757 |
| 2020-07-20 |
COVID-19: Pain Management in Patients with SARS-CoV-2 Infection-Molecular Mechanisms, Challenges, and Perspectives (edit) |
10.3390/BRAINSCI10070465 |
| 2020-07-20 |
Identification and Analysis of Unstructured, Linear B-Cell Epitopes in SARS-CoV-2 Virion Proteins for Vaccine Development (edit) |
10.3390/VACCINES8030397 |
| 2020-07-20 |
Age-Dependent Progression of SARS-CoV-2 Infection in Syrian Hamsters (edit) |
10.3390/V12070779 |
| 2020-07-20 |
Point-of-Use Rapid Detection of SARS-CoV-2: Nanotechnology-Enabled Solutions for the COVID-19 Pandemic (edit) |
10.3390/IJMS21145126 |
| 2020-07-20 |
HLA-DR Deficiency and Immunosuppression-Related End-Organ Failure in SARS-CoV2 Infection (edit) |
10.1213/ANE.0000000000005140 |
| 2020-07-20 |
Virological surveillance of SARS-CoV-2 in an Italian northern area: comparison of Real Time RT PCR cycle threshold (Ct) values in three epidemic periods (edit) |
10.23750/ABM.V91I9-S.10138 |
| 2020-07-20 |
Detection of SARS-CoV-2 on hospital surfaces (edit) |
10.23750/ABM.V91I9-S.10137 |
| 2020-07-20 |
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial (edit) |
10.1016/S0140-6736(20)31604-4 |
| 2020-07-20 |
Comparison of serologic and molecular SARS-CoV 2 results in a large cohort in Southern Tuscany demonstrates a role for serologic testing to increase diagnostic sensitivity (edit) |
10.1016/J.CLINBIOCHEM.2020.07.002 |
| 2020-07-20 |
SARS-CoV-2 infection among healthcare workers in a hospital in Madrid, Spain (edit) |
10.1016/J.JHIN.2020.07.020 |
| 2020-07-20 |
Clinical comorbidities, characteristics, and outcomes of mechanically ventilated patients in the State of Michigan with SARS-CoV-2 pneumonia (edit) |
10.1016/J.JCLINANE.2020.110005 |
| 2020-07-20 |
Interferons and viruses induce a novel primate-specific isoform dACE2 and not the SARS-CoV-2 receptor ACE2 (edit) |
10.1101/2020.07.19.210955 |
| 2020-07-20 |
Inhibitors of VPS34 and lipid metabolism suppress SARS-CoV-2 replication (edit) |
10.1101/2020.07.18.210211 |
| 2020-07-20 |
Cryo-electron Microscopy and Exploratory Antisense Targeting of the 28-kDa Frameshift Stimulation Element from the SARS-CoV-2 RNA Genome (edit) |
10.1101/2020.07.18.209270 |
| 2020-07-20 |
Dynamics and significance of the antibody response to SARS-CoV-2 infection (edit) |
10.1101/2020.07.18.20155374 |
| 2020-07-20 |
Assessment of severity of acute pancreatitis in a Sars-CoV-2 pandemia (edit) |
10.1002/BJS.11818 |
| 2020-07-20 |
The COVID-19 conundrum: SARS-CoV-2 is not present in bile (edit) |
10.1002/BJS.11820 |
| 2020-07-20 |
Incidence of SARS-CoV-2 infection in inflammatory bowel disease (edit) |
10.1111/JGH.15191 |
| 2020-07-20 |
Current coronavirus (SARS-CoV-2) epidemiological, diagnostic and therapeutic approaches: An updated review until June 2020 (edit) |
10.17179/EXCLI2020-2554 |
| 2020-07-20 |
Cold agglutinin disease following SARS-CoV-2 and Mycoplasma pneumoniae co-infections (edit) |
10.1002/CCR3.3152 |
| 2020-07-20 |
Practical Guidance for Dietary Management of Patients With Inflammatory Bowel Disease During the SARS-CoV2 Pandemic (edit) |
10.1016/J.JAND.2020.07.019 |
| 2020-07-20 |
Acute Stroke as the Presenting Symptom of SARS-CoV-2 Infection in a Young Patient with Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (edit) |
10.1016/J.JSTROKECEREBROVASDIS.2020.105167 |
| 2020-07-19 |
Effect of bromhexine on clinical outcomes and mortality in COVID-19 patients: A randomized clinical trial (edit) |
10.34172/BI.2020.27 |
| 2020-07-19 |
SARS-Cov-2 Natural or Artificial? That is the Question (edit) |
10.31487/J.CMR.2020.01.06 |
| 2020-07-19 |
What HIV in the brain can teach us about SARS-CoV-2 neurologic complications? (edit) |
10.1089/AID.2020.0161 |
| 2020-07-19 |
SARS-COV-2 as a trigger for autoimmune disease: report of two cases of Graves' disease after COVID-19 (edit) |
10.1007/S40618-020-01366-7 |
| 2020-07-19 |
Foreseeing a worsening of pediatric malnutrition following SARS-CoV-2 in low and middle-income countries such as Pakistan (edit) |
10.1016/J.PEDN.2020.06.016 |
| 2020-07-19 |
Asymptomatic SARS-CoV-2 infection in two patients with multiple sclerosis treated with fingolimod (edit) |
10.1016/J.MSARD.2020.102414 |
| 2020-07-19 |
Body mass index and acute respiratory distress severity in patients with and without SARS-CoV-2 infection (edit) |
10.1016/J.BJA.2020.07.006 |
| 2020-07-19 |
Rapid and sensitive detection of SARS-CoV-2 antibodies by biolayer interferometry (edit) |
10.1101/2020.07.17.20156281 |
| 2020-07-19 |
Targeting TMPRSS2 in SARS-CoV-2 Infection (edit) |
10.1016/J.MAYOCP.2020.06.018 |
| 2020-07-18 |
Rapid and inexpensive whole-genome sequencing of SARS-CoV-2 using 1200 bp tiled amplicons and Oxford Nanopore Rapid Barcoding (edit) |
10.1093/BIOMETHODS/BPAA014 |
| 2020-07-18 |
Structural basis for the inhibition of the papain-like protease of SARS-CoV-2 by small molecules (edit) |
10.1101/2020.07.17.208959 |
| 2020-07-18 |
The landscape of SARS-CoV-2 RNA modifications (edit) |
10.1101/2020.07.18.204362 |
| 2020-07-18 |
SARS-CoV-2 Infection-Associated Hemophagocytic Lymphohistiocytosis (edit) |
10.1093/AJCP/AQAA124 |
| 2020-07-18 |
Isolated post SARS‑CoV‑2 diplopia (edit) |
10.1007/S00415-020-10072-6 |
| 2020-07-18 |
Could a specific ACE2 activator drug improve the clinical outcome of SARS-CoV-2? A potential pharmacological insight (edit) |
10.1080/17512433.2020.1798760 |
| 2020-07-18 |
Mortality in COVID-19 disease patients: Correlating Association of Major histocompatibility complex (MHC) with severe acute respiratory syndrome 2 (SARS-CoV-2) variants (edit) |
10.1016/J.IJID.2020.07.016 |
| 2020-07-18 |
A molecular docking study revealed that synthetic peptides induced conformational changes in the structure of SARS-CoV-2 spike glycoprotein, disrupting the interaction with human ACE2 receptor (edit) |
10.1016/J.IJBIOMAC.2020.07.174 |
| 2020-07-18 |
Response to: Letter to the Editor on "Bonafè M, Prattichizzo F, Giuliani A, Storci G, Sabbatinelli J, Olivieri F. Inflamm-aging: Why older men are the most susceptible to SARS-CoV-2 complicated outcomes. Cytokine Growth Factor Rev" by Eugenia Quiros (edit) |
10.1016/J.CYTOGFR.2020.07.013 |
| 2020-07-18 |
SARS-CoV-2 detection in different respiratory sites: A systematic review and meta-analysis (edit) |
10.1016/J.EBIOM.2020.102903 |
| 2020-07-18 |
Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with 2019 Novel Coronavirus (SARS-CoV-2) Infection (edit) |
10.1155/2020/8875987 |
| 2020-07-18 |
Meningoencephalitis from SARS-CoV-2 infection (edit) |
10.1016/J.IDCR.2020.E00919 |
| 2020-07-18 |
Profiling of Initial Available SARS-CoV-2 Sequences from Iranian Related COVID-19 Patients (edit) |
10.22074/CELLJ.2020.7524 |
| 2020-07-18 |
Research during SARS-CoV-2 pandemic: To "Preprint" or not to "Preprint", that is the question (edit) |
10.1016/J.MEDCLE.2020.05.002 |
| 2020-07-18 |
The Cumulative Rate of SARS-CoV-2 Infection in Chinese Hemodialysis Patients (edit) |
10.1016/J.EKIR.2020.07.010 |
| 2020-07-18 |
Transmission of SARS-CoV-2 through the air (edit) |
10.1016/J.CMRP.2020.07.005 |
| 2020-07-17 |
Development of a simple in vitro assay to identify and evaluate nucleotide analogs against SARS-CoV-2 RNA-dependent RNA polymerase (edit) |
10.1101/2020.07.16.205799 |
| 2020-07-17 |
Designing a multi-epitope vaccine against SARS-CoV-2: an immunoinformatics approach (edit) |
10.1080/07391102.2020.1792347 |
| 2020-07-17 |
Approach to the mechanism of action of hydroxychloroquine on SARS-CoV-2: a molecular docking study (edit) |
10.1080/07391102.2020.1792993 |
| 2020-07-17 |
Visceral Adiposity and High Intramuscular Fat Deposition Independently Predict Critical Illness in Patients with Sars-COV-2 (edit) |
10.1002/OBY.22971 |
| 2020-07-17 |
Retrospective Observational Study of Brain Magnetic Resonance Imaging Findings in Patients with Acute SARS-CoV-2 Infection and Neurological Manifestations (edit) |
10.1148/RADIOL.2020202422 |
| 2020-07-17 |
Detection and Genetic Characterization of Community-Based SARS-CoV-2 Infections - New York City, March 2020 (edit) |
10.15585/MMWR.MM6928A5 |
| 2020-07-17 |
Author Correction: COVID-19 Disease Map, building a computational repository of SARS-CoV-2 virus-host interaction mechanisms (edit) |
10.1038/S41597-020-00589-W |
| 2020-07-17 |
SARS-CoV-2 Main Protease: A Molecular Dynamics Study (edit) |
10.1021/ACS.JCIM.0C00575 |
| 2020-07-17 |
Absence of Apparent Transmission of SARS-CoV-2 from Two Stylists After Exposure at a Hair Salon with a Universal Face Covering Policy - Springfield, Missouri, May 2020 (edit) |
10.15585/MMWR.MM6928E2 |
| 2020-07-17 |
SARS-CoV-2 RNAemia in a Healthy Blood Donor 40 Days After Respiratory Illness Resolution (edit) |
10.7326/L20-0725 |
| 2020-07-17 |
Neutralizing and cross-reacting antibodies: implications for immunotherapy and SARS-CoV-2 vaccine development (edit) |
10.1080/21645515.2020.1787074 |
| 2020-07-17 |
Tracing and analysis of 288 early SARS-CoV-2 infections outside China: A modeling study (edit) |
10.1371/JOURNAL.PMED.1003193 |
| 2020-07-17 |
In Reply: Correctly Interpreting SARS-CoV-2 Serologic Assays (edit) |
10.1093/CLINCHEM/HVAA166 |
| 2020-07-17 |
Correctly Interpreting SARS-CoV-2 Serologic Assays (edit) |
10.1093/CLINCHEM/HVAA165 |
| 2020-07-17 |
The utility of native MS for understanding the mechanism of action of repurposed therapeutics in COVID-19: heparin as a disruptor of the SARS-CoV-2 interaction with its host cell receptor (edit) |
10.1021/ACS.ANALCHEM.0C02449 |
| 2020-07-17 |
Drug repurposing studies targeting SARS-CoV-2: an ensemble docking approach on drug target 3C-like protease (3CLpro) (edit) |
10.1080/07391102.2020.1792344 |
| 2020-07-17 |
A literature review of 2019 novel coronavirus (SARS-CoV2) infection in neonates and children (edit) |
10.1038/S41390-020-1065-5 |
| 2020-07-17 |
Running out of bullets: the challenging management of acute hepatitis and SARS-COV-2 from the SMatteo COvid19 Registry (SMACORE) (edit) |
10.1111/LIV.14609 |
| 2020-07-17 |
Predicting SARS-CoV-2 infection trend using technical analysis indicators (edit) |
10.1017/DMP.2020.254 |
| 2020-07-17 |
Comprehensive Review on Current Interventions, Diagnostic, and Nanotechnology Perspectives against SARS-CoV-2 (edit) |
10.1021/ACS.BIOCONJCHEM.0C00323 |
| 2020-07-17 |
Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2 (edit) |
10.1126/SCIENCE.ABC8665 |
| 2020-07-17 |
SARS-CoV-2 as a Factor to Disbalance the Renin-Angiotensin System: A Suspect in the Case of Exacerbated IL-6 Production (edit) |
10.4049/JIMMUNOL.2000642 |
| 2020-07-17 |
SARS-CoV-2 failure to infect or replicate in mosquitoes: an extreme challenge (edit) |
10.1038/S41598-020-68882-7 |
| 2020-07-17 |
Cryo-EM analysis of the post-fusion structure of the SARS-CoV spike glycoprotein (edit) |
10.1038/S41467-020-17371-6 |
| 2020-07-17 |
Author Correction: Scalable and robust SARS-CoV-2 testing in an academic center (edit) |
10.1038/S41587-020-0623-Z |
| 2020-07-17 |
Recurrence of positive SARS-CoV-2 viral RNA in recovered COVID-19 patients during medical isolation observation (edit) |
10.1038/S41598-020-68782-W |
| 2020-07-17 |
Pulmonary immune responses against SARS-CoV-2 infection: harmful or not? (edit) |
10.1007/S00134-020-06170-8 |
| 2020-07-17 |
[Erratum to: Basic principles of replication and immunology of SARS-CoV-2] (edit) |
10.1007/S00347-020-01185-4 |
| 2020-07-17 |
Evaluations of the serological test in the diagnosis of 2019 novel coronavirus (SARS-CoV-2) infections during the COVID-19 outbreak (edit) |
10.1007/S10096-020-03978-6 |
| 2020-07-17 |
Variplex™ test system fails to reliably detect SARS-CoV-2 directly from respiratory samples without RNA extraction (edit) |
10.1007/S10096-020-03983-9 |
| 2020-07-17 |
SARS-CoV-2-related pneumonia can be successfully managed in patients with metastatic neuroendocrine tumors: a critical point of view (edit) |
10.1007/S12020-020-02419-W |
| 2020-07-17 |
Routine childhood immunisation during the COVID-19 pandemic in Africa: a benefit-risk analysis of health benefits versus excess risk of SARS-CoV-2 infection (edit) |
10.1016/S2214-109X(20)30308-9 |
| 2020-07-17 |
Phylogenetic and phylodynamic analyses of SARS-CoV-2 (edit) |
10.1016/J.VIRUSRES.2020.198098 |
| 2020-07-17 |
Body temperature and host species preferences of SARS-CoV-2 (edit) |
10.1016/J.CMI.2020.07.017 |
| 2020-07-17 |
SARS-Cov-2 Was Not Found in the Peritoneal Fluid of an Asymptomatic Patient Undergoing Laparoscopic Appendectomy (edit) |
10.1097/SLE.0000000000000837 |
| 2020-07-17 |
SARS-CoV-2 induced thrombocytopenia as an important biomarker significantly correlated with abnormal coagulation function, increased intravascular blood clot risk and mortality in COVID-19 patients (edit) |
10.1186/S40164-020-00172-4 |
| 2020-07-17 |
Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1α/Glycolysis-Dependent Axis (edit) |
10.1016/J.CMET.2020.07.007 |
| 2020-07-17 |
Development of a Multi-Antigenic SARS-CoV-2 Vaccine Using a Synthetic Poxvirus Platform (edit) |
10.21203/RS.3.RS-40198/V1 |
| 2020-07-17 |
Assessment of the Economic and Health-Care Impact of COVID-19 (SARS-CoV-2) on Public and Private Dental Surgeries in Spain: A Pilot Study (edit) |
10.3390/IJERPH17145139 |
| 2020-07-17 |
Genetic Diversity Among SARS-CoV2 Strains in South America may Impact Performance of Molecular Detection (edit) |
10.3390/PATHOGENS9070580 |
| 2020-07-17 |
A Novel Multiplex qRT-PCR Assay to Detect SARS-CoV-2 Infection: High Sensitivity and Increased Testing Capacity (edit) |
10.3390/MICROORGANISMS8071064 |
| 2020-07-17 |
Demographic and Comorbidities Data Description of Population in Mexico with SARS-CoV-2 Infected Patients(COVID19): An Online Tool Analysis (edit) |
10.3390/IJERPH17145173 |
| 2020-07-17 |
Polymorphism and Selection Pressure of SARS-CoV-2 Vaccine and Diagnostic Antigens: Implications for Immune Evasion and Serologic Diagnostic Performance (edit) |
10.3390/PATHOGENS9070584 |
| 2020-07-17 |
The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity (edit) |
10.1016/J.CELL.2020.07.012 |
| 2020-07-17 |
Understanding genomic diversity, pan-genome, and evolution of SARS-CoV-2 (edit) |
10.7717/PEERJ.9576 |
| 2020-07-17 |
SARS-CoV-2 and Thrombosis: More Than Just by Chance (edit) |
10.1016/J.AMJMS.2020.07.023 |
| 2020-07-17 |
Clinical evaluation of five different automated SARS-CoV-2 serology assays in a cohort of hospitalized COVID-19 patients (edit) |
10.1016/J.JCV.2020.104549 |
| 2020-07-17 |
Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein (edit) |
10.3389/FGENE.2020.00783 |
| 2020-07-17 |
Hydroxychloroquine prophylaxis for SARS-CoV-2 infection among healthcare workers (edit) |
10.4103/IJMR.IJMR_2372_20 |
| 2020-07-17 |
Pharmacokinetic considerations on the repurposing of ivermectin for treatment of COVID-19 (edit) |
10.1111/BCP.14476 |
| 2020-07-17 |
Serial serum SARS-CoV-2 RNA results in two COVID-19 cases with severe respiratory failure (edit) |
10.1016/J.JIAC.2020.07.003 |
| 2020-07-17 |
False-positive SARS-CoV-2 serology in 3 children with Kawasaki disease (edit) |
10.1016/J.DIAGMICROBIO.2020.115141 |
| 2020-07-17 |
[Is chronic obstructive pulmonary disease a protective factor in SARS-CoV2 infection? The importance of bronchodilator treatment] (edit) |
10.1016/J.RCE.2020.07.001 |
| 2020-07-17 |
Development of cell-based pseudovirus entry assay to identify potential viral entry inhibitors and neutralizing antibodies against SARS-CoV-2 (edit) |
10.1016/J.GENDIS.2020.07.006 |
| 2020-07-17 |
Sleep and wake impairment in patients with SARS-CoV2 infection (edit) |
10.1016/J.SLEEP.2020.06.036 |
| 2020-07-17 |
The role of serological testing in the SARS-CoV-2 outbreak (edit) |
|
| 2020-07-17 |
Crystal structures of SARS-CoV-2 ADP-ribose phosphatase: from the apo form to ligand complexes (edit) |
10.1107/S2052252520009653 |
| 2020-07-16 |
Sensitive and specific immunohistochemistry protocols for detection of SARS-CoV-2 nucleocapsid and spike proteins in formalin-fixed, paraffin-embedded COVID-19 patient tissues (edit) |
10.21203/RS.3.PEX-1011/V1 |
| 2020-07-16 |
The value of serology testing to manage SARS-CoV-2 infections (edit) |
10.1183/13993003.02411-2020 |
| 2020-07-16 |
Gene expression and in situ protein profiling of candidate SARS-CoV-2 receptors in human airway epithelial cells and lung tissue (edit) |
10.1183/13993003.01123-2020 |
| 2020-07-16 |
Increased expression of ACE2, the SARS-CoV-2 entry receptor, in alveolar and bronchial epithelium of smokers and COPD subjects (edit) |
10.1183/13993003.02378-2020 |
| 2020-07-16 |
Socioeconomic correlates of the SARS-CoV 2 and Influenza H1N1 outbreaks (edit) |
10.1183/13993003.01400-2020 |
| 2020-07-16 |
Characteristics and Outcomes of Health and Social Care workers testing positive for SARS-CoV-2 in the Tayside region of Scotland (edit) |
10.1183/13993003.02568-2020 |
| 2020-07-16 |
Transmission of droplet-conveyed infectious agents such as SARS-CoV-2 by speech and vocal exercises during speech therapy: preliminary experiment concerning airflow velocity (edit) |
10.1007/S00405-020-06200-7 |
| 2020-07-16 |
Effects on QT interval of hydroxychloroquine associated with ritonavir/darunavir or azithromycin in patients with SARS-CoV-2 infection (edit) |
10.1007/S00380-020-01671-4 |
| 2020-07-16 |
Were protective procedures against SARS-CoV-2 effective in an orthopaedic and trauma centre during the lockdown period? A retrospective study (edit) |
10.1007/S00264-020-04729-0 |
| 2020-07-16 |
How haemophilia A impacts severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) treatment: a case report (edit) |
10.1007/S11239-020-02227-Z |
| 2020-07-16 |
Subacute thyroiditis in a patient infected with SARS-COV-2: an endocrine complication linked to the COVID-19 pandemic (edit) |
10.1007/S42000-020-00230-W |
| 2020-07-16 |
Re-visiting preoperative SARS-CoV-2 testing using a Bayesian approach (edit) |
10.1007/S12630-020-01767-5 |
| 2020-07-16 |
Serological chemiluminescence immunoassay for the diagnosis of SARS-CoV-2 infection (edit) |
10.1002/JCLA.23466 |
| 2020-07-16 |
"A community system": A critical foundation for the epidemic prevention and control of SARS-CoV-2 (edit) |
10.1002/HPM.3005 |
| 2020-07-16 |
Evidence supporting the use of peptides and peptidomimetics as potential SARS-CoV-2 (COVID-19) therapeutics (edit) |
10.4155/FMC-2020-0180 |
| 2020-07-16 |
Blood stewardship: Conservation and supply of blood components during the SARS-CoV-2 pandemic (edit) |
10.1111/TRF.15995 |
| 2020-07-16 |
Association between detectable SARS-COV-2 RNA in anal swabs and disease severity in patients with Coronavirus Disease 2019 (edit) |
10.1002/JMV.26307 |
| 2020-07-16 |
Encephalitic syndrome and anosmia in COVID-19: do these clinical presentations really reflect SARS-CoV-2 neurotropism? A theory based on the review of 25 COVID-19 cases (edit) |
10.1002/JMV.26309 |
| 2020-07-16 |
Initial report on Spanish pediatric oncologic, hematologic, and post stem cell transplantation patients during SARS-CoV-2 pandemic (edit) |
10.1002/PBC.28557 |
| 2020-07-16 |
Rapid Gel Card Agglutination Assays for Serological Analysis Following SARS-CoV-2 Infection in Humans (edit) |
10.1021/ACSSENSORS.0C01050 |
| 2020-07-16 |
Rapid SARS-CoV-2 whole-genome sequencing and analysis for informed public health decision-making in the Netherlands (edit) |
10.1038/S41591-020-0997-Y |
| 2020-07-16 |
The interaction between SARS-CoV-2 and ACE2 may have consequences for skeletal muscle viral susceptibility and myopathies (edit) |
10.1152/JAPPLPHYSIOL.00321.2020 |
| 2020-07-16 |
Rapid inactivation of SARS-CoV-2 with Deep-UV LED irradiation (edit) |
10.1080/22221751.2020.1796529 |
| 2020-07-16 |
Nasopharyngeal SARS-CoV-2 load at hospital admission as predictor of mortality (edit) |
10.1093/CID/CIAA956 |
| 2020-07-16 |
The Value of Human Challenges in SARS-2-nCoV Vaccine Development (edit) |
10.1093/CID/CIAA1013 |
| 2020-07-16 |
Direct on-the-spot detection of SARS-CoV-2 in patients (edit) |
10.1177/1535370220941819 |
| 2020-07-16 |
Prevalence of SARS-CoV-2 infection in asymtomatic pregnant women and their partners in a tertiary care hospital in Portugal (edit) |
10.1080/14767058.2020.1793323 |
| 2020-07-16 |
SARS-CoV-2 is not present in the vaginal fluid of pregnant women with COVID-19 (edit) |
10.1080/14767058.2020.1793318 |
| 2020-07-16 |
[DZK Recommendations for Tuberculosis, BCG and COVID-19 in Germany - (Official Abbreviation of Coronavirus Disease 2019 Caused by the New Coronavirus SARS-CoV-2)] (edit) |
10.1055/A-1199-6721 |
| 2020-07-16 |
Variation in SARS-CoV-2 Prevalence in US Skilled Nursing Facilities (edit) |
10.1111/JGS.16752 |
| 2020-07-16 |
The utility of chest CT and RT-PCR screening of asymptomatic patients for SARS-CoV-2 (COVID-19) prior to semi-urgent or urgent hospital procedures (edit) |
10.1017/ICE.2020.331 |
| 2020-07-16 |
Delivery table shield to assist suspected and confirmed SARS-CoV-2 positive-women in labor (edit) |
10.1016/J.AJOG.2020.07.022 |
| 2020-07-16 |
Lack of association between chilblains outbreak and SARS-CoV-2: histological and serological findings from a new immunoassay (edit) |
10.1016/J.JAAD.2020.07.048 |
| 2020-07-16 |
No evidence of SARS-CoV-2 circulation before the identification of the first Swiss SARS-CoV-2 case (edit) |
10.1016/J.IJANTIMICAG.2020.106100 |
| 2020-07-16 |
Coronavirus infection (SARS-CoV-2) in obesity and diabetes comorbidities: is heat shock response determinant for the disease complications? (edit) |
10.1186/S13098-020-00572-W |
| 2020-07-16 |
Social Distancing Metrics and Estimates of SARS-CoV-2 Transmission Rates: Associations Between Mobile Telephone Data Tracking and R (edit) |
10.1097/PHH.0000000000001240 |
| 2020-07-16 |
Clock genes may drive seasonal variation in SARS-CoV-2 infectivity: are we due for a second wave of COVID-19 in the fall? (edit) |
10.23812/20-359-L-35 |
| 2020-07-16 |
From Anti-SARS-CoV-2 Immune Responses to COVID-19 via Molecular Mimicry (edit) |
10.3390/ANTIB9030033 |
| 2020-07-16 |
The spread of 2019-nCoV in China was primarily driven by population density. Comment on "Association between short-term exposure to air pollution and COVID-19 infection: Evidence from China" by Zhu et al (edit) |
10.1016/J.SCITOTENV.2020.141028 |
| 2020-07-16 |
Hemorrhagic stroke in hispanics with severe SARS-CoV2 infection (edit) |
10.1016/J.JNS.2020.117046 |
| 2020-07-16 |
Spironolactone may provide protection from SARS-CoV-2: Targeting androgens, angiotensin converting enzyme 2 (ACE2), and renin-angiotensin-aldosterone system (RAAS) (edit) |
10.1016/J.MEHY.2020.110112 |
| 2020-07-16 |
Structural stability of the SARS-CoV-2 main protease: Can metal ions affect function? (edit) |
10.1016/J.JINORGBIO.2020.111179 |
| 2020-07-16 |
The Loss of Bcl-6 Expressing T Follicular Helper Cells and the Absence of Germinal Centers in COVID-19 (edit) |
10.2139/SSRN.3652322 |
| 2020-07-16 |
Kinetics and Isotype Assessment of Antibodies Targeting the Spike Protein Receptor Binding Domain of SARS-CoV-2 In COVID-19 Patients as a function of Age and Biological Sex (edit) |
10.1101/2020.07.15.20154443 |
| 2020-07-16 |
Prominent Hypercoagulability Associated With Inflammatory State Among Cancer Patients With SARS-CoV-2 Infection (edit) |
10.3389/FONC.2020.01345 |
| 2020-07-16 |
The Coronavirus Pandemic (SARS-CoV-2): New Problems Demand New Solutions, the Alternative of Mesenchymal (Stem) Stromal Cells (edit) |
10.3389/FCELL.2020.00645 |
| 2020-07-16 |
Administration of Immunoglobulins in SARS-CoV-2-Positive Patient Is Associated With Fast Clinical and Radiological Healing: Case Report (edit) |
10.3389/FMED.2020.00388 |
| 2020-07-16 |
Sars-CoV-2-infeksjon under svangerskapet (edit) |
10.4045/TIDSSKR.20.0489 |
| 2020-07-16 |
Crystal structure, chemical reactivity, kinetic and thermodynamic studies of new ligand derived from 4-hydroxycoumarin: Interaction with SARS-CoV-2 (edit) |
10.1016/J.MOLSTRUC.2020.128918 |
| 2020-07-16 |
Non-exposure procedure to aerosols during a tracheostomy under biosafety isolation in SARS CoV-2 (edit) |
10.1016/J.OTOT.2020.06.003 |
| 2020-07-16 |
General surgeons' attitudes towards COVID-19: A national survey during the SARS-CoV-2 virus outbreak (edit) |
10.1007/S10353-020-00649-W |
| 2020-07-16 |
Guillain-Barré syndrome as the first manifestation of SARS-CoV-2 infection (edit) |
10.1016/J.NRL.2020.07.001 |
| 2020-07-16 |
Repurposing CD8+ T cell immunity against SARS-CoV-2 for cancer immunotherapy: a positive aspect of the COVID-19 pandemic? (edit) |
10.1080/2162402X.2020.1794424 |
| 2020-07-15 |
A direct RNA-protein interaction atlas of the SARS-CoV-2 RNA in infected human cells (edit) |
10.1101/2020.07.15.204404 |
| 2020-07-15 |
SARS-CoV-2 Antibody Responses Do Not Predict COVID-19 Disease Severity (edit) |
10.1093/AJCP/AQAA123 |
| 2020-07-15 |
[Specific characteristics of cardiopulmonary resuscitation in times of SARS-CoV-2] (edit) |
10.1007/S00101-020-00814-6 |
| 2020-07-15 |
COVID-19 pandemic: management of patients affected by SARS-CoV-2 in Rome COVID Hospital 2 Trauma Centre and safety of our surgical team (edit) |
10.1007/S00264-020-04715-6 |
| 2020-07-15 |
Social Determinants of Health and Risk of SARS-CoV-2 Infection in Community-Dwelling Older Adults Living in a Rural Latin American Setting (edit) |
10.1007/S10900-020-00887-9 |
| 2020-07-15 |
SARS-CoV-2/COVID-19: a primer for cardiologists (edit) |
10.1007/S12471-020-01475-1 |
| 2020-07-15 |
Spectrum of Headaches Associated With SARS-CoV-2 Infection: Study of Healthcare Professionals (edit) |
10.1111/HEAD.13902 |
| 2020-07-15 |
Current Status of Multiple Drug Molecules, and Vaccines: An Update in SARS-CoV-2 Therapeutics (edit) |
10.1007/S12035-020-02022-0 |
| 2020-07-15 |
Neurological manifestations of SARS-CoV-2 - a systemic review (edit) |
10.5603/PJNNS.A2020.0050 |
| 2020-07-15 |
A putative new SARS-CoV protein, 3c, encoded in an ORF overlapping ORF3a (edit) |
10.1099/JGV.0.001469 |
| 2020-07-15 |
Systematic Review and Meta-analysis of Effectiveness of Treatment Options Against SARS-CoV-2 infection (edit) |
10.1002/JMV.26302 |
| 2020-07-15 |
Liver Transplant Recipients Infected with SARS-CoV-2 in the Early Postoperative Period: Lessons from a Single Center in the Epicenter of the Pandemic (edit) |
10.1111/TID.13418 |
| 2020-07-15 |
Analytical and clinical validation of an ELISA for specific SARS-CoV-2 IgG, IgA and IgM antibodies (edit) |
10.1002/JMV.26303 |
| 2020-07-15 |
Presymptomatic Transmission of SARS-CoV-2 Amongst Residents and Staff at a Skilled Nursing Facility: Results of Real-Time PCR and Serologic Testing (edit) |
10.1093/CID/CIAA991 |
| 2020-07-15 |
SARS-CoV-2 infects and damages the mature and immature olfactory sensory neurons of hamsters (edit) |
10.1093/CID/CIAA995 |
| 2020-07-15 |
Hypofibrinolytic state and high thrombin generation may play a major role in sars-cov2 associated thrombosis (edit) |
10.1111/JTH.15016 |
| 2020-07-15 |
SARS-CoV-2 (COVID-19) and Cystic Fibrosis (edit) |
10.1152/AJPLUNG.00225.2020 |
| 2020-07-15 |
Potently neutralizing and protective human antibodies against SARS-CoV-2 (edit) |
10.1038/S41586-020-2548-6 |
| 2020-07-15 |
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls (edit) |
10.1038/S41586-020-2550-Z |
| 2020-07-15 |
Clinical characteristics in patients with SARS-CoV-2/HBV co-infection (edit) |
10.1111/JVH.13362 |
| 2020-07-15 |
Comparing dynamics and determinants of SARS-CoV-2 transmissions among health care workers of adult and pediatric settings in central Paris (edit) |
10.1093/CID/CIAA977 |
| 2020-07-15 |
Rapid Quantification of SARS-CoV-2-Neutralizing Antibodies Using Propagation-Defective Vesicular Stomatitis Virus Pseudotypes (edit) |
10.3390/VACCINES8030386 |
| 2020-07-15 |
Health Surveillance and Response to SARS-CoV-2 Mass Testing in Health Workers of a Large Italian Hospital in Verona, Veneto (edit) |
10.3390/IJERPH17145104 |
| 2020-07-15 |
Why Should SARS-CoV-2 Post-Pandemic Recovery Funding Be Used to Foster a Physician-Scientist Program? (edit) |
10.20344/AMP.14421 |
| 2020-07-15 |
Discovery of M Protease inhibitors encoded by SARS-CoV-2 (edit) |
10.1128/AAC.00872-20 |
| 2020-07-15 |
SARS-CoV-2 Virologic and Immunologic Correlates in Patients with Olfactory and Taste Disorders (edit) |
10.3390/MICROORGANISMS8071052 |
| 2020-07-15 |
SARS-CoV-2 Infections and ACE2: Clinical Outcomes Linked With Increased Morbidity and Mortality in Individuals With Diabetes (edit) |
10.2337/DBI20-0019 |
| 2020-07-15 |
Ligand- and structure-based virtual screening of Lamiaceae diterpenes with potential activity against a novel coronavirus (2019-nCoV) (edit) |
10.2174/1568026620666200716114546 |
| 2020-07-15 |
A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology (edit) |
10.1038/S41564-020-0770-5 |
| 2020-07-15 |
Nosocomial transmission prevention of SARS-Cov-2 using a preoperative chest CT: a monocentric study during the outbreak (edit) |
10.1016/J.JHIN.2020.07.005 |
| 2020-07-15 |
Creutzfeldt-Jakob disease in a man with COVID-19: SARS-CoV-2-accelerated neurodegeneration? (edit) |
10.1016/J.BBI.2020.07.007 |
| 2020-07-15 |
Design of a Multi-epitope Vaccine against SARS-CoV-2 using Immunoinformatics approach (edit) |
10.1016/J.IJBIOMAC.2020.07.117 |
| 2020-07-15 |
Prophylactic and Therapeutic Inhibition of In Vitro SARS-CoV-2 Replication by Oleandrin (edit) |
10.1101/2020.07.15.203489 |
| 2020-07-15 |
Bivalent binding of a fully human IgG to the SARS-CoV-2 spike proteins reveals mechanisms of potent neutralization (edit) |
10.1101/2020.07.14.203414 |
| 2020-07-15 |
Clinical Electroencephalography Findings and Considerations in Hospitalized Patients with Coronavirus SARS-CoV-2 (edit) |
10.1101/2020.07.13.20152207 |
| 2020-07-15 |
Intermolecular interaction among Remdesivir, RNA and RNA-dependent RNA polymerase of SARS-CoV-2 analyzed by fragment molecular orbital calculation (edit) |
10.1016/J.JMGM.2020.107695 |
| 2020-07-15 |
SARS-CoV-2 Infection of Ocular Cells from Human Adult Donor Eyes and hESC-Derived Eye Organoids (edit) |
10.2139/SSRN.3650574 |
| 2020-07-15 |
Atypical presentation of SARS-CoV-2 infection in male genitalia (edit) |
10.1016/J.EUCR.2020.101349 |
| 2020-07-15 |
A SARS-CoV-2 vaccine candidate: In-silico cloning and validation (edit) |
10.1016/J.IMU.2020.100394 |
| 2020-07-15 |
SARS-CoV-2 Virions or Ubiquitous Cell Structures? Actual Dilemma in COVID-19 Era (edit) |
10.1016/J.EKIR.2020.07.003 |
| 2020-07-15 |
Epidemiologic and clinical characteristics of 42 deaths caused by SARS-CoV-2 infection in Wuhan, China: A retrospective study (edit) |
10.1016/J.BSHEAL.2020.07.007 |
| 2020-07-15 |
Point of Care Nucleic Acid Testing for SARS-CoV-2 in Hospitalized Patients: A Clinical Validation Trial and Implementation Study (edit) |
10.1016/J.XCRM.2020.100062 |
| 2020-07-15 |
Spread of SARS-CoV-2 through Latin America and the Caribbean region: A look from its economic conditions, climate and air pollution indicators (edit) |
10.1016/J.ENVRES.2020.109938 |
| 2020-07-14 |
Syncytia formation by SARS-CoV-2 infected cells (edit) |
10.1101/2020.07.14.202028 |
| 2020-07-14 |
A Randomized Trial of Ivermectin-Doxycycline and Hydroxychloroquine-Azithromycin therapy on COVID19 patients (edit) |
10.21203/RS.3.RS-38896/V1 |
| 2020-07-14 |
The Coronavirus SARS-Cov-2: the Complexity of Infection Pathogenesis, the Search of Vaccines and Possible Future Pandemics (edit) |
10.31631/2073-3046-2020-19-3-4-20 |
| 2020-07-14 |
Prone positioning under VV-ECMO in SARS-CoV-2-induced acute respiratory distress syndrome (edit) |
10.1186/S13054-020-03162-4 |
| 2020-07-14 |
The spectrum of pathological findings in coronavirus disease (COVID-19) and the pathogenesis of SARS-CoV-2 (edit) |
10.1186/S13000-020-00999-9 |
| 2020-07-14 |
The Australasian COVID-19 Trial (ASCOT) to assess clinical outcomes in hospitalised patients with SARS-CoV-2 infection (COVID-19) treated with lopinavir/ritonavir and/or hydroxychloroquine compared to standard of care: A structured summary of a stud (edit) |
10.1186/S13063-020-04576-9 |
| 2020-07-14 |
Comparison of Extraction Methods and Thermocyclers for SARS-CoV-2 Molecular Detection using Clinical Specimens (edit) |
10.1128/JCM.01622-20 |
| 2020-07-14 |
Evaluation of six commercial mid to high volume antibody and six point of care lateral flow assays for detection of SARS-CoV-2 antibodies (edit) |
10.1128/JCM.01361-20 |
| 2020-07-14 |
Exploring the SARS-CoV-2 virus-host-drug interactome for drug repurposing (edit) |
10.1038/S41467-020-17189-2 |
| 2020-07-14 |
Aerosol and environmental surface monitoring for SARS-CoV-2 RNA in a designated hospital for severe COVID-19 patients (edit) |
10.1017/S0950268820001570 |
| 2020-07-14 |
Delivery care during the SARS-CoV-2 epidemic in Italy: an instant survey (edit) |
10.1017/DMP.2020.250 |
| 2020-07-14 |
SARS-CoV-2 proteome microarray for global profiling of COVID-19 specific IgG and IgM responses (edit) |
10.1038/S41467-020-17488-8 |
| 2020-07-14 |
A stochastic agent-based model of the SARS-CoV-2 epidemic in France (edit) |
10.1038/S41591-020-1001-6 |
| 2020-07-14 |
Transplacental transmission of SARS-CoV-2 infection (edit) |
10.1038/S41467-020-17436-6 |
| 2020-07-14 |
First-in-Man: Case Report of Selective C-Reactive Protein Apheresis in a Patient with SARS-CoV-2 Infection (edit) |
10.12659/AJCR.925020 |
| 2020-07-14 |
The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based antihypertensive therapies-reply (edit) |
10.1007/S11739-020-02436-7 |
| 2020-07-14 |
Combined throat/nasal swab sampling for SARS-CoV-2 is equivalent to nasopharyngeal sampling (edit) |
10.1007/S10096-020-03972-Y |
| 2020-07-14 |
A mobile DNA laboratory for forensic science adapted to coronavirus SARS-CoV-2 diagnosis (edit) |
10.1007/S10096-020-03989-3 |
| 2020-07-14 |
High Prevalence of SARS-CoV-2 Infection Among the Uninsured Hispanic/Latino Population: a Retrospective Cohort Study (edit) |
10.1007/S11606-020-06026-3 |
| 2020-07-14 |
No evidence of SARS-CoV-2 RNA among blood donors: A multicenter study in Hubei, China (edit) |
10.1111/TRF.15943 |
| 2020-07-14 |
COVID-19 and chronic obstructive pulmonary disease: therapeutic potential of blocking SARS-CoV2 adhesion factors (edit) |
10.1111/IMJ.14887 |
| 2020-07-14 |
Computational discovery of small drug-like compounds as potential inhibitors of SARS-CoV-2 main protease (edit) |
10.1080/07391102.2020.1792989 |
| 2020-07-14 |
Does the human placenta express the canonical cell entry mediators for SARS-CoV-2? (edit) |
10.7554/ELIFE.58716 |
| 2020-07-14 |
SARS-CoV-2 in the first trimester of pregnancy: potential interference in placentation (edit) |
10.1080/14767058.2020.1792879 |
| 2020-07-14 |
Absence of in-flight transmission of SARS-CoV-2 likely due to use of face masks on board (edit) |
10.1093/JTM/TAAA117 |
| 2020-07-14 |
Detection of SARS-CoV-2 RNA in commercial passenger aircraft and cruise ship wastewater: a surveillance tool for assessing the presence of COVID-19 infected travelers (edit) |
10.1093/JTM/TAAA116 |
| 2020-07-14 |
omputer modelling of a potential agent against SARS-Cov-2 (COVID-19) protease (edit) |
10.1002/PROT.25980 |
| 2020-07-14 |
Can the Environmental Phagocyte Acanthamoeba Be a Useful Model to Study SARS-CoV-2 Pathogenicity, Infectivity, and Evasion of Cellular Immune Defenses? (edit) |
10.1021/ACSCHEMNEURO.0C00401 |
| 2020-07-14 |
Calcium Channel Blockers: A Possible Potential Therapeutic Strategy for the Treatment of Alzheimer's Dementia Patients with SARS-CoV-2 Infection (edit) |
10.1021/ACSCHEMNEURO.0C00391 |
| 2020-07-14 |
Anti-SARS-CoV-2 antibody testing in IBD healthcare professionals: are we currently able to provide COVID-free IBD clinics? (edit) |
10.1080/00365521.2020.1791244 |
| 2020-07-14 |
An immunotherapeutic method for COVID-19 patients: a soluble ACE2-Anti-CD16 VHH to block SARS-CoV-2 Spike protein (edit) |
10.1080/21645515.2020.1787066 |
| 2020-07-14 |
Clinical and Pathological Findings in SARS-CoV-2 Disease Outbreaks in Farmed Mink (Neovison vison) (edit) |
10.1177/0300985820943535 |
| 2020-07-14 |
Universal Masking to Prevent SARS-CoV-2 Transmission-The Time Is Now (edit) |
10.1001/JAMA.2020.13107 |
| 2020-07-14 |
Association Between Universal Masking in a Health Care System and SARS-CoV-2 Positivity Among Health Care Workers (edit) |
10.1001/JAMA.2020.12897 |
| 2020-07-14 |
Magnitude and kinetics of anti-SARS-CoV-2 antibody responses and their relationship to disease severity (edit) |
10.1093/CID/CIAA979 |
| 2020-07-14 |
Management of crash and burn patients with SARS-CoV-2 associated ARDS (edit) |
10.1111/JOCS.14699 |
| 2020-07-14 |
Single-cell RNA Expression Profiling of ACE2, The Receptor of SARS-CoV-2 (edit) |
10.1164/RCCM.202001-0179LE |
| 2020-07-14 |
An mRNA Vaccine against SARS-CoV-2 - Preliminary Report (edit) |
10.1056/NEJMOA2022483 |
| 2020-07-14 |
In vitro evaluation of antiviral activity of single and combined repurposable drugs against SARS-CoV-2 (edit) |
10.1016/J.ANTIVIRAL.2020.104878 |
| 2020-07-14 |
Lower prevalence of antibodies neutralizing SARS-CoV-2 in group O French blood donors (edit) |
10.1016/J.ANTIVIRAL.2020.104880 |
| 2020-07-14 |
Challenges and issues of SARS-CoV-2 pool testing (edit) |
10.1016/S1473-3099(20)30516-8 |
| 2020-07-14 |
Rapid implementation of SARS-CoV-2 sequencing to investigate cases of health-care associated COVID-19: a prospective genomic surveillance study (edit) |
10.1016/S1473-3099(20)30562-4 |
| 2020-07-14 |
Serology-informed estimates of SARS-CoV-2 infection fatality risk in Geneva, Switzerland (edit) |
10.1016/S1473-3099(20)30584-3 |
| 2020-07-14 |
Challenges and issues of SARS-CoV-2 pool testing - Authors' reply (edit) |
10.1016/S1473-3099(20)30455-2 |
| 2020-07-14 |
Selenium - associated gene signatures within the SARS-CoV-2 - host genomic interaction interface (edit) |
10.1016/J.FREERADBIOMED.2020.07.014 |
| 2020-07-14 |
Epidemiology and Clinical Presentation of Children Hospitalized with SARS-CoV-2 Infection in Suburbs of Paris (edit) |
10.3390/JCM9072227 |
| 2020-07-14 |
An Epidemiological Study on the Prevalence of the Clinical Features of SARS-CoV-2 Infection in Romanian People (edit) |
10.3390/IJERPH17145082 |
| 2020-07-14 |
SARS-CoV-2 induces transcriptional signatures in human lung epithelial cells that promote lung fibrosis (edit) |
10.1186/S12931-020-01445-6 |
| 2020-07-14 |
Spontaneous Pneumomediastinum Associated With SARS-CoV-2: Infrequent Complication of the Novel Disease (edit) |
10.7759/CUREUS.9189 |
| 2020-07-14 |
Direct and indirect effects of the SARS-CoV-2 pandemic on Gaucher Disease patients in Spain: Time to reconsider home-based therapies? (edit) |
10.1016/J.BCMD.2020.102478 |
| 2020-07-14 |
Presence and infectivity of SARS-CoV-2 virus in wastewaters and rivers (edit) |
10.1016/J.SCITOTENV.2020.140911 |
| 2020-07-14 |
Comparative multiplexed interactomics of SARS-CoV-2 and homologous coronavirus non-structural proteins identifies unique and shared host-cell dependencies (edit) |
10.1101/2020.07.13.201517 |
| 2020-07-14 |
Single-nucleotide conservation state annotation of SARS-CoV-2 genome (edit) |
10.1101/2020.07.13.201277 |
| 2020-07-14 |
SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2 (edit) |
10.1101/2020.07.14.201616 |
| 2020-07-14 |
Luminore CopperTouch™ surface coating effectively inactivates SARS-CoV-2, Ebola and Marburg viruses in vitro (edit) |
10.1101/2020.07.05.20146043 |
| 2020-07-14 |
Antibody responses to SARS-CoV2 are distinct in children with MIS-C compared to adults with COVID-19 (edit) |
10.1101/2020.07.12.20151068 |
| 2020-07-14 |
Molecular pathogenesis of secondary bacterial infection associated to viral infections including SARS-CoV-2 (edit) |
10.1016/J.JIPH.2020.07.003 |
| 2020-07-14 |
Recombinant protein targeting and opsonizing spike glycoprotein for enhancing SARS-CoV-2 phagocytosis (edit) |
10.1016/J.MEHY.2020.110108 |
| 2020-07-14 |
AGTR2, one possible novel key gene for the entry of SARS-CoV-2 into human cells (edit) |
10.1109/TCBB.2020.3009099 |
| 2020-07-14 |
Multisystem Inflammatory Syndrome With Complete Kawasaki Disease Features Associated With SARS-CoV-2 Infection in a Young Adult. A Case Report (edit) |
10.3389/FMED.2020.00428 |
| 2020-07-14 |
Therapeutic Strategies Against COVID-19 and Structural Characterization of SARS-CoV-2: A Review (edit) |
10.3389/FMICB.2020.01723 |
| 2020-07-14 |
Biosafety threats of the rapidly established labs for SARS-CoV-2 tests in China (edit) |
10.1016/J.ENVINT.2020.105964 |
| 2020-07-14 |
Acidic electrolyzed water potently inactivates SARS-CoV-2 depending on the amount of free available chlorine contacting with the virus (edit) |
10.1016/J.BBRC.2020.07.029 |
| 2020-07-14 |
Dépistage des porteurs du SARS-CoV-2 : et les tests salivaires ? (edit) |
10.1016/J.BANM.2020.07.031 |
| 2020-07-13 |
Anti-SARS-CoV-2 IgG from severely ill COVID-19 patients promotes macrophage hyper-inflammatory responses (edit) |
10.1101/2020.07.13.190140 |
| 2020-07-13 |
Modulating the transcriptional landscape of SARS-CoV-2 as an effective method for developing antiviral compounds (edit) |
10.1101/2020.07.12.199687 |
| 2020-07-13 |
SARS-CoV-2 Nucleocapsid Assembly Inhibitors: Repurposing Antiviral and Antimicrobial Drugs Targeting Nucleocapsid-RNA Interaction (edit) |
10.26434/CHEMRXIV.12587336.V2 |
| 2020-07-13 |
SARS-CoV-2 infection testing at delivery: a clinical and epidemiological priority (edit) |
10.1080/14767058.2020.1788532 |
| 2020-07-13 |
NPC1 as a Modulator of Disease Severity and Viral Entry of Sars-CoV-2 (edit) |
10.2174/1566524020666200713175426 |
| 2020-07-13 |
Is FURIN gene expression in salivary glands related to SARS-CoV-2 infectivity through saliva? (edit) |
10.1136/JCLINPATH-2020-206788 |
| 2020-07-13 |
Efficacy and safety of interferon β-1a in treatment of severe COVID-19: A randomized clinical trial (edit) |
10.1128/AAC.01061-20 |
| 2020-07-13 |
Structural basis of a shared antibody response to SARS-CoV-2 (edit) |
10.1126/SCIENCE.ABD2321 |
| 2020-07-13 |
Broad and differential animal ACE2 receptor usage by SARS-CoV-2 (edit) |
10.1128/JVI.00940-20 |
| 2020-07-13 |
The SARS-CoV-2 N protein is a good component in a vaccine (edit) |
10.1128/JVI.01279-20 |
| 2020-07-13 |
Structural basis for helicase-polymerase coupling in the SARS-CoV-2 replication-transcription complex (edit) |
10.1101/2020.07.08.194084 |
| 2020-07-13 |
Severe SARS-CoV-2 infection in humans is defined by a shift in the serum lipidome resulting in dysregulation of eicosanoid immune mediators (edit) |
10.1101/2020.07.09.20149849 |
| 2020-07-13 |
Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2 (edit) |
10.1038/S41594-020-0469-6 |
| 2020-07-13 |
Collateral damage: Fear from SARS-CoV2-infection causing Takotsubo cardiomyopathy (edit) |
10.1007/S00392-020-01706-W |
| 2020-07-13 |
Prediction Model Based on the Combination of Cytokines and Lymphocyte Subsets for Prognosis of SARS-CoV-2 Infection (edit) |
10.1007/S10875-020-00821-7 |
| 2020-07-13 |
Vertical transmission of SARS-CoV-2 infection and preterm birth (edit) |
10.1007/S10096-020-03964-Y |
| 2020-07-13 |
Evaluation of seven commercial SARS-CoV-2 RNA detection kits based on real-time polymerase chain reaction (PCR) in China (edit) |
10.1515/CCLM-2020-0271 |
| 2020-07-13 |
SARS-CoV-2 RT-PCR and Chest CT, two complementary approaches for COVID-19 diagnosis (edit) |
10.1007/S11604-020-01016-1 |
| 2020-07-13 |
SARS-CoV-2 diagnostic diary: from rumors to the first case. Early reports of molecular tests from the military research and diagnostic institute of Rio de Janeiro (edit) |
10.1590/0074-02760200200 |
| 2020-07-13 |
A Surface Coating that Rapidly Inactivates SARS-CoV-2 (edit) |
10.1021/ACSAMI.0C11425 |
| 2020-07-13 |
Identification of potential drugs against SARS-CoV-2 non-structural protein 1 (nsp1) (edit) |
10.1080/07391102.2020.1792992 |
| 2020-07-13 |
Airborne Transmission of SARS-CoV-2: Theoretical Considerations and Available Evidence (edit) |
10.1001/JAMA.2020.12458 |
| 2020-07-13 |
Montelukast drug activity and potential against SARS-CoV-2 (edit) |
10.1002/JMV.26299 |
| 2020-07-13 |
The role of host genetics in the immune response to SARS-CoV-2 and COVID-19 susceptibility and severity (edit) |
10.1111/IMR.12897 |
| 2020-07-13 |
Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients (edit) |
10.1016/J.CELL.2020.06.044 |
| 2020-07-13 |
SARS-CoV-2 Infection and Thrombosis: Phlegmasia Cerulea Dolens Presenting with Venous Gangrene in a Child (edit) |
10.1016/J.JPEDS.2020.07.032 |
| 2020-07-13 |
Viral CpG deficiency provides no evidence that dogs were intermediate hosts for SARS-CoV-2 (edit) |
10.1093/MOLBEV/MSAA178 |
| 2020-07-13 |
mTORC inhibitor Sirolimus deprograms monocytes in "cytokine storm" in SARS-CoV2 secondary hemophagocytic lymphohistiocytosis- like syndrome (edit) |
10.1016/J.CLIM.2020.108539 |
| 2020-07-13 |
SARS-CoV2 in patients on antiviral HBV and HCV therapy in Spain (edit) |
10.1016/J.JHEP.2020.07.007 |
| 2020-07-13 |
Mutational Frequencies of SARS-CoV-2 Genome during the Beginning Months of the Outbreak in USA (edit) |
10.3390/PATHOGENS9070565 |
| 2020-07-13 |
High Throughput Virtual Screening to Discover Inhibitors of the Main Protease of the Coronavirus SARS-CoV-2 (edit) |
10.3390/MOLECULES25143193 |
| 2020-07-13 |
COVID-19/SARS-CoV-2 Infection: Lysosomes and Lysosomotropism Implicate New Treatment Strategies and Personal Risks (edit) |
10.3390/IJMS21144953 |
| 2020-07-13 |
Antibody kinetics in primary- and secondary-care physicians with mild to moderate SARS-CoV-2 infection (edit) |
10.1080/22221751.2020.1793690 |
| 2020-07-13 |
A perspective on potential antibody-dependent enhancement of SARS-CoV-2 (edit) |
10.1038/S41586-020-2538-8 |
| 2020-07-13 |
Cold sensitivity of the SARS-CoV-2 spike ectodomain (edit) |
10.1101/2020.07.12.199588 |
| 2020-07-13 |
Sensitivity assessment of droplet digital PCR for SARS-CoV-2 detection (edit) |
10.3892/IJMM.2020.4673 |
| 2020-07-13 |
Making waves: Wastewater surveillance of SARS-CoV-2 for population-based health management (edit) |
10.1016/J.WATRES.2020.116181 |
| 2020-07-13 |
SARS-CoV-2 infection pathogenesis is related to oxidative stress as a response to aggression (edit) |
10.1016/J.MEHY.2020.110102 |
| 2020-07-13 |
Patient characteristics, clinical course and factors associated to ICU mortality in critically ill patients infected with SARS-CoV-2 in Spain: A prospective, cohort, multicentre study (edit) |
10.1016/J.REDAR.2020.07.003 |
| 2020-07-13 |
[Pregnancy, birth, and puerperium with SARS-CoV-2 and COVID-19] (edit) |
10.1007/S00129-020-04637-9 |
| 2020-07-13 |
Symmetric peripheral polyarthritis developed during SARS-CoV-2 infection (edit) |
10.1016/S2665-9913(20)30216-2 |
| 2020-07-13 |
Oncolytic effect of SARS-CoV2 in a patient with NK lymphoma (edit) |
10.23750/ABM.V91I3.10141 |
| 2020-07-12 |
SARS-CoV-2 will constantly sweep its tracks: a vaccine containing CpG motifs in 'lasso' for the multi-faced virus (edit) |
10.1007/S00011-020-01377-3 |
| 2020-07-12 |
In Silico Investigation of the SARS CoV2 Protease with Thymoquinone Major Constituent of Nigella Sativa (edit) |
10.2174/1570163817666200712164406 |
| 2020-07-12 |
Guillain-Barré Syndrome Associated with SARS-CoV-2 Infection in a Pediatric Patient (edit) |
10.1093/TROPEJ/FMAA044 |
| 2020-07-12 |
Architecture and self-assembly of the SARS-CoV-2 nucleocapsid protein (edit) |
10.1002/PRO.3909 |
| 2020-07-12 |
Decrease of non-classical and intermediate monocyte subsets in severe acute SARS-CoV-2 infection (edit) |
10.1002/CYTO.A.24188 |
| 2020-07-12 |
SARS-CoV-2: An immunogenetics call to arms (edit) |
10.1111/IJI.12504 |
| 2020-07-12 |
Eicosapentaenoic free fatty acid to treat patients with SARS-Cov2 infection (edit) |
10.1016/J.MEHY.2020.110095 |
| 2020-07-12 |
Fetal deaths in pregnancies with SARS-CoV-2 infection in Brazil: A case series (edit) |
10.1016/J.CRWH.2020.E00243 |
| 2020-07-12 |
Bilateral spontaneous pneumothorax in SARS-CoV-2 infection: A very rare, life-threatening complication (edit) |
10.1016/J.AJEM.2020.07.018 |
| 2020-07-12 |
Monitoring antibody response following SARS-CoV-2 infection: diagnostic efficiency of 4 automated immunoassays (edit) |
10.1016/J.DIAGMICROBIO.2020.115140 |
| 2020-07-11 |
Longitudinal evaluation and decline of antibody responses in SARS-CoV-2 infection (edit) |
10.1101/2020.07.09.20148429 |
| 2020-07-11 |
Could SARS-CoV-2 or COVID-19 Be a Biological Weapon? (edit) |
10.18502/IJPH.V49IS1.3691 |
| 2020-07-11 |
Guillain-Barre Syndrome Associated with SARS-CoV-2 Detection and a COVID-19 Infection in a Child (edit) |
10.1093/JPIDS/PIAA086 |
| 2020-07-11 |
Clinical characteristics and outcome of SARS-CoV-2 infection in Italian pediatric oncology patients: a study from the Infectious Diseases Working Group of the AIEOP (edit) |
10.1093/JPIDS/PIAA088 |
| 2020-07-11 |
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection risk during elective peri-operative care: a narrative review (edit) |
10.1111/ANAE.15221 |
| 2020-07-11 |
The impact of SARS-CoV-2 on surgical education - challenges and potential solutions (edit) |
10.1002/BJS.11793 |
| 2020-07-11 |
Remdesivir during induction chemotherapy for newly diagnosed paediatric acute lymphoblastic leukaemia with concomitant SARS-CoV-2 infection (edit) |
10.1111/BJH.17014 |
| 2020-07-11 |
SARS-CoV-2, COVID-19 pandemic, "coronawar"… oops; something was forgotten. Cardiovascular disease is still here! The collateral damage (edit) |
10.1111/JOCS.14791 |
| 2020-07-11 |
Successful coronary artery bypass operation in a SARS-COV-2 infected patient with acute coronary syndrome (edit) |
10.1111/JOCS.14784 |
| 2020-07-11 |
Aerosol-mediated transmission of SARS-Cov-2 or COVID-19 in the cardiac surgical operating room (edit) |
10.1111/JOCS.14728 |
| 2020-07-11 |
Persistently positive severe acute respiratory syndrome coronavirus 2 (SARS-COV2) nasopharyngeal PCR in a kidney transplant recipient (edit) |
10.1111/TID.13408 |
| 2020-07-11 |
Comparison of hydroxychloroquine, lopinavir/ritonavir, and standard of care in critically ill patients with SARS-CoV-2 pneumonia: an opportunistic retrospective analysis (edit) |
10.1186/S13054-020-03117-9 |
| 2020-07-11 |
A case presentation for positive SARS-CoV-2 RNA recurrence in a patient with a history of type 2 diabetes that had recovered from severe COVID-19 (edit) |
10.1016/J.DIABRES.2020.108300 |
| 2020-07-11 |
Silent Hypoxia in Patients with SARS CoV-2 Infection before Hospital Discharge (edit) |
10.1016/J.IJID.2020.07.014 |
| 2020-07-11 |
Population Genetics of SARS-CoV-2: Disentangling Effects of Sampling Bias and Infection Clusters (edit) |
10.1016/J.GPB.2020.06.001 |
| 2020-07-11 |
Control of SARS-CoV-2 infection in rituximab-treated neuroimmunological patients (edit) |
10.1007/S00415-020-10046-8 |
| 2020-07-11 |
Design of engineered surfaces for prospective detection of Sars-CoV-2 using quartz crystal microbalance based techniques (edit) |
10.1080/14789450.2020.1794831 |
| 2020-07-11 |
Evaluation of Commercial qPCR Kits for Detection of SARS-CoV-2 in Pooled Samples (edit) |
10.3390/DIAGNOSTICS10070472 |
| 2020-07-11 |
SARS-CoV-2: the endocrinological protective clinical model derived from patients with prostate cancer (edit) |
10.1177/2042018820942385 |
| 2020-07-11 |
SARS-CoV-2 infection in severe pediatric Crohn's disease. What about anti-tumor necrosis factor α therapy? (edit) |
10.1016/J.DLD.2020.06.047 |
| 2020-07-11 |
No arguments for extra risk from ibuprofen in SARS-COV2 infection (edit) |
10.1016/J.THERAP.2020.07.006 |
| 2020-07-11 |
Involvement of Spike Protein, Furin, and ACE2 in SARS-CoV-2-Related Cardiovascular Complications (edit) |
10.1007/S42399-020-00400-2 |
| 2020-07-11 |
Histolo-radiological dissociation in pulmonary fibrosis secondary to SARS-CoV-2 infection (edit) |
10.1016/J.MEDIN.2020.06.018 |
| 2020-07-11 |
Perioperative management of patients with suspected or severe infection with SARS-CoV-2 coronavirus programmed for the implementation of electronic devices for the control of chronic pain (edit) |
10.1016/J.REDAR.2020.06.010 |
| 2020-07-10 |
Stabilizing the Closed SARS-CoV-2 Spike Trimer (edit) |
10.1101/2020.07.10.197814 |
| 2020-07-10 |
A drug repurposing screen identifies hepatitis C antivirals as inhibitors of the SARS-CoV-2 main protease (edit) |
10.1101/2020.07.10.197889 |
| 2020-07-10 |
Self-reported symptoms of SARS-CoV-2 infection in a non-hospitalized population: results from the large Italian web-based EPICOVID19 cross-sectional survey (edit) |
10.2196/21866 |
| 2020-07-10 |
The practical challenges of making clinical use of the quantitative value for SARS-CoV-2 viral load across several dynamics (edit) |
10.1093/CID/CIAA958 |
| 2020-07-10 |
Energetics and IC50 based epitope screening in SARS CoV-2 (COVID 19) spike protein by immunoinformatic analysis implicating for a suitable vaccine development (edit) |
10.1186/S12967-020-02435-4 |
| 2020-07-10 |
Forensic DNA testing during the SARS-CoV-2 pandemic (edit) |
10.1016/J.FSIGEN.2020.102346 |
| 2020-07-10 |
A Case for Targeting Th17 Cells and IL-17A in SARS-CoV-2 Infections (edit) |
10.4049/JIMMUNOL.2000554 |
| 2020-07-10 |
Direct Comparison of SARS-CoV-2 Analytical Limits of Detection across Seven Molecular Assays (edit) |
10.1128/JCM.01535-20 |
| 2020-07-10 |
Adaptive Evolution of Peptide Inhibitors for Mutating SARS-CoV-2 (edit) |
10.26434/CHEMRXIV.12622667 |
| 2020-07-10 |
Retraction Note to: SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion (edit) |
10.1038/S41423-020-0498-4 |
| 2020-07-10 |
Replication-competent vesicular stomatitis virus vaccine vector protects against SARS-CoV-2-mediated pathogenesis (edit) |
10.1101/2020.07.09.196386 |
| 2020-07-10 |
Comprehensive in-vivo secondary structure of the SARS-CoV-2 genome reveals novel regulatory motifs and mechanisms (edit) |
10.1101/2020.07.10.197079 |
| 2020-07-10 |
SARS-CoV-2 infection in the lungs of human ACE2 transgenic mice causes severe inflammation, immune cell infiltration, and compromised respiratory function (edit) |
10.1101/2020.07.09.196188 |
| 2020-07-10 |
Severely ill COVID-19 patients display augmented functional properties in SARS-CoV-2-reactive CD8 + T cells (edit) |
10.1101/2020.07.09.194027 |
| 2020-07-10 |
Distinct patterns of SARS-CoV-2 transmission in two nearby communities in Wisconsin, USA (edit) |
10.1101/2020.07.09.20149104 |
| 2020-07-10 |
SARS-CoV-2 Seroprevalence Among Parturient Women (edit) |
10.1101/2020.07.08.20149179 |
| 2020-07-10 |
COVID-19 pandemic predictions using the modified Bateman SIZ model and observational data for Heidelberg, Germany: Effect of vaccination with a SARS-CoV-2 vaccine, coronavirus testing and application of the Corona-Warn-App (edit) |
10.5414/CP203846 |
| 2020-07-10 |
Analytical sensitivity and efficiency comparisons of SARS-CoV-2 RT-qPCR primer-probe sets (edit) |
10.1038/S41564-020-0761-6 |
| 2020-07-10 |
SARS-CoV-2 on the neural battleground (edit) |
10.1038/S41577-020-0399-X |
| 2020-07-10 |
CRISPRing for host genes regulating SARS-CoV-2 (edit) |
10.1038/S41577-020-0400-8 |
| 2020-07-10 |
Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein (edit) |
10.1038/S41591-020-0998-X |
| 2020-07-10 |
Gene expression pattern differences in primary human pulmonary epithelial cells infected with MERS-CoV or SARS-CoV-2 (edit) |
10.1007/S00705-020-04730-3 |
| 2020-07-10 |
Infectivity, virulence, pathogenicity, host-pathogen interactions of SARS and SARS-CoV-2 in experimental animals: a systematic review (edit) |
10.1007/S11259-020-09778-9 |
| 2020-07-10 |
In defense of the Unified Health System in the context of SARS-CoV-2 pandemic (edit) |
10.1590/0034-7167-2020-0247 |
| 2020-07-10 |
Acute Kidney Injury by SARS-CoV-2 virus in patients with COVID-19: an integrative review (edit) |
10.1590/0034-7167-2020-0354 |
| 2020-07-10 |
SARS-COV-2 Maternal-Child Transmission: Can It Occur Before Delivery and How Do We Prove It? (edit) |
10.1097/INF.0000000000002820 |
| 2020-07-10 |
Probable Vertical Transmission of SARS-CoV-2 Infection (edit) |
10.1097/INF.0000000000002821 |
| 2020-07-10 |
INTRAUTERINE TRANSMISSION OF SARS-COV-2 INFECTION IN A PRETERM INFANT (edit) |
10.1097/INF.0000000000002815 |
| 2020-07-10 |
CCR5 Δ32 minorallele is associated with susceptibility to SARS-CoV-2 infection and death: An epidemiological investigation (edit) |
10.1016/J.CCA.2020.07.012 |
| 2020-07-10 |
When hospitals Harm: Multi-modal entry of SARS-CoV-2 into inpatient healthcare (edit) |
10.1093/CID/CIAA957 |
| 2020-07-10 |
Indian Publications on SARS-CoV-2: A bibliometric study of WHO COVID-19 database (edit) |
10.1016/J.DSX.2020.07.007 |
| 2020-07-10 |
The hypothesis that SARS-CoV-2 affects male reproductive ability by regulating autophagy (edit) |
10.1016/J.MEHY.2020.110083 |
| 2020-07-10 |
IMPLEMENTATION OF UNIVERSAL TESTING FOR SARS-CoV-2 IN PREGNANT WOMEN WITH INTENDED ADMISSION FOR DELIVERY (edit) |
10.1016/J.AJOG.2020.07.011 |
| 2020-07-10 |
Brief validation of the novel GeneXpert Xpress SARS-CoV-2 PCR assay (edit) |
10.1016/J.JVIROMET.2020.113925 |
| 2020-07-10 |
Capillary electrophoresis of PCR fragments with 5´-labelled primers for testing the SARS-Cov-2 (edit) |
10.1016/J.JVIROMET.2020.113937 |
| 2020-07-10 |
Commercial SARS-CoV-2 Molecular Assays: Superior Analytical Sensitivity of cobas SARS-CoV-2 Relative to NxTAG Cov Extended Panel and ID NOW COVID-19 Test (edit) |
10.5858/ARPA.2020-0283-SA |
| 2020-07-10 |
Immunoglobulin fragment F(ab')2 against RBD potently neutralizes SARS-CoV-2 in vitro (edit) |
10.1016/J.ANTIVIRAL.2020.104868 |
| 2020-07-10 |
Genome-wide analysis of Indian SARS-CoV-2 genomes for the identification of genetic mutation and SNP (edit) |
10.1016/J.MEEGID.2020.104457 |
| 2020-07-10 |
Long-term infection of SARS-CoV-2 changed the body's immune status (edit) |
10.1016/J.CLIM.2020.108524 |
| 2020-07-10 |
Natural transmission of bat-like SARS-CoV-2PRRA variants in COVID-19 patients (edit) |
10.1093/CID/CIAA953 |
| 2020-07-10 |
SARS-CoV-2 antibody prevalence in blood in a large school community subject to a Covid-19 outbreak: a cross-sectional study (edit) |
10.1093/CID/CIAA955 |
| 2020-07-10 |
Initial and Repeated Point Prevalence Surveys to Inform SARS-CoV-2 Infection Prevention in 26 Skilled Nursing Facilities - Detroit, Michigan, March-May 2020 (edit) |
10.15585/MMWR.MM6927E1 |
| 2020-07-10 |
Limiting positive end-expiratory pressure to protect renal function in SARS-CoV-2 critically ill patients (edit) |
10.1016/J.JCRC.2020.07.008 |
| 2020-07-10 |
Clinical application of rapid diagnostic test kit for SARS-CoV-2 antibodies into the field of patient care (edit) |
10.1016/J.JMII.2020.07.003 |
| 2020-07-10 |
Reorganization of the functional gastrointestinal disorders unit during the SARS-CoV-2 outbreak - Practical Recommendations (edit) |
10.1016/J.DLD.2020.07.011 |
| 2020-07-10 |
Structure-based drug designing and immunoinformatics approach for SARS-CoV-2 (edit) |
10.1126/SCIADV.ABB8097 |
| 2020-07-10 |
The importance of cycle threshold values in interpreting molecular tests for SARS-CoV-2 (edit) |
10.1016/J.DIAGMICROBIO.2020.115130 |
| 2020-07-10 |
SARS-CoV-2 (COVID-19) pneumonia: Incidental finding on 18F-FDG PET/CT study for vasculitis diagnosis (edit) |
10.1016/J.REMN.2020.06.013 |
| 2020-07-10 |
Bioinformatics analysis of epitope-based vaccine design against the novel SARS-CoV-2 (edit) |
10.1186/S40249-020-00713-3 |
| 2020-07-10 |
SARS-CoV-2 Molecular Network Structure (edit) |
10.3389/FPHYS.2020.00870 |
| 2020-07-10 |
Inpatient Neurology Consultations During the Onset of the SARS-CoV-2 New York City Pandemic: A Single Center Case Series (edit) |
10.3389/FNEUR.2020.00805 |
| 2020-07-10 |
Combined Prophylactic and Therapeutic Use Maximizes Hydroxychloroquine Anti-SARS-CoV-2 Effects in vitro (edit) |
10.3389/FMICB.2020.01704 |
| 2020-07-10 |
Identification of SARS-CoV-2 Cell Entry Inhibitors by Drug Repurposing Using in silico Structure-Based Virtual Screening Approach (edit) |
10.3389/FIMMU.2020.01664 |
| 2020-07-10 |
The Potential Effect of Novel Coronavirus SARS-CoV-2 on NK Cells; A Perspective on Potential Therapeutic Interventions (edit) |
10.3389/FIMMU.2020.01692 |
| 2020-07-10 |
Commentary: SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China (edit) |
10.3389/FONC.2020.01223 |
| 2020-07-10 |
Clinical Characteristics and Eosinophils in Young SARS-CoV-2-Positive Chinese Travelers Returning to Shanghai (edit) |
10.3389/FPUBH.2020.00368 |
| 2020-07-10 |
Transmission Routes Analysis of SARS-CoV-2: A Systematic Review and Case Report (edit) |
10.3389/FCELL.2020.00618 |
| 2020-07-10 |
Epigenetic Regulator miRNA Pattern Differences Among SARS-CoV, SARS-CoV-2, and SARS-CoV-2 World-Wide Isolates Delineated the Mystery Behind the Epic Pathogenicity and Distinct Clinical Characteristics of Pandemic COVID-19 (edit) |
10.3389/FGENE.2020.00765 |
| 2020-07-10 |
Inhibition of SARS-CoV-2 main protease 3CLpro by means of α-ketoamide and pyridone-containing pharmaceuticals using in silico molecular docking (edit) |
10.1016/J.MOLSTRUC.2020.128878 |
| 2020-07-10 |
Encephalitis associated with the SARS-CoV-2 virus: A case report (edit) |
10.1016/J.INAT.2020.100821 |
| 2020-07-10 |
Effectiveness of corticoid pulses in patients with cytokine storm syndrome induced by SARS-CoV-2 infection (edit) |
10.1016/J.MEDCLE.2020.07.002 |
| 2020-07-10 |
Clinical challenges in chronic obstructive pulmonary disease in patients who suffered SARS-CoV-2 infection (edit) |
10.1016/J.MEDCLE.2020.04.012 |
| 2020-07-10 |
[Nutritional support for critically ill patients suffering from SARS-CoV-2 infection] (edit) |
10.1016/J.PRATAN.2020.07.002 |
| 2020-07-10 |
Implications of SARS-CoV-2 genetic diversity and mutations on pathogenicity of the COVID-19 and biomedical interventions (edit) |
10.1016/J.JTUMED.2020.06.005 |
| 2020-07-10 |
Adipose-derived mesenchymal stromal cells for the treatment of patients with severe SARS-CoV-2 pneumonia requiring mechanical ventilation. A proof of concept study (edit) |
10.1016/J.ECLINM.2020.100454 |
| 2020-07-10 |
In Defense of Our Patients: Indirect Negative Neurological Consequences of SARS-CoV-2 in the New York Epicenter (edit) |
10.1016/J.JSTROKECEREBROVASDIS.2020.105127 |
| 2020-07-09 |
Clinical Manifestation and the Risk of Exposure to SARS-CoV-2 (COVID-19) (edit) |
|
| 2020-07-09 |
Decline of humoral responses against SARS-CoV-2 Spike in convalescent individuals (edit) |
10.1101/2020.07.09.194639 |
| 2020-07-09 |
Molecular architecture of the SARS-CoV-2 virus (edit) |
10.1101/2020.07.08.192104 |
| 2020-07-09 |
Emergence of a Zoonotic Pathogen - Novel Coronavirus (SARS-CoV-2) in the Context of Changing Environment (edit) |
10.24321/0019.5138.202021 |
| 2020-07-09 |
Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike (edit) |
10.1101/2020.07.09.193680 |
| 2020-07-09 |
Music of microbiota against SARS CoV-2 (edit) |
|
| 2020-07-09 |
Modeling the Novel Coronavirus (SARS-CoV-2) Outbreak in Sicily, Italy (edit) |
10.3390/IJERPH17144964 |
| 2020-07-09 |
SARS-CoV-2 Infection in Febrile Neonates (edit) |
10.1093/JPIDS/PIAA084 |
| 2020-07-09 |
Double-bright (CD56bright/CD16bright) NK cell adoptive immunotherapy for SARS-CoV-2 (edit) |
10.1111/BJH.17010 |
| 2020-07-09 |
Basic Immunology may lead to translational therapeutic rationale:: SARS-CoV-2 and Rheumatic Diseases (edit) |
10.1111/ECI.13342 |
| 2020-07-09 |
Disrupting the Electrical Circuit: New Onset Atrial Fibrillation in a Patient With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (edit) |
10.7759/CUREUS.9082 |
| 2020-07-09 |
Transpulmonary pressure in SARS-CoV-2-associated acute respiratory distress syndrome: a single-center observational study (edit) |
10.1186/S13054-020-03129-5 |
| 2020-07-09 |
Molecular mechanisms of sex bias differences in COVID-19 mortality (edit) |
10.1186/S13054-020-03118-8 |
| 2020-07-09 |
Evolving geographic diversity in SARS-CoV2 and in silico analysis of replicating enzyme 3CLpro targeting repurposed drug candidates (edit) |
10.1186/S12967-020-02448-Z |
| 2020-07-09 |
Human B cell clonal expansion and convergent antibody responses to SARS-CoV-2 (edit) |
10.1101/2020.07.08.194456 |
| 2020-07-09 |
SARS-CoV-2 prevalence in an asymptomatic cancer cohort - results and consequences for clinical routine (edit) |
10.1186/S13014-020-01609-0 |
| 2020-07-09 |
Challenges in evaluating SARS-CoV-2 vaccines during the COVID-19 pandemic (edit) |
10.1503/CMAJ.201237 |
| 2020-07-09 |
Holder pasteurization of donated human milk is effective in inactivating SARS-CoV-2 (edit) |
10.1503/CMAJ.201309 |
| 2020-07-09 |
Correction: Guillain-Barré syndrome related to SARS-CoV-2 infection (edit) |
10.1212/NXI.0000000000000850 |
| 2020-07-09 |
Coding-Complete Genome Sequence of SARS-CoV-2 Isolate from Bangladesh by Sanger Sequencing (edit) |
10.1128/MRA.00626-20 |
| 2020-07-09 |
Coding-Complete Genome Sequences of Two SARS-CoV-2 Isolates from Early Manifestations of COVID-19 in Israel (edit) |
10.1128/MRA.00677-20 |
| 2020-07-09 |
Comparison of test performance of commercial anti-SARS-CoV-2 immunoassays in serum and plasma samples (edit) |
10.1016/J.CCA.2020.07.007 |
| 2020-07-09 |
Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice (edit) |
10.1038/S41467-020-17409-9 |
| 2020-07-09 |
Detection of SARS-CoV-2 in formalin-fixed paraffin-embedded tissue sections using commercially available reagents (edit) |
10.1038/S41374-020-0464-X |
| 2020-07-09 |
SARS-CoV-2 and bat RaTG13 spike glycoprotein structures inform on virus evolution and furin-cleavage effects (edit) |
10.1038/S41594-020-0468-7 |
| 2020-07-09 |
Revealing COVID-19 transmission in Australia by SARS-CoV-2 genome sequencing and agent-based modeling (edit) |
10.1038/S41591-020-1000-7 |
| 2020-07-09 |
A Confirmed Case of SARS-CoV-2 Pneumonia with Routine RT-PCR Negative and Virus Variation in Guangzhou, China (edit) |
10.1093/CID/CIAA941 |
| 2020-07-09 |
Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicentre observational study (edit) |
10.1016/S2352-4642(20)30215-7 |
| 2020-07-09 |
Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers (edit) |
10.1016/S0140-6736(20)31484-7 |
| 2020-07-09 |
Is Guillain-Barrè syndrome triggered by SARS-CoV-2? Case report and literature review (edit) |
10.1007/S10072-020-04553-9 |
| 2020-07-09 |
Characterization of heparin and severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) spike glycoprotein binding interactions (edit) |
10.1016/J.ANTIVIRAL.2020.104873 |
| 2020-07-09 |
Bioactive compounds from marine resources against novel corona virus (2019-nCoV): in silico study for corona viral drug (edit) |
10.1080/14786419.2020.1791115 |
| 2020-07-09 |
SARS-CoV-2 Receptor ACE2 is upregulated in Colonic Organoids from Hypertensive Rats (edit) |
10.1161/HYPERTENSIONAHA.120.15725 |
| 2020-07-09 |
Computational insights into tetracyclines as inhibitors against SARS-CoV-2 Mpro via combinatorial molecular simulation calculations (edit) |
10.1016/J.LFS.2020.118080 |
| 2020-07-09 |
ERCP and SARS-COV-2: an urgent procedure that should be immune (edit) |
10.1080/00365521.2020.1789210 |
| 2020-07-09 |
Understanding The Complex Relationship Between Androgens and SARS-CoV2 (edit) |
10.1016/J.UROLOGY.2020.06.048 |
| 2020-07-09 |
Adaptation of Russian population to SARS-CoV-2: Asymptomatic course, comorbidities, mortality, and other respiratory viruses - A reply to Fear versus Data: Short Communication to International Journal of Antimicrobial Agents (edit) |
10.1016/J.IJANTIMICAG.2020.106093 |
| 2020-07-09 |
SARS-CoV and SARS-CoV-2 main protease residue interaction networks change when bound to inhibitor N3 (edit) |
10.1016/J.JSB.2020.107575 |
| 2020-07-09 |
The study on the treatment of Xuebijing injection (XBJ) in adults with severe or critical Corona Virus Disease 2019 and the inhibitory effect of XBJ against SARS-CoV-2 (edit) |
10.1016/J.PHRS.2020.105073 |
| 2020-07-09 |
Disappearance of antibodies to SARS-CoV-2 in a Covid-19 patient after recovery (edit) |
10.1016/J.CMI.2020.07.009 |
| 2020-07-09 |
Viral shedding dynamics in asymptomatic and mildly symptomatic patients infected with SARS-CoV-2 (edit) |
10.1016/J.CMI.2020.07.008 |
| 2020-07-09 |
Feco-Oral Transmission of SARS-CoV-2: A Review (edit) |
10.1177/1010539520940931 |
| 2020-07-09 |
Does SARS-CoV-2 infection cause sperm DNA fragmentation? Possible link with oxidative stress (edit) |
10.1080/13625187.2020.1787376 |
| 2020-07-09 |
Clinical exacerbation of SARS-CoV2 infection after fingolimod withdrawal (edit) |
10.1002/JMV.26279 |
| 2020-07-09 |
Duration of SARS-CoV-2 RNA shedding and factors associated with prolonged viral shedding in patients with COVID-19 (edit) |
10.1002/JMV.26280 |
| 2020-07-09 |
Chronic treatment with hydroxychloroquine and SARS-CoV-2 infection (edit) |
10.1002/JMV.26286 |
| 2020-07-09 |
Early use of tocilizumab in the prevention of adult respiratory failure in SARS-CoV-2 infections and the utilization of interleukin-6 levels in the management (edit) |
10.1002/JMV.26288 |
| 2020-07-09 |
Immune responses and pathogenesis in persistently PCR-positive patients with SARS-CoV-2 infection (edit) |
10.1002/JMV.26287 |
| 2020-07-09 |
SARS-CoV-2 in river water: Implications in low sanitation countries (edit) |
10.1016/J.SCITOTENV.2020.140832 |
| 2020-07-09 |
Negative Transmission of SARS-CoV-2 to Hand-Expressed Colostrum from SARS-CoV-2-Positive Mothers (edit) |
10.1089/BFM.2020.0183 |
| 2020-07-09 |
Adverse reactions of drugs specifically used for treatment of SARS-CoV-2 infection (edit) |
10.1016/J.MEDCLI.2020.06.019 |
| 2020-07-09 |
Risk of SARS-CoV-2 infection and clinical outcomes in multiple sclerosis patients in La Rioja (Spain) (edit) |
10.1016/J.MEDCLI.2020.06.021 |
| 2020-07-09 |
BCG Against SARS-CoV-2: Second Youth of an Old Age Vaccine? (edit) |
10.3389/FPHAR.2020.01050 |
| 2020-07-09 |
Pre-existing diabetes is worse for SARS-CoV-2 infection; an endothelial perspective (edit) |
10.1016/J.NUMECD.2020.07.007 |
| 2020-07-09 |
Massive subcutaneous emphysema in patient SARS-CoV-2 positive (edit) |
10.1016/J.REDAR.2020.06.011 |
| 2020-07-08 |
In vivo structural characterization of the whole SARS-CoV-2 RNA genome identifies host cell target proteins vulnerable to re-purposed drugs (edit) |
10.1101/2020.07.07.192732 |
| 2020-07-08 |
Tainted Hand Sanitizer Leads to Outbreak of Methanol Toxicity During SARS-CoV-2 Pandemic (edit) |
10.1016/J.ANNEMERGMED.2020.07.011 |
| 2020-07-08 |
Effectiveness of Ivermectin as add-on Therapy in COVID-19 Management (Pilot Trial) (edit) |
10.1101/2020.07.07.20145979 |
| 2020-07-08 |
Room Temperature Structure of SARS-CoV-2 NSP10/NSP16 Methyltransferase in a Complex with SAM Determined by Fixed-Target Serial Crystallography (edit) |
10.2210/PDB6XKM/PDB |
| 2020-07-08 |
Myopericarditis, Rhabdomyolysis, and Acute Hepatic Injury: Sole Expression of a SARS-CoV-2 Infection (edit) |
10.1161/CIRCIMAGING.120.010907 |
| 2020-07-08 |
Single-cell analysis of SARS-CoV-2 receptor ACE2 and spike protein priming expression of proteases in the human heart (edit) |
10.1093/CVR/CVAA191 |
| 2020-07-08 |
Direct evidence of active SARS-CoV-2 replication in the intestine (edit) |
10.1093/CID/CIAA925 |
| 2020-07-08 |
Real-world evaluation of a novel technology for quantitative simultaneous antibody detection against multiple SARS-CoV-2 antigens in a cohort of patients presenting with COVID-19 syndrome (edit) |
10.1039/D0AN01066A |
| 2020-07-08 |
Systematic profiling of ACE2 expression in diverse physiological and pathological conditions for COVID-19/SARS-CoV-2 (edit) |
10.1111/JCMM.15607 |
| 2020-07-08 |
Changes in RT-PCR test results and symptoms during the menstrual cycle of female individuals infected with SARS-CoV-2: Report of two cases (edit) |
10.1002/JMV.26275 |
| 2020-07-08 |
SARS-CoV2 and immunosuppression: a double-edged sword (edit) |
10.1111/TID.13404 |
| 2020-07-08 |
DISEQUILIBRIUM BETWEEN THE CLASSIC RENIN-ANGIOTENSIN SYSTEM AND ITS OPPOSING ARM IN SARS-COV-2 RELATED LUNG INJURY (edit) |
10.1152/AJPLUNG.00189.2020 |
| 2020-07-08 |
The early antibody response to SARS-Cov-2 infection (edit) |
10.1515/CCLM-2020-0617 |
| 2020-07-08 |
Response of anti-SARS-CoV-2 total antibodies to nucleocapsid antigen in COVID-19 patients: a longitudinal study (edit) |
10.1515/CCLM-2020-0962 |
| 2020-07-08 |
Optimising benefits of testing key workers for infection with SARS-CoV-2: A mathematical modelling analysis (edit) |
10.1093/CID/CIAA901 |
| 2020-07-08 |
Investigating SARS-CoV-2 surface and air contamination in an acute healthcare setting during the peak of the COVID-19 pandemic in London (edit) |
10.1093/CID/CIAA905 |
| 2020-07-08 |
Rapid Emergence of SARS-CoV-2 in the Greater New York Metropolitan Area: Geolocation, Demographics, Positivity Rates, and Hospitalization for 46,793 Persons Tested by Northwell Health (edit) |
10.1093/CID/CIAA922 |
| 2020-07-08 |
Potential impact of SARS-CoV-2 infection on the thymus (edit) |
10.1139/CJM-2020-0170 |
| 2020-07-08 |
Presenting Features and Early Mortality from SARS-CoV-2 Infection in Cancer Patients during the Initial Stage of the COVID-19 Pandemic in Europe (edit) |
10.3390/CANCERS12071841 |
| 2020-07-08 |
Assessment of Knowledge, Attitudes, and Practices towards New Coronavirus (SARS-CoV-2) of Health Care Professionals in Greece before the Outbreak Period (edit) |
10.3390/IJERPH17144925 |
| 2020-07-08 |
Severe acute respiratory syndrome coronavirus 2(SARS-CoV-2) infection during late pregnancy: a report of 18 patients from Wuhan, China (edit) |
10.1186/S12884-020-03026-3 |
| 2020-07-08 |
The pandemic characteristics of 2019-nCoV: case-control study for severity and geographic locations for 2019-nCoV epidemics worldwide (edit) |
10.1186/S13052-020-00856-X |
| 2020-07-08 |
Effect of Systemic Inflammatory Response to SARS-CoV-2 on Lopinavir and Hydroxychloroquine Plasma Concentrations (edit) |
10.1128/AAC.01177-20 |
| 2020-07-08 |
Under Allocation: Critical Supply Chain Hurdles Negatively Impact the Ability of Community Hospitals to Perform Repeat SARS-CoV-2 Testing (edit) |
10.1128/JCM.01160-20 |
| 2020-07-08 |
Continuous flexibility analysis of SARS-CoV-2 Spike prefusion structures (edit) |
10.1101/2020.07.08.191072 |
| 2020-07-08 |
SARS-CoV-2 infection induces germinal center responses with robust stimulation of CD4 T follicular helper cells in rhesus macaques (edit) |
10.1101/2020.07.07.191007 |
| 2020-07-08 |
LY6E Restricts the Entry of Human Coronaviruses, Including the Currently Pandemic SARS-CoV-2 (edit) |
10.1128/JVI.00562-20 |
| 2020-07-08 |
Genomic Analysis of Early SARS-CoV-2 Variants Introduced in Mexico (edit) |
10.1128/JVI.01056-20 |
| 2020-07-08 |
Modeling reductions in SARS-CoV-2 transmission and hospital burden achieved by prioritizing testing using a clinical prediction rule (edit) |
10.1101/2020.07.07.20148510 |
| 2020-07-08 |
Novel SARS-CoV-2 specific antibody and neutralization assays reveal wide range of humoral immune response during COVID-19 (edit) |
10.1101/2020.07.07.20148106 |
| 2020-07-08 |
Acute hypokinetic-rigid syndrome following SARS-CoV-2 infection (edit) |
10.1212/WNL.0000000000010282 |
| 2020-07-08 |
Headache and impaired consciousness level associated with SARS-CoV-2 in CSF: A case report (edit) |
10.1212/WNL.0000000000010213 |
| 2020-07-08 |
SARS-CoV-2 is transmitted via contact and via the air between ferrets (edit) |
10.1038/S41467-020-17367-2 |
| 2020-07-08 |
Single cell transcriptome revealed SARS-CoV-2 entry genes enriched in colon tissues and associated with coronavirus infection and cytokine production (edit) |
10.1038/S41392-020-00237-0 |
| 2020-07-08 |
Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospital (edit) |
10.1038/S41467-020-17318-X |
| 2020-07-08 |
Clinical characteristics and outcome of SARS-CoV-2-infected patients with haematological diseases: a retrospective case study in four hospitals in Italy, Spain and the Netherlands (edit) |
10.1038/S41375-020-0960-4 |
| 2020-07-08 |
Prevalence of COVID-19 diagnosis in Dutch CML patients during the 2020 SARS-CoV2 pandemic. A prospective cohort study (edit) |
10.1038/S41375-020-0964-0 |
| 2020-07-08 |
Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer (edit) |
10.1038/S42003-020-1088-9 |
| 2020-07-08 |
Population-based surveys of antibodies against SARS-CoV-2 in Southern Brazil (edit) |
10.1038/S41591-020-0992-3 |
| 2020-07-08 |
Oscillation of SARS CoV-2 RNA load in a cohort of children and adolescents with neuro-psychiatric disorders resident in a nursing home of Lombardy Region (Italy) (edit) |
10.1016/J.JINF.2020.07.009 |
| 2020-07-08 |
Factors affecting stability and infectivity of SARS-CoV-2 (edit) |
10.1016/J.JHIN.2020.07.009 |
| 2020-07-08 |
Rapid recovery of a SARS-CoV-2 infected X-linked agammaglobulinemia patient after infusion of COVID-19 convalescent plasma (edit) |
10.1016/J.JAIP.2020.06.046 |
| 2020-07-08 |
Lack of sensitivity of an IVD/CE-labeled kit targeting the S gene for detection of SARS-CoV-2 (edit) |
10.1016/J.CMI.2020.06.036 |
| 2020-07-08 |
Monitoring environmental contamination caused by SARS-CoV-2 in a healthcare facility by using adenosine triphosphate testing (edit) |
10.1016/J.AJIC.2020.06.207 |
| 2020-07-08 |
Temporal Change of SARS-CoV-2 in Clinical Specimens of COVID-19 Pneumonia Patients (edit) |
10.4269/AJTMH.20-0551 |
| 2020-07-08 |
Proteome-wide Data Analysis Reveals Tissue-specific Network Associated with SARS-CoV-2 Infection (edit) |
10.1093/JMCB/MJAA033 |
| 2020-07-08 |
Povidone-Iodine Demonstrates Rapid In Vitro Virucidal Activity Against SARS-CoV-2, The Virus Causing COVID-19 Disease (edit) |
10.1007/S40121-020-00316-3 |
| 2020-07-08 |
Are Hospitals Safe? A Prospective Study on SARS-CoV-2 Prevalence and Outcome on Surgical Fracture Patients. A Closer Look at Hip Fracture Patients (edit) |
10.1097/BOT.0000000000001899 |
| 2020-07-08 |
Natural-like products as potential SARS-CoV-2 Mpro inhibitors: in-silico drug discovery (edit) |
10.1080/07391102.2020.1790037 |
| 2020-07-08 |
Potential of NO donor furoxan as SARS-CoV-2 main protease (Mpro) inhibitors: in silico analysis (edit) |
10.1080/07391102.2020.1790038 |
| 2020-07-08 |
Identification of bioactive molecule from Withania somnifera (Ashwagandha) as SARS-CoV-2 main protease inhibitor (edit) |
10.1080/07391102.2020.1790425 |
| 2020-07-08 |
Are antiphospholipid antibodies associated with thrombotic complications in critically ill COVID-19 patients? (edit) |
10.1016/J.THROMRES.2020.07.016 |
| 2020-07-08 |
[Nasopharyngeal carriage of SARS-CoV-2 among health personnel with symptoms suggestive of COVID-19 in a University Hospital in the Paris suburbs] (edit) |
10.1016/J.REVMED.2020.06.017 |
| 2020-07-08 |
Recurrent positive SARS-CoV-2 RNA tests in recovered and discharged patients (edit) |
10.1016/J.RCE.2020.06.012 |
| 2020-07-08 |
Emotions and Opinions of Adult Patients with Haemophilia During the COVID-19 (Coronavirus Disease 2019) Pandemic Caused by SARS-CoV-2: A Monocentric Survey (edit) |
10.2147/PPA.S257225 |
| 2020-07-08 |
Phylogenomic proximity and comparative proteomic analysis of SARS-CoV-2 (edit) |
10.1016/J.GENREP.2020.100777 |
| 2020-07-08 |
Guillain-Barré syndrome and SARS-CoV-2 (edit) |
10.1186/S42466-020-00066-0 |
| 2020-07-08 |
Using primary literature on SARS-CoV-2 to promote student learning about evolution (edit) |
10.1002/ECE3.6501 |
| 2020-07-07 |
SARS-CoV-2 Nsp1 binds ribosomal mRNA channel to inhibit translation (edit) |
10.1101/2020.07.07.191676 |
| 2020-07-07 |
The global and local distribution of RNA structure throughout the SARS-CoV-2 genome (edit) |
10.1101/2020.07.06.190660 |
| 2020-07-07 |
SARS-CoV-2 cytopathogenesis in cultured cells and in COVID-19 autoptic lung, evidences of lipid involvement (edit) |
10.21203/RS.3.RS-39274/V1 |
| 2020-07-07 |
Pathology and pathogenicity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (edit) |
10.1177/1535370220942126 |
| 2020-07-07 |
Obesity, overweight and survival in critically ill patients with SARS-CoV-2 pneumonia: is there an obesity paradox? Preliminary results from Italy (edit) |
10.1177/2047487320939675 |
| 2020-07-07 |
Exploring the acceptability of controlled human infection with SARSCoV2-a public consultation (edit) |
10.1186/S12916-020-01670-2 |
| 2020-07-07 |
Analysis of SARS-CoV-2 RNA-dependent RNA polymerase as a potential therapeutic drug target using a computational approach (edit) |
10.1186/S12967-020-02439-0 |
| 2020-07-07 |
Postinfectious brainstem encephalitis associated with SARS-CoV-2 (edit) |
10.1136/JNNP-2020-323816 |
| 2020-07-07 |
Infection with novel coronavirus (SARS-CoV-2) causes pneumonia in Rhesus macaques (edit) |
10.1038/S41422-020-0364-Z |
| 2020-07-07 |
SARS-CoV-2-specific T cells without antibodies (edit) |
10.1038/S41577-020-0393-3 |
| 2020-07-07 |
Pregnancy and postpartum outcomes in a universally tested population for SARS-CoV-2 in New York City: A prospective cohort study (edit) |
10.1111/1471-0528.16403 |
| 2020-07-07 |
Animal-based food systems are unsafe: SARS-CoV-2 fosters the debate on meat consumption (edit) |
10.1017/S1368980020002657 |
| 2020-07-07 |
SARS-CoV-2 infection in a neutropenic pediatric patient with leukemia: Addressing the need for universal guidelines for treatment of SARS-CoV-2-positive, immunocompromised patients (edit) |
10.1002/PBC.28546 |
| 2020-07-07 |
Young Children Presenting With Fever and Rash in the Midst of SARS-CoV-2 Outbreak in New York (edit) |
10.1177/0009922820941631 |
| 2020-07-07 |
Pathophysiology of SARS-CoV-2 infection in patients with intracerebral hemorrhage (edit) |
10.18632/AGING.103511 |
| 2020-07-07 |
Interaction of hydroxychloroquine with SARS-CoV2 functional proteins using all-atoms non-equilibrium alchemical simulations (edit) |
10.1039/D0CC03558K |
| 2020-07-07 |
An update on the origin of SARS-CoV-2: Despite closest identity, bat (RaTG13) and pangolin derived coronaviruses varied in the critical binding site and O-linked glycan residues (edit) |
10.1002/JMV.26261 |
| 2020-07-07 |
Heart Transplantation in the Era of the SARS-CoV-2 Pandemic: Is It Safe and Feasible? (edit) |
10.1111/CTR.14029 |
| 2020-07-07 |
RNA-dependent RNA Polymerase of SARS-CoV-2 as a Therapeutic Target (edit) |
10.1002/JMV.26264 |
| 2020-07-07 |
HIV and SARS CoV-2 co-infection: A retrospective, record based, case series from South India (edit) |
10.1002/JMV.26271 |
| 2020-07-07 |
SARS-CoV-2 viral load and antibody responses: the case for convalescent plasma therapy (edit) |
10.1172/JCI139760 |
| 2020-07-07 |
WITHDRAWN: ASSOCIATION OF INITIAL VIRAL LOAD IN SARS-CoV-2 PATIENTS WITH OUTCOME AND SYMPTOMS (edit) |
10.1016/J.AJPATH.2020.06.012 |
| 2020-07-07 |
Double-quencher probes improve detection sensitivity toward Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in a reverse-transcription polymerase chain reaction (RT-PCR) assay (edit) |
10.1016/J.JVIROMET.2020.113926 |
| 2020-07-07 |
Implications of SARS-CoV-2 Mutations for Genomic RNA Structure and Host microRNA Targeting (edit) |
10.3390/IJMS21134807 |
| 2020-07-07 |
SARS-CoV-2, ACE2, and Hydroxychloroquine: Cardiovascular Complications, Therapeutics, and Clinical Readouts in the Current Settings (edit) |
10.3390/PATHOGENS9070546 |
| 2020-07-07 |
Heat Inactivation of Different Types of SARS-CoV-2 Samples: What Protocols for Biosafety, Molecular Detection and Serological Diagnostics? (edit) |
10.3390/V12070735 |
| 2020-07-07 |
Protein Coding and Long Noncoding RNA (lncRNA) Transcriptional Landscape in SARS-CoV-2 Infected Bronchial Epithelial Cells Highlight a Role for Interferon and Inflammatory Response (edit) |
10.3390/GENES11070760 |
| 2020-07-07 |
Mutation Patterns of Human SARS-CoV-2 and Bat RaTG13 Coronavirus Genomes Are Strongly Biased Towards C>U Transitions, Indicating Rapid Evolution in Their Hosts (edit) |
10.3390/GENES11070761 |
| 2020-07-07 |
A one-step, one-tube real-time RT-PCR based assay with an automated analysis for detection of SARS-CoV-2 (edit) |
10.1016/J.HELIYON.2020.E04405 |
| 2020-07-07 |
Clinical Frailty Scale for risk stratification in patients with SARS-CoV-2 infection (edit) |
10.1136/JIM-2020-001410 |
| 2020-07-07 |
Differences in SARS-CoV-2 recommendations from major ophthalmology societies worldwide (edit) |
10.1136/BMJOPHTH-2020-000525 |
| 2020-07-07 |
Urticaria and angioedema as a prodromal cutaneous manifestation of SARS-CoV-2 (COVID-19) infection (edit) |
10.1136/BCR-2020-236981 |
| 2020-07-07 |
Unique transcriptional changes in coagulation cascade genes in SARS-CoV-2-infected lung epithelial cells: A potential factor in COVID-19 coagulopathies (edit) |
10.1101/2020.07.06.182972 |
| 2020-07-07 |
Minimization of spreading of SARS-CoV-2 via household waste produced by subjects affected by COVID-19 or in quarantine (edit) |
10.1016/J.SCITOTENV.2020.140803 |
| 2020-07-07 |
Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice (edit) |
10.1016/J.CELREP.2020.107940 |
| 2020-07-07 |
Cytologic and molecular correlates of SARS-CoV-2 infection of the nasopharynx (edit) |
10.1016/J.ANNDIAGPATH.2020.151565 |
| 2020-07-07 |
SARS-CoV-2 antibody screening in healthcare workers in a tertiary centre in North West England (edit) |
10.1016/J.JCV.2020.104545 |
| 2020-07-07 |
Children and Fecal SARS-CoV-2 shedding: Just the tip of the Iceberg of Italian COVID-19 outbreak? (edit) |
10.1016/J.DLD.2020.06.039 |
| 2020-07-07 |
Multiple sclerosis following SARS-CoV-2 infection (edit) |
10.1016/J.MSARD.2020.102377 |
| 2020-07-07 |
Working Hypothesis for Glucose Metabolism and SARS-CoV-2 Replication: Interplay Between the Hexosamine Pathway and Interferon RF5 Triggering Hyperinflammation. Role of BCG Vaccine? (edit) |
10.3389/FENDO.2020.00514 |
| 2020-07-07 |
Challenges in the Management of SARS-CoV2 Infection: The Role of Oral Bacteriotherapy as Complementary Therapeutic Strategy to Avoid the Progression of COVID-19 (edit) |
10.3389/FMED.2020.00389 |
| 2020-07-07 |
Single-Cell Transcriptomic Analysis of SARS-CoV-2 Reactive CD4 + T Cells (edit) |
10.2139/SSRN.3641939 |
| 2020-07-07 |
Incidence of surgical abdominal emergencies during SARS-CoV-2 pandemic (edit) |
10.1016/J.CIRESP.2020.06.017 |
| 2020-07-07 |
The potential exposure and transmission risk of SARS-CoV-2 through sludge treatment and disposal (edit) |
10.1016/J.RESCONREC.2020.105043 |
| 2020-07-07 |
[Algorithm for flexible decision-making in the intra-hospital management of patients with the changing requirements of the SARS-CoV-2 pandemic] (edit) |
10.1007/S10049-020-00748-X |
| 2020-07-07 |
Additional diagnostic testing of the 2019 novel coronavirus (SARS-CoV-2) (edit) |
10.1007/S13273-020-00096-4 |
| 2020-07-07 |
Ozone (O3) and SARS-CoV-2: Physiological Bases and Their Therapeutic Possibilities According to COVID-19 Evolutionary Stage (edit) |
10.1007/S42399-020-00328-7 |
| 2020-07-07 |
SARS-CoV-2 in fruit bats, ferrets, pigs, and chickens: an experimental transmission study (edit) |
10.1016/S2666-5247(20)30089-6 |
| 2020-07-06 |
Intracardiac and aortic thrombi in the setting of SARS-CoV-2 infection (edit) |
10.1093/EHJCR/YTAA199 |
| 2020-07-06 |
Novel multiple swab method enables high efficiency in SARS-CoV-2 screenings without loss of sensitivity for screening of a complete population (edit) |
10.1111/TRF.15973 |
| 2020-07-06 |
Kidney transplant patients with SARS-CoV-2 infection: the brescia renal COVID task force experience (edit) |
10.1111/AJT.16176 |
| 2020-07-06 |
Considerations around the SARS-CoV-2 Spike Protein with particular attention to COVID-19 brain infection and neurological symptoms (edit) |
10.1021/ACSCHEMNEURO.0C00373 |
| 2020-07-06 |
The theoretical mortality risk of an asymptomatic patient with a negative SARS-CoV-2 test developing COVID-19 following elective orthopaedic surgery (edit) |
10.1302/0301-620X.102B9.BJJ-2020-1147.R1 |
| 2020-07-06 |
Possibility of HIV-1 protease inhibitors-clinical trial drugs as repurposed drugs for SARS-CoV-2 main protease: a molecular docking, molecular dynamics and binding free energy simulation study (edit) |
10.1080/07391102.2020.1786459 |
| 2020-07-06 |
Screening of phytochemical compounds of Tinospora cordifolia for their inhibitory activity on SARS-CoV-2: an in silico study (edit) |
10.1080/07391102.2020.1787226 |
| 2020-07-06 |
Developing a SARS-CoV-2 Vaccine at Warp Speed (edit) |
10.1001/JAMA.2020.12190 |
| 2020-07-06 |
Clinical Validity of Serum Antibodies to SARS-CoV-2: A Case-Control Study (edit) |
10.7326/M20-2889 |
| 2020-07-06 |
Comparison of the diagnostic performance with whole blood and plasma of four rapid antibody tests for SARS-CoV-2 (edit) |
10.1515/CCLM-2020-0817 |
| 2020-07-06 |
Serum IgM against SARS-CoV-2 correlates with in-hospital mortality in severe/critical patients with COVID-19 in Wuhan, China (edit) |
10.18632/AGING.103417 |
| 2020-07-06 |
Evaluating use cases for human challenge trials in accelerating SARS-CoV-2 vaccine development (edit) |
10.1093/CID/CIAA935 |
| 2020-07-06 |
Seroprevalence of SARS-CoV-2 Among Frontline Healthcare Personnel During the First Month of Caring for COVID-19 Patients - Nashville, Tennessee (edit) |
10.1093/CID/CIAA936 |
| 2020-07-06 |
Liver involvement is not associated with mortality: results from a large cohort of SARS-CoV-2 positive patients (edit) |
10.1111/APT.15996 |
| 2020-07-06 |
Development of a Sterile Personal Protective Equipment Donning and Doffing Procedure to Protect Surgical Teams from SARS-CoV-2 Exposure during the COVID-19 Pandemic (edit) |
10.1089/SUR.2020.140 |
| 2020-07-06 |
Risk of SARS-CoV-2 transmission by aerosols, the rational use of masks, and protection of healthcare workers from COVID-19 (edit) |
10.1186/S13756-020-00763-0 |
| 2020-07-06 |
Comparative analysis of synovial inflammation after SARS-CoV-2 infection (edit) |
10.1136/ANNRHEUMDIS-2020-218315 |
| 2020-07-06 |
Response to: 'Comparative analysis of synovial inflammation after SARS-CoV-2 infection' by Alivernini et al (edit) |
10.1136/ANNRHEUMDIS-2020-218368 |
| 2020-07-06 |
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia (edit) |
10.1038/S41467-020-17292-4 |
| 2020-07-06 |
In Silico Screening of Potential Chinese Herbal Medicine Against COVID-19 by Targeting SARS-CoV-2 3CLpro and Angiotensin Converting Enzyme II Using Molecular Docking (edit) |
10.1007/S11655-020-3476-X |
| 2020-07-06 |
Revisiting potential druggable targets against SARS-CoV-2 and repurposing therapeutics under preclinical study and clinical trials: A comprehensive review (edit) |
10.1002/DDR.21709 |
| 2020-07-06 |
Seroprevalence of anti-SARS-CoV-2 among blood donors in Rio de Janeiro, Brazil (edit) |
10.11606/S1518-8787.2020054002643 |
| 2020-07-06 |
Clinical evaluation of the BioFire® Respiratory Panel 2.1 and detection of SARS-CoV-2 (edit) |
10.1016/J.JCV.2020.104538 |
| 2020-07-06 |
Structural features of coronavirus SARS-CoV-2 spike protein: Targets for vaccination (edit) |
10.1016/J.LFS.2020.118056 |
| 2020-07-06 |
Disinfection of N95 masks artificially contaminated with SARS-CoV-2 and ESKAPE bacteria using hydrogen peroxide plasma: impact on the reutilization of disposable devices (edit) |
10.1016/J.AJIC.2020.06.216 |
| 2020-07-06 |
Environmental Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) from Medical Equipment in Long-Term Care Facilities undergoing COVID-19 Outbreaks (edit) |
10.1016/J.AJIC.2020.07.001 |
| 2020-07-06 |
Potential transmission of SARS-CoV-2 on a flight from Singapore to Hanghzou, China: An epidemiological investigation (edit) |
10.1016/J.TMAID.2020.101816 |
| 2020-07-06 |
Immunopathology of SARS-CoV-2 Infection: Immune Cells and Mediators, Prognostic Factors, and Immune-Therapeutic Implications (edit) |
10.3390/IJMS21134782 |
| 2020-07-06 |
Discovery of Drug-like Ligands for the Mac1 Domain of SARS-CoV-2 Nsp3 (edit) |
10.1101/2020.07.06.190413 |
| 2020-07-06 |
N and O glycosylation of the SARS-CoV-2 spike protein (edit) |
10.1101/2020.07.05.187344 |
| 2020-07-06 |
SARS-CoV-2 contributes to altering the post-transcriptional regulatory networks across human tissues by sponging RNA binding proteins and micro-RNAs (edit) |
10.1101/2020.07.06.190348 |
| 2020-07-06 |
Conserved Genomic Terminals of SARS-CoV-2 as Co-evolving Functional Elements and Potential Therapeutic Targets (edit) |
10.1101/2020.07.06.190207 |
| 2020-07-06 |
Comparison of Transgenic and Adenovirus hACE2 Mouse Models for SARS-CoV-2 Infection (edit) |
10.1101/2020.07.06.190066 |
| 2020-07-06 |
Quantification of SARS-CoV-2 antibodies with eight commercially available immunoassays (edit) |
10.1016/J.JCV.2020.104540 |
| 2020-07-06 |
Reckoning a fungal metabolite, Pyranonigrin A as a potential Main protease (Mpro) inhibitor of novel SARS-CoV-2 virus identified using docking and molecular dynamics simulation (edit) |
10.1016/J.BPC.2020.106425 |
| 2020-07-06 |
Comparison of the diagnostic sensitivity of SARS-CoV-2 nucleoprotein and glycoprotein-based antibody tests (edit) |
10.1016/J.JCV.2020.104544 |
| 2020-07-06 |
Performance evaluation of Abbott ARCHITECT SARS-CoV-2 IgG immunoassay in comparison with indirect immunofluorescence and virus microneutralization test (edit) |
10.1016/J.JCV.2020.104539 |
| 2020-07-06 |
First results of a national external quality assessment scheme for the detection of SARS-CoV-2 genome sequences (edit) |
10.1016/J.JCV.2020.104537 |
| 2020-07-06 |
Evaluation of the Aptima™ transcription-mediated amplification assay (Hologic®) for detecting SARS-CoV-2 in clinical specimens (edit) |
10.1016/J.JCV.2020.104541 |
| 2020-07-06 |
SARS-CoV-2-IgG response is different in COVID-19 outpatients and asymptomatic contact persons (edit) |
10.1016/J.JCV.2020.104542 |
| 2020-07-06 |
False negative SARS-CoV-2 PCR - A case report and literature review (edit) |
10.1016/J.RMCR.2020.101140 |
| 2020-07-06 |
Extent of infectious SARS-CoV-2 aerosolisation as a result of oesophagogastroduodenoscopy or colonoscopy (edit) |
10.12968/HMED.2020.0348 |
| 2020-07-06 |
[Histopathological findings following SARS-CoV-2 infection with and without treatment-Report of three autopsies] (edit) |
10.1007/S00194-020-00408-X |
| 2020-07-06 |
Employing bioactive compounds derived from Ipomoea obscura (L.) to evaluate potential inhibitor for SARS-CoV-2 main protease and ACE2 protein (edit) |
10.1002/FFT2.29 |
| 2020-07-05 |
Genetic risk factors for death with SARS-CoV-2 from the UK Biobank (edit) |
10.1101/2020.07.01.20144592 |
| 2020-07-05 |
SARS-CoV-2 receptor ACE2 gene expression in small intestine correlates with age (edit) |
10.1007/S00726-020-02870-Z |
| 2020-07-05 |
A role for human leucocyte antigens in the susceptibility to SARS-Cov-2 infection observed in transplant patients (edit) |
10.1111/IJI.12505 |
| 2020-07-05 |
Snapshot of the evolution and mutation patterns of SARS-CoV-2 (edit) |
10.1101/2020.07.04.187435 |
| 2020-07-05 |
SARS-CoV2 envelope protein: Non-synonymous mutations and its consequences (edit) |
10.1016/J.YGENO.2020.07.001 |
| 2020-07-05 |
Identification of potential inhibitors against SARS-CoV-2 by targeting proteins responsible for envelope formation and virion assembly using docking based virtual screening, and pharmacokinetics approaches (edit) |
10.1016/J.MEEGID.2020.104451 |
| 2020-07-05 |
Assessment of sample pooling for SARS-CoV-2 molecular testing for screening of asymptomatic persons in Tunisia (edit) |
10.1016/J.DIAGMICROBIO.2020.115125 |
| 2020-07-04 |
Coronary artery dilatation in a child with hyperinflammatory syndrome with SARS-CoV-2-positive serology (edit) |
10.1093/EURHEARTJ/EHAA536 |
| 2020-07-04 |
SARS-CoV-2 oral associated lesions: discussion of elicited response (edit) |
10.1111/ODI.13532 |
| 2020-07-04 |
Coagulopathy and mesenteric ischaemia in severe SARS CoV-2 infection (edit) |
10.1111/ANS.16151 |
| 2020-07-04 |
Deep throat saliva as an alternative diagnostic specimen type for the detection of SARS-CoV-2 (edit) |
10.1002/JMV.26258 |
| 2020-07-04 |
Protein structure analysis of the interactions between SARS-CoV-2 spike protein and the human ACE2 receptor: from conformational changes to novel neutralizing antibodies (edit) |
10.1007/S00018-020-03580-1 |
| 2020-07-04 |
Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study) (edit) |
10.1007/S12072-020-10072-8 |
| 2020-07-04 |
SARS-CoV-2 Spike protein variant D614G increases infectivity and retains sensitivity to antibodies that target the receptor binding domain (edit) |
10.1101/2020.07.04.187757 |
| 2020-07-04 |
A pH-dependent switch mediates conformational masking of SARS-CoV-2 spike (edit) |
10.1101/2020.07.04.187989 |
| 2020-07-04 |
The Sensitivity of Respiratory Tract Specimens for the Detection of SARS-CoV-2: A Protocol for a Living Systematic Review and Meta-Analysis (edit) |
10.1101/2020.07.02.20144543 |
| 2020-07-04 |
Household Transmission of SARS-CoV-2 from Adults to Children (edit) |
10.1016/J.JPEDS.2020.07.009 |
| 2020-07-04 |
Germany's first COVID-19 deceased: a 59-year-old man presenting with diffuse alveolar damage due to SARS-CoV-2 infection (edit) |
10.1007/S00428-020-02872-Y |
| 2020-07-04 |
The autopsy at the time of SARS-CoV-2: Protocol and lessons (edit) |
10.1016/J.ANNDIAGPATH.2020.151562 |
| 2020-07-04 |
Asthma prevalence in patients with SARS-CoV-2 infection detected by RT-PCR not requiring hospitalization (edit) |
10.1016/J.RMED.2020.106084 |
| 2020-07-04 |
A first case of Mild Encephalitis with Reversible Splenial Lesion(MERS) as a presenting feature of SARS-CoV-2 (edit) |
10.1016/J.NEUROL.2020.06.001 |
| 2020-07-04 |
The effect of latitude and PM2.5 on spreading of SARS-CoV-2 in tropical and temperate zone countries (edit) |
10.1016/J.ENVPOL.2020.115176 |
| 2020-07-04 |
Pancytopenia during SARS-CoV-2 infection (edit) |
10.1016/J.MEDCLI.2020.06.016 |
| 2020-07-04 |
Computational evaluation of major components from plant essential oils as potent inhibitors of SARS-CoV-2 spike protein (edit) |
10.1016/J.MOLSTRUC.2020.128823 |
| 2020-07-04 |
SARS-CoV-2 in sewer systems and connected facilities (edit) |
10.1016/J.PSEP.2020.06.049 |
| 2020-07-04 |
Study of ARIMA and least square support vector machine (LS-SVM) models for the prediction of SARS-CoV-2 confirmed cases in the most affected countries (edit) |
10.1016/J.CHAOS.2020.110086 |
| 2020-07-04 |
Computational analysis of the SARS-CoV-2 and other viruses based on the Kolmogorov's complexity and Shannon's information theories (edit) |
10.1007/S11071-020-05771-8 |
| 2020-07-04 |
Clinical management of a Nigerian patient affected by sickle cell disease with rare blood group and persistent SARS-CoV-2 positivity (edit) |
10.1002/JHA2.53 |
| 2020-07-04 |
Early mortality risk stratification after SARS-CoV-2 infection (edit) |
10.1016/J.MEDIN.2020.06.011 |
| 2020-07-04 |
Low Utility of Repeat Real-Time PCR Testing for SARS-CoV-2 in Clinical Specimens (edit) |
10.1016/J.MAYOCP.2020.06.020 |
| 2020-07-04 |
Free-floating right heart thrombus with pulmonary embolism in SARS-CoV-2 patient (edit) |
10.1016/J.MEDCLI.2020.06.014 |
| 2020-07-03 |
In vitro efficacy of a copper iodine complex PPE disinfectant for SARS-CoV-2 inactivation (edit) |
10.12688/F1000RESEARCH.24651.1 |
| 2020-07-03 |
Insights of Novel Coronavirus (SARS-CoV-2) disease outbreak, management and treatment (edit) |
10.3934/MICROBIOL.2020013 |
| 2020-07-03 |
Map of SARS-CoV-2 spike epitopes not shielded by glycans (edit) |
10.1101/2020.07.03.186825 |
| 2020-07-03 |
SARS-CoV-2: ACE inhibitors, disastrous or desirable? (edit) |
10.3126/JBS.V7I1.29852 |
| 2020-07-03 |
Tracking changes in SARS-CoV-2 Spike: evidence that D614G increases infectivity of the COVID-19 virus (edit) |
10.1016/J.CELL.2020.06.043 |
| 2020-07-03 |
Brief Report of Co-infections with SARS-CoV-2 and Other Respiratory Pathogens (edit) |
10.1017/ICE.2020.322 |
| 2020-07-03 |
Phylogenetic Analysis and Structural Perspectives of RNA-Dependent RNA-Polymerase Inhibition from SARs-CoV-2 with Natural Products (edit) |
10.1007/S12539-020-00381-9 |
| 2020-07-03 |
Investigation of Nosocomial SARS-CoV-2 Transmission from Two Patients to Health Care Workers Identifies Close Contact but not Airborne Transmission Events (edit) |
10.1017/ICE.2020.321 |
| 2020-07-03 |
Should We Be Screening for SARS-CoV-2 in IBD Patients Before Initiation of Biologic Therapy? (edit) |
10.1093/IBD/IZAA173 |
| 2020-07-03 |
Review of Societal Recommendations Regarding Management of Patients With Inflammatory Bowel Disease During the SARS-CoV-2 Pandemic (edit) |
10.1093/IBD/IZAA174 |
| 2020-07-03 |
Epitope based peptide vaccine against SARS-COV2: an immune-informatics approach (edit) |
10.1080/07391102.2020.1787227 |
| 2020-07-03 |
Bacterial protein azurin and derived peptides as potential anti-SARS-CoV-2 agents: insights from molecular docking and molecular dynamics simulations (edit) |
10.1080/07391102.2020.1787864 |
| 2020-07-03 |
Towards the rational utilization of SARS-CoV-2 serological tests in clinical practice (edit) |
10.1515/CCLM-2020-0880 |
| 2020-07-03 |
Antiphospholipid antibodies in patients with COVID-19: a relevant observation? (edit) |
10.1111/JTH.14994 |
| 2020-07-03 |
Shotgun proteomics analysis of SARS-CoV-2-infected cells and how it can optimize whole viral particle antigen production for vaccines (edit) |
10.1080/22221751.2020.1791737 |
| 2020-07-03 |
Screening for SARS-CoV-2 Infection Within a Psychiatric Hospital and Considerations for Limiting Transmission Within Residential Psychiatric Facilities - Wyoming, 2020 (edit) |
10.15585/MMWR.MM6926A4 |
| 2020-07-03 |
Serial Laboratory Testing for SARS-CoV-2 Infection Among Incarcerated and Detained Persons in a Correctional and Detention Facility - Louisiana, April-May 2020 (edit) |
10.15585/MMWR.MM6926E2 |
| 2020-07-03 |
Universal SARS-Cov-2 Screening in Women Admitted for Delivery in a Large Managed Care Organization (edit) |
10.1055/S-0040-1714060 |
| 2020-07-03 |
Retrospective Screening for SARS-CoV-2 RNA in California, USA, Late 2019 (edit) |
10.3201/EID2610.202296 |
| 2020-07-03 |
Disappearance of SARS-CoV-2 Antibodies in Infants Born to Women with COVID-19, Wuhan, China (edit) |
10.3201/EID2610.202328 |
| 2020-07-03 |
Severe Acute Respiratory Syndrome Coronavirus 2 Prevalence, Seroprevalence, and Exposure Among Evacuees from Wuhan, China, 2020 (edit) |
10.3201/EID2609.201590 |
| 2020-07-03 |
Unlocking children's voices during SARS-CoV-2 coronavirus (COVID-19) pandemic lockdown (edit) |
10.1136/ARCHDISCHILD-2020-319894 |
| 2020-07-03 |
Refusal of viral testing during the SARS-CoV-2 pandemic (edit) |
10.7861/CLINMED.2020-0388 |
| 2020-07-03 |
Paracentral acute middle maculopathy and acute macular neuroretinopathy following SARS-CoV-2 infection (edit) |
10.1038/S41433-020-1069-8 |
| 2020-07-03 |
SARS-COV-2 and eye immunity: the lesson was learned but we are not done yet. Brainstorming on possible pathophysiology inspired by ocular models (edit) |
10.1007/S10792-020-01495-1 |
| 2020-07-03 |
Radiomics nomogram for the prediction of 2019 novel coronavirus pneumonia caused by SARS-CoV-2 (edit) |
10.1007/S00330-020-07032-Z |
| 2020-07-03 |
No SARS-CoV-2 detection in the German CAPNETZ cohort of community acquired pneumonia before COVID-19 peak in March 2020 (edit) |
10.1007/S15010-020-01471-Y |
| 2020-07-03 |
SARS-CoV-2 surveillance for a non-human primate breeding research facility (edit) |
10.1111/JMP.12483 |
| 2020-07-03 |
Asymptomatic SARS-CoV-2 infection in Belgian long-term care facilities (edit) |
10.1016/S1473-3099(20)30560-0 |
| 2020-07-03 |
Exaggerated risk of transmission of COVID-19 by fomites (edit) |
10.1016/S1473-3099(20)30561-2 |
| 2020-07-03 |
ASSOCIATION OF INITIAL VIRAL LOAD IN SARS-CoV-2 PATIENTS WITH OUTCOME AND SYMPTOMS (edit) |
10.1016/J.AJPATH.2020.07.001 |
| 2020-07-03 |
Letter in Response to Article in Journal of Infection: "High SARS-CoV-2 antibody prevalence among healthcare workers exposed to COVID-19 patients" (edit) |
10.1016/J.JINF.2020.07.001 |
| 2020-07-03 |
SARS-CoV-2 infections and COVID-19 mortalities strongly correlate with ACE1 I/D genotype (edit) |
10.1016/J.GENE.2020.144944 |
| 2020-07-03 |
Serologic Detection of Latent SARS-CoV-2 Infections in Hemodialysis Centers: A Multi-center, Retrospective Study in Wuhan, China (edit) |
10.1053/J.AJKD.2020.06.008 |
| 2020-07-03 |
Inhale, then exhale: start afresh to diagnose SARS-CoV-2 by non-invasive face mask sampling technique (edit) |
10.1016/J.CMI.2020.06.034 |
| 2020-07-03 |
Massive transient damage of the olfactory epithelium associated with infection of sustentacular cells by SARS-CoV-2 in golden Syrian hamsters (edit) |
10.1016/J.BBI.2020.06.032 |
| 2020-07-03 |
Non-invasive CPAP in mild and moderate ARDS secondary to SARS-CoV-2 (edit) |
10.1016/J.RESP.2020.103489 |
| 2020-07-03 |
Letter to the Editor Regarding the recent contribution by Roussel et al. (SARS-CoV-2: Fear Versus Data) (edit) |
10.1016/J.IJANTIMICAG.2020.106074 |
| 2020-07-03 |
Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design (edit) |
10.3390/VACCINES8030355 |
| 2020-07-03 |
Atherosclerosis as Pathogenetic Substrate for Sars-Cov2 Cytokine Storm (edit) |
10.3390/JCM9072095 |
| 2020-07-03 |
Primum non nocere - Are chloroquine and hydroxychloroquine safe prophylactic/treatment options for SARS-CoV-2 (covid-19)? (edit) |
10.11606/S1518-8787.2020054002631 |
| 2020-07-03 |
Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study (edit) |
10.1016/S0140-6736(20)31483-5 |
| 2020-07-03 |
SARS-CoV-2 seroprevalence in COVID-19 hotspots (edit) |
10.1016/S0140-6736(20)31482-3 |
| 2020-07-03 |
Smoking, SARS-CoV-2 and COVID-19: A review of reviews considering implications for public health policy and practice (edit) |
10.18332/TID/124788 |
| 2020-07-03 |
Transmission of SARS-CoV-2 via fecal-oral and aerosols-borne routes: Environmental dynamics and implications for wastewater management in underprivileged societies (edit) |
10.1016/J.SCITOTENV.2020.140709 |
| 2020-07-03 |
Reply to correspondence: Vaginal delivery in a woman infected with SARS-CoV-2 - The first case reported in Portugal (edit) |
10.1016/J.EJOGRB.2020.07.009 |
| 2020-07-03 |
Human-IgG-Neutralizing Monoclonal Antibodies Block the SARS-CoV-2 Infection (edit) |
10.1016/J.CELREP.2020.107918 |
| 2020-07-03 |
Adherence to social distancing and use of personal protective equipment and the risk of SARS-CoV-2 infection in a cohort of patients with multiple sclerosis (edit) |
10.1016/J.MSARD.2020.102359 |
| 2020-07-03 |
Potential Causes and Consequences of Gastrointestinal Disorders during a SARS-CoV-2 Infection (edit) |
10.1016/J.CELREP.2020.107915 |
| 2020-07-03 |
Transpulmonary electrotherapy for reduction of lung viral load of SARS-CoV-2 in patients with COVID-19 (edit) |
10.1016/J.MEHY.2020.110071 |
| 2020-07-03 |
Identification of novel mutations in RNA-dependent RNA polymerases of SARS-CoV-2 and their implications on its protein structure (edit) |
10.7717/PEERJ.9492 |
| 2020-07-03 |
Corrigendum to "COVID-19-related Complications and Decompression Illness Share Main Features. Could the SARS-CoV2-related complications rely on blood foaming?" [Med Hypothesis 144 (2020) 109918] (edit) |
10.1016/J.MEHY.2020.110063 |
| 2020-07-03 |
Acute abdomen -like-presentation associated with SARS-CoV-2 infection (edit) |
10.1016/J.IDCR.2020.E00895 |
| 2020-07-03 |
While We Wait for a Vaccine Against SARS-CoV-2, Why Not Think About Available Drugs? (edit) |
10.3389/FPHYS.2020.00820 |
| 2020-07-03 |
In-Depth Bioinformatic Analyses of Nidovirales Including Human SARS-CoV-2, SARS-CoV, MERS-CoV Viruses Suggest Important Roles of Non-canonical Nucleic Acid Structures in Their Lifecycles (edit) |
10.3389/FMICB.2020.01583 |
| 2020-07-03 |
Low Humoral Immune Response and Ineffective Clearance of SARS-Cov-2 in a COVID-19 Patient With CLL During a 69-Day Follow-Up (edit) |
10.3389/FONC.2020.01272 |
| 2020-07-03 |
SARS-COV-2 Infection and Kawasaki Disease: Case Report of a Hitherto Unrecognized Association (edit) |
10.3389/FPED.2020.00398 |
| 2020-07-03 |
Current Findings Regarding Natural Components With Potential Anti-2019-nCoV Activity (edit) |
10.3389/FCELL.2020.00589 |
| 2020-07-03 |
Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2 (edit) |
10.1016/J.CHOM.2020.06.021 |
| 2020-07-03 |
A Replication-Competent Vesicular Stomatitis Virus for Studies of SARS-CoV-2 Spike-Mediated Cell Entry and Its Inhibition (edit) |
10.1016/J.CHOM.2020.06.020 |
| 2020-07-03 |
Expanded Mesenchymal Stem Cells: a novel therapeutic approach of SARS-CoV-2 pneumonia (COVID-19). Concepts regarding a first case in Spain (edit) |
10.1016/J.MEDCLI.2020.06.018 |
| 2020-07-03 |
SARS-CoV2 coronavirus: so far polite with children. Debatable immunological and non-immunological evidence (edit) |
10.1016/J.ALLER.2020.05.003 |
| 2020-07-03 |
Understanding the andromeda strain - The role of cytokine release, coagulopathy and antithrombin III in SARS-CoV2 critical illness (edit) |
10.1016/J.BLRE.2020.100731 |
| 2020-07-03 |
SARS-CoV-2 infection in pregnancy: A systematic review and meta-analysis of clinical features and pregnancy outcomes (edit) |
10.1016/J.ECLINM.2020.100446 |
| 2020-07-02 |
Early postmortem mapping of SARS-CoV-2 RNA in patients with COVID-19 and correlation to tissue damage (edit) |
10.1101/2020.07.01.182550 |
| 2020-07-02 |
Microfluidic Immunoassays for Sensitive and Simultaneous Detection of IgG/IgM/Antigen of SARS-CoV-2 within 15 min (edit) |
10.1021/ACS.ANALCHEM.0C01635 |
| 2020-07-02 |
Expert Opinion on the Management and Follow-up of Uveitis Patients during SARS-CoV-2 Outbreak (edit) |
10.1080/1744666X.2020.1791086 |
| 2020-07-02 |
Clinical Implications of SARS-CoV-2 Infection in the Viable Preterm Period (edit) |
10.1055/S-0040-1713851 |
| 2020-07-02 |
Is povidone-iodine mouthwash effective against SARS-CoV-2? First in vivo tests (edit) |
10.1111/ODI.13526 |
| 2020-07-02 |
Group testing performance evaluation for SARS-CoV-2 massive scale screening and testing (edit) |
10.1186/S12874-020-01048-1 |
| 2020-07-02 |
Clinical characteristics of four cancer patients with SARS-CoV-2 infection in Wuhan, China (edit) |
10.1186/S40249-020-00707-1 |
| 2020-07-02 |
Hydroxychloroquine efficacy and safety in preventing SARS-CoV-2 infection and COVID-19 disease severity during pregnancy (COVID-Preg): a structured summary of a study protocol for a randomised placebo controlled trial (edit) |
10.1186/S13063-020-04557-Y |
| 2020-07-02 |
Controlled human infection with SARS-CoV-2 to study COVID-19 vaccines and treatments: bioethics in Utopia (edit) |
10.1136/MEDETHICS-2020-106476 |
| 2020-07-02 |
Complete Genome Sequence of a 2019 Novel Coronavirus (SARS-CoV-2) Strain Causing a COVID-19 Case in Morocco (edit) |
10.1128/MRA.00633-20 |
| 2020-07-02 |
Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques (edit) |
10.1126/SCIENCE.ABC5343 |
| 2020-07-02 |
A candidate multi-epitope vaccine against SARS-CoV-2 (edit) |
10.1038/S41598-020-67749-1 |
| 2020-07-02 |
[Ophthalmological care of SARS-CoV-2 positive patients in intensive care units] (edit) |
10.1007/S00347-020-01159-6 |
| 2020-07-02 |
Oropharyngeal Secretion as Alternative for SARS-CoV-2 Detection (edit) |
10.1177/0022034520940292 |
| 2020-07-02 |
Construction and immunogenic studies of a mFc fusion receptor binding domain (RBD) of spike protein as a subunit vaccine against SARS-CoV-2 infection (edit) |
10.1039/D0CC03263H |
| 2020-07-02 |
Care of Asymptomatic SARS-CoV-2 positive Kidney Transplant Recipients (edit) |
10.1111/TRI.13691 |
| 2020-07-02 |
Clinical characteristics and factors associated with long-term viral excretion in patients with SARS-CoV-2 infection: a single center 28-day study (edit) |
10.1093/INFDIS/JIAA388 |
| 2020-07-02 |
An Initial Evaluation of the Agreement Between Two SARS-CoV-2 Serologic Assays (edit) |
10.1093/JALM/JFAA114 |
| 2020-07-02 |
Aneurysmal subarachnoid hemorrhage in a SARS-CoV-2 positive testing: casual or causal? (edit) |
10.1080/02688697.2020.1787343 |
| 2020-07-02 |
Modeling of the Transmission of Coronaviruses, Measles Virus, Influenza Virus, Mycobacterium tuberculosis, and Legionella pneumophila in Dental Clinics (edit) |
10.1177/0022034520940288 |
| 2020-07-02 |
Review of the SARS-CoV-2 in Wuhan and Analysis as Well as Prediction of Therapeutic Drugs (edit) |
10.1089/VIM.2020.0027 |
| 2020-07-02 |
Letter by Weir Regarding Article, "Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2" (edit) |
10.1161/CIRCRESAHA.120.317294 |
| 2020-07-02 |
Response by Gheblawi et al to Letter Regarding Article, "Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2" (edit) |
10.1161/CIRCRESAHA.120.317332 |
| 2020-07-02 |
Main Routes of Entry and Genomic Diversity of SARS-CoV-2, Uganda (edit) |
10.3201/EID2610.202575 |
| 2020-07-02 |
High Proportion of Asymptomatic SARS-CoV-2 Infections in 9 Long-Term Care Facilities, Pasadena, California, USA, April 2020 (edit) |
10.3201/EID2610.202694 |
| 2020-07-02 |
Estimation of country-level basic reproductive ratios for novel Coronavirus (SARS-CoV-2/COVID-19) using synthetic contact matrices (edit) |
10.1371/JOURNAL.PCBI.1008031 |
| 2020-07-02 |
Impact of the SARS-CoV-2 outbreak on pediatric liver transplant recipients residing in Lombardy, Northern Italy (edit) |
10.1002/LT.25840 |
| 2020-07-02 |
Complete blood count might help to identify subjects with high probability of testing positive to SARS-CoV-2 (edit) |
10.7861/CLINMED.2020-0373 |
| 2020-07-02 |
Emergence of Kawasaki disease related to SARS-CoV-2 infection in an epicentre of the French COVID-19 epidemic: a time-series analysis (edit) |
10.1016/S2352-4642(20)30175-9 |
| 2020-07-02 |
Longitudinal anti-SARS-CoV-2 antibody profile and neutralization activity of a COVID-19 patient (edit) |
10.1016/J.JINF.2020.06.076 |
| 2020-07-02 |
SARS-CoV-2 positivity in rectal swabs implication for possible transmission (edit) |
10.1016/J.JGAR.2020.06.011 |
| 2020-07-02 |
Letter to the Editor in response to the article "Lack of type 1 diabetes involvement in the SARS-CoV-2 population: Only a particular coincidence? (edit) |
10.1016/J.DIABRES.2020.108306 |
| 2020-07-02 |
The incidence of the novel coronavirus SARS-CoV-2 among asymptomatic patients: a systematic review (edit) |
10.1016/J.IJID.2020.06.098 |
| 2020-07-02 |
Snowballing transmission of COVID-19 (SARS-CoV-2) through wastewater: Any sustainable preventive measures to curtail the scourge in low-income countries? (edit) |
10.1016/J.SCITOTENV.2020.140680 |
| 2020-07-02 |
SARS-CoV-2: Repurposed Drugs and Novel Therapeutic Approaches-Insights into Chemical Structure-Biological Activity and Toxicological Screening (edit) |
10.3390/JCM9072084 |
| 2020-07-02 |
6-Thioguanine blocks SARS-CoV-2 replication by inhibition of PLpro protease activities (edit) |
10.1101/2020.07.01.183020 |
| 2020-07-02 |
Hidden genomic diversity of SARS-CoV-2: implications for qRT-PCR diagnostics and transmission (edit) |
10.1101/2020.07.02.184481 |
| 2020-07-02 |
Development of a Synthetic Poxvirus-Based SARS-CoV-2 Vaccine (edit) |
10.1101/2020.07.01.183236 |
| 2020-07-02 |
Mass Screening for SARS-CoV-2 Infection among Residents and Staff in Twenty-eight Long-term Care Facilities in Fulton County, Georgia (edit) |
10.1101/2020.07.01.20144162 |
| 2020-07-02 |
Lockdown measures and relative changes in the age-specific incidence of SARS-CoV-2 in Spain (edit) |
10.1101/2020.06.30.20143560 |
| 2020-07-02 |
Trend Dynamics of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmission in 16 Cities of Hubei Province, China (edit) |
10.2147/CLEP.S254806 |
| 2020-07-02 |
The SARS-Cov-2 threat in Cracolândia, an open-air drug use scene in Brazil (edit) |
10.1016/J.DRUGPO.2020.102835 |
| 2020-07-02 |
Turning the Tide: Natural Products and Natural-Product-Inspired Chemicals as Potential Counters to SARS-CoV-2 Infection (edit) |
10.3389/FPHAR.2020.01013 |
| 2020-07-02 |
The Impact of SARS-Cov-2 Virus Infection on the Endocrine System (edit) |
10.1210/JENDSO/BVAA082 |
| 2020-07-02 |
Safer Singing During the SARS-CoV-2 Pandemic: What We Know and What We Don't (edit) |
10.1016/J.JVOICE.2020.06.028 |
| 2020-07-02 |
Implications of COVID-19 (SARS-CoV-2) for the anesthesiological practice (edit) |
10.5867/MEDWAVE.2020.06.7950 |
| 2020-07-02 |
A Patient with Bilateral Conjunctivitis Positive for Sars-Cov-2 RNA in Conjunctival Sample (edit) |
10.1097/ICO.0000000000002485 |
| 2020-07-02 |
Short-term exposure to ambient air quality of the most polluted Indian cities due to lockdown amid SARS-CoV-2 (edit) |
10.1016/J.ENVRES.2020.109835 |
| 2020-07-02 |
Design and Implementation of a Regional Inpatient Psychiatry Unit for Patients who are Positive for Asymptomatic SARS-CoV-2 (edit) |
10.1016/J.PSYM.2020.06.018 |
| 2020-07-02 |
Activation of cytotoxic T cell population and inversion of CD4:CD8 ratio as manifestations of cellular immune response in SARS-COV-2 infection (edit) |
10.1007/S12308-020-00405-9 |
| 2020-07-02 |
Anthroponotic risk of SARS-CoV-2, precautionary mitigation, and outbreak management (edit) |
10.1016/S2666-5247(20)30086-0 |
| 2020-07-02 |
Rational use of SARS-CoV-2 polymerase chain reaction tests within institutions caring for the vulnerable (edit) |
10.12688/F1000RESEARCH.24872.1 |
| 2020-07-02 |
SARS-CoV-2 Infections: An ACE in the Hole and Systems Biology Studies-a Research Agenda (edit) |
10.1016/J.MAYOCP.2020.06.044 |
| 2020-07-01 |
In silico identification of conserved cis-acting RNA elements in the SARS-CoV-2 genome (edit) |
10.2217/FVL-2020-0163 |
| 2020-07-01 |
An unexpected recovery of patients with pulmonary arterial hypertension and SARS-CoV-2 pneumonia: a case series (edit) |
10.1177/2045894020956581 |
| 2020-07-01 |
Intra-genome variability in the dinucleotide composition of SARS-CoV-2 (edit) |
10.1093/VE/VEAA057 |
| 2020-07-01 |
A Patient In The Incubation Period Of Sars-Cov-2 Submitted To Openheart Surgery (edit) |
|
| 2020-07-01 |
Can quantitative RT-PCR for SARS-CoV-2 help in better management of patients and control of coronavirus disease 2019 pandemic (edit) |
10.4103/IJMM.IJMM_20_380 |
| 2020-07-01 |
Analysis of multi-sample pools in the detection of SARS-CoV-2 RNA for mass screening: An Indian perspective (edit) |
10.4103/IJMM.IJMM_20_273 |
| 2020-07-01 |
A simple, safe and sensitive method for SARS-CoV-2 inactivation and RNA extraction for RT-qPCR (edit) |
10.1101/2020.06.29.179176 |
| 2020-07-01 |
Paediatric orthopaedics in lockdown: A study on the effect of the SARS-Cov-2 pandemic on acute paediatric orthopaedics and trauma (edit) |
10.1302/2633-1462.17.BJO-2020-0086.R1 |
| 2020-07-01 |
How to Determine When SARS-CoV-2 Antibody Testing Is or Is Not Useful for Population Screening: A Tutorial (edit) |
10.1177/2381468320963068 |
| 2020-07-01 |
Temporal signal and the phylodynamic threshold of SARS-CoV-2 (edit) |
10.1093/VE/VEAA061 |
| 2020-07-01 |
Evaluation of NGS-based approaches for SARS-CoV-2 whole genome characterisation (edit) |
10.1093/VE/VEAA075 |
| 2020-07-01 |
Emerging phylogenetic structure of the SARS-CoV-2 pandemic (edit) |
10.1093/VE/VEAA082 |
| 2020-07-01 |
periscope: sub-genomic RNA identification in SARS-CoV-2 Genomic Sequencing Data (edit) |
10.1101/2020.07.01.181867 |
| 2020-07-01 |
The 1.5 A Crystal Structure of the Co-factor Complex of NSP7 and the C-terminal Domain of NSP8 from SARS CoV-2 (edit) |
10.2210/PDB6XIP/PDB |
| 2020-07-01 |
The future of neurorehabilitation after the SARS-CoV-2 pandemic (edit) |
10.1016/J.NRLENG.2020.06.003 |
| 2020-07-01 |
High Contagiousness and Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2 (edit) |
10.3201/EID2607.200282 |
| 2020-07-01 |
Is There a Role for Lung Ultrasound During the COVID-19 Pandemic? (edit) |
10.1002/JUM.15284 |
| 2020-07-01 |
Elevated Plasmin(ogen) as a Common Risk Factor for COVID-19 Susceptibility (edit) |
10.1152/PHYSREV.00013.2020 |
| 2020-07-01 |
Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19 (edit) |
10.1002/JMV.25785 |
| 2020-07-01 |
Neuroinfection may contribute to pathophysiology and clinical manifestations of COVID-19 (edit) |
10.1111/APHA.13473 |
| 2020-07-01 |
Epidemiological analysis of COVID-19 and practical experience from China (edit) |
10.1002/JMV.25813 |
| 2020-07-01 |
The COVID-19 Pandemic: Effects on Low and Middle-Income Countries (edit) |
10.1213/ANE.0000000000004846 |
| 2020-07-01 |
Coronaviruses and SARS-CoV-2: A Brief Overview (edit) |
10.1213/ANE.0000000000004845 |
| 2020-07-01 |
COVID-19 and Lessons to be Learned from Prior Coronavirus Outbreaks (edit) |
10.1513/ANNALSATS.202002-149PS |
| 2020-07-01 |
A primer on viral-associated olfactory loss in the era of COVID-19 (edit) |
10.1002/ALR.22578 |
| 2020-07-01 |
Rheumatologists' perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets (edit) |
10.1007/S10067-020-05073-9 |
| 2020-07-01 |
Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)? (edit) |
10.1016/J.JAUT.2020.102452 |
| 2020-07-01 |
Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms (edit) |
10.1016/J.BBI.2020.04.027 |
| 2020-07-01 |
Chimeric Antigen Receptor T Cell Therapy During the COVID-19 Pandemic (edit) |
10.1016/J.BBMT.2020.04.008 |
| 2020-07-01 |
Prevention and control measures in radiology department for COVID-19 (edit) |
10.1007/S00330-020-06850-5 |
| 2020-07-01 |
Physiological and pathological regulation of ACE2, the SARS-CoV-2 receptor (edit) |
10.1016/J.PHRS.2020.104833 |
| 2020-07-01 |
Covid-19 and immunomodulation in IBD (edit) |
10.1136/GUTJNL-2020-321269 |
| 2020-07-01 |
Assessing the Burden of Nondeferrable Major Uro-oncologic Surgery to Guide Prioritisation Strategies During the COVID-19 Pandemic: Insights from Three Italian High-volume Referral Centres (edit) |
10.1016/J.EURURO.2020.03.054 |
| 2020-07-01 |
Management challenges for chronic dysimmune neuropathies during the COVID-19 pandemic (edit) |
10.1002/MUS.26896 |
| 2020-07-01 |
The impact of nutrition on COVID-19 susceptibility and long-term consequences (edit) |
10.1016/J.BBI.2020.04.040 |
| 2020-07-01 |
Reducing droplet spread during airway manipulation: lessons from the COVID-19 pandemic in Singapore (edit) |
10.1016/J.BJA.2020.04.007 |
| 2020-07-01 |
Is Adipose Tissue a Reservoir for Viral Spread, Immune Activation and Cytokine Amplification in COVID-19 (edit) |
10.1002/OBY.22843 |
| 2020-07-01 |
The epidemiological and clinical features of COVID-19 and lessons from this global infectious public health event (edit) |
10.1016/J.JINF.2020.04.011 |
| 2020-07-01 |
The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19 (edit) |
10.1016/J.JAUT.2020.102468 |
| 2020-07-01 |
Managing childhood allergies and immunodeficiencies during respiratory virus epidemics - the 2020 COVID-19 pandemic (edit) |
10.1111/PAI.13262 |
| 2020-07-01 |
The emergence of a novel coronavirus (SARS-CoV-2) disease and their neuroinvasive propensity may affect in COVID-19 patients (edit) |
10.1002/JMV.25918 |
| 2020-07-01 |
Is SARS-CoV-2 Also an Enteric Pathogen with Potential Fecal-Oral Transmission: A COVID-19 Virological and Clinical Review (edit) |
10.1053/J.GASTRO.2020.04.052 |
| 2020-07-01 |
Occupational exposure to SARS-CoV-2 in burns treatment during the COVID-19 epidemic: Specific diagnosis and treatment protocol (edit) |
10.1016/J.BIOPHA.2020.110176 |
| 2020-07-01 |
Head and neck survivorship care in the times of the SARS-CoV-2 pandemic (edit) |
10.1002/HED.26235 |
| 2020-07-01 |
Candidate drugs against SARS-CoV-2 and COVID-19 (edit) |
10.1016/J.PHRS.2020.104859 |
| 2020-07-01 |
SARS-CoV-2 receptor ACE2-dependent implications on the cardiovascular system: From basic science to clinical implications (edit) |
10.1016/J.YJMCC.2020.04.031 |
| 2020-07-01 |
New understanding of the damage of SARS-CoV-2 infection outside the respiratory system (edit) |
10.1016/J.BIOPHA.2020.110195 |
| 2020-07-01 |
Severe respiratory SARS-CoV2 infection: Does ACE2 receptor matter? (edit) |
10.1016/J.RMED.2020.105996 |
| 2020-07-01 |
Potential Therapeutic Targets and Promising Drugs for Combating SARS-CoV-2 (edit) |
10.1111/BPH.15092 |
| 2020-07-01 |
Utilization of deceased donors during a pandemic: An argument against using SARS-CoV-2 positive donors (edit) |
10.1111/AJT.15969 |
| 2020-07-01 |
Continuous hydroxychloroquine or colchicine therapy does not prevent infection with SARS-CoV-2: Insights from a large healthcare database analysis (edit) |
10.1016/J.AUTREV.2020.102566 |
| 2020-07-01 |
Potential Applications of Plant Biotechnology against SARS-CoV-2 (edit) |
10.1016/J.TPLANTS.2020.04.009 |
| 2020-07-01 |
Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19 (edit) |
10.1111/ALL.14364 |
| 2020-07-01 |
Tele-health in neurology: an indispensable tool in the management of the SARS-CoV-2 epidemic (edit) |
10.1007/S00415-020-09898-X |
| 2020-07-01 |
The mental health of those whose rights have been taken away: An essay on the mental health of indigenous peoples in the face of the 2019 Coronavirus (2019-NCOV) outbreak (edit) |
10.1016/J.PSYCHRES.2020.113094 |
| 2020-07-01 |
Angiotensin-converting enzyme-2 (ACE2), SARS-CoV-2 and pathophysiology of coronavirus disease 2019 (COVID-19) (edit) |
10.1002/PATH.5471 |
| 2020-07-01 |
Evidence and possible mechanisms of rare maternal-fetal transmission of SARS-CoV-2 (edit) |
10.1016/J.JCV.2020.104447 |
| 2020-07-01 |
The basic reproduction number of SARS-CoV-2 in Wuhan is about to die out, how about the rest of the World? (edit) |
10.1002/RMV.2111 |
| 2020-07-01 |
Importance of SARs-Cov-2 anosmia: From phenomenology to neurobiology (edit) |
10.1016/J.COMPPSYCH.2020.152184 |
| 2020-07-01 |
[Narrative review of the immune response against coronavirus: An overview, applicability for SARS-COV-2, and therapeutic implications] (edit) |
10.1016/J.ANPEDI.2020.04.016 |
| 2020-07-01 |
Minimizing SARS-CoV-2 exposure when performing surgical interventions during the covid-19 pandemic (edit) |
10.1136/NEURINTSURG-2020-016161 |
| 2020-07-01 |
Mysterious Virus: A Review on Behavior and Treatment Approaches of the Novel Coronavirus, 2019-nCoV (edit) |
10.1016/J.ARCMED.2020.04.022 |
| 2020-07-01 |
SARS-CoV-2 Virulence: Interplay of Floating Virus-Laden Particles, Climate, and Humans (edit) |
10.1002/ADBI.202000105 |
| 2020-07-01 |
The Landscape of Human Cancer Proteins Targeted by SARS-CoV-2 (edit) |
10.1158/2159-8290.CD-20-0559 |
| 2020-07-01 |
Facing SARS-CoV-2 outbreak in immunotherapy era (edit) |
10.2217/FON-2020-0340 |
| 2020-07-01 |
Physicochemical properties of SARS-CoV-2 for drug targeting, virus inactivation and attenuation, vaccine formulation and quality control (edit) |
10.1002/ELPS.202000121 |
| 2020-07-01 |
Small droplet aerosols in poorly ventilated spaces and SARS-CoV-2 transmission (edit) |
10.1016/S2213-2600(20)30245-9 |
| 2020-07-01 |
SARS-CoV-2 infection and overactivation of Nlrp3 inflammasome as a trigger of cytokine "storm" and risk factor for damage of hematopoietic stem cells (edit) |
10.1038/S41375-020-0887-9 |
| 2020-07-01 |
[Surgery during the SARS-CoV-2 pandemic : Recommendations on operative procedures] (edit) |
10.1007/S00113-020-00830-6 |
| 2020-07-01 |
Dengue Fever, COVID-19 (SARS-CoV-2), and Antibody-Dependent Enhancement (ADE): A Perspective (edit) |
10.1002/CYTO.A.24047 |
| 2020-07-01 |
SARS-CoV-2 infection in a highly experienced person living with HIV (edit) |
10.1097/QAD.0000000000002572 |
| 2020-07-01 |
Comparison of the Clinical Features of SARS-CoV-2, Other Coronavirus and Influenza Infections in Infants Less Than 1-Year-Old (edit) |
10.1097/INF.0000000000002705 |
| 2020-07-01 |
Endocrine changes in SARS-CoV-2 patients and lessons from SARS-CoV (edit) |
10.1136/POSTGRADMEDJ-2020-137934 |
| 2020-07-01 |
Focus on a 2019-novel coronavirus (SARS-CoV-2) (edit) |
10.2217/FMB-2020-0063 |
| 2020-07-01 |
Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts (edit) |
10.1002/JLB.3COVR0520-272R |
| 2020-07-01 |
Our Lane in the COVID-19 Pandemic (edit) |
10.1177/1524839920928603 |
| 2020-07-01 |
Laboratory diagnosis of SARS-CoV-2 - A review of current methods (edit) |
10.1016/J.JIPH.2020.06.005 |
| 2020-07-01 |
Nature Documentaries: An Antidote to Anxiety and Fear in the Time of COVID-19 Pandemic (edit) |
10.1097/NUR.0000000000000526 |
| 2020-07-01 |
Physical activity: Benefits and challenges during the COVID-19 pandemic (edit) |
10.1111/SMS.13710 |
| 2020-07-01 |
Economic Shocks From the Novel COVID-19 Pandemic for Anesthesiologists and Their Practices (edit) |
10.1213/ANE.0000000000004882 |
| 2020-07-01 |
Special strategies and management of urological diseases during the COVID-19 pandemic: initial experiences from a Medical Center of China (edit) |
10.1590/S1677-5538.IBJU.2020.S102 |
| 2020-07-01 |
Clinical and Surgical Assistance in Prostate Cancer during the COVID-19 Pandemic: Implementation of assistance protocols (edit) |
10.1590/S1677-5538.IBJU.2020.S106 |
| 2020-07-01 |
Consideration in the management of renal cell carcinoma during the COVID-19 Pandemic (edit) |
10.1590/S1677-5538.IBJU.2020.S108 |
| 2020-07-01 |
[Antithrombotic treatments in patients with SARS-CoV-2 infection: from current evidence to reasonable recommendations - A position paper from the Italian Working Group on Atherosclerosis, Thrombosis and Vascular Biology] (edit) |
10.1714/3386.33634 |
| 2020-07-01 |
[Late occurrence of pulmonary embolsim in SARS-CoV-2 pneumonia: a case series] (edit) |
10.1714/3386.33638 |
| 2020-07-01 |
[Importance of corneal organ culture in donors with possible SARS-CoV-2 infections] (edit) |
10.1007/S00347-020-01152-Z |
| 2020-07-01 |
[First results of investigations of SARS-CoV‑2 RNA in human corneal tissue] (edit) |
10.1007/S00347-020-01151-0 |
| 2020-07-01 |
Wastewater monitoring of SARS-CoV-2: lessons from illicit drug policy (edit) |
10.1016/S2468-1253(20)30158-8 |
| 2020-07-01 |
Recognizing and controlling airborne transmission of SARS-CoV-2 in indoor environments (edit) |
10.1111/INA.12697 |
| 2020-07-01 |
SARS-CoV-2 infection and stem cells: Interaction and intervention (edit) |
10.1016/J.SCR.2020.101859 |
| 2020-07-01 |
[What is the importance of the conjunctiva as a potential transmission pathway for SARS-CoV-2 infections?] (edit) |
10.1007/S00347-020-01150-1 |
| 2020-07-01 |
The SARS-CoV-2, tears, and ocular surface debate: What we know and what we need to know (edit) |
10.4103/IJO.IJO_1881_20 |
| 2020-07-01 |
[Seroprevalence and SARS-CoV-2 testing in healthcare occupations] (edit) |
10.1007/S00347-020-01158-7 |
| 2020-07-01 |
[Can SARS-CoV-2 infect the eye?-An overview of the receptor status in ocular tissue] (edit) |
10.1007/S00347-020-01160-Z |
| 2020-07-01 |
Using the Systems Engineering Initiative for Patient Safety (SEIPS) model to describe critical care nursing during the SARS-CoV-2 pandemic (2020) (edit) |
10.1111/NICC.12514 |
| 2020-07-01 |
CORDITE: The Curated CORona Drug InTERactions Database for SARS-CoV-2 (edit) |
10.1016/J.ISCI.2020.101297 |
| 2020-07-01 |
A SARS-CoV-2 Coronavirus Nucleocapsid Antigen-Detecting Half-Strip Lateral Flow Assay Towards the Development of Point of Care Tests Using Commercially Available Reagents (edit) |
10.1021/ACS.ANALCHEM.0C01975 |
| 2020-07-01 |
SARS-CoV-2 Infection and Cardiovascular Disease: COVID-19 Heart (edit) |
10.1016/J.HLC.2020.05.101 |
| 2020-07-01 |
Clinical and Epidemiological Features of SARS-CoV-2 Patients in SARI Ward of a Tertiary Care Centre in New Delhi (edit) |
|
| 2020-07-01 |
Pneumocystis Jirovecii Pneumonia and SARS-CoV-2 Co-Infection in newly diagnosed HIV-1 infection (edit) |
10.1093/CID/CIAA906 |
| 2020-07-01 |
Beware of False-Positive Results with SARS-CoV-2 Antibody Tests (edit) |
|
| 2020-07-01 |
Systematic Review and Meta-Analysis of the Efficacy of Nanoscale Materials Against Coronaviruses-Possible Potential Antiviral Agents for SARS-CoV-2 (edit) |
10.1109/TNB.2020.2997257 |
| 2020-07-01 |
Retrospective detection of SARS-CoV-2 in hospitalized patients with influenza-like illness (edit) |
10.1080/22221751.2020.1785952 |
| 2020-07-01 |
Screening the general population for SARS CoV-2 virus and COVID-19 antibodies: a counter-argument (edit) |
10.1093/JALM/JFAA104 |
| 2020-07-01 |
Prolonged persistence of SARS-CoV-2 in the upper respiratory tract of asymptomatic infected individuals (edit) |
10.1093/QJMED/HCAA212 |
| 2020-07-01 |
SARS-CoV-2 vaccination-A plea for fast and coordinated action (edit) |
10.1111/ZPH.12740 |
| 2020-07-01 |
Urosepsis Increases the Risk of Pulmonary Embolism in Patients Affected by SARS-CoV-2 (edit) |
10.1097/JU.0000000000001228 |
| 2020-07-01 |
Prediction of the transition from sub-exponential to the exponential transmission of SARS-CoV-2 and epidemic nowcasting for metro-zones: Experiences from Chennai-Metro-Merge, India (edit) |
10.2196/21152 |
| 2020-07-01 |
Development and multicenter performance evaluation of fully automated SARS-CoV-2 IgM and IgG immunoassays (edit) |
10.1515/CCLM-2020-0548 |
| 2020-07-01 |
Blood sampling after COVID-19 - How to organize large scale phlebotomy services in the post SARS CoV-2 era (edit) |
10.1515/CCLM-2020-0671 |
| 2020-07-01 |
Neutrophil-to-lymphocyte ratio predicts the clearance of SARS-CoV-2 RNA in mild COVID-19 patients - a retrospective analysis from Dongxihu Fangcang Hospital in Wuhan, China (edit) |
10.1515/CCLM-2020-0733 |
| 2020-07-01 |
Accelerating Development of SARS-CoV-2 Vaccines - The Role for Controlled Human Infection Models (edit) |
10.1056/NEJMP2020076 |
| 2020-07-01 |
Infectious Disease Transmission Models to Predict, Evaluate, and Improve Understanding of SARS-COV-2 Trajectory and Interventions (edit) |
10.1513/ANNALSATS.202005-501PS |
| 2020-07-01 |
Vertical transmission risk of SARS-CoV-2 infection in the third trimester: a systematic scoping review (edit) |
10.1080/14767058.2020.1786055 |
| 2020-07-01 |
Coinfection with SARS-CoV-2 and influenza A virus (edit) |
10.1136/BCR-2020-236812 |
| 2020-07-01 |
Angiotensin-converting enzyme 2, a SARS-CoV-2 receptor, is upregulated by interleukin-6 via STAT3 signaling in synovial tissues (edit) |
10.3899/JRHEUM.200547 |
| 2020-07-01 |
Increasing Temperature and Relative Humidity Accelerates Inactivation of SARS-CoV-2 on Surfaces (edit) |
10.1128/MSPHERE.00441-20 |
| 2020-07-01 |
Increased CSF levels of IL-1β, IL-6, and ACE in SARS-CoV-2-associated encephalitis (edit) |
10.1212/NXI.0000000000000821 |
| 2020-07-01 |
Mining of epitopes on spike protein of SARS-CoV-2 from COVID-19 patients (edit) |
10.1038/S41422-020-0366-X |
| 2020-07-01 |
[Development and implementation of an operational concept in a university eye hospital in the SARS-CoV-2 pandemic] (edit) |
10.1007/S00347-020-01156-9 |
| 2020-07-01 |
[Basic principles of viral replication and the immunology of the SARS-CoV-2] (edit) |
10.1007/S00347-020-01155-W |
| 2020-07-01 |
Association of Digestive Symptoms and Hospitalization in Patients With SARS-CoV-2 Infection (edit) |
10.14309/AJG.0000000000000712 |
| 2020-07-01 |
Experiences from the SARS-CoV-2 Pandemic: How One Orthopaedic Practice Pivoted to Serve Their Community (edit) |
10.2106/JBJS.20.00690 |
| 2020-07-01 |
No evidence of SARS-Cov-2 infection by PCR or serology in children with pseudochilblain (edit) |
10.1111/BJD.19349 |
| 2020-07-01 |
Finding Camel-ot: A Holy Grail against pandemic SARS-CoV-2? (edit) |
10.1126/SCIIMMUNOL.ABD4758 |
| 2020-07-01 |
The use of SARS-CoV-2-related coronaviruses from bats and pangolins to polarize mutations in SARS-Cov-2 (edit) |
10.1007/S11427-020-1764-2 |
| 2020-07-01 |
Epitope-based peptide vaccines predicted against novel coronavirus disease caused by SARS-CoV-2 (edit) |
10.1016/J.VIRUSRES.2020.198082 |
| 2020-07-01 |
Impact of SARS-CoV-2 on Hospital Acquired Infection Rates in the United States: Predictions and Early Results (edit) |
10.1016/J.AJIC.2020.06.209 |
| 2020-07-01 |
INCIDENCE OF ARRHYTHMIAS AND ELECTROCARDIOGRAPHIC ABNORMALITIES IN SYMPTOMATIC PEDIATRIC PATIENTS WITH PCR POSITIVE SARS-CoV-2 INFECTION INCLUDING DRUG INDUCED CHANGES IN THE CORRECTED QT INTERVAL (QTc) (edit) |
10.1016/J.HRTHM.2020.06.033 |
| 2020-07-01 |
Azithromycin and SARS-CoV-2 infection: where we are now and where we are going (edit) |
10.1016/J.JGAR.2020.06.016 |
| 2020-07-01 |
Ancestral origin, antigenic resemblance and epidemiological insights of novel coronavirus (SARS-CoV-2): Global burden and Bangladesh perspective (edit) |
10.1016/J.MEEGID.2020.104440 |
| 2020-07-01 |
Multi-System Inflammatory Syndrome in Children (MIS-C) Following SARS-CoV-2 Infection: Review of Clinical Presentation, Hypothetical Pathogenesis, and Proposed Management (edit) |
10.3390/CHILDREN7070069 |
| 2020-07-01 |
Prolonged presence of SARS-CoV-2 in a COVID-19 case with rheumatoid arthritis taking iguratimod treated with ciclesonide (edit) |
10.1016/J.JIAC.2020.06.022 |
| 2020-07-01 |
High affinity binding of SARS-CoV-2 spike protein enhances ACE2 carboxypeptidase activity (edit) |
10.1101/2020.07.01.182659 |
| 2020-07-01 |
Genetic architecture of host proteins interacting with SARS-CoV-2 (edit) |
10.1101/2020.07.01.182709 |
| 2020-07-01 |
Facing SARS-CoV-2 Pandemic at a COVID-19 Regional Children's Hospital in Italy (edit) |
10.1097/INF.0000000000002811 |
| 2020-07-01 |
ACE2 and TMPRSS2 expression by clinical, HLA, immune, and microbial correlates across 34 human cancers and matched normal tissues: implications for SARS-CoV-2 COVID-19 (edit) |
10.1136/JITC-2020-001020 |
| 2020-07-01 |
Pidotimod in Paucisymptomatic SARS-CoV2 Infected Patients (edit) |
10.4084/MJHID.2020.048 |
| 2020-07-01 |
Impact of SARS CoV-2 in Hemoglobinopathies with Immune Disfunction and Epidemiology. A Protective Mechanism from Beta Chain Hemoglobin Defects? (edit) |
10.4084/MJHID.2020.052 |
| 2020-07-01 |
[SARS-CoV-2 infection: implications for sexual and reproductive health. A position statement of the Asociación Española de Andrología, Medicina Sexual y Reproductiva (ASESA)] (edit) |
10.1016/J.ANDROL.2020.06.001 |
| 2020-07-01 |
SARS-CoV-2-related chilblains (edit) |
10.1503/CMAJ.201348 |
| 2020-07-01 |
Immunité cellulaire contre SARS-CoV-2 : substrat de l’immunité croisée entre coronavirus saisonniers et SARS-CoV-2 ? (edit) |
|
| 2020-07-01 |
International external quality assessment for SARS-CoV-2 molecular detection and survey on clinical laboratory preparedness during the COVID-19 pandemic, April/May 2020 (edit) |
10.2807/1560-7917.ES.2020.25.27.2001223 |
| 2020-07-01 |
SARS-CoV-2 and HIV coinfection: clinical experience from Rhode Island, United States (edit) |
10.1002/JIA2.25573 |
| 2020-07-01 |
SARS-CoV-2; What We Know so far (edit) |
10.34172/AIM.2020.47 |
| 2020-07-01 |
[SARS-CoV-2 infection and the eye] (edit) |
10.1007/S00347-020-01161-Y |
| 2020-07-01 |
Successful sequencing of the first SARS-CoV-2 genomes from Croatian patients (edit) |
|
| 2020-07-01 |
Organizational aspects of intensive care unit resource allocation in a primary respiratory intensive care center specialized for the treatment of SARS-COV-2 patients (edit) |
|
| 2020-07-01 |
Introductions and early spread of SARS-CoV-2 in France, 24 January to 23 March 2020 (edit) |
10.2807/1560-7917.ES.2020.25.26.2001200 |
| 2020-07-01 |
[The naked king in the pandemic: about the production and communication of scientific knowledge at the time of SARS-CoV-2.] (edit) |
10.1701/3407.33920 |
| 2020-07-01 |
Comprehensive mapping of immune perturbations associated with severe COVID-19 (edit) |
10.1126/SCIIMMUNOL.ABD7114 |
| 2020-07-01 |
Need for Speed: From Human SARS-CoV-2 Samples to Protective and Efficacious Antibodies in Weeks (edit) |
10.1016/J.CELL.2020.06.017 |
| 2020-07-01 |
SARS-CoV-2 infection in conjunctival tissue (edit) |
10.1016/S2213-2600(20)30272-1 |
| 2020-07-01 |
SARS-CoV-2 infection in conjunctival tissue - Authors' reply (edit) |
10.1016/S2213-2600(20)30273-3 |
| 2020-07-01 |
Alteration of Liver Biomarkers in Patients with SARS-CoV-2 (COVID-19) (edit) |
10.2147/JIR.S257078 |
| 2020-07-01 |
SARS-CoV-2 T cell immunity: Specificity, function, durability, and role in protection (edit) |
10.1126/SCIIMMUNOL.ABD6160 |
| 2020-07-01 |
Comparison of Unsupervised Home Self-collected Midnasal Swabs With Clinician-Collected Nasopharyngeal Swabs for Detection of SARS-CoV-2 Infection (edit) |
10.1001/JAMANETWORKOPEN.2020.16382 |
| 2020-07-01 |
Patterns of HIV and SARS-CoV-2 co-infection in Wuhan, China (edit) |
10.1002/JIA2.25568 |
| 2020-07-01 |
Convalescent plasma treatment for SARS-CoV-2 infection: analysis of the first 436 donors in England, 22 April to 12 May 2020 (edit) |
10.2807/1560-7917.ES.2020.25.28.2001260 |
| 2020-07-01 |
Monoclonal antibodies for the S2 subunit of spike of SARS-CoV-1 cross-react with the newly-emerged SARS-CoV-2 (edit) |
10.2807/1560-7917.ES.2020.25.28.2000291 |
| 2020-07-01 |
SARS-CoV-2 IgG seroprevalence in blood donors located in three different federal states, Germany, March to June 2020 (edit) |
10.2807/1560-7917.ES.2020.25.28.2001285 |
| 2020-07-01 |
Association of Social Distancing, Population Density, and Temperature With the Instantaneous Reproduction Number of SARS-CoV-2 in Counties Across the United States (edit) |
10.1001/JAMANETWORKOPEN.2020.16099 |
| 2020-07-01 |
Simulation-based training and assessment of mobile pre-hospital SARS-CoV-2 diagnostic teams in Styria, Austria (edit) |
10.1097/MD.0000000000021081 |
| 2020-07-01 |
Transmission of SARS-CoV-2 by Children (edit) |
10.3238/ARZTEBL.2020.0553 |
| 2020-07-01 |
Potential usefulness of pentoxifylline, a non-specific phosphodiesterase inhibitor with anti-inflammatory, anti-thrombotic, antioxidant, and anti-fibrogenic properties, in the treatment of SARS-CoV-2 (edit) |
10.26355/EURREV_202007_21921 |
| 2020-07-01 |
The impact of SARS-CoV-2 pandemic on Oncologic and Degenerative Spine Surgery Department activity: the experience of Rizzoli Orthopaedic Institute under COVID-19 lockdown (edit) |
10.26355/EURREV_202007_21926 |
| 2020-07-01 |
[Analysis of fatality rates case of SARS-CoV-2 infection in the Autonomous Communities of Spain] (edit) |
10.1016/J.SEMERG.2020.06.013 |
| 2020-07-01 |
Can ACE2 expression explain SARS-CoV-2 infection of the respiratory epithelia in COVID-19? (edit) |
10.15252/MSB.20209841 |
| 2020-07-01 |
Prevalence of SARS-CoV-2 Infection Among Asymptomatic Health Care Workers in the Greater Houston, Texas, Area (edit) |
10.1001/JAMANETWORKOPEN.2020.16451 |
| 2020-07-01 |
Why Healthcare Workers Ought to Be Prioritized in ASMR During the SARS-CoV-2 Pandemic (edit) |
10.1080/15265161.2020.1779411 |
| 2020-07-01 |
Virus-host interactome and proteomic survey of PBMCs from COVID-19 patients reveal potential virulence factors influencing SARS-CoV-2 pathogenesis (edit) |
10.1016/J.MEDJ.2020.07.002 |
| 2020-07-01 |
Audio Interview: New SARS-CoV-2 Vaccine Results, with Peter Piot (edit) |
10.1056/NEJME2026514 |
| 2020-07-01 |
SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity (edit) |
10.1136/JITC-2020-000862 |
| 2020-07-01 |
SARS-CoV-2 seroprevalence among parturient women in Philadelphia (edit) |
10.1126/SCIIMMUNOL.ABD5709 |
| 2020-07-01 |
[Diagnostic of SARS-Cov-2 and the radical uncertainty] (edit) |
10.1016/J.JHQR.2020.07.001 |
| 2020-07-01 |
How does SARS-CoV-2 cause COVID-19? (edit) |
10.1126/SCIENCE.ABC6156 |
| 2020-07-01 |
Duration of SARS-CoV-2 RNA detection in COVID-19 patients in home isolation, Rhineland-Palatinate, Germany, 2020 - an interval-censored survival analysis (edit) |
10.2807/1560-7917.ES.2020.25.30.2001292 |
| 2020-07-01 |
Assessment of SARS-CoV-2 Screening Strategies to Permit the Safe Reopening of College Campuses in the United States (edit) |
10.1001/JAMANETWORKOPEN.2020.16818 |
| 2020-07-01 |
SARS-CoV-2 infection in a psoriatic arthritis patient treated with IL-17 inhibitor (edit) |
10.1016/J.MEHY.2020.110040 |
| 2020-07-01 |
Short report - Usefulness of point-of-care ultrasound in pediatric SARS-CoV-2 infection (edit) |
10.26355/EURREV_202007_22284 |
| 2020-07-01 |
From SARS-CoV to SARS-CoV2: a potential guide to better understanding of pathophysiology of the disease and potential therapeutic modality (edit) |
10.26355/EURREV_202007_22286 |
| 2020-07-01 |
Clinical characteristics and outcomes of 2019-nCoV-infected patients admitted at different time periods (edit) |
10.26355/EURREV_202007_22287 |
| 2020-07-01 |
Molecular modelling of the antiviral action of Resveratrol derivatives against the activity of two novel SARS CoV-2 and 2019-nCoV receptors (edit) |
10.26355/EURREV_202007_22288 |
| 2020-07-01 |
SARS-CoV-2 vs. SARS-CoV-1 management: antibiotics and inflammasome modulators potential (edit) |
10.26355/EURREV_202007_22293 |
| 2020-07-01 |
[SARS-CoV-2 and Microbiological Diagnostic Dynamics in COVID-19 Pandemic] (edit) |
10.5578/MB.69839 |
| 2020-07-01 |
SARS-CoV-2 infection associated with micturition syncope: Our experience with 4 case reports (edit) |
10.1097/MD.0000000000021512 |
| 2020-07-01 |
Selecting a SARS-CoV-2/COVID Molecular Testing Method for Your Laboratory (edit) |
10.1093/JALM/JFAA076 |
| 2020-07-01 |
In silico screening of known small molecules to bind ACE2 specific RBD on Spike glycoprotein of SARS-CoV-2 for repurposing against COVID-19 (edit) |
10.12688/F1000RESEARCH.24143.1 |
| 2020-07-01 |
Unexpected SARS-CoV-2 cardiorespiratory arrest in a myopathy patient undergoing immunosuppressive treatment: A case report (edit) |
10.1097/MD.0000000000021377 |
| 2020-07-01 |
Children with SARS-CoV-2 infection during an epidemic in China (outside of Hubei province) (edit) |
10.21037/ATM-20-2908 |
| 2020-07-01 |
Machine learning-based CT radiomics method for predicting hospital stay in patients with pneumonia associated with SARS-CoV-2 infection: a multicenter study (edit) |
10.21037/ATM-20-3026 |
| 2020-07-01 |
SARS-CoV-2 and Extended Lockdown: A New Lesson for India's Alcohol Policy? (edit) |
|
| 2020-07-01 |
SARS-Cov-2 Infection and Pulmonary Thromboembolism - The Prothrombotic State in COVID-19 (edit) |
10.36660/ABC.20200427 |
| 2020-07-01 |
COVID-19, SARS-CoV-2, and Export Controls (edit) |
10.1089/HS.2020.0048 |
| 2020-07-01 |
Pooled Testing for SARS-CoV-2 in Hospitalized Patients (edit) |
10.12788/JHM.3501 |
| 2020-07-01 |
Modelling the downhill of the Sars-Cov-2 in Italy and a universal forecast of the epidemic in the world (edit) |
10.1016/J.CHAOS.2020.110064 |
| 2020-07-01 |
Sars-CoV-2: les anticorps recueillis au POC (edit) |
10.1016/S1773-035X(20)30209-4 |
| 2020-07-01 |
Sars-CoV-2 et Kawasaki, rapprochement à risque (edit) |
10.1016/S1773-035X(20)30215-X |
| 2020-07-01 |
Characterization and Treatment of SARS-CoV-2 in Nasal and Bronchial Human Airway Epithelia (edit) |
10.1016/J.XCRM.2020.100059 |
| 2020-07-01 |
Influence of the coronavirus 2 (SARS-Cov-2) pandemic on acute appendicitis (edit) |
10.1016/J.ANPEDE.2020.04.010 |
| 2020-07-01 |
SARS-CoV-2 Detection using Real Time PCR by a Commercial Diagnostic Kit (edit) |
|
| 2020-07-01 |
Systematic Review on Repurposing Use of Favipiravir Against SARS-CoV-2 (edit) |
|
| 2020-07-01 |
Increased Incidence, Morbidity, and Mortality in Human Coronavirus NL63 Associated with ACE Inhibitor Therapy and Implication in SARS-CoV-2 (COVID-19) (edit) |
|
| 2020-07-01 |
Reduction of ADAMTS13 Levels Predicts Mortality in SARS-CoV-2 Patients (edit) |
10.1055/S-0040-1716379 |
| 2020-07-01 |
Perfect as the Enemy of the Good: Using Low-Sensitivity Tests to Mitigate SARS-CoV-2 Outbreaks (edit) |
|
| 2020-07-01 |
Chest CT accuracy in the diagnosis of SARS-CoV-2 infection: initial experience in a cancer center (edit) |
10.1590/0100-3984.2020.0040 |
| 2020-07-01 |
Prevalence of SARS-CoV-2 (Covid-19) in Italians and in immigrants in an area of Northern Italy (Reggio Emilia) (edit) |
10.19191/EP20.4.P304.061 |
| 2020-07-01 |
Commentary on Acquired Factor XI Deficiency during SARS-CoV-2 Infection: Not Only Thrombosis (edit) |
10.1055/S-0040-1716839 |
| 2020-07-01 |
Acquired Factor XI Deficiency during SARS-CoV-2 Infection: Not Only Thrombosis (edit) |
10.1055/S-0040-1714696 |
| 2020-07-01 |
Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020 (edit) |
10.4103/IJMR.IJMR_3290_20 |
| 2020-07-01 |
Utility of a modified heat inactivation method for direct detection of SARS-CoV-2 by RT-qPCR in viral transport medium bypassing RNA extraction: A preliminary study (edit) |
10.4103/IJMR.IJMR_3121_20 |
| 2020-06-30 |
Enlightenments of Asymptomatic Cases of SARS-CoV-2 Infection (edit) |
10.2478/JTIM-2020-0017 |
| 2020-06-30 |
Identification of Geographic Specific SARS-Cov-2 Mutations by Random Forest Classification and Variable Selection Methods (edit) |
|
| 2020-06-30 |
SARS-CoV-2 diagnostic testing alternatives for Latin America (edit) |
10.25100/CM.V51I2.4272 |
| 2020-06-30 |
SARS-CoV-2 pandemic and the population with dementia. Recommendations under the auspices of the Polish Psychiatric Association (edit) |
10.12740/PP/122780 |
| 2020-06-30 |
Concerns and Coping Strategies of Persons Under Institutional Quarantine During SARS-CoV-2 Pandemic (edit) |
10.4103/IJPC.IJPC_176_20 |
| 2020-06-30 |
Case Report: Renal potassium wasting in SARS-CoV-2 infection (edit) |
10.12688/F1000RESEARCH.24621.1 |
| 2020-06-30 |
Structure of the full SARS-CoV-2 RNA genome in infected cells (edit) |
10.1101/2020.06.29.178343 |
| 2020-06-30 |
Conformational dynamics of SARS-CoV-2 trimeric spike glycoprotein in complex with receptor ACE2 revealed by cryo-EM (edit) |
10.1101/2020.06.30.177097 |
| 2020-06-30 |
SARS-CoV-2 Molecular Clock and Zoonosis (edit) |
10.5897/JGMV2020.0078 |
| 2020-06-30 |
Early Data From Case Series of Tracheostomy in Patients With SARS-CoV-2 (edit) |
10.1177/0194599820940655 |
| 2020-06-30 |
Is asthma an exclusionary condition for SARS-CoV-2 infection in China? (edit) |
10.1080/02770903.2020.1789873 |
| 2020-06-30 |
Evaluation of SARS-CoV-2 viral RNA in fecal samples (edit) |
10.1186/S12985-020-01359-1 |
| 2020-06-30 |
Hospital preparedness for mass critical care during SARS-CoV-2 pandemic (edit) |
10.1186/S13054-020-03104-0 |
| 2020-06-30 |
Multiple approaches for massively parallel sequencing of SARS-CoV-2 genomes directly from clinical samples (edit) |
10.1186/S13073-020-00751-4 |
| 2020-06-30 |
How should data on airborne transmission of SARS-CoV-2 change occupational health guidelines? (edit) |
10.1136/OEMED-2020-106707 |
| 2020-06-30 |
No evidence of vertical transmission of SARS-CoV-2 after induction of labour in an immune-suppressed SARS-CoV-2-positive patient (edit) |
10.1136/BCR-2020-235581 |
| 2020-06-30 |
A Comprehensive Review of Animal Models for Coronaviruses: SARS-CoV-2, SARS-CoV, and MERS-CoV (edit) |
10.1007/S12250-020-00252-Z |
| 2020-06-30 |
SARS-CoV-2 Transmission and the Risk of Aerosol Generating Procedures (edit) |
10.1164/RCCM.2020C11 |
| 2020-06-30 |
Culture-Competent SARS-CoV-2 in Nasopharynx of Symptomatic Neonates, Children, and Adolescents (edit) |
10.3201/EID2610.202403 |
| 2020-06-30 |
Comparison of In Vitro Inactivation of SARS CoV-2 with Hydrogen Peroxide and Povidone-Iodine Oral Antiseptic Rinses (edit) |
10.1111/JOPR.13220 |
| 2020-06-30 |
Impact of SARS-CoV-2 Viral Load on Risk of Intubation and Mortality Among Hospitalized Patients with Coronavirus Disease 2019 (edit) |
10.1093/CID/CIAA851 |
| 2020-06-30 |
Methylprednisolone added to tocilizumab reduces mortality in SARS-CoV-2 pneumonia: An observational study (edit) |
10.1111/JOIM.13145 |
| 2020-06-30 |
Antibody responses against SARS-CoV-2 in COVID-19 patients (edit) |
10.1002/JMV.26241 |
| 2020-06-30 |
Clinical characteristics and risk factors of mild-to-moderate COVID-19 patients with false negative SARS-CoV-2 nucleic acid (edit) |
10.1002/JMV.26242 |
| 2020-06-30 |
Correction to Considering the Effects of Microbiome and Diet on SARS-CoV-2 Infection: Nanotechnology Roles (edit) |
10.1021/ACSNANO.0C04407 |
| 2020-06-30 |
Large SARS-CoV-2 Outbreak Caused by Asymptomatic Traveler, China (edit) |
10.3201/EID2609.201798 |
| 2020-06-30 |
Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo' (edit) |
10.1038/S41586-020-2488-1 |
| 2020-06-30 |
The ABC's of disaster management: Managing apheresis operations during the SARS-CoV-2 pandemic (edit) |
10.1002/JCA.21803 |
| 2020-06-30 |
SARS-CoV-2 in Italy: Population Density correlates with Morbidity and Mortality (edit) |
10.7883/YOKEN.JJID.2020.200 |
| 2020-06-30 |
Chest CT evaluation of 11 persistent asymptomatic patients with SARS-CoV-2 infection (edit) |
10.7883/YOKEN.JJID.2020.264 |
| 2020-06-30 |
SARS-CoV-2 disease severity and diabetes: why the connection and what is to be done? (edit) |
10.1186/S12979-020-00192-Y |
| 2020-06-30 |
Duration of Respiratory and Gastrointestinal Viral Shedding in Children With SARS-CoV-2: A Systematic Review and Synthesis of Data (edit) |
10.1097/INF.0000000000002814 |
| 2020-06-30 |
Elevation of Ace2 as a SARS-CoV-2 entry receptor gene expression in Alzheimer's disease (edit) |
10.1016/J.JINF.2020.06.072 |
| 2020-06-30 |
Repurposing Therapeutics for Potential Treatment of SARS-CoV-2: A Review (edit) |
10.3390/V12070705 |
| 2020-06-30 |
Influence of Herbal Medicines on HMGB1 Release, SARS-CoV-2 Viral Attachment, Acute Respiratory Failure, and Sepsis. A Literature Review (edit) |
10.3390/IJMS21134639 |
| 2020-06-30 |
Vasculopathy and Coagulopathy Associated with SARS-CoV-2 Infection (edit) |
10.3390/CELLS9071583 |
| 2020-06-30 |
Evidence for SARS-CoV-2 Infection of Animal Hosts (edit) |
10.3390/PATHOGENS9070529 |
| 2020-06-30 |
Body Composition Findings by Computed Tomography in SARS-CoV-2 Patients: Increased Risk of Muscle Wasting in Obesity (edit) |
10.3390/IJMS21134670 |
| 2020-06-30 |
Unsupervised cluster analysis of SARS-CoV-2 genomes indicates that recent (June 2020) cases in Beijing are from a genetic subgroup that consists of mostly European and South(east) Asian samples, of which the latter are the most recent (edit) |
10.1101/2020.06.22.165936 |
| 2020-06-30 |
A glycan cluster on the SARS-CoV-2 spike ectodomain is recognized by Fab-dimerized glycan-reactive antibodies (edit) |
10.1101/2020.06.30.178897 |
| 2020-06-30 |
Mutations from bat ACE2 orthologs markedly enhance ACE2-Fc neutralization of SARS-CoV-2 (edit) |
10.1101/2020.06.29.178459 |
| 2020-06-30 |
Discovery of Synergistic and Antagonistic Drug Combinations against SARS-CoV-2 In Vitro (edit) |
10.1101/2020.06.29.178889 |
| 2020-06-30 |
Glycans on the SARS-CoV-2 Spike Control the Receptor Binding Domain Conformation (edit) |
10.1101/2020.06.26.173765 |
| 2020-06-30 |
SARS-CoV-2 Infection of Pluripotent Stem Cell-derived Human Lung Alveolar Type 2 Cells Elicits a Rapid Epithelial-Intrinsic Inflammatory Response (edit) |
10.1101/2020.06.30.175695 |
| 2020-06-30 |
Environmental contamination by SARS-CoV-2 of an imported case during incubation period (edit) |
10.1016/J.SCITOTENV.2020.140620 |
| 2020-06-30 |
Pushing past the tipping points in containment trajectories of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemics: A simple arithmetic rationale for crushing the curve instead of merely flattening it (edit) |
10.1016/J.IDM.2020.06.001 |
| 2020-06-30 |
Co-infection of influenza B virus and SARS-CoV-2: A case report from Taiwan (edit) |
10.1016/J.JMII.2020.06.011 |
| 2020-06-30 |
Challenges and management options of tubo-ovarian cancer in the midst of SARS-CoV-2 pandemic (edit) |
10.1016/J.EJSO.2020.06.043 |
| 2020-06-30 |
Regulatory Cross Talk Between SARS-CoV-2 Receptor Binding and Replication Machinery in the Human Host (edit) |
10.3389/FPHYS.2020.00802 |
| 2020-06-30 |
Willingness to Seek Diagnostic Testing for SARS-CoV-2 With Home, Drive-through, and Clinic-Based Specimen Collection Locations (edit) |
10.1093/OFID/OFAA269 |
| 2020-06-30 |
SARS-CoV-2: A Piece of Bad News (edit) |
10.5222/MMJ.2020.82584 |
| 2020-06-30 |
Endometrial susceptibility to SARS CoV-2: explained by gene expression across the menstrual cycle? (edit) |
10.1016/J.FERTNSTERT.2020.06.046 |
| 2020-06-30 |
First detection of SARS-CoV-2 RNA in wastewater in North America: A study in Louisiana, USA (edit) |
10.1016/J.SCITOTENV.2020.140621 |
| 2020-06-30 |
Potential Zoonotic Origins of SARS-CoV-2 and Insights for Preventing Future Pandemics Through One Health Approach (edit) |
10.7759/CUREUS.8932 |
| 2020-06-30 |
Comments on "An insertion unique to SARS-CoV-2 exhibits super antigenic character strengthened by recent mutations" by Cheng MH et al.2020 (edit) |
10.6026/97320630016474 |
| 2020-06-30 |
Predicted peptide patterns from the SARS-CoV-2 proteome for MS-MS based diagnosis (edit) |
10.6026/97320630016477 |
| 2020-06-29 |
Minireview of progress in the structural study of SARS-CoV-2 proteins (edit) |
10.1016/J.CRMICR.2020.06.003 |
| 2020-06-29 |
SARS-CoV-2 envelope protein causes acute respiratory distress syndrome (ARDS)-like pathological damage and constitutes an antiviral target (edit) |
10.1101/2020.06.27.174953 |
| 2020-06-29 |
Proteins Nsp12 and 13 of SARS-CoV-2 Have Mitochondrial Recognition Signal: A Connection with Cellular Mitochondrial Dysfunction and Disease Manifestation (edit) |
10.20944/PREPRINTS202006.0352.V1 |
| 2020-06-29 |
SARS-CoV-2 in human sewage in Santa Catalina, Brazil, November 2019 (edit) |
10.1101/2020.06.26.20140731 |
| 2020-06-29 |
A sequence alignment and analysis of SARS-CoV-2 spike glycoprotein (edit) |
|
| 2020-06-29 |
Comparing Nasopharyngeal and Mid-Turbinate Nasal Swab Testing for the Identification of SARS-CoV-2 (edit) |
10.1093/CID/CIAA882 |
| 2020-06-29 |
Prognostic Accuracy of the SIRS, qSOFA, and NEWS for Early Detection of Clinical Deterioration in SARS-CoV-2 Infected Patients (edit) |
10.3346/JKMS.2020.35.E234 |
| 2020-06-29 |
Repurposing of FDA-approved antivirals, antibiotics, anthelmintics, antioxidants, and cell protectives against SARS-CoV-2 papain-like protease (edit) |
10.1080/07391102.2020.1784291 |
| 2020-06-29 |
SARS-CoV-2 infection in kidney transplant recipients (edit) |
10.1111/TID.13394 |
| 2020-06-29 |
Rapid identification of SARS-CoV-2-infected patients at the emergency department using routine testing (edit) |
10.1515/CCLM-2020-0593 |
| 2020-06-29 |
Evaluation of eleven rapid tests for detection of antibodies against SARS-CoV-2 (edit) |
10.1515/CCLM-2020-0628 |
| 2020-06-29 |
SARS-CoV-2: march toward adaptation (edit) |
10.1002/JMV.26233 |
| 2020-06-29 |
Absence of SARS-CoV-2 in Semen of a COVID-19 Patient Cohort (edit) |
10.1111/ANDR.12848 |
| 2020-06-29 |
SARS-CoV-2 infection in healthcare personnel with high-risk occupational exposure: evaluation of seven-day exclusion from work policy (edit) |
10.1093/CID/CIAA888 |
| 2020-06-29 |
SARS-CoV-2 Infection Results in Serious Kidney Impairment: More Studies Need to Be Explored (edit) |
10.1159/000508089 |
| 2020-06-29 |
The Fuzzy Connection between SARS-CoV-2 Infection and Loss of Renal Function (edit) |
10.1159/000508087 |
| 2020-06-29 |
Computing the Effects of SARS-CoV-2 on Respiration Regulatory Mechanisms in COVID-19 (edit) |
10.1021/ACSCHEMNEURO.0C00349 |
| 2020-06-29 |
Boning up: amino-bisphophonates as immunostimulants and endosomal disruptors of dendritic cell in SARS-CoV-2 infection (edit) |
10.1186/S12967-020-02433-6 |
| 2020-06-29 |
Association between obesity and clinical prognosis in patients infected with SARS-CoV-2 (edit) |
10.1186/S40249-020-00703-5 |
| 2020-06-29 |
Sars-Cov-2 interference in HEME production: is it the time for an early predictive biomarker? (edit) |
10.1007/S00109-020-01945-4 |
| 2020-06-29 |
Measures for preventing nosocomial infection with SARS-CoV-2 in hematology departments (edit) |
10.1007/S00277-020-04127-X |
| 2020-06-29 |
Clomipramine Could Be Useful in Preventing Neurological Complications of SARS-CoV-2 Infection (edit) |
10.1007/S11481-020-09939-2 |
| 2020-06-29 |
SARS-CoV-2 Does Not Replicate in Aedes Mosquito Cells nor Present in Field-Caught Mosquitoes from Wuhan (edit) |
10.1007/S12250-020-00251-0 |
| 2020-06-29 |
Current evidence on possible oral manifestations of SARS-CoV-2 infection (edit) |
10.1111/ODI.13517 |
| 2020-06-29 |
SARS-CoV-2 and Streptococcus pneumoniae coinfection as a cause of severe pneumonia in an infant (edit) |
10.1002/PPUL.24916 |
| 2020-06-29 |
Hand hygiene in high-complexity sectors as an integrating element in the combat of Sars-CoV-2 (edit) |
10.1590/0034-7167-2020-0316 |
| 2020-06-29 |
SARS-CoV-2 and the COVID-19 disease: a mini review on diagnostic methods (edit) |
10.1590/S1678-9946202062044 |
| 2020-06-29 |
Androgen deprivation and SARS-CoV-2 in men with prostate cancer (edit) |
10.1016/J.ANNONC.2020.06.015 |
| 2020-06-29 |
First case of persistent pancytopenia associated with SARS-CoV-2 bone marrow infiltration in an immunocompromised patient (edit) |
10.1016/J.ANNONC.2020.06.016 |
| 2020-06-29 |
Snapshot PCR Surveillance for SARS-CoV-2 in Hospital Staff in England (edit) |
10.1016/J.JINF.2020.06.069 |
| 2020-06-29 |
SARS-CoV-2 Detection, Viral Load and Infectivity over the Course of an Infection: SARS-CoV-2 Detection, Viral Load and Infectivity (edit) |
10.1016/J.JINF.2020.06.067 |
| 2020-06-29 |
Lack of Complications in Patients with Eosinophilic Gastrointestinal Diseases During SARS-CoV-2 Outbreak (edit) |
10.1016/J.JAIP.2020.06.041 |
| 2020-06-29 |
Characterizations of SARS-CoV-2 mutational profile, spike protein stability and viral transmission (edit) |
10.1016/J.MEEGID.2020.104445 |
| 2020-06-29 |
Gene signatures of SARS-CoV/SARS-CoV-2-infected ferret lungs in short- and long-term models (edit) |
10.1016/J.MEEGID.2020.104438 |
| 2020-06-29 |
Microbial Natural Products as Potential Inhibitors of SARS-CoV-2 Main Protease (Mpro) (edit) |
10.3390/MICROORGANISMS8070970 |
| 2020-06-29 |
Does SARS-CoV-2 Trigger Stress-InducedAutoimmunity by Molecular Mimicry? A Hypothesis (edit) |
10.3390/JCM9072038 |
| 2020-06-29 |
SARS-CoV-2-related deaths in routine forensic autopsy practice: histopathological patterns (edit) |
10.1007/S00414-020-02354-5 |
| 2020-06-29 |
S2 Subunit of SARS-nCoV-2 Interacts with Tumor Suppressor Protein p53 and BRCA: an In Silico Study (edit) |
10.1016/J.TRANON.2020.100814 |
| 2020-06-29 |
Delving deep into the structural aspects of a furin cleavage site inserted into the spike protein of SARS-CoV-2: A structural biophysical perspective (edit) |
10.1016/J.BPC.2020.106420 |
| 2020-06-29 |
Phosphorylation modulates liquid-liquid phase separation of the SARS-CoV-2 N protein (edit) |
10.1101/2020.06.28.176248 |
| 2020-06-29 |
SARS-CoV-2 infection of primary human lung epithelium for COVID-19 modeling and drug discovery (edit) |
10.1101/2020.06.29.174623 |
| 2020-06-29 |
Retrospective Analysis of 2019-nCov-Infected Cases in Dongyang, Southeastern China (edit) |
10.1155/2020/7056707 |
| 2020-06-29 |
SARS-CoV-2 Transmission in a Dental Practice in Spain: After the Outbreak (edit) |
10.1155/2020/8828616 |
| 2020-06-29 |
Evaluation of the RealStar® SARS-CoV-2 RT-PCR kit RUO performances and limit of detection (edit) |
10.1016/J.JCV.2020.104520 |
| 2020-06-29 |
Comparison of commercial lateral flow immunoassays and ELISA for SARS-CoV-2 antibody detection (edit) |
10.1016/J.JCV.2020.104529 |
| 2020-06-29 |
Using Serology with Models to Clarify the Trajectory of the SARS-CoV-2 Emerging Outbreak (edit) |
10.1016/J.IT.2020.06.011 |
| 2020-06-29 |
Clinical performance of a rapid test compared to a microplate test to detect total anti SARS-CoV-2 antibodies directed to the spike protein (edit) |
10.1016/J.JCV.2020.104528 |
| 2020-06-29 |
Human iPSC-Derived Cardiomyocytes Are Susceptible to SARS-CoV-2 Infection (edit) |
10.1016/J.XCRM.2020.100052 |
| 2020-06-28 |
Reposition of montelukast either alone or in combination with levocetirizine against SARS-CoV-2 (edit) |
10.1016/J.MEHY.2020.110046 |
| 2020-06-28 |
Early Results from SARS-CoV-2 PCR testing of Healthcare Workers at an Academic Medical Center in New York City (edit) |
10.1093/CID/CIAA867 |
| 2020-06-28 |
Infant Case of Co-infection with SARS-CoV-2 and Citrobacter koseri Urinary Infection (edit) |
10.1093/TROPEJ/FMAA032 |
| 2020-06-28 |
Heat inactivation of serum interferes with the immunoanalysis of antibodies to SARS-CoV-2 (edit) |
10.1002/JCLA.23411 |
| 2020-06-28 |
The ACE2 expression in Sertoli cells and germ cells may cause male reproductive disorder after SARS-CoV-2 infection (edit) |
10.1111/JCMM.15541 |
| 2020-06-28 |
Saxifraga spinulosa-Derived Components Rapidly Inactivate Multiple Viruses Including SARS-CoV-2 (edit) |
10.3390/V12070699 |
| 2020-06-28 |
A facile Q-RT-PCR assay for monitoring SARS-CoV-2 growth in cell culture (edit) |
10.1101/2020.06.26.174698 |
| 2020-06-28 |
Cost Benefit Analysis of Limited Reopening Relative to a Herd Immunity Strategy or Shelter in Place for SARS-CoV-2 in the United States (edit) |
10.1101/2020.06.26.20141044 |
| 2020-06-28 |
SARS-CoV-2 Infection in Patients with Down Syndrome, Congenital Heart Disease, and Pulmonary Hypertension: Is Down Syndrome a Risk Factor? (edit) |
10.1016/J.JPEDS.2020.06.076 |
| 2020-06-28 |
A Lesson Not To Be Forgotten. Ophthalmologists in Northern Italy Become Internists During the SARS-CoV-2 Pandemic (edit) |
10.1016/J.AJO.2020.04.044 |
| 2020-06-28 |
The Global Phosphorylation Landscape of SARS-CoV-2 Infection (edit) |
10.1016/J.CELL.2020.06.034 |
| 2020-06-28 |
Immune and bioinformatics identification of T cell and B cell epitopes in the protein structure of SARS-CoV-2: A systematic review (edit) |
10.1016/J.INTIMP.2020.106738 |
| 2020-06-28 |
Bilateral posterior cerebral artery territory infarction in a SARS-Cov-2 infected patient: discussion about an unusual case (edit) |
10.1016/J.JSTROKECEREBROVASDIS.2020.105095 |
| 2020-06-27 |
Structures, conformations and distributions of SARS-CoV-2 spike protein trimers on intact virions (edit) |
10.1101/2020.06.27.174979 |
| 2020-06-27 |
A role for selenium-dependent GPX1 in SARS-CoV-2 virulence (edit) |
10.1093/AJCN/NQAA177 |
| 2020-06-27 |
Positive SARS-CoV-2 RNA recurs repeatedly in a case recovered from COVID-19: dynamic results from 108 days of follow-up (edit) |
10.1093/FEMSPD/FTAA031 |
| 2020-06-27 |
Out of the Darkness-Into the Light: Value of SARS-CoV-2 Antibody Testing in Populations to Benefit Public Health and in Individuals for Peace of Mind (edit) |
10.1093/JALM/JFAA105 |
| 2020-06-27 |
Group Testing for Sars-Cov-2 to Enable Rapid Scale-Up of Testing and Real-Time Surveillance of Incidence (edit) |
10.1093/INFDIS/JIAA378 |
| 2020-06-27 |
Rapid Uptake of Home-Based HIV Self-testing During Social Distancing for SARS-CoV2 Infection in Oregon (edit) |
10.1007/S10461-020-02959-2 |
| 2020-06-27 |
Treatment of Psoriasis - Unburdened by Fear During SARS-CoV2 Menace (edit) |
10.1080/09546634.2020.1788704 |
| 2020-06-27 |
Is SARS-CoV-2 Serology Relevant for Hemodialysis Patients With COVID-19? (edit) |
10.1053/J.AJKD.2020.06.006 |
| 2020-06-27 |
In Reply to 'Is SARS-CoV-2 Serology Relevant for Hemodialysis Patients With COVID-19?' (edit) |
10.1053/J.AJKD.2020.06.005 |
| 2020-06-27 |
Strategies to prevent SARS-CoV-2 transmission during dermatologic head and neck surgery (edit) |
10.1016/J.JAAD.2020.06.983 |
| 2020-06-27 |
Utility of nasopharyngeal swabs in series before hospitalization during SARS-CoV-2 outbreak (edit) |
10.1016/J.JHIN.2020.06.032 |
| 2020-06-27 |
Validation of a commercially available SARS-CoV-2 serological immunoassay (edit) |
10.1016/J.CMI.2020.06.024 |
| 2020-06-27 |
SARS-CoV-2 pathophysiology and assessment of coronaviruses in CNS diseases with a focus on therapeutic targets (edit) |
10.1016/J.BBADIS.2020.165889 |
| 2020-06-27 |
SARS-CoV-2 pneumonia in hospitalized asthmatic patients did not induce severe exacerbation (edit) |
10.1016/J.JAIP.2020.06.032 |
| 2020-06-27 |
Critical Sequence Hot-spots for Binding of nCOV-2019 to ACE2 as Evaluated by Molecular Simulations (edit) |
10.1101/2020.06.27.175448 |
| 2020-06-27 |
Assessment and management of the risk of SARS-CoV-2 infection in an IVF laboratory (edit) |
10.1016/J.RBMO.2020.06.017 |
| 2020-06-27 |
Doxycycline or minocycline may be a viable treatment option against SARS-CoV-2 (edit) |
10.1016/J.MEHY.2020.110054 |
| 2020-06-26 |
In situ structural analysis of SARS-CoV-2 spike reveals flexibility mediated by three hinges (edit) |
10.1101/2020.06.26.173476 |
| 2020-06-26 |
A cytosine-to-uracil change within the programmed -1 ribosomal frameshift signal of SARS-CoV-2 results in structural similarities with the MERS-CoV signal (edit) |
10.1101/2020.06.26.174193 |
| 2020-06-26 |
Tipiracil binds to uridine site and inhibits Nsp15 endoribonuclease NendoU from SARS-CoV-2 (edit) |
10.1101/2020.06.26.173872 |
| 2020-06-26 |
A close look at the biology of SARS-CoV-2, and the potential influence of weather conditions and seasons on COVID-19 case spread (edit) |
10.1186/S40249-020-00688-1 |
| 2020-06-26 |
QT interval prolongation under hydroxychloroquine/ azithromycin association for inpatients with SARS-CoV-2 lower respiratory tract infection (edit) |
10.1002/CPT.1968 |
| 2020-06-26 |
SARS-CoV-2 and HIV protease inhibitors: why lopinavir/ritonavir will not work for COVID-19 infection (edit) |
10.3851/IMP3365 |
| 2020-06-26 |
Cutaneous manifestations in SARS-CoV-2 infection (COVID-19): a French experience and a systematic review of the literature (edit) |
10.1111/JDV.16775 |
| 2020-06-26 |
Recent outbreak of chilblain-like lesions is not directly related with SARS-CoV-2 infection (edit) |
10.1111/JDV.16776 |
| 2020-06-26 |
COVID-19: A series of important recent clinical and laboratory reports in immunology and pathogenesis of SARS-CoV-2 infection and care of allergy patients (edit) |
10.1111/ALL.14472 |
| 2020-06-26 |
Ensuring Uptake of Vaccines against SARS-CoV-2 (edit) |
10.1056/NEJMP2020926 |
| 2020-06-26 |
Postmortem swabs in the Sars-CoV-2 Pandemic: Report on 12 complete clinical autopsy cases (edit) |
10.5858/ARPA.2020-0362-SA |
| 2020-06-26 |
Ocular Surface Expression of SARS-CoV-2 Receptors (edit) |
10.1080/09273948.2020.1772314 |
| 2020-06-26 |
COVID-19 symptoms predictive of healthcare workers' SARS-CoV-2 PCR results (edit) |
10.1371/JOURNAL.PONE.0235460 |
| 2020-06-26 |
What to expect from antibody assays of SARS-CoV-2? (edit) |
10.1093/JALM/JFAA100 |
| 2020-06-26 |
Characteristics of Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status - United States, January 22-June 7, 2020 (edit) |
10.15585/MMWR.MM6925A1 |
| 2020-06-26 |
Data, reagents, assays and merits of proteomics for SARS-CoV-2 research and testing (edit) |
10.1074/MCP.RA120.002164 |
| 2020-06-26 |
Case of acute arthritis following SARS-CoV-2 infection (edit) |
10.1136/ANNRHEUMDIS-2020-218281 |
| 2020-06-26 |
A Potently Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection (edit) |
10.4049/JIMMUNOL.2000583 |
| 2020-06-26 |
SARS-CoV-2: too infectious to handle? (edit) |
10.1038/S41577-020-0383-5 |
| 2020-06-26 |
Infectability of human BrainSphere neurons suggests neurotropism of SARS-CoV-2 (edit) |
10.14573/ALTEX.2006111 |
| 2020-06-26 |
SARS-CoV-2-associated cold agglutinin disease: a report of two cases (edit) |
10.1007/S00277-020-04129-9 |
| 2020-06-26 |
Molecular evolution and phylogenetic analysis of SARS-CoV-2 and hosts ACE2 protein suggest Malayan pangolin as intermediary host (edit) |
10.1007/S42770-020-00321-1 |
| 2020-06-26 |
Environmental concern regarding the effect of humidity and temperature on 2019-nCoV survival: fact or fiction (edit) |
10.1007/S11356-020-09733-W |
| 2020-06-26 |
Identification of a Potential Peptide Inhibitor of SARS-CoV-2 Targeting its Entry into the Host Cells (edit) |
10.1007/S40268-020-00312-5 |
| 2020-06-26 |
Myeloma care adaptations in the UK during SARS-CoV-2 pandemic: challenges and measurable outcomes (edit) |
10.1111/EJH.13479 |
| 2020-06-26 |
Evaluation of interference effects from hemolysis, icterus and lipemia on the Roche Elecsys® Anti-SARS-CoV-2 assay (edit) |
10.1016/J.CCA.2020.06.041 |
| 2020-06-26 |
Designing a novel mRNA vaccine against SARS-CoV-2: An immunoinformatics approach (edit) |
10.1016/J.IJBIOMAC.2020.06.213 |
| 2020-06-26 |
Efficacy of a novel SARS-CoV-2 detection kit without RNA extraction and purification (edit) |
10.1016/J.IJID.2020.06.074 |
| 2020-06-26 |
SARS-CoV, MERS-CoV and SARS-CoV-2 infections in pregnancy and fetal development (edit) |
10.1016/J.JOGOH.2020.101846 |
| 2020-06-26 |
Regional Association of Disability and SARS-CoV-2 Infection in 369 Counties of the United States (edit) |
10.1101/2020.06.24.20139212 |
| 2020-06-26 |
Evaluation of two commercial and two non-commercial immunoassays for the detection of prior infection to SARS-CoV-2 (edit) |
10.1101/2020.06.24.20139006 |
| 2020-06-26 |
SARS-CoV-2 Evolutionary Adaptation toward Host Entry and Recognition of Receptor O-Acetyl Sialylation in Virus-Host Interaction (edit) |
10.3390/IJMS21124549 |
| 2020-06-26 |
Data and Text Mining Help Identify Key Proteins Involved in the Molecular Mechanisms Shared by SARS-CoV-2 and HIV-1 (edit) |
10.3390/MOLECULES25122944 |
| 2020-06-26 |
Lessons from SARS-CoV-2 Pandemic: Evolution, Disease Dynamics and Future (edit) |
10.3390/BIOLOGY9060141 |
| 2020-06-26 |
Clinical and Psychological Impact of COVID-19 Infection in Adult Patients with Eosinophilic Gastrointestinal Disorders during the SARS-CoV-2 Outbreak (edit) |
10.3390/JCM9062011 |
| 2020-06-26 |
Molecular and Serological Tests for COVID-19 a Comparative Review of SARS-CoV-2 Coronavirus Laboratory and Point-of-Care Diagnostics (edit) |
10.3390/DIAGNOSTICS10060434 |
| 2020-06-26 |
SARS-CoV-2 RNA detection in the air and on surfaces in the COVID-19 ward of a hospital in Milan, Italy (edit) |
10.1016/J.SCITOTENV.2020.140540 |
| 2020-06-26 |
Analysis of adjunctive serological detection to nucleic acid test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection diagnosis (edit) |
10.1016/J.INTIMP.2020.106746 |
| 2020-06-26 |
GSK-3 Inhibition as a Therapeutic Approach Against SARs CoV2: Dual Benefit of Inhibiting Viral Replication While Potentiating the Immune Response (edit) |
10.3389/FIMMU.2020.01638 |
| 2020-06-26 |
Overview: Systemic Inflammatory Response Derived From Lung Injury Caused by SARS-CoV-2 Infection Explains Severe Outcomes in COVID-19 (edit) |
10.3389/FIMMU.2020.01626 |
| 2020-06-26 |
Is SARSCoV-2 nasopharyngeal swab still a gold standard in children? (edit) |
10.1016/J.MEHY.2020.110041 |
| 2020-06-26 |
Urban-Rural Polarisation in Times of the Corona Outbreak? The Early Demographic and Geographic Patterns of the SARS-CoV-2 Epidemic in the Netherlands (edit) |
10.1111/TESG.12437 |
| 2020-06-26 |
Encephalopathy as neurological involvement of SARS-COV-2 infection (edit) |
10.1016/J.CLINPR.2020.100034 |
| 2020-06-26 |
Multi-triazole-resistant Aspergillus fumigatus and SARS-CoV-2 co-infection: A lethal combination (edit) |
10.1016/J.MMCR.2020.06.005 |
| 2020-06-25 |
Antiviral Drug Screen of Kinase inhibitors Identifies Cellular Signaling Pathways Critical for SARS-CoV-2 Replication (edit) |
10.1101/2020.06.24.150326 |
| 2020-06-25 |
Cutaneous manifestations of SARS-CoV-2 infection: a clinical update (edit) |
10.1111/JDV.16774 |
| 2020-06-25 |
COVID-19 chilblain-like lesion: immunohistochemical demonstration of SARS-CoV-2 spike protein in blood vessel endothelium and sweat gland epithelium in a PCR-negative patient (edit) |
10.1111/BJD.19338 |
| 2020-06-25 |
Incidence of SARS-CoV-2 vertical transmission: a meta-analysis (edit) |
10.1136/ARCHDISCHILD-2020-319791 |
| 2020-06-25 |
Genome Sequence of SARS-CoV-2 Isolate Cali-01, from Colombia, Obtained Using Oxford Nanopore MinION Sequencing (edit) |
10.1128/MRA.00573-20 |
| 2020-06-25 |
Acute necrotizing encephalopathy with SARS-CoV-2 RNA confirmed in cerebrospinal fluid (edit) |
10.1212/WNL.0000000000010250 |
| 2020-06-25 |
Testing strategy for SARS-CoV-2 in the paediatric emergency department (edit) |
10.1136/ARCHDISCHILD-2020-319806 |
| 2020-06-25 |
Inhibition of SARS-CoV-2 by type I and type III interferons (edit) |
10.1074/JBC.AC120.013788 |
| 2020-06-25 |
SARS-CoV-2 (COVID-19) structural and evolutionary dynamicome: Insights into functional evolution and human genomics (edit) |
10.1074/JBC.RA120.014873 |
| 2020-06-25 |
[Possibilities of employment of pregnant women in the health care system in association with SARS-CoV-2] (edit) |
10.1007/S00063-020-00704-0 |
| 2020-06-25 |
[SARS-CoV-2/COVID-19: systematic review of requirements for personal protective equipment in primary patient contact and organization of the operating area] (edit) |
10.1007/S00104-020-01229-0 |
| 2020-06-25 |
IL-1R blockade is not effective in patients with hematological malignancies and severe SARS-CoV-2 infection (edit) |
10.1007/S00277-020-04160-W |
| 2020-06-25 |
Acute inflammatory demyelinating polyneuritis in association with an asymptomatic infection by SARS-CoV-2 (edit) |
10.1007/S00415-020-10014-2 |
| 2020-06-25 |
[Baricitinib in the treatment of SARS-CoV-2 infection] (edit) |
10.37201/REQ/047.2020 |
| 2020-06-25 |
Immunoinformatics study to search epitopes of spike glycoprotein from SARS-CoV-2 as potential vaccine (edit) |
10.1080/07391102.2020.1780944 |
| 2020-06-25 |
Predictive value of National Early Warning Score 2 (NEWS2) for intensive care unit admission in patients with SARS-CoV-2 infection (edit) |
10.1080/23744235.2020.1784457 |
| 2020-06-25 |
LIPS method for the detection of SARS-CoV-2 antibodies to spike and nucleocapsid proteins (edit) |
10.1002/EJI.202048715 |
| 2020-06-25 |
Antibody tests for identification of current and past infection with SARS-CoV-2 (edit) |
10.1002/14651858.CD013652 |
| 2020-06-25 |
Filtration Efficiencies of Nanoscale Aerosol by Cloth Mask Materials Used to Slow the Spread of SARS CoV-2 (edit) |
10.1021/ACSNANO.0C05025 |
| 2020-06-25 |
Update Alert: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults (edit) |
10.7326/L20-0887 |
| 2020-06-25 |
Imaging findings in coronavirus infections: SARS-CoV, MERS-CoV, and SARS-CoV-2 (edit) |
10.1259/BJR.20200515 |
| 2020-06-25 |
Prevalence of serum IgG antibodies against SARS-CoV-2 among clinic staff (edit) |
10.1371/JOURNAL.PONE.0235417 |
| 2020-06-25 |
Estimation of SARS-CoV-2 infection fatality rate by real-time antibody screening of blood donors (edit) |
10.1093/CID/CIAA849 |
| 2020-06-25 |
Sensitivity of nasopharyngeal swabs and saliva for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (edit) |
10.1093/CID/CIAA848 |
| 2020-06-25 |
Dynamic of SARS-CoV-2 RT-PCR positivity and seroprevalence among high-risk health care workers and hospital staff (edit) |
10.1016/J.JHIN.2020.06.028 |
| 2020-06-25 |
Viral dynamics of SARS-CoV-2 in saliva from infected patients (edit) |
10.1016/J.JINF.2020.06.059 |
| 2020-06-25 |
Children and SARS-CoV-2 infection: innocent bystanders…until proven otherwise (edit) |
10.1016/J.CMI.2020.06.017 |
| 2020-06-25 |
Could anti-CD20 therapy jeopardise the efficacy of a SARS-CoV-2 vaccine? (edit) |
10.1016/J.EJCA.2020.06.017 |
| 2020-06-25 |
Virtual screening of approved drugs as potential SARS-CoV-2 main protease inhibitors (edit) |
10.1016/J.COMPBIOLCHEM.2020.107325 |
| 2020-06-25 |
Preliminary Virtual Screening Studies to Identify GRP78 Inhibitors Which May Interfere with SARS-CoV-2 Infection (edit) |
10.3390/PH13060132 |
| 2020-06-25 |
Development and Evaluation of a duo SARS-CoV-2 RT-qPCR Assay Combining Two Assays Approved by the World Health Organization Targeting the Envelope and the RNA-Dependant RNA Polymerase (RdRp) Coding Regions (edit) |
10.3390/V12060686 |
| 2020-06-25 |
MicroGMT: A Mutation Tracker for SARS-CoV-2 and Other Microbial Genome Sequences (edit) |
10.3389/FMICB.2020.01502 |
| 2020-06-25 |
SARS-CoV-2 and EBV coinfection (edit) |
10.1016/J.MEDCLI.2020.06.017 |
| 2020-06-25 |
Lung cysts in a patient with SARS-CoV-2 (edit) |
10.1016/J.MEDCLI.2020.06.015 |
| 2020-06-25 |
Importance of the One Health approach to study the SARS-CoV-2 in Latin America (edit) |
10.1016/J.ONEHLT.2020.100147 |
| 2020-06-25 |
From H1N1 to 2019-nCoV, what do we learn? (edit) |
10.1016/J.CJTEE.2020.06.005 |
| 2020-06-25 |
Chronic kidney disease and SARS-CoV-2 outbreak: Lazio region organizational model (edit) |
10.1093/CKJ/SFAA097 |
| 2020-06-25 |
Multiorgan inflammatory syndrome associated with SARS-CoV-2 in a child (edit) |
10.4045/TIDSSKR.20.0485 |
| 2020-06-25 |
Applications of machine learning and artificial intelligence for Covid-19 (SARS-CoV-2) pandemic: A review (edit) |
10.1016/J.CHAOS.2020.110059 |
| 2020-06-25 |
The Association of Cardiovascular Diseases and Diabetes Mellitus with COVID-19 (SARS-CoV-2) and Their Possible Mechanisms (edit) |
10.1007/S42399-020-00376-Z |
| 2020-06-24 |
Synthetic Heparan Sulfate Mimetic Pixatimod (PG545) Potently Inhibits SARS-CoV-2 By Disrupting The Spike-ACE2 interaction (edit) |
10.1101/2020.06.24.169334 |
| 2020-06-24 |
Efficacy of Serology Testing in Predicting Reinfection in Patients with SARS-CoV-2 (edit) |
10.1017/DMP.2020.216 |
| 2020-06-24 |
"How much do young Italians know about COVID-19 and what are their attitudes towards the Sars-CoV-2? Results of a cross-sectional study" (edit) |
10.1017/DMP.2020.205 |
| 2020-06-24 |
Nanopore Targeted Sequencing for the Accurate and Comprehensive Detection of SARS-CoV-2 and Other Respiratory Viruses (edit) |
10.1002/SMLL.202002169 |
| 2020-06-24 |
Prolonged Shedding of SARS-CoV-2 RNA among Patients with COVID-19 (edit) |
10.1017/ICE.2020.307 |
| 2020-06-24 |
Prolonged Duration of SARS-CoV-2 Viral Positivity in a Crohn's Disease Patient (edit) |
10.1093/IBD/IZAA175 |
| 2020-06-24 |
SARS-CoV-2 environmental contamination associated with persistently infected COVID-19 patients (edit) |
10.1111/IRV.12783 |
| 2020-06-24 |
Molecular Basis for ADP-ribose Binding to the Mac1 Domain of SARS-CoV-2 Nsp3 (edit) |
10.1021/ACS.BIOCHEM.0C00309 |
| 2020-06-24 |
SARS-CoV-2-induced Acute Respiratory Distress Syndrome: Pulmonary Mechanics and Gas Exchange Abnormalities (edit) |
10.1513/ANNALSATS.202005-462RL |
| 2020-06-24 |
Screening of Chloroquine, Hydroxychloroquine and its derivatives for their binding affinity to multiple SARS-CoV-2 protein drug targets (edit) |
10.1080/07391102.2020.1782265 |
| 2020-06-24 |
Pharmacoinformatics and molecular dynamics simulation studies reveal potential covalent and FDA-approved inhibitors of SARS-CoV-2 main protease 3CLpro (edit) |
10.1080/07391102.2020.1782768 |
| 2020-06-24 |
Binding insight of clinically oriented drug famotidine with the identified potential target of SARS-CoV-2 (edit) |
10.1080/07391102.2020.1784795 |
| 2020-06-24 |
Insights into SARS-CoV-2, the Coronavirus Underlying COVID-19: Recent Genomic Data and the Development of Reverse Genetics Systems (edit) |
10.1099/JGV.0.001458 |
| 2020-06-24 |
Oral erosions and petechiae during SARS-CoV-2 infection (edit) |
10.1002/JMV.26221 |
| 2020-06-24 |
Clinical and biological data on the use of hydroxychloroquine against SARS-CoV-2 could support the role of the NLRP3 inflammasome in the pathogenesis of respiratory disease (edit) |
10.1002/JMV.26217 |
| 2020-06-24 |
SARS-CoV-2 and SARS-CoV: Virtual Screening of Potential inhibitors targeting RNA-dependent RNA polymerase activity (NSP12) (edit) |
10.1002/JMV.26222 |
| 2020-06-24 |
Detecting SARS-CoV-2 RNA in conjunctival secretions: is it a valuable diagnostic method of COVID-19? (edit) |
10.1002/JMV.26219 |
| 2020-06-24 |
Antiviral activities of mycophenolic acid and IMD-0354 against SARS-CoV-2 (edit) |
10.1111/1348-0421.12828 |
| 2020-06-24 |
SARS-CoV-2-reactive interferon-γ-producing CD8+ T cells in patients hospitalized with Coronavirus Disease 2019 (edit) |
10.1002/JMV.26213 |
| 2020-06-24 |
Clinical Characteristics of Acute Respiratory Syndrome with SARS-CoV-2 Infection in Children in South China (edit) |
10.1002/PPUL.24921 |
| 2020-06-24 |
Masks for Prevention of Respiratory Virus Infections, Including SARS-CoV-2, in Health Care and Community Settings: A Living Rapid Review (edit) |
10.7326/M20-3213 |
| 2020-06-24 |
Prolonged Infectivity of SARS-CoV-2 in Fomites (edit) |
10.3201/EID2609.201788 |
| 2020-06-24 |
Methemoglobinemia in Patient with G6PD Deficiency and SARS-CoV-2 Infection (edit) |
10.3201/EID2609.202353 |
| 2020-06-24 |
Antibody Responses to SARS-CoV-2 at 8 Weeks Postinfection in Asymptomatic Patients (edit) |
10.3201/EID2610.202211 |
| 2020-06-24 |
Rapid roll out of SARS-CoV-2 antibody testing-a concern (edit) |
10.1136/BMJ.M2420 |
| 2020-06-24 |
Asymptomatic SARS-CoV-2 infection: the tip or the iceberg? (edit) |
10.1136/THORAXJNL-2020-215337 |
| 2020-06-24 |
Rampant C→U Hypermutation in the Genomes of SARS-CoV-2 and Other Coronaviruses: Causes and Consequences for Their Short- and Long-Term Evolutionary Trajectories (edit) |
10.1128/MSPHERE.00408-20 |
| 2020-06-24 |
Autoantibodies related to systemic autoimmune rheumatic diseases in severely ill patients with COVID-19 (edit) |
10.1136/ANNRHEUMDIS-2020-218009 |
| 2020-06-24 |
Structural plasticity of SARS-CoV-2 3CL Mpro active site cavity revealed by room temperature X-ray crystallography (edit) |
10.1038/S41467-020-16954-7 |
| 2020-06-24 |
Recombinant human ACE2: potential therapeutics of SARS-CoV-2 infection and its complication (edit) |
10.1038/S41401-020-0430-6 |
| 2020-06-24 |
Utility of CT scan in patients with initial negative PCR for SARS-CoV2: a report of three cases (edit) |
10.1007/S15010-020-01467-8 |
| 2020-06-24 |
Should Asymptomatic and Low-Risk Individuals be Tested for SARS-CoV-2? (edit) |
10.1007/S11606-020-06000-Z |
| 2020-06-24 |
SARS-CoV-2 and biomimetics: What saves the planet will save our health (edit) |
10.1111/JOIM.13128 |
| 2020-06-24 |
A joint action in times of pandemic: the German BioImaging recommendations for operating imaging core facilities during the SARS-Cov-2 emergency (edit) |
10.1002/CYTO.A.24178 |
| 2020-06-24 |
Clinical Features and Outcome of SARS-CoV-2 Infection in Children: A Systematic Review and Meta-analysis (edit) |
|
| 2020-06-24 |
Could urinary ACE2 protein level help identify individuals susceptible to SARS-CoV-2 infection and complication? (edit) |
10.1007/S11427-020-1759-4 |
| 2020-06-24 |
Room-temperature-storable PCR Mixes for SARS-CoV-2 Detection (edit) |
10.1016/J.CLINBIOCHEM.2020.06.013 |
| 2020-06-24 |
Early experiences of SARS-CoV2 infection in severe asthmatics receiving biologic therapy (edit) |
10.1016/J.JAIP.2020.06.027 |
| 2020-06-24 |
Direct SARS-CoV-2 infection of the heart potentiates the cardiovascular sequelae of COVID-19 (edit) |
10.1016/J.DRUDIS.2020.06.021 |
| 2020-06-24 |
Mask wearing in pre-symptomatic patients prevents SARS-CoV-2 transmission: An epidemiological analysis (edit) |
10.1016/J.TMAID.2020.101803 |
| 2020-06-24 |
Screening for neurotropism of SARS-CoV-2 among COVID patients requiring neurosurgical interventions (edit) |
10.1016/J.WNEU.2020.06.128 |
| 2020-06-24 |
Letter to the Editor: SARS-CoV-2 and Traumatic Cervical Acute Spinal Cord Injury: An Appraisal (edit) |
10.1016/J.WNEU.2020.06.134 |
| 2020-06-24 |
Class A G Protein-Coupled Receptor Antagonist Famotidine as a Therapeutic Alternative Against SARS-CoV2: An In Silico Analysis (edit) |
10.3390/BIOM10060954 |
| 2020-06-24 |
Neurological Consequences of 2019-nCoV Infection: A Comprehensive Literature Review (edit) |
10.7759/CUREUS.8790 |
| 2020-06-24 |
The SARS-CoV-2 receptor, Angiotensin converting enzyme 2 (ACE2) is required for human endometrial stromal cell decidualization (edit) |
10.1101/2020.06.23.168252 |
| 2020-06-24 |
Response to 'Multimorbidity and SARS-CoV-2 infection in UK biobank' (edit) |
10.1016/J.DSX.2020.06.033 |
| 2020-06-24 |
PEDIATRIC INFLAMMATORY MULTISYSTEM SYNDROME WITH CENTRAL NERVOUS SYSTEM INVOLVEMENT AND HYPOCOMPLEMENTEMIA FOLLOWING SARS-COV-2 INFECTION (edit) |
10.1097/INF.0000000000002804 |
| 2020-06-24 |
Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies (edit) |
10.1016/J.CELL.2020.06.025 |
| 2020-06-24 |
Mild SARS-CoV-2 infections in children might be based on evolutionary biology and linked with host reactive oxidative stress and antioxidant capabilities (edit) |
10.1016/J.NMNI.2020.100723 |
| 2020-06-24 |
Recombinant SARS-CoV-2 spike S1-Fc fusion protein induced high levels of neutralizing responses in nonhuman primates (edit) |
10.1016/J.VACCINE.2020.06.066 |
| 2020-06-24 |
Unique fibrinogen-binding motifs in the nucleocapsid phosphoprotein of SARS CoV-2: Potential implications in host-pathogen interactions (edit) |
10.1016/J.MEHY.2020.110030 |
| 2020-06-24 |
SARS-CoV-2 and the sympathetic immune response: Dampening inflammation with antihypertensive drugs (Clonidine and Propranolol) (edit) |
10.1016/J.MEHY.2020.110039 |
| 2020-06-24 |
Spontaneous Major Hemorrhage in COVID-19 Patients: Another Brick in the Wall of SARS-CoV-2-Associated Coagulation Disorders? (edit) |
10.1016/J.JVIR.2020.06.010 |
| 2020-06-24 |
SARS-CoV-2 in children and adolescents in Norway: confirmed infection, hospitalisations and underlying conditions (edit) |
10.4045/TIDSSKR.20.0457 |
| 2020-06-24 |
Coronavirus in Continuous Flux: From SARS-CoV to SARS-CoV-2 (edit) |
10.1002/ADVS.202001474 |
| 2020-06-24 |
Heart block in patients with coronavirus disease 2019: A case series of 3 patients infected with SARS-CoV-2 (edit) |
10.1016/J.HRCR.2020.06.014 |
| 2020-06-24 |
Dynamic Regulation of SARS-Cov-2 Binding and Cell Entry Mechanisms in Remodeled Human Ventricular Myocardium (edit) |
10.1016/J.JACBTS.2020.06.007 |
| 2020-06-24 |
Expression profiling meta-analysis of ACE2 and TMPRSS2, the putative anti-inflammatory receptor and priming protease of SARS-CoV-2 in human cells, and identification of putative modulators (edit) |
10.1016/J.REDOX.2020.101615 |
| 2020-06-23 |
The dynamic treatment of SARS-CoV-2 disease (edit) |
10.1080/08998280.2020.1780086 |
| 2020-06-23 |
Towards a pharmacochemical hypothesis of the prophylaxis of SARS-CoV-2 by psychoactive substances (edit) |
10.1016/J.MEHY.2020.110025 |
| 2020-06-23 |
SARS-CoV-2 structure and replication characterized by in situ cryo-electron tomography (edit) |
10.1101/2020.06.23.167064 |
| 2020-06-23 |
Platelets can contain SARS-CoV-2 RNA and are hyperactivated in COVID-19 (edit) |
10.1101/2020.06.23.20137596 |
| 2020-06-23 |
Biochemical evidence of furin specificity and potential for phospho-regulation at Spike protein S1/S2 cleavage site in SARS-CoV2 but not in SARS-CoV1 or MERS-CoV (edit) |
10.1101/2020.06.23.166900 |
| 2020-06-23 |
Selective Naked-Eye Detection of SARS-CoV-2 Mediated by N Gene Targeted Antisense Oligonucleotide Capped Plasmonic Nanoparticles (edit) |
10.1021/ACSNANO.0C03822 |
| 2020-06-23 |
Systemic analysis of putative SARS-CoV-2 entry and processing genes in cardiovascular tissues identifies a positive correlation of BSG with age in endothelial cells (edit) |
10.1101/2020.06.23.165324 |
| 2020-06-23 |
Clinical Implications of SARS-Cov2 Interaction with Renin Angiotensin System (edit) |
10.1016/J.JACC.2020.04.028 |
| 2020-06-23 |
Re-analysis of SARS-CoV-2-infected host cell proteomics time-course data by impact pathway analysis and network analysis: a potential link with inflammatory response (edit) |
10.18632/AGING.103524 |
| 2020-06-23 |
Compassionate Use of Tocilizumab for Treatment of SARS-CoV-2 Pneumonia (edit) |
10.1093/CID/CIAA812 |
| 2020-06-23 |
Role of von Willebrand Factor and ADAMTS-13 in the Pathogenesis of Thrombi in SARS-CoV-2 Infection: Time to Rethink (edit) |
10.1055/S-0040-1713400 |
| 2020-06-23 |
CT findings of patients infected with SARS-CoV-2 (edit) |
10.1186/S12880-020-00471-6 |
| 2020-06-23 |
COVID-19: ICU delirium management during SARS-CoV-2 pandemic-pharmacological considerations (edit) |
10.1186/S13054-020-03072-5 |
| 2020-06-23 |
Actions required to assure continuous supply of anti-rheumatic medication during the SARS-CoV-2/COVID-19 pandemic. Response to: 'Treatment adherence behaviours in rheumatic diseases during pandemic COVID-19: a Latin American experience' by Pineda-Si (edit) |
10.1136/ANNRHEUMDIS-2020-218223 |
| 2020-06-23 |
Nervous system: subclinical target of SARS-CoV-2 infection (edit) |
10.1136/JNNP-2020-323881 |
| 2020-06-23 |
A mathematical model reveals the influence of population heterogeneity on herd immunity to SARS-CoV-2 (edit) |
10.1126/SCIENCE.ABC6810 |
| 2020-06-23 |
[Digital surveillance tools for contact tracking of infected persons by SARS-CoV-2.] (edit) |
|
| 2020-06-23 |
Ecological and epidemiological models are both useful for SARS-CoV-2 (edit) |
10.1038/S41559-020-1246-Y |
| 2020-06-23 |
Is the oral cavity relevant in SARS-CoV-2 pandemic? (edit) |
10.1007/S00784-020-03413-2 |
| 2020-06-23 |
Isolated olfactory cleft involvement in SARS-CoV-2 infection: prevalence and clinical correlates (edit) |
10.1007/S00405-020-06165-7 |
| 2020-06-23 |
Preoperative SARS-CoV-2 screening: Can it really rule out COVID-19? (edit) |
10.1007/S12630-020-01746-W |
| 2020-06-23 |
Perception of the 2020 SARS-CoV-2 pandemic among medical professionals in Germany: results from a nationwide online survey (edit) |
10.1080/22221751.2020.1785951 |
| 2020-06-23 |
Targeting SARS-COV-2 non-structural protein 16: a virtual drug repurposing study (edit) |
10.1080/07391102.2020.1779133 |
| 2020-06-23 |
Could SARS-CoV-2 affect male fertility? (edit) |
10.1111/AND.13712 |
| 2020-06-23 |
Antibodies to SARS-CoV-2 and their potential for therapeutic passive immunization (edit) |
10.7554/ELIFE.57877 |
| 2020-06-23 |
SARS-CoV-2 infection of the placenta (edit) |
10.1172/JCI139569 |
| 2020-06-23 |
Platelet Gene Expression and Function in COVID-19 Patients (edit) |
10.1182/BLOOD.2020007214 |
| 2020-06-23 |
Elucidation of Cellular Targets and Exploitation of the Receptor Binding Domain of SARS-CoV-2 for vaccine and monoclonal antibody synthesis (edit) |
10.1002/JMV.26212 |
| 2020-06-23 |
Lessons from SARS-CoV-2 screening in a Brazilian Organ Transplant Unit (edit) |
10.1111/TID.13376 |
| 2020-06-23 |
SARS-CoV-2 infection in kidney transplant recipients: experience of the italian marche region (edit) |
10.1111/TID.13377 |
| 2020-06-23 |
Pediatric hematology oncology during SARS-CoV-2: A brief communication of 28 patients and changes in clinical practice from a single institute in Pakistan (edit) |
10.1002/PBC.28527 |
| 2020-06-23 |
Benign course of SARS-CoV-2 infection in a series of pediatric oncology patients (edit) |
10.1002/PBC.28504 |
| 2020-06-23 |
Structural Basis of the SARS-CoV-2/SARS-CoV Receptor Binding and Small-Molecule Blockers as Potential Therapeutics (edit) |
10.1146/ANNUREV-PHARMTOX-061220-093932 |
| 2020-06-23 |
Asymptomatic SARS-CoV-2 Infection in Nursing Homes, Barcelona, Spain, April 2020 (edit) |
10.3201/EID2609.202603 |
| 2020-06-23 |
The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): A systematic review and meta-analysis of 148 studies from 9 countries (edit) |
10.1371/JOURNAL.PONE.0234765 |
| 2020-06-23 |
ACE2 and TMPRSS2 variation in savanna monkeys (Chlorocebus spp.): Potential risk for zoonotic/anthroponotic transmission of SARS-CoV-2 and a potential model for functional studies (edit) |
10.1371/JOURNAL.PONE.0235106 |
| 2020-06-23 |
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) infection in cancer population: Are patient-related symptoms helpful to track a harmful invisible? (edit) |
10.1002/IJC.33167 |
| 2020-06-23 |
SARS-CoV-2: An Update on Potential Antivirals in Light of SARS-CoV Antiviral Drug Discoveries (edit) |
10.3390/VACCINES8020335 |
| 2020-06-23 |
SARS-CoV-2 infection in liver-Author's reply (edit) |
10.1016/J.JHEP.2020.06.028 |
| 2020-06-23 |
The ORF6, ORF8 and nucleocapsid proteins of SARS-CoV-2 inhibit type I interferon signaling pathway (edit) |
10.1016/J.VIRUSRES.2020.198074 |
| 2020-06-23 |
Do established infection prevention and control measures prevent spread of SARS-CoV-2 to the hospital environment beyond the patient room? (edit) |
10.1016/J.JHIN.2020.06.026 |
| 2020-06-23 |
Impact of the outbreak of SARS-CoV-2 infection on urgent gynecological care (edit) |
10.1016/J.JOGOH.2020.101841 |
| 2020-06-23 |
Reply to Radermacher et al on "Serum Hydrogen Sulfide and Outcome Association in Pneumonia by the Sars-cov-2 Coronavirus" (edit) |
10.1097/SHK.0000000000001603 |
| 2020-06-23 |
Accommodating individual travel history, global mobility, and unsampled diversity in phylogeography: a SARS-CoV-2 case study (edit) |
10.1101/2020.06.22.165464 |
| 2020-06-23 |
Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular Probes (edit) |
10.1101/2020.06.22.166033 |
| 2020-06-23 |
Serologic cross-reactivity of SARS-CoV-2 with endemic and seasonal Betacoronaviruses (edit) |
10.1101/2020.06.22.20137695 |
| 2020-06-23 |
No detection of SARS-CoV-2 in cystic fibrosis patients at the Regional (Lazio) Reference Center for CF in Italy (edit) |
10.1016/J.JCF.2020.06.018 |
| 2020-06-23 |
Why is SARS-CoV-2 infection more severe in obese men? The gut lymphatics - Lung axis hypothesis (edit) |
10.1016/J.MEHY.2020.110023 |
| 2020-06-23 |
Potential spreading risks and disinfection challenges of medical wastewater by the presence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) viral RNA in septic tanks of Fangcang Hospital (edit) |
10.1016/J.SCITOTENV.2020.140445 |
| 2020-06-23 |
Allocation criteria for an initial shortage of a future SARS-CoV-2 vaccine and necessary measures for global immunity (edit) |
10.1016/J.VACCINE.2020.06.058 |
| 2020-06-23 |
Logistical challenges for potential SARS-CoV-2 vaccine and a call to research institutions, developers and manufacturers (edit) |
10.1016/J.VACCINE.2020.06.056 |
| 2020-06-23 |
SARS-CoV-2: Virology, epidemiology, immunology and vaccine development (edit) |
10.1016/J.BIOLOGICALS.2020.06.005 |
| 2020-06-23 |
CD209L/L-SIGN and CD209/DC-SIGN act as receptors for SARS-CoV-2 and are differentially expressed in lung and kidney epithelial and endothelial cells (edit) |
10.1101/2020.06.22.165803 |
| 2020-06-23 |
A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19 (edit) |
10.1101/2020.06.22.165712 |
| 2020-06-23 |
SARS-CoV-2 titers in wastewater foreshadow dynamics and clinical presentation of new COVID-19 cases (edit) |
10.1101/2020.06.15.20117747 |
| 2020-06-23 |
Identification of multiple large deletions in ORF7a resulting in in-frame gene fusions in clinical SARS-CoV-2 isolates (edit) |
10.1016/J.JCV.2020.104523 |
| 2020-06-23 |
Re: Hanbing Song, Bobak Seddighzadeh, Matthew R. Cooperberg, Franklin W. Huang. Expression of ACE2 and TMPRSS2, the SARS-CoV-2 Receptor and Co-Receptor, in Prostate Epithelial Cells. Eur Urol. In press DOI: 10.1016/j.eururo.2020.04.065 (edit) |
10.1016/J.EURURO.2020.06.034 |
| 2020-06-23 |
Evaluation of simple nucleic acid extraction methods for the detection of SARS-CoV-2 in nasopharyngeal and saliva specimens during global shortage of extraction kits (edit) |
10.1016/J.JCV.2020.104519 |
| 2020-06-23 |
Nanobodies: Prospects of Expanding the Gamut of Neutralizing Antibodies Against the Novel Coronavirus, SARS-CoV-2 (edit) |
10.3389/FIMMU.2020.01531 |
| 2020-06-23 |
Cotton-Tipped Plastic Swabs for SARS-CoV-2 RT-qPCR Diagnosis to Prevent Supply Shortages (edit) |
10.3389/FCIMB.2020.00356 |
| 2020-06-23 |
Children Infected With SARS-CoV-2 From Family Clusters (edit) |
10.3389/FPED.2020.00386 |
| 2020-06-23 |
Impact of SARS-CoV-2 (Coronavirus) Pandemic on Public Mental Health (edit) |
10.3389/FPUBH.2020.00292 |
| 2020-06-23 |
Correction to Investigation into SARS-CoV-2 Resistance of Compounds in Garlic Essential Oil (edit) |
10.1021/ACSOMEGA.0C02641 |
| 2020-06-23 |
[Infection by SARS-CoV-2 in pregnancy and possibility of transmission to neonates: A systematic revision] (edit) |
10.1016/J.SEMERG.2020.06.011 |
| 2020-06-23 |
Impact of the SARS-CoV-2 epidemic on private ENT consulting practice during the first month of lockdown in Réunion Island in 2020 (edit) |
10.1016/J.ANORL.2020.06.013 |
| 2020-06-23 |
[Usefulness of chest ultrasound in a neonatal infection due to SARS-CoV-2] (edit) |
10.1016/J.ANPEDI.2020.04.027 |
| 2020-06-23 |
Response to letter to the editor by Abhipsha Sur Roy and Amol Joshi regarding the article: 'Multimorbidity and SARS-CoV-2 infection in UK Biobank' (Chudasama et al.). (edit) |
10.1016/J.DSX.2020.06.034 |
| 2020-06-23 |
Coronaviruses in cats and other companion animals: Where does SARS-CoV-2/COVID-19 fit? (edit) |
10.1016/J.VETMIC.2020.108777 |
| 2020-06-23 |
Azafluorene derivatives as inhibitors of SARS CoV-2 RdRp: Synthesis, physicochemical, quantum chemical, modeling and molecular docking analysis (edit) |
10.1016/J.MOLSTRUC.2020.128741 |
| 2020-06-23 |
Identification and classification of differentially expressed genes reveal potential molecular signature associated with SARS-CoV-2 infection in lung adenocarcinomal cells (edit) |
10.1016/J.IMU.2020.100384 |
| 2020-06-22 |
Multiple organ dysfunction in SARS-CoV-2: MODS-CoV-2 (edit) |
10.1080/17476348.2020.1778470 |
| 2020-06-22 |
nCOV-19 peptides mass fingerprinting identification, binding, and blocking of inhibitors flavonoids and anthraquinone of Moringa oleifera and hydroxychloroquine (edit) |
10.1080/07391102.2020.1778534 |
| 2020-06-22 |
Unknown SARS-CoV-2 pneumonia detected by PET/CT in patients with cancer (edit) |
10.1177/0300891620935983 |
| 2020-06-22 |
Structure-based virtual screening and molecular dynamics simulation of SARS-CoV-2 Guanine-N7 methyltransferase (nsp14) for identifying antiviral inhibitors against COVID-19 (edit) |
10.1080/07391102.2020.1778535 |
| 2020-06-22 |
In silico identification of potential inhibitors from Cinnamon against main protease and spike glycoprotein of SARS CoV-2 (edit) |
10.1080/07391102.2020.1779129 |
| 2020-06-22 |
Sars-cov-2 host entry and replication inhibitors from Indian ginseng: an in-silico approach (edit) |
10.1080/07391102.2020.1778539 |
| 2020-06-22 |
Virtual screening and dynamics of potential inhibitors targeting RNA binding domain of nucleocapsid phosphoprotein from SARS-CoV-2 (edit) |
10.1080/07391102.2020.1778536 |
| 2020-06-22 |
SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology (edit) |
10.1099/JGV.0.001453 |
| 2020-06-22 |
Lessons from a lumbar burst fracture patient infected with SARS-CoV-2 (edit) |
10.18632/AGING.103414 |
| 2020-06-22 |
Development of a lateral flow immunoassay strip for rapid detection of IgG antibody against SARS-CoV-2 virus (edit) |
10.1039/D0AN00629G |
| 2020-06-22 |
Diagnostic efficacy of anti-SARS-CoV-2 IgG/IgM test for Covid-19: A meta-analysis (edit) |
10.1002/JMV.26211 |
| 2020-06-22 |
COVID-19 Multisystem Inflammatory Syndrome in Three Teenagers with Confirmed SARS-CoV-2 Infection (edit) |
10.1002/JMV.26206 |
| 2020-06-22 |
Mass Spectrometric Identification of SARS-CoV-2 Proteins from Gargle Solution Samples of COVID-19 Patients (edit) |
10.1021/ACS.JPROTEOME.0C00280 |
| 2020-06-22 |
Evaluation of green tea polyphenols as novel corona virus (SARS CoV-2) main protease (Mpro) inhibitors - an in silico docking and molecular dynamics simulation study (edit) |
10.1080/07391102.2020.1779818 |
| 2020-06-22 |
Remdesivir (GS-5734) as a therapeutic option of 2019-nCOV main protease - in silico approach (edit) |
10.1080/07391102.2020.1781694 |
| 2020-06-22 |
Sars-CoV-2 infection: the same virus can cause different cutaneous manifestations: reply from authors (edit) |
10.1111/BJD.19317 |
| 2020-06-22 |
Evaluation of Conjunctival Swab PCR Results in Patients with SARS-CoV-2 Infection (edit) |
10.1080/09273948.2020.1775261 |
| 2020-06-22 |
Tackling SARS-CoV-2: proposed targets and repurposed drugs (edit) |
10.4155/FMC-2020-0147 |
| 2020-06-22 |
Clinical characteristics of older and younger patients infected with SARS-CoV-2 (edit) |
10.18632/AGING.103535 |
| 2020-06-22 |
Drug repurposing against SARS-CoV-2 using E-pharmacophore based virtual screening, molecular docking and molecular dynamics with main protease as the target (edit) |
10.1080/07391102.2020.1779819 |
| 2020-06-22 |
PET and SPECT Imaging in the SARS-CoV-2 Pandemic (edit) |
10.2174/187447101302200622143626 |
| 2020-06-22 |
Identification of common deletions in the spike protein of SARS-CoV-2 (edit) |
10.1128/JVI.00790-20 |
| 2020-06-22 |
IMPACT OF GLUCOCORTICOID TREATMENT IN SARS-COV-2 INFECTION MORTALITY: A RETROSPECTIVE CONTROLLED COHORT STUDY (edit) |
10.1128/AAC.01168-20 |
| 2020-06-22 |
A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2 (edit) |
10.1126/SCIENCE.ABC6952 |
| 2020-06-22 |
Structural and functional conservation of the programmed -1 ribosomal frameshift signal of SARS coronavirus 2 (SARS-CoV-2) (edit) |
10.1074/JBC.AC120.013449 |
| 2020-06-22 |
Analytical and Clinical Comparison of Three Nucleic Acid Amplification Tests for SARS-CoV-2 Detection (edit) |
10.1128/JCM.01134-20 |
| 2020-06-22 |
Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development (edit) |
10.1073/PNAS.2009799117 |
| 2020-06-22 |
Using influenza surveillance networks to estimate state-specific prevalence of SARS-CoV-2 in the United States (edit) |
10.1126/SCITRANSLMED.ABC1126 |
| 2020-06-22 |
Implications of SARS CoV-2 positivity in amniotic membranes for ophthalmologists (edit) |
10.1038/S41433-020-1051-5 |
| 2020-06-22 |
Preclinical data from SARS-CoV-2 mRNA vaccine (edit) |
10.1038/S41577-020-0377-3 |
| 2020-06-22 |
SARS-CoV-2 viral loads and serum IgA/IgG immune responses in critically ill COVID-19 patients (edit) |
10.1007/S00134-020-06157-5 |
| 2020-06-22 |
A multicenter national survey of children with SARS-CoV-2 infection admitted to Spanish Pediatric Intensive Care Units (edit) |
10.1007/S00134-020-06146-8 |
| 2020-06-22 |
Mortality risk in post-operative head and neck cancer patients during the SARS-Cov2 pandemic: early experiences (edit) |
10.1007/S00405-020-06138-W |
| 2020-06-22 |
Laboratory characteristics of pregnant compared to non-pregnant women infected with SARS-CoV-2 (edit) |
10.1007/S00404-020-05655-7 |
| 2020-06-22 |
[Screening of Mothers in a COVID-19 Low-Prevalence Region: Determination of SARS-CoV-2 Antibodies in 401 Mothers from Rostock by ELISA and Confirmation by Immunofluorescence] (edit) |
10.1055/A-1197-4293 |
| 2020-06-22 |
SARS-CoV-2 RNA identification in nasopharyngeal swabs: issues in pre-analytics (edit) |
10.1515/CCLM-2020-0749 |
| 2020-06-22 |
Prevalence of comorbidities in patients and mortality cases affected by SARS-CoV2: a systematic review and meta-analysis (edit) |
10.1590/S1678-9946202062043 |
| 2020-06-22 |
Human Leukocyte Transcriptional Response to SARS-CoV-2 Infection (edit) |
10.6061/CLINICS/2020/E2078 |
| 2020-06-22 |
Meditation and Yoga Practices as Potential Adjunctive Treatment of SARS-CoV-2 Infection and COVID-19: A Brief Overview of Key Subjects (edit) |
10.1089/ACM.2020.0177 |
| 2020-06-22 |
Large-scale implementation of pooled RNA extraction and RT-PCR for SARS-CoV-2 detection (edit) |
10.1016/J.CMI.2020.06.009 |
| 2020-06-22 |
Report of Positive Placental Swabs for SARS-CoV-2 in an Asymptomatic Pregnant Woman with COVID-19 (edit) |
10.3390/MEDICINA56060306 |
| 2020-06-22 |
The Strategic Alliance between Clinical and Molecular Science in the War against SARS-CoV-2, with the Rapid-Diagnostics Test as an Indispensable Weapon for Front Line Doctors (edit) |
10.3390/IJMS21124446 |
| 2020-06-22 |
Is serological response to SARS-CoV-2 preserved in MS patients on ocrelizumab treatment? A case report (edit) |
10.1016/J.MSARD.2020.102323 |
| 2020-06-22 |
SARS-CoV-2 growth, furin-cleavage-site adaptation and neutralization using serum from acutely infected, hospitalized COVID-19 patients (edit) |
10.1101/2020.06.19.154930 |
| 2020-06-22 |
In vivo antiviral host response to SARS-CoV-2 by viral load, sex, and age (edit) |
10.1101/2020.06.22.165225 |
| 2020-06-22 |
Female reproductive tract has low concentration of SARS-CoV2 receptors (edit) |
10.1101/2020.06.20.163097 |
| 2020-06-22 |
Co-infection of MERS-CoV and SARS-CoV-2 in the same host: A silent threat (edit) |
10.1016/J.JIPH.2020.06.017 |
| 2020-06-22 |
Multiplex detection and dynamics of IgG antibodies to SARS-CoV2 and the highly pathogenic human coronaviruses SARS-CoV and MERS-CoV (edit) |
10.1016/J.JCV.2020.104521 |
| 2020-06-22 |
SARS-CoV-2 infection in dialysis patients in northern Italy: a single-centre experience (edit) |
10.1093/CKJ/SFAA084 |
| 2020-06-22 |
Myocyte Specific Upregulation of ACE2 in Cardiovascular Disease: Implications for SARS-CoV-2 Mediated Myocarditis (edit) |
10.1161/CIRCULATIONAHA.120.047911 |
| 2020-06-22 |
The role of the urologist, BCG vaccine administration, and SARS-CoV-2: An overview (edit) |
10.1002/BCO2.21 |
| 2020-06-22 |
Universal Shelter-in-Place Versus Advanced Automated Contact Tracing and Targeted Isolation: A Case for 21st-Century Technologies for SARS-CoV-2 and Future Pandemics (edit) |
10.1016/J.MAYOCP.2020.06.027 |
| 2020-06-21 |
Risk of SARS-CoV-2 transmission to medical staff and patients from an exposure to a COVID-19-positive ophthalmologist (edit) |
10.1007/S00417-020-04790-W |
| 2020-06-21 |
Posterior oropharyngeal saliva for the detection of SARS-CoV-2 (edit) |
10.1093/CID/CIAA797 |
| 2020-06-21 |
Attenuated interferon and pro-inflammatory response in SARS-CoV-2-infected human dendritic cells is associated with viral antagonism of STAT1 phosphorylation (edit) |
10.1093/INFDIS/JIAA356 |
| 2020-06-21 |
Smell and taste dysfunction in patients with SARS-CoV-2 infection: A review of epidemiology, pathogenesis, prognosis, and treatment options (edit) |
10.12932/AP-030520-0826 |
| 2020-06-21 |
Is 0.5% Hydrogen Peroxide Effective against SARS-CoV-2? (edit) |
10.1111/ODI.13503 |
| 2020-06-21 |
SARS-CoV-2 and Oral Ulcers; a Causative Agent or a Predisposing Factor? (edit) |
10.1111/ODI.13498 |
| 2020-06-21 |
SARS-CoV-2 infection in two pediatric patients with immune cytopenias: A single institution experience during the pandemic (edit) |
10.1002/PBC.28503 |
| 2020-06-21 |
Deaths in SARS-Cov-2 Positive Patients in Italy: The Influence of Underlying Health Conditions on Lethality (edit) |
10.3390/IJERPH17124450 |
| 2020-06-21 |
Laboratory characteristics of patients infected with the novel SARS-CoV-2 virus (edit) |
10.1016/J.JINF.2020.06.039 |
| 2020-06-21 |
RAPID SALIVARY TEST SUITABLE FOR A MASS SCREENING PROGRAM TO DETECT SARS-COV-2: A DIAGNOSTIC ACCURACY STUDY (edit) |
10.1016/J.JINF.2020.06.042 |
| 2020-06-21 |
Older age is associated with sustained detection of SARS-CoV-2 in nasopharyngeal swab samples (edit) |
10.1016/J.JINF.2020.06.046 |
| 2020-06-21 |
Biosafety and biosecurity approaches to restrain/contain and counter SARS-CoV-2/COVID-19 pandemic: a rapid-review (edit) |
10.3906/BIY-2005-63 |
| 2020-06-21 |
Phylogenetic analysis of SARS-CoV-2 genomes in Turkey (edit) |
10.3906/BIY-2005-35 |
| 2020-06-21 |
An updated analysis of variations in SARS-CoV-2 genome (edit) |
10.3906/BIY-2005-111 |
| 2020-06-21 |
Integration of transcriptomic profile of SARS-CoV-2 infected normal human bronchial epi-thelial cells with metabolic and protein-protein interaction networks (edit) |
10.3906/BIY-2005-115 |
| 2020-06-21 |
Identification of the nucleotide substitutions in 62 SARS-CoV-2 sequences from Turkey (edit) |
10.3906/BIY-2005-69 |
| 2020-06-21 |
Virtual drug repurposing study against SARS-CoV-2 TMPRSS2 target (edit) |
10.3906/BIY-2005-112 |
| 2020-06-21 |
SARS-CoV-2 isolation and propagation from Turkish COVID-19 patients (edit) |
10.3906/BIY-2004-113 |
| 2020-06-21 |
SARS-CoV-2 neutralizing antibody development strategies (edit) |
10.3906/BIY-2005-91 |
| 2020-06-21 |
Interaction of certain monoterpenoid hydrocarbons with the receptor binding domain of 2019 novel coronavirus (2019-nCoV), transmembrane serine protease 2 (TMPRSS2), cathepsin B, and cathepsin L (CatB/L) and their pharmacokinetic properties (edit) |
10.3906/BIY-2005-46 |
| 2020-06-21 |
Mesenchymal stem cell derived extracellular vesicles: promising immunomodulators against autoimmune, autoinflammatory disorders and SARS-CoV-2 infection (edit) |
10.3906/BIY-2002-79 |
| 2020-06-21 |
Antiviral Activity and Safety of Darunavir/Cobicistat for the Treatment of COVID-19 (edit) |
10.1093/OFID/OFAA241 |
| 2020-06-20 |
D614G mutation of SARS-CoV-2 spike protein enhances viral infectivity (edit) |
10.1101/2020.06.20.161323 |
| 2020-06-20 |
Comparative Genomics and Integrated Network Approach Unveiled Undirected Phylogeny Patterns, Co-mutational Hotspots, Functional Crosstalk and Regulatory Interactions in SARS-CoV-2 (edit) |
10.1101/2020.06.20.162560 |
| 2020-06-20 |
Stand on the Same Side Against Covid-19 - Diagnostic, Screening Tools and Pathways for Clinical and Preventive Purposes (edit) |
10.13128/SUBSTANTIA-967 |
| 2020-06-20 |
A proposed role for the SARS-CoV-2 nucleocapsid protein in the formation and regulation of biomolecular condensates (edit) |
10.1096/FJ.202001351 |
| 2020-06-20 |
Evidence of SARS-CoV-2 mRNA in endomyocardial biopsies of patients with clinically suspected myocarditis tested negative for COVID-19 in nasopharyngeal swab (edit) |
10.1093/CVR/CVAA160 |
| 2020-06-20 |
Social distancing measures: evidence of interruption of seasonal influenza activity and early lessons of the SARS-CoV-2 pandemic (edit) |
10.1093/CID/CIAA834 |
| 2020-06-20 |
Varied clinical presentation and outcome of SARS-CoV-2 infection in liver transplant recipients: initial experience at a single center in Madrid, Spain (edit) |
10.1111/TID.13372 |
| 2020-06-20 |
SARS-CoV-2 endothelial infection causes COVID-19 chilblains: histopathological, immunohistochemical and ultraestructural study of 7 paediatric cases (edit) |
10.1111/BJD.19327 |
| 2020-06-20 |
Telemedicine and the 2019 Coronavirus (SARS-CoV-2) (edit) |
10.1111/IJCP.13592 |
| 2020-06-20 |
First case of SARS-COV-2 sequencing in cerebrospinal fluid of a patient with suspected demyelinating disease (edit) |
10.1007/S00415-020-09996-W |
| 2020-06-20 |
The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies: comment (edit) |
10.1007/S11739-020-02406-Z |
| 2020-06-20 |
Fatal SARS-CoV-2 infection in a renal transplant recipient (edit) |
10.1007/S13730-020-00496-4 |
| 2020-06-20 |
Optimized qRT-PCR Approach for the Detection of Intra- and Extra-Cellular SARS-CoV-2 RNAs (edit) |
10.3390/IJMS21124396 |
| 2020-06-20 |
Persistent positivity and fluctuations of SARS-CoV-2 RNA in clinically-recovered COVID-19 patients (edit) |
10.1016/J.JINF.2020.06.024 |
| 2020-06-20 |
Discovering small-molecule therapeutics against SARS-CoV-2 (edit) |
10.1016/J.DRUDIS.2020.06.017 |
| 2020-06-20 |
Guillain-Barré syndrome in a patient infected with SARS-CoV-2, a case report (edit) |
10.1016/J.JNEUROIM.2020.577294 |
| 2020-06-20 |
Pulmonary surfactant itself must be a strong defender against SARS-CoV-2 (edit) |
10.1016/J.MEHY.2020.110020 |
| 2020-06-20 |
Attenuation of antibody response to SARS-CoV-2 in a patient on ocrelizumab with hypogammaglobulinemia (edit) |
10.1016/J.MSARD.2020.102315 |
| 2020-06-20 |
SARS-CoV-2 Screening Test for Japanese Returnees From Wuhan, China, January 2020 (edit) |
10.1093/OFID/OFAA243 |
| 2020-06-20 |
SARS-CoV-2 pandemic lockdown: Effects on air quality in the industrialized Gujarat state of India (edit) |
10.1016/J.SCITOTENV.2020.140391 |
| 2020-06-20 |
First environmental surveillance for the presence of SARS-CoV-2 RNA in wastewater and river water in Japan (edit) |
10.1016/J.SCITOTENV.2020.140405 |
| 2020-06-20 |
Universal laboratory testing for SARS-CoV-2 in hyperacute stroke during the COVID-19 pandemic (edit) |
10.1016/J.JSTROKECEREBROVASDIS.2020.105061 |
| 2020-06-20 |
SARS-CoV-2 E protein is a potential ion channel that can be inhibited by Gliclazide and Memantine (edit) |
10.1016/J.BBRC.2020.05.206 |
| 2020-06-20 |
Analogies between SARS-CoV-2 infection dynamics and batch chemical reactor behavior (edit) |
10.1016/J.CES.2020.115918 |
| 2020-06-20 |
A global-scale ecological niche model to predict SARS-CoV-2 coronavirus infection rate (edit) |
10.1016/J.ECOLMODEL.2020.109187 |
| 2020-06-20 |
A machine learning model to identify early stage symptoms of SARS-Cov-2 infected patients (edit) |
10.1016/J.ESWA.2020.113661 |
| 2020-06-20 |
Acute Myopericarditis in a Patient With Mild SARS-CoV-2 Respiratory Infection (edit) |
10.1016/J.CJCO.2020.06.008 |
| 2020-06-19 |
Nucleocapsid protein of SARS-CoV-2 phase separates into RNA-rich polymerase-containing condensates (edit) |
10.1101/2020.06.18.160648 |
| 2020-06-19 |
Proteotyping SARS-CoV-2 virus from nasopharyngeal swabs: a proof-of-concept focused on a 3 min mass spectrometry window (edit) |
10.1101/2020.06.19.161000 |
| 2020-06-19 |
A single dose of recombinant VSV-ΔG-spike vaccine provides protection against SARS-CoV-2 challenge (edit) |
10.1101/2020.06.18.160655 |
| 2020-06-19 |
Systemic steroids and risk of fecal-oral shedding and increased transmission of SARS-CoV-2 in pemphigus cases (edit) |
10.1016/J.CLINDERMATOL.2020.06.006 |
| 2020-06-19 |
Mechanism and inhibition of SARS-CoV-2 PLpro (edit) |
10.1101/2020.06.18.160614 |
| 2020-06-19 |
Drug repurposing screens reveal FDA approved drugs active against SARS-Cov-2 (edit) |
10.1101/2020.06.19.161042 |
| 2020-06-19 |
Multi-pronged human protein mimicry by SARS-CoV-2 reveals bifurcating potential for MHC detection and immune evasion (edit) |
10.1101/2020.06.19.161620 |
| 2020-06-19 |
Tackling the SARS-CoV-2 main protease using hybrid derivatives of 1,5-disubstituted tetrazole-1,2,3-triazoles: an in silico assay (edit) |
10.7717/PEERJ-PCHEM.10 |
| 2020-06-19 |
COVID-19 pandemic reveals the peril of ignoring metadata standards (edit) |
10.1038/S41597-020-0524-5 |
| 2020-06-19 |
Is sweat a possible route of transmission of SARS-CoV-2? (edit) |
10.1177/1535370220935409 |
| 2020-06-19 |
Natural compounds from Clerodendrum spp. as possible therapeutic candidates against SARS-CoV-2: An in silico investigation (edit) |
10.1080/07391102.2020.1780947 |
| 2020-06-19 |
How to expedite early phase SARS-CoV-2 vaccine trials in pandemic setting - a practical perspective (edit) |
10.1111/BCP.14435 |
| 2020-06-19 |
Known SARS-CoV-2 infections: The tip of an important iceberg (edit) |
10.1002/HPM.3006 |
| 2020-06-19 |
Individual variation of the SARS-CoV-2 receptor ACE2 gene expression and regulation (edit) |
10.1111/ACEL.13168 |
| 2020-06-19 |
SARS-COV-2 As Possible Inducer of Viral Reactivations (edit) |
10.1111/DTH.13878 |
| 2020-06-19 |
[SARS-CoV-2 protease: an excellent target to develop drugs against COVID-19] (edit) |
10.1051/MEDSCI/2020106 |
| 2020-06-19 |
Effective control of SARS-CoV-2 transmission between healthcare workers during a period of diminished community prevalence of COVID-19 (edit) |
10.7554/ELIFE.59391 |
| 2020-06-19 |
Distinct infection process of SARS-CoV-2 in human bronchial epithelial cells line (edit) |
10.1002/JMV.26200 |
| 2020-06-19 |
Probable causes and risk factors for positive SARS-CoV-2 test in recovered patients: Evidence from Brunei Darussalam (edit) |
10.1002/JMV.26199 |
| 2020-06-19 |
The clinical characteristics of pediatric inpatients with SARS-CoV-2 infection: a meta-analysis and systematic review (edit) |
10.1002/JMV.26208 |
| 2020-06-19 |
Developing a Fully-glycosylated Full-length SARS-CoV-2 Spike Protein Model in a Viral Membrane (edit) |
10.1021/ACS.JPCB.0C04553 |
| 2020-06-19 |
The Epidemiology of SARS-CoV-2 in a Pediatric Healthcare Network in the United States (edit) |
10.1093/JPIDS/PIAA074 |
| 2020-06-19 |
Interferon-β 1a inhibits SARS-CoV-2 in vitro when administered after virus infection (edit) |
10.1093/INFDIS/JIAA350 |
| 2020-06-19 |
A case of an Infant with SARS-CoV-2 hepatitis early after liver transplantation (edit) |
10.1111/PETR.13778 |
| 2020-06-19 |
Novel technique using an echo probe cover prevents oral-fecal transmission of SARS-CoV-2 during urgent colonoscopies (edit) |
10.1055/A-1187-1018 |
| 2020-06-19 |
Critical medical ecology and SARS-COV-2 in the urban environment: a pragmatic, dynamic approach to explaining and planning for research and practice (edit) |
10.1186/S40249-020-00694-3 |
| 2020-06-19 |
Efficacy and safety of aerosolized intra-tracheal dornase alfa administration in patients with SARS-CoV-2-induced acute respiratory distress syndrome (ARDS): a structured summary of a study protocol for a randomised controlled trial (edit) |
10.1186/S13063-020-04488-8 |
| 2020-06-19 |
Temporal profiling of plasma cytokines, chemokines and growth factors from mild, severe and fatal COVID-19 patients (edit) |
10.1038/S41392-020-0211-1 |
| 2020-06-19 |
In situ detection of SARS-CoV-2 in lungs and airways of patients with COVID-19 (edit) |
10.1038/S41379-020-0595-Z |
| 2020-06-19 |
Synergistic antiviral effects against SARS-CoV-2 by plant-based molecules (edit) |
10.1007/S00299-020-02560-W |
| 2020-06-19 |
Correction to: Dying with SARS-CoV-2 infection-an autopsy study of the first consecutive 80 cases in Hamburg, Germany (edit) |
10.1007/S00414-020-02336-7 |
| 2020-06-19 |
Air contamination with SARS-CoV-2 in the operating room (edit) |
10.1007/S00540-020-02814-7 |
| 2020-06-19 |
Isolation and Growth Characteristics of SARS-CoV-2 in Vero Cell (edit) |
10.1007/S12250-020-00241-2 |
| 2020-06-19 |
SARS-CoV-2, where to now? (edit) |
10.1111/TBED.13654 |
| 2020-06-19 |
Are urologists in trouble by SARS-CoV-2? Reflexions and recommendations for specific interventions (edit) |
10.1111/BJU.15141 |
| 2020-06-19 |
Recovery from SARS-CoV-2 infection is Associated with Serum BDNF Restoration (edit) |
10.1016/J.JINF.2020.06.038 |
| 2020-06-19 |
Impact of Heat-Inactivation on the detection of SARS-CoV-2 IgM and IgG Antibody by ELISA (edit) |
10.1016/J.CCA.2020.06.032 |
| 2020-06-19 |
Differences of SARS-CoV-2 Shedding Duration in Sputum and Nasopharyngeal Swab Specimens among Adult Inpatients with COVID-19 (edit) |
10.1016/J.CHEST.2020.06.015 |
| 2020-06-19 |
Characteristics of 1,573 healthcare workers who underwent nasopharyngeal swab for SARS-CoV-2 in Milano, Lombardy, Italy (edit) |
10.1016/J.CMI.2020.06.013 |
| 2020-06-19 |
Evaluation of Protection Level, Respiratory Safety, and Practical Aspects of Commercially Available Snorkel Masks as Personal Protection Devices Against Aerosolized Contaminants and SARS-CoV2 (edit) |
10.3390/IJERPH17124347 |
| 2020-06-19 |
COVID-19: The Potential Treatment of Pulmonary Fibrosis Associated with SARS-CoV-2 Infection (edit) |
10.3390/JCM9061917 |
| 2020-06-19 |
Geranium and Lemon Essential Oils and Their Active Compounds Downregulate Angiotensin-Converting Enzyme 2 (ACE2), a SARS-CoV-2 Spike Receptor-Binding Domain, in Epithelial Cells (edit) |
10.3390/PLANTS9060770 |
| 2020-06-19 |
Prevalence of Sars-Cov-2 Infection in Health Workers (HWs) and Diagnostic Test Performance: The Experience of a Teaching Hospital in Central Italy (edit) |
10.3390/IJERPH17124417 |
| 2020-06-19 |
Short-Term Dexamethasone in Sars-CoV-2 Patients (edit) |
|
| 2020-06-19 |
Response to Letter Regarding "How Should the Rehabilitation Community Prepare for 2019-nCoV?" (edit) |
10.1016/J.APMR.2020.04.015 |
| 2020-06-19 |
Application of System Biology to Explore the Association of Neprilysin, Angiotensin-Converting Enzyme 2 (ACE2), and Carbonic Anhydrase (CA) in Pathogenesis of SARS-CoV-2 (edit) |
10.1186/S12575-020-00124-6 |
| 2020-06-19 |
A Human Pluripotent Stem Cell-based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and Organoids (edit) |
10.1016/J.STEM.2020.06.015 |
| 2020-06-19 |
Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike (edit) |
10.1016/J.CHOM.2020.06.010 |
| 2020-06-19 |
Standardized Testing Demonstrates Altered Odor Detection Sensitivity and Hedonics in Asymptomatic College Students as SARS-CoV-2 Emerged Locally (edit) |
10.1101/2020.06.17.20106302 |
| 2020-06-19 |
Distinct genetic spectrums and evolution patterns of SARS-CoV-2 (edit) |
10.1101/2020.06.16.20132902 |
| 2020-06-19 |
Critical Role of Type III Interferon in Controlling SARS-CoV-2 Infection in Human Intestinal Epithelial Cells (edit) |
10.1016/J.CELREP.2020.107863 |
| 2020-06-19 |
Antimicrobial stewardship interventions to minimize healthcare worker exposure to SARS-CoV-2 (edit) |
10.1017/ICE.2020.302 |
| 2020-06-19 |
Detection of SARS-CoV-2 RNA residue on object surfaces in nucleic acid testing laboratory using droplet digital PCR (edit) |
10.1016/J.SCITOTENV.2020.140370 |
| 2020-06-19 |
The SARS-CoV-2 effect: an opportunity to reduce general anaesthesia rates for Caesarean section? (edit) |
10.1016/J.BJA.2020.06.021 |
| 2020-06-19 |
A Snapshot of the Global Race for Vaccines Targeting SARS-CoV-2 and the COVID-19 Pandemic (edit) |
10.3389/FPHAR.2020.00937 |
| 2020-06-19 |
Activation of Ang-(1-7)/Mas Receptor Is a Possible Strategy to Treat Coronavirus (SARS-CoV-2) Infection (edit) |
10.3389/FPHYS.2020.00730 |
| 2020-06-19 |
Quercetin and Vitamin C: An Experimental, Synergistic Therapy for the Prevention and Treatment of SARS-CoV-2 Related Disease (COVID-19) (edit) |
10.3389/FIMMU.2020.01451 |
| 2020-06-19 |
Severe infection due to the SARS-CoV-2 coronavirus: Experience of a tertiary hospital with COVID-19 patients during the 2020 pandemic (edit) |
10.1016/J.MEDIN.2020.05.018 |
| 2020-06-19 |
Guidelines for therapy of patients with chronic myeloproliferative neoplasms during the novel coronavirus SARS-CoV2 pandemic (edit) |
10.1016/J.HTCT.2020.06.005 |
| 2020-06-19 |
Ayurvedic treatment of COVID-19/SARS-CoV-2: A case report (edit) |
10.1016/J.JAIM.2020.06.001 |
| 2020-06-19 |
SARS-CoV-2 infection in children (edit) |
10.14744/TURKPEDIATRIARS.2020.20270 |
| 2020-06-19 |
High-flow oxygen therapy with spontaneous breathing prono position in SARS-CoV-2 pneumonia (edit) |
10.1016/J.REDAR.2020.05.014 |
| 2020-06-19 |
Yidu-toxicity blocking lung decoction ameliorates inflammation in severe pneumonia of SARS-COV-2 patients with Yidu-toxicity blocking lung syndrome by eliminating IL-6 and TNF-a (edit) |
10.1016/J.BIOPHA.2020.110436 |
| 2020-06-19 |
[SARS-CoV-2 pandemic and assisted reproduction] (edit) |
10.1016/J.GINE.2020.06.004 |
| 2020-06-19 |
Conjunctivitis as a Sentinel of SARS-CoV-2 Infection: a Need of Revision for Mild Symptoms (edit) |
10.1007/S42399-020-00360-7 |
| 2020-06-18 |
Unexpected free fatty acid binding pocket in the cryo-EM structure of SARS-CoV-2 spike protein (edit) |
10.1101/2020.06.18.158584 |
| 2020-06-18 |
Experimental and natural evidence of SARS-CoV-2 infection-induced activation of type I interferon responses (edit) |
10.1101/2020.06.18.158154 |
| 2020-06-18 |
The SARS-CoV-2 Spike protein has a broad tropism for mammalian ACE2 proteins (edit) |
10.1101/2020.06.17.156471 |
| 2020-06-18 |
Exosomal microRNAs Drive Thrombosis in COVID-19 (edit) |
10.1101/2020.06.16.20133256 |
| 2020-06-18 |
Current and Future Challenges In Drug Therapeutics for Sars-Cov-2 Infection in Covid-19 Pandemic (edit) |
10.34297/AJBSR.2020.09.001374 |
| 2020-06-18 |
The ORF3a protein of SARS-CoV-2 induces apoptosis in cells (edit) |
10.1038/S41423-020-0485-9 |
| 2020-06-18 |
Regional BCG vaccination policy in former East- and West Germany may impact on both severity of SARS-CoV-2 and incidence of childhood leukemia (edit) |
10.1038/S41375-020-0871-4 |
| 2020-06-18 |
Convergent antibody responses to SARS-CoV-2 in convalescent individuals (edit) |
10.1038/S41586-020-2456-9 |
| 2020-06-18 |
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections (edit) |
10.1038/S41591-020-0965-6 |
| 2020-06-18 |
Scalable and robust SARS-CoV-2 testing in an academic center (edit) |
10.1038/S41587-020-0588-Y |
| 2020-06-18 |
Blueprint for a pop-up SARS-CoV-2 testing lab (edit) |
10.1038/S41587-020-0583-3 |
| 2020-06-18 |
Associations Between Built Environment, Neighborhood Socioeconomic Status, and SARS-CoV-2 Infection Among Pregnant Women in New York City (edit) |
10.1001/JAMA.2020.11370 |
| 2020-06-18 |
SARS-CoV-2 Positivity Rate for Latinos in the Baltimore-Washington, DC Region (edit) |
10.1001/JAMA.2020.11374 |
| 2020-06-18 |
SARS-CoV-2 Infections in Children - Multi-Center Surveillance, United States, January-March 2020 (edit) |
10.1093/JPIDS/PIAA075 |
| 2020-06-18 |
Back to Normal: An Old Physics Route to Reduce SARS-CoV-2 Transmission in Indoor Spaces (edit) |
10.1021/ACSNANO.0C04596 |
| 2020-06-18 |
Discovery of New Hydroxyethylamine Analogs against 3CLpro Protein Target of SARS-CoV-2: Molecular Docking, Molecular Dynamics Simulation, and Structure-Activity Relationship Studies (edit) |
10.1021/ACS.JCIM.0C00326 |
| 2020-06-18 |
Full genome sequence of the first SARS-CoV-2 detected in Mexico (edit) |
10.1007/S00705-020-04695-3 |
| 2020-06-18 |
No Detectable Surge in SARS-CoV-2 Transmission Attributable to the April 7, 2020 Wisconsin Election (edit) |
10.2105/AJPH.2020.305770 |
| 2020-06-18 |
Combined drug repurposing and virtual screening strategies with molecular dynamics simulation identified potent inhibitors for SARS-CoV-2 main protease (3CLpro) (edit) |
10.1080/07391102.2020.1779128 |
| 2020-06-18 |
Identification of bioactive compounds from Glycyrrhiza glabra as possible inhibitor of SARS-CoV-2 spike glycoprotein and non-structural protein-15: a pharmacoinformatics study (edit) |
10.1080/07391102.2020.1779132 |
| 2020-06-18 |
Identification of a novel dual-target scaffold for 3CLpro and RdRp proteins of SARS-CoV-2 using 3D-similarity search, molecular docking, molecular dynamics and ADMET evaluation (edit) |
10.1080/07391102.2020.1779130 |
| 2020-06-18 |
Patients with Congenital Bleeding Disorders Appear to be Less Severely Affected by SARS-CoV-2: Is Inherited Hypocoagulability Overcoming Acquired Hypercoagulability of Coronavirus Disease 2019 (COVID-19)? (edit) |
10.1055/S-0040-1713435 |
| 2020-06-18 |
Minor aphthae associated with SARS-CoV-2 infection (edit) |
10.1111/IJD.15004 |
| 2020-06-18 |
E-cigarette-induced pulmonary inflammation and dysregulated repair are mediated by nAChR α7 receptor: role of nAChR α7 in SARS-CoV-2 Covid-19 ACE2 receptor regulation (edit) |
10.1186/S12931-020-01396-Y |
| 2020-06-18 |
SARS CoV-2 aggravates cellular metabolism mediated complications in COVID-19 infection (edit) |
10.1111/DTH.13871 |
| 2020-06-18 |
Timing of antiviral treatment initiation is critical to reduce SARS-CoV-2 viral load (edit) |
10.1002/PSP4.12543 |
| 2020-06-18 |
Functional characteristics of patients with SARS-CoV-2 pneumonia at 30 days post infection (edit) |
10.1183/13993003.01754-2020 |
| 2020-06-18 |
Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)? (edit) |
10.1183/13993003.01634-2020 |
| 2020-06-18 |
Infant With SARS-CoV-2 Infection Causing Severe Lung Disease Treated With Remdesivir (edit) |
10.1542/PEDS.2020-1701 |
| 2020-06-18 |
SARS-CoV-2 Infection in Infants Less than 90 Days Old (edit) |
10.1016/J.JPEDS.2020.06.047 |
| 2020-06-18 |
Anticipating SARS-CoV-2 Vaccine Testing, Licensure, and Recommendations for Use (edit) |
10.1016/J.JPEDS.2020.06.048 |
| 2020-06-18 |
Targeting the SARS-CoV-2 spike glycoprotein prefusion conformation: virtual screening and molecular dynamics simulations applied to the identification of potential fusion inhibitors (edit) |
10.1016/J.VIRUSRES.2020.198068 |
| 2020-06-18 |
Elective endotracheal intubation for urgent GI endoscopy among hospitalized patients with SARS-CoV-2 (edit) |
10.1016/J.GIE.2020.06.039 |
| 2020-06-18 |
When interferon tiptoes through COVID-19: Pernio-like lesions and their prognostic implications during SARS-CoV-2 infection (edit) |
10.1016/J.JAAD.2020.06.052 |
| 2020-06-18 |
High rate of pulmonary thromboembolism in patients with SARS-CoV-2 pneumonia (edit) |
10.1016/J.CMI.2020.06.011 |
| 2020-06-18 |
Comparative analysis of SARS-CoV-2 receptor ACE2 expression in multiple solid tumors and matched non-diseased tissues (edit) |
10.1016/J.MEEGID.2020.104428 |
| 2020-06-18 |
Ageusia, gastrointestinal symptoms and marked asthenia in late December. A single case report with positive SARS-Cov2 IgG in Italy (edit) |
10.1016/J.IJID.2020.06.047 |
| 2020-06-18 |
Acute respiratory distress syndrome due to SARS-CoV-2 and Influenza A co-infection in an Italian patient: mini-review of the literature (edit) |
10.1016/J.IJID.2020.06.056 |
| 2020-06-18 |
Allergy clinics in times of the SARS-CoV-2 pandemic: an integrated model (edit) |
10.1186/S13601-020-00333-Y |
| 2020-06-18 |
Negative SARS-CoV-2 PCR in patients with chilblain-like lesions (edit) |
10.1016/S1473-3099(20)30518-1 |
| 2020-06-18 |
May Parkinson's disease be a protective factor against CNS involvement by SARS-CoV2? (edit) |
10.1016/J.PARKRELDIS.2020.06.012 |
| 2020-06-18 |
Are Animals a Neglected Transmission Route of SARS-CoV-2? (edit) |
10.3390/PATHOGENS9060480 |
| 2020-06-18 |
Rapid Direct Nucleic Acid Amplification Test without RNA Extraction for SARS-CoV-2 Using a Portable PCR Thermocycler (edit) |
10.3390/GENES11060664 |
| 2020-06-18 |
Microbiota Modulating Nutritional Approaches to Countering the Effects of Viral Respiratory Infections Including SARS-CoV-2 through Promoting Metabolic and Immune Fitness with Probiotics and Plant Bioactives (edit) |
10.3390/MICROORGANISMS8060921 |
| 2020-06-18 |
Symptomatology in head and neck district in coronavirus disease (COVID-19): A possible neuroinvasive action of SARS-CoV-2 (edit) |
10.1016/J.AMJOTO.2020.102612 |
| 2020-06-18 |
The SARS-CoV-2 pandemic impact on rhinology research: A survey of the American Rhinologic Society (edit) |
10.1016/J.AMJOTO.2020.102617 |
| 2020-06-18 |
The SARS-CoV-2 nucleocapsid protein is dynamic, disordered, and phase separates with RNA (edit) |
10.1101/2020.06.17.158121 |
| 2020-06-18 |
Potent Neutralizing Monoclonal Antibodies Directed to Multiple Epitopes on the SARS-CoV-2 Spike (edit) |
10.1101/2020.06.17.153486 |
| 2020-06-18 |
Cryo-EM structure of the SARS-CoV-2 3a ion channel in lipid nanodiscs (edit) |
10.1101/2020.06.17.156554 |
| 2020-06-18 |
Detection of antibodies to the SARS-CoV-2 spike glycoprotein in both serum and saliva enhances detection of infection (edit) |
10.1101/2020.06.16.20133025 |
| 2020-06-18 |
The association of SARS-CoV-2 infection and acute disseminated encephalomyelitis without prominent clinical pulmonary symptoms (edit) |
10.1016/J.JNS.2020.117001 |
| 2020-06-18 |
Molecular Alterations Prompted by SARS-CoV-2 Infection: Induction of Hyaluronan, Glycosaminoglycan and Mucopolysaccharide Metabolism (edit) |
10.1016/J.ARCMED.2020.06.011 |
| 2020-06-18 |
Potential of SARS-CoV-2 to Cause CNS Infection: Biologic Fundamental and Clinical Experience (edit) |
10.3389/FNEUR.2020.00659 |
| 2020-06-18 |
Nasopharyngeal Swabs Are More Sensitive Than Oropharyngeal Swabs for COVID-19 Diagnosis and Monitoring the SARS-CoV-2 Load (edit) |
10.3389/FMED.2020.00334 |
| 2020-06-18 |
Reactive oxygen species as an initiator of toxic innate immune responses in retort to SARS-CoV-2 in an ageing population, consider N-acetylcysteine as early therapeutic intervention (edit) |
10.1016/J.TOXREP.2020.06.003 |
| 2020-06-18 |
Three Decades of Interferon-β in Multiple Sclerosis: Can We Repurpose This Information for the Management of SARS-CoV2 Infection? (edit) |
10.3389/FIMMU.2020.01459 |
| 2020-06-18 |
A comprehensive investigation of the mRNA and protein level of ACE2, the putative receptor of SARS-CoV-2, in human tissues and blood cells (edit) |
10.7150/IJMS.46695 |
| 2020-06-18 |
Severity of respiratory failure and outcome of patients needing a ventilatory support in the Emergency Department during Italian novel coronavirus SARS-CoV2 outbreak: Preliminary data on the role of Helmet CPAP and Non-Invasive Positive Pressure Ven (edit) |
10.1016/J.ECLINM.2020.100419 |
| 2020-06-18 |
Repurposing current therapeutic regimens against SARS-CoV-2 (Review) (edit) |
10.3892/ETM.2020.8905 |
| 2020-06-18 |
Significance of physiotherapy in "SARS-CoV-2/COVID-19: An Epidemic" (edit) |
10.4103/ATM.ATM_169_20 |
| 2020-06-18 |
Host range of SARS-CoV-2 and implications for public health (edit) |
10.1016/S2666-5247(20)30069-0 |
| 2020-06-17 |
SARS-CoV-2 in multiple myeloma: initial observation and management (edit) |
10.1080/10428194.2020.1780588 |
| 2020-06-17 |
X-ray Crystallographic Structure of Orf9b from SARS-CoV-2 (edit) |
10.2210/PDB6Z4U/PDB |
| 2020-06-17 |
Multi-level proteomics reveals host-perturbation strategies of SARS-CoV-2 and SARS-CoV (edit) |
10.1101/2020.06.17.156455 |
| 2020-06-17 |
A thermostable, closed, SARS-CoV-2 spike protein trimer (edit) |
10.1101/2020.06.15.152835 |
| 2020-06-17 |
Novel SARS-CoV-2 outbreak and COVID19 disease; a systemic review on the global pandemic (edit) |
10.1016/J.GENDIS.2020.06.004 |
| 2020-06-17 |
Crystal structure of 2019-nCoV nsp16-nsp10 complex (edit) |
10.2210/PDB7BQ7/PDB |
| 2020-06-17 |
COVID-19 in 2 Persons with Mild Upper Respiratory Symptoms on a Cruise Ship, Japan (edit) |
10.3201/EID2606.200452 |
| 2020-06-17 |
SARS-CoV-2-Infektion vor ersten Symptomen (edit) |
10.1007/S11298-020-7979-8 |
| 2020-06-17 |
Letter: May Cooler Heads Prevail During a Pandemic: Stroke in COVID-19 Patients or COVID-19 in Stroke Patients? (edit) |
10.1093/NEUROS/NYAA283 |
| 2020-06-17 |
Addressing Hearing loss to Improve Communication during COVID-19 Pandemic (edit) |
10.1111/JGS.16674 |
| 2020-06-17 |
The SARS-CoV-2 Coronavirus and the COVID-19 Outbreak (edit) |
10.1590/S1677-5538.IBJU.2020.S101 |
| 2020-06-17 |
Summary and considerations in genitourinary cancer patient care during the COVID-19 Pandemic (edit) |
|
| 2020-06-17 |
Targeting the entry step of SARS-CoV-2: a promising therapeutic approach (edit) |
10.1038/S41392-020-0195-X |
| 2020-06-17 |
Ruxolitinib for the treatment of SARS-CoV-2 induced acute respiratory distress syndrome (ARDS) (edit) |
10.1038/S41375-020-0907-9 |
| 2020-06-17 |
COVIDep: a web-based platform for real-time reporting of vaccine target recommendations for SARS-CoV-2 (edit) |
10.1038/S41596-020-0358-9 |
| 2020-06-17 |
Discovery of Aptamers Targeting Receptor-Binding Domain of the SARS-CoV-2 Spike Glycoprotein (edit) |
10.1021/ACS.ANALCHEM.0C01394 |
| 2020-06-17 |
The discovery of a putative allosteric site in SARS-CoV-2 spike protein by an integrated structural/dynamical approach (edit) |
10.1021/ACS.JPROTEOME.0C00273 |
| 2020-06-17 |
Critical Differences Between the Binding Features of the Spike Proteins of SARS-CoV-2 and SARS-CoV (edit) |
10.1021/ACS.JPCB.0C04317 |
| 2020-06-17 |
Cellular Nanosponges Inhibit SARS-CoV-2 Infectivity (edit) |
10.1021/ACS.NANOLETT.0C02278 |
| 2020-06-17 |
Reply to "Indications and timing for tracheostomy in patients with SARS CoV2-related" by Ferri et al (edit) |
10.1007/S00405-020-06134-0 |
| 2020-06-17 |
Breathing Is Enough: For the Spread of Influenza Virus and SARS-CoV-2 by Breathing Only (edit) |
10.1089/JAMP.2020.1616 |
| 2020-06-17 |
Unexpected kinetics of anti-SARS-CoV-2 total antibodies in two patients with chronic lymphocytic leukemia (edit) |
10.1111/BJH.16954 |
| 2020-06-17 |
SARS-CoV-2 infection: the same virus can cause different cutaneous manifestations: reply from the authors (edit) |
10.1111/BJD.19321 |
| 2020-06-17 |
Targeting the interleukin-17 pathway to prevent acute respiratory distress syndrome associated with SARS-CoV-2 infection (edit) |
10.1111/RESP.13875 |
| 2020-06-17 |
Infliximab for severe ulcerative colitis and subsequent SARS-CoV-2 pneumonia: a stone for two birds (edit) |
10.1136/GUTJNL-2020-321760 |
| 2020-06-17 |
Black-White Risk Differentials in COVID-19 (SARS-COV2) Transmission, Mortality and Case Fatality in the United States: Translational Epidemiologic Perspective and Challenges (edit) |
10.3390/IJERPH17124322 |
| 2020-06-17 |
Epidemiological control measures and predicted number of infections for SARS-CoV-2 pandemic: case study Serbia march-april 2020 (edit) |
10.1016/J.HELIYON.2020.E04238 |
| 2020-06-17 |
Household studies provide key insights on the transmission of, and susceptibility to, SARS-CoV-2 (edit) |
10.1016/S1473-3099(20)30514-4 |
| 2020-06-17 |
Issues to be considered when planning sero-epidemiological studies in regions with a low incidence of SARS-CoV-2 (edit) |
10.1016/J.AJIC.2020.06.176 |
| 2020-06-17 |
On the relationship between androgen-deprivation therapy for prostate cancer and risk of infection by SARS-CoV-2 (edit) |
10.1016/J.ANNONC.2020.06.005 |
| 2020-06-17 |
Dual function of sialic acid in gastrointestinal SARS-CoV-2 infection (edit) |
10.1016/J.ETAP.2020.103436 |
| 2020-06-17 |
Low Transmission Risk of 9 Asymptomatic Carriers Tested Positive for both SARS-CoV-2 Nucleic Acid and Serum IgG (edit) |
10.1016/J.JINF.2020.06.034 |
| 2020-06-17 |
High SARS-CoV-2 infection rates in respiratory staff nurses and correlation of COVID-19 symptom patterns with PCR positivity and relative viral loads (edit) |
10.1016/J.JINF.2020.06.035 |
| 2020-06-17 |
SARS-CoV-2 and co-infections detection in nasopharyngeal throat swabs of COVID-19 patients by metagenomics (edit) |
10.1016/J.JINF.2020.06.033 |
| 2020-06-17 |
SARS-CoV-2-related Hypercoagulable State Leading to Ischemic Enteritis Secondary to Superior Mesenteric Artery Thrombosis (edit) |
10.1016/J.CGH.2020.06.024 |
| 2020-06-17 |
Comparison of commercial realtime reverse transcription PCR assays for the detection of SARS-CoV-2 (edit) |
10.1016/J.JCV.2020.104510 |
| 2020-06-17 |
Anakinra as a potential alternative in the treatment of severe acute respiratory infection associated with SARS-CoV-2 refractory to tocilizumab (edit) |
10.1016/J.REUMA.2020.06.003 |
| 2020-06-17 |
Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding (edit) |
10.1101/2020.06.17.157982 |
| 2020-06-17 |
Characterization of the SARS-CoV-2 S Protein: Biophysical, Biochemical, Structural, and Antigenic Analysis (edit) |
10.1101/2020.06.14.150607 |
| 2020-06-17 |
Asymptomatic and presymptomatic transmission of SARS-CoV-2: A systematic review (edit) |
10.1101/2020.06.11.20129072 |
| 2020-06-17 |
Novel rapid identification of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) by real-time RT-PCR using BD Max Open System in Taiwan (edit) |
10.7717/PEERJ.9318 |
| 2020-06-17 |
Pharmacologic management of patients with hepatic and pancreatic diseases that involve immunosuppressive therapies. Positioning within the framework of the SARS-CoV-2 (COVID-19) pandemic (edit) |
10.1016/J.RGMX.2020.06.001 |
| 2020-06-17 |
Concordance between two rapid diagnostic tests for the detection of antibodies against SARS-CoV-2 (edit) |
10.1016/J.SEMERG.2020.06.009 |
| 2020-06-17 |
SARS-CoV-2 infection risk assessment in the endometrium: viral infection-related gene expression across the menstrual cycle (edit) |
10.1016/J.FERTNSTERT.2020.06.026 |
| 2020-06-17 |
Cumulative incidence and diagnosis of SARS-CoV-2 infection in New York (edit) |
10.1016/J.ANNEPIDEM.2020.06.004 |
| 2020-06-17 |
When success means focusing on the oxygen delivery. A case of conventional management of severe hypoxemia in SARS-CoV-2 (edit) |
10.1016/J.MEDIN.2020.06.003 |
| 2020-06-17 |
Epidemiological and Clinical Features of SARS-CoV-2: A Retrospective Study from East Karachi, Pakistan (edit) |
10.7759/CUREUS.8679 |
| 2020-06-17 |
Co‑expression of peripheral olfactory receptors with SARS‑CoV‑2 infection mediators: Potential implications beyond loss of smell as a COVID‑19 symptom (edit) |
10.3892/IJMM.2020.4646 |
| 2020-06-17 |
SARS-CoV-2 pandemic: An overview (edit) |
10.1016/J.JBIOR.2020.100736 |
| 2020-06-17 |
Consecutive false-negative rRT-PCR test results for SARS-CoV-2 in patients after clinical recovery from COVID-19 (edit) |
10.1002/JMV.26192 |
| 2020-06-17 |
Immunoinformatics characterization of SARS-CoV-2 spike glycoprotein for prioritization of epitope based multivalent peptide vaccine (edit) |
10.1016/J.MOLLIQ.2020.113612 |
| 2020-06-17 |
Genome-wide CRISPR screen reveals host genes that regulate SARS-CoV-2 infection (edit) |
10.1101/2020.06.16.155101 |
| 2020-06-16 |
Does Longer Leukocyte Telomere Length and Higher Physical Fitness Protect Master Athletes From Consequences of Coronavirus (SARS-CoV-2) Infection? (edit) |
10.3389/FSPOR.2020.00087 |
| 2020-06-16 |
In silico analysis of SARS-CoV-2 spike glycoprotein and insights into antibody binding (edit) |
10.3897/RIO.6.E55281 |
| 2020-06-16 |
Cell entry of SARS-CoV-2 conferred by angiotensin-converting enzyme 2 (ACE2) of different species (edit) |
10.1101/2020.06.15.153916 |
| 2020-06-16 |
The in vitro antiviral activity of the anti-hepatitis C virus (HCV) drugs daclatasvir and sofosbuvir against SARS-CoV-2 (edit) |
10.1101/2020.06.15.153411 |
| 2020-06-16 |
Oral drug repositioning candidates and synergistic remdesivir combinations for the prophylaxis and treatment of COVID-19 (edit) |
10.1101/2020.06.16.153403 |
| 2020-06-16 |
Reperfusion of STEMI in the COVID-19 Era - Business as Usual? (edit) |
10.1161/CIRCULATIONAHA.120.047122 |
| 2020-06-16 |
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up (edit) |
10.1016/J.JACC.2020.04.031 |
| 2020-06-16 |
The Obstacle Course of Reperfusion for STEMI in the COVID-19 Pandemics (edit) |
10.1161/CIRCULATIONAHA.120.047523 |
| 2020-06-16 |
Coronavirus breakthrough: dexamethasone is first drug shown to save lives (edit) |
10.1038/D41586-020-01824-5 |
| 2020-06-16 |
A Call For a Three-tiered Pandemic Public Health Strategy in Context of SARS-CoV-2 (edit) |
10.1089/REJ.2020.2363 |
| 2020-06-16 |
Widespread SARS-CoV-2 laboratory surveillance program to minimize asymptomatic transmission in high-risk inpatient and congregate living settings (edit) |
10.1017/ICE.2020.301 |
| 2020-06-16 |
Environmental Surface Testing for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) during Prolonged Isolation of an Asymptomatic Carrier (edit) |
10.1017/ICE.2020.300 |
| 2020-06-16 |
Upper and Lower Airways Functional Examination in Asthma and Respiratory Allergic Deseases. Considerations in the SARS-CoV-2 Post-Pandemic Situation (edit) |
10.18176/JIACI.0625 |
| 2020-06-16 |
Ig-like ACE2 protein therapeutics: A revival in development during the COVID-19 pandemic (edit) |
10.1080/19420862.2020.1782600 |
| 2020-06-16 |
The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection (edit) |
10.1186/S13054-020-03062-7 |
| 2020-06-16 |
Correction to: Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial (edit) |
10.1186/S13063-020-04504-X |
| 2020-06-16 |
Consensus statement of the Italian society of pediatric allergy and immunology for the pragmatic management of children and adolescents with allergic or immunological diseases during the COVID-19 pandemic (edit) |
10.1186/S13052-020-00843-2 |
| 2020-06-16 |
Anticipatory prescribing in community end-of-life care in the UK and Ireland during the COVID-19 pandemic: online survey (edit) |
10.1136/BMJSPCARE-2020-002394 |
| 2020-06-16 |
Position statement of the Royal Spanish Football Federation for the resumption of football activities after the COVID-19 pandemic (June 2020) (edit) |
10.1136/BJSPORTS-2020-102640 |
| 2020-06-16 |
Routine vaccination during covid-19 pandemic response (edit) |
10.1136/BMJ.M2392 |
| 2020-06-16 |
Acute Start Peritoneal Dialysis during the COVID-19 Pandemic: Outcomes and Experiences (edit) |
10.1681/ASN.2020050599 |
| 2020-06-16 |
The Nucleocapsid Protein of SARS-CoV-2: a Target for Vaccine Development (edit) |
10.1128/JVI.00647-20 |
| 2020-06-16 |
'Healthcare Heroes': problems with media focus on heroism from healthcare workers during the COVID-19 pandemic (edit) |
10.1136/MEDETHICS-2020-106398 |
| 2020-06-16 |
Protections against the Risk of Airborne SARS-CoV-2 Infection (edit) |
10.1128/MSYSTEMS.00390-20 |
| 2020-06-16 |
Reply to McDonald, "Protections against the Risk of Airborne SARS-CoV-2 Infection" (edit) |
10.1128/MSYSTEMS.00435-20 |
| 2020-06-16 |
Optimization of primer sets and detection protocols for SARS-CoV-2 of coronavirus disease 2019 (COVID-19) using PCR and real-time PCR (edit) |
10.1038/S12276-020-0452-7 |
| 2020-06-16 |
Impact of the COVID-19 pandemic on life expectancy in Madrid (Spain) (edit) |
10.1093/PUBMED/FDAA087 |
| 2020-06-16 |
COVID-19 pandemic: a large boulder on the head of stoma patients (edit) |
10.1002/BJS.11754 |
| 2020-06-16 |
SARS-CoV-2 Viral Inactivation Using Low Dose Povidone-Iodine Oral Rinse-Immediate Application for the Prosthodontic Practice (edit) |
10.1111/JOPR.13207 |
| 2020-06-16 |
To what extent do children transmit SARS-CoV-2 virus? (edit) |
10.1111/JPC.14937 |
| 2020-06-16 |
Luxembourg's Approach to Research Integrity during the COVID-19 Pandemic (edit) |
10.1080/08989621.2020.1778473 |
| 2020-06-16 |
Development of an automatic integrated gene detection system for novel Severe acute respiratory syndrome-related coronavirus (SARS-CoV 2) (edit) |
10.1080/22221751.2020.1782774 |
| 2020-06-16 |
Older Adults and the Economic Impact of the COVID-19 Pandemic (edit) |
10.1080/08959420.2020.1773191 |
| 2020-06-16 |
Virus strain from a mild COVID-19 patient in Hangzhou represents a new trend in SARS-CoV-2 evolution potentially related to Furin cleavage site (edit) |
10.1080/22221751.2020.1781551 |
| 2020-06-16 |
SARS-CoV-2 genomic surveillance in Taiwan revealed novel ORF8-deletion mutant and clade possibly associated with infections in Middle East (edit) |
10.1080/22221751.2020.1782271 |
| 2020-06-16 |
A cross-sectional community-based observational study of asymptomatic SARS-CoV-2 prevalence in the greater Indianapolis area (edit) |
10.1002/JMV.26182 |
| 2020-06-16 |
Comparison and Application of Different Immunoassay Methods for the Detection of SARS-CoV-2 (edit) |
10.1002/JMV.26187 |
| 2020-06-16 |
Dermatological findings in SARS-CoV-2 positive patients: An observational study from North India (edit) |
10.1111/DTH.13849 |
| 2020-06-16 |
Asymptomatic SARS-CoV-2 infection and COVID-19 mortality during an outbreak investigation in a skilled nursing facility (edit) |
10.1093/CID/CIAA763 |
| 2020-06-16 |
[Epidemiology of SARS-CoV-2 infection and COVID-19] (edit) |
10.1007/S00108-020-00834-9 |
| 2020-06-16 |
Where are the hernias? A paradoxical decrease in emergency hernia surgery during COVID-19 pandemic (edit) |
10.1007/S10029-020-02250-2 |
| 2020-06-16 |
Correction to: Challenges and opportunities for graduate students in public health during the COVID-19 pandemic (edit) |
10.17269/S41997-020-00369-4 |
| 2020-06-16 |
Computational investigation on Andrographis paniculata phytochemicals to evaluate their potency against SARS-CoV-2 in comparison to known antiviral compounds in drug trials (edit) |
10.1080/07391102.2020.1777901 |
| 2020-06-16 |
The "Three Italy" of the COVID-19 epidemic and the possible involvement of SARS-CoV-2 in triggering complications other than pneumonia (edit) |
10.1007/S13365-020-00862-Z |
| 2020-06-16 |
Seroepidemiologic Study Designs for Determining SARS-COV-2 Transmission and Immunity (edit) |
10.3201/EID2609.201840 |
| 2020-06-16 |
Breast unit Efficacy with the relocation of the surgical breast team during the COVID-19 pandemic (edit) |
10.1111/TBJ.13934 |
| 2020-06-16 |
Patient Perspectives on Audio-Only Virtual Prenatal Visits Amidst the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pandemic (edit) |
10.1097/AOG.0000000000004026 |
| 2020-06-16 |
Clinical and epidemiological characteristics of pediatric SARS-CoV-2 infections in China: A multicenter case series (edit) |
10.1371/JOURNAL.PMED.1003130 |
| 2020-06-16 |
Stroke care in Europe during the COVID-19 pandemic (edit) |
10.1111/ENE.14401 |
| 2020-06-16 |
Behavioral and psychosocial responses of people receiving treatment for advanced lung cancer during the COVID-19 pandemic: a qualitative analysis (edit) |
10.1002/PON.5445 |
| 2020-06-16 |
COVID-19: The Endocrine opportunity in a pandemic (edit) |
10.23736/S0391-1977.20.03216-2 |
| 2020-06-16 |
Euglycemic diabetic ketoacidosis in a patient with type 1 diabetes and SARS-CoV-2 pneumonia: case report and review of the literature (edit) |
10.1080/17843286.2020.1780390 |
| 2020-06-16 |
De novo design of protein peptides to block association of the SARS-CoV-2 spike protein with human ACE2 (edit) |
10.18632/AGING.103416 |
| 2020-06-16 |
Proper Management of People with Obesity during the COVID-19 Pandemic (edit) |
10.7570/JOMES20056 |
| 2020-06-16 |
Strategies to Prevent SARS-CoV-2-Mediated Eosinophilic Disease in Association with COVID-19 Vaccination and Infection (edit) |
10.1159/000509368 |
| 2020-06-16 |
Pool size selection when testing for SARS-CoV-2 (edit) |
10.1093/CID/CIAA774 |
| 2020-06-16 |
Asymptomatic and symptomatic SARS-CoV-2 infections in close contacts of COVID-19 patients: a seroepidemiological study (edit) |
10.1093/CID/CIAA771 |
| 2020-06-16 |
SARS-CoV-2 antibodies in adults in Madrid, Spain (edit) |
10.1093/CID/CIAA769 |
| 2020-06-16 |
Characteristics and Outcomes of 241 Births to Women With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection at Five New York City Medical Centers (edit) |
10.1097/AOG.0000000000004025 |
| 2020-06-16 |
Clinical course of a critically ill patient with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (edit) |
10.1007/S10047-020-01183-Y |
| 2020-06-16 |
Performance Assessment of SARS-CoV-2 PCR Assays Developed by WHO Referral Laboratories (edit) |
10.3390/JCM9061871 |
| 2020-06-16 |
Vaccines and Therapies in Development for SARS-CoV-2 Infections (edit) |
10.3390/JCM9061885 |
| 2020-06-16 |
In silico prediction of potential inhibitors for the Main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing (edit) |
10.1016/J.JIPH.2020.06.016 |
| 2020-06-16 |
The SARS-Cov-2 pandemic: a good time for stem cell transplantation? (edit) |
10.1016/J.BBMT.2020.06.009 |
| 2020-06-16 |
Risk and Management of Patients with Mastocytosis and MCAS in the SARS-CoV-2 (COVID-19) Pandemic: Expert Opinions (edit) |
10.1016/J.JACI.2020.06.009 |
| 2020-06-16 |
Abdominal Surgery in Patients with COVID-19: Detection of SARS-CoV-2 in Abdominal and Adipose Tissues (edit) |
10.1097/SLA.0000000000004165 |
| 2020-06-16 |
The Integrin Binding Peptide, ATN-161, as a Novel Therapy for SARS-CoV-2 Infection (edit) |
10.1101/2020.06.15.153387 |
| 2020-06-16 |
Field-deployable, rapid diagnostic testing of saliva samples for SARS-CoV-2 (edit) |
10.1101/2020.06.13.20129841 |
| 2020-06-16 |
Age-dependent assessment of genes involved in cellular senescence, telomere and mitochondrial pathways in human lung tissue of smokers, COPD and IPF: Associations with SARS-CoV-2 COVID-19 ACE2-TMPRSS2-Furin-DPP4 axis (edit) |
10.1101/2020.06.14.20129957 |
| 2020-06-16 |
Evaluation of SARS-CoV-2 in Breastmilk from 18 Infected Women (edit) |
10.1101/2020.06.12.20127944 |
| 2020-06-16 |
Re: Androgen-deprivation Therapies for Prostate Cancer and Risk of Infection by SARS-CoV-2: A Population-based Study (n = 4532) (edit) |
10.1016/J.EURURO.2020.06.014 |
| 2020-06-16 |
Neuromechanisms of SARS-CoV-2: A Review (edit) |
10.3389/FNANA.2020.00037 |
| 2020-06-16 |
COVID-19 Is Distinct From SARS-CoV-2-Negative Community-Acquired Pneumonia (edit) |
10.3389/FCIMB.2020.00322 |
| 2020-06-16 |
Clinical Features of 33 Cases in Children Infected With SARS-CoV-2 in Anhui Province, China-A Multi-Center Retrospective Cohort Study (edit) |
10.3389/FPUBH.2020.00255 |
| 2020-06-16 |
The Modulation of Mucosal Antiviral Immunity by Immunobiotics: Could They Offer Any Benefit in the SARS-CoV-2 Pandemic? (edit) |
10.3389/FPHYS.2020.00699 |
| 2020-06-16 |
Use of Machine Learning and Artificial Intelligence to predict SARS-CoV-2 infection from Full Blood Counts in a population (edit) |
10.1016/J.INTIMP.2020.106705 |
| 2020-06-16 |
SARS-COV-2 in Ophthalmology: Current Evidence and Standards for Clinical Practice (edit) |
10.20344/AMP.14118 |
| 2020-06-16 |
Proteasome activator PA28γ-dependent degradation of coronavirus disease (COVID-19) nucleocapsid protein (edit) |
10.1016/J.BBRC.2020.06.058 |
| 2020-06-16 |
Mouse Model of SARS-CoV-2 Reveals Inflammatory Role of Type I Interferon Signaling (edit) |
10.2139/SSRN.3628297 |
| 2020-06-16 |
Satellite-detected tropospheric nitrogen dioxide and spread of SARS-CoV-2 infection in Northern Italy (edit) |
10.1016/J.SCITOTENV.2020.140278 |
| 2020-06-15 |
Genome-wide mapping of therapeutically-relevant SARS-CoV-2 RNA structures (edit) |
10.1101/2020.06.15.151647 |
| 2020-06-15 |
Microscopy-based assay for semi-quantitative detection of SARS-CoV-2 specific antibodies in human sera (edit) |
10.1101/2020.06.15.152587 |
| 2020-06-15 |
Naturally mutated spike proteins of SARS-CoV-2 variants show differential levels of cell entry (edit) |
10.1101/2020.06.15.151779 |
| 2020-06-15 |
The potential of melatonin in the prevention and attenuation of oxidative hemolysis and myocardial injury from cd147 SARS-CoV-2 spike protein receptor binding (edit) |
10.32794/MR11250069 |
| 2020-06-15 |
Is It Time to Liberate Resources for Organ Transplantation Amid the COVID-19 Pandemic? (edit) |
10.1177/1526924820933839 |
| 2020-06-15 |
Potential implications of SARS-CoV-2 epidemic in Africa: where are we going from now? (edit) |
10.1186/S12879-020-05147-8 |
| 2020-06-15 |
When SARS-CoV-2 comes knocking on your lab door: Individual scientists' experiences during the pandemic (edit) |
10.15252/EMBR.202050946 |
| 2020-06-15 |
Utility and risk of dermatologic medications during the COVID-19 pandemic (edit) |
10.1111/DTH.13833 |
| 2020-06-15 |
Extensive pneumatosis intestinalis and portal venous gas mimicking mesenteric ischaemia in a patient with SARS-CoV-2 (edit) |
10.1308/RCSANN.2020.0145 |
| 2020-06-15 |
Risk of infections in psoriasis. A lesson to learn during the SARS-CoV-2 pandemic (edit) |
10.1111/BJD.19190 |
| 2020-06-15 |
Assessment of the preparedness of obstetrics and gynecology healthcare systems during the COVID-19 pandemic in Libya (edit) |
10.1002/IJGO.13273 |
| 2020-06-15 |
Flattening the emotional distress curve: A behavioral health pandemic response strategy for COVID-19 (edit) |
10.1037/AMP0000694 |
| 2020-06-15 |
Moral medical decision-making: Colliding sacred values in response to COVID-19 pandemic (edit) |
10.1037/TRA0000612 |
| 2020-06-15 |
Psychological aspects of employment instability during the COVID-19 pandemic (edit) |
10.1037/TRA0000769 |
| 2020-06-15 |
"When the going gets tough, the tough get-Creative": Israeli Jewish religious leaders find religiously innovative ways to preserve community members' sense of belonging and resilience during the COVID-19 pandemic (edit) |
10.1037/TRA0000822 |
| 2020-06-15 |
The effects of nonconventional palliative and end-of-life care during COVID-19 pandemic on mental health-Junior doctors' perspective (edit) |
10.1037/TRA0000628 |
| 2020-06-15 |
Coronavirus disease (COVID-19) pandemic: Furnishing experiences from India (edit) |
10.1037/TRA0000770 |
| 2020-06-15 |
On the Role of Chest Radiography and CT in the Coronavirus Disease (COVID-19) Pandemic (edit) |
10.2214/AJR.20.23411 |
| 2020-06-15 |
Molecular simulation of SARS-CoV-2 spike protein binding to pangolin ACE2 or human ACE2 natural variants reveals altered susceptibility to infection (edit) |
10.1099/JGV.0.001452 |
| 2020-06-15 |
Hospital-Wide SARS-CoV-2 Antibody Screening in 3056 Staff in a Tertiary Center in Belgium (edit) |
10.1001/JAMA.2020.11160 |
| 2020-06-15 |
Implementation of field hospital pharmacy services during the COVID-19 pandemic (edit) |
10.1093/AJHP/ZXAA211 |
| 2020-06-15 |
Screening for SARS-CoV-2 infection in pediatric oncology patients during the epidemic peak in Italy (edit) |
10.1002/PBC.28466 |
| 2020-06-15 |
Taste and smell impairment in SARS-CoV-2 recovers early and spontaneously: Experimental data strongly linked to clinical data (edit) |
10.1021/ACSCHEMNEURO.0C00296 |
| 2020-06-15 |
Managing Your Chronic Lung Disease During the COVID-19 Pandemic (edit) |
10.1164/RCCM.2020C8 |
| 2020-06-15 |
Orthopedic surgery residents' perception of online education in their programs during the COVID-19 pandemic: should it be maintained after the crisis? (edit) |
10.1080/17453674.2020.1776461 |
| 2020-06-15 |
Sport and exercise during and beyond the COVID-19 pandemic (edit) |
10.1177/2047487320933260 |
| 2020-06-15 |
Effect of extended use N95 respirators and eye protection on personal protective equipment (PPE) utilization during SARS-CoV-2 outbreak in Singapore (edit) |
10.1186/S13756-020-00753-2 |
| 2020-06-15 |
Preventing Dengue Epidemics during the COVID-19 Pandemic (edit) |
10.4269/AJTMH.20-0480 |
| 2020-06-15 |
Violence against women in the covid-19 pandemic: we need upstream approaches to break the intergenerational cycle (edit) |
10.1136/BMJ.M2327 |
| 2020-06-15 |
Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail (edit) |
10.1126/SCIENCE.ABD0827 |
| 2020-06-15 |
Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model (edit) |
10.1126/SCIENCE.ABC7520 |
| 2020-06-15 |
Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies (edit) |
10.1126/SCIENCE.ABD0831 |
| 2020-06-15 |
Diabetes Epidemiology in the COVID-19 Pandemic (edit) |
10.2337/DC20-1295 |
| 2020-06-15 |
Covid-19: the medical students responding to the pandemic (edit) |
10.1136/BMJ.M2160 |
| 2020-06-15 |
International comparison of guidelines for managing neonates at the early phase of the SARS-CoV-2 pandemic (edit) |
10.1038/S41390-020-0976-5 |
| 2020-06-15 |
Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease (edit) |
10.1038/S41422-020-0356-Z |
| 2020-06-15 |
Modeling SARS-CoV-2 infection in mice (edit) |
10.1038/S41684-020-0582-5 |
| 2020-06-15 |
Acute smell and taste loss in outpatients: all infected with SARS-CoV-2? (edit) |
10.4193/RHIN20.199 |
| 2020-06-15 |
COVID-19 pandemic in India (edit) |
10.1093/EURHEARTJ/EHAA493 |
| 2020-06-15 |
Releasing Migrants from Detention During the Covid-19 Pandemic (edit) |
10.1007/S11606-020-05954-4 |
| 2020-06-15 |
Psychological Aspects of the COVID-19 Pandemic (edit) |
10.1007/S11606-020-05955-3 |
| 2020-06-15 |
To fight SARS-CoV-2: putting your guns down (edit) |
10.17269/S41997-020-00339-W |
| 2020-06-15 |
Use of Telemedicine and Virtual Care for Remote Treatment in Response to COVID-19 Pandemic (edit) |
10.1007/S10916-020-01596-5 |
| 2020-06-15 |
Clinical Outcomes and Prognosis of Patients with HIV and SARS-CoV-2 Co-infection (edit) |
10.1002/JMV.26177 |
| 2020-06-15 |
Use of amantadine in a patient with SARS-Cov-2 (edit) |
10.1002/JMV.26179 |
| 2020-06-15 |
Blood donation and the global COVID-19 pandemic: areas for social science research (edit) |
10.1111/VOX.12974 |
| 2020-06-15 |
Epidemiological features and viral shedding in children with SARS-CoV-2 infection (edit) |
10.1002/JMV.26180 |
| 2020-06-15 |
Clinical use of Convalescent Plasma in the COVID-19 pandemic; a transfusion-focussed gap analysis with recommendations for future research priorities (edit) |
10.1111/VOX.12973 |
| 2020-06-15 |
Oncology care in a lower middle-income country during the COVID-19 pandemic (edit) |
10.1002/PBC.28438 |
| 2020-06-15 |
Specific pathways to prevent SARS-CoV-2 infection in case of repeated hospital admissions for radiotherapy (edit) |
10.1002/PBC.28463 |
| 2020-06-15 |
Challenges in teaching human anatomy to students with intellectual disabilities during the Covid-19 pandemic (edit) |
10.1002/ASE.1991 |
| 2020-06-15 |
Therapeutic approach to skin reactions caused by personal protective equipment (PPE) during COVID-19 pandemic: An experience from a tertiary hospital in Granada, Spain (edit) |
10.1111/DTH.13838 |
| 2020-06-15 |
A dearth of specifications regarding primary diagnostic monitors (PDMs) for nuclear medicine leaves us with little guidance during the COVID-19 pandemic (edit) |
10.1002/ACM2.12949 |
| 2020-06-15 |
Collateral Damage of the COVID-19 Pandemic on Nutritional Quality and Physical Activity: Perspective from South Korea (edit) |
10.1002/OBY.22935 |
| 2020-06-15 |
Reorganizing a Medicine Residency Program in Response to the COVID-19 Pandemic in New York (edit) |
10.1097/ACM.0000000000003548 |
| 2020-06-15 |
Ten Days to Implementation of 3D-Printed Masks for a Level-I Orthopaedic Trauma Practice During the COVID-19 Pandemic (edit) |
10.2106/JBJS.20.00881 |
| 2020-06-15 |
Cardiac rehabilitation activities during the COVID-19 pandemic in Italy. Position Paper of the AICPR (Italian Association of Clinical Cardiology, Prevention and Rehabilitation) (edit) |
10.4081/MONALDI.2020.1439 |
| 2020-06-15 |
[The role of speech in the transmission of SARSCoV-2: recommendations for confined spaces] (edit) |
10.21149/11665 |
| 2020-06-15 |
A Putative Role of de-Mono-ADP-Ribosylation of STAT1 by the SARS-CoV-2 Nsp3 Protein in the Cytokine Storm Syndrome of COVID-19 (edit) |
10.3390/V12060646 |
| 2020-06-15 |
Cancer and SARS-CoV-2 Infection: Diagnostic and Therapeutic Challenges (edit) |
10.3390/CANCERS12061581 |
| 2020-06-15 |
Reorganization Tips from a Sarcoma Unit at Time of the COVID-19 Pandemic in Italy: Early Experience from a Regional Referral Oncologic Center (edit) |
10.3390/JCM9061868 |
| 2020-06-15 |
Systematic Review of Clinical Insights into Novel Coronavirus (CoVID-19) Pandemic: Persisting Challenges in U.S. Rural Population (edit) |
10.3390/IJERPH17124279 |
| 2020-06-15 |
Save the ICU and save lives during the COVID-19 pandemic (edit) |
10.1186/S40560-020-00456-1 |
| 2020-06-15 |
Critical importance of early introduction of prevention measures for SARS-CoV-2 infection in endoscopy units (edit) |
10.1016/J.GIE.2020.06.023 |
| 2020-06-15 |
Therapeutic decisions in inflammatory bowel disease in the SARS-Cov-2 pandemic (edit) |
10.1053/J.GASTRO.2020.05.083 |
| 2020-06-15 |
TNFα-antagonist use and mucosal inflammation are associated with increased intestinal expression of SARS-CoV-2 host protease TMPRSS2 in patients with inflammatory bowel disease (edit) |
10.1053/J.GASTRO.2020.05.091 |
| 2020-06-15 |
Correlation between arterial blood gas test and CT volumetry in patients with SARS-CoV-2 in the emergency department (edit) |
10.1016/J.IJID.2020.06.033 |
| 2020-06-15 |
Retrospective screening for SARS-CoV-2 in Greater Glasgow and Clyde ICUs between December 2019 and February 2020 (edit) |
10.1016/J.JINF.2020.06.022 |
| 2020-06-15 |
Four point-of-care lateral flow immunoassays for diagnosis of COVID-19 and for assessing dynamics of antibody responses to SARS-CoV-2 (edit) |
10.1016/J.JINF.2020.06.023 |
| 2020-06-15 |
Characteristics of liver function in patients with SARS-CoV-2 and chronic HBV co-infection (edit) |
10.1016/J.CGH.2020.06.017 |
| 2020-06-15 |
Exposure and Seroconversion to SARS-CoV-2 Among Obstetric Healthcare Providers Following a Contained Outbreak (edit) |
10.1016/J.AJOG.2020.06.029 |
| 2020-06-15 |
Potential inhibitors of the interaction between ACE2 and SARS-CoV-2 (RBD), to develop a drug (edit) |
10.1016/J.LFS.2020.117970 |
| 2020-06-15 |
Combination of Serological Total Antibody and RT-PCR Test for Detection of SARS-CoV-2 Infections (edit) |
10.1016/J.JVIROMET.2020.113919 |
| 2020-06-15 |
Effectiveness of isolation, testing, contact tracing, and physical distancing on reducing transmission of SARS-CoV-2 in different settings: a mathematical modelling study (edit) |
10.1016/S1473-3099(20)30457-6 |
| 2020-06-15 |
Applying lessons from the Ebola vaccine experience for SARS-CoV-2 and other epidemic pathogens (edit) |
10.1038/S41541-020-0204-7 |
| 2020-06-15 |
Novel SARS-CoV-2/COVID-19: Origin, pathogenesis, genes and genetic variations, immune responses and phylogenetic analysis (edit) |
10.1016/J.GENREP.2020.100752 |
| 2020-06-15 |
Performance of six SARS-CoV-2 immunoassays in comparison with microneutralisation (edit) |
10.1016/J.JCV.2020.104512 |
| 2020-06-15 |
The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in vitro models of the human blood-brain barrier (edit) |
10.1101/2020.06.15.150912 |
| 2020-06-15 |
Pulmonary toxicity and inflammatory response of e-cigarettes containing medium-chain triglyceride oil and vitamin E acetate: Implications in the pathogenesis of EVALI but independent of SARS-COV-2 COVID-19 related proteins (edit) |
10.1101/2020.06.14.151381 |
| 2020-06-15 |
Novel ACE2-IgG1 fusions with improved activity against SARS-CoV2 (edit) |
10.1101/2020.06.15.152157 |
| 2020-06-15 |
The D614G mutation in SARS-CoV-2 Spike increases transduction of multiple human cell types (edit) |
10.1101/2020.06.14.151357 |
| 2020-06-15 |
Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech) (edit) |
10.1016/J.JCV.2020.104511 |
| 2020-06-15 |
Is spinal anaesthesia an aerosol-generating procedure? Transmission of SARS-CoV-2 from patient to anaesthetist (edit) |
10.1016/J.BJA.2020.06.015 |
| 2020-06-15 |
[Investigación en cáncer en el contexto de la pandemia de la enfermedad por SARS-CoV-2] (edit) |
|
| 2020-06-15 |
Age-dependent assessment of genes involved in cellular senescence, telomere and mitochondrial pathways in human lung tissue of smokers, COPD and IPF: Associations with SARS-CoV-2 COVID-19 ACE2-TMPRSS2-Furin-DPP4 axis (edit) |
10.21203/RS.3.RS-35347/V1 |
| 2020-06-15 |
Progress in Treatment of Myocardial Injury in Patients with 2019-nCoV: A Chinese Experience (edit) |
10.1532/HSF.2959 |
| 2020-06-15 |
Home-based Testing for SARS-CoV-2: Leveraging Prehospital Resources for Vulnerable Populations (edit) |
10.5811/WESTJEM.2020.5.47769 |
| 2020-06-14 |
The serotonin reuptake inhibitor Fluoxetine inhibits SARS-CoV-2 (edit) |
10.1101/2020.06.14.150490 |
| 2020-06-14 |
Surgical Oncologists and the COVID-19 Pandemic: Guiding Cancer Patients Effectively through Turbulence and Change (edit) |
10.1245/S10434-020-08673-6 |
| 2020-06-14 |
Occupational skin disease during the COVID-19 pandemic, as captured in a Dermatology staff clinic in the United Kingdom (edit) |
10.1111/JDV.16754 |
| 2020-06-14 |
Use of Contemporary Live Tele-Video Conferencing for Continuing Surgical Training at the time of COVID-19 pandemic (edit) |
10.1111/ANS.16105 |
| 2020-06-14 |
Oncological Surgery During the COVID-19 Pandemic: The Need for Deep and Lasting Measures (edit) |
10.1634/THEONCOLOGIST.2020-0360 |
| 2020-06-14 |
The impacts of the COVID-19 pandemic on medical students in Australia (edit) |
10.1111/ANS.16103 |
| 2020-06-14 |
Pitfalls in SARS-CoV-2 PCR diagnostics (edit) |
10.1111/TBED.13684 |
| 2020-06-14 |
Evolution of Cancer Care in Response to the COVID-19 Pandemic (edit) |
10.1634/THEONCOLOGIST.2020-0451 |
| 2020-06-14 |
Role of RNA Guanine Quadruplexes in Favoring the Dimerization of SARS Unique Domain in Coronaviruses (edit) |
10.1021/ACS.JPCLETT.0C01097 |
| 2020-06-14 |
Implementation of Continuous Glucose Monitoring in the Hospital: Emergent Considerations for Remote Glucose Monitoring During the COVID-19 Pandemic (edit) |
10.1177/1932296820932903 |
| 2020-06-14 |
The Sexual and Reproductive Health of Adolescents and Young Adults During the COVID-19 Pandemic (edit) |
10.1363/PSRH.12151 |
| 2020-06-14 |
Contraception and reproductive planning during the COVID-19 pandemic (edit) |
10.1080/17512433.2020.1782738 |
| 2020-06-14 |
Digital Approaches for Remote Pediatric Healthcare Delivery during the Coronavirus (Covid-19) Pandemic: Existing Evidence and A Call for Further Research (edit) |
10.2196/20049 |
| 2020-06-14 |
Neurotropism of SARS-CoV-2: COVID-19 presenting with an acute manic episode (edit) |
10.1136/BCR-2020-236123 |
| 2020-06-14 |
Takotsubo cardiomyopathy triggered by SARS-CoV-2 infection in a critically ill patient (edit) |
10.1136/BCR-2020-236561 |
| 2020-06-14 |
Inoculum at the time of SARS-CoV-2 exposure and risk of disease severity (edit) |
10.1016/J.IJID.2020.06.035 |
| 2020-06-14 |
Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2 Infection: A Multi-institutional Study from New York City (edit) |
10.1016/J.JPEDS.2020.06.045 |
| 2020-06-14 |
Characteristics, Cardiac involvement, and Outcomes of Multisystem Inflammatory Disease of Childhood (MIS-C) Associated with SARS-CoV-2 Infection (edit) |
10.1016/J.JPEDS.2020.06.044 |
| 2020-06-14 |
Quality Improvement Tool to Rapidly Identify Risk Factors for SARS-CoV-2 Infection among Healthcare Workers (edit) |
10.1016/J.JHIN.2020.06.012 |
| 2020-06-14 |
Phyloevolutionary analysis of SARS-CoV-2 in Nigeria (edit) |
10.1016/J.NMNI.2020.100717 |
| 2020-06-14 |
Nasal-Swab Testing Misses Patients with Low SARS-CoV-2 Viral Loads (edit) |
10.1101/2020.06.12.20128736 |
| 2020-06-14 |
Genome sequencing of the first SARS-CoV-2 reported from patients with COVID-19 in Ecuador (edit) |
10.1101/2020.06.11.20128330 |
| 2020-06-14 |
Laboratory diagnosis of SARS-CoV-2: available approaches and limitations (edit) |
10.1016/J.NMNI.2020.100713 |
| 2020-06-14 |
Testing for SARS-CoV-2 (COVID-19): a systematic review and clinical guide to molecular and serological in-vitro diagnostic assays (edit) |
10.1016/J.RBMO.2020.06.001 |
| 2020-06-13 |
Paraviral eruptions in the era of COVID-19: Do some skin manifestations point to a natural resistance to SARS-CoV-2? (edit) |
10.1016/J.CLINDERMATOL.2020.06.005 |
| 2020-06-13 |
Sentinel surveillance of SARS-CoV-2 in wastewater anticipates the occurrence of COVID-19 cases (edit) |
10.1101/2020.06.13.20129627 |
| 2020-06-13 |
The COVID-19 pandemic and health inequalities (edit) |
10.1136/JECH-2020-214401 |
| 2020-06-13 |
Is Hypertension a Real Risk Factor for Poor Prognosis in the COVID-19 Pandemic? (edit) |
10.1007/S11906-020-01057-X |
| 2020-06-13 |
SARS-CoV-2 impact in a community-based hematological ward in an Italian Red Zone (edit) |
10.1007/S00277-020-04116-0 |
| 2020-06-13 |
Feasibility of enhanced recovery after surgery program in colorectal surgery during COVID-19 pandemic in Italy: should we change something? (edit) |
10.1007/S13304-020-00827-1 |
| 2020-06-13 |
SARS-CoV-2, skin lesions and the need of a multidisciplinary approach (edit) |
10.1111/JDV.16745 |
| 2020-06-13 |
The red half moon nail sign: a novel manifestation of Coronavirus infection (edit) |
10.1111/JDV.16747 |
| 2020-06-13 |
Ten challenging questions about SARS-CoV-2 and COVID-19 (edit) |
10.1080/17476348.2020.1782197 |
| 2020-06-13 |
Scientific Collaboration During the COVID-19 Pandemic: N95DECON.org (edit) |
10.1093/ANNWEH/WXAA057 |
| 2020-06-13 |
The Society of Behavioral Sleep Medicine (SBSM) COVID-19 Task Force: Objectives and Summary Recommendations for Managing Sleep during a Pandemic (edit) |
10.1080/15402002.2020.1776288 |
| 2020-06-13 |
Short-term stress-related increasing cases of alopecia areata during the COVID-19 pandemic (edit) |
10.1080/09546634.2020.1782820 |
| 2020-06-13 |
Real-Time Smart Patient Monitoring and Assessment Amid COVID-19 Pandemic - an Alternative Approach to Remote Monitoring (edit) |
10.1007/S10916-020-01599-2 |
| 2020-06-13 |
Incidental COVID-19 in a Heart-Kidney Transplant Recipient with Malnutrition and Recurrent Infections: Implications for the SARS-CoV-2 Immune Response (edit) |
10.1111/TID.13367 |
| 2020-06-13 |
Salivary detection of SARS-CoV-2 (COVID-19) and implications for oral health-care providers (edit) |
10.1002/HED.26322 |
| 2020-06-13 |
Pharmaceutical care to hospital outpatients during the COVID-19 pandemic. Telepharmacy (edit) |
10.7399/FH.11498 |
| 2020-06-13 |
Maintaining comprehensive pharmacy services during a pandemic: recommendations from a designated COVID-19 facility (edit) |
10.1093/AJHP/ZXAA194 |
| 2020-06-13 |
Sars-CoV-2 infection: the same virus can cause different cutaneous manifestations (edit) |
10.1111/BJD.19311 |
| 2020-06-13 |
An Illustration of SARS-CoV-2 Dissemination Within a Skilled Nursing Facility Using Heat Maps (edit) |
10.1111/JGS.16642 |
| 2020-06-13 |
Violence against women in Italy during the COVID-19 pandemic (edit) |
10.1002/IJGO.13270 |
| 2020-06-13 |
Management strategies adopted by a pediatric palliative care network in northern Italy during the COVID-19 pandemic (edit) |
10.1111/APA.15411 |
| 2020-06-13 |
COVID-19 pandemic and Zagreb earthquakes as stressors in patients with temporomandibular disorders (edit) |
10.1111/ODI.13488 |
| 2020-06-13 |
Guillain-Barré syndrome after SARS-CoV-2 infection (edit) |
10.1111/ENE.14398 |
| 2020-06-13 |
Major cluster of pediatric " true " primary chilblains during the COVID-19 pandemic: a consequence of lifestyle changes due to lockdown (edit) |
10.1111/JDV.16751 |
| 2020-06-13 |
Potential Antiviral Options against SARS-CoV-2 Infection (edit) |
10.3390/V12060642 |
| 2020-06-13 |
Response of Practicing Chiropractors during the Early Phase of the COVID-19 Pandemic: A Descriptive Report (edit) |
10.1016/J.JMPT.2020.05.001 |
| 2020-06-13 |
SARS-CoV-2 RNA Detection in Gastrointestinal Sample Displays Poor Performance (edit) |
10.1053/J.GASTRO.2020.05.084 |
| 2020-06-13 |
The Dilemma in the Management of GI Bleeding During the COVID-19 Pandemic (edit) |
10.1053/J.GASTRO.2020.05.088 |
| 2020-06-13 |
"SARS-CoV-2 in the peritoneal waste of patients treated with peritoneal dialysis" (edit) |
10.1016/J.KINT.2020.05.034 |
| 2020-06-13 |
Math and aftermath of COVID-19 pandemic and its interrelationship from the resilience perspective (edit) |
10.1016/J.JINF.2020.06.020 |
| 2020-06-13 |
Temperature and the difference in impact of SARS CoV-2 infection (COVID-19) between tropical and non-tropical regions in Taiwan (edit) |
10.1016/J.TMAID.2020.101790 |
| 2020-06-13 |
Adoption of telerehabilitation in a developing country before and during the COVID-19 pandemic (edit) |
10.1016/J.REHAB.2020.06.001 |
| 2020-06-13 |
ACE2 and TMPRSS2 are expressed on the human ocular surface, suggesting susceptibility to SARS-CoV-2 infection (edit) |
10.1016/J.JTOS.2020.06.007 |
| 2020-06-13 |
Effect of COVID-19 pandemic on practice in european radiation oncology centers (edit) |
10.1016/J.RADONC.2020.06.007 |
| 2020-06-13 |
Incidence of Acute Ischemic Stroke and Rate of Mechanical Thrombectomy During the COVID-19 Pandemic in a Large Tertiary Care Telemedicine Network (edit) |
10.1016/J.WNEU.2020.06.053 |
| 2020-06-13 |
Importation of SARS-CoV-2 infection leads to major COVID-19 epidemic in Taiwan (edit) |
10.1016/J.IJID.2020.06.031 |
| 2020-06-13 |
The assessment of transmission efficiency and latent infection period on asymptomatic carriers of SARS-CoV-2 infection (edit) |
10.1016/J.IJID.2020.06.036 |
| 2020-06-13 |
A case report of SARS-CoV-2 confirmed in saliva specimens up to 37 days after onset: Proposal of saliva specimens for COVID-19 diagnosis and virus monitoring (edit) |
10.1016/J.JIAC.2020.06.011 |
| 2020-06-13 |
Single-cell transcriptomic analysis of SARS-CoV-2 reactive CD4 + T cells (edit) |
10.1101/2020.06.12.148916 |
| 2020-06-13 |
Molecular pharmacology of ciclesonide against SARS-CoV-2 (edit) |
10.1016/J.JACI.2020.05.029 |
| 2020-06-13 |
Impact of SARS-CoV-2 on a high volume endoscopy center in Italy (edit) |
10.1016/J.DLD.2020.06.009 |
| 2020-06-13 |
Lights and shadows of SARS-CoV-2 infection risk assessment in endoscopy (edit) |
10.1016/J.DLD.2020.06.013 |
| 2020-06-13 |
Functional urology surgery and SARS-CoV-2: how and why surgical activity should be resumed now, adapting to the new reality (edit) |
10.1016/J.ACURO.2020.06.001 |
| 2020-06-13 |
Growth, detection, quantification, and inactivation of SARS-CoV-2 (edit) |
10.1016/J.VIROL.2020.05.015 |
| 2020-06-12 |
A multi centre randomized open label trial of chloroquine for the treatment of adults with SARS-CoV-2 infection in Vietnam (edit) |
10.12688/WELLCOMEOPENRES.15936.1 |
| 2020-06-12 |
Evolution and epidemic spread of SARS-CoV-2 in Brazil (edit) |
10.1101/2020.06.11.20128249 |
| 2020-06-12 |
Serial Interval Distribution of SARS-CoV-2 Infection in Brazil (edit) |
10.1101/2020.06.09.20127043 |
| 2020-06-12 |
Persistent SARS-CoV-2 replication in severe COVID-19 (edit) |
10.1101/2020.06.10.20127837 |
| 2020-06-12 |
Prediction of non-canonical routes for SARS-CoV-2 infection in human placenta cells (edit) |
10.1101/2020.06.12.148411 |
| 2020-06-12 |
SARS-CoV-2 Infections and Serologic Responses from a Sample of U.S. Navy Service Members - USS Theodore Roosevelt, April 2020 (edit) |
10.15585/MMWR.MM6923E4 |
| 2020-06-12 |
First Reported Cases of SARS-CoV-2 Infection in Companion Animals - New York, March-April 2020 (edit) |
10.15585/MMWR.MM6923E3 |
| 2020-06-12 |
SARS-CoV-2 infection in children with febrile neutropenia (edit) |
10.1007/S00277-020-04115-1 |
| 2020-06-12 |
Paediatric Inflammatory Multisystem Syndrome: Temporally Associated with SARS-CoV-2 (PIMS-TS): Cardiac Features, Management and Short-Term Outcomes at a UK Tertiary Paediatric Hospital (edit) |
10.1007/S00246-020-02391-2 |
| 2020-06-12 |
Should cyclosporine be useful in renal transplant recipients affected by SARS-CoV-2? (edit) |
10.1111/AJT.16141 |
| 2020-06-12 |
Detection of viral SARS-CoV-2 genomes and histopathological changes in endomyocardial biopsies (edit) |
10.1002/EHF2.12805 |
| 2020-06-12 |
SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists (edit) |
10.1080/22221751.2020.1780953 |
| 2020-06-12 |
Inflammatory Bowel Disease and COVID-19-"Preventive" Sick Certificates as a Frequent Coping Strategy in the Face of the Pandemic (edit) |
10.1093/IBD/IZAA155 |
| 2020-06-12 |
False-positive reverse transcriptase polymerase chain reaction screening for SARS-CoV-2 in the setting of urgent head and neck surgery and otolaryngologic emergencies during the pandemic: Clinical implications (edit) |
10.1002/HED.26317 |
| 2020-06-12 |
Computational Determination of Potential Inhibitors of SARS-CoV-2 Main Protease (edit) |
10.1021/ACS.JCIM.0C00491 |
| 2020-06-12 |
Decoding SARS-CoV-2 transmission, evolution and ramification on COVID-19 diagnosis, vaccine, and medicine (edit) |
10.1021/ACS.JCIM.0C00501 |
| 2020-06-12 |
Guidance for rebooting electrophysiology through the COVID-19 pandemic from the Heart Rhythm Society and the American Heart Association Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology (edit) |
10.1161/CIRCEP.120.008999 |
| 2020-06-12 |
Trapped in a Double Bind: Chinese Overseas Student Anxiety during the COVID-19 Pandemic (edit) |
10.1080/10410236.2020.1775439 |
| 2020-06-12 |
Telemedicine is a useful tool to deliver care to patients with Amyotrophic Lateral Sclerosis during COVID-19 pandemic: results from Southern Italy (edit) |
10.1080/21678421.2020.1773502 |
| 2020-06-12 |
Letter to the editor: neurosurgical practice in COVID-19 pandemic: from the view of academic departments in India, Japan and China (edit) |
10.1080/02688697.2020.1759784 |
| 2020-06-12 |
Lopinavir/ritonavir as a third agent in the antiviral regimen for SARS-CoV-2 infection (edit) |
10.1080/1120009X.2020.1775424 |
| 2020-06-12 |
The Prevalence of SARS-CoV-2 IgG Antibodies in Intensive Care Unit (ICU) Healthcare Personnel (HCP) and its Implications - A Single-Center, Prospective, Pilot Study (edit) |
10.1017/ICE.2020.298 |
| 2020-06-12 |
COVID-19 Pandemic, Unemployment, and Civil Unrest: Underlying Deep Racial and Socioeconomic Divides (edit) |
10.1001/JAMA.2020.11132 |
| 2020-06-12 |
Health Care Policy After the COVID-19 Pandemic (edit) |
10.1001/JAMA.2020.10777 |
| 2020-06-12 |
A Simple Method for Detection of a Novel Coronavirus (SARS-CoV-2) using One-step RT-PCR followed by Restriction Fragment Length Polymorphism (edit) |
10.1002/JMV.26171 |
| 2020-06-12 |
The epidemiology and clinical characteristics of co-infection of SARS-CoV-2 and influenza viruses in patients during COVID-19 outbreak (edit) |
10.1002/JMV.26163 |
| 2020-06-12 |
Change of the diagnostic distribution in applicants to dermatology after COVID-19 pandemic: What it whispers to us? (edit) |
10.1111/DTH.13804 |
| 2020-06-12 |
SARS-CoV-2 was found in the bile juice from a patient with severe COVID-19 (edit) |
10.1002/JMV.26169 |
| 2020-06-12 |
Effect of the COVID-19 pandemic on anxiety among children with cystic fibrosis and their mothers (edit) |
10.1002/PPUL.24900 |
| 2020-06-12 |
Natural History of Asymptomatic SARS-CoV-2 Infection (edit) |
10.1056/NEJMC2013020 |
| 2020-06-12 |
Rapid detection of novel coronavirus/Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) by reverse transcription-loop-mediated isothermal amplification (edit) |
10.1371/JOURNAL.PONE.0234682 |
| 2020-06-12 |
Case Report: Implementation of a Digital Chatbot to Screen Health System Employees during the COVID-19 Pandemic (edit) |
10.1093/JAMIA/OCAA130 |
| 2020-06-12 |
Guillain-Barré syndrome in a patient with antibodies against SARS-COV-2 (edit) |
10.1111/ENE.14388 |
| 2020-06-12 |
COVID-19 pandemic: Practical considerations on the organization of an allergy clinic - an EAACI/ARIA Position Paper (edit) |
10.1111/ALL.14453 |
| 2020-06-12 |
Maternal transmission of SARS-COV-2 to the neonate, and possible routes for such transmission: A systematic review and critical analysis (edit) |
10.1111/1471-0528.16362 |
| 2020-06-12 |
COVID-19 pandemic repercussions on the use and management of plastics (edit) |
10.1021/ACS.EST.0C02178 |
| 2020-06-12 |
[In Focus: SARS-CoV-2 and the COVID-19 Pandemic] (edit) |
10.1055/A-1173-5888 |
| 2020-06-12 |
Infection prevention and control in nursing severe coronavirus disease (COVID-19) patients during the pandemic (edit) |
10.1186/S13054-020-03076-1 |
| 2020-06-12 |
Covid-19: Urgent cancer referrals fall by 60%, showing "brutal" impact of pandemic (edit) |
10.1136/BMJ.M2386 |
| 2020-06-12 |
Scope, quality, and inclusivity of clinical guidelines produced early in the covid-19 pandemic: rapid review (edit) |
10.1136/BMJ.M2371 |
| 2020-06-12 |
Collateral damage of the covid-19 pandemic: a Dutch perinatal perspective (edit) |
10.1136/BMJ.M2326 |
| 2020-06-12 |
Saving the Diabetic Foot During the COVID-19 Pandemic: A Tale of Two Cities (edit) |
10.2337/DC20-1176 |
| 2020-06-12 |
Recommendations for altitude training programming to preserve athletes' health after COVID-19 pandemic (edit) |
10.1136/BJSPORTS-2020-102561 |
| 2020-06-12 |
The role of furin cleavage site in SARS-CoV-2 spike protein-mediated membrane fusion in the presence or absence of trypsin (edit) |
10.1038/S41392-020-0184-0 |
| 2020-06-12 |
SARS-CoV-2 has a sweet tooth (edit) |
10.1038/S41577-020-0368-4 |
| 2020-06-12 |
Reduction in cardiovascular emergency admissions in Monaco during the COVID-19 pandemic (edit) |
10.1007/S00392-020-01687-W |
| 2020-06-12 |
Isolated post SARS-CoV-2 diplopia (edit) |
10.1007/S00415-020-09987-X |
| 2020-06-12 |
Mixed central and peripheral nervous system disorders in severe SARS-CoV-2 infection (edit) |
10.1007/S00415-020-09986-Y |
| 2020-06-12 |
Bilateral carotid artery dissection in a SARS-CoV-2 infected patient: causality or coincidence? (edit) |
10.1007/S00415-020-09984-0 |
| 2020-06-12 |
Regional differences in hospital admissions for ST-elevation and non-ST-elevation myocardial infarctions during the Coronavirus disease-19 (COVID-19) pandemic in Austria (edit) |
10.1007/S00508-020-01698-7 |
| 2020-06-12 |
Management of patients with SARS-CoV-2 infections and of patients with chronic lung diseases during the COVID-19 pandemic (as of 9 May 2020) : Statement of the Austrian Society of Pneumology (ASP) (edit) |
10.1007/S00508-020-01691-0 |
| 2020-06-12 |
Positive tracheal SARS-CoV-2 RNA test after three negative SARS-CoV-2 RNA tests in a patient with COVID-19 (edit) |
10.1007/S12630-020-01742-0 |
| 2020-06-12 |
COVID-19 Pandemic. New challenge for hospital pharmacy services (edit) |
10.7399/FH.11511 |
| 2020-06-12 |
Pharmaceutical management of the COVID-19 pandemic in a mid-size hospital (edit) |
10.7399/FH.11499 |
| 2020-06-12 |
Hospital Pharmacy: Comprehensive management of medical devices during SARS-CoV-2 (edit) |
10.7399/FH.11486 |
| 2020-06-12 |
Pharmaceutical care in hospitalized patients. (Management of the COVID-19 pandemic crisis. A new challenge for pharmacy services) (edit) |
10.7399/FH.11513 |
| 2020-06-12 |
Hospital Pharmacy Compounding against COVID-19 pandemic (edit) |
10.7399/FH.11492 |
| 2020-06-12 |
The Improbability of the Rapid Development of a Vaccine for SARS-CoV-2 (edit) |
10.1016/J.YMTHE.2020.06.005 |
| 2020-06-12 |
"Social Media Misinformation"-An Epidemic within the COVID-19 Pandemic (edit) |
10.4269/AJTMH.20-0592 |
| 2020-06-12 |
Gendered effects of school closures during the COVID-19 pandemic (edit) |
10.1016/S0140-6736(20)31377-5 |
| 2020-06-12 |
SARS-CoV-2 shedding and seroconversion among passengers quarantined after disembarking a cruise ship: a case series (edit) |
10.1016/S1473-3099(20)30364-9 |
| 2020-06-12 |
Clinical characteristics of COVID-19 in 104 people with SARS-CoV-2 infection on the Diamond Princess cruise ship: a retrospective analysis (edit) |
10.1016/S1473-3099(20)30482-5 |
| 2020-06-12 |
Asymptomatic SARS-CoV-2 infection (edit) |
10.1016/S1473-3099(20)30460-6 |
| 2020-06-12 |
The Need to Adapt the Rescue Chain for Out-of-Hospital Cardiac Arrest during the COVID-19 Pandemic: Experience from the Paris Fire Brigade Basic Life Support and Advanced Life Support Teams (edit) |
10.1016/J.RESUSCITATION.2020.06.005 |
| 2020-06-12 |
Meta-analysis investigating the relationship between clinical features, outcomes, and severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia (edit) |
10.1016/J.AJIC.2020.06.008 |
| 2020-06-12 |
Safety use of hydroxychloroquine and its combination with azithromycin in the context of Sars-CoV-2 outbreak: Clinical experience in a Belgian tertiary center (edit) |
10.1016/J.TMAID.2020.101788 |
| 2020-06-12 |
Eltrombopag is a potential target for drug intervention in SARS-CoV-2 spike protein (edit) |
10.1016/J.MEEGID.2020.104419 |
| 2020-06-12 |
Deep Brain Stimulation Telemedicine for Psychiatric Patients during the COVID-19 Pandemic (edit) |
10.1016/J.BRS.2020.06.011 |
| 2020-06-12 |
Contamination of personal protective equipment by SARS-CoV-2 during routine care of patients with mild COVID-19 (edit) |
10.1016/J.JINF.2020.06.021 |
| 2020-06-12 |
Elevated nucleoprotein-induced interferon-γ release in COVID-19 patients detected in a SARS-CoV-2 enzyme-linked immunosorbent spot assay (edit) |
10.1016/J.JINF.2020.06.015 |
| 2020-06-12 |
Sustainability of SARS-CoV-2 in aerosols: Should we worry about airborne transmission? (edit) |
10.1016/J.JHIN.2020.06.018 |
| 2020-06-12 |
Wuhan COVID-19, data - an example to show the importance of public health interventions to fight against the pandemic (edit) |
10.1016/J.TOX.2020.152523 |
| 2020-06-12 |
A reply to Dr. Pan's and Dr. Wu's response: "Wuhan COVID-19 data - An example to show the importance of public health interventions to fight against the pandemic" (edit) |
10.1016/J.TOX.2020.152524 |
| 2020-06-12 |
Molecular conservation and differential mutation on ORF3a gene in Indian SARS-CoV2 genomes (edit) |
10.1016/J.YGENO.2020.06.016 |
| 2020-06-12 |
Recommendations for Dental Care during COVID-19 Pandemic (edit) |
10.3390/JCM9061833 |
| 2020-06-12 |
Should We Perform Old-for-Old Kidney Transplantation during the COVID-19 Pandemic? The Risk for Post-Operative Intensive Stay (edit) |
10.3390/JCM9061835 |
| 2020-06-12 |
Letter to the editor in response to: COVID-19 pandemic and challenges for socio-economic issues, healthcare and national programs in India (Gopalan and Misra) (edit) |
10.1016/J.DSX.2020.06.019 |
| 2020-06-12 |
Dental Care Provision during Coronavirus Disease 2019 (COVID-19) Pandemic: The Importance of Continuous Support for Vulnerable Patients (edit) |
10.3390/MEDICINA56060294 |
| 2020-06-12 |
The legal extension of the role of pharmacists in light of the COVID-19 global pandemic (edit) |
10.1016/J.SAPHARM.2020.05.033 |
| 2020-06-12 |
Equitable Care for Critically Ill Patients from Culturally Diverse Communities in the COVID-19 Pandemic (edit) |
10.1089/JPM.2020.0347 |
| 2020-06-12 |
Association of COVID-19 pandemic with meteorological parameters over Singapore (edit) |
10.1016/J.SCITOTENV.2020.140112 |
| 2020-06-12 |
The treatment and outcome of a pulmonary sarcomatoid carcinoma patient infected with SARS-CoV-2 (edit) |
10.1016/J.LUNGCAN.2020.06.006 |
| 2020-06-12 |
Plasma from donors convalescent from SARS-CoV-2 infection-A matter of priorities (edit) |
10.1016/J.TRACLI.2020.05.002 |
| 2020-06-12 |
Coinfection with HIV and SARS-CoV-2 in Wuhan, China: A 12-person case series (edit) |
10.1097/QAI.0000000000002424 |
| 2020-06-12 |
Risk of SARS-CoV-2 infection among contacts of individuals with COVID-19 in Hangzhou, China (edit) |
10.1016/J.PUHE.2020.05.016 |
| 2020-06-12 |
The SARS-CoV-2 crisis: A crisis of reductionism? (edit) |
10.1016/J.PUHE.2020.06.019 |
| 2020-06-12 |
Structural basis for potent neutralization of SARS-CoV-2 and role of antibody affinity maturation (edit) |
10.1101/2020.06.12.148692 |
| 2020-06-12 |
Is Sexual Route a Matter of Concern for the SARS-CoV-2/COVID-19? (edit) |
10.1016/J.ARCMED.2020.06.008 |
| 2020-06-12 |
Specific viral RNA drives the SARS CoV-2 nucleocapsid to phase separate (edit) |
10.1101/2020.06.11.147199 |
| 2020-06-12 |
The D614G mutation in the SARS-CoV-2 spike protein reduces S1 shedding and increases infectivity (edit) |
10.1101/2020.06.12.148726 |
| 2020-06-12 |
At-home self-collection of saliva, oropharyngeal swabs and dried blood spots for SARS-CoV-2 diagnosis and serology: post-collection acceptability of specimen collection process and patient confidence in specimens (edit) |
10.1101/2020.06.10.20127845 |
| 2020-06-12 |
New Strategy for COVID-19: An Evolutionary Role for RGD Motif in SARS-CoV-2 and Potential Inhibitors for Virus Infection (edit) |
10.3389/FPHAR.2020.00912 |
| 2020-06-12 |
Re: Jan-Niclas Mumm, Andreas Osterman, Michael Ruzicka, et al. Urinary Frequency as a Possible Overlooked Symptom in COVID-19 Patients: Does SARS-CoV-2 Cause Viral Cystitis? Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.05.013: Severe In (edit) |
10.1016/J.EURURO.2020.06.006 |
| 2020-06-12 |
SARS-CoV-2 Pathogenesis: Imbalance in the Renin-Angiotensin System Favors Lung Fibrosis (edit) |
10.3389/FCIMB.2020.00340 |
| 2020-06-12 |
SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy (edit) |
10.7150/THNO.48076 |
| 2020-06-12 |
Genotyping SARS-CoV-2 through an interactive web application (edit) |
10.1016/S2589-7500(20)30140-0 |
| 2020-06-11 |
IgA dominates the early neutralizing antibody response to SARS-CoV-2 (edit) |
10.1101/2020.06.10.20126532 |
| 2020-06-11 |
Modeling the structure of the frameshift stimulatory pseudoknot in SARS-CoV-2 reveals multiple possible conformers (edit) |
10.1101/2020.06.08.141150 |
| 2020-06-11 |
Remdesivir but not famotidine inhibits SARS-CoV-2 replication in human pluripotent stem cell-derived intestinal organoids (edit) |
10.1101/2020.06.10.144816 |
| 2020-06-11 |
SARS-CoV-2 Does Not Spread Through ECMO or Dialysis Membranes (edit) |
10.1164/RCCM.202004-1339LE |
| 2020-06-11 |
Low prevalence of IgG antibodies to SARS-CoV-2 in cancer patients with COVID-19 (edit) |
10.1002/IJC.33148 |
| 2020-06-11 |
The possible impairment of respiratory-related neural loops may be associated with the silent pneumonia induced by SARS-CoV-2 (edit) |
10.1002/JMV.26158 |
| 2020-06-11 |
When do you say it's SARS-CoV-2-associated diarrhea? (edit) |
10.1111/JGH.15141 |
| 2020-06-11 |
Targeting SARS-CoV-2: Novel Source of Antiviral Compound(s) against COVID-19? (edit) |
10.1021/ACSCHEMNEURO.0C00312 |
| 2020-06-11 |
Existence of SARS-CoV-2 in Wastewater: Implications for Its Environmental Transmission in Developing Communities (edit) |
10.1021/ACS.EST.0C02777 |
| 2020-06-11 |
A Report of the Telepsychiatric Evaluation of SARS-CoV-2 Patients (edit) |
10.1089/TMJ.2020.0125 |
| 2020-06-11 |
Airborne SARS-CoV-2 is Rapidly Inactivated by Simulated Sunlight (edit) |
10.1093/INFDIS/JIAA334 |
| 2020-06-11 |
Poor outcome and prolonged persistence of SARS-CoV-2 RNA in COVID-19 patients with haematological malignancies; King's College Hospital experience (edit) |
10.1111/BJH.16935 |
| 2020-06-11 |
The impact of SARS-Cov-2 pandemic on stroke care: A warning message (edit) |
10.1111/ENE.14394 |
| 2020-06-11 |
Risk following a SARS-CoV-2 exposure from a nocturnal hemodialysis patient utilizing continuous positive airway pressure (CPAP) (edit) |
10.1017/ICE.2020.291 |
| 2020-06-11 |
Impact of SARS-CoV-2 pandemic on mental health in the elderly: perspective from a psychogeriatric clinic at a tertiary hospital in Sao Paulo, Brazil (edit) |
10.1017/S1041610220001180 |
| 2020-06-11 |
RT-PCR tests for SARS-CoV-2 processed at a large Italian Hospital and false negative results among COVID-19 confirmed cases (edit) |
10.1017/ICE.2020.290 |
| 2020-06-11 |
Complete Genome Sequence of a Novel Coronavirus (SARS-CoV-2) Isolate from Bangladesh (edit) |
10.1128/MRA.00568-20 |
| 2020-06-11 |
Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort (edit) |
10.1136/ANNRHEUMDIS-2020-217960 |
| 2020-06-11 |
Holding CoVID in check through JAK? The MPN-approved compound ruxolitinib as a potential strategy to treat SARS-CoV-2 induced systemic hyperinflammation (edit) |
10.1038/S41375-020-0898-6 |
| 2020-06-11 |
Hematopoietic stem cell transplantation from an infected SARS-CoV2 donor sibling (edit) |
10.1038/S41409-020-0969-3 |
| 2020-06-11 |
Recurrence of immune thrombocytopenia at the time of SARS-CoV-2 infection (edit) |
10.1007/S00277-020-04130-2 |
| 2020-06-11 |
Do we really need to invoke heroic measures for early SARS-CoV-2 outbreak detection? (edit) |
10.1007/S10654-020-00654-Z |
| 2020-06-11 |
Miller Fisher syndrome diagnosis and treatment in a patient with SARS-CoV-2 (edit) |
10.1007/S13365-020-00858-9 |
| 2020-06-11 |
Natural Products as Potential Leads Against Coronaviruses: Could They be Encouraging Structural Models Against SARS-CoV-2? (edit) |
10.1007/S13659-020-00250-4 |
| 2020-06-11 |
Clinical manifestations and evidence of neurological involvement in 2019 novel coronavirus SARS-CoV-2: a systematic review and meta-analysis (edit) |
10.1007/S00415-020-09974-2 |
| 2020-06-11 |
COVID-19 encephalopathy: detection of antibodies against SARS-CoV-2 in CSF (edit) |
10.1007/S00415-020-09975-1 |
| 2020-06-11 |
The lurking scourge of multidrug resistant Candida auris in times of COVID-19 pandemic (edit) |
10.1016/J.JGAR.2020.06.003 |
| 2020-06-11 |
Low risk for SARS-CoV2 symptomatic infection and early complications in pediatric patients during the ongoing CoVID19 epidemics in Lombardy (edit) |
10.1016/J.CMI.2020.06.006 |
| 2020-06-11 |
Detection of SARS-CoV-2 RNA in fecal specimens of patients with confirmed COVID-19: a meta-analysis (edit) |
10.1016/J.JINF.2020.06.012 |
| 2020-06-11 |
Structural analysis of the putative SARS-CoV-2 primase complex (edit) |
10.1016/J.JSB.2020.107548 |
| 2020-06-11 |
Could sudden sensorineural hearing loss be the sole manifestation of COVID-19? An investigation into SARS-COV-2 in the etiology of sudden sensorineural hearing loss (edit) |
10.1016/J.IJID.2020.06.023 |
| 2020-06-11 |
Multiple assays in a real-time RT-PCR SARS-CoV-2 panel can mitigate the risk of loss of sensitivity by new genomic variants during the COVID-19 outbreak (edit) |
10.1016/J.IJID.2020.06.027 |
| 2020-06-11 |
Efforts to Minimize the Impact of Lockdown on Migrant Workers in India During the COVID-19 Pandemic (edit) |
10.4088/PCC.20COM02648 |
| 2020-06-11 |
Perspective of Medical Students on the COVID-19 Pandemic: A Survey of 9 Medical Schools in Uganda (edit) |
10.2196/19847 |
| 2020-06-11 |
Digital Media's Role in COVID-19 Pandemic (edit) |
10.2196/20156 |
| 2020-06-11 |
Resuming liver transplantation amid the COVID-19 pandemic (edit) |
10.1016/S2468-1253(20)30187-4 |
| 2020-06-11 |
Political casualties of the COVID-19 pandemic (edit) |
10.1016/S1473-3099(20)30496-5 |
| 2020-06-11 |
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study (edit) |
10.1016/S0140-6736(20)31304-0 |
| 2020-06-11 |
Recommendations for head and neck surgical oncology practice in a setting of acute severe resource constraint during the COVID-19 pandemic: an international consensus (edit) |
10.1016/S1470-2045(20)30334-X |
| 2020-06-11 |
Rapid Deployment of Chiropractic Telehealth at 2 Worksite Health Centers in Response to the COVID-19 Pandemic: Observations from the Field (edit) |
10.1016/J.JMPT.2020.05.008 |
| 2020-06-11 |
Rational Perspectives on Risk and Certainty for Dentistry During the COVID-19 Pandemic (edit) |
10.1016/J.AJIC.2020.06.007 |
| 2020-06-11 |
Sequence homology between human PARP14 and the SARS-CoV-2 ADP ribose 1'-phosphatase (edit) |
10.1016/J.IMLET.2020.05.008 |
| 2020-06-11 |
First detection of SARS-CoV-2 by real-time reverse-transcriptase-polymerase-chain-reaction (RT-PCR) assay in pleural fluid (edit) |
10.1016/J.CHEST.2020.05.583 |
| 2020-06-11 |
Global Impact of the COVID-19 Pandemic on Endoscopy: An International Survey of 252 Centers from 55 Countries (edit) |
10.1053/J.GASTRO.2020.06.009 |
| 2020-06-11 |
Guidance for rebooting electrophysiology through the COVID-19 pandemic from the Heart Rhythm Society and the American Heart Association Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology (edit) |
10.1016/J.HRTHM.2020.06.012 |
| 2020-06-11 |
Relative Abundance of SARS-CoV-2 Entry Genes in the Enterocytes of the Lower Gastrointestinal Tract (edit) |
10.3390/GENES11060645 |
| 2020-06-11 |
COVID-19 Infection Diagnosis: Potential Impact of Isothermal Amplification Technology to Reduce Community Transmission of SARS-CoV-2 (edit) |
10.3390/DIAGNOSTICS10060399 |
| 2020-06-11 |
Redefining diabetic foot disease management service during COVID-19 pandemic (edit) |
10.1016/J.DSX.2020.06.023 |
| 2020-06-11 |
Recreational waters - A potential transmission route for SARS-CoV-2 to humans? (edit) |
10.1016/J.SCITOTENV.2020.140122 |
| 2020-06-11 |
Facial Plastic and Reconstructive Surgery During the COVID-19 Pandemic: Implications in Craniomaxillofacial Trauma and Head and Neck Reconstruction (edit) |
10.1097/SAP.0000000000002492 |
| 2020-06-11 |
Learning at home during the COVID-19 pandemic: An initiative of Latin American students (edit) |
10.5867/MEDWAVE.2020.05.7933 |
| 2020-06-11 |
Should we unstress SARS-CoV-2 infected cells? (edit) |
10.1016/J.CYTOGFR.2020.06.011 |
| 2020-06-11 |
Maxillofacial services in the COVID-19 (SARS-CoV-2) pandemic - early lessons from the Italian experience (edit) |
10.1016/J.BJOMS.2020.04.049 |
| 2020-06-11 |
Hydroxychloroquine Proves Ineffective in Hamsters and Macaques Infected with SARS-CoV-2 (edit) |
10.1101/2020.06.10.145144 |
| 2020-06-11 |
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness (edit) |
10.1101/2020.06.11.145920 |
| 2020-06-11 |
Shielding and Beyond: The Roles of Glycans in SARS-CoV-2 Spike Protein (edit) |
10.1101/2020.06.11.146522 |
| 2020-06-11 |
Proteomic Profiling in Biracial Cohorts Implicates DC-SIGN as a Mediator of Genetic Risk in COVID-19 (edit) |
10.1101/2020.06.09.20125690 |
| 2020-06-11 |
SARS-CoV-2 Risk Management in Clinical Psychiatry: A Few Considerations on How to Deal With an Unrivaled Threat (edit) |
10.3389/FPSYT.2020.00550 |
| 2020-06-11 |
[Neonatal apnea as initial manifestation of SARS-CoV-2 infection] (edit) |
10.1016/J.ANPEDI.2020.05.008 |
| 2020-06-11 |
Retrospective search of SARS-CoV-2 in respiratory samples in Vallès Occidental (Barcelona, Spain) before the first case was reported (edit) |
10.1016/J.EIMC.2020.05.019 |
| 2020-06-11 |
Ref. no. DLD-20-852: Onset of ulcerative colitis during SARS-Cov-2 infection (edit) |
10.1016/J.DLD.2020.06.003 |
| 2020-06-11 |
Assessing Immune Response to SARS-CoV-2 Infection (edit) |
10.2147/ITT.S264138 |
| 2020-06-11 |
SARS-CoV-2 (COVID 19) Infection in Hypertensive Patients and in Patients With Cardiac Disease (edit) |
10.7759/CUREUS.8557 |
| 2020-06-11 |
Relevance of SARS-CoV-2 in food safety and food hygiene: potential preventive measures, suggestions and nanotechnological approaches (edit) |
10.1007/S13337-020-00611-0 |
| 2020-06-11 |
Systematic literature review on novel corona virus SARS-CoV-2: a threat to human era (edit) |
10.1007/S13337-020-00604-Z |
| 2020-06-11 |
[Cutaneous drug eruption in a patient infected with SARS-CoV2] (edit) |
10.1016/J.SEMERG.2020.06.005 |
| 2020-06-11 |
ICU decision making based on Living Systematic Review strategy during SARS-CoV-2 pandemic. Results of a prospective case serie (edit) |
10.1016/J.MEDIN.2020.06.001 |
| 2020-06-11 |
On the evolutionary epidemiology of SARS-CoV-2 (edit) |
10.1016/J.CUB.2020.06.031 |
| 2020-06-11 |
Modelling aerosol transport and virus exposure with numerical simulations in relation to SARS-CoV-2 transmission by inhalation indoors (edit) |
10.1016/J.SSCI.2020.104866 |
| 2020-06-11 |
Systematic SARS-CoV-2 screening in cerebrospinal fluid during the COVID-19 pandemic (edit) |
10.1016/S2666-5247(20)30066-5 |
| 2020-06-11 |
Colitis as a Sole Presentation of SARS-CoV-2 Infection: Case Report (edit) |
10.1007/S42399-020-00346-5 |
| 2020-06-11 |
The use of disinfection tunnels or disinfectant spraying of humans as a measure to reduce the spread of the SARS-CoV-2 virus (edit) |
|
| 2020-06-10 |
Electrolyte Disturbances in SARS-CoV-2 Infection (edit) |
10.12688/F1000RESEARCH.24441.2 |
| 2020-06-10 |
Prolonged SARS-CoV-2 Viral Shedding in Patients with COVID-19 was Associated with Delayed Initiation of Arbidol Treatment: a retrospective cohort study (edit) |
10.1101/2020.06.09.20076646 |
| 2020-06-10 |
Disposition of Patients with COVID-19 Infection Whose Respiratory Specimens Remain SARS-CoV-2 PCR-Positive (edit) |
10.1017/ICE.2020.286 |
| 2020-06-10 |
Identification of 22 N-glycosites on spike glycoprotein of SARS-CoV-2 and accessible surface glycopeptide motifs: implications for vaccination and antibody therapeutics (edit) |
10.1093/GLYCOB/CWAA052 |
| 2020-06-10 |
Letter to the Editor: The characteristics of two patients co-infected with SARS-CoV-2 and HIV in Wuhan, China (edit) |
10.1002/JMV.26155 |
| 2020-06-10 |
Are errors in otorhinolaryngology always a sign of medical malpractice? Review of the literature and new perspectives in the SARS-CoV-2 (COVID-19) era (edit) |
10.14639/0392-100X-N0674 |
| 2020-06-10 |
Impact of the SARS-CoV-2 pandemic on health-care workers (edit) |
10.1080/21548331.2020.1771010 |
| 2020-06-10 |
Assessment of SARS-CoV-2 Transmission Among Attendees of Live Concert Events in Japan Using Contact Tracing Data (edit) |
10.1093/JTM/TAAA096 |
| 2020-06-10 |
Structural basis of potential binding mechanism of remdesivir to SARS-CoV-2 RNA dependent RNA polymerase (edit) |
10.1021/ACS.JPCB.0C04198 |
| 2020-06-10 |
Open questions for harnessing autophagy-modulating drugs in the SARS-CoV-2 war: Hope or Hype? (edit) |
10.1080/15548627.2020.1779531 |
| 2020-06-10 |
COVID-19: viral-host interactome analyzed by network based-approach model to study pathogenesis of SARS-CoV-2 infection (edit) |
10.1186/S12967-020-02405-W |
| 2020-06-10 |
Fighting on two fronts: drug-drug interactions in people living with HIV infected with SARS-CoV-2 (edit) |
10.1136/EJHPHARM-2020-002390 |
| 2020-06-10 |
Genomic determinants of pathogenicity in SARS-CoV-2 and other human coronaviruses (edit) |
10.1073/PNAS.2008176117 |
| 2020-06-10 |
SARS-CoV-2 COVID-19 susceptibility and lung inflammatory storm by smoking and vaping (edit) |
10.1186/S12950-020-00250-8 |
| 2020-06-10 |
The 2020 coronavirus lockdown and seismic monitoring of anthropic activities in Northern Italy (edit) |
10.1038/S41598-020-66368-0 |
| 2020-06-10 |
Molecular structure analyses suggest strategies to therapeutically target SARS-CoV-2 (edit) |
10.1038/S41467-020-16779-4 |
| 2020-06-10 |
SARS-CoV-2 downregulation of ACE2 and pleiotropic effects of ACEIs/ARBs (edit) |
10.1038/S41440-020-0488-Z |
| 2020-06-10 |
mRNA Vaccines: Possible Tools to Combat SARS-CoV-2 (edit) |
10.1007/S12250-020-00243-0 |
| 2020-06-10 |
Perceived versus proven SARS-CoV-2-specific immune responses in health-care professionals (edit) |
10.1007/S15010-020-01461-0 |
| 2020-06-10 |
Lithium as a candidate treatment for COVID-19: Promises and pitfalls (edit) |
10.1002/DDR.21701 |
| 2020-06-10 |
Overlapping findings or oral manifestations in new SARS-CoV-2 infection? (edit) |
10.1111/ODI.13478 |
| 2020-06-10 |
[Healthcare, European Stability Mechanism and public funding following the Covid-19 pandemic] (edit) |
|
| 2020-06-10 |
SARS-CoV-2 Infektion bei Kindern und Jugendlichen: Ein Literaturüberblick der AG Infektiologie der ÖGKJ1 (edit) |
10.1007/S00608-020-00794-1 |
| 2020-06-10 |
Investigating the dynamics of COVID-19 pandemic in India under lockdown (edit) |
10.1016/J.CHAOS.2020.109988 |
| 2020-06-10 |
A Guide for Oncologic Patient Management during Covid-19 Pandemic: The Initial Experience of an Italian Oncologic Hub with Exemplificative Focus on Uro-Oncologic Patients (edit) |
10.3390/CANCERS12061513 |
| 2020-06-10 |
Prospects of Replication-Deficient Adenovirus Based Vaccine Development against SARS-CoV-2 (edit) |
10.3390/VACCINES8020293 |
| 2020-06-10 |
Observed and Potential Impacts of the COVID-19 Pandemic on the Environment (edit) |
10.3390/IJERPH17114140 |
| 2020-06-10 |
The Emergence of Risk Communication Networks and the Development of Citizen Health-Related Behaviors during the COVID-19 Pandemic: Social Selection and Contagion Processes (edit) |
10.3390/IJERPH17114148 |
| 2020-06-10 |
COVID-19 Pandemic in the Italian Population: Validation of a Post-Traumatic Stress Disorder Questionnaire and Prevalence of PTSD Symptomatology (edit) |
10.3390/IJERPH17114151 |
| 2020-06-10 |
Broad-Spectrum Host-Based Antivirals Targeting the Interferon and Lipogenesis Pathways as Potential Treatment Options for the Pandemic Coronavirus Disease 2019 (COVID-19) (edit) |
10.3390/V12060628 |
| 2020-06-10 |
The Anticoagulant Nafamostat Potently Inhibits SARS-CoV-2 S Protein-Mediated Fusion in a Cell Fusion Assay System and Viral Infection In Vitro in a Cell-Type-Dependent Manner (edit) |
10.3390/V12060629 |
| 2020-06-10 |
Letter-to-the-Editor: Alternative Interpretation to the Findings Reported in Visualization of SARS-CoV-2 Virus Invading the Human Placenta Using Electron Microscopy (edit) |
10.1016/J.AJOG.2020.06.016 |
| 2020-06-10 |
Right Place, Right Time: Serendipitous Opportunities in a Urology Fellowship Disrupted by the COVID-19 Pandemic (edit) |
10.1016/J.UROLOGY.2020.05.061 |
| 2020-06-10 |
The COVID-19 Pandemic and Tuberculosis in Taiwan (edit) |
10.1016/J.JINF.2020.06.014 |
| 2020-06-10 |
Detection of SARS-CoV-2 in Fecal Samples from Patients with Asymptomatic and Mild COVID-19 in Korea (edit) |
10.1016/J.CGH.2020.06.005 |
| 2020-06-10 |
Impact of the COVID-19 pandemic on the workflow of an ambulatory endoscopy center: an assessment by discrete event simulation (edit) |
10.1016/J.GIE.2020.06.008 |
| 2020-06-10 |
Assessing the risk of dupilumab use for atopic dermatitis during the COVID-19 pandemic (edit) |
10.1016/J.JAAD.2020.06.015 |
| 2020-06-10 |
Outbreak of chilblain-like acral lesions in children in the metropolitan area of Milan, Italy, during the COVID-19 pandemic (edit) |
10.1016/J.JAAD.2020.06.019 |
| 2020-06-10 |
Presence of SARS-CoV-2 RNA in Isolation Ward Environment 28 Days after Exposure (edit) |
10.1016/J.IJID.2020.06.015 |
| 2020-06-10 |
Potential of coronavirus 3C-like protease inhibitors for the development of new anti-SARS-CoV-2 drugs: Insights from structures of protease and inhibitors (edit) |
10.1016/J.IJANTIMICAG.2020.106055 |
| 2020-06-10 |
Severe Acute Respiratory Syndrome Coronavirus -2 (SARS-CoV-2): A global pandemic and treatments strategies (edit) |
10.1016/J.IJANTIMICAG.2020.106054 |
| 2020-06-10 |
Serologic testing of coronaviruses from MERS-CoV to SARS-CoV-2: Learning from the past and anticipating the future (edit) |
10.1016/J.TMAID.2020.101785 |
| 2020-06-10 |
Anti-SARS-CoV-2 hyperimmune plasma workflow (edit) |
10.1016/J.TRANSCI.2020.102850 |
| 2020-06-10 |
Psychotropics drugs with cationic amphiphilic properties may afford some protection against SARS-CoV-2: A mechanistic hypothesis (edit) |
10.1016/J.PSYCHRES.2020.113220 |
| 2020-06-10 |
Current emerging SARS-CoV-2 pandemic: Potential direct/indirect negative impacts of virus persistence and related therapeutic drugs on the aquatic compartments (edit) |
10.1016/J.ENVRES.2020.109808 |
| 2020-06-10 |
A predictive tool for identification of SARS-CoV-2 PCR-negative emergency department patients using routine test results (edit) |
10.1016/J.JCV.2020.104502 |
| 2020-06-10 |
COVID-19 pandemic and associated lockdown as a "Global Human Confinement Experiment" to investigate biodiversity conservation (edit) |
10.1016/J.BIOCON.2020.108665 |
| 2020-06-10 |
A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing Antibodies (edit) |
10.1016/J.CELL.2020.06.011 |
| 2020-06-10 |
Reply to "MRI Evaluation of the Olfactory Clefts in Patients with SARS-CoV-2 Infection Revealed an Unexpected Mechanism for Olfactory Function Loss" (edit) |
10.1016/J.ACRA.2020.05.025 |
| 2020-06-10 |
Clinical characteristics and management of a liver transplanted patient admitted with SARS-CoV-2 infection (edit) |
10.1016/J.CLINRE.2020.05.014 |
| 2020-06-10 |
A Rare Deletion in SARS-CoV-2 ORF6 Dramatically Alters the Predicted Three-Dimensional Structure of the Resultant Protein (edit) |
10.1101/2020.06.09.134460 |
| 2020-06-10 |
The utility of native MS for understanding the mechanism of action of repurposed therapeutics in COVID-19: heparin as a disruptor of the SARS-CoV-2 interaction with its host cell receptor (edit) |
10.1101/2020.06.09.142794 |
| 2020-06-10 |
Morphological Cell Profiling of SARS-CoV-2 Infection Identifies Drug Repurposing Candidates for COVID-19 (edit) |
10.1101/2020.05.27.117184 |
| 2020-06-10 |
SARS-CoV-2 nucleocapsid protein undergoes liquid-liquid phase separation stimulated by RNA and partitions into phases of human ribonucleoproteins (edit) |
10.1101/2020.06.09.141101 |
| 2020-06-10 |
Interferon-Induced Transmembrane Protein (IFITM3) Is Upregulated Explicitly in SARS-CoV-2 Infected Lung Epithelial Cells (edit) |
10.3389/FIMMU.2020.01372 |
| 2020-06-10 |
Data stream dataset of SARS-CoV-2 genome (edit) |
10.1016/J.DIB.2020.105829 |
| 2020-06-10 |
SARS-CoV-2 pandemic and emergency medicine: The worst is yet to come (edit) |
10.1016/J.AJEM.2020.06.014 |
| 2020-06-10 |
High-Throughput Transcription-mediated amplification on the Hologic Panther is a highly sensitive method of detection for SARS-CoV-2 (edit) |
10.1016/J.JCV.2020.104501 |
| 2020-06-10 |
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Induced Cardiovascular Syndrome: Etiology, Outcomes, and Management (edit) |
10.7759/CUREUS.8543 |
| 2020-06-10 |
Presence of mismatches between diagnostic PCR assays and coronavirus SARS-CoV-2 genome (edit) |
10.1098/RSOS.200636 |
| 2020-06-10 |
Guillain-Barré Syndrome in a Patient With Evidence of Recent SARS-CoV-2 Infection (edit) |
10.1016/J.MAYOCP.2020.05.029 |
| 2020-06-10 |
Atypical lymphocyte morphology in SARS-CoV-2 infection (edit) |
10.1016/J.PRP.2020.153063 |
| 2020-06-10 |
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection after allogeneic stem cell transplantation (edit) |
10.1002/CCR3.2984 |
| 2020-06-09 |
SARS-CoV-2 triggered neutrophil extracellular traps (NETs) mediate COVID-19 pathology (edit) |
10.1101/2020.06.08.20125823 |
| 2020-06-09 |
Could injured skin be a reservoir for SARS-CoV-2 virus spread? (edit) |
10.1016/J.CLINDERMATOL.2020.06.004 |
| 2020-06-09 |
Cholesterol 25-hydroxylase suppresses SARS-CoV-2 replication by blocking membrane fusion (edit) |
10.1101/2020.06.08.141077 |
| 2020-06-09 |
ICON (Ivermectin in COvid Nineteen) study: Use of Ivermectin is Associated with Lower Mortality in Hospitalized Patients with COVID19 (edit) |
10.1101/2020.06.06.20124461 |
| 2020-06-09 |
An analysis of SARS-CoV-2 viral load by patient age (edit) |
10.1101/2020.06.08.20125484 |
| 2020-06-09 |
The hypothalamus as a hub for SARS-CoV-2 brain infection and pathogenesis (edit) |
10.1101/2020.06.08.139329 |
| 2020-06-09 |
SARS-CoV-2 placental infection and inflammation leading to fetal distress and neonatal multi-organ failure in an asymptomatic woman (edit) |
10.1101/2020.06.08.20110437 |
| 2020-06-09 |
A cluster of tertiary transmissions of 2019 novel coronavirus (SARS-CoV-2) in the community from infectors with common cold symptoms (edit) |
10.3904/KJIM.2020.122 |
| 2020-06-09 |
Viability of SARS-CoV-2 in faecal bio-aerosols (edit) |
10.1111/CODI.15181 |
| 2020-06-09 |
Postnatal SARS-CoV-2 Infection and Immunological Reaction: A Prospective Family Cohort Study (edit) |
10.1111/PAI.13302 |
| 2020-06-09 |
Anti-A Isohemagglutinin titers and SARS-CoV2 neutralization: implications for children and convalescent plasma selection (edit) |
10.1111/BJH.16932 |
| 2020-06-09 |
SARS-CoV-2 Infection and High-Risk Non-Muscle-Invasive Bladder Cancer: Are There Any Common Features? (edit) |
10.1159/000509065 |
| 2020-06-09 |
Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2 (edit) |
10.1038/S41586-020-2423-5 |
| 2020-06-09 |
Successful implementation of preventive measures leads to low relevance of SARS-CoV-2 in liver transplant patients: Observations from a German outpatient department (edit) |
10.1111/TID.13363 |
| 2020-06-09 |
Persistent Smell Loss Following Undetectable SARS-CoV-2 (edit) |
10.1177/0194599820934769 |
| 2020-06-09 |
Guillain-Barré syndrome associated with leptomeningeal enhancement following SARS-CoV-2 infection (edit) |
10.7861/CLINMED.2020-0213 |
| 2020-06-09 |
Sofosbuvir as a potential alternative to treat the SARS-CoV-2 epidemic (edit) |
10.1038/S41598-020-66440-9 |
| 2020-06-09 |
Immune Responses to SARS-CoV, MERS-CoV and SARS-CoV-2 (edit) |
10.1007/5584_2020_549 |
| 2020-06-09 |
Self-Reported Loss of Smell and Taste in SARS-CoV-2 Patients: Primary Care Data to Guide Future Early Detection Strategies (edit) |
10.1007/S11606-020-05933-9 |
| 2020-06-09 |
The possible protective role of α-synuclein against the SARS-CoV-2 infections in patients with Parkinson's disease (edit) |
10.1002/MDS.28185 |
| 2020-06-09 |
Prolonged SARS-CoV-2 shedding and mild course of COVID-19 in a patient after recent heart transplantation (edit) |
10.1111/AJT.16133 |
| 2020-06-09 |
Analysis of the Hosts and Transmission Paths of SARS-CoV-2 in the COVID-19 Outbreak (edit) |
10.3390/GENES11060637 |
| 2020-06-09 |
Immunoinformatics and Structural Analysis for Identification of Immunodominant Epitopes in SARS-CoV-2 as Potential Vaccine Targets (edit) |
10.3390/VACCINES8020290 |
| 2020-06-09 |
Laboratory Biosafety Considerations of SARS-CoV-2 at Biosafety Level 2 (edit) |
10.1089/HS.2020.0021 |
| 2020-06-09 |
Could Water and Sanitation Shortfalls Exacerbate SARS-CoV-2 Transmission Risks? (edit) |
10.4269/AJTMH.20-0462 |
| 2020-06-09 |
The impact of the COVID-19 pandemic on patients with OCD: Effects of contamination symptoms and remission state before the quarantine in a preliminary naturalistic study (edit) |
10.1016/J.PSYCHRES.2020.113213 |
| 2020-06-09 |
Vaginal delivery in COVID-19 pregnant women: anorectum as a potential alternative route of SARS-CoV-2 transmission (edit) |
10.1016/J.AJOG.2020.06.012 |
| 2020-06-09 |
Protecting the Homeless During The COVID-19 Pandemic (edit) |
10.1016/J.CHEST.2020.05.577 |
| 2020-06-09 |
Role of the GTNGTKR motif in the N-terminal receptor-binding domain of the SARS-CoV-2 spike protein (edit) |
10.1016/J.VIRUSRES.2020.198058 |
| 2020-06-09 |
Will the guidelines and recommendations for surgery during COVID-19 pandemic still be valid if it becomes endemic? (edit) |
10.1016/J.IJSU.2020.06.011 |
| 2020-06-09 |
Expression of SARS-CoV-2 Receptor ACE2 and Coincident Host Response Signature Varies by Asthma Inflammatory Phenotype (edit) |
10.1016/J.JACI.2020.05.051 |
| 2020-06-09 |
Reflection on SARS-CoV-2 infection of container ship seafarers (edit) |
10.1016/J.TMAID.2020.101787 |
| 2020-06-09 |
Survey of Academic US Programs Regarding the Impact of the COVID-19 Pandemic on Clinical Practice, Education and Research in Neurosurgery (edit) |
10.1016/J.WNEU.2020.06.028 |
| 2020-06-09 |
Clinical evaluation of serological IgG antibody response on the Abbott Architect for established SARS-CoV-2 infection (edit) |
10.1016/J.CMI.2020.05.036 |
| 2020-06-09 |
Suggestions from Cremona, Italy - two months into the pandemic at the frontline of COVID-19 in Europe (edit) |
10.1016/J.CMI.2020.05.038 |
| 2020-06-09 |
COVID-19 Pandemic and Nationwide Lockdown - Implications of the Double Trouble on Radiotherapy Practice in India (edit) |
10.1016/J.CLON.2020.06.004 |
| 2020-06-09 |
Adjuvant Systemic Anti-cancer Therapy in Early Breast Cancer During the COVID-19 Pandemic: Differences between Clinicians and Patients in Perception of Treatment Risks and Benefits (edit) |
10.1016/J.CLON.2020.06.001 |
| 2020-06-09 |
Screening and druggability analysis of some plant metabolites against SARS-CoV-2: An integrative computational approach (edit) |
10.1016/J.IMU.2020.100367 |
| 2020-06-09 |
COVID-19, a pandemic that affects more than just physical health: Two case reports (edit) |
10.1016/J.AJP.2020.102200 |
| 2020-06-09 |
The Surgical Health Services Research Agenda for the COVID-19 Pandemic (edit) |
10.1097/SLA.0000000000004126 |
| 2020-06-09 |
Developing an Algorithm to Guide Resumption of Operative Activity in the COVID-19 Pandemic and Beyond (edit) |
10.1097/SLA.0000000000004123 |
| 2020-06-09 |
Electrocautery, Diathermy, and Surgical Energy Devices: Are Surgical Teams at Risk During the COVID-19 Pandemic? (edit) |
10.1097/SLA.0000000000004112 |
| 2020-06-09 |
Position Statement of Transplant activity in the Middle East in era of COVID-19 Pandemic (edit) |
10.1097/TP.0000000000003348 |
| 2020-06-09 |
Diagnostic utility of additional whole-chest CT as part of an acute abdominal pain CT imaging pathway during the COVID-19 pandemic (edit) |
10.1016/J.CRAD.2020.06.002 |
| 2020-06-09 |
Potential dual dengue and SARS-CoV-2 infection in Thailand: A case study (edit) |
10.1016/J.HELIYON.2020.E04175 |
| 2020-06-09 |
Variability between testing methods for SARS-CoV-2 nucleic acid detection 16 days post-discharge: a case report (edit) |
10.1515/CCLM-2020-0328 |
| 2020-06-09 |
Increased susceptibility of SARS-CoV2 infection on oral cancer patients; cause and effects: An hypothesis (edit) |
10.1016/J.MEHY.2020.109987 |
| 2020-06-09 |
The future of neurorehabilitation after the SARS-CoV-2 pandemic (edit) |
10.1016/J.NRL.2020.06.003 |
| 2020-06-09 |
SARS-CoV-2 infection among asymptomatic homebound subjects in Milan, Italy (edit) |
10.1016/J.EJIM.2020.06.010 |
| 2020-06-09 |
Fate of respiratory droplets in tropical vs temperate environments and implications for SARS-CoV-2 transmission (edit) |
10.1016/J.MEHY.2020.109958 |
| 2020-06-09 |
Structural basis of a public antibody response to SARS-CoV-2 (edit) |
10.1101/2020.06.08.141267 |
| 2020-06-09 |
Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses (edit) |
10.1101/2020.06.08.140871 |
| 2020-06-09 |
Relationship between Anti-Spike Protein Antibody Titers and SARS-CoV-2 In Vitro Virus Neutralization in Convalescent Plasma (edit) |
10.1101/2020.06.08.138990 |
| 2020-06-09 |
Quantifying the prevalence of SARS-CoV-2 long-term shedding among non-hospitalized COVID-19 patients (edit) |
10.1101/2020.06.02.20120774 |
| 2020-06-09 |
Sex differences in immune responses to SARS-CoV-2 that underlie disease outcomes (edit) |
10.1101/2020.06.06.20123414 |
| 2020-06-09 |
Longitudinal Surveillance for SARS-CoV-2 RNA Among Asymptomatic Staff in Five Colorado Skilled Nursing Facilities: Epidemiologic, Virologic and Sequence Analysis (edit) |
10.1101/2020.06.08.20125989 |
| 2020-06-09 |
Intestinal Flora as a Potential Strategy to Fight SARS-CoV-2 Infection (edit) |
10.3389/FMICB.2020.01388 |
| 2020-06-09 |
Could Sex/Gender Differences in ACE2 Expression in the Lungs Contribute to the Large Gender Disparity in the Morbidity and Mortality of Patients Infected With the SARS-CoV-2 Virus? (edit) |
10.3389/FCIMB.2020.00327 |
| 2020-06-09 |
Transmission of SARS-CoV-2, Required Developments in Research and Associated Public Health Concerns (edit) |
10.3389/FMED.2020.00310 |
| 2020-06-09 |
Analysis of Possible Intermediate Hosts of the New Coronavirus SARS-CoV-2 (edit) |
10.3389/FVETS.2020.00379 |
| 2020-06-09 |
Crystal Structure of the SARS-CoV-2 Non-structural Protein 9, Nsp9 (edit) |
10.1016/J.ISCI.2020.101258 |
| 2020-06-09 |
[Pituitary tumor resection in a patient with SARS-CoV-2 (COVID-19) infection. A case report and suggested airway management guidelines] (edit) |
10.1016/J.BJAN.2020.06.001 |
| 2020-06-09 |
Otorhinolaryngologists and the SARS-CoV-2 virus (edit) |
10.4045/TIDSSKR.20.0423 |
| 2020-06-09 |
Identification of potential inhibitors of three key enzymes of SARS-CoV2 using computational approach (edit) |
10.1016/J.COMPBIOMED.2020.103848 |
| 2020-06-09 |
Temperature in Nursing Home Residents Systematically Tested for SARS-CoV-2 (edit) |
10.1016/J.JAMDA.2020.06.009 |
| 2020-06-09 |
SARS-CoV2 drives JAK1/2-dependent local and systemic complement hyper-activation (edit) |
10.21203/RS.3.RS-33390/V1 |
| 2020-06-09 |
Efficient production of recombinant SARS-CoV-2 spike protein using the baculovirus-silkworm system (edit) |
10.1016/J.BBRC.2020.06.020 |
| 2020-06-09 |
Genome sequencing and the diagnosis of novel coronavirus (SARS-COV-2) in Africa: how far are we? (edit) |
|
| 2020-06-09 |
Potential chimeric peptides to block the SARS-CoV-2 spike receptor-binding domain (edit) |
10.12688/F1000RESEARCH.24074.1 |
| 2020-06-08 |
Air and environmental sampling for SARS-CoV-2 around hospitalized patients with coronavirus disease 2019 (COVID-19) (edit) |
10.1017/ICE.2020.282 |
| 2020-06-08 |
Cross-sectional evaluation of humoral responses against SARS-CoV-2 Spike (edit) |
10.1101/2020.06.08.140244 |
| 2020-06-08 |
A call for the appropriate application of clinical pharmacological principles in the search for safe and efficacious COVID-19 (SARS-COV-2) treatments (edit) |
10.1111/BCP.14416 |
| 2020-06-08 |
Clinical performance of different SARS-CoV-2 IgG antibody tests (edit) |
10.1002/JMV.26145 |
| 2020-06-08 |
Long-term and herd immunity against SARS-CoV-2: implications from current and past knowledge (edit) |
10.1093/FEMSPD/FTAA025 |
| 2020-06-08 |
Single-cell RNA analysis on ACE2 expression provides insights into SARS-CoV-2 potential entry into the bloodstream and heart injury (edit) |
10.1002/JCP.29802 |
| 2020-06-08 |
SARS-COV-2 and Male Reproductive Health (edit) |
10.5935/1518-0557.20200047 |
| 2020-06-08 |
Decoding SARS-CoV-2 Hijacking of Host Mitochondria in Pathogenesis of COVID-19 (edit) |
10.1152/AJPCELL.00224.2020 |
| 2020-06-08 |
COVID-19 Interview: Dr. Belgin Eroğlu Kesim on Women in Science Advancing SARS-CoV-2 Tests-"One Health" and Changing the World for the Better (edit) |
10.1089/OMI.2020.0090 |
| 2020-06-08 |
Effect of Environmental Conditions on SARS-CoV-2 Stability in Human Nasal Mucus and Sputum (edit) |
10.3201/EID2609.202267 |
| 2020-06-08 |
Remote Rehabilitation Conferences in the Age of SARS-CoV-2 (edit) |
10.1097/PHM.0000000000001498 |
| 2020-06-08 |
SARS-CoV-2-Related Inflammatory Multisystem Syndrome in Children: Different or Shared Etiology and Pathophysiology as Kawasaki Disease? (edit) |
10.1001/JAMA.2020.10370 |
| 2020-06-08 |
Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2 (edit) |
10.1001/JAMA.2020.10369 |
| 2020-06-08 |
SARS-CoV-2: what is known and what there is to know. Focus on coagulation and lipids (edit) |
10.1111/ECI.13311 |
| 2020-06-08 |
Rapid In-Vitro Inactivation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Using Povidone-Iodine Oral Antiseptic Rinse (edit) |
10.1111/JOPR.13209 |
| 2020-06-08 |
Uncovering psychobehavioral implications of SARS-CoV-2 infection in Iran (edit) |
10.1111/TBED.13662 |
| 2020-06-08 |
Neutrophil Elastase Inhibitors: A potential prophylactic treatment option for SARS-CoV-2-induced respiratory complications? (edit) |
10.1186/S13054-020-03023-0 |
| 2020-06-08 |
The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study pr (edit) |
10.1186/S13063-020-04421-Z |
| 2020-06-08 |
A pilot study of therapeutic plasma exchange for serious SARS CoV-2 disease (COVID-19): A structured summary of a randomized controlled trial study protocol (edit) |
10.1186/S13063-020-04454-4 |
| 2020-06-08 |
Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial (edit) |
10.1186/S13063-020-04422-Y |
| 2020-06-08 |
Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population based cohort study (edit) |
10.1136/BMJ.M2107 |
| 2020-06-08 |
Suramin inhibits SARS-CoV-2 infection in cell culture by interfering with early steps of the replication cycle (edit) |
10.1128/AAC.00900-20 |
| 2020-06-08 |
Clinical Performance of SARS-CoV-2 Molecular Testing (edit) |
10.1128/JCM.00995-20 |
| 2020-06-08 |
Performance Characteristics of Four High-Throughput Immunoassays for Detection of IgG Antibodies against SARS-CoV-2 (edit) |
10.1128/JCM.01243-20 |
| 2020-06-08 |
Genomic surveillance reveals multiple introductions of SARS-CoV-2 into Northern California (edit) |
10.1126/SCIENCE.ABB9263 |
| 2020-06-08 |
Antibody signature induced by SARS-CoV-2 spike protein immunogens in rabbits (edit) |
10.1126/SCITRANSLMED.ABC3539 |
| 2020-06-08 |
Dissecting antibody-mediated protection against SARS-CoV-2 (edit) |
10.1038/S41577-020-0359-5 |
| 2020-06-08 |
Myocarditis in the era of SARS-CoV-2: one piece of a complex puzzle? (edit) |
10.1007/S00059-020-04949-5 |
| 2020-06-08 |
The potential of drug repositioning as a short-term strategy for the control and treatment of COVID-19 (SARS-CoV-2): a systematic review (edit) |
10.1007/S00705-020-04693-5 |
| 2020-06-08 |
[Biological therapy after COVID-19 infection : No reactivation of a COVID-19 infection with positive SARS-CoV-2 antibody status under biological therapy] (edit) |
10.1007/S00393-020-00824-0 |
| 2020-06-08 |
Evaluation of the EDI enzyme linked immunosorbent assays for the detection of SARS-CoV-2 IgM and IgG antibodies in human plasma (edit) |
10.1016/J.CCA.2020.05.047 |
| 2020-06-08 |
SARS-COV-2 infection: Across the border into the family (edit) |
10.1016/J.TMAID.2020.101784 |
| 2020-06-08 |
Evaluation of Chemical Protocols for Inactivating SARS-CoV-2 Infectious Samples (edit) |
10.3390/V12060624 |
| 2020-06-08 |
2019-nCoV: Measures Adopted at the Departments of Oral Surgery and Radiology during the Period of an Uncontrolled Transmission Increase (edit) |
10.3390/DJ8020057 |
| 2020-06-08 |
Diet Supplementation, Probiotics, and Nutraceuticals in SARS-CoV-2 Infection: A Scoping Review (edit) |
10.3390/NU12061718 |
| 2020-06-08 |
SARS-CoV-2 infection in patients with autoimmune rheumatic diseases in northeast Italy: A cross-sectional study on 916 patients (edit) |
10.1016/J.JAUT.2020.102502 |
| 2020-06-08 |
Annex #1 as of 8 June 2020 to: Management of SARS-CoV-2 infection: recommendations of the Polish Association of Epidemiologists and Infectiologists as of March 31, 2020 (edit) |
10.20452/PAMW.15424 |
| 2020-06-08 |
Multiplexing primer/probe sets for detection of SARS-CoV-2 by qRT-PCR (edit) |
10.1016/J.JCV.2020.104499 |
| 2020-06-08 |
Psychological distress in the shadow of the COVID-19 pandemic: Preliminary development of an assessment scale (edit) |
10.1016/J.PSYCHRES.2020.113202 |
| 2020-06-08 |
COVID-19 online surveys need to follow standards and guidelines: Comment on "does COVID-19 pandemic affect sexual behavior? A cross-sectional, cross-national online survey" and "binge watching behavior during COVID 19 pandemic: A cross-sectional, cr (edit) |
10.1016/J.PSYCHRES.2020.113211 |
| 2020-06-08 |
Ethics for surgeons during the COVID-19 pandemic, review article (edit) |
10.1016/J.AMSU.2020.06.003 |
| 2020-06-08 |
The Effect of Shelter-in-Place Orders and the COVID-19 Pandemic on Orthopaedic Trauma at a Community Level II Trauma Center (edit) |
10.1097/BOT.0000000000001860 |
| 2020-06-08 |
Vascularized Composite Allotransplantation in a Post-COVID-19 Pandemic World (edit) |
10.1097/PRS.0000000000007231 |
| 2020-06-08 |
The COVID-19 Pandemic: Implications for Medical Students and Plastic Surgery Residency Applicants (edit) |
10.1097/PRS.0000000000007232 |
| 2020-06-08 |
The COVID-19 Pandemic: Crisis Management for Plastic Surgeons (edit) |
10.1097/PRS.0000000000007230 |
| 2020-06-08 |
Forecasting the spread of the COVID-19 pandemic in Saudi Arabia using ARIMA prediction model under current public health interventions (edit) |
10.1016/J.JIPH.2020.06.001 |
| 2020-06-08 |
Guillain-Barré syndrome associated with SARS-CoV-2 infection. Comments after 16 published cases (edit) |
10.1016/J.NRL.2020.06.002 |
| 2020-06-08 |
Analysis of a SARS-CoV-2-Infected Individual Reveals Development of Potent Neutralizing Antibodies with Limited Somatic Mutation (edit) |
10.1016/J.IMMUNI.2020.06.001 |
| 2020-06-08 |
Detection of SARS-CoV-2 by bronchoscopy after negative nasopharyngeal testing: Stay vigilant for COVID-19 (edit) |
10.1016/J.RMCR.2020.101120 |
| 2020-06-08 |
Occult SARS-CoV-2 infection; a possible hypothesis for viral relapse (edit) |
10.1016/J.MEHY.2020.109980 |
| 2020-06-08 |
Effective Inhibition of SARS-CoV-2 Entry by Heparin and Enoxaparin Derivatives (edit) |
10.1101/2020.06.08.140236 |
| 2020-06-08 |
SARS-CoV-2-specific T cells exhibit unique features characterized by robust helper function, lack of terminal differentiation, and high proliferative potential (edit) |
10.1101/2020.06.08.138826 |
| 2020-06-08 |
Broad and strong memory CD4 + and CD8 + T cells induced by SARS-CoV-2 in UK convalescent COVID-19 patients (edit) |
10.1101/2020.06.05.134551 |
| 2020-06-08 |
Policy Implications of an Approximate Linear Infection Model for SARS-CoV-2 (edit) |
10.1101/2020.06.04.20122549 |
| 2020-06-08 |
Evaluation of rapid antigen test for detection of SARS-CoV-2 virus (edit) |
10.1016/J.JCV.2020.104500 |
| 2020-06-08 |
Lack of Association Between Genetic Variants at ACE2 and TMPRSS2 Genes Involved in SARS-CoV-2 Infection and Human Quantitative Phenotypes (edit) |
10.3389/FGENE.2020.00613 |
| 2020-06-08 |
Pulse immunosuppressive therapy for multiple sclerosis during the SARS-CoV-2 lockdown de-escalation plan: Safety algorithm (edit) |
10.1016/J.NRL.2020.06.001 |
| 2020-06-08 |
Insights into Potential Mechanisms of Injury and Treatment Targets in COVID-19, SARS-Cov-2 Infection (edit) |
10.15344/2456-8007/2020/147 |
| 2020-06-08 |
Bioinformatics studies on a function of the SARS-CoV-2 spike glycoprotein as the binding of host sialic acid glycans (edit) |
10.1016/J.COMPBIOMED.2020.103849 |
| 2020-06-08 |
Genetic variants that influence SARS-CoV-2 receptor TMPRSS2 expression among population cohorts from multiple continents (edit) |
10.1016/J.BBRC.2020.05.179 |
| 2020-06-08 |
Identification of SARS-CoV-2 Vaccine Epitopes Predicted to Induce Long-Term Population-Scale Immunity (edit) |
10.1016/J.XCRM.2020.100036 |
| 2020-06-08 |
Stability and neutralising capacity of SARS-CoV-2-specific antibodies in convalescent plasma (edit) |
10.1016/S2666-5247(20)30037-9 |
| 2020-06-08 |
Optimising SARS-CoV-2 pooled testing for low-resource settings (edit) |
10.1016/S2666-5247(20)30056-2 |
| 2020-06-08 |
Impact of SARS-CoV-2 infection in patients with cystic fibrosis in Spain: Incidence and results of the national CF-COVID19-Spain survey (edit) |
10.1016/J.RMED.2020.106062 |
| 2020-06-07 |
Neuropilin-1 facilitates SARS-CoV-2 cell entry and provides a possible pathway into the central nervous system (edit) |
10.1101/2020.06.07.137802 |
| 2020-06-07 |
Occurrence and Timing of Subsequent SARS-CoV-2 RT-PCR Positivity Among Initially Negative Patients (edit) |
10.1093/CID/CIAA722 |
| 2020-06-07 |
SARS-CoV-2 containment in complex surgical units during the COVID-19 pandemic (edit) |
10.1002/BJS.11727 |
| 2020-06-07 |
SARS-CoV-2 outbreak and lockdown in a Northern Italy hospital. Comparison with Scandinavian no-lockdown country (edit) |
10.1111/ECI.13302 |
| 2020-06-07 |
Emerging viral mutants in Australia suggest RNA recombination event in the SARS-CoV-2 genome (edit) |
10.5694/MJA2.50657 |
| 2020-06-07 |
SARS-COV-2 children transmission: the evidence is that today we do not have enough evidence (edit) |
10.1111/APA.15396 |
| 2020-06-07 |
The origin and underlying driving forces of the SARS-CoV-2 outbreak (edit) |
10.1186/S12929-020-00665-8 |
| 2020-06-07 |
Association between time from SARS-CoV-2 onset to case confirmation and time to recovery across sociodemographic strata in Singapore (edit) |
10.1136/JECH-2020-214516 |
| 2020-06-07 |
Silibinin and SARS-CoV-2: Dual Targeting of Host Cytokine Storm and Virus Replication Machinery for Clinical Management of COVID-19 Patients (edit) |
10.3390/JCM9061770 |
| 2020-06-07 |
Burnout syndrome in Romanian medical residents in time of the COVID-19 pandemic (edit) |
10.1016/J.MEHY.2020.109972 |
| 2020-06-07 |
How the COVID-19 Pandemic Is Reshaping the Trade Landscape and What to Do About It (edit) |
10.1007/S10272-020-0890-4 |
| 2020-06-07 |
High mortality rate in cancer patients with symptoms of COVID-19 with or without detectable SARS-COV-2 on RT-PCR (edit) |
10.1016/J.EJCA.2020.05.028 |
| 2020-06-07 |
Maternal postnatal health during the COVID-19 pandemic: Vigilance is needed (edit) |
10.1016/J.MIDW.2020.102781 |
| 2020-06-07 |
Persistence of SARS-CoV-2 virus RNA in feces: A case series of children (edit) |
10.1016/J.JIPH.2020.05.025 |
| 2020-06-07 |
Deceiving SARS-CoV-2 molecular-tropism clues - A combinational contemporary strategy (edit) |
10.1016/J.MEHY.2020.109976 |
| 2020-06-07 |
Early-Morning vs Spot Posterior Oropharyngeal Saliva for Diagnosis of SARS-CoV-2 Infection: Implication of Timing of Specimen Collection for Community-Wide Screening (edit) |
10.1093/OFID/OFAA210 |
| 2020-06-07 |
Serology confirms SARS-CoV-2 infection in PCR-negative children presenting with Paediatric Inflammatory Multi-System Syndrome (edit) |
10.1101/2020.06.05.20123117 |
| 2020-06-06 |
Involvement in Catalonia of the Anaesthesiology and Resuscitation Services in the SARS-CoV-2 pandemic. A real, cost-effective solution to an unprecedented health crisis (edit) |
10.1016/J.REDAR.2020.05.013 |
| 2020-06-06 |
Can the SARS-CoV-2 PCR Cycle Threshold Value and Time from Symptom Onset to Testing Predict Infectivity? (edit) |
10.1093/CID/CIAA735 |
| 2020-06-06 |
Propagation, Inactivation, and Safety Testing of SARS-CoV-2 (edit) |
10.3390/V12060622 |
| 2020-06-06 |
First documentation of persistent SARS-CoV-2 infection presenting with late acute severe myocarditis (edit) |
10.1016/J.CJCA.2020.06.005 |
| 2020-06-06 |
Clinical features of discharged COVID-19 patients with an extended SARS-CoV-2 RNA positive signal in respiratory samples (edit) |
10.1016/J.VIRUSRES.2020.198047 |
| 2020-06-06 |
Treatment of SARS-CoV-2 with high dose oral zinc salts: A report on four patients (edit) |
10.1016/J.IJID.2020.06.006 |
| 2020-06-06 |
Evaluation of an Electrostatic Spray Disinfectant Technology for Rapid Decontamination of Portable Equipment and Large Open Areas in the Era of SARS-CoV-2 (edit) |
10.1016/J.AJIC.2020.06.002 |
| 2020-06-06 |
Outbreak of SARS-CoV2: Pathogenesis of infection and cardiovascular involvement (edit) |
10.1016/J.HJC.2020.05.007 |
| 2020-06-06 |
Preventing SARS-CoV-2 transmission in rehabilitation pools and therapeutic water environments (edit) |
10.1016/J.JHIN.2020.06.003 |
| 2020-06-06 |
Guidelines and recommendations during the COVID-19 pandemic: A word of caution (edit) |
10.1016/J.AMJSURG.2020.06.005 |
| 2020-06-06 |
A chilblain epidemic during the COVID-19 pandemic. A sign of natural resistance to SARS-CoV-2? (edit) |
10.1016/J.MEHY.2020.109959 |
| 2020-06-06 |
Review of practical recommendations for otolaryngologists and head and neck surgeons during the COVID-19 pandemic (edit) |
10.1016/J.ANL.2020.05.022 |
| 2020-06-06 |
Influence of age and gender on arrival of patients with ST-segment elevation acute myocardial infarction to tertiary centers during COVID-19 pandemic. Experience of Madrid, Spain, STEMI network (Codigo Infarto Madrid) (edit) |
10.1016/J.AJEM.2020.06.013 |
| 2020-06-06 |
Re: 'Non-COVID-19 visits to emergency departments during the pandemic: the impact of fear' (edit) |
10.1016/J.PUHE.2020.05.063 |
| 2020-06-06 |
"Possible protective role of contact Lens against SARS COV 2" (edit) |
10.1016/J.JFO.2020.05.004 |
| 2020-06-06 |
Verapamil as treatment for refractory status epilepticus secondary to PRES syndrome on a SARS-Cov-2 infected patient (edit) |
10.1016/J.SEIZURE.2020.06.008 |
| 2020-06-06 |
SARS-CoV-2 infection in cancer patients undergoing active treatment: analysis of clinical features and predictive factors for severe respiratory failure and death (edit) |
10.1016/J.EJCA.2020.06.001 |
| 2020-06-06 |
Assessing the application of a pseudovirus system for emerging SARS-CoV-2 and re-emerging avian influenza virus H5 subtypes in vaccine development (edit) |
10.1016/J.BJ.2020.06.003 |
| 2020-06-06 |
COVID-19 as a confounding factor in a child submitted to staged surgical palliation of hypoplastic left heart syndrome: One of the first reports of SARS-CoV-2 infection in patients with congenital heart disease (edit) |
10.1016/J.JTCVS.2020.05.081 |
| 2020-06-06 |
Prevalence of SARS-CoV-2 infection in general practitioners and nurses in primary care and nursing homes in the Healthcare Area of León and associated factors (edit) |
10.1016/J.SEMERG.2020.05.014 |
| 2020-06-06 |
Famotidine Against SARS-CoV2: A Hope or Hype? (edit) |
10.1016/J.MAYOCP.2020.05.027 |
| 2020-06-06 |
Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2 (edit) |
10.1016/J.CELL.2020.06.008 |
| 2020-06-05 |
Concealed SARS-CoV-2 interstitial pneumonia unmasked by infarct-like acute myocarditis (edit) |
10.1093/EHJCR/YTAA158 |
| 2020-06-05 |
Potential Role of Oral Rinses Targeting the Viral Lipid Envelope in SARS-CoV-2 Infection (edit) |
10.1093/FUNCTION/ZQAA002 |
| 2020-06-05 |
SARS-CoV-2 proteases cleave IRF3 and critical modulators of inflammatory pathways (NLRP12 and TAB1): implications for disease presentation across species and the search for reservoir hosts (edit) |
10.1101/2020.06.05.135699 |
| 2020-06-05 |
Neuropilin-1 is a host factor for SARS-CoV-2 infection (edit) |
10.1101/2020.06.05.134114 |
| 2020-06-05 |
SARS-CoV-2 genomic and subgenomic RNAs in diagnostic samples are not an indicator of active replication (edit) |
10.1101/2020.06.01.20119750 |
| 2020-06-05 |
SARS-CoV-2/COVID-19 and physical distancing: risk for circadian rhythm dysregulation, advice to alleviate it, and natural experiment research opportunities (edit) |
10.1080/07420528.2020.1772811 |
| 2020-06-05 |
Risk estimation of the SARS-CoV-2 acute respiratory disease outbreak outside China (edit) |
10.1186/S12976-020-00127-6 |
| 2020-06-05 |
SARS-CoV-2 (COVID-19) Vaccine Development and Production: An Ethical Way Forward (edit) |
10.1017/S096318012000047X |
| 2020-06-05 |
The influence of the SARS-CoV-2 pandemic on esophagogastric cancer services: an international survey of esophagogastric surgeons (edit) |
10.1093/DOTE/DOAA054 |
| 2020-06-05 |
SARS-CoV-2 and dentistry (edit) |
10.1007/S00784-020-03381-7 |
| 2020-06-05 |
Repurposing Nimesulide, a Potent Inhibitor of the B0AT1 Subunit of the SARS-CoV-2 Receptor, as a Therapeutic Adjuvant of COVID-19 (edit) |
10.1177/2472555220934421 |
| 2020-06-05 |
Serum concentrations of interleukin-6 (IL-6) in the general adult population: possible implications for anti-IL-6 therapy in SARS-Cov-2 infection and IL-6-related diseases (edit) |
10.18176/JIACI.0601 |
| 2020-06-05 |
Failed antibody response in a renal transplant recipient with SARS-CoV-2 infected (edit) |
10.1111/TID.13349 |
| 2020-06-05 |
First detection and genome sequencing of SARS-CoV-2 in an infected cat in France (edit) |
10.1111/TBED.13659 |
| 2020-06-05 |
Venous thromboembolism in patients with COVID-19 (SARS-CoV-2 infection) - a position paper of the German Society of Angiology (DGA) (edit) |
10.1024/0301-1526/A000885 |
| 2020-06-05 |
Identification of nsp1 gene as the target of SARS-CoV-2 real-time RT-PCR using nanopore whole genome sequencing (edit) |
10.1002/JMV.26140 |
| 2020-06-05 |
Cholesterol: A new game player accelerating endothelial injuries caused by SARS-CoV-2? (edit) |
10.1152/AJPENDO.00255.2020 |
| 2020-06-05 |
Exposure to SARS-CoV-2 in a high transmission setting increases the risk of severe COVID-19 compared to exposure to a low transmission setting? (edit) |
10.1093/JTM/TAAA094 |
| 2020-06-05 |
SARS-CoV-2 as a trigger of neurodegeneration: thinking ahead (edit) |
10.1002/MDS.28178 |
| 2020-06-05 |
SARS-CoV2 as a potential trigger of neurodegenerative diseases (edit) |
10.1002/MDS.28179 |
| 2020-06-05 |
Rheumatic diseases during pregnancy and SARS-CoV-2: An appeal for medication adherence (edit) |
10.1002/IJGO.13255 |
| 2020-06-05 |
Emerging evidence to support not always "Just saying no" to SARS-CoV-2 positive donors (edit) |
10.1111/AJT.16119 |
| 2020-06-05 |
False Negative Tests for SARS-CoV-2 Infection - Challenges and Implications (edit) |
10.1056/NEJMP2015897 |
| 2020-06-05 |
Challenges faced by patients with morphea in the era of SARS-CoV-2 (edit) |
10.1080/09546634.2020.1775771 |
| 2020-06-05 |
SARS-CoV-2 infection in pregnant women: are there long-term effects in offspring's brain development? (edit) |
10.23736/S0026-4784.20.04598-0 |
| 2020-06-05 |
Vertical Transmission of SARS-CoV-2: What is the Optimal Definition? (edit) |
10.1055/S-0040-1712457 |
| 2020-06-05 |
Management of Care for Neonates Born to SARS-CoV-2 Positive Women with or without Clinical Symptoms (COVID-19) (edit) |
10.1055/A-1168-2845 |
| 2020-06-05 |
Miller-Fisher syndrome after SARS-CoV-2 infection (edit) |
10.1111/ENE.14383 |
| 2020-06-05 |
A systematic review of neurological manifestations of SARS-CoV-2 infection: the devil is hidden in the details (edit) |
10.1111/ENE.14382 |
| 2020-06-05 |
Multi-Center Evaluation of the Cepheid Xpert Xpress SARS-CoV-2 Assay for the Detection of SARS-CoV-2 in Oropharyngeal Swab Specimens (edit) |
10.1128/JCM.01288-20 |
| 2020-06-05 |
EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2 (edit) |
10.1136/ANNRHEUMDIS-2020-217877 |
| 2020-06-05 |
Enhanced receptor binding of SARS-CoV-2 through networks of hydrogen-bonding and hydrophobic interactions (edit) |
10.1073/PNAS.2008209117 |
| 2020-06-05 |
Implications of antibody-dependent enhancement of infection for SARS-CoV-2 countermeasures (edit) |
10.1038/S41587-020-0577-1 |
| 2020-06-05 |
Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China (edit) |
10.1038/S41591-020-0949-6 |
| 2020-06-05 |
Immune evasion via SARS-CoV-2 ORF8 protein? (edit) |
10.1038/S41577-020-0360-Z |
| 2020-06-05 |
SARS-CoV-2 cross-reactivity in healthy donors (edit) |
10.1038/S41577-020-0362-X |
| 2020-06-05 |
SARS-CoV-2 infection in infants under 1 year of age in Wuhan City, China (edit) |
10.1007/S12519-020-00368-Y |
| 2020-06-05 |
Efficacy of Almitrine in The Treatment of Hypoxemia in Sars-Cov-2 Acute Respiratory Distress Syndrome (edit) |
10.1016/J.CHEST.2020.05.573 |
| 2020-06-05 |
IgG Antibody Response to SARS-CoV-2 Infection and Viral RNA Persistence in Patients on Maintenance Hemodialysis (edit) |
10.1053/J.AJKD.2020.05.009 |
| 2020-06-05 |
SARS-CoV-2 RNA from droplets to faeces: a new focus for proctologists. Correspondence (edit) |
10.1016/J.IJSU.2020.05.087 |
| 2020-06-05 |
A Preliminary Investigation on the Statistical Correlations between SARS-CoV-2 Spread and Local Meteorology (edit) |
10.3390/IJERPH17114051 |
| 2020-06-05 |
Could anticoagulation therapy prior to SARS-CoV-2 infection prevent complications and the need for mechanical ventilation? (edit) |
10.23736/S0026-4806.20.06672-0 |
| 2020-06-05 |
Simulating social distancing measures in household and close contact transmission of SARS-CoV-2 (edit) |
10.1590/0102-311X00099920 |
| 2020-06-05 |
AusDiagnostics SARS-CoV-2 kits shown to be more sensitive than reference laboratory test (edit) |
10.1016/J.JCV.2020.104485 |
| 2020-06-05 |
A Snapshot from the Department of Urology in Bergamo Evaluating the Timeline of the SARS-CoV-2 Outbreak: Which Patients Are We Missing? (edit) |
10.1016/J.EUF.2020.05.022 |
| 2020-06-05 |
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Mimicking as Pulmonary Tuberculosis in an Inmate (edit) |
10.7759/CUREUS.8464 |
| 2020-06-05 |
Smoking and SARS-CoV-2: Are Polish health professionals at higher risk of infection? (edit) |
10.18332/TID/122760 |
| 2020-06-05 |
Intersecting Pandemics: Impact of SARS-CoV-2 (COVID-19) Protective Behaviors on People Living with HIV, Atlanta, Georgia (edit) |
10.1097/QAI.0000000000002414 |
| 2020-06-05 |
RAGE receptor: May be a potential inflammatory mediator for SARS-COV-2 infection? (edit) |
10.1016/J.MEHY.2020.109950 |
| 2020-06-05 |
Intra-abdominal hypertension as a trigger of "gut failure" in SARS-CoV-2 infection: Effect of open abdomen (OA) and negative pressure therapy (NPT) on respiratory and gastrointestinal (GI) function (edit) |
10.1016/J.MEHY.2020.109954 |
| 2020-06-05 |
A Systematic Review on Guidelines and Recommendations for Urology Standard of Care During the COVID-19 Pandemic (edit) |
10.1016/J.EUF.2020.05.020 |
| 2020-06-05 |
Combating sars-cov-2 through lipoxins, proteasome, caveolin and nuclear factor-κb pathways in non-pregnant and pregnant populations (edit) |
|
| 2020-06-05 |
Projections for COVID-19 pandemic in India and effect of temperature and humidity (edit) |
10.1016/J.DSX.2020.05.045 |
| 2020-06-05 |
Emergency implementation of telemedicine for epilepsy in Spain: Results of a survey during SARS-CoV-2 pandemic (edit) |
10.1016/J.YEBEH.2020.107211 |
| 2020-06-05 |
Virtudes y dificultades en los test diagnósticos de la infección por el SARS-CoV-2 (edit) |
10.1016/J.MEDCLI.2020.05.019 |
| 2020-06-05 |
New evidences that discard the possible vertical transmission of SARS-CoV-2 during pregnancy (edit) |
10.1016/J.MEDCLI.2020.05.021 |
| 2020-06-05 |
Pearls to Pivoting a Multidisciplinary Prostate Cancer Survivorship Program During the COVID-19 Pandemic (edit) |
10.1016/J.EUO.2020.05.008 |
| 2020-06-05 |
Does the maternal-fetal transmission of SARS-CoV-2 occur during pregnancy? (edit) |
10.1016/J.RCE.2020.06.001 |
| 2020-06-05 |
[Impact of the pandemic COVID-19 in andrology. Recommendations in daily clinical practice] (edit) |
10.1016/J.ANDROL.2020.05.001 |
| 2020-06-05 |
Computational analysis of microRNA-mediated interactions in SARS-CoV-2 infection (edit) |
10.7717/PEERJ.9369 |
| 2020-06-05 |
[Contact tracing in patients infected with SARS-CoV-2. The fundamental role of Primary Health Care and Public Health] (edit) |
10.1016/J.SEMERG.2020.06.001 |
| 2020-06-05 |
Insights on cross-species transmission of SARS-CoV-2 from structural modeling (edit) |
10.1101/2020.06.05.136861 |
| 2020-06-05 |
Reparations for Black American Descendants of Persons Enslaved in the U.S. and Their Estimated Impact on SARS-CoV-2 Transmission (edit) |
10.1101/2020.06.04.20112011 |
| 2020-06-05 |
Combination of Ruxolitinib and Eculizumab for Treatment of Severe SARS-CoV-2-Related Acute Respiratory Distress Syndrome: A Controlled Study (edit) |
10.3389/FPHAR.2020.00857 |
| 2020-06-05 |
Disentangling the Hypothesis of Host Dysosmia and SARS-CoV-2: The Bait Symptom That Hides Neglected Neurophysiological Routes (edit) |
10.3389/FPHYS.2020.00671 |
| 2020-06-05 |
Main Clinical Features of COVID-19 and Potential Prognostic and Therapeutic Value of the Microbiota in SARS-CoV-2 Infections (edit) |
10.3389/FMICB.2020.01302 |
| 2020-06-05 |
SARS-CoV-2 Genome Analysis of Japanese Travelers in Nile River Cruise (edit) |
10.3389/FMICB.2020.01316 |
| 2020-06-05 |
The Lung Macrophage in SARS-CoV-2 Infection: A Friend or a Foe? (edit) |
10.3389/FIMMU.2020.01312 |
| 2020-06-05 |
ACE2, Much More Than Just a Receptor for SARS-COV-2 (edit) |
10.3389/FCIMB.2020.00317 |
| 2020-06-05 |
The Use of Microbial Accessible and Fermentable Carbohydrates and/or Butyrate as Supportive Treatment for Patients With Coronavirus SARS-CoV-2 Infection (edit) |
10.3389/FMED.2020.00292 |
| 2020-06-05 |
Activity and Health During the SARS-CoV2 Pandemic (ASAP): Study Protocol for a Multi-National Network Trial (edit) |
10.3389/FMED.2020.00302 |
| 2020-06-05 |
Is the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) present intraperitoneally in patients with coronavirus disease 2019 (COVID-19) infection undergoing emergency operations? (edit) |
10.1016/J.SURG.2020.05.033 |
| 2020-06-05 |
[Possible protective factors of SARS-CoV-2 infection in a vulnerable patient: Report of a case] (edit) |
10.1016/J.SEMERG.2020.05.013 |
| 2020-06-05 |
Inanimate surfaces as potential source of 2019-nCoV spread and their disinfection with biocidal agents (edit) |
10.1007/S13337-020-00603-0 |
| 2020-06-05 |
Control of SARS-CoV-2 transmission in orthodontic practice (edit) |
10.1016/J.AJODO.2020.05.006 |
| 2020-06-05 |
2019-nCoV Outbreak Declared as Public Health Emergency of International Concern: What Next? (edit) |
10.4103/IJPVM.IJPVM_63_20 |
| 2020-06-05 |
Comparison of virus concentration methods for the RT-qPCR-based recovery of murine hepatitis virus, a surrogate for SARS-CoV-2 from untreated wastewater (edit) |
10.1016/J.SCITOTENV.2020.139960 |
| 2020-06-05 |
SARS-CoV-2 Fulminant Myocarditis (edit) |
10.1016/J.JACCAS.2020.05.060 |
| 2020-06-04 |
The Zinc Finger Antiviral Protein restricts SARS-CoV-2 (edit) |
10.1101/2020.06.04.134379 |
| 2020-06-04 |
Olfactory transmucosal SARS-CoV-2 invasion as port of Central Nervous System entry in COVID-19 patients (edit) |
10.1101/2020.06.04.135012 |
| 2020-06-04 |
Targeting SARS-CoV-2 using polycomb inhibitors as antiviral agents (edit) |
10.2217/EPI-2020-0154 |
| 2020-06-04 |
Influence of diabetes mellitus on the severity and fatality of SARS-CoV-2 infection (edit) |
10.1111/DOM.14105 |
| 2020-06-04 |
Analysis of the causes of moral injury in the outbreak of 2019-nCoV (edit) |
10.1037/TRA0000720 |
| 2020-06-04 |
SARS-CoV-2 Human Challenge Trials: Too Risky, Too Soon (edit) |
10.1093/INFDIS/JIAA314 |
| 2020-06-04 |
Universal screening for SARS-CoV-2 in asymptomatic obstetric patients in Tokyo, Japan (edit) |
10.1002/IJGO.13252 |
| 2020-06-04 |
Distribution of ACE2, CD147, CD26 and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors (edit) |
10.1111/ALL.14429 |
| 2020-06-04 |
Experimental Aerosol Survival of SARS-CoV-2 in Artificial Saliva and Tissue Culture Media at Medium and High Humidity (edit) |
10.1080/22221751.2020.1777906 |
| 2020-06-04 |
In silico veritas? Potential limitations for SARS-CoV-2 vaccine development based on T-cell epitope prediction (edit) |
10.1371/JOURNAL.PPAT.1008607 |
| 2020-06-04 |
On setting expectations for a SARS-CoV-2 Vaccine (edit) |
10.1093/CID/CIAA726 |
| 2020-06-04 |
Neutralizing Antibodies Responses to SARS-CoV-2 in COVID-19 Inpatients and Convalescent Patients (edit) |
10.1093/CID/CIAA721 |
| 2020-06-04 |
Providing a laboratory diagnostic service for pandemic SARS-CoV-2 in a developing country (edit) |
10.1093/TRSTMH/TRAA037 |
| 2020-06-04 |
The natural history and transmission potential of asymptomatic SARS-CoV-2 infection (edit) |
10.1093/CID/CIAA711 |
| 2020-06-04 |
COVID-19 polyradiculitis in 24 patients without SARS-CoV-2 in the cerebro-spinal fluid (edit) |
10.1002/JMV.26121 |
| 2020-06-04 |
Comment on "Genetic variants and source of introduction of SARS-CoV-2 in South America" (edit) |
10.1002/JMV.26122 |
| 2020-06-04 |
Increasing Host Cellular Receptor-Angiotensin-Converting Enzyme 2 (ACE2) Expression by Coronavirus may Facilitate 2019-nCoV (or SARS-CoV-2) Infection (edit) |
10.1002/JMV.26139 |
| 2020-06-04 |
Letter to the Editor: A Missing Link between SARS-CoV-2 and the Eye?: ACE2 Expression on the Ocular Surface (edit) |
10.1002/JMV.26136 |
| 2020-06-04 |
NANDA-I, NOC, and NIC Linkages to SARS-Cov-2 (Covid-19): Part 1. Community Response (edit) |
10.1111/2047-3095.12291 |
| 2020-06-04 |
Utility of lateral flow tests in SARS-CoV-2 infection monitorization (edit) |
10.37201/REQ/052.2020 |
| 2020-06-04 |
Neonates Hospitalized with Community-Acquired SARS-CoV-2 in a Colorado Neonatal Intensive Care Unit (edit) |
10.1159/000508962 |
| 2020-06-04 |
Involvement of interleukin 6 in SARS-CoV-2 infection: siltuximab as a therapeutic option against COVID-19 (edit) |
10.1136/EJHPHARM-2020-002322 |
| 2020-06-04 |
Complete Genome Sequence of a SARS-CoV-2 Strain Isolated in Northern Germany (edit) |
10.1128/MRA.00520-20 |
| 2020-06-04 |
Autoimmune and inflammatory diseases following COVID-19 (edit) |
10.1038/S41584-020-0448-7 |
| 2020-06-04 |
Dying with SARS-CoV-2 infection-an autopsy study of the first consecutive 80 cases in Hamburg, Germany (edit) |
10.1007/S00414-020-02317-W |
| 2020-06-04 |
Antiphospholipid antibodies in patient with acute lower member ischemia and pulmonary thromboembolism as a result of infection by SARS-CoV2 (edit) |
10.1007/S10067-020-05194-1 |
| 2020-06-04 |
Induced Pluripotent Stem Cells (iPSCs) Derived 3D Human Lung Organoids from Different Ethnicities to Understand the SARS-CoV2 Severity/Infectivity Percentage (edit) |
10.1007/S12015-020-09989-2 |
| 2020-06-04 |
SARS-Coronavirus-2 Nsp13 Possesses NTPase and RNA Helicase Activities That Can Be Inhibited by Bismuth Salts (edit) |
10.1007/S12250-020-00242-1 |
| 2020-06-04 |
An Exit Strategy for Resuming Non-Emergency Neurosurgery after SARS-CoV-2: a UK Perspective (edit) |
10.1016/J.WNEU.2020.05.246 |
| 2020-06-04 |
Molecular analysis of several in-house rRT-PCR protocols for SARS-CoV-2 detection in the context of genetic variability of the virus in Colombia (edit) |
10.1016/J.MEEGID.2020.104390 |
| 2020-06-04 |
Global Coronavirus Pandemic (SARS CoV-2): Past, Present, And Future Of Pediatric Dermatology (edit) |
10.1111/DTH.13767 |
| 2020-06-04 |
SARS-CoV-2 antibody characterization in emergency department, hospitalized and convalescent patients by two semi-quantitative immunoassays (edit) |
10.1016/J.CCA.2020.06.004 |
| 2020-06-04 |
Healthcare Personnel Exposure to a Patient with Asymptomatic SARS-CoV2 Infection during a Prolonged Surgical Intervention (edit) |
10.1016/J.AJIC.2020.05.036 |
| 2020-06-04 |
Patients with COVID-19 and neurological manifestations show undetectable SARS-CoV-2 RNA levels in the cerebrospinal fluid (edit) |
10.1016/J.IJID.2020.05.123 |
| 2020-06-04 |
[Recommendations for a gradual and controlled resumption of electroconvulsive therapy in France during the period of lifting of the containment and of the COVID-19 pandemic linked to SARS-CoV-2] (edit) |
10.1016/J.ENCEP.2020.05.008 |
| 2020-06-04 |
Gastrointestinal Bleeding in Patients with Severe SARS-CoV-2 (edit) |
10.14309/AJG.0000000000000719 |
| 2020-06-04 |
Public Health Emergency and Crisis Management: Case Study of SARS-CoV-2 Outbreak (edit) |
10.3390/IJERPH17113984 |
| 2020-06-04 |
The Prediction of miRNAs in SARS-CoV-2 Genomes: hsa-miR Databases Identify 7 Key miRs Linked to Host Responses and Virus Pathogenicity-Related KEGG Pathways Significant for Comorbidities (edit) |
10.3390/V12060614 |
| 2020-06-04 |
Multimorbidity and SARS-CoV-2 infection in UK Biobank (edit) |
10.1016/J.DSX.2020.06.003 |
| 2020-06-04 |
SARS-CoV-2 in upper and lower airway samples of a laryngectomized patient: New insights and many lessons (edit) |
10.1016/J.ORALONCOLOGY.2020.104841 |
| 2020-06-04 |
Letter to the Editor on "Bonafè M, Prattichizzo F, Giuliani A, Storci G, Sabbatinelli J, Olivieri F. Inflamm-aging: Why older men are the most susceptible to SARS-CoV-2 complicated outcomes. Cytokine Growth Factor Rev" (edit) |
10.1016/J.CYTOGFR.2020.06.002 |
| 2020-06-04 |
Pancreatic involvement in SARS-CoV-2: case report and living review (edit) |
10.15403/JGLD-2618 |
| 2020-06-04 |
Pandemics and social stigma: Who's next? Italy's experience with COVID-19 (edit) |
10.1016/J.PUHE.2020.05.054 |
| 2020-06-04 |
Could we benefit from oral self-examination during the COVID-19 pandemic? (edit) |
10.1016/J.ORALONCOLOGY.2020.104840 |
| 2020-06-04 |
Obesity prolongs the hospital stay in patients affected by COVID-19, and may impact on SARS-COV-2 shedding (edit) |
10.1016/J.ORCP.2020.05.009 |
| 2020-06-04 |
COVID-19 vaccine development: Time to consider SARS-CoV-2 challenge studies? (edit) |
10.1016/J.VACCINE.2020.06.007 |
| 2020-06-04 |
A nonlinear epidemiological model considering asymptotic and quarantine classes for SARS CoV-2 virus (edit) |
10.1016/J.CHAOS.2020.109953 |
| 2020-06-04 |
The continued epidemic threat of SARS-CoV-2 and implications for the future of global public health (edit) |
10.1016/J.COVIRO.2020.05.010 |
| 2020-06-04 |
Human iPSC-derived alveolar and airway epithelial cells can be cultured at air-liquid interface and express SARS-CoV-2 host factors (edit) |
10.1101/2020.06.03.132639 |
| 2020-06-04 |
SARS-CoV2 Testing: The Limit of Detection Matters (edit) |
10.1101/2020.06.02.131144 |
| 2020-06-04 |
Landscape and Selection of Vaccine Epitopes in SARS-CoV-2 (edit) |
10.1101/2020.06.04.135004 |
| 2020-06-04 |
Detection of asymptomatic SARS-CoV-2 exposed individuals by a sensitive S-based ELISA (edit) |
10.1101/2020.06.02.20120477 |
| 2020-06-04 |
Laboratory Testing Methods for Novel Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) (edit) |
10.3389/FCELL.2020.00468 |
| 2020-06-04 |
Can Lung Ultrasound be Used to Screen for Pulmonary Embolism in Patients with SARS-CoV-2 Pneumonia? (edit) |
10.12890/2020_001748 |
| 2020-06-03 |
Seroprevalence of SARS-CoV-2 in Hong Kong and in residents evacuated from Hubei province, China: a multicohort study (edit) |
10.1016/S2666-5247(20)30053-7 |
| 2020-06-03 |
Preparing to Perform Trauma and Orthopaedic Surgery on Patients with COVID-19 (edit) |
10.2106/JBJS.20.00454 |
| 2020-06-03 |
Guidelines for Ambulatory Surgery Centers for the Care of Surgically Necessary/Time-Sensitive Orthopaedic Cases during the COVID-19 Pandemic (edit) |
10.2106/JBJS.20.00489 |
| 2020-06-03 |
Prevalence of SARS-CoV-2 Antibodies Among Healthcare Workers at a Tertiary Academic Hospital in New York City (edit) |
10.1007/S11606-020-05926-8 |
| 2020-06-03 |
The case for routine screening for SARS-CoV-2 before surgery (edit) |
10.1007/S12630-020-01730-4 |
| 2020-06-03 |
Thromboinflammatory response in SARS-CoV-2 sepsis (edit) |
10.1177/0025817220926915 |
| 2020-06-03 |
SARS-CoV-2 more than a respiratory virus: Its potential role in neuropathogenesis (edit) |
10.1021/ACSCHEMNEURO.0C00251 |
| 2020-06-03 |
Prevalence of Asymptomatic SARS-CoV-2 Infection: A Narrative Review (edit) |
10.7326/M20-3012 |
| 2020-06-03 |
SARS-CoV-2 RNA Detection on Disposable Wooden Chopsticks, Hong Kong (edit) |
10.3201/EID2609.202135 |
| 2020-06-03 |
Effectiveness of N95 Respirator Decontamination and Reuse against SARS-CoV-2 Virus (edit) |
10.3201/EID2609.201524 |
| 2020-06-03 |
The Importance of Advancing SARS-CoV-2 Vaccines in Children (edit) |
10.1093/CID/CIAA712 |
| 2020-06-03 |
Utilising Point of Care Diagnostics to Minimise Nosocomial Infection in the 2019 Novel Coronavirus (SARS-CoV-2) Pandemic (edit) |
10.1093/QJMED/HCAA185 |
| 2020-06-03 |
First case of acute pancreatitis related to SARS-CoV-2 infection (edit) |
10.1002/BJS.11741 |
| 2020-06-03 |
Evidence for mutations in SARS-CoV-2 Italian isolates potentially affecting virus transmission (edit) |
10.1002/JMV.26104 |
| 2020-06-03 |
A case of SARS-CoV-2 infection in an untreated HIV patient in Tokyo, Japan (edit) |
10.1002/JMV.26102 |
| 2020-06-03 |
Potential Neuroinvasive Pathways of SARS-CoV-2: Deciphering the Spectrum of Neurological Deficit Seen in Coronavirus Disease 2019 (COVID-19) (edit) |
10.1002/JMV.26105 |
| 2020-06-03 |
Functional prediction and frequency of coding variants in human ACE2 at binding sites with SARS-CoV-2 spike protein on different populations (edit) |
10.1002/JMV.26126 |
| 2020-06-03 |
High-Coverage SARS-CoV-2 Genome Sequences Acquired by Target Capture Sequencing (edit) |
10.1002/JMV.26116 |
| 2020-06-03 |
Direct endothelial damage and vasculitis due to SARS-CoV-2 in small bowel submucosa of CoViD-19 patient with diarrhea (edit) |
10.1002/JMV.26119 |
| 2020-06-03 |
Structural variations and expression profiles of the SARS-CoV-2 host invasion genes in Lung cancer (edit) |
10.1002/JMV.26107 |
| 2020-06-03 |
Understanding the possible origin and genotyping of first Bangladeshi SARS-CoV-2 strain (edit) |
10.1002/JMV.26115 |
| 2020-06-03 |
''Determining Host Factors Contributing to Disease Severity in a Family Cluster of 29 Hospitalized SARS-CoV-2 Patients: Could Genetic Factors Be Relevant in the Clinical Course of COVID-19?'' (edit) |
10.1002/JMV.26106 |
| 2020-06-03 |
Tocilizumab Administration in Patients with SARS-CoV-2 Infection: Subcutaneous Injection versus Intravenous Infusion (edit) |
10.1002/JMV.26124 |
| 2020-06-03 |
Re-test Positive for SARS-CoV-2 RNA of "Recovered" Patients with COVID-19: Persistence, Sampling issues, or Re-infection? (edit) |
10.1002/JMV.26114 |
| 2020-06-03 |
Shielding for patients using a single-use vinyl-box under continuous aerosol suction to minimize SARS-CoV-2 transmission during emergency endoscopy (edit) |
10.1111/DEN.13713 |
| 2020-06-03 |
Swabs Collected by Patients or Health Care Workers for SARS-CoV-2 Testing (edit) |
10.1056/NEJMC2016321 |
| 2020-06-03 |
COVID and Coagulation: Bleeding and Thrombotic Manifestations of SARS-CoV2 Infection (edit) |
10.1182/BLOOD.2020006520 |
| 2020-06-03 |
[SARS-CoV-2 infection (COVID-19): what can we expect?] (edit) |
10.1055/A-1114-3699 |
| 2020-06-03 |
Diagnostic Performance of a Rapid Point of Care Test for SARS-CoV-2 in an Urban ED Setting (edit) |
10.1111/ACEM.14039 |
| 2020-06-03 |
Expression of Receptors for SARS-CoV-2 in the Gut of Patients with Inflammatory Bowel Disease (edit) |
10.5009/GNL20112 |
| 2020-06-03 |
[Delivery of oral health in andalusian health service on the de-escalation of SARS-CoV-2] (edit) |
|
| 2020-06-03 |
A randomized multicenter clinical trial to evaluate the efficacy of melatonin in the prophylaxis of SARS-CoV-2 infection in high-risk contacts (MeCOVID Trial): A structured summary of a study protocol for a randomised controlled trial (edit) |
10.1186/S13063-020-04436-6 |
| 2020-06-03 |
Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a ran (edit) |
10.1186/S13063-020-04446-4 |
| 2020-06-03 |
Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised con (edit) |
10.1186/S13063-020-04400-4 |
| 2020-06-03 |
SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines (edit) |
10.1186/S12967-020-02392-Y |
| 2020-06-03 |
Efficacy and safety of antiviral treatment for COVID-19 from evidence in studies of SARSCoV-2 and other acute viral infections: a systematic review and meta-analysis (edit) |
10.1503/CMAJ.200647 |
| 2020-06-03 |
Diagnostic testing for SARS-CoV-2 (edit) |
10.1503/CMAJ.200858 |
| 2020-06-03 |
Pre-Procedural Surveillance Testing for SARS-CoV-2 in an Asymptomatic Population in the Seattle Region Shows Low Rates of Positivity (edit) |
10.1128/JCM.01193-20 |
| 2020-06-03 |
Procedures for Flow Cytometry-Based Sorting of Unfixed Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infected Cells and Other Infectious Agents (edit) |
10.1002/CYTO.A.24040 |
| 2020-06-03 |
Risk of SARS-CoV-2 infection and disease in metastatic triple-negative breast cancer patients treated with immune checkpoint inhibitors (edit) |
10.2217/IMT-2020-0142 |
| 2020-06-03 |
Comprehensive investigation of an in-hospital transmission cluster of a symptomatic SARS-CoV-2-positive physician among patients and healthcare workers in Germany (edit) |
10.1017/ICE.2020.268 |
| 2020-06-03 |
Contamination of FFP3 masks with SARS-COV-2 during endotracheal intubation (edit) |
10.1017/ICE.2020.269 |
| 2020-06-03 |
Mission command: applying principles of military leadership to the SARS-CoV-2 (COVID-19) crisis: more than just 'mission command' (edit) |
10.1136/BMJMILITARY-2020-001525 |
| 2020-06-03 |
Detection of SARS-CoV-2 antibodies using commercial assays and seroconversion patterns in hospitalized patients (edit) |
10.1016/J.JINF.2020.05.077 |
| 2020-06-03 |
Comparison of SARS-CoV-2 detection in nasopharyngeal swab and saliva (edit) |
10.1016/J.JINF.2020.05.071 |
| 2020-06-03 |
SARS-CoV-2 infection, clinical features and outcome of COVID-19 in United Kingdom nursing homes (edit) |
10.1016/J.JINF.2020.05.073 |
| 2020-06-03 |
High SARS-CoV-2 Antibody Prevalence among Healthcare Workers Exposed to COVID-19 Patients (edit) |
10.1016/J.JINF.2020.05.067 |
| 2020-06-03 |
SARS-CoV-2 RNA detection in tears and conjunctival secretions of COVID-19 patients with conjunctivitis (edit) |
10.1016/J.JINF.2020.05.070 |
| 2020-06-03 |
Temperature-dependent surface stability of SARS-CoV-2 (edit) |
10.1016/J.JINF.2020.05.074 |
| 2020-06-03 |
Protective role of ACE2 and its downregulation in SARS-CoV-2 infection leading to Macrophage Activation Syndrome: Therapeutic implications (edit) |
10.1016/J.LFS.2020.117905 |
| 2020-06-03 |
Optimizing high-yield production of SARS-CoV-2 soluble spike trimers for serology assays (edit) |
10.1016/J.PEP.2020.105686 |
| 2020-06-03 |
Homogeneous circle-to-circle amplification for real-time optomagnetic detection of SARS-CoV-2 RdRp coding sequence (edit) |
10.1016/J.BIOS.2020.112356 |
| 2020-06-03 |
Neonatal SARS-CoV-2 infection (edit) |
10.6061/CLINICS/2020/E1996 |
| 2020-06-03 |
SARS-Cov-2 and environmental protection: A collective psychology agenda for environmental psychology research (edit) |
10.1016/J.JENVP.2020.101444 |
| 2020-06-03 |
Clinical Insights for Gastroenterology and Hepatology Providers during the COVID-19 Pandemic (edit) |
10.15403/JGLD-2603 |
| 2020-06-03 |
Real-time reverse transcription loop-mediated isothermal amplification for rapid detection of SARS-CoV-2 (edit) |
10.7717/PEERJ.9278 |
| 2020-06-03 |
Prisoners in a pandemic: We should think about detainees during Covid-19 outbreak (edit) |
10.1016/J.FSISYN.2020.05.004 |
| 2020-06-03 |
SARS-CoV-2: diagnostic and design conundrums in the context of male factor infertility (edit) |
10.1016/J.RBMO.2020.05.014 |
| 2020-06-03 |
[Therapeutic dilemmas in SARS-CoV-2 disease, a challenge for geriatrics] (edit) |
10.1016/J.REGG.2020.05.003 |
| 2020-06-03 |
[Evolution and treatment of storm cytoquine syndrome associated to SARS-CoV-2 infection among octogenarians] (edit) |
10.1016/J.REGG.2020.05.004 |
| 2020-06-03 |
Sarbecovirus comparative genomics elucidates gene content of SARS-CoV-2 and functional impact of COVID-19 pandemic mutations (edit) |
10.1101/2020.06.02.130955 |
| 2020-06-03 |
Highly multiplexed oligonucleotide probe-ligation testing enables efficient extraction-free SARS-CoV-2 detection and viral genotyping (edit) |
10.1101/2020.06.03.130591 |
| 2020-06-03 |
Molecular Insights Into SARS COV-2 Interaction With Cardiovascular Disease: Role of RAAS and MAPK Signaling (edit) |
10.3389/FPHAR.2020.00836 |
| 2020-06-03 |
Rapid Antibody Testing for SARS-CoV-2 in Asymptomatic and Paucisymptomatic Healthcare Professionals in Hematology and Oncology Units Identifies Undiagnosed Infections (edit) |
10.1097/HS9.0000000000000408 |
| 2020-06-03 |
[The role of children in the transmission of SARS-CoV-2] (edit) |
|
| 2020-06-03 |
[Suspected sepsis in a 10-week-old infant and SARS-CoV-2 detection in cerebrospinal fluid and pharynx] (edit) |
10.1007/S00112-020-00942-8 |
| 2020-06-02 |
The ABO blood group locus and a chromosome 3 gene cluster associate with SARS-CoV-2 respiratory failure in an Italian-Spanish genome-wide association analysis (edit) |
10.1101/2020.05.31.20114991 |
| 2020-06-02 |
Zoonotic risk of SARS-COV-2 (edit) |
10.12968/COAN.2020.0049 |
| 2020-06-02 |
Potential for developing a SARS-CoV receptor-binding domain (RBD) recombinant protein as a heterologous human vaccine against coronavirus infectious disease (COVID)-19 (edit) |
10.1080/21645515.2020.1740560 |
| 2020-06-02 |
SARS-CoV-2 Infection in Health Care Workers: Cross-sectional Analysis of an Otolaryngology Unit (edit) |
10.1177/0194599820932162 |
| 2020-06-02 |
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a review (edit) |
10.1186/S12943-020-01218-1 |
| 2020-06-02 |
SARS-CoV-2 serology: Test, test, test, but interpret with caution! (edit) |
10.7861/CLINMED.2020-0170 |
| 2020-06-02 |
Asymptomatic SARS-CoV-2 Transmission from Community Contacts in Healthcare Workers (edit) |
10.1097/SLA.0000000000003968 |
| 2020-06-02 |
Management of nutritional consultations in local clinics during SARS-CoV-2 pandemic (edit) |
10.23736/S1121-421X.20.02716-6 |
| 2020-06-02 |
Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms (edit) |
10.1007/S00011-020-01370-W |
| 2020-06-02 |
Asymptomatic carriage and transmission of SARS-CoV-2: What do we know? (edit) |
10.1007/S12630-020-01729-X |
| 2020-06-02 |
SARS-CoV-2: a potential trigger for subacute thyroiditis? Insights from a case report (edit) |
10.1007/S40618-020-01312-7 |
| 2020-06-02 |
The Faith Community and the SARS-CoV-2 Outbreak: Part of the Problem or Part of the Solution? (edit) |
10.1007/S10943-020-01048-X |
| 2020-06-02 |
Science, Religion, Government, and SARS-CoV-2: A Time for Synergy (edit) |
10.1007/S10943-020-01047-Y |
| 2020-06-02 |
Hand Eczema Pandemic Caused by SARS-CoV-2 Hygiene Measures: The Setup of a Hand Eczema Helpline for Hospital Personnel (edit) |
10.1111/JDV.16695 |
| 2020-06-02 |
Clinical Performance of the Roche SARS-CoV-2 Serologic Assay (edit) |
10.1093/CLINCHEM/HVAA132 |
| 2020-06-02 |
Clinical performance of the Elecsys electrochemiluminescent immunoassay for the detection of SARS-CoV-2 total antibodies (edit) |
10.1093/CLINCHEM/HVAA131 |
| 2020-06-02 |
Potential pitfalls of routine SARS-CoV-2 serology for mass screening (edit) |
10.1002/JMV.26034 |
| 2020-06-02 |
Amplification of human β-glucoronidase gene for appraising the accuracy of negative SARS-CoV-2 RT-PCR results in upper respiratory tract specimens (edit) |
10.1002/JMV.26112 |
| 2020-06-02 |
Clearance and Persistence of SARS-CoV-2 RNA in COVID-19 patients (edit) |
10.1002/JMV.26103 |
| 2020-06-02 |
The association between severe or death COVID-19 and autoimmune disease: a systematic review and meta-analysis (edit) |
10.1016/J.JINF.2020.05.065 |
| 2020-06-02 |
SARS-CoV-2: is the liver merely a bystander to severe disease? (edit) |
10.1016/J.JHEP.2020.05.035 |
| 2020-06-02 |
Co-expression of SARS-CoV-2 entry genes in the superficial adult human conjunctival, limbal and corneal epithelium suggests an additional route of entry via the ocular surface (edit) |
10.1016/J.JTOS.2020.05.013 |
| 2020-06-02 |
Excretion of Sars-Cov-2 in human breastmilk samples (edit) |
10.1016/J.CMI.2020.05.027 |
| 2020-06-02 |
New onset anosmia and ageusia in adult patients diagnosed with SARS-CoV-2 (edit) |
10.1016/J.CMI.2020.05.026 |
| 2020-06-02 |
Exploring the genomic and proteomic variations of SARS-CoV-2 spike glycoprotein: A computational biology approach (edit) |
10.1016/J.MEEGID.2020.104389 |
| 2020-06-02 |
SARS-CoV-2 (Covid-19): Interferon-epsilon may be responsible of decreased mortality in females (edit) |
10.1016/J.JRI.2020.103154 |
| 2020-06-02 |
COVID-19: A pandemic with positive and negative outcomes on resource and waste flows and stocks (edit) |
10.1016/J.RESCONREC.2020.104979 |
| 2020-06-02 |
Establishment of a safety protocol for the administration of treatments in multiple sclerosis during the SARS-CoV-2 pandemic (edit) |
10.1016/J.MSARD.2020.102244 |
| 2020-06-02 |
Re: 'Rapid point-of-care testing for SARS-CoV-2 in a community screening setting shows low sensitivity' (edit) |
10.1016/J.PUHE.2020.05.048 |
| 2020-06-02 |
Direct diagnostic testing of SARS-CoV-2 without the need for prior RNA extraction (edit) |
10.1101/2020.05.28.20115220 |
| 2020-06-02 |
Detection of SARS-CoV-2 neutralizing antibodies with a cell-free PCR assay (edit) |
10.1101/2020.05.28.20105692 |
| 2020-06-02 |
Exhaled breath is a significant source of SARS-CoV-2 emission (edit) |
10.1101/2020.05.31.20115154 |
| 2020-06-02 |
Quantitative assessment of the risk of airborne transmission of SARS-CoV-2 infection: prospective and retrospective applications (edit) |
10.1101/2020.06.01.20118984 |
| 2020-06-02 |
SARS-CoV-2 and dental treatments (edit) |
10.18683/GERMS.2020.1187 |
| 2020-06-02 |
SARS-CoV-2 in Romania - analysis of the first confirmed case and evolution of the pandemic in Romania in the first three months (edit) |
10.18683/GERMS.2020.1198 |
| 2020-06-02 |
Variant analysis of SARS-CoV-2 genomes (edit) |
10.2471/BLT.20.253591 |
| 2020-06-02 |
An integrated national scale SARS-CoV-2 genomic surveillance network (edit) |
10.1016/S2666-5247(20)30054-9 |
| 2020-06-02 |
Amino acid variation analysis of surface spike glycoprotein at 614 in SARS-CoV-2 strains (edit) |
10.1016/J.GENDIS.2020.05.006 |
| 2020-06-02 |
Is there value in a two-step diagnostic algorithm to confirm SARS-CoV-2 in South Africa? (edit) |
10.7196/SAMJ.2020.V110I7.14853 |
| 2020-06-02 |
Affordable digital innovation to reduce SARS-CoV-2 transmission among healthcare workers (edit) |
10.7196/SAMJ.2020.V110I7.14879 |
| 2020-06-01 |
The SARS-CoV-2 Virus may Remain Viable on Oral Appliances for up to 3 Days? (edit) |
|
| 2020-06-01 |
Impact of household quarantine on SARS-Cov-2 infection in mainland China: A mean-field modelling approach (edit) |
10.3934/MBE.2020248 |
| 2020-06-01 |
In defence of extrapolation but not improvisation in SARS-CoV-2 lung disease (edit) |
10.1183/20734735.0113-2020 |
| 2020-06-01 |
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection: let the virus be its own demise (edit) |
10.2217/FVL-2020-0068 |
| 2020-06-01 |
Consensus virtual screening of dark chemical matter and food chemicals uncover potential inhibitors of SARS-CoV-2 main protease (edit) |
10.1039/D0RA04922K |
| 2020-06-01 |
Speech Processor Care in the SARS-CoV-2 Era (edit) |
10.1097/01.HJ.0000669876.19166.E3 |
| 2020-06-01 |
The novel Coronavirus (SARS-CoV-2) is a one health issue (edit) |
10.1016/J.ONEHLT.2020.100123 |
| 2020-06-01 |
Coronavirus disease (COVID-19) and neonate: What neonatologist need to know (edit) |
10.1002/JMV.25740 |
| 2020-06-01 |
The neuroinvasive potential of SARS‐CoV2 may be at least partially responsible for the respiratory failure of COVID‐19 patients (edit) |
10.1002/JMV.25728 |
| 2020-06-01 |
A new threat from an old enemy: Re‑emergence of coronavirus (Review) (edit) |
10.3892/IJMM.2020.4555 |
| 2020-06-01 |
Clinician Wellness During the COVID-19 Pandemic: Extraordinary Times and Unusual Challenges for the Allergist/Immunologist (edit) |
10.1016/J.JAIP.2020.04.001 |
| 2020-06-01 |
Clinical trial analysis of 2019-nCoV therapy registered in China (edit) |
10.1002/JMV.25733 |
| 2020-06-01 |
Understanding SARS-CoV-2-Mediated Inflammatory Responses: From Mechanisms to Potential Therapeutic Tools (edit) |
10.1007/S12250-020-00207-4 |
| 2020-06-01 |
A review of the 2019 Novel Coronavirus (COVID-19) based on current evidence (edit) |
10.1016/J.IJANTIMICAG.2020.105948 |
| 2020-06-01 |
Coronavirus Disease 2019 (COVID-19) and Beyond: Micropractices for Burnout Prevention and Emotional Wellness (edit) |
10.1016/J.JACR.2020.03.013 |
| 2020-06-01 |
Coronavirus Disease 2019 (COVID-19) Pandemic and Pregnancy (edit) |
10.1016/J.AJOG.2020.03.021 |
| 2020-06-01 |
COVID-19, SARS and MERS: are they closely related? (edit) |
10.1016/J.CMI.2020.03.026 |
| 2020-06-01 |
Vertical Transmission of Coronavirus Disease 19 (COVID-19) from Infected Pregnant Mothers to Neonates: A Review (edit) |
10.1080/15513815.2020.1747120 |
| 2020-06-01 |
[Remdesivir, the antiviral hope against SARS-CoV-2] (edit) |
|
| 2020-06-01 |
The Rapid Assessment and Early Warning Models for COVID-19 (edit) |
10.1007/S12250-020-00219-0 |
| 2020-06-01 |
The pathogenesis and treatment of the `Cytokine Storm' in COVID-19 (edit) |
10.1016/J.JINF.2020.03.037 |
| 2020-06-01 |
The COVID-19 Global Rheumatology Alliance: collecting data in a pandemic (edit) |
10.1038/S41584-020-0418-0 |
| 2020-06-01 |
Gastrointestinal and Liver Manifestations in Patients with COVID-19 (edit) |
10.1097/JCMA.0000000000000319 |
| 2020-06-01 |
Potential therapeutic agents against COVID-19: What we know so far (edit) |
10.1097/JCMA.0000000000000318 |
| 2020-06-01 |
A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group (edit) |
10.1634/THEONCOLOGIST.2020-0213 |
| 2020-06-01 |
Why are pregnant women susceptible to COVID-19? An immunological viewpoint (edit) |
10.1016/J.JRI.2020.103122 |
| 2020-06-01 |
A cascade of causes that led to the COVID-19 tragedy in Italy and in other European Union countries (edit) |
|
| 2020-06-01 |
ISUOG Consensus Statement on rationalization of early-pregnancy care and provision of ultrasonography in context of SARS-CoV-2 (edit) |
10.1002/UOG.22046 |
| 2020-06-01 |
ISUOG Consensus Statement on rationalization of gynecological ultrasound services in context of SARS-CoV-2 (edit) |
10.1002/UOG.22047 |
| 2020-06-01 |
Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic (edit) |
10.1016/J.CLIM.2020.108409 |
| 2020-06-01 |
Drug repositioning an alternative for the treatment of coronavirus COVID-19 (edit) |
10.1016/J.IJANTIMICAG.2020.105969 |
| 2020-06-01 |
Mesenchymal Stem Cell Therapy for COVID-19: Present or Future (edit) |
10.1007/S12015-020-09973-W |
| 2020-06-01 |
Performance of Electrophysiology Procedures at an Academic Medical Center Amidst the 2020 Coronavirus (COVID-19) Pandemic (edit) |
10.1111/JCE.14493 |
| 2020-06-01 |
Orthopaedic Education During the COVID-19 Pandemic (edit) |
10.5435/JAAOS-D-20-00292 |
| 2020-06-01 |
Peri-operative Considerations in Urgent Surgical Care of Suspected and Confirmed COVID-19 Orthopedic Patients: Operating rooms protocols and recommendations in the Current COVID-19 Pandemic (edit) |
10.5435/JAAOS-D-20-00227 |
| 2020-06-01 |
A Bioethical Perspective for Navigating Moral Dilemmas Amidst the COVID-19 Pandemic (edit) |
10.5435/JAAOS-D-20-00371 |
| 2020-06-01 |
Searching therapeutic strategy of new coronavirus pneumonia from angiotensin-converting enzyme 2: the target of COVID-19 and SARS-CoV (edit) |
10.1007/S10096-020-03883-Y |
| 2020-06-01 |
Practice Management During the COVID-19 Pandemic (edit) |
10.5435/JAAOS-D-20-00379 |
| 2020-06-01 |
Ongoing Clinical Trials for the Management of the COVID-19 Pandemic (edit) |
10.1016/J.TIPS.2020.03.006 |
| 2020-06-01 |
Mechanism of thrombocytopenia in COVID-19 patients (edit) |
10.1007/S00277-020-04019-0 |
| 2020-06-01 |
Commentary on the management of total laryngectomy patients during the COVID-19 pandemic (edit) |
10.1002/HED.26183 |
| 2020-06-01 |
Cardiovascular Pharmacology in the Time of COVID-19: A Focus on Angiotensin Converting Enzyme 2 (edit) |
10.1097/FJC.0000000000000840 |
| 2020-06-01 |
Departmental Experience and Lessons Learned With Accelerated Introduction of Telemedicine During the COVID-19 Crisis (edit) |
10.5435/JAAOS-D-20-00380 |
| 2020-06-01 |
Binding of SARS-CoV-2 and angiotensin-converting enzyme 2: clinical implications (edit) |
10.1093/CVR/CVAA096 |
| 2020-06-01 |
SARS-CoV-2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen Production, and Test Setup (edit) |
10.1002/CPMC.100 |
| 2020-06-01 |
Targeting potential drivers of COVID-19: Neutrophil extracellular traps (edit) |
10.1084/JEM.20200652 |
| 2020-06-01 |
Considerations for Obstetric Care during the COVID-19 Pandemic (edit) |
10.1055/S-0040-1710051 |
| 2020-06-01 |
European Society of Trauma and Emergency Surgery (ESTES) recommendations for trauma and emergency surgery preparation during times of COVID-19 infection (edit) |
10.1007/S00068-020-01364-7 |
| 2020-06-01 |
The Impact of the COVID-19 Pandemic on Cancer Patients (edit) |
10.1097/COC.0000000000000712 |
| 2020-06-01 |
COVID-19 in children: Current status (edit) |
10.1097/JCMA.0000000000000323 |
| 2020-06-01 |
American Society for Transplantation and Cellular Therapy Pharmacy Special Interest Group Position Statement on Pharmacy Practice Management and Clinical Management for COVID-19 in Hematopoietic Cell Transplantation and Cellular Therapy Patients in (edit) |
10.1016/J.BBMT.2020.04.005 |
| 2020-06-01 |
Epidemiology and clinical features of COVID-19: A review of current literature (edit) |
10.1016/J.JCV.2020.104357 |
| 2020-06-01 |
The prevention and management of the coronavirus disease 2019 (COVID-19) outbreak in radiology departments in epidemic areas (edit) |
10.1007/S11604-020-00974-W |
| 2020-06-01 |
Chloroquine for SARS-CoV-2: Implications of Its Unique Pharmacokinetic and Safety Properties (edit) |
10.1007/S40262-020-00891-1 |
| 2020-06-01 |
CD147 as a Target for COVID-19 Treatment: Suggested Effects of Azithromycin and Stem Cell Engagement (edit) |
10.1007/S12015-020-09976-7 |
| 2020-06-01 |
COVID-19 and the clinical hematology laboratory (edit) |
10.1111/IJLH.13229 |
| 2020-06-01 |
[Ensuring mental health care during the SARS-CoV-2 epidemic in France: A narrative review] (edit) |
10.1016/J.ENCEP.2020.04.005 |
| 2020-06-01 |
The need for urogenital tract monitoring in COVID-19 (edit) |
10.1038/S41585-020-0319-7 |
| 2020-06-01 |
Elevated troponin in patients with Coronavirus Disease 2019 (COVID-19): possible mechanisms (edit) |
10.1016/J.CARDFAIL.2020.04.009 |
| 2020-06-01 |
Startups in times of crisis – A rapid response to the COVID-19 pandemic (edit) |
10.1016/J.JBVI.2020.E00169 |
| 2020-06-01 |
Dermatologists and SARS-CoV-2: The impact of the pandemic on daily practice (edit) |
10.1111/JDV.16515 |
| 2020-06-01 |
Scientific research progress of COVID-19/ SARS-CoV-2 in the first five months (edit) |
10.1111/JCMM.15364 |
| 2020-06-01 |
Hunting coronavirus SARS-CoV-2 (2019-nCoV): from laboratory testing back to basic research (edit) |
10.1097/JCMA.0000000000000332 |
| 2020-06-01 |
Topical preparations to reduce SARS-CoV-2 aerosolization in head and neck mucosal surgery (edit) |
10.1002/HED.26200 |
| 2020-06-01 |
SARS-CoV-2: Is it the newest spark in the TORCH? (edit) |
10.1016/J.JCV.2020.104372 |
| 2020-06-01 |
Potential Fecal Transmission of SARS-CoV-2: Current Evidence and Implications for Public Health (edit) |
10.1016/J.IJID.2020.04.057 |
| 2020-06-01 |
The pivotal link between ACE2 deficiency and SARS-CoV-2 infection (edit) |
10.1016/J.EJIM.2020.04.037 |
| 2020-06-01 |
Frequently asked questions regarding SARS-CoV-2 in cancer patients-recommendations for clinicians caring for patients with malignant diseases (edit) |
10.1038/S41375-020-0832-Y |
| 2020-06-01 |
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the Central Nervous System (edit) |
10.1016/J.TINS.2020.04.004 |
| 2020-06-01 |
[Challenges for psychotropics in the context of the SARS-Cov-2 pandemic] (edit) |
10.1016/J.ENCEP.2020.04.009 |
| 2020-06-01 |
Angiotensin-converting enzyme-2 in SARS-CoV-2 infection: good or bad? (edit) |
10.1097/HJH.0000000000002472 |
| 2020-06-01 |
Emergency services and the fight against the SARS-CoV-2 pandemic (edit) |
|
| 2020-06-01 |
[Informations on psychotropics and their adaptations for patients suffering from mental disorders in France during the SARS-CoV-2 epidemic] (edit) |
10.1016/J.ENCEP.2020.04.006 |
| 2020-06-01 |
Guillain-Barre syndrome during SARS-CoV-2 pandemic: a case report and review of recent literature (edit) |
10.1111/JNS.12382 |
| 2020-06-01 |
Involvement of the Nervous System in SARS-CoV-2 Infection (edit) |
10.1007/S12640-020-00219-8 |
| 2020-06-01 |
Could an endo-lysosomal ion channel be the Achilles heel of SARS-CoV2? (edit) |
10.1016/J.CECA.2020.102212 |
| 2020-06-01 |
Is the kidney a target of SARS-CoV-2? (edit) |
10.1152/AJPRENAL.00160.2020 |
| 2020-06-01 |
ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome (edit) |
10.1016/J.JMII.2020.04.015 |
| 2020-06-01 |
[Takotsubo syndrome during SARS-CoV-2 pneumonia: a possible cardiovascular complication] (edit) |
10.1714/3359.33323 |
| 2020-06-01 |
Potential neurological impact of coronaviruses: implications for the novel SARS-CoV-2 (edit) |
10.1007/S10072-020-04469-4 |
| 2020-06-01 |
Panique et pandémie: revue de la littérature sur les liens entre le trouble panique et l'épidémie à SARS-CoV-2 (edit) |
10.1016/J.ENCEP.2020.05.010 |
| 2020-06-01 |
Assurer les soins aux patients souffrant de troubles psychiques en France pendant l’épidémie à SARS-CoV-2 (edit) |
10.1016/J.ENCEP.2020.03.001 |
| 2020-06-01 |
Acute inflammation and pathogenesis of SARS-CoV-2 infection: Cannabidiol as a potential anti-inflammatory treatment? (edit) |
10.1016/J.CYTOGFR.2020.05.008 |
| 2020-06-01 |
The Proteins of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS CoV-2 or n-COV19), the Cause of COVID-19 (edit) |
10.1007/S10930-020-09901-4 |
| 2020-06-01 |
Presence of viral RNA of SARS-CoV-2 in conjunctival swab specimens of COVID-19 patients (edit) |
10.4103/IJO.IJO_1287_20 |
| 2020-06-01 |
Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis (edit) |
10.1016/S0140-6736(20)31142-9 |
| 2020-06-01 |
Two Detailed Plaque Assay Protocols for the Quantification of Infectious SARS-CoV-2 (edit) |
10.1002/CPMC.105 |
| 2020-06-01 |
Exercise in the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) era: A Question and Answer session with the experts Endorsed by the section of Sports Cardiology & Exercise of the European Association of Preventive Cardiology (EAPC) (edit) |
10.1177/2047487320930596 |
| 2020-06-01 |
Transmission routes of SARS-CoV-2 and protective measures in dental clinics during the COVID-19 pandemic (edit) |
|
| 2020-06-01 |
SARS-CoV-2 pandemic and Vitamin D deficiency - a double trouble (edit) |
10.1111/PHPP.12579 |
| 2020-06-01 |
Expedited SARS-CoV-2 Screening of Donors and Recipients Supports Continued Solid Organ Transplant (edit) |
10.1111/AJT.16081 |
| 2020-06-01 |
SARS-CoV-2, which induces COVID-19, causes kawasaki-like disease in children: role of pro-inflammatory and anti-inflammatory cytokines (edit) |
10.23812/EDITORIAL-RONCONI-E-59 |
| 2020-06-01 |
Virtual Screening-Driven Drug Discovery of SARS-CoV2 Enzyme Inhibitors Targeting Viral Attachment, Replication, Post-Translational Modification and Host Immunity Evasion Infection Mechanisms (edit) |
10.1080/07391102.2020.1776639 |
| 2020-06-01 |
Identification of potential natural inhibitors of SARS-CoV2 main protease by molecular docking and simulation studies (edit) |
10.1080/07391102.2020.1776157 |
| 2020-06-01 |
Virtual screening, ADME/T, and binding free energy analysis of anti-viral, anti-protease, and anti-infectious compounds against NSP10/NSP16 methyltransferase and main protease of SARS CoV-2 (edit) |
10.1080/10799893.2020.1772298 |
| 2020-06-01 |
Comparing the Binding Interactions in the Receptor Binding Domains of SARS-CoV-2 and SARS-CoV (edit) |
10.1021/ACS.JPCLETT.0C01064 |
| 2020-06-01 |
Airborne Spread of SARS-CoV-2 and a Potential Role for Air Disinfection (edit) |
10.1001/JAMA.2020.7603 |
| 2020-06-01 |
SARS-CoV-2 and Guillain-Barré syndrome: AIDP variant with favorable outcome (edit) |
10.1111/ENE.14368 |
| 2020-06-01 |
TMPRSS2 and ACE2 Coexpression in SARS-CoV-2 Salivary Glands Infection (edit) |
10.1177/0022034520933589 |
| 2020-06-01 |
Maintaining a Viable Donor Milk Supply During the SARS-CoV-2 (COVID-19) Pandemic (edit) |
10.1177/0890334420931828 |
| 2020-06-01 |
Coagulation modifiers targeting SARS-CoV-2 main protease Mpro for COVID-19 treatment: an in silico approach (edit) |
10.1590/0074-02760200179 |
| 2020-06-01 |
SARS-CoV-2 Laboratory Testing in India's Pandemic Response: A Public Health Perspective (edit) |
10.4103/IJPH.IJPH_491_20 |
| 2020-06-01 |
Genome analysis of SARS-CoV-2 isolates occurring in India: Present scenario (edit) |
10.4103/IJPH.IJPH_506_20 |
| 2020-06-01 |
Wastewater monitoring and public health surveillance of SARS-CoV-2 (edit) |
10.4103/IJPH.IJPH_490_20 |
| 2020-06-01 |
A Surgical Protocol to Mitigate the SARS-CoV-2 Transmission Using Multifocal Povidone-Iodine Applications in Lacrimal Surgeries During Coronavirus Disease 2019 (COVID-19) Pandemic (edit) |
10.1097/IOP.0000000000001746 |
| 2020-06-01 |
Transmission secondaire de SARS-CoV-2 : pendant combien de temps un cas symptomatique peut-il transmettre le virus ? (edit) |
|
| 2020-06-01 |
SARS-CoV-2 Gastrointestinal Infection Causing Hemorrhagic Colitis: Implications for Detection and Transmission of COVID-19 Disease (edit) |
10.14309/AJG.0000000000000667 |
| 2020-06-01 |
Add to your learning experience as a histopathology professional: dealing with the SARS-Cov-2 pandemic and publications in this issue (edit) |
10.1080/01478885.2020.1748365 |
| 2020-06-01 |
Clinical performance of the Luminex NxTAG CoV Extended Panel for SARS-CoV-2 detection in nasopharyngeal specimens of COVID-19 patients in Hong Kong (edit) |
10.1128/JCM.00936-20 |
| 2020-06-01 |
Emerging phenotype of SARS-CoV2 associated pancreatitis (edit) |
10.1053/J.GASTRO.2020.05.069 |
| 2020-06-01 |
Acute disseminated encephalomyelitis after SARS-CoV-2 infection (edit) |
10.1212/NXI.0000000000000797 |
| 2020-06-01 |
Analysis of Gastrointestinal and Hepatic Manifestations of SARS-CoV-2 Infection in 892 patients in Queens, NY (edit) |
10.1016/J.CGH.2020.05.049 |
| 2020-06-01 |
Aerosol generating procedures and infective risk to healthcare workers: SARS-CoV-2 - the limits of the evidence (edit) |
10.1016/J.JHIN.2020.05.037 |
| 2020-06-01 |
Challenges and countermeasures in the prevention of nosocomial infections of SARS-CoV-2 before resumption of work: implications for the dermatology department (edit) |
10.1016/J.JAAD.2020.05.131 |
| 2020-06-01 |
Special Communication: Evaluation and Treatment of Thoracic Outlet Syndrome During the Global Pandemic Due to SARS-CoV-2 and COVID-19 (edit) |
10.1016/J.JVS.2020.05.048 |
| 2020-06-01 |
Evaluation of novel antigen-based rapid detection test for the diagnosis of SARS-CoV-2 in respiratory samples (edit) |
10.1016/J.IJID.2020.05.098 |
| 2020-06-01 |
Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patients (edit) |
10.1038/S41467-020-16638-2 |
| 2020-06-01 |
Clinical Validation of a SARS-CoV-2 Real-Time Reverse Transcription PCR Assay Targeting the Nucleocapsid Gene (edit) |
10.1093/JALM/JFAA089 |
| 2020-06-01 |
Acute myocarditis and multisystem inflammatory emerging disease following SARS-CoV-2 infection in critically ill children (edit) |
10.1186/S13613-020-00690-8 |
| 2020-06-01 |
Deep Learning Based Drug Screening for Novel Coronavirus 2019-nCov (edit) |
10.1007/S12539-020-00376-6 |
| 2020-06-01 |
Discovery of G-quadruplex-forming sequences in SARS-CoV-2 (edit) |
10.1093/BIB/BBAA114 |
| 2020-06-01 |
Infection with SARS-CoV-2 causes abnormal laboratory results of multiple organs in patients (edit) |
10.18632/AGING.103255 |
| 2020-06-01 |
Protective Adaptive Immunity Against Severe Acute Respiratory Syndrome Coronaviruses 2 (SARS-CoV-2) and Implications for Vaccines (edit) |
10.7759/CUREUS.8399 |
| 2020-06-01 |
SARS-CoV-2 and prostatitis: Dangerous relationship for male sexual and reproductive health (edit) |
10.1016/J.MEHY.2020.109914 |
| 2020-06-01 |
Brief clinical evaluation of six high-throughput SARS-CoV-2 IgG antibody assays (edit) |
10.1016/J.JCV.2020.104480 |
| 2020-06-01 |
Practical Guidelines for Collection, Manipulation and Inactivation of SARS-CoV-2 and COVID-19 Clinical Specimens (edit) |
10.1002/CPCY.77 |
| 2020-06-01 |
COVID-19: The Potential Role of Copper and N-acetylcysteine (NAC) in a Combination of Candidate Antiviral Treatments Against SARS-CoV-2 (edit) |
10.21873/INVIVO.11946 |
| 2020-06-01 |
Potential Antiviral Drugs for SARS-Cov-2 Treatment: Preclinical Findings and Ongoing Clinical Research (edit) |
10.21873/INVIVO.11949 |
| 2020-06-01 |
Ocular Manifestations of COVID-19 (SARS-CoV-2): A Critical Review of Current Literature (edit) |
10.21873/INVIVO.11952 |
| 2020-06-01 |
SARS-CoV-2 orf1b Gene Sequence in the NTNG1 Gene on Human Chromosome 1 (edit) |
10.21873/INVIVO.11953 |
| 2020-06-01 |
Human Gene Sequences in SARS-CoV-2 and Other Viruses (edit) |
10.21873/INVIVO.11954 |
| 2020-06-01 |
Endoplasmic Reticulum Stress Markers in SARS-COV-2 Infection and Pneumonia: Case-Control Study (edit) |
10.21873/INVIVO.11956 |
| 2020-06-01 |
SARS-CoV-2 and liver damage: a possible pathogenetic link (edit) |
10.21037/HBSN-20-437 |
| 2020-06-01 |
SARS-CoV-2: Environment and spread: An annotated selection of World Wide Web sites relevant to the topics in environmental microbiology (edit) |
10.1111/1462-2920.15089 |
| 2020-06-01 |
The treatment of inflammatory bowel disease during the SARS-CoV-2 epidemic – practical advices: (A COVID–19-pandémia orvosszakmai kérdései) (edit) |
10.1556/650.2020.31871 |
| 2020-06-01 |
COVID-19-related complications and decompression illness share main features.: Could the SARS-CoV2-related complications rely on blood foaming? (edit) |
10.1016/J.MEHY.2020.109918 |
| 2020-06-01 |
Können Haustiere Corona auf ihre Besitzer übertragen? : SARS-CoV-2 bei Hunden und Katzen (edit) |
10.1007/S15006-020-0549-X |
| 2020-06-01 |
Lehren aus einer Kreuzfahrt mit SARS-CoV-2 (edit) |
10.1007/S15006-020-0544-2 |
| 2020-06-01 |
Traditional Chinese medicine practices used in COVID-19 (Sars-cov 2/Coronavirus-19) treatment in clinic and their effects on the cardiovascular system (edit) |
10.5543/TKDA.2020.03374 |
| 2020-06-01 |
SARS-Cov2 Clinical Diagnostics: Academic Scientists Take on the COVID-19 Pandemic (edit) |
10.1016/J.MEDJ.2020.06.002 |
| 2020-06-01 |
The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients (edit) |
10.1126/SCIIMMUNOL.ABC8413 |
| 2020-06-01 |
Genome-Wide Identification and Characterization of Point Mutations in the SARS-CoV-2 Genome (edit) |
10.24171/J.PHRP.2020.11.3.05 |
| 2020-06-01 |
Detection and Isolation of SARS-CoV-2 in Serum, Urine, and Stool Specimens of COVID-19 Patients from the Republic of Korea (edit) |
10.24171/J.PHRP.2020.11.3.02 |
| 2020-06-01 |
Genetic structure of SARS-CoV-2 reflects clonal superspreading and multiple independent introduction events, North-Rhine Westphalia, Germany, February and March 2020 (edit) |
10.2807/1560-7917.ES.2020.25.22.2000746 |
| 2020-06-01 |
SARS-CoV-2-related paediatric inflammatory multisystem syndrome, an epidemiological study, France, 1 March to 17 May 2020 (edit) |
10.2807/1560-7917.ES.2020.25.22.2001010 |
| 2020-06-01 |
Public health in the eye of the storm: what can we learn from the COVID-19 pandemic experience to strengthen public health services in Europe? (edit) |
10.1093/EURPUB/CKAA089 |
| 2020-06-01 |
Response to COVID-19 pandemic: Beyond medical education in Brazil (edit) |
10.1111/JOCS.14648 |
| 2020-06-01 |
COVID-19 pandemic: Beyond medical education in Brazil (edit) |
10.1111/JOCS.14646 |
| 2020-06-01 |
Bedside veno-venous ECMO cannulation: A pertinent strategy during the COVID-19 pandemic (edit) |
10.1111/JOCS.14641 |
| 2020-06-01 |
COVID-19 pandemic and the need for objective criteria for ICU admissions (edit) |
10.1016/J.JCLINANE.2020.109945 |
| 2020-06-01 |
Rapid report: Early demand, profiles and concerns of mental health users during the coronavirus (COVID-19) pandemic (edit) |
10.1016/J.INVENT.2020.100327 |
| 2020-06-01 |
Could SARS-CoV-2/COVID-19 simply fade away? (edit) |
|
| 2020-06-01 |
Emerging coronaviruses: first SARS, second MERS and third SARS-CoV-2: epidemiological updates of COVID-19 (edit) |
|
| 2020-06-01 |
Bacterial and fungal infections among patients with SARS-CoV-2 pneumonia (edit) |
|
| 2020-06-01 |
Comprehensive review of mask utility and challenges during the COVID-19 pandemic (edit) |
|
| 2020-06-01 |
Preparing for emerging respiratory pathogens such as SARS-CoV, MERS-CoV, and SARS-CoV-2 (edit) |
|
| 2020-06-01 |
Cognitive load and performance of health care professionals in donning and doffing PPE before and after a simulation-based educational intervention and its implications during the COVID-19 pandemic for biosafety (edit) |
|
| 2020-06-01 |
Laboratory Findings in SARS-CoV-2 Infections in Zigong, China: Key Points for Serum Prealbumin (edit) |
10.7754/CLIN.LAB.2020.200419 |
| 2020-06-01 |
[Current situation in Urology practice in Spain during the COVID-19 pandemic.] (edit) |
|
| 2020-06-01 |
[Management of neurourological patients during the COVID-19 pandemic.] (edit) |
|
| 2020-06-01 |
Emotional Health in the Midst of the Coronavirus Disease 2019 (COVID-19) Pandemic (edit) |
10.1016/J.WNEU.2020.03.068 |
| 2020-06-01 |
Psychological support for health care workers during the COVID-19 pandemic (edit) |
10.1503/CMAJ.75864 |
| 2020-06-01 |
The first six weeks - setting up a UK urgent dental care centre during the COVID-19 pandemic (edit) |
10.1038/S41415-020-1708-2 |
| 2020-06-01 |
Decoy ACE2-expressing extracellular vesicles that competitively bind SARS-CoV-2 as a possible COVID-19 therapy (edit) |
10.1042/CS20200623 |
| 2020-06-01 |
Is SARS-CoV-2 transfusion transmitted? (edit) |
10.1111/TRF.15831 |
| 2020-06-01 |
Genetic Analysis Tracks SARS-CoV-2 Mutations in Human Hosts (edit) |
10.1001/JAMA.2020.9825 |
| 2020-06-01 |
SARS-CoV2 may evade innate immune response, causing uncontrolled neutrophil extracellular traps formation and multi-organ failure (edit) |
10.1042/CS20200531 |
| 2020-06-01 |
CT suggests discharged Covid-19 patients who were retested RT-PCR positive again for SARS-CoV-2 more likely had false negative RT-PCR tests before discharging (edit) |
10.21037/QIMS-2020-19 |
| 2020-06-01 |
Hemophagocytic lymphohistiocytosis in SARS-CoV-2 infection (edit) |
10.1182/BLOOD.2020006505 |
| 2020-06-01 |
Morphological changes in a case of SARS-CoV-2 infection (edit) |
10.1182/BLOOD.2020006665 |
| 2020-06-01 |
Diving and hyperbaric medicine in the SARS-CoV-2 pandemic (edit) |
10.28920/DHM50.2.90-91 |
| 2020-06-01 |
Persisting SARS-CoV-2 viremia after rituximab therapy: Two cases with fatal outcome and a review of literature (edit) |
10.1111/BJH.16896 |
| 2020-06-01 |
SARS-CoV-2 infection in farmed minks, the Netherlands, April and May 2020 (edit) |
10.2807/1560-7917.ES.2020.25.23.2001005 |
| 2020-06-01 |
Meta-analysis of diagnostic performance of serological tests for SARS-CoV-2 antibodies up to 25 April 2020 and public health implications (edit) |
10.2807/1560-7917.ES.2020.25.23.2000980 |
| 2020-06-01 |
Letter to the editor: Wide indication for SARS-CoV-2-testing allowed identification of international risk areas during the early phase of the COVID-19 pandemic in Germany (edit) |
10.2807/1560-7917.ES.2020.25.23.2001119 |
| 2020-06-01 |
Distanciation sociale, masques, protection oculaire: comment prévenir la transmission interpersonnelle de SARS-CoV-2 (edit) |
|
| 2020-06-01 |
Audio Interview: A Look at SARS-CoV-2 Transmission (edit) |
10.1056/NEJME2022576 |
| 2020-06-01 |
SARS-CoV-2 pandemic in the western world: the lessons learned (edit) |
10.4997/JRCPE.2020.205 |
| 2020-06-01 |
Coronavirus SARS-Cov-2 and arterial hypertension - facts and myths (edit) |
|
| 2020-06-01 |
Mortality statistics in England and Wales: the SARS-CoV-2 paradox (edit) |
10.1177/0300060520931298 |
| 2020-06-01 |
[Pragmatic proposals of respiratory follow-up for patients with SARS-CoV-2 infection established in record time for all healthcare practioners] (edit) |
10.1016/J.RMR.2020.05.005 |
| 2020-06-01 |
Modelling testing frequencies required for early detection of a SARS-CoV-2 outbreak on a university campus (edit) |
10.1101/2020.06.01.20118885 |
| 2020-06-01 |
When science goes viral: The research response during three months of the COVID-19 outbreak (edit) |
10.1016/J.BIOPHA.2020.110451 |
| 2020-06-01 |
[How to communicate with families of patients in complete isolation during SARS-CoV-2 pandemic multidisciplinary working group "ComuniCoViD".] (edit) |
10.1701/3394.33757 |
| 2020-06-01 |
C’è una relazione tra inquinamento atmosferico e SARS-CoV-2? (edit) |
10.1701/3394.33763 |
| 2020-06-01 |
Erratum for the Report: "Estimating the burden of SARS-CoV-2 in France," by H. Salje, C. Tran Kiem, N. Lefrancq, N. Courtejoie, P. Bosetti, J. Paireau, A. Andronico, N. Hozé, J. Richet, C.-L. Dubost, Y. Le Strat, J. Lessler, D. Levy-Bruhl, A. Fontan (edit) |
10.1126/SCIENCE.ABD4246 |
| 2020-06-01 |
Multicentre comparison of quantitative PCR-based assays to detect SARS-CoV-2, Germany, March 2020 (edit) |
10.2807/1560-7917.ES.2020.25.24.2001057 |
| 2020-06-01 |
Prevalence of SARS-CoV-2 specific neutralising antibodies in blood donors from the Lodi Red Zone in Lombardy, Italy, as at 06 April 2020 (edit) |
10.2807/1560-7917.ES.2020.25.24.2001031 |
| 2020-06-01 |
Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome (edit) |
10.1126/SCIIMMUNOL.ABD2071 |
| 2020-06-01 |
How can we reduce the risks of SARS-CoV-2 (COVID-19) for dentists and their patients? (edit) |
10.1038/S41432-020-0092-8 |
| 2020-06-01 |
Are hydroxychloroquine and chloroquine effective in the treatment of SARS-COV-2 (COVID-19)? (edit) |
10.1038/S41432-020-0098-2 |
| 2020-06-01 |
Saliva: a diagnostic option and a transmission route for 2019-nCoV (edit) |
10.1038/S41432-020-0104-8 |
| 2020-06-01 |
Could there be a link between oral hygiene and the severity of SARS-CoV-2 infections? (edit) |
10.1038/S41415-020-1747-8 |
| 2020-06-01 |
[Progress and analysis on the development of 2019-nCoV vaccine] (edit) |
10.7507/1001-5515.202004025 |
| 2020-06-01 |
Interfascial plane blocks as shortcut alternatives for regional anesthesia and pain management for SARS-CoV-2 days: Not deeper, not longer. Be safe for everyone (edit) |
10.1016/J.JCLINANE.2020.109948 |
| 2020-06-01 |
Myocarditis in a 16-year-old boy positive for SARS-CoV-2 (edit) |
10.1016/S0140-6736(20)31307-6 |
| 2020-06-01 |
Ultra-High-Throughput Clinical Proteomics Reveals Classifiers of COVID-19 Infection (edit) |
10.1016/J.CELS.2020.05.012 |
| 2020-06-01 |
Omics-Driven Systems Interrogation of Metabolic Dysregulation in COVID-19 Pathogenesis (edit) |
10.1016/J.CMET.2020.06.016 |
| 2020-06-01 |
RNA-GPS Predicts SARS-CoV-2 RNA Residency to Host Mitochondria and Nucleolus (edit) |
10.1016/J.CELS.2020.06.008 |
| 2020-06-01 |
Remote Monitoring of Patients in Quarantine in the Era of SARS-CoV-2 Pandemic (edit) |
10.3233/SHTI200486 |
| 2020-06-01 |
Topological analysis of SARS CoV-2 main protease (edit) |
10.1063/5.0013029 |
| 2020-06-01 |
The role of children in transmission of SARS-CoV-2: A rapid review (edit) |
10.7189/JOGH.10.011101 |
| 2020-06-01 |
SARS-CoV-2 does not replicate in embryonated hen's eggs or in MDCK cell lines (edit) |
10.2807/1560-7917.ES.2020.25.25.2001122 |
| 2020-06-01 |
The hemagglutinin-esterase gene in human coronaviruses SARS-CoV-2, HKU1 and OC43 (edit) |
10.26355/EURREV_202006_21630 |
| 2020-06-01 |
Rapid and sensitive diagnostic procedure for multiple detection of pandemic Coronaviridae family members SARS-CoV-2, SARS-CoV, MERS-CoV and HCoV: a translational research and cooperation between the Phan Chau Trinh University in Vietnam and Universi (edit) |
10.26355/EURREV_202006_21713 |
| 2020-06-01 |
Editorial - Children infected by SARS-CoV-2 (edit) |
10.26355/EURREV_202006_21714 |
| 2020-06-01 |
Primer design for quantitative real-time PCR for the emerging Coronavirus SARS-CoV-2 (edit) |
10.7150/THNO.47649 |
| 2020-06-01 |
The many faces of interstitial pneumonia: a case of presumed SARS-CoV-2 infection (edit) |
10.4414/SMW.2020.20312 |
| 2020-06-01 |
Covid-19 : after Ebola, towards a new emergence of SARS-CoV-2 in Africa? (edit) |
10.1684/VIR.2020.0847 |
| 2020-06-01 |
Mother to Child SARS-CoV-2 Transmission: Fact or Fantasy (edit) |
10.1684/VIR.2020.0838 |
| 2020-06-01 |
Microthrombotic Complications of COVID-19 Are Likely Due to Embolism of Circulating Endothelial Derived Ultralarge von Willebrand Factor (eULVWF) Decorated-Platelet Strings (edit) |
|
| 2020-06-01 |
Surgical, Economic, and Psychological Impacts of SARS-COV-2 on a Kansas Community Hospital System (edit) |
10.1177/0003134820924394 |
| 2020-06-01 |
Evolution of effective serial interval of SARS-CoV-2 by non-pharmaceutical interventions (edit) |
10.21203/RS.3.RS-32486/V1 |
| 2020-06-01 |
[Management of critically ill adults in a Pediatric Intensive Care Unit as response to SARS-CoV2 pandemic] (edit) |
10.32641/RCHPED.V91I3.2547 |
| 2020-06-01 |
Genome-wide computational prediction of miRNAs in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) revealed target genes involved in pulmonary vasculature and antiviral innate immunity (edit) |
10.22099/MBRC.2020.36507.1487 |
| 2020-06-01 |
Les officinaux Prêts à participer au dépistage des patients infectés par le sars-CoV-2 (edit) |
10.1016/S0515-3700(20)30235-4 |
| 2020-06-01 |
[Pathogenic, clinical and diagnostic characteristics of the SARS-CoV-2 pandemic] (edit) |
10.4067/S0716-10182020000300265 |
| 2020-06-01 |
Optimizing RT-PCR detection of SARS-CoV-2 for developing countries using pool testing (edit) |
10.4067/S0716-10182020000300276 |
| 2020-06-01 |
Pediatric Multisystemic Inflammatory Syndrome Associated With SARS-CoV-2 Infection (edit) |
10.3238/ARZTEBL.2020.0431 |
| 2020-05-31 |
Sofosbuvir protects human brain organoids against SARS-CoV-2 (edit) |
10.1101/2020.05.30.125856 |
| 2020-05-31 |
No advice to discontinue antirheumatic therapy for non-medical reasons in light of SARS-CoV-2. Response to: 'Treatment adherence of patients with sytemic rheumatic diseases in COVID-19 pandemic' by Fragoulis et al (edit) |
10.1136/ANNRHEUMDIS-2020-217987 |
| 2020-05-31 |
Strategies for Liver Transplantation during the SARS CoV-2 Outbreak Preliminary Experience from a Single Center in France (edit) |
10.1111/AJT.16082 |
| 2020-05-31 |
Tocilizumab therapy in five solid and composite tissue transplant recipients with early ARDS due to SARS-CoV-2 (edit) |
10.1111/AJT.16080 |
| 2020-05-31 |
Predicting mortality due to SARS-CoV-2: A mechanistic score relating obesity and diabetes to COVID-19 outcomes in Mexico (edit) |
10.1210/CLINEM/DGAA346 |
| 2020-05-31 |
Adaptation to SARS-CoV-2 under stress: Role of distorted information (edit) |
10.1111/ECI.13294 |
| 2020-05-31 |
Development of a Portable, Ultra-Rapid and Ultra-Sensitive Cell-Based Biosensor for the Direct Detection of the SARS-CoV-2 S1 Spike Protein Antigen (edit) |
10.3390/S20113121 |
| 2020-05-31 |
Does spitting in public play a role in transmitting SARS-CoV-2? (edit) |
10.1016/J.TMAID.2020.101759 |
| 2020-05-31 |
Comparison of clinical and epidemiological characteristics of asymptomatic and symptomatic SARS-CoV-2 infection: A multi-center study in Sichuan Province, China (edit) |
10.1016/J.TMAID.2020.101754 |
| 2020-05-31 |
Fast SARS-CoV-2 detection by RT-qPCR in preheated nasopharyngeal swab samples (edit) |
10.1016/J.IJID.2020.05.099 |
| 2020-05-31 |
The influenza virus, SARS-CoV-2, and the airways: Clarification for the otorhinolaryngologist (edit) |
10.1016/J.ANORL.2020.05.015 |
| 2020-05-31 |
Should We Try SARS-CoV-2 Helicase Inhibitors for COVID-19 Therapy? (edit) |
10.1016/J.ARCMED.2020.05.024 |
| 2020-05-31 |
Anaesthesia preparedness for COVID-19 pandemic readiness: a medication preservation strategy (edit) |
10.1016/J.BJA.2020.05.027 |
| 2020-05-31 |
Healthcare delivery in India amid the Covid-19 pandemic: Challenges and opportunities (edit) |
10.20529/IJME.2020.064 |
| 2020-05-31 |
Hydroxychloroquine as Prophylaxis for Coronavirus SARS-CoV-2 Infection: Review of the Ongoing Clinical Trials (edit) |
10.1016/J.ARBRES.2020.05.008 |
| 2020-05-31 |
Potential Limitations in the Use of Arterial Oxygen Pressure in Respiratory Disorders Produced by SARS-CoV-2 (edit) |
10.1016/J.ARBRES.2020.05.022 |
| 2020-05-31 |
Extracorporeal membrane oxygenation in patients with SARS-CoV-2 (edit) |
10.1016/J.HRTLNG.2020.05.009 |
| 2020-05-31 |
Computational View toward the Inhibition of SARS-CoV-2 Spike Glycoprotein and the 3CL Protease (edit) |
10.3390/COMPUTATION8020053 |
| 2020-05-31 |
Molecular docking analysis of N-substituted Oseltamivir derivatives with the SARS-CoV-2 main protease (edit) |
10.6026/97320630016404 |
| 2020-05-31 |
Comments on Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease by Dai et al.(2020) (edit) |
10.6026/97320630016432 |
| 2020-05-31 |
Views on Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease by Dai et al. (2020) (edit) |
10.6026/97320630016435 |
| 2020-05-30 |
Efficacy and safety of interferon beta-1a in treatment of severe COVID-19: A randomized clinical trial (edit) |
10.1101/2020.05.28.20116467 |
| 2020-05-30 |
Towards a better case fatality estimate for SARS-CoV-2 during the early phase of the United States outbreak (edit) |
10.1093/CID/CIAA639 |
| 2020-05-30 |
Asymptomatic transmission of SARS-CoV-2 and implications for mass gatherings (edit) |
10.1111/IRV.12767 |
| 2020-05-30 |
What is the role of SARS-CoV-2 PCR testing in discontinuation of transmission-based precautions for COVID-19 patients? (edit) |
10.1093/CID/CIAA671 |
| 2020-05-30 |
Cohort PCR Testing: A Strategic Method for Rapid SARS-CoV-2 Screening (edit) |
10.1093/AJCP/AQAA092 |
| 2020-05-30 |
Detectable severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human breast milk of a mildly symptomatic patient with coronavirus disease 2019 (COVID-19) (edit) |
10.1093/CID/CIAA673 |
| 2020-05-30 |
Impact of Public Health Interventions on Seasonal Influenza Activity During the SARS-CoV-2 Outbreak in Korea (edit) |
10.1093/CID/CIAA672 |
| 2020-05-30 |
Low prevalence of SARS-CoV-2 among pregnant and postpartum patients with universal screening in Seattle, Washington (edit) |
10.1093/CID/CIAA675 |
| 2020-05-30 |
Maximum Daily Temperature, Precipitation, Ultra-Violet Light and Rates of Transmission of SARS-Cov-2 in the United States (edit) |
10.1093/CID/CIAA681 |
| 2020-05-30 |
Assessing the impact of non-pharmaceutical interventions on SARS-CoV-2 transmission in Switzerland (edit) |
10.4414/SMW.2020.20295 |
| 2020-05-30 |
Speeding tumor genotyping during the SARS-CoV-2 outbreak through liquid biopsy (edit) |
10.1002/CNCR.32983 |
| 2020-05-30 |
A Conceptual Discussion about R0 of SARS-COV-2 in Healthcare Settings (edit) |
10.1093/CID/CIAA682 |
| 2020-05-30 |
Performance of SARS-CoV-2 antibody assays in different stages of the infection: Comparison of commercial ELISA and rapid tests (edit) |
10.1093/INFDIS/JIAA305 |
| 2020-05-30 |
SARS-COV-2 infection presenting as ST-elevationmyocardial infarction (edit) |
10.1002/CCD.28974 |
| 2020-05-30 |
Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19 (edit) |
10.1186/S12941-020-00368-W |
| 2020-05-30 |
Analysis of RNA sequences of 3636 SARS-CoV-2 collected from 55 countries reveals selective sweep of one virus type (edit) |
10.4103/IJMR.IJMR_1125_20 |
| 2020-05-30 |
Mapping the genomic landscape & diversity of COVID-19 based on >3950 clinical isolates of SARS-CoV-2: Likely origin & transmission dynamics of isolates sequenced in India (edit) |
10.4103/IJMR.IJMR_1253_20 |
| 2020-05-30 |
Evaluation of RdRp & ORF-1b-nsp14-based real-time RT-PCR assays for confirmation of SARS-CoV-2 infection: An observational study (edit) |
10.4103/IJMR.IJMR_1256_20 |
| 2020-05-30 |
A cluster of SARS-CoV-2 infection among Italian tourists visiting India, March 2020 (edit) |
10.4103/IJMR.IJMR_1722_20 |
| 2020-05-30 |
Contact lens use at the time of SARS-CoV-2 pandemic for healthcare workers (edit) |
10.4103/IJMR.IJMR_1492_20 |
| 2020-05-30 |
Relationship between clinical types and radiological subgroups defined by latent class analysis in 2019 novel coronavirus pneumonia caused by SARS-CoV-2 (edit) |
10.1007/S00330-020-06973-9 |
| 2020-05-30 |
Low Cost Homemade System to Disinfect Food Items from SARS-CoV-2 (edit) |
10.1007/S10916-020-01594-7 |
| 2020-05-30 |
An update on SARS-CoV-2/COVID-19 with particular reference to its clinical pathology, pathogenesis, immunopathology and mitigation strategies (edit) |
10.1016/J.TMAID.2020.101755 |
| 2020-05-30 |
Comparison of the Elecsys® Anti-SARS-CoV-2 immunoassay with the EDITM enzyme linked immunosorbent assays for the detection of SARS-CoV-2 antibodies in human plasma (edit) |
10.1016/J.CCA.2020.05.049 |
| 2020-05-30 |
Diagnostic performances and thresholds: the key to harmonization in serological SARS-CoV-2 assays? (edit) |
10.1016/J.CCA.2020.05.050 |
| 2020-05-30 |
Options for Personal Protective Equipment During the SARS-CoV-2 Pandemic Used in New Orleans, Louisiana (edit) |
10.1016/J.JAIP.2020.05.021 |
| 2020-05-30 |
A recombinant Lactobacillus plantarum strain expressing the spike protein of SARS-CoV-2 (edit) |
10.1016/J.IJBIOMAC.2020.05.239 |
| 2020-05-30 |
Environmental contamination of SARS-CoV-2 during the COVID-19 outbreak in South Korea (edit) |
10.1016/J.AJIC.2020.05.027 |
| 2020-05-30 |
Gastrointestinal endoscopy operation--A potential transmission risk for SARS-CoV-2 (edit) |
10.1016/J.AJIC.2020.05.025 |
| 2020-05-30 |
SARS-CoV-2 molecular and phylogenetic analysis in COVID-19 patients: A preliminary report from Iran (edit) |
10.1016/J.MEEGID.2020.104387 |
| 2020-05-30 |
SARS-CoV-2 Infection and the Liver (edit) |
10.3390/PATHOGENS9060430 |
| 2020-05-30 |
Persistent detection of SARS-CoV-2 RNA in patients and healthcare workers with COVID-19 (edit) |
10.1016/J.JCV.2020.104477 |
| 2020-05-30 |
Novel therapeutic targets for SARS-CoV-2-induced acute lung injury: Targeting a potential IL-1β/neutrophil extracellular traps feedback loop (edit) |
10.1016/J.MEHY.2020.109906 |
| 2020-05-30 |
Ribosomal proteins as a possible tool for blocking SARS-COV 2 virus replication for a potential prospective treatment (edit) |
10.1016/J.MEHY.2020.109904 |
| 2020-05-30 |
N-Acetylcysteine: A potential therapeutic agent for SARS-CoV-2 (edit) |
10.1016/J.MEHY.2020.109862 |
| 2020-05-30 |
Periodontal pockets: A potential reservoir for SARS-CoV-2? (edit) |
10.1016/J.MEHY.2020.109907 |
| 2020-05-30 |
Implementation of rapid SARS-CoV-2 antigenic testing in a laboratory without access to molecular methods: Experiences of a general hospital (edit) |
10.1016/J.JCV.2020.104472 |
| 2020-05-30 |
SARS-CoV-2 PCR and antibody testing for an entire rural community: methods and feasibility of high-throughput testing procedures (edit) |
10.1101/2020.05.29.20116426 |
| 2020-05-30 |
Early transmission of SARS-CoV-2 in South Africa: An epidemiological and phylogenetic report (edit) |
10.1101/2020.05.29.20116376 |
| 2020-05-30 |
A serological assay to detect SARS-CoV-2 antibodies in at-home collected finger-prick dried blood spots (edit) |
10.1101/2020.05.29.20116004 |
| 2020-05-30 |
Expression of angiotensin-converting enzyme 2 and proteases in COVID-19 patients: A potential role of cellular FURIN in the pathogenesis of SARS-CoV-2 (edit) |
10.1016/J.MEHY.2020.109893 |
| 2020-05-30 |
SARS-Cov-2RNA found on particulate matter of Bergamo in Northern Italy: First evidence (edit) |
10.1016/J.ENVRES.2020.109754 |
| 2020-05-30 |
The continuum of SARS-CoV-2's neurotropism and the potential for immune-mediated neuronal injury (edit) |
10.1016/J.SEIZURE.2020.05.014 |
| 2020-05-30 |
Structural and Biochemical Characterization of the nsp12-nsp7-nsp8 Core Polymerase Complex from SARS-CoV-2 (edit) |
10.1016/J.CELREP.2020.107774 |
| 2020-05-30 |
SARS-CoV-2-A Tough Opponent for the Immune System (edit) |
10.1016/J.ARCMED.2020.05.020 |
| 2020-05-30 |
Nepalese Medical Students in the COVID-19 Pandemic: Ways Forward (edit) |
10.31729/JNMA.4924 |
| 2020-05-30 |
SARS-CoV-2 coinfections: Could influenza and the common cold be beneficial? (edit) |
10.1002/JMV.26098 |
| 2020-05-30 |
Smell and taste disorders: warning signs for SARS-CoV-2 infection (edit) |
10.1016/J.BJORL.2020.05.003 |
| 2020-05-30 |
Structure-based Design of Prefusion-stabilized SARS-CoV-2 Spikes (edit) |
10.1101/2020.05.30.125484 |
| 2020-05-30 |
Sars-CoV-2 Envelope and Membrane Proteins: Structural Differences Linked to Virus Characteristics? (edit) |
10.1155/2020/4389089 |
| 2020-05-30 |
Nurse Educators as Agents of Change in the SARS-CoV-2 Pandemic (edit) |
10.1016/J.NWH.2020.05.010 |
| 2020-05-30 |
Telehealth in the times of SARS-CoV-2 infection for the otolaryngologist (edit) |
10.1016/J.WJORL.2020.04.008 |
| 2020-05-30 |
Emergent and urgent otologic surgeries during the SARS-CoV-2 pandemic: a protocol and review of literature (edit) |
10.1016/J.WJORL.2020.05.006 |
| 2020-05-29 |
Optimized pseudotyping conditions for the SARS-COV2 Spike glycoprotein (edit) |
10.1101/2020.05.28.122671 |
| 2020-05-29 |
Bioengineered probiotics to control SARS-CoV-2 infection (edit) |
10.3897/RIO.6.E54802 |
| 2020-05-29 |
Temporal evolution and adaptation of SARS-COV-2 codon usage (edit) |
10.1101/2020.05.29.123976 |
| 2020-05-29 |
Shortlisting Phytochemicals Exhibiting Inhibitory Activity against Major Proteins of SARS-CoV-2 through Virtual Screening (edit) |
10.21203/RS.3.RS-31834/V1 |
| 2020-05-29 |
Stand on the Same Side - Preventing a Second Wave of Covid-19's Outbreak (edit) |
10.13128/SUBSTANTIA-950 |
| 2020-05-29 |
Welche Probenmaterialien für den Nachweis von SARS-CoV-2? (edit) |
10.1007/S15033-020-1825-2 |
| 2020-05-29 |
Ethnic and socioeconomic differences in SARS-CoV-2 infection: prospective cohort study using UK Biobank (edit) |
10.1186/S12916-020-01640-8 |
| 2020-05-29 |
Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2 (edit) |
10.1038/S41392-020-0191-1 |
| 2020-05-29 |
Novel Coronavirus Disease (COVID-19) and Biologic Therapy for Psoriasis: Successful Recovery in Two Patients After Infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (edit) |
10.1007/S13555-020-00394-8 |
| 2020-05-29 |
Guillain-Barré syndrome with facial diplegia related to SARS-CoV-2 infection (edit) |
10.1017/CJN.2020.106 |
| 2020-05-29 |
Minimizing pharmacotherapy-related healthcare worker exposure to SARS-CoV-2 (edit) |
10.1093/AJHP/ZXAA190 |
| 2020-05-29 |
A novel simple scoring model for predicting severity of patients with SARS-CoV-2 infection (edit) |
10.1111/TBED.13651 |
| 2020-05-29 |
SARS-CoV-2 perturbs the Renin-Angiotensin System and energy metabolism (edit) |
10.1152/AJPENDO.00219.2020 |
| 2020-05-29 |
Detection of SARS-CoV-2 in Human Retinal Biopsies of Deceased COVID-19 Patients (edit) |
10.1080/09273948.2020.1770301 |
| 2020-05-29 |
Docking study of Chloroquine and Hydroxychloroquine interaction with SARS-CoV-2 spike glycoprotein-An in silico insight into the comparative efficacy of repurposing antiviral drugs (edit) |
10.1080/07391102.2020.1775703 |
| 2020-05-29 |
Withanone and withaferin-A are predicted to interact with transmembrane protease serine 2 (TMPRSS2) and block entry of SARS-CoV-2 into cells (edit) |
10.1080/07391102.2020.1775704 |
| 2020-05-29 |
Potential RNA-dependent RNA polymerase inhibitors as prospective therapeutics against SARS-CoV-2 (edit) |
10.1099/JMM.0.001203 |
| 2020-05-29 |
Universal and Serial Laboratory Testing for SARS-CoV-2 at a Long-Term Care Skilled Nursing Facility for Veterans - Los Angeles, California, 2020 (edit) |
10.15585/MMWR.MM6921E1 |
| 2020-05-29 |
What We Need to Consider During and After the SARS-CoV-2 Pandemic (edit) |
10.1089/VBZ.2020.2652 |
| 2020-05-29 |
Pathogen reduction of SARS-CoV-2 virus in plasma and whole blood using riboflavin and UV light (edit) |
10.1371/JOURNAL.PONE.0233947 |
| 2020-05-29 |
Reply to 'Ibuprofen and thromboembolism in SARS-COV2' (edit) |
10.1111/JTH.14934 |
| 2020-05-29 |
Glucocorticoid therapy delays the clearance of SARS-CoV-2 RNA in an asymptomatic COVID-19 patient (edit) |
10.1002/JMV.26086 |
| 2020-05-29 |
Recurrent positive SARS-CoV-2 - immune certificate may not be valid (edit) |
10.1002/JMV.26074 |
| 2020-05-29 |
The Novel Coronavirus SARS-CoV-2: From a Zoonotic Infection to Coronavirus Disease-19 (COVID19) (edit) |
10.1002/JMV.26072 |
| 2020-05-29 |
Are we now observing an increasing number of coinfections between SARS-CoV-2 and other respiratory pathogens? (edit) |
10.1002/JMV.26089 |
| 2020-05-29 |
The potential transmission of SARS-CoV-2 from patients with negative RT-PCR swab tests to others: two related clusters of COVID-19 outbreak (edit) |
10.7883/YOKEN.JJID.2020.165 |
| 2020-05-29 |
A Case of COVID-19 Patient with False-negative for SARS-CoV-2 of Pharyngeal Swab, from a Chinese traveller Returning from Wuhan, Hubei Province, China, January 2020 (edit) |
10.7883/YOKEN.JJID.2020.240 |
| 2020-05-29 |
It is currently unknown whether SARS-CoV-2 is viable in semen or whether COVID-19 damages sperm (edit) |
10.1111/ANDR.12831 |
| 2020-05-29 |
Novel Immunoglobulin Domain Proteins Provide Insights into Evolution and Pathogenesis of SARS-CoV-2-Related Viruses (edit) |
10.1128/MBIO.00760-20 |
| 2020-05-29 |
Introductions and early spread of SARS-CoV-2 in the New York City area (edit) |
10.1126/SCIENCE.ABC1917 |
| 2020-05-29 |
Responding to SARS-CoV-2 in South Africa: What can we learn from drug-resistant tuberculosis? (edit) |
10.1183/13993003.01369-2020 |
| 2020-05-29 |
Detection of air and surface contamination by SARS-CoV-2 in hospital rooms of infected patients (edit) |
10.1038/S41467-020-16670-2 |
| 2020-05-29 |
Relationship between ACE-inhibitors, ARBs and SARS-CoV-2 infection: where are we? (edit) |
10.23736/S0026-4725.20.05271-8 |
| 2020-05-29 |
Suitability and Sufficiency of telehealth clinician-observed participant-collected samples for SARS-CoV2 testing: the iCollect Cohort Pilot Study (edit) |
10.2196/19731 |
| 2020-05-29 |
SARS-CoV-2 Antibody Testing - Questions to be asked (edit) |
10.1016/J.JACI.2020.05.020 |
| 2020-05-29 |
Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study (edit) |
10.1016/S0140-6736(20)31182-X |
| 2020-05-29 |
Lack of Antiviral Activity of Darunavir against SARS-CoV-2 (edit) |
10.1016/J.IJID.2020.05.085 |
| 2020-05-29 |
Nasoseptal Flap Necrosis After Endoscopic Skull Base Surgery in the Setting of SARS-CoV-2/COVID-19 (edit) |
10.1016/J.WNEU.2020.05.237 |
| 2020-05-29 |
Selective CD8 cell reduction by SARS-CoV-2 is associated with a worse prognosis and systemic inflammation in COVID-19 patients (edit) |
10.1016/J.CLIM.2020.108486 |
| 2020-05-29 |
Emergence of SARS-CoV-2 through recombination and strong purifying selection (edit) |
10.1126/SCIADV.ABB9153 |
| 2020-05-29 |
Rates of symptomatic SARS-CoV-2 infection in patients with autoimmune liver diseases in Northern Italy: a telemedicine study (edit) |
10.1016/J.CGH.2020.05.047 |
| 2020-05-29 |
In Silico Evaluation of the Effectivity of Approved Protease Inhibitors against the Main Protease of the Novel SARS-CoV-2 Virus (edit) |
10.3390/MOLECULES25112529 |
| 2020-05-29 |
A Review on SARS-CoV-2 Virology, Pathophysiology, Animal Models, and Anti-Viral Interventions (edit) |
10.3390/PATHOGENS9060426 |
| 2020-05-29 |
17β-Estradiol, a potential ally to alleviate SARS-CoV-2 infection (edit) |
10.6061/CLINICS/2020/E1980 |
| 2020-05-29 |
Disproportionate Case Reduction After Ban of Elective Surgeries During the SARS-CoV-2 Pandemic (edit) |
10.1097/BSD.0000000000001017 |
| 2020-05-29 |
Airborne SARS-CoV-2: Weighing the Evidence for Its Role in Community Transmission (edit) |
10.3961/JPMPH.20.120 |
| 2020-05-29 |
Earlier and widespread screening for SARS-CoV-2 is needed for first responders (edit) |
10.1016/J.AJEM.2020.05.070 |
| 2020-05-29 |
Immunologic characterization of a immunosuppressed multiple sclerosis patient that recovered from SARS-CoV-2 infection (edit) |
10.1016/J.JNEUROIM.2020.577282 |
| 2020-05-29 |
SARS-COV-2 associated acute pancreatitis: Cause, consequence or epiphenomenon? (edit) |
10.1016/J.PAN.2020.05.019 |
| 2020-05-29 |
SARS-CoV-2, "common cold" coronaviruses' cross-reactivity and "herd immunity": The razor of Ockham (1285-1347)? (edit) |
10.4081/IDR.2020.8647 |
| 2020-05-29 |
A SARS-CoV-2 serological assay to determine the presence of blocking antibodies that compete for human ACE2 binding (edit) |
10.1101/2020.05.27.20114652 |
| 2020-05-29 |
Structures of human antibodies bound to SARS-CoV-2 spike reveal common epitopes and recurrent features of antibodies (edit) |
10.1101/2020.05.28.121533 |
| 2020-05-29 |
SARS-CoV-2 infection induces EMT-like molecular changes, including ZEB1-mediated repression of the viral receptor ACE2, in lung cancer models (edit) |
10.1101/2020.05.28.122291 |
| 2020-05-29 |
Evidence of significant natural selection in the evolution of SARS-CoV-2 in bats, not humans (edit) |
10.1101/2020.05.28.122366 |
| 2020-05-29 |
An Italian Neurology Outpatient Clinic Facing SARS-CoV-2 Pandemic: Data From 2,167 Patients (edit) |
10.3389/FNEUR.2020.00564 |
| 2020-05-29 |
Lessons Learned to Date on COVID-19 Hyperinflammatory Syndrome: Considerations for Interventions to Mitigate SARS-CoV-2 Viral Infection and Detrimental Hyperinflammation (edit) |
10.3389/FIMMU.2020.01131 |
| 2020-05-29 |
An Online Observational Study of Patients With Olfactory and Gustory Alterations Secondary to SARS-CoV-2 Infection (edit) |
10.3389/FPUBH.2020.00243 |
| 2020-05-29 |
Transmission of SARS-CoV-2 and Other Infections at Large Sports Gatherings: A Surprising Gap in Our Knowledge (edit) |
10.3389/FMED.2020.00277 |
| 2020-05-29 |
Covid-19 and cardiovascular risk: Susceptibility to infection to SARS-CoV-2, severity and prognosis of Covid-19 and blockade of the renin-angiotensin-aldosterone system. An evidence-based viewpoint (edit) |
10.1016/J.NUMECD.2020.05.013 |
| 2020-05-29 |
Assessment of SARS-CoV-2 in human semen-a cohort study (edit) |
10.1016/J.FERTNSTERT.2020.05.028 |
| 2020-05-28 |
Comprehensive Transcriptomic Analysis of COVID-19 Blood, Lung, and Airway (edit) |
10.1101/2020.05.28.121889 |
| 2020-05-28 |
Trained Immunity: a Tool for Reducing Susceptibility to and the Severity of SARS-CoV-2 Infection (edit) |
10.1016/J.CELL.2020.04.042 |
| 2020-05-28 |
The amount of cytokine-release defines different shades of Sars-Cov2 infection (edit) |
10.1177/1535370220928964 |
| 2020-05-28 |
Associations of hypertension with the severity and fatality of SARS-CoV-2 infection: A meta-analysis (edit) |
10.1017/S095026882000117X |
| 2020-05-28 |
Complete Genome Sequence of SARS-CoV-2 in a Tiger from a U.S. Zoological Collection (edit) |
10.1128/MRA.00468-20 |
| 2020-05-28 |
Coding-Complete Genome Sequences of Two SARS-CoV-2 Isolates from Egypt (edit) |
10.1128/MRA.00489-20 |
| 2020-05-28 |
Clinical Evaluation and Utilization of Multiple Molecular In Vitro Diagnostic Assays for the Detection of SARS-CoV-2 (edit) |
10.1093/AJCP/AQAA097 |
| 2020-05-28 |
More bricks in the wall against SARS-CoV-2 infection: involvement of γ9δ2 T cells (edit) |
10.1038/S41423-020-0473-0 |
| 2020-05-28 |
The Allplex 2019-nCoV (Seegene) assay: which performances are for SARS-CoV-2 infection diagnosis? (edit) |
10.1007/S10096-020-03930-8 |
| 2020-05-28 |
Clinical features and outcome of HIV/SARS-CoV-2 co-infected patients in the Bronx, New York City (edit) |
10.1002/JMV.26077 |
| 2020-05-28 |
Coinfection with SARS-CoV-2 and other respiratory pathogens in COVID-19 patients in Guangzhou, China (edit) |
10.1002/JMV.26073 |
| 2020-05-28 |
COVID-19: Consider IL6 receptor antagonist for the therapy of cytokine storm syndrome in SARS-CoV-2 infected patients (edit) |
10.1002/JMV.26078 |
| 2020-05-28 |
The Diagnosis of SARS-CoV2 Pneumonia: A Review of Laboratory and Radiological Testing Results (edit) |
10.1002/JMV.26081 |
| 2020-05-28 |
Sex-based dimorphism in the SARS-CoV2 virulence (edit) |
10.1111/JOIM.13093 |
| 2020-05-28 |
Oxygen-ozone therapy as adjuvant in the current emergency in SARS-COV-2 infection: a clinical study (edit) |
10.23812/20-250-E-56 |
| 2020-05-28 |
Characteristics of Children With Reactivation of SARS-CoV-2 Infection After Hospital Discharge (edit) |
10.1177/0009922820928057 |
| 2020-05-28 |
Identification of Potential Inhibitors of SARS-COV-2 Endoribonuclease (EndoU) from FDA Approved Drugs: A Drug Repurposing Approach to find Therapeutics for COID19 (edit) |
10.1080/07391102.2020.1775127 |
| 2020-05-28 |
A computational prediction of SARS-CoV-2 structural protein inhibitors from Azadirachta indica (Neem) (edit) |
10.1080/07391102.2020.1774419 |
| 2020-05-28 |
A Novel Vaccine Employing Non-Replicating Rabies Virus Expressing Chimeric SARS-CoV-2 Spike Protein Domains: Functional Inhibition of Viral/Nicotinic Acetylcholine Receptor Complexes (edit) |
10.12659/MSM.926016 |
| 2020-05-28 |
Clinical Utility of Buccal Swabs for Sars-Cov-2 Detection in Covid-19-Infected Children (edit) |
10.1093/JPIDS/PIAA068 |
| 2020-05-28 |
Is the Rigidity of SARS-CoV-2 Spike Receptor-Binding Motif the Hallmark for Its Enhanced Infectivity? Insights from All-Atoms Simulations (edit) |
10.1021/ACS.JPCLETT.0C01148 |
| 2020-05-28 |
[SARS-CoV-2 infection and its relation with the nutritional status] (edit) |
|
| 2020-05-28 |
Metatranscriptomic Characterization of COVID-19 Identified A Host Transcriptional Classifier Associated With Immune Signaling (edit) |
10.1093/CID/CIAA663 |
| 2020-05-28 |
Familial cluster of SARS-CoV-2 infection associated with a railway journey (edit) |
10.1093/JTM/TAAA088 |
| 2020-05-28 |
Treating the SARS-CoV-2-positive patient with cancer: A proposal for a pragmatic and transparent ethical process (edit) |
10.1002/CNCR.32962 |
| 2020-05-28 |
[Implementation of an operational concept in an ENT clinic in the context of the SARS-CoV-2 pandemic] (edit) |
10.1055/A-1174-0234 |
| 2020-05-28 |
Implication of SARS-CoV-2 evolution in the sensitivity of RT-qPCR diagnostic assays (edit) |
10.1016/S1473-3099(20)30435-7 |
| 2020-05-28 |
Unfolding SARS-CoV-2 viral genome to understand its gene expression regulation (edit) |
10.1016/J.MEEGID.2020.104386 |
| 2020-05-28 |
Chronic conventional disease-modifying anti-rheumatic drugs masking severe SARS-CoV-2 manifestations in an elderly rheumatic patient (edit) |
10.1016/J.JINF.2020.05.043 |
| 2020-05-28 |
Qualitative serology in patients recovered from SARS CoV 2 infection (edit) |
10.1016/J.JINF.2020.05.057 |
| 2020-05-28 |
Improved sensitivity using a dual target, E and RdRp assay for the diagnosis of SARS-CoV-2 infection: Experience at a large NHS Foundation Trust in the UK (edit) |
10.1016/J.JINF.2020.05.061 |
| 2020-05-28 |
Co-infection of SARS-CoV-2 and Influenza virus in Early Stage of the COVID-19 Epidemic in Wuhan, China (edit) |
10.1016/J.JINF.2020.05.041 |
| 2020-05-28 |
Persistent SARS-CoV-2 infection and the risk for cancer (edit) |
10.1016/J.MEHY.2020.109882 |
| 2020-05-28 |
Interaction of the prototypical α-ketoamide inhibitor with the SARS-CoV-2 main protease active site in silico: Molecular dynamic simulations highlight the stability of the ligand-protein complex (edit) |
10.1016/J.COMPBIOLCHEM.2020.107292 |
| 2020-05-28 |
Considerations for the management of home parenteral nutrition during the SARS-CoV-2 pandemic: A position paper from the Home Artificial Nutrition and Chronic Intestinal Failure Special Interest Group of ESPEN (edit) |
10.1016/J.CLNU.2020.05.023 |
| 2020-05-28 |
SARS-CoV2 RNA detection in a pancreatic pseudocyst sample (edit) |
10.1016/J.PAN.2020.05.016 |
| 2020-05-28 |
Validation and verification of the Abbott RealTime SARS-CoV-2 assay analytical and clinical performance (edit) |
10.1016/J.JCV.2020.104474 |
| 2020-05-28 |
Integrated sample inactivation, amplification, and Cas13-based detection of SARS-CoV-2 (edit) |
10.1101/2020.05.28.119131 |
| 2020-05-28 |
Single-dose replicating RNA vaccine induces neutralizing antibodies against SARS-CoV-2 in nonhuman primates (edit) |
10.1101/2020.05.28.121640 |
| 2020-05-28 |
Optimizing high-yield production of SARS-CoV-2 soluble spike trimers for serology assays (edit) |
10.1101/2020.05.27.120204 |
| 2020-05-28 |
Seroprevalence of SARS-CoV-2 among children visiting a hospital during the initial Seattle outbreak (edit) |
10.1101/2020.05.26.20114124 |
| 2020-05-28 |
Proteolytic Cleavage of the SARS-CoV-2 Spike Protein and the Role of the Novel S1/S2 Site (edit) |
10.1016/J.ISCI.2020.101212 |
| 2020-05-28 |
SARS-CoV-2 as a protective factor for cardiovascular mortality? (edit) |
10.1016/J.ATHEROSCLEROSIS.2020.05.008 |
| 2020-05-28 |
Tracking the Genomic Footprints of SARS-CoV-2 Transmission (edit) |
10.1016/J.TIG.2020.05.009 |
| 2020-05-28 |
Single-copy sensitive, field-deployable, and simultaneous dual-gene detection of SARS-CoV-2 RNA via modified RT-RPA (edit) |
10.1038/S41421-020-0175-X |
| 2020-05-28 |
The eighth alternative to evidence based medicine in the early era of the COVID-19 pandemic: Too much emergency and emotion, too little evidence (edit) |
10.1016/J.EJIM.2020.05.040 |
| 2020-05-28 |
How We Do It: Modified Residency Programming and Adoption of Remote Didactic Curriculum During the COVID-19 Pandemic (edit) |
10.1016/J.JSURG.2020.05.026 |
| 2020-05-28 |
Children and adolescents in the CoVid-19 pandemic: Schools and daycare centers are to be opened again without restrictions. The protection of teachers, educators, carers and parents and the general hygiene rules do not conflict with this (edit) |
10.3205/DGKH000346 |
| 2020-05-28 |
SARS-CoV-2 Infection: Beyond the Interstitial Pneumonia (edit) |
10.1016/J.AMJMS.2020.05.033 |
| 2020-05-28 |
Analysis of Rapidly Emerging Variants in Structured Regions of the SARS-CoV-2 Genome (edit) |
10.1101/2020.05.27.120105 |
| 2020-05-28 |
Innate Immune Signaling and Proteolytic Pathways in the Resolution or Exacerbation of SARS-CoV-2 in Covid-19: Key Therapeutic Targets? (edit) |
10.3389/FIMMU.2020.01229 |
| 2020-05-28 |
Carvedilol and COVID-19: A Potential Role in Reducing Infectivity and Infection Severity of SARS-CoV-2 (edit) |
10.1016/J.AMJMS.2020.05.030 |
| 2020-05-28 |
Potentially repurposable drugs for COVID-19 identified from SARS-CoV-2 Host Protein Interactome (edit) |
10.21203/RS.3.RS-30363/V1 |
| 2020-05-28 |
Travel restrictions and SARS-CoV-2 transmission: an effective distance approach to estimate impact (edit) |
10.2471/BLT.20.255679 |
| 2020-05-27 |
Stochasticity and heterogeneity in the transmission dynamics of SARS-CoV-2 (edit) |
|
| 2020-05-27 |
A theory on SARS-COV-2 susceptibility: reduced TLR7-activity as a mechanistic link between men, obese and elderly (edit) |
10.23812/20-221-L-49 |
| 2020-05-27 |
Universal SARS-CoV-2 testing on admission to Labor and Delivery: Low prevalence among asymptomatic obstetric patients (edit) |
10.1017/ICE.2020.255 |
| 2020-05-27 |
Are patients with systemic lupus erythematosus more prone to result false-positive for SARS-CoV2 serology? (edit) |
|
| 2020-05-27 |
Ratcheting Down the Virulence of SARS-CoV-2 in the COVID-19 Pandemic (edit) |
10.1002/JMV.26067 |
| 2020-05-27 |
SARS-CoV-2 in urine. - Should Endourologists be concerned and what PPE measures should be taken to protect the Endourologist when in theatre ? (edit) |
10.1089/END.2020.0476 |
| 2020-05-27 |
[Evaluation of different genes in the RT-PCR detection of SARS-CoV-2 in respiratory samples and its evolution in infection] (edit) |
10.37201/REQ/045.2020 |
| 2020-05-27 |
Evaluating the use of posterior oropharyngeal saliva in a point-of-care assay for the detection of SARS-CoV-2 (edit) |
10.1080/22221751.2020.1775133 |
| 2020-05-27 |
Discovery of alliin as a putative inhibitor of the main protease of SARS-CoV-2 by molecular docking (edit) |
10.2144/BTN-2020-0038 |
| 2020-05-27 |
Diagnostic performance of a SARS-CoV-2 IgG/IgM lateral flow immunochromatography assay in symptomatic patients presenting to the emergency department (edit) |
10.1515/CCLM-2020-0635 |
| 2020-05-27 |
SARS-CoV-2 Phylogenetic Analysis, Lazio Region, Italy, February-March 2020 (edit) |
10.3201/EID2608.201525 |
| 2020-05-27 |
Reducing transmission of SARS-CoV-2 (edit) |
10.1126/SCIENCE.ABC6197 |
| 2020-05-27 |
SARS-CoV-2 pandemic: clinical picture of COVID-19 and implications for research (edit) |
10.1136/THORAXJNL-2020-215024 |
| 2020-05-27 |
Guillain-Barré syndrome related to SARS-CoV-2 infection (edit) |
10.1212/NXI.0000000000000785 |
| 2020-05-27 |
Comparison of the Accula SARS-CoV-2 Test with a Laboratory-Developed Assay for Detection of SARS-CoV-2 RNA in Clinical Nasopharyngeal Specimens (edit) |
10.1128/JCM.01072-20 |
| 2020-05-27 |
Comparison of two commercial molecular tests and a laboratory-developed modification of the CDC 2019-nCoV RT-PCR assay for the detection of SARS-CoV-2 (edit) |
10.1128/JCM.00938-20 |
| 2020-05-27 |
Patients with Common Cold Coronaviruses Tested Negative for IgG Antibody to SARS-CoV-2 (edit) |
10.1128/JCM.01029-20 |
| 2020-05-27 |
Anosmia and dysgeusia associated with SARS-CoV-2 infection: an age-matched case-control study (edit) |
10.1503/CMAJ.200869 |
| 2020-05-27 |
Acute Portal Vein Thrombosis in SARS-CoV-2 Infection: A Case Report (edit) |
10.14309/AJG.0000000000000711 |
| 2020-05-27 |
High prevalence of antinuclear antibodies and lupus anticoagulant in patients hospitalized for SARS-CoV2 pneumonia (edit) |
10.1007/S10067-020-05180-7 |
| 2020-05-27 |
Animal models of mechanisms of SARS-CoV-2 infection and COVID-19 pathology (edit) |
10.1111/BPH.15143 |
| 2020-05-27 |
Shortlisting SARS-CoV-2 Peptides for Targeted Studies from Experimental Data-Dependent Acquisition Tandem Mass Spectrometry Data (edit) |
10.1002/PMIC.202000107 |
| 2020-05-27 |
Has the SARS-CoV-2 outbreak influenced the uptake of a popular smoking cessation app in UK smokers? An interrupted time series analysis (edit) |
10.2196/19494 |
| 2020-05-27 |
[Rapid point-of-care serology testing for sars-cov-2] (edit) |
|
| 2020-05-27 |
SARS-CoV-2 and Research Funding: Do No Harm (edit) |
10.1089/HS.2020.0053 |
| 2020-05-27 |
Metformin and SARS-CoV-2: mechanistic lessons on air pollution to weather the cytokine/thrombotic storm in COVID-19 (edit) |
10.18632/AGING.103347 |
| 2020-05-27 |
Prediction of Novel Inhibitors of the Main Protease (M-pro) of SARS-CoV-2 through Consensus Docking and Drug Reposition (edit) |
10.3390/IJMS21113793 |
| 2020-05-27 |
Cannabinoid Receptor Type 2: A Possible Target in SARS-CoV-2 (CoV-19) Infection? (edit) |
10.3390/IJMS21113809 |
| 2020-05-27 |
Spatial-Temporal Variations in Atmospheric Factors Contribute to SARS-CoV-2 Outbreak (edit) |
10.3390/V12060588 |
| 2020-05-27 |
Impact of SARS-CoV2 (Covid-19) on dental practices: Economic analysis (edit) |
10.1016/J.JDENT.2020.103387 |
| 2020-05-27 |
Single cell RNA sequencing analysis did not predict hepatocyte infection by SARS-CoV-2 (edit) |
10.1016/J.JHEP.2020.05.030 |
| 2020-05-27 |
A Mouse Model of SARS-CoV-2 Infection and Pathogenesis (edit) |
10.1016/J.CHOM.2020.05.020 |
| 2020-05-27 |
Current evidence on pancreatic involvement in SARS-CoV-2 infection (edit) |
10.1016/J.PAN.2020.05.015 |
| 2020-05-27 |
A SARS-CoV-2 familial cluster infection reveals asymptomatic transmission to children (edit) |
10.1016/J.JIPH.2020.05.018 |
| 2020-05-27 |
"The ancient and the new": is there an interaction between cytomegalovirus and SARS-CoV-2 infection? (edit) |
10.1186/S12979-020-00185-X |
| 2020-05-27 |
Alltest rapid lateral flow immunoassays is reliable in diagnosing SARS-CoV-2 infection from 14 days after symptom onset: A prospective single-center study (edit) |
10.1016/J.JCV.2020.104473 |
| 2020-05-27 |
Evaluation of the commercially available LightMix® Modular E-gene kit using clinical and proficiency testing specimens for SARS-CoV-2 detection (edit) |
10.1016/J.JCV.2020.104476 |
| 2020-05-27 |
SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract (edit) |
10.1016/J.CELL.2020.05.042 |
| 2020-05-27 |
[The RAAS and SARS-CoV-2: A riddle to solve] (edit) |
10.1016/J.HIPERT.2020.05.005 |
| 2020-05-27 |
The Covid-19 pandemic (edit) |
10.1111/1740-9713.01396 |
| 2020-05-27 |
The impact of the Covid-19 pandemic on Italian mobility (edit) |
10.1111/1740-9713.01400 |
| 2020-05-27 |
Effectiveness of corticoid pulses in patients with cytokine storm syndrome induced by SARS-CoV-2 infection (edit) |
10.1016/J.MEDCLI.2020.04.018 |
| 2020-05-27 |
Management of clozapine treatment during the COVID-19 pandemic (edit) |
10.1177/2045125320928167 |
| 2020-05-27 |
Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling (edit) |
10.1101/2020.05.27.118893 |
| 2020-05-27 |
Development and validation of IMMUNO-COV™: a high-throughput clinical assay for detecting antibodies that neutralize SARS-CoV-2 (edit) |
10.1101/2020.05.26.117549 |
| 2020-05-27 |
Fighting the Host Reaction to SARS-COv-2 in Critically Ill Patients: The Possible Contribution of Off-Label Drugs (edit) |
10.3389/FIMMU.2020.01201 |
| 2020-05-27 |
Could SARS-CoV-2-Induced Hyperinflammation Magnify the Severity of Coronavirus Disease (CoViD-19) Leading to Acute Respiratory Distress Syndrome? (edit) |
10.3389/FIMMU.2020.01206 |
| 2020-05-27 |
Challenging clinical and organizational scenarios in cardiovascular diseases during the SARS-CoV-2 pandemic in Poland. Can we do better? (edit) |
10.5114/AIC.2020.95734 |
| 2020-05-27 |
Bioengineering tools to speed up the discovery and preclinical testing of vaccines for SARS-CoV-2 and therapeutic agents for COVID-19 (edit) |
10.7150/THNO.47406 |
| 2020-05-27 |
Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2 (edit) |
10.2139/SSRN.3606354 |
| 2020-05-27 |
The Heterogeneous Landscape and Early Evolution of Pathogen-Associated CpG Dinucleotides in SARS-CoV-2 (edit) |
10.2139/SSRN.3611280 |
| 2020-05-27 |
Elective Surgery during SARS-Cov-2/COVID-19 Pandemic: Safety Protocols with Literature Review (edit) |
10.1097/GOX.0000000000002973 |
| 2020-05-26 |
Simeprevir potently suppresses SARS-CoV-2 replication and synergizes with remdesivir (edit) |
10.1101/2020.05.26.116020 |
| 2020-05-26 |
Generation of human bronchial organoids for SARS-CoV-2 research (edit) |
10.1101/2020.05.25.115600 |
| 2020-05-26 |
IMPACT OF GLUCOCORTICOID TREATMENT IN SARS-COV-2 INFECTION MORTALITY: A RETROSPECTIVE CONTROLLED COHORT STUDY (edit) |
10.1101/2020.05.22.20110544 |
| 2020-05-26 |
Emergence of Low-density Inflammatory Neutrophils Correlates with Hypercoagulable State and Disease Severity in COVID-19 Patients (edit) |
10.1101/2020.05.22.20106724 |
| 2020-05-26 |
Tensions between research and public health: modelling the risks and benefits of SARS-CoV-2 vaccine field trials versus human infection challenge studies (edit) |
10.1101/2020.05.18.20106187 |
| 2020-05-26 |
Considering the Effects of Microbiome and Diet on SARS-CoV-2 Infection: Nanotechnology Roles (edit) |
10.1021/ACSNANO.0C03402 |
| 2020-05-26 |
Sars-CoV-2 Induced Coagulopathy and Prognosis in Hospitalized Patients: A Snapshot from Italy (edit) |
10.1055/S-0040-1712918 |
| 2020-05-26 |
SARS-CoV-2 Ausbruchssituation: Appell an den Bundesgesundheitsminister und die Gesundheitsbehörden der Bundesländer zur Verschiebung der Umsetzung des Vertriebsweges von Gerinnungsfaktorenzubereitungen (edit) |
10.1055/A-1081-6879 |
| 2020-05-26 |
Late onset of acral necrosis after SARS-CoV-2 infection resolution (edit) |
10.1111/JDV.16668 |
| 2020-05-26 |
Ophthalmology and SARS-CoV-2: Blind toward those who fight blindness? (edit) |
10.1177/1120672120929961 |
| 2020-05-26 |
Inappropriate Nasopharyngeal Sampling for SARS-CoV-2 Detection Is a Relevant Cause of False-Negative Reports (edit) |
10.1177/0194599820931793 |
| 2020-05-26 |
Molecular Detection of SARS-CoV-2 Infection in FFPE Samples and Histopathologic Findings in Fatal SARS-CoV-2 Cases (edit) |
10.1093/AJCP/AQAA091 |
| 2020-05-26 |
Complications and outcomes of SARS-CoV-2 in pregnancy: where and what is the evidence? (edit) |
10.1080/10641955.2020.1769645 |
| 2020-05-26 |
Onset of occupational hand eczema among healthcare workers during the SARS-CoV-2 pandemic - comparing a single surgical site with a COVID-19 intensive care unit (edit) |
10.1111/COD.13618 |
| 2020-05-26 |
[About public health communication strategies and campaigns: what do you know about 2019-nCoV?] (edit) |
|
| 2020-05-26 |
Abdominal fluid samples (negative for SARS-CoV-2) from a critically unwell patient with respiratory COVID-19 (edit) |
10.1002/BJS.11713 |
| 2020-05-26 |
Caution in the management of SARS-CoV-2 infection in males (edit) |
10.1111/ANDR.12829 |
| 2020-05-26 |
SARS-CoV-2 strategically mimics proteolytic activation of human ENaC (edit) |
10.7554/ELIFE.58603 |
| 2020-05-26 |
Indications and timing for tracheostomy in patients with SARS CoV2-related (edit) |
10.1007/S00405-020-06068-7 |
| 2020-05-26 |
Prevalence of SARS-CoV-2 Among Patients Admitted for Childbirth in Southern Connecticut (edit) |
10.1001/JAMA.2020.8904 |
| 2020-05-26 |
Adverse Consequences of Rushing a SARS-CoV-2 Vaccine: Implications for Public Trust (edit) |
10.1001/JAMA.2020.8917 |
| 2020-05-26 |
Post-infectious Guillain-Barré syndrome related to SARS-CoV-2 infection: a case report (edit) |
10.1007/S00415-020-09907-Z |
| 2020-05-26 |
Miller-Fisher-like syndrome related to SARS-CoV-2 infection (COVID 19) (edit) |
10.1007/S00415-020-09912-2 |
| 2020-05-26 |
Sars-CoV-2 in the context of past coronaviruses epidemics: Consideration for prenatal care (edit) |
10.1002/PD.5759 |
| 2020-05-26 |
SARS-CoV-2 Presence in seminal fluid: myth or reality (edit) |
10.1111/ANDR.12825 |
| 2020-05-26 |
More on Neurologic Features in Severe SARS-CoV-2 Infection (edit) |
10.1056/NEJMC2015132 |
| 2020-05-26 |
More on Neurologic Features in Severe SARS-CoV-2 Infection. Reply (edit) |
10.1056/NEJMC2015132 |
| 2020-05-26 |
Gangrenous cholecystitis during hospitalization for SARS-CoV2 infection (edit) |
10.1007/S13304-020-00814-6 |
| 2020-05-26 |
Rapid and robust bioanalytical assays are critical for SARS-CoV-2 therapeutic and vaccine development and beyond (edit) |
10.4155/BIO-2020-0116 |
| 2020-05-26 |
"The storm has arrived": the impact of SARS-CoV-2 on medical students (edit) |
10.1007/S40037-020-00592-2 |
| 2020-05-26 |
Clinical Significance of Blue-Green Neutrophil and Monocyte Cytoplasmic Inclusions in SARS-CoV-2 Positive Critically Ill Patients (edit) |
10.1111/BJH.16882 |
| 2020-05-26 |
Cutaneous small-vessel vasculitis associated with novel 2019 coronavirus SARS-CoV-2 infection (COVID-19) (edit) |
10.1111/JDV.16663 |
| 2020-05-26 |
SARS-CoV-2, bacterial co-infections, and AMR: the deadly trio in COVID-19? (edit) |
10.15252/EMMM.202012560 |
| 2020-05-26 |
Mass Drug Administration and Worms Experience in Africa: Envisage Repurposing Ivermectin for SARS-COV-2 (edit) |
10.4269/AJTMH.20-0295 |
| 2020-05-26 |
Potential Immunoregulatory and Antiviral/SARS-CoV-2 Activities of Nitric Oxide (edit) |
10.12659/MSM.925679 |
| 2020-05-26 |
A human neutralizing antibody targets the receptor binding site of SARS-CoV-2 (edit) |
10.1038/S41586-020-2381-Y |
| 2020-05-26 |
Human neutralizing antibodies elicited by SARS-CoV-2 infection (edit) |
10.1038/S41586-020-2380-Z |
| 2020-05-26 |
Model for Taking Care of Patients with Early Childhood Caries during the SARS-Cov-2 Pandemic (edit) |
10.3390/IJERPH17113751 |
| 2020-05-26 |
Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2 (edit) |
10.3390/V12060582 |
| 2020-05-26 |
Analysis of SARS-CoV-2 Screening Clinic (Including Drive-Through System) Data at a Single University Hospital in South Korea from 27 January 2020 to 31 March 2020 during the COVID-19 Outbreak (edit) |
10.3390/HEALTHCARE8020145 |
| 2020-05-26 |
Early Phylogenetic Diversification of SARS-CoV-2: Determination of Variants and the Effect on Epidemiology, Immunology, and Diagnostics (edit) |
10.3390/JCM9061615 |
| 2020-05-26 |
Severe SARS-CoV-2 Infection in Children With Suspected Acute Abdomen: A Case Series From a Tertiary Hospital in Spain (edit) |
10.1097/INF.0000000000002777 |
| 2020-05-26 |
Pan‑cancer analysis of transmembrane protease serine 2 and cathepsin L that mediate cellular SARS‑CoV‑2 infection leading to COVID-19 (edit) |
10.3892/IJO.2020.5071 |
| 2020-05-26 |
High throughput virtual screening reveals SARS-CoV-2 multi-target binding natural compounds to lead instant therapy for COVID-19 treatment (edit) |
10.1016/J.IJBIOMAC.2020.05.184 |
| 2020-05-26 |
A case of transient existence of SARS-CoV-2 RNA in the respiratory tract with the absence of anti-SARS-CoV-2 antibody response (edit) |
10.1016/J.IJID.2020.05.070 |
| 2020-05-26 |
Clinical Characteristics of Critically Ill Patients Co-infected with SARS-CoV-2 and the Influenza Virus in Wuhan, China (edit) |
10.1016/J.IJID.2020.05.068 |
| 2020-05-26 |
Invasive pulmonary aspergillosis complicating SARS-CoV-2 pneumonia: A diagnostic challenge (edit) |
10.1016/J.TMAID.2020.101752 |
| 2020-05-26 |
SARS-CoV-2: Naso-bronchial cytological correlations (edit) |
10.1016/J.AMJOTO.2020.102549 |
| 2020-05-26 |
SARS-CoV-2 infection serology: a useful tool to overcome lockdown? (edit) |
10.1038/S41420-020-0275-2 |
| 2020-05-26 |
COVID-19 serology at population scale: SARS-CoV-2-specific antibody responses in saliva (edit) |
10.1101/2020.05.24.20112300 |
| 2020-05-26 |
A Unique Clade of SARS-CoV-2 Viruses is Associated with Lower Viral Loads in Patient Upper Airways (edit) |
10.1101/2020.05.19.20107144 |
| 2020-05-26 |
SARS-CoV-2 known and unknowns, implications for the water sector and wastewater-based epidemiology to support national responses worldwide: early review of global experiences with the COVID-19 pandemic (edit) |
10.2166/WQRJ.2020.100 |
| 2020-05-26 |
Contribution of certified registered nurse anaesthetists to the management of the COVID-19 pandemic health crisis (edit) |
10.1016/J.ICCN.2020.102888 |
| 2020-05-26 |
Procedures to minimize viral diffusion in the intensive care unit during the COVID-19 pandemic (edit) |
10.1016/J.ICCN.2020.102894 |
| 2020-05-26 |
Rapid Decline in Online Search Queries for Hip and Knee Arthroplasties Concurrent With the COVID-19 Pandemic (edit) |
10.1016/J.ARTH.2020.05.051 |
| 2020-05-26 |
Clinical Characteristics and Outcome for Four SARS-CoV-2-infected Cancer Patients Treated with Immune Checkpoint Inhibitors (edit) |
10.1016/J.EURURO.2020.05.024 |
| 2020-05-26 |
Recommendations of the Polish Society of Forensic Medicine and Criminology and National Consultant for forensic medicine with regard to performing forensic post-mortem examinations in case of confirmed COVID-19 disease and suspected SARS CoV-2 infec (edit) |
|
| 2020-05-26 |
Classification criteria for the deceased referred for forensic post-mortem examinations with regard to epidemiological risk posed by SARS CoV-2/COVID-19 during the pandemic (edit) |
|
| 2020-05-26 |
Methylation Pathways and SARS-CoV-2 Lung Infiltration and Cell Membrane-Virus Fusion Are Both Subject to Epigenetics (edit) |
10.3389/FCIMB.2020.00290 |
| 2020-05-26 |
Can Stem Cells Beat COVID-19: Advancing Stem Cells and Extracellular Vesicles Toward Mainstream Medicine for Lung Injuries Associated With SARS-CoV-2 Infections (edit) |
10.3389/FBIOE.2020.00554 |
| 2020-05-25 |
Mass Spectrometric detection of SARS-CoV-2 virus in scrapings of the epithelium of the nasopharynx of infected patients via Nucleocapsid N protein (edit) |
10.1101/2020.05.24.113043 |
| 2020-05-25 |
Coronavirus SARS-CoV-2: Hypotheses of Impact on the Circulatory System, Prospects for the Use of Perfluorocarbon Emulsion, and Feasibility of Biophysical Research Methods (edit) |
10.15360/1813-9779-2020-3-0-1 |
| 2020-05-25 |
Immunochromatographic test for the detection of SARS-CoV-2 in saliva (edit) |
10.1101/2020.05.20.20107631 |
| 2020-05-25 |
SARS-CoV-2 epitopes are recognized by a public and diverse repertoire of human T-cell receptors (edit) |
10.1101/2020.05.20.20107813 |
| 2020-05-25 |
The IGNITE Trial: Participant Recruitment Lessons Prior to SARS-CoV-2 (edit) |
10.1101/2020.05.19.20107458 |
| 2020-05-25 |
Genomic surveillance of SARS-CoV-2 in Thailand reveals mixed imported populations, a local lineage expansion and a virus with truncated ORF7a (edit) |
10.1101/2020.05.22.20108498 |
| 2020-05-25 |
SARS-CoV-2 lethality decreased over time in two Italian Provinces (edit) |
10.1101/2020.05.23.20110882 |
| 2020-05-25 |
Anti-SARS-CoV-2 IgG antibodies are associated with reduced viral load (edit) |
10.1101/2020.05.22.20110551 |
| 2020-05-25 |
Spread dynamics of SARS-CoV-2 epidemic in China: a phylogenetic analysis (edit) |
10.1101/2020.05.20.20107854 |
| 2020-05-25 |
Prevalence of SARS-CoV-2 infection among asymptomatic healthcare workers in greater Houston: a cross-sectional analysis of surveillance data from a large healthcare system (edit) |
10.1101/2020.05.21.20107581 |
| 2020-05-25 |
SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood from the San Francisco Bay Area (edit) |
10.1101/2020.05.19.20107482 |
| 2020-05-25 |
Standardization of enzyme-linked immunosorbent assays for serosurveys of the SARS-CoV-2 pandemic using clinical and at-home blood sampling (edit) |
10.1101/2020.05.21.20109280 |
| 2020-05-25 |
SARS-CoV-2 infection in London, England: Impact of lockdown on community point-prevalence, March-May 2020 (edit) |
10.1101/2020.05.21.20109017 |
| 2020-05-25 |
Epidemiological study to detect active SARS-CoV-2 infections and seropositive persons in a selected cohort of employees in the Frankfurt am Main metropolitan area (edit) |
10.1101/2020.05.20.20107730 |
| 2020-05-25 |
COVID-19 Outcomes in 4712 consecutively confirmed SARS-CoV2 cases in the city of Madrid. (edit) |
10.1101/2020.05.22.20109850 |
| 2020-05-25 |
A systems approach to inflammation identifies therapeutic targets in SARS-CoV-2 infection (edit) |
10.1101/2020.05.23.20110916 |
| 2020-05-25 |
Validation of a chemiluminescent assay for specific SARS-CoV-2 antibody (edit) |
10.1515/CCLM-2020-0594 |
| 2020-05-25 |
In-silico strategies for probing chloroquine based inhibitors against SARS-CoV-2 (edit) |
10.1080/07391102.2020.1772111 |
| 2020-05-25 |
Repurposing approved drugs as inhibitors of SARS-CoV-2 S-protein from molecular modeling and virtual screening (edit) |
10.1080/07391102.2020.1772885 |
| 2020-05-25 |
Structural and Simulation analysis of hot spot residues interactions of SARS-CoV 2 with Human ACE2 receptor (edit) |
10.1080/07391102.2020.1773318 |
| 2020-05-25 |
Prevention of thrombosis in pregnant women with suspected SARS-CoV-2 infection: clinical management algorithm (edit) |
10.1002/UOG.22096 |
| 2020-05-25 |
Clinical Significance of a High SARS-CoV-2 Viral Load in the Saliva (edit) |
10.3346/JKMS.2020.35.E195 |
| 2020-05-25 |
SARS-CoV-2 RT-PCR: at least 2 viral targets are needed (edit) |
10.1080/23744235.2020.1769178 |
| 2020-05-25 |
Recurrence of positive SARS-CoV-2 in patients recovered from COVID-19 (edit) |
10.1002/JMV.26056 |
| 2020-05-25 |
Severe SARS-CoV-2 pneumonia in a 58-year-old patient with HIV: a clinical case report from the Republic of Cyprus (edit) |
10.1002/JMV.26053 |
| 2020-05-25 |
SARS-CoV-2 spike glycoprotein-binding proteins expressed by upper respiratory tract bacteria may prevent severe viral infection (edit) |
10.1002/1873-3468.13845 |
| 2020-05-25 |
A Statistical Modeling of the Course of COVID-19 (SARS-CoV-2) Outbreak: A Comparative Analysis (edit) |
10.1177/1010539520928180 |
| 2020-05-25 |
Send cat and dog samples to test for SARS-CoV-2 (edit) |
10.1136/VR.M2019 |
| 2020-05-25 |
SARS-CoV-2: Viral Mechanisms and Possible Therapeutic Targets - What to learn from Rheumatologists? (edit) |
10.3899/JRHEUM.200657 |
| 2020-05-25 |
Does SARS-CoV-2 infection cause chronic neurological complications? (edit) |
10.1007/S11357-020-00207-Y |
| 2020-05-25 |
A DNA Aptamer Based Method for Detection of SARS-CoV-2 Nucleocapsid Protein (edit) |
10.1007/S12250-020-00236-Z |
| 2020-05-25 |
Hyponatremia, IL-6, and SARS-CoV-2 (COVID-19) infection: may all fit together? (edit) |
10.1007/S40618-020-01301-W |
| 2020-05-25 |
Use of an antiviral filter attached to a pleural drain bottle to prevent aerosol contamination with SARS-CoV-2 (edit) |
10.7861/CLINMED.2020-0246 |
| 2020-05-25 |
Could the D614 G substitution in the SARS-CoV-2 spike (S) protein be associated with higher COVID-19 mortality? (edit) |
10.1016/J.IJID.2020.05.071 |
| 2020-05-25 |
Mobile phones: a forgotten source of SARS-CoV-2 transmission (edit) |
10.1016/J.AJIC.2020.05.019 |
| 2020-05-25 |
The impact of novel coronavirus SARS-CoV-2 among healthcare workers in hospitals: An aerial overview (edit) |
10.1016/J.AJIC.2020.05.020 |
| 2020-05-25 |
In Silico computational screening of Kabasura Kudineer - Official Siddha Formulation and JACOM against SARS-CoV-2 spike protein (edit) |
10.1016/J.JAIM.2020.05.009 |
| 2020-05-25 |
Tropical biology and conservation in the time of the COVID-19 pandemic (edit) |
10.1111/BTP.12802 |
| 2020-05-25 |
Factors related to SARS-CoV-2 infection in healthcare professionals in Spain. The SANICOVI project (edit) |
10.1016/J.ENFCLI.2020.05.021 |
| 2020-05-24 |
The ORF8 Protein of SARS-CoV-2 Mediates Immune Evasion through Potently Downregulating MHC-I (edit) |
10.1101/2020.05.24.111823 |
| 2020-05-24 |
Modelling SARS-COV2 Spread in London: Approaches to Lift the Lockdown (edit) |
10.1016/J.JINF.2020.05.037 |
| 2020-05-24 |
A new pharmacological approach based on remdesivir aerosolized administration on sars-cov-2 pulmonary inflammation: a possible and rational therapeutic application (edit) |
10.1016/J.MEHY.2020.109876 |
| 2020-05-24 |
A Rapid Review of the Asymptomatic Proportion of PCR-Confirmed SARS-CoV-2 Infections in Community Settings (edit) |
10.1101/2020.05.20.20108183 |
| 2020-05-24 |
Absence of nosocomial transmission of coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 in the pre-pandemic phase in Hong Kong (edit) |
10.1016/J.AJIC.2020.05.018 |
| 2020-05-24 |
A Systematic Review and Meta-analysis of Therapeutic options against SARS-CoV-2 (edit) |
10.1101/2020.05.20.20108365 |
| 2020-05-24 |
Quantification of SARS-CoV-2 and cross-assembly phage (crAssphage) from wastewater to monitor coronavirus transmission within communities (edit) |
10.1101/2020.05.21.20109181 |
| 2020-05-24 |
Fatal SARS-CoV-2 coinfection in course of EBV-associated lymphoproliferative disease (edit) |
10.1007/S00277-020-04098-Z |
| 2020-05-24 |
Analytical comparisons of SARS-COV-2 detection by qRT-PCR and ddPCR with multiple primer/probe sets (edit) |
10.1080/22221751.2020.1772679 |
| 2020-05-24 |
Duration of SARS-CoV-2 viral RNA in asymptomatic carriers (edit) |
10.1186/S13054-020-02952-0 |
| 2020-05-24 |
New onset of loss of smell or taste in household contacts of home-isolated SARS-CoV-2-positive subjects (edit) |
10.1007/S00405-020-06066-9 |
| 2020-05-24 |
Lack of viral clearance by the combination of hydroxychloroquine and azithromycin or lopinavir and ritonavir in SARS-CoV-2-related acute respiratory distress syndrome (edit) |
10.1186/S13613-020-00678-4 |
| 2020-05-24 |
Specific organization for in-hospital belatacept infusion to avoid nosocomial transmission during the SARS-CoV-2 pandemic (edit) |
10.1111/AJT.16074 |
| 2020-05-24 |
Microbicidal Actives with Virucidal Efficacy against SARS-CoV-2 (edit) |
10.1016/J.AJIC.2020.05.015 |
| 2020-05-24 |
Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases (edit) |
10.1016/J.CLIM.2020.108480 |
| 2020-05-24 |
Genetic variation in SARS-CoV-2 may explain variable severity of COVID-19 (edit) |
10.1016/J.MEHY.2020.109877 |
| 2020-05-24 |
Structure-based drug designing for potential antiviral activity of selected natural products from Ayurveda against SARS-CoV-2 spike glycoprotein and its cellular receptor (edit) |
10.1007/S13337-020-00598-8 |
| 2020-05-23 |
Computational Strategies to Combat COVID-19: Useful Tools to Accelerate SARS-CoV-2 and Coronavirus Research (edit) |
10.20944/PREPRINTS202005.0376.V1 |
| 2020-05-23 |
What do we know about SARS-CoV-2 transmission? A systematic review and meta-analysis of the secondary attack rate, serial interval, and asymptomatic infection (edit) |
10.1101/2020.05.21.20108746 |
| 2020-05-23 |
Análisis del impacto del confinamiento en el número de reproducción del SARS-Cov-2 en España (edit) |
10.1016/J.GACETA.2020.05.003 |
| 2020-05-23 |
Comment et pourquoi adapter le masque Décathlon EasyBreath® pour les soignants prenant en charge des patients infectés par le SARS-CoV-2? (edit) |
10.1016/J.AFORL.2020.05.002 |
| 2020-05-23 |
First detection of SARS-CoV-2 in untreated wastewaters in Italy (edit) |
10.1016/J.SCITOTENV.2020.139652 |
| 2020-05-23 |
Congregate Shelter Characteristics and Prevalence of Asymptomatic SARS-CoV-2 (edit) |
10.1101/2020.05.21.20108985 |
| 2020-05-23 |
Effective Screening of SARS-CoV-2 Neutralizing Antibodies in Patient Serum using Lentivirus Particles Pseudotyped with SARS-CoV-2 Spike Glycoprotein (edit) |
10.1101/2020.05.21.20108951 |
| 2020-05-23 |
Rapid implementation and validation of a cold-chain free SARS-CoV-2 diagnostic testing workflow to support surge capacity (edit) |
10.1016/J.JCV.2020.104469 |
| 2020-05-23 |
A potential role for cyclophosphamide in the mitigation of acute respiratory distress syndrome among patients with SARS-CoV-2 (edit) |
10.1016/J.MEHY.2020.109850 |
| 2020-05-23 |
Trends of SARS-CoV-2 infection worldwide: Role of population density, age structure, and climate on transmission and case fatality (edit) |
10.1101/2020.05.20.20104257 |
| 2020-05-23 |
Co-infections among patients with COVID-19: the need for combination therapy with non-anti-SARS-CoV-2 agents? (edit) |
10.1016/J.JMII.2020.05.013 |
| 2020-05-23 |
Recomendaciones Para El Manejo Del Paciente Con Enfermedad Renal Crónica Con Sars-Cov-2 (edit) |
10.1016/J.ENFCLI.2020.05.017 |
| 2020-05-23 |
Zinc Iodide in combination with Dimethyl Sulfoxide for treatment of SARS-CoV-2 and other viral infections (edit) |
10.1016/J.MEHY.2020.109866 |
| 2020-05-23 |
Development and clinical application of a rapid and sensitive loop-mediated isothermal amplification test for SARS-CoV-2 infection (edit) |
10.1101/2020.05.20.20108530 |
| 2020-05-23 |
Spatial and temporal dynamics of SARS-CoV-2 in COVID-19 patients: A systematic review (edit) |
10.1101/2020.05.21.20108605 |
| 2020-05-23 |
SARS-CoV-2 Associated Guillain-Barre Syndrome with Dysautonomia (edit) |
10.1002/MUS.26988 |
| 2020-05-23 |
Can thrombotic events be a major concern in hepatocellular carcinoma patients under systemic treatment during SARS-Cov-2? (edit) |
10.1111/LIV.14545 |
| 2020-05-23 |
Response to "SARS-CoV-2 Testing and Outcomes in the First 30 Days after the First Case of COVID-19 at an Australian Children's Hospital" (edit) |
10.1111/1742-6723.13560 |
| 2020-05-23 |
Whole nucleocapsid protein of SARS-CoV-2 may cause false positive results in serological assays (edit) |
10.1093/CID/CIAA637 |
| 2020-05-23 |
Lack of Efficacy of SGLT2-i in Severe Pneumonia Related to Novel Coronavirus (nCoV) Infection: No Little Help from Our Friends (edit) |
10.1007/S13300-020-00844-8 |
| 2020-05-23 |
SARS-CoV-2 Infection Leads to Neurological Dysfunction (edit) |
10.1007/S11481-020-09924-9 |
| 2020-05-23 |
Dynamic viral SARS-CoV-2 RNA shedding in in children: preliminary data and clinical consideration of Italian regional center (edit) |
10.1093/JPIDS/PIAA065 |
| 2020-05-23 |
Transmission of SARS-CoV-2 via close contact and respiratory droplets among hACE2 mice (edit) |
10.1093/INFDIS/JIAA281 |
| 2020-05-23 |
SARS-CoV-2 related liver impairment - perception may not be the reality (edit) |
10.1016/J.JHEP.2020.05.025 |
| 2020-05-23 |
Negative Pressure Tent to Reduce Exposure of Health Care Workers to SARS CoV-2 During Aerosol Generating Respiratory Therapies (edit) |
10.1016/J.CHEST.2020.04.070 |
| 2020-05-23 |
High expression of ACE2 on the keratinocytes reveals skin as a potential target for SARS-CoV-2 (edit) |
10.1016/J.JID.2020.05.087 |
| 2020-05-23 |
Proposed Resumption of Surgery Algorithm Following the Corona Virus SARS-CoV-2 Pandemic (edit) |
10.1016/J.JVS.2020.05.024 |
| 2020-05-23 |
Evaluation of the EUROIMMUN Anti-SARS-CoV-2 ELISA Assay for detection of IgA and IgG antibodies (edit) |
10.1016/J.JCV.2020.104468 |
| 2020-05-23 |
Age-related expression of SARS-CoV-2 priming protease TMPRSS2 in the developing lung (edit) |
10.1101/2020.05.22.111187 |
| 2020-05-23 |
Targeting the SARS-CoV-2 Main Protease to Repurpose Drugs for COVID-19 (edit) |
10.1101/2020.05.23.112235 |
| 2020-05-23 |
Methods of inactivation of SARS-CoV-2 for downstream biological assays (edit) |
10.1101/2020.05.21.108035 |
| 2020-05-23 |
The emergence of SARS-CoV-2 in Europe and the US (edit) |
10.1101/2020.05.21.109322 |
| 2020-05-23 |
Primer for intensive care unit (ICU) redeployment of the noncritical care surgeon: Insights from the epicenter of the coronavirus disease 2019 (COVID-19) pandemic (edit) |
10.1016/J.SURG.2020.05.010 |
| 2020-05-23 |
Iodine, a preventive and curative agent in the COVID-19 pandemic? (edit) |
10.1016/J.MEHY.2020.109860 |
| 2020-05-23 |
Emergency implantation of a teleneurology service at the neuromuscular unit of Hospital Regional de Málaga during the SARS-CoV-2 pandemic (edit) |
10.1016/J.NRL.2020.05.008 |
| 2020-05-23 |
Detection of respiratory viruses in patients with suspected SARS-CoV-2 infection (edit) |
10.1016/J.EIMC.2020.05.006 |
| 2020-05-23 |
Patients With the Novel SARS-Cov-2 Disease Require a Novel Standard of Care-Med-Psych (edit) |
10.1016/J.PSYM.2020.05.015 |
| 2020-05-23 |
An Atypical Presentation of Acute Pulmonary Embolism With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pneumonia (edit) |
10.7759/CUREUS.8249 |
| 2020-05-23 |
The Novel Coronavirus SARS-CoV-2 Vulnerability Association with ABO/Rh Blood Types (edit) |
10.30699/IJP.2020.125135.2367 |
| 2020-05-22 |
Dynamically evolving novel overlapping gene as a factor in the SARS-CoV-2 pandemic (edit) |
10.1101/2020.05.21.109280 |
| 2020-05-22 |
A novel one-step single-tube nested quantitative Real-Time PCR assay for highly sensitive detection of SARS-CoV-2 (edit) |
10.1021/ACS.ANALCHEM.0C01884 |
| 2020-05-22 |
ddPCR: a more accurate tool for SARS-CoV-2 detection in low viral load specimens (edit) |
10.1080/22221751.2020.1772678 |
| 2020-05-22 |
A Call for Consistency in Official Naming of the Disease Caused by SARS-CoV-2 in Non-English Languages (edit) |
10.1017/DMP.2020.169 |
| 2020-05-22 |
SARS-CoV-2 RNA concentrations in primary municipal sewage sludge as a leading indicator of COVID-19 outbreak dynamics (edit) |
10.1101/2020.05.19.20105999 |
| 2020-05-22 |
SARS-CoV2 vaccines: Slow is fast (edit) |
10.1126/SCIADV.ABC7428 |
| 2020-05-22 |
Chest X-ray features of SARS-CoV-2 in the emergency department: a multicenter experience from northern Italian hospitals (edit) |
10.1016/J.RMED.2020.106036 |
| 2020-05-22 |
Structural basis for RNA replication by the SARS-CoV-2 polymerase (edit) |
10.1016/J.CELL.2020.05.034 |
| 2020-05-22 |
Side effects of ruxolitinib in patients with SARS-CoV-2 infection: two case reports (edit) |
10.1016/J.IJANTIMICAG.2020.106023 |
| 2020-05-22 |
Molecular epidemiology of SARS-CoV-2 in Faisalabad, Pakistan: A real-world clinical experience (edit) |
10.1016/J.MEEGID.2020.104374 |
| 2020-05-22 |
Amplification of human β-glucoronidase gene for appraising the accuracy of negative SARS-CoV-2 RT-PCR results in upper respiratory tract specimens (edit) |
10.1101/2020.05.20.20105312 |
| 2020-05-22 |
High seroreactivity against SARS-CoV-2 Spike epitopes in a pre SARS-CoV-2 cohort: implications for antibody testing and vaccine design (edit) |
10.1101/2020.05.18.20105189 |
| 2020-05-22 |
Pathophysiology of SARS-CoV-2: targeting of endothelial cells renders a complex disease with thrombotic microangiopathy and aberrant immune response. The Mount Sinai COVID-19 autopsy experience (edit) |
10.1101/2020.05.18.20099960 |
| 2020-05-22 |
Efficient Prevalence Estimation and Population Screening for SARS-CoV-2 (edit) |
10.1101/2020.05.18.20105882 |
| 2020-05-22 |
Higher plasma levels of Chemokine CCL19 are associated with poor SARS-CoV-2 acute respiratory distress syndrome (ARDS) outcomes. (edit) |
10.1101/2020.05.21.20051300 |
| 2020-05-22 |
Consensus study of risk factors and symptoms of SARS-CoV-2 (COVID-19) using biomedical literature and social media data (edit) |
10.1101/2020.05.17.20104729 |
| 2020-05-22 |
Prevalence Threshold and Temporal Interpretation of Screening Tests: The Example of the SARS-CoV-2 (COVID-19) Pandemic (edit) |
10.1101/2020.05.17.20104927 |
| 2020-05-22 |
Unravelling lead antiviral phytochemicals for the inhibition of SARS-CoV-2 Mpro enzyme through in silico approach (edit) |
10.1016/J.LFS.2020.117831 |
| 2020-05-22 |
COVID19-Global: A shiny application to perform a global comparative data visualization for the SARS-CoV-2 epidemic (edit) |
10.1101/2020.05.18.20105684 |
| 2020-05-22 |
Early antibody response to SARS-CoV-2 (edit) |
10.1101/2020.05.19.20099317 |
| 2020-05-22 |
Full genome viral sequences inform patterns of SARS-CoV-2 spread into and within Israel (edit) |
10.1101/2020.05.21.20104521 |
| 2020-05-22 |
Evaluation of nCoV-QS (MiCo BioMed) for RT-qPCR detection of SARS-CoV-2 from nasopharyngeal samples using CDC FDA EUA qPCR kit as a gold standard: an example of the need of validation studies (edit) |
10.1016/J.JCV.2020.104454 |
| 2020-05-22 |
Effect of Heat inactivation on Real-Time Reverse Transcription PCR of the SARS-COV-2 Detection (edit) |
10.1101/2020.05.19.20101469 |
| 2020-05-22 |
SARS-CoV-2 RNA contamination of inanimate surfaces and virus viability in a health care emergency unit (edit) |
10.1016/J.CMI.2020.05.009 |
| 2020-05-22 |
Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France (edit) |
10.1101/2020.05.19.20101832 |
| 2020-05-22 |
Performance of six SARS-CoV-2 immunoassays in comparison with microneutralisation (edit) |
10.1101/2020.05.18.20101618 |
| 2020-05-22 |
Detection of SARS-CoV-2 from raw patient samples by coupled high temperature reverse transcription and amplification (edit) |
10.1101/2020.05.19.20103150 |
| 2020-05-22 |
Changes in RT-PCR-positive SARS-CoV-2 rates in adults and children according to the epidemic stages (edit) |
10.1101/2020.05.18.20098863 |
| 2020-05-22 |
On the importance of population-based serological surveys of SARS-CoV-2 without overlooking their inherent uncertainties (edit) |
10.1016/J.PUHIP.2020.100013 |
| 2020-05-22 |
Expression of SARS-CoV-2 receptor, ACE2, and TMPRSS2 in the lung airways is lower in children compared to adults and increases due to smoking and COPD (edit) |
10.1016/J.OMTM.2020.05.013 |
| 2020-05-22 |
SARS-CoV-2 and Diabetes: New Challenges for the Disease (edit) |
10.1016/J.DIABRES.2020.108228 |
| 2020-05-22 |
Chemistry and Biology of SARS-CoV-2 (edit) |
10.1016/J.CHEMPR.2020.04.023 |
| 2020-05-22 |
Evaluation of a high-speed but low-throughput RT-qPCR system for SARS-CoV-2 detection (edit) |
10.1016/J.JHIN.2020.05.025 |
| 2020-05-22 |
Decrease and Delay in Hospitalization for Acute Coronary Syndromes during the 2020 SARS-CoV-2 Pandemic (edit) |
10.1016/J.CJCA.2020.05.023 |
| 2020-05-22 |
The EPICENTRE (ESPNIC Covid pEdiatric Neonatal Registry) initiative: background and protocol for the international SARS-CoV-2 infections registry (edit) |
10.1007/S00431-020-03690-9 |
| 2020-05-22 |
Temporal Correlation Between Neurological and Gastrointestinal Symptoms of SARS-CoV-2 (edit) |
10.1093/IBD/IZAA131 |
| 2020-05-22 |
The impact of SARS-CoV-2 on sleep (edit) |
10.5664/JCSM.8598 |
| 2020-05-22 |
Glecaprevir and Maraviroc are high-affinity inhibitors of SARS-CoV-2 main protease: Possible therapeutic implication in COVID-19 (edit) |
10.1042/BSR20201256 |
| 2020-05-22 |
A Case Report of Neonatal Acute Respiratory Failure Due to SARS-CoV-2 (edit) |
10.1093/JPIDS/PIAA064 |
| 2020-05-22 |
Clinical and Epidemiological Features of a Family Cluster of Symptomatic and Asymptomatic SARS-CoV-2 Infection (edit) |
10.1093/JPIDS/PIAA060 |
| 2020-05-22 |
Systematic Analysis of ACE2 and TMPRSS2 Expression in Salivary Glands Reveals Underlying Transmission Mechanism Caused by SARS-CoV-2 (edit) |
10.1002/JMV.26045 |
| 2020-05-22 |
Involvement of ADAMTS13 and von Willebrand factor in thromboembolic events in patients infected with SARS-CoV-2 (edit) |
10.1111/IJLH.13244 |
| 2020-05-22 |
Why Challenge Trials of SARS-CoV-2 Vaccines Could Be Ethical Despite Risk of Severe Adverse Events (edit) |
10.1002/EAHR.500056 |
| 2020-05-22 |
A Reverse-Transcription Recombinase-Aided Amplification Assay for Rapid Detection of the 2019 Novel Coronavirus (SARS-CoV-2) (edit) |
10.1021/ACS.ANALCHEM.0C01032 |
| 2020-05-22 |
SARS-CoV-2, from its current highly contagious spreading towards the global development of an effective and safe vaccine: challenges and uncertainties (edit) |
10.1080/14740338.2020.1773789 |
| 2020-05-22 |
Predicting infectious SARS-CoV-2 from diagnostic samples (edit) |
10.1093/CID/CIAA638 |
| 2020-05-22 |
Characterization of an asymptomatic cohort of SARS-COV-2 infected individuals outside of Wuhan, China (edit) |
10.1093/CID/CIAA629 |
| 2020-05-22 |
Therapy with agents acting on the renin-angiotensin system and risk of SARS-CoV-2 infection (edit) |
10.1093/CID/CIAA634 |
| 2020-05-22 |
Test Agreement Between Roche Cobas 6800 and Cepheid GeneXpert Xpress SARS-CoV-2 Assays at High Cycle Threshold Ranges (edit) |
10.1128/JCM.01187-20 |
| 2020-05-22 |
A perspective on modern advances for COVID-19 (SARS-CoV-2) therapeutics (edit) |
10.5152/EURJRHEUM.2020.2065 |
| 2020-05-22 |
Antiviral Efficacies of FDA-Approved Drugs against SARS-CoV-2 Infection in Ferrets (edit) |
10.1128/MBIO.01114-20 |
| 2020-05-22 |
Antibodies against immunogenic epitopes with high sequence identity to SARS-CoV-2 in patients with autoimmune dermatomyositis (edit) |
10.1136/ANNRHEUMDIS-2020-217522 |
| 2020-05-22 |
SARS-CoV-2 infection in ambulatory and hospitalised Spanish children (edit) |
10.1136/ARCHDISCHILD-2020-319366 |
| 2020-05-22 |
Incidental SARS-CoV-2-related findings in asymptomatic patients in [18F]-FDG-PET/CT-potential insights (edit) |
10.1007/S00259-020-04869-W |
| 2020-05-22 |
The interplay of Hypertension, ACE-2 and SARS-CoV-2: Emerging data as the "Ariadne's thread" for the "labyrinth" of COVID-19 (edit) |
10.1016/J.HJC.2020.05.003 |
| 2020-05-22 |
Prolonged fecal shedding of SARS-CoV-2 in pediatric patients. A quantitative evidence synthesis (edit) |
10.1097/MPG.0000000000002798 |
| 2020-05-22 |
Drug treatment of SARS-Cov2: Potential effects in patients with substance use disorders (SUD) (edit) |
10.1016/J.JPSYCHORES.2020.110159 |
| 2020-05-22 |
Potently neutralizing human antibodies that block SARS-CoV-2 receptor binding and protect animals (edit) |
10.1101/2020.05.22.111005 |
| 2020-05-22 |
Neurological Manifestations of COVID-19 (SARS-CoV-2): A Review (edit) |
10.3389/FNEUR.2020.00518 |
| 2020-05-22 |
SARS-CoV-2 Infection and the Newborn (edit) |
10.3389/FPED.2020.00294 |
| 2020-05-22 |
Approaches to Daily Monitoring of the SARS-CoV-2 Outbreak in Northern Italy (edit) |
10.3389/FPUBH.2020.00222 |
| 2020-05-22 |
New Insights of Emerging SARS-CoV-2: Epidemiology, Etiology, Clinical Features, Clinical Treatment, and Prevention (edit) |
10.3389/FCELL.2020.00410 |
| 2020-05-22 |
Evaluation of Ultraviolet-C Light for Rapid Decontamination of Airport Security Bins in the Era of SARS-CoV-2 (edit) |
10.20411/PAI.V5I1.373 |
| 2020-05-22 |
Activation of the SARS-CoV-2 Receptor Ace2 by Cytokines Through Pan JAK-STAT Enhancers (edit) |
10.2139/SSRN.3601827 |
| 2020-05-22 |
Patient factors associated with SARS-CoV-2 in an admitted emergency department population (edit) |
10.1002/EMP2.12145 |
| 2020-05-21 |
Trimeric SARS-CoV-2 Spike interacts with dimeric ACE2 with limited intra-Spike avidity (edit) |
10.1101/2020.05.21.109157 |
| 2020-05-21 |
ACE2-independent interaction of SARS-CoV-2 spike protein to human epithelial cells can be inhibited by unfractionated heparin (edit) |
10.1101/2020.05.21.107870 |
| 2020-05-21 |
Updated approaches against SARS-CoV-2 (edit) |
10.1128/AAC.00483-20 |
| 2020-05-21 |
A suspicious role of interferon in the pathogenesis of SARS-CoV-2 by enhancing expression of ACE2 (edit) |
10.1038/S41392-020-0185-Z |
| 2020-05-21 |
To Interpret the SARS-CoV-2 Test, Consider the Cycle Threshold Value (edit) |
10.1093/CID/CIAA619 |
| 2020-05-21 |
SARS-CoV-2 as an extrahepatic precipitator of acute-on-chronic liver failure (edit) |
10.1111/LIV.14540 |
| 2020-05-21 |
Low risk of SARS-CoV-2 transmission through the ocular surface (edit) |
10.1111/AOS.14471 |
| 2020-05-21 |
Family planning: an essential health activity in the pandemic of SARS-CoV-2 (edit) |
10.1080/13625187.2020.1768368 |
| 2020-05-21 |
Subacute thyroiditis after SARS-CoV-2 infection (edit) |
10.1210/CLINEM/DGAA276 |
| 2020-05-21 |
HIV and SARS-CoV-2 co-infection: A case report from Uganda (edit) |
10.1002/JMV.26044 |
| 2020-05-21 |
Epidemiological and clinical characteristics of discharged patients infected with SARS-CoV-2 on the Qinghai plateau (edit) |
10.1002/JMV.26032 |
| 2020-05-21 |
Structure of replicating SARS-CoV-2 polymerase (edit) |
10.1038/S41586-020-2368-8 |
| 2020-05-21 |
Reply to Sánchez-Pacheco et al., Chookajorn, and Mavian et al.: Explaining phylogenetic network analysis of SARS-CoV-2 genomes (edit) |
10.1073/PNAS.2007433117 |
| 2020-05-21 |
SARS-CoV-2-Induced Kawasaki-Like Hyperinflammatory Syndrome: A Novel COVID Phenotype in Children (edit) |
10.1542/PEDS.2020-1711 |
| 2020-05-21 |
Immune Thrombocytopenia (ITP) in a SARS-CoV-2 Positive Pediatric Patient (edit) |
10.1542/PEDS.2020-1419 |
| 2020-05-21 |
Tiger team: a panel of human neutralizing mAbs targeting SARS-CoV-2 spike at multiple epitopes (edit) |
10.1101/2020.05.20.106609 |
| 2020-05-21 |
Pathogenesis of SARS-CoV-2 in transgenic mice expressing human angiotensin-converting enzyme 2 (edit) |
10.1016/J.CELL.2020.05.027 |
| 2020-05-21 |
Diagnostic Tests for SARS-CoV-2: Implications in Head and Neck Oncology (edit) |
10.1016/J.ORALONCOLOGY.2020.104813 |
| 2020-05-21 |
Rationale and design of the PRAETORIAN-COVID trial: A double-blind, placebo-controlled randomized clinical trial with valsartan for PRevention of Acute rEspiraTORy dIstress syndrome in hospitAlized patieNts with SARS-COV-2 Infection Disease (edit) |
10.1016/J.AHJ.2020.05.010 |
| 2020-05-21 |
Imported and locally transmitted mild SARS-CoV-2 pneumonia cases in Japan (edit) |
10.1016/J.JIAC.2020.05.014 |
| 2020-05-21 |
Intra-host Variation and Evolutionary Dynamics of SARS-CoV-2 Population in COVID-19 Patients (edit) |
10.1101/2020.05.20.103549 |
| 2020-05-21 |
Immunogenic profile of SARS-CoV-2 spike in individuals recovered from COVID-19 (edit) |
10.1101/2020.05.17.20104869 |
| 2020-05-21 |
In-Vivo Toxicity Studies and In-Vitro Inactivation of SARS-CoV-2 by Povidone-iodine In-situ Gel Forming Formulations (edit) |
10.1101/2020.05.18.103184 |
| 2020-05-21 |
Altered cytokine levels and immune responses in patients with SARS-CoV-2 infection and related conditions (edit) |
10.1016/J.CYTO.2020.155143 |
| 2020-05-21 |
CD8+ T cell cross-reactivity against SARS-CoV-2 conferred by other coronavirus strains and influenza virus (edit) |
10.1101/2020.05.20.107292 |
| 2020-05-21 |
RdRp mutations are associated with SARS-CoV-2 genome evolution (edit) |
10.1101/2020.05.20.104885 |
| 2020-05-21 |
An acceptable method to evaluate the analytical performance of real-time fluorescent RT-PCR targeting SARS-CoV-2 (edit) |
10.1101/2020.05.18.20105247 |
| 2020-05-21 |
The SARS-CoV-2 cytopathic effect is blocked with autophagy modulators (edit) |
10.1101/2020.05.16.091520 |
| 2020-05-21 |
Type I and Type III IFN Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures (edit) |
10.1101/2020.05.19.105437 |
| 2020-05-21 |
Detection of SARS-CoV-2 in pets living with COVID-19 owners diagnosed during the COVID-19 lockdown in Spain: A case of an asymptomatic cat with SARS-CoV-2 in Europe (edit) |
10.1101/2020.05.14.20101444 |
| 2020-05-21 |
Capillary Electrophoresis of PCR fragments with 5’-labelled primers for testing the SARS-Cov-2 (edit) |
10.1101/2020.05.16.099242 |
| 2020-05-21 |
Development and Validation of Two In-house, Low-Cost SARS-CoV-2 Detection Assays (edit) |
10.1101/2020.05.18.20105510 |
| 2020-05-21 |
Lung ultrasound findings in patients with novel SARS-CoV2 (edit) |
10.1101/2020.05.18.20105775 |
| 2020-05-21 |
SARS-CoV-2 targets cortical neurons of 3D human brain organoids and shows neurodegeneration-like effects (edit) |
10.1101/2020.05.20.106575 |
| 2020-05-21 |
Immunoinformatic analysis of the SARS-CoV-2 envelope protein as a strategy to assess cross-protection against COVID-19 (edit) |
10.1016/J.MICINF.2020.05.013 |
| 2020-05-21 |
The Dynamic Changes of Antibodies against SARS-CoV-2 during the Infection and Recovery of COVID-19 (edit) |
10.1101/2020.05.18.20105155 |
| 2020-05-21 |
Off-label use of tocilizumab for the treatment of SARS-CoV-2 pneumonia in Milan, Italy (edit) |
10.1016/J.EJIM.2020.05.011 |
| 2020-05-21 |
A replication-competent vesicular stomatitis virus for studies of SARS-CoV-2 spike-mediated cell entry and its inhibition (edit) |
10.1101/2020.05.20.105247 |
| 2020-05-21 |
Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients: comment (edit) |
10.1007/S11739-020-02373-5 |
| 2020-05-21 |
Organoids of human airways to study infectivity and cytopathy of SARS-CoV-2 (edit) |
10.1016/S2213-2600(20)30238-1 |
| 2020-05-21 |
Pathology and Pathogenesis of SARS-CoV-2 Associated with Fatal Coronavirus Disease, United States (edit) |
10.3201/EID2609.202095 |
| 2020-05-21 |
Images in Practice: Painful Cutaneous Vasculitis in a SARS-Cov-2 IgG-Positive Child (edit) |
10.1007/S40122-020-00174-4 |
| 2020-05-21 |
A simple algorithm helps early identification of SARS-CoV-2 infection patients with severe progression tendency (edit) |
10.1007/S15010-020-01446-Z |
| 2020-05-21 |
Detection of SARS-CoV-2 in human breastmilk (edit) |
10.1016/S0140-6736(20)31181-8 |
| 2020-05-21 |
Harnessing the natural anti-glycan immune response to limit the transmission of enveloped viruses such as SARS-CoV-2 (edit) |
10.1371/JOURNAL.PPAT.1008556 |
| 2020-05-21 |
Initial Gastrointestinal Manifestations in Patients with SARS-CoV-2 in 112 patients from Veracruz (Southeastern Mexico) (edit) |
10.1053/J.GASTRO.2020.05.055 |
| 2020-05-21 |
Do Matrix Metalloproteases mediate the SARS-CoV-2-related damage to the Central Nervous System? (edit) |
10.1016/J.BBI.2020.05.050 |
| 2020-05-21 |
SARS-CoV-2 Persisted in Lung Tissue Despite Disappearance in Other Clinical Samples (edit) |
10.1016/J.CMI.2020.05.013 |
| 2020-05-21 |
Smoking-Mediated Upregulation of the Androgen Pathway Leads to Increased SARS-CoV-2 Susceptibility (edit) |
10.3390/IJMS21103627 |
| 2020-05-21 |
Novel Dynamic Structures of 2019-nCoV with Nonlocal Operator via Powerful Computational Technique (edit) |
10.3390/BIOLOGY9050107 |
| 2020-05-21 |
Tripartite Combination of Candidate Pandemic Mitigation Agents: Vitamin D, Quercetin, and Estradiol Manifest Properties of Medicinal Agents for Targeted Mitigation of the COVID-19 Pandemic Defined by Genomics-Guided Tracing of SARS-CoV-2 Targets in (edit) |
10.3390/BIOMEDICINES8050129 |
| 2020-05-21 |
Is SARS-CoV-2 associated with liver dysfunction in COVID-19 patients? (edit) |
10.1016/J.CLINRE.2020.05.002 |
| 2020-05-21 |
First description of SARS-CoV-2 in ascites (edit) |
10.1016/J.IDCR.2020.E00836 |
| 2020-05-21 |
SARS-CoV-2 and the Liver: Considerations in Hepatitis B and Hepatitis C Infections (edit) |
10.1002/CLD.970 |
| 2020-05-21 |
[DRESS syndrome simulating coronavirus 2019-NcoV disease] (edit) |
10.1016/J.SEMERG.2020.05.012 |
| 2020-05-21 |
Insights on early mutational events in SARS-CoV-2 virus reveal founder effects across geographical regions (edit) |
10.7717/PEERJ.9255 |
| 2020-05-21 |
Rapid Isothermal Amplification and Portable Detection System for SARS-CoV-2 (edit) |
10.1101/2020.05.21.108381 |
| 2020-05-21 |
An insertion unique to SARS-CoV-2 exhibits superantigenic character strengthened by recent mutations (edit) |
10.1101/2020.05.21.109272 |
| 2020-05-21 |
Modeling and Simulation of a Fully-glycosylated Full-length SARS-CoV-2 Spike Protein in a Viral Membrane (edit) |
10.1101/2020.05.20.103325 |
| 2020-05-21 |
Respiratory Distress in SARS-CoV-2 without Lung Damage: Phrenic Paralysis Should Be Considered in COVID-19 Infection (edit) |
10.12890/2020_001728 |
| 2020-05-21 |
Potential Treatments for SARS-CoV-2 Infection (edit) |
10.1002/CLD.969 |
| 2020-05-21 |
Telemedicine and Telehepatology During the COVID-19 Pandemic (edit) |
10.1002/CLD.971 |
| 2020-05-21 |
STudy of Alteplase for Respiratory failure in SARS-Cov2/COVID-19: Study Design of the Phase IIa STARS Trial (edit) |
10.1002/RTH2.12395 |
| 2020-05-21 |
Perspective: Cell therapy, SARS-CoV-2, COVID-19, and James Lind (edit) |
10.1002/ACG2.88 |
| 2020-05-20 |
SARS-CoV-2 Nsp9 RNA-replicase (edit) |
10.2210/PDB6WXD/PDB |
| 2020-05-20 |
1.45 Angstrom Resolution Crystal Structure of C-terminal Dimerization Domain of Nucleocapsid Phosphoprotein from SARS-CoV-2 (edit) |
10.2210/PDB6YUN/PDB |
| 2020-05-20 |
Psychological Impact of 2019 Novel Coronavirus (2019-nCoV) Outbreak on Health Workers in China (edit) |
10.1017/S0950268820001090 |
| 2020-05-20 |
SARS-CoV-2 infection in Spanish children with chronic kidney pathologies (edit) |
10.1007/S00467-020-04597-1 |
| 2020-05-20 |
Model based approach for estimating the dosage regimen of indomethacin a potential antiviral treatment of patients infected with SARS CoV-2 (edit) |
10.1007/S10928-020-09690-4 |
| 2020-05-20 |
Microvascular alterations in patients with SARS-COV-2 severe pneumonia (edit) |
10.1186/S13613-020-00680-W |
| 2020-05-20 |
Possible prophylactic or preventive role of topical povidone iodine during accidental ocular exposure to 2019-nCoV (edit) |
10.1007/S00417-020-04752-2 |
| 2020-05-20 |
Stroke in patients with SARS-CoV-2 infection: case series (edit) |
10.1007/S00415-020-09885-2 |
| 2020-05-20 |
The role of SARS-CoV-2 antibodies in COVID-19: Healing in most, harm at times (edit) |
10.1111/RESP.13852 |
| 2020-05-20 |
Low testosterone levels predict clinical adverse outcomes in SARS-CoV-2 pneumonia patients (edit) |
10.1111/ANDR.12821 |
| 2020-05-20 |
Triazavirin - Potential inhibitor for 2019-nCoV Coronavirus M protease: A DFT study (edit) |
10.2174/1566524020666200521075848 |
| 2020-05-20 |
Withanone and Caffeic Acid Phenethyl Ester are Predicted to Interact with Main Protease (Mpro) of SARS-CoV-2 and Inhibit its Activity (edit) |
10.1080/07391102.2020.1772108 |
| 2020-05-20 |
Expression of the SARS-CoV-2 ACE2 Receptor in the Human Airway Epithelium (edit) |
10.1164/RCCM.202003-0541OC |
| 2020-05-20 |
Simulated Sunlight Rapidly Inactivates SARS-CoV-2 on Surfaces (edit) |
10.1093/INFDIS/JIAA274 |
| 2020-05-20 |
Renin-angiotensin-aldosterone system dysregulation and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (edit) |
10.1093/EURHEARTJ/EHAA423 |
| 2020-05-20 |
Renin-angiotensin system and SARS-CoV-2 infection: there is a before and after (edit) |
10.1093/EURHEARTJ/EHAA451 |
| 2020-05-20 |
Estrogen regulates the expression of SARS-CoV-2 receptor ACE2 in differentiated airway epithelial cells (edit) |
10.1152/AJPLUNG.00153.2020 |
| 2020-05-20 |
Gemcitabine, lycorine and oxysophoridine inhibit novel coronavirus (SARS-CoV-2) in cell culture (edit) |
10.1080/22221751.2020.1772676 |
| 2020-05-20 |
SARS-CoV-2: The Path of Prevention and Control (edit) |
10.2174/1871526520666200520112848 |
| 2020-05-20 |
Potential differential effects of renin-angiotensin system inhibitors on SARS-CoV-2 infection and lung injury in COVID-19 (edit) |
10.1038/S41440-020-0478-1 |
| 2020-05-20 |
Symptomatic Infants have Higher Nasopharyngeal SARS-CoV-2 Viral Loads but Less Severe Disease than Older Children (edit) |
10.1093/CID/CIAA608 |
| 2020-05-20 |
Pregnancy affected by SARS-CoV-2 infection: a flash report from Michigan (edit) |
10.1080/14767058.2020.1765334 |
| 2020-05-20 |
Replication of SARS-CoV-2 in human respiratory epithelium (edit) |
10.1128/JVI.00957-20 |
| 2020-05-20 |
DNA vaccine protection against SARS-CoV-2 in rhesus macaques (edit) |
10.1126/SCIENCE.ABC6284 |
| 2020-05-20 |
SARS-CoV-2 infection protects against rechallenge in rhesus macaques (edit) |
10.1126/SCIENCE.ABC4776 |
| 2020-05-20 |
Presence of SARS-Coronavirus-2 RNA in sewage and correlation with reported COVID-19 prevalence in the early stage of the epidemic in the Netherlands (edit) |
10.1021/ACS.ESTLETT.0C00357 |
| 2020-05-20 |
Quantifying antibody kinetics and RNA shedding during early-phase SARS-CoV-2 infection (edit) |
10.1101/2020.05.15.20103275 |
| 2020-05-20 |
Predicting SARS-CoV-2 infection trend using technical analysis indicators (edit) |
10.1101/2020.05.13.20100784 |
| 2020-05-20 |
When Can Elimination of SARS-CoV-2 Infection be Assumed? Simulation Modelling in a Case Study Island Nation (edit) |
10.1101/2020.05.16.20104240 |
| 2020-05-20 |
The specificity of Japanese PCR assays for SARS-CoV-2 exceeds 99.7% (edit) |
10.1101/2020.05.15.20103515 |
| 2020-05-20 |
Extended Storage of SARS-CoV2 Nasopharyngeal Swabs Does Not Negatively Impact Results of Molecular-Based Testing (edit) |
10.1101/2020.05.16.20104158 |
| 2020-05-20 |
Multi-Antigenic Virus-like Particle of SARS CoV-2 produced in Saccharomyces cerevisiae as a vaccine candidate (edit) |
10.1101/2020.05.18.099234 |
| 2020-05-20 |
Transcriptional profiling of immune and inflammatory responses in the context of SARS-CoV-2 fungal superinfection in a human airway epithelial model (edit) |
10.1101/2020.05.19.103630 |
| 2020-05-20 |
Serological prevalence of antibodies to SARS CoV-2 amongst cancer centre staff (edit) |
10.1101/2020.05.16.20099408 |
| 2020-05-20 |
SARS-CoV-2 seroconversion in health care workers (edit) |
10.1101/2020.05.18.20105197 |
| 2020-05-20 |
Monitoring and predicting SARS-CoV-2 epidemic in France after deconfinement using a multiscale age-stratified rate model (edit) |
10.1101/2020.05.15.20099465 |
| 2020-05-20 |
What Is Required to Prevent a Second Major Outbreak of SARS-CoV-2 upon Lifting Quarantine in Wuhan City, China (edit) |
10.1016/J.XINN.2020.04.006 |
| 2020-05-20 |
Emerging phylogenetic structure of the SARS-CoV-2 pandemic (edit) |
10.1101/2020.05.19.103846 |
| 2020-05-20 |
Antiviral activity of Glucosylceramide synthase inhibitors against SARS-CoV-2 and other RNA virus infections (edit) |
10.1101/2020.05.18.103283 |
| 2020-05-20 |
Human IgG cell neutralizing monoclonal antibodies block SARS-CoV-2 infection (edit) |
10.1101/2020.05.19.104117 |
| 2020-05-20 |
Search for asymptomatic carriers of SARS-CoV-2 in healthcare workers during the pandemic: a Spanish experience (edit) |
10.1101/2020.05.18.20103283 |
| 2020-05-20 |
The Seasonal End of Human Coronavirus Hospital Admissions with Implications for SARS-CoV-2 (edit) |
10.1101/2020.05.15.20103416 |
| 2020-05-20 |
Human Coronavirus Infections—Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS), and SARS-CoV-2 (edit) |
10.1016/B978-0-12-801238-3.11634-4 |
| 2020-05-20 |
Upper airway gene expression differentiates COVID-19 from other acute respiratory illnesses and reveals suppression of innate immune responses by SARS-CoV-2 (edit) |
10.1101/2020.05.18.20105171 |
| 2020-05-20 |
SARS-CoV-2: The viral shedding vs infectivity dilemma (edit) |
10.1016/J.IDH.2020.05.002 |
| 2020-05-20 |
Proteasome Inhibitors as a Possible Therapy for SARS-CoV-2 (edit) |
10.3390/IJMS21103622 |
| 2020-05-20 |
SARS-CoV-2: virus mutations in specific European populations (edit) |
10.1016/J.NMNI.2020.100696 |
| 2020-05-20 |
Faecal shedding of SARS-CoV-2: considerations for hospital settings (edit) |
10.1016/J.JHIN.2020.05.019 |
| 2020-05-20 |
Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals (edit) |
10.1016/J.CELL.2020.05.015 |
| 2020-05-20 |
RT-PCR for SARS-CoV-2: quantitative versus qualitative (edit) |
10.1016/S1473-3099(20)30424-2 |
| 2020-05-20 |
IL-6: relevance for immunopathology of SARS-CoV-2 (edit) |
10.1016/J.CYTOGFR.2020.05.009 |
| 2020-05-20 |
Type I interferons can be detected in respiratory swabs from SARS-Cov-2 infected patients (edit) |
10.1016/J.JCV.2020.104450 |
| 2020-05-20 |
Overwhelming Mutations or SNPs of SARS-CoV-2: A Point of Caution (edit) |
10.1016/J.GENE.2020.144792 |
| 2020-05-20 |
PREVENTION AND PROTECTION MEASURES OF HEALTHCARE WORKERS EXPOSED IN HEALTH SETTINGS TO SEVERE ACUTE RESPIRATORY INFECTIONS FROM SARS-COV-2 IN A UNIVERSITY HOSPITAL IN BARI, APULIA REGION, SOUTHERN ITALY (edit) |
10.1016/J.JHIN.2020.05.024 |
| 2020-05-20 |
Pausing cancer screening during the SARS-CoV-2 pandemic: should we revisit the recommendations? (edit) |
10.1016/J.EJCA.2020.04.016 |
| 2020-05-20 |
Rescue fibrinolysis in suspected massive pulmonary embolism during SARS-CoV-2 pandemic (edit) |
10.1016/J.RESUSCITATION.2020.05.020 |
| 2020-05-20 |
Specific EEG Encephalopathy Pattern in SARS-CoV-2 Patients (edit) |
10.3390/JCM9051545 |
| 2020-05-20 |
High Mortality Rates for SARS-CoV-2 Infection in Patients with Pre-existing Chronic Liver Disease and Cirrhosis: Preliminary Results from an International Registry (edit) |
10.1016/J.JHEP.2020.05.013 |
| 2020-05-20 |
A Structural View of SARS-CoV-2 RNA Replication Machinery: RNA Synthesis, Proofreading and Final Capping (edit) |
10.3390/CELLS9051267 |
| 2020-05-20 |
Management of the mother-infant dyad with suspected or confirmed SARS-CoV-2 infection in a highly epidemic context (edit) |
10.3233/NPM-200478 |
| 2020-05-20 |
Children are protected against SARS-CoV-2 infection (edit) |
10.1016/J.JCV.2020.104451 |
| 2020-05-20 |
New Coronavirus (SARS-CoV-2): advances to flatten the curve the prison population (edit) |
10.1590/0037-8682-0219-2020 |
| 2020-05-20 |
Nosocomial SARS-CoV-2 Infections in Japan: A Crosssectional Newspaper Database Survey (edit) |
10.34172/IJHPM.2020.75 |
| 2020-05-20 |
An in-silico approach to develop of a multi-epitope vaccine candidate against SARS-CoV-2 envelope (E) protein (edit) |
10.21203/RS.3.RS-30374/V1 |
| 2020-05-20 |
Preeclampsia Treatment in SARS-CoV-2 (edit) |
10.1016/J.AJOGMF.2020.100146 |
| 2020-05-19 |
The role of echocardiography in SARS-CoV-2 pandemic: a compromise among appropriateness, safety and clinical impact (edit) |
10.4081/MONALDI.2020.1358 |
| 2020-05-19 |
Rumors and incorrect reports are more deadly than the new coronavirus (SARS-CoV-2) (edit) |
10.1186/S13756-020-00738-1 |
| 2020-05-19 |
SARS-CoV-2 detection with CRISPR diagnostics (edit) |
10.1038/S41421-020-0174-Y |
| 2020-05-19 |
Continuous positive airway pressure to avoid intubation in SARS-CoV-2 pneumonia: a two-period retrospective case-control study (edit) |
10.1183/13993003.01692-2020 |
| 2020-05-19 |
COVID-19 and vaping: risk for increased susceptibility to SARS-CoV-2 infection? (edit) |
10.1183/13993003.01645-2020 |
| 2020-05-19 |
Factors associated with prolonged viral shedding and impact of Lopinavir/Ritonavir treatment in hospitalised non-critically ill patients with SARS-CoV-2 infection (edit) |
10.1183/13993003.00799-2020 |
| 2020-05-19 |
Serology characteristics of SARS-CoV-2 infection since exposure and post symptom onset (edit) |
10.1183/13993003.00763-2020 |
| 2020-05-19 |
Exploring Diseases/Traits and Blood Proteins Causally Related to Expression of ACE2, the Putative Receptor of SARS-CoV-2: A Mendelian Randomization Analysis Highlights Tentative Relevance of Diabetes-Related Traits (edit) |
10.2337/DC20-0643 |
| 2020-05-19 |
SARS-CoV-2 pulmonary infection revealed by subcutaneous emphysema and pneumomediastinum (edit) |
10.1007/S00134-020-06078-3 |
| 2020-05-19 |
[18F]-FDG PET/CT for suspected lymphoma relapse in a patient with concomitant pneumococcal pneumonia during COVID-19 outbreak: unexpected SARS-Cov-2 co-infection despite double RT-PCR negativity (edit) |
10.1007/S00259-020-04838-3 |
| 2020-05-19 |
The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies (edit) |
10.1007/S11739-020-02364-6 |
| 2020-05-19 |
SARS-CoV2-related myocarditis-like syndroms: Shakespeare´s question: What´s in a name? (edit) |
10.1002/EJHF.1899 |
| 2020-05-19 |
SARS-CoV-2 lgM/lgG antibody detection confirms the infection after three negative nucleic acid detection (edit) |
10.1111/JCMM.15275 |
| 2020-05-19 |
The diabetic lung: an easy target for SARS-CoV-2? (edit) |
10.1002/DMRR.3346 |
| 2020-05-19 |
Telehealth visits in a tertiary cardiovascular centre as a response of the healthcare system to the pandemic of SARS-CoV-2 in Poland (edit) |
10.20452/PAMW.15370 |
| 2020-05-19 |
Gnotobiotic Rats Reveal that Gut Microbiota Regulates Colonic mRNA of Ace2, the Receptor for SARS-CoV-2 Infectivity (edit) |
10.1161/HYPERTENSIONAHA.120.15360 |
| 2020-05-19 |
Detection of Nucleocapsid Antibody to SARS-CoV-2 is More Sensitive than Antibody to Spike Protein in COVID-19 Patients (edit) |
10.1093/INFDIS/JIAA273 |
| 2020-05-19 |
Influence of storage conditions on SARS-CoV-2 nucleic acid detection in throat swabs (edit) |
10.1093/INFDIS/JIAA272 |
| 2020-05-19 |
4 Cases: HIV and SARS-CoV-2 Co-infection in patients from Long Island, New York (edit) |
10.1002/JMV.26029 |
| 2020-05-19 |
Organoids demonstrate gut infection by SARS-CoV-2 (edit) |
10.1038/S41575-020-0317-5 |
| 2020-05-19 |
Antibody Tests in Detecting SARS-CoV-2 Infection: A Meta-Analysis (edit) |
10.3390/DIAGNOSTICS10050319 |
| 2020-05-19 |
Longitudinal Monitoring of SARS-CoV-2 IgM and IgG Seropositivity to Detect COVID-19 (edit) |
10.1093/JALM/JFAA079 |
| 2020-05-19 |
SARS-COV-2 pandemic: the significance of underlying conditions (edit) |
10.1093/OCCMED/KQAA084 |
| 2020-05-19 |
Reducing SARS-CoV-2 transmission in the UK: A behavioural science approach to identifying options for increasing adherence to social distancing and shielding vulnerable people (edit) |
10.1111/BJHP.12428 |
| 2020-05-19 |
Characterization and noncovalent inhibition of the deubiquitinase and deISGylase activity of SARS-CoV-2 papain-like protease (edit) |
10.1021/ACSINFECDIS.0C00168 |
| 2020-05-19 |
Aggregate Prevalence of Chemosensory and Sinonasal Dysfunction in SARS-CoV-2 and Related Coronaviruses (edit) |
10.1177/0194599820929278 |
| 2020-05-19 |
Laboratory-Proven Asymptomatic SARS-CoV-2 (COVID-19) Infection on 18F-FDG PET/CT (edit) |
10.1097/RLU.0000000000003141 |
| 2020-05-19 |
Potential Unconventional Medicines for the Treatment of SARS-CoV-2 (edit) |
10.1055/A-1170-4624 |
| 2020-05-19 |
[Coronavirus (SARS-CoV-2) - Outbreak in North Rhine-Westphalia (District of Heinsberg) - First diagnosis of a COVID-19 manifestation in a couple] (edit) |
10.1055/A-1163-1335 |
| 2020-05-19 |
Clinical Implications of Universal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Testing in Pregnancy (edit) |
10.1097/AOG.0000000000003983 |
| 2020-05-19 |
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Universal Testing Experience on a Los Angeles Labor and Delivery Unit (edit) |
10.1097/AOG.0000000000003987 |
| 2020-05-19 |
Lymphopenia and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Among Hospitalized Obstetric Patients (edit) |
10.1097/AOG.0000000000003984 |
| 2020-05-19 |
Is Universal Testing for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Needed on All Labor and Delivery Units? (edit) |
10.1097/AOG.0000000000003972 |
| 2020-05-19 |
SARS, MERS and SARS-CoV-2 (COVID-19) treatment: a patent review (edit) |
10.1080/13543776.2020.1772231 |
| 2020-05-19 |
Keeping up with the information explosion: a surge in consumption of data on pediatric SARS-CoV-2 infection by pediatric emergency physicians (edit) |
10.1186/S12245-020-00285-X |
| 2020-05-19 |
Data Analysis of Infection Rates Among Exposed Healthcare Workers Could Reveal Effective Prophylactics Against SARS-CoV-2 (edit) |
10.1007/5584_2020_540 |
| 2020-05-19 |
The Italian paediatric society raccomandations on children and adolescents extra-domestic activities during the SARS COV-2 emergency phase 2 (edit) |
10.1186/S13052-020-00826-3 |
| 2020-05-19 |
Electron microscopy of SARS-CoV-2: a challenging task - Authors' reply (edit) |
10.1016/S0140-6736(20)31185-5 |
| 2020-05-19 |
Quantitative SARS-CoV-2 antibody screening of healthcare workers in the southern part of Kyoto city during the COVID-19 peri-pandemic period (edit) |
10.1101/2020.05.12.20098962 |
| 2020-05-19 |
Flatten the Curve! Modeling SARS-CoV-2/COVID-19 Growth in Germany on the County Level (edit) |
10.1101/2020.05.14.20101667 |
| 2020-05-19 |
Reproducing SARS-CoV-2 epidemics by region-specific variables and modeling contact tracing App containment (edit) |
10.1101/2020.05.14.20101675 |
| 2020-05-19 |
Knowledge of novel coronavirus (SARS-COV-2) among a Georgian population (edit) |
10.1101/2020.05.14.20101642 |
| 2020-05-19 |
The Clinical and Economic Value of a Successful Shutdown During the SARS-CoV-2 Pandemic in Germany (edit) |
10.1101/2020.05.12.20098996 |
| 2020-05-19 |
Comparison of SARS-CoV-2 detection in nasopharyngeal swab and saliva (edit) |
10.1101/2020.05.13.20100206 |
| 2020-05-19 |
Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2 (edit) |
10.1101/2020.05.18.102467 |
| 2020-05-19 |
SARS-CoV-2 Detection in Different Respiratory Sites: A Systematic Review and Meta-Analysis (edit) |
10.1101/2020.05.14.20102038 |
| 2020-05-19 |
Agent-Based Simulation for Evaluation of Contact-Tracing Policies Against the Spread of SARS-CoV-2 (edit) |
10.1101/2020.05.12.20098970 |
| 2020-05-19 |
Silent Disease and Loss of Taste and Smell are Common Manifestations of SARS-COV-2 Infection in a Quarantine Facility: First report from Saudi Arabia (edit) |
10.1101/2020.05.13.20100222 |
| 2020-05-19 |
Characteristics and outcome of SARS-CoV-2 infection in cancer patients. (edit) |
10.1101/2020.05.14.20101576 |
| 2020-05-19 |
Neutralizing antibody and soluble ACE2 inhibition of a replication-competent VSV-SARS-CoV-2 and a clinical isolate of SARS-CoV-2 (edit) |
10.1101/2020.05.18.102038 |
| 2020-05-19 |
Immunologic perturbations in severe COVID-19/SARS-CoV-2 infection (edit) |
10.1101/2020.05.18.101717 |
| 2020-05-19 |
High speed large scale automated isolation of SARS-CoV-2 from clinical samples using miniaturized co-culture coupled with high content screening (edit) |
10.1101/2020.05.14.097295 |
| 2020-05-19 |
SARS-CoV2 infection in farmed mink, Netherlands, April 2020 (edit) |
10.1101/2020.05.18.101493 |
| 2020-05-19 |
Does the human placenta express the canonical cell entry mediators for SARS-CoV-2? (edit) |
10.1101/2020.05.18.101485 |
| 2020-05-19 |
Controlling the SARS-CoV-2 Spike Glycoprotein Conformation (edit) |
10.1101/2020.05.18.102087 |
| 2020-05-19 |
Repurposing of Miglustat to inhibit the coronavirus Severe Acquired Respiratory Syndrome SARS-CoV-2 (edit) |
10.1101/2020.05.18.101691 |
| 2020-05-19 |
Lack of type 1 diabetes involvement in SARS-COV-2 population: Only a particular coincidence? (edit) |
10.1016/J.DIABRES.2020.108220 |
| 2020-05-19 |
The 2019-nCoV pandemic in the global south: A Tsunami ahead (edit) |
10.1016/J.ECLINM.2020.100384 |
| 2020-05-19 |
Tale of three seeding patterns of SARS-CoV-2 in Saudi Arabia (edit) |
10.1016/S1473-3099(20)30425-4 |
| 2020-05-19 |
Sars-Cov-2 hurricane impacting proctology outpatient clinics and proctologic emergencies. On the verge of phase 2, learning from phase 1. Correspondence (edit) |
10.1016/J.IJSU.2020.05.049 |
| 2020-05-19 |
SARS-CoV-2 Viral load Assessment in Respiratory Samples (edit) |
10.1016/J.JCV.2020.104439 |
| 2020-05-19 |
Is SARS-CoV-2 (COVID-19) postviral olfactory dysfunction (PVOD) different from other PVOD? (edit) |
10.1016/J.WJORL.2020.05.004 |
| 2020-05-19 |
Immunoglobulines hyperimmunes anti-SARS-CoV-2, un choix stratégique urgent (edit) |
10.1016/J.BANM.2020.05.041 |
| 2020-05-19 |
Urinary Frequency as a Possibly Overlooked Symptom in COVID-19 Patients: Does SARS-CoV-2 Cause Viral Cystitis? (edit) |
10.1016/J.EURURO.2020.05.013 |
| 2020-05-19 |
Electron microscopy of SARS-CoV-2: a challenging task (edit) |
10.1016/S0140-6736(20)31188-0 |
| 2020-05-19 |
The FDA-approved gold drug auranofin inhibits novel coronavirus (SARS-COV-2) replication and attenuates inflammation in human cells (edit) |
10.1016/J.VIROL.2020.05.002 |
| 2020-05-19 |
Clinical evaluation of AusDiagnostics SARS-CoV-2 multiplex tandem PCR assay (edit) |
10.1016/J.JCV.2020.104448 |
| 2020-05-19 |
Rapid Implementation of a SARS-CoV-2 Diagnostic qRT-PCR Test with Emergency Use Authorization at a Large Academic Safety-Net Hospital (edit) |
10.1016/J.MEDJ.2020.05.001 |
| 2020-05-19 |
The role of selectivity of the SARS-CoV-2 virus for human genetic profiles in susceptibility and resistance to COVID-19 (edit) |
10.1016/J.NMNI.2020.100697 |
| 2020-05-19 |
Invasion Science and the Global Spread of SARS-CoV-2 (edit) |
10.1016/J.TREE.2020.05.004 |
| 2020-05-19 |
Systematic analysis of acute liver injury during SARS-CoV-2 infection (edit) |
10.1016/J.DLD.2020.05.006 |
| 2020-05-19 |
Les représentations de la pandémie SARS-CoV-2 et du confinement dans une patientèle de psychiatrie libérale à Paris (edit) |
10.1016/J.AMP.2020.05.004 |
| 2020-05-19 |
Two False Negative Test Results in a Symptomatic Patient with a Confirmed Case of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and Suspected Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (SJS/TEN) (edit) |
10.7759/CUREUS.8198 |
| 2020-05-19 |
Clinical Characteristics of Patients Infected With the Novel 2019 Coronavirus (SARS-Cov-2) in Guangzhou, China (edit) |
10.1093/OFID/OFAA187 |
| 2020-05-19 |
Localization of Cell Receptor-Related Genes of SARS-CoV-2 in the Kidney through Single-Cell Transcriptome Analysis (edit) |
10.1159/000508162 |
| 2020-05-18 |
Challenges and cares to promote rational use of chloroquine and hydroxychloroquine in the management of coronavirus disease 2019 (COVID-19) pandemic: a timely review (edit) |
10.1080/10937404.2020.1752340 |
| 2020-05-18 |
Epidemiology of coronavirus disease 2019(COVID-19) caused by SARS-CoV-2 (edit) |
10.1017/DMP.2020.155 |
| 2020-05-18 |
Are Iranian Sulfur mustard-exposed survivors more vulnerable to SARS-CoV-2: some similarity in their pathogenesis (edit) |
10.1017/DMP.2020.156 |
| 2020-05-18 |
COVID-19: What do we need to know about ICU delirium during the SARS-CoV-2 pandemic? (edit) |
10.5114/AIT.2020.95164 |
| 2020-05-18 |
Viral loads in throat and anal swabs in children infected with SARS-CoV-2 (edit) |
10.1080/22221751.2020.1771219 |
| 2020-05-18 |
Design of multi-epitope vaccine candidate against SARS-CoV-2: a In-Silico study (edit) |
10.1080/07391102.2020.1770127 |
| 2020-05-18 |
SARS-CoV-2/COVID-19: Evidence-Based Recommendations on Diagnosis and Therapy (edit) |
10.1055/A-1156-3991 |
| 2020-05-18 |
Surgical Outcomes after Systematic Preoperative SARS-CoV-2 Screening (edit) |
10.1016/J.SURG.2020.05.006 |
| 2020-05-18 |
Potent neutralizing antibodies against SARS-CoV-2 identified by high-throughput single-cell sequencing of convalescent patients' B cells (edit) |
10.1016/J.CELL.2020.05.025 |
| 2020-05-18 |
Pulmonary embolism and Sars-Cov-2 infection: a new indication for surgical pulmonary endarterectomy? (edit) |
10.1016/J.HRTLNG.2020.05.007 |
| 2020-05-18 |
A preliminary study on serological assay for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 238 admitted hospital patients (edit) |
10.1016/J.MICINF.2020.05.008 |
| 2020-05-18 |
More on "Association between ABO blood groups and risk of SARS-CoV-2 Pneumonia" (edit) |
10.1111/BJH.16845 |
| 2020-05-18 |
Cross-reactive antibody response between SARS-CoV-2 and SARS-CoV infections (edit) |
10.1016/J.CELREP.2020.107725 |
| 2020-05-18 |
Seroprevalence of SARS-CoV-2-Specific Antibodies Among Adults in Los Angeles County, California, on April 10-11, 2020 (edit) |
10.1001/JAMA.2020.8279 |
| 2020-05-18 |
Is there relationship between SARS-CoV 2 and the complement C3 and C4? (edit) |
10.3906/SAG-2004-336 |
| 2020-05-18 |
Potential Sensitivity of Wastewater Monitoring for SARS-CoV-2: Comparison with Norovirus Cases (edit) |
10.1021/ACS.EST.0C02271 |
| 2020-05-18 |
Community Mitigation During SARS-CoV-2 Pandemic: Mission Impossible in Developing Countries (edit) |
10.1089/POP.2020.0095 |
| 2020-05-18 |
Infectious SARS-CoV-2 in Feces of Patient with Severe COVID-19 (edit) |
10.3201/EID2608.200681 |
| 2020-05-18 |
Reactivation of SARS-CoV-2 after Recovery (edit) |
10.1111/PED.14312 |
| 2020-05-18 |
Vertical transmission of COVID-19: SARS-CoV-2 RNA on the fetal side of the placenta in pregnancies with COVID-19 positive mothers and neonates at birth (edit) |
10.1016/J.AJOGMF.2020.100145 |
| 2020-05-18 |
Effects of SARS-CoV-2 infection on pregnant women and their infants: A retrospective study in Wuhan, China (edit) |
10.5858/ARPA.2020-0232-SA |
| 2020-05-18 |
Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody (edit) |
10.1038/S41586-020-2349-Y |
| 2020-05-18 |
Clinical Characteristics of 46 Pregnant Women with a SARS-CoV-2 Infection in Washington State (edit) |
10.1016/J.AJOG.2020.05.031 |
| 2020-05-18 |
Musculoskeletal symptoms in SARS-CoV-2 (COVID-19) patients (edit) |
10.1186/S13018-020-01702-W |
| 2020-05-18 |
Serum Hydrogen Sulfide and Outcome Association in Pneumonia by the SARS-CoV-2 Coronavirusxs (edit) |
10.1097/SHK.0000000000001562 |
| 2020-05-18 |
The impacts of the novel SARS-CoV-2 outbreak on surgical oncology - A letter to the editor on "The Socio-Economic Implications of the Coronavirus and COVID-19 Pandemic: A Review" (edit) |
10.1016/J.IJSU.2020.05.032 |
| 2020-05-18 |
Susceptible supply limits the role of climate in the early SARS-CoV-2 pandemic (edit) |
10.1126/SCIENCE.ABC2535 |
| 2020-05-18 |
SARS-CoV-2 causes COVID-19-like disease in cynomolgus macaques (edit) |
10.1038/S41684-020-0571-8 |
| 2020-05-18 |
Coronavirus disease 2019 (SARS-CoV-2) and colonization of ocular tissues and secretions: a systematic review (edit) |
10.1038/S41433-020-0926-9 |
| 2020-05-18 |
SARS-COV-2 infection in children and newborns: a systematic review (edit) |
10.1007/S00431-020-03684-7 |
| 2020-05-18 |
Evidence for host-dependent RNA editing in the transcriptome of SARS-CoV-2 (edit) |
10.1126/SCIADV.ABB5813 |
| 2020-05-18 |
Binding of the SARS-CoV-2 Spike Protein to Glycans (edit) |
10.1101/2020.05.17.100537 |
| 2020-05-18 |
Architecture and self-assembly of the SARS-CoV-2 nucleocapsid protein (edit) |
10.1101/2020.05.17.100685 |
| 2020-05-18 |
Identification of five antiviral compounds from the Pandemic Response Box targeting SARS-CoV-2 (edit) |
10.1101/2020.05.17.100404 |
| 2020-05-18 |
Spread of the Novel Coronavirus (SARS-CoV-2): Modeling and Simulation of Control Strategies (edit) |
10.1101/2020.05.11.20098418 |
| 2020-05-18 |
Robust computational design and evaluation of peptide vaccines for cellular immunity with application to SARS-CoV-2 (edit) |
10.1101/2020.05.16.088989 |
| 2020-05-18 |
Retrospective Pooled Screening for SARS-CoV-2 RNA in late 2019 (edit) |
10.1101/2020.05.14.20102079 |
| 2020-05-18 |
Feasibility of SARS-CoV-2 virus detection from consumer-grade cotton swabs (edit) |
10.1101/2020.05.12.20073577 |
| 2020-05-18 |
Traces of SARS-CoV-2 RNA in the Blood of COVID-19 Patients (edit) |
10.1101/2020.05.10.20097055 |
| 2020-05-18 |
Ebselen as a highly active inhibitor of PLProCoV2 (edit) |
10.1101/2020.05.17.100768 |
| 2020-05-18 |
Anti-Spike, anti-Nucleocapsid and neutralizing antibodies in SARS-CoV-2 hospitalized patients and asymptomatic carriers (edit) |
10.1101/2020.05.12.20098236 |
| 2020-05-18 |
Human coronavirus reinfection dynamics: lessons for SARS-CoV-2 (edit) |
10.1101/2020.05.11.20086439 |
| 2020-05-18 |
Is the Current N95 Respirator Filtration Efficiency Test Sufficient for Evaluating Protection Against Submicrometer Particles Containing SARS-CoV-2? (edit) |
10.1101/2020.05.14.20102327 |
| 2020-05-18 |
High sensitivity CDC EUA SARS-CoV-2 kit-based End Point-PCR assay. (edit) |
10.1101/2020.05.11.20098590 |
| 2020-05-18 |
SARS-CoV-2 amino acid substitutions widely spread in the human population are mainly located in highly conserved segments of the structural proteins (edit) |
10.1101/2020.05.16.099499 |
| 2020-05-18 |
SARS-CoV-2 spillover into hospital outdoor environments (edit) |
10.1101/2020.05.12.20097105 |
| 2020-05-18 |
No SARS-CoV-2 carriage observed in children attending daycare centers during the first weeks of the epidemic in Belgium. (edit) |
10.1101/2020.05.13.20095190 |
| 2020-05-18 |
Clinical assessment and validation of a rapid and sensitive SARS-CoV-2 test using reverse-transcription loop-mediated isothermal amplification (edit) |
10.1101/2020.05.12.20095638 |
| 2020-05-18 |
Blocking Coronavirus 19 Infection via the SARS-CoV-2 Spike Protein: Initial Steps (edit) |
10.1021/ACSMEDCHEMLETT.0C00233 |
| 2020-05-18 |
ALTERED MOLECULAR PATHWAYS OBSERVED IN NASO-OROPHARYNGEAL SAMPLES OF SARS-CoV-2 PATIENTS (edit) |
10.1101/2020.05.14.20102558 |
| 2020-05-18 |
Substantial underestimation of SARS-CoV-2 infection in the United States due to incomplete testing and imperfect test accuracy (edit) |
10.1101/2020.05.12.20091744 |
| 2020-05-18 |
Analytical performance of lateral flow immunoassay for SARS-CoV-2 exposure screening on venous and capillary blood samples (edit) |
10.1101/2020.05.13.20098426 |
| 2020-05-18 |
COVID-19 genomic susceptibility: Definition of ACE2 variants relevant to human infection with SARS-CoV-2 in the context of ACMG/AMP Guidance (edit) |
10.1101/2020.05.12.20098160 |
| 2020-05-18 |
SARS-CoV-2/COVID-19 und neuromuskuläre Erkrankungen (edit) |
10.1007/S42451-020-00198-2 |
| 2020-05-18 |
Perceived versus proven SARS-CoV-2 specific immune responses in health care workers (edit) |
10.1101/2020.05.12.20094524 |
| 2020-05-18 |
Pregnancy and Neonatal Outcomes in SARS-CoV-2 Infection: a systematic review (edit) |
10.1101/2020.05.11.20098368 |
| 2020-05-18 |
SARS-CoV-2 seroprevalence trends in healthy blood donors during the COVID-19 Milan outbreak (edit) |
10.1101/2020.05.11.20098442 |
| 2020-05-18 |
Prevalence of SARS-CoV-2 infection in the Luxembourgish population: the CON-VINCE study. (edit) |
10.1101/2020.05.11.20092916 |
| 2020-05-18 |
Molecular conservation and Differential mutation on ORF3a gene in Indian SARS-CoV2 genomes (edit) |
10.1101/2020.05.14.096107 |
| 2020-05-18 |
Distinct conformational states of SARS-CoV-2 spike protein (edit) |
10.1101/2020.05.16.099317 |
| 2020-05-18 |
Computational Study of Ions and Water Permeation and Transportation Mechanisms of the SARS-CoV-2 Pentameric E Protein Channel (edit) |
10.1101/2020.05.17.099143 |
| 2020-05-18 |
Rapid Detection of IgM Antibodies against the SARS-CoV-2 Virus via Colloidal Gold Nanoparticle-Based Lateral-Flow Assay (edit) |
10.1021/ACSOMEGA.0C01554 |
| 2020-05-18 |
SEIR Modeling of the Italian Epidemic of SARS-CoV-2 Using Computational Swarm Intelligence (edit) |
10.3390/IJERPH17103535 |
| 2020-05-18 |
Detection of IgM and IgG antibodies against SARS-CoV-2 in patients with autoimmune diseases (edit) |
10.1016/S2665-9913(20)30128-4 |
| 2020-05-18 |
Point-of-Care Diagnostic Tests for Detecting SARS-CoV-2 Antibodies: A Systematic Review and Meta-Analysis of Real-World Data (edit) |
10.3390/JCM9051515 |
| 2020-05-18 |
SARS-CoV-2 in Pregnancy: A Comprehensive Summary of Current Guidelines (edit) |
10.3390/JCM9051521 |
| 2020-05-18 |
Symptomatic SARS-CoV-2 infections display specific IgG Fc structures (edit) |
10.1101/2020.05.15.20103341 |
| 2020-05-18 |
[Recommendations for communicating bad news by phone during the SARS-CoV-2 pandemicRecomendações para a comunicação de más notícias por telefone durante a pandemia do SARS-CoV-2] (edit) |
10.26633/RPSP.2020.69 |
| 2020-05-18 |
Analyses of spike protein from first deposited sequences of SARS-CoV2 from West Bengal, India (edit) |
10.12688/F1000RESEARCH.23805.1 |
| 2020-05-18 |
Anti-SARS-CoV-2 hyperimmune immunoglobulins, an urgent strategic choice (edit) |
10.1016/J.BANM.2020.05.042 |
| 2020-05-17 |
Fast and low-cost detection of SARS-CoV-2 peptides by tandem mass spectrometry in clinical samples (edit) |
10.21203/RS.3.RS-28883/V1 |
| 2020-05-17 |
Potential Presymptomatic Transmission of SARS-CoV-2, Zhejiang Province, China, 2020 (edit) |
10.3201/EID2605.200198 |
| 2020-05-17 |
Risk for Transportation of 2019 Novel Coronavirus Disease from Wuhan to Other Cities in China (edit) |
10.3201/EID2605.200146 |
| 2020-05-17 |
Persistent viral shedding of SARS-CoV-2 in faeces - a rapid review (edit) |
10.1111/CODI.15138 |
| 2020-05-17 |
Ligand-centered assessment of SARS-CoV-2 drug target models in the Protein Data Bank (edit) |
10.1111/FEBS.15366 |
| 2020-05-17 |
Acute heart failure in multisystem inflammatory syndrome in children (MIS-C) in the context of global SARS-CoV-2 pandemic (edit) |
10.1161/CIRCULATIONAHA.120.048360 |
| 2020-05-17 |
Counter-regulatory 'Renin-Angiotensin' System-based Candidate Drugs to Treat COVID-19 Diseases in SARS-CoV-2-infected patients (edit) |
10.2174/1871526520666200518073329 |
| 2020-05-17 |
Dynamics of antibodies to SARS-CoV-2 in a case with SARS-CoV-2 infection (edit) |
10.1016/J.IJID.2020.05.042 |
| 2020-05-17 |
Kidney biopsy findings in a critically ill COVID-19 patient with dialysis-dependent acute kidney injury: a case against "SARS-CoV-2 nephropathy" (edit) |
10.1016/J.EKIR.2020.05.005 |
| 2020-05-17 |
Distribution of the SARS-CoV-2 Pandemic and Its Monthly Forecast Based on Seasonal Climate Patterns (edit) |
10.3390/IJERPH17103493 |
| 2020-05-17 |
The SARS-CoV-2 T-cell immunity is directed against the spike, membrane, and nucleocapsid protein and associated with COVID 19 severity (edit) |
10.1101/2020.05.13.20100636 |
| 2020-05-17 |
Improved survival outcome in SARs-CoV-2 (COVID-19) Acute Respiratory Distress Syndrome patients with Tocilizumab administration (edit) |
10.1101/2020.05.13.20100081 |
| 2020-05-17 |
Progression, recovery and fatality in patients with SARS-CoV-2 related pneumonia in Wuhan, China: a single-centered, retrospective, observational study (edit) |
10.1101/2020.05.12.20099739 |
| 2020-05-17 |
SARS-CoV-2 Detection in Istanbul Wastewater Treatment Plant Sludges (edit) |
10.1101/2020.05.12.20099358 |
| 2020-05-17 |
The first 100 days of SARS-CoV-2 control in Vietnam (edit) |
10.1101/2020.05.12.20099242 |
| 2020-05-17 |
Country differences in hospitalisation, length of stay and admission to Intensive Care Units due to SARS-CoV-2 infection: a rapid review of available literature (edit) |
10.1101/2020.05.12.20099473 |
| 2020-05-17 |
Triaging of Respiratory Protective Equipment on the assumed risk of SARS-CoV-2 aerosol exposure in patient-facing healthcare workers delivering secondary care: a rapid review (edit) |
10.1101/2020.05.13.20101139 |
| 2020-05-17 |
Implications of SARS-CoV-2 mutations for genomic RNA structure and host microRNA targeting (edit) |
10.1101/2020.05.15.098947 |
| 2020-05-17 |
Mechanistic modeling of the SARS-CoV-2 and immune system interplay unravels design principles for diverse clinicopathological outcomes (edit) |
10.1101/2020.05.16.097238 |
| 2020-05-17 |
Deposition distribution of the new coronavirus (SARS-CoV-2) in the human airways upon exposure to cough-generated aerosol (edit) |
10.1101/2020.05.13.20100057 |
| 2020-05-17 |
A comprehensive germline variant and expression analyses of ACE2, TMPRSS2 and SARS-CoV-2 activator FURIN genes from the Middle East: Combating SARS-CoV-2 with precision medicine (edit) |
10.1101/2020.05.16.099176 |
| 2020-05-17 |
EEG findings in acutely ill patients investigated for SARS-CoV-2/COVID-19: A small case series preliminary report (edit) |
10.1002/EPI4.12399 |
| 2020-05-17 |
COVID-19 Pandemic: A Big Challenge in Iran and the World (edit) |
10.18502/IJAAI.V19I(S1.R1).2846 |
| 2020-05-17 |
Sitagliptin Repositioning in SARS-CoV-2: Effects on ACE-2, CD-26, and Inflammatory Cytokine Storms in the Lung (edit) |
10.18502/IJAAI.V19I(S1.R1).2849 |
| 2020-05-17 |
Bradykinin as a Probable Aspect in SARS-Cov-2 Scenarios: Is Bradykinin Sneaking out of Our Sight? (edit) |
10.18502/IJAAI.V19I(S1.R1).2850 |
| 2020-05-17 |
COVID-19 Pandemic Hemoperfusion Therapy Versus Plasma Exchange Therapy in Intensive Care (edit) |
10.18502/IJAAI.V19I(S1.R1).2848 |
| 2020-05-16 |
Rapid Quantification and Neutralization Assays for Novel Coronavirus SARS-CoV-2 Using Avicel RC-591 Semi-Solid Overlay (edit) |
10.20944/PREPRINTS202005.0264.V1 |
| 2020-05-16 |
Ibuprofen and thromboembolism in SARS-COV2 (edit) |
10.1111/JTH.14901 |
| 2020-05-16 |
Management of Hepatocellular Cancer in the time of SARS-CoV-2 (edit) |
10.1111/LIV.14517 |
| 2020-05-16 |
Novel Drugs Targeting the SARS-CoV-2/COVID-19 Machinery (edit) |
10.2174/1568026620999200517043137 |
| 2020-05-16 |
First motor seizure as presenting symptom of SARS-CoV-2 infection (edit) |
10.1007/S10072-020-04460-Z |
| 2020-05-16 |
Added value of 18F-FDG PET/CT in a SARS-CoV-2-infected complex case with persistent fever (edit) |
10.1007/S00259-020-04860-5 |
| 2020-05-16 |
Early experience with remdesivir in SARS-CoV-2 pneumonia (edit) |
10.1007/S15010-020-01448-X |
| 2020-05-16 |
SARS-CoV2 bilateral pneumonia: chest X-ray evolution (edit) |
10.1016/J.MEDIN.2020.03.004 |
| 2020-05-16 |
SARS-CoV-2 RNA in wastewater anticipated COVID-19 occurrence in a low prevalence area (edit) |
10.1016/J.WATRES.2020.115942 |
| 2020-05-16 |
SARS-CoV-2 infection and air pollutants: Correlation or causation? (edit) |
10.1016/J.SCITOTENV.2020.139489 |
| 2020-05-16 |
Clinical and biochemical characteristics of patients admitted to ICU with SARS-CoV-2 (edit) |
10.1016/J.MEDIN.2020.05.003 |
| 2020-05-16 |
[Recommendations on cardiopulmonary resuscitation in patients with suspected or confirmed SARS-CoV-2 infection (COVID-19). Executive summary] (edit) |
10.1016/J.MEDIN.2020.05.004 |
| 2020-05-16 |
Re: Al-Muharraqi MA. Testing recommendation for COVID-19 (SARS-CoV-2) in patients planned for surgery - continuing the service and 'suppressing' the pandemic. Br J Oral Maxillofac Surg. 2020 Apr 13 pii: S0266-4356(20)30164-9. doi: 10.1016/j.bjoms.20 (edit) |
10.1016/J.BJOMS.2020.05.012 |
| 2020-05-16 |
Perioperative Outcomes of Urological Surgery in Patients with SARS-CoV-2 Infection (edit) |
10.1016/J.EURURO.2020.05.012 |
| 2020-05-16 |
MRI evaluation of the olfactory clefts in patients with SARS-CoV-2 infection revealed an unexpected mechanism for olfactory function loss (edit) |
10.1016/J.ACRA.2020.05.013 |
| 2020-05-16 |
A combined oropharyngeal/nares swab is a suitable alternative to nasopharyngeal swabs for the detection of SARS-CoV-2 (edit) |
10.1016/J.JCV.2020.104442 |
| 2020-05-16 |
A family cluster of COVID-19 involving an asymptomatic case with persistently positive SARS-CoV-2 in anal swabs (edit) |
10.1016/J.TMAID.2020.101745 |
| 2020-05-16 |
Cigarette smoke exposure and inflammatory signaling increase the expression of the SARS-CoV-2 receptor ACE2 in the respiratory tract (edit) |
10.1016/J.DEVCEL.2020.05.012 |
| 2020-05-16 |
SARS-CoV-2 infection may mask another infection (edit) |
10.1016/J.ANORL.2020.05.005 |
| 2020-05-16 |
Analysis of SARS-CoV-2 RNA-Sequences by Interpretable Machine Learning Models (edit) |
10.1101/2020.05.15.097741 |
| 2020-05-16 |
Convergent Antibody Responses to SARS-CoV-2 Infection in Convalescent Individuals (edit) |
10.1101/2020.05.13.092619 |
| 2020-05-16 |
Distribution of ACE2, CD147, cyclophilins, CD26 and other SARS-CoV-2 associated molecules in human tissues and immune cells in health and disease (edit) |
10.1101/2020.05.14.090332 |
| 2020-05-16 |
SARS-CoV-2 transcriptome analysis and molecular cataloguing of immunodominant epitopes for multi-epitope based vaccine design (edit) |
10.1101/2020.05.14.097170 |
| 2020-05-16 |
Pre-existing and de novo humoral immunity to SARS-CoV-2 in humans (edit) |
10.1101/2020.05.14.095414 |
| 2020-05-16 |
Recommendations for sample pooling on the Cepheid GeneXpert® system using the Cepheid Xpert® Xpress SARS-CoV-2 assay (edit) |
10.1101/2020.05.14.097287 |
| 2020-05-16 |
Sequence characterization and molecular modeling of clinically relevant variants of the SARS-CoV-2 main protease (edit) |
10.1101/2020.05.15.097493 |
| 2020-05-16 |
Favipiravir strikes the SARS-CoV-2 at its Achilles heel, the RNA polymerase (edit) |
10.1101/2020.05.15.098731 |
| 2020-05-16 |
SARS-CoV2 (COVID-19) Structural/Evolution Dynamicome: Insights into functional evolution and human genomics (edit) |
10.1101/2020.05.15.098616 |
| 2020-05-16 |
IgA MAb blocks SARS-CoV-2 Spike-ACE2 interaction providing mucosal immunity (edit) |
10.1101/2020.05.15.096719 |
| 2020-05-16 |
Analytical and Clinical Comparison of Three Nucleic Acid Amplification Tests for SARS-CoV-2 Detection (edit) |
10.1101/2020.05.14.097311 |
| 2020-05-16 |
A single dose SARS-CoV-2 simulating particle vaccine induces potent neutralizing activities (edit) |
10.1101/2020.05.14.093054 |
| 2020-05-16 |
Two mutations P/L and Y/C in SARS-CoV-2 helicase domain exist together and influence helicase RNA binding (edit) |
10.1101/2020.05.14.095224 |
| 2020-05-16 |
Broad sarbecovirus neutralizing antibodies define a key site of vulnerability on the SARS-CoV-2 spike protein (edit) |
10.1101/2020.05.15.096511 |
| 2020-05-16 |
Structural analysis of the SARS-CoV-2 methyltransferase complex involved in coronaviral RNA cap creation (edit) |
10.1101/2020.05.15.097980 |
| 2020-05-16 |
Phylogenetic Analysis of SARS-CoV-2 Genomes in Turkey (edit) |
10.1101/2020.05.15.095794 |
| 2020-05-16 |
Characteristic Temporary Loss of Taste and Olfactory Senses in SARS-CoV-2-positive-Individuals with Mild Symptoms (edit) |
10.20411/PAI.V5I1.374 |
| 2020-05-16 |
Preliminary information on prevention of infections caused by SARS-COV-2 virus in endoscopic laboratories (edit) |
10.26444/AAEM/122137 |
| 2020-05-15 |
Systemic treatment of patients with solid tumors during the COVID-19 (SARS-CoV-2) pandemic — comprehensive recommendations of the Polish Society of Clinical Oncology (edit) |
10.5603/OCP.2020.0012 |
| 2020-05-15 |
Coronavirus Disease (COVID-19) in Children - What We Know So Far and What We Do Not? (edit) |
|
| 2020-05-15 |
Facepiece Filtering Respirators with Exhalation Valve should not be used in the Community to Limit SARS-CoV-2 Diffusion (edit) |
10.1017/ICE.2020.244 |
| 2020-05-15 |
SARS-CoV-2 pandemic : Time to revive the cyclophilin inhibitor alisporivir (edit) |
10.1093/CID/CIAA587 |
| 2020-05-15 |
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19 (edit) |
10.1016/J.CELL.2020.04.026 |
| 2020-05-15 |
Evidence of Increasing Diversification of Emerging SARS-CoV-2 Strains (edit) |
10.1002/JMV.26018 |
| 2020-05-15 |
Early trends for SARS-CoV-2 infection in central and north Texas and impact on other circulating respiratory viruses (edit) |
10.1002/JMV.26010 |
| 2020-05-15 |
Skin Involvement in SARS-CoV-2 Infection: Case Series (edit) |
10.1002/JMV.26012 |
| 2020-05-15 |
First comprehensive computational analysis of functional consequences of TMPRSS2 SNPs in susceptibility to SARS-CoV-2 among different populations (edit) |
10.1080/07391102.2020.1767690 |
| 2020-05-15 |
Marine natural compounds as potents inhibitors against the main protease of SARS-CoV-2. A molecular dynamic study (edit) |
10.1080/07391102.2020.1769733 |
| 2020-05-15 |
Indomethacin and resveratrol as potential treatment adjuncts for SARS-CoV-2/COVID-19 (edit) |
10.1111/IJCP.13535 |
| 2020-05-15 |
First experience of SARS-CoV-2 infections in solid organ transplant recipients in the Swiss Transplant Cohort Study (edit) |
10.1111/AJT.16062 |
| 2020-05-15 |
Unusual presentation of acute coronary syndrome in a patient with SARS-CoV-2 infection (edit) |
10.1093/EHJCI/JEAA147 |
| 2020-05-15 |
Symptoms and immunoglobulin development in hospital staff exposed to a SARS-CoV-2 outbreak (edit) |
10.1111/PAI.13278 |
| 2020-05-15 |
Prolonged prone position ventilation for SARS-CoV-2 patients is feasible and effective (edit) |
10.1186/S13054-020-02956-W |
| 2020-05-15 |
Saliva as an Alternate Specimen Source for Detection of SARS-CoV-2 in Symptomatic Patients Using Cepheid Xpert Xpress SARS-CoV-2 (edit) |
10.1128/JCM.01109-20 |
| 2020-05-15 |
Stability of SARS-CoV-2 in PBS for Molecular Detection (edit) |
10.1128/JCM.01094-20 |
| 2020-05-15 |
Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies (edit) |
10.1038/S41423-020-0458-Z |
| 2020-05-15 |
Clinical features and development of sepsis in patients infected with SARS-CoV-2: a retrospective analysis of 150 cases outside Wuhan, China (edit) |
10.1007/S00134-020-06084-5 |
| 2020-05-15 |
The role of environmental factors to transmission of SARS-CoV-2 (COVID-19) (edit) |
10.1186/S13568-020-01028-0 |
| 2020-05-15 |
[Epidemiological Aspects, Clinic And Control Mechanisms Of Sars-Cov-2pandemic: Situation In Spain] (edit) |
10.1016/J.ENFCLI.2020.05.001 |
| 2020-05-15 |
No Need of Transforming Gastroenterology Units to COVID Units at the Time of SARS-COV2 Infection - A Single-Center Analysis from Northern Italy (edit) |
10.1016/J.DLD.2020.05.010 |
| 2020-05-15 |
Pharmacological characteristics of patients infected with SARS-Cov-2 admitted to Intensive Care Unit in South of France (edit) |
10.1016/J.THERAP.2020.05.005 |
| 2020-05-15 |
SARS-CoV-2 infection in very preterm pregnancy: experiences from two cases (edit) |
10.1016/J.EJOGRB.2020.05.025 |
| 2020-05-15 |
Investigating the genomic landscape of novel coronavirus (2019-nCoV) to identify non-synonymous mutations for use in diagnosis and drug design (edit) |
10.1016/J.JCV.2020.104441 |
| 2020-05-15 |
Follow-up and management of head and neck cancer patients during the 2019 novel coronavirus (SARS-CoV-2) disease pandemic (edit) |
10.1016/J.ADRO.2020.04.031 |
| 2020-05-15 |
Hygiène à la maison : un rempart contre le COVID-19 pour se protéger du SARS-CoV-2 (edit) |
10.1016/J.BANM.2020.05.019 |
| 2020-05-15 |
Hygiene at home: A bulwark against COVID-19 to be protect from SARS-CoV-2 (edit) |
10.1016/J.BANM.2020.05.020 |
| 2020-05-15 |
Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults (edit) |
10.7326/M20-1515 |
| 2020-05-15 |
Committee Recommendations for Resuming Cardiac Surgery Activity in the SARS-CoV-2 Era: Guidance from an International Cardiac Surgery Consortium (edit) |
10.1016/J.ATHORACSUR.2020.05.004 |
| 2020-05-15 |
Who is most likely to be infected with SARS-CoV-2? (edit) |
10.1016/S1473-3099(20)30395-9 |
| 2020-05-15 |
Importance of precise data on SARS-CoV-2 transmission dynamics control (edit) |
10.1016/S1473-3099(20)30359-5 |
| 2020-05-15 |
Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study (edit) |
10.1016/S1473-3099(20)30371-6 |
| 2020-05-15 |
Ruptured popliteal artery aneurysm complicated with ARDS secondary to SARS-CoV-2 infection (edit) |
10.1016/J.AVSG.2020.05.012 |
| 2020-05-15 |
Detection of SARS-CoV-2 on high-touch surfaces in a clinical microbiology laboratory (edit) |
10.1016/J.JHIN.2020.05.017 |
| 2020-05-15 |
A multiple center clinical evaluation of an ultra-fast single-tube assay for SARS-CoV-2 RNA (edit) |
10.1016/J.CMI.2020.05.007 |
| 2020-05-15 |
THE 11TH TRIAL OF A CARDIOVASCULAR CLINICAL TRIALIST -CORONAVIRUS-2 (SARS-CoV2): PART 1 (edit) |
10.1097/CRD.0000000000000316 |
| 2020-05-15 |
Preparedness of European diagnostic microbiology labs for detection of SARS-CoV-2, March 2020 (edit) |
10.1016/J.JCV.2020.104432 |
| 2020-05-15 |
Why is SARS-CoV-2 infection milder among children? (edit) |
10.6061/CLINICS/2020/E1947 |
| 2020-05-15 |
Susceptibility of the Elderly to SARS-CoV-2 Infection: ACE-2 Overexpression, Shedding, and Antibody-dependent Enhancement (ADE) (edit) |
10.6061/CLINICS/2020/E1912 |
| 2020-05-15 |
Use of Saliva for Diagnosis and Monitoring the SARS-CoV-2: A General Perspective (edit) |
10.3390/JCM9051491 |
| 2020-05-15 |
COVID-19 (SARS-Cov-2) and the heart - An ominous association (edit) |
10.1016/J.CARREV.2020.05.009 |
| 2020-05-15 |
Network Analysis and Transcriptome Profiling Identify Autophagic and Mitochondrial Dysfunctions in SARS-CoV-2 Infection (edit) |
10.1101/2020.05.13.092536 |
| 2020-05-15 |
Characteristic and quantifiable COVID-19-like abnormalities in CT- and PET/CT-imaged lungs of SARS-CoV-2-infected crab-eating macaques (Macaca fascicularis) (edit) |
10.1101/2020.05.14.096727 |
| 2020-05-15 |
Patient DNA cross-reactivity of the CDC SARS-CoV-2 extraction control leads to an inherent potential for false negative results (edit) |
10.1101/2020.05.13.094839 |
| 2020-05-15 |
Growth factor receptor signaling inhibition prevents SARS-CoV-2 replication (edit) |
10.1101/2020.05.14.095661 |
| 2020-05-15 |
SARS-CoV-2 antibody seroprevalence in industry workers in Split-Dalmatia and Sibenik-Knin County, Croatia (edit) |
10.1101/2020.05.11.20095158 |
| 2020-05-15 |
Identification of conserved epitopes in SARS-CoV-2 spike and nucleocapsid protein (edit) |
10.1101/2020.05.14.095133 |
| 2020-05-15 |
Novel ACE2-Independent Carbohydrate-Binding of SARS-CoV-2 Spike Protein to Host Lectins and Lung Microbiota (edit) |
10.1101/2020.05.13.092478 |
| 2020-05-15 |
Unveiling diffusion pattern and structural impact of the most invasive SARS-CoV-2 spike mutation (edit) |
10.1101/2020.05.14.095620 |
| 2020-05-15 |
Rapid implementation of real-time SARS-CoV-2 sequencing to investigate healthcare-associated COVID-19 infections (edit) |
10.1101/2020.05.08.20095687 |
| 2020-05-15 |
Immunoinformatic identification of B cell and T cell epitopes in the SARS-CoV-2 proteome (edit) |
10.1101/2020.05.14.093757 |
| 2020-05-15 |
ACE2-Variants Indicate Potential SARS-CoV-2-Susceptibility in Animals: An Extensive Molecular Dynamics Study (edit) |
10.1101/2020.05.14.092767 |
| 2020-05-15 |
Screening of healthcare workers for SARS-CoV-2 highlights the role of asymptomatic carriage in COVID-19 transmission (edit) |
10.1101/2020.05.09.20082909 |
| 2020-05-15 |
Predicting the Immunogenicity of T cell epitopes: From HIV to SARS-CoV-2 (edit) |
10.1101/2020.05.14.095885 |
| 2020-05-15 |
Crystal structures of SARS-CoV-2 ADP-ribose phosphatase (ADRP): from the apo form to ligand complexes (edit) |
10.1101/2020.05.14.096081 |
| 2020-05-15 |
Potent neutralization of SARS-CoV-2 in vitro and in an animal model by a human monoclonal antibody (edit) |
10.1101/2020.05.13.093088 |
| 2020-05-15 |
Exosomes Facilitate Transmission of SARS-CoV-2 Genome into Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (edit) |
10.1101/2020.05.14.093583 |
| 2020-05-15 |
Estimation of the incubation period of SARS-CoV-2 in Vietnam (edit) |
10.1101/2020.05.09.20096800 |
| 2020-05-15 |
Comment je fais: Prise en charge des patients en Radiologie Interventionnelle Oncologique en période de pandémie au SARS-CoV-2 (edit) |
10.1016/J.JIDI.2020.05.003 |
| 2020-05-15 |
High SARS-CoV-2 Attack Rate Following Exposure at a Choir Practice - Skagit County, Washington, March 2020 (edit) |
10.15585/MMWR.MM6919E6 |
| 2020-05-15 |
Two outbreaks of SARS-CoV-2 in department of surgery in a Wuhan hospital (edit) |
10.1016/J.INFPIP.2020.100065 |
| 2020-05-15 |
The origin of SARS-CoV-2 in Istanbul: Sequencing findings from the epicenter of the pandemic in Turkey (edit) |
10.14744/NCI.2020.90532 |
| 2020-05-15 |
The Covid-19 pandemic and India's cardiovascular disease burden: Finding the right balance (edit) |
10.20529/IJME.2020.059 |
| 2020-05-15 |
Interferon-α2b Treatment for COVID-19 (edit) |
10.3389/FIMMU.2020.01061 |
| 2020-05-15 |
Is SARS-CoV-2 Vertically Transmitted? (edit) |
10.3389/FPED.2020.00276 |
| 2020-05-14 |
Infection of dogs with SARS-CoV-2 (edit) |
10.1038/S41586-020-2334-5 |
| 2020-05-14 |
Characteristics and outcomes of patients with breast cancer diagnosed with SARS-Cov-2 infection at an academic center in New York City (edit) |
10.1007/S10549-020-05667-6 |
| 2020-05-14 |
Potential anti-viral activity of approved repurposed drug against main protease of SARS-CoV-2: an in silico based approach (edit) |
10.1080/07391102.2020.1768902 |
| 2020-05-14 |
Angiotension-converting enzyme inhibitors and angiotensin-receptor blockers are not associated with increased risk of SARS-CoV-2 infection (edit) |
10.1093/JTM/TAAA069 |
| 2020-05-14 |
Positive detection of SARS-CoV-2 combined HSV1 and HHV6B virus nucleic acid in tear and conjunctival secretions of a non-conjunctivitis COVID-19 patient with obstruction of common lacrimal duct (edit) |
10.1111/AOS.14456 |
| 2020-05-14 |
In Silico Exploration of Molecular Mechanism of Clinically Oriented Drugs for Possibly Inhibiting SARS-CoV-2's Main Protease (edit) |
10.1021/ACS.JPCLETT.0C00994 |
| 2020-05-14 |
Interleukin-6 Receptor Antagonist Therapy to Treat SARS-CoV-2 Driven Inflammatory Syndrome in a Renal Transplant Recipient (edit) |
10.1111/TID.13326 |
| 2020-05-14 |
Proteomics of SARS-CoV-2-infected host cells reveals therapy targets (edit) |
10.1038/S41586-020-2332-7 |
| 2020-05-14 |
Respiratory failure in patients infected with SARS-CoV-2 (edit) |
10.3949/CCJM.87A.CCC025 |
| 2020-05-14 |
Probable congenital SARS-CoV-2 infection in a neonate born to a woman with active SARS-CoV-2 infection (edit) |
10.1503/CMAJ.200821 |
| 2020-05-14 |
Complete Genome Sequences of SARS-CoV-2 Strains Detected in Malaysia (edit) |
10.1128/MRA.00383-20 |
| 2020-05-14 |
Publisher Correction: A human monoclonal antibody blocking SARS-CoV-2 infection (edit) |
10.1038/S41467-020-16452-W |
| 2020-05-14 |
SARS-CoV-2 likes it cool (edit) |
10.1038/S41577-020-0341-2 |
| 2020-05-14 |
Expressions and significances of the angiotensin-converting enzyme 2 gene, the receptor of SARS-CoV-2 for COVID-19 (edit) |
10.1007/S11033-020-05478-4 |
| 2020-05-14 |
Interaction of the spike protein RBD from SARS-CoV-2 with ACE2: Similarity with SARS-CoV, hot-spot analysis and effect of the receptor polymorphism (edit) |
10.1016/J.BBRC.2020.05.028 |
| 2020-05-14 |
[OnabotulinumtoxinA infiltration and nerve blocks in patients with headache and neuralgia: safety recommendations to prevent SARS-CoV-2 infection] (edit) |
10.1016/J.NRL.2020.05.004 |
| 2020-05-14 |
[Guide for follow-up of patients with SARS-CoV-2 pneumonia. Management proposals developed by the French-language Respiratory Medicine Society. Version of 10 May 2020] (edit) |
10.1016/J.RMR.2020.05.001 |
| 2020-05-14 |
Facial diplegia, a possible atypical variant of Guillain-Barré Syndrome as a rare neurological complication of SARS-CoV-2 (edit) |
10.1016/J.JOCN.2020.05.016 |
| 2020-05-14 |
How to increase the SARS-CoV-2 detection rate through the nasopharyngeal swab? (edit) |
10.1016/J.ORALONCOLOGY.2020.104802 |
| 2020-05-14 |
Acute asthma management during SARS-CoV2-pandemic 2020 (edit) |
10.1016/J.WAOJOU.2020.100125 |
| 2020-05-14 |
Transmission routes of SARS-CoV-2 (edit) |
10.1016/J.JDS.2020.05.005 |
| 2020-05-14 |
Optimizing Medication Treatment of Opioid Use Disorder During COVID-19 (SARS-CoV-2) (edit) |
10.1097/ADM.0000000000000678 |
| 2020-05-14 |
SARS-CoV-2 infection diagnosed only by cell culture isolation before the local outbreak in an Italian seven-week-old suckling baby (edit) |
10.1016/J.IJID.2020.05.035 |
| 2020-05-14 |
'Led by the science', evidence gaps, and the risks of aerosol transmission of SARS-COV-2 (edit) |
10.1016/J.RESUSCITATION.2020.05.019 |
| 2020-05-14 |
Characterization of eight novel full-length genomes of SARS-CoV-2 among imported COVID-19 cases from abroad in Yunnan, China (edit) |
10.1016/J.JINF.2020.05.016 |
| 2020-05-14 |
The changing landscape of SARS-CoV-2: Implications for the maternal-infant dyad (edit) |
10.3233/NPM-200460 |
| 2020-05-14 |
Considerations for the outpatient practice in pediatric surgery during the novel SARS-CoV-2Pandemic (edit) |
10.1016/J.JPEDSURG.2020.05.012 |
| 2020-05-14 |
Clinical characteristics of 9 cancer patients with SARS-CoV-2 infection (edit) |
10.1186/S13020-020-00328-8 |
| 2020-05-14 |
SARS-CoV-2 and COVID-19: is interleukin-6 (IL-6) the 'culprit lesion' of ARDS onset? What is there besides Tocilizumab? SGP130Fc (edit) |
10.1016/J.CYTOX.2020.100029 |
| 2020-05-14 |
A Novel Synonymous Mutation of SARS-CoV-2: Is This Possible to Affect Their Antigenicity and Immunogenicity? (edit) |
10.3390/VACCINES8020220 |
| 2020-05-14 |
Highly Conserved Homotrimer Cavity Formed by the SARS-CoV-2 Spike Glycoprotein: A Novel Binding Site (edit) |
10.3390/JCM9051473 |
| 2020-05-14 |
Recent Insight into SARS-CoV2 Immunopathology and Rationale for Potential Treatment and Preventive Strategies in COVID-19 (edit) |
10.3390/VACCINES8020224 |
| 2020-05-14 |
COVID-19 and Individual Genetic Susceptibility/Receptivity: Role of ACE1/ACE2 Genes, Immunity, Inflammation and Coagulation. Might the Double X-chromosome in Females Be Protective against SARS-CoV-2 Compared to the Single X-Chromosome in Males? (edit) |
10.3390/IJMS21103474 |
| 2020-05-14 |
Lessons from a rapid systematic review of early SARS-CoV-2 serosurveys (edit) |
10.1101/2020.05.10.20097451 |
| 2020-05-14 |
Cross-sectional IgM and IgG profiles in SARS-CoV-2 infection (edit) |
10.1101/2020.05.10.20097535 |
| 2020-05-14 |
Lung Disease Network Reveals the Impact of Comorbidity on SARS-CoV-2 infection (edit) |
10.1101/2020.05.13.092577 |
| 2020-05-14 |
A rapid, point of care red blood cell agglutination assay for detecting antibodies against SARS-CoV-2 (edit) |
10.1101/2020.05.13.094490 |
| 2020-05-14 |
Propagation, inactivation, and safety testing of SARS-CoV-2 (edit) |
10.1101/2020.05.13.094482 |
| 2020-05-14 |
In Vitro Inhibition of SARS-CoV-2 Infection by Bovine Lactoferrin (edit) |
10.1101/2020.05.13.093781 |
| 2020-05-14 |
A Computational Toolset for Rapid Identification of SARS-CoV-2, other Viruses, and Microorganisms from Sequencing Data (edit) |
10.1101/2020.05.12.092163 |
| 2020-05-14 |
Comparison of SARS-CoV-2 Indirect and Direct Detection Methods (edit) |
10.1101/2020.05.12.092387 |
| 2020-05-14 |
Evaluation Of SYBR Green Real Time PCR For Detecting SARS-CoV-2 From Clinical Samples (edit) |
10.1101/2020.05.13.093609 |
| 2020-05-14 |
Laboratory validation of an RNA/DNA hybrid tagmentation based mNGS workflow on SARS-CoV-2 and other respiratory RNA viruses detection (edit) |
10.1101/2020.05.12.20099754 |
| 2020-05-14 |
Insights into molecular evolution recombination of pandemic SARS-CoV-2 using Saudi Arabian sequences (edit) |
10.1101/2020.05.13.093971 |
| 2020-05-14 |
Epidemiology, risk factors and clinical course of SARS-CoV-2 infected patients in a Swiss university hospital: an observational retrospective study (edit) |
10.1101/2020.05.11.20097741 |
| 2020-05-14 |
Structure of SARS-CoV-2 main protease in the apo state reveals the inactive conformation (edit) |
10.1101/2020.05.12.092171 |
| 2020-05-14 |
ChAdOx1 nCoV-19 vaccination prevents SARS-CoV-2 pneumonia in rhesus macaques (edit) |
10.1101/2020.05.13.093195 |
| 2020-05-14 |
Tracing two causative SNPs reveals SARS-CoV-2 transmission in North America population (edit) |
10.1101/2020.05.12.092056 |
| 2020-05-14 |
Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein (edit) |
10.1101/2020.05.12.091462 |
| 2020-05-14 |
Comparison of the Accula SARS-CoV-2 Test with a Laboratory-Developed Assay for Detection of SARS-CoV-2 RNA in Clinical Nasopharyngeal Specimens (edit) |
10.1101/2020.05.12.092379 |
| 2020-05-14 |
Genome Analysis of SARS-CoV-2 Isolate from Bangladesh (edit) |
10.1101/2020.05.13.094441 |
| 2020-05-14 |
Functional prediction and comparative population analysis of variants in genes for proteases and innate immunity related to SARS-CoV-2 infection (edit) |
10.1101/2020.05.13.093690 |
| 2020-05-14 |
Antibody repertoire induced by SARS-CoV-2 spike protein immunogens (edit) |
10.1101/2020.05.12.091918 |
| 2020-05-14 |
Infection Groups Differential (IGD) Score Reveals Infection Ability Difference between SARS-CoV-2 and Other Coronaviruses (edit) |
10.1101/2020.05.12.090324 |
| 2020-05-14 |
Asymptomatic Seroconversion of Immunoglobulins to SARS-CoV-2 in a Pediatric Dialysis Unit (edit) |
10.1001/JAMA.2020.8438 |
| 2020-05-14 |
Pathogenesis and transmission of SARS-CoV-2 in golden hamsters (edit) |
10.1038/S41586-020-2342-5 |
| 2020-05-14 |
Are pangolins the intermediate host of the 2019 novel coronavirus (SARS-CoV-2)? (edit) |
10.1371/JOURNAL.PPAT.1008421 |
| 2020-05-14 |
Recommendation of fecal specimen for routine molecular detection of SARS-CoV-2 and for COVID-19 discharge criteria (edit) |
10.1080/20477724.2020.1765651 |
| 2020-05-14 |
Assessing risk factors for SARS-CoV-2 infection in patients presenting with symptoms in Shanghai, China: a multicentre, observational cohort study (edit) |
10.1016/S2589-7500(20)30109-6 |
| 2020-05-14 |
Scaling up testing for COVID-19 in Africa: Responding to the pandemic in ways that strengthen health systems (edit) |
10.4102/AJLM.V9I1.1244 |
| 2020-05-14 |
Disconnect between community testing and hospitalization for SARS-CoV-2 (COVID-19) infection (edit) |
10.1080/08998280.2020.1762439 |
| 2020-05-14 |
Reproductive health in the time of SARS-CoV-2 (edit) |
10.1111/1469-8676.12809 |
| 2020-05-14 |
Inappropriate risk perception for SARS-CoV-2 infection among Italian HCWs in the eve of COVID-19 pandemic (edit) |
10.23750/ABM.V91I3.9727 |
| 2020-05-13 |
Vitamin D and SARS-CoV-2 virus/COVID-19 disease (edit) |
10.1136/BMJNPH-2020-000089 |
| 2020-05-13 |
Crystal Structure of Nsp16-Nsp10 Heterodimer from SARS-CoV-2 with 7-methyl-GpppA and S-adenosyl-L-homocysteine in the Active Site and Sulfates in the mRNA Binding Groove (edit) |
10.2210/PDB6WRZ/PDB |
| 2020-05-13 |
An oral live attenuated vaccine strategy against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/2019-nCoV) (edit) |
10.3897/RIO.6.E53767 |
| 2020-05-13 |
Crystal Structure of the Second Form of the Co-factor Complex of NSP7 and the C-terminal Domain of NSP8 from SARS CoV-2 (edit) |
10.2210/PDB6WTC/PDB |
| 2020-05-13 |
Structure of replicating SARS-CoV-2 polymerase (edit) |
10.2210/PDB6YYT/PDB |
| 2020-05-13 |
Identification of bioactive molecules from Tea plant as SARS-CoV-2 main protease inhibitors (edit) |
10.1080/07391102.2020.1766572 |
| 2020-05-13 |
First ultrastructural autoptic findings of SARS-Cov-2 in olfactory pathways and brainstem (edit) |
10.23736/S0375-9393.20.14772-2 |
| 2020-05-13 |
SARS-CoV-2 Rates in BCG-Vaccinated and Unvaccinated Young Adults (edit) |
10.1001/JAMA.2020.8189 |
| 2020-05-13 |
The first case of acquired hemophilia A associated with SARS-CoV-2 infection (edit) |
10.1002/AJH.25865 |
| 2020-05-13 |
Genetic variants and source of introduction of SARS-CoV-2 in South America (edit) |
10.1002/JMV.26001 |
| 2020-05-13 |
SARS-CoV-2 immunogenicity at the crossroads (edit) |
10.1111/ALL.14360 |
| 2020-05-13 |
The challenges of establishing adequate capacity for SARS-COV-2 testing (edit) |
10.5694/MJA2.50610 |
| 2020-05-13 |
Prolonged SARS-Cov-2 RNA Detection in Anal/Rectal Swabs and Stool Specimens in COVID-19 Patients After Negative Conversion in Nasopharyngeal RT-PCR Test (edit) |
10.1002/JMV.26007 |
| 2020-05-13 |
Fatal Eosinophilic Myocarditis in a Healthy 17-Year-Old Male with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2c) (edit) |
10.1080/15513815.2020.1761491 |
| 2020-05-13 |
Clinical Performance of Two SARS-CoV-2 Serologic Assays (edit) |
10.1093/CLINCHEM/HVAA120 |
| 2020-05-13 |
COVID-19 and gastrointestinal endoscopy: Importance of reducing SARS-CoV-2 infection risks of medical workers and preserving personal protective equipment resources (edit) |
10.1111/DEN.13720 |
| 2020-05-13 |
Multiorgan and Renal Tropism of SARS-CoV-2 (edit) |
10.1056/NEJMC2011400 |
| 2020-05-13 |
Transmission of SARS-CoV-2 in Domestic Cats (edit) |
10.1056/NEJMC2013400 |
| 2020-05-13 |
Safe performance of diagnostic bronchoscopy/EBUS during the SARS-CoV-2 pandemic (edit) |
10.1111/RESP.13843 |
| 2020-05-13 |
Development of multi-specific humanized llama antibodies blocking SARS-CoV-2/ACE2 interaction with high affinity and avidity (edit) |
10.1080/22221751.2020.1768806 |
| 2020-05-13 |
The role of passive immunization in the age of SARS-CoV-2: an update (edit) |
10.1186/S40001-020-00414-5 |
| 2020-05-13 |
The airborne lifetime of small speech droplets and their potential importance in SARS-CoV-2 transmission (edit) |
10.1073/PNAS.2006874117 |
| 2020-05-13 |
A Case Series of the 2019 Novel Coronavirus (SARS-CoV-2) in Three Febrile Infants in New York (edit) |
10.1542/PEDS.2020-1056 |
| 2020-05-13 |
Estimating the burden of SARS-CoV-2 in France (edit) |
10.1126/SCIENCE.ABC3517 |
| 2020-05-13 |
Evaluation of a rapid diagnostic assay for detection of SARS CoV-2 antigen in nasopharyngeal swab (edit) |
10.1128/JCM.00977-20 |
| 2020-05-13 |
Large-scale, in-house production of viral transport media to support SARS-CoV-2 PCR testing in a multi-hospital healthcare network during the COVID-19 pandemic (edit) |
10.1128/JCM.00913-20 |
| 2020-05-13 |
Comparison of SARS-CoV-2 spike protein binding to ACE2 receptors from human, pets, farm animals, and putative intermediate hosts (edit) |
10.1128/JVI.00831-20 |
| 2020-05-13 |
The COVID-19 Host Genetics Initiative, a global initiative to elucidate the role of host genetic factors in susceptibility and severity of the SARS-CoV-2 virus pandemic (edit) |
10.1038/S41431-020-0636-6 |
| 2020-05-13 |
Infection of bat and human intestinal organoids by SARS-CoV-2 (edit) |
10.1038/S41591-020-0912-6 |
| 2020-05-13 |
Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: Impact on adverse outcomes in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (edit) |
10.1016/J.AHJ.2020.05.002 |
| 2020-05-13 |
SARS-CoV-2-induces acute and refractory relapse of systemic capillary leak syndrome (Clarkson's disease) (edit) |
10.1016/J.AMJMED.2020.03.057 |
| 2020-05-13 |
Visualization of SARS-CoV-2 virus invading the human placenta using electron microscopy (edit) |
10.1016/J.AJOG.2020.05.023 |
| 2020-05-13 |
How SARS-CoV-2 is forcing us to reconsider and reorganize our daily neurosurgical practice (edit) |
10.1016/J.NEUCHI.2020.05.001 |
| 2020-05-13 |
A global effort to define the human genetics of protective immunity to SARS-CoV-2 infection (edit) |
10.1016/J.CELL.2020.05.016 |
| 2020-05-13 |
Identification of SARS-CoV RBD-targeting monoclonal antibodies with cross-reactive or neutralizing activity against SARS-CoV-2 (edit) |
10.1016/J.ANTIVIRAL.2020.104820 |
| 2020-05-13 |
Putting a balance on the aerosolization debate around SARS-CoV-2 (edit) |
10.1016/J.JHIN.2020.05.014 |
| 2020-05-13 |
[Chronic obstructive pulmonary disease and SARS-CoV-2 infection. What do we know so far?] (edit) |
10.1016/J.ARBRES.2020.04.016 |
| 2020-05-13 |
nSynergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: what molecular dynamics studies of virus-host interactions reveal (edit) |
10.1016/J.IJANTIMICAG.2020.106020 |
| 2020-05-13 |
The dilemmas of the classification of SARS-CoV-2 infection without clinical manifestations: asymptomatic or presymptomatic (edit) |
10.1016/J.JFMA.2020.05.009 |
| 2020-05-13 |
A study on infectivity of asymptomatic SARS-CoV-2 carriers (edit) |
10.1016/J.RMED.2020.106026 |
| 2020-05-13 |
Rho kinase inhibitors for SARS-CoV-2 induced acute respiratory distress syndrome: Support from Bartter's and Gitelman's syndrome patients (edit) |
10.1016/J.PHRS.2020.104903 |
| 2020-05-13 |
Comparison of Cepheid Xpert Xpress and Abbott ID Now to Roche cobas for the Rapid Detection of SARS-CoV-2 (edit) |
10.1016/J.JCV.2020.104428 |
| 2020-05-13 |
Real-time PCR-based SARS-CoV-2 detection in Canadian Laboratories (edit) |
10.1016/J.JCV.2020.104433 |
| 2020-05-13 |
SARS-CoV-2-specific antibody detection in healthcare workers in Germany with direct contact to COVID-19 patients (edit) |
10.1016/J.JCV.2020.104437 |
| 2020-05-13 |
Validation of SARS-CoV-2 detection across multiple specimen types (edit) |
10.1016/J.JCV.2020.104438 |
| 2020-05-13 |
Detection of SARS-CoV-2 is comparable in clinical samples preserved in saline or viral transport media (edit) |
10.1016/J.JMOLDX.2020.04.209 |
| 2020-05-13 |
Sars-CoV-2 and black population: ACE2 as shield or blade? (edit) |
10.1016/J.MEEGID.2020.104361 |
| 2020-05-13 |
Acute kidney injury in pregnant women following SARS-CoV-2 infection: A case report from Iran (edit) |
10.1016/J.RMCR.2020.101090 |
| 2020-05-13 |
Preliminary pragmatic lessons from the SARS-CoV-2 pandemic from France (edit) |
10.1016/J.ACCPM.2020.05.005 |
| 2020-05-13 |
The MERS-CoV receptor DPP4 as a candidate binding target of the SARS-CoV-2 spike (edit) |
10.1016/J.ISCI.2020.101160 |
| 2020-05-13 |
Could patients taking isotretinoin therapy be immune against SARS-COV-2? (edit) |
10.1111/DTH.13573 |
| 2020-05-13 |
SARS-CoV-2 Shedding from Asymptomatic Patients: Contribution of Potential Extrapulmonary Tissue Reservoirs (edit) |
10.4269/AJTMH.20-0279 |
| 2020-05-13 |
SARS-CoV-2: A New Song Recalls an Old Melody (edit) |
10.1016/J.CHOM.2020.04.019 |
| 2020-05-13 |
An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study (edit) |
10.1016/S0140-6736(20)31103-X |
| 2020-05-13 |
SARS-CoV-2 receptor ACE2 gene expression and RAAS inhibitors (edit) |
10.1016/S2213-2600(20)30224-1 |
| 2020-05-13 |
On the interactions of the receptor-binding domain of SARS-CoV-1 and SARS-CoV-2 spike proteins with monoclonal antibodies and the receptor ACE2 (edit) |
10.1016/J.VIRUSRES.2020.198021 |
| 2020-05-13 |
Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection (edit) |
10.1016/J.BBI.2020.05.037 |
| 2020-05-13 |
Variation in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reaction-Based SARS-CoV-2 Tests by Time Since Exposure (edit) |
10.7326/M20-1495 |
| 2020-05-13 |
Meta-analysis of transcriptomes of SARS-Cov2 infected human lung epithelial cells identifies transmembrane serine proteases co-expressed with ACE2 and biological processes related to viral entry, immunity, inflammation and cellular stress (edit) |
10.1101/2020.05.12.091314 |
| 2020-05-13 |
Static All-Atom Energetic Mappings of the SARS-Cov-2 Spike Protein with Potential Latch Identification of the Down State Protomer (edit) |
10.1101/2020.05.12.091090 |
| 2020-05-13 |
Pericyte-specific vascular expression of SARS-CoV-2 receptor ACE2 – implications for microvascular inflammation and hypercoagulopathy in COVID-19 patients (edit) |
10.1101/2020.05.11.088500 |
| 2020-05-13 |
The SARS-CoV-2 conserved macrodomain is a highly efficient ADP-ribosylhydrolase enzyme (edit) |
10.1101/2020.05.11.089375 |
| 2020-05-13 |
Children’s Hospital Los Angeles COVID-19 Analysis Research Database (CARD) - A Resource for Rapid SARS-CoV-2 Genome Identification Using Interactive Online Phylogenetic Tools (edit) |
10.1101/2020.05.11.089763 |
| 2020-05-13 |
Evaluation of the EUROIMMUN Anti-SARS-CoV-2 ELISA Assay for detection of IgA and IgG antibodies (edit) |
10.1101/2020.05.11.089862 |
| 2020-05-13 |
Androgen Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men (edit) |
10.1101/2020.05.12.091082 |
| 2020-05-13 |
Potential antiviral options against SARS-CoV-2 infection (edit) |
10.1101/2020.05.12.091165 |
| 2020-05-13 |
Mutation landscape of SARS-CoV-2 reveals three mutually exclusive clusters of leading and trailing single nucleotide substitutions (edit) |
10.1101/2020.05.07.082768 |
| 2020-05-13 |
Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual (edit) |
10.1101/2020.05.12.091298 |
| 2020-05-13 |
Characterization of SARS-CoV-2 viral diversity within and across hosts (edit) |
10.1101/2020.05.07.083410 |
| 2020-05-13 |
Comparative analysis of antiviral efficacy of FDA-approved drugs against SARS-CoV-2 in human lung cells: Nafamostat is the most potent antiviral drug candidate (edit) |
10.1101/2020.05.12.090035 |
| 2020-05-13 |
ReScan, a Multiplex Diagnostic Pipeline, Pans Human Sera for SARS-CoV-2 Antigens (edit) |
10.1101/2020.05.11.20092528 |
| 2020-05-13 |
SARS-CoV-2 activates lung epithelia cell proinflammatory signaling and leads to immune dysregulation in COVID-19 patients by single-cell sequencing (edit) |
10.1101/2020.05.08.20096024 |
| 2020-05-13 |
Identification of Immune complement function as a determinant of adverse SARS-CoV-2 infection outcome (edit) |
10.1101/2020.05.05.20092452 |
| 2020-05-13 |
Defining the Pandemic at the State Level: Sequence-Based Epidemiology of the SARS-CoV-2 virus by the Arizona COVID-19 Genomics Union (ACGU) (edit) |
10.1101/2020.05.08.20095935 |
| 2020-05-13 |
Rapid response flow cytometric assay for the detection of antibody responses to SARS-CoV-2 (edit) |
10.1101/2020.05.09.20091447 |
| 2020-05-13 |
SARS-CoV-2 receptor networks in diabetic kidney disease, BK-Virus nephropathy and COVID-19 associated acute kidney injury (edit) |
10.1101/2020.05.09.20096511 |
| 2020-05-13 |
An Online Repository of Solvation Thermodynamic and Structural Maps of SARS-CoV-2 Targets (edit) |
10.26434/CHEMRXIV.12275705 |
| 2020-05-13 |
AYUSH, modern medicine and the Covid-19 pandemic (edit) |
10.20529/IJME.2020.058 |
| 2020-05-13 |
Interactome of SARS-CoV-2 / nCoV19 modulated host proteins with computationally predicted PPIs (edit) |
10.21203/RS.3.RS-28592/V1 |
| 2020-05-13 |
Acute myocarditis as the main clinical manifestation of SARS-CoV 2 infection (edit) |
10.4081/IDR.2020.8609 |
| 2020-05-12 |
Elucidating biophysical basis of binding of inhibitors to SARS-CoV-2 main protease by using molecular dynamics simulations and free energy calculations (edit) |
10.1080/07391102.2020.1768149 |
| 2020-05-12 |
Truncated human Angiotensin Converting Enzyme 2; a potential inhibitor of SARS-CoV-2 spike glycoprotein and potent COVID-19 therapeutic agent (edit) |
10.1080/07391102.2020.1768150 |
| 2020-05-12 |
Breath diagnostics in the era of SARS-CoV-2 - in clinical and research arena (edit) |
10.1088/1752-7163/AB924A |
| 2020-05-12 |
Respiratory disease in rhesus macaques inoculated with SARS-CoV-2 (edit) |
10.1038/S41586-020-2324-7 |
| 2020-05-12 |
Impact of international travel dynamics on domestic spread of 2019-nCoV in India: origin-based risk assessment in importation of infected travelers (edit) |
10.1186/S12992-020-00575-2 |
| 2020-05-12 |
RNA genome conservation and secondary structure in SARS-CoV-2 and SARS-related viruses: a first look (edit) |
10.1261/RNA.076141.120 |
| 2020-05-12 |
Venous thromboembolism in SARS-CoV-2 patients: only a problem in ventilated ICU patients, or is there more to it? (edit) |
10.1183/13993003.01201-2020 |
| 2020-05-12 |
Distinct features of SARS-CoV-2-specific IgA response in COVID-19 patients (edit) |
10.1183/13993003.01526-2020 |
| 2020-05-12 |
The role of the exposome in promoting resilience or susceptibility after SARS-CoV-2 infection (edit) |
10.1038/S41370-020-0232-4 |
| 2020-05-12 |
A serological assay to detect SARS-CoV-2 seroconversion in humans (edit) |
10.1038/S41591-020-0913-5 |
| 2020-05-12 |
A technical report from the Italian SARS-CoV-2 outbreak. Postmortem sampling and autopsy investigation in cases of suspected or probable COVID-19 (edit) |
10.1007/S12024-020-00258-9 |
| 2020-05-12 |
Recruitability and effect of PEEP in SARS-Cov-2-associated acute respiratory distress syndrome (edit) |
10.1186/S13613-020-00675-7 |
| 2020-05-12 |
[The "Historic Study" SOLIDARITY-Research's Answer to the Sars-CoV-2 Pandemic] (edit) |
10.1007/S00048-020-00257-5 |
| 2020-05-12 |
SARS-CoV-2 and myocardial injury: a role for Nox2? (edit) |
10.1007/S11739-020-02348-6 |
| 2020-05-12 |
SARS-CoV-2 infection in two patients following recent lung transplantation (edit) |
10.1111/AJT.15998 |
| 2020-05-12 |
Use of SARS-CoV-2 infected deceased organ donors: Should we always "just say no?" (edit) |
10.1111/AJT.16000 |
| 2020-05-12 |
In vitro data of current therapies for SARS-CoV-2 (edit) |
10.2174/0929867327666200513075430 |
| 2020-05-12 |
SARS-CoV-2 proteins (version 2020.2) in the IUPHAR/BPS Guide to Pharmacology Database (edit) |
10.2218/GTOPDB/F1034/2020.2 |
| 2020-05-12 |
SARS-CoV-2 Impact on Elective Orthopaedic Surgery: Implications for Post-Pandemic Recovery (edit) |
10.2106/JBJS.20.00602 |
| 2020-05-12 |
Neonatal Early-Onset Infection With SARS-CoV-2 in a Newborn Presenting With Encephalitic Symptoms (edit) |
10.1097/INF.0000000000002735 |
| 2020-05-12 |
Diagnostic Performance of Chest X-Ray for COVID-19 Pneumonia During the SARS-CoV-2 Pandemic in Lombardy, Italy (edit) |
10.1097/RTI.0000000000000533 |
| 2020-05-12 |
Virtual Screening of Natural Products against Type II Transmembrane Serine Protease (TMPRSS2), the Priming Agent of Coronavirus 2 (SARS-CoV-2) (edit) |
10.3390/MOLECULES25102271 |
| 2020-05-12 |
Essential Oils as Antiviral Agents. Potential of Essential Oils to Treat SARS-CoV-2 Infection: An In-Silico Investigation (edit) |
10.3390/IJMS21103426 |
| 2020-05-12 |
A snapshot of SARS-CoV-2 genome availability up to April 2020 and its implications (edit) |
10.2196/19170 |
| 2020-05-12 |
Identification of Human Single-Domain Antibodies against SARS-CoV-2 (edit) |
10.1016/J.CHOM.2020.04.023 |
| 2020-05-12 |
Age, inflammation and disease location are critical determinants of intestinal expression of SARS-CoV-2 receptor ACE2 and TMPRSS2 in inflammatory bowel disease (edit) |
10.1053/J.GASTRO.2020.05.030 |
| 2020-05-12 |
Development of passive immunity against SARS-CoV-2 for management of immunodeficient patients - a perspective (edit) |
10.1016/J.JACI.2020.04.043 |
| 2020-05-12 |
Health status of patients with Autoimmune Liver Disease during SARS-CoV-2 outbreak in northern Italy (edit) |
10.1016/J.JHEP.2020.05.008 |
| 2020-05-12 |
SARS-CoV2 in the peritoneal waste in a patient treated with peritoneal dialysis (edit) |
10.1016/J.KINT.2020.05.005 |
| 2020-05-12 |
Impact of building ventilation systems and habitual indoor incense burning on SARS-CoV-2 virus transmissions in Middle Eastern countries (edit) |
10.1016/J.SCITOTENV.2020.139356 |
| 2020-05-12 |
Spillover of SARS-CoV-2 into novel wild hosts in North America: A conceptual model for perpetuation of the pathogen (edit) |
10.1016/J.SCITOTENV.2020.139358 |
| 2020-05-12 |
Knowledge-based repositioning of the anti-HCV direct antiviral agent Sofosbuvir as SARS-CoV-2 treatment (edit) |
10.1186/S13027-020-00302-X |
| 2020-05-12 |
A Rapid, Cost-Effective Tailed Amplicon Method for Sequencing SARS-CoV-2 (edit) |
10.1101/2020.05.11.088724 |
| 2020-05-12 |
The Association of Social Distancing, Population Density, and Temperature with the SARS-CoV-2 Instantaneous Reproduction Number in Counties Across the United States (edit) |
10.1101/2020.05.08.20094474 |
| 2020-05-12 |
Stability of SARS-CoV-2 on environmental surfaces and in human excreta (edit) |
10.1101/2020.05.07.20094805 |
| 2020-05-12 |
SARS-CoV-2 Infection Associated Hemophagocytic Lymphohistiocytosis: An autopsy series with clinical and laboratory correlation. (edit) |
10.1101/2020.05.07.20094888 |
| 2020-05-12 |
Pre-Procedural Surveillance Testing for SARS-CoV-2 in an Asymptomatic Population Shows Low Rates of Positivity (edit) |
10.1101/2020.05.08.20078592 |
| 2020-05-12 |
Predicted success of prophylactic antiviral therapy to block or delay SARS-CoV-2 infection depends on the targeted mechanism (edit) |
10.1101/2020.05.07.20092965 |
| 2020-05-12 |
Structural insight into the putative role of novel SARS CoV-2 E protein in viral infection: a potential target for LAV development and therapeutic strategies (edit) |
10.1101/2020.05.11.088781 |
| 2020-05-12 |
Characteristics and outcomes of pregnant women hospitalised with confirmed SARS-CoV-2 infection in the UK: a national cohort study using the UK Obstetric Surveillance System (UKOSS) (edit) |
10.1101/2020.05.08.20089268 |
| 2020-05-12 |
Total predicted MHC-I epitope load is inversely associated with mortality from SARS-CoV-2 (edit) |
10.1101/2020.05.08.20095430 |
| 2020-05-12 |
Significant Relaxation of SARS-CoV-2-Targeted Non-Pharmaceutical Interventions Will Result in Profound Mortality: A New York State Modelling Study (edit) |
10.1101/2020.05.08.20095505 |
| 2020-05-12 |
SARS-CoV-2 ORF3b is a potent interferon antagonist whose activity is further increased by a naturally occurring elongation variant (edit) |
10.1101/2020.05.11.088179 |
| 2020-05-12 |
Clinical Course and Risk Factors for Recurrence of Positive SARS-CoV-2 RNA: A Retrospective Cohort Study from Wuhan, China (edit) |
10.1101/2020.05.08.20095018 |
| 2020-05-12 |
Rapid isolation of potent SARS-CoV-2 neutralizing antibodies and protection in a small animal model (edit) |
10.1101/2020.05.11.088674 |
| 2020-05-12 |
Evidence for strong mutation bias towards, and selection against, T/U content in SARS-CoV2: implications for attenuated vaccine design (edit) |
10.1101/2020.05.11.088112 |
| 2020-05-12 |
Activation of the SARS-CoV-2 receptor Ace2 by cytokines through pan JAK-STAT enhancers (edit) |
10.1101/2020.05.11.089045 |
| 2020-05-12 |
Drive-through testing for SARS-CoV-2 in symptomatic health and social care workers and household members: an observational cohort study in Tayside, Scotland (edit) |
10.1101/2020.05.08.20078386 |
| 2020-05-12 |
Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection (edit) |
10.3389/FIMMU.2020.01022 |
| 2020-05-12 |
Fatal Pulmonary Thromboembolism in SARS-CoV-2-Infection (edit) |
10.1016/J.CARPATH.2020.107227 |
| 2020-05-12 |
Pulmonary rehabilitation principles in SARS-COV-2 infection (COVID-19): A guideline for the acute and subacute rehabilitation (edit) |
10.5606/TFTRD.2020.6444 |
| 2020-05-11 |
SARS-CoV-2, a novel virus with an unusual cardiac feature: inverted takotsubo syndrome (edit) |
10.1093/EURHEARTJ/EHAA390 |
| 2020-05-11 |
SARS-CoV-2 Transmission from Presymptomatic Meeting Attendee, Germany (edit) |
10.3201/EID2608.201235 |
| 2020-05-11 |
Screening of healthcare workers for SARS-CoV-2 highlights the role of asymptomatic carriage in COVID-19 transmission (edit) |
10.7554/ELIFE.58728 |
| 2020-05-11 |
Household Transmission of SARS-CoV-2, Zhuhai, China, 2020 (edit) |
10.1093/CID/CIAA557 |
| 2020-05-11 |
The SARS-CoV-2 epidemic in Zimbabwe: Quo vadis? (edit) |
10.1093/CID/CIAA552 |
| 2020-05-11 |
SARS-CoV-2 (COVID-19): What do we know about children? A systematic review (edit) |
10.1093/CID/CIAA556 |
| 2020-05-11 |
Co-infection of SARS CoV-2 and influenza A in a Pediatric Patient in Germany (edit) |
10.1055/A-1163-7385 |
| 2020-05-11 |
Low-dose radiotherapy for SARS-CoV-2 pneumonia (edit) |
10.1007/S00066-020-01634-8 |
| 2020-05-11 |
Glycaemic Control Among People with Type 1 Diabetes During Lockdown for the SARS-CoV-2 Outbreak in Italy (edit) |
10.1007/S13300-020-00829-7 |
| 2020-05-11 |
Allergen Immunotherapy in the era of SARS-CoV-2 (edit) |
10.18176/JIACI.0568 |
| 2020-05-11 |
Development of a rapid test kit for SARS-CoV-2: an example of product design (edit) |
10.1007/S42242-020-00075-7 |
| 2020-05-11 |
Spontaneous pneumomediastinum occurring in the SARS-COV-2 infection (edit) |
10.1016/J.IDCR.2020.E00806 |
| 2020-05-11 |
Molecular docking and dynamic simulations for antiviral compounds against SARS-CoV-2: A computational study (edit) |
10.1016/J.IMU.2020.100345 |
| 2020-05-11 |
Pharynx gargle samples are suitable for SARS-CoV-2 diagnostic and save personal protective equipment and swabs (edit) |
10.1017/ICE.2020.229 |
| 2020-05-11 |
Regional difference in the rate of spread of SARS-CoV-2 (edit) |
10.1017/ICE.2020.223 |
| 2020-05-11 |
A Survey of SARS-CoV-2 Preparedness Among Hospitals in Idaho (edit) |
10.1017/ICE.2020.218 |
| 2020-05-11 |
Utility of Re-testing for Diagnosis of SARS-CoV-2/COVID-19 in Hospitalized Patients: Impact of the Interval between Tests (edit) |
10.1017/ICE.2020.224 |
| 2020-05-11 |
A case of HIV and SARS-CoV-2 co-infection in Singapore (edit) |
10.1097/QAI.0000000000002401 |
| 2020-05-11 |
Considerations for Assessing Risk of Provider Exposure to SARS-CoV-2 after a Negative Test (edit) |
10.1097/ALN.0000000000003392 |
| 2020-05-11 |
Parallel epidemics, or nearly so: certainties and uncertainties about sars-cov-2 in italy (edit) |
10.1016/J.DIABRES.2020.108195 |
| 2020-05-11 |
Universal SARS-CoV-2 testing of pregnant women admitted for delivery in two Italian regions (edit) |
10.1016/J.AJOG.2020.05.017 |
| 2020-05-11 |
Environmental contamination by SARS-CoV-2 in a designated hospital for coronavirus disease 2019 (edit) |
10.1016/J.AJIC.2020.05.003 |
| 2020-05-11 |
Mental health and the SARS-CoV-2 pandemic (edit) |
10.1016/J.RPSM.2020.04.010 |
| 2020-05-11 |
A Novel Bat Coronavirus Closely Related to SARS-CoV-2 Contains Natural Insertions at the S1/S2 Cleavage Site of the Spike Protein (edit) |
10.1016/J.CUB.2020.05.023 |
| 2020-05-11 |
Estimation of airborne viral emission: Quanta emission rate of SARS-CoV-2 for infection risk assessment (edit) |
10.1016/J.ENVINT.2020.105794 |
| 2020-05-11 |
Multi-center evaluation of cepheid xpert® xpress SARS-CoV-2 point-of-care test during the SARS-CoV-2 pandemic (edit) |
10.1016/J.JCV.2020.104426 |
| 2020-05-11 |
Business Intelligence applied to Emergency Medical Services in the Lombardy region during SARS-CoV-2 epidemic (edit) |
10.23750/ABM.V91I2.9557 |
| 2020-05-11 |
Point-of-Care diagnostic of SARS-CoV-2: knowledge, attitudes, and perceptions (KAP) of medical workforce in Italy (edit) |
10.23750/ABM.V91I2.9573 |
| 2020-05-11 |
Primum non nocere. The SARS-CoV-2 pandemic course in oldest (edit) |
10.23750/ABM.V91I2.9624 |
| 2020-05-11 |
Stop playing with data: there is no sound evidence that Bacille Calmette-Guérin may avoid SARS-CoV-2 infection (for now) (edit) |
10.23750/ABM.V91I2.9700 |
| 2020-05-11 |
SARS-CoV-2 infection in children in Parma (edit) |
10.23750/ABM.V91I2.9563 |
| 2020-05-11 |
Preliminary epidemiological analysis on children and adolescents with novel coronavirus disease (2019-nCoV) in a central area of Calabria region (edit) |
10.23750/ABM.V91I2.9550 |
| 2020-05-11 |
Major sports events and the transmission of SARS-CoV-2: analysis of seven case-studies in Europe (edit) |
10.23750/ABM.V91I2.9699 |
| 2020-05-11 |
Post SARS-CoV-2 Guillain-Barré syndrome (edit) |
10.1016/J.CLINPH.2020.05.003 |
| 2020-05-11 |
Immune checkpoint inhibitors in SARS-CoV-2 infected cancer patients: the spark that ignites the fire? (edit) |
10.1016/J.LUNGCAN.2020.05.006 |
| 2020-05-11 |
Vaginal delivery in a woman infected with SARS-CoV-2 - The first case reported in Portugal (edit) |
10.1016/J.EJOGRB.2020.05.007 |
| 2020-05-11 |
[Neurological manifestations of SARS-CoV-2 infection] (edit) |
10.1016/J.SEMERG.2020.05.004 |
| 2020-05-11 |
Angiotensin converting enzyme: A review on expression profile and its association with human disorders with special focus on SARS-CoV-2 infection (edit) |
10.1016/J.VPH.2020.106680 |
| 2020-05-11 |
SARS-CoV-2 spike protein binds heparan sulfate in a length- and sequence-dependent manner (edit) |
10.1101/2020.05.10.087288 |
| 2020-05-11 |
Prediction analysis of SARS-COV-2 entry in Livestock and Wild animals (edit) |
10.1101/2020.05.08.084327 |
| 2020-05-11 |
Clinical performance of SARS-CoV-2 IgG antibody tests and potential protective immunity (edit) |
10.1101/2020.05.08.085506 |
| 2020-05-11 |
Screening of SARS-CoV-2 among homeless people, asylum seekers and other people living in precarious conditions in Marseille, France, March April 2020. (edit) |
10.1101/2020.05.05.20091934 |
| 2020-05-11 |
Mobility trends provide a leading indicator of changes in SARS-CoV-2 transmission (edit) |
10.1101/2020.05.07.20094441 |
| 2020-05-11 |
Negative nasopharyngeal SARS-CoV-2 PCR conversion in Response to different therapeutic interventions (edit) |
10.1101/2020.05.08.20095679 |
| 2020-05-11 |
What factors increase the risk of complications in SARS-CoV-2 positive patients? A cohort study in a nationwide Israeli health organization (edit) |
10.1101/2020.05.07.20091652 |
| 2020-05-11 |
The contribution of asymptomatic SARS-CoV-2 infections to transmission - a model-based analysis of the Diamond Princess outbreak (edit) |
10.1101/2020.05.07.20093849 |
| 2020-05-11 |
Prediction of 2019-nCov in Italy based on PSO and inversion analysis (edit) |
10.1101/2020.05.08.20095869 |
| 2020-05-11 |
Disinfection effect of pulsed xenon ultraviolet irradiation on SARS-CoV-2 and implications for environmental risk of COVID-19 transmission (edit) |
10.1101/2020.05.06.20093658 |
| 2020-05-11 |
Characteristics of 1,573 healthcare workers who underwent nasopharyngeal swab for SARS-CoV-2 in Milano, Lombardy, Italy (edit) |
10.1101/2020.05.07.20094276 |
| 2020-05-11 |
Multi-omics study revealing tissue-dependent putative mechanisms of SARS-CoV-2 drug targets on viral infections and complex diseases (edit) |
10.1101/2020.05.07.20093286 |
| 2020-05-11 |
A Droplet Digital PCR Assay to Detect SARS-CoV-2 RNA (edit) |
10.1101/2020.05.06.20090449 |
| 2020-05-11 |
Rapid and extraction-free detection of SARS-CoV-2 from saliva with colorimetric LAMP (edit) |
10.1101/2020.05.07.20093542 |
| 2020-05-11 |
Serological signatures of SARS-CoV-2 infection: Implications for antibody-based diagnostics (edit) |
10.1101/2020.05.07.20093963 |
| 2020-05-11 |
The ongoing COVID-19 epidemic in Minas Gerais, Brazil: insights from epidemiological data and SARS-CoV-2 whole genome sequencing. (edit) |
10.1101/2020.05.05.20091611 |
| 2020-05-11 |
Ischaemic stroke and SARS-CoV-2 infection: A causal or incidental association? (edit) |
10.1016/J.NRL.2020.05.002 |
| 2020-05-11 |
[Skin lesions in a patient with SARS-COV-2 infection] (edit) |
10.1016/J.ANPEDI.2020.04.020 |
| 2020-05-11 |
[The effects of quarantine for SARS-CoV-2 on sleep: An online survey] (edit) |
10.1016/J.ENCEP.2020.05.003 |
| 2020-05-11 |
Gaucher disease and SARS-CoV-2 infection: Emerging management challenges (edit) |
10.1016/J.YMGME.2020.05.002 |
| 2020-05-11 |
[Influence of the coronavirus 2 (SARS-Cov-2) pandemic on acute appendicitis] (edit) |
10.1016/J.ANPEDI.2020.04.022 |
| 2020-05-11 |
Immunoinformatics-guided designing of epitope-based subunit vaccines against the SARS Coronavirus-2 (SARS-CoV-2) (edit) |
10.1016/J.IMBIO.2020.151955 |
| 2020-05-11 |
Long-term Positivity to SARS-CoV-2: A Clinical Case of COVID-19 with Persistent Evidence of Infection (edit) |
10.12890/2020_001707 |
| 2020-05-11 |
SARS-COV-2 Presenting as New Onset Atrial Fibrillation: A Case Report (edit) |
10.7759/CUREUS.8054 |
| 2020-05-11 |
Re: Testing recommendation for COVID-19 (SARS-CoV-2) in patients planned for surgery - continuing the service and 'suppressing' the pandemic (edit) |
10.1016/J.BJOMS.2020.05.005 |
| 2020-05-11 |
Autopsy findings from the first known death from Severe Acute Respiratory Syndrome SARS-CoV-2 in Spain (edit) |
10.1016/J.PATOL.2020.04.002 |
| 2020-05-11 |
Neurotrauma in the Time of SARS-COV 2: A Checklist for Its Safe Management (edit) |
10.1055/S-0040-1712553 |
| 2020-05-11 |
Solar ultraviolet radiation sensitivity of SARS-CoV-2 (edit) |
10.1016/S2666-5247(20)30013-6 |
| 2020-05-10 |
SARS-CoV-2 Testing and Outcomes in the First 30 Days after the First Case of COVID-19 at an Australian Children's Hospital (edit) |
10.1111/1742-6723.13550 |
| 2020-05-10 |
Informal carers in severe mental health conditions: Issues raised by the United Kingdom SARS-CoV-2 (COVID-19) Pandemic (edit) |
10.1177/0020764020927046 |
| 2020-05-10 |
SARS-CoV-2 Inflammatory Syndrome. Clinical Features and Rationale for Immunological Treatment (edit) |
10.3390/IJMS21093377 |
| 2020-05-10 |
SARS-CoV-2/COVID-19: Viral Genomics, Epidemiology, Vaccines, and Therapeutic Interventions (edit) |
10.3390/V12050526 |
| 2020-05-10 |
The immunologic status of newborns born to SARS-CoV2-infected mothers in Wuhan, China (edit) |
10.1016/J.JACI.2020.04.038 |
| 2020-05-10 |
Human Intestinal Defensin 5 Inhibits SARS-CoV-2 Invasion by Cloaking ACE2 (edit) |
10.1053/J.GASTRO.2020.05.015 |
| 2020-05-10 |
SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19 (edit) |
10.1016/J.JHEP.2020.05.002 |
| 2020-05-10 |
From SARS-CoV to SARS-CoV-2: safety and broad-spectrum are important for coronavirus vaccine development (edit) |
10.1016/J.MICINF.2020.05.004 |
| 2020-05-10 |
On the crucial role of multilingual biomedical databases on epidemic events (SARS-CoV-2 analysis) (edit) |
10.1016/J.IJID.2020.05.023 |
| 2020-05-10 |
Response to SARS-CoV-2 Pandemic in a Non-COVID-19 Designated Latin-American Neurosurgery Department (edit) |
10.1016/J.WNEU.2020.05.019 |
| 2020-05-10 |
Does lopinavir really inhibit SARS-CoV-2? (edit) |
10.1016/J.PHRS.2020.104898 |
| 2020-05-10 |
Elevated ACE2 expression in the olfactory neuroepithelium: implications for anosmia and upper respiratory SARS-CoV-2 entry and replication (edit) |
10.1101/2020.05.08.084996 |
| 2020-05-10 |
Intra-genome variability in the dinucleotide composition of SARS-CoV-2 (edit) |
10.1101/2020.05.08.083816 |
| 2020-05-10 |
The RBD Of The Spike Protein Of SARS-Group Coronaviruses Is A Highly Specific Target Of SARS-CoV-2 Antibodies But Not Other Pathogenic Human and Animal Coronavirus Antibodies (edit) |
10.1101/2020.05.06.20093377 |
| 2020-05-10 |
Immunity Passports for SARS-CoV-2: an online experimental study of the impact of antibody test terminology on perceived risk and behaviour (edit) |
10.1101/2020.05.06.20093401 |
| 2020-05-10 |
Pre-treatment of the clinical sample with Proteinase K allows detection of SARS-CoV-2 in the absence of RNA extraction (edit) |
10.1101/2020.05.07.083139 |
| 2020-05-10 |
Mathematical Modeling & the Transmission Dynamics of SARS-CoV-2 in Cali, Colombia: Implications to a 2020 Outbreak & public health preparedness (edit) |
10.1101/2020.05.06.20093526 |
| 2020-05-10 |
Sensitivity and specificity of a rapid test for assessment of exposure to SARS-CoV-2 in a community-based setting in Brazil (edit) |
10.1101/2020.05.06.20093476 |
| 2020-05-10 |
A simple arithmetic rationale for crushing the epidemic curve of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) instead of flattening it (edit) |
10.1101/2020.05.06.20093112 |
| 2020-05-10 |
Recurrence of SARS-CoV-2 PCR positivity in COVID-19 patients: a single center experience and potential implications (edit) |
10.1101/2020.05.06.20089573 |
| 2020-05-10 |
ACE2 and TMPRSS2 are expressed on the human ocular surface, suggesting susceptibility to SARS-CoV-2 infection (edit) |
10.1101/2020.05.09.086165 |
| 2020-05-10 |
Letter to the Editor: "Embracing Disruptive Change During the SARS-CoV 2 Pandemic" (edit) |
10.1016/J.WNEU.2020.05.048 |
| 2020-05-09 |
Current State of Knowledge About SARS-CoV-2 and COVID-19 Disease in Pregnant Women (edit) |
10.12659/MSM.924725 |
| 2020-05-09 |
Diagnosis and recovery from SARS-CoV-2 infection is challenging in kidney patients: tests are an issue (edit) |
10.20452/PAMW.15345 |
| 2020-05-09 |
Inflammatory Bowel Diseases and Biological Treatment in SARS-CoV-2 Era. Why Not? (edit) |
10.1093/IBD/IZAA110 |
| 2020-05-09 |
Anosmia as a presenting symptom of SARS-CoV-2 infection in healthcare workers - A systematic review of the literature, case series, and recommendations for clinical assessment and management (edit) |
10.4193/RHIN20.189 |
| 2020-05-09 |
Can dried blood spots (DBS) contribute to conducting comprehensive SARS-CoV-2 antibody tests? (edit) |
10.1002/DTA.2816 |
| 2020-05-09 |
SARS-CoV-2 asymptomatic infection in a patient under treatment with dupilumab (edit) |
10.1111/JDV.16619 |
| 2020-05-09 |
Pregnant and postpartum women with SARS-CoV-2 infection in intensive care in Sweden (edit) |
10.1111/AOGS.13901 |
| 2020-05-09 |
Atypical erythema multiforme palmar plaques lesions due to Sars-Cov-2 (edit) |
10.1111/JDV.16623 |
| 2020-05-09 |
25-Hydroxyvitamin D Concentrations Are Lower in Patients with Positive PCR for SARS-CoV-2 (edit) |
10.3390/NU12051359 |
| 2020-05-09 |
Designing of improved drugs for COVID-19: Crystal structure of SARS-CoV-2 main protease Mpro (edit) |
10.1038/S41392-020-0178-Y |
| 2020-05-09 |
A SARS-Cov2-negative corona victim (edit) |
10.1007/S00392-020-01668-Z |
| 2020-05-09 |
How should we overcome the threat by the pandemic of 2019-nCoV? Epidemic simulation using the SIRS model (edit) |
10.1007/S10067-020-05083-7 |
| 2020-05-09 |
Whole genome sequencing and phylogenetic analysis of SARS-CoV-2 strains from the index and early patients with COVID-19 in Dubai, United Arab Emirates, 29 January to 18 March 2020 (edit) |
10.1101/2020.05.06.080606 |
| 2020-05-09 |
Comparison of SARS-CoV-2 spike protein binding to human, pet, farm animals, and putative intermediate hosts ACE2 and ACE2 receptors (edit) |
10.1101/2020.05.08.084061 |
| 2020-05-09 |
SARS-CoV-2 proteins exploit host’s genetic and epigenetic mediators for the annexation of key host signaling pathways that confers its immune evasion and disease pathophysiology (edit) |
10.1101/2020.05.06.050260 |
| 2020-05-09 |
A potent neutralizing human antibody reveals the N-terminal domain of the Spike protein of SARS-CoV-2 as a site of vulnerability (edit) |
10.1101/2020.05.08.083964 |
| 2020-05-09 |
ACE2 coding variants in different populations and their potential impact on SARS-CoV-2 binding affinity (edit) |
10.1101/2020.05.08.084384 |
| 2020-05-09 |
Efficacy of a novel iodine complex solution, CupriDyne, in inactivating SARS-CoV-2 (edit) |
10.1101/2020.05.08.082701 |
| 2020-05-09 |
A phylodynamic workflow to rapidly gain insights into the dispersal history and dynamics of SARS-CoV-2 lineages (edit) |
10.1101/2020.05.05.078758 |
| 2020-05-09 |
AI334 and AQ806 antibodies recognize the spike S protein from SARS-CoV-2 by ELISA (edit) |
10.1101/2020.05.08.084103 |
| 2020-05-09 |
Coarse-grained molecular simulations of the binding of the SARS-CoV 2 spike protein RBD to the ACE2 cell receptor (edit) |
10.1101/2020.05.07.083212 |
| 2020-05-09 |
Multiple expression assessments of ACE2 and TMPRSS2 SARS-CoV-2 entry molecules in the urinary tract and their associations with clinical manifestations of COVID-19 (edit) |
10.1101/2020.05.08.083618 |
| 2020-05-09 |
Lung biopsy cells transcriptional landscape from COVID-19 patient stratified lung injury in SARS-CoV-2 infection through impaired pulmonary surfactant metabolism (edit) |
10.1101/2020.05.07.082297 |
| 2020-05-09 |
A preliminary study on analytical performance of serological assay for SARS-CoV-2 IgM/IgG and application in clinical practice (edit) |
10.1101/2020.05.05.20092551 |
| 2020-05-09 |
Clinical onset serial interval and diagnostic serial interval of SARS-CoV-2/COVID-19 in South Korea (edit) |
10.1101/2020.05.05.20070946 |
| 2020-05-09 |
The race to find a SARS-CoV-2 drug can only be won by a few chosen drugs: a systematic review of registers of clinical trials of drugs aimed at preventing or treating COVID-19 (edit) |
10.1101/2020.05.05.20091785 |
| 2020-05-09 |
Screening for SARS-CoV-2 infections with colorimetric RT-LAMP and LAMP sequencing (edit) |
10.1101/2020.05.05.20092288 |
| 2020-05-09 |
Detection of SARS-CoV-2 RNA on public surfaces in a densely populated urban area of Brazil (edit) |
10.1101/2020.05.07.20094631 |
| 2020-05-09 |
Whole-lung Low Dose Irradiation for SARS-Cov2 Induced Pneumonia in the Geriatric Population: An Old Effective Treatment for a New Disease? Recommendation of the International Geriatric Radiotherapy Group (edit) |
10.14336/AD.2020.0506 |
| 2020-05-09 |
Characteristics of SARS-CoV-2 and potential pharmacological treatment (edit) |
10.18388/PB.2020_321 |
| 2020-05-08 |
Angiotensin Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System (edit) |
10.1161/CIRCRESAHA.120.317015 |
| 2020-05-08 |
A Precision Medicine Approach to SARS-CoV-2 Pandemic Management (edit) |
10.1007/S40521-020-00258-8 |
| 2020-05-08 |
Detection of SARS-COV-2 in Placental and Fetal Membrane Samples (edit) |
10.1016/J.AJOGMF.2020.100133 |
| 2020-05-08 |
Asymptomatic Cases with SARS-CoV-2 Infection (edit) |
10.1002/JMV.25990 |
| 2020-05-08 |
High prevalence of olfactory and taste disorder during SARS-CoV-2 infection in outpatients (edit) |
10.1002/JMV.25995 |
| 2020-05-08 |
Comparison of SARS-CoV-2 Detection from Nasopharyngeal Swab Samples by the Roche cobas® 6800 SARS-CoV-2 Test and a Laboratory-Developed Real-Time RT-PCR test (edit) |
10.1002/JMV.25988 |
| 2020-05-08 |
A comparison study of SARS-CoV-2 IgG antibody between male and female COVID-19 patients: a possible reason underlying different outcome between sex (edit) |
10.1002/JMV.25989 |
| 2020-05-08 |
Evaluation of SARS-CoV-2 neutralizing antibodies using of a CPE-based Colorimetric live virus micro-neutralization assay in human serum samples (edit) |
10.1002/JMV.25986 |
| 2020-05-08 |
Comment on "Central Nervous System Involvement by Severe Acute Respiratory Syndrome Coronavirus -2 (SARS-CoV-2)" (edit) |
10.1002/JMV.25991 |
| 2020-05-08 |
In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs (edit) |
10.1002/JMV.25987 |
| 2020-05-08 |
RAAs inhibitors and outcome in patients with SARS-CoV-2 pneumonia. A case series study (edit) |
10.1161/HYPERTENSIONAHA.120.15312 |
| 2020-05-08 |
Prolonged Persistence of SARS-CoV-2 RNA in Body Fluids (edit) |
10.3201/EID2608.201097 |
| 2020-05-08 |
Changes in SARS-CoV-2 Positivity Rate in Outpatients in Seattle and Washington State, March 1-April 16, 2020 (edit) |
10.1001/JAMA.2020.8097 |
| 2020-05-08 |
SARS-CoV-2 receptor ACE2 expression in the human heart: cause of a post-pandemic wave of heart failure? (edit) |
10.1093/EURHEARTJ/EHAA410 |
| 2020-05-08 |
SARS-CoV-2 and Multiple Sclerosis: Not all immune depleting DMTs are equal or bad (edit) |
10.1002/ANA.25770 |
| 2020-05-08 |
SARS-CoV-2 Pandemic: Review of the Literature and Proposal for Safe Autopsy Practice (edit) |
10.5858/ARPA.2020-0165-SA |
| 2020-05-08 |
Sexual Health in the SARS-CoV-2 Era (edit) |
10.7326/M20-2004 |
| 2020-05-08 |
Rapid detection of SARS-CoV-2 by low volume real-time single tube reverse transcription recombinase polymerase amplification using an exo probe with an internally linked quencher (exo-IQ) (edit) |
10.1093/CLINCHEM/HVAA116 |
| 2020-05-08 |
Effectiveness of interventions targeting air travellers for delaying local outbreaks of SARS-CoV-2 (edit) |
10.1093/JTM/TAAA068 |
| 2020-05-08 |
COVID-19 and Keeping Clean: A Narrative Review to Ascertain the Efficacy of Personal Protective Equipment to Safeguard Healthcare Workers Against SARS-CoV-2 (edit) |
10.1542/HPEDS.2020-0135 |
| 2020-05-08 |
Quantifying the improvement in confirmation efficiency of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during the early phase of outbreak in Hong Kong in 2020 (edit) |
10.1016/J.IJID.2020.05.015 |
| 2020-05-08 |
Early SARS-CoV-2 outbreak detection by sewage-based epidemiology (edit) |
10.1016/J.SCITOTENV.2020.139298 |
| 2020-05-08 |
Can SARS-CoV-2-infected women breastfeed after viral clearance? (edit) |
10.1631/JZUS.B2000095 |
| 2020-05-08 |
Symptom profiles and risk factors for hospitalization in patients with SARS-CoV-2 and COVID-19: A Large Cohort from South America (edit) |
10.1053/J.GASTRO.2020.05.014 |
| 2020-05-08 |
Multivesicular Bodies (MVB) Mimicking SARS-CoV-2 in patients without COVID-19 (edit) |
10.1016/J.KINT.2020.05.003 |
| 2020-05-08 |
A report from the Brescia Renal COVID Task Force on the clinical characteristics and short-term outcome of hemodialysis patients with SARS-CoV-2 infection (edit) |
10.1016/J.KINT.2020.04.030 |
| 2020-05-08 |
Infection control challenge in setting up a temporary test centre at Hong Kong International Airport for rapid diagnosis of COVID-19 due to SARS-CoV-2 (edit) |
10.1016/J.JHIN.2020.05.006 |
| 2020-05-08 |
Firearms or SARS-Cov-2: what is the most lethal? (edit) |
10.1016/J.PUHE.2020.04.033 |
| 2020-05-08 |
Clinical characteristics and changes of chest CT features in 307 patients with common COVID-19 pneumonia infected SARS-CoV-2: A multicenter study in Jiangsu, China (edit) |
10.1016/J.IJID.2020.05.006 |
| 2020-05-08 |
A Combined approach of MALDI-TOF Mass Spectrometry and multivariate analysis as a potential tool for the detection of SARS-CoV-2 virus in nasopharyngeal swabs (edit) |
10.1101/2020.05.07.082925 |
| 2020-05-08 |
COVID-19 Scenarios: an interactive tool to explore the spread and associated morbidity and mortality of SARS-CoV-2 (edit) |
10.1101/2020.05.05.20091363 |
| 2020-05-08 |
IDentif.AI: Artificial Intelligence Pinpoints Remdesivir in Combination with Ritonavir and Lopinavir as an Optimal Regimen Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (edit) |
10.1101/2020.05.04.20088104 |
| 2020-05-08 |
The intensity of COVID-19 outbreaks is modulated by SARS-CoV-2 free-living survival and environmental transmission (edit) |
10.1101/2020.05.04.20090092 |
| 2020-05-08 |
COVID-19: Viral-host interactome analyzed by network based-approach model to study pathogenesis of SARS-CoV-2 infection (edit) |
10.1101/2020.05.07.082487 |
| 2020-05-08 |
Clinical Performance of SARS-CoV-2 Molecular Testing (edit) |
10.1101/2020.05.06.20093575 |
| 2020-05-08 |
The coding capacity of SARS-CoV-2 (edit) |
10.1101/2020.05.07.082909 |
| 2020-05-08 |
A simple RNA preparation method for SARS-CoV-2 detection by RT-qPCR (edit) |
10.1101/2020.05.07.083048 |
| 2020-05-08 |
SARS-CoV-2 detection in setting of viral swab scarcity: are MRSA swabs and viral swabs equivalent? (edit) |
10.1101/2020.05.04.20084657 |
| 2020-05-08 |
Health Care WorkersMental Health During the First Weeks of the SARS-CoV-2 Pandemic in Switzerland: A Cross-Sectional Study (edit) |
10.1101/2020.05.04.20088625 |
| 2020-05-08 |
Sensitivity of Nasopharyngeal, Nasal and Throat Swab for the Detection of SARS-CoV-2 (edit) |
10.1101/2020.05.05.20084889 |
| 2020-05-08 |
Environmental sampling for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during a coronavirus disease (COVID-19) outbreak aboard a commercial cruise ship (edit) |
10.1101/2020.05.02.20088567 |
| 2020-05-08 |
Shared Antigen-specific CD8+ T cell Responses Against the SARS-COV-2 Spike Protein in HLA A*02:01 COVID-19 Participants (edit) |
10.1101/2020.05.04.20085779 |
| 2020-05-08 |
Evidence of a significant secretory-IgA-dominant SARS-CoV-2 immune response in human milk following recovery from COVID-19 (edit) |
10.1101/2020.05.04.20089995 |
| 2020-05-08 |
Global genetic diversity patterns and transmissions of SARS-CoV-2 (edit) |
10.1101/2020.05.05.20091413 |
| 2020-05-08 |
Reduced mortality and shorten ICU stay in SARS-COV-2 pneumonia: a low PEEP strategy (edit) |
10.1101/2020.05.03.20089318 |
| 2020-05-08 |
Suramin inhibits SARS-CoV-2 infection in cell culture by interfering with early steps of the replication cycle (edit) |
10.1101/2020.05.06.081968 |
| 2020-05-08 |
The heterogeneous landscape and early evolution of pathogen-associated CpG and UpA dinucleotides in SARS-CoV-2 (edit) |
10.1101/2020.05.06.074039 |
| 2020-05-08 |
Occurrence and Timing of Subsequent SARS-CoV-2 RT-PCR Positivity Among Initially Negative Patients (edit) |
10.1101/2020.05.03.20089151 |
| 2020-05-08 |
A Modified ACE2 peptide mimic to block SARS-CoV2 entry (edit) |
10.1101/2020.05.07.082230 |
| 2020-05-08 |
Meta-analysis of diagnostic performance of serological tests for SARS-CoV-2 antibodies and public health implications (edit) |
10.1101/2020.05.03.20084160 |
| 2020-05-08 |
Etiologic Subtypes of Ischemic Stroke in SARS-COV-2 Virus patients (edit) |
10.1101/2020.05.03.20077206 |
| 2020-05-08 |
Single-cell longitudinal analysis of SARS-CoV-2 infection in human bronchial epithelial cells (edit) |
10.1101/2020.05.06.081695 |
| 2020-05-08 |
Epigenetic regulator miRNA pattern differences among SARS-CoV, SARS-CoV-2 and SARS-CoV-2 world-wide isolates delineated the mystery behind the epic pathogenicity and distinct clinical characteristics of pandemic COVID-19 (edit) |
10.1101/2020.05.06.081026 |
| 2020-05-08 |
The SARS-CoV-2-like virus found in captive pangolins from Guangdong should be better sequenced (edit) |
10.1101/2020.05.07.077016 |
| 2020-05-08 |
A mouse-adapted SARS-CoV-2 model for the evaluation of COVID-19 medical countermeasures (edit) |
10.1101/2020.05.06.081497 |
| 2020-05-08 |
[SARS-CoV-2: A peculiar presentation] (edit) |
10.1016/J.SEMERG.2020.05.001 |
| 2020-05-08 |
Research during SARS-CoV-2 pandemic: To "Preprint" or not to "Preprint", that is the question (edit) |
10.1016/J.MEDCLI.2020.05.002 |
| 2020-05-08 |
Comparison of a laboratory-developed test targeting the envelope gene with three nucleic acid amplification tests for detection of SARS-CoV-2 (edit) |
10.1016/J.JCV.2020.104427 |
| 2020-05-08 |
Could BCG Vaccination Induce Protective Trained Immunity for SARS-CoV-2? (edit) |
10.3389/FIMMU.2020.00970 |
| 2020-05-08 |
Call to Action: SARS-CoV-2 and CerebrovAscular DisordErs (CASCADE) (edit) |
10.1016/J.JSTROKECEREBROVASDIS.2020.104938 |
| 2020-05-07 |
A Crispr-Cas9 System Designed to Introduce Point Mutations into the Human <em>ACE2</em> Gene to Weaken the Interaction of the ACE2 Receptor with the SARS-CoV-2 S Protein<strong> </strong> (edit) |
10.20944/PREPRINTS202005.0134.V1 |
| 2020-05-07 |
Isolation of SARS-CoV-2-related coronavirus from Malayan pangolins (edit) |
10.1038/S41586-020-2313-X |
| 2020-05-07 |
The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice (edit) |
10.1038/S41586-020-2312-Y |
| 2020-05-07 |
Implications of SARS-CoV-2 Infection and COVID-19 Crisis on Clinical Cancer Care: Report of the University Cancer Center Hamburg (edit) |
10.1159/000508272 |
| 2020-05-07 |
How we should respond to the Coronavirus SARS-CoV-2 outbreak: A German perspective (edit) |
10.3233/CH-209004 |
| 2020-05-07 |
Development of SARS-CoV-2 vaccines: should we focus on mucosal immunity? (edit) |
10.1080/14712598.2020.1767062 |
| 2020-05-07 |
Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19 (edit) |
10.1136/ANNRHEUMDIS-2020-217690 |
| 2020-05-07 |
Near-Complete Genome Sequence of a 2019 Novel Coronavirus (SARS-CoV-2) Strain Causing a COVID-19 Case in Peru (edit) |
10.1128/MRA.00303-20 |
| 2020-05-07 |
Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence in Boise, Idaho (edit) |
10.1128/JCM.00941-20 |
| 2020-05-07 |
Median-joining network analysis of SARS-CoV-2 genomes is neither phylogenetic nor evolutionary (edit) |
10.1073/PNAS.2007062117 |
| 2020-05-07 |
Sampling bias and incorrect rooting make phylogenetic network tracing of SARS-COV-2 infections unreliable (edit) |
10.1073/PNAS.2007295117 |
| 2020-05-07 |
Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofur (edit) |
10.1038/S41594-020-0440-6 |
| 2020-05-07 |
Protective humoral immunity in SARS-CoV-2 infected pediatric patients (edit) |
10.1038/S41423-020-0438-3 |
| 2020-05-07 |
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the neuroendocrine stress axis (edit) |
10.1038/S41380-020-0758-9 |
| 2020-05-07 |
Expression of SARS-CoV-2 receptor ACE2 and TMPRSS2 in human primary conjunctival and pterygium cell lines and in mouse cornea (edit) |
10.1038/S41433-020-0939-4 |
| 2020-05-07 |
SARS-CoV-2 Infection with Different Radiological Insights (edit) |
10.3390/DIAGNOSTICS10050283 |
| 2020-05-07 |
Nasopharyngeal swabs during SARS-CoV-2 pandemic: a role for the otolaryngologist (edit) |
10.1007/S00405-020-06027-2 |
| 2020-05-07 |
Post-exposure prophylaxis or pre-emptive therapy for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): study protocol for a pragmatic randomized-controlled trial (edit) |
10.1007/S12630-020-01684-7 |
| 2020-05-07 |
Two patients with acute meningo-encephalitis concomitant to SARS-CoV-2 infection (edit) |
10.1111/ENE.14298 |
| 2020-05-07 |
SARS-CoV-2-Induced Immune Dysregulation and Myocardial Injury Risk in China: Insights from the ERS-COVID-19 Study (edit) |
10.1161/CIRCRESAHA.120.317070 |
| 2020-05-07 |
Assessment of SARS-CoV-2 replication in the context of other respiratory viruses (edit) |
10.1016/S2213-2600(20)30227-7 |
| 2020-05-07 |
Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures (edit) |
10.1016/S2213-2600(20)30193-4 |
| 2020-05-07 |
Inflammatory bowel disease and the SARS-CoV-2 pandemic: more speed, less haste (edit) |
10.1053/J.GASTRO.2020.05.013 |
| 2020-05-07 |
Computational screening of antagonist against the SARS-CoV-2 (COVID-19) coronavirus by molecular docking (edit) |
10.1016/J.IJANTIMICAG.2020.106012 |
| 2020-05-07 |
Dynamic profile for the detection of anti-SARS-CoV-2 antibodies using four immunochromatographic assays (edit) |
10.1016/J.JINF.2020.04.033 |
| 2020-05-07 |
Multivessel spontaneous coronary artery dissection presenting in a patient with severe acute SARS-CoV-2 respiratory infection (edit) |
10.1093/EURHEARTJ/EHAA400 |
| 2020-05-07 |
3CL Hydrolase Based Multi Epitope Peptide Vaccine Against Sars-CoV-2 Using Immunoinformatics (edit) |
10.1002/JMV.25993 |
| 2020-05-07 |
Expression of the SARS-CoV-2 Entry Proteins, ACE2 and TMPRSS2, in Cells of the Olfactory Epithelium: Identification of Cell Types and Trends with Age (edit) |
10.1021/ACSCHEMNEURO.0C00210 |
| 2020-05-07 |
Molecular detection of SARS-CoV-2 in formalin fixed paraffin embedded specimens (edit) |
10.1172/JCI.INSIGHT.139042 |
| 2020-05-07 |
Metagenomic analysis reveals clinical SARS-CoV-2 infection and bacterial or viral superinfection and colonization (edit) |
10.1093/CLINCHEM/HVAA106 |
| 2020-05-07 |
Association between ABO blood groups and risk of SARS-CoV-2 pneumonia (edit) |
10.1111/BJH.16797 |
| 2020-05-07 |
Knowledge-based structural models of SARS-CoV-2 proteins and their complexes with potential drugs (edit) |
10.1002/1873-3468.13806 |
| 2020-05-07 |
Outcome of a patient with refractory Hodgkin's Lymphoma on pembrolizumab, infected with SARS-CoV-2 (edit) |
10.1111/BJH.16798 |
| 2020-05-07 |
SARS-CoV-2 possible contamination of genital area: implications for sexual and vertical transmission routes (edit) |
10.1111/JDV.16591 |
| 2020-05-07 |
Improvement of SARS-CoV2 symptoms following Guselkumab injection in a psoriatic patient (edit) |
10.1111/JDV.16590 |
| 2020-05-07 |
What about the original antigenic sin of the humans versus SARS-CoV-2? (edit) |
10.1016/J.MEHY.2020.109824 |
| 2020-05-07 |
SARS-CoV-2 detection by direct rRT-PCR without RNA extraction (edit) |
10.1016/J.JCV.2020.104423 |
| 2020-05-07 |
SARS-CoV-2 and enhancing antibodies (edit) |
10.1016/J.JCV.2020.104424 |
| 2020-05-07 |
Inhibition of the replication of SARS-CoV-2 in human cells by the FDA-approved drug chlorpromazine (edit) |
10.1101/2020.05.05.079608 |
| 2020-05-07 |
Multiple SARS-CoV-2 introductions shaped the early outbreak in Central Eastern Europe: comparing Hungarian data to a worldwide sequence data-matrix (edit) |
10.1101/2020.05.06.080119 |
| 2020-05-07 |
Repeated seroprevalence of anti-SARS-CoV-2 IgG antibodies in a population-based sample from Geneva, Switzerland (edit) |
10.1101/2020.05.02.20088898 |
| 2020-05-07 |
Unsupervised cluster analysis of SARS-CoV-2 genomes reflects its geographic progression and identifies distinct genetic subgroups of SARS-CoV-2 virus (edit) |
10.1101/2020.05.05.079061 |
| 2020-05-07 |
Evaluation of nCoV-QS (MiCo BioMed) for RT-qPCR detection of SARS-CoV-2 from nasopharyngeal samples using CDC FDA EUA qPCR kit as a gold standard: an example of the need of validation studies. (edit) |
10.1101/2020.05.01.20081034 |
| 2020-05-07 |
Neutralization of SARS-CoV-2 by destruction of the prefusion Spike (edit) |
10.1101/2020.05.05.079202 |
| 2020-05-07 |
Identification of novel mutations in RNA-dependent RNA polymerases of SARS-CoV-2 and their implications on its protein structure (edit) |
10.1101/2020.05.05.079939 |
| 2020-05-07 |
Development and simulation of fully glycosylated molecular models of ACE2-Fc fusion proteins and their interaction with the SARS-CoV-2 spike protein binding domain (edit) |
10.1101/2020.05.05.079558 |
| 2020-05-07 |
The landscape of host genetic factors involved in infection to common viruses and SARS-CoV-2 (edit) |
10.1101/2020.05.01.20088054 |
| 2020-05-07 |
SARS-CoV-2 codon usage bias downregulates host expressed genes with similar codon usage (edit) |
10.1101/2020.05.05.079087 |
| 2020-05-07 |
Immune alterations during SARS-CoV-2-related acute respiratory distress syndrome (edit) |
10.1101/2020.05.01.20087239 |
| 2020-05-07 |
First Data-Set on SARS-CoV-2 Detection for Istanbul Wastewaters in Turkey (edit) |
10.1101/2020.05.03.20089417 |
| 2020-05-07 |
Clinical challenges in chronic obstructive pulmonary disease in patients who suffered SARS-CoV-2 infection (edit) |
10.1016/J.MEDCLI.2020.04.015 |
| 2020-05-07 |
Coronavirus Disease (COVID-19-SARS-CoV-2) and Nutrition: Is Infection in Italy Suggesting a Connection? (edit) |
10.3389/FIMMU.2020.00944 |
| 2020-05-07 |
The Presentation and Diagnosis of the First Known Community-Transmitted Case of SARS-CoV-2 in the Republic of Ireland (edit) |
|
| 2020-05-07 |
Vitamin D Deficiency and ARDS after SARS-CoV-2 Infection (edit) |
|
| 2020-05-06 |
Structure of SARS-CoV-2 nsp16/nsp10 ternary complex (edit) |
10.2210/PDB6WKS/PDB |
| 2020-05-06 |
X-ray Structure of SARS-CoV-2 main protease bound to Boceprevir at 1.45 A (edit) |
10.2210/PDB6WNP/PDB |
| 2020-05-06 |
The 1.95 A Crystal Structure of the Co-factor Complex of NSP7 and the C-terminal Domain of NSP8 from SARS-CoV-2 (edit) |
10.2210/PDB6WQD/PDB |
| 2020-05-06 |
Transcriptomics Curation of SARS-CoV-2 Related Host Genes in Mice With COVID-19 Comorbidity: A Pilot Study (edit) |
|
| 2020-05-06 |
Current efforts and challenges facing responses to 2019-nCoV in Africa (edit) |
10.1186/S41256-020-00148-1 |
| 2020-05-06 |
Bioinformatic prediction of potential T cell epitopes for SARS-Cov-2 (edit) |
10.1038/S10038-020-0771-5 |
| 2020-05-06 |
SARS-CoV-2 human disinfection chambers: a critical analysis (edit) |
10.1093/OCCMED/KQAA078 |
| 2020-05-06 |
Asymptomatic SARS-CoV-2 infections: what we need to know? (edit) |
10.1017/ICE.2020.201 |
| 2020-05-06 |
Hematuria Associated With SARS-CoV-2 Infection in a Child (edit) |
10.1097/INF.0000000000002737 |
| 2020-05-06 |
SARS-CoV-2 disease and children under treatment for cancer (edit) |
10.1002/PBC.28346 |
| 2020-05-06 |
Potential anti-SARS-CoV-2 drug candidates identified through virtual screening of the ChEMBL database for compounds that target the main coronavirus protease (edit) |
10.1002/2211-5463.12875 |
| 2020-05-06 |
Potential Cytoprotective Activity of Ozone Therapy in SARS-CoV-2/COVID-19 (edit) |
10.3390/ANTIOX9050389 |
| 2020-05-06 |
Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays (edit) |
10.3390/V12050513 |
| 2020-05-06 |
Interpreting Diagnostic Tests for SARS-CoV-2 (edit) |
10.1001/JAMA.2020.8259 |
| 2020-05-06 |
SARS-CoV-2: Spike glycoprotein structural diversity, phylogeny and potential animal host identification (edit) |
10.1002/JMV.25976 |
| 2020-05-06 |
The anti-HIV Drug Nelfinavir Mesylate (Viracept) is a Potent Inhibitor of Cell Fusion Caused by the SARS-CoV-2 Spike (S) Glycoprotein Warranting further Evaluation as an Antiviral against COVID-19 infections (edit) |
10.1002/JMV.25985 |
| 2020-05-06 |
Comments on "Cross-species transmission of the newly identified coronavirus 2019-nCoV" (edit) |
10.1002/JMV.25983 |
| 2020-05-06 |
Preventing spread of SARS-CoV-2 and preparing for the COVID-19 outbreak in the surgical department: perspectives from two Scandinavian countries (edit) |
10.1093/JSCR/RJAA131 |
| 2020-05-06 |
COVID-2019 associated overexpressed Prevotella proteins mediated host-pathogen interactions and their role in coronavirus outbreak (edit) |
10.1093/BIOINFORMATICS/BTAA285 |
| 2020-05-06 |
SARS-CoV-2 viral spike G614 mutation exhibits higher case fatality rate (edit) |
10.1111/IJCP.13525 |
| 2020-05-06 |
Perspective: SARS-CoV-2, COVID-19 and Haematologists (edit) |
10.1159/000508021 |
| 2020-05-06 |
COVID-19: Ophthalmological Aspects of the SARS-CoV 2 Global Pandemic (edit) |
10.1055/A-1164-9381 |
| 2020-05-06 |
Intensive care for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a makeshift ICU in Wuhan (edit) |
10.1186/S13054-020-02914-6 |
| 2020-05-06 |
SARS-CoV-2 in pregnancy: symptomatic pregnant women are only the tip of the iceberg (edit) |
10.1016/J.AJOG.2020.05.005 |
| 2020-05-06 |
Rapid development of an inactivated vaccine candidate for SARS-CoV-2 (edit) |
10.1126/SCIENCE.ABC1932 |
| 2020-05-06 |
Inhibition of SARS-CoV-2 infection by the cyclophilin inhibitor Alisporivir (Debio 025) (edit) |
10.1128/AAC.00876-20 |
| 2020-05-06 |
Design of potent membrane fusion inhibitors against SARS-CoV-2, an emerging coronavirus with high fusogenic activity (edit) |
10.1128/JVI.00635-20 |
| 2020-05-06 |
Cell entry mechanisms of SARS-CoV-2 (edit) |
10.1073/PNAS.2003138117 |
| 2020-05-06 |
SARS-CoV-2 Testing, Prevalence, and Predictors of COVID-19 in Patients with Inflammatory Bowel Disease in Northern California (edit) |
10.1053/J.GASTRO.2020.05.009 |
| 2020-05-06 |
An Extensive Meta-Metagenomic Search Identifies SARS-CoV-2-Homologous Sequences in Pangolin Lung Viromes (edit) |
10.1128/MSPHERE.00160-20 |
| 2020-05-06 |
Gene of the month: the 2019-nCoV/SARS-CoV-2 novel coronavirus spike protein (edit) |
10.1136/JCLINPATH-2020-206658 |
| 2020-05-06 |
Characteristics of asymptomatic patients with SARS-CoV-2 infection in Jinan, China (edit) |
10.1016/J.MICINF.2020.04.011 |
| 2020-05-06 |
SARS-CoV-2: air/aerosols and surfaces in laboratory and clinical settings (edit) |
10.1016/J.JHIN.2020.05.001 |
| 2020-05-06 |
Applying principles of behaviour change to reduce SARS-CoV-2 transmission (edit) |
10.1038/S41562-020-0887-9 |
| 2020-05-06 |
COVID-19: The environmental implications of shedding SARS-CoV-2 in human faeces (edit) |
10.1016/J.ENVINT.2020.105790 |
| 2020-05-06 |
SARS-CoV-2 infection and glucose homeostasis in pregnancy. What about antenatal corticosteroids? (edit) |
10.1016/J.DSX.2020.04.045 |
| 2020-05-06 |
Haemorrhagic conjunctivitis with pseudomembranous related to SARS-CoV-2 (edit) |
10.1016/J.AJOC.2020.100735 |
| 2020-05-06 |
Animal-to-Human Viral Transitions: Is SARS-CoV-2 an Evolutionary Successful One? (edit) |
10.1007/S00239-020-09947-Z |
| 2020-05-06 |
Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients: comment (edit) |
10.1007/S11739-020-02358-4 |
| 2020-05-06 |
COVID-19 (SARS-CoV-2 Infection) and Children: Pediatric Neurologist's Perspective (edit) |
10.1007/S12098-020-03326-8 |
| 2020-05-06 |
An infant with a mild SARS-CoV-2 infection detected only by anal swabs: a case report (edit) |
10.1016/J.BJID.2020.04.009 |
| 2020-05-06 |
Expression of ACE2, the SARS-CoV-2 Receptor, and TMPRSS2 in Prostate Epithelial Cells (edit) |
10.1016/J.EURURO.2020.04.065 |
| 2020-05-06 |
How to reduce the potential risk of vertical transmission of SARS-CoV-2 during vaginal delivery? (edit) |
10.1016/J.EJOGRB.2020.04.065 |
| 2020-05-06 |
Geospatially Referenced Demographic Agent-Based Modeling of SARS-CoV-2-Infection (COVID-19) Dynamics and Mitigation Effects in a Real-world Community (edit) |
10.1101/2020.05.03.20089235 |
| 2020-05-06 |
Alpha 1 Antitrypsin is an Inhibitor of the SARS-CoV2–Priming Protease TMPRSS2 (edit) |
10.1101/2020.05.04.077826 |
| 2020-05-06 |
Bulk and single-cell gene expression profiling of SARS-CoV-2 infected human cell lines identifies molecular targets for therapeutic intervention (edit) |
10.1101/2020.05.05.079194 |
| 2020-05-06 |
Baseline pulmonary levels of CD8+ T cells and NK cells inversely correlate with expression of the SARS-CoV-2 entry receptor ACE2 (edit) |
10.1101/2020.05.04.075291 |
| 2020-05-06 |
Efficient prevalence estimation and infected sample identification with group testing for SARS-CoV-2 (edit) |
10.1101/2020.05.01.20086801 |
| 2020-05-06 |
Selectomic and Evolvability Analyses of the Highly Pathogenic Betacoronaviruses SARS-CoV-2, SARS-CoV, and MERS-CoV (edit) |
10.1101/2020.05.05.078956 |
| 2020-05-06 |
Test Agreement Between Roche Cobas 6800 and Cepheid GeneXpert Xpress SARS-CoV-2 Assays at High Cycle Threshold Ranges (edit) |
10.1101/2020.05.05.078501 |
| 2020-05-06 |
Global Spread of SARS-CoV-2 Subtype with Spike Protein Mutation D614G is Shaped by Human Genomic Variations that Regulate Expression of TMPRSS2 and MX1 Genes (edit) |
10.1101/2020.05.04.075911 |
| 2020-05-06 |
Repeated population-based surveys of antibodies against SARS-CoV-2 in Southern Brazil (edit) |
10.1101/2020.05.01.20087205 |
| 2020-05-06 |
Dose prediction for repurposing nitazoxanide in SARS-CoV-2 treatment or chemoprophylaxis (edit) |
10.1101/2020.05.01.20087130 |
| 2020-05-06 |
A strategy for finding people infected with SARS-CoV-2: optimizing pooled testing at low prevalence (edit) |
10.1101/2020.05.02.20087924 |
| 2020-05-06 |
SARS-CoV-2 Spike Glycoprotein Receptor Binding Domain is Subject to Negative Selection with Predicted Positive Selection Mutations (edit) |
10.1101/2020.05.04.077842 |
| 2020-05-06 |
A new role for Biofoundries in rapid prototyping, development, and validation of automated clinical diagnostic tests for SARS-CoV-2 (edit) |
10.1101/2020.05.02.20088344 |
| 2020-05-06 |
Validation of a commercially available SARS-CoV-2 serological Immunoassay (edit) |
10.1101/2020.05.02.20080879 |
| 2020-05-06 |
Incorporating and Addressing Testing Bias Within Estimates of Epidemic Dynamics for SARS-CoV-2 (edit) |
10.1101/2020.05.02.20088120 |
| 2020-05-06 |
Pooling RT-PCR test of SARS-CoV-2 for large cohort of 'healthy' and infection-suspected patients: A prospective and consecutive study on 1,000 individuals (edit) |
10.1101/2020.05.04.20088146 |
| 2020-05-06 |
Translation-associated mutational U-pressure in the first ORF of SARS-CoV-2 and other coronaviruses (edit) |
10.1101/2020.05.05.078238 |
| 2020-05-06 |
Comparison of two commercial molecular tests and a laboratory-developed modification of the CDC 2019-nCOV RT-PCR assay for the qualitative detection of SARS-CoV-2 from upper respiratory tract specimens (edit) |
10.1101/2020.05.02.20088740 |
| 2020-05-06 |
Does BCG protect against SARS-CoV-2 infection ?: elements of proof. (edit) |
10.1101/2020.05.01.20087437 |
| 2020-05-06 |
Identification of IgG antibody response to SARS-CoV-2 spike protein and its receptor binding domain does not predict rapid recovery from COVID-19 (edit) |
10.1101/2020.05.01.20087684 |
| 2020-05-06 |
Ultra-fast and onsite interrogation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in environmental specimens via surface enhanced Raman scattering (SERS) (edit) |
10.1101/2020.05.02.20086876 |
| 2020-05-06 |
Antibodies to SARS/CoV-2 in arbitrarily-selected Atlanta residents (edit) |
10.1101/2020.05.01.20087478 |
| 2020-05-06 |
Impact of policy interventions and social distancing on SARS-CoV-2 transmission in the United States (edit) |
10.1101/2020.05.01.20088179 |
| 2020-05-06 |
Frequency of routine testing for SARS-CoV-2 to reduce transmission among workers (edit) |
10.1101/2020.04.30.20087015 |
| 2020-05-06 |
The immune system of children: the key to understanding SARS-CoV-2 susceptibility? (edit) |
10.1016/S2352-4642(20)30135-8 |
| 2020-05-06 |
What the Corona (SARS-CoV 2) pandemic, climate change, and the biodiversity crisis teach us about human nature (edit) |
10.1111/ETH.13031 |
| 2020-05-06 |
B cell clonal expansion and convergent antibody responses to SARS-CoV-2 (edit) |
10.21203/RS.3.RS-27220/V1 |
| 2020-05-05 |
Inhibition of papain-like protease PLpro blocks SARS-CoV-2 spread and promotes anti-viral immunity (edit) |
10.21203/RS.3.RS-27134/V1 |
| 2020-05-05 |
Nsp7 and Spike Glycoprotein of SARS-CoV-2 Are Envisaged as Potential Targets of Vitamin D and Ivermectin (edit) |
10.20944/PREPRINTS202005.0084.V1 |
| 2020-05-05 |
COVID-19 Disease Map, building a computational repository of SARS-CoV-2 virus-host interaction mechanisms (edit) |
10.1038/S41597-020-0477-8 |
| 2020-05-05 |
Otolaryngology Residency Application during the SARS-CoV-2 (COVID-19) Pandemic (edit) |
10.1177/0194599820925037 |
| 2020-05-05 |
Olfactory and gustatory dysfunction caused by SARS-CoV-2: comparison with cases of infection with influenza and other viruses (edit) |
10.1017/ICE.2020.196 |
| 2020-05-05 |
An Evidence Based Perspective on mRNA-SARS-CoV-2 Vaccine Development (edit) |
10.12659/MSM.924700 |
| 2020-05-05 |
The lysosome: A potential juncture between SARS-CoV-2 infectivity and Niemann-Pick disease type C, with therapeutic implications (edit) |
10.1096/FJ.202000654R |
| 2020-05-05 |
Preliminary data on outcomes of SARS-CoV-2 infection in a Spanish single centre cohort of kidney recipients (edit) |
10.1111/AJT.15970 |
| 2020-05-05 |
Use of telemedicine to provide clinical pharmacy services during the SARS-CoV-2 pandemic (edit) |
10.1093/AJHP/ZXAA112 |
| 2020-05-05 |
Pooling of Nasopharyngeal Swab Specimens for SARS-CoV-2 detection by RT-PCR (edit) |
10.1002/JMV.25971 |
| 2020-05-05 |
Letter to the Editor: Three cases of re-detectable positive SARS-CoV-2 RNA in recovered COVID-19 patients with antibodies (edit) |
10.1002/JMV.25968 |
| 2020-05-05 |
Management of Febrile Neutropenia Associated With SARS-CoV-2 Infection in a Patient With Cancer (edit) |
10.1200/OP.20.00197 |
| 2020-05-05 |
Acute Parotitis: A Possible Precocious Clinical Manifestation of SARS-CoV-2 Infection? (edit) |
10.1177/0194599820926992 |
| 2020-05-05 |
Potential infectious risk from the pets carrying SARS-CoV-2 (edit) |
10.1016/J.TMAID.2020.101737 |
| 2020-05-05 |
SARS-CoV-2 infection anxieties and general population restrictions delay diagnosis and treatment of acute haematological malignancies (edit) |
10.1111/BJH.16785 |
| 2020-05-05 |
Observations about sexual and other routes of SARS-CoV-2 transmission and its prevention (edit) |
10.1111/CED.14274 |
| 2020-05-05 |
Convalescent donor SARS-COV-2-specific cytotoxic T lymphocyte infusion as a possible treatment option for COVID-19 patients with severe disease - has not received enough attention till date (edit) |
10.1111/BJH.16780 |
| 2020-05-05 |
Acute on Chronic Liver Failure from Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (edit) |
10.1111/LIV.14506 |
| 2020-05-05 |
Oral vesiculobullous lesions associated with SARS-CoV-2 infection (edit) |
10.1111/ODI.13382 |
| 2020-05-05 |
Digitally aided telemedicine during the SARS-CoV-2 pandemic to screen oral medicine emergencies (edit) |
10.1111/ODI.13383 |
| 2020-05-05 |
SARS-CoV-2, Testosterone and frailty in males (PROTEGGIMI): A multidimensional research project (edit) |
10.1111/ANDR.12811 |
| 2020-05-05 |
Considerations for pharmacoepidemiological analyses in the SARS-CoV-2 pandemic (edit) |
10.1002/PDS.5029 |
| 2020-05-05 |
Estimation of Unreported Novel Coronavirus (SARS-CoV-2) Infections from Reported Deaths: A Susceptible-Exposed-Infectious-Recovered-Dead Model (edit) |
10.3390/JCM9051350 |
| 2020-05-05 |
Acute Kidney Injury in SARS-CoV-2 Infection: Direct Effect of Virus on Kidney Proximal Tubule Cells (edit) |
10.3390/IJMS21093275 |
| 2020-05-05 |
SARS-CoV-2 & Covid-19: Key-Roles of the 'Renin-Angiotensin' System / Vitamin D Impacting Drug and Vaccine Developments (edit) |
10.2174/1871526520999200505174704 |
| 2020-05-05 |
SARS-CoV-2 RNA polymerase as target for antiviral therapy (edit) |
10.1186/S12967-020-02355-3 |
| 2020-05-05 |
SARS-CoV-2 and ORF3a: Nonsynonymous Mutations, Functional Domains, and Viral Pathogenesis (edit) |
10.1128/MSYSTEMS.00266-20 |
| 2020-05-05 |
Ultrastructural Evidence for Direct Renal Infection with SARS-CoV-2 (edit) |
10.1681/ASN.2020040432 |
| 2020-05-05 |
SARS-CoV-2 and myocardial injury: Few answers, many questions (edit) |
10.3949/CCJM.87A.CCC001 |
| 2020-05-05 |
Impact of corticosteroid therapy on outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection: a systematic review and meta-analysis (edit) |
10.1038/S41375-020-0848-3 |
| 2020-05-05 |
SARS-CoV-2-mediated inflammatory response in lungs: should we look at RAGE? (edit) |
10.1007/S00011-020-01353-X |
| 2020-05-05 |
Fecal testing for SARS-CoV-2 in patients undergoing elective lower gastrointestinal endoscopy (edit) |
10.1111/JGH.15087 |
| 2020-05-05 |
A Path to Resume Aesthetic Care: Executive Summary of Project AesCert Guidance Supplement-Practical Considerations for Aesthetic Medicine Professionals Supporting Clinic Preparedness in Response to the SARS-CoV-2 Outbreak (edit) |
10.1089/FPSAM.2020.0239 |
| 2020-05-05 |
Reply to: 'No evidence for an increased liver uptake of SARS-CoV-2 in metabolic associated fatty liver disease' (edit) |
10.1016/J.JHEP.2020.04.039 |
| 2020-05-05 |
Distinct changes in the real-time PCR detectability of certain SARS-CoV-2 target sequences (edit) |
10.1016/J.CCA.2020.05.002 |
| 2020-05-05 |
SARS-CoV-2 infection among patients with systemic autoimmune diseases (edit) |
10.1016/J.AUTREV.2020.102575 |
| 2020-05-05 |
SARS-CoV-2: "Three-steps" infection model and CSF diagnostic implication (edit) |
10.1016/J.BBI.2020.05.002 |
| 2020-05-05 |
Coding potential and sequence conservation of SARS-CoV-2 and related animal viruses (edit) |
10.1016/J.MEEGID.2020.104353 |
| 2020-05-05 |
Emergence of genomic diversity and recurrent mutations in SARS-CoV-2 (edit) |
10.1016/J.MEEGID.2020.104351 |
| 2020-05-05 |
Adverse drug reactions of hydroxychloroquine: Analysis of French pre-pandemic SARS-CoV2 pharmacovigilance data (edit) |
10.1016/J.THERAP.2020.05.001 |
| 2020-05-05 |
Evaluation of two automated and three rapid lateral flow immunoassays for the detection of anti-SARS-CoV-2 antibodies (edit) |
10.1016/J.JCV.2020.104413 |
| 2020-05-05 |
COVID-19 Management and Arrhythmia: Risks and Challenges for Clinicians Treating Patients Affected by SARS-CoV-2 (edit) |
10.3389/FCVM.2020.00085 |
| 2020-05-05 |
SARS-CoV-2 and influenza virus co-infection (edit) |
10.1016/S0140-6736(20)31052-7 |
| 2020-05-05 |
Computational methods to develop potential neutralizing antibody Fab region against SARS-CoV-2 as therapeutic and diagnostic tool (edit) |
10.1101/2020.05.02.071506 |
| 2020-05-05 |
Global prediction of unreported SARS-CoV2 infection from observed COVID-19 cases (edit) |
10.1101/2020.04.29.20083485 |
| 2020-05-05 |
The UCSC SARS-CoV-2 Genome Browser (edit) |
10.1101/2020.05.04.075945 |
| 2020-05-05 |
Sensitivity evaluation of 2019 novel coronavirus (SARS-CoV-2) RT-PCR detection kits and strategy to reduce false negative (edit) |
10.1101/2020.04.28.20083956 |
| 2020-05-05 |
Monitoring social distancing and SARS-CoV-2 transmission in Brazil using cell phone mobility data (edit) |
10.1101/2020.04.30.20082172 |
| 2020-05-05 |
Distinguishing between COVID-19 and the common cold in a primary care setting - comparison of patients with positive and negative SARS-CoV-2 PCR results. (edit) |
10.1101/2020.04.27.20081877 |
| 2020-05-05 |
Missense variants in ACE2 are predicted to encourage and inhibit interaction with SARS-CoV-2 Spike and contribute to genetic risk in COVID-19 (edit) |
10.1101/2020.05.03.074781 |
| 2020-05-05 |
Pathogen Reduction of SARS-CoV-2 Virus in Plasma and Whole Blood using Riboflavin and UV Light (edit) |
10.1101/2020.05.03.074971 |
| 2020-05-05 |
Temporal signal and the phylodynamic threshold of SARS-CoV-2 (edit) |
10.1101/2020.05.04.077735 |
| 2020-05-05 |
Catalytic cleavage of HEAT and subsequent covalent binding of the tetralone moiety by the SARS-CoV-2 main protease (edit) |
10.1101/2020.05.02.043554 |
| 2020-05-05 |
Complexity in SARS-CoV-2 genome data: Price theory of mutant isolates (edit) |
10.1101/2020.05.04.077511 |
| 2020-05-05 |
Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication (edit) |
10.1101/2020.05.03.073080 |
| 2020-05-05 |
Characterizations of SARS-CoV-2 mutational profile, spike protein stability and viral transmission (edit) |
10.1101/2020.05.03.066266 |
| 2020-05-05 |
Computational analysis on the ACE2-derived peptides for neutralizing the ACE2 binding to the spike protein of SARS-CoV-2 (edit) |
10.1101/2020.05.03.075473 |
| 2020-05-05 |
Probable causes and risk factors for positive SARS-CoV-2 test in recovered patients: Evidence from Brunei Darussalam (edit) |
10.1101/2020.04.30.20086082 |
| 2020-05-05 |
Humoral immune response and prolonged PCR positivity in a cohort of 1343 SARS-CoV 2 patients in the New York City region (edit) |
10.1101/2020.04.30.20085613 |
| 2020-05-05 |
Effective Heat Inactivation of SARS-CoV-2 (edit) |
10.1101/2020.04.29.20085498 |
| 2020-05-05 |
Antibody Profiling and Prevalence in the US population during the SARS-CoV2 Pandemic (edit) |
10.1101/2020.04.29.20085068 |
| 2020-05-05 |
Group Testing Performance Evaluation for SARS-CoV-2 Massive Scale Screening and Testing (edit) |
10.1101/2020.05.02.20080390 |
| 2020-05-05 |
A clinical and biological framework on the role of visceral fat tissue and leptin in SARS-CoV-2 infection related respiratory failure (edit) |
10.1101/2020.04.30.20086108 |
| 2020-05-05 |
Sensitivity of nasopharyngeal swabs and saliva for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (edit) |
10.1101/2020.05.01.20081026 |
| 2020-05-05 |
SARS-CoV-2 Infection of the Placenta (edit) |
10.1101/2020.04.30.20083907 |
| 2020-05-05 |
Single-cell Transcriptome Analysis Indicates New Potential Regulation Mechanism of ACE2 and NPs signaling among heart failure patients infected with SARS-CoV-2 (edit) |
10.1101/2020.04.30.20081257 |
| 2020-05-05 |
Group testing for SARS-CoV-2 allows for up to 10-fold efficiency increase across realistic scenarios and testing strategies (edit) |
10.1101/2020.04.30.20085290 |
| 2020-05-05 |
Lockdown exit strategies and risk of a second epidemic peak: a stochastic agent-based model of SARS-CoV-2 epidemic in France (edit) |
10.1101/2020.04.30.20086264 |
| 2020-05-05 |
Presence and vitality of SARS-CoV-2 virus in wastewaters and rivers (edit) |
10.1101/2020.05.01.20086009 |
| 2020-05-05 |
Preliminary Results of Seroprevalence of SARS-CoV-2 at Community Clinics in Tokyo (edit) |
10.1101/2020.04.29.20085449 |
| 2020-05-05 |
Proteolytic Cleavage of the SARS-CoV-2 Spike Protein and the Role of the Novel S1/S2 Site (edit) |
10.2139/SSRN.3581359 |
| 2020-05-05 |
Integrative Network Biology Framework Elucidates Molecular Mechanisms of SARS-CoV-2 Pathogenesis (edit) |
10.2139/SSRN.3581857 |
| 2020-05-05 |
The Impact of SARS-CoV-2 on Inflammatory Bowel Disease (edit) |
10.1159/000508114 |
| 2020-05-04 |
Considerations for Treating CoronaVirus (Sars-Cov-2) Infection with Passive Immunotherapy (edit) |
10.13128/SUBSTANTIA-924 |
| 2020-05-04 |
Corona, COVID-19, SARS-CoV-2 (edit) |
10.1007/S00058-020-1496-8 |
| 2020-05-04 |
A human monoclonal antibody blocking SARS-CoV-2 infection (edit) |
10.1038/S41467-020-16256-Y |
| 2020-05-04 |
Understanding the binding affinity of noscapines with protease of SARS-CoV-2 for COVID-19 using MD simulations at different temperatures (edit) |
10.1080/07391102.2020.1752310 |
| 2020-05-04 |
Calculating an institutional personal protective equipment (PPE) burn rate to project future usage patterns during the 2020 SARS-CoV-2 pandemic (edit) |
10.1017/ICE.2020.190 |
| 2020-05-04 |
Deducing the N- and O- glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2 (edit) |
10.1093/GLYCOB/CWAA042 |
| 2020-05-04 |
Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review (edit) |
10.1111/APM.13047 |
| 2020-05-04 |
FDA-approved thiol-reacting drugs that potentially bind into the SARS-CoV-2 main protease, essential for viral replication (edit) |
10.1080/07391102.2020.1764393 |
| 2020-05-04 |
The Role of Scientific Publishing in the SARS-CoV-2 Pandemic (edit) |
10.1002/PHAR.2402 |
| 2020-05-04 |
Balancing Expediency and Scientific Rigor in SARS-CoV-2 Vaccine Development (edit) |
10.1093/INFDIS/JIAA234 |
| 2020-05-04 |
Rapid reconstruction of SARS-CoV-2 using a synthetic genomics platform (edit) |
10.1038/S41586-020-2294-9 |
| 2020-05-04 |
Response to 'To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (Covid-19) pandemic' by Parperis (edit) |
10.1136/ANNRHEUMDIS-2020-217634 |
| 2020-05-04 |
SARS-CoV-2 detection in formalin-fixed paraffin-embedded tissue specimens from surgical resection of tongue squamous cell carcinoma (edit) |
10.1136/JCLINPATH-2020-206635 |
| 2020-05-04 |
Early Neonatal SARS-CoV-2 Infection Manifesting With Hypoxemia Requiring Respiratory Support (edit) |
10.1542/PEDS.2020-1121 |
| 2020-05-04 |
Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2 Test (edit) |
10.1128/JCM.00926-20 |
| 2020-05-04 |
Site-specific glycan analysis of the SARS-CoV-2 spike (edit) |
10.1126/SCIENCE.ABB9983 |
| 2020-05-04 |
Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs (edit) |
10.1128/AAC.00819-20 |
| 2020-05-04 |
"No dose" lung ultrasound correlation with "low dose" CT scan for early diagnosis of SARS-CoV-2 pneumonia (edit) |
10.1007/S00134-020-06058-7 |
| 2020-05-04 |
High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study (edit) |
10.1007/S00134-020-06062-X |
| 2020-05-04 |
SARS-CoV-2 can induce brain and spine demyelinating lesions (edit) |
10.1007/S00701-020-04374-X |
| 2020-05-04 |
[Evolution of CT manifestations in a Coronavirus (2019-nCoV) pneumonia patient] (edit) |
10.1007/S00063-020-00694-Z |
| 2020-05-04 |
New evidence of SARS-CoV-2 transmission through the ocular surface (edit) |
10.1007/S00417-020-04726-4 |
| 2020-05-04 |
Slit-lamp evaluation during SARS-CoV-2 pandemic: safety first! (edit) |
10.1007/S00417-020-04729-1 |
| 2020-05-04 |
Detect to protect: pneumoperitoneum gas samples for SARS-CoV-2 and biohazard testing (edit) |
10.1007/S00464-020-07611-7 |
| 2020-05-04 |
SARS-CoV-2 variants: relevance for symptom granularity, epidemiology, immunity (herd, vaccines), virus origin and containment? (edit) |
10.1111/1462-2920.15053 |
| 2020-05-04 |
A case of improved oxygenation in SARS-CoV-2 positive patient on nasal cannula undergoing prone positioning (edit) |
10.1016/J.RMCR.2020.101070 |
| 2020-05-04 |
Drone delivery of AED's and personal protective equipment in the era of SARS-CoV-2 (edit) |
10.1016/J.RESUSCITATION.2020.04.038 |
| 2020-05-04 |
The arrival of SARS-CoV-2 in Venezuela (edit) |
10.1016/S0140-6736(20)31053-9 |
| 2020-05-04 |
In Silico Design of Antiviral Peptides Targeting the Spike Protein of SARS-CoV-2 (edit) |
10.1016/J.PEPTIDES.2020.170328 |
| 2020-05-04 |
Neurosurgical practice during the SARS-CoV-2 pandemic: a worldwide survey (edit) |
10.1016/J.WNEU.2020.04.204 |
| 2020-05-04 |
[Risk of hepatitis B reactivation associated with treatment against SARS-CoV-2 (COVID-19) with corticosteroids] (edit) |
10.1016/J.RCE.2020.04.012 |
| 2020-05-04 |
Coast-to-Coast Spread of SARS-CoV-2 during the Early Epidemic in the United States (edit) |
10.1016/J.CELL.2020.04.021 |
| 2020-05-04 |
Evidence for and against vertical transmission for SARS-CoV-2 (COVID-19) (edit) |
10.1016/J.AJOG.2020.04.039 |
| 2020-05-04 |
Design of a peptide-based subunit vaccine against novel coronavirus SARS-CoV-2 (edit) |
10.1016/J.MICPATH.2020.104236 |
| 2020-05-04 |
Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (n=4532) (edit) |
10.1016/J.ANNONC.2020.04.479 |
| 2020-05-04 |
On airborne transmission and control of SARS-Cov-2 (edit) |
10.1016/J.SCITOTENV.2020.139178 |
| 2020-05-04 |
Rapid and sensitive detection of SARS-CoV-2 RNA using the Simplexa™ COVID-19 direct assay (edit) |
10.1016/J.JCV.2020.104416 |
| 2020-05-04 |
Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing (edit) |
10.1038/S41421-020-0168-9 |
| 2020-05-04 |
A favorable outcome of pneumonia COVID 19 in an advanced lung cancer patient with severe neutropenia: Is immunosuppression a risk factor for SARS-COV2 infection? (edit) |
10.1016/J.LUNGCAN.2020.04.029 |
| 2020-05-04 |
Self-collection: An appropriate alternative during the SARS-CoV-2 pandemic (edit) |
10.1016/J.JCV.2020.104417 |
| 2020-05-04 |
Interleukin-6 levels in children developing SARS-CoV-2 infection (edit) |
10.1016/J.PEDNEO.2020.04.007 |
| 2020-05-04 |
Neutralizing Antibodies Isolated by a site-directed Screening have Potent Protection on SARS-CoV-2 Infection (edit) |
10.1101/2020.05.03.074914 |
| 2020-05-04 |
Design of an Epitope-Based Peptide Vaccine against the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): A Vaccine Informatics Approach (edit) |
10.1101/2020.05.03.074930 |
| 2020-05-04 |
Detection of SARS-CoV-2 in Human Breast Milk (edit) |
10.1101/2020.04.28.20075523 |
| 2020-05-04 |
Large scale genomic analysis of 3067 SARS-CoV-2 genomes reveals a clonal geo-distribution and a rich genetic variations of hotspots mutations (edit) |
10.1101/2020.05.03.074567 |
| 2020-05-04 |
Development and validation of direct RT-LAMP for SARS-CoV-2 (edit) |
10.1101/2020.04.29.20075747 |
| 2020-05-04 |
Sensitivity assessment of SARS-CoV-2 PCR assays developed by WHO referral laboratories (edit) |
10.1101/2020.05.03.20072207 |
| 2020-05-04 |
Commercial stocks of SARS-CoV-2 RNA may report low concentration values, leading to artificially increased apparent sensitivity of diagnostic assays (edit) |
10.1101/2020.04.28.20077602 |
| 2020-05-04 |
Enzyme immunoassay for SARS-CoV-2 antibodies in dried blood spot samples: A minimally-invasive approach to facilitate community- and population-based screening (edit) |
10.1101/2020.04.28.20081844 |
| 2020-05-04 |
Knowledge of Latin American gastroenterologists and endoscopists regarding SARS-CoV-2 infection (edit) |
10.1016/J.RGMX.2020.04.003 |
| 2020-05-04 |
Small bowel ischemia and SARS-CoV-2 infection: an underdiagnosed distinct clinical entity (edit) |
10.1016/J.SURG.2020.04.035 |
| 2020-05-04 |
Dental autopsy recommendations in SARS-CoV-2 infected cases (edit) |
10.1016/J.FSISYN.2020.04.004 |
| 2020-05-04 |
Guillain-Barré Syndrome Associated with SARS-CoV-2 infection (edit) |
10.1016/J.MEDIN.2020.04.015 |
| 2020-05-03 |
Development and validation of a UHPLC-MS/MS method for quantification of the prodrug remdesivir and its metabolite GS-441524: a tool for clinical pharmacokinetics of SARS-CoV-2/COVID-19 and Ebola virus disease (edit) |
10.1093/JAC/DKAA152 |
| 2020-05-03 |
Does SARS-CoV-2 cause viral myocarditis in COVID-19 patients? (edit) |
10.1093/EURHEARTJ/EHAA392 |
| 2020-05-03 |
SARS-CoV-2 spread in Northern Italy: what about the pollution role? (edit) |
10.1007/S10661-020-08317-Y |
| 2020-05-03 |
Correction to: SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes (edit) |
10.1007/S11357-020-00193-1 |
| 2020-05-03 |
The pathogenesis and alternative treatment of SARS-CoV2 (edit) |
10.1016/J.IMR.2020.100421 |
| 2020-05-03 |
SARS-CoV-2 was already spreading in France in late December 2019 (edit) |
10.1016/J.IJANTIMICAG.2020.106006 |
| 2020-05-03 |
SARS-CoV-2: Combating Coronavirus Emergence (edit) |
10.1016/J.IMMUNI.2020.04.016 |
| 2020-05-03 |
Prevalence of IgG antibodies to SARS-CoV-2 among emergency department employees (edit) |
10.1016/J.AJEM.2020.04.076 |
| 2020-05-03 |
COVID-19-related prejudice toward Asian medical students: A consequence of SARS-CoV-2 fears in Poland (edit) |
10.1016/J.JIPH.2020.04.013 |
| 2020-05-03 |
Viral kinetics of SARS-CoV-2 in asymptomatic carriers and presymptomatic patients (edit) |
10.1016/J.IJID.2020.04.083 |
| 2020-05-03 |
Transcriptional landscape of SARS-CoV-2 infection dismantles pathogenic pathways activated by the virus, proposes unique sex-specific differences and predicts tailored therapeutic strategies (edit) |
10.1016/J.AUTREV.2020.102571 |
| 2020-05-03 |
SARS-COV-2 infection in patients with cancer undergoing checkpoint blockade: Clinical course and outcome (edit) |
10.1016/J.EJCA.2020.04.026 |
| 2020-05-03 |
Inflamm-aging: Why older men are the most susceptible to SARS-CoV-2 complicated outcomes (edit) |
10.1016/J.CYTOGFR.2020.04.005 |
| 2020-05-03 |
Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals (edit) |
10.1016/J.IMMUNI.2020.04.023 |
| 2020-05-03 |
Molecular detection of SARS-CoV-2 using a reagent-free approach (edit) |
10.1101/2020.04.28.20083626 |
| 2020-05-03 |
Enhanced Contact Investigations for Nine Early Travel-Related Cases of SARS-CoV-2 in the United States (edit) |
10.1101/2020.04.27.20081901 |
| 2020-05-03 |
Structural and Functional Implications of Non-synonymous Mutations in the Spike protein of 2,954 SARS-CoV-2 Genomes (edit) |
10.1101/2020.05.02.071811 |
| 2020-05-03 |
Early trends for SARS-CoV-2 infection in central and north Texas and impact on other circulating respiratory viruses (edit) |
10.1101/2020.04.30.20086116 |
| 2020-05-03 |
Failure of the cobas® SARS-CoV-2 (Roche) E-gene assay is associated with a C-to-T transition at position 26340 of the SARS-CoV-2 genome (edit) |
10.1101/2020.04.28.20083337 |
| 2020-05-03 |
Pre-test probability for SARS-Cov-2-related Infection Score: the PARIS score (edit) |
10.1101/2020.04.28.20081687 |
| 2020-05-03 |
Rapid adaptation of SARS-CoV-2 in BALB/c mice: Novel mouse model for vaccine efficacy (edit) |
10.1101/2020.05.02.073411 |
| 2020-05-03 |
SARS-CoV-2 is well adapted for humans. What does this mean for re-emergence? (edit) |
10.1101/2020.05.01.073262 |
| 2020-05-03 |
Genome-wide variations of SARS-CoV-2 infer evolution relationship and transmission route (edit) |
10.1101/2020.04.27.20081349 |
| 2020-05-03 |
Release of potential pro-inflammatory peptides from SARS-CoV-2 spike glycoproteins in neutrophil-extracellular traps (edit) |
10.1101/2020.05.02.072439 |
| 2020-05-03 |
An artificial intelligence system reveals liquiritin inhibits SARS-CoV-2 by mimicking type I interferon (edit) |
10.1101/2020.05.02.074021 |
| 2020-05-03 |
Ultra-Sensitive High-Resolution Profiling of Anti-SARS-CoV-2 Antibodies for Detecting Early Seroconversion in COVID-19 Patients (edit) |
10.1101/2020.04.28.20083691 |
| 2020-05-03 |
Comprehensive characterization of N- and O- glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2 (edit) |
10.1101/2020.05.01.071688 |
| 2020-05-03 |
CoV-Seq: SARS-CoV-2 Genome Analysis and Visualization (edit) |
10.1101/2020.05.01.071050 |
| 2020-05-03 |
PSGL-1 blocks SARS-CoV-2 S protein-mediated virus attachment and infection of target cells (edit) |
10.1101/2020.05.01.073387 |
| 2020-05-03 |
Identification of Drugs Blocking SARS-CoV-2 Infection using Human Pluripotent Stem Cell-derived Colonic Organoids (edit) |
10.1101/2020.05.02.073320 |
| 2020-05-03 |
Beyond the Spike: identification of viral targets of the antibody response to SARS-CoV-2 in COVID-19 patients (edit) |
10.1101/2020.04.30.20085670 |
| 2020-05-03 |
Critically ill SARS-CoV-2 patients display lupus-like hallmarks of extrafollicular B cell activation (edit) |
10.1101/2020.04.29.20083717 |
| 2020-05-03 |
Hospital-at-Home as an Alternative to Release the Overload of Healthcare Systems During the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pandemic (edit) |
10.1016/J.JAMDA.2020.04.024 |
| 2020-05-03 |
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Related Deaths in French Long-Term Care Facilities: The "Confinement Disease" Is Probably More Deleterious Than the Coronavirus Disease-2019 (COVID-19) Itself (edit) |
10.1016/J.JAMDA.2020.04.023 |
| 2020-05-02 |
Novel 2019 coronavirus SARS-CoV-2 (COVID-19): an overview for emergency clinicians (edit) |
|
| 2020-05-02 |
SARS-CoV-2 infection in a psoriatic patient treated with IL-17 inhibitor (edit) |
10.1111/JDV.16571 |
| 2020-05-02 |
Still much to learn about the diagnostic role of SARS-CoV-2 antibody detection (edit) |
10.1093/CID/CIAA532 |
| 2020-05-02 |
Longitudinal Change of SARS-Cov2 Antibodies in Patients with COVID-19 (edit) |
10.1093/INFDIS/JIAA229 |
| 2020-05-02 |
Diffuse cutaneous manifestation in a new mother with COVID-19 (SARS-Cov-2) (edit) |
10.1111/IJD.14919 |
| 2020-05-02 |
Occurrence of SARS-CoV-2 during mycophenolate mofetil treatment for pemphigus (edit) |
10.1111/JDV.16578 |
| 2020-05-02 |
Sports Health During the SARS-Cov-2 Pandemic (edit) |
10.1007/S40279-020-01288-7 |
| 2020-05-02 |
SARS-CoV-2 asymptomatic and symptomatic patients and risk for transfusion transmission (edit) |
10.1111/TRF.15841 |
| 2020-05-02 |
A PATH TO RESUME AESTHETIC CARE EXECUTIVE SUMMARY OF PROJECT AesCert™ GUIDANCE SUPPLEMENT: PRACTICAL CONSIDERATIONS FOR AESTHETIC MEDICINE PROFESSIONALS SUPPORTING CLINIC PREPAREDNESS IN RESPONSE TO THE SARS-CoV-2 OUTBREAK (edit) |
10.1089/ABC.2020.0239 |
| 2020-05-02 |
Identification of new anti-nCoV drug chemical compounds from Indian spices exploiting SARS-CoV-2 main protease as target (edit) |
10.1080/07391102.2020.1763202 |
| 2020-05-02 |
An investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study (edit) |
10.1080/07391102.2020.1763201 |
| 2020-05-02 |
Immune environment modulation in pneumonia patients caused by coronavirus: SARS-CoV, MERS-CoV and SARS-CoV-2 (edit) |
10.18632/AGING.103101 |
| 2020-05-02 |
Smoking and SARS-CoV-2 Disease (COVID-19): Dangerous Liaisons or Confusing Relationships? (edit) |
10.3390/JCM9051321 |
| 2020-05-02 |
The anti-influenza virus drug, arbidol is an efficient inhibitor of SARS-CoV-2 in vitro (edit) |
10.1038/S41421-020-0169-8 |
| 2020-05-02 |
Large-scale, in-house production of viral transport media to support SARS-CoV-2 PCR testing in a multi-hospital healthcare network during the COVID-19 pandemic (edit) |
10.1101/2020.04.29.20085514 |
| 2020-05-02 |
SARS-CoV-2 receptor mutation in Egyptian population (edit) |
10.1101/2020.04.27.20082206 |
| 2020-05-02 |
Comparative transcriptome analysis reveals the intensive early-stage responses of host cells to SARS-CoV-2 infection (edit) |
10.1101/2020.04.30.071274 |
| 2020-05-02 |
On spatial molecular arrangements of SARS-CoV2 genomes of Indian patients (edit) |
10.1101/2020.05.01.071985 |
| 2020-05-02 |
Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospital (edit) |
10.1101/2020.04.27.20082289 |
| 2020-05-02 |
Dysregulation in mTOR/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells (edit) |
10.1101/2020.04.30.070383 |
| 2020-05-02 |
Individual variation in susceptibility or exposure to SARS-CoV-2 lowers the herd immunity threshold (edit) |
10.1101/2020.04.27.20081893 |
| 2020-05-02 |
SARS-CoV2 quantification using RT-dPCR: a faster and safer alternative to assist viral genomic copies assessment using RT-qPCR (edit) |
10.1101/2020.05.01.072728 |
| 2020-05-02 |
Rapidly fatal pneumonitis from immunotherapy and concurrent SARS-CoV-2 infection in a patient with newly diagnosed lung cancer (edit) |
10.1101/2020.04.29.20085738 |
| 2020-05-02 |
SARS-CoV-2 spike protein predicted to form stable complexes with host receptor protein orthologues from mammals (edit) |
10.1101/2020.05.01.072371 |
| 2020-05-02 |
Broad-spectrum antiviral activity of naproxen: from Influenza A to SARS-CoV-2 Coronavirus (edit) |
10.1101/2020.04.30.069922 |
| 2020-05-02 |
Distinct Inductions of and Responses to Type I and Type III Interferons Promote Infections in Two SARS-CoV-2 Isolates (edit) |
10.1101/2020.04.30.071357 |
| 2020-05-02 |
Potent antiviral effect of protoporphyrin IX and verteporfin on SARS-CoV-2 infection (edit) |
10.1101/2020.04.30.071290 |
| 2020-05-02 |
Can Nebulised Heparin Reduce Time to Extubation in SARS CoV 2 The CHARTER Study Protocol (edit) |
10.1101/2020.04.28.20082552 |
| 2020-05-02 |
Validation of an extraction-free RT-PCR protocol for detection of SARS-CoV2 RNA (edit) |
10.1101/2020.04.29.20085910 |
| 2020-05-02 |
Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence Testing in Idaho (edit) |
10.1101/2020.04.27.20082362 |
| 2020-05-02 |
SARS-CoV-2 genomes recovered by long amplicon tiling multiplex approach using nanopore sequencing and applicable to other sequencing platforms (edit) |
10.1101/2020.04.30.069039 |
| 2020-05-02 |
Mutational spectra of SARS-CoV-2 orf1ab polyprotein and Signature mutations in the United States of America (edit) |
10.1101/2020.05.01.071654 |
| 2020-05-02 |
Rampant C->U hypermutation in the genomes of SARS-CoV-2 and other coronaviruses – causes and consequences for their short and long evolutionary trajectories (edit) |
10.1101/2020.05.01.072330 |
| 2020-05-02 |
Computational Electrostatics Predict Variations in SARS-CoV-2 Spike and Human ACE2 Interactions (edit) |
10.1101/2020.04.30.071175 |
| 2020-05-02 |
Ecologic correlation between underlying population level morbidities and COVID-19 case fatality rate among countries infected with SARS-CoV-2 (edit) |
10.1101/2020.04.28.20082370 |
| 2020-05-02 |
Molecular Architecture of Early Dissemination and Evolution of the SARS-CoV-2 Virus in Metropolitan Houston, Texas (edit) |
10.1101/2020.05.01.072652 |
| 2020-05-02 |
How SARS-CoV-2 has Changed the Activities in a Regional Hand Surgery Centre in Italy (edit) |
10.1055/S-0040-1710444 |
| 2020-05-01 |
Official French SARS-CoV-2 guidelines for cancer patients, a triage solution with precision medicine (edit) |
10.2217/CRC-2020-0018 |
| 2020-05-01 |
The Functional Medicine Approach to COVID-19: Primer on SARS-CoV-2 Testing (edit) |
|
| 2020-05-01 |
[SARS-CoV-2 infection: do not neglect neurological symptoms!] (edit) |
|
| 2020-05-01 |
[Routine vaccinations during SARS-CoV-2 epidemics] (edit) |
|
| 2020-05-01 |
Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs (edit) |
10.21203/RS.3.RS-26344/V1 |
| 2020-05-01 |
Importance of Bats in Wildlife: Not Just Carriers of Pandemic SARS-CoV-2 and Other Viruses (edit) |
10.22207/JPAM.14.SPL1.05 |
| 2020-05-01 |
The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak (edit) |
10.1016/J.JAUT.2020.102433 |
| 2020-05-01 |
Coronavirus Disease 2019 (COVID-19) and Pregnancy: What obstetricians need to know (edit) |
10.1016/J.AJOG.2020.02.017 |
| 2020-05-01 |
The explosive epidemic outbreak of novel coronavirus disease 2019 (COVID-19) and the persistent threat of respiratory tract infectious diseases to global health security (edit) |
10.1097/MCP.0000000000000676 |
| 2020-05-01 |
Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV (edit) |
10.1002/JMV.25709 |
| 2020-05-01 |
Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China (edit) |
10.1007/S00392-020-01626-9 |
| 2020-05-01 |
The SARS-CoV-2 outbreak: what we know (edit) |
10.1016/J.IJID.2020.03.004 |
| 2020-05-01 |
Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic? (edit) |
10.1097/HJH.0000000000002450 |
| 2020-05-01 |
The emotional impact of Coronavirus 2019-nCoV (new Coronavirus disease) (edit) |
10.1016/J.PSYCHRES.2020.112915 |
| 2020-05-01 |
COVID-19 infection and rheumatoid arthritis: Faraway, so close! (edit) |
10.1016/J.AUTREV.2020.102523 |
| 2020-05-01 |
[CT imaging features of patients with different clinical types of coronavirus disease 2019 (COVID-19)] (edit) |
|
| 2020-05-01 |
Therapeutic opportunities to manage COVID-19/SARS-CoV-2 infection: Present and future (edit) |
10.4103/IJO.IJO_639_20 |
| 2020-05-01 |
[Follow-up testing of viral nucleic acid in discharged patients with moderate type of 2019 coronavirus disease (COVID-19)] (edit) |
|
| 2020-05-01 |
The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China (edit) |
10.1016/J.CLIM.2020.108393 |
| 2020-05-01 |
Our Response to COVID-19 as Endocrinologists and Diabetologists (edit) |
10.1210/CLINEM/DGAA148 |
| 2020-05-01 |
International Guidelines on Radiation Therapy for Breast Cancer During the COVID-19 Pandemic (edit) |
10.1016/J.CLON.2020.03.006 |
| 2020-05-01 |
Robot assisted surgery during the COVID-19 pandemic, especially for gynecological cancer: a statement of the Society of European Robotic Gynaecological Surgery (SERGS) (edit) |
10.3802/JGO.2020.31.E59 |
| 2020-05-01 |
COVID-19 in the Nuclear Medicine Department, be prepared for ventilation scans as well! (edit) |
10.1097/MNM.0000000000001196 |
| 2020-05-01 |
A British Society of Thoracic Imaging statement: considerations in designing local imaging diagnostic algorithms for the COVID-19 pandemic (edit) |
10.1016/J.CRAD.2020.03.008 |
| 2020-05-01 |
Immune responses and pathogenesis of SARS-CoV-2 during an outbreak in Iran: Comparison with SARS and MERS (edit) |
10.1002/RMV.2107 |
| 2020-05-01 |
[Clinical experience of high-flow nasal cannula oxygen therapy in severe corona virus disease 2019 (COVID-19) patients] (edit) |
|
| 2020-05-01 |
Cardiac and arrhythmic complications in patients with COVID-19 (edit) |
10.1111/JCE.14479 |
| 2020-05-01 |
Traumatic stress in the age of COVID-19: A call to close critical gaps and adapt to new realities (edit) |
10.1037/TRA0000592 |
| 2020-05-01 |
Coronavirus Disease 19 (COVID-19): Implications for Clinical Dental Care (edit) |
10.1016/J.JOEN.2020.03.008 |
| 2020-05-01 |
[Roles of multidisciplinary team (MDT) in diagnosis and treatment of suspected cases of corona virus disease 2019 (COVID-19)] (edit) |
|
| 2020-05-01 |
Perinatal aspects on the covid-19 pandemic: a practical resource for perinatal-neonatal specialists (edit) |
10.1038/S41372-020-0665-6 |
| 2020-05-01 |
COVID-19: its impact on dental schools in Italy, clinical problems in endodontic therapy and general considerations (edit) |
10.1111/IEJ.13291 |
| 2020-05-01 |
COVID-19 and emerging viral infections: The case for interferon lambda (edit) |
10.1084/JEM.20200653 |
| 2020-05-01 |
COVID-19 and vitamin D-Is there a link and an opportunity for intervention? (edit) |
10.1152/AJPENDO.00138.2020 |
| 2020-05-01 |
Can spironolactone be used to prevent COVID-19-induced acute respiratory distress syndrome in patients with hypertension? (edit) |
10.1152/AJPENDO.00136.2020 |
| 2020-05-01 |
Novel Coronavirus (COVID-19): What You Need to Know (edit) |
10.1177/2165079920914947 |
| 2020-05-01 |
COVID-19 and rheumatology: first steps towards a different future? (edit) |
10.1136/ANNRHEUMDIS-2020-217494 |
| 2020-05-01 |
A review of initial data on pregnancy during the COVID-19 outbreak: implications for assisted reproductive treatments (edit) |
10.5935/1518-0557.20200030 |
| 2020-05-01 |
COVID-19, Cancer, and Financial Toxicity (edit) |
10.1188/20.ONF.253-254 |
| 2020-05-01 |
Covid-19, the pandemic war: Implication for neurologists (edit) |
10.1016/J.NEUROL.2020.03.002 |
| 2020-05-01 |
[COVID-19 pandemia: Impact on the cariovascular system. Data of 1st April 2020] (edit) |
10.1016/J.ANCARD.2020.04.001 |
| 2020-05-01 |
Approaches to the management of patients in oral and maxillofacial surgery during COVID-19 pandemic (edit) |
10.1016/J.JCMS.2020.03.011 |
| 2020-05-01 |
Angiotensin-converting enzyme 2 in severe acute respiratory syndrome coronavirus and SARS-CoV-2: A double-edged sword? (edit) |
10.1096/FJ.202000782 |
| 2020-05-01 |
Coronavirus Infections in Children Including COVID-19: An Overview of the Epidemiology, Clinical Features, Diagnosis, Treatment and Prevention Options in Children (edit) |
10.1097/INF.0000000000002660 |
| 2020-05-01 |
[New insights into the seriousness of acute myocardial injury during COVID-19] (edit) |
10.1714/3343.33128 |
| 2020-05-01 |
[Being a cardiologist at the time of SARS-COVID-19: is it time to reconsider our way of working?] (edit) |
10.1714/3343.33133 |
| 2020-05-01 |
[COVID-19 and coronary artery disease: selective and collaborative use of resources during public health crisis] (edit) |
10.1714/3343.33135 |
| 2020-05-01 |
Melatonin: Roles in influenza, Covid-19, and other viral infections (edit) |
10.1002/RMV.2109 |
| 2020-05-01 |
COVID-19 pandemic: Lessons learned and future directions (edit) |
10.4103/IJO.IJO_843_20 |
| 2020-05-01 |
All India Ophthalmological Society - Indian Journal of Ophthalmology consensus statement on preferred practices during the COVID-19 pandemic (edit) |
10.4103/IJO.IJO_871_20 |
| 2020-05-01 |
Effect of COVID-19 related lockdown on ophthalmic practice and patient care in India: Results of a survey (edit) |
10.4103/IJO.IJO_797_20 |
| 2020-05-01 |
A tribute to frontline corona warriors--Doctors and other professionals who sacrificed their life while saving patients during the ongoing COVID-19 pandemic (edit) |
10.4103/IJO.IJO_754_20 |
| 2020-05-01 |
Toolkit for survival: How to run and manage ophthalmic practices during the difficult time of COVID-19 crisis (edit) |
10.4103/IJO.IJO_823_20 |
| 2020-05-01 |
Ophthalmology in the time of corona: Measures taken in a tertiary eye care hospital in Rajasthan against COVID-19 spread (edit) |
10.4103/IJO.IJO_700_20 |
| 2020-05-01 |
Respiratory rehabilitation in elderly patients with COVID-19: A randomized controlled study (edit) |
10.1016/J.CTCP.2020.101166 |
| 2020-05-01 |
Déjà vu: Stimulating open drug discovery for SARS-CoV-2 (edit) |
10.1016/J.DRUDIS.2020.03.019 |
| 2020-05-01 |
[EMCAM (Multiple Sclerosis Autonomous Community of Madrid) document for the management of patients with multiple sclerosis during the SARS-CoV-2 pandemic] (edit) |
10.33588/RN.7009.2020155 |
| 2020-05-01 |
Angry viruses make us sick: a child's depiction of SARS-CoV-2 (edit) |
10.1002/EJI.202070057 |
| 2020-05-01 |
[Current guidance of the German Society of Rheumatology for the care of patients with rheumatic diseases during the SARS-CoV-2/Covid 19 pandemic] (edit) |
10.1007/S00393-020-00799-Y |
| 2020-05-01 |
Spike mutation pipeline reveals the emergence of a more transmissible form of SARS-CoV-2 (edit) |
10.1101/2020.04.29.069054 |
| 2020-05-01 |
Assessment of SARS-CoV-2 Infection Prevalence in Homeless Shelters - Four U.S. Cities, March 27-April 15, 2020 (edit) |
10.15585/MMWR.MM6917E1 |
| 2020-05-01 |
Why the SARS-Cov-2 has prolonged spreading time in children? (edit) |
10.1002/PPUL.24795 |
| 2020-05-01 |
SARS-CoV-2 pneumonia and pulmonary embolism in a 66-year-old female (edit) |
10.20452/PAMW.15333 |
| 2020-05-01 |
Public Health Measures and the Reproduction Number of SARS-CoV-2 (edit) |
10.1001/JAMA.2020.7878 |
| 2020-05-01 |
Early detection of SARS-CoV-2 antibodies in COVID-19 patients as a serologic marker of infection (edit) |
10.1093/CID/CIAA523 |
| 2020-05-01 |
SARS-CoV-2 pandemic and repercussions for male infertility patients: a proposal for the individualized provision of andrological services (edit) |
10.1111/ANDR.12809 |
| 2020-05-01 |
Performing the nasopharyngeal and oropharyngeal swab for 2019-novel coronavirus (SARS-CoV-2) safely: How to dress, undress, and technical notes (edit) |
10.1002/HED.26230 |
| 2020-05-01 |
Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients (edit) |
10.1080/22221751.2020.1762515 |
| 2020-05-01 |
An 81 nucleotide deletion in SARS-CoV-2 ORF7a identified from sentinel surveillance in Arizona (Jan-Mar 2020) (edit) |
10.1128/JVI.00711-20 |
| 2020-05-01 |
How related is SARS-CoV-2 to other coronaviruses? (edit) |
10.1136/VR.M1452 |
| 2020-05-01 |
SARS-CoV-2 productively infects human gut enterocytes (edit) |
10.1126/SCIENCE.ABC1669 |
| 2020-05-01 |
Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir (edit) |
10.1126/SCIENCE.ABC1560 |
| 2020-05-01 |
A rational roadmap for SARS-CoV-2/COVID-19 pharmacotherapeutic research and development. IUPHAR Review 29 (edit) |
10.1111/BPH.15094 |
| 2020-05-01 |
Insights into the inhibitory potential of selective phytochemicals against Mpro of 2019-nCoV: a computer-aided study (edit) |
10.1007/S11224-020-01536-6 |
| 2020-05-01 |
SARS-CoV-2 Infection in Hospitalized Patients with Kidney Disease (edit) |
10.1016/J.EKIR.2020.04.024 |
| 2020-05-01 |
Impact of SARS-CoV-2 infection on neurodegenerative and neuropsychiatric diseases: a delayed pandemic? (edit) |
10.1016/J.NRL.2020.04.002 |
| 2020-05-01 |
The diagnostic value of rapid anti IgM and IgG detecting tests in the identification of patients with SARS CoV-2 virus infection (edit) |
10.1556/650.2020.31859 |
| 2020-05-01 |
Additional safety consideration for azithromycin in the management of SARS-CoV-2 infection (edit) |
10.1503/CMAJ.75427 |
| 2020-05-01 |
Editorial debate: Challenges an oncologist has to face during the SARS-CoV-2 pandemic within a universal healthcare system (edit) |
10.1136/ESMOOPEN-2020-000790 |
| 2020-05-01 |
[Cerebral venous thrombosis and SARS-CoV-2 infection] (edit) |
10.33588/RN.7010.2020204 |
| 2020-05-01 |
Clinical Features and Outcomes of 98 Patients Hospitalized with SARS-CoV-2 Infection in Daegu, South Korea: A Brief Descriptive Study (edit) |
10.3349/YMJ.2020.61.5.431 |
| 2020-05-01 |
SARS-CoV-2 and Eosinophilia (edit) |
10.7754/CLIN.LAB.2020.200248 |
| 2020-05-01 |
Hybridization Chain Reactions Targeting the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (edit) |
10.3390/IJMS21093216 |
| 2020-05-01 |
[Diagnostic efficacy of three test kits for SARS-CoV-2 nucleic acid detection] (edit) |
|
| 2020-05-01 |
The correlation between SARS-CoV-2 infection and rheumatic disease (edit) |
10.1016/J.AUTREV.2020.102557 |
| 2020-05-01 |
Using the diagnostic model based on routine laboratory tests to distinguish patients infected with SARS-CoV-2 from those infected with influenza virus (edit) |
10.1016/J.IJID.2020.04.078 |
| 2020-05-01 |
HiJAKing SARS-CoV-2? The potential role of JAK inhibitors in the management of COVID-19 (edit) |
10.1126/SCIIMMUNOL.ABC5367 |
| 2020-05-01 |
[SARS-CoV-2, a point in the storm] (edit) |
|
| 2020-05-01 |
[Venous thrombotic risk related to SARS-CoV-2 : prevalence, recommendations and perspectives] (edit) |
|
| 2020-05-01 |
SARS-CoV-2 (COVID-19) and Chronic Myeloid Leukemia (CML): a Case Report and Review of ABL Kinase Involvement in Viral Infection (edit) |
10.4084/MJHID.2020.031 |
| 2020-05-01 |
Delivery in Asymptomatic Italian Woman with SARS-CoV-2 Infection (edit) |
10.4084/MJHID.2020.033 |
| 2020-05-01 |
SARS CoV-2 (COVID-19): lessons to be learned by Brazilian Physical Therapists (edit) |
10.1016/J.BJPT.2020.04.004 |
| 2020-05-01 |
Tortoises, hares, and vaccines: A cautionary note for SARS-CoV-2 vaccine development (edit) |
10.1016/J.VACCINE.2020.04.073 |
| 2020-05-01 |
Long-term conditions and severe acute respiratory syndrome SARS-CoV-2 (COVID-19) (edit) |
10.12968/BJCN.2020.25.5.247 |
| 2020-05-01 |
Ultrasonography and SARS-CoV 2 infection: a review of what we know and do not yet know (edit) |
10.11152/MU-2612 |
| 2020-05-01 |
Multicentre Italian study of SARS-CoV-2 infection in children and adolescents, preliminary data as at 10 April 2020 (edit) |
10.2807/1560-7917.ES.2020.25.18.2000600 |
| 2020-05-01 |
Evaluation of commercial and automated SARS-CoV-2 IgG and IgA ELISAs using coronavirus disease (COVID-19) patient samples (edit) |
10.2807/1560-7917.ES.2020.25.18.2000603 |
| 2020-05-01 |
[Lack of clinical evidence for the use of hydroxychloroquine to treat SARS-CoV-2 infection] (edit) |
|
| 2020-05-01 |
Quels liens entre le SARS-CoV-2 et la maladie de Kawasaki ? (edit) |
|
| 2020-05-01 |
Transmission du SARS-CoV-2 chez les nouveau-nés, les enfants et les adolescents symptomatiques (edit) |
|
| 2020-05-01 |
Novel human coronavirus (SARS-CoV-2): A lesson from animal coronaviruses (edit) |
10.1016/J.VETMIC.2020.108693 |
| 2020-05-01 |
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmission in Patients With Cancer Still Being Described (edit) |
10.1016/J.CLON.2020.04.013 |
| 2020-05-01 |
Five-minute point-of-care testing for SARS-CoV-2: Not there yet (edit) |
10.1016/J.JCV.2020.104410 |
| 2020-05-01 |
TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes (edit) |
10.1126/SCIIMMUNOL.ABC3582 |
| 2020-05-01 |
Keeping on the high quality of healthcare in Greek Inflammatory Bowel Disease patients in the SARS-CoV-2 era (edit) |
10.1016/J.CGH.2020.04.076 |
| 2020-05-01 |
How we treat patients with lung cancer during the SARS-CoV-2 pandemic (edit) |
10.1136/ESMOOPEN-2020-000785 |
| 2020-05-01 |
Potential implications of SARS-CoV-2 on pregnancy (edit) |
10.1016/J.TJOG.2020.03.025 |
| 2020-05-01 |
Serology for SARS-CoV-2: Apprehensions, opportunities, and the path forward (edit) |
10.1126/SCIIMMUNOL.ABC6347 |
| 2020-05-01 |
Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19) (edit) |
10.3389/FIMMU.2020.00827 |
| 2020-05-01 |
Points & Pearls: Novel 2019 Coronavirus SARS-CoV-2 (COVID-19) An Overview for Emergency Clinicians (edit) |
|
| 2020-05-01 |
Potential pharmacological perspectives for the treatment/prevention of the SARS-COV-2 infection in opioid dependent patients (edit) |
10.5055/JOM.2020.0564 |
| 2020-05-01 |
Opportunity of periodic monitoring of COVID-19 patients, asymptomatic virus carriers, and postinfectious individuals with IgM/IgG rapid antibody tests among healthcare workers during SARS-CoV-2 pandemic (edit) |
10.1556/650.2020.31862 |
| 2020-05-01 |
COVID-19 Special Column: Principles Behind the Technology for Detecting SARS-CoV-2, the Cause of COVID-19 (edit) |
|
| 2020-05-01 |
SARS-CoV-2 identification in lungs, heart and kidney specimens by transmission and scanning electron microscopy (edit) |
10.26355/EURREV_202005_21217 |
| 2020-05-01 |
[Asymptomatic SARS-CoV-2 infection in children: a clinical analysis of 20 cases] (edit) |
|
| 2020-05-01 |
Identification of variable sites in Sars-CoV-2 and their abundance profiles in time (edit) |
10.1101/2020.04.30.071027 |
| 2020-05-01 |
Regressing SARS-CoV-2 sewage measurements onto COVID-19 burden in the population: a proof-of-concept for quantitative environmental surveillance (edit) |
10.1101/2020.04.26.20073569 |
| 2020-05-01 |
Shedding of infectious SARS-CoV-2 in symptomatic neonates, children and adolescents (edit) |
10.1101/2020.04.27.20076778 |
| 2020-05-01 |
Potential spreading risks and disinfection challenges of medical wastewater by the presence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) viral RNA in septic tanks of fangcang hospital (edit) |
10.1101/2020.04.28.20083832 |
| 2020-05-01 |
Origin of imported SARS-CoV-2 strains in The Gambia identified from Whole Genome Sequences (edit) |
10.1101/2020.04.30.070771 |
| 2020-05-01 |
Fast SARS-CoV-2 detection protocol based on RNA precipitation and RT-qPCR in nasopharyngeal swab samples (edit) |
10.1101/2020.04.26.20081307 |
| 2020-05-01 |
SARS-CoV-2 selectively mimics a cleavable peptide of human ENaC in a strategic hijack of host proteolytic machinery (edit) |
10.1101/2020.04.29.069476 |
| 2020-05-01 |
High frequency of SARS-CoV-2 RNAemia and association with severe disease (edit) |
10.1101/2020.04.26.20080101 |
| 2020-05-01 |
Tracing Back the Temporal Change of SARS-CoV-2 with Genomic Signatures (edit) |
10.1101/2020.04.24.057380 |
| 2020-05-01 |
Susceptibility of tree shrew to SARS-CoV-2 infection (edit) |
10.1101/2020.04.30.029736 |
| 2020-05-01 |
Determining the source of transmission of SARS-CoV-2 infection in a healthcare worker (edit) |
10.1101/2020.04.27.20077016 |
| 2020-05-01 |
ACE2 and TMPRSS2 expression by clinical, HLA, immune, and microbial correlates across 34 human cancers and matched normal tissues: implications for SARS-COV-2 COVID-19 (edit) |
10.1101/2020.04.29.20082867 |
| 2020-05-01 |
False positives in reverse transcription PCR testing for SARS-CoV-2 (edit) |
10.1101/2020.04.26.20080911 |
| 2020-05-01 |
FACT- Frankfurt adjusted COVID-19 testing- a novel method enables high-throughput SARS-CoV-2 screening without loss of sensitivity (edit) |
10.1101/2020.04.28.20074187 |
| 2020-05-01 |
Spatial-temporal variations of atmospheric factors contribute to SARS-CoV-2 outbreak (edit) |
10.1101/2020.04.26.20080846 |
| 2020-05-01 |
[SARS-CoV2 in pediatrics: Beyond the infection] (edit) |
10.1016/J.ANPEDI.2020.04.011 |
| 2020-05-01 |
„Es wird mehrere Pandemie-Impfstoffe geben“ : SARS-CoV-2 / COVID-19 (edit) |
10.1007/S15006-020-0525-5 |
| 2020-05-01 |
Alternative splicing of ACE2 possibly generates variants that may limit the entry of SARS-CoV-2: a potential therapeutic approach using SSOs (edit) |
10.1042/CS20200419 |
| 2020-05-01 |
Therapien gegen COVID-19 — ein Update : SARS-CoV-2-Pandemie (edit) |
10.1007/S15006-020-0505-9 |
| 2020-05-01 |
Drive-Through Testing: A Unique, Efficient Method of Collecting Large Volume of Specimens During the SARS-CoV-2 (COVID-19) Pandemic (edit) |
10.1016/J.MAYOCP.2020.04.030 |
| 2020-05-01 |
SARS-CoV-2 pneumonia with subcutaneous emphysema, mediastinal emphysema, and pneumothorax: A case report (edit) |
10.1097/MD.0000000000020208 |
| 2020-05-01 |
The potential effects of widespread community transmission of SARS-CoV-2 infection in the World Health Organization African Region: a predictive model (edit) |
10.1136/BMJGH-2020-002647 |
| 2020-05-01 |
Cancer datasets and the SARS-CoV-2 pandemic: establishing principles for collaboration (edit) |
10.1136/ESMOOPEN-2020-000825 |
| 2020-05-01 |
Blood supply and transfusion support in southern Italy: findings during the first four weeks of the SARS-CoV-2 pandemic (edit) |
10.2450/2020.0107-20 |
| 2020-05-01 |
Reduction of secondary transmission of SARS-CoV-2 in households by face mask use, disinfection and social distancing: a cohort study in Beijing, China (edit) |
10.1136/BMJGH-2020-002794 |
| 2020-05-01 |
Editorial - Sofosbuvir/Velpatasvir as a combination with strong potential activity against SARS-CoV2 (COVID-19) infection: how to use direct-acting antivirals as broad-spectrum antiviral agents (edit) |
10.26355/EURREV_202005_21297 |
| 2020-05-01 |
No infectious risk of COVID-19 patients with long-term fecal 2019-nCoV nucleic acid positive (edit) |
10.26355/EURREV_202005_21370 |
| 2020-05-01 |
Neurological complications in patients with SARS-CoV-2 infection: a systematic review (edit) |
10.1590/0004-282X20200051 |
| 2020-05-01 |
Asymptotic estimates of SARS-CoV-2 infection counts and their sensitivity to stochastic perturbation (edit) |
10.1063/5.0008834 |
| 2020-05-01 |
Testing animals for SARS-CoV-2 (edit) |
10.1136/VR.M2093 |
| 2020-05-01 |
Letter to the editor: SARS-CoV-2 detection by real-time RT-PCR (edit) |
10.2807/1560-7917.ES.2020.25.21.2000880 |
| 2020-05-01 |
Authors' response: SARS-CoV-2 detection by real-time RT-PCR (edit) |
10.2807/1560-7917.ES.2020.25.21.2001035 |
| 2020-05-01 |
COVID-19 Pandemic: Are There Unique Cutaneous Manifestations in Patients Infected With SARS-CoV-2? (edit) |
|
| 2020-05-01 |
Persistent viral shedding lasting over 60 days in a mild COVID-19 patient with ongoing positive SARS-CoV-2 (edit) |
10.21037/QIMS.2020.04.08 |
| 2020-05-01 |
Should computed tomography (CT) be used as a screening or follow-up tool for asymptomatic patients with SARS-CoV-2 infection? (edit) |
10.21037/QIMS.2020.04.10 |
| 2020-05-01 |
Renin-angiotensin system and SARS-CoV-2 interaction: underlying mechanisms and potential clinical implications (edit) |
10.4149/GPB_2020019 |
| 2020-05-01 |
SARS-CoV-2 in the Employees of a Large University Hospital (edit) |
10.3238/ARZTEBL.2020.0344 |
| 2020-05-01 |
Multidisciplinary team management and cesarean delivery for a Jordanian woman infected with SARS-COV-2: A case report (edit) |
10.1016/J.CRWH.2020.E00212 |
| 2020-05-01 |
The management of orthopedics and traumatology patients during SARS-CoV-2 pandemic (edit) |
10.5152/J.AOTT.2020.20166 |
| 2020-05-01 |
Criminal medical liability in the context of Covid-19 pandemic (edit) |
|
| 2020-05-01 |
Tunisian Recommendations for resumption of Reproductive Medicine activity in the Covid-19 pandemic (edit) |
|
| 2020-05-01 |
Attitudes of health professionals towards the response to the COVID-19 pandemic in Maghreb (edit) |
|
| 2020-05-01 |
A follow-up study of children infected with SARS-CoV-2 from western China (edit) |
10.21037/ATM-20-3192 |
| 2020-05-01 |
Re-appearance of the SARS-CoV-2 virus nucleic acid in patients recovering from COVID-19 (edit) |
10.21037/ATM-20-2491 |
| 2020-05-01 |
The positive of stool test for SARS-CoV-2: a report of 9 cases in Changsha, outside Wuhan, China (edit) |
10.21037/ATM-20-2165 |
| 2020-05-01 |
Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection (edit) |
10.1503/CMAJ.200978 |
| 2020-05-01 |
[Neurological aspects of the COVID-19 pandemic caused by the SARS-CoV-2 coronavirus] (edit) |
10.18071/ISZ.73.0171 |
| 2020-05-01 |
Coagulation Panel in Patients with SARS-CoV2 Infection (COVID-19) (edit) |
|
| 2020-05-01 |
Knowledge, Awareness and Practice of Health care Professionals amid SARS-CoV-2, Corona Virus Disease Outbreak (edit) |
10.12669/PJMS.36.COVID19-S4.2704 |
| 2020-05-01 |
Parosmia as an Early Symptom of Acute SARS-CoV-2 Infection (edit) |
10.3238/ARZTEBL.2020.0328 |
| 2020-05-01 |
Intracerebral Hemorrhage and SARS-CoV-2: Association or Causation (edit) |
|
| 2020-05-01 |
[Infection prevention in dental care during the outbreak of SARS-CoV-2] (edit) |
10.5177/NTVT.2020.05.20031 |
| 2020-05-01 |
Impact of SARS-Cov2 on Endoscopic Trans-Nasal Skull Base Surgeries (edit) |
|
| 2020-05-01 |
National sero-surveillance to monitor the trend of SARS-CoV-2 infection transmission in India: Protocol for community-based surveillance (edit) |
10.4103/IJMR.IJMR_1818_20 |
| 2020-05-01 |
Development of indigenous IgG ELISA for the detection of anti-SARS-CoV-2 IgG (edit) |
10.4103/IJMR.IJMR_2232_20 |
| 2020-05-01 |
Healthcare workers & SARS-CoV-2 infection in India: A case-control investigation in the time of COVID-19 (edit) |
10.4103/IJMR.IJMR_2234_20 |
| 2020-05-01 |
Evaluation of the susceptibility of mice & hamsters to SARS-CoV-2 infection (edit) |
10.4103/IJMR.IJMR_2235_20 |
| 2020-05-01 |
Pandemic SARS-CoV-2 laboratory preparedness in India: An opportunity beyond diagnostics (edit) |
10.4103/IJMR.IJMR_1548_20 |
| 2020-05-01 |
What settings have been linked to SARS-CoV-2 transmission clusters? (edit) |
10.12688/WELLCOMEOPENRES.15889.1 |
| 2020-05-01 |
SARS-CoV-2 Pandemic--A Complicated Case of Appendicitis (edit) |
10.3238/ARZTEBL.2020.0364 |
| 2020-05-01 |
[Discussion and prospect of infusion of NK cells in the treatment of SARS-CoV-2 infection] (edit) |
|
| 2020-05-01 |
Transmission and prevention of SARS-CoV-2 (COVID-19) in prisons (edit) |
10.18176/RESP.00015 |
| 2020-05-01 |
[Comparative analysis of structural characteristics and epitopes in S proteins between SARS-CoV-2 and SARS-CoV] (edit) |
10.3785/J.ISSN.1008-9292.2020.06.06 |
| 2020-05-01 |
How to Face the Post-SARS-CoV-2 Outbreak Era in Private Dental Practice: Current Evidence for Avoiding Cross-infections (edit) |
10.4103/JISPCD.JISPCD_202_20 |
| 2020-05-01 |
Qui habitat: coexistence or extinction of SARS-CoV-2? (edit) |
10.1111/1469-8676.12881 |
| 2020-05-01 |
Acute transverse myelitis associated with SARS-CoV-2: A Case-Report (edit) |
10.1016/J.BBIH.2020.100091 |
| 2020-05-01 |
SARS-CoV2: Diagnostic tests available to the clinician (edit) |
|
| 2020-05-01 |
Non-Oncological PET/CT imaging during SARS-CoV-2 pandemic (edit) |
|
| 2020-04-30 |
Identification of Drugs Blocking SARS-CoV-2 Infection using Human Pluripotent Stem Cell-derived Colonic Organoids (edit) |
10.21203/RS.3.RS-24782/V1 |
| 2020-04-30 |
Has India met this enemy before? From an eternal optimist’s perspective: SARS-CoV-2 (edit) |
|
| 2020-04-30 |
An assessment of real-time RT-PCR kits for SARS-CoV-2 detection (edit) |
10.7883/YOKEN.JJID.2020.108 |
| 2020-04-30 |
Characteristics of SARS-CoV-2 isolated from asymptomatic carrier in Tokyo (edit) |
10.7883/YOKEN.JJID.2020.137 |
| 2020-04-30 |
SARS-CoV-2 will continue to circulate in the human population: an opinion from the point of view of the virus-host relationship (edit) |
10.1007/S00011-020-01352-Y |
| 2020-04-30 |
SARS-CoV-2 virus and liver expression of host receptors: Putative mechanisms of liver involvement in COVID-19 (edit) |
10.1111/LIV.14500 |
| 2020-04-30 |
Atypical Imaging Findings in Leukemia With SARS-CoV-2 Infection (edit) |
10.2214/AJR.20.23154 |
| 2020-04-30 |
Second-Trimester Miscarriage in a Pregnant Woman With SARS-CoV-2 Infection (edit) |
10.1001/JAMA.2020.7233 |
| 2020-04-30 |
Protecting healthcare workers from inhaled SARS-CoV-2 virus (edit) |
10.1093/OCCMED/KQAA077 |
| 2020-04-30 |
Co-infection in SARS-CoV-2 infected Patients: Where Are Influenza Virus and Rhinovirus/Enterovirus? (edit) |
10.1002/JMV.25953 |
| 2020-04-30 |
Comment on "The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients" (edit) |
10.1002/JMV.25960 |
| 2020-04-30 |
Povidone-iodine gargle as a prophylactic intervention to interrupt the transmission of SARS-CoV-2 (edit) |
10.1111/ODI.13378 |
| 2020-04-30 |
Emergency Room Neurology in times of COVID-19: Malignant Ischemic Stroke and SARS-COV2 Infection (edit) |
10.1111/ENE.14286 |
| 2020-04-30 |
Characteristics and diagnosis rate of 5,630 subjects receiving SARS-CoV-2 nucleic acid tests from Wuhan, China (edit) |
10.1172/JCI.INSIGHT.137662 |
| 2020-04-30 |
Modeling SARS-CoV-2 positivity using laboratory data: timing is everything (edit) |
10.1093/CLINCHEM/HVAA108 |
| 2020-04-30 |
Does Cigarette Smoking Protect Against SARS-CoV-2 Infection? (edit) |
10.1093/NTR/NTAA073 |
| 2020-04-30 |
Response to "Dose rationale for favipiravir use in patients infected with SARS-CoV-2" (edit) |
10.1002/CPT.1878 |
| 2020-04-30 |
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing (edit) |
10.1038/S41586-020-2286-9 |
| 2020-04-30 |
Clinical course and outcome of 107 patients infected with the novel coronavirus, SARS-CoV-2, discharged from two hospitals in Wuhan, China (edit) |
10.1186/S13054-020-02895-6 |
| 2020-04-30 |
SARS-CoV-2 pandemic and the cardiovascular system: What the non-cardiologist needs to know (edit) |
10.7861/CLINMED.2020-0158 |
| 2020-04-30 |
Status of SARS-CoV-2 in cerebrospinal fluid of patients with COVID-19 and stroke (edit) |
10.1136/JNNP-2020-323522 |
| 2020-04-30 |
SARS-CoV-2-reactive T cells in patients and healthy donors (edit) |
10.1038/S41577-020-0333-2 |
| 2020-04-30 |
Inactivated vaccine for SARS-CoV-2 (edit) |
10.1038/S41577-020-0334-1 |
| 2020-04-30 |
Editorial: Nicotine and SARS-CoV-2: COVID-19 may be a disease of the nicotinic cholinergic system (edit) |
10.1016/J.TOXREP.2020.04.012 |
| 2020-04-30 |
Radiological findings for diagnosis of SARS-CoV-2 pneumonia (COVID-19) (edit) |
10.1016/J.MEDCLE.2020.03.004 |
| 2020-04-30 |
Early histologic findings of pulmonary SARS-CoV-2 infection detected in a surgical specimen (edit) |
10.1007/S00428-020-02829-1 |
| 2020-04-30 |
[Deaths in nine regions of Italy in February/March 2020: "Mortality Excess Loupe" for SARS-CoV-2/COVID-19-Epidemiology in Germany] (edit) |
10.1055/A-1160-5859 |
| 2020-04-30 |
Special Considerations in the Management of Patients with Myelodysplastic Syndrome / Myeloproliferative Neoplasm Overlap Syndromes During the SARS-CoV-2 Pandemic (edit) |
10.1002/AJH.25853 |
| 2020-04-30 |
Thromboembolic Events in Patients with SARS-CoV-2 (edit) |
10.1016/J.JVS.2020.04.488 |
| 2020-04-30 |
Liu Shen capsule shows antiviral and anti-inflammatory abilities against novel coronavirus SARS-CoV-2 via suppression of NF-κB signaling pathway (edit) |
10.1016/J.PHRS.2020.104850 |
| 2020-04-30 |
Possible use of the mucolytic drug, bromhexine hydrochloride, as a prophylactic agent against SARS-CoV-2 infection based on its action on the Transmembrane Serine Protease 2 (edit) |
10.1016/J.PHRS.2020.104853 |
| 2020-04-30 |
Admission hyperglycemia and radiological findings of SARS-CoV2 in patients with and without diabetes (edit) |
10.1016/J.DIABRES.2020.108185 |
| 2020-04-30 |
Lower detection rates of SARS-COV2 antibodies in cancer patients vs healthcare workers after symptomatic COVID-19 (edit) |
10.1016/J.ANNONC.2020.04.475 |
| 2020-04-30 |
Low rate of SARS-CoV-2 spread among health care personnel using ordinary personal protection equipment in a medium-incidence setting (edit) |
10.1016/J.CMI.2020.04.042 |
| 2020-04-30 |
Environmental contamination of SARS-CoV-2 in healthcare premises (edit) |
10.1016/J.JINF.2020.04.034 |
| 2020-04-30 |
Value and Challenges: Nucleic Acid Amplification Tests for SARS-CoV-2 in Hospitalized COVID-19 Patients (edit) |
10.1016/J.JINF.2020.04.036 |
| 2020-04-30 |
French ICUs fight back: An example of regional ICU organisation to tackle the SARS-CoV-2 outbreak (edit) |
10.1016/J.ACCPM.2020.03.018 |
| 2020-04-30 |
No evidence for an increased liver uptake of SARS-CoV-2 in metabolic associated fatty liver disease (edit) |
10.1016/J.JHEP.2020.04.035 |
| 2020-04-30 |
Bioinformatic analysis and identification of single-stranded RNA sequences recognized by TLR7/8 in the SARS-CoV-2, SARS-CoV, and MERS-CoV genomes (edit) |
10.1016/J.MICINF.2020.04.009 |
| 2020-04-30 |
Molecular mimicry between SARS-CoV-2 and respiratory pacemaker neurons (edit) |
10.1016/J.AUTREV.2020.102556 |
| 2020-04-30 |
SARS-CoV-2 infection complicated by inflammatory syndrome. Could high-dose human immunoglobulin for intravenous use (IVIG) be beneficial? (edit) |
10.1016/J.AUTREV.2020.102559 |
| 2020-04-30 |
Single-cell transcriptome analysis of the novel coronavirus (SARS-CoV-2) associated gene ACE2 expression in normal and non-obstructive azoospermia (NOA) human male testes (edit) |
10.1007/S11427-020-1705-0 |
| 2020-04-30 |
The SARS-CoV-2 Exerts a Distinctive Strategy for Interacting with the ACE2 Human Receptor (edit) |
10.3390/V12050497 |
| 2020-04-30 |
Codon Usage and Phenotypic Divergences of SARS-CoV-2 Genes (edit) |
10.3390/V12050498 |
| 2020-04-30 |
[How to approach management of surgical vitreoretinal disease during the SARS-CoV-2 Covid-19 pandemic?] (edit) |
10.1016/J.JFO.2020.04.011 |
| 2020-04-30 |
The implications of preliminary screening and diagnosis: Clinical characteristics of 33 mild patients with SARS-CoV-2 infection in Hunan, China (edit) |
10.1016/J.JCV.2020.104397 |
| 2020-04-30 |
Arterial Mesenteric Thrombosis as a Complication of SARS-CoV-2 Infection (edit) |
10.12890/2020_001690 |
| 2020-04-30 |
Biochemical characterization of SARS-CoV-2 nucleocapsid protein (edit) |
10.1016/J.BBRC.2020.04.136 |
| 2020-04-30 |
Could the Inhibition of Endo-Lysosomal Two-Pore Channels (TPCs) by the Natural Flavonoid Naringenin Represent an Option to Fight SARS-CoV-2 Infection? (edit) |
10.3389/FMICB.2020.00970 |
| 2020-04-30 |
Potential SARS-CoV-2 Preimmune IgM Epitopes (edit) |
10.3389/FIMMU.2020.00932 |
| 2020-04-30 |
Are Children Most of the Submerged Part of SARS-CoV-2 Iceberg? (edit) |
10.3389/FPED.2020.00213 |
| 2020-04-30 |
The Impact of the Current SARS-CoV-2 Pandemic on Neonatal Care (edit) |
10.3389/FPED.2020.00247 |
| 2020-04-30 |
Activity profiling and structures of inhibitor-bound SARS-CoV-2-PLpro protease provides a framework for anti-COVID-19 drug design (edit) |
10.1101/2020.04.29.068890 |
| 2020-04-30 |
SARS-CoV-2 Spike S1 Receptor Binding Domain undergoes Conformational Change upon Interaction with Low Molecular Weight Heparins (edit) |
10.1101/2020.04.29.068486 |
| 2020-04-30 |
Evaluation of 19 antiviral drugs against SARS-CoV-2 Infection (edit) |
10.1101/2020.04.29.067983 |
| 2020-04-30 |
Glycosaminoglycans induce conformational change in the SARS-CoV-2 Spike S1 Receptor Binding Domain (edit) |
10.1101/2020.04.29.068767 |
| 2020-04-30 |
Noncanonical junctions in subgenomic RNAs of SARS-CoV-2 lead to variant open reading frames (edit) |
10.1101/2020.04.28.066951 |
| 2020-04-30 |
An engineered stable mini-protein to plug SARS-Cov-2 Spikes (edit) |
10.1101/2020.04.29.067728 |
| 2020-04-30 |
Inferred duration of infectious period of SARS-CoV-2: rapid scoping review and analysis of available evidence for asymptomatic and symptomatic COVID-19 cases (edit) |
10.1101/2020.04.25.20079889 |
| 2020-04-30 |
A collection of designed peptides to target SARS-Cov-2 – ACE2 interaction: PepI-Covid19 database (edit) |
10.1101/2020.04.28.051789 |
| 2020-04-30 |
Genetic structure of SARS-CoV-2 in Western Germany reflects clonal superspreading and multiple independent introduction events (edit) |
10.1101/2020.04.25.20079517 |
| 2020-04-30 |
Increased travel times to United States SARS-CoV-2 testing sites: a spatial modeling study (edit) |
10.1101/2020.04.25.20074419 |
| 2020-04-30 |
Controlling the SARS-CoV-2 outbreak, insights from large scale whole genome sequences generated across the world (edit) |
10.1101/2020.04.28.066977 |
| 2020-04-30 |
Validation of a single-step, single-tube reverse transcription-loop-mediated isothermal amplification assay for rapid detection of SARS-CoV-2 RNA (edit) |
10.1101/2020.04.28.067363 |
| 2020-04-30 |
SUCCESSFUL MANUFACTURING OF CLINICAL-GRADE SARS-CoV-2 SPECIFIC T CELLS FOR ADOPTIVE CELL THERAPY (edit) |
10.1101/2020.04.24.20077487 |
| 2020-04-30 |
Analyses of spike protein from first deposited sequences of SARS-CoV2 from West Bengal, India (edit) |
10.1101/2020.04.28.066985 |
| 2020-04-30 |
Angiotensin II suppression in SARS-CoV-2 infection: a therapeutic approach (edit) |
10.1016/J.NEFRO.2020.04.006 |
| 2020-04-30 |
Potential risks of SARS-CoV-2 infection on reproductive health (edit) |
10.1016/J.RBMO.2020.04.018 |
| 2020-04-30 |
The biological characteristics of SARS-CoV-2 spike protein Pro330-Leu650 (edit) |
10.1016/J.VACCINE.2020.04.070 |
| 2020-04-30 |
SARS-CoV-2 epidemic in India: epidemiological features and in silico analysis of the effect of interventions (edit) |
10.12688/F1000RESEARCH.23496.1 |
| 2020-04-30 |
Clinical ethics during the Covid-19 pandemic: Missing the trees for the forest (edit) |
10.20529/IJME.2020.053 |
| 2020-04-30 |
Use of Spironolactone in SARS-CoV-2 ARDS Patients (edit) |
10.5152/TJAR.2020.569 |
| 2020-04-30 |
Repurposing of known anti-virals as potential inhibitors for SARS-CoV-2 main protease using molecular docking analysis (edit) |
10.6026/97320630016301 |
| 2020-04-30 |
Molecular docking analysis of Withaferin A from Withania somnifera with the Glucose regulated protein 78 (GRP78) receptor and the SARS-CoV-2 main protease (edit) |
10.6026/97320630016411 |
| 2020-04-30 |
SARS-CoV-2 in Iceland (edit) |
10.1126/SCIENCE.368.6490.485-D |
| 2020-04-30 |
HIV and SARS-CoV-2 co-infection: The diagnostic challenges of dual pandemics (edit) |
10.7196/SAMJ.2020.V110I6.14825 |
| 2020-04-29 |
STRUCTURE OF THE SARS-CoV-2 ORF7A ENCODED ACCESSORY PROTEIN (edit) |
10.2210/PDB6W37/PDB |
| 2020-04-29 |
High-resolution structure of the SARS-CoV-2 NSP3 Macro X domain (edit) |
10.2210/PDB6WEY/PDB |
| 2020-04-29 |
An in-silico evaluation of different Saikosaponins for their potency against SARS-CoV-2 using NSP15 and fusion spike glycoprotein as targets (edit) |
10.1080/07391102.2020.1762741 |
| 2020-04-29 |
The Effects of the COVID-19/SARS-CoV-2 Pandemic Outbreak on Otolaryngology Activity in Italy (edit) |
10.1177/0145561320923893 |
| 2020-04-29 |
Which Dermatology Patients Attend to Dermatology Outpatient Clinics During the SARS-CoV-2 Outbreak in Turkey and What Happened to Them? (edit) |
10.1111/DTH.13470 |
| 2020-04-29 |
The Effect of Chloroquine, Hydroxychloroquine and Azithromycin on the Corrected QT Interval in Patients with SARS-CoV-2 Infection (edit) |
10.1161/CIRCEP.120.008662 |
| 2020-04-29 |
HIV/SARS-CoV-2 co-infected patients in Istanbul, Turkey (edit) |
10.1002/JMV.25955 |
| 2020-04-29 |
Prolonged SARS-CoV-2 RNA shedding: Not a rare phenomenon (edit) |
10.1002/JMV.25952 |
| 2020-04-29 |
Developing Vaccines for SARS-CoV-2 and Future Epidemics and Pandemics: Applying Lessons from Past Outbreaks (edit) |
10.1089/HS.2020.0043 |
| 2020-04-29 |
Response to "Quantitative clinical pharmacology input to SARS-CoV-2 therapeutics should be based on robust data" (edit) |
10.1002/CPT.1873 |
| 2020-04-29 |
Quantitative clinical pharmacology input to SARS-CoV-2 therapeutics should be based on robust data (edit) |
10.1002/CPT.1872 |
| 2020-04-29 |
Hyposalivation as a potential risk for SARS-CoV-2 infection: Inhibitory role of saliva (edit) |
10.1111/ODI.13375 |
| 2020-04-29 |
B Cells, Viruses, and the SARS-CoV-2/COVID-19 Pandemic of 2020 (edit) |
10.1089/VIM.2020.0055 |
| 2020-04-29 |
Comparison of Commercially Available and Laboratory Developed Assays for in vitro Detection of SARS-CoV-2 in Clinical Laboratories (edit) |
10.1128/JCM.00821-20 |
| 2020-04-29 |
Putative contributions of circadian clock and sleep in the context of SARS-CoV-2 infection (edit) |
10.1183/13993003.01023-2020 |
| 2020-04-29 |
SARS-CoV-2 self-isolation: recommendations for people with a vision impairment (edit) |
10.1038/S41433-020-0917-X |
| 2020-04-29 |
Antibody responses to SARS-CoV-2 in patients with COVID-19 (edit) |
10.1038/S41591-020-0897-1 |
| 2020-04-29 |
The Need for Diabetes Care Customization in the ICU at the Time of SARS-CoV-2 Outbreak (edit) |
10.1007/S13300-020-00824-Y |
| 2020-04-29 |
Dose rationale for favipiravir use in patients infected with SARS-CoV-2 (edit) |
10.1002/CPT.1877 |
| 2020-04-29 |
Decoding the evolution and transmissions of the novel pneumonia coronavirus (SARS-CoV-2 / HCoV-19) using whole genomic data (edit) |
10.24272/J.ISSN.2095-8137.2020.022 |
| 2020-04-29 |
Epitope based vaccine prediction for SARS-COV-2 by deploying immuno-informatics approach (edit) |
10.1016/J.IMU.2020.100338 |
| 2020-04-29 |
Does vitamin D status impact mortality from SARS-CoV-2 infection? (edit) |
10.1016/J.MEDIDD.2020.100041 |
| 2020-04-29 |
Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza (edit) |
10.1016/J.CELL.2020.04.020 |
| 2020-04-29 |
Evidence of short-range aerosol transmission of SARS-CoV-2 and call for universal airborne precautions for anesthesiologists during the COVID-19 pandemic (edit) |
10.1213/ANE.0000000000004933 |
| 2020-04-29 |
Bee venom and SARS-CoV-2 (edit) |
10.1016/J.TOXICON.2020.04.105 |
| 2020-04-29 |
Antiviral activities of type I interferons to SARS-CoV-2 infection (edit) |
10.1016/J.ANTIVIRAL.2020.104811 |
| 2020-04-29 |
Putting some context to the aerosolization debate around SARS-CoV-2 (edit) |
10.1016/J.JHIN.2020.04.040 |
| 2020-04-29 |
SARS-CoV-2 positivity in a discharged COVID-19 patient: A Case report (edit) |
10.1016/J.CMI.2020.04.032 |
| 2020-04-29 |
Comparative seasonalities of influenza A, B and 'common cold' coronaviruses - setting the scene for SARS-CoV-2 infections and possible unexpected host immune interactions (edit) |
10.1016/J.JINF.2020.04.032 |
| 2020-04-29 |
SARS-CoV2 entry and spread in the lymphatic drainage system of the brain (edit) |
10.1016/J.BBI.2020.04.080 |
| 2020-04-29 |
Non-SARS CoV2 positive critical patients: Sons of a lesser God? (edit) |
10.1016/J.EJIM.2020.04.047 |
| 2020-04-29 |
Gynecological malignancies with asymptomatic SARS-CoV-2 infection during the convalescence of outbreak (edit) |
10.1016/J.YGYNO.2020.04.709 |
| 2020-04-29 |
SARS-CoV-2 infection and obesity: Common inflammatory and metabolic aspects (edit) |
10.1016/J.DSX.2020.04.033 |
| 2020-04-29 |
A single centre study of viral community-acquired pneumonia in children: No evidence of SARS-CoV-2 from October 2019 to March 2020 (edit) |
10.1016/J.JCV.2020.104385 |
| 2020-04-29 |
Operative team checklist for aerosol generating procedures to minimise exposure of healthcare workers to SARS-CoV-2 (edit) |
10.1016/J.IJPORL.2020.110075 |
| 2020-04-29 |
Viral detection and serological response in critically ill patients with SARS-CoV-2. Implications for isolation withdrawal (edit) |
10.1016/J.MEDIN.2020.04.014 |
| 2020-04-29 |
Elective Surgery During the SARS-CoV-2 Pandemic (COVID-19): A Morbimortality Analysis and Recommendations on Patient Prioritisation and Security Measures (edit) |
10.1016/J.CIRESP.2020.04.029 |
| 2020-04-29 |
Comparison of four new commercial serologic assays for determination of SARS-CoV-2 IgG (edit) |
10.1016/J.JCV.2020.104394 |
| 2020-04-29 |
SARS-CoV-2 and gastrointestinal tract: The dark side of the pandemic (edit) |
10.1016/J.DLD.2020.04.028 |
| 2020-04-29 |
A model for 2019-nCoV infection with treatment (edit) |
10.1101/2020.04.24.20077958 |
| 2020-04-29 |
Epidemiological and clinical characteristics of discharged patients infected with SARS-CoV-2 on the Qinghai plateau (edit) |
10.1101/2020.04.23.20077644 |
| 2020-04-29 |
No Detectable Surge in SARS-CoV-2 Transmission due to the April 7, 2020 Wisconsin Election (edit) |
10.1101/2020.04.24.20078345 |
| 2020-04-29 |
Sequential informed pooling approach to detect SARS-CoV2 infection (edit) |
10.1101/2020.04.24.20077966 |
| 2020-04-29 |
On the estimation of the total number of SARS-CoV-2 infections (edit) |
10.1101/2020.04.23.20077446 |
| 2020-04-29 |
Effectiveness of isolation, testing, contact tracing and physical distancing on reducing transmission of SARS-CoV-2 in different settings (edit) |
10.1101/2020.04.23.20077024 |
| 2020-04-29 |
Test performance evaluation of SARS-CoV-2 serological assays (edit) |
10.1101/2020.04.25.20074856 |
| 2020-04-29 |
FIRST DETECTION OF SARS-COV-2 IN UNTREATED WASTEWATERS IN ITALY (edit) |
10.1101/2020.04.25.20079830 |
| 2020-04-29 |
Interim Analysis of Pandemic Coronavirus Disease 2019 (COVID-19) and the SARS-CoV-2 virus in Latin America and the Caribbean: Morbidity, Mortality and Molecular Testing Trends in the Region (edit) |
10.1101/2020.04.25.20079863 |
| 2020-04-29 |
Genomics of Indian SARS-CoV-2: Implications in genetic diversity, possible origin and spread of virus (edit) |
10.1101/2020.04.25.20079475 |
| 2020-04-29 |
The role of asymptomatic SARS-CoV-2 infections: rapid living systematic review and meta-analysis (edit) |
10.1101/2020.04.25.20079103 |
| 2020-04-29 |
Pooled RNA sample reverse transcriptase real time PCR assay for SARS CoV-2 infection: a reliable, faster and economical method. (edit) |
10.1101/2020.04.25.20079095 |
| 2020-04-29 |
The natural history and transmission potential of asymptomatic SARS-CoV-2 infection (edit) |
10.1101/2020.04.27.20082347 |
| 2020-04-29 |
Cotton tipped plastic swabs for SARS-CoV-2 RT-qPCR diagnosis to prevent supplies shortage. (edit) |
10.1101/2020.04.28.20079947 |
| 2020-04-29 |
Intra-host site-specific polymorphisms of SARS-CoV-2 is consistent across multiple samples and methodologies (edit) |
10.1101/2020.04.24.20078691 |
| 2020-04-29 |
RNA-GPS Predicts SARS-CoV-2 RNA Localization to Host Mitochondria and Nucleolus (edit) |
10.1101/2020.04.28.065201 |
| 2020-04-29 |
SARS-CoV-2 CT-scan dataset: A large dataset of real patients CT scans for SARS-CoV-2 identification (edit) |
10.1101/2020.04.24.20078584 |
| 2020-04-29 |
Heparin inhibits cellular invasion by SARS-CoV-2: structural dependence of the interaction of the surface protein (spike) S1 receptor binding domain with heparin (edit) |
10.1101/2020.04.28.066761 |
| 2020-04-28 |
Plasma metabolomic and lipidomic alterations associated with COVID-19 (edit) |
10.1093/NSR/NWAA086 |
| 2020-04-28 |
Diagnosing COVID-19: The Disease and Tools for Detection (edit) |
10.1021/ACSNANO.0C02624 |
| 2020-04-28 |
Case Report of a SARS-CoV-2 Infection in a Patient With Ulcerative Colitis on Tofacitinib (edit) |
10.1093/IBD/IZAA093 |
| 2020-04-28 |
Tracheotomy in the SARS-CoV-2 Pandemic (edit) |
10.1002/HED.26214 |
| 2020-04-28 |
The Importance Of Naturally Attenuated Sars-Cov-2 In The Fight Against Covid-19 (edit) |
10.1111/1462-2920.15039 |
| 2020-04-28 |
Isolation of Infectious SARS-CoV-2 from Urine of a COVID-19 Patient (edit) |
10.1080/22221751.2020.1760144 |
| 2020-04-28 |
Cats under the shadow of the SARS-CoV-2 pandemic (edit) |
10.1111/TBED.13599 |
| 2020-04-28 |
Long-term Coexistence of SARS-CoV-2 with Antibody Response in COVID-19 Patients (edit) |
10.1002/JMV.25946 |
| 2020-04-28 |
A Novel Plan to Deal with SARS-CoV-2 and COVID-19 Disease (edit) |
10.1002/JMV.25945 |
| 2020-04-28 |
Covid-19, Coronavirus, SARS-CoV-2 and the small bowel (edit) |
10.17235/REED.2020.7137/2020 |
| 2020-04-28 |
Pandemic responses: Planning to neutralize SARS-CoV-2 and prepare for future outbreaks (edit) |
10.1371/JOURNAL.PMED.1003123 |
| 2020-04-28 |
SARS-CoV-2 Serology: Much Hype, Little Data (edit) |
10.1093/CLINCHEM/HVAA107 |
| 2020-04-28 |
Rapid detection of SARS-CoV-2 in saliva: Can an endodontist take the lead in point-of-care COVID-19 testing? (edit) |
10.1111/IEJ.13317 |
| 2020-04-28 |
Analysis of the susceptibility of lung cancer patients to SARS-CoV-2 infection (edit) |
10.1186/S12943-020-01209-2 |
| 2020-04-28 |
Shining a light on the evidence for hydroxychloroquine in SARS-CoV-2 (edit) |
10.1186/S13054-020-02894-7 |
| 2020-04-28 |
COVID-19: ICU delirium management during SARS-CoV-2 pandemic (edit) |
10.1186/S13054-020-02882-X |
| 2020-04-28 |
Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues (edit) |
10.1186/S40249-020-00662-X |
| 2020-04-28 |
Patients with Cancer Appear More Vulnerable to SARS-COV-2: A Multicenter Study during the COVID-19 Outbreak (edit) |
10.1158/2159-8290.CD-20-0422 |
| 2020-04-28 |
Response to 'Is there a future for hydroxychloroquine/chloroquine in prevention of SARS-CoV-2 infection (COVID-19)?' by Moiseev et al (edit) |
10.1136/ANNRHEUMDIS-2020-217636 |
| 2020-04-28 |
Preliminary recommendations of the German Society of Rheumatology (DGRh eV) for the management of patients with inflammatory rheumatic diseases during the SARS-CoV-2/Covid-19 pandemic (edit) |
10.1136/ANNRHEUMDIS-2020-217628 |
| 2020-04-28 |
The Immunocompromised Transplant Recipient and SARS-CoV-2 Infection (edit) |
10.1681/ASN.2020040416 |
| 2020-04-28 |
Outpatient Management of the Kidney Transplant Recipient during the SARS-CoV-2 Virus Pandemic (edit) |
10.2215/CJN.04510420 |
| 2020-04-28 |
Treatment of Proximal Femoral Fragility Fractures in Patients with COVID-19 During the SARS-CoV-2 Outbreak in Northern Italy (edit) |
10.2106/JBJS.20.00617 |
| 2020-04-28 |
Pathological evidence for residual SARS-CoV-2 in pulmonary tissues of a ready-for-discharge patient (edit) |
10.1038/S41422-020-0318-5 |
| 2020-04-28 |
Innovative "Bring-Service-Near-Your-Home" Operations under Corona-Virus (COVID-19/SARS-CoV-2) Outbreak: Can Logistics Become the Messiah? (edit) |
10.1016/J.TRE.2020.101961 |
| 2020-04-28 |
Structural elucidation of SARS-CoV-2 vital proteins: Computational methods reveal potential drug candidates against main protease, Nsp12 polymerase and Nsp13 helicase (edit) |
10.1016/J.JPHA.2020.04.008 |
| 2020-04-28 |
Clinical presentations and outcomes of SARS-CoV-2 infected pneumonia in pregnant women and health status of their neonates (edit) |
10.1016/J.SCIB.2020.04.040 |
| 2020-04-28 |
SARS-CoV-2 and Bats: From Flight to Fighting COVID-19 (edit) |
10.1016/J.JACBTS.2020.04.012 |
| 2020-04-28 |
Group Testing for SARS-CoV-2: Forward to the Past? (edit) |
10.1007/S41669-020-00217-8 |
| 2020-04-28 |
Response of ophthalmologists in Israel to the novel coronavirus (2019-nCoV) outbreak (edit) |
10.1007/S00417-020-04694-9 |
| 2020-04-28 |
Epidemiological and clinical features of asymptomatic patients with SARS-CoV-2 infection (edit) |
10.1002/JMV.25944 |
| 2020-04-28 |
SARS-CoV-2 and the Hidden Carriers - Sewage, Feline, and Blood Transfusion (edit) |
10.1002/JMV.25956 |
| 2020-04-28 |
The ethical challenges of the SARS-CoV-2 pandemic in the global south and the global north - same and different (edit) |
10.1111/DEWB.12263 |
| 2020-04-28 |
Surgical management of suspected or confirmed SARS-CoV-2 (COVID-19)-positive patients: a model stemming from the experience at Level III Hospital in Emilia-Romagna, Italy (edit) |
10.1007/S00068-020-01377-2 |
| 2020-04-28 |
SARS-CoV-2-Induced Vomiting as Onset Symptom in a Patient with COVID-19 (edit) |
10.1007/S10620-020-06285-4 |
| 2020-04-28 |
Structural and Evolutionary Analysis Indicate That the SARS-CoV-2 Mpro Is a Challenging Target for Small-Molecule Inhibitor Design (edit) |
10.3390/IJMS21093099 |
| 2020-04-28 |
The Severe Acute Respiratory Syndrome Coronavirus-2 (SARS CoV-2) in Dentistry. Management of Biological Risk in Dental Practice (edit) |
10.3390/IJERPH17093067 |
| 2020-04-28 |
On Facing the SARS-CoV-2 (COVID-19) with Combination of Nanomaterials and Medicine: Possible Strategies and First Challenges (edit) |
10.3390/NANO10050852 |
| 2020-04-28 |
Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China (edit) |
10.1016/J.CELL.2020.04.023 |
| 2020-04-28 |
Arbidol: A potential antiviral drug for the treatment of SARS-CoV-2 by blocking the trimerization of viral spike glycoprotein ? (edit) |
10.1016/J.IJANTIMICAG.2020.105998 |
| 2020-04-28 |
Acute Pulmonary Embolism in SARS-CoV-2 Infection Treated with Surgical Embolectomy (edit) |
10.1016/J.ATHORACSUR.2020.04.013 |
| 2020-04-28 |
Mechanisms of increased morbidity and mortality of SARS-CoV-2 infection in individuals with diabetes: what this means for an effective management strategy (edit) |
10.1016/J.METABOL.2020.154254 |
| 2020-04-28 |
SARS-CoV2 induced respiratory distress: Can cannabinoids be added to anti-viral therapies to reduce lung inflammation? (edit) |
10.1016/J.BBI.2020.04.079 |
| 2020-04-28 |
Guillain-Barré Syndrome as a Complication of SARS-CoV-2 Infection (edit) |
10.1016/J.BBI.2020.04.074 |
| 2020-04-28 |
The SARS-CoV-2 seroprevalence is the key factor for deconfinement in France (edit) |
10.1016/J.JINF.2020.04.031 |
| 2020-04-28 |
Protective immunity after COVID-19 has been questioned: What can we do without SARS-CoV-2-IgG detection? (edit) |
10.1016/J.CELLIMM.2020.104114 |
| 2020-04-28 |
Molecular diagnostics at the times of SARS-CoV-2 outbreak (edit) |
10.1515/DX-2020-0050 |
| 2020-04-28 |
A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells (edit) |
10.1016/J.MOLCEL.2020.04.022 |
| 2020-04-28 |
Anti-RAS drugs and SARS-CoV-2 infection (edit) |
10.1016/J.APSB.2020.04.013 |
| 2020-04-28 |
Detection of low levels of SARS-CoV-2 RNA from nasopharyngeal swabs using three commercial molecular assays (edit) |
10.1016/J.JCV.2020.104387 |
| 2020-04-28 |
Clinical evaluation of a SARS-CoV-2 RT-PCR assay on a fully automated system for rapid on-demand testing in the hospital setting (edit) |
10.1016/J.JCV.2020.104390 |
| 2020-04-28 |
A SARS-CoV-2 vaccine candidate would likely match all currently circulating strains (edit) |
10.1101/2020.04.27.064774 |
| 2020-04-28 |
Disparate temperature-dependent virus – host dynamics for SARS-CoV-2 and SARS-CoV in the human respiratory epithelium (edit) |
10.1101/2020.04.27.062315 |
| 2020-04-28 |
Remdesivir potently inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in mice (edit) |
10.1101/2020.04.27.064279 |
| 2020-04-28 |
SARS-CoV-2 Detection Using an Isothermal Amplification Reaction and a Rapid, Inexpensive Protocol for Sample Inactivation and Purification (edit) |
10.1101/2020.04.23.20076877 |
| 2020-04-28 |
Emergence of multiple variants of SARS-CoV-2 with signature structural changes (edit) |
10.1101/2020.04.26.062471 |
| 2020-04-28 |
Resident physician exposure to novel coronavirus (2019-nCoV, SARS-CoV-2) within New York City during exponential phase of COVID-19 pandemic: Report of the New York City Residency Program Directors COVID-19 Research Group (edit) |
10.1101/2020.04.23.20074310 |
| 2020-04-28 |
Association of Digestive Symptoms and Hospitalization in Patients with SARS-CoV-2 Infection (edit) |
10.1101/2020.04.23.20076935 |
| 2020-04-28 |
Resilient SARS-CoV-2 diagnostics workflows including viral heat inactivation (edit) |
10.1101/2020.04.22.20074351 |
| 2020-04-28 |
Role of 1’-Ribose Cyano Substitution for Remdesivir to Effectively Inhibit both Nucleotide Addition and Proofreading in SARS-CoV-2 Viral RNA Replication (edit) |
10.1101/2020.04.27.063859 |
| 2020-04-28 |
Racial and Ethnic Disparities in SARS-CoV-2 Pandemic: Analysis of a COVID-19 Observational Registry for a Diverse U.S. Metropolitan Population (edit) |
10.1101/2020.04.24.20073148 |
| 2020-04-28 |
Comparison of SARS-CoV-2 Exit Strategies Building Blocks (edit) |
10.1101/2020.04.23.20072850 |
| 2020-04-28 |
Estimation of SARS-CoV-2 infection fatality rate by real-time antibody screening of blood donors (edit) |
10.1101/2020.04.24.20075291 |
| 2020-04-28 |
Specific mutations in SARS-CoV2 RNA dependent RNA polymerase and helicase alter protein structure, dynamics and thus function: Effect on viral RNA replication (edit) |
10.1101/2020.04.26.063024 |
| 2020-04-28 |
Structure of replicating SARS-CoV-2 polymerase (edit) |
10.1101/2020.04.27.063180 |
| 2020-04-28 |
Quality control of low-frequency variants in SARS-CoV-2 genomes (edit) |
10.1101/2020.04.26.062422 |
| 2020-04-28 |
Marked Up-Regulation of ACE2 in Hearts of Patients With Obstructive Hypertrophic Cardiomyopathy: Implications for SARS-CoV-2-Mediated COVID-19 (edit) |
10.1016/J.MAYOCP.2020.04.028 |
| 2020-04-28 |
Pooling of samples for testing for SARS-CoV-2 in asymptomatic people (edit) |
10.1016/S1473-3099(20)30362-5 |
| 2020-04-28 |
[Comment] Treatment strategies to fight the new coronavirus SARS-CoV-2: A challenge for a Rubik's Cube solver (edit) |
10.3892/ETM.2020.8692 |
| 2020-04-27 |
First reported nosocomial outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a pediatric dialysis unit (edit) |
10.1093/CID/CIAA491 |
| 2020-04-27 |
Profile of IgG and IgM antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (edit) |
10.1093/CID/CIAA489 |
| 2020-04-27 |
Early risk factors for the duration of SARS-CoV-2 viral positivity in COVID-19 patients (edit) |
10.1093/CID/CIAA490 |
| 2020-04-27 |
COVID-19 and the digestive system: protection and management during the SARS-CoV-2 pandemic (edit) |
10.17235/REED.2020.7128/2020 |
| 2020-04-27 |
Olfactory and rhinological evaluations in SARS-CoV-2 patients complaining of olfactory loss (edit) |
10.4193/RHIN20.136 |
| 2020-04-27 |
Acute pulmonary embolism in conjunction with intramural right ventricular thrombus in a SARS-CoV-2-positive patient (edit) |
10.1093/EHJCI/JEAA115 |
| 2020-04-27 |
Prevalence of SARS-CoV-2 Infection in Residents of a Large Homeless Shelter in Boston (edit) |
10.1001/JAMA.2020.6887 |
| 2020-04-27 |
Is global BCG vaccination-induced trained immunity relevant to the progression of SARS-CoV-2 pandemic? (edit) |
10.1111/ALL.14345 |
| 2020-04-27 |
Vaginal delivery in SARS-CoV-2 infected pregnant women in Northern Italy: a retrospective analysis (edit) |
10.1111/1471-0528.16278 |
| 2020-04-27 |
Aerodynamic analysis of SARS-CoV-2 in two Wuhan hospitals (edit) |
10.1038/S41586-020-2271-3 |
| 2020-04-27 |
[The SARS-CoV-2 Pandemic and an Attempted Suicide of a Patient with Delusional Disorder] (edit) |
10.1055/A-1158-1745 |
| 2020-04-27 |
Natural products may interfere with SARS-CoV-2 attachment to the host cell (edit) |
10.1080/07391102.2020.1761881 |
| 2020-04-27 |
A Molecular Modeling Approach to Identify Effective Antiviral Phytochemicals against the Main Protease of SARS-CoV-2 (edit) |
10.1080/07391102.2020.1761883 |
| 2020-04-27 |
Clinical phenotypes of SARS-CoV-2: Implications for clinicians and researchers (edit) |
10.1183/13993003.01028-2020 |
| 2020-04-27 |
Evaluation of Transport Media and Specimen Transport Conditions for the Detection of SARS-CoV-2 Using Real Time Reverse Transcription PCR (edit) |
10.1128/JCM.00708-20 |
| 2020-04-27 |
Evaluation of the QIAstat-Dx Respiratory SARS-CoV-2 Panel, the first rapid multiplex PCR commercial assay for SARS-CoV-2 detection (edit) |
10.1128/JCM.00630-20 |
| 2020-04-27 |
Comparison of Four Molecular In Vitro Diagnostic Assays for the Detection of SARS-CoV-2 in Nasopharyngeal Specimens (edit) |
10.1128/JCM.00743-20 |
| 2020-04-27 |
[Obesity and 2019-nCoV. A risky relationship] (edit) |
10.1016/J.RCE.2020.04.008 |
| 2020-04-27 |
Prediction of numbers of the accumulative confirmed patients (NACP) and the plateau phase of 2019-nCoV in China (edit) |
10.1007/S11571-020-09588-4 |
| 2020-04-27 |
SARS-CoV-2 infection in a patient on chronic hydroxychloroquine therapy: Implications for prophylaxis (edit) |
10.1016/J.IDCR.2020.E00778 |
| 2020-04-27 |
Exercise against SARS-CoV-2 (COVID-19): Does workout intensity matter? (A mini review of some indirect evidence related to obesity) (edit) |
10.1016/J.OBMED.2020.100245 |
| 2020-04-27 |
Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards (edit) |
10.1007/S10096-020-03913-9 |
| 2020-04-27 |
Screening of Clinically Approved and Investigation Drugs as Potential Inhibitors of SARS-CoV-2 Main Protease and Spike Receptor-Binding Domain Bound with ACE2 COVID19 Target Proteins: A Virtual Drug Repurposing Study (edit) |
10.26434/CHEMRXIV.12032712 |
| 2020-04-27 |
Novel biosensor platforms for the detection of coronavirus infection and SARS-CoV-2 (edit) |
10.1097/JCMA.0000000000000337 |
| 2020-04-27 |
Genomic Analysis and Comparative Multiple Sequence of SARS-CoV2 (edit) |
10.1097/JCMA.0000000000000335 |
| 2020-04-27 |
Impact of contact tracing on SARS-CoV-2 transmission (edit) |
10.1016/S1473-3099(20)30357-1 |
| 2020-04-27 |
Genotyping coronavirus SARS-CoV-2: methods and implications (edit) |
10.1016/J.YGENO.2020.04.016 |
| 2020-04-27 |
Potentially irreversible olfactory and gustatory impairments in COVID-19: Indolent vs. fulminant SARS-CoV-2 neuroinfection (edit) |
10.1016/J.BBI.2020.04.071 |
| 2020-04-27 |
SARS-CoV-2: A new virus but a familiar inflammation brain pattern (edit) |
10.1016/J.BBI.2020.04.066 |
| 2020-04-27 |
Persistence of intestinal SARS-CoV-2 infection in patients with COVID-19 leads to re-admission after pneumonia resolved (edit) |
10.1016/J.IJID.2020.04.063 |
| 2020-04-27 |
SARS-COV2 INFECTION AND LUNG CANCER PATIENTS: the potential role of IL17 target therapy (edit) |
10.1016/J.JTHO.2020.04.015 |
| 2020-04-27 |
Air quality status during 2020 Malaysia Movement Control Order (MCO) due to 2019 novel coronavirus (2019-nCoV) pandemic (edit) |
10.1016/J.SCITOTENV.2020.139022 |
| 2020-04-27 |
Association between climate variables and global transmission oF SARS-CoV-2 (edit) |
10.1016/J.SCITOTENV.2020.138997 |
| 2020-04-27 |
A cluster of health care workers with COVID-19 pneumonia caused by SARS-CoV-2 (edit) |
10.1016/J.JMII.2020.04.013 |
| 2020-04-27 |
Medical masks and Respirators for the Protection of Healthcare Workers from SARS-CoV-2 and other viruses (edit) |
10.1016/J.PULMOE.2020.04.009 |
| 2020-04-27 |
Nosocomial infection with SARS-Cov-2 within Departments of Digestive Surgery (edit) |
10.1016/J.JVISCSURG.2020.04.016 |
| 2020-04-27 |
Post-intensive care syndrome after SARS-CoV-2 pandemic (edit) |
10.1016/J.MEDIN.2020.04.011 |
| 2020-04-27 |
Hydroxychloroquine as an aerosol might markedly reduce and even prevent severe clinical symptoms after SARS-CoV-2 infection (edit) |
10.1016/J.MEHY.2020.109783 |
| 2020-04-27 |
Living evidence for SARS-CoV-2 (edit) |
10.1016/J.MEDIN.2020.04.012 |
| 2020-04-27 |
SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues (edit) |
10.1016/J.CELL.2020.04.035 |
| 2020-04-27 |
[COVID19-Tracker: a shiny app to analise data on SARS-CoV-2 epidemic in Spain] (edit) |
10.1016/J.GACETA.2020.04.002 |
| 2020-04-27 |
Structural Basis of RNA Cap Modification by SARS-CoV-2 Coronavirus (edit) |
10.1101/2020.04.26.061705 |
| 2020-04-27 |
SARS-CoV-2 On-the-Spot Virus Detection Directly From Patients (edit) |
10.1101/2020.04.22.20072389 |
| 2020-04-27 |
Comparison of Commercially Available and Laboratory Developed Assays for in vitro Detection of SARS-CoV-2 in Clinical Laboratories (edit) |
10.1101/2020.04.24.20074559 |
| 2020-04-27 |
Ethnic and socioeconomic differences in SARS-CoV-2 infection: prospective cohort study using UK Biobank (edit) |
10.1101/2020.04.22.20075663 |
| 2020-04-27 |
Long period dynamics of viral load and antibodies for SARS-CoV-2 infection: an observational cohort study (edit) |
10.1101/2020.04.22.20071258 |
| 2020-04-27 |
How fast does the SARS-Cov-2 virus really mutate in heterogeneous populations? (edit) |
10.1101/2020.04.23.20076075 |
| 2020-04-27 |
To breastfeed or not to breastfeed? Lack of evidence on the presence of SARS-CoV-2 in breastmilk of pregnant women with COVID-19 (edit) |
10.26633/RPSP.2020.59 |
| 2020-04-27 |
[Acute respiratory distress syndrome secondary to SARS-CoV-2 infection in an infant] (edit) |
10.1016/J.RMR.2020.04.009 |
| 2020-04-27 |
Surgical Strategies in the Era of SARS-CoV-2 (edit) |
10.11604/PAMJ.2020.35.2.22975 |
| 2020-04-27 |
A potential role for AHR in SARS-CoV-2 pathology (edit) |
10.21203/RS.3.RS-25639/V1 |
| 2020-04-26 |
CoV2ID: Detection and Therapeutics Oligo Database for SARS-CoV-2 (edit) |
10.1101/2020.04.19.048991 |
| 2020-04-26 |
Letter: The Risk of COVID-19 Infection During Neurosurgical Procedures: A Review of Severe Acute Respiratory Distress Syndrome Coronavirus 2 (SARS-CoV-2) Modes of Transmission and Proposed Neurosurgery-Specific Measures for Mitigation (edit) |
10.1093/NEUROS/NYAA157 |
| 2020-04-26 |
DPP4 inhibition: preventing SARS-CoV-2 infection and/or progression of COVID-19? (edit) |
10.1002/DMRR.3330 |
| 2020-04-26 |
Evaluation of ocular symptoms and tropism of SARS-CoV-2 in patients confirmed with COVID-19 (edit) |
10.1111/AOS.14445 |
| 2020-04-26 |
Noscapine, a possible drug candidate for attenuation of cytokine release associated with SARS-CoV-2 (edit) |
10.1002/DDR.21676 |
| 2020-04-26 |
SARS-CoV-2 RNA dependent RNA polymerase (RdRp) targeting: An in silico perspective (edit) |
10.1080/07391102.2020.1761882 |
| 2020-04-26 |
Will environmental impacts of social distancing due to the SARS-CoV-2 pandemic decrease allergic disease? (edit) |
10.1016/J.JACI.2020.04.026 |
| 2020-04-26 |
SARS-CoV-2 in the ocular surface of COVID-19 patients (edit) |
10.1186/S40662-020-00189-0 |
| 2020-04-26 |
Feasibility of Known RNA Polymerase Inhibitors as Anti-SARS-CoV-2 Drugs (edit) |
10.3390/PATHOGENS9050320 |
| 2020-04-26 |
Comparing the analytical performance of three SARS-CoV-2 molecular diagnostic assays (edit) |
10.1016/J.JCV.2020.104384 |
| 2020-04-26 |
Pooling of Nasopharyngeal Swab Specimens for SARS-CoV-2 detection by RT-PCR (edit) |
10.1101/2020.04.22.20075598 |
| 2020-04-26 |
SARS-CoV-2 Productively Infects Human Gut Enterocytes (edit) |
10.1101/2020.04.25.060350 |
| 2020-04-26 |
A rapid, low cost, and highly sensitive SARS-CoV-2 diagnostic based on whole genome sequencing (edit) |
10.1101/2020.04.25.061499 |
| 2020-04-26 |
The proportion testing positive for SARS-COV-2 among the tested population in the U.S.: Benefits of the positive test ratio under scaled testing scenarios (edit) |
10.1101/2020.04.21.20074070 |
| 2020-04-26 |
Antibody tests in detecting SARS-CoV-2 infection: a meta-analysis (edit) |
10.1101/2020.04.22.20074914 |
| 2020-04-26 |
SARS-CoV-2 RNA titers in wastewater anticipated COVID-19 occurrence in a low prevalence area (edit) |
10.1101/2020.04.22.20075200 |
| 2020-04-26 |
Lack of association between genetic variants at ACE2 and TMPRSS2 genes involved in SARS-CoV-2 infection and human quantitative phenotypes (edit) |
10.1101/2020.04.22.20074963 |
| 2020-04-26 |
Rapid SARS-CoV-2 whole genome sequencing for informed public health decision making in the Netherlands (edit) |
10.1101/2020.04.21.050633 |
| 2020-04-26 |
Characterization of intra-host SARS-CoV-2 variants improves phylogenomic reconstruction and may reveal functionally convergent mutations (edit) |
10.1101/2020.04.22.044404 |
| 2020-04-26 |
Optimized qRT-PCR approach for the detection of intra- and extra-cellular SARS-CoV-2 RNAs (edit) |
10.1101/2020.04.20.052258 |
| 2020-04-26 |
Insight towards the effect of the multibasic cleavage site of SARS-CoV-2 spike protein on cellular proteases (edit) |
10.1101/2020.04.25.061507 |
| 2020-04-26 |
Comparison of Cepheid Xpert Xpress and Abbott ID Now to Roche cobas for the Rapid Detection of SARS-CoV-2 (edit) |
10.1101/2020.04.22.055327 |
| 2020-04-26 |
MINERVA: A facile strategy for SARS-CoV-2 whole genome deep sequencing of clinical samples (edit) |
10.1101/2020.04.25.060947 |
| 2020-04-25 |
Expression of SARS-CoV-2 Entry Molecules ACE2 and TMPRSS2 in the Gut of Patients With IBD (edit) |
10.1093/IBD/IZAA085 |
| 2020-04-25 |
Transmission risk of SARS-CoV-2 to healthcare workers -observational results of a primary care hospital contact tracing (edit) |
10.4414/SMW.2020.20257 |
| 2020-04-25 |
RT-LAMP for rapid diagnosis of coronavirus SARS-CoV-2 (edit) |
10.1111/1751-7915.13586 |
| 2020-04-25 |
SARS-CoV-2 Pandemic and The Need for Transplant-oriented Trials (edit) |
10.1111/TRI.13626 |
| 2020-04-25 |
Absence of severe complications from SARS-CoV-2 infection in children with rheumatic diseases treated with biologic drugs (edit) |
10.3899/JRHEUM.200483 |
| 2020-04-25 |
Treatment of SARS-CoV-2: How far have we reached? (edit) |
10.5582/DDT.2020.03008 |
| 2020-04-25 |
Recommendations on the clinical management of the COVID-19 infection by the «new coronavirus» SARS-CoV2. Spanish Paediatric Association working group (edit) |
10.1016/J.ANPEDE.2020.02.002 |
| 2020-04-25 |
Chaos game representation dataset of SARS-CoV-2 genome (edit) |
10.1016/J.DIB.2020.105618 |
| 2020-04-25 |
Masks and thermometers: Paramount measures to stop the rapid spread of SARS-CoV-2 in the United States (edit) |
10.1016/J.GENDIS.2020.04.011 |
| 2020-04-25 |
IgA-Ab response to spike glycoprotein of SARS-CoV-2 in patients with COVID-19: A longitudinal study (edit) |
10.1016/J.CCA.2020.04.026 |
| 2020-04-25 |
In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect (edit) |
10.1016/J.MICPATH.2020.104228 |
| 2020-04-25 |
Searching for SARS-COV-2 on Particulate Matter: A Possible Early Indicator of COVID-19 Epidemic Recurrence (edit) |
10.3390/IJERPH17092986 |
| 2020-04-25 |
Why not consider an endothelin receptor antagonist against SARS-CoV-2? (edit) |
10.1016/J.MEHY.2020.109792 |
| 2020-04-25 |
Airborne route and bad use of ventilation systems as non-negligible factors in SARS-CoV-2 transmission (edit) |
10.1016/J.MEHY.2020.109781 |
| 2020-04-25 |
A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis (edit) |
10.1016/J.JCF.2020.04.012 |
| 2020-04-25 |
SARS-CoV-2 Isolation and Propagation from Turkish COVID-19 patients (edit) |
10.1101/2020.04.23.056309 |
| 2020-04-25 |
Search for SARS-CoV-2 inhibitors in currently approved drugs to tackle COVID-19 pandemia (edit) |
10.1101/2020.04.23.055756 |
| 2020-04-25 |
Validation of a SARS-CoV-2 spike protein ELISA for use in contact investigations and sero-surveillance (edit) |
10.1101/2020.04.24.057323 |
| 2020-04-25 |
Multi-epitope based peptide vaccine design against SARS-CoV-2 using its spike protein (edit) |
10.1101/2020.04.23.055467 |
| 2020-04-25 |
Introductions and early spread of SARS-CoV-2 in France (edit) |
10.1101/2020.04.24.059576 |
| 2020-04-25 |
Treating Influenza and SARS-CoV-2 via mRNA-encoded Cas13a (edit) |
10.1101/2020.04.24.060418 |
| 2020-04-25 |
The anti-HIV Drug Nelfinavir Mesylate (Viracept) is a Potent Inhibitor of Cell Fusion Caused by the SARS-CoV-2 Spike (S) Glycoprotein Warranting further Evaluation as an Antiviral against COVID-19 infections (edit) |
10.1101/2020.04.24.060376 |
| 2020-04-25 |
Genetic analysis of the novel SARS-CoV-2 host receptor TMPRSS2 in different populations (edit) |
10.1101/2020.04.23.057190 |
| 2020-04-25 |
Critical role of type III interferon in controlling SARS-CoV-2 infection, replication and spread in primary human intestinal epithelial cells (edit) |
10.1101/2020.04.24.059667 |
| 2020-04-25 |
A follow-up study of children infected with SARS-CoV-2 from Western China (edit) |
10.1101/2020.04.20.20073288 |
| 2020-04-25 |
ACE2 polymorphisms and individual susceptibility to SARS-CoV-2 infection: insights from an in silico study (edit) |
10.1101/2020.04.23.057042 |
| 2020-04-25 |
Evolution and molecular characteristics of SARS-CoV-2 genome (edit) |
10.1101/2020.04.24.058933 |
| 2020-04-25 |
Genomic, geographic and temporal distributions of SARS-CoV-2 mutations (edit) |
10.1101/2020.04.22.055863 |
| 2020-04-24 |
Epidemiological characteristics of COVID-19 in medical staff members of neurosurgery departments in Hubei province: A multicentre descriptive study (edit) |
10.1101/2020.04.20.20064899 |
| 2020-04-24 |
Higher mortality in men from COVID19 infection-understanding the factors that drive the differences between the biological sexes (edit) |
10.1101/2020.04.19.20062174 |
| 2020-04-24 |
Understanding the Collective Responses of Populations to the COVID-19 Pandemic in Mainland China (edit) |
10.1101/2020.04.20.20068676 |
| 2020-04-24 |
Modest effects of contact reduction measures on the reproduction number of SARS-CoV-2 in the most affected European countries and the US (edit) |
10.1101/2020.04.20.20067538 |
| 2020-04-24 |
RDA COVID-19; recommendations and guidelines, 1st release 24 April 2020 (edit) |
10.15497/RDA00046 |
| 2020-04-24 |
Conjunctivitis and COVID‐19: a meta‐analysis (edit) |
10.1002/JMV.25938 |
| 2020-04-24 |
COVID-19 in Iran, a comprehensive investigation from exposure to treatment outcomes (edit) |
10.1101/2020.04.20.20072421 |
| 2020-04-24 |
The post-lockdown period should be used to acquire effective therapies for future resurgence in SARS-Cov-2 infections (edit) |
|
| 2020-04-24 |
Application of "Mobile Hospital" against 2019-nCoV in China (edit) |
10.1017/S0950268820000862 |
| 2020-04-24 |
PTSD as the second tsunami of the SARS-Cov2 pandemic (edit) |
10.1017/S0033291720001336 |
| 2020-04-24 |
Thoughts on What Chemists Can Contribute to Fighting SARS-CoV-2 - A Short Note on Hand Sanitizers, Drug Candidates and Outreach (edit) |
10.1002/ANIE.202004721 |
| 2020-04-24 |
Discovery of Potential Multi-Target-Directed Ligands by Targeting Host-specific SARS-CoV-2 Structurally Conserved Main Protease$ (edit) |
10.1080/07391102.2020.1760137 |
| 2020-04-24 |
Andrographolide As a Potential Inhibitor of SARS-CoV-2 Main Protease: An In Silico Approach (edit) |
10.1080/07391102.2020.1760136 |
| 2020-04-24 |
Tobacco Smoking Increases the Lung Gene Expression of ACE2, the Receptor of SARS-CoV-2 (edit) |
10.1164/RCCM.202003-0693LE |
| 2020-04-24 |
Early Institutional Head and Neck Oncologic and Microvascular Surgery Practice Patterns Across the United States During the SARS-CoV-2 (COVID19) Pandemic (edit) |
10.1002/HED.26189 |
| 2020-04-24 |
Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility (edit) |
10.1056/NEJMOA2008457 |
| 2020-04-24 |
Retrospective study of risk factors for severe SARS-Cov-2 infections in hospitalized adult patients (edit) |
10.20452/PAMW.15312 |
| 2020-04-24 |
SARS-CoV-2 infection masquerading as a possible pulmonary embolism (edit) |
10.20452/PAMW.15310 |
| 2020-04-24 |
Terra incognita: clinically suspected myocarditis in a SARS-CoV-2 positive patient (edit) |
10.20452/PAMW.15309 |
| 2020-04-24 |
Asymptomatic SARS-CoV-2 Infection in Household Contacts of a Healthcare Provider, Wuhan, China (edit) |
10.3201/EID2608.201016 |
| 2020-04-24 |
Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Randomized Clinical Trial (edit) |
10.1001/JAMANETWORKOPEN.2020.8857 |
| 2020-04-24 |
Diagnostic accuracy of an automated chemiluminescent immunoassay for anti-SARS-CoV-2 IgM and IgG antibodies: an Italian experience (edit) |
10.1002/JMV.25932 |
| 2020-04-24 |
Persistent viral RNA positivity during recovery period of a patient with SARS-CoV-2 infection (edit) |
10.1002/JMV.25940 |
| 2020-04-24 |
Optimization of group size in pool testing strategy for SARS-CoV-2: A simple mathematical model (edit) |
10.1002/JMV.25929 |
| 2020-04-24 |
SARS-CoV-2 can be detected in urine, blood, anal swabs and oropharyngeal swabs specimens (edit) |
10.1002/JMV.25936 |
| 2020-04-24 |
Asymptomatic SARS-CoV-2 infected case with viral detection positive in stool but negative in nasopharyngeal samples lasts for 42 days (edit) |
10.1002/JMV.25941 |
| 2020-04-24 |
SARS-CoV-2 infection in children - Understanding the immune responses and controlling the pandemic (edit) |
10.1111/PAI.13267 |
| 2020-04-24 |
SARS-CoV-2 infection presenting as a febrile rash (edit) |
10.1111/JDV.16528 |
| 2020-04-24 |
SARS-CoV-2 infection in a 76-year-old man with negative results for nasopharyngeal swabs and possible nosocomial transmission (edit) |
10.1503/CMAJ.200641 |
| 2020-04-24 |
Clinical Evaluation of Three Sample-To-Answer Platforms for the Detection of SARS-CoV-2 (edit) |
10.1128/JCM.00783-20 |
| 2020-04-24 |
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vertical Transmission in Neonates Born to Mothers With Coronavirus Disease 2019 (COVID-19) Pneumonia (edit) |
10.1097/AOG.0000000000003926 |
| 2020-04-24 |
Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig (edit) |
10.1038/S41467-020-16048-4 |
| 2020-04-24 |
SARS-CoV-2 infection of kidney organoids prevented with soluble human ACE2 (edit) |
10.1038/S41581-020-0291-8 |
| 2020-04-24 |
Reply to the Letter to the Editor: Protection of computed tomography suites from SARS-CoV-2 infection in a tertiary emergency hospital (edit) |
10.1007/S11604-020-00979-5 |
| 2020-04-24 |
SARS-Cov-2 (human) and COVID-19: Primer 2020 (edit) |
10.1007/S12072-020-10049-7 |
| 2020-04-24 |
Neonatal Resuscitation Where the Mother Has a Suspected or Confirmed Novel Coronavirus (SARS-CoV-2) Infection: Suggestion for a Pragmatic Action Plan (edit) |
10.1159/000507935 |
| 2020-04-24 |
Air purifiers: A supplementary measure to remove airborne SARS-CoV-2 (edit) |
10.1016/J.BUILDENV.2020.106918 |
| 2020-04-24 |
[Nosocomial infection with SARS-Cov-2 within Departments of Digestive Surgery] (edit) |
10.1016/J.JCHIRV.2020.04.012 |
| 2020-04-24 |
RT-qPCR Testing of SARS-CoV-2: A Primer (edit) |
10.3390/IJMS21083004 |
| 2020-04-24 |
Serum albumin-mediated strategy for the effective targeting of SARS-CoV-2 (edit) |
10.1016/J.MEHY.2020.109790 |
| 2020-04-24 |
Comparison of the Panther Fusion and a laboratory-developed test targeting the envelope gene for detection of SARS-CoV-2 (edit) |
10.1016/J.JCV.2020.104383 |
| 2020-04-24 |
Use of drugs with potential cardiac effect in the setting of SARS-CoV-2 infection (edit) |
10.1016/J.ACVD.2020.04.003 |
| 2020-04-24 |
Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses: (Trends in Immunology 41, 355-359; 2020) (edit) |
10.1016/J.IT.2020.04.008 |
| 2020-04-24 |
A PATIENT WITH NEUROLOGICAL MANIFESTATIONS AS UNIQUE PRESENTATION OF SARS-CoV-2 INFECTION (edit) |
10.1016/J.NRL.2020.04.010 |
| 2020-04-24 |
SARS-CoV-2 and the Use of Chloroquine as an Antiviral Treatment (edit) |
10.3389/FMED.2020.00184 |
| 2020-04-24 |
[SARS-CoV-2 and cancer in France: Resident in oncology on the front line. Testimony of residents in oncology in two French clusters: Grand-Est and Île-de-France] (edit) |
10.1016/J.BULCAN.2020.04.002 |
| 2020-04-24 |
Functional and Genetic Analysis of Viral Receptor ACE2 Orthologs Reveals a Broad Potential Host Range of SARS-CoV-2 (edit) |
10.1101/2020.04.22.046565 |
| 2020-04-24 |
STAT2 signaling as double-edged sword restricting viral dissemination but driving severe pneumonia in SARS-CoV-2 infected hamsters (edit) |
10.1101/2020.04.23.056838 |
| 2020-04-24 |
Recombinant SARS-CoV-2 spike S1-Fc fusion protein induced high levels of neutralizing responses in nonhuman primates (edit) |
10.1101/2020.04.21.052209 |
| 2020-04-24 |
Targeted Proteomics for the Detection of SARS-CoV-2 Proteins (edit) |
10.1101/2020.04.23.057810 |
| 2020-04-24 |
Self-reported symptoms of covid-19 including symptoms most predictive of SARS-CoV-2 infection, are heritable (edit) |
10.1101/2020.04.22.20072124 |
| 2020-04-24 |
The production of antibodies for SARS-CoV-2 and its clinical implication (edit) |
10.1101/2020.04.20.20065953 |
| 2020-04-24 |
Immune defects and cardiovascular risk in X chromosome monosomy mosaicism mediated by loss of chromosome Y. A risk factor for SARS-CoV-2 vulnerability in elderly men? (edit) |
10.1101/2020.04.19.20071357 |
| 2020-04-24 |
Scalable and Resilient SARS-CoV-2 testing in an Academic Centre (edit) |
10.1101/2020.04.19.20071373 |
| 2020-04-24 |
Predicting mortality due to SARS-CoV-2: A mechanistic score relating obesity and diabetes to COVID-19 outcomes in Mexico (edit) |
10.1101/2020.04.20.20072223 |
| 2020-04-24 |
The risk of SARS-CoV-2 transmission in the healthcare setting and potential impact of cohorting strategies (edit) |
10.1101/2020.04.20.20073080 |
| 2020-04-24 |
Detection of Nucleocapsid Antibody to SARS-CoV-2 is More Sensitive than Antibody to Spike Protein in COVID-19 Patients (edit) |
10.1101/2020.04.20.20071423 |
| 2020-04-24 |
ESTIMATING R0 OF SARS-COV-2 IN HEALTHCARE SETTINGS (edit) |
10.1101/2020.04.20.20072462 |
| 2020-04-24 |
Rapid identification of SARS-CoV-2-infected patients at the emergency department using routine testing (edit) |
10.1101/2020.04.20.20067512 |
| 2020-04-24 |
Identification of potential treatments for COVID-19 through artificial intelligence-enabled phenomic analysis of human cells infected with SARS-CoV-2 (edit) |
10.1101/2020.04.21.054387 |
| 2020-04-24 |
Prevalence of SARS-CoV-2 infection in previously undiagnosed health care workers at the onset of the U.S. COVID-19 epidemic (edit) |
10.1101/2020.04.20.20072470 |
| 2020-04-24 |
Tracking the onset date of the community spread of SARS-CoV-2 in Western Countries (edit) |
10.1101/2020.04.20.20073007 |
| 2020-04-24 |
SARS-CoV-2 serological analysis of COVID-19 hospitalized patients, pauci-symptomatic individuals and blood donors. (edit) |
10.1101/2020.04.21.20068858 |
| 2020-04-24 |
Preliminary support for a “dry swab, extraction free” protocol for SARS-CoV-2 testing via RT-qPCR (edit) |
10.1101/2020.04.22.056283 |
| 2020-04-24 |
Protocol and reagents for pseudotyping lentiviral particles with SARS-CoV-2 Spike protein for neutralization assays (edit) |
10.1101/2020.04.20.051219 |
| 2020-04-24 |
Estimating the burden of SARS-CoV-2 in France (edit) |
10.1101/2020.04.20.20072413 |
| 2020-04-24 |
Mapping the Immunodominance Landscape of SARS-CoV-2 Spike Protein for the Design of Vaccines against COVID-19 (edit) |
10.1101/2020.04.23.056853 |
| 2020-04-24 |
Rapid, sensitive, full genome sequencing of Severe Acute Respiratory Syndrome Virus Coronavirus 2 (SARS-CoV-2) (edit) |
10.1101/2020.04.22.055897 |
| 2020-04-24 |
Current and emerging diagnostic tests available for the novel COVID-19 global pandemic (edit) |
10.12688/AASOPENRES.13059.1 |
| 2020-04-23 |
The emergence of a novel coronavirus (SARS-CoV-2), their biology and therapeutic options (edit) |
10.1128/JCM.00187-20 |
| 2020-04-23 |
Incidence of Adverse Drug Reactions in COVID‐19 patients in China: an active monitoring study by Hospital Pharmacovigilance System (edit) |
10.1002/CPT.1866 |
| 2020-04-23 |
How is immunosuppressive status affecting children and adults in SARS-CoV-2 infection? A systematic review (edit) |
10.1016/J.JINF.2020.04.026 |
| 2020-04-23 |
Contrast enhanced ultrasonography (CEUS) to detect abdominal microcirculatory disorders in severe cases of COVID-19 infection: First experience (edit) |
10.3233/CH-209003 |
| 2020-04-23 |
Clinical Characteristics of 20,662 Patients with COVID-19 in mainland China: A Systemic Review and Meta-analysis (edit) |
10.1101/2020.04.18.20070565 |
| 2020-04-23 |
Repositioned chloroquine and hydroxychloroquine as antiviral prophylaxis for COVID-19: A protocol for rapid systematic review of randomized controlled trials (edit) |
10.1101/2020.04.18.20071167 |
| 2020-04-23 |
A deadly spillover: SARS-CoV-2 outbreak (edit) |
10.1080/13543776.2020.1760838 |
| 2020-04-23 |
Corticosteroid use for 2019-nCoV infection: A double-edged sword (edit) |
10.1017/ICE.2020.165 |
| 2020-04-23 |
Double-Edged Spike-Are SARS-CoV-2 Serologic Tests Safe Right Now? (edit) |
10.1093/LABMED/LMAA025 |
| 2020-04-23 |
Esophageal oncologic surgery in SARS-CoV-2 (COVID-19) emergency (edit) |
10.1093/DOTE/DOAA028 |
| 2020-04-23 |
Double-Edged Spike: Are SARS-CoV-2 Serologic Tests Safe Right Now? (edit) |
10.1093/AJCP/AQAA071 |
| 2020-04-23 |
Immunomodulators and immunosuppressants in the era of SARS-CoV-2 - could laboratory tests be the missing link? (edit) |
10.1080/09546634.2020.1760195 |
| 2020-04-23 |
Rapid and sensitive detection of anti-SARS-CoV-2 IgG using lanthanide-doped nanoparticles-based lateral flow immunoassay (edit) |
10.1021/ACS.ANALCHEM.0C00784 |
| 2020-04-23 |
How should we treat pregnant women infected with SARS-CoV-2? (edit) |
10.1111/1471-0528.16270 |
| 2020-04-23 |
Does high cardiorespiratory fitness confer some protection against pro-inflammatory responses after infection by SARS-CoV-2? (edit) |
10.1002/OBY.22849 |
| 2020-04-23 |
SARS-CoV-2 viral load in sputum correlates with risk of COVID-19 progression (edit) |
10.1186/S13054-020-02893-8 |
| 2020-04-23 |
Genetic Roadmap for Kidney Involvement of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (edit) |
10.2215/CJN.04370420 |
| 2020-04-23 |
Myositis as a manifestation of SARS-CoV-2 (edit) |
10.1136/ANNRHEUMDIS-2020-217573 |
| 2020-04-23 |
Comparison of Abbott ID Now and Abbott m2000 methods for the detection of SARS-CoV-2 from nasopharyngeal and nasal swabs from symptomatic patients (edit) |
10.1128/JCM.00798-20 |
| 2020-04-23 |
Severe liver failure during SARS-CoV-2 infection (edit) |
10.1136/GUTJNL-2020-321350 |
| 2020-04-23 |
SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes (edit) |
10.1038/S41591-020-0868-6 |
| 2020-04-23 |
Vaccines for SARS-CoV-2: Lessons from Other Coronavirus Strains (edit) |
10.1007/S40121-020-00300-X |
| 2020-04-23 |
Correction to: Development of a Novel Reverse Transcription Loop-Mediated Isothermal Amplification Method for Rapid Detection of SARS-CoV-2 (edit) |
10.1007/S12250-020-00223-4 |
| 2020-04-23 |
Study of SARS-CoV-2 in semen and urine samples of a volunteer with positive naso-pharyngeal swab (edit) |
10.1007/S40618-020-01261-1 |
| 2020-04-23 |
Application of a portable instrument for rapid and reliable detection of SARS-CoV-2 infection in any environment (edit) |
10.1111/IMR.12857 |
| 2020-04-23 |
Highly sensitive detection of SARS-CoV-2 RNA by multiplex rRT-PCR for molecular diagnosis of COVID-19 by clinical laboratories (edit) |
10.1016/J.CCA.2020.04.023 |
| 2020-04-23 |
SARS-CoV-2 and DPP4 inhibition: is it time to pray for Janus Bifrons? (edit) |
10.1016/J.DIABRES.2020.108162 |
| 2020-04-23 |
The role of community-wide wearing of face mask for control of coronavirus disease 2019 (COVID-19) epidemic due to SARS-CoV-2 (edit) |
10.1016/J.JINF.2020.04.024 |
| 2020-04-23 |
Dynamics of anti-SARS-Cov-2 IgM and IgG antibodies among COVID-19 patients (edit) |
10.1016/J.JINF.2020.04.019 |
| 2020-04-23 |
Clinical Features and Outcomes of Asymptomatic Cases of SARS-CoV-2 Infection (edit) |
10.1016/J.JINF.2020.04.027 |
| 2020-04-23 |
Reliability and usefulness of a rapid IgM-IgG antibody test for the diagnosis of SARS-CoV-2 infection: a preliminary report (edit) |
10.1016/J.JINF.2020.04.022 |
| 2020-04-23 |
Can the enteric nervous system be an alternative entrance door in SARS-CoV2 neuroinvasion? (edit) |
10.1016/J.BBI.2020.04.060 |
| 2020-04-23 |
Personal protective equipment in the response to the SARS-CoV-2 outbreak - A letter to the editor on "World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19)" (Int J Surg 2020; 76:71-6) (edit) |
10.1016/J.IJSU.2020.04.051 |
| 2020-04-23 |
SARSCoV-2 infection and the upper limbs deep vein thrombosis risk (edit) |
10.1016/J.AVSG.2020.04.037 |
| 2020-04-23 |
A strategy targeting monocyte-macrophage differentiation to avoid pulmonary complications in SARS-Cov2 infection (edit) |
10.1016/J.CLIM.2020.108442 |
| 2020-04-23 |
Emerging genetic diversity among clinical isolates of SARS-CoV-2: Lessons for today (edit) |
10.1016/J.MEEGID.2020.104330 |
| 2020-04-23 |
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Emergence, History, Basic and Clinical Aspects (edit) |
10.1016/J.SJBS.2020.04.033 |
| 2020-04-23 |
Air pollution and SARS-CoV-2 in the Po Valley: possible environmental persistence? (edit) |
10.23736/S0026-4806.20.06586-6 |
| 2020-04-23 |
Shedding Light on the Effect of Natural Anti-Herpesvirus Alkaloids on SARS-CoV-2: A Treatment Option for COVID-19 (edit) |
10.3390/V12040476 |
| 2020-04-23 |
Putative Inhibitors of SARS-CoV-2 Main Protease from A Library of Marine Natural Products: A Virtual Screening and Molecular Modeling Study (edit) |
10.3390/MD18040225 |
| 2020-04-23 |
A data-driven hypothesis on the epigenetic dysregulation of host metabolism by SARS coronaviral infection: Potential implications for the SARS-CoV-2 modus operandi (edit) |
10.1016/J.MEHY.2020.109759 |
| 2020-04-23 |
Smoking habit and hospitalization for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-related pneumonia: The unsolved paradox behind the evidence (edit) |
10.1016/J.EJIM.2020.04.042 |
| 2020-04-23 |
Convalescent Plasma: Therapeutic Hope or Hopeless Strategy in the SARS-CoV-2 Pandemic (edit) |
10.1016/J.TMRV.2020.04.001 |
| 2020-04-23 |
SARS-CoV-2 detection in the pericardial fluid of a patient with cardiac tamponade (edit) |
10.1016/J.EJIM.2020.04.045 |
| 2020-04-23 |
The Malnutritional Status of the Host as a Virulence Factor for New Coronavirus SARS-CoV-2 (edit) |
10.3389/FMED.2020.00146 |
| 2020-04-23 |
Caring for cardiac patients amidst the SARS-CoV-2 pandemic: The scrambled pieces of the puzzle (edit) |
10.1016/J.REPC.2020.04.008 |
| 2020-04-23 |
Trends of SARS-Cov-2 infection in 67 countries: Role of climate zone, temperature, humidity and curve behavior of cumulative frequency on duplication time (edit) |
10.1101/2020.04.18.20070920 |
| 2020-04-23 |
The genomic variation landscape of globally-circulating clades of SARS-CoV-2 defines a genetic barcoding scheme (edit) |
10.1101/2020.04.21.054221 |
| 2020-04-23 |
A Semiempirical Dynamical Model to Forecast the Propagation of Epidemics: The Case of the Sars-Cov-2 in Spain (edit) |
10.1101/2020.04.19.20071860 |
| 2020-04-23 |
TMPRSS2 and TMPRSS4 mediate SARS-CoV-2 infection of human small intestinal enterocytes (edit) |
10.1101/2020.04.21.054015 |
| 2020-04-23 |
Population genomics insights into the recent evolution of SARS-CoV-2 (edit) |
10.1101/2020.04.21.054122 |
| 2020-04-23 |
The anticoagulant nafamostat potently inhibits SARS-CoV-2 infection in vitro: an existing drug with multiple possible therapeutic effects (edit) |
10.1101/2020.04.22.054981 |
| 2020-04-23 |
Identification of super-transmitters of SARS-CoV-2 (edit) |
10.1101/2020.04.19.20071399 |
| 2020-04-23 |
Epidemiological impact of SARS-CoV-2 vaccination: mathematical modeling analyses (edit) |
10.1101/2020.04.19.20070805 |
| 2020-04-23 |
Detection of SARS-CoV-2 RNA by direct RT-qPCR on nasopharyngeal specimens without extraction of viral RNA (edit) |
10.1101/2020.04.18.20070755 |
| 2020-04-23 |
A study on control of novel corona-virus (2019-nCoV) disease process by using PID controller (edit) |
10.1101/2020.04.19.20071654 |
| 2020-04-23 |
Indian Academy of Cytologists National Guidelines for Cytopathology Laboratories for Handling Suspected and Positive COVID-19 (SARS-CoV-2) Patient Samples (edit) |
10.4103/JOC.JOC_44_20 |
| 2020-04-23 |
Leadership and early strategic response to the SARS-CoV-2 pandemic at a COVID-19 designated hospital in South Africa (edit) |
10.7196/SAMJ.2020V110I6.14809 |
| 2020-04-22 |
Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2 (edit) |
10.2210/PDB6WIQ/PDB |
| 2020-04-22 |
Hypothesis: Advanced Biotechnological Treatment Approaches Against SARS-CoV-2 (COVID-19) (edit) |
10.38124/IJISRT20APR398 |
| 2020-04-22 |
The Need for Next Generation Diagnostic and Surveillance Technologies to Battle SARS-CoV-2 Pandemic (edit) |
10.37756/BK.20.2.4.2 |
| 2020-04-22 |
Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease (edit) |
10.1126/SCIENCE.ABB4489 |
| 2020-04-22 |
Systematic rapid "living" review on rehabilitation needs due to covid-19: update to march 31st 2020 (edit) |
10.23736/S1973-9087.20.06329-7 |
| 2020-04-22 |
[Expression analysis of 2019-nCoV related ACE2 and TMPRSS2 in eye tissues] (edit) |
10.3760/CMA.J.CN112142-20200310-00170 |
| 2020-04-22 |
COVID-19 Pandemic: Health System and Community Response to a Text Message (Text4Hope) Program Supporting Mental Health in Alberta (edit) |
10.1017/DMP.2020.114 |
| 2020-04-22 |
MANAGEMENT OF COVID-19 OUTBREAK IN ARGENTINA: THE BEGINNING (edit) |
10.1017/DMP.2020.116 |
| 2020-04-22 |
Outbreak trends of CoronaVirus (COVID-19) in India: A Prediction (edit) |
10.1017/DMP.2020.115 |
| 2020-04-22 |
Can the COVID-19 crisis strengthen our treatment escalation planning and resuscitation decision making? (edit) |
10.1093/AGEING/AFAA083 |
| 2020-04-22 |
Epidemiological and clinical characteristics of 26 asymptomatic SARS-CoV-2 carriers (edit) |
10.1093/INFDIS/JIAA205 |
| 2020-04-22 |
Multicenter initial guidance on use of antivirals for children with COVID-19/SARS-CoV-2 (edit) |
10.1093/JPIDS/PIAA045 |
| 2020-04-22 |
Fever without a source in a young infant due to SARS-CoV-2 (edit) |
10.1093/JPIDS/PIAA044 |
| 2020-04-22 |
Vaccine confidence in the time of COVID-19 (edit) |
10.1007/S10654-020-00634-3 |
| 2020-04-22 |
Points to consider in the preparation and transfusion of COVID-19 convalescent plasma (edit) |
10.1111/VOX.12939 |
| 2020-04-22 |
Two X-linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover (edit) |
10.1111/PAI.13263 |
| 2020-04-22 |
Successful containment of COVID-19 outbreak in a large maternity and perinatal center while continuing clinical service (edit) |
10.1111/PAI.13265 |
| 2020-04-22 |
COVID-19 and viral hepatitis elimination programs: Are we stepping backward? (edit) |
10.1111/LIV.14486 |
| 2020-04-22 |
Transmission potential of asymptomatic and paucisymptomatic SARS-CoV-2 infections: a three-family cluster study in China (edit) |
10.1093/INFDIS/JIAA206 |
| 2020-04-22 |
Telemedicine in neurosurgery during the novel coronavirus (COVID-19) pandemic (edit) |
|
| 2020-04-22 |
Letter to the Editor Regarding: "An Imperative Need for Research on the Role of Environmental Factors in Transmission of Novel Coronavirus (COVID-19)" -Secondhand and Thirdhand Smoke As Potential Sources of COVID-19 (edit) |
10.1021/ACS.EST.0C02041 |
| 2020-04-22 |
Unexpected Findings of Coronavirus Disease (COVID-19) at the Lung Bases on Abdominopelvic CT (edit) |
10.2214/AJR.20.23240 |
| 2020-04-22 |
Special Issue: Digital Health in Times of COVID-19 (edit) |
10.1089/OMI.2020.0049 |
| 2020-04-22 |
Knowledge of Coronavirus disease 2019 (COVID-19) by medical personnel in a rural area of Thailand: an observation (edit) |
10.1017/ICE.2020.159 |
| 2020-04-22 |
CT challenges the result of SARS-CoV-2 nucleic acid test in a suspected COVID-19 case (edit) |
10.1017/ICE.2020.171 |
| 2020-04-22 |
Critical role of Wuhan cabin hospital in controlling local COVID-19 pandemic (edit) |
10.1017/ICE.2020.167 |
| 2020-04-22 |
Borderless collaboration is needed for COVID-19; a disease that knows no borders (edit) |
10.1017/ICE.2020.162 |
| 2020-04-22 |
The depressive state of Denmark during the COVID-19 pandemic (edit) |
10.1017/NEU.2020.15 |
| 2020-04-22 |
Transparency and information sharing could help abate the COVID-19 pandemic (edit) |
10.1017/ICE.2020.174 |
| 2020-04-22 |
May hydrogen peroxide reduce the hospitalization rate and complications of SARS-CoV-2 infection? (edit) |
10.1017/ICE.2020.170 |
| 2020-04-22 |
Ramadan coincides with the Covid-19 pandemic: What should be done? (edit) |
10.1017/DMP.2020.117 |
| 2020-04-22 |
Extended use or reuse of N95 respirators during COVID-19 pandemic: an overview of national regulatory authorities' recommendations (edit) |
10.1017/ICE.2020.173 |
| 2020-04-22 |
Anosmia as a prominent symptom of COVID-19 infection (edit) |
10.4193/RHIN20.140 |
| 2020-04-22 |
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Children and Adolescents (edit) |
10.1001/JAMAPEDIATRICS.2020.1467 |
| 2020-04-22 |
Risks of ACE inhibitor and ARB usage in COVID‐19: evaluating the evidence (edit) |
10.1002/CPT.1863 |
| 2020-04-22 |
Preliminary estimating the reproduction number of the coronavirus disease (COVID-19) outbreak in Republic of Korea and Italy by 5 March 2020 (edit) |
10.1016/J.IJID.2020.04.044 |
| 2020-04-22 |
Hydroxychloroquine for the management of COVID-19: Hope or Hype? A Systematic review of the current evidence (edit) |
10.1101/2020.04.16.20068205 |
| 2020-04-22 |
Effectiveness of Intravenous Immunoglobulin for Children with Severe COVID-19: A Rapid Review (edit) |
10.1101/2020.04.17.20064444 |
| 2020-04-22 |
Effectiveness and Safety of Glucocorticoids to Treat COVID-19: A Rapid Review and Meta-Analysis (edit) |
10.1101/2020.04.17.20064469 |
| 2020-04-22 |
Persistent viral shedding of SARS-CoV-2 in faeces - a rapid review (edit) |
10.1101/2020.04.17.20069526 |
| 2020-04-22 |
The role of corticosteroids in the management of critically ill patients with coronavirus disease 2019 (COVID-19): A meta-analysis (edit) |
10.1101/2020.04.17.20069773 |
| 2020-04-22 |
The Novel Coronavirus Disease (COVID-19): A PRISMA Systematic Review and Meta-analysis of Clinical and Paraclinical characteristics (edit) |
10.1101/2020.04.19.20071456 |
| 2020-04-22 |
Alterations in Smell or Taste in Mildly Symptomatic Outpatients With SARS-CoV-2 Infection (edit) |
10.1001/JAMA.2020.6771 |
| 2020-04-22 |
Evaluation of the auxiliary diagnostic value of antibody assays for the detection of novel coronavirus (SARS-CoV-2) (edit) |
10.1002/JMV.25919 |
| 2020-04-22 |
Anti-SARS-CoV-2 virus antibody levels in convalescent plasma of six donors who have recovered from COVID-19 (edit) |
10.18632/AGING.103102 |
| 2020-04-22 |
Impact of population movement on the spread of 2019-nCoV in China (edit) |
10.1080/22221751.2020.1760143 |
| 2020-04-22 |
Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant (edit) |
10.1186/S12967-020-02344-6 |
| 2020-04-22 |
To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (COVID-19) pandemic (edit) |
10.1136/ANNRHEUMDIS-2020-217557 |
| 2020-04-22 |
The most eagerly awaited summer of the Anthropocene: A perspective of SARS-CoV-2 decay and seasonal change (edit) |
10.1016/J.GSD.2020.100400 |
| 2020-04-22 |
SARS-CoV-2 pandemic expanding in sub-Saharan Africa: Considerations for COVID-19 in people living with HIV (edit) |
10.1016/J.ECLINM.2020.100342 |
| 2020-04-22 |
Thrombotic events in SARS-CoV-2 patients: an urgent call for ultrasound screening (edit) |
10.1007/S00134-020-06040-3 |
| 2020-04-22 |
SARS-CoV-2 as potential cause of cardiac inflammation and heart failure. Is it the virus, hyperinflammation, or MODS? (edit) |
10.1007/S00059-020-04925-Z |
| 2020-04-22 |
Emergency Endoscopy During the SARS-CoV-2 Pandemic in the North of Italy: Experience from St. Orsola University Hospital-Bologna (edit) |
10.1007/S10620-020-06270-X |
| 2020-04-22 |
Inpatient care for dermatological patients during SARS-CoV-2 - a case report from Portugal (edit) |
10.1111/IJD.14913 |
| 2020-04-22 |
Asymptomatiske smittebærere av sars-CoV-2 i sykehjem (edit) |
10.4045/TIDSSKR.20.0316 |
| 2020-04-22 |
Sex-Specific SARS-CoV-2 Mortality: Among Hormone-Modulated ACE2 Expression, Risk of Venous Thromboembolism and Hypovitaminosis D (edit) |
10.3390/IJMS21082948 |
| 2020-04-22 |
Screening FMT donors during the COVID-19 pandemic: a protocol for stool SARS-CoV-2 viral quantification (edit) |
10.1016/S2468-1253(20)30124-2 |
| 2020-04-22 |
No SARS-CoV-2 detected in amniotic fluid in mid-pregnancy (edit) |
10.1016/S1473-3099(20)30320-0 |
| 2020-04-22 |
Presepsin in risk stratification of SARS-CoV-2 patients (edit) |
10.1016/J.CCA.2020.04.020 |
| 2020-04-22 |
Prevalence and Characteristics of Gastrointestinal Symptoms in Patients with SARS-CoV-2 Infection in the United States: A Multicenter Cohort Study (edit) |
10.1053/J.GASTRO.2020.04.045 |
| 2020-04-22 |
Association of Respiratory Allergy, Asthma and Expression of the SARS-CoV-2 Receptor, ACE2 (edit) |
10.1016/J.JACI.2020.04.009 |
| 2020-04-22 |
Repurposing the mucolytic cough suppressant and TMPRSS2 protease inhibitor bromhexine for the prevention and management of SARS-CoV-2 infection (edit) |
10.1016/J.PHRS.2020.104837 |
| 2020-04-22 |
ACE2 Expression in Pancreas May Cause Pancreatic Damage After SARS-CoV-2 Infection (edit) |
10.1016/J.CGH.2020.04.040 |
| 2020-04-22 |
Travel rush during Chinese Spring Festival and the 2019-nCoV (edit) |
10.1016/J.TMAID.2020.101686 |
| 2020-04-22 |
SARS-CoV-2 and COVID-19: What are our options? Where should we focus our attention on to find new drugs and strategies? (edit) |
10.1016/J.TMAID.2020.101685 |
| 2020-04-22 |
Suggesting Ritonavir against COVID-19/SARS-CoV-2 (edit) |
10.1016/J.MEHY.2020.109764 |
| 2020-04-22 |
2019-nCoV-SARS-CoV-2 (COVID-19) infection: Crucıalıty of Furın and relevance wıth cancer (edit) |
10.1016/J.MEHY.2020.109770 |
| 2020-04-22 |
Ad hoc laboratory-based surveillance of SARS-CoV-2 by real-time RT-PCR using minipools of RNA prepared from routine respiratory samples (edit) |
10.1016/J.JCV.2020.104381 |
| 2020-04-22 |
Phytotherapeutics and SARS-CoV-2 infection: Potential role of bioflavonoids (edit) |
10.1016/J.MEHY.2020.109766 |
| 2020-04-22 |
SARS-CoV-2 infection control measures for the anesthesiology department: experience from the Sichuan Provincial People's Hospital, China (edit) |
10.1016/J.JCLINANE.2020.109846 |
| 2020-04-22 |
American Association of Hip and Knee Surgeons Advocacy Efforts in Response to the SARS-CoV-2 Pandemic (edit) |
10.1016/J.ARTH.2020.04.050 |
| 2020-04-22 |
Guillain-Barré syndrome associated with SARS-CoV-2 infection (edit) |
10.1016/J.NRL.2020.04.007 |
| 2020-04-22 |
Intensive Medicine and Nursing Home Care in Times of SARS CoV-2: A Norwegian Perspective (edit) |
10.1016/J.JAGP.2020.04.016 |
| 2020-04-22 |
Computational analysis of SARS-CoV-2/COVID-19 surveillance by wastewater-based epidemiology locally and globally: Feasibility, economy, opportunities and challenges (edit) |
10.1016/J.SCITOTENV.2020.138875 |
| 2020-04-22 |
Hypothesized behavioral host manipulation by SARS-CoV2/COVID-19 infection (edit) |
10.1016/J.MEHY.2020.109750 |
| 2020-04-22 |
Prioritisation of potential anti-SARS-CoV-2 drug repurposing opportunities based on ability to achieve adequate target site concentrations derived from their established human pharmacokinetics (edit) |
10.1101/2020.04.16.20068379 |
| 2020-04-22 |
Revealing COVID-19 Transmission by SARS-CoV-2 Genome Sequencing and Agent Based Modelling (edit) |
10.1101/2020.04.19.048751 |
| 2020-04-22 |
Synonymous mutations and the molecular evolution of SARS-Cov-2 origins (edit) |
10.1101/2020.04.20.052019 |
| 2020-04-22 |
A Scalable, Easy-to-Deploy, Protocol for Cas13-Based Detection of SARS-CoV-2 Genetic Material (edit) |
10.1101/2020.04.20.052159 |
| 2020-04-22 |
Structural Basis of SARS-CoV-2 Spike Protein Priming by TMPRSS2 (edit) |
10.1101/2020.04.21.052639 |
| 2020-04-22 |
Large-scale implementation of pooled RNA-extraction and RT-PCR for SARS-CoV-2 detection (edit) |
10.1101/2020.04.17.20069062 |
| 2020-04-22 |
Inhibition of PIKfyve kinase prevents infection by EBOV and SARS-CoV-2 (edit) |
10.1101/2020.04.21.053058 |
| 2020-04-22 |
Bioinformatics Study on Structural Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2) For Better Understanding the Vaccine Development (edit) |
10.1101/2020.04.21.053199 |
| 2020-04-22 |
Human iPSC-Derived Cardiomyocytes are Susceptible to SARS-CoV-2 Infection (edit) |
10.1101/2020.04.21.051912 |
| 2020-04-22 |
Saliva is more sensitive for SARS-CoV-2 detection in COVID-19 patients than nasopharyngeal swabs (edit) |
10.1101/2020.04.16.20067835 |
| 2020-04-22 |
Cholesterol Metabolism--Impact for SARS-CoV-2 Infection Prognosis, Entry, and Antiviral Therapies (edit) |
10.1101/2020.04.16.20068528 |
| 2020-04-22 |
Importance of Social Distancing: Modeling the spread of 2019-nCoV using Susceptible-Infected-Quarantined-Recovered-t model (edit) |
10.1101/2020.04.17.20069245 |
| 2020-04-22 |
Artificial intelligence predicts the immunogenic landscape of SARS-CoV-2: toward universal blueprints for vaccine designs (edit) |
10.1101/2020.04.21.052084 |
| 2020-04-22 |
Cross-reactive neutralization of SARS-CoV-2 by serum antibodies from recovered SARS patients and immunized animals (edit) |
10.1101/2020.04.20.052126 |
| 2020-04-22 |
Elucidating the differences in the molecular mechanism of receptor binding between 2019-nCoV and the SARS-CoV viruses using computational tools (edit) |
10.1101/2020.04.21.053009 |
| 2020-04-22 |
Enisamium is a small molecule inhibitor of the influenza A virus and SARS-CoV-2 RNA polymerases (edit) |
10.1101/2020.04.21.053017 |
| 2020-04-22 |
Molecular Detection of SARS-CoV-2 in Formalin Fixed Paraffin Embedded Specimens (edit) |
10.1101/2020.04.21.042911 |
| 2020-04-22 |
Presence of SARS-CoV-2 reactive T cells in COVID-19 patients and healthy donors (edit) |
10.1101/2020.04.17.20061440 |
| 2020-04-22 |
COVID-19 diagnosis and study of serum SARS-CoV-2 specific IgA, IgM and IgG by chemiluminescence immunoanalysis (edit) |
10.1101/2020.04.17.20064907 |
| 2020-04-22 |
SARS-CoV-2 Encodes a PPxY Late Domain Motif that is Known to Enhance Budding and Spread in Enveloped RNA Viruses (edit) |
10.1101/2020.04.20.052217 |
| 2020-04-22 |
Dynamical asymmetry exposes 2019-nCoV prefusion spike (edit) |
10.1101/2020.04.20.052290 |
| 2020-04-22 |
Predicting the epidemic curve of the coronavirus (SARS-CoV-2) disease (COVID-19) using artificial intelligence (edit) |
10.1101/2020.04.17.20069666 |
| 2020-04-22 |
Evidence for probable aerosol transmission of SARS-CoV-2 in a poorly ventilated restaurant (edit) |
10.1101/2020.04.16.20067728 |
| 2020-04-22 |
Comparison of Four Molecular In Vitro Diagnostic Assays for the Detection of SARS-CoV-2 in Nasopharyngeal Specimens (edit) |
10.1101/2020.04.17.20069864 |
| 2020-04-22 |
An 81 base-pair deletion in SARS-CoV-2 ORF7a identified from sentinel surveillance in Arizona (Jan-Mar 2020) (edit) |
10.1101/2020.04.17.20069641 |
| 2020-04-22 |
Computational Models Identify Several FDA Approved or Experimental Drugs as Putative Agents Against SARS-CoV-2 (edit) |
10.26434/CHEMRXIV.12153594 |
| 2020-04-22 |
Criminalisation of transmission of SARS-CoV-2: A potential challenge to controlling the outbreak in South Africa (edit) |
10.7196/SAMJ.2020V110I6.14753 |
| 2020-04-21 |
SARS-CoV-2 Epidemiology and Control, Different Scenarios for Turkey (edit) |
10.3906/SAG-2003-260 |
| 2020-04-21 |
The early impact of the Covid-19 pandemic on the global and Turkish economy (edit) |
10.3906/SAG-2004-6 |
| 2020-04-21 |
Coronaviruses and SARS-COV-2 (edit) |
10.3906/SAG-2004-127 |
| 2020-04-21 |
COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs (edit) |
10.3906/SAG-2004-168 |
| 2020-04-21 |
Managing COVID-19-Positive Maternal-Infant Dyads: An Italian Experience (edit) |
10.1089/BFM.2020.0095 |
| 2020-04-21 |
Consequences of COVID-19 on international medical graduates and students applying to residencies in the United States (edit) |
10.3946/KJME.2020.156 |
| 2020-04-21 |
Trauma and orthopaedics in the COVID-19 pandemic: breaking every wave (edit) |
10.11622/SMEDJ.2020063 |
| 2020-04-21 |
Variable computed tomography appearances of COVID-19 (edit) |
10.11622/SMEDJ.2020066 |
| 2020-04-21 |
An elderly couple with COVID-19 pneumonia treated in Singapore: contrasting clinical course and management (edit) |
10.11622/SMEDJ.2020064 |
| 2020-04-21 |
Insights on Otolaryngology Residency Training during the COVID-19 Pandemic (edit) |
10.1177/0194599820922502 |
| 2020-04-21 |
Impact of the COVID-19 Pandemic on the Management of Head and Neck Malignancies (edit) |
10.1177/0194599820921413 |
| 2020-04-21 |
Flexible Laryngoscopy and COVID-19 (edit) |
10.1177/0194599820921395 |
| 2020-04-21 |
Peritoneal Dialysis in the time of COVID-19 (edit) |
10.1177/0896860820921657 |
| 2020-04-21 |
Detroit Under Siege: The Enemy Within: The impact of the Covid-19 Collision (edit) |
10.1017/ICE.2020.154 |
| 2020-04-21 |
Report from the COVID-19 Virtual Summit, Disaster Experts Speak Out, March 31, 2020 (edit) |
10.1017/S1049023X20000552 |
| 2020-04-21 |
Redistributing of Working Schedules by the Infective Principle - Will The COVID-19 Pandemic Finally Make Us Remember the Names of People We Shake Hands With? (edit) |
10.1017/ICE.2020.155 |
| 2020-04-21 |
Recommendation of a practical guideline for safe tracheostomy during the COVID-19 pandemic (edit) |
10.1007/S00405-020-05993-X |
| 2020-04-21 |
Response of a tertiary dermatology department to COVID-19 (edit) |
10.1111/AJD.13298 |
| 2020-04-21 |
Comment on "Cutaneous manifestations in COVID-19: a first perspective " by Recalcati S (edit) |
10.1111/JDV.16519 |
| 2020-04-21 |
Obesity and SARS-CoV-2: a population to safeguard (edit) |
10.1002/DMRR.3325 |
| 2020-04-21 |
COVID-19: Leaving Lockdown - Of Schrodinger, Cats, Testing and Masks (edit) |
10.1111/IJCP.13519 |
| 2020-04-21 |
Zoonotic origins of human coronavirus 2019 (HCoV-19 / SARS-CoV-2): why is this work important? (edit) |
10.24272/J.ISSN.2095-8137.2020.031 |
| 2020-04-21 |
Challenges in Heart Transplantation in the Era of COVID-19 (edit) |
10.1161/CIRCULATIONAHA.120.047096 |
| 2020-04-21 |
Preparing for COVID-19's aftermath: simple steps to address social determinants of health (edit) |
10.1177/0141076820921655 |
| 2020-04-21 |
A Frail Health Care System for an Old Population: Lesson form the COVID-19 Outbreak in Italy (edit) |
10.1093/GERONA/GLAA087 |
| 2020-04-21 |
Challenges in the Care of IBD Patients During the CoViD-19 Pandemic: Report From a "Red Zone" Area in Northern Italy (edit) |
10.1093/IBD/IZAA084 |
| 2020-04-21 |
COVID-19 Infection in Patients with Sickle Cell Disease (edit) |
10.1111/BJH.16734 |
| 2020-04-21 |
Letter to the Editor: Acute hypertriglyceridemia in patients with COVID-19 receiving tocilizumab (edit) |
10.1002/JMV.25907 |
| 2020-04-21 |
Epidemiological trends of COVID-19 epidemic in Italy during March 2020. From 1,000 to 100,000 cases (edit) |
10.1002/JMV.25908 |
| 2020-04-21 |
CT imaging features of 4,121 patients with COVID-19: a meta-analysis (edit) |
10.1002/JMV.25910 |
| 2020-04-21 |
Psychological stress of medical staffs during outbreak of COVID-19 and adjustment strategy (edit) |
10.1002/JMV.25914 |
| 2020-04-21 |
Comment on Li et al.: COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis (edit) |
10.1002/JMV.25912 |
| 2020-04-21 |
Central Nervous System Involvement by Severe Acute Respiratory Syndrome Coronavirus -2 (SARS-CoV-2) (edit) |
10.1002/JMV.25915 |
| 2020-04-21 |
Understanding evolution of SARS-CoV-2: a perspective from analysis of genetic diversity of RdRp gene (edit) |
10.1002/JMV.25909 |
| 2020-04-21 |
An effective screening and management process in the outpatient clinic for patients requiring hospitalization during the COVID-19 pandemic (edit) |
10.1002/JMV.25916 |
| 2020-04-21 |
Obesity is associated with severe forms of COVID-19 (edit) |
10.1002/OBY.22842 |
| 2020-04-21 |
Targeting the Adipose Tissue in COVID-19 (edit) |
10.1002/OBY.22844 |
| 2020-04-21 |
Society for Vascular Medicine (SVM) Leaders Respond to the COVID-19 Crisis (edit) |
10.1177/1358863X20922772 |
| 2020-04-21 |
Public health decision-making in the real world: Four points to reshape it after COVID-19 (edit) |
10.1017/DMP.2020.108 |
| 2020-04-21 |
Public Health and COVID-19: From Response to Recovery (edit) |
10.1017/DMP.2020.111 |
| 2020-04-21 |
COVID-19 Community Stabilization and Sustainability Framework: An Integration of the Maslow Hierarchy of Needs and Social Determinants of Health (edit) |
10.1017/DMP.2020.109 |
| 2020-04-21 |
After the COVID-19 Pandemic: The Next Wave of Health Challenges for Older Adults (edit) |
10.1093/GERONA/GLAA102 |
| 2020-04-21 |
Responding to the COVID-19 outbreak in Singapore: Staff Protection and Staff Temperature and Sickness Surveillance Systems (edit) |
10.1093/CID/CIAA468 |
| 2020-04-21 |
Letter to the Editor: "Our Response to COVID-19 as Endocrinologists and Diabetologists" (edit) |
10.1210/CLINEM/DGAA224 |
| 2020-04-21 |
Cutaneous Clinico-Pathological Findings in three COVID-19-Positive Patients Observed in the Metropolitan Area of Milan, Italy (edit) |
10.2340/00015555-3490 |
| 2020-04-21 |
COVID-19, Postacute Care Preparedness, and Nursing Homes (edit) |
10.1111/JGS.16499 |
| 2020-04-21 |
Participant and Caregiver Perspectives on Clinical Research During Covid-19 Pandemic (edit) |
10.1111/JGS.16500 |
| 2020-04-21 |
Varicella-like exanthem associated with COVID-19 in an 8-year-old girl: A diagnostic clue? (edit) |
10.1111/PDE.14201 |
| 2020-04-21 |
Managing a tertiary-level NICU in the time of COVID-19: Lessons learned from a high-risk zone (edit) |
10.1002/PPUL.24788 |
| 2020-04-21 |
COVID-19 in a High-Risk Dual Heart and Kidney Transplant Recipient (edit) |
10.1111/AJT.15936 |
| 2020-04-21 |
Is COVID-19 the first pandemic that evolves into a panzootic? (edit) |
10.12834/VETIT.2246.12523.1 |
| 2020-04-21 |
Fast Identification of Possible Drug Treatment of Coronavirus Disease -19 (COVID-19) Through Computational Drug Repurposing Study (edit) |
10.1021/ACS.JCIM.0C00179 |
| 2020-04-21 |
Mobilization and Preparation of a Large Urban Academic Center During the COVID-19 Pandemic (edit) |
10.1513/ANNALSATS.202003-259PS |
| 2020-04-21 |
Lessons learned from COVID-19 epidemic in Iran: The role of medical education (edit) |
10.1080/0142159X.2020.1754376 |
| 2020-04-21 |
Family Member Visits to Critically Ill Patients During COVID-19: A New Pathway (Telemed J E Health 2020. [Epub ahead of print]; DOI: 10.1089/tmj.2020.29040.rb) (edit) |
10.1089/TMJ.2020.0097 |
| 2020-04-21 |
Information Overload: A Method to Share Updates among Frontline Staff during the COVID-19 Pandemic (edit) |
10.1177/0194599820922988 |
| 2020-04-21 |
Annals for Hospitalists Inpatient Notes - Preparing for Battle: How Hospitalists Can Manage the Stress of COVID-19 (edit) |
10.7326/M20-1897 |
| 2020-04-21 |
Rapid detection of COVID-19 coronavirus using a reverse transcriptional loop-mediated isothermal amplification (RT-LAMP) diagnostic platform (edit) |
10.1093/CLINCHEM/HVAA102 |
| 2020-04-21 |
Response letter to Eosinophil count in severe coronavirus disease 2019 (COVID-19) (edit) |
10.1093/QJMED/HCAA138 |
| 2020-04-21 |
Eosinophil count in severe coronavirus disease 2019 (COVID-19) (edit) |
10.1093/QJMED/HCAA137 |
| 2020-04-21 |
Clinical and Autoimmune Characteristics of Severe and Critical Cases with COVID-19 (edit) |
10.1111/CTS.12805 |
| 2020-04-21 |
A Call for Rational Intensive Care in the Era of COVID-19 (edit) |
10.1165/RCMB.2020-0151LE |
| 2020-04-21 |
Protecting older people from COVID-19: should the United Kingdom start at age 60? (edit) |
10.1177/0141076820921107 |
| 2020-04-21 |
What COVID-19 means for non-neurotypical children and their families (edit) |
10.1038/S41390-020-0913-7 |
| 2020-04-21 |
[Management of Patients with COVID-19 - Recommendations from a Palliative Care Perspective] (edit) |
10.1055/A-1156-2759 |
| 2020-04-21 |
Prevention and Treatment of Venous Thromboembolism Associated with Coronavirus Disease 2019 Infection: A Consensus Statement before Guidelines (edit) |
10.1055/S-0040-1710019 |
| 2020-04-21 |
Addressing the Experience of Children and Adolescents During the COVID-19 Pandemic (edit) |
10.4088/JCP.20ED13394 |
| 2020-04-21 |
COVID-19 FAQ's in Pediatric Cardiac Surgery (edit) |
10.1177/2150135120924653 |
| 2020-04-21 |
COVID-19 and orthopaedic surgeons: the Indian scenario (edit) |
10.1177/0049475520921616 |
| 2020-04-21 |
COVID-19: Facts, Cultural Considerations, and Risk of Stigmatization (edit) |
10.1177/1043659620917724 |
| 2020-04-21 |
What will we learn from covid-19? That we live in an uncertain world (edit) |
10.1136/BMJ.M1578 |
| 2020-04-21 |
Covid-19: doctors are warned not to go public about PPE shortages (edit) |
10.1136/BMJ.M1592 |
| 2020-04-21 |
Covid 19: death certification in England and Wales (edit) |
10.1136/BMJ.M1571 |
| 2020-04-21 |
Covid-19: the precarious position of Spain's nursing homes (edit) |
10.1136/BMJ.M1586 |
| 2020-04-21 |
Validation of the Hologic's Aptima Unisex and Multitest Specimen collection kits used for Endocervical and Male Urethral Swab Specimen (Aptima Swab) for sample collection of SARS-CoV-2 (edit) |
10.1128/JCM.00753-20 |
| 2020-04-21 |
Saliva as a non-invasive specimen for detection of SARS-CoV-2 (edit) |
10.1128/JCM.00776-20 |
| 2020-04-21 |
Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study (edit) |
10.1136/BMJ.M1443 |
| 2020-04-21 |
Managing high clinical suspicion COVID-19 inpatients with negative RT-PCR: a pragmatic and limited role for thoracic CT (edit) |
10.1136/THORAXJNL-2020-214916 |
| 2020-04-21 |
Tackling covid-19: are the costs worth the benefits? (edit) |
10.1136/BMJ.M1496 |
| 2020-04-21 |
SARS-CoV-2 infection associated with spontaneous pneumothorax (edit) |
10.1503/CMAJ.200609 |
| 2020-04-21 |
Redesign of a rural emergency department to prepare for the COVID-19 pandemic (edit) |
10.1503/CMAJ.200509 |
| 2020-04-21 |
Covid-19: UK pledges to reintroduce contact tracing to fight virus (edit) |
10.1136/BMJ.M1591 |
| 2020-04-21 |
Covid-19: Trump stokes protests against social distancing measures (edit) |
10.1136/BMJ.M1596 |
| 2020-04-21 |
Lung Ultrasound in Children With COVID-19 (edit) |
10.1542/PEDS.2020-1157 |
| 2020-04-21 |
Mitigating the Impacts of the COVID-19 Pandemic Response on At-Risk Children (edit) |
10.1542/PEDS.2020-0973 |
| 2020-04-21 |
Is there a future for hydroxychloroquine/chloroquine in prevention of SARS-CoV-2 infection (COVID-19)? (edit) |
10.1136/ANNRHEUMDIS-2020-217570 |
| 2020-04-21 |
Hydroxychloroquine reduces the risk of covid-19 in patients with rheumatic diseases: myth or reality? (edit) |
10.1136/ANNRHEUMDIS-2020-217556 |
| 2020-04-21 |
Covid-19 and mental health: a transformational opportunity to apply an evidence-based approach to clinical practice and research (edit) |
10.1136/EBMENTAL-2020-300155 |
| 2020-04-21 |
Covid-19: Brazil's president rallies supporters against social distancing (edit) |
10.1136/BMJ.M1589 |
| 2020-04-21 |
The potential danger of suboptimal antibody responses in COVID-19 (edit) |
10.1038/S41577-020-0321-6 |
| 2020-04-21 |
COVID-19: the risk of respiratory techniques in healthcare workers (edit) |
10.1038/S41393-020-0472-0 |
| 2020-04-21 |
Maintenance of ophthalmic specialist out-patient service during the COVID-19 outbreak: The University of Hong Kong experience (edit) |
10.1038/S41433-020-0887-Z |
| 2020-04-21 |
Carpal Fracture and COVID-19 Infection: Observation from Thailand (edit) |
10.1007/S43465-020-00112-8 |
| 2020-04-21 |
[COVID-19 in hospitalized children and adolescents] (edit) |
10.1007/S00112-020-00919-7 |
| 2020-04-21 |
Converting Home Spaces into Food Gardens at the Time of Covid-19 Quarantine: all the Benefits of Plants in this Difficult and Unprecedented Period (edit) |
10.1007/S10745-020-00147-3 |
| 2020-04-21 |
Key elements of preparedness for pandemic coronavirus disease 2019 (COVID-19) in nuclear medicine units (edit) |
10.1007/S00259-020-04780-4 |
| 2020-04-21 |
Treating neovascular age-related macular degeneration in the era of COVID-19 (edit) |
10.1007/S00417-020-04693-W |
| 2020-04-21 |
The Radiology Department during the COVID-19 pandemic: a challenging, radical change (edit) |
10.1007/S00330-020-06871-0 |
| 2020-04-21 |
Does COVID-19 affect male fertility? (edit) |
10.1007/S00345-020-03208-W |
| 2020-04-21 |
Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response (edit) |
10.1007/S11886-020-01292-3 |
| 2020-04-21 |
Sonographic signs and patterns of COVID-19 pneumonia (edit) |
10.1186/S13089-020-00171-W |
| 2020-04-21 |
The paramount importance of serological surveys of SARS-CoV-2 infection and immunity (edit) |
10.1007/S10654-020-00635-2 |
| 2020-04-21 |
Imaging characteristics of initial chest computed tomography and clinical manifestations of patients with COVID-19 pneumonia (edit) |
10.1007/S11604-020-00973-X |
| 2020-04-21 |
The response during a pandemic is a blurred vision of the future. Reflections on the Lombardy reorganization of the neurosurgical emergencies during the COVID-19 (edit) |
10.1007/S00701-020-04327-4 |
| 2020-04-21 |
Advances in COVID-19: the virus, the pathogenesis, and evidence-based control and therapeutic strategies (edit) |
10.1007/S11684-020-0773-X |
| 2020-04-21 |
Knowledge, Perceptions, and Attitude of Egyptians Towards the Novel Coronavirus Disease (COVID-19) (edit) |
10.1007/S10900-020-00827-7 |
| 2020-04-21 |
Patient self-proning with high-flow nasal cannula improves oxygenation in COVID-19 pneumonia (edit) |
10.1007/S12630-020-01661-0 |
| 2020-04-21 |
The Effect of COVID-19 on Youth Mental Health (edit) |
10.1007/S11126-020-09744-3 |
| 2020-04-21 |
The COVID-19 pandemic: some lessons learned about crisis preparedness and management, and the need for international benchmarking to reduce deficits (edit) |
10.1111/1462-2920.15029 |
| 2020-04-21 |
Therapeutic uncertainties in people with cardiometabolic diseases and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 or COVID-19) (edit) |
10.1111/DOM.14062 |
| 2020-04-21 |
The challenge of managing patients with COVID-19 and acute behavioural disturbances (edit) |
10.1111/1742-6723.13522 |
| 2020-04-21 |
A Case of SARS-CoV-2-pneumonia with successful antiviral therapy in a 77-year-old male with heart transplant (edit) |
10.1111/AJT.15932 |
| 2020-04-21 |
Covid-19 and Namaste (edit) |
10.1111/IRV.12746 |
| 2020-04-21 |
COVID-19 and cardiovascular disorder (edit) |
10.23736/S0026-4725.20.05269-X |
| 2020-04-21 |
Respiratory Support in Novel Coronavirus Disease (COVID-19) Patients, with a Focus on Resource-Limited Settings (edit) |
10.4269/AJTMH.20-0283 |
| 2020-04-21 |
FALSE-NEGATIVE RESULTS OF INITIAL RT-PCR ASSAYS FOR COVID-19: A SYSTEMATIC REVIEW (edit) |
10.1101/2020.04.16.20066787 |
| 2020-04-21 |
Can Nanotechnology and Materials Science Help the Fight against SARS-CoV-2? (edit) |
10.3390/NANO10040802 |
| 2020-04-21 |
Characteristics and prognosis of patients with inflammatory bowel disease during the SARS-CoV-2 pandemic in the Basque Country (Spain) (edit) |
10.1053/J.GASTRO.2020.04.043 |
| 2020-04-21 |
Combination of Biodata Mining and Computational Modelling in Identification and Characterization of ORF1ab Polyprotein of SARS-CoV-2 Isolated from Oronasopharynx of an Iranian Patient (edit) |
10.1186/S12575-020-00121-9 |
| 2020-04-21 |
Ocular Findings and Proportion with Conjunctival SARS-COV-2 in COVID-19 Patients (edit) |
10.1016/J.OPHTHA.2020.04.028 |
| 2020-04-21 |
Sleep problems and medical isolation during the SARS-CoV-2 outbreak (edit) |
10.1016/J.SLEEP.2020.04.014 |
| 2020-04-21 |
Co-infection with SARS-CoV-2 and influenza A virus (edit) |
10.1016/J.IDCR.2020.E00775 |
| 2020-04-21 |
Coronavirus Pandemic (SARS-COV-2): Pre-Exercise Screening Questionnaire (PESQ) for Telepresential Exercise (edit) |
10.3389/FPUBH.2020.00146 |
| 2020-04-21 |
Is Pakistan's Response to Coronavirus (SARS-CoV-2) Adequate to Prevent an Outbreak? (edit) |
10.3389/FMED.2020.00158 |
| 2020-04-21 |
Epidemiological and Genomic Analysis of SARS-CoV-2 in Ten Patients from a Mid-sized City outside of Hubei, China (edit) |
10.1101/2020.04.16.20058560 |
| 2020-04-21 |
Sequencing identifies multiple, early introductions of SARS-CoV2 to New York City Region (edit) |
10.1101/2020.04.15.20064931 |
| 2020-04-21 |
Interplay of host regulatory network on SARS-CoV-2 binding and replication machinery (edit) |
10.1101/2020.04.20.050138 |
| 2020-04-21 |
Development and Multicenter Performance Evaluation of The First Fully Automated SARS-CoV-2 IgM and IgG Immunoassays (edit) |
10.1101/2020.04.16.20067231 |
| 2020-04-21 |
Two patients with acute meningo-encephalitis concomitant to SARS-CoV-2 infection (edit) |
10.1101/2020.04.17.20060251 |
| 2020-04-21 |
Exceptional diversity and selection pressure on SARS-CoV and SARS-CoV-2 host receptor in bats compared to other mammals (edit) |
10.1101/2020.04.20.051656 |
| 2020-04-21 |
Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease (edit) |
10.1101/2020.04.20.051581 |
| 2020-04-21 |
Integrated analyses of single-cell atlases reveal age, gender, and smoking status associations with cell type-specific expression of mediators of SARS-CoV-2 viral entry and highlights inflammatory programs in putative target cells (edit) |
10.1101/2020.04.19.049254 |
| 2020-04-21 |
Design an efficient multi-epitope peptide vaccine candidate against SARS-CoV-2: An in silico analysis (edit) |
10.1101/2020.04.20.051557 |
| 2020-04-21 |
Blocking antibodies against SARS-CoV-2 RBD isolated from a phage display antibody library using a competitive biopanning strategy (edit) |
10.1101/2020.04.19.049643 |
| 2020-04-21 |
Limited SARS-CoV-2 diversity within hosts and following passage in cell culture (edit) |
10.1101/2020.04.20.051011 |
| 2020-04-21 |
Phylodynamics of SARS-CoV-2 transmission in Spain (edit) |
10.1101/2020.04.20.050039 |
| 2020-04-21 |
A Pediatric Emergency Department Protocol to Avoid Intrahospital Spread of SARS-CoV-2 during the Outbreak in Bergamo, Italy (edit) |
10.1016/J.JPEDS.2020.04.026 |
| 2020-04-21 |
Structural Similarity of SARS-CoV2 Mpro and HCV NS3/4A Proteases Suggests New Approaches for Identifying Existing Drugs Useful as COVID-19 Therapeutics (edit) |
10.26434/CHEMRXIV.12153615 |
| 2020-04-21 |
Leveraging polymerase chain reaction technique (GeneXpert) to upscaling testing capacity for SARS-CoV-2 (COVID-19) in Nigeria: a game changer (edit) |
10.11604/PAMJ.2020.35.2.22693 |
| 2020-04-21 |
SARS-CoV-2 cellular tropism (edit) |
10.1016/S2666-5247(20)30008-2 |
| 2020-04-21 |
Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study (edit) |
10.1016/S2666-5247(20)30004-5 |
| 2020-04-20 |
Position statement of expert panel of the Polish Allergology Society on the management of patients with bronchial asthma and allergic diseases during SARS-Cov-2 pandemics (edit) |
10.5114/PJA.2020.94606 |
| 2020-04-20 |
Rapid Detection of COVID-19 Causative Virus (SARS-CoV-2) in Human Nasopharyngeal Swab Specimens Using Field-Effect Transistor-Based Biosensor (edit) |
10.1021/ACSNANO.0C02823 |
| 2020-04-20 |
COVID-19 Contact Tracing and Data Protection Can Go Together (edit) |
10.2196/19359 |
| 2020-04-20 |
A Brief Telephone Severity Scoring System and Therapeutic Living Centers Solved Acute Hospital-Bed Shortage during the COVID-19 Outbreak in Daegu, Korea (edit) |
10.3346/JKMS.2020.35.E152 |
| 2020-04-20 |
Fast Screening Systems for COVID-19 (edit) |
10.3346/JKMS.2020.35.E153 |
| 2020-04-20 |
Walk-Through Screening Center for COVID-19: an Accessible and Efficient Screening System in a Pandemic Situation (edit) |
10.3346/JKMS.2020.35.E154 |
| 2020-04-20 |
COVID-19 Screening Center: How to Balance between the Speed and Safety? (edit) |
10.3346/JKMS.2020.35.E157 |
| 2020-04-20 |
Preparing Hospitals for Coronavirus (COVID-19) (edit) |
10.1080/21548331.2020.1757337 |
| 2020-04-20 |
Peptide-like and small-molecule inhibitors against Covid-19 (edit) |
10.1080/07391102.2020.1757510 |
| 2020-04-20 |
Development of a reverse transcription-loop-mediated isothermal amplification as a rapid early-detection method for novel SARS-CoV-2 (edit) |
10.1080/22221751.2020.1756698 |
| 2020-04-20 |
Moroccan Medicinal plants as inhibitors of COVID-19: Computational investigations (edit) |
10.1080/07391102.2020.1758790 |
| 2020-04-20 |
Drug repurposing for coronavirus (COVID-19): in silico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes (edit) |
10.1080/07391102.2020.1758791 |
| 2020-04-20 |
Different longitudinal patterns of nucleic acid and serology testing results based on disease severity of COVID-19 patients (edit) |
10.1080/22221751.2020.1756699 |
| 2020-04-20 |
Chinese expert consensus on diagnosis and treatment of coagulation dysfunction in COVID-19 (edit) |
10.1186/S40779-020-00247-7 |
| 2020-04-20 |
Could COVID-19 represents a negative prognostic factor in patients with stroke? (edit) |
10.1017/ICE.2020.146 |
| 2020-04-20 |
Olfactory and taste disorder: the first and only sign in a patient with SARS-CoV-2 pneumonia (edit) |
10.1017/ICE.2020.151 |
| 2020-04-20 |
Covid-19: The daunting experience of health workers in Sardinia, Italy (edit) |
10.1017/ICE.2020.149 |
| 2020-04-20 |
The Fight Against Covid-19: A Report From The Italian Trenches (edit) |
10.1017/S1041610220000630 |
| 2020-04-20 |
Psychological support in times of COVID-19: the Essen community-based CoPE concept (edit) |
10.1093/PUBMED/FDAA053 |
| 2020-04-20 |
Assessing the impact of the covid-19 pandemic and accompanying mitigation efforts on older adults (edit) |
10.1093/GERONA/GLAA099 |
| 2020-04-20 |
Down-regulated gene expression spectrum and immune responses changed during the disease progression in COVID-19 patients (edit) |
10.1093/CID/CIAA462 |
| 2020-04-20 |
Management for patients with pediatric surgical disease during the COVID-19 epidemic (edit) |
10.1007/S00383-020-04656-6 |
| 2020-04-20 |
Therapeutic strategies for critically ill patients with COVID-19 (edit) |
10.1186/S13613-020-00661-Z |
| 2020-04-20 |
COVID-19 diagnosis does not rule out other concomitant diseases (edit) |
10.1111/ECI.13241 |
| 2020-04-20 |
Nowruz travelers and the COVID-19 pandemic in Iran (edit) |
10.1017/ICE.2020.152 |
| 2020-04-20 |
World leaders' usage of Twitter in response to the COVID-19 pandemic: a content analysis (edit) |
10.1093/PUBMED/FDAA049 |
| 2020-04-20 |
EXPRESS: COVID-19 and Stroke - A Global World Stroke Organisation perspective (edit) |
10.1177/1747493020923472 |
| 2020-04-20 |
COVID-19: Limiting the Risks for Eye Care Professionals (edit) |
10.1080/09273948.2020.1755442 |
| 2020-04-20 |
Letter to the Editor: "Our Response to COVID-19 as Endocrinologists and Diabetologists" (edit) |
10.1210/CLINEM/DGAA212 |
| 2020-04-20 |
Health Care Heroes of the COVID-19 Pandemic (edit) |
10.1001/JAMA.2020.6197 |
| 2020-04-20 |
Letter: Collateral Pandemic in Face of the Present COVID-19 Pandemic: A Neurosurgical Perspective (edit) |
10.1093/NEUROS/NYAA155 |
| 2020-04-20 |
Our Education, Our Concerns: Medical Student Education Impact due to COVID-19 (edit) |
10.1111/MEDU.14181 |
| 2020-04-20 |
Surgical Infection Society Guidance for Operative and Peri-Operative Care of Adult Patients Infected by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) (edit) |
10.1089/SUR.2020.101 |
| 2020-04-20 |
Telehealth Transformation: COVID-19 and the rise of Virtual Care (edit) |
10.1093/JAMIA/OCAA067 |
| 2020-04-20 |
Caregiving at a Physical Distance: Initial Thoughts for COVID-19 and Beyond (edit) |
10.1111/JGS.16495 |
| 2020-04-20 |
Elder Abuse in the COVID-19 Era (edit) |
10.1111/JGS.16496 |
| 2020-04-20 |
Distinct Viral Clades of SARS-CoV-2: Implications for Modeling of Viral Spread (edit) |
10.1002/JMV.25902 |
| 2020-04-20 |
Causes of hypogeusia/hyposmia in SARS-CoV2 infected patients (edit) |
10.1002/JMV.25903 |
| 2020-04-20 |
Positive result of Sars-Cov-2 in faeces and sputum from discharged patient with COVID-19 in Yiwu, China (edit) |
10.1002/JMV.25905 |
| 2020-04-20 |
Serological tests facilitate identification of asymptomatic SARS-CoV-2 infection in Wuhan, China (edit) |
10.1002/JMV.25904 |
| 2020-04-20 |
SARS-CoV-2 infection in beta thalassemia: preliminary data from the Italian experience (edit) |
10.1002/AJH.25840 |
| 2020-04-20 |
Description of COVID-19 cases along with the measures taken on prevention and control in Zhejiang, China (edit) |
10.1002/JMV.25906 |
| 2020-04-20 |
SARS-CoV-2: What Can Saliva Tell Us? (edit) |
10.1111/ODI.13365 |
| 2020-04-20 |
Emergency Palliative Care Planning and Support in a COVID-19 Pandemic (edit) |
10.1089/JPM.2020.0195 |
| 2020-04-20 |
Pursuing a Good Death in the Time of COVID-19 (edit) |
10.1089/JPM.2020.0198 |
| 2020-04-20 |
SARS-CoV-2: First Do No Harm (edit) |
10.1164/RCCM.202004-1153ED |
| 2020-04-20 |
COVID-19 (Coronavirus Disease 2019): Opportunities and Challenges for Digital Health and the Internet of Medical Things in China (edit) |
10.1089/OMI.2020.0047 |
| 2020-04-20 |
Comment on "Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade" (edit) |
10.1159/000507786 |
| 2020-04-20 |
Editorial: low population mortality from COVID-19 in countries south of latitude 35 degrees North - supports vitamin D as a factor determining severity (edit) |
10.1111/APT.15777 |
| 2020-04-20 |
PPE and possible routes of airborne spread during the COVID-19 pandemic (edit) |
10.1111/ANAE.15097 |
| 2020-04-20 |
SARS-CoV-2: A new aetiology for atypical lymphocytes (edit) |
10.1111/BJH.16730 |
| 2020-04-20 |
Off-Label Therapies for COVID-19-Are We All In This Together? (edit) |
10.1002/CPT.1862 |
| 2020-04-20 |
Consensus guidelines for managing the airway in patients with COVID-19 (edit) |
10.1111/ANAE.15081 |
| 2020-04-20 |
Who speaks for nursing? COVID-19 highlighting gaps in leadership (edit) |
10.1111/JOCN.15305 |
| 2020-04-20 |
COVID-19 under the SARS Cloud: Mental Health Nursing during the Pandemic in Hong Kong (edit) |
10.1111/JPM.12639 |
| 2020-04-20 |
Management of Acute Myocardial Infarction During the COVID-19 Pandemic (edit) |
10.1002/CCD.28946 |
| 2020-04-20 |
Experiences of Patients with Rheumatic Diseases in the US During Early Days of the COVID-19 Pandemic (edit) |
10.1002/ACR2.11148 |
| 2020-04-20 |
Thromboembolic events and apparent heparin resistance in patients infected with SARS-CoV-2 (edit) |
10.1111/IJLH.13230 |
| 2020-04-20 |
[Thoughts of the COVID-19 outbreak phases changed from emergency response to combination of emergency response and regular prevention and control] (edit) |
10.3760/CMA.J.CN112338-20200404-00516 |
| 2020-04-20 |
Coronavirus disease 2019 (COVID-19): two case reports from a family cluster (edit) |
10.21037/APM.2020.03.34 |
| 2020-04-20 |
Salvage use of tissue plasminogen activator (tPA) in the setting of acute respiratory distress syndrome (ARDS) due to COVID-19 in the USA: a Markov decision analysis (edit) |
10.1186/S13017-020-00305-4 |
| 2020-04-20 |
Covid-19: the precarious position of Spain's nursing homes (edit) |
10.1136/BMJ.M1554 |
| 2020-04-20 |
COVID-19 More Frequent, Severe in Cancer Patients (edit) |
10.1158/2159-8290.CD-NB2020-032 |
| 2020-04-20 |
Managing COVID-19 symptoms (including at the end of life) in the community: summary of NICE guidelines (edit) |
10.1136/BMJ.M1461 |
| 2020-04-20 |
Cytology in the time of coronavirus disease (covid-19): an Italian perspective (edit) |
10.1136/JCLINPATH-2020-206614 |
| 2020-04-20 |
Covid-19: public health experts demand evidence behind UK's short self-isolation advice (edit) |
10.1136/BMJ.M1574 |
| 2020-04-20 |
Covid-19: "Steady the front line! There is no retreat from here" (edit) |
10.1136/BMJ.M1540 |
| 2020-04-20 |
Covid-19, prison crowding, and release policies (edit) |
10.1136/BMJ.M1551 |
| 2020-04-20 |
Covid-19: Experts question guidance to reuse PPE (edit) |
10.1136/BMJ.M1577 |
| 2020-04-20 |
Partha Kar: What will come after the covid-19 crisis? (edit) |
10.1136/BMJ.M1553 |
| 2020-04-20 |
Covid-19: We need to be open about rationing ventilators (edit) |
10.1136/BMJ.M1542 |
| 2020-04-20 |
Contraception in the Era of COVID-19 (edit) |
10.9745/GHSP-D-20-00119 |
| 2020-04-20 |
Impact of cancelling foundation year rotations due to the covid-19 outbreak in the UK (edit) |
10.1136/POSTGRADMEDJ-2020-137775 |
| 2020-04-20 |
Covid-19 is an opportunity for gender equality within the workplace and at home (edit) |
10.1136/BMJ.M1546 |
| 2020-04-20 |
Rituximab for granulomatosis with polyangiitis in the pandemic of covid-19: lessons from a case with severe pneumonia (edit) |
10.1136/ANNRHEUMDIS-2020-217549 |
| 2020-04-20 |
Nafamostat mesylate blocks activation of SARS-CoV-2: New treatment option for COVID-19 (edit) |
10.1128/AAC.00754-20 |
| 2020-04-20 |
Is ethnicity linked to incidence or outcomes of covid-19? (edit) |
10.1136/BMJ.M1548 |
| 2020-04-20 |
Covid-19 infection in Crohn's disease under treatment with adalimumab (edit) |
10.1136/GUTJNL-2020-321240 |
| 2020-04-20 |
Faecal calprotectin indicates intestinal inflammation in COVID-19 (edit) |
10.1136/GUTJNL-2020-321388 |
| 2020-04-20 |
COVID-19 and Calcineurin Inhibitors: Should They Get Left Out in the Storm? (edit) |
10.1681/ASN.2020030348 |
| 2020-04-20 |
Neurointervention for emergent large vessel occlusion during the covid-19 pandemic (edit) |
10.1136/NEURINTSURG-2020-016117 |
| 2020-04-20 |
Coronavirus (COVID-19) Pandemic: What the Nuclear Medicine Departments Should Know (edit) |
10.2967/JNMT.120.247296 |
| 2020-04-20 |
Association Between Ages and Clinical Characteristics and Outcomes of Coronavirus Disease 2019 (edit) |
10.1183/13993003.01112-2020 |
| 2020-04-20 |
Covid19: minimising risk to healthcare workers during aerosol producing respiratory therapy using an innovative constant flow canopy (edit) |
10.1183/13993003.01017-2020 |
| 2020-04-20 |
Neurology in the time of covid-19 (edit) |
10.1136/JNNP-2020-323414 |
| 2020-04-20 |
Neurological manifestations of the coronavirus (SARS-CoV-2) pandemic 2019-2020 (edit) |
10.1136/JNNP-2020-323177 |
| 2020-04-20 |
Adapting to a pandemic - conducting oncology trials during the SARS-CoV-2 pandemic (edit) |
10.1158/1078-0432.CCR-20-1364 |
| 2020-04-20 |
Reorganize and survive-a recommendation for healthcare services affected by COVID-19-the ophthalmology experience (edit) |
10.1038/S41433-020-0871-7 |
| 2020-04-20 |
Lessons after the early management of the COVID-19 outbreak in a pediatric transplant and hemato-oncology center embedded within a COVID-19 dedicated hospital in Lombardia, Italy. Estote parati (edit) |
10.1038/S41409-020-0895-4 |
| 2020-04-20 |
Nutrition amid the COVID-19 pandemic: a multi-level framework for action (edit) |
10.1038/S41430-020-0634-3 |
| 2020-04-20 |
Human monoclonal antibodies block the binding of SARS-CoV-2 spike protein to angiotensin converting enzyme 2 receptor (edit) |
10.1038/S41423-020-0426-7 |
| 2020-04-20 |
Prevention and control strategies for the diagnosis and treatment of cancer patients during the COVID-19 pandemic (edit) |
10.1038/S41416-020-0854-2 |
| 2020-04-20 |
COVID-19 Q&A: Animal care continues (edit) |
10.1038/S41684-020-0548-7 |
| 2020-04-20 |
COVID-19 Q&A: Keeping a cancer core going (edit) |
10.1038/S41684-020-0549-6 |
| 2020-04-20 |
Predicting turning point, duration and attack rate of COVID-19 outbreaks in major Western countries (edit) |
10.1016/J.CHAOS.2020.109829 |
| 2020-04-20 |
COVID-19 Pandemic in India: What Lies Ahead (edit) |
10.1007/S12291-020-00886-6 |
| 2020-04-20 |
Préconisations cardiologiques lors de l’utilisation d’un traitement pouvant entraîner des troubles conductifs ou un allongement de l’intervalle QT dans le COVID-19 (edit) |
10.1016/J.AMCP.2020.04.002 |
| 2020-04-20 |
The Moral Obligation of Nurse Leaders: COVID-19 (edit) |
10.1016/J.MNL.2020.04.008 |
| 2020-04-20 |
Chest CT Findings of Early and Progressive Phase COVID-19 Infection from a US Patient (edit) |
10.1016/J.RADCR.2020.04.031 |
| 2020-04-20 |
A short review on antibody therapy for COVID-19 (edit) |
10.1016/J.NMNI.2020.100682 |
| 2020-04-20 |
Morbilliform Exanthem Associated with COVID-19 (edit) |
10.1016/J.JDCR.2020.04.015 |
| 2020-04-20 |
Time to 'Buddy Up' - Simple Strategies to Support Oncologists During the Covid-19 Pandemic (edit) |
10.1016/J.ADRO.2020.04.004 |
| 2020-04-20 |
Personal reflections of an emergency general surgeon on the COVID-19 pandemic (edit) |
10.1007/S00068-020-01363-8 |
| 2020-04-20 |
Ventilation of COVID-19 patients in intensive care units (edit) |
10.1007/S00059-020-04923-1 |
| 2020-04-20 |
Coronavirus Disease 19 (COVID-19) complicated with pneumonia in a patient with rheumatoid arthritis receiving conventional disease-modifying antirheumatic drugs (edit) |
10.1007/S00296-020-04584-7 |
| 2020-04-20 |
COVID-19 patients and the radiology department - advice from the European Society of Radiology (ESR) and the European Society of Thoracic Imaging (ESTI) (edit) |
10.1007/S00330-020-06865-Y |
| 2020-04-20 |
Pharmacologic Therapy for COVID-19 Infection (edit) |
10.1007/S10900-020-00821-Z |
| 2020-04-20 |
A Case Series of Recurrent Viral RNA Positivity in Recovered COVID-19 Chinese Patients (edit) |
10.1007/S11606-020-05822-1 |
| 2020-04-20 |
We Can't Just Wash Our Hands: a Primary Care Physician's Thoughts on COVID-19 and Her Community (edit) |
10.1007/S11606-020-05831-0 |
| 2020-04-20 |
Practical Implications of Novel Coronavirus COVID-19 on Hospital Operations, Board Certification, and Medical Education in Surgery in the USA (edit) |
10.1007/S11605-020-04596-5 |
| 2020-04-20 |
Bariatric Surgical Practice During the Initial Phase of COVID-19 Outbreak (edit) |
10.1007/S11695-020-04617-X |
| 2020-04-20 |
Safe(r) transesophageal echocardiography and COVID-19 (edit) |
10.1007/S12630-020-01667-8 |
| 2020-04-20 |
Clinical Manifestation and Laboratory Characteristics of SARS-CoV-2 Infection in Pregnant Women (edit) |
10.1007/S12250-020-00227-0 |
| 2020-04-20 |
Is COVID-19 a proteiform disease inducing also molecular mimicry phenomena? (edit) |
10.1007/S12192-020-01112-1 |
| 2020-04-20 |
COVID-19 infection may cause ketosis and ketoacidosis (edit) |
10.1111/DOM.14057 |
| 2020-04-20 |
COVID-19 and psoriasis : should we fear for patients treated with biologics? (edit) |
10.1111/DTH.13434 |
| 2020-04-20 |
Doxycycline, a widely used antibiotic in dermatology with a possible anti-inflammatory action against IL-6 in COVID-19 outbreak (edit) |
10.1111/DTH.13437 |
| 2020-04-20 |
Family violence and COVID-19: Increased vulnerability and reduced options for support (edit) |
10.1111/INM.12735 |
| 2020-04-20 |
Transplant programmes during COVID-19: Unintended consequences for health inequality (edit) |
10.1111/AJT.15931 |
| 2020-04-20 |
Case Report: The First Case of Novel Coronavirus Disease (COVID-19) in Bhutan (edit) |
10.4269/AJTMH.20-0259 |
| 2020-04-20 |
The Pandemic of Hate Is Giving Novel Coronavirus Disease (COVID-19) a Helping Hand (edit) |
10.4269/AJTMH.20-0285 |
| 2020-04-20 |
Chinese Public Attention to COVID-19 Epidemic: Based on Social Media (edit) |
10.2196/18825 |
| 2020-04-20 |
The Technique and Justification for Minimally Invasive Surgery in COVID-19 Pandemic: Laparoscopic Anterior Resection for Near Obstructed Rectal Carcinoma (edit) |
10.1089/LAP.2020.0241 |
| 2020-04-20 |
COVID-19 in India: Moving from containment to mitigation (edit) |
10.4103/IJMR.IJMR_860_20 |
| 2020-04-20 |
The suspected SARS-Cov-2 infection in a Charcot-Marie-Tooth patient undergoing postsurgical rehabilitation: the value of telerehabilitation for evaluation and continuing treatment (edit) |
10.1097/MRR.0000000000000418 |
| 2020-04-20 |
Understanding SARS-CoV-2: Genetic Diversity, Transmission and Cure in Human (edit) |
10.1007/S12088-020-00869-4 |
| 2020-04-20 |
Potential therapeutic effects of dipyridamole in the severely ill patients with COVID-19 (edit) |
10.1016/J.APSB.2020.04.008 |
| 2020-04-20 |
D3Targets-2019-nCoV: a webserver for predicting drug targets and for multi-target and multi-site based virtual screening against COVID-19 (edit) |
10.1016/J.APSB.2020.04.006 |
| 2020-04-20 |
Rewriting the rules for care of MDS and AML patients in the time of COVID-19 (edit) |
10.1016/J.LRR.2020.100201 |
| 2020-04-20 |
Thoracic radiation therapy during COVID-19: provisional guidelines from a comprehensive cancer center within a pandemic epicenter (edit) |
10.1016/J.ADRO.2020.04.008 |
| 2020-04-20 |
Hydroxychloroquine Versus COVID-19: A Rapid Systematic Review and Meta-Analysis (edit) |
10.1101/2020.04.14.20065276 |
| 2020-04-20 |
Darunavir does not prevent SARS-CoV-2 infection in HIV patients (edit) |
10.1016/J.PHRS.2020.104826 |
| 2020-04-20 |
Bayesian phylodynamic inference on the temporal evolution and global transmission of SARS-CoV-2 (edit) |
10.1016/J.JINF.2020.04.016 |
| 2020-04-20 |
The old but new: Can unfractioned heparin and low molecular weight heparins inhibit proteolytic activation and cellular internalization of SARS-CoV2 by inhibition of host cell proteases? (edit) |
10.1016/J.MEHY.2020.109743 |
| 2020-04-20 |
Interpret with caution: An evaluation of the commercial AusDiagnostics versus in-house developed assays for the detection of SARS-CoV-2 virus (edit) |
10.1016/J.JCV.2020.104374 |
| 2020-04-20 |
Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites (edit) |
10.1016/J.APSB.2020.04.009 |
| 2020-04-20 |
Co-Infection with SARS-COV-2 and Parainfluenza in a young adult patient with pneumonia: Case Report (edit) |
10.1016/J.IDCR.2020.E00762 |
| 2020-04-20 |
Rapid development of an inactivated vaccine for SARS-CoV-2 (edit) |
10.1101/2020.04.17.046375 |
| 2020-04-20 |
Estimating SARS-CoV-2 seroprevalence and epidemiological parameters with uncertainty from serological surveys (edit) |
10.1101/2020.04.15.20067066 |
| 2020-04-20 |
Shotgun Transcriptome and Isothermal Profiling of SARS-CoV-2 Infection Reveals Unique Host Responses, Viral Diversification, and Drug Interactions (edit) |
10.1101/2020.04.20.048066 |
| 2020-04-20 |
SARS-COV-2 comorbidity network and outcome in hospitalized patients in Crema, Italy (edit) |
10.1101/2020.04.14.20053090 |
| 2020-04-20 |
A dynamic nomenclature proposal for SARS-CoV-2 to assist genomic epidemiology (edit) |
10.1101/2020.04.17.046086 |
| 2020-04-20 |
Efficient high throughput SARS-CoV-2 testing to detect asymptomatic carriers (edit) |
10.1101/2020.04.14.20064618 |
| 2020-04-20 |
Comparison of SARS-CoV2 N gene real-time RT-PCR targets and commercially available mastermixes (edit) |
10.1101/2020.04.17.047118 |
| 2020-04-20 |
The crystal structure of nsp10-nsp16 heterodimer from SARS-CoV-2 in complex with S-adenosylmethionine (edit) |
10.1101/2020.04.17.047498 |
| 2020-04-20 |
Proteome-wide analysis of differentially-expressed SARS-CoV-2 antibodies in early COVID-19 infection (edit) |
10.1101/2020.04.14.20064535 |
| 2020-04-20 |
Mass Spectrometric Identification of SARS-CoV-2 Proteins from Gargle Solution Samples of COVID-19 Patients (edit) |
10.1101/2020.04.18.047878 |
| 2020-04-20 |
Rapid direct nucleic acid amplification test without RNA extraction for SARS-CoV-2 using a portable PCR thermocycler (edit) |
10.1101/2020.04.17.042366 |
| 2020-04-20 |
Broad and differential animal ACE2 receptor usage by SARS-CoV-2 (edit) |
10.1101/2020.04.19.048710 |
| 2020-04-20 |
Temporal detection and phylogenetic assessment of SARS-CoV-2 in municipal wastewater (edit) |
10.1101/2020.04.15.20066746 |
| 2020-04-20 |
The Early Natural History of SARS-CoV-2 Infection: Clinical Observations From an Urban, Ambulatory COVID-19 Clinic (edit) |
10.1016/J.MAYOCP.2020.04.010 |
| 2020-04-19 |
Introducing special cutaneous "sign" tribute to health care workers managing "SARS-CoV-2" (COVID-19) (edit) |
10.1016/J.CLINDERMATOL.2020.04.009 |
| 2020-04-19 |
Molecular Docking and Molecular Dynamic Study of Two Viral Proteins Associated with SARS-CoV-2 with Ivermectin (edit) |
10.20944/PREPRINTS202004.0334.V1 |
| 2020-04-19 |
Antibodies to SARS-CoV-2 and Their Potential for Therapeutic Passive Immunization (edit) |
10.20944/PREPRINTS202004.0326.V1 |
| 2020-04-19 |
Profile of RT-PCR for SARS-CoV-2: a preliminary study from 56 COVID-19 patients (edit) |
10.1093/CID/CIAA460 |
| 2020-04-19 |
Testing for SARS-CoV-2: Can We Stop at Two? (edit) |
10.1093/CID/CIAA459 |
| 2020-04-19 |
Antibody Detection and Dynamic Characteristics in Patients with COVID-19 (edit) |
10.1093/CID/CIAA461 |
| 2020-04-19 |
Adapting to a novel disruptive threat: Nuclear Cardiology Service in the time of the Coronavirus (COVID-19) Outbreak 2020 (SARS REBOOT) (edit) |
10.1007/S12350-020-02117-0 |
| 2020-04-19 |
How effective response to COVID-19 relies on nursing research (edit) |
10.1002/NUR.22025 |
| 2020-04-19 |
Surge capacity of intensive care units in case of acute increase in demand caused by COVID-19 in Australia (edit) |
10.5694/MJA2.50596 |
| 2020-04-19 |
Paediatric Anaesthetic implications of COVID-19 - A Review of Current Literature (edit) |
10.1111/PAN.13889 |
| 2020-04-19 |
The outbreak of Novel Coronavirus disease (COVID-19) caused a worrying delay in the diagnosis of oral cancer in north-west Italy: the Turin Metropolitan Area experience (edit) |
10.1111/ODI.13362 |
| 2020-04-19 |
Cardiovascular surgery in the COVID-19 pandemic (edit) |
10.1111/JOCS.14559 |
| 2020-04-19 |
Cardiac involvement in COVID-19 patients: Risk factors, predictors, and complications: A review (edit) |
10.1111/JOCS.14538 |
| 2020-04-19 |
D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19 (edit) |
10.1111/JTH.14859 |
| 2020-04-19 |
Supporting pandemic response using genomics and bioinformatics: a case study on the emergent SARS-CoV-2 outbreak (edit) |
10.1111/TBED.13588 |
| 2020-04-19 |
Critically ill SARS-CoV-2-infected patients are not stratified as sepsis by the qSOFA (edit) |
10.1186/S13613-020-00664-W |
| 2020-04-19 |
Caring for Patients with Advanced Stage Cancer at the Time of COVID-19 (edit) |
10.1634/THEONCOLOGIST.2020-0230 |
| 2020-04-19 |
COVID-19 and spinal cord injuries: the viewpoint from an emergency department resident with quadriplegia (edit) |
10.1111/1742-6723.13525 |
| 2020-04-19 |
Abortion in the context of COVID-19: a human rights imperative (edit) |
10.1080/26410397.2020.1758394 |
| 2020-04-19 |
Detection of SARS-CoV-2 RNA and antibodies in diverse samples: Protocol to validate the sufficiency of provider-observed home-collected blood, saliva and oropharyngeal samples (edit) |
10.2196/19054 |
| 2020-04-19 |
COVID-19 mobile positioning surveillance and contact tracing, and patient privacy (edit) |
10.2196/19139 |
| 2020-04-19 |
2019 Novel coronavirus (COVID-19) overview (edit) |
10.1007/S10389-020-01258-3 |
| 2020-04-19 |
A "One-Health" approach for diagnosis and molecular characterization of SARS-CoV-2 in Italy (edit) |
10.1016/J.ONEHLT.2020.100135 |
| 2020-04-19 |
PAK1-blockers: Potential Therapeutics against COVID-19 (edit) |
10.1016/J.MEDIDD.2020.100039 |
| 2020-04-19 |
Breastfeeding of Infants Born to Mothers with COVID-19: A Rapid Review (edit) |
10.1101/2020.04.13.20064378 |
| 2020-04-19 |
Health Education for Parents During the COVID-19 Outbreak Public Health Education for Parents During the Outbreak of COVID-19: A Rapid Review (edit) |
10.1101/2020.04.14.20064741 |
| 2020-04-19 |
Phylogenetic Analysis and Structural Modeling of SARS-CoV-2 Spike Protein Reveals an Evolutionary Distinct and Proteolytically Sensitive Activation Loop (edit) |
10.1016/J.JMB.2020.04.009 |
| 2020-04-19 |
Protein structure analysis of the interactions between SARS-CoV-2 spike protein and the human ACE2 receptor: from conformational changes to novel neutralizing antibodies (edit) |
10.1101/2020.04.17.046185 |
| 2020-04-19 |
Distinct Structural Flexibility within SARS-CoV-2 Spike Protein Reveals Potential Therapeutic Targets (edit) |
10.1101/2020.04.17.047548 |
| 2020-04-19 |
The scRNA-seq expression profiling of the receptor ACE2 and the cellular protease TMPRSS2 reveals human organs susceptible to COVID-19 infection (edit) |
10.1101/2020.04.16.045690 |
| 2020-04-19 |
Transcriptional Difference between SARS-COV-2 and other Human Coronaviruses Revealed by Sub-genomic RNA Profiling (edit) |
10.1101/2020.04.16.043224 |
| 2020-04-19 |
Significant expression of FURIN and ACE2 on oral epithelial cells may facilitate the efficiency of SARS-CoV-2 entry (edit) |
10.1101/2020.04.18.047951 |
| 2020-04-19 |
Potential microenvironment of SARS-CoV-2 infection in airway epithelial cells revealed by Human Protein Atlas database analysis (edit) |
10.1101/2020.04.16.045799 |
| 2020-04-19 |
Patient-derived mutations impact pathogenicity of SARS-CoV-2 (edit) |
10.1101/2020.04.14.20060160 |
| 2020-04-19 |
An in silico map of the SARS-CoV-2 RNA Structurome (edit) |
10.1101/2020.04.17.045161 |
| 2020-04-19 |
SARS-Cov-2 RNA Found on Particulate Matter of Bergamo in Northern Italy: First Preliminary Evidence (edit) |
10.1101/2020.04.15.20065995 |
| 2020-04-19 |
Neutralizing Antibodies Responses to SARS-CoV-2 in COVID-19 Inpatients and Convalescent Patients (edit) |
10.1101/2020.04.15.20065623 |
| 2020-04-18 |
Will COVID-19 infection be less severe in ulcerative colitis than in Crohn's patients due to a lower rate of smokers? (edit) |
10.1093/ECCO-JCC/JJAA077 |
| 2020-04-18 |
Impact of anti-tnfα antibodies on the risk of Covid-19 and its severity in patients with inflammatory Bowel Diseases (edit) |
10.1093/ECCO-JCC/JJAA076 |
| 2020-04-18 |
Electronic cigarette and vaping should be discouraged during the new coronavirus SARS-CoV-2 pandemic (edit) |
10.1007/S00204-020-02744-Z |
| 2020-04-18 |
Research in the Time of Coronavirus: Continuing Ongoing Studies in the Midst of the COVID-19 Pandemic (edit) |
10.1007/S10461-020-02868-4 |
| 2020-04-18 |
The Burden of COVID-19 in People Living with HIV: A Syndemic Perspective (edit) |
10.1007/S10461-020-02871-9 |
| 2020-04-18 |
Progress and Concept for COVID-19 Vaccine Development (edit) |
10.1002/BIOT.202000147 |
| 2020-04-18 |
Novel coronavirus disease (COVID-19) in children (edit) |
10.3906/SAG-2004-174 |
| 2020-04-18 |
COVID-19 outbreak control, example of ministry of health of Turkey (edit) |
10.3906/SAG-2004-187 |
| 2020-04-18 |
Assessment of Specimen Pooling to Conserve SARS CoV-2 Testing Resources (edit) |
10.1093/AJCP/AQAA064 |
| 2020-04-18 |
Letter: Transmission of COVID-19 During Neurosurgical Procedures-Some Thoughts From the United Kingdom (edit) |
10.1093/NEUROS/NYAA126 |
| 2020-04-18 |
Letter: COVID-19 Infection Affects Surgical Outcome of Chronic Subdural Hematoma (edit) |
10.1093/NEUROS/NYAA140 |
| 2020-04-18 |
The impact of coronavirus infectious disease 19 (COVID-19) on oral health (edit) |
10.1111/ODI.13359 |
| 2020-04-18 |
Les droits humains des enfants en situation de handicap en cas d'urgence sanitaire: le défi du COVID-19 (edit) |
10.1111/DMCN.14549 |
| 2020-04-18 |
Taking the Longer View of COVID-19 (edit) |
10.1634/THEONCOLOGIST.2020-0313 |
| 2020-04-18 |
Bilirubin levels in patients with mild and severe Covid-19: a pooled analysis (edit) |
10.1111/LIV.14477 |
| 2020-04-18 |
[Public health literacy in the face of the Covid-19 pandemic emergency] (edit) |
10.21149/11408 |
| 2020-04-18 |
Screen mirroring, screen casting and screen sharing during COVID-19: What a dermatologist should know (edit) |
10.1111/CED.14247 |
| 2020-04-18 |
Thromboembolic risk and anticoagulant therapy in COVID-19 patients: Emerging evidence and call for action (edit) |
10.1111/BJH.16727 |
| 2020-04-18 |
Changes in Blood Coagulation in Patients with Severe Coronavirus Disease 2019 (COVID-19): a Meta-Analysis (edit) |
10.1111/BJH.16725 |
| 2020-04-18 |
Telemedicine and support groups in order to improve the adherence to treatment and health related quality of life in patients affected by inflammatory skin conditions during COVID-19 emergency (edit) |
10.1111/CED.14245 |
| 2020-04-18 |
Why we should not stop giving aspirin to pregnant women during the COVID-19 pandemic (edit) |
10.1002/UOG.22049 |
| 2020-04-18 |
Severe COVID-19 during Pregnancy and Possible Vertical Transmission (edit) |
10.1055/S-0040-1710050 |
| 2020-04-18 |
COVID-19 in otolaryngologist practice: a review of current knowledge (edit) |
10.1007/S00405-020-05968-Y |
| 2020-04-18 |
Covid-19 epidemic in Italy: evolution, projections and impact of government measures (edit) |
10.1007/S10654-020-00631-6 |
| 2020-04-18 |
Maximizing Digital Interventions for Youth in the Midst of Covid-19: Lessons from the Adolescent Trials Network for HIV Interventions (edit) |
10.1007/S10461-020-02870-W |
| 2020-04-18 |
Advanced forecasting of SARS-CoV-2 related deaths in Italy, Germany, Spain, and New York State (edit) |
10.1111/ALL.14327 |
| 2020-04-18 |
Successful Guselkumab treatment in a psoriatic patient affected with Cornelia de Lange Syndrome, and prosecution during the COVID-19 pandemic (edit) |
10.1111/DTH.13433 |
| 2020-04-18 |
Forced Disruption of Anatomy Education in Australia and New Zealand: An Acute Response to the Covid-19 Pandemic (edit) |
10.1002/ASE.1968 |
| 2020-04-18 |
Containing COVID-19 in rural and remote areas: experiences from China (edit) |
10.1093/JTM/TAAA060 |
| 2020-04-18 |
Community Universal Face Mask Use during the COVID 19 pandemic-from households to travelers and public spaces (edit) |
10.1093/JTM/TAAA056 |
| 2020-04-18 |
Social media panic and COVID-19 in India (edit) |
10.1093/JTM/TAAA057 |
| 2020-04-18 |
A Single Mass Gathering Resulted in Massive Transmission of COVID-19 Infections in Malaysia with Further International Spread (edit) |
10.1093/JTM/TAAA059 |
| 2020-04-18 |
COVID-19 and ENT Pediatric otolaryngology during the COVID-19 pandemic. Guidelines of the French Association of Pediatric Otorhinolaryngology (AFOP) and French Society of Otorhinolaryngology (SFORL) (edit) |
10.1016/J.ANORL.2020.04.010 |
| 2020-04-18 |
Identification of Potential Binders of the Main Protease 3CLpro of the COVID-19 via Structure-Based Ligand Design and Molecular Modeling (edit) |
10.1016/J.CPLETT.2020.137489 |
| 2020-04-18 |
COVID-19 and the policy sciences: initial reactions and perspectives (edit) |
10.1007/S11077-020-09381-4 |
| 2020-04-18 |
COVID 19 Outbreak: Potential of Biochemistry Speciality (edit) |
10.1007/S12291-020-00885-7 |
| 2020-04-18 |
[Management of the COVID-19 epidemic by public health establishments - Analysis by the Fédération Hospitalière de France] (edit) |
10.1016/J.JCHIRV.2020.04.009 |
| 2020-04-18 |
Tracing New Clinical Manifestations in Patients with COVID-19 in Chile and Its Potential Relationship with the SARS-CoV-2 Divergence (edit) |
10.1007/S40475-020-00205-2 |
| 2020-04-18 |
Guillain-Barré Syndrome associated with SARS-CoV-2 infection (edit) |
10.1016/J.IDCR.2020.E00771 |
| 2020-04-18 |
A rapid transition to voluntary breath hold from device-assisted moderate deep inspiration breath hold for patients receiving breast radiotherapy during the COVID-19 pandemic (edit) |
10.1016/J.ADRO.2020.04.007 |
| 2020-04-18 |
Fear in the age of COVID-19 (edit) |
10.1016/J.ADRO.2020.04.006 |
| 2020-04-18 |
Precision medicine in COVID-19: IL-1β a potential target (edit) |
10.1016/J.JACBTS.2020.04.006 |
| 2020-04-18 |
What are the Underlying Transmission Patterns of COVID-19 Outbreak? - An Age-specific Social Contact Characterization (edit) |
10.1016/J.ECLINM.2020.100354 |
| 2020-04-18 |
Laboratory data analysis of novel coronavirus (COVID-19) screening in 2510 patients (edit) |
10.1016/J.CCA.2020.04.018 |
| 2020-04-18 |
Put a lid on it: Are faecal bio-aerosols a route of transmission for SARS-CoV-2? (edit) |
10.1016/J.JHIN.2020.04.024 |
| 2020-04-18 |
Viral dynamics of SARS-CoV-2 across a spectrum of disease severity in COVID-19 (edit) |
10.1016/J.JINF.2020.04.014 |
| 2020-04-18 |
Suppressed T cell-mediated immunity in patients with COVID-19: a clinical retrospective study in Wuhan, China (edit) |
10.1016/J.JINF.2020.04.012 |
| 2020-04-18 |
Virtual Visits for Care of Patients with Heart Failure in the Era of COVID-19: A Statement from the Heart Failure Society of America (edit) |
10.1016/J.CARDFAIL.2020.04.008 |
| 2020-04-18 |
Challenges of managing the asymptomatic carriers of SARS-CoV-2 (edit) |
10.1016/J.TMAID.2020.101677 |
| 2020-04-18 |
Current data on the cardiovascular effects of the COVID-19 (edit) |
10.1016/J.HJC.2020.04.001 |
| 2020-04-18 |
The immediate mental health impacts of the COVID-19 pandemic among people with or without quarantine managements (edit) |
10.1016/J.BBI.2020.04.045 |
| 2020-04-18 |
Acute At Home Management of Anaphylaxis During the Covid-19 Pandemic (edit) |
10.1016/J.JAIP.2020.04.022 |
| 2020-04-18 |
A model for a ventilator-weaning and early rehabilitation unit to deal with post-ICU impairments with severe COVID-19 (edit) |
10.1016/J.REHAB.2020.04.002 |
| 2020-04-18 |
The role of physical and rehabilitation medicine in the COVID-19 pandemic: the clinician's view (edit) |
10.1016/J.REHAB.2020.04.001 |
| 2020-04-18 |
Preliminary therapeutic drug monitoring data of β-lactams in critically ill patients with SARS-CoV-2 infection (edit) |
10.1016/J.ACCPM.2020.04.005 |
| 2020-04-18 |
[Breast cancer management during the COVID 19 pandemic: the CNGOF takes action] (edit) |
10.1016/J.GOFS.2020.04.009 |
| 2020-04-18 |
Comparison of nasopharyngeal and oropharyngeal swabs for SARS-CoV-2 detection in 353 patients received tests with both specimens simultaneously (edit) |
10.1016/J.IJID.2020.04.023 |
| 2020-04-18 |
Cardiovascular complications in COVID-19 (edit) |
10.1016/J.AJEM.2020.04.048 |
| 2020-04-18 |
iPad deployment for virtual evaluation in the emergency department during the COVID-19 pandemic (edit) |
10.1016/J.AJEM.2020.04.025 |
| 2020-04-18 |
A sporadic COVID-19 pneumonia treated with extracorporeal membrane oxygenation in Tokyo, Japan: A case report (edit) |
10.1016/J.JIAC.2020.03.018 |
| 2020-04-18 |
A Validation Study for the Successful Isolation Policy in China: a Meta-Analysis in COVID-19 (edit) |
10.1101/2020.04.15.20065102 |
| 2020-04-18 |
The impact of early scientific literature in response to COVID-19: a scientometric perspective (edit) |
10.1101/2020.04.15.20066183 |
| 2020-04-18 |
Mesenchymal stromal cells for COVID-19: A living systematic review protocol (edit) |
10.1101/2020.04.13.20064162 |
| 2020-04-18 |
A Novel Reverse Transcription Loop-Mediated Isothermal Amplification Method for Rapid Detection of SARS-CoV-2 (edit) |
10.3390/IJMS21082826 |
| 2020-04-18 |
The Architecture of SARS-CoV-2 Transcriptome (edit) |
10.1016/J.CELL.2020.04.011 |
| 2020-04-18 |
Rapid point-of-care testing for SARS-CoV-2 in a community screening setting shows low sensitivity (edit) |
10.1016/J.PUHE.2020.04.009 |
| 2020-04-18 |
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response (edit) |
10.1016/J.DSX.2020.04.020 |
| 2020-04-18 |
Less is More: Intelligent Intensive Care for SARS-CoV-2 Based on the Imaging Data (edit) |
10.1016/J.JMIR.2020.04.002 |
| 2020-04-18 |
Abdominal Wall Surgery After SARS-CoV-2: Time to Reestablish Postponed Non-essential Procedures? (edit) |
10.1016/J.CIRESP.2020.04.011 |
| 2020-04-18 |
Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients (edit) |
10.1016/J.EBIOM.2020.102763 |
| 2020-04-18 |
SARS-CoV-2 infection associated with diplopia and anti-acetylcholine receptor antibodies (edit) |
10.1016/J.NRL.2020.04.003 |
| 2020-04-18 |
Síndrome de Guillain-Barré fatal tras infección por virus SARS-CoV2 (edit) |
10.1016/J.NRL.2020.04.004 |
| 2020-04-18 |
First confirmed detection of SARS-CoV-2 in untreated wastewater in Australia: A proof of concept for the wastewater surveillance of COVID-19 in the community (edit) |
10.1016/J.SCITOTENV.2020.138764 |
| 2020-04-18 |
Comparative dynamic aerosol efficiencies of three emergent coronaviruses and the unusual persistence of SARS-CoV-2 in aerosol suspensions (edit) |
10.1101/2020.04.13.20063784 |
| 2020-04-18 |
SARS-CoV-2 is transmitted via contact and via the air between ferrets (edit) |
10.1101/2020.04.16.044503 |
| 2020-04-18 |
A Large-scale Drug Repositioning Survey for SARS-CoV-2 Antivirals (edit) |
10.1101/2020.04.16.044016 |
| 2020-04-18 |
Epidemic Landscape and Forecasting of SARS-CoV-2 in India (edit) |
10.1101/2020.04.14.20065151 |
| 2020-04-18 |
Single-cell analysis of human lung epithelia reveals concomitant expression of the SARS-CoV-2 receptor ACE2 with multiple virus receptors and scavengers in alveolar type II cells (edit) |
10.1101/2020.04.16.045617 |
| 2020-04-18 |
Multinational modeling of SARS-CoV-2 spreading dynamics: Insights on the heterogeneity of COVID-19 transmission and its potential healthcare burden (edit) |
10.1101/2020.04.14.20064956 |
| 2020-04-18 |
Investigating the genomic landscape of novel coronavirus (2019-nCoV) to identify non-synonymous mutations for use in diagnosis and drug design (edit) |
10.1101/2020.04.16.043273 |
| 2020-04-18 |
Phenotype of SARS-CoV-2-specific T-cells in COVID-19 patients with acute respiratory distress syndrome (edit) |
10.1101/2020.04.11.20062349 |
| 2020-04-18 |
Broad Host Range of SARS-CoV-2 Predicted by Comparative and Structural Analysis of ACE2 in Vertebrates (edit) |
10.1101/2020.04.16.045302 |
| 2020-04-18 |
Shotgun proteomics of SARS-CoV-2 infected cells and its application to the optimisation of whole viral particle antigen production for vaccines (edit) |
10.1101/2020.04.17.046193 |
| 2020-04-18 |
Sybodies targeting the SARS-CoV-2 receptor-binding domain (edit) |
10.1101/2020.04.16.045419 |
| 2020-04-18 |
Massive and rapid COVID-19 testing is feasible by extraction-free SARS-CoV-2 RT-qPCR (edit) |
10.1101/2020.04.17.20067348 |
| 2020-04-18 |
Optimizing RT-PCR detection of SARS-CoV-2 for developing countries using pool testing (edit) |
10.1101/2020.04.15.20067199 |
| 2020-04-18 |
Statins as early therapy to mitigate COVID-19 (SARS-CoV-2)-associated ARDS and cytokine storm syndrome - time is of the essence (edit) |
|
| 2020-04-18 |
SARS-CoV-2 pandemic in India: what might we expect? (edit) |
10.1007/S10668-020-00739-5 |
| 2020-04-17 |
#Homeoffice – Der Blick auf den Schreibtisch (edit) |
|
| 2020-04-17 |
Timing of Community Mitigation and Changes in Reported COVID-19 and Community Mobility - Four U.S. Metropolitan Areas, February 26-April 1, 2020 (edit) |
10.15585/MMWR.MM6915E2 |
| 2020-04-17 |
Community Transmission of SARS-CoV-2 at Two Family Gatherings - Chicago, Illinois, February-March 2020 (edit) |
10.15585/MMWR.MM6915E1 |
| 2020-04-17 |
Characteristics of Health Care Personnel with COVID-19 - United States, February 12-April 9, 2020 (edit) |
10.15585/MMWR.MM6915E6 |
| 2020-04-17 |
Geographic Differences in COVID-19 Cases, Deaths, and Incidence - United States, February 12-April 7, 2020 (edit) |
10.15585/MMWR.MM6915E4 |
| 2020-04-17 |
Striving as a nation to become an academic leader in the COVID-19 crisis (edit) |
10.11622/SMEDJ.2020059 |
| 2020-04-17 |
COVID-19 - where do we go from here? (edit) |
10.11622/SMEDJ.2020060 |
| 2020-04-17 |
Keeping an eye on COVID-19: Ophthalmic care and triage for general practitioners (edit) |
10.31128/AJGP-COVID-10 |
| 2020-04-17 |
Self-care of medical staff in primary care: An issue that needs attention during the COVID-19 outbreak (edit) |
10.31128/AJGP-COVID-11 |
| 2020-04-17 |
Radiological approaches to COVID-19 pneumonia (edit) |
10.3906/SAG-2004-160 |
| 2020-04-17 |
Crushing the curve, the role of national and international institutions and policy makers in COVID-19 pandemic (edit) |
10.3906/SAG-2004-167 |
| 2020-04-17 |
Protective measures for COVID-19 for healthcare providers and laboratory personnel (edit) |
10.3906/SAG-2004-132 |
| 2020-04-17 |
Epidemiology of COVID-19 (edit) |
10.3906/SAG-2004-172 |
| 2020-04-17 |
Physical Distancing and Emotional Closeness Amidst COVID-19 (edit) |
10.1027/0227-5910/A000710 |
| 2020-04-17 |
COVID-19, Australia: Epidemiology Report 11 (Reporting week to 23:59 AEST 12 April 2020) (edit) |
10.33321/CDI.2020.44.34 |
| 2020-04-17 |
COVID-19: Protecting Healthcare Workers is a priority (edit) |
10.1017/ICE.2020.148 |
| 2020-04-17 |
Environmental cleaning is effective for the eradication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in contaminated hospital rooms: A patient from the Diamond Princess cruise ship (edit) |
10.1017/ICE.2020.144 |
| 2020-04-17 |
Early phases of COVID-19 management in a low-income country: Case of Bangladesh (edit) |
10.1017/ICE.2020.147 |
| 2020-04-17 |
Saliva: potential diagnostic value and transmission of 2019-nCoV (edit) |
10.1038/S41368-020-0080-Z |
| 2020-04-17 |
A geroscience perspective on COVID-19 mortality (edit) |
10.1093/GERONA/GLAA094 |
| 2020-04-17 |
Smell dysfunction: a biomarker for COVID-19 (edit) |
10.1002/ALR.22587 |
| 2020-04-17 |
COVID-19: Time for precision epidemiology (edit) |
10.1177/1535370220919349 |
| 2020-04-17 |
Cost-effectiveness of rivaroxaban plus aspirin (dual pathway inhibition) for prevention of ischaemic events in patients with cardiovascular disease: on top optimisation of secondary prevention medication in the context of COVID-19 pandemia (edit) |
10.1177/2047487320920754 |
| 2020-04-17 |
Attenuated SARS-CoV-2 variants with deletions at the S1/S2 junction (edit) |
10.1080/22221751.2020.1756700 |
| 2020-04-17 |
Assessment of the quality of systematic reviews on COVID-19: A comparative study of previous coronavirus outbreaks (edit) |
10.1002/JMV.25901 |
| 2020-04-17 |
Lack of dyspnea in Covid-19 patients; another neurological conundrum? (edit) |
10.1111/ENE.14265 |
| 2020-04-17 |
The Impact of the Covid-19 Pandemic on Current Anatomy Education and Future Careers: A Student's Perspective (edit) |
10.1002/ASE.1966 |
| 2020-04-17 |
SARS-CoV-2 From the Trenches: A Perspective From New York City (edit) |
10.2214/AJR.20.23302 |
| 2020-04-17 |
Lung Base Findings of Coronavirus Disease (COVID-19) on Abdominal CT in Patients With Predominant Gastrointestinal Symptoms (edit) |
10.2214/AJR.20.23232 |
| 2020-04-17 |
Reply to "CT Is Not a Screening Tool for Coronavirus Disease (COVID-19) Pneumonia" (edit) |
10.2214/AJR.20.23288 |
| 2020-04-17 |
Well-aerated Lung on Admitting Chest CT to Predict Adverse Outcome in COVID-19 Pneumonia (edit) |
10.1148/RADIOL.2020201433 |
| 2020-04-17 |
After Covid-19 (edit) |
10.1093/CID/CIAA455 |
| 2020-04-17 |
Weak Induction of Interferon Expression by SARS-CoV-2 Supports Clinical Trials of Interferon Lambda to Treat Early COVID-19 (edit) |
10.1093/CID/CIAA453 |
| 2020-04-17 |
The Promise and Peril of Antibody Testing for COVID-19 (edit) |
10.1001/JAMA.2020.6170 |
| 2020-04-17 |
From Mitigation to Containment of the COVID-19 Pandemic: Putting the SARS-CoV-2 Genie Back in the Bottle (edit) |
10.1001/JAMA.2020.6572 |
| 2020-04-17 |
Masks and Coronavirus Disease 2019 (COVID-19) (edit) |
10.1001/JAMA.2020.6437 |
| 2020-04-17 |
Symptom Screening at Illness Onset of Health Care Personnel With SARS-CoV-2 Infection in King County, Washington (edit) |
10.1001/JAMA.2020.6637 |
| 2020-04-17 |
The characteristics of household transmission of COVID-19 (edit) |
10.1093/CID/CIAA450 |
| 2020-04-17 |
Albert Camus' 'The COVID-19 Plague' Revisited (edit) |
10.1093/CID/CIAA454 |
| 2020-04-17 |
SARS-CoV-2 infection (COVID-19) in febrile infants without respiratory distress (edit) |
10.1093/CID/CIAA452 |
| 2020-04-17 |
Management of elective aortic valve replacement over the long term in the era of COVID-19 (edit) |
10.1093/EJCTS/EZAA152 |
| 2020-04-17 |
The COVID-19 outbreak and its impact on hospitals in Italy: the model of cardiac surgery (edit) |
10.1093/EJCTS/EZAA151 |
| 2020-04-17 |
Detectable serum SARS-CoV-2 viral load (RNAaemia) is closely correlated with drastically elevated interleukin 6 (IL-6) level in critically ill COVID-19 patients (edit) |
10.1093/CID/CIAA449 |
| 2020-04-17 |
The duration of viral shedding of discharged patients with severe COVID-19 (edit) |
10.1093/CID/CIAA451 |
| 2020-04-17 |
COVID-19 and ischemic heart disease emergencies: What cardiac surgery should expect? (edit) |
10.1111/JOCS.14556 |
| 2020-04-17 |
Laboratory testing of SARS-CoV, MERS-CoV, and SARS-CoV-2 (2019-nCoV): Current status, challenges, and countermeasures (edit) |
10.1002/RMV.2106 |
| 2020-04-17 |
Covid-19 and the Need for Health Care Reform (edit) |
10.1056/NEJMP2000821 |
| 2020-04-17 |
Africa in the Path of Covid-19 (edit) |
10.1056/NEJMP2008193 |
| 2020-04-17 |
The Untold Toll - The Pandemic's Effects on Patients without Covid-19 (edit) |
10.1056/NEJMMS2009984 |
| 2020-04-17 |
Clinical Characteristics of Pregnant Women with Covid-19 in Wuhan, China (edit) |
10.1056/NEJMC2009226 |
| 2020-04-17 |
Clinical Characteristics of Covid-19 in New York City (edit) |
10.1056/NEJMC2010419 |
| 2020-04-17 |
Covid-19 and Immunity in Aging Populations - A New Research Agenda (edit) |
10.1056/NEJMP2006761 |
| 2020-04-17 |
ST-Segment Elevation in Patients with Covid-19 - A Case Series (edit) |
10.1056/NEJMC2009020 |
| 2020-04-17 |
Guillain-Barré Syndrome Associated with SARS-CoV-2 (edit) |
10.1056/NEJMC2009191 |
| 2020-04-17 |
CT of Coronavirus Disease (COVID-19) Pneumonia: A Reference Standard Is Needed (edit) |
10.2214/AJR.20.23286 |
| 2020-04-17 |
COVID-19 Associated Hepatitis Complicating Recent Living Donor Liver Transplantation (edit) |
10.5858/ARPA.2020-0186-SA |
| 2020-04-17 |
COVID-19 Transmission in Dental Practice: Brief Review of Preventive Measures in Italy (edit) |
10.1177/0022034520920580 |
| 2020-04-17 |
Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients With Hypertension Hospitalized With COVID-19 (edit) |
10.1161/CIRCRESAHA.120.317134 |
| 2020-04-17 |
COVID-19 in older adults: clinical, psychosocial, and public health considerations (edit) |
10.1172/JCI.INSIGHT.139292 |
| 2020-04-17 |
Erratum to: COVID-19 Through the Lens of Gerontology (edit) |
10.1093/GERONA/GLAA080 |
| 2020-04-17 |
Population movement, city closure in Wuhan and geographical expansion of the 2019-nCoV pneumonia infection in China in January 2020 (edit) |
10.1093/CID/CIAA422 |
| 2020-04-17 |
The BTK-inhibitor ibrutinib may protect against pulmonary injury in COVID-19 infected patients (edit) |
10.1182/BLOOD.2020006288 |
| 2020-04-17 |
SARS-CoV-2 Isolation From Ocular Secretions of a Patient With COVID-19 in Italy With Prolonged Viral RNA Detection (edit) |
10.7326/M20-1176 |
| 2020-04-17 |
Letter: Rongeurs, Neurosurgeons, and COVID-19: How Do We Protect Health Care Personnel During Neurosurgical Operations in the Midst of Aerosol-Generation From High-Speed Drills? (edit) |
10.1093/NEUROS/NYAA139 |
| 2020-04-17 |
Letter: Adaptation Under Fire: Two Harvard Neurosurgical Services During the COVID-19 Pandemic (edit) |
10.1093/NEUROS/NYAA146 |
| 2020-04-17 |
Rapid Development of Telehealth Capabilities within Pediatric Patient Portal Infrastructure for COVID-19 Care: Barriers, Solutions, Results (edit) |
10.1093/JAMIA/OCAA065 |
| 2020-04-17 |
In Reply: Precautions for Endoscopic Transnasal Skull Base Surgery During the COVID-19 Pandemic (edit) |
10.1093/NEUROS/NYAA145 |
| 2020-04-17 |
The Essential Role of Home- and Community-Based Physical Therapists During the COVID-19 Pandemic (edit) |
10.1093/PTJ/PZAA069 |
| 2020-04-17 |
Impact of COVID-19 on Physical Therapist Practice in Portugal (edit) |
10.1093/PTJ/PZAA071 |
| 2020-04-17 |
Laryngeal oedema associated with COVID-19 complicating airway management (edit) |
10.1111/ANAE.15092 |
| 2020-04-17 |
Secure communication conduits during COVID19 lockdown (edit) |
10.1111/CED.14244 |
| 2020-04-17 |
A case of COVID-19 presenting in clinical picture resembling chilblains disease. First report from the Middle East (edit) |
10.1111/CED.14243 |
| 2020-04-17 |
Thrombocytopenia and Its Association with Mortality in Patients with COVID-19 (edit) |
10.1111/JTH.14848 |
| 2020-04-17 |
Should SARS-CoV-2 influence immunosuppressive therapy for autoimmune blistering diseases? (edit) |
10.1111/JDV.16491 |
| 2020-04-17 |
Hypercoagulability of COVID-19 patients in Intensive Care Unit. A Report of Thromboelastography Findings and other Parameters of Hemostasis (edit) |
10.1111/JTH.14850 |
| 2020-04-17 |
RE: ISTH interim guidance to recognition and management of coagulopathy in COVID-19 (edit) |
10.1111/JTH.14853 |
| 2020-04-17 |
Skin Reactions to Non-glove Personal Protective Equipment: An Emerging Issue in the COVID-19 Pandemic (edit) |
10.1111/JDV.16492 |
| 2020-04-17 |
The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome (edit) |
10.1111/JTH.14854 |
| 2020-04-17 |
Covid-19: Countermeasure for N95 mask-induced pressure sore (edit) |
10.1111/JDV.16490 |
| 2020-04-17 |
Thromboinflammation and the hypercoagulability of COVID-19 (edit) |
10.1111/JTH.14849 |
| 2020-04-17 |
Potential of Heparin and Nafamostat Combination Therapy for COVID-19 (edit) |
10.1111/JTH.14858 |
| 2020-04-17 |
COVID19 and acute coagulopathy in pregnancy (edit) |
10.1111/JTH.14856 |
| 2020-04-17 |
ISTH interim guidance on recognition and management of coagulopathy in COVID-19: A Comment (edit) |
10.1111/JTH.14860 |
| 2020-04-17 |
The COVID-19 pandemics: shall we expect andrological consequences? A call for contributions to ANDROLOGY (edit) |
10.1111/ANDR.12804 |
| 2020-04-17 |
Managing New-Onset Type 1 Diabetes During the COVID-19 Pandemic: Challenges and Opportunities (edit) |
10.1089/DIA.2020.0161 |
| 2020-04-17 |
Stone Care Triage During COVID-19 at the University of Washington (edit) |
10.1089/END.2020.29080.ISM |
| 2020-04-17 |
Editorial. Pediatric neurosurgery along with Children's Hospitals' innovations are rapid and uniform in response to the COVID-19 pandemic (edit) |
10.3171/2020.4.PEDS20240 |
| 2020-04-17 |
Editorial. COVID-19 and spinal surgery (edit) |
10.3171/2020.4.SPINE20468 |
| 2020-04-17 |
Editorial. Impact of COVID-19 on neurosurgery resident training and education (edit) |
10.3171/2020.3.JNS20965 |
| 2020-04-17 |
Editorial. Innovations in neurosurgical education during the COVID-19 pandemic: is it time to reexamine our neurosurgical training models? (edit) |
10.3171/2020.4.JNS201012 |
| 2020-04-17 |
Editorial. COVID-19 and academic neurosurgery (edit) |
10.3171/2020.4.JNS201013 |
| 2020-04-17 |
Editorial. COVID-19 and its impact on neurosurgery: our early experience in Singapore (edit) |
10.3171/2020.4.JNS201026 |
| 2020-04-17 |
Editorial. A neurosurgery resident's response to COVID-19: anything but routine (edit) |
10.3171/2020.4.JNS201028 |
| 2020-04-17 |
Editorial. Neurosurgical priority setting during a pandemic: COVID-19 (edit) |
10.3171/2020.4.JNS201031 |
| 2020-04-17 |
Editorial. COVID-19 outbreak and its countermeasures in the Republic of Korea (edit) |
10.3171/2020.4.JNS201062 |
| 2020-04-17 |
Editorial. Task shifting and task sharing for neurosurgeons amidst the COVID-19 pandemic (edit) |
10.3171/2020.4.JNS201056 |
| 2020-04-17 |
The scientific rationale for the use of simple masks or improvised face coverings to trap exhaled aerosols and possibly reduce the breathborne spread of COVID-19 (edit) |
10.1088/1752-7163/AB8A55 |
| 2020-04-17 |
ESGE and ESGENA Position Statement on gastrointestinal endoscopy and the COVID-19 pandemic (edit) |
10.1055/A-1155-6229 |
| 2020-04-17 |
Serological survey of SARS-CoV-2 for experimental, domestic, companion and wild animals excludes intermediate hosts of 35 different species of animals (edit) |
10.1111/TBED.13577 |
| 2020-04-17 |
Addressing mental health care for bereavements during COVID-19 pandemic (edit) |
10.1111/PCN.13008 |
| 2020-04-17 |
The application of strong matrix management and PDCA cycle in the management of severe COVID-19 patients (edit) |
10.1186/S13054-020-02871-0 |
| 2020-04-17 |
Covid-19: European officials warn that exiting lockdown will be "very long" and will require cooperation (edit) |
10.1136/BMJ.M1549 |
| 2020-04-17 |
Covid-19: Cancer Research urges mass testing to enable care to continue during pandemic (edit) |
10.1136/BMJ.M1561 |
| 2020-04-17 |
Keep older healthcare workers off the covid-19 front line (edit) |
10.1136/BMJ.M1511 |
| 2020-04-17 |
Covid-19: Disproportionate impact on ethnic minority healthcare workers will be explored by government (edit) |
10.1136/BMJ.M1562 |
| 2020-04-17 |
Clinical features of covid-19 (edit) |
10.1136/BMJ.M1470 |
| 2020-04-17 |
What's happening in covid-19 ICUs? An intensive care doctor answers some common questions (edit) |
10.1136/BMJ.M1552 |
| 2020-04-17 |
Covid-19 is shattering US cancer care (edit) |
10.1136/BMJ.M1544 |
| 2020-04-17 |
Covid-19: state governors assert control over US response as Trump struggles for a role (edit) |
10.1136/BMJ.M1564 |
| 2020-04-17 |
PPE guidance for covid-19: be honest about resource shortages (edit) |
10.1136/BMJ.M1507 |
| 2020-04-17 |
Covid-19: ibuprofen can be used for symptoms, says UK agency, but reasons for change in advice are unclear (edit) |
10.1136/BMJ.M1555 |
| 2020-04-17 |
Harnessing CAR T Cell Insights to Develop Treatments for Hyperinflammatory Responses in COVID-19 patients (edit) |
10.1158/2159-8290.CD-20-0473 |
| 2020-04-17 |
Covid-19: Government cannot say whether NHS will run out of protective gowns this weekend (edit) |
10.1136/BMJ.M1566 |
| 2020-04-17 |
Athletes as community; athletes in community: covid-19, sporting mega-events and athlete health protection (edit) |
10.1136/BJSPORTS-2020-102433 |
| 2020-04-17 |
Comparison of Abbott ID Now, Diasorin Simplexa, and CDC FDA EUA methods for the detection of SARS-CoV-2 from nasopharyngeal and nasal swabs from individuals diagnosed with COVID-19 (edit) |
10.1128/JCM.00760-20 |
| 2020-04-17 |
The Detection of SARS-CoV-2 using the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays (edit) |
10.1128/JCM.00772-20 |
| 2020-04-17 |
European Society of Minimally Invasive Neurological Therapy (ESMINT) recommendations for optimal interventional neurovascular management in the covid-19 era (edit) |
10.1136/NEURINTSURG-2020-016137 |
| 2020-04-17 |
Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model (edit) |
10.1126/SCIENCE.ABB7314 |
| 2020-04-17 |
Cytokine release syndrome in severe COVID-19 (edit) |
10.1126/SCIENCE.ABB8925 |
| 2020-04-17 |
Human leukocyte antigen susceptibility map for SARS-CoV-2 (edit) |
10.1128/JVI.00510-20 |
| 2020-04-17 |
The role of Nuclear Medicine for COVID-19 - Time to act now (edit) |
10.2967/JNUMED.120.246611 |
| 2020-04-17 |
Yttrium-90 Radioembolization: Telemedicine during COVID-19 outbreak, opportunity for prime time (edit) |
10.2967/JNUMED.120.246389 |
| 2020-04-17 |
Letter to the Editor: Who was the first doctor to report the Covid-19 outbreak in Wuhan, China? (edit) |
10.2967/JNUMED.120.247262 |
| 2020-04-17 |
British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic (edit) |
10.1136/GUTJNL-2020-321244 |
| 2020-04-17 |
Miller Fisher Syndrome and polyneuritis cranialis in COVID-19 (edit) |
10.1212/WNL.0000000000009619 |
| 2020-04-17 |
COVID-19 tsunami: the first case of a spinal cord injury patient in Italy (edit) |
10.1038/S41394-020-0274-9 |
| 2020-04-17 |
Macrophages: a Trojan horse in COVID-19? (edit) |
10.1038/S41577-020-0317-2 |
| 2020-04-17 |
Will we see protection or reinfection in COVID-19? (edit) |
10.1038/S41577-020-0316-3 |
| 2020-04-17 |
A map of SARS-CoV-2 and host cell interactions (edit) |
10.1038/S41577-020-0318-1 |
| 2020-04-17 |
The race against COVID-19 (edit) |
10.1038/S41565-020-0680-Y |
| 2020-04-17 |
COVID-19 Research in Brief: 11 April to 17 April, 2020 (edit) |
10.1038/D41591-020-00011-3 |
| 2020-04-17 |
Caring for our cancer patients in the wake of COVID-19 (edit) |
10.1038/S41416-020-0843-5 |
| 2020-04-17 |
PET imaging of COVID-19: the target and the number (edit) |
10.1007/S00259-020-04820-Z |
| 2020-04-17 |
[A cross sectional study on patients with inflammatory rheumatic diseases in terms of their compliance to their immunsuppressive medication during COVID-19 pandemic] (edit) |
10.1007/S00393-020-00800-8 |
| 2020-04-17 |
Multiple sclerosis and the risk of infection: considerations in the threat of the novel coronavirus, COVID-19/SARS-CoV-2 (edit) |
10.1007/S00415-020-09822-3 |
| 2020-04-17 |
Letter to the editor by Dobran Mauro, Paracino Riccardo, and Iacoangeli Maurizio regarding "Neurosurgery during the COVID-19 pandemic: update from Lombardy, northern Italy." Zoia C, Bongetta D, Veiceschi P, Cenzato M, Di Meco F, Locatelli D, Boeris (edit) |
10.1007/S00701-020-04332-7 |
| 2020-04-17 |
Lead the way or leave the way: leading a Department of Orthopedics through the COVID-19 pandemic (edit) |
10.1007/S00590-020-02670-X |
| 2020-04-17 |
Digital triage for people with multiple sclerosis in the age of COVID-19 pandemic (edit) |
10.1007/S10072-020-04391-9 |
| 2020-04-17 |
Possible link between anosmia and COVID-19: sniffing out the truth (edit) |
10.1007/S00405-020-05966-0 |
| 2020-04-17 |
Summary of 20 tracheal intubation by anesthesiologists for patients with severe COVID-19 pneumonia: retrospective case series (edit) |
10.1007/S00540-020-02778-8 |
| 2020-04-17 |
Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)? (edit) |
10.1007/S40264-020-00935-2 |
| 2020-04-17 |
Coronavirus (COVID-19) in Haiti: A Call for Action (edit) |
10.1007/S10900-020-00825-9 |
| 2020-04-17 |
Symptoms, Stress, and HIV-Related Care Among Older People Living with HIV During the COVID-19 Pandemic, Miami, Florida (edit) |
10.1007/S10461-020-02869-3 |
| 2020-04-17 |
Gastrointestinal symptoms associated with severity of coronavirus disease 2019 (COVID-19): a pooled analysis (edit) |
10.1007/S11739-020-02329-9 |
| 2020-04-17 |
Recapitulation of SARS-CoV-2 infection and cholangiocyte damage with human liver ductal organoids (edit) |
10.1007/S13238-020-00718-6 |
| 2020-04-17 |
Crystal structure of Nsp15 endoribonuclease NendoU from SARS-CoV-2 (edit) |
10.1002/PRO.3873 |
| 2020-04-17 |
Dosing will be a key success factor in repurposing antivirals for COVID-19 (edit) |
10.1111/BCP.14314 |
| 2020-04-17 |
Preterm delivery in pregnant woman with critical COVID-19 pneumonia and vertical transmission (edit) |
10.1002/PD.5713 |
| 2020-04-17 |
Tracheostomy during COV-SARS-CoV-2 pandemic: Recommendations from the New York Head and Neck Society (edit) |
10.1002/HED.26166 |
| 2020-04-17 |
Response to recent commentaries regarding the involvement of angiotensin-converting enzyme 2 (ACE2) and renin-angiotensin system blockers in SARS-CoV-2 infections (edit) |
10.1002/DDR.21672 |
| 2020-04-17 |
The performance of chest CT in evaluating the clinical severity of COVID-19 pneumonia: identifying critical cases based on CT characteristics (edit) |
10.1097/RLI.0000000000000689 |
| 2020-04-17 |
Are Surgeons in India prepared for COVID-19? (edit) |
10.1007/S12262-020-02185-Z |
| 2020-04-17 |
ADHD management during the COVID-19 pandemic: guidance from the European ADHD Guidelines Group (edit) |
10.1016/S2352-4642(20)30110-3 |
| 2020-04-17 |
SARS-CoV-2 and viral sepsis: observations and hypotheses (edit) |
10.1016/S0140-6736(20)30920-X |
| 2020-04-17 |
Prevention of COVID-19 in patients with inflammatory bowel disease in Wuhan, China (edit) |
10.1016/S2468-1253(20)30121-7 |
| 2020-04-17 |
Chloroquine or hydroxychloroquine for prophylaxis of COVID-19 (edit) |
10.1016/S1473-3099(20)30296-6 |
| 2020-04-17 |
COVID-19 in Latin America (edit) |
10.1016/S1473-3099(20)30303-0 |
| 2020-04-17 |
COVID-19: endgames (edit) |
10.1016/S1473-3099(20)30298-X |
| 2020-04-17 |
COVID-19 disrupts vaccine delivery (edit) |
10.1016/S1473-3099(20)30304-2 |
| 2020-04-17 |
Rural areas at risk during COVID-19 pandemic (edit) |
10.1016/S1473-3099(20)30301-7 |
| 2020-04-17 |
Gaps in India's preparedness for COVID-19 control (edit) |
10.1016/S1473-3099(20)30300-5 |
| 2020-04-17 |
COVID19 during pregnancy: a systematic review of reported cases (edit) |
10.1016/J.AJOG.2020.04.013 |
| 2020-04-17 |
Detection and analysis of nucleic acid in various biological samples of COVID-19 patients (edit) |
10.1016/J.TMAID.2020.101673 |
| 2020-04-17 |
SARS-CoV-2 RNA detection of hospital isolation wards hygiene monitoring during the Coronavirus Disease 2019 outbreak in a Chinese hospital (edit) |
10.1016/J.IJID.2020.04.024 |
| 2020-04-17 |
Specific ACE2 Expression in Small Intestinal Enterocytes may Cause Gastrointestinal Symptoms and Injury after 2019-nCoV Infection (edit) |
10.1016/J.IJID.2020.04.027 |
| 2020-04-17 |
On the molecular determinants the SARS-CoV-2 attack (edit) |
10.1016/J.CLIM.2020.108426 |
| 2020-04-17 |
Weathering the cytokine storm in susceptible patients with severe SARS-CoV-2 infection (edit) |
10.1016/J.JAIP.2020.04.014 |
| 2020-04-17 |
The Second Worldwide Wave of Interest in Coronavirus since the COVID-19 Outbreaks in South Korea, Italy and Iran: A Google Trends Study (edit) |
10.1016/J.BBI.2020.04.042 |
| 2020-04-17 |
The immunological case for staying active during the COVID-19 pandemic (edit) |
10.1016/J.BBI.2020.04.041 |
| 2020-04-17 |
Rapid Detection of Asymptomatic COVID-19 by CT Image-Guidance for Stereotactic Ablative Radiotherapy (edit) |
10.1016/J.JTHO.2020.04.007 |
| 2020-04-17 |
[Gynecological surgery during the COVID-19 Pandemic: take home messages] (edit) |
10.1016/J.GOFS.2020.04.007 |
| 2020-04-17 |
Diarrhea is associated with prolonged symptoms and viral carriage in COVID-19 (edit) |
10.1016/J.CGH.2020.04.030 |
| 2020-04-17 |
Prevention of exposure and dispersion of COVID-19 using air purifiers: challenges and concerns (edit) |
10.4178/EPIH.E2020027 |
| 2020-04-17 |
Advice Regarding Systemic Therapy in Patients with Urological Cancers During the COVID-19 Pandemic (edit) |
10.1016/J.EURURO.2020.03.026 |
| 2020-04-17 |
Can Global Pharmaceutical Supply Chains Scale Up Sustainably for the COVID-19 Crisis? (edit) |
10.1016/J.RESCONREC.2020.104868 |
| 2020-04-17 |
A Brave New World: Lessons from the COVID-19 Pandemic for Transitioning to Sustainable Supply and Production (edit) |
10.1016/J.RESCONREC.2020.104894 |
| 2020-04-17 |
Anosmia, hyposmia, and dysgeusia as indicators for positive SARS-CoV-2 infection (edit) |
10.1016/J.WJORL.2020.04.001 |
| 2020-04-17 |
A Review of Salivary Diagnostics and Its Potential Implication in Detection of Covid-19 (edit) |
10.7759/CUREUS.7708 |
| 2020-04-17 |
COVID-19 convalescent plasma transfusion (edit) |
10.1016/J.HTCT.2020.04.003 |
| 2020-04-17 |
How to manage lymphoid malignancies during novel 2019 coronavirus (CoVid-19) outbreak: a Brazilian task force recommendation (edit) |
10.1016/J.HTCT.2020.04.002 |
| 2020-04-17 |
COVID-19 Epidemic and Enhancing China's National Biosecurity System (edit) |
10.1016/J.JOBB.2020.03.002 |
| 2020-04-17 |
COVID-19 complicated by Acute Pulmonary Embolism and Right-Sided Heart Failure (edit) |
10.1016/J.JACCAS.2020.04.008 |
| 2020-04-17 |
COVID-19 Clinical Trials: A Primer for the Cardiovascular and Cardio-Oncology Communities (edit) |
10.1016/J.JACCAO.2020.04.002 |
| 2020-04-17 |
Case Report: Hepatotoxicity Associated with the Use of Hydroxychloroquine in a Patient with Novel Coronavirus Disease (COVID-19) (edit) |
10.4269/AJTMH.20-0276 |
| 2020-04-17 |
Case Report: The Importance of Novel Coronavirus Disease (COVID-19) and Coinfection with Other Respiratory Pathogens in the Current Pandemic (edit) |
10.4269/AJTMH.20-0266 |
| 2020-04-17 |
Reflections on Resilience during the Novel Coronavirus Disease (COVID-19) Pandemic: Six Lessons from Working in Resource-Denied Settings (edit) |
10.4269/AJTMH.20-0274 |
| 2020-04-17 |
COVID-19 paranoia in a patient suffering from schizophrenic psychosis - a case report (edit) |
10.1016/J.PSYCHRES.2020.113001 |
| 2020-04-17 |
Addressing collegiate mental health amid COVID-19 pandemic (edit) |
10.1016/J.PSYCHRES.2020.113003 |
| 2020-04-17 |
Using Social Media to Mine and Analyze Public Opinion Related to COVID-19 in China (edit) |
10.3390/IJERPH17082788 |
| 2020-04-17 |
Extracorporeal Membrane Oxygenation in the Treatment of Severe Pulmonary and Cardiac Compromise in COVID-19: Experience with 32 patients (edit) |
10.1097/MAT.0000000000001185 |
| 2020-04-17 |
Efficacy and Safety of Antibiotic Agents in Children with COVID-19: A Rapid Review (edit) |
10.1101/2020.04.13.20064402 |
| 2020-04-17 |
COVID-19 Antibody Seroprevalence in Santa Clara County, California (edit) |
10.1101/2020.04.14.20062463 |
| 2020-04-17 |
Lymphocytopaenia is associated with severe SARS-CoV-2 disease: A Systematic Review and Meta-Analysis of Clinical Data (edit) |
10.1101/2020.04.14.20064659 |
| 2020-04-17 |
Automated and semi-automated contact tracing: Protocol for a rapid review of available evidence and current challenges to inform the control of COVID-19 (edit) |
10.1101/2020.04.14.20063636 |
| 2020-04-17 |
Effects of temperature and humidity on the spread of COVID-19: A systematic review (edit) |
10.1101/2020.04.14.20064923 |
| 2020-04-17 |
Association of inflammatory markers with the severity of COVID-19 (edit) |
10.1101/2020.04.14.20065680 |
| 2020-04-17 |
Chest Computed Tomography for the Diagnosis of Patients with Coronavirus Disease 2019 (COVID-19): A Rapid Review and Meta-Analysis (edit) |
10.1101/2020.04.14.20064733 |
| 2020-04-17 |
Nosocomial Infections Among Patients with COVID-19, SARS and MERS: A Rapid Review and Meta-Analysis (edit) |
10.1101/2020.04.14.20065730 |
| 2020-04-17 |
Analysis of SARS-CoV-2 Antibodies in COVID-19 Convalescent Plasma using a Coronavirus Antigen Microarray (edit) |
10.1101/2020.04.15.043364 |
| 2020-04-17 |
Relationship between COVID-19 death toll doubling time and national BCG vaccination policy (edit) |
10.1101/2020.04.06.20055251 |
| 2020-04-17 |
The effect of Arbidol Hydrochloride on reducing mortality of Covid-19 patients: a retrospective study of real world date from three hospitals in Wuhan (edit) |
10.1101/2020.04.11.20056523 |
| 2020-04-17 |
Lopinavir/ritonavir for the treatment of COVID-19: A living systematic review protocol (edit) |
10.1101/2020.04.11.20062109 |
| 2020-04-17 |
BCG VACCINES MAY NOT REDUCE COVID-19 MORTALITY RATES (edit) |
10.1101/2020.04.11.20062232 |
| 2020-04-17 |
Clinical Characteristics of Children with COVID-19: A Rapid Review and Meta-Analysis (edit) |
10.1101/2020.04.13.20064352 |
| 2020-04-17 |
Reflections about the impact of the SARS-COV-2/COVID-19 pandemic on mental health (edit) |
10.1590/1516-4446-2020-0981 |
| 2020-04-17 |
Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2 (edit) |
10.1016/J.CELL.2020.04.004 |
| 2020-04-17 |
Facing the SARS-CoV-2 (COVID-19) outbreak with IL-6R antagonists (edit) |
10.5152/EURJRHEUM.2020.20061 |
| 2020-04-17 |
SARS-CoV-2 and the testis: similarity with other viruses and routes of infection (edit) |
10.1016/J.RBMO.2020.04.009 |
| 2020-04-17 |
International Mental Health perspectives on the novel coronavirus SARS-CoV-2 pandemic (edit) |
10.1016/J.RPSM.2020.04.002 |
| 2020-04-17 |
State-of-the-art tools unveil potent drug targets amongst clinically approved drugs to inhibit helicase in SARS-CoV-2 (edit) |
10.5114/AOMS.2020.94567 |
| 2020-04-17 |
2019-NCoV: What Every Neurologist Should Know? (edit) |
10.4103/AIAN.AIAN_210_20 |
| 2020-04-17 |
Evaluation of lockdown impact on SARS-CoV-2 dynamics through viral genome quantification in Paris wastewaters (edit) |
10.1101/2020.04.12.20062679 |
| 2020-04-17 |
Age could be driving variable SARS-CoV-2 epidemic trajectories worldwide (edit) |
10.1101/2020.04.13.20059253 |
| 2020-04-17 |
Long-term Coexistence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) with Antibody Response in Coronavirus Disease 2019 (COVID-19) Patients (edit) |
10.1101/2020.04.13.20040980 |
| 2020-04-17 |
The December 2019 New Corona Virus (SARS-CoV-2) Outbreak: A Behavioral Infectious Disease Policy Model (edit) |
10.1101/2020.04.13.20063610 |
| 2020-04-17 |
Estimation of airborne viral emission: quanta emission rate of SARS-CoV-2 for infection risk assessment (edit) |
10.1101/2020.04.12.20062828 |
| 2020-04-17 |
Monitoring and predicting viral dynamics in SARS-CoV-2-infected Patients (edit) |
10.1101/2020.04.14.20060491 |
| 2020-04-17 |
Estimating the effective reproduction number of the 2019-nCoV in China (edit) |
10.1101/2020.01.27.20018952 |
| 2020-04-17 |
Revealing variants in SARS-CoV-2 interaction domain of ACE2 and loss of function intolerance through analysis of >200,000 exomes (edit) |
10.1101/2020.04.07.030544 |
| 2020-04-17 |
Delayed clearance of SARS-CoV2 in male compared to female patients: High ACE2 expression in testes suggests possible existence of gender-specific viral reservoirs (edit) |
10.1101/2020.04.16.20060566 |
| 2020-04-17 |
A blueprint for the implementation of a validated approach for the detection of SARS-Cov2 in clinical samples in academic facilities (edit) |
10.1101/2020.04.14.041319 |
| 2020-04-17 |
Analysis of the SARS-Cov-2 epidemic in Lombardy (Italy) in its early phase. Are we going in the right direction? (edit) |
10.1101/2020.04.12.20062919 |
| 2020-04-17 |
Estimating the number of SARS-CoV-2 infections in the United States (edit) |
10.1101/2020.04.13.20064519 |
| 2020-04-16 |
Beyond R0: Heterogeneity in secondary infections and probabilistic epidemic forecasting (edit) |
10.1101/2020.02.10.20021725 |
| 2020-04-16 |
COVID-19 in Children in the United States: Intensive Care Admissions, Estimated Total Infected, and Projected Numbers of Severe Pediatric Cases in 2020 (edit) |
10.1097/PHH.0000000000001190 |
| 2020-04-16 |
Computational Design of ACE2-Based Peptide Inhibitors of SARS-CoV-2 (edit) |
10.1021/ACSNANO.0C02857 |
| 2020-04-16 |
A Case for Participatory Disease Surveillance of the COVID-19 Pandemic in India (edit) |
10.2196/18795 |
| 2020-04-16 |
Innovative screening tests for COVID-19 in South Korea (edit) |
10.15441/CEEM.20.032 |
| 2020-04-16 |
India fights hard to neutralize the spread of Covid-19 (edit) |
10.1017/ICE.2020.140 |
| 2020-04-16 |
Shelter hospital: glimmers of hope in treating COVID-19 (edit) |
10.1017/DMP.2020.105 |
| 2020-04-16 |
Investigating the determinants of high Case-Fatality Rate for COVID-19 in Italy (edit) |
10.1017/DMP.2020.106 |
| 2020-04-16 |
Pandemic March: COVID-19's first wave circumnavigates the globe (edit) |
10.1017/DMP.2020.103 |
| 2020-04-16 |
A Tool to Early Predict Severe Corona Virus Disease 2019 (COVID-19) : A Multicenter Study using the Risk Nomogram in Wuhan and Guangdong, China (edit) |
10.1093/CID/CIAA443 |
| 2020-04-16 |
Aging in Times of the COVID-19 Pandemic: Avoiding Ageism and Fostering Intergenerational Solidarity (edit) |
10.1093/GERONB/GBAA051 |
| 2020-04-16 |
Thoracic ultrasound and SARS-COVID-19: a pictorial essay (edit) |
10.1007/S40477-020-00458-7 |
| 2020-04-16 |
Novel Coronavirus Disease (COVID-19) and Biologic Therapy in Psoriasis: Infection Risk and Patient Counseling in Uncertain Times (edit) |
10.1007/S13555-020-00377-9 |
| 2020-04-16 |
The Case for a Temporary COVID-19 Income Tax Levy Now, During the Crisis (edit) |
10.1007/S40258-020-00585-6 |
| 2020-04-16 |
Management of COVID-19 Related Paediatric Blood Samples in a Clinical Haematology Laboratory (edit) |
10.1111/BJH.16721 |
| 2020-04-16 |
Reactive lymphocytes in patients with Covid-19 (edit) |
10.1111/BJH.16690 |
| 2020-04-16 |
COVID-19 pandemic: what consequences for cardiac rehabilitation? (edit) |
10.4081/MONALDI.2020.1315 |
| 2020-04-16 |
Relationships among lymphocyte subsets, cytokines, and the pulmonary inflammation index in coronavirus (COVID-19) infected patients (edit) |
10.1111/BJH.16659 |
| 2020-04-16 |
Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome (edit) |
10.1161/CIRCULATIONAHA.120.047349 |
| 2020-04-16 |
Real-time RT-PCR in COVID-19 detection: issues affecting the results (edit) |
10.1080/14737159.2020.1757437 |
| 2020-04-16 |
COVID-19 affects Healthy Pediatricians more than Pediatric Patients (edit) |
10.1017/ICE.2020.139 |
| 2020-04-16 |
Impact of COVID-19 on Traditional Healthcare Associated Infection Prevention Efforts (edit) |
10.1017/ICE.2020.141 |
| 2020-04-16 |
Positive RT-PCR tests among discharged COVID-19 patients in Shenzhen, China (edit) |
10.1017/ICE.2020.134 |
| 2020-04-16 |
Global Preparedness Against COVID-19: We Must Leverage the Power of Digital Health (edit) |
10.2196/18980 |
| 2020-04-16 |
Predictive Mathematical Models of the COVID-19 Pandemic: Underlying Principles and Value of Projections (edit) |
10.1001/JAMA.2020.6585 |
| 2020-04-16 |
Finding Effective Treatments for COVID-19: Scientific Integrity and Public Confidence in a Time of Crisis (edit) |
10.1001/JAMA.2020.6434 |
| 2020-04-16 |
Meeting the Care Needs of Older Adults Isolated at Home During the COVID-19 Pandemic (edit) |
10.1001/JAMAINTERNMED.2020.1661 |
| 2020-04-16 |
Comment of the potential risks of sexual and vertical transmission of Covid-19 infection (edit) |
10.1093/CID/CIAA445 |
| 2020-04-16 |
Sequential analysis of viral load in a neonate and her mother infected with SARS-CoV-2 (edit) |
10.1093/CID/CIAA447 |
| 2020-04-16 |
Vietnam's response to COVID-19: Prompt and proactive actions (edit) |
10.1093/JTM/TAAA047 |
| 2020-04-16 |
Why health promotion matters to the COVID-19 pandemic, and vice versa (edit) |
10.1093/HEAPRO/DAAA042 |
| 2020-04-16 |
Decline of acute coronary syndrome admissions in Austria since the outbreak of COVID-19: the pandemic response causes cardiac collateral damage (edit) |
10.1093/EURHEARTJ/EHAA314 |
| 2020-04-16 |
SARS-CoV-2 and Legionella Co-infection in a Person Returning from a Nile Cruise (edit) |
10.1093/JTM/TAAA053 |
| 2020-04-16 |
High prevalence of SARS-CoV-2 infection in repatriation flights to Greece from three European countries (edit) |
10.1093/JTM/TAAA054 |
| 2020-04-16 |
Reducing onward spread of COVID-19 from imported cases: quarantine and 'stay at home' measures for travellers and returning residents to Singapore (edit) |
10.1093/JTM/TAAA049 |
| 2020-04-16 |
Failure in initial stage containment of global COVID-19 epicenters (edit) |
10.1002/JMV.25883 |
| 2020-04-16 |
COVID-19: Recommended sampling sites at different stage of the disease (edit) |
10.1002/JMV.25892 |
| 2020-04-16 |
Case fatality rate analysis of Italian COVID-19 outbreak (edit) |
10.1002/JMV.25894 |
| 2020-04-16 |
Evaluation of Antiviral Therapies for Coronavirus Disease 2019 (COVID-19) Pneumonia in Shanghai, China (edit) |
10.1002/JMV.25893 |
| 2020-04-16 |
Off-label Use of Tocilizumab in Patients with SARS-CoV-2 Infection (edit) |
10.1002/JMV.25897 |
| 2020-04-16 |
Virological and Clinical Cure in Covid-19 Patients Treated with Hydroxychloroquine: A Systematic Review and Meta-Analysis (edit) |
10.1002/JMV.25898 |
| 2020-04-16 |
High IL-6/IFN-γ ratio could be associated with severe disease in COVID-19 patients (edit) |
10.1002/JMV.25900 |
| 2020-04-16 |
Management of the difficult airway in the COVID-19 pandemic: Illustrative complex head and neck cancer scenario (edit) |
10.1002/HED.26175 |
| 2020-04-16 |
Head and neck virtual medicine in a pandemic era: Lessons from COVID-19 (edit) |
10.1002/HED.26174 |
| 2020-04-16 |
Disproportionate impact of COVID-19 pandemic on head and neck cancer survivors (edit) |
10.1002/HED.26170 |
| 2020-04-16 |
There is no routine head and neck exam during the COVID-19 pandemic (edit) |
10.1002/HED.26168 |
| 2020-04-16 |
How to Guarantee the Best of Care to Patients with Cancer During the COVID-19 Epidemic: The Italian Experience (edit) |
10.1634/THEONCOLOGIST.2020-0267 |
| 2020-04-16 |
How to avoid nosocomial spread during Tracheostomy for Covid-19 patients (edit) |
10.1002/HED.26167 |
| 2020-04-16 |
Managing head and neck cancer patients with tracheostomy or laryngectomy during the COVID-19 pandemic (edit) |
10.1002/HED.26171 |
| 2020-04-16 |
A Framework for Prioritizing Head and Neck Surgery during the COVID-19 Pandemic (edit) |
10.1002/HED.26184 |
| 2020-04-16 |
COVID-19: 2020 a year in turmoil (edit) |
10.1111/JTH.14816 |
| 2020-04-16 |
The Role of Data Registries in the Time of COVID-19 (edit) |
10.1161/CIRCOUTCOMES.120.006766 |
| 2020-04-16 |
Hospital Preparedness for COVID-19: A Practical Guide from a Critical Care Perspective (edit) |
10.1164/RCCM.202004-1037CP |
| 2020-04-16 |
Chest CT and Coronavirus Disease (COVID-19): A Critical Review of the Literature to Date (edit) |
10.2214/AJR.20.23202 |
| 2020-04-16 |
The SARS-CoV-2 receptor ACE2 expression of maternal-fetal interface and fetal organs by single-cell transcriptome study (edit) |
10.1371/JOURNAL.PONE.0230295 |
| 2020-04-16 |
Mental health problems and social media exposure during COVID-19 outbreak (edit) |
10.1371/JOURNAL.PONE.0231924 |
| 2020-04-16 |
Estimating the Maximum Capacity of COVID-19 Cases Manageable per Day Given a Health Care System's Constrained Resources (edit) |
10.7326/M20-1169 |
| 2020-04-16 |
COVID-19 outbreak in Italy: protecting worker health and the response of the Italian Industrial Hygienists Association (edit) |
10.1093/ANNWEH/WXAA044 |
| 2020-04-16 |
How we deal with the COVID-19 epidemic in an Italian pediatric onco-hematology clinic located in a region at high density of cases (edit) |
10.1111/BJH.16699 |
| 2020-04-16 |
The Utah Model: mental bandwidth and strategic risk generation in COVID-19 airway management (edit) |
10.1111/ANAE.15086 |
| 2020-04-16 |
Whole body point of care ultrasound for COVID-19: a multi-system approach to a multi-system disease (edit) |
10.1111/ANAE.15087 |
| 2020-04-16 |
The use of UV fluorescent powder for COVID-19 airway management simulation training (edit) |
10.1111/ANAE.15089 |
| 2020-04-16 |
Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID-19 Pandemic: AASLD Expert Panel Consensus Statement (edit) |
10.1002/HEP.31281 |
| 2020-04-16 |
Plasmacytoid lymphocytes in SARS-CoV-2 infection (Covid-19) (edit) |
10.1002/AJH.25834 |
| 2020-04-16 |
The role of children in the transmission of mild SARS-CoV-2 infection (edit) |
10.1111/APA.15310 |
| 2020-04-16 |
COVID-19 and student nurses: a view from England (edit) |
10.1111/JOCN.15298 |
| 2020-04-16 |
Non-cutaneous considerations of COVID19 for dermatology practices (edit) |
10.1111/JOCD.13444 |
| 2020-04-16 |
A Policy to Do Better Next Time: Lessons Learned from the Covid-19 Pandemic (edit) |
10.1002/ACR2.11145 |
| 2020-04-16 |
COVID-19 and Working Conditions in Health Care (edit) |
10.1159/000507765 |
| 2020-04-16 |
Considerations for obesity, vitamin D, and physical activity amidst the COVID-19 pandemic (edit) |
10.1002/OBY.22838 |
| 2020-04-16 |
Coronavirus Anxiety Scale: A brief mental health screener for COVID-19 related anxiety (edit) |
10.1080/07481187.2020.1748481 |
| 2020-04-16 |
COVID-19 pneumonia: ARDS or not? (edit) |
10.1186/S13054-020-02880-Z |
| 2020-04-16 |
A case of a readmitted patient who recovered from COVID-19 in Chengdu, China (edit) |
10.1186/S13054-020-02877-8 |
| 2020-04-16 |
Acute kidney injury in SARS-CoV-2 infected patients (edit) |
10.1186/S13054-020-02872-Z |
| 2020-04-16 |
Management of rheumatic diseases in the time of covid-19 pandemic: perspectives of rheumatology practitioners from India (edit) |
10.1136/ANNRHEUMDIS-2020-217509 |
| 2020-04-16 |
Covid-19: Mental health consequences of pandemic need urgent research, paper advises (edit) |
10.1136/BMJ.M1515 |
| 2020-04-16 |
Covid-19: Coronavirus was first described in The BMJ in 1965 (edit) |
10.1136/BMJ.M1547 |
| 2020-04-16 |
Covid-19: Japan prepares to extend state of emergency nationwide as "untraceable" cases soar (edit) |
10.1136/BMJ.M1543 |
| 2020-04-16 |
Gastroenterology department operational reorganisation at the time of covid-19 outbreak: an Italian and Chinese experience (edit) |
10.1136/GUTJNL-2020-321143 |
| 2020-04-16 |
High-flow nasal cannula for COVID-19 patients: low risk of bio-aerosol dispersion (edit) |
10.1183/13993003.00892-2020 |
| 2020-04-16 |
Demographic science aids in understanding the spread and fatality rates of COVID-19 (edit) |
10.1073/PNAS.2004911117 |
| 2020-04-16 |
COVID-19 pandemic in India: challenges and silver linings (edit) |
10.1136/POSTGRADMEDJ-2020-137780 |
| 2020-04-16 |
How is biomedical research funding faring during the COVID-19 lockdown? (edit) |
10.1038/D41591-020-00010-4 |
| 2020-04-16 |
CRISPR-Cas12-based detection of SARS-CoV-2 (edit) |
10.1038/S41587-020-0513-4 |
| 2020-04-16 |
Genomic characterization of a novel SARS-CoV-2 (edit) |
10.1016/J.GENREP.2020.100682 |
| 2020-04-16 |
Protecting patients and healthcare personnel from COVID-19: considerations for practice and outpatient care in cardiology (edit) |
10.1007/S00059-020-04922-2 |
| 2020-04-16 |
[Telemedicine in the fight against SARS-COV-2-opportunities and possible applications in otorhinolaryngology : Narrative review] (edit) |
10.1007/S00106-020-00864-7 |
| 2020-04-16 |
Balneotherapy and human immune function in the era of COVID-19 (edit) |
10.1007/S00484-020-01914-Z |
| 2020-04-16 |
How Can Blockchain Help People in the Event of Pandemics Such as the COVID-19? (edit) |
10.1007/S10916-020-01577-8 |
| 2020-04-16 |
A diagnostic model for coronavirus disease 2019 (COVID-19) based on radiological semantic and clinical features: a multi-center study (edit) |
10.1007/S00330-020-06829-2 |
| 2020-04-16 |
COVID-19 outbreak and steroids administration: are patients treated for Sars-Cov-2 at risk of adrenal insufficiency? (edit) |
10.1007/S40618-020-01253-1 |
| 2020-04-16 |
Understanding the Impact of COVID-19 on Latino Sexual Minority Men in a US HIV Hot Spot (edit) |
10.1007/S10461-020-02862-W |
| 2020-04-16 |
Collective Call to Action for HIV/AIDS Community-Based Collaborative Science in the Era of COVID-19 (edit) |
10.1007/S10461-020-02860-Y |
| 2020-04-16 |
Clinical characteristics of COVID-19 in children compared with adults in Shandong Province, China (edit) |
10.1007/S15010-020-01427-2 |
| 2020-04-16 |
COVID-19 in solid organ transplant recipients: a single-center case series from Spain (edit) |
10.1111/AJT.15929 |
| 2020-04-16 |
Estimation of basic reproduction number for COVID-19 and the reasons for its differences (edit) |
10.1111/IJCP.13518 |
| 2020-04-16 |
The prospects for the SARS-CoV-2 pandemic in Africa (edit) |
10.15252/EMMM.202012488 |
| 2020-04-16 |
Management of ART and COVID-19: Infertility in times of pan- demic. What now? (edit) |
10.5935/1518-0557.20200031 |
| 2020-04-16 |
Airborne or droplet precautions for health workers treating COVID-19? (edit) |
10.1093/INFDIS/JIAA189 |
| 2020-04-16 |
Regulation and Trust: 3-Month Follow-up Study on COVID-19 Mortality in 25 European Countries (edit) |
10.2196/19218 |
| 2020-04-16 |
Comparison of throat swabs and sputum specimens for viral nucleic acid detection in 52 cases of novel coronavirus (SARS-Cov-2)-infected pneumonia (COVID-19) (edit) |
10.1515/CCLM-2020-0187 |
| 2020-04-16 |
Routine blood tests as a potential diagnostic tool for COVID-19 (edit) |
10.1515/CCLM-2020-0398 |
| 2020-04-16 |
Coinfection of SARS-CoV-2 and multiple respiratory pathogens in children (edit) |
10.1515/CCLM-2020-0434 |
| 2020-04-16 |
Analytical performances of a chemiluminescence immunoassay for SARS-CoV-2 IgM/IgG and antibody kinetics (edit) |
10.1515/CCLM-2020-0443 |
| 2020-04-16 |
Assessment of immune response to SARS-CoV-2 with fully automated MAGLUMI 2019-nCoV IgG and IgM chemiluminescence immunoassays (edit) |
10.1515/CCLM-2020-0473 |
| 2020-04-16 |
Women and children first: the need for ringfencing during the COVID-19 pandemic (edit) |
10.1515/JPM-2020-0149 |
| 2020-04-16 |
The Impact of COVID-19 in Psychiatry (edit) |
10.4088/PCC.20L02627 |
| 2020-04-16 |
A Guide to Facial Trauma Triage and Precautions in the COVID-19 Pandemic (edit) |
10.1089/FPSAM.2020.0185 |
| 2020-04-16 |
Health Communication Through News Media During the Early Stage of the COVID-19 Outbreak in China: A Digital Topic Modeling Approach (edit) |
10.2196/19118 |
| 2020-04-16 |
Mission command: applying principles of military leadership to the SARS-Cov-2 (covid-19) crisis (edit) |
10.1136/BMJMILITARY-2020-001485 |
| 2020-04-16 |
Case series of coronavirus (SARS-CoV-2) in a military recruit school: clinical, sanitary and logistical implications (edit) |
10.1136/BMJMILITARY-2020-001482 |
| 2020-04-16 |
Contributory Role of Positron Emission Tomography in a Left Ventricular Assist Device Recipient at the time of COVID-19 pandemic (edit) |
10.1097/MAT.0000000000001176 |
| 2020-04-16 |
First successful treatment of COVID-19 induced refractory cardiogenic plus vasoplegic shock by combination of pVAD and ECMO - a case report (edit) |
10.1097/MAT.0000000000001178 |
| 2020-04-16 |
COVID-19 Respiratory Failure: Targeting Inflammation on VV-ECMO Support (edit) |
10.1097/MAT.0000000000001177 |
| 2020-04-16 |
COVID-19 putting patients at risk of unplanned extubation and airway providers at increased risk of contamination (edit) |
10.1213/ANE.0000000000004890 |
| 2020-04-16 |
FECAL-ORAL TRANSMISSION OF SARS-COV-2 IN CHILDREN: IS IT TIME TO CHANGE OUR APPROACH? (edit) |
10.1097/INF.0000000000002704 |
| 2020-04-16 |
Obstetricians on the Coronavirus Disease 2019 (COVID-19) Front Lines and the Confusing World of Personal Protective Equipment (edit) |
10.1097/AOG.0000000000003919 |
| 2020-04-16 |
Protecting workers aged 60-69 years from COVID-19 (edit) |
10.1016/S1473-3099(20)30311-X |
| 2020-04-16 |
Wearing face masks in the community during the COVID-19 pandemic: altruism and solidarity (edit) |
10.1016/S0140-6736(20)30918-1 |
| 2020-04-16 |
Endoscopy in inflammatory bowel diseases during the COVID-19 pandemic and post-pandemic period (edit) |
10.1016/S2468-1253(20)30119-9 |
| 2020-04-16 |
COVID-19: time to plan for prompt universal access to diagnostics and treatments (edit) |
10.1016/S2214-109X(20)30137-6 |
| 2020-04-16 |
Blood transfusion strategies and ECMO during the COVID-19 pandemic - Authors' reply (edit) |
10.1016/S2213-2600(20)30174-0 |
| 2020-04-16 |
Blood transfusion strategies and ECMO during the COVID-19 pandemic (edit) |
10.1016/S2213-2600(20)30173-9 |
| 2020-04-16 |
Kidney transplant programmes during the COVID-19 pandemic (edit) |
10.1016/S2213-2600(20)30182-X |
| 2020-04-16 |
Severe Acute Proximal Pulmonary Embolism and COVID-19: A Word of Caution (edit) |
10.1016/J.ATHORACSUR.2020.04.005 |
| 2020-04-16 |
Multicenter analysis of clinical characteristics and outcome of COVID-19 patients with liver injury (edit) |
10.1016/J.JHEP.2020.04.010 |
| 2020-04-16 |
Inflammatory bowel diseases and COVID-19: the invisible enemy (edit) |
10.1053/J.GASTRO.2020.04.032 |
| 2020-04-16 |
Resource-sparing urgent endoscopies by a mobile on-call team in the Paris area during the COVID-19 outbreak (edit) |
10.1016/J.GIE.2020.04.021 |
| 2020-04-16 |
ERCP during the pandemic of COVID-19 in Wuhan, China (edit) |
10.1016/J.GIE.2020.04.022 |
| 2020-04-16 |
Plexiglass barrier box to improve ERCP safety during the COVID-19 pandemic (edit) |
10.1016/J.GIE.2020.04.020 |
| 2020-04-16 |
Vascular surgery department adjustments in the era of the COVID-19 pandemic (edit) |
10.1016/J.JVS.2020.04.017 |
| 2020-04-16 |
Perspectives on vascular surgical practice change due to COVID-19 at a non-academic tertiary care center (edit) |
10.1016/J.JVS.2020.04.016 |
| 2020-04-16 |
Early Experience in the COVID-19 pandemic from a Vascular Surgery Unit in a Singapore Tertiary Hospital (edit) |
10.1016/J.JVS.2020.04.014 |
| 2020-04-16 |
COVID-19 and diabetes management: What should be considered? (edit) |
10.1016/J.DIABRES.2020.108151 |
| 2020-04-16 |
COVID-19 drive through testing: An effective strategy for conserving personal protective equipment (edit) |
10.1016/J.AJIC.2020.04.010 |
| 2020-04-16 |
The AAD COVID-19 Registry: Crowdsourcing Dermatology in the Age of COVID-19 (edit) |
10.1016/J.JAAD.2020.04.045 |
| 2020-04-16 |
Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients (edit) |
10.1016/J.JAAD.2020.04.044 |
| 2020-04-16 |
Letter from the Editors: Big Data and Cutaneous Manifestations of COVID-19 (edit) |
10.1016/J.JAAD.2020.04.050 |
| 2020-04-16 |
Overzealous hand hygiene during COVID 19 pandemic causing increased incidence of hand eczema among general population (edit) |
10.1016/J.JAAD.2020.04.047 |
| 2020-04-16 |
Teledermatology in the Era of COVID-19: Experience of an Academic Department of Dermatology (edit) |
10.1016/J.JAAD.2020.04.048 |
| 2020-04-16 |
United States Cutaneous Lymphoma Consortium Recommendations for Treatment of Cutaneous Lymphomas During the COVID-19 Pandemic (edit) |
10.1016/J.JAAD.2020.04.049 |
| 2020-04-16 |
COVID-19 and Racial Disparities (edit) |
10.1016/J.JAAD.2020.04.046 |
| 2020-04-16 |
Risk factors for severe COVID-19: evidence from 167 hospitalized patients in Anhui, China (edit) |
10.1016/J.JINF.2020.04.010 |
| 2020-04-16 |
Clinical characteristics of older patients: The experience of a geriatric short-stay unit dedicated to patients with COVID-19 in France (edit) |
10.1016/J.JINF.2020.04.009 |
| 2020-04-16 |
Risk Factors Associated with Disease Severity and Length of Hospital Stay in COVID-19 Patients (edit) |
10.1016/J.JINF.2020.04.008 |
| 2020-04-16 |
Chloroquine Paradox May Cause More Damage Than Help Fight COVID-19 (edit) |
10.1016/J.MICINF.2020.04.004 |
| 2020-04-16 |
Renin-angiotensin system at the heart of COVID-19 pandemic (edit) |
10.1016/J.BIOCHI.2020.04.008 |
| 2020-04-16 |
COVID-19 travel restrictions and the International Health Regulations - call for an open debate on easing of travel restrictions (edit) |
10.1016/J.IJID.2020.04.029 |
| 2020-04-16 |
Association of the COVID-19 pandemic with Internet Search Volumes: A Google TrendsTM Analysis (edit) |
10.1016/J.IJID.2020.04.033 |
| 2020-04-16 |
Meningoencephalitis without Respiratory Failure in a Young Female Patient with COVID-19 Infection in Downtown Los Angeles, Early April 2020 (edit) |
10.1016/J.BBI.2020.04.024 |
| 2020-04-16 |
Practical diagnosis and treatment of suspected venous thromboembolism during COVID-19 Pandemic (edit) |
10.1016/J.JVSV.2020.04.009 |
| 2020-04-16 |
Upsurge of deep venous thrombosis in patients affected by COVID-19: preliminary data and possible explanations (edit) |
10.1016/J.JVSV.2020.04.004 |
| 2020-04-16 |
Can post-exposure prophylaxis for COVID-19 be considered as one of outbreak response strategies in long-term care hospitals? (edit) |
10.1016/J.IJANTIMICAG.2020.105988 |
| 2020-04-16 |
Cytokine storm and immunomodulatory therapy in COVID-19: role of chloroquine and anti-IL-6 monoclonal antibodies (edit) |
10.1016/J.IJANTIMICAG.2020.105982 |
| 2020-04-16 |
Combating Devastating COVID -19 by Drug Repurposing (edit) |
10.1016/J.IJANTIMICAG.2020.105984 |
| 2020-04-16 |
Treating hypoxemic patients with SARS-COV-2 pneumonia: Back to applied physiology (edit) |
10.1016/J.ACCPM.2020.04.003 |
| 2020-04-16 |
Alert to Potential Contagiousness: A Case of Lung Cancer with Asymptomatic SARS-CoV-2 Infection (edit) |
10.1016/J.JTHO.2020.04.005 |
| 2020-04-16 |
A severe case with co-infection of SARS-CoV-2 and common respiratory pathogens (edit) |
10.1016/J.TMAID.2020.101672 |
| 2020-04-16 |
Coronavirus Disease 2019 (COVID-19) and healthcare-associated infections: Emerging and future challenges for public health in Brazil (edit) |
10.1016/J.TMAID.2020.101675 |
| 2020-04-16 |
COVID-19: The time for action is just now; It's still not too late (edit) |
10.1016/J.TMAID.2020.101676 |
| 2020-04-16 |
Review of Artificial Intelligence Techniques in Imaging Data Acquisition, Segmentation and Diagnosis for COVID-19 (edit) |
10.1109/RBME.2020.2987975 |
| 2020-04-16 |
Clinical Consensus Recommendations Regarding Non-Invasive Respiratory Support in the Adult Patient with Acute Respiratory Failure Secondary to SARS-CoV-2 infection (edit) |
10.1016/J.REDAR.2020.03.006 |
| 2020-04-16 |
CT imaging of the COVID-19 (edit) |
10.1016/J.JFMA.2020.04.006 |
| 2020-04-16 |
Clinical characteristics and diagnostic challenges of pediatric COVID-19: A systematic review and meta-analysis (edit) |
10.1016/J.JFMA.2020.04.007 |
| 2020-04-16 |
Continuing education in oral cancer during coronavirus disease 2019 (covid-19) outbreak (edit) |
10.1016/J.ORALONCOLOGY.2020.104713 |
| 2020-04-16 |
The use of simulation to prepare and improve responses to infectious disease outbreaks like COVID-19: practical tips and resources from Norway, Denmark, and the UK (edit) |
10.1186/S41077-020-00121-5 |
| 2020-04-16 |
Chest CT features and their role in COVID-19 (edit) |
10.1016/J.JRID.2020.04.001 |
| 2020-04-16 |
COVID-19 Clinical Trials: A Primer for the Cardiovascular and Cardio-Oncology Communities (edit) |
10.1016/J.JACBTS.2020.04.003 |
| 2020-04-16 |
Unity amidst uncertainty: COVID-19 pandemic fosters collaboration in rheumatology community (edit) |
10.1016/S2665-9913(20)30082-5 |
| 2020-04-16 |
Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registries (edit) |
10.1016/S2665-9913(20)30095-3 |
| 2020-04-16 |
Transient Brugada-like ECG pattern in a patient with Coronavirus Disease 2019 (COVID-19) (edit) |
10.1016/J.JACCAS.2020.04.007 |
| 2020-04-16 |
Modified Routine Cardiac Imaging Surveillance of Adult Cancer Patients and Survivors during the COVID-19 Pandemic (edit) |
10.1016/J.JACCAO.2020.04.001 |
| 2020-04-16 |
The Known into the Unknown: Brugada syndrome and COVID-19 (edit) |
10.1016/J.JACCAS.2020.04.006 |
| 2020-04-16 |
SARS-Cov-2 infection: Response of human immune system and possible implications for the rapid test and treatment (edit) |
10.1016/J.INTIMP.2020.106519 |
| 2020-04-16 |
Elective surgery in the time of COVID-19 (edit) |
10.1016/J.AMJSURG.2020.04.014 |
| 2020-04-16 |
Early pulmonary rehabilitation for SARS-CoV-2 pneumonia: Experience from an intensive care unit outside of the Hubei province in China (edit) |
10.1016/J.HRTLNG.2020.04.007 |
| 2020-04-16 |
Ivermectin and Novel Coronavirus Disease (COVID-19): Keeping Rigor in Times of Urgency (edit) |
10.4269/AJTMH.20-0271 |
| 2020-04-16 |
Prevalence of self-reported depression and anxiety among pediatric medical staff members during the COVID-19 outbreak in Guiyang, China (edit) |
10.1016/J.PSYCHRES.2020.113005 |
| 2020-04-16 |
The psychological impact of COVID-19 on medical students [Letter] (edit) |
10.1016/J.PSYCHRES.2020.113020 |
| 2020-04-16 |
What do we know about the SARS-CoV-2 coronavirus in the environment? (edit) |
10.1016/J.SCITOTENV.2020.138647 |
| 2020-04-16 |
Combining Point-of-Care Diagnostics and Internet of Medical Things (IoMT) to Combat the COVID-19 Pandemic (edit) |
10.3390/DIAGNOSTICS10040224 |
| 2020-04-16 |
Naive Forecast for COVID-19 in Utah Based on the South Korea and Italy Models-the Fluctuation between Two Extremes (edit) |
10.3390/IJERPH17082750 |
| 2020-04-16 |
COVID-19, Chloroquine Repurposing, and Cardiac Safety Concern: Chirality Might Help (edit) |
10.3390/MOLECULES25081834 |
| 2020-04-16 |
COVID-19 Pandemic and the Crisis of Health Systems: The Experience of the Apulia Cancer Network and of the Comprehensive Cancer Center Istituto Tumori "Giovanni Paolo II" of Bari (edit) |
10.3390/IJERPH17082763 |
| 2020-04-16 |
An academic allergy unit during COVID-19 pandemic in Italy (edit) |
10.1016/J.JACI.2020.04.003 |
| 2020-04-16 |
The COVID-19 pandemic: Technology use to support the wellbeing of children (edit) |
10.1016/J.PEDN.2020.04.013 |
| 2020-04-16 |
Consideration of povidone-iodine as a public health intervention for COVID-19: Utilization as "Personal Protective Equipment" for frontline providers exposed in high-risk head and neck and skull base oncology care (edit) |
10.1016/J.ORALONCOLOGY.2020.104724 |
| 2020-04-16 |
Clinical features and multidisciplinary treatment outcome of COVID-19 pneumonia: A report of three cases (edit) |
10.1016/J.JFMA.2020.04.008 |
| 2020-04-16 |
Responding to COVID-19 pandemic: Why a strong health system is required (edit) |
10.4103/IJMR.IJMR_761_20 |
| 2020-04-16 |
COVID‑19 in Northern Italy: An integrative overview of factors possibly influencing the sharp increase of the outbreak (Review) (edit) |
10.3892/MMR.2020.11079 |
| 2020-04-16 |
Identifying common pharmacotherapies associated with reduced COVID-19 morbidity using electronic health records (edit) |
10.1101/2020.04.11.20061994 |
| 2020-04-16 |
Cardiovascular Diseases and COVID-19 Mortality and Intensive Care Unit Admission: A Systematic Review and Meta-analysis (edit) |
10.1101/2020.04.12.20062869 |
| 2020-04-16 |
Characteristics and outcomes of a cohort of SARS-CoV-2 patients in the Province of Reggio Emilia, Italy (edit) |
10.1101/2020.04.13.20063545 |
| 2020-04-16 |
Smoking is Associated with COVID-19 Progression: A Meta-Analysis (edit) |
10.1101/2020.04.13.20063669 |
| 2020-04-16 |
SARS-CoV-2 (COVID-19) and intravascular volume management strategies in the critically ill (edit) |
10.1080/08998280.2020.1754700 |
| 2020-04-16 |
Evidence Based Treatment of SARS-CoV2: A Narrative Review (edit) |
10.5152/TURKTHORACJ.2020.20041 |
| 2020-04-16 |
The Risk of SARS-CoV-2 in Immunosuppressed IBD Patients (edit) |
10.1093/CROCOL/OTAA026 |
| 2020-04-16 |
SARS-CoV-2 infection in patients on renal replacement therapy. Report of the COVID-19 Registry of the Spanish Society of Nephrology (SEN) (edit) |
10.1016/J.NEFRO.2020.04.002 |
| 2020-04-16 |
Relevance of enriched expression of SARS-CoV-2 binding receptor ACE2 in gastrointestinal tissue with pathogenesis of digestive symptoms, diabetes-associated mortality, and disease recurrence in COVID-19 patients (edit) |
10.1101/2020.04.14.040204 |
| 2020-04-16 |
Humanized Single Domain Antibodies Neutralize SARS-CoV-2 by Targeting Spike Receptor Binding Domain (edit) |
10.1101/2020.04.14.042010 |
| 2020-04-16 |
Glycosaminoglycan binding motif at S1/S2 proteolytic cleavage site on spike glycoprotein may facilitate novel coronavirus (SARS-CoV-2) host cell entry (edit) |
10.1101/2020.04.14.041459 |
| 2020-04-16 |
Analysis of SARS-CoV-2-controlled autophagy reveals spermidine, MK-2206, and niclosamide as putative antiviral therapeutics (edit) |
10.1101/2020.04.15.997254 |
| 2020-04-16 |
Genome based Evolutionary study of SARS-CoV-2 towards the Prediction of Epitope Based Chimeric Vaccine (edit) |
10.1101/2020.04.15.036285 |
| 2020-04-16 |
Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2 (edit) |
10.1101/2020.04.15.043166 |
| 2020-04-16 |
TMPRSS2 and furin are both essential for proteolytic activation and spread of SARS-CoV-2 in human airway epithelial cells and provide promising drug targets (edit) |
10.1101/2020.04.15.042085 |
| 2020-04-16 |
A transcription regulatory network within the ACE2 locus may promote a pro-viral environment for SARS-CoV-2 by modulating expression of host factors (edit) |
10.1101/2020.04.14.042002 |
| 2020-04-16 |
Designing a multi-epitope peptide-based vaccine against SARS-CoV-2 (edit) |
10.1101/2020.04.15.040618 |
| 2020-04-16 |
De novo 3D models of SARS-CoV-2 RNA elements and small-molecule-binding RNAs to guide drug discovery (edit) |
10.1101/2020.04.14.041962 |
| 2020-04-16 |
SARS-CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and Other Drugs for the Treatment of the New Coronavirus (edit) |
|
| 2020-04-15 |
Coronavirus latest: Trump halts funding for WHO (edit) |
10.1038/D41586-020-00154-W |
| 2020-04-15 |
Temporal dynamics in viral shedding and transmissibility of COVID-19 (edit) |
10.1038/S41591-020-0869-5 |
| 2020-04-15 |
Temporal dynamics in viral shedding and transmissibility of COVID-19 (edit) |
10.1101/2020.03.15.20036707 |
| 2020-04-15 |
Exhaled breath condensate as a potential specimen for diagnosing COVID-19 (edit) |
10.4155/BIO-2020-0083 |
| 2020-04-15 |
Practical Implementation of COVID-19 Patient Flags into an Antimicrobial Stewardship Program's Prospective Review (edit) |
10.1017/ICE.2020.133 |
| 2020-04-15 |
COVID-19: What Paramedics Need to Know! (edit) |
10.1017/CEM.2020.367 |
| 2020-04-15 |
Psychological Impact and Coping Strategies of Frontline Medical Staff in Hunan Between January and March 2020 During the Outbreak of Coronavirus Disease 2019 (COVID‑19) in Hubei, China (edit) |
10.12659/MSM.924171 |
| 2020-04-15 |
ADAM17 inhibition may exert a protective effect on COVID-19 (edit) |
10.1093/NDT/GFAA093 |
| 2020-04-15 |
Evolution of CT findings in patients with mild COVID-19 pneumonia (edit) |
10.1007/S00330-020-06823-8 |
| 2020-04-15 |
SARS-CoV-2: At the Crossroad Between Aging and Neurodegeneration (edit) |
10.1002/MDS.28084 |
| 2020-04-15 |
Waiting for COVID-19 (edit) |
10.1111/JPC.14891 |
| 2020-04-15 |
[Application of tracheotomy in the treatment of severe cases of COVID-19] (edit) |
10.3760/CMA.J.ISSN.1673-0860.2020.0009 |
| 2020-04-15 |
Editor Responsibility and Scientific Integrity During the COVID-19 Outbreak (edit) |
10.4274/BALKANMEDJ.GALENOS.2020.2020.4.001 |
| 2020-04-15 |
Severe Pneumonia Due to SARS-CoV-2 and Respiratory Syncytial Virus Infection: A Case Report (edit) |
10.1177/0009922820920016 |
| 2020-04-15 |
SARS-CoV-2 Infection in a 2-Week-Old Male With Neutropenia (edit) |
10.1177/0009922820920014 |
| 2020-04-15 |
Hypertension, the renin-angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19 (edit) |
10.1093/CVR/CVAA097 |
| 2020-04-15 |
COVID-19 Preparedness in Michigan Nursing Homes (edit) |
10.1111/JGS.16490 |
| 2020-04-15 |
Pulmonary thrombosis in 2019-nCoV pneumonia? (edit) |
10.1111/JTH.14818 |
| 2020-04-15 |
On the alert for cytokine storm: Immunopathology in COVID-19 (edit) |
10.1002/ART.41285 |
| 2020-04-15 |
The Impact of the COVID-19 Pandemic on the Radiology Research Enterprise: Radiology Scientific Expert Panel (edit) |
10.1148/RADIOL.2020201393 |
| 2020-04-15 |
The Economic Impact of the COVID-19 Pandemic on Radiology Practices (edit) |
10.1148/RADIOL.2020201495 |
| 2020-04-15 |
Prognostic value of NT-proBNP in patients with severe COVID-19 (edit) |
10.1186/S12931-020-01352-W |
| 2020-04-15 |
COVID-19 randomised trial protocols: rapid publication without barriers (edit) |
10.1186/S13063-020-04304-3 |
| 2020-04-15 |
Prognosis when using extracorporeal membrane oxygenation (ECMO) for critically ill COVID-19 patients in China: a retrospective case series (edit) |
10.1186/S13054-020-2840-8 |
| 2020-04-15 |
Just when I thought I was out, they pull me back in: the older physician in the COVID-19 pandemic (edit) |
10.1017/S1041610220000599 |
| 2020-04-15 |
Covid-19 (Coronavirus): Challenges for Psychiatry (edit) |
10.1192/BJP.2020.86 |
| 2020-04-15 |
COVID-19 and African Americans (edit) |
10.1001/JAMA.2020.6548 |
| 2020-04-15 |
Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens (edit) |
10.1001/JAMA.2020.6266 |
| 2020-04-15 |
Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human hearts (edit) |
10.1093/EURHEARTJ/EHAA311 |
| 2020-04-15 |
Key words to be adopted for COVID-19 research (edit) |
10.1093/EURHEARTJ/EHAA322 |
| 2020-04-15 |
Letter: Neurosurgery and Coronavirus (COVID-19) Epidemic: Doing our Part (edit) |
10.1093/NEUROS/NYAA115 |
| 2020-04-15 |
Letter: Precautions for Endoscopic Transnasal Skull Base Surgery During the COVID-19 Pandemic (edit) |
10.1093/NEUROS/NYAA125 |
| 2020-04-15 |
Could HIV infection alter the clinical course of SARS-CoV-2 infection? When less is better (edit) |
10.1002/JMV.25881 |
| 2020-04-15 |
Hyperglycemia, Hydroxychloroquine, and the COVID-19 Epidemic (edit) |
10.1002/JMV.25887 |
| 2020-04-15 |
Treatment with convalescent plasma for COVID-19 patients in Wuhan, China (edit) |
10.1002/JMV.25882 |
| 2020-04-15 |
Global guidance for surgical care during the COVID-19 pandemic (edit) |
10.1002/BJS.11646 |
| 2020-04-15 |
Clinical characteristics of 3,062 COVID-19 patients: a meta-analysis (edit) |
10.1002/JMV.25884 |
| 2020-04-15 |
Analysis of 92 deceased patients with COVID-19 (edit) |
10.1002/JMV.25891 |
| 2020-04-15 |
Coinfection with COVID-19 and Coronavirus HKU1 - the critical need for repeat testing if clinically indicated (edit) |
10.1002/JMV.25890 |
| 2020-04-15 |
The impact of COPD and smoking history on the severity of Covid-19: A systemic review and meta-analysis (edit) |
10.1002/JMV.25889 |
| 2020-04-15 |
The impact of covid-19 on rehabilitation services and activities. Letter to the editor in response to official document of SIMFER (edit) |
10.23736/S1973-9087.20.06296-6 |
| 2020-04-15 |
Rehabilitation and respiratory management in the acute and early post-acute phase. "Instant paper from the field" on rehabilitation answers to the Covid-19 emergency (edit) |
10.23736/S1973-9087.20.06305-4 |
| 2020-04-15 |
Critically-ill COVID-19 patient (edit) |
10.3906/SAG-2004-122 |
| 2020-04-15 |
Emerging and reemerging respiratory viral infections up to Covid-19 (edit) |
10.3906/SAG-2004-126 |
| 2020-04-15 |
Antiviral treatment of COVID-19 (edit) |
10.3906/SAG-2004-145 |
| 2020-04-15 |
COVID-19: Prevention and control measures in community (edit) |
10.3906/SAG-2004-146 |
| 2020-04-15 |
SARS-CoV-2 Viral Load in Clinical Samples of Critically Ill Patients (edit) |
10.1164/RCCM.202003-0572LE |
| 2020-04-15 |
The Science Underlying COVID-19: Implications for the Cardiovascular System (edit) |
10.1161/CIRCULATIONAHA.120.047549 |
| 2020-04-15 |
Comparison of the Indicators of Psychological Stress in the Population of Hubei Province and Non-Endemic Provinces in China During Two Weeks During the Coronavirus Disease 2019 (COVID-19) Outbreak in February 2020 (edit) |
10.12659/MSM.923767 |
| 2020-04-15 |
Clinician Education and Adoption of Preventive Measures for COVID-19: A Survey of a Convenience Sample of General Practitioners in Lombardy, Italy (edit) |
10.7326/M20-1447 |
| 2020-04-15 |
COVID-19 vaginal delivery - a case report (edit) |
10.1111/AJO.13173 |
| 2020-04-15 |
Exaggerated information and COVID-19 outbreak (edit) |
10.1111/ECI.13226 |
| 2020-04-15 |
Concerns related to COVID-19 pandemic among patients with Inflammatory Bowel Disease, and its influence on patients management (edit) |
10.1111/ECI.13233 |
| 2020-04-15 |
Improving Communication About COVID-19 and Other Emerging Infectious Diseases (edit) |
10.1111/ECI.13225 |
| 2020-04-15 |
SARS-CoV-2 infection in a psoriatic patient treated with IL-23 inhibitor (edit) |
10.1111/JDV.16468 |
| 2020-04-15 |
Comment on: Cutaneous manifestations in COVID-19: a first perspective. Safety concerns of clinical images and skin biopsies (edit) |
10.1111/JDV.16470 |
| 2020-04-15 |
Carving out a place for internal medicine during COVID-19 epidemic in Italy (edit) |
10.1111/JOIM.13079 |
| 2020-04-15 |
Viral exanthem in COVID-19, a clinical enigma with biological significance (edit) |
10.1111/JDV.16469 |
| 2020-04-15 |
COVID-19 and Cutaneous manifestations (edit) |
10.1111/JDV.16483 |
| 2020-04-15 |
Urticarial eruption in COVID-19 infection (edit) |
10.1111/JDV.16472 |
| 2020-04-15 |
Face the COVID-19 emergency: measures applied in an Italian Dermatologic Clinic (edit) |
10.1111/JDV.16476 |
| 2020-04-15 |
Liver impairment associated with disease progression in COVID-19 patients (edit) |
10.1111/LIV.14481 |
| 2020-04-15 |
Venous thromboembolism in COVID-19 patients (edit) |
10.1111/JTH.14842 |
| 2020-04-15 |
Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19 (edit) |
10.1111/JTH.14844 |
| 2020-04-15 |
The Impact of COVID-19 on Bariatric Surgery: Re-Defining Psychosocial Care (edit) |
10.1002/OBY.22836 |
| 2020-04-15 |
Impact of the COVID-19 pandemic on therapeutic choices in Thrombosis-Hemostasis (edit) |
10.1111/JTH.14845 |
| 2020-04-15 |
Does COVID-19 Disprove the Obesity Paradox in ARDS? (edit) |
10.1002/OBY.22835 |
| 2020-04-15 |
Neurologic Features in Severe SARS-CoV-2 Infection (edit) |
10.1056/NEJMC2008597 |
| 2020-04-15 |
Death from Covid-19 of 23 Health Care Workers in China (edit) |
10.1056/NEJMC2005696 |
| 2020-04-15 |
Droplets and Aerosols in the Transmission of SARS-CoV-2 (edit) |
10.1056/NEJMC2009324 |
| 2020-04-15 |
Safety at the Time of the COVID-19 Pandemic: How to Keep our Oncology Patients and Healthcare Workers Safe (edit) |
10.6004/JNCCN.2020.7572 |
| 2020-04-15 |
[Responsibilities of Weaning Centers during the COVID-19 Pandemic Outbreak - Recommendations for the Assignment of ICU Capacities in COVID-19 Patients as shown by the Berlin-Brandenburg POST-SAVE-Model] (edit) |
10.1055/A-1153-9710 |
| 2020-04-15 |
Benefits, Open questions and Challenges of the use of Ultrasound in the COVID-19 pandemic era. The views of a panel of worldwide international experts (edit) |
10.1055/A-1149-9872 |
| 2020-04-15 |
A Clinical Study of Noninvasive Assessment of Lung Lesions in Patients with Coronavirus Disease-19 (COVID-19) by Bedside Ultrasound (edit) |
10.1055/A-1154-8795 |
| 2020-04-15 |
The Royal College of Pathologists of Australasia (RCPA) position statement on COVID-19 (edit) |
10.31128/AJGP-COVID-09 |
| 2020-04-15 |
Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis (edit) |
|
| 2020-04-15 |
ANZICS guiding principles for complex decision making during the COVID-19 pandemic (edit) |
|
| 2020-04-15 |
Oculoplastic surgery practice during the COVID-19 novel coronavirus pandemic: experience sharing from Hong Kong (edit) |
10.1080/01676830.2020.1754435 |
| 2020-04-15 |
Reverse vaccinology approach to design a novel multi-epitope vaccine candidate against COVID-19: an in silico study (edit) |
10.1080/07391102.2020.1756411 |
| 2020-04-15 |
Covid-19: WHO and South Korea investigate reconfirmed cases (edit) |
10.1136/BMJ.M1498 |
| 2020-04-15 |
Covid-19: Guidance is urgently needed on who should be treated in event of shortages, say lawyers (edit) |
10.1136/BMJ.M1503 |
| 2020-04-15 |
Mitigating the psychological effects of COVID-19 on health care workers (edit) |
10.1503/CMAJ.200519 |
| 2020-04-15 |
Chest CT imaging of an early Canadian case of COVID-19 in a 28-year-old man (edit) |
10.1503/CMAJ.200431 |
| 2020-04-15 |
Covid-19: Trump halts WHO funding in move labelled "petulant" and "short sighted" (edit) |
10.1136/BMJ.M1502 |
| 2020-04-15 |
AACR Calls on Congress to Take Immediate Action Against COVID-19 and Protect Patients with Cancer During the Pandemic (edit) |
10.1158/2159-8290.CD-20-0449 |
| 2020-04-15 |
Covid-19: UK government is urged to publish daily care home deaths as it promises more testing (edit) |
10.1136/BMJ.M1504 |
| 2020-04-15 |
Swivel-HEPA-ETT (SHE) bougie and HEPA-ETT (HE) methods for safe intubation while managing patients with COVID-19 (edit) |
10.1136/EMERMED-2020-209625 |
| 2020-04-15 |
Festina lente: hydroxychloroquine, covid-19 and the role of the rheumatologist (edit) |
10.1136/ANNRHEUMDIS-2020-217480 |
| 2020-04-15 |
SLE, hydroxychloroquine and no SLE patients with covid-19: a comment (edit) |
10.1136/ANNRHEUMDIS-2020-217506 |
| 2020-04-15 |
Does hydroxychloroquine prevent the transmission of covid-19? (edit) |
10.1136/ANNRHEUMDIS-2020-217501 |
| 2020-04-15 |
Role of immunosuppressive therapy in rheumatic diseases concurrent with covid-19 (edit) |
10.1136/ANNRHEUMDIS-2020-217460 |
| 2020-04-15 |
EMA advice on renin-angiotensin system medicines during covid-19 pandemic (edit) |
10.1136/DTB.2020.000026 |
| 2020-04-15 |
Hydroxychloroquine and covid-19 (edit) |
10.1136/POSTGRADMEDJ-2020-137785 |
| 2020-04-15 |
Society of NeuroInterventional Surgery recommendations for the care of emergent neurointerventional patients in the setting of covid-19 (edit) |
10.1136/NEURINTSURG-2020-016098 |
| 2020-04-15 |
Inner Workings: Molecular biologists offer "wartime service" in the effort to test for COVID-19 (edit) |
10.1073/PNAS.2006240117 |
| 2020-04-15 |
Nasal swab sampling for SARS-CoV-2: A convenient alternative in time of nasopharyngeal swab shortage (edit) |
10.1128/JCM.00721-20 |
| 2020-04-15 |
COVID-19 and spinal cord injury and disease: results of an international survey (edit) |
10.1038/S41394-020-0275-8 |
| 2020-04-15 |
COVID-19: risk for cytokine targeting in chronic inflammatory diseases? (edit) |
10.1038/S41577-020-0312-7 |
| 2020-04-15 |
Provision of cancer care during the COVID-19 pandemic (edit) |
10.1038/S41571-020-0370-6 |
| 2020-04-15 |
COVID-19 Q&A: Collaborating and coordinating keeps a zebrafish facility going (edit) |
10.1038/S41684-020-0534-0 |
| 2020-04-15 |
[Return of ancestral fears with coronavirus, Covid-19] (edit) |
10.1016/J.BANM.2020.04.007 |
| 2020-04-15 |
[Whether to make decisions "on the fly" regarding treatment for SARS-CoV-2 infection] (edit) |
10.1016/J.RCE.2020.04.004 |
| 2020-04-15 |
[Treatment of the COVID-19 pandemic: Preventing a missed opportunity] (edit) |
10.1016/J.RCE.2020.04.005 |
| 2020-04-15 |
Convalescent plasma: A possible treatment of COVID-19 in India (edit) |
10.1016/J.MJAFI.2020.04.006 |
| 2020-04-15 |
Initial impacts of global risk mitigation measures taken during the combatting of the COVID-19 pandemic (edit) |
10.1016/J.SSCI.2020.104773 |
| 2020-04-15 |
Is Pakistan on track to have COVID-19 transmission and mortality rates similar to those of Italy, Iran or the USA? (edit) |
10.1007/S40267-020-00726-W |
| 2020-04-15 |
[SARS-CoV-2 infection may result in appendicular syndrome: Chest CT scan before appendectomy] (edit) |
10.1016/J.JCHIRV.2020.04.007 |
| 2020-04-15 |
Air Pollution and the Novel Covid-19 Disease: a Putative Disease Risk Factor (edit) |
10.1007/S42399-020-00274-4 |
| 2020-04-15 |
Anticipating the 'Second Wave' of Health Care Strain in COVID19 Pandemic (edit) |
10.1016/J.JACCAS.2020.04.005 |
| 2020-04-15 |
Importance of inclusion of pregnant and breastfeeding women in COVID-19 therapeutic trials (edit) |
10.1093/CID/CIAA444 |
| 2020-04-15 |
The changing patter of COVID-19 in China: A tempo-geographic analysis of the SARS-CoV-2 epidemic (edit) |
10.1093/CID/CIAA423 |
| 2020-04-15 |
Epidemiology of seasonal coronaviruses: Establishing the context for COVID-19 emergence (edit) |
10.1093/INFDIS/JIAA185 |
| 2020-04-15 |
COVID19 impact on nuclear medicine: an Australian perspective (edit) |
10.1007/S00259-020-04812-Z |
| 2020-04-15 |
Nuclear medicine in responding to global pandemic COVID-19-American College of Nuclear Medicine member experience (edit) |
10.1007/S00259-020-04799-7 |
| 2020-04-15 |
COVID-19 pandemic: guidance for nuclear medicine departments (edit) |
10.1007/S00259-020-04825-8 |
| 2020-04-15 |
The double burden of disease of COVID-19 in cardiovascular patients: overlapping conditions could lead to overlapping treatments (edit) |
10.1007/S10654-020-00628-1 |
| 2020-04-15 |
Comment on "COVID-19 infection control protocol inside computed tomography suites" (edit) |
10.1007/S11604-020-00975-9 |
| 2020-04-15 |
Internal Hernia in the Times of COVID-19: to Laparoscope or Not to Laparoscope? (edit) |
10.1007/S11695-020-04598-X |
| 2020-04-15 |
Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients (edit) |
10.1007/S11739-020-02331-1 |
| 2020-04-15 |
Computational Identification of Small Interfering RNA Targets in SARS-CoV-2 (edit) |
10.1007/S12250-020-00221-6 |
| 2020-04-15 |
EMPLOYING DERMATOLOGISTS ON THE FRONTLINE AGAINST COVID-19: ALL HANDS ON DECK (edit) |
10.1111/DTH.13420 |
| 2020-04-15 |
CORRESPONDANCE: Reflections and new developments within the COVID-19 pandemic (edit) |
10.1002/ALR.22582 |
| 2020-04-15 |
Rigorous Randomized Controlled Trial Implementation in the Era of Novel Coronavirus Disease (COVID-19) (edit) |
10.4269/AJTMH.20-0262 |
| 2020-04-15 |
Biobanking During the COVID-19 Pandemic (edit) |
10.1089/BIO.2020.29069.JJV |
| 2020-04-15 |
Trying To Do It All: Being a Physician-Mother during the COVID-19 Pandemic (edit) |
10.1089/JPM.2020.0182 |
| 2020-04-15 |
Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases (edit) |
10.1016/J.TRSL.2020.04.007 |
| 2020-04-15 |
COVID-19 Presenting as Acute Hepatitis (edit) |
10.14309/AJG.0000000000000660 |
| 2020-04-15 |
Digestive Symptoms in COVID-19 Patients With Mild Disease Severity: Clinical Presentation, Stool Viral RNA Testing, and Outcomes (edit) |
10.14309/AJG.0000000000000664 |
| 2020-04-15 |
Neuroanesthesia Practice During the COVID-19 Pandemic: Recommendations from Society for Neuroscience in Anesthesiology & Critical Care (SNACC) (edit) |
10.1097/ANA.0000000000000691 |
| 2020-04-15 |
The impact of despecialisation and redeployment on surgical training in the midst of the COVID-19 pandemic (edit) |
10.1016/J.IJSU.2020.03.082 |
| 2020-04-15 |
Pharmacologic treatment of transplant recipients infected with SARS-CoV-2: considerations regarding therapeutic drug monitoring and drug-drug interactions (edit) |
10.1097/FTD.0000000000000761 |
| 2020-04-15 |
COVID-19: guidance for infection prevention and control in nuclear medicine (edit) |
10.1097/MNM.0000000000001206 |
| 2020-04-15 |
Where to buy face masks? Survey of applications using Taiwan's open data in the time of COVID-19 (edit) |
10.1097/JCMA.0000000000000325 |
| 2020-04-15 |
Smell and taste dysfunction in patients with COVID-19 (edit) |
10.1016/S1473-3099(20)30293-0 |
| 2020-04-15 |
COVID-19 and the coming epidemic in US immigration detention centres (edit) |
10.1016/S1473-3099(20)30295-4 |
| 2020-04-15 |
Utility of hyposmia and hypogeusia for the diagnosis of COVID-19 (edit) |
10.1016/S1473-3099(20)30297-8 |
| 2020-04-15 |
The UK Coronavirus Cancer Monitoring Project: protecting patients with cancer in the era of COVID-19 (edit) |
10.1016/S1470-2045(20)30230-8 |
| 2020-04-15 |
Enteric involvement in hospitalised patients with COVID-19 outside Wuhan (edit) |
10.1016/S2468-1253(20)30118-7 |
| 2020-04-15 |
Hydroxychloroquine in the management of critically ill patients with COVID-19: the need for an evidence base (edit) |
10.1016/S2213-2600(20)30172-7 |
| 2020-04-15 |
COVID-19 in patients with HIV: clinical case series (edit) |
10.1016/S2352-3018(20)30111-9 |
| 2020-04-15 |
Boosting the arsenal against COVID-19 through computational drug repurposing (edit) |
10.1016/J.DRUDIS.2020.04.005 |
| 2020-04-15 |
SARS-CoV-2 shedding and infectivity - Authors' reply (edit) |
10.1016/S0140-6736(20)30869-2 |
| 2020-04-15 |
SARS-CoV-2 shedding and infectivity (edit) |
10.1016/S0140-6736(20)30868-0 |
| 2020-04-15 |
Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science (edit) |
10.1016/S2215-0366(20)30168-1 |
| 2020-04-15 |
Pregnant versus non-pregnant SARS-CoV-2 and COVID-19 Hospital Admissions: The first 4 weeks in New York (edit) |
10.1016/J.AJOG.2020.04.012 |
| 2020-04-15 |
Environmental virus surveillance in the isolation ward of COVID-19 (edit) |
10.1016/J.JHIN.2020.04.020 |
| 2020-04-15 |
Innovative technologies for hand hygiene monitoring are urgently needed in the fight against COVID-19 (edit) |
10.1016/J.JHIN.2020.04.005 |
| 2020-04-15 |
Maintaining the quality standards of care for inflammatory bowel disease patients during the COVID-19 pandemic (edit) |
10.1016/J.CGH.2020.04.028 |
| 2020-04-15 |
Risk factors for disease severity, unimprovement, and mortality of COVID-19 patients in Wuhan, China (edit) |
10.1016/J.CMI.2020.04.012 |
| 2020-04-15 |
A report of three COVID-19 cases with prolonged viral RNA detection in anal swabs (edit) |
10.1016/J.CMI.2020.04.010 |
| 2020-04-15 |
Angiotensin receptor blockers and COVID-19 (edit) |
10.1016/J.PHRS.2020.104832 |
| 2020-04-15 |
Risk factors of fatal outcome in hospitalized subjects with coronavirus disease 2019 from a nationwide analysis in China (edit) |
10.1016/J.CHEST.2020.04.010 |
| 2020-04-15 |
Which intravascular access should we use in patients with suspected/confirmed COVID-19? (edit) |
10.1016/J.RESUSCITATION.2020.04.014 |
| 2020-04-15 |
COVID-19: Four Paediatric Cases in Malaysia (edit) |
10.1016/J.IJID.2020.03.049 |
| 2020-04-15 |
The differential psychological distress of populations affected by the COVID-19 pandemic (edit) |
10.1016/J.BBI.2020.04.031 |
| 2020-04-15 |
The use of personal protective equipment in the COVID-19 pandemic era (edit) |
10.1016/J.AJEM.2020.04.028 |
| 2020-04-15 |
Adaption of the emergency department decontamination room for airway management during COVID-19 (edit) |
10.1016/J.AJEM.2020.04.031 |
| 2020-04-15 |
Corrigendum to "World Health Organization declares Global Emergency: A review of the 2019 Novel Coronavirus (COVID-19)" [Int. J. Surg. 76 (2020) 71-76] (edit) |
10.1016/J.IJSU.2020.03.036 |
| 2020-04-15 |
Hajj in the Time of COVID-19 (edit) |
10.1016/J.IDH.2020.04.001 |
| 2020-04-15 |
Embracing telemedicine into your otolaryngology practice amid the COVID-19 crisis: An invited commentary (edit) |
10.1016/J.AMJOTO.2020.102490 |
| 2020-04-15 |
Treatment efficacy analysis of traditional Chinese medicine for novel coronavirus pneumonia (COVID-19): an empirical study from Wuhan, Hubei Province, China (edit) |
10.1186/S13020-020-00317-X |
| 2020-04-15 |
Mathematical prediction of the time evolution of the COVID-19 pandemic in Italy by a Gauss error function and Monte Carlo simulations (edit) |
10.1140/EPJP/S13360-020-00383-Y |
| 2020-04-15 |
Cancer care under the outbreak of COVID-19: A perspective from Italian tertiary referral center for surgical oncology (edit) |
10.1016/J.EJSO.2020.04.004 |
| 2020-04-15 |
Ethical questions related to Covid-19 and ENT practice (edit) |
10.1016/J.ANORL.2020.04.009 |
| 2020-04-15 |
Guillain Barre syndrome associated with COVID-19 infection: A case report (edit) |
10.1016/J.JOCN.2020.04.062 |
| 2020-04-15 |
Remaining Academically Connected While Socially Distant: Leveraging Technology to Support Dispersed Radiology and Nuclear Medicine Training Programs in the Era of COVID-19 (edit) |
10.1016/J.ACRA.2020.04.005 |
| 2020-04-15 |
COVID-19 Pulmonary Involvement: Is Really an Interstitial Pneumonia? (edit) |
10.1016/J.ACRA.2020.04.010 |
| 2020-04-15 |
Navigating "Down Time" During COVID-19 (edit) |
10.1016/J.ACRA.2020.04.006 |
| 2020-04-15 |
Lessons learned from 9/11: Mental health perspectives on the COVID-19 pandemic (edit) |
10.1016/J.PSYCHRES.2020.113024 |
| 2020-04-15 |
The anatomy of panic buying related to the current COVID-19 pandemic (edit) |
10.1016/J.PSYCHRES.2020.113015 |
| 2020-04-15 |
Association between short-term exposure to air pollution and COVID-19 infection: Evidence from China (edit) |
10.1016/J.SCITOTENV.2020.138704 |
| 2020-04-15 |
COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role? (edit) |
10.1016/J.MSARD.2020.102120 |
| 2020-04-15 |
Areas of academic research with the impact of COVID-19 (edit) |
10.1016/J.AJEM.2020.04.022 |
| 2020-04-15 |
First isolation of SARS-CoV-2 from clinical samples in India (edit) |
10.4103/IJMR.IJMR_1029_20 |
| 2020-04-15 |
Pregnancy outcomes, Newborn complications and Maternal-Fetal Transmission of SARS-CoV-2 in women with COVID-19: A systematic review (edit) |
10.1101/2020.04.11.20062356 |
| 2020-04-15 |
[Management guidelines for vulnerable workers and persons and SARS-CoV-2 in Catalonian businesses] (edit) |
|
| 2020-04-15 |
Comparative Global Epidemiological Investigation of SARS-CoV-2 and SARS-CoV Diseases Using Meta-MUMS Tool Through Incidence, Mortality, and Recovery Rates (edit) |
10.1016/J.ARCMED.2020.04.005 |
| 2020-04-15 |
Case-finding: Fast, Available, and Efficient Font-line Diagnostics for SARS-CoV-2 (edit) |
10.1016/J.ARCMED.2020.04.008 |
| 2020-04-15 |
Global Threat of SARS-CoV-2/COVID-19 and the Need for More and Better Diagnostic Tools (edit) |
10.1016/J.ARCMED.2020.04.003 |
| 2020-04-15 |
Identification of SARS-CoV-2 Cell Entry Inhibitors by Drug Repurposing Using in Silico Structure-Based Virtual Screening Approach (edit) |
10.26434/CHEMRXIV.12005988 |
| 2020-04-15 |
A crisis within the crisis: The mental health situation of refugees in the world during the 2019 coronavirus (2019-nCoV) outbreak (edit) |
10.1016/J.PSYCHRES.2020.113000 |
| 2020-04-15 |
Clinical evaluation of a rapid colloidal gold immunochromatography assay for SARS-Cov-2 IgM/IgG (edit) |
|
| 2020-04-15 |
Review: Hydroxychloroquine and Chloroquine for Treatment of SARS-CoV-2 (COVID-19) (edit) |
10.1093/OFID/OFAA130 |
| 2020-04-15 |
SARS-CoV-2 infection may result in appendicular syndrome: Chest CT scan before appendectomy (edit) |
10.1016/J.JVISCSURG.2020.04.007 |
| 2020-04-15 |
Early Multi-organ Point-of-Care Ultrasound Evaluation of Respiratory Distress During SARS-CoV-2 Outbreak: Case Report (edit) |
10.5811/CPCEM.2020.4.47524 |
| 2020-04-15 |
Effect of various decontamination procedures on disposable N95 mask integrity and SARS-CoV-2 infectivity (edit) |
10.1101/2020.04.11.20062331 |
| 2020-04-15 |
Analysis of the mutation dynamics of SARS-CoV-2 reveals the spread history and emergence of RBD mutant with lower ACE2 binding affinity (edit) |
10.1101/2020.04.09.034942 |
| 2020-04-15 |
Discovery of baicalin and baicalein as novel, natural product inhibitors of SARS-CoV-2 3CL protease in vitro (edit) |
10.1101/2020.04.13.038687 |
| 2020-04-15 |
The FDA- approved gold drug Auranofin inhibits novel coronavirus (SARS-COV-2) replication and attenuates inflammation in human cells (edit) |
10.1101/2020.04.14.041228 |
| 2020-04-15 |
Assessment of N95 respirator decontamination and re-use for SARS-CoV-2 (edit) |
10.1101/2020.04.11.20062018 |
| 2020-04-15 |
The origin and underlying driving forces of the SARS-CoV-2 outbreak (edit) |
10.1101/2020.04.12.038554 |
| 2020-04-15 |
Comparative in vitro transcriptomic analyses of COVID-19 candidate therapy hydroxychloroquine suggest limited immunomodulatory evidence of SARS-CoV-2 host response genes (edit) |
10.1101/2020.04.13.039263 |
| 2020-04-15 |
Genetic variability in the expression of the SARS-CoV-2 host cell entry factors across populations (edit) |
10.1101/2020.04.06.027698 |
| 2020-04-15 |
SARS‐CoV‐2, an evolutionary perspective of interaction with human ACE2 reveals undiscovered amino acids necessary for complex stability (edit) |
10.1111/EVA.12980 |
| 2020-04-15 |
A High-Coverage SARS-CoV-2 Genome Sequence Acquired by Target Capture Sequencing (edit) |
10.1101/2020.04.11.20061507 |
| 2020-04-15 |
High-surety isothermal amplification and detection of SARS-CoV-2, including with crude enzymes (edit) |
10.1101/2020.04.13.039941 |
| 2020-04-15 |
Rapid diagnosis of SARS-CoV-2 infection by detecting IgG and IgM antibodies with an immunochromatographic device: a prospective single-center study (edit) |
10.1101/2020.04.11.20062158 |
| 2020-04-15 |
Identification of potential vaccine candidates against SARS-CoV-2, A step forward to fight novel coronavirus 2019-nCoV: A Reverse Vaccinology Approach (edit) |
10.1101/2020.04.13.039198 |
| 2020-04-15 |
The global population of SARS-CoV-2 is composed of six major subtypes (edit) |
10.1101/2020.04.14.040782 |
| 2020-04-15 |
Single Nucleus Multiomic Profiling Reveals Age-Dynamic Regulation of Host Genes Associated with SARS-CoV-2 Infection (edit) |
10.1101/2020.04.12.037580 |
| 2020-04-15 |
Analysis of Maternal Coronavirus Infections and Neonates Born to Mothers with 2019-nCoV; a Systematic Review (edit) |
|
| 2020-04-15 |
Novel coronavirus (2019-nCov): do you have enough intensive care units? (edit) |
10.1016/J.MEDIN.2020.04.007 |
| 2020-04-14 |
SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells (edit) |
10.15252/EMBJ.2020105114 |
| 2020-04-14 |
SARS-CoV-2 Vaccines: Status Report (edit) |
10.1016/J.IMMUNI.2020.03.007 |
| 2020-04-14 |
[Scientific statement on using of renin angiotensin system blockers in patients with cardiovascular disease and COVID-19] (edit) |
10.3760/CMA.J.ISSN.0253-3758.2020.0014 |
| 2020-04-14 |
[Prognostic value of myocardial injury in patients with COVID-19] (edit) |
10.3760/CMA.J.CN112148-20200313-00202 |
| 2020-04-14 |
Love in the time of coronavirus: training and service during COVID-19 (edit) |
10.11622/SMEDJ.2020053 |
| 2020-04-14 |
Global thread of COVID 19 and evacuatıon of the cıtızens of dıfferent countrıes (edit) |
10.3906/SAG-2004-21 |
| 2020-04-14 |
Navigating the Ethics of COVID-19 in Otolaryngology (edit) |
10.1177/0194599820920850 |
| 2020-04-14 |
There is nothing new under the sun: Ageism and intergenerational tension in the age of the COVID-19 outbreak (edit) |
10.1017/S1041610220000575 |
| 2020-04-14 |
Challenges and responses: a tertiary hospital in 2019-nCoV epidemic (edit) |
10.1017/DMP.2020.93 |
| 2020-04-14 |
Public health concerns and unsubstantiated claims at the intersection of vaping and COVID-19 (edit) |
10.1093/NTR/NTAA064 |
| 2020-04-14 |
Managing bioanalytical studies during the COVID-19 pandemic: an overview (edit) |
10.4155/BIO-2020-0082 |
| 2020-04-14 |
Public Education and Electronic Awareness of the New Coronavirus (COVID-19): Experiences From Iran (edit) |
10.1017/DMP.2020.94 |
| 2020-04-14 |
Typical takotsubo syndrome triggered by SARS-CoV-2 infection (edit) |
10.1093/EURHEARTJ/EHAA306 |
| 2020-04-14 |
Transient complete heart block in a patient with critical COVID-19 (edit) |
10.1093/EURHEARTJ/EHAA307 |
| 2020-04-14 |
Cloth masks versus medical masks for COVID-19 protection (edit) |
10.5603/CJ.A2020.0054 |
| 2020-04-14 |
Extracorporeal membrane oxygenation in COVID-19 (edit) |
10.5603/CJ.A2020.0053 |
| 2020-04-14 |
Optimizing hydroxychloroquine dosing for patients with COVID-19: An integrative modeling approach for effective drug repurposing (edit) |
10.1002/CPT.1856 |
| 2020-04-14 |
Defining Protective Epitopes for COVID-19 Vaccination Models (edit) |
10.1002/JMV.25876 |
| 2020-04-14 |
Detection of SARS-CoV-2 by RT-PCR in anal from patients who have recovered from coronavirus disease 2019 (edit) |
10.1002/JMV.25875 |
| 2020-04-14 |
Computed Tomography Imaging of an HIV-infected Patient with Coronavirus Disease 2019 (COVID-19) (edit) |
10.1002/JMV.25879 |
| 2020-04-14 |
Impact, Strategies and Opportunities for Early and Mid-Career Cardiovascular Researchers During the COVID-19 Pandemic (edit) |
10.1161/CIRCULATIONAHA.120.047394 |
| 2020-04-14 |
Mental health burden for the public affected by the COVID-19 outbreak in China: Who will be the high-risk group? (edit) |
10.1080/13548506.2020.1754438 |
| 2020-04-14 |
Significance of Serology Testing to Assist Timely Diagnosis of SARS-CoV-2 infections: Implication from a Family Cluster (edit) |
10.1080/22221751.2020.1752610 |
| 2020-04-14 |
COVID-19 infections are also affected by human ACE1 D/I polymorphism (edit) |
10.1515/CCLM-2020-0425 |
| 2020-04-14 |
How sexual medicine is facing the outbreak of COVID-19: experience of Italian urological community and future perspectives (edit) |
10.1038/S41443-020-0270-4 |
| 2020-04-14 |
Human antibodies can neutralize SARS-CoV-2 (edit) |
10.1038/S41577-020-0313-6 |
| 2020-04-14 |
Priorities for Cath labs in the COVID-19 tsunami (edit) |
10.1093/EURHEARTJ/EHAA308 |
| 2020-04-14 |
Might renin-angiotensin system blockers play a role in the COVID-19 pandemic? (edit) |
10.1093/EHJCVP/PVAA030 |
| 2020-04-14 |
Coronavirus Disease 2019 (COVID-19) and Mental Health for Children and Adolescents (edit) |
10.1001/JAMAPEDIATRICS.2020.1456 |
| 2020-04-14 |
Editorial: Covid-19 and Physical and Rehabilitation Medicine (edit) |
10.2340/16501977-2679 |
| 2020-04-14 |
Rehabilitation of COVID-19 patients (edit) |
10.2340/16501977-2678 |
| 2020-04-14 |
Covid-19 and Post Intensive Care Syndrome: A Call for Action (edit) |
10.2340/16501977-2677 |
| 2020-04-14 |
Inhibitors of the renin-angiotensin system: The potential role in the pathogenesis of COVID-19 (edit) |
10.5603/CJ.A2020.0056 |
| 2020-04-14 |
COVID-19 challenge for modern medicine (edit) |
10.5603/CJ.A2020.0055 |
| 2020-04-14 |
Letter: Covid-19 and vitamin D-authors' reply (edit) |
10.1111/APT.15764 |
| 2020-04-14 |
COVID-19, Arrhythmic Risk and Inflammation: Mind the Gap! (edit) |
10.1161/CIRCULATIONAHA.120.047293 |
| 2020-04-14 |
CT Findings of Pregnant Women With Coronavirus Disease (COVID-19) Pneumonia (edit) |
10.2214/AJR.20.23212 |
| 2020-04-14 |
CT Is Not a Screening Tool for Coronavirus Disease (COVID-19) Pneumonia (edit) |
10.2214/AJR.20.23220 |
| 2020-04-14 |
COVID-19 Pandemic: What Every Otolaryngologist-Head and Neck Surgeon Needs to Know for Safe Airway Management (edit) |
10.1177/0194599820919751 |
| 2020-04-14 |
Pediatric Otolaryngology Divisional and Institutional Preparatory Response at Seattle Children's Hospital after COVID-19 Regional Exposure (edit) |
10.1177/0194599820919748 |
| 2020-04-14 |
Otolaryngology Providers Must Be Alert for Patients with Mild and Asymptomatic COVID-19 (edit) |
10.1177/0194599820920649 |
| 2020-04-14 |
A Commentary on Safety Precautions for Otologic Surgery during the COVID-19 Pandemic (edit) |
10.1177/0194599820919741 |
| 2020-04-14 |
Is glucose-6-phosphate dehydrogenase enzyme deficiency a factor in Coronavirus-19 (COVID-19) infections and deaths? (edit) |
10.1080/20477724.2020.1751388 |
| 2020-04-14 |
COVID-19 Pandemic: Experiences in China and implications for its prevention and treatment worldwide (edit) |
10.2174/1568009620666200414151419 |
| 2020-04-14 |
What's Important: Redeployment of the Orthopaedic Surgeon During the COVID-19 Pandemic: Perspectives from the Trenches (edit) |
10.2106/JBJS.20.00574 |
| 2020-04-14 |
Clinical Research and Trials-A "Nonessential" Victim of the COVID-19 Pandemic? (edit) |
10.14309/AJG.0000000000000663 |
| 2020-04-14 |
Clinical Characteristics of COVID-19 Patients With Digestive Symptoms in Hubei, China: A Descriptive, Cross-Sectional, Multicenter Study (edit) |
10.14309/AJG.0000000000000620 |
| 2020-04-14 |
Caution Warranted: Using the Institute for Health Metrics and Evaluation Model for Predicting the Course of the COVID-19 Pandemic (edit) |
10.7326/M20-1565 |
| 2020-04-14 |
Cardiac drugs and outcome in COVID - 19 (edit) |
10.1093/QJMED/HCAA127 |
| 2020-04-14 |
Cardiac drugs and outcome in COVID-19: Reply (edit) |
10.1093/QJMED/HCAA128 |
| 2020-04-14 |
Lessons learned from the COVID-19 pandemic (edit) |
10.1111/APA.15307 |
| 2020-04-14 |
Spread of SARS-CoV-2 in the Icelandic Population (edit) |
10.1056/NEJMOA2006100 |
| 2020-04-14 |
Not Dying Alone - Modern Compassionate Care in the Covid-19 Pandemic (edit) |
10.1056/NEJMP2007781 |
| 2020-04-14 |
Drug Evaluation during the Covid-19 Pandemic (edit) |
10.1056/NEJMP2009457 |
| 2020-04-14 |
Improved Prognosis in Cystic Fibrosis: Consideration for Intensive Care During the COVID-19 Pandemic (edit) |
10.1164/RCCM.202004-0999LE |
| 2020-04-14 |
The Baffling Case of Ischemic Stroke Disappearance from the Casualty Department in the COVID-19 Era (edit) |
10.1159/000507666 |
| 2020-04-14 |
Clinical Trials during the SARS-CoV-2 Pandemic (edit) |
10.1159/000507582 |
| 2020-04-14 |
Extreme genomic CpG deficiency in SARS-CoV-2 and evasion of host antiviral defense (edit) |
10.1093/MOLBEV/MSAA094 |
| 2020-04-14 |
Emergency Colorectal Surgery in a COVID-19 Pandemic Epicenter (edit) |
|
| 2020-04-14 |
Experience summary of a COVID-19 designated community hospital and its operation model (edit) |
10.23736/S0031-0808.20.03908-7 |
| 2020-04-14 |
Do checkpoint inhibitors compromise the cancer patients' immunity and increase the vulnerability to COVID-19 infection? (edit) |
10.2217/IMT-2020-0077 |
| 2020-04-14 |
Methodological challenges of analysing COVID-19 data during the pandemic (edit) |
10.1186/S12874-020-00972-6 |
| 2020-04-14 |
Why tocilizumab could be an effective treatment for severe COVID-19? (edit) |
10.1186/S12967-020-02339-3 |
| 2020-04-14 |
Anti-IL6R role in treatment of COVID-19-related ARDS (edit) |
10.1186/S12967-020-02333-9 |
| 2020-04-14 |
How to transform a general hospital into an "infectious disease hospital" during the epidemic of COVID-19 (edit) |
10.1186/S13054-020-02864-Z |
| 2020-04-14 |
The model of epidemic (COVID-19) prevention and control in rural of China (edit) |
10.1186/S13054-020-02874-X |
| 2020-04-14 |
Covid-19: Death rate in England and Wales reaches record high because of covid-19 (edit) |
10.1136/BMJ.M1484 |
| 2020-04-14 |
Covid-19: why we need a national health and social care service (edit) |
10.1136/BMJ.M1465 |
| 2020-04-14 |
Covid-19: Black people and other minorities are hardest hit in US (edit) |
10.1136/BMJ.M1483 |
| 2020-04-14 |
Prediction models for diagnosis and prognosis in Covid-19 (edit) |
10.1136/BMJ.M1464 |
| 2020-04-14 |
Covid-19: Third of surgeons do not have adequate PPE, royal college warns (edit) |
10.1136/BMJ.M1492 |
| 2020-04-14 |
Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period (edit) |
10.1126/SCIENCE.ABB5793 |
| 2020-04-14 |
Repurposing Didanosine as a Potential Treatment for COVID-19 Using Single-Cell RNA Sequencing Data (edit) |
10.1128/MSYSTEMS.00297-20 |
| 2020-04-14 |
Taking the right measures to control COVID-19 in ophthalmology: the experience of a tertiary eye care referral center in Italy (edit) |
10.1038/S41433-020-0880-6 |
| 2020-04-14 |
German recommendations for critically ill patients with COVID‑19 (edit) |
10.1007/S00063-020-00689-W |
| 2020-04-14 |
Outcomes in Patients with COVID-19 Infection Taking ACEI/ARB (edit) |
10.1007/S11886-020-01291-4 |
| 2020-04-14 |
The epidemiology and clinical information about COVID-19 (edit) |
10.1007/S10096-020-03874-Z |
| 2020-04-14 |
Our darkest hours (being neurosurgeons during the COVID-19 war) (edit) |
10.1007/S00701-020-04333-6 |
| 2020-04-14 |
Common breaches in biosafety during donning and doffing of protective personal equipment used in the care of COVID-19 patients (edit) |
10.1007/S12630-020-01648-X |
| 2020-04-14 |
Social distancing: implications for the operating room in the face of COVID-19 (edit) |
10.1007/S12630-020-01651-2 |
| 2020-04-14 |
Locating and repurposing anesthetic machines as intensive care unit ventilators during the COVID-19 pandemic (edit) |
10.1007/S12630-020-01657-W |
| 2020-04-14 |
Recommendations for Metabolic and Bariatric Surgery During the COVID-19 Pandemic from IFSO (edit) |
10.1007/S11695-020-04578-1 |
| 2020-04-14 |
The Importance of the Minimum Dosage Necessary for UVC Decontamination of N95 Respirators during the COVID-19 Pandemic (edit) |
10.1111/PHPP.12562 |
| 2020-04-14 |
Psoriasis and Psoriatic Arthritis: how to manage Immunosuppressants in COVID-19 days (edit) |
10.1111/DTH.13415 |
| 2020-04-14 |
At the center of the COVID-19 pandemic: lessons learned for otolaryngology-head and neck surgery in China (edit) |
10.1002/ALR.22585 |
| 2020-04-14 |
Cytosine drives evolution of SARS-CoV-2 (edit) |
10.1111/1462-2920.15025 |
| 2020-04-14 |
COVID-19 - Looking beyond the immediate concerns (edit) |
10.1002/ALR.22583 |
| 2020-04-14 |
Preliminary recommendations for lung surgery during COVID-19 epidemic period (edit) |
10.1111/1759-7714.13423 |
| 2020-04-14 |
Recommendations of individualized medical treatment and common adverse events management for lung cancer patients during the outbreak of COVID-19 epidemic (edit) |
10.1111/1759-7714.13424 |
| 2020-04-14 |
Launch and global reach of an online COVID-19 course in multiple languages on OpenWHO in the first quarter of 2020 (edit) |
10.2196/19076 |
| 2020-04-14 |
Data Mining and Content Analysis of the Chinese Social Media Platform Weibo During the Early COVID-19 Outbreak: Retrospective Observational Infoveillance Study (edit) |
10.2196/18700 |
| 2020-04-14 |
Hydroxychloroquine use during the COVID-19 pandemic 2020 (edit) |
10.31128/AJGP-COVID-08 |
| 2020-04-14 |
What Does Plant-Based Vaccine Technology Offer to the Fight against COVID-19? (edit) |
10.3390/VACCINES8020183 |
| 2020-04-14 |
Coronavirus Diseases (COVID-19) Current Status and Future Perspectives: A Narrative Review (edit) |
10.3390/IJERPH17082690 |
| 2020-04-14 |
Molecular Investigation of SARS-CoV-2 Proteins and Their Interactions with Antiviral Drugs (edit) |
10.3390/V12040445 |
| 2020-04-14 |
Roles and Responsibilities of the Orthopaedic Community and the Society During COVID-19 Pandemic (edit) |
10.1007/S43465-020-00105-7 |
| 2020-04-14 |
Novel Coronavirus Disease (COVID-19): Global Health Equity in Pandemic Response (edit) |
10.4269/AJTMH.20-0260 |
| 2020-04-14 |
Keep Socially (but Not Physically) Connected and Carry on: Preventing Suicide in the Age of COVID-19 (edit) |
10.4088/JCP.20COM13370 |
| 2020-04-14 |
Ophthalmology and Glaucoma Practice in the COVID-19 Era (edit) |
10.1097/IJG.0000000000001519 |
| 2020-04-14 |
15 Smartphone Apps for Older Adults to Use While in Isolation During the COVID-19 Pandemic (edit) |
10.5811/WESTJEM.2020.4.47372 |
| 2020-04-14 |
Taking care of older patients with cancer in the context of COVID-19 pandemic (edit) |
10.1016/S1470-2045(20)30229-1 |
| 2020-04-14 |
COVID-19: health literacy is an underestimated problem (edit) |
10.1016/S2468-2667(20)30086-4 |
| 2020-04-14 |
Mental health effects of school closures during COVID-19 (edit) |
10.1016/S2352-4642(20)30109-7 |
| 2020-04-14 |
Global COVID-19 fatality analysis reveals Hubei-like countries potentially with severe outbreaks (edit) |
10.1016/J.JINF.2020.03.029 |
| 2020-04-14 |
Comparative computational analysis of SARS-CoV-2 nucleocapsid protein epitopes in taxonomically related coronaviruses (edit) |
10.1016/J.MICINF.2020.04.002 |
| 2020-04-14 |
Practice recommendations for risk-adapted head and neck cancer radiotherapy during the COVID-19 pandemic: an ASTRO-ESTRO consensus statement (edit) |
10.1016/J.IJROBP.2020.04.016 |
| 2020-04-14 |
Considerations for Drug Interactions on QTc in Exploratory COVID-19 (Coronavirus Disease 2019) Treatment (edit) |
10.1016/J.HRTHM.2020.04.016 |
| 2020-04-14 |
Could IL-17 represent a new therapeutic target for the treatment and/or management of COVID-19-related respiratory syndrome?: This paper is dedicated to Sofia Maione born during COVID-19 outbreak (edit) |
10.1016/J.PHRS.2020.104791 |
| 2020-04-14 |
Clinical characteristics of 80 hospitalized frontline medical workers infected with COVID-19 in Wuhan, China (edit) |
10.1016/J.JHIN.2020.04.019 |
| 2020-04-14 |
Preparedness for COVID-19 infection prevention in Korea: Single-center experience (edit) |
10.1016/J.JHIN.2020.04.018 |
| 2020-04-14 |
Thoughts about COVID-19 (edit) |
10.1016/J.IJSU.2020.04.015 |
| 2020-04-14 |
Europe's response to COVID-19 in March and April 2020 - A letter to the editor on "World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19)" (Int J Surg 2020;76:71-6) (edit) |
10.1016/J.IJSU.2020.04.011 |
| 2020-04-14 |
Surgical operations during the COVID-19 outbreak: should elective surgeries be suspended? (edit) |
10.1016/J.IJSU.2020.04.005 |
| 2020-04-14 |
Two known therapies could be useful as adjuvant therapy in critical patients infected by COVID-19 (edit) |
10.1016/J.REDAR.2020.03.004 |
| 2020-04-14 |
Endourological Stone Management in the Era of the COVID-19 (edit) |
10.1016/J.EURURO.2020.03.042 |
| 2020-04-14 |
Radiology Management and COVID-19 in Resource Limited Setting (edit) |
10.1016/J.ACRA.2020.03.021 |
| 2020-04-14 |
The Role of Oral and Maxillofacial Surgeons in COVID-19 Response (edit) |
10.1016/J.JOMS.2020.04.016 |
| 2020-04-14 |
Keeping pace: An ED communications strategy for COVID-19 (edit) |
10.1016/J.AJEM.2020.04.033 |
| 2020-04-14 |
The intriguing features of COVID-19 in children and its impact on the pandemic (edit) |
10.1016/J.JPED.2020.04.001 |
| 2020-04-14 |
Disruptive Modifications to Cardiac Critical Care Delivery During the Covid-19 Pandemic: An International Perspective (edit) |
10.1016/J.JACC.2020.04.029 |
| 2020-04-14 |
First COVID-19 infections in the Philippines: a case report (edit) |
10.1186/S41182-020-00203-0 |
| 2020-04-14 |
Changes in Subway Ridership in Response to COVID-19 in Seoul, South Korea: Implications for Social Distancing (edit) |
10.7759/CUREUS.7668 |
| 2020-04-14 |
Prevalence and severity of corona virus disease 2019 (COVID-19): A systematic review and meta-analysis (edit) |
10.1016/J.JCV.2020.104371 |
| 2020-04-14 |
Stressors of nurses in psychiatric hospitals during the COVID-19 outbreak (edit) |
10.1016/J.PSYCHRES.2020.112956 |
| 2020-04-14 |
Psychological preparedness for the COVID-19 pandemic, perspectives from India (edit) |
10.1016/J.PSYCHRES.2020.112999 |
| 2020-04-14 |
Epidemic of COVID-19 in China and associated Psychological Problems (edit) |
10.1016/J.AJP.2020.102092 |
| 2020-04-14 |
Zinc and respiratory tract infections: Perspectives for COVID‑19 (Review) (edit) |
10.3892/IJMM.2020.4575 |
| 2020-04-14 |
Clinical presentation and initial management critically ill patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in Brescia, Italy (edit) |
10.1016/J.JCRC.2020.04.004 |
| 2020-04-14 |
Efficacy of remdesivir versus placebo for the treatment of COVID-19: A protocol for systematic review and meta-analysis of randomized controlled trials (edit) |
10.1101/2020.04.09.20059196 |
| 2020-04-14 |
Case- fatality rate in COVID- 19 patients: A meta-analysis of publicly accessible database (edit) |
10.1101/2020.04.09.20059683 |
| 2020-04-14 |
Clinical features and management of severe COVID-19: A retrospective study in Wuxi, Jiangsu Province, China (edit) |
10.1101/2020.04.10.20060335 |
| 2020-04-14 |
Hydroxychloroquine in patients with COVID-19: an open-label, randomized, controlled trial (edit) |
10.1101/2020.04.10.20060558 |
| 2020-04-14 |
No evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for COVID-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial (edit) |
10.1101/2020.04.10.20060699 |
| 2020-04-14 |
Pre-labor anorectal swab for SARS-CoV-2 in COVID-19 patients: is it time to think about it? (edit) |
10.1016/J.EJOGRB.2020.04.023 |
| 2020-04-14 |
SARS-COV-2 infection (coronavirus disease 2019) for the gastrointestinal consultant (edit) |
10.3748/WJG.V26.I14.1546 |
| 2020-04-14 |
Blockade of SARS-CoV-2 infection by recombinant soluble ACE2 (edit) |
10.1016/J.KINT.2020.04.009 |
| 2020-04-14 |
Evaluation of a COVID-19 IgM and IgG rapid test; an efficient tool for assessment of past exposure to SARS-CoV-2 (edit) |
10.1080/20008686.2020.1754538 |
| 2020-04-14 |
Genomics functional analysis and drug screening of SARS-CoV-2 (edit) |
10.1016/J.GENDIS.2020.04.002 |
| 2020-04-14 |
Lessons learned from SARS-CoV and MERS-CoV: FDA-approved Abelson tyrosine-protein kinase 2 inhibitors may help us combat SARS-CoV-2 (edit) |
10.5114/AOMS.2020.94504 |
| 2020-04-14 |
Estimating required lockdown cycles before immunity to SARS-CoV-2: Model-based analyses of susceptible population sizes, S0, in seven European countries including the UK and Ireland (edit) |
10.1101/2020.04.10.20060426 |
| 2020-04-14 |
Bioinformatic characterization of angiotensin-converting enzyme 2, the entry receptor for SARS-CoV-2 (edit) |
10.1101/2020.04.13.038752 |
| 2020-04-14 |
Next weeks of SARS-CoV-2: Projection model to predict time evolution scenarios of accumulated cases in Spain (edit) |
10.1101/2020.04.09.20059881 |
| 2020-04-14 |
Near- and forecasting the SARS-COV-2 epidemic requires a global view and multiple methods (edit) |
10.1101/2020.04.09.20059402 |
| 2020-04-14 |
Anosmia and dysgeusia in patients with mild SARS-CoV-2 infection (edit) |
10.1101/2020.04.11.20055483 |
| 2020-04-14 |
Immunological assays for SARS-CoV-2: an analysis of available commercial tests to measure antigen and antibodies (edit) |
10.1101/2020.04.10.20061150 |
| 2020-04-14 |
Optimal Control applied to a SEIR model of 2019-nCoV with social distancing (edit) |
10.1101/2020.04.10.20061069 |
| 2020-04-14 |
Potency and timing of antiviral therapy as determinants of duration of SARS CoV-2 shedding and intensity of inflammatory response (edit) |
10.1101/2020.04.10.20061325 |
| 2020-04-14 |
Scaling diagnostics in times of COVID-19: Colorimetric Loop-mediated Isothermal Amplification (LAMP) assisted by a 3D-printed incubator for cost-effective and scalable detection of SARS-CoV-2 (edit) |
10.1101/2020.04.09.20058651 |
| 2020-04-14 |
Myocyte Specific Upregulation of ACE2 in Cardiovascular Disease: Implications for SARS-CoV-2 mediated myocarditis (edit) |
10.1101/2020.04.09.20059204 |
| 2020-04-14 |
SARS-CoV-2 diagnostic testing in Africa: needs and challenges (edit) |
10.11604/PAMJ.2020.35.4.22703 |
| 2020-04-14 |
A SARS-CoV-2 Vaccination Strategy Focused on Population-Scale Immunity (edit) |
10.2139/SSRN.3575161 |
| 2020-04-13 |
Computational Guided Drug Repurposing for Targeting 2'-O-Ribose Methyltransferase of SARS-CoV-2 (edit) |
10.26434/CHEMRXIV.12111138.V1 |
| 2020-04-13 |
SARS-CoV-2: a storm is raging (edit) |
10.1172/JCI137647 |
| 2020-04-13 |
Biological treatment during COVID-19 outbreak (edit) |
10.1080/09546634.2020.1749548 |
| 2020-04-13 |
Teledermatology: a useful tool to fight COVID-19 (edit) |
10.1080/09546634.2020.1750557 |
| 2020-04-13 |
Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2 via integrated computational approach (edit) |
10.1080/07391102.2020.1751298 |
| 2020-04-13 |
Will plant-made biopharmaceuticals play a role in the fight against COVID-19? (edit) |
10.1080/14712598.2020.1752177 |
| 2020-04-13 |
Asymptomatic Patients with Novel Coronavirus Disease (COVID-19) (edit) |
10.4274/BALKANMEDJ.GALENOS.2020.2020.4.20 |
| 2020-04-13 |
Impact of COVID 19: perspectives from gastroenterology (edit) |
10.11622/SMEDJ.2020051 |
| 2020-04-13 |
The COVID-19 outbreak: issue of face masks (edit) |
10.1017/ICE.2020.129 |
| 2020-04-13 |
Application and effects of fever screening system in the prevention of nosocomial infection in the only designated hospital of coronavirus disease 2019 (COVID-19) in Shenzhen, China (edit) |
10.1017/ICE.2020.119 |
| 2020-04-13 |
COVID-19 as a psychological contagion: A new Pandora's box to close? (edit) |
10.1017/ICE.2020.127 |
| 2020-04-13 |
Concise Communication: Covid-19 and the N95 Respirator Shortage: Closing the Gap (edit) |
10.1017/ICE.2020.124 |
| 2020-04-13 |
Development of a protective device for RT-PCR testing SARS-CoV-2 in COVID-19 patients (edit) |
10.1017/ICE.2020.121 |
| 2020-04-13 |
Italian Physical Therapists' Response to the Novel COVID-19 Emergency (edit) |
10.1093/PTJ/PZAA060 |
| 2020-04-13 |
Distinct characteristics of COVID-19 patients with initial rRT-PCR positive and negative results for SARS-CoV-2 (edit) |
10.1111/ALL.14316 |
| 2020-04-13 |
Delayed Initiation of Remdesivir in a COVID-19 Positive Patient (edit) |
10.1002/PHAR.2403 |
| 2020-04-13 |
Editorial: Challenges to Opioid Use Disorders During COVID-19 (edit) |
10.1111/AJAD.13031 |
| 2020-04-13 |
Cancer and COVID-19: A CALL For Comments (edit) |
10.1002/PON.5384 |
| 2020-04-13 |
A systematic review of the prophylactic role of chloroquine and hydroxychloroquine in Coronavirus Disease-19 (COVID-19) (edit) |
10.1111/1756-185X.13842 |
| 2020-04-13 |
Risk of COVID-19 for patients with obesity (edit) |
10.1111/OBR.13034 |
| 2020-04-13 |
Use of Convalescent Plasma Therapy in Two COVID-19 Patients with Acute Respiratory Distress Syndrome in Korea (edit) |
10.3346/JKMS.2020.35.E149 |
| 2020-04-13 |
Loopholes in Current Infection Control and Prevention Practices Against COVID-19 in Radiology Department and Improvement Suggestions (edit) |
10.1177/0846537120916852 |
| 2020-04-13 |
Society coexisting with COVID-19 (edit) |
10.1017/ICE.2020.130 |
| 2020-04-13 |
Update on use of chloroquine/hydroxychloroquine to treat coronavirus disease 2019 (COVID-19) (edit) |
10.5582/BST.2020.03072 |
| 2020-04-13 |
Prawa człowieka dzieci niepełnosprawnych w sytuacjach kryzysowych: wyzwanie COVID-19 (edit) |
10.1111/DMCN.14544 |
| 2020-04-13 |
Reply to: "Reporting of all cardiac medications and their outcome in COVID-19" (edit) |
10.1002/JMV.25868 |
| 2020-04-13 |
C-reactive protein correlates with CT findings and predicts severe COVID-19 early (edit) |
10.1002/JMV.25871 |
| 2020-04-13 |
Influenza-like illnesses caused by a cluster of imported Italian COVID-19 (edit) |
10.1002/JMV.25869 |
| 2020-04-13 |
COVID-19 indirect contact transmission through the oral mucosa must not be ignored (edit) |
10.1111/JOP.13019 |
| 2020-04-13 |
COVID-19: Herd Immunity and Convalescent Plasma Transfer Therapy (edit) |
10.1002/JMV.25870 |
| 2020-04-13 |
COVID-19 and gastrointestinal endoscopies: current insights and emergent strategies (edit) |
10.1111/DEN.13693 |
| 2020-04-13 |
Existing bitter medicines for fighting 2019-nCoV-associated infectious diseases (edit) |
10.1096/FJ.202000502 |
| 2020-04-13 |
COVID-19 Lung Injury is Not High Altitude Pulmonary Edema (edit) |
10.1089/HAM.2020.0055 |
| 2020-04-13 |
COVID-19 and Home Positive Airway Pressure (PAP) Therapy (edit) |
10.1164/RCCM.2020C6 |
| 2020-04-13 |
The management of biologics in dermatologic patients in the 2019-nCoV era (edit) |
10.1080/09546634.2020.1749544 |
| 2020-04-13 |
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review (edit) |
10.1001/JAMA.2020.6019 |
| 2020-04-13 |
Oncology Practice During the COVID-19 Pandemic (edit) |
10.1001/JAMA.2020.6236 |
| 2020-04-13 |
Donning and doffing of personal protective equipment (PPE) for angiography during the COVID-19 crisis (edit) |
10.1093/EURHEARTJ/EHAA283 |
| 2020-04-13 |
Call to action for the cardiovascular side of COVID-19 (edit) |
10.1093/EURHEARTJ/EHAA301 |
| 2020-04-13 |
COVID-19-related myocarditis in a 21-year-old female patient (edit) |
10.1093/EURHEARTJ/EHAA288 |
| 2020-04-13 |
Neprilysin inhibitor-angiotensin II receptor blocker combination (sacubitril/valsartan): rationale for adoption in SARS-CoV-2 patients (edit) |
10.1093/EHJCVP/PVAA028 |
| 2020-04-13 |
Initiating adjunct low dose-hydroxyurea therapy for stroke prevention in children with SCA during the COVID-19 pandemic (edit) |
10.1182/BLOOD.2020005992 |
| 2020-04-13 |
The VACCINES Act, Deciphering Vaccine Hesitancy in the Time of COVID19 (edit) |
10.1093/CID/CIAA433 |
| 2020-04-13 |
Integrated Hospital Quarantine System against COVID-19 (edit) |
10.1002/KJM2.12216 |
| 2020-04-13 |
COVID-19 and Renin Angiotensin Blockers: Current Evidence and Recommendations (edit) |
10.1161/CIRCULATIONAHA.120.047022 |
| 2020-04-13 |
Response to the Letter to the Editor: How to Deal with Suspended Oral Treatment during the COVID-19 Epidemic (edit) |
10.1177/0022034520920166 |
| 2020-04-13 |
Letter to the Editor: How to Deal with Suspended Oral Treatment during the COVID-19 Epidemic (edit) |
10.1177/0022034520920169 |
| 2020-04-13 |
Treatment considerations for coronavirus (COVID-19) (edit) |
10.1080/21548331.2020.1754618 |
| 2020-04-13 |
Emergence of Novel Coronavirus and COVID-19: whether to stay or die out? (edit) |
10.1080/1040841X.2020.1739001 |
| 2020-04-13 |
Coronavirus Disease (COVID-19) Pandemic: A Race Against Time (edit) |
10.2174/1568026620999200413145654 |
| 2020-04-13 |
A Review of State Guidelines for Elective Orthopaedic Procedures During the COVID-19 Outbreak (edit) |
10.2106/JBJS.20.00510 |
| 2020-04-13 |
Public Health Interventions to Mitigate Early Spread of SARS-CoV-2 in Poland (edit) |
10.12659/MSM.924730 |
| 2020-04-13 |
COVID-19: The Worst Days of Our Careers (edit) |
10.7326/M20-1715 |
| 2020-04-13 |
Limits of Detection of Six Approved RT-PCR Kits for the Novel SARS-coronavirus-2 (SARS-CoV-2) (edit) |
10.1093/CLINCHEM/HVAA099 |
| 2020-04-13 |
"We're staying at home". Association of self-perceptions of aging, personal and family resources and loneliness with psychological distress during the lock-down period of COVID-19 (edit) |
10.1093/GERONB/GBAA048 |
| 2020-04-13 |
Use of self-administered surveys through QR code and same center telemedicine in a walk-in clinic in the era of COVID-19 (edit) |
10.1093/JAMIA/OCAA054 |
| 2020-04-13 |
Hematological findings and complications of COVID-19 (edit) |
10.1002/AJH.25829 |
| 2020-04-13 |
Ethical and Legal Challenges During the COVID-19 Pandemic - Are We Thinking About Rural Hospitals? (edit) |
10.1111/JRH.12447 |
| 2020-04-13 |
Rapid and Severe Covid-19 Pneumonia with Severe Acute Chest Syndrome in a Sickle Cell Patient Successfully Treated with Tocilizumab (edit) |
10.1002/AJH.25833 |
| 2020-04-13 |
Navigating Nonessential Research Trials During COVID19: The Push We Needed For Using Digital Technology To Increase Access For Rural Participants? (edit) |
10.1111/JRH.12446 |
| 2020-04-13 |
A Commentary on Rural-Urban Disparities in COVID-19 Testing Rates per 100,000 and Risk Factors (edit) |
10.1111/JRH.12450 |
| 2020-04-13 |
Preventing Suicide in Rural Communities During the COVID-19 Pandemic (edit) |
10.1111/JRH.12448 |
| 2020-04-13 |
COVID-19: Thoughts and comments from a Tertiary Liver Transplant Center in France (edit) |
10.1111/AJT.15918 |
| 2020-04-13 |
First case of COVID-19 in a kidney transplant recipient treated with belatacept (edit) |
10.1111/AJT.15919 |
| 2020-04-13 |
Early Impact of COVID-19 on Transplant Center Practices and Policies in the United States (edit) |
10.1111/AJT.15915 |
| 2020-04-13 |
Immunosuppressive therapy maintenance in a kidney transplant recipient SARS-CoV-2 pneumonia: a case report (edit) |
10.1111/AJT.15920 |
| 2020-04-13 |
Mental Health and the Covid-19 Pandemic (edit) |
10.1056/NEJMP2008017 |
| 2020-04-13 |
Universal Screening for SARS-CoV-2 in Women Admitted for Delivery (edit) |
10.1056/NEJMC2009316 |
| 2020-04-13 |
SARS-CoV-2: Olfaction, Brain Infection, and the Urgent Need for Clinical Samples Allowing Earlier Virus Detection (edit) |
10.1021/ACSCHEMNEURO.0C00172 |
| 2020-04-13 |
Stability and Viability of SARS-CoV-2 (edit) |
10.1056/NEJMC2007942 |
| 2020-04-13 |
Stability and Viability of SARS-CoV-2. Reply (edit) |
10.1056/NEJMC2007942 |
| 2020-04-13 |
Clinical Presentation of COVID-19: A Systematic Review Focusing on Upper Airway Symptoms (edit) |
10.1177/0145561320920762 |
| 2020-04-13 |
COVID-19 and neuromuscular disorders (edit) |
10.1212/WNL.0000000000009566 |
| 2020-04-13 |
Acute neurology during the COVID-19 pandemic: Supporting the front line (edit) |
10.1212/WNL.0000000000009564 |
| 2020-04-13 |
How COVID-19 could ruin weather forecasts and climate records (edit) |
10.1038/D41586-020-00924-6 |
| 2020-04-13 |
Contracting HIV or Contracting SAR-CoV-2 (COVID- 19) in Pregnancy? Balancing the Risks and Benefits (edit) |
10.1007/S10461-020-02861-X |
| 2020-04-13 |
Three unsuspected CT diagnoses of COVID-19 (edit) |
10.1007/S10140-020-01775-4 |
| 2020-04-13 |
Cancer Surgery and COVID19 (edit) |
10.1245/S10434-020-08462-1 |
| 2020-04-13 |
Milan 2020: COVID-19, neuro-oncology and much more (edit) |
10.1007/S11060-020-03495-8 |
| 2020-04-13 |
A Call to Action: Novel Ways that Hepatologists Can Contribute to Patient Care During the COVID-19 Pandemic (edit) |
10.1007/S10620-020-06251-0 |
| 2020-04-13 |
COVID-19: How to Prepare for the Pandemic? (edit) |
10.1007/S12098-020-03293-0 |
| 2020-04-13 |
Clinical characteristics of 19 neonates born to mothers with COVID-19 (edit) |
10.1007/S11684-020-0772-Y |
| 2020-04-13 |
Chloroquine and Hydroxychloroquine in the Era of SARS - CoV2: Caution on Their Cardiac Toxicity (edit) |
10.1002/PHAR.2387 |
| 2020-04-13 |
A framework for open tracheostomy in COVID-19 patients (edit) |
10.1111/COA.13549 |
| 2020-04-13 |
Care for diabetes with COVID-19: Advice from China (edit) |
10.1111/1753-0407.13036 |
| 2020-04-13 |
Emergency Open-source Three-dimensional Printable Ventilator Circuit Splitter and Flow Regulator during the COVID-19 Pandemic (edit) |
10.1097/ALN.0000000000003332 |
| 2020-04-13 |
Coinfection of Influenza Virus and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2) (edit) |
10.1097/INF.0000000000002688 |
| 2020-04-13 |
Febrile Infant: COVID-19 in Addition to the Usual Suspects (edit) |
10.1097/INF.0000000000002693 |
| 2020-04-13 |
Use of Handheld Transceiver for Hospital Healthcare Workers-Caregiver Communication During the Coronavirus disease 2019 (COVID-19) Outbreak in Pediatric Emergency Department (edit) |
10.1097/INF.0000000000002689 |
| 2020-04-13 |
COVID-19: Financial Stress Test for Academic Medical Centers (edit) |
10.1097/ACM.0000000000003418 |
| 2020-04-13 |
Five Questions for Residency Leadership in the Time of COVID-19: Reflections of Chief Medical Residents From an Internal Medicine Program (edit) |
10.1097/ACM.0000000000003419 |
| 2020-04-13 |
Role of mask/respirator protection against SARS-CoV-2 (edit) |
10.1213/ANE.0000000000004873 |
| 2020-04-13 |
Pediatric Airway Management in COVID-19 patients - Consensus Guidelines from the Society for Pediatric Anesthesia's Pediatric Difficult Intubation Collaborative and the Canadian Pediatric Anesthesia Society (edit) |
10.1213/ANE.0000000000004872 |
| 2020-04-13 |
Preventing COVID-19 in low- and middle-income countries (edit) |
10.1007/S40267-020-00728-8 |
| 2020-04-13 |
Tip of the Spear: An Interview with the Washington State Nursing Care Quality Assurance Commission at the onset of the COVID-19 Pandemic (edit) |
10.1016/J.TELN.2020.04.005 |
| 2020-04-13 |
All about COVID-19 in brief (edit) |
10.1016/J.NMNI.2020.100678 |
| 2020-04-13 |
Adapting palliative radiation therapy for bone metastases during the Covid-19 pandemic: GEMO position paper (edit) |
10.1016/J.JBO.2020.100291 |
| 2020-04-13 |
Otorhinolaryngologists and Coronavirus Disease 2019 (COVID-19) (edit) |
10.1055/S-0040-1709724 |
| 2020-04-13 |
High Risk of COVID-19 Infection for Head and Neck Surgeons (edit) |
10.1055/S-0040-1709725 |
| 2020-04-13 |
[COVID-19 and the Invisible Damage] (edit) |
10.20344/AMP.13911 |
| 2020-04-13 |
Oligonucleotides and the COVID-19 Pandemic: A Perspective (edit) |
10.1089/NAT.2020.0868 |
| 2020-04-13 |
SALIVA IS A RELIABLE TOOL TO DETECT SARS-CoV-2 (edit) |
10.1016/J.JINF.2020.04.005 |
| 2020-04-13 |
Teleurology in the Time of Covid-19 Pandemic: Here to Stay? (edit) |
10.1016/J.UROLOGY.2020.04.004 |
| 2020-04-13 |
PCCM at the battlefront against COVID-19 in Wuhan, China (edit) |
10.1016/J.CHEST.2020.04.007 |
| 2020-04-13 |
Grief During the COVID-19 Pandemic: Considerations for Palliative Care Providers (edit) |
10.1016/J.JPAINSYMMAN.2020.04.012 |
| 2020-04-13 |
Anosmia in a healthcare worker with COVID-19 in Madrid, Spain (edit) |
10.1016/J.TMAID.2020.101666 |
| 2020-04-13 |
Mental Wellness system for COVID-19 (edit) |
10.1016/J.BBI.2020.04.032 |
| 2020-04-13 |
A longitudinal study on the mental health of general population during the COVID-19 epidemic in China (edit) |
10.1016/J.BBI.2020.04.028 |
| 2020-04-13 |
Prediction of COVID-19 transmission dynamics using a mathematical model considering behavior changes (edit) |
10.4178/EPIH.E2020026 |
| 2020-04-13 |
The first case of COVID-19 infection in a 75-day-old infant in Jahrom City, south of Iran (edit) |
10.1016/J.JFMA.2020.03.015 |
| 2020-04-13 |
The Orthopaedic Trauma Service and COVID-19 - Practice Considerations to Optimize Outcomes and Limit Exposure (edit) |
10.1097/BOT.0000000000001782 |
| 2020-04-13 |
Lung Transplantation for elderly patients with end-stage COVID-19 Pneumonia (edit) |
10.1097/SLA.0000000000003955 |
| 2020-04-13 |
COVID-19 & the General Surgical Department - Measures to Reduce Spread of SARS-COV-2 Among Surgeons (edit) |
10.1097/SLA.0000000000003957 |
| 2020-04-13 |
COVID-19 Preparedness within the Surgical, Obstetric and Anesthetic Ecosystem in Sub Saharan Africa (edit) |
10.1097/SLA.0000000000003964 |
| 2020-04-13 |
Emergency Surgery in Suspected COVID-19 Patients with Acute Abdomen: Case Series and Perspectives (edit) |
10.1097/SLA.0000000000003961 |
| 2020-04-13 |
The Distancing of Surgeon from Patient in the era of COVID-19: Bring on the Innovation (edit) |
10.1097/SLA.0000000000003962 |
| 2020-04-13 |
The Appropriate Use of Testing for COVID-19 (edit) |
10.5811/WESTJEM.2020.4.47370 |
| 2020-04-13 |
Psychological status of parents of hospitalized children during the COVID-19 epidemic in China (edit) |
10.1016/J.PSYCHRES.2020.112953 |
| 2020-04-13 |
Assessing ACE2 expression patterns in lung tissues in the pathogenesis of COVID-19 (edit) |
10.1016/J.JAUT.2020.102463 |
| 2020-04-13 |
COVID-19 in long-term care facilities: An upcoming threat that cannot be ignored (edit) |
10.1016/J.JMII.2020.04.008 |
| 2020-04-13 |
The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients (edit) |
10.1016/J.INTIMP.2020.106504 |
| 2020-04-13 |
Coronavirus-19 disease (COVID-19): A case series of early suspected cases reported and the implications towards the response to the pandemic in Zimbabwe (edit) |
10.1016/J.JMII.2020.04.002 |
| 2020-04-13 |
How to prevent outbreak of a hospital-affiliated dementia day-care facility in the pandemic COVID-19 infection in Taiwan (edit) |
10.1016/J.JMII.2020.04.007 |
| 2020-04-13 |
COVID-19 virus outbreak forecasting of registered and recovered cases after sixty day lockdown in Italy: A data driven model approach (edit) |
10.1016/J.JMII.2020.04.004 |
| 2020-04-13 |
Personal protective equipment and Covid 19- a risk to healthcare staff? (edit) |
10.1016/J.BJOMS.2020.04.015 |
| 2020-04-13 |
Testing recommendation for COVID-19 (SARS-CoV-2) in patients planned for surgery - continuing the service and 'suppressing' the pandemic (edit) |
10.1016/J.BJOMS.2020.04.014 |
| 2020-04-13 |
Challenges of methadone maintenance treatment during the COVID-19 epidemic in China: Policy and service recommendations (edit) |
10.1016/J.EURONEURO.2020.03.018 |
| 2020-04-13 |
Coronavirus drugs: Using plasma from recovered patients as a treatment for COVID-19 (edit) |
10.3233/JRS-201017 |
| 2020-04-13 |
Operating during the COVID-19 pandemic: How to reduce medical error (edit) |
10.1016/J.BJOMS.2020.04.002 |
| 2020-04-13 |
Health anxiety and behavioural changes of pregnant women during the COVID-19 pandemic (edit) |
10.1016/J.EJOGRB.2020.04.022 |
| 2020-04-13 |
Continuous temperature monitoring by a wearable device for early detection of febrile events in the SARS-CoV-2 outbreak in Taiwan, 2020 (edit) |
10.1016/J.JMII.2020.04.005 |
| 2020-04-13 |
Risk of SARS-CoV-2 Diffusion when Performing Minimally Invasive Surgery During the COVID-19 Pandemic (edit) |
10.1016/J.EURURO.2020.04.015 |
| 2020-04-13 |
The risk of SARS-CoV-2 transmission to pets and other wild and domestic animals strongly mandates a one-health strategy to control the COVID-19 pandemic (edit) |
10.1016/J.ONEHLT.2020.100133 |
| 2020-04-13 |
A Computational Approach to Design Potential siRNA Molecules as a Prospective Tool for Silencing Nucleocapsid Phosphoprotein and Surface Glycoprotein Gene of SARS-CoV-2 (edit) |
10.1101/2020.04.10.036335 |
| 2020-04-13 |
Insights on early mutational events in SARS-CoV-2 virus reveal founder effects across geographical regions (edit) |
10.1101/2020.04.09.034462 |
| 2020-04-13 |
The potential for antibody-dependent enhancement of SARS-CoV-2 infection: Translational implications for vaccine development (edit) |
10.1017/CTS.2020.39 |
| 2020-04-13 |
Immuno-informatics Characterization SARS-CoV-2 Spike Glycoprotein for Prioritization of Epitope based Multivalent Peptide Vaccine (edit) |
10.1101/2020.04.05.026005 |
| 2020-04-13 |
Mechanistic modeling of the SARS-CoV-2 disease map (edit) |
10.1101/2020.04.12.025577 |
| 2020-04-13 |
Sequence, infectivity and replication kinetics of SARS-CoV-2 isolated from COVID-19 patients in Canada (edit) |
10.1101/2020.04.11.037382 |
| 2020-04-12 |
Preparing an obstetric unit in the heart of the epidemic strike of COVID-19: quick reorganization tips (edit) |
10.1080/14767058.2020.1749258 |
| 2020-04-12 |
Should Institutions Disclose the Names of Employees with Covid-19? (edit) |
10.1002/HAST.1107 |
| 2020-04-12 |
Morphological anomalies of circulating blood cells in COVID-19 (edit) |
10.1002/AJH.25824 |
| 2020-04-12 |
We urgently need guidelines for managing COVID-19 in children with comorbidities (edit) |
10.1111/APA.15304 |
| 2020-04-12 |
Blood and blood product use during COVID-19 Infection (edit) |
10.1002/AJH.25823 |
| 2020-04-12 |
Threatening drug-drug interaction in a kidney transplant patient with Coronavirus Disease 2019 (COVID-19) (edit) |
10.1111/TID.13286 |
| 2020-04-12 |
Precautions in ophthalmic practice in a hospital with the risk of COVID-19: experience from China (edit) |
10.1111/AOS.14436 |
| 2020-04-12 |
Association of chemosensory dysfunction and Covid-19 in patients presenting with influenza-like symptoms (edit) |
10.1002/ALR.22579 |
| 2020-04-12 |
The Evolving Pandemic of COVID-19 and Interventional Cardiology (edit) |
10.1002/CCD.28894 |
| 2020-04-12 |
Editorial: Facemasks and the Covid 19 pandemic: What advice should health professionals be giving the general public about the wearing of facemasks? (edit) |
10.1111/NHS.12724 |
| 2020-04-12 |
Letter: Covid-19, and vitamin D (edit) |
10.1111/APT.15752 |
| 2020-04-12 |
Is it ethical to be a 'whistleblower' during COVID-19 pandemic? Ethical challenges confronted by health care workers in China (edit) |
10.1111/JAN.14376 |
| 2020-04-12 |
The pandemic paradox: the consequences of COVID-19 on domestic violence (edit) |
10.1111/JOCN.15296 |
| 2020-04-12 |
Nursing homes and COVID-19: we can and should do better (edit) |
10.1111/JOCN.15297 |
| 2020-04-12 |
Containing COVID-19 in the emergency room: the role of improved case detection and segregation of suspect cases (edit) |
10.1111/ACEM.13984 |
| 2020-04-12 |
G6PD and chloroquine: Selecting the treatment against SARS-CoV-2? (edit) |
10.1111/JCMM.15312 |
| 2020-04-12 |
Unpacking the black box: How to promote citizen engagement through government social media during the COVID-19 crisis (edit) |
10.1016/J.CHB.2020.106380 |
| 2020-04-12 |
Gastrointestinal Symptoms and COVID-19: Case-Control Study from the United States (edit) |
10.1053/J.GASTRO.2020.04.017 |
| 2020-04-12 |
Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan (edit) |
10.1016/J.JACI.2020.04.006 |
| 2020-04-12 |
Chloroquine as prophylactic agent against COVID-19? (edit) |
10.1016/J.IJANTIMICAG.2020.105980 |
| 2020-04-12 |
CT imaging and clinical course of asymptomatic cases with COVID-19 pneumonia at admission in Wuhan, China (edit) |
10.1016/J.JINF.2020.04.004 |
| 2020-04-12 |
Minimally invasive surgery at the time of Covid-19: The OR staff needs protection (edit) |
10.1016/J.JMIG.2020.04.010 |
| 2020-04-12 |
A search for medications to treat COVID-19 via in silico molecular docking models of the SARS-CoV-2 spike glycoprotein and 3CL protease (edit) |
10.1016/J.TMAID.2020.101646 |
| 2020-04-12 |
Impact Of Sars-Cov-2 And Its Reverberation In Global Higher Education And Mental Health (edit) |
10.1016/J.PSYCHRES.2020.112977 |
| 2020-04-12 |
Ways of Protecting Religious Older Adults from the Consequences of COVID-19 (edit) |
10.1016/J.JAGP.2020.04.004 |
| 2020-04-12 |
Epidemiological and initial clinical characteristics of patients with family aggregation of COVID-19 (edit) |
10.1016/J.JCV.2020.104360 |
| 2020-04-12 |
Sentiment analysis of nationwide lockdown due to COVID 19 outbreak: Evidence from India (edit) |
10.1016/J.AJP.2020.102089 |
| 2020-04-12 |
Mental Health Services in Lombardy during COVID-19 outbreak (edit) |
10.1016/J.PSYCHRES.2020.112980 |
| 2020-04-12 |
Analysis of Ten Microsecond simulation data of SARS-CoV-2 dimeric main protease (edit) |
10.1101/2020.04.10.036020 |
| 2020-04-12 |
Structural interactions between pandemic SARS-CoV-2 spike glycoprotein and human Furin protease (edit) |
10.1101/2020.04.10.036533 |
| 2020-04-12 |
SARS-CoV-2 detection with CRISPR diagnostics (edit) |
10.1101/2020.04.10.023358 |
| 2020-04-12 |
Comparison of SARS-CoV-2 infections among 3 species of non-human primates (edit) |
10.1101/2020.04.08.031807 |
| 2020-04-12 |
Blueprint for a Pop-up SARS-CoV-2 Testing Lab (edit) |
10.1101/2020.04.11.20061424 |
| 2020-04-12 |
Scutellaria baicalensis extract and baicalein inhibit replication of SARS-CoV-2 and its 3C-like protease in vitro (edit) |
10.1101/2020.04.10.035824 |
| 2020-04-12 |
Evaluation of heating and chemical protocols for inactivating SARS-CoV-2 (edit) |
10.1101/2020.04.11.036855 |
| 2020-04-12 |
Three adjacent nucleotide changes spanning two residues in SARS-CoV-2 nucleoprotein: possible homologous recombination from the transcription-regulating sequence (edit) |
10.1101/2020.04.10.029454 |
| 2020-04-12 |
Positive selection of ORF3a and ORF8 genes drives the evolution of SARS-CoV-2 during the 2020 COVID-19 pandemic (edit) |
10.1101/2020.04.10.035964 |
| 2020-04-12 |
Cell-Type-Specific Expression of Renin-Angiotensin-System Components in the Human Body and Its Relevance to SARS-CoV-2 Infection (edit) |
10.1101/2020.04.11.034603 |
| 2020-04-12 |
The SARS-CoV-2 receptor-binding domain elicits a potent neutralizing response without antibody-dependent enhancement (edit) |
10.1101/2020.04.10.036418 |
| 2020-04-11 |
COVID-19 and Italy: what next? (edit) |
10.1016/S0140-6736(20)30627-9 |
| 2020-04-11 |
Low-dose corticosteroid therapy does not delay viral clearance in patients with COVID-19 (edit) |
10.1016/J.JINF.2020.03.039 |
| 2020-04-11 |
Recurrent PCR positivity after hospital discharge of people with coronavirus disease 2019 (COVID-19) (edit) |
10.1016/J.JINF.2020.03.024 |
| 2020-04-11 |
My Future in Medicine: How COVID-19 is Inspiring the Next Generation of Infectious Disease Specialists (edit) |
10.1093/INFDIS/JIAA178 |
| 2020-04-11 |
Urgent Considerations for the Neuro-oncologic Treatment of Patients with Gliomas During the COVID-19 Pandemic (edit) |
10.1093/NEUONC/NOAA090 |
| 2020-04-11 |
The COVID-19 Pandemic: Experiences of a Geriatrician-Hospitalist Caring for Older Adults (edit) |
10.1111/JGS.16481 |
| 2020-04-11 |
Collaborative Delirium Prevention in the Age of COVID-19 (edit) |
10.1111/JGS.16480 |
| 2020-04-11 |
Breaking social isolation amidst Covid-19: a viewpoint on improving access to technology in long term care facilities (edit) |
10.1111/JGS.16478 |
| 2020-04-11 |
Staying in A Burning House: Perks and Perils of A Hotline in The Times of COVID-19 (edit) |
10.1111/JGS.16479 |
| 2020-04-11 |
SARS-CoV2 (COVID-19) infection: is fetal surgery in times of national disasters reasonable? (edit) |
10.1002/PD.5702 |
| 2020-04-11 |
COVID-19 and SARS: differences and similarities (edit) |
10.1111/DTH.13395 |
| 2020-04-11 |
Emergency measures for acute oral mucosa diseases during the outbreak of COVID-19 (edit) |
10.1111/ODI.13350 |
| 2020-04-11 |
COVID-19: How Can Rural Community Pharmacies Respond to the Outbreak? (edit) |
10.1111/JRH.12439 |
| 2020-04-11 |
COVID-19 During the Opioid Epidemic - Exacerbation of Stigma and Vulnerabilities (edit) |
10.1111/JRH.12442 |
| 2020-04-11 |
A Primary Care Response to COVID-19 for Patients with an Opioid Use Disorder (edit) |
10.1111/JRH.12438 |
| 2020-04-11 |
Fecal Shedding of SARS CoV-2: Implications for Disease Spread and Quarantine (edit) |
|
| 2020-04-11 |
A Low-cost Solution for Retro-fitment of HEPA Filter in Healthcare Facilities Providing Care to COVID-19 Patients (edit) |
|
| 2020-04-11 |
Presentation of new onset anosmia during the COVID-19 pandemic (edit) |
10.4193/RHIN20.116 |
| 2020-04-11 |
Letter: Academic Neurosurgery Department Response to COVID-19 Pandemic: The University of Miami/Jackson Memorial Hospital Model (edit) |
10.1093/NEUROS/NYAA118 |
| 2020-04-11 |
Thromboprophylaxis and laboratory monitoring for in-hospital patients with COVID-19 - a Swiss consensus statement by the Working Party Hemostasis (edit) |
10.4414/SMW.2020.20247 |
| 2020-04-11 |
Practical Guidance for Managing EMG Requests and Testing during the COVID-19 Pandemic (edit) |
10.1002/MUS.26891 |
| 2020-04-11 |
Introducing the Percent, Number, Availability, and Capacity [PNAC] Spatial Approach to Identify Priority Rural Areas Requiring Targeted Health Support in Light of COVID-19: A Commentary and Application (edit) |
10.1111/JRH.12436 |
| 2020-04-11 |
Caring for Miners During the Coronavirus Disease-2019 (COVID-19) Pandemic (edit) |
10.1111/JRH.12444 |
| 2020-04-11 |
Using Telehealth as a Tool for Rural Hospitals in the COVID-19 Pandemic Response (edit) |
10.1111/JRH.12443 |
| 2020-04-11 |
Telehealth Policies Impacting Federally Qualified Health Centers (FQHCs)in Face of COVID-19 (edit) |
10.1111/JRH.12445 |
| 2020-04-11 |
Benign COVID-19 in an immunocompromised cancer patient - the case of a married couple (edit) |
10.4414/SMW.2020.20246 |
| 2020-04-11 |
Classification system and case definition for SARS-CoV-2 infection in pregnant women, fetuses, and neonates (edit) |
10.1111/AOGS.13870 |
| 2020-04-11 |
Exploring possible mechanisms for COVID-19 induced thrombocytopenia: Unanswered Questions (edit) |
10.1111/JTH.14832 |
| 2020-04-11 |
Clinical characteristics and outcomes of older patients with coronavirus disease 2019 (COVID-19) in Wuhan, China (2019): a single-centered, retrospective study (edit) |
10.1093/GERONA/GLAA089 |
| 2020-04-11 |
CT features of SARS-CoV-2 pneumonia according to clinical presentation: a retrospective analysis of 120 consecutive patients from Wuhan city (edit) |
10.1007/S00330-020-06854-1 |
| 2020-04-11 |
The role of Mental Health Home Hospitalization Care during the COVID-19 pandemic (edit) |
10.1111/ACPS.13173 |
| 2020-04-11 |
The use of google trends to investigate the loss of smell related searches during COVID-19 outbreak (edit) |
10.1002/ALR.22580 |
| 2020-04-11 |
Dead body management in times of Covid-19 and its potential impact on the availability of cadavers for medical education in India (edit) |
10.1002/ASE.1962 |
| 2020-04-11 |
Good IgA bad IgG in SARS-CoV-2 infection? (edit) |
10.1093/CID/CIAA426 |
| 2020-04-11 |
The fast territorial expansion of the Covid-19 in Spain (edit) |
10.2188/JEA.JE20200123 |
| 2020-04-11 |
False negative rate of COVID-19 is eliminated by using nasal swab test (edit) |
10.1016/J.TMAID.2020.101668 |
| 2020-04-11 |
Mortality of a pregnant patient diagnosed with COVID-19: A case report with clinical, radiological, and histopathological findings (edit) |
10.1016/J.TMAID.2020.101665 |
| 2020-04-11 |
A HIGH-VOLUME THORACIC SURGERY DIVISION INTO THE STORM OF THE COVID-19 PANDEMIC (edit) |
10.1016/J.ATHORACSUR.2020.03.015 |
| 2020-04-11 |
Triage of scarce critical care resources in COVID-19: an implementation guide for regional allocation An expert panel report of the Task Force for Mass Critical Care and the American College of Chest Physicians (edit) |
10.1016/J.CHEST.2020.03.063 |
| 2020-04-11 |
2019-nCoV Pandemic: A disruptive and stressful atmosphere for Indian academic fraternity (edit) |
10.1016/J.BBI.2020.04.025 |
| 2020-04-11 |
Collaborative Multi-Disciplinary Incident Command at Seattle Children's Hospital for Rapid Preparatory Pediatric Surgery Countermeasures to the COVID-19 Pandemic (edit) |
10.1016/J.JAMCOLLSURG.2020.04.012 |
| 2020-04-11 |
Delivering High-Quality Vascular Care via Telehealth during the COVID-19 Pandemic (edit) |
10.1016/J.JVS.2020.04.010 |
| 2020-04-11 |
Doing the right thing for the right reason when treating ruptured abdominal aortic aneurysms in the COVID-19 era (edit) |
10.1016/J.JVS.2020.04.009 |
| 2020-04-11 |
The evidence of SARS-CoV-2 infection on ocular surface (edit) |
10.1016/J.JTOS.2020.03.010 |
| 2020-04-11 |
Evidence Based Management Guideline for the COVID-19 Pandemic - Review article (edit) |
10.1016/J.IJSU.2020.04.001 |
| 2020-04-11 |
COVID-19 in the perioperative period of lung resection: a brief report from a single thoracic surgery department in Wuhan, China (edit) |
10.1016/J.JTHO.2020.04.003 |
| 2020-04-11 |
LUNG CANCER SURGICAL MANAGEMENT DURING THE OUTBREAK OF COVID-19 (edit) |
10.1016/J.JTHO.2020.03.027 |
| 2020-04-11 |
Online learning in the time of COVID-19 (edit) |
10.1016/J.TMAID.2020.101669 |
| 2020-04-11 |
Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study (edit) |
10.1016/J.TMAID.2020.101663 |
| 2020-04-11 |
What are the factors influencing the COVID-19 outbreak in Latin America? (edit) |
10.1016/J.TMAID.2020.101667 |
| 2020-04-11 |
Epidemiological and clinical features of 125 Hospitalized Patients with COVID-19 in Fuyang, Anhui, China (edit) |
10.1016/J.IJID.2020.03.070 |
| 2020-04-11 |
The Relationship between the Migrant Population's Migration Network and the Risk of COVID-19 Transmission in China-Empirical Analysis and Prediction in Prefecture-Level Cities (edit) |
10.3390/IJERPH17082630 |
| 2020-04-11 |
Planning and coordination of the radiological response to the coronavirus disease 2019 (COVID-19) pandemic: the Singapore experience (edit) |
10.1016/J.CRAD.2020.03.028 |
| 2020-04-11 |
Community-based prevention and control of COVID-19: Experience from China (edit) |
10.1016/J.AJIC.2020.03.012 |
| 2020-04-11 |
Take proactive measures for the pandemic COVID-19 infection in the dialysis facilities (edit) |
10.1016/J.JFMA.2020.03.022 |
| 2020-04-11 |
The COVID-19 outbreak: From "black swan" to global challenges and opportunities (edit) |
10.1016/J.PULMOE.2020.03.002 |
| 2020-04-11 |
FFP2-mondmasker of chirurgisch mondkapje bij COVID-19 (edit) |
10.1007/S12445-020-0586-9 |
| 2020-04-11 |
Recommendations for Surgery During the Novel Coronavirus (COVID-19) Epidemic (edit) |
10.1007/S12262-020-02173-3 |
| 2020-04-11 |
How to reorganize the access of children in a radiotherapy department in the era of COVID19, in order to protect themselves and elderly patients (edit) |
10.1016/J.ADRO.2020.04.002 |
| 2020-04-11 |
COVID-19: Reducing the risk of infection might increase the risk of intimate partner violence (edit) |
10.1016/J.ECLINM.2020.100348 |
| 2020-04-11 |
COVID-19, Medicine, and Sports (edit) |
10.1016/J.ASMR.2020.04.003 |
| 2020-04-11 |
High flow nasal cannula is a good treatment option for COVID-19 (edit) |
10.1016/J.HRTLNG.2020.03.018 |
| 2020-04-11 |
Olfactory Bulb Magnetic Resonance Imaging in SARS-CoV-2-Induced Anosmia: The First Report (edit) |
10.1016/J.ACRA.2020.04.002 |
| 2020-04-11 |
Neonatal COVID-19: little evidence and the need for more information (edit) |
10.1016/J.JPED.2020.04.002 |
| 2020-04-11 |
From the insight of glucose metabolism disorder: Oxygen therapy and blood glucose monitoring are crucial for quarantined COVID-19 patients (edit) |
10.1016/J.ECOENV.2020.110614 |
| 2020-04-11 |
Central nervous system manifestations of COVID-19: A systematic review (edit) |
10.1016/J.JNS.2020.116832 |
| 2020-04-11 |
Can an effective SARS-CoV-2 vaccine be developed for the older population? (edit) |
10.1186/S12979-020-00180-2 |
| 2020-04-11 |
COVID-19: Crisis Management in Congenital Heart Surgery (edit) |
10.1016/J.ATHORACSUR.2020.04.001 |
| 2020-04-11 |
Managing patients with cancer in the COVID-19 era (edit) |
10.1016/J.EJCA.2020.03.028 |
| 2020-04-11 |
Pulmonary embolism in patients with COVID-19: Time to change the paradigm of computed tomography (edit) |
10.1016/J.THROMRES.2020.04.011 |
| 2020-04-11 |
Changes in air quality during the lockdown in Barcelona (Spain) one month into the SARS-CoV-2 epidemic (edit) |
10.1016/J.SCITOTENV.2020.138540 |
| 2020-04-11 |
People experiencing homelessness: Their potential exposure to COVID-19 (edit) |
10.1016/J.PSYCHRES.2020.112945 |
| 2020-04-11 |
Psychological status of surgical staff during the COVID-19 outbreak (edit) |
10.1016/J.PSYCHRES.2020.112955 |
| 2020-04-11 |
Psychological symptoms of ordinary Chinese citizens based on SCL-90 during the level I emergency response to COVID-19 (edit) |
10.1016/J.PSYCHRES.2020.112992 |
| 2020-04-11 |
More clinical warning indicators should be explored for monitoring COVID-19 patients' condition (edit) |
10.1016/J.IJCARD.2020.04.010 |
| 2020-04-11 |
French consensus on management of head and neck cancer surgery during COVID-19 pandemic (edit) |
10.1016/J.ANORL.2020.04.008 |
| 2020-04-11 |
Chest Imaging in Patients Hospitalized With COVID-19 Infection - A Case Series (edit) |
10.1067/J.CPRADIOL.2020.04.001 |
| 2020-04-11 |
Strategic plan for management in oral and maxillofacial surgery during COVID-19 epidemic (edit) |
10.1016/J.ORALONCOLOGY.2020.104715 |
| 2020-04-11 |
An oncologist perspective on COVID 19: A mysterious cryptic virus (edit) |
10.1016/J.ORALONCOLOGY.2020.104694 |
| 2020-04-11 |
Unlikely SARS-CoV-2 vertical transmission from mother to child: A case report (edit) |
10.1016/J.JIPH.2020.04.004 |
| 2020-04-11 |
Radiology Residency Preparedness and Response to the COVID-19 Pandemic (edit) |
10.1016/J.ACRA.2020.04.001 |
| 2020-04-11 |
What Has the COVID-19 Pandemic Taught Us so Far? Addressing the Problem from a Hepatologist's Perspective (edit) |
10.14218/JCTH.2020.00024 |
| 2020-04-11 |
Prone Position in Management of COVID-19 Patients; a Commentary (edit) |
|
| 2020-04-11 |
Sustainable response to the COVID-19 pandemic in the operating theatre: we need more than just personal protective equipment (edit) |
10.1016/J.BJA.2020.04.002 |
| 2020-04-11 |
Leveraging existing quality improvement communication strategies during the COVID-19 crisis: Creation of an Emergency Department COVID-19 Case Conference (edit) |
10.1016/J.AJEM.2020.04.021 |
| 2020-04-11 |
Ger Rijkers: Persistence of Memory in Times of COVID-19 (edit) |
10.1016/J.IT.2020.04.002 |
| 2020-04-11 |
The need of health policy perspective to protect Healthcare Workers during COVID-19 pandemic. A GRADE rapid review on the N95 respirators effectiveness (edit) |
10.1101/2020.04.06.20054841 |
| 2020-04-11 |
Chloroquine diphosphate in two different dosages as adjunctive therapy of hospitalized patients with severe respiratory syndrome in the context of coronavirus (SARS-CoV-2) infection: Preliminary safety results of a randomized, double-blinded, phase I (edit) |
10.1101/2020.04.07.20056424 |
| 2020-04-11 |
Convalescent Plasma to Treat COVID-19: Chinese Strategy and Experiences (edit) |
10.1101/2020.04.07.20056440 |
| 2020-04-11 |
Can people with asymptomatic or pre-symptomatic COVID-19 infect others: a systematic review of primary data (edit) |
10.1101/2020.04.08.20054023 |
| 2020-04-11 |
Exercising caution in correlating COVID-19 incidence and mortality rates with BCG vaccination policies due to variable rates of SARS CoV-2 testing (edit) |
10.1101/2020.04.08.20056051 |
| 2020-04-11 |
Prognostic factors for severity and mortality in patients infected with COVID-19: A living systematic review protocol (edit) |
10.1101/2020.04.08.20056598 |
| 2020-04-11 |
Liver injury is associated with severe Coronavirus disease 2019 (COVID‑19) infection: a systematic review and meta-analysis of retrospective studies (edit) |
10.1101/2020.04.09.20056242 |
| 2020-04-11 |
Risk factors for mortality of adult inpatients with Coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis of retrospective studies (edit) |
10.1101/2020.04.09.20056291 |
| 2020-04-11 |
BCG protects against COVID-19? A word of caution (edit) |
10.1101/2020.04.09.20056903 |
| 2020-04-11 |
A Case of Coinfection with SARS-COV-2 and Cytomegalovirus in the Era of COVID-19 (edit) |
10.12890/2020_001652 |
| 2020-04-11 |
On the interactions of the receptor-binding domain of SARS-CoV-1 and SARS-CoV-2 spike proteins with monoclonal antibodies and the receptor ACE2 (edit) |
10.1101/2020.04.05.026377 |
| 2020-04-11 |
Clinical evaluation of a SARS-CoV-2 RT-PCR assay on a fully automated system for rapid on-demand testing in the hospital setting (edit) |
10.1101/2020.04.07.20056234 |
| 2020-04-11 |
High-throughput extraction of SARS-CoV-2 RNA from nasopharyngeal swabs using solid-phase reverse immobilization beads (edit) |
10.1101/2020.04.08.20055731 |
| 2020-04-11 |
SARS-CoV-2 / 2019-Novel Corona Virus: An Epidemic to Pandemic (edit) |
10.26452/IJRPS.V11ISPL1.2067 |
| 2020-04-11 |
Rapid in silico design of antibodies targeting SARS-CoV-2 using machine learning and supercomputing (edit) |
10.1101/2020.04.03.024885 |
| 2020-04-11 |
Systemic analysis of tissue cells potentially vulnerable to SARS-CoV-2 infection by the protein-proofed single-cell RNA profiling of ACE2, TMPRSS2 and Furin proteases (edit) |
10.1101/2020.04.06.028522 |
| 2020-04-11 |
Human monoclonal antibodies block the binding of SARS-CoV-2 spike protein to angiotensin converting enzyme 2 receptor (edit) |
10.1101/2020.04.06.20055475 |
| 2020-04-11 |
Development of a dual-gene loop-mediated isothermal amplification (LAMP) detection assay for SARS-CoV-2: A preliminary study (edit) |
10.1101/2020.04.08.20056986 |
| 2020-04-11 |
A streamlined approach to rapidly detect SARS-CoV-2 infection, avoiding RNA extraction (edit) |
10.1101/2020.04.06.20054114 |
| 2020-04-11 |
Evaluation of nine commercial SARS-CoV-2 immunoassays (edit) |
10.1101/2020.04.09.20056325 |
| 2020-04-11 |
ACE2 fragment as a decoy for novel SARS-Cov-2 virus (edit) |
10.1101/2020.04.06.028647 |
| 2020-04-11 |
Fast SARS-CoV-2 detection by RT-qPCR in preheated nasopharyngeal swab samples (edit) |
10.1101/2020.04.08.20058495 |
| 2020-04-11 |
Exploring the genomic and proteomic variations of SARS-CoV-2 spike glycoprotein: a computational biology approach (edit) |
10.1101/2020.04.07.030924 |
| 2020-04-11 |
Self-collection: an appropriate alternative during the SARS-CoV-2 pandemic (edit) |
10.1101/2020.04.09.20057901 |
| 2020-04-11 |
SARS-CoV-2 and human milk: what is the evidence? (edit) |
10.1101/2020.04.07.20056812 |
| 2020-04-11 |
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection During Pregnancy In China: A Retrospective Cohort Study (edit) |
10.1101/2020.04.07.20053744 |
| 2020-04-11 |
How much of SARS-CoV-2 Infections is India detecting? A model-based estimation (edit) |
10.1101/2020.04.09.20059014 |
| 2020-04-11 |
Human ACE2 receptor polymorphisms predict SARS-CoV-2 susceptibility (edit) |
10.1101/2020.04.07.024752 |
| 2020-04-11 |
Modeling the impact of human mobility and travel restrictions on the potential spread of SARS-CoV-2 in Taiwan (edit) |
10.1101/2020.04.07.20053439 |
| 2020-04-11 |
De novo design of high-affinity antibody variable regions (Fv) against the SARS-CoV-2 spike protein (edit) |
10.1101/2020.04.09.034868 |
| 2020-04-11 |
Estimates of the Undetected Rate among the SARS-CoV-2 Infected using Testing Data from Iceland (edit) |
10.1101/2020.04.06.20055582 |
| 2020-04-11 |
In-depth Bioinformatic Analyses of Human SARS-CoV-2, SARS-CoV, MERS-CoV, and Other Nidovirales Suggest Important Roles of Noncanonical Nucleic Acid Structures in Their Lifecycles (edit) |
10.1101/2020.04.09.031252 |
| 2020-04-11 |
A study of SARS-CoV-2 evolution in Italy: from early days to secondary effects after social distancing (edit) |
10.1101/2020.04.06.20055392 |
| 2020-04-11 |
Integrative Network Biology Framework Elucidates Molecular Mechanisms of SARS-CoV-2 Pathogenesis (edit) |
10.1101/2020.04.09.033910 |
| 2020-04-11 |
Estimation of the percentages of asymptomatic patients and undiagnosed patients of the novel coronavirus (SARS-CoV-2) infection in Hokkaido, Japan by using birth-death process with recursive full tracing (edit) |
10.1101/2020.04.06.20053934 |
| 2020-04-11 |
Introductions and early spread of SARS-CoV-2 in the New York City area (edit) |
10.1101/2020.04.08.20056929 |
| 2020-04-11 |
Modeling layered non-pharmaceutical interventions against SARS-CoV-2 in the United States with Corvid (edit) |
10.1101/2020.04.08.20058487 |
| 2020-04-11 |
Homologous protein domains in SARS-CoV-2 and measles, mumps and rubella viruses: preliminary evidence that MMR vaccine might provide protection against COVID-19 (edit) |
10.1101/2020.04.10.20053207 |
| 2020-04-11 |
Type 2 and interferon inflammation strongly regulate SARS-CoV-2 related gene expression in the airway epithelium (edit) |
10.1101/2020.04.09.034454 |
| 2020-04-11 |
Potential host range of multiple SARS-like coronaviruses and an improved ACE2-Fc variant that is potent against both SARS-CoV-2 and SARS-CoV-1 (edit) |
10.1101/2020.04.10.032342 |
| 2020-04-11 |
Currently available intravenous immunoglobulin (Gamunex®-C and Flebogamma® DIF) contains antibodies reacting against SARS-CoV-2 antigens (edit) |
10.1101/2020.04.07.029017 |
| 2020-04-11 |
SARS-CoV-2 infection in Health Care Workers in a large public hospital in Madrid, Spain, during March 2020 (edit) |
10.1101/2020.04.07.20055723 |
| 2020-04-10 |
Molecular Docking Analysis of Selected Natural Products from Plants for Inhibition of SARS-CoV-2 Main Protease (edit) |
10.18520/CS/V118/I7/1087-1092 |
| 2020-04-10 |
Regional air pollution persistence links to covid19 infection zoning (edit) |
10.1016/J.JINF.2020.03.045 |
| 2020-04-10 |
Social media WeChat infers the development trend of COVID-19 (edit) |
10.1016/J.JINF.2020.03.050 |
| 2020-04-10 |
Evaluation of control measures for COVID-19 in Wuhan, China (edit) |
10.1016/J.JINF.2020.03.043 |
| 2020-04-10 |
Rapid asymptomatic transmission of COVID-19 during the incubation period demonstrating strong infectivity in a cluster of youngsters aged 16-23 years outside Wuhan and characteristics of young patients with COVID-19: A prospective contact-tracing stu (edit) |
10.1016/J.JINF.2020.03.006 |
| 2020-04-10 |
Airborne precautions recommended in Wuhan, China for bedside fiberoptic bronchoscopy examination of patients with COVID-19 (edit) |
10.1016/J.JINF.2020.03.055 |
| 2020-04-10 |
Presymptomatic Transmission of SARS-CoV-2 - Singapore, January 23-March 16, 2020 (edit) |
10.15585/MMWR.MM6914E1 |
| 2020-04-10 |
Rapid Sentinel Surveillance for COVID-19 - Santa Clara County, California, March 2020 (edit) |
10.15585/MMWR.MM6914E3 |
| 2020-04-10 |
Detection of SARS-CoV-2 Among Residents and Staff Members of an Independent and Assisted Living Community for Older Adults - Seattle, Washington, 2020 (edit) |
10.15585/MMWR.MM6914E2 |
| 2020-04-10 |
Coronavirus Disease 2019 in Children - United States, February 12-April 2, 2020 (edit) |
10.15585/MMWR.MM6914E4 |
| 2020-04-10 |
Surgical management of head and neck tumours during the SARS-CoV (Covid-19) pandemic (edit) |
10.14639/0392-100X-N0783 |
| 2020-04-10 |
SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes (edit) |
10.1007/S11357-020-00186-0 |
| 2020-04-10 |
A cut above COVID-19- surgical perspectives from a public health institution in Singapore during a coronavirus epidemic (edit) |
10.1111/ANS.15904 |
| 2020-04-10 |
COVID-19 and the ANZ J Surgery (edit) |
10.1111/ANS.15906 |
| 2020-04-10 |
[Asymptomatic and pre-symptomatic cases of COVID-19 contribution to spreading the epidemic and need for targeted control strategies] (edit) |
10.3760/CMA.J.CN112338-20200406-00517 |
| 2020-04-10 |
Vaginal Delivery Report of a Healthy Neonate Born to a Convalescent Mother with COVID-19 (edit) |
10.1002/JMV.25857 |
| 2020-04-10 |
Response to Ribeiro da Silva et al.,"Role of Nonstructural Proteins in the Pathogenesis of SARS-CoV-2 (edit) |
10.1002/JMV.25863 |
| 2020-04-10 |
The clinical feature of silent infections of novel coronavirus infection (COVID-19) in Wenzhou (edit) |
10.1002/JMV.25861 |
| 2020-04-10 |
Clinical and demographic characteristics of patients dying from COVID-19 in Italy versus China (edit) |
10.1002/JMV.25860 |
| 2020-04-10 |
SARS-CoV-2 may be related to conjunctivitis but not necessarily spread through the conjunctiva SARS-CoV-2 and conjunctiva (edit) |
10.1002/JMV.25856 |
| 2020-04-10 |
Conjunctiva is not a preferred gateway of entry for SARS-CoV-2 to infect respiratory tract (edit) |
10.1002/JMV.25859 |
| 2020-04-10 |
Handling and Processing of Blood Specimens from Patients with COVID-19 for Safe Studies on Cell Phenotype and Cytokine Storm (edit) |
10.1002/CYTO.A.24009 |
| 2020-04-10 |
Harnessing Innate Immunity to Eliminate SARS-CoV-2 and Ameliorate COVID-19 Disease (edit) |
10.1152/PHYSIOLGENOMICS.00033.2020 |
| 2020-04-10 |
Duration of SARS-CoV-2 viral shedding during COVID-19 infection (edit) |
10.1080/23744235.2020.1748705 |
| 2020-04-10 |
Chronic Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Is High Among Intensive Care Unit Patients With Non-COVID-19 Sepsis but Carry a Moderately Increased Risk of Death (edit) |
10.1161/HYPERTENSIONAHA.120.15178 |
| 2020-04-10 |
COVID-19 in Italy: impact of containment measures and prevalence estimates of infection in the general population (edit) |
10.23750/ABM.V91I3-S.9511 |
| 2020-04-10 |
King Lear Under COVID-19 Lockdown (edit) |
10.1001/JAMA.2020.6186 |
| 2020-04-10 |
The Mental Health Consequences of COVID-19 and Physical Distancing: The Need for Prevention and Early Intervention (edit) |
10.1001/JAMAINTERNMED.2020.1562 |
| 2020-04-10 |
Seasonal Influenza Activity During the SARS-CoV-2 Outbreak in Japan (edit) |
10.1001/JAMA.2020.6173 |
| 2020-04-10 |
Association of Public Health Interventions With the Epidemiology of the COVID-19 Outbreak in Wuhan, China (edit) |
10.1001/JAMA.2020.6130 |
| 2020-04-10 |
Data Error in Viewpoint on COVID-19 in Italy (edit) |
10.1001/JAMA.2020.6122 |
| 2020-04-10 |
Public Health Interventions for COVID-19: Emerging Evidence and Implications for an Evolving Public Health Crisis (edit) |
10.1001/JAMA.2020.5910 |
| 2020-04-10 |
Safety Considerations in the Laboratory Testing of Specimens Suspected or Known to Contain the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (edit) |
10.1093/LABMED/LMAA018 |
| 2020-04-10 |
Myocardial localization of coronavirus in COVID-19 cardiogenic shock (edit) |
10.1002/EJHF.1828 |
| 2020-04-10 |
COVID-19 with Different Severity: A Multi-center Study of Clinical Features (edit) |
10.1164/RCCM.202002-0445OC |
| 2020-04-10 |
Predictors for imaging progression on chest CT from coronavirus disease 2019 (COVID-19) patients (edit) |
10.18632/AGING.102999 |
| 2020-04-10 |
Will COVID-19 become the next neglected tropical disease? (edit) |
10.1371/JOURNAL.PNTD.0008271 |
| 2020-04-10 |
ILROG Emergency Guidelines for Radiation Therapy of Hematological Malignancies During the COVID-19 Pandemic (edit) |
10.1182/BLOOD.2020006028 |
| 2020-04-10 |
COVID-19 Autopsies, Oklahoma, USA (edit) |
10.1093/AJCP/AQAA062 |
| 2020-04-10 |
Plasminogen improves lung lesions and hypoxemia in patients with COVID-19 (edit) |
10.1093/QJMED/HCAA121 |
| 2020-04-10 |
Safety testing improvised COVID-19 personal protective equipment based on a modified full-face snorkel mask (edit) |
10.1111/ANAE.15085 |
| 2020-04-10 |
Management of ovarian cancer during the COVID-19 pandemic (edit) |
10.1002/IJGO.13167 |
| 2020-04-10 |
Telemedicine in Liver Disease and Beyond: Can the COVID-19 Crisis Lead to Action? (edit) |
10.1002/HEP.31276 |
| 2020-04-10 |
Global challenges to urology practice during COVID-19 pandemic (edit) |
10.1111/BJU.15082 |
| 2020-04-10 |
COVID-19 , School Closings and Weight Gain (edit) |
10.1002/OBY.22825 |
| 2020-04-10 |
Why does Japan have so few cases of COVID19? (edit) |
10.15252/EMMM.202012481 |
| 2020-04-10 |
Clinical and ethical challenges for emergency departments during communicable disease outbreaks: can lessons from Ebola Virus Disease be applied to the COVID-19 pandemic? (edit) |
10.1111/1742-6723.13514 |
| 2020-04-10 |
Compassionate Use of Remdesivir for Patients with Severe Covid-19 (edit) |
10.1056/NEJMOA2007016 |
| 2020-04-10 |
Editorial. Early lessons in the management of COVID-19 for the pediatric neurosurgical community from the leadership of the American Society of Pediatric Neurosurgeons (edit) |
10.3171/2020.3.PEDS20215 |
| 2020-04-10 |
Editorial. Neurosurgery in the storm of COVID-19: suggestions from the Lombardy region, Italy (ex malo bonum) (edit) |
10.3171/2020.3.JNS20960 |
| 2020-04-10 |
Protecting Labor and Delivery Personnel from COVID-19 during the Second Stage of Labor (edit) |
10.1055/S-0040-1709689 |
| 2020-04-10 |
COVID-19: A Relationship to Climate and Environmental Conditions? (edit) |
10.1111/DTH.13399 |
| 2020-04-10 |
The Effect of Quarantine and Isolation for COVID-19 in General Population and Dermatologic Treatments (edit) |
10.1111/DTH.13398 |
| 2020-04-10 |
Cancer Care Goes Virtual in Response to COVID-19 (edit) |
10.1158/2159-8290.CD-NB2020-027 |
| 2020-04-10 |
Allocation of scarce resources during the COVID-19 pandemic: a Jewish ethical perspective (edit) |
10.1136/MEDETHICS-2020-106242 |
| 2020-04-10 |
Clinical evaluation of the cobas SARS-CoV-2 test and a diagnostic platform switch during 48 hours in the midst of the COVID-19 pandemic (edit) |
10.1128/JCM.00599-20 |
| 2020-04-10 |
A method to prevent SARS-CoV-2 IgM false positives in gold immunochromatography and enzyme-linked immunosorbent assays (edit) |
10.1128/JCM.00375-20 |
| 2020-04-10 |
Structure of the RNA-dependent RNA polymerase from COVID-19 virus (edit) |
10.1126/SCIENCE.ABB7498 |
| 2020-04-10 |
Coronavirus disease 2019 (COVID-19): we don't leave women alone (edit) |
10.1007/S00038-020-01369-4 |
| 2020-04-10 |
How to Handle a COVID-19 Patient in the Angiographic Suite (edit) |
10.1007/S00270-020-02476-8 |
| 2020-04-10 |
Perspective: cardiovascular disease and the Covid-19 pandemic (edit) |
10.1007/S00395-020-0792-4 |
| 2020-04-10 |
Managing Cutaneous Immune-Mediated Diseases During the COVID-19 Pandemic (edit) |
10.1007/S40257-020-00514-2 |
| 2020-04-10 |
Learnings for Health Economics from the Early Stages of the COVID-19 Pandemic (edit) |
10.1007/S41669-020-00216-9 |
| 2020-04-10 |
Experiences of practicing surgical neuro-oncology during the COVID-19 pandemic (edit) |
10.1007/S11060-020-03489-6 |
| 2020-04-10 |
May we deliver neuro-oncology in difficult times (e.g. COVID-19)? (edit) |
10.1007/S11060-020-03496-7 |
| 2020-04-10 |
"Fast, faster, and fastest: science on the run during COVID-19 drama"-"do not forget the liver" (edit) |
10.1007/S12072-020-10042-0 |
| 2020-04-10 |
Management of COVID-19 in patients after liver transplantation: Beijing working party for liver transplantation (edit) |
10.1007/S12072-020-10043-Z |
| 2020-04-10 |
First case of COVID-19 complicated with fulminant myocarditis: a case report and insights (edit) |
10.1007/S15010-020-01424-5 |
| 2020-04-10 |
First considerations on the SARS-CoV-2 epidemic in the Dialysis Units of Piedmont and Aosta Valley, Northern Italy (edit) |
10.1007/S40620-020-00732-1 |
| 2020-04-10 |
Os direitos humanos das crianças com deficiência durante emergências de saúde: o desafio do COVID-19 (edit) |
10.1111/DMCN.14528 |
| 2020-04-10 |
Novel Coronavirus (SARS-CoV-2) Infection in A Renal Transplant Recipient: Case Report (edit) |
10.1111/AJT.15897 |
| 2020-04-10 |
The COVID-19 pandemic and mental health impacts (edit) |
10.1111/INM.12726 |
| 2020-04-10 |
Fatal outcome in a liver transplant recipient with COVID-19 (edit) |
10.1111/AJT.15909 |
| 2020-04-10 |
Going Virtual to Support Anatomy Education: A STOP GAP in the Midst of the Covid-19 Pandemic (edit) |
10.1002/ASE.1963 |
| 2020-04-10 |
Rehabilitation following critical illness in people with COVID-19 infection (edit) |
10.1097/PHM.0000000000001443 |
| 2020-04-10 |
A carton-made protective shield for suspicious/confirmed COVID-19 intubation and extubation during surgery (edit) |
10.1213/ANE.0000000000004869 |
| 2020-04-10 |
What's Important: What Is Our Role in the COVID-19 Pandemic? (edit) |
10.2106/JBJS.20.00444 |
| 2020-04-10 |
Chronic liver disease is not associated with severity or mortality in Coronavirus disease 2019 (COVID-19): a pooled analysis (edit) |
10.1097/MEG.0000000000001742 |
| 2020-04-10 |
COVID-19 - A Guide to Rapid Implementation of Telehealth Services: A Playbook for the Pediatric Gastroenterologist (edit) |
10.1097/MPG.0000000000002749 |
| 2020-04-10 |
The indirect benefit on respiratory health from the world's effort to reduce transmission of SARS - CoV-2 (edit) |
10.1016/J.CHEST.2020.03.062 |
| 2020-04-10 |
A call to action : the need for autopsies to determine the full extent of organ involvement associated with COVID-19 infections (edit) |
10.1016/J.CHEST.2020.03.060 |
| 2020-04-10 |
Care of the Pregnant Woman with COVID-19 in Labor and Delivery: Anesthesia, Emergency cesarean delivery, Differential diagnosis in the acutely ill parturient, Care of the newborn, and Protection of the healthcare personnel (edit) |
10.1016/J.AJOG.2020.04.005 |
| 2020-04-10 |
Cardiothoracic Education in the Time of COVID-19: How I Teach It (edit) |
10.1016/J.ATHORACSUR.2020.04.002 |
| 2020-04-10 |
COVID-19 and the liver: the perils of non-peer reviewed science in times of a pandemic (edit) |
10.1053/J.GASTRO.2020.04.007 |
| 2020-04-10 |
Why does SARS-CoV-2 invade the gastrointestinal epithelium? (edit) |
10.1053/J.GASTRO.2020.04.006 |
| 2020-04-10 |
AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: Expert Commentary (edit) |
10.1053/J.GASTRO.2020.04.012 |
| 2020-04-10 |
High Prevalence of Concurrent Gastrointestinal Manifestations in Patients with SARS-CoV-2: Early Experience from California (edit) |
10.1053/J.GASTRO.2020.04.008 |
| 2020-04-10 |
Endoscopy units and the COVID-19 Outbreak: A Multi-Center Experience from Italy (edit) |
10.1053/J.GASTRO.2020.04.003 |
| 2020-04-10 |
Remdesivir and SARS-CoV-2: Structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites (edit) |
10.1016/J.ANTIVIRAL.2020.104793 |
| 2020-04-10 |
Collateral consequences of COVID-19 epidemic in Greater Paris (edit) |
10.1016/J.RESUSCITATION.2020.04.010 |
| 2020-04-10 |
In-hospital cardiac arrest outcomes among patients with COVID-19 pneumonia in Wuhan, China (edit) |
10.1016/J.RESUSCITATION.2020.04.005 |
| 2020-04-10 |
Taipei Azalea - Supraglottic airways (SGA) preassembled with high-efficiency particulate air (HEPA) filters to simplify prehospital airway management for patients with out-of-hospital cardiac arrests (OHCA) during Coronavirus Disease 2019 (COVID-19) (edit) |
10.1016/J.RESUSCITATION.2020.03.021 |
| 2020-04-10 |
Should anti-diabetic medications be reconsidered amid COVID-19 pandemic? (edit) |
10.1016/J.DIABRES.2020.108146 |
| 2020-04-10 |
Highlights for management of patients with Autoimmune Liver Disease during COVID-19 pandemia (edit) |
10.1016/J.JHEP.2020.04.002 |
| 2020-04-10 |
A cluster of pneumonia associated with the SARS-Cov-2 outside of Wuhan related to a house-warming banquet (edit) |
10.1016/J.JINF.2020.03.034 |
| 2020-04-10 |
Household Transmission of SARS-CoV-2 (edit) |
10.1016/J.JINF.2020.03.040 |
| 2020-04-10 |
Re: Profile of Specific Antibodies to SARS-CoV-2: The First Report (edit) |
10.1016/J.JINF.2020.03.052 |
| 2020-04-10 |
Serological immunochromatographic approach in diagnosis with SARS-CoV-2 infected COVID-19 patients (edit) |
10.1016/J.JINF.2020.03.051 |
| 2020-04-10 |
Arbidol monotherapy is superior to lopinavir/ritonavir in treating COVID-19 (edit) |
10.1016/J.JINF.2020.03.060 |
| 2020-04-10 |
Evolutionary analysis of SARS-CoV-2: how mutation of Non-Structural Protein 6 (NSP6) could affect viral autophagy (edit) |
10.1016/J.JINF.2020.03.058 |
| 2020-04-10 |
High-resolution computed tomographic imaging disclosing COVID-19 pneumonia: a powerful tool in diagnosis (edit) |
10.1016/J.JINF.2020.03.047 |
| 2020-04-10 |
Dynamics of faecal SARS-CoV-2 in infected children during the convalescent phase (edit) |
10.1016/J.JINF.2020.03.049 |
| 2020-04-10 |
Nosocomial SARS-CoV-2 infection among nurses in Wuhan at a single centre (edit) |
10.1016/J.JINF.2020.03.036 |
| 2020-04-10 |
Effect of regular intravenous immunoglobulin therapy on prognosis of severe pneumonia in patients with COVID-19 (edit) |
10.1016/J.JINF.2020.03.044 |
| 2020-04-10 |
Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis (edit) |
10.1016/J.JINF.2020.03.041 |
| 2020-04-10 |
Imported COVID-19 Cases Pose New Challenges for China (edit) |
10.1016/J.JINF.2020.03.048 |
| 2020-04-10 |
Arterial hypertension and risk of death in patients with COVID-19 infection: systematic review and meta-analysis (edit) |
10.1016/J.JINF.2020.03.059 |
| 2020-04-10 |
Lymphocyte subset (CD4+, CD8+) counts reflect the severity of infection and predict the clinical outcomes in patients with COVID-19 (edit) |
10.1016/J.JINF.2020.03.054 |
| 2020-04-10 |
Duration for carrying SARS-CoV-2 in COVID-19 patients (edit) |
10.1016/J.JINF.2020.03.053 |
| 2020-04-10 |
Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19 (edit) |
10.1016/J.JINF.2020.04.002 |
| 2020-04-10 |
A potential inhibitory role for integrin in the receptor targeting of SARS-CoV-2 (edit) |
10.1016/J.JINF.2020.03.046 |
| 2020-04-10 |
Coronavirus (COVID-19), First Indication of Efficacy of Gene-Eden-VIR/Novirin in SARS-CoV-2 Infections (edit) |
10.1016/J.IJANTIMICAG.2020.105971 |
| 2020-04-10 |
COVID-19 in a tertiary hospital from Romania: Epidemiology, preparedness and clinical challenges (edit) |
10.1016/J.TMAID.2020.101662 |
| 2020-04-10 |
Rapid Implementation of Inpatient Telepalliative Medicine Consultations during COVID-19 Pandemic (edit) |
10.1016/J.JPAINSYMMAN.2020.04.001 |
| 2020-04-10 |
A comparison of burnout frequency among oncology physicians and nurses working on the front lines and usual wards during the COVID-19 epidemic in Wuhan, China (edit) |
10.1016/J.JPAINSYMMAN.2020.04.008 |
| 2020-04-10 |
Plausibility of therapeutic effects of Rho kinase inhibitors against Severe Acute Respiratory Syndrome Coronavirus 2 (COVID-19) (edit) |
10.1016/J.PHRS.2020.104808 |
| 2020-04-10 |
A Dermatologic Manifestation of COVID-19: Transient Livedo Reticularis (edit) |
10.1016/J.JAAD.2020.04.018 |
| 2020-04-10 |
Adalimumab for Treatment of Hidradenitis Suppurativa During the COVID-19 Pandemic: Safety Considerations (edit) |
10.1016/J.JAAD.2020.04.030 |
| 2020-04-10 |
Reply to "COVID-19, syphilis and biologic therapies for psoriasis and psoriatic arthritis: A word of caution" (edit) |
10.1016/J.JAAD.2020.03.103 |
| 2020-04-10 |
Reply to "COVID-19 can present with a rash and be mistaken for Dengue": Petechial rash in a patient with COVID-19 infection (edit) |
10.1016/J.JAAD.2020.04.016 |
| 2020-04-10 |
Biologics for psoriasis during COVID-19 outbreak (edit) |
10.1016/J.JAAD.2020.04.004 |
| 2020-04-10 |
Various forms of skin rash in COVID-19 : a reply (edit) |
10.1016/J.JAAD.2020.04.035 |
| 2020-04-10 |
Does Hydroxychloroquine Combat COVID-19? A Timeline of Evidence (edit) |
10.1016/J.JAAD.2020.04.031 |
| 2020-04-10 |
Hydroxychloroquine and ivermectin: a synergistic combination for COVID-19 chemoprophylaxis and/or treatment? (edit) |
10.1016/J.JAAD.2020.04.017 |
| 2020-04-10 |
Optimizing Teledermatology Visits for Dermatology Resident Education During the COVID-19 Pandemic (edit) |
10.1016/J.JAAD.2020.03.097 |
| 2020-04-10 |
Back to the Basics: Diluted Bleach for COVID-19 (edit) |
10.1016/J.JAAD.2020.04.033 |
| 2020-04-10 |
Reply to: "Biologics for psoriasis during COVID-19 outbreak" (edit) |
10.1016/J.JAAD.2020.04.014 |
| 2020-04-10 |
Recommendations on dermatologic surgery during the COVID-19 pandemic (edit) |
10.1016/J.JAAD.2020.04.034 |
| 2020-04-10 |
Treatment considerations for patients with pemphigus during the COVID-19 pandemic (edit) |
10.1016/J.JAAD.2020.04.005 |
| 2020-04-10 |
SARS-COV-2 infection is likely to be androgen mediated (edit) |
10.1016/J.JAAD.2020.04.032 |
| 2020-04-10 |
Novel Approach to Reduce Transmission of COVID-19 During Tracheostomy (edit) |
10.1016/J.JAMCOLLSURG.2020.04.014 |
| 2020-04-10 |
Surgeons, Ethics, and COVID-19: Early Lessons Learned (edit) |
10.1016/J.JAMCOLLSURG.2020.03.028 |
| 2020-04-10 |
Positive effects of COVID-19 control measures on influenza prevention (edit) |
10.1016/J.IJID.2020.04.009 |
| 2020-04-10 |
Adoption of personal protective measures by ordinary citizens during the COVID-19 outbreak in Japan (edit) |
10.1016/J.IJID.2020.04.014 |
| 2020-04-10 |
Google searches for the keywords of "wash hands" predict the speed of national spread of COVID-19 outbreak among 21 countries (edit) |
10.1016/J.BBI.2020.04.020 |
| 2020-04-10 |
Encephalitis as a clinical manifestation of COVID-19 (edit) |
10.1016/J.BBI.2020.04.017 |
| 2020-04-10 |
COVID-19 or Lung Cancer: what should we treat? (edit) |
10.1016/J.JTHO.2020.04.001 |
| 2020-04-10 |
COVID-19 - Considerations for the paediatric rheumatologist (edit) |
10.1016/J.CLIM.2020.108420 |
| 2020-04-10 |
Clinical Features of COVID-19-Related Liver Damage (edit) |
10.1016/J.CGH.2020.04.002 |
| 2020-04-10 |
The Use of Nonsteroidal Anti-inflammatory Drugs in Urological Practice in the COVID-19 Era: Is "Safe Better than Sorry"? (edit) |
10.1016/J.EURURO.2020.03.033 |
| 2020-04-10 |
COVID-19 Research in Brief: 4 April to 10 April, 2020 (edit) |
10.1038/D41591-020-00009-X |
| 2020-04-10 |
Coronavirus (COVID-19):: Persoonlijke beschermingsmiddelen voor medisch personeel (edit) |
10.1007/S12498-020-0733-Z |
| 2020-04-10 |
Is Sub-Saharan Africa prepared for COVID-19? (edit) |
10.1186/S41182-020-00206-X |
| 2020-04-10 |
Reflections on COVID-19 (edit) |
10.1016/J.JOGN.2020.04.002 |
| 2020-04-10 |
Molecular Mechanism of Evolution and Human Infection with SARS-CoV-2 (edit) |
10.3390/V12040428 |
| 2020-04-10 |
A Review of SARS-CoV-2 and the Ongoing Clinical Trials (edit) |
10.3390/IJMS21072657 |
| 2020-04-10 |
COVID-19: A Brief Overview of the Discovery Clinical Trial (edit) |
10.3390/PH13040065 |
| 2020-04-10 |
Clinical and epidemiologic profile of the initial COVID-19 patients at a tertiary care centre in India (edit) |
10.4081/MONALDI.2020.1294 |
| 2020-04-10 |
Incidence of thrombotic complications in critically ill ICU patients with COVID-19 (edit) |
10.1016/J.THROMRES.2020.04.013 |
| 2020-04-10 |
Social media and telemedicine for oral diagnosis and counselling in the COVID-19 era (edit) |
10.1016/J.ORALONCOLOGY.2020.104685 |
| 2020-04-10 |
SARS-CoV-2-encoded nucleocapsid protein acts as a viral suppressor of RNA interference in cells (edit) |
10.1007/S11427-020-1692-1 |
| 2020-04-10 |
[Distributions of time, place, and population of novel coronavirus disease 2019 (COVID-19) from January 20 to February 10, 2020, in China] (edit) |
10.1016/J.RCE.2020.04.001 |
| 2020-04-10 |
[Controversy regarding ACE inhibitors / ARBs in Covid-19] (edit) |
10.1016/J.RECESP.2020.03.014 |
| 2020-04-10 |
[Fulminant myocarditis due to COVID-19] (edit) |
10.1016/J.RECESP.2020.04.001 |
| 2020-04-10 |
The Heart in COVID19: Primary Target or Secondary Bystander? (edit) |
10.1016/J.JACBTS.2020.04.001 |
| 2020-04-10 |
COVID-19 for the Cardiologist: A Current Review of the Virology, Clinical Epidemiology, Cardiac and Other Clinical Manifestations and Potential Therapeutic Strategies (edit) |
10.1016/J.JACBTS.2020.04.002 |
| 2020-04-10 |
Exploring Personal Protection During High-Risk PCI in a COVID-19 Patient: Impella CP Mechanical Support During ULMCA Bifurcation Stenting (edit) |
10.1016/J.JACCAS.2020.03.006 |
| 2020-04-10 |
The Novel Coronavirus Disease (COVID-19) Threat for Patients with Cardiovascular Disease and Cancer (edit) |
10.1016/J.JACCAO.2020.03.001 |
| 2020-04-10 |
Oncology in the Time of COVID-19 (edit) |
|
| 2020-04-10 |
Ventilation-Perfusion Scans During the Coronavirus Disease 2019 (COVID-19) Outbreak (edit) |
10.1016/J.JACR.2020.03.017 |
| 2020-04-10 |
Airborne transmission of SARS-CoV-2: The world should face the reality (edit) |
10.1016/J.ENVINT.2020.105730 |
| 2020-04-10 |
The Role of YouTube and the Entertainment Industry in Saving Lives by Educating and Mobilizing the Public to Adopt Behaviors for Community Mitigation of COVID-19: Successive Sampling Design Study (edit) |
10.2196/19145 |
| 2020-04-10 |
Correlation Between Relative Nasopharyngeal Virus RNA Load and Lymphocyte Count Disease Severity in Patients with COVID-19 (edit) |
10.1089/VIM.2020.0062 |
| 2020-04-10 |
Clinical characteristics of 225 patients with COVID-19 in a tertiary Hospital near Wuhan, China (edit) |
10.1016/J.JCV.2020.104363 |
| 2020-04-10 |
Epidemiological characteristics and clinical features of 32 critical and 67 noncritical cases of COVID-19 in Chengdu (edit) |
10.1016/J.JCV.2020.104366 |
| 2020-04-10 |
Clinical characteristics and risk assessment of newborns born to mothers with COVID-19 (edit) |
10.1016/J.JCV.2020.104356 |
| 2020-04-10 |
Consistency analysis of COVID-19 nucleic acid tests and the changes of lung CT (edit) |
10.1016/J.JCV.2020.104359 |
| 2020-04-10 |
COVID 19: Impact of lock-down on mental health and tips to overcome (edit) |
10.1016/J.AJP.2020.102088 |
| 2020-04-10 |
The Need of Research Initiatives Amidst and After the Covid-19 Pandemic: A Message from the Editors of the European Journal of Vascular and Endovascular Surgery (edit) |
10.1016/J.EJVS.2020.04.002 |
| 2020-04-10 |
Acute pulmonary embolism in a patient with COVID-19 pneumonia (edit) |
10.1016/J.DIII.2020.04.001 |
| 2020-04-10 |
Recommendations for protecting against and mitigating the COVID-19 pandemic in long-term care facilities (edit) |
10.1016/J.JMII.2020.04.003 |
| 2020-04-10 |
Challenges of Convalescent Plasma Therapy on COVID-19 (edit) |
10.1016/J.JCV.2020.104358 |
| 2020-04-10 |
COVID-19 pandemic and addiction: Current problems and future concerns (edit) |
10.1016/J.AJP.2020.102064 |
| 2020-04-10 |
Homeless mentally ill people and COVID-19 pandemic: The two-way sword for LMICs (edit) |
10.1016/J.AJP.2020.102067 |
| 2020-04-10 |
Adult cardiac surgery during the COVID-19 Pandemic: A Tiered Patient Triage Guidance Statement (edit) |
10.1016/J.ATHORACSUR.2020.04.003 |
| 2020-04-10 |
Cardiovascular and Logistic Issues Associated With COVID-19 Pandemic (edit) |
10.1016/J.HLC.2020.03.014 |
| 2020-04-10 |
The Italian Outbreak of COVID-19: Conditions, Contributors, and Concerns (edit) |
10.1016/J.MAYOCP.2020.04.003 |
| 2020-04-10 |
Preparedness for COVID-19: in situ simulation to enhance infection control systems in the intensive care unit (edit) |
10.1016/J.BJA.2020.04.001 |
| 2020-04-10 |
Audiological profile of asymptomatic Covid-19 PCR-positive cases (edit) |
10.1016/J.AMJOTO.2020.102483 |
| 2020-04-10 |
COVID-19 admissions calculators: General population and paediatric cohort (edit) |
10.1016/J.EARLHUMDEV.2020.105043 |
| 2020-04-10 |
Fibreoptic tracheal intubation in COVID-19: not so fast (edit) |
10.1016/J.BJA.2020.04.005 |
| 2020-04-10 |
Academic Radiology Departmental Operational Strategy Related to the Coronavirus Disease 2019 (COVID-19) Pandemic (edit) |
10.1016/J.JACR.2020.04.004 |
| 2020-04-10 |
Re: Ventilation-Perfusion Scans During the Coronavirus Disease 2019 (COVID-19) Outbreak (edit) |
10.1016/J.JACR.2020.03.028 |
| 2020-04-10 |
Seven discharged patients turning positive again for SARS-CoV-2 on quantitative RT-PCR (edit) |
10.1016/J.AJIC.2020.03.017 |
| 2020-04-10 |
Further Evidence of a Possible Correlation Between the Severity of Covid-19 and BCG Immunization (edit) |
10.1101/2020.04.07.20056994 |
| 2020-04-10 |
Safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide-spread use for COVID-19: a multinational, network cohort and self-controlled case series study (edit) |
10.1101/2020.04.08.20054551 |
| 2020-04-10 |
Recommendations for a safety dental care management during SARS-CoV-2 pandemic (edit) |
10.26633/RPSP.2020.51 |
| 2020-04-10 |
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) envelope (E) protein harbors a conserved BH3-like sequence (edit) |
10.1101/2020.04.09.033522 |
| 2020-04-10 |
Relative Abundance of SARS-CoV-2 Entry Genes in the Enterocytes of the Lower Gastrointestinal Tract (edit) |
10.1101/2020.04.08.033001 |
| 2020-04-10 |
Vulnerabilities of the SARS-CoV-2 virus to proteotoxicity – opportunity for repurposed chemotherapy of COVID-19 infection (edit) |
10.1101/2020.04.07.029488 |
| 2020-04-10 |
Protocol for a multicentre study of nosocomial SARS-CoV2 transmission The NOSO-COR Project (edit) |
10.1101/2020.04.08.20057471 |
| 2020-04-10 |
SARS-CoV-2 might manipulate against its host the immunity RNAi/Dicer/Ago system (edit) |
10.1101/2020.04.08.031856 |
| 2020-04-10 |
The spatial and cell-type distribution of SARS-CoV-2 receptor ACE2 in human and mouse brain (edit) |
10.1101/2020.04.07.030650 |
| 2020-04-10 |
Spatial modeling cannot currently differentiate SARS-CoV-2 coronavirus and human distributions on the basis of climate in the United States (edit) |
10.1101/2020.04.08.20057281 |
| 2020-04-10 |
Gene expression and in situ protein profiling of candidate SARS-CoV-2 receptors in human airway epithelial cells and lung tissue (edit) |
10.1101/2020.04.07.030742 |
| 2020-04-10 |
Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug Carmofur (edit) |
10.1101/2020.04.09.033233 |
| 2020-04-10 |
Robust neutralization assay based on SARS-CoV-2 S-bearing vesicular stomatitis virus (VSV) pseudovirus and ACE2-overexpressed BHK21 cells (edit) |
10.1101/2020.04.08.026948 |
| 2020-04-10 |
Variation in False Negative Rate of RT-PCR Based SARS-CoV-2 Tests by Time Since Exposure (edit) |
10.1101/2020.04.07.20051474 |
| 2020-04-10 |
Room-temperature-storable PCR Mixes for SARS-CoV-2 Detection (edit) |
10.1101/2020.04.07.029934 |
| 2020-04-10 |
The aging transcriptome and cellular landscape of the human lung in relation to SARS-CoV-2 (edit) |
10.1101/2020.04.07.030684 |
| 2020-04-10 |
Analysis of the SARS-CoV-2 spike protein glycan shield: implications for immune recognition (edit) |
10.1101/2020.04.07.030445 |
| 2020-04-10 |
Optimization of SARS-CoV-2 detection by RT-QPCR without RNA extraction (edit) |
10.1101/2020.04.06.028902 |
| 2020-04-10 |
Characterizing geographical and temporal dynamics of novel coronavirus SARS-CoV-2 using informative subtype markers (edit) |
10.1101/2020.04.07.030759 |
| 2020-04-10 |
Decoding the lethal effect of SARS-CoV-2 (novel coronavirus) strains from global perspective: molecular pathogenesis and evolutionary divergence (edit) |
10.1101/2020.04.06.027854 |
| 2020-04-10 |
Structural Basis for the Inhibition of the RNA-Dependent RNA Polymerase from SARS-CoV-2 by Remdesivir (edit) |
10.1101/2020.04.08.032763 |
| 2020-04-10 |
Immunoglobulin fragment F(ab’)2 against RBD potently neutralizes SARS-CoV-2 in vitro (edit) |
10.1101/2020.04.07.029884 |
| 2020-04-09 |
¿SARS-CoV-2 de Humanos a Animales? ¿Nueva amenaza de zoonosis? (edit) |
10.35839/REPIS.4.2.714 |
| 2020-04-09 |
Structure of Mpro from COVID-19 virus and discovery of its inhibitors (edit) |
10.1038/S41586-020-2223-Y |
| 2020-04-09 |
Role of anaesthesiologists during the coronavirus disease 2019 outbreak in China (edit) |
10.1016/J.BJA.2020.03.022 |
| 2020-04-09 |
Is Regional Anesthesia Safe Enough in Suspected or Confirmed COVID-19 Patients? (edit) |
10.1021/ACSCHEMNEURO.0C00146 |
| 2020-04-09 |
The COVID-19 vaccine development landscape (edit) |
10.1038/D41573-020-00073-5 |
| 2020-04-09 |
Coronavirus SARS-CoV-2: filtering fact from fiction in the infodemic: Q&A with virologist Professor Urs Greber (edit) |
10.1002/1873-3468.13784 |
| 2020-04-09 |
Dentists' Awareness, Perception, and Attitude Regarding COVID-19 and Infection Control: Cross-Sectional Study Among Jordanian Dentists (edit) |
10.2196/18798 |
| 2020-04-09 |
Misinformation of COVID-19 on the Internet: Infodemiology Study (edit) |
10.2196/18444 |
| 2020-04-09 |
COVID-19 pandemic: stop panic abandonment of household pets (edit) |
10.1093/JTM/TAAA046 |
| 2020-04-09 |
Keep Taking Your ACE Inhibitors and ARBs During the COVID 19 Pandemic (edit) |
10.1093/JTM/TAAA045 |
| 2020-04-09 |
COVID-19, Australia: Epidemiology Report 10 (Reporting week to 23:59 AEST 5 April 2020) (edit) |
10.33321/CDI.2020.44.30 |
| 2020-04-09 |
Level of under-reporting including under-diagnosis before the first peak of COVID-19 in various countries: Preliminary Retrospective Results Based on Wavelets and Deterministic Modeling (edit) |
10.1017/ICE.2020.116 |
| 2020-04-09 |
Just the Facts: Recommendations on Point of Care Ultrasound Use and Machine Infection Control During the COVID-19 Pandemic (edit) |
10.1017/CEM.2020.364 |
| 2020-04-09 |
Resource Allocation and Decision Making for Pediatric and Congenital Cardiac Catheterization During the Novel Coronavirus SARS-CoV-2 (COVID-19) Pandemic: A U.S. Multi-Institutional Perspective (edit) |
|
| 2020-04-09 |
Early virus clearance and delayed antibody response in a case of COVID-19 with a history of co-infection with HIV-1 and HCV (edit) |
10.1093/CID/CIAA408 |
| 2020-04-09 |
Comparative replication and immune activation profiles of SARS-CoV-2 and SARS-CoV in human lungs: an ex vivo study with implications for the pathogenesis of COVID-19 (edit) |
10.1093/CID/CIAA410 |
| 2020-04-09 |
Treating head and neck tumors during the SARS-CoV-2 epidemic, 2019-2020: Sichuan Cancer Hospital (edit) |
10.1002/HED.26161 |
| 2020-04-09 |
Improving staff safety during tracheostomy in COVID-19 patients (edit) |
10.1002/HED.26163 |
| 2020-04-09 |
COVID-19 pandemic: Effects and evidence-based recommendations for otolaryngology and head and neck surgery practice (edit) |
10.1002/HED.26164 |
| 2020-04-09 |
Interim Guidance for Basic and Advanced Life Support in Adults, Children, and Neonates With Suspected or Confirmed COVID-19: From the Emergency Cardiovascular Care Committee and Get With the Guidelines®-Resuscitation Adult and Pediatric Task Forces (edit) |
10.1161/CIRCULATIONAHA.120.047463 |
| 2020-04-09 |
Physical inactivity and cardiovascular disease at the time of coronavirus disease 2019 (COVID-19) (edit) |
10.1177/2047487320916823 |
| 2020-04-09 |
Coronavirus-19 Disease (COVID-19) and Decrease in Blood Donation: Experience of Iranian Blood Transfusion Organization (IBTO) (edit) |
10.1111/VOX.12930 |
| 2020-04-09 |
False-negative of RT-PCR and prolonged nucleic acid conversion in COVID-19: Rather than recurrence (edit) |
10.1002/JMV.25855 |
| 2020-04-09 |
Role of Nonstructural Proteins in the Pathogenesis of SARS-CoV-2 (edit) |
10.1002/JMV.25858 |
| 2020-04-09 |
Stand Together and Deliver: Challenges and Opportunities for Rheumatology Education During the COVID19 Pandemic (edit) |
10.1002/ART.41278 |
| 2020-04-09 |
COVID-19, or the triumph of monogamy? (edit) |
10.23736/S0391-1977.20.03207-1 |
| 2020-04-09 |
Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission (edit) |
10.1093/CID/CIAA415 |
| 2020-04-09 |
Prediction for Progression Risk in Patients with COVID-19 Pneumonia: the CALL Score (edit) |
10.1093/CID/CIAA414 |
| 2020-04-09 |
Predictors of refractory Coronavirus disease (COVID-19) pneumonia (edit) |
10.1093/CID/CIAA409 |
| 2020-04-09 |
Factors associated with prolonged viral RNA shedding in patients with COVID-19 (edit) |
10.1093/CID/CIAA351 |
| 2020-04-09 |
Impact of the COVID-19 Pandemic on the Urologist's clinical practice in Brazil: a management guideline proposal for low- and middle-income countries during the crisis period (edit) |
10.1590/S1677-5538.IBJU.2020.04.03 |
| 2020-04-09 |
COVID-19 Exposes the Cracks in Our Already Fragile Mental Health System (edit) |
10.2105/AJPH.2020.305699 |
| 2020-04-09 |
Cardiopulmonary Resuscitation During the COVID-19 Pandemic: A View from Trainees on the Frontline (edit) |
10.1161/CIRCULATIONAHA.120.047260 |
| 2020-04-09 |
Will Complement Inhibition be the New Target in Treating COVID-19 Related Systemic Thrombosis? (edit) |
10.1161/CIRCULATIONAHA.120.047419 |
| 2020-04-09 |
Self-Isolation Compliance In The COVID-19 Era Influenced By Compensation: Findings From A Recent Survey In Israel (edit) |
10.1377/HLTHAFF.2020.00382 |
| 2020-04-09 |
Salivary Glands: Potential Reservoirs for COVID-19 Asymptomatic Infection (edit) |
10.1177/0022034520918518 |
| 2020-04-09 |
Awareness, Attitudes, and Actions Related to COVID-19 Among Adults With Chronic Conditions at the Onset of the U.S. Outbreak: A Cross-sectional Survey (edit) |
10.7326/M20-1239 |
| 2020-04-09 |
Generalizability of COVID-19 Clinical Prediction Models (edit) |
10.1093/CID/CIAA417 |
| 2020-04-09 |
Food Safety and COVID-19 (edit) |
10.1001/JAMA.2020.5877 |
| 2020-04-09 |
Annals On Call - COVID-19: Is Chloroquine the Answer? (edit) |
10.7326/A20-0003 |
| 2020-04-09 |
Ensuring Access to Medications in the US During the COVID-19 Pandemic (edit) |
10.1001/JAMA.2020.6016 |
| 2020-04-09 |
Response of a European surgical department to the COVID-19 crisis (edit) |
10.4414/SMW.2020.20241 |
| 2020-04-09 |
Delivery in pregnant women infected with SARS-CoV-2: A fast review (edit) |
10.1002/IJGO.13166 |
| 2020-04-09 |
Commentary: Challenges for PhD students during COVID-19 pandemic: Turning crisis into an opportunity (edit) |
10.1002/BMB.21351 |
| 2020-04-09 |
High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation (edit) |
10.1002/OBY.22831 |
| 2020-04-09 |
Abortion during the Covid-19 Pandemic - Ensuring Access to an Essential Health Service (edit) |
10.1056/NEJMP2008006 |
| 2020-04-09 |
Disease Control, Civil Liberties, and Mass Testing - Calibrating Restrictions during the Covid-19 Pandemic (edit) |
10.1056/NEJMP2007637 |
| 2020-04-09 |
Pediatric Endocrinology in the Time of the COVID-19 Pandemic (edit) |
10.1159/000507703 |
| 2020-04-09 |
Mental Health and Psychosocial Problems of Medical Health Workers during the COVID-19 Epidemic in China (edit) |
10.1159/000507639 |
| 2020-04-09 |
COVID-19 the showdown for mass casualty preparedness and management: the Cassandra Syndrome (edit) |
10.1186/S13017-020-00304-5 |
| 2020-04-09 |
Covid-19: Staff at Nightingale Hospital in London get wellbeing area courtesy of John Lewis (edit) |
10.1136/BMJ.M1451 |
| 2020-04-09 |
Clinicians are leading service reconfiguration to cope with covid-19 (edit) |
10.1136/BMJ.M1444 |
| 2020-04-09 |
Face masks for the public during the covid-19 crisis (edit) |
10.1136/BMJ.M1435 |
| 2020-04-09 |
Covid-19: should the public wear face masks? (edit) |
10.1136/BMJ.M1442 |
| 2020-04-09 |
Covid-19: Doctors and nurses donate samples to study disease (edit) |
10.1136/BMJ.M1446 |
| 2020-04-09 |
Covid-19: Quarantine works when introduced early alongside other measures, finds review (edit) |
10.1136/BMJ.M1450 |
| 2020-04-09 |
COVID-19 and the gastrointestinal tract: more than meets the eye (edit) |
10.1136/GUTJNL-2020-321195 |
| 2020-04-09 |
Self-screening to reduce medical resource consumptions facing the COVID-19 pandemic (edit) |
10.1136/EMERMED-2020-209647 |
| 2020-04-09 |
COVID-19: community CPAP and NIV should be stopped unless medically necessary to support life (edit) |
10.1136/THORAXJNL-2020-214890 |
| 2020-04-09 |
Case for continuing community NIV and CPAP during the COVID-19 epidemic (edit) |
10.1136/THORAXJNL-2020-214913 |
| 2020-04-09 |
Covid-19: Japan declares state of emergency as Tokyo cases soar (edit) |
10.1136/BMJ.M1447 |
| 2020-04-09 |
Impact of COVID-19 on Children and Pediatricians (edit) |
|
| 2020-04-09 |
Serial Computed Tomography Manifestations in a Child with Coronavirus Disease (COVID-19) Pneumonia (edit) |
|
| 2020-04-09 |
When COVID-19 meets centralized, personalized power (edit) |
10.1038/S41562-020-0872-3 |
| 2020-04-09 |
Kidney involvement in COVID-19 and rationale for extracorporeal therapies (edit) |
10.1038/S41581-020-0284-7 |
| 2020-04-09 |
COVID-19: immunopathology and its implications for therapy (edit) |
10.1038/S41577-020-0308-3 |
| 2020-04-09 |
Lopinavir-ritonavir in severe COVID-19 (edit) |
10.1038/S41591-020-0849-9 |
| 2020-04-09 |
Clinical and epidemiological characteristics of children with COVID-19 (edit) |
10.1038/S41591-020-0846-Z |
| 2020-04-09 |
Spread of SARS-CoV-2 (edit) |
10.1038/S41591-020-0850-3 |
| 2020-04-09 |
Virological assessment of SARS-CoV-2 (edit) |
10.1038/S41591-020-0848-X |
| 2020-04-09 |
If the world fails to protect the economy, COVID-19 will damage health not just now but also in the future (edit) |
10.1038/S41591-020-0863-Y |
| 2020-04-09 |
A framework for identifying regional outbreak and spread of COVID-19 from one-minute population-wide surveys (edit) |
10.1038/S41591-020-0857-9 |
| 2020-04-09 |
Inhibitors of the renin-angiotensin system and SARS-CoV-2 infection (edit) |
10.1007/S00059-020-04920-4 |
| 2020-04-09 |
Inpatient and outpatient case prioritization for patients with neuro-oncologic disease amid the COVID-19 pandemic: general guidance for neuro-oncology practitioners from the AANS/CNS Tumor Section and Society for Neuro-Oncology (edit) |
10.1007/S11060-020-03488-7 |
| 2020-04-09 |
SARS-CoV-2 and Europe: timing of containment measures for outbreak control (edit) |
10.1007/S15010-020-01420-9 |
| 2020-04-09 |
Operating Room Guide for Confirmed or Suspected COVID-19 Pregnant Patients Requiring Cesarean Delivery (edit) |
10.1055/S-0040-1709683 |
| 2020-04-09 |
Corticosteroid Guidance for Pregnancy during COVID-19 Pandemic (edit) |
10.1055/S-0040-1709684 |
| 2020-04-09 |
[SARS CoV-2/COVID-19: Evidence-Based Recommendation on Diagnosis and Therapy] (edit) |
10.1055/A-1146-8674 |
| 2020-04-09 |
[Obstetric Anesthesia During the SARS-CoV-2 Pandemic - a Brief Overview of Published Recommendations for Action by National and International Specialist Societies and Committees] (edit) |
10.1055/A-1144-5562 |
| 2020-04-09 |
Chirurgische Aspekte zur Tracheostomie bei Covid-19 positiven Patienten – Stellungnahme im Auftrag der Deutschen Gesellschaft für HNO-Heilkunde, Kopf- und Halschirurgie (DGHNO-KHC) und der AG Laryngologie & Trachealerkrankungen (edit) |
10.1055/A-1151-7932 |
| 2020-04-09 |
[COVID-19 Crisis: Early Observations on a Pandemic's Psychiatric Problems] (edit) |
10.1055/A-1147-2889 |
| 2020-04-09 |
Slowdown of urology residents' learning curve during COVID-19 emergency (edit) |
10.1111/BJU.15076 |
| 2020-04-09 |
An Urgent Need for "Common Cold Units" to Study Novel Coronavirus Disease (COVID-19) (edit) |
10.4269/AJTMH.20-0246 |
| 2020-04-09 |
Whose life to save? Scarce resources allocation in the COVID-19 outbreak (edit) |
10.1136/MEDETHICS-2020-106227 |
| 2020-04-09 |
A Spanish-translated clinical algorithm for management of suspected SARS-CoV-2 infection in pregnant women (edit) |
10.1016/S1473-3099(20)30285-1 |
| 2020-04-09 |
Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19 (edit) |
10.1016/S2352-3026(20)30109-5 |
| 2020-04-09 |
Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed (edit) |
10.1016/S0140-6736(20)30858-8 |
| 2020-04-09 |
COVID-19 and risks to the supply and quality of tests, drugs, and vaccines (edit) |
10.1016/S2214-109X(20)30136-4 |
| 2020-04-09 |
Delayed access or provision of care in Italy resulting from fear of COVID-19 (edit) |
10.1016/S2352-4642(20)30108-5 |
| 2020-04-09 |
COVID-19 in long-term liver transplant patients: preliminary experience from an Italian transplant centre in Lombardy (edit) |
10.1016/S2468-1253(20)30116-3 |
| 2020-04-09 |
COVID-19: Respiratory support outside the intensive care unit (edit) |
10.1016/S2213-2600(20)30176-4 |
| 2020-04-09 |
Challenges in lung cancer therapy during the COVID-19 pandemic (edit) |
10.1016/S2213-2600(20)30170-3 |
| 2020-04-09 |
SARS-Cov-2 in Spanish Intensive Care: Early Experience with 15-day Survival In Vitoria (edit) |
10.1016/J.ACCPM.2020.04.001 |
| 2020-04-09 |
In silico studies on therapeutic agents for COVID-19: Drug repurposing approach (edit) |
10.1016/J.LFS.2020.117652 |
| 2020-04-09 |
Knowledge, attitude and practice regarding COVID-19 among health care workers in Henan, China (edit) |
10.1016/J.JHIN.2020.04.012 |
| 2020-04-09 |
Preventing the Transmission of COVID-19 Amongst Healthcare Workers (edit) |
10.1016/J.JHIN.2020.04.008 |
| 2020-04-09 |
Body Temperature Measurement to Prevent Pandemic COVID-19 in Hospitals in Taiwan: Repeated Measurement is Necessary (edit) |
10.1016/J.JHIN.2020.04.004 |
| 2020-04-09 |
Medically-Necessary, Time-Sensitive Procedures: A Scoring System to Ethically and Efficiently Manage Resource Scarcity and Provider Risk During the COVID-19 Pandemic (edit) |
10.1016/J.JAMCOLLSURG.2020.04.011 |
| 2020-04-09 |
Rapid Response of an Academic Surgical Department to the COVID-19 Pandemic: Implications for Patients, Surgeons, and the Community (edit) |
10.1016/J.JAMCOLLSURG.2020.04.007 |
| 2020-04-09 |
Ethical Rationing of Personal Protective Equipment to Minimize Moral Residue During the COVID-19 Pandemic (edit) |
10.1016/J.JAMCOLLSURG.2020.03.031 |
| 2020-04-09 |
Ethics in the Time of Coronavirus: Recommendations in the COVID-19 Pandemic (edit) |
10.1016/J.JAMCOLLSURG.2020.04.004 |
| 2020-04-09 |
Surgical Response to COVID-19 Pandemic: A Singapore Perspective (edit) |
10.1016/J.JAMCOLLSURG.2020.04.003 |
| 2020-04-09 |
Ongoing Lessons During the COVID-19 Pandemic (edit) |
10.1016/J.JAMCOLLSURG.2020.04.005 |
| 2020-04-09 |
COVID-19 and dengue fever: A dangerous combination for the health system in Brazil (edit) |
10.1016/J.TMAID.2020.101659 |
| 2020-04-09 |
COVID-19: Travel health and the implications for sub -Saharan Africa (edit) |
10.1016/J.TMAID.2020.101645 |
| 2020-04-09 |
A cross-sectional comparison of epidemiological and clinical features of patients with coronavirus disease (COVID-19) in Wuhan and outside Wuhan, China (edit) |
10.1016/J.TMAID.2020.101664 |
| 2020-04-09 |
COVID-19 and diabetes: Knowledge in progress (edit) |
10.1016/J.DIABRES.2020.108142 |
| 2020-04-09 |
Creating Dermatology Guidelines for Covid-19: The Pitfalls of Applying Evidence Based Medicine to an Emerging Infectious Disease (edit) |
10.1016/J.JAAD.2020.04.002 |
| 2020-04-09 |
The use of Janus kinase inhibitors in the time of SARS-CoV-2 (edit) |
10.1016/J.JAAD.2020.03.099 |
| 2020-04-09 |
Sexual transmission of SARS-CoV-2: a new possible route of infection? (edit) |
10.1016/J.JAAD.2020.03.098 |
| 2020-04-09 |
Health-Related Quality of Life in Common Variable Immunodeficiency Italian Patients Switched to Remote Assistance During the COVID-19 Pandemic (edit) |
10.1016/J.JAIP.2020.04.003 |
| 2020-04-09 |
French Sarcoma Group proposals for management of sarcoma patients during COVID-19 outbreak (edit) |
10.1016/J.ANNONC.2020.03.308 |
| 2020-04-09 |
Testing for COVID-19 in lung cancer patients (edit) |
10.1016/J.ANNONC.2020.04.002 |
| 2020-04-09 |
COVID-19: Initial experience of an international group of hand surgeons (edit) |
10.1016/J.HANSUR.2020.04.001 |
| 2020-04-09 |
Considerations in the Triage of Urologic Surgeries During the COVID-19 Pandemic (edit) |
10.1016/J.EURURO.2020.03.027 |
| 2020-04-09 |
Human biases and the SARS-CoV-2 pandemic (edit) |
10.1016/J.ICCN.2020.102861 |
| 2020-04-09 |
[Managing patients in dialysis and with kidney transplant infected with Covid-19] (edit) |
|
| 2020-04-09 |
An account of the first hours of the Covid-19 epidemic at the Nephrology Unit in Lodi (Lombardy) (edit) |
|
| 2020-04-09 |
Covid-19 and its impact on nephropathic patients: the experience at Ospedale "Guglielmo da Saliceto" in Piacenza (edit) |
|
| 2020-04-09 |
[Covid-19 in patients on dialysis: infection prevention and control strategies] (edit) |
|
| 2020-04-09 |
One Academic Health System's Early (and Ongoing) Experience Responding to COVID-19: Recommendations From the Initial Epicenter of the Pandemic in the United States (edit) |
10.1097/ACM.0000000000003410 |
| 2020-04-09 |
Provider Burnout and Fatigue During the COVID-19 Pandemic: Lessons Learned from a High-Volume Intensive Care Unit (edit) |
10.1213/ANE.0000000000004866 |
| 2020-04-09 |
Incidental CT Findings Suspicious for Covid-19 Associated Pneumonia on Nuclear Medicine Exams: Recognition and Management Plan (edit) |
10.1097/RLU.0000000000003100 |
| 2020-04-09 |
Rapid COVID-19-related Clinical Adaptations and Unanticipated Risks (edit) |
10.1097/ALN.0000000000003333 |
| 2020-04-09 |
What's Old is New! Similarities Between SARS-CoV-2 and HIV (edit) |
10.1097/JNC.0000000000000174 |
| 2020-04-09 |
Rehospitalization of a Recovered Coronavirus Disease 19 (COVID-19) Child With Positive Nucleic Acid Detection (edit) |
10.1097/INF.0000000000002690 |
| 2020-04-09 |
Considerations for Drug Interactions on QTc in Exploratory COVID-19 (Coronavirus Disease 2019) Treatment (edit) |
10.1016/J.JACC.2020.04.016 |
| 2020-04-09 |
Reduction in ST-Segment Elevation Cardiac Catheterization Laboratory Activations in the United States during COVID-19 Pandemic (edit) |
10.1016/J.JACC.2020.04.011 |
| 2020-04-09 |
COVID-19 as a factor influencing air pollution? (edit) |
10.1016/J.ENVPOL.2020.114466 |
| 2020-04-09 |
COVID-19: From bench to bed side (edit) |
10.1016/J.DSX.2020.04.011 |
| 2020-04-09 |
Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers (edit) |
10.1016/J.DSX.2020.03.016 |
| 2020-04-09 |
scRNA-seq Profiling of Human Testes Reveals the Presence of the ACE2 Receptor, A Target for SARS-CoV-2 Infection in Spermatogonia, Leydig and Sertoli Cells (edit) |
10.3390/CELLS9040920 |
| 2020-04-09 |
Mesenchymal Stromal Cell Secretome for Severe COVID-19 Infections: Premises for the Therapeutic Use (edit) |
10.3390/CELLS9040924 |
| 2020-04-09 |
Top Concerns of Tweeters During the COVID-19 Pandemic: Infoveillance Study (edit) |
10.2196/19016 |
| 2020-04-09 |
Cloud-Based System for Effective Surveillance and Control of COVID-19: Useful Experiences From Hubei, China (edit) |
10.2196/18948 |
| 2020-04-09 |
Covid -19 in der Praxis (edit) |
10.1007/S00060-020-7053-X |
| 2020-04-09 |
An Infectious cDNA Clone of SARS-CoV-2 (edit) |
10.1016/J.CHOM.2020.04.004 |
| 2020-04-09 |
Clinical and surgical consequences of the COVID-19 pandemic for patients with pediatric urological problems: Statement of the EAU guidelines panel for paediatric urology, March 30 2020 (edit) |
10.1016/J.JPUROL.2020.04.007 |
| 2020-04-09 |
Biological and Epidemiological Trends in the Prevalence and Mortality due to Outbreaks of Novel Coronavirus COVID-19 (edit) |
10.1016/J.JKSUS.2020.04.004 |
| 2020-04-09 |
Preventive measures and management of COVID-19 in pregnancy (edit) |
10.1007/S40267-020-00725-X |
| 2020-04-09 |
[Re: "Strategy for the practice of digestive and oncological surgery during the Covid-19 epidemic"] (edit) |
10.1016/J.JCHIRV.2020.04.005 |
| 2020-04-09 |
Southern Italy: How the supply of radiation therapy, patient outcomes, and risk to health care providers have changed during the COVID-19 Pandemic (edit) |
10.1016/J.ADRO.2020.03.016 |
| 2020-04-09 |
Collapsing Glomerulopathy in a Patient With Coronavirus Disease 2019 (COVID-19) (edit) |
10.1016/J.EKIR.2020.04.002 |
| 2020-04-09 |
Pathogenic Priming Likely Contributes to Serious and Critical Illness and Mortality in COVID-19 via Autoimmunity (edit) |
10.1016/J.JTAUTO.2020.100051 |
| 2020-04-09 |
COVID-19 infection among asymptomatic and symptomatic pregnant women: Two weeks of confirmed presentations to an affiliated pair of New York City hospitals (edit) |
10.1016/J.AJOGMF.2020.100118 |
| 2020-04-09 |
Schizophrenia and COVID-19: risks and recommendations (edit) |
10.1590/1516-4446-2020-0010 |
| 2020-04-09 |
Structured thoracic computed tomography report for COVID-19 pandemic (edit) |
10.31744/EINSTEIN_JOURNAL/2020ED5720 |
| 2020-04-09 |
Personality differences and COVID-19: are extroversion and conscientiousness personality traits associated with engagement with containment measures? (edit) |
10.1590/2237-6089-2020-0029 |
| 2020-04-09 |
Presentation of pulmonary infection on CT in COVID-19: initial experience in Brazil (edit) |
10.36416/1806-3756/E20200121 |
| 2020-04-09 |
Nonpharmaceutical interventions for tackling the COVID-19 epidemic in Brazil (edit) |
10.5123/S1679-49742020000200009 |
| 2020-04-09 |
Foot and Ankle Surgery during COVID-19 Pandemic (edit) |
10.1016/J.FAS.2020.04.002 |
| 2020-04-09 |
Three lessons for the COVID-19 response from pandemic HIV (edit) |
10.1016/S2352-3018(20)30110-7 |
| 2020-04-09 |
Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations (edit) |
10.1016/J.DSX.2020.04.004 |
| 2020-04-09 |
Considerations for the Treatment of Oesophageal Cancer With Radiotherapy During the COVID-19 Pandemic (edit) |
10.1016/J.CLON.2020.04.001 |
| 2020-04-09 |
A Pinch of Prevention is Worth a Pound of Cure: Proactive Dentistry in the Wake of COVID-19 (edit) |
10.1016/J.JOMS.2020.03.036 |
| 2020-04-09 |
The Financial Impact of COVID-19 on Our Practice (edit) |
10.1016/J.JOMS.2020.03.045 |
| 2020-04-09 |
Extubation of patients with COVID-19 (edit) |
10.1016/J.BJA.2020.03.016 |
| 2020-04-09 |
Virtual Learning during the COVID-19 Pandemic: A Disruptive Technology in Graduate Medical Education (edit) |
10.1016/J.JACC.2020.04.015 |
| 2020-04-09 |
Adapting the Educational Environment for Cardiovascular Fellows-in-Training During the COVID-19 Pandemic (edit) |
10.1016/J.JACC.2020.04.013 |
| 2020-04-09 |
Impact of meteorological factors on the COVID-19 transmission: A multi-city study in China (edit) |
10.1016/J.SCITOTENV.2020.138513 |
| 2020-04-09 |
Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short-term outcome (edit) |
10.1016/J.JCV.2020.104354 |
| 2020-04-09 |
Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past (edit) |
10.1016/J.JCV.2020.104362 |
| 2020-04-09 |
French consensus regarding precautions during tracheostomy and post-tracheostomy care in the context of COVID-19 pandemic (edit) |
10.1016/J.ANORL.2020.04.006 |
| 2020-04-09 |
Epidemiologic and Clinical Characteristics of 26 Cases of COVID-19 Arising from Patient-to-Patient Transmission in Liaocheng, China (edit) |
10.2147/CLEP.S249903 |
| 2020-04-09 |
Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China (edit) |
10.1016/J.JCV.2020.104364 |
| 2020-04-09 |
Acute stress, behavioural symptoms and mood states among school-age children with attention-deficit/hyperactive disorder during the COVID-19 outbreak (edit) |
10.1016/J.AJP.2020.102077 |
| 2020-04-09 |
Tracking the impact of interventions against COVID-19 in absence of extensive testing (edit) |
10.4103/IJMR.IJMR_864_20 |
| 2020-04-09 |
The fight against COVID-19 and the restoration of trust in Chinese medical professionals (edit) |
10.1016/J.AJP.2020.102072 |
| 2020-04-09 |
A single center observational study of the clinical characteristics and short-term outcome of 20 kidney transplant patients admitted for SARS-CoV2 pneumonia (edit) |
10.1016/J.KINT.2020.04.002 |
| 2020-04-09 |
Absence of SARS-CoV-2 infection in cats and dogs in close contact with a cluster of COVID-19 patients in a veterinary campus (edit) |
10.1101/2020.04.07.029090 |
| 2020-04-09 |
Sequence-based prediction of vaccine targets for inducing T cell responses to SARS-CoV-2 utilizing the bioinformatics predictor RECON (edit) |
10.1101/2020.04.06.027805 |
| 2020-04-09 |
The IMPDH inhibitor merimepodib suppresses SARS-CoV-2 replication in vitro (edit) |
10.1101/2020.04.07.028589 |
| 2020-04-08 |
Effective containment explains sub-exponential growth in confirmed cases of recent COVID-19 outbreak in Mainland China (edit) |
10.1126/SCIENCE.ABB4557 |
| 2020-04-08 |
Letter to the Editor Regarding the Viewpoint "Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanism" (edit) |
10.1021/ACSCHEMNEURO.0C00174 |
| 2020-04-08 |
First impact on services and their preparation. "Instant paper from the field" on rehabilitation answers to the Covid-19 emergency (edit) |
10.23736/S1973-9087.20.06303-0 |
| 2020-04-08 |
Inquiring into Benefits of Independent Activation of Non-Classical Renin-Angiotensin System in the Clinical Prognosis and Reduction of COVID-19 mortality (edit) |
10.1093/CID/CIAA402 |
| 2020-04-08 |
PCR Assays Turned Positive in 25 Discharged COVID-19 Patients (edit) |
10.1093/CID/CIAA398 |
| 2020-04-08 |
Why Only Test Symptomatic Patients? Consider Random Screening for COVID-19 (edit) |
10.1007/S40258-020-00579-4 |
| 2020-04-08 |
Call for Papers: The pathophysiology of COVID-19 and SARS-CoV-2 infection (edit) |
10.1152/AJPLUNG.00136.2020 |
| 2020-04-08 |
ANNALS EXPRESS: Electrolyte Imbalances in Patients with Severe Coronavirus Disease 2019 (COVID-19) (edit) |
10.1177/0004563220922255 |
| 2020-04-08 |
The Lebanese Society of Medical Oncology (LSMO) statement on the care of patients with cancer during the COVID-19 pandemic (edit) |
10.2217/FON-2020-0252 |
| 2020-04-08 |
SECURE-Psoriasis: A de-identified registry of psoriasis patients diagnosed with COVID-19 (edit) |
10.1080/09546634.2020.1753996 |
| 2020-04-08 |
In-silico homology assisted identification of inhibitor of RNA binding against 2019-nCoV N-protein (N terminal domain) (edit) |
10.1080/07391102.2020.1753580 |
| 2020-04-08 |
Targeting SARS-CoV-2: A Systematic Drug Repurposing Approach to Identify Promising Inhibitors Against 3C-like Proteinase and 2'-O-RiboseMethyltransferase (edit) |
10.1080/07391102.2020.1753577 |
| 2020-04-08 |
Inside the heart of COVID-19 (edit) |
10.1093/CVR/CVAA086 |
| 2020-04-08 |
COVID-19 precautions: easier said than done when patients are homeless (edit) |
10.5694/MJA2.50571 |
| 2020-04-08 |
Corticosteroid treatment of patients with coronavirus disease 2019 (COVID-19) (edit) |
10.5694/MJA2.50577 |
| 2020-04-08 |
Analyzing situational awareness through public opinion to predict adoption of social distancing amid pandemic COVID-19 (edit) |
10.1002/JMV.25840 |
| 2020-04-08 |
Reporting of all cardiac medications and their outcome in COVID - 19 (edit) |
10.1002/JMV.25843 |
| 2020-04-08 |
Comment on "Organ-protective Effect of Angiotensin-converting Enzyme 2 and its Effect on the Prognosis of COVID-19" (edit) |
10.1002/JMV.25848 |
| 2020-04-08 |
Reply to Comments on 'Co-infection of SARS-CoV-2 and HIV in a patient in Wuhan city, China' (edit) |
10.1002/JMV.25838 |
| 2020-04-08 |
Patterns of heart Injury in COVID - 19 and relation to outcome (edit) |
10.1002/JMV.25847 |
| 2020-04-08 |
Mask is the possible key for self-isolation in COVID-19 pandemic (edit) |
10.1002/JMV.25846 |
| 2020-04-08 |
Vaso-occlusive Crisis and Acute Chest Syndrome in Sickle Cell Disease due to 2019 Novel Coronavirus Disease (COVID-19) (edit) |
10.1002/AJH.25821 |
| 2020-04-08 |
Special considerations for the management of COVID-19 pediatric patients in the operating room and pediatric intensive care unit in a tertiary hospital in Singapore (edit) |
10.1111/PAN.13863 |
| 2020-04-08 |
IV anakinra for macrophage activation syndrome may hold lessons for treatment of cytokine storm in the setting of COVID19 (edit) |
10.1002/ACR2.11140 |
| 2020-04-08 |
Rapid progression of lung inflammatory infiltrates in SARS-CoV-2 infection in a young man (edit) |
10.20452/PAMW.15290 |
| 2020-04-08 |
Clinical Course and Outcomes of 344 Intensive Care Patients with COVID-19 (edit) |
10.1164/RCCM.202003-0736LE |
| 2020-04-08 |
Policies and Guidelines for COVID-19 Preparedness: Experiences from the University of Washington (edit) |
10.1148/RADIOL.2020201326 |
| 2020-04-08 |
Sudden and Complete Olfactory Loss Function as a Possible Symptom of COVID-19 (edit) |
10.1001/JAMAOTO.2020.0832 |
| 2020-04-08 |
Screening and Severity of Coronavirus Disease 2019 (COVID-19) in Children in Madrid, Spain (edit) |
10.1001/JAMAPEDIATRICS.2020.1346 |
| 2020-04-08 |
A Bold Response to the COVID-19 Pandemic: Medical Students, National Service, and Public Health (edit) |
10.1001/JAMA.2020.6166 |
| 2020-04-08 |
CAPACITY-COVID: a European registry to determine the role of cardiovascular disease in the COVID-19 pandemic (edit) |
10.1093/EURHEARTJ/EHAA280 |
| 2020-04-08 |
Acute myocarditis presenting as a reverse Tako-Tsubo syndrome in a patient with SARS-CoV-2 respiratory infection (edit) |
10.1093/EURHEARTJ/EHAA286 |
| 2020-04-08 |
COVID-19 Obstetrics Task Force, Lombardy, Italy: executive management summary and short report of outcome (edit) |
10.1002/IJGO.13162 |
| 2020-04-08 |
American Geriatrics Society (AGS) Policy Brief: COVID-19 and Nursing Homes (edit) |
10.1111/JGS.16477 |
| 2020-04-08 |
Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review (edit) |
10.1002/14651858.CD013574 |
| 2020-04-08 |
COVID-19: Important Therapy Considerations and Approaches in this Hour of Need (edit) |
10.1002/PHAR.2396 |
| 2020-04-08 |
Considerations for statin therapy in patients with COVID-19 (edit) |
10.1002/PHAR.2397 |
| 2020-04-08 |
Therapeutic Potential for Tetracyclines in the Treatment of COVID-19 (edit) |
10.1002/PHAR.2395 |
| 2020-04-08 |
COVID-19: A Call for Physical Scientists and Engineers (edit) |
10.1021/ACSNANO.0C02618 |
| 2020-04-08 |
Considerations for Drug Interactions on QTc in Exploratory COVID-19 (Coronavirus Disease 2019) Treatment (edit) |
10.1161/CIRCULATIONAHA.120.047521 |
| 2020-04-08 |
Challenges Faced by Medical Journals During the COVID-19 Pandemic (edit) |
10.1200/JCO.20.00858 |
| 2020-04-08 |
Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis (edit) |
10.18632/AGING.103000 |
| 2020-04-08 |
Chest Computed Tomography for Detection of Coronavirus Disease 2019 (COVID-19): Don't Rush the Science (edit) |
10.7326/M20-1382 |
| 2020-04-08 |
Rapid Design and Implementation of an Integrated Patient Self-Triage and Self-Scheduling Tool for COVID-19 (edit) |
10.1093/JAMIA/OCAA051 |
| 2020-04-08 |
Migraine in the Time of COVID-19 (edit) |
10.1111/HEAD.13803 |
| 2020-04-08 |
Battling COVID-19: Critical care and peri-operative healthcare resource management strategies in a tertiary academic medical centre in Singapore (edit) |
10.1111/ANAE.15074 |
| 2020-04-08 |
Infection control in non-clinical areas during COVID-19 pandemic (edit) |
10.1111/ANAE.15075 |
| 2020-04-08 |
COVID-19: The Uninvited Guest in the Intensive Care Unit (ICU) Implications for Pharmacotherapy (edit) |
10.1002/PHAR.2394 |
| 2020-04-08 |
Tissue Plasminogen Activator (tPA) Treatment for COVID-19 Associated Acute Respiratory Distress Syndrome (ARDS): A Case Series (edit) |
10.1111/JTH.14828 |
| 2020-04-08 |
Hydroxychloroquine for treatment of SARS-CoV-2 infection? Improving our confidence in a model-based approach to dose selection (edit) |
10.1111/CTS.12797 |
| 2020-04-08 |
"We Signed Up for This!" - Student and Trainee Responses to the Covid-19 Pandemic (edit) |
10.1056/NEJMP2005234 |
| 2020-04-08 |
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19 (edit) |
10.1056/NEJMC2007575 |
| 2020-04-08 |
Biomarkers of biological age as predictors of COVID-19 disease severity (edit) |
10.18632/AGING.103052 |
| 2020-04-08 |
COVID-19: the perspective of Italian embryologists managing the IVF laboratory in pandemic emergency (edit) |
10.1093/HUMREP/DEAA074 |
| 2020-04-08 |
Letaler Verlauf einer Influenza-Pneumonie und Literaturrecherche in Zeiten der wachsenden Aufmerksamkeit für das neue Coronavirus Sars-CoV-2 (edit) |
10.1055/A-1150-8261 |
| 2020-04-08 |
Neonatal Resuscitation and Postresuscitation Care of Infants Born to Mothers with Suspected or Confirmed SARS-CoV-2 Infection (edit) |
10.1055/S-0040-1709688 |
| 2020-04-08 |
Intubation and mechanical ventilation of patients with COVID-19: what should we tell them? (edit) |
10.4081/MONALDI.2020.1296 |
| 2020-04-08 |
Traditional Chinese herbal medicine for treating novel coronavirus (COVID-19) pneumonia: protocol for a systematic review and meta-analysis (edit) |
10.1186/S13643-020-01343-4 |
| 2020-04-08 |
Home PAP devices in COVID-19 infected patients (edit) |
10.5664/JCSM.8490 |
| 2020-04-08 |
Mathematical modelling of COVID-19 transmission and mitigation strategies in the population of Ontario, Canada (edit) |
10.1503/CMAJ.200476 |
| 2020-04-08 |
Social distancing to combat COVID-19: We are all on the front line (edit) |
10.1503/CMAJ.200606 |
| 2020-04-08 |
Projecting demand for critical care beds during COVID-19 outbreaks in Canada (edit) |
10.1503/CMAJ.200457 |
| 2020-04-08 |
Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection (edit) |
10.1503/CMAJ.200528 |
| 2020-04-08 |
Covid-19: Africa records over 10 000 cases as lockdowns take hold (edit) |
10.1136/BMJ.M1439 |
| 2020-04-08 |
Covid-19: testing times (edit) |
10.1136/BMJ.M1403 |
| 2020-04-08 |
Chloroquine and hydroxychloroquine in covid-19 (edit) |
10.1136/BMJ.M1432 |
| 2020-04-08 |
Learning from Adversity: Lessons from the COVID-19 Crisis (edit) |
10.3899/JRHEUM.200411 |
| 2020-04-08 |
Possible Consequences of a Shortage of Hydroxychloroquine for Lupus Patients Amid the COVID-19 Pandemic (edit) |
10.3899/JRHEUM.200395 |
| 2020-04-08 |
Phylogenetic network analysis of SARS-CoV-2 genomes (edit) |
10.1073/PNAS.2004999117 |
| 2020-04-08 |
Covid-19: Testing times for the government-but not for NHS staff (edit) |
10.1136/BMJ.M1433 |
| 2020-04-08 |
No Association of COVID-19 transmission with temperature or UV radiation in Chinese cities (edit) |
10.1183/13993003.00517-2020 |
| 2020-04-08 |
Pathogenesis of COVID-19 from a cell biologic perspective (edit) |
10.1183/13993003.00607-2020 |
| 2020-04-08 |
Clinical characteristics and outcomes of hospitalised patients with COVID-19 treated in Hubei (epicenter) and outside Hubei (non-epicenter): A Nationwide Analysis of China (edit) |
10.1183/13993003.00562-2020 |
| 2020-04-08 |
Predictors of Mortality for Patients with COVID-19 Pneumonia Caused by SARS-CoV-2: A Prospective Cohort Study (edit) |
10.1183/13993003.00524-2020 |
| 2020-04-08 |
ACE-2 Expression in the Small Airway Epithelia of Smokers and COPD Patients: Implications for COVID-19 (edit) |
10.1183/13993003.00688-2020 |
| 2020-04-08 |
Managing the supportive care needs of those affected by COVID-19 (edit) |
10.1183/13993003.00815-2020 |
| 2020-04-08 |
Comparative Performance of SARS-CoV-2 Detection Assays using Seven Different Primer/Probe Sets and One Assay Kit (edit) |
10.1128/JCM.00557-20 |
| 2020-04-08 |
International expansion of a novel SARS-CoV-2 mutant (edit) |
10.1128/JVI.00567-20 |
| 2020-04-08 |
COVID-19 brings drug development to a halt (edit) |
10.1038/D41573-020-00069-1 |
| 2020-04-08 |
Coordinating the COVID-19 pipeline (edit) |
10.1038/D41573-020-00068-2 |
| 2020-04-08 |
COVID-19 in humanitarian settings and lessons learned from past epidemics (edit) |
10.1038/S41591-020-0851-2 |
| 2020-04-08 |
Potential of chloroquine and hydroxychloroquine to treat COVID-19 causes fears of shortages among people with systemic lupus erythematosus (edit) |
10.1038/S41591-020-0853-0 |
| 2020-04-08 |
What can European radiologists learn from the outbreak of COVID-19 in China? A discussion with a radiologist from Wuhan (edit) |
10.1007/S00330-020-06841-6 |
| 2020-04-08 |
No lockdown for neurological diseases during COVID19 pandemic infection (edit) |
10.1007/S10072-020-04389-3 |
| 2020-04-08 |
Coronavirus: Update Related to the Current Outbreak of COVID-19 (edit) |
10.1007/S40121-020-00295-5 |
| 2020-04-08 |
Commentary on Ferguson, et al., "Impact of Non-pharmaceutical Interventions (NPIs) to Reduce COVID-19 Mortality and Healthcare Demand" (edit) |
10.1007/S11538-020-00726-X |
| 2020-04-08 |
Liver transplantation and COVID-19 (Coronavirus) infection: guidelines of the liver transplant Society of India (LTSI) (edit) |
10.1007/S12072-020-10041-1 |
| 2020-04-08 |
Ultrarapid diagnosis, microscope imaging, genome sequencing, and culture isolation of SARS-CoV-2 (edit) |
10.1007/S10096-020-03869-W |
| 2020-04-08 |
Management of Cancer Surgery Cases During the COVID-19 Pandemic: Considerations (edit) |
10.1245/S10434-020-08461-2 |
| 2020-04-08 |
Expert consensus from the Italian Society for Colposcopy and Cervico-Vaginal Pathology (SICPCV) for colposcopy and outpatient surgery of the lower genital tract during the COVID-19 pandemic (edit) |
10.1002/IJGO.13158 |
| 2020-04-08 |
Radiological findings and clinical characteristics of pregnant women with COVID-19 pneumonia (edit) |
10.1002/IJGO.13165 |
| 2020-04-08 |
A global recommendation for restrictive provision of fertility treatments during the COVID-19 pandemic (edit) |
10.1111/AOGS.13851 |
| 2020-04-08 |
Four cases from a family cluster were diagnosed as COVID-19 after 14-day of quarantine period (edit) |
10.1002/JMV.25849 |
| 2020-04-08 |
Does recombinant human Erythropoietin administration in critically ill COVID-19 patients have miraculous therapeutic effects? (edit) |
10.1002/JMV.25839 |
| 2020-04-08 |
Data Analysis of Coronavirus CoVID-19 Epidemic in South Korea Based on Recovered and Death Cases (edit) |
10.1002/JMV.25850 |
| 2020-04-08 |
Diabetes and the COVID-19 Pandemic: How Insights from Recent Experience Might Guide Future Management (edit) |
10.1089/MET.2020.0037 |
| 2020-04-08 |
Survey of COVID-19 Disease Among Orthopaedic Surgeons in Wuhan, People's Republic of China (edit) |
10.2106/JBJS.20.00417 |
| 2020-04-08 |
What's Important: Weathering the COVID-19 Crisis: Time for Leadership, Vigilance, and Unity (edit) |
10.2106/JBJS.20.00419 |
| 2020-04-08 |
What's Important: Facing Fear in the Time of COVID-19 (edit) |
10.2106/JBJS.20.00469 |
| 2020-04-08 |
Reflections on the COVID-19 Pandemic (edit) |
10.1590/S1677-5538.IBJU.2020.04.02 |
| 2020-04-08 |
The Distance Teaching Practice of Combined Mode of Massive Open Online Course Micro-Video for Interns in Emergency Department During the COVID-19 Epidemic Period (edit) |
10.1089/TMJ.2020.0079 |
| 2020-04-08 |
Early preemptive immune modulators (corticosteroids) for severe pneumonia patients infected with SARS-CoV-2 (edit) |
10.3345/CEP.2020.00290 |
| 2020-04-08 |
Telemedicine and the COVID-19 Pandemic, Lessons for the Future (edit) |
10.1089/TMJ.2020.29040.RB |
| 2020-04-08 |
Development of a Novel, Genome Subtraction-Derived, SARS-CoV-2-Specific COVID-19-nsp2 Real-Time RT-PCR Assay and Its Evaluation Using Clinical Specimens (edit) |
10.3390/IJMS21072574 |
| 2020-04-08 |
Exploring the Relevance of Senotherapeutics for the Current SARS-CoV-2 Emergency and Similar Future Global Health Threats (edit) |
10.3390/CELLS9040909 |
| 2020-04-08 |
Spatio-Temporal Patterns of the 2019-nCoV Epidemic at the County Level in Hubei Province, China (edit) |
10.3390/IJERPH17072563 |
| 2020-04-08 |
Respiratory health in athletes: facing the COVID-19 challenge (edit) |
10.1016/S2213-2600(20)30175-2 |
| 2020-04-08 |
Tuberculosis and HIV responses threatened by COVID-19 (edit) |
10.1016/S2352-3018(20)30109-0 |
| 2020-04-08 |
Alcohol use and misuse during the COVID-19 pandemic: a potential public health crisis? (edit) |
10.1016/S2468-2667(20)30088-8 |
| 2020-04-08 |
Beware of the second wave of COVID-19 (edit) |
10.1016/S0140-6736(20)30845-X |
| 2020-04-08 |
Localising an asset-based COVID-19 response in Ecuador (edit) |
10.1016/S0140-6736(20)30851-5 |
| 2020-04-08 |
Recommendations from national regulatory agencies for ongoing cancer trials during the COVID-19 pandemic (edit) |
10.1016/S1470-2045(20)30226-6 |
| 2020-04-08 |
Super-spreading events and contribution to transmission of MERS, SARS, and COVID-19 (edit) |
10.1016/J.JHIN.2020.04.002 |
| 2020-04-08 |
Sterilization of disposable face masks by means of standardized dry and steam sterilization processes; an alternative in the fight against mask shortages due to COVID-19 (edit) |
10.1016/J.JHIN.2020.04.001 |
| 2020-04-08 |
Disinfection of N95 respirators by ionized hydrogen peroxide during pandemic coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 (edit) |
10.1016/J.JHIN.2020.04.003 |
| 2020-04-08 |
Characteristics of health worker fatality in China during the outbreak of COVID-19 infection (edit) |
10.1016/J.JINF.2020.03.030 |
| 2020-04-08 |
SAA is a biomarker to distinguish the severity and prognosis of Coronavirus Disease 2019 (COVID-19) (edit) |
10.1016/J.JINF.2020.03.035 |
| 2020-04-08 |
Clinical and CT imaging features of 2019 novel coronavirus disease (COVID-19) (edit) |
10.1016/J.JINF.2020.03.033 |
| 2020-04-08 |
The Role of Phylogenetic Analysis in Clarifying the Infection Source of a COVID-19 Patient (edit) |
10.1016/J.JINF.2020.03.031 |
| 2020-04-08 |
Strategies to trace back the origin of COVID-19 (edit) |
10.1016/J.JINF.2020.03.032 |
| 2020-04-08 |
A tale of two pandemics: How will COVID-19 and global trends in physical inactivity and sedentary behavior affect one another? (edit) |
10.1016/J.PCAD.2020.04.005 |
| 2020-04-08 |
Implication of non-alcoholic fatty liver diseases (NAFLD) in patients with COVID-19: a preliminary analysis (edit) |
10.1016/J.JHEP.2020.03.044 |
| 2020-04-08 |
Cardiovascular risks of hydroxychloroquine in treatment and prophylaxis of COVID-19 patients: A scientific statement from the Indian Heart Rhythm Society (edit) |
10.1016/J.IPEJ.2020.04.003 |
| 2020-04-08 |
A few thoughts and evidence on the COViD-19 pandemic (edit) |
10.1016/J.MEDMAL.2020.04.003 |
| 2020-04-08 |
Diarrhea during COVID-19 infection: pathogenesis, epidemiology, prevention and management (edit) |
10.1016/J.CGH.2020.04.001 |
| 2020-04-08 |
Emergency response to the outbreak of COVID-19: the Korean case (edit) |
10.1016/J.MICINF.2020.04.001 |
| 2020-04-08 |
Association of COVID-19 infection with pregnancy outcomes in healthcare workers and general women (edit) |
10.1016/J.CMI.2020.03.034 |
| 2020-04-08 |
Challenges and issues about organising a hospital to respond to the COVID-19 outbreak: experience from a French reference centre (edit) |
10.1016/J.CMI.2020.04.002 |
| 2020-04-08 |
The role and response of palliative care and hospice services in epidemics and pandemics: a rapid review to inform practice during the COVID-19 pandemic (edit) |
10.1016/J.JPAINSYMMAN.2020.03.029 |
| 2020-04-08 |
Mathematical model of infection kinetics and its analysis for COVID-19, SARS and MERS (edit) |
10.1016/J.MEEGID.2020.104306 |
| 2020-04-08 |
Virtual Interviews in the Era of COVID-19: A Primer for Applicants (edit) |
10.1016/J.JSURG.2020.03.020 |
| 2020-04-08 |
The Restructuring of Structural Heart Disease Practice During The Covid-19 Pandemic (edit) |
10.1016/J.JACC.2020.04.009 |
| 2020-04-08 |
COVID-19 and haemostasis: a position paper from Italian Society on Thrombosis and Haemostasis (SISET) (edit) |
10.2450/2020.0083-20 |
| 2020-04-08 |
Staying active in isolation: Telerehabilitation for individuals with the SARS-CoV-2 infection (edit) |
10.1097/PHM.0000000000001441 |
| 2020-04-08 |
Innovation in Response to the COVID-19 Pandemic Crisis (edit) |
10.1097/ACM.0000000000003402 |
| 2020-04-08 |
Medical Student Mobilization During A Crisis: Lessons From A COVID-19 Medical Student Response Team (edit) |
10.1097/ACM.0000000000003401 |
| 2020-04-08 |
Determining Urgent/Emergent status of Gastrointestinal (GI) Endoscopic Procedures in an Ambulatory Care Setting during the Coronavirus Disease of 2019 (COVID-19) Pandemic: Additional Factors that need to be considered (edit) |
10.1213/ANE.0000000000004861 |
| 2020-04-08 |
Anesthetic Management of Endovascular Treatment of Acute Ischemic Stroke During COVID-19 Pandemic: Consensus Statement from Society for Neuroscience in Anesthesiology & Critical Care (SNACC)_Endorsed by Society of Vascular & Interventional Neurology (edit) |
10.1097/ANA.0000000000000688 |
| 2020-04-08 |
Telemedicine for Pediatric Inflammatory bowel disease in the Era of COVID-19 (edit) |
10.1097/MPG.0000000000002747 |
| 2020-04-08 |
Study of knowledge, attitude, anxiety & perceived mental healthcare need in Indian population during COVID-19 pandemic (edit) |
10.1016/J.AJP.2020.102083 |
| 2020-04-08 |
Rapid surveillance of COVID-19 in the United States using a prospective space-time scan statistic: Detecting and evaluating emerging clusters (edit) |
10.1016/J.APGEOG.2020.102202 |
| 2020-04-08 |
COVID-19 pandemic & head and neck cancer patients management: The role of virtual multidisciplinary team meetings (edit) |
10.1016/J.ORALONCOLOGY.2020.104693 |
| 2020-04-08 |
Covid-19 and cancer patients: Choosing wisely is the key (edit) |
10.1016/J.DLD.2020.03.030 |
| 2020-04-08 |
Is low sodium intake a risk factor for severe and fatal COVID-19 infection? (edit) |
10.1016/J.EJIM.2020.04.003 |
| 2020-04-08 |
Situation analysis and an insight into assessment of pandemic COVID-19 (edit) |
10.1016/J.JTUMED.2020.04.001 |
| 2020-04-08 |
[Surgery and the Covid-19 epidemic: some additional precautions] (edit) |
10.1016/J.JCHIRV.2020.04.002 |
| 2020-04-08 |
The preventive strategies of GI physicians during the COVID-19 pandemic (edit) |
10.1016/J.NMNI.2020.100676 |
| 2020-04-08 |
Important Steps to Control COVID-19/SARS-CoV-2 Infection (edit) |
10.1007/S42399-020-00271-7 |
| 2020-04-08 |
The Imperfect Cytokine Storm: Severe COVID-19 with ARDS in Patient on Durable LVAD Support (edit) |
10.1016/J.JACCAS.2020.04.001 |
| 2020-04-08 |
[The Impact of the COVID-19 Pandemic on Mental Health] (edit) |
10.20344/AMP.13877 |
| 2020-04-08 |
Remote consultations in the era of COVID-19 pandemic: Preliminary experience in a regional Australian public acute mental health care setting (edit) |
10.1016/J.AJP.2020.102074 |
| 2020-04-08 |
COVID-19 in People with Mental Illness: Challenges and Vulnerabilities (edit) |
10.1016/J.AJP.2020.102051 |
| 2020-04-08 |
Neurotropism of SARS-CoV 2: Mechanisms and manifestations (edit) |
10.1016/J.JNS.2020.116824 |
| 2020-04-08 |
Cardiac Surgery in Canada During the COVID-19 Pandemic: A Guidance Statement From the Canadian Society of Cardiac Surgeons (edit) |
10.1016/J.CJCA.2020.04.001 |
| 2020-04-08 |
Guidance On Minimizing Risk of Drug-Induced Ventricular Arrhythmia During Treatment of COVID-19: A Statement from the Canadian Heart Rhythm Society (edit) |
10.1016/J.CJCA.2020.04.003 |
| 2020-04-08 |
What Is the Role of Angiotensin-Converting Enzyme 2 (ACE2) in COVID-19 Infection in Hypertensive Patients With Diabetes? (edit) |
10.1016/J.CJCA.2020.03.049 |
| 2020-04-08 |
Recommendations of the Spanish Society of Otolaryngology and Head and Neck Surgery for performing tracheotomies in patients infected by the coronavirus, Covid-19 (edit) |
10.1016/J.OTORRI.2020.03.001 |
| 2020-04-08 |
Will the status of infection prevention and control (IPC) professionals be improved in the context of COVID-19? (edit) |
10.1016/J.AJIC.2020.04.003 |
| 2020-04-08 |
Surgery and the COVID-19 epidemic: Some additional precautions. Re: "Strategy for the practice of digestive and oncological surgery during the COVID-19 epidemic" (edit) |
10.1016/J.JVISCSURG.2020.04.002 |
| 2020-04-08 |
Anaesthesia and COVID-19: infection control (edit) |
10.1016/J.BJA.2020.03.025 |
| 2020-04-08 |
Active constituents and mechanisms of Respiratory Detox Shot, a traditional Chinese medicine prescription, for COVID-19 control and prevention: Network-molecular docking-LC-MSE analysis (edit) |
10.1016/J.JOIM.2020.03.004 |
| 2020-04-08 |
COVID-19 pneumonia with hemoptysis: Acute segmental pulmonary emboli associated with novel coronavirus infection (edit) |
10.1016/J.AJEM.2020.04.011 |
| 2020-04-08 |
Chest CT in patients suspected of COVID-19 infection: A reliable alternative for RT-PCR (edit) |
10.1016/J.AJEM.2020.04.016 |
| 2020-04-08 |
Real-time estimation and prediction of mortality caused by COVID-19 with patient information based algorithm (edit) |
10.1016/J.SCITOTENV.2020.138394 |
| 2020-04-08 |
Chloroquine and hydroxychloroquine for the treatment of COVID-19: A living systematic review protocol (edit) |
10.1101/2020.04.03.20052530 |
| 2020-04-08 |
Interaction between malarial transmission and BCG vaccination with COVID-19 incidence in the world map: A changing landscape human immune system? (edit) |
10.1101/2020.04.03.20052563 |
| 2020-04-08 |
Connecting BCG Vaccination and COVID-19: Additional Data (edit) |
10.1101/2020.04.07.20053272 |
| 2020-04-08 |
Management of the SARS-CoV-2 (COVID-19) coronavirus epidemic in hemodialysis units (edit) |
10.1016/J.NEFRO.2020.04.001 |
| 2020-04-08 |
Decontamination and Reuse of N95 Respirators with Hydrogen Peroxide Vapor to Address Worldwide Personal Protective Equipment Shortages During the SARS-CoV-2 (COVID-19) Pandemic (edit) |
10.1177/1535676020919932 |
| 2020-04-08 |
A model to predict SARS-CoV-2 infection based on the first three-month surveillance data in Brazil. (edit) |
10.1101/2020.04.05.20047944 |
| 2020-04-08 |
Lack of Antiviral Activity of Darunavir against SARS-CoV-2 (edit) |
10.1101/2020.04.03.20052548 |
| 2020-04-08 |
Targeting the catecholamine-cytokine axis to prevent SARS-CoV-2 cytokine storm syndrome (edit) |
10.1101/2020.04.02.20051565 |
| 2020-04-08 |
Genomic determinants of pathogenicity in SARS-CoV-2 and other human coronaviruses (edit) |
10.1101/2020.04.05.026450 |
| 2020-04-08 |
Optimize Clinical Laboratory Diagnosis of COVID-19 from Suspect Cases by Likelihood Ratio of SARS-CoV-2 IgM and IgG antibody (edit) |
10.1101/2020.04.07.20053660 |
| 2020-04-08 |
Extraction-free COVID-19 (SARS-CoV-2) diagnosis by RT-PCR to increase capacity for national testing programmes during a pandemic (edit) |
10.1101/2020.04.06.028316 |
| 2020-04-08 |
Computational target-based drug repurposing of elbasvir, an antiviral drug predicted to bind multiple SARS-CoV-2 proteins (edit) |
10.26434/CHEMRXIV.12084822 |
| 2020-04-07 |
SARS-CoV-2 detection in patients with influenza-like illness (edit) |
10.1038/S41564-020-0713-1 |
| 2020-04-07 |
An "Infodemic": Leveraging High-Volume Twitter Data to Understand Public Sentiment for the COVID-19 Outbreak (edit) |
10.1101/2020.04.03.20052936 |
| 2020-04-07 |
A protocol for adding knowledge to Wikidata, a case report (edit) |
10.1101/2020.04.05.026336 |
| 2020-04-07 |
Pregnant women in the exposure to COVID-19 infection outbreak: the unseen risk factors and preventive healthcare patterns (edit) |
10.1080/14767058.2020.1749257 |
| 2020-04-07 |
Highly pathogenic coronavirus N protein aggravates lung injury by MASP-2-mediated complement over-activation (edit) |
10.1101/2020.03.29.20041962 |
| 2020-04-07 |
Population-Level Interest and Telehealth Capacity of US Hospitals in Response to COVID-19: Cross-Sectional Analysis of Google Search and National Hospital Survey Data (edit) |
10.2196/18961 |
| 2020-04-07 |
COVID-19 and the Heart (edit) |
10.1161/CIRCRESAHA.120.317055 |
| 2020-04-07 |
SARS-CoV-2: the Lombardy scenario in numbers (edit) |
10.1017/ICE.2020.115 |
| 2020-04-07 |
Adaptation of the National Plan for the Prevention and Fight Against Pandemic Influenza to the 2020 COVID-19 epidemic in France (edit) |
10.1017/DMP.2020.82 |
| 2020-04-07 |
COVID-19: From Epidemic to Pandemic (edit) |
10.1017/DMP.2020.84 |
| 2020-04-07 |
Alert for SARS-CoV-2 infection caused by fecal aerosols in rural areas in China (edit) |
10.1017/ICE.2020.114 |
| 2020-04-07 |
Is There a Guarantee That the Crisis of COVID-19 Will not Be Repeated? (edit) |
10.1017/DMP.2020.83 |
| 2020-04-07 |
Impact of the COVID-19 pandemic on urology residency training in Italy (edit) |
10.23736/S0393-2249.20.03868-0 |
| 2020-04-07 |
Coronavirus COV-19/SARS-CoV-2 affects women less than men: clinical response to viral infection (edit) |
10.23812/EDITORIAL-CONTI-3 |
| 2020-04-07 |
[Consideration of surgeons participating in COVID-19 emergency medical rescue] (edit) |
10.3760/CMA.J.CN112139-20200317-00226 |
| 2020-04-07 |
Facing COVID-19 in Ophthalmology department (edit) |
10.1080/02713683.2020.1752737 |
| 2020-04-07 |
Deployment of convalescent plasma for the prevention and treatment of COVID-19 (edit) |
10.1172/JCI138745 |
| 2020-04-07 |
Work stress among Chinese nurses to support Wuhan for fighting against the COVID-19 epidemic (edit) |
10.1111/JONM.13014 |
| 2020-04-07 |
A possible probiotic (S. salivarius K12) approach to improve oral and lung microbiotas and raise defenses against SARS-CoV-2 (edit) |
10.23736/S0026-4806.20.06570-2 |
| 2020-04-07 |
ANNALS EXPRESS: On the Clinical Utility of Cardiac Troponin measurement in COVID-19 Infection (edit) |
10.1177/0004563220921888 |
| 2020-04-07 |
NYC Innocence Lost: Cardiology in the COVID-19 Pandemic (edit) |
10.1161/CIRCULATIONAHA.120.047265 |
| 2020-04-07 |
Hospitalization and Critical Care of 109 Decedents with COVID-19 Pneumonia in Wuhan, China (edit) |
10.1513/ANNALSATS.202003-225OC |
| 2020-04-07 |
Biological treatment use amid the COVID-19 era, a close look at the unresolved perplexity (edit) |
10.1080/09546634.2020.1752886 |
| 2020-04-07 |
The Role of Chest Imaging in Patient Management during the COVID-19 Pandemic: A Multinational Consensus Statement from the Fleischner Society (edit) |
10.1148/RADIOL.2020201365 |
| 2020-04-07 |
Challenging Times for Children With Transfusion-dependent Thalassemia Amid the COVID-19 Pandemic (edit) |
|
| 2020-04-07 |
Radiographic and Clinical Features of Children with 2019 Novel Coronavirus (COVID-19) Pneumonia (edit) |
|
| 2020-04-07 |
Denominator matters in estimating COVID-19 mortality rates (edit) |
10.1093/EURHEARTJ/EHAA282 |
| 2020-04-07 |
COVID-19 experience in Bergamo, Italy (edit) |
10.1093/EURHEARTJ/EHAA279 |
| 2020-04-07 |
Strategies to control COVID-19 and future pandemics in Africa and around the globe (edit) |
10.1093/EURHEARTJ/EHAA278 |
| 2020-04-07 |
Towards Optimization of Hydroxychloroquine Dosing in Intensive Care Unit COVID-19 Patients (edit) |
10.1093/CID/CIAA394 |
| 2020-04-07 |
COVID-19 and Iran: swimming with hands tied! (edit) |
10.4414/SMW.2020.20242 |
| 2020-04-07 |
COVID-19 And Older Adults: What We Know (edit) |
10.1111/JGS.16472 |
| 2020-04-07 |
ISUOG Safety Committee Position Statement on use of personal protective equipment and hazard mitigation in relation to SARS-CoV-2 for practitioners undertaking obstetric and gynecological ultrasound (edit) |
10.1002/UOG.22035 |
| 2020-04-07 |
Informing Emergency Care for COVID-19 patients: The COVID-19 Emergency Department (COVED) Quality Improvement Project Protocol (edit) |
10.1111/1742-6723.13513 |
| 2020-04-07 |
A Community Letter Regarding Sharing Bimolecular Simulation Data for COVID-19 (edit) |
10.1021/ACS.JCIM.0C00319 |
| 2020-04-07 |
Code Blue During the COVID-19 Pandemic (edit) |
10.1161/CIRCOUTCOMES.120.006779 |
| 2020-04-07 |
Clinical Features and Chest CT Manifestations of Coronavirus Disease (COVID-19) (edit) |
10.2214/AJR.20.23141 |
| 2020-04-07 |
Vascular Changes Detected With Thoracic CT in Coronavirus Disease (COVID-19) Might Be Significant Determinants for Accurate Diagnosis and Optimal Patient Management (edit) |
10.2214/AJR.20.23185 |
| 2020-04-07 |
Role and Management of a Head and Neck Department during the COVID-19 Outbreak in Lombardy (edit) |
10.1177/0194599820917914 |
| 2020-04-07 |
The Challenge of Preventing COVID-19 Spread in Correctional Facilities (edit) |
10.1001/JAMA.2020.5427 |
| 2020-04-07 |
What Other Countries Can Learn From Italy During the COVID-19 Pandemic (edit) |
10.1001/JAMAINTERNMED.2020.1447 |
| 2020-04-07 |
US Public Concerns About the COVID-19 Pandemic From Results of a Survey Given via Social Media (edit) |
10.1001/JAMAINTERNMED.2020.1369 |
| 2020-04-07 |
Understanding and Addressing Sources of Anxiety Among Health Care Professionals During the COVID-19 Pandemic (edit) |
10.1001/JAMA.2020.5893 |
| 2020-04-07 |
Intersecting U.S. Epidemics: COVID-19 and Lack of Health Insurance (edit) |
10.7326/M20-1491 |
| 2020-04-07 |
Locally Informed Simulation to Predict Hospital Capacity Needs During the COVID-19 Pandemic (edit) |
10.7326/M20-1260 |
| 2020-04-07 |
Pain Management Best Practices from Multispecialty Organizations during the COVID-19 Pandemic and Public Health Crises (edit) |
10.1093/PM/PNAA127 |
| 2020-04-07 |
Maternal and Perinatal Outcomes with COVID-19: a systematic review of 108 pregnancies (edit) |
10.1111/AOGS.13867 |
| 2020-04-07 |
Caring for patients with pain during the COVID-19 pandemic: Consensus recommendations from an international expert panel (edit) |
10.1111/ANAE.15076 |
| 2020-04-07 |
Clinical Characteristics of COVID-19 After Gynecologic Oncology Surgery in Three Women: A Retrospective Review of Medical Records (edit) |
10.1634/THEONCOLOGIST.2020-0157 |
| 2020-04-07 |
Strengthening the Power of Nurses in Combating COVID-19 (edit) |
10.1111/JONM.13023 |
| 2020-04-07 |
Impact of the COVID-19 pandemic on surgical services: early experiences at a nominated COVID-19 centre (edit) |
10.1111/ANS.15900 |
| 2020-04-07 |
Cytologic and histologic samples from patients infected by the novel coronavirus 2019 SARS-CoV-2: An italian institutional experience focusing on biosafety procedures (edit) |
10.1002/CNCY.22281 |
| 2020-04-07 |
International perspectives: Impact of the COVID-19 Pandemic on cytology (edit) |
10.1002/CNCY.22275 |
| 2020-04-07 |
COVID-19, chronicle of an expected pandemic (edit) |
10.15252/EMMM.202012463 |
| 2020-04-07 |
Going remote: Maintaining normalcy in our pathology laboratories during the COVID-19 pandemic (edit) |
10.1002/CNCY.22276 |
| 2020-04-07 |
COVID-19 Outbreak: An Overview (edit) |
10.1159/000507423 |
| 2020-04-07 |
Nuclear medicine in SARS-CoV-2 pandemia: 18F-FDG-PET/CT to visualize COVID-19 (edit) |
10.1055/A-1152-2341 |
| 2020-04-07 |
A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID-19: Will cases of psoriasis increase after COVID-19 pandemic? (edit) |
10.1111/DTH.13383 |
| 2020-04-07 |
[Experience of tracheotomy for critical patients with COVID-19: a case report] (edit) |
10.3760/CMA.J.CN115330-20200229-00142 |
| 2020-04-07 |
Surgery in COVID-19 patients: operational directives (edit) |
10.1186/S13017-020-00307-2 |
| 2020-04-07 |
First statement on preparation for the COVID-19 pandemic in large German Speaking University-based radiation oncology departments (edit) |
10.1186/S13014-020-01527-1 |
| 2020-04-07 |
COVID-19 and the RAAS-a potential role for angiotensin II? (edit) |
10.1186/S13054-020-02862-1 |
| 2020-04-07 |
Fighting against the common enemy of COVID-19: a practice of building a community with a shared future for mankind (edit) |
10.1186/S40249-020-00650-1 |
| 2020-04-07 |
A new clinical trial to test high-dose vitamin C in patients with COVID-19 (edit) |
10.1186/S13054-020-02851-4 |
| 2020-04-07 |
End-stage Heart Failure with COVID-19: Strong Evidence of Myocardial Injury by 2019-nCoV (edit) |
10.1016/J.JCHF.2020.04.001 |
| 2020-04-07 |
Should chloroquine and hydroxychloroquine be used to treat COVID-19? A rapid review (edit) |
10.3399/BJGPOPEN20X101069 |
| 2020-04-07 |
Ready for a long fight against the COVID-19 outbreak: an innovative model of tiered primary health care in Taiwan (edit) |
10.3399/BJGPOPEN20X101068 |
| 2020-04-07 |
Covid-19: Why Germany's case fatality rate seems so low (edit) |
10.1136/BMJ.M1395 |
| 2020-04-07 |
The doctors navigating covid-19 with no internet (edit) |
10.1136/BMJ.M1417 |
| 2020-04-07 |
Covid-19: doctors still do not have #properPPE (edit) |
10.1136/BMJ.M1423 |
| 2020-04-07 |
Prediction models for diagnosis and prognosis of covid-19 infection: systematic review and critical appraisal (edit) |
10.1136/BMJ.M1328 |
| 2020-04-07 |
COVID-19 and Kawasaki Disease: Novel Virus and Novel Case (edit) |
10.1542/HPEDS.2020-0123 |
| 2020-04-07 |
Early consensus management for non-ICU ARF SARS-CoV-2 emergency in Italy: from ward to trenches (edit) |
10.1183/13993003.00632-2020 |
| 2020-04-07 |
2019 Novel Coronavirus (COVID-19) Pandemic: Built Environment Considerations To Reduce Transmission (edit) |
10.1128/MSYSTEMS.00245-20 |
| 2020-04-07 |
Covid-19: What is the evidence for cloth masks? (edit) |
10.1136/BMJ.M1422 |
| 2020-04-07 |
Let's conquer COVID-19 and sustain our abilities (edit) |
10.1038/S41394-020-0271-Z |
| 2020-04-07 |
Survey of ophthalmology practitioners in A&E on current COVID-19 guidance at three Major UK Eye Hospitals (edit) |
10.1038/S41433-020-0857-5 |
| 2020-04-07 |
SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion (edit) |
10.1038/S41423-020-0424-9 |
| 2020-04-07 |
COVID-19 and cancer: what we know so far (edit) |
10.1038/S41571-020-0366-2 |
| 2020-04-07 |
Management of orthodontic emergencies during 2019-NCOV (edit) |
10.1186/S40510-020-00310-Y |
| 2020-04-07 |
Double Jeopardy: Methamphetamine Use and HIV as Risk Factors for COVID-19 (edit) |
10.1007/S10461-020-02854-W |
| 2020-04-07 |
How Do We Balance Tensions Between COVID-19 Public Health Responses and Stigma Mitigation? Learning from HIV Research (edit) |
10.1007/S10461-020-02856-8 |
| 2020-04-07 |
A case report of COVID-19 with false negative RT-PCR test: necessity of chest CT (edit) |
10.1007/S11604-020-00967-9 |
| 2020-04-07 |
Renin-Angiotensin System Inhibition in Cardiovascular Patients at the Time of COVID19: Much Ado for Nothing? A Statement of Activity from the Directors of the Board and the Scientific Directors of the Italian Society of Hypertension (edit) |
10.1007/S40292-020-00380-3 |
| 2020-04-07 |
Intrauterine vertical transmission of SARS-CoV-2: what we know so far (edit) |
10.1002/UOG.22045 |
| 2020-04-07 |
COVID-19: Risk Groups, Mechanistic Insights, and Challenges (edit) |
10.1111/IJCP.13512 |
| 2020-04-07 |
Neurological manifestations in COVID-19 caused by SARS-CoV-2 (edit) |
10.1111/CNS.13372 |
| 2020-04-07 |
Public Health and Ethics Intersect at New Levels With Gerontological Nursing in COVID-19 Pandemic (edit) |
10.3928/00989134-20200403-01 |
| 2020-04-07 |
Health risks and potential remedies during prolonged lockdowns for coronavirus disease 2019 (COVID-19) (edit) |
10.1515/DX-2020-0041 |
| 2020-04-07 |
Between Scylla and Charybdis - Oncologic Decision Making in the Time of Covid-19 (edit) |
10.1056/NEJMP2006588 |
| 2020-04-07 |
Integrated Radiologic Algorithm for COVID-19 Pandemic (edit) |
10.1097/RTI.0000000000000516 |
| 2020-04-07 |
"What Were You Before the War?" Repurposing Psychiatry During the COVID-19 Pandemic (edit) |
10.4088/JCP.20COM13373 |
| 2020-04-07 |
Psychiatry's Niche Role in the COVID-19 Pandemic (edit) |
10.4088/JCP.20COM13363 |
| 2020-04-07 |
Lung Involvement Found on Chest CT Scan in a Pre-Symptomatic Person with SARS-CoV-2 Infection: A Case Report (edit) |
10.3390/TROPICALMED5020056 |
| 2020-04-07 |
What Does COVID-19 Mean for the Pathology-Urology Interaction? (edit) |
10.1016/J.EURURO.2020.03.041 |
| 2020-04-07 |
COVID-19: Hygiene and Public Health to the front (edit) |
10.23750/ABM.V91I3-S.9507 |
| 2020-04-07 |
Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2 (edit) |
10.1016/J.CELL.2020.03.045 |
| 2020-04-07 |
POCUS in COVID-19: pearls and pitfalls (edit) |
10.1016/S2213-2600(20)30166-1 |
| 2020-04-07 |
COVID-19, school closures, and child poverty: a social crisis in the making (edit) |
10.1016/S2468-2667(20)30084-0 |
| 2020-04-07 |
Invisible spread of SARS-CoV-2 (edit) |
10.1016/S1473-3099(20)30263-2 |
| 2020-04-07 |
Making decisions to mitigate COVID-19 with limited knowledge (edit) |
10.1016/S1473-3099(20)30280-2 |
| 2020-04-07 |
Invisible spread of SARS-CoV-2 - Authors' reply (edit) |
10.1016/S1473-3099(20)30275-9 |
| 2020-04-07 |
Type 1 interferons as a potential treatment against COVID-19 (edit) |
10.1016/J.ANTIVIRAL.2020.104791 |
| 2020-04-07 |
Clinical and Imaging features of COVID-19 Patients: Analysis of Data from High-Altitude Areas (edit) |
10.1016/J.JINF.2020.03.026 |
| 2020-04-07 |
COVID-19 in patients with diabetes: risk factors that increase morbidity (edit) |
10.1016/J.METABOL.2020.154224 |
| 2020-04-07 |
Letter to Editor: Vicarious traumatization in the general public, members, and non-members of medical teams aiding in COVID-19 control (edit) |
10.1016/J.BBI.2020.04.006 |
| 2020-04-07 |
The serostatus approach to fighting COVID-19 (edit) |
10.1016/J.IJID.2020.03.080 |
| 2020-04-07 |
Development of Reverse Transcription Loop-Mediated Isothermal Amplification Assays Targeting SARS-CoV-2 (edit) |
10.1016/J.JMOLDX.2020.03.006 |
| 2020-04-07 |
Palliative Care in the time of COVID-19: Reflections from the frontline (edit) |
10.1016/J.JPAINSYMMAN.2020.03.023 |
| 2020-04-07 |
Symptom Cluster of ICU nurses treating COVID-19 pneumonia patients in Wuhan, China (edit) |
10.1016/J.JPAINSYMMAN.2020.03.039 |
| 2020-04-07 |
Which Melbourne metropolitan areas are vulnerable to COVID-19 based on age, disability and access to health services? Using spatial analysis to identify service gaps and inform delivery (edit) |
10.1016/J.JPAINSYMMAN.2020.03.041 |
| 2020-04-07 |
Conservative management of Covid-19 patients - emergency palliative care in action (edit) |
10.1016/J.JPAINSYMMAN.2020.03.030 |
| 2020-04-07 |
Crisis Symptom Management and Patient Communication Protocols Are Important Tools for All Clinicians Responding to COVID-19 (edit) |
10.1016/J.JPAINSYMMAN.2020.03.028 |
| 2020-04-07 |
Rapid and visual detection of 2019 novel coronavirus (SARS-CoV-2) by a reverse transcription loop-mediated isothermal amplification assay (edit) |
10.1016/J.CMI.2020.04.001 |
| 2020-04-07 |
COVID-19 in a patient with long-term use of glucocorticoids: A study of a familial cluster (edit) |
10.1016/J.CLIM.2020.108413 |
| 2020-04-07 |
Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients (edit) |
10.1016/J.CLIM.2020.108410 |
| 2020-04-07 |
Ethical practice during the COVID-19 pandemic (edit) |
10.1016/J.ADAJ.2020.03.038 |
| 2020-04-07 |
CT Manifestation of COVID-19 Pneumonia; Role of Multiplanar Imaging (edit) |
10.1016/J.ACRA.2020.03.028 |
| 2020-04-07 |
Infection Control against COVID-19 in Departments of Radiology (edit) |
10.1016/J.ACRA.2020.03.025 |
| 2020-04-07 |
Challenges in paediatric inflammatory bowel diseases in the COVID-19 time (edit) |
10.1016/J.DLD.2020.03.015 |
| 2020-04-07 |
First COVID-19 suicide case in Bangladesh due to fear of COVID-19 and xenophobia: Possible suicide prevention strategies (edit) |
10.1016/J.AJP.2020.102073 |
| 2020-04-07 |
COVID-19 from veterinary medicine and one health perspectives: What animal coronaviruses have taught us (edit) |
10.1016/J.RVSC.2020.04.009 |
| 2020-04-07 |
Clinical and computed tomographic (CT) images characteristics in the patients with COVID-19 infection: What should radiologists need to know? (edit) |
10.3233/XST-200670 |
| 2020-04-07 |
Laparoscopy at all costs? Not now during COVID-19 and not for acute care surgery and emergency colorectal surgery: a practical algorithm from a Hub Tertiary teaching hospital in Northern Lombardy, Italy (edit) |
10.1097/TA.0000000000002727 |
| 2020-04-07 |
Mental health of medical workers in Pakistan during the pandemic COVID-19 outbreak (edit) |
10.1016/J.AJP.2020.102080 |
| 2020-04-07 |
Psychiatrist in post-COVID-19 era - Are we prepared? (edit) |
10.1016/J.AJP.2020.102082 |
| 2020-04-07 |
Prediction of COVID-19 Outbreak in China and Optimal Return Date for University Students Based on Propagation Dynamics (edit) |
10.1007/S12204-020-2167-2 |
| 2020-04-07 |
CIRD-F: Spread and Influence of COVID-19 in China (edit) |
10.1007/S12204-020-2168-1 |
| 2020-04-07 |
Preliminary Assessment of the COVID-19 Outbreak Using 3-Staged Model e-ISHR (edit) |
10.1007/S12204-020-2169-0 |
| 2020-04-07 |
D2EA: Depict the Epidemic Picture of COVID-19 (edit) |
10.1007/S12204-020-2170-7 |
| 2020-04-07 |
Japan ECMOnet for COVID-19: telephone consultations for cases with severe respiratory failure caused by COVID-19 (edit) |
10.1186/S40560-020-00440-9 |
| 2020-04-07 |
A comprehensive Chinese experience against SARS-CoV-2 in ophthalmology (edit) |
10.1186/S40662-020-00187-2 |
| 2020-04-07 |
Issues relevant to mental health promotion in frontline health care providers managing quarantined/isolated COVID19 patients (edit) |
10.1016/J.AJP.2020.102084 |
| 2020-04-07 |
Patients with chronic illness urgently need integrated physical and psychological care during the COVID-19 outbreak (edit) |
10.1016/J.AJP.2020.102081 |
| 2020-04-07 |
Suspected myocardial injury in patients with COVID-19: Evidence from front-line clinical observation in Wuhan, China (edit) |
10.1016/J.IJCARD.2020.03.087 |
| 2020-04-07 |
Guidelines for dental care provision during the COVID-19 pandemic (edit) |
10.1016/J.SDENTJ.2020.04.001 |
| 2020-04-07 |
Determining the spatial effects of COVID-19 using the spatial panel data model (edit) |
10.1016/J.SPASTA.2020.100443 |
| 2020-04-07 |
Respirators and surgical facemasks for COVID-19: implications for MRI (edit) |
10.1016/J.CRAD.2020.03.029 |
| 2020-04-07 |
COVID-19 in Singapore and Malaysia: Rising to the Challenges of Orthopaedic Practice in an Evolving Pandemic (edit) |
10.5704/MOJ.2007.001 |
| 2020-04-07 |
Clinical and epidemiological characteristics of Coronavirus Disease 2019 (COVID-19) patients (edit) |
10.1101/2020.04.02.20050989 |
| 2020-04-07 |
A Systematic Meta-Analysis of CT Features of COVID-19: Lessons from Radiology (edit) |
10.1101/2020.04.04.20052241 |
| 2020-04-07 |
Clinical characteristics of COVID-19 infection in pregnant women: a systematic review and meta-analysis (edit) |
10.1101/2020.04.05.20053983 |
| 2020-04-07 |
The relationship of COVID-19 severity with cardiovascular disease and its traditional risk factors: A systematic review and meta-analysis (edit) |
10.1101/2020.04.05.20054155 |
| 2020-04-07 |
Mandated Bacillus Calmette-Guérin (BCG) vaccination predicts flattened curves for the spread of COVID-19 (edit) |
10.1101/2020.04.05.20054163 |
| 2020-04-07 |
Timing of antiviral treatment initiation is critical to reduce SARS-Cov-2 viral load (edit) |
10.1101/2020.04.04.20047886 |
| 2020-04-07 |
The potential genetic network of human brain SARS-CoV-2 infection (edit) |
10.1101/2020.04.06.027318 |
| 2020-04-07 |
Initial evidence of higher morbidity and mortality due to SARS-CoV-2 in regions with lower air quality (edit) |
10.1101/2020.04.04.20053595 |
| 2020-04-07 |
Estimate of the development of the epidemic reproduction number Rt from Coronavirus SARS-CoV-2 case data and implications for political measures based on prognostics (edit) |
10.1101/2020.04.04.20053637 |
| 2020-04-07 |
Estimating false-negative detection rate of SARS-CoV-2 by RT-PCR (edit) |
10.1101/2020.04.05.20053355 |
| 2020-04-07 |
Study of Epidemiological Characteristics and In-silico Analysis of the Effect of Interventions in the SARS-CoV-2 Epidemic in India (edit) |
10.1101/2020.04.05.20053884 |
| 2020-04-07 |
Indoor transmission of SARS-CoV-2 (edit) |
10.1101/2020.04.04.20053058 |
| 2020-04-07 |
SARS-CoV-2 titers in wastewater are higher than expected from clinically confirmed cases (edit) |
10.1101/2020.04.05.20051540 |
| 2020-04-07 |
Toilets dominate environmental detection of SARS-CoV-2 virus in a hospital (edit) |
10.1101/2020.04.03.20052175 |
| 2020-04-07 |
Portable and accurate diagnostics for COVID-19: Combined use of the miniPCR thermocycler and a well-plate reader for SARS-CoV-2 virus detection (edit) |
10.1101/2020.04.03.20052860 |
| 2020-04-06 |
The Three Steps Needed to End the COVID-19 Pandemic: Bold Public Health Leadership, Rapid Innovations, and Courageous Political Will (edit) |
10.2196/19043 |
| 2020-04-06 |
Clinical Course and Outcomes of Patients with Severe Acute Respiratory Syndrome Coronavirus 2 Infection: a Preliminary Report of the First 28 Patients from the Korean Cohort Study on COVID-19 (edit) |
10.3346/JKMS.2020.35.E142 |
| 2020-04-06 |
Critically ill patients with COVID-19 in Hong Kong: a multicentre retrospective observational cohort study (edit) |
|
| 2020-04-06 |
Biologic therapy for psoriasis during the covid-19 outbreak is not a choice (edit) |
10.1080/09546634.2020.1749545 |
| 2020-04-06 |
Computational studies of drug repurposing and synergism of lopinavir, oseltamivir and ritonavir binding with SARS-CoV-2 Protease against COVID-19 (edit) |
10.1080/07391102.2020.1752802 |
| 2020-04-06 |
How to deal with 2019 novel coronavirus (COVID-19): a public health practice from the Centers for Disease Control and Prevention in Zhanggong District, Ganzhou City, China (edit) |
10.1017/ICE.2020.110 |
| 2020-04-06 |
Core principles for infection prevention in hemodialysis centers during the COVID-19 pandemic (edit) |
10.1017/ICE.2020.109 |
| 2020-04-06 |
Reducing hand recontamination of health workers during COVID-19 (edit) |
10.1017/ICE.2020.111 |
| 2020-04-06 |
The twitter pandemic: The critical role of twitter in the dissemination of medical information and misinformation during the COVID-19 Pandemic (edit) |
10.1017/CEM.2020.361 |
| 2020-04-06 |
Management-supportive measures for managers of healthcare organizations during the COVID-19 epidemic (edit) |
10.1017/ICE.2020.108 |
| 2020-04-06 |
Sleep Health Service in China During the COVID-19 Outbreak (edit) |
10.5664/JCSM.8472 |
| 2020-04-06 |
Lung ultrasound and computed tomographic findings in pregnant woman with COVID-19 (edit) |
10.1002/UOG.22034 |
| 2020-04-06 |
COVID-19 and Urology: A Comprehensive Review of the Literature (edit) |
10.1111/BJU.15071 |
| 2020-04-06 |
Minimizing the risk of COVID-19 among patients on dialysis (edit) |
10.1038/S41581-020-0280-Y |
| 2020-04-06 |
Fighting COVID-19 exhausts T cells (edit) |
10.1038/S41577-020-0304-7 |
| 2020-04-06 |
Dysregulation of lung myeloid cells in COVID-19 (edit) |
10.1038/S41577-020-0303-8 |
| 2020-04-06 |
In the eye of the COVID-19 cytokine storm (edit) |
10.1038/S41577-020-0305-6 |
| 2020-04-06 |
COVID-19 in pregnancy with comorbidities: More liberal testing strategy is needed (edit) |
10.1111/AOGS.13862 |
| 2020-04-06 |
About the origin of the first two Sars-CoV-2 infections in Italy: inference not supported by appropriate sequence analysis (edit) |
10.1002/JMV.25833 |
| 2020-04-06 |
Structural variations in human ACE2 may influence its binding with SARS-CoV-2 spike protein (edit) |
10.1002/JMV.25832 |
| 2020-04-06 |
COVID-19 infection in a paucisymptomatic infant: Raising the index of suspicion in epidemic settings (edit) |
10.1002/PPUL.24754 |
| 2020-04-06 |
A global needs assessment in times of a global crisis: world psychiatry response to the COVID-19 pandemic (edit) |
10.1192/BJO.2020.25 |
| 2020-04-06 |
Conducting Clinical Research During the COVID-19 Pandemic: Investigator and Participant Perspectives (edit) |
10.2196/18887 |
| 2020-04-06 |
Novel Coronavirus in Cape Town Informal Settlements: Feasibility of Using Informal Dwelling Outlines to Identify High Risk Areas for COVID-19 Transmission From A Social Distancing Perspective (edit) |
10.2196/18844 |
| 2020-04-06 |
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy (edit) |
10.1001/JAMA.2020.5394 |
| 2020-04-06 |
The COVID-19 Pandemic in the US: A Clinical Update (edit) |
10.1001/JAMA.2020.5788 |
| 2020-04-06 |
Sample Pooling as a Strategy to Detect Community Transmission of SARS-CoV-2 (edit) |
10.1001/JAMA.2020.5445 |
| 2020-04-06 |
Impact of the COVID-19 pandemic on Parkinson's disease and movement disorders (edit) |
10.1002/MDS.28067 |
| 2020-04-06 |
Mitigating and learning from the impact of COVID-19 infection on addictive disorders (edit) |
10.1111/ADD.15080 |
| 2020-04-06 |
Coronavirus disease (COVID-19): Characteristics in children and considerations for dentists providing their care (edit) |
10.1111/IPD.12653 |
| 2020-04-06 |
Protecting Medical Trainees on the COVID-19 Frontlines Saves Us All (edit) |
10.1161/CIRCULATIONAHA.120.047454 |
| 2020-04-06 |
Kidney diseases in the time of COVID-19: major challenges to patient care (edit) |
10.1172/JCI138871 |
| 2020-04-06 |
Considering mutational meltdown as a potential SARS-CoV-2 treatment strategy (edit) |
10.1038/S41437-020-0314-Z |
| 2020-04-06 |
A Word from OLAW: COVID-19 guidance (edit) |
10.1038/S41684-020-0526-0 |
| 2020-04-06 |
Effectiveness of Surgical and Cotton Masks in Blocking SARS-CoV-2: A Controlled Comparison in 4 Patients (edit) |
10.7326/M20-1342 |
| 2020-04-06 |
Psychological Impact of the COVID-19 Pandemic on Health Care Workers in Singapore (edit) |
10.7326/M20-1083 |
| 2020-04-06 |
COVID-19 and liver disease (edit) |
10.1111/LIV.14470 |
| 2020-04-06 |
The COVID-19 (Coronavirus) Pandemic: Reflections on the Roles of Librarians and Information Professionals (edit) |
10.1111/HIR.12307 |
| 2020-04-06 |
Triage Considerations for Patients Referred for Structural Heart Disease Intervention During the Coronavirus Disease 2019 (COVID-19) Pandemic: An ACC /SCAI Consensus Statement (edit) |
10.1002/CCD.28910 |
| 2020-04-06 |
High-Sensitivity Cardiac Troponin Can Be An Ally in the Fight Against COVID-19 (edit) |
10.1161/CIRCULATIONAHA.120.047008 |
| 2020-04-06 |
Psychosomatic Medicine and Covid-19 Pandemic (edit) |
10.1159/000507640 |
| 2020-04-06 |
CT imaging changes of corona virus disease 2019(COVID-19): a multi-center study in Southwest China (edit) |
10.1186/S12967-020-02324-W |
| 2020-04-06 |
Covid-19: A&E visits in England fall by 25% in week after lockdown (edit) |
10.1136/BMJ.M1401 |
| 2020-04-06 |
Seattle's covid-19 lessons are yielding hope (edit) |
10.1136/BMJ.M1389 |
| 2020-04-06 |
Covid-19 and the rise of racism (edit) |
10.1136/BMJ.M1384 |
| 2020-04-06 |
Covid-19: Don't apply advance care plans to groups of people, doctors' leaders warn (edit) |
10.1136/BMJ.M1419 |
| 2020-04-06 |
Covid-19: UK government writes off £13.4bn of hospital debts to ease pressures (edit) |
10.1136/BMJ.M1407 |
| 2020-04-06 |
Social distancing in covid-19: what are the mental health implications? (edit) |
10.1136/BMJ.M1379 |
| 2020-04-06 |
Breast feeding at the time of COVID-19: do not forget expressed mother's milk, please (edit) |
10.1136/ARCHDISCHILD-2020-319149 |
| 2020-04-06 |
Supporting colleagues during covid-19: the intensive care consultant (edit) |
10.1136/BMJ.M1264 |
| 2020-04-06 |
Covid-19: NICE advises against using NSAIDs for fever in patients with suspected cases (edit) |
10.1136/BMJ.M1409 |
| 2020-04-06 |
An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice (edit) |
10.1126/SCITRANSLMED.ABB5883 |
| 2020-04-06 |
Lessons from covid-19: visiting patients at home and assessing comorbidities (edit) |
10.1136/BMJ.M1385 |
| 2020-04-06 |
Covid-19 pandemic: a public and global mental health opportunity for social transformation? (edit) |
10.1136/BMJ.M1383 |
| 2020-04-06 |
Effectiveness of convalescent plasma therapy in severe COVID-19 patients (edit) |
10.1073/PNAS.2004168117 |
| 2020-04-06 |
Preparing a neurology department for SARS-CoV-2 (COVID-19): Early experiences at Columbia University Irving Medical Center and the New York Presbyterian Hospital in New York City (edit) |
10.1212/WNL.0000000000009519 |
| 2020-04-06 |
Nutritional management in hospital setting during SARS-CoV-2 pandemic: a real-life experience (edit) |
10.1038/S41430-020-0625-4 |
| 2020-04-06 |
Clinicolaboratory study of 25 fatal cases of COVID-19 in Wuhan (edit) |
10.1007/S00134-020-06023-4 |
| 2020-04-06 |
Correction to: Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China (edit) |
10.1007/S00134-020-06028-Z |
| 2020-04-06 |
Special issues on using the MoCA for remote assessment during COVID-19 2 (edit) |
10.1111/JGS.16469 |
| 2020-04-06 |
Tocilizumab treatment in COVID-19: A single center experience (edit) |
10.1002/JMV.25801 |
| 2020-04-06 |
Daily medical education for confined students during COVID-19 pandemic: a simple videoconference solution (edit) |
10.1002/CA.23601 |
| 2020-04-06 |
Visualizing an unseen enemy; mobilizing structural biology to counter COVID-19 (edit) |
10.1107/S2053230X20004847 |
| 2020-04-06 |
Assessing the severity of COVID-19 (edit) |
10.5123/S1679-49742020000200008 |
| 2020-04-06 |
Driving forces for COVID-19 clinical trials using chloroquine: the need to choose the right research questions and outcomes (edit) |
10.1590/0037-8682-0155-2020 |
| 2020-04-06 |
Food (in)security in Brazil in the context of the SARS-CoV-2 pandemic (edit) |
10.1590/0102-311X00055220 |
| 2020-04-06 |
In Silico Discovery of Candidate Drugs against Covid-19 (edit) |
10.3390/V12040404 |
| 2020-04-06 |
A Comprehensive Literature Review on the Clinical Presentation, and Management of the Pandemic Coronavirus Disease 2019 (COVID-19) (edit) |
10.7759/CUREUS.7560 |
| 2020-04-06 |
Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations (edit) |
10.1016/S2213-2600(20)30161-2 |
| 2020-04-06 |
Understanding pathways to death in patients with COVID-19 (edit) |
10.1016/S2213-2600(20)30165-X |
| 2020-04-06 |
Love in the time of COVID-19: negligence in the Nicaraguan response (edit) |
10.1016/S2214-109X(20)30131-5 |
| 2020-04-06 |
Maintaining HIV care during the COVID-19 pandemic (edit) |
10.1016/S2352-3018(20)30105-3 |
| 2020-04-06 |
Economic sanctions and Iran's capacity to respond to COVID-19 (edit) |
10.1016/S2468-2667(20)30083-9 |
| 2020-04-06 |
School closure and management practices during coronavirus outbreaks including COVID-19: a rapid systematic review (edit) |
10.1016/S2352-4642(20)30095-X |
| 2020-04-06 |
Management of Patients with Crohn's Disease and Ulcerative Colitis During the COVID-19 Pandemic: Results of an International Meeting (edit) |
10.1053/J.GASTRO.2020.04.002 |
| 2020-04-06 |
More evidence is urgently needed to confirm the relation between angiotensin-converting enzyme inhibitors and COVID-19 (edit) |
10.1016/J.YJMCC.2020.04.003 |
| 2020-04-06 |
Does the COVID-19 outbreak identify a broader need for an urgent transformation of cancer clinical trials research? (edit) |
10.1016/J.CCT.2020.105997 |
| 2020-04-06 |
Commentary: COVID-19 and diabetes (edit) |
10.1016/J.DIABRES.2020.108138 |
| 2020-04-06 |
Any possible role of phosphodiesterase type 5 inhibitors in the treatment of severe COVID19 infections? A lesson from urology (edit) |
10.1016/J.CLIM.2020.108414 |
| 2020-04-06 |
New clinical experiences and evaluation of clinical and paraclinical features of deceased patients with COVID-19 infection referred to Shahid Mostafa Khomeini Hospital of Ilam, Iranin (edit) |
10.1016/J.TMAID.2020.101657 |
| 2020-04-06 |
COVID-19 pandemic and economic cost; impact on forcibly displaced people (edit) |
10.1016/J.TMAID.2020.101661 |
| 2020-04-06 |
COVID-19 is not just a flu. Learn from Italy and act now (edit) |
10.1016/J.TMAID.2020.101655 |
| 2020-04-06 |
High-resolution Chest CT Features and Clinical Characteristics of Patients Infected with COVID-19 in Jiangsu, China (edit) |
10.1016/J.IJID.2020.04.003 |
| 2020-04-06 |
JACI: In Practice Response to COVID-19 Pandemic (edit) |
10.1016/J.JAIP.2020.03.027 |
| 2020-04-06 |
Methanol Poisoning Emerging as the Result of COVID-19 Outbreak; Radiologic Perspective (edit) |
10.1016/J.ACRA.2020.03.029 |
| 2020-04-06 |
Analysis of Characteristics in Death Patients with COVID-19 Pneumonia without Underlying Diseases (edit) |
10.1016/J.ACRA.2020.03.023 |
| 2020-04-06 |
COVID-19 in a Kidney Transplant Patient (edit) |
10.1016/J.EURURO.2020.03.036 |
| 2020-04-06 |
Attitudes of Anesthesiology Specialists and Residents Toward Patients Infected with the Novel Coronavirus (COVID-19): A National Survey Study (edit) |
10.1089/SUR.2020.097 |
| 2020-04-06 |
SARS-CoV-2 inflames the heart. The importance of awareness of myocardial injury in COVID-19 patients (edit) |
10.1016/J.IJCARD.2020.03.086 |
| 2020-04-06 |
CORONA-steps for tracheotomy in COVID-19 patients: A staff-safe method for airway management (edit) |
10.1016/J.ORALONCOLOGY.2020.104682 |
| 2020-04-06 |
Fighting against COVID-19: Innovative strategies for clinical pharmacists (edit) |
10.1016/J.SAPHARM.2020.04.003 |
| 2020-04-06 |
The impact of the COVID-19 pandemic on the provision of surgical care (edit) |
10.1093/JSCR/RJAA087 |
| 2020-04-06 |
A field indoor air measurement of SARS-CoV-2 in the patient rooms of the largest hospital in Iran (edit) |
10.1016/J.SCITOTENV.2020.138401 |
| 2020-04-06 |
Modeling and forecasting of epidemic spreading: The case of Covid-19 and beyond (edit) |
10.1016/J.CHAOS.2020.109794 |
| 2020-04-06 |
Mental health advice for frontline healthcare providers caring for patients with COVID-19 (edit) |
10.1007/S12630-020-01650-3 |
| 2020-04-06 |
La chirurgie digestive urgente, victime collatérale de la crise du Covid-19? (edit) |
10.1016/J.JCHIRV.2020.04.001 |
| 2020-04-06 |
How should health systems prepare for the evolving COVID-19 pandemic? Reflections from the perspective of a Tertiary Cancer Center (edit) |
10.6061/CLINICS/2020/E1864 |
| 2020-04-06 |
Fast and simple high-throughput testing of COVID 19 (edit) |
10.1016/J.DENTAL.2020.04.001 |
| 2020-04-06 |
Should we expect neurological symptoms in the SARS-CoV-2 epidemic? (edit) |
10.1016/J.NRL.2020.03.001 |
| 2020-04-06 |
Challenges and solutions for addressing critical shortage of supply chain for personal and protective equipment (PPE) arising from Coronavirus disease (COVID19) pandemic - Case study from the Republic of Ireland (edit) |
10.1016/J.SCITOTENV.2020.138532 |
| 2020-04-06 |
Evaluation of the lockdowns for the SARS-CoV-2 epidemic in Italy and Spain after one month follow up (edit) |
10.1016/J.SCITOTENV.2020.138539 |
| 2020-04-06 |
Investigating hypothiocyanite against SARS-CoV-2 (edit) |
10.1016/J.IJHEH.2020.113520 |
| 2020-04-06 |
Conducting phase 1 cancer clinical trials during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-related disease pandemic (edit) |
10.1016/J.EJCA.2020.03.023 |
| 2020-04-06 |
[French Society for Surgical Oncology (SFCO) guidelines for the management of surgical oncology in the pandemic context of COVID 19] (edit) |
10.1016/J.BULCAN.2020.03.010 |
| 2020-04-06 |
Intrapartum care of women with COVID-19: A practical approach (edit) |
10.1016/J.EJOGRB.2020.04.018 |
| 2020-04-06 |
Invasive fungal diseases during COVID-19: We should be prepared (edit) |
10.1016/J.MYCMED.2020.100971 |
| 2020-04-06 |
Antiviral therapy in management of COVID-19: a systematic review on current evidence (edit) |
|
| 2020-04-06 |
COVID-19 Pneumonia in Asymptomatic Trauma Patients; Report of 8 Cases (edit) |
|
| 2020-04-06 |
Full Spectrum of Cancer Patients in SARS-CoV-2 Infection Still Being Described (edit) |
10.1016/J.CLON.2020.03.016 |
| 2020-04-06 |
Association of BCG vaccination policy with prevalence and mortality of COVID-19 (edit) |
10.1101/2020.03.30.20048165 |
| 2020-04-06 |
Differential COVID-19-attributable mortality and BCG vaccine use in countries (edit) |
10.1101/2020.04.01.20049478 |
| 2020-04-06 |
Facemasks and similar barriers to prevent respiratory illness such as COVID-19: A rapid systematic review (edit) |
10.1101/2020.04.01.20049528 |
| 2020-04-06 |
Epidemiological Characteristics of COVID-19: A Systemic Review and Meta-Analysis (edit) |
10.1101/2020.04.01.20050138 |
| 2020-04-06 |
Case fatality rate in COVID-19: a systematic review and meta-analysis (edit) |
10.1101/2020.04.01.20050476 |
| 2020-04-06 |
Therapeutic Management of COVID-19 Patients: A systematic review (edit) |
10.1101/2020.04.02.20051029 |
| 2020-04-06 |
CovProfile: profiling the viral genome and gene expressions of SARS-COV-2 (edit) |
10.1101/2020.04.05.026146 |
| 2020-04-06 |
Computational analysis suggests putative intermediate animal hosts of the SARS-CoV-2 (edit) |
10.1101/2020.04.04.025080 |
| 2020-04-06 |
Energetics based epitope screening in SARS CoV-2 (COVID 19) spike glycoprotein by Immuno-informatic analysis aiming to a suitable vaccine development (edit) |
10.1101/2020.04.02.021725 |
| 2020-04-06 |
Current Strategies and Approaches in Combating SARS-CoV-2 Virus that Causes COVID-19 (edit) |
10.2174/157018081705200403092546 |
| 2020-04-06 |
LY6E Restricts the Entry of Human Coronaviruses, including the currently pandemic SARS-CoV-2 (edit) |
10.1101/2020.04.02.021469 |
| 2020-04-06 |
SARS-CoV-2 and SARS-CoV differ in their cell tropism and drug sensitivity profiles (edit) |
10.1101/2020.04.03.024257 |
| 2020-04-06 |
Indomethacin has a potent antiviral activity against SARS CoV-2 in vitro and canine coronavirus in vivo (edit) |
10.1101/2020.04.01.017624 |
| 2020-04-06 |
Patient-collected tongue, nasal, and mid-turbinate swabs for SARS-CoV-2 yield equivalent sensitivity to health care worker collected nasopharyngeal swabs (edit) |
10.1101/2020.04.01.20050005 |
| 2020-04-06 |
Structural basis of RNA recognition by the SARS-CoV-2 nucleocapsid phosphoprotein (edit) |
10.1101/2020.04.02.022194 |
| 2020-04-06 |
Did pangolins help spread SARS-CoV-2? (edit) |
10.1021/CEN-09813-SCICON7 |
| 2020-04-06 |
Triphosphates of the Two Components in DESCOVY and TRUVADA are Inhibitors of the SARS-CoV-2 Polymerase (edit) |
10.1101/2020.04.03.022939 |
| 2020-04-06 |
Rapid community-driven development of a SARS-CoV-2 tissue simulator (edit) |
10.1101/2020.04.02.019075 |
| 2020-04-06 |
Prediction and Evolution of B Cell Epitopes of Surface Protein in SARS-CoV-2 (edit) |
10.1101/2020.04.03.022723 |
| 2020-04-06 |
In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication (edit) |
10.1101/2020.04.03.023846 |
| 2020-04-06 |
Widespread use of face masks in public may slow the spread of SARS CoV-2: an ecological study (edit) |
10.1101/2020.03.31.20048652 |
| 2020-04-06 |
Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications (edit) |
10.1101/2020.03.30.20047365 |
| 2020-04-06 |
Cryptic transmission of SARS-CoV-2 in Washington State (edit) |
10.1101/2020.04.02.20051417 |
| 2020-04-06 |
Atazanavir inhibits SARS-CoV-2 replication and pro-inflammatory cytokine production (edit) |
10.1101/2020.04.04.020925 |
| 2020-04-06 |
A snapshot of SARS-CoV-2 genome availability up to 30th March, 2020 and its implications (edit) |
10.1101/2020.04.01.020594 |
| 2020-04-06 |
One-step RNA extraction for RT-qPCR detection of 2019-nCoV (edit) |
10.1101/2020.04.02.022384 |
| 2020-04-06 |
Leveraging mRNAs sequences to express SARS-CoV-2 antigens in vivo (edit) |
10.1101/2020.04.01.019877 |
| 2020-04-06 |
Topological Analysis of SARS CoV-2 Main Protease (edit) |
10.1101/2020.04.03.023887 |
| 2020-04-06 |
Assessment of Specimen Pooling to Conserve SARS CoV-2 Testing Resources (edit) |
10.1101/2020.04.03.20050195 |
| 2020-04-06 |
A case of SARS-CoV-2 carrier for 32 days with several times false negative nucleic acid tests (edit) |
10.1101/2020.03.31.20045401 |
| 2020-04-06 |
Could SARS-CoV-2 be transmitted via speech droplets? (edit) |
10.1101/2020.04.02.20051177 |
| 2020-04-06 |
Rapid evidence summary on SARS-CoV-2 survivorship and disinfection, and a reusable PPE protocol using a double-hit process (edit) |
10.1101/2020.04.02.20051409 |
| 2020-04-06 |
COVID19-Tracker: A shiny app to produce comprehensive data visualization for SARS-CoV-2 epidemic in Spain (edit) |
10.1101/2020.04.01.20049684 |
| 2020-04-06 |
Flattening the curve before it flattens us: hospital critical care capacity limits and mortality from novel coronavirus (SARS-CoV2) cases in US counties (edit) |
10.1101/2020.04.01.20049759 |
| 2020-04-06 |
Fixed Wing Patient Air Transport during the Covid-19 Pandemic (edit) |
10.1016/J.AMJ.2020.04.001 |
| 2020-04-06 |
Pangolins Harbor SARS-CoV-2-Related Coronaviruses (edit) |
10.1016/J.TIM.2020.04.001 |
| 2020-04-05 |
Resilience or Resistance: A personal response to COVID-19 (edit) |
10.1111/MEDU.14170 |
| 2020-04-05 |
Macrolide treatment for COVID-19: Will this be the way forward? (edit) |
10.5582/BST.2020.03058 |
| 2020-04-05 |
A Simple Decision Analysis of a Mandatory Lockdown Response to the COVID-19 Pandemic (edit) |
10.1007/S40258-020-00581-W |
| 2020-04-05 |
COVID-19 Pandemic, a War to be Won: Understanding its Economic Implications for Africa (edit) |
10.1007/S40258-020-00580-X |
| 2020-04-05 |
The Effects of COVID-19 on Academic Activities and Surgical Education in Italy (edit) |
10.1080/08941939.2020.1748147 |
| 2020-04-05 |
COVID-19 Related Misinformation on Social Media: A Qualitative Study from Iran (edit) |
10.2196/18932 |
| 2020-04-05 |
Interpreting COVID-19 and Virtual Care Trends: Cohort Study (edit) |
10.2196/18811 |
| 2020-04-05 |
Infection and Rapid Transmission of SARS-CoV-2 in Ferrets (edit) |
10.1016/J.CHOM.2020.03.023 |
| 2020-04-05 |
In Vitro Diagnostic Assays for COVID-19: Recent Advances and Emerging Trends (edit) |
10.3390/DIAGNOSTICS10040202 |
| 2020-04-05 |
Prioritizing systemic therapies for genitourinary malignancies: Canadian recommendations during the COVID-19 pandemic (edit) |
10.5489/CUAJ.6595 |
| 2020-04-05 |
Preventing the spread of COVID-19 in digestive endoscopy during the resuming period: meticulous execution of screening procedures (edit) |
10.1016/J.GIE.2020.03.3855 |
| 2020-04-05 |
Gastrointestinal endoscopy during COVID-19 pandemic: an updated review of guidelines and statements from international and national societies (edit) |
10.1016/J.GIE.2020.03.3854 |
| 2020-04-05 |
Rational hand hygiene during COVID-19 pandemic (edit) |
10.1016/J.JAAD.2020.03.090 |
| 2020-04-05 |
The role of close contacts tracking management in COVID-19 prevention: A cluster investigation in Jiaxing, China (edit) |
10.1016/J.JINF.2020.03.015 |
| 2020-04-05 |
It is too soon to attribute ADE to COVID-19 (edit) |
10.1016/J.MICINF.2020.03.005 |
| 2020-04-05 |
COVID-19 and dengue, co-epidemics in Ecuador and other countries in Latin America: Pushing strained health care systems over the edge (edit) |
10.1016/J.TMAID.2020.101656 |
| 2020-04-05 |
Corona (COVID-19) time musings: Our involvement in COVID-19 pathogenesis, diagnosis, treatment and vaccine planning (edit) |
10.1016/J.AUTREV.2020.102538 |
| 2020-04-05 |
A chaotic and stressed environment for 2019-nCoV suspected, infected and other people in India: Fear of mass destruction and causality (edit) |
10.1016/J.AJP.2020.102049 |
| 2020-04-05 |
COVID-19 checklist: Mask, gloves, and video chatting with grandpa (edit) |
10.1016/J.PSYCHRES.2020.112986 |
| 2020-04-05 |
COVID-19: Considering the prevalence of schizophrenia in the coming decades (edit) |
10.1016/J.PSYCHRES.2020.112982 |
| 2020-04-05 |
Opinion to address a potential personal protective equipment shortage in the global community during the COVID-19 outbreak (edit) |
10.1016/J.POLYMDEGRADSTAB.2020.109162 |
| 2020-04-05 |
Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection (edit) |
10.1016/J.ECLINM.2020.100331 |
| 2020-04-05 |
Potent Antiviral Activities of Type I Interferons to SARS-CoV-2 Infection (edit) |
10.1101/2020.04.02.022764 |
| 2020-04-05 |
In-silico analysis of SARS-CoV-2 genomes: Insights from SARS encoded non-coding RNAs (edit) |
10.1101/2020.03.31.018499 |
| 2020-04-04 |
COVID-19 pneumonia manifestations at the admission on chest ultrasound, radiographs, and CT: single-center study and comprehensive radiologic literature review (edit) |
10.1016/J.EJRO.2020.100231 |
| 2020-04-04 |
COVID-19 and Telemedicine: Immediate action required for maintaining healthcare providers well-being (edit) |
10.1016/J.JCV.2020.104345 |
| 2020-04-04 |
Primary stratification and identification of suspected Corona virus disease 2019 (COVID-19) from clinical perspective by a simple scoring proposal (edit) |
10.1186/S40779-020-00246-8 |
| 2020-04-04 |
Updating the diagnostic criteria of COVID-19 "suspected case" and "confirmed case" is necessary (edit) |
10.1186/S40779-020-00245-9 |
| 2020-04-04 |
SARS-COV-2 and infectivity: Possible increase in infectivity associated to integrin motif expression (edit) |
10.1002/JMV.25831 |
| 2020-04-04 |
COVID-19: protecting our ENT workforce (edit) |
10.1111/COA.13542 |
| 2020-04-04 |
Liver transplantation in an ICU dominated by COVID-19 (edit) |
10.1002/LT.25770 |
| 2020-04-04 |
Respiratory failure alone does not suggest central nervous system invasion by SARS-CoV-2 (edit) |
10.1002/JMV.25828 |
| 2020-04-04 |
Response to Commentary on "The neuroinvasive potential of SARS-CoV-2 may play a role in the respiratory failure of COVID-19 patients" (edit) |
10.1002/JMV.25824 |
| 2020-04-04 |
An alteration of the dopamine synthetic pathway is possibly involved in the pathophysiology of COVID-19 (edit) |
10.1002/JMV.25826 |
| 2020-04-04 |
Dealing with sleep problems during home confinement due to the COVID-19 outbreak: practical recommendations from a task force of the European CBT-I Academy (edit) |
10.1111/JSR.13052 |
| 2020-04-04 |
Clinician Mental Health and Well-Being During Global Healthcare Crises: Evidence Learned From Prior Epidemics for COVID-19 Pandemic (edit) |
10.1111/WVN.12439 |
| 2020-04-04 |
Pulmonary High-Resolution Computed Tomography (HRCT) Findings of Patients with Early-Stage Coronavirus Disease 2019 (COVID-19) in Hangzhou, China (edit) |
10.12659/MSM.923885 |
| 2020-04-04 |
Favipiravir: pharmacokinetics and concerns about clinical trials for 2019-nCoV infection (edit) |
10.1002/CPT.1844 |
| 2020-04-04 |
Hospital surge capacity in a tertiary emergency referral centre during the COVID-19 outbreak in Italy (edit) |
10.1111/ANAE.15072 |
| 2020-04-04 |
The use of high-flow nasal oxygen in COVID-19 (edit) |
10.1111/ANAE.15073 |
| 2020-04-04 |
SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells (edit) |
10.15252/EMBJ.20105114 |
| 2020-04-04 |
Personal protective equipment during the COVID-19 pandemic - a narrative review (edit) |
10.1111/ANAE.15071 |
| 2020-04-04 |
Management of Inflammatory Bowel Diseases in the Wake of COVID-19 Pandemic (edit) |
10.1111/JGH.15056 |
| 2020-04-04 |
COVID-19 transmission through asymptomatic carriers is a challenge to containment (edit) |
10.1111/IRV.12743 |
| 2020-04-04 |
Medical Masks vs N95 Respirators for Preventing COVID-19 in Health Care Workers A Systematic Review and Meta-Analysis of Randomized Trials (edit) |
10.1111/IRV.12745 |
| 2020-04-04 |
Protection of CT suites from COVID‑19 infection in a tertiary emergency hospital (edit) |
10.1007/S11604-020-00964-Y |
| 2020-04-04 |
Global interim guidance on coronavirus disease 2019 (COVID-19) during pregnancy and puerperium from FIGO and allied partners: Information for healthcare professionals (edit) |
10.1002/IJGO.13156 |
| 2020-04-04 |
Mental health during and after the COVID-19 emergency in Italy (edit) |
10.1111/PCN.13004 |
| 2020-04-04 |
Laboratory Parameters in Detection of COVID-19 Patients with Positive RT-PCR; a Diagnostic Accuracy Study (edit) |
|
| 2020-04-04 |
Dermatology Residents and the Care of COVID-19 Patients (edit) |
10.1016/J.JAAD.2020.03.086 |
| 2020-04-04 |
COVID-19 contagion and contamination through hands of trauma patients: what risks and what precautions? (edit) |
10.1016/J.JHIN.2020.03.037 |
| 2020-04-04 |
Interleukin-6 as a potential biomarker of COVID-19 progression (edit) |
10.1016/J.MEDMAL.2020.04.002 |
| 2020-04-04 |
BARICITINIB - A JANUASE KINASE INHIBITOR - NOT AN IDEAL OPTION FOR MANAGEMENT OF COVID 19 (edit) |
10.1016/J.IJANTIMICAG.2020.105967 |
| 2020-04-04 |
COVID-19 in the Eastern Mediterranean Region and Saudi Arabia: Prevention and Therapeutic Strategies (edit) |
10.1016/J.IJANTIMICAG.2020.105968 |
| 2020-04-04 |
COVID-19 Infection in italian people with diabetes: lessons learned for our future (an experience to be used) (edit) |
10.1016/J.DIABRES.2020.108137 |
| 2020-04-04 |
[Taking preventive measures immediately: evidence from China on COVID-19] (edit) |
10.1016/J.GACETA.2020.03.002 |
| 2020-04-04 |
CT chest findings in coronavirus disease-19 (COVID-19) (edit) |
10.1016/J.JFMA.2020.03.010 |
| 2020-04-04 |
Keeping the Wheels of the Scientific Endeavor Turning during the COVID-19 Pandemic (edit) |
10.1016/J.CELS.2020.03.007 |
| 2020-04-04 |
Can atmospheric pollution be considered a co-factor in extremely high level of SARS-CoV-2 lethality in Northern Italy? (edit) |
10.1016/J.ENVPOL.2020.114465 |
| 2020-04-04 |
COVID-19: A promising cure for the global panic (edit) |
10.1016/J.SCITOTENV.2020.138277 |
| 2020-04-04 |
Upper airway symptoms in coronavirus disease 2019 (COVID-19) (edit) |
10.1016/J.AMJOTO.2020.102474 |
| 2020-04-04 |
COVID-19 Guidance for Triage of Operations for Thoracic Malignancies: A Consensus Statement from Thoracic Surgery Outcomes Research Network (edit) |
10.1016/J.ATHORACSUR.2020.03.005 |
| 2020-04-04 |
Unprecedented disruption of lives and work: Health, distress and life satisfaction of working adults in China one month into the COVID-19 outbreak (edit) |
10.1016/J.PSYCHRES.2020.112958 |
| 2020-04-04 |
Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: Guidelines for physicians (edit) |
10.1016/J.DSX.2020.04.001 |
| 2020-04-04 |
ICER's timelines for assessments extended due to COVID-19 (edit) |
10.1007/S40274-020-6689-5 |
| 2020-04-04 |
Investigating the cases of novel coronavirus disease (COVID-19) in China using dynamic statistical techniques (edit) |
10.1016/J.HELIYON.2020.E03747 |
| 2020-04-04 |
Cognitive biases operating behind the rejection of government safety advisories during COVID19 Pandemic (edit) |
10.1016/J.AJP.2020.102048 |
| 2020-04-04 |
Travel health risk perceptions of Chinese international students in Australia - Implications for COVID-19 (edit) |
10.1016/J.IDH.2020.03.002 |
| 2020-04-04 |
A Sever case of of SARS-CoV-2 infection in Gansu (edit) |
10.1016/J.NMNI.2020.100674 |
| 2020-04-04 |
[Covid-19 and some ethical issues in France] (edit) |
10.1016/J.JEMEP.2020.100510 |
| 2020-04-04 |
Coalition: Advocacy for prospective clinical trials to test the post-exposure potential of hydroxychloroquine against COVID-19 (edit) |
10.1016/J.ONEHLT.2020.100131 |
| 2020-04-04 |
Management Of Patients On Dialysis And With Kidney Transplant During SARS-COV-2 (COVID-19) Pandemic In Brescia, Italy (edit) |
10.1016/J.EKIR.2020.04.001 |
| 2020-04-04 |
The role of afferent pulmonary innervation in poor prognosis of acute respiratory distress syndrome in COVID-19 patients and proposed use of resiniferatoxin (RTX) to improve patient outcomes in advanced disease state: A review (edit) |
10.1016/J.MEDIDD.2020.100033 |
| 2020-04-04 |
Correlation between weather and Covid-19 pandemic in Jakarta, Indonesia (edit) |
10.1016/J.SCITOTENV.2020.138436 |
| 2020-04-04 |
Rapid Scholarly Dissemination and Cardiovascular Community Engagement to Combat the Infodemic of the COVID-19 Pandemic (edit) |
10.1016/J.CJCA.2020.03.042 |
| 2020-04-04 |
Smartphone-enabled wireless otoscope-assisted online telemedicine during the COVID-19 outbreak (edit) |
10.1016/J.AMJOTO.2020.102476 |
| 2020-04-04 |
Palliative care strategies offer guidance to clinicians and comfort for COVID-19 patient and families (edit) |
10.1016/J.HRTLNG.2020.04.001 |
| 2020-04-04 |
A Mini Review on Current Clinical and Research Findings for Children Suffering from COVID-19 (edit) |
10.1101/2020.03.30.20044545 |
| 2020-04-04 |
Angiotensin II Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors Usage is Associated with Improved Inflammatory Status and Clinical Outcomes in COVID-19 Patients With Hypertension (edit) |
10.1101/2020.03.31.20038935 |
| 2020-04-04 |
Detecting SARS-CoV-2 at point of care: Preliminary data comparing Loop-mediated isothermal amplification (LAMP) to PCR (edit) |
10.1101/2020.04.01.20047357 |
| 2020-04-04 |
Genomic epidemiology of SARS-CoV-2 in Guangdong Province, China (edit) |
10.1101/2020.04.01.20047076 |
| 2020-04-04 |
Fully human single-domain antibodies against SARS-CoV-2 (edit) |
10.1101/2020.03.30.015990 |
| 2020-04-04 |
Single-cell RNA Analysis on ACE2 Expression Provides Insight into SARS-CoV-2 Blood Entry and Heart Injury (edit) |
10.1101/2020.03.31.20047621 |
| 2020-04-04 |
El SARS-CoV-2, una nueva zoonosis pandémica que amenaza al mundo (edit) |
10.1016/J.VACUN.2020.03.001 |
| 2020-04-03 |
Respiratory virus shedding in exhaled breath and efficacy of face masks (edit) |
10.1038/S41591-020-0843-2 |
| 2020-04-03 |
SARS-CoV-2 neutralizing serum antibodies in cats: a serological investigation (edit) |
10.1101/2020.04.01.021196 |
| 2020-04-03 |
The Impact of the COVID-19 Pandemic on Disabled and Hospice Home Care Patients (edit) |
10.1093/GERONA/GLAA081 |
| 2020-04-03 |
Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12–March 28, 2020 (edit) |
10.15585/MMWR.MM6913E2 |
| 2020-04-03 |
Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro (edit) |
10.1016/J.ANTIVIRAL.2020.104786 |
| 2020-04-03 |
Impact of COVID-19 and Future Emerging Viruses on Hematopoietic Cell Transplantation and Other Cellular Therapies (edit) |
10.1089/SCD.2020.0064 |
| 2020-04-03 |
China empowers Internet hospital to fight against COVID-19 (edit) |
10.1016/J.JINF.2020.03.061 |
| 2020-04-03 |
Asymptomatic and Presymptomatic SARS-CoV-2 Infections in Residents of a Long-Term Care Skilled Nursing Facility - King County, Washington, March 2020 (edit) |
10.15585/MMWR.MM6913E1 |
| 2020-04-03 |
A call to arms: a perspective of safe general surgery in Singapore during the COVID-19 pandemic (edit) |
10.11622/SMEDJ.2020049 |
| 2020-04-03 |
Chapter of Gastroenterologists professional guidance on risk mitigation for gastrointestinal endoscopy during COVID-19 pandemic in Singapore (edit) |
10.11622/SMEDJ.2020050 |
| 2020-04-03 |
Clinics in Diagnostic Imaging: COVID-19 atypical pneumonia (edit) |
10.11622/SMEDJ.2020045 |
| 2020-04-03 |
Narrative synthesis of psychological and coping responses towards emerging infectious disease outbreaks in the general population: practical considerations for the COVID-19 pandemic (edit) |
10.11622/SMEDJ.2020046 |
| 2020-04-03 |
COVID-19: Challenges and opportunities for dermatology response (edit) |
10.1080/09546634.2020.1751040 |
| 2020-04-03 |
Harmonizing the COVID-19 cacophony: People need guidance (edit) |
10.1017/ICE.2020.105 |
| 2020-04-03 |
Lessons Learned From Korea: Covid-19 Pandemic (edit) |
10.1017/ICE.2020.104 |
| 2020-04-03 |
COVID-19 among medical personnel in the operating room (edit) |
10.1017/ICE.2020.106 |
| 2020-04-03 |
Case Report on Early Diagnosis of COVID-19 (edit) |
10.1017/DMP.2020.66 |
| 2020-04-03 |
How Is COVID-19 Affecting South Korea? What Is Our Current Strategy? (edit) |
10.1017/DMP.2020.69 |
| 2020-04-03 |
Limited early warnings and public attention to COVID-19 in China, January-February, 2020: a longitudinal cohort of randomly sampled Weibo users (edit) |
10.1017/DMP.2020.68 |
| 2020-04-03 |
A consensus statement on the use of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in relation to COVID-19 (corona virus disease 2019) (edit) |
|
| 2020-04-03 |
COVID-19 and smoking (edit) |
10.1093/NTR/NTAA059 |
| 2020-04-03 |
Consensus statement on the use of clozapine during the COVID-19 pandemic (edit) |
10.1503/JPN.200061 |
| 2020-04-03 |
Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan: A Retrospective Observational Study (edit) |
10.1164/RCCM.202003-0543OC |
| 2020-04-03 |
Substituting Angiotensin-(1-7) to Prevent Lung Damage in SARSCoV2 Infection? (edit) |
10.1161/CIRCULATIONAHA.120.047297 |
| 2020-04-03 |
Safe Handling of Containers of Expressed Human Milk in all Settings During the SARS-CoV-2 (COVID-19) Pandemic (edit) |
10.1177/0890334420919083 |
| 2020-04-03 |
The challenges and considerations of community-based preparedness at the onset of COVID-19 outbreak in Iran, 2020 (edit) |
10.1017/S0950268820000783 |
| 2020-04-03 |
Biorisk assessment for infrastructure & biosafety requirements for the laboratories providing coronavirus SARS-CoV-2/(COVID-19) diagnosis (edit) |
10.4103/IJMR.IJMR_763_20 |
| 2020-04-03 |
Addressing the COVID-19 Pandemic in Populations With Serious Mental Illness (edit) |
10.1001/JAMAPSYCHIATRY.2020.0894 |
| 2020-04-03 |
Personal Risk and Societal Obligation Amidst COVID-19 (edit) |
10.1001/JAMA.2020.5450 |
| 2020-04-03 |
Coronavirus Disease 2019 (COVID-19) Infection and Renin Angiotensin System Blockers (edit) |
10.1001/JAMACARDIO.2020.1282 |
| 2020-04-03 |
COVID-19 pandemic and cardiac imaging: EACVI recommendations on precautions, indications, prioritization, and protection for patients and healthcare personnel (edit) |
10.1093/EHJCI/JEAA072 |
| 2020-04-03 |
Experiences and lesson strategies for cardiology from the COVID-19 outbreak in Wuhan, China, by 'on the scene' cardiologists (edit) |
10.1093/EURHEARTJ/EHAA266 |
| 2020-04-03 |
SARS-CoV-2, the medical profession, ventilator beds, and mortality predictions: personal reflections of an Australian clinician (edit) |
10.5694/MJA2.50579 |
| 2020-04-03 |
Comments on "coinfection of SARS-CoV-2 and HIV in a patient in Wuhan city, China" (edit) |
10.1002/JMV.25821 |
| 2020-04-03 |
Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2: A systematic review and meta-analysis (edit) |
10.1002/JMV.25822 |
| 2020-04-03 |
Response to Carletti et al, "About the origin of the first two SARS-CoV-2 infections in Italy: Inference not supported by appropriate sequence analysis" (edit) |
10.1002/JMV.25823 |
| 2020-04-03 |
Neutrophil-to-lymphocyte ratio and lymphocyte-to-C-reactive protein ratio in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis (edit) |
10.1002/JMV.25819 |
| 2020-04-03 |
COVID-19 and diabetes (edit) |
10.1111/DME.14300 |
| 2020-04-03 |
Familial hypercholesterolemia and COVID-19: triggering of increased sustained cardiovascular risk (edit) |
10.1111/JOIM.13070 |
| 2020-04-03 |
Letter by Pilz et al Regarding Article, "Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on ST-Elevation Myocardial Infarction Care in Hong Kong, China" (edit) |
10.1161/CIRCOUTCOMES.120.006734 |
| 2020-04-03 |
The Variety of Cardiovascular Presentations of COVID-19 (edit) |
10.1161/CIRCULATIONAHA.120.047164 |
| 2020-04-03 |
Chest CT Features of COVID-19 in Rome, Italy (edit) |
10.1148/RADIOL.2020201237 |
| 2020-04-03 |
Regarding "Artificial Intelligence Distinguishes COVID-19 from Community Acquired Pneumonia on Chest CT" (edit) |
10.1148/RADIOL.2020201178 |
| 2020-04-03 |
Los derechos humanos de los niños con discapacidad durante emergencias sanitarias: el desafío de COVID-19 (edit) |
10.1111/DMCN.14529 |
| 2020-04-03 |
Positive externalities of an epidemic: The case of the coronavirus (COVID-19) in China (edit) |
10.1002/JMV.25830 |
| 2020-04-03 |
Global approaches for global challenges: The possible support of rehabilitation in the management of COVID-19 (edit) |
10.1002/JMV.25829 |
| 2020-04-03 |
The effectiveness of the quarantine of Wuhan city against the Corona Virus Disease 2019 (COVID-19): well-mixed SEIR model analysis (edit) |
10.1002/JMV.25827 |
| 2020-04-03 |
The Presence of SARS-CoV-2 RNA in Feces of COVID-19 Patients (edit) |
10.1002/JMV.25825 |
| 2020-04-03 |
Detection of antibodies against SARS-CoV-2 in patients with COVID-19 (edit) |
10.1002/JMV.25820 |
| 2020-04-03 |
WhatsApp messenger as a teledermatology tool during coronavirus disease (COVID-19): From Bedside to Phone-side (edit) |
10.1111/CED.14227 |
| 2020-04-03 |
COVID-19 Pneumonia as a Cause of Acute Chest Syndrome in an Adult Sickle Cell Patient (edit) |
10.1002/AJH.25809 |
| 2020-04-03 |
SARS Cov2 infection in a renal transplanted patients. A case report (edit) |
10.1111/AJT.15902 |
| 2020-04-03 |
Successful Treatment of Severe COVID-19 Pneumonia in a Liver Transplant Recipient (edit) |
10.1111/AJT.15901 |
| 2020-04-03 |
The COVID-19 outbreak in Italy: Initial implications for organ transplantation programs (edit) |
10.1111/AJT.15904 |
| 2020-04-03 |
Endonasal instrumentation and aerosolization risk in the era of COVID-19: simulation, literature review, and proposed mitigation strategies (edit) |
10.1002/ALR.22577 |
| 2020-04-03 |
A familial cluster, including a kidney transplant recipient, of Coronavirus Disease 2019 (COVID-19) in Wuhan, China (edit) |
10.1111/AJT.15903 |
| 2020-04-03 |
COVID-19 in posttransplant patients-report of 2 cases (edit) |
10.1111/AJT.15896 |
| 2020-04-03 |
Lessons unfolding from pediatric cases of COVID-19 disease caused by SARS-CoV-2 infection (edit) |
10.1002/PPUL.24748 |
| 2020-04-03 |
The isolation period should be longer: Lesson from a child infected with SARS-CoV-2 in Chongqing, China (edit) |
10.1002/PPUL.24763 |
| 2020-04-03 |
COVID-19 in children and altered inflammatory responses (edit) |
10.1038/S41390-020-0881-Y |
| 2020-04-03 |
Considerations on Colorectal Cancer Care in a COVID-19 Pandemic Epicenter (edit) |
|
| 2020-04-03 |
[Epidemiological characteristics of COVID-19 in Shaanxi province] (edit) |
10.3760/CMA.J.CN112338-20200225-00172 |
| 2020-04-03 |
[Comparison of two epidemic patterns of COVID-19 and evaluation of prevention and control effectiveness: an analysis based on Guangzhou and Wenzhou] (edit) |
10.3760/CMA.J.CN112338-20200303-00242 |
| 2020-04-03 |
Covid-19: Increased demand for steroid inhalers causes "distressing" shortages (edit) |
10.1136/BMJ.M1393 |
| 2020-04-03 |
COVID-19 outbreak and its monetary implications for dental practices, hospitals and healthcare workers (edit) |
10.1136/POSTGRADMEDJ-2020-137781 |
| 2020-04-03 |
Managing clinical trials for covid-19: the importance of ethics committees (edit) |
10.1136/BMJ.M1369 |
| 2020-04-03 |
Covid-19: PHE upgrades PPE advice for all patient contacts with risk of infection (edit) |
10.1136/BMJ.M1391 |
| 2020-04-03 |
COVID-19 and the Inpatient Dialysis Unit: Managing Resources During Contingency Planning Pre-Crisis (edit) |
10.2215/CJN.03750320 |
| 2020-04-03 |
A highly conserved cryptic epitope in the receptor-binding domains of SARS-CoV-2 and SARS-CoV (edit) |
10.1126/SCIENCE.ABB7269 |
| 2020-04-03 |
Covid-19: how a virus is turning the world upside down (edit) |
10.1136/BMJ.M1336 |
| 2020-04-03 |
Projecting hospital utilization during the COVID-19 outbreaks in the United States (edit) |
10.1073/PNAS.2004064117 |
| 2020-04-03 |
Covid-19 worldwide: we need precise data by age group and sex urgently (edit) |
10.1136/BMJ.M1366 |
| 2020-04-03 |
A pandemic in times of global tourism: superspreading and exportation of COVID-19 cases from a ski area in Austria (edit) |
10.1128/JCM.00588-20 |
| 2020-04-03 |
The Laboratory Diagnosis of COVID-19 Infection: Current Issues and Challenges (edit) |
10.1128/JCM.00512-20 |
| 2020-04-03 |
Regional anesthesia in patients with suspected COVID-19 infection (edit) |
10.1136/RAPM-2020-101477 |
| 2020-04-03 |
On being a neurologist in Italy at the time of the COVID-19 outbreak (edit) |
10.1212/WNL.0000000000009508 |
| 2020-04-03 |
Covid-19: government promises 100 000 tests per day in England by end of April (edit) |
10.1136/BMJ.M1392 |
| 2020-04-03 |
Controversies of renin-angiotensin system inhibition during the COVID-19 pandemic (edit) |
10.1038/S41581-020-0279-4 |
| 2020-04-03 |
COVID-19 in Africa (edit) |
10.1038/S41562-020-0870-5 |
| 2020-04-03 |
COVID-19 Research in Brief: 28 March to 3 April, 2020 (edit) |
10.1038/D41591-020-00008-Y |
| 2020-04-03 |
Mentoring during the COVID-19 pandemic (edit) |
10.1038/D41586-020-01028-X |
| 2020-04-03 |
Safely conducting essential research in the face of COVID-19 (edit) |
10.1038/D41586-020-01027-Y |
| 2020-04-03 |
Care for the psychological status of frontline medical staff fighting against COVID-19 (edit) |
10.1093/CID/CIAA385 |
| 2020-04-03 |
New measures for COVID-19 response: a lesson from the Wenzhou experience (edit) |
10.1093/CID/CIAA386 |
| 2020-04-03 |
The indispensable role of chest CT in the detection of coronavirus disease 2019 (COVID-19) (edit) |
10.1007/S00259-020-04795-X |
| 2020-04-03 |
Health services provision of 48 public tertiary dental hospitals during the COVID-19 epidemic in China (edit) |
10.1007/S00784-020-03267-8 |
| 2020-04-03 |
Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2 (edit) |
10.1007/S11239-020-02105-8 |
| 2020-04-03 |
The Impacts of Isolation Measures Against SARS-CoV-2 Infection on Sexual Health (edit) |
10.1007/S10461-020-02853-X |
| 2020-04-03 |
Clear plastic drapes may be effective at limiting aerosolization and droplet spray during extubation: implications for COVID-19 (edit) |
10.1007/S12630-020-01649-W |
| 2020-04-03 |
Rapid Scale-Up of Telehealth during the COVID-19 Pandemic and Implications for Subspecialty Care in Rural Areas (edit) |
10.1111/JRH.12433 |
| 2020-04-03 |
Strategies for Disseminating and Implementing COVID-19 Public Health Prevention Practices in Rural Areas (edit) |
10.1111/JRH.12432 |
| 2020-04-03 |
Proactive and Comprehensive Community Health Actions to Fight the COVID-19 Epidemic: Initial Lessons From Vietnam (edit) |
10.1111/JRH.12430 |
| 2020-04-03 |
Ethics and Economic Growth in the Age of COVID 19: What Is a Just Society to Do? (edit) |
10.1111/JRH.12434 |
| 2020-04-03 |
Early Lessons on the Importance of Lung Imaging in Novel Coronavirus Disease (COVID-19) (edit) |
10.4269/AJTMH.20-0225 |
| 2020-04-03 |
A Call for Randomized Controlled Trials to Test the Efficacy of Chloroquine and Hydroxychloroquine as Therapeutics against Novel Coronavirus Disease (COVID-19) (edit) |
10.4269/AJTMH.20-0230 |
| 2020-04-03 |
Focus on the "Crosstalk" Between COVID-19 and Urogenital Systems (edit) |
10.1097/JU.0000000000001068 |
| 2020-04-03 |
Implementing Telemedicine in Response to the 2020 COVID-19 Pandemic (edit) |
10.1097/JU.0000000000001033 |
| 2020-04-03 |
Triaging Office-Based Urologic Procedures During the COVID-19 Pandemic (edit) |
10.1097/JU.0000000000001034 |
| 2020-04-03 |
We Should Not Ignore What Scientific Articles Are Telling US: A Lesson From the Italian COVID19 Experience (edit) |
10.1097/JU.0000000000001069 |
| 2020-04-03 |
Recommendations for Tiered Stratification of Urologic Surgery Urgency in the COVID-19 Era (edit) |
10.1097/JU.0000000000001067 |
| 2020-04-03 |
Gastrointestinal symptoms as the first, atypical indication of SARS-CoV-2 infection (edit) |
10.20452/PAMW.15278 |
| 2020-04-03 |
Severe course of COVID-19 in a middle-aged man without risk factors (edit) |
10.20452/PAMW.15277 |
| 2020-04-03 |
Call to Action: Announcing the Traditional, Complementary and Integrative Health and Medicine COVID-19 Support Registry (edit) |
10.1089/ACM.2020.29083.JJW |
| 2020-04-03 |
Triage Considerations for Patients Referred for Structural Heart Disease Intervention During the Coronavirus Disease 2019 (COVID-19) Pandemic: An ACC /SCAI Consensus Statement (edit) |
10.1016/J.JCIN.2020.04.001 |
| 2020-04-03 |
A Mobile Health Platform to Disseminate Validated Institutional Measurements During the COVID-19 Outbreak: Utilization-Focused Evaluation Study (edit) |
10.2196/18668 |
| 2020-04-03 |
Internet Hospitals Help Prevent and Control the Epidemic of COVID-19 in China: Multicenter User Profiling Study (edit) |
10.2196/18908 |
| 2020-04-03 |
Are UK doctors getting sufficient protective equipment against covid-19? (edit) |
10.1136/BMJ.M1396 |
| 2020-04-03 |
Your COVID-19 Intubation Kit (edit) |
10.1213/ANE.0000000000004855 |
| 2020-04-03 |
Importance of oral and nasal decontamination for patients undergoing anesthetics during the COVID-19 era (edit) |
10.1213/ANE.0000000000004854 |
| 2020-04-03 |
Oral and nasal decontamination for COVID-19 patients: more harm than good? (edit) |
10.1213/ANE.0000000000004853 |
| 2020-04-03 |
Recommendations for respiratory rehabilitation in adults with COVID-19 (edit) |
10.1097/CM9.0000000000000848 |
| 2020-04-03 |
Mesenchymal Stem Cell Therapy Can Transcend Perianal Crohn's Disease: How Colorectal Surgeons Can Help in the COVID-19 Crisis (edit) |
10.1097/DCR.0000000000001700 |
| 2020-04-03 |
Preparing African anticancer centres in the COVID-19 outbreak (edit) |
10.1016/S1470-2045(20)30216-3 |
| 2020-04-03 |
Preparedness for COVID-19 in the oncology community in Africa (edit) |
10.1016/S1470-2045(20)30220-5 |
| 2020-04-03 |
Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection? (edit) |
10.1016/S2213-2600(20)30167-3 |
| 2020-04-03 |
Impact of school closures for COVID-19 on the US health-care workforce and net mortality: a modelling study (edit) |
10.1016/S2468-2667(20)30082-7 |
| 2020-04-03 |
Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease (edit) |
10.1016/J.LFS.2020.117627 |
| 2020-04-03 |
From China: hope and lessons for COVID-19 control (edit) |
10.1016/S1473-3099(20)30264-4 |
| 2020-04-03 |
Baricitinib for COVID-19: a suitable treatment? (edit) |
10.1016/S1473-3099(20)30262-0 |
| 2020-04-03 |
Baricitinib for COVID-19: a suitable treatment? - Authors' reply (edit) |
10.1016/S1473-3099(20)30270-X |
| 2020-04-03 |
A planetary health perspective on COVID-19: a call for papers (edit) |
10.1016/S2542-5196(20)30078-4 |
| 2020-04-03 |
COVID-19 Pandemic: Staged Management of Surgical Services for Gynecology and Obstetrics (edit) |
10.1016/J.AJOG.2020.03.038 |
| 2020-04-03 |
Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples from the Hong Kong Cohort and Systematic Review and Meta-analysis (edit) |
10.1053/J.GASTRO.2020.03.065 |
| 2020-04-03 |
Observation and analysis of 26 cases of asymptomatic SARS-COV2 infection (edit) |
10.1016/J.JINF.2020.03.028 |
| 2020-04-03 |
What is the role of rheumatologists in the era of COVID-19? (edit) |
10.1016/J.AUTREV.2020.102539 |
| 2020-04-03 |
The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease (edit) |
10.1016/J.AUTREV.2020.102537 |
| 2020-04-03 |
ACE2 at the centre of COVID-19 from paucisymptomatic infections to severe pneumonia (edit) |
10.1016/J.AUTREV.2020.102536 |
| 2020-04-03 |
Reply to "The use of traditional Chinese medicines to treat SARS-CoV-2 may cause more harm than good" (edit) |
10.1016/J.PHRS.2020.104775 |
| 2020-04-03 |
The use of Traditional Chinese Medicines to treat SARS-CoV-2 may cause more harm than good (edit) |
10.1016/J.PHRS.2020.104776 |
| 2020-04-03 |
The GReek study in the Effects of Colchicine in COvid-19 complications prevention (GRECCO-19 study): rationale and study design (edit) |
10.1016/J.HJC.2020.03.002 |
| 2020-04-03 |
Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection (edit) |
10.1016/J.IJANTIMICAG.2020.105960 |
| 2020-04-03 |
Perspectives: Potential Therapeutic Options for SARS-CoV-2 Patients Based on Feline Infectious Peritonitis Strategies: Central Nervous System Invasion and Drug Coverage (edit) |
10.1016/J.IJANTIMICAG.2020.105964 |
| 2020-04-03 |
The FDA-approved Drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro (edit) |
10.1016/J.ANTIVIRAL.2020.104787 |
| 2020-04-03 |
Spatial epidemic dynamics of the COVID-19 outbreak in China (edit) |
10.1016/J.IJID.2020.03.076 |
| 2020-04-03 |
Extracorporeal membrane oxygenation (ECMO): does it have a role in the treatment of severe COVID-19? (edit) |
10.1016/J.IJID.2020.03.058 |
| 2020-04-03 |
The enlightenment from two cases of asymptomatic infection with SARS-CoV-2: is it safe after 14 days of isolation? (edit) |
10.1016/J.IJID.2020.03.041 |
| 2020-04-03 |
Clinical characteristics of 25 death cases with COVID-19: a retrospective review of medical records in a single medical center, Wuhan, China (edit) |
10.1016/J.IJID.2020.03.053 |
| 2020-04-03 |
Perspectives on Surgery in the time of COVID-19: Safety First (edit) |
10.1016/J.JMIG.2020.04.003 |
| 2020-04-03 |
Clinical characteristics of non-critically ill patients with novel coronavirus infection (COVID-19) in a Fangcang Hospital (edit) |
10.1016/J.CMI.2020.03.032 |
| 2020-04-03 |
Residency and Fellowship Program Accreditation: Effects of the Novel Coronavirus (COVID-19) Pandemic (edit) |
10.1016/J.JAMCOLLSURG.2020.03.026 |
| 2020-04-03 |
Suspected acute abdomen as an extrapulmonary manifestation of Covid-19 infection (edit) |
10.1016/J.CIRESP.2020.03.006 |
| 2020-04-03 |
Surgical Management of Patients With COVID-19 Infection. Recommendations of the Spanish Association of Surgeons (edit) |
10.1016/J.CIRESP.2020.04.001 |
| 2020-04-03 |
Using Technology to Maintain the Education of Residents During the COVID-19 Pandemic (edit) |
10.1016/J.JSURG.2020.03.018 |
| 2020-04-03 |
The occurrence of diarrhea in COVID-19 patients (edit) |
10.1016/J.CLINRE.2020.03.017 |
| 2020-04-03 |
Hepatic and gastrointestinal involvement in coronavirus disease 2019 (COVID-19): What do we know till now? (edit) |
10.1016/J.AJG.2020.03.002 |
| 2020-04-03 |
Maxillofacial Trauma Management During COVID-19: Multidisciplinary Recommendations (edit) |
10.1089/FPSAM.2020.0158 |
| 2020-04-03 |
COVID-19, Australia: Epidemiology Report 9 (Reporting week to 23:59 AEDT 29 March 2020) (edit) |
10.33321/CDI.2020.44.29 |
| 2020-04-03 |
Effects of Social Grooming on Incivility in COVID-19 (edit) |
10.1089/CYBER.2020.0201 |
| 2020-04-03 |
"Pandemic fear" and COVID-19: mental health burden and strategies (edit) |
10.1590/1516-4446-2020-0008 |
| 2020-04-03 |
Chest radiography and computed tomography findings from a Brazilian patient with COVID-19 pneumonia (edit) |
10.1590/0037-8682-0134-2020 |
| 2020-04-03 |
COVID-19 OUTBREAK IN NORTHERN ITALY: VIEWPOINT OF THE MILAN AREA SURGICAL COMMUNITY (edit) |
10.1097/TA.0000000000002695 |
| 2020-04-03 |
Pregnancy and Sars-Cov-2: A Novel Virus in a Unique Population (edit) |
|
| 2020-04-03 |
Covid-19: The Pandemic of Our Time (edit) |
|
| 2020-04-03 |
Provision of Service During the Covid-19 Pandemic (edit) |
|
| 2020-04-03 |
Protecting Our Longevity Dividend During Covid-19 (edit) |
|
| 2020-04-03 |
Caring for the Psychological Well-Being of Healthcare Professionals in the Covid-19 Pandemic Crisis (edit) |
|
| 2020-04-03 |
Social Media Spread During Covid-19: The Pros and Cons of Likes and Shares (edit) |
|
| 2020-04-03 |
Optimisation of Vitamin D Status for Enhanced Immuno-protection Against Covid-19 (edit) |
|
| 2020-04-03 |
Vitamin D, Covid-19 and Children (edit) |
|
| 2020-04-03 |
Supply of Personal Protective Equipment (PPE) During the Covid-19 Pandemic (edit) |
|
| 2020-04-03 |
Anosmia and ageusia are emerging as symptoms in patients with COVID-19: What does the current evidence say? (edit) |
10.3332/ECANCER.2020.ED98 |
| 2020-04-03 |
The COVID-19 pandemic: Important considerations for contact lens practitioners (edit) |
10.1016/J.CLAE.2020.03.012 |
| 2020-04-03 |
Hospital pharmacists' pharmaceutical care for hospitalized patients with COVID-19: Recommendations and guidance from clinical experience (edit) |
10.1016/J.SAPHARM.2020.03.027 |
| 2020-04-03 |
Challenges of SARS-CoV-2 and lessons learnt from SARS in Guangdong Province, China (edit) |
10.1016/J.JCV.2020.104341 |
| 2020-04-03 |
Recommendations on management of the SARS-CoV-2 coronavirus pandemic (Covid-19) in kidney transplant patients (edit) |
10.1016/J.NEFRO.2020.03.002 |
| 2020-04-03 |
Epidemic psychiatry: The opportunities and challenges of COVID-19 (edit) |
10.1016/J.GENHOSPPSYCH.2020.03.009 |
| 2020-04-03 |
Early nutritional supplementation in non-critically ill patients hospitalized for the 2019 novel coronavirus disease (COVID-19): Rationale and feasibility of a shared pragmatic protocol (edit) |
10.1016/J.NUT.2020.110835 |
| 2020-04-03 |
Effects of COVID 19 pandemic in daily life (edit) |
10.1016/J.CMRP.2020.03.011 |
| 2020-04-03 |
Potential TRPV1 blockade to treat severe lung dysfunction in COVID-19 infection (edit) |
10.1016/J.MEDIDD.2020.100034 |
| 2020-04-03 |
[Palliation in patients with severe COVID-19] (edit) |
|
| 2020-04-03 |
Operational Strategies to Prevent Coronavirus Disease 2019 (COVID-19) Spread in Radiology: Experience From a Singapore Radiology Department After Severe Acute Respiratory Syndrome (edit) |
10.1016/J.JACR.2020.03.027 |
| 2020-04-03 |
SARS-CoV-2 and COVID-19 (edit) |
10.1016/J.JMII.2020.03.033 |
| 2020-04-03 |
The coronavirus pandemic and aerosols: Does COVID-19 transmit via expiratory particles? (edit) |
10.1080/02786826.2020.1749229 |
| 2020-04-03 |
Anosmia and Dysgeusia in the Absence of Other Respiratory Diseases: Should COVID-19 Infection Be Considered? (edit) |
10.12890/2020_001641 |
| 2020-04-03 |
Medication Shortages During the COVID-19 Crisis: What We Must Do (edit) |
10.1016/J.MAYOCP.2020.04.001 |
| 2020-04-03 |
Orthopedic surgery post COVID-19: an opportunity for innovation and transformation (edit) |
10.1016/J.JSE.2020.03.024 |
| 2020-04-03 |
[Clozapine prescription in the wake of the coronavirus (SARS CoV-2) outbreak: What measures? Why?] (edit) |
10.1016/J.ENCEP.2020.04.001 |
| 2020-04-03 |
Clinical features, Diagnosis, and Treatment of COVID-19: A systematic review of case reports and case series (edit) |
10.1101/2020.03.28.20046151 |
| 2020-04-03 |
Interleukin-6 in COVID-19: A Systematic Review and Meta-Analysis (edit) |
10.1101/2020.03.30.20048058 |
| 2020-04-03 |
COVID-19 infection during pregnancy: A systematic review to summarize possible symptoms, treatments, and pregnancy outcomes (edit) |
10.1101/2020.03.31.20049304 |
| 2020-04-03 |
Clinical Manifestations of Children with COVID-19: a Systematic Review (edit) |
10.1101/2020.04.01.20049833 |
| 2020-04-03 |
The QT Interval in Patients with SARS-CoV-2 Infection Treated with Hydroxychloroquine/Azithromycin (edit) |
10.1101/2020.04.02.20047050 |
| 2020-04-03 |
Radiological findings for diagnosis of SARS-CoV-2 pneumonia (COVID-19) (edit) |
10.1016/J.MEDCLI.2020.03.004 |
| 2020-04-03 |
Lopinavir/ritonavir did not shorten the duration of SARS CoV-2 shedding in patients with mild pneumonia in Taiwan (edit) |
10.1016/J.JMII.2020.03.032 |
| 2020-04-03 |
T Cell Epitope-Based Vaccine Design for Pandemic Novel Coronavirus 2019-nCoV (edit) |
10.26434/CHEMRXIV.12029523 |
| 2020-04-03 |
Novel Coronavirus (2019-nCoV) in Disguise (edit) |
10.7759/CUREUS.7521 |
| 2020-04-03 |
Meteorological factors correlate with transmission of 2019-nCoV: Proof of incidence of novel coronavirus pneumonia in Hubei Province, China (edit) |
10.1101/2020.04.01.20050526 |
| 2020-04-03 |
In silico approach for designing of a multi-epitope based vaccine against novel Coronavirus (SARS-COV-2) (edit) |
10.1101/2020.03.31.017459 |
| 2020-04-03 |
Deducing the N- and O- glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2 (edit) |
10.1101/2020.04.01.020966 |
| 2020-04-03 |
Using ILI surveillance to estimate state-specific case detection rates and forecast SARS-CoV-2 spread in the United States (edit) |
10.1101/2020.04.01.20050542 |
| 2020-04-03 |
Insights into The Codon Usage Bias of 13 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Isolates from Different Geo-locations (edit) |
10.1101/2020.04.01.019463 |
| 2020-04-03 |
LxxIxE-like Motif in Spike Protein of SARS-CoV-2 that is Known to Recruit the Host PP2A-B56 Phosphatase Mimics Artepillin C, an Immunomodulator, of Brazilian Green Propolis (edit) |
10.1101/2020.04.01.020941 |
| 2020-04-03 |
A SARS-CoV-2 Vaccination Strategy Focused on Population-Scale Immunity (edit) |
10.1101/2020.03.31.018978 |
| 2020-04-03 |
Urological recommendations regarding surgical care of suspected or confirmed SARS-CoV-2 or COVID-19 + patients (edit) |
10.1016/J.ACURO.2020.04.001 |
| 2020-04-02 |
Frequent Hand Washing for COVID-19 Prevention Can Cause Hand Dermatitis: Management Tips (edit) |
10.7759/CUREUS.7506 |
| 2020-04-02 |
Can the Coronavirus Disease 2019 (COVID-19) Affect the Eyes? A Review of Coronaviruses and Ocular Implications in Humans and Animals (edit) |
10.1080/09273948.2020.1738501 |
| 2020-04-02 |
Chloroquine and hydroxychloroquine to treat COVID-19: between hope and caution (edit) |
10.1080/15563650.2020.1748194 |
| 2020-04-02 |
An assessment of United States dermatology practices during the COVID-19 outbreak (edit) |
10.1080/09546634.2020.1750556 |
| 2020-04-02 |
A case of imported COVID-19 diagnosed by PCR-positive lower respiratory specimen but with PCR-negative throat swabs (edit) |
10.1080/23744235.2020.1744711 |
| 2020-04-02 |
Just the Facts: Protecting frontline clinicians during the COVID-19 pandemic (edit) |
10.1017/CEM.2020.359 |
| 2020-04-02 |
[From SARS to COVID-19: pathogens, receptor, pathogenesis and principles of the treatment] (edit) |
10.3760/CMA.J.CN112151-20200318-00220 |
| 2020-04-02 |
Global Telemedicine Implementation and Integration Within Health Systems to Fight the COVID-19 Pandemic: A Call to Action (edit) |
10.2196/18810 |
| 2020-04-02 |
The COVID-19 pandemic: we are all in this together (edit) |
10.1093/CID/CIAA369 |
| 2020-04-02 |
COVID-19 and experiences of moral injury in front-line key workers (edit) |
10.1093/OCCMED/KQAA052 |
| 2020-04-02 |
Governmental Public Health Powers During the COVID-19 Pandemic: Stay-at-home Orders, Business Closures, and Travel Restrictions (edit) |
10.1001/JAMA.2020.5460 |
| 2020-04-02 |
Critical health literacy and the COVID-19 crisis (edit) |
10.1093/HEAPRO/DAAA040 |
| 2020-04-02 |
Response to: Sore throat in COVID-19: comment on "Clinical characteristics of hospitalized patients with SARS-CoV-2 infection: A single arm meta-analysis" (edit) |
10.1002/JMV.25818 |
| 2020-04-02 |
Early advice on managing children with cancer during the COVID-19 pandemic and a call for sharing experiences (edit) |
10.1002/PBC.28327 |
| 2020-04-02 |
Older people and COVID-19: Isolation, risk and ageism (edit) |
10.1111/JOCN.15274 |
| 2020-04-02 |
Liver impairment in COVID-19 patients: a retrospective analysis of 115 cases from a single center in Wuhan city, China (edit) |
10.1111/LIV.14455 |
| 2020-04-02 |
The versatile heparin in COVID-19 (edit) |
10.1111/JTH.14821 |
| 2020-04-02 |
Teaching in the time of COVID-19 (edit) |
10.1002/BMB.21348 |
| 2020-04-02 |
Differential Diagnosis for Coronavirus Disease (COVID-19): Beyond Radiologic Features (edit) |
10.2214/AJR.20.23119 |
| 2020-04-02 |
COVID-19 Outbreak Associated with Air Conditioning in Restaurant, Guangzhou, China, 2020 (edit) |
10.3201/EID2607.200764 |
| 2020-04-02 |
Use of Rapid Online Surveys to Assess People's Perceptions During Infectious Disease Outbreaks: A Cross-sectional Survey on COVID-19 (edit) |
10.2196/18790 |
| 2020-04-02 |
Emergence of a Novel Coronavirus (COVID-19): Protocol for Extending Surveillance Used by the Royal College of General Practitioners Research and Surveillance Centre and Public Health England (edit) |
10.2196/18606 |
| 2020-04-02 |
Preventive Behaviors Conveyed on YouTube to Mitigate Transmission of COVID-19: Cross-Sectional Study (edit) |
10.2196/18807 |
| 2020-04-02 |
Isolated sudden onset anosmia in COVID-19 infection. A novel syndrome? (edit) |
10.4193/RHIN20.114 |
| 2020-04-02 |
Communication Skills in the Age of COVID-19 (edit) |
10.7326/M20-1376 |
| 2020-04-02 |
First Mildly Ill, Non-Hospitalized Case of Coronavirus Disease 2019 (COVID-19) Without Viral Transmission in the United States - Maricopa County, Arizona, 2020 (edit) |
10.1093/CID/CIAA374 |
| 2020-04-02 |
When Epidemics Collide: Coronavirus Disease 2019 (COVID-19) and the Opioid Crisis (edit) |
10.7326/M20-1210 |
| 2020-04-02 |
Collision of the COVID-19 and Addiction Epidemics (edit) |
10.7326/M20-1212 |
| 2020-04-02 |
Coronavirus disease 2019 (COVID-19): a clinical update (edit) |
10.1007/S11684-020-0767-8 |
| 2020-04-02 |
Uncertainty in using chest computed tomography in early coronavirus disease (COVID-19) (edit) |
10.1007/S12630-020-01639-Y |
| 2020-04-02 |
Post-donation COVID-19 identification in blood donors (edit) |
10.1111/VOX.12925 |
| 2020-04-02 |
The impact of the SARS-CoV-2 outbreak on the safety and availability of blood transfusions in Italy (edit) |
10.1111/VOX.12928 |
| 2020-04-02 |
Collecting and evaluating convalescent plasma for COVID-19 treatment: why and how (edit) |
10.1111/VOX.12926 |
| 2020-04-02 |
How young patients with cancer perceive the Covid-19 (coronavirus) epidemic in Milan, Italy: is there room for other fears? (edit) |
10.1002/PBC.28318 |
| 2020-04-02 |
Thinking Globally, Acting Locally - The U.S. Response to Covid-19 (edit) |
10.1056/NEJMP2006740 |
| 2020-04-02 |
Covid-19 and Health Care's Digital Revolution (edit) |
10.1056/NEJMP2005835 |
| 2020-04-02 |
Flattening the Curve for Incarcerated Populations - Covid-19 in Jails and Prisons (edit) |
10.1056/NEJMP2005687 |
| 2020-04-02 |
SARS-CoV-2 is not detectable in the vaginal fluid of women with severe COVID-19 infection (edit) |
10.1093/CID/CIAA375 |
| 2020-04-02 |
Gargle lavage as a safe and sensitive alternative to swab samples to diagnose COVID-19: a case report in Japan (edit) |
10.1093/CID/CIAA377 |
| 2020-04-02 |
Coronavirus SARS-CoV-2: Empfehlungen für die nuklearmedizinische Versorgung in nuklearmedizinischen Kliniken/Abteilungen mit Therapiestation und Praxen, Instituten sowie Ordinationen (edit) |
10.1055/A-1147-6722 |
| 2020-04-02 |
COVID-19: Uncharted waters (edit) |
10.31128/AJGP-COVID-01 |
| 2020-04-02 |
Australia’s primary care COVID-19 response (edit) |
10.31128/AJGP-COVID-02 |
| 2020-04-02 |
General practice, COVID-19 and living with uncertainty (edit) |
10.31128/AJGP-COVID-03 |
| 2020-04-02 |
A novel treatment approach to the novel coronavirus: an argument for the use of therapeutic plasma exchange for fulminant COVID-19 (edit) |
10.1186/S13054-020-2836-4 |
| 2020-04-02 |
Fighting covid-19 outbreaks in prisons (edit) |
10.1136/BMJ.M1362 |
| 2020-04-02 |
Covid-19: Can France's ethical support units help doctors make challenging decisions? (edit) |
10.1136/BMJ.M1291 |
| 2020-04-02 |
Are UK doctors getting sufficient protective equipment against covid-19? (edit) |
10.1136/BMJ.M1297 |
| 2020-04-02 |
Lessons from the Experience in Wuhan to Reduce Risk of COVID-19 Infection in Patients Undergoing Long-Term Hemodialysis (edit) |
10.2215/CJN.03420320 |
| 2020-04-02 |
To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (Covid-19) pandemic (edit) |
10.1136/ANNRHEUMDIS-2020-217367 |
| 2020-04-02 |
Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies (edit) |
10.1136/ANNRHEUMDIS-2020-217424 |
| 2020-04-02 |
Hydroxychloroquine: a potential ethical dilemma for rheumatologists during the COVID-19 pandemic (edit) |
10.3899/JRHEUM.200369 |
| 2020-04-02 |
Covid-19: doctors' visas are automatically extended for one year (edit) |
10.1136/BMJ.M1381 |
| 2020-04-02 |
Covid-19: Patients who are improving could have treatment withdrawn if others could benefit more (edit) |
10.1136/BMJ.M1382 |
| 2020-04-02 |
Covid-19: Rules on sharing confidential patient information are relaxed in England (edit) |
10.1136/BMJ.M1378 |
| 2020-04-02 |
Covid-19: four fifths of cases are asymptomatic, China figures indicate (edit) |
10.1136/BMJ.M1375 |
| 2020-04-02 |
Practice of endoscopy during COVID-19 pandemic: position statements of the Asian Pacific Society for Digestive Endoscopy (APSDE-COVID statements) (edit) |
10.1136/GUTJNL-2020-321185 |
| 2020-04-02 |
Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection (edit) |
10.1136/GUTJNL-2020-321013 |
| 2020-04-02 |
Prevention of nosocomial SARS-CoV-2 transmission in endoscopy: international recommendations and the need for a gold standard (edit) |
10.1136/GUTJNL-2020-321154 |
| 2020-04-02 |
Treating multiple sclerosis and neuromyelitis optica spectrum disorder during the COVID-19 pandemic (edit) |
10.1212/WNL.0000000000009507 |
| 2020-04-02 |
What the stock market tells us about the post-COVID-19 world (edit) |
10.1038/S41562-020-0869-Y |
| 2020-04-02 |
Cancer, COVID-19 and the precautionary principle: prioritizing treatment during a global pandemic (edit) |
10.1038/S41571-020-0362-6 |
| 2020-04-02 |
Lockdown in Italy: personal stories of doing science during the COVID-19 quarantine (edit) |
10.1038/D41586-020-01001-8 |
| 2020-04-02 |
Safeguard research in the time of COVID-19 (edit) |
10.1038/S41591-020-0852-1 |
| 2020-04-02 |
In reply: Uncertainty in using chest computed tomography in early coronavirus disease (COVID-19) (edit) |
10.1007/S12630-020-01640-5 |
| 2020-04-02 |
Decreased "WBC*LYM" was observed in SARS-CoV-2-infected patients from a fever clinic in Wuhan (edit) |
10.1515/CCLM-2020-0270 |
| 2020-04-02 |
One disease, different features: COVID-19 laboratory and radiological findings in three Italian patients (edit) |
10.1515/CCLM-2020-0319 |
| 2020-04-02 |
Laboratory diagnostics within a modular hospital at the time of Coronavirus disease 2019 (COVID-19) in Wuhan (edit) |
10.1515/CCLM-2020-0332 |
| 2020-04-02 |
Clinical laboratory and SARS-CoV-2 infection: where do we stand? (edit) |
10.1515/CCLM-2020-0372 |
| 2020-04-02 |
Public engagement is key for containing COVID-19 pandemic (edit) |
10.4103/IJMR.IJMR_780_20 |
| 2020-04-02 |
Cancer guidelines during the COVID-19 pandemic (edit) |
10.1016/S1470-2045(20)30217-5 |
| 2020-04-02 |
Medical student involvement in the COVID-19 response (edit) |
10.1016/S0140-6736(20)30795-9 |
| 2020-04-02 |
Monitoring behavioural insights related to COVID-19 (edit) |
10.1016/S0140-6736(20)30729-7 |
| 2020-04-02 |
Global coalition to accelerate COVID-19 clinical research in resource-limited settings (edit) |
10.1016/S0140-6736(20)30798-4 |
| 2020-04-02 |
Monitoring the COVID-19 epidemic in the context of widespread local transmission (edit) |
10.1016/S2213-2600(20)30162-4 |
| 2020-04-02 |
COVID-19: the current situation in Afghanistan (edit) |
10.1016/S2214-109X(20)30124-8 |
| 2020-04-02 |
Why inequality could spread COVID-19 (edit) |
10.1016/S2468-2667(20)30085-2 |
| 2020-04-02 |
Tocilizumab, an anti-IL6 receptor antibody, to treat Covid-19-related respiratory failure: a case report (edit) |
10.1016/J.ANNONC.2020.03.300 |
| 2020-04-02 |
Fighting the battle against SARS-CoV-2 as gastroenterologists in Italy (edit) |
10.1053/J.GASTRO.2020.03.067 |
| 2020-04-02 |
Faecal-oral transmission of SARS-COV-2: practical implications (edit) |
10.1053/J.GASTRO.2020.03.066 |
| 2020-04-02 |
Uneventful course in IBD patients during SARS-CoV-2 outbreak in northern Italy (edit) |
10.1053/J.GASTRO.2020.03.062 |
| 2020-04-02 |
Cleveland Clinic Akron General Urology Residency Program's COVID-19 Experience (edit) |
10.1016/J.UROLOGY.2020.04.001 |
| 2020-04-02 |
USE OF A MODIFIED VENTILATION MASK TO AVOID AEROSOLIZING SPREAD OF DROPLETS FOR SHORT ENDOSCOPIC PROCEDURES DURING CORONAVIRUS COVID-19 OUTBREAK (edit) |
10.1016/J.GIE.2020.03.3853 |
| 2020-04-02 |
COVID-19 pandemic through the lens of a gastroenterology fellow: looking for the silver lining (edit) |
10.1016/J.GIE.2020.03.3852 |
| 2020-04-02 |
Effects of the COVID-19 Outbreak in Northern Italy: Perspectives from the Bergamo Neurosurgery Department (edit) |
10.1016/J.WNEU.2020.03.179 |
| 2020-04-02 |
3CLpro inhibitors as a potential therapeutic option for COVID-19: Available evidence and ongoing clinical trials (edit) |
10.1016/J.PHRS.2020.104779 |
| 2020-04-02 |
Delivery of infection from asymptomatic carriers of COVID-19 in a familial cluster (edit) |
10.1016/J.IJID.2020.03.042 |
| 2020-04-02 |
Precautions for Operating Room Team Members during the COVID-19 Pandemic (edit) |
10.1016/J.JAMCOLLSURG.2020.03.030 |
| 2020-04-02 |
Surgical Decision Making in the Era of COVID-19: A New Set of Rules (edit) |
10.1016/J.JMIG.2020.04.001 |
| 2020-04-02 |
Understanding the "Scope" of the Problem: Why Laparoscopy is Considered Safe During the COVID-19 Pandemic (edit) |
10.1016/J.JMIG.2020.04.002 |
| 2020-04-02 |
Repurposing antimalarials and other drugs for COVID-19 (edit) |
10.1016/J.TMAID.2020.101658 |
| 2020-04-02 |
Clinical features of the first cases and a cluster of Coronavirus Disease 2019 (COVID-19) in Bolivia imported from Italy and Spain (edit) |
10.1016/J.TMAID.2020.101653 |
| 2020-04-02 |
Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidence (edit) |
10.1016/J.TMAID.2020.101647 |
| 2020-04-02 |
Summary of the COVID-19 outbreak in Vietnam - Lessons and suggestions (edit) |
10.1016/J.TMAID.2020.101651 |
| 2020-04-02 |
Incidence of novel coronavirus (2019-nCoV) infection among people under home quarantine in Shenzhen, China (edit) |
10.1016/J.TMAID.2020.101660 |
| 2020-04-02 |
Behavioral and Emotional Disorders in Children during the COVID-19 Epidemic (edit) |
10.1016/J.JPEDS.2020.03.013 |
| 2020-04-02 |
The "helmet bundle" in COVID-19 patients undergoing non invasive ventilation (edit) |
10.1016/J.ICCN.2020.102859 |
| 2020-04-02 |
Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses (edit) |
10.1016/J.IT.2020.03.007 |
| 2020-04-02 |
COVID-19 pneumonia in Taiwan (edit) |
10.1016/J.JFMA.2020.03.009 |
| 2020-04-02 |
Author reply to Letters to the Editor "CT chest findings in coronavirus disease (COVID-19)" (edit) |
10.1016/J.JFMA.2020.03.012 |
| 2020-04-02 |
[Coronavirus infection (COVID-19) in Anales de Pediatría] (edit) |
10.1016/J.ANPEDI.2020.03.004 |
| 2020-04-02 |
Dental journals and coronavirus disease (COVID-19): A current view (edit) |
10.1016/J.ORALONCOLOGY.2020.104664 |
| 2020-04-02 |
Tracking COVID-19 in Europe: An Infodemiology Study (edit) |
10.2196/18941 |
| 2020-04-02 |
COVID-19 Pandemic and JBJS (edit) |
10.2106/JBJS.20.00471 |
| 2020-04-02 |
Managing patients with chronic pain during the Covid-19 outbreak: considerations for the rapid introduction of remotely supported (e-health) pain management services (edit) |
10.1097/J.PAIN.0000000000001885 |
| 2020-04-02 |
Epidemiology, virology, and clinical features of severe acute respiratory syndrome -coronavirus-2 (SARS-CoV-2; Coronavirus Disease-19) (edit) |
10.3345/CEP.2020.00493 |
| 2020-04-02 |
Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths (edit) |
10.3390/NU12040988 |
| 2020-04-02 |
The possible of immunotherapy for COVID-19: A systematic review (edit) |
10.1016/J.INTIMP.2020.106455 |
| 2020-04-02 |
Challenges with the management of older patients with cancer during the COVID-19 pandemic (edit) |
10.1016/J.JGO.2020.03.020 |
| 2020-04-02 |
Hearing loss and COVID-19: A note (edit) |
10.1016/J.AMJOTO.2020.102473 |
| 2020-04-02 |
Low-cost production of handrubs and face shields in developing countries fighting the COVID19 pandemic (edit) |
10.1016/J.AJIC.2020.03.016 |
| 2020-04-02 |
Nutrition support in the time of SARS-CoV-2 (COVID-19) (edit) |
10.1016/J.NUT.2020.110834 |
| 2020-04-02 |
The novel coronavirus (2019-nCoV) in pregnancy: What we need to know (edit) |
10.1016/J.EJOGRB.2020.04.006 |
| 2020-04-02 |
End-of-life decisions and care in the midst of a global coronavirus (COVID-19) pandemic (edit) |
10.1016/J.ICCN.2020.102862 |
| 2020-04-02 |
Cardiovascular Considerations in Treating Patients with Coronavirus (COVID-19) (edit) |
10.1097/FJC.0000000000000836 |
| 2020-04-02 |
ACE2, COVID19 and serum ACE as a possible biomarker to predict severity of disease (edit) |
10.1016/J.JCV.2020.104350 |
| 2020-04-02 |
Keratoconjunctivitis as the initial medical presentation of the novel coronavirus disease 2019 (COVID-19) (edit) |
10.1016/J.JCJO.2020.03.003 |
| 2020-04-02 |
Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper (edit) |
10.1016/J.JHEPR.2020.100113 |
| 2020-04-02 |
Several potential risks of novel coronavirus (COVID-19) pneumonia outbreaks in hospitals (edit) |
10.1016/J.AJIC.2020.04.001 |
| 2020-04-02 |
Physiotherapists during COVID-19: usual business, in unusual times (edit) |
10.1016/J.JPHYS.2020.03.012 |
| 2020-04-02 |
Healthcare impact of COVID-19 epidemic in India: A stochastic mathematical model (edit) |
10.1016/J.MJAFI.2020.03.022 |
| 2020-04-02 |
[Triage strategy for suspected cases of COVID-19 with increasing numbers of patients] (edit) |
10.1007/S10049-020-00700-Z |
| 2020-04-02 |
On a Statistical Transmission Model in Analysis of the Early Phase of COVID-19 Outbreak (edit) |
10.1007/S12561-020-09277-0 |
| 2020-04-02 |
Suggestions on the prevention of COVID-19 for health care workers in department of otorhinolaryngology head and neck surgery (edit) |
10.1016/J.WJORL.2020.03.002 |
| 2020-04-02 |
Telemental Health in the Context of a Pandemic: the COVID-19 Experience (edit) |
10.1007/S40501-020-00210-2 |
| 2020-04-02 |
Covid-19, Coronavirus and Mental Health Rehabilitation at Times of Crisis (edit) |
10.1007/S40737-020-00162-Z |
| 2020-04-02 |
A living systematic review protocol for COVID-19 clinical trial registrations (edit) |
10.12688/WELLCOMEOPENRES.15821.1 |
| 2020-04-02 |
Dr. Hong Yu leads a team battling against the COVID-19 outbreak in Wuhan (edit) |
10.1016/J.LERS.2020.03.002 |
| 2020-04-02 |
Prudently conduct the engineering and synthesis of the SARS-CoV-2 virus (edit) |
10.1016/J.SYNBIO.2020.03.002 |
| 2020-04-02 |
Linear Regression Analysis to predict the number of deaths in India due to SARS-CoV-2 at 6 weeks from day 0 (100 cases - March 14th 2020) (edit) |
10.1016/J.DSX.2020.03.017 |
| 2020-04-02 |
Addressing Challenges in Obtaining Emergency Medicine Away Rotations and Standardized Letters of Evaluation Due to COVID-19 Pandemic (edit) |
10.5811/WESTJEM.2020.3.47444 |
| 2020-04-02 |
Re-emergence of SARS-CoV2 in a discharged COVID-19 case (edit) |
10.1016/J.JMII.2020.03.031 |
| 2020-04-02 |
Experience and suggestion of medical practices for burns during the outbreak of COVID-19 (edit) |
10.1016/J.BURNS.2020.03.014 |
| 2020-04-02 |
Identification of a common deletion in the spike protein of SARS-CoV-2 (edit) |
10.1101/2020.03.31.015941 |
| 2020-04-02 |
Molecular Basis for ADP-ribose Binding to the Macro-X Domain of SARS-CoV-2 Nsp3 (edit) |
10.1101/2020.03.31.014639 |
| 2020-04-02 |
SARS-CoV-2 receptor and entry genes are expressed by sustentacular cells in the human olfactory neuroepithelium (edit) |
10.1101/2020.03.31.013268 |
| 2020-04-02 |
Characterization and treatment of SARS-CoV-2 in nasal and bronchial human airway epithelia (edit) |
10.1101/2020.03.31.017889 |
| 2020-04-02 |
Virus-host interactome and proteomic survey of PMBCs from COVID-19 patients reveal potential virulence factors influencing SARS-CoV-2 pathogenesis (edit) |
10.1101/2020.03.31.019216 |
| 2020-04-02 |
Comparative genomics suggests limited variability and similar evolutionary patterns between major clades of SARS-CoV-2 (edit) |
10.1101/2020.03.30.016790 |
| 2020-04-02 |
A Gaussian model for the time development of the Sars-Cov-2 corona pandemic disease. Predictions for Germany made on March 30, 2020 (edit) |
10.1101/2020.03.31.20048942 |
| 2020-04-02 |
Assessment of the SARS-CoV-2 basic reproduction number, R 0, based on the early phase of COVID-19 outbreak in Italy (edit) |
10.1016/J.BSHEAL.2020.03.004 |
| 2020-04-02 |
Stability of SARS-CoV-2 in different environmental conditions (edit) |
10.1016/S2666-5247(20)30003-3 |
| 2020-04-01 |
SARS-CoV-2 infection among returnees on charter flights to Japan from Hubei, China: a report from National Center for Global Health and Medicine (edit) |
10.35772/GHM.2020.01036 |
| 2020-04-01 |
U.S. Economic Activity During the Early Weeks of the SARS-Cov-2 Outbreak (edit) |
10.3386/W26954 |
| 2020-04-01 |
Bezobjawowe zakażenia SARS-CoV-2 u dzieci – czy i w jaki sposób należy je monitorować w kolejnych miesiącach pandemii? (edit) |
10.15374/FZ2020017 |
| 2020-04-01 |
The crystal structure of papain-like protease of SARS CoV-2 (edit) |
10.2210/PDB6W9C/PDB |
| 2020-04-01 |
COULD NOVEL CORONA VIRUS (SARS-CoV-2) BE THE EVOLVING FACE OF A NEWGENERATION OF GENETICALLY COMPLEX EPIDEMIOLOGICAL CHALLENGE? (edit) |
10.31674/MJMR.2020.V04I02.006 |
| 2020-04-01 |
Coronaviruses: genome structure, replication, and pathogenesis (edit) |
10.1002/JMV.25681 |
| 2020-04-01 |
Molecular diagnosis of a novel coronavirus (2019-nCoV) causing an outbreak of pneumonia (edit) |
10.1093/CLINCHEM/HVAA029 |
| 2020-04-01 |
The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 (edit) |
10.1038/S41564-020-0695-Z |
| 2020-04-01 |
CT Imaging of the 2019 Novel Coronavirus (2019-nCoV) Pneumonia (edit) |
10.1148/RADIOL.2020200236 |
| 2020-04-01 |
[Recommendations for critically ill patients with COVID-19] (edit) |
10.1007/S00063-020-00674-3 |
| 2020-04-01 |
The proximal origin of SARS-CoV-2 (edit) |
10.1038/S41591-020-0820-9 |
| 2020-04-01 |
Emerging 2019 Novel Coronavirus (2019-nCoV) Pneumonia (edit) |
10.1148/RADIOL.2020200274 |
| 2020-04-01 |
Successful containment of COVID-19: the WHO-Report on the COVID-19 outbreak in China (edit) |
10.1007/S15010-020-01409-4 |
| 2020-04-01 |
Racing Towards the Development of Diagnostics for a Novel Coronavirus (2019-nCoV) (edit) |
10.1093/CLINCHEM/HVAA038 |
| 2020-04-01 |
Is schizophrenia research relevant during the COVID-19 pandemic? (edit) |
10.1016/J.SCHRES.2020.04.002 |
| 2020-04-01 |
Letalidad del COVID-19: ausencia de patrón epidemiológico (edit) |
10.1016/J.GACETA.2020.04.001 |
| 2020-04-01 |
Can Chinese Medicine Be Used for Prevention of Corona Virus Disease 2019 (COVID-19)? A Review of Historical Classics, Research Evidence and Current Prevention Programs (edit) |
10.1007/S11655-020-3192-6 |
| 2020-04-01 |
Changes of CT findings in a 2019 novel coronavirus (2019-nCoV) pneumonia patient (edit) |
10.1093/QJMED/HCAA038 |
| 2020-04-01 |
Puzzle of highly pathogenic human coronaviruses (2019-nCoV) (edit) |
10.1007/S13238-020-00693-Y |
| 2020-04-01 |
Coronavirus 2019-nCoV: A brief perspective from the front line (edit) |
10.1016/J.JINF.2020.02.010 |
| 2020-04-01 |
World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19) (edit) |
10.1016/J.IJSU.2020.02.034 |
| 2020-04-01 |
COVID-19: Not a Simple Public Health Emergency (edit) |
10.1017/S1049023X2000031X |
| 2020-04-01 |
The convalescent sera option for containing COVID-19 (edit) |
10.1172/JCI138003 |
| 2020-04-01 |
COVID19 -Nuclear Medicine Departments, be prepared! (edit) |
10.1097/MNM.0000000000001183 |
| 2020-04-01 |
Émergence du coronavirus SARS-CoV-2 : faire face à l'épidémie de COVID-19 (edit) |
|
| 2020-04-01 |
[Coronavirus disease 2019 (COVID-19): update for anesthesiologists and intensivists March 2020] (edit) |
10.1007/S00101-020-00758-X |
| 2020-04-01 |
Expert consensus for managing pregnant women and neonates born to mothers with suspected or confirmed novel coronavirus (COVID-19) infection (edit) |
10.1002/IJGO.13146 |
| 2020-04-01 |
COVID-19: A Singapore Orthopedic Resident's Musings in the Emergency Department (edit) |
10.1111/ACEM.13970 |
| 2020-04-01 |
COVID-19: a fast evolving pandemic (edit) |
10.1093/TRSTMH/TRAA025 |
| 2020-04-01 |
Patients with mental health disorders in the COVID-19 epidemic (edit) |
10.1016/S2215-0366(20)30090-0 |
| 2020-04-01 |
Mental health care for international Chinese students affected by the COVID-19 outbreak (edit) |
10.1016/S2215-0366(20)30089-4 |
| 2020-04-01 |
[COVID-19 coronavirus: what implications for Cardiology?] (edit) |
10.1714/3328.32981 |
| 2020-04-01 |
Practical indications for the prevention and management of SARS-CoV-2 in ambulatory dialysis patients: lessons from the first phase of the epidemics in Lombardy (edit) |
10.1007/S40620-020-00727-Y |
| 2020-04-01 |
COVID-19: opportunity arises from a world health crisis (edit) |
10.1007/S10928-020-09681-5 |
| 2020-04-01 |
Senior Medical Students in the COVID-19 Response: An Opportunity to Be Proactive (edit) |
10.1111/ACEM.13972 |
| 2020-04-01 |
Assessment of Health Information About COVID-19 Prevention on the Internet: Infodemiological Study (edit) |
10.2196/18717 |
| 2020-04-01 |
As We Went to Press: COVID-19 Continues to Spread (edit) |
10.1097/01.NAJ.0000659956.26994.75 |
| 2020-04-01 |
What the cruise-ship outbreaks reveal about COVID-19 (edit) |
10.1038/D41586-020-00885-W |
| 2020-04-01 |
COVID-19 in a patient with chronic lymphocytic leukaemia (edit) |
10.1016/S2352-3026(20)30074-0 |
| 2020-04-01 |
US public health budget cuts in the face of COVID-19 (edit) |
10.1016/S1473-3099(20)30182-1 |
| 2020-04-01 |
We're in this together: helping veterinarians navigate COVID-19 (edit) |
10.2460/JAVMA.256.8.868 |
| 2020-04-01 |
Letter to the editor: Headline stress disorder caused by Netnews during the outbreak of COVID-19 (edit) |
10.1111/HEX.13055 |
| 2020-04-01 |
Fast reshaping of intensive care unit facilities in a large metropolitan hospital in Milan, Italy: facing the COVID-19 pandemic emergency (edit) |
|
| 2020-04-01 |
[SARS-CoV-2-a challenge for all of us] (edit) |
10.1007/S00347-020-01097-3 |
| 2020-04-01 |
Correction to: Practical indications for the prevention and management of SARS-CoV-2 in ambulatory dialysis patients: lessons from the first phase of the epidemics in Lombardy (edit) |
10.1007/S40620-020-00729-W |
| 2020-04-01 |
Mental Health and Psychological Intervention Amid COVID-19 Outbreak: Perspectives from South Korea (edit) |
10.3349/YMJ.2020.61.4.271 |
| 2020-04-01 |
Have a heart during the COVID-19 crisis: Making the case for cardiac rehabilitation in the face of an ongoing pandemic (edit) |
10.1177/2047487320915665 |
| 2020-04-01 |
Coronavirus Disease 2019 (COVID-19): Do Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect? (edit) |
10.1161/JAHA.120.016509 |
| 2020-04-01 |
Coronavirus Disease 2019 (COVID-19) and Cardiovascular Disease: A Viewpoint on the Potential Influence of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers on Onset and Severity of Severe Acute Respiratory Syndrome Coronavirus 2 (edit) |
10.1161/JAHA.120.016219 |
| 2020-04-01 |
COVID19 and Breastfeeding: Not That Simple (edit) |
10.1177/0890334420917102 |
| 2020-04-01 |
Editorial: Managing the march of COVID-19: lessons from the HIV and AIDS epidemic (edit) |
10.2989/16085906.2020.1749792 |
| 2020-04-01 |
COVID-19 - is the ACE2 just a foe? (edit) |
10.1152/AJPLUNG.00119.2020 |
| 2020-04-01 |
Temporary Emergency Guidance to US Stroke Centers During the COVID-19 Pandemic (edit) |
10.1161/STROKEAHA.120.030023 |
| 2020-04-01 |
Implications for Online Management: Two Cases with COVID-19 (edit) |
10.1089/TMJ.2020.0066 |
| 2020-04-01 |
Protected Code Stroke: Hyperacute Stroke Management During the Coronavirus Disease 2019 (COVID-19) Pandemic (edit) |
10.1161/STROKEAHA.120.029838 |
| 2020-04-01 |
When infection prevention enters the temple: Intergenerational social distancing and COVID-19 (edit) |
10.1017/ICE.2020.100 |
| 2020-04-01 |
The consequences of the COVID-19 pandemic on mental health and implications for clinical practice (edit) |
10.1192/J.EURPSY.2020.35 |
| 2020-04-01 |
Epidemiologic Features of 135 Patients With Coronavirus Disease (COVID-19) in Tianjin, China (edit) |
10.1017/DMP.2020.63 |
| 2020-04-01 |
How to surge to face SARS-CoV-2 outbreak. Lessons learned from Lumbardy, Italy (edit) |
10.1017/DMP.2020.64 |
| 2020-04-01 |
[An epidemiologic thinking on the diagnosis criteria of COVID-19] (edit) |
10.3760/CMA.J.CN112338-20200226-00181 |
| 2020-04-01 |
[Epidemiological characteristics of COVID-19 in Gansu province] (edit) |
10.3760/CMA.J.CN112338-20200229-00216 |
| 2020-04-01 |
[Investigation of an epidemic cluster caused by COVID⁃19 cases in incubation period in Shanghai] (edit) |
10.3760/CMA.J.CN112338-20200302-00236 |
| 2020-04-01 |
[Progress and challenge of vaccine development against 2019 novel coronavirus (2019-nCoV)] (edit) |
10.3760/CMA.J.CN112150-20200317-00366 |
| 2020-04-01 |
[First case of neonate with COVID-19 in China] (edit) |
10.3760/CMA.J.CN112140-20200212-00081 |
| 2020-04-01 |
Predicting COVID-19 Incidence Through Analysis of Google Trends Data in Iran: Data Mining and Deep Learning Pilot Study (edit) |
10.2196/18828 |
| 2020-04-01 |
Share mobile and social-media data to curb COVID-19 (edit) |
10.1038/D41586-020-00908-6 |
| 2020-04-01 |
Speculation is not evidence: antihypertensive therapy and COVID-19 (edit) |
10.1093/EHJCVP/PVAA021 |
| 2020-04-01 |
Environment and Personal Protective Equipment Tests for SARS-CoV-2 in the Isolation Room of an Infant With Infection (edit) |
10.7326/M20-0942 |
| 2020-04-01 |
Potential Legal Liability for Withdrawing or Withholding Ventilators During COVID-19: Assessing the Risks and Identifying Needed Reforms (edit) |
10.1001/JAMA.2020.5442 |
| 2020-04-01 |
Testing Individuals for Coronavirus Disease 2019 (COVID-19) (edit) |
10.1001/JAMA.2020.5388 |
| 2020-04-01 |
Active and Effective Measures for the Care of Patients With Cancer During the COVID-19 Spread in China (edit) |
10.1001/JAMAONCOL.2020.1198 |
| 2020-04-01 |
Combating COVID-19 with Chloroquine (edit) |
10.1093/JMCB/MJAA015 |
| 2020-04-01 |
Treating COVID-19 with Chloroquine (edit) |
10.1093/JMCB/MJAA014 |
| 2020-04-01 |
[Legal Issues of Resource Allocation in the COVID-19 Pandemic - Between Utilitarianism and Life Value Indifference] (edit) |
10.1055/A-1146-1160 |
| 2020-04-01 |
SARS-CoV-2/COVID-19: Empfehlungen für die Radiologische Versorgung – Eine Stellungnahme, der Deutschen Röntgengesellschaft (DRG), der Deutschen Gesellschaft für Neuroradiologie (DGNR), der Gesellschaft für Pädiatrische Radiologie (GPR), der Deutsche (edit) |
10.1055/A-1149-3625 |
| 2020-04-01 |
Why the immune system fails to mount an adaptive immune response to a Covid -19 infection (edit) |
10.1111/TRI.13611 |
| 2020-04-01 |
COVID19: Why justice and transparency in hospital triage policies are paramount (edit) |
10.1111/BIOE.12744 |
| 2020-04-01 |
Differences between COVID-19 and suspected then confirmed SARS-CoV-2-negative pneumonia: a retrospective study from a single center (edit) |
10.1002/JMV.25810 |
| 2020-04-01 |
SARS-CoV-2 pandemics: The lack of critical reflection addressing short- and long-term challenges (edit) |
10.1002/HPM.2977 |
| 2020-04-01 |
Is Pakistan prepared for the COVID-19 epidemic? A questionnaire-based survey (edit) |
10.1002/JMV.25814 |
| 2020-04-01 |
What does androgenetic alopecia have to do with COVID-19? An insight into a potential new therapy (edit) |
10.1111/DTH.13365 |
| 2020-04-01 |
A New Symptom of COVID-19: Loss of Taste and Smell (edit) |
10.1002/OBY.22809 |
| 2020-04-01 |
Obesity and its Implications for COVID-19 Mortality (edit) |
10.1002/OBY.22818 |
| 2020-04-01 |
COVID 19 and the Patient with Obesity - The Editors Speak Out (edit) |
10.1002/OBY.22808 |
| 2020-04-01 |
Anosmia and ageusia: common findings in COVID-19 patients (edit) |
10.1002/LARY.28692 |
| 2020-04-01 |
Treatment approach in locally advanced rectal cancer during Coronavirus (COVID-19) pandemic: long course or short course? (edit) |
10.1111/CODI.15058 |
| 2020-04-01 |
Isolation and rapid sharing of the 2019 novel coronavirus (SARS-CoV-2) from the first patient diagnosed with COVID-19 in Australia (edit) |
10.5694/MJA2.50569 |
| 2020-04-01 |
An Uncomplicated Delivery in a Patient with Covid-19 in the United States (edit) |
10.1056/NEJMC2007605 |
| 2020-04-01 |
Universal Masking in Hospitals in the Covid-19 Era (edit) |
10.1056/NEJMP2006372 |
| 2020-04-01 |
The fiscal value of human lives lost from coronavirus disease (COVID-19) in China (edit) |
10.1186/S13104-020-05044-Y |
| 2020-04-01 |
[From Tuberculosis to COVID-19: Legal and Constitutional Framework Regarding Compulsory Isolation/Treatment due to Contagious Diseases in Portugal] (edit) |
10.20344/AMP.13562 |
| 2020-04-01 |
Covid-19: UK deaths are higher than previously reported, new data suggest (edit) |
10.1136/BMJ.M1330 |
| 2020-04-01 |
Covid-19: Hospitals can remove 15% cap on testing of NHS staff (edit) |
10.1136/BMJ.M1339 |
| 2020-04-01 |
Covid-19: Use radiotherapy only if "unavoidable," says NICE (edit) |
10.1136/BMJ.M1338 |
| 2020-04-01 |
Socioeconomic gradient in health and the covid-19 outbreak (edit) |
10.1136/BMJ.M1329 |
| 2020-04-01 |
David Oliver: Covid-19 will make us stop some activities for good (edit) |
10.1136/BMJ.M1148 |
| 2020-04-01 |
Covid-19: death rate is 0.66% and increases with age, study estimates (edit) |
10.1136/BMJ.M1327 |
| 2020-04-01 |
Covid-19: US gives emergency approval to hydroxychloroquine despite lack of evidence (edit) |
10.1136/BMJ.M1335 |
| 2020-04-01 |
Covid-19: New York City deaths pass 1000 as Trump tells Americans to distance for 30 days (edit) |
10.1136/BMJ.M1333 |
| 2020-04-01 |
Clinical Research Slows as COVID-19 Surges (edit) |
10.1158/2159-8290.CD-NB2020-021 |
| 2020-04-01 |
Diagnostic evaluation of pulmonary embolism during the COVID-19 pandemic (edit) |
10.2967/JNUMED.120.245571 |
| 2020-04-01 |
Dr. Li Wenliang and the Time of COVID-19 (edit) |
10.2967/JNUMED.120.245712 |
| 2020-04-01 |
INCIDENTAL FINDINGS SUGGESTIVE OF COVID-19 IN ASYMPTOMATIC PATIENTS UNDERGOING NUCLEAR MEDICINE PROCEDURES IN A HIGH PREVALENCE REGION (edit) |
10.2967/JNUMED.120.246256 |
| 2020-04-01 |
Imaging clinic operations in the times of COVID-19: Strategies, Precautions and Experiences (edit) |
10.2967/JNUMED.120.245738 |
| 2020-04-01 |
Does COVID19 infect the brain? If so, smokers might be at a higher risk (edit) |
10.1124/MOLPHARM.120.000014 |
| 2020-04-01 |
The COVID-19 pandemic: major risks to healthcare and other workers on the front line (edit) |
10.1136/OEMED-2020-106567 |
| 2020-04-01 |
Neurologists and Covid-19: A note on courage in a time of uncertainty (edit) |
10.1212/WNL.0000000000009496 |
| 2020-04-01 |
COVID-19 is catalyzing the adoption of teleneurology (edit) |
10.1212/WNL.0000000000009494 |
| 2020-04-01 |
Computational inference of selection underlying the evolution of the novel coronavirus, SARS-CoV-2 (edit) |
10.1128/JVI.00411-20 |
| 2020-04-01 |
Isolation and full-length genome characterization of SARS-CoV-2 from COVID-19 cases in Northern Italy (edit) |
10.1128/JVI.00543-20 |
| 2020-04-01 |
Perinatal-Neonatal Management of COVID-19 Infection - Guidelines of the Federation of Obstetric and Gynecological Societies of India (FOGSI), National Neonatology Forum of India (NNF), and Indian Academy of Pediatrics (IAP) (edit) |
|
| 2020-04-01 |
Potential covalent drugs targeting the main protease of the SARS-CoV-2 coronavirus (edit) |
10.1093/BIOINFORMATICS/BTAA224 |
| 2020-04-01 |
The COVID-19 pandemic calls for spatial distancing and social closeness: not for social distancing! (edit) |
10.1007/S00038-020-01366-7 |
| 2020-04-01 |
Reply to ocular manifestation, eye protection, and COVID-19 (edit) |
10.1007/S00417-020-04663-2 |
| 2020-04-01 |
Development of a Novel Reverse Transcription Loop-Mediated Isothermal Amplification Method for Rapid Detection of SARS-CoV-2 (edit) |
10.1007/S12250-020-00218-1 |
| 2020-04-01 |
Warning Against the Use of Anti-Inflammatory Medicines to Cure COVID-19: Building Castles in the Air (edit) |
10.1007/S12325-020-01321-1 |
| 2020-04-01 |
Proposal of a low-dose, long-pitch, dual-source chest CT protocol on third-generation dual-source CT using a tin filter for spectral shaping at 100 kVp for CoronaVirus Disease 2019 (COVID-19) patients: a feasibility study (edit) |
10.1007/S11547-020-01179-X |
| 2020-04-01 |
Sore throat in COVID-19: Comment on "Clinical characteristics of hospitalized patients with SARS-CoV-2 infection: A single arm meta-analysis" (edit) |
10.1002/JMV.25815 |
| 2020-04-01 |
Comments on Zhang et al.: Clinical trial analysis of 2019-nCoV therapy registered in China (edit) |
10.1002/JMV.25806 |
| 2020-04-01 |
Fecal transmission in COVID-19: A potential shedding route (edit) |
10.1002/JMV.25816 |
| 2020-04-01 |
SARS-CoV-2 spike protein favors ACE2 from Bovidae and Cricetidae (edit) |
10.1002/JMV.25817 |
| 2020-04-01 |
Our Italian Experience Using Lung Ultrasound for Identification, Grading and Serial Follow-up of Severity of Lung Involvement for Management of Patients with COVID-19 (edit) |
10.1111/ECHO.14664 |
| 2020-04-01 |
Priorities for global health community in COVID-19 pandemic (edit) |
10.1111/DTH.13361 |
| 2020-04-01 |
Comment on "COVID-19 and psoriasis: Is it time to limit treatment with immunosuppressants? A call for action" (edit) |
10.1111/DTH.13360 |
| 2020-04-01 |
Clinical findings in a patient with haemophilia A affected by COVID-19 (edit) |
10.1111/HAE.14000 |
| 2020-04-01 |
Coronavirus disease 2019 (COVID-19): facts and controversies (edit) |
10.1111/DTH.13366 |
| 2020-04-01 |
Covid-19 : articuler au mieux le savoir scientifique et le pouvoir politique (edit) |
|
| 2020-04-01 |
COVID-19: global consequences for oncology (edit) |
10.1016/S1470-2045(20)30175-3 |
| 2020-04-01 |
Emergency departments and the COVID-19 pandemic: making the most of limited resources (edit) |
10.1136/EMERMED-2020-209660 |
| 2020-04-01 |
Vaccine designers take first shots at COVID-19 (edit) |
10.1126/SCIENCE.368.6486.14 |
| 2020-04-01 |
As normalcy returns, can China keep COVID-19 at bay? (edit) |
10.1126/SCIENCE.368.6486.18 |
| 2020-04-01 |
Making allowances for COVID-19 (edit) |
10.1126/SCIENCE.368.6486.98 |
| 2020-04-01 |
Special report: The simulations driving the world's response to COVID-19 (edit) |
10.1038/D41586-020-01003-6 |
| 2020-04-01 |
Audio Interview: Lessons from Covid-19 Hotspots (edit) |
10.1056/NEJME2007783 |
| 2020-04-01 |
The COVID-19: Role of Ambulatory Surgery Facilities in This Global Pandemic (edit) |
10.1213/ANE.0000000000004847 |
| 2020-04-01 |
Characteristics and Early Prognosis of COVID-19 Infection in Fracture Patients (edit) |
10.2106/JBJS.20.00390 |
| 2020-04-01 |
European Society For Emergency Medicine position paper on emergency medical systems response to COVID-19 (edit) |
10.1097/MEJ.0000000000000701 |
| 2020-04-01 |
COVID-19: emergency medicine perspectives from Hong Kong (edit) |
10.1097/MEJ.0000000000000708 |
| 2020-04-01 |
First case of COVID-19 in a patient with multiple myeloma successfully treated with tocilizumab (edit) |
10.1182/BLOODADVANCES.2020001907 |
| 2020-04-01 |
Message from the Editor: Stem Cell Science in the Time of COVID-19 (edit) |
10.1016/J.STEMCR.2020.03.022 |
| 2020-04-01 |
Master Regulator Analysis of the SARS-CoV-2/Human Interactome (edit) |
10.3390/JCM9040982 |
| 2020-04-01 |
Covid-19 crisis forces CVS to cut services (edit) |
10.1136/VR.M1343 |
| 2020-04-01 |
In other covid-19 news (edit) |
10.1136/VR.M1347 |
| 2020-04-01 |
Possible treatment of Covid-19 with a therapeutic vaccine (edit) |
10.1136/VR.M1302 |
| 2020-04-01 |
Can companion animals become infected with Covid-19? (edit) |
10.1136/VR.M1322 |
| 2020-04-01 |
Coping with Covid-19 (edit) |
10.1136/VR.M1355 |
| 2020-04-01 |
Learning from our immunological history: What can SARS-CoV teach us about SARS-CoV-2? (edit) |
10.1126/SCIIMMUNOL.ABB8618 |
| 2020-04-01 |
How we treat patients with lung cancer during the SARS-CoV-2 pandemic: primum non nocere (edit) |
10.1136/ESMOOPEN-2020-000765 |
| 2020-04-01 |
UK senior police officer with COVID-19 (edit) |
10.1016/S2213-2600(20)30164-8 |
| 2020-04-01 |
Using observational data to quantify bias of traveller-derived COVID-19 prevalence estimates in Wuhan, China (edit) |
10.1016/S1473-3099(20)30229-2 |
| 2020-04-01 |
Modelling COVID-19 transmission: from data to intervention (edit) |
10.1016/S1473-3099(20)30258-9 |
| 2020-04-01 |
US NICUs and donor milk banks brace for COVID-19 (edit) |
10.1016/S2352-4642(20)30103-6 |
| 2020-04-01 |
Strategic plan for management of COVID-19 in paediatric haematology and oncology departments (edit) |
10.1016/S2352-3026(20)30104-6 |
| 2020-04-01 |
Handling the COVID-19 pandemic in the oncological setting (edit) |
10.1016/S2352-3026(20)30108-3 |
| 2020-04-01 |
Essential care of critical illness must not be forgotten in the COVID-19 pandemic (edit) |
10.1016/S0140-6736(20)30793-5 |
| 2020-04-01 |
Racism and discrimination in COVID-19 responses (edit) |
10.1016/S0140-6736(20)30792-3 |
| 2020-04-01 |
Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence? (edit) |
10.1016/S1474-4422(20)30109-5 |
| 2020-04-01 |
COVID-19 pandemic in west Africa (edit) |
10.1016/S2214-109X(20)30123-6 |
| 2020-04-01 |
SARS-CoV-2 in wastewater: potential health risk, but also data source (edit) |
10.1016/S2468-1253(20)30087-X |
| 2020-04-01 |
COVID-19, syphilis and biologic therapies for psoriasis and psoriatic arthritis: A word of caution (edit) |
10.1016/J.JAAD.2020.03.079 |
| 2020-04-01 |
Ultraviolet germicidal irradiation: possible method for respirator disinfection to facilitate reuse during COVID-19 pandemic (edit) |
10.1016/J.JAAD.2020.03.085 |
| 2020-04-01 |
The SARS-CoV-2 epidemic: how the Italian public is being informed (edit) |
10.1016/J.CMI.2020.03.037 |
| 2020-04-01 |
Guidance for Cardiac Electrophysiology During the Coronavirus (COVID-19) Pandemic from the Heart Rhythm Society COVID-19 Task Force; Electrophysiology Section of the American College of Cardiology; and the Electrocardiography and Arrhythmias Committ (edit) |
10.1016/J.HRTHM.2020.03.028 |
| 2020-04-01 |
Probable aircraft transmission of Covid-19 in-flight from the Central African Republic to France (edit) |
10.1016/J.TMAID.2020.101643 |
| 2020-04-01 |
Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and COVID-19 infection during pregnancy (edit) |
10.1016/J.TMAID.2020.101641 |
| 2020-04-01 |
Pancreatic injury patterns in patients with COVID-19 pneumonia (edit) |
10.1053/J.GASTRO.2020.03.055 |
| 2020-04-01 |
The Global Impact of COVID-19 on Vascular Surgical Services (edit) |
10.1016/J.JVS.2020.03.024 |
| 2020-04-01 |
A military perspective on the vascular surgeon's response to the COVID-19 pandemic (edit) |
10.1016/J.JVS.2020.03.036 |
| 2020-04-01 |
Potential effect of blood purification therapy in reducing cytokine storm as a late complication of critically ill COVID-19 (edit) |
10.1016/J.CLIM.2020.108408 |
| 2020-04-01 |
Palliative Care Pandemic Pack: a Specialist Palliative Care Service response to planning the COVID-19 pandemic (edit) |
10.1016/J.JPAINSYMMAN.2020.03.026 |
| 2020-04-01 |
Recommendations for the surgical management of gynecological cancers during the COVID-19 pandemic - FRANCOGYN group for the CNGOF (edit) |
10.1016/J.JOGOH.2020.101729 |
| 2020-04-01 |
COVID-19 will not leave behind refugees and migrants (edit) |
10.1016/S0140-6736(20)30758-3 |
| 2020-04-01 |
The COVID-19 pandemic in the USA: what might we expect? (edit) |
10.1016/S0140-6736(20)30743-1 |
| 2020-04-01 |
A planetary health perspective on COVID-19: a call for papers (edit) |
10.1016/S0140-6736(20)30742-X |
| 2020-04-01 |
Developing antibody tests for SARS-CoV-2 (edit) |
10.1016/S0140-6736(20)30788-1 |
| 2020-04-01 |
The importance of designing and implementing participatory surveillance system: An approach as early detection and prevention of novel coronavirus (2019-nCov) (edit) |
10.1016/J.AJIC.2020.03.013 |
| 2020-04-01 |
Klug entscheiden : bei SARS-CoV-2 und anderen Infektionen (edit) |
10.1007/S15006-020-0312-3 |
| 2020-04-01 |
Topische Steroide trotz COVID-19 nicht absetzen! : Atemwegserkrankungen (edit) |
10.1007/S15006-020-0308-Z |
| 2020-04-01 |
COVID-19 and Cancer: Lessons From a Pooled Meta-Analysis (edit) |
10.1200/GO.20.00097 |
| 2020-04-01 |
Lung transplantation as therapeutic option in acute respiratory distress syndrome for COVID-19-related pulmonary fibrosis (edit) |
10.1097/CM9.0000000000000839 |
| 2020-04-01 |
COVID-19 virus and children: What do we know? (edit) |
10.1016/J.ARCPED.2020.03.001 |
| 2020-04-01 |
Journal Flexibility in the Troubling Times of COVID-19 (edit) |
10.1104/PP.20.00347 |
| 2020-04-01 |
The COVID-19 pandemic requires a unified global response (edit) |
10.1007/S12020-020-02293-6 |
| 2020-04-01 |
Evidence synthesis relevant to COVID-19: a protocol for multiple systematic reviews and overviews of systematic reviews (edit) |
10.5867/MEDWAVE.2020.03.7867 |
| 2020-04-01 |
ACE2 the Janus-faced protein - from cardiovascular protection to severe acute respiratory syndrome-coronavirus and COVID-19 (edit) |
10.1042/CS20200363 |
| 2020-04-01 |
COVID-19: Emergency Medicine Physician Empowered to Shape Perspectives on This Public Health Crisis (edit) |
10.7759/CUREUS.7504 |
| 2020-04-01 |
KCDC Risk Assessments on the Initial Phase of the COVID-19 Outbreak in Korea (edit) |
10.24171/J.PHRP.2020.11.2.02 |
| 2020-04-01 |
Cross-Country Comparison of Case Fatality Rates of COVID-19/SARS-COV-2 (edit) |
10.24171/J.PHRP.2020.11.2.03 |
| 2020-04-01 |
Coronavirus Disease-19: Summary of 2,370 Contact Investigations of the First 30 Cases in the Republic of Korea (edit) |
10.24171/J.PHRP.2020.11.2.04 |
| 2020-04-01 |
Coronavirus Disease-19: The First 7,755 Cases in the Republic of Korea (edit) |
10.24171/J.PHRP.2020.11.2.05 |
| 2020-04-01 |
Epidemiological and Clinical Aspects of COVID-19; a Narrative Review (edit) |
|
| 2020-04-01 |
Indications for healthcare surge capacity in European countries facing an exponential increase in coronavirus disease (COVID-19) cases, March 2020 (edit) |
10.2807/1560-7917.ES.2020.25.13.2000323 |
| 2020-04-01 |
Only strict quarantine measures can curb the coronavirus disease (COVID-19) outbreak in Italy, 2020 (edit) |
10.2807/1560-7917.ES.2020.25.13.2000280 |
| 2020-04-01 |
Whole genome and phylogenetic analysis of two SARS-CoV-2 strains isolated in Italy in January and February 2020: additional clues on multiple introductions and further circulation in Europe (edit) |
10.2807/1560-7917.ES.2020.25.13.2000305 |
| 2020-04-01 |
Understanding coronavirus disease (COVID-19) risk perceptions among the public to enhance risk communication efforts: a practical approach for outbreaks, Finland, February 2020 (edit) |
10.2807/1560-7917.ES.2020.25.13.2000317 |
| 2020-04-01 |
[French Sarcoma Group proposals for management of sarcoma patients during COVID-19 outbreak] (edit) |
10.1016/J.BULCAN.2020.03.009 |
| 2020-04-01 |
COVID-19: review Indigenous peoples' data (edit) |
10.1038/D41586-020-01032-1 |
| 2020-04-01 |
EDITORIAL: COVID-19 and Anxiety and Depression in 2020 (edit) |
10.1002/DA.23014 |
| 2020-04-01 |
[Coronavirus and COVID-19 : focus on a galopping pandemic] (edit) |
|
| 2020-04-01 |
[COVID-19 andcardiovascular diseases] (edit) |
|
| 2020-04-01 |
COVID-19 and Family Doctors (edit) |
10.22454/FAMMED.2020.515917 |
| 2020-04-01 |
Research towards treating COVID-19 (edit) |
10.12968/BJCN.2020.25.4.204 |
| 2020-04-01 |
COVID-19 in the community (edit) |
10.12968/BJCN.2020.25.4.161 |
| 2020-04-01 |
COVID-19 and emergency planning (edit) |
10.12968/BJCN.2020.25.4.184 |
| 2020-04-01 |
Legal aspects of COVID-19 pandemic management for community nurses (edit) |
10.12968/BJCN.2020.25.4.196 |
| 2020-04-01 |
Audio Interview: Emerging Tools in the Fight against Covid-19 (edit) |
10.1056/NEJME2009651 |
| 2020-04-01 |
[Be alert to superposed effect of seasonal influenza while fighting against COVID-19] (edit) |
|
| 2020-04-01 |
[Health protection guideline of conference designated hotel during COVID-19 outbreak] (edit) |
10.3760/CMA.J.CN112150-20200217-00127 |
| 2020-04-01 |
[Disinfection guideline of public transport during COVID-19 outbreak] (edit) |
10.3760/CMA.J.CN112150-20200217-00129 |
| 2020-04-01 |
[Health protection guideline of enterprises during COVID-19 outbreak] (edit) |
10.3760/CMA.J.CN112150-20200217-00122 |
| 2020-04-01 |
[Health protection guideline of schools and other educational institutions during COVID-19 outbreak] (edit) |
10.3760/CMA.J.CN112150-20200217-00123 |
| 2020-04-01 |
[Health protection guideline of hotels reconstructed as isolation places for close contacts during COVID-19 outbreak] (edit) |
10.3760/CMA.J.CN112150-20200217-00124 |
| 2020-04-01 |
[Technical guideline for disinfection of wastewater and wastes of medical organizations during COVID-19 outbreak] (edit) |
10.3760/CMA.J.CN112150-20200217-00125 |
| 2020-04-01 |
[The network investigation on knowledge, attitude and practice about COVID-19 of the residents in Anhui Province] (edit) |
10.3760/CMA.J.CN112150-20200205-00069 |
| 2020-04-01 |
[Transmission routes of 2019-novel coronavirus (2019-nCoV)] (edit) |
|
| 2020-04-01 |
[Analysis of coronavirus disease-19 (COVID-19) based on SARS autopsy] (edit) |
10.3760/CMA.J.CN112151-20200211-00114 |
| 2020-04-01 |
Science in the time of COVID-19 (edit) |
10.1038/S41594-020-0423-7 |
| 2020-04-01 |
Upheaval in cancer care during the COVID-19 outbreak (edit) |
10.3332/ECANCER.2020.ED97 |
| 2020-04-01 |
Covid-19, dans les brouillards français de l’hydroxychloroquine (edit) |
|
| 2020-04-01 |
Incorporating telemedicine as part of COVID-19 outbreak response systems (edit) |
10.37765/AJMC.2020.42784 |
| 2020-04-01 |
IR of Iran National Mobilization against COVID-19 Epidemic (edit) |
10.34172/AIM.2020.01 |
| 2020-04-01 |
COVID-19 Pandemic and Comparative Health Policy Learning in Iran (edit) |
10.34172/AIM.2020.02 |
| 2020-04-01 |
The Exponentially Increasing Rate of Patients Infected with COVID-19 in Iran (edit) |
10.34172/AIM.2020.03 |
| 2020-04-01 |
A Model for COVID-19 Prediction in Iran Based on China Parameters (edit) |
10.34172/AIM.2020.05 |
| 2020-04-01 |
COVID-19 and Iranian Medical Students; A Survey on Their Related-Knowledge, Preventive Behaviors and Risk Perception (edit) |
10.34172/AIM.2020.06 |
| 2020-04-01 |
COVID19 Prevention & Care; A Cancer Specific Guideline (edit) |
10.34172/AIM.2020.07 |
| 2020-04-01 |
Efficacy of Mass Quarantine as Leverage of Health System Governance During COVID-19 Outbreak: A Mini Policy Review (edit) |
10.34172/AIM.2020.08 |
| 2020-04-01 |
Epidemiology and Clinical Characteristics of COVID-19 (edit) |
10.34172/AIM.2020.09 |
| 2020-04-01 |
Improved Early Recognition of Coronavirus Disease-2019 (COVID-19): Single-Center Data from a Shanghai Screening Hospital (edit) |
10.34172/AIM.2020.10 |
| 2020-04-01 |
The COVID-19 Emergency Response Should Include a Mental Health Component (edit) |
10.34172/AIM.2020.12 |
| 2020-04-01 |
Evaluation of the Level of Anxiety among Iranian Multiple Sclerosis Fellowships During the Outbreak of COVID-19 (edit) |
10.34172/AIM.2020.13 |
| 2020-04-01 |
Fighting COVID-19 in Iran; Economic Challenges Ahead (edit) |
10.34172/AIM.2020.14 |
| 2020-04-01 |
Role of Social Media and Telemedicine in Diagnosis & Management of COVID-19; An Experience of the Iranian Society of Radiology (edit) |
10.34172/AIM.2020.15 |
| 2020-04-01 |
Strategic planning and recommendations for healthcare workers during the COVID-19 pandemic (edit) |
10.1016/J.AJEM.2020.04.024 |
| 2020-04-01 |
G20 leaders must answer to COVID-19 (edit) |
10.1126/SCIENCE.ABC1025 |
| 2020-04-01 |
Evacuation of quarantine-qualified nationals from Wuhan for COVID-19 outbreak - Taiwan experience (edit) |
10.1016/J.JMII.2020.03.023 |
| 2020-04-01 |
Dentistry and coronavirus (COVID-19) - moral decision-making (edit) |
10.1038/S41415-020-1482-1 |
| 2020-04-01 |
Palliative care and the COVID-19 pandemic (edit) |
10.1016/S0140-6736(20)30822-9 |
| 2020-04-01 |
The gendered dimensions of COVID-19 (edit) |
10.1016/S0140-6736(20)30823-0 |
| 2020-04-01 |
Centring sexual and reproductive health and justice in the global COVID-19 response (edit) |
10.1016/S0140-6736(20)30801-1 |
| 2020-04-01 |
Offline: COVID-19-bewilderment and candour (edit) |
10.1016/S0140-6736(20)30850-3 |
| 2020-04-01 |
Regulators split on antimalarials for COVID-19 (edit) |
10.1016/S0140-6736(20)30817-5 |
| 2020-04-01 |
Virtual health care in the era of COVID-19 (edit) |
10.1016/S0140-6736(20)30818-7 |
| 2020-04-01 |
[COVID-19 and people followed for breast cancer: French guidelines for clinical practice of Nice-St Paul de Vence, in collaboration with the Collège Nationale des Gynécologues et Obstétriciens Français (CNGOF), the Société d'Imagerie de la FEMme (SI (edit) |
10.1016/J.BULCAN.2020.03.008 |
| 2020-04-01 |
Correspondence from Northern Italy about our experience with COVID-19 (edit) |
10.1016/J.JPEDSURG.2020.03.028 |
| 2020-04-01 |
Poor survival with extracorporeal membrane oxygenation in acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19): Pooled analysis of early reports (edit) |
10.1016/J.JCRC.2020.03.011 |
| 2020-04-01 |
COVID-19 and endocrine diseases. A statement from the European Society of Endocrinology (edit) |
10.1007/S12020-020-02294-5 |
| 2020-04-01 |
The consequences of COVID-19 for gastroenterology nursing (edit) |
10.12968/BJON.2020.29.7.390 |
| 2020-04-01 |
Patient safety and litigation in the NHS post-COVID-19 (edit) |
10.12968/BJON.2020.29.7.444 |
| 2020-04-01 |
COVID-19 UPDATE (edit) |
10.6002/ECT.2020.000E |
| 2020-04-01 |
Can Hepatitis A Vaccine Provide Protection Against COVID-19? (edit) |
10.6002/ECT.2020.0109 |
| 2020-04-01 |
Infection Control in the Medical Imaging Department During the COVID-19 Pandemic (edit) |
10.1016/J.JMIR.2020.03.005 |
| 2020-04-01 |
What We Know So Far (As of March 26, 2020) About COVID-19-An MRT Point of View (edit) |
10.1016/J.JMIR.2020.03.004 |
| 2020-04-01 |
Editorial - COVID-19 (edit) |
10.1111/BJH.16678 |
| 2020-04-01 |
Cancer Center Recommendations to Mitigate COVID-19 Impact in Patients With Cancer: Low-Resource Settings Version (edit) |
10.1200/GO.20.00093 |
| 2020-04-01 |
Life in the Time of COVID-19 (edit) |
10.1249/JSR.0000000000000708 |
| 2020-04-01 |
COVID-19 and Indian Pediatrics (edit) |
|
| 2020-04-01 |
Combating COVID-19: health equity matters (edit) |
10.1038/S41591-020-0823-6 |
| 2020-04-01 |
Digital technology and COVID-19 (edit) |
10.1038/S41591-020-0824-5 |
| 2020-04-01 |
On the responsible use of digital data to tackle the COVID-19 pandemic (edit) |
10.1038/S41591-020-0832-5 |
| 2020-04-01 |
Sars-CoV-2 (COVID-19) Outbreak and Breast Cancer Surgery in Turkey (edit) |
10.5152/EJBH.2020.300320 |
| 2020-04-01 |
Lung Changes on Chest CT During 2019 Novel Coronavirus (COVID-19) Pneumonia (edit) |
10.5152/EJBH.2020.010420 |
| 2020-04-01 |
Serological Assays for SARS-CoV-2 Infectious Disease: Benefits, Limitations and Perspectives (edit) |
|
| 2020-04-01 |
Imaging Findings in Four COVID-19 Patients (edit) |
|
| 2020-04-01 |
COVID-19: fail to prepare, prepare to fail (edit) |
10.1177/0141076820918796 |
| 2020-04-01 |
COVID-19: Driving while looking in the rear-view mirror (edit) |
10.1177/0141076820918485 |
| 2020-04-01 |
[Possible unregistered SARS-CoV-2 infection in a young man with anosmia and ageusia] (edit) |
|
| 2020-04-01 |
Working in isolation to find a cure for COVID-19 (edit) |
10.1038/D41586-020-01026-Z |
| 2020-04-01 |
Excess cases of influenza-like illnesses synchronous with coronavirus disease (COVID-19) epidemic, France, March 2020 (edit) |
10.2807/1560-7917.ES.2020.25.14.2000326 |
| 2020-04-01 |
An alternative workflow for molecular detection of SARS-CoV-2 - escape from the NA extraction kit-shortage, Copenhagen, Denmark, March 2020 (edit) |
10.2807/1560-7917.ES.2020.25.14.2000398 |
| 2020-04-01 |
Roll-out of SARS-CoV-2 testing for healthcare workers at a large NHS Foundation Trust in the United Kingdom, March 2020 (edit) |
10.2807/1560-7917.ES.2020.25.14.2000433 |
| 2020-04-01 |
Impact of Nutrition and Diet on COVID-19 Infection and Implications for Kidney Health and Kidney Disease Management (edit) |
10.1053/J.JRN.2020.03.006 |
| 2020-04-01 |
Vielversprechender Impfstoffkandidat gegen COVID-19 identifiziert (edit) |
10.1007/S15006-020-0398-7 |
| 2020-04-01 |
Diskussion um NSAR in Zeiten von Covid-19 : Fiebersenkung und Schmerztherapie (edit) |
10.1007/S15006-020-0372-4 |
| 2020-04-01 |
Covid-19-Pandemie: Das macht sie mit der Psyche (edit) |
10.1007/S15006-020-0364-4 |
| 2020-04-01 |
[Respiratory diseases, allergy and COVID-19 infection. First news from Wuhan] (edit) |
10.1016/J.REVAL.2020.03.003 |
| 2020-04-01 |
Concerns for activated breathing control (ABC) with breast cancer in the era of COVID-19: Maximizing infection control while minimizing heart dose (edit) |
10.1016/J.ADRO.2020.03.009 |
| 2020-04-01 |
Prostate Cancer Radiotherapy Recommendations in Response to COVID-19 (edit) |
10.1016/J.ADRO.2020.03.010 |
| 2020-04-01 |
Breast radiotherapy under COVID-19 pandemic resource constraints -- approaches to defer or shorten treatment from a Comprehensive Cancer Center in the United States (edit) |
10.1016/J.ADRO.2020.03.013 |
| 2020-04-01 |
COVID-19 Outbreak: an Update on Therapeutic Options (edit) |
10.1007/S42399-020-00264-6 |
| 2020-04-01 |
Systematic review of the efficacy and safety of antiretroviral drugs against SARS, MERS or COVID-19: initial assessment (edit) |
10.1002/JIA2.25489 |
| 2020-04-01 |
Impact of the COVID-19 Epidemic on a Pan-Asian Academic Oncology Clinical Trial (edit) |
10.1200/GO.20.00072 |
| 2020-04-01 |
Audio Interview: Caring for Patients with Covid-19 (edit) |
10.1056/NEJME2011242 |
| 2020-04-01 |
[Bronchoalveolar lavage fluid was used to diagnose two cases of 2019-nCoV infection] (edit) |
10.3760/CMA.J.CN112147-20200224-00167 |
| 2020-04-01 |
[Thinking on clinical rational use of TCM injection in the treatment of novel coronavirus pneumonia (COVID-19)] (edit) |
10.3760/CMA.J.CN112137-20200221-00388 |
| 2020-04-01 |
COVID-19 vaccination clinical trials should consider multiple doses of BCG (edit) |
|
| 2020-04-01 |
Radiation therapy during the coronavirus disease 2019 (covid-19) pandemic in Italy: a view of the nation's young oncologists (edit) |
10.1136/ESMOOPEN-2020-000779 |
| 2020-04-01 |
How do we decide to de-isolate COVID-19 patients? (edit) |
10.1016/J.JMII.2020.03.025 |
| 2020-04-01 |
Protect Indigenous peoples from COVID-19 (edit) |
10.1126/SCIENCE.ABC0073 |
| 2020-04-01 |
Vets can help government tackle Covid-19 (edit) |
10.1136/VR.M3002 |
| 2020-04-01 |
Covid-19 wake-up call for exotic pet trade (edit) |
10.1136/VR.M1517 |
| 2020-04-01 |
In other Covid-19 news (edit) |
10.1136/VR.M1524 |
| 2020-04-01 |
Free 24-hour specialist support during Covid-19 (edit) |
|
| 2020-04-01 |
Resources during covid-19 (edit) |
|
| 2020-04-01 |
Government advice needed on TB testing during Covid-19 outbreak (edit) |
10.1136/VR.M1453 |
| 2020-04-01 |
Can cats become infected with Covid-19? (edit) |
10.1136/VR.M1455 |
| 2020-04-01 |
We should err on side of caution with Covid-19 advice (edit) |
10.1136/VR.M1488 |
| 2020-04-01 |
Covid-19 has changed how we teach students (edit) |
10.1136/VR.M1535 |
| 2020-04-01 |
Vets would not manage Covid-19 this way (edit) |
10.1136/VR.M3004 |
| 2020-04-01 |
Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19 (edit) |
10.1136/JITC-2020-000878 |
| 2020-04-01 |
Ordonnance 2 COVID-19 : pas de fermeture obligatoire des cabinets (edit) |
|
| 2020-04-01 |
Vaccins anti-covid-19 : les recherches de johnson & johnson, sanofi et pasteur (edit) |
|
| 2020-04-01 |
Covid-19 : que sait-on des patients admis en soins intensifs ? (edit) |
|
| 2020-04-01 |
Covid-19, dans les brouillards de l’hydroxychloroquine (2) (edit) |
|
| 2020-04-01 |
COVID-19: Navigating Uncertainties Together (edit) |
10.1016/J.CELL.2020.03.041 |
| 2020-04-01 |
Endocrinology in the time of COVID-19 (edit) |
10.1530/EJE-20-0386 |
| 2020-04-01 |
COVID-19 in the USA: a question of time (edit) |
10.1016/S0140-6736(20)30863-1 |
| 2020-04-01 |
Sustaining containment of COVID-19 in China (edit) |
10.1016/S0140-6736(20)30864-3 |
| 2020-04-01 |
COVID-19 exacerbating inequalities in the US (edit) |
10.1016/S0140-6736(20)30893-X |
| 2020-04-01 |
Flooded by the torrent: the COVID-19 drug pipeline (edit) |
10.1016/S0140-6736(20)30894-1 |
| 2020-04-01 |
Sarah Gilbert: carving a path towards a COVID-19 vaccine (edit) |
10.1016/S0140-6736(20)30796-0 |
| 2020-04-01 |
[Analysis of special ehealth service for corona virus disease 2019 (COVID-19) pneumonia] (edit) |
|
| 2020-04-01 |
[Management strategy for the resumption of regular diagnosis and treatment in gastrointestinal surgery department during the outbreak of coronavirus disease 2019 (COVID-19)] (edit) |
10.3760/CMA.J.ISSN.1671-0274.2020-0316-00146 |
| 2020-04-01 |
[Analysis of selective endoscopy results during the epidemic of coronavirus disease 2019 (COVID-19)] (edit) |
10.3760/CMA.J.ISSN.1671-0274.2020-0316-00147 |
| 2020-04-01 |
[Airway management of COVID-19 patients with severe pneumonia] (edit) |
10.3760/CMA.J.CN115330-20200221-00105 |
| 2020-04-01 |
Children may be less affected than adults by novel coronavirus (COVID-19) (edit) |
10.1111/JPC.14876 |
| 2020-04-01 |
[COVID-19 - 2019] (edit) |
|
| 2020-04-01 |
[Clinical and epidemiological characteristics of SARS-CoV-2] (edit) |
|
| 2020-04-01 |
[Principles in health policy during the SARS-CoV-2 outbreak - major lessons from South East-Asia] (edit) |
|
| 2020-04-01 |
[COVID-19, THE KIDNEY AND HYPERTENSION] (edit) |
|
| 2020-04-01 |
[Ethical decision-making framework for the allocation of scarce mechanical ventilators during the COVID-19 crisis] (edit) |
|
| 2020-04-01 |
Imaging features and mechanisms of novel coronavirus pneumonia (COVID-19): Study Protocol Clinical Trial (SPIRIT Compliant) (edit) |
10.1097/MD.0000000000019900 |
| 2020-04-01 |
[Recommendations on the identification and transfer of children with critical diabetes during the COVID-19 outbreak] (edit) |
|
| 2020-04-01 |
[Clinical features of children with SARS-CoV-2 infection: an analysis of 115 cases] (edit) |
|
| 2020-04-01 |
[Clinical features of children with SARS-CoV-2 infection: an analysis of 13 cases from Changsha, China] (edit) |
|
| 2020-04-01 |
[Research advances in cardiovascular system damage caused by SARS-CoV-2 in children] (edit) |
|
| 2020-04-01 |
Lung ultrasonography in a woman with COVID-19: This examination could be remote (edit) |
10.1503/CMAJ.75302 |
| 2020-04-01 |
Clarifying the role of lung ultrasonography in COVID-19 respiratory disease (edit) |
10.1503/CMAJ.75311 |
| 2020-04-01 |
Who should wear a face mask? Experts weigh in on Canada's COVID-19 response (edit) |
10.1503/CMAJ.1095863 |
| 2020-04-01 |
Guidelines for the management of surgical departments in non-uniform hospitals during the COVID-19 pandemic (edit) |
10.5604/01.3001.0014.1039 |
| 2020-04-01 |
Dilemmas and Priorities in the Neonatal Intensive Care Unit during the COVID-19 Pandemic (edit) |
|
| 2020-04-01 |
COVID-19 and the CRISPR Community Response (edit) |
10.1089/CRISPR.2020.29092.RBA |
| 2020-04-01 |
Probable Pangolin Origin of SARS-CoV-2 Associated with the COVID-19 Outbreak (edit) |
10.1016/J.CUB.2020.03.063 |
| 2020-04-01 |
Coronavirus disease (COVID-19): a scoping review (edit) |
10.2807/1560-7917.ES.2020.25.15.2000125 |
| 2020-04-01 |
Potential lethal outbreak of coronavirus disease (COVID-19) among the elderly in retirement homes and long-term facilities, France, March 2020 (edit) |
10.2807/1560-7917.ES.2020.25.15.2000448 |
| 2020-04-01 |
SARS-CoV2 infection and primary school closure (edit) |
10.2807/1560-7917.ES.2020.25.15.2000617 |
| 2020-04-01 |
Let us not forget the mask in our attempts to stall the spread of COVID-19 (edit) |
10.5588/IJTLD.20.0124 |
| 2020-04-01 |
COVID-19 and lung pathology (edit) |
10.4103/IJPM.IJPM_280_20 |
| 2020-04-01 |
Why is SARS-CoV-2 testing not possible in every medical laboratory? (edit) |
10.4103/0377-4929.282722 |
| 2020-04-01 |
COVID-19: searching for clues among other respiratory viruses (edit) |
10.1111/IMCB.12336 |
| 2020-04-01 |
[CoViD-19: we knew everything but we didn't understand anything.] (edit) |
10.1701/3347.33174 |
| 2020-04-01 |
[CoViD-19 and PPE: some of us will die because of the shortage.] (edit) |
10.1701/3347.33175 |
| 2020-04-01 |
[The choices in CoViD-19's time.] (edit) |
10.1701/3347.33177 |
| 2020-04-01 |
[Facing Covid-19 in Italy: ethics, logistics, and therapeutics on the epidemic's front line] (edit) |
10.1701/3347.33179 |
| 2020-04-01 |
[Post-Normal Pandemics: why CoViD-19 requires a new approach to science.] (edit) |
10.1701/3347.33181 |
| 2020-04-01 |
[It's world war at CoViD-19. The first battle on the front of the viral invasion against the exitus for interstitial pneumonia was decisive.] (edit) |
10.1701/3347.33187 |
| 2020-04-01 |
A pregnant woman and the SARS-CoV-2 infection: how are barriers easily crossed? (edit) |
10.1701/3347.33190 |
| 2020-04-01 |
L’ospedale al tempo del CoViD-19, diario di bordo (edit) |
10.1701/3347.33191 |
| 2020-04-01 |
CoViD-19: pensieri di un soldato ferito in guerra (edit) |
10.1701/3347.33193 |
| 2020-04-01 |
Di fronte al SARS-CoV-2 siamo tutti uguali? (edit) |
10.1701/3347.33194 |
| 2020-04-01 |
Predicting Mortality Risk in Patients with COVID-19 Using Artificial Intelligence to Help Medical Decision-Making (edit) |
10.1101/2020.03.30.20047308 |
| 2020-04-01 |
Risk factors for severe corona virus disease 2019 (COVID-19) patients : a systematic review and meta analysis (edit) |
10.1101/2020.03.30.20047415 |
| 2020-04-01 |
[An analysis of global research on SARS-CoV-2] (edit) |
10.7507/1001-5515.202002034 |
| 2020-04-01 |
In the face of the SARS-CoV-2 outbreak, do people suffering from oncological disease need specific attention? (edit) |
10.26355/EURREV_202004_20794 |
| 2020-04-01 |
The nucleic acid test of induced sputum should be used for estimation of patients cure with 2019-nCov (edit) |
10.26355/EURREV_202004_20795 |
| 2020-04-01 |
SARS-CoV-2 causing pneumonia-associated respiratory disorder (COVID-19): diagnostic and proposed therapeutic options (edit) |
10.26355/EURREV_202004_20871 |
| 2020-04-01 |
COVID-19 Tragic Pandemic: Concerns over Unintentional "Directed Accelerated Evolution" of Novel Coronavirus (SARS-CoV-2) and Introducing a Modified Treatment Method for ARDS (edit) |
10.31661/JBPE.V0I0.2003-1085 |
| 2020-04-01 |
Atypical presentation of SARS-CoV-2 infection: A case report (edit) |
10.12998/WJCC.V8.I7.1265 |
| 2020-04-01 |
The probability of detection of SARS-CoV-2 in saliva (edit) |
10.1177/0962280220915049 |
| 2020-04-01 |
„Anwendung von Antikörper-Schnelltests ist Körperverletzung“ : SARS-CoV-2-Diagnostik -- Interviewpartner: Dr. Matthias Orth (edit) |
10.1007/S15006-020-0412-0 |
| 2020-04-01 |
Schutz vor SARS-CoV-2: Wie viel Maske sollte es sein? : COVID-19-Pandemie (edit) |
10.1007/S15006-020-0411-1 |
| 2020-04-01 |
Properties of Coronavirus and SARS-CoV-2 (edit) |
|
| 2020-04-01 |
[Diagnosis, treatment, control and prevention of SARS-CoV-2 and coronavirus disease 2019: back to the future] (edit) |
10.13345/J.CJB.200115 |
| 2020-04-01 |
[Optimization of a fluorescent qPCR detection for RNA of SARS-CoV-2] (edit) |
10.13345/J.CJB.200088 |
| 2020-04-01 |
Strong associations and moderate predictive value of early symptoms for SARS-CoV-2 test positivity among healthcare workers, the Netherlands, March 2020 (edit) |
10.2807/1560-7917.ES.2020.25.16.2000508 |
| 2020-04-01 |
Serological assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), March 2020 (edit) |
10.2807/1560-7917.ES.2020.25.16.2000421 |
| 2020-04-01 |
[SARS-CoV-2 infection and solid organ transplantation] (edit) |
|
| 2020-04-01 |
Origine de SARS-CoV-2 : le probable et le possible (edit) |
|
| 2020-04-01 |
[Options for controlling new Corona virus infection - 2019-nCoV] (edit) |
|
| 2020-04-01 |
Hypertransaminasemia in the course of infection with SARS-CoV-2: Incidence and pathogenetic hypothesis (edit) |
10.12998/WJCC.V8.I8.1385 |
| 2020-04-01 |
Could host cell receptor alteration prevent SARS-CoV-2 viral entry? - Hype or hope (edit) |
10.26355/EURREV_202004_21040 |
| 2020-04-01 |
Bioinformatic analysis indicates that SARS-CoV-2 is unrelated to known artificial coronaviruses (edit) |
10.26355/EURREV_202004_21041 |
| 2020-04-01 |
Faced with 2019-nCoV outbreak, we have learned our lessons from SARS of 2003 (edit) |
10.26355/EURREV_202004_20982 |
| 2020-04-01 |
A profiling analysis on the receptor ACE2 expression reveals the potential risk of different type of cancers vulnerable to SARS-CoV-2 infection (edit) |
10.21037/ATM.2020.03.61 |
| 2020-04-01 |
SARS-CoV-2 infection virological diagnosis (edit) |
|
| 2020-04-01 |
The Renin-Angiotensin system and SARS-CoV-2 infection: A role for the ACE2 receptor? (edit) |
10.1177/1470320320926911 |
| 2020-04-01 |
An 'asymptomatic' driver with COVID-19: atypical suspected myocarditis by SARS-CoV-2 (edit) |
10.21037/CDT.2020.03.08 |
| 2020-04-01 |
Combined prophylactic and therapeutic use maximizes hydroxychloroquine anti-SARS-CoV-2 effects in vitro (edit) |
10.1101/2020.03.29.014407 |
| 2020-04-01 |
SARS-CoV-2 infection in health care workers: a retrospective analysis and a model study (edit) |
10.1101/2020.03.29.20047159 |
| 2020-04-01 |
Evolutionary origins of the SARS-CoV-2 sarbecovirus lineage responsible for the COVID-19 pandemic (edit) |
10.1101/2020.03.30.015008 |
| 2020-04-01 |
Global versus focused isolation during the SARS-CoV-2 pandemic-A cost-effectiveness analysis (edit) |
10.1101/2020.03.30.20047860 |
| 2020-04-01 |
Stochastic Compartmental Modelling of SARS-CoV-2 with Approximate Bayesian Computation (edit) |
10.1101/2020.03.29.20046862 |
| 2020-04-01 |
Detection of Air and Surface Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Hospital Rooms of Infected Patients (edit) |
10.1101/2020.03.29.20046557 |
| 2020-04-01 |
Analytical sensitivity and efficiency comparisons of SARS-COV-2 qRT-PCR primer-probe sets (edit) |
10.1101/2020.03.30.20048108 |
| 2020-04-01 |
Molecular Docking Analysis of Some Phytochemicals on Two Sars-Cov-2 Targets (edit) |
10.1101/2020.03.31.017657 |
| 2020-04-01 |
Prediction of SARS-CoV-2 epitopes across 9360 HLA class I alleles (edit) |
10.1101/2020.03.30.016931 |
| 2020-04-01 |
Computational Prediction of the Comprehensive SARS-CoV-2 vs. Human Interactome to Guide the Design of Therapeutics (edit) |
10.1101/2020.03.29.014381 |
| 2020-04-01 |
Scrutinizing the SARS-CoV-2 protein information for the designing an effective vaccine encompassing both the T-cell and B-cell epitopes (edit) |
10.1101/2020.03.26.009209 |
| 2020-04-01 |
HTCC as a highly effective polymeric inhibitor of SARS-CoV-2 and MERS-CoV (edit) |
10.1101/2020.03.29.014183 |
| 2020-04-01 |
Sequence variation among SARS-CoV-2 isolates in Taiwan (edit) |
10.1101/2020.03.29.014290 |
| 2020-04-01 |
Perception of emergent epidemic of COVID-2019 / SARS CoV-2 on the Polish Internet (edit) |
10.1101/2020.03.29.20046789 |
| 2020-04-01 |
Biophysical characterization of the SARS-CoV-2 spike protein binding with the ACE2 receptor and implications for infectivity (edit) |
10.1101/2020.03.30.015891 |
| 2020-04-01 |
Sequence analysis of SARS-CoV-2 genome reveals features important for vaccine design (edit) |
10.1101/2020.03.30.016832 |
| 2020-04-01 |
Epitope-based chimeric peptide vaccine design against S, M and E proteins of SARS-CoV-2 etiologic agent of global pandemic COVID-19: an in silico approach (edit) |
10.1101/2020.03.30.015164 |
| 2020-04-01 |
Atlas of ACE2 gene expression in mammals reveals novel insights in transmisson of SARS-Cov-2 (edit) |
10.1101/2020.03.30.015644 |
| 2020-04-01 |
Re-insights into origin and adaptation of SARS-CoV-2 (edit) |
10.1101/2020.03.30.015685 |
| 2020-04-01 |
Potent neutralizing antibodies in the sera of convalescent COVID-19 patients are directed against conserved linear epitopes on the SARS-CoV-2 spike protein (edit) |
10.1101/2020.03.30.015461 |
| 2020-04-01 |
Structural analysis of SARS-CoV-2 and predictions of the human interactome (edit) |
10.1101/2020.03.28.013789 |
| 2020-04-01 |
Outpatient strategies and the changing SARS-CoV-2 epidemic (edit) |
10.1183/23120541.00111-2020 |
| 2020-04-01 |
Acute Respiratory Decompensation Requiring Intubation in Pregnant Women with SARS-CoV-2 (COVID-19) (edit) |
10.1055/S-0040-1712925 |
| 2020-04-01 |
Postmortem Examination in Two Cases of Death Related to 2019-nCoV Infection and the Experience of On-site Protection (edit) |
10.12116/J.ISSN.1004-5619.2020.02.006 |
| 2020-04-01 |
Perplexity of a retired virologist facing at SARS-CoV-2 (edit) |
|
| 2020-04-01 |
Perspectives on the development of neutralizing antibodies against SARS-CoV-2 (edit) |
10.1093/ABT/TBAA009 |
| 2020-04-01 |
Beyond ventilatory support: challenges in general practice and in the treatment of critically Ill children and adolescents with SARS-CoV-2 infection (edit) |
10.1590/1806-9282.66.4.521 |
| 2020-04-01 |
Ventilatory support recommendations in children with Sars-CoV-2 (edit) |
10.1590/1806-9282.66.4.528 |
| 2020-04-01 |
Sars-CoV-2: A clinical update - II (edit) |
10.1590/1806-9282.66.4.547 |
| 2020-04-01 |
SARS-CoV-2: minireview and review of first case in Foshan, China (edit) |
10.1183/23120541.00090-2020 |
| 2020-04-01 |
False-negative RT-PCR in SARS-CoV-2 disease: experience from an Italian COVID-19 unit (edit) |
10.1183/23120541.00324-2020 |
| 2020-04-01 |
D-dimer as an indicator of prognosis in SARS-CoV-2 infection: a systematic review (edit) |
10.1183/23120541.00260-2020 |
| 2020-04-01 |
[Determination Methods of 2019 Novel Coronavirus (SARS-CoV-2)] (edit) |
10.3969/J.ISSN.1671-7104.2020.04.017 |
| 2020-04-01 |
Acute Cerebellar Strokes with Anoxic Brain Injury After a Cardiopulmonary Arrest in SARS-CoV-2 Patient (edit) |
|
| 2020-04-01 |
Evaluation of a rapid serological test for detection of IgM and igG antibodies against SARS-CoV-2 under field conditions (edit) |
10.17843/RPMESP.2020.372.5534 |
| 2020-04-01 |
COVID-19: la pandemia por el nuevo virus SARS-CoV-2 (edit) |
10.17843/RPMESP.2020.372.5411 |
| 2020-04-01 |
Agentes potencialmente terapéuticos contra el SARS-CoV-2: revisión rápida de la evidencia (edit) |
10.17843/RPMESP.2020.372.5409 |
| 2020-04-01 |
Escasa información genómica en bases de datos públicas para investigar el SARS-CoV-2 en Latinoamérica (edit) |
10.17843/RPMESP.2020.372.5396 |
| 2020-04-01 |
Rol del ultrasonido pulmonar en el diagnóstico de la neumonía por SARS-CoV-2: ¿Alternativa a la escasez de tomógrafos? (edit) |
10.17843/RPMESP.2020.372.5506 |
| 2020-04-01 |
Análisis preliminar in silico de azitromicina con proteínas humanas relacionadas al SARS-CoV-2 (edit) |
10.17843/RPMESP.2020.372.5465 |
| 2020-04-01 |
SARS-CoV-2 viral sepsis with meningoencephalitis (edit) |
10.4103/IJMM.IJMM_20_291 |
| 2020-04-01 |
[Application of laboratory diagnostic technologies for SARS-CoV-2: current progress and prospect] (edit) |
10.12122/J.ISSN.1673-4254.2020.04.24 |
| 2020-04-01 |
[Prevention and control of SARS-CoV-2 infection in clinical laboratories: implementation of contingency plan and postpandemic response strategies] (edit) |
10.12122/J.ISSN.1673-4254.2020.04.25 |
| 2020-03-31 |
Why Italian ENT physicians should be aware of SARS-CoV-2 (edit) |
10.14639/0392-100X-N0738 |
| 2020-03-31 |
Annals On Call - Protecting Health Care Workers From COVID-19 (edit) |
10.7326/A20-0002 |
| 2020-03-31 |
Dealing with COVID-19: initial perspectives of a small radiology department (edit) |
10.11622/SMEDJ.2020043 |
| 2020-03-31 |
Nano Research for COVID-19 (edit) |
10.1021/ACSNANO.0C02540 |
| 2020-03-31 |
COVID-19, ACE2, and the cardiovascular consequences (edit) |
10.1152/AJPHEART.00217.2020 |
| 2020-03-31 |
Guidance for Cardiac Electrophysiology During the Coronavirus (COVID-19) Pandemic from the Heart Rhythm Society COVID-19 Task Force; Electrophysiology Section of the American College of Cardiology; and the Electrocardiography and Arrhythmias Committ (edit) |
10.1161/CIRCULATIONAHA.120.047063 |
| 2020-03-31 |
COVID-19 Pandemic, Corona Viruses, and Diabetes Mellitus (edit) |
10.1152/AJPENDO.00124.2020 |
| 2020-03-31 |
COVID-19 and the Urology Match: Perspectives and a Call to Action (edit) |
10.1097/JU.0000000000001037 |
| 2020-03-31 |
3D CT of Novel Coronavirus (COVID-19) Pneumonia (edit) |
10.1148/RADIOL.2020201183 |
| 2020-03-31 |
COVID-19-associated Acute Hemorrhagic Necrotizing Encephalopathy: CT and MRI Features (edit) |
10.1148/RADIOL.2020201187 |
| 2020-03-31 |
Radiology Department Preparedness for COVID-19: Facing an Unexpected Outbreak of the Disease (edit) |
10.1148/RADIOL.2020201214 |
| 2020-03-31 |
Challenges and Potential Solutions of Stroke Care During the Coronavirus Disease 2019 (COVID-19) Outbreak (edit) |
10.1161/STROKEAHA.120.029701 |
| 2020-03-31 |
Epidemiological Characteristics on the Clustering Nature of COVID-19 in Qingdao City, 2020: A Descriptive Analysis (edit) |
10.1017/DMP.2020.59 |
| 2020-03-31 |
COVID-19 disease Emergency Operational Instructions for Mental Health Departments issued by the Italian Society of Epidemiological Psychiatry (edit) |
10.1017/S2045796020000372 |
| 2020-03-31 |
Mortality Rate of Infection With COVID-19 in Korea From the Perspective of Underlying Disease (edit) |
10.1017/DMP.2020.60 |
| 2020-03-31 |
Asymptomatic and Human-to-Human Transmission of SARS-CoV-2 in a 2-Family Cluster, Xuzhou, China (edit) |
10.3201/EID2607.200718 |
| 2020-03-31 |
How to reduce the likelihood of coronavirus-19 (CoV-19 or SARS-CoV-2) infection and lung inflammation mediated by IL-1 (edit) |
10.23812/EDITORIAL-CONTI-2 |
| 2020-03-31 |
SARS-CoV-2 (COVID-19) by the numbers (edit) |
10.7554/ELIFE.57309 |
| 2020-03-31 |
Interventional radiology and COVID-19: evidence-based measures to limit transmission (edit) |
10.5152/DIR.2020.20166 |
| 2020-03-31 |
How imaging should properly be used in COVID-19 outbreak: an Italian experience (edit) |
10.5152/DIR.2020.30320 |
| 2020-03-31 |
Emergency cesarean section on severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2) confirmed patient (edit) |
10.4097/KJA.20116 |
| 2020-03-31 |
63-year-old male treated for COVID-19 (edit) |
10.20452/PAMW.15271 |
| 2020-03-31 |
Recommendations of management in SARS-CoV-2 infection of the Polish Association of Epidemiologists and Infectiologists (edit) |
10.20452/PAMW.15270 |
| 2020-03-31 |
Chloroquine in COVID-19: the evidence (edit) |
10.4081/MONALDI.2020.1290 |
| 2020-03-31 |
Data-based analysis, modelling and forecasting of the COVID-19 outbreak (edit) |
10.1371/JOURNAL.PONE.0230405 |
| 2020-03-31 |
Forecasting the novel coronavirus COVID-19 (edit) |
10.1371/JOURNAL.PONE.0231236 |
| 2020-03-31 |
Disparities in Age-Specific Morbidity and Mortality from SARS-CoV-2 in China and the Republic of Korea (edit) |
10.1093/CID/CIAA354 |
| 2020-03-31 |
Initial COVID-19 affecting cardiac patients in China (edit) |
10.1093/EURHEARTJ/EHAA257 |
| 2020-03-31 |
Recommendations from the Peking Union Medical College Hospital for the management of acute myocardial infarction during the COVID-19 outbreak (edit) |
10.1093/EURHEARTJ/EHAA258 |
| 2020-03-31 |
Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should Know (edit) |
10.7326/M20-1334 |
| 2020-03-31 |
Medical Student Education in the Time of COVID-19 (edit) |
10.1001/JAMA.2020.5227 |
| 2020-03-31 |
Community Prevalence of SARS-CoV-2 Among Patients With Influenzalike Illnesses Presenting to a Los Angeles Medical Center in March 2020 (edit) |
10.1001/JAMA.2020.4958 |
| 2020-03-31 |
Humans, Viruses, and the Eye-An Early Report From the COVID-19 Front Line (edit) |
10.1001/JAMAOPHTHALMOL.2020.1294 |
| 2020-03-31 |
Safety Recommendations for Evaluation and Surgery of the Head and Neck During the COVID-19 Pandemic (edit) |
10.1001/JAMAOTO.2020.0780 |
| 2020-03-31 |
Surgical Considerations for Tracheostomy During the COVID-19 Pandemic: Lessons Learned From the Severe Acute Respiratory Syndrome Outbreak (edit) |
10.1001/JAMAOTO.2020.0764 |
| 2020-03-31 |
Balancing Health Privacy, Health Information Exchange and Research in the Context of the COVID-19 Pandemic (edit) |
10.1093/JAMIA/OCAA039 |
| 2020-03-31 |
Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei Province, China (edit) |
10.1001/JAMAOPHTHALMOL.2020.1291 |
| 2020-03-31 |
CD-sACE2 Inclusion Compounds: An Effective Treatment for Corona Virus Disease 2019 (COVID-19) (edit) |
10.1002/JMV.25804 |
| 2020-03-31 |
Response to "Comments on 'Zhang et al.: Clinical trial analysis of 2019-nCoV therapy registered in China '" (edit) |
10.1002/JMV.25803 |
| 2020-03-31 |
Analysis of heart injury laboratory parameters in 273 COVID-19 patients in one hospital in Wuhan, China (edit) |
10.1002/JMV.25809 |
| 2020-03-31 |
Potential utilities of mask-wearing and instant hand hygiene for fighting SARS-CoV-2 (edit) |
10.1002/JMV.25805 |
| 2020-03-31 |
Diabetes is a risk factor for the progression and prognosis of COVID-19 (edit) |
10.1002/DMRR.3319 |
| 2020-03-31 |
Covid-19 and diabetes mellitus: unveiling the interaction of two pandemics (edit) |
10.1002/DMRR.3321 |
| 2020-03-31 |
Overview of guidance for endoscopy during the coronavirus disease 2019 (COVID-19) pandemic (edit) |
10.1111/JGH.15053 |
| 2020-03-31 |
Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statement (edit) |
10.1111/ALL.14302 |
| 2020-03-31 |
ISUOG Consensus Statement on organization of routine and specialist obstetric ultrasound services in the context of COVID-19 (edit) |
10.1002/UOG.22029 |
| 2020-03-31 |
Novel Coronavirus-19 (COVID-19) in the immunocompromised transplant recipient: #Flatteningthecurve (edit) |
10.1111/AJT.15890 |
| 2020-03-31 |
Network pharmacology-based analysis of the role of traditional Chinese herbal medicines in the treatment of COVID-19 (edit) |
10.21037/APM.2020.03.27 |
| 2020-03-31 |
The outbreak of COVID-19 coronavirus and its impact on global mental health (edit) |
10.1177/0020764020915212 |
| 2020-03-31 |
Covid-19 in China: ten critical issues for intensive care medicine (edit) |
10.1186/S13054-020-02848-Z |
| 2020-03-31 |
Covid-19: Doctors still at "considerable risk" from lack of PPE, BMA warns (edit) |
10.1136/BMJ.M1316 |
| 2020-03-31 |
Cancer Labs Pivot to Battle COVID-19 (edit) |
10.1158/2159-8290.CD-ND2020-006 |
| 2020-03-31 |
Covid-19: Contact tracing requires ending the hostile environment (edit) |
10.1136/BMJ.M1320 |
| 2020-03-31 |
Lung ultrasound findings in a 64-year-old woman with COVID-19 (edit) |
10.1503/CMAJ.200414 |
| 2020-03-31 |
EMA advice on the use of NSAIDs for Covid-19 (edit) |
10.1136/DTB.2020.000021 |
| 2020-03-31 |
An investigation of transmission control measures during the first 50 days of the COVID-19 epidemic in China (edit) |
10.1126/SCIENCE.ABB6105 |
| 2020-03-31 |
Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing (edit) |
10.1126/SCIENCE.ABB6936 |
| 2020-03-31 |
Covid-19: healthcare staff in hotspot areas are prioritised as testing expands (edit) |
10.1136/BMJ.M1318 |
| 2020-03-31 |
WHO must prioritise the needs of older people in its response to the covid-19 pandemic (edit) |
10.1136/BMJ.M1285 |
| 2020-03-31 |
Global outbreak of COVID-19: a new challenge? (edit) |
10.3855/JIDC.12530 |
| 2020-03-31 |
Spatial-temporal distribution of COVID-19 in China and its prediction: A data-driven modeling analysis (edit) |
10.3855/JIDC.12585 |
| 2020-03-31 |
The novel zoonotic COVID-19 pandemic: An expected global health concern (edit) |
10.3855/JIDC.12671 |
| 2020-03-31 |
As COVID-19 cases, deaths and fatality rates surge in Italy, underlying causes require investigation (edit) |
10.3855/JIDC.12734 |
| 2020-03-31 |
COVID-19 and Paediatric Inflammatory Bowel Diseases: Global Experience and Provisional Guidance (March 2020) from the Paediatric IBD Porto group of ESPGHAN (edit) |
10.1097/MPG.0000000000002729 |
| 2020-03-31 |
Triaging Spine Surgery in the COVID-19 Era (edit) |
10.1097/BSD.0000000000000988 |
| 2020-03-31 |
A Comparative Study of Chest Computed Tomography Features in Young and Older Adults With Corona Virus Disease (COVID-19) (edit) |
10.1097/RTI.0000000000000513 |
| 2020-03-31 |
COVID-19: a new challenge for human beings (edit) |
10.1038/S41423-020-0407-X |
| 2020-03-31 |
Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak: a study based on single-cell transcriptome analysis (edit) |
10.1007/S00134-020-06026-1 |
| 2020-03-31 |
Inefficiency of Sera from Mice Treated with Pseudotyped SARS-CoV to Neutralize 2019-nCoV Infection (edit) |
10.1007/S12250-020-00214-5 |
| 2020-03-31 |
Infection control protocol inside computed tomography suites during COVID-19 outbreak (edit) |
10.1007/S11604-020-00963-Z |
| 2020-03-31 |
Ultra-high-resolution computed tomography can demonstrate alveolar collapse in novel coronavirus (COVID-19) pneumonia (edit) |
10.1007/S11604-020-00956-Y |
| 2020-03-31 |
Solidarity and Transparency against the COVID-19 Pandemic (edit) |
10.1111/DTH.13359 |
| 2020-03-31 |
COVID-19 Testing in South Korea: Current Status and the Need for Faster Diagnostics (edit) |
10.3343/ALM.2020.40.5.349 |
| 2020-03-31 |
COVID-19 From a Psychiatry Perspective: Meeting the Challenges (edit) |
10.4088/JCP.20ED13358 |
| 2020-03-31 |
COVID-19 Diary From a Psychiatry Department in Italy (edit) |
10.4088/JCP.20COM13357 |
| 2020-03-31 |
A Viewpoint From Paris on the COVID-19 Pandemic: A Necessary Turn to Telepsychiatry (edit) |
10.4088/JCP.20COM13361 |
| 2020-03-31 |
The Importance of Diagnostic Testing during a Viral Pandemic: Early Lessons from Novel Coronavirus Disease (COVID-19) (edit) |
10.4269/AJTMH.20-0216 |
| 2020-03-31 |
[Coinfection between dengue and covid-19: need for approach in endemic zones.] (edit) |
10.31053/1853.0605.V77.N1.28031 |
| 2020-03-31 |
Lectin-like Intestinal Defensin Inhibits 2019-nCoV Spike binding to ACE2 (edit) |
10.1101/2020.03.29.013490 |
| 2020-03-31 |
COVID-19 in Hemodialysis Patients: A Report of 5 Cases (edit) |
10.1053/J.AJKD.2020.03.009 |
| 2020-03-31 |
Primary care management of the coronavirus (COVID-19) (edit) |
10.4102/SAFP.V62I1.5115 |
| 2020-03-31 |
Laboratory preparedness for SARS-CoV-2 testing in India: Harnessing a network of Virus Research & Diagnostic Laboratories (edit) |
10.4103/IJMR.IJMR_594_20 |
| 2020-03-31 |
Development of in vitro transcribed RNA as positive control for laboratory diagnosis of SARS-CoV-2 in India (edit) |
10.4103/IJMR.IJMR_671_20 |
| 2020-03-31 |
Lessons learned from first COVID-19 cases in the United States (edit) |
10.1213/ANE.0000000000004840 |
| 2020-03-31 |
Utility of Substandard Face Mask Options for Health Care Workers During the COVID-19 Pandemic (edit) |
10.1213/ANE.0000000000004841 |
| 2020-03-31 |
Images in Clinical ECT: Immediate impact of COVID-19 on ECT Practice (edit) |
10.1097/YCT.0000000000000688 |
| 2020-03-31 |
ECT during COVID-19: An Essential Medical Procedure - Maintaining Service Viability and Accessibility (edit) |
10.1097/YCT.0000000000000689 |
| 2020-03-31 |
COVID-19 and immigration detention in the USA: time to act (edit) |
10.1016/S2468-2667(20)30081-5 |
| 2020-03-31 |
Impacts of COVID-19 on vulnerable children in temporary accommodation in the UK (edit) |
10.1016/S2468-2667(20)30080-3 |
| 2020-03-31 |
Refugee and migrant health in the COVID-19 response (edit) |
10.1016/S0140-6736(20)30791-1 |
| 2020-03-31 |
Ensuring global access to COVID-19 vaccines (edit) |
10.1016/S0140-6736(20)30763-7 |
| 2020-03-31 |
Medicine: before COVID-19, and after (edit) |
10.1016/S0140-6736(20)30756-X |
| 2020-03-31 |
Protecting the psychological health of children through effective communication about COVID-19 (edit) |
10.1016/S2352-4642(20)30097-3 |
| 2020-03-31 |
Estimating case fatality rates of COVID-19 (edit) |
10.1016/S1473-3099(20)30245-0 |
| 2020-03-31 |
SARS-CoV-2: a time for clear and immediate action (edit) |
10.1016/S1473-3099(20)30250-4 |
| 2020-03-31 |
Running a virtual allergy division and training program in the time of COVID-19 pandemic (edit) |
10.1016/J.JACI.2020.03.018 |
| 2020-03-31 |
A segregated-team model to maintain cancer care during the COVID-19 outbreak at an academic center in Singapore (edit) |
10.1016/J.ANNONC.2020.03.306 |
| 2020-03-31 |
COVID-19 Infection in Cancer Patients: Early Observations and Unanswered Questions (edit) |
10.1016/J.ANNONC.2020.03.297 |
| 2020-03-31 |
C-reactive protein levels in the early stage of COVID-19 (edit) |
10.1016/J.MEDMAL.2020.03.007 |
| 2020-03-31 |
A rapid fatal evolution of Coronavirus Disease-19 (COVID-19) in an advanced lung cancer patient with a long time response to nivolumab (edit) |
10.1016/J.JTHO.2020.03.021 |
| 2020-03-31 |
18F-FDG uptake in Asymptomatic SARS-CoV-2 (COVID-19) patient, referred to PET/CT for Non-Small Cells Lung Cancer restaging (edit) |
10.1016/J.JTHO.2020.03.022 |
| 2020-03-31 |
Safety of Ibuprofen in Patients With COVID-19: Causal or Confounded? (edit) |
10.1016/J.CHEST.2020.03.040 |
| 2020-03-31 |
Treatment With Convalescent Plasma for Critically Ill Patients With SARS-CoV-2 Infection (edit) |
10.1016/J.CHEST.2020.03.039 |
| 2020-03-31 |
Beyond the assistance: additional exposure situations to COVID-19 for healthcare workers (edit) |
10.1016/J.JHIN.2020.03.033 |
| 2020-03-31 |
Ark of Life and Hope：Role of Cabin Hospital in Facing COVID-19 (edit) |
10.1016/J.JHIN.2020.03.032 |
| 2020-03-31 |
Active Surveillance for Suspected COVID-19 Cases in Inpatients with Information Technology (edit) |
10.1016/J.JHIN.2020.03.027 |
| 2020-03-31 |
Patients with advanced basal cell carcinomas in treatment with sonic hedgehog inhibitors during the coronavirus disease 2019 (COVID-19) period: Management and adherence to treatment (edit) |
10.1016/J.JAAD.2020.03.057 |
| 2020-03-31 |
Use of Systemic Immunomodulatory Therapies During the Coronavirus Disease 2019 (COVID-19) Pandemic (edit) |
10.1016/J.JAAD.2020.03.056 |
| 2020-03-31 |
Shell disorder analysis predicts greater resilience of the SARS-CoV-2 (COVID-19) outside the body and in body fluids (edit) |
10.1016/J.MICPATH.2020.104177 |
| 2020-03-31 |
A Systematic Review of COVID-19 Epidemiology Based on Current Evidence (edit) |
10.3390/JCM9040967 |
| 2020-03-31 |
People with Suspected COVID-19 Symptoms Were More Likely Depressed and Had Lower Health-Related Quality of Life: The Potential Benefit of Health Literacy (edit) |
10.3390/JCM9040965 |
| 2020-03-31 |
Prediction of Number of Cases of 2019 Novel Coronavirus (COVID-19) Using Social Media Search Index (edit) |
10.3390/IJERPH17072365 |
| 2020-03-31 |
Impact of the COVID-19 Pandemic on Mental Health and Quality of Life among Local Residents in Liaoning Province, China: A Cross-Sectional Study (edit) |
10.3390/IJERPH17072381 |
| 2020-03-31 |
COVID-19 in patients with cardiovascular diseases (edit) |
10.1016/J.ACVD.2020.03.009 |
| 2020-03-31 |
On the frontline against COVID-19: Community pharmacists' contribution during a public health crisis (edit) |
10.1016/J.SAPHARM.2020.03.015 |
| 2020-03-31 |
[First case of neonatal infection due to SARS-CoV-2 in Spain] (edit) |
10.1016/J.ANPEDI.2020.03.002 |
| 2020-03-31 |
The brain, another potential target organ, needs early protection from SARS-CoV-2 neuroinvasion (edit) |
10.1007/S11427-020-1690-Y |
| 2020-03-31 |
Unknown unknowns - COVID-19 and potential global mortality (edit) |
10.1016/J.EARLHUMDEV.2020.105026 |
| 2020-03-31 |
Strategy for the practice of digestive and oncological surgery during the Covid-19 epidemic (edit) |
10.1016/J.JVISCSURG.2020.03.008 |
| 2020-03-31 |
Coronavirus Disease (COVID-19) and Pediatric Patients: A Review of Epidemiology, Symptomatology, Laboratory and Imaging Results to Guide the Development of a Management Algorithm (edit) |
10.7759/CUREUS.7485 |
| 2020-03-31 |
COVID-19 in Colombia endpoints. Are we different, like Europe? (edit) |
10.1016/J.SAPHARM.2020.03.013 |
| 2020-03-31 |
Academic Community's Efforts to Guide the Fight Against Coronavirus Disease 2019 (COVID-19) Epidemic in Korea (edit) |
10.3961/JPMPH.20.084 |
| 2020-03-31 |
Letter to the Editor: Coronavirus Disease 2019 (COVID-19), Infectivity, and the Incubation Period (edit) |
10.3961/JPMPH.20.065 |
| 2020-03-31 |
Author Response: Coronavirus Disease 2019 (COVID-19), Infectivity, and the Incubation Period (edit) |
10.3961/JPMPH.20.066 |
| 2020-03-31 |
Hopelessness, helplessness and resilience: The importance of safeguarding our trainees' mental wellbeing during the COVID-19 pandemic (edit) |
10.1016/J.NEPR.2020.102780 |
| 2020-03-31 |
Abdominal and testicular pain: An atypical presentation of COVID-19 (edit) |
10.1016/J.AJEM.2020.03.052 |
| 2020-03-31 |
Cannabidiol as prophylaxis for SARS-CoV-2 and COVID-19? Unfounded claims versus potential risks of medications during the pandemic (edit) |
10.1016/J.SAPHARM.2020.03.020 |
| 2020-03-31 |
Favorable changes of CT findings in a patient with COVID-19 pneumonia after treatment with tocilizumab (edit) |
10.1016/J.DIII.2020.03.010 |
| 2020-03-31 |
COVID-19: Is a paradigm change to be expected in health care and transfusion medicine? (edit) |
10.1016/J.TRACLI.2020.03.005 |
| 2020-03-31 |
Will the COVID-19 pandemic make us reconsider the relevance of short food supply chains and local productions? (edit) |
10.1016/J.TIFS.2020.03.041 |
| 2020-03-31 |
How to risk-stratify elective surgery during the COVID-19 pandemic? (edit) |
10.1186/S13037-020-00235-9 |
| 2020-03-31 |
A novel presentation of COVID-19 via community acquired infection (edit) |
10.1016/J.VISJ.2020.100760 |
| 2020-03-31 |
How to protect the protectors: 10 lessons to learn for doctors fighting the COVID-19 coronavirus (edit) |
10.1016/J.MJAFI.2020.03.009 |
| 2020-03-31 |
Coronavirus Disease 2019 (COVID-19): we shall overcome (edit) |
10.1007/S10098-020-01843-W |
| 2020-03-31 |
Propagation analysis and prediction of the COVID-19 (edit) |
10.1016/J.IDM.2020.03.002 |
| 2020-03-31 |
COVID-19: How can a department of general surgery survive in a pandemic? (edit) |
10.1016/J.SURG.2020.03.012 |
| 2020-03-31 |
[Covid-19 epidemic: guidelines issued by the French society of oncology radiotherapy (SFRO) for oncology radiotherapy professionals] (edit) |
10.1016/J.CANRAD.2020.03.007 |
| 2020-03-31 |
Brief Summary of Potential SARS-CoV-2 Prophylactic and Treatment Drugs in the Emergency Department (edit) |
10.5811/WESTJEM.2020.3.47328 |
| 2020-03-31 |
ESPEN expert statements and practical guidance for nutritional management of individuals with SARS-CoV-2 infection (edit) |
10.1016/J.CLNU.2020.03.022 |
| 2020-03-31 |
CoViD-19 Immunopathology and Immunotherapy (edit) |
10.6026/97320630016219 |
| 2020-03-31 |
Epidemiology, genome, and clinical features of the pandemic SARS-CoV-2: a recent view (edit) |
10.1016/J.NMNI.2020.100672 |
| 2020-03-31 |
SARS-CoV-2 Infection in Patients with Lung Cancer: Current Clinical Context (edit) |
10.1016/J.ARBRES.2020.03.018 |
| 2020-03-31 |
Studies on Computational Molecular Interaction Between SARS-CoV-2 Main Protease and Natural Products (edit) |
10.26434/CHEMRXIV.12024789 |
| 2020-03-31 |
Contingency Plans in a Radiation Oncology Department Amid the 2019-nCoV Outbreak in Switzerland (edit) |
10.1016/J.ADRO.2020.03.012 |
| 2020-03-31 |
Investigation into SARS-CoV-2 Resistance of Compounds in Garlic Essential Oil (edit) |
10.1021/ACSOMEGA.0C00772 |
| 2020-03-31 |
The SARS-CoV-2 epidemic outbreak: a review of plausible scenarios of containment and mitigation for Mexico (edit) |
10.1101/2020.03.28.20046276 |
| 2020-03-31 |
Determination of daily reproduction numbers of SARS-CoV2 based on death cases suggests more rapid initial spread in Italy and the United States (edit) |
10.1101/2020.03.28.20046094 |
| 2020-03-31 |
The first three months of the COVID-19 epidemic: Epidemiological evidence for two separate strains of SARS-CoV-2 viruses spreading and implications for prevention strategies (edit) |
10.1101/2020.03.28.20036715 |
| 2020-03-31 |
Inferring Timing of Infection Using Within-host SARS-CoV-2 Infection Dynamics Model: Are "Imported Cases" Truly Imported? (edit) |
10.1101/2020.03.30.20040519 |
| 2020-03-31 |
SARS-CoV-2 detection from nasopharyngeal swab samples without RNA extraction (edit) |
10.1101/2020.03.28.013508 |
| 2020-03-31 |
A one-enzyme RT-qPCR assay for SARS-CoV-2, and procedures for reagent production (edit) |
10.1101/2020.03.29.013342 |
| 2020-03-31 |
Cigarette smoke exposure and inflammatory signaling increase the expression of the SARS-CoV-2 receptor ACE2 in the respiratory tract (edit) |
10.1101/2020.03.28.013672 |
| 2020-03-31 |
COVID-19 and SARSCoV2 (edit) |
10.4264/NUMA.79.1_47 |
| 2020-03-31 |
The Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Directly Decimates Human Spleens and Lymph Nodes (edit) |
10.1101/2020.03.27.20045427 |
| 2020-03-31 |
Ad hoc laboratory-based surveillance of SARS-CoV-2 by real-time RT-PCR using minipools of RNA prepared from routine respiratory samples (edit) |
10.1101/2020.03.30.20043513 |
| 2020-03-31 |
A Genomic Survey of SARS-CoV-2 Reveals Multiple Introductions into Northern California without a Predominant Lineage (edit) |
10.1101/2020.03.27.20044925 |
| 2020-03-31 |
Crystal structure of the SARS-CoV-2 non-structural protein 9, Nsp9 (edit) |
10.1101/2020.03.28.013920 |
| 2020-03-31 |
Computational Design of Peptides to Block Binding of the SARS-CoV-2 Spike Protein to Human ACE2 (edit) |
10.1101/2020.03.28.013607 |
| 2020-03-31 |
Pay attention to situation of SARS-CoV-2 and TCM advantages in treatment of novel coronavirus infection (edit) |
10.1016/J.CHMED.2020.03.004 |
| 2020-03-30 |
Nelfinavir Is Active Against SARS-CoV-2 in Vero E6 Cells (edit) |
10.26434/CHEMRXIV.12039888.V1 |
| 2020-03-30 |
A cohort of cancer patients with no reported cases of SARS-CoV-2 infection: the possible preventive role of Methylene Blue (edit) |
10.13128/SUBSTANTIA-888 |
| 2020-03-30 |
Study on the public psychological states and its related factors during the outbreak of coronavirus disease 2019 (COVID-19) in some regions of China (edit) |
10.1080/13548506.2020.1746817 |
| 2020-03-30 |
Letter to the Editor: Angiotensin-converting enzyme 2: an ally or a Trojan horse? Implications to SARS-CoV-2-related cardiovascular complications (edit) |
10.1152/AJPHEART.00215.2020 |
| 2020-03-30 |
International Perspectives Concerning Donor Milk Banking During the SARS-CoV-2 (COVID-19) Pandemic (edit) |
10.1177/0890334420917661 |
| 2020-03-30 |
Timely Diagnosis and Treatment Shortens the Time to Resolution of Coronavirus Disease (COVID-19) Pneumonia and Lowers the Highest and Last CT Scores From Sequential Chest CT (edit) |
10.2214/AJR.20.23078 |
| 2020-03-30 |
Rules for scientific progress while living with the COVID-19 Pandemic: from 'benchside' to 'fireside.' (edit) |
10.1080/15384047.2020.1747775 |
| 2020-03-30 |
Response to Wen and Li. Anesthesia Procedure of Emergency Operation for Patients with Suspected or Confirmed COVID-19 (DOI: 10.1089/sur.2020.040) (edit) |
10.1089/SUR.2020.088 |
| 2020-03-30 |
Diagnosis and Management of COVID-19 Disease (edit) |
10.1164/RCCM.2020C1 |
| 2020-03-30 |
Unprecedented Solutions for Extraordinary Times: Helping Long-Term Care Settings Deal with the COVID-19 Pandemic (edit) |
10.1017/ICE.2020.98 |
| 2020-03-30 |
Fast nosocomial spread of SARS-CoV2 in a French geriatric unit Lyon Study Group on Covid-19 infection (edit) |
10.1017/ICE.2020.99 |
| 2020-03-30 |
Shelter hospital mode: how to prevent novel coronavirus infection 2019 (COVID-19) hospital-acquired infection? (edit) |
10.1017/ICE.2020.97 |
| 2020-03-30 |
Roadblocks to Infection Prevention Efforts in Healthcare SARS-CoV-2/COVID-19 Response (edit) |
10.1017/DMP.2020.55 |
| 2020-03-30 |
Just the Facts: Airway management during the COVID-19 pandemic (edit) |
10.1017/CEM.2020.353 |
| 2020-03-30 |
[Quick community survey on the impact of COVID-19 outbreak for the healthcare of people living with HIV] (edit) |
10.3760/CMA.J.CN112338-20200314-00345 |
| 2020-03-30 |
[Recommendations CCAFU on the management of cancers of the urogenital system during an epidemic with Coronavirus COVID-19] (edit) |
10.1016/J.PUROL.2020.03.009 |
| 2020-03-30 |
COVID-19 threatens health systems in sub-Saharan Africa: the eye of the crocodile (edit) |
10.1172/JCI138493 |
| 2020-03-30 |
A Study of Basic Needs and Psychological Wellbeing of Medical Workers in the Fever Clinic of a Tertiary General Hospital in Beijing during the COVID-19 Outbreak (edit) |
10.1159/000507453 |
| 2020-03-30 |
Pathways for urology patients during the COVID-19 pandemic (edit) |
10.23736/S0393-2249.20.03861-8 |
| 2020-03-30 |
Facing in real time the challenges of the Covid-19 epidemic for rehabilitation (edit) |
10.23736/S1973-9087.20.06286-3 |
| 2020-03-30 |
Structural basis of receptor recognition by SARS-CoV-2 (edit) |
10.1038/S41586-020-2179-Y |
| 2020-03-30 |
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor (edit) |
10.1038/S41586-020-2180-5 |
| 2020-03-30 |
Methanol Mass Poisoning Outbreak: A Consequence of COVID-19 Pandemic and Misleading Messages on Social Media (edit) |
10.34172/IJOEM.2020.1983 |
| 2020-03-30 |
The Impact of COVID-19 on Italy: A Lesson for the Future (edit) |
10.34172/IJOEM.2020.1984 |
| 2020-03-30 |
Life-threatening cardiac tamponade complicating myo-pericarditis in COVID-19 (edit) |
10.1093/EURHEARTJ/EHAA253 |
| 2020-03-30 |
The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2 (edit) |
10.1093/CVR/CVAA078 |
| 2020-03-30 |
Novel Coronavirus Pneumonia (COVID-19) Progression Course in 17 Discharged Patients: Comparison of Clinical and Thin-Section CT Features During Recovery (edit) |
10.1093/CID/CIAA271 |
| 2020-03-30 |
Acute pulmonary embolism and COVID-19 pneumonia: a random association? (edit) |
10.1093/EURHEARTJ/EHAA254 |
| 2020-03-30 |
The Late Arrival of COVID-19 in Africa - Mitigating Pan-Continental Spread (edit) |
10.1093/CID/CIAA353 |
| 2020-03-30 |
Characteristics of peripheral lymphocyte subset alteration in COVID-19 pneumonia (edit) |
10.1093/INFDIS/JIAA150 |
| 2020-03-30 |
SARS-CoV-2-Positive Sputum and Feces After Conversion of Pharyngeal Samples in Patients With COVID-19 (edit) |
10.7326/M20-0991 |
| 2020-03-30 |
A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19 (edit) |
10.7326/M20-1223 |
| 2020-03-30 |
A Community Transmitted Case of Severe Acute Respiratory Distress Syndrome due to SARS CoV2 in the United States (edit) |
10.1093/CID/CIAA347 |
| 2020-03-30 |
SARS-CoV-2 Testing (edit) |
10.1093/AJCP/AQAA052 |
| 2020-03-30 |
Older Clinicians and the Surge in Novel Coronavirus Disease 2019 (COVID-19) (edit) |
10.1001/JAMA.2020.4978 |
| 2020-03-30 |
Mental health in the Covid-19 pandemic (edit) |
10.1093/QJMED/HCAA110 |
| 2020-03-30 |
Diagnosis and treatment of an acute severe pneumonia patient with COVID-19: Case report (edit) |
10.1002/JMV.25802 |
| 2020-03-30 |
Concerns regarding calculation of fatality rate of Chinese samples in COVID-19 meta-analysis (edit) |
10.1002/JMV.25799 |
| 2020-03-30 |
Performance of VivaDiag COVID-19 IgM/IgG Rapid Test is inadequate for diagnosis of COVID-19 in acute patients referring to emergency room department (edit) |
10.1002/JMV.25800 |
| 2020-03-30 |
Proposal for International Standardization of the Use of Lung Ultrasound for Patients With COVID-19: A Simple, Quantitative, Reproducible Method (edit) |
10.1002/JUM.15285 |
| 2020-03-30 |
Novel coronavirus treatment with ribavirin: Groundwork for an evaluation concerning COVID-19 (edit) |
10.1002/JMV.25798 |
| 2020-03-30 |
Caution should be exercised for the detection of SARS-CoV-2, especially in the elderly (edit) |
10.1002/JMV.25796 |
| 2020-03-30 |
Health psychology and the coronavirus (COVID-19) global pandemic: A call for research (edit) |
10.1111/BJHP.12414 |
| 2020-03-30 |
Cancer Research Ethics and COVID-19 (edit) |
10.1634/THEONCOLOGIST.2020-0221 |
| 2020-03-30 |
Social media for rapid knowledge dissemination: early experience from the COVID-19 pandemic (edit) |
10.1111/ANAE.15057 |
| 2020-03-30 |
Migraine Care in the Era of COVID-19: Clinical Pearls and Plea to Insurers (edit) |
10.1111/HEAD.13810 |
| 2020-03-30 |
The possible impact of COVID-19 on colorectal surgery in Italy (edit) |
10.1111/CODI.15054 |
| 2020-03-30 |
Veterinary oncologists adapting to COVID-19 pandemic (edit) |
10.1111/VCO.12593 |
| 2020-03-30 |
Coronavirus disease 2019 (COVID-19) outbreak at the Department of Ophthalmology, Oslo University Hospital, Norway (edit) |
10.1111/AOS.14426 |
| 2020-03-30 |
COVID-19 Related School Closings and Risk of Weight Gain Among Children (edit) |
10.1002/OBY.22813 |
| 2020-03-30 |
Developing Covid-19 Vaccines at Pandemic Speed (edit) |
10.1056/NEJMP2005630 |
| 2020-03-30 |
Covid-19 in Critically Ill Patients in the Seattle Region - Case Series (edit) |
10.1056/NEJMOA2004500 |
| 2020-03-30 |
Feeding Low-Income Children during the Covid-19 Pandemic (edit) |
10.1056/NEJMP2005638 |
| 2020-03-30 |
Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19 (edit) |
10.1056/NEJMSR2005760 |
| 2020-03-30 |
Covid-19 Does Not Lead to a "Typical" Acute Respiratory Distress Syndrome (edit) |
10.1164/RCCM.202003-0817LE |
| 2020-03-30 |
Covid-19: how coronavirus will change the face of general practice forever (edit) |
10.1136/BMJ.M1279 |
| 2020-03-30 |
Covid-19: Trump extends physical distancing to 30 April, as cases climb in New York (edit) |
10.1136/BMJ.M1289 |
| 2020-03-30 |
Covid-19: why is the UK government ignoring WHO's advice? (edit) |
10.1136/BMJ.M1284 |
| 2020-03-30 |
News Feature: Avoiding pitfalls in the pursuit of a COVID-19 vaccine (edit) |
10.1073/PNAS.2005456117 |
| 2020-03-30 |
Evaluation of saline, phosphate buffered saline and minimum essential medium as potential alternatives to viral transport media for SARS-CoV-2 testing (edit) |
10.1128/JCM.00590-20 |
| 2020-03-30 |
Evaluation of Nucleocapsid and Spike Protein-based ELISAs for detecting antibodies against SARS-CoV-2 (edit) |
10.1128/JCM.00461-20 |
| 2020-03-30 |
COVID-19 and chronological aging: senolytics and other anti-aging drugs for the treatment or prevention of corona virus infection? (edit) |
10.18632/AGING.103001 |
| 2020-03-30 |
COVID-19: response plan for International Medical Assistance companies (edit) |
10.1097/MEJ.0000000000000704 |
| 2020-03-30 |
Antihypertensive treatment with ACEI/ARB of patients with COVID-19 complicated by hypertension (edit) |
10.1038/S41440-020-0433-1 |
| 2020-03-30 |
Interaction between RAAS inhibitors and ACE2 in the context of COVID-19 (edit) |
10.1038/S41569-020-0368-X |
| 2020-03-30 |
Reply to: 'Interaction between RAAS inhibitors and ACE2 in the context of COVID-19' (edit) |
10.1038/S41569-020-0369-9 |
| 2020-03-30 |
Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion (edit) |
10.1038/S41422-020-0305-X |
| 2020-03-30 |
Emerging prophylaxis strategies against COVID-19 (edit) |
10.4081/MONALDI.2020.1289 |
| 2020-03-30 |
COVID-19, rheumatic diseases and immunosuppressive drugs: an appeal for medication adherence (edit) |
10.1007/S00296-020-04566-9 |
| 2020-03-30 |
Coronavirus disease 2019 (COVID-19) and anti-rheumatic drugs (edit) |
10.1007/S00296-020-04570-Z |
| 2020-03-30 |
Ocular manifestation, eye protection, and COVID-19 (edit) |
10.1007/S00417-020-04662-3 |
| 2020-03-30 |
Diagnostic performance of chest CT to differentiate COVID-19 pneumonia in non-high-epidemic area in Japan (edit) |
10.1007/S11604-020-00958-W |
| 2020-03-30 |
Clinical and Transmission Characteristics of Covid-19 - A Retrospective Study of 25 Cases from a Single Thoracic Surgery Department (edit) |
10.1007/S11596-020-2176-2 |
| 2020-03-30 |
Headaches Associated With Personal Protective Equipment - A Cross-Sectional Study Among Frontline Healthcare Workers During COVID-19 (edit) |
10.1111/HEAD.13811 |
| 2020-03-30 |
COVID-19 Pandemic - Is Virtual Urology Clinic the answer to keeping the cancer pathway moving? (edit) |
10.1111/BJU.15061 |
| 2020-03-30 |
Analysis on 54 Mortality Cases of Coronavirus Disease 2019 in the Republic of Korea from January 19 to March 10, 2020 (edit) |
10.3346/JKMS.2020.35.E132 |
| 2020-03-30 |
COVID-19 and non-communicable diseases (edit) |
10.1136/POSTGRADMEDJ-2020-137742 |
| 2020-03-30 |
Response to the COVID-19 Epidemic: The Chinese Experience and Implications for Other Countries (edit) |
10.3390/IJERPH17072304 |
| 2020-03-30 |
Corona Virus (COVID-19) "Infodemic" and Emerging Issues through a Data Lens: The Case of China (edit) |
10.3390/IJERPH17072309 |
| 2020-03-30 |
Novel Coronavirus Infection (COVID-19) in Humans: A Scoping Review and Meta-Analysis (edit) |
10.3390/JCM9040941 |
| 2020-03-30 |
The First 75 Days of Novel Coronavirus (SARS-CoV-2) Outbreak: Recent Advances, Prevention, and Treatment (edit) |
10.3390/IJERPH17072323 |
| 2020-03-30 |
The surgeons and the COVID-19 pandemic (edit) |
10.1590/0100-6991E-20202536 |
| 2020-03-30 |
Outbreak investigation in cargo ship in times of COVID-19 crisis, Port of Santos, Brazil (edit) |
10.11606/S1518-8787.2020054002461 |
| 2020-03-30 |
Screening faecal microbiota transplant donors for SARS-CoV-2 by molecular testing of stool is the safest way forward (edit) |
10.1016/S2468-1253(20)30089-3 |
| 2020-03-30 |
Dementia care during COVID-19 (edit) |
10.1016/S0140-6736(20)30755-8 |
| 2020-03-30 |
Being a Doctor Will Never Be the Same After the COVID-19 Pandemic (edit) |
10.1016/J.AMJMED.2020.03.003 |
| 2020-03-30 |
Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up (edit) |
10.1016/J.JINF.2020.03.019 |
| 2020-03-30 |
No Evidence of Rapid Antiviral Clearance or Clinical Benefit with the Combination of Hydroxychloroquine and Azithromycin in Patients with Severe COVID-19 Infection (edit) |
10.1016/J.MEDMAL.2020.03.006 |
| 2020-03-30 |
Applying Palliative Care Principles to Communicate with Children about COVID-19 (edit) |
10.1016/J.JPAINSYMMAN.2020.03.020 |
| 2020-03-30 |
Creating a Palliative Care Inpatient Response Plan for COVID19 - The UW Medicine Experience (edit) |
10.1016/J.JPAINSYMMAN.2020.03.025 |
| 2020-03-30 |
Home care for cancer patients during COVID-19 pandemic: the "double triage" protocol (edit) |
10.1016/J.JPAINSYMMAN.2020.03.021 |
| 2020-03-30 |
The emotional impact of COVID-19: From medical staff to common people (edit) |
10.1016/J.BBI.2020.03.032 |
| 2020-03-30 |
Maximizing the Calm Before the Storm: Tiered Surgical Response Plan for Novel Coronavirus (COVID-19) (edit) |
10.1016/J.JAMCOLLSURG.2020.03.019 |
| 2020-03-30 |
Will the quality of research remain the same during the COVID-19 pandemic? (edit) |
10.1016/J.CGH.2020.03.054 |
| 2020-03-30 |
Expert opinion of the Working Group on Echocardiography of the Polish Cardiac Society on performing echocardiographic examinations during COVID-19 pandemic (edit) |
10.33963/KP.15265 |
| 2020-03-30 |
[Epidemiological update on SARS-CoV-2 infection in Spain. Comments on the management of infection in pediatrics] (edit) |
10.1016/J.ANPEDI.2020.03.001 |
| 2020-03-30 |
The 2019 novel coronavirus disease (COVID-19) pandemic: A review of the current evidence (edit) |
10.4103/IJMR.IJMR_519_20 |
| 2020-03-30 |
Initial ELSO Guidance Document: ECMO for COVID-19 Patients with Severe Cardiopulmonary Failure (edit) |
10.1097/MAT.0000000000001173 |
| 2020-03-30 |
From the Editor's Desk: COVID-19 Update (edit) |
10.1097/MAT.0000000000001174 |
| 2020-03-30 |
Maternal and neonatal outcomes of pregnant women with COVID-19 pneumonia: a case-control study (edit) |
10.1093/CID/CIAA352 |
| 2020-03-30 |
COVID-19 (edit) |
10.5213/INJ.2020EDI.001 |
| 2020-03-30 |
Sharing Our Experience of Operating an Endoscopy Unit in the Midst of a COVID-19 Outbreak (edit) |
10.5946/CE.2020.076 |
| 2020-03-30 |
COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting? (edit) |
10.3332/ECANCER.2020.1023 |
| 2020-03-30 |
COVID-19 Pandemic: Public Health Implications in Nepal (edit) |
10.3126/NJE.V10I1.28269 |
| 2020-03-30 |
COVID-19 and Liver Dysfunction: Current Insights and Emergent Therapeutic Strategies (edit) |
10.14218/JCTH.2020.00018 |
| 2020-03-30 |
Practical insights for paediatric otolaryngology surgical cases and performing microlaryngobronchoscopy during the COVID-19 pandemic (edit) |
10.1016/J.IJPORL.2020.110030 |
| 2020-03-30 |
Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model (edit) |
10.1016/J.CSBJ.2020.03.025 |
| 2020-03-30 |
Science Education in the Era of a Pandemic: How Can History, Philosophy and Sociology of Science Contribute to Education for Understanding and Solving the Covid-19 Crisis? (edit) |
10.1007/S11191-020-00122-W |
| 2020-03-30 |
Physiotherapy management for COVID-19 in the acute hospital setting: clinical practice recommendations (edit) |
10.1016/J.JPHYS.2020.03.011 |
| 2020-03-30 |
COVID-19 therapeutic options for patients with kidney disease (edit) |
10.1016/J.KINT.2020.03.015 |
| 2020-03-30 |
Age-related rhesus macaque models of COVID-19 (edit) |
10.1002/AME2.12108 |
| 2020-03-30 |
Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial (edit) |
10.1101/2020.03.22.20040758 |
| 2020-03-30 |
Role of Chloroquine and Hydroxychloroquine in the Treatment of COVID-19 Infection- A Systematic Literature Review (edit) |
10.1101/2020.03.24.20042366 |
| 2020-03-30 |
Effects of hypertension, diabetes and coronary heart disease on COVID-19 diseases severity: a systematic review and meta-analysis (edit) |
10.1101/2020.03.25.20043133 |
| 2020-03-30 |
Laboratory findings, signs and symptoms, clinical outcomes of Patients with COVID-19 Infection: an updated systematic review and meta-analysis (edit) |
10.1101/2020.03.25.20043703 |
| 2020-03-30 |
Clinical and Paraclinical Characteristics of COVID-19 patients: A systematic review and meta-analysis (edit) |
10.1101/2020.03.26.20044057 |
| 2020-03-30 |
Medical treatment of 55 patients with COVID-19 from seven cities in northeast China who fully recovered: a single-center, retrospective, observational study (edit) |
10.1101/2020.03.28.20045955 |
| 2020-03-30 |
Development and external validation of a prognostic multivariable model on admission for hospitalized patients with COVID-19 (edit) |
10.1101/2020.03.28.20045997 |
| 2020-03-30 |
Clinical Consensus Recommendations Regarding Non-Invasive Respiratory Support in the Adult Patient with Acute Respiratory Failure Secondary to SARS-CoV-2 infection (edit) |
10.1016/J.ARBRES.2020.03.005 |
| 2020-03-30 |
Diagnostic Indexes of a Rapid IgG/IgM Combined Antibody Test for SARS-CoV-2 (edit) |
10.1101/2020.03.26.20044883 |
| 2020-03-30 |
Comparative performance of four nucleic acid amplification tests for SARS-CoV-2 virus (edit) |
10.1101/2020.03.26.010975 |
| 2020-03-30 |
A considerable proportion of individuals with asymptomatic SARS-CoV-2 infection in Tibetan population (edit) |
10.1101/2020.03.27.20043836 |
| 2020-03-30 |
Evaluation the auxiliary diagnosis value of antibodies assays for detection of novel coronavirus (SARS-Cov-2) causing an outbreak of pneumonia (COVID-19) (edit) |
10.1101/2020.03.26.20042044 |
| 2020-03-30 |
SARS-CoV-2 detection using digital PCR for COVID-19 diagnosis, treatment monitoring and criteria for discharge (edit) |
10.1101/2020.03.24.20042689 |
| 2020-03-30 |
What is required to prevent a second major outbreak of the novel coronavirus SARS-CoV-2 upon lifting the metropolitan-wide quarantine of Wuhan city, China (edit) |
10.1101/2020.03.24.20042374 |
| 2020-03-30 |
Persistent SARS-CoV-2 presence is companied with defects in adaptive immune system in non-severe COVID-19 patients (edit) |
10.1101/2020.03.26.20044768 |
| 2020-03-30 |
Analysis and Prediction of False Negative Results for SARS-CoV-2 Detection with Pharyngeal Swab Specimen in COVID-19 Patients: A Retrospective Study (edit) |
10.1101/2020.03.26.20043042 |
| 2020-03-30 |
A Multi-hospital Study in Wuhan, China：Protective Effects of Non-menopause and Female Hormones on SARS-CoV-2 infection (edit) |
10.1101/2020.03.26.20043943 |
| 2020-03-30 |
Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins (edit) |
10.1101/2020.03.28.013276 |
| 2020-03-30 |
Dispersion of a new coronavirus SARS-CoV-2 by airlines in 2020: Temporal estimates of the outbreak in Mexico. (edit) |
10.1101/2020.03.24.20042168 |
| 2020-03-30 |
SARS-CoV-2 asymptomatic and symptomatic patients and risk for transfusion transmission (edit) |
10.1101/2020.03.29.20039529 |
| 2020-03-30 |
Evaluations of serological test in the diagnosis of 2019 novel coronavirus (SARS-CoV-2) infections during the COVID-19 outbreak (edit) |
10.1101/2020.03.27.20045153 |
| 2020-03-30 |
No SARS-CoV-2 in expressed prostatic secretion of patients with coronavirus disease 2019: a descriptive multicentre study in China (edit) |
10.1101/2020.03.26.20044198 |
| 2020-03-30 |
Comparative Genomic Analysis of Rapidly Evolving SARS-CoV-2 Viruses Reveal Mosaic Pattern of Phylogeographical Distribution (edit) |
10.1101/2020.03.25.006213 |
| 2020-03-30 |
An alternative workflow for molecular detection of SARS-CoV-2 - escape from the NA extraction kit-shortage (edit) |
10.1101/2020.03.27.20044495 |
| 2020-03-30 |
Children are unlikely to have been the primary source of household SARS-CoV-2 infections (edit) |
10.1101/2020.03.26.20044826 |
| 2020-03-30 |
Failed detection of the full-length genome of SARS-CoV-2 by ultra-deep sequencing from the recovered and discharged patients retested viral PCR positive (edit) |
10.1101/2020.03.27.20043299 |
| 2020-03-30 |
Evaluation of Group Testing for SARS-CoV-2 RNA (edit) |
10.1101/2020.03.27.20043968 |
| 2020-03-30 |
The comparative superiority of IgM-IgG antibody test to real-time reverse transcriptase PCR detection for SARS-CoV-2 infection diagnosis (edit) |
10.1101/2020.03.28.20045765 |
| 2020-03-30 |
Early Spread of SARS-Cov-2 in the Icelandic Population (edit) |
10.1101/2020.03.26.20044446 |
| 2020-03-30 |
Whole Genome Analysis and Targeted Drug Discovery Using Computational Methods and High Throughput Screening Tools for Emerged Novel Coronavirus (2019-nCoV) (edit) |
|
| 2020-03-29 |
Correlation between universal BCG vaccination policy and reduced morbidity and mortality for COVID-19: an epidemiological study (edit) |
10.1101/2020.03.24.20042937 |
| 2020-03-29 |
Modeling of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Proteins by Machine Learning and Physics-Based Refinement (edit) |
10.1101/2020.03.25.008904 |
| 2020-03-29 |
Structure-Based Design, Synthesis and Biological Evaluation of Peptidomimetic Aldehydes as a Novel Series of Antiviral Drug Candidates Targeting the SARS-CoV-2 Main Protease (edit) |
10.1101/2020.03.25.996348 |
| 2020-03-29 |
Design of potent membrane fusion inhibitors against SARS-CoV-2, an emerging coronavirus with high fusogenic activity (edit) |
10.1101/2020.03.26.009233 |
| 2020-03-29 |
Re-analysis of SARS-CoV-2 infected host cell proteomics time-course data by impact pathway analysis and network analysis. A potential link with inflammatory response. (edit) |
10.1101/2020.03.26.009605 |
| 2020-03-29 |
Structural Basis for Potent Neutralization of Betacoronaviruses by Single-domain Camelid Antibodies (edit) |
10.1101/2020.03.26.010165 |
| 2020-03-29 |
Site-specific analysis of the SARS-CoV-2 glycan shield (edit) |
10.1101/2020.03.26.010322 |
| 2020-03-29 |
The Nucleocapsid Protein of SARS-CoV-2 Abolished Pluripotency in Human Induced Pluripotent Stem Cells (edit) |
10.1101/2020.03.26.010694 |
| 2020-03-29 |
SARS-CoV-2 proteome microarray for mapping COVID-19 antibody interactions at amino acid resolution (edit) |
10.1101/2020.03.26.994756 |
| 2020-03-29 |
SARS-CoV-2 exhibits intra-host genomic plasticity and low-frequency polymorphic quasispecies (edit) |
10.1101/2020.03.27.009480 |
| 2020-03-29 |
SARS-CoV-2 and ORF3a: Non-Synonymous Mutations and Polyproline Regions (edit) |
10.1101/2020.03.27.012013 |
| 2020-03-29 |
RNA genome conservation and secondary structure in SARS-CoV-2 and SARS-related viruses (edit) |
10.1101/2020.03.27.012906 |
| 2020-03-29 |
Frequency and Distribution of Chest Radiographic Findings in COVID-19 Positive Patients (edit) |
10.1148/RADIOL.2020201160 |
| 2020-03-29 |
Clinical characteristics of 54 medical staff with COVID-19: A retrospective study in a single center in Wuhan, China (edit) |
10.1002/JMV.25793 |
| 2020-03-29 |
Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission (edit) |
10.1111/APT.15731 |
| 2020-03-29 |
Detectable SARS-CoV-2 Viral RNA in Feces of Three Children during Recovery Period of COVID-19 Pneumonia (edit) |
10.1002/JMV.25795 |
| 2020-03-29 |
Genomic characterization and phylogenetic analysis of SARS-COV-2 in Italy (edit) |
10.1002/JMV.25794 |
| 2020-03-29 |
Phylogenetic analysis of the first four SARS-CoV-2 cases in Chile (edit) |
10.1002/JMV.25797 |
| 2020-03-29 |
European Task Force on Atopic Dermatitis (ETFAD) statement on severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2)-infection and atopic dermatitis (edit) |
10.1111/JDV.16411 |
| 2020-03-29 |
Sixty-eight consecutive patients assessed for COVID-19 infection: Experience from a UK Regional infectious diseases Unit (edit) |
10.1111/IRV.12739 |
| 2020-03-29 |
Italian Society of Interventional Cardiology (GISE) position paper for Cath lab-specific preparedness recommendations for healthcare providers in case of suspected, probable or confirmed cases of COVID-19 (edit) |
10.1002/CCD.28888 |
| 2020-03-29 |
Precautionary measures needed for ophthalmologists during pandemic of the coronavirus disease 2019 (COVID-19) (edit) |
10.1111/AOS.14438 |
| 2020-03-29 |
COVID-19: Face masks and human-to-human transmission (edit) |
10.1111/IRV.12740 |
| 2020-03-29 |
Antipsoriatic treatments during COVID-19 outbreak (edit) |
10.1111/DTH.13345 |
| 2020-03-29 |
Covid-19: Doctors are told not to perform CPR on patients in cardiac arrest (edit) |
10.1136/BMJ.M1282 |
| 2020-03-29 |
High population densities catalyze the spread of COVID-19 (edit) |
10.1093/JTM/TAAA038 |
| 2020-03-29 |
ASPHER statement on the novel coronavirus disease (COVID-19) outbreak emergency (edit) |
10.1007/S00038-020-01362-X |
| 2020-03-29 |
The correlation between viral clearance and biochemical outcomes of 94 COVID-19 infected discharged patients (edit) |
10.1007/S00011-020-01342-0 |
| 2020-03-29 |
COVID-19 treatment by repurposing drugs until the vaccine is in sight (edit) |
10.1002/DDR.21666 |
| 2020-03-29 |
COVID-19 in endoscopy: Time to do more? (edit) |
10.1016/J.GIE.2020.03.3848 |
| 2020-03-29 |
Coronavirus disease 2019 (COVID-19): current status and future perspectives (edit) |
10.1016/J.IJANTIMICAG.2020.105951 |
| 2020-03-29 |
The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality (edit) |
10.1016/J.IJANTIMICAG.2020.105954 |
| 2020-03-29 |
COVID-19, diabetes mellitus and ACE2: The conundrum (edit) |
10.1016/J.DIABRES.2020.108132 |
| 2020-03-29 |
Progress and Prospects on Vaccine Development against SARS-CoV-2 (edit) |
10.3390/VACCINES8020153 |
| 2020-03-29 |
Novel Coronavirus 2019 (2019-nCoV) Infection: Part I - Preparedness and Management in the Pediatric Intensive Care Unit in Resource-limited Settings (edit) |
|
| 2020-03-29 |
Novel Coronavirus 2019 (2019-nCoV) Infection: Part II - Respiratory Support in the Pediatric Intensive Care Unit in Resource-limited Settings (edit) |
|
| 2020-03-29 |
Measles Immunization: Worth Considering Containment Strategy for SARS-CoV-2 Global Outbreak (edit) |
|
| 2020-03-29 |
Herbal medicine and pattern identification for treating COVID-19: a rapid review of guidelines (edit) |
10.1016/J.IMR.2020.100407 |
| 2020-03-29 |
Knowledge and attitudes of medical staff in Chinese psychiatric hospitals regarding COVID-19 (edit) |
10.1016/J.BBIH.2020.100064 |
| 2020-03-29 |
Characteristic Electrocardiographic Manifestations in Patients With COVID-19 (edit) |
10.1016/J.CJCA.2020.03.028 |
| 2020-03-29 |
Angiotensin-Converting Enzyme 2 as the Molecular Bridge Between Epidemiologic and Clinical Features of COVID-19 (edit) |
10.1016/J.CJCA.2020.03.026 |
| 2020-03-28 |
Codon usage and evolutionary rates of the 2019-nCoV genes (edit) |
10.1101/2020.03.25.006569 |
| 2020-03-28 |
Non-neural expression of SARS-CoV-2 entry genes in the olfactory epithelium suggests mechanisms underlying anosmia in COVID-19 patients (edit) |
10.1101/2020.03.25.009084 |
| 2020-03-28 |
The effects of misleading media reports about COVID-19 on Chinese tourists’ mental health: a perspective article (edit) |
10.1080/13032917.2020.1747208 |
| 2020-03-28 |
Spotlight on Jails: COVID-19 Mitigation Policies Needed Now (edit) |
10.1093/CID/CIAA346 |
| 2020-03-28 |
Papa Giovanni XXIII Bergamo Hospital at the time of the COVID-19 outbreak: letter from the warfront (edit) |
10.1111/IJLH.13207 |
| 2020-03-28 |
Base protocol for real time active random surveillance of coronavirus disease (COVID-19) – Adapting veterinary methodology to public health (edit) |
10.1016/J.ONEHLT.2020.100129 |
| 2020-03-28 |
Monitoring Transmissibility and Mortality of COVID-19 in Europe (edit) |
10.1016/J.IJID.2020.03.050 |
| 2020-03-28 |
COVID-19 outbreak and inflammatory bowel disease management: a questionnaire survey from realistic practice (edit) |
10.1093/ECCO-JCC/JJAA064 |
| 2020-03-28 |
The Role of Emergency Radiology in COVID-19: From Preparedness to Diagnosis (edit) |
10.1177/0846537120916419 |
| 2020-03-28 |
[Challenges to prevent and control the outbreak of Novel Coronavirus Pneumonia (COVID-19)] (edit) |
10.3760/CMA.J.CN112338-20200216-00108 |
| 2020-03-28 |
Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019 (edit) |
10.1093/CID/CIAA344 |
| 2020-03-28 |
Quantitative Detection and Viral Load Analysis of SARS-CoV-2 in Infected Patients (edit) |
10.1093/CID/CIAA345 |
| 2020-03-28 |
Sourcing Personal Protective Equipment During the COVID-19 Pandemic (edit) |
10.1001/JAMA.2020.5317 |
| 2020-03-28 |
Coronavirus disease 2019 (COVID-19) outbreak: Could pigs be vectors for human infections? (edit) |
10.1111/XEN.12591 |
| 2020-03-28 |
Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19) (edit) |
10.1007/S00134-020-06022-5 |
| 2020-03-28 |
Neurosurgery during the COVID-19 pandemic: update from Lombardy, northern Italy (edit) |
10.1007/S00701-020-04305-W |
| 2020-03-28 |
Reply to "Does hand hygiene reduce SARS-CoV-2 transmission?" (edit) |
10.1007/S00417-020-04653-4 |
| 2020-03-28 |
Prevalence and impact of diabetes among people infected with SARS-CoV-2 (edit) |
10.1007/S40618-020-01236-2 |
| 2020-03-28 |
Multi-omics Evaluation of Gastrointestinal and Other Clinical Characteristics of SARS-CoV-2 and COVID-19 (edit) |
10.1053/J.GASTRO.2020.03.045 |
| 2020-03-28 |
Using psychoneuroimmunity against COVID-19 (edit) |
10.1016/J.BBI.2020.03.025 |
| 2020-03-28 |
Considering the challenge of the Covid-19 pandemic, is there a need to adapt the guidelines for basic life support resuscitation? (edit) |
10.1016/J.RESUSCITATION.2020.03.010 |
| 2020-03-28 |
Molecular characterization of SARS-CoV-2 in the first COVID-19 cluster in France reveals an amino acid deletion in nsp2 (Asp268del) (edit) |
10.1016/J.CMI.2020.03.020 |
| 2020-03-28 |
Follow-up of asymptomatic patients with SARS-CoV-2 infection (edit) |
10.1016/J.CMI.2020.03.024 |
| 2020-03-28 |
COVID-19 in children: More than meets the eye (edit) |
10.1016/J.TMAID.2020.101649 |
| 2020-03-28 |
Complex emergencies of COVID-19: management and experience in Zhuhai, China (edit) |
10.1016/J.IJANTIMICAG.2020.105961 |
| 2020-03-28 |
The epidemiology, diagnosis and treatment of COVID-19 (edit) |
10.1016/J.IJANTIMICAG.2020.105955 |
| 2020-03-28 |
The cardiovascular burden of coronavirus disease 2019 (COVID-19) with a focus on congenital heart disease (edit) |
10.1016/J.IJCARD.2020.03.063 |
| 2020-03-28 |
COVID 19 in INDIA: Strategies to combat from combination threat of life and livelihood (edit) |
10.1016/J.JMII.2020.03.024 |
| 2020-03-28 |
A Case of COVID-19 Pneumonia in a Young Male with Full Body Rash as a Presenting Symptom (edit) |
10.5811/CPCEM.2020.3.47349 |
| 2020-03-28 |
A systems approach to preventing and responding to COVID-19 (edit) |
10.1016/J.ECLINM.2020.100325 |
| 2020-03-28 |
The association between international and domestic air traffic and the coronavirus (COVID-19) outbreak (edit) |
10.1016/J.JMII.2020.03.026 |
| 2020-03-28 |
Broad anti-coronaviral activity of FDA approved drugs against SARS-CoV-2 in vitro and SARS-CoV in vivo (edit) |
10.1101/2020.03.25.008482 |
| 2020-03-28 |
A Mathematical Modelling Approach in the Spread of the Novel 2019 Coronavirus SARS-CoV-2 (COVID-19) Pandemic (edit) |
10.29333/EJGM/7861 |
| 2020-03-27 |
A New Predictor of Disease Severity in Patients with COVID-19 in Wuhan, China (edit) |
10.1101/2020.03.24.20042119 |
| 2020-03-27 |
Global profiling of SARS-CoV-2 specific IgG/ IgM responses of convalescents using a proteome microarray (edit) |
10.1101/2020.03.20.20039495 |
| 2020-03-27 |
Anti-hypertensive Angiotensin II receptor blockers associated to mitigation of disease severity in elderly COVID-19 patients (edit) |
10.1101/2020.03.20.20039586 |
| 2020-03-27 |
ACE2 Expression is Increased in the Lungs of Patients with Comorbidities Associated with Severe COVID-19 (edit) |
10.1101/2020.03.21.20040261 |
| 2020-03-27 |
COVID-19 outbreak response: a first assessment of mobility changes in Italy following national lockdown (edit) |
10.1101/2020.03.22.20039933 |
| 2020-03-27 |
A special case of COVID-19 with long duration of viral shedding for 49 days (edit) |
10.1101/2020.03.22.20040071 |
| 2020-03-27 |
The Effect of Large-Scale Anti-Contagion Policies on the Coronavirus (COVID-19) Pandemic (edit) |
10.1101/2020.03.22.20040642 |
| 2020-03-27 |
Factors associated with prolonged viral shedding and impact of Lopinavir/Ritonavir treatment in patients with SARS-CoV-2 infection (edit) |
10.1101/2020.03.22.20040832 |
| 2020-03-27 |
Scarce COVID-19 Testing Capabilities at Urgent Care Centers in States with Greatest Disease Burden (edit) |
10.1101/2020.03.22.20040923 |
| 2020-03-27 |
Quantifying treatment effects of hydroxychloroquine and azithromycin for COVID-19: a secondary analysis of an open label non-randomized clinical trial (Gautret et al, 2020) (edit) |
10.1101/2020.03.22.20040949 |
| 2020-03-27 |
Simulation-based Estimation of the Spread of COVID-19 in Iran (edit) |
10.1101/2020.03.22.20040956 |
| 2020-03-27 |
Therapeutic Application of Chloroquine in Clinical Trials for COVID-19 (edit) |
10.1101/2020.03.22.20040964 |
| 2020-03-27 |
COVID-19 attack rate increases with city size (edit) |
10.1101/2020.03.22.20041004 |
| 2020-03-27 |
Clinical features and the maternal and neonatal outcomes of pregnant women with coronavirus disease 2019 (edit) |
10.1101/2020.03.22.20041061 |
| 2020-03-27 |
Exponential damping key to successful containment of COVID-19 outbreak (edit) |
10.1101/2020.03.22.20041111 |
| 2020-03-27 |
Is scaling-up COVID-19 testing cost-saving? (edit) |
10.1101/2020.03.22.20041137 |
| 2020-03-27 |
Global transmission network of SARS-CoV-2: from outbreak to pandemic (edit) |
10.1101/2020.03.22.20041145 |
| 2020-03-27 |
Delaying the COVID-19 epidemic in Australia: Evaluating the effectiveness of international travel bans (edit) |
10.1101/2020.03.22.20041244 |
| 2020-03-27 |
Critical Care for Patients with Severe Covid-19 in Sichuan Province, China: Provincial Cohort Study (edit) |
10.1101/2020.03.22.20041277 |
| 2020-03-27 |
Elevated serum IgM levels indicate poor outcome in patients with coronavirus disease 2019 pneumonia: A retrospective case-control study (edit) |
10.1101/2020.03.22.20041285 |
| 2020-03-27 |
Structure-based modeling of SARS-CoV-2 peptide/HLA-A02 antigens (edit) |
10.1101/2020.03.23.004176 |
| 2020-03-27 |
Immune Cell Profiling of COVID-19 Patients in the Recovery Stage by Single-Cell Sequencing (edit) |
10.1101/2020.03.23.20039362 |
| 2020-03-27 |
Air Pollution Reduction and Mortality Benefit during the COVID-19 Outbreak in China (edit) |
10.1101/2020.03.23.20039842 |
| 2020-03-27 |
Gastrointestinal tract symptoms in coronavirus disease 2019: Analysis of clinical symptoms in adult patients (edit) |
10.1101/2020.03.23.20040279 |
| 2020-03-27 |
Anaesthesia and infection control in cesarean section of pregnant women with coronavirus disease 2019 (COVID-19) (edit) |
10.1101/2020.03.23.20040394 |
| 2020-03-27 |
Modelling SARS-CoV-2 Dynamics: Implications for Therapy (edit) |
10.1101/2020.03.23.20040493 |
| 2020-03-27 |
Climate affects global patterns of COVID-19 early outbreak dynamics (edit) |
10.1101/2020.03.23.20040501 |
| 2020-03-27 |
Analysis of adaptive immune cell populations and phenotypes in the patients infected by SARS-CoV-2 (edit) |
10.1101/2020.03.23.20040675 |
| 2020-03-27 |
Clinical Characteristics Hospitalized Patients with SARS-Cov-2 and HBV Co-infection (edit) |
10.1101/2020.03.23.20040733 |
| 2020-03-27 |
A demographic adjustment to improve measurement of COVID-19 severity at the developing stage of the pandemic (edit) |
10.1101/2020.03.23.20040998 |
| 2020-03-27 |
Impact of changing case definitions for COVID-19 on the epidemic curve and transmission parameters in mainland China (edit) |
10.1101/2020.03.23.20041319 |
| 2020-03-27 |
Spatio-temporal propagation of COVID-19 pandemics (edit) |
10.1101/2020.03.23.20041517 |
| 2020-03-27 |
Core Outcome Set for Traditional Chinese and Western Medicine Clinical Trials of COVID-19 (edit) |
10.1101/2020.03.23.20041533 |
| 2020-03-27 |
Modeling COVID-19 epidemics in an Excel spreadsheet: Democratizing the access to first-hand accurate predictions of epidemic outbreaks (edit) |
10.1101/2020.03.23.20041590 |
| 2020-03-27 |
Multiple-Input Deep Convolutional Neural Network Model for COVID-19 Forecasting in China (edit) |
10.1101/2020.03.23.20041608 |
| 2020-03-27 |
Radiographic Findings and other Predictors in Adults with Covid-19 (edit) |
10.1101/2020.03.23.20041673 |
| 2020-03-27 |
Serology characteristics of SARS-CoV-2 infection since the exposure and post symptoms onset (edit) |
10.1101/2020.03.23.20041707 |
| 2020-03-27 |
A Social Network Model of the COVID-19 Pandemic (edit) |
10.1101/2020.03.23.20041798 |
| 2020-03-27 |
Population-Level Mortality Rates from Novel Coronavirus (COVID-19) in South Korea (edit) |
10.1101/2020.03.23.20041814 |
| 2020-03-27 |
History of Coronary Heart Disease Increases the Mortality Rate of Coronavirus Disease 2019 (COVID-19) Patients: A Nested Case-Control Study Based on Publicly Reported Confirmed Cases in Mainland China (edit) |
10.1101/2020.03.23.20041848 |
| 2020-03-27 |
Modelling strategies to organize healthcare workforce during pandemics: application to COVID-19 (edit) |
10.1101/2020.03.23.20041863 |
| 2020-03-27 |
Coincidence of COVID-19 epidemic and olfactory dysfunction outbreak (edit) |
10.1101/2020.03.23.20041889 |
| 2020-03-27 |
SARS-CoV-2 infection in 86 healthcare workers in two Dutch hospitals in March 2020 (edit) |
10.1101/2020.03.23.20041913 |
| 2020-03-27 |
Haplotype networks of SARS-CoV-2 infections in the Diamond Princess cruise ship outbreak (edit) |
10.1101/2020.03.23.20041970 |
| 2020-03-27 |
Is a COVID19 Quarantine Justified in Chile or USA Right Now? (edit) |
10.1101/2020.03.23.20042002 |
| 2020-03-27 |
Computational simulations reveal the binding dynamics between human ACE2 and the receptor binding domain of SARS-CoV-2 spike protein (edit) |
10.1101/2020.03.24.005561 |
| 2020-03-27 |
Topoisomerase III-beta is required for efficient replication of positive-sense RNA viruses (edit) |
10.1101/2020.03.24.005900 |
| 2020-03-27 |
Automatic Identification of SARS Coronavirus using Compression-Complexity Measures (edit) |
10.1101/2020.03.24.006007 |
| 2020-03-27 |
In-Silico evidence for two receptors based strategy of SARS-CoV-2 (edit) |
10.1101/2020.03.24.006197 |
| 2020-03-27 |
Transmission dynamics of SARS-COV-2 in China: impact of public health interventions (edit) |
10.1101/2020.03.24.20036285 |
| 2020-03-27 |
Lactate dehydrogenase, a Risk Factor of Severe COVID-19 Patients (edit) |
10.1101/2020.03.24.20040162 |
| 2020-03-27 |
Systematic review and critical appraisal of prediction models for diagnosis and prognosis of COVID-19 infection (edit) |
10.1101/2020.03.24.20041020 |
| 2020-03-27 |
Hydrogen Peroxide Vapor sterilization of N95 respirators for reuse (edit) |
10.1101/2020.03.24.20041087 |
| 2020-03-27 |
Modeling for Corona Virus Outbreak in IRAN (edit) |
10.1101/2020.03.24.20041095 |
| 2020-03-27 |
Anaesthetic managment and clinical outcomes of parturients with COVID-19: a multicentre, retrospective, propensity score matched cohort study (edit) |
10.1101/2020.03.24.20042176 |
| 2020-03-27 |
Mechanical Ventilator Milano (MVM):A Novel Mechanical Ventilator Designed for Mass Scale Production in response to the COVID-19 Pandemics (edit) |
10.1101/2020.03.24.20042234 |
| 2020-03-27 |
Disparities in Age-Specific Morbidity and Mortality from SARS-CoV-2 in China and the Republic of Korea (edit) |
10.1101/2020.03.24.20042598 |
| 2020-03-27 |
Reproducibility and reporting practices in COVID-19 preprint manuscripts (edit) |
10.1101/2020.03.24.20042796 |
| 2020-03-27 |
Age-dependent effects in the transmission and control of COVID-19 epidemics (edit) |
10.1101/2020.03.24.20043018 |
| 2020-03-27 |
Estimation of SARS-CoV-2 Infection Prevalence in Santa Clara County (edit) |
10.1101/2020.03.24.20043067 |
| 2020-03-27 |
World governments should protect their population from COVID-19 pandemic using Italy and Lombardy as precursor (edit) |
10.1101/2020.03.25.20042713 |
| 2020-03-27 |
Questionnaire assessment helps the self-management of patients with inflammatory bowel disease during the outbreak of Coronavirus Disease 2019 (edit) |
10.1101/2020.03.25.20043364 |
| 2020-03-27 |
UV Sterilization of Personal Protective Equipment with Idle Laboratory Biosafety Cabinets During the Covid-19 Pandemic (edit) |
10.1101/2020.03.25.20043489 |
| 2020-03-27 |
Outbreak analysis with a logistic growth model shows COVID-19 suppression dynamics in China (edit) |
10.1101/2020.03.25.20043539 |
| 2020-03-27 |
On the assessment of more reliable COVID-19 infected number: the italian case. (edit) |
10.1101/2020.03.25.20043562 |
| 2020-03-27 |
Acute gastrointestinal injury in critically ill patients with coronavirus disease 2019 in Wuhan, China (edit) |
10.1101/2020.03.25.20043570 |
| 2020-03-27 |
Epidemiological Tools that Predict Partial Herd Immunity to SARS Coronavirus 2 (edit) |
10.1101/2020.03.25.20043679 |
| 2020-03-27 |
Prevalence, Severity and Mortality associated with COPD and Smoking in patients with COVID-19: A Rapid Systematic Review and Meta-Analysis (edit) |
10.1101/2020.03.25.20043745 |
| 2020-03-27 |
The current state of COVID-19 in Australia: importation and spread (edit) |
10.1101/2020.03.25.20043877 |
| 2020-03-27 |
A Simple Mathematical Model for Estimating the Inflection Points of COVID-19 Outbreaks (edit) |
10.1101/2020.03.25.20043893 |
| 2020-03-27 |
The potential SARS-CoV-2 entry inhibitor (edit) |
10.1101/2020.03.26.009803 |
| 2020-03-27 |
Evaluation of COVID-19 RT-qPCR test in multi-sample pools (edit) |
10.1101/2020.03.26.20039438 |
| 2020-03-27 |
A comparison study of SARS-CoV-2 IgG antibody between male and female COVID-19 patients: a possible reason underlying different outcome between gender. (edit) |
10.1101/2020.03.26.20040709 |
| 2020-03-27 |
Serological diagnostic kit of SARS-CoV-2 antibodies using CHO-expressed full-length SARS-CoV-2 S1 proteins (edit) |
10.1101/2020.03.26.20042184 |
| 2020-03-27 |
Severe airport sanitarian control could slow down the spreading of COVID-19 pandemics in Brazil (edit) |
10.1101/2020.03.26.20044370 |
| 2020-03-27 |
La Pandemia del COVID-19 [The COVID-19 Pandemic] (edit) |
10.37980/IM.JOURNAL.RMDP.2020872 |
| 2020-03-27 |
Treatment of COVID-19 patients: Justicia adhatoda leaves extract is a strong remedy for COVID-19 – Case report analysis and docking based study (edit) |
10.26434/CHEMRXIV.12038604 |
| 2020-03-27 |
Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study (edit) |
10.1038/S41392-020-0148-4 |
| 2020-03-27 |
Surveillance to improve evidence for community control decisions during the COVID-19 pandemic – Opening the animal epidemic toolbox for Public Health (edit) |
10.1016/J.ONEHLT.2020.100130 |
| 2020-03-27 |
Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients (edit) |
10.1016/J.JINF.2020.03.005 |
| 2020-03-27 |
COVID-19 Infection: Implications for Perioperative and Critical Care Physicians (edit) |
10.1097/ALN.0000000000003303 |
| 2020-03-27 |
Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) - United States, February 12-March 16, 2020 (edit) |
10.15585/MMWR.MM6912E2 |
| 2020-03-27 |
COVID-19 in a Long-Term Care Facility - King County, Washington, February 27-March 9, 2020 (edit) |
10.15585/MMWR.MM6912E1 |
| 2020-03-27 |
Public Health Responses to COVID-19 Outbreaks on Cruise Ships - Worldwide, February-March 2020 (edit) |
10.15585/MMWR.MM6912E3 |
| 2020-03-27 |
Faith, Politics and the COVID-19 Pandemic: The Turkish Response (edit) |
10.1080/01459740.2020.1745482 |
| 2020-03-27 |
CSC Expert Consensus on Principles of Clinical Management of Patients with Severe Emergent Cardiovascular Diseases during the COVID-19 Epidemic (edit) |
10.1161/CIRCULATIONAHA.120.047011 |
| 2020-03-27 |
The Impact of COVID-19 on Radiology Trainees (edit) |
10.1148/RADIOL.2020201222 |
| 2020-03-27 |
Trust in humanitarian aid from the earthquake 2017 to COVID-19 in Iran: A policy analysis (edit) |
10.1017/DMP.2020.54 |
| 2020-03-27 |
Posttraumatic stress symptoms and attitude toward crisis mental health services among clinically stable patients with COVID-19 in China (edit) |
10.1017/S0033291720000999 |
| 2020-03-27 |
COVID-19: "A Tale of Two Epidemics" March 20, 2020 (edit) |
10.1017/DMP.2020.58 |
| 2020-03-27 |
Translating COVID-19 Pandemic Surge Theory to Practice in the Emergency Department: How to Expand Structure (edit) |
10.1017/DMP.2020.57 |
| 2020-03-27 |
COVID-19 positive test result from a private hospital laboratory: Neglecting to report and problems with national infection control (edit) |
10.1017/ICE.2020.93 |
| 2020-03-27 |
Chloroquine and COVID-19, where do we stand? (edit) |
10.1016/J.MEDMAL.2020.03.004 |
| 2020-03-27 |
The Role of the Global Health Development/Eastern Mediterranean Public Health Network and the Eastern Mediterranean Field Epidemiology Training Programs in Preparedness for COVID-19 (edit) |
10.2196/18503 |
| 2020-03-27 |
Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19) (edit) |
10.1001/JAMACARDIO.2020.1017 |
| 2020-03-27 |
Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19) (edit) |
10.1001/JAMACARDIO.2020.1096 |
| 2020-03-27 |
The Importance of Addressing Advance Care Planning and Decisions About Do-Not-Resuscitate Orders During Novel Coronavirus 2019 (COVID-19) (edit) |
10.1001/JAMA.2020.4894 |
| 2020-03-27 |
Association of Coronavirus Disease 2019 (COVID-19) With Myocardial Injury and Mortality (edit) |
10.1001/JAMACARDIO.2020.1105 |
| 2020-03-27 |
A Framework for Rationing Ventilators and Critical Care Beds During the COVID-19 Pandemic (edit) |
10.1001/JAMA.2020.5046 |
| 2020-03-27 |
Negligible risk of the COVID-19 resurgence caused by work resuming in China (outside Hubei): a statistical probability study (edit) |
10.1093/PUBMED/FDAA046 |
| 2020-03-27 |
A War on Two Fronts: Cancer Care in the Time of COVID-19 (edit) |
10.7326/M20-1133 |
| 2020-03-27 |
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma (edit) |
10.1001/JAMA.2020.4783 |
| 2020-03-27 |
Convalescent Plasma to Treat COVID-19: Possibilities and Challenges (edit) |
10.1001/JAMA.2020.4940 |
| 2020-03-27 |
Are certain drugs associated with enhanced mortality in COVID-19? (edit) |
10.1093/QJMED/HCAA103 |
| 2020-03-27 |
Application of personal-oriented digital technology in preventing transmission of COVID-19, China (edit) |
10.1007/S11845-020-02215-5 |
| 2020-03-27 |
Medical education and care in dermatology during the SARS-CoV2 pandemia: challenges and chances (edit) |
10.1111/JDV.16391 |
| 2020-03-27 |
Perioperative Presentation of COVID-19 Disease in a Liver Transplant Recipient (edit) |
10.1002/HEP.31257 |
| 2020-03-27 |
What dermatologists could do to cope with the novel coronavirus (SARS-CoV-2): a dermatologist's perspective from China (edit) |
10.1111/JDV.16389 |
| 2020-03-27 |
SARS-CoV-2: What do we know so far? (edit) |
10.1111/APHA.13470 |
| 2020-03-27 |
SARS-CoV-2 and HIV (edit) |
10.1002/JMV.25782 |
| 2020-03-27 |
Might the many positive COVID19 subjects in Italy have been caused by resident bat-derived zoonotic β-coronaviruses instead of the Wuhan (China) outbreak? (edit) |
10.1002/JMV.25777 |
| 2020-03-27 |
Epidemiology of Covid-19 (edit) |
10.1056/NEJMC2005157 |
| 2020-03-27 |
Epidemiology of Covid-19. Reply (edit) |
10.1056/NEJMC2005157 |
| 2020-03-27 |
Clinical Characteristics of Covid-19 in China (edit) |
10.1056/NEJMC2005203 |
| 2020-03-27 |
Clinical Characteristics of Covid-19 in China. Reply (edit) |
10.1056/NEJMC2005203 |
| 2020-03-27 |
Undocumented U.S. Immigrants and Covid-19 (edit) |
10.1056/NEJMP2005953 |
| 2020-03-27 |
Epidemiology of Covid-19 in a Long-Term Care Facility in King County, Washington (edit) |
10.1056/NEJMOA2005412 |
| 2020-03-27 |
Special attention to nurses' protection during the COVID-19 epidemic (edit) |
10.1186/S13054-020-2841-7 |
| 2020-03-27 |
Covid-19: hospitals brace for disaster as US surpasses China in number of cases (edit) |
10.1136/BMJ.M1278 |
| 2020-03-27 |
Covid-19: what do trainees need to know? (edit) |
10.1136/BMJ.M1276 |
| 2020-03-27 |
Covid-19: diabetes clinicians set up social media account to help alleviate patients' fears (edit) |
10.1136/BMJ.M1262 |
| 2020-03-27 |
Covid-19: medical students and FY1 doctors to be given early registration to help combat covid-19 (edit) |
10.1136/BMJ.M1268 |
| 2020-03-27 |
Non-steroidal anti-inflammatory drugs and covid-19 (edit) |
10.1136/BMJ.M1185 |
| 2020-03-27 |
Covid-19: "Illogical" lack of testing is causing healthy staff to self-isolate, BMA chief warns (edit) |
10.1136/BMJ.M1277 |
| 2020-03-27 |
Covid-19: Lack of PPE in care homes is risking spread of virus, leaders warn (edit) |
10.1136/BMJ.M1280 |
| 2020-03-27 |
Covid-19: Researchers launch app to track spread of symptoms in the UK (edit) |
10.1136/BMJ.M1263 |
| 2020-03-27 |
Covid-19 and long term conditions: what if you have cancer, diabetes, or chronic kidney disease? (edit) |
10.1136/BMJ.M1270 |
| 2020-03-27 |
Guidance needed for singlehanded GPs to deal with covid-19 pandemic (edit) |
10.1136/BMJ.M1261 |
| 2020-03-27 |
Sound Science before Quick Judgement Regarding RAS Blockade in COVID-19 (edit) |
10.2215/CJN.03530320 |
| 2020-03-27 |
COVID-19 Global Pandemic: Options for Management of Gynecologic Cancers (edit) |
10.1136/IJGC-2020-001419 |
| 2020-03-27 |
Reflections on Nursing Ingenuity During the COVID-19 Pandemic (edit) |
10.1097/JNN.0000000000000525 |
| 2020-03-27 |
Alcohol consumption in the Covid-19 Era (edit) |
10.23736/S1121-421X.20.02698-7 |
| 2020-03-27 |
Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV (edit) |
10.1038/S41467-020-15562-9 |
| 2020-03-27 |
Facing up to the uncertainties of COVID-19 (edit) |
10.1038/S41562-020-0865-2 |
| 2020-03-27 |
How behavioural science data helps mitigate the COVID-19 crisis (edit) |
10.1038/S41562-020-0866-1 |
| 2020-03-27 |
Does hand hygiene reduce SARS-CoV-2 transmission? (edit) |
10.1007/S00417-020-04652-5 |
| 2020-03-27 |
Brief report of the first cured 2019-nCoV pneumonia patient in West China Hospital (edit) |
10.1007/S10096-020-03866-Z |
| 2020-03-27 |
Simulation as a tool for assessing and evolving your current personal protective equipment: lessons learned during the coronavirus disease (COVID-19) pandemic (edit) |
10.1007/S12630-020-01638-Z |
| 2020-03-27 |
Consensus guidelines for managing the airway in patients with COVID-19: Guidelines from the Difficult Airway Society, the Association of Anaesthetists the Intensive Care Society, the Faculty of Intensive Care Medicine and the Royal College of Anaest (edit) |
10.1111/ANAE.15054 |
| 2020-03-27 |
COVID-19 in the pediatric population (edit) |
10.1111/DTH.13339 |
| 2020-03-27 |
COVID-19 Infection in a Patient with End-Stage Kidney Disease (edit) |
10.1159/000507261 |
| 2020-03-27 |
COVID-19, Australia: Epidemiology Report 8 (Reporting period from 19:00 AEDT 14 March to 23:59 AEDT 22 March 2020) (edit) |
10.33321/CDI.2020.44.28 |
| 2020-03-27 |
Preliminary Results of Initial Testing for Coronavirus (COVID-19) in the Emergency Department (edit) |
10.5811/WESTJEM.2020.3.47348 |
| 2020-03-27 |
The COVID-19 response must be disability inclusive (edit) |
10.1016/S2468-2667(20)30076-1 |
| 2020-03-27 |
Tracking COVID-19 responsibly (edit) |
10.1016/S0140-6736(20)30693-0 |
| 2020-03-27 |
A role for CT in COVID-19? What data really tell us so far (edit) |
10.1016/S0140-6736(20)30728-5 |
| 2020-03-27 |
Mental health considerations for children quarantined because of COVID-19 (edit) |
10.1016/S2352-4642(20)30096-1 |
| 2020-03-27 |
COVID-19 infection in children (edit) |
10.1016/S2213-2600(20)30152-1 |
| 2020-03-27 |
Understanding COVID-19: what does viral RNA load really mean? (edit) |
10.1016/S1473-3099(20)30237-1 |
| 2020-03-27 |
Clinical and virological data of the first cases of COVID-19 in Europe: a case series (edit) |
10.1016/S1473-3099(20)30200-0 |
| 2020-03-27 |
The many estimates of the COVID-19 case fatality rate (edit) |
10.1016/S1473-3099(20)30244-9 |
| 2020-03-27 |
How emergency departments prepare for virus disease outbreaks like COVID-19 (edit) |
10.1097/MEJ.0000000000000703 |
| 2020-03-27 |
Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19) (edit) |
10.1097/CCM.0000000000004363 |
| 2020-03-27 |
Number of COVID-19 cases in Chile at 120 days with data at 21/03/2020 and threshold of daily effort to flatten the epi-curve (edit) |
10.5867/MEDWAVE.2020.02.7861 |
| 2020-03-27 |
The Fear of COVID-19 Scale: Development and Initial Validation (edit) |
10.1007/S11469-020-00270-8 |
| 2020-03-27 |
[SARS-CoV-2/COVID 19 Infection and Solid Cancers: Synthesis of Recommendations for Health Professionals] (edit) |
10.1016/J.BULCAN.2020.03.001 |
| 2020-03-27 |
Necessitating repeated chest CT in COVID-19 pneumonia (edit) |
10.1016/J.JFMA.2020.03.006 |
| 2020-03-27 |
Dynamic change process of target genes by RT-PCR testing of SARS-Cov-2 during the course of a Coronavirus Disease 2019 patient (edit) |
10.1016/J.CCA.2020.03.032 |
| 2020-03-27 |
Considerations in performing endoscopy during the COVID-19 pandemic (edit) |
10.1016/J.GIE.2020.03.3758 |
| 2020-03-27 |
Can Bioactive Lipids Inactivate Coronavirus (COVID-19)? (edit) |
10.1016/J.ARCMED.2020.03.004 |
| 2020-03-27 |
SARS-CoV-2 infection presenting with hematochezia (edit) |
10.1016/J.MEDMAL.2020.03.005 |
| 2020-03-27 |
Risk-adapted Treatment Strategy For COVID-19 Patients (edit) |
10.1016/J.IJID.2020.03.047 |
| 2020-03-27 |
Telehealth: Helping Your Patients and Practice Survive and Thrive During the COVID-19 Crisis with Rapid Quality Implementation (edit) |
10.1016/J.JAAD.2020.03.052 |
| 2020-03-27 |
What Should Palliative Care's Response be to the COVID-19 Epidemic? (edit) |
10.1016/J.JPAINSYMMAN.2020.03.013 |
| 2020-03-27 |
Molecular characterization of SARS-CoV-2 from the first case of COVID-19 in Italy (edit) |
10.1016/J.CMI.2020.03.025 |
| 2020-03-27 |
Lessons Learned During the COVID-19 Virus Pandemic (edit) |
10.1016/J.JAMCOLLSURG.2020.03.018 |
| 2020-03-27 |
Virology, Epidemiology, Pathogenesis, and Control of COVID-19 (edit) |
10.3390/V12040372 |
| 2020-03-27 |
COVID-19 pneumonia: what is the role of imaging in diagnosis? (edit) |
10.36416/1806-3756/E20200114 |
| 2020-03-27 |
A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-Repurposing (edit) |
10.1101/2020.03.22.002386 |
| 2020-03-27 |
Full-genome sequences of the first two SARS-CoV-2 viruses from India (edit) |
10.4103/IJMR.IJMR_663_20 |
| 2020-03-27 |
[Therapeutic options for genitourinary cancers during the epidemic period of COVID-19] (edit) |
10.1016/J.BULCAN.2020.03.003 |
| 2020-03-27 |
Protecting High-Risk Cardiac Patients During the COVID-19 Outbreak (edit) |
10.1053/J.JVCA.2020.03.043 |
| 2020-03-27 |
Associations between immune-suppressive and stimulating drugs and novel COVID-19-a systematic review of current evidence (edit) |
10.3332/ECANCER.2020.1022 |
| 2020-03-27 |
How should we implement radiotherapy for cancer patients in China during the endemic period of COVID-19? (edit) |
10.1016/J.RADONC.2020.03.016 |
| 2020-03-27 |
COVID-19 and the Renin-Angiotensin System (edit) |
10.1016/J.EKIR.2020.03.024 |
| 2020-03-27 |
Radiation Therapy in King County, Washington During the COVID-19 Pandemic: Balancing Patient Care, Transmission Mitigation, and Resident Training (edit) |
10.1016/J.ADRO.2020.03.007 |
| 2020-03-27 |
Responding to COVID-19: Perspectives from the Chinese Society of Gastroenterology (edit) |
10.1053/J.GASTRO.2020.03.046 |
| 2020-03-27 |
De Novo Design of New Chemical Entities (NCEs) for SARS-CoV-2 Using Artificial Intelligence (edit) |
10.26434/CHEMRXIV.11998347 |
| 2020-03-27 |
State-of-the-art tools to identify druggable protein ligand of SARS-CoV-2 (edit) |
10.5114/AOMS.2020.94046 |
| 2020-03-26 |
A Multicentre Study of 2019 Novel Coronavirus Disease Outcomes of Cancer Patients in Wuhan, China (edit) |
10.1101/2020.03.21.20037127 |
| 2020-03-26 |
Human leukocyte antigen susceptibility map for SARS-CoV-2 (edit) |
10.1101/2020.03.22.20040600 |
| 2020-03-26 |
scRNA-seq reveals ACE2 and TMPRSS2 expression in TROP2+ Liver Progenitor Cells: Implications in COVID-19 associated Liver Dysfunction (edit) |
10.1101/2020.03.23.002832 |
| 2020-03-26 |
FEP-based screening prompts drug repositioning against COVID-19 (edit) |
10.1101/2020.03.23.004580 |
| 2020-03-26 |
Comparison of the spatiotemporal characteristics of the COVID-19 and SARS outbreaks in mainland China (edit) |
10.1101/2020.03.23.20034058 |
| 2020-03-26 |
Estimating the number of undetected COVID-19 cases exported internationally from all of China (edit) |
10.1101/2020.03.23.20038331 |
| 2020-03-26 |
Transmission Potential of SARS-CoV-2 in Viral Shedding Observed at the University of Nebraska Medical Center (edit) |
10.1101/2020.03.23.20039446 |
| 2020-03-26 |
Analysis of Serologic Cross-Reactivity Between Common Human Coronaviruses and SARS-CoV-2 Using Coronavirus Antigen Microarray (edit) |
10.1101/2020.03.24.006544 |
| 2020-03-26 |
Moving-average based index to evaluate the epidemic trend of COVID-19 outbreak (edit) |
10.1101/2020.03.24.20027730 |
| 2020-03-26 |
Symptomatology during seasonal coronavirus infections in children is associated with viral and bacterial co-detection (edit) |
10.1101/2020.03.24.20038828 |
| 2020-03-26 |
Estimating the ascertainment rate of SARS-CoV-2 infection in Wuhan, China: implications for management of the global outbreak (edit) |
10.1101/2020.03.24.20042218 |
| 2020-03-26 |
Metabolic disturbances and inflammatory dysfunction predict severity of coronavirus disease 2019 (COVID-19): a retrospective study (edit) |
10.1101/2020.03.24.20042283 |
| 2020-03-26 |
Fundamental principles of epidemic spread highlight the immediate need for large-scale serological surveys to assess the stage of the SARS-CoV-2 epidemic (edit) |
10.1101/2020.03.24.20042291 |
| 2020-03-26 |
A Fully Automatic Deep Learning System for COVID-19 Diagnostic and Prognostic Analysis (edit) |
10.1101/2020.03.24.20042317 |
| 2020-03-26 |
Comorbid Diabetes Mellitus was Associated with Poorer Prognosis in Patients with COVID-19: A Retrospective Cohort Study (edit) |
10.1101/2020.03.24.20042358 |
| 2020-03-26 |
Viral Kinetics and Antibody Responses in Patients with COVID-19 (edit) |
10.1101/2020.03.24.20042382 |
| 2020-03-26 |
Acute kidney injury at early stage as a negative prognostic indicator of patients with COVID-19: a hospital-based retrospective analysis (edit) |
10.1101/2020.03.24.20042408 |
| 2020-03-26 |
Human Mobility Restrictions and the Spread of the Novel Coronavirus (2019-nCoV) in China (edit) |
10.1101/2020.03.24.20042424 |
| 2020-03-26 |
Early chest computed tomography to diagnose COVID-19 from suspected patients: A multicenter retrospective study (edit) |
10.1101/2020.03.24.20042432 |
| 2020-03-26 |
Home collection of nasal swabs for detection of influenza in the Household Influenza Vaccine Evaluation Study (edit) |
10.1101/2020.03.24.20042556 |
| 2020-03-26 |
Modes of contact and risk of transmission in COVID-19 among close contacts (edit) |
10.1101/2020.03.24.20042606 |
| 2020-03-26 |
COVID-19 infection induces readily detectable morphological and inflammation-related phenotypic changes in peripheral blood monocytes, the severity of which correlate with patient outcome (edit) |
10.1101/2020.03.24.20042655 |
| 2020-03-26 |
Mathematical modeling of COVID-19 transmission and mitigation strategies in the population of Ontario, Canada (edit) |
10.1101/2020.03.24.20042705 |
| 2020-03-26 |
A model to estimate bed demand for COVID-19 related hospitalization (edit) |
10.1101/2020.03.24.20042762 |
| 2020-03-26 |
COVID-19 clinical characteristics, and sex-specific risk of mortality: Systematic Review and Meta-analysis (edit) |
10.1101/2020.03.24.20042903 |
| 2020-03-26 |
An artificial intelligence-based first-line defence against COVID-19: digitally screening citizens for risks via a chatbot (edit) |
10.1101/2020.03.25.008805 |
| 2020-03-26 |
Risk Factors Associated with Clinical Outcomes in 323 COVID-19 Patients in Wuhan, China (edit) |
10.1101/2020.03.25.20037721 |
| 2020-03-26 |
An international comparison of the second derivative of COVID-19 deaths after implementation of social distancing measures (edit) |
10.1101/2020.03.25.20041475 |
| 2020-03-26 |
Estimating the maximum daily number of incident COVID-19 cases manageable by a healthcare system (edit) |
10.1101/2020.03.25.20043711 |
| 2020-03-26 |
Coast-to-coast spread of SARS-CoV-2 in the United States revealed by genomic epidemiology (edit) |
10.1101/2020.03.25.20043828 |
| 2020-03-26 |
Responding to COVID-19: How to Navigate a Public Health Emergency Legally and Ethically (edit) |
10.1002/HAST.1090 |
| 2020-03-26 |
Epidemiological characteristics of 2019-ncoV infections in Shaanxi, China by February 8, 2020 (edit) |
10.1183/13993003.00310-2020 |
| 2020-03-26 |
The clinical dynamics of 18 cases of COVID-19 outside of Wuhan, China (edit) |
10.1183/13993003.00398-2020 |
| 2020-03-26 |
Intubation and Ventilation amid the COVID-19 Outbreak: Wuhan's Experience (edit) |
10.1097/ALN.0000000000003296 |
| 2020-03-26 |
The COVID-19 Pandemic: Making Sense of Rumor and Fear (edit) |
10.1080/01459740.2020.1745481 |
| 2020-03-26 |
Another Day in Dystopia. Italy in the Time of COVID-19 (edit) |
10.1080/01459740.2020.1746300 |
| 2020-03-26 |
End-of-life care in the emergency department for the patient imminently dying of a highly transmissible acute respiratory infection (such as COVID-19) (edit) |
10.1017/CEM.2020.352 |
| 2020-03-26 |
Absence of contamination of personal protective equipment (PPE) by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (edit) |
10.1017/ICE.2020.91 |
| 2020-03-26 |
An Effective Model for the Outpatient Management of COVID-19 (edit) |
10.1017/ICE.2020.92 |
| 2020-03-26 |
[Interpretation of pathological changes for "Guidelines for the Diagnosis and Treatment of COVID-19 by the National Health Commission (Trial Version 7)"] (edit) |
10.3760/CMA.J.CN112151-20200318-00221 |
| 2020-03-26 |
[Risk assessment and early warning of imported COVID-19 in 21 cities, Guangdong province] (edit) |
10.3760/CMA.J.CN112338-20200226-00190 |
| 2020-03-26 |
[Analysis on cluster cases of COVID-19 in Tianjin] (edit) |
10.3760/CMA.J.CN112338-20200225-00165 |
| 2020-03-26 |
[Epidemiological analysis on 1 052 cases of COVID-19 in epidemic clusters] (edit) |
10.3760/CMA.J.CN112338-20200301-00223 |
| 2020-03-26 |
Digital Mental Health and COVID-19: Using Technology Today to Accelerate the Curve on Access and Quality Tomorrow (edit) |
10.2196/18848 |
| 2020-03-26 |
Facts and reflections on COVID-19 and anti-hypertensives drugs (edit) |
10.5582/DDT.2020.01017 |
| 2020-03-26 |
Remote Treatment Delivery in Response to the COVID-19 Pandemic (edit) |
10.1159/000507376 |
| 2020-03-26 |
Are patients with inflammatory bowel disease at increased risk for Covid-19 infection? (edit) |
10.1093/ECCO-JCC/JJAA061 |
| 2020-03-26 |
Can SARS-CoV-2 Infection Be Acquired In Utero?: More Definitive Evidence Is Needed (edit) |
10.1001/JAMA.2020.4868 |
| 2020-03-26 |
Possible Vertical Transmission of SARS-CoV-2 From an Infected Mother to Her Newborn (edit) |
10.1001/JAMA.2020.4621 |
| 2020-03-26 |
Antibodies in Infants Born to Mothers With COVID-19 Pneumonia (edit) |
10.1001/JAMA.2020.4861 |
| 2020-03-26 |
Turbulent Gas Clouds and Respiratory Pathogen Emissions: Potential Implications for Reducing Transmission of COVID-19 (edit) |
10.1001/JAMA.2020.4756 |
| 2020-03-26 |
Neonatal Early-Onset Infection With SARS-CoV-2 in 33 Neonates Born to Mothers With COVID-19 in Wuhan, China (edit) |
10.1001/JAMAPEDIATRICS.2020.0878 |
| 2020-03-26 |
Is There an Association Between COVID-19 Mortality and the Renin-Angiotensin System-a Call for Epidemiologic Investigations (edit) |
10.1093/CID/CIAA329 |
| 2020-03-26 |
Self-reported olfactory and taste disorders in SARS-CoV-2 patients: a cross-sectional study (edit) |
10.1093/CID/CIAA330 |
| 2020-03-26 |
Simulation of the clinical and pathological manifestations of Coronavirus Disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease pathogenesis and transmissibility (edit) |
10.1093/CID/CIAA325 |
| 2020-03-26 |
Toward Universal Deployable Guidelines for the Care of Patients With COVID-19 (edit) |
10.1001/JAMA.2020.5110 |
| 2020-03-26 |
Management of Critically Ill Adults With COVID-19 (edit) |
10.1001/JAMA.2020.4914 |
| 2020-03-26 |
[The Covid-19 pandemic and otolaryngology: What it comes down to?] (edit) |
10.1055/A-1095-2344 |
| 2020-03-26 |
CT morphology of COVID-19: Case report and review of literature (edit) |
10.1055/A-1142-4094 |
| 2020-03-26 |
Cutaneous manifestations in COVID-19: a first perspective (edit) |
10.1111/JDV.16387 |
| 2020-03-26 |
Gastrointestinal endoscopy during COVID-19 pandemic (edit) |
10.1111/JGH.15048 |
| 2020-03-26 |
COVID-19 and economy (edit) |
10.1111/DTH.13329 |
| 2020-03-26 |
Preventing the Spread of COVID-19 to Nursing Homes: Experience from a Singapore Geriatric Centre (edit) |
10.1111/JGS.16447 |
| 2020-03-26 |
[Prevention and control of SARS-CoV-2 (Covid-19) coronavirus infection in hemodialysis units] (edit) |
10.21149/11330 |
| 2020-03-26 |
Geriatric Care during Public Health Emergencies: Lessons Learned from Novel Corona Virus Disease (COVID-19) Pandemic (edit) |
10.1080/01634372.2020.1746723 |
| 2020-03-26 |
The world's largest refugee camp prepares for covid-19 (edit) |
10.1136/BMJ.M1205 |
| 2020-03-26 |
Covid-19: doctors' leaders warn that staff could quit and may die over lack of protective equipment (edit) |
10.1136/BMJ.M1257 |
| 2020-03-26 |
Italian doctors call for protecting healthcare workers and boosting community surveillance during covid-19 outbreak (edit) |
10.1136/BMJ.M1254 |
| 2020-03-26 |
Covid-19: medical schools given powers to graduate final year students early to help NHS (edit) |
10.1136/BMJ.M1227 |
| 2020-03-26 |
Europe's migrant containment policies threaten the response to covid-19 (edit) |
10.1136/BMJ.M1213 |
| 2020-03-26 |
Covid-19: Gilead withdraws orphan drug designation from potential treatment after criticism (edit) |
10.1136/BMJ.M1259 |
| 2020-03-26 |
Covid-19: India imposes lockdown for 21 days and cases rise (edit) |
10.1136/BMJ.M1251 |
| 2020-03-26 |
Covid-19: Don't forget the impact on US family physicians (edit) |
10.1136/BMJ.M1260 |
| 2020-03-26 |
Covid-19: FDA approves use of convalescent plasma to treat critically ill patients (edit) |
10.1136/BMJ.M1256 |
| 2020-03-26 |
Covid-19: what treatments are being investigated? (edit) |
10.1136/BMJ.M1252 |
| 2020-03-26 |
Report from the American Society for Microbiology COVID-19 International Summit, 23 March 2020: Value of Diagnostic Testing for SARS-CoV-2/COVID-19 (edit) |
10.1128/MBIO.00722-20 |
| 2020-03-26 |
Covid-19: risk factors for severe disease and death (edit) |
10.1136/BMJ.M1198 |
| 2020-03-26 |
Managing mental health challenges faced by healthcare workers during covid-19 pandemic (edit) |
10.1136/BMJ.M1211 |
| 2020-03-26 |
Clinical and CT features of early-stage patients with COVID-19: a retrospective analysis of imported cases in Shanghai, China (edit) |
10.1183/13993003.00407-2020 |
| 2020-03-26 |
Comorbidity and its impact on 1590 patients with Covid-19 in China: A Nationwide Analysis (edit) |
10.1183/13993003.00547-2020 |
| 2020-03-26 |
Urgent need of a management plan for survivors of COVID-19 (edit) |
10.1183/13993003.00764-2020 |
| 2020-03-26 |
Covid-19: What is the UK's testing strategy? (edit) |
10.1136/BMJ.M1222 |
| 2020-03-26 |
Perioperative COVID-19 Defense: An Evidence-Based Approach for Optimization of Infection Control and Operating Room Management (edit) |
10.1213/ANE.0000000000004829 |
| 2020-03-26 |
COVID-19: Biomedical research in a world under social-distancing measures (edit) |
10.1038/D41591-020-00005-1 |
| 2020-03-26 |
Identifying SARS-CoV-2 related coronaviruses in Malayan pangolins (edit) |
10.1038/S41586-020-2169-0 |
| 2020-03-26 |
Seven tips to manage your mental health and well-being during the COVID-19 outbreak (edit) |
10.1038/D41586-020-00933-5 |
| 2020-03-26 |
COVID-19 and the otolaryngologist - preliminary evidence-based review (edit) |
10.1002/LARY.28672 |
| 2020-03-26 |
Advice regarding COVID-19 and use of immunomodulators, in patients with severe dermatological diseases (edit) |
10.1111/AJD.13295 |
| 2020-03-26 |
Maternal health care management during the outbreak of coronavirus disease 2019 (COVID-19) (edit) |
10.1002/JMV.25787 |
| 2020-03-26 |
Stability issues of RT-PCR testing of SARS-CoV-2 for hospitalized patients clinically diagnosed with COVID-19 (edit) |
10.1002/JMV.25786 |
| 2020-03-26 |
Safe Delivery for COVID-19 Infected Pregnancies (edit) |
10.1111/1471-0528.16231 |
| 2020-03-26 |
A Genomic Perspective on the Origin and Emergence of SARS-CoV-2 (edit) |
10.1016/J.CELL.2020.03.035 |
| 2020-03-26 |
COVID-19 Outbreak and Surgical Practice: Unexpected Fatality in Perioperative Period (edit) |
10.1097/SLA.0000000000003925 |
| 2020-03-26 |
In Silico assessment of the impact of 2019 novel coronavirus (2019-nCoV) genomic variation on published real-time quantitative polymerase chain reaction detection assays (edit) |
10.1097/CM9.0000000000000817 |
| 2020-03-26 |
The looming pandemic of COVID-19: What therapeutic options do we have now? (edit) |
10.1097/JCMA.0000000000000310 |
| 2020-03-26 |
A citizen's thoughts about COVID-19 (edit) |
10.1016/S0140-6736(20)30692-9 |
| 2020-03-26 |
COVID-19 gives the lie to global health expertise (edit) |
10.1016/S0140-6736(20)30739-X |
| 2020-03-26 |
Estimation of the COVID-19 burden in Egypt through exported case detection (edit) |
10.1016/S1473-3099(20)30233-4 |
| 2020-03-26 |
CT screening for early diagnosis of SARS-CoV-2 infection - Authors' reply (edit) |
10.1016/S1473-3099(20)30247-4 |
| 2020-03-26 |
CT screening for early diagnosis of SARS-CoV-2 infection (edit) |
10.1016/S1473-3099(20)30241-3 |
| 2020-03-26 |
Efforts escalate to protect homeless people from COVID-19 in UK (edit) |
10.1016/S2213-2600(20)30160-0 |
| 2020-03-26 |
Antihypertensive drugs and risk of COVID-19? (edit) |
10.1016/S2213-2600(20)30153-3 |
| 2020-03-26 |
Antihypertensive drugs and risk of COVID-19? - Authors' reply (edit) |
10.1016/S2213-2600(20)30159-4 |
| 2020-03-26 |
ECMO for ARDS due to COVID-19 (edit) |
10.1016/J.HRTLNG.2020.03.012 |
| 2020-03-26 |
Comparison of Hospitalized Patients with Acute Respiratory Distress Syndrome Caused by COVID-19 and H1N1 (edit) |
10.1016/J.CHEST.2020.03.032 |
| 2020-03-26 |
Clinical characteristics of COVID-19-infected cancer patients: A retrospective case study in three hospitals within Wuhan, China (edit) |
10.1016/J.ANNONC.2020.03.296 |
| 2020-03-26 |
COVID-19 and diabetes: Can DPP4 inhibition play a role? (edit) |
10.1016/J.DIABRES.2020.108125 |
| 2020-03-26 |
COVID-19: Pandemic Contingency Planning for the Allergy and Immunology Clinic (edit) |
10.1016/J.JAIP.2020.03.012 |
| 2020-03-26 |
Ethical Outpatient Dermatology Care During the Coronavirus (COVID-19) Pandemic (edit) |
10.1016/J.JAAD.2020.03.047 |
| 2020-03-26 |
COVID-19 and Immunomodulator/Immunosuppressant Use in Dermatology (edit) |
10.1016/J.JAAD.2020.03.046 |
| 2020-03-26 |
COVID-19, a UK perspective (edit) |
10.1097/MEJ.0000000000000700 |
| 2020-03-26 |
Human Saliva: Non-Invasive Fluid for Detecting Novel Coronavirus (2019-nCoV) (edit) |
10.3390/IJERPH17072225 |
| 2020-03-26 |
Strengths, Weaknesses, Opportunities and Threats (SWOT) Analysis of China's Prevention and Control Strategy for the COVID-19 Epidemic (edit) |
10.3390/IJERPH17072235 |
| 2020-03-26 |
Integrative considerations during the COVID-19 pandemic (edit) |
10.1016/J.EXPLORE.2020.03.007 |
| 2020-03-26 |
Respiratory physiotherapy in patients with COVID-19 infection in acute setting: a Position Paper of the Italian Association of Respiratory Physiotherapists (ARIR) (edit) |
10.4081/MONALDI.2020.1285 |
| 2020-03-26 |
Hyperglycemia and the novel Covid-19 infection: Possible pathophysiologic mechanisms (edit) |
10.1016/J.MEHY.2020.109699 |
| 2020-03-26 |
SARS-CoV-2 outbreak: How can pharmacists help? (edit) |
10.1016/J.SAPHARM.2020.03.018 |
| 2020-03-26 |
Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries (edit) |
10.1016/J.DSX.2020.03.011 |
| 2020-03-26 |
Recommendations and guidance for providing pharmaceutical care services during COVID-19 pandemic: A China perspective (edit) |
10.1016/J.SAPHARM.2020.03.012 |
| 2020-03-26 |
Everything old is new again: COVID-19 and public health (edit) |
10.1016/J.PEDN.2020.03.014 |
| 2020-03-26 |
Kidney International and the COVID-19 infection (edit) |
10.1016/J.KINT.2020.03.010 |
| 2020-03-26 |
The COVID-19 pandemic: implications for the cytology laboratory (edit) |
10.1016/J.JASC.2020.03.001 |
| 2020-03-26 |
Working through the COVID-19 outbreak: Rapid review and recommendations for MSK and allied heath personnel (edit) |
10.1016/J.JCOT.2020.03.014 |
| 2020-03-26 |
The appropriate position of radiology in COVID-19 diagnosis and treatment-current status and opinion from China (edit) |
10.1007/S42058-020-00030-6 |
| 2020-03-26 |
Maintenance Hemodialysis and Coronavirus Disease 2019 (COVID-19): Saving Lives With Caution, Care, and Courage (edit) |
10.1016/J.XKME.2020.03.003 |
| 2020-03-26 |
Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants (edit) |
10.1016/J.JPHA.2020.03.009 |
| 2020-03-26 |
Abdominal Pain: A Real Challenge in Novel COVID-19 Infection (edit) |
10.12890/2020_001632 |
| 2020-03-26 |
SARS-CoV-2 Infection in Pregnancy - a Review of the Current Literature and Possible Impact on Maternal and Neonatal Outcome (edit) |
10.1055/A-1134-5951 |
| 2020-03-26 |
Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): An Update (edit) |
10.7759/CUREUS.7423 |
| 2020-03-26 |
Molecular Docking study of Receptor Binding Domain of SARS-CoV-2 Spike Glycoprotein with Saikosaponin, a Triterpenoid Natural Product (edit) |
10.26434/CHEMRXIV.12033774 |
| 2020-03-26 |
In Silico Guided Drug Repurposing to Combat SARS-CoV-2 by Targeting Mpro, the Key Virus Specific Protease (edit) |
10.26434/CHEMRXIV.12030345 |
| 2020-03-26 |
Epidemiological update on SARS-CoV-2 infection in Spain. Comments on the management of infection in pediatrics (edit) |
10.1016/J.ANPEDE.2020.03.001 |
| 2020-03-26 |
Glycoinformatics approach for identifying target positions to inhibit initial binding of SARS-CoV-2 S1 protein to the host cell (edit) |
10.1101/2020.03.25.007898 |
| 2020-03-25 |
Crystal Structure of the methyltransferase-stimulatory factor complex of NSP16 and NSP10 from SARS CoV-2 (edit) |
10.2210/PDB6W61/PDB |
| 2020-03-25 |
General measures in cath lab management during SARS-CoV-2 pandemics (edit) |
10.31160/JOTCI202028A202003 |
| 2020-03-25 |
Potent human neutralizing antibodies elicited by SARS-CoV-2 infection (edit) |
10.1101/2020.03.21.990770 |
| 2020-03-25 |
SARS-CoV-2 launches a unique transcriptional signature from in vitro, ex vivo, and in vivo systems (edit) |
10.1101/2020.03.24.004655 |
| 2020-03-25 |
The Trial of Chloroquine in the Treatment of Corona Virus Disease 2019 (COVID-19) and Its Research Progress in Forensic Toxicology. (edit) |
10.12116/J.ISSN.1004-5619.2020.02.001 |
| 2020-03-25 |
Combating COVID-19—The role of robotics in managing public health and infectious diseases (edit) |
10.1126/SCIROBOTICS.ABB5589 |
| 2020-03-25 |
The effect of human mobility and control measures on the COVID-19 epidemic in China (edit) |
10.1126/SCIENCE.ABB4218 |
| 2020-03-25 |
COVID-19 needs a Manhattan Project (edit) |
10.1126/SCIENCE.ABB8654 |
| 2020-03-25 |
Solidarity Trial (edit) |
10.1186/ISRCTN83971151 |
| 2020-03-25 |
Precautions for Intubating Patients with COVID-19 (edit) |
10.1097/ALN.0000000000003288 |
| 2020-03-25 |
All Feet On Deck-The Role of Podiatry During the COVID-19 Pandemic: Preventing hospitalizations in an overburdened healthcare system, reducing amputation and death in people with diabetes (edit) |
10.7547/20-051 |
| 2020-03-25 |
Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers (edit) |
10.1161/HYPERTENSIONAHA.120.15082 |
| 2020-03-25 |
Publishing in the time of COVID-19 (edit) |
10.7554/ELIFE.57162 |
| 2020-03-25 |
Novel coronavirus SARS-CoV-2: familial spread resulting in COVID-19 pneumonia in a pediatric patient (edit) |
10.5152/DIR.2020.20157 |
| 2020-03-25 |
Management strategy of novel coronavirus (COVID-19) pneumonia in the radiology department: a Chinese experience (edit) |
10.5152/DIR.2020.20167 |
| 2020-03-25 |
COVID-19 in intensive care. Some necessary steps for health care workers (edit) |
10.4081/MONALDI.2020.1284 |
| 2020-03-25 |
Epidemiological and Clinical Predictors of COVID-19 (edit) |
10.1093/CID/CIAA322 |
| 2020-03-25 |
The first locally acquired novel case of 2019-nCoV infection in a healthcare worker in the Paris area (edit) |
10.1093/CID/CIAA171 |
| 2020-03-25 |
An Acute Respiratory Infection Runs Into the Most Common Noncommunicable Epidemic-COVID-19 and Cardiovascular Diseases (edit) |
10.1001/JAMACARDIO.2020.0934 |
| 2020-03-25 |
Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China (edit) |
10.1001/JAMACARDIO.2020.0950 |
| 2020-03-25 |
SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China (edit) |
10.1001/JAMAONCOL.2020.0980 |
| 2020-03-25 |
Postacute Care Preparedness for COVID-19: Thinking Ahead (edit) |
10.1001/JAMA.2020.4686 |
| 2020-03-25 |
Analysis of Epidemiological and Clinical features in older patients with Corona Virus Disease 2019 (COVID-19) out of Wuhan (edit) |
10.1093/CID/CIAA242 |
| 2020-03-25 |
A midpoint perspective on the COVID-19 pandemic (edit) |
10.11622/SMEDJ.2020036 |
| 2020-03-25 |
COVID-19 containment: China provides important lessons for global response (edit) |
10.1007/S11684-020-0766-9 |
| 2020-03-25 |
Suggestions for infection prevention and control in digestive endoscopy during current 2019-nCoV pneumonia outbreak in Wuhan, Hubei province, China (edit) |
10.1055/A-1128-4313 |
| 2020-03-25 |
Why is COVID-19 so mild in children? (edit) |
10.1111/APA.15271 |
| 2020-03-25 |
Optimizing COVID-19 candidate therapeutics: Thinking Without Borders (edit) |
10.1111/CTS.12790 |
| 2020-03-25 |
Coronavirus Disease 2019 in Geriatrics and Long-term Care: The ABCDs of COVID-19 (edit) |
10.1111/JGS.16445 |
| 2020-03-25 |
Leukoerythroblastic reaction in a patient with COVID-19 infection (edit) |
10.1002/AJH.25793 |
| 2020-03-25 |
Considerations for Cardiac Catheterization Laboratory Procedures During the COVID-19 Pandemic Perspectives from the Society for Cardiovascular Angiography and Interventions Emerging Leader Mentorship (SCAI ELM) Members and Graduates (edit) |
10.1002/CCD.28887 |
| 2020-03-25 |
Critical Supply Shortages - The Need for Ventilators and Personal Protective Equipment during the Covid-19 Pandemic (edit) |
10.1056/NEJMP2006141 |
| 2020-03-25 |
A Message to Our Community in the Midst of the COVID-19 Pandemic (edit) |
10.1089/HUM.2020.29121.TRF |
| 2020-03-25 |
Covid-19: how to be careful with trust and expertise on social media (edit) |
10.1136/BMJ.M1160 |
| 2020-03-25 |
Covid-19 and long term conditions: what if you have cancer, diabetes, or chronic kidney disease? (edit) |
10.1136/BMJ.M1174 |
| 2020-03-25 |
Covid-19: Trump declares intention to "re-open economy" within weeks against experts' advice (edit) |
10.1136/BMJ.M1217 |
| 2020-03-25 |
Covid-19: experts question analysis suggesting half UK population has been infected (edit) |
10.1136/BMJ.M1216 |
| 2020-03-25 |
Covid-19: a remote assessment in primary care (edit) |
10.1136/BMJ.M1182 |
| 2020-03-25 |
David Oliver: Covid-19-recriminations and political point scoring must wait (edit) |
10.1136/BMJ.M1153 |
| 2020-03-25 |
COVID-19: faecal-oral transmission? (edit) |
10.1038/S41575-020-0295-7 |
| 2020-03-25 |
Suggestions for safety and protection control in Department of Nuclear Medicine during the outbreak of COVID-19 (edit) |
10.1007/S00259-020-04779-X |
| 2020-03-25 |
CT image visual quantitative evaluation and clinical classification of coronavirus disease (COVID-19) (edit) |
10.1007/S00330-020-06817-6 |
| 2020-03-25 |
Hospital response to the COVID-19 outbreak: the experience in Shanghai, China (edit) |
10.1111/JAN.14364 |
| 2020-03-25 |
Covid-19 and the Digestive System (edit) |
10.1111/JGH.15047 |
| 2020-03-25 |
Structural Genomics of SARS-CoV-2 Indicates Evolutionary Conserved Functional Regions of Viral Proteins (edit) |
10.3390/V12040360 |
| 2020-03-25 |
Could Intravenous Immunoglobulin Collected from Recovered Coronavirus Patients Protect against COVID-19 and Strengthen the Immune System of New Patients? (edit) |
10.3390/IJMS21072272 |
| 2020-03-25 |
Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study (edit) |
10.1016/S1473-3099(20)30198-5 |
| 2020-03-25 |
COVID-19 in children: the link in the transmission chain (edit) |
10.1016/S1473-3099(20)30236-X |
| 2020-03-25 |
The Italian health system and the COVID-19 challenge (edit) |
10.1016/S2468-2667(20)30074-8 |
| 2020-03-25 |
COVID-19: extending or relaxing distancing control measures (edit) |
10.1016/S2468-2667(20)30072-4 |
| 2020-03-25 |
The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study (edit) |
10.1016/S2468-2667(20)30073-6 |
| 2020-03-25 |
Viral screening before initiation of biologics in patients with inflammatory bowel disease during the COVID-19 outbreak (edit) |
10.1016/S2468-1253(20)30085-6 |
| 2020-03-25 |
Parenting in a time of COVID-19 (edit) |
10.1016/S0140-6736(20)30736-4 |
| 2020-03-25 |
The official French guidelines to protect patients with cancer against SARS-CoV-2 infection (edit) |
10.1016/S1470-2045(20)30204-7 |
| 2020-03-25 |
Challenges posed by COVID-19 to children with cancer (edit) |
10.1016/S1470-2045(20)30205-9 |
| 2020-03-25 |
The role of CT in case ascertainment and management of COVID-19 pneumonia in the UK: insights from high-incidence regions (edit) |
10.1016/S2213-2600(20)30132-6 |
| 2020-03-25 |
SARS-CoV-2 Infection in a Pediatric Department in Milan: A Logistic Rather Than a Clinical Emergency (edit) |
10.1097/INF.0000000000002687 |
| 2020-03-25 |
Initial Clinical Impressions of the Critical Care of COVID-19 Patients in Seattle, New York City, and Chicago (edit) |
10.1213/ANE.0000000000004830 |
| 2020-03-25 |
A UK-wide British Society of Thoracic Imaging COVID-19 imaging repository and database: design, rationale and implications for education and research (edit) |
10.1016/J.CRAD.2020.03.005 |
| 2020-03-25 |
Initial rapid and proactive response for the COVID-19 outbreak - Taiwan's experience (edit) |
10.1016/J.JFMA.2020.03.007 |
| 2020-03-25 |
Corrigendum to "Traditional Chinese medicine for COVID-19 treatment" [Pharmacol. Res. 155 (2020) 104743] (edit) |
10.1016/J.PHRS.2020.104768 |
| 2020-03-25 |
A pregnant woman with COVID-19 in Central America (edit) |
10.1016/J.TMAID.2020.101639 |
| 2020-03-25 |
Importing coronavirus disease 2019 (COVID-19) into China after international air travel (edit) |
10.1016/J.TMAID.2020.101620 |
| 2020-03-25 |
Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study (edit) |
10.1016/J.LFS.2020.117592 |
| 2020-03-25 |
Diagnosis of the Coronavirus disease (COVID-19): rRT-PCR or CT? (edit) |
10.1016/J.EJRAD.2020.108961 |
| 2020-03-25 |
COVID-19: An Unintended Force for Medical Revolution? (edit) |
|
| 2020-03-25 |
COVID-19 Pandemic and Acute Myocardial Infarction: Management Protocol From A British Cardiac Centre (edit) |
10.1097/HPC.0000000000000222 |
| 2020-03-25 |
The COVID-19 Intubation and Ventilation Pathway (CiVP); a Commentary (edit) |
|
| 2020-03-25 |
Routine childhood immunization may protect against COVID-19 (edit) |
10.1016/J.MEHY.2020.109689 |
| 2020-03-25 |
Is traditional Chinese medicine useful in the treatment of COVID-19? (edit) |
10.1016/J.AJEM.2020.03.046 |
| 2020-03-25 |
Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic (edit) |
10.1016/J.JNS.2020.116803 |
| 2020-03-25 |
Cardiovascular disease and COVID-19 (edit) |
10.1016/J.DSX.2020.03.013 |
| 2020-03-25 |
Contentious issues and evolving concepts in the clinical presentation and management of patients with COVID-19 infectionwith reference to use of therapeutic and other drugs used in Co-morbid diseases (Hypertension, diabetes etc) (edit) |
10.1016/J.DSX.2020.03.012 |
| 2020-03-25 |
Duration of serum neutralizing antibodies for SARS-CoV-2: Lessons from SARS-CoV infection (edit) |
10.1016/J.JMII.2020.03.015 |
| 2020-03-25 |
Daily Situation Report on Coronavirus disease (COVID-19) in Iran; March 25, 2020 (edit) |
|
| 2020-03-25 |
Detection of serum IgM and IgG for COVID-19 diagnosis (edit) |
10.1007/S11427-020-1688-9 |
| 2020-03-25 |
COVID-19, Mental Health and Aging: A Need for New Knowledge to Bridge Science and Service (edit) |
10.1016/J.JAGP.2020.03.007 |
| 2020-03-25 |
Life in the pandemic: Some reflections on nursing in the context of COVID-19 (edit) |
10.1111/JOCN.15257 |
| 2020-03-25 |
Coronavirus Disease 2019 (COVID-19) CT Findings: A Systematic Review and Meta-analysis (edit) |
10.1016/J.JACR.2020.03.006 |
| 2020-03-25 |
Breast Cancer Diagnosis, Treatment and Follow-Up During COVID-19 Pandemic (edit) |
10.5152/EJBH.2020.240320 |
| 2020-03-25 |
Why is it difficult to accurately predict the COVID-19 epidemic? (edit) |
10.1016/J.IDM.2020.03.001 |
| 2020-03-25 |
Novel decoy cellular vaccine strategy utilizing transgenic antigen-expressing cells as immune presenter and adjuvant in vaccine prototype against SARS-CoV-2 virus (edit) |
10.1016/J.MEDIDD.2020.100026 |
| 2020-03-25 |
COVID-19 Infection Unmasking Brugada Syndrome (edit) |
10.1016/J.HRCR.2020.03.012 |
| 2020-03-25 |
Chinese Health Care Workers and COVID-19: For Whom the Bell Tolls (edit) |
10.1016/J.JACBTS.2020.03.009 |
| 2020-03-25 |
Outcome of Coronavirus spectrum infections (SARS, MERS, COVID 1 -19) during pregnancy: a systematic review and meta-analysis (edit) |
10.1016/J.AJOGMF.2020.100107 |
| 2020-03-25 |
PROTEIN-NUCLEIC ACID INTERFACE (PNAI) INHIBITOR DRUG MOLECULES FOR SARS-COV-2 (edit) |
10.26434/CHEMRXIV.12026736 |
| 2020-03-25 |
Characterisation of the transcriptome and proteome of SARS-CoV-2 using direct RNA sequencing and tandem mass spectrometry reveals evidence for a cell passage induced in-frame deletion in the spike glycoprotein that removes the furin-like cleavage si (edit) |
10.1101/2020.03.22.002204 |
| 2020-03-25 |
Emergence of SARS-CoV-2 and its outlook (edit) |
10.35772/GHM.2020.01009 |
| 2020-03-24 |
Epidemic Trend and Transmission Risk of SARS-CoV-2 after Government Intervention in the Mainland of China: A Mathematical Model Study (edit) |
10.2139/SSRN.3539669 |
| 2020-03-24 |
COVID-19: decision making and palliative care (edit) |
10.4414/SMW.2020.20233 |
| 2020-03-24 |
COVID-19 Challenges Basic Researchers (edit) |
10.1158/2159-8290.CD-NB2020-018 |
| 2020-03-24 |
Potential biochemical markers to identify severe cases among COVID-19 patients (edit) |
10.1101/2020.03.19.20034447 |
| 2020-03-24 |
MATHEMATICAL PREDICTIONS FOR COVID-19 AS A GLOBAL PANDEMIC (edit) |
10.1101/2020.03.19.20038794 |
| 2020-03-24 |
Window of Opportunity for Mitigation to Prevent Overflow of ICU capacity in Chicago by COVID-19 (edit) |
10.1101/2020.03.20.20040048 |
| 2020-03-24 |
Characterizing occupations that cannot work from home: a means to identify susceptible worker groups during the COVID-19 pandemic (edit) |
10.1101/2020.03.21.20031336 |
| 2020-03-24 |
Infection Control of 2019 Novel Corona Virus Disease (COVID-19) in Cancer Patients undergoing Radiotherapy in Wuhan (edit) |
10.1101/2020.03.21.20037051 |
| 2020-03-24 |
Effect of SARS-CoV-2 infection upon male gonadal function: A single center-based study (edit) |
10.1101/2020.03.21.20037267 |
| 2020-03-24 |
A New, Simple Projection Model for COVID-19 Pandemic (edit) |
10.1101/2020.03.21.20039867 |
| 2020-03-24 |
Myocardial injury is associated with in-hospital mortality of confirmed or suspected COVID-19 in Wuhan, China: A single center retrospective cohort study (edit) |
10.1101/2020.03.21.20040121 |
| 2020-03-24 |
Tracking and forecasting milepost moments of the epidemic in the early-outbreak: framework and applications to the COVID-19 (edit) |
10.1101/2020.03.21.20040139 |
| 2020-03-24 |
Predicting the number of reported and unreported cases for the COVID-19 epidemic in South Korea, Italy, France and Germany (edit) |
10.1101/2020.03.21.20040154 |
| 2020-03-24 |
Epidemiological parameters of coronavirus disease 2019: a pooled analysis of publicly reported individual data of 1155 cases from seven countries (edit) |
10.1101/2020.03.21.20040329 |
| 2020-03-24 |
Meplazumab treats COVID-19 pneumonia: an open-labelled, concurrent controlled add-on clinical trial (edit) |
10.1101/2020.03.21.20040691 |
| 2020-03-24 |
First Clinical Study Using HCV Protease Inhibitor Danoprevir to Treat Naive and Experienced COVID-19 Patients (edit) |
10.1101/2020.03.22.20034041 |
| 2020-03-24 |
High risk of infection caused posttraumatic stress symptoms in individuals with poor sleep quality: A study on influence of coronavirus disease (COVID-19) in China (edit) |
10.1101/2020.03.22.20034504 |
| 2020-03-24 |
The impact of temperature and absolute humidity on the coronavirus disease 2019 (COVID-19) outbreak - evidence from China (edit) |
10.1101/2020.03.22.20038919 |
| 2020-03-24 |
Estimating excess 1- year mortality from COVID-19 according to underlying conditions and age in England: a rapid analysis using NHS health records in 3.8 million adults (edit) |
10.1101/2020.03.22.20040287 |
| 2020-03-24 |
Hypertension and Diabetes Delay the Viral Clearance in COVID-19 Patients (edit) |
10.1101/2020.03.22.20040774 |
| 2020-03-24 |
A comparative multi-centre study on the clinical and imaging features of comfirmed and uncomfirmed patients with COVID-19 (edit) |
10.1101/2020.03.22.20040782 |
| 2020-03-24 |
Analysis of psychological state and clinical psychological intervention model of patients with COVID-19 (edit) |
10.1101/2020.03.22.20040899 |
| 2020-03-24 |
Mechanistic-statistical SIR modelling for early estimation of the actual number of cases and mortality rate from COVID-19 (edit) |
10.1101/2020.03.22.20040915 |
| 2020-03-24 |
Social distancing strategies for curbing the COVID-19 epidemic (edit) |
10.1101/2020.03.22.20041079 |
| 2020-03-24 |
Energetics Based Modeling of Hydroxychloroquine and Azithromycin Binding to the SARS-CoV-2 Spike (S)Protein - ACE2 Complex (edit) |
10.26434/CHEMRXIV.12015792 |
| 2020-03-24 |
On the Generation of Novel Ligands for SARS-CoV-2 Protease and ACE2 Receptor via Constrained Graph Variational Autoencoders (edit) |
10.26434/CHEMRXIV.12011157 |
| 2020-03-24 |
Protein Structure and Sequence Reanalysis of 2019-nCoV Genome Refutes Snakes as Its Intermediate Host and the Unique Similarity between Its Spike Protein Insertions and HIV-1 (edit) |
10.1021/ACS.JPROTEOME.0C00129 |
| 2020-03-24 |
How to perform lung ultrasound in pregnant women with suspected COVID-19 infection (edit) |
10.1002/UOG.22028 |
| 2020-03-24 |
COVID-19, Urologists and Hospitals (edit) |
10.22037/UJ.V0I0.6064 |
| 2020-03-24 |
COVID-19 Epidemic in the Middle Province of Northern Italy: Impact, Logistics, and Strategy in the First Line Hospital (edit) |
10.1017/DMP.2020.51 |
| 2020-03-24 |
COVID-19: the new challenge for rheumatologists (edit) |
|
| 2020-03-24 |
Novel 2019 coronavirus SARS-CoV-2 (COVID-19): An updated overview for emergency clinicians (edit) |
|
| 2020-03-24 |
Covid-19 infection and mortality - A physiologist's perspective enlightening clinical features and plausible interventional strategies (edit) |
10.1152/AJPLUNG.00097.2020 |
| 2020-03-24 |
Critical Organizational Issues for Cardiologists in the COVID-19 Outbreak: A Frontline Experience From Milan, Italy (edit) |
10.1161/CIRCULATIONAHA.120.047070 |
| 2020-03-24 |
CT Findings of Coronavirus Disease (COVID-19) Severe Pneumonia (edit) |
10.2214/AJR.20.23035 |
| 2020-03-24 |
Novel Screening and Triage Strategy in Iran During Deadly Coronavirus Disease 2019 (COVID-19) Epidemic: Value of Humanitarian Teleconsultation Service (edit) |
10.1016/J.JACR.2020.03.015 |
| 2020-03-24 |
The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management and Infection Control in a Radiology Department (edit) |
10.1016/J.JACR.2020.03.011 |
| 2020-03-24 |
Rapid Response to COVID-19: Health Informatics Support for Outbreak Management in an Academic Health System (edit) |
10.1093/JAMIA/OCAA037 |
| 2020-03-24 |
COVID-19 and Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: What Is the Evidence? (edit) |
10.1001/JAMA.2020.4812 |
| 2020-03-24 |
Treating COVID-19-Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials During Pandemics (edit) |
10.1001/JAMA.2020.4742 |
| 2020-03-24 |
Recommendations for the admission of patients with COVID-19 to intensive care and intermediate care units (ICUs and IMCUs) (edit) |
10.4414/SMW.2020.20227 |
| 2020-03-24 |
COVID-19 pandemic: palliative care for elderly and frail patients at home and in residential and nursing homes (edit) |
10.4414/SMW.2020.20235 |
| 2020-03-24 |
Clare Gerada: Doctors on the covid-19 front line also need to protect themselves and their colleagues (edit) |
10.1136/BMJ.M1121 |
| 2020-03-24 |
Don't forget chronic lung and immune conditions during covid-19, says WHO (edit) |
10.1136/BMJ.M1192 |
| 2020-03-24 |
Covid-19: most patients require mechanical ventilation in first 24 hours of critical care (edit) |
10.1136/BMJ.M1201 |
| 2020-03-24 |
Covid-19: UK lockdown is "crucial" to saving lives, say doctors and scientists (edit) |
10.1136/BMJ.M1204 |
| 2020-03-24 |
Covid-19: trials of four potential treatments to generate "robust data" of what works (edit) |
10.1136/BMJ.M1206 |
| 2020-03-24 |
Covid-19: local implementation of tracing and testing programmes could enable some schools to reopen (edit) |
10.1136/BMJ.M1187 |
| 2020-03-24 |
Football cannot restart soon during the COVID-19 emergency! A critical perspective from the Italian experience and a call for action (edit) |
10.1136/BJSPORTS-2020-102306 |
| 2020-03-24 |
Covid-19: medical students should not work outside their competency, says BMA (edit) |
10.1136/BMJ.M1197 |
| 2020-03-24 |
The Rheumatologist's Role in Covid-19 (edit) |
10.3899/JRHEUM.200334 |
| 2020-03-24 |
Epidemiological data from the COVID-19 outbreak, real-time case information (edit) |
10.1038/S41597-020-0448-0 |
| 2020-03-24 |
Is Hydroxychloroquine a possible post-exposure prophylaxis drug to limit the transmission to health care workers exposed to COVID19? (edit) |
10.1093/CID/CIAA320 |
| 2020-03-24 |
Inflammatory bowel disease care in the COVID-19 pandemic era: the Humanitas, Milan experience (edit) |
10.1093/ECCO-JCC/JJAA058 |
| 2020-03-24 |
Could chloroquine /hydroxychloroquine be harmful in Coronavirus Disease 2019 (COVID-19) treatment? (edit) |
10.1093/CID/CIAA321 |
| 2020-03-24 |
Coronavirus disease 2019 (COVID-19): update for anesthesiologists and intensivists March 2020 (edit) |
10.1007/S00101-020-00760-3 |
| 2020-03-24 |
Practical considerations for performing regional anesthesia: lessons learned from the COVID-19 pandemic (edit) |
10.1007/S12630-020-01637-0 |
| 2020-03-24 |
Disseminated intravascular coagulation in patients with 2019-nCoV pneumonia (edit) |
10.1111/JTH.14781 |
| 2020-03-24 |
Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms (edit) |
10.1136/GUTJNL-2020-320926 |
| 2020-03-24 |
National UK programme of community health workers for COVID-19 response (edit) |
10.1016/S0140-6736(20)30735-2 |
| 2020-03-24 |
Immunosuppression for hyperinflammation in COVID-19: a double-edged sword? (edit) |
10.1016/S0140-6736(20)30691-7 |
| 2020-03-24 |
COVID-19 in Europe: the Italian lesson (edit) |
10.1016/S0140-6736(20)30690-5 |
| 2020-03-24 |
Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China: a retrospective, single-centre, descriptive study (edit) |
10.1016/S1473-3099(20)30176-6 |
| 2020-03-24 |
Management of pregnant women infected with COVID-19 (edit) |
10.1016/S1473-3099(20)30191-2 |
| 2020-03-24 |
Early in the epidemic: impact of preprints on global discourse about COVID-19 transmissibility (edit) |
10.1016/S2214-109X(20)30113-3 |
| 2020-03-24 |
The host's angiotensin-converting enzyme polymorphism may explain epidemiological findings in COVID-19 infections (edit) |
10.1016/J.CCA.2020.03.031 |
| 2020-03-24 |
Telemedicine in the Era of COVID-19 (edit) |
10.1016/J.JAIP.2020.03.008 |
| 2020-03-24 |
Physical exercise as therapy to fight against the mental and physical consequences of COVID-19 quarantine: Special focus in older people (edit) |
10.1016/J.PCAD.2020.03.009 |
| 2020-03-24 |
Commentary: COVID-19 in Patients with Diabetes (edit) |
10.1016/J.METABOL.2020.154217 |
| 2020-03-24 |
Diabetes patients with COVID-19 need better blood glucose management in Wuhan, China (edit) |
10.1016/J.METABOL.2020.154216 |
| 2020-03-24 |
Sars-Cov-2: Underestimated damage to nervous system (edit) |
10.1016/J.TMAID.2020.101642 |
| 2020-03-24 |
Prevalence of Underlying Diseases in Hospitalized Patients with COVID-19: a Systematic Review and Meta-Analysis (edit) |
|
| 2020-03-24 |
High-resolution computed tomography manifestations of COVID-19 infections in patients of different ages (edit) |
10.1016/J.EJRAD.2020.108972 |
| 2020-03-24 |
COVID 19 a challenge for emergency medicine and every health care professional (edit) |
10.1016/J.AJEM.2020.03.038 |
| 2020-03-24 |
The impact of Coronavirus (COVID-19) on head and neck cancer patients' care (edit) |
10.1016/J.RADONC.2020.03.020 |
| 2020-03-24 |
Coronavirus Disease (COVID-19): A primer for emergency physicians (edit) |
10.1016/J.AJEM.2020.03.036 |
| 2020-03-24 |
No evidence supports the use of ether and chloroform inhalation for treating COVID-19 (edit) |
10.26633/RPSP.2020.41 |
| 2020-03-24 |
COVID-19: Global radiation oncology's targeted response for pandemic preparedness (edit) |
10.1016/J.CTRO.2020.03.009 |
| 2020-03-24 |
Predicting the impacts of epidemic outbreaks on global supply chains: A simulation-based analysis on the coronavirus outbreak (COVID-19/SARS-CoV-2) case (edit) |
10.1016/J.TRE.2020.101922 |
| 2020-03-24 |
Assessing Viral Shedding and Infectivity of Tears in Coronavirus Disease 2019 (COVID-19) Patients (edit) |
10.1016/J.OPHTHA.2020.03.026 |
| 2020-03-24 |
Preventing intra-hospital infection and transmission of COVID-19 in healthcare workers (edit) |
10.1016/J.SHAW.2020.03.001 |
| 2020-03-24 |
Precautions and Procedures for Coronary and Structural Cardiac Interventions During the COVID-19 Pandemic: Guidance from Canadian Association of Interventional Cardiology (edit) |
10.1016/J.CJCA.2020.03.027 |
| 2020-03-24 |
Brief Review on COVID-19: The 2020 Pandemic Caused by SARS-CoV-2 (edit) |
10.7759/CUREUS.7386 |
| 2020-03-24 |
Knowledge-Based Structural Models of SARS-CoV-2 Proteins and Their Complex with Potential Drugs (edit) |
10.26434/CHEMRXIV.12021330 |
| 2020-03-23 |
Ethnografie und visuelle Anthropologie in Zeiten des Coronavirus SARS-CoV-2 (edit) |
|
| 2020-03-23 |
Fair Allocation of Scarce Medical Resources in the Time of Covid-19 (edit) |
10.1056/NEJMSB2005114 |
| 2020-03-23 |
Smoking, vaping and hospitalization for COVID-19 (edit) |
10.32388/Z69O8A |
| 2020-03-23 |
Forecasting COVID-19’s Trajectory (edit) |
10.1103/PHYSICS.13.43 |
| 2020-03-23 |
The Toughest Triage — Allocating Ventilators in a Pandemic (edit) |
10.1056/NEJMP2005689 |
| 2020-03-23 |
The feasibility of convalescent plasma therapy in severe COVID-19 patients: a pilot study (edit) |
10.1101/2020.03.16.20036145 |
| 2020-03-23 |
High incidence of asymptomatic SARS-CoV-2 infection, Chongqing, China (edit) |
10.1101/2020.03.16.20037259 |
| 2020-03-23 |
Cross-reaction of sera from COVID-19 patients with SARS-CoV assays. (edit) |
10.1101/2020.03.17.20034454 |
| 2020-03-23 |
Now-casting the COVID-19 epidemic: The use case of Japan, March 2020 (edit) |
10.1101/2020.03.18.20037473 |
| 2020-03-23 |
ACE-2 Expression in the Small Airway Epithelia of Smokers and COPD Patients: Implications for COVID-19 (edit) |
10.1101/2020.03.18.20038455 |
| 2020-03-23 |
Geo temporal distribution of 1,688 Chinese healthcare workers infected with COVID-19 in severe conditions, a secondary data analysis (edit) |
10.1101/2020.03.19.20032532 |
| 2020-03-23 |
Trend analysis of the COVID-19 pandemic in China and the rest of the world (edit) |
10.1101/2020.03.19.20037192 |
| 2020-03-23 |
Insignificant effect of counter measure for coronavirus infectious disease -19 in Japan (edit) |
10.1101/2020.03.19.20037945 |
| 2020-03-23 |
Climatic influences on the worldwide spread of SARS-CoV-2 (edit) |
10.1101/2020.03.19.20038158 |
| 2020-03-23 |
Association between Clinical, Laboratory and CT Characteristics and RT-PCR Results in the Follow-up of COVID-19 patients (edit) |
10.1101/2020.03.19.20038315 |
| 2020-03-23 |
Supervised Machine Learning for the Early Prediction of Acute Respiratory Distress Syndrome (ARDS) (edit) |
10.1101/2020.03.19.20038364 |
| 2020-03-23 |
Clinical Characteristics of Coronavirus Disease 2019 in Hainan, China (edit) |
10.1101/2020.03.19.20038539 |
| 2020-03-23 |
Bibliometric Analysis of Global Scientific Research on SARSCoV-2 (COVID-19) (edit) |
10.1101/2020.03.19.20038752 |
| 2020-03-23 |
A model for COVID-19 prediction in Iran based on China parameters (edit) |
10.1101/2020.03.19.20038950 |
| 2020-03-23 |
Modelling the epidemiological trend and behavior of COVID-19 in Italy (edit) |
10.1101/2020.03.19.20038968 |
| 2020-03-23 |
An exploratory randomized, controlled study on the efficacy and safety of lopinavir/ritonavir or arbidol treating adult patients hospitalized with mild/moderate COVID-19 (ELACOI) (edit) |
10.1101/2020.03.19.20038984 |
| 2020-03-23 |
Effectiveness and safety of antiviral or antibody treatments for coronavirus: A rapid review (edit) |
10.1101/2020.03.19.20039008 |
| 2020-03-23 |
Forecasting ultra-early intensive care strain from COVID-19 in England (edit) |
10.1101/2020.03.19.20039057 |
| 2020-03-23 |
Assessing the potential impact of COVID-19 in Brazil: Mobility, Morbidity and the burden on the Health Care System (edit) |
10.1101/2020.03.19.20039131 |
| 2020-03-23 |
Role of meteorological temperature and relative humidity in the January-February 2020 propagation of 2019-nCoV in Wuhan, China (edit) |
10.1101/2020.03.19.20039164 |
| 2020-03-23 |
The local stability of a modified multi-strain SIR model for emerging viral strains (edit) |
10.1101/2020.03.19.20039198 |
| 2020-03-23 |
Basic and effective reproduction numbers of COVID-19 cases in South Korea excluding Sincheonji cases (edit) |
10.1101/2020.03.19.20039347 |
| 2020-03-23 |
AI-assisted CT imaging analysis for COVID-19 screening: Building and deploying a medical AI system in four weeks (edit) |
10.1101/2020.03.19.20039354 |
| 2020-03-23 |
Chinese and Italian COVID-19 outbreaks can be correctly described by a modified SIRD model (edit) |
10.1101/2020.03.19.20039388 |
| 2020-03-23 |
Healthcare worker absenteeism, child care costs, and COVID-19 school closures: a simulation analysis (edit) |
10.1101/2020.03.19.20039404 |
| 2020-03-23 |
Predicting COVID-19 malignant progression with AI techniques (edit) |
10.1101/2020.03.20.20037325 |
| 2020-03-23 |
High COVID-19 incidence among Norwegian travellers returned from Lombardy: implications for travel restrictions (edit) |
10.1101/2020.03.20.20038406 |
| 2020-03-23 |
Estimating the reproduction number of COVID-19 in Iran using epidemic modeling (edit) |
10.1101/2020.03.20.20038422 |
| 2020-03-23 |
Screening and managing of suspected or confirmed novel coronavirus (COVID-19) patients: experiences from a tertiary hospital outside Hubei province (edit) |
10.1101/2020.03.20.20038679 |
| 2020-03-23 |
COVID-19: Modelling Local Transmission and Morbidity effects to provide an estimate of overall Relative Healthcare Resource Impact by General Practice Granularity (edit) |
10.1101/2020.03.20.20039024 |
| 2020-03-23 |
The Population Attributable Fraction (PAF) of cases due to gatherings and groups with relevance to COVID-19 mitigation strategies (edit) |
10.1101/2020.03.20.20039537 |
| 2020-03-23 |
Covid-19 health care demand and mortality in Sweden in response to non-pharmaceutical (NPIs) mitigation and suppression scenarios (edit) |
10.1101/2020.03.20.20039594 |
| 2020-03-23 |
A Tempo-geographic Analysis of Global COVID-19 Epidemic Outside of China (edit) |
10.1101/2020.03.20.20039602 |
| 2020-03-23 |
The Effectiveness of Social Distancing in Mitigating COVID-19 Spread: a modelling analysis (edit) |
10.1101/2020.03.20.20040055 |
| 2020-03-23 |
SARS-CoV-2, an evolutionary perspective of interaction with human ACE2 reveals undiscovered amino acids necessary for complex stability (edit) |
10.1101/2020.03.21.001933 |
| 2020-03-23 |
Clinical characteristics and reasons of different duration from onset to release from quarantine for patients with COVID-19 Outside Hubei province, China. (edit) |
10.1101/2020.03.21.20038778 |
| 2020-03-23 |
Optimization of Microbiological Laboratory Detection Strategy for Patients in A Designated Hospital Treating Novel Coronavirus Pneumonia in Anhui Province (edit) |
10.1101/2020.03.21.20039065 |
| 2020-03-23 |
From a single host to global spread. The global mobility based modelling of the COVID-19 pandemic implies higher infection and lower detection rates than current estimates. (edit) |
10.1101/2020.03.21.20040444 |
| 2020-03-23 |
Epidemiological and clinical characteristics of COVID-19 in Shenzhen, the largest migrant city of China (edit) |
10.1101/2020.03.22.20035246 |
| 2020-03-23 |
Aggregated mobility data could help fight COVID-19 (edit) |
10.1126/SCIENCE.ABB8021 |
| 2020-03-23 |
Drive-Through Screening Center for COVID-19: a Safe and Efficient Screening System against Massive Community Outbreak (edit) |
10.3346/JKMS.2020.35.E123 |
| 2020-03-23 |
First Pediatric Case of Coronavirus Disease 2019 in Korea (edit) |
10.3346/JKMS.2020.35.E124 |
| 2020-03-23 |
COVID-19: gastrointestinal symptoms and potential sources of 2019-nCoV transmission (edit) |
10.5114/AIT.2020.93867 |
| 2020-03-23 |
Lung Recruitability in SARS-CoV-2 Associated Acute Respiratory Distress Syndrome: A Single-center, Observational Study (edit) |
10.1164/RCCM.202003-0527LE |
| 2020-03-23 |
A COVID-19 Transmission within a family cluster by presymptomatic infectors in China (edit) |
10.1093/CID/CIAA316 |
| 2020-03-23 |
Dermatology staff participate in fight against Covid-19 in China (edit) |
10.1111/JDV.16390 |
| 2020-03-23 |
COVID-19: A global transplant perspective on successfully navigating a pandemic (edit) |
10.1111/AJT.15876 |
| 2020-03-23 |
Transmission electron microscopy imaging of SARS-CoV-2 (edit) |
10.4103/IJMR.IJMR_577_20 |
| 2020-03-23 |
Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults (edit) |
10.1111/APA.15270 |
| 2020-03-23 |
Urology practice during COVID-19 pandemic (edit) |
10.23736/S0393-2249.20.03846-1 |
| 2020-03-23 |
Risk of COVID-19 importation to the Pacific islands through global air travel (edit) |
10.1017/S0950268820000710 |
| 2020-03-23 |
Changing the editorial process at JCI and JCI Insight in response to the COVID-19 pandemic (edit) |
10.1172/JCI138305 |
| 2020-03-23 |
Recommendations by the SEPD and AEG, both in general and on the operation of gastrointestinal endoscopy and gastroenterology units, concerning the current SARS-CoV-2 pandemic (March, 18) (edit) |
10.17235/REED.2020.7052/2020 |
| 2020-03-23 |
The Role of Telehealth in Reducing the Mental Health Burden from COVID-19 (edit) |
10.1089/TMJ.2020.0068 |
| 2020-03-23 |
Public Mental Health Crisis during COVID-19 Pandemic, China (edit) |
10.3201/EID2607.200407 |
| 2020-03-23 |
The impact of COVID-19 on the provision of donor hematopoietic stem cell products worldwide: collateral damage (edit) |
10.1038/S41409-020-0873-X |
| 2020-03-23 |
COVID-19 and the crisis of national development (edit) |
10.1038/S41562-020-0852-7 |
| 2020-03-23 |
Insights from nanomedicine into chloroquine efficacy against COVID-19 (edit) |
10.1038/S41565-020-0674-9 |
| 2020-03-23 |
Rising to the Challenge of the Novel SARS-coronavirus-2 (SARS-CoV-2): Advice for Pulmonary and Critical Care and an Agenda for Research (edit) |
10.1164/RCCM.202003-0741ED |
| 2020-03-23 |
Ventilatory Ratio in Hypercapnic Mechanically Ventilated Patients with COVID-19 Associated ARDS (edit) |
10.1164/RCCM.202002-0373LE |
| 2020-03-23 |
Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade (edit) |
10.1159/000507305 |
| 2020-03-23 |
Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy (edit) |
10.1001/JAMA.2020.4683 |
| 2020-03-23 |
Covid-19: European drugs agency to review safety of ibuprofen (edit) |
10.1136/BMJ.M1168 |
| 2020-03-23 |
Covid-19: Highest risk patients are asked to stay at home for 12 weeks (edit) |
10.1136/BMJ.M1170 |
| 2020-03-23 |
Covid-19: give NHS staff rest spaces and free parking not thank yous, says doctor (edit) |
10.1136/BMJ.M1171 |
| 2020-03-23 |
Covid-19: six million doses of hydroxychloroquine donated to US despite lack of evidence (edit) |
10.1136/BMJ.M1166 |
| 2020-03-23 |
Covid-19: identifying and isolating asymptomatic people helped eliminate virus in Italian village (edit) |
10.1136/BMJ.M1165 |
| 2020-03-23 |
Covid-19: US testing ramps up as early response draws harsh criticism (edit) |
10.1136/BMJ.M1167 |
| 2020-03-23 |
Clinical trials suspended in UK to prioritise covid-19 studies and free up staff (edit) |
10.1136/BMJ.M1172 |
| 2020-03-23 |
Covid-19: doctors in final trimester of pregnancy should avoid direct patient contact (edit) |
10.1136/BMJ.M1173 |
| 2020-03-23 |
WHO must prioritise the needs of older people in its response to the covid-19 pandemic (edit) |
10.1136/BMJ.M1164 |
| 2020-03-23 |
COVID-19 infection: the perspectives on immune responses (edit) |
10.1038/S41418-020-0530-3 |
| 2020-03-23 |
ISUOG Safety Committee Position Statement: safe performance of obstetric and gynecological scans and equipment cleaning in the context of COVID-19 (edit) |
10.1002/UOG.22027 |
| 2020-03-23 |
Recommendations for Endotracheal Intubation of COVID-19 Patients (edit) |
10.1213/ANE.0000000000004803 |
| 2020-03-23 |
Angiotensin II for the Treatment of COVID-19-Related Vasodilatory Shock (edit) |
10.1213/ANE.0000000000004825 |
| 2020-03-23 |
Evolutionary Trajectory for the Emergence of Novel Coronavirus SARS-CoV-2 (edit) |
10.3390/PATHOGENS9030240 |
| 2020-03-23 |
Routes for COVID-19 importation in Brazil (edit) |
10.1093/JTM/TAAA042 |
| 2020-03-23 |
Health measures to travelers and cruise ships in response to COVID-19 (edit) |
10.1093/JTM/TAAA043 |
| 2020-03-23 |
Protecting healthcare personnel from 2019-nCoV infection risks: lessons and suggestions (edit) |
10.1007/S11684-020-0765-X |
| 2020-03-23 |
COVID-19: mitigating transmission via wastewater plumbing systems (edit) |
10.1016/S2214-109X(20)30112-1 |
| 2020-03-23 |
The first infant case of COVID-19 acquired from a secondary transmission in Vietnam (edit) |
10.1016/S2352-4642(20)30091-2 |
| 2020-03-23 |
Scientific and ethical basis for social-distancing interventions against COVID-19 (edit) |
10.1016/S1473-3099(20)30190-0 |
| 2020-03-23 |
The first COVID-19 case in Afghanistan acquired from Iran (edit) |
10.1016/S1473-3099(20)30231-0 |
| 2020-03-23 |
Interventions to mitigate early spread of SARS-CoV-2 in Singapore: a modelling study (edit) |
10.1016/S1473-3099(20)30162-6 |
| 2020-03-23 |
COVID-19 and medical education (edit) |
10.1016/S1473-3099(20)30226-7 |
| 2020-03-23 |
SARS-CoV-2: virus dynamics and host response (edit) |
10.1016/S1473-3099(20)30235-8 |
| 2020-03-23 |
Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study (edit) |
10.1016/S1473-3099(20)30196-1 |
| 2020-03-23 |
The value of mitigating epidemic peaks of COVID-19 for more effective public health responses (edit) |
10.1590/0037-8682-0135-2020 |
| 2020-03-23 |
Immediate Health Surveillance Response to COVID-19 Epidemic (edit) |
10.5123/S1679-49742020000100021 |
| 2020-03-23 |
Imaging manifestations and diagnostic value of chest CT of coronavirus disease 2019 (COVID-19) in the Xiaogan area (edit) |
10.1016/J.CRAD.2020.03.004 |
| 2020-03-23 |
An update on COVID-19 for the radiologist - A British society of Thoracic Imaging statement (edit) |
10.1016/J.CRAD.2020.03.003 |
| 2020-03-23 |
COVID-19 and Dialysis Units: What Do We Know Now and What Should We Do? (edit) |
10.1053/J.AJKD.2020.03.008 |
| 2020-03-23 |
Inside China and COVID-19: Questions and answers (edit) |
10.1016/J.TMAID.2020.101640 |
| 2020-03-23 |
How to link patients with suspicious COVID-19 to health system from the community pharmacies? A route proposal (edit) |
10.1016/J.SAPHARM.2020.03.007 |
| 2020-03-23 |
Incidentally Diagnosed COVID-19 Infection in Trauma Patients; a Clinical Experience (edit) |
|
| 2020-03-23 |
Risks of Novel Coronavirus Disease (COVID-19) in Pregnancy; a Narrative Review (edit) |
|
| 2020-03-23 |
[Editorial] Possibility of transmission through dogs being a contributing factor to the extreme Covid‑19 outbreak in North Italy (edit) |
10.3892/MMR.2020.11037 |
| 2020-03-23 |
Cytokine storms in COVID-19 cases? (edit) |
10.4045/TIDSSKR.20.0239 |
| 2020-03-23 |
The impending storm: COVID-19, pandemics and our overwhelmed emergency departments (edit) |
10.1016/J.AJEM.2020.03.033 |
| 2020-03-23 |
Daily Situation Report on Coronavirus disease (COVID-19) in Iran; March 23, 2020 (edit) |
|
| 2020-03-23 |
Facial mask: A necessity to beat COVID-19 (edit) |
10.1016/J.BUILDENV.2020.106827 |
| 2020-03-23 |
1,000,000 cases of COVID-19 outside of China: The date predicted by a simple heuristic (edit) |
10.1016/J.GLOEPI.2020.100023 |
| 2020-03-23 |
Severe air pollution events not avoided by reduced anthropogenic activities during COVID-19 outbreak (edit) |
10.1016/J.RESCONREC.2020.104814 |
| 2020-03-23 |
The international imperative to rapidly and inexpensively monitor community-wide Covid-19 infection status and trends (edit) |
10.1016/J.SCITOTENV.2020.138149 |
| 2020-03-23 |
Development and Evaluation of an AI System for COVID-19 Diagnosis (edit) |
10.1101/2020.03.20.20039834 |
| 2020-03-23 |
Identification of Key Interactions Between SARS-CoV-2 Main Protease and Inhibitor Drug Candidates (edit) |
10.26434/CHEMRXIV.12009636 |
| 2020-03-23 |
Ultrasensitive and Whole-Course Encapsulated Field Detection of 2019-nCoV Gene Applying Exponential Amplification from RNA Combined with Chemical Probes (edit) |
10.26434/CHEMRXIV.12012789 |
| 2020-03-23 |
Exploring the Effect of 2019-nCoV Containment Policies on Crime: The Case of Los Angeles (edit) |
10.31219/OSF.IO/GCPQ8 |
| 2020-03-23 |
Initial Simulation of SARS-CoV2 Spread and Intervention Effects in the Continental US (edit) |
10.1101/2020.03.21.20040303 |
| 2020-03-22 |
Questions raised by COVID-19 case descriptions (edit) |
10.1111/JPC.14872 |
| 2020-03-22 |
Building a COVID-19 Vulnerability Index (edit) |
10.1101/2020.03.16.20036723 |
| 2020-03-22 |
Molecular characterization of SARS-CoV-2 in the first COVID-19 cluster in France reveals an amino-acid deletion in nsp2 (Asp268Del) (edit) |
10.1101/2020.03.19.998179 |
| 2020-03-22 |
All-in-One Dual CRISPR-Cas12a (AIOD-CRISPR) Assay: A Case for Rapid, Ultrasensitive and Visual Detection of Novel Coronavirus SARS-CoV-2 and HIV virus (edit) |
10.1101/2020.03.19.998724 |
| 2020-03-22 |
COVID-19 coronavirus vaccine design using reverse vaccinology and machine learning (edit) |
10.1101/2020.03.20.000141 |
| 2020-03-22 |
COVID-19 Vaccine Candidates: Prediction and Validation of 174 SARS-CoV-2 Epitopes (edit) |
10.1101/2020.03.20.000794 |
| 2020-03-22 |
Emergence of SARS-CoV-2 through Recombination and Strong Purifying Selection (edit) |
10.1101/2020.03.20.000885 |
| 2020-03-22 |
RT-qPCR DETECTION OF SARS-CoV-2 RNA FROM PATIENT NASOPHARYNGEAL SWAB USING QIAGEN RNEASY KITS OR DIRECTLY VIA OMISSION OF AN RNA EXTRACTION STEP (edit) |
10.1101/2020.03.20.001008 |
| 2020-03-22 |
Replication of SARS-CoV-2 in human respiratory epithelium (edit) |
10.1101/2020.03.20.999029 |
| 2020-03-22 |
Comparative analyses of SAR-CoV2 genomes from different geographical locations and other coronavirus family genomes reveals unique features potentially consequential to host-virus interaction and pathogenesis (edit) |
10.1101/2020.03.21.001586 |
| 2020-03-22 |
Respiratory disease and virus shedding in rhesus macaques inoculated with SARS-CoV-2 (edit) |
10.1101/2020.03.21.001628 |
| 2020-03-22 |
Covid-19 mass testing facilities could end the epidemic rapidly (edit) |
10.1136/BMJ.M1163 |
| 2020-03-22 |
Global coronavirus pandemic (2019-nCOV): Implication for an Italian medium size dermatological clinic of a ii level hospital (edit) |
10.1111/JDV.16386 |
| 2020-03-22 |
Alzheimer's Disease Research Enterprise in the Era of COVID-19/SARS-CoV-2 (edit) |
10.1002/ALZ.12093 |
| 2020-03-22 |
COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome? (edit) |
|
| 2020-03-22 |
Are my patients with rheumatic diseases at higher risk of COVID-19? (edit) |
10.1136/ANNRHEUMDIS-2020-217322 |
| 2020-03-22 |
COVID-19 can present with a rash and be mistaken for Dengue (edit) |
10.1016/J.JAAD.2020.03.036 |
| 2020-03-22 |
Dermatology practices as vectors for COVID-19 transmission: a call for immediate cessation of non-emergent dermatology visits (edit) |
10.1016/J.JAAD.2020.03.037 |
| 2020-03-22 |
Information Diet in Covid-19 Crisis; a Commentary (edit) |
|
| 2020-03-22 |
COVID-19 Outbreak: An Overview on Dentistry (edit) |
10.3390/IJERPH17062094 |
| 2020-03-22 |
Doctors and healthcare workers at frontline of COVID 19 epidemic: Admiration, a pat on the back, and need for extreme caution (edit) |
10.1016/J.DSX.2020.03.006 |
| 2020-03-22 |
Daily Situation Report on Coronavirus disease (COVID-19) in Iran; March 22, 2020 (edit) |
|
| 2020-03-21 |
Potential Neutralizing Antibodies Discovered for Novel Corona Virus Using Machine Learning (edit) |
10.1101/2020.03.14.992156 |
| 2020-03-21 |
Scientometric Trends for Coronaviruses and Other Emerging Viral Infections (edit) |
10.1101/2020.03.17.995795 |
| 2020-03-21 |
Development and utilization of an intelligent application for aiding COVID-19 diagnosis (edit) |
10.1101/2020.03.18.20035816 |
| 2020-03-21 |
Nucleotide Analogues as Inhibitors of SARS-CoV-2 Polymerase (edit) |
10.1101/2020.03.18.997585 |
| 2020-03-21 |
Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs (edit) |
10.1101/2020.03.20.999730 |
| 2020-03-21 |
Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19) (edit) |
10.1093/CID/CIAA310 |
| 2020-03-21 |
The potential added value of FDG PET/CT for COVID-19 pneumonia (edit) |
10.1007/S00259-020-04767-1 |
| 2020-03-21 |
Prepare to adapt: Blood supply and transfusion support during the first 2 weeks of the 2019 Novel Coronavirus (COVID-19) pandemic affecting Washington State (edit) |
10.1111/TRF.15789 |
| 2020-03-21 |
Clinical features and treatment of COVID-19 patients in northeast Chongqing (edit) |
10.1002/JMV.25783 |
| 2020-03-21 |
[When COVID-19 encounters interstitial lung disease: challenges and management] (edit) |
10.3760/CMA.J.CN112147-20200315-00339 |
| 2020-03-21 |
Responding to the COVID-19 pandemic in complex humanitarian crises (edit) |
10.1186/S12939-020-01162-Y |
| 2020-03-21 |
Coronavirus Disease 2019 (COVID-19) and Cardiovascular Disease (edit) |
10.1161/CIRCULATIONAHA.120.046941 |
| 2020-03-21 |
Putting resiliency of a health system to the test: COVID-19 in Taiwan (edit) |
10.1016/J.JFMA.2020.03.002 |
| 2020-03-21 |
New therapeutic opportunities for COVID-19 patients with Tocilizumab: Possible correlation of interleukin-6 receptor inhibitors with osteonecrosis of the jaws (edit) |
10.1016/J.ORALONCOLOGY.2020.104659 |
| 2020-03-21 |
Comparisons of nucleic acid conversion time of SARS-CoV-2 of different samples in ICU and non-ICU patients (edit) |
10.1016/J.JINF.2020.03.013 |
| 2020-03-21 |
Herd immunity - estimating the level required to halt the COVID-19 epidemics in affected countries (edit) |
10.1016/J.JINF.2020.03.027 |
| 2020-03-21 |
Wuhan and Hubei COVID-19 mortality analysis reveals the critical role of timely supply of medical resources (edit) |
10.1016/J.JINF.2020.03.018 |
| 2020-03-21 |
Profile of Specific Antibodies to SARS-CoV-2: The First Report (edit) |
10.1016/J.JINF.2020.03.012 |
| 2020-03-21 |
Renin-angiotensin system: The unexpected flaw inside the human immune system revealed by SARS-CoV-2 (edit) |
10.1016/J.MEHY.2020.109686 |
| 2020-03-21 |
Screening for Chinese medical staff mental health by SDS and SAS during the outbreak of COVID-19 (edit) |
10.1016/J.JPSYCHORES.2020.110102 |
| 2020-03-21 |
Potential Treatments for COVID-19; a Narrative Literature Review (edit) |
|
| 2020-03-21 |
Effective Risk Communication for Public Health Emergency: Reflection on the COVID-19 (2019-nCoV) Outbreak in Wuhan, China (edit) |
10.3390/HEALTHCARE8010064 |
| 2020-03-21 |
Can COVID-19 present unusual GI symptoms? (edit) |
10.1016/J.JMII.2020.03.020 |
| 2020-03-21 |
Society of Cardiovascular Computed Tomography guidance for use of cardiac computed tomography amidst the COVID-19 pandemic Endorsed by the American College of Cardiology (edit) |
10.1016/J.JCCT.2020.03.002 |
| 2020-03-21 |
Mental health and a novel coronavirus (2019-nCoV) in China (edit) |
10.1016/J.JAD.2020.03.041 |
| 2020-03-20 |
Canine SARS-CoV-2 infection (edit) |
10.21203/RS.3.RS-18713/V1 |
| 2020-03-20 |
Homology Modeling of TMPRSS2 Yields Candidate Drugs That May Inhibit Entry of SARS-CoV-2 into Human Cells (edit) |
10.26434/CHEMRXIV.12009582.V1 |
| 2020-03-20 |
Hydroxychloroquine and azithromycin as a treatment of COVID‐19: results of an open‐label non‐randomized clinical trial (edit) |
10.1016/J.IJANTIMICAG.2020.105949 |
| 2020-03-20 |
Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors (edit) |
10.1126/SCIENCE.ABB3405 |
| 2020-03-20 |
COVID-19: Forecasting short term hospital needs in France (edit) |
10.1101/2020.03.16.20036939 |
| 2020-03-20 |
Maximum entropy method for estimating the reproduction number: An investigation for COVID-19 in China (edit) |
10.1101/2020.03.14.20035659 |
| 2020-03-20 |
Change in outbreak epicenter and its impact on the importation risks of COVID-19 progression: a modelling study (edit) |
10.1101/2020.03.17.20036681 |
| 2020-03-20 |
Estimating the Risks from COVID-19 Infection in Adult Chemotherapy Patients (edit) |
10.1101/2020.03.18.20038067 |
| 2020-03-20 |
Spatial Visualization of Cluster-Specific COVID-19 Transmission Network in South Korea During the Early Epidemic Phase (edit) |
10.1101/2020.03.18.20038638 |
| 2020-03-20 |
A Tool to Early Predict Severe 2019-Novel Coronavirus Pneumonia (COVID-19) : A Multicenter Study using the Risk Nomogram in Wuhan and Guangdong, China (edit) |
10.1101/2020.03.17.20037515 |
| 2020-03-20 |
Chinese Public Attention to COVID-19 Epidemic: Based on Social Media (edit) |
10.1101/2020.03.18.20038026 |
| 2020-03-20 |
Hydroxychloroquine and Azithromycin as a treatment of COVID-19: preliminary results of an open-label non-randomized clinical trial (edit) |
10.1101/2020.03.16.20037135 |
| 2020-03-20 |
Estimating Preventable COVID19 Infections Related to Elective Outpatient Surgery in Washington State: A Quantitative Model (edit) |
10.1101/2020.03.18.20037952 |
| 2020-03-20 |
Pandemic dynamics of COVID-19 using epidemic stage, instantaneous reproductive number and pathogen genome identity (GENI) score: modeling molecular epidemiology (edit) |
10.1101/2020.03.17.20037481 |
| 2020-03-20 |
Stopping the Spread of COVID-19 (edit) |
10.1001/JAMA.2020.4269 |
| 2020-03-20 |
GENOMIC CHARACTERISATION AND PHYLOGENETIC ANALYSIS OF SARS-COV-2 IN ITALY (edit) |
10.1101/2020.03.15.20032870 |
| 2020-03-20 |
Development and validation of a rapid single-step reverse transcriptase loop-mediated isothermal amplification (RT-LAMP) system potentially to be used for reliable and high-throughput screening of COVID-19 (edit) |
10.1101/2020.03.15.20036376 |
| 2020-03-20 |
Analysis of Epidemic Situation of New Coronavirus Infection at Home and Abroad Based on Rescaled Range (R/S) Method (edit) |
10.1101/2020.03.15.20036756 |
| 2020-03-20 |
Regaining perspective on SARS-CoV-2 molecular tracing and its implications (edit) |
10.1101/2020.03.16.20034470 |
| 2020-03-20 |
Advance of Novel Coronavirus Registration Clinical Trial (edit) |
10.1101/2020.03.16.20034934 |
| 2020-03-20 |
Evaluation of Nucleocapsid and Spike Protein-based ELISAs for detecting antibodies against SARS-CoV-2 (edit) |
10.1101/2020.03.16.20035014 |
| 2020-03-20 |
Effect of continuous renal replacement therapy on all-cause mortality in COVID-19 patients undergoing invasive mechanical ventilation: a retrospective cohort study (edit) |
10.1101/2020.03.16.20036780 |
| 2020-03-20 |
Transmissibility of 2019 Novel Coronavirus: zoonotic vs. human to human transmission, China, 2019-2020 (edit) |
10.1101/2020.03.16.20037036 |
| 2020-03-20 |
Roles of meteorological conditions in COVID-19 transmission on a worldwide scale (edit) |
10.1101/2020.03.16.20037168 |
| 2020-03-20 |
Hundreds of severe pediatric COVID-19 infections in Wuhan prior to the lockdown (edit) |
10.1101/2020.03.16.20037176 |
| 2020-03-20 |
Short-range airborne route dominates exposure of respiratory infection during close contact (edit) |
10.1101/2020.03.16.20037291 |
| 2020-03-20 |
Characterization of anti-viral immunity in recovered individuals infected by SARS-CoV-2 (edit) |
10.1101/2020.03.17.20036640 |
| 2020-03-20 |
Evaluation of recombinant nucleocapsid and spike proteins for serological diagnosis of novel coronavirus disease 2019 (COVID-19) (edit) |
10.1101/2020.03.17.20036954 |
| 2020-03-20 |
Machine Learning the Phenomenology of COVID-19 From Early Infection Dynamics (edit) |
10.1101/2020.03.17.20037309 |
| 2020-03-20 |
How to improve adherence with quarantine: Rapid review of the evidence (edit) |
10.1101/2020.03.17.20037408 |
| 2020-03-20 |
Favipiravir versus Arbidol for COVID-19: A Randomized Clinical Trial (edit) |
10.1101/2020.03.17.20037432 |
| 2020-03-20 |
The prevention of nosocomial SARS-CoV2 transmission in endoscopy: a systematic review of recommendations within gastroenterology to identify best practice. (edit) |
10.1101/2020.03.17.20037564 |
| 2020-03-20 |
Incidence, clinical characteristics and prognostic factor of patients with COVID-19: a systematic review and meta-analysis (edit) |
10.1101/2020.03.17.20037572 |
| 2020-03-20 |
Sentinel Event Surveillance to Estimate Total SARS-CoV-2 Infections, United States (edit) |
10.1101/2020.03.17.20037648 |
| 2020-03-20 |
Simple Mathematics on Covid-19 Expansion (edit) |
10.1101/2020.03.17.20037663 |
| 2020-03-20 |
Modeling and Forecasting Trend of COVID-19 Epidemic in Iran (edit) |
10.1101/2020.03.17.20037671 |
| 2020-03-20 |
Tracing DAY-ZERO and Forecasting the Fade out of the COVID-19 Outbreak in Lombardy, Italy: A Compartmental Modelling and Numerical Optimization Approach. (edit) |
10.1101/2020.03.17.20037689 |
| 2020-03-20 |
Estimating cases of COVID-19 from Daily Death Data in Italy (edit) |
10.1101/2020.03.17.20037697 |
| 2020-03-20 |
Intensive Care Unit Resource Planning During COVID-19 Emergency at the Regional Level: the Italian case. (edit) |
10.1101/2020.03.17.20037788 |
| 2020-03-20 |
Reverse transcription loop-mediated isothermal amplification combined with nanoparticles-based biosensor for diagnosis of COVID-19 (edit) |
10.1101/2020.03.17.20037796 |
| 2020-03-20 |
AAEDM: Theoretical Dynamic Epidemic Diffusion Model and Covid-19 Korea Pandemic Cases (edit) |
10.1101/2020.03.17.20037838 |
| 2020-03-20 |
Double-Quencher Probes Improved the Detection Sensitivity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) by One-Step RT-PCR (edit) |
10.1101/2020.03.17.20037903 |
| 2020-03-20 |
High transmissibility of COVID-19 near symptom onset (edit) |
10.1101/2020.03.18.20034561 |
| 2020-03-20 |
Preliminary evidence that higher temperatures are associated with lower incidence of COVID-19, for cases reported globally up to 29th February 2020 (edit) |
10.1101/2020.03.18.20036731 |
| 2020-03-20 |
Epidemiology of seasonal coronaviruses: Establishing the context for COVID-19 emergence (edit) |
10.1101/2020.03.18.20037101 |
| 2020-03-20 |
Investigating the Impact of Asymptomatic Carriers on COVID-19 Transmission (edit) |
10.1101/2020.03.18.20037994 |
| 2020-03-20 |
Antibody responses to SARS-CoV-2 in COVID-19 patients: the perspective application of serological tests in clinical practice (edit) |
10.1101/2020.03.18.20038018 |
| 2020-03-20 |
SARS-CoV-2 specific antibody responses in COVID-19 patients (edit) |
10.1101/2020.03.18.20038059 |
| 2020-03-20 |
Predicting the epidemic trend of COVID-19 in China and across the world using the machine learning approach (edit) |
10.1101/2020.03.18.20038117 |
| 2020-03-20 |
Non-severe vs severe symptomatic COVID-19: 104 cases from the outbreak on the cruise ship “Diamond Princess” in Japan (edit) |
10.1101/2020.03.18.20038125 |
| 2020-03-20 |
Comparison of the coronavirus pandemic dynamics in Europe, USA and South Korea (edit) |
10.1101/2020.03.18.20038133 |
| 2020-03-20 |
A brief review of antiviral drugs evaluated in registered clinical trials for COVID-19 (edit) |
10.1101/2020.03.18.20038190 |
| 2020-03-20 |
Assessing the Global Tendency of COVID-19 Outbreak (edit) |
10.1101/2020.03.18.20038224 |
| 2020-03-20 |
Response and role of palliative care during the COVID-19 pandemic: a national telephone survey of hospices in Italy (edit) |
10.1101/2020.03.18.20038448 |
| 2020-03-20 |
Dynamic profile of severe or critical COVID-19 cases (edit) |
10.1101/2020.03.18.20038513 |
| 2020-03-20 |
Extended SIR prediction of the epidemics trend of COVID-19 in Italy and compared with Hunan, China (edit) |
10.1101/2020.03.18.20038570 |
| 2020-03-20 |
PREDICTING THE EVOLUTION OF COVID-19 IN PORTUGAL USING AN ADAPTED SIR MODEL PREVIOUSLY USED IN SOUTH KOREA FOR THE MERS OUTBREAK (edit) |
10.1101/2020.03.18.20038612 |
| 2020-03-20 |
A prospect on the use of antiviral drugs to control local outbreaks of COVID-19 (edit) |
10.1101/2020.03.19.20038182 |
| 2020-03-20 |
Fear, Access, and the Real-Time Estimation of Etiological Parameters for Outbreaks of Novel Pathogens (edit) |
10.1101/2020.03.19.20038729 |
| 2020-03-20 |
A framework for identifying regional outbreak and spread of COVID-19 from one-minute population-wide surveys (edit) |
10.1101/2020.03.19.20038844 |
| 2020-03-20 |
A Novel Triage Tool of Artificial Intelligence Assisted Diagnosis Aid System for Suspected COVID-19 pneumonia In Fever Clinics (edit) |
10.1101/2020.03.19.20039099 |
| 2020-03-20 |
An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 and multiple endemic, epidemic and bat coronavirus (edit) |
10.1101/2020.03.19.997890 |
| 2020-03-20 |
The first-in-class peptide binder to the SARS-CoV-2 spike protein (edit) |
10.1101/2020.03.19.999318 |
| 2020-03-20 |
SARS-CoV-2 and Coronavirus Disease 2019: What We Know So Far (edit) |
10.3390/PATHOGENS9030231 |
| 2020-03-20 |
Misguided drug advice for COVID-19 (edit) |
10.1126/SCIENCE.ABB8034 |
| 2020-03-20 |
Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2) (edit) |
10.1016/J.PHRS.2020.104761 |
| 2020-03-20 |
pH Dependent Differential Binding Behavior of Prtotease Inhibitor Molecular Drugs for SARS-COV-2 (edit) |
10.26434/CHEMRXIV.12009018 |
| 2020-03-20 |
Clinical and CT imaging features of the COVID-19 pneumonia: Focus on pregnant women and children (edit) |
10.1016/J.JINF.2020.03.007 |
| 2020-03-20 |
Initial Investigation of Transmission of COVID-19 Among Crew Members During Quarantine of a Cruise Ship - Yokohama, Japan, February 2020 (edit) |
10.15585/MMWR.MM6911E2 |
| 2020-03-20 |
Evaluation of the Effectiveness of Surveillance and Containment Measures for the First 100 Patients with COVID-19 in Singapore - January 2-February 29, 2020 (edit) |
10.15585/MMWR.MM6911E1 |
| 2020-03-20 |
Coronavirus disease 2019 (COVID-19) outbreak in Iran: Actions and problems (edit) |
10.1017/ICE.2020.86 |
| 2020-03-20 |
The role of masks and respirator protection against SARS-CoV-2 (edit) |
10.1017/ICE.2020.83 |
| 2020-03-20 |
Public health measures to slow community spread of COVID-19 (edit) |
10.1093/INFDIS/JIAA123 |
| 2020-03-20 |
Social Capital and Sleep Quality in Individuals Who Self-Isolated for 14 Days During the Coronavirus Disease 2019 (COVID-19) Outbreak in January 2020 in China (edit) |
10.12659/MSM.923921 |
| 2020-03-20 |
Knowledge and Perceptions of COVID-19 Among the General Public in the United States and the United Kingdom: A Cross-sectional Online Survey (edit) |
10.7326/M20-0912 |
| 2020-03-20 |
COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression (edit) |
10.1093/JAC/DKAA114 |
| 2020-03-20 |
SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19? (edit) |
10.1093/EURHEARTJ/EHAA235 |
| 2020-03-20 |
Recommendations for the prevention, mitigation and containment of the emerging SARS-CoV-2 (COVID-19) pandemic in haemodialysis centres (edit) |
10.1093/NDT/GFAA069 |
| 2020-03-20 |
Telehealth for global emergencies: Implications for coronavirus disease 2019 (COVID-19) (edit) |
10.1177/1357633X20916567 |
| 2020-03-20 |
COVID-19 (Coronavirus) (edit) |
10.1089/LRB.2020.29084.COV |
| 2020-03-20 |
Diagnostic Value of Chest CT in Coronavirus Disease 2019 (COVID-19) (edit) |
10.2174/1573405616999200320163751 |
| 2020-03-20 |
Supporting Clinicians During the COVID-19 Pandemic (edit) |
10.7326/M20-1033 |
| 2020-03-20 |
Will COVID‐19 be a litmus test for post‐Ebola sub‐Saharan Africa? (edit) |
10.1002/JMV.25780 |
| 2020-03-20 |
Navigating Coronavirus Disease 2019 (Covid-19) in Physiatry: A CAN report for Inpatient Rehabilitation Facilities (edit) |
10.1002/PMRJ.12369 |
| 2020-03-20 |
Clinical features in pediatric COVID-19 (edit) |
10.1002/PPUL.24737 |
| 2020-03-20 |
Covid-19 and the Stiff Upper Lip - The Pandemic Response in the United Kingdom (edit) |
10.1056/NEJMP2005755 |
| 2020-03-20 |
Early Introduction of Severe Acute Respiratory Syndrome Coronavirus 2 into Europe (edit) |
10.3201/EID2607.200359 |
| 2020-03-20 |
Rhabdomyolysis as Potential Late Complication Associated with COVID-19 (edit) |
10.3201/EID2607.200445 |
| 2020-03-20 |
Managing Cancer Care During the COVID-19 Pandemic: Agility and Collaboration Toward a Common Goal (edit) |
10.6004/JNCCN.2020.7560 |
| 2020-03-20 |
Mitigating Risk of COVID-19 in Dialysis Facilities (edit) |
10.2215/CJN.03340320 |
| 2020-03-20 |
Covid-19: control measures must be equitable and inclusive (edit) |
10.1136/BMJ.M1141 |
| 2020-03-20 |
Covid-19: GPs can stop health checks for over 75s and routine medicine reviews (edit) |
10.1136/BMJ.M1157 |
| 2020-03-20 |
Covid-19: 15 000 deregistered doctors are told, "Your NHS needs you" (edit) |
10.1136/BMJ.M1152 |
| 2020-03-20 |
Hiding in Plain Sight: an Approach to Treating Patients with Severe COVID-19 Infection (edit) |
10.1128/MBIO.00398-20 |
| 2020-03-20 |
Challenges for NHS hospitals during covid-19 epidemic (edit) |
10.1136/BMJ.M1117 |
| 2020-03-20 |
Covid-19: experts question the evidence behind closing London Underground and city metros during the pandemic (edit) |
10.1136/BMJ.M1154 |
| 2020-03-20 |
Covid-19: cases grow in US as Trump pushes promise of a malaria drug (edit) |
10.1136/BMJ.M1155 |
| 2020-03-20 |
Covid-19: medical students to be employed by NHS as part of epidemic response (edit) |
10.1136/BMJ.M1156 |
| 2020-03-20 |
Practical laboratory considerations amidst the COVID-19 outbreak: early experience from Singapore (edit) |
10.1136/JCLINPATH-2020-206563 |
| 2020-03-20 |
Autopsy in suspected COVID-19 cases (edit) |
10.1136/JCLINPATH-2020-206522 |
| 2020-03-20 |
Covid-19 fatality is likely overestimated (edit) |
10.1136/BMJ.M1113 |
| 2020-03-20 |
A Unique Protease Cleavage Site Predicted in the Spike Protein of the Novel Pneumonia Coronavirus (2019-nCoV) Potentially Related to Viral Transmissibility (edit) |
10.1007/S12250-020-00212-7 |
| 2020-03-20 |
Case report of COVID-19 in a kidney transplant recipient: Does immunosuppression alter the clinical presentation? (edit) |
10.1111/AJT.15874 |
| 2020-03-20 |
Prolonged presence of SARS-CoV-2 viral RNA in faecal samples (edit) |
10.1016/S2468-1253(20)30083-2 |
| 2020-03-20 |
COVID-19: Impact on health of people & wealth of nations (edit) |
10.4103/IJMR.IJMR_664_20 |
| 2020-03-20 |
COVID-19 and the liver: little cause for concern (edit) |
10.1016/S2468-1253(20)30084-4 |
| 2020-03-20 |
Mass gathering events and reducing further global spread of COVID-19: a political and public health dilemma (edit) |
10.1016/S0140-6736(20)30681-4 |
| 2020-03-20 |
Treatment for severe acute respiratory distress syndrome from COVID-19 (edit) |
10.1016/S2213-2600(20)30127-2 |
| 2020-03-20 |
Rational use of face masks in the COVID-19 pandemic (edit) |
10.1016/S2213-2600(20)30134-X |
| 2020-03-20 |
Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases (edit) |
10.1016/S2213-2600(20)30121-1 |
| 2020-03-20 |
An update on CT chest findings in coronavirus disease-19 (COVID-19) (edit) |
10.1016/J.HRTLNG.2020.03.007 |
| 2020-03-20 |
Coronavirus Disease (COVID-19): Spectrum of CT Findings and Temporal Progression of the Disease (edit) |
10.1016/J.ACRA.2020.03.003 |
| 2020-03-20 |
Imaging Features of Coronavirus disease 2019 (COVID-19): Evaluation on Thin-Section CT (edit) |
10.1016/J.ACRA.2020.03.002 |
| 2020-03-20 |
A cured patient with 2019-nCoV pneumonia (edit) |
10.1016/J.AMJMED.2020.02.023 |
| 2020-03-20 |
One size does not fit all - Patterns of vulnerability and resilience in the COVID-19 pandemic and why heterogeneity of disease matters (edit) |
10.1016/J.BBI.2020.03.016 |
| 2020-03-20 |
Traumatization in medical staff helping with COVID-19 control (edit) |
10.1016/J.BBI.2020.03.020 |
| 2020-03-20 |
The index case of SARS-CoV-2 in Scotland: a case report (edit) |
10.1016/J.JINF.2020.03.022 |
| 2020-03-20 |
The Progression of Computed Tomographic (CT) Images in Patients with Coronavirus Disease (COVID-19) Pneumonia: The CT progression of COVID-19 pneumonia (edit) |
10.1016/J.JINF.2020.03.020 |
| 2020-03-20 |
Rapid response to COVID-19 outbreak in Northern Italy: how to convert a classic infectious disease ward into a COVID-19 response centre (edit) |
10.1016/J.JHIN.2020.03.020 |
| 2020-03-20 |
Don't overlook digestive symptoms in patients with 2019 novel coronavirus disease (COVID-19) (edit) |
10.1016/J.CGH.2020.03.043 |
| 2020-03-20 |
Buffer areas in emergency department to handle potential COVID-19 community infection in Taiwan (edit) |
10.1016/J.TMAID.2020.101635 |
| 2020-03-20 |
Rapid viral diagnosis and ambulatory management of suspected COVID-19 cases presenting at the infectious diseases referral hospital in Marseille, France, - January 31st to March 1st, 2020: A respiratory virus snapshot (edit) |
10.1016/J.TMAID.2020.101632 |
| 2020-03-20 |
Should the Holy Week 2020 be cancelled in Latin America due to the COVID-19 pandemic? (edit) |
10.1016/J.TMAID.2020.101633 |
| 2020-03-20 |
COVID-19: Facemask use prevalence in international airports in Asia, Europe and the Americas, March 2020 (edit) |
10.1016/J.TMAID.2020.101637 |
| 2020-03-20 |
COVID-19: Active measures to support community-dwelling older adults (edit) |
10.1016/J.TMAID.2020.101638 |
| 2020-03-20 |
Epidemiological, clinical characteristics of cases of SARS-CoV-2 infection with abnormal imaging findings (edit) |
10.1016/J.IJID.2020.03.040 |
| 2020-03-20 |
COVID-19 Disease With Positive Fecal and Negative Pharyngeal and Sputum Viral Tests (edit) |
10.14309/AJG.0000000000000610 |
| 2020-03-20 |
Deep Learning Localization of Pneumonia: 2019 Coronavirus (COVID-19) Outbreak (edit) |
10.1097/RTI.0000000000000512 |
| 2020-03-20 |
Mediastinal Emphysema, Giant Bulla, and Pneumothorax Developed during the Course of COVID-19 Pneumonia (edit) |
10.3348/KJR.2020.0180 |
| 2020-03-20 |
Key Considerations for Radiologists When Diagnosing the Novel Coronavirus Disease (COVID-19) (edit) |
10.3348/KJR.2020.0190 |
| 2020-03-20 |
A Patient with COVID-19 Presenting a False-Negative Reverse Transcriptase Polymerase Chain Reaction Result (edit) |
10.3348/KJR.2020.0195 |
| 2020-03-20 |
Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 (COVID-19) in Wuhan, China: a retrospective study (edit) |
10.1097/CM9.0000000000000824 |
| 2020-03-20 |
An Ounce of Prevention: Coronavirus (COVID-19) and Mass Gatherings (edit) |
10.7759/CUREUS.7345 |
| 2020-03-20 |
The psychological impact of the COVID-19 epidemic on college students in China (edit) |
10.1016/J.PSYCHRES.2020.112934 |
| 2020-03-20 |
Smoking Upregulates Angiotensin-Converting Enzyme-2 Receptor: A Potential Adhesion Site for Novel Coronavirus SARS-CoV-2 (Covid-19) (edit) |
10.3390/JCM9030841 |
| 2020-03-20 |
Kidney disease is associated with in-hospital death of patients with COVID-19 (edit) |
10.1016/J.KINT.2020.03.005 |
| 2020-03-20 |
Clinical trials on drug repositioning for COVID-19 treatment (edit) |
10.26633/RPSP.2020.40 |
| 2020-03-20 |
Is There a Role for Tissue Plasminogen Activator (tPA) as a Novel Treatment for Refractory COVID-19 Associated Acute Respiratory Distress Syndrome (ARDS)? (edit) |
10.1097/TA.0000000000002694 |
| 2020-03-20 |
The preventive strategies of community hospital in the battle of fighting pandemic COVID-19 in Taiwan (edit) |
10.1016/J.JMII.2020.03.019 |
| 2020-03-20 |
A Promising Anti-Cytokine-Storm Targeted Therapy for COVID-19: The Artificial-Liver Blood-Purification System (edit) |
10.1016/J.ENG.2020.03.006 |
| 2020-03-20 |
Early reflection on the global impact of COVID19, and implications for physiotherapy (edit) |
10.1016/J.PHYSIO.2020.03.003 |
| 2020-03-20 |
Homology Modeling of TMPRSS2 Yields Candidate Drugs That May Inhibit Entry of SARS-CoV-2 into Human Cells (edit) |
10.26434/CHEMRXIV.12009582 |
| 2020-03-20 |
SARS-CoV-2 (edit) |
10.1097/JBR.0000000000000063 |
| 2020-03-20 |
COVID-19, SARS-CoV2, INFECTION: CURRENT EPIDEMIOLOGICAL ANALYSIS AND MODELING OF DISEASE (edit) |
10.21673/ANADOLUKLIN.707038 |
| 2020-03-19 |
Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China (edit) |
10.1038/S41591-020-0822-7 |
| 2020-03-19 |
New blood tests for antibodies could show true scale of coronavirus pandemic (edit) |
10.1126/SCIENCE.ABB8028 |
| 2020-03-19 |
COVID-19, Australia: Epidemiology Report 7: Reporting week ending 19:00 AEDT 14 March 2020 (edit) |
10.33321/CDI.2020.44.23 |
| 2020-03-19 |
COVID-19 pandemic: perspectives on an unfolding crisis (edit) |
10.1002/BJS.11627 |
| 2020-03-19 |
Forecasting of COVID-19 Confirmed Cases in Different Countries with ARIMA Models (edit) |
10.1101/2020.03.13.20035345 |
| 2020-03-19 |
Is a 14-day quarantine period optimal for effectively controlling coronavirus disease 2019 (COVID-19)? (edit) |
10.1101/2020.03.15.20036533 |
| 2020-03-19 |
Identification of FDA Approved Drugs Targeting COVID-19 Virus by Structure-Based Drug Repositioning (edit) |
10.26434/CHEMRXIV.12003930 |
| 2020-03-19 |
Clinical progression of patients with COVID-19 in Shanghai, China (edit) |
10.1016/J.JINF.2020.03.004 |
| 2020-03-19 |
SARS-CoV-2 enterocolitis with persisting to excrete the virus for approximately two weeks after recovering from diarrhea: A case report (edit) |
10.1017/ICE.2020.87 |
| 2020-03-19 |
[ACE2 in the context of 2019-nCoV infection: friend or foe?] (edit) |
10.3760/CMA.J.CN112148-20200303-00149 |
| 2020-03-19 |
Safety Considerations in the Laboratory Testing of Specimens Suspected or Known to Contain the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (edit) |
10.1093/AJCP/AQAA047 |
| 2020-03-19 |
Alert for non-respiratory symptoms of Coronavirus Disease 2019 (COVID-19) patients in epidemic period: A case report of familial cluster with three asymptomatic COVID-19 patients (edit) |
10.1002/JMV.25776 |
| 2020-03-19 |
A doubt of multiple introduction of SARS-CoV-2 in Italy: A preliminary overview (edit) |
10.1002/JMV.25773 |
| 2020-03-19 |
Should patients stop their biologic treatment during the COVID-19 pandemic (edit) |
10.1080/09546634.2020.1742438 |
| 2020-03-19 |
Serial Interval of COVID-19 among Publicly Reported Confirmed Cases (edit) |
10.3201/EID2606.200357 |
| 2020-03-19 |
Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State (edit) |
10.1001/JAMA.2020.4326 |
| 2020-03-19 |
Securing the Safety Net and Protecting Public Health During a Pandemic: Medicaid's Response to COVID-19 (edit) |
10.1001/JAMA.2020.4272 |
| 2020-03-19 |
Temporal Changes of CT Findings in 90 Patients with COVID-19 Pneumonia: A Longitudinal Study (edit) |
10.1148/RADIOL.2020200843 |
| 2020-03-19 |
Artificial Intelligence Distinguishes COVID-19 from Community Acquired Pneumonia on Chest CT (edit) |
10.1148/RADIOL.2020200905 |
| 2020-03-19 |
The critical role of laboratory medicine during coronavirus disease 2019 (COVID-19) and other viral outbreaks (edit) |
10.1515/CCLM-2020-0240 |
| 2020-03-19 |
WHO Declares COVID-19 a Pandemic (edit) |
10.23750/ABM.V91I1.9397 |
| 2020-03-19 |
Natural small molecules as inhibitors of coronavirus lipid-dependent attachment to host cells: a possible strategy for reducing SARS-COV-2 infectivity? (edit) |
10.23750/ABM.V91I1.9402 |
| 2020-03-19 |
COVID-19 epidemic in Switzerland: on the importance of testing, contact tracing and isolation (edit) |
10.4414/SMW.2020.20225 |
| 2020-03-19 |
Co-infection with SARS-CoV-2 and Human Metapneumovirus (edit) |
|
| 2020-03-19 |
Partha Kar: Covid-19-we must keep faith in our experts (edit) |
10.1136/BMJ.M1143 |
| 2020-03-19 |
Covid-19: schools set to close across UK except for children of health and social care workers (edit) |
10.1136/BMJ.M1140 |
| 2020-03-19 |
Covid-19: UK government calls on industry to help boost testing capacity to 25 000 people a day (edit) |
10.1136/BMJ.M1118 |
| 2020-03-19 |
CT appearance of severe, laboratory-proven coronavirus disease 2019 (COVID-19) in a Caucasian patient in Berlin, Germany (edit) |
10.1055/A-1138-8783 |
| 2020-03-19 |
Probable Pangolin Origin of SARS-CoV-2 Associated with the COVID-19 Outbreak (edit) |
10.1016/J.CUB.2020.03.022 |
| 2020-03-19 |
Use of antiviral drugs to reduce COVID-19 transmission (edit) |
10.1016/S2214-109X(20)30114-5 |
| 2020-03-19 |
The global community needs to swiftly ramp up the response to contain COVID-19 (edit) |
10.1016/S0140-6736(20)30679-6 |
| 2020-03-19 |
COVID-19 and the consequences of isolating the elderly (edit) |
10.1016/S2468-2667(20)30061-X |
| 2020-03-19 |
Viral dynamics in mild and severe cases of COVID-19 (edit) |
10.1016/S1473-3099(20)30232-2 |
| 2020-03-19 |
Estimation of COVID-19 outbreak size in Italy (edit) |
10.1016/S1473-3099(20)30227-9 |
| 2020-03-19 |
The outbreak of Coronavirus Disease 2019 (COVID-19)-An emerging global health threat (edit) |
10.1016/J.JIPH.2020.02.033 |
| 2020-03-19 |
Global epidemiology of coronavirus disease 2019 (COVID-19): disease incidence, daily cumulative index, mortality, and their association with country healthcare resources and economic status (edit) |
10.1016/J.IJANTIMICAG.2020.105946 |
| 2020-03-19 |
Letter from Italy: First practical indications for radiation therapy departments during COVID-19 outbreak (edit) |
10.1016/J.IJROBP.2020.03.007 |
| 2020-03-19 |
Predicting the angiotensin converting enzyme 2 (ACE2) utilizing capability as the receptor of SARS-CoV-2 (edit) |
10.1016/J.MICINF.2020.03.003 |
| 2020-03-19 |
[SARS-CoV-2 infection during pregnancy. Information and proposal of management care. CNGOF] (edit) |
10.1016/J.GOFS.2020.03.014 |
| 2020-03-19 |
High-flow nasal-oxygenation-assisted fibreoptic tracheal intubation in critically ill patients with COVID-19 pneumonia: a prospective randomised controlled trial (edit) |
10.1016/J.BJA.2020.02.020 |
| 2020-03-19 |
Contact lens practice in the time of COVID-19 (edit) |
10.1016/J.CLAE.2020.03.007 |
| 2020-03-19 |
Spike protein recognition of mammalian ACE2 predicts the host range and an optimized ACE2 for SARS-CoV-2 infection (edit) |
10.1016/J.BBRC.2020.03.047 |
| 2020-03-19 |
The evolution of CT characteristics in the patients with COVID-19 pneumonia (edit) |
10.1016/J.JINF.2020.03.014 |
| 2020-03-19 |
Multiple parameters required for diagnosis of COVID-19 in clinical practice (edit) |
10.1016/J.JINF.2020.03.016 |
| 2020-03-19 |
Managing COVID-19 in the oncology clinic and avoiding the distraction effect (edit) |
10.1016/J.ANNONC.2020.03.286 |
| 2020-03-19 |
Lack of SARS-CoV-2 RNA environmental contamination in a tertiary referral hospital for infectious diseases in Northern Italy (edit) |
10.1016/J.JHIN.2020.03.018 |
| 2020-03-19 |
SARS-CoV-2: fear versus data (edit) |
10.1016/J.IJANTIMICAG.2020.105947 |
| 2020-03-19 |
The Impact of COVID-19 Epidemic Declaration on Psychological Consequences: A Study on Active Weibo Users (edit) |
10.3390/IJERPH17062032 |
| 2020-03-19 |
The challenge of emergency medicine facing the COVID-19 outbreak (edit) |
10.1097/MEJ.0000000000000699 |
| 2020-03-19 |
Bronchoscopy in the Age of COVID-19 (edit) |
10.1097/LBR.0000000000000682 |
| 2020-03-19 |
Do children need a longer time to shed SARS-CoV-2 in stool than adults? (edit) |
10.1016/J.JMII.2020.03.010 |
| 2020-03-19 |
Evolving reporting criteria of COVID-19 in Taiwan during the epidemic (edit) |
10.1016/J.JMII.2020.03.014 |
| 2020-03-19 |
Impact of COVID-19 infection on pregnancy outcomes and the risk of maternal-to-neonatal intrapartum transmission of COVID-19 during natural birth (edit) |
10.1017/ICE.2020.84 |
| 2020-03-19 |
The COVID-19 pandemic: The 'black swan' for mental health care and a turning point for e-health (edit) |
10.1016/J.INVENT.2020.100317 |
| 2020-03-19 |
A systematic approach is needed to contain COVID-19 globally (edit) |
10.1016/J.SCIB.2020.03.024 |
| 2020-03-19 |
Mesenchymal stem cells and management of COVID-19 pneumonia (edit) |
10.1016/J.MEDIDD.2020.100019 |
| 2020-03-18 |
The crystal structure of Nsp9 RNA binding protein of SARS CoV-2 (edit) |
10.2210/PDB6W4B/PDB |
| 2020-03-18 |
Crystal structure of SARS-CoV-2 spike receptor-binding domain bound with ACE2 (edit) |
10.2210/PDB6M0J/PDB |
| 2020-03-18 |
1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2 (edit) |
10.2210/PDB6W4H/PDB |
| 2020-03-18 |
Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain (edit) |
10.2210/PDB6M3M/PDB |
| 2020-03-18 |
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19 (edit) |
10.1056/NEJMOA2001282 |
| 2020-03-18 |
A serological assay to detect SARS-CoV-2 seroconversion in humans (edit) |
10.1101/2020.03.17.20037713 |
| 2020-03-18 |
SARS-CoV-2, the Virus that Causes COVID-19: Cytometry and the New Challenge for Global Health (edit) |
10.1002/CYTO.A.24002 |
| 2020-03-18 |
The Cholera Epidemics in Hamburg and What to Learn for COVID-19 (SARS-CoV-2) (edit) |
10.1002/CYTO.A.23999 |
| 2020-03-18 |
Efficient inactivation of SARS-CoV-2 by WHO-recommended hand rub formulations and alcohols (edit) |
10.1101/2020.03.10.986711 |
| 2020-03-18 |
The effects of border control and quarantine measures on global spread of COVID-19 (edit) |
10.1101/2020.03.13.20035261 |
| 2020-03-18 |
Multi-city modeling of epidemics using spatial networks: Application to 2019-nCov (COVID-19) coronavirus in India (edit) |
10.1101/2020.03.13.20035386 |
| 2020-03-18 |
Serological immunochromatographic approach in diagnosis with SARS-CoV-2 infected COVID-19 patients (edit) |
10.1101/2020.03.13.20035428 |
| 2020-03-18 |
Clinical characteristics and durations of hospitalized patients with COVID-19 in Beijing: a retrospective cohort study (edit) |
10.1101/2020.03.13.20035436 |
| 2020-03-18 |
Comparative Performance of SARS-CoV-2 Detection Assays using Seven Different Primer/Probe Sets and One Assay Kit (edit) |
10.1101/2020.03.13.20035618 |
| 2020-03-18 |
Epidemiological Trends of Coronavirus Disease 2019 in China (edit) |
10.1101/2020.03.13.20035642 |
| 2020-03-18 |
Excess cases of Influenza like illnesses in France synchronous with COVID19 invasion. (edit) |
10.1101/2020.03.14.20035741 |
| 2020-03-18 |
Expected impact of COVID-19 outbreak in a major metropolitan area in Brazil (edit) |
10.1101/2020.03.14.20035873 |
| 2020-03-18 |
Assessment of public attention, risk perception, emotional and behavioural responses to the COVID-19 outbreak: social media surveillance in China (edit) |
10.1101/2020.03.14.20035956 |
| 2020-03-18 |
Tracking the Covid-19 pandemic : Simple visualization of the epidemic states and trajectories of select European countries & assessing the effects of delays in official response. (edit) |
10.1101/2020.03.14.20035964 |
| 2020-03-18 |
Indications for healthcare surge capacity in European countries facing an exponential increase in COVID19 cases (edit) |
10.1101/2020.03.14.20035980 |
| 2020-03-18 |
CoViD--19: An Automatic, Semiparametric Estimation Method for the Population Infected in Italy (edit) |
10.1101/2020.03.14.20036103 |
| 2020-03-18 |
Highly accurate and sensitive diagnostic detection of SARS-CoV-2 by digital PCR (edit) |
10.1101/2020.03.14.20036129 |
| 2020-03-18 |
Correcting under-reported COVID-19 case numbers (edit) |
10.1101/2020.03.14.20036178 |
| 2020-03-18 |
Propagation analysis and prediction of the COVID-19 (edit) |
10.1101/2020.03.14.20036202 |
| 2020-03-18 |
Blood single cell immune profiling reveals the interferon-MAPK pathway mediated adaptive immune response for COVID-19 (edit) |
10.1101/2020.03.15.20033472 |
| 2020-03-18 |
Temporal relationship between outbound traffic from Wuhan and the 2019 coronavirus disease (COVID-19) incidence in China (edit) |
10.1101/2020.03.15.20034199 |
| 2020-03-18 |
A high efficient hospital emergency responsive mode is the key of successful treatment of 100 COVID-19 patients in Zhuhai (edit) |
10.1101/2020.03.15.20034629 |
| 2020-03-18 |
International expansion of a novel SARS-CoV-2 mutant (edit) |
10.1101/2020.03.15.20035204 |
| 2020-03-18 |
Demographic science aids in understanding the spread and fatality rates of COVID-19 (edit) |
10.1101/2020.03.15.20036293 |
| 2020-03-18 |
The clinical and epidemiological features and hints of 82 confirmed COVID-19 pediatric cases aged 0-16 in Wuhan, China (edit) |
10.1101/2020.03.15.20036319 |
| 2020-03-18 |
Coronavirus disease-19: Summary of 2,370 Contact Investigations of the First 30 Cases in the Republic of Korea (edit) |
10.1101/2020.03.15.20036350 |
| 2020-03-18 |
Coronavirus disease-19: The First 7,755 Cases in the Republic of Korea (edit) |
10.1101/2020.03.15.20036368 |
| 2020-03-18 |
Routes for COVID-19 importation in Brazil (edit) |
10.1101/2020.03.15.20036392 |
| 2020-03-18 |
Understanding Epidemic Data and Statistics: A case study of COVID-19 (edit) |
10.1101/2020.03.15.20036418 |
| 2020-03-18 |
Effects of temperature variation and humidity on the mortality of COVID-19 in Wuhan (edit) |
10.1101/2020.03.15.20036426 |
| 2020-03-18 |
Transmissibility of coronavirus disease 2019 (COVID-19) in Chinese cities with different transmission dynamics of imported cases (edit) |
10.1101/2020.03.15.20036541 |
| 2020-03-18 |
Estimating unobserved SARS-CoV-2 infections in the United States (edit) |
10.1101/2020.03.15.20036582 |
| 2020-03-18 |
Effect of large-scale testing platform in prevention and control of the COVID-19 pandemic: an empirical study with a novel numerical model (edit) |
10.1101/2020.03.15.20036624 |
| 2020-03-18 |
Stability of SARS-CoV-2 in different environmental conditions (edit) |
10.1101/2020.03.15.20036673 |
| 2020-03-18 |
Computational analysis of microRNA-mediated interactions in SARS-CoV-2 infection (edit) |
10.1101/2020.03.15.992438 |
| 2020-03-18 |
An emergent clade of SARS-CoV-2 linked to returned travellers from Iran (edit) |
10.1101/2020.03.15.992818 |
| 2020-03-18 |
A Cryptic Site of Vulnerability on the Receptor Binding Domain of the SARS-CoV-2 Spike Glycoprotein (edit) |
10.1101/2020.03.15.992883 |
| 2020-03-18 |
Master Regulator Analysis of the SARS-CoV-2/Human interactome (edit) |
10.1101/2020.03.15.992925 |
| 2020-03-18 |
Cross-reactive antibody response between SARS-CoV-2 and SARS-CoV infections (edit) |
10.1101/2020.03.15.993097 |
| 2020-03-18 |
Acute myelitis after SARS-CoV-2 infection: a case report. (edit) |
10.1101/2020.03.16.20035105 |
| 2020-03-18 |
Recapitulation of SARS-CoV-2 Infection and Cholangiocyte Damage with Human Liver Organoids (edit) |
10.1101/2020.03.16.990317 |
| 2020-03-18 |
Structure of RNA-dependent RNA polymerase from 2019-nCoV, a major antiviral drug target (edit) |
10.1101/2020.03.16.993386 |
| 2020-03-18 |
Multiple approaches for massively parallel sequencing of HCoV-19 (SARS-CoV-2) genomes directly from clinical samples (edit) |
10.1101/2020.03.16.993584 |
| 2020-03-18 |
Evidence of the Recombinant Origin and Ongoing Mutations in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (edit) |
10.1101/2020.03.16.993816 |
| 2020-03-18 |
The sequence of human ACE2 is suboptimal for binding the S spike protein of SARS coronavirus 2 (edit) |
10.1101/2020.03.16.994236 |
| 2020-03-18 |
Comparative Pathogenesis Of COVID-19, MERS And SARS In A Non-Human Primate Model (edit) |
10.1101/2020.03.17.995639 |
| 2020-03-18 |
Safe patient transport for COVID-19 (edit) |
10.1186/S13054-020-2828-4 |
| 2020-03-18 |
The difference in the incubation period of 2019 novel coronavirus (SARS-CoV-2) infection between travelers to Hubei and nontravelers: The need for a longer quarantine period (edit) |
10.1017/ICE.2020.81 |
| 2020-03-18 |
Presidential Powers and Response to COVID-19 (edit) |
10.1001/JAMA.2020.4335 |
| 2020-03-18 |
Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19 (edit) |
10.1093/JTM/TAAA041 |
| 2020-03-18 |
COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics (edit) |
10.1080/21645515.2020.1735227 |
| 2020-03-18 |
COVID-19: Social distancing, ACE 2 receptors, protease inhibitors and beyond? (edit) |
10.1111/IJCP.13503 |
| 2020-03-18 |
SARS-CoV-2 Infection in Children (edit) |
10.1056/NEJMC2005073 |
| 2020-03-18 |
Facing Covid-19 in Italy - Ethics, Logistics, and Therapeutics on the Epidemic's Front Line (edit) |
10.1056/NEJMP2005492 |
| 2020-03-18 |
Covid-19 - The Law and Limits of Quarantine (edit) |
10.1056/NEJMP2004211 |
| 2020-03-18 |
Covid-19 - The Search for Effective Therapy (edit) |
10.1056/NEJME2005477 |
| 2020-03-18 |
COVID-19 – Information der AG Thoraxdiagnostik der Deutschen Röntgengesellschaft (edit) |
10.1055/A-1112-8430 |
| 2020-03-18 |
COVID-19 infection epidemic: the medical management strategies in Heilongjiang Province, China (edit) |
10.1186/S13054-020-2832-8 |
| 2020-03-18 |
Host susceptibility to severe COVID-19 and establishment of a host risk score: findings of 487 cases outside Wuhan (edit) |
10.1186/S13054-020-2833-7 |
| 2020-03-18 |
Covid-19: pregnant doctors should speak to occupational health, say experts (edit) |
10.1136/BMJ.M1104 |
| 2020-03-18 |
Covid-19 exposes weaknesses in European response to outbreaks (edit) |
10.1136/BMJ.M1075 |
| 2020-03-18 |
Covid-19: how doctors and healthcare systems are tackling coronavirus worldwide (edit) |
10.1136/BMJ.M1090 |
| 2020-03-18 |
Covid-19: all non-urgent elective surgery is suspended for at least three months in England (edit) |
10.1136/BMJ.M1106 |
| 2020-03-18 |
COVID-19: Knowns, Unknowns, and Questions (edit) |
10.1128/MSPHERE.00203-20 |
| 2020-03-18 |
Journal Flexibility in the Troubling Times of COVID-19 (edit) |
10.1105/TPC.20.00223 |
| 2020-03-18 |
Correction to: COVID-19: a novel coronavirus and a novel challenge for critical care (edit) |
10.1007/S00134-020-06009-2 |
| 2020-03-18 |
Lower mortality of COVID-19 by early recognition and intervention: experience from Jiangsu Province (edit) |
10.1186/S13613-020-00650-2 |
| 2020-03-18 |
There may be virus in conjunctival secretion of patients with COVID-19 (edit) |
10.1111/AOS.14413 |
| 2020-03-18 |
The possibility of COVID-19 transmission from eye to nose (edit) |
10.1111/AOS.14412 |
| 2020-03-18 |
Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro (edit) |
10.1038/S41421-020-0156-0 |
| 2020-03-18 |
American Association for Bronchology and Interventional Pulmonology (AABIP) Statement on the Use of Bronchoscopy and Respiratory Specimen Collection in Patients with Suspected or Confirmed COVID-19 Infection (edit) |
10.1097/LBR.0000000000000681 |
| 2020-03-18 |
Point-of-Care RNA-Based Diagnostic Device for COVID-19 (edit) |
10.3390/DIAGNOSTICS10030165 |
| 2020-03-18 |
Advance of promising targets and agents against 2019-nCoV in China (edit) |
10.1016/J.DRUDIS.2020.02.011 |
| 2020-03-18 |
Transmission potential and severity of COVID-19 in South Korea (edit) |
10.1016/J.IJID.2020.03.031 |
| 2020-03-18 |
COVID-19 in Italy: momentous decisions and many uncertainties (edit) |
10.1016/S2214-109X(20)30110-8 |
| 2020-03-18 |
COVID-19 battle during the toughest sanctions against Iran (edit) |
10.1016/S0140-6736(20)30668-1 |
| 2020-03-18 |
Will COVID-19 generate global preparedness? (edit) |
10.1016/S0140-6736(20)30559-6 |
| 2020-03-18 |
Health security capacities in the context of COVID-19 outbreak: an analysis of International Health Regulations annual report data from 182 countries (edit) |
10.1016/S0140-6736(20)30553-5 |
| 2020-03-18 |
Should biologics for psoriasis be interrupted in the era of COVID-19? (edit) |
10.1016/J.JAAD.2020.03.031 |
| 2020-03-18 |
SARS-CoV-2 turned positive in a discharged patient with COVID-19 arouses concern regarding the present standard for discharge (edit) |
10.1016/J.IJID.2020.03.007 |
| 2020-03-18 |
Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the Coronavirus Disease 2019 (COVID-19) Pandemic (edit) |
10.1016/J.JACC.2020.03.031 |
| 2020-03-18 |
South Korea is reporting intimate details of COVID-19 cases: has it helped? (edit) |
10.1038/D41586-020-00740-Y |
| 2020-03-18 |
Role of changes in SARS-CoV-2 spike protein in the interaction with the human ACE2 receptor: An in silico analysis (edit) |
10.17179/EXCLI2020-1167 |
| 2020-03-18 |
[The novel coronavirus covid-19 pandemic] (edit) |
10.31053/1853.0605.V77.N1.27935 |
| 2020-03-18 |
We have to write and share valid and reliable information on COVID-19 (edit) |
|
| 2020-03-18 |
COVID-19 Personal Protective Equipment (PPE) for the emergency physician (edit) |
10.1016/J.VISJ.2020.100740 |
| 2020-03-18 |
Progress and prospect on imaging diagnosis of COVID-19 (edit) |
10.1007/S42058-020-00031-5 |
| 2020-03-18 |
An Epidemiological Study on COVID-19: A Rapidly Spreading Disease (edit) |
10.7759/CUREUS.7313 |
| 2020-03-17 |
Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1 (edit) |
10.1056/NEJMC2004973 |
| 2020-03-17 |
The spread of the COVID ‐19 coronavirus (edit) |
10.15252/EMBR.202050334 |
| 2020-03-17 |
Coronavirus Disease 2019 (COVID-19) in Italy (edit) |
10.1001/JAMA.2020.4344 |
| 2020-03-17 |
Deep Learning-based Detection for COVID-19 from Chest CT using Weak Label (edit) |
10.1101/2020.03.12.20027185 |
| 2020-03-17 |
Mental health status among family members of health care workers in Ningbo, China during the Coronavirus Disease 2019 (COVID-19) outbreak: a Cross-sectional Study (edit) |
10.1101/2020.03.13.20033290 |
| 2020-03-17 |
A Cybernetics-based Dynamic Infection Model for Analyzing SARS-COV-2 Infection Stability and Predicting Uncontrollable Risks (edit) |
10.1101/2020.03.13.20034082 |
| 2020-03-17 |
If containment is not possible, how do we minimize mortality for COVID-19 and other emerging infectious disease outbreaks? (edit) |
10.1101/2020.03.13.20034892 |
| 2020-03-17 |
Impacts of social and economic factors on the transmission of coronavirus disease (COVID-19) in China (edit) |
10.1101/2020.03.13.20035238 |
| 2020-03-17 |
Impact of city and residential unit lockdowns on prevention and control of COVID-19 (edit) |
10.1101/2020.03.13.20035253 |
| 2020-03-17 |
Wuhan and Hubei COVID-19 mortality analysis reveals the critical role of timely supply of medical resources (edit) |
10.1101/2020.03.13.20035410 |
| 2020-03-17 |
Impact of the contact and exclusion rates on the spread of COVID-19 pandemic (edit) |
10.1101/2020.03.13.20035485 |
| 2020-03-17 |
Using rapid online surveys to assess perceptions during infectious disease outbreaks: a cross-sectional survey on Covid-19 among the general public in the United States and United Kingdom (edit) |
10.1101/2020.03.13.20035568 |
| 2020-03-17 |
Modelling the epidemic 2019-nCoV event in Italy: a preliminary note (edit) |
10.1101/2020.03.14.20034884 |
| 2020-03-17 |
RBD mutations from circulating SARS-CoV-2 strains enhance the structural stability and human ACE2 affinity of the spike protein (edit) |
10.1101/2020.03.15.991844 |
| 2020-03-17 |
Characterization of the SARS-CoV-2 Spike in an Early Prefusion Conformation (edit) |
10.1101/2020.03.16.994152 |
| 2020-03-17 |
A Diabetic Patient With 2019-nCoV (COVID-19) Infection Who Recovered and Was Discharged From Hospital (edit) |
10.1097/RTI.0000000000000506 |
| 2020-03-17 |
Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26 (edit) |
10.1080/22221751.2020.1739565 |
| 2020-03-17 |
A 55-Day-Old Female Infant infected with COVID 19: presenting with pneumonia, liver injury, and heart damage (edit) |
10.1093/INFDIS/JIAA113 |
| 2020-03-17 |
An Analysis of 38 Pregnant Women with COVID-19, Their Newborn Infants, and Maternal-Fetal Transmission of SARS-CoV-2: Maternal Coronavirus Infections and Pregnancy Outcomes (edit) |
10.5858/ARPA.2020-0901-SA |
| 2020-03-17 |
Correlation between travellers departing from Wuhan before the Spring Festival and subsequent spread of COVID-19 to all provinces in China (edit) |
10.1093/JTM/TAAA036 |
| 2020-03-17 |
The positive impact of lockdown in Wuhan on containing the COVID-19 outbreak in China (edit) |
10.1093/JTM/TAAA037 |
| 2020-03-17 |
Early Clinical and CT Manifestations of Coronavirus Disease 2019 (COVID-19) Pneumonia (edit) |
10.2214/AJR.20.22961 |
| 2020-03-17 |
Epidemiologic and Clinical Characteristics of 91 Hospitalized Patients with COVID-19 in Zhejiang, China: A retrospective, multi-centre case series (edit) |
10.1093/QJMED/HCAA089 |
| 2020-03-17 |
A guideline for homology modeling of the proteins from newly discovered betacoronavirus, 2019 novel coronavirus (2019-nCoV) (edit) |
10.1002/JMV.25768 |
| 2020-03-17 |
Under the epidemic situation of COVID-19, should special attention to pregnant women be given? (edit) |
10.1002/JMV.25771 |
| 2020-03-17 |
Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19 (edit) |
10.1002/JMV.25770 |
| 2020-03-17 |
Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on ST-Segment-Elevation Myocardial Infarction Care in Hong Kong, China (edit) |
10.1161/CIRCOUTCOMES.120.006631 |
| 2020-03-17 |
Perinatal Transmission of COVID-19 Associated SARS-CoV-2: Should We Worry? (edit) |
10.1093/CID/CIAA226 |
| 2020-03-17 |
Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review (edit) |
10.1186/S40249-020-00646-X |
| 2020-03-17 |
Working together to contain and manage COVID-19 (edit) |
10.1503/CMAJ.200428 |
| 2020-03-17 |
Covid-19: UK starts social distancing after new model points to 260 000 potential deaths (edit) |
10.1136/BMJ.M1089 |
| 2020-03-17 |
Covid-19: Doctors warn of humanitarian catastrophe at Europe's largest refugee camp (edit) |
10.1136/BMJ.M1097 |
| 2020-03-17 |
Covid-19: BMA calls for rapid testing and appropriate protective equipment for doctors (edit) |
10.1136/BMJ.M1099 |
| 2020-03-17 |
Covid-19: trainees will not move jobs in April (edit) |
10.1136/BMJ.M1088 |
| 2020-03-17 |
Covid-19: Trump sought to buy vaccine developer exclusively for US, say German officials (edit) |
10.1136/BMJ.M1100 |
| 2020-03-17 |
To control the covid-19 outbreak, young, healthy patients should avoid the emergency department (edit) |
10.1136/BMJ.M1040 |
| 2020-03-17 |
Covid-19 and community mitigation strategies in a pandemic (edit) |
10.1136/BMJ.M1066 |
| 2020-03-17 |
Helen Salisbury: What might we learn from the covid-19 pandemic? (edit) |
10.1136/BMJ.M1087 |
| 2020-03-17 |
COVID-19 pneumonia: infection control protocol inside computed tomography suites (edit) |
10.1007/S11604-020-00948-Y |
| 2020-03-17 |
A Trip through Southeast Asian Airports in Times of COVID19 (edit) |
10.4269/AJTMH.20-0153 |
| 2020-03-17 |
Covid-19: Slå ring! (edit) |
10.4045/TIDSSKR.20.0219 |
| 2020-03-17 |
Investigation of three clusters of COVID-19 in Singapore: implications for surveillance and response measures (edit) |
10.1016/S0140-6736(20)30528-6 |
| 2020-03-17 |
Preparedness is essential for malaria-endemic regions during the COVID-19 pandemic (edit) |
10.1016/S0140-6736(20)30561-4 |
| 2020-03-17 |
COVID-19: the need for continuous medical education and training (edit) |
10.1016/S2213-2600(20)30125-9 |
| 2020-03-17 |
Screening of faecal microbiota transplant donors during the COVID-19 outbreak: suggestions for urgent updates from an international expert panel (edit) |
10.1016/S2468-1253(20)30082-0 |
| 2020-03-17 |
Stepping Forward: Urologists' Efforts During the COVID-19 Outbreak in Singapore (edit) |
10.1016/J.EURURO.2020.03.004 |
| 2020-03-17 |
Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine (edit) |
10.1016/J.IJANTIMICAG.2020.105945 |
| 2020-03-17 |
Exuberant Plasmocytosis in Bronchoalveolar Lavage Specimen of the First Patient Requiring Extracorporeal Membrane Oxygenation for SARS-CoV-2 in Europe (edit) |
10.1016/J.JTHO.2020.03.008 |
| 2020-03-17 |
Computed Tomography Manifestations of 5 Cases of the Novel Coronavirus Disease 2019 (COVID-19) Pneumonia From Patients Outside Wuhan (edit) |
10.1097/RTI.0000000000000508 |
| 2020-03-17 |
Prevention of SARS-CoV-2 infection in patients with decompensated cirrhosis (edit) |
10.1016/S2468-1253(20)30080-7 |
| 2020-03-17 |
COVID-19 in pregnant women - Authors' reply (edit) |
10.1016/S1473-3099(20)30192-4 |
| 2020-03-17 |
COVID-19 in pregnant women (edit) |
10.1016/S1473-3099(20)30175-4 |
| 2020-03-17 |
COVID-19: towards controlling of a pandemic (edit) |
10.1016/S0140-6736(20)30673-5 |
| 2020-03-17 |
Evidence informing the UK's COVID-19 public health response must be transparent (edit) |
10.1016/S0140-6736(20)30667-X |
| 2020-03-17 |
Clinical course and mortality risk of severe COVID-19 (edit) |
10.1016/S0140-6736(20)30633-4 |
| 2020-03-17 |
Prisons and custodial settings are part of a comprehensive response to COVID-19 (edit) |
10.1016/S2468-2667(20)30058-X |
| 2020-03-17 |
What Should Gastroenterologists and Patients Know About COVID-19? (edit) |
10.1016/J.CGH.2020.03.020 |
| 2020-03-17 |
Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients (edit) |
10.1038/S41423-020-0401-3 |
| 2020-03-17 |
Diagnosis and Treatment Plan for COVID-19 (Trial Version 6) (edit) |
10.1097/CM9.0000000000000819 |
| 2020-03-17 |
COVID-19: a novel zoonotic disease caused by a coronavirus from China: what we know and what we don't (edit) |
10.1071/MA20013 |
| 2020-03-17 |
Daily Situation Report on Coronavirus disease (COVID-19) in Iran; March 17, 2020 (edit) |
|
| 2020-03-17 |
Understanding of guidance for acupuncture and moxibustion interventions on COVID-19 (Second edition) issued by CAAM (edit) |
10.1016/J.WJAM.2020.03.005 |
| 2020-03-17 |
Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus (edit) |
10.1128/JVI.00127-20 |
| 2020-03-17 |
The initial response of the laboratory diagnosis team to SARS-CoV-2 in Japan and the current situation (edit) |
10.1254/JPSSUPPL.93.0_2-ES-1 |
| 2020-03-17 |
Nonstructural proteins of Novel Coronavirus (SARS-CoV-2) (edit) |
10.1254/JPSSUPPL.93.0_2-ES-2 |
| 2020-03-17 |
Pay attention to SARS‐CoV‐2 infection in children (edit) |
10.1002/PED4.12178 |
| 2020-03-17 |
Optimising influenza vaccination during a SARS-CoV-2 epidemic in South Africa could help maintain the integrity of our healthcare system (edit) |
10.7196/SAMJ.2020.V110I4.14692 |
| 2020-03-17 |
The SARS-CoV-2 pandemic: An urgent need to relook at the training of the African health workforce (edit) |
10.7196/SAMJ.2020.V110I4.14713 |
| 2020-03-16 |
Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV2) (edit) |
10.1126/SCIENCE.ABB3221 |
| 2020-03-16 |
SARS-CoV-2 and COVID-19: The most important research questions (edit) |
10.1186/S13578-020-00404-4 |
| 2020-03-16 |
Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19 (edit) |
10.1038/S41591-020-0819-2 |
| 2020-03-16 |
Duration of viral detection in throat and rectum of a patient with COVID-19 (edit) |
10.1101/2020.03.07.20032052 |
| 2020-03-16 |
Active or latent tuberculosis increases susceptibility to COVID-19 and disease severity (edit) |
10.1101/2020.03.10.20033795 |
| 2020-03-16 |
Strongly heterogeneous transmission of COVID-19 in mainland China: local and regional variation (edit) |
10.1101/2020.03.10.20033852 |
| 2020-03-16 |
Estimation of the final size of the second phase of the coronavirus epidemic by the logistic model (edit) |
10.1101/2020.03.11.20024901 |
| 2020-03-16 |
Clinical features and outcomes of 2019 novel coronavirus-infected patients with cardiac injury (edit) |
10.1101/2020.03.11.20030957 |
| 2020-03-16 |
Relationship between the ABO Blood Group and the COVID-19 Susceptibility (edit) |
10.1101/2020.03.11.20031096 |
| 2020-03-16 |
Evaluating the effect of public health intervention on the global-wide spread trajectory of Covid-19 (edit) |
10.1101/2020.03.11.20033639 |
| 2020-03-16 |
Social distance and SARS memory: impact on the public awareness of 2019 novel coronavirus (COVID-19) outbreak (edit) |
10.1101/2020.03.11.20033688 |
| 2020-03-16 |
Generalized logistic growth modeling of the COVID-19 outbreak in 29 provinces in China and in the rest of the world (edit) |
10.1101/2020.03.11.20034363 |
| 2020-03-16 |
A Method to Model Outbreaks of New Infectious Diseases with Pandemic Potential such as COVID-19 (edit) |
10.1101/2020.03.11.20034512 |
| 2020-03-16 |
Environmental contamination of the SARS-CoV-2 in healthcare premises: An urgent call for protection for healthcare workers (edit) |
10.1101/2020.03.11.20034546 |
| 2020-03-16 |
Heat inactivation of serum interferes with the immunoanalysis of antibodies to SARS-CoV-2 (edit) |
10.1101/2020.03.12.20034231 |
| 2020-03-16 |
Rational evaluation of various epidemic models based on the COVID-19 data of China (edit) |
10.1101/2020.03.12.20034595 |
| 2020-03-16 |
Impact assessment of non-pharmaceutical interventions against COVID-19 and influenza in Hong Kong: an observational study (edit) |
10.1101/2020.03.12.20034660 |
| 2020-03-16 |
Ocular manifestations and clinical characteristics of 534 cases of COVID-19 in China: A cross-sectional study (edit) |
10.1101/2020.03.12.20034678 |
| 2020-03-16 |
Clinical Characteristics of 34 Children with Coronavirus Disease-2019 in the West of China: a Multiple-center Case Series (edit) |
10.1101/2020.03.12.20034686 |
| 2020-03-16 |
Spread of SARS-CoV-2 Coronavirus likely to be constrained by climate (edit) |
10.1101/2020.03.12.20034728 |
| 2020-03-16 |
Immunopathological characteristics of coronavirus disease 2019 cases in Guangzhou, China (edit) |
10.1101/2020.03.12.20034736 |
| 2020-03-16 |
Impact of self-imposed prevention measures and short-term government intervention on mitigating and delaying a COVID-19 epidemic (edit) |
10.1101/2020.03.12.20034827 |
| 2020-03-16 |
The first report of the prevalence of COVID-19 in Chronic myelogenous leukemia patients in the core epidemic area of China:multicentre, cross-sectional survey (edit) |
10.1101/2020.03.12.20034876 |
| 2020-03-16 |
Immune phenotyping based on neutrophil-to-lymphocyte ratio and IgG predicts disease severity and outcome for patients with COVID-19 (edit) |
10.1101/2020.03.12.20035048 |
| 2020-03-16 |
Preliminary evaluation of voluntary event cancellation as a countermeasure against the COVID-19 outbreak in Japan as of 11 March, 2020 (edit) |
10.1101/2020.03.12.20035220 |
| 2020-03-16 |
Health, distress, and life satisfaction of people one-month into COVID-19 outbreak in China (edit) |
10.1101/2020.03.13.20034496 |
| 2020-03-16 |
Triaging patients in the outbreak of the 2019 novel coronavirus (edit) |
10.1101/2020.03.13.20035212 |
| 2020-03-16 |
Influence factors of death risk among COVID-19 patients in Wuhan, China: a hospital-based case-cohort study (edit) |
10.1101/2020.03.13.20035329 |
| 2020-03-16 |
Structural and functional conservation of the programmed -1 ribosomal frameshift signal of SARS-CoV-2 (edit) |
10.1101/2020.03.13.991083 |
| 2020-03-16 |
Systematic review and meta-analysis of predictive symptoms and comorbidities for severe COVID-19 infection (edit) |
10.1101/2020.03.15.20035360 |
| 2020-03-16 |
The SARS-CoV-2 outbreak from a one health perspective (edit) |
10.1016/J.ONEHLT.2020.100127 |
| 2020-03-16 |
Prominent changes in blood coagulation of patients with SARS-CoV-2 infection (edit) |
10.1515/CCLM-2020-0188 |
| 2020-03-16 |
Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19) (edit) |
10.1515/CCLM-2020-0285 |
| 2020-03-16 |
Recommendations for anesthesia in patients suspected of COVID-19 Coronavirus infection (edit) |
10.4097/KJA.20110 |
| 2020-03-16 |
Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China (edit) |
10.1093/CID/CIAA270 |
| 2020-03-16 |
Report on the Epidemiological Features of Coronavirus Disease 2019 (COVID-19) Outbreak in the Republic of Korea from January 19 to March 2, 2020 (edit) |
10.3346/JKMS.2020.35.E112 |
| 2020-03-16 |
[Comparison of pathological changes and pathogenic mechanisms caused by H1N1 influenza virus, highly pathogenic H5N1 avian influenza virus, SARS-CoV, MERS-CoV and 2019-nCoV coronavirus] (edit) |
10.3760/CMA.J.CN112151-20200301-00155 |
| 2020-03-16 |
[Management strategies for patients with gynecological malignancies during the outbreak of COVID19] (edit) |
10.3760/CMA.J.CN112141-20200302-00168 |
| 2020-03-16 |
Impact of COVID-19 outbreak on rehabilitation services and Physical and Rehabilitation Medicine (PRM) physicians' activities in Italy. An official document of the Italian PRM Society (SIMFER) (edit) |
10.23736/S1973-9087.20.06256-5 |
| 2020-03-16 |
Radiology Department Preparedness for COVID-19: Radiology Scientific Expert Panel (edit) |
10.1148/RADIOL.2020200988 |
| 2020-03-16 |
COVID-19 and the Risk to Health Care Workers: A Case Report (edit) |
10.7326/L20-0175 |
| 2020-03-16 |
Estimation of Coronavirus Disease 2019 (COVID-19) Burden and Potential for International Dissemination of Infection From Iran (edit) |
10.7326/M20-0696 |
| 2020-03-16 |
Is novel coronavirus disease (COVID-19) transmitted through conjunctiva? (edit) |
10.1002/JMV.25753 |
| 2020-03-16 |
Potentially repurposing adamantanes for COVID-19 (edit) |
10.1002/JMV.25752 |
| 2020-03-16 |
Managing COVID-19 in Low- and Middle-Income Countries (edit) |
10.1001/JAMA.2020.4169 |
| 2020-03-16 |
Editorial Concern-Possible Reporting of the Same Patients With COVID-19 in Different Reports (edit) |
10.1001/JAMA.2020.3980 |
| 2020-03-16 |
Potential impact of seasonal forcing on a SARS-CoV-2 pandemic (edit) |
10.4414/SMW.2020.20224 |
| 2020-03-16 |
Treatment of COVID-19: old tricks for new challenges (edit) |
10.1186/S13054-020-2818-6 |
| 2020-03-16 |
Covid-19: junior doctor calls on colleagues to gather supplies for staff working long hours (edit) |
10.1136/BMJ.M1072 |
| 2020-03-16 |
On the front lines of coronavirus: the Italian response to covid-19 (edit) |
10.1136/BMJ.M1065 |
| 2020-03-16 |
Covid-19: medical schools are urged to fast-track final year students (edit) |
10.1136/BMJ.M1064 |
| 2020-03-16 |
Covid-19: outbreak could last until spring 2021 and see 7.9 million hospitalised in the UK (edit) |
10.1136/BMJ.M1071 |
| 2020-03-16 |
COVID-19 in Children: Initial Characterization of the Pediatric Disease (edit) |
10.1542/PEDS.2020-0834 |
| 2020-03-16 |
Epidemiology of COVID-19 Among Children in China (edit) |
10.1542/PEDS.2020-0702 |
| 2020-03-16 |
Clinical features of pediatric patients with COVID-19: a report of two family cluster cases (edit) |
10.1007/S12519-020-00356-2 |
| 2020-03-16 |
Brain Awareness Week, CoVID-19 infection and Neurological Sciences (edit) |
10.1007/S10072-020-04338-0 |
| 2020-03-16 |
Lidocaine during intubation and extubation in patients with coronavirus disease (COVID-19) (edit) |
10.1007/S12630-020-01627-2 |
| 2020-03-16 |
Safety and efficacy of different anesthetic regimens for parturients with COVID-19 undergoing Cesarean delivery: a case series of 17 patients (edit) |
10.1007/S12630-020-01630-7 |
| 2020-03-16 |
A Sequence Homology and Bioinformatic Approach Can Predict Candidate Targets for Immune Responses to SARS-CoV-2 (edit) |
10.1016/J.CHOM.2020.03.002 |
| 2020-03-16 |
Rapidly increasing cumulative incidence of coronavirus disease (COVID-19) in the European Union/European Economic Area and the United Kingdom, 1 January to 15 March 2020 (edit) |
10.2807/1560-7917.ES.2020.25.11.2000285 |
| 2020-03-16 |
Influenza-associated pneumonia as reference to assess seriousness of coronavirus disease (COVID-19) (edit) |
10.2807/1560-7917.ES.2020.25.11.2000258 |
| 2020-03-16 |
On the possibility of interrupting the coronavirus (COVID-19) epidemic based on the best available scientific evidence (edit) |
10.1590/1980-549720200021 |
| 2020-03-16 |
Covid-19: Vi som tror vi ikke kan hjelpe (edit) |
10.4045/TIDSSKR.20.0217 |
| 2020-03-16 |
COVID-19: consider cytokine storm syndromes and immunosuppression (edit) |
10.1016/S0140-6736(20)30628-0 |
| 2020-03-16 |
COVID-19: delay, mitigate, and communicate (edit) |
10.1016/S2213-2600(20)30128-4 |
| 2020-03-16 |
Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19) (edit) |
10.1016/J.EJIM.2020.03.014 |
| 2020-03-16 |
How Should the Rehabilitation Community Prepare for 2019-nCoV? (edit) |
10.1016/J.APMR.2020.03.003 |
| 2020-03-16 |
Could enhanced influenza and pneumococcal vaccination programs help limit the potential damage from SARS-CoV-2 to fragile health systems of southern hemisphere countries this winter? (edit) |
10.1016/J.IJID.2020.03.030 |
| 2020-03-16 |
Transmission of COVID-19 in the terminal stage of incubation period: a familial cluster (edit) |
10.1016/J.IJID.2020.03.027 |
| 2020-03-16 |
Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2 (edit) |
10.1038/S41421-020-0153-3 |
| 2020-03-16 |
Catheterization Laboratory Considerations During the Coronavirus (COVID-19) Pandemic: From ACC's Interventional Council and SCAI (edit) |
10.1016/J.JACC.2020.03.021 |
| 2020-03-16 |
Prevalence and predictors of PTSS during COVID-19 outbreak in China hardest-hit areas: Gender differences matter (edit) |
10.1016/J.PSYCHRES.2020.112921 |
| 2020-03-16 |
COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses (edit) |
10.1016/J.JARE.2020.03.005 |
| 2020-03-16 |
Daily Situation Report on Coronavirus disease (COVID-19) in Iran; March 16, 2020 (edit) |
|
| 2020-03-16 |
2019-nCoV-Pneumonie ähnelt radiologisch SARS und MERS (edit) |
10.1007/S15033-020-1801-X |
| 2020-03-16 |
Covid-19 current advice for pathologists (edit) |
10.32074/1591-951X-12-20 |
| 2020-03-16 |
The impact of the COVID-19 epidemic on the utilization of emergency dental services (edit) |
10.1016/J.JDS.2020.02.002 |
| 2020-03-16 |
Panic of Buying Toilet Papers: A Historical Memory or a Horrible Truth? Systematic Review of Gastrointestinal Manifestations of COVID-19 (edit) |
10.5812/HEPATMON.102729 |
| 2020-03-15 |
High sensitivity detection of coronavirus SARS-CoV-2 using multiplex PCR and a multiplex-PCR-based metagenomic method (edit) |
10.1101/2020.03.12.988246 |
| 2020-03-15 |
The architecture of SARS-CoV-2 transcriptome (edit) |
10.1101/2020.03.12.988865 |
| 2020-03-15 |
Nucleotide Analogues as Inhibitors of SARS-CoV Polymerase (edit) |
10.1101/2020.03.12.989186 |
| 2020-03-15 |
Rhesus macaques can be effectively infected with SARS-CoV-2 via ocular conjunctival route (edit) |
10.1101/2020.03.13.990036 |
| 2020-03-15 |
Reinfection could not occur in SARS-CoV-2 infected rhesus macaques (edit) |
10.1101/2020.03.13.990226 |
| 2020-03-15 |
Accurate Identification of SARS-CoV-2 from Viral Genome Sequences using Deep Learning (edit) |
10.1101/2020.03.13.990242 |
| 2020-03-15 |
Differential Antibody Recognition by Novel SARS-CoV-2 and SARS-CoV Spike Protein Receptor Binding Domains: Mechanistic Insights and Implications for the Design of Diagnostics and Therapeutics (edit) |
10.1101/2020.03.13.990267 |
| 2020-03-15 |
Dark Proteome of Newly Emerged SARS-CoV-2 in Comparison with Human and Bat Coronaviruses (edit) |
10.1101/2020.03.13.990598 |
| 2020-03-15 |
Development of CRISPR as a prophylactic strategy to combat novel coronavirus and influenza (edit) |
10.1101/2020.03.13.991307 |
| 2020-03-15 |
SARS-CoV-2 receptor ACE2 and TMPRSS2 are predominantly expressed in a transient secretory cell type in subsegmental bronchial branches (edit) |
10.1101/2020.03.13.991455 |
| 2020-03-15 |
A highly conserved cryptic epitope in the receptor-binding domains of SARS-CoV-2 and SARS-CoV (edit) |
10.1101/2020.03.13.991570 |
| 2020-03-15 |
SARS-CoV-2 invades host cells via a novel route: CD147-spike protein (edit) |
10.1101/2020.03.14.988345 |
| 2020-03-15 |
[Impact of complicated myocardial injury on the clinical outcome of severe or critically ill COVID-19 patients] (edit) |
10.3760/CMA.J.CN112148-20200228-00137 |
| 2020-03-15 |
[Genomic analysis of a 2019-nCoV strain in the first COVID-19 patient found in Hangzhou, Zhejiang, China] (edit) |
10.3760/CMA.J.CN112150-20200217-00128 |
| 2020-03-15 |
[A pathological report of three COVID-19 cases by minimally invasive autopsies] (edit) |
10.3760/CMA.J.CN112151-20200312-00193 |
| 2020-03-15 |
Care of haematology patients in a COVID-19 epidemic (edit) |
10.1111/BJH.16620 |
| 2020-03-15 |
COVID-19 and mycoplasma pneumoniae coinfection (edit) |
10.1002/AJH.25785 |
| 2020-03-15 |
A Generic Computer-Assisted Four-Pronged Approach for the Management of Emerging Global Pathogens: Some Comments on COVID-19 (edit) |
10.2174/1573409916999200316102548 |
| 2020-03-15 |
Keeping the Fire House Running: A Proposed Approach to Mitigate Spread of COVID-19 Among Public Safety Personnel (edit) |
10.5811/WESTJEM.2020.3.47298 |
| 2020-03-15 |
The global battle against SARS-CoV-2 and COVID-19 (edit) |
10.7150/IJBS.45587 |
| 2020-03-15 |
SARS-CoV-2: an Emerging Coronavirus that Causes a Global Threat (edit) |
10.7150/IJBS.45053 |
| 2020-03-15 |
Evaluation of SARS-CoV-2 RNA shedding in clinical specimens and clinical characteristics of 10 patients with COVID-19 in Macau (edit) |
10.7150/IJBS.45357 |
| 2020-03-15 |
Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective (edit) |
10.7150/IJBS.45538 |
| 2020-03-15 |
Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2 (edit) |
10.7150/IJBS.45123 |
| 2020-03-15 |
Targeting the Endocytic Pathway and Autophagy Process as a Novel Therapeutic Strategy in COVID-19 (edit) |
10.7150/IJBS.45498 |
| 2020-03-15 |
Progression of Mental Health Services during the COVID-19 Outbreak in China (edit) |
10.7150/IJBS.45120 |
| 2020-03-15 |
Tribute to health workers in China: A group of respectable population during the outbreak of the COVID-19 (edit) |
10.7150/IJBS.45135 |
| 2020-03-15 |
The COVID-19 outbreak and psychiatric hospitals in China: managing challenges through mental health service reform (edit) |
10.7150/IJBS.45072 |
| 2020-03-15 |
Knowledge, attitudes, and practices towards COVID-19 among Chinese residents during the rapid rise period of the COVID-19 outbreak: a quick online cross-sectional survey (edit) |
10.7150/IJBS.45221 |
| 2020-03-15 |
COVID-19: One world, one health (edit) |
10.4045/TIDSSKR.20.0212 |
| 2020-03-15 |
Daily Situation Report on Coronavirus disease (COVID-19) in Iran; March 15, 2020 (edit) |
|
| 2020-03-15 |
CT Scans of Patients with 2019 Novel Coronavirus (COVID-19) Pneumonia (edit) |
10.7150/THNO.45016 |
| 2020-03-14 |
[COVID-19 complicated with DIC: 2 cases report and literatures review] (edit) |
10.3760/CMA.J.ISSN.0253-2727.2020.0001 |
| 2020-03-14 |
COVID-19 and rationally layered social distancing (edit) |
10.1111/IJCP.13501 |
| 2020-03-14 |
Limiting spread of COVID-19 from cruise ships - lessons to be learnt from Japan (edit) |
10.1093/QJMED/HCAA092 |
| 2020-03-14 |
Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies (edit) |
10.23812/CONTI-E |
| 2020-03-14 |
Back to the spring of Wuhan: facts and hope of COVID-19 outbreak (edit) |
10.1007/S11684-020-0758-9 |
| 2020-03-14 |
Diagnosis and clinical management of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection: an operational recommendation of Peking Union Medical College Hospital (V2.0) (edit) |
10.1080/22221751.2020.1735265 |
| 2020-03-14 |
Clinical Features and Chest CT Manifestations of Coronavirus Disease 2019 (COVID-19) in a Single-Center Study in Shanghai, China (edit) |
10.2214/AJR.20.22959 |
| 2020-03-14 |
Coronavirus Disease 2019 (COVID-19): A Systematic Review of Imaging Findings in 919 Patients (edit) |
10.2214/AJR.20.23034 |
| 2020-03-14 |
Coronavirus (COVID-19) outbreak: what the department of endoscopy should know (edit) |
10.1016/J.GIE.2020.03.019 |
| 2020-03-14 |
Testing the repatriated for SARS-Cov2: Should laboratory-based quarantine replace traditional quarantine? (edit) |
10.1016/J.TMAID.2020.101624 |
| 2020-03-14 |
2019 Novel Coronavirus Disease (COVID-19): Paving the Road for Rapid Detection and Point-of-Care Diagnostics (edit) |
10.3390/MI11030306 |
| 2020-03-14 |
Is Romania ready to face the novel coronavirus (COVID-19) outbreak? The role of incoming travelers and that of Romanian diaspora (edit) |
10.1016/J.TMAID.2020.101628 |
| 2020-03-14 |
Mapping the incidence of the COVID-19 hotspot in Iran - Implications for Travellers (edit) |
10.1016/J.TMAID.2020.101630 |
| 2020-03-14 |
Spatial transmission of COVID-19 via public and private transportation in China (edit) |
10.1016/J.TMAID.2020.101626 |
| 2020-03-14 |
Internationally lost COVID-19 cases (edit) |
10.1016/J.JMII.2020.03.013 |
| 2020-03-14 |
COVID-19: Yet another coronavirus challenge in transplantation (edit) |
10.1016/J.HEALUN.2020.03.007 |
| 2020-03-14 |
Daily Situation Report on Coronavirus disease (COVID-19) in Iran; March 14, 2020 (edit) |
|
| 2020-03-14 |
Patients with respiratory symptoms are at greater risk of COVID-19 transmission (edit) |
10.1016/J.RMED.2020.105935 |
| 2020-03-13 |
The reproductive number of COVID-19 is higher compared to SARS coronavirus (edit) |
10.1093/JTM/TAAA021 |
| 2020-03-13 |
Estimates of the severity of COVID-19 disease (edit) |
10.1101/2020.03.09.20033357 |
| 2020-03-13 |
Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy (edit) |
10.1001/JAMA.2020.4031 |
| 2020-03-13 |
Teicoplanin: an alternative drug for the treatment of coronavirus COVID-19? (edit) |
10.1016/J.IJANTIMICAG.2020.105944 |
| 2020-03-13 |
Trainees and covid-19: your questions answered (edit) |
10.1136/BMJ.M1059 |
| 2020-03-13 |
The effect of control strategies that reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China (edit) |
10.1101/2020.03.09.20033050 |
| 2020-03-13 |
Epidemiological, Clinical Characteristics and Outcome of Medical Staff Infected with COVID-19 in Wuhan, China: A Retrospective Case Series Analysis (edit) |
10.1101/2020.03.09.20033118 |
| 2020-03-13 |
Clinical features of imported cases of coronavirus disease 2019 in Tibetan patients in the Plateau area (edit) |
10.1101/2020.03.09.20033126 |
| 2020-03-13 |
Age specificity of cases and attack rate of novel coronavirus disease (COVID-19) (edit) |
10.1101/2020.03.09.20033142 |
| 2020-03-13 |
The demand for inpatient and ICU beds for COVID-19 in the US: lessons from Chinese cities (edit) |
10.1101/2020.03.09.20033241 |
| 2020-03-13 |
Genomic epidemiology of a densely sampled COVID19 outbreak in China (edit) |
10.1101/2020.03.09.20033365 |
| 2020-03-13 |
Novel Coronavirus (COVID-19) Knowledge and Perceptions: A Survey of Healthcare Workers (edit) |
10.1101/2020.03.09.20033381 |
| 2020-03-13 |
The Impact of School Closure for COVID-19 on the US Healthcare Workforce and the Net Mortality Effects (edit) |
10.1101/2020.03.09.20033415 |
| 2020-03-13 |
Lessons drawn from China and South Korea for managing COVID-19 epidemic: insights from a comparative modeling study (edit) |
10.1101/2020.03.09.20033464 |
| 2020-03-13 |
Modeling the situation of COVID-19 and effects of different containment strategies in China with dynamic differential equations and parameters estimation (edit) |
10.1101/2020.03.09.20033498 |
| 2020-03-13 |
The time scale of asymptomatic transmission affects estimates of epidemic potential in the COVID-19 outbreak (edit) |
10.1101/2020.03.09.20033514 |
| 2020-03-13 |
Protocol of a randomized controlled trial testing inhaled Nitric Oxide in mechanically ventilated patients with severe acute respiratory syndrome in COVID-19 (SARS-CoV-2). (edit) |
10.1101/2020.03.09.20033530 |
| 2020-03-13 |
Protocol for a randomized controlled trial testing inhaled nitric oxide therapy in spontaneously breathing patients with COVID-19 (edit) |
10.1101/2020.03.10.20033522 |
| 2020-03-13 |
Maternal and neonatal outcomes of pregnant women with COVID-19 pneumonia: a case-control study (edit) |
10.1101/2020.03.10.20033605 |
| 2020-03-13 |
Analysis clinical features of COVID-19 infection in secondary epidemic area and report potential biomarkers in evaluation (edit) |
10.1101/2020.03.10.20033613 |
| 2020-03-13 |
The Prediction for Development of COVID-19 in Global Major Epidemic Areas Through Empirical Trends in China by Utilizing State Transition Matrix Model (edit) |
10.1101/2020.03.10.20033670 |
| 2020-03-13 |
Effectiveness of isolation and contact tracing for containment and slowing down a COVID-19 epidemic: a modelling study (edit) |
10.1101/2020.03.10.20033738 |
| 2020-03-13 |
Inferring the number of COVID-19 cases from recently reported deaths (edit) |
10.1101/2020.03.10.20033761 |
| 2020-03-13 |
Prediction of the COVID-19 outbreak based on a realistic stochastic model (edit) |
10.1101/2020.03.10.20033803 |
| 2020-03-13 |
Virus strain of a mild COVID-19 patient in Hangzhou representing a new trend in SARS-CoV-2 evolution related to Furin cleavage site (edit) |
10.1101/2020.03.10.20033944 |
| 2020-03-13 |
Rigidity, normal modes and flexible motion of a SARS-CoV-2 (COVID-19) protease structure (edit) |
10.1101/2020.03.10.986190 |
| 2020-03-13 |
Prolonged presence of SARS-CoV-2 in feces of pediatric patients during the convalescent phase (edit) |
10.1101/2020.03.11.20033159 |
| 2020-03-13 |
Estimation of instant case fatality rate of COVID-19 in Wuhan and Hubei based on daily case notification data (edit) |
10.1101/2020.03.11.20034215 |
| 2020-03-13 |
Predicting the cumulative number of cases for the COVID-19 epidemic in China from early data (edit) |
10.1101/2020.03.11.20034314 |
| 2020-03-13 |
Novel and potent inhibitors targeting DHODH, a rate-limiting enzyme in de novo pyrimidine biosynthesis, are broad-spectrum antiviral against RNA viruses including newly emerged coronavirus SARS-CoV-2 (edit) |
10.1101/2020.03.11.983056 |
| 2020-03-13 |
A data-driven drug repositioning framework discovered a potential therapeutic agent targeting COVID-19 (edit) |
10.1101/2020.03.11.986836 |
| 2020-03-13 |
The inhaled corticosteroid ciclesonide blocks coronavirus RNA replication by targeting viral NSP15 (edit) |
10.1101/2020.03.11.987016 |
| 2020-03-13 |
Discovery of a 382-nt deletion during the early evolution of SARS-CoV-2 (edit) |
10.1101/2020.03.11.987222 |
| 2020-03-13 |
A human monoclonal antibody blocking SARS-CoV-2 infection (edit) |
10.1101/2020.03.11.987958 |
| 2020-03-13 |
Politicians: please work together to minimise the spread of COVID-19 (edit) |
|
| 2020-03-13 |
[Epidemiological characteristics of confirmed COVID-19 cases in Tianjin] (edit) |
10.3760/CMA.J.CN112338-20200221-00146 |
| 2020-03-13 |
[COVID-19 Pandemic: global epidemiological trends and China's subsequent preparedness and responses] (edit) |
10.3760/CMA.J.CN112338-20200301-00222 |
| 2020-03-13 |
COVID-19: An Update on the Epidemiological, Clinical, Preventive and Therapeutic Evidence and Guidelines of Integrative Chinese-Western Medicine for the Management of 2019 Novel Coronavirus Disease (edit) |
10.1142/S0192415X20500378 |
| 2020-03-13 |
What further should be done to control COVID-19 outbreaks in addition to cases isolation and contact tracing measures? (edit) |
10.1186/S12916-020-01551-8 |
| 2020-03-13 |
A Review of Coronavirus Disease-2019 (COVID-19) (edit) |
10.1007/S12098-020-03263-6 |
| 2020-03-13 |
[Which sampling method for the upper respiratory tract specimen should be taken to diagnose patient with COVID-19?] (edit) |
10.3760/CMA.J.CN115330-20200223-00116 |
| 2020-03-13 |
Interrupting transmission of COVID-19: lessons from containment efforts in Singapore (edit) |
10.1093/JTM/TAAA039 |
| 2020-03-13 |
An exclusive 42 amino acid signature in pp1ab protein provides insights into the evolutive history of the 2019 novel human-pathogenic coronavirus (SARS-CoV-2) (edit) |
10.1002/JMV.25758 |
| 2020-03-13 |
The potential chemical structure of anti-SARS-CoV-2 RNA-dependent RNA polymerase (edit) |
10.1002/JMV.25761 |
| 2020-03-13 |
The establishment of reference sequence for SARS-CoV-2 and variation analysis (edit) |
10.1002/JMV.25762 |
| 2020-03-13 |
Involving antimicrobial stewardship programs in COVID-19 response efforts: All hands on deck (edit) |
10.1017/ICE.2020.69 |
| 2020-03-13 |
From Containment to Mitigation of COVID-19 in the US (edit) |
10.1001/JAMA.2020.3882 |
| 2020-03-13 |
Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms (edit) |
10.1021/ACSCHEMNEURO.0C00122 |
| 2020-03-13 |
Can Lung US Help Critical Care Clinicians in the Early Diagnosis of Novel Coronavirus (COVID-19) Pneumonia? (edit) |
10.1148/RADIOL.2020200847 |
| 2020-03-13 |
Case-Fatality Risk Estimates for COVID-19 Calculated by Using a Lag Time for Fatality (edit) |
10.3201/EID2606.200320 |
| 2020-03-13 |
The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status (edit) |
10.1186/S40779-020-00240-0 |
| 2020-03-13 |
Bearing the brunt of covid-19: older people in low and middle income countries (edit) |
10.1136/BMJ.M1052 |
| 2020-03-13 |
Budgeting for covid-19: changing the narrative and narrating the change (edit) |
10.1136/BMJ.M1053 |
| 2020-03-13 |
Covid-19: GPs call for same personal protective equipment as hospital doctors (edit) |
10.1136/BMJ.M1055 |
| 2020-03-13 |
Covid-19: UK holds off closing schools and restricts testing to people in hospital (edit) |
10.1136/BMJ.M1060 |
| 2020-03-13 |
Combination of western medicine and Chinese traditional patent medicine in treating a family case of COVID-19 in Wuhan (edit) |
10.1007/S11684-020-0757-X |
| 2020-03-13 |
Evolution of Computed Tomography Manifestations in Five Patients Who Recovered from Coronavirus Disease 2019 (COVID-19) Pneumonia (edit) |
10.3348/KJR.2020.0157 |
| 2020-03-13 |
What Is Needed to Make Interventional Radiology Ready for COVID-19? Lessons from SARS-CoV Epidemic (edit) |
10.3348/KJR.2020.0163 |
| 2020-03-13 |
2019 Novel Coronavirus (COVID-19) Pneumonia with Hemoptysis as the Initial Symptom: CT and Clinical Features (edit) |
10.3348/KJR.2020.0181 |
| 2020-03-13 |
First known person-to-person transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the USA (edit) |
10.1016/S0140-6736(20)30607-3 |
| 2020-03-13 |
COVID-19, ECMO, and lymphopenia: a word of caution (edit) |
10.1016/S2213-2600(20)30119-3 |
| 2020-03-13 |
Viral loads of SARS-CoV, MERS-CoV and SARS-CoV-2 in respiratory specimens: What have we learned? (edit) |
10.1016/J.TMAID.2020.101629 |
| 2020-03-13 |
Clinical diagnostic value of CT imaging in COVID-19 with multiple negative RT-PCR testing (edit) |
10.1016/J.TMAID.2020.101627 |
| 2020-03-13 |
Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis (edit) |
10.1016/J.TMAID.2020.101623 |
| 2020-03-13 |
Timely blood glucose management for the outbreak of 2019 novel coronavirus disease (COVID-19) is urgently needed (edit) |
10.1016/J.DIABRES.2020.108118 |
| 2020-03-13 |
Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19) (edit) |
10.1016/J.IJID.2020.03.020 |
| 2020-03-13 |
Clinical features and dynamics of viral load in imported and non-imported patients with COVID-19 (edit) |
10.1016/J.IJID.2020.03.022 |
| 2020-03-13 |
The novel coronavirus (SARS-CoV-2) emergency and the role of timely and effective national health surveillance (edit) |
10.1590/0102-311X00019620 |
| 2020-03-13 |
Policies on the use of respiratory protection for hospital health workers to protect from coronavirus disease (COVID-19) (edit) |
10.1016/J.IJNURSTU.2020.103567 |
| 2020-03-13 |
Featuring COVID-19 cases via screening symptomatic patients with epidemiologic link during flu season in a medical center of central Taiwan (edit) |
10.1016/J.JMII.2020.03.008 |
| 2020-03-13 |
Daily Situation Report on Coronavirus disease (COVID-19) in Iran; March 13, 2020 (edit) |
|
| 2020-03-13 |
Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding (edit) |
10.1038/S41591-020-0817-4 |
| 2020-03-13 |
Coronavirus Goes Viral: Quantifying the COVID-19 Misinformation Epidemic on Twitter (edit) |
10.7759/CUREUS.7255 |
| 2020-03-13 |
SARS-CoV-2 Entry Genes Are Most Highly Expressed in Nasal Goblet and Ciliated Cells within Human Airways (edit) |
|
| 2020-03-12 |
Real estimates of mortality following COVID-19 infection (edit) |
10.1016/S1473-3099(20)30195-X |
| 2020-03-12 |
A Novel Approach for a Novel Pathogen: using a home assessment team to evaluate patients for 2019 novel coronavirus (SARS-CoV-2) (edit) |
10.1093/CID/CIAA256 |
| 2020-03-12 |
Detection of Covid-19 in Children in Early January 2020 in Wuhan, China (edit) |
10.1056/NEJMC2003717 |
| 2020-03-12 |
Retrospective Analysis of Clinical Features in 101 Death Cases with COVID-19 (edit) |
10.1101/2020.03.09.20033068 |
| 2020-03-12 |
Early, low-dose and short-term application of corticosteroid treatment in patients with severe COVID-19 pneumonia: single-center experience from Wuhan, China (edit) |
10.1101/2020.03.06.20032342 |
| 2020-03-12 |
Quantifying dynamics of SARS-CoV-2 transmission suggests that epidemic control and avoidance is feasible through instantaneous digital contact tracing (edit) |
10.1101/2020.03.08.20032946 |
| 2020-03-12 |
The effectiveness of full and partial travel bans against COVID-19 spread in Australia for travellers from China. (edit) |
10.1101/2020.03.09.20032045 |
| 2020-03-12 |
First 12 patients with coronavirus disease 2019 (COVID-19) in the United States (edit) |
10.1101/2020.03.09.20032896 |
| 2020-03-12 |
Development of Reverse Transcription Loop-mediated Isothermal Amplification (RT-LAMP) Assays Targeting SARS-CoV-2 (edit) |
10.1101/2020.03.09.983064 |
| 2020-03-12 |
Inhibition of SARS-CoV-2 infection (previously 2019-nCoV) by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion (edit) |
10.1101/2020.03.09.983247 |
| 2020-03-12 |
Epidemiological and clinical characteristics of COVID-19 in adolescents and young adults (edit) |
10.1101/2020.03.10.20032136 |
| 2020-03-12 |
Effects of Chinese strategies for controlling the diffusion and deterioration of novel coronavirus-infected pneumonia in China (edit) |
10.1101/2020.03.10.20032755 |
| 2020-03-12 |
Revealing the influence of national public health policies for the outbreak of the SARS-CoV-2 epidemic in Wuhan, China through status dynamic modeling (edit) |
10.1101/2020.03.10.20032995 |
| 2020-03-12 |
The SARS-CoV-2 exerts a distinctive strategy for interacting with the ACE2 human receptor (edit) |
10.1101/2020.03.10.986398 |
| 2020-03-12 |
Dysregulation of immune response in patients with COVID-19 in Wuhan, China (edit) |
10.1093/CID/CIAA248 |
| 2020-03-12 |
A case report of neonatal COVID-19 infection in China (edit) |
10.1093/CID/CIAA225 |
| 2020-03-12 |
A comparative study on the clinical features of COVID-19 pneumonia to other pneumonias (edit) |
10.1093/CID/CIAA247 |
| 2020-03-12 |
COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis (edit) |
10.1002/JMV.25757 |
| 2020-03-12 |
[Epidemiological investigation on a cluster epidemic of COVID-19 in a collective workplace in Tianjin] (edit) |
10.3760/CMA.J.CN112338-20200219-00121 |
| 2020-03-12 |
COVID-19 Infection: Early Lessons (edit) |
10.1177/0846537120914428 |
| 2020-03-12 |
Coronavirus Disease 2019 (COVID-19): Emerging and Future Challenges for Dental and Oral Medicine (edit) |
10.1177/0022034520914246 |
| 2020-03-12 |
Indirect Virus Transmission in Cluster of COVID-19 Cases, Wenzhou, China, 2020 (edit) |
10.3201/EID2606.200412 |
| 2020-03-12 |
Supporting the Health Care Workforce During the COVID-19 Global Epidemic (edit) |
10.1001/JAMA.2020.3972 |
| 2020-03-12 |
Serial interval in determining the estimation of reproduction number of the novel coronavirus disease (COVID-19) during the early outbreak (edit) |
10.1093/JTM/TAAA033 |
| 2020-03-12 |
Histopathologic Changes and SARS-CoV-2 Immunostaining in the Lung of a Patient With COVID-19 (edit) |
10.7326/M20-0533 |
| 2020-03-12 |
SARS-CoV-2 Infection among Travelers Returning from Wuhan, China (edit) |
10.1056/NEJMC2003100 |
| 2020-03-12 |
History in a Crisis - Lessons for Covid-19 (edit) |
10.1056/NEJMP2004361 |
| 2020-03-12 |
Estimating the reproductive number and the outbreak size of Novel Coronavirus disease (COVID-19) using mathematical model in Republic of Korea (edit) |
10.4178/EPIH.E2020011 |
| 2020-03-12 |
Video consultations for covid-19 (edit) |
10.1136/BMJ.M998 |
| 2020-03-12 |
Complete Genome Sequence of a 2019 Novel Coronavirus (SARS-CoV-2) Strain Isolated in Nepal (edit) |
10.1128/MRA.00169-20 |
| 2020-03-12 |
Covid-19: GPs call for appraisals and CQC inspections to be suspended (edit) |
10.1136/BMJ.M1038 |
| 2020-03-12 |
Covid-19: Trump cancels all flights from Europe, apart from the UK (edit) |
10.1136/BMJ.M1037 |
| 2020-03-12 |
Covid-19: WHO declares pandemic because of "alarming levels" of spread, severity, and inaction (edit) |
10.1136/BMJ.M1036 |
| 2020-03-12 |
Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells (edit) |
10.1073/PNAS.2002589117 |
| 2020-03-12 |
Protecting Health Care Workers during the COVID-19 Coronavirus Outbreak -Lessons from Taiwan's SARS response (edit) |
10.1093/CID/CIAA255 |
| 2020-03-12 |
18F-FDG PET/CT and COVID-19 (edit) |
10.1007/S00259-020-04762-6 |
| 2020-03-12 |
China's local governments are combating COVID-19 with unprecedented responses - from a Wenzhou governance perspective (edit) |
10.1007/S11684-020-0755-Z |
| 2020-03-12 |
Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection (edit) |
10.1007/S11684-020-0754-0 |
| 2020-03-12 |
SARS-CoV-2 RNA more readily detected in induced sputum than in throat swabs of convalescent COVID-19 patients (edit) |
10.1016/S1473-3099(20)30174-2 |
| 2020-03-12 |
New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? (edit) |
10.1016/J.IJANTIMICAG.2020.105938 |
| 2020-03-12 |
[Recommendations on the clinical management of the COVID-19 infection by the «new coronavirus» SARS-CoV2. Spanish Paediatric Association working group] (edit) |
10.1016/J.ANPEDI.2020.02.001 |
| 2020-03-12 |
Experience of different upper respiratory tract sampling strategies for detection of COVID-19 (edit) |
10.1016/J.JHIN.2020.03.012 |
| 2020-03-12 |
Applications of google search trends for risk communication in infectious disease management: A case study of COVID-19 outbreak in Taiwan (edit) |
10.1016/J.IJID.2020.03.021 |
| 2020-03-12 |
Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis (edit) |
10.1016/J.IJID.2020.03.017 |
| 2020-03-12 |
Patients of COVID-19 may benefit from sustained lopinavir-combined regimen and the increase of eosinophil may predict the outcome of COVID-19 progression (edit) |
10.1016/J.IJID.2020.03.013 |
| 2020-03-12 |
Information Typology in Coronavirus (COVID-19) Crisis; a Commentary (edit) |
|
| 2020-03-12 |
Asymptomatic SARS-CoV-2 infected patients with persistent negative CT findings (edit) |
10.1016/J.EJRAD.2020.108956 |
| 2020-03-12 |
Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases (edit) |
10.1021/ACSCENTSCI.0C00272 |
| 2020-03-12 |
Climate Change, Covid-19, Preparedness, and Consciousness (edit) |
10.1016/J.EXPLORE.2020.02.022 |
| 2020-03-12 |
Coronavirus Disease 2019 (COVID-19) Pneumonia in a Hemodialysis Patient (edit) |
10.1016/J.XKME.2020.03.001 |
| 2020-03-12 |
Emerging Therapeutic Strategies for COVID-19 patients (edit) |
10.15190/D.2020.2 |
| 2020-03-12 |
Exploring the Active Compounds of Traditional Mongolian Medicine Agsirga in Intervention of Novel Coronavirus (2019-nCoV) Based on HPLC-Q-Exactive-MS/MS and Molecular Docking Method (edit) |
10.26434/CHEMRXIV.11955273 |
| 2020-03-12 |
Revealing the Potency of Citrus and Galangal Constituents to Halt SARS-CoV-2 Infection (edit) |
10.20944/PREPRINTS202003.0214.V1 |
| 2020-03-11 |
Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? (edit) |
10.1016/S2213-2600(20)30116-8 |
| 2020-03-11 |
The crystal structure of COVID-19 main protease in apo form (edit) |
10.2210/PDB6M03/PDB |
| 2020-03-11 |
Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2 in the complex with ADP ribose (edit) |
10.2210/PDB6W02/PDB |
| 2020-03-11 |
COVID-19 main protease with unliganded active site (2019-nCoV, coronavirus disease 2019, SARS-CoV-2) (edit) |
10.2210/PDB6Y84/PDB |
| 2020-03-11 |
PanDDA analysis group deposition -- Crystal Structure of COVID-19 main protease in complex with Z1367324110 (edit) |
10.2210/PDB5R81/PDB |
| 2020-03-11 |
PanDDA analysis group deposition -- Crystal Structure of COVID-19 main protease in complex with Z219104216 (edit) |
10.2210/PDB5R82/PDB |
| 2020-03-11 |
PanDDA analysis group deposition -- Crystal Structure of COVID-19 main protease in complex with Z44592329 (edit) |
10.2210/PDB5R83/PDB |
| 2020-03-11 |
From SARS and MERS CoVs to SARS‐CoV‐2: Moving toward more biased codon usage in viral structural and nonstructural genes (edit) |
10.1002/JMV.25754 |
| 2020-03-11 |
COVID-19, Australia: Epidemiology Report 6: Reporting week ending 1900 AEDT 7 March 2020 (edit) |
10.33321/CDI.2020.44.21 |
| 2020-03-11 |
Clinical Characteristics on 25 Discharged Patients with COVID-19 Virus Returning (edit) |
10.1101/2020.03.06.20031377 |
| 2020-03-11 |
Rapid Detection of 2019 Novel Coronavirus SARS-CoV-2 Using a CRISPR-based DETECTR Lateral Flow Assay (edit) |
10.1101/2020.03.06.20032334 |
| 2020-03-11 |
Estimation of incubation period distribution of COVID-19 using disease onset forward time: a novel cross-sectional and forward follow-up study (edit) |
10.1101/2020.03.06.20032417 |
| 2020-03-11 |
Prevalence and Risk Factors of Acute Posttraumatic Stress Symptoms during the COVID-19 Outbreak in Wuhan, China (edit) |
10.1101/2020.03.06.20032425 |
| 2020-03-11 |
The epidemiological characteristics of 2019 novel coronavirus diseases (COVID-19) in Jingmen,Hubei,China (edit) |
10.1101/2020.03.07.20031393 |
| 2020-03-11 |
Prognostic value of NT-proBNP in patients with severe COVID-19 (edit) |
10.1101/2020.03.07.20031575 |
| 2020-03-11 |
Analytical sensibility and specificity of two RT-qPCR protocols for SARS-CoV-2 detection performed in an automated workflow (edit) |
10.1101/2020.03.07.20032326 |
| 2020-03-11 |
Diagnosis of Acute Respiratory Syndrome Coronavirus 2 Infection by Detection of Nucleocapsid Protein (edit) |
10.1101/2020.03.07.20032524 |
| 2020-03-11 |
Clinical Characteristics of Coronavirus Pneumonia 2019 (COVID-19): An Updated Systematic Review (edit) |
10.1101/2020.03.07.20032573 |
| 2020-03-11 |
Analysis of early renal injury in COVID-19 and diagnostic value of multi-index combined detection (edit) |
10.1101/2020.03.07.20032599 |
| 2020-03-11 |
Clinical outcomes of 402 patients with COVID-2019 from a single center in Wuhan, China (edit) |
10.1101/2020.03.07.20032672 |
| 2020-03-11 |
A retrospective study of the clinical characteristics of COVID-19 infection in 26 children (edit) |
10.1101/2020.03.08.20029710 |
| 2020-03-11 |
Transmission potential of COVID-19 in Iran (edit) |
10.1101/2020.03.08.20030643 |
| 2020-03-11 |
Mortality of COVID-19 is Associated with Cellular Immune Function Compared to Immune Function in Chinese Han Population (edit) |
10.1101/2020.03.08.20031229 |
| 2020-03-11 |
Clinical Characteristics of SARS-CoV-2 Pneumonia Compared to Controls in Chinese Han Population (edit) |
10.1101/2020.03.08.20031658 |
| 2020-03-11 |
Clinical Characteristics of Two Human to Human Transmitted Coronaviruses: Corona Virus Disease 2019 versus Middle East Respiratory Syndrome Coronavirus. (edit) |
10.1101/2020.03.08.20032821 |
| 2020-03-11 |
Prediction of COVID-19 Spreading Profiles in South Korea, Italy and Iran by Data-Driven Coding (edit) |
10.1101/2020.03.08.20032847 |
| 2020-03-11 |
A deterministic epidemic model for the emergence of COVID-19 in China (edit) |
10.1101/2020.03.08.20032854 |
| 2020-03-11 |
Aerodynamic Characteristics and RNA Concentration of SARS-CoV-2 Aerosol in Wuhan Hospitals during COVID-19 Outbreak (edit) |
10.1101/2020.03.08.982637 |
| 2020-03-11 |
Data-driven discovery of clinical routes for severity detection in COVID-19 pediatric cases (edit) |
10.1101/2020.03.09.20032219 |
| 2020-03-11 |
Ascertainment rate of novel coronavirus disease (COVID-19) in Japan (edit) |
10.1101/2020.03.09.20033183 |
| 2020-03-11 |
A proposal of alternative primers for the ARTIC Network's multiplex PCR to improve coverage of SARS-CoV-2 genome sequencing (edit) |
10.1101/2020.03.10.985150 |
| 2020-03-11 |
In silico Design of novel Multi-epitope recombinant Vaccine based on Coronavirus surface glycoprotein (edit) |
10.1101/2020.03.10.985499 |
| 2020-03-11 |
Development of a Laboratory-safe and Low-cost Detection Protocol for SARS-CoV-2 of the Coronavirus Disease 2019 (COVID-19) (edit) |
10.5607/EN20009 |
| 2020-03-11 |
COVID-19 and psoriasis: Is it time to limit treatment with immunosuppressants? A call for action (edit) |
10.1111/DTH.13298 |
| 2020-03-11 |
[How to understand the histopathology of SARS and COVID-19 associated with acute respiratory distress syndrome] (edit) |
10.3760/CMA.J.CN112151-20200309-00185 |
| 2020-03-11 |
[Practice and Reflection on the Battle against COVID-19 by Guangdong Medical Aid Team in the city of Honghu] (edit) |
10.3760/CMA.J.CN112137-20200228-00496 |
| 2020-03-11 |
Where are we now with COVID-19? (edit) |
10.1111/IJCP.13497 |
| 2020-03-11 |
[Comparison of epidemic characteristics between SARS in2003 and COVID-19 in 2020 in Guangzhou] (edit) |
10.3760/CMA.J.CN112338-20200228-00209 |
| 2020-03-11 |
Care for Critically Ill Patients With COVID-19 (edit) |
10.1001/JAMA.2020.3633 |
| 2020-03-11 |
Detection of SARS-CoV-2 in Different Types of Clinical Specimens (edit) |
10.1001/JAMA.2020.3786 |
| 2020-03-11 |
Co-infection with SARS-CoV-2 and Influenza A Virus in Patient with Pneumonia, China (edit) |
10.3201/EID2606.200299 |
| 2020-03-11 |
How Should U.S. Hospitals Prepare for Coronavirus Disease 2019 (COVID-19)? (edit) |
10.7326/M20-0907 |
| 2020-03-11 |
Coronavirus Disease 2019 (COVID-19): Protecting Hospitals From the Invisible (edit) |
10.7326/M20-0751 |
| 2020-03-11 |
Co-infection of SARS-CoV-2 and HIV in a patient in Wuhan city, China (edit) |
10.1002/JMV.25732 |
| 2020-03-11 |
Virtually Perfect? Telemedicine for Covid-19 (edit) |
10.1056/NEJMP2003539 |
| 2020-03-11 |
Geographical tracking and mapping of coronavirus disease COVID-19/severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic and associated events around the world: how 21st century GIS technologies are supporting the global fight against (edit) |
10.1186/S12942-020-00202-8 |
| 2020-03-11 |
Covid-19: UK ramps up testing by 500% as health minister tests positive for virus (edit) |
10.1136/BMJ.M1003 |
| 2020-03-11 |
Covid-19: UK budget gives £94 a week statutory sick pay to self-isolators and their carers (edit) |
10.1136/BMJ.M1001 |
| 2020-03-11 |
Covid-19: Trump proposes tax cuts and improved health insurance, but millions are not covered (edit) |
10.1136/BMJ.M993 |
| 2020-03-11 |
Nigeria responds to COVID-19; first case detected in sub-Saharan Africa (edit) |
10.1038/D41591-020-00004-2 |
| 2020-03-11 |
How to balance acute myocardial infarction and COVID-19: the protocols from Sichuan Provincial People's Hospital (edit) |
10.1007/S00134-020-05993-9 |
| 2020-03-11 |
Chest computed tomography in children with COVID-19 respiratory infection (edit) |
10.1007/S00247-020-04656-7 |
| 2020-03-11 |
Chest computed tomography images of early coronavirus disease (COVID-19) (edit) |
10.1007/S12630-020-01625-4 |
| 2020-03-11 |
Preparing for a COVID-19 pandemic: a review of operating room outbreak response measures in a large tertiary hospital in Singapore (edit) |
10.1007/S12630-020-01620-9 |
| 2020-03-11 |
Rapid Identification of Potential Inhibitors of SARS-CoV-2 Main Protease by Deep Docking of 1.3 Billion Compounds (edit) |
10.1002/MINF.202000028 |
| 2020-03-11 |
COVID-19: a potential public health problem for homeless populations (edit) |
10.1016/S2468-2667(20)30053-0 |
| 2020-03-11 |
Can Nigeria contain the COVID-19 outbreak using lessons from recent epidemics? (edit) |
10.1016/S2214-109X(20)30101-7 |
| 2020-03-11 |
Implications of COVID-19 for patients with pre-existing digestive diseases (edit) |
10.1016/S2468-1253(20)30076-5 |
| 2020-03-11 |
Early dynamics of transmission and control of COVID-19: a mathematical modelling study (edit) |
10.1016/S1473-3099(20)30144-4 |
| 2020-03-11 |
Sex difference and smoking predisposition in patients with COVID-19 (edit) |
10.1016/S2213-2600(20)30117-X |
| 2020-03-11 |
Comorbidities and multi-organ injuries in the treatment of COVID-19 (edit) |
10.1016/S0140-6736(20)30558-4 |
| 2020-03-11 |
COVID-19: the medium is the message (edit) |
10.1016/S0140-6736(20)30600-0 |
| 2020-03-11 |
An update on the 2019-nCoV outbreak (edit) |
10.1016/J.AJIC.2020.01.023 |
| 2020-03-11 |
Behavioral considerations and impact on personal protective equipment (PPE) use: Early lessons from the coronavirus (COVID-19) outbreak (edit) |
10.1016/J.JAAD.2020.03.013 |
| 2020-03-11 |
Letter from the Editor: Occupational skin disease among healthcare workers during the Coronavirus (COVID-19) epidemic (edit) |
10.1016/J.JAAD.2020.03.012 |
| 2020-03-11 |
COVID 19: Will the 2020 Hajj pilgrimage and Tokyo Olympic Games be cancelled? (edit) |
10.1016/J.TMAID.2020.101622 |
| 2020-03-11 |
The effectiveness of quarantine and isolation determine the trend of the COVID-19 epidemics in the final phase of the current outbreak in China (edit) |
10.1016/J.IJID.2020.03.018 |
| 2020-03-11 |
Preliminary estimation of the novel coronavirus disease (COVID-19) cases in Iran: A modelling analysis based on overseas cases and air travel data (edit) |
10.1016/J.IJID.2020.03.019 |
| 2020-03-11 |
Covid-19: Italiensk leksjon (edit) |
10.4045/TIDSSKR.20.0210 |
| 2020-03-11 |
TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib (edit) |
10.1016/J.JMII.2020.03.005 |
| 2020-03-11 |
Modeling the epidemic dynamics and control of COVID-19 outbreak in China (edit) |
10.1007/S40484-020-0199-0 |
| 2020-03-11 |
Repurposing Therapeutics for COVID-19: Supercomputer-Based Docking to the SARS-CoV-2 Viral Spike Protein and Viral Spike Protein-Human ACE2 Interface (edit) |
10.26434/CHEMRXIV.11871402 |
| 2020-03-11 |
SARS-CoV-2 infected host cell proteomics reveal potential therapy targets (edit) |
10.21203/RS.3.RS-17218/V1 |
| 2020-03-10 |
Annals On Call - Understanding the Spread of COVID-19 (edit) |
10.7326/A20-0001 |
| 2020-03-10 |
The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application (edit) |
10.7326/M20-0504 |
| 2020-03-10 |
Aerosol and surface stability of HCoV-19 (SARS-CoV-2) compared to SARS-CoV-1 (edit) |
10.1101/2020.03.09.20033217 |
| 2020-03-10 |
Genetic evolution analysis of 2019 novel coronavirus and coronavirus from other species (edit) |
10.1016/J.MEEGID.2020.104285 |
| 2020-03-10 |
Covid-19: roundup of latest news (edit) |
10.1136/BMJ.M969 |
| 2020-03-10 |
Sensitive one-step isothermal detection of pathogen-derived RNAs (edit) |
10.1101/2020.03.05.20031971 |
| 2020-03-10 |
SARS-CoV-2 is sensitive to type I interferon pretreatment (edit) |
10.1101/2020.03.07.982264 |
| 2020-03-10 |
In silico approach to accelerate the development of mass spectrometry-based proteomics methods for detection of viral proteins: Application to COVID-19 (edit) |
10.1101/2020.03.08.980383 |
| 2020-03-10 |
Whole Genome Sequence Analysis and Homology Modelling of a 3C Like Peptidase and a Non-Structural Protein 3 of the SARS-CoV-2 Shows Protein Ligand Interaction with an Aza-Peptide and a Noncovalent Lead Inhibitor with Possible Antiviral Properties (edit) |
10.26434/CHEMRXIV.11846943 |
| 2020-03-10 |
On a knife's edge of a COVID-19 pandemic: is containment still possible? (edit) |
10.17061/PHRP3012000 |
| 2020-03-10 |
COVID-19, A Clinical Syndrome Manifesting as Hypersensitivity Pneumonitis (edit) |
10.3947/IC.2020.52.1.110 |
| 2020-03-10 |
[Provisional guidelines on autopsy practice for deaths associated with COVID-19] (edit) |
10.3760/CMA.J.CN112151-20200309-00184 |
| 2020-03-10 |
The SARS-CoV-2 Outbreak: Diagnosis, Infection Prevention, and Public Perception (edit) |
10.1093/CLINCHEM/HVAA080 |
| 2020-03-10 |
COVID-19 Presents High Risk to Older Persons (edit) |
10.1111/JGS.16426 |
| 2020-03-10 |
Performance of radiologists in differentiating COVID-19 from viral pneumonia on chest CT (edit) |
10.1148/RADIOL.2020200823 |
| 2020-03-10 |
Covid-19: UK trade talks with EU must not hinder cooperation in tackling threat, BMA warns (edit) |
10.1136/BMJ.M988 |
| 2020-03-10 |
Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis (edit) |
10.1016/J.PCAD.2020.03.001 |
| 2020-03-10 |
COVID-19 spike-host cell receptor GRP78 binding site prediction (edit) |
10.1016/J.JINF.2020.02.026 |
| 2020-03-10 |
Vicarious traumatization in the general public, members, and non-members of medical teams aiding in COVID-19 control (edit) |
10.1016/J.BBI.2020.03.007 |
| 2020-03-10 |
An Invited Commentary on "World Health Organization declares global emergency: A review of the 2019 novel Coronavirus (COVID-19)": Emergency or new reality? (edit) |
10.1016/J.IJSU.2020.03.002 |
| 2020-03-10 |
A commentary on "World Health Organization declares global emergency: A review of the 2019 novel Coronavirus (COVID-19)" (edit) |
10.1016/J.IJSU.2020.03.001 |
| 2020-03-10 |
Makeshift hospitals for COVID-19 patients: where health-care workers and patients need sufficient ventilation for more protection (edit) |
10.1016/J.JHIN.2020.03.008 |
| 2020-03-10 |
Clinical considerations for patients with diabetes in times of COVID-19 epidemic (edit) |
10.1016/J.DSX.2020.03.002 |
| 2020-03-10 |
A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19 (edit) |
10.1016/J.JCRC.2020.03.005 |
| 2020-03-10 |
Composition of human-specific slow codons and slow di-codons in SARS-CoV and 2019-nCoV are lower than other coronaviruses suggesting a faster protein synthesis rate of SARS-CoV and 2019-nCoV (edit) |
10.1016/J.JMII.2020.03.002 |
| 2020-03-10 |
A patient with SARS-CoV-2 infection during pregnancy in Qingdao, China (edit) |
10.1016/J.JMII.2020.03.004 |
| 2020-03-10 |
A case of COVID-19 and pneumonia returning from Macau in Taiwan: Clinical course and anti-SARS-CoV-2 IgG dynamic (edit) |
10.1016/J.JMII.2020.03.003 |
| 2020-03-10 |
Clinical characteristics of novel coronavirus disease 2019 (COVID-19) in newborns, infants and children (edit) |
10.1016/J.PEDNEO.2020.03.001 |
| 2020-03-09 |
How will country-based mitigation measures influence the course of the COVID-19 epidemic? (edit) |
10.1016/S0140-6736(20)30567-5 |
| 2020-03-09 |
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study (edit) |
10.1016/S0140-6736(20)30566-3 |
| 2020-03-09 |
Diagnosis and Management of First Case of COVID-19 in Canada: Lessons applied from SARS (edit) |
10.1093/CID/CIAA227 |
| 2020-03-09 |
AI-aided design of novel targeted covalent inhibitors against SARS-CoV-2 (edit) |
10.1101/2020.03.03.972133 |
| 2020-03-09 |
Comparison of severe and non-severe COVID-19 pneumonia: review and meta-analysis (edit) |
10.1101/2020.03.04.20030965 |
| 2020-03-09 |
Exploring diseases/traits and blood proteins causally related to expression of ACE2, the putative receptor of 2019-nCov: A Mendelian Randomization analysis (edit) |
10.1101/2020.03.04.20031237 |
| 2020-03-09 |
Clinical presentation and virological assessment of hospitalized cases of coronavirus disease 2019 in a travel-associated transmission cluster (edit) |
10.1101/2020.03.05.20030502 |
| 2020-03-09 |
Modeling the Comparative Impact of Individual Quarantine vs. Active Monitoring of Contacts for the Mitigation of COVID-19 (edit) |
10.1101/2020.03.05.20031088 |
| 2020-03-09 |
Clinical characterization and chest CT findings in laboratory-confirmed COVID-19: a systematic review and meta-analysis (edit) |
10.1101/2020.03.05.20031518 |
| 2020-03-09 |
Estimating the infection and case fatality ratio for COVID-19 using age-adjusted data from the outbreak on the Diamond Princess cruise ship (edit) |
10.1101/2020.03.05.20031773 |
| 2020-03-09 |
The Impact of Host-Based Early Warning on Disease Outbreaks (edit) |
10.1101/2020.03.06.20029793 |
| 2020-03-09 |
The Evaluation of Sleep Disturbances for Chinese Frontline Medical Workers under the Outbreak of COVID-19 (edit) |
10.1101/2020.03.06.20031278 |
| 2020-03-09 |
A preliminary study on serological assay for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 238 admitted hospital patients (edit) |
10.1101/2020.03.06.20031856 |
| 2020-03-09 |
Substrate specificity profiling of SARS-CoV-2 Mpro protease provides basis for anti-COVID-19 drug design (edit) |
10.1101/2020.03.07.981928 |
| 2020-03-09 |
COVID-19 and gender-specific difference: Analysis of public surveillance data in Hong Kong and Shenzhen, China, from January 10 to February 15, 2020 (edit) |
10.1017/ICE.2020.64 |
| 2020-03-09 |
[Epidemiological investigation of a family clustering of COVID-19] (edit) |
10.3760/CMA.J.CN112338-20200223-00152 |
| 2020-03-09 |
[COVID-19 with post-chemotherapy agranulocytosis in childhood acute leukemia: a case report] (edit) |
10.3760/CMA.J.ISSN.0253-2727.2020.0004 |
| 2020-03-09 |
SARS-CoV-2 and COVID-19: facing the pandemic together as citizens and cardiovascular practitioners (edit) |
10.23736/S0026-4725.20.05250-0 |
| 2020-03-09 |
In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (edit) |
10.1093/CID/CIAA237 |
| 2020-03-09 |
Preparing for COVID-19: early experience from an intensive care unit in Singapore (edit) |
10.1186/S13054-020-2814-X |
| 2020-03-09 |
Covid-19: emergency departments lack proper isolation facilities, senior medic warns (edit) |
10.1136/BMJ.M953 |
| 2020-03-09 |
Covid-19: out-of-hours providers are drafted in to manage non-urgent patients in community (edit) |
10.1136/BMJ.M959 |
| 2020-03-09 |
COVID-19: Emerging compassion, courage and resilience in the face of misinformation and adversity (edit) |
10.1111/JOCN.15231 |
| 2020-03-09 |
COVID-19 with spontaneous pneumomediastinum (edit) |
10.1016/S1473-3099(20)30156-0 |
| 2020-03-09 |
[The novel coronavirus Covid-19: What are the ophthalmic risks?] (edit) |
10.1016/J.JFO.2020.02.001 |
| 2020-03-09 |
Atypical lung feature on chest CT in a lung adenocarcinoma cancer patient infected with COVID-19 (edit) |
10.1016/J.ANNONC.2020.03.001 |
| 2020-03-09 |
Reverse Logistics Network Design for Effective Management of Medical Waste in Epidemic Outbreaks: Insights from the Coronavirus Disease 2019 (COVID-19) Outbreak in Wuhan (China) (edit) |
10.3390/IJERPH17051770 |
| 2020-03-09 |
Liver and Kidney Injuries in COVID-19 and Their Effects on Drug Therapy; a Letter to Editor (edit) |
|
| 2020-03-09 |
Transplantation of ACE2- Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 Pneumonia (edit) |
10.14336/AD.2020.0228 |
| 2020-03-09 |
Hospital biopreparedness in the Looming Presence of SARS-CoV-2/COVID-19 (edit) |
10.1002/HSR2.149 |
| 2020-03-09 |
Nuevo coronavirus 2019-ncov: impacto en salud global (edit) |
10.22206/CYSA.2020.V4I1.PP5-9 |
| 2020-03-08 |
Timely development of vaccines against SARS-CoV-2 (edit) |
10.1080/22221751.2020.1737580 |
| 2020-03-08 |
Outcome reporting from protocols of clinical trials of Coronavirus Disease 2019 (COVID-19): a review (edit) |
10.1101/2020.03.04.20031401 |
| 2020-03-08 |
Interaction of the spike protein RBD from SARS-CoV-2 with ACE2: similarity with SARS-CoV, hot-spot analysis and effect of the receptor polymorphism (edit) |
10.1101/2020.03.04.976027 |
| 2020-03-08 |
Cryo-electron microscopy structure of the SADS-CoV spike glycoprotein provides insights into an evolution of unique coronavirus spike proteins (edit) |
10.1101/2020.03.04.976258 |
| 2020-03-08 |
Genome-wide data inferring the evolution and population demography of the novel pneumonia coronavirus (SARS-CoV-2) (edit) |
10.1101/2020.03.04.976662 |
| 2020-03-08 |
Novel Immunoglobulin Domain Proteins Provide Insights into Evolution and Pathogenesis Mechanisms of SARS-Related Coronaviruses (edit) |
10.1101/2020.03.04.977736 |
| 2020-03-08 |
Appealing for Efficient, Well Organized Clinical Trials on COVID-19 (edit) |
10.1101/2020.03.05.20031476 |
| 2020-03-08 |
Acute Myocardial Injury of Patients with Coronavirus Disease 2019 (edit) |
10.1101/2020.03.05.20031591 |
| 2020-03-08 |
A data-driven assessment of early travel restrictions related to the spreading of the novel COVID-19 within mainland China (edit) |
10.1101/2020.03.05.20031740 |
| 2020-03-08 |
Estimating the generation interval for COVID-19 based on symptom onset data (edit) |
10.1101/2020.03.05.20031815 |
| 2020-03-08 |
A mathematical model for estimating the age-specific transmissibility of a novel coronavirus (edit) |
10.1101/2020.03.05.20031849 |
| 2020-03-08 |
Role of temperature and humidity in the modulation of the doubling time of COVID-19 cases (edit) |
10.1101/2020.03.05.20031872 |
| 2020-03-08 |
Emotional responses and coping strategies of nurses and nursing college students during COVID-19 outbreak (edit) |
10.1101/2020.03.05.20031898 |
| 2020-03-08 |
COVID-19 early warning score: a multi-parameter screening tool to identify highly suspected patients (edit) |
10.1101/2020.03.05.20031906 |
| 2020-03-08 |
The prevalence and influencing factors for anxiety in medical workers fighting COVID-19 in China: A cross-sectional survey (edit) |
10.1101/2020.03.05.20032003 |
| 2020-03-08 |
Amplicon based MinION sequencing of SARS-CoV-2 and metagenomic characterisation of nasopharyngeal swabs from patients with COVID-19 (edit) |
10.1101/2020.03.05.20032011 |
| 2020-03-08 |
Direct RNA sequencing and early evolution of SARS-CoV-2 (edit) |
10.1101/2020.03.05.976167 |
| 2020-03-08 |
LY6E impairs coronavirus fusion and confers immune control of viral disease (edit) |
10.1101/2020.03.05.979260 |
| 2020-03-08 |
Estimating the scale of COVID-19 Epidemic in the United States: Simulations Based on Air Traffic directly from Wuhan, China (edit) |
10.1101/2020.03.06.20031880 |
| 2020-03-08 |
Transmission of corona virus disease 2019 during the incubation period may lead to a quarantine loophole (edit) |
10.1101/2020.03.06.20031955 |
| 2020-03-08 |
CORONAVIRUS IN PREGNANCY AND DELIVERY: RAPID REVIEW AND EXPERT CONSENSUS (edit) |
10.1101/2020.03.06.20032144 |
| 2020-03-08 |
Evaluating the secondary transmission pattern and epidemic prediction of the COVID-19 in metropolitan areas of China (edit) |
10.1101/2020.03.06.20032177 |
| 2020-03-08 |
Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites (edit) |
10.1101/2020.03.06.977876 |
| 2020-03-08 |
Monoclonal antibodies for the S2 subunit of spike of SARS-CoV cross-react with the newly-emerged SARS-CoV-2 (edit) |
10.1101/2020.03.06.980037 |
| 2020-03-08 |
[Biological characters analysis of COVID-19 patient accompanied with aplastic anemia] (edit) |
10.3760/CMA.J.ISSN.0253-2727.2020.0003 |
| 2020-03-08 |
[Screening and management of asymptomatic infection of corona virus disease 2019 (COVID-19)] (edit) |
10.3760/CMA.J.CN112150-20200229-00220 |
| 2020-03-08 |
An outbreak of COVID-19 caused by a new coronavirus: what we know so far (edit) |
10.5694/MJA2.50530 |
| 2020-03-08 |
Is SARS-CoV-2 originated from laboratory? A rebuttal to the claim of formation via laboratory recombination (edit) |
10.1080/22221751.2020.1738279 |
| 2020-03-08 |
Positive result of Sars-Cov-2 in sputum from a cured patient with COVID-19 (edit) |
10.1016/J.TMAID.2020.101619 |
| 2020-03-08 |
Understanding Unreported Cases in the COVID-19 Epidemic Outbreak in Wuhan, China, and the Importance of Major Public Health Interventions (edit) |
10.3390/BIOLOGY9030050 |
| 2020-03-07 |
ddPCR: a more sensitive and accurate tool for SARS-CoV-2 detection in low viral load specimens (edit) |
10.1101/2020.02.29.20029439 |
| 2020-03-07 |
68 Consecutive patients assessed for COVID-19 infection; experience from a UK regional infectious disease unit (edit) |
10.1101/2020.02.29.20029462 |
| 2020-03-07 |
Epidemiologic Characteristics of COVID-19 in Guizhou, China (edit) |
10.1101/2020.03.01.20028944 |
| 2020-03-07 |
Risk estimation and prediction by modeling the transmission of the novel coronavirus (COVID-19) in mainland China excluding Hubei province (edit) |
10.1101/2020.03.01.20029629 |
| 2020-03-07 |
Evaluation of the potential incidence of COVID-19 and effectiveness of contention measures in Spain: a data-driven approach (edit) |
10.1101/2020.03.01.20029801 |
| 2020-03-07 |
The effect of human mobility and control measures on the COVID-19 epidemic in China (edit) |
10.1101/2020.03.02.20026708 |
| 2020-03-07 |
Transmission and clinical characteristics of coronavirus disease 2019 in 104 outside-Wuhan patients, China (edit) |
10.1101/2020.03.04.20026005 |
| 2020-03-07 |
Nanopore target sequencing for accurate and comprehensive detection of SARS-CoV-2 and other respiratory viruses (edit) |
10.1101/2020.03.04.20029538 |
| 2020-03-07 |
[Analysis of the pregnancy outcomes in pregnant women with COVID-19 in Hubei Province] (edit) |
10.3760/CMA.J.CN112141-20200218-00111 |
| 2020-03-07 |
COVID-19 Therapeutic and Prevention (edit) |
10.1016/J.IJANTIMICAG.2020.105937 |
| 2020-03-07 |
Positive rate of RT-PCR detection of SARS-CoV-2 infection in 4880 cases from one hospital in Wuhan, China, from Jan to Feb 2020 (edit) |
10.1016/J.CCA.2020.03.009 |
| 2020-03-07 |
2019 novel coronavirus (2019-nCoV) outbreak: A new challenge (edit) |
10.1016/J.JGAR.2020.02.021 |
| 2020-03-07 |
A systematic review investigating the effectiveness of face mask use in limiting the spread of COVID-19 among medically not diagnosed individuals: shedding light on current recommendations provided to individuals not medically diagnosed with COVID-19 (edit) |
10.21203/RS.3.RS-16701/V1 |
| 2020-03-06 |
Active Monitoring of Persons Exposed to Patients with Confirmed COVID-19 — United States, January–February 2020 (edit) |
10.15585/MMWR.MM6909E1 |
| 2020-03-06 |
Novel Coronavirus (2019-nCoV) Situation Report in France 0306 (edit) |
|
| 2020-03-06 |
Trump claims public health warnings on covid-19 are a conspiracy against him (edit) |
10.1136/BMJ.M941 |
| 2020-03-06 |
The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak (edit) |
10.1126/SCIENCE.ABA9757 |
| 2020-03-06 |
A nationwide survey of psychological distress among Chinese people in the COVID-19 epidemic: implications and policy recommendations (edit) |
10.1136/GPSYCH-2020-100213 |
| 2020-03-06 |
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein (edit) |
10.1016/J.CELL.2020.02.058 |
| 2020-03-06 |
Are high-performing health systems resilient against the COVID-19 epidemic? (edit) |
10.1016/S0140-6736(20)30551-1 |
| 2020-03-06 |
Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus (2019-nCoV) related coronavirus model (edit) |
10.1097/CM9.0000000000000797 |
| 2020-03-06 |
Covid-19: are we getting the communications right? (edit) |
10.1136/BMJ.M919 |
| 2020-03-06 |
How does the outbreak of 2019-nCoV spread in mainland China? A retrospective analysis of the dynamic transmission routes (edit) |
10.1101/2020.03.01.20029645 |
| 2020-03-06 |
The potential role of IL-6 in monitoring severe case of coronavirus disease 2019 (edit) |
10.1101/2020.03.01.20029769 |
| 2020-03-06 |
Clinical and Laboratory Profiles of 75 Hospitalized Patients with Novel Coronavirus Disease 2019 in Hefei, China (edit) |
10.1101/2020.03.01.20029785 |
| 2020-03-06 |
Preliminary epidemiological analysis on children and adolescents with novel coronavirus disease 2019 outside Hubei Province, China: an observational study utilizing crowdsourced data (edit) |
10.1101/2020.03.01.20029884 |
| 2020-03-06 |
Close contacts and household transmission of SARS-CoV-2 in China: a content analysis based on local Heath Commissions' public disclosures. (edit) |
10.1101/2020.03.02.20029868 |
| 2020-03-06 |
Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome (edit) |
10.1101/2020.03.02.20029975 |
| 2020-03-06 |
The timing of one-shot interventions for epidemic control (edit) |
10.1101/2020.03.02.20030007 |
| 2020-03-06 |
Estimation of COVID-19 outbreak size in Italy based on international case exportations (edit) |
10.1101/2020.03.02.20030049 |
| 2020-03-06 |
Validity of Wrist and Forehead Temperature in Temperature Screening in the General Population During the Outbreak of 2019 Novel Coronavirus: a prospective real-world study (edit) |
10.1101/2020.03.02.20030148 |
| 2020-03-06 |
Estimating the burden of United States workers exposed to infection or disease: a key factor in containing risk of COVID-19 infection (edit) |
10.1101/2020.03.02.20030288 |
| 2020-03-06 |
Preliminary estimating the reproduction number of the coronavirus disease (COVID-19) outbreak in Republic of Korea and Italy by 5 March 2020 (edit) |
10.1101/2020.03.02.20030312 |
| 2020-03-06 |
Preliminary estimation of the novel coronavirus disease (COVID-19) cases in Iran: a modelling analysis based on overseas cases and air travel data (edit) |
10.1101/2020.03.02.20030320 |
| 2020-03-06 |
Clinical features and outcomes of 221 patients with COVID-19 in Wuhan, China (edit) |
10.1101/2020.03.02.20030452 |
| 2020-03-06 |
Rapid metagenomic characterization of a case of imported COVID-19 in Cambodia (edit) |
10.1101/2020.03.02.968818 |
| 2020-03-06 |
Viral Architecture of SARS-CoV-2 with Post-Fusion Spike Revealed by Cryo-EM (edit) |
10.1101/2020.03.02.972927 |
| 2020-03-06 |
A novel bat coronavirus reveals natural insertions at the S1/S2 cleavage site of the Spike protein and a possible recombinant origin of HCoV-19 (edit) |
10.1101/2020.03.02.974139 |
| 2020-03-06 |
Partial RdRp sequences offer a robust method for Coronavirus subgenus classification (edit) |
10.1101/2020.03.02.974311 |
| 2020-03-06 |
Effect of non-pharmaceutical interventions for containing the COVID-19 outbreak in China (edit) |
10.1101/2020.03.03.20029843 |
| 2020-03-06 |
Transmission interval estimates suggest pre-symptomatic spread of COVID-19 (edit) |
10.1101/2020.03.03.20029983 |
| 2020-03-06 |
Epidemiological and clinical features of 291 cases with coronavirus disease 2019 in areas adjacent to Hubei, China: a double-center observational study (edit) |
10.1101/2020.03.03.20030353 |
| 2020-03-06 |
Restoration of leukomonocyte counts is associated with viral clearance in COVID-19 hospitalized patients (edit) |
10.1101/2020.03.03.20030437 |
| 2020-03-06 |
Modelling-based evaluation of the effect of quarantine control by the Chinese government in the coronavirus disease 2019 outbreak (edit) |
10.1101/2020.03.03.20030445 |
| 2020-03-06 |
Evolving Epidemiology and Impact of Non-pharmaceutical Interventions on the Outbreak of Coronavirus Disease 2019 in Wuhan, China (edit) |
10.1101/2020.03.03.20030593 |
| 2020-03-06 |
SOCRATES: An online tool leveraging a social contact data sharing initiative to assess mitigation strategies for COVID-19 (edit) |
10.1101/2020.03.03.20030627 |
| 2020-03-06 |
Immunodepletion with Hypoxemia: A Potential High Risk Subtype of Coronavirus Disease 2019 (edit) |
10.1101/2020.03.03.20030650 |
| 2020-03-06 |
Clinical findings in critical ill patients infected with SARS-Cov-2 in Guangdong Province, China: a multi-center, retrospective, observational study (edit) |
10.1101/2020.03.03.20030668 |
| 2020-03-06 |
Key Points of Clinical and CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV) Imported Pneumonia Based On 21 Cases Analysis (edit) |
10.1101/2020.03.03.20030775 |
| 2020-03-06 |
Caution: The clinical characteristics of COVID-19 patients at admission are changing (edit) |
10.1101/2020.03.03.20030833 |
| 2020-03-06 |
Prediction of New Coronavirus Infection Based on a Modified SEIR Model (edit) |
10.1101/2020.03.03.20030858 |
| 2020-03-06 |
Psychological impact of the coronavirus disease 2019 (COVID-19) outbreak on healthcare workers in China (edit) |
10.1101/2020.03.03.20030874 |
| 2020-03-06 |
Clinical Features of Patients Infected with the 2019 Novel Coronavirus (COVID-19) in Shanghai, China (edit) |
10.1101/2020.03.04.20030395 |
| 2020-03-06 |
Serological detection of 2019-nCoV respond to the epidemic: A useful complement to nucleic acid testing (edit) |
10.1101/2020.03.04.20030916 |
| 2020-03-06 |
Study of the mental health status of medical personnel dealing with new coronavirus pneumonia (edit) |
10.1101/2020.03.04.20030973 |
| 2020-03-06 |
Case fatality risk of novel coronavirus diseases 2019 in China (edit) |
10.1101/2020.03.04.20031005 |
| 2020-03-06 |
Clinical characteristics of 101 non-surviving hospitalized patients with COVID-19: A single center, retrospective study (edit) |
10.1101/2020.03.04.20031039 |
| 2020-03-06 |
How to differentiate COVID-19 pneumonia from heart failure with computed tomography at initial medical contact during epidemic period (edit) |
10.1101/2020.03.04.20031047 |
| 2020-03-06 |
Adjusted age-specific case fatality ratio during the COVID-19 epidemic in Hubei, China, January and February 2020 (edit) |
10.1101/2020.03.04.20031104 |
| 2020-03-06 |
Projecting the transmission dynamics of SARS-CoV-2 through the post-pandemic period (edit) |
10.1101/2020.03.04.20031112 |
| 2020-03-06 |
Human Kidney is a Target for Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (edit) |
10.1101/2020.03.04.20031120 |
| 2020-03-06 |
The impact of social distancing and epicenter lockdown on the COVID-19 epidemic in mainland China: A data-driven SEIQR model study (edit) |
10.1101/2020.03.04.20031187 |
| 2020-03-06 |
A pilot study of hydroxychloroquine in treatment of patients with common coronavirus disease-19 (COVID-19) (edit) |
10.3785/J.ISSN.1008-9292.2020.03.03 |
| 2020-03-06 |
[Advances on presymptomatic or asymptomatic carrier transmission of COVID-19] (edit) |
10.3760/CMA.J.CN112338-20200228-00207 |
| 2020-03-06 |
[Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19] (edit) |
10.3760/CMA.J.CN112148-20200225-00123 |
| 2020-03-06 |
The transmission and diagnosis of 2019 novel coronavirus infection disease (COVID-19): A Chinese perspective (edit) |
10.1002/JMV.25749 |
| 2020-03-06 |
Transmission dynamics of the COVID-19 outbreak and effectiveness of government interventions: A data-driven analysis (edit) |
10.1002/JMV.25750 |
| 2020-03-06 |
Patients with RT-PCR Confirmed COVID-19 and Normal Chest CT (edit) |
10.1148/RADIOL.2020200702 |
| 2020-03-06 |
FDG PET/CT of COVID-19 (edit) |
10.1148/RADIOL.2020200770 |
| 2020-03-06 |
What can early Canadian experience screening for COVID-19 teach us about how to prepare for a pandemic? (edit) |
10.1503/CMAJ.200305 |
| 2020-03-06 |
What we do when a COVID-19 patient needs an operation: operating room preparation and guidance (edit) |
10.1007/S12630-020-01617-4 |
| 2020-03-06 |
Reasons for healthcare workers becoming infected with novel coronavirus disease 2019 (COVID-19) in China (edit) |
10.1016/J.JHIN.2020.03.002 |
| 2020-03-06 |
Arguments in favour of remdesivir for treating SARS-CoV-2 infections (edit) |
10.1016/J.IJANTIMICAG.2020.105933 |
| 2020-03-06 |
A confirmed asymptomatic carrier of 2019 novel coronavirus (SARS-CoV-2) (edit) |
10.1097/CM9.0000000000000798 |
| 2020-03-06 |
High-throughput sequencing for confirmation of suspected 2019-nCoV infection identified by fluorescence quantitative polymerase chain reaction (edit) |
10.1097/CM9.0000000000000792 |
| 2020-03-06 |
Managing neonates with respiratory failure due to SARS-CoV-2 - Authors' reply (edit) |
10.1016/S2352-4642(20)30072-9 |
| 2020-03-06 |
Managing neonates with respiratory failure due to SARS-CoV-2 (edit) |
10.1016/S2352-4642(20)30073-0 |
| 2020-03-06 |
SARS-CoV-2 is an appropriate name for the new coronavirus (edit) |
10.1016/S0140-6736(20)30557-2 |
| 2020-03-06 |
COVID-19: the gendered impacts of the outbreak (edit) |
10.1016/S0140-6736(20)30526-2 |
| 2020-03-06 |
And now for something completely different: from 2019-nCoV and COVID-19 to 2020-nMan (edit) |
10.1016/J.PULMOE.2020.02.010 |
| 2020-03-06 |
Duration of quarantine in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a question needing an answer (edit) |
10.1016/J.JHIN.2020.03.003 |
| 2020-03-06 |
Immediate Psychological Responses and Associated Factors during the Initial Stage of the 2019 Coronavirus Disease (COVID-19) Epidemic among the General Population in China (edit) |
10.3390/IJERPH17051729 |
| 2020-03-06 |
The outbreak of SARS-CoV-2 pneumonia calls for viral vaccines (edit) |
10.1038/S41541-020-0170-0 |
| 2020-03-06 |
Covid-19 spreads in US (edit) |
10.1016/S0262-4079(20)30472-3 |
| 2020-03-05 |
Predicting the Angiotensin Converting Enzyme 2 (ACE2) Utilizing Capability as the Receptor of SARS-CoV-2 (edit) |
10.20944/PREPRINTS202003.0091.V1 |
| 2020-03-05 |
First Case of 2019 Novel Coronavirus in the United States (edit) |
10.1056/NEJMOA2001191 |
| 2020-03-05 |
Novel Coronavirus (2019-nCoV) Situation Report in France 0305 (edit) |
|
| 2020-03-05 |
Covid-19: 90% of cases will hit NHS over nine week period, chief medical officer warns (edit) |
10.1136/BMJ.M918 |
| 2020-03-05 |
Coronavirus disease 2019 (covid-19): a guide for UK GPs (edit) |
10.1136/BMJ.M800 |
| 2020-03-05 |
Molecular immune pathogenesis and diagnosis of COVID-19 (edit) |
10.1016/J.JPHA.2020.03.001 |
| 2020-03-05 |
Effective Treatment of Severe COVID-19 Patients with Tocilizumab (edit) |
|
| 2020-03-05 |
Monitoring Disease Transmissibility of 2019 Novel Coronavirus Disease in Zhejiang, China (edit) |
10.1101/2020.03.02.20028704 |
| 2020-03-05 |
Epidemiology and Transmission of COVID-19 in Shenzhen China: Analysis of 391 cases and 1,286 of their close contacts (edit) |
10.1101/2020.03.03.20028423 |
| 2020-03-05 |
Strong evolutionary convergence of receptor-binding protein spike between COVID-19 and SARS-related coronaviruses (edit) |
10.1101/2020.03.04.975995 |
| 2020-03-05 |
Escalating infection control response to the rapidly evolving epidemiology of the coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 in Hong Kong (edit) |
10.1017/ICE.2020.58 |
| 2020-03-05 |
The novel coronavirus (COVID-19) infection in Hangzhou: An experience to share (edit) |
10.1017/ICE.2020.62 |
| 2020-03-05 |
The Effects of Social Support on Sleep Quality of Medical Staff Treating Patients with Coronavirus Disease 2019 (COVID-19) in January and February 2020 in China (edit) |
10.12659/MSM.923549 |
| 2020-03-05 |
[Characteristics, causes, diagnosis and treatment of coagulation dysfunction in patients with COVID-19] (edit) |
10.3760/CMA.J.ISSN.0253-2727.2020.0002 |
| 2020-03-05 |
[Analysis of bronchoscope-guided tracheal intubation in 12 cases with COVID-19 under the personal protective equipment with positive pressure protective hood] (edit) |
10.3760/CMA.J.CN112147-20200222-00153 |
| 2020-03-05 |
[Investigation and analysis on characteristics of a cluster of COVID-19 associated with exposure in a department store in Tianjin] (edit) |
10.3760/CMA.J.CN112338-20200221-00139 |
| 2020-03-05 |
[Epidemiological analysis on a family cluster of COVID-19] (edit) |
10.3760/CMA.J.CN112338-20200221-00147 |
| 2020-03-05 |
[WITHDRAWN: Potential false-positive rate among the 'asymptomatic infected individuals' in close contacts of COVID-19 patients] (edit) |
10.3760/CMA.J.CN112338-20200221-00144 |
| 2020-03-05 |
Effective Chemicals against Novel Coronavirus (COVID-19) in China (edit) |
10.2174/1568026620999200305145032 |
| 2020-03-05 |
Coronavirus Disease COVID-19: A New Threat to Public Health (edit) |
10.2174/1568026620999200305144319 |
| 2020-03-05 |
Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures (edit) |
10.1002/JMV.25748 |
| 2020-03-05 |
Clinical and CT features in pediatric patients with COVID-19 infection: Different points from adults (edit) |
10.1002/PPUL.24718 |
| 2020-03-05 |
What we know so far: COVID-19 current clinical knowledge and research (edit) |
10.7861/CLINMED.2019-CORON |
| 2020-03-05 |
SARS-CoV-2 induced diarrhoea as onset symptom in patient with COVID-19 (edit) |
10.1136/GUTJNL-2020-320891 |
| 2020-03-05 |
COVID-19 and the cardiovascular system (edit) |
10.1038/S41569-020-0360-5 |
| 2020-03-05 |
Novel corona virus disease (COVID-19) in pregnancy: What clinical recommendations to follow? (edit) |
10.1111/AOGS.13836 |
| 2020-03-05 |
Lymphopenic community acquired pneumonia as signature of severe COVID-19 infection (edit) |
10.1016/J.JINF.2020.02.029 |
| 2020-03-05 |
Identification of the hyper-variable genomic hotspot for the novel coronavirus SARS-CoV-2 (edit) |
10.1016/J.JINF.2020.02.027 |
| 2020-03-05 |
Public health might be endangered by possible prolonged discharge of SARS-CoV-2 in stool (edit) |
10.1016/J.JINF.2020.02.031 |
| 2020-03-05 |
Remdesivir as a possible therapeutic option for the COVID-19 (edit) |
10.1016/J.TMAID.2020.101615 |
| 2020-03-05 |
Taking the right measures to control COVID-19 (edit) |
10.1016/S1473-3099(20)30152-3 |
| 2020-03-05 |
Can we contain the COVID-19 outbreak with the same measures as for SARS? (edit) |
10.1016/S1473-3099(20)30129-8 |
| 2020-03-05 |
Respiratory support for patients with COVID-19 infection (edit) |
10.1016/S2213-2600(20)30110-7 |
| 2020-03-05 |
Diagnosis of SARS-CoV-2 Infection based on CT scan vs. RT-PCR: Reflecting on Experience from MERS-CoV (edit) |
10.1016/J.JHIN.2020.03.001 |
| 2020-03-05 |
Recurrence of positive SARS-CoV-2 RNA in COVID-19: A case report (edit) |
10.1016/J.IJID.2020.03.003 |
| 2020-03-05 |
The Treatment and Outcome of a Lung Cancer Patient Infected with SARS-CoV-2 (edit) |
10.1016/J.JTHO.2020.02.025 |
| 2020-03-05 |
A case of 2019 novel coronavirus infected pneumonia with twice negative 2019-nCoV nucleic acid testing within 8 days (edit) |
10.1097/CM9.0000000000000788 |
| 2020-03-05 |
Co-infections of SARS-CoV-2 with multiple common respiratory pathogens in infected patients (edit) |
10.1007/S11427-020-1668-5 |
| 2020-03-05 |
Structural, glycosylation and antigenic variation between 2019 novel coronavirus (2019-nCoV) and SARS coronavirus (SARS-CoV) (edit) |
10.1007/S13337-020-00571-5 |
| 2020-03-05 |
Insight Derived from Molecular Docking and Molecular Dynamics Simulations into the Binding Interactions Between HIV-1 Protease Inhibitors and SARS-CoV-2 3CLpro (edit) |
10.26434/CHEMRXIV.11932995 |
| 2020-03-05 |
Insight Derived from Molecular Docking and Molecular Dynamics Simulations into the Binding Interactions Between HIV-1 Protease Inhibitors and SARS-CoV-2 3CLpro (edit) |
10.26434/CHEMRXIV.11932995.V1 |
| 2020-03-04 |
Novel Coronavirus (2019-nCoV) Situation Report in France (edit) |
|
| 2020-03-04 |
CT Imaging and Differential Diagnosis of COVID-19 (edit) |
10.1177/0846537120913033 |
| 2020-03-04 |
COVID-19: What Can We Learn From Stories From the Trenches? (edit) |
10.1177/0846537120913497 |
| 2020-03-04 |
Genomic diversity of SARS-CoV-2 in Coronavirus Disease 2019 patients (edit) |
10.1093/CID/CIAA203 |
| 2020-03-04 |
Covid-19: hoarding and misuse of protective gear is jeopardising the response, WHO warns (edit) |
10.1136/BMJ.M869 |
| 2020-03-04 |
Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China (edit) |
10.1007/S11427-020-1661-4 |
| 2020-03-04 |
Insights into the Recent 2019 Novel Coronavirus (SARS-CoV-2) in Light of Past Human Coronavirus Outbreaks (edit) |
10.3390/PATHOGENS9030186 |
| 2020-03-04 |
Li Wenliang, a face to the frontline healthcare worker. The first doctor to notify the emergence of the SARS-CoV-2, (COVID-19), outbreak (edit) |
10.1016/J.IJID.2020.02.052 |
| 2020-03-04 |
Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2 (edit) |
10.1126/SCIENCE.ABB2762 |
| 2020-03-04 |
Review of the Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) (edit) |
10.1007/S11606-020-05762-W |
| 2020-03-04 |
Chloroquine and hydroxychloroquine as available weapons to fight COVID-19 (edit) |
10.1016/J.IJANTIMICAG.2020.105932 |
| 2020-03-04 |
Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2 (edit) |
10.2210/PDB6VXS/PDB |
| 2020-03-04 |
Crystal structure of the free enzyme of the SARS-CoV-2 (2019-nCoV) main protease (edit) |
10.2210/PDB6Y2E/PDB |
| 2020-03-04 |
Crystal structure (monoclinic form) of the complex resulting from the reaction between SARS-CoV-2 (2019-nCoV) main protease and tert-butyl (1-((S)-1-(((S)-4-(benzylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)amino)-3-cyclopropyl-1-oxoprop (edit) |
10.2210/PDB6Y2F/PDB |
| 2020-03-04 |
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor (edit) |
10.1016/J.CELL.2020.02.052 |
| 2020-03-04 |
Déjà Vu or Jamais Vu? How the Severe Acute Respiratory Syndrome Experience Influenced a Singapore Radiology Department's Response to the Coronavirus Disease (COVID-19) Epidemic (edit) |
10.2214/AJR.20.22927 |
| 2020-03-04 |
COVID-19, Australia: Epidemiology Report 5: Reporting week ending 19:00 AEDT 29 February 2020 (edit) |
10.33321/CDI.2020.44.20 |
| 2020-03-04 |
Relations of parameters for describing the epidemic of COVID―19 by the Kermack―McKendrick model (edit) |
10.1101/2020.02.26.20027797 |
| 2020-03-04 |
Analysis of epidemiological characteristics of coronavirus 2019 infection and preventive measures in Shenzhen China: a heavy population city (edit) |
10.1101/2020.02.28.20028555 |
| 2020-03-04 |
The Impact of the COVID-19 Outbreak on the Medical Treatment of Chinese Children with Chronic Kidney Disease (CKD)：A Multicenter Cross-section Study in the Context of a Public Health Emergency of International Concern (edit) |
10.1101/2020.02.28.20029199 |
| 2020-03-04 |
Association of Cardiovascular Manifestations with In-hospital Outcomes in Patients with COVID-19: A Hospital Staff Data (edit) |
10.1101/2020.02.29.20029348 |
| 2020-03-04 |
Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study (edit) |
10.1101/2020.03.01.20029074 |
| 2020-03-04 |
Epidemiological and clinical features of 2019-nCoV acute respiratory disease cases in Chongqing municipality, China: a retrospective, descriptive, multiple-center study (edit) |
10.1101/2020.03.01.20029397 |
| 2020-03-04 |
Systematic Review of the Registered Clinical Trials of Coronavirus Disease 2019 (COVID-19) (edit) |
10.1101/2020.03.01.20029611 |
| 2020-03-04 |
COVID-19 Epidemic Outside China: 34 Founders and Exponential Growth (edit) |
10.1101/2020.03.01.20029819 |
| 2020-03-04 |
Clinical Characteristics of Patients with Severe Pneumonia Caused by the 2019 Novel Coronavirus in Wuhan, China (edit) |
10.1101/2020.03.02.20029306 |
| 2020-03-04 |
Isolation and characterization of SARS-CoV-2 from the first US COVID-19 patient (edit) |
10.1101/2020.03.02.972935 |
| 2020-03-04 |
Hematologic parameters in patients with COVID-19 infection (edit) |
10.1002/AJH.25774 |
| 2020-03-04 |
Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics (edit) |
10.1002/DDR.21656 |
| 2020-03-04 |
[Prediction modeling with data fusion and prevention strategy analysis for the COVID-19 outbreak] (edit) |
10.3760/CMA.J.CN112338-20200216-00107 |
| 2020-03-04 |
Air, Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From a Symptomatic Patient (edit) |
10.1001/JAMA.2020.3227 |
| 2020-03-04 |
A glimpse into the origins of genetic diversity in SARS-CoV-2 (edit) |
10.1093/CID/CIAA213 |
| 2020-03-04 |
Coronavirus Disease 2019 (COVID-19): Role of Chest CT in Diagnosis and Management (edit) |
10.2214/AJR.20.22954 |
| 2020-03-04 |
From the frontline of COVID-19 - How prepared are we as obstetricians: a commentary (edit) |
10.1111/1471-0528.16192 |
| 2020-03-04 |
[Mental health survey of 230 medical staff in a tertiary infectious disease hospital for COVID-19] (edit) |
10.3760/CMA.J.CN121094-20200219-00063 |
| 2020-03-04 |
Improved molecular diagnosis of COVID-19 by the novel, highly sensitive and specific COVID-19-RdRp/Hel real-time reverse transcription-polymerase chain reaction assay validated in vitro and with clinical specimens (edit) |
10.1128/JCM.00310-20 |
| 2020-03-04 |
Novel antibody epitopes dominate the antigenicity of spike glycoprotein in SARS-CoV-2 compared to SARS-CoV (edit) |
10.1038/S41423-020-0385-Z |
| 2020-03-04 |
Mitigate the effects of home confinement on children during the COVID-19 outbreak (edit) |
10.1016/S0140-6736(20)30547-X |
| 2020-03-04 |
Has China faced only a herald wave of SARS-CoV-2? (edit) |
10.1016/S0140-6736(20)30521-3 |
| 2020-03-04 |
Outbreak investigation for COVID-19 in northern Vietnam (edit) |
10.1016/S1473-3099(20)30159-6 |
| 2020-03-04 |
Covert COVID-19 and false-positive dengue serology in Singapore (edit) |
10.1016/S1473-3099(20)30158-4 |
| 2020-03-04 |
Liver injury in COVID-19: management and challenges (edit) |
10.1016/S2468-1253(20)30057-1 |
| 2020-03-04 |
Clinical manifestations and outcome of SARS-CoV-2 infection during pregnancy (edit) |
10.1016/J.JINF.2020.02.028 |
| 2020-03-04 |
Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis (edit) |
10.1016/J.CCA.2020.03.004 |
| 2020-03-04 |
Traditional Chinese medicine for COVID-19 treatment (edit) |
10.1016/J.PHRS.2020.104743 |
| 2020-03-04 |
A conceptual model for the coronavirus disease 2019 (COVID-19) outbreak in Wuhan, China with individual reaction and governmental action (edit) |
10.1016/J.IJID.2020.02.058 |
| 2020-03-04 |
Serial interval of novel coronavirus (COVID-19) infections (edit) |
10.1016/J.IJID.2020.02.060 |
| 2020-03-04 |
Iranian mental health during the COVID-19 epidemic (edit) |
10.1016/J.AJP.2020.101990 |
| 2020-03-04 |
Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths (edit) |
10.1016/J.JMII.2020.02.012 |
| 2020-03-04 |
The 2019-nCoV epidemic control strategies and future challenges of building healthy smart cities (edit) |
10.1177/1420326X20910408 |
| 2020-03-03 |
On the origin and continuing evolution of SARS-CoV-2 (edit) |
10.1093/NSR/NWAA036 |
| 2020-03-03 |
Risk of COVID-19 for patients with cancer (edit) |
10.1016/S1470-2045(20)30149-2 |
| 2020-03-03 |
COVID-19: a novel coronavirus and a novel challenge for critical care (edit) |
10.1007/S00134-020-05955-1 |
| 2020-03-03 |
Coronavirus Disease 2019 (COVID-19): A critical care perspective beyond China (edit) |
10.1016/J.ACCPM.2020.03.001 |
| 2020-03-03 |
Response to COVID-19 in Taiwan: Big Data Analytics, New Technology, and Proactive Testing (edit) |
10.1001/JAMA.2020.3151 |
| 2020-03-03 |
Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China (edit) |
10.1007/S00134-020-05991-X |
| 2020-03-03 |
Guidelines for pregnant women with suspected SARS-CoV-2 infection (edit) |
10.1016/S1473-3099(20)30157-2 |
| 2020-03-03 |
Mass masking in the COVID-19 epidemic: people need guidance (edit) |
10.1016/S0140-6736(20)30520-1 |
| 2020-03-03 |
Crystal structure of Nsp15 endoribonuclease NendoU from SARS-CoV-2 (edit) |
10.1101/2020.03.02.968388 |
| 2020-03-03 |
Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target (edit) |
10.1007/S00134-020-05985-9 |
| 2020-03-03 |
Predictions for the binding domain and potential new drug targets of 2019-nCoV (edit) |
10.1101/2020.02.26.961938 |
| 2020-03-03 |
Strategies for vaccine design for corona virus using Immunoinformatics techniques (edit) |
10.1101/2020.02.27.967422 |
| 2020-03-03 |
Molecular Dynamics Simulations Indicate the SARS-CoV-2 Mpro Is Not a Viable Target for Small-Molecule Inhibitors Design (edit) |
10.1101/2020.02.27.968008 |
| 2020-03-03 |
Comparative genomic analysis revealed specific mutation pattern between human coronavirus SARS-CoV-2 and Bat-SARSr-CoV RaTG13 (edit) |
10.1101/2020.02.27.969006 |
| 2020-03-03 |
Epidemiological and clinical features of COVID-19 patients with and without pneumonia in Beijing, China (edit) |
10.1101/2020.02.28.20028068 |
| 2020-03-03 |
Risk factors related to hepatic injury in patients with corona virus disease 2019 (edit) |
10.1101/2020.02.28.20028514 |
| 2020-03-03 |
Clinical significance of IgM and IgG test for diagnosis of highly suspected COVID-19 infection (edit) |
10.1101/2020.02.28.20029025 |
| 2020-03-03 |
Highly ACE2 Expression in Pancreas May Cause Pancreas Damage After SARS-CoV-2 Infection (edit) |
10.1101/2020.02.28.20029181 |
| 2020-03-03 |
Closed environments facilitate secondary transmission of coronavirus disease 2019 (COVID-19) (edit) |
10.1101/2020.02.28.20029272 |
| 2020-03-03 |
Precautions are Needed for COVID-19 Patients with Coinfection of Common Respiratory Pathogens (edit) |
10.1101/2020.02.29.20027698 |
| 2020-03-03 |
Vicarious traumatization in the general public, members, and non-members of medical teams aiding in COVID-19 control (edit) |
10.1101/2020.02.29.20029322 |
| 2020-03-03 |
The spatiotemporal estimation of the dynamic risk and the international transmission of 2019 Novel Coronavirus (COVID-19) outbreak: A global perspective (edit) |
10.1101/2020.02.29.20029413 |
| 2020-03-03 |
An epidemiological forecast model and software assessing interventions on COVID-19 epidemic in China (edit) |
10.1101/2020.02.29.20029421 |
| 2020-03-03 |
Detectable serum SARS-CoV-2 viral load (RNAaemia) is closely associated with drastically elevated interleukin 6 (IL-6) level in critically ill COVID-19 patients (edit) |
10.1101/2020.02.29.20029520 |
| 2020-03-03 |
A simple model to assess Wuhan lock-down effect and region efforts during COVID-19 epidemic in China Mainland (edit) |
10.1101/2020.02.29.20029561 |
| 2020-03-03 |
Machine learning-based CT radiomics model for predicting hospital stay in patients with pneumonia associated with SARS-CoV-2 infection: A multicenter study (edit) |
10.1101/2020.02.29.20029603 |
| 2020-03-03 |
The within-host viral kinetics of SARS-CoV-2 (edit) |
10.1101/2020.02.29.965418 |
| 2020-03-03 |
The 2019 coronavirus (SARS-CoV-2) surface protein (Spike) S1 Receptor Binding Domain undergoes conformational change upon heparin binding (edit) |
10.1101/2020.02.29.971093 |
| 2020-03-03 |
An ultrasensitive, rapid, and portable coronavirus SARS-CoV-2 sequence detection method based on CRISPR-Cas12 (edit) |
10.1101/2020.02.29.971127 |
| 2020-03-03 |
Effects of weather-related social distancing on city-scale transmission of respiratory viruses (edit) |
10.1101/2020.03.02.20027599 |
| 2020-03-03 |
Forecasting the Cumulative Number of COVID-19 Deaths in China: a Boltzmann Function-based Modeling Study (edit) |
10.1101/2020.03.02.20030064 |
| 2020-03-03 |
Estimation of local novel coronavirus (COVID-19) cases in Wuhan, China from off-site reported cases and population flow data from different sources (edit) |
10.1101/2020.03.02.20030080 |
| 2020-03-03 |
Rapid Detection of SARS-CoV-2 Using Reverse transcription RT-LAMP method (edit) |
10.1101/2020.03.02.20030130 |
| 2020-03-03 |
Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019 (edit) |
10.1101/2020.03.02.20030189 |
| 2020-03-03 |
Multi-epitope vaccine design using an immunoinformatics approach for 2019 novel coronavirus in China (SARS-CoV-2) (edit) |
10.1101/2020.03.03.962332 |
| 2020-03-03 |
Immunoinformatics-aided identification of T cell and B cell epitopes in the surface glycoprotein of 2019-nCoV (edit) |
10.1002/JMV.25698 |
| 2020-03-03 |
[Thinking on Clinical rational use of TCM injection in the treatment of novel coronavirus pneumonia (COVID-19)] (edit) |
10.3760/CMA.J.ISSN.CN112137-20200221-00388 |
| 2020-03-03 |
Identification of COVID-19 Can be Quicker through Artificial Intelligence framework using a Mobile Phone-Based Survey in the Populations when Cities/Towns Are Under Quarantine (edit) |
10.1017/ICE.2020.61 |
| 2020-03-03 |
Analyzing the epidemiological outbreak of COVID-19: A visual exploratory data analysis approach (edit) |
10.1002/JMV.25743 |
| 2020-03-03 |
[Estimating the basic reproduction number of COVID-19 in Wuhan, China] (edit) |
10.3760/CMA.J.CN112338-20200210-00086 |
| 2020-03-03 |
[Novel coronavirus pneumonia (COVID-19) CT distribution and sign features] (edit) |
10.3760/CMA.J.CN112147-20200217-00106 |
| 2020-03-03 |
[Expert recommendations on the management of patients with advanced non-small cell lung cancer during epidemic of COVID-19 (Trial version)] (edit) |
10.3760/CMA.J.CN112147-20200221-00138 |
| 2020-03-03 |
[Epidemic trend of corona virus disease 2019 (COVID-19) in mainland China] (edit) |
10.3760/CMA.J.CN112150-20200222-00163 |
| 2020-03-03 |
Priorities for the US Health Community Responding to COVID-19 (edit) |
10.1001/JAMA.2020.3413 |
| 2020-03-03 |
Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore (edit) |
10.1001/JAMA.2020.3204 |
| 2020-03-03 |
The pandemic of social media panic travels faster than the COVID-19 outbreak (edit) |
10.1093/JTM/TAAA031 |
| 2020-03-03 |
Novel coronavirus (2019-nCoV): Update on 3rd Coronavirus Outbreak of 21st Century (edit) |
10.1093/QJMED/HCAA081 |
| 2020-03-03 |
Solidarity with China as it holds the global front line during COVID-19 outbreak (edit) |
10.1093/JTM/TAAA027 |
| 2020-03-03 |
Imaging changes in severe COVID-19 pneumonia (edit) |
10.1007/S00134-020-05976-W |
| 2020-03-03 |
Relation Between Chest CT Findings and Clinical Conditions of Coronavirus Disease (COVID-19) Pneumonia: A Multicenter Study (edit) |
10.2214/AJR.20.22976 |
| 2020-03-03 |
Helping the Radiologist: The Role of Scientific Journals to Help Prevent the Spread of COVID-19 (edit) |
10.1148/RADIOL.2020200661 |
| 2020-03-03 |
Covid-19: UK could delay non-urgent care and call doctors back from leave and retirement (edit) |
10.1136/BMJ.M854 |
| 2020-03-03 |
Transmission routes of 2019-nCoV and controls in dental practice (edit) |
10.1038/S41368-020-0075-9 |
| 2020-03-03 |
Evidence for Gastrointestinal Infection of SARS-CoV-2 (edit) |
10.1053/J.GASTRO.2020.02.055 |
| 2020-03-03 |
COVID-19: Gastrointestinal Manifestations and Potential Fecal-Oral Transmission (edit) |
10.1053/J.GASTRO.2020.02.054 |
| 2020-03-03 |
Association between 2019-nCoV transmission and N95 respirator use (edit) |
10.1016/J.JHIN.2020.02.021 |
| 2020-03-03 |
Effective strategies to prevent coronavirus disease-2019 (COVID-19) outbreak in hospital (edit) |
10.1016/J.JHIN.2020.02.022 |
| 2020-03-03 |
Practical experiences and suggestions for the 'eagle-eyed observer': a novel promising role for controlling nosocomial infection in the COVID-19 outbreak (edit) |
10.1016/J.JHIN.2020.02.020 |
| 2020-03-03 |
Clinical and CT imaging features of 2019 novel coronavirus disease (COVID-19) (edit) |
10.1016/J.JINF.2020.02.022 |
| 2020-03-03 |
Nonstructural proteins NS7b and NS8 are likely to be phylogenetically associated with evolution of 2019-nCoV (edit) |
10.1016/J.MEEGID.2020.104272 |
| 2020-03-03 |
The coronavirus 2019-nCoV epidemic: Is hindsight 20/20? (edit) |
10.1016/J.ECLINM.2020.100289 |
| 2020-03-03 |
Nepal's First Case of COVID-19 and public health response (edit) |
10.1093/TREEPHYS/TPAA024 |
| 2020-03-03 |
The SARS-CoV-2 Vaccine Pipeline: an Overview (edit) |
10.1007/S40475-020-00201-6 |
| 2020-03-03 |
The inflection point about COVID-19 may have passed (edit) |
10.1016/J.SCIB.2020.02.025 |
| 2020-03-03 |
Computational Prediction of Mutational Effects on the SARS-CoV-2 Binding by Relative Free Energy Calculations (edit) |
10.26434/CHEMRXIV.11902623 |
| 2020-03-03 |
Computational Prediction of Mutational Effects on the SARS-CoV-2 Binding by Relative Free Energy Calculations (edit) |
10.26434/CHEMRXIV.11902623.V2 |
| 2020-03-02 |
COVID-19 and the anti-lessons of history (edit) |
10.1016/S0140-6736(20)30468-2 |
| 2020-03-02 |
Covid-19: US health department staff sent to meet citizens returning from China weren’t protected, claims whistleblower (edit) |
10.1136/BMJ.M833 |
| 2020-03-02 |
First two months of the 2019 Coronavirus Disease (COVID-19) epidemic in China: real-time surveillance and evaluation with a second derivative model (edit) |
10.1186/S41256-020-00137-4 |
| 2020-03-02 |
Covid-19: a digital epidemic (edit) |
10.1136/BMJ.M764 |
| 2020-03-02 |
Screening of FDA-approved drugs using a MERS-CoV clinical isolate from South Korea identifies potential therapeutic options for COVID-19 (edit) |
10.1101/2020.02.25.965582 |
| 2020-03-02 |
Transmission characteristics of the COVID-19 outbreak in China: a study driven by data (edit) |
10.1101/2020.02.26.20028431 |
| 2020-03-02 |
CRISPR-based surveillance for COVID-19 using genomically-comprehensive machine learning design (edit) |
10.1101/2020.02.26.967026 |
| 2020-03-02 |
A machine learning-based model for survival prediction in patients with severe COVID-19 infection (edit) |
10.1101/2020.02.27.20028027 |
| 2020-03-02 |
Evaluation of Enzyme-Linked Immunoassay and Colloidal Gold- Immunochromatographic Assay Kit for Detection of Novel Coronavirus (SARS-Cov-2) Causing an Outbreak of Pneumonia (COVID-19) (edit) |
10.1101/2020.02.27.20028787 |
| 2020-03-02 |
Analysis on the Clinical Characteristics of 36 Cases of Novel Coronavirus Pneumonia in Kunming (edit) |
10.1101/2020.02.28.20029173 |
| 2020-03-02 |
Designing of a next generation multiepitope based vaccine (MEV) against SARS-COV-2: Immunoinformatics and in silico approaches (edit) |
10.1101/2020.02.28.970343 |
| 2020-03-02 |
Mutations, Recombination and Insertion in the Evolution of 2019-nCoV (edit) |
10.1101/2020.02.29.971101 |
| 2020-03-02 |
Kallikrein 13: a new player in coronaviral infections (edit) |
10.1101/2020.03.01.971499 |
| 2020-03-02 |
A Chinese Case of COVID-19 Did Not Show Infectivity During the Incubation Period: Based on an Epidemiological Survey (edit) |
10.3961/JPMPH.20.048 |
| 2020-03-02 |
[Cardiac manifestations of patients with COVID-19 pneumonia and related treatment recommendations] (edit) |
10.3760/CMA.J.ISSN.CN112148-20200213-00077 |
| 2020-03-02 |
[Diagnostic and therapeutic strategies of lung cancer patients during the outbreak of 2019 novel coronavirus disease (COVID-19)] (edit) |
10.3760/CMA.J.CN112152-20200229-00152 |
| 2020-03-02 |
[Clinical characteristics and outcomes of 112 cardiovascular disease patients infected by 2019-nCoV] (edit) |
10.3760/CMA.J.CN112148-20200220-00105 |
| 2020-03-02 |
Imaging changes of severe COVID-19 pneumonia in advanced stage (edit) |
10.1007/S00134-020-05990-Y |
| 2020-03-02 |
The novel coronavirus (SARS-CoV-2) infections in China: prevention, control and challenges (edit) |
10.1007/S00134-020-05977-9 |
| 2020-03-02 |
Critical care crisis and some recommendations during the COVID-19 epidemic in China (edit) |
10.1007/S00134-020-05979-7 |
| 2020-03-02 |
Hospital Emergency Management Plan During the COVID-19 Epidemic (edit) |
10.1111/ACEM.13951 |
| 2020-03-02 |
SARS-CoV-2 infection in children: Transmission dynamics and clinical characteristics (edit) |
10.1016/J.JFMA.2020.02.009 |
| 2020-03-02 |
Possible Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in a Public Bath Center in Huai'an, Jiangsu Province, China (edit) |
10.1001/JAMANETWORKOPEN.2020.4583 |
| 2020-03-02 |
SARS-CoV-2 in Romania - situation update and containment strategies (edit) |
10.18683/GERMS.2020.1179 |
| 2020-03-02 |
Potential Inhibitors Targeting RNA-Dependent RNA Polymerase Activity (NSP12) of SARS-CoV-2 (edit) |
10.20944/PREPRINTS202003.0024.V1 |
| 2020-03-01 |
The within-host viral kinetics of SARS-CoV-2 (edit) |
10.3934/MBE.2020159 |
| 2020-03-01 |
Coronavirus-Panik beschleunigt die Digitalisierung (edit) |
|
| 2020-03-01 |
Pneumonia of Unknown Etiology in Wuhan, China: Potential for International Spread Via Commercial Air Travel (edit) |
10.1093/JTM/TAAA008 |
| 2020-03-01 |
Potential for global spread of a novel coronavirus from China (edit) |
10.1093/JTM/TAAA011 |
| 2020-03-01 |
The outbreak of COVID-19 (edit) |
10.1097/JCMA.0000000000000270 |
| 2020-03-01 |
Clinical and High-Resolution CT Features of the COVID-19 Infection (edit) |
10.1097/RLI.0000000000000674 |
| 2020-03-01 |
COVID-19: too little, too late? (edit) |
10.1016/S0140-6736(20)30522-5 |
| 2020-03-01 |
Coronavirus disinfection in histopathology (edit) |
10.1080/01478885.2020.1734718 |
| 2020-03-01 |
[Pregnant Women With New Coronavirus Infection: A Clinical Characteristics and Placental Pathological Analysis of Three Cases] (edit) |
10.3760/CMA.J.CN112151-20200225-00138 |
| 2020-03-01 |
Wuhan coronavirus (2019-nCoV): The need to maintain regular physical activity while taking precautions (edit) |
10.1016/J.JSHS.2020.02.001 |
| 2020-03-01 |
Novel Coronavirus disease 2019 (COVID-19): The importance of recognising possible early ocular manifestation and using protective eyewear (edit) |
10.1136/BJOPHTHALMOL-2020-315994 |
| 2020-03-01 |
Three Emerging Coronaviruses in Two Decades (edit) |
10.1093/AJCP/AQAA029 |
| 2020-03-01 |
Isolation, quarantine, social distancing and community containment: pivotal role for old-style public health measures in the novel coronavirus (2019-nCoV) outbreak (edit) |
10.1093/JTM/TAAA020 |
| 2020-03-01 |
Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China (edit) |
10.1016/J.MICINF.2020.01.003 |
| 2020-03-01 |
Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19) (edit) |
10.12932/AP-200220-0773 |
| 2020-03-01 |
Therapeutic options for the 2019 novel coronavirus (2019-nCoV) (edit) |
10.1038/D41573-020-00016-0 |
| 2020-03-01 |
Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study (edit) |
10.1016/J.ENG.2020.03.007 |
| 2020-03-01 |
Covid-19 escalates (edit) |
10.1016/S0262-4079(20)30569-8 |
| 2020-03-01 |
Estimate the incubation period of coronavirus 2019 (COVID-19) (edit) |
10.1101/2020.02.24.20027474 |
| 2020-03-01 |
Preventing COVID-19 prejudice in academia (edit) |
10.1126/SCIENCE.ABB4870 |
| 2020-03-01 |
COVID-19 drives new threat to bats in China (edit) |
10.1126/SCIENCE.ABB3088 |
| 2020-03-01 |
Travellers give wings to novel coronavirus (2019-nCoV) (edit) |
10.1093/JTM/TAAA015 |
| 2020-03-01 |
Quantifying the association between domestic travel and the exportation of novel coronavirus (2019-nCoV) cases from Wuhan, China in 2020: a correlational analysis (edit) |
10.1093/JTM/TAAA022 |
| 2020-03-01 |
The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future (edit) |
10.1016/J.MICINF.2020.02.002 |
| 2020-03-01 |
Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic (edit) |
10.12932/AP-200220-0772 |
| 2020-03-01 |
Occupational risks for COVID-19 infection (edit) |
10.1093/OCCMED/KQAA036 |
| 2020-03-01 |
[Dynamic basic reproduction number based evaluation for current prevention and control of COVID-19 outbreak in China] (edit) |
10.3760/CMA.J.CN112338-20200209-00080 |
| 2020-03-01 |
[Fitting and forecasting the trend of COVID-19 by SEIR(+ CAQ) dynamic model] (edit) |
10.3760/CMA.J.CN112338-20200216-00106 |
| 2020-03-01 |
[Drug interaction monitoring of lopinavir / ritonavir in COVID-19 patients with cancer] (edit) |
10.3760/CMA.J.CN112138-20200219-00097 |
| 2020-03-01 |
The Wuhan SARS-CoV-2-What's next for China (edit) |
10.1002/JMV.25738 |
| 2020-03-01 |
[COVID-19. The only certainty is the uncertainty] (edit) |
10.17992/LBL.2020.03.469 |
| 2020-03-01 |
Mystery deepens over animal source of coronavirus (edit) |
10.1038/D41586-020-00548-W |
| 2020-03-01 |
Open peer-review platform for COVID-19 preprints (edit) |
10.1038/D41586-020-00613-4 |
| 2020-03-01 |
Audio Interview: What Clinicians Need to Know in Diagnosing and Treating Covid-19 (edit) |
10.1056/NEJME2004244 |
| 2020-03-01 |
A potential role for integrins in host cell entry by SARS-CoV-2 (edit) |
10.1016/J.ANTIVIRAL.2020.104759 |
| 2020-03-01 |
Can China's COVID-19 strategy work elsewhere? (edit) |
10.1126/SCIENCE.367.6482.1061 |
| 2020-03-01 |
Machine Learning, COVID-19 (2019-nCoV), and multi-OMICS (edit) |
10.1002/CYTO.A.23990 |
| 2020-03-01 |
Proposed protocol to keep COVID-19 out of hospitals (edit) |
10.1503/CMAJ.1095852 |
| 2020-03-01 |
The Coronavirus Disease 2019 (COVID-19) (edit) |
10.3928/19382359-20200219-01 |
| 2020-03-01 |
First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020 (edit) |
10.2807/1560-7917.ES.2020.25.9.2000178 |
| 2020-03-01 |
Evaluation of a quantitative RT-PCR assay for the detection of the emerging coronavirus SARS-CoV-2 using a high throughput system (edit) |
10.2807/1560-7917.ES.2020.25.9.2000152 |
| 2020-03-01 |
Rapid establishment of laboratory diagnostics for the novel coronavirus SARS-CoV-2 in Bavaria, Germany, February 2020 (edit) |
10.2807/1560-7917.ES.2020.25.9.2000173 |
| 2020-03-01 |
Updated rapid risk assessment from ECDC on the outbreak of COVID-19: increased transmission globally (edit) |
10.2807/1560-7917.ES.2020.25.9.2003051 |
| 2020-03-01 |
Potential scenarios for the progression of a COVID-19 epidemic in the European Union and the European Economic Area, March 2020 (edit) |
10.2807/1560-7917.ES.2020.25.9.2000202 |
| 2020-03-01 |
COVID-19: time for WHO to reconsider its stance towards Taiwan (edit) |
10.1038/D41586-020-00693-2 |
| 2020-03-01 |
L’informazione utile sul coronavirus (SARS-CoV-2) non è controllata? (edit) |
10.1701/3315.32860 |
| 2020-03-01 |
Audio Interview: Making Decisions about Covid-19 Testing and Treatment for Your Patients (edit) |
10.1056/NEJME2004856 |
| 2020-03-01 |
Lack of maternal-fetal SARS-CoV-2 transmission (edit) |
10.1038/S41591-020-0810-Y |
| 2020-03-01 |
[Respiratory support for severe 2019-nCoV pneumonia suffering from acute respiratory failure: time and strategy] (edit) |
10.3760/CMA.J.ISSN.1001-0939.2020.03.006 |
| 2020-03-01 |
[Pulmonary rehabilitation guidelines in the principle of 4S for patients infected with 2019 novel coronavirus (2019-nCoV)] (edit) |
10.3760/CMA.J.ISSN.1001-0939.2020.03.007 |
| 2020-03-01 |
[Expert consensus on the use of corticosteroid in patients with 2019-nCoV pneumonia] (edit) |
10.3760/CMA.J.ISSN.1001-0939.2020.03.008 |
| 2020-03-01 |
RCVS may relax guidance due to Covid-19 (edit) |
10.1136/VR.M1009 |
| 2020-03-01 |
Using public health law to contain the spread of COVID-19 (edit) |
10.12968/BJON.2020.29.5.326 |
| 2020-03-01 |
COVID-19 in the Shadows of MERS-CoV in the Kingdom of Saudi Arabia (edit) |
10.2991/JEGH.K.200218.003 |
| 2020-03-01 |
Don't rush to deploy COVID-19 vaccines and drugs without sufficient safety guarantees (edit) |
10.1038/D41586-020-00751-9 |
| 2020-03-01 |
Getting ready for the next pandemic COVID-19: Why we need to be more prepared and less scared (edit) |
10.5055/JEM.2020.0461 |
| 2020-03-01 |
Tabletop exercise to prepare institutions of higher education for an outbreak of COVID-19 (edit) |
10.5055/JEM.2020.0463 |
| 2020-03-01 |
Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020 (edit) |
10.2807/1560-7917.ES.2020.25.10.2000180 |
| 2020-03-01 |
Updated rapid risk assessment from ECDC on the novel coronavirus disease 2019 (COVID-19) pandemic: increased transmission in the EU/EEA and the UK (edit) |
10.2807/1560-7917.ES.2020.25.10.2003121 |
| 2020-03-01 |
Audio Interview: New Research on Possible Treatments for Covid-19 (edit) |
10.1056/NEJME2005759 |
| 2020-03-01 |
[2019-nCoV: new challenges from coronavirus] (edit) |
|
| 2020-03-01 |
Videosprechstunde wegen SARS-CoV-2? (edit) |
10.1007/S15006-020-0246-9 |
| 2020-03-01 |
COVID-19 in der Allgemeinarztpraxis (edit) |
10.1007/S15006-020-0237-X |
| 2020-03-01 |
Countries test tactics in 'war' against COVID-19 (edit) |
10.1126/SCIENCE.367.6484.1287 |
| 2020-03-01 |
Point-of-Care Lung Ultrasound findings in novel coronavirus disease-19 pnemoniae: a case report and potential applications during COVID-19 outbreak (edit) |
10.26355/EURREV_202003_20549 |
| 2020-03-01 |
Differences and similarities between Severe Acute Respiratory Syndrome (SARS)-CoronaVirus (CoV) and SARS-CoV-2. Would a rose by another name smell as sweet? (edit) |
10.26355/EURREV_202003_20551 |
| 2020-03-01 |
COVID-19: protecting health-care workers (edit) |
10.1016/S0140-6736(20)30644-9 |
| 2020-03-01 |
Offline: COVID-19-a reckoning (edit) |
10.1016/S0140-6736(20)30669-3 |
| 2020-03-01 |
Canada and COVID-19: learning from SARS (edit) |
10.1016/S0140-6736(20)30670-X |
| 2020-03-01 |
The Novel Coronavirus (SARS-CoV-2) Epidemic (edit) |
|
| 2020-03-01 |
Mental Health Strategies to Combat the Psychological Impact of COVID-19 Beyond Paranoia and Panic (edit) |
|
| 2020-03-01 |
Rapid Progression to Acute Respiratory Distress Syndrome: Review of Current Understanding of Critical Illness from COVID-19 Infection (edit) |
|
| 2020-03-01 |
Consideration of the respiratory support strategy of severe acute respiratory failure caused by SARS-CoV-2 infection in children (edit) |
|
| 2020-03-01 |
[Perinatal and neonatal management plan for prevention and control of SARS-CoV-2 infection (2nd Edition)] (edit) |
|
| 2020-03-01 |
[An interpretation on perinatal and neonatal management plan for prevention and control of SARS-CoV-2 infection (2nd Edition)] (edit) |
|
| 2020-03-01 |
[Response plan in the neonatal intensive care unit during epidemic of SARS-CoV-2 infection (2nd Edition)] (edit) |
|
| 2020-03-01 |
[SARS-CoV-2 infection with gastrointestinal symptoms as the first manifestation in a neonate] (edit) |
|
| 2020-03-01 |
[Twin girls infected with SARS-CoV-2] (edit) |
|
| 2020-03-01 |
[Emergency plan for inter-hospital transfer of newborns with SARS-CoV-2 infection] (edit) |
|
| 2020-03-01 |
Serological and molecular findings during SARS-CoV-2 infection: the first case study in Finland, January to February 2020 (edit) |
10.2807/1560-7917.ES.2020.25.11.2000266 |
| 2020-03-01 |
Coronavirus disease (COVID-19) in a paucisymptomatic patient: epidemiological and clinical challenge in settings with limited community transmission, Italy, February 2020 (edit) |
10.2807/1560-7917.ES.2020.25.11.2000230 |
| 2020-03-01 |
COVID-19: ban 'orientalism' by critics of wildlife trade (edit) |
10.1038/D41586-020-00870-3 |
| 2020-03-01 |
COVID-19: protect great apes during human pandemics (edit) |
10.1038/D41586-020-00859-Y |
| 2020-03-01 |
Care for laboratory animals during COVID-19 crisis (edit) |
10.1038/D41586-020-00869-W |
| 2020-03-01 |
Audio Interview: Practical Measures to Help Prevent Covid-19 (edit) |
10.1056/NEJME2006742 |
| 2020-03-01 |
Cancer Care Delivery Challenges Amidst Coronavirus Disease - 19 (COVID-19) Outbreak: Specific Precautions for Cancer Patients and Cancer Care Providers to Prevent Spread (edit) |
10.31557/APJCP.2020.21.3.569 |
| 2020-03-01 |
Expanded Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) as a Therapeutic Strategy in Managing Critically Ill COVID-19 Patients: The Case for Compassionate Use (edit) |
|
| 2020-03-01 |
Covid-19 : essai clinique européen ; éthique pharmaceutique (edit) |
|
| 2020-03-01 |
Race to find COVID-19 treatments accelerates (edit) |
10.1126/SCIENCE.367.6485.1412 |
| 2020-03-01 |
With COVID-19, modeling takes on life and death importance (edit) |
10.1126/SCIENCE.367.6485.1414-B |
| 2020-03-01 |
[The Management of Blood Glucose Should be Emphasized in the Treatment of COVID-19] (edit) |
10.12182/20200360606 |
| 2020-03-01 |
[Clinical Study and CT Findings of a Familial Cluster of Pneumonia with Coronavirus Disease 2019 (COVID-19)] (edit) |
10.12182/20200360107 |
| 2020-03-01 |
Telemedicine services thrive during Covid-19 (edit) |
10.1136/VR.M1231 |
| 2020-03-01 |
In other Covid-19 news (edit) |
10.1136/VR.M1236 |
| 2020-03-01 |
Can companion animals become infected with Covid-19? (edit) |
10.1136/VR.M1194 |
| 2020-03-01 |
Ensuring animal welfare during Covid-19 pandemic (edit) |
10.1136/VR.M1195 |
| 2020-03-01 |
Fortbildung in Zeiten von COVID-19 (edit) |
10.1007/S15006-020-0276-3 |
| 2020-03-01 |
COVID-19: learning from experience (edit) |
10.1016/S0140-6736(20)30686-3 |
| 2020-03-01 |
Offline: COVID-19 and the NHS-"a national scandal" (edit) |
10.1016/S0140-6736(20)30727-3 |
| 2020-03-01 |
Venezuelan migrants "struggling to survive" amid COVID-19 (edit) |
10.1016/S0140-6736(20)30718-2 |
| 2020-03-01 |
WHO launches crowdfund for COVID-19 response (edit) |
10.1016/S0140-6736(20)30719-4 |
| 2020-03-01 |
COVID-19 cacophony: is there any orchestra conductor? (edit) |
10.1016/S0140-6736(20)30491-8 |
| 2020-03-01 |
Cochrane Corner: Coronavirus (COVID-19): infection control and prevention measures (edit) |
10.1071/HC15950 |
| 2020-03-01 |
Staff Mental Health Self-Assessment During the COVID-19 Outbreak (edit) |
10.12809/EAAP2014 |
| 2020-03-01 |
COVID-19 information propagation dynamics in the Chinese Sina-microblog (edit) |
10.3934/MBE.2020146 |
| 2020-03-01 |
Effects of media reporting on mitigating spread of COVID-19 in the early phase of the outbreak (edit) |
10.3934/MBE.2020147 |
| 2020-03-01 |
Effect of delay in diagnosis on transmission of COVID-19 (edit) |
10.3934/MBE.2020149 |
| 2020-03-01 |
Rapid assessment of regional SARS-CoV-2 community transmission through a convenience sample of healthcare workers, the Netherlands, March 2020 (edit) |
10.2807/1560-7917.ES.2020.25.12.2000334 |
| 2020-03-01 |
Coronavirus disease (COVID-19) Community Testing Team in Scotland: A 14-day review, 6 to 20 February 2020 (edit) |
10.2807/1560-7917.ES.2020.25.12.2000217 |
| 2020-03-01 |
Potential short-term outcome of an uncontrolled COVID-19 epidemic in Lombardy, Italy, February to March 2020 (edit) |
10.2807/1560-7917.ES.2020.25.12.2000293 |
| 2020-03-01 |
Updated rapid risk assessment from ECDC on coronavirus disease 2019 (COVID-19) pandemic: increased transmission in the EU/EEA and the UK (edit) |
10.2807/1560-7917.ES.2020.25.12.2003261 |
| 2020-03-01 |
Estimating the infection and case fatality ratio for coronavirus disease (COVID-19) using age-adjusted data from the outbreak on the Diamond Princess cruise ship, February 2020 (edit) |
10.2807/1560-7917.ES.2020.25.12.2000256 |
| 2020-03-01 |
[Interpretation of "Guidelines for the Diagnosis and Treatment of Novel Coronavirus (2019-nCoV) Infection by the National Health Commission (Trial Version 5)"] (edit) |
10.3760/CMA.J.CN112137-20200205-00199 |
| 2020-03-01 |
[Emerging infections, the great challenge of global health: Covid-19] (edit) |
10.21149/11284 |
| 2020-03-01 |
[Covid-19: the new pathology caused by a coronavirus] (edit) |
10.21149/11276 |
| 2020-03-01 |
Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19) (edit) |
10.4014/JMB.2003.03011 |
| 2020-03-01 |
Protecting healthcare workers from SARS-CoV-2 infection: practical indications (edit) |
10.1183/16000617.0068-2020 |
| 2020-03-01 |
[Consensus Report from Turkish Society of Cardiology: COVID-19 and Cardiovascular Diseases. What cardiologists should know. (25th March 2020)] (edit) |
10.5543/TKDA.2020.97198 |
| 2020-03-01 |
Urgent need for individual mobile phone and institutional reporting of at home, hospitalized, and intensive care unit cases of SARS-CoV-2 (COVID-19) infection (edit) |
10.31083/J.RCM.2020.01.42 |
| 2020-03-01 |
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic and Transfusion Medicine: reflections from Italy (edit) |
10.2450/2020.0071-20 |
| 2020-03-01 |
Blood transfusion during the COVID-19 outbreak (edit) |
10.2450/2020.0076-20 |
| 2020-03-01 |
Responding to COVID-19: The UW Medicine Information Technology Services Experience (edit) |
10.1055/S-0040-1709715 |
| 2020-03-01 |
[Suggestions on delivery management of pregnant women with COVID-19] (edit) |
10.3760/CMA.J.CN112141-20200224-00128 |
| 2020-03-01 |
[Systematic perinatal management of the pregnant women and neonates during the epidemic of COVID-19] (edit) |
10.3760/CMA.J.CN112141-20200221-00123 |
| 2020-03-01 |
[Perioperative management of cesarean section for pregnant women with suspected or confirmed COVID-19] (edit) |
10.3760/CMA.J.CN112141-20200220-00118 |
| 2020-03-01 |
[Investigation on demands for antenatal care services among 2 002 pregnant women during the epidemic of COVID-19 in Shanghai] (edit) |
10.3760/CMA.J.CN112141-20200218-00112 |
| 2020-03-01 |
Canadian Geriatrics Society COVID-19 Recommendations for Older Adults. What Do Older Adults Need To Know? (edit) |
|
| 2020-03-01 |
A call for caution in extrapolating chest CT sensitivity for COVID-19 derived from hospital data to patients among general population (edit) |
10.21037/QIMS.2020.03.04 |
| 2020-03-01 |
Utilizing integrating network pharmacological approaches to investigate the potential mechanism of Ma Xing Shi Gan Decoction in treating COVID-19 (edit) |
10.26355/EURREV_202003_20704 |
| 2020-03-01 |
Successful treatment of COVID-19 using extracorporeal membrane oxygenation, a case report (edit) |
10.26355/EURREV_202003_20705 |
| 2020-03-01 |
A classifier prediction model to predict the status of Coronavirus COVID-19 patients in South Korea (edit) |
10.26355/EURREV_202003_20709 |
| 2020-03-01 |
Clinical characteristics of 161 cases of corona virus disease 2019 (COVID-19) in Changsha (edit) |
10.26355/EURREV_202003_20711 |
| 2020-03-01 |
COVID-19: emerging protective measures (edit) |
10.26355/EURREV_202003_20713 |
| 2020-03-01 |
Inositol and pulmonary function. Could myo-inositol treatment downregulate inflammation and cytokine release syndrome in SARS-CoV-2? (edit) |
10.26355/EURREV_202003_20715 |
| 2020-03-01 |
Modified SEIR and AI prediction of the epidemics trend of COVID-19 in China under public health interventions (edit) |
10.21037/JTD.2020.02.64 |
| 2020-03-01 |
[Rapid establishment of traditional Chinese medicine prevention and treatment of 2019-nCoV based on clinical experience and molecular docking] (edit) |
10.19540/J.CNKI.CJCMM.20200206.501 |
| 2020-03-01 |
[Study on screening potential traditional Chinese medicines against 2019-nCoV based on Mpro and PLP] (edit) |
10.19540/J.CNKI.CJCMM.20200216.401 |
| 2020-03-01 |
[Study on treatment of "cytokine storm" by anti-2019-nCoV prescriptions based on arachidonic acid metabolic pathway] (edit) |
10.19540/J.CNKI.CJCMM.20200224.405 |
| 2020-03-01 |
[Analysis on pattern of prescriptions and syndromes of traditional Chinese medicine for prevention and treatment of COVID-19] (edit) |
10.19540/J.CNKI.CJCMM.20200218.502 |
| 2020-03-01 |
[Study on medication regularity of traditional Chinese medicine in treatment of COVID-19 based on data mining] (edit) |
10.19540/J.CNKI.CJCMM.20200220.502 |
| 2020-03-01 |
[Strategy of pharmaceutical care services for clinical Chinese pharmacists in coronavirus disease 2019 (COVID-19)] (edit) |
10.19540/J.CNKI.CJCMM.20200211.501 |
| 2020-03-01 |
Coronavirus disease (COVID-19) pandemic (edit) |
|
| 2020-03-01 |
Novel Coronavirus Disease (COVID-19) and Central Nervous System Complications: What Neurologist Need to Know (edit) |
|
| 2020-03-01 |
Reflections on the quality of health care after the SARS-CoV-2 pandemic (edit) |
10.1016/J.JHQR.2020.03.004 |
| 2020-03-01 |
[Rapid investigation plan of clinical courses and key diagnosis and treatment equipment requirements for the patients of the 2019 Novel Coronavirus Pneumonia (COVID-19)] (edit) |
10.3760/CMA.J.ISSN.0254-6450.2020.03.002 |
| 2020-03-01 |
[An urgent call for raising the scientific rigorousness of clinical trials on COVID-19] (edit) |
10.3760/CMA.J.ISSN.0254-6450.2020.03.004 |
| 2020-03-01 |
COVID 19 uncertainty (edit) |
10.1080/07399332.2020.1747311 |
| 2020-03-01 |
Counting Coronavirus Disease 2019 (COVID-19) Cases: Case Definitions, Screened Populations and Testing Techniques Matter (edit) |
|
| 2020-03-01 |
MSMA Recommends "Shelter-In-Place" to Missouri Governor to Curb COVID-19 (edit) |
|
| 2020-03-01 |
MSMA Urges Congress Independent Physician Financial Stability in Economic COVID-19 Relief Legislation (edit) |
|
| 2020-03-01 |
COVID-19 Teaches Hard Lessons (edit) |
|
| 2020-03-01 |
Saint Louis University School of Medicine and Vaccine Center Mobilize for COVID-19 Pandemic (edit) |
|
| 2020-03-01 |
A Critical Appraisal of COVID-19 in Malaysia and Beyond (edit) |
10.21315/MJMS2020.27.2.1 |
| 2020-03-01 |
A quickly, effectively screening process of novel corona virus disease 2019 (COVID-19) in children in Shanghai, China (edit) |
10.21037/ATM.2020.03.22 |
| 2020-03-01 |
CT imaging of coronavirus disease 2019 (COVID-19): from the qualitative to quantitative (edit) |
10.21037/ATM.2020.02.91 |
| 2020-03-01 |
Scarcity in the Covid-19 Pandemic (edit) |
10.1002/HAST.1093 |
| 2020-03-01 |
Navigating the Unchartered Waters in the Time of COVID-19 (edit) |
10.5688/AJPE8063 |
| 2020-03-01 |
A Moderate Case of COVID-19 Viral Pneumonia During the SARS-CoV-2 Pandemic (edit) |
10.3238/ARZTEBL.2020.0219 |
| 2020-03-01 |
Comprehensive update on current outbreak of novel coronavirus infection (2019-nCoV) (edit) |
10.21037/ATM.2020.02.92 |
| 2020-03-01 |
[Effect of heat inactivation of blood samples on the efficacy of three detection methods of SARS-CoV-2 antibodies] (edit) |
10.12122/J.ISSN.1673-4254.2020.03.03 |
| 2020-03-01 |
Do SARS-CoV2 viral proteins have neuromodulatory properties? (edit) |
10.4103/0028-3886.283760 |
| 2020-03-01 |
Rationale of the WHO document on Risk Communication and Community Engagement (RCCE) readiness and response to the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and of the Italian Decalogue for Prevention Departments (edit) |
10.15167/2421-4248/JPMH2020.61.1.1502 |
| 2020-03-01 |
Epidemiology, diagnosis, treatment, and future perspectives concerning SARS-COV-2: a review article (edit) |
10.1590/1806-9282.66.3.370 |
| 2020-03-01 |
Antiviral Therapy during the Coronavirus Disease (COVID-19) Pandemic: Is It Appropriate to Treat Patients in the Absence of Significant Evidence? (edit) |
|
| 2020-03-01 |
Digital healthcare: The only solution for better healthcare during COVID-19 pandemic? (edit) |
10.1016/J.IHJ.2020.04.001 |
| 2020-03-01 |
Update on the target structures of SARS-CoV-2: A systematic review (edit) |
10.4103/IJP.IJP_338_20 |
| 2020-03-01 |
Pituitary tumor resection in a patient with SARS-CoV-2 (COVID-19) infection. A case report and suggested airway management guidelines (edit) |
10.1016/J.BJANE.2020.05.003 |
| 2020-03-01 |
[Transmission of Sars-Cov-2 and ventilation of indoor environments. Technical notes and preventive measures] (edit) |
|
| 2020-02-29 |
Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study (edit) |
10.1016/S0140-6736(20)30260-9 |
| 2020-02-29 |
[Medical Diagnosis and Treatment Strategies for Malignant Tumors of the Digestive System During the Outbreak of Novel Coronavirus Pneumonia] (edit) |
10.3760/CMA.J.CN112152-20200227-00141 |
| 2020-02-29 |
Discovering drugs to treat coronavirus disease 2019 (COVID-19) (edit) |
10.5582/DDT.2020.01012 |
| 2020-02-29 |
Highland of COVID-19 outside Hubei: epidemic characteristics, control and projections of Wenzhou, China (edit) |
10.1101/2020.02.25.20024398 |
| 2020-02-29 |
Stochastic discrete epidemic modeling of COVID-19 transmission in the Province of Shaanxi incorporating public health intervention and case importation (edit) |
10.1101/2020.02.25.20027615 |
| 2020-02-29 |
Evaluation of the clinical characteristics of suspected or confirmed cases of COVID-19 during home care with isolation: A new retrospective analysis based on O2O (edit) |
10.1101/2020.02.26.20028084 |
| 2020-02-29 |
Rapid Molecular Detection of SARS-CoV-2 (COVID-19) Virus RNA Using Colorimetric LAMP (edit) |
10.1101/2020.02.26.20028373 |
| 2020-02-29 |
Modelling the coronavirus disease (COVID-19) outbreak on the Diamond Princess ship using the public surveillance data from January 20 to February 20, 2020 (edit) |
10.1101/2020.02.26.20028449 |
| 2020-02-29 |
The Effects of "Fangcang, Huoshenshan, and Leishenshan" Makeshift Hospitals and Temperature on the Mortality of COVID-19 (edit) |
10.1101/2020.02.26.20028472 |
| 2020-02-29 |
Infection Dynamics of Coronavirus Disease 2019 (Covid-19) Modeled with the Integration of the Eyring Rate Process Theory and Free Volume Concept (edit) |
10.1101/2020.02.26.20028571 |
| 2020-02-29 |
Heart injury signs are associated with higher and earlier mortality in coronavirus disease 2019 (COVID-19) (edit) |
10.1101/2020.02.26.20028589 |
| 2020-02-29 |
Prediction of the Epidemic of COVID-19 Based on Quarantined Surveillance in China (edit) |
10.1101/2020.02.27.20027169 |
| 2020-02-29 |
Sex differences in clinical findings among patients with coronavirus disease 2019 (COVID-19) and severe condition (edit) |
10.1101/2020.02.27.20027524 |
| 2020-02-29 |
Therapeutic effects of dipyridamole on COVID-19 patients with coagulation dysfunction (edit) |
10.1101/2020.02.27.20027557 |
| 2020-02-29 |
Hypokalemia and Clinical Implications in Patients with Coronavirus Disease 2019 (COVID-19) (edit) |
10.1101/2020.02.27.20028530 |
| 2020-02-29 |
Modeling the Epidemic Dynamics and Control of COVID-19 Outbreak in China (edit) |
10.1101/2020.02.27.20028639 |
| 2020-02-29 |
Transmission potential of COVID-19 in South Korea (edit) |
10.1101/2020.02.27.20028829 |
| 2020-02-29 |
A simple ecological model captures the transmission pattern of the coronavirus COVID-19 outbreak in China (edit) |
10.1101/2020.02.27.20028928 |
| 2020-02-29 |
Clinical characteristics of 36 non-survivors with COVID-19 in Wuhan, China (edit) |
10.1101/2020.02.27.20029009 |
| 2020-02-29 |
The Clinical and Chest CT Features Associated with Severe and Critical COVID-19 Pneumonia (edit) |
10.1097/RLI.0000000000000672 |
| 2020-02-29 |
Clinical trials for the treatment of Coronavirus disease 2019 (COVID-19): A rapid response to urgent need (edit) |
10.1007/S11427-020-1660-2 |
| 2020-02-29 |
COVID-19 in Latin America: The implications of the first confirmed case in Brazil (edit) |
10.1016/J.TMAID.2020.101613 |
| 2020-02-29 |
Similarity in Case Fatality Rates (CFR) of COVID-19/SARS-COV-2 in Italy and China (edit) |
10.3855/JIDC.12600 |
| 2020-02-29 |
Transmission potential of the novel coronavirus (COVID-19) onboard the diamond Princess Cruises Ship, 2020 (edit) |
10.1016/J.IDM.2020.02.003 |
| 2020-02-29 |
Potential Therapeutic Agents for COVID-19 Based on the Analysis of Protease and RNA Polymerase Docking (edit) |
10.20944/PREPRINTS202002.0242.V2 |
| 2020-02-28 |
Update: Public Health Response to the Coronavirus Disease 2019 Outbreak — United States, February 24, 2020 (edit) |
10.15585/MMWR.MM6908E1 |
| 2020-02-28 |
Covid-19 — Navigating the Uncharted (edit) |
10.1056/NEJME2002387 |
| 2020-02-28 |
Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts (edit) |
10.1016/S2214-109X(20)30074-7 |
| 2020-02-28 |
Q&A: The novel coronavirus outbreak causing COVID-19 (edit) |
10.1186/S12916-020-01533-W |
| 2020-02-28 |
COVID-19 outbreak on the Diamond Princess cruise ship: estimating the epidemic potential and effectiveness of public health countermeasures (edit) |
10.1093/JTM/TAAA030 |
| 2020-02-28 |
Radiology Perspective of Coronavirus Disease 2019 (COVID-19): Lessons From Severe Acute Respiratory Syndrome and Middle East Respiratory Syndrome (edit) |
10.2214/AJR.20.22969 |
| 2020-02-28 |
Covid-19 goes global (edit) |
10.1016/S0262-4079(20)30424-3 |
| 2020-02-28 |
Rapid random access detection of the novel SARS-coronavirus-2 (SARS-CoV-2, previously 2019-nCoV) using an open access protocol for the Panther Fusion (edit) |
10.1016/J.JCV.2020.104305 |
| 2020-02-28 |
Management strategies of neonatal jaundice during the coronavirus disease 2019 outbreak (edit) |
10.1007/S12519-020-00347-3 |
| 2020-02-28 |
A Well Infant with Coronavirus Disease 2019 (COVID-19) with High Viral Load (edit) |
10.1093/CID/CIAA201 |
| 2020-02-28 |
Covid-19: school closures and bans on mass gatherings will need to be considered, says England's CMO (edit) |
10.1136/BMJ.M806 |
| 2020-02-28 |
Preventing a covid-19 pandemic (edit) |
10.1136/BMJ.M810 |
| 2020-02-28 |
Covid-19: preparedness, decentralisation, and the hunt for patient zero (edit) |
10.1136/BMJ.M799 |
| 2020-02-28 |
COVID-19—New Insights on a Rapidly Changing Epidemic (edit) |
10.1001/JAMA.2020.3072 |
| 2020-02-28 |
A simple magnetic nanoparticles-based viral RNA extraction method for efficient detection of SARS-CoV-2 (edit) |
10.1101/2020.02.22.961268 |
| 2020-02-28 |
Increasing Host Cellular Receptor—Angiotensin-Converting Enzyme 2 (ACE2) Expression by Coronavirus may Facilitate 2019-nCoV Infection (edit) |
10.1101/2020.02.24.963348 |
| 2020-02-28 |
Open-source analytics tools for studying the COVID-19 coronavirus outbreak (edit) |
10.1101/2020.02.25.20027433 |
| 2020-02-28 |
An Effective CTL Peptide Vaccine for Ebola Zaire Based on Survivors’ CD8+ Targeting of a Particular Nucleocapsid Protein Epitope with Potential Implications for COVID-19 Vaccine Design (edit) |
10.1101/2020.02.25.963546 |
| 2020-02-28 |
Comparative analysis of primer-probe sets for the laboratory confirmation of SARS-CoV-2 (edit) |
10.1101/2020.02.25.964775 |
| 2020-02-28 |
Epitope-based peptide vaccine design and target site characterization against novel coronavirus disease caused by SARS-CoV-2 (edit) |
10.1101/2020.02.25.965434 |
| 2020-02-28 |
Prediction of receptorome for human-infecting virome (edit) |
10.1101/2020.02.27.967885 |
| 2020-02-28 |
2019_nCoV/SARS-CoV-2: rapid classification of betacoronaviruses and identification of Traditional Chinese Medicine as potential origin of zoonotic coronaviruses (edit) |
10.1111/LAM.13285 |
| 2020-02-28 |
Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2 (edit) |
10.1007/S00259-020-04735-9 |
| 2020-02-28 |
Clinical characteristics of hospitalized patients with SARS-CoV-2 infection: A single arm meta-analysis (edit) |
10.1002/JMV.25735 |
| 2020-02-28 |
Development of epitope-based peptide vaccine against novel coronavirus 2019 (SARS-COV-2): Immunoinformatics approach (edit) |
10.1002/JMV.25736 |
| 2020-02-28 |
Responding to Covid-19 - A Once-in-a-Century Pandemic? (edit) |
10.1056/NEJMP2003762 |
| 2020-02-28 |
Clinical Characteristics of Coronavirus Disease 2019 in China (edit) |
10.1056/NEJMOA2002032 |
| 2020-02-28 |
Saudi Arabia`s measures to curb the COVID-19 outbreak: temporary suspension of the Umrah pilgrimage (edit) |
10.1093/JTM/TAAA029 |
| 2020-02-28 |
Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer (edit) |
10.1016/J.JTHO.2020.02.010 |
| 2020-02-28 |
From SARS-CoV to 2019-nCoV Outbreak: Similarities in the Early Epidemics and Prediction of Future Trends (edit) |
10.1097/CM9.0000000000000776 |
| 2020-02-28 |
Distribution of the COVID-19 epidemic and correlation with population emigration from wuhan, China (edit) |
10.1097/CM9.0000000000000782 |
| 2020-02-28 |
Single-cell RNA sequencing data suggest a role for angiotensin-converting enzyme 2 in kidney impairment in patients infected with 2019-nCoV (edit) |
10.1097/CM9.0000000000000783 |
| 2020-02-28 |
A case of 2019 Novel Coronavirus in a pregnant woman with preterm delivery (edit) |
10.1093/CID/CIAA200 |
| 2020-02-28 |
A family cluster of SARS-CoV-2 infection involving 11 patients in Nanjing, China (edit) |
10.1016/S1473-3099(20)30147-X |
| 2020-02-28 |
The response of Milan's Emergency Medical System to the COVID-19 outbreak in Italy (edit) |
10.1016/S0140-6736(20)30493-1 |
| 2020-02-28 |
Novel coronavirus disease (Covid-19): The first two patients in the UK with person to person transmission (edit) |
10.1016/J.JINF.2020.02.020 |
| 2020-02-28 |
Anti-HCV, nucleotide inhibitors, repurposing against COVID-19 (edit) |
10.1016/J.LFS.2020.117477 |
| 2020-02-28 |
Is Africa prepared for tackling the COVID-19 (SARS-CoV-2) epidemic. Lessons from past outbreaks, ongoing pan-African public health efforts, and implications for the future (edit) |
10.1016/J.IJID.2020.02.049 |
| 2020-02-28 |
Anesthetic Management of Patients with COVID 19 Infections during Emergency Procedures (edit) |
10.1053/J.JVCA.2020.02.039 |
| 2020-02-28 |
Clinical study of mesenchymal stem cell treating acute respiratory distress syndrome induced by epidemic Influenza A (H7N9) infection, a hint for COVID-19 treatment (edit) |
10.1016/J.ENG.2020.02.006 |
| 2020-02-28 |
The SARS-CoV-2 receptor ACE2 expression of maternal-fetal interface and fetal organs by single cell transcriptome study (edit) |
10.1101/2020.02.27.967760 |
| 2020-02-27 |
Comorbidity and its impact on 1,590 patients with COVID-19 in China: A Nationwide Analysis (edit) |
10.1101/2020.02.25.20027664 |
| 2020-02-27 |
COVID-19: preparing for superspreader potential among Umrah pilgrims to Saudi Arabia (edit) |
10.1016/S0140-6736(20)30466-9 |
| 2020-02-27 |
Positive RT-PCR Test Results in Patients Recovered From COVID-19 (edit) |
10.1001/JAMA.2020.2783 |
| 2020-02-27 |
COVID-19: Perspectives on the Potential Novel Global Threat (edit) |
10.2174/1574887115999200228100745 |
| 2020-02-27 |
Nepal's First Case of COVID-19 and public health response (edit) |
10.1093/JTM/TAAA024 |
| 2020-02-27 |
COVID-19: combining antiviral and anti-inflammatory treatments (edit) |
10.1016/S1473-3099(20)30132-8 |
| 2020-02-27 |
Outbreak of Novel Coronavirus (SARS-Cov-2): First Evidences From International Scientific Literature and Pending Questions (edit) |
10.3390/HEALTHCARE8010051 |
| 2020-02-27 |
Structure of Mpro from COVID-19 virus and discovery of its inhibitors (edit) |
10.1101/2020.02.26.964882 |
| 2020-02-27 |
Epidemiological Development of Novel Coronavirus Pneumonia in China and Its Forecast (edit) |
10.1101/2020.02.21.20026229 |
| 2020-02-27 |
Spike protein binding prediction with neutralizing antibodies of SARS-CoV-2 (edit) |
10.1101/2020.02.22.951178 |
| 2020-02-27 |
The landscape of lung bronchoalveolar immune cells in COVID-19 revealed by single-cell RNA sequencing (edit) |
10.1101/2020.02.23.20026690 |
| 2020-02-27 |
TWIRLS, an automated topic-wise inference method based on massive literature, suggests a possible mechanism via ACE2 for the pathological changes in the human host after coronavirus infection (edit) |
10.1101/2020.02.24.20025437 |
| 2020-02-27 |
WeChat, a Chinese social media, may early detect the SARS-CoV-2 outbreak in 2019 (edit) |
10.1101/2020.02.24.20026682 |
| 2020-02-27 |
Clinical and radiographic features of cardiac injury in patients with 2019 novel coronavirus pneumonia (edit) |
10.1101/2020.02.24.20027052 |
| 2020-02-27 |
Spread and control of COVID-19 in China and their associations with population movement, public health emergency measures, and medical resources (edit) |
10.1101/2020.02.24.20027623 |
| 2020-02-27 |
Transmission potential of the novel coronavirus (COVID-19) onboard the Diamond Princess Cruises Ship, 2020 (edit) |
10.1101/2020.02.24.20027649 |
| 2020-02-27 |
Correlation Analysis Between Disease Severity and Inflammation-related Parameters in Patients with COVID-19 Pneumonia (edit) |
10.1101/2020.02.25.20025643 |
| 2020-02-27 |
Age-dependent risks of Incidence and Mortality of COVID-19 in Hubei Province and Other Parts of China (edit) |
10.1101/2020.02.25.20027672 |
| 2020-02-27 |
Application and optimization of RT-PCR in diagnosis of SARS-CoV-2 infection (edit) |
10.1101/2020.02.25.20027755 |
| 2020-02-27 |
Prevalence and clinical features of 2019 novel coronavirus disease (COVID-19) in the Fever Clinic of a teaching hospital in Beijing: a single-center, retrospective study (edit) |
10.1101/2020.02.25.20027763 |
| 2020-02-27 |
Genomic variations of SARS-CoV-2 suggest multiple outbreak sources of transmission (edit) |
10.1101/2020.02.25.20027953 |
| 2020-02-27 |
Clinical Data on Hospital Environmental Hygiene Monitoring and Medical Staff Protection during the Coronavirus Disease 2019 Outbreak (edit) |
10.1101/2020.02.25.20028043 |
| 2020-02-27 |
Clinical Features of COVID-19 Related Liver Damage (edit) |
10.1101/2020.02.26.20026971 |
| 2020-02-27 |
The definition and risks of Cytokine Release Syndrome-Like in 11 COVID-19-Infected Pneumonia critically ill patients: Disease Characteristics and Retrospective Analysis (edit) |
10.1101/2020.02.26.20026989 |
| 2020-02-27 |
The infection evidence of SARS-COV-2 in ocular surface： a single-center cross-sectional study (edit) |
10.1101/2020.02.26.20027938 |
| 2020-02-27 |
Case fatality rate of novel coronavirus disease 2019 in China (edit) |
10.1101/2020.02.26.20028076 |
| 2020-02-27 |
Estimation of country-level basic reproductive ratios for novel Coronavirus (COVID-19) using synthetic contact matrices (edit) |
10.1101/2020.02.26.20028167 |
| 2020-02-27 |
Clinical characteristics of 82 death cases with COVID-19 (edit) |
10.1101/2020.02.26.20028191 |
| 2020-02-27 |
Community responses during the early phase of the COVID-19 epidemic in Hong Kong: risk perception, information exposure and preventive measures (edit) |
10.1101/2020.02.26.20028217 |
| 2020-02-27 |
Clinical features and sexual transmission potential of SARS-CoV-2 infected female patients: a descriptive study in Wuhan, China (edit) |
10.1101/2020.02.26.20028225 |
| 2020-02-27 |
Perceptions of the Adult US Population regarding the Novel Coronavirus Outbreak (edit) |
10.1101/2020.02.26.20028308 |
| 2020-02-27 |
Evolutionary history, potential intermediate animal host, and cross-species analyses of SARS-CoV-2 (edit) |
10.1002/JMV.25731 |
| 2020-02-27 |
Development and Clinical Application of A Rapid IgM-IgG Combined Antibody Test for SARS-CoV-2 Infection Diagnosis (edit) |
10.1002/JMV.25727 |
| 2020-02-27 |
Novel coronavirus COVID-19: an overview for emergency clinicians (edit) |
|
| 2020-02-27 |
[Surgical treatment for esophageal cancer during the outbreak of COVID-19] (edit) |
10.3760/CMA.J.CN112152-20200226-00128 |
| 2020-02-27 |
Essentials for Radiologists on COVID-19: An Update-Radiology Scientific Expert Panel (edit) |
10.1148/RADIOL.2020200527 |
| 2020-02-27 |
Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series (edit) |
10.1136/BMJ.M792 |
| 2020-02-27 |
[Analysis on epidemic situation and spatiotemporal changes of COVID-19 in Anhui] (edit) |
10.3760/CMA.J.CN112150-20200221-00150 |
| 2020-02-27 |
[The importance of strengthening the ability of fundamental disease prevention and control system from the perspective of the epidemic situation of COVID-19] (edit) |
10.3760/CMA.J.CN112150-20200220-00149 |
| 2020-02-27 |
COVID-19: Zoonotic aspects (edit) |
10.1016/J.TMAID.2020.101607 |
| 2020-02-27 |
Characteristics of COVID-19 infection in Beijing (edit) |
10.1016/J.JINF.2020.02.018 |
| 2020-02-27 |
Secondary attack rate and superspreading events for SARS-CoV-2 (edit) |
10.1016/S0140-6736(20)30462-1 |
| 2020-02-27 |
Lessons for managing high-consequence infections from first COVID-19 cases in the UK (edit) |
10.1016/S0140-6736(20)30463-3 |
| 2020-02-27 |
Looming threat of COVID-19 infection in Africa: act collectively, and fast (edit) |
10.1016/S0140-6736(20)30464-5 |
| 2020-02-27 |
Convalescent plasma as a potential therapy for COVID-19 (edit) |
10.1016/S1473-3099(20)30141-9 |
| 2020-02-27 |
Trend and forecasting of the COVID-19 outbreak in China (edit) |
10.1016/J.JINF.2020.02.014 |
| 2020-02-27 |
COVID-19 in medical personnel: observation from Thailand (edit) |
10.1016/J.JHIN.2020.02.016 |
| 2020-02-27 |
Clinical characteristics of laboratory confirmed positive cases of SARS-CoV-2 infection in Wuhan, China: A retrospective single center analysis (edit) |
10.1016/J.TMAID.2020.101606 |
| 2020-02-27 |
Asymptomatic coronavirus infection: MERS-CoV and SARS-CoV-2 (COVID-19) (edit) |
10.1016/J.TMAID.2020.101608 |
| 2020-02-27 |
On the Coronavirus (COVID-19) Outbreak and the Smart City Network: Universal Data Sharing Standards Coupled with Artificial Intelligence (AI) to Benefit Urban Health Monitoring and Management (edit) |
10.3390/HEALTHCARE8010046 |
| 2020-02-27 |
Preliminary case report on the SARS-CoV-2 cluster in the UK, France, and Spain (edit) |
10.4414/SMW.2020.20212 |
| 2020-02-27 |
Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods (edit) |
10.1016/J.APSB.2020.02.008 |
| 2020-02-27 |
Repurposing Therapeutics for COVID-19: Supercomputer-Based Docking to the SARS-CoV-2 Viral Spike Protein and Viral Spike Protein-Human ACE2 Interface (edit) |
10.26434/CHEMRXIV.11871402.V3 |
| 2020-02-26 |
Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases (edit) |
10.1148/RADIOL.2020200642 |
| 2020-02-26 |
De-isolating COVID-19 Suspect Cases: A Continuing Challenge (edit) |
10.1093/CID/CIAA179 |
| 2020-02-26 |
COVID-19, Australia: Epidemiology Report 4 (Reporting week ending 19:00 AEDT 22 February 2020) (edit) |
10.33321/CDI.2020.44.17 |
| 2020-02-26 |
Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review (edit) |
10.3390/JCM9030623 |
| 2020-02-26 |
Clinical characteristics of 25 death cases infected with COVID-19 pneumonia: a retrospective review of medical records in a single medical center, Wuhan, China (edit) |
10.1101/2020.02.19.20025239 |
| 2020-02-26 |
Clinical and pathological characteristics of 2019 novel coronavirus disease (COVID-19): a systematic review (edit) |
10.1101/2020.02.20.20025601 |
| 2020-02-26 |
Generation of antibodies against COVID-19 virus for development of diagnostic tools (edit) |
10.1101/2020.02.20.20025999 |
| 2020-02-26 |
2019 Novel Coronavirus can be detected in urine, blood, anal swabs and oropharyngeal swabs samples (edit) |
10.1101/2020.02.21.20026179 |
| 2020-02-26 |
Real-time monitoring the transmission potential of COVID-19 in Singapore, February 2020 (edit) |
10.1101/2020.02.21.20026435 |
| 2020-02-26 |
Trends in Transmissibility of 2019 Novel Coronavirus-infected Pneumonia in Wuhan and 29 Provinces in China (edit) |
10.1101/2020.02.21.20026468 |
| 2020-02-26 |
Estimating the serial interval of the novel coronavirus disease (COVID-19): A statistical analysis using the public data in Hong Kong from January 16 to February 15, 2020 (edit) |
10.1101/2020.02.21.20026559 |
| 2020-02-26 |
SARS-CoV-2 transmission in cancer patients of a tertiary hospital in Wuhan (edit) |
10.1101/2020.02.22.20025320 |
| 2020-02-26 |
Temperature significant change COVID-19 Transmission in 429 cities (edit) |
10.1101/2020.02.22.20025791 |
| 2020-02-26 |
Neurological Manifestations of Hospitalized Patients with COVID-19 in Wuhan, China: a retrospective case series study (edit) |
10.1101/2020.02.22.20026500 |
| 2020-02-26 |
A Peptide-based Magnetic Chemiluminescence Enzyme Immunoassay for Serological Diagnosis of Corona Virus Disease 2019 (COVID-19) (edit) |
10.1101/2020.02.22.20026617 |
| 2020-02-26 |
Applying chemical reaction transition theory to predict the latent transmission dynamics of coronavirus outbreak in China (edit) |
10.1101/2020.02.22.20026815 |
| 2020-02-26 |
Intrinsic growth rules of patients infected, dead and cured with 2019 novel coronavirus in mainland China (edit) |
10.1101/2020.02.23.20024802 |
| 2020-02-26 |
Conjunctival polymerase chain reaction-tests of 2019 novel coronavirus in patients in Shenyang,China (edit) |
10.1101/2020.02.23.20024935 |
| 2020-02-26 |
Epidemiologic and Clinical Characteristics of 91 Hospitalized Patients with COVID-19 in Zhejiang, China: A retrospective, multi-centre case series (edit) |
10.1101/2020.02.23.20026856 |
| 2020-02-26 |
Gender differences in patients with COVID-19: Focus on severity and mortality (edit) |
10.1101/2020.02.23.20026864 |
| 2020-02-26 |
Mental health status and coping strategy of medical workers in China during The COVID-19 outbreak (edit) |
10.1101/2020.02.23.20026872 |
| 2020-02-26 |
Deep learning Enables Accurate Diagnosis of Novel Coronavirus (COVID-19) with CT images (edit) |
10.1101/2020.02.23.20026930 |
| 2020-02-26 |
Clinical features and laboratory inspection of novel coronavirus pneumonia (COVID-19) in Xiangyang, Hubei (edit) |
10.1101/2020.02.23.20026963 |
| 2020-02-26 |
Characterizing the transmission and identifying the control strategy for COVID-19 through epidemiological modeling (edit) |
10.1101/2020.02.24.20026773 |
| 2020-02-26 |
2019 novel coronavirus disease in hemodialysis (HD) patients: Report from one HD center in Wuhan, China (edit) |
10.1101/2020.02.24.20027201 |
| 2020-02-26 |
Can routine laboratory tests discriminate 2019 novel coronavirus infected pneumonia from other community-acquired pneumonia? (edit) |
10.1101/2020.02.25.20024711 |
| 2020-02-26 |
Chest Radiographic and CT Findings of the 2019 Novel Coronavirus Disease (COVID-19): Analysis of Nine Patients Treated in Korea (edit) |
10.3348/KJR.2020.0132 |
| 2020-02-26 |
2019 Novel Coronavirus (COVID-19) Pneumonia: Serial Computed Tomography Findings (edit) |
10.3348/KJR.2020.0112 |
| 2020-02-26 |
Passengers' destinations from China: low risk of Novel Coronavirus (2019-nCoV) transmission into Africa and South America (edit) |
10.1017/S0950268820000424 |
| 2020-02-26 |
Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection (edit) |
10.1002/JMV.25725 |
| 2020-02-26 |
Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2 (edit) |
10.1002/JMV.25726 |
| 2020-02-26 |
[Airway management of COVID-19 patients with severe pneumonia] (edit) |
10.3760/CMA.J.ISSN.1673-0860.2020.04.001 |
| 2020-02-26 |
No credible evidence supporting claims of the laboratory engineering of SARS-CoV-2 (edit) |
10.1080/22221751.2020.1733440 |
| 2020-02-26 |
Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity (edit) |
10.1080/22221751.2020.1732837 |
| 2020-02-26 |
Covid-19: Italy confirms 11 deaths as cases spread from north (edit) |
10.1136/BMJ.M757 |
| 2020-02-26 |
Negative Nasopharyngeal and Oropharyngeal Swab Does Not Rule Out COVID-19 (edit) |
10.1128/JCM.00297-20 |
| 2020-02-26 |
Severe SARS-CoV-2 infections: practical considerations and management strategy for intensivists (edit) |
10.1007/S00134-020-05967-X |
| 2020-02-26 |
The COVID-19 outbreak and implications for the Tokyo 2020 Summer Olympic Games (edit) |
10.1016/J.TMAID.2020.101604 |
| 2020-02-26 |
Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19):A multi-center study in Wenzhou city, Zhejiang, China (edit) |
10.1016/J.JINF.2020.02.016 |
| 2020-02-26 |
Simulating and forecasting the cumulative confirmed cases of SARS-CoV-2 in china by Boltzmann function-based regression analyses (edit) |
10.1016/J.JINF.2020.02.019 |
| 2020-02-26 |
2019-novel Coronavirus severe adult respiratory distress syndrome in two cases in Italy: An uncommon radiological presentation (edit) |
10.1016/J.IJID.2020.02.043 |
| 2020-02-26 |
First case of Coronavirus Disease 2019 (COVID-19) pneumonia in Taiwan (edit) |
10.1016/J.JFMA.2020.02.007 |
| 2020-02-26 |
COVID-19 and Blood Safety: Help with a Dilemma (edit) |
10.1016/J.TMRV.2020.02.004 |
| 2020-02-26 |
Computers and viral diseases. Preliminary bioinformatics studies on the design of a synthetic vaccine and a preventative peptidomimetic antagonist against the SARS-CoV-2 (2019-nCoV, COVID-19) coronavirus (edit) |
10.1016/J.COMPBIOMED.2020.103670 |
| 2020-02-26 |
One world, one health: The novel coronavirus COVID-19 epidemic (edit) |
10.1016/J.MEDCLE.2020.02.001 |
| 2020-02-26 |
A time delay dynamic system with external source for the local outbreak of 2019-nCoV (edit) |
10.1080/00036811.2020.1732357 |
| 2020-02-25 |
COVID-19 Orf3b protein: the putative biological function and the therapeutic target (edit) |
10.21203/RS.2.24483/V1 |
| 2020-02-25 |
Are children less susceptible to COVID-19? (edit) |
10.1016/J.JMII.2020.02.011 |
| 2020-02-25 |
Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies (edit) |
10.3390/V12030254 |
| 2020-02-25 |
Covid-19: surge in cases in Italy and South Korea makes pandemic look more likely (edit) |
10.1136/BMJ.M751 |
| 2020-02-25 |
A Novel Approach of Consultation on 2019 Novel Coronavirus (COVID-19)-Related Psychological and Mental Problems: Structured Letter Therapy (edit) |
10.30773/PI.2020.0047 |
| 2020-02-25 |
COVID-19: Real-time dissemination of scientific information to fight a public health emergency of international concern (edit) |
10.5582/BST.2020.01056 |
| 2020-02-25 |
Rapid Detection of Novel Coronavirus (COVID-19) by Reverse Transcription-Loop-Mediated Isothermal Amplification (edit) |
10.1101/2020.02.19.20025155 |
| 2020-02-25 |
Rapid colorimetric detection of COVID-19 coronavirus using a reverse tran-scriptional loop-mediated isothermal amplification (RT-LAMP) diagnostic plat-form: iLACO (edit) |
10.1101/2020.02.20.20025874 |
| 2020-02-25 |
A Novel Method for the Estimation of a Dynamic Effective Reproduction Number (Dynamic-R) in the CoViD-19 Outbreak (edit) |
10.1101/2020.02.22.20023267 |
| 2020-02-25 |
Cryo-EM structures of HKU2 and SADS-CoV spike glycoproteins and insights into coronavirus evolution (edit) |
10.1101/2020.02.23.961912 |
| 2020-02-25 |
Estimation of risk factors for COVID-19 mortality - preliminary results (edit) |
10.1101/2020.02.24.20027268 |
| 2020-02-25 |
Lessons learnt from 288 COVID-19 international cases: importations over time, effect of interventions, underdetection of imported cases (edit) |
10.1101/2020.02.24.20027326 |
| 2020-02-25 |
Estimation of COVID-2019 burden and potential for international dissemination of infection from Iran (edit) |
10.1101/2020.02.24.20027375 |
| 2020-02-25 |
Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019-nCoV (edit) |
10.1002/CBIC.202000047 |
| 2020-02-25 |
Combination of RT-qPCR testing and clinical features for diagnosis of COVID-19 facilitates management of SARS-CoV-2 outbreak (edit) |
10.1002/JMV.25721 |
| 2020-02-25 |
Early phylogenetic estimate of the effective reproduction number of SARS-CoV-2 (edit) |
10.1002/JMV.25723 |
| 2020-02-25 |
Anesthesia Procedure of Emergency Operation for Patients with Suspected or Confirmed COVID-19 (edit) |
10.1089/SUR.2020.040 |
| 2020-02-25 |
Challenges and countermeasures for organ donation during the SARS-CoV-2 epidemic: the experience of Sichuan Provincial People's Hospital (edit) |
10.1007/S00134-020-05978-8 |
| 2020-02-25 |
Emergent Strategies for the Next Phase of COVID-19 (edit) |
10.3947/IC.2020.52.1.105 |
| 2020-02-25 |
Potential association between COVID-19 mortality and health-care resource availability (edit) |
10.1016/S2214-109X(20)30068-1 |
| 2020-02-25 |
Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2 (edit) |
10.1016/J.JINF.2020.02.017 |
| 2020-02-25 |
From SARS-CoV to SARS-CoV-2: The response and challenge of forensic infectious disease autopsy (edit) |
10.12116/J.ISSN.1004-5619.2020.01.001 |
| 2020-02-25 |
Academician Cong Bin: Autopsy of SARS-CoV-2 infection is needed to be strengthened (edit) |
10.12116/J.ISSN.1004-5619.2020.01.002 |
| 2020-02-25 |
Gross examination report of a COVID-19 death autopsy (edit) |
10.12116/J.ISSN.1004-5619.2020.01.005 |
| 2020-02-25 |
Safety protection of forensic examination during the epidemic of COVID-19 (edit) |
10.12116/J.ISSN.1004-5619.2020.01.006 |
| 2020-02-25 |
Protection of forensic scene investigation and postmortem examination during the epidemic period of COVID-19 (edit) |
10.12116/J.ISSN.1004-5619.2020.01.007 |
| 2020-02-25 |
In silico identification of vaccine targets for 2019-nCoV (edit) |
10.12688/F1000RESEARCH.22507.1 |
| 2020-02-25 |
Exploring the Active Compounds of Traditional Mongolian Medicine in Intervention of Novel Coronavirus (2019-nCoV) Based on Molecular Docking Method (edit) |
10.26434/CHEMRXIV.11882838 |
| 2020-02-25 |
Candidate Targets for Immune Responses to 2019-Novel Coronavirus (nCoV): Sequence Homology- and Bioinformatic-Based Predictions (edit) |
10.2139/SSRN.3541361 |
| 2020-02-24 |
RETRACTED: Chinese medical staff request international medical assistance in fighting against COVID-19 (edit) |
10.1016/S2214-109X(20)30065-6 |
| 2020-02-24 |
COVID-19 control in China during mass population movements at New Year (edit) |
10.1016/S0140-6736(20)30421-9 |
| 2020-02-24 |
Estimated effectiveness of symptom and risk screening to prevent the spread of COVID-19 (edit) |
10.7554/ELIFE.55570 |
| 2020-02-24 |
Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations (edit) |
10.1038/S41421-020-0147-1 |
| 2020-02-24 |
High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa (edit) |
10.1038/S41368-020-0074-X |
| 2020-02-24 |
Facing the COVID-19 outbreak: What should we know and what could we do? (edit) |
10.1002/JMV.25720 |
| 2020-02-24 |
The Author's Response: Case of the Index Patient Who Caused Tertiary Transmission of Coronavirus Disease 2019 in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Pneumonia Monitored by Quantitative RT-PCR (edit) |
10.3346/JKMS.2020.35.E89 |
| 2020-02-24 |
Letter to the Editor: Case of the Index Patient Who Caused Tertiary Transmission of Coronavirus Disease 2019 in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Pneumonia Monitored by Quantitative RT-PCR (edit) |
10.3346/JKMS.2020.35.E88 |
| 2020-02-24 |
Viral Load Kinetics of SARS-CoV-2 Infection in First Two Patients in Korea (edit) |
10.3346/JKMS.2020.35.E86 |
| 2020-02-24 |
Virus Isolation from the First Patient with SARS-CoV-2 in Korea (edit) |
10.3346/JKMS.2020.35.E84 |
| 2020-02-24 |
Does SARS-CoV-2 has a longer incubation period than SARS and MERS? (edit) |
10.1002/JMV.25708 |
| 2020-02-24 |
Viral load of SARS-CoV-2 in clinical samples (edit) |
10.1016/S1473-3099(20)30113-4 |
| 2020-02-24 |
Profiling ACE2 expression in colon tissue of healthy adults and colorectal cancer patients by single-cell transcriptome analysis (edit) |
10.1101/2020.02.15.20023457 |
| 2020-02-24 |
Phase adjusted estimation of the number of 2019 novel coronavirus cases in Wuhan, China (edit) |
10.1101/2020.02.18.20024281 |
| 2020-02-24 |
Clinical characteristics of 50466 patients with 2019-nCoV infection (edit) |
10.1101/2020.02.18.20024539 |
| 2020-02-24 |
Early Phylogenetic Estimate Of The Effective Reproduction Number Of 2019-nCoV (edit) |
10.1101/2020.02.19.20024851 |
| 2020-02-24 |
Study of the lymphocyte change between COVID-19 and non-COVID-19 pneumonia cases suggesting other factors besides uncontrolled inflammation contributed to multi-organ injury (edit) |
10.1101/2020.02.19.20024885 |
| 2020-02-24 |
The cross-sectional study of hospitalized coronavirus disease 2019 patients in Xiangyang, Hubei province (edit) |
10.1101/2020.02.19.20025023 |
| 2020-02-24 |
A descriptive study of the impact of diseases control and prevention on the epidemics dynamics and clinical features of SARS-CoV-2 outbreak in Shanghai, lessons learned for metropolis epidemics prevention (edit) |
10.1101/2020.02.19.20025031 |
| 2020-02-24 |
Trends and prediction in daily incidence of novel coronavirus infection in China, Hubei Province and Wuhan City: an application of Farr law (edit) |
10.1101/2020.02.19.20025148 |
| 2020-02-24 |
Estimating the risk of 2019 Novel Coronavirus death during the course of the outbreak in China, 2020 (edit) |
10.1101/2020.02.19.20025163 |
| 2020-02-24 |
A Note on COVID-19 Diagnosis Number Prediction Model in China (edit) |
10.1101/2020.02.19.20025262 |
| 2020-02-24 |
SARS-CoV-2 infection does not significantly cause acute renal injury: an analysis of 116 hospitalized patients with COVID-19 in a single hospital, Wuhan, China (edit) |
10.1101/2020.02.19.20025288 |
| 2020-02-24 |
Early Prediction of Disease Progression in 2019 Novel Coronavirus Pneumonia Patients Outside Wuhan with CT and Clinical Characteristics (edit) |
10.1101/2020.02.19.20025296 |
| 2020-02-24 |
Effectiveness of control strategies for Coronavirus Disease 2019: a SEIR dynamic modeling study (edit) |
10.1101/2020.02.19.20025387 |
| 2020-02-24 |
Generalized anxiety disorder, depressive symptoms and sleep quality during COVID-19 epidemic in China: a web-based cross-sectional survey (edit) |
10.1101/2020.02.19.20025395 |
| 2020-02-24 |
The serial interval of COVID-19 from publicly reported confirmed cases (edit) |
10.1101/2020.02.19.20025452 |
| 2020-02-24 |
Novel Coronavirus 2019 (Covid-19) epidemic scale estimation: topological network-based infection dynamic model (edit) |
10.1101/2020.02.20.20023572 |
| 2020-02-24 |
COVID-19 in Wuhan: Immediate Psychological Impact on 5062 Health Workers (edit) |
10.1101/2020.02.20.20025338 |
| 2020-02-24 |
ACP risk grade: a simple mortality index for patients with confirmed or suspected severe acute respiratory syndrome coronavirus 2 disease (COVID-19) during the early stage of outbreak in Wuhan, China (edit) |
10.1101/2020.02.20.20025510 |
| 2020-02-24 |
Clinical characteristics of 51 patients discharged from hospital with COVID-19 in Chongqing，China (edit) |
10.1101/2020.02.20.20025536 |
| 2020-02-24 |
The efficacy of convalescent plasma for the treatment of severe influenza (edit) |
10.1101/2020.02.20.20025593 |
| 2020-02-24 |
Clinical Characteristics of 24 Asymptomatic Infections with COVID-19 Screened among Close Contacts in Nanjing, China (edit) |
10.1101/2020.02.20.20025619 |
| 2020-02-24 |
Breadth of concomitant immune responses underpinning viral clearance and patient recovery in a non-severe case of COVID-19 (edit) |
10.1101/2020.02.20.20025841 |
| 2020-02-24 |
Estimating the Asymptomatic Proportion of 2019 Novel Coronavirus onboard the Princess Cruises Ship, 2020 (edit) |
10.1101/2020.02.20.20025866 |
| 2020-02-24 |
Evaluating the impact of international airline suspensions on the early global spread of COVID-19 (edit) |
10.1101/2020.02.20.20025882 |
| 2020-02-24 |
From Isolation to Coordination: How Can Telemedicine Help Combat the COVID-19 Outbreak? (edit) |
10.1101/2020.02.20.20025957 |
| 2020-02-24 |
Assessing the impact of a symptom-based mass screening and testing intervention during a novel infectious disease outbreak: The case of COVID-19 (edit) |
10.1101/2020.02.20.20025973 |
| 2020-02-24 |
CoVID-19 in Japan: What could happen in the future? (edit) |
10.1101/2020.02.21.20026070 |
| 2020-02-24 |
Epidemiological characteristics of 1212 COVID-19 patients in Henan, China (edit) |
10.1101/2020.02.21.20026112 |
| 2020-02-24 |
Public Exposure to Live Animals, Behavioural Change, and Support in Containment Measures in response to COVID-19 Outbreak: a population-based cross sectional survey in China (edit) |
10.1101/2020.02.21.20026146 |
| 2020-02-24 |
Comparison of throat swabs and sputum specimens for viral nucleic acid detection in 52 cases of novel coronavirus (SARS-Cov-2) infected pneumonia (COVID-19) (edit) |
10.1101/2020.02.21.20026187 |
| 2020-02-24 |
Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study (edit) |
10.1101/2020.02.21.20026328 |
| 2020-02-24 |
Association of radiologic findings with mortality of patients infected with 2019 novel coronavirus in Wuhan, China (edit) |
10.1101/2020.02.22.20024927 |
| 2020-02-24 |
Development and Evaluation of A CRISPR-based Diagnostic For 2019-novel Coronavirus (edit) |
10.1101/2020.02.22.20025460 |
| 2020-02-24 |
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention (edit) |
10.1001/JAMA.2020.2648 |
| 2020-02-24 |
Epitopes for a 2019-nCoV vaccine (edit) |
10.1038/S41423-020-0377-Z |
| 2020-02-24 |
Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses (edit) |
10.1038/S41564-020-0688-Y |
| 2020-02-24 |
Assessing the Impact of Reduced Travel on Exportation Dynamics of Novel Coronavirus Infection (COVID-19) (edit) |
10.3390/JCM9020601 |
| 2020-02-24 |
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study (edit) |
10.1016/S2213-2600(20)30079-5 |
| 2020-02-24 |
Staff safety during emergency airway management for COVID-19 in Hong Kong (edit) |
10.1016/S2213-2600(20)30084-9 |
| 2020-02-24 |
Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study (edit) |
10.1016/S1473-3099(20)30086-4 |
| 2020-02-24 |
COVID-19 pneumonia: what has CT taught us? (edit) |
10.1016/S1473-3099(20)30134-1 |
| 2020-02-24 |
Unveiling the Origin and Transmission of 2019-nCoV (edit) |
10.1016/J.TIM.2020.02.001 |
| 2020-02-24 |
Protocol for the development of a rapid advice guideline for prevention, management and care of children with 2019 novel coronavirus infection (edit) |
10.21037/APM.2020.02.33 |
| 2020-02-24 |
From SARS to COVID-19: A previously unknown SARS- related coronavirus (SARS-CoV-2) of pandemic potential infecting humans - Call for a One Health approach (edit) |
10.1016/J.ONEHLT.2020.100124 |
| 2020-02-23 |
Public responses to the novel 2019 coronavirus (2019-nCoV) in Japan: Mental health consequences and target populations (edit) |
10.1111/PCN.12988 |
| 2020-02-22 |
Estimation of the reproductive number of Novel Coronavirus (COVID-19) and the probable outbreak size on the Diamond Princess cruise ship: A data-driven analysis (edit) |
10.1016/J.IJID.2020.02.033 |
| 2020-02-22 |
Is COVID-19 receiving ADE from other coronaviruses? (edit) |
10.1016/J.MICINF.2020.02.006 |
| 2020-02-22 |
The role of institutional trust in preventive and treatment-seeking behaviors during the 2019 novel coronavirus (2019-nCoV) outbreak among residents in Hubei, China (edit) |
10.1101/2020.02.15.20023333 |
| 2020-02-22 |
Functional pangenome analysis suggests inhibition of the protein E as a readily available therapy for COVID-2019 (edit) |
10.1101/2020.02.17.952895 |
| 2020-02-22 |
Potential T-cell and B-cell Epitopes of 2019-nCoV (edit) |
10.1101/2020.02.19.955484 |
| 2020-02-22 |
Rapid reconstruction of SARS-CoV-2 using a synthetic genomics platform (edit) |
10.1101/2020.02.21.959817 |
| 2020-02-22 |
[Detection of 2019-nCoV in the pathological paraffin embedded tissue] (edit) |
10.3760/CMA.J.CN112151.20200219.00001 |
| 2020-02-22 |
The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? (edit) |
10.1093/IJE/DYAA033 |
| 2020-02-22 |
18F-FDG PET/CT findings of COVID-19: a series of four highly suspected cases (edit) |
10.1007/S00259-020-04734-W |
| 2020-02-22 |
Novel coronavirus (2019-nCoV) cases in Hong Kong and implications for further spread (edit) |
10.1016/J.JINF.2020.02.002 |
| 2020-02-22 |
Short-term Forecasts of the COVID-19 Epidemic in Guangdong and Zhejiang, China: February 13-23, 2020 (edit) |
10.3390/JCM9020596 |
| 2020-02-22 |
Emergence of Novel Coronavirus 2019-nCoV: Need for Rapid Vaccine and Biologics Development (edit) |
10.3390/PATHOGENS9020148 |
| 2020-02-22 |
Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV (edit) |
10.3390/V12020244 |
| 2020-02-21 |
scRNA-seq Profiling of Human Testes Reveals the Presence of ACE2 Receptor, a Target for SARS-CoV-2 Infection, in Spermatogonia, Leydig and Sertoli Cells (edit) |
10.20944/PREPRINTS202002.0299.V1 |
| 2020-02-21 |
Bioinformatic Analysis Reveals That the Reproductive System is Potentially at Risk from SARS-CoV-2 (edit) |
10.20944/PREPRINTS202002.0307.V1 |
| 2020-02-21 |
Presumed Asymptomatic Carrier Transmission of COVID-19 (edit) |
10.1001/JAMA.2020.2565 |
| 2020-02-21 |
Potential benefits of precise corticosteroids therapy for severe 2019-nCoV pneumonia (edit) |
10.1038/S41392-020-0127-9 |
| 2020-02-21 |
Rules on isolation rooms for suspected covid-19 cases in GP surgeries to be relaxed (edit) |
10.1136/BMJ.M707 |
| 2020-02-21 |
Adaptive COVID-19 Treatment Trial (edit) |
10.31525/CT1-NCT04280705 |
| 2020-02-21 |
Fingolimod in COVID-19 (edit) |
10.31525/CT1-NCT04280588 |
| 2020-02-21 |
SARS-CoV-2 and SARS-CoV Spike-RBD Structure and Receptor Binding Comparison and Potential Implications on Neutralizing Antibody and Vaccine Development (edit) |
10.1101/2020.02.16.951723 |
| 2020-02-21 |
Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses (edit) |
10.1101/2020.02.16.951913 |
| 2020-02-21 |
Protection of Rhesus Macaque from SARS-Coronavirus challenge by recombinant adenovirus vaccine (edit) |
10.1101/2020.02.17.951939 |
| 2020-02-21 |
X-ray Structure of Main Protease of the Novel Coronavirus SARS-CoV-2 Enables Design of α-Ketoamide Inhibitors (edit) |
10.1101/2020.02.17.952879 |
| 2020-02-21 |
Molecular mechanism of evolution and human infection with the novel coronavirus (2019-nCoV) (edit) |
10.1101/2020.02.17.952903 |
| 2020-02-21 |
Estimating the cure rate and case fatality rate of the ongoing epidemic COVID-19 (edit) |
10.1101/2020.02.18.20024513 |
| 2020-02-21 |
Pangolin homology associated with 2019-nCoV (edit) |
10.1101/2020.02.19.950253 |
| 2020-02-21 |
Crystal structure of the 2019-nCoV spike receptor-binding domain bound with the ACE2 receptor (edit) |
10.1101/2020.02.19.956235 |
| 2020-02-21 |
Structural basis for the recognition of the 2019-nCoV by human ACE2 (edit) |
10.1101/2020.02.19.956946 |
| 2020-02-21 |
Mucin 4 Protects Female Mice from Coronavirus Pathogenesis (edit) |
10.1101/2020.02.19.957118 |
| 2020-02-21 |
A Multiscale and Comparative Model for Receptor Binding of 2019 Novel Coronavirus and the Implication of its Life Cycle in Host Cells (edit) |
10.1101/2020.02.20.958272 |
| 2020-02-21 |
SARS-CoV-2: a novel deadly virus in a globalised world (edit) |
|
| 2020-02-21 |
COVID-19: another infectious disease emerging at the animal-human interface (edit) |
|
| 2020-02-21 |
The non-contact handheld cutaneous infra-red thermometer for fever screening during the COVID-19 global emergency (edit) |
10.1016/J.JHIN.2020.02.010 |
| 2020-02-21 |
Chinese medical personnel against the 2019-nCoV (edit) |
10.1016/J.JINF.2020.02.011 |
| 2020-02-21 |
Analysis of angiotensin-converting enzyme 2 (ACE2) from different species sheds some light on cross-species receptor usage of a novel coronavirus 2019-nCoV (edit) |
10.1016/J.JINF.2020.02.013 |
| 2020-02-21 |
Genetic diversity and evolution of SARS-CoV-2 (edit) |
10.1016/J.MEEGID.2020.104260 |
| 2020-02-21 |
One world, one health: The novel coronavirus COVID-19 epidemic (edit) |
10.1016/J.MEDCLI.2020.02.002 |
| 2020-02-21 |
Communicating the Risk of Death from Novel Coronavirus Disease (COVID-19) (edit) |
10.3390/JCM9020580 |
| 2020-02-21 |
Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like protease (3CL pro) structure: virtual screening reveals velpatasvir, ledipasvir, and other drug repurposing candidates (edit) |
10.12688/F1000RESEARCH.22457.2 |
| 2020-02-21 |
Exploring the Binding Mechanism and Accessible Angle of SARS-CoV-2 Spike and ACE2 by Molecular Dynamics Simulation and Free Energy Calculation (edit) |
10.26434/CHEMRXIV.11877492 |
| 2020-02-21 |
Exploring the Binding Mechanism and Accessible Angle of SARS-CoV-2 Spike and ACE2 by Molecular Dynamics Simulation and Free Energy Calculation (edit) |
10.26434/CHEMRXIV.11877492.V1 |
| 2020-02-20 |
Chest CT Findings in Coronavirus Disease-19 (COVID-19): Relationship to Duration of Infection (edit) |
10.1148/RADIOL.2020200463 |
| 2020-02-20 |
Coronavirus COVID-19 impacts to dentistry and potential salivary diagnosis (edit) |
10.1007/S00784-020-03248-X |
| 2020-02-20 |
Preparedness and vulnerability of African countries against importations of COVID-19: a modelling study (edit) |
10.1016/S0140-6736(20)30411-6 |
| 2020-02-20 |
Characteristics of and Public Health Responses to the Coronavirus Disease 2019 Outbreak in China (edit) |
10.3390/JCM9020575 |
| 2020-02-20 |
Enteric involvement of coronaviruses: is faecal–oral transmission of SARS-CoV-2 possible? (edit) |
10.1016/S2468-1253(20)30048-0 |
| 2020-02-20 |
COVID-19, Australia: Epidemiology Report 3: Reporting week ending 19:00 AEDT 15 February 2020 (edit) |
10.33321/CDI.2020.44.15 |
| 2020-02-20 |
Aberrant pathogenic GM-CSF+ T cells and inflammatory CD14+CD16+ monocytes in severe pulmonary syndrome patients of a new coronavirus (edit) |
10.1101/2020.02.12.945576 |
| 2020-02-20 |
Candidate targets for immune responses to 2019-Novel Coronavirus (nCoV): sequence homology- and bioinformatic-based predictions (edit) |
10.1101/2020.02.12.946087 |
| 2020-02-20 |
Multivariate Analyses of Codon Usage of SARS-CoV-2 and other betacoronaviruses (edit) |
10.1101/2020.02.15.950568 |
| 2020-02-20 |
Utilize State Transition Matrix Model to Predict the Novel Corona Virus Infection Peak and Patient Distribution (edit) |
10.1101/2020.02.16.20023614 |
| 2020-02-20 |
SEIR Transmission dynamics model of 2019 nCoV coronavirus with considering the weak infectious ability and changes in latency duration (edit) |
10.1101/2020.02.16.20023655 |
| 2020-02-20 |
Fractal kinetics of COVID-19 pandemic (edit) |
10.1101/2020.02.16.20023820 |
| 2020-02-20 |
Estimating the case fatality ratio of the COVID-19 epidemic in China (edit) |
10.1101/2020.02.17.20023630 |
| 2020-02-20 |
Evidence for gastrointestinal infection of SARS-CoV-2 (edit) |
10.1101/2020.02.17.20023721 |
| 2020-02-20 |
The reproductive number R0 of COVID-19 based on estimate of a statistical time delay dynamical system (edit) |
10.1101/2020.02.17.20023747 |
| 2020-02-20 |
Estimating number of global importations of COVID-19 from Wuhan, risk of transmission outside mainland China and COVID-19 introduction index between countries outside mainland China (edit) |
10.1101/2020.02.17.20024075 |
| 2020-02-20 |
Clinical features and progression of acute respiratory distress syndrome in coronavirus disease 2019 (edit) |
10.1101/2020.02.17.20024166 |
| 2020-02-20 |
Tracking and Predicting COVID-19 Epidemic in China Mainland (edit) |
10.1101/2020.02.17.20024257 |
| 2020-02-20 |
Isolation and Characterization of 2019-nCoV-like Coronavirus from Malayan Pangolins (edit) |
10.1101/2020.02.17.951335 |
| 2020-02-20 |
Kidney impairment is associated with in-hospital death of COVID-19 patients (edit) |
10.1101/2020.02.18.20023242 |
| 2020-02-20 |
Estimation of the epidemic properties of the 2019 novel coronavirus: A mathematical modeling study (edit) |
10.1101/2020.02.18.20024315 |
| 2020-02-20 |
Reduction and Functional Exhaustion of T Cells in Patients with Coronavirus Disease 2019 (COVID-19) (edit) |
10.1101/2020.02.18.20024364 |
| 2020-02-20 |
Psychological responses, behavioral changes and public perceptions during the early phase of the COVID-19 outbreak in China: a population based cross-sectional survey (edit) |
10.1101/2020.02.18.20024448 |
| 2020-02-20 |
Modeling and Prediction of the 2019 Coronavirus Disease Spreading in China Incorporating Human Migration Data (edit) |
10.1101/2020.02.18.20024570 |
| 2020-02-20 |
Association of Population Migration and Coronavirus Disease 2019 Epidemic Control (edit) |
10.1101/2020.02.18.20024661 |
| 2020-02-20 |
Are pangolins the intermediate host of the 2019 novel coronavirus (2019-nCoV) ? (edit) |
10.1101/2020.02.18.954628 |
| 2020-02-20 |
Structure and immune recognition of the porcine epidemic diarrhea virus spike protein (edit) |
10.1101/2020.02.18.955195 |
| 2020-02-20 |
Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein (edit) |
10.1101/2020.02.19.956581 |
| 2020-02-20 |
[Preliminary Recommendations for Lung Surgery during 2019 Novel Coronavirus Disease (COVID-19) Epidemic Period] (edit) |
10.3779/J.ISSN.1009-3419.2020.03.01 |
| 2020-02-20 |
[Clinical Management of Lung Cancer Patients during the Outbreak of 2019 Novel Coronavirus Disease (COVID-19)] (edit) |
10.3779/J.ISSN.1009-3419.2020.03.02 |
| 2020-02-20 |
COVID-19 in Singapore-Current Experience: Critical Global Issues That Require Attention and Action (edit) |
10.1001/JAMA.2020.2467 |
| 2020-02-20 |
Lessons learned from the 2019-nCoV epidemic on prevention of future infectious diseases (edit) |
10.1016/J.MICINF.2020.02.004 |
| 2020-02-20 |
Comments on "Preliminary estimation of the basic reproduction number of novel Coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven Analysis in the early phase of the outbreak" (edit) |
10.1016/J.IJID.2020.02.024 |
| 2020-02-20 |
The basic reproduction number of novel coronavirus (2019-nCoV) estimation based on exponential growth in the early outbreak in China from 2019 to 2020: A reply to Dhungana (edit) |
10.1016/J.IJID.2020.02.025 |
| 2020-02-20 |
COVID-19: A critical care perspective informed by lessons learnt from other viral epidemics (edit) |
10.1016/J.ACCPM.2020.02.002 |
| 2020-02-20 |
Potential inhibitors against papain-like protease of novel coronavirus (SARS-CoV-2) from FDA approved drugs (edit) |
10.26434/CHEMRXIV.11860011 |
| 2020-02-20 |
Potential inhibitors against papain-like protease of novel coronavirus (SARS-CoV-2) from FDA approved drugs (edit) |
10.26434/CHEMRXIV.11860011.V2 |
| 2020-02-19 |
Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies (edit) |
10.5582/BST.2020.01047 |
| 2020-02-19 |
Defining the Epidemiology of Covid-19 — Studies Needed (edit) |
10.1056/NEJMP2002125 |
| 2020-02-19 |
Sensitivity of Chest CT for COVID-19: Comparison to RT-PCR (edit) |
10.1148/RADIOL.2020200432 |
| 2020-02-19 |
Covid-19: a puzzle with many missing pieces (edit) |
10.1136/BMJ.M627 |
| 2020-02-19 |
The first Vietnamese case of COVID-19 acquired from China (edit) |
10.1016/S1473-3099(20)30111-0 |
| 2020-02-19 |
Emerging Understanding of Etiology and Epidemiology of the Novel Coronavirus (COVID-19) infection in Wuhan, China (edit) |
10.20944/PREPRINTS202002.0283.V1 |
| 2020-02-19 |
An interactive web-based dashboard to track COVID-19 in real time (edit) |
10.1016/S1473-3099(20)30120-1 |
| 2020-02-19 |
2019 novel coronavirus disease (COVID-19) in Taiwan: Reports of two cases from Wuhan, China (edit) |
10.1016/J.JMII.2020.02.009 |
| 2020-02-19 |
Risk Assessment of Novel Coronavirus COVID-19 Outbreaks Outside China (edit) |
10.3390/JCM9020571 |
| 2020-02-19 |
Rigidity of the Outer Shell Predicted by a Protein Intrinsic Disorder Model Sheds Light on the COVID-19 (Wuhan-2019-nCoV) Infectivity (edit) |
10.3390/BIOM10020331 |
| 2020-02-19 |
Critical care response to a hospital outbreak of the 2019-nCoV infection in Shenzhen, China (edit) |
10.1186/S13054-020-2786-X |
| 2020-02-19 |
Association between 2019-nCoV transmission and N95 respirator use (edit) |
10.1101/2020.02.18.20021881 |
| 2020-02-19 |
Asymptomatic cases in a family cluster with SARS-CoV-2 infection (edit) |
10.1016/S1473-3099(20)30114-6 |
| 2020-02-19 |
Single-cell Analysis of ACE2 Expression in Human Kidneys and Bladders Reveals a Potential Route of 2019-nCoV Infection (edit) |
10.1101/2020.02.08.939892 |
| 2020-02-19 |
Structural modeling of 2019-novel coronavirus (nCoV) spike protein reveals a proteolytically-sensitive activation loop as a distinguishing feature compared to SARS-CoV and related SARS-like coronaviruses (edit) |
10.1101/2020.02.10.942185 |
| 2020-02-19 |
Recombination and lineage-specific mutations led to the emergence of SARS-CoV-2 (edit) |
10.1101/2020.02.10.942748 |
| 2020-02-19 |
Identification of 2019-nCoV related coronaviruses in Malayan pangolins in southern China (edit) |
10.1101/2020.02.13.945485 |
| 2020-02-19 |
Estimate number of individuals infected with the 2019-novel coronavirus in South Korea due to the influx of international students from countries with virus risk: a simulation study (edit) |
10.1101/2020.02.15.20023234 |
| 2020-02-19 |
Evaluating new evidence in the early dynamics of the novel coronavirus COVID-19 outbreak in Wuhan, China with real time domestic traffic and potential asymptomatic transmissions (edit) |
10.1101/2020.02.15.20023440 |
| 2020-02-19 |
Estimating the Case Fatality Risk of COVID-19 using Cases from Outside China (edit) |
10.1101/2020.02.15.20023499 |
| 2020-02-19 |
Epidemic analysis of COVID-19 in China by dynamical modeling (edit) |
10.1101/2020.02.16.20023465 |
| 2020-02-19 |
Simulating and Forecasting the Cumulative Confirmed Cases of SARS-CoV-2 in China by Boltzmann Function-based Regression Analyses (edit) |
10.1101/2020.02.16.20023564 |
| 2020-02-19 |
Estimation of the final size of the coronavirus epidemic by the logistic model (edit) |
10.1101/2020.02.16.20023606 |
| 2020-02-19 |
Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients (edit) |
10.1101/2020.02.16.20023671 |
| 2020-02-19 |
Study on SARS-COV-2 transmission and the effects of control measures in China (edit) |
10.1101/2020.02.16.20023770 |
| 2020-02-19 |
When will the battle against novel coronavirus end in Wuhan: a SEIR modeling analysis (edit) |
10.1101/2020.02.16.20023804 |
| 2020-02-19 |
Risk map of the novel coronavirus (2019-nCoV) in China: proportionate control is needed (edit) |
10.1101/2020.02.16.20023838 |
| 2020-02-19 |
Clinical and immunologic features in severe and moderate forms of Coronavirus Disease 2019 (edit) |
10.1101/2020.02.16.20023903 |
| 2020-02-19 |
COVID-19 in a Designated Infectious Diseases HospitalOutside Hubei Province,China (edit) |
10.1101/2020.02.17.20024018 |
| 2020-02-19 |
Epidemic Situation of Novel Coronavirus Pneumonia in China mainland (edit) |
10.1101/2020.02.17.20024034 |
| 2020-02-19 |
Structure of dimeric full-length human ACE2 in complex with B0AT1 (edit) |
10.1101/2020.02.17.951848 |
| 2020-02-19 |
Open access epidemiological data from the COVID-19 outbreak (edit) |
10.1016/S1473-3099(20)30119-5 |
| 2020-02-19 |
A Single and Two-Stage, Closed-Tube, Molecular Test for the 2019 Novel Coronavirus (COVID-19) at Home, Clinic, and Points of Entry (edit) |
10.26434/CHEMRXIV.11860137 |
| 2020-02-19 |
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation (edit) |
10.1126/SCIENCE.ABB2507 |
| 2020-02-19 |
Genomic variance of the 2019-nCoV coronavirus (edit) |
10.1002/JMV.25700 |
| 2020-02-19 |
[Cluster investigation Technical Guidelines for the 2019 Novel Coronavirus Pneumonia (COVID-19), China (1st Trial Version)] (edit) |
|
| 2020-02-19 |
Preparing for the Most Critically Ill Patients With COVID-19: The Potential Role of Extracorporeal Membrane Oxygenation (edit) |
10.1001/JAMA.2020.2342 |
| 2020-02-19 |
SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients (edit) |
10.1056/NEJMC2001737 |
| 2020-02-19 |
Letter from China: covid-19 on the grapevine, on the internet, and in commerce (edit) |
10.1136/BMJ.M643 |
| 2020-02-19 |
Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series (edit) |
10.1136/BMJ.M606 |
| 2020-02-19 |
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China (edit) |
10.1111/ALL.14238 |
| 2020-02-19 |
Mental health care for medical staff in China during the COVID-19 outbreak (edit) |
10.1016/S2215-0366(20)30078-X |
| 2020-02-19 |
Psychological interventions for people affected by the COVID-19 epidemic (edit) |
10.1016/S2215-0366(20)30073-0 |
| 2020-02-19 |
Online mental health services in China during the COVID-19 outbreak (edit) |
10.1016/S2215-0366(20)30077-8 |
| 2020-02-19 |
The neglected health of international migrant workers in the COVID-19 epidemic (edit) |
10.1016/S2215-0366(20)30076-6 |
| 2020-02-19 |
Mental health services for older adults in China during the COVID-19 outbreak (edit) |
10.1016/S2215-0366(20)30079-1 |
| 2020-02-19 |
Initiation of a new infection control system for the COVID-19 outbreak (edit) |
10.1016/S1473-3099(20)30110-9 |
| 2020-02-19 |
Statement in support of the scientists, public health professionals, and medical professionals of China combatting COVID-19 (edit) |
10.1016/S0140-6736(20)30418-9 |
| 2020-02-19 |
A Novel Coronavirus (COVID-19) Outbreak: A Call for Action (edit) |
10.1016/J.CHEST.2020.02.014 |
| 2020-02-19 |
Coronavirus (COVID-19) Outbreak: What the Department of Radiology Should Know (edit) |
10.1016/J.JACR.2020.02.008 |
| 2020-02-19 |
Traditional Chinese medicine is a resource for drug discovery against 2019 novel coronavirus (SARS-CoV-2) (edit) |
10.1016/J.JOIM.2020.02.004 |
| 2020-02-19 |
Rapid Identification of Potential Inhibitors of SARS-CoV-2 Main Protease by Deep Docking of 1.3 Billion Compounds (edit) |
10.26434/CHEMRXIV.11860077 |
| 2020-02-18 |
The 2019-nCoV Coronavirus: Are there two routes to infection? (edit) |
10.1287/ORMS.2020.02.01 |
| 2020-02-18 |
Pathological findings of COVID-19 associated with acute respiratory distress syndrome (edit) |
10.1016/S2213-2600(20)30076-X |
| 2020-02-18 |
Virus against virus: a potential treatment for 2019-nCov (SARS-CoV-2) and other RNA viruses (edit) |
10.1038/S41422-020-0290-0 |
| 2020-02-18 |
Evidence of SARS-CoV-2 Infection in Returning Travelers from Wuhan, China (edit) |
10.1056/NEJMC2001899 |
| 2020-02-18 |
Economic impacts of Wuhan 2019-nCoV on China and the world (edit) |
10.1002/JMV.25706 |
| 2020-02-18 |
Can Search Query Forecast successfully in China's 2019-nCov pneumonia? (edit) |
10.1101/2020.02.12.20022400 |
| 2020-02-18 |
Analysis of meteorological conditions and prediction of epidemic trend of 2019-nCoV infection in 2020 (edit) |
10.1101/2020.02.13.20022715 |
| 2020-02-18 |
Estimating the distribution of the incubation period of 2019 novel coronavirus (COVID-19) infection between travelers to Hubei, China and non-travelers (edit) |
10.1101/2020.02.13.20022822 |
| 2020-02-18 |
A simple laboratory parameter facilitates early identification of COVID-19 patients (edit) |
10.1101/2020.02.13.20022830 |
| 2020-02-18 |
Clinical Characteristics of 2019 Novel Infected Coronavirus Pneumonia：A Systemic Review and Meta-analysis (edit) |
10.1101/2020.02.14.20021535 |
| 2020-02-18 |
Assessing the impact of reduced travel on exportation dynamics of novel coronavirus infection (COVID-19) (edit) |
10.1101/2020.02.14.20022897 |
| 2020-02-18 |
Estimating the Efficacy of Traffic Blockage and Quarantine for the Epidemic Caused by 2019-nCoV (COVID-19) (edit) |
10.1101/2020.02.14.20022913 |
| 2020-02-18 |
A new transmission route for the propagation of the SARS-CoV-2 coronavirus (edit) |
10.1101/2020.02.14.20022939 |
| 2020-02-18 |
Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (COVID-19) (edit) |
10.1101/2020.02.14.20023127 |
| 2020-02-18 |
A model simulation study on effects of intervention measures in Wuhan COVID-19 epidemic (edit) |
10.1101/2020.02.14.20023168 |
| 2020-02-18 |
Coronavirus covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate (edit) |
10.1136/BMJ.M641 |
| 2020-02-18 |
Outbreak of novel coronavirus (COVID-19): What is the role of radiologists? (edit) |
10.1007/S00330-020-06748-2 |
| 2020-02-18 |
Development of Genetic Diagnostic Methods for Novel Coronavirus 2019 (nCoV-2019) in Japan (edit) |
10.7883/YOKEN.JJID.2020.061 |
| 2020-02-17 |
Vital Surveillances: The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020 (edit) |
|
| 2020-02-17 |
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges (edit) |
10.1016/J.IJANTIMICAG.2020.105924 |
| 2020-02-17 |
The role of absolute humidity on transmission rates of the COVID-19 outbreak (edit) |
10.1101/2020.02.12.20022467 |
| 2020-02-17 |
Structure analysis of the receptor binding of 2019-nCoV (edit) |
10.1016/J.BBRC.2020.02.071 |
| 2020-02-17 |
Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody (edit) |
10.1080/22221751.2020.1729069 |
| 2020-02-17 |
[The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China] (edit) |
10.3760/CMA.J.ISSN.0254-6450.2020.02.003 |
| 2020-02-17 |
Case of the Index Patient Who Caused Tertiary Transmission of COVID-19 Infection in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Infected Pneumonia Monitored by Quantitative RT-PCR (edit) |
10.3346/JKMS.2020.35.E79 |
| 2020-02-17 |
A deep learning algorithm using CT images to screen for Corona Virus Disease (COVID-19) (edit) |
10.1101/2020.02.14.20023028 |
| 2020-02-17 |
Optimizing diagnostic strategy for novel coronavirus pneumonia, a multi-center study in Eastern China (edit) |
10.1101/2020.02.13.20022673 |
| 2020-02-17 |
Potential impact of seasonal forcing on a SARS-CoV-2 pandemic (edit) |
10.1101/2020.02.13.20022806 |
| 2020-02-17 |
The Efficacy of Contact Tracing for the Containment of the 2019 Novel Coronavirus (COVID-19). (edit) |
10.1136/JECH-2020-214051 |
| 2020-02-17 |
The Efficacy of Contact Tracing for the Containment of the 2019 Novel Coronavirus (COVID-19). (edit) |
10.1101/2020.02.14.20023036 |
| 2020-02-17 |
Challenges to the system of reserve medical supplies for public health emergencies: reflections on the outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic in China (edit) |
10.5582/BST.2020.01043 |
| 2020-02-17 |
Timely research papers about COVID-19 in China (edit) |
10.1016/S0140-6736(20)30375-5 |
| 2020-02-17 |
Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like Protease (3CLpro) Structure: Virtual Screening Reveals Velpatasvir, Ledipasvir, and Other Drug Repurposing Candidates (edit) |
10.26434/CHEMRXIV.11831103 |
| 2020-02-17 |
Dose prediction of lopinavir/ritonavir for 2019-novel coronavirus (2019-nCoV) infection based on mathematic modeling (edit) |
10.4103/1995-7645.277815 |
| 2020-02-16 |
The COVID‐19 epidemic (edit) |
10.1111/TMI.13383 |
| 2020-02-16 |
Cryo-EM Structure of the 2019-nCoV Spike in the Prefusion Conformation (edit) |
10.1101/2020.02.11.944462 |
| 2020-02-16 |
[Inhibitors of RAS Might Be a Good Choice for the Therapy of COVID-19 Pneumonia] (edit) |
10.3760/CMA.J.ISSN.1001-0939.2020.0014 |
| 2020-02-16 |
[Cluster investigation Technical Guidelines for the 2019 Novel Coronavirus Pneumonia (COVID-19), China (1st Trial Version)] (edit) |
10.3760/CMA.J.ISSN.0254-6450.2020.03.001 |
| 2020-02-16 |
The coronavirus (COVID-19) epidemic and patient safety (edit) |
10.1016/J.JAAD.2020.02.031 |
| 2020-02-16 |
Battle against novel coronavirus 2019-nCoV: International commitment to develop worldwide informing campaigns (edit) |
10.34172/HPP.2020.15 |
| 2020-02-15 |
Chloroquine for the 2019 novel coronavirus SARS-CoV-2 (edit) |
10.1016/J.IJANTIMICAG.2020.105923 |
| 2020-02-15 |
Identification of a Pangolin Niche for a 2019-nCoV-like Coronavirus via an Extensive Meta-metagenomic Search (edit) |
10.1101/2020.02.08.939660 |
| 2020-02-15 |
Structural genomics and interactomics of 2019 Wuhan novel coronavirus, 2019-nCoV, indicate evolutionary conserved functional regions of viral proteins (edit) |
10.1101/2020.02.10.942136 |
| 2020-02-14 |
HIV-1 did not contribute to the 2019-nCoV genome (edit) |
10.1080/22221751.2020.1727299 |
| 2020-02-14 |
Persons Evaluated for 2019 Novel Coronavirus - United States, January 2020 (edit) |
10.15585/MMWR.MM6906E1 |
| 2020-02-14 |
Long-Term Persistence of IgG Antibodies in SARS-CoV Infected Healthcare Workers (edit) |
10.1101/2020.02.12.20021386 |
| 2020-02-14 |
A spatial model of CoVID-19 transmission in England and Wales: early spread and peak timing (edit) |
10.1101/2020.02.12.20022566 |
| 2020-02-14 |
Understanding the present status and forecasting of COVID―19 in Wuhan (edit) |
10.1101/2020.02.13.20022251 |
| 2020-02-14 |
Quantifying bias of COVID-19 prevalence and severity estimates in Wuhan, China that depend on reported cases in international travelers (edit) |
10.1101/2020.02.13.20022707 |
| 2020-02-14 |
Transmission dynamics and evolutionary history of 2019-nCoV (edit) |
10.1002/JMV.25701 |
| 2020-02-14 |
[An update on the epidemiological characteristics of novel coronavirus pneumonia（COVID-19）] (edit) |
10.3760/CMA.J.ISSN.0254-6450.2020.02.002 |
| 2020-02-14 |
Full spectrum of COVID-19 severity still being depicted (edit) |
10.1016/S0140-6736(20)30308-1 |
| 2020-02-14 |
Full spectrum of COVID-19 severity still being depicted - Authors' reply (edit) |
10.1016/S0140-6736(20)30371-8 |
| 2020-02-14 |
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China (edit) |
10.1016/S1470-2045(20)30096-6 |
| 2020-02-14 |
Real-Time Estimation of the Risk of Death from Novel Coronavirus (COVID-19) Infection: Inference Using Exported Cases (edit) |
10.3390/JCM9020523 |
| 2020-02-14 |
Potential of large "first generation" human-to-human transmission of 2019-nCoV (edit) |
10.1002/JMV.25693 |
| 2020-02-14 |
Structural modeling of 2019-novel coronavirus (nCoV) spike protein reveals a proteolytically-sensitive activation loop as a distinguishing feature compared to SARS-CoV and related SARS-like coronaviruses (edit) |
|
| 2020-02-13 |
Time Course of Lung Changes On Chest CT During Recovery From 2019 Novel Coronavirus (COVID-19) Pneumonia (edit) |
10.1148/RADIOL.2020200370 |
| 2020-02-13 |
First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures, January 2020 (edit) |
10.2807/1560-7917.ES.2020.25.6.2000094 |
| 2020-02-13 |
Do not violate the International Health Regulations during the COVID-19 outbreak (edit) |
10.1016/S0140-6736(20)30373-1 |
| 2020-02-13 |
Latest updates on COVID-19 from the European Centre for Disease Prevention and Control (edit) |
10.2807/1560-7917.ES.2020.25.6.2002131 |
| 2020-02-13 |
Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan, China (edit) |
10.1007/S00330-020-06731-X |
| 2020-02-13 |
Laboratory readiness and response for novel coronavirus (2019-nCoV) in expert laboratories in 30 EU/EEA countries, January 2020 (edit) |
10.2807/1560-7917.ES.2020.25.6.2000082 |
| 2020-02-13 |
Serial interval of novel coronavirus (2019-nCoV) infections (edit) |
10.1101/2020.02.03.20019497 |
| 2020-02-13 |
Teicoplanin potently blocks the cell entry of 2019-nCoV (edit) |
10.1101/2020.02.05.935387 |
| 2020-02-13 |
Potentially highly potent drugs for 2019-nCoV (edit) |
10.1101/2020.02.05.936013 |
| 2020-02-13 |
Evidence of recombination in coronaviruses implicating pangolin origins of nCoV-2019 (edit) |
10.1101/2020.02.07.939207 |
| 2020-02-13 |
The immune vulnerability landscape of the 2019 Novel Coronavirus, SARS-CoV-2 (edit) |
10.1101/2020.02.08.939553 |
| 2020-02-13 |
Data-Based Analysis, Modelling and Forecasting of the COVID-19 outbreak (edit) |
10.1101/2020.02.11.20022186 |
| 2020-02-13 |
Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCoV, in the nasal tissue (edit) |
10.1101/2020.02.11.20022228 |
| 2020-02-13 |
Lockdown may partially halt the spread of 2019 novel coronavirus in Hubei province, China (edit) |
10.1101/2020.02.11.20022236 |
| 2020-02-13 |
Statistics based predictions of coronavirus 2019-nCoV spreading in mainland China (edit) |
10.1101/2020.02.12.20021931 |
| 2020-02-13 |
Estimating the daily trend in the size of the COVID-19 infected population in Wuhan (edit) |
10.1101/2020.02.12.20022277 |
| 2020-02-13 |
Epidemic size of novel coronavirus-infected pneumonia in the Epicenter Wuhan: using data of five-countries' evacuation action (edit) |
10.1101/2020.02.12.20022285 |
| 2020-02-13 |
Clinical diagnosis of 8274 samples with 2019-novel coronavirus in Wuhan (edit) |
10.1101/2020.02.12.20022327 |
| 2020-02-13 |
ACE2 Expression in Kidney and Testis May Cause Kidney and Testis Damage After 2019-nCoV Infection (edit) |
10.1101/2020.02.12.20022418 |
| 2020-02-13 |
Interventions targeting air travellers early in the pandemic may delay local outbreaks of SARS-CoV-2 (edit) |
10.1101/2020.02.12.20022426 |
| 2020-02-13 |
Early epidemiological assessment of the transmission potential and virulence of coronavirus disease 2019 (COVID-19) in Wuhan City: China, January-February, 2020 (edit) |
10.1101/2020.02.12.20022434 |
| 2020-02-13 |
Outbreak of COVID-19 - an urgent need for good science to silence our fears? (edit) |
10.11622/SMEDJ.2020018 |
| 2020-02-13 |
Straining the System: Novel Coronavirus (COVID-19) and Preparedness for Concomitant Disasters (edit) |
10.2105/AJPH.2020.305618 |
| 2020-02-13 |
COVID-19: what is next for public health? (edit) |
10.1016/S0140-6736(20)30374-3 |
| 2020-02-13 |
Potential inhibitors against 2019-nCoV coronavirus M protease from clinically approved medicines (edit) |
10.1016/J.JGG.2020.02.001 |
| 2020-02-12 |
Outbreak of Pneumonia of Unknown Etiology in Wuhan China: the Mystery and the Miracle (edit) |
10.1002/JMV.25678 |
| 2020-02-12 |
Practical recommendations for critical care and anesthesiology teams caring for novel coronavirus (2019-nCoV) patients (edit) |
10.1007/S12630-020-01591-X |
| 2020-02-12 |
Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records (edit) |
10.1016/S0140-6736(20)30360-3 |
| 2020-02-12 |
Chest CT for Typical 2019-nCoV Pneumonia: Relationship to Negative RT-PCR Testing (edit) |
10.1148/RADIOL.2020200343 |
| 2020-02-12 |
Community pharmacist in public health emergencies: Quick to action against the coronavirus 2019-nCoV outbreak (edit) |
10.1016/J.SAPHARM.2020.02.003 |
| 2020-02-12 |
Preliminary prediction of the basic reproduction number of the Wuhan novel coronavirus 2019-nCoV (edit) |
10.1111/JEBM.12376 |
| 2020-02-12 |
Abnormal respiratory patterns classifier may contribute to large-scale screening of people infected with COVID-19 in an accurate and unobtrusive manner (edit) |
|
| 2020-02-12 |
COVID-19, Australia: Epidemiology Report 2: Reporting week ending 19:00 AEDT 8 February 2020 (edit) |
10.33321/CDI.2020.44.14 |
| 2020-02-12 |
Design of multi epitope-based peptide vaccine against E protein of human COVID-19: An immunoinformatics approach (edit) |
10.1101/2020.02.04.934232 |
| 2020-02-12 |
The Essential Facts of Wuhan Novel Coronavirus Outbreak in China and Epitope-based Vaccine Designing against COVID-19 (edit) |
10.1101/2020.02.05.935072 |
| 2020-02-12 |
The Pathogenicity of SARS-CoV-2 in hACE2 Transgenic Mice (edit) |
10.1101/2020.02.07.939389 |
| 2020-02-12 |
Caution on Kidney Dysfunctions of COVID-19 Patients (edit) |
10.1101/2020.02.08.20021212 |
| 2020-02-12 |
The insert sequence in SARS-CoV-2 enhances spike protein cleavage by TMPRSS (edit) |
10.1101/2020.02.08.926006 |
| 2020-02-12 |
Simulating the infected population and spread trend of 2019-nCov under different policy by EIR model (edit) |
10.1101/2020.02.10.20021519 |
| 2020-02-12 |
Neutrophil-to-Lymphocyte Ratio Predicts Severe Illness Patients with 2019 Novel Coronavirus in the Early Stage (edit) |
10.1101/2020.02.10.20021584 |
| 2020-02-12 |
Statistical Inference for Coronavirus Infected Patients in Wuhan (edit) |
10.1101/2020.02.10.20021774 |
| 2020-02-12 |
Distribution of the 2019-nCoV Epidemic and Correlation with Population Emigration from Wuhan, China (edit) |
10.1101/2020.02.10.20021824 |
| 2020-02-12 |
Characteristics of lymphocyte subsets and cytokines in peripheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia (NCP) (edit) |
10.1101/2020.02.10.20021832 |
| 2020-02-12 |
Facemask shortage and the coronavirus disease (COVID-19) outbreak: Reflection on public health measures (edit) |
10.1101/2020.02.11.20020735 |
| 2020-02-12 |
Evaluating the accuracy of different respiratory specimens in the laboratory diagnosis and monitoring the viral shedding of 2019-nCoV infections (edit) |
10.1101/2020.02.11.20021493 |
| 2020-02-12 |
Ophthalmologic evidence against the interpersonal transmission of 2019 novel coronavirus through conjunctiva (edit) |
10.1101/2020.02.11.20021956 |
| 2020-02-12 |
Epidemiological and Clinical Characteristics of 17 Hospitalized Patients with 2019 Novel Coronavirus Infections Outside Wuhan, China (edit) |
10.1101/2020.02.11.20022053 |
| 2020-02-12 |
Primary Care Practitioners' Response to 2019 Novel Coronavirus Outbreak in China (edit) |
10.1101/2020.02.11.20022095 |
| 2020-02-12 |
Healthcare-resource-adjusted vulnerabilities towards the 2019-nCoV epidemic across China (edit) |
10.1101/2020.02.11.20022111 |
| 2020-02-12 |
The first two cases of 2019-nCoV in Italy: Where they come from? (edit) |
10.1002/JMV.25699 |
| 2020-02-12 |
[Respiratory support for severe 2019-nCoV pneumonia suffering from acute respiratory failure: time and strategy] (edit) |
10.3760/CMA.J.ISSN.1001-0939.2020.0010 |
| 2020-02-12 |
The global spread of 2019-nCoV: a molecular evolutionary analysis (edit) |
10.1080/20477724.2020.1725339 |
| 2020-02-12 |
Novel coronavirus (SARS-CoV-2) epidemic: a veterinary perspective (edit) |
10.12834/VETIT.2173.11599.1 |
| 2020-02-12 |
Pre- and Posttreatment Chest CT Findings: 2019 Novel Coronavirus (2019-nCoV) Pneumonia (edit) |
10.1148/RADIOL.2020200323 |
| 2020-02-12 |
A Locally Transmitted Case of SARS-CoV-2 Infection in Taiwan (edit) |
10.1056/NEJMC2001573 |
| 2020-02-12 |
On the use of corticosteroids for 2019-nCoV pneumonia (edit) |
10.1016/S0140-6736(20)30361-5 |
| 2020-02-12 |
Anti-Chinese sentiment during the 2019-nCoV outbreak (edit) |
10.1016/S0140-6736(20)30358-5 |
| 2020-02-12 |
Toning down the 2019-nCoV media hype-and restoring hope (edit) |
10.1016/S2213-2600(20)30070-9 |
| 2020-02-12 |
What are the risks of COVID-19 infection in pregnant women? (edit) |
10.1016/S0140-6736(20)30365-2 |
| 2020-02-12 |
Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China (edit) |
10.1002/JMV.25689 |
| 2020-02-12 |
2019-nCoV - Towards a 4th generation vaccine (edit) |
10.6026/97320630016139 |
| 2020-02-12 |
Early in the Epidemic: Impact of Preprints on Global Discourse of 2019-nCoV Transmissibility (edit) |
10.2139/SSRN.3536663 |
| 2020-02-11 |
Initial Cluster of Novel Coronavirus (2019-nCoV) Infections in Wuhan, China Is Consistent with Substantial Human-to-Human Transmission (edit) |
10.3390/JCM9020488 |
| 2020-02-11 |
Severe acute respiratory syndrome-related coronavirus: The species and its viruses – a statement of the Coronavirus Study Group (edit) |
10.1101/2020.02.07.937862 |
| 2020-02-11 |
Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19) (edit) |
10.1101/2020.02.03.20020248 |
| 2020-02-11 |
Diarrhea may be underestimated: a missing link in 2019 novel coronavirus (edit) |
10.1101/2020.02.03.20020289 |
| 2020-02-11 |
Bulk and single-cell transcriptomics identify tobacco-use disparity in lung gene expression of ACE2, the receptor of 2019-nCov (edit) |
10.1101/2020.02.05.20020107 |
| 2020-02-11 |
Networks of information token recurrences derived from genomic sequences may reveal hidden patterns in epidemic outbreaks: A case study of the 2019-nCoV coronavirus. (edit) |
10.1101/2020.02.07.20021139 |
| 2020-02-11 |
The Novel Coronavirus, 2019-nCoV, is Highly Contagious and More Infectious Than Initially Estimated (edit) |
10.1101/2020.02.07.20021154 |
| 2020-02-11 |
Transmission Dynamics of 2019-nCoV in Malaysia (edit) |
10.1101/2020.02.07.20021188 |
| 2020-02-11 |
Tracking the spread of novel coronavirus (2019-nCoV) based on big data (edit) |
10.1101/2020.02.07.20021196 |
| 2020-02-11 |
Exploring the coronavirus epidemic using the new WashU Virus Genome Browser (edit) |
10.1101/2020.02.07.939124 |
| 2020-02-11 |
Feasibility of controlling 2019-nCoV outbreaks by isolation of cases and contacts (edit) |
10.1101/2020.02.08.20021162 |
| 2020-02-11 |
Estimation of the Time-Varying Reproduction Number of COVID-19 Outbreak in China (edit) |
10.1101/2020.02.08.20021253 |
| 2020-02-11 |
Assessing the plausibility of subcritical transmission of 2019-nCoV in the United States (edit) |
10.1101/2020.02.08.20021311 |
| 2020-02-11 |
The effect of travel restrictions on the spread of the 2019 novel coronavirus (2019-nCoV) outbreak (edit) |
10.1101/2020.02.09.20021261 |
| 2020-02-11 |
Spatially Explicit Modeling of 2019-nCoV Epidemic Trend based on Mobile Phone Data in Mainland China (edit) |
10.1101/2020.02.09.20021360 |
| 2020-02-11 |
Assessing the Tendency of 2019-nCoV (COVID-19) Outbreak in China (edit) |
10.1101/2020.02.09.20021444 |
| 2020-02-11 |
The lockdown of Hubei Province causing different transmission dynamics of the novel coronavirus (2019-nCoV) in Wuhan and Beijing (edit) |
10.1101/2020.02.09.20021477 |
| 2020-02-11 |
Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China (edit) |
10.1101/2020.02.10.20021675 |
| 2020-02-11 |
Alpha-ketoamides as broad-spectrum inhibitors of coronavirus and enterovirus replication (edit) |
10.1101/2020.02.10.936898 |
| 2020-02-11 |
Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein (edit) |
10.1038/S41423-020-0374-2 |
| 2020-02-11 |
Early lessons from the frontline of the 2019-nCoV outbreak (edit) |
10.1016/S0140-6736(20)30356-1 |
| 2020-02-11 |
Minimise nosocomial spread of 2019-nCoV when treating acute respiratory failure (edit) |
10.1016/S0140-6736(20)30359-7 |
| 2020-02-11 |
2019-nCoV, fake news, and racism (edit) |
10.1016/S0140-6736(20)30357-3 |
| 2020-02-11 |
2019-nCoV: Polite with children! (edit) |
10.4081/PR.2020.8495 |
| 2020-02-11 |
D3Targets-2019-nCoV: A Web Server to Identify Potential Targets for Antivirals Against 2019-nCoV (edit) |
10.26434/CHEMRXIV.11831163 |
| 2020-02-11 |
The fiscal value of human lives lost from Novel Coronavirus (2019-nCoV) in China (edit) |
10.21203/RS.2.23296/V1 |
| 2020-02-10 |
Potential Maternal and Infant Outcomes from (Wuhan) Coronavirus 2019-nCoV Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections (edit) |
10.3390/V12020194 |
| 2020-02-10 |
The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade (edit) |
10.1016/J.ANTIVIRAL.2020.104742 |
| 2020-02-10 |
Coronaphobia: Fear and the 2019-nCoV outbreak (edit) |
10.1016/J.JANXDIS.2020.102196 |
| 2020-02-09 |
Protein structure and sequence re-analysis of 2019-nCoV genome does not indicate snakes as its intermediate host or the unique similarity between its spike protein insertions and HIV-1 (edit) |
10.1101/2020.02.04.933135 |
| 2020-02-09 |
Analysis of the epidemic growth of the early 2019-nCoV outbreak using internationally confirmed cases (edit) |
10.1101/2020.02.06.20020941 |
| 2020-02-09 |
Clinical characteristics of 2019 novel coronavirus infection in China (edit) |
10.1101/2020.02.06.20020974 |
| 2020-02-09 |
Incorporating Human Movement Data to Improve Epidemiological Estimates for 2019-nCoV (edit) |
10.1101/2020.02.07.20021071 |
| 2020-02-09 |
Epidemiologic characteristics of early cases with 2019 novel coronavirus (2019-nCoV) disease in Korea (edit) |
10.4178/EPIH.E2020007 |
| 2020-02-09 |
Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury (edit) |
10.1007/S11427-020-1643-8 |
| 2020-02-08 |
[Expert consensus on the use of corticosteroid in patients with 2019-nCoV pneumonia] (edit) |
10.3760/CMA.J.ISSN.1001-0939.2020.0007 |
| 2020-02-07 |
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China (edit) |
10.1001/JAMA.2020.1585 |
| 2020-02-07 |
Preparedness and vulnerability of African countries against introductions of 2019-nCoV (edit) |
10.1101/2020.02.05.20020792 |
| 2020-02-07 |
Initial Public Health Response and Interim Clinical Guidance for the 2019 Novel Coronavirus Outbreak - United States, December 31, 2019-February 4, 2020 (edit) |
10.15585/MMWR.MM6905E1 |
| 2020-02-07 |
Pandemic potential of 2019-nCoV (edit) |
10.1016/S1473-3099(20)30068-2 |
| 2020-02-07 |
Evolution of CT Manifestations in a Patient Recovered from 2019 Novel Coronavirus (2019-nCoV) Pneumonia in Wuhan, China (edit) |
10.1148/RADIOL.2020200269 |
| 2020-02-07 |
CT Manifestations of Two Cases of 2019 Novel Coronavirus (2019-nCoV) Pneumonia (edit) |
10.1148/RADIOL.2020200280 |
| 2020-02-07 |
ACE2 expression by colonic epithelial cells is associated with viral infection, immunity and energy metabolism (edit) |
10.1101/2020.02.05.20020545 |
| 2020-02-07 |
A database resource for Genome-wide dynamics analysis of Coronaviruses on a historical and global scale (edit) |
10.1101/2020.02.05.920009 |
| 2020-02-07 |
[Interpretation of "Guidelines for the Diagnosis and Treatment of Novel Coronavirus (2019-nCoV) Infection by the National Health Commission (Trial Version 5)"] (edit) |
10.3760/CMA.J.ISSN.0376-2491.2020.0001 |
| 2020-02-07 |
In Beijing, coronavirus 2019-nCoV has created a siege mentality (edit) |
10.1136/BMJ.M516 |
| 2020-02-07 |
Clinical Features and Treatment of 2019-nCov Pneumonia Patients in Wuhan: Report of A Couple Cases (edit) |
10.1007/S12250-020-00203-8 |
| 2020-02-07 |
Compensation of ACE2 Function for Possible Clinical Management of 2019-nCoV-Induced Acute Lung Injury (edit) |
10.1007/S12250-020-00205-6 |
| 2020-02-07 |
Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China (edit) |
10.1016/J.CHOM.2020.02.001 |
| 2020-02-07 |
2019-nCoV in context: lessons learned? (edit) |
10.1016/S2542-5196(20)30035-8 |
| 2020-02-07 |
2019-nCoV epidemic: address mental health care to empower society (edit) |
10.1016/S0140-6736(20)30309-3 |
| 2020-02-07 |
Coronavirus 2019-nCoV: Is the genie already out of the bottle? (edit) |
10.1016/J.TMAID.2020.101577 |
| 2020-02-07 |
Estimation of the Transmission Risk of the 2019-nCoV and Its Implication for Public Health Interventions (edit) |
10.3390/JCM9020462 |
| 2020-02-07 |
A data driven time-dependent transmission rate for tracking an epidemic: a case study of 2019-nCoV (edit) |
10.1016/J.SCIB.2020.02.005 |
| 2020-02-07 |
Finding an Accurate Early Forecasting Model from Small Dataset: A Case of 2019-nCoV Novel Coronavirus Outbreak (edit) |
10.9781/IJIMAI.2020.02.002 |
| 2020-02-07 |
Is lithium a potential treatment for the novel Wuhan (2019-nCoV) coronavirus? A scoping review (edit) |
10.12688/F1000RESEARCH.22299.1 |
| 2020-02-06 |
Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20-28 January 2020 (edit) |
10.2807/1560-7917.ES.2020.25.5.2000062 |
| 2020-02-06 |
Effectiveness of airport screening at detecting travellers infected with novel coronavirus (2019-nCoV) (edit) |
10.2807/1560-7917.ES.2020.25.5.2000080 |
| 2020-02-06 |
A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version) (edit) |
10.1186/S40779-020-0233-6 |
| 2020-02-06 |
2019-nCoV acute respiratory disease, Australia: Epidemiology Report 1 (Reporting week 26 January - 1 February 2020) (edit) |
10.33321/CDI.2020.44.13 |
| 2020-02-06 |
Emerging Coronavirus 2019-nCoV Pneumonia (edit) |
|
| 2020-02-06 |
Note from the editors: World Health Organization declares novel coronavirus (2019-nCoV) sixth public health emergency of international concern (edit) |
10.2807/1560-7917.ES.2020.25.5.200131E |
| 2020-02-06 |
Evidence and characteristics of human-to-human transmission of SARS-CoV-2 (edit) |
10.1101/2020.02.03.20019141 |
| 2020-02-06 |
Epidemic doubling time of the COVID-19 epidemic by Chinese province (edit) |
10.1101/2020.02.05.20020750 |
| 2020-02-06 |
Imaging changes in patients with 2019-nCov (edit) |
10.1007/S00330-020-06713-Z |
| 2020-02-06 |
2019-nCoV transmission through the ocular surface must not be ignored (edit) |
10.1016/S0140-6736(20)30313-5 |
| 2020-02-06 |
2019-nCoV epidemic: what about pregnancies? (edit) |
10.1016/S0140-6736(20)30311-1 |
| 2020-02-05 |
Using predicted imports of 2019-nCoV cases to determine locations that may not be identifying all imported cases (edit) |
10.1101/2020.02.04.20020495 |
| 2020-02-05 |
Assessing spread risk of Wuhan novel coronavirus within and beyond China, January-April 2020: a travel network-based modelling study (edit) |
10.1101/2020.02.04.20020479 |
| 2020-02-05 |
The 2019 Novel Coronavirus (2019-nCoV): Novel Virus, Old Challenges (edit) |
10.20344/AMP.13547 |
| 2020-02-05 |
RNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreak (edit) |
10.1080/22221751.2020.1725399 |
| 2020-02-05 |
The crystal structure of COVID-19 main protease in complex with an inhibitor N3 (edit) |
10.2210/PDB6LU7/PDB |
| 2020-02-05 |
Machine intelligence design of 2019-nCoV drugs (edit) |
10.1101/2020.01.30.927889 |
| 2020-02-05 |
Integrative Bioinformatics Analysis Provides Insight into the Molecular Mechanisms of 2019-nCoV (edit) |
10.1101/2020.02.03.20020206 |
| 2020-02-05 |
Network-based Drug Repurposing for Human Coronavirus (edit) |
10.1101/2020.02.03.20020263 |
| 2020-02-05 |
Getting to zero quickly in the 2019-nCov epidemic with vaccines or rapid testing (edit) |
10.1101/2020.02.03.20020271 |
| 2020-02-05 |
Specific ACE2 Expression in Cholangiocytes May Cause Liver Damage After 2019-nCoV Infection (edit) |
10.1101/2020.02.03.931766 |
| 2020-02-05 |
Machine learning using intrinsic genomic signatures for rapid classification of novel pathogens: COVID-19 case study (edit) |
10.1101/2020.02.03.932350 |
| 2020-02-05 |
Preliminary identification of potential vaccine targets for the COVID-19 coronavirus (SARS-CoV-2) based on SARS-CoV immunological studies (edit) |
10.1101/2020.02.03.933226 |
| 2020-02-05 |
Population movement, city closure and spatial transmission of the 2019-nCoV infection in China (edit) |
10.1101/2020.02.04.20020339 |
| 2020-02-05 |
Epidemiological parameter review and comparative dynamics of influenza, respiratory syncytial virus, rhinovirus, human coronavirus, and adenovirus (edit) |
10.1101/2020.02.04.20020404 |
| 2020-02-05 |
The impact of traffic isolation in Wuhan on the spread of 2019-nCov (edit) |
10.1101/2020.02.04.20020438 |
| 2020-02-05 |
Forecasting the Wuhan coronavirus (2019-nCoV) epidemics using a simple (simplistic) model - update (Feb. 8, 2020) (edit) |
10.1101/2020.02.04.20020461 |
| 2020-02-05 |
Risk assessment of novel coronavirus COVID-19 outbreaks outside China (edit) |
10.1101/2020.02.04.20020503 |
| 2020-02-05 |
The novel Chinese coronavirus (2019-nCoV) infections: Challenges for fighting the storm (edit) |
10.1111/ECI.13209 |
| 2020-02-05 |
Reporting, Epidemic Growth, and Reproduction Numbers for the 2019 Novel Coronavirus (2019-nCoV) Epidemic (edit) |
10.7326/M20-0358 |
| 2020-02-05 |
[Pulmonary rehabilitation guidelines in the principle of 4S for patients infected with 2019 novel coronavirus (2019-nCoV)] (edit) |
10.3760/CMA.J.ISSN.1001-0939.2020.0004 |
| 2020-02-05 |
A novel coronavirus (2019-nCoV) causing pneumonia-associated respiratory syndrome (edit) |
10.1038/S41423-020-0372-4 |
| 2020-02-05 |
Reducing mortality from 2019-nCoV: host-directed therapies should be an option (edit) |
10.1016/S0140-6736(20)30305-6 |
| 2020-02-05 |
Homology Models of Coronavirus 2019-nCoV 3CLpro Protease (edit) |
10.26434/CHEMRXIV.11637294 |
| 2020-02-05 |
Epitope finding in 2019 novel coronavirus (2019-nCoV): The first world report (edit) |
10.4103/1995-7645.277515 |
| 2020-02-05 |
Novel coronavirus (2019-nCoV) update: What we know and what is unknown (edit) |
10.4103/1995-7645.277795 |
| 2020-02-05 |
Imported cases of 2019-novel coronavirus (2019-nCoV) infections in Thailand: Mathematical modelling of the outbreak (edit) |
10.4103/1995-7645.277516 |
| 2020-02-05 |
Technical guidance for laboratory testing of 2019-nCoV infection (Third Edition) (edit) |
10.1016/J.BSHEAL.2020.02.001 |
| 2020-02-05 |
A strategy to prevent future epidemics similar to the 2019-nCoV outbreak (edit) |
10.1016/J.BSHEAL.2020.01.003 |
| 2020-02-04 |
Recent advances in the detection of respiratory virus infection in humans (edit) |
10.1002/JMV.25674 |
| 2020-02-04 |
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro (edit) |
10.1038/S41422-020-0282-0 |
| 2020-02-04 |
Baricitinib as potential treatment for 2019-nCoV acute respiratory disease (edit) |
10.1016/S0140-6736(20)30304-4 |
| 2020-02-04 |
The incubation period of 2019-nCoV from publicly reported confirmed cases: estimation and application (edit) |
10.1101/2020.02.02.20020016 |
| 2020-02-04 |
The Rate of Underascertainment of Novel Coronavirus (2019-nCoV) Infection: Estimation Using Japanese Passengers Data on Evacuation Flights (edit) |
10.3390/JCM9020419 |
| 2020-02-04 |
2019 Novel Coronavirus (2019-nCoV) Pneumonia (edit) |
10.1148/RADIOL.2020200257 |
| 2020-02-04 |
Emerging threats from zoonotic coronaviruses-from SARS and MERS to 2019-nCoV (edit) |
10.1016/J.JMII.2020.02.001 |
| 2020-02-04 |
Pathogenicity and transmissibility of 2019-nCoV-A quick overview and comparison with other emerging viruses (edit) |
10.1016/J.MICINF.2020.01.004 |
| 2020-02-04 |
Outbreak of novel Corona virus (2019-nCoV); implications for travelers to Pakistan (edit) |
10.1016/J.TMAID.2020.101571 |
| 2020-02-04 |
Chest CT Findings in 2019 Novel Coronavirus (2019-nCoV) Infections from Wuhan, China: Key Points for the Radiologist (edit) |
10.1148/RADIOL.2020200241 |
| 2020-02-04 |
CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV) (edit) |
10.1148/RADIOL.2020200230 |
| 2020-02-04 |
Fast assessment of human receptor-binding capability of 2019 novel coronavirus (2019-nCoV) (edit) |
10.1101/2020.02.01.930537 |
| 2020-02-04 |
Genomic variance of the 2019-nCoV coronavirus (edit) |
10.1101/2020.02.02.931162 |
| 2020-02-04 |
A new pandemic out of China: the Wuhan 2019-nCoV coronavirus syndrome (edit) |
10.1016/J.HLPT.2020.02.001 |
| 2020-02-04 |
Homology Models of the Papain-Like Protease PLpro from Coronavirus 2019-nCoV (edit) |
10.26434/CHEMRXIV.11799705 |
| 2020-02-03 |
Study claiming new coronavirus can be transmitted by people without symptoms was flawed (edit) |
10.1126/SCIENCE.ABB1524 |
| 2020-02-03 |
A pneumonia outbreak associated with a new coronavirus of probable bat origin (edit) |
10.1038/S41586-020-2012-7 |
| 2020-02-03 |
Molecular Modeling Evaluation of the Binding Abilities of Ritonavir and Lopinavir to Wuhan Pneumonia Coronavirus Proteases (edit) |
10.1101/2020.01.31.929695 |
| 2020-02-03 |
A new coronavirus associated with human respiratory disease in China (edit) |
10.1038/S41586-020-2008-3 |
| 2020-02-03 |
The Fight against the 2019-nCoV Outbreak: an Arduous March Has Just Begun (edit) |
10.3346/JKMS.2020.35.E56 |
| 2020-02-03 |
Highly Distinguished Amino Acid Sequences of 2019-nCoV (Wuhan Coronavirus) (edit) |
10.1101/2020.01.31.929497 |
| 2020-02-03 |
Potent neutralization of 2019 novel coronavirus by recombinant ACE2-Ig (edit) |
10.1101/2020.02.01.929976 |
| 2020-02-03 |
[2019-nCoV: new challenges from coronavirus] (edit) |
10.3760/CMA.J.ISSN.0253-9624.2020.0001 |
| 2020-02-02 |
2019-nCoV, first death outside China (edit) |
|
| 2020-02-02 |
Reconciling early-outbreak preliminary estimates of the basic reproductive number and its uncertainty: a new framework and applications to the novel coronavirus (2019-nCoV) outbreak (edit) |
10.1101/2020.01.30.20019877 |
| 2020-02-02 |
Early dynamics of transmission and control of 2019-nCoV: a mathematical modelling study (edit) |
10.1101/2020.01.31.20019901 |
| 2020-02-02 |
Predicting commercially available antiviral drugs that may act on the novel coronavirus (2019-nCoV), Wuhan, China through a drug-target interaction deep learning model (edit) |
10.1101/2020.01.31.929547 |
| 2020-02-02 |
Real time estimation of the risk of death from novel coronavirus (2019-nCoV) infection: Inference using exported cases (edit) |
10.1101/2020.01.29.20019547 |
| 2020-02-02 |
Modelling the epidemic trend of the 2019-nCOV outbreak in Hubei Province, China (edit) |
10.1101/2020.01.30.20019828 |
| 2020-02-02 |
Transmission and epidemiological characteristics of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infected Pneumonia (COVID-19): preliminary evidence obtained in comparison with 2003-SARS (edit) |
10.1101/2020.01.30.20019836 |
| 2020-02-02 |
Effectiveness of airport screening at detecting travellers infected with 2019-nCoV (edit) |
10.1101/2020.01.31.20019265 |
| 2020-02-02 |
Genome Detective Coronavirus Typing Tool for rapid identification and characterization of novel coronavirus genomes (edit) |
10.1101/2020.01.31.928796 |
| 2020-02-01 |
Rapid outbreak response requires trust (edit) |
10.1038/S41564-020-0670-8 |
| 2020-02-01 |
The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells (edit) |
10.1101/2020.01.31.929042 |
| 2020-02-01 |
Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury (edit) |
10.1016/S0140-6736(20)30317-2 |
| 2020-02-01 |
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding (edit) |
10.1016/S0140-6736(20)30251-8 |
| 2020-02-01 |
Early estimation of the case fatality rate of COVID-19 in mainland China: a data-driven analysis (edit) |
10.21037/ATM.2020.02.66 |
| 2020-02-01 |
Estimating the Unreported Number of Novel Coronavirus (2019-nCoV) Cases in China in the First Half of January 2020: A Data-Driven Modelling Analysis of the Early Outbreak (edit) |
10.3390/JCM9020388 |
| 2020-02-01 |
Early Epidemiological and Clinical Characteristics of 28 Cases of Coronavirus Disease in South Korea (edit) |
10.24171/J.PHRP.2020.11.1.03 |
| 2020-02-01 |
Epidemiological research priorities for public health control of the ongoing global novel coronavirus (2019-nCoV) outbreak (edit) |
10.2807/1560-7917.ES.2020.25.6.2000110 |
| 2020-02-01 |
Offline: 2019-nCoV-"A desperate plea" (edit) |
10.1016/S0140-6736(20)30299-3 |
| 2020-02-01 |
What to do next to control the 2019-nCoV epidemic? (edit) |
10.1016/S0140-6736(20)30300-7 |
| 2020-02-01 |
Novel Wuhan (2019-nCoV) Coronavirus (edit) |
10.1164/RCCM.2014P7 |
| 2020-02-01 |
Novel coronavirus 2019-nCoV: prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV (edit) |
10.26355/EURREV_202002_20379 |
| 2020-02-01 |
The possible origins of 2019-nCoV coronavirus (edit) |
|
| 2020-02-01 |
Offline: 2019-nCoV outbreak-early lessons (edit) |
10.1016/S0140-6736(20)30212-9 |
| 2020-02-01 |
2019-nCoV : leçons d’incertitudes et de mondialisation (edit) |
|
| 2020-02-01 |
COVID-19: fighting panic with information (edit) |
10.1016/S0140-6736(20)30379-2 |
| 2020-02-01 |
[Dynamic changes of chest CT imaging in patients with corona virus disease-19 (COVID-19)] (edit) |
|
| 2020-02-01 |
[Management of corona virus disease-19 (COVID-19): the Zhejiang experience] (edit) |
|
| 2020-02-01 |
Audio Interview: Preparing for the Spread of Covid-19 (edit) |
10.1056/NEJME2003319 |
| 2020-02-01 |
Where did SARS-CoV-2 come from? (edit) |
10.1136/VR.M740 |
| 2020-02-01 |
Wuhan novel coronavirus (COVID-19): why global control is challenging? (edit) |
10.1016/J.PUHE.2020.02.001 |
| 2020-02-01 |
Indian pharma threatened by COVID-19 shutdowns in China (edit) |
10.1016/S0140-6736(20)30459-1 |
| 2020-02-01 |
Letter to the editor: Plenty of coronaviruses but no SARS-CoV-2 (edit) |
10.2807/1560-7917.ES.2020.25.8.2000171 |
| 2020-02-01 |
Differential diagnosis of illness in patients under investigation for the novel coronavirus (SARS-CoV-2), Italy, February 2020 (edit) |
10.2807/1560-7917.ES.2020.25.8.2000170 |
| 2020-02-01 |
Early transmission patterns of coronavirus disease 2019 (COVID-19) in travellers from Wuhan to Thailand, January 2020 (edit) |
10.2807/1560-7917.ES.2020.25.8.2000097 |
| 2020-02-01 |
Authors' response: Plenty of coronaviruses but no SARS-CoV-2 (edit) |
10.2807/1560-7917.ES.2020.25.8.2000197 |
| 2020-02-01 |
Latest assessment on COVID-19 from the European Centre for Disease Prevention and Control (ECDC) (edit) |
10.2807/1560-7917.ES.2020.25.8.2002271 |
| 2020-02-01 |
Understanding COVID-19 new diagnostic guidelines - a message of reassurance from an internal medicine doctor in Shanghai (edit) |
10.4414/SMW.2020.20216 |
| 2020-02-01 |
COVID-19 (Novel Coronavirus 2019) - recent trends (edit) |
10.26355/EURREV_202002_20378 |
| 2020-02-01 |
Novel Coronavirus 2019 (Sars-CoV2): a global emergency that needs new approaches? (edit) |
10.26355/EURREV_202002_20396 |
| 2020-02-01 |
Effectiveness for the Response to COVID-19: The MERS Outbreak Containment Procedures (edit) |
10.24171/J.PHRP.2020.11.1.01 |
| 2020-02-01 |
Identification of Coronavirus Isolated from a Patient in Korea with COVID-19 (edit) |
10.24171/J.PHRP.2020.11.1.02 |
| 2020-02-01 |
Contact Transmission of COVID-19 in South Korea: Novel Investigation Techniques for Tracing Contacts (edit) |
10.24171/J.PHRP.2020.11.1.09 |
| 2020-02-01 |
Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia (edit) |
10.21037/TP.2020.02.06 |
| 2020-02-01 |
The role of CT for Covid-19 patient's management remains poorly defined (edit) |
10.21037/ATM.2020.02.71 |
| 2020-02-01 |
[Challenges and countermeasures on Chinese malaria elimination programme during the coronavirus disease 2019 (COVID-19) outbreak] (edit) |
10.16250/J.32.1374.2020036 |
| 2020-02-01 |
CT imaging of two cases of one family cluster 2019 novel coronavirus (2019-nCoV) pneumonia: inconsistency between clinical symptoms amelioration and imaging sign progression (edit) |
10.21037/QIMS.2020.02.10 |
| 2020-02-01 |
Is A Problem Shared, A Problem Halved? Not Always! The Novel Coronavirus COVID-19 Outbreak (edit) |
10.5005/JP-JOURNALS-10071-23365 |
| 2020-02-01 |
National Institute for the Infectious Diseases "L. Spallanzani", IRCCS. Recommendations for COVID-19 clinical management (edit) |
10.4081/IDR.2020.8543 |
| 2020-02-01 |
Genomic analysis of SARS-CoV-2 strains among Indians returning from Italy, Iran & China, & Italian tourists in India (edit) |
|
| 2020-02-01 |
[Analysis of variation and evolution of SARS-CoV-2 genome] (edit) |
10.12122/J.ISSN.1673-4254.2020.02.02 |
| 2020-02-01 |
[Laboratory testing techniques for SARS-CoV-2] (edit) |
10.12122/J.ISSN.1673-4254.2020.02.04 |
| 2020-01-31 |
Uncanny similarity of unique inserts in the 2019-nCoV spike protein to HIV-1 gp120 and Gag (edit) |
10.1101/2020.01.30.927871 |
| 2020-01-31 |
The digestive system is a potential route of 2019-nCov infection: a bioinformatics analysis based on single-cell transcriptomes (edit) |
10.1101/2020.01.30.927806 |
| 2020-01-31 |
Insights into Cross-species Evolution of Novel Human Coronavirus 2019-nCoV and Defining Immune Determinants for Vaccine Development (edit) |
10.1101/2020.01.29.925867 |
| 2020-01-31 |
Evolution and variation of 2019-novel coronavirus (edit) |
10.1101/2020.01.30.926477 |
| 2020-01-31 |
Engineered unnatural ubiquitin for optimal detection of deubiquitinating enzymes (edit) |
10.1101/2020.01.30.926881 |
| 2020-01-31 |
Origins of MERS-CoV, and lessons for 2019-nCoV (edit) |
10.1016/S2542-5196(20)30032-2 |
| 2020-01-31 |
2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness (edit) |
10.3855/JIDC.12425 |
| 2020-01-31 |
2019-nCoV: The Identify-Isolate-Inform (3I) Tool Applied to a Novel Emerging Coronavirus (edit) |
10.5811/WESTJEM.2020.1.46760 |
| 2020-01-31 |
Laboratory biosafety guide for 2019-nCoV (Second Edition) (edit) |
10.1016/J.BSHEAL.2020.01.001 |
| 2020-01-30 |
Wettlauf gegen die Krankheit – wie gefährlich ist das Coronavirus? (edit) |
|
| 2020-01-30 |
Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany (edit) |
10.1056/NEJMC2001468 |
| 2020-01-30 |
Estimated effectiveness of traveller screening to prevent international spread of 2019 novel coronavirus (2019-nCoV) (edit) |
10.1101/2020.01.28.20019224 |
| 2020-01-30 |
Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020 (edit) |
10.2807/1560-7917.ES.2020.25.4.2000058 |
| 2020-01-30 |
Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of the outbreak (edit) |
10.1016/J.IJID.2020.01.050 |
| 2020-01-30 |
Novel coronavirus (2019-nCoV) early-stage importation risk to Europe, January 2020 (edit) |
10.2807/1560-7917.ES.2020.25.4.2000057 |
| 2020-01-30 |
The association between domestic train transportation and novel coronavirus (2019-nCoV) outbreak in China from 2019 to 2020: A data-driven correlational report (edit) |
10.1016/J.TMAID.2020.101568 |
| 2020-01-30 |
Potential inhibitors for 2019-nCoV coronavirus M protease from clinically approved medicines (edit) |
10.1101/2020.01.29.924100 |
| 2020-01-30 |
The next big threat to global health? 2019 novel coronavirus (2019-nCoV): What advice can we give to travellers? - Interim recommendations January 2020, from the Latin-American society for Travel Medicine (SLAMVI) (edit) |
10.1016/J.TMAID.2020.101567 |
| 2020-01-30 |
Identification of potential cross-protective epitope between a new type of coronavirus (2019-nCoV) and severe acute respiratory syndrome virus (edit) |
10.1016/J.JGG.2020.01.003 |
| 2020-01-29 |
Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia (edit) |
10.1056/NEJMOA2001316 |
| 2020-01-29 |
Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event (edit) |
10.1016/J.MEEGID.2020.104212 |
| 2020-01-29 |
Therapeutic Drugs Targeting 2019-nCoV Main Protease by High-Throughput Screening (edit) |
10.1101/2020.01.28.922922 |
| 2020-01-29 |
Wuhan: Britons to be evacuated as scientists estimate 44 000 cases of 2019-nCOV in the city (edit) |
10.1136/BMJ.M351 |
| 2020-01-29 |
La comunicación científica y el acceso abierto en la contención de enfermedades: El caso del Coronavirus novel 2019 (2019-nCoV) (edit) |
10.35839/REPIS.4.1.613 |
| 2020-01-29 |
Beware of asymptomatic transmission: Study on 2019-nCoV prevention and control measures based on extended SEIR model (edit) |
10.1101/2020.01.28.923169 |
| 2020-01-28 |
Importation and Human-to-Human Transmission of a Novel Coronavirus in Vietnam (edit) |
10.1056/NEJMC2001272 |
| 2020-01-28 |
Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan (edit) |
10.1080/22221751.2020.1719902 |
| 2020-01-28 |
Breaking down of the healthcare system: Mathematical modelling for controlling the novel coronavirus (2019-nCoV) outbreak in Wuhan, China (edit) |
10.1101/2020.01.27.922443 |
| 2020-01-28 |
The novel coronavirus (2019-nCoV) outbreak: think the unthinkable and be prepared to face the challenge (edit) |
10.1515/DX-2020-0015 |
| 2020-01-28 |
Drug treatment options for the 2019-new coronavirus (2019-nCoV) (edit) |
10.5582/BST.2020.01020 |
| 2020-01-28 |
The incubation period of 2019-nCoV infections among travellers from Wuhan, China (edit) |
10.1101/2020.01.27.20018986 |
| 2020-01-28 |
Nelfinavir was predicted to be a potential inhibitor of 2019-nCov main protease by an integrative approach combining homology modelling, molecular docking and binding free energy calculation (edit) |
10.1101/2020.01.27.921627 |
| 2020-01-28 |
Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event (edit) |
10.1101/2020.01.26.920249 |
| 2020-01-27 |
Medical Journals and the 2019-nCoV Outbreak (edit) |
10.1056/NEJME2001329 |
| 2020-01-27 |
Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019-nCoV (edit) |
10.26434/CHEMRXIV.11728983 |
| 2020-01-27 |
Use of the informational spectrum methodology for rapid biological analysis of the novel coronavirus 2019-nCoV: prediction of potential receptor, natural reservoir, tropism and therapeutic/vaccine target (edit) |
10.12688/F1000RESEARCH.22149.1 |
| 2020-01-26 |
Wuhan seafood market may not be source of novel virus spreading globally (edit) |
10.1126/SCIENCE.ABB0611 |
| 2020-01-26 |
Transmission dynamics of 2019 novel coronavirus (2019-nCoV) (edit) |
10.1101/2020.01.25.919787 |
| 2020-01-26 |
From SARS-CoV to Wuhan 2019-nCoV Outbreak: Similarity of Early Epidemic and Prediction of Future Trends (edit) |
10.1101/2020.01.24.919241 |
| 2020-01-26 |
Single-cell RNA expression profiling of ACE2, the receptor of SARS-CoV-2 (edit) |
10.1101/2020.01.26.919985 |
| 2020-01-25 |
Complete genome characterisation of a novel coronavirus associated with severe human respiratory disease in Wuhan, China (edit) |
10.1101/2020.01.24.919183 |
| 2020-01-24 |
Wuhan scientists: What it’s like to be on lockdown (edit) |
10.1038/D41586-020-00191-5 |
| 2020-01-24 |
What you need to know about the Wuhan coronavirus (edit) |
10.1038/D41586-020-00209-Y |
| 2020-01-24 |
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China (edit) |
10.1016/S0140-6736(20)30183-5 |
| 2020-01-24 |
Pattern of early human-to-human transmission of Wuhan 2019-nCoV (edit) |
10.1101/2020.01.23.917351 |
| 2020-01-24 |
The Extent of Transmission of Novel Coronavirus in Wuhan, China, 2020 (edit) |
10.3390/JCM9020330 |
| 2020-01-24 |
Return of the Coronavirus: 2019-nCoV (edit) |
10.3390/V12020135 |
| 2020-01-24 |
IDM editorial statement on the 2019-nCoV (edit) |
10.1016/J.IDM.2020.01.003 |
| 2020-01-24 |
Emerging understandings of 2019-nCoV (edit) |
10.1016/S0140-6736(20)30186-0 |
| 2020-01-24 |
Novel coronavirus 2019-nCoV: early estimation of epidemiological parameters and epidemic predictions (edit) |
10.1101/2020.01.23.20018549 |
| 2020-01-24 |
Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of the outbreak (edit) |
10.1101/2020.01.23.916395 |
| 2020-01-23 |
Why snakes probably aren’t spreading the new China virus (edit) |
10.1038/D41586-020-00180-8 |
| 2020-01-23 |
Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin (edit) |
10.1101/2020.01.22.914952 |
| 2020-01-23 |
Note from the editors: novel coronavirus (2019-nCoV) (edit) |
10.2807/1560-7917.ES.2020.25.3.2001231 |
| 2020-01-23 |
Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020 (edit) |
10.2807/1560-7917.ES.2020.25.3.2000044 |
| 2020-01-22 |
Homologous recombination within the spike glycoprotein of the newly identified coronavirus may boost cross‐species transmission from snake to human (edit) |
10.1002/JMV.25682 |
| 2020-01-22 |
Alarm over China virus, extreme Arctic warming and a volcano on alert (edit) |
10.1038/D41586-020-00109-1 |
| 2020-01-22 |
Functional assessment of cell entry and receptor usage for lineage B β-coronaviruses, including 2019-nCoV (edit) |
10.1101/2020.01.22.915660 |
| 2020-01-22 |
Genomic and protein structure modelling analysis depicts the origin and infectivity of 2019-nCoV, a new coronavirus which caused a pneumonia outbreak in Wuhan, China (edit) |
10.1101/2020.01.20.913368 |
| 2020-01-21 |
Stop the Wuhan virus (edit) |
10.1038/D41586-020-00153-X |
| 2020-01-21 |
How quickly does the Wuhan virus spread? (edit) |
10.1038/D41586-020-00146-W |
| 2020-01-20 |
China coronavirus: cases surge as official admits human to human transmission (edit) |
10.1136/BMJ.M236 |
| 2020-01-20 |
New virus surging in Asia rattles scientists (edit) |
10.1038/D41586-020-00129-X |
| 2020-01-15 |
A new illness, an Earth-size exoplanet and a 12-year prison sentence (edit) |
10.1038/D41586-020-00088-3 |
| 2020-01-14 |
The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China (edit) |
10.1016/J.IJID.2020.01.009 |
| 2020-01-01 |
Assessing the risks posed by SARS-CoV-2 in and via North American bats—Decision framing and rapid risk assessment (edit) |
10.3133/OFR20201060 |
| 2020-01-01 |
[SARS-CoV-2 (COVID-19) as a predictor of neuroinflammation and neurodegeneration: potential therapy strategies] (edit) |
10.17116/JNEVRO202012008258 |
| 2020-01-01 |
[Simultaneous diagnosis and favorable evolution of infection with Pneumocystis jirovecii, SARS-CoV-2 and advanced HIV] (edit) |
|
| 2020-01-01 |
[Are health personnel well protected against SARS-CoV-2?] (edit) |
|
| 2020-01-01 |
[Non-SARS-CoV-2 biomedical research in times of pandemic and post-pandemic] (edit) |
|
| 2020-01-01 |
RETROSPECTIVE ANALYSIS OF INTERVENTIONS PERFORMED BY EMERGENCY MEDICAL TEAMS IN POLAND BEFORE AND DURING THE SARS COV-2 PANDEMIC (edit) |
|
| 2020-01-01 |
Clinical risk profile associated with SARS-CoV-2 infection and complications in the emergency area of a pediatric COVID-19 center (edit) |
10.24875/BMHIM.20000198 |
| 2020-01-01 |
Saliva as a promising biofluid for SARS-CoV-2 detection during the early stages of infection (edit) |
10.24875/BMHIM.20000204 |
| 2020-01-01 |
SARS-CoV-2: previous coronaviruses, immune response, and development of vaccines (edit) |
10.24875/BMHIM.20000191 |
| 2020-01-01 |
SARS-CoV-2 and influenza: a comparative overview and treatment implications (edit) |
10.24875/BMHIM.20000183 |
| 2020-01-01 |
Manifestaciones extrapulmonares de la infección por SARS-CoV-2 (edit) |
10.24875/CIRU.20000363 |
| 2020-01-01 |
Oxygen therapy via high flow nasal cannula in severe respiratory failure caused by Sars-Cov-2 infection: a real-life observational study (edit) |
10.1177/1753466620963016 |
| 2020-01-01 |
The duration of SARS-CoV-2 shedding in patients recovering from COVID-19 (edit) |
|
| 2020-01-01 |
A How-to Guide to Building a Robust SARS-CoV-2 Testing Program at a University-Based Health System (edit) |
10.1177/2374289520958200 |
| 2020-01-01 |
COVID Care Clinic: A Unique Way for Family Medicine to Care for the Community During the SARS-CoV-2 (COVID-19) Pandemic (edit) |
10.1177/2150132720957442 |
| 2020-01-01 |
Prevention of SARS-COV-2 coronavirus spread at the Auschwitz-Birkenau State Museum in Poland. The most visited Memorial site in the world during the COVID-19 pandemic (edit) |
10.32394/PE.74.23 |
| 2020-01-01 |
SARS-CoV-2 and HIV: Epidemiology, Treatment, and Lessons Learned from HIV (edit) |
10.24875/AIDSREV.20000070 |
| 2020-01-01 |
The impact of SARS-CoV-2 on the mental health of healthcare workers in a hospital setting-A Systematic Review (edit) |
10.1002/1348-9585.12175 |
| 2020-01-01 |
ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to SARS-COV-2 in Cancer Patients (edit) |
10.1177/0963689720968749 |
| 2020-01-01 |
[Analysis of anti-SARS-CoV-2 IgG antibodies in hematologic patients with asymptomatic or mildly symptomatic COVID-19 infections] (edit) |
10.11406/RINKETSU.61.1459 |
| 2020-01-01 |
Airway management in a prehospital setting during the SARS-CoV-2 pandemic (edit) |
10.5114/AIT.2020.100536 |
| 2020-01-01 |
Age-related gene expression alterations by SARS-CoV-2 infection contribute to poor prognosis in elderly (edit) |
|
| 2020-01-01 |
Identification of a repurposed drug as an inhibitor of Spike protein of human coronavirus SARS-CoV-2 by computational methods (edit) |
|
| 2020-01-01 |
Furin Protease: From SARS CoV-2 to Anthrax, Diabetes, and Hypertension (edit) |
10.7812/TPP/20.187 |
| 2020-01-01 |
[SARS-CoV-2 and COVID-19: not at the end of doubts, questions and controversies] (edit) |
|
| 2020-01-01 |
[Systematic preoperative SARS-CoV-2 screening by chest CT before urological surgery] (edit) |
|
| 2020-01-01 |
[On the use of corticosteroids for critically ill patients with SARS-CoV-2 interstitial pneumonia] (edit) |
|
| 2020-01-01 |
[Role of physical and rehabilitation medicine in the aftermath of SARS-CoV-2 disease] (edit) |
|
| 2020-01-01 |
COVID-19 prognosis: what we know of the significance and prognostic value of liver-related laboratory parameters in SARS-CoV-2 infection (edit) |
|
| 2020-01-01 |
Coronaviruses and gastrointestinal symptoms: an old liaison for the new SARS-CoV-2 (edit) |
|
| 2020-01-01 |
Investigating the human protein-host protein interactome of SARS-CoV-2 infection in the small intestine (edit) |
|
| 2020-01-01 |
Multisystem inflammatory syndrome in children and SARS-CoV-2: A scoping review (edit) |
10.3233/PRM-200794 |
| 2020-01-01 |
Recomendaciones para procedimientos quirúrgicos durante la pandemia de COVID-19 (SARS-CoV-2). Liderazgo hacia el retorno a lo electivo (edit) |
10.24875/CIRU.20000692 |
| 2020-01-01 |
Medidas de prevención y control para SARS-CoV-2 (COVID-19) en cirugía (edit) |
10.24875/CIRU.20000599 |
| 2020-01-01 |
Whole-genome sequence analysis and homology modelling of the main protease and non-structural protein 3 of SARS-CoV-2 reveal an aza-peptide and a lead inhibitor with possible antiviral properties (edit) |
10.1039/D0NJ00974A |
| 2020-01-01 |
Neutralizing Antibody Responses to SARS-CoV-2 in a COVID-19 Recovered Patient Cohort and Their Implications (edit) |
10.2139/SSRN.3566211 |
| 2020-01-01 |
Anti-SARS-CoV-2 neutralizing monoclonal antibodies: clinical pipeline (edit) |
10.1080/19420862.2020.1854149 |
| 2020-01-01 |
The suggested management of endotracheal intubation in a patient infected with or suspected of SARS-CoV-2 infection (edit) |
10.5114/AIT.2020.101375 |
| 2020-01-01 |
Morphology, Genome Organization, Replication, and Pathogenesis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (edit) |
10.1007/978-981-15-4814-7_3 |
| 2020-01-01 |
An emergent clade of SARS-CoV-2 linked to returned travellers from Iran (edit) |
10.1093/VE/VEAA027 |
| 2020-01-01 |
Host Immune Response and Immunobiology of Human SARS-CoV-2 Infection (edit) |
10.1007/978-981-15-4814-7_5 |
| 2020-01-01 |
SARS-CoV-2/COVID-19, Lymphatic vessels, lymph, and lymphology (edit) |
|
| 2020-01-01 |
Command and control in hospitals during SARS-CoV-2 pandemic: The windmill model of disaster response (edit) |
10.5055/JEM.2020.0520 |
| 2020-01-01 |
Gallium maltolate has in vitro antiviral activity against SARS-CoV-2 and is a potential treatment for COVID-19 (edit) |
10.1177/2040206620983780 |
| 2020-01-01 |
Alkaloids and flavonoids from African phytochemicals as potential inhibitors of SARS-Cov-2 RNA-dependent RNA polymerase: an in silico perspective (edit) |
10.1177/2040206620984076 |
| 2020-01-01 |
Position paper: Impact on medical and health personnel in the SARS-CoV-2 pandemic (edit) |
10.24875/GMM.M20000432 |
| 2020-01-01 |
Tomographic behavior of pneumonia caused by SARS-CoV-2 (edit) |
10.24875/GMM.M20000426 |
| 2020-01-01 |
SARS-CoV-2 lung disease in a patient with pulmonary sarcoidosis - case report (edit) |
10.5603/ARM.A2020.0199 |
| 2020-01-01 |
Spirometry during the SARS-CoV-2 pandemic. Guidelines and practical advice from the expert panel of Respiratory Physiopathology Assembly of Polish Respiratory Society (edit) |
10.5603/ARM.A2020.0186 |
| 2020-01-01 |
Phylogeography of SARS-CoV-2 pandemic in Spain: a story of multiple introductions, micro-geographic stratification, founder effects, and super-spreaders (edit) |
10.24272/J.ISSN.2095-8137.2020.217 |
| 2020-01-01 |
Structural Insight Reveals SARS-CoV-2 Orf7a as an Immunomodulating Factor for Human CD14+ Monocytes (edit) |
10.2139/SSRN.3699795 |
| 2020-01-01 |
SARS-CoV-2 Receptor ACE2 is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Enriched in Specific Cell Subsets Across Tissues (edit) |
10.2139/SSRN.3555145 |
| 2020-01-01 |
The Nucleocapsid Protein of SARS-CoV-2 Abolished Pluripotency in Human Induced Pluripotent Stem Cells (edit) |
10.2139/SSRN.3561932 |
| 2020-01-01 |
3-Hydroxyphthalic Anhydride-Modified Chicken Ovalbumin as a Potential Candidate Inhibits SARS-CoV-2 Infection by Disrupting the Interaction of Spike Protein With Host ACE2 Receptor (edit) |
10.3389/FPHAR.2020.603830 |
| 2020-01-01 |
Drug Repurposing Screens Reveal FDA Approved Drugs Active Against SARS-CoV-2 (edit) |
10.2139/SSRN.3678908 |
| 2020-01-01 |
Real-World Effectiveness of Hydroxychloroquine, Azithromycin, and Ivermectin Among Hospitalized COVID-19 Patients: Results of a Target Trial Emulation Using Observational Data from a Nationwide Healthcare System in Peru (edit) |
10.2139/SSRN.3710623 |
| 2020-01-01 |
Antiviral Effect of High-Dose Ivermectin in Adults with COVID-19: A Pilot Randomised, Controlled, Open Label, Multicentre Trial (edit) |
10.2139/SSRN.3714649 |
| 2020-01-01 |
Ivermectin as a potential COVID-19 treatment from the pharmacokinetic point of view: antiviral levels are not likely attainable with known dosing regimens (edit) |
10.1080/13102818.2020.1775118 |
| 2020-01-01 |
Effectiveness of Ivermectin in SARS-CoV-2/COVID-19 Patients (edit) |
10.18483/IJSCI.2378 |
| 2020-01-01 |
The MERS-CoV Receptor DPP4 as a Candidate Binding Target of the SARS-CoV-2 Spike (edit) |
10.2139/SSRN.3570560 |
| 2020-01-01 |
The SARS-CoV-2 Receptor-Binding Domain Elicits a Potent Neutralizing Response Without Antibody-Dependent Enhancement (edit) |
10.2139/SSRN.3575134 |
| 2020-01-01 |
Inhibition of SARS-CoV-2 main protease by phenolic compounds from Manilkara hexandra (Roxb.) Dubard assisted by metabolite profiling and in silico virtual screening (edit) |
10.1039/D0RA05679K |
| 2020-01-01 |
Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike (edit) |
10.2139/SSRN.3613273 |
| 2020-01-01 |
Exploration of Inhibitors for SARS-CoV-2's Papain-Like Protease (edit) |
10.3389/FCHEM.2020.624163 |
| 2020-01-01 |
Molecular Docking Reveals Ivermectin and Remdesivir as Potential Repurposed Drugs Against SARS-CoV-2 (edit) |
10.3389/FMICB.2020.592908 |
| 2020-01-01 |
SARS-COV-2 and the sorcerer’s apprentices (edit) |
|
| 2020-01-01 |
Patient-Derived Mutations Impact Pathogenicity of SARS-CoV-2 (edit) |
10.2139/SSRN.3578153 |
| 2020-01-01 |
SARS-CoV-2: A brief review (edit) |
10.15761/GIMCI.1000200 |
| 2020-01-01 |
Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2 (edit) |
10.3389/FPHAR.2020.592737 |
| 2020-01-01 |
SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2 (edit) |
10.2139/SSRN.3657535 |
| 2020-01-01 |
The Spatial and Cell-Type Distribution of SARS-CoV-2 Receptor ACE2 in the Human and Mouse Brains (edit) |
10.3389/FNEUR.2020.573095 |
| 2020-01-01 |
Elevated Glucose Levels Favor Sars-Cov-2 Infection and Monocyte Response Through a Hif-1α/Glycolysis Dependent Axis (edit) |
10.2139/SSRN.3606770 |
| 2020-01-01 |
ACE2 partially dictates the host range and tropism of SARS-CoV-2 (edit) |
10.1016/J.CSBJ.2020.11.032 |
| 2020-01-01 |
SARS-CoV-2 Mediated Endothelial Dysfunction: The Potential Role of Chronic Oxidative Stress (edit) |
10.3389/FPHYS.2020.605908 |
| 2020-01-01 |
SARS-CoV-2 nsp1: Bioinformatics, Potential Structural and Functional Features, and Implications for Drug/Vaccine Designs (edit) |
10.3389/FMICB.2020.587317 |
| 2020-01-01 |
Carnivorous (edit) |
|
| 2020-01-01 |
The SARS-CoV-2, a new pandemic zoonosis that threatens the world (edit) |
10.1016/J.VACUNE.2020.05.001 |
| 2020-01-01 |
SARS-CoV-2 Nsp1 Suppresses Host But Not Viral Translation Through a Bipartite Mechanism (edit) |
10.2139/SSRN.3696749 |
| 2020-01-01 |
Tax policy measures to combat the SARS-CoV-2 pandemic and considerations to improve tax compliance: A behavioral perspective (edit) |
10.2139/SSRN.3692370 |
| 2020-01-01 |
Tax Policy Measures to Combat the SARS-CoV-2 Pandemic and Considerations to Improve Tax Compliance: A Behavioral Perspective (edit) |
10.1628/FA-2020-0014 |
| 2020-01-01 |
The SARS-CoV-2 Transcriptional Metabolic Signature in Lung Epithelium (edit) |
10.2139/SSRN.3650499 |
| 2020-01-01 |
SARS-CoV-2 RNA detected in blood products from patients with COVID-19 is not associated with infectious virus (edit) |
10.12688/WELLCOMEOPENRES.16002.2 |
| 2020-01-01 |
Anti-HIV drug repurposing against SARS-CoV-2 (edit) |
10.1039/D0RA01899F |
| 2020-01-01 |
Endocytic uptake of SARS-CoV-2: the critical roles of pH, Ca2+, and NAADP (edit) |
10.1093/FUNCTION/ZQAA003 |
| 2020-01-01 |
Methylene Blue Inhibits the SARS-CoV-2 Spike-ACE2 Protein-Protein Interaction-a Mechanism that can Contribute to its Antiviral Activity Against COVID-19 (edit) |
10.3389/FPHAR.2020.600372 |
| 2020-01-01 |
Host Genetic Variants Potentially Associated With SARS-CoV-2: A Multi-Population Analysis (edit) |
10.3389/FGENE.2020.578523 |
| 2020-01-01 |
Hydroxychloroquine with or Without Azithromycin for Treatment of Early SARS-CoV-2 Infection Among High-Risk Outpatient Adults: A Randomized Clinical Trial (edit) |
10.2139/SSRN.3745831 |
| 2020-01-01 |
Grace Under Pressure: Resilience, Burnout, and Wellbeing in Frontline Workers in the United Kingdom and Republic of Ireland During the SARS-CoV-2 Pandemic (edit) |
10.3389/FPSYG.2020.576229 |
| 2020-01-01 |
Polska pielęgniarka w czasie pandemii zakażeń SARS-CoV-2 – różne perspektywy wykonywania zawodu (edit) |
10.4467/20842627OZ.20.014.12767 |
| 2020-01-01 |
Gene Expression Profiling Reveals the Shared and Distinct Transcriptional Signatures in Human Lung Epithelial Cells Infected With SARS-CoV-2, MERS-CoV, or SARS-CoV: Potential Implications in Cardiovascular Complications of COVID-19 (edit) |
10.3389/FCVM.2020.623012 |
| 2020-01-01 |
Sars-Cov-2 And Betacoronavirus : What Have We Learned In 8 Months? (edit) |
10.21307/PM-2020.59.3.14 |
| 2020-01-01 |
In silico Screening of Natural Compounds as Potential Inhibitors of SARS-CoV-2 Main Protease and Spike RBD: Targets for COVID-19 (edit) |
10.3389/FMOLB.2020.599079 |
| 2020-01-01 |
Elucidating Interactions Between SARS-CoV-2 Trimeric Spike Protein and ACE2 Using Homology Modeling and Molecular Dynamics Simulations (edit) |
10.3389/FCHEM.2020.622632 |
| 2020-01-01 |
Evolutionary Dynamics and Dissemination Pattern of the SARS-CoV-2 Lineage B.1.1.33 During the Early Pandemic Phase in Brazil (edit) |
10.3389/FMICB.2020.615280 |
| 2020-01-01 |
SARS-CoV-2 Proteins Exploit Host's Genetic and Epigenetic Mediators for the Annexation of Key Host Signaling Pathways (edit) |
10.3389/FMOLB.2020.598583 |
| 2020-01-01 |
Development of Plant-Produced Recombinant ACE2-Fc Fusion Protein as a Potential Therapeutic Agent Against SARS-CoV-2 (edit) |
10.3389/FPLS.2020.604663 |
| 2020-01-01 |
Person to person transmission of pneumonia associated with the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a familial cluster analysis in North Central Nigeria (edit) |
10.11604/PAMJ.2020.37.99.23609 |
| 2020-01-01 |
SARS-cov-2 is a biological warfare weapon (edit) |
10.47054/SD202021B |
| 2020-01-01 |
Hypertonic saline nasal irrigation and gargling as an inexpensive practical adjunctive weapon to combat asymptomatic SARS-CoV-2 infections. A case report (edit) |
10.15761/TIM.1000249 |
| 2020-01-01 |
Severity of Respiratory Failure and Outcome of Patients Needing a Ventilatory Support in the Emergency Department During Italian Novel Coronavirus SARS-CoV-2 Outbreak: Preliminary Data on the Role of Helmet CPAP and Non-Invasive Ventilation (edit) |
10.2139/SSRN.3566170 |
| 2020-01-01 |
Ethical Guidelines for SARS-CoV-2 Digital Tracking and Tracing Systems (edit) |
10.2139/SSRN.3582550 |
| 2020-01-01 |
COMPARISON OF MOLECULAR AND SEROLOGICAL TESTS FOR SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) IN POST-EXPOSURE EMPLOYEES OF THE NEPHROLOGY DEPARTMENT (edit) |
10.36740/WLEK202012103 |
| 2020-01-01 |
Progress on the basic reproduction number of SARS-CoV-2 (edit) |
|
| 2020-01-01 |
SARS-CoV-2 RNA reference materials (edit) |
|
| 2020-01-01 |
Research Progress of Nucleic Acid Detection Technology Platforms for New Coronavirus SARS-CoV-2 (edit) |
10.19756/J.ISSN.0253-3820.201259 |
| 2020-01-01 |
Antibody testing for COVID-19: A report from the National COVID Scientific Advisory Panel (edit) |
10.12688/WELLCOMEOPENRES.15927.1 |
| 2020-01-01 |
The Impact of the COVID-19 Pandemic on Invasive Pneumococcal Disease and the Risk of Pneumococcal Coinfection with SARS-CoV-2: Prospective National Cohort Surveillance, England (edit) |
10.2139/SSRN.3700890 |
| 2020-01-01 |
Coronavirus disease 2019 (COVID-19): diagnosis and prognosis (edit) |
10.46701/BG.2020022020120 |
| 2020-01-01 |
New China virus: Five questions scientists are asking (edit) |
10.1038/D41586-020-00166-6 |
| 2020-01-01 |
This scientist hopes to test coronavirus drugs on animals in locked-down Wuhan (edit) |
10.1038/D41586-020-00190-6 |
| 2020-01-01 |
New virus in China requires international control effort (edit) |
10.1038/D41586-020-00135-Z |
| 2020-01-01 |
Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR (edit) |
10.2807/1560-7917.ES.2020.25.3.2000045 |
| 2020-01-01 |
How to train the health personnel for protecting themselves from novel coronavirus (COVID-19) infection during their patient or suspected case care (edit) |
10.3352/JEEHP.2020.17.10 |
| 2020-01-01 |
Real-time forecasts of the COVID-19 epidemic in China from February 5th to February 24th, 2020 (edit) |
10.1016/J.IDM.2020.02.002 |
| 2020-01-01 |
An updated estimation of the risk of transmission of the novel coronavirus (2019-nCov) (edit) |
10.1016/J.IDM.2020.02.001 |
| 2020-01-01 |
Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes (edit) |
10.1080/22221751.2020.1729071 |
| 2020-01-01 |
Coronaviruses - new emerging pathogens (edit) |
10.2298/VSP2002139K |
| 2020-01-01 |
Respuestas de Supervisores y Reguladores Financieros al COVID-19 (Financial Regulators' Responses to COVID/19) (edit) |
10.2139/SSRN.3554557 |
| 2020-01-01 |
'Unprecedented demand' for OTC painkillers as COVID-19 outbreak spreads (edit) |
10.1211/PJ.2020.20207830 |
| 2020-01-01 |
The race to stop COVID-19 (edit) |
10.1211/PJ.2020.20207792 |
| 2020-01-01 |
COVID-19: tell us your experiences (edit) |
10.1211/PJ.2020.20207809 |
| 2020-01-01 |
Advice on NSAIDs and COVID-19 (edit) |
10.1211/PJ.2020.20207839 |
| 2020-01-01 |
COVID-19: Tell us how you are coping (edit) |
10.1211/PJ.2020.20207848 |
| 2020-01-01 |
2019-novel Coronavirus (2019-nCoV): estimating the case fatality rate - a word of caution (edit) |
10.4414/SMW.2020.20203 |
| 2020-01-01 |
What goes on board aircraft? Passengers include Aedes, Anopheles, 2019-nCoV, dengue, Salmonella, Zika, et al (edit) |
10.1016/J.TMAID.2020.101572 |
| 2020-01-01 |
Maps, masks and media - Traveller and practitioner resources for 2019 novel coronavirus (2019-nCoV) acute respiratory virus (edit) |
10.1016/J.TMAID.2020.101574 |
| 2020-01-01 |
Novel coronavirus disease (COVID-19) outbreak: Now is the time to refresh pandemic plans (edit) |
|
| 2020-01-01 |
Challenges and Countermeasures of Integrative Cancer Therapy in the Epidemic of COVID-19 (edit) |
10.1177/1534735420912811 |
| 2020-01-01 |
Coronavirus (Covid-19) outbreak on the cruise ship Diamond Princess (edit) |
10.5603/MH.2020.0003 |
| 2020-01-01 |
Editorial: COVID-19 and Older Adults (edit) |
10.1007/S12603-020-1349-9 |
| 2020-01-01 |
Hemorrhagic Problem Among the Patients With COVID-19: Clinical Summary of 41 Thai Infected Patients (edit) |
10.1177/1076029620918308 |
| 2020-01-01 |
The Impact of the COVID-19 Pandemic on Parkinson's Disease: Hidden Sorrows and Emerging Opportunities (edit) |
10.3233/JPD-202038 |
| 2020-01-01 |
Current Drugs with Potential for Treatment of COVID-19: A Literature Review (edit) |
10.18433/JPPS31002 |
| 2020-01-01 |
SARS-CoV-2 invades the West. How to face a COVID-19 epidemic in Lombardy, Northern Italy? (edit) |
|
| 2020-01-01 |
Videoconferences of Infectious Diseases: An educational tool that transcends borders. A useful tool also for the current COVID-19 pandemic (edit) |
|
| 2020-01-01 |
Genomic Epidemiology and its importance in the study of the COVID-19 pandemic (edit) |
|
| 2020-01-01 |
Vademecum for the treatment of people with COVID-19. Edition 2.0, 13 March 2020 (edit) |
|
| 2020-01-01 |
Clinical manifestation, diagnosis, prevention and control of SARS-CoV-2 (COVID-19) during the outbreak period (edit) |
|
| 2020-01-01 |
Exploring the genetics, ecology of SARS-COV-2 and climatic factors as possible control strategies against COVID-19 (edit) |
|
| 2020-01-01 |
SARS-CoV-2, SARS-CoV, and MERS-COV: A comparative overview (edit) |
|
| 2020-01-01 |
Protection and disinfection policies against SARS-CoV-2 (COVID-19) (edit) |
|
| 2020-01-01 |
Perspective on the COVID-19 Coronavirus Outbreak (edit) |
10.2174/138620732302200406130010 |
| 2020-01-01 |
Emergence of novel coronavirus SARS-CoV2 in China and the response in Mexico (edit) |
10.24875/GMM.M20000345 |
| 2020-01-01 |
From the handling of an outbreak by an unknown pathogen in Wuhan to the preparedness and response in the face of the emergence of Covid-19 in Mexico (edit) |
10.24875/GMM.M20000346 |
| 2020-01-01 |
Diagnosing COVID-19: Did We Miss Anything? (edit) |
|
| 2020-01-01 |
Gastrointestinal Presentation in COVID-19 in Indonesia: A Case Report (edit) |
|
| 2020-01-01 |
The Importance of Chest CT Scan in COVID-19 (edit) |
|
| 2020-01-01 |
Clinical Progression of COVID-19 Patient with Extended Incubation Period, Delayed RT-PCR Time-to-positivity, and Potential Role of Chest CT-scan (edit) |
|
| 2020-01-01 |
COVID-19 and Indonesia (edit) |
|
| 2020-01-01 |
COVID-19 Pandemia and Public and Global Mental Health from the Perspective of Global Health Securit (edit) |
10.24869/PSYD.2020.6 |
| 2020-01-01 |
The Importance of Psychodynamic Approach during COVID-19 Pandemic (edit) |
10.24869/PSYD.2020.15 |
| 2020-01-01 |
Crisis Psychodrama in the Era of COVID-19 (edit) |
10.24869/PSYD.2020.22 |
| 2020-01-01 |
Impact of Human Disasters and COVID-19 Pandemic on Mental Health: Potential of Digital Psychiatry (edit) |
10.24869/PSYD.2020.25 |
| 2020-01-01 |
COVID-19 Pandemic and Impending Global Mental Health Implications (edit) |
10.24869/PSYD.2020.32 |
| 2020-01-01 |
Assessing Knowledge, Attitudes and Practices of dental practitioners regarding the COVID-19 pandemic: A multinational study (edit) |
10.17219/DMP/119743 |
| 2020-01-01 |
Novel Coronavirus (COVID-19): Leveraging Telemedicine to Optimize Care While Minimizing Exposures and Viral Transmission (edit) |
|
| 2020-01-01 |
Winning Together: Novel Coronavirus (COVID-19) Infographic (edit) |
10.4103/0974-2700.281047 |
| 2020-01-01 |
Predicting the mortality due to Covid-19 by the next month for Italy, Iran and South Korea; a simulation study (edit) |
|
| 2020-01-01 |
COVID-19 first stage in Japan - how we treat 'Diamond Princess Cruise Ship' with 3700 passengers? (edit) |
10.1002/AMS2.506 |
| 2020-01-01 |
Veno-venous extracorporeal membrane oxygenation for severe pneumonia: COVID-19 case in Japan (edit) |
10.1002/AMS2.509 |
| 2020-01-01 |
COVID-19: A new digital dawn? (edit) |
10.1177/2055207620920083 |
| 2020-01-01 |
Opioid use disorder and the COVID 19 pandemic: A call to sustain regulatory easements and further expand access to treatment (edit) |
10.1080/08897077.2020.1752351 |
| 2020-01-01 |
Medication Patterns and Disease Progression Among 165 Patients with Coronavirus Disease 2019 (COVID-19) in Wuhan, China: A Single-Centered, Retrospective, Observational Study (edit) |
10.2139/SSRN.3551323 |
| 2020-01-01 |
Improving the efficacy of Chloroquine and Hydroxychloroquine against SARS-CoV-2 may require Zinc additives - A better synergy for future COVID-19 clinical trials (edit) |
|
| 2020-01-01 |
The New Challenge of Geriatrics: Saving Frail Older People from the SARS-COV-2 Pandemic Infection (edit) |
10.1007/S12603-020-1356-X |
| 2020-01-01 |
[Recommendations of the Society of Gastroenterology of Peru to avoid the spread of SARS-CoV-2 through digestive endoscopy procedures] (edit) |
|
| 2020-01-01 |
Polish Society of Gynecology and Obstetrics statement on safety measures and performance of ultrasound examinations in obstetrics and gynecology during the SARS-CoV-2 pandemic (edit) |
10.5603/GP.2020.0045 |
| 2020-01-01 |
[What is the origin of SARS-CoV-2?] (edit) |
|
| 2020-01-01 |
Multivariate analyses of codon usage of SARS-CoV-2 and other betacoronaviruses (edit) |
10.1093/VE/VEAA032 |
| 2020-01-01 |
A novel coronavirus (SARS-CoV-2) and COVID-19 (edit) |
|
| 2020-01-01 |
[Otorhinolaryngological aspects of the disease course in children infected with SARS-CoV-2 virus] (edit) |
10.17116/OTORINO20208502163 |
| 2020-01-01 |
[Etiology of epidemic outbreaks COVID-19 on Wuhan, Hubei province, Chinese People Republic associated with 2019-nCoV (Nidovirales, Coronaviridae, Coronavirinae, Betacoronavirus, Subgenus Sarbecovirus): lessons of SARS-CoV outbreak.] (edit) |
10.36233/0507-4088-2020-65-1-6-15 |
| 2020-01-01 |
SARS-CoV-2: the emergence of a viral pathogen causing havoc on human existence (edit) |
10.1007/S12041-020-01205-X |
| 2020-01-01 |
The Coincidence of 2 Epidemics, Coccidioidomycosis and SARS-CoV-2: A Case Report (edit) |
10.1177/2324709620930540 |
| 2020-01-01 |
SARS-CoV-2 pandemic in Italy: ethical and organizational considerations (edit) |
10.4081/MRM.2020.672 |
| 2020-01-01 |
Characteristics and assessment of the usefulness of serological tests in the diagnostic of infections caused by coronavirus SARS-CoV-2 on the basis of available manufacturer's data and literature review (edit) |
10.32394/PE.74.11 |
| 2020-01-01 |
Collaborated effort against SARS-CoV-2 outbreak in China (edit) |
10.1002/CTM2.7 |
| 2020-01-01 |
Can routine laboratory tests discriminate SARS-CoV-2-infected pneumonia from other causes of community-acquired pneumonia? (edit) |
10.1002/CTM2.23 |
| 2020-01-01 |
Mutations in SARS-CoV-2 viral RNA identified in Eastern India: Possible implications for the ongoing outbreak in India and impact on viral structure and host susceptibility (edit) |
|
| 2020-01-01 |
[Source of the COVID-19 pandemic: ecology and genetics of coronaviruses (Betacoronavirus: Coronaviridae) SARS-CoV, SARS-CoV-2 (subgenus Sarbecovirus), and MERS-CoV (subgenus Merbecovirus).] (edit) |
10.36233/0507-4088-2020-65-2-62-70 |
| 2020-01-01 |
ACE2 diversity in placental mammals reveals the evolutionary strategy of SARS-CoV-2 (edit) |
10.1590/1678-4685-GMB-2020-0104 |
| 2020-01-01 |
Care of acute coronary syndromes during the health contingency due to a SARS-CoV-2 outbreak (edit) |
10.24875/ACM.M20000062 |
| 2020-01-01 |
The SARS-CoV-2 (COVID-19) coronavirus pandemic: current situation and implications for Mexico (edit) |
10.24875/ACM.M20000064 |
| 2020-01-01 |
Brief annotations on cytokine release syndrome and interleukin-6 therapeutic blockage in SARS-CoV-2/COVID-19 (edit) |
10.24875/ACM.M20000067 |
| 2020-01-01 |
Potential pro-arrhythmic effects of pharmacotherapy against SARS-CoV-2 (edit) |
10.24875/ACM.M20000061 |
| 2020-01-01 |
Recommendations for the care of patients with diabetes mellitus with risk factors or established cardiovascular disease and SARS-CoV-2mellitus con factores de riesgo o enfermedad cardiovascular establecida y SARS-CoV-2 (edit) |
10.24875/ACM.M20000074 |
| 2020-01-01 |
Pandemics: COVID-19 (edit) |
10.24875/CIRU.20000234 |
| 2020-01-01 |
Potent neutralization of SARS-CoV-2 by human antibody heavy-chain variable domains isolated from a large library with a new stable scaffold (edit) |
10.1080/19420862.2020.1778435 |
| 2020-01-01 |
Preventing SARS-CoV-2 infection by blocking a tissue serine protease (edit) |
10.1177/2049936120933076 |
| 2020-01-01 |
Compassionate Communication and End-of-Life Care for Critically Ill Patients with SARS-CoV-2 Infection (edit) |
|
| 2020-01-01 |
Saliva-based PCR tests for SARS-CoV-2 detection (edit) |
10.2334/JOSNUSD.20-0267 |
| 2020-01-01 |
Geriatric Syndromes and SARS-Cov-2: More than Just Being Old (edit) |
10.14283/JFA.2020.17 |
| 2020-01-01 |
MEXICAN HUMAN LEUKOCYTE ANTIGEN ALLELES MIGHT PREDICT CLINICAL OUTCOME IN SARS-COV-2 INFECTED PATIENTS (edit) |
10.24875/RIC.20000135 |
| 2020-01-01 |
OLFACTORY DISORDERS IN SARS-COV-2 INFECTION: CONSIDERATIONS IN AGING (edit) |
10.24875/RIC.20000157 |
| 2020-01-01 |
OPERATIONAL RECOMMENDATIONS FOR THE ATTENTION AND PREVENTION OF SARS-COV-2 INFECTION AT INTERVENTIONAL BRONCHOSCOPY UNITS (edit) |
10.24875/RIC.20000217 |
| 2020-01-01 |
DISPERSION OF A NEW CORONAVIRUS SARS-COV-2 BY AIRLINES IN 2020: TEMPORAL ESTIMATES OF THE OUTBREAK IN MEXICO (edit) |
10.24875/RIC.20000113 |
| 2020-01-01 |
IMPACT OF COMORBIDITIES IN MEXICAN SARS-COV-2-POSITIVE PATIENTS: A RETROSPECTIVE ANALYSIS IN A NATIONAL COHORT (edit) |
10.24875/RIC.20000207 |
| 2020-01-01 |
Getting Ahead of the Curve: How Ochsner Became a Leader in SARS-CoV-2 Diagnostic Testing (edit) |
10.31486/TOJ.20.0055 |
| 2020-01-01 |
Assessment of risk conferred by coding and regulatory variations of TMPRSS2 and CD26 in susceptibility to SARS-CoV-2 infection in human (edit) |
10.1007/S12041-020-01217-7 |
| 2020-01-01 |
[About population tests to detect anti-SARS-CoV-2 antibodies] (edit) |
|
| 2020-01-01 |
Don't forget ototoxicity during the SARS-CoV-2 (Covid-19) pandemic! (edit) |
10.1177/2058738420941754 |
| 2020-01-01 |
Newly Emergent 2019-nCoV and New Uses of an Old Medicine, Doxycycline; A Hypothesis (edit) |
10.2174/187152652003200720151519 |
| 2020-01-01 |
Vulnerabilities of the SARS-CoV-2 Virus to Proteotoxicity — Opportunity for Repurposed Chemotherapy of COVID-19 Infection (edit) |
10.2139/SSRN.3582068 |
| 2020-01-01 |
What does a gastroenterologist need to know in the time of SARS-CoV-2 pandemia? (edit) |
|
| 2020-01-01 |
Course of a SARS-COV-2 pneumonia in a middle-aged male patient (edit) |
|
| 2020-01-01 |
Histopathological findings in the advanced natural evolution of the SARS-CoV-2 infection (edit) |
10.47162/RJME.61.1.23 |
| 2020-01-01 |
Novel Coronavirus SARS-CoV-2 Target and Disable Natural Killer Cells: Core Immune Effectors for Fighting the Disease (edit) |
10.1615/CRITREVIMMUNOL.2020034441 |
| 2020-01-01 |
Serology Testing for SARS-CoV-2: Benefits and Challenges (edit) |
10.30699/IJP.2020.39841 |
| 2020-01-01 |
Drive-through Satellite Testing: An Efficient Precautionary Method of Screening Patients for SARS-CoV-2 in a Rural Healthcare Setting (edit) |
10.1177/2150132720947963 |
| 2020-01-01 |
Possible deferral of diagnostic and therapeutic procedures for patients with abnormal screening tests results in cervical cancer secondary prevention in current SARS-CoV-2 pandemic Interim guidelines of the Polish Society of Gynecologists and Obstet (edit) |
10.5603/GP.2020.0103 |
| 2020-01-01 |
Legal and ethical implications of wastewater monitoring of SARS-CoV-2 for COVID-19 surveillance (edit) |
10.1093/JLB/LSAA039 |
| 2020-01-01 |
SARS-CoV-2 Coronavirus Pandemic: Now Is the Right Time to Stop Smoking (edit) |
|
| 2020-01-01 |
A novel biparatopic hybrid antibody-ACE2 fusion that blocks SARS-CoV-2 infection: implications for therapy (edit) |
10.1080/19420862.2020.1804241 |
| 2020-01-01 |
No evidence for distinct types in the evolution of SARS-CoV-2 (edit) |
10.1093/VE/VEAA034 |
| 2020-01-01 |
Cutaneous susceptibility to SARS-CoV-2 infection according to the expression of viral entry factors in the skin (edit) |
10.24875/GMM.20000308 |
| 2020-01-01 |
The big challenge of SARS-CoV-2 latency: testes as reservoir (edit) |
10.24875/GMM.20000295 |
| 2020-01-01 |
Role of SARS-CoV-2 neurotropism and neuroinvasion in COVID-19 patients disease severity (edit) |
10.24875/GMM.20000307 |
| 2020-01-01 |
COVID-19: implications of SARS-CoV-2 in Colombia (edit) |
10.24875/GMM.20000289 |
| 2020-01-01 |
Gaceta Médica de México in SARS-CoV-2 pandemic times (edit) |
10.24875/GMM.M20000395 |
| 2020-01-01 |
Challenges in the Management of Sickle Cell Disease During SARS-CoV-2 Pandemic (edit) |
10.1177/1076029620955240 |
| 2020-01-01 |
Proposed practice guidelines for burn centres in the context of the SARS-CoV-2 pandemic (edit) |
10.5114/AIT.2020.98299 |
| 2020-01-01 |
An infection-oriented approach for thoracic endovascular aortic repair in a SARS-CoV-2 positive patient. A case report (edit) |
|
| 2020-01-01 |
Recommendations of the Expert Group of the Polish Society of Gynecologists and Obstetricians regarding gynecological examination and treatment of a minor during the SARS-CoV-2 pandemic (edit) |
10.5603/GP.2020.0112 |
| 2020-01-01 |
The Sars-Cov-2 Pandemic and the Brave New Digital World of Environmental Enrichment to Prevent Brain Aging and Cognitive Decline (edit) |
10.14283/JPAD.2020.39 |
| 2020-01-01 |
Reducing transmission of SARS-CoV-2 in ophthalmology with nasal and oral decontamination (edit) |
10.1177/2515841420951392 |
| 2020-01-01 |
How do arbidol and its analogs inhibit the SARS-CoV-2? (edit) |
10.4149/BLL_2020_115 |
| 2020-01-01 |
Ingavirin might be a promising agent to combat Severe Acute Respiratory Coronavirus 2 (SARS-CoV-2) (edit) |
|
| 2019-05-20 |
Genussgeschichten in Zeiten von Corona? (edit) |
|
| 2019-01-04 |
COULD NOVEL CORONA VIRUS (SARS-CoV-2) BE THE EVOLVING FACE OF A NEWGENERATIONOFGENETICALLYCOMPLEXEPIDEMIOLOGICALCHALLENGE? (edit) |
10.31674/MJMR.2019.V04I02.001 |
|
Origin, evolution and global spread of SARS-CoV-2 (edit) |
10.5802/CRBIOL.29 |
|
What can we learn about SARS-CoV-2 prevalence from testing and hospital data? (edit) |
|
|
Possible Human-to-Dog Transmission of SARS-CoV-2, Italy, 2020 (edit) |
10.3201/EID2707.204959 |
|
SARS-CoV-2 infects cells after viral entry via clathrin-mediated endocytosis (edit) |
10.1016/J.JBC.2021.100306 |
|
SARS-CoV-2 B.1.617 mutations L452 and E484Q are not synergistic for antibody evasion (edit) |
|
|
LitCovid (edit) |
|
|
The feasibility of targeted test-trace-isolate for the control of SARS-CoV-2 variants (edit) |
10.12688/F1000RESEARCH.51164.1 |
|
Increase of SARS-CoV-2 RNA load in faecal samples prompts for rethinking of SARS-CoV-2 biology and COVID-19 epidemiology (edit) |
10.12688/F1000RESEARCH.52540.3 |
|
The chaperone GRP78 is a host auxiliary factor for SARS-CoV-2 and GRP78 depleting antibody blocks viral entry and infection (edit) |
10.1016/J.JBC.2021.100759 |
|
Inhibition of acid sphingomyelinase by ambroxol prevents SARS-CoV-2 entry into epithelial cells (edit) |
10.1016/J.JBC.2021.100701 |
|
Cytokine Signature Induced by SARS-CoV-2 Spike Protein in a Mouse Model (edit) |
10.3389/FIMMU.2020.621441 |
|
GESS (edit) |
|
|
Ensembl COVID-19 resource (edit) |
|
|
SCoV2-MD (edit) |
|
|
VarEPS (edit) |
|
|
Glucosylceramide synthase inhibitors prevent replication of SARS-CoV-2 and influenza virus (edit) |
10.1016/J.JBC.2021.100470 |
|
PANORAMIC (edit) |
|
|
Between Plague and Corona. Epidemics in the past and present (edit) |
|
|
Annotating Protein Structures for Understanding SARS-CoV-2 Interactome (edit) |
|
|
Investigation of SARS-CoV-2 seroprevalence in relation to natural infection and vaccination between October 2020 and September 2021 in the Czech Republic: a prospective national cohort study (edit) |
10.1136/BMJOPEN-2022-068258 |
|
Function and Safety Study of SARS-CoV-2 Synthetic Minigene Vaccines (edit) |
|
|
Anti-SARS-CoV-2 Inactivated Convalescent Plasma in the Treatment of COVID-19 (edit) |
|
|
Multicenter Study on Nosocomial Transmission of SARS-CoV-2 Virus (edit) |
|
|
Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) to Prevent SARS-CoV-2 Infection (edit) |
|
|
Stem Cell Educator Therapy Treat the Viral Inflammation Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (edit) |
|
|
The Use of PUL-042 Inhalation Solution to Reduce the Severity of COVID-19 in Adults Positive for SARS-CoV-2 Infection (edit) |
|
|
Acute Respiratory Failure and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Real Life (edit) |
|
|
Norway's Corona Law (edit) |
|
|
Coronavirus Tech Handbook (edit) |
|
|
COVIDTESTS - Rapid and affordable Point-of-Care diagnostics for SARS-CoV-2 virus and COVID-19 diagnosis and management (edit) |
|
|
Consenso colombiano de atención, diagnóstico y manejo de la infección por sars-cov-2/covid-19 en establecimientos de atención de la salud - recomendaciones basadas en consenso de expertos e informadas en la evidencia (edit) |
10.22354/IN.V24I3.851 |
|
Norwegian Coronavirus Disease 2019 Study (edit) |
|
|
The Vietnam Chloroquine Treatment on COVID-19 (edit) |
|
|
REDUCING HEALTH CARE WORKERS ABSENTEEISM IN SARS-CoV-2 PANDEMIC THROUGH BACILLUS CALMETTE-GUÉRIN VACCINATION, A RANDOMIZED CONTROLLED TRIAL (edit) |
|
|
Chemoprophylaxis of SARS-CoV-2 Infection (COVID-19) in Exposed Healthcare Workers (edit) |
|
|
Comparison Of Therapeutics for Hospitalized Patients Infected With SARS-CoV-2 In a Pragmatic aDaptive randoMizED Clinical Trial During the COVID-19 Pandemic (COVID MED Trial) (edit) |
|
|
A Longitudinal Study of SARS-CoV-2 Positive Patients Testing Nasal Swabs and Collecting Blood Samples for Research (edit) |
|
|
In-depth Immunological Investigation of COVID-19. (edit) |
|
|
Convalescent Plasma to Limit Coronavirus Associated Complications (edit) |
|
|
Sero-epidemiological Study of the SARS-CoV-2 Virus in France: Constitution of a Collection of Human Biological Samples (edit) |
|
|
Efficacy and Safety of Emapalumab and Anakinra in Reducing Hyperinflammation and Respiratory Distress in Patients With COVID-19 Infection. (edit) |
|
|
Efficacy and Safety Human Coronavirus Immune Plasma (HCIP) vs. Control (SARS-CoV-2 Non-immune Plasma) Among Adults Exposed to COVID-19 (edit) |
|
|
Expanded Access Treatment Protocol: Remdesivir (RDV; GS-5734) for the Treatment of SARS-CoV2 (CoV) Infection (edit) |
|
|
Anti-il6 Treatment of Serious COVID-19 Disease With Threatening Respiratory Failure (edit) |
|
|
Colchicine Coronavirus SARS-CoV2 Trial (edit) |
|
|
Biomarkers for Identification of SARS-COV-2 Infection (edit) |
|
|
Factors Associated With a Positive SARS-CoV-2 Serology in Contact Subjects at High/Moderate Risk of Coronavirus SARS-CoV-2 Infection (CoV-CONTACT-SERO) (edit) |
|
|
Behavior, Environment And Treatments for Covid-19 (edit) |
|
|
The Efficacy of Different Anti-viral Drugs in (Severe Acute Respiratory Syndrome-Corona Virus-2) SARS-CoV-2 (edit) |
|
|
Impact of Swab Site and Sample Collector on Testing Sensitivity for SARS-CoV-2 Virus in Symptomatic Individuals (edit) |
|
|
Acute Encephalopathy in Critically Ill Patients With SARS-Cov-2 Infection (edit) |
|
|
COVID-19 Patients Characterization, Biobank, Treatment Response and Outcome Predictor (edit) |
|
|
COVID-19: Healthcare Worker Bioresource: Immune Protection and Pathogenesis in SARS-CoV-2 (edit) |
|
|
Predictors of Respiratory Failure in SARS-Cov-2 Infection (edit) |
|
|
Randomized, Controlled, Double-blind Clinical Trial Comparing the Efficacy and Safety of Chemoprophylaxis With Hydroxychloroquine in Patients Under Biological Treatment and / or JAK Inhibitors in the Prevention of SARS-CoV-2 Infection (edit) |
|
|
Hydroxychloroquine as Post Exposure Prophylaxis for SARS-CoV-2(HOPE Trial) (edit) |
|
|
EPICOS Clinical Trial for the Prevention of Infection in Healthcare Personnel (edit) |
|
|
Hydroxychloroquine to Prevent Covid19 Pneumonia (ALBERTA HOPE-Covid19) (edit) |
|
|
Efficacy and Safety of Hydroxychloroquine and Azithromycin for the Treatment of Hospitalized Patients With Moderate to Severe COVID-19 (edit) |
|
|
ACE Inhibitors or ARBs Discontinuation in Context of SARS-CoV-2 Pandemia (edit) |
|
|
Hydroxychloroquine for COVID-19 PEP (edit) |
|
|
Corona in Bayern (edit) |
|
|
COVID-19 in Patients With HIV (edit) |
|
|
Prospective Study in Patients With Advanced or Metastatic Cancer and SARS-CoV-2 (COVID-19) Infection (edit) |
|
|
Morbidity and Mortality Due to Deferral of Aortic Valve Replacement in Patients With Severe Aortic Stenosis (edit) |
|
|
Cell Therapy Using Umbilical Cord-derived Mesenchymal Stromal Cells in SARS-CoV-2-related ARDS (edit) |
|
|
Safety in Convalescent Plasma Transfusion to COVID-19 (edit) |
|
|
Study Testing Convalescent Plasma vs Best Supportive Care (edit) |
|
|
Clinical Trial of Combined Use of Hydroxychloroquine, Azithromycin, and Tocilizumab for the Treatment of COVID-19 (edit) |
|
|
COVID-19 Biological Samples Collection (edit) |
|
|
Survey of the Anxiety Associated With the SARS-CoV-2 Pandemic (edit) |
|
|
Kekulés Corona Compass (edit) |
|
|
CoroNAT: Coronavirus neuraliserende antistof terapi (edit) |
|
|
COVID-19 dataset (edit) |
|
|
SARS-CoV-2-Queries (edit) |
|
|
Nextstrain's Genomic epidemiology of novel coronavirus - Global subsampling dashboard (edit) |
|
|
Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine induces equivalent preclinical antibody titers and viral neutralization to recovered COVID-19 patients (edit) |
10.1101/2020.04.22.055608 |
|
COVID-19 Disease Map (edit) |
10.17881/COVID19-DISEASE-MAP |
|
Association Between BMI and SARS-CoV-2 (edit) |
|
|
Dose-Confirmation Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1273 COVID-19 Vaccine in Adults Aged 18 Years and Older (edit) |
|
|
LSE COVID-19 Blog (edit) |
|
This SPARQL query is available under CCZero.